                                        

       Science-Based Medicine Reviews: Politics, MAHA & The Right to Try

           A Critical Guide for the Health Practitioner and Consumer 

                                  2025 Edition

                                        

                       Executive Editor Steven Novella MD

                      Managing Editor David Gorski MD PhD

                         Series Editor Mark Crislip MD

                                 Introduction 

                                 Steven Novella

The world of health care is becoming an increasingly complex and challenging
place. The internet is changing the way we generate and access information, and 
health information is one of the most popular uses of the internet. It
represents an unprecedented democratization of information and opinion. 

While there are many advantages and benefits to such information access, there
are also many challenges to health professionals, regulators, academics, and
consumers. There is a proliferation of health related products and services,
with many provocative health claims. Regulations are generally not keeping up,
and often have been watered down, in the face of this onslaught of claims and
products. 

The consumer is left with an overwhelming array of health claims, many of which 
challenge and even directly oppose the traditional experts and institutions. 

The mission of Science-Based Medicine (SBM) is to be a source of reliable
information and analysis to help navigate the wild west of health information on
the internet and elsewhere. The authors who contribute to this series of
e-books are all physicians and other health care professionals who have a great 
deal of experience educating the public about complex medical issues.  We
especially take on controversial issues and try to expose pseudoscience and
fraud wherever possible.

The Philosophy of Science-Based Medicine

The philosophy of SBM, at its core, is simple: Safe and effective health care is
critical to everyone’s quality of life; so much so that it is generally
considered a basic human right. Therefore, health care products and services
that work and are safe are better than those that do not work or are unsafe. 

The best method for determining which interventions and health products are safe
and effective is, without question, good science. Therefore it is in everyone’s
best interest for health care to be systematically evaluated by the best
science available.

Too often the nature of science itself is misunderstood or misrepresented to the
public. Science is not an arcane and privileged discipline. By its very nature 
it is meant to be transparent and public. Science is nothing more than a
systematic and careful use of evidence and logic to evaluate factual claims. And
good science possesses certain virtues that are not unique to science but
generic to all intellectual endeavors: fairly accounting for all available
evidence, using valid and internally consistent logic, using unambiguous
concepts and language, proper use of statistics, being quantitatively precise
and accurate, and above all being honest.

And yet there are numerous and powerful influences in society that strongly
appose the scientific basis of medicine. Driven by some combination of ideology 
or the desire for profit they wish to eliminate standards of science in health
care, or (often under the guise of “health care freedom”) create a double
standard in which unscientific methods and products can thrive unchecked. Others
simply lack the training or knowledge to achieve minimal standards of quality
for scientific medicine. And even the best traditions of scientific medicine can
benefit from more critical analysis.

Recognition of the need for careful scientific analysis in medicine partly stems
from a recognition that it is very difficult (almost impossible) to reliably
assess treatments anecdotally. Human perception, memory, and cognition are prone
to a host of flaws, weaknesses, and biases that will tend to mislead us,
especially towards conclusions that we wish to be true. Placebo effects,
confirmation bias, and simple statistics can make any intervention seem
effective, even when they are worthless or harmful. 

Science-Based Medicine vs Evidence-Based Medicine

Within the practice of medicine there is already a recognition of the need to
raise the standards of evidence and the availability of the best evidence to the
practitioner and the consumer – formalized in the movement known as
evidence-based medicine (EBM). 

EBM is a vital and positive influence on the practice of medicine, but it has
its limitations. EBM tends to focus on clinical trial results to the exclusion
of scientific plausibility. The focus on trial results (which, in the EBM
lexicon, is what is meant by “evidence”) has its utility, but fails to properly 
deal with medical modalities that are highly implausible, or seem to defy
well-established findings in science.

All of science describes the same reality, and therefore it must (if it is
functioning properly) all be mutually compatible. Collectively, science builds
one cumulative model of the natural world. This means we can make rational
judgments about what is likely to be true based upon what is already well
established. This does not necessarily equate to rejecting new ideas
out-of-hand, but rather to adjusting the threshold of evidence required to
establish a new claim based upon the prior scientific plausibility of the new
claim. Failure to do so leads to conclusions and recommendations that are not
reliable, and therefore medical practices that are probably not safe and
effective.

The SBM Series

This is why the authors of this series strongly advocate for science based
medicine – the use of the best scientific evidence available, in the light of
our cumulative scientific knowledge from all relevant disciplines, in evaluating
health claims, practices, and products. 

Some of the articles here will analyze individual studies, and explore the
strengths and weaknesses of their methods, separating what the study really
tells us from how it may be represented in the media. Other articles will
summarize what many studies tell us about a specific medical question. 

We will also explore health information on the internet, separating out which
information is reliable from that which is misleading, erroneous, or possibly
even fraudulent. Likewise we will critique mainstream media coverage of health
topics, giving the reader specific tools for to critically analyze health
information for themselves.

Other articles will explore topics related to health regulation and academia.
Regulations have struggled to keep up with the rapidly changing health care
market place, with critical gaps that leave the health care consumer responsible
for their own protection. Academic institutions themselves, long the defenders 
of high standards of scholarship in all fields, including medicine, have been
infiltrated by promoters of pseudoscientific belief systems. The result is that 
there is no longer any single reliable guarantee of scientific integrity. 

The SBM series of e-books is organized by topic, such as acupuncture,
chiropractic, homeopathy, and many others.  The books are collections of essays,
not intended to be a systematic reference, but rather to explore the various
scientific issues related to each topic. The goal is to give the reader critical
thinking skills and a deeper understanding of, not just the current findings of
science, but the process of science, specifically how it relates to health care
and the topic of each book. 

Science-based medicine can serve as your pocket guide through the wilderness of 
health information.

As of 2025, there are over 5000 essays on the Science Based Medicine website. I 
do no know about you, but I find it difficult to find any post I wrote, much
less one written by another contributor. 


So I have updated the books  and include almost all the articles through 2025.
The volumes are


CAM Concepts

Chiropractic

COVID 

Critical Thinking

Diet and Nutrition

Ethics and CAM

Herbs, Supplements, and Diet

Homeopathy

Infections and Immunity

Law and CAM

Media and Internet

Medicine, Public Health, Dentistry and Pediatrics

Miscellaneous CAM

Naturopathy

Neurology and Psychiatry

Placebo

Quackademic Medicine

Regulation. FDA and FTC

SBM or EBM

Stem Cells, Genetics, AI and Gender

Supplements, Vitamins and Herbs

Vaccine & Anivax

Vaccines and Autism

Vaccines and Preventable Infections


The articles are roughly organized by publication date and topic. Many articles 
will be in multiple volumes as an essay of, for example, chiropractic and law
will be found in both the chiropractic volume and the law volume.


You may find the organization a bit odd. I do. But 4700 plus articles are
difficult to organize and I have more to do in my retirement than work of these 
volumes.


Still, if you find I have missed a nentry or some glaring error, drop me a note 
and I will fix it for the next edition.


About the authors

Steven P. Novella, MD – Founder and Executive Editor Science Based Medicine.

Founder and currently Executive Editor of Science-Based Medicine Steven Novella,
MD.

David H. Gorski, MD, PhD – Managing Editor. Science Based Medicine.

Mark A. Crislip, MD. Editor, Science Based Medicine Guides. 

He did he editing of all the volumes so is to blame for any mistakes.

As to all the other contributors, if you are interested click on the ‘Link’ at
top of each essay to go the SBM site, where further information about each
author can be found.

A Note On References


The chapters in this book were originally blog entries at
ScienceBasedMedicine.org.

Blog and web pages lend themselves to hyperlinks to sources and references that 
are tedious to translate into footnotes for this ebook.

Under the title of each essay is a hyperlink, cleverly titled ‘Link’, to the
original blog entry with all the hyperlinks and references, as well as the
comments to the blogs, which often have interesting and thoughtful insights by
our readers, as well as some curious comments by the not so thoughtful.

Graphs, tables and links to videos are not in included these essays due to
issues of copyright and permission.  However, thanks to the ‘Link’, the graphics
are a click away.

Thanks for reading the site.

Mark Crislip  

Right to Try

Dr. Who?

Jann Bellamy on May 2, 2013

Link

If the “Health Freedom” movement has its way, everyone in the United States will
be able to practice medicine. It may be quack medicine but that doesn’t seem to
bother them. Short of that, chiropractors, naturopaths and acupuncturists are
aiming to reinvent themselves primary care providers and even physicians. As
David Gorski pointed out, this will reduce medical doctors to just another
iteration of physician, the “allopathic” type, equal in stature to the
chiropractic, naturopathic and acupuncture types. These “physicians” already
call themselves “doctor” (e.g., “Doctor of Oriental Medicine”) and claim to
graduate from four-year “doctoral” programs. This despite the fact that their
schools operate outside the mainstream American university system and avoid some
of the basics of typical graduate programs, such as entrance exams, as well as 
the extensive clinical training required for medical doctors.

Consumers are confused by all of this, and who wouldn’t be? In 2008 and 2010,
surveys done for the American Medical Association by outside firms revealed that
many patients did not know the qualifications of their healthcare provider. The
comparisons were between allied health professions (e.g., audiologists and
nurse practitioners) and medical doctors, but chiropractors were included. In
2008, 38 per cent of those surveyed (n=850) thought chiropractors were medical
doctors, although that dropped to 31 per cent in 2010. Still, we are talking
about roughly one-third of the survey participants.

The surveys also asked about the use of the term “physician” and confusion in
advertising materials.

(Sorry, my visual aids are not as titillating as Dr. Gorski’s, but I couldn’t
find any Penthouse covers relevant to this topic.)

Etiquette weighs in: a digression

Before we go any further, let’s digress into a topic raised in the comments of a
previous post: who should use the title “Doctor,” at least in what is referred 
to somewhat quaintly as “social settings.” But first, a disclaimer: This advice 
only applies to the United States. Your country may have a totally different set
of rules.

I consulted the experts on this, that is, the etiquette experts, people no one
pays much attention to anymore. I found what is known in the legal field as a
“split of authority.” Miss Manners (Judith Martin) says “Dr.” should be reserved
for those in the medical profession, although she also thinks people should be 
called what they want to be called. So, if someone insists, then “Dr.” it is. On
the other hand, Letitia Baldridge, who served as social secretary to Jacqueline
Kennedy Onassis when she was first lady, is (or was, she passed away last year)
of the opinion that your academic title is also your social setting title.
Emily Post sides with Miss Manners. In social settings, she advises one start
with by addressing both Ph.Ds and medical doctors as “Dr.” and if the former
prefer some other title, they will tell you.

So now you know.

Truth in Healthcare Marketing

A bill introduced in the U.S. House of Representatives, with bipartisan support,
aims to clear things up in the professional, if not social, setting. H.R. 1427,
the “Truth in Healthcare Marketing Act,” would prohibit any “deceptive or
misleading” statement or act that “misrepresents” a person’s “education,
training, degree, license or clinical expertise.” If H.R. 1427 becomes law, such
misrepresentations would be a violation of the Federal Trade Commission Act,
which prohibits, among other things, any unfair or deceptive advertising or
marketing practice.

Under the proposed Act, the information must be deceptive or misleading, but the
bill also specifies that it must “misrepresent” the education, training,
degree, license or clinical expertise. But if information is deceptive or
misleading, I would argue that it by definition it “misrepresents” so I am not
clear whether, as a practical matter, that is an additional requirement or not.

In any event, misrepresentation of a license or degree should be pretty clear
cut, but I’m not sure where the boundaries might fall around misrepresentation
of one’s education, training, or clinical expertise. Of course, there are always
the egregious cases, like the Colorado chiropractor claiming to be an
endocrinologist whose treatments could “reverse diabetes.” Having a wimpy
chiropractic board administer a delicate wrist slap is one thing; having the
Feds after you is quite another.

As we’ve noted on SBM, both naturopaths and chiropractors claim their education 
and training is sufficient to practice as a primary care physician. They promote
the idea that their schools offer an education that is either the equivalent
of, or close to, that of a medical doctor. A chart handed out by naturopaths in 
support of their Colorado licensing bill claims they have more hours of
education in pharmacology than medical doctors. And a chart published by the
American Chiropractic Association (ACA), posted below, purports to show that
chiropractic students have more combined classroom and clinical hours than
medical students. (The ACA made similar overblown statements in a brief filed
with a Colorado court.) Assuming these claims are made in a context otherwise
covered by the Act (such as advertising by a chiropractor) would representations
like this pass muster under the proposed “Truth in Healthcare Marketing Act of 
2013”?

Let’s look at a description of chiropractic education from the American
Chiropractic Association’s website. [Emphasis added.]

   Chiropractic Education

   Educational requirements for doctors of chiropractic are among the most
   stringent of any of the health care professions.

   The typical applicant at a chiropractic college has already acquired nearly
   four years of pre-medical undergraduate college education, including courses 
   in biology, inorganic and organic chemistry, physics, psychology and related 
   lab work. Once accepted into an accredited chiropractic college, the
   requirements become even more demanding — four to five academic years of
   professional study are the standard. Because of the hands-on nature of
   chiropractic, and the intricate adjusting techniques, a significant portion
   of time is spent in clinical training.

   Doctors of chiropractic — who are licensed to practice in all 50 states, the 
   District of Columbia, and in many nations around the world — undergo a
   rigorous education in the healing sciences, similar to that of medical
   doctors. In some areas, such as anatomy, physiology, and rehabilitation, they
   receive more intensive education than most medical doctors or physical
   therapists.

   Like other primary health care doctors, chiropractic students spend a
   significant portion of their curriculum studying clinical subjects related to
   evaluating and caring for patients. Typically, as part of their professional
   training, they must complete a minimum of a one-year clinical-based program 
   dealing with actual patient care. In total, the curriculum includes a minimum
   of 4,200 hours of classroom, laboratory and clinical experience. [Then why
   does the chart say 4820?]  The course of study is approved by an accrediting 
   agency which is fully recognized by the U.S. Department of Education. This
   has been the case for more than 25 years.

   Before they are allowed to practice, doctors of chiropractic must pass
   national board examinations and become state-licensed. Chiropractic colleges 
   also offer post-graduate continuing education programs in specialty fields
   ranging from sports injuries and occupational health to orthopedics and
   neurology. These programs allow chiropractors to specialize in a healthcare
   discipline or meet state re-licensure requirements.

   This extensive education prepares doctors of chiropractic to diagnose health 
   care problems, treat the problems when they are within their scope of
   practice and refer patients to other health care practitioners when
   appropriate.

[Hmmm. The ACA says that “intricate adjusting techniques” are taught in
chiropractic college as part of the “significant portion of time” spent in
clinical training? And what do chiropractors “adjust”? Subluxations! So much for
the claims that detecting and correcting subluxations is not emphasized and is 
taught only as a historical concept in chiropractic schools.]

Misleading or deceptive?

Before we parse this description, note some of the relevant criteria by which
the information is judged under the FTC Act.

  1. No intent to deceive must be present. Innocent misrepresentations are covered 
    by the FTC Act.

  2. How an average or unsophisticated person, not the expert, would view the
    information is the standard. Would it mislead an average consumer?

  3. The information is looked at as a whole and can be deemed deceptive even
    though the individual statements made are literally true.

  4. The claims made must be material to the consumer, that is, the information
    must be important to consumers and likely to affect their choice of, or
    conduct regarding, a product or service.

It is interesting to note that the ACA’s discussion of chiropractic education
may be, for the most part, literally true. (Although I seriously doubt that the 
chiropractic student’s education in anatomy or physiology is more “intensive”
than that of a medical student, especially considering their narrow focus on the
musculoskeletal system.) But, as we know, literal truth is not the standard. We
have to look at the information taken as a whole.

Here is where I think the information might be deceptive or misleading as
interpreted by the average consumer who would consider a health care provider’s 
education to be important but who is not familiar with the health professional
educational system. Those more familiar with medical education can likely add to
my observations.

  1. Hours and calendar years are used to compare education, when in fact the
    number of hours or years is not an indication of quality or rigor. (By this 
    standard, elementary school is more demanding than college.) Nor are
    classroom and clinical hours inclusive of all time spent in learning. What
    about time spent in independent research?

  2. While the chart notes the years spent in residency are not included, failing
    to count those leaves out a substantial and important difference between
    chiropractic and medical education.

  3. There is no mention of the chiropractic student’s focus on the musculoskeletal
    system or the fact that medical students have far more education in any
    number of subjects, such as pharmacology, primary care, and pediatrics as
    well as the body’s other systems, such as cardiovascular and reproductive.
    Nor do chiropractic students have clinical training in a variety of
    specialties.

  4. There is no mention of the focus on the musculoskeletal system in actual
    chiropractic practice. In fact, chiropractors are referred to as primary
    health care practitioners.

  5. The mention of “post-graduate” educational programs leading to “specialties,” 
    fails to note that these are mostly limited to courses taken over a number
    of weekends with little (perhaps no) actual clinical training.

My conclusion is that this description viewed as a whole would leave the average
consumer with the false impression that chiropractic education is equal in
rigor and breadth to a medical education and qualifies graduates to practice as 
primary care physicians. Under federal law, this need not be the only
interpretation possible to violate the FTC Act, but it is certainly one a
reasonable consumer could reach. Again, about one third of survey participants
actually thought chiropractors are medical doctors. To the extent that
chiropractors use similar information in their advertising and other
communications with the public they would be vulnerable to suits claiming
violation of the FTC Act.

But that’s not all.

The bill also requires the FTC to undertake a study of healthcare professionals 
to:

  1. Identify acts and practices constituting a violation of the new law, their
    frequency, and instances of harm or injury caused.

  2. Determine whether health care professionals are complying with state laws
    requiring disclosure of the type of license they hold.

  3. “Identify instances where any State public policy has permitted acts and
    practices which violate section 3(a),” the section prohibiting deceptive or 
    misleading statements, discussed above.

I, for one, will be more than happy to “identify . . . State policy” permitting 
these deceptive practices. For instance:

  1. Licensing chiropractors, naturopaths and acupuncturists as primary care
    providers, either explicitly or de facto through wide scopes of practice.

  2. Effectively giving out licenses to practice quackery by permitting such
    practices as the “detection” and “correction” of subluxations, prescribing
    homeopathic “remedies,” iridology, cranial sacral therapy, energy healing . 
    . . well, I could go on and on. I will quote state laws and regulations,
    chapter and verse.

  3. Allowing self-regulation (including the right to write their own regulations) 
    through the creation of state board dominated by “CAM” practitioners. Once
    these practitioners are governed by their own boards, which have exclusive
    jurisdiction to discipline them, it is difficult to hold them accountable.

  4. Blindly accepting, lock, stock and barrel, whatever education, testing,
    certification, training, continuing education, and the like these
    practitioners chose to create for themselves without any outside scrutiny
    (other than the Department of Education accrediting agency requirements,
    which reject science as an appropriate standard for health care education).

If done properly, this report could be at least a PR disaster for CAM providers.
(Or not. Government reports about problems with dietary supplements do not seem
to have tempered the public’s enthusiasm for supplements.) And it might even
embarrass some states into actually instituting reforms, such as, say, a single,
science-based standard for all health care practitioners.

If H.R. 1427 becomes law, I’ll be sitting by the computer, Federal Trade
Commission, waiting for your e-mail. You can reach me through the SBM website.

“Right to try” laws and Dallas Buyers’ Club: Great movie, terrible for patients 
and terrible policy

“Right-to-try” is a new kind of bill that claims to give terminally ill patients
the “right to try” experimental therapeutics that have passed phase 1 testing. 
It’s a smokescreen, no more real than the movie that seemingly inspired it.

David Gorski on March 8, 2014

Link

One of my favorite shows right now is True Detective, an HBO show in which two
cops pursue a serial killer over the course of over 17 years. Starring Woody
Harrelson and Matthew McConaughey, it’s an amazingly creepy show, and
McConaughey is amazing at playing his character, Rustin Cohle. I’m sad that the 
show will be ending tomorrow, but I really do want to see how it ends.

Unfortunately, as much as I like Matthew McConaughey as an actor, he is in part 
responsible for re-inspiring a movement that has the potential to do profound
harm to patients and cancer research. That’s because his other big role over the
last year has been in an Oscar-nominated movie, Dallas Buyers Club, where he
plays Ron Woodroof, an early AIDS patient who in the 1980s smuggled unapproved
pharmaceutical drugs into Texas when he thought he found them effective at
alleviating his symptoms, distributing them to fellow sufferers by establishing 
the “Dallas Buyers Club” while battling the FDA. I haven’t seen the movie, and I
really don’t want to, given that, from everything I’ve heard about it, it’s
basically the story of a “brave maverick” who bucks the FDA, complete with all
the tropes about indifferent bureaucrats who don’t care if these brave patients 
die. That might not be so bad if it weren’t also riddled with inaccuracies and
misinterpretations of the AIDS crisis in the 1980s. Worse, the real Woodruff
rejected the one truly promising drug at the time, AZT, as hopelessly toxic and 
instead smuggled drugs like Peptide T, which never panned out. Basically, what
Woodruff appears to have smuggled as part of his activities for the “Dallas
Buyers Club” was a mixture of useless supplements, experimental drugs that were 
never approved, and a handful of experimental drugs that showed promise.
Meanwhile, the movie portrays the FDA as the implacable enemy of these sorts of 
activities, jackbooted thugs not unlike the stereotype promoted by “health
freedom” quacks who don’t like the FDA preventing them from selling their
quackery. As far as I can tell without actually seeing the movie, the overall
message is a typical uplifting story of an underdog who fights the power and in 
doing so finds redemption.

Of course, Dallas Buyers Club is just a movie, no matter how good a movie it
might be and no matter how much Matthew McConaughey might have deserved an Oscar
for his performance. Unfortunately, it appears that legislators in several
states seem to think that it should serve as a template for health policy. This 
public policy, which is extremely bad policy and is being considered and
promoted in four different states, comes in the form of bills known as “right to
try” bills. Basically, “right to try” bills, if passed into law, would grant
terminally ill patients the right to have access to experimental therapies.
According to these laws, the drugs need only have passed phase I trials. Now,
remember, phase I trials do not demonstrate efficacy. They are only designed to 
test for safety and toxicity, determine the maximum tolerated dose, and provide 
an estimate for the dose to use in real clinical trials. The concept of “right
to try” bills is highly popular, because if you don’t know a lot about medicine 
and how clinical trials work it sounds like a good idea What could be the
possible harm, after all? A lot, it turns out, but I’ll get to that in a moment.
First, let’s take a look at the rationale for Arizona’s “right to try” bill,
which is being promoted by the Goldwater Institute:

Arizona legislators are poised to green-light legislation in committee Thursday 
that would pave the way for terminally ill patients to access experimental drugs
not yet cleared for market. Known as the “Right to Try” Act, similar bills are 
currently being considered by lawmakers in Colorado, Louisiana and Missouri, and
legislators in California and Massachusetts have expressed interest.

Designed by the Goldwater Institute, the Right to Try Act would enable
terminally ill patients who have exhausted all of their available treatment
options to access experimental drugs that have been deemed safe but whose
efficacy has yet to be determined. Under the current system, even after an
investigational drug has passed the Food and Drug Administration’s Phase I (the 
testing phase during which safety is established), it can take an additional six
or more years for the drug to be approved for market–even if clinical trials
are yielding promising results.

And while many patients facing terminal illness attempt to get into those
clinical trials, the vast majority cannot, because they are too far along in
their illnesses or because of other factors. 40% of cancer patients pursue
admission into clinical trials, but only 3% succeed. Last year, more than
500,000 Americans died from cancer alone.

According to Christina Corieri, a health care policy analyst at the Goldwater
Institute, the tragedy is that many of the drugs terminal patients can’t access 
today will be saving the lives of future patients just a few years from now.

“The sickest Americans don’t have the luxury of time to wait for these drugs to 
come to market through the traditional process,” said Corieri. “The Right to Try
Act puts the decision about whether to try an experimental treatment back where
it belongs: in the hands of patients and their doctors.”

This is, of course, partially true. There is always an inherent conflict between
wanting to push for faster approval of drugs in order to treat patients who are
dying now and the need for rigorous testing to assure safety, so that more
patients aren’t harmed than helped. Patients and their families ask, “What’s the
harm?” while advocates like Corieri sell their policy with the assumption that 
experimental drugs are highly likely to help these patients, or at least not so 
unlikely as not to be worth trying. Here’s the problem. Just because a drug has 
passed phase I trials does not mean that it is effective. It does, however,
frequently mean that the drugs have significant side effects. Indeed,
determining those adverse events is part of the entire reason that we do
clinical trials in the first place.

“Right to try” laws versus science

The “right to try” bill currently being considered in Arizona follows the
template for such bills that are metastasizing to other states, such as
Colorado, so I’ll look at it first. The text of the bill is available online.
The major provisions of the bill includes the following definition of an
eligible patient:

1. “ELIGIBLE PATIENT” MEANS A PERSON WHO MEETS ALL OF THE FOLLOWING:(a) HAS A
TERMINAL ILLNESS.(b) HAS CONSIDERED ALL OTHER TREATMENT OPTIONS CURRENTLY
APPROVED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION.(c) HAS RECEIVED A
PRESCRIPTION OR RECOMMENDATION FROM THE PERSON’S PHYSICIAN FOR AN
INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE.(d) HAS GIVEN WRITTEN
INFORMED CONSENT FOR THE USE OF THE INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR 
DEVICE OR, IF THE PATIENT IS A MINOR OR LACKS THE MENTAL CAPACITY TO PROVIDE
INFORMED CONSENT, A PARENT OR LEGAL GUARDIAN HAS GIVEN WRITTEN INFORMED CONSENT 
ON THE PATIENT’S BEHALF.(e) HAS DOCUMENTATION FROM THE PERSON’S PHYSICIAN THAT
THE PERSON HAS MET THE REQUIREMENTS OF THIS PARAGRAPH.

The bill defines an “investigational” drug as a drug that’s passed phase I
trials but is not yet FDA-approved. The bill doesn’t require manufacturers of an
investigational drug to make it available, but basically allows them to do so
if they so choose. Tellingly, the bill also doesn’t require that the
manufacturer provide the drug for free, as it must to patients undergoing
clinical trials in order to achieve FDA approval:

A. A MANUFACTURER OF AN INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE MAY
MAKE AVAILABLE THE MANUFACTURER’S INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR
DEVICE TO ELIGIBLE PATIENTS PURSUANT TO THIS ARTICLE. THIS ARTICLE DOES NOT
REQUIRE THAT A MANUFACTURER MAKE AVAILABLE AN INVESTIGATIONAL DRUG, BIOLOGICAL
PRODUCT OR DEVICE TO AN ELIGIBLE PATIENT.

B. A MANUFACTURER MAY:1. PROVIDE AN INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR 
DEVICE TO AN ELIGIBLE PATIENT WITHOUT RECEIVING COMPENSATION.2. REQUIRE AN
ELIGIBLE PATIENT TO PAY THE COSTS OF OR ASSOCIATED WITH THE MANUFACTURE OF THE
INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE.C. THIS ARTICLE DOES NOT
REQUIRE A HEALTH CARE INSURER TO PROVIDE COVERAGE FOR THE COST OF ANY
INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE. A HEALTH CARE INSURER MAY
PROVIDE COVERAGE FOR AN INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE.

And, to top it all off, the bill prohibits the state medical board (or any other
state regulatory board) from going after the license of any physician or health
care practitioner who recommends and/or administers such investigational agents
to patients while making any state official or employee who attempts to block
access of an eligible investigational drug to an eligible terminally ill patient
potentially guilty of a class 1 misdemeanor. If the bill passes both chambers
in Arizona, it would next go to the voters in November. My guess is that if the 
bill makes it onto the ballot this fall, it will likely pass. I can picture the 
ads now. They’ll feature cute, terminally ill children and brave adults battling
fatal diseases invoking their right to choose what goes into their body and
begging voters to “give them a chance to live” and asking, “What’s the harm?”
Against such images it will be hard for science-based medicine to prevail.

Currently, similar bills are wending their ways through the legislatures of
multiple states, including Colorado (of course!), Missouri (where legislators
recently listened to emotional testimony and the bill is sponsored by a
legislator, Jim Neely, whose daughter suffers from stage IV colon cancer), and
Louisiana, while states as disparate as Utah, Oklahoma, Massachusetts, and
California are showing early interest in such laws. The bills under
consideration are basically all based on the Goldwater Institute’s template
(indeed, the Arizona bill is almost verbatim the same), which is based on this
policy report available on the Goldwater Institute’s website, deceptively
entitled Everyone Deserves the Right to Try: Empowering the Terminally Ill to
Take Control of their Treatment.

The report itself is loaded with emotionally charged language about the FDA and 
terminally ill patients and highly dubious statements. For example, it’s hard
not to notice that every experimental drug is apparently “potentially
life-saving,” at least the ones that made it through phase I trials. There’s so 
much loaded language, coupled with so many dubious assertions, that I can only
hit the “high” points, such as they are. For instance, the Goldwater Institute
bemoans the expansion of FDA authority in the 1960s by the Kefauver-Harris
Amendments that required that the FDA not just require demonstration of safety
but of efficacy as well before approving new drugs. This expansion of FDA power 
was in reaction to the thalidomide debacle, leading the Goldwater Institute to
make the rather bizarre (OK, very bizarre) argument that because the issue with 
thalidomide was a safety problem, not an efficacy problem and because
thalidomide was never approved in the US (mainly due to the FDA, let’s not
forget), the expansion of FDA power in response to the thalidomide debacle was
“unwarranted.”

Another highly dubious argument follows:

Phase I involves administering the investigational drug to a small group of 20
to 80 volunteers to test for toxicity and immediately observable side effects.30
The major emphasis of Phase I testing is safety. Over 60 percent of
investigational drugs in Phase I testing are deemed safe enough to move on to
Phase II.

Seriously? Phase I trials can be as few as 20 patients. That is not enough to
determine safety, nor is it intended to. Phase I trials are designed primarily
to identify major side effects and to use a process known as dose escalation to 
determine what is commonly referred to as the “maximum tolerated dose.” It is
utterly impossible for such a small clinical trial to determine the safety of a 
drug, and even the Goldwater Institute inadvertently undermines its own
argument. Note how the report says that over 60% of investigational drugs pass
phase I testing and are determined to be “safe enough to move on to phase II.”
That’s the standard: No unexpected major adverse events and a side effect
profile that isn’t grossly more unsafe than the disease itself. Phase II and
Phase III trials are needed to confirm safety. That’s why the premature
diffusion of unapproved drugs has the potential to increase morbidity from
adverse events and even hasten death. One example is amonifide for treating
breast cancer. The drug made it through phase I trials, but serious
life-threatening hematologic toxicity emerged during phase II trials.

Think of phase I trials as a screening test looking for the most obvious
toxicities, with phase II and III studies confirming them. Indeed, even phase
III trials can’t always adequately demonstrate that a drug is safe; it’s not
uncommon for less common adverse effects not to show up until post-marketing
surveillance, when much larger numbers of patients receive the drug. Moreover,
only 5% of all cancer drugs that enter clinical testing are ultimately approved 
for patient use. Among drugs tested in phase II trials, only 30% go on to phase 
III.

The Goldwater Institute also doesn’t like the current expanded access programs, 
not because it doesn’t like expanded access programs, obviously. (After all,
what are “right to try” laws other than much more liberal expanded access
programs?) No, what the Goldwater Institute doesn’t like is the current system
because of all those nasty regulations. Under current law, the Food and Drug
Administration Modernization Act (FDAMA) of 1997, single patient INDs (we’re
discussed these before in the context of Stanislaw Burzynski patients), which
are basically compassionate use exemptions, can only be granted if:

  1. The patient’s physician determines the patient has no comparable or
    satisfactory alternative therapy;

  2. the FDA determines there is sufficient evidence of safety and effectiveness to
    support the use of the investigational drug;

  3. the FDA determines that provision of the investigational drug will not
    interfere with the initiation, conduct, or completion of clinical
    investigations to support marketing approval; and

  4. the sponsor or clinical investigator submits information sufficient to satisfy
    the IND requirements.

  5. the sponsor of the investigational drug must also be willing to supply the
    drug to the patient.

If all of these conditions are met, then the treating physician or drug sponsor 
submits an IND application, a proposed treatment plan, and a commitment to
obtain informed consent from the patient and permission from the Institutional
Review Board (IRB). No one denies that the process could be more streamlined.
The report lists some of the burdens of the IND process and bemoans the FDA’s
veto power over single patient INDs. What’s particularly disturbing about what
the Goldwater Institute advocates, though, is its attack on the FDA’s
requirement for a full IRB review of single patient IND applications as being a 
bad thing that keeps patients from accessing drugs. The language sounds as
though it could have been written by Stanislaw Burzynski himself. Particularly
Orwellian is the part of the report that demands that legislators must “act to
protect patients.” I don’t know about you, but I’m not sure how, basically,
stripping all restrictions on letting patients have access to drugs that have
passed only phase I trials “protects patients,” but then I’m not a libertarian.

The Goldwater Institute justifies its proposal through still more dubious
assertions. For instance, the report starts out with patient anecdotes in which 
patients with terminal cancers exhausted all conventional therapies and then
applied for experimental therapies, which they either couldn’t get or had to
wait too long to get. In each case, the stories are told in such a way as to
suggest that “if only” these patients had had access to experimental drugs
sooner they might have survived. This is, of course, nonsense. All these
patients had stage IV cancer. Barring the incredibly unlikely possibility that
an experimental drug is a miracle cure for advanced cancer even better than what
the quacks claim in Tijuana for their treatments, these unfortunate patients
would have died anyway. True, if the drug were effective, they might have gotten
a few more weeks or months, but they would have died. Using such stories is
nothing more than tugging at the reader’s heartstrings. It is not a good
scientific argument.

Actually, there isn’t a single good scientific argument in the entire report.
There’s a survey of orthopedic surgeons cited in which a majority of them have
said they thought that the slow FDA approval process had hurt patients. This is 
well-nigh meaningless for a discussion like this one because (1) most orthopedic
surgeons don’t take care of cancer patients (orthopedic oncology is a
subspecialty, and, fortunately, orthopedic malignancies are rare) and (2)
orthopedic surgeons are much bigger into medical devices than drugs. Moreover
this survey is bundled in a table with other with results of other surveys that 
range from 1995 to 2007. Finally, the reference cited is from the Competitive
Enterprise Institute, a free market “non-profit public policy organization
dedicated to advancing the principles of limited government, free enterprise,
and individual liberty.” I will admit that I’m a bit disappointed that between
68% and 73% of physicians would support a proposal to change FDA law so that
unapproved drugs or medical devices could be made available to physicians as
long as they carried a warning label about their unapproved status. Apparently, 
the physicians polled didn’t realize what a boon to pharmaceutical companies
this would be! Why bother with those pesky and expensive phase II and phase III 
trials if you could market your unproven drugs or medical devices direct to
doctors to use on patients after nothing more than a favorable phase I?

Unfortunately, the “right to try” movement is not limited just to the US. A
reader made me aware of a similar bill being promoted in the UK right now. Known
as the Medical Innovation Bill, this legislation was introduced into the House 
of Lords by Lord Maurice Saatchi, whose wife Josephine Hart died of cancer in
2011. While it’s easy to feel sympathy for Lord Saatchi, that doesn’t change how
misguided the Medical Innovation Bill is. The bill is similar to “right to try”
laws in that its ostensible purpose is to allow patients with terminal diseases
to undergo treatments that are experimental or unorthodox. It’s different in
the sort of tack it takes. First, Lord Saatchi seems obsessively focused on
shielding doctors who use unconventional treatments from liability for doing so,
even though malpractice suits are not nearly as big a concern for physicians in
the UK as they are in the US. (One UK physician described them to me as being
virtually “not an issue” for most docs in the UK.) That’s one difference.

Another difference is that Lord Saatchi’s bill doesn’t so much allow the use of 
experimental drugs outside of a clinical trial as to claim both to support
“innovation” and to “expose the maverick.” Supporting the bill, Lord Saatchi
claims that the “NHS predicts it will face a bill of up to £24 billion for legal
cases in the coming years, and the figure is rising,” but doesn’t say how many 
years or how much of that is due to doctors being sued for using unapproved
treatments for patients who are dying. My guess, but I don’t have the data, is
that that fraction is very, very small. Even in the US it’s pretty rare for
dying patients (or their families) to sue doctors who try unconventional
therapies on them. The other aspect of the bill is this:

Doctors will not be protected by the Saatchi Bill unless they go through a
rigorous and specific process to ensure that the attempted innovation is the
right course of action for the patient.

As the draft Bill states in paragraph 2 (3a) a doctor wishing to try a new
treatment – for example in the case where standard treatments aren’t working –
must consult a body of senior and relevant medical experts and get their
consent.

The doctor must also record their opinion, including and dissenting voices.

The decision of the panel of experts must then be presented to the patient –
including any contrary opinions if there are any – and the patient must of
course also agree to go through with the innovative treatment.

Finally, the note of the opinions must then be attached to the patient’s consent
form as a permanent record.

Only then will the doctor be legally covered by the Bill.

The Bill imposes a much higher standard of consent than other health
legislation.

If that’s truly the case, one wonders why the alternative medicine community has
rallied behind this bill. If, as Lord Saatchi claims, this bill would tighten
up considerably regulations over “brave maverick doctors,” why does one of the
biggest organizations promoting quackery in the world, the Alliance for Natural 
Health, so strongly support it, the way it has supported, for example, Stanislaw
Burzynski, arguably one of the most famous “brave maverick doctors” in the
world? My guess is that it all hinges on the definition of “medical experts” in 
the bill. After all, for “integrative medicine,” who will be the “experts”?
Other “integrative medicine” docs, of course! Meanwhile, in the comments we see 
stories like this from Dr W. Witvliet, who linked to this website on his name
(I’ll let the website speak for itself but cite his comment):

my patient, was threatened with loss of his NHS contract just as I was if I
refused to stop advising patients that arterial disease is reversible even
though I had the photographic evidence from the retinal arteries to prove it.The
new science which I named CardioRetinometry not only eliminates

coronary heart disease and heart bypass operations but also reduces the
incidence of cancer and diabetes.

It is so suppressed by the NHS that they were forced to get me struck off the
register on a technical misconduct charge, for defending public health, despite 
my having 200 written testimonials and no lay complaint against me.

Quacks seem very enthusiastic about this bill. I wonder why. I also can’t help
but note that supporters of Stanislaw Burzynski are enthusiastic supporters of
“right to try” laws in the U.S. Indeed, Steve and Melissa Heil, whose daughter
has a brain tumor and is being treated by Stanislaw Burzynski, were prominent
among the patients and patients’ families testifying in favor of the Missouri
“right to try” bill. Again, I wonder why. Parents like the Heils, I can
understand. They honestly, albeit almost certainly mistakenly, believe that
antineoplastons are the only thing keeping their daughter alive. Other than with
family members who watched loved ones die and have been mistakenly led to
believe that “right to try” bills might have saved their loved ones, I find it
hard to be charitable with most supporters of “right to try” bills, as they
appear to be mostly ideologically motivated, like the Goldwater Institute, or
motivated by support for quackery, like the ANH.

I will likely have to look into Lord Saatchi’s bill in more detail, but it sure 
does smell, as one Twitter user described “right to try” laws, like a “Trojan
duck,” a wonderful term that I will have to appropriate forthwith for
legislation that appears reasonable on the surface but upon closer examination
will promote the wider use of quackery. It is also based on the same magical
thinking that underlies “right to try” laws.

The magical thinking behind “right to try” laws…

Given how bad an idea “right to try” laws are, here’s the funny thing: They
almost certainly won’t do what they are designed to do. The reason is simple.
They are nothing but state laws, and the FDA controls drug approval. Arizona can
say as much as it wants that patients can get any investigational drug they
want, but what the state of Arizona says is meaningless as long as the FDA says 
that you have to have a single-patient IND approved for patients to have access 
to an investigational agent outside the auspices of a clinical trial being
undertaken to win approval for the drug. Because the FDA exercises a lot of its 
power through the federal government’s power to regulate interstate commerce,
perhaps the only way I can imagine for a state to get around this would be if
the pharmaceutical company is in the same state as the patient. If the company
ships an investigational drug across state lines in violation of federal law,
it’s screwed. Of course, even this might not be enough, because a lot of states 
have a “mini-FDA” act, which bans the use of drugs that haven’t been
FDA-approved. Indeed, the only reason Stanislaw Burzynski managed to get away
with administering antineoplastons to patients early in his career is because at
the time Texas didn’t have a mini-FDA act, and Burzynski was very careful never
to ship antineoplastons across state lines.

Even more pertinent, drug companies need their drugs to be FDA approved to
recoup their investment in drug development and make a profit, because without
FDA approval they can’t sell the drug. The Arizona “right to try” law requires
that the “investigational drug” (1) have passed phase I trials and (2) still be 
in the clinical trial process. There’s only one reason for a drug to be still in
clinical trials after phase I trials, and that’s because the drug company still
wants FDA approval for its drug; i.e., that it hasn’t abandoned development.
That means the investigational drug is still under FDA regulation. A single
patient IND would still be required. Pharmaceutical companies providing drugs to
patients in “right to try” states without proper INDs would be violating FDA
regulations and would thus endanger their chances of ultimate FDA approval. In
other words, these “right to try” laws are nothing but feel-good placebos. They 
have no real effect because reputable pharmaceutical companies will not cross
the FDA by providing an investigational drug to patients without a proper IND.
That means that the only companies that might take advantage of “right to try”
laws would be disreputable companies like Stanislaw Burzynski’s institute. Like 
Burzynski, “right to try” laws offer nothing to cancer patients but false hope. 
In fact, I’m hard-pressed to think of anyone whom these laws would benefit other
than Burzynski, which makes me wonder if his minions have anything to do with
promoting them.

Indeed, making essentially untested drugs more widely available, as these “right
to try” laws propose to do, will be far more likely to harm the individual
patient than to help him. Advocates of these bills ask, “What’s the harm?” I’ll 
tell you: If there’s anything worse than dying of a terminal illness, it’s dying
of a terminal illness and suffering unnecessary complications or pain for no
benefit and having to pay for the medications causing the complications
yourself. Remember, these laws allow the pharmaceutical companies to charge for 
their investigational medications. They don’t all necessarily require the
company to provide the drug for free, as current law does in the case of single 
patient INDs. For example, as discussed before, the Arizona law doesn’t require 
drug companies to provide the investigational agent for free; the Colorado bill 
is being amended to have that requirement by its cosponsor Janak Joshi.

Worse, Dallas Buyers Club-style “right to try” laws risk undermining our entire 
clinical trial enterprise, which is a major part of the scientific basis for
evidence-based medicine. After all, if early-stage experimental drugs were made 
widely available outside of clinical trials and taken for a wide variety of
cancers, the signal-to-noise ratio would become very low. It would become very
difficult to tell which drugs were working and for which cancers (and which were
not), particularly since it would be reasonable to expect that such a policy
would result in enrollments in clinical trials plummeting. And what would be the
potential payoff for the shredding of patient protections proposed in these
bills, even if the FDA didn’t put the kibosh on widely providing experimental
drugs early in clinical testing (and, make no mistake, only having passed a
phase I trial is early in clinical testing)? Very little at best, if even any at
all. In reality, the likelihood of saving the lives of even a handful cancer
patients by giving them access to early-stage investigational agents is quite
low and hard to justify on a moral and practical basis, given the high
likelihood of potential harm or premature death to so many other patients
through the damage or destruction of a system that has been built up at such
cost over several decades.

The entire justification for “right to try” laws also seems to rest on a
misperception that there are “miracle drugs” out there that we will have to wait
years for because the FDA is too slow to approve them. However, if there really
were such a “miracle drug” that was amazingly effective compared to anything we
have now, a large randomized phase III trial would not be necessary to detect
its efficacy. Indeed, its efficacy could show up in even a small phase I trial
or, at the latest, in phase II trials. There’d be examples of clinical trial
subjects demonstrating amazing tumor shrinkage or even outright cures. In
reality, we don’t see these things in phase I trials, because there are no
miracle drugs, at least not yet (if there ever will be). Dallas Buyers
Club-style “right to try” bills rest on a fantasy, and it’s a fantasy of false
hope. Indeed, these bills serve an ideological purpose rooted in libertarian
politics far more than they serve patients. It’s not coincidental that virtually
the only sign of opposition to the Missouri “right to try” bill was from
lobbyists representing the hospice community, who warned lawmakers that such
legislation raises false hopes for patients when further treatment is likely
futile.

The same is clearly true for Lord Saatchi’s Medical Innovation Bill, which seems
to rest on an underlying assumption that there is a cornucopia of
“unconventional” treatments out there waiting that could save thousands of
patients with terminal cases of cancer and other diseases, if only doctors were 
allowed to use them more widely. Never mind that pesky scientific and clinical
trial process that’s usually needed to demonstrate whether a treatment works or 
not. Given Lord Saatchi’s experience watching his wife die of cancer, one can
understand his sentiments. However, I will point out that I watched my
mother-in-law die what was undoubtedly an equally unpleasant death from
metastatic breast cancer, and I know that no treatment, conventional or
“unconventional,” could have saved her life. And, yes, I saw to it that she was 
evaluated by one of the best, if not the best, phase I oncologist in the world, 
an oncologist who is currently part of a Stand Up To Cancer Dream Team of
researchers. My wife and I learned the pain and frustration of being informed
that that she wasn’t eligible for any phase I trials. It is painful for me to
admit this publicly, but I think it is important for you (and Lord Saatchi, if
he sees this) to know that I have a personal understanding of the pain of
watching a loved one die of cancer after having been told there’s nothing more
that can be done for her. I still conclude that “right to try” bills and Lord
Saatchi’s Medical Innovation Bill are profoundly misguided and based on magical 
thinking that I myself was tempted by.

Conclusion

These bills seem new, but they’re just the latest wrinkle on an old story. We’ve
been down this road before, just without an Oscar-nominated movie to add glitz 
to the campaign. For example, the Abigail Alliance has been lobbying for similar
“right to try” laws for a decade now. Libertarians love these bad ideas
because, you know, the market cures all and people should be allowed to sell and
buy pretty much anything they want. So does the press because of the human
interest stories coupled with the “little guy” battling the FDA. Even though
expanded access programs could definitely use some tweaking, never forget that
the reason the laws we have exist is to protect the public against drugs that
don’t work or are too toxic and, just as importantly, from companies that would 
sell such drugs with no evidence of efficacy or safety and from “investigators” 
like Stanislaw Burzynski.

Supporters often point to the example of Gleevec (imatinib) for chronic
myelogenous leukemia (CML), and, indeed, Gleevec did show spectacular results in
its first phase I trial. What advocates gloss over is that results like what
were seen in three early stage phase I/II trials for Gleevec in CML are
incredibly rare. In fact, before Gleevec, such results were virtually
unprecedented:

Two years later, this chemical, which was called ST1571 and eventually renamed
Gleevec, entered its first clinical trial: a small phase I trial involving just 
31 patients. Remarkably, all 31 individuals experienced complete remission; in
other words, their blood counts returned to normal. In some of these patients,
there was also cytogenetic remission, meaning that the Philadelphia chromosome
was no longer found in their blood cells. As Druker noted, “That was virtually
unheard of in a phase I clinical trial. Usually in a phase I clinical trial, if 
you see a 20% response rate, that’s remarkable. We had a drug that was extremely
well-tolerated and had a 100% response rate. It was absolutely incredible to
see this unfold” (Taubes, 2003). Subsequent clinical trials produced results
just as astonishing.

Also, Gleevec was an unusual drug from a mechanistic standpoint as well because 
CML depends upon a single mutation resulting in a single aberrant protein whose 
targeting can completely reverse the cancer:

In a way, Gleevec is an exceptional case, and the same success is not likely to 
be achieved with other cancers any time soon. Unlike most other cancers, which
are caused by a multitude of complex interacting genetic and environmental
factors and therefore have many targets, CML is caused by a single aberrant
protein related to a consistent chromosomal translocation. Scientists were thus 
able to focus all of their efforts on this single target. Nonetheless, the
Gleevec story is no less an excellent and, some would say, beautiful example of 
how knowledge of the biological functioning of a cell can lead to life-saving
medical treatment.

If there’s a drug that’s shown as incredible a result in an early phase I trial 
as Gleevec, I am unaware of it. Again, that’s the point. Gleevecs of the world
are rare, but Dallas Buyers Club “right to try” legislation rests on the
assumption that they are much more common than they actually are and that
thousands of patients with terminal cancer would be saved if only the FDA
weren’t such prigs about insisting on evidence of efficacy and safety. It’s a
fantasy, not reality.

Don’t forget: Dallas Buyers Club is just a movie, nothing more. It might be a
really great movie (given its Oscar nominations and McConaughey’s winning Best
Actor, it almost certainly is), but it’s not fact. It’s a fictionalized account 
of man’s battle with AIDS that is designed to entertain and uplift more than to 
teach about history and science. As such, it’s a terrible model for health
policy. Widespread adoption of Dallas Buyers Club-inspired “right to try” laws
is far more likely to harm rather than help patients with cancer and terminal
diseases.

The illusions of “right to try” laws

Jann Bellamy on March 6, 2014

Link

[Ed. Note: For additional commentary on why “right-to-try” laws are such a bad
idea, see “Right to try” laws and Dallas Buyers’ Club: Great movie, terrible for
patients and terrible policy and The false hope of “right-to-try” metastasizes 
to Michigan.]

There is nothing like a touching anecdote to spur a politician into action. And 
those who want to try investigational drugs outside the FDA’s clinical trial
process have touching anecdotes in spades. If I, or a loved one, had a terminal 
cancer, I’d probably be right there with them, telling my story and hoping to
get my hands on an investigational drug, no matter how slim the chance for
improvement it offered. But a less emotion-driven analysis of so-called “Right
to Try” bills currently before several state legislatures reveals some sobering 
truths about the false promises behind these bills, promises which in some cases
appear to be driven more by political ideology than genuine concern for
patients.

“Right to Try” bills are pending before four state legislatures: Colorado,
Louisiana, Arizona and Missouri. We’ll get to the details of these in a bit.
Legislators in other states have expressed an interest in filing similar bills. 
On February 26th, a Missouri legislative committee “heard emotional debate from 
supporters of a bill that would allow makers of investigational drugs,
biological products or devices to make them available to eligible terminal
patients.” Among those testifying were the parents of a young girl with a brain 
tumor and the father, a physician, of a patient with metastatic colon cancer.
These stories are hard to hear and make it hard to say no.

The Right to Try bill has been christened with another catchy name (Warning!
Link to credulous media report!) – the Dallas Buyer’s Club bill after the
terrific movie which just won Matthew McConaughey and Jared Leto Academy Awards 
for best actor and best supporting actor, and deservedly so. It depicts a macho,
homophobic, HIV-infected cowboy (McConaughey) who saves the day battling the
evil, bureaucratic FDA and the medical establishment. He skirts the law to bring
life-saving drugs to AIDS patients at a time when AIDS was pretty much a death 
sentence. The plot even includes a delicensed American doctor who supplies the
unapproved drugs from his Mexican clinic. And dietary supplements, of course.
(You’d be tempted to suspect Stanislaw Burzynski, Hulda Clark and a naturopath
co-authored the script.) But no matter its merits as a movie, it is just that, a
movie. It is based on a true story but its interpretation of events has been
called into question. (Orac also deconstructs the factual inaccuracies on
Respectful Insolence today.) Nevertheless, it is a public relations boon to the 
Right to Try promoters, although, considering their decidedly right-leaning
political inclinations, there has to be a certain amount of squeamishness in
associating their cause with a movie featuring raunchy, sexually-explicit
scenes, lots and lots of cussing, and a colorfully dressed trans-gender person
(Leto) as its most sympathetic character. 

Attempts to liberalize FDA’s expanded access

The genesis of these bills can be traced to another young cancer victim,
21-year-old Abigail Burroughs, who died of the disease in 2001. Abigail herself 
led a lobbying and media campaign to urge greater access to investigational
drugs after one was recommended by her oncologist. After her death, her father
formed the Abigail Alliance for Better Access to Developmental Drugs because
they considered the FDA’s expanded access policy insufficient.

To help us better understand what the Alliance wanted, here’s a brief
explanation from the FDA of how the extremely complicated process for a new drug
approval works:

   The first step for a company seeking approval to sell a new drug is to
   perform laboratory and animal tests to learn how the drug works and if it
   will be safe enough to be tested in humans. The company submits an
   Investigational New Drug Application (IND) for FDA’s review prior to testing 
   in humans. The company performs a series of clinical trials in humans in
   three phases, which FDA monitors, to test if the drug is effective and safe. 
   Next, the company sends its data from all these tests to FDA’s Center for
   Drug Evaluation and Research (CDER) in a New Drug Application (NDA). A team
   of CDER physicians, statisticians, toxicologists, pharmacologists, chemists
   and other scientists review the data and proposed labeling. If this review
   establishes that a drug’s benefits outweigh its known risks for its proposed 
   use, the drug is approved for sale.

(New biologics and medical devices are regulated by the FDA in a somewhat
different manner, but from now on we are going to focus on drugs because that
appears to be the main target of the Alliance and other advocacy groups.)

In 2003, the Abigail Alliance and the Washington Legal Foundation filed a
Citizen’s Petition with the FDA requesting that the Agency amend its IND
regulations “to grant Initial Approval for promising drugs, biologics, and
devices intended to treat life-threatening diseases with unmet needs,” and to
seek “regulatory changes to permit expanded availability of developmental
lifesaving drugs following phase 1 clinical trials and at all subsequent stages 
of the trial and review process.”

A Phase I Clinical Trial, which typically involves only a few patients, is
designed to assess toxicity and dosing but does not establish either the safety 
or efficacy of a drug. While the trial may incidentally show some evidence of
efficacy, that initial evidence is not always borne out in later phases. As our 
good friend Orac explained:

   Phase I clinical trials represent the very first time a promising new
   substance is ever given to humans. The intent is not really therapeutic.
   Rather, it is to gather toxicity data and to determine the optimal dose.
   Basically, what is done is something called a dose escalation, where
   increasing doses are tried until toxicity is observed. The usual patients
   enrolled in these trials when done for cancer drugs have advanced disease
   that is incurable with present modalities. One reason for this is that in
   many cases it would be unethical to try such drugs out in patients who could 
   expect to have a chance at long-term survival using conventional treatments, 
   and that healthy volunteers would be unlikely to be willing to undergo the
   risk of toxicity from these very powerful drugs. Another reason is that
   sometimes we can see anti-tumor activity even in a phase I trial. However, it
   is not expected that antitumor activity will be observed, and not observing 
   activity would not preclude moving on to a larger, randomized Phase II trial,
   in which the drug is tested against specific tumors.

The FDA denied the Petition and the Alliance sued the FDA in federal court
claiming that terminally ill patients had a constitutional right to access
as-yet-unapproved drugs. The U.S. District Court disagreed and the Alliance lost
the case, but that decision was overturned by the U.S. Court of Appeals for the
District of Columbia Circuit. A three-judge panel of the Court held that where 
there are no other FDA-approved treatment options, a terminally ill patient has 
a constitutionally-protected “fundamental right” to access investigational drugs
This decision became the subject of some debate among legal scholars,
especially on the right end of the political spectrum. They were torn between
their distaste for federal regulation they regard as limiting personal freedoms 
and their distaste for courts finding constitutional rights not specifically
enumerated in the Constitution itself, which is exactly what the Court of
Appeals had done.

The FDA then requested a rehearing en banc, that is, before the full Court of
Appeals. Here, the FDA was joined in seeking a reversal of the decision by
several medical organizations, including the American Society of Clinical
Oncologists. The Court’s en banc decision was 8-2 against the Alliance, a
decisive victory for the FDA. The Alliance filed a petition for  certiorari
asking the U.S. Supreme Court to hear the case but the Supreme Court denied the 
petition. That does not mean the Supreme Court might not decide the issue in a
future case, but for now the Court of Appeals decision stands.

Meanwhile, over in the U.S. Congress, Sen. Sam Brownback introduced
Alliance-supported legislation allowing expanded access to investigational drugs
not already available under the FDA’s rules, but it didn’t go anywhere. (It
contained some disturbing provisions gutting placebo controls in clinical
trials.) Later, Rep. Diane Watson introduced the Compassionate Access Act of
2010, but the bill never made it past the House Subcommittee on Health.

There are a number of good reasons to disagree with the position taken by the
Alliance in its suit against the FDA and the two bills it supported, and we will
get to some of the reasons to oppose expanded access in a minute. But before we
move on to the Right to Try bills, I want to note the extent of access to
investigational drugs at issue up to this point. The first Court of Appeals
decision held that where there are no other treatment options, terminally ill
patients have a fundamental right to access investigational drugs. And both
Congressional bills retained some FDA oversight of the expanded access process.

A more radical approach

Enter the Goldwater Institute, an extremely conservative think tank which,
beyond lambasting the Affordable Care Act, doesn’t seem to have any real
interest in healthcare policy. The Institute is named for, and was founded “with
the blessing of,” the late U.S. Sen. (and unsuccessful presidential candidate) 
Barry Goldwater. The Institute’s model statute, on which the current state
“Right to Try” bills are based, doesn’t just liberalize FDA requirements for
access to investigational drugs. It completely removes FDA from the picture. The
model statute conveniently comes complete with pre-packaged legislative
findings so a legislature doesn’t have to bother with making an independent
determination of the wisdom of the Right to Try bill.

Here are the main provisions, with a few comments (more of those later):

  1. The drug must have successfully completed Phase I clinical trials and still be
    involved in the clinical trial process. As we know, Phase I is designed to 
    assess toxicity and dosing but not safety or effectiveness. And any evidence
    of either safety or effectiveness which appears at this point may not hold 
    up in later phases of the process.

  2. To access the drug, the patient must have a “terminal illness,” defined
    broadly as “an advanced stage of a disease with an unfavorable prognosis and
    no known cure.”

  3. The patient, in consultation with “a physician” (no matter the physician’s
    lack of expertise in treating cancer or other terminal illnesses, or, for
    that matter, never having a previous relationship with the patient at all)
    has “considered” (not tried, “considered”) all other FDA-approved treatment 
    options. There is no mention of how the drug is to be administered, how the 
    dose is to be calibrated, or what follow-up must be provided.

  4. The patient has a prescription “or recommendation” for the drug and has given 
    informed consent (or it has been given for him if he is a minor or mentally 
    incapacitated).

  5. All of the above must be documented by the physician. Just “documented;” no
    medical rationale for the decision needed.

  6. The drug’s manufacturer can, but is not required to, make the drug available
    (although it can do so without an actual prescription) and can choose
    whether or not to charge the patient. “Drug manufacturer” is not defined;
    clinical trials do not necessarily involve a “manufacturer.”

  7. Insurance companies can, but don’t have to, cover the cost of the drug itself.
    Other costs of treatment with the drug are not addressed.

  8. The state medical board is prohibited from taking action against the physician
    “solely based on a medical professional’s recommendation, prescription or
    treatment with a the investigational drug.” “Solely based on” is not further
    defined.

  9. Any “official, employee, or agent of the State” who blocks access, or even
    attempts to block access, is guilty of a class-one misdemeanor punishable by
    up to 6 months in jail and a $2,500 fine.

In other words, extremely powerful drugs with no evidence of safety or efficacy 
would be removed from FDA jurisdiction once the cursory requirements of this
legislation have been met. Disciplinary action against a physician would be
thwarted, and perhaps denied altogether, possibly even in cases where the
physician fell far below the standard of care. Yet physicians and manufacturers 
would remain subject to liability for injuries even if they comply with the act.
No matter how devastating the effects of an unapproved drug might be, or how
reasonable their actions might be, any state employee or official who takes
action to block access could wind up in jail for 6 months and paying a $2,500
fine.

What could possibly go wrong? A lot, that’s what. Physicians with
less-than-pristine intent could set up practices specializing in filling out the
paperwork necessary for patient access. And what if, after careful evaluation, 
an ethical, competent physician has to refuse a patient’s desperate pleas to
facilitate access? Patients could be deterred from participating in clinical
trials, lured by the false “get-well-quick” promises of an unapproved and costly
drug. And patients in the last months of their lives could be diverted from
palliative care and a meaningful opportunity to spend time with loved ones by an
experimental drug with terrible side effects that, in fact, kills rather than
cures them. One could even envision a scenario where a patient who pushes aside 
other options in favor of an investigational drug ends up thereby disqualifying 
himself from a later clinical trial offering a real hope of improvement. What if
child welfare authorities try to intervene in favor of a terminally ill child
who is about to be treated with a horribly inappropriate drug? Will they go to
jail?

The proposed statutory language is based on a Goldwater Institute “Policy
Report,” with the superficially appealing title, “Everyone Deserves the Right to
Try: Empowering the Terminally Ill to Take Control of Their Treatment.” It
contains a number of dubious claims about expanded access, among them:

  1. Expansion of FDA authority in the 1960’s to require that a drug demonstrate
    efficacy was “drastic” and “unwarranted.”

  2. Polls purportedly showing medical specialists think the drug process is too
    slow, a broad assertion that says nothing about whether they would halt all 
    FDA supervision for particular patients once a drug passed Phase I trials.

  3. “The major emphasis of Phase I testing is safety” and drugs that have passed
    Phase I have “passed basic safety testing.” This is a half-truth that could 
    leave the uninformed with the impression that the FDA has decided at this
    early stage that a drug is actually safe.

  4. The report speaks of patients “battling an immediate life-threatening illness”
    who “lack other treatment options.” Yet neither of these situations is
    required before their legislation would allow access to investigational
    drugs. The report also makes the hyperbolic claim that the FDA’s regulations
    “impair health” or “cause death.”

  5. Drugs that have cleared Phase I are continually referred to as “potentially
    life-saving,” an assertion partially refuted by their own statistics. They
    note that 30% of drugs make it from Phase Two (which tests efficacy) to
    Phase Three. And that is for any drug demonstrating efficacy for any
    purpose, not just those designed to treat terminal illnesses.

  6. The report claims that “risk to an individual patient outside the clinical
    trial is no greater than the risk the FDA is permitting patients inside the 
    trial to take.” Likewise, the report claims that informed consent will be an
    adequate protection because it is the same informed consent used in the
    clinical trials. Hardly. Clinical trial participants are carefully chosen
    based on certain eligibility requirements, and are closely monitored. If at 
    any time it becomes apparent that further testing (for a particular
    participant or for all of them) is inappropriate, the FDA can pull the plug.
    An Institutional Review Board must sign off on the informed consent. None
    of these safety measures apply to patients allowed access by this
    legislation. There’s not even a requirement that administration of the drug 
    be supervised or that the patient be followed at all.

There are other insufficiencies in the “Policy Report,” but we’ll leave it at
that.  In fact, the whole idea is so poorly thought out and so ill-considered 
the science-based community is really piling it on this week, with SBM’s own
cancer expert weighing in, as well as our pal Orac.

We’ve already touched on some of the legal complications-in-waiting that might
appear if the Goldwater Institute’s bill is passed. Indeed, the enthusiasts
backing Right to Try bills in their states have had to clean up some of the more
obvious drafting oversights. All states tightened the definition of terminal
illness. Arizona excludes primary care physicians from the definition of
physician. Missouri excluded controlled substances and Colorado added some
protection against liability for manufacturers.

Political theater at taxpayer expense

But I’ve saved the biggest legal complication for last. Right to Try laws, as
proposed here, are either wholly unconstitutional or at least unconstitutional
in the majority of possible applications. That is because the FDA has exclusive 
jurisdiction over the regulation of drugs via Congress’s constitutional
authority to regulate interstate commerce and state laws that impinge on that
exclusivity are pre-empted. Federal drug laws regulate not only the approval
process for new drugs, but also the misbranding and adulteration of drugs, both 
of which could come into play with the provision of an unapproved drug to a
patient. It might be possible to envision a scenario where a manufacturer could 
have an operation that is so devoid of any interstate commerce it would fall
outside the FDA’s jurisdiction. That would be extremely difficult to do
although, according to David Gorksi, that is exactly what Stanislaw Burzynski
did early in his career, before he started the (never completed) FDA approval
process.

But here’s another hurdle: the drug must have passed a Phase I Clinical trial
and still be involved in the clinical trial process. Colorado specifies that
this must be an FDA-approved clinical trial; the other versions do not. However,
they strongly imply that we are talking about an FDA drug approval process here
by reference to the drug’s not yet having received the agency’s approval. Once 
the FDA-drug approval process is underway, the manufacturer is by definition
under FDA jurisdiction. (Is there even such a thing as a non-FDA drug-approval, 
clinical trial process?) The FDA is certain to take a dim view of a manufacturer
with a drug still in clinical trials going off and distributing that same drug 
to patients outside the trial process.

Could the FDA expanded access program use some more expanding? Perhaps. Could
the FDA drug approval process as a whole be improved? Most definitely, and the
place to start is adequate funding by Congress. But all the Right to Try
legislation does is engender false hopes that access to “potentially life-saving
drugs” is just around the corner. Of course, the Goldwater Institute won’t be
paying for the ensuing litigation over the constitutionality of state right to
try laws. That burden will fall doubly on the taxpayers, as both state and
federal resources will be consumed. But it can benefit nicely from the political
theater that allows it to pose as a champion of state rights and individual
freedom defending a bill it most certainly knows cannot survive constitutional
scrutiny.

The Compassionate Freedom of Choice Act: Ill-advised “right to try” goes federal

David Gorski on April 27, 2014

Link

Not too long ago, I expressed alarm at a series of bills that were popping up
like so much kudzu in various state legislatures, namely “right to try” bills.
Both Jann Bellamy and I warned that these bills gave a false illusion of hope to
patients with terminal illnesses. Basically, these laws claim to grant the
“right” of patients with terminal illnesses to access promising experimental
medicines that have not yet been approved by the FDA. Indeed, these
investigational drugs need merely to have passed phase I trials, and these
“right to try” laws would allow them to be used in pretty much any human with a 
terminal illness who can persuade a pharmaceutical company to let them have such
drugs. Of course, as I pointed out, such laws are based on a false premise,
namely that there are lots of promising drugs out there that could save lots of 
lives of terminally ill patients, if only the hidebound FDA would get out of the
way and let the people try them. The problem (besides the false assumption
behind such laws) is that they are all state laws, and the FDA and federal law
still trump state laws with respect to drug approval.

Apparently, advocates of “right to try” laws have gotten around to trying to
take care of that little obstacle, too. I’m referring to a federal law under
consideration in the House of Representatives and championed by the usual
suspects, including the Alliance for Natural Health USA, a “health freedom”
group that has yet to see a pro-quackery bill it doesn’t like.

In any case, at the time I originally learned about this bill, HR 4475, which
was introduced by Rep. Morgan Griffith (R-VA) and entitled “The Compassionate
Freedom of Choice Act of 2014,” its text hadn’t yet been published to the
Congressional website. I did learn that the bill has been floating around for a 
while in various forms (for instance, former Representative Ron Paul (R-TX)
apparently introduced it.) Now its text has been published, as Guy Chapman has
noted. He calls it a “quack’s charter,” and he’s only off by a bit. The bill
doesn’t go quite as far as he believes, but the bill is still plenty bad, man.
If enacted, HR 4475 would amend the Food, Drug, and Cosmetic Act by inserting
after section 561 (21 U.S.C. 360bbb) the text of HR 4475. This section of the
Food, Drug, and Cosmetic Act is entitled “Expanded Access to Unapproved
Therapies and Diagnostics,” and it’s the section of the act that regulates
exactly that. The interesting thing is that this particular section of existing 
law is the framework under which the whole system of single patient INDs (also
known as “compassionate use exemptions”) is already based. As I’ve described
before, single patients can receive promising unapproved drugs under what’s
known as a single patient IND, which has to be approved by the Institutional
Review Board and the FDA and allows single patients to receive unapproved drugs.
You can (and many have) argued that the single patient IND process is too
cumbersome and restrictive, but HR 4475 seeks to (mostly) nuke this requirement.
You’ll see what I mean in a minute.

First, the law states that:

   Nothing in this Act or section 351 of the Public Health Service Act prevents 
   or restricts, and the Food and Drug Administration shall not implement or
   enforce any provision of law preventing or restricting, the manufacture,
   importation, distribution, or sale of an investigational drug or device
   intended for use by a terminally ill patient in accordance with subsection
   (b).

Guy Chapman went a bit beyond what the law would actually permit in his
analysis, I’m afraid. HR 4475 clearly does not authorize the use of quackery
like Hoxsey therapy, Gerson therapy, or anything else like that in terminally
ill patients, although I suppose it is theoretically possible that advocates
could get an IND for one of these quackeries and then carry out a phase I
clinical trial, after which the quackery would fall under the definition of an
investigational drug or device according to HR 4475. (In this, perhaps the
Gonzalez protocol would qualify, given that it’s undergone two clinical trials, 
the last of which was disastrously negative, but it was a clinical trial.) HR
4475 does, however, basically allow unfettered access by “terminally ill”
patients to any “investigational” drug or device, which is defined as a drug or 
device that “(1) has not yet been approved, licensed, or cleared for commercial 
distribution under section 505, 510(k), or 515 of this Act or section 351 of the
Public Health Service Act, and cannot otherwise be lawfully marketed in the
United States; and (2) is or has been the subject of one or more clinical
trials.” In other words, it’s very much like one of those “right to try” laws
that are such a horrible idea but nonetheless are popping up like kudzu in state
legislatures.

Again, however, the difference is that “right to try” laws in states would have 
little or no effect, because the FDA would still rule supreme over drug
approval, and federal law trumps state law. HR 4475 would in essence codify
“right to try” in the federal law under which the FDA works, which would do many
orders of magnitude more harm to cancer patients and terminally ill patients.
Basically, this law would allow any “terminally ill” patient access to any
investigational drug with an IND that’s gone through at least phase I trials.
I’ve explained before in great detail why that’s such a horrible idea, but it’s 
worth briefly repeating the following point. Most investigational drugs that
make it past phase I trials still end up failing. The chances for doing harm far
exceed any chance for benefit. Drugs with seemingly miraculous activity against
cancer, like Gleevec, that show up in phase I clinical trials are exceedingly
rare. Indeed, HR 4475 says nothing about whether the clinical trials the
investigational drug or device being to be used in terminally ill patients has
undergone even need to show promise or not. Under HR 4475, a drug that
completely failed in phase I clinical trials by showing unacceptable toxicity
(for example) could be distributed to a terminally ill patient as long as the
patient is told that the drug failed phase I clinical trials.

Next up in HR 4475, there’s this:

  1. (b) Patient Requirements.–In order for an investigational drug or device to be
    intended for use in accordance with this subsection, such drug or device
    must be intended for use by a patient who has–

    1. (1) been diagnosed with a terminal illness by a licensed physician;

    2. (2) been informed by a licensed physician that no drug or device that is
      lawfully marketed in the United States is likely to cure the illness; and

    3. (3) executed a written informed consent document that states–

      1. A) the known and potential risks and benefits of such drug or device; and

      2. B) any indications of the illness for which a drug or device is lawfully
         marketed, or for which treatment is otherwise available, in the United 
         States.

  2. c) Prohibition on Requiring the Disclosure, Collection, and Reporting of
    Certain Information by Food and Drug Administration.–

    1. (1) In general.–The Commissioner of Food and Drugs may not require the
      disclosure, collection, or reporting of–

      1. (A) any information related to the delivery, administration, or use of an 
         investigational drug or device pursuant to this section; or

      2. (B) any information related to the clinical outcomes experienced by a
         terminally ill patient supplied an investigational drug or device
         pursuant to this section.

    2. (2) Exception.–Nothing in this subsection prevents the sponsor of a clinical
      trial from voluntarily disclosing, collecting, or reporting information
      to the Food and Drug Administration.

One notes that “terminal illness” is not defined. I could go all Orac-style
snarky on you and point out that life itself is a terminal illness (one that’s
sexually transmitted, as well). We all die eventually. On the other hand, there 
are other diseases that are arguably terminal that can take a long time to kill.
Even metastatic breast cancer is now potentially survivable for several years, 
even longer if it’s an indolent type with a low volume of metastatic tumor.
Where do you draw the line in defining “terminal”? Normally, for purposes of
laws, “terminal illness” is defined according to a certain estimated prognosis
for life expectancy, be it six months, a year, or whatever. Even Abraham’s law
did that. My guess is that this is to allow the widest number and variety of
people with “terminal” illnesses access to unapproved treatments as possible.
All you have to do is to find a doctor to say you’re terminal and there are no
approved drugs or devices that can save you, and you’re good to go! Really? Any 
licensed physician, regardless of specialty? Moreover, under these
circumstances, as described in this bill, “informed consent” is a joke, a cruel 
parody of real informed consent. In clinical trials, even in single patient
INDs, the informed consent process is lengthy and detailed. In any event, the
bill reads as though it were written specifically for Stanislaw Burzynski, as it
would allow someone like him to abuse the IND process without even the threat
of the FDA bothering him.

Now here’s the kicker. One of the criticisms of “right to try” laws is that drug
and device companies won’t want to allow patients to have access to their
investigational drugs or devices because adverse outcomes might affect their
application for approval to the FDA. HR 4475 has that covered:

  1. (c) Prohibition on Requiring the Disclosure, Collection, and Reporting of
    Certain Information by Food and Drug Administration.–

    1. (1) In general.–The Commissioner of Food and Drugs may not require the
      disclosure, collection, or reporting of—

      1. (A) any information related to the delivery, administration, or use of an 
         investigational drug or device pursuant to this section; or

      2. (B) any information related to the clinical outcomes experienced by a
         terminally ill patient supplied an investigational drug or device
         pursuant to this section.

    2. (2) Exception.–Nothing in this subsection prevents the sponsor of a clinical
      trial from voluntarily disclosing, collecting, or reporting information
      to the Food and Drug Administration.

In other words, the drug and device companies who allow “terminally ill”
patients to use unapproved drugs and devices don’t even have to collect data on 
the outcomes patients who take their unapproved drugs or use their unapproved
devices under this law, and, if they choose to do so, don’t have to report those
outcomes to the FDA. It’s all voluntary. It’s hard to imagine a provision more 
irresponsible than this. Add to the parody of “informed consent” in this law is 
the fact that the law basically makes any reporting of patient response or
adverse events completely voluntary. Basically, if you’re a terminally ill
patient, this law strips away all the copious protections for human subjects in 
research that the law currently provides. You’re completely on your own, and the
drug company is not responsible for anything, so much so that the law even ends
with this provision:

   Except in the case of gross negligence or willful misconduct, any person who 
   manufactures, imports, distributes, prescribes, dispenses, or administers an 
   investigational drug or device in accordance with section 561A shall not be
   liable in any action under Federal or State law for any loss, damage, or
   injury arising out of, relating to, or resulting from–

  1. the design, development, clinical testing and investigation, manufacturing,
    labeling, distribution, sale, purchase, donation, dispensing, prescription, 
    administration, or use of the drug or device; or

  2. the safety or effectiveness of the drug or device.

In other words, if something goes wrong, the terminally ill patient or his
surviving relatives can’t even sue, unless there’s obvious gross negligence or
willful misconduct, whatever that is, even if there turns out to be an obvious
defect in the design of the drug or device. In other words – terminally ill
patients, you’re completely on your own. Masquerading as a “health freedom” law 
that will let terminally ill patients have access to experimental drugs under a 
process less difficult than currently existing IND procedures, HR 4475 is a
stealth assault on the very heart of clinical trial ethics. Remember, one of the
main principles of the Common Rule and other statements of principles regarding
human research subject protection is that vulnerable groups need more, not less
protection. Those particularly vulnerable groups are traditionally defined as
children, prisoners, and students, the former of whom rely on parents to
exercise judgment and the latter two of whom are subject to potential coercion. 
I would argue that terminally ill patients are a particularly vulnerable
population in that they are desperate and prone to grasp at anything represented
as having a chance of saving their lives. If anything, they need more, not
less, protection.

Basically, HR 4475 is a solution in search of a problem. It’s based on the
assumption that there are just oodles and oodles of new investigational drugs
out there that could save the lives of lots and lots of terminally ill patients,
if only the government would get out of the way and let the people have access 
to them. This is libertarian magical thinking at its most pernicious; there’s no
compelling evidence for this assumption and plenty of evidence against it.
(And, no, my characterization of this assumption underlying HR 4475 is not a
straw man.) Even if you view the IND process as being in dire need of
liberalization, it’s still a “solution” that won’t fix the process but will, in 
essence, destroy the process. It’s also clearly one of a number of attempts by
the health freedom movement to get a “foot in the door.” If successful, then
similar arguments will be made to expand the “right to try” principle and
decrease regulation on investigational agents for larger and larger populations.
Although HR 4475 is clearly not explicitly designed to aid quacks who peddle
treatments like Gerson therapy or the Gonzalez protocol, it would be a godsend
to someone like Burzynski, and it could potentially be a boon to unethical drug 
and device companies, who would be free to peddle their investigational drugs
and devices, both promising and even those that failed, to that most vulnerable 
of patient populations, patients with no hope of survival. Health freedom,
indeed. Apparently “health freedom” means the freedom of pharmaceutical
companies to provide treatments whose efficacy is unknown and that are unlikely 
to make a significant difference in outcome (or even might be toxic) without
actually having to learn anything from the exercise.

The false hope of “right-to-try” metastasizes to Michigan

State “right-to-try” bills are springing up like kudzu all over the US. Their
advocates promise that they will save lives by allowing terminally ill patients 
access to experimental therapeutics, when in fact they are highly unlikely to do
any such thing given that the federal government, not the states, controls drug
approval. In reality, right-to-try laws are a cruel sham that will do no such
thing and lack even basic protections for desperate patients. Their purpose is
to build political pressure to neuter the FDA. Unfortunately, right-to-try bills
nearly always pass, as one just did in Michigan.

David Gorski on July 21, 2014

Link

Ed. note: Please read disclaimer in Dr. Gorski’s profile!

There are times when supporting science-based health policy and opposing health 
policies that sound compassionate but are not are easily portrayed as though I’m
opposing mom, apple pie, and the American flag. One such type of misguided
policy that I’ve opposed is a category of bills that have been finding their way
into state legislatures lately known as “right to try” bills. Jann Bellamy and 
I have both written about them before, and with the passage of the first such
bill into law in Colorado in May, I had been meaning to revisit the topic.
Although “right-to-try” laws are a bad policy idea that’s not new, versions of
such bills having been championed by, for example, the Abigail Alliance for at
least a decade, the recent popularity of the movie Dallas Buyers Club  appears
to have given them a new boost, such that Colorado state Senator Irene Aguilar
even frequently referred to her state’s right-to-try bill as the “Dallas Buyers 
Club” bill. It’s a topic I’ve been meaning to revisit since the news out of
Colorado, but apparently I needed a nudge, given that it’s two months later now.

Unfortunately, that nudge came in the form of a right-to-try bill (Senate Bill
991) being introduced into the legislature in Michigan by Senator John
Pappageorge and unanimously passing, almost without comment by the committee and
certainly with minimal news coverage, through the first hurdle, the Michigan
Senate Health Policy Committee. In parallel, the same legislation (House Bill
5651) has been introduced into the Michigan House of Representatives.

I joke (somewhat grimly) about seeming to be opposing mom, apple pie, and the
American flag (not to mention apparently also about wanting to disembowel
puppies) when I discuss right-to-try bills, but there’s a reason for that. These
bills tend to have not just broad bipartisan support in the legislature,
because opposing such laws seems on the surface to be the equivalent of denying 
dying patients a last ditch chance at life, but broad support among the public
because of the seemingly reasonable question, “What’s the harm?” Unfortunately, 
disaster can result when normal human compassion for fellow suffering humans is 
yoked to misinformation and misunderstanding of science (in this case how
clinical trials work), who really controls drug development and regulation in
the US, and the real harm that using such drugs prematurely can cause. For
right-to-try, the result is perniciously popular legislation that provides lots 
of false hope and virtually no benefit to terminally ill patients. In the face
of this, even politicians with a reasonable understanding of the science, why
such laws represent nothing but false hope, and why, even if they go into effect
without objection by the FDA, would be far more likely to harm patients than
help them, hesitate.

Right-to-try in Colorado

Before I get to my own state, let’s look at Colorado’s right-to-try law. One
thing that I feel obligated to point out again is that virtually all the recent 
“right-to-try” bills introduced into state legislature have been based on model 
legislation designed by the Goldwater Institute, a libertarian think tank whose 
specious and misleading arguments for such legislation I’ve discussed before and
will revisit and update in this post. In her previous post on right-to-try
bills, Jann Bellamy mentioned that there is “nothing like a touching anecdote to
spur a politician into action,” and she’s right. That’s why the Goldwater
Institute’s web page on its right-to-try initiatives is populated with
heart-wrenching testimonials of mostly cancer patients arguing that, if only
they had had access to experimental drugs, they might survive or of patients who
died whose families tearfully argue that “if only” right to try had been in
place their loved ones might not have died. In the wake of the passage of
Colorado’s right-to-try law in May, anecdotes ruled, heart-wrenching anecdotes
such as this one about Nick Auden, a Colorado man with stage IV melanoma who
died six months before the legislation passed:

Who isn’t moved by the struggles of a father who wants to survive for his
children? Who wouldn’t want to help this man? What kind of monster am I to
oppose a law that would provide brave suffering patients like Nick Auden another
shot at life, no matter how slim the chance? Such is the level of discourse
directed at those who have the temerity to point out that right-to-try laws are 
a sham, false hope, and far more likely to harm terminally ill patients than
help them; that is, if they have any effect whatsoever, which is unlikely. They 
are what I like to call placebo laws in that they make the body politic feel
better but have no real effect on the underlying problem that they are meant to 
address. Indeed, as Jann Bellamy pointed out, a much less emotion-driven
analysis of these so-called “right-to-try” bills currently before several state 
legislatures reveals disturbing truths about the false promises behind these
bills, promises which in some cases appear to be driven more by political
ideology than genuine concern for patients.

This can be seen by a simple comparison of the text of the Goldwater Institute
model legislation and the final text of the Colorado right-to-try law as
enacted. The Colorado law, in fact, bears a very close similarity to the
Goldwater Institute model legislation. Some differences between the Goldwater
Institute template and the actual Colorado law that leapt out at me included
that the Colorado law:

  1. Adds a mention that the drug approval process in the US “protects future
    patients from premature, ineffective, and unsafe medications and treatments 
    over the long run, but the process” (not in the Goldwater template text) and
    “often takes many years” (in the Goldwater text)

  2. Alters eligibility to include patients who have “been unable to participate in
    a clinical trial for the terminal illness within one hundred miles of the
    patient’s home address for the terminal illness, or not been accepted to the
    clinical trial within one week of completion of the clinical trial
    application process”

  3. States that “an insurer may deny coverage to an eligible patient from the time
    the eligible patient begins use of the investigational drug, biologic
    product, or device through a period not to exceed six months from the time
    the investigational drug, biologic product, or device is no longer used by
    the eligible patient; except that coverage may not be denied for a
    preexisting condition and for coverage for benefits which commenced prior to
    the time the eligible patient begins use of such drug, biologic product or 
    device”

There are other differences, of course, but they’re mostly wording and
Colorado-specific language about state statutes effected. I tend to interpret #1
as having been added to make it sound less as though the FDA approval process
is useless, as the Goldwater text does. My guess about #2 is that it was
undoubtedly added in order to exclude patients who just want experimental drugs 
but aren’t interested in enrolling in a clinical trial. Finally, I’m not
completely sure how to interpret #3 and would welcome a lawyer’s input
(particularly if it’s a health lawyer), but it sounds rather ominous in that it 
allows insurers to deny new coverage to a patient for a six month period from
the time the patient starts use of an investigational drug, but can’t deny
coverage for a preexisting condition (i.e., the condition that led the patient
to be terminally ill, and any other preexisting conditions) or any benefits that
commenced prior to the time the patient starts using an experimental drug or
device. On the other hand, to me the language implies that insurance companies
can deny coverage for any new problems that come up after the patient starts
using experimental therapy, whether caused by that therapy or not. So if the
patient develops a complication from the treatment, he’s out of luck. If he
happens to be hit by a car, he might be out of luck. Thus, a bill that sounds
compassionate appears to have a cruel, punishing twist embedded in it.

Indeed, this law is very “libertarian” in that it says that patients can try an 
experimental therapy that’s passed phase I trials to phase II or beyond, but
anything that happens after that is all on them. (Indeed, right-to-try would
allow access to a drug that’s only passed phase I, even if the phase II trial
hasn’t accrued a single patient yet, as long as there’s a phase II trial open.) 
The doctor recommending the treatment is off the hook, no matter how bad his
decision to recommend the experimental therapy was. The drug company is off the 
hook, no matter how many problems the drug might have. The insurance companies
appear to be off the hook, complete with a potential loophole to let them refuse
to cover various treatments in terminally ill patients.

At this point, I think it’s a good idea for me to remind my readers once again
that that these right-to-try laws cover any drug, treatment, or experimental
device that has passed phase I clinical trials. Indeed, in the video above, the 
reporter made a highly misleading statement when she stated that the Colorado
“right-to-try” law “only applies to drugs that have been deemed safe by the
FDA.” That statement is so wrong it’s not even wrong, as skeptics sometimes like
to say. Just because a drug has passed phase I clinical trials does not—I
repeat, does not—mean that the drug has been “deemed safe by the FDA.” Phase I
trials, also known as “first in human” trials, don’t enroll very many patients. 
Sometimes it’s as few as 20 patients, sometimes even less. That is not enough to
adequately determine safety, nor is it intended to. That’s because phase I
trials are designed primarily to identify major side effects and to use a
process known as dose escalation to determine what is commonly referred to as
the “maximum tolerated dose” (MTD). It is utterly impossible for such a small
clinical trial to adequately assess the safety of a drug. All it can do is to
make sure there are no unexpected major adverse events, that the expected side
effects are tolerable, and that the drug has a side effect profile that isn’t
grossly more unsafe than the disease itself. Phase II and phase III trials are
needed to confirm safety. That’s why the premature diffusion of unapproved drugs
has the potential to increase morbidity from adverse events and even hasten
death. One example is amonifide for treating breast cancer. The drug made it
through phase I trials, but serious life-threatening hematologic toxicity
emerged during phase II trials.

Think of phase I trials as a screening test looking for the most obvious
toxicities, with phase II and III studies confirming them. Indeed, even phase
III trials can’t always adequately demonstrate that a drug is safe; it’s not
uncommon for less common adverse effects not to show up until post-marketing
surveillance, when much larger numbers of patients receive the drug. Moreover,
only 5% of all cancer drugs that enter clinical testing are ultimately approved 
for patient use. Among drugs tested in phase II trials, only 30% go on to phase 
III. So, to equate having passed phase I clinical trials with having been
“deemed safe by the FDA” betrays a profound misunderstanding at the heart of the
bill of what a phase I trial is and what passing it means. The potential for
disaster is there.

The false hope of right-to-try metastasizes to Michigan

I’ll discuss more of what’s wrong with right-to-try laws and how misguided they 
are, but first I want to take look at the right-to try bills currently under
consideration in the Michigan legislature. Oddly enough, I was completely
unaware that a right-to-try bill had been introduced into the Michigan
legislature until last week, when I got a message from a concerned person.
Before that contact, as hard as it is to believe right now, I had heard
absolutely nothing about these bills, but I’m a fast learner. I didn’t have much
help, though, because there was very little media notice taken of the Senate
hearing about this bill other than a Detroit Free Press article that I found
days after the hearing and self-serving articles on John Pappageorge’s website
touting mistakenly how this bill would allow “access to potentially life-saving 
treatments.” Either that, or I missed it because I was out of town at TAM in the
days leading up to the hearing. Whatever the case, going back to look over the 
coverage, I found that the Freep article bought in the same compassionate but
incorrect framing as was the case in the other states considering such laws:

   Arlene Kalley has lived with terminal cancer for years — and with each new
   drug she uses to keep the disease at bay, her options dwindle.

   Earlier today, the Michigan Senate’s health policy committee approved a bill 
   that would offer Kalley and other terminally ill patients in Michigan better 
   access to experimental medication.

   It doesn’t require manufacturers to provide the drug nor does it require
   insurers to cover the costs. But it gives patients a “right to try,” said
   Sen. John Pappageorge, R-Troy, whose first wife died of cancer in 1993.

   He introduced the bill earlier this year after speaking with Terry Kalley, a 
   partner with Global Logistics Strategies in Bloomfield Hills.

And this is how the idea for introducing bill came about:

   His wife, Arlene, was taking Avastin in 2011 to keep metastatic breast cancer
   at bay when the U.S. Food and Drug Administration yanked its approval of the
   drug, questioning its safety and efficacy.

   Ultimately, Arlene Kalley was able to keep taking Avastin because it still
   was being used to treat other cancers, but the experience got the Kalleys
   thinking about what could happen if Arlene Kalley’s current treatment is no
   longer effective one day.

While I can understand why this case might have led the Kalleys to wonder about 
right to try, I must point out here that Avastin was a very different case than 
situations envisioned in right-to-try legislation. Specifically, Avastin had
undergone randomized clinical trials (RCTs) beyond phase I and had already been 
approved for other cancers before being approved by the “fast track” approval
process for advanced breast cancer. Its approval for advanced breast cancer was 
based on two RCTs that showed a modest increase in progression-free survival
(PFS) when Avastin was added to chemotherapy, but no effect on overall survival 
(OS). In 2008, based on a program to “fast track” promising drugs that was
developed in 1990s, the FDA gave provisional approval to Genentech to market
Avastin for metastatic breast cancer with the condition that Genentech had to
perform additional studies to verify the results upon which the original
approval had been based. At the time, there was a great deal of argument over
whether this was a wise decision, particularly given how expensive Avastin is
and the lack of evidence that it improved quality of life or overall survival.
Unfortunately, the results of those additional clinical trials were very
disappointing to all of us who take care of breast cancer patients. The AVADO
trial only found an increase in PFS of less than a month when Avastin was added 
to docetaxel with no increase in OS, while the RIBBON-1 trial found an
improvement in PFS of 2.9 months when added to capecitabine, and 1.2 months when
added to anthracycline-based chemotherapy. That’s why in July 2010 the FDA
advisory committee revoked the fast track approval.

In other words, although I realize that Arlene Kalley was simply worried about
what her options would be if her current treatment regimen ceases to keep her
cancer in check, in a manner of speaking she is inadvertently comparing apples
and oranges in a way that could lead those unfamiliar with the Avastin saga to
believe that Avastin and right-to-try are related by anything other than the
fact that she has done well on Avastin thus far. I bring this up because the
saga of Avastin for breast cancer is relevant to right-to-try bills, but not in 
the manner implied. Contrary to the arguments made in favor of right-to-try laws
that a single phase I trial is enough for a treatment to be deemed “safe,” even
though Avastin was FDA-approved for other cancers and provisionally approved
for breast cancer, in the subsequent clinical trials for advanced breast cancer 
there was evidence of harm due to Avastin. That harm likely accounted for why
the increase in PFS did not translate into an improvement in OS. Specifically,
the drug’s toxicity likely “took back” those gains in PFS. As Fran Visco of the 
National Breast Cancer Coalition put it, “The FDA should never have approved
Avastin for breast cancer to begin with. We don’t see evidence of benefit, but
we do see evidence of harm.” And that was just Avastin, not a drug with much
less extensive testing, such as the experimental therapies right-to-try bills
propose releasing “into the wild,” so to speak.

So what do the Michigan bills SB 991 (Senate) and HB 5651 (House) propose? It’s 
basically very similar to the Colorado law and the Goldwater Institute
boilerplate, with a couple of notable exceptions. For example, SB 991 requires:

  1. A statement in the “written informed consent” for using the experimental drug 
    that informs the patient that “the patient’s eligibility for hospice care
    may be withdrawn if the patient begins curative treatment and that care may 
    be reinstated if the curative treatment ends and the patient meets hospice
    eligibility requirements.”

  2. A statement in the “written informed consent” for using the experimental drug 
    that attests that the “patient understands that he or she is liable for all 
    expenses consequent to the use of the investigational drug, biological
    product, or device and that this liability extends to the patient’s estate, 
    unless a contract between the patient and the manufacturer of the drug,
    biological product, or device states otherwise.”

The first of these is odd and unnecessary in that hospices tell patients up
front that if they undertake curative treatment again they are no longer
eligible to be in hospice while undergoing the treatment. Including such a
provision in SB 991 strikes me as redundant, a duplication of law and policy
that already exists for hospices. The second of these is to me quite
objectionable. Not only does it put the patient on the hook for any expenses or 
debt that he incurs using experimental treatments, but it seems custom-made for 
drug companies, to make sure that they get their money for experimental
therapies administered under “right-to-try,” no matter what, even letting them
go after a deceased patient’s estate, something that will frequently be
necessary because patients eligible for “right-to-try” by definition have a
terminal illness, and the vast majority of even the most promising drugs will
likely only prolong their life, not save it. Either way, both of these Michigan 
provisions make a bad bill even worse.

In fairness, though, there is also a provision that explicitly states that a
patient’s heirs are not liable for outstanding debt related to the treatment or 
lack of insurance and specifies that this act “does not affect any mandatory
health care coverage for participation in clinical trials under the insurance
code of 1956, 1956 PA 218, MCL 500.100 to 500.8302,” which, unlike the weasely
language in Colorado’s law, means that insurance companies must continue to
cover all treatments not related to the experimental treatment. Also in
fairness, SB 991 does add a provision to the usual Goldwater Institute
boilerplate that states that “an official, employee, or agent of this state
shall not block or attempt to block an eligible patient’s access to an
investigational drug, biological product, or device” by adding that “counseling,
advice, or a recommendation consistent with medical standards of care from a
licensed health care provider is not a violation of this section.” As faculty at
a state institution, I would have been very worried about the part about not
blocking access as a provision that might get me in trouble if I were simply to 
voice my medical opinion.

There was also a curious substitution resulting in a “substituted bill” for SB
991 that stops referring to “terminal illnesses” and instead refers to such
illnesses as “advanced illnesses”:

   (a) “Advanced illness” means a disease or medical or surgical condition with 
   significant functional impairment that is not reversible even with
   administration of current federal drug administration approved and available 
   treatments that is expected to result in death or a state of unconsciousness 
   from which recovery is not expected. For purposes of this act only, advanced 
   illness has the same general meaning as terminal illness has in the medical
   community.

For the life of me, I can’t figure out why this change was made, when the
substituted bill states that for the purposes of this bill “advanced illness has
the same general meaning as terminal illness has in the medical field.” I can’t
help but get a sneaking suspicion, which could be wrong, that perhaps the
bill’s sponsors are already thinking ahead to eventually expand eligibility for 
right-to-try to patients who are not terminally ill by laying the groundwork to 
have “advanced illness” associated with right-to-try rather than just terminal
illness. I could be wrong, of course. Alternatively maybe there’s some
regulatory or political reason for the substitution. Either way, the Michigan
right-to-try bills are in some ways worse and in some ways not as bad as the
Colorado right-to-try law. That doesn’t change how much these laws are flawed in
their very conception.

The problem with right to try

I can understand the desperation of families, at least, facing the loss of a
loved one to a terminal disease, be it cancer or something just as bad or even
worse, such as amyotropic lateral sclerosis (ALS), more commonly known to the
public as Lou Gehrig’s disease. After all, it was only five years ago that my
wife and I faced the death of her mother from metastatic triple negative breast 
cancer, including brain metastases. Knowing, as all cancer doctors do, that it
could happen to me (particularly now that I’m on the wrong side of 50), I can’t 
even guarantee that I wouldn’t be tempted by the siren call of right-to-try were
one of these bills, or some variant thereof, to be passed into law in Michigan 
and I later was diagnosed with a terminal illness.

Even so, when people ask, “What’s the harm? and “How can it get worse?” I know
that there is harm and it can get worse. If there’s anything worse than dying
prematurely of a terminal illness, it’s accelerating your demise, suffering
unnecessarily during the little time you have left, and/or emptying your bank
account while doing either or both of these things. Compassion impels us to want
to help terminally ill people in any way we can, but a less emotional analysis 
of right-to-try bills, coupled with a knowledge of the science and conduct of
clinical trials reveals that these laws, as currently constituted, are almost
universally a bad idea. Indeed, with such a low bar for a drug or device to
qualify for right-to-try (a single phase I trial), it’s almost guaranteed that
such laws are highly unlikely to help, at the cost of a not-insignificant risk
of causing harm. These laws would be less odious if the bar had been raised a
bit, for instance requiring that at least a phase II trial before a drug is
eligible, but that’s not what any of these bills propose.

Right-to-try laws also provide false hope. For one thing, these laws rest on the
faulty assumption that there are all sorts of “miracle drugs” out there that
can save the lives of terminally ill patients if only the FDA would get out of
the way. This assumption becomes rapidly apparent perusing the Goldwater
Institute’s pages on right to try, which is packed with loaded language about
the FDA and terminally ill patients, with every experimental drug apparently
“potentially life-saving” and patients dying because they can’t get these drugs.
Besides the greater likelihood of resulting in patient harm than help, contrary
to what their advocates promise, right-to-try laws won’t deliver increased
access to experimental drugs. The reason, as Jann and I have both explained at
more length before, is because the federal government, through the FDA, controls
drug approval, and federal law trumps state law. State right-to-try laws have
no power over the FDA, and nothing states can do can compel the FDA to abide by 
their right-to-try laws. Moreover, drug companies are understandably reluctant
to allow just anyone the use of investigational drugs still in clinical trials, 
because if something bad happens it could very well affect their application for
approval:

   However, companies and regulators alike have expressed some hesitancies about
   the program. For companies, expanded access means letting products out of
   tightly controlled and heavily monitored environments, potentially subjecting
   the product to incorrect use and previously-unknown adverse events, which
   would still need to be reported to FDA. Such incidents could potentially
   raise questions for regulators, thereby harming the chance of a product
   getting to market. Further, some companies have expressed their fears about
   expanded access programs robbing their clinical trials of some patients,
   which could reduce the statistical validity of a trial and potentially harm
   other patients by delaying a drug’s path to market.

Another issue is a practical one. Manufacturing a new drug for the first time is
expensive, which is why, quite often, only enough is manufactured to supply
approved clinical trials to be used to support an application for FDA approval. 
“On-demand” manufacturing would not be easy to implement, particularly if enough
patients asked for the drug under right-to-try. This could be a particular
problem for small biotechnology companies, which often can barely scrape
together the capital to do the necessary clinical trials to support FDA
approval. Given that these small biotech companies are often the most innovative
and least likely to be seeking approval for “me-too” drugs, the effect of
right-to-try on the pharmaceutical industry’s already weak innovation could be
significant.

It’s also important to note that right-to-try laws are more about ideology than 
science. Proponents and supporters of right-to-try tend to use arguments very
similar to those used by the “health freedom movement” that rely on questions
like, “Who owns you?” and appeals to the belief that the government shouldn’t
tell people how they should manage their health. For instance, the Alliance for 
Natural Health USA, a key “health freedom” organization that advocates relaxing 
laws regulating the practice of medicine, the better to let more quackery
flourish, is very much in favor of a federal version of “right-to-try,” which is
every bit as much a bad idea as the state right-to-try laws, given that it
would actually do something. The Goldwater Institute, in an article promoting
right-to-try, gives itself away by bemoaning the expansion of FDA authority in
the 1960s by the Kefauver-Harris Amendments that required that the FDA not just 
require demonstration of safety but of efficacy as well before approving new
drugs. This expansion of FDA power was in reaction to the thalidomide debacle,
leading the Goldwater Institute to make the bizarre argument that because the
issue with thalidomide was a safety problem, not an efficacy problem and because
thalidomide was never approved in the US (mainly due to the FDA, let’s not
forget), the expansion of FDA power in response to the thalidomide debacle was
“unwarranted.”

Unfortunately, right-to-try bills and laws are nothing but feel-good measures
that provide the illusion of actually doing something without actually doing
anything substantive to help desperately ill patients, particularly given that
the FDA already has an expanded access program to allow patients to use drugs
outside of clinical trials. There are estimated to be 1,000 requests per year
now, and it is uncommon for the FDA to deny a request for expanded access.
Indeed, in FY2013, only three such requests were denied; in 2012, four; in 2011,
one; and in 2010, sixteen. If, as proponents of these bills believe, expanded
access programs aren’t easy enough to access, the answer is not to pass state
right-to-try laws. It’s to reform the FDA’s expanded use program, something
that’s occurred before and is ongoing, just as the FDA has developed a
“fast-track” approval program, the same one under which Avastin was approved.

As David Kroll pointed out, true compassionate use reform will require that we
as a society come to an agreement about the balance between access and
scientific rigor, realizing that unapproved drugs, particularly the biologicals,
such as monoclonal antibodies (which are very tricky to manufacture), are often
in short supply. It doesn’t help terminally ill patients if patients demanding 
right-to-try put companies in a dilemma in which they either surrender some of
their precious stock of investigational drug for “right-to-try” requests, thus
endangering the company’s ability to conduct proper clinical trials, nor does it
help patients to spend their life’s savings on investigational drugs that are
unlikely to help them and could hurt them. Although their supporters are
well-meaning and sincerely think they are helping the most desperate of their
fellow human beings, right-to-try laws are a cruel sham perpetrated on
terminally ill patients and should be opposed wherever they metastasize.

Using the fear of Ebola to promote the placebo legislation that is “right to
try”

Libertarians and free market fundamentalists generally detest the FDA and want
to dramatically decrease its power in the belief that the free market can
guarantee the safety of drugs better than a government agency that requires
strong scientific evidence of efficacy and safety before approval. Not
surprisingly, they’re at it again, this time in the service of promoting
“right-to-try” laws and using the fear of Ebola to argue for a weakening of FDA 
regulatory standards and to falsely claim that the FDA’s caution kills more
people than it saves.

David Gorski on November 2, 2014

Link





Rick Snyder at 2011 Michigan Gubernatorial Inauguration

Perhaps the most pervasive medical conspiracy theory of all involves stories
that there exist out there all sorts of fantastic cures for cancer and other
deadly diseases but you can’t have them because (1) “they” don’t want you to
know about them (as I like to call it, the Kevin Trudeau approach) and/or (2)
the evil jackbooted thugs of the FDA are so close-minded and blinded by science 
that they crush any attempt to market such drugs and, under the most charitable 
assessment under this myth, dramatically slow down the approval of such cures.
The first version usually involves “natural” cures or various other alternative 
medicine cures that are being “suppressed” by the FDA, FTC, state medical
boards, and various other entities, usually at the behest of their pharma
overlords. The second version is less extreme but no less fantasy-based. It
tends to be tightly associated with libertarian and small government fantasists 
and a loose movement in medicine with similar beliefs known as the “health
freedom” movement, whose members posit that, if only the heavy hand of
government were removed and the jack-booted thugs of the FDA reined in, free
market innovation would flourish, and the cures so long suppressed by an
overweening and oppressive regulatory apparatus would burst the floodgates.
Under this views, these cures, long held back by the dam of the FDA, would flow 
immediately to the people, and there would be much rejoicing. (Funny how it
didn’t work out that way before the Pure Food and Drug Act of 1906.) Of course, 
I can’t help but note that in general, in this latter idea, these fantastical
benefits seem to be reserved only for those who have the cash, because, well,
the free market fixes everything. At least, that seems to be the belief system
at the heart of many of these conspiracy theories.

The idea that the FDA is keeping cures from desperate terminally ill people,
either intentionally or unintentionally, through its insistence on a rigorous,
science-based approval process in which drugs are taken through preclinical
work, phase 1, phase 2, and phase 3 testing before approval is one of the major 
driving beliefs commonly used to justify so-called “right-to-try” laws. These
bills have been infiltrating state houses like so much kudzu, and the Ebola
outbreak has only added fuel to the fire based on the accelerated use of ZMapp, 
a humanized monoclonal antibody against the Ebola virus, in some patients even
though it hadn’t been tested in humans yet (more on that later). Already four of
these laws have been passed (in Colorado, Missouri, Louisiana, and now
Michigan) with a referendum in Arizona almost certain to pass next week to bring
the total to five states with such laws. Basically, these laws, as I’ve
described, claim to allow access to experimental drugs to terminally ill
patients with a couple of major conditions: First, that the drug has passed
phase I clinical trials and second that the patient has exhausted all approved
therapies. As I’ve explained before more than once, first when the law hit the
news big time in Arizona and then when a right-to-try bill was introduced into
the legislature here in Michigan, they do nothing of the sort and are being
promoted based on a huge amount of misinformation detailed in the links earlier.
First, having passed phase 1 does not mean a drug is safe, but right-to-try
advocates, particularly the main group spearheading these laws, the Goldwater
Institute, make that claim incessantly. Second, they vastly overstate the
likelihood that a given experimental drug will help a given patient. The list
goes on.

Unfortunately, two weeks ago, the cruel sham that was the Michigan right-to-try 
bill was passed into law and signed by Governor Rick Snyder. It’s rather
interesting how this came about. Senator John Pappageorge introduced Senate Bill
991 in the Michigan Senate over the summer. There was very little news
coverage, which I considered odd, given the heavy news coverage of right-to-try 
bills in other states. In fact, I only happened to hear that the Michigan
right-to-try bill had even been introduced into the Senate when a colleague
whose job in part happens to involve dealing with the legislature gave me a
heads up. I also learned from asking around that, in addition to home grown
patient advocates supporting the bill, there was a flack from the Goldwater
Institute flown in to testify and that no one from Michigan universities or
academic medical centers was particularly eager to testify against the bill due 
to the expected backlash.

As I’ve said many times before, both in posts about right to try and about
Stanislaw Burzynski, I can totally understand the patient impetus for these
laws, given that I have had family members with terminal illnesses.
Unfortunately, however, forces like the Goldwater Institute are taking advantage
of the very human desire not to die and not to be forced to watch one’s loved
ones die, all in order to push bad legislation. Indeed, the Goldwater Institute 
uses terminally ill patients desperate for their lives in much the same way
Stanislaw Burzynski uses them: As shields and weapons in their battle against
the FDA and state medical boards. That’s why, as I’ve morbidly joked before,
being against right-to-try in the eye of the public is not unlike being against 
Mom, apple pie, the American flag, and puppies, hence the reluctance of even
doctors doing clinical trials to publicly voice opposition. The most predictable
attack against anyone who dares to publicly oppose these bills has been to
portray opponents as not just callous, but as practically twirling their
mustaches with delight and cackling evilly while watching terminally ill
patients die without hope. (I exaggerate—but only slightly.) Few are the
physicians and scientists (and even fewer still the medical centers and
universities) who want to risk being portrayed that way, and one person who did 
testify against the bill reported enduring withering looks from patient
advocates there to testify for the bill, who, like Burzynski patients and
families, really do view opponents of right-to-try as enemies actively seeking
to cause harm and to prevent them from saving their lives or the lives of family
members.

Before I knew it, Senate Bill 991 had passed overwhelmingly. So, seeing what was
coming next, I wrote to my House Representative to urge that he oppose the
bill, House Bill 5651. He was receptive and a little surprised that anyone would
be against the bill, but he admitted that my arguments made him think. Even so,
I was under no illusion that he was likely ever to vote against it. He didn’t. 
Because it was too late and the law had already been passed by the senate,
making writing to my state senator (whom we’ve met before) pointless, I instead 
wrote his opponent running for his State Senate seat, because (1) she is in the 
House and could still affect the outcome and (2) perhaps she wanted to hear from
someone considering voting for her. I never got a response; so at least in that
aspect my Representative did better. At least he listened and responded. None
of it, whether it came from me or the feeble opposition, mattered. It is, after 
all, an election year, and every single one of these legislators, as well as
Rick Snyder, are running for election or re-election. On October 1, House Bill
5651 passed the House unanimously and was signed by Governor Rick Snyder on
October 17. Interestingly, despite my having tried to pay close attention to
news reports and House activity, I only learned of this a week ago, when news
stories noted that Snyder had already signed the bill! There was virtually no
discussion and very little news coverage. The fix appeared to have been in, as
this bill passed with about as close to zero news coverage as I’ve seen for a
bill this major in every other state where it’s appeared.

Not surprisingly, “health freedom” advocates and some libertarians are declaring
this a big “win” for patients’ rights. It’s nothing of the sort. The flavor of 
the arguments can best be seen in two articles from Reason.com’s Nick Gillespie,
who is clearly clueless about clinical trials. Basically, he took to Reason.com
to gloat, referencing an article from over two weeks ago that he entitled “The 
Upside of Ebola (Yes, There May Actually Be One)“. It’s about as blatant a move 
to take advantage of the Ebola outbreak to promote bad right-to-try legislation 
as I’ve ever seen. The subtitle exults:

   A rising death toll, mass panic, scary mortality rate—what could possibly be 
   good about the out-of-control epidemic? It may accelerate the adoption of
   laws giving patients more power.

So let me get this straight. Thousands of people are dying of a horrible disease
in Africa while people in the U.S. are freaking out about the possibility of
the virus causing outbreaks right here at home, and Gillespie sees these events,
apparently more than anything else, as an opportunity to push his libertarian
agenda with respect to medicine. No one would be that cynical, would he? Wrong:

   Ebola’s arrival and seeming spread in America is causing mass panic,
   tasteless Internet jokes, and incredibly poorly timed magazine covers. Can
   anything good come out of the disease, which has no known cure and a
   terrifying mortality rate of 50 percent?

   Yes. To the extent it forces a conversation about the regulations surrounding
   the development of new drugs and the right of terminal patients to
   experiment with their own bodies, Ebola in the United States may well
   accelerate adoption of so-called right-to-try laws. These radical laws allow 
   terminally ill patients access to drugs, devices, and treatments that haven’t
   yet been fully approved by the Federal Drug Administration and other medical
   authorities. The patients and their estates agree not to bring legal action 
   against caregivers, pharmaceutical companies, and insurers.

   You don’t have to be a doctrinaire libertarian—though it helps—to see the
   value in letting people with nothing left to lose experiment on themselves.
   They may get a new lease on life. The rest of us get meaningful information
   that may speed up the development of the next great medical intervention.

Actually, you do rather have to be a doctrinaire libertarian to have a
reality-distortion field as powerful as Nick Gillespie’s to write drivel like
this. Ebola and right-to-try laws. Hmmmm. How is one thing not like the other
(or not related to the other)? First of all, Gillespie’s rationale is a complete
non sequitur, clearly designed to take advantage of the Ebola panic to persuade
people that right-to-try laws are a good idea, even though such laws would not 
have had one whit of an effect on the odd patient in the US who might be
infected with Ebola. After all, Ebola, as deadly as it is, is not a terminal
illness. With good supportive care, around half, possibly more, survive the
disease. Second, I can’t help but note that existing FDA mechanisms got ZMapp to
American Ebola patients rather rapidly, even briefly bypassing phase 1 studies,
no need for right-to-try laws necessary. But excuse me. What Gillespie says is 
that Ebola and ZMapp are “forcing a conversation.” I suppose that’s true, but
it’s the wrong conversation, a profoundly deceptive conversation, in which an
advocate of right-to-try laws shamelessly takes plays on people’s fears of Ebola
to promote these bad laws. Claiming that there is “no good argument against
right-to-try” (wrong, wrong, wrong, wrong), Gillespie also shamelessly attacks
straw men, representing the primary argument against right-to-try as giving
patients “false hope.” There are lots of other reasons why these are bad laws.

But Gillespie is just getting warmed up:

   But what’s already cruel is the FDA’s drug-testing process. It’s massively
   expensive and overly long, costing between $800 million and $1 billion to
   bring a drug to market and taking a decade or more to complete the approval
   process. There’s every reason to believe that the FDA approval process is
   killing as many or more people than it saves, especially as the FDA doesn’t
   allow approvals from Europe and elsewhere to stand in for trials here.

No. Just no. There is not “every reason to believe” anything of the sort. See?
Once again, there’s the myth that there are all these fantastic cures out there 
that the FDA, through its bureaucratic inertia, is keeping from you. I am rather
grateful, though, that Gillespie, through his link, makes his intent very
clear. The article to which he links is entitled “Kill The FDA (Before It Kills 
Again).” In the article, referencing the movie Dallas Buyers Club—which I
finally saw on cable and was surprised to find that, leaving aside its
historical inaccuracies about the AIDS epidemic in the 1980s, taken just as a
movie it was at best just OK (I was seriously disappointed)—Gillespie proclaims 
that the FDA “continues to choke down the supply of life-saving and
life-enhancing drugs that will everyone agrees will play a massive role not just
in reducing future health care costs but in improving the quality of all our
lives.” And what is his rationale? Wrap your mind around this:

   As my Reason colleague Ronald Bailey has written, this means the FDA’s
   caution “may be killing more people than it saves.” How’s that? “If it takes 
   the FDA ten years to approve a drug that saves 20,000 lives per year that
   means that 200,000 people died in the meantime.”

Completely missing from Bailey’s and Gillespie’s equation is the number of drugs
that the FDA doesn’t approve because they don’t show efficacy and safety that
could allow even more than those 20,000 people a year to die or even actively
kill some of them. As conceded by even Bailey, it was the FDA that prevented,
for example, approval of Thalidomide in the US and the rash of birth defects
seen elsewhere in the world. Bailey’s argument is, at best, tenuous, at worse
misleading. (I favor worst. It’s just plain misleading.) Gillespie notes:

   A 2006 Government Accountability Office (GAO) study found that the number of 
   new drug applications submitted to the FDA between 1993 and 2004 increased by
   just 38 percent despite an increase in research and development of 147
   percent. The mismatch, said GAO, was the result of many factors, ranging from
   basic issues with translating discoveries into usable drugs, patent law, and
   dubious business decisions by drug makers. But the problems also included
   “uncertainty regarding regulatory standards for determining whether a drug
   should be approved as safe and effective,” a reality that almost certainly
   made pharmaceutical companies more likely to tweak old drugs rather than go
   all in on new medicines.

Notice how this is another non sequitur applied to right-to-try laws, given that
the answer to this problem would be improving regulatory clarity, not passing
state-by-state right-to-try laws. Think of it this way: What’s more uncertain?
The FDA or having different laws in different states regarding “right to try”?
Gillespie’s citing his previous article claiming that the FDA is killing you in 
an article promoting right-to-try is a very good indication what these laws are 
really about. Let’s be very, very clear here. They are not about helping
patients. That’s how they are sold to desperately ill patients, which is why I
must repeat: In reality libertarians like Gillespie and Bailey are using
desperately ill patients in the same way that Stanislaw Burzynski uses his
patients: As a powerful tool to sway public opinion against the FDA and towards 
their viewpoint.

There’s a reason that certain aspects of these laws are not as widely emphasized
in the PR offensive in favor of right to try. It’s because they are pure
“health freedom” and libertarian wingnuttery. For example, if you look at the
Goldwater Institute template for right to try laws, which, unfortunately, has
been the basis of every right to try law passed and under consideration, you’ll 
notice a number of highly problematic clauses. As I’ve discussed multiple times,
there is the requirement that the drug or device has only passed phase 1
trials, which, given how few drugs that have passed phase 1 actually make it
through to approval, is a really low bar, especially since most phase 1 trials
involve fewer than around 25 patients.

More disturbing are the financial aspects. The Goldwater Institute legislative
language template (to which the Michigan legislation is virtually identical)
allows drug companies to charge patients, with no provision to help patients pay
for exercising right-to-try. Indeed, it specifically states that the bill “does
not require any governmental agency to pay costs associated with the use, care,
or treatment of a patient with an investigational drug, biological product, or 
device” and that insurance companies do not have to pay for costs associated
with the use of such therapies. You know what this means? Insurance companies
could refuse to pay for care related to complications that might occur because
of experimental treatments. You use an experimental drug and suffer a
complication? Too bad! Your insurance company can cut you off! Now, it’s
unlikely that government entities like Medicare or Medicaid would do that, but
insurance companies certainly will.

Basically, what this law says is: If you can afford it yourself, no help, you
can have it. If not, you’re S.O.L. As I’ve pointed out, if there’s one thing
worse than dying of a terminal illness, it’s suffering unnecessary complications
from a drug that is incredibly unlikely to save or significantly prolong your
life and bankrupting yourself and family in the process. Right-to-try encourages
just that. What’s more compassionate? Attacking the FDA and degrading the
approval process that requires drug safety and efficacy while dangling false
hope in front of patients or standing up and protecting patients from the harm
such a policy could cause? Let’s just put it this way: I predict that Stanislaw 
Burzynski will soon be sending antineoplastons to patients in right-to-try
states if, as he keeps bragging, the FDA has allowed him to reopen his clinical 
trials. After all, his antineoplastons would qualify just fine under
right-to-try laws if they’re back under clinical trial. Indeed, if there’s one
thing the decades-long battle between the FDA and Burzynski tells us, it’s that 
the FDA actually bends over way too far backwards to allow manufacturers of
dubious drugs to prove themselves.

Finally, the anti-FDA rhetoric, such as linked to by Gillespie, is a very good
indication that the true purpose of right-to-try legislation is to neuter the
FDA’s power to control drug approval, thus greatly loosening or even eliminating
hurdles to the drug approval process. It is no coincidence that the strongest, 
richest, and most vocal proponents of these laws are the Goldwater Institute and
libertarians like Nick Gillespie and Ronald Bailey, who, not coincidentally,
think that the FDA is “killing us.” Those articles are a definite “tell.” It’s
also clearly a strategy to get right-to-try passed in as many states as possible
and get referendums passed by wide margins to pressure the federal government
to weaken the FDA.

In the end, though, right-to-try laws are what I like to call “placebo” laws in 
that they make people who pass them and support them feel good but don’t
actually address the problem that they are supposedly intended to address. Drug 
approval regulatory authority lies with the FDA; it could completely ignore
state right-to-try laws. Even supporters realize this and realize that there
will likely lead to a “long, drawn-out court battle over state vs. federal
sovereignty.” The FDA also already has a compassionate use program and rarely
turns down such requests. Admittedly, the application process is long and
probably too onerous, but the answer to that problem is not to pass state
right-to-try laws. It’s to address the issue at the federal level. I’ve also
said in an interview that, now that my state government has foolishly passed a
right-to-try law, one of two things is likely to happen: Either nothing, because
federal authority trumps state authority, or disaster for patients, doctors,
and, yes, biotech and drug companies. Everybody, myself included, wants to help 
terminally ill patients. After all, I’ve seen too many of them. Right-to-try and
similar misguided efforts, however, are not the way.

                              Health Care Freedom

                                 Steven Novella

                                      Link

Freedom is a cherished commodity in our culture, as it should be. Our laws are
largely based upon the premise that individuals should have the liberty to do
what they want, unless there is a compelling public or governmental concern that
overrides such liberties.

It is therefore no surprise that freedom is a common marketing theme – selling
the idea of individuality or personal freedom of choice.

The marketers of dubious, unscientific, or fraudulent health care products and
services are savvy to the marketing theme of freedom and have used it to great
effect. It is all ultimately, however, a deception. There is an ulterior motive 
that has nothing to do with the freedoms of the public but rather is an end run 
around regulations meant to protect the public.

Health Care Regulation and the Standard of Care

The primary deception of the health care freedom movement is that it pretends to
be about the freedom of the individual consumer, but rather it is about the
freedom (from regulation and the standard of care) of the seller or provider.
Health care freedom is ultimately anti-consumer and pro-industry.

To understand this you have to understand the contract that health care
providers have with society and the role of regulation.  Selling health care
services or products is not a universal right. Rather it is treated as a
privilege, one that is earned by adhering to a certain quality control standard.
The obvious purpose of this is to protect the public from useless, harmful, or 
fraudulent health claims or practice.

Practitioners earn this privilege through licensure, which requires completion
of a proscribed training program, the passing of exams, and adherence to a set
of ethics and guidelines. Most people would agree that not anyone should be
allowed to hang up the proverbial shingle and start performing brain surgery.
Conversely this means that the public should be protected from untrained
charlatans trying to pass themselves off as brain surgeons.

This regulation of practitioners is also tied to the concept of the standard of 
care. This means that if one is licensed as a medical physician, they should
practice medicine. Having a license as a specific kind of professional should
not allow one to do anything under that umbrella. In health care this means
staying within the broadly defined standard of care.

Practitioners who stray too far from the accepted practices of their profession 
can be disciplined by the states who grant them their license. This is
reasonable because the license to practice is a privilege that comes with
specific strings attached, including the requirement to stay within the scope of
practice of your profession.

For products there are federal regulations meant to protect the public from
fraud or harm. The FDA in the United States controls drugs and medical devices
and has very rigorous standards of evidence for both safety and effectiveness.

Health Care Freedom

There are those with a libertarian political bent who argue that all this
quality control is not necessary, that the free market can sort it all out, or
that individual freedoms are more important than protecting the public from bad 
medicine. Although I strongly disagree with this position, I grant this is
largely a political position – which means it is partly a personal choice. What 
do you value more – protection or freedom?

However, there is another group promoting health care freedom, and not because
of their libertarian ideology. Specifically these are practitioners who wish to 
be freed from regulation or the scope of their license and those who wish to
sell products that either violate FDA regulations or that are simply fraudulent.

These two camps have found common cause (for example). Libertarian Ron Paul has 
embraced so-called alternative medical practices and made it part of his
campaign against “unbridled government regulation.”

(As an aside, recently, to add a bit of confusion, the term “health care
freedom” has been adopted by several organizations who are promoting freedom to 
choose one’s own insurance plan and physician. This has nothing to do with the
health care freedom movement I am discussing.)

Health Care Freedom Laws

Sixteen states in the US have so-called health care freedom laws. Essentially
what these laws do is create a double standard. The wording in each state is
different, but their effect is the same – a practitioner of unscientific methods
cannot have their license taken away or acted against because they are
practicing substandard care as long as that care is deemed “alternative.” In
other words, if an MD is practicing “conventional” medicine but what they are
doing is significantly below the standard of care (it is demonstrably unsafe or 
ineffective), the state can act against their license. If, however, the same
physician practices the same incompetent medicine, but labels it “alternative”
they are immune from any action.

I have personally encountered exactly this situation. I was asked to give
standard of care testimony against a Florida neurologist who was practicing, in 
my opinion, outright quackery. It was determined by the court, after hearing all
the testimony, that indeed the physician was practicing substandard care.
However, he appealed under Florida’s health care freedom law, claiming that what
he was doing was alternative, and this appeal was successful. So now he is free
to practice his unmitigated quackery, unhindered by any quality control.

Unfortunately these laws are making steady progress. There are groups who
relentlessly lobby for such laws, usually under the public radar. Slowly, the
standard of care is being erased from medical practice.

Conclusion

Essentially, con artists, charlatans, and snake-oil salesmen have discovered
that they can shield themselves from regulations meant to protect the public
from their malfeasance by simply cloaking what they do in the flag of freedom.

They have found common cause with those who are sincere, but simply misguided – 
they believe that their treatments are effective and valid and are frustrated by
the fact that they are not validated by science and do not meet the standard of
care. Failing to win acceptance for their modality with research, they then
dismiss the standard of care as biased against them, and seek to subvert it.

The promoters of dubious indications for chelation therapy, for example, have
been on the forefront of the health care freedom movement.

Finally, they have joined forces with the ideologically libertarian,who oppose
government regulations of all kinds. At least libertarians are honest about
their agenda – they want less government regulation.

Ultimately issues of regulation vs freedom are societal and political. They are 
not strictly about science, although with regard to medicine the standard of
care is (or at least should be) based upon scientific evidence. My point in this
post is not to take a political side. Rather, to point out the real agenda and 
implications of the health care freedom movement.

Health care freedom laws are about giving practitioners and marketers freedom
from regulations and the standard of care. It is not about the public’s freedom 
of choice. It is about eliminating scientific standards for those who want to
engage in unscientific practices.

There is also a parallel to be made with other recent “freedom” movements, such 
as creationists promoting academic freedom. Science teachers and professors who 
want to teach their religious views or simply nonsense that is not accepted by
the mainstream scientific community as science, are playing the same “freedom”
card. They confuse (or at least pretend to confuse) legitimate measures to
ensure academic quality with oppressing academic freedom. But what they really
want is to subvert academic quality to their own ideological agenda.

I don’t mind honest and open discussions about the proper balance between
freedom and regulation for quality control.  But the health care freedom and
academic freedom movements are not honest and open. They are deceptive about
their true intention. To them “freedom” is just a marketing ploy.

Sarah Hershberger: “Health freedom” and parental rights vs. child welfare

David Gorski on October 12, 2015

Link



Sarah Hershberger, pictured with her family in a screenshot from a 2014
Reason.tv video.

One of the more depressing topics that I regularly write about on this blog
includes of analyses of news stories of children with cancer whose parents
decided to stop science-based treatment (usually the chemotherapy) and use
quackery instead. There are, of course, variations on this theme, but these
stories take form that generally resembles this outline: A child is diagnosed
with a highly treatable cancer with an excellent cure rate. Standard
science-based treatment is begun, but the child suffers severe side effects from
the chemotherapy. After an incomplete course of chemotherapy, the parents,
alarmed at their child’s suffering, start balking at further chemotherapy,
either because the child refuses further treatment or because they do. At some
point in this process the parents become aware of the claims of practitioners of
this or that alternative medicine, who tell them that their child’s cancer can 
be cured without toxic chemotherapy, and, wooed by the siren song of a promise
of a cure without suffering, the parents choose that instead. At this point,
physicians, alarmed at the parents’ choice, call in their state’s child
protective services team, and a court battle ensues. Sometimes the court battle 
results in an order that the child complete conventional therapy, as it did
with, for example, Daniel Hauser or Cassandra Callender. Sometimes it ends with 
a compromise in which the child and/or parents can choose an unconventional
practitioner, as in the case of Abraham Cherrix. All too often the courts
utterly fail to protect children with cancer, as the Canadian courts did in the 
cases of Makayla Sault and JJ. Not infrequently, if the court rules against the 
parents, the parents flee with their child to avoid treatment, as happened with 
Daniel Hauser, Abraham Cherrix, and Sarah Hershberger. Usually, they ultimately 
come back.

However they turn out, over the years of looking into them I’ve found that these
stories tend to bear a depressing similarity and predictability. For example,
if the child does well, it is always attributed to the alternative treatment,
even when the child received a significant amount of conventional therapy. This 
attribution derives from a fundamental misunderstanding of how the treatment of 
cancer works in that the problem with incomplete cancer treatment is not that it
can’t cure the cancer but that it has less of a chance of doing so. As I’ve
explained many times, the reason that treatment regimens for many pediatric
cancers involve two years’ worth of chemotherapy is that over time pediatric
oncologists learned the hard way that, although the first cycle of chemotherapy 
(usually called induction chemotherapy) can lead to remission, without the
additional cycles the chances of recurrence are very high—unacceptably so.
Consequently, children who stop chemotherapy early can be in remission; they’ve 
just been put at a high risk of recurrence.

The medical neglect of an Amish girl from Ohio

This brings us to the case of Sarah Hershberger, mentioned above, who has been
in the news again lately described as being “cancer-free.” Before I address this
new development, a brief recap of her case is in order. Hershberger is a
10-year-old Amish girl living in Medina County, Ohio, who was diagnosed in 2013 
with T-cell lymphoblastic lymphoma, an aggressive form of lymphoma. She
underwent chemotherapy for a few weeks under the care of pediatric oncologists
at Akron Children’s Hospital (ACH), but then decided she didn’t want it anymore 
because of the side effects. Her parents, convinced that the chemotherapy was
killing Sarah, instead of insisting that she undergo potentially curative
therapy, which her doctors estimated to have an 85% chance of eliminating her
cancer, refused to let her undergo any further therapy. Their refusal led ACH to
sue to obtain medical guardianship of the girl in order to make sure that she
would undergo curative chemotherapy. The first ruling in the case in a Medina
County court was for the parents. Then on appeal the 9th District Ohio Court of 
Appeals ordered Medina County Judge John Lohn to take another look at the case, 
ruling that he had failed to weigh adequately which course would best serve her 
interests — the decision of her parents to withhold treatment (at her request)
or to appoint a limited guardian to make medical decisions, as proposed by Akron
Children’s Hospital. Not surprisingly, Judge Lohn reiterated his previous
ruling, finding that appointment of a guardian would interfere “with Sarah’s
need and desire to be cared for by her loving parents” and stating that “the
guardianship will not promote Sarah’s interests.” Ultimately, Judge Lohn’s
decision was reversed on appeal to the 9th District Ohio Court of Appeals.
Ultimately, a nurse named Maria Schimer was appointed Sarah’s medical guardian, 
who weathered an incredible amount of abuse for her willingness to step up and
take this role.

So for, so good, right?

Well, no, as I mentioned before, the Hershbergers fled. It’s unclear where,
because at the time it wasn’t clear whether they had gone to Mexico or were
hiding out in the Amish community in Medina County, where law enforcement
officials were not exactly enthusiastic about seriously searching for her.
According to David Michael, she was in Central America receiving treatments that
included high dose vitamin C and B17 (the latter a.k.a. as Laetrile), oxygen
therapy, detoxification methods, and IV chelation therapy, as well as a special 
diet.

It didn’t take long for a Libertarian “health freedom”-advocating lawyer at the 
1851 Center for Constitutional Law to latch on to the Hershbergers’ case, and,
ultimately, Schimer ended up resigning as medical guardian because she couldn’t 
actually fulfill her role and monitor Sarah’s health once the family went into
hiding. After this, ACH seemed to back off. When last I noted Hershberger’s case
in February 2014, the libertarians at Reason.tv were, despicably, defending the
medical neglect of this child as a valid exercise of parental rights and
“health freedom” while revealing that they had also taken her to a local
naturopath named Angela Lowther in Avon Lake, OH. After that point, even though 
I had Google Alerts set up for this case, I saw almost no news; that is, until
now.

How is Sarah Hershberger doing now?

I was originally going to blog about this two weeks ago, when I first noted that
Maurice Thompson, Executive Director of the 1851 Center for Constitutional Law,
had posted an update, ‘Amish Daughter Healthy Despite Health Care “Experts.”‘
However, I wanted to be able to read the actual court documents, given that
Thompson’s blog post was predictably and relentlessly one-sided, referring to
Sarah Hershberger’s case as “medical kidnapping” and calling her illness a “mild
form of cancer.” One notes that childhood T-cell lymphoblastic lymphoma is not 
a “mild” cancer, and the only reason it has such a high cure rate is because of 
modern chemotherapy, complete with induction chemotherapy (which Sarah
underwent), consolidation, and maintenance. Before modern chemotherapy regimens,
childhood non-Hodgkin’s lymphoma (which Sarah’s is a form of) had a virtually
100% mortality. Worse, a child’s best shot is her first shot at treatment. The
prognosis for relapsed non-Hodgkin’s lymphoma like the one Sarah has is quite
poor, and survival requires a bone marrow transplant.

So what can we tell about what is really going on? Unfortunately, the court
documents have not yet been posted at the Medina County Court site. Because the 
story has, two weeks later, made its way into the national news in the form of a
story entitled “Judge ends court-ordered guardianship of Amish girl in
chemotherapy fight” and the international news in the form of a Daily Mail story
based on the AP story entitled “Amish girl, 12, is ‘cancer free’ two years
after her family was forced into hiding over court battle to force her to have
chemotherapy, as judge drops case“, I feel I can no longer wait for the court
documents to make it to the website. I have to try to parse what I can now from 
what’s in the news. For instance, quotes that Thompson included from the ruling 
in his blog post are clearly cherry-picked, including:

   Two years later, having never undergone chemotherapy, Sarah couldn’t be
   healthier. Court records disclosed at yesterday’s hearing indicated the
   following:

  1. “[Sarah] exhibits no symptoms of lymphoma”

  2. “There are no reports or indications that Sarah cannot keep up with her work
    or her siblings on a daily basis.”

  3. “Medicine is not always right, as evidenced by Sarah’s survival in the face of
    ‘certainty’ she would die without treatment”

  4. “There is no need for Sarah’s health to be on the Court’s radar”

Elsewhere, Thompson is a lot more circumspect, even acknowledging that, just
because Sarah looks healthy now doesn’t mean she is cancer-free:

   Maurice Thompson, the executive director for the libertarian nonprofit 1851
   Center for Constitutional Law, said the girl, Sarah Hershberger, shows no
   signs of cancer and appears to be healthy.

   “She had MRIs and bloodwork, and the judge over the last year helped
   facilitate at least one trip to the Cleveland Clinic. The MRIs did not show
   any cancer,” Thompson told The Gazette on Friday.

   He said the family will continue to treat the girl with less-invasive,
   alternative medicine.

   “Once you have it, you’re never 100 percent out of the woods, whether or not 
   you get chemotherapy,” he said. “I know how she looks isn’t really an
   indication of whether she has cancer, but she’s looking very healthy.”

I couldn’t help but notice one thing in Thompson’s statement above. It might be 
nothing, or it might be indicative that all is not quite as well as he portrays.
Notice how he points out that she had MRIs and bloodwork but only mentioned
that the MRIs didn’t show any evidence of cancer. I found the omission of
whether the bloodwork showed any evidence of cancer to be curious. As I said, it
might just be my skeptical antennae being hypersensitive, but one wonders. On
the other hand, presumably if Sarah’s bloodwork did show signs of cancer the
judge likely would not have ruled the way he did.

It’s also interesting to note the contrast between what Thompson wrote on his
blog and what he said to an AP reporter. For instance, on his blog he said, “Two
years later, having never undergone chemotherapy, Sarah couldn’t be healthier,”
and castigated experts who “have no skin in the game” and “arrogantly
pontificate without fear of consequences” while being “in fact frequently
wrong.” I don’t know about “frequently,” but, in the case of a child with a
treatable cancer, if the oncologists are telling me that she has a high chance
of dying without further treatment I tend to go with the oncologists. Indeed,
there’s a pretty high probability now that Sarah’s cancer will not relapse, as
most relapses for T-cell lymphoblastic lymphomas occur within two years of
completion of treatment. Knowing that, as I’ve said many times before, it would 
be a great thing if Sarah Hershberger does ultimately survive despite grossly
incomplete treatment, because I don’t want to see a child who might be saved die
unnecessarily of cancer, ever. If the price of Hershberger’s survival is a
cavalcade of quacks exulting about how the oncologists were wrong and natural
therapies cured her, so be it.

The point is this. If Sarah survives without a relapse, I will rejoice. To me,
it will be a fantastic thing because it will mean that she is one of the lucky
ones who didn’t relapse after her induction therapy, even though she never
underwent consolidation or maintenance therapy. If she survives without a
relapse, it will have been due far more to the conventional induction
chemotherapy she received (plus a lot of luck) than to any of the quackery to
which her family subjected her. In essence, she will have survived in spite of
her parents, in spite of the quackery, and in spite of the “health freedom”
machinations of Maurice Thompson. Remember, the additional chemotherapy after
induction chemotherapy decreases the chance of tumor recurrence, and as far as
I’ve been able to glean Hershberger responded very well to her induction phase. 
I realize that this is a message I have to repeat time and time again when I
encounter these cases, that it was the science-based treatment—not the
quackery—that cured the patient, but it is nonetheless true. Unfortunately, it
is a difficult concept to explain, while it is very easy for quacks to make such
cases seem to be excellent examples validating their claims that it is better
to treat cancer with “natural” therapies.

Fortunately, there is still some hope that the court will not completely wash
its hands of the case, as the judge cautioned the parents:

   However, Dunn cautioned her parents that she is not fully recovered and
   warned that they still have a duty to provide her care under Ohio law.

   ‘Her parents are not free to act entirely as they may choose,’ the judge
   said.

On the other hand, who’s going to report the Hershbergers if they endanger
Sarah’s life again? Probably no one.

What the Hershberger story is really about

I started this post by listing the general form stories like that of Sarah
Hershberger take, but there is one more aspect of these stories, perhaps the
most important aspect of all, and that is what these conflicts are really about.
At their heart, they are less about quackery versus science-based medicine,
although that is an important aspect of them, than they are about two things.
The first is so-called “health freedom,” which I like to define as the freedom
of quacks to ply their quackery and patients to choose quackery. Of course,
competent adults already have the freedom to choose quackery if they so
desire—or no treatment at all—for a life-threatening disease. No government, at 
least not in the US, is going to force a competent adult to undergo chemotherapy
for a treatable cancer. The government might require practitioners to be
licensed, as state governments do, or that health care claims be backed by
evidence, as the federal government through the FTC does, or that treatments
used show evidence of efficacy and safety, as the FDA does, but it won’t require
a competent adult to undergo unwanted treatment.

That’s where the second issue comes in, and that issue is a child’s right to
proper medical care. Traditionally, parents, as guardians of their children, are
granted great latitude in how they choose medical care for their children.
Indeed, there is a widespread attitude that the parents’ power to determine what
is best for their children is pretty close to absolute, which is why stories
like Sarah Hershberger’s rile up not just the pro-quackery community but large
swaths of people who seem to conflate their own right to choose whatever medical
care they want for themselves with an absolute right to decide medical care for
their children. We see this conflict when children die because parents choose
prayer over medicine, as happened with Madeline Neumann, an 11-year-old girl
whose parents let her die of diabetic ketoacidosis. Neumann’s case was unusual
in that the parents were actually convicted.

To get an idea of how much deference courts grant to parental “rights,” consider
the case of Catherine and Herbert Schaible. This is a couple who belong to a
church that rejects modern medicine in favor of prayer. In 2009, they were
convicted of involuntary manslaughter in the death of their two-year-old son
Kent, who developed an upper respiratory infection that later worsened to become
severe pneumonia. The Schaibles never took him to a doctor as he got sicker and
sicker. The court sentenced the Schaibles to ten years’ probation with a
promise that they would take their other children to a doctor when they became
ill. To say that this did not work out well is the understatement of the decade.
In 2013, their seven-month-old son Brandon died under nearly exactly the same
circumstances. He developed an upper respiratory infection that was complicated 
with pneumonia and ultimately died of bacterial pneumonia and dehydration. Yes, 
because of deference to parental rights, a second child died unnecessarily in
the very same family.

Similarly, in Sarah Hershberger’s case, “parental rights” ended up trumping the 
child’s right to effective medical care. Indeed, Maurice Thompson is quite
explicit in his desire to strip the courts of pretty much all power to intervene
to prevent medical neglect, as he stated in his blog post two weeks ago,
referring to the court’s action as “medical kidnapping”:

   The Ohio General Assembly – – members of which laud health care freedom,
   family values, and parental choice while campaigning for office – – cannot
   justify maintenance of Ohio’s wide-open and highly subjective “best interests
   of the child” test. This test allows county judges to overrule health care, 
   educational, and other important decisions of suitable Ohio parents. Once
   overruled, children can be immediately seized from their homes.

   In the wake of Sarah’s case, this concept came to be known as “medical
   kidnapping.”

   The Hershberger’s case is a lesson for all of us: we’re not as smart as we
   think we are. Knowledge is decentralized, and when in doubt, those closest to
   the situation, families (and not government experts with special
   designations next to their names) must make life-altering decisions.

   Further, Sarah’s good health bolsters the case against forced health care
   that we supposedly cannot live without (literally, in this case).

   It is now time for Ohio legislators to protect Ohio families from wayward
   judges. This can be done by reforming Ohio’s unconstitutional “best interests
   of the child” test.

Note that what Thompson really appears to mean when he refers to “reforming”
Ohio’s “best interests of the child” test is its elimination, given his extreme 
hostility towards it as an unacceptable infringement on the parents’ freedom.
This is the sort of rhetoric frequently used by antivaccinationists as well. For
instance, Rand Paul made no bones about it in February. Irritated by questions 
about his opposition to school vaccine mandates in the wake of the Disneyland
measles outbreak in January, Paul said bluntly and rather petulantly, “The state
doesn’t own the children. Parents own the children, and it is an issue of
freedom.” We hear the same rhetoric from “Dr. Bob” Sears, who has frequently
equated freedom from vaccines with just plain “freedom,” period. He even went so
far as to liken school vaccine mandates to fascism, complete with comparisons
to the Holocaust.

At its heart, the Hershberger case is yet another example of how society seems
to approve of a view that children are, in essence, their parents’ property more
than they are autonomous beings who have their own rights beyond those of their
parents. Whenever society tries to intervene to prevent parents, who are nearly
always well-meaning and think they are doing what is best for their children,
from harming their children through medical neglect, as parents who refuse
effective cancer treatment for their children do, there is always strong
opposition. I realize that it’s a complicated question to determine when and
under what circumstances it is appropriate for the state to intervene to protect
a child from the bad medical decisions by her parents, but until this attitude 
that children are their parents’ property changes, there will be more Sarah
Hershbergers and Brandon Schaibles.

       t

As in 2014, “right-to-try” laws continue to metastasize in 2015

David Gorski on May 18, 2015

Link



Last year, I did several posts on what I consider to be a profoundly misguided
and potentially harmful type of law known as “right-to-try.” Beginning about a
year and a half ago, promoted by the libertarian think tank known as the
Goldwater Institute, right-to-try laws began popping up in state legislatures,
which I likened to Dallas Buyers Club laws. Both Jann Bellamy and I wrote about 
how these laws are far more likely to do harm than good, and that is a position 
that I maintain today. The idea behind these laws is to give terminally ill
patients access to experimental drugs—in some cases drugs that have only passed 
phase I testing—that might help them. It’s an understandable, albeit flawed
argument. After all, it’s perfectly understandable why terminally ill patients
would fight for drugs that give them hope, and it’s just as understandable why
politicians and the public would see such a goal as a good thing. In practice,
as I will explain again in the context of this update, such laws are far more
likely to harm patients than help them. Indeed, as you will see, in the year
since the first wave of right-to-try laws have passed, not a single patient that
I can find has obtained access to experimental drugs under a right-to-try law, 
much less been helped by them.

Unfortunately, given how effectively “right to try” has been sold on grounds of 
providing terminally ill patients hope and as a matter of personal freedom, it’s
clear that this wave is not going to abate. Since Colorado passed the very
first right-to-try law almost exactly a year ago today, a total of 17 more
states now have passed passed similar legislation, the most recent being
Tennessee, and 22 others have introduced legislation. It’s a good bet that
right-to-try will pass in all of those states, because, as I’ve explained many
times before and in many interviews, if you don’t understand clinical trial
ethics and science, opposing the concept of right-to-try comes across like
opposing Mom, apple pie, and the American flag. It also leaves opponents open to
false—but seemingly convincing—charges of callousness towards the terminally
ill on the order of taking pleasure from drop kicking yipping puppies through
flaming goalposts. (I exaggerate, but only slightly, I assure you.)

The con game that is “right-to-try” metastasizes

As I’ve pointed out many times before, opposing right-to-try is actually
pro-patient, because these right-to-try laws that are passing all follow an
explicit template written by the Goldwater Institute, and that template is very 
much a sham. For one thing, states do not control drug approval; the federal
government through the FDA does. Consequently, state-level right to try laws,
while giving the appearance of giving access to experimental drugs to patients, 
do nothing to actually achieve that goal. Worse, even if a patient were to get
an experimental drug through right-to-try, these laws very much reflect the
think tank that created them in that they leave the patient basically on his
own. He can be charged the full cost of the investigational drug, which means
that the only people who might be able to take advantage of these laws are those
who are already rich or who are very good at fundraising. Worse, these laws
explicitly indemnify drug companies and physicians from any liability arising
from adverse outcomes, which means that even if a physician committed
malpractice in advising or administering right-to-try drugs he probably couldn’t
be sued. Moreover, such laws explicitly bar state employees from blocking or
attempting to block an eligible patient’s access to an investigational drug or
treatment. Even though there is a clause that says “counseling, advice, or a
recommendation consistent with medical standards of care from a licensed health 
care provider is not a violation of this section,” where does “advice” end and
“blocking” begin? Certainly as a physician in what is now a right-to-try state
whose law has identical language, I wonder.

Even worse still, many of these laws, such as the one in Michigan, are written
such that if a patient suffers a complication from a right-to-try drug or
treatment his insurance company can argue that it doesn’t have to pay for the
resulting care to treat that complication. Indeed, Colorado’s law requires that 
informed consent for right-to-try must explicitly make clear that, “the
patient’s health insurer and provider are not obligated to pay for any care or
treatments consequent to the use of the investigational drug, biologic product, 
or device” and that “in-home health care may be denied.” Elsewhere, the Colorado
right-to-try law states:

   An insurer may deny coverage to an eligible patient from the time the
   eligible patient begins use of the investigational drug, biologic product, or
   device through a period not to exceed six months from the time the
   investigational drug, biologic product, or device is no longer used by the
   patient; except that coverage may not be denied for a preexisting condition
   and for coverage of benefits which commenced prior to the time the eligible
   patient begins use of such drug, biologic product, or device.

In other words, if you access an experimental treatment under right-to-try, and 
you suffer a complication from the investigational treatment, you could well be 
out of luck getting your insurance company to pay for the medical and/or
surgical treatment necessary to treat that complication. If your insurance
company so decides, you’ll be on the hook for everything subsequent to that
treatment. Indeed, to me the language in some of these bills implies that
insurance companies can deny coverage for any new problems that come up after
the patient starts using experimental therapy, whether caused by that therapy or
not. These issues have largely been ignored in the news coverage of these laws,
but the oncology community is finally waking up to them, as demonstrated by an 
article published a couple of weeks ago in HemeOnc Today in an article entitled 
“Expansion of ‘Right to Try’ legislation raises ethical, safety concerns“:

   “There are a lot of issues not addressed in the bill that make the
   feasibility more challenging,” W. Thomas Purcell, MD, MBA, associate director
   for clinical services at the University of Colorado Cancer Center and
   executive medical director of oncology services at University of Colorado
   Hospital, told HemOnc Today. “If the drug is made available, who is going to 
   administer it? Who is going to pay for any side effects related to the
   treatment? Are insurance companies going to cover any treatment-related
   complications? There are a lot of practical things that come into play with
   the introduction of the law, although the law doesn’t address any of those
   things.”

Actually, although he raises the same concerns I’ve been raising for over a year
now, Dr. Purcell is about as wrong as wrong can be about one thing. The problem
is not that the laws don’t address these things. It’s that the laws do address 
these things rather explicitly. Dr. Purcell seems blind to how these laws
address these things, which is in a way likely to be highly detrimental to
patients. In fact, I wonder if Dr. Purcell has even read his own state’s law! It
says right there in black and white that insurance companies don’t have to pay 
for care or complications related to such drugs! That means that either the
patient does, or we taxpayers do when patients suffering such complications are 
forced to go on Medicaid because they can no longer afford their medical care.

Another example of someone echoing what I’ve said many times appears here:

   “People do not actually read the bills,” Alison Bateman-House, PhD, MPH, MA, 
   Rudin postdoctoral fellow in the division of medical ethics at New York
   University Langone Medical Center, told HemOnc Today. “They think ‘Right to
   Try’ sounds fantastic and allows access to treat terminally ill patients. How
   could you not support that? For the most part, the response that we’ve seen 
   is that these laws don’t do much, aside from giving people hope.”

Dr. Bateman-House is also partially wrong. The problem is not that people don’t 
read the bills. It’s that people don’t understand the anti-patient implications 
of the bills in terms of insurance coverage, eliminating the right to sue, and
the like; don’t understand clinical trials; and don’t understand that it is the 
federal government, not state governments, who control drug approval and access 
to experimental drugs. Indeed, when I’m in a cynical mood, I wonder if Goldwater
Institute flacks do understand all these things but don’t care because they’re 
playing a long game designed to weaken the FDA in the name of an ideology that, 
against all evidence to the contrary, preaches that the free market can assure
drug safety and efficacy better than any government agency. Indeed, this intent 
can be seen in one version of the Goldwater Institute template (and in the
Michigan right-to-try law), which changed the term “terminal illness” to
“advanced illness,” without really changing the definition. I would not be
surprised if, a few years from now, after the majority of states have passed
right-to-try, there is a push to open up “right-to-try” to serious medical
conditions that are not terminal on the basis of “fairness” and “compassion.”
It’s coming. Mark my words.

Finally, there are the issues of safety and false hope. As I’ve said before, as 
hard as it is to believe, there are things worse than suffering a terminal
illness; for instance, suffering a terminal illness and then bankrupting
yourself before you die or suffering a terminal illness and then suffering a
major complication of an experimental treatment that you have to pay for, thus
bankrupting yourself before you die. Now, consider this. The only requirement
for an investigational drug or treatment to be made available under right-to-try
is that it has to have passed phase I testing and still be in clinical trials
(i.e., phase II or III studies). Again, as I’ve described before, this is an
incredibly low bar for safety, given that most phase I trials include less than 
30 patients and are meant mainly as screening trials to identify the worst side 
effects and an appropriate dose to use in phase II trials. Yet, as I described
before, the Goldwater Institute blatantly describes drugs that have passed phase
I testing as having had their safety adequately established. It’s a lie.

Indeed, as is pointed out in the HemeOnc Today article, the risk for toxicity is
actually higher in patients who would exercise right-to-try because by
definition such patients have to be ineligible for a clinical trial. Remember,
clinical trials are designed to minimize risks and maximize potential benefits
because it is an ethical imperative in human experimentation, codified in the
Common Rule and the Helsinki Declaration. One way they do that is to design the 
inclusion and exclusion criteria to achieve that end. Moreover, there have been 
cases where the use of an experimental therapy has become popular based on
public pressure related to early evidence.

An excellent example of just what I’ve been warning about for a long time shows 
up in the HemeOnc Today article citing Dr. Yoram T. Unguru, a pediatric
oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai
Hospital in Baltimore and bioethicist at The Johns Hopkins Berman Institute of
Bioethics:

   In multiple cases, access to an experimental therapy has been expedited due
   to an early benefit observed in early studies that was not substantiated in
   subsequent research, Unguru said. One example was the use of autologous bone 
   marrow transplantation in women with metastatic breast cancer, based on
   preliminary data published in 1995 in the Journal of Clinical Oncology.

   “This completely backfired,” Unguru said. “In addition to being poorly
   designed, the study raises serious ethical concerns and, ultimately, people
   did much worse, including some who even died. This is why we go through the
   laborious, lengthy and, at times, seemingly maddening trial phases.”

   Although physicians and drug companies are required to report data attained
   from patients treated through the FDA’s compassionate use program, Right to
   Try laws do not carry such stipulations.

And, as Colin Begg, PhD, chairman and attending biostatistician in the
department of epidemiology and biostatistics at Memorial Sloan Kettering Cancer 
Center, adds, echoing (again) things I’ve been warning about for over a year:

   Eliminating the FDA from the equation may have many significant consequences.

   “There is good reason we have the FDA,” Begg said. “The rigorous testing with
   scientific methods of drugs that come through the pipeline is absolutely
   essential. Without it, the market would be flooded with drugs that do not
   work. You would have a cupboard full of drugs that you would want to try, and
   you would have no idea which one to try because there would be no reliable
   evidence about the efficacy of any one of them.”

   Right-to-try laws may create a precedence for additional changes to drug R&D.

   “If we go down this road, there might be a loosening of the standards of drug
   approval in the first place, and that would be bad for public health,” Begg 
   said. “This movement may ultimately lead to situations where … drugs, in
   general, would no longer have to go through such rigorous testing to see if
   they work.”

Unfortunately, what Dr. Unguru and Begg apparently fail to realize is that the
libertarian Goldwater Institute cares little or nothing about the difficult
balancing of patient rights versus patient safety and societal good that our
current clinical trial system tries to maintain, with varying degrees of success
depending on the specific situation. An argument, for example, that
right-to-try might make it more difficult to recruit patients to clinical trials
holds exactly zero water with the Goldwater Institute and most other supporters
of right-to-try. Indeed, associated as it is with the “health freedom”
movement, the goals of the Goldwater Institute’s right-to-try push appear to
align quite nicely with the goal of some libertarians to eliminate most of the
FDA’s authority because of an ideology, which views any government intrusion
into the free market with a jaundiced eye and even believes that the unfettered 
free market will take care of sorting out safety and efficacy of drugs. We all
know how that worked out before the passage of the original act creating the FDA
in 1906 and the Kefauver Harris Amendment of 1962 that introduced the
requirement that drug manufacturers demonstrate efficacy as well as safety to
the FDA before a drug is approved.

Those of us who take care of breast cancer patients remember Dr. Unguru’s
cautionary tale from the 1990s. Indeed, the clinical trial publication that
fueled the demand for high dose chemotherapy with bone marrow transplant for
advanced breast cancer was ultimately retracted. The bandwagon effect is a
powerful force affecting politics and even prominent researchers and physicians 
before the evidence is adequate to recommend a treatment. If this can happen
with a treatment as incredibly toxic and risky as bone marrow ablation with high
dose chemotherapy followed by stem cell rescue, imagine how easily it can
happen with less spectacular examples.

Over a year ago, when the states on the vanguard of the right-to-try movement
were first seeing such legislation introduced, I learned the hard way just how
willing the movement was to paint its opponents as those proverbial
puppy-kicking, American flag burning, cold-hearted “scientists.” Indeed, back
then almost the only people I saw routinely speaking out against right-to-try
were noted bioethicist Arthur Caplan and little ol’ me, an insignificant
blogger. When right-to-try was introduced into my own state’s legislature, my
interaction with my state representative, who politely thanked me for pointing
out the many problems with right to try, but made it clear through his response 
that he was likely going to vote for it anyway, showed that, from a political
standpoint at least, ethics- and science-based medicine were not likely to
prevail in Michigan or anywhere else over the emotional appeal of “doing
something” to help terminally ill patients. It didn’t matter whether that
“something” will actually do what it promises or not. Later, I met with an
advocate of the biotech industry who testified against the bill. He described a 
scene in which he was the lone expert testifying against right-to-try versus a
flack from the Goldwater Institute and patients with terminal illnesses and
their families, the latter of whom all glared at him as though he were
personally going to execute them or their ill family member. I learned that no
one associated with a major cancer center was willing to publicly oppose
right-to-try, even though they uniformly thought it was a horrible idea. If I
had found out about the hearing in time to have made the trip to Lansing—as I
recall, it occurred with little notice and on one of my operating room days—I
honestly don’t know if I would have had the wherewithal to do so myself, given
the pushback I had received from my previous posts on the matter.

As I said, right-to-try is a con game perpetrated on desperate patients,
offering them false hope but instead delivering nothing of value that can’t be
obtained under FDA compassionate use programs, as is pointed out by the opinion 
piece written by Dr. Jeffrey M. Peppercorn, a medical oncologist specializing in
breast cancer at Massachusetts General Hospital, in a point-counterpoint forum 
included after the HemeOnc Today article that asks: Do the changes to the FDA’s 
compassionate use program eliminate the need for ‘Right to Try’ laws? Dr.
Peppercorn takes the “yes” position:

   However, the question is not whether promotion of access to promising drugs
   for patients with terminal disease is justified, but how this can best be
   accomplished. The same imperative that drives Right to Try laws underlies the
   FDA’s compassionate use program. The primary difference is that access to
   experimental drugs through compassionate use programs is regulated in the
   interest of both the patient and society. Physicians must seek FDA approval
   before a manufacturer provides the unproven drug, and the rationale for use
   of the drug, absence of alternatives, informed consent and review by an
   independent institutional review board must be documented. In addition,
   toxicities and outcomes after administration must be reported. This process
   promotes responsible practice of evidence-based medicine — even as the
   evidence evolves — and provides a chance for monitoring, both of the specific
   intervention and of the use of experimental therapy more generally. Although
   the process can be burdensome, the FDA has recently streamlined the
   application to allow for completion in less than 45 minutes and still allows 
   for rapid approval of emergency access by phone when this is clinically
   justified.

Exactly.

The key difference between right-to-try and FDA compassionate use programs is
that right-to-try strips pretty much all protections from patients who would use
it; requires them to pay for the drug and any care related to the drug;
prevents them from suing manufacturers and doctors if something goes wrong;
prevents the state from taking action against the licenses of providers who give
patients bad advice recommending right-to-try; tells insurance companies that, 
not only do they not have to pay for the investigational agent or device, but
they don’t have to pay for any complications arising from use of the
investigational agent or device; and makes doctors and other health care
providers working for right-to-try states leery of advising too strongly against
right-to-try, lest they be prosecuted for “blocking” access to experimental
drugs. FDA compassionate use programs, in marked contrast, require review and
oversight by an institutional review board (IRB). The other difference was that,
although 99.5% of compassionate use/expanded access requests are approved by
the FDA, the process was onerous. As Dr. Peppercorn points out, that is rapidly 
changing, arguably eliminating the “need” for right-to-try. Yet right-to-try
marches on, because the reason for right-to-try is not as represented by the
Goldwater Institute. Rather, it’s to weaken and ultimately neuter the FDA.

Other pernicious effects of right-to-try

Patients come first, and must always come first, which is why my key objection
to right-to-try remains (and will always remain) that it is bad for patients.
However, the HemeOnc Today article also points out other problems with the
legislation. One is that it presents a major dilemma to industry. Now, I realize
that few people are particularly sympathetic to industry, and even we “pharma
shills” (at least that’s what right-to-try proponents and those supporting
alternative medicine, groups that not-infrequently overlap, call us) recognize
that pharma is nowhere near innocent in provoking that reaction. Now that
right-to-try laws are metastasizing throughout the US, oncologists are finally
taking notice of the alarms that we few have been sounding:

   The fact that manufacturers are not liable if a drug obtained through Right
   to Try fails or causes significant harm may allow pharmaceutical companies to
   benefit from such legislation, Unguru said.

   “The way the laws are written, pharmaceutical companies are under no
   commitment to release these drugs, but should patients be able to access
   them, there is almost no consequence in the event of a bad outcome,” Unguru
   said. “Bypassing the current regulatory system means that some drugs that may
   not be safe or ready for widespread use essentially get a ‘free pass.’ Some 
   pharmaceutical companies might see such laws as a way to test their drugs in 
   a way they typically would not be able to without being held accountable.”

   This would pose significant safety issues to society.

   “It is hard to argue that individual patients who are dying and want access
   to a drug should not get it,” Begg said. “But the concern I have is that the 
   ability of drug companies to market drugs that have not been properly tested 
   is not in the interest of the public.”

The Texas State Senate and House have passed versions of a Goldwater
Institute-inspired right-to-try law. The only difference in the two bills is
that the House version would allow manufacturers to provide experimental drugs
to patients at cost, whereas the Senate version would require that companies
that provide such drugs donate them. Assuming the two versions are reconciled
and passed and the governor signs the bill, say goodbye to any chance of
shutting down Stanislaw Burzynski, as the law would explicitly bar the Texas
Medical Board from pursuing its current action against Burzynski’s medical
license, given that he could claim his antineoplastons have passed phase I
clinical trials and are in phase II, which makes them eligible for right-to-try.
Even if the Senate version prevails, Burzynski’s business model of providing
his unproven antineoplastons for free but charging big bucks for “case
management” fees would remain intact.

Most drug companies are not as unethical as Burzynski, however, which is why
most do not support right-to-try and the Pharmaceutical Research and
Manufacturers of America (PhRMA) is not supportive, as described in the HemeOnc 
Today article. Pharmaceutical companies remember incidents like this:

   In the past, public pressure has forced pharmaceutical companies to grant
   access under compassionate use.

   Last year, Chimerix denied Josh Hardy — a then 7-year-old boy who developed
   an adenovirus infection after undergoing a bone marrow transplant for
   rhabdoid tumor of the kidney — access to the experimental antiviral drug
   brincidofovir (CMX001). After a social media firestorm — which included death
   threats to the company’s leadership — Chimerix commenced an open-label phase
   3 trial so Hardy could enroll and receive treatment.

   “This became publicized, and everyone assumed that if Josh Hardy got
   brincidofovir he would survive,” Bateman-House said. “He did get
   brincidofovir, and he did survive. Thomas Duncan, the man who died of Ebola
   in Texas, got the same drug and died. Chimerix is a small drug company and
   brincidofovir is its only drug in development, and its stock took a nosedive 
   after Duncan’s death. If it were not for the fact that phase 3 trials were
   already close to completion, this could have killed the company. If Josh
   Hardy had died, that could have killed the company.”

In other words:

   “It can go either way — you’re damned if you do and you’re damned if you
   don’t,” Unguru said. “If you release the drug and it does badly, then you’re 
   going to get bad press. If you don’t release it, then you risk being
   vilified.”

And if the company charges for the drug and things go badly, it will be doubly
vilified, even though small pharmaceutical companies often have just enough
venture capital to make enough of the drug to do the clinical trials necessary
for approval, and releasing drug jeopardizes its ability to do those trials.

Physicians are also put in a bind when a patient has exhausted everything and
wants to pursue right-to-try. End-of-life discussions are very difficult to
begin with, because, as I’ve pointed out before, no physician wants to be hope’s
executioner. Yet, sometimes that is our job, and the best we can offer is
palliation. Given that right-to-try theoretically requires less effort than an
expanded access exception, there will be enormous pressure on physicians to
accede to the wishes of a terminally ill patient to pursue right-to-try even if 
the physician thinks it won’t work. The option of right-to-try might thus
actually provide a physician with an option to avoid the hard discussion that
end-of-life care entails and just facilitate the patient’s getting the drug. As 
Dr. Charles F. Levenback, professor in the department of gynecologic oncology
and reproductive medicine at The University of Texas MD Anderson Cancer Center, 
puts it:

   “I’ve heard ethicists say physicians may go in the direction of compassionate
   use to avoid the difficult conversation about mortality and the limits of
   what we can provide,” Levenback said. “All of compassionate use is predicated
   on the physician’s responsibility to be candid about the purpose of
   treatment — palliative vs. curative — and setting the patient’s expectations 
   correctly.”

Correct. However, some doctors are better at doing this than others.

The track record of right-to-try thus far

Given that it’s now been a year, or nearly so, since the first batch of states
passed their right-to-try initiatives, I asked a simple question: Has a
terminally ill patient obtained an investigational agent through right-to-try
yet? Note that I didn’t even ask whether a single terminally ill patient has
benefitted from right-to-try, because that’s much more difficult to ascertain.
Doing extensive Google searches, I could not find a single example, although I
did come up with a lot of examples of patients expressing hope that such laws
would get them access to investigational drugs (like this one). My next thought 
was that, if anyone would know of a case in which a terminally ill patient has
been granted access to an experimental drug under right-to-try, it would be the 
Goldwater Institute. So I engaged Christina Sandefur, Vice President for Policy,
on Twitter thusly:

.@cmsandefur Except that #RightToTry laws don’t really do that. False promise.

— David Gorski (@gorskon) May 6, 2015

I then asked:

.@cmsandefur Has anyone anywhere gotten experimental drug under #RightToTry?
It’s been a year now since Colorado. I know of no case. — David Gorski
(@gorskon) May 6, 2015

Her response:

@gorskon these laws are just now going into effect,& it takes time to acclimate 
to overhaul of status quo. Offer to have a real convo stands

— Christina Sandefur (@cmsandefur) May 6, 2015

Which resulted in:

@gorskon Again,I welcome thoughtful,substantive discussion, but I’m not
interested in unproductive back-and-forth. You know where to find us — Christina
Sandefur (@cmsandefur) May 6, 2015

What’s irritating about this exchange is that I was trying to engage Ms.
Sandefur in a “thoughtful convo”—or, at least, as thoughtful a conversation as
you can have on Twitter. What is it with people like this who seem to want to
try to get me on the telephone to discuss such matters when they can’t manage to
engage me online, be it on Twitter, the comments of my blog posts, or even by
e-mail, where you can have a really thoughtful conversation? I tend to suspect
it’s because they don’t want to leave a “paper trail” (or an “electron trail” in
the case of e-mail exchanges) documenting what they actually said. Perhaps I
should respond to her that I’d be happy to talk to her on the phone, but only if
she gives me permission to record the conversation. (In turn, I, of course,
will give her permission to do the same.) In any case, I think it reasonable to 
assume that, if there were a patient in Colorado—or anywhere else, for that
matter—who has successfully obtained an experimental drug under right-to-try,
Sandefur would know about it and would not have hesitated to provide links to
relevant news stories. She did not. Instead she chose to dodge the question and 
make excuses. Similarly, Kurt Altman, national policy adviser and general
counsel for Goldwater Institute, mentioned no patients who had yet benefited
from right-to-try in his “counterpoint” to Dr. Peppercorn’s opinion piece. I
know he would have if such a patient existed. Certainly, if I were writing in
favor of right-to-try, I would use the examples of such patients if they
existed. Others have also noted that there appears as yet not to be a single
patient who has obtained an experimental drug through a right-to-try law, much
less benefited from it. Indeed, one man moved to Missouri to try to take
advantage of right-to-try for his amyotrophic lateral sclerosis and has thus far
failed.

Right-to-try laws: Bad for patients

I have little doubt that some version of right-to-try will likely pass in every 
state in which it has been introduced, which means we could be looking at up to 
40 states, possibly more, with such laws by next year. It must be emphasized
that the vast majority of legislators proposing such bills and passing them into
laws and the patients lobbying for right-to-try do so with the best intentions,
believing such laws will help terminally ill patients. These patients,
according to mistaken popular belief, have nothing left to lose when in fact
they do, even though it might not seem that way. In the idealistic desire to
help the terminally ill, supporters of right-to-try either don’t pay attention
to or downplay the significant negative aspects of these bills, which permit the
loss of insurance coverage, stripping of IRB protections that patients
receiving such medications through expanded access programs, the economic
injustice in which only the rich or those capable of raising large sums of money
could benefit if the drug company was unwilling to provide the investigational 
drug for free, and the potential additional risk of harm that can come from
using experimental drugs outside the rigorous design and protections of clinical
trials. Most people are similarly unaware that granting less controlled access 
to such medications is far more likely to cause an individual patient harm than 
good. Moreover, liberalization of expanded access programs to vastly decrease
the burden of paperwork and effort on the part of physicians and patient has
already been placed in draft guidelines, rendering right-to-try unnecessary.

So why are right-to-try laws so popular? In an editorial last year published in 
JAMA Internal Medicine entitled “The Strange Allure of State “Right-to-Try”
Laws“, Patricia Zettler and Henry Greely ask the same question, noting that a
recommendation from a physician is no substitute for the evidence of safety and 
effectiveness that comes from later-phase clinical trials:

   So what is the point of these laws? A skeptic might point out that opposing
   experimental treatments for dying people is unpopular. Patients have
   publicized—and gained public support for—their efforts to obtain experimental
   treatments through social media. Lawmakers have little to lose politically
   by supporting these laws. Companies, seeing their ineffectiveness, have no
   powerful reasons to oppose them. And libertarians can celebrate an attack on 
   big government. The problem is that all these efforts are unlikely to
   actually help the patients with life-threatening diseases. Indeed, these laws
   may be harmful if they draw attention and resources away from efforts to
   develop effective treatments, engender confusion about the FDA pathway for
   compassionate use of medications, or create false hopes for terminally ill
   patients.

All of which right-to-try laws do, and worse.

There will always be a conflict between personal freedom and protecting
patients, as well as ensuring maximal societal good. We see this in opposition
to school vaccine mandates, support for cancer quackery and dubious stem cell
clinics, and, of course, right-to-try. Unfortunately right-to-try laws represent
dangerous placebo legislation. They only give the illusion of doing something
given that the FDA, not the states, controls drug approval. The reason for their
existence is not so much to help patients, but as part of a long game to build 
a groundswell of support for policies that would ultimately hobble the FDA’s
ability to oversee the efficacy and safety of drugs. These laws are bad for
patients, bad for doctors, bad for drug development, and bad for science. That’s
why going through the states is the wrong way to attack this problem. If we as 
a society believe that terminally ill patients should have easier access to
investigational drugs, then reforming how the FDA handles compassionate use
exemptions, not a patchwork of state laws with no teeth, is how it should be
done.


ADDITIONAL READING:

  1. The illusions of “right to try” laws

  2. “Right to try” laws and Dallas Buyers’ Club: Great movie, terrible for
    patients and terrible policy

  3. The Compassionate Freedom of Choice Act: Ill-advised “right to try” goes
    federal

  4. The false hope of “right-to-try” metastasizes to Michigan

  5. Using the fear of Ebola to promote the placebo legislation that is “right to
    try”

Elsewhere:

How State Right-To-Try Laws Create False Expectations.

The authors get it:

   Putting aside the invalidity of RTT laws and the false hope they create,
   these laws also fail to address more fundamental health and safety issues.
   RTT laws seek to grant vulnerable patients access to unproven and potentially
   harmful drugs or other medical products without any expert safeguards, such 
   as scientific or ethical review by an Institutional Review Board or similar
   body.

   Moreover, these laws undermine the clinical trial infrastructure regulated by
   FDA, which was developed to ensure that medical products are tested on a
   sufficiently diverse population in a scientifically sound manner to bring
   safe and effective products to market. By allowing anyone to obtain an
   experimental treatment outside the confines of a regulated clinical trial,
   RTT laws reduce incentives to participate in clinical trials, increasing the 
   complexity of recruiting sufficient study participants.

   Further, due to complex manufacturing requirements, there may be only limited
   amounts of investigational product available, so RTT laws, if they resulted 
   in patients receiving investigational treatments outside of clinical trials, 
   may divert resources needed for those clinical trials. As a result, the
   trials—upon which FDA approval ultimately depends—may be slowed. Although
   touting ostensibly laudable goals, RTT laws do not take any steps to navigate
   the thorny issues raised by use of experimental treatments, including
   potential delay in getting FDA approved products to the market, where they
   can benefit the public at large.

The cruel sham that will not die: Right-to-try marches on in California and
beyond

State “right-to-try” bills are springing up like kudzu all over the US. Their
advocates promise that they would save lives by allowing terminally ill patients
access to experimental therapeutics. This is a delusion; even the most fervent 
supporters of right-to-try have trouble pointing to a single patient who has
benefited from such a law. In reality, right-to-try laws are a cruel sham that
will do no such thing and lack even basic protections for desperate patients.
Their purpose is to build political pressure to neuter the FDA.

David Gorski on August 29, 2016

Tweet



We here at SBM, particularly Jann Bellamy and myself, frequently write about
naturopathic licensing laws, noting that naturopaths are relentless. They keep
trying and trying to get states to pass laws granting their specialty licensure,
and, like the Terminator trying to kill Sarah Connor or her son, they
absolutely will not stop, ever, until science-based medicine is dead there are
naturopathic licensing laws in all 50 states by 2025. Part of their strategy is 
that they never give up. No matter how many times a given state legislature
denies them what they want, they are soon back, and they keep coming back again 
and again and again and again until they get the law they want passed. It’s the 
problem with playing defense, naturopaths can fail as many times as they have
resources for, defenders of science-based medicine can’t afford to fail once.
Worse, once such laws are passed, naturopaths are back again and again and again
and again to keep trying to expand their scope of practice. It never ceases to 
amaze me that physicians’ groups go ballistic protecting their turf when advance
practice nurses lobby to expand their scope of practice to encompass what they 
are trained for but remain more or less silent when naturopathic quacks push to 
have the state place its imprimatur on their pseudoscience.

Sadly, I’ve come to the conclusion that “right to try” laws are a lot like
naturopathic licensing laws in that respect, only worse. Why worse? Unlike
naturopathic licensing bills, right-to-try bills rarely die; most of them pass. 
In fact, only one right-to-try bill that I’m aware of has ever been successfully
resisted and blocked from becoming law, and that required a veto by the
governor. I’m referring, of course, to the California right-to-try bill vetoed
last fall by Governor Jerry Brown. Amazingly, Brown’s veto held. Well, a new
right-to-try bill is back in California, less than a year after the old
right-to-try law had been vetoed. Passed in the legislature by overwhelming
margins, it’s now back on Gov. Brown’s desk, and he has to decide what to do
with it.

Its supporters hope that this time will be different, that this time Gov. Brown 
will sign the bill. They might be right. The rationale Gov. Brown used when
vetoing the bill was that he wanted to wait to see what happened with reform of 
the FDA Expanded Access (sometimes called “Compassionate Use”) program. It’s
quite possible that, despite the FDA moving forward with such reform,
right-to-try advocates might persuade the governor that it isn’t enough. They’re
wrong. In any case, given the resurrection of the California right-to-try law, 
now seemed like a good time to review what’s been happening with these laws
since last year and discuss the situation in California and at the federal
level. It isn’t good for patients or drug development. On the other hand, now
that it’s been nearly two and a half years since the first right-to-try law was 
passed in Colorado, we have time to see just what a sham these laws are.

But first, since it’s been nearly a year since I last discussed right-to-try,
let’s review why these laws are so pernicious.

The false promise of right-to-try

Right-to-try laws have been proliferating with kudzu-like tenacity throughout
the US since 2014. Since Colorado passed its law in April 2014, the total of
states with right-to-try laws on the books has reached 31. That’s an
astonishingly high number of nearly identical state laws to have been passed in 
such a short span of time. It’s not surprising, as you will see. Right-to-try
laws give the appearance of helping terminally ill patients, and voting for them
lets legislators feel good about themselves without actually confronting hard
choices, not to mention to appear to be doing something helpful when they are
not. On the surface, they are very, very appealing, to the point where I’ve
grimly joked that opposing right-to-try appears akin to advocating disemboweling
puppies or being against mom, apple pie, and the American flag. I myself have
experienced some of that vitriol, and know from various private conversations
that university medical centers and pharma think these laws are a horrible idea.
Yet, it is very rare for an official representative to state outright
opposition to such laws. (Note: I do not represent my university or cancer
center in any way on right-to-try. See? Even I feel obligated to point that
out!)

In any case, right-to-try is a movement started by the libertarian Goldwater
Institute, ostensibly to give terminally ill patients the “right to try”
experimental treatments without interference from the FDA. Indeed, the Goldwater
Institute provided the template for these laws, and all right-to-try laws that 
I’ve examined hew pretty closely to this template (many even use the exact
language provided by the Goldwater Institute), with customizations intended to
make individual laws fit into the legal and regulatory framework of the state
passing them. In reality, right-to-try is a cruel sham. Such laws provide an
illusion of providing potential cures to desperately ill and dying patients in
the form of experimental drugs when in reality they do nothing of the sort.
Instead, they raise the hopes of the patients rallying to persuade their
lawmakers to pass these laws and then basically doing nothing for them.

There are several reasons why right-to-try laws are a cruel sham. First and
foremost, states do not have authority over drug approval. The FDA does, and
federal law trumps state law. That means right-to-try laws are, in essence,
meaningless and almost certainly would likely be struck down as unconstitutional
if taken to court. On the other hand, it’s hard not to suspect that the
Goldwater Institute wants these laws to be challenged in court. Second, it’s
incredibly rare that an experimental drug will make the difference between life 
and death in a terminally ill patient. Yet it is that hope that supporters of
right-to-try laws, in particular the Goldwater Institute, have shamelessly
exploited to rally patient groups and to persuade legislators to pass these laws
all over the nation. Basically, the Goldwater Institute has sold patients and
legislators on a lie. It’s very understandable why desperate patients dying of a
terminal illness would be willing to try almost anything; exploiting that
desperation is a feature, not a bug, of the campaign to pass right-to-try laws.

Worse, even if right-to-try laws actually worked as the Goldwater Institute
claims they should work, they would be very dangerous to patients. The reason is
simple. The eligibility requirements for a drug to be made available for
right-to-try are risibly low and betray a total lack of understanding of how
drug development works. Basically, for an experimental drug to be considered for
right-to-try, the only requirements are experimental drug (1) have passed phase
I trials and (2) still be in clinical trials (e.g., phase II or III). Of
course, phase I trials are not designed to test efficacy. Their purpose is to
work out optimal dosage, identify the maximal tolerated dose, and identify major
side effects. Worse, these trials usually only consist of a few tens of
patients, often less than 30. To propose letting seriously ill patients use
potentially toxic drugs that have been tested in so few people and not
demonstrated to be efficacious and safe is to invite disaster. Moreover, the
vast majority of experimental drugs that pass phase I never make it to market.

Basically, the whole right-to-try movement is built on a delusion, namely that
there is a river of cures to serious and fatal disease in the pipeline, but that
the only reason they aren’t flowing to the people is because of the overly
cautious bureaucracy and excessively burdensome regulations of the FDA. If the
people could just get the FDA out of the way—or so the delusions go—cures would 
flow to the people, all courtesy of the magic of the free market, which will
sort out problems with safety and efficacy. No, I am not exaggerating. I’ve
discussed before in great detail the profoundly deceptive arguments made by
libertarians that the FDA is killing patients through its caution.

Of course, right-to-try laws were never really intended to help patients,
although patients were sold on the idea that they are. Remember the source. The 
Goldwater Institute is a profoundly libertarian think tank whose primary goal is
to reduce the influence of government; as such, it is opposed to what it views 
as “excessive regulation,” which, if you read the Goldwater Institute’s website,
seems to be nearly all laws or regulations that restrain business, the free
market, or personal choice, even reasonable ones. It is thus unsurprising that, 
consistent with their libertarian origin, right-to-try laws neither require nor 
provide any financial support for patients, who are basically on their own when 
it comes to paying what could be the substantial financial charges. Insurance
companies and government plans don’t have to pay. Worse, as I’ve pointed out
elsewhere, the language of many of these laws could be interpreted as not
requiring insurance companies to pay for medical expenses related to
complications due to taking the experimental drug. Just as bad, right-to-try
laws also strip away many patient protections. For instance, right-to-try laws
indemnify doctors recommending an experimental treatment under right-to-try,
making it impossible to sue them for malpractice and impossible for state
medical boards to discipline them. It doesn’t matter if the suggestion for a
right-to-try drug was even appropriate. Finally, given that the FDA, not the
states, controls drug approval, drug companies will be highly reluctant to offer
experimental drugs under right-to-try without the prior approval of the FDA,
and the FDA already has programs for single patient INDs, also known as
“Compassionate Use”, to allow patients access to experimental drugs. This
process still requires ethical oversight by an institutional review board (IRB),
providing another layer of patient protection. Nothing in right-to-try does.

Last year, I challenged the Goldwater Institute through its executive VP
Christina Sandefur and other right-to-try supporters to produce a single example
of a terminally ill patient who had benefitted from right-to try or who had
even been granted access to an experimental drug, basing my challenge on the
case of Bob Bardone, who had amyotrophic lateral sclerosis, a fatal degenerative
neurological disease also known as Lou Gehrig’s disease. This was a man who
moved to Missouri because of its right-to-try law, hoping to gain access to
experimental therapies. The short version of the story is: He didn’t. I did a
bit of Googling to see if in the interim there had been any patients who
received experimental medication under right-to-try. I couldn’t find any. Out of
curiosity, I tried again:

@gorskon yes, we are aware of patients being treated

— Christina Sandefur (@cmsandefur) August 24, 2016

Further questioning didn’t produce any specifics, but I’ll keep at it. Maybe
I’ll start e-mailing legislators who sponsored right-to-try bills and ask them
if they know of anyone who’s benefited, starting in Michigan. Elsewhere, I found
out that the Goldwater Institute is claiming that it knows of 40 patients
receiving experimental therapies under right-to-try. One of my fears is that
those patients are probably in Texas and are probably receiving Stanislaw
Burzynski’s antineoplaston therapy, which, while initially seeming to be a
potentially promising anticancer treatment, has not produced any convincing
evidence that it works for any cancer. These days, it’s quackery. I’ve stated
from the beginning how right-to-try is custom-made to benefit a quack like
Burzynski, whose ANPS did make it through phase I clinical trials and are,
thanks to the FDA’s failure, back in clinical trials again. I have no way of
determining if my fears are justified, though.

Be that as it may, despite trying, I have not been able to find a single story
of a patient receiving experimental therapeutics under right-to-try, and the
Goldwater Institute isn’t giving any details, which leads me to believe that its
story is almost certainly a crock. After all, right-to-try is one of its most
important initiatives. If there were terminally ill patients benefiting from
experimental drugs under right-to-try, you’d expect the Goldwater Institute
would be trumpeting the news, and you’d also expect that the patients themselves
would be more than happy to let the media do profiles of them. I would
certainly expect these things; yet I see nothing. Also, think of it this way.
Even if there really are 40 patients receiving an experimental drug under
right-to-try, since 2009, the FDA has granted between 936 and 1,873 Expanded
Access requests a year and approves the overwhelming majority of requests,
including a 300% increase in emergency INDs, which are requests for single
patients who don’t have time to complete the regulatory paperwork. Right-to-try,
even if it works as the Goldwater Institute claims it wants it to, is having a 
negligible effect compared to the FDA’s already existing policies—just as I’ve
told you it would many times. And that’s if you accept the Goldwater Institute’s
estimate of 40 patients at face value, which I most definitely do not. I’d be
willing to bet it’s much closer to zero, if not actually zero. Of course, the
Goldwater Institute could always prove me wrong.

Right-to-try returns from the grave in California

Having reviewed why right-to-try is a sham, let me now circle back to what’s
happening in California:

   A bill that would allow terminally ill people to obtain experimental drugs
   appears headed to Governor Brown’s desk for the second year in a row. Brown
   vetoed a similar measure last year, but supporters believe conditions are
   right for him to sign it this time around.

   Brown said he vetoed last year’s “Right-to-Try” measure because he wanted
   time to see how changes to the FDA’s “Compassionate Use” program streamlined 
   the process of getting experimental drugs to terminal patients.

   Nearly a year later, the new bill’s supporters say it’s time for California
   to step in with its own solution, because the modified federal initiative has
   not reduced the minimum 30-day wait for drugs.

   “The process may have to start over if the FDA has even one question,” said
   the bill’s author, Assembly Majority Leader Ian Calderon (D-Whittier).
   “Terminally ill patients can still end up waiting weeks and months” for an
   approval.

   Calderon’s measure would allow drug manufacturers to give certain terminally 
   ill people access to drugs not yet approved by the FDA.

Calderon is, of course, parroting the same exaggerated claims made by the
Goldwater Institute. In fact, the FDA has actually dramatically simplified the
Expanded Access application process, such that, as mentioned above, the result
has been a large increase in emergency INDs.

Let’s take a look at the bill, AB-1668 Investigational drugs, biological
products, and devices. Reading it over, I see that it’s the same old nonsense,
except that it goes even further than a typical right-to-try law. For example,
look at the definition of “eligible patient” for right-to-try in AB 1668:

   (b) “Eligible patient” means a person who meets all of the following
   conditions:

   (1) Has an immediately life-threatening disease or condition.

   (2) Has considered all other treatment options currently approved by the
   United States Food and Drug Administration.

   (3) Has not been accepted to participate in the nearest clinical trial to his
   or her home for the immediately life-threatening disease or condition
   identified in paragraph (1) within one week of completion of the clinical
   trial application process, or, in the treating physician’s medical judgment, 
   it is unreasonable for the patient to participate in that clinical trial due 
   to the patient’s current condition and stage of disease.

   (4) Has received a recommendation from his or her primary physician and a
   consulting physician for an investigational drug, biological product, or
   device.

   (5) Has given written informed consent for the use of the investigational
   drug, biological product, or device, or, if he or she lacks the capacity to
   consent, his or her legally authorized representative has given written
   informed consent on his or her behalf.

   (6) Has documentation from his or her primary physician and a consulting
   physician attesting that the patient has met the requirements of this
   subdivision.

“Immediately life-threatening disease or condition”? That’s incredibly broad. A 
severe case of pneumonia could be “immediately life-threatening.” A heart attack
is “immediately life-threatening.” A stroke is “immediately life-threatening.” 
An “immediately life-threatening” illness is not the same thing as a terminal
illness. Yet this bill tries to have it both ways, as it defines “immediately
life-threatening disease or condition” as “a stage of disease in which there is 
a reasonable likelihood that death will occur within a matter of months.” That
implies something less acute, but “within a matter of months” encompasses more
immediately life-threatening diseases as well. Basically, the definition is the 
very definition of vague double talk that would likely result in court battles
over interpretation if anyone ever actually tried to invoke it who didn’t have
an undeniable terminal illness. Maybe that was the intention. (Strike the
“maybe.”) In any case, this bill, if passed, would be far broader than most of
the right-to-try laws I’ve reviewed.

Consistent with the libertarian origins of the bill, AB 1688 does exactly zero
to help terminally ill patients access experimental drugs. Check it out:

   11548.2. (a) Notwithstanding Section 110280, 111520, or 111550, a
   manufacturer of an investigational drug, biological product, or device may
   make available the manufacturer’s investigational drug, biological product,
   or device to an eligible patient pursuant to this article. This article does 
   not require that a manufacturer make available an investigational drug,
   biological product, or device to an eligible patient.

   (b) A manufacturer may do both of the following:

   (1) Provide an investigational drug, biological product, or device to an
   eligible patient without receiving compensation.

   (2) Require an eligible patient to pay the costs of, or associated with, the 
   manufacture of the investigational drug, biological product, or device.

   (c) (1) This article does not expand the coverage provided under Sections
   1370.4 and 1370.6 of this code, Sections 10145.3 and 10145.4 of the Insurance
   Code, or Sections 14087.11 and 14132.98 of the Welfare and Institutions
   Code.

   (2) This article does not require a health benefit plan to provide coverage
   for the cost of any investigational drug, biological product, or device, or
   the costs of services related to the use of an investigational drug,
   biological product, or device under this article. A health benefit plan may
   provide coverage for an investigational drug, biological product, or device
   made available pursuant to this section.

So basically AB 1668 allows drug companies to charge whatever they want for a
drug that’s only passed the most basic of basic clinical trials, Phase I. It
doesn’t require health plans to cover the charges for these experimental drugs. 
It doesn’t require state government to cover the costs of right-to-try drugs. I 
even interpret that part about health plans not being required to provide
coverages for the “costs of services related to the use of an investigational
drug, biological product, or device under this article” to be potentially
interpretable as meaning that health plans don’t have to pay for complications
due to the use of experimental drugs under right-to-try. The bill also does
this:

   111548.3. (a) Notwithstanding any other law, a state regulatory board shall
   not revoke, fail to renew, or take any other disciplinary action against a
   physician’s license based on the physician’s recommendation to an eligible
   patient regarding, or prescription for or treatment with, an investigational 
   drug, biological product, or device if the recommendation or prescription is 
   consistent with protocol approved by the physician’s institutional review
   board or an accredited independent institutional review board.

And this:

   111548.5. This article does not create a private cause of action, and actions
   taken pursuant to this article shall not serve as a basis for a civil,
   criminal, or disciplinary claim or cause of action, including, but not
   limited to, product liability, medical negligence, or wrongful death, against
   a manufacturer of an investigational drug, biological product, or device, or
   against any other person or entity involved in the care of an eligible
   patient for harm done to the eligible patient or his or her heirs resulting
   from the investigational drug, biological product, or device, or the use or
   nonuse thereof, if the manufacturer or other person or entity has complied
   with the terms of this article in relation to the eligible patient, unless
   there was a failure to exercise reasonable care.

In other words, just like the case with all the other right-to-try bills, under 
AB 1668 a doctor who recommends an experimental drug under right-to-try can’t be
sued or disciplined by the state medical board. Neither drug manufacturers nor 
doctors recommending right-to-try drugs can be sued for liability. Basically,
like every other right-to-try law, this bill, if passed, would be a travesty for
patients. Under the guise of providing them access to potentially life-saving
drugs (which it doesn’t do), AB 1668 basically puts patients with
life-threatening illnesses completely on their own. Not very patient-friendly at
all. Basically, it tells patients, “You’re completely on your own.”

Perusing other websites about right-to-try, I found nothing to disabuse me of
this conclusion. In fact, looking at the FAQ on the Right-to-Try website, I find
the same misinformation and lies about right-to-try that I found two years ago.
For example:

   Q: SOME CRITICS SAY RIGHT TO TRY IS JUST “FEEL GOOD” LEGISLATION THAT WON’T
   ACTUALLY HELP ANYONE. IS THIS TRUE?

   A: No. Right To Try laws give people with terminal illnesses the legal right 
   to use investigational medications years before they might otherwise be
   available on the market. No one can guarantee that a particular treatment
   will be effective, but these laws return choice and control over treatment
   options to where it is most effective: with patients and their doctors.

Actually, it is true. Right-to-try is just “feel good legislation” that won’t
help anyone, much less terminally ill patients. Same as it ever was.

Here’s hoping that Gov. Brown shows the same political courage now that he
showed last year when the previous right-to-try bill came across his desk.
Contrary to how they are portrayed, right-to-try laws are among the most
cynical, patient-hostile laws there are. Under the guise of helping terminally
ill patients pursue hope, they strip them of many legal protections, open them
up to exploitation by drug companies, and sell them false hope.

Meanwhile, let’s take a look at what’s happening at the federal level.

Right-to-try goes federal

The purpose of right-to-try laws is to undermine the authority of the FDA, build
pressure for a federal law weakening the FDA, and to provide a pretext for
lawsuits designed to challenge the FDA’s authority to regulate drugs. The reason
why the Goldwater Institute thinks this year is the time is, as, Alice
Bateman-House puts it:

@gorskon Yes but I’m afraid much more support now. Goldwater’s playbook was get 
laws in at least 25 states & then claim mandate for fed law

— Alison Bateman-House (@ABatemanHouse) August 24, 2016

Personally, I also think that the Goldwater Institute is hoping that a patient
will try to access an experimental drug under right-to-try, be denied, and then 
sue, producing a case that will go all the way to the Supreme Court. Whatever
the intent of the Goldwater Institute is regarding the courts, unlike the case
at the state level, the Goldwater Institute and right-to-try advocates have had 
a harder time achieving its aim at the federal level. For example, when
right-to-try laws were first starting to be passed at the state level, the
Compassionate Freedom of Choice Act of 2014 was introduced. It was basically a
quack manifesto, and fortunately it didn’t go anywhere. Of course, the Goldwater
Institute’s intent had been the long game all along. So it’s not surprising
that another federal bill has been introduced:

   A bill introduced in the US Senate on Tuesday becomes the latest legislative 
   effort to expand the ability of terminally ill patients to gain access to
   experimental medicines. The legislation, which joins a companion bill that
   was introduced in the House last summer, would prohibit the federal
   government, including the US Food and Drug Administration, from taking any
   action to prevent patient access.

   The bill, which was introduced by Senator Ron Johnson (R-Wis.), comes after
   28 states have passed so-called “Right to Try” laws. These allow patients to 
   leapfrog a drug-development process that takes years before new treatments
   become available. And the laws reflect rising frustration with an FDA program
   called expanded access, in which people who are seriously ill can obtain a
   drug under development, even though they aren’t enrolled in a clinical trial.

This story is from May; since then three more states have passed right-to-try.
The federal bill, submitted to the Senate, is S.2912, The Trickett Wendler Right
to Try Act of 2016. Fortunately, thus far the bill has been languishing in the 
US Senate Committee on Health, Education, Labor, and Pensions, as its companion 
bill, H.R.3012, The Right To Try Act of 2015 has been languishing in the
relevant House committee since last summer. Given that this is an election year 
and not much of anything is happening legislatively (heck, Congress can’t even
seem to pass a budget), this bill is unlikely to pass this Congress, but it’s
not hard to imagine its being introduced next year, with much more support.
Let’s take a look at what it does.

I’m not a lawyer, as we say, but this law is clear enough that I understand what
it could do. First, it explicitly states that state right-to-try laws trump the
Federal Food, Drug, and Cosmetic Act and the Controlled Substances Act:

   (a) IN GENERAL.—Notwithstanding the Federal Food, Drug, and Cosmetic Act (21 
   U.S.C. 301 et seq.), the Controlled Substances Act (21 U.S.C. 801 et seq.),
   and any other provision of Federal law, the Federal Government shall not take
   any action to prohibit or restrict—

   (1) the production, manufacture, distribution, prescribing, or dispensing of 
   an experimental drug, biological product, or device that—

   (A) is intended to treat a patient who has been diagnosed with a terminal
   illness; and(B) is authorized by, and in accordance with, State law; and

   (2) the possession or use of an experimental drug, biological product, or
   device—(A) that is described in subparagraphs (A) and (B) of paragraph (1);
   and(B) for which the patient has received a certification from a physician,
   who is in good standing with the physician’s certifying organization or
   board, that the patient has exhausted, or otherwise does not meet qualifying 
   criteria to receive, any other available treatment options.

In other words, this bill, if passed, would explicitly federalize each state’s
right-to-try law, in the process eliminating the FDA’s ability to protect
terminally ill patients from what could be dangerous or inappropriate drugs.
Worse, it trusts the states not to produce right-to-try laws that are too
dangerous, the sole exception is that it requires that the illness being treated
be “terminal.” The problem, of course, is that this bill does not define
“terminal.”

Next up:

   (1) NO LIABILITY.—Notwithstanding any other provision of law, no liability
   shall lie against a producer, manufacturer, distributor, prescriber,
   dispenser, possessor, or user of an experimental drug, biological product, or
   device for the production, manufacture, distribution, prescribing,
   dispensing, possession, or use of an experimental drug, biological product,
   or device that is in compliance with subsection (a).

This clause basically removes federal liability from physicians and drug
companies that offer a drug under right-to-try. If a patient suffers because of 
the inappropriate use of such a drug, the patient (or, given that the patients
under this bill have terminal illnesses, the family) has no recourse to sue the 
manufacturer under federal law, in addition to having no recourse under state
law. Add to that the lack of oversight by an IRB, and this law is profoundly
anti-patient—just like state right-to-try laws.

Finally:

   (2) NO USE OF OUTCOMES.—Notwithstanding any other provision of law, the
   outcome of any production, manufacture, distribution, prescribing,
   dispensing, possession, or use of an experimental drug, biological product,
   or device that was done in compliance with subsection (a) shall not be used
   by a Federal agency reviewing the experimental drug, biological product, or
   device to delay or otherwise adversely impact review or approval of such
   experimental drug, biological product, or device.

This clause is clearly intended to address the concern of drug and device
manufacturers that if they provide an experimental therapeutic to a patient
under right-to-try and the patient suffers complications due to the treatment,
the approval of its product might well be adversely impacted. This, of course,
is not an unreasonable concern on the part of manufacturers, given that it can
easily cost $1 billion to bring a drug or device to market, and by the time the 
product has passed phase I clinical trials a great deal of that cost has already
been invested in development. However, this goes too far. Basically, it says
that even if a patient death is clearly due to use of an experimental drug under
right-to-try, that death should not be considered by the FDA in deciding
whether to approve the drug. Think of it this way. Let’s say dozens of patients 
die from using an experimental drug under right-to-try. This bill, if passed,
would bar the FDA from even considering those deaths in its deliberations over
whether to approve the drug.

Basically, the Trickett Wendler Right to Try Act of 2016 would not help
terminally patients. It would endanger them. Proponents often ask, “What does a 
terminally ill patient have to lose?” The answers are simple. They can lose
money, perhaps their life savings, given that accessing right-to-try could
easily cost tens or hundreds of thousands of dollars. That’s because, when you
come right down to it, “right to try” is a misnomer. It’s really “right to buy.”
If you’re terminally ill and don’t have the money or the means to raise it,
right-to-try will not help you. Worse, thanks to right-to-try, terminally ill
patients can lose some of their precious quality time remaining with their loved
ones if they suffer complications that place them in a hospital or prematurely 
kill them.

Right-to-try laws: A cruel sham that is profoundly anti-patient

The California right-to-try bill being considered by Gov. Jerry Brown, like the 
Trickett Wendler Right to Try Act of 2016 and all of the other right-to-try laws
based on the Goldwater Institute template and passed by other states, is
profoundly anti-patient. Like the equally ill-advised 21st Century Cures Act,
right-to-try bills are based on the delusion that there are oodles and oodles of
cures for deadly diseases out there that could save thousands of lives if only 
the evil government and FDA would step aside and get out of the way of the free 
market. I say “delusion” because the FDA, despite being underfunded, is actually
pretty efficient at new drug approvals, evaluating nearly all new drug
applications within 6 to 10 months, an impressive turnaround for such complex
assessments. Indeed, the FDA actually acts more rapidly than its European
counterparts approving new drugs. Basically, there is no evidence that the FDA
hampers overall medical innovation, nor is there evidence that the FDA’s current
requirements lead to higher drug prices or cost lives.

None of this is to say that the FDA is perfect. Far from it. Certainly there is 
a discussion to be had about how, in the case of desperate patients with
terminal illnesses, we as a society should balance individual rights versus
risk/benefit considerations in making decisions about how freely we allow
experimental therapeutics to be used to try to save these patients. It’s not as 
though we haven’t had this discussion before, either. We had it in the 1980s
during the AIDS epidemic, and we’ve periodically revisited it since then. This
is another such time, and the FDA has actually responded by vastly simplifying
its procedure for granting Expanded Access, and the vast majority of such
requests are granted.

It must be reiterated that, as much as right-to-try is enormously popular
because no one wants to deny a terminally ill patients his or her “last chance,”
the purpose of right-to-try was never to help terminally ill patients. There is
no evidence, at least none that the Goldwater Institute has yet produced or
that I’ve been able to find anywhere, that right-to-try has allowed a single
terminally ill patient to access an experimental drug or helped him or her to
live longer, much less that it has saved a single life. Unfortunately,
right-to-try has been a cynically successful strategy to weaponize sympathetic
patients and basic human empathy for patients facing imminent death to attack
and ultimately greatly weaken the FDA.

The cruel sham that is right-to-try raises its ugly head at the federal level
again

Ill-advised right-to-try bills are spreading like kudzu through state
legislatures. Now federal legislators want to insert right-to-try language into 
the bill that funds FDA drug approval. Given the support of powerful Republicans
like Vice President Mike Pence for right-to-try, is it too late to stop this
juggernaut and protect patients?

David Gorski on April 17, 2017

Link



Anyone who has been reading this blog for the last three years or so knows that 
I’m not a fan of so-called “right-to-try” laws. Basically such laws, which have 
sprung up like kudzu since 2014 and now exist in 33 states, purport to allow
terminally ill patients the “right to try” experimental therapeutics. Thus far, 
they have been sold to the public as giving terminally ill patients “one last
shot” and touting how such laws could save lives. As a result, as I’ve grimly
quipped on multiple occasions, to politicians opposing right-to-try laws is akin
to opposing motherhood, apple pie, and the American flag; you just don’t do it 
and expect to be re-elected. It’s much easier just to go along than to explain
to the voters, the vast majority of whom do not understand the drug approval
process and therefore do not understand why right-to-try laws are harmful to the
very patients their proponents purport to be helping and why they’re such an
astonishingly bad idea, particularly as currently formulated. That would require
going into the details (which I will do shortly). So at the state level,
right-to-try advocates have basically won. Just shy of 2/3 of the states have
passed such laws in a mere three years, and I wouldn’t be surprised if the
remaining 17 states without a right-to-try law pass such laws within the next
year or two.

All right-to-try laws thus far hew very closely to model legislation written and
promoted by a libertarian think tank, the Goldwater Institute, with a few
state-specific differences here and there, and share several key features. They 
also share one key shortcoming, and that’s federal law. States do not regulate
drug approval in the U.S.; the federal government does, through the Food and
Drug Administration (FDA). In general, the FDA has not supported right-to-try
laws, but has liberalized expanded access programs (also sometimes called
compassionate use) to make it easier for terminally ill patients to access
experimental therapeutics outside of FDA-sanctioned clinical trials. Not
surprisingly, I’ve as yet been unable to find a single compelling example of a
patient who has been helped by access to an experimental therapeutic through a
state right-to-try law, although I’ve found that cancer quack Stanislaw
Burzynski has taken advantage of Texas’ right-to-try law to ply his quackery,
just as I warned that he would three years ago. Basically, right-to-try laws are
a solution looking for a problem or, as I like to call them, placebo
legislation. They make lawmakers feel good, but they do nothing concrete to help
actual patients. It’s also important to remember that the real purpose of
right-to-try laws is not to help patients, but to neuter the FDA’s ability to
regulate certain drugs, consistent with the source of this legislation. Passing 
state right-to-try laws is part of a strategy to build pressure to pass a
federal right-to-try law and thus weaken the FDA:

@gorskon Yes but I'm afraid much more support now. Goldwater's playbook was get 
laws in at least 25 states & then claim mandate for fed law

— Alison Bateman-House (@ABatemanHouse) August 24, 2016

Thus far, proponents have failed not once, but twice, to pass a federal
right-to-try law, once in the form of The Compassionate Freedom of Choice Act of
2014 and then again last year in the form of the The Trickett Wendler Right to 
Try Act of 2016, which fortunately failed to pass. Now they’re at it again.

If you can’t pass a right-to-try law, bury it in an omnibus bill

With the election of Donald Trump and both houses of Congress under the control 
of Republicans, a decidedly deregulatory mood has overtaken the government.
Moreover, Vice President Mike Pence supports right-to-try laws, having signed
one into law when he was Governor of Indiana. So you’d think that right-to-try
would just pass, and then President Trump would sign it. Yes, The Trickett
Wendler Right to Try Act has been reintroduced this session, but proponents
apparently don’t want to wait that long. The Prescription Drug User Fee Act
(PDUFA) is the law that allows the FDA to collect user fees from drug companies 
to fund the drug approval process. The current legislative authority for the
PDUFA expires at the end of September and needs to be renewed before then.
Right-to-try proponents thus see an opportunity to sneak a provision into the
PDUFA renewal that would serve their ends as well as a federal right-to-try law:

   And now, for the first time, federal legislation is gaining traction.

   Congressional supporters may try to attach a measure — drafted with a unique 
   and highly controversial restriction on the FDA — to the agency’s must-pass
   funding bill this year. The anti-regulatory mood dominating Washington is
   boosting these efforts.

More detail can be found in this account (behind a paywall, so I’ll quote a bit 
more liberally than usual):

   The ‘Right to Try’ movement is gaining momentum at the federal level with
   support from both the Trump Administration and Republicans in Congress to
   enact legislation that would direct FDA not to interfere with existing state 
   laws and allow terminally ill patients to access unapproved treatments.

   The “Right to Try” movement now has the explicit backing of the White House
   and enactment of legislation to prevent FDA from interfering with state laws 
   in that area may now be inevitable. Vice President Mike Pence met with
   right-to-try advocates Feb. 7. Pence is a backer of opening up broader access
   for compassionate use; as governor of Indiana, he signed state “Right to
   Try” legislation in law in 2015 and made statements during the Presidential
   campaign in support of such efforts. (Indiana is one of 33 states to enact
   legislation.) The official “readout” of Pence’s meeting makes clear that his 
   support for the effort is now Administration policy.

   Pence’s meeting builds on statements made by President Trump before a Jan. 31
   meeting with pharmaceutical CEOs, where he talked about the need to “change 
   a lot of rules” in drug regulation. (Also see “Trump Promises Changes To ‘A
   Lot Of Rules’ At US FDA” – Pink Sheet, 31 Jan, 2017.) “One thing that’s
   always disturbed me is we come up with a new drug for a patient who is
   terminal, and the FDA says we can’t have this drug used on the patient. But
   the patient within four weeks will be dead,” President Trump said. “They say 
   ‘well we still can’t approve the drug and we don’t know if the drug works or 
   if it doesn’t work but we can’t approve the drug because we don’t want to
   hurt the patient.’ But the patient is not going to live more than four
   weeks.”

This is a fallacious argument frequently used by right-to-try advocates.
Basically patients with only four weeks to live are highly unlikely to be helped
by pretty much anything, experimental or otherwise. However, they can be
harmed. Right-to-try proponents often ask, “What’s the harm?” or “How can it get
worse?” It can. A terminally ill patient could lose those four weeks with his
family or could suffer far more than he would have otherwise with palliative
care. Be that as it may, it’s clear that right-to-try backers, having thus far
been unable to use state right-to-try statutes to force the FDA to grant access 
to experimental therapeutics and failed to pass a federal law, are going to try 
to sneak a right-to-try provision into the bill that will fund much of the FDA’s
operations for the next four years.

To understand why this move is such a threat to patients, let’s briefly review
what state right-to-try laws claim to do (which is a lot) and actually do
(almost nothing) and then review the federal right-to-try bill that’s been
re-introduced.

State right-to-try laws: Harmful placebo legislation addressing a nonexistent
problem

I mentioned before that all the state right-to-try laws hew pretty tightly to an
approved model legislation template originally published by the Goldwater
Institute. Such legislation includes several major shared features. First is the
requirement that the disease the patient has be terminal, usually defined as
having a life expectancy of less than six months, although the model legislation
is more vague, requiring an “advanced disease,” defined as “progressive disease
or medical or surgical condition that entails significant functional
impairment, that is not considered by a treating physician to be reversible even
with administration of current federal drug administration approved and
available treatments, and that, without life-sustaining procedures, will soon
result in death.” Various states define this condition in somewhat different
ways, but you get the idea.

One of the most problematic passages, if not the most problematic passage, is
the one where the term “investigational drug, biologic product, or device” is
defined:

   “Investigational drug, biological product, or device” means a drug,
   biological product, or device that has successfully completed phase 1 of a
   clinical trial but has not yet been approved for general use by the United
   States food and drug administration and remains under investigation in a
   United States food and drug administration-approved clinical trial.

Every right-to-try bill or law I’ve read uses minor variations of the above
definition. Anyone who knows anything about drug development knows that having
completed a phase 1 trial is a dangerously low bar to clear to allow more
widespread use of a drug. Basically phase 1 trials are small trials, usually
consisting of less than 30 subjects, that look for major toxicities and adverse 
events. That is not enough to determine safety, nor is it intended to. Phase I
trials are designed primarily to identify major side effects and to use a
process known as dose escalation to determine what is commonly referred to as
the “maximum tolerated dose.” It is utterly impossible for such a small clinical
trial to determine the safety of a drug. Phase II and Phase III trials are
needed to confirm safety. Think of phase I trials as a screening test looking
for the most obvious toxicities, with phase II and III studies confirming them. 
Indeed, even phase III trials can’t always adequately demonstrate that a drug is
safe; it’s not uncommon for less common adverse effects not to show up until
post-marketing surveillance, when much larger numbers of patients receive the
drug. Moreover, only 5% of all cancer drugs that enter clinical testing are
ultimately approved for patient use. Among drugs tested in phase II trials, only
30% go on to phase 3. I like to point to the cautionary example of amonifide
for treating breast cancer. The drug made it through phase I trials, but serious
life-threatening hematologic toxicity emerged during phase II trials.

Right-to-try laws limit who can access them by wealth. The reason is that all of
them have a provision that says that health insurance companies do not have to 
pay for such treatment. They can pay if they so desire, but what’s the
likelihood of an insurance company paying for an experimental treatment?
However, nearly all right-to-try laws also say that the company providing the
experimental therapeutic under right-to-try can charge the patient for it. (One 
notable exception, as I learned a year ago, is Texas, where the right-to-try law
bars charging the patient.) A terminally ill patient could easily go bankrupt
before he died paying for drugs accessed through right-to-try laws, and many
couldn’t access experimental therapeutics through such laws in any event because
they simply don’t have the money or the fundraising wherewithal to do so.

In Michigan, the requirement is particularly suspect in that it requires
“written informed consent” for using the experimental drug that attests that the
“patient understands that he or she is liable for all expenses consequent to
the use of the investigational drug, biological product, or device and that this
liability extends to the patient’s estate, unless a contract between the
patient and the manufacturer of the drug, biological product, or device states
otherwise.” This puts the patient on the hook for any expenses or debt that he
incurs using experimental treatments, but also seems custom-made for drug
companies, to make sure that they get their money for experimental therapies
administered under “right-to-try,” no matter what. Basically, they can go after 
a deceased patient’s estate, something that will frequently be necessary because
patients eligible for “right-to-try” by definition have a terminal illness, and
the vast majority of even the most promising drugs will, at the very best,
prolong their life, not save it. It goes beyond that, though. If a patient uses 
a right-to-try drug and suffers complications, these laws basically state that
the insurance company doesn’t have to pay for care resulting from that
complication, and all such laws state that patients undergoing right-to-try
therapies lose their coverage for hospice.

Right-to-try laws are patient-hostile in other ways, too, as Jann Bellamy and I 
have described many times. The most egregious example of which is how they strip
patient protections away from patients who access them. One way to see this is 
by comparing what happens when a patient accesses an experimental therapeutic
under the FDA expanded access program to what happens when another patient
accesses one under a right-to-try law. Under FDA expanded access, patients
retain full protections under federal and state laws. They can sue for
malpractice if there is any, and their care is still monitored by an
institutional review board (IRB), with any adverse events recorded and
considered by the FDA. Moreover, the FDA approves nearly all such requests
(99%). In contrast, under right-to-try, there is no IRB oversight. It’s all
between the company and the patient.

Right-to-try laws also limit what patients can do in the event of malpractice or
negligence. All of them immunize physicians advising or administering
right-to-try medications against malpractice suits or actions against their
medical license by the state medical board for doing so. All of them contain
provisions broadly immunizing companies providing experimental therapeutics
under right-to-try from liability. All of them contain provisions stating that
state employees can’t interfere with a patient seeking right-to-try, which could
be interpreted to mean that a doctor at an academic medical center at a state
university couldn’t counsel a patient not to seek right-to-try without running
afoul of the law. As Jann notes, even if state authorities believe, for example,
that an elderly person is being exploited for financial gain by a physician,
presumably this provision would prohibit their acting.

As you can see, these state laws are potentially very harmful, but they’re easy 
to demagogue. Anyone supporting them can easily paint himself as the champion of
terminally ill patients with no hope left, while those of us who oppose such
laws have the difficult task of explaining clinical trials and how these laws
harm patients. Indeed, when right-to-try came to Michigan, I was endlessly
frustrated by how pretty much none of our major medical schools or cancer
centers would speak out. Flacks from the Goldwater Institute, complete with
patients with compelling stories, were there in abundance, though.

I called state right-to-try placebo legislation because it basically does
nothing while making everyone feel better. That’s why federal legislation is in 
the works.

Federal right-to-try

Two of the biggest hurdles to actually utilizing state right-to-try laws include
the authority of the FDA, which preempts state laws, and the fact that the FDA 
has thus far taken a dim view of companies using experimental therapeutics
outside the auspices of an FDA-sanctioned clinical trial or under its expanded
access program. Enter federal right-to-try bills. The most recent ones are S.
204: Trickett Wendler Right to Try Act of 2017, introduced into the Senate by
Ron Johnson (R-WI) and H.R. 878: Right to Try Act of 2017, introduced by Rep.
Andy Biggs (R-AZ). Both are basically the same as the bill introduced last year.
They both have two main provisions:

   (1)No liabilityNotwithstanding any other provision of law, no liability shall
   lie against a producer, manufacturer, distributor, prescriber, dispenser,
   possessor, or user of an experimental drug, biological product, or device for
   the production, manufacture, distribution, prescribing, dispensing,
   possession, or use of an experimental drug, biological product, or device
   that is in compliance with subsection (a).

   (2)No use of outcomesNotwithstanding any other provision of law, the outcome 
   of any production, manufacture, distribution, prescribing, dispensing,
   possession, or use of an experimental drug, biological product, or device
   that was done in compliance with subsection (a) shall not be used by a
   Federal agency reviewing the experimental drug, biological product, or device
   to delay or otherwise adversely impact review or approval of such
   experimental drug, biological product, or device.

These provisions are pretty self-explanatory. These bills would prevent federal 
lawsuits against drug or device manufacturers, dispensers, users, or physicians 
prescribing or administering right-to-try. The more pernicious part of the bill 
is the second provision, which would explicitly bar the FDA from considering any
adverse events that occur in patients using right-to-try laws in its decision
whether to approve or reject an application for approval to market. This clause 
is clearly intended to address the concern of drug and device manufacturers that
if they provide an experimental therapeutic to a patient under right-to-try and
the patient suffers complications due to the treatment, the approval of its
product might well be jeopardized. This, of course, is not an unreasonable
concern on the part of manufacturers, given that it can easily cost $1 billion
to bring a drug or device to market, and by the time the product has passed
phase I clinical trials a great deal of that cost has already been invested in
development. However, this clause goes way too far. Basically, it says that even
if a patient death is clearly due to use of an experimental drug under
right-to-try, that death should not be considered by the FDA in deciding whether
to approve the drug. Think of it this way. Let’s say dozens of patients die
from using an experimental drug under right-to-try. This bill, if passed, would 
bar the FDA from even considering those deaths during its deliberations
regarding whether to approve the drug for marketing or not. This is not a good
thing for patients.

Basically, the Trickett Wendler Right to Try Act of 2017 would not help
terminally patients. It would endanger them. Proponents often ask, “What does a 
terminally ill patient have to lose?” The answers are simple. They can lose
money, perhaps their life savings, given that accessing right-to-try could
easily cost tens or hundreds of thousands of dollars. That’s because, when you
come right down to it, “right to try” is a misnomer. It’s really “right to buy.”
If you’re terminally ill and don’t have the money or the means to raise it,
right-to-try will not help you. Worse, thanks to right-to-try, terminally ill
patients can lose some of their precious quality time remaining with their loved
ones if they suffer complications that place them in a hospital or prematurely 
kill them.

The New York University School of Medicine Working Group on Compassionate Use
and Pre-Approval Process has published an excellent bullet-point summary of the 
problems with right-to-try, as well as policy suggestions going forward.

Right-to-try against patients

As I wrote this, I contemplated a simple question: Which federal action is
worse? Would passing the Trickett Wendler Right To Try Act of 2017 be worse, or 
would sneaking a right-to-try provision into the must-pass PDUFA be worse? The
answer is not obvious. Trickett Wendler would prevent the FDA from considering
outcomes in patients undergoing right-to-try treatments in its approval
deliberations, which would have the potential to be disastrous, particularly if 
right-to-try usage of experimental therapeutics becomes more widespread.
Meanwhile adding right-to-try to the bill that funds the FDA, in essence
baking-in a ban on interfering with patients seeking experimental therapeutics
under state right-to-try has the potential to cause a lot of harm, because state
right-to-try bills do not prevent the FDA from considering outcomes of patients
accessing experimental therapeutics. At least, I don’t think it does but can’t 
be sure. The specific language of the right-to-try provision of PDUFA hasn’t
been revealed yet. If that language contains a Trickett Wendler-like ban on the 
FDA using outcomes from right-to-try patients in its considerations of drug
approval, then the PDUFA approach will be equally, if not more, harmful.
Basically, both the PDUFA and Trickett Wendler bills are plenty bad.

As has been the case since 2014, I remain frustrated by the relative lack of
pushback by the medical community against such ill-advised right-to-try bills
and efforts. I’m not the only one. Beth E. Roxland, senior adviser on law,
ethics, and policy at NYU Langone Medical School agrees:

   Roxland, the NYU ethicist, is watching, dismayed, as the right-to-try bills
   sweep the country.

   “What I see is, unfortunately, very little pushback in terms of what the
   downsides could be,” she said. “If anything, it’s just picking up steam.”

   Roxland said she has spoken to medical industry leaders and policymakers who 
   support the rights of patients to seek potentially lifesaving treatments, but
   who feel the right-to-try laws, as written, will ultimately harm patients.
   She said these leaders are frequently reluctant to to [sic] express nuanced
   objections in the face of more emotionally charged arguments. “It’s hard to
   argue against when it’s framed as the terminally ill having the right to save
   their lives,” she said. “How do you argue against that?”

   This could be one reason why the FDA and major trade groups, including the
   American Medical Association and the Pharmaceutical Research and
   Manufacturers of America, have taken no public stance on the legislation.

Roxland’s experience mirrors my own. Everyone in academia or pharma with whom
I’ve ever discussed right-to-try thinks these laws are a horrible idea that will
harm patients, but no one wants to be the one to speak out, for the reasons
listed by Roxland above or, as I put it, because they don’t want to be perceived
as yanking a dying patient’s last hope away. Of course, that’s not what we’re
doing, but that’s what right-to-try advocates have successfully portrayed us as 
doing.

For instance, it wasn’t until earlier this month that the largest oncology
professional society, the American Society of Clinical Oncology (ASCO)
finally—finally!—came out forcefully against right-to-try. In a statement, ASCO 
noted:

   As the leading medical society for physicians involved in cancer treatment
   and research, the American Society of Clinical Oncology (ASCO) supports
   access to investigational drugs outside of clinical trials when there are
   adequate patient protections in place. However, ASCO is concerned that
   existing and proposed RTT laws do not adequately protect patients, do little 
   to facilitate patient access to such therapies, and potentially interfere
   with recent reforms that are already streamlining patients’ access to
   investigational agents.

Comparing the existing system for expanded access to right-to-try laws, ASCO
finds many problems:

   ASCO is concerned that most RTT laws, while well intentioned, are not an
   effective mechanism for improving access to investigational drugs for
   terminally ill patients and may cause unintended harms, for the following
   reasons:

  1. Right-to-try laws do not include an enforcement mechanism to provide access,
    since they do not require or compel drug manufacturers to provide
    investigational products. As such, these laws do not remove a frequent
    barrier to access.

  2. These laws place no legal obligations on insurers to pay for the routine care 
    costs associated with delivery of treatment – unlike coverage requirements
    that do exist for patients who participate in clinical trials. As a result, 
    RTT laws establish no new rights or protections for patients.

  3. Independent review of the potential safety and efficacy of investigational
    drugs is important for patient safety. Under the expanded access program,
    the FDA conducts a prompt review of the available data and makes an
    independent assessment on behalf of the patient. Such review is bypassed in 
    RTT laws.

And:

   Moreover, these laws as currently envisioned and enacted will interfere with 
   already- streamlined and effective protocols, potentially putting patients at
   high risk for unclear benefit. Specifically, these measures will:

  1. Jeopardize insurance coverage for the cost of patient care associated with the
    use of investigational drugs, particularly in the case of complications
    caused by these drugs;

  2. Circumvent the government’s responsibility to monitor and protect the safety
    of patients seeking access to investigational products; and

  3. Fail to provide adequate transparency, in part due to a lack of reporting
    requirements, on how patients respond to investigational drugs under a
    right-to-try scenario.

   In addition to their lack of patient protections, RTT laws do not mitigate
   the delays that can occur during the expanded access application process. For
   example, regardless of whether under RTT or the FDA process, applicants must
   determine a sponsor’s willingness to provide the investigational drug.
   Providers and patients consistently report difficulty locating information
   about drug manufacturer contacts for such requests, significant delays in
   response and even denial of the request altogether.

Sound familiar? This is exactly what I’ve been saying for three years now, along
with every other opponent of right-to-try who actually spoke up. ASCO goes on
to describe strategies by which expanded access programs can be strengthened and
patients provided more access to experimental therapeutics, complete with
current protections. Unfortunately, ASCO is a day late and a dollar short.
Actually, it’s three years late. The time for oncology professional associations
to speak up was in 2014, as the first right-to-try bills were wending their
ways through state legislatures, not now. Then, ASCO might have influenced the
debate in a positive way. Now, it’s almost certainly too late.

All along, too few people have been willing to point out that right-to-try is
not about helping patients. Consider the source of right-to-try, after all.
Rather, it’s about this:

   But the increased momentum is raising alarms, with opponents saying that such
   laws largely offer false hope. That’s because many drug companies are
   reluctant to provide medications outside of clinical trials — and why critics
   insist that the FDA is not the problem. In 2016, they note, the agency
   revamped its “expanded access” program to speed unapproved drugs to patients 
   who have no alternatives and can’t get into clinical trials. The FDA approves
   almost all such requests, the data shows.

   “A lot of this is smoke and mirrors for some other agenda,” said Andrew
   McFadyen, executive director of the Toronto-based Isaac Foundation, which
   assists U.S. and Canadian patients seeking access to medications. “A weaker
   FDA is what they are after.”

Exactly. Kudos to Mr. McFadyen for stating the obvious. Right-to-try is a
strategy by libertarians to neuter the FDA, as could be seen rather plainly
during the Ebola scare, when libertarians openly argued that the FDA was
“killing patients” and that right-to-try was the answer.

I’ve pointed out before how the entire justification for “right to try” laws
rests on a misperception that there are “miracle drugs” out there that we will
have to wait years for because the FDA is too slow to approve them. Not only is 
this a myth (the FDA is actually pretty fast at approving new drug applications 
compared to, for example, its European counterpart), but if there really were
such a “miracle drug” that was amazingly effective compared to anything we have 
now, a large randomized phase III trial would not be necessary to detect its
efficacy. Indeed, its efficacy could show up in even a small phase I trial or,
at the latest, in phase II trials, and, under previous policy and even more so
under the 21st Century Cures Act, the FDA can consider that evidence in
approving a drug. There would be examples of clinical trial subjects
demonstrating amazing tumor shrinkage or even outright cures. In reality, we
don’t see these things in phase I trials, because there are no miracle drugs, at
least not yet. (The closest to a “miracle drug” I can think of is Gleevec, and 
drugs like Gleevec are rare.)

“Right to try” laws rest on a fantasy, and it’s a fantasy of false hope. Indeed,
these bills serve an ideological purpose rooted in libertarian politics, free
market fundamentalism that claims that deregulation is the cure for everything, 
and the desire to weaken the FDA that flows from such beliefs. Unfortunately,
because stakeholders in medicine who recognized this were too timid to speak up,
it is probably too late to stop some form of a federal “right-to-try” bill or
provision from becoming law. Let that be a lesson to us.

The cruel sham of “right-to-try” takes a giant step towards becoming federal law

So-called “right-to-try” is a cruel sham that holds out the false hope of
survival to terminally ill patients and their families. In return, all they have
to give up is patient protections and agree to pay to be guinea pigs to test a 
drug company’s product. The product of an ideology that uses the terminally ill 
as shields to hide the ideological motives behind the law, which are to hobble
the FDA, right-to-try is a terrible idea. It’s bad for patients, but it just
passed the Senate and could well become the law of the land when the House
reconvenes in September if it isn’t stopped.

David Gorski on August 5, 2017

Link



The moment I have feared ever since Republicans took control of all three
branches of government last fall has come one step closer to reality. Actually, 
it’s merely one of many. occurrences that I have feared, given that Donald Trump
has been our President for over six months. Although you won’t find much in the
news about it, yesterday the Senate easily passed a federal version of
so-called “right-to-try.” Senator Ron Johnson, who threatened to hold up Senate 
business unless a right-to-try rider was approved for the bill funding the FDA
for the next seven years, was ecstatic:

I’m proud the Senate stood up for terminally ill patients who just want to
reclaim their freedom – who want the right to hope. #RightToTry
pic.twitter.com/JcyLaDCJ3o

— Senator Ron Johnson (@SenRonJohnson) August 3, 2017

As was Christina Sandefur of the Goldwater Institute, the libertarian think tank
that concocted the idea of “right-to-try” and of cynically enlisting terminally
ill patients as sympathetic pawns and shields against criticism in its
never-ending war on government regulation in general and the ability of the FDA 
to protect patients from unsafe and ineffective drugs:

@MiraSorvino US Senate unanimously passed #RightToTry today! This bipartisan
effort puts patients 1st, not politics. Thx for your support!

— Christina Sandefur (@cmsandefur) August 3, 2017

Basically, all that has to happen in September, which is when Congress will
reconvene, is for the House to pass this law too. One the one hand, I’m relieved
that it’s just the standalone law that passed and that right-to-try wasn’t
attached to the bill that allows the FDA to collect user fees from companies
seeking FDA approval for their drugs and devices, but that doesn’t make the bill
any less dangerous to patients. I will also grant that, as you will see, the
bill as passed is not as bad as the original version of the bill (S. 204:
Trickett Wendler Right to Try Act of 2017), but it still has the potential to do
a lot of mischief, endanger a lot of patients, and empower a lot of scammers.
To understand why, though, you need to understand what right-to-try is.

Right-to-try: A cruel sham that politicians can’t oppose

I’ve written many times before over the last three years about how
“right-to-try” laws have swept the states. When last I wrote about right-to-try,
37 states had passed such laws over the course of a mere three years, and I
observed at the time that it wouldn’t surprise me in the least if most or all of
the remaining states were to pass such laws within the next year or two.
Basically, the idea behind these laws is that the FDA is killing patients (I’m
only exaggerating slightly) through its slow drug approval, overcaution, and
bureaucratic inertia, or at least letting them die because life-saving drugs are
being held up. So the idea, hatched by the Goldwater Institute was that
terminally ill patients should have the “right-to-try” experimental drugs not
yet approved by the FDA because they have nothing more to lose. Of course, it’s 
not true that they have nothing more to lose, but I’ll discuss that more later. 
Basically, right-to-try laws purport to allow the terminally ill “one last shot”
by letting them access experimental therapeutics outside of FDA-sanctioned
clinical trials. However, these laws operate under a number of false
assumptions, not the least of which is the caricature of the FDA as being slow, 
inefficient, and unwilling to bend, as you will see. They also strip away a
number of protections for patients, as you will also see.

Who could argue with giving terminally ill patients “one last shot,” right? That
is, of course, the issue. On the surface, these laws sound very pro-patient,
but they are in reality a Trojan horse designed to weaken the regulatory power
of the FDA. They are a cruel sham, an illusion. As I’ve said from the beginning,
Dallas Buyers Club might have been a good movie (I actually was disappointed in
it when I actually saw it), but it’s a horrible basis for public policy on drug
regulation. Indeed, right-to-try is a triumph of marketing that allowed anyone 
who perceived how it degrades patient protections, sells false hope, and harms
the clinical trial process to no one’s benefit as heartless monsters who have no
empathy for dying patients and value science over people. Indeed, this is
exactly the sort of rhetoric one sees aimed at opponents on Twitter:

Amen to that! Thank you 4 your tireless efforts Christina. Ignore those like
healthy @gorskon who thinks we all should die 4 science & FDA

— B Hanson (@SCPioneer) August 4, 2017

And:

Holding back innovation is bad for patients? The same dying patients in search
of better options, often when there are none. Why the angst?

— Stefanie C (@CowleyStef) August 4, 2017

Basically, if you speak out for patients and against right-to-try, you will be
painted as cold and indifferent to the suffering of terminally ill patients. For
me, nothing could be further from the truth. Either that, or you’ll be painted 
as being in the pocket of big pharma. All of this propaganda had a very chilling
effect on criticism. I realize it’s an unscientific sample, but I know of no
one involved in, for instance, cancer clinical trials at academic medical
centers who supports right-to-try. Yet, whenever right-to-try bills were
introduced in various states, the silence from medical professional
organizations, universities, cancer centers, and the like was deafening. When
right-to-try came to Michigan, almost no one testified against it, and the
Goldwater Institute was free fly in a parade of families of patients with
terminal illnesses who were convinced that right-to-try would give their loved
ones a shot at life. The same sort of thing happened in the Senate over S.204:

   But more liberal lawmakers faced significant lobbying, featuring
   heartbreaking stories of young children or newlyweds facing shortened lives. 
   Meanwhile, the most powerful opposition, the drug industry and doctors’
   groups, kept their disagreement very low-profile. Their soft voices gave
   lawmakers little political protection for a “no” vote.

   “There’s no doubt about it — there are a lot of patients out there that think
   this is the answer to their prayers. … They certainly believed that, and
   they pushed their members of Congress to support a bill that in many cases
   the members of Congress thought was not a good idea,” said Zuckerman.

   PhRMA’s low-profile on right-to-try hurt detractors from the outset. The
   industry group never took a formal position on the state right-to-try laws or
   earlier federal proposals. But it consistently reiterated its concerns about
   any approach to experimental medicines that sought to bypass the FDA and the
   clinical trial process. Of the major drug makers, only Merck formally came
   out against the earlier Johnson bill.

   “It’s huge,” NYU’s Bateman-House said of PhRMA’s reluctance to take a
   stronger public stance. “When I speak with legislators, they say, ‘Well if
   it’s that bad, why isn’t pharma speaking against it?’”

The same could be said of the American Society of Clinical Oncology (ASCO),
which spent the last three years taking no position on right-to-try until three 
months ago, by which time it was too little, too late. It’s not for nothing that
nearly every time I write about right-to-try, I remark sardonically that
opposing right-to-try is perceived by most people the same way as opposing mom, 
apple pie, and the American flag—or worse, wanting to kill mom, defile apple
pie, and shred the American flag. Again, I exaggerate, but not by much.

By drafting terminally ill patients into its war with the FDA, the Goldwater
Institute could basically falsely equate criticism of right-to-try with attacks 
on dying patients. It was a cynical and very likely intentional strategy, and it
worked brilliantly to silence groups that could have been the most effective
opposition to right-to-try until it was too late. But what’s wrong with
right-to-try anyway? To answer that, I’ll briefly reiterate the problems with
state right-to-try laws and then to discuss the problem with the federal
right-to-try bill as passed.

The problem with state right-to-try laws

All the state right-to-try laws hew pretty tightly to an approved model
legislation template originally developed by the Goldwater Institute. Given
that, all state right-to-try laws share several major features. The first was
the requirement that the disease the patient has be terminal, usually defined as
having a life expectancy of less than six months, although the model
legislation is more vague, requiring an “advanced disease,” defined as
“progressive disease or medical or surgical condition that entails significant
functional impairment, that is not considered by a treating physician to be
reversible even with administration of current federal drug administration
approved and available treatments, and that, without life-sustaining procedures,
will soon result in death.” Various states define this condition in somewhat
different ways, but you get the idea. In fact, the federal legislation uses a
definition more like the latter than the former.

One of the most problematic passages, if not the most problematic passage, in
all right-to-try laws, including the federal one passed by the Senate, is the
definition of “investigational drug, biologic product, or device”:

   “Investigational drug, biological product, or device” means a drug,
   biological product, or device that has successfully completed phase 1 of a
   clinical trial but has not yet been approved for general use by the United
   States food and drug administration and remains under investigation in a
   United States food and drug administration-approved clinical trial.

Every right-to-try bill or law I’ve read uses minor variations of the above
definition. Anyone who knows anything about drug development shudders when
reading passages like that. The reason is that having completed a phase 1 trial 
is a dangerously low bar to clear to allow more widespread use of a drug.
Basically phase 1 trials are small trials, usually consisting of less than 30
subjects, that look for major toxicities and adverse events. That is not enough 
to determine safety, nor is it intended to. Phase I trials are designed
primarily to identify major side effects and to use a process known as dose
escalation to determine what is commonly referred to as the “maximum tolerated
dose.” It is utterly impossible for such a small clinical trial to determine the
safety of a drug. Phase II and Phase III trials are needed to confirm safety.
Think of phase I trials as a screening test looking for the most obvious
toxicities, with phase II and III studies confirming them. Indeed, even phase
III trials can’t always adequately demonstrate that a drug is safe; it’s not
uncommon for less common adverse effects not to show up until post-marketing
surveillance, when much larger numbers of patients receive the drug. Moreover,
only 5% of all cancer drugs that enter clinical testing are ultimately approved 
for patient use. Among drugs tested in phase II trials, only 30% go on to phase 
3. I like to point to the cautionary example of amonifide for treating breast
cancer. The drug made it through phase I trials, but serious life-threatening
hematologic toxicity emerged during phase II trials.

Another problem with right-to-try laws is that they are extremely inequitable.
Basically, right-to-try laws limit who can access them by wealth. The reason is 
that all of them have a provision that says that health insurance companies do
not have to pay for right-to-try treatments and most such laws allow drug
companies to charge whatever they see fit for the experimental drug. Insurance
companies can pay if they so desire, but what’s the likelihood of an insurance
company paying for an experimental treatment? It goes beyond that, though. If a 
patient uses a right-to-try drug and suffers complications, these laws basically
state that the insurance company doesn’t have to pay for care resulting from
that complication, and all such laws state that patients undergoing right-to-try
therapies lose their coverage for hospice while undergoing right-to-try
treatment. Thus, a terminally ill patient could easily go bankrupt before he
died paying for drugs accessed through right-to-try laws, and many couldn’t
access experimental therapeutics through such laws in any event because they
simply don’t have the money or the fundraising wherewithal to do so.

Right-to-try laws also limit what patients can do in the event of malpractice or
negligence. All of them immunize physicians advising or administering
right-to-try medications against malpractice suits or actions against their
medical license by the state medical board for doing so. All of them contain
provisions broadly immunizing companies providing experimental therapeutics
under right-to-try from liability. All of them contain provisions stating that
state employees can’t interfere with a patient seeking right-to-try, which could
be interpreted to mean that a doctor at an academic medical center at a state
university couldn’t counsel a patient not to seek right-to-try without running
afoul of the law. As Jann notes, even if state authorities believe, for example,
that an elderly person is being exploited for financial gain by a physician,
presumably this provision would prohibit their acting.

Right-to-try laws are patient-hostile in other ways, too, as Jann Bellamy and I 
have described many times. The most egregious example of which is how they strip
protections away from patients who access them. One way to see this is by
comparing what happens when a patient accesses an experimental therapeutic under
the FDA expanded access program to what happens when another patient accesses
one under a right-to-try law. Under FDA expanded access, patients retain full
protections under federal and state laws. They can sue for malpractice if there 
is any, and their care is still monitored by an institutional review board
(IRB), with any adverse events recorded and considered by the FDA. Moreover, the
FDA approves nearly all such requests (99%). In contrast, under right-to-try,
there is no IRB oversight. It’s all between the company and the patient.

Finally, I not infrequently call state right-to-try laws placebo legislation
because such laws basically does nothing while making everyone feel better.
That’s because the federal government, not the states, controls drug approval.
Basically, the state can say that patients have a “right-to-try,” but only the
federal government can actually guarantee such a “right.” It’s actually
fortunate that state-level right-to-try laws are placebo laws, because if they
actually did what’s in their text they would be profoundly harmful to patients.

The problem with the version of “right-to-try” passed by the Senate

In marked contrast to state-level laws, any federal right-to-try bill that
becomes law would not be placebo legislation. It would be harmful, and the
Trickett Wendler Right to Try Act of 2017, although amended to be less harmful
than the original version, is still a danger to patients. I described in detail 
what was in the original version of this bill in previous posts; so I won’t
dwell too much on it. The key points of the original bill were:

  1. No interference by the federal government with state right-to-try laws.

  2. No liability for either drug companies providing right-to-try or doctors
    recommending right-to-try

  3. No use of outcomes from patients accessing right-to-try in FDA consideration
    of drug approval.

So let’s look at Substitute_Amendment_S.20415. It’s still bad, but not as bad
because there are amendments that mitigate some of the worst aspects of the
original. Unfortunately, it still uses an overly broad definition of who can
access right-to-try. Basically, anyone with a serious illness as defined by the 
FDA is eligible. The bill also retains the dangerously nonsensical provision
that any drug that’s passed phase I trials and is still in active development
can be accessed through right-to-try.

One thing the new “right-to-try” does is to change the provision in the original
version that forbade the FDA from considering outcomes observed in patients
accessing a drug by right-to-try in its deliberations over whether to approve
the drug or not:

   (1) IN GENERAL.—Notwithstanding any other provision of this Act, the Public
   Health Service Act, or any other provision of Federal law, the Secretary may 
   not use a clinical outcome associated with the use of an eligible
   investigational drug pursuant to this section to delay or adversely affect
   the review or approval of such drug under section 505 of this Act or section 
   351 of the Public Health Service Act unless—

   (A) the Secretary makes a determination, in accordance with paragraph (2),
   that use of such clinical outcome is critical to determining the safety of
   the eligible investigational drug; or

   (B) the sponsor requests use of such outcomes.

The “Secretary” above is the Secretary of Health and Human Services, although
the HHS Secretary can delegate the decision to the FDA Commissioner.

The new right-to-try also requires the FDA to post information regarding
right-to-try on its website:

   (1) IN GENERAL.—The manufacturer or sponsor of an eligible investigational
   drug shall submit to the Secretary an annual summary of any use of such drug 
   under this section. The summary shall include the number of doses supplied,
   the number of patients treated, the uses for which the drug was made
   available, and any known serious adverse events. The Secretary shall specify 
   by regulation the dead line of submission of such annual summary and may
   amend section 312.33 of title 21, Code of Federal Regulations (or any
   successor regulations) to require the submission of such annual summary in
   conjunction with the annual report for an applicable investigational new drug
   application for such drug.

   (2) POSTING OF INFORMATION.—The Secretary shall post an annual summary report
   of the use of this section on the internet website of the Food and Drug
   Administration, including the number of drugs for which clinical outcomes
   associated with the use of an eligible investigational drug pursuant to this 
   section was—

   (A) used in accordance with subsection (c)(1)(A);(B) used accordance with
   subsection (c)(1)(B); and(C) not used in the review of an application under
   section 505 of this Act or section 351 of the Public Health Service Act.

As you can see, this is better, but still problematic. Basically, the FDA
Commissioner can decide on an individual basis whether or not to use
right-to-try outcomes in considering the approval of a drug. I can see
considerable potential for favoritism and abuse in this provision, in which
favored companies can do what they like and not have to worry about whether
right-to-try outcomes will count against them and less favored companies will
have to worry. it is, however, good that at least there will be some
transparency, as some information will have to be made publicly available.

The modified bill also softens the protections against lawsuits against
manufacturers and doctors recommending right-to-try with an exception to
immunity if “the relevant conduct constitutes reckless or willful misconduct,
gross negligence, or an intentional tort under any applicable State law.” Now,
I’m not a lawyer, but here’s one huge problem with this that I see. State
right-to-try laws in general completely immunize manufacturers providing
experimental therapeutics under the law and doctors recommending such
therapeutics from any legal liability; so in those states there would be nothing
patients could sue for, even in the case of “reckless or willful misconduct,
gross negligence, or an intentional tort.” If there are any lawyers out there,
feel free to correct me if I’m wrong, but it appears that only in states without
right-to-try would this provision mean anything.

What now?

Now that S.204 has been passed by the Senate, it moves on to the House, where,
unfortunately, it is highly likely to pass. Given the anti-regulatory mood of
the current Congress, coupled with the successful branding of right-to-try
opponents as either in the pocket of big pharma or indifferent to the suffering 
of the terminally ill, it will be very, very difficult to stop this bill. That
doesn’t mean that we shouldn’t continue to try, but we should have no illusions.
We are likely to see what happens if right-to-try becomes the law of the land
at the federal level. While it’s true that this version is not quite as patient-
and science-hostile as the original version, it is, unfortunately, plenty bad, 
man.

It’s also not as though we haven’t had a chance to see if right-to-try provides 
any of the benefits claimed for it. Unfortunately, thus far, right-to-try has
been a miserable failure, despite three years for it to have proven its worth. I
know. I’ve looked for “success stories,” and the Goldwater Institute has been
unable to provide them.

Sandefur has, however, been able to provide the same old talking points about
the FDA Expanded Access Program and about how slow the FDA allegedly is
approving drugs. It actually turns out that the FDA is faster than its European 
counterparts approving drugs and that the expanded access program is nowhere
near as onerous as ideologues like Sandefur like to paint it. Indeed, there is a
nice FAQ maintained by the NYU Working Group on Compassionate Use and
Pre-Approval Access that answers pretty much every talking point, and I’ve
discussed these same talking points before. It’s basically a lot of
misinformation promoted by ideologues.

Nor is this “success story” persuasive if you look into it more:

   Now, as to Right to Try: when real-life examples of its early success are
   reported, Klugman’s response is to deny that they are true—and this is
   frankly bizarre. Dr. Delpassand has testified to Congress that within a year 
   of his state’s enacting Right to Try, he successfully treated 78 terminally
   ill cancer patients using LU-177, a drug that had successfully completed its 
   three phases of the FDA-approved clinical trials and has been available in
   European countries for years, but has still not received final FDA approval
   for sale. I should know, since I’m his lawyer: Dr. Delpassand had
   administered a successful FDA-approved clinical trial for LU-177 therapy for 
   five years, but was then told by the FDA that he could not add more patients 
   to the trial. Right to Try enabled him to continue administering LU-177 to
   patients suffering from neuroendocrine cancer after the FDA blocked the
   trial’s expansion. His patients were exceedingly grateful. One said that
   without Right to Try, he “would have had to go on disability to make trips to
   Switzerland.” Another said he “would have traveled to Switzerland for this
   same treatment and follow-up appointments every three months,” but thanks to 
   Right to Try and Dr. Delplassand, he was able to stay in the United States
   and spend the time with his wife and kids. “This law,” he told me, “has been 
   a life saver!”

I discussed the example of Dr. Delpassand and his company Excel Diagnostics in
detail before, as well as how Dr. Delpassand is a cheerleader for the Goldwater 
Institute who’s done promotional videos for right-to-try before. Basically, the 
treatment being promoted by Dr. Delpassand for neuroendocrine tumors has
promise. It even was found in a phase III trial published earlier this year to
produce a significant increase in progression-free survival for midgut
neuroendocrine tumors. However, as I described in depth, there was something
fishy about the story. He claimed to be administering his radionuclide treatment
under Texas’s right-to-try law, but he was charging patients and the Texas
right-to-try law, as I was so pointedly reminded when I discussed the issue,
doesn’t allow manufacturers to charge for their experimental therapeutic.

Basically, reading between the lines in Sandefur’s article, I now think I know
what happened, and, to put it kindly, it’s not exactly what is being claimed.
What it sounds like to me from Sandefur’s carefully worded account, plus what
I’ve looked up before, is that, after having reached his accrual target for his 
clinical trial, Dr. Delpassand wanted to add additional patients to it even
though the trial was closed. The FDA balked at this request—and understandably
so. The reason was almost certainly that adding patients to a clinical trial
after it’s closed is, in essence, changing the design of the trial post-hoc. It 
would also have increased the time necessary to analyze the trial. So Dr.
Delpassant appears to have used the right-to-try law to get what he wanted. As I
documented before from a patient webpage, he also appeared to be charging
patients close to $40,000 for the treatment, although it is unclear whether he
charged for his radionuclide or not or whether he followed the Stanislaw
Burzynski method and charged large sums of money for everything else but the
drug and thus made money that way.

I mention the Houston Cancer Quack Stanislaw Burzynski on purpose, because,
before Dr. Delpassand, he was the only “investigator” I had heard of who had
actually used right-to-try to bypass the FDA and continue to administer his
antineoplastons. I fear his is the business model that right-to-try will enable,
complete with exploitation of patients on a greater-than-Burzynski scale.

Meanwhile:

   “This bill is inherently deceptive,” Alison Bateman-House, a medical ethicist
   at New York University who led the charge against Johnson’s bills, wrote in 
   an email. “What [patients] have a right to (and did long before this bill) is
   to ask drug companies for permission to use their experimental drugs outside
   of clinical trials. If the drug company says no, both before and after this 
   legislation, that’s the final word: neither the FDA nor the courts have to
   power to make companies provide access to their experimental
   drugs-in-development.”

Unfortunately, the deception worked brilliantly. One doesn’t have to go far on
Twitter to find comments like this:

With all do respect, how dare you try to take away someones very last hope.

— Beth Fairchild (@bethfairchildnc) August 4, 2017

Of course, it pains me to be viewed this way by the very people I least want to 
cause any further distress, the terminally ill, but it’s unavoidable. That’s
what I mean when I point out how the Goldwater Institute intentionally uses
terminally ill patients as shields against its ideologically motivated
libertarian attack on the FDA. Criticize right-to-try, and you’re quickly
branded as heartless, arrogant, and, above all, attacking terminally ill
patients, no matter how much nuance you use or how much you try to point out how
much potential right-to-try has to harm patients and even legitimize the
exploitative business model of someone like Stanislaw Burzynski.

And, of course, the Goldwater Institute is right in the thick of it:

Wrong. Stop trying to scare people. Patients must sign informed consent
documents just like a trial and they are protected from malpractice.

— Goldwater Institute (@GoldwaterInst) August 4, 2017

And:

No one is immune from malpractice. If this were your big concern, you'd be happy
w Senate bill clarification on this point. Just stop.

— Goldwater Institute (@GoldwaterInst) August 4, 2017

That last one made me laugh, because it was so amazingly, jaw-droopingly
disingenuous. Yes, the federal bill just passed by the Senate does not immunize 
doctors involved with right-to-try from malpractice suits. In a nutshell, it
says that the federal law doesn’t affect anything you can sue for in state
court. But didn’t the Goldwater Institute read its own template for right-to-try
bills in the 37 states where they’ve passed so far? In virtually every one of
those states, the right-to-try explicitly bars suing physicians who oversee and 
prescribe medications or treatments under right-to-try for malpractice and bars 
the state medical boards from taking action against them related to
right-to-try. The Goldwater Institute is full of lawyers. Surely it knows that
the federal law is thus virtually irrelevant to this question, as malpractice is
a matter of state law and state level right-to-try laws immunize physicians
against malpractice related to right-to-try. Indeed, that’s probably the reason 
why right-to-try advocates didn’t object too strongly to adding that particular 
provision to the federal law.

It’s very much understandable why so many terminally ill patients and their
families have embraced right-to-try, even though it is basically the
distillation of the libertarian ethos in which you can have “choice” and “one
last chance” if you have money or are able to acquire it and are totally on your
own if you don’t or if you are unfortunate enough to suffer an
all-too-predictable and likely complication from an experimental therapeutic.
So-called “right-to-try” is a cruel sham that holds out the false hope of
survival to terminally ill patients and their families. In return, all they have
to give up is patient protections and agree to pay to be guinea pigs to test a 
drug company’s product. The product of an ideology that uses the terminally ill 
as shields to hide the ideological motives behind the law, which are to hobble
the FDA, right-to-try is a terrible idea. It’s bad for patients, but it just
passed the Senate and could well become the law of the land when the House
reconvenes in September if it isn’t stopped. In the end, it is not cold, cruel, 
or indifferent to oppose right-to-try. It is not anti-patient. Quite the
opposite, in fact. It is as pro-patient as you can get to try to stop this cruel
sham that preys on the desperation of dying patients in order to enlist them in
a crusade to neuter the very agency that is responsible for protecting them
from quacks and charlatans like Stanislaw Burzynski.

The very worst version of the sham known as “right-to-try” is poised to become
law

“Right-to-try” laws are a cruel sham that purport to allow terminally ill
patients access to promising experimental drugs. In reality, they strip away
many protections and leave vulnerable patients on their own. After four years
and a number of toothless state laws, a federal version of “right-to-try” is
poised to become law. A version passed by the Senate could be voted on in the
House as early as tomorrow and is the worst version under consideration.
Unfortunately, it is likely to pass. If it does, this federal version of
“right-to-try” will leave terminally ill patients on their own and will likely
be the first step in returning the FDA to its pre-thalidomide state, in which it
only required evidence of safety, not efficacy, to approve drugs.

David Gorski on May 21, 2018

Link



This is it. This is likely the climax, and I fear that the outcome will not be
good.

I’m referring to the plan for the House of Representatives to vote on the Senate
version of a federal “right-to-try” bill, which I learned about from STAT News 
late last week:

   The House is set to take up a controversial “right-to-try” bill next week —
   and if it passes, the Food and Drug Administration will have to work harder
   to protect patients than it would if a different version of the legislation
   were advancing, Commissioner Scott Gottlieb told STAT in an interview.

   Gottlieb’s comments, made at FDA headquarters on Thursday, indicate that one 
   of President Trump’s top lieutenants believes Congress is moving forward with
   a bill that contains less of his agency’s input than an alternative version 
   of the bill — a more recent, updated bill that passed the House in March but 
   ultimately stalled in the Senate

   Broadly, right-to-try legislation aims to give terminally ill patients a
   different pathway to access experimental treatments that are not FDA
   approved.

Regular readers might be familiar with the saga of right-to-try, which Jann
Bellamy and I have written about many times before. However, given that the last
time I visited this saga was in January, when right-to-try supporters, with the
help of Vice President Mike Pence and the Koch Brothers’ Americans for
Prosperity and Freedom Partners, were making a final push to pass a federal
right-to-try law, it’s still worth going through the history of how we got to
this point, where Congress is on the verge of passing a bill that, if passed,
would strip important patient protections from terminally ill patients. It’s a
saga that goes back four years. We will look at the actual bill being considered
in the House, so that I can explain why it’s actually the worse possible
option, but first a little history.

How right-to-try got here

As I pointed out what seems to me to be so long ago, when a right-to-try bill
was on the verge of passing in Colorado, when right-to-try came to my own state,
and as these laws spread like kudzu all over the US, even coming back from the 
dead after a veto in California, the very concept behind right-to-try is
designed not to help patients, but to give the appearance of helping terminally 
ill patients as it serves as the first step in cutting the FDA out of drug
approval and regulation as much as possible. Consider: these laws, being state
laws, have no teeth because drug approval is under federal jurisdiction. Sure, a
state can say that patients have a right to experimental therapeutics, but
unless the FDA agrees to say yes, no company with a drug in clinical trials for 
FDA approval is going to risk the wrath of the FDA by taking part in
right-to-try. Basically, such laws are sold based on false hope and fear.
Indeed, some libertarians even used the fear of Ebola as a tactic to promote
such laws and accused the FDA of killing patients with bureaucratic inertia.

It’s much worse than that, however, because these laws are actively
anti-patient, the claims of their supporters notwithstanding. The only
requirements these laws have for testing of the drugs being “tried” are (1) that
they have passed phase I clinical trials and (2) that they are still under
development and undergoing further clinical trials. Anyone out there who is
familiar with clinical trials knows that passing phase I is an incredibly low
bar for safety. Phase I trials are “first in human” trials in which a small
number of patients test the drug. Basically, the dose is escalated until
unacceptable toxicity is encountered. The dose just below that is called the
“maximum tolerated dose,” or MTD. The main purposes of phase I trials is thus to
identify the highest dose that can be safely used and to identify the most
severe adverse reactions and side effects. That’s it. Phase I trials are not
designed to determine if a drug has any efficacy. Saying that a drug that’s
passed phase I testing is safe, as I’ve heard many right-to-try advocates claim,
is utter and complete bullshit. Phase I trials do not prove safety. They merely
show that the drug is not too toxic to continue with efficacy testing.

Consistent with their libertarian origin, right-to-try laws also strip away many
protections from patients. First, there is no requirement that companies
provide the drugs for free or at a reduced price. Indeed, these laws explicitly 
state that insurance companies are under no obligation to pay, even though such 
a statement is unnecessary given that insurance companies don’t reimburse for
experimental therapies. As a result, the only people who would potentially be
able to access right-to-try are the rich or people who are very good at
fundraising. A terminally ill person trying to access right-to-try can easily
spend away his estate or even go bankrupt before dying. It’s even worse than
that. The language in many of these laws can be interpreted to mean not just
that insurance companies don’t have to pay for right-to-try but that they don’t 
have to pay for medical care as a result of complications suffered from using a 
drug under right-to-try.

Another aspect of these bills is, as Jann Bellamy and I have described many
times, how, compared to existing expanded access programs, they strip patient
protections away from patients who access them. One way to see this is by
comparing what happens when a patient accesses an experimental therapeutic under
the FDA expanded access program to what happens when another patient accesses
one under a right-to-try law. Under FDA expanded access, patients retain full
protections under federal and state laws. They can sue for malpractice if there 
is any, and their care is still monitored by an institutional review board
(IRB), with any adverse events recorded and considered by the FDA. Moreover, the
FDA approves nearly all such requests (99%). In contrast, under right-to-try,
there is no IRB oversight. It’s all between the company and the patient, a
libertarian paradise!

These laws also immunize companies providing right-to-try drugs and physicians
overseeing their administration from liability. Right-to-try laws also limit
what patients can do in the event of malpractice or negligence. All of them
broadly immunize physicians advising or administering right-to-try medications
or using right-to-try devices against malpractice suits or actions against their
medical license by the state medical board related to their participation in
right-to-try. All of them also immunize companies providing experimental
therapeutics under right-to-try from liability. All of them contain provisions
stating that state employees can’t interfere with a patient seeking
right-to-try, which could be interpreted to mean that a doctor at an academic
medical center at a state university couldn’t counsel a patient not to seek
right-to-try without running afoul of the law. As Jann notes, even if state
authorities believe, for example, that an elderly person is being exploited for 
financial gain by a physician, presumably this provision would prohibit their
acting.

Of course, the ideologues at the Goldwater Institute knew all along that state
laws weren’t going to do anything to make access to experimental therapeutics
easier for terminally ill patients. Indeed, not surprisingly, they haven’t;
basically right-to-try thus far has been a miserable failure, with almost no one
accessing drugs through it. There’s a reason why I refer to state right-to-try 
laws as “placebo” legislation. They give the appearance of doing something but
really don’t do anything to address the issue of making experimental drugs more 
widely available to terminally ill patients. The idea, of course, was for these 
state laws to build momentum and pressure for Congress to act. The first
iteration of federal laws was the Compassionate Freedom of Choice Act of 2014.
It didn’t go anywhere, probably because it was too early. Another federal
right-to-try bill was introduced in 2016, but it, too, went nowhere, likely
stymied by electoral politics.

Then last year a federal right-to-try effort was undertaken again in the form of
S. 204: The Trickett Wendler Right to Try Act of 2017, introduced into the
Senate by Ron Johnson (R-WI) and H.R. 878: Right to Try Act of 2017, introduced 
by Rep. Andy Biggs (R-AZ). An attempt was made to insert right-to-try language
into The Prescription Drug User Fee Act (PDUFA), the law that allows the FDA to 
collect user fees from drug companies to fund the drug approval process, which
was due to expire at the end of last September and needed to be renewed. To get 
a vote on right-to-try, Sen. Johnson held PDUFA hostage by threatening to
obstruct it. Fortunately, this effort failed, but a version of right-to-try did 
ultimately pass the Senate, the Trickett Wendler Right to Try Act of 2017. This 
is the bill that is coming up for a vote next week. Oddly enough, it’s not the
most recent version of the bill.

The Trickett Wendler Right to Try Act

So let’s discuss the bill again, S. 204, the Trickett Wendler Right to Try Act
of 2017 (or, if you want the full version of the name, the Trickett Wendler,
Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017).
The bill was championed by Sen. Ron Johnson (R-WI), who has been flogging it for
at least two years and managed to get a vote on the bill by threatening to hold
the renewal of the bill funding the FDA hostage unless right-to-try provisions 
were attached to it. Had that happened, that would have been a disaster, because
it would have “baked” right-to-try into the very founding legislation that
funds the FDA through user fees. Ultimately, Sen. Johnson appears to have been
placated by a promise to put right-to-try to a vote. Predictably, the bill
passed unanimously last August.

When the bill went over to the House, there was less enthusiasm for it, at least
as written. Indeed, Sen. Greg Walden, Chairman of the House Energy and Commerce
Committee, was opposed to the bill as written, and his was the committee that
had to vote to send the bill to the floor for a vote. Unfortunately, then as
now, Rep. Walden was under great pressure from the Koch-backed Freedom Partners,
Vice President Mike Pence, and the House leadership to send the bill to the
floor for a vote. Rep. Walden managed to improve the bill considerably by
actually consulting with the FDA, although, as I’ll briefly relate, even the new
House version that was passed (H.R. 5247) wasn’t that great. It just wasn’t as 
awful as S. 204.

And, make no mistake, S.204 is awful. Let’s take a look at some of the
provisions. As with all the state right-to-try laws, it defines an “eligible
investigational drug” for right-to-try as a drug that has passed phase I
testing, has not been approved by the FDA but has a pending application for
approval, and is undergoing further clinical trials. Now here’s where things get
patient-hostile:

   (c) Use Of Clinical Outcomes.—

   “(1) IN GENERAL.—Notwithstanding any other provision of this Act, the Public 
   Health Service Act, or any other provision of Federal law, the Secretary may 
   not use a clinical outcome associated with the use of an eligible
   investigational drug pursuant to this section to delay or adversely affect
   the review or approval of such drug under section 505 of this Act or section 
   351 of the Public Health Service Act unless—

   “(A) the Secretary makes a determination, in accordance with paragraph (2),
   that use of such clinical outcome is critical to determining the safety of
   the eligible investigational drug; or

   “(B) the sponsor requests use of such outcomes.

So, basically, S. 204 as passed states that the FDA can’t use a clinical outcome
or adverse event associated with the use of a right-to-try drug in its
determination of licensure for sale unless the Secretary of Health and Human
Services decides that the use of these outcomes is critical to determining the
safety of the drug or the applicant wants them used. Not the FDA official
charged with overseeing the approval of the drug. Not even the FDA Commissioner.
The Secretary of HHS. How often do you think that the HHS Secretary will step
in and insist on the use of right-to-try outcomes for the approval of a drug?
I’d be willing to bet that the answer would be: Not very often—or even basically
never.

It is fortunate, then, that there is an additional provision that allows the HHS
Secretary to delegate this authority. This provision, however, is less than it 
appears:

   (2) LIMITATION.—If the Secretary makes a determination under paragraph
   (1)(A), the Secretary shall provide written notice of such determination to
   the sponsor, including a public health justification for such determination, 
   and such notice shall be made part of the administrative record. Such
   determination shall not be delegated below the director of the agency center 
   that is charged with the premarket review of the eligible investigational
   drug.

This is somewhat better, in that the HHS Secretary can delegate this decision to
the FDA Commissioner or the director of the specific agency within the FDA
charged with premarket review of the drug. Even so, notice the language. Rather 
than what the default should be (that all outcome data should be considered when
examining a drug for FDA approval), this law would force the HHS Secretary or a
high level delegate, to justify including right-to-try outcomes in the
deliberations over whether the drug under consideration should receive FDA
approval for marketing. In other words, the burden of proof is on the FDA, not
the company seeking approval for its drug, as to why right-to-try outcomes
should be included.

Then, of course, there are provisions regarding liability:

   (b) No Liability.—

   (1) ALLEGED ACTS OR OMISSIONS.—With respect to any alleged act or omission
   with respect to an eligible investigational drug provided to an eligible
   patient pursuant to section 561B of the Federal Food, Drug, and Cosmetic Act 
   and in compliance with such section, no liability in a cause of action shall 
   lie against—

   (A) a sponsor or manufacturer; or

   (B) a prescriber, dispenser, or other individual entity (other than a sponsor
   or manufacturer), unless the relevant conduct constitutes reckless or
   willful misconduct, gross negligence, or an intentional tort under any
   applicable State law.

I find it rather fascinating (and telling) that there is a carve-out from the
freedom from liability of doctors who administer right-to-try such that this
provision no longer applies to willful or “criminal misconduct, “reckless
misconduct,” or “gross negligence relative to the applicable standard of care
and practice with respect to the administration or dispensing of such
investigational drug.” So, in fairness, this is an improvement, although one
wonders why this carve-out from the immunity from liability for sponsors and
manufacturers? Basically, S. 204 leaves doctors out to twist in the wind but
still protects manufacturers.

There are also provisions in S. 204 that require the FDA to publish right-to-try
usage to its website. That is probably the least objectionable part of the
bill.

To the House and back

When S. 204 went over to the House, it ultimately became H.R. 5247, and, thanks 
to Rep. Walden’s committee working with the FDA, there were a number of
improvements. For example:

   (ii) The requirements described in this clause are the requirements under
   subsection (b) or (c) of section 561, including—

   (I) the reporting of safety information, from clinical trials or any other
   source, as required by section 312.32 of title 21, Code of Federal
   Regulations (or any successor regulations);

   (II) ensuring that the informed consent requirements of part 50 of title 21, 
   Code of the Federal Regulations (or any successor regulations) are met; and

   (III) ensuring that review by an institutional review board is obtained in a 
   manner consistent with the requirements of part 56 of title 21, Code of the
   Federal Regulations (or any successor regulations).

This seems to be requiring informed consent through standard federal
regulations. However, there is a caveat, as noted by Holly Fernandez Lynch,
whose Tweetstorm is worth revisiting:

1. The House is poised to pass its #righttotry bill this week. Here's the
version released late Friday night: https://t.co/WmwmxFaGpm

— HollyFernandezLynch (@HollyLynchez) March 11, 2018

She points out that those federal regulations explicitly state: “No informed
consent, whether oral or written, may include any exculpatory language through
which the subject or the representative is made to waive or appear to waive any 
of the subject’s legal rights, or releases or appears to release the
investigator, the sponsor, the institution, or its agents from liability for
negligence.” This is a conflict that would probably require rewriting that
section of federal regulations on informed consent. There is also now the
requirement that an institutional review board (IRB) be involved in any
right-to-try requests. I’m not sure how this would work, given that the bill
would cut the FDA out of right-to-try requests. As Fernandez notes hopefully,
perhaps IRBs charged with overseeing such requests would ask the FDA for
guidance.

I won’t go into much more detail about the House version that passed, because
that’s not the version being voted on this week. Basically, the House version
that passed is a significant improvement over the version that passed the Senate
and will be voted on the House as is this week. However, it was still pretty
bad. Of course, leave it to Congress to pick the worst of the two bills out
there.

The final push

Make no mistake. There are powerful forces pushing for this vote. In the normal 
course of Congressional activity, what would happen next is that there would be 
a conference committee to reconcile the House and Senate versions of the bill
that have passed, and then the reconciled bill would be voted on again by the
House and the Senate. This is not what is happening. Here’s what is happening
and why.

Originally, the House version that passed was going to the Senate for
consideration. At that time, Sen. Charles Schumer blocked consideration of that 
bill:

   The announcement on Thursday that it will take up the Senate’s bill comes as 
   congressional momentum had appeared to grind to a halt the past two months,
   leaving the path forward on the measure unclear.

   Senate Democrats last year didn’t object to the bill Johnson introduced with 
   Sen. Joe Donnelly (D-Ind.), which also sidesteps the FDA.

   But since the opposition from House Democrats, Senate Minority Leader Charles
   Schumer (D-N.Y.) has voiced concerns about taking the FDA out of the
   equation and objected to a request to bring the House bill up by unanimous
   consent.

   House Democrats voiced concerns about patient safety that were echoed by some
   advocacy groups.

At the time, this move appeared to doom right-to-try. Unfortunately, as I said
before, powerful forces are backing right-to-try, including the Koch brothers
and Vice President Mike Pence. I fear that opponents to right-to-try might have 
shot themselves in the foot by blocking the Senate from considering the House
version, which, while bad, is not as bad as the Senate version. (At least the
House version leaves open the possibility of IRBs being involved in right-to-try
cases.) As a result, the only option that right-to-try supporters had left was 
to try to get the House to pass the even more awful Senate version essentially
as is, and they used various parliamentary rules to make it happen. Basically,
the fix appears to be in, as Richard Plotkin notes:

   It appears the Senate understood that H.R. 5247 shouldn’t be brought up for a
   vote, which resulted in the current effort to have the House approve S. 204.
   It is not disputed that S. 204 was passed by the Senate in response to Sen. 
   Ron Johnson (R-Wisc.) putting a hold on Prescription Drug User Fee Act
   (PDUFA).

   Because of this, there was no real opportunity for the Senate to consider S. 
   204 on the merits. In other words, S. 204 does not have the support of the
   Senate and was approved based on the unconscionable “wheeling and dealing” by
   Johnson.

Add to that pressure from Vice President Pence, President Trump, and the Koch
brothers, and this is going to be damned difficult to stop. Indeed, I fear that 
FDA Commissioner Scott Gottlieb appears to have given up completely, as these
recent Tweets show:

I'm comfortable with both versions of the legislation; the bills put forward by 
both Chairman Walden and Chairman Johnson — and #FDA is ready to work to
implement either measure to promote access to promising therapies for terminal
patients and protect their interests

— Scott Gottlieb, M.D. (@SGottliebFDA) May 17, 2018

I want to thank @statnews for correcting the earlier version of their story on
right to try by @ikeswetlitz that mischaracterized parts of our discussion; we
appreciate the publication’s responsiveness

— Scott Gottlieb, M.D. (@SGottliebFDA) May 18, 2018

Here’s a reminder of what Gottlieb said that STAT News interview:

   Gottlieb said his agency will have to work harder to protect patients than it
   would have had to under the structure set up in the alternative bill, which 
   was spearheaded in large part by Energy and Commerce Committee Chairman Greg 
   Walden of Oregon. The bill the House will vote on next week, from Sen. Ron
   Johnson (R-Wis.), didn’t include as much of the FDA’s input and could open
   the pathway to more patients.

   “In terms of making sure that it balances [access to experimental drugs]
   against appropriate patient protections, I think the Walden bill gives us
   less work to do,” Gottlieb said. “With the Johnson bill, we’d have to do a
   little bit more … in guidance and perhaps in regulation to achieve some of
   those goals, and I think those are the goals that Congress wants us to
   achieve.”

   He said the newer Walden bill “baked in more of the technical assistance we
   provided.”

And his walkback:

   In a subsequent interview Thursday afternoon, Gottlieb added that he is
   supportive of the Johnson bill, and said he had not realized the House was
   set to vote on that bill when he spoke with STAT earlier in the day.

   “We can implement the Johnson bill in a way that achieves what Chairman
   Walden set out to do,” Gottlieb said.

   “We felt that there were certain aspects of the [Johnson] legislation that
   could be modified to build in additional patient protections, but if you
   weren’t able to do that legislatively, that [there] was a pathway by which
   you do that administratively and still remain consistent with both the letter
   and the spirit of this law,” he added.

Is that whistling I hear at the gate of the graveyard? Sadly, it sounds that
Gottlieb has resigned himself to this awful bill passing.

The real purpose of right-to-try

In the end, right-to-try has almost nothing to do with actually helping
terminally ill patients access promising experimental therapeutics that might
save their lives. It never has been. In actuality, right-to-try is a first step 
in weakening the FDA, with the ultimate goal of reducing it to a
pre-thalidomide, pre-Kefauver-Harris Amendment, which required the FDA to assure
not just drug safety but efficacy as well.

If right-to-try passes this week (and if it passes President Trump will sign it 
into law), you can bet that not long after right-to-try passes, the
anti-regulation ideologues at the Goldwater Institute will start asking, “Why
should right-to-try apply only to terminally ill patients? What about patients
who are just seriously ill?” And so it will begin. It’s already begun on other
fronts. For instance, the Goldwater Institute has launched a campaign in the
name of “free speech” to allow manufacturers to share information with
physicians about off-label uses of approved drugs. Elsewhere, the Foundation for
Economic Education is promoting its Free to Choose Medicine plan, which would
basically require only safety testing of drugs for them to be approved, thus
moving us back to the pre-1962 situation. Right-to-try is just the beginning.

Right-to-try is only a little about helping patients. It’s far more about
dismantling the FDA and giving drug and device manufacturers more freedom to
market drugs and devices with much less testing. Patient advocates are going to 
keep fighting right up to the vote, and I urge SBM readers to contact their
Representatives. Never say die, and it isn’t over until the fat lady sings.
However, I fear that we will find out the effects. I also fear that the next
steps will be to loosen regulations against promoting off-label drug use,
expanding the definition of who’s eligible for right-to-try, and otherwise
dismantling patient protections in the name of “deregulation.”

Bills remove impediments to ill-advised state “right to try” laws, shield
wrongdoers, and hide adverse events

Congressional bills will unleash state “right to try” laws, block terminally ill
patients from redress for damages caused by negligent doctors and drug
companies, and hide adverse drug events from the public.

Jann Bellamy on March 2, 2017

Link





Since 2014, 33 states have passed so-called “right to try” laws. These laws
purport to give patients with a terminal illness access to “potentially
lifesaving” drugs, biologics and medical devices that have not yet been approved
by the FDA, but without all the regulatory protections required by the FDA’s
“compassionate use” program, even though the FDA grants almost all requests.
Promoted by patient advocacy groups and the libertarian Goldwater Institute, and
aided by plenty of heart-wrenching anecdotes, right to try bills have sailed
through state legislatures.

Notably missing from the cheerleading section have been medical ethicists (also 
here), physicians and physician organizations, and the drug industry itself, as 
well as David Gorksi here at Science-Based Medicine (plus me, once) and our good
friend Orac over at Respectful Insolence. (See full list at the end of this
post.) Critics find the claims that “potentially lifesaving” drugs will actually
benefit terminal patients overblown, the risks underappreciated, and the
procedures for obtaining unapproved drugs inadequate to protect patients from
adverse consequences, both medical and financial.

The controversy to this point has operated pretty much in the theoretical arena,
given that right to try laws have two huge stumbling blocks which prevent drug 
companies from wanting to participate:

  1. They are almost certainly unconstitutional as an attempt to bypass federal
    regulation, and,

  2. nothing protects drug, device or biologics manufacturers from getting into hot
    water with the FDA for side-stepping the approval process or liability for 
    damages caused by their products.

All that will change if a new Senate Bill or its House counterpart removing
federal obstacles to the full implementation of state right to try laws passes
and is signed into law by President Trump. (An almost certainty if it gets to
his desk, given his antipathy to the FDA.) Unfortunately, even then we may not
know who was right about right to try laws and their “potentially lifesaving”
consequences. That is because, per the pending bills:

  1. Their implementation will be carried out completely shielded from any
    regulatory oversight;

  2. Results are barred from use to improve outcomes for other patients; and

  3. Complaints for even the most egregious malfeasance will never see the light of
    day.

State “right to try” laws

The Goldwater Institute’s model act has served as a template for state right to 
try laws. (These laws cover drugs, medical devices and biologics, but for
simplicity’s sake from now on we’ll just say “drug.”) Although states sometimes 
amend the model act’s recommended language, state right to try laws typically
have the following provisions (excluding liability issues, which we’ll get to in
a minute):

  1. The drug must have successfully completed Phase I clinical trials and still be
    involved in the FDA’s clinical trial process. As we know, Phase I is
    designed to assess toxicity and dosing but not safety or effectiveness. And 
    any evidence of either safety or effectiveness which appears at this point
    may not hold up in later phases of the process.

  2. To access the drug, the patient must have a “terminal illness,” defined
    broadly as “an advanced stage of a disease with an unfavorable prognosis and
    no known cure.” (Not all states use this term; California requires that the
    patient have an “immediately life-threatening disease or condition,”
    meaning, “a stage of disease in which there is a reasonable likelihood that 
    death will occur within a matter of months.”)

  3. The patient, in consultation with “a physician” (no matter the physician’s
    lack of expertise in treating cancer or other terminal illnesses, or, for
    that matter, never having a previous relationship with the patient at all)
    has “considered” all other FDA-approved treatment options.

  4. The patient has a prescription “or recommendation” for the drug and has given 
    informed consent (or it has been given for him if he is a minor or mentally 
    incapacitated).

  5. The drug’s manufacturer can, but is not required to, make the drug available
    and can choose whether to charge the patient.

  6. Insurance companies can, but don’t have to, cover the cost of the drug itself.
    (Unless they’re forced to, I think it’s safe to assume insurers are not
    going to pay.)

  7. The state medical board is prohibited from acting against a healthcare
    provider “based solely on” the recommendation, prescription or treatment
    with the investigational drug.” “Based solely on” is not further defined.

  8. Any “official, employee, or agent of the State” is prohibited from blocking or
    attempting to block patient access to a drug, no matter what the
    circumstances. Thus, even if state authorities believe, for example, that an
    elderly person is being exploited for financial gain by a physician,
    presumably this provision would prohibit their acting.

  9. Written informed consent is required, including acknowledgement that current
    treatments are not likely to prolong the patient’s life, a description of
    the best and worst outcomes (including worse symptoms and a hastened death) 
    of using the investigational drug, acknowledgment that insurance is not
    obligated to pay for any of this and that it may jeopardize the patient’s
    eligibility for hospice. The patient must understand that he, or his estate,
    is liable for all expenses consequent to treatment, which can be
    substantial.

Of course, this guarantee that the patient will be knowledgeable about the
consequences is illusory if the knowledge isn’t there. As David Gorski pointed
out, Phase I trials leave much to be discovered about the drug under
investigation:

   Phase I trials can be as few as 20 patients. That is not enough to determine 
   safety, nor is it intended to. Phase I trials are designed primarily to
   identify major side effects and to use a process known as dose escalation to 
   determine what is commonly referred to as the “maximum tolerated dose.” It is
   utterly impossible for such a small clinical trial to determine the safety
   of a drug. . . . Phase II and Phase III trials are needed to confirm safety. 
   That’s why the premature diffusion of unapproved drugs has the potential to
   increase morbidity from adverse events and even hasten death. One example is 
   amonifide for treating breast cancer. The drug made it through phase I
   trials, but serious life-threatening hematologic toxicity emerged during
   phase II trials. . . . Indeed, even phase III trials can’t always adequately 
   demonstrate that a drug is safe; it’s not uncommon for less common adverse
   effects not to show up until post-marketing surveillance, when much larger
   numbers of patients receive the drug. Moreover, only 5% of all cancer drugs
   that enter clinical testing are ultimately approved for patient use [because 
   they meet the FDA’s standards for safety and efficacy]. Among drugs tested in
   phase II trials, only 30% go on to phase III.

In other words, investigational drugs get out of Phase I with high odds that
they aren’t safe and don’t work. As a former pharmacology professor who has
worked in drug development both for the FDA and industry said:

   “Right-to-try” legislation“makes sense for people who don’t understand the
   complexities of the drug development process. As a rare Republican working at
   the FDA and a generally politically conservative person, I am all for more
   freedom and less government intervention — but not when it comes to drug
   approval. The truth is, I am not quite ready to entrust the general public
   (or, for that matter, a senator with no scientific or clinical background) to
   circumvent the FDA through “right-to-try” and to make independent
   recommendations regarding clinical pharmacology, pharmacogenomics,
   biomarkers, and long-term drug safety.

Big Pharma has its doubts as well:

   “We have serious concerns with any approach to make investigational medicines
   available that seeks to bypass the oversight of the Food and Drug
   Administration and clinical trial process, which is not in the best interest 
   of patients and public health,” said Sascha Haverfield, vice president of
   scientific and regulatory affairs for the Pharmaceutical Research and
   Manufacturers of America. He suggested that medical providers, the
   pharmaceutical industry and FDA should seek ways to improve access to
   clinical trials.

Despite the hyperbole about potentially lifesaving drugs, there is no actual
evidence that right to try has benefitted a single soul. As Orac noted, the
Goldwater Institute is claiming that a Texas physician is defying the FDA and
bravely offering treatments via Texas’s right to try law, but they offer no
evidence that this has been successful. (In fact, Orac discovered that one of
this physician’s patients has died of cancer after a GoFundMe plea to pay for
her treatments, to the tune of $38,000, but the details of whether this was
through right to try are murky.)

Greenlighting “right to try” implementation

Part of the reason proponents’ claims regarding the putative benefits of right
to try laws remain untested is that that drug companies are reluctant to provide
experimental treatments outside clinical trials. They fear liability for
injuries to patients and that adverse events will affect the likelihood that
their drugs will be approved in the simultaneously ongoing FDA approval process.

These fears will be allayed, and any constitutional impediments to
implementation resolved, if the recently introduced Senate Bill 204 or House of 
Representatives Bill 878 become law. Both prohibit the federal government from
taking any action “to prohibit or restrict” the use of drugs (or devices or
biologics) “intended to treat a patient who has been diagnosed with a terminal
illness” (which has the same meaning as in state law; again, not all states use 
that term) and “is authorized by, and in accordance with state law.” The bills
repeat the states’ requirement that the drug must have successfully passed Phase
I clinical trials and still be in the FDA’s drug-approval pipeline.

They also require that the patient have:

   received a certification from a physician, who is in good standing with the
   physician’s certifying organization or board, that the patient has exhausted,
   or does not meet qualifying criteria to receive, any other available
   treatment options.

These provisions will do away with any threats of the FDA’s acting against a
drug company for stepping outside the rules and obviate any constitutional
issues. But the last one also appears to encourage even more futile treatments
than the state right to try laws. According to the model act, the patient and
his physician need only have agreed that available treatments “are unlikely to
prolong the patient’s life.” These bills seem to require that patients exhaust
marginally beneficial treatments (“any other available treatment options”)
before accessing investigational drugs.

For all the supposed concern about helping some terminal patients access
“potentially lifesaving” treatments via unapproved drugs, these bills remain
oddly unconcerned about other, equally terminal patients whose lives may depend 
on approved drugs. Any useful information that might come out of treatment with 
an investigational drug accessed via right to try can’t be considered by the FDA
in determining whether to approve the drug:

   the outcome of any production . . . dispensing, possessing or use of an
   experimental drug . . . shall not be used by a Federal agency reviewing the
   experimental drug . . . to delay or otherwise adversely impact review or
   approval . . .

Of course, who’s keeping track anyway? S. 204 and H.R. 878 do not require any
record keeping or reporting of results. To my knowledge, the only state
requiring reporting of results, including adverse events, to the authorities is 
California. An example of why this is a reckless waste of potentially valuable
information occurred just yesterday in the news that Juno Therapeutics had
pulled the plug on a once-promising treatment for a rare form of leukemia due to
five deaths in clinical trials. Deaths of patients who access treatment via
right to try are either unrecorded or, if known, cannot be used in assessing
whether the treatment should be approved.

The Goldwater Institute’s model act does not relieve physicians and drug
companies from liability for negligence. The model act does provide that the
right to try law will not create a private right of action as long as the
physician or company “is complying in good faith with the terms of this act and 
has exercised reasonable care.” In other words, while the usual state tort laws 
permitting suits for negligence (including malpractice) are not affected, the
right to try law in and of itself does not create a new cause of action for
damages arising out of treatment with an investigational drug. Even if a
particular state didn’t adopt the model act’s language and doesn’t mention
liability at all, we can safely assume that the state’s usual tort laws apply
and the patient could sue for damages for negligence.

S. 204 and H.R. 878 would override state tort law by absolving drug companies
and physicians of all liability, not only for negligence, but for gross
negligence as well, as long as they act in accordance with the state right to
try law and the physician certifies that the patient has exhausted or doesn’t
meet the qualifying criteria for other treatment options.

Given that none other than Dr. Stanislaw Burzynski has helped himself to the
benefits of his state’s right to try law, we should all be concerned.

A bill with the same language was considered in the last Congress but was
stopped by Sen. Harry Reid. Sen. Reid is gone now and Republicans have their
knives out for “abusive” federal regulation, aided and abetted by a president
who openly disdains the FDA and its “slow and burdensome” approval process
getting in the way of “miracles.” Right to try laws have a better chance than
ever to be transformed from (as David Gorski rightly called them) feel-good
placebo legislation into a libertarian purgative for the FDA. Unfortunately,
terminally ill patients, not Congress, the president, or the state legislatures,
will suffer the side effects.


Other SBM “Right to Try” posts

  1. Right-to-try is now law. Let patients beware! (6/4/18)

  2. The very worst version of the sham known as “right-to-try” is poised to become
    law (5/21/18)

  3. The final push to pass a federal version of the cruel sham of “right-to-try”
    is underway (1/15/18)

  4. The cruel sham of “right-to-try” takes a giant step towards becoming federal
    law (8/5/17)

  5. Sen. Ron Johnson: Holding the bill funding the FDA hostage unless the cruel
    sham that is right-to-try is added to it (7/17/17)

  6. The cruel sham that is right-to-try raises its ugly head at the federal level 
    again (4/17/17)

  7. A victory and a more substantial defeat for the cruel sham known as “right to 
    try” (9/30/16)

  8. “Right to try:” A miserable failure thus far (9/8/16)

  9. “Right to try” goes federal, thus far unsuccessfully (9/6/16)

  10. The cruel sham that will not die: Right to try marches on in California and
    beyond (8/29/16)

  11. The cruel sham that is “right-to-try” has returned to California (8/24/16)

  12. Governor Jerry Brown protects patients by vetoing California’s right-to-try
    bill (10/13/15)

  13. As in 2014, “right-to-try” laws continue to metastasize in 2015 (5/18/15)

  14. As in 2014, “right-to-try” laws continue to metastasize in 2015, part 2
    (5/26/15)

  15. Using the fear of Ebola to promote the placebo legislation that is “right to
    try” (11/2/14)

  16. Ebola, “right to try” and placebo legislation (10/28/14)

  17. The false hope of “right-to-try” metastasizes to Michigan (8/21/14)

  18. USA TODAY flubs it big time over right-to-try laws (8/19/14)

  19. The cruel sham of “right to try” comes to Michigan (8/14/14)

  20. The Compassionate Freedom of Choice Act: Ill-advised “right to try” goes
    federal (4/27/14)

  21. “Right to try” laws and Dallas Buyers Club: Great movie, terrible for patients
    and terrible policy (3/8/14)

  22. Dallas Buyers Club-inspired “right to try” laws: Good movies don’t make good
    policy (3/6/14)

  23. The illusions of “right to try” laws (3/6/14)

Sen. Ron Johnson: Holding the bill funding the FDA hostage unless the cruel sham
that is right-to-try is added to it

Advocates claim that “right-to-try” laws help terminally patients by allowing
them access to experimental drugs before approval, when, in fact, such laws
strip legal and regulatory protections from patients using such drugs and their 
purpose is actually to undermine and weaken the FDA. Now advocates led by Sen.
Ron Johnson (R-WI) are making a new push to pass right-to-try by embedding it in
the very law that authorizes the FDA to collect fees from companies seeking FDA
approval for their products. They might well succeed.

David Gorski on July 17, 2017

Link



Here we go again.

It’s been a while since I’ve written about the cruel sham that is known as
“right to try.” Anyone who’s been reading this blog a while (or even read the
first sentence of this paragraph) knows that I’m not a fan of right-to-try laws.
Neither is Jann Bellamy. Basically such laws, which have sprung up like kudzu
since the movement to pass them gained momentum three years ago, claim to allow 
terminally ill patients the “right to try” experimental therapeutics. Thus far, 
they have been sold to the public as giving terminally ill patients “one last
shot” and touting how such laws could save some of their lives. As a result, as 
I’ve grimly quipped on multiple occasions, to politicians opposing right-to-try 
laws has become very much akin to opposing motherhood, apple pie, and the
American flag. So most of them, even ones with misgivings, find that it’s much
easier to go along than to explain to the voters, the vast majority of whom do
not understand the drug approval process and therefore do not understand why
right-to-try laws are harmful to the very patients their proponents purport to
be helping. So at the state level, right-to-try advocates have basically won. As
of this writing, 37 states have passed such laws in a mere three years, and I
wouldn’t be surprised if the remaining 13 states without a right-to-try law pass
their own versions within the next year or two. Indeed, when Governor Jerry
Brown vetoed California’s first attempt at a right-to-try law, I was surprised
that he had the guts to do it. Thus far, he’s the only governor that I know of
to have vetoed a right-to-try bill, and even then the California legislature
passed another one a year later that he signed. Basically, in any state where a 
right-to-try law is introduced, it ultimately passes.

Part of the reason why I like to refer to right-to-try as “placebo legislation” 
is because states don’t have the power to regulate drug approval; that is,
unless a drug is entirely developed and marketed only within one state, which
(unless you’re Stanislaw Burzynski) never happens. The federal government does, 
and that process is controlled by the U.S. Food and Drug Administration. The
libertarian “think tank” the Goldwater Institute, which developed the model
legislation upon which virtually all state-level right-to-try laws are based, is
quite blatant about understanding that, as a practical matter, state
right-to-try laws do, in essence, nothing. Indeed, right-to-try laws, despite
over three years on the books for the oldest ones, have thus far been a
miserable failure in getting experimental drugs to patients, their claimed
purpose, the claims of their proponents notwithstanding. Basically, no patient
represented as having gotten drugs under right-to-try did not already have
access through the FDA’s expanded access program. Of course, the purpose of
state laws is not really to make it easier for experimental therapeutics to
reach terminally ill patients. Even the Goldwater Institute knows that states
alone can do very little to do that. The real purpose behind these laws is to
build pressure on Congress to pass a federal law and, at the same time, to gut
the regulatory power of the FDA. As a byproduct, because such laws allow very
early stage experimental therapeutics to be “tried,” such laws also have the
potential to encourage quackery like Stanislaw Burzynski’s antineoplastons.

Thus far, right-to-try advocates have tried twice that I know of to pass a
federal right-to-try law, first in the form of the Compassionate Freedom of
Choice Act in 2014 and then last year in the form of the Trickett Wendler Right 
to Try Act of 2016. Fortunately, neither bill went anywhere, and both basically 
died in committee. But, like naturopaths seeking state licensure, right-to-try
advocates are as relentless as the Terminator. They can’t be bargained with.
They can’t be reasoned with. They absolutely will not stop, ever, until laws
protecting the terminally ill from exploitation are dead. So it’s not surprising
that Senator Ron Johnson (R-WI), who introduced the last right-to-try bill, is 
at it again:

   Sen. Ron Johnson is threatening to hold up a bill funding the Food and Drug
   Administration unless the House sends the Senate a version of the bill that
   expands terminally ill patients’ access to experimental drugs.

   Johnson, R-Wis., is hoping the House includes the so-called “right to try”
   language in a funding bill it will take up on Wednesday under a suspension of
   House rules. But if not, he said he expects to prevent quick passage of the 
   bill in the Senate once the upper chamber receives it.

   “If the House bill comes to the Senate without ‘right to try’ language in it,
   I will have no choice but to object to any unanimous consent agreements
   related to it or any related bill unless right to try is added or the Senate 
   is given an opportunity to vote on my right to try bill as an amendment,”
   Johnson said in a statement obtained first by the Washington Examiner. “It is
   time to stand up for terminally ill patients who just want reclaim their
   freedom by having the right to try and save their own lives – who want the
   right to hope.”

Sen. Johnson also published a longer statement on his website. The bill to which
Sen. Johnson is referring is the Prescription Drug User Fee Act (PDUFA), which 
is the law that allows the FDA to collect user fees from drug companies to fund 
the drug approval process. It turns out that the current legislative authority
for the PDUFA expires at the end of September and needs to be renewed before
then if the FDA is to continue to function. Right-to-try proponents thus see an 
opportunity to sneak a provision into the PDUFA renewal that would serve their
ends as well as a federal right-to-try law—better, in fact, because getting a
“right-to-try” provision into PDUFA would “bake” right-to-try into the FDA for
at least the next seven years of its funding. I first noted this effort three
months ago.

Unsurprisingly, Sen. Johnson isn’t just limiting his efforts to PDUFA. He’s
resurrected his previous right-to-try bill, as well:

   Johnson’s efforts on advancing right-to-try stalled in the Senate last year, 
   something he blamed at the time on then-Minority Leader Harry Reid. Johnson’s
   2017 version of the bill has 46 co-sponsors, including bipartisan support
   from Democratic Sens. Joe Donnelly and Joe Manchin of Indiana and West
   Virginia, respectively, and independent Sen. Angus King of Maine.

   “I have spoken with House leadership and Chairman Walden over the last
   several weeks and encouraged them to support incorporating right-to-try
   legislation in the FDA reauthorization bill that is set to pass the House on 
   Wednesday,” Johnson said. “It is my hope that they will support the millions 
   of Americans and their families suffering from terminal illnesses by
   including right to try language in this bill.”

Notice how much Sen. Johnson oversells right-to-try in the form of his proposed 
amendment to PDUFA and, now, S. 204, the Trickett Wendler Right to Try Act of
2017. He paints it as something that could potentially help millions of
Americans suffering from terminal illnesses. Of course, the vast majority of
Americans suffering from terminal illnesses suffer from diseases that derive
from one thing: Old age. We’re talking heart failure, stroke, cancer, and in the
coming years, dementia, such as Alzheimer’s disease. These are diseases for
which granting access to experimental therapeutics before they’re approved is
incredibly unlikely to save lives and very unlikely even to prolong very many
lives. No one doubts that the legislators sponsoring such legislation feel real 
compassion for terminally ill patients and want to help. It’s just that they’re 
going about it in the wrong way. To see why, let’s step back and review the
issues with state and federal right-to-try laws.

The basic premise behind right-to-try laws is that people are dying in droves
because the FDA is too slow, bureaucratic, and hidebound to allow dying
patients’ access to experimental drugs that are still undergoing clinical trials
to be approved by the FDA. No, really, that’s the argument libertarians, at
least, actually make, that the FDA is literally (yes, I mean literally—just ask 
Nick Gillespie and Ronald Bailey) “killing” people. Enter right-to-try, laws
that purport to allow terminally ill patients to access experimental
therapeutics in a desperate bid to save their lives.

It all sounds reasonable on the surface, right? Who could possibly object to
letting people who don’t have anything to lose to try such drugs? The problem is
that even those with “nothing to lose” actually do have something to lose, such
as their family’s inheritance, good quality of life, time with their loved
ones, or even what little time they have left. Indeed, what is very
intentionally not emphasized are other aspects of these laws that are
potentially profoundly harmful to patients. For instance, there is no mechanism 
in most right-to-try laws to help patients seeking to access experimental
therapeutics financially. Indeed, as I’ve pointed out every time I’ve written
about right-to-try, if you look at the language of the actual bills you’ll see
that they go out of their way to emphasize that health insurance companies do
not have to pay for right-to-try treatments. Indeed, the language is often such 
that the laws could easily be interpreted to absolve health insurance companies 
from paying for the treatment of complications arising from the use of
right-to-try drugs or devices! Given that such bills also allow pharmaceutical
companies to charge for experimental therapeutics and such expenses can be very 
high, this effectively means that only the rich or those skilled (or whose
families are skilled) at using social media to raise a lot of money fast could
potentially access right-to-try.

All right-to-try bills also explicitly eliminate or very much limit the right of
patients to sue for malpractice and the power of state medical boards to go
after the license of physicians who use right-to-try. If something goes wrong
then that’s the fault of the physician, not the drug, and the patient using
right-to-try basically has no recourse. Nor can drug manufacturers be sued;
right-to-try gives them immunity. So, basically these laws tell terminally ill
patients: Good luck. You’re on your own. Given that right-to-try laws also only 
require that experimental therapeutics have passed phase I trials and still be
in clinical trials to be eligible, there’s a high probability of adverse events 
and harm. Indeed, I not uncommonly laugh derisively and contemptuously (and
contemptuously and derisively) whenever I hear a Goldwater Institute flack claim
with a straight face that right-to-try only allows drugs that have been shown
to be safe, because phase I trials generally only have a few dozen patients
followed briefly. Let’s just put it this way: No one who knows what he’s talking
about views drugs that have passed phase I trials as having been “shown to be
safe.” Anyone who says that either doesn’t know what he is talking about or is
lying. At best, such drugs have been shown not to be obviously and immediately
dangerous.

As I’ve discussed at least twice, a federal right-to-try law would be so much
worse than state right-to-try laws because it would actually do something. It
would not be placebo legislation; it would be harmful. Basically, it would
federalize right-to-try, but that’s not all it would do. Let’s review the 2017
version, which is virtually identical to the 2016 version. As all previous
versions have done, the 2017 version would make it impossible to sue any
“producer, manufacturer, distributor, prescriber, dispenser, possessor, or user 
of an experimental drug, biological product, or device for the production,
manufacture, distribution, prescribing, dispensing, possession, or use of an
experimental drug, biological product, or device that is in compliance” with
this law. This clause basically removes federal liability from physicians and
drug companies that offer a drug under right-to-try. If a patient suffers
because of the inappropriate use of such a drug, the patient (or, given that the
patients under this bill have terminal illnesses, the family) has no recourse
to sue the manufacturer under federal law, in addition to having no recourse
under state law. That’s bad enough. Even worse is that the use of experimental
drugs under right-to-try, unlike the use of experimental drugs under
“compassionate use” or early access programs, is not overseen by an
Institutional Review Board (IRB), the committee at each institution doing human 
subjects research whose function is to protect patient interests. If anything,
the federal version is even more anti-patient than state right-to-try laws.

Then there’s this:

   (2)No use of outcomesNotwithstanding any other provision of law, the outcome 
   of any production, manufacture, distribution, prescribing, dispensing,
   possession, or use of an experimental drug, biological product, or device
   that was done in compliance with subsection (a) shall not be used by a
   Federal agency reviewing the experimental drug, biological product, or device
   to delay or otherwise adversely impact review or approval of such
   experimental drug, biological product, or device.

Obviously, this clause is intended to reassure drug and device manufacturers,
whose main concern about right-to-try is that if they let a patient use their
experimental drug or device and a patient suffers a complication from it,
approval of that drug or device could be in jeopardy. So what does Sen. Johnson 
do? He adds a clause to his bill forbidding FDA to use outcomes data from
patients using right-to-try drugs in its deliberations on approving drugs! Even 
if a patient death—heck, make it dozens or even hundreds of patient deaths—can
be clearly attributed to the use of an experimental drug, if that drug was used 
under right-to-try in all the cases this law would tell the FDA that it has to
turn a blind eye to all the carnage in considering whether the drug can be
approved. I kid you not. Think I’m exaggerating? Look at the language of the
bill!

Horrifyingly, given the change in administrations, this abomination of a bill
very well might pass. Indeed, just today Vice President Mike Pence Tweeted:

.@POTUS & I support a Right to Try law b/c it will give families like the
Mongiello's hope & a fighting chance. We're going to get this done
pic.twitter.com/gJ6j28jKSC

— Vice President Pence (@VP) July 17, 2017

Alison Bateman-House, Kelly McBride Folkers, and Arthur Caplan point out that
two myths underpin right-to-try:

   Although promoted in many cases by individuals with benevolent intentions,
   the right-to-try approach is based on two myths. The first is that the FDA’s 
   expanded access program, which allows patients to use an experimental drug
   outside of a clinical trial if the drug’s manufacturer agrees to provide it, 
   is slow and ineffective. In fact, it is hard to envision how the agency could
   provide a faster turn-around time on expanded access requests while still
   conducting a thorough review of a patient’s medical history and proposed
   treatment plan. The form that physicians must submit to the FDA for review
   after a company agrees to supply a patient with an experimental drug requires
   less than one hour to complete. The FDA approves more than 99 percent of
   these requests, and it does so, on average, within four days. For emergency
   requests, the agency responds in one day or less. And this is no “rubber
   stamp” review: A recent study found that FDA reviewers weighed in with
   valuable suggestions about how to improve the proposal, making it more likely
   to help than hurt the patient.

   The second myth—one that is especially pernicious—is that right-to-try
   legislation will allow patients faster and more guaranteed access to
   experimental drugs by cutting out the bureaucratic “middleman” (the FDA).
   Indeed, the central objective of right-to-try legislation is to end FDA
   oversight over the use of experimental drugs. For terminally ill patients,
   ending FDA oversight over experimental drugs would expose the patients to
   exploitation without guaranteeing access to the drugs they seek. And
   weakening the FDA puts everyone else who takes drugs or uses medical devices 
   or vaccines at grave risk.

Exactly. Right-to-try is a Trojan horse designed to gut the FDA’s authority to
regulate and approve experimental therapeutics. It’s also the “foot in the door”
for more deregulation. Imagine, for instance, that right-to-try is approved.
You can bet that in a couple of years (or even sooner) the Goldwater Institute
will start asking why right-to-try is restricted only to “terminally ill”
patients. Why, it will ask, shouldn’t patients with serious medical conditions
that are not immediately life-threatening “reap the benefits” of right-to-try?

The NYU School of Medicine Working Group on Compassionate Use and Pre-Approval
Access has published a three-page fact sheet about right-to-try. Most important 
is to strengthen and streamline the FDA’s Expanded Access Program while at the
same time making it appealing to drug companies to participate. Right-to-try
might fails on all these counts. It is the very epitome of H.L. Mencken’s maxim,
“For every complex problem there is an answer that is clear, simple, and
wrong.” In the case of right-to-try, unfortunately, this answer is not only
clear, simple, and wrong, but it’s incredibly appealing because it uses the
compassion we all feel for the terminally ill to short circuit our critical
thinking abilities for a purpose (gutting the FDA) that most of the bill’s
sponsors and supporters don’t understand but that the Goldwater Institute does.

The final push to pass a federal version of the cruel sham of “right-to-try” is 
under way

Right-to-try laws are a cruel sham that claim to help terminally ill patients by
providing them with earlier access to experimental therapeutics, even though
they do very little in this regard. Promoted primarily by the libertarian think 
tank the Goldwater Institute, in reality they are a strategy to weaken the FDA’s
regulatory power to assure that marketed drugs are safe and effective. Now, a
final push is on, with the help of the Koch brothers, to pass right-to-try. For 
the sake of patients, this push must fail.

David Gorski on January 15, 2018

Link



Two weeks into 2018, I once again find myself discussing an issue that I’ve been
discussing for nearly four years now. I’m referring, of course, to a law known 
as “right-to-try.” Such laws, all based on a legislative template published by
the libertarian Goldwater Institute, purport to allow terminally ill patients to
bypass the FDA and access experimental drugs that have passed only phase I
testing. As anyone with a basic knowledge of clinical trials knows, this is an
incredibly low bar for safety, and phase I trials are not even designed to show 
efficacy. When the right-to-try movement made its first big splash on the
national scene back in 2014, which was when several states beginning with
Colorado passed the first right-to-try laws, both Jann Bellamy and I pointed out
how these laws, seemingly inspired by the movie Dallas Buyers Club, were an
illusion, a sham, a misguided and actively patient-hostile “solution” (why will 
be explained below) to a problem that right-to-try advocates greatly exaggerated
in order to promote these laws. Indeed, in 2014 some libertarian advocates even
latched on to the fear of Ebola as a scare tactic to advocate for right-to-try,
while others (like Nick Gillespie and Ron Bailey) accused the FDA of killing
millions through slow approval of new drugs. I kid you not. Basically,
right-to-try advocates succeeded in portraying opposition to right-to-try as
callous and betraying a lack of compassion for terminally ill patients as well
as an assault on freedom itself, all mixed, of course, with a heaping helping of
anti-government rhetoric directed at the FDA. Basically, the reason so many
states passed these laws so quickly was through a combination of ignorance among
the general public of how drugs are approved and a campaign to demonize
opponents, such that opposition to right-to-try was perceived among politicians 
as akin to opposition to mom, apple pie, and the American flag.

Eventually, as these laws metastasized, passing in more and more states (38 as
of October!), advocates promoted a federal version of the law. The first
attempt, the Compassionate Freedom of Choice Act, went nowhere in 2014. So did
the second attempt in 2016. Of course, such a law could not have passed then
because it almost certainly would have been vetoed by the previous President,
but the point is that it didn’t even get out of committee both times. Then came 
President Donald Trump and a push for deregulation. Let’s just say that the
environment in Washington had…changed. For one thing, Vice President Mike Pence 
is a supporter of right-to-try. In any event, The Trickett Wendler Right to Try 
Act was reintroduced in 2017. When even in a Republican Senate the bill appeared
to be going nowhere, its sponsor, Senator Ron Johnson, threatened to hold the
renewal of the bill authorizing the FDA to collect user fees from companies
seeking FDA approval for their drugs hostage if right-to-try language was not
added to it. Ultimately, to mollify him, Senate leadership agreed to hold a vote
on Sen. Johnson’s bill, and, as almost always happens when such a bill comes up
for a vote, it passed easily.

That was the situation in August, when last I wrote about right-to-try. To be
honest, I was surprised that the House hadn’t passed the bill and President
Trump hadn’t signed it into law yet. Unfortunately, earlier this week I learned 
that one last push is being made to pass the bill. Before I discuss that, let’s 
take a look at why right-to-try laws are so problematic and harmful to patients.

The problem with right-to-try (state version)

As I mentioned before, the push to pass right-to-try legislation at the state
level is basically a product of forces that want very much to weaken the FDA’s
power to approve and regulate drugs, with each law following rather closely,
with minor variations, the legislative template originally published by a
libertarian think tank, the Goldwater Institute. Such legislation includes
several major shared features. First is the requirement that the disease the
patient has be terminal, usually defined as having a life expectancy of less
than six months, although the model legislation is more vague, requiring an
“advanced disease,” defined as “progressive disease or medical or surgical
condition that entails significant functional impairment, that is not considered
by a treating physician to be reversible even with administration of current
federal drug administration approved and available treatments, and that, without
life-sustaining procedures, will soon result in death.” Various states define
this condition in somewhat different ways, some with some room for
interpretation.

One of the most problematic passages, if not the most problematic passage, is
the one where the term “investigational drug, biologic product, or device” is
defined:

   “Investigational drug, biological product, or device” means a drug,
   biological product, or device that has successfully completed phase 1 of a
   clinical trial but has not yet been approved for general use by the United
   States food and drug administration [sic] and remains under investigation in 
   a United States food and drug administration-approved clinical trial.

Every right-to-try bill or law I’ve ever read uses the above definition or
relatively minor variations. Anyone who knows anything about drug development
knows that having completed a phase 1 trial is a dangerously low bar to clear to
allow more widespread use of a drug. Basically phase 1 trials are small trials,
usually consisting of less than 30 subjects, that look for major toxicities and
adverse events. That is not enough to determine safety, nor is it intended to. 
It is utterly impossible for such a small clinical trial to determine the safety
of a drug. Phase I trials are designed primarily to identify major side effects
and to use a process known as dose escalation to determine what is commonly
referred to as the “maximum tolerated dose,” the intent also being to find the
best dose to use in subsequent Phase II and Phase III trials. Moreover, only 5% 
of all cancer drugs that enter clinical testing are ultimately approved for
patient use. Among drugs tested in phase II trials, only 30% go on to phase 3.

Right-to-try laws are also profoundly unjust, as nearly all of them limit who
can access experimental drugs by wealth. The reason is that all of right-to-try 
laws have a provision that says that health insurance companies do not have to
pay for such treatment and nearly all of them also say that the company
providing the experimental therapeutic under right-to-try can charge the patient
for it. A terminally ill patient could easily go bankrupt before he dies, and
many couldn’t access experimental therapeutics through such laws in any event
because they simply don’t have the money or the fundraising wherewithal to do
so. In at least one state I know of, the right-to-try law allows a drug company 
to go after a deceased patient’s estate to collect. It goes beyond that, though.
If a patient uses a right-to-try drug and suffers complications, many of these 
laws essentially state that the insurance company doesn’t have to pay for care
resulting from that complication, and most such laws state that patients
undergoing right-to-try therapies lose their coverage for hospice.

Right-to-try laws are patient-hostile in other ways, too, as Jann Bellamy and I 
have described many times. The most egregious example of which is how they strip
patient protections away from patients who access them. One way to see this is 
by comparing what happens when a patient accesses an experimental therapeutic
under the FDA expanded access program to what happens when another patient
accesses one under a right-to-try law. Under FDA expanded access, patients
retain full protections under federal and state laws. They can sue for
malpractice if there is any, and their care is still monitored by an
institutional review board (IRB), with any adverse events recorded and
considered by the FDA. Moreover, the FDA approves nearly all such requests
(99%). In contrast, under right-to-try, there is no IRB oversight. It’s all
between the company and the patient, a libertarian paradise!

Right-to-try laws also limit what patients can do in the event of malpractice or
negligence. All of them broadly immunize physicians advising or administering
right-to-try medications or using right-to-try devices against malpractice suits
or actions against their medical license by the state medical board related to 
their participation in right-to-try. All of them also immunize companies
providing experimental therapeutics under right-to-try from liability. All of
them contain provisions stating that state employees can’t interfere with a
patient seeking right-to-try, which could be interpreted to mean that a doctor
at an academic medical center at a state university couldn’t counsel a patient
not to seek right-to-try without running afoul of the law. As Jann notes, even
if state authorities believe, for example, that an elderly person is being
exploited for financial gain by a physician, presumably this provision would
prohibit their acting.

I frequently refer to state right-to-try laws placebo laws because they
basically do nothing but make advocates and legislators feel as though they did 
something good for terminally ill patients. After all, the FDA controls drug
approval, and its power overrides state law. For that reason, few would be the
drug companies willing to risk their FDA approval by providing experimental
drugs to patients without the FDA’s permission. Of course, the Goldwater
Institute is not run by idiots. Its leadership knows this. The purpose of
state-level right-to-try laws was never really to help terminally ill patients. 
It was to put pressure on lawmakers to pass a federal right-to-try law as a
first big step towards weakening the FDA.

H.R. 878: Right to Try Act of 2017

H.R. 878: Right to Try Act of 2017 is simpler than most state-level laws and is 
currently very similar to the bill passed by the Senate in August (S. 204:
Trickett Wendler Right to Try Act of 2017). It has two main provisions. First:

   Notwithstanding the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et
   seq.), the Controlled Substances Act (21 U.S.C. 801 et seq.), and any other
   provision of Federal law, the Federal Government shall not take any action to
   prohibit or restrict—

   (1)the production, manufacture, distribution, prescribing, or dispensing of
   an experimental drug, biological product, or device that—

   (A)is intended to treat a patient who has been diagnosed with a terminal
   illness; and

   (B)is authorized by, and in accordance with, State law; and

   (2)the possession or use of an experimental drug, biological product, or
   device—

   (A)that is described in subparagraphs (A) and (B) of paragraph (1); and

   (B)for which the patient has received a certification from a physician, who
   is in good standing with the physician’s certifying organization or board,
   that the patient has exhausted, or otherwise does not meet qualifying
   criteria to receive, any other available treatment options.

In essence, this part of the law would basically tell FDA and other regulatory
agencies not to interfere with the use of experimental drugs by terminally ill
patients under state right-to-try laws. That’s no surprise, although the
language does seem a bit broader than I would have expected—but, as they say, I 
am not a lawyer. For purposes of this bill, experimental drugs are defined the
same way as in state right-to-try laws, any drug that’s passed phase I clinical 
trials.

Now here’s the truly pernicious, stupid part of the bill:

   (b)No liability or use of outcomes

   (1)No liability. Notwithstanding any other provision of law, no liability
   shall lie against a producer, manufacturer, distributor, prescriber,
   dispenser, possessor, or user of an experimental drug, biological product, or
   device for the production, manufacture, distribution, prescribing,
   dispensing, possession, or use of an experimental drug, biological product,
   or device that is in compliance, with subsection (a).

   (2)No use of outcomes. Notwithstanding any other provision of law, the
   outcome of any production, manufacture, distribution, prescribing,
   dispensing, possession, or use of an experimental drug, biological product,
   or device that was done in compliance with subsection (a) shall not be used
   by a Federal agency reviewing the experimental drug, biological product, or
   device to delay or otherwise adversely impact review or approval of such
   experimental drug, biological product, or device.

The part about liability is self-explanatory. It basically immunizes
manufacturers, distributers, doctors, and patients against federal liability for
using and possessing experimental drugs, just as state right-to-try laws
immunize them against state liability. No surprise there.

The real surprise is the part barring the FDA and other regulatory agencies from
using reported outcomes from patients using experimental drugs under
right-to-try. That means that if a patient uses an experimental drug under
right-to-try and suffers a serious adverse reaction, the FDA cannot consider
that reaction in its deliberations over approval of the drug. This clause is
obviously intended to address the concern of drug and device manufacturers that 
if they provide an experimental therapeutic to a patient under right-to-try and 
the patient suffers complications due to the treatment, the approval of its
product might well be jeopardized. This, of course, is not an unreasonable
concern on the part of manufacturers, given that it can cost as much as $1
billion to bring a drug or device to market, and by the time the product has
passed phase I clinical trials a great deal of that cost has already been
invested in development. However, this clause goes way, way too far. Basically, 
it means that even if a patient death is clearly due to use of an experimental
drug under right-to-try, that death cannot be considered by the FDA in deciding 
whether to approve the drug.

Think of it this way. Let’s say dozens of patients die from using an
experimental drug under right-to-try. This bill, if passed, would bar the FDA
from even considering those deaths during its deliberations regarding whether to
approve the drug for marketing or not. This is not a good thing for patients.
It is profoundly anti-patient. Basically, the Trickett Wendler Right to Try Act 
of 2017 would not help terminally patients. It would endanger them. Existing
Expanded Access (sometimes also called Compassionate Use) programs by the FDA
are, as I pointed out above, no longer so onerous and requests under them are
almost always approved. Right-to-try laws only strip away patient protections
without providing any potentially useful new rights to terminally ill patients.

As I like to do whenever I write about right-to-try, here I will refer readers
to the excellent bullet point summary of the problems with right-to-try
published by the New York University School of Medicine Working Group on
Compassionate Use and Pre-Approval Process.

The Koch brothers make a last push to pass right-to-try

About a week ago, I saw this Tweet:

They finally came out of the shadows!! #righttotryKoch-backed groups launch
'Right to Try' campaign https://t.co/OwKWNUU059

— Alison Bateman-House (@ABatemanHouse) January 8, 2018

The story from the Tweet reports:

   Koch brothers-backed groups are launching a campaign urging Congress to pass 
   legislation allowing terminally ill patients to request access to
   experimental drugs the Food and Drug Administration (FDA) hasn’t approved.

   Nearly 40 states have this law, known as “Right to Try,” already on their
   books. But Freedom Partners, in partnership with Americans for Prosperity —
   two groups funded in part by billionaire brothers Charles and David Koch —
   say federal legislation is needed to assuage patient fears that the federal
   government will override state laws.

   The new push, launched Monday, consists of a lobbying effort, 30- and
   six-second digital ads, a social media effort and more.

On Twitter, we can see Americans for Prosperity is pushing the message and the
ads:

Congress should act to allow terminally-ill patients the #RightToTry treatments 
that could potentially save their lives. https://t.co/FB4A7qGpc2

— AFP (@AFPhq) January 14, 2018

Here’s the main ad being used by Americans for Prosperity and Freedom Partners
to promote right-to-try:

Congress is on the cusp of delivering real hope to millions of Americans who are
desperately seeking potentially life-saving treatments that are just out of
their reach. Support #RightToTry. https://t.co/1TEg2G6kyj
pic.twitter.com/2tNK2ifmgq

— Freedom Partners (@FreedomPartners) January 12, 2018

The ad is nauseating in the extreme, full of the usual exaggerated and
misleading talking points and appeals to emotion commonly used by right-to-try
advocates. So is the propaganda appearing on the Freedom Partners website.
Indeed, its arguments are disingenuous and misleading in the extreme:

   Though the FDA boasts of granting over 99% of expanded access requests it
   receives, it only received 1,757 requests for expanded access in total last
   year, minuscule in comparison to the 596,000 Americans who died of cancer in 
   2015, the 155,000 who died of chronic lower respiratory diseases, or the
   111,000 who died of Alzheimer’s. This number is troubling in light of the
   nearly 26,000 patients receiving experimental treatments in France in 2016
   under a similar program, meaning nearly fifteen times as many patients
   receiving experimental treatments in a country one-fifth the size. Underlying
   this disparity is the burden placed on patients by the FDA, discouraging
   them from even submitting a formal application.

   In an article for The Goldwater Institute, Carla Mann Woods, formerly a
   medical device industry executive, and now a board member of the Alfred E.
   Mann Institute for Biomedical Engineering at the University of Southern
   California, put it this way: “In this era of both scientific revolution and
   information where anyone can find anything on the Internet, ask yourself
   this: Can you actually believe that only 1,200 dying Americans want to live
   badly enough to find a legitimately applicable, unapproved therapy and ask to
   get it?”

No one is arguing that we shouldn’t do better in expanding access to
experimental drugs. However, comparing compassionate use approvals to the total 
number of patients dying of cancer is a false metric given that the vast
majority of terminally ill patients wouldn’t be likely to qualify for most
experimental drugs anyway, either based on disease type, burden, or comorbid
conditions. As for the example of France, I can’t help but note the the French
National Agency for Medicines and Health Safety report cited. I was puzzled at
first, as I saw little reference to what Freedom Partners was talking about, but
it would appear that it was talking about a Temporary Authorization for Use
(TAU):

   A Temporary Authorisation for Use is an exceptional, special procedure which,
   since 1994, has given numerous patients, for whom there is no available
   alternative treatment, access to medicines that do not have a MA in France.
   They may be named-patient Temporary Authorisations for Use (TAUn), i.e.
   granted for a specific named patient, or concern a group of patients (cohort 
   Temporary Authorisation for Use, TAUc).

   Since 2012, ANSM has been developing a new policy aimed at expanding the use 
   of cohort TAUs in order to foster fair, closely monitored access to
   innovative treatments for patients whose treatment options have been
   exhausted.

In fact, this is a false and deceptive comparison. Access to unlicensed drugs in
France under a TAU is a very different beast compared to access to unlicensed
drugs through right-to-try in that the French government still has to approve
the use of unlicensed medicines. In France, a drug requires a marketing
authorization (MA) and price and reimbursement agreements. Indeed:

   The French early access programme is one of the few European
   compassionate-use programmes to allow cohorts of patients. In fact, two types
   of ATU status exist. The first one, known as nominative ATU, is available on
   a named-patient basis under the responsibility of the prescribing physician.
   The second one, cohort ATU, is intended to apply to a group of patients and 
   is established at the request of the pharmaceutical company for specific
   indications [8], Hospital pharmacies are exclusively in charge of supplying
   ATUs to in- or outpatients. As with other drugs, hospital pharmacies purchase
   ATUs by directly negotiating with manufacturers. Pharmaceutical companies
   have the freedom to determine ATU pricing. The National Health Insurance
   (NHI) is responsible for the cost associated with these treatments. For
   outpatients, NHI fully reimburses ATU expenditures to hospitals on the
   presentation of bills. For ATUs delivered to hospitalized patients,
   additional funding, known as ‘MIGAC’ (Missions d’intérêt Général et d’Aide à 
   la Contractualisation), is available to hospitals on top of the
   diagnosis-related group (DRG) funding. Several blockbusters have been
   available in France through the ATU programme prior to getting an MA.
   Examples include: bevacizumab (Avastin®), erlotinib (Tarceva®), lenalidomide 
   (Revlimid®), ranibizumab (Fucentis®) and sorafenib (Nexavar®).

   If granted, the programme guarantees patient access before MA and also during
   the time of agreement on reimbursement and price.

The contrast between the French early access program and right-to-try could not 
be more clear. TAU is not a right-to-try law. In the French program, government 
regulatory agencies are heavily involved. (Indeed, in the very report referenced
by Freedom Partners, it points out that there must be good evidence that the
drug is likely to work before a TAU will be issued and details how the
government must monitor usage.) In contrast, under right-to-try, the FDA is
explicitly cut out of the decision-making process and can’t even consider
results seen in patients using right-to-try in determining whether to approve an
experimental drug. In the French program, the government pays for the
experimental drug. Under right-to-try, the patient is completely on his or her
own. You get the idea. The Freedom Partners’ propaganda is so deceptive as to be
virtually a lie. In fact, the existence of the French TAU program puts the lie 
to the claim that right-to-try is needed to expand access to experimental drugs.
The French have done it without sacrificing regulatory oversight through a
right-to-try law. We could too if we so desired.

In retrospect, the involvement of the Koch brothers makes a lot of sense. I had 
always suspected that there had to be much more behind the right-to-try effort
than just the Goldwater Institute, which, while influential, is not nearly large
enough to have mounted such an effort in so many states over such a short
period of time on its own. I can’t help but remember back when right-to-try
passed almost in secret in Michigan, the Goldwater Institute was able to fly in 
patient advocates from all over the country. It was a suitably impressive
effort. The involvement of the Koch brothers reinforces more than ever my
conclusion that right-to-try is not (and never was) about helping terminally ill
patients. It’s always been about weakening the FDA’s ability to regulate drugs.

An excellent editorial by Steven Joffe and Holly Fernandez Lynch in the latest
New England Journal of Medicine makes this very point, the first time I’ve seen 
it so explicitly argued in a large mainstream medical journal. Although they
think that the potential harm to patients and clinical trials may be overstated 
by opponents, they recognize the real purpose of right-to-try as the
“foot-in-the-door” to further deregulation that would weaken the FDA’s health
mission:

   Nevertheless, its passage would remain important. Indeed, the serious
   consideration the legislation is being given reflects a broader effort to
   weaken medical product regulation. The Goldwater Institute has launched a
   campaign in the name of free speech to allow manufacturers to share
   information with physicians and others about off-label uses of approved
   drugs, which has resulted in at least one state law to that effect. The FDA
   has traditionally tightly regulated this practice, but recent federal court
   cases have threatened its authority in the name of protecting truthful
   commercial speech. The FDA’s new commissioner, Scott Gottlieb, appears poised
   to move the agency toward a more permissive stance on off-label
   communication.

   If a federal right-to-try bill becomes law, the long-standing principle that 
   broad access to medical products should await evidence of safety and efficacy
   will contend with the principle that patients with life-threatening diseases
   should have unfettered access to agents that have passed a bare minimum of
   safety testing. This logic could ultimately extend to patients with serious
   chronic illnesses and, conceptually at least, to all patients who find their 
   approved treatment options unsatisfactory.

This is what I’ve been arguing for nearly four years now, that right-to-try is
only part of a broader push to weaken the FDA and, if passed, that the next step
would be to push to make right-to-try apply to more than just terminally ill
patients. Ultimately, the push would be to make it apply to everyone. It’s good 
to see this argument explicitly stated in the pages of a journal as highly read 
and respected as the NEJM.

What now?

Until now, the likelihood of passing right-to-try in the House was considered
rather low. Indeed, in October, FDA Commissioner Scott Gottlieb testified and
requested changes to the bill, noting, “If enacted without changes, sponsors and
other persons providing eligible investigational drugs to eligible patients
under the specified conditions of the bill would not be subject to a number of
sections of the FD&C Act and FDA regulations related to clinical trials,
premarket approval, and labeling. The current language in S. 204 may therefore
preclude FDA from taking enforcement actions based on those provisions.” He also
stated, “The perception is that this legislation will pressure companies to
supply more expanded access drugs but that remains to be seen,” noting in his
written testimony:

   It is important to note that access to investigational products requires the 
   active cooperation of the treating physician, industry, and FDA in order to
   be successful. The most common obstacle to access to the investigational
   product is the willingness or ability of companies to provide it. Neither FDA
   nor physicians or patients can compel a company to make a product available 
   – and companies may decline requests for a variety of reasons. For example,
   they may have produced only a limited quantity of the product (companies ramp
   up manufacturing after marketing approval), have minimal resources to
   administer expanded access requests, or have concerns that granting requests 
   for expanded access may exacerbate the challenge of recruiting clinical trial
   participants – and delay product development.

In other words, the FDA could oversee more expanded access requests, but
companies are reluctant to take part.

There’s still hope of stopping right-to-try, however. One hopeful sign is that
Senator Greg Walden, Chairman of the House Energy and Commerce Committee, is
opposed to the bill, and his is the committee that has to vote to send the bill 
to the floor for a vote. Unfortunately, he is under great pressure from the
Koch-backed Freedom Partners, Vice President Mike Pence, and the House
leadership to send the bill to the floor for a vote. Another is that the version
passed by the House would have to be basically identical to the version passed 
by the Senate last year to avoid a conference committee and two new votes, one
in the House and one in the Senate. If the House version is changed
sufficiently, which is not unlikely, then those votes will have to occur, and
there will be a chance to block the bill again. It’s not clear how much time
there is. With a potential government shutdown looming on Friday if a budget
isn’t passed, I’m optimistic that no floor vote will happen on right-to-try this
week, but that doesn’t mean that it won’t come up soon after that.

One of the clearest problems that let right-to-try become the behemoth that it
is now is the lack of resistance to it. I’ve complained loudly about how none of
the major medical organizations expressed opposition early on, probably because
they didn’t want to be painted as the bad guys. Indeed, the American Society of
Clinical Oncology, to its shame, said nothing official about right-to-try until
its statement of opposition last April, three years after the first laws were
passing. More of that will be required, and it will be important to let
legislators know that there is actual opposition to this bill among the public
by contacting our Representatives.

Right-to-try is a cruel sham by the Goldwater Institute using terminally ill
patients as cannon fodder in its interminable war against government regulation.
Here is where it needs to be stopped, because if it isn’t it will only be the
first step, or, as Joffe and Fernandez Lynch put it:

   Are we prepared to abandon the FDA’s gatekeeping role in favor of unfettered 
   patient autonomy and market forces, risking precisely the problems that
   prompted Congress to grant the FDA its present authority? The agency has made
   substantial progress in balancing the needs of desperate patients and the
   principle that all patients deserve evidence that the benefits of medical
   products justify their risks. We upset that balance, and diminish the FDA’s
   public health mission, at our peril.

It can’t be stated too often. The goal of right-to-try is not to help terminally
ill patients. It’s to diminish and weaken the FDA.

Right-to-try is now law. Let patients beware!

Last week, President Trump signed the worst federal right-to-try bill under
consideration by Congress into law. Its purpose was never to help terminally ill
patients, and now that it’s law there will be nothing the FDA can do to protect
vulnerable terminally ill patients who choose it. That’s a feature, not a bug. 
That’s because right-to-try is the result of a collaboration between the
quack-friendly hospital chain Cancer Treatment Centers of America and the
über-libertarian Goldwater Institute.

David Gorski on June 4, 2018

Link



Two weeks ago, I warned that the worst version of a federal right-to-try bill
being then considered by Congress was on the verge of passing, thanks to
pressure from President Trump, Vice President Pence, and the Koch brothers. At
the time, I really had very little hope that anything could stop the bill, given
how it had been resurrected from death and brought to the House floor with, in 
essence, no debate. To no one’s surprise, the bill passed, and on Wednesday
President Trump signed it into law with great fanfare. There’s no need to go
into the machinations of how that happened today, as I discussed it in depth two
weeks ago. Suffice to say that there were two versions of the bill, one passed 
by the Senate last summer (the worst version, the one that is now law) and the
House version, which had been extensively modified in the House Energy and
Commerce Committee, chaired by Rep. Greg Walden with input from the FDA, passed 
in March. Rather than try to resolve the differences between the two versions of
the bills in conference committee, the House leadership basically pulled
various parliamentary maneuvers to bring the Senate version to a vote as is, and
it passed.

Patients will likely suffer, and the topic of this post will be how right-to-try
can be used to sell snake oil. It’s not as simple as some who have argued
against such laws have claimed, but it is not as difficult as proponents of
right-to-try retort, either. But first, what is “right-to-try”?

Right-to-try: State laws pressure the federal government

“Right-to-try” is an initiative conceived and spearheaded by the libertarian
“think tank” (why I use the scare quotes, I’ll explain momentarily) the
Goldwater Institute. Consistent with the libertarian, anti-regulation bent of
the Goldwater Institute, the stated idea (or should I say talking point?) is to 
make it easier for terminally ill patients to access experimental drugs without 
so much FDA “interference.” To that end, all right-to-try laws contain certain
elements, which is not surprising given that they are all based on a legislative
template composed by the Goldwater Institute:

  1. Anyone with a terminal illness is eligible for right-to-try.

  2. Any drug that’s passed phase I trials, has an IND, and is still under clinical
    trials is eligible for right-to-try.

  3. There is no liability for doctors or companies participating in right-to-try.

  4. Insurance doesn’t have to pay for right-to-try drugs. (As I’ve discussed on a 
    number of occasions, this provision can also be reasonably interpreted as
    saying that insurance companies also don’t have to pay for the treatment of 
    complications that might occur as a result of the use of a right-to-try
    drugs.)

  5. Patients wanting right-to-try drugs are on their own when it comes to cost. (A
    few states—for example, Texas, forbid companies charging for right-to-try
    drugs.)

  6. Drug companies don’t have to provide their experimental drug under
    right-to-try if they do not wish to. It is this provision that has led some 
    critics to note that “right-to-try” is really more like “right-to-ask,”
    given that drug companies are under no obligation to provide their
    experimental drugs to anyone, paid or unpaid.

None of these provisions should be surprising, given the source of the
legislative template and most of the propaganda to pass right-to-try. Again,
right-to-try is a product of the Goldwater Institute, which tries to paint
itself as a libertarian “think tank,” but has never been a true think tank.
Rather, it has always been a far right-wing advocacy organization, so much so
that before he died Barry Goldwater actually wanted his name removed from the
group, but backed off because the Institute was dear to his brother.
Unfortunately, the press treats the Goldwater Institute as a real think tank
when it really isn’t. Rather, it’s part of the American Legislative Exchange
Council (ALEC), a corporate-funded bill mill.

That’s why, before there was a single right-to-try law passed at the state level
in 2014, there was a Goldwater Institute-written legislative template, a
pre-written bill that could be (and was) modified as needed by various states to
fit into their existing legal and regulatory framework. It’s why all
state-level right-to-try laws contain the elements listed above with minor
exceptions, including libertarian tropes like elimination of liability for
companies and doctors participating in right-to-try, and provisions that
basically leave terminally ill patients on their own if things go south. It’s
why the Koch brothers’ threw their weight behind right-to-try and started lying 
about it. Moreover, the for-profit hospital chain Cancer Treatment Centers of
America (CTCA) played an integral role in the genesis of right-to-try:

   In September 2012, a group of executives from the Cancer Treatment Centers of
   America reached out to the Goldwater Institute, a small, libertarian think
   tank named for the former senator and presidential candidate.

   Goldwater — which has in past years accepted support from major conservative 
   organizations like the Charles Koch Foundation and Donors Capital Fund — had 
   taken on a wide-ranging libertarian agenda that included activism on campus
   free speech and school choice. The for-profit hospital chain CTCA also has
   its own ties to the Koch family.

   CTCA and, ultimately, the Goldwater experts believed the FDA’s existing
   expanded access program — through which the agency approves some 99 percent
   of requests from dying patients who can’t get into clinical trials but want
   to try experimental treatments — was too cumbersome.

   It was time to do something about it, and a consultant with CTCA, Chuck
   Warren, coined the term “right to try,” recalled Starlee Coleman, a Goldwater
   senior adviser.

As the article explains, CTCA and the Goldwater Institute decided to start with 
the states. The rest is history. I also note that we’ve written about CTCA
before. It’s a chain of for-profit cancer hospitals that market “integrative
medicine” quackery along with conventional medicine. So, yes, right-to-try was
the product of a hospital chain that supplements its income selling quackery
like “naturopathic oncology,” doing questionable genomic testing, and inflating 
its survival statistics though the cherry picking of patients.

Of course, even the Goldwater Institute flacks knew that state right-to-try laws
had no teeth. The power to approve drugs rests at the federal level, with the
Food and Drug Administration (FDA). States can proclaim in their laws that
terminally ill patients had a right-to-try experimental drugs, but the FDA still
oversees drug approval, and few would be the drug companies with hundreds of
millions of dollars invested in an experimental drug would be likely to risk
that by providing the drug to patients outside of clinical trials needed to gain
FDA approval. Again, the people at the Goldwater Institute who thought of this 
initiative are not stupid. They knew that state laws were not likely to have any
real effect on providing experimental drugs to terminally ill patients, and
indeed they have not, as far as I’ve been able to tell, claims by the Goldwater 
Institute and Dr. Ebrahim Delpassand notwithstanding. Still, one has to
grudgingly admire the effort. Getting forty nearly identical laws passed in
forty states in only a bit more than four years, with only one veto (in
California, where a second try got right-to-try passed) is an impressive
achievement.

This brings us to the federal right-to-try law just signed into law last week,
specifically the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew
Bellina Right to Try Act of 2017. The main provisions of this law are:

  1. Terminally ill patients (as defined by state law in right-to-try states) have 
    the right to bypass the FDA and obtain experimental drugs from the company
    making them. The FDA is not involved in this decision, nor is there
    institutional review board (IRB, ethics board) oversight. Basically,
    critical protections provided by the FDA to patients in clinical trials are 
    not in effect in right-to-try.

  2. Drugs eligible for right-to-try need only have passed phase I clinical trials,
    have an investigational new drug (IND) application with the FDA, and be in 
    phase II clinical testing. As I’ve discussed more times than I can remember,
    this provision is insanity. Right-to-try advocates (like the Goldwater
    Institute) have frequently claimed that this assures that the drug to be
    “tried” is safe, which is nonsense. Phase I trials usually only enroll less 
    than 30 patients, and are designed primarily to screen out drugs with
    toxicities too severe to continue testing.

  3. Doctors prescribing right-to-try drug treatment, pharmacists dispensing the
    drugs, and companies providing right-to-try drugs are shielded from
    liability. While fear of liability is not an unreasonable concern regarding 
    experimental therapeutics, the blanket protection from liability goes rather
    too far in this law.

  4. The FDA Commissioner cannot use outcomes from right-to-try drug use in his
    consideration of whether to approve a new drug for market unless the sponsor
    (drug company) requests it or the Secretary of Health and Human Services
    determines that such outcomes are “critical to determining the safety of the
    eligible investigational drug.” In this case the HHS Secretary must justify
    this decision in writing. The HHS Secretary can also delegate this decision
    no lower than to the director of the relevant agency in the FDA in charge
    of approving the drug under consideration. Anyone want to guess how willing 
    the HHS Secretary will be to do this very often?

Worst of all, right-to-try is entirely unnecessary, given that expanded access
programs in the FDA approve >99% of applications to use experimental drugs
outside of clinical trials and do so without stripping away scientific and
ethical oversight the way that right-to-try does.

Right-to-try: Legalizing the Burzynski practice model

Regular readers of the blog will be familiar with Stanislaw Burzynski, the
Polish expat physician who arrived in the US in the early 1970s; discovered
peptides he dubbed “antineoplastons,” that, according to him, inhibited cancer
growth and metastasis; left his university (Baylor) and started administering
them to patients and thereby built up a cult following of people who believed
his claims that he could treat hopeless cancers like glioblastoma and diffuse
intrinsic pontine glioma (DIPG), when, as I’ve documented more times than I can 
remember, he could not produce evidence that antineoplastons were effective
against any cancer. I don’t feel obligated to go into all the ins and outs of
the Burzynski cancer quackery saga here. Anyone interested can read my article
in Skeptical Inquirer from a few years ago that tells the saga in great detail
or peruse the posts here on SBM under the Stanislaw Burzynski tag or at my
“friend’s” blog under the same tag. It’s a sordid, four decade saga of how a
cancer quack has managed to charge desperate patients hundreds of thousands of
dollars for an ineffective, toxic drug and not only to get away with it, but to 
be lionized as a hero in alternative medicine circles.

What’s relevant to right-to-try is a tactic that Burzynski’s lawyer, Richard
Jaffe, hit upon the late 1990s, when Burzynski was being prosecuted for 75
counts of insurance fraud and violations of the Food, Drug, and Cosmetics Act.
As part of this process, Judge Simeon Lake of the U.S. District Court for the
Southern District of Texas, ruled that Burzynski’s “continued pretrial release” 
was contingent upon his administering his drugs exclusively through FDA-approved
clinical trials. Under pressure from Representative Joe Barton (R-Texas) and
his committee, the FDA entered talks to let Burzynski do clinical trials, even
though prosecutors pleaded with FDA officials not to do so because it would
undermine their case. Antineoplastons had passed phase I trials by that time;
so, at the urging of his lawyer, Burzynski cleverly filed for 72 phase 2
clinical trials for every cancer he wanted to treat. This became his business
model for the next 20 years. Patients would be recruited to the Burzynski Clinic
largely through promotion by believers on alt med-friendly websites and as a
result of a documentary-cum-propaganda film by Eric Merola, be enrolled in one
of Burzynski’s phase 2 trials, and be charged tens or hundreds of thousands of
dollars in “consulting fees” for the privilege.

It’s not too hard to see where I’m going with this in light of the passage of
right-to-try. Basically, right-to-try is Burzynski’s business model, only
easier. Why easier? The federal right-to-try law only requires that there be an 
open IND and there be clinical trials open. Under right-to-try, Burzynski could 
simply keep doing what he’s doing and not even bother to enroll most of his
patients in his phase 2 trials, providing antineoplastons to them under
right-to-try and only slowly accruing enough patients to keep his clinical
trials appearing viable. Basically, right-to-try has not only functionally
legalized the Burzynski practice model, it has facilitated it, making it easier 
for him to continue. Indeed, as long as he keeps a single phase 2 trial open, I 
don’t see any reason why he couldn’t just keep doing the bulk of his business in
right-to-try and, given that he’s 75 years old, keep doing so until he runs out
the clock and either retires or dies.

What about other quacks?

Of course, Burzynski is a special and unique case. Few quacks have a drug that’s
passed phase I testing, an IND, and a long history of open clinical trials, no 
matter how dubious. That’s why, when I see right-to-try critics going on about
how treating the terminally ill with quackery is now basically legal, I have to 
point out that not just any quackery can be administered under right-to-try. Not
just any unproven drug can qualify. That doesn’t mean, however, that there is
not much harm to be done to the terminally ill.

The first form of quackery that came to mind to me as likely to jump into the
right-to-try business included stem cell clinics. I’ve been writing about quack 
stem cell clinics more than I can remember, and, yes, the FDA has recently tried
to crack down on stem cell clinics selling unproven treatments. (I hope it
succeeds.) However, some of these stem cell clinics claim to be doing clinical
trials. They’re mostly crappy observational clinical trials without a control
arm, but they are clinical trials.

Now, imagine, if you will, a stem cell clinic whose doctors want to operate
under right-to-try. What would it have to do? First, it would have to get an IND
for its stem cell treatment, after which it would have to conduct a phase I
trial and show safety. There are a number of stem cell clinics that could, if
their doctors so desired, accomplish this. The next step would be to register a 
phase 2 clinical trial. I don’t pretend that this would necessarily be easy or
cheap, because the FDA does need a scientific rationale. I suspect that some
stem cell clinics could manage it, though, particularly given that the FDA
appears, though its new enforcement initiative, to be encouraging such clinics
to treat their cell therapies as drugs and get them approved. Once a phase 2
trial is set up, the treatments could be marketed to patients eligible for
right-to-try.

Finally, one could imagine the less scrupulous drug companies clearing out their
vaults of drugs that passed phase I but, for whatever reason, were never
advanced to phase 2 testing. Reasons for not continuing can be many, ranging
from too much expense to insufficient evidence for potential efficacy, but under
right-to-try such drugs could be resurrected, their INDs reinstated, and phase 
2 trials given the go-ahead.

Will stem cell clinics and drug companies do this? My guess is: Probably not, at
least not now. However, remember the purpose of right-to-try. It’s
anti-regulation, more than anything else. Its purpose is to weaken the FDA (more
on that in a moment), more than anything else. As a result of the law’s
libertarian origins, I’ve predicted all along that, once right-to-try became
law, its advocates would next work to expand the definition of who’s eligible
for right-to-try. First, they’ll do what some have already done in some states
and make right-to-try available to the “seriously ill.” After all, why should
just the terminally ill “benefit”? The ultimate goal will be to make
right-to-try available to basically everyone, at which point the FDA will become
beside the point. When and if that happens, that’s when the two strategies
above could result in real profits.

Then there’s the issue of how the FDA will implement this law. It’s not a
coincidence that, now that the bill has become law, the mask has come off of
right-to-try.

Sen. Ron Johnson schools FDA Commissioner Scott Gottlieb on the real purpose of 
right-to-try

From the very beginning, over four years ago when the first Colorado
right-to-try law was being considered, I’ve repeatedly and consistently warned
that the real purpose of right-to-try is not and never has been to help
terminally ill patients (although in fairness undoubtedly right-to-try advocates
believe they are helping terminally ill patients), but rather to weaken the
FDA. Whenever I point out that right-to-try is a tool, a step if you will,
towards the ultimate dismantling of the FDA, inevitably someone will take
umbrage and insist so very, very righteously that, no, that’s not the purpose of
right-to-try at all. They also accuse me of a lack of compassion, as though
compassion for the terminally ill requires that I buy their dubious arguments
and the premises behind them. Now that right-to-try is law, however, the mask is
coming off. One of the architects of the federal right-to-try law that
President Trump signed on Wednesday, Sen. Ron Johnson, rebuked FDA Commissioner 
Scott Gottlieb last week. Indeed, the day after President Trump signed the bill 
into law, Sen. Johnson set Dr. Gottlieb straight on the true purpose of
right-to-try, as I discovered in a STAT News article, “‘Right-to-try’ law
intended to weaken the FDA, measure’s sponsor says in blunt remarks“, which
reported on a letter written by Sen. Johnson to Dr. Gottlieb in response to
remarks that Gottlieb had made about right-to-try two weeks ago entitled Johnson
to FDA: Agency Should Comply with Right to Try Law. First, Sen. Johnson laid
out the “offense” by Gottlieb that riled him up:

   In a recent article about right to try, you appeared to suggest that the FDA 
   would need to issue regulations to balance the law’s requirement against
   “patient protections.” The article quoted you as saying:

  1. “In terms of making sure that it balances [access to experimental drugs]
    against appropriate patient protections . . . with [S. 204], we’d have to do
    a little bit more . . . in guidance and perhaps in regulation to achieve
    some of those goals.”

  2. “We felt that there were certain aspects of [S. 204] that could be modified to
    build in additional patient protections, but if you weren’t able to do that
    legislatively, that there [was] a pathway by which you do that
    administratively and still remain consistent with the letter and the spirit 
    of this law.”

   You later tweeted: “I stand ready to implement [right to try] in a way that
   achieves Congress’ intent to promote access and protect patients; and build
   on #FDA’s longstanding commitment to these important goals.”

Silly Dr. Gottlieb! Poor Dr. Gottlieb! He was actually deluded enough (or he
deluded himself enough) that right-to-try was about expanding access to
experimental therapies for people with terminal illnesses. Dr. Gottlieb, as I’ve
discussed, was the “least bad” choice Trump could have made for FDA
Commissioner. Sure, he’s a real pharma shill, having more pharma ties than I’ve 
ever seen in an FDA Commissioner before and is all for “streamlining” drug
approval processes (translation: making them easier and less rigorous), but he
still exists within a continuum of “normal” among FDA Commissioners, albeit on
the conservative end. He’s not a hyper-libertarian Peter Theil crony who thinks 
the free market will take care of drug safety, nor does he think that online
rating systems, a “Yelp for drugs” if you will, would be effective at assuring
drug safety. Gottlieb is, in contrast, the sort of FDA Commissioner that any
Republican administration might have appointed. He actually believes in the
mission of the FDA, as he showed when under his leadership the FDA started
cracking down on quack stem cell clinics.

Because Gottlieb believes in the mission of the FDA, he understands how bad this
new law is, how it will cut the FDA out of the process, leaving terminally ill 
patients unprotected by institutional review boards (IRBs)—or much of anything
else, for that matter. So he tried to say how the FDA would work to implement
the law, including trying to do what the FDA is supposed to do and protect
patients accessing right-to-try medications. It’s what any responsible FDA
Commissioner, even one who was a pharma shill or is very much in favor of
“streamlining” FDA approval processes, would do.

Sen. Johnson wasted no time in setting Dr. Gottlieb straight on that score:

   As I made clear to my colleagues in the Senate and the House before each body
   voted on S. 204, this legislation is fundamentally about empowering patients
   to make decisions in cooperation with their doctors and the developers of
   potentially life-saving therapies. This law intends to diminish the FDA’s
   power over people’s lives, not increase it.

I told you so. In the name of patient “empowerment” right-to-try is really about
cutting the FDA out of the process of drug companies marketing their wares to
desperate patients. Johnson makes that very explicitly clear in no uncertain
terms:

   It is designed to work within existing FDA regulations, definitions, and
   approval processes. It is not meant to grant FDA more power or enable the FDA
   to write new guidance, rules, or regulations that would limit the ability of
   an individual facing a life-threatening disease from accessing treatments.
   Under this law, the FDA’s oversight with respect to patient safety within a
   Phase I trial remains unchanged; the current thresholds for successful
   completion of such a trial phase remains unchanged.

That last bit about phase I trial requirements is a red herring. No one is
claiming that right-to-try changes phase I clinical trial requirements. What
right-to-try does do is something incredibly dangerous, as I’ve discussed above.
It makes any drug that has passed phase I trials and has an active
investigational new drug (IND) application and is in ongoing clinical trials
eligible for right-to-try.

Let me expand a bit on what I said above about this. It is deceptive as hell to 
call drugs that have passed phase I “safe,” as I’ve seen right-to-try advocates 
do more times than I can remember. Phase I trials generally only involve less
than 30 patients and are not designed to verify drug safety. Rather, they are
designed to detect the worst toxicities and make sure that the drug isn’t too
toxic or hazardous to continue to test in phase II and III clinical trials.
(There’s a big difference.) Phase I trials also do not demonstrate efficacy.
They are not designed to do that, either. Basically, think of phase I trials as 
a screening test to make sure an experimental drug isn’t too dangerous and might
have activity, enough to justify further clinical trials. Only around 10-15% of
drugs that pass phase I go on to be approved by the FDA.

Ironically, Sen. Johnson is not entirely wrong in one thing that he asserts. It 
is true that right-to-try does not provide any new rights that patients didn’t
already have before under expanded use programs. It also certainly doesn’t do
anything to increase FDA power. After all, the bill’s primary sponsor just told 
Scott Gottlieb that that the very purpose of the bill was to weaken his agency
and that he should, basically, stay out of right-to-try cases.

If that’s not clear enough, Johnson drives home the point. First, he wants as
many patients as possible to be eligible for right-to-try:

   S. 204, as originally introduced, applied to patients “with a terminal
   illness,” as defined by state law. I rejected the FDA’s proposed
   definition—“immediately life-threatening disease or condition”— because it
   would exclude patients with Duchenne muscular dystrophy, an illness that I
   explicitly intended to be covered by the legislation. As enacted, S. 204
   defines terminal illness as “life-threatening disease or condition,” a
   definition that exists in current federal regulation. The FDA confirmed that 
   this definition would include patients diagnosed with Duchenne muscular
   dystrophy.

Of course, state right-to-try laws generally define a “terminal illness” as one 
that is likely to cause death within six months, although the definition varies 
somewhat and some states don’t even necessarily require a “terminal” illness. Be
that as it may, Sen. Johnson makes it very clear: Right-to-try should victimize
apply to as many patients as possible.

Next up, don’t bother me with any outcomes that might reflect badly on the
experimental drug:

   S. 204 requires that the Secretary of Health and Human Services may not use a
   clinical outcome associated with the use of an eligible investigational drug
   to delay or adversely affect the drug’s review or approval, unless use of
   that clinical outcome is critical to determining safety. This language is not
   intended to enable the FDA to expand the scope of existing safety
   determinations about investigational drugs.

No one ever said that it did, least of all Scott Gottlieb, at least as far as I 
can tell. As mentioned above, the language in the federal right-to-try law bends
over backwards to make sure there are no consequences for companies agreeing to
provide experimental medications to patients under the law. Indeed, one thing
that I didn’t mention is that the original version of Sen. Johnson’s
right-to-try bill explicitly banned the FDA from using outcomes from patients
using an experimental drug under right-to-try in its consideration. Period.
Seriously, I mean this. The original version of Sen. Johnson’s bill would have
banned the FDA from even considering outcomes of patients who access
right-to-try in its considerations over whether to approve a drug. At least the 
version that passed allows such consideration, although it requires jumping
through some hoops and puts the burden of proof on the FDA, not the company
seeking approval for its drug, to show why right-to-try outcomes should be
included.

The FDA capitulates

Sadly, the FDA appears to have thrown in the towel, although I don’t know that
there’s anything else it could have done:

   In a separate email to staff Wednesday, Janet Woodcock, who directs the
   agency’s Center for Drug Evaluation and Research, told staff to direct any
   inquiries about the new law to drug companies.

   “We believe that sponsors are in the best position to provide information on 
   the development status of their products,” Woodcock wrote.

In other words, if Congress is going to cut the FDA out of right-to-try
decisions and regulation, screw it all. Patients, don’t call us. Congress has
eliminated our authority to deal with this. Call the company that makes the drug
you’re interested. Congress cut us out; we can no longer interfere. You’re on
your own.

Just yesterday, Gottlieb appeared to be whistling past the graveyard:

The new 'Right to Try' legislation provides another pathway for patients facing 
life threatening illnesses to access experimental drugs, under physician
supervision. This new pathway will provide a second option for sponsors who are 
willing to make drugs available pre-approval

— Scott Gottlieb, M.D. (@SGottliebFDA) June 3, 2018

Compassionate use or “expanded access” programs have long been around, and, as
I’ve said many times, the best way to allow access to experimental drugs to the 
terminally ill or to patients with compelling need outside of a clinical trial
before they are approved is through such programs. Such programs ensure the
continued involvement of the FDA to protect patients, as well as oversight by an
IRB. Right-to-try explicitly cuts the FDA out of the process and has no
provision for IRB oversight.

Dr. Gottlieb said basically the same thing later in the same thread:

Ultimately, a burden rests with sponsors developing potentially life-saving or
life-extending drugs to consider making these products available, pre-approval, 
to patients who qualify for access. There's clearly a consensus among American
families that patients want these options

— Scott Gottlieb, M.D. (@SGottliebFDA) June 3, 2018

In other words, again, the FDA is powerless, thanks to the new right-to-try law.
We can’t do anything to force sponsors (drug companies) to make their drugs
available before approval.

It goes beyond that, however. On Twitter, stem cell biologist Paul Knoepfler
asked:

What happens if a for-profit firm claims they are doing RTT but don't follow the
rules. Under the new law can FDA go after them & if not, who will?
https://t.co/32Ddq13XMv

— Paul Knoepfler (@pknoepfler) May 31, 2018

That’s a very good question indeed. Remember, the intent of the law is to cut
the FDA out of the equation as much as possible. How will the FDA actually
respond when a company claims to be doing right-to-try but isn’t following the
requirements of the law? Given Sen. Johnson’s negative reaction to even the
suggestion that the FDA still has a role protecting patients using right-to-try,
it would be a politically dicey thing for the FDA to try to intervene too
vigorously. Would Gottlieb be up for it? I don’t know.

All is not hopeless. There might be ways that the FDA can get back in, as
suggested by Holly Fernandez Lynch of the Department of Medical Ethics and
Health Policy at Perelman School of Medicine, University of Pennsylvania, but
I’m not sure that I buy some of them:

  1. Clarify that it is not enough to have a life-threatening illness, but rather
    that the illness should be immediately life-threatening.

  2. Require adverse event reporting not via the right to try law, but rather under
    the terms of the overarching IND for the drug (this may be tricky, but not 
    entirely implausible).

  3. Clarify what it means for a Phase 1 trial to be completed, i.e., what is
    success?

  4. Require that sponsors develop contracts with certifying physicians that in
    order to access the drug, the physician must collect and report safety data.

  5. Specify the sorts of adverse event data that needs to be collected in order to
    satisfy the requirements of the annual summary.

  6. Post as much information publicly as possible, to help patients and their
    physicians understand that the unlikelihood that right to try will be
    helpful.

  7. Encourage patients and companies to utilize the expanded access pathway rather
    than right to try.

  8. Encourage sponsors and investigators to allow for the broadest clinical trial 
    inclusion consistent with participant safety and scientific integrity.

Senator Johnson just shot down #1 (with extreme prejudice, to boot!) in his
letter to Scott Gottlieb. #2 is less plausible than Lynch seems to think, given 
the “no use of outcomes” provision in the law. #3 is actually a good idea, but
won’t really do much more than decrease slightly the number of drugs eligible
for right-to-try. In reality #5, 6, 7, and 8 are probably the best bets,
although #7 is likely to be a bust, as the FDA really doesn’t have any tools to 
encourage the use of expanded access rather than right-to-try.

The subtext to all this is, of course, that the FDA doesn’t want to and is
basically washing its hands of the problem and dropping it in the lap of drug
companies, which is kind of funny if you think about it. After all, right-to-try
is supposed to be about more “freedom” for both patients and sponsors. That
“freedom” will have a price. For sponsors, it will be to deal with right-to-try 
requests with no guidance. For patients, however, the price will be financial
(sponsors could charge exorbitant prices for their wares), the risk of
significant complications, up to and including premature death, from
right-to-try.

All this in the name of “freedom.”

“Right to try” laws create tremendous legal uncertainties; FDA expanded access
preferable

The Goldwater Institute and the Kochs pushed “right to try” laws in an attempt
to get rid of FDA oversight of access to investigational drugs. Instead, they
created tremendous legal uncertainties, making the FDA’s expanded access program
preferable for all.

Jann Bellamy on January 17, 2019

Link



The U.S. now offers 43 different pathways for patients with serious or
life-threatening diseases or conditions who want to try drugs under
investigation, but not yet approved, by the FDA. This comprises one federal and 
41 separate state “right to try” (RTT) laws, all passed in the last few years,
as well as the FDA’s long-standing expanded access (EA) program. Unfortunately, 
instead of actually improving patient access, as promised, the addition of state
and federal RTT laws has created a confusing, and sometimes contradictory,
patchwork, introducing new legal issues for patients, physicians, and drug
manufacturers.

(The FDA’s EA program works with the sponsor of an Investigational New Drug
[IND] Application, which is not necessarily a drug manufacturer, but, for ease
of reference, we’ll use the term “drug manufacturer” or “drug company” in this
post.)

It was not always this way. Prior to the passage of the first “right to try” law
in Colorado in 2014, access to investigational drugs, that is, drugs currently 
making their way through the FDA approval process but not yet on the market, was
available (unless the patient was enrolled in a clinical trial) only through
the FDA’s expanded access (sometimes called “compassionate use”) program, first 
established in the 1970s. Under EA, the FDA oversees the process of granting
patient access to investigational drugs, although the final decision rests with 
the drug manufacturer. According to a recent statement from FDA Commissioner Dr.
Robert Gottlieb, in the last five years, the FDA has authorized more than 9,000
applications for drugs, biologics and medical devices (the latter two are also 
available via EA), approximately 99% of all requests.

That is not to say the expanded access program is without its problems. Patients
and physicians complained of lack of information, burdensome paperwork, and
delays. Drug companies were worried about whether adverse events from use of
investigational drugs they provided would be used against them in the drug
approval process.

In response to these complaints, as well as a 2017 GAO report, the FDA stepped
up its efforts to make expanded access more user friendly. The FDA issued
guidance on EA to the drug industry in 2016 (updated in 2017). The agency also
commissioned an independent report, the results of which were released in
November of last year, that made further recommendations for improvement. Dr.
Gottlieb has vowed to implement these as well. They include reducing the time
physicians spend on paperwork to an estimated 45 minutes, more information on
the FDA website, and expedited Institutional Review Board (IRB) consideration of
EA requests.

Although the independent report found significant progress in reducing delays
and satisfaction among stakeholders (patients, physicians, drug manufacturers)
with the process, by that point the “right to try” train had already left the
station. State “right to try” laws were specifically intended to remove FDA
oversight of a patient’s request for and, if the request is granted by the drug 
manufacturer, receipt of, investigational drugs. Actually, “right to try” is a
misnomer: Like the FDA’s EA program, all these laws guarantee is a “right to
ask” a drug manufacturer for access to an investigational drug, a request the
manufacturer is under no obligation to grant. This may be why the FDA uses the
more modest term “expanded access” instead of the false promise implied in
“right to try.”

As noted, 41 states have “right to try” laws with similar, though varying,
requirements. In May of last year, Congress passed, and President Trump signed, 
a federal “right to try” law with provisions comparable to that of the states’
laws. An article in Health Affairs summed up the differences between the new
federal law and the existing FDA EA program.

   There are notable differences between the two pathways. RTT applies only to
   investigational drugs; EA includes all types of medical products. RTT
   requires drugs to have completed a Phase 1 (dosage-setting) trial, while EA
   can permit access to products in any stage of development. RTT provides
   liability protection to companies and everyone else involved in therapeutic
   attempt; EA does not. The biggest difference concerns oversight: in EA, the
   treating physician, drug company, FDA, and IRB work together to ensure that
   only patients who have no other treatment options receive access; that costs 
   are appropriate; that informed consent is legally and ethically sound; and
   that the proposed treatment plan offers a favorable risk/benefit profile for 
   the patient. Under RTT, only the treating physician and the drug company —
   neither of whom is a neutral party — provide oversight. In the best case, the
   physician and company can together plan an ethical protocol that offers the 
   highest chance of benefit and the least risk to the patient. In the worst
   case, an unscrupulous physician and company can work together to sell
   useless, possibly risky, treatments to patients.

SBM’s managing editor and resident cancer expert, Dr. David Gorski, and our good
friend Orac have blogged about the problems of “right to try” laws, and I have 
contributed a couple of posts myself. (You can find a list of SBM “right to try”
posts here.) I’ll not repeat the many concerns both we and others, including
physicians, ethicists and drug companies, have raised about these laws. Rather, 
this post will explore how a libertarian desire to cut the government out of the
process may have backfired, driving patients, physicians, and especially drug
manufacturers, back into the arms of the very agency they sought to eliminate:
the FDA.

RTT SNAFU

The “right-to-try” movement was fueled by the Goldwater Institute and the Koch
brothers (at the suggestion of the CAM-friendly Cancer Treatment Centers of
America) who were looking for a stick with which to poke the FDA in the eye and 
apparently not overly concerned with how the process would play out in actual
practice. This is not to deny the sincere wishes of patients and their families 
for a reprieve from serious illness, their genuine frustration with the FDA, or 
their good faith in wanting to expedite access. Unfortunately, however, the
Goldwater Institute’s prepackaged draft of a “right to try” bill is the one that
got introduced in state legislatures, thereby providing a template that aligned
more with their libertarian goals than a practical solution to the problem (or,
more correctly, non-problem, as the FDA’s EA program already existed.)

Into this breach of forethought, the law of unintended consequences happily
stepped. In their attempt to grease the wheels of access to investigational
drugs, RTT has instead introduced new complications for all involved, ones that 
will potentially require years of litigation to resolve and most certainly have 
already given lawyers expert in the field of drug regulation scores of billable 
hours.

First, unlike the FDA’s regulations and guidance governing the EA process, there
is no regulatory infrastructure spelling out just how patients and physicians
should go about accessing investigational drugs or how drug companies should
respond. Normally, an agency under whose jurisdiction a particular matter falls 
would flesh out new legislation impacting the agency’s remit with informal
guidance and formal regulations. Basic stuff like forms, established procedures,
eligibility guidelines, explanation of terms left undefined in the law (like
“informed consent”) and phone numbers to call if you need help are usually
within the purview of the regulatory agencies.

It looked as if the FDA was setting about fulfilling its traditional regulatory 
role when Dr. Gottlieb announced last year that the FDA might need to draft
guidance and regulations to implement the new federal RTT law. This drew a swift
rebuke from Sen. Ron Johnson (R-Wis.), the principal sponsor of the law, who
told the FDA to butt out of the process. This, in turn, prompted another FDA
official to tell those inquiring about RTT to go ask the drug manufacturer if
they have questions about eligibility.

That advice has now been memorialized on the FDA’s website, which devotes one
page to RTT:

   If you are interested in Right to Try, you should discuss this pathway with
   your licensed physician. Companies who develop and make drugs and biologics, 
   also known as sponsors, can provide information about whether their
   drug/biologic is considered an eligible investigational drug under Right to
   Try and if they are able to provide the drug/biologic under the Right to Try 
   Act.

In other words, good luck with that!

Disturbingly, this also means that it is not at all clear who will go after the 
bad actors when things go south for patients who choose the RTT route.

In any event, this is not a role drug companies, who worked to maintain the
FDA’s oversight when Congress was debating RTT, particularly relish. As Dr.
Robert Cardiff, former FDA Commissioner and now at Duke Health, pointed out,

   For the traditional pharma and biotech companies, the last thing they want is
   chaos. The requirements for good evidence protect them from charlatans . . .

Ironically, this desire to avoid uncertainty about the RTT process has led some 
companies to direct persons who inquire about access via the RTT law right back 
to the FDA’s EA program.

Another snafu is that the RTT laws, in supposedly streamlining access to
investigational drugs, added liability protections for drug companies as a
deal-sweetener. They also removed “obstacles” like patient protections, such as 
IRB oversight. What proponents failed to consider, however, is that drug
companies can, and do, add their own liability protections contractually when
access is sought via the FDA’s EA program. In other words, liability protection 
may not be the big attraction for drug companies RTT fans thought it might be.
Likewise, one law firm is suggesting drug companies consider adding their own
IRB requirement, or some other form of institutional review process,
contractually before granting access via RTT, even though RTT doesn’t require
it. What RTT laws were supposed to take away in the interest of speed, the drug 
companies may simply add back in on their own via contract.

Finally, and this is a big one:

   the tremendous uncertainty surrounding the governing law when federal “right 
   to try” overlays a state “right to try” statute.

To figure this out, drug companies are going to have to (or, actually their
lawyers are going to have to) take a deep dive into the Supremacy Clause of the 
U.S. Constitution because, with 41 state and one federal RTT law on the books,
it is not at all clear which provisions of which law apply in any given
situation. This is such a big issue one law firm is suggesting that, even the
with touted advantages of RTT over EA for manufacturers – less government
oversight, protection from liability, and limits on the use of adverse events in
determining drug approval – this complexity may tip the scales favor of using
EA.

I’ll try to keep this as simple as possible. The Supremacy Clause makes federal 
law “the Supreme Law of the Land”. Where state law stands in obstacle to federal
law, federal law prevails. This is why everyone, including me, thought the
state RTT laws would not survive a court challenge, because they are in direct
conflict with the FDA’s exclusive jurisdiction over new drug approval. Drug
companies could just ignore the state RTT laws because of their obvious conflict
with federal law.

The new federal RTT law, however, has thrown a monkey wrench into the system.
The federal law does not specifically preempt the state RTT laws, so the
question becomes whether a particular state’s law and the new federal RTT law
conflict. If so, the federal law preempts state law and state requirements can
be ignored. If not, and there are good arguments that, with at least some
provisions (such as informed consent) this is the case, then the manufacturer
must comply with both state and federal requirements. As a practical matter, in 
each state, a drug manufacturer is likely to encounter both provisions that
conflict and those that do not, thereby having to meet all federal requirements 
as well as some state mandates, but not others.

Mind you, there are no certainties in the drug manufacturer’s choices of which
provisions to comply with and which it can ignore, leaving itself open to a
court challenge to its decisions. Or, the company could decide to seek a
declaratory judgment and leave it up to a court to make the choices on its
behalf. Either way, it is an added, and considerable, expense a manufacturer
would not face with the FDA’s EA program.

Thus, as these lawyers point out,

   The ironic result for those who advocated “right to try” as a means of
   simplifying and expediting access may be that stakeholders operating under
   the federal “right to try” framework may now have to navigate two layers of
   regulations – one federal and the other state — with the latter consisting of
   a national patchwork of state-by-state variations.

I’ll add another complexity to this conundrum: Suppose the patient lives in
State A and plans to ingest the drug she hopes to access via RTT there; her
physician, who will dispense the drug, is just across the state line in State B;
the drug manufacturer is in State C. Which state’s RTT law applies? That’s a
decision the patient, physician, and drug company have to make even before
getting into the preemption question.

Why bother with all of this when a manufacturer can simply choose, as a matter
of policy, not to consider RTT requests, directing patients instead to the
already familiar FDA expanded access program?

So, congratulations Goldwater Institute and the Messrs. Koch. Your effort to
undermine the FDA looks like it backfired because drug manufacturers (at least
the ethical ones) simply don’t want to deal with many problems raised by “right 
to try” and prefer the FDA after all.

Note: I will be on a trip and happily out of internet range when this post goes 
up. I’ll try to answer any questions or concerns raised in the comments when I
return next week.

Federal “right-to-try” over a year later: Still a failure and still about the
money (and weakening the FDA)

Federal “right-to-try” legislation was passed and signed into law by President
Trump over a year ago. Advocates promised that lots of terminally ill people who
were dying then would be saved by having the right to “try” experimental
therapies outside of the context of clinical trials. That has not happened. This
should come as no surprise, because right-to-try was never about getting
experimental drugs to dying patients. It was always about weakening the FDA and 
making money.

David Gorski on September 16, 2019

Link



It’s been a while since I’ve written about “right-to-try“, the law that passed
over a year ago, promising to let patients with terminal illnesses have access
to experimental drugs outside of the context of a clinical trial. The claims
made by the law’s supporters were quite expansive, such as that the law would
save many lives by getting promising experimental therapeutics to patients who
needed them faster. This was recognized as total BS by those of us who actually 
deal with clinical trials and know the low rate of success of experimental drugs
in passing clinical trials and being licensed by the FDA. However, the genius
of the people who devised the original state-level precursor of right-to-try is 
that their message guaranteed that any critic of right-to-try (such as myself)
could easily be tarred as cruel, uncaring, and not wanting terminally ill people
to have a shot at living, and that’s exactly what they did. They weaponized
terminally ill patients, in much the way Stanislaw Burzynski did to protect
himself from the FDA, to cow doctors and scientists from speaking out.

It’s why not a single cancer center or professional society spoke out against
right-to-try when it was still early enough to have a chance of stopping it and 
by the time the American Society of Clinical Oncology did it was too late.
Indeed, right-to-try supporters did this in Michigan, where the few advocates
arguing against a right-to-try law were greeted with angry stares from patients 
and patient advocates. Indeed, it’s not for nothing that nearly every time I
write about right-to-try, I remark sardonically that opposing right-to-try is
perceived by most people the same way as opposing mom, apple pie, and the
American flag—or worse, wanting to kill mom, defile apple pie, and shred the
American flag. Again, I exaggerate, but not by much.

I was prodded to write about right-to-try again when I saw an article in STAT+
by Ed Silverman, “Right to try ‘remains a bust,’ as many drug makers prefer FDA 
reviews“. Unfortunately, it’s behind a paywall. Fortunately, I was willing to
burn a 30-day trial of STAT+ to get into the topic again. Basically, unlike the 
predictions of right-to-try advocates since 2013, when the push to pass the
first state-level right-to-try law began, all the way through last year, when
the federal right-to-try law passed and was signed into law, there hasn’t been a
rush of patients accessing experimental drugs without the “pesky interference” 
of the U.S. Food and Drug Administration:

   Despite the hubbub over the “right-to-try” law, a recent survey found that
   nearly half of drug makers indicated they would require regulators to review 
   a decision to provide an experimental treatment to a person with a
   life-threatening disease.

   Specifically, 13 of 29 drug companies indicated they want a relevant
   regulatory authority to review requests that are granted to such people. Of
   these, six specified they would ask the Food and Drug Administration to
   conduct a review and five stated they require a research ethics committee or 
   institutional review board, according to a report from the Government
   Accountability Office.

   The results show many drug makers still prefer to follow the mandate in the
   FDA expanded access program, which was created to provide a route for people 
   with serious or life-threatening illnesses to request experimental treatments
   from the pharmaceutical industry. The program requires a physician to submit
   a request to a drug company, and for the FDA to sign off on providing a
   medicine.

Silverman notes that this is in contrast to right-to-try, which does not require
a drugmaker to receive endorsement from the FDA before making an experimental
drug available to a patient, also noting another key part of the propaganda that
got right-to-try passed, namely that the FDA is too slow to approve new drugs
and that its expanded access program is too cumbersome. Of course, as I’ve
discussed multiple times before, it was at one time true that the expanded
access program was cumbersome, but in recent years the FDA has made great
strides in streamlining its expanded access program. I’ve also noted that the
FDA approval process is not slow, given what needs to be done. Indeed, it’s as
fast or faster than the systems in most industrialized countries, including the 
EU.

Before I get into just how much of a failure right-to-try has been, let’s take a
moment to recount how we got here.

Right-to-try: A brief history

As I’ve described before, “right-to-try” is an initiative conceived and
spearheaded by the libertarian “think tank” (why I use the scare quotes, I’ll
explain momentarily) the Goldwater Institute. Consistent with the libertarian,
anti-regulation bent of the Goldwater Institute, the stated idea (or should I
say talking point?) is to make it easier for terminally ill patients to access
experimental drugs without so much FDA “interference”. To that end, all
right-to-try laws contain certain elements, which is not surprising given that
they are all based on a legislative template composed by the Goldwater
Institute:

  1. Anyone with a terminal illness is eligible for right-to-try.

  2. Any drug that’s passed phase I trials, has an investigational new drug (IND)
    application, and is still under clinical trials is eligible for
    right-to-try.

  3. There is no liability for doctors or companies participating in right-to-try.

  4. Insurance doesn’t have to pay for right-to-try drugs. (As I’ve discussed on a 
    number of occasions, this provision can also be reasonably interpreted as
    saying that insurance companies also don’t have to pay for the treatment of 
    complications that might occur as a result of the use of a right-to-try
    drugs.)

  5. Patients wanting right-to-try drugs are on their own when it comes to cost. (A
    few states—for example, Texas—forbid companies charging for right-to-try
    drugs.)

  6. Drug companies don’t have to provide their experimental drug under
    right-to-try if they do not wish to. It is this provision that has led some 
    critics to note that “right-to-try” is really more like “right-to-ask,”
    given that drug companies are under no obligation to provide their
    experimental drugs to anyone, paid or unpaid.

None of these provisions should be surprising, given the source of the
legislative template and most of the propaganda to pass right-to-try. Again,
right-to-try is a product of the Goldwater Institute, which tries to paint
itself as a libertarian “think tank”, but has never been a true think tank.
Rather, it has always been a far right-wing advocacy organization, so much so
that before he died Barry Goldwater actually wanted his name removed from the
group, but backed off because the Institute was dear to his brother.
Unfortunately, the press treats the Goldwater Institute as a real think tank
when it really isn’t. Rather, it’s part of the American Legislative Exchange
Council (ALEC), a corporate-funded bill mill that generates legislative
templates for states to use to pass laws friendly to right wing interests.

That’s why, before there was a single right-to-try law passed at the state level
in 2014, there was a Goldwater Institute-written legislative template, a
pre-written bill that could be (and was) modified as needed by various states to
fit into their existing legal and regulatory framework. It’s why all
state-level right-to-try laws contain the elements listed above with minor
exceptions, including libertarian tropes like elimination of liability for
companies and doctors participating in right-to-try, and provisions that
basically leave terminally ill patients on their own if things go south. It’s
why the Koch brothers’ threw their weight behind right-to-try and started lying 
about it. Moreover, the for-profit hospital chain Cancer Treatment Centers of
America (CTCA) played an integral role in the genesis of right-to-try:

   In September 2012, a group of executives from the Cancer Treatment Centers of
   America reached out to the Goldwater Institute, a small, libertarian think
   tank named for the former senator and presidential candidate.

   Goldwater — which has in past years accepted support from major conservative 
   organizations like the Charles Koch Foundation and Donors Capital Fund — had 
   taken on a wide-ranging libertarian agenda that included activism on campus
   free speech and school choice. The for-profit hospital chain CTCA also has
   its own ties to the Koch family.

   CTCA and, ultimately, the Goldwater experts believed the FDA’s existing
   expanded access program — through which the agency approves some 99 percent
   of requests from dying patients who can’t get into clinical trials but want
   to try experimental treatments — was too cumbersome.

   It was time to do something about it, and a consultant with CTCA, Chuck
   Warren, coined the term “right to try,” recalled Starlee Coleman, a Goldwater
   senior adviser.

As the article explains, CTCA and the Goldwater Institute decided to start with 
the states. The rest is history. I also note that we’ve written about CTCA
before. It’s a chain of for-profit cancer hospitals that market “integrative
medicine” quackery along with conventional medicine. So, yes, right-to-try was
the product of a hospital chain that markets itself by selling quackery
alongside standard medical care, quackery like “naturopathic oncology“, doing
questionable genomic testing, and inflating its survival statistics through the 
cherry picking of patients. Demonstrating how shadowy the whole arrangement was,
few people knew CTCA was behind the Goldwater Institute’s push for
right-to-try. Hell, I didn’t know about it until a couple of years ago, even
though I’ve been writing about right-to-try since 2014.

Of course, even the Goldwater Institute flacks knew that state right-to-try laws
had no teeth. The power to approve drugs rests at the federal level, with the
Food and Drug Administration (FDA). States can proclaim in their laws that
terminally ill patients had a right-to-try experimental drugs, but the FDA still
oversees drug approval, and few drug companies with hundreds of millions of
dollars invested in an experimental drug would be likely to risk that by
providing the drug to patients outside of clinical trials needed to gain FDA
approval. Again, the people at the Goldwater Institute who thought of this
initiative are not stupid. They knew that state laws were not likely to have any
real effect on providing experimental drugs to terminally ill patients, and
indeed, as far as I’ve been able to tell, prior to the passage of the federal
right-to-try bill these state-level laws had not had any real effect, claims by 
the Goldwater Institute and Dr. Ebrahim Delpassand notwithstanding. Still, one
has to grudgingly admire the effort. Getting forty nearly identical laws passed 
in forty states in only a bit more than four years, with only one veto (in
California, where a second try got right-to-try passed) is an impressive
achievement.

Federal right-to-try

This brings us to the federal right-to-try law signed over a year ago,
officially known as the Trickett Wendler, Frank Mongiello, Jordan McLinn, and
Matthew Bellina Right to Try Act of 2017. The main provisions of this law are:

  1. Terminally ill patients (as defined by state law in right-to-try states) have 
    the right to bypass the FDA and obtain experimental drugs from the company
    making them. The FDA is not involved in this decision, nor is there
    institutional review board (IRB, ethics board) oversight. Basically,
    critical protections provided by the FDA to patients in clinical trials are 
    not in effect in right-to-try.

  2. Drugs eligible for right-to-try need only have passed phase I clinical trials,
    have an IND application with the FDA, and be in phase II clinical testing. 
    As I’ve discussed more times than I can remember, this provision is
    insanity. Right-to-try advocates (like the Goldwater Institute) have
    frequently claimed that this assures that the drug to be “tried” is safe,
    which is nonsense. Phase I trials usually only enroll less than 30 patients,
    and are designed primarily to screen out drugs with toxicities too severe
    to continue testing.

  3. Doctors prescribing right-to-try drug treatment, pharmacists dispensing the
    drugs, and companies providing right-to-try drugs are shielded from
    liability. While fear of liability is not an unreasonable concern regarding 
    experimental therapeutics, the blanket protection from liability goes rather
    too far in this law.

  4. The FDA Commissioner cannot use outcomes from right-to-try drug use in his
    consideration of whether to approve a new drug for market unless the sponsor
    (drug company) requests it or the Secretary of Health and Human Services
    determines that such outcomes are “critical to determining the safety of the
    eligible investigational drug.” In this case the HHS Secretary must justify
    this decision in writing. The HHS Secretary can also delegate this decision
    no lower than to the director of the relevant agency in the FDA in charge
    of approving the drug under consideration. Anyone want to guess how willing 
    the HHS Secretary will be to do this very often?

Worst of all, I’d like to emphasize again, right-to-try is entirely unnecessary,
given that expanded access programs in the FDA approve >99% of applications to 
use experimental drugs outside of clinical trials and do so without stripping
away scientific and ethical oversight the way that right-to-try does.

The track record of the federal right-to-try law

State-level right-to try laws were an utter failure, with basically not a single
patient. Sure, there was the case touted by the Goldwater Institute of Dr.
Ebrahim Delpassand, founder of Excel Diagnostics and Nuclear Oncology Center, in
which 80 patients supposedly gained access to an experimental agent called
Lutathera under the Texas right-to-try law. But, as an NYU working group on
compassionate access pointed out, Lutathera was already available on a
compassionate use basis, which makes it a stretch to claim that these patients
got this experimental drug because of right-to-try. Of course, this brings me to
another issue. Delpassand made quite the splash advertising his company as the 
only company at the time in Texas willing to use the state right-to-try law to
get drugs to patients, in essence using right-to-try as a sales pitch. As NYU
notes, people in states with right-to-try laws who received access to
investigational medical products have “done so under the FDA’s pre-approval
access provisions, which predate right-to-try laws. And the FDA has signed off
on these people getting these investigational medical products with minimal
delay.”

So what’s happened thus far since the passage of the federal law? Let’s go back 
to the STAT+ article, which quotes Art Caplan:

   “The right to try remains a bust,” said Arthur Caplan, who heads the division
   of medical ethics at the NYU School of Medicine and has tracked
   compassionate use programs.

   “Right to try continues to get a lot of attention, but hasn’t really changed 
   anything. It still remains up to a company to make drugs available, not a
   doctor’s request or patient lobbying or advocacy. And companies still want to
   work with the FDA. They think the FDA has perspective or inside information 
   about a dose or when to use a drug.”

   Indeed, despite momentum at the state level that resulted in a federal law,
   no requirements were put in place requiring a drug company to provide an
   experimental treatment upon request, he noted. For this reason, Caplan
   argued, the law has had appreciable no effect. As of June, only two people
   are reportedly known to have received an experimental medicine.

   “At the end of the day, [companies] control their products. It’s their
   property. You can pass a law saying people can try things, but unless you
   obligate companies to give something, there’s no right to gain access,” he
   added. “There are no teeth.”

And he’s right. Besides being completely redundant, the federal right-to-try law
has the added harmful effect of trying to cut the FDA out of decisions
regarding whether a company will grant access to its experimental drugs. Not
surprisingly, drug and biotech companies want the predictability and safety net 
of some sort of review by the FDA. True, it’s not a majority of the companies
surveyed, but it’s a significant minority.

About those two cases

Of course, the Goldwater Institute and libertarian supporters of right-to-try
such as Reason like to tout the two people who supposedly benefited from
right-to-try. If you look at the cases, they are less impressive than touted and
more evidence that right-to-try has been a massive failure.

The first, for instance, is a man with glioblastoma (who remains anonymous), who
was reported by Bloomberg in January to have received Gliovac, an experimental 
treatment for brain cancers, from Epitopoietic Research Corp., or ERC, a
closely-held Belgian company that is testing it in human trials. We have no idea
how he did or if he’s even still alive, and I’ve been unable to find more
information. However, bioethicist Art Caplan and colleagues analyzed the case in
The Health Care Blog and found some oddities:

   A close look at the details of this “first” right to try case shows both the 
   FDA and UC Irvine’s IRB were involved. So why did ERC-USA choose the right to
   try pathway over the expanded access program? UC Irvine’s IRB states that
   the institution follows the statutory requirements of California’s right to
   try law, which mandates more stringent reporting and informed consent
   requirements than the federal law.

   ERC-USA notified the FDA that it planned to treat a patient under the Right
   to Try Act. The company received an acknowledgement from the FDA in July
   2018—nearly six months before the patient started receiving treatment in late
   November. Right to try proponents have asserted that the FDA’s expanded
   access program contains unnecessary bureaucratic steps that discourage
   patients from seeking experimental therapies in the first place. But ERC-USA 
   likely chose to involve the FDA and UC Irvine its IRB to ensure that any
   provision of an experimental agent to a patient outside of a clinical trial
   wouldn’t interfere with the product’s clinical development and to confirm
   that the patient was aware of possible risks and benefits.

Of course, this is something that those of us critical of right-to-try have been
warning all along, that companies are risk-averse. After investing so much
money in developing a drug, they don’t want to take any chances so late in the
process that giving a drug to a patient outside of an FDA-sanctioned clinical
trial might endanger their chances of obtaining FDA approval. Caplan and the
Working Group on Compassionate Use and Preapproval Access (CUPA) at NYU also
note that the reports indicated that the company had gotten several requests for
access to its drug under right-to-try, asking: Why did this man get access and 
no others? What was the process to evaluate the requests and decide who would
get the drug? Was there any influence from an outside group? Be that as it may, 
though, the point is that this wasn’t a good example of a patient accessing a
drug through right-to-try. The FDA was involved, as was an IRB.

Then there’s Matthew Bellina, whose name was part of the right-to-try bill. He’s
a man with amyotrophic lateral sclerosis, a fatal degenerative neurological
disease. As I’ve said before, it’s one of the most horrible diseases out there, 
as it gradually robs you of your ability to move and to breathe. News reports
indicate that he was treated with an experimental drug called NurOwn® through
right-to-try (supposedly) by a company called Brainstorm. Brainstorm is an
interesting case. Back in June 2018, right after the federal right-to-try bill
became law, Brainstorm made the news for, in essence, turning right-to-try into 
its business model:

   A small biotechnology company may be the first to offer dying patients
   unproven drugs under a new U.S. law called Right to Try that deregulated
   access to such experimental treatments.

   But it won’t be for free: Brainstorm Cell Therapeutics Inc. would charge for 
   a therapy it is developing for the deadly condition known as Lou Gehrig’s
   disease. While details are still being worked out, the company’s chief
   executive officer pointed to the price of bespoke cell therapies used to
   treat cancer that cost more than $300,000.

   “Companies cannot be NGOs,” the nongovernmental organizations that help
   provide care to impoverished countries, Brainstorm CEO Chaim Lebovits said in
   a phone interview. “We have to have an incentive.”

   If it decides to proceed, Brainstorm — a company with no drug on the market
   yet and no revenue — would introduce a profit motive into an effort many
   expected to be altruistic, adding more controversy to an already contentious 
   debate. Small drugmakers where much of the innovation in medicine originates 
   can’t afford to provide their compounds for free, and terminally ill patients
   with no other options may be eager to pay for access. There would be little 
   protection for patients already grappling with a tumultuous time in their
   lives, adding financial risk to the known medical gamble.

NurOwn®, it turns out, is a stem cell-based therapy that reeks of dubious stem
cell treatments, quackery even. Check out the page on this treatment and see if 
you don’t share my concerns. Basically, BrainStorm uses mesenchymal stem cells
(MSCs). To be fair, just because quack stem cell clinics claim to be using MSCs 
to treat all manner of diseases doesn’t mean that BrainStorm isn’t on to
something, but I must admit that I find the scientific justification for its ALS
treatment to be rather spotty. For instance, there is a phase I trial that
shows a single dose of MSCs was safe. There’s also a phase 1/2a clinical trial
carried out at Hadassah Medical Center in Jerusalem that suggests an effect on
two measures of ALS progression at a marginally statistically significant level 
that are probably transient. Is there something there? Maybe. Even though the
scientific justification seems to be a bit of handwaving, with genetically
engineered MSCs basically making a bunch of growth factors for neurons seemingly
without a lot of careful targeting based on the pathophysiology of ALS, maybe
it’s worth doing phase III clinical trials on. However, one thing I will say for
sure is that it is not worth paying for before phase III trials show it to be
efficacious and safe, with a clinically meaningful effect in ALS patients.
Fierce Biotech notes that there is also a phase 2 trial that “found limited
evidence of efficacy, with placebo matching NurOwn on measures of lung function 
and ALS progression”. Basically, in the phase 2 trial NurOwn was unable to slow 
the progression of ALS compared to placebo, leading the company to start doing a
responder analysis to try to find a signal indicating efficacy. To me the
existing evidence of efficacy for NurOwn is barely enough to justify continuing 
with a phase III trial, but apparently BrainStorm disagrees.

Ultimately, Brainstorm abandoned its rather flagrant effort to profit from
right-to-try and is currently continuing its Phase III trial, and has said
publicly it will not give the treatment to patients other than Bellina under
right to try because of financial difficulties. It’s also stated that it “would 
provide Bellina access as a thank you for his advocacy around the law”. In other
words, by treating Bellina, Brainstorm was currying favor with President Trump 
and the powerful legislators who got the law passed.

Only two patients, one of which involved the FDA and the other obviously treated
to curry favor, are not an impressive record for right-to-try. As Art Caplan
has noted, the president promised that tens of thousands, hundreds of thousands 
of people would be getting access to unapproved drugs. So far, only one person
has. That’s leaving aside the exploitation of patients that appears to be
coming.

Beacon of Hope: Monetizing right-to-try?

Last Friday, my attention was drawn to this Twitter thread by Jeremy Snyder,
bioethics faculty at Simon Fraser University:

BoH head Richar Garr @irgarr will be at a Florida ALS Association event tomorrow
to launch BoH. It bills RTT as a "new legal channel to access treatments that
are in clinical development" https://t.co/Qac0tiqz0U

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

As that didn't happen, BoH is marketing itself as providing developers with a
pool of test subjects that will allow for faster clinical trials outside of FDA 
oversight. pic.twitter.com/h0ZWo0Lohq

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

Where it gets really weird is where @DonnaYoungDC noticed that there is another 
BoH CRO. This one is an affiliate of Beacon Pharmaceutical, both of which are
also interested in using RTT to make clinical research faster and cheaper
https://t.co/t9Eu6WIGLD

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

In fact, Beacon pharma seemed to be largely focused on an initial coin offering 
– BeaCoin – before getting into the RTT racket. pic.twitter.com/nd6RFgrG3w

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

Blockchain and Bitcoin? Those are enormous red flags to me!

More recently, Beacon Pharma has entered into an agreement with Jupiter, Florida
to create a pharmaceutical startup accelerator that seems consistent with the
above model minus the discussion of BeaCoin https://t.co/VIeEtNxddJ

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

See also, Beacon Pharma's presentation to the Jupiter City Council if you really
want to get into the weeds (Item 13, about 12' in) https://t.co/VaZI40LSsR

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

But @DonnaYoungDC says that Garr and Beacon CEO Nancy Torres Kaufman
@Ihaveadream24 say they aren't connected. To be true, we need to accept that
there are or were two CROs named Beacon of Hope, located less than 50 miles
apart in South Florida, with very similar business plans

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

I'm not sure there is anything nefarious about all of this. It is just strange
and opaque. When we're dealing with clinical trials, expanded access, and real
people with real illnesses who are desperately hoping for better health,
however, transparency is needed.

— Jeremy Snyder (@jeremycsnyder) September 13, 2019

Basically, as described by Paul Knoepfler at The Niche, Beacon of Hope is going 
to be all about facilitating right-to-try at scale for industry, as shown in
this interview with Richard Garr, the founder of the company, who was—big red
flag!—formerly CEO for a stem cell company:

   What exactly is Beacon of Hope CRO? Is it a for-profit company?

   RG: Bohcro is the first CRO dedicated exclusively to facilitating Right to
   Try programs, at scale, for the industry. Yes, while we provide access for
   patients to RTT treatment programs, we work for the drug developers like any 
   CRO, and we are paid by them, and only by them, and yes we are a for profit
   company. We are also focused on fusing the Right to Try treatment programs
   with the collection of RWD through a proprietary system to accelerate
   development timelines and significantly reduce development costs.

Reading the interview, I can’t help but think that Beacon of Hope is the first
of an industry that will use right-to-try to exploit patients. Basically, I
suspect that decreasing costs and accelerating timelines will take precedence
over anything resembling rigorous science. For example, when Knoepfler notes
that there’ll be few subjects, no controls, and no blinding and asked how the
firm could generate strong data, Garr responds with, in essence, word salad and 
handwaving. Nothing he says convinces me that right-to-try will produce any
useful data or that his company will facilitate patients receiving experimental 
therapies.

The whole concept makes me very uneasy. Beacon of Hope CRO is specifically
marketing services for right-to-try sponsors. These sponsors really shouldn’t be
profiting off of right-to-try. Worse, a for-profit CRO seeking to match
sponsors with right-to-try patients is incentivized to match as many patients as
possible with sponsors using the right-to-try mechanism. It’s soliciting
business from sponsors, and doing so by convincing them to bypass the FDA with
the argument that right-to-try would be cheaper and get them data faster. Will
Beacon of Hope CRO be the first of a whole industry of companies seeking to
profit off of right-to-try? I fear that it will be.

That’s because right-to-try was never about helping terminally ill patients, not
really. It was always about ideology more than anything else. It was always
about weakening the FDA’s ability to regulate drug approval, to cut it out of
the process whenever possible, and letting companies profit. Terminally ill
patients were always an afterthought. It should be no surprise that right-to-try
has been a spectacular failure thus far at getting terminally ill patients
access to experimental drugs. Unfortunately, it shows signs that it could be a
success at producing a whole new cottage industry taking advantage of those
terminally ill patients.

Donald Trump bragged that “right-to-try” has saved thousands of lives. It
hasn’t.

Former President Donald Trump bragged in his acceptance speech at the Republican
National Convention that “right-to-try” had saved “thousands of lives”? What’s 
the real story? (Hint: Nowhere near that.)

David Gorski on July 22, 2024

Link



Back in the beforetime (i.e., before 2020, when COVID-19 changed everything), a 
frequent topic for me (and Jann Bellamy) dating back a decade was the push for
“right-to-try” laws. The very first time that I wrote about “right-to-try,” I
compared the idea to the movie Dallas Buyers’ Club, noting that it might make
material for a great movie but that it was terrible for patients and terrible
policy. (More detail on why a little later.) I also noted how, with the support 
of the “free market” Goldwater Institute, right-to-try laws started
metastasizing to various states, including my own. Ultimately, these laws passed
in state after state after state. As long as they stayed at the state level,
however, right-to-try laws were largely performative and ceremonial, given that 
the federal government, through the Food & Drug Administration (FDA), regulates 
drug approval, not the states. Basically, these state laws gave the illusion
that something was being done, when, in fact, at the federal level nothing
changed.

The endgame of the Goldwater Institute, which provided the template legislation 
to be customized to work for each individual state, was never the passing dozens
of state right-to-try laws, of course. Those laws were merely the first step.
They were designed to pressure Congress to pass a federal right-to-try law by
amassing political support and then allowing advocates to use the argument that 
state laws weren’t enough because the FDA was in charge of drug approval and
regulation. Various pushes to pass a federal right-to-try law were made in 2014 
and in 2016. None of these efforts went anywhere until after Donald Trump became
President in 2017. Even after Trump became President, it took nearly a year and
a half for the Goldwater Institute and other right-wing “free market” think
tanks to finally push a federal right-to-try bill over the finish line,
spearheaded by Senator Ron Johnson (R-Wisconsin), who has been a not-infrequent 
topic of this blog going back years due to his desire to “deregulate” medicine
and, more recently during the pandemic, his having become a raging antivax and
anti-public health loon who likes to host “roundtables” featuring the worst
COVID-19 cranks and antivaxxers. Ultimately, Congress passed a federal
“right-to-try” bill, President Donald Trump signed the bill into law in 2018.

Given that it’s been five years since I last wrote about right-to-try. So why am
I writing about it now? Simple. In his acceptance speech to the Republican
National Convention last Thursday, former President Donald Trump bragged about
right-to-try, as though it were one of his signature accomplishments while in
office. Let’s take a look at what he said in his 92-minute speech:

Right to Try, Right to Try is a big deal. We’ve got Right to Try. They were
trying to get that for 52 years. Somebody’s terminally ill. And hopefully
there’s nobody in this audience, but it does happen, a lot. They’re terminally
ill and they can’t use our new space-age drugs and other things that we are way 
ahead with. We have the greatest doctors in the world. The greatest laboratories
in the world, and you can’t do it. They’ve been trying to get that approved for
52 years, wasn’t that easy. The insurance companies didn’t want to do it. They 
didn’t want the risk. The labs didn’t want to do it because if it didn’t work,
people are pretty far down the line toward death. They didn’t want to do it. The
doctors didn’t want to have it on their record.

So I got everybody into an office — 52 years, they tried. Sounds simple, but
it’s not. And I got them to agree that somebody that needs it will, instead of
going to Asia or Europe or some place, or if you have no money, going home and
dying — just die — we got them to sign an agreement. They agreed to it, where
they’re not going to sue anybody. They can get all of this stuff. They’re going 
to get it really fast, and what’s happened is we’re saving thousands and
thousands of lives. It’s incredible. Right to Try. It’s … great feeling.

This moment led me to wonder what the actual results of “right-to-try” have
been; that is, after I got done facepalming at the rest of the nonsense
surrounding Trump’s claim that right-to-try was “saving thousands of lives.” One
bit of nonsense is that “we’ve” been fighting for right-to-try for 52 years. I 
have no idea where Trump got that figure from, because in reality right-to-try
emerged around 2013-2014, which is when I first took notice and started writing 
about it. I suppose that he might have been referring to various programs to
make access to experimental therapeutics easier that do date back to the late
1970s, although even current expanded access programs that exist in the US were 
largely a product of activism on behalf of AIDS patients during the AIDS
epidemic in the 1980s. Ironically, one of the earliest examples of expanded
access was for medical cannabis for glaucoma in 1976, which spawned a lawsuit
(Randall v. U.S.), the ruling in which provided the legal basis for 1978
expanded access program for medical cannabis for glaucoma and then later in the 
1980s for experimental AIDS therapeutics.

Regardless of all of Trump’s usual obfuscation and wholesale making stuff up, I 
thought it worthwhile to revisit right-to-try, given how long it’s been since
I’ve written about it. Is it really “saving thousands of lives”? (Spoiler alert:
The answer is no.) This should not be surprising given how poor the results
were in 2019, a year after the law passed and just before the COVID-19 pandemic 
changed everything. First of all, what is “right-to-try”? I’ve called it a cruel
sham, and Jann Bellamy has called it an illusion, but why do we characterize
the law this way?

Right to try

Ostensibly, “right-to-try” laws were named because they supposedly grant
terminally ill patients the “right to try”; i.e., access to experimental
therapeutics. On the surface, this idea sounds benign enough. After all, what
kind of heartless bastard could possibly oppose granting desperate, dying people
a “chance,” a “right to try” anything that might save them. However, those of
us who know drug development immediately saw the problem with the concept, and, 
as always, the devil is in the details. In this case, as I will explain, the
details involved not only regulatory misconceptions, a deceptive view of what
phase 1 clinical trials test for, and an excessively optimistic idea of the
likelihood that an individual patient might benefit from gaining access to an
experimental therapeutic, but various practical issues, such as who pays for the
medication. (Hint: Given that “right-to-try” is a highly “free market” and
libertarian concept, it isn’t the government or the pharmaceutical companies.)
That doesn’t even consider that these laws, including the federal law, were the 
end result of a quack-friendly chain of cancer centers, Cancer Treatment Centers
of America (CTCA), and the rabidly anti-regulation Goldwater Institute, to
which CTCA had reached out to propose the idea. (As an aside, CTCA was acquired 
by the City of Hope Cancer Center in 2022 and CTCA facilities have since been
rebranded under the parent name. That might be a topic for a future post.)

The biggest problem from a scientific and patient safety standpoint with
“right-to-try” was (and is) that, according to these laws, drugs to be “tried”
need only have passed phase 1 trials for them to be made available to patients. 
Let me just emphasize now, as I’ve emphasized in every post I’ve ever written
about right-to-try, phase 1 trials do not demonstrate efficacy. They are only
designed to test for safety and toxicity, determine the maximum tolerated dose, 
and provide an estimate for the dose to use in the actual randomized clinical
trials designed to determine if the drug works for the intended indication.
Think of phase 1 trials as a screening test looking for the most obvious
toxicities, with phase II and III studies confirming them. Indeed, even phase 3 
trials can’t always adequately demonstrate that a drug is safe; it’s not
uncommon for less common adverse effects not to show up until post-marketing
surveillance, when much larger numbers of patients receive the drug. Moreover,
only 5% of all cancer drugs that enter clinical testing are ultimately approved 
for patient use. Among drugs tested in phase 2 trials, only 30% go on to phase
3.

The concept of “right to try” bills was immediately highly popular, because if
you don’t know a lot about medicine and how clinical trials work it sounds like 
a good idea. What could be the possible harm, after all? Indeed, it’s not for
nothing that nearly every time I write about right-to-try, I remark sardonically
that opposing right-to-try is perceived by most people the same way as opposing
mom, apple pie, and the American flag—or worse, the same way as wanting to kill
mom, actually defile apple pie à la American Pie, and shred the American flag. 
I exaggerate, but not by much.

The federal “right-to-try law” is officially known as the Trickett Wendler,
Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017.
Its main provisions include:

  1. Terminally ill patients (as defined by state law in right-to-try states) have 
    the right to bypass the FDA and obtain experimental drugs from the company
    making them. The FDA is not involved in this decision, nor is there
    institutional review board (IRB, ethics board) oversight. Basically,
    critical protections provided by the FDA to patients in clinical trials are 
    not in effect in right-to-try.

  2. Drugs eligible for right-to-try need only have passed phase 1 clinical trials,
    have an IND application with the FDA, and be in phase 2 clinical testing.
    As I’ve discussed more times than I can remember, this provision is
    insanity. Right-to-try advocates (like the Goldwater Institute) have
    frequently claimed that this assures that the drug to be “tried” is safe,
    which is nonsense. Phase 1 trials usually only enroll less than 30 patients,
    and are designed primarily to screen out drugs with toxicities too severe
    to justify continued testing in phase 2 trials.

  3. Doctors prescribing right-to-try drug treatment, pharmacists dispensing the
    drugs, and companies providing right-to-try drugs are shielded from
    liability. While fear of liability is not an unreasonable concern regarding 
    experimental therapeutics, in my not-so-humble opinion, the blanket
    protection from liability goes too far in this law, seemingly shielding
    doctors from all liability, not just liability related to adverse events and
    outcomes from the experimental therapeutic.

  4. The FDA Commissioner cannot use outcomes from right-to-try drug use in his
    consideration of whether to approve a new drug for market unless the sponsor
    (drug company) requests it or the Secretary of Health and Human Services
    determines that such outcomes are “critical to determining the safety of the
    eligible investigational drug.” In this case the HHS Secretary must justify
    this decision in writing. The HHS Secretary can also delegate this decision
    no lower than to the director of the relevant agency in the FDA in charge
    of approving the drug under consideration. Anyone want to guess how willing 
    the HHS Secretary will be to do this very often?

Worst of all, I’d like to emphasize again, right-to-try is entirely unnecessary,
given that expanded access programs in the FDA approve >99% of applications to 
use experimental drugs outside of clinical trials and do so without stripping
away scientific and ethical oversight the way that right-to-try does.

Now let’s compare the above to the requirements of the FDA’s Expanded Access
Program as of 2018, right before right-to-try was signed into law:

   Sometimes called “compassionate use”, expanded access is a potential pathway 
   for a patient with a serious or immediately life-threatening disease or
   condition to gain access to an investigational medical product (drug,
   biologic, or medical device) for treatment outside of clinical trials when no
   comparable or satisfactory alternative therapy options are available.

   Expanded access may be appropriate when all the following apply:

  1. Patient has a serious or immediately life-threatening disease or condition.

  2. There is no comparable or satisfactory alternative therapy to diagnose,
    monitor, or treat the disease or condition.

  3. Patient enrollment in a clinical trial is not possible.

  4. Potential patient benefit justifies the potential risks of treatment.

  5. Providing the investigational medical product will not interfere with
    investigational trials that could support a medical product’s development or
    marketing approval for the treatment indication.

   Investigational drugs, biologics or medical devices have not yet been
   approved or cleared by FDA and FDA has not found these products to be safe
   and effective for their specific use. Furthermore, the investigational
   medical product may, or may not, be effective in the treatment of the
   condition, and use of the product may cause unexpected serious side effects.

Basically, right-to-try is expanded access without FDA or IRB oversight. It
allows any doctor, quack or not, to determine whether the potential benefits of 
an experimental therapeutic (be it drug or device) justifies the risk of
treatment, based on just phase 1 clinical testing, which does not establish
safety or efficacy. (Indeed, there is a reason why cancer quack Stanislaw
Burzynski tried to use right-to-try to sell his quackery and that COVID-19
quacks did the same.) Again, remember. Phase 1 testing generally enrolls at most
a few dozen patients, often fewer, to test for the most obvious toxicities and 
to find a dose to use for phase 2 clinical trials. You cannot say that potential
patient benefits outweigh the risks based solely on phase 1 clinical trial
results. At best, you can say that the drug is not dangerously toxic. Again, the
very purpose of right-to-try was to eliminate FDA oversight over an expanded
access-like program that lacks even rudimentary patient protections. That is a
feature, not a bug, of the law, as right-to-try was always intended as a major
step in neutering the FDA’s regulatory authority. Another feature of the law is 
that it has no mechanism to pay for “right-to-try” experimental therapeutics,
which means that the patient and patient’s family are on the hook for the often 
massive expense of “trying” experimental therapeutics, consistent with the
libertarian, “free market,” antiregulatory origin of the law.

But has right-to-try done what Donald Trump claimed in his acceptance speech? I 
think you know the answer to that.

Right-to-try in practice

The last time I wrote about right-to-try in 2019, I tried to evaluate how it had
actually functioned, basing my post on a STAT+ News article by Ed Silverman
critically examining the effect of the law during its first year, from which
I’ll briefly quote:

Despite the hubbub over the “right-to-try” law, a recent survey found that
nearly half of drug makers indicated they would require regulators to review a
decision to provide an experimental treatment to a person with a
life-threatening disease.

Specifically, 13 of 29 drug companies indicated they want a relevant regulatory 
authority to review requests that are granted to such people. Of these, six
specified they would ask the Food and Drug Administration to conduct a review
and five stated they require a research ethics committee or institutional review
board, according to a report from the Government Accountability Office.

The results show many drug makers still prefer to follow the mandate in the FDA 
expanded access program, which was created to provide a route for people with
serious or life-threatening illnesses to request experimental treatments from
the pharmaceutical industry. The program requires a physician to submit a
request to a drug company, and for the FDA to sign off on providing a medicine.

Silverman noted that this is in contrast to right-to-try, which does not require
a drugmaker to receive endorsement from the FDA before making an experimental
drug available to a patient, also noting another key part of the propaganda that
had gotten right-to-try passed, namely that the FDA is too slow to approve new 
drugs and that its expanded access program is too cumbersome. Of course, as I
had discussed multiple times before (and continue to do now), it might have been
true at one time that the expanded access program was too cumbersome for the
average patient, but in recent years the FDA had made great strides in
streamlining the program. I had also noted that the FDA approval process is not 
slow, given what needs to be done. Indeed, at the time right-to-try was made
law, as fast or faster than the systems in most industrialized countries,
including the EU. In any case, in 2019 STAT News noted that during the first
year of right-to-try only two patients had gained access to experimental
therapeutics using the law.

The first patient was a man with glioblastoma, and it was noted that, even
though he had invoked right-to-try, the company still involved the FDA and an
IRB:

A close look at the details of this “first” right to try case shows both the FDA
and UC Irvine’s IRB were involved. So why did ERC-USA choose the right to try
pathway over the expanded access program? UC Irvine’s IRB states that the
institution follows the statutory requirements of California’s right to try law,
which mandates more stringent reporting and informed consent requirements than 
the federal law.

ERC-USA notified the FDA that it planned to treat a patient under the Right to
Try Act. The company received an acknowledgement from the FDA in July
2018—nearly six months before the patient started receiving treatment in late
November. Right to try proponents have asserted that the FDA’s expanded access
program contains unnecessary bureaucratic steps that discourage patients from
seeking experimental therapies in the first place. But ERC-USA likely chose to
involve the FDA and UC Irvine its IRB to ensure that any provision of an
experimental agent to a patient outside of a clinical trial wouldn’t interfere
with the product’s clinical development and to confirm that the patient was
aware of possible risks and benefits.

The second case involved a patient with amyotrophic lateral sclerosis (a.k.a.
Lou Gehrig’s disease), a fatal progressive degenerative disease of the nervous
system, and the company offering right-to-try, Brainstorm, sounded very much
like a quack stem cell company that had, in essence, turned right-to-try into
its business model, as I discussed when I characterized right-to-try being all
about the Benjamins and neutering the FDA.

So what’s happened since 2019? Suffice to say that Donald Trump’s claim that
right-to-try is saving the lives of “thousands” of patients is utterly divorced 
from reality. As a number of news sources have pointed out, for instance,
Politico:

However, the Right to Try pathway was only used for four drugs last year. In
fiscal 2023, the FDA received nearly 2,300 compassionate use requests and
allowed most to proceed.

In actuality, 99% of expanded access requests had been granted by the FDA in the
year prior to the passage of “right-to-try.” Politico also reported that only
four applications were received in 2023, but the article is behind one of the
more persistent paywalls that I’ve ever seen; so I couldn’t get into the full
details. The most recent FDA report on right-to-try reveals, however, that
between 2018 and 2022, there were only 12 drugs for which right-to-try was
invoked, and, yes, in 2023 only four. In other words, only roughly three orders 
of magnitude less than what Trump claimed, and it is very likely that most uses 
did not save the life of the patients involved.

In other words, five years after its passage, right-to-try has been a
spectacular failure. It does not do what its proponents claimed that it would
do. It provides no advantage or benefit above and beyond what the FDA expanded
access program provides in terms of letting seriously or terminally ill patients
access promising investigational drugs not yet approved by the FDA. It is a
sham, and a cruel one, as I’ve argued all along. The only “good” it might do is 
for unscrupulous companies that want to use it as a profit center or facilitate 
its use as a profit center. It is thus indeed fortunate that right-to-try has
been such an abject failure thus far, as it could have been harming thousands of
patients but thus far has not.

Unfortunately, should Trump be elected President again, the same forces that
pushed for right-to-try want to “improve” it:

The slow uptake has led some of the law’s biggest proponents to call on Trump to
expand upon the program in his first 100 days if he’s elected in November,
likely reopening the debate into the FDA’s role in the oversight of access to
experimental treatments. Right to Try supporters want Trump to encourage drug
manufacturers to participate through incentives and benefits, and Trump’s
campaign said he is open to changes to the law.

And Representative Andy Biggs (R-Arizona):

The lawmaker wants Trump to expand the law in his first 100 days if he wins
reelection — an idea the Trump campaign said the former president is open to.

“We protect and give some immunities and benefits to pharmaceutical companies,” 
Biggs said. “We could have provided more of an incentive to pharmaceutical
companies to provide these drugs and biologics to people who need them.”

This sounds like a recipe for the federal government to pay or otherwise
incentivize pharmaceutical and device manufacturers to bypass the FDA and sell
their wares directly to patients, as long as the patient is ill enough.

If Trump is elected again, you can bet that right-to-try will be expanded,
patient protections further eroded, and pharmaceutical companies incentivized to
use it to bypass the clinical trial process used by the FDA to approve drugs,
all as just part of a much broader agenda to destroy the “administrative state.”
That’s because right-to-try was never about helping desperate terminally ill
patients. Rather, it’s always been a wedge whose tip is those very patients
being jammed into the FDA regulatory apparatus in order to open it up to the
radical “free market” and all its attendant quackery.

The 21st Century Cures Act: The (Somewhat) Good, The (Mostly) Bad, and The
(Very) Ugly

David Gorski on August 10, 2015

Link



The 21st Century Cures Act: Unnecessary and misguided.

The approval of new drugs and medical devices is a process fraught with
scientific, political, and ethical landmines. Inherent in any such process is an
unavoidable conflict between rigorous science and safety on the one side, which
tend to slow the process down by requiring large randomized clinical trials
that can take years, versus forces that demand faster approval. For example,
patients suffering from deadly diseases demand faster approval of drugs that
might give them the hope of surviving their disease, or at least of surviving
considerably longer. This is a powerful force for reform, as evidenced by
HIV/AIDS activism in the 1980s and 1990s that led to the development of
fast-track approval mechanisms for drugs for life-threatening conditions, a
change whose effects have been mixed. It’s also a powerful force potentially for
ill, as I’ve documented in my posts about the understandable but misguided
“right-to-try” movement. After all, what politician can say no to a constituency
representing desperately ill people who only want a shot at survival? It’s not 
all desperate patients, however. Also wanting more rapid drug approval are
powerful business interests in the form of the pharmaceutical and medical device
industries, for whom the time and expense of prolonged clinical trials eat into
profits and make some drugs not worth developing from a business standpoint.

In 1962, after Frances O. Kelsey, MD, PhD (who died on Friday at the age of 101)
successfully prevented the approval of the drug thalidomide in the US, a drug
found to cause serious birth defects, Congress passed the Kefauver-Harris Drug
Amendments to the Federal Food, Drug, and Cosmetic Act. These amendments
required that drug companies not just show safety before their drugs could be
FDA-approved, as had been the case prior to the amendments, but also to provide 
substantial evidence of effectiveness for the product’s intended use. That
evidence had to be in the form of adequate and well-controlled clinical trials, 
which at the time was considered a revolutionary requirement. (Believe it or
not, no requirement for high quality clinical trials existed before 1962.) This 
led to the current system of phase I, II, III, and IV clinical trials in force
in the United States today. The amendments also included a requirement for
informed consent of study subjects and codified good manufacturing processes, as
well as the requirement that adverse events be reported. This has been, with
some tweaking over the years, the law of the land regarding how the FDA approves
drugs for specific indications

Medicine is a lot more complex now than it was in the 1960s however, and there
has been a growing sentiment that the system is, if not broken, at least
functioning in a way that is behind the times, a manner that was acceptable and 
appropriate 40 years ago but is no longer so in this era of genomics, precision 
medicine (formerly known as “personalized medicine”), and targeted therapies.
The new drug approval process, which can take up to a decade and cost a billion 
dollars, it is argued, is too rigid, cumbersome, and slow for the 21st century. 
(Why it wasn’t too rigid, cumbersome, and slow in the 20th century, no one seems
to say. I guess that “21st century” sounds way cooler.)

Into this ongoing controversy have marched Rep. Fred Upton (R-Mich.) and Rep.
Diana DeGette (D-Colo.), who have sponsored a bill passed by the House of
Representatives in a rare display of bipartisanship in July. The bill, H.R.6, is
entitled the “21st Century Cures Act“. Given how it passed the House by a vote 
of 344-77, one would think that it should glide through the Senate easily.
Certainly, its sponsors and supporters have mounted a mighty PR effort. That
might not be the case, given that in the Senate a single senator can hold up or 
even kill a bill through a filibuster, and to shut down a filibuster or prevent 
a threatened filibuster requires 60 votes. Be that as it may, I’m not so much
interested in the politics of this bill, which, if it survives the Senate, will 
almost certainly be significantly amended, but rather what the bill does.

I’ve been meaning to write about the 21st Century Cures Act since I first read
about it in a news report a few months ago. As with most bills, there’s some
good, there’s some bad, and there’s some ugly. Do the bad and the ugly outweigh 
the good? Sadly, they do. Let’s take a look.

21st century cures: The (somewhat) good

Perhaps the best thing about this bill is that it increases the budget of the
National Institutes of Health (NIH). Achieving agreement on this was not easy,
as many Republicans oppose any sort of “expansion” of government, and the
overall zeitgeist in Congress is to slash, not increase funding (except, of
course, for the military). First, the bill mandates a 3% real increase in the
NIH budget per year for the next three years. Second, it provides an additional 
$1.86 billion a year in the form of an “innovation” fund that would primarily
support young scientists and precision medicine. Those of us who run
laboratories competing for NIH research funding know that the NIH budget has
been, in essence, frozen for nearly a decade now. The tiny increases that have
been approved have not been enough to keep up with inflation, leading to a 20%
decline in the NIH budget in inflation-adjusted dollars since 2003 with a
concomitant decline in the number of the R01-equivalent grants (the R01 is the
gold standard, multi-year grant that every NIH-funded researcher strives for) of
30%. In 2013, the sequestration added insult to injury with a disastrous
additional effect on the NIH budget.

This decline in funding and opportunity for R01 grants, which give labs
stability, has led to great concern that the leadership of the US in biomedical 
sciences will be eroded irreparably. In the “trenches” (where I am), the mood is
very, very gloomy, with scientists expressing increasing degrees of despair and
pessimism and NIH director Francis Collins warning that budget cuts put US
science at risk and that China and other countries will soon surpass us. In
particular, it is definitely not a good time to be a researcher in medical
academia, particularly if you are a young investigator whose application for
tenure depends upon being awarded NIH or NIH-equivalent funding. The addition of
more money to the NIH budget and a fund, part of which will be targeted to
young investigators, can only help that.

As for the fund for precision medicine research, I’m of a mixed mind about this.
There is no doubt that this is arguably the most exciting time in history to be
in biomedical research, which is why the dearth of NIH funding makes it
simultaneously the most frustrating time in history to be in biomedical
research. We finally have the tools to delve the depths of the mysteries of the 
genome and use the information to design better treatments for cancer and a wide
variety of other diseases, but we lack the resources to use them. It’s like
owning a brand new Maserati but there’s no gasoline to be found to drive it, or 
maybe having the biggest, baddest car of all in the world of Mad Max but having 
to fight for precious gasoline to run it.

That being said, I also think that precision medicine has been hyped far beyond 
what it could ever possibly deliver. Definitely, with President Obama’s new
precision medicine initiative, precision medicine is the buzzword everyone likes
to use. It’s often sold in near-miraculous terms about what it will do, in much
the same way the human genome project was sold in similar terms in the 1990s,
just as the “war on cancer” was sold in the early 1970s. Results didn’t match
the hype, which is why on the tenth anniversary of the publication of the human 
genome and the 40th anniversary of the “war on cancer,” we saw articles
declaring both “failures”. I’m guessing that every five or ten year anniversary 
after this, we’ll see similar articles. I can’t wait to see the disappointed and
pessimistic articles about the “war on cancer” in 2021, its 50th anniversary.
I’m being facetious, but for a serious purpose: Precision medicine can’t
possibly live up to the hype. That doesn’t mean I don’t consider it a promising 
avenue, but I have no reason to expect that progress in precision medicine will 
be anything other than incremental. Maybe it will be faster than in
pre-precision medicine days, but it will be incremental nonetheless. Besides,
all the real hype has moved on to immunologic therapies of cancer, which, if you
believe Fred Hutchinson Cancer Research Center president Dr. Gary Gilliland,
who declared that cancer is “running scared” and that, thanks to new immunologic
therapies, “it is actually plausible that in 10 years we will have cures and
therapies for most, if not all, human cancers.”

Yes, I’m being a bit sarcastic, but if you want to see skeptical takes on
precision medicine, I recommend a recent op-eds by Michael Joyner in the New
York Times about “moonshot medicine,” Rita Rubin in JAMA declaring precision
medicine to be more about politics, Cynthia Graber in The New Yorker, and Ronald
Bayer and Sandro Galea in the most recent New England Journal of Medicine.
Basically, the number of conditions whose outcome can be greatly affected by
targeting specific mutations is relatively small, far smaller than the impact
likely would be from duller, less “sexy” interventions, such as figuring out how
to get people to lose weight, exercise more, and drink and smoke less. I
remember how in the 1990s Judah Folkman’s work targeting tumor angiogenesis was 
touted as a “silver bullet” to treat cancer in just the way cardiologist Eric
Topol is quoted by Rita Rubin in JAMA as saying about precision medicine:

   The science is catapulting forward. You can now come up with so much big data
   on each individual, and it is changing medicine.

And:

   “However, it’s not just about the sequence,” Topol added. “That’s just one
   layer of the information. If you really want to change medicine, youhave to
   have all the information on the individual.” That includes their environment,
   the bacteria in their gut, and other distinguishing characteristics, he
   said.

The problem is whether focusing in the genetic underpinnings of disease will
provide the “most bang for the buck,” given how difficult and expensive targeted
drugs are to develop. However, if getting some money for precision medicine is 
the price for an increase in the overall budget of the NIH and funneling more
funding to young researchers, I’m willing to pay it. My preceding passages
aside, I’m actually optimistic about the potential of precision medicine; I just
don’t think that it will result in Star Trek-like treatments any time soon. (I 
remember several other “cures for cancer” touted during my professional lifetime
that weren’t.) I’m just more cautious in my optimism, as I pointed out when I
answered the question, “Why haven’t we cured cancer yet?”

There are other bits of “good” in the bill, such as a provision making
deidentified data from NIH-funded clinical trials more easily available to
researchers and facilitating collaborative research, speeding up the review of
new vaccines by the Advisory Committee on Immunization Practices, requiring a
strategic plan every five years to identify research opportunities and strategic
focus areas, reducing administrative burdens on researchers, and limiting the
term of office of directors of centers and institutes to five years (with
reappointment by the NIH director possible). The act also requires the directors
of each institute to “establish programs to conduct or support research
projects that pursue innovative approaches to major contemporary challenges in
biomedical research that involve inherent high risk, but have the potential to
lead to breakthroughs” and “set aside a specific percentage of funding, to be
determined by the Director of NIH for each national research institute, for such
projects.” I’ve been a bit skeptical of such initiatives in the past, and such 
orders have gone forth before, usually to be lost in the NIH bureaucracy, but I 
have no objection to their being in this law. Another potentially useful part of
the bill is a “sense of Congress” that the “National Institute on Minority
Health and Health Disparities (NIMHD) should include within its strategic plan
ways to increase representation of underrepresented communities in clinical
trials.”

The (mostly) bad and the (very) ugly

The central question regarding my supporting the 21st Century Cures Act is
whether the decent—but not spectacularly so—provisions in the bill outweigh the 
bad and the ugly. To answer this question, let’s take a closer look. In
examining this bill, it is important to note the central assumptions behind the 
bill. The first, as mentioned in the previous section, is that “precision
medicine” will save us all. The second is that we have to get “creative” in
loosening regulatory requirements. In reality, there are several provisions in
this that bill would markedly undermine the scientific basis of drug approval in
this country in the name of “flexibility” and speed. Indeed, the scariest part 
of the grant is the section entitled “Subtitle D—Modern Trial Design And
Evidence Development“, which requires the FDA, in essence, to water down its
standards for approving drugs.

Some of this is not inherently bad. For instance, the act would require the FDA 
to incorporate “the use of adaptive trial designs and Bayesian methods in
clinical trials, including clinical trials proposed or submitted to help to
satisfy the substantial evidence standard under section 505(d) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 355(d)).” We are, of course, fans of
Bayesian methods, and I’ve discussed adaptive clinical trials before, such as
the I-SPY 2 trial. Basically, an adaptive clinical trial uses patient outcomes
to immediately inform further treatment decisions. They often involve:

  1. Interim analyses to stop or to adjust patient accrual

  2. Interim analyses to assess stopping the trial early either for success,
    futility or harm

  3. Reversing the hypothesis of non-inferiority to superiority or vice versa

  4. Dropping arms or doses or adjusting doses based on outcomes

  5. Modification of the randomization rate to increase the probability that a
    patient is allocated to the most appropriate arm

Another hot area in adaptive design is the use of biomarkers as the basis for
adapting the trial. In fact, the FDA is already moving to allow for this sort of
trial design in its regulations and has issued draft guidelines for such
designs for clinical trials of drugs and biologics as well as medical devices.
Also, as a 2008 review of adaptive trial designs notes:

   It is a concern whether the application of adaptive design methods may have
   introduced some unexpected operational bias, which may have an impact on
   accuracy and reliability of the obtained statistical inference. It is also a 
   concern whether the application of adaptive design methods is able to control
   the overall type I error rate at the prespecified level of significance. As 
   a result, regulatory agencies such as the US FDA request strategies or plans 
   for preventing possible operation biases and for controlling the overall type
   I error rate be developed. In addition, the sponsors are encourage to begin 
   a dialogue about adaptive designs with medical reviewers and/or statistical
   reviewers from the regulatory agencies as early as possible (preferably at
   least a year) before the planning of a trial.

A type I error is defined as the rejection of a null hypothesis that is actually
true. In other words, it’s a false positive that finds that the intervention
tested “works” when in fact the results in the experimental group are
indistinguishable from the control. Obviously, adaptive designs are no panacea. 
They’re designed to get faster results, but they do so at the price of
increasing the risk of false positive conclusions and positive study results
that are difficult to interpret. However, it might not be an unreasonable
trade-off to accept methods that have a higher risk of false positives for the
payoff of faster approval or needing fewer clinical trial subjects. That is more
a value judgment than anything else and depends on how much the false positive 
rate is elevated.

Here’s where things get “badder” and even ugly, in Section 505F, entitled,
worryingly enough, “Utilizing evidence from clinical experience“:

   (a) In General.—The Secretary shall establish a program to evaluate the
   potential use of evidence from clinical experience—

   “(1) to help to support the approval of a new indication for a drug approved 
   under section 505(b); and

   “(2) to help to support or satisfy postapproval study requirements.

   “(b) Evidence From Clinical Experience Defined.—In this section, the term
   ‘evidence from clinical experience’ means data regarding the usage, or the
   potential benefits or risks, of a drug derived from sources other than
   randomized clinical trials, including from observational studies, registries,
   and therapeutic use.

A homeopath would love this provision, and, I’m sure, so would drug companies.
Why bother with the time, bother, and expense of those pesky clinical trials to 
get your drug approved for additional indications, when you can rely on clinical
experiences based on therapeutic use, uncontrolled observational studies, or
registries instead? If I were the CEO of a pharmaceutical company, I’d love it. 
Indeed, the one thing this provision most definitely does not do is to speed
effective treatments to patients. Rather, it smacks of being a payoff to
pharmaceutical companies.

Next up is a section that takes a good idea too far, namely the use of
biomarkers in clinical trials. Biomarkers are basically measurable indicators of
the presence or severity of a disease or condition – it’s anything that can be 
used to assess or follow the progress of a disease or treatment. One common
biomarker is the prostate-specific antigen (PSA), routinely used to follow
prostate cancer for response to treatment and recurrence. For purposes of the
21st Century Cures Act, a biomarker is defined as, “a characteristic (such as a 
physiologic, pathologic, or anatomic characteristic or measurement) that is
objectively measured and evaluated as an indicator of normal biologic processes,
pathologic processes, or biological responses to a therapeutic intervention;
and (B) such term includes a surrogate endpoint.” In this bill, biomarkers can
be used as the basis for drug approval:

   “(9) SURROGATE ENDPOINT.—The term ‘surrogate endpoint’ means a marker, such
   as a laboratory measurement, radiographic image, physical sign, or other
   measure, that is not itself a direct measurement of clinical benefit, and—

   “(A) is known to predict clinical benefit and could be used to support
   traditional approval of a drug or biological product; or

   “(B) is reasonably likely to predict clinical benefit and could be used to
   support the accelerated approval of a drug or biological product in
   accordance with section 506(c).

Now, this in and of itself is nothing new. Drugs are provisionally approved on
the basis of biomarkers frequently, such as drugs that lower cholesterol.
However, as Jerry Avorn and Aaron S. Kesselheim noted in the New England Journal
of Medicine:

   The bill would also encourage the FDA to rely more on biomarkers and other
   surrogate measures rather than actual clinical end points in assessing the
   efficacy of both drugs and devices. The FDA already uses surrogate end points
   in about half of new drug approvals. Some biomarkers are accurate predictors
   of disease risk and can be useful measures of the efficacy of a new drug
   (such as low-density lipoprotein cholesterol for statins). But though a
   drug’s effect on a biomarker can make approval quicker and less costly,
   especially if the comparator is placebo, it may not always predict the drug’s
   capacity to improve patient outcomes. Bevacizumab (Avastin) delayed tumor
   progression in advanced breast cancer but was shown not to benefit patients. 
   Similarly, rosiglitazone (Avandia) lowered glycated hemoglobin levels in
   patients with diabetes even as it increased their risk of myocardial
   infarction. In 2013, patients began to receive a new drug for tuberculosis
   approved on the basis of a randomized trial relying on a surrogate measure of
   bacterial counts in the sputum — even though patients given the drug in that
   trial had a death rate four times that in the comparison group, mostly from 
   tuberculosis. These provisions in the legislation would not immediately
   change FDA approval standards, but they would give the agency greater
   discretion, backed by congressional support, to approve drugs on the basis of
   less rigorous data.

However, right now the FDA also requires further post-approval studies to verify
that the effect on the biomarker or surrogate endpoint actually results in
concrete benefit to the patient. Examples include improved survival in cancer or
decreased cardiovascular deaths in patients with hypertension.

Does this worry you? It sure worries me. The bill also explicitly encourages
using less rigorous evidence. For instance, in the case of antibiotics needed to
treat “serious or life-threatening infection” in patients with an “unmet
medical need,” the FDA would be allowed to accept “nontraditional” measures of
efficacy, including “preclinical, pharmacologic, or pathophysiologic evidence;
nonclinical susceptibility and pharmacokinetic data, data from phase 2 clinical 
trials; and such other confirmatory evidence as the secretary [of health and
human services] determines appropriate to approve the drug.” True, such drugs
would carry a disclaimer on the label, but does anyone think this really would
make sure that these drugs were only used for the “unmet medical need”? Worse,
the bill makes further clinical trials to verify that these “nontraditional
measures” actually correlate with improved outcomes optional.

As if these provisions loosening the required standard of evidence were not
enough, things get really scary in the realm of medical devices by creating an
expedited approval pathway. Take a look at what would be considered adequate
evidence for the approval of medical devices under this pathway:

   (ii) For purposes of clause (i), valid scientific evidence may include—

   “(I) evidence described in well-documented case histories, including registry
   data, that are collected and monitored under a protocol determined to be
   acceptable by the Secretary;

   “(II) studies published in peer-reviewed journals; and

   “(III) data collected in countries other than the United States so long as
   such data otherwise meet the criteria specified in this subparagraph.

It gets worse, though. If the device manufacturer submits studies published in
peer-reviewed trials, the FDA would have to submit a request for the underlying 
data, but even if it couldn’t get that data it would still have to consider the 
study. Even more incredibly, as noted in the NEJM, another section of the law
allows device makers to pay a third-party organization to determine whether the 
manufacturer can be relied upon to assess the safety and efficacy of changes it 
makes to its devices instead of submitting an application to the FDA. It’s hard 
for me to view this provision as anything other than free market faith run amok 
and/or a payoff to the device industry.

But that’s still not all.

The act also politicizes the process of drug development. Provisions in Sections
2021/2022 in essence create a parallel process by which standards for approval 
of drugs or devices are developed, as described by a Yale Law School researcher,
Greg Gonsalves, in an article by Julia Belluz:

   What industry is asking for here are adjudications on the use of key drug
   development tools very early on, with the guidance of outside experts now
   taking the central role rather than that of scientists at FDA. These
   decisions [then become] political ones in tete-a-tetes between [the experts] 
   and the Secretary of Health and Human Services, and commitments to an
   approval pathway using these drug development tools are agreed upon in an
   almost binding fashion and are difficult to step away from.

These outside experts will include experts chosen by the companies being
regulated.

There’s other mischief in this act as well. For instance, it would weaken
informed consent protections on patients by adding another category when it is
acceptable to forego informed consent, namely when “the proposed clinical
testing poses no more than minimal risk to the human subject and includes
appropriate safeguards to protect the rights, safety, and welfare of the human
subject.” As Merrill Goozner put it, even if the risk is minimal, why would the 
authors of this legislation waive a central tenet of international agreements
designed to protect the rights of human subjects in clinical trials? I don’t
understand, either, particularly since the act doesn’t define “minimal risk” or 
specify who determines whether a study is minimal risk. The number of studies
that would be facilitated by such a change in the requirement for informed
consent must be vanishingly small.

Then there’s a provision that sidesteps the Sunshine Act, adding an exemption
for reporting medical education payments, which has the effect of increasing the
number of things drug companies can pay doctors for without having to report
them to the physician payment Sunshine database.

The FDA doesn’t need the 21st Century Cures Act

When I first learned of the 21st Century Cures Act, I wanted to like it. I
really did. I especially wanted to support it because it provides more funding
to the NIH. Even though the act does put too much faith in precision medicine as
the be-all and end-all of progress in biomedical research, at least it boosts
the NIH budget and provides more funding for early career investigators, who are
being particularly harshly squeezed right now. Indeed, I don’t know why they do
it, given how small their chances are of attaining NIH funding, which is
usually a necessary prelude to winning tenure. The problem is the rest of the
bill, which, while not explicitly ordering the FDA to use a lower standard of
evidence to approve drugs and devices, opens the door—and outright
encourages—less rigorous science in the name of speed.

Like misguided right-to-try laws, none of these additional provisions are
needed, and much of what else is in the bill is likely to be harmful to the
scientific rigor of the FDA drug approval process. As author Joseph Gulfo, a
critic of how FDA approves drugs who is actually in favor of less regulation and
who might be expected to be in favor of a bill like this, argues, the FDA
already has the power to do most of what is in the 21st Century Cures Act. Gregg
Gonsalves and Mark Harrington, former members of Act Up/New York, and David A. 
Kessler, commissioner of the FDA from 1990 to 1997, agree that the FDA already
has the tools to do what the bill’s sponsors want.

Again, the underlying assumption behind the 21st Century Cures Act is that the
system is so broken that radical reform is urgently needed. It turns out that
that’s an exaggeration. For instance:

   An underlying premise of the bill is the need to accelerate approval for new 
   products, but this process is already quite efficient. A third of new drugs
   are currently approved on the basis of a single pivotal trial; the median
   size for all pivotal trials is just 760 patients. More than two thirds of new
   drugs are approved on the basis of studies lasting 6 months or less — a
   potential problem for medications designed to be taken for a lifetime. Once
   the Food and Drug Administration (FDA) starts its review, it approves new
   medications about as quickly as any regulatory agency in the world,
   evaluating nearly all new drug applications within 6 to 10 months, an
   impressive turnaround for such complex assessments.

Indeed, it’s been pointed out that the FDA now approves drugs faster than most
European regulatory agencies. Moreover, as examples such as Avastin for breast
cancer suggest, under accelerated approval we might be approving some drugs too 
quickly.

The bill has also been characterized as a “Christmas tree,” something upon which
to hang everything on the wishlist of every healthcare-related interest group
that’s been frustrated over the last several years:

   According to the Senate’s lobbying database, the number of groups listing the
   21st Century Cures Act as a lobbying issue grew from 62 in the second
   quarter of last year to 222 in the first quarter of this year.

   “It became a Christmas tree,” said Billy Wynne, of Thorn Run Partners, who
   has lobbied the bill. “Many people see it as the moonshot opportunity for
   lots of stuff,” another lobbyist said.

Basically, the 21st Century Cures Act is a solution in search of a problem.
Well, not quite. Increasing funding to the NIH is definitely a laudable goal,
given how much NIH funding has plummeted in real dollars since 2003. Increasing 
funding to the FDA is also a laudable goal, although some have argued that the
bill doesn’t increase it enough to cover the new responsibilities placed on the 
FDA. Everything else in the bill is nothing more than a fantasy solution to a
nonexistent problem rooted in the belief that if we decrease the standard of
evidence for new treatments somehow, magically, lots of “21st Century Cures”
will be approved. The bill in its current form is a danger to patients and
should not be passed.

Montana’s new “right to try”: Opening the door to profit from unproven drugs

Montana recently finalized rules to implement its expansion of “right-to-try.”
providing a chance for the unscrupulous to profit.

David Gorski on August 3, 2026

Link

During the pandemic, I had a saying about antivax tropes and disinformation:
Everything old is new again. That saying applies even more in the age of “make
America healthy again” (MAHA), the loose coalition of “health freedom”
activists, antivaxxers (yes, MAHA is inseparable from antivax, no matter how
much its proponents claim otherwise), and advocates of “complementary and
alternative medicine” (CAM, also known as “integrative medicine”) and outright
alternative medicine quackery. The main difference now, of course, is that,
unlike the case in past decades, MAHA is in charge of the government. The result
is that we have a Director of the National Institutes of Health who wants to
convert the NIH into the “research arm of MAHA,” a Secretary of Health and Human
Services working on dismantling federal vaccination infrastructure, and a Food 
and Drug Administration being pushed in one direction to approve unproven
peptide medications while demanding “saline placebo”-controlled randomized
clinical trials for vaccines, whether such trials are ethical or not. In writing
about it all, I’ve been meaning to revisit a strain of “health freedom” that
I’ve been writing about for well over a decade, the “right-to-try” movement,
which now fits comfortably under the MAHA umbrella.

“Right-to-try,” as you might recall, involves letting terminally ill patients
access experimental therapeutics that have passed phase I clinical trials
indicating gross safety (i.e., no major adverse events observed in a small
number of patients). I’ve explained in depth why these laws are a bad idea, and 
why their purpose was never quite as advertised (to offer these therapeutics to 
patients with no other options) but in reality to serve as a wedge to start to
whittle away at the FDA’s power to regulate pharmaceuticals. (More on that
later, as I haven’t discussed it in a long time.)

First, however, I want to take a look at what the State of Montana—yes,
Montana!—has done with respect to “right-to-try,” which is essentially to take
it far beyond what any state (or the federal government when it passed the
right-to-try 2017) has tried to do, starting with two stories published late
last week in the MIT Technology Review, one reasonable and one highly
irresponsible. The reasonable one is entitled Montana’s plan to become an
experimental medical hub just pushed forward, while the irresponsible one is
framed in the usual terms of how this will supposedly help desperate patients
and entitled Montana’s new “right to try” law can’t come soon enough for some.
Basically, the final rules have been drafted to implement SB 535, which amended 
Montana’s “right to try” bill originally passed in 2015. Here’s how the first
article describes the new program in Montana:

As of this week in Montana, any biotech company with an experimental drug has a 
clear path to selling it to consumers. Companies whose drugs have been through
preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to 
apply to a newly established review board for approval. Once its treatment is
rubber-stamped, the company can set the price of the drug and sell it via
experimental treatment clinics, the first of which is likely to be up and
running around the end of this year.

Montana’s latest right-to-try legislation is unique. While other jurisdictions
with similar laws limit access to drugs to people with terminal illness, in
Montana access is theoretically available to anyone who gives informed consent
and can pay. That includes people desperate for treatments for rare diseases. It
also includes those who are interested in longevity and want to try out drugs
pitched as preventive therapies.

I trust that, just from this, readers can see why this is a horrible idea. To
understand more deeply, let’s recap the origins of “right-to-try” and how it
went from a movement to pass laws in various states to a federal law. More
importantly, let’s look at how Montana is likely a harbinger of what advocates
of “Right-to-Try 2.0” (RTT 2.0) want for the whole country, although Montana
goes beyond even this.

Right-to-Try: Created by the Goldwater Institute to weaken the FDA

Come with me to a (seemingly) much more innocent time, before the shift in the
antivax movement’s political center of gravity had turned sharply and
definitively to the right, before the pandemic and the tsunami of health
misinformation, anti-public health activism, and quackery overwhelmed us, and
before the term “MAHA” was even an action potential in one of RFK Jr.’s addled
neurons. The year was 2014, and Jann Bellamy and I both noticed the incipient
“right-to-try” movement promoting “right-to-try” laws. Jann described the
Illusions of “right-to-try” laws, and I pointed out that the ethos behind
right-to-try was not unlike the Dallas Buyers Club, noting that it was a great
movie but a terrible basis for drug regulation policy, not to mention terrible
for patients. It was not for nothing that I regularly refer to right-to-try as a
cruel sham. Nothing in the more than 12 years since then has changed my mind
about it, but even before MAHA the concept was so seductive that many states
passed right-to-try laws, and ultimately, after Donald Trump assumed the
Presidency for the first time, a federal right-to-try law was passed. Despite
its advocates’ claims, a year after it passed, right-to-try was a failure, and
it was still a failure in 2024, when, during his campaign to become President a 
second time, Donald Trump falsely claimed that right-to-try had saved thousands 
of lives.

But what is “right-to-try,” or, if you will, Right-to-Try 1.0? The first thing
you need to know about it is that the über-libertarian Goldwater Institute was
the prime mover promoting state right-to-try laws back during the initial push
for these laws between 2013-2016 or so. Indeed, nearly all of the first wave of 
“right-to-try” bills introduced into state legislatures were based on model
legislation designed by the Goldwater Institute, which states like Colorado
modified so that the language fit within its existing statutes. But what did
right-to-try laws claim to offer? I’ll list key provisions from the first wave
of right-to-try, basically paraphrasing them from the Goldwater Institute’s
legislative template:

  1. Eligible patients. An eligible patient has a terminal disease; has, in
    consultation with a physician, considered all other treatment options
    currently approved by the FDA; has been given a prescription or
    recommendation by a physician for an investigational drug, biological
    product, or device; and has given informed consent in writing for the use of
    the investigational drug, biological product, or device.
  2. Terminal Disease. Terminal disease is defined as an “advanced stage of a
    disease with an unfavorable prognosis and no known cure.”
  3. Investigational Drug, Biological Product, or Device. This is defined as a
    “drug, biological product or device which has successfully completed Phase
    One of clinical trials, but has not been approved for general use by the
    Food and Drug Administration.”
  4. Availability. A manufacturer of an investigational drug, biological product,
    or device has the option of making its investigational drug, biological
    product, or device available to eligible patients under this act. Nothing in
    this act shall be interpreted to require that a manufacturer make an
    investigational drug, biological product, or device available.
  5. Costs. Manufacturers are permitted to provide an investigational drug,
    biological product, or device to eligible patients without receiving
    compensation but may require eligible patients to pay the costs associated
    with the manufacture of the investigational drug, biological product, or
    device.
  6. Insurance. Insurance companies and government health care programs are not
    required to provide coverage for the cost of any investigational drug,
    biological product, or device, although they may choose to do so if desired.
  7. Professional licensing. No medical licensing board shall revoke a license,
    fail to renew a license, or take any other action against a license solely
    based on a medical professional’s recommendation, prescription, or treatment
    with an investigational drug, biological product, or device.
Again, most of the laws passed a decade ago were based on this template, with
some tweaks here and there depending on the specific state. I’m going to harp on
one thing here, because the Montana definition of “investigational” is the same
as the Goldwater template, namely that any drug that has passed phase I trials 
is fair game for right-to-try. As I like to point out ad nauseam, phase I trials
are small “first in human” trials in which a new investigational drug is given 
to volunteers at different doses, and the volunteers are screened for adverse
events and any effect on the disease or pathology targeted by the drug. Phase I 
trials typically enroll only at most a few dozen subjects, and sometimes it’s as
few as ten. A drug that has passed phase I trials has not, by any stretch of
the imagination, been demonstrated to be “safe.” It has been demonstrated not to
have any serious adverse events that are common enough to show up in such a
small test population and has thus been deemed “safe enough,” if you will, to
proceed to phase II clinical trials. Also, phase I trials do not demonstrate
efficacy. They are not designed to do that. It’s nice if there is evidence of an
effect on the disease being targeted, but the trial is designed mainly to make 
sure that there aren’t any common or unexpected adverse events that render the
drug more dangerous than the condition being treated. That’s it. It was
irresponsible enough of the original right-to-try to allow such drugs to be
administered as described above, but it’s even worse to do what the new Montana 
right-to-try will do and basically let pharmaceutical and biotech companies
market such drugs to desperate patients, as long as they pay an application fee.

The other thing about phase I drugs is that the percentage of these drugs that
make it through phase II and phase III clinical trials to go on to be
FDA-approved is quite low. Indeed, only 5% of all cancer drugs that enter
clinical testing are ultimately approved for patient use. Among drugs that make 
it past phase I, only 30% go on to phase III. There is a steep winnowing process
for candidate drugs as they go through the three phases of the FDA-required
drug testing process, such that only somewhere between 15-30% make it through
the process to be approved, even as conceded by the State of Montana. In other
words, the chances that an investigational drug might help a desperate patient
if it passed phase I are probably much lower than one in ten, but the chances of
adverse events that cause harm are certainly much, much higher, and that’s
leaving aside the financial toxicity.

I bring that up because the original right-to-try is that it betrayed its roots 
coming from a libertarian think tank. Patients are basically on their own in
terms of the cost; that is, unless a highly benevolent drug company is willing
to pay. Insurance doesn’t have to cover it, and in some laws that I discussed
back in the day it was unclear whether insurance would be required to pay for
additional medical care from serious adverse events caused by use of an
experimental therapeutic under right-to-try. (Indeed, the version of the law
introduced in Michigan included a provision that allowed drug companies to go
after a deceased patient’s estate to recover costs.) There is no liability for
companies or doctors, nor are there any penalties for doctors who irresponsibly 
promote right-to-try. Yet the laws keep passing because to the average person
they seem so “reasonable,” and, after all, what sort of hard-hearted bastard do 
you have to be to deny a terminally ill patient the chance to try an
experimental drug that might help them, even if the chance that it will do more 
good than harm is small?

But where did right-to-try come from? It’s even worse than having come from a
libertarian think tank. It also turns out that the for-profit hospital chain
Cancer Treatment Centers of America (CTCA) played an integral role in the
genesis of right-to-try:

In September 2012, a group of executives from the Cancer Treatment Centers of
America reached out to the Goldwater Institute, a small, libertarian think tank 
named for the former senator and presidential candidate.

Goldwater — which has in past years accepted support from major conservative
organizations like the Charles Koch Foundation and Donors Capital Fund — had
taken on a wide-ranging libertarian agenda that included activism on campus free
speech and school choice. The for-profit hospital chain CTCA also has its own
ties to the Koch family.

CTCA and, ultimately, the Goldwater experts believed the FDA’s existing expanded
access program — through which the agency approves some 99 percent of requests 
from dying patients who can’t get into clinical trials but want to try
experimental treatments — was too cumbersome.

It was time to do something about it, and a consultant with CTCA, Chuck Warren, 
coined the term “right to try,” recalled Starlee Coleman, a Goldwater senior
adviser.

CTCA and the Goldwater Institute decided to start with the states, and,
unfortunately, the rest is history. I also note that we’ve written about CTCA
before. It’s a chain of for-profit cancer hospitals that market “integrative
medicine” quackery along with conventional medicine. So, yes, right-to-try was
the product of a hospital chain that markets itself by selling quackery
alongside standard medical care, quackery like “naturopathic oncology“, doing
questionable genomic testing, and inflating its survival statistics through the 
cherry-picking of patients. Demonstrating how shadowy the whole arrangement was,
few people knew CTCA was behind the Goldwater Institute’s push for
right-to-try. Even I didn’t know it until the federal law passed.

Ever since right-to-try conquered the states and a version of it was passed into
federal law in 2018, its advocates have been chafing at even the minimal
restrictions that exist under the law, the first of them being the requirement
that the patient have a “terminal illness.” The Montana law represents the
ultimate expression of this dissatisfaction, as you will see.

Montana: Paving the way to fleece desperate patients legally

Let’s go back and look at the Montana law as described in the MIT article. Once 
again, there is no requirement that the patient have a terminal illness, or even
a serious illness. As the article points out, the program is open to “people
desperate for treatments for rare disease” and “those who are interested in
longevity and want to try out drugs pitched as preventive therapies.” That
latter category, of course, will be a boon to quacks everywhere, who can
presumably just run a quickie phase I trial, declare their supplement or product
“safe,” and then profit. Going back to the MIT Technology Report story, which
relates the origin of this program, which is the result of SB 535, which was
designed to expand the original Montana right-to-try bill beyond terminally ill 
patients:

“Montana first passed a right-to-try law in 2015. In 2023, with the support of
state senator Ken Bogner, the state expanded the law to include all patients,
not those just with terminal disease. Last year, Bogner told MIT Technology
Review that his vision was to focus “more on preventative medicine” rather than 
“just treating diseases once they show up.”

Bogner says he had “started working on a bill” that would become the 2023 law
when the Alliance for Longevity Initiatives (A4LI), a nonprofit “dedicated to
advancing legislation and policies aimed at increasing healthy human lifespan,” 
got in touch. A4LI connected Bogner with others who helped draft the bill and
testified in support of it.

Once that law was in place, the tech entrepreneur and longevity enthusiast
Niklas Anzinger got involved. Anzinger has been working to establish a
jurisdiction to fast-track the search for drugs that might deliver radical life 
extension. He is based in Próspera—a private city and “special economic zone” in
Roatán, Honduras, which is already home to a separate clinic that sells
experimental stem-cell and gene therapies. Anzinger founded a community there
called Infinita City; he has also founded an investment company and ”

Silly me for thinking that this law is an excuse to allow longevity quacks to
sell their wares legally! Let’s just say that Montana is just an expansion of
Anzinger’s empire now:

As the founder of Infinita VC, a venture capital firm based in the charter city 
of Próspera in Honduras..He leverages special economic zones and enables
legislation  to unlock “stranded technologies” — innovations held back by
traditional regulatory frameworks.

Operating within Prospera, Infinita is building a biotech-focused district that 
demonstrates how competitive governance can foster development. He pursues a
decentralized strategy with 3–5 physical hubs, starting with Prospera and
expanding to innovative US states like Montana under its SB 535 right-to-try
framework.

And:

Niklas sees parallels between the longevity and crypto communities, including a 
shared ethos of questioning centralized systems and viewing institutions like
the FDA as bottlenecks to progress. He believes the transition to more
privatized and decentralized systems is already underway, with governments
competing for talent and investment, and sees projects like Prospera as key
steps in creating a “Cambrian explosion” of new jurisdictions and network
states.

Oh, goody. Because I want my drug development to be like cryptocurrency! And
also “experimental” gene therapies and stem cell therapies being developed with 
minimal oversight because Anzinger “questions centralized systems” and views the
FDA as a “bottleneck” to progress.

But, wait! Montana tells us the law and rules have provisions to protect
patients:

The state’s Department of Health and Human Services recently finalized rules to 
implement the law. The rules stipulate that patient consumers provide fully
informed consent and that each application be reviewed by a board that includes 
a Montana-certified doctor, expert scientists, and an ethicist. Supporters of
the law stress that they want the process to be responsible. “It will be done in
a very rigorous way, with qualified medical professionals and appropriate
oversight,” says Matt Kaeberlein, a scientist on the first board, which was
formed independently of the state health department.

But other experts are worried about the potential for harm in selling unproven
treatments to people without oversight from the US Food and Drug Administration.
“I would be concerned,” says Aaron Kesselheim, a professor of medicine at
Harvard Medical School with expertise in health policy and drug regulation.

So a board will review each application? That makes me feel so much better. In
fairness, Kaeberlein is a legitimate longevity researcher and faculty at the
University of Washington. So why did he agree to be on the Montana Experimental 
Treatment Review Board, a private entity set up to review applications for the
Montana right to try program? (As an aside, I like how the METRB website notes
drily, “The Board’s review is a process-level safety check within the SB535
experimental treatment framework, is not a guarantee of safety or outcome for
any patient, and creates no physician-patient relationship and no reliance for
any patient.”) According to him:

Dr. Kaeberlein has long argued that the current development and approval process
for new therapies is too slow and expensive. At the same time, he has
frequently criticized the “Wild West” approach to longevity medicine.

“What interests me about Montana’s approach is that it attempts to create a
middle ground,” he said. “Rather than pushing patients toward medical tourism or
unregulated clinics, it seeks to establish a framework with independent review,
physician oversight, informed consent, and systematic data collection. Whether 
that framework ultimately succeeds remains to be seen, but I believe it’s worth 
trying to make it as rigorous and scientifically credible as possible. That’s
why I agreed to participate.”

Would it be wrong of me to retort, “Oh, you sweet summer child”? Or maybe not.
According to the MIT Technology review article, Kaeberlein “has a prominent
media presence, has long raised his own concerns about access to other unproven 
treatments, including peptides and stem-cell therapies.”

In fairness, the current board looks mostly unobjectionable from a scientific
standpoint, and without going in depth into each member’s history I’d have a
hard time saying more. I do know, however, that Flanigan is a libertarian who
has written a book entitled Pharmaceutical Freedom.

Here’s the full panel:

Montana Experimental Treatment Review Board members.
Here’s the thing. It’s just a step. It will be very interesting to see what
happens the first time this panel rejects a right-to-try application. My
prediction is that, given the involvement of longevity aficionados at the
genesis of this project makes me highly suspicious of just how much this is
about granting patients access to promising drugs and how much it is about
bypassing the FDA’s regulatory authority to allow unethical companies to profit 
by selling early-stage experimental therapeutics to patients, cash (or credit
card) on the barrelhead. The law basically allows clinics to be set up for this 
purpose, and it is even mentioned in some of the stories that it is expected
that the first of such clinics will open by the end of this year.

Yes, right now the panel doesn’t look like quacks and currently is the only
review panel in the state, but the MIT Technology review article notes that
“Anzinger says that other groups are free to establish their own” review
panels,” and the only requirements for such panels that I could find is that
they consist of at least four members, including at least one Montana-licensed
physician, at least one researcher with expertise in clinical outcome data, and 
at least one ethicist. You know how quacks like to form their own institutional 
review boards? What’s in the law to prevent them from doing the same thing in
creating right-to-try review boards?

Moreover, Kaeberlein points to the difference between current existing expanded 
access programs administered by the FDA in this way, as if it were a good thing:

There are some key differences between expanded access, which allows seriously
ill people to apply for access to experimental drugs that might not have been
through any human trials, and Montana’s approach.

And:

Kaeberlein also highlights another key difference, which is cost. Companies that
make their treatments available through expanded access are only able to charge
for the costs of making, transporting, and monitoring the drug, and they must
justify the eventual price to the FDA. In Montana, they can charge whatever
price they want. Stanley of WinSanTor says he plans to sell his drugs “at cost.”
But Ceres’s Joudinaud says that he’d be more interested in selling his at a
market price. When asked what that might be, he hinted that the prices of new
drugs for rare diseases can be high. In recent years, the median price of such
drugs was $218,872.

“Instead of simply creating a legal pathway for patients, it also creates a
business model that companies may actually be willing to use,” says Kaeberlein.

No wonder certain companies are salivating at the prospect of profit:

But the moment when people start spending money on these treatments is already
fast approaching. While Montana’s first ETRB prepares to review its first
applications, clinics that hope to be part of the program are busy addressing
the requirements laid out in the state’s new rules. Treatment rooms are being
outfitted. Medical directors are being hired. And experimental treatments should
be reaching patients in the coming months.

To my eye, even with the “safeguard” of the METRB, this program goes far beyond 
right-to-try in terms of a predatory libertarian model that locks out anyone who
isn’t wealthy enough to pay for an unproven drug that probably won’t work. I
predict that it won’t be long before we start seeing fundraising campaigns on
social media from desperate patients wanting money to go to Montana to obtain
unproven experimental drugs, the same way such campaigns by patients of cancer
quack Stanislaw Burzynski made the news and went viral on social media 10-15
years ago. Am I being unfair? No doubt Kaeberlein would say so. I’m sure that if
he sees this post he will be quite taken aback and feel that I’m being unfair. 
Let’s just say that this ain’t my first rodeo, and I see the way that quacks
could easily take advantage of this. Heck, maybe Stanislaw Burzynski will move
his clinic to Montana. Or maybe not. He’s an octogenarian now, and such a move
would be very difficult. It must be tempting, though. Montana’s right-to-try
environment is custom-made for a quack like Burzynski to flourish, particularly 
given that he’s weaponized clinical trials to maintain his ability to keep
selling his product.

Ironically, the only thing that might slow this down in Montana is that a lot of
companies are afraid of what effect a disaster happening under right-to-try
(e.g., the death of a patient using their product) would have on their
reputation and relationship with the FDA, which they still count on to approve
their drugs for sale in the US. That alone will be enough for the larger, more
reputable companies to be wary of this program, but smaller companies might see 
the profit potential as too tempting compared to what it will take for them to
get their candidate drugs through the FDA approval process.

Montana, “Right-to-Try 2.0,” and beyond

The spin that Montana has placed on “right-to-try” isn’t all. The Goldwater
Institute, not satisfied with the original right-to-try, has promulgated
“Right-to-Try 2.0,” which appears custom-designed to enable just about anything.

Rapid medical innovations have made it possible to take an individual’s genetic 
information and create a treatment for that individual person. More patients,
especially those with rare and ultra-rare illnesses, will pursue these
treatments when they have exhausted other options. Unfortunately, the FDA’s
current regulatory scheme is not designed to handle these kinds of individual
treatments, and that will keep life-saving medication out of the hands of
patients unless reforms are adopted.

Under the FDA’s outdated system, new treatments are subject to a clinical trial,
which is designed to learn something about a treatment that will be generally
applicable to all the patients with the same disease. The current clinical trial
evaluation is based on treatments for large population, not an individual
patient which were not a reality when the system was created more than a
half-century ago. The end result is that an individualized treatment is still
subjected to the same clinical trial process as a single treatment that is
intended for hundreds or thousands of patients. But that’s not how these new
individualized treatments work.

For example, a therapeutic cancer vaccine can be designed based on an
individual’s diseased cells or unique genetic mutations, allowing it to
stimulate the patient’s immune response and target cancerous tumors. But that
unique treatment only works for that patient. The FDA’s existing clinical trial 
system cannot work in cases like this because its safety and testing protocols
aren’t matched to this kind of singular treatment.

One wonders, then, how, for example, CART-T cell therapy was ever approved. This
is a form of therapy in which a patient’s own white blood cells are used to
generate patient-specific therapies. There are problems, of course, developing
individualized therapies and testing them for FDA approval, but the Goldwater
Institute writes as though it were the first organization ever to address the
problem. The FDA has been researching the “N-of-1” problem for years and has
developed frameworks to approve therapies of this type without large randomized 
controlled clinical trials. A deeper discussion of this is beyond the scope of
this post, although perhaps I should undertake one in the future. In the
meantime, there are groups like the N-of-1 Collaborative, and in 2024 a
framework was proposed to guide researchers regarding the evidence base needed
to approve such treatments targeting an individual genetic variant. Meanwhile,
the FDA has issued draft guidance on another framework for drug approval based
on plausible mechanisms. I’m not saying that the problem has been solved. What I
am saying is it’s a lie to claim that FDA doesn’t take the unique challenges
that individualized therapies present into account and that Right-to-Try 2.0 is 
not a solution, but rather an opening to all manner of quacks to do
“individualized” treatments without worrying about pesky things like FDA
approval.

Just look at what Goldwater proposes regarding eligibility. The
drugs/treatments:

  1. must be investigational
  2. must be individualized to the specific patient, and
  3. must be based on analysis of the patient’s genomic sequence, human
    chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products
    (such as enzymes and other types of proteins), or metabolites.
While the patient must:

  1. Be diagnosed with a life-threatening or severely debilitating illness;
  2. Have considered approved treatment options;
  3. Have a recommendation for an investigative individualized treatment from their
    physician; and
  4. Give written informed consent regarding the risks associated with taking the
    investigational treatment.
My skeptical antennae started twitching wildly as I read the use of the word
“individualized” over and over again. After all, what is the quackery known as
“functional medicine” but “individualized medicine” on steroids with lack of
oversight? Basically, this Right-to-Try 2.0 looks like a back door to let
functional medicine doctors do whatever they like.

As much as I rail against the antivax component of MAHA, the “health freedom”
component is arguably more dangerous to science-based medicine, and at the
vanguard of “health freedom” is right-to-try. While some of the anti-regulation 
libertarians who falsely believe that the FDA is killing people through
bureaucratic slowness and inefficiency and think that the “free market” can
guarantee drug safety and efficacy might really believe that right-to-try is
about protecting patients, I argue that it is more about taking as much power
away from the FDA as possible and taking us back to the 19th century in terms of
drug science, safety, and efficacy. Worse, now that the current administration 
is in power, right-to-try advocates might just succeed. At the very minimum, as 
far as drug regulation goes, Montana is looking to be a great place to set up a 
Hallwang-style clinic in which conventional medicine is mixed with unproven
experimental therapeutics and alternative medicine.


“Health Freedom” Leaders are Health Authoritarians

“The centerpiece of the MAHA and health freedom agenda has been removal of mRNA 
shots.”

Jonathan Howard on October 3, 2026

Link


There is nothing more fake, phony, and disingenuous than the “health freedom”
movement. It’s also dangerous, and it has hurt many people already. Here are
three examples of why.

“The centerpiece of the MAHA and health freedom agenda has been removal of mRNA 
shots.”

“160 physicians, scientists and activists” recently penned an open letter to
Secretary Kennedy and President Trump. Regarding the Removal of the mRNA
Platform. It said:

Dear Secretary Kennedy and President Trump,As influential leaders within the
MAHA and health freedom movements, we are writing to object to policies under
your oversight related to the mRNA platform, and to call you to act on our
policy goals.

While the centerpiece of the MAHA and health freedom agenda has been removal of
mRNA shots, you have failed to take decisive action on this front despite
overwhelming credible evidence to the harm of this technology. Instead, your
policies related to mRNA technology are neutered and self-defeating, putting
pregnant women and children at risk, misleading parents and eroding their
rights, and failing to help those harmed by vaccines.

If you continue to ignore our central issue of removing the mRNA platform, the 
MAHA and health freedom movements will withdraw their support of you, and you
will face the political consequences.

Read that again: “the centerpiece of the MAHA and health freedom agenda has been
removal of mRNA shots.” Several of these 160 physicians, scientists, and
activists have graced the pages of SBM previously, and this letter reveals
either their inability to see the contradiction of that sentiment or their
indifference to it. Either way, the outcome is the same. When it comes to a
vaccine with clear benefits, it’s your body, their choice.

At one level, the sheer absurdity of banning voluntary vaccines in the name of
“health freedom” is comical, and it’s always nice to see MAHA turn on itself.
I’ll never get tired of seeing Kennedy become woven into the conspiracies he
promoted and attacked by the forces he enabled now that he’s the establishment.

However, such Orwellian abuses of language are never benign, and there’s a dark 
side to this.

“Four Kids in One Faith-Healing Family Died. Authorities Could Do Nothing.”

The flip side of the “health freedom” movement trying to take away your vaccines
is that they feel entitled to do whatever they want to their children. Not only
are unvaccinated people dying of measles again; Audrey Dutton recently
published two wrenching ProPublica pieces on the tragic consequences of “health 
freedom”. According to her article, Children in a Faith-Healing Sect Keep Dying.
The State Lets It Happen:

At least 15 babies and children from the faith-healing sect died between 2015
and 2025 from illnesses that doctors could have successfully treated, the
experts concluded.

The estimate of preventable deaths is almost certainly an undercount. The
experts could not evaluate six more deaths because coroner records were
incomplete or unavailable. In another four cases, they couldn’t say with
confidence whether medical care would have changed the outcome.

The other article, Four Kids in One Faith-Healing Family Died. Authorities Could
Do Nothing said:

Emma Joyce was sick and vomiting for days until she stopped breathing in her
parents’ arms, in a small gray farmhouse in rural Idaho. It was August 2009, and
she was 3 years old.

The following summer, Emma Joyce’s little sister got sick. Ava Joan wouldn’t eat
or drink anything but a few grapes and some Sprite in a sippy cup. She was
breathing hard and fast. And when she vomited, it came out black, the hallmark
of internal bleeding. She died in her mother’s arms in July 2010 from a
complication of untreated diabetes.

Less than two years later, the girls’ toddler brother died from the same
complication of untreated diabetes that killed Ava Joan.

And nine years after that, another sibling died: a 4-year-old boy who’d suffered
for weeks with similar symptoms.

It explained why:

An exemption in Idaho law shields faith-healing parents from criminal
prosecution for conduct that otherwise would be charged as neglect. It also
keeps police and social workers from stepping in to protect a dead child’s
surviving siblings.

The “health freedom” movement didn’t believe in health freedom for these
children. The notion that children are independent humans with their own rights 
is appalling to them. Even today, instead of trying to protect these children,
Kennedy is droning on about “medical tyranny,” and how AI will save us from it.

“He Should Be In Jail!” Fauci Lied, People D**d. The Pandemic Scandal Continues
To Deepen

Even before the pandemic, “health freedom” advocates didn’t hide their thirst
for revenge and punishment. Over 10 years ago, Dr. David Gorski wrote an article
titled The Violent Rhetoric of the Antivaccine Movement. This was followed up
by The Violent Rhetoric of the Antivaccine Movement, Vaxxed Edition, The Violent
Rhetoric of the Antivaccine Movement: ‘Vaccine Holocaust’ And Potential
Impending Attacks on Journalists, and The Violent Rhetoric of the Antivaccine
Movement Intensifies.

This had consequences. An article from 2019 about vaccine hero Dr. Richard Pan
was titled Woman Arrested After Throwing Menstrual Blood on California Senators.

COVID supercharged all this. Today, they want to incarcerate, or even execute,
scientists who tried to save lives in 2020. Even though Nazis were hanged at
Nuremberg, there’s an overwhelming amount of such content, such as Jimmy Dore & 
Bret Weinstein: Nuremberg Violations & How People Were Forced To Take COVID
Vaccines. The videos below feature Del Bigtree making such threats.

This isn’t just people blowing off steam. There are consequences to this
rhetoric, and “health freedom” advocates can read the news as well as you and I.
Fauci’s children needed security, and Hotez was stalked at home. A man deluded 
by COVID conspiracies murdered a heroic Atlanta policeman and shot up the CDC.
According to a recent article, Public Health Leaders Report Widespread
Harassment, Threats After COVID-19:

Of 109 leaders interviewed for the study, 76% were threatened or harassed, a
category of backlash the researchers deemed “extraordinary.”

Among the experiences shared by public health leaders:

  1. The FBI’s arrest of a person making ongoing credible death threats. “That was 
    the ﬁrst time I felt scared because in his house he had over 100 guns…”
  2. A public health official described a persistent “scary,” “obsessed” male
    “stalker” who sent a picture of someone strangling a child the same age as
    her child.
  3. “The worst day was [when] I came home from work one day. … I came home and on 
    my front door I found a note taped. And when I opened it up, it was a threat
    to kill my dog. And it had a picture of my dog in my backyard.”
Who in their right mind would work to contain a future pandemic knowing “health 
freedom” advocates will unleash this on them?

And thus it becomes clear that the “health freedom” movement is run by health
authoritarians. They want to impose their anti-vaccine agenda on you, to
threaten and intimidate scientists, and to let parents treat their children as
disposable objects. This needs to be opposed, not appeased.

Patients Blinded by Stem Cell Therapy: FDA (and consumers) win a legal victory!

The Food and Drug Administration just won a court case supporting the agency’s
ability to regulate stem cell clinics that rely on client-derived adipose
tissues. This is a win for consumer protection, though too late to help those
already harmed.

David Weinberg on June 10, 2019

Link



[Editor’s note: Dr. Gorski is once again too busy with another looming grant
deadline to provide a new post. Fortunately, some interesting stem cell events
provided Dr. David Weinberg with a good news story he’d like to share with us.]

An SBM article last year described three women who sought treatment for macular 
degeneration at a stem cell clinic in Florida. Each woman underwent liposuction.
The liposuction material was processed, mixed with platelet-rich plasma derived
from their own blood, and injected into both of their eyes. Things quickly
deteriorated. Each woman rapidly lost vision in both eyes to the point or legal 
blindness. In the most extreme case, one woman lost all ability to perceive
light in both eyes.

A second article provided additional information about the company (U.S. Stem
Cell, formerly Bioheart) and its Chief Scientific Officer, Kristin Comella. The 
Company claims to be a “World leader in research and development of stem cell
and regenerative medicine treatments” but SEC filings reveal that in 2017 and
2018 they spent a paltry .1% of operating expenses on research and development. 
Emblematic of their posturing toward research, they had previously announced
plans to perform a clinical trial to study adipose derived stem cell treatment
of macular degeneration, but abandoned the study before enrolling a single
patient. Despite the lack of data to establish the safety and efficacy of this
treatment, for $5,000 each, they sold this treatment to the three aforementioned
women, with tragic results.

Kristin Comella, the Chief Scientific Officer and very much the public face and 
voice of the company, has a Ph.D in Stem Cell Biology. It is noteworthy that she
earned this degree only after she held the Chief Scientific Officer position
for several years. Prior to that, her highest degree was a M.S. in chemical
engineering. It is equally noteworthy that her Ph.D was awarded by the Panama
College of Cell Science, an unaccredited offshore virtual college that hands out
PhD degrees in 3 years for tuition of $2,950/year ($2,700 if paid in advance).

U.S. Stem Cell and Dr. Comella sold and promoted adipose derived stem cell
treatment for an astounding variety of maladies with little more than anecdotal 
evidence. They sold the treatment in their own clinics, and also operated a
business teaching other healthcare professionals how to perform the treatments.

U.S. Stem Cell’s activities earned the attention of the FDA. In 2017 the FDA
inspected their facility in Sunrise Florida. They declared that the treatments
that U.S Stem Cell was performing amounted to the illegal marketing of an
unapproved drug, and that they were in violation of numerous statutes regulating
the production of this drug. The infractions were enumerated in a warning
letter.

In order to continue their practices legally, they would need to perform a
lengthy and expensive process of clinical trials, and if proven safe and
effective, they could then submit a Biologic Licensing Application (BLA). If
approved they could then legally produce and sell their product.

Rather than cease operations and comply with the FDA warning letter, U.S. Stem
Cell argued that the FDA had “wrongly defined these in clinic procedures as a
drug” and opined that “If the federal government were to interfere with a
person’s ability to obtain and utilize their own cells in their body to heal
themselves, this could be a gross violation of the constitution”. They continued
to treat patients in defiance of the FDA directives.

Based on the lack of response to their warning letter, on May 9, 2018 the FDA
went to federal court seeking permanent injunctions against U.S. Stem Cell and
another West Coast stem cell network. U.S. Stem Cell remained defiant and vowed 
to “vigorously defend a lawsuit filed today by the U.S. Department of Justice at
the request of the U.S. Food and Drug Administration (FDA).”

The FDA is an executive agency under the Department of Health and Human
Services. The Food Drug and Cosmetics Act of 1938 increased federal oversight of
drugs. Congress has delegated certain regulatory responsibility to the FDA.
Rules and regulations written by the FDA are codified in the Code of Federal
Regulations (CFR). The FDA has asserted authority over certain aspects of stem
cell treatment, and has made efforts to clarify the regulations in this new
technology. Until recently, they have done very little to intervene against
individual providers of so-called gray market in stem cells. For many critics of
the retail stem cell industry, the FDA warning letter and subsequent legal
proceedings against specific stem cell providers is a welcome and promising turn
of events. Since filed in May 2019, interested parties on all sides of the stem
cell controversy have been awaiting the results of the legal proceedings.

On June 3, 2019 a judge of the Southern District of Florida upheld the FDA’s
injunctions against U.S. Stem Cell. I could not find an official statement from 
U.S. Stem Cell, but a New York Times article refers to a correspondence by
Kristen Comella, Chief Scientific Officer: “While we believe there is
substantial evidence to prove the efficacy of this protocol, we must immediately
comply with the court as we review the decision”.

Sadly, it is too late to protect the women blinded by the by treatment they
received at U.S. Stem Cell, but this is a favorable decision for those of us who
have been critical of the growing stem cell industry. This is one ruling
regarding one type of treatment at one specific clinic, but has far-reaching
implications. Hopefully, it signals a greater visibility of the FDA in asserting
its authority to protect consumers. It affirms that, contrary to the protests
of U.S. Stem Cell, the FDA is acting within its jurisdiction in regulating
certain aspects of the stem cell industry.

Other stem cell clinics using adipose-derived stem cells would be wise to
re-evaluate their business practices. The implications for this ruling would
seem to extend beyond the use of cells derived from adipose tissue, so this
represents a threat to many other retail stem cell providers.

The ink is barely dry on this court ruling and the consequences remain unknown. 
Given the facts of the case, this seems like the best outcome. It is unknown if 
U.S. Stem Cell will appeal this decision.

Self-Treating with Serious Drugs on the Rise

Steven Novella on April 23, 2025

Link

One of the greatest innovations benefiting public health was regulation. In the 
pre-FDA “patent medicine” days, there were countless products on the market that
ranged from useless to directly harmful. This was a time when you could sell
radioactive tonics, cocaine-laced elixirs, and products containing poisons, like
turpentine. The sellers of these products made many unsupported claims and
preyed disproportionately on the poor. While there were some real medicine in
the mix, like aspirin, on the whole the industry did more harm than good.

The 1906 Pure Food and Drug Act transformed the industry. In the name of
consumer protection, this law and later revisions required that ingredients be
accurately listed on the label, that products could not make claims that were
not evidence-based and reviewed, and that products had to demonstrate safety.
Requiring that something as vital as medicine be safe, effective, and
transparent seems obvious, and we mostly take these protections for granted.

And yet, over the last three decades we have been systematically unravelling
these fundamental protections. We are arguably getting close to a “post
regulation” era, with a functional return of patent medicines and snake oil. The
most critical inflection point here was the Dietary Supplement Health and
Education Act of 1994, which essentially deregulated the supplement industry and
created the category of “structure function” claims that can be made without
review.

In my opinion, there is no meaningful difference today between the supplement
industry and the patent medicine industry of the 19th century. They make
wide-ranging and often implausible claims without evidence to back them up,
products are rife with substitution, contamination, and adulteration, and there 
is very little efficacy to be had. And on the whole I would say the industry
does far more harm than good.

There is another layer to this trend toward deregulation, and that is
decriminalization for serious drugs. I am not arguing that criminalization for
drugs like cannabis is the optimal way to deal with them. I would prefer
thoughtful evidence-based regulation, but now we are headed back toward the
pre-FDA wild west.

Cannabis is just one example. David has written an excellent series of articles 
on cannabis as the new herbalism, so I won’t repeat that here. I also agree with
his take, that the new popularity of medical cannabis “(1) vastly inflates the 
potential of medicinal uses of marijuana and (2) ascribes near-mystical powers
to smoking or making extracts out of marijuana, rather than identifying and
isolating constituents of the plant that might have medicinal value.”

Just as with herbalism, we are dealing with years of propaganda convincing much 
of the public that herbs (including cannabis) are somehow not drugs. This is
mostly just the appeal to nature fallacy, but also often includes an appeal to
ancient wisdom, and to consumer self-empowerment. These marketing methods, by
the way, are identical to those of the patent medicine industry of the 19th
century.

What this leads to is a culture of self-treatment and experimentation, without a
sufficient appreciation for the risk/benefit analysis. This is combined with
social media, which allows for the rapid spread of dubious claims, and the
fomenting of anti-expertise conspiracy theories and a post-truth culture.

Another example is Kratom, which we have also covered. Kratom is quite simply a 
drug that causes opiate-like effects, including psychoactive effects, addiction,
and withdrawal. It can cause liver damage and a host of other side effects and 
toxicities. This does not mean it isn’t a useful drug – all drugs have side
effects. But like all drugs, we need to understand its constituents, control for
dosing, and study the pharmacodynamics and kinetics to be able to determine its
safe use. In effect it currently is a narcotic-like over-the-counter
unregulated drug.

Now psilocybin (usually sourced from mushrooms) is emerging as another common
product of self-treatment that is skirting regulations. Like cannabis, it is
being decriminalized in many states, but without substituting criminalization
with regulation. Use is spiking recently, including among children. Many people 
are using it to self-treat depression and anxiety.

Psilocybin and other hallucinogenics are an interesting category of psychoactive
drugs, and may ultimately lead to effective new treatments for some conditions.
Like cannabis, being criminalized hampered research. But now there is an
overcorrection.

For all of these drugs, we need to chart a course from heavy-handed
criminalization to evidence-based regulation. Quite simply, these and other
compounds are powerful drugs, with all the risks that entails, including
addiction. What would be optimal for public health is for there to be continued 
research into drugs like these, just like any new drug, to establish safe and
effective use.

We have a long history that clearly indicates without such evidence-based
regulation the net result will be more harm than good.


Monsanto gets injunction against California’s mandated cancer warning for
glyphosate

A federal district court permanently enjoined California from requiring a cancer
warning for glyphosate on First Amendment grounds. The battle between the law
and science continues.

Jann Bellamy on July 30, 2020

Link



In June, a federal district court ruled that California’s Proposition 65 cancer 
warning requirement for glyphosate violates the First Amendment rights of
Monsanto and other plaintiffs and forbade the state from enforcing the warning
mandate via a permanent injunction. (National Ass’n of Wheat Growers et al. v.
Becerra [PDF])

The Safe Drinking Water and Toxic Enforcement Act of 1986, popularly known as
“Proposition 65” or “Prop 65”, is a California law requiring publication of a
list of substances (the “Prop 65 list”) known to the state to cause cancer or to
be a reproductive toxicant. A substance’s being listed is determined by the
scientific opinion of, among others, the EPA, the FDA, and the International
Agency for Research on Cancer (IARC). The law prohibits businesses from
knowingly exposing individuals to substances on the list without providing a
“clear and reasonable warning”. Glyphosate was added to the Prop 65 list as a
chemical known to cause cancer in July, 2017.

Noncompliance with Prop 65 can be expensive, resulting in penalties up to $2,500
per day for each failure to provide an adequate warning. Enforcement actions
can be brought by the California Attorney General, as well as other state and
local legal officials, like District Attorneys. The law also has what is known
as a “bounty hunter” provision, allowing any person (whether they’ve suffered
any harm or not) to bring a private enforcement action and recover 25% of the
penalty, as well as attorneys’ fees and costs.

Before we return to the case, a brief SBM refresher on glyphosate. Glyphosate is
an herbicide widely used to control weeds in various settings and is an active 
ingredient in Monsanto’s Roundup. In a 2014 SBM post, Steve Novella described
glyphosate as “The New Bogeyman“, targeted by anti-GMO activists. As he
explained, due to the introduction of Roundup-resistant GMO crops, its use has
increased significantly in the last 20 years, hence its identification with
GMOs. In this particular post, Dr. Novella deconstructs the claim that
glyphosate causes autism and that “Half of All Children Will Be Autistic by
2025”, demonstrating how the “evidence” behind this claim confuses correlation
with causation. In a more recent display of bogeyman hunting, anti-vaccine crank
Robert F. Kennedy, Jr., claimed that vaccines and glyphosate are behind the
current obesity epidemic, a ludicrous assertion David Gorski nicely eviscerated 
in a post earlier this year.

In 2018 and 2019, Dr. Novella again reviewed the scientific evidence, this time 
in the context of a lawsuit alleging that an agricultural worker’s lymphoma was 
caused by exposure to Roundup, resulting in a $289 million judgment against
Monsanto, upheld on appeal.

   At present from all existing evidence I think the best conclusion is that
   there may be a small correlation between the highest levels of agricultural
   exposure of glyphosate and some types of lymphoma, but the existing evidence 
   is not of sufficient quality and consistency for a final determination. It
   does warrant further study, but also indicates that any potential risk is
   likely small. In the meantime it certainly makes sense for agricultural
   workers who deal with pesticides of any type to practice good safety – using 
   protection suits and breathing masks, for example.

In adding glyphosate to the Prop 65 list, California itself did a bit of
evidence cherry-picking. In 2015, the IARC classified glyphosate as “probably
carcinogenic” to humans based on “sufficient evidence” that it caused cancer in 
experimental animals and “limited evidence” that it could cause cancer in
humans. However, as the court pointed out in its decision, several other
organizations, including the EPA, other agencies within the World Health
Organization, and government regulators from multiple countries, have concluded 
that there is insufficient or no evidence that glyphosate causes cancer. The EPA
reaffirmed its determination in April, 2019, and again in August 2019, stating 
that it would not approve herbicide labels with a Prop 65 warning, as such
labels would be false and misleading and “misbranded” under the federal
herbicide labeling law.

Nevertheless, as a result of the IARC’s classification of glyphosate as probably
carcinogenic, it was added to the Prop 65 list, triggering the attendant
warning requirement, to take effect in July, 2018.

In November, 2017, Monsanto and several farming associations, including the
National Association of Wheat Growers and the National Association of Corn
Growers, sued the State of California alleging that the listing of glyphosate
under Prop 65 as a carcinogen, and the resulting warning requirements, violated 
their First Amendment rights by forcing them to make “false, misleading, and
highly controversial statements”.

After earlier entering a preliminary injunction precluding California’s
enforcement of the warning requirement, the court considered whether a permanent
injunction was warranted.

California argued that the suit was not “ripe” for a decision because, due to
certain “safe harbor” provisions in the Prop 65 law, enforcement action was
unlikely. That argument was rejected by the court based, in part, on the “bounty
hunter” feature of the law which, in the words of the California Court of
Appeals, made institution of Prop 65 litigation “easy — and almost absurdly easy
at the pleading stage and pretrial stages”.

The court then turned to the question of whether requiring Monsanto and the
other plaintiffs to warn the public of glyphosate’s presumed carcinogenicity
violated their First Amendment rights against “compelled speech”. As explained
by one constitutional scholar, the government may no more compel one to speak
(in this case, in the form of a public warning) than it can punish one for
speaking.

   Speech compulsions, the [U.S. Supreme] Court has often held, are as
   constitutionally suspect as are speech restrictions: “[T]he First Amendment
   guarantees ‘freedom of speech,’ a term necessarily comprising the decision of
   both what to say and what not to say.” [Citations omitted.]

However, the Supreme Court has held that the government can require disclosure
of “purely factual and uncontroversial information” about commercial goods and
services (e.g., requiring sellers to indicate where their products come from;
requiring lawyers to disclose information about fees). That caselaw does not
apply here, the court decided, in light of the inconsistency between the IRAC’s 
determination and that of others, such as the EPA, meaning that the Prop 65
warning about glyphosate was neither factual nor uncontroversial.

Thus, the Prop 65 warning would have to withstand a stricter test to pass muster
under the First Amendment. As summarized by attorneys writing for the FDA Law
Blog, under this standard, California

   may restrict commercial speech when the restriction directly advances an
   important governmental interest and the restriction may not be more extensive
   than necessary to serve that governmental interest. The Court determined
   that the Prop 65 warning for glyphosate is misleading because it requires a
   warning that the chemical is known to the state of California to cause cancer
   when that statement is not true – only one organization concluded glyphosate
   was “probably carcinogenic” (IARC), and a multitude of other organizations
   that reviewed the safety of the product found the opposite. Requiring a
   misleading statement does not directly advance the interest of the state in
   informing consumers regarding potential cancer hazards. Thus, the warning
   could not be justified as a valid restriction on commercial speech and,
   therefore, is contrary to the First Amendment of the Constitution.

As of this writing, no Notice of Appeal appears on the U.S. District Court for
the Eastern District of California’s online docket and the 30-day time for
appeal has passed, indicating that California will not appeal the decision.

As the FDA Law Blog points out, the glyphosate decision may affect ongoing
litigation involving the Prop 65 warning for acrylamide, “a popular target for
bounty hunters”, which is under a similar First Amendment challenge.

   Acrylamide is the result of a chemical reaction (known as the Maillard
   reaction) which takes place in certain types of starchy foods when they are
   cooked at high temperatures or otherwise processed using heat. The Maillard
   reaction contributes to taste, aroma and color. It occurs in a multitude of
   foods such as French fries, breakfast cereals, baked goods and roasted
   coffee.

The plaintiffs, including the California Chamber of Commerce, claim the Prop 65 
warning, based on the IARC and the EPA’s determination of carcinogenicity,
requires producers and sellers of foods containing acrylamide to make false,
misleading, and controversial statements about their products and to mislead
consumers, who will avoid their products based on incorrect information. This is
because, they say, the IARC and EPA relied on studies of lab animals fed or
injected with virtually pure acrylamide and, in fact, there is no evidence that 
acrylamide is a human carcinogen. The district court has yet to rule on that
claim.

The glyphosate and acrylamide cases are two recent examples of litigation
resolving clashes between government-compelled or, in some cases, prohibited
speech and science. These cases have dealt with, among other subjects, a Florida
ban on physicians discussing gun safety issues with parents, San Francisco’s
sugar-sweetened beverage warning law, a prohibition against co-called “sexual
orientation conversion therapy”, and physicians’ forced display of ultrasounds
and recitation of government-scripted information to patients seeking abortions.
No doubt they won’t be the last.

How to make the opioid epidemic worse in Pennsylvania

Two bills are pending in the Pennsylvania legislature – SB 675 aimed at
restricting prescription of buprenorphine, and HB 1005 that imposes reporting
requirements in cases of suspected drug overdose. Both are a bad idea, and I
hope Pennsylvania Governor Tom Wolf will continue his past trends of vetoing bad
bills that will harm his constituents.

Braden MacBeth on December 6, 2019

Link



The opioid epidemic is without a doubt the biggest ongoing public health crisis 
right now. It’s especially bad in my home state of Pennsylvania, which has had
some of the highest rates of opioid overdose deaths for a very long time. In
June, Senate Bill 675 was passed in the PA State Senate and HB1005 passed in the
house. Both of these bills were proposed and passed under the pretense that
they would help stop opioid abuse and prevent opioid overdose deaths. SB675
heavily restricts the circumstances under which physicians can prescribe drugs
such as methadone and buprenorphine to treat opioid-use disorder. SB675 would
also severely punish any prescriber who violates the act, subjecting them to
disciplinary action, license revocation, and possible fines. Put simply, this
bill would put arbitrary constraints on the ability of physicians to treat
opioid use disorder for absolutely no public health benefits. HB1005 would
require healthcare providers to record all patient information if they treat
them for what they suspect is a drug overdose in the PDMP for no real benefit to
anyone. These bills have the potential to seriously impede the public health
effort to prevent opioid deaths, and the politicians that proposed them clearly 
don’t understand opioid use disorder, buprenorphine, or the opioid epidemic.
Let’s look at why.

SB675

PHARM 322: Intro to buprenorphine

Before we can talk about the effects of this bill, we have to talk about
buprenorphine. Buprenorphine was patented in 1965 and approved for use in the
1980s, so it’s been around for a while now. SB675 sort of asserts that doctors
need special training to prescribe buprenorphine. I was under the impression
that doctors already had the necessary training; it’s called medical school,
residency, and CME. While I have none of that special training, my googling
skills are tough to match. Let’s look at what this drug does and why we really
need it. Welcome to PHARM 322, it’s so easy a random programmer at a plastics
company can figure it out.

Buprenorphine is an opioid just like oxycodone, fentanyl, or morphine; but it
has some really cool properties that make it ideal for treating opioid use
disorder. Buprenorphine is a partial opioid agonist, so it doesn’t exhibit the
same effects as other opioids. Fentanyl is a full opioid agonist and binds very 
tightly to the opioid receptors and provides significant pain-relief at the
proper dosage, but low blood pressure and respiratory depression at high
dosages. Buprenorphine only partially binds to the receptor; while it has
similar effects similar to other opioids at low dosages, the effects don’t
increase as you increase the dosage. As a result, it isn’t really possible to
get a euphoric effect or cause respiratory depression with buprenorphine.

Opioid use disorder is a serious medical condition, and the symptoms of opioid
withdrawal can be absolutely brutal. Symptoms of opioid withdrawal include:
restlessness, insomnia, body aches, vomiting, diarrhea, hallucination, and
seizures. A Cochrane review determined that buprenorphine was much better at
relieving the symptoms of opioid withdrawal compared to clonidine or lofexidine.
Patients who received it would stay in treatment longer and be more likely to
complete their scheduled treatment. But buprenorphine has properties that make
it even better than other drugs for treating opioid use disorder.

Let’s say somebody is taking buprenorphine and decides to shoot up a ton of
heroin, what happens? Nothing. Buprenorphine has a very high affinity for the
mu-opioid receptors, and will out-compete most other opioids for the mu-opioid
receptors. The one notable exception is fentanyl, which can compete with
buprenorphine. Buprenorphine also has a half-life of 37 hours. It would be
really, really hard to come up with a drug for treating opioid use disorder with
more ideal properties than buprenorphine. So you’re probably wondering, since
buprenorphine is an opioid couldn’t you abuse it like every other opioid? I
guess, if you ignore the fact that it’s a partial opioid agonist and won’t
really get you that high. There are also a lot of safeguards in place to prevent
people from doing that. Suboxone, one of the most common buprenorphine
formulations, also contains naloxone. When taken orally, the nalaxone simply
isn’t absorbed, but if someone were to snort or inject it the medication the
naloxone would also be absorbed and the buprenorphine would have little to no
effect. Furthermore there are extended release injections that patients can
receive on a weekly basis, so diverting or abusing it literally isn’t possible. 
Finally even if buprenorphine abuse was rampant, it’s not, it would still be
better than everyone doing fentanyl.

SB675: Bad reasons and tall tales

The reasons that politicians have stated for proposing these bills are highly
questionable. On Senator Michele Brook’s website, she explains her reasons for
proposing a bill:

   In the past few years, we have read many unsettling news stories pertaining
   to fraud and the illegal handling of the treatment drug Suboxone, which
   contains the opioid buprenorphine and naloxone…Suboxone has been sold and
   re-sold on the black market and has even become the drug of choice for some
   who are struggling with addiction.

It’s really hard to estimate the size of a black market for suboxone…because…ya 
know…it’s a black market. It’s true that suboxone has become the drug of choice 
for people who are struggling with addiction, that’s why doctors prescribe it.
According to Dr. Michelle Lofwall, an addiction specialist, many people try to
treat themselves when they fail to get into addiction treatment programs. Many
people get buprenorphine off the black market because they have no other way to 
get it. By passing this bill you’re essentially forcing people suffering from
opioid use disorder to either purchase it off the black market or buy other
opioids. Which would you rather they buy off the black market: fentanyl or
suboxone? Not-Pro Pro-Tip: Fentanyl is the one that people are overdosing on.

   She cited several recent instances of abuse. A State Trooper in Huntingdon
   lost his life when a criminal traded his Suboxone for a firearm

Tragically, on December 30th 2016, State Trooper Landon Weaver was shot and
killed when investigating a protection from abuse complaint. According to the
police, his killer had traded five suboxone pills for a stolen handgun. While
this was a tragic, one person using suboxone as a medium of exchange to buy a
gun isn’t really relevant and not a good reason to restrict suboxone. They
could’ve used any other medium of exchange, including, but not limited to:
Pokémon cards, Beanie Babies, CSGO weapon skins and…oh right…cash. Weaver’s
killer didn’t get a gun just because he had access to suboxone to trade for a
gun.

   A child in Scranton was seriously injured when he ingested a strip of
   Suboxone hidden in a Dora the Explorer book.

I’m sorry, but I don’t believe this story. The Dora the Explorer book thing just
makes it too unbelievable. I looked at the PA court records attempting to find 
the case and charges reported in The Times Tribune, but came up empty. It
probably didn’t happen. I’ve reviewed a lot of research on the pediatric
toxicity of buprenorphine, accidental exposure is rare, and deaths are even more
rare. A great write-up in Emergency Medicine News states “accidental oral BPN
exposure is relatively safe when compared with the serious consequences of
morphine or methadone ingestion in children”. A study published in Pediatrics
looked at 86 cases of accidental buprenorphine ingestion and found that
overdoses were generally well tolerated. Poison Control was able to manage 26%
of cases at home without complications. There were no deaths and no report of
serious injury. I don’t buy this story, and it’s certainly not a good reason to 
arbitrarily restrict suboxone. Parents should store their medications in a safe 
place outside the reach of young children.

   In Pittsburgh, the founder and staff of an opioid treatment facility pleaded 
   guilty to health care fraud after submitting claims to Medicaid and Medicare 
   to cover the costs of unlawfully prescribed drugs. And in Philadelphia, a
   doctor admitted to submitting illegal prescriptions for more than 18,000
   doses of buprenorphine, netting him $5 million through these illegal sales.

In both of these cases the providers were committing fraud. They also illegally 
dispensed these medications and fraudulently billed insurers for other opioids. 
It was highly likely that the people receiving the prescriptions were diverting 
those medications. This is the strongest argument you could make in favor of
this bill and even then it isn’t a good argument.

DATA2K and SB675: More harm than good

So with the misinformation and bad arguments out of the way, let’s get into why 
these bills will hurt Pennsylvania’s fight against the opioid epidemic and will 
make it worse. Providers already have to jump through hoops to prescribe
buprenorphine to begin with. In 2000 the Drug Addiction Treatment Act was passed
that placed serious limits on physicians’ ability to prescribe buprenorphine.
The act only allows physicians to prescribe buprenorphine and methadone for
opioid use disorder outside of an opioid-treatment program if they get a special
waiver. In order to apply for the waiver a physician has to, in addition to the
usual stuff, have a specialty or subspecialty certification from the American
Board of Medical Specialties, the American Society of Addiction Medicine, or the
American Osteopathic Association. So how do you get one? You have to take an
8-hour course in buprenorphine. Many of these courses cost money, and would
require taking a day off of work or doing it on the weekend.

After giving up a perfectly good Saturday and doing a bunch of nonsense
paperwork as a physician, can you make it rain suboxone scripts now? Not quite. 
Once you obtain the waiver, you can only prescribe the drug to 30 patients until
the next year, then you can increase you patient panel size. But don’t worry,
after you prescribe at the 30 patient limit for a year, you can put in a request
to increase your panel limit to 275. Now you might reasonably argue that it’s a
bit suspicious a doctor would go from not prescribing buprenorphine at all to
needing to prescribe it to more than 30 patients. Fair enough, but I never
understood Dr. Gorski’s love for Gloryhammer. Spotify doesn’t limit how many
times I can play their music just because I’ve only recently become enlightened.
If doctors are prescribing negligently or nefariously, we can and should crack 
down them. We can do that without putting arbitrary constraints on providers who
are trying to get the appropriate treatment to people who really need it.

Let’s say that physician really does have 31 patients who need treatment with
suboxone. One of those patients is going to need to figure something else out,
and that has real consequences. A JAMA article published in June looked at the
characteristics of US counties with high opioid overdose deaths. 71% of rural
counties, and 46% of non-rural counties, lacked access to a single provider that
could prescribe buprenorphine or methadone. Counties at risk had higher rates
of opioid prescriptions, and lower numbers of providers capable of providing
buprenorphine or methadone treatment. Methadone treatment was associated with a 
53% reduction in deaths, and buprenorphine was associated with a 37% reduction
in those with opioid use disorder. The numbers show we need to expand the use of
these medications, not restrict them.

So what does SB675 add to this absolute dumpster fire of a system for doctors
trying to treat their patients? Well to be able to prescribe a patient
buprenorphine under SB675, the following criteria has to be met:

   (1) The patient provides evidence demonstrating active participation in an
   addiction treatment program licensed by the department.(2) The evidence of
   participation in the addiction treatment program is documented in the
   patient’s medical record.(3) The buprenorphine office-based prescriber is
   certified by the department as provided under subsection (a).

I think there’s an underlying assumption being made with these policies that
doesn’t actually work. The assumption is that buprenorphine isn’t the first line
treatment for opioid use disorder. Buprenorphine is the first line treatment
for opioid use disorder according to the Veterans Health Association,
Up-To-Date, the American Psychiatric Association, and the American Medical
Association.

I’m not going to fault politicians for this misconception here, it’s really easy
to see why they would think that. There’s this term being used by all of these 
very prestigious medical organizations and websites with regard to buprenorphine
and methadone treatment: “Medication Assisted Treatment”. This term is
literally only applied to the treatment of opioid use disorder using medication 
like buprenorphine and methadone. To those medical organizations, I must ask:
could you from a purely PR perspective…stop using that term? It implies that
taking medication is somehow abnormal or wrong. We don’t call taking amlodipine 
to treat hypertension “medication assisted treatment” of hypertension. The use
of the term should be scrubbed from prominent publications in favor of a more
apt term: “treatment”. I’m not pointing this out to be pedantic; our use of
terminology when we communicate with the public really matters. If you want the 
public to see medications for treating opioid-use disorder as normal, you have
to talk about them like they are normal.

While there are a fair amount of certified opioid treatment programs in
Pennsylvania, there are still serious problems with access to them. Researchers 
at the West Chester University of Pennsylvania published an excellent review of 
the availability and efficacy of these programs. The short of it is there are a 
lot of people in Pennsylvania not able to access their care they desperately
need. They found that treatment centers only partially cover the central and
eastern portions of the state. Worse still, there was a lack of access to
providers who could prescribe buprenorphine in northern-most and southern-most
edges of Pennsylvania. Many of these programs have hours of operation that make 
it hard for people to get care from them. This bill will only make it harder for
people to get access to the most effective treatment for opioid use disorder,
and will lead to more overdose deaths as a result.

I want to take a moment to appreciate the absurdity of a world where this bill
is law. Let’s say you are struggling to get off of opioids. Like with all
medical problems, you should probably consult your primary care provider first. 
They could easily diagnose you with opioid use disorder, but they can’t
prescribe you the medication that is the first-line therapy to treat it. In
order for them to do that, you have to go participate in a certified opioid
treatment program which may not even be available to you. Let’s assume you’re
lucky enough to live in an area that has a certified OTP, you can both afford it
and the OTP has operating hours slightly better than a bank. After the time it 
takes to begin active treatment with the OTP, only then you could you go back to
your PCP to get the first line treatment to treat the medical condition that
you have. In addition to paying for on-going treatment from the OTP that you may
or may not need, you also have to pay for additional visits to your doctor.

Maybe you believe that a patient receiving buprenorphine treatment from a
primary care physician instead of being active in a certified treatment program 
is less than ideal. Here’s the rub, we don’t live an ideal world. Our world is
messy and imperfect. We have to make do with less than ideal circumstances. We
can’t just wish our desired circumstances into reality. Buprenorphine and
methadone are the first-line treatment for opioid use disorder, the keystone of 
an effective treatment plan. This bill does nothing to improve the quality of
care those in an OTP are receiving, but limits access to the most effective
treatment option for anyone who isn’t active in an OTP. This will undoubtedly
make it harder for people to access quality medical care, and should be vetoed
as a result.

HB1005

But, like, why though?

HB1005 is an amendment to a bill that was proposed in the House of
Representatives and passed around the same time as SB675 passed in the senate.
It would require that this system be created and that first responders and
physicians document everything about an overdose event, including the name, date
of birth, address, and gender of the victim. In addition to the date and time
of the overdose event, address where the drug-related overdose took place,
whether an opioid antagonist was administered, whether the overdose resulted in 
death, and the identity of the drug the person overdosed on within 2 weeks of
the overdose event occurring.

There are a lot of ridiculous assumptions being made here. I really doubt such a
system would be of much use to doctors in the case of opioid overdose because
the treatment is the same regardless of what opioid was overdosed on. Did they
overdose on opioids and are they suffering from respiratory depression? Then
give Naloxone. The system would only be beneficial if a physician has already
seen the patient for opioid overdose, and the record was in the system and could
be found. Chances are high except that if someone overdoses and goes to the
emergency room two times, they’re going to the same emergency room and probably 
seeing the same physician. The hospital wouldn’t need access to such records
because they already have them, they’ve seen the person before. So really the
only case this system would be beneficial is if someone suffered from an opioid 
overdose once, overdosed again and was taken to a different hospital, the
physician successfully looked up the patient in the system, and physicians
actually needed that information to successfully treat the patient in the first 
place. I would usually say something like “I’m sure there’s some hypothetical
edge case where that might be a good idea, but also don’t do that”, but I can’t 
even come up with a good hypothetical edge case. The PA Medical Society (PAMED) 
has come out against the bill stating that it would require physicians and first
responders to get information about the patient that may not be readily
available. In my opinion it would require spending lots of money to modify an
existing system that provides little to no benefit. I think that money could be 
better spent actually tackling the opioid epidemic and not annoying medical
professionals.

Conclusion: Nope. Nope. Nope.

We do a lot of things better than other states here in Pennsylvania, and it’s
hard not to feel a little tribalistic. We have neat stuff here that Californians
could only dream of like water, and not selling plasma to pay for an apartment.
We’re better than Florida at not being Florida. But we’re also showing up the
lesser states in opioid deaths, where we are the uncontested champions.
According to the CDC data in 2017, Pennsylvania had 5,388 overdose deaths, the
highest number of opioid deaths in the entire country. There is a lot that could
be done to combat this problem, and it would be easy to make headway on this
issue.

HB1005 does nothing to empower healthcare professionals, gives them more
meaningless paperwork, and would be a waste of public money. SB675 would
arbitrarily restrict access to buprenorphine treatment to an even more absurd
degree. These bills were based on nothing more than misconceptions about opioid 
use disorder and buprenorphine, and urban legends. SB675 will make
Pennsylvania’s opioid problem far, far worse. When doctors get their license to 
prescribe controlled substances, they can prescribe whatever opioids are
necessary with no issues. But if a patient gets addicted to those opioids by no 
fault of either party, doctors have to jump through all kinds of regulatory
hoops to be able to take care of that patient. This is ridiculous and the most
obvious opportunity for improvement. Why would we want to make this problem even
worse with SB675? This is an epidemic and we have no margin for error.

Unfortunately, I think that both of these bills are going to pass the house and 
senate. Both of these bills have passed either the house or senate, and will
probably pass the other chamber. Despite the objections of PAMED and the
Pennsylvania College of Emergency Physicians. I don’t think we can sway a
majority vote in either chamber, but we can convince one person to do the right 
thing and that’s all that matters. I’m going to need your help with this, but I 
think we can get PA Governor Tom Wolf to see this post.

A personal note for the Governor of Pennsylvania Tom Wolf

Hi there! I genuinely like you, Governor Wolf. You have consistently done the
right thing and vetoed bills that are an affront to science, decency, and common
sense. Like when you vetoed SB321, which would imposed nonsensical restrictions
on doctors’ abilities to provide care and women’s right to make decisions about
their health. I’m just asking you to go to bat for Team Science and more
importantly Pennsylvania yet again. These bills will only make things worse.
Don’t take it from me, listen to the experts at the American Medical
Association, the American Psychiatric Association, the PA Medical Society, and
the PA Psychiatric Society.

But while we’re on the topic, now is as good a time as any to talk about real
ways to combat the opioid epidemic. The American College of Toxicology, the
American Academy of Emergency Medicine and the American College of Emergency
Physicians have all endorsed removing the buprenorphine waiver requirement. A
public health campaign to teach the public about buprenorphine treatment would
go a long way at fighting the myth that it’s “substituting on addiction for
another”. I am more than happy to talk to anyone in the PA House of
Representatives, Senate, or the governor’s office about these issues anytime.
Governor Wolf, please treat SB675 and HB1005 like I treat de_train on FaceIt:
veto that trash.

More, please! A victim of cancer quack Robert O. Young wins a $105 million
settlement

Robert O. Young is a cancer quack who claims to be a naturopath who promotes
what he calls “pH Miracle Living.” He claims that cancer is caused by excess
acid and that the way to prevent and cure cancer is to “alkalinize the blood.”
Two and a half years ago, he was convicted of practicing medicine without a
license. Last week, a woman whose breast cancer progressed to incurable while
being treated by Young won a $105 million settlement in a lawsuit against him.
Maybe civil suits can succeed where state medical boards have failed.

David Gorski on November 5, 2018

Link



A major focus of my blogging for Science-Based Medicine (SBM) has been to
leverage my understanding of cancer as a cancer clinician and scientist to
deconstruct alternative cancer cure testimonials. Whichever quack is behind such
testimonials, over the years I’ve made it one of my main goals to demonstrate
how seemingly convincing stories are damned near close to never good evidence of
an anticancer effect due to the intervention used in the testimonial. Indeed, I
refer to these stories as “testimonials” rather than anecdotes or case reports.
In medicine, the word “case report” has a specific meaning as an organized,
detailed description of a case, something that testimonials almost always lack. 
In reality, these testimonials are marketing, either to sell a product to make a
profit, to sell a story because the patient telling the story has become a true
believer in the quackery chosen, or both. Unfortunately, as we learned from a
survey released by the American Society of Clinical Oncology (ASCO) last week,
belief in alternative cancer cures is prevalent in the US, with 39% of the
population agreeing with a statement that alternative medicine “natural
treatments” can cure cancer by themselves, without conventional surgery,
chemotherapy, or radiation therapy, a percentage that approaches 50% among young
adults.

From my perspective, a large part of the reason for the prevalence of beliefs
like this is that alternative cancer cure testimonials are effective. They’re
the reason that cancer quacks like Robert O. Young attracted people with cancer 
to Rancho del Sol, his 40-acre ranch located in Valley Center, California, for
so many years before the law finally caught up with him, promising to cure them 
with his “pH Miracle Living” program, which involves “alkaline water” and a
number of other treatments claiming to “alkalinize the body.” I’ve written about
Young’s quackery rather extensively, particularly in this post and on my
not-so-super-secret other blog; so I won’t go into a lot of detail, other than
to point out a couple of things. First, this was what Young claimed about
cancer:

   The following is a summary of understanding cancerous tissues:

   Cancer is not a cell but a poisonous acidic liquid.

   A cancer cell, is a cell that has been spoiled or poisoned by metabolic or
   gastrointestinal acids.

   A tumor is the body’s protective mechanism to encapsulate spoiled or poisoned
   cells from excess acid that has not been properly eliminated through
   urination, perspiration, defecation or respiration.

   The tumor is the body’s solution to protect healthy cells and tissues.

   Cancer is a systemic acidic condition that settles at the weakest parts of
   the body – not a localized problem that metastases.

   Metastases is localized acids spoiling other cells much like a rotten apple
   spoiling a bushel of healthy apples.

   There is no such thing as a cancer cell. A cancer cell was once a healthy
   cell that has been spoiled by acid.

   The tumor is not the problem but the solution to protect healthy cells and
   tissues from being spoiled from other rotting cells and tissues.

   The only solution to the acidic liquids that poison body cells causing the
   effects that medical savants call cancer is to alkalize and energize the
   body.

   In conclusion, the human body is alkaline by design and acidic by function!
   If we desire a healthy body we must maintain that alkaline design.

This is wrong on so many levels, particularly the part about cancer cells being 
healthy cells “spoiled by acid” but also including his claims that “alkalinizing
the body” will cure cancer. I also note that he claimed that viruses are
“molecular acids” (he claimed his “pH Miracle Living” could cure HIV/AIDS as
well) and that he is basically a germ theory denialist as well, having used the 
tragic death of a Brazilian model due to sepsis to claim that sepsis is not
caused by bacterial infection, but rather by “acidic lifestyle choices,
including acidic food, drink, and drugs – especially dextrose and/or antibiotic 
IV’s given at hospitals around the world.”

However, the case that made Robert O. Young most infamous was that of Kim
Tinkham. Tinkham, you might recall, was a woman diagnosed with breast cancer who
appeared on The Oprah Winfrey Show over 11 years ago. During the interview,
Tinkham told Oprah that she was not going to undergo surgery, chemotherapy, or
radiation but that, thanks to The Secret, she believed that the universe would
bring her healing, which was why she chose to use alternative medicine to treat 
her cancer. (Often forgotten these days is that Oprah was a big proponent of The
Secret back then, which preaches that if you want something badly enough,
visualize something clearly enough, the universe will manifest it for you.) Who 
was the quack that Tinkham chose? You guessed it: Robert O. Young. As a result, 
Tinkham became a passionate advocate for Young’s quackery, even recording
YouTube videos with him to tout his “pH Miracle Living.” Ultimately, Tinkham
died of her disease, although it did take over three years to happen. No one
knows how many other cancer patients who didn’t talk to Oprah Winfrey chose to
trust Young, with the same results.

Oddly enough, none of them ever sued Young; that is, until now. Indeed, last
week was a very bad week for Robert O. Young, because he was on the wrong end of
a $105 million judgment of a lawsuit brought by one of his victims. First,
however, let’s back up a couple of years to see what befell Young.

The further fall of Robert O. Young

As I alluded to above, the law finally did catch up with fake “doctor” Robert O.
Young nearly three years ago, when he was arrested for practicing medicine
without a license, as well as other charges, including fraud. He was convicted
of multiple counts of practicing medicine without a license, but the jury
deadlocked on other charges, including the fraud charges. The prosecutor planned
to retry him for the charges over which the jury had deadlocked, but ultimately
a plea deal was struck in which Young did spend time in prison, had to admit in
open court that he was not a microbiologist, hematologist, a medical or
naturopathic doctor, or a trained scientist, and could no longer offer any sort 
of medical treatments at his ranch. (Basically, Young claimed to be a
naturopath, but he had actually gotten his degree from a diploma mill.)

Since he got out of prison, I haven’t heard much about Young, and that’s good.
It means that he hasn’t been practicing his quackery. Oddly enough, though, I
also never heard about the lawsuit brought against him in late 2015 by a former 
patient of his, Dawn Kali. (Oh, well, I guess I can’t catch everything.) The
suit specifically charged Young with holding himself out as a licensed medical
doctor, advising Kali (who had been diagnosed with breast cancer) not to have
her tumor removed or to undergo chemotherapy, and treating her with his “pH
injections” and other alternative medical therapies. Her further claim was that 
this was all done under the cover of a doctor named Ben Johnson who “did not
have a physician-patient relationship with Plaintiff, but negligently allowed
Defendants Young and pH Miracle Living to use his name and license as a cover
for their negligent, unlicensed, conduct.”

Here’s a news story from a couple of weeks ago, when the case went to trial:

From the story:

   He [Young] is now defending his controversial therapies in civil court, where
   former patient Dawn Kali is suing him for fraud and other wrongdoing.

   Kali told the jury she was diagnosed with breast cancer 10 years ago. She
   explained in detail how she rejected chemotherapy, radiation and other
   conventional Western cancer treatments and instead followed Young’s advice
   and alternative treatments.

   Kali said her cancer continued to spread, despite Young’s reassurances that
   his treatments, if followed strictly, would cure her disease.

   One of Kali’s attorneys, Bibi Fell, said her client now has stage four
   invasive breast cancer and has a life expectancy of about four years.

   Kali’s lawyers are asking the jury to award their client more than $10
   million in general and punitive damages.

To be sure, a ten year course without treatment is considerably longer than
average for breast cancer. As I’ve discussed many times before, we know from
historical data from Middlesex Hospital in the UK that the median survival for
untreated breast cancer in the pre-mammography era was 2.7 years. However,
breast cancer is a very heterogeneous disease, and biologically it can behave
very differently in many women, and we also know from the same study that there 
is a “long tail” to the survival curve, with 3.6% of women with untreated breast
cancer being alive at ten years. These days, we would expect the number to be
larger, given that so many breast cancers are diagnosed by mammography and are
thus much earlier in their progression than cancers diagnosed during the period 
85-203 years ago covered by the study to which I’m referring. None of this means
that Young actually helped her or that any of his methods are effective against
cancer. There’s no evidence that they could be or that they are. It just means 
that Kali likely has a more indolent form of breast cancer.

You might notice that the lawsuit only asked for $10 million (although another
site implied that $50 million was being sought). The verdict, however, included 
an award to the plaintiff much, much larger than that:

I’m not a lawyer, but whenever a jury awards a plaintiff a lot more money in
judgment than was being requested, it’s usually to send a message. This can be
because the plaintiff was particularly sympathetic and/or the defendant was
particularly unsympathetic or clearly lying and/or the offense was particularly 
egregious.

I only have part of the trial transcript, but it’s Young’s testimony (PDF1 and
PDF2). Predictably, he testified that Kali knew he wasn’t a medical doctor and
that she was free to seek conventional cancer care any time, but a lot of his
other testimony was pretty damning. We learn from him that “retreats” at his
ranch were a minimum of seven days and could run up to $2,000 a day. Of course, 
she likely heard disingenuous responses like this one, which came in response to
a question about whether or not Young had ever done “blood analysis” on Kali’s 
blood:

   Well, for the benefit of those who are listening to this testimony, the live 
   blood test is a test where you take a finger prick and you take that one drop
   of blood and you put that on a slide. Then using a compound microscope you
   look at those cells. And there are specific ways that those particular cells 
   should look. So it’s not a quantitative test. It doesn’t give you a number,
   it gives you a view.

   And since red blood cells are being changed at 5 million per second, that
   picture could evolve different ways over a period of 120 days, which is the
   life of a red blood cell.

   So I would take a drop of blood, not for diagnostic purposes, but I would
   take a drop of blood, I would put that on a slide and allow the client to see
   the quality of their blood.

   And based on millions of samples of blood that I have taken over 40 years, it
   is obvious to someone who has been trained in live and dry blood cell
   microscopy by one of the greatest scientists in the world – – Professor
   Murray Reicher from Essen, Germany — that when you are studying looking at
   blood, it’s not to diagnose any disease, but to allow that person to see the 
   quality of the blood and to note changes in that blood if someone is doing
   lifestyle changes or diet changes. It’s been the nature of my research for 40
   years.

“Live blood analysis” (as well as “dried blood analysis”) is utter quackery.
It’s basically looking at blood and making things up about it. It’s not for
nothing that Mark Crislip once referred to it as “the modern auguries.”

Now here’s the disingenuousness:

   I looked at Dawn’s blood and what I said, I can’t remember. But I would have 
   commented not quantitatively, but qualitatively. I would show her a picture
   of what a healthy red blood cell looks like — which is round and symmetrical,
   even in color, even in shape, even in size — and I would show her a picture 
   of what unhealthy blood looks like, which is uneven in shape, uneven in its
   color, and its form.

After this he denied telling Kali whether he saw cancer cells in her blood,
going on about how you can’t see cancer cells in blood analysis. He also claimed
that he was just trying to help, that he never charged Kali anything, and that 
the pH Miracle Ranch paid for thermography, cancer marker tests, ultrasounds,
and more. Then he kept being disingenuous during his questioning by the
plaintiff’s attorney:

   Q. Did you advise Dawn Kali not to get a biopsy of the lumps in her breast
   and armpit?

   A. That was her decision. I never told her not to get a biopsy. Never.

   Q. Did you ever recommend to her not to get a biopsy?

   A. Never.

   Q. Did you ever recommend to her not to get surgery?

   A. Never. That was her decision in 2007, 2009, 2012, even when she went to
   the doctor in 2013. This is all Dawn Kali.

   Q. Did you ever recommend to her not to get radiation?

   A. That subject never came up. I never heard that word, “radiation,” coming
   out of her mouth.

   Q. Did you ever recommend to her not to get chemotherapy?

   A. Absolutely not. We had clients that were receiving chemotherapy, and we
   supported any client and their medical doctors.

   Q. Did you ever recommend to any of your clients not to get a biopsy?

   A. That’s beyond my belief system. You know — yes, you know, Hippocrates
   says, you know, do no harm, but the bottom line is the patient is in control 
   of their decisions. It’s their decision, not my decision. Absolutely would I 
   — would I not tell somebody not to do something, especially if they are
   getting advice from their medical doctor. It’s just — I can’t — I can’t
   oversee that. And that just goes beyond — beyond my belief system.

I wouldn’t believe Young about any of this, given his long history of writing
how the treatment for cancer is not chemotherapy, radiation, or surgery, but
correcting the patient’s pH, and I’m guessing the jury didn’t believe him
either, given that he was led through some of his past quack claims in one of
his books by the plaintiff’s attorney and reconfirmed his belief in all of them.
For example:

   Q. (As read): “Cancer is not a cell but an acidic liquid that spoils
   ourselves, whatever acids are not properly eliminated through urination,
   perspiration, respiration or defecation.”

   Do you agree with that statement?

   A. Yes.

   Q. (As read): “Hence, all cancers are the expulsion of acids from the blood
   and then tissues at different points and are essentially of the same
   character and evolving from the one cause, namely, systematic acidosis.”

   Do you agree with that?

   A. Absolutely.

   Q. (As read): “Breast cancer is the leading cause of death in women, and
   these fatty tissues, parenthesis, breast areas, are being used by the body to
   bind or collect the acids in order to protect the organs that sustain life?”
   Do you agree with that statement?

   A. Yes.

   Q. (As read): “If you don’t want cancer, if you want to prevent it, you have 
   to pee or eliminate your acid through urination or perspiration. And if you
   are a cancer sufferer, you have to pee your way to health because cancer is
   not a cell but a poisoning acidic liquid.”

   Do you agree with that?

   A. A poisoning acidic liquid of the cells, yes.

   Q. Of the cells? You mean in the cells?

   A. No. Can I explain?

   Q. You’ll have a chance when your lawyer —

   A. I’ll explain later. Okay.

   Q. (As read): “So cancer is a systematic acidic condition that settles in the
   weakest parts of the body, not a local problem that metastasizes. You see,
   metastases is localized acid that spoil other cells much like a rotten apple 
   spoiling the bushel of other healthy apples.” Do you agree with that
   statement?

   A. I do.

   Q. (As read): “The cure, the prevention, the reversal for cancer is not found
   in the treatment of tissue but rather in maintaining the alkaline design of 
   the human organism. And the most important test that you can do to determine 
   whether you are in a state of over acidity is testing the pH of the fluids.”

   Do you agree?

   A. I agree.

   Q. (As read): “So are tumors bad or good? They are good because they are the 
   expression of the body in preservation mode trying to prevent healthy tissue 
   from spoiling.”

   Agree or disagree?

   A. I agree.

This goes on for several pages of the transcript, during which Young repeatedly 
confirms his belief in cancer as reaction to cells “spoiled by acid”, his belief
that bacteria don’t cause infections, and a number of other pseudoscientific
beliefs. Worst among these is victim blaming, in which he agreed with statements
from his book stating that:

  1. “All cancerous tissue is curable, not all patients are. I’ll say it one more
    time. All cancerous tissue is preventable, reversible, curable, but not all 
    patients are because they are not willing to do what it takes to bring their
    body in balance.”

  2. “Cancerous tissue by any name is nothing more than a consequence of choice.”

  3. “Someone doesn’t get breast or brain cancer. You have to work on it every
    day.”

It kept getting worse and worse. Young claimed that over 300 patients had come
to his ranch with cancer and left without it, that he had a high success rate
with stage IV metastatic cancer.

He also compared himself to Jesus.

The verdict, and why more victims of quacks should sue

Assuming that the plaintiff’s attorney did her job well (and she appears to
have), Young’s testimony had to be disastrous, as he blathered on about how
cancer is the body’s reaction to cells “spoiled by acid,” how viruses are
“molecular acids,” how cancer can be cured with diet and “alkalinization” alone,
and tried to evade questions. We also learn that, since he got out of prison
has been doing some lectures, although he denies that he’s done any retreats. On
the other hand, he sounded as though he planned on doing a retreat in Italy in 
2019. I got the impression from his testimony that Young was definitely planning
on taking his quackery overseas as soon as he can. I can’t help but wonder if
that’s another part of the reason that the jury ruled as it did, for a total of 
$105 million.

Young and his attorney Conrad Joyner also, predictably, blasted the verdict:

   “It’s totally outrageous,” Young said of the verdict when reached by phone
   Friday afternoon. “It’s one-tenth of a billion.”

   He also said it was “appalling” that the jury awarded so much more than the
   plaintiff had sought.

And Joyner’s reaction:

Joyner said he sees the case as “ripe for appeal”:

   “I have never heard of a jury case with that much damages where the jury
   comes back in about three hours,” Joyner said. “I wonder how much thought
   they really put into it.”

   Young said there was “a tremendous amount of evidence” he was not allowed to 
   present to the jury. He said he would appeal.

Of course he will.

I’ve discussed before how ineffective state medical boards are in reining in
even utter quacks. It’s problem that’s frustrated me ever since I started paying
attention to cancer quackery and other alternative medicine. Not infrequently, 
I’ve wondered why victims of cancer quacks (or their families, given that the
victims usually die of their cancers before a lawsuit can be concluded) don’t
sue the quacks who victimized them more often. I suspect that part of the reason
is embarrassment on the part of the patient and family that the patient has
been taken advantage of and believed the quack. On the other hand, people who
have been financially defrauded for other reasons don’t seem to have this same
reluctance to sue.

Whatever the reason, if there’s one thing I can say about this case is that it
couldn’t have happened to a more appropriate guy. Robert O. Young was one of the
first cancer quacks I took notice of back when I was first discovering how deep
the rabbit hole of alternative medicine is. He’s been one of the most
egregious, preaching the most blatantly pseudoscientific nonsense and charging
huge sums for it. So you’ll pardon me if I’m feeling more than a bit of
schadenfreude to see him not only having had to serve time in prison, but to be 
facing a judgment and selling his ranch, for which he’s asking $3.2 million.

More please. I want to see more victims sue their quacks. Maybe if state medical
boards can’t stop them, civil lawsuits can. A guy can dream, can’t he?

Report: Health Care Sharing Ministries pose risks to consumers and insurance
markets

Health care sharing ministries are exempt from virtually all regulation, do not 
guarantee payment, and offer extremely limited coverage. Because their features 
closely resemble traditional insurance products, they can confuse consumers into
thinking they are buying conventional health insurance.

Jann Bellamy on August 16, 2018

Link



A recent report highlights risks to consumers and the insurance market posed by 
health care sharing ministries (HCSMs), religious organizations (mostly
Christian) which cover members’ healthcare costs through contributions from
other members. HCSMs are exempt from virtually all regulation, do not guarantee 
payment, and offer extremely limited coverage. Because their features closely
resemble traditional insurance products, they may confuse consumers into
thinking they are buying conventional health insurance. And because HCSMs
operate outside the purview of insurance regulators, lack of data hampers
assessment of their impact on consumers and the health insurance market.

“Health Care Sharing Ministries: What Are the Risks to Consumers and Insurance
Markets”, was authored by health policy experts from Georgetown University and
funded by The Commonwealth Fund, a charitable organization which describes
itself as supporting a “high-performing health care system that achieves better 
access, improved quality, and greater efficiency, particularly for society’s
most vulnerable”. The authors analyzed laws governing HCSMs in all states,
interviewed officials in 13 states, and reviewed membership requirements and
benefits of five HCSMs.

HCSMs resemble health insurance, so consumers may think they are purchasing
health insurance, when, in fact, they are not. The most striking difference
between HCSMs and health insurance is the lack of guaranteed payment, even when 
a member’s health care expenses are included under the HCSM’s benefits package. 
And, as we shall see, members may have little recourse against their HCSMs if
they are stuck with the bill.

In a typical health care sharing ministry, according to the authors, members
contribute periodically (usually monthly) to cover the medical expenses of other
members. HCSMs either match paying members with other members who need funding 
for health care costs or pay covered medical expenses directly from the pool of 
contributions. Most have features that mimic traditional insurance, such as
payments resembling deductibles, monthly premiums, co-payments, a defined
benefits package, use of provider networks, and levels of coverage similar in
name to policies governed by the Affordable Care Act (e.g., gold, silver and
bronze plans). HCSMs are sold by brokers, who are paid commissions, just like
traditional health insurance.

Yet, because they don’t meet the Affordable Care Act’s (ACA) definition of
“insurance”, HCSMs are not subject to the consumer protection provisions of the 
ACA. And although some courts have declared that HCSMs legally constitute the
business of insurance, no state currently regulates HCSMs as insurers, exempting
them from the laws governing conventional health insurance companies. Thirty
states have enacted “safe harbor” rules that specifically exempt HCSMs from
insurance regulation if they comply with minimal reporting requirements. In
contrast, state insurance laws typically protect health insurance policy holders
through, for example, minimum capital and surplus requirements (to ensure
claims are paid), examinations, financial statement reporting requirements, and 
complaint procedures.

Because HCSMs are not subject to the ACA’s consumer protection provisions, major
differences exist between ACA-compliant conventional health insurance and an
HCSM that could profoundly impact members’ health and finances. Coverage for
pre-existing conditions, required by the ACA, may be limited or excluded
altogether. The report’s authors note that most HCSMs will share costs for
pre-existing conditions only if the condition was cured and year or more has
passed without symptoms or treatment. For example, a Samaritan Ministries
member’s heart condition would not be eligible unless symptom- and
treatment-free for five years. While the ACA bans charging higher rates based on
health status, HCSMs do not and some refuse membership to those who cannot pass
a medical exam. Nor do HCSMs have to cover the ACA’s essential benefits, such
as preventive care, like vaccines, or prescription drugs, and most either do not
provide this coverage or have significant limitations. HCSMs do not have to
comply with the ACA’s dollar caps on health care services or out-of-pocket
expenses either.

My own review of the report’s “Key Features of Health Care Sharing Ministries”
revealed that religious belief appears to outweigh good medical care in some
instances. For example, maternity services are eligible for cost sharing under
Altrua Ministries coverage only if the woman is married. Medi-Share Christian
Care Ministry excludes “non-Biblical lifestyles and choices” such as alcohol and
drug-related injuries and out-of-wedlock maternity. Most HCSMs excluded mental 
health expenses, such as psychiatric care, and one excluded conditions caused by
weight gain.

Examples of HCSMs refusing to pay medical expenses have been reported in the
media. One organization, Christian Healthcare Ministries, went into receivership
with $34 million in unpaid claims and a $14 million judgment was entered
against two of its officials for fraud and breach of fiduciary duties.

HCSMs were originally created as an option for religious communities that
objected to traditional insurance. Since the ACA passed, however, HCSMs are
being marketed more broadly, including to employers for employee coverage, and
sold by insurance agents. Although the lack of state oversight means enrollment 
figures are hard to come by, estimates are that HCSM membership has grown from
fewer than 200,000 to one million since enactment of the ACA. States reported
that there was an increase in marketing of HCSMs during open-enrollment periods,
along with a concomitant increase in calls from consumers, mostly from those
who incorrectly believed they had purchased health insurance.

   Most [officials] expressed concern that some [HCSMs] appeared to be
   functioning in ways that differed from their original intent. Nearly all
   respondents who noted such concerns said that many HCSMS use features that
   are very similar to insurance and may therefore mislead consumers into
   thinking they are enrolling in coverage that guarantees payment for a covered
   claim.

Of the 30 states that exempt HCSMs from the laws regulating insurance, five
don’t even require written disclaimer that the organization is not an insurance 
company. Only six require an annual audit. This lack of regulation has left
state officials in the dark: None of the officials from 13 states interviewed
for this report could say for sure which HCSMs were active in their state or how
many individuals were enrolled. Because they have no legal mechanism for
getting information from these organizations, some officials resorted to reading
local news reports or HCSM newsletters to gather more information.

Unlike health insurers subject to state insurance laws, there is no specific
legal mechanism for acting on consumer complaints either. One official noted
that the state couldn’t act on consumer complaints of unpaid claims unless there
was evidence of actual fraud.

Another concern: drawing healthy individuals from the ACA-regulated market,
potentially affecting the individual market risk pool. Some regulators suspect
that HCSMs are drawing people priced out of the ACA marketplace coverage because
they don’t qualify for premium subsidies. While HCSMs do have lower up-front
costs, consumers may not understand what they are buying and be in for a nasty
surprise when payment is not forthcoming for an expensive medical procedure even
though it is eligible under the HCSM’s plan.

Yet there is legislative hostility to regulation of HCSMs:

   Regulators in one state had begun taking action against an HCSM for doing
   business without obtaining a license, but the legislature responded by
   passing a safe harbor. Another respondent said that legislation to strengthen
   their safe harbor’s notice requirement had been defeated, making regulators 
   doubtful they could obtain even modest protections for consumers. Following
   regulatory scrutiny of an HCSM’s operations, a third state’s legislature
   expanded the definition of HCSMs exempt from state regulation, making the
   HCSM’s operations legal under the revised safe harbor definition.

The health policy experts who authored the report suggest that, at a minimum,
all states, regardless of whether they have a safe harbor for HCSMs, should
collect data; for example, obtaining membership numbers through required audits 
and monitoring the use of brokers. That, at least, would allow states to better 
understand the role HCSMs are currently playing in the insurance market.

In my view, this legislative pampering of HCSMs is of a piece with the broader
effort by Republicans to undermine the Affordable Care Act (along with “skinny” 
plans, association plans, and the repeal of the individual mandate), perhaps
with a dose of deference to religious ideology thrown in for good measure. Of
course, the larger problem is that the U.S. continues to resist sane solutions
to health care coverage that other first-world nations figured out long ago. The
result is, according to the National Association of State Legislatures:

   When compared to other countries—Australia, Canada, France, Germany, the
   Netherlands, New Zealand, Norway, Sweden, Switzerland and the United
   Kingdom—the United States ranks last or near the bottom on measures related
   to health indicators, such as access, efficiency and equity.

In those countries, the idea that health care sharing ministries are a viable
option for paying healthcare costs would be greeted with the disdain the idea
deserves. In the U.S., we not only consider HCSMs a reasonable alternative to
health insurance, we protect them from effective regulation.

Reiki: Fraudulent Misrepresentation

Jann Bellamy on June 12, 2014

Link



The Center for Integrative Medicine at the Cleveland Clinic sells reiki
treatments (also here) to patients with cancer, fertility issues, Parkinson’s
Disease and digestive problems, as well as other diseases and conditions. The
Center’s website ad describes reiki as

   a form of hands-on, natural healing that uses universal life force energy . .
   . [a] vital life force energy that flows through all living things. This
   gentle energy is limitless in abundance and is believed to be a spiritual
   form of energy. The Reiki practitioner is the conduit between you and the
   source of the universal life force energy. . . You may experience the energy 
   as sensations such as heat, tingling, or pulsing where the practitioner
   places her hands on your body, or you may feel these sensations move through 
   your body to other locations. This is the energy flowing into you.

This “universal life force energy” is described as having certain positive
effects on one’s own energy, such as “energetically balancing” one physically,
replenishing one’s supply of energy, improving distribution of that energy in
the body, and dissolving “energy blockages.” It also increases one’s
“vibrational frequencies,” although how these frequencies relate to one’s
energy, or to anything else for that matter, is not made clear.

The Center claims that reiki has specific medical benefits. These include:

  1. Lessening symptoms and side effects of traditional treatments

  2. Success in all types of physical healing

  3. Detoxifying the body

  4. Pain relief

  5. Stimulating bone and tissue healing after injury or surgery

  6. Stimulating the body’s immune system

If you are in good health, the Center recommends monthly reiki treatments to
“enhance your ability to respond to unhealthy elements in your environment and
help you to handle stress.”

For those of you not familiar with the Cleveland Clinic, it is a top ranked (and
here) U.S. hospital, although it has experienced some difficulties of late.
According to its website:

   All health information posted on the site is based on the latest research and
   national treatment standards, and have been written or reviewed and approved
   by Cleveland Clinic physicians or health professionals unless otherwise
   specified.

The website is HonCode certified.

The Cleveland Clinic is not the only hospital selling reiki to patients.
According to a recent article in the Washington Post:

   More than 60 U.S. hospitals have adopted Reiki as part of patient services,
   according to a UCLA study, and Reiki education is offered at 800 hospitals.

The Cleveland Clinic touts this popularity as a selling point for reiki:

   Its popularity has spread all over the world, and is now used in many medical
   facilities, such as hospitals and hospices.

Which brings up an interesting question: Could a medical facility’s selling
reiki to the public give rise to an individual or class action lawsuit for
fraud? If so, then hospitals and other health care facilities are needlessly
subjecting themselves to liability, something they generally go to great strides
to avoid.

Homeopathy could serve as a cautionary tale for the hospital industry. Numerous 
class actions based on fraud, as well as consumer protection laws, have been
filed against homeopathic remedy manufacturers in the last several years. (Class
actions can aggregate many small claims of financial loss for plaintiffs
unlikely to bring individual suits.) To my knowledge, all of these have settled,
costing the companies millions of dollars. One manufacturer has decided to opt 
out of the American and Canadian markets because of liability concerns.
Homeopathic products are still very much on the shelves but, then again,
homeopathic remedy companies seem fairly shameless. I would think that medical
facilities, which trade on their reputations for excellence in patient care,
have a lot more to fear from a suit for fraudulent misrepresentation.

I wrote about CAM and fraud a couple of years ago, but it is a subject worth
revisiting. As we’ve seen, the mere lack of scientific plausibility, evidence of
effectiveness or collateral damage doesn’t appear to penetrate the mindset of
those who engage in CAM promotion. Perhaps the unseemly optics of being a
defendant in an action for fraud, plus the possible financial impact, could
chill the passion for integrating pseudoscience into otherwise respectable
medical organizations.

The law of fraudulent misrepresentation

What is fraud? It can take a number of forms: tort, contract, criminal. The
concept has been incorporated into several specialized state and federal laws,
such as deceptive trade practices, consumer protection and securities laws.
Here, we are discussing what is known as the tort of fraudulent
misrepresentation, also called deceit. Fraud is a very old concept adopted in
America from the English legal system when it became an independent country with
its own system of laws. While the law of fraudulent misrepresentation varies in
some respects from jurisdiction to jurisdiction, here we’ll use a general
statement of its elements from the Restatement 2d of Torts. (The Restatement is 
sort of “best practices” guide to certain areas of the law composed by experts
in the field.)

If you want to successfully sue someone for fraudulent misrepresentation, you
have to prove certain defined elements of that tort. Let’s imagine a
hypothetical case in which the plaintiff is a cancer patient who receives
ongoing treatment at a certain hospital. In our discussion, we’ll assume that
the patient has seen the hospital’s website advertisement for reiki and that it 
contains the same information as the Cleveland Clinic’s ad. The patient has
decided to purchase a session with one of the hospital’s integrative medicine
center’s practitioners. We’ll also assume that the information given to our
cancer patient in person is the same as, or at least not inconsistent with, the 
information in the ad.

Here’s what the patient will have to prove to win his case against the hospital:

  1. The hospital fraudulently made a misrepresentation of fact or opinion.

  2. The hospital intended to induce the patient to purchase a reiki session.

  3. The patient acted in justifiable reliance on the misrepresentation.

  4. Pecuniary damage to the patient resulting from his reliance.

Let’s get a few of these out of the way right off the bat. The hospital
obviously intends that the patient rely on its advertisement for reiki in
purchasing its services, that is, it “intends to induce plaintiff to act.” And, 
to the extent the patient paid for those services, the patient has suffered
damages, even though the amount may be small. The hospital would also be liable 
for any physical harm caused by reiki. As reiki has no known ill effects, a fact
that undercuts its very credibility as a treatment, we can safely assume
physical harm won’t be an issue.

(Although it would certainly make for an amusing case if the patient claimed
that reiki actually messed up his “energy distribution,” thereby making him even
more ill. How would the hospital defend against that? Would it put on evidence 
that this energy doesn’t exist and can’t cause any harm, thus proving the
patient’s case for misrepresentation?)

Misrepresentation of facts

To recap, here’s what the patient is told: During reiki, a practitioner receives
energy from a source, then proceeds to replenish the patient’s own energy
and/or manipulate the patient’s energy by causing it to move through the body.
The practitioner can also unblock energy to facilitate its proper flow.
Objective evidence that energy is flowing may be felt by the patient in the form
of heat, tingling or pulsing. Treatment effects are both a positive effect on
the body’s energy itself and specific improvements in the patient’s medical
condition, such as stimulation of bone and tissue healing after injury or
surgery, an unspecified “success” in physical healing and “detoxifying” the
body.

Here is what we actually know about reiki:

  1. There is no evidence that this “energy” exists or that it’s putative deficit
    or suboptimal movement is detrimental to health.

  2. Physical effects such as tingling must be attributed to some other phenomena.

  3. Reiki is ineffective, although it may evoke some sort of placebo response.

  4. “Detoxification” and “boosting the immune system,” are bogus.

So, yes, there are misrepresentations in the ad.

Even if the hospital were to argue that the statements are in fact true and that
there was some evidence (no matter how poor) in support of the ad’s claims, we 
can still characterize the ad as misleading.

   A statement containing a half-truth may be as misleading as a statement
   wholly false. Thus, a statement that contains only favorable matters and
   omits all reference to unfavorable matters is as much a false represention as
   if all the facts stated were untrue.

Restatement 2d of Torts, Sec. 529, comment a.

To avoid characterization as misleading, the ad should, at the very least,
inform the patient of reiki’s lack of plausibility and the extremely poor
quality of the evidence supporting its use. Even at that, it might not pass
muster.

Are these misrepresentations fraudulent?

Whether a misrepresentation is fraudulent refers solely to the hospitals
knowledge of the untrue character of it representations. I know hospitals are
business entities, such as corporations, and they can’t “know” anything except
through their employees and other agents who act for them. But to keep it
simple, we’ll just refer to the hospital itself instead of having to say “the
hospital’s employee” or “the hospital’s agent.” And we won’t worry about whether
the reiki practitioner was totally clueless and really believed what the ad
said. Hopefully she doesn’t hold such a position of authority that there is no
medical doctor somewhere up the supervisory line who holds the responsibility of
knowing what she is up to. Why? Because no medical doctor could credibly
testify he did not know, or did not strongly suspect, that the ad wasn’t telling
the full story. Or, at the least, he knew there must be some disconfirming
evidence to contradict the ad’s claims. His knowledge is the hospital’s
knowledge from a legal standpoint.

The law of fraudulent misrepresentation does not get into issues of whether the 
hospital’s intent was pure or whether it was “trying to help.” “Intent” refers
to the intent to withhold information, or to give false information, not intent 
in some evil sense. What the law requires, if you are selling a product or
service to a consumer, is that you tell the consumer what you know about the
product or service and you don’t leave out information that a person purchasing 
your product would want to know. (I think we can safely assume that a patient
would want to know that a treatment is worthless.)

If you don’t have the complete story, but you operate with a reckless
indifference to what the complete story is, you can also be held liable. Or if
you represent something as fact when you actually know you don’t have all the
facts, or don’t think you do, you can be held liable as well. In short, you
can’t represent something as a fact unless you indeed know it is a fact, or at
least honestly think you know it as a fact, without doubts or a disregard for
the facts. A hospital that presents itself as offering the best care, yet fails 
to determine the full extent of the evidence for (or against) that care, or
knows there is other evidence out there that may contradict what it is telling
patients, is potentially liable for fraudulent misrepresentation whether the
treatment is chemotherapy or reiki. It makes no difference as far as liability
is concerned.

Was our patient’s reliance on the hospital’s claims justifiable?

So far, we’ve looked at the hospital’s conduct and found that, based on the
facts we’ve used in our hypothetical, the hospital has both misrepresented the
facts and has done so intentionally. Let’s turn to our cancer patient, because
to successfully make out a case for fraudulent misrepresentation, we have to
show that the patient (a) relied on the misrepresentation in deciding to
purchase a reiki treatment and that (b) the reliance was justified.

We’ve already determined that the patient relied on the hospital’s information –
otherwise, why would he buy the treatment? But was his reliable justifiable?

If the patient were you or I (if you are a faithful SBM reader), we would know
that the hospital’s claims are false, and we wouldn’t win. Actual knowledge of
falsity bars recovery. But what about other patients, who don’t know anything
about reiki? Are they required to do their own research? No, not in an action
for fraudulent misrepresentation, even where the falsity of the information
about reiki could have been ascertained without much trouble or expense. (Say,
by reading Science-Based Medicine, or Wikipedia, or Respectful Insolence.) If a 
patient is highly suspicious, there might be a question of whether he relied on 
the misrepresentations or whether his reliance was justifiable, and some
jurisdictions do impose a duty to investigate where there is reason to suspect a
statement is false.

But the standard is not whether a reasonable person would investigate these
claims. That is the standard for contributory negligence – what a reasonable
person would do – and contributory negligence is not applicable in fraudulent
misrepresentation lawsuits, because it is an intentional tort. The only question
would be is whether the patient himself was suspicious of falsity. (And that
would be a dicey question for the defendant’s attorney to ask the plaintiff:
“Didn’t you even suspect my client’s statements were false?”) He is not required
to investigate. This is especially true where, as here, the plaintiff may
particularly vulnerable due to his illness and the defendant knows of that
vulnerability. (Of course, the hospital could not be heard to argue that it
didn’t know its cancer patients are vulnerable due to their illness.) It is also
especially true where there is a relationship of trust and confidence between
the plaintiff and defendant, a situation that most certainly describes that
between a patient and hospital, especially where the hospital advertises itself 
as providing top notch care.

Closing argument

To sum up the case for our cancer patient: The hospital advertised a treatment, 
reiki, claiming it provides specific health benefits by adding to, moving and/or
unblocking the patient’s “energy.” The hospital knew these claims are false (or
it disregarded the facts), yet intended that our patient rely on these false
claims in order to induce him to purchase one or more reiki sessions. The
plaintiff did, in fact, rely on the hospital’s statements of health benefits and
was justified in believing reiki could actually produce these benefits, a
reliance grounded, in part, because he believed that his hospital would provide 
accurate health information. Our patient has proved all the elements of
fraudulent misrepresentation and should win his case.

Reiki: Fraudulent Misrepresentation – Revisited

Factual misrepresentations about manipulating “energy” in a patient’s body and
its positive effects on health are integral to reiki. They can also be the basis
of an action for fraudulent misrepresentation.

Jann Bellamy on September 28, 2017

Tweet



I’m on vacation, so I’ve updated a post from several years ago.

Six years ago, I confessed in one of my early SBM posts that, during my
continuing education about so-called “complementary and alternative” medicine
[I’d add “integrative medicine” now], one question presented itself in my mind
over and over: Isn’t that fraud? In that post I concluded:

   As criticism of CAM for scientific implausibility grows and study after study
   fails to support claims of effectiveness, we may reach a point where it
   becomes impossible for the CAM practitioner to avoid knowing that CAM is
   based on misrepresentations, making it much harder to defeat claims of
   fraudulent misrepresentation.

Wrong! At least in part. There’s no doubt the putative evidence base for CAM
products and practices has shriveled in the past six years as we’ve chronicled
in many SBM posts on subjects like acupuncture, homeopathy, chiropractic, and
supplements. But those who promote CAM, now rebranded as “integrative medicine,”
appear to be totally unfazed by the prospect that they are fudging on the facts
and possibly subjecting themselves to liability.

A few years later, I pointed out how claims made by the venerable Cleveland
Clinic for reiki might well constitute the tort of fraudulent misrepresentation.
Unfortunately, no one seems to have listened. While some of the Cleveland
Clinic’s material on reiki appears to have been rewritten since that post,
demonstrable misrepresentations remain. They’ve even added a new form of “energy
medicine” (the category of woo under which reiki is catalogued) called “Eden
Energy Medicine.” (If you’d like to read a big load of woo-speak “explaining”
Eden Energy Medicine, you can do so here, complete with a discussion of “energy 
points” and, as you’d expect , “quantum compatibility.”)

In fact, the Cleveland Clinic publicly reaffirmed its commitment to quackademic 
medicine just this year. After public outcry over an anti-vaccination screed
written by the director of the Cleveland Clinic Wellness Institute forced the
Clinic’s CEO to issue a strongly-worded statement supporting vaccination
science, some wondered if this might signal a repudiation of pseudoscience.

Sadly, no. A full-throated defense of selling services with no plausibility
and/or insufficient evidence of effectiveness followed quickly on the heels of
the Cleveland Clinic’s mea culpa. The Cleveland Clinic’s Wellness Institute
still offers acupuncture, acupressure, laser acupuncture, craniosacral therapy, 
therapeutic touch, functional medicine, chiropractic, and herbs (also here) as
well as “energy medicine,” in addition to the aforementioned reiki and Eden
Energy Medicine. It proffers wholly credulous descriptions of “integrative”
treatments on its website.

The Wellness Institute describes reiki as:

   hands-on, natural healing that uses the universal life force energy . . . [a]
   vital life force energy that flows through all living things . . . The Reiki
   practitioner is the conduit between the patient and the source of the
   universal life force energy; the energy flows through the practitioner’s
   energy field and through her hands to the patient. . . . [She] places her
   hands in specific energy locations . . . [t]he length of time determined by
   the flow of energy through her hands. . . . The patient experiences the
   energy as sensations such as heat, tingling, or pulsing where the
   practitioner has placed her hands. Sometimes, the sensations are felt moving 
   through the body.

This “universal life force energy” has, according to the Institute, certain
positive effects, such as dissolving “energy blockages” and “supply[ing]
universal life force energy to the body.” It also increases one’s “vibrational
frequency on physical, mental emotional and spiritual levels,” although how
these frequencies relate to one’s energy, or to anything else for that matter,
is not made clear.

In its explanation of energy medicine, under the heading “What We Treat” (note
the use of the word “treat”), the Institute claims that various “energy
techniques,” such as the practitioner moving her hands over the body, creates
“new energy patterns” which “improve health.” The Institute asserts that energy 
medicine in general, including reiki, benefits certain medical conditions,
including:

  1. Depression

  2. Digestive issues

  3. Autoimmune conditions

  4. Cancer treatment recovery

  5. Hormone imbalance

As for reiki in particular, the Institute says it will “improve overall health” 
and “may do the following:”

  1. Detoxifying the body

  2. Help to relieve pain

  3. Stimulate bone and tissue healing after injury or surgery

  4. Stimulate the body’s immune system

If you are in good health, the Institute recommends monthly reiki treatments to:

   enhance your ability to respond to unhealthy elements in your environment and
   help you to handle stress. By promoting the harmonious distribution of
   energy, Reiki is an excellent form of preventive medicine.

According to its website:

   All health information posted on the site is based on the latest research and
   national treatment standards, and have been written or reviewed and approved
   by Cleveland Clinic physicians or health professionals unless otherwise
   specified.

Of course, the Cleveland Clinic is not the only hospital selling reiki to
patients. According to an article in the Washington Post:

   More than 60 U.S. hospitals have adopted Reiki as part of patient services,
   according to a UCLA study, and Reiki education is offered at 800 hospitals.

Which brings up an interesting question: Could a medical facility’s selling
reiki to the public give rise to an individual or class action lawsuit for
fraud? If so, then hospitals and other health care facilities are needlessly
subjecting themselves to liability, something they generally go to great strides
to avoid.

The law of fraudulent misrepresentation

What is fraud? It can take a number of forms: tort, contract, criminal. The
concept has been incorporated into several specialized state and federal laws,
such as deceptive trade practices, consumer protection and securities laws.
Here, we are discussing what is known as the tort of fraudulent
misrepresentation, also called deceit. Fraud is a very old concept adopted in
America from the English legal system when it became an independent country with
its own system of laws. While the law of fraudulent misrepresentation varies in
some respects from jurisdiction to jurisdiction, here we’ll use a general
statement of its elements from the Restatement 2d of Torts. (The Restatement is 
sort of “best practices” guide to certain areas of the law composed by experts
in the field.)

If you want to successfully sue someone for fraudulent misrepresentation, you
have to prove certain defined elements of that tort. Let’s imagine a
hypothetical case in which the plaintiff is a cancer patient who has had surgery
to resect a tumor and receives ongoing treatment at a hospital. In our
discussion, we’ll assume that the patient has seen his hospital’s website
advertisement for energy medicine, specifically reiki, and that it contains the 
same information as the Cleveland Clinic’s. The patient has decided to purchase 
several sessions with one of the hospital’s integrative medicine center’s
practitioners. We’ll also assume that the information given to our cancer
patient in person is the same as, or at least not inconsistent with, the
information on the Cleveland Clinic’s website.

Here’s what the patient will have to prove to win his case against the hospital:

  1. The hospital fraudulently made a misrepresentation of fact or opinion.

  2. The hospital intended to induce the patient to purchase a reiki session.

  3. The patient acted in justifiable reliance on the misrepresentation.

  4. Pecuniary damage to the patient resulting from his reliance.

Let’s get a couple of these out of the way right off the bat. The hospital
obviously intends that the patient rely on its advertisement for reiki in
purchasing its services, that is, it “intends to induce plaintiff to act.” And, 
to the extent the patient paid for those services, the patient has suffered
damages, even though the amount may be small. The hospital would also be liable 
for any physical harm caused by reiki. As reiki has no known ill effects, a fact
that undercuts its very credibility as a treatment, we can safely assume
physical harm won’t be an issue.

(Although it would certainly make for an amusing case if the patient claimed
that reiki actually messed up his “energy distribution,” thereby making him even
more ill. How would the hospital defend against that? Would it put on evidence 
that this energy doesn’t exist and can’t cause any harm, thus proving the
patient’s case for misrepresentation?)

Misrepresentation of facts

To recap, here’s what the patient is told: During reiki, a practitioner receives
energy from a source, then proceeds to manipulate the patient’s energy by
causing it to move through the body. The practitioner can also unblock energy to
facilitate its proper flow. Objective evidence that energy is flowing may be
felt by the patient in the form of heat, tingling or pulsing. Treatment effects 
are both a positive effect on the body’s energy itself and specific improvements
in the patient’s medical condition, such as stimulation of bone and tissue
healing after surgery, pain relief, stimulation of the immune system, and
“detoxifying” the body.

Here is what we actually know about reiki:

  1. There is no evidence that this “energy” exists or that it’s putative deficit
    or suboptimal movement is detrimental to health.

  2. Physical effects such as tingling must be attributed to some other phenomena.

  3. There is no credible evidence that reiki is effective for any medical
    condition, although it may evoke some sort of placebo response.

  4. “Detoxification” and “boosting the immune system,” are bogus.

So, yes, there are misrepresentations in the ad.

Even if the hospital were to argue that the statements are in fact true and that
there was some evidence (no matter how poor) in support of the ad’s claims, we 
can still characterize the ad as misleading.

   A statement containing a half-truth may be as misleading as a statement
   wholly false. Thus, a statement that contains only favorable matters and
   omits all reference to unfavorable matters is as much a false represention as
   if all the facts stated were untrue.

Restatement 2d of Torts, Sec. 529, comment a.

To avoid characterization as misleading, the ad should, at the very least,
inform the patient of reiki’s lack of plausibility and the extremely poor
quality of the evidence supporting its use. Even at that, it might not pass
muster.

Are these misrepresentations fraudulent?

Whether a misrepresentation is fraudulent refers solely to the hospital’s
knowledge of the untrue character of it representations. Of course, hospitals
are business entities, such as corporations, and they can’t “know” anything
except through their employees and other agents who act for them. But to keep it
simple, we’ll just refer to the hospital itself instead of having to say “the
hospital’s employee” or “the hospital’s agent.” And we won’t worry about whether
the reiki practitioner was totally clueless and really believed what the ad
said. Hopefully, she doesn’t hold such a position of authority that there is no 
medical doctor somewhere up the supervisory line who has the responsibility of
knowing what she is up to. Why? Because no medical doctor could credibly testify
he did not know, or did not strongly suspect, that the ad wasn’t telling the
full story. Or, at the least, he knew there must be some disconfirming evidence 
to contradict the ad’s claims. His knowledge is the hospital’s knowledge from a 
legal standpoint.

The law of fraudulent misrepresentation does not get into issues of whether the 
hospital’s intent was pure or whether it was “trying to help.” “Intent” refers
to the intent to withhold information, or to give false information, not intent 
in some evil sense. What the law requires, if you are selling a product or
service to a consumer, is that you tell the consumer what you know about the
product or service and you don’t leave out information that a person purchasing 
your product would want to know. (I think we can safely assume that a patient
would want to know that a treatment is worthless.)

If you don’t have the complete story, but you operate with a reckless
indifference to what the complete story is, you can also be held liable. Or if
you represent something as fact when you actually know you don’t have all the
facts, or think you might not have all the facts, you can be held liable as
well. In short, you can’t represent something as a fact unless you indeed know
it is a fact, or at least honestly think you know it as a fact, without doubts
or a disregard for the facts. A hospital that presents itself as offering the
best care, yet fails to determine the full extent of the evidence for (or
against) that care, or knows there is other evidence out there that may
contradict what it is telling patients, is potentially liable for fraudulent
misrepresentation whether the treatment is chemotherapy or reiki. It makes no
difference as far as liability is concerned.

Was our patient’s reliance on the hospital’s claims justifiable?

So far, we’ve looked at the hospital’s conduct and found that, based on the
facts we’ve used in our hypothetical, the hospital has both misrepresented the
facts and has done so intentionally. Let’s turn to our cancer patient, because
to successfully make out a case for fraudulent misrepresentation, we have to
show that the patient (a) relied on the misrepresentation in deciding to
purchase a reiki treatment and that (b) the reliance was justified.

We’ve already determined that the patient relied on the hospital’s information –
otherwise, why would he buy the treatment? But was his reliable justifiable?

If the patient were you (if you are a faithful SBM reader) or I, we would know
that the hospital’s claims are false, and we wouldn’t win. Actual knowledge of
falsity bars recovery. But what about other patients, who don’t know anything
about reiki? Are they required to do their own research? No, not in an action
for fraudulent misrepresentation, even where the falsity of the information
about reiki could have been ascertained without much trouble or expense. (Say,
by reading Science-Based Medicine, or Wikipedia, or Respectful Insolence.) If a 
patient is highly suspicious, there might be a question of whether he relied on 
the misrepresentations or whether his reliance was justifiable, and some
jurisdictions do impose a duty to investigate where there is reason to suspect a
statement is false.

But the standard is not whether a reasonable person would investigate these
claims. That is the standard for contributory negligence – what a reasonable
person would do – and contributory negligence is not applicable in fraudulent
misrepresentation lawsuits, because it is an intentional tort. The only question
would be is whether the patient himself was suspicious of falsity. (And that
would be a dicey question for the defendant’s attorney to ask the plaintiff:
“Didn’t you even suspect my client’s statements were false?”) He is not required
to investigate. This is especially true where, as here, the plaintiff may
particularly vulnerable due to his illness and the defendant knows of that
vulnerability. (Of course, the hospital could not be heard to argue that it
didn’t know its cancer patients are vulnerable due to their illness.) It is also
especially true where there is a relationship of trust and confidence between
the plaintiff and defendant, a situation that most certainly describes that
between a patient and hospital, especially where the hospital advertises itself 
as providing top notch care.

Closing argument

To sum up the case for our cancer patient: The hospital advertised a treatment, 
reiki, claiming it provides specific health benefits by adding to, moving and/or
unblocking the patient’s “energy.” The hospital knew these claims are false, or
it disregarded the facts, yet intended that our patient rely on these false
claims in order to induce him to purchase one or more reiki sessions. The
plaintiff did, in fact, rely on the hospital’s statements of health benefits and
was justified in believing reiki could actually produce these benefits, a
reliance grounded, in part, because he believed that his hospital would provide 
accurate health information. Our patient has proved all the elements of
fraudulent misrepresentation and should win his case.

COVID

The FDA’s Proposed “Black Box” Warning for COVID-19 Vaccines

The real hazard is not the vaccines, but the warning itself

Henry Miller on December 23, 2025

Link


During my 15 years at the U.S. Food and Drug Administration (FDA) as a medical
reviewer of drugs and vaccines, Special Assistant to the Commissioner, and
founding director of the Office of Biotechnology, I developed great respect for 
the Agency. Many of the professionals boasted deep expertise in their arcane
fields of science, medicine, and regulation, and had been there for many years. 
Sometimes, I thought approvals were granted more slowly than necessary, but
generally, appropriate caution and integrity dictated decisions that could
affect the health and safety of millions of Americans.

Over the past year, all that has changed. Huge numbers of staff have been fired 
or resigned, and appointees to leadership posts have been inconceivably poor
choices—unqualified; lacking respect for science and public health; being guided
by Health and Human Services Secretary Robert F. Kennedy Jr.’s unhinged,
unscientific views; and making decisions that will undermine public health.

The worst may be yet to come.

For more than half a century, the FDA’s “black box” warning on drug labels has
served as the agency’s strongest regulatory signal—a red flag reserved for
medicines that carry a clear, serious, and well-established risk of death or
irreversible harm. Opioids earn black boxes because they kill tens of thousands 
of Americans each year through addiction and overdose. ACAM2000, a live-virus
smallpox and mpox vaccine used only in tightly controlled settings, carries one 
because of well-documented risks of myocarditis, encephalitis, and death.
Isotretinoin (Accutane) bears one because it causes catastrophic birth defects
if taken during pregnancy. Here is the black box warning on the label of
Zyprexa, which is used to treat schizophrenia and bipolar disorder:

Against that backdrop, the reported plan by the FDA to impose a black box
warning on COVID-19 vaccines is not merely misguided—it would constitute
professional malfeasance that risks undermining one of the greatest
public-health achievements of the past century.

No evidence

According to multiple reports, the proposal is being driven internally by Dr.
Vinay Prasad, the rude, misguided FDA’s chief medical and scientific officer and
director of the Center for Biologics Evaluation and Research (CBER), with the
approval of Health and Human Services Secretary Robert F. Kennedy Jr., a
long-time vaccine critic. The plan has shocked outside experts because, quite
simply, there is no evidentiary basis for it.

Following a tsunami of outrage from the scientific and medical communities about
the negative impacts on public health that such a move would cause, FDA
Commissioner Marty Makary backed down, saying on December 15th that there were
no plans for it at this time. Many FDA-watchers, including this author, are
unconvinced.

What a Black Box Warning Is—and What It Is Not

A black-box warning is not a neutral informational update. It is the FDA’s most 
aggressive regulatory communication via product labeling, intended to alert
clinicians and patients to risks so grave that they may outweigh a product’s
benefits or require extreme restrictions on its use.

When a black box appears at the top of a drug label, it sends a blunt message:
This product can kill you or cause devastating harm.

The FDA does not use this tool lightly—or at least, it is not supposed to. Black
box warnings typically follow copious amounts of accumulated data, clear causal
links, and extensive public review. They are often accompanied by advisory
committee meetings, safety communications, and transparent analyses explaining
why the warning is justified.

None of that appears to be happening here.

As Harvard regulatory expert Dr. Aaron Kesselheim has noted, black box decisions
usually involve a discernible process: public notification, advisory committee 
review, and open discussion of the evidence. In this case, there has been no
advisory committee, no publicly released analysis, and no explanation of what
new data—if any—justify elevating COVID-19 vaccines into the FDA’s most
dangerous category.

The Safety Record the FDA Is Ignoring

The irony is difficult to miss. COVID-19 vaccines are among the most intensively
studied medical products ever deployed.

Before authorization, they were tested in randomized, placebo-controlled trials 
involving roughly 75,000 participants. After authorization, they were
administered to hundreds of millions of Americans and more than 13 billion
people worldwide, with safety monitored through multiple overlapping systems:
clinical trials, active surveillance networks, national registries, and
pharmacovigilance programs across more than 90 countries.

A recently published update confirmed the long-term safety of the mRNA COVID-19 
vaccines:

In this national cohort study of 28 million individuals [in France], the results
found no increased risk of 4-year all-cause mortality in individuals aged 18 to
59 years vaccinated against COVID-19, further supporting the safety of the mRNA
vaccines that are widely used worldwide.

The results are unequivocal. Serious adverse events are rare. Catastrophic
outcomes are rarer, almost nonexistent.

Risk must always be balanced against benefits. One modeling study estimated that
in the first year alone, COVID-19 vaccines averted nearly 20 million deaths
worldwide. In the United States, they dramatically reduced hospitalizations,
intensive care admissions, and deaths across every adult age group. More
recently, CDC data show that during the 2024–25 respiratory virus season,
vaccinated children had a substantially lower risk of COVID-related emergency
department and urgent-care visits.

Against this overwhelming benefit, what is the alleged risk that justifies a
black box?

Myocarditis: A Known Risk, Already Addressed

The administration has repeatedly pointed to myocarditis—heart inflammation—as a
concern. But myocarditis associated with mRNA COVID-19 vaccines is neither
common nor often serious.

It was detected early, investigated intensively, and transparently communicated 
by the CDC and FDA years ago. The risk was found to be highest in adolescent and
young adult males, typically after the second dose given at a short interval
following the first. Most cases were mild and resolved quickly with conservative
treatment. Critically, U.S. surveillance has found no confirmed
myocarditis-related deaths or heart transplants linked to mRNA vaccination in
adolescents or young adults. [link?]

Moreover, the risk has declined substantially as dosing intervals were
lengthened—a change made precisely because the regulatory system was functioning
as intended.

These facts are already reflected in current labeling. In May, the FDA expanded 
existing warnings in prescribing information for Pfizer and Moderna COVID
vaccines to note that the observed risk of myocarditis and pericarditis has been
highest in males aged 12 through 24.

That is how safety regulation is supposed to work: proportionate,
evidence-based, and responsive. A black box warning would represent a quantum
leap beyond that—suggesting risks comparable to opioids or teratogenic
drugs—without any comparable evidence.

Claims Without Data: A Regulatory Red Flag

The most alarming aspect of the proposal may be how little information has been 
provided to justify it.

In a late-November memo to CBER staff, Dr. Prasad claimed that FDA scientists
had “found that at least 10 children have died after and because of receiving
COVID-19 vaccination.” No ages. No medical histories. No vaccine brands. No
timelines. No causal analyses. No public data.

That is not how vaccine safety science works.

As Dr. Fiona Havers, a former CDC epidemiologist who resigned over political
interference, has emphasized, vaccines—like all medical interventions—can be
temporally associated with rare adverse events. Determining causality requires
detailed clinical review, background rate comparisons, and transparent methods. 
None of that has been shared.

Fear-mongering, plain and simple

To raise the specter of pediatric deaths while withholding evidence is not
caution. It is fear-mongering, which has become an alarmingly familiar trademark
of Robert F. Kennedy, Jr.’s HHS agencies.

Even more troubling, these claims are being amplified in an environment in which
anti-vaccine organizations are openly pressuring regulators. Earlier this
month, Children’s Health Defense—the nonprofit formerly led by HHS Secretary
Kennedy—filed a citizen petition urging the FDA to revoke COVID-19 vaccine
licenses altogether, arguing they are “misbranded.” That claim has been
repeatedly rejected by courts, scientists, and regulators.

Process Abandoned, Politics Ascendant

The FDA’s legitimacy rests on one core principle: Decisions are made through
transparent, evidence-based processes insulated from political pressure.

That principle is now in jeopardy.

Dr. Prasad himself is a controversial figure, known long before joining the FDA 
for outspoken criticism of COVID-19 vaccines and public health measures. His
tumultuous tenure—appointment, resignation under pressure, and rapid
reinstatement—has raised serious concerns about independence and governance
within the agency. He has asked subordinates who disagree with him to tender
their resignations.

The result, as one former federal health official put it, is “death by a
thousand cuts”: a steady drip-drip-drip of messaging that exaggerates vaccine
risks, minimizes benefits, and erodes public trust. Claims that vaccines are
riskier when given together, that the day-of-birth dose of Hepatitis B vaccine
should be delayed, or that children receive “too many” vaccines with “dangerous 
ingredients,” directly contradict decades of immunology and epidemiology.

A black box warning would be yet another life-threatening cut.

The Predictable Consequences

We do not need to speculate about what will happen if COVID-19 vaccines receive 
a black box warning. We have decades of evidence on how such warnings affect
behavior: They reduce prescribing and deter patients from being vaccinated.
Sometimes they are appropriate; sometimes they overshoot, leading to unintended 
harm. In psychiatry, for example, poorly communicated warnings have been
associated with reduced treatment and worse outcomes.

Applied to COVID-19 vaccines, the consequences would be stark. Uptake would
fall. Hesitant parents would opt out. Clinicians would face legal and ethical
uncertainty. And preventable hospitalizations and deaths would rise—especially
among older adults, immunocompromised people, and unvaccinated children.

As Dr. Angela Rasmussen, a virologist and co-editor-in-chief of the journal
Vaccine, has noted, a black box warning signals that a product is inherently
dangerous. That message would be broadcast not only to U.S. patients, but
globally—handing anti-vaccine movements a powerful new talking point, stamped
with FDA authority.

A Warning About the FDA Itself

Most alarming of all is what this episode signals about the FDA’s future.

If black box warnings can be imposed without transparent data, without advisory 
committee review, and without clear causal evidence—based instead on ideological
opposition to a product—then no vaccine, and no drug, is safe from politicized 
regulation.

That would mark a fundamental break with the consensus that built the FDA into a
world-class drug regulator.

It is bitterly ironic that this assault is occurring under an administration
that inherits Operation Warp Speed—an unprecedented scientific and logistical
success that delivered safe, effective vaccines in record time. What was once
touted, correctly, as a triumph of American innovation and regulation is now
being discredited by the very government that once claimed credit for it.

The Ethical Failure

Public-health communication carries moral weight. Governments have an obligation
to convey risks accurately, proportionately, and in context. To emphasize
speculative harms while ignoring documented benefits is not neutrality—it is
distortion. It violates the ethical duty to protect the public with honest,
complete information.

Rare adverse events should be studied. Signals should be investigated. But the
bar for a black box warning is—and must remain—extraordinarily high.

On the evidence available, that bar has not been met. Not remotely.

A Line That Must Not Be Crossed

If the FDA proceeds with a black box warning for COVID-19 vaccines without
releasing its data, convening independent experts, and demonstrating a clear,
causal, life-threatening risk that outweighs enormous benefits, it will not be
acting as a scientific regulator. It will be acting as a political instrument.

The cost will not be measured in headlines or lawsuits. It will be measured in
missed vaccinations, overflowing hospitals, an increased burden of long COVID,
and lives lost needlessly.

The real hazard is not the vaccines, but the warning itself.

     W


NewsGuard identifies social media “super-spreaders” of COVID-19 misinformation

NewsGuard has identified “super-spreaders” of COVID-19 misinformation on
Facebook and Twitter, including Dr. Joseph Mercola, the NVIC, Rush Limbaugh, and
Ty Bollinger.

Jann Bellamy on May 21, 2020

Link



NewsGuard, a company that evaluates and rates news and information websites,
recently analyzed Facebook Pages and Twitter accounts to identify what it calls 
“super-spreaders” of COVID-19 misinformation, Rush Limbaugh, Dr. Joseph Mercola,
and the National Vaccine Information Center among them. (There are separate
lists of Facebook and Twitter super-spreaders in Europe.)

To qualify as a super-spreader, a Facebook Page or Twitter account must have
published or shared “clearly and egregiously false content about the virus”,
have more than 100,000 page “likes” or followers, respectively, and have been
active on the date NewsGuard published its data — that is, neither Facebook nor 
Twitter had acted as of that date to take down the misinformation.

NewGuard describes this as an ongoing project, one among several designed to out
COVID-19 misinformation, and notes that the listed Pages and accounts may not
be the most frequent offenders or have the largest audiences – they simply met
the criteria for this particular data set. NewsGuard’s larger message, it seems,
is that, despite promises by Facebook and Twitter to effectively police their
products for COVID-19 misinformation, whatever they are doing isn’t working, a
point we’ll return to in a moment.

But first, the lists.

Among the 31 Facebook super-spreaders, whose combined accounts reach over 21
million followers, the top spot goes to Global Informers (which I’d never heard 
of) with almost 5 million “likes”. Described as an “English-language page for a 
business with an address in Turkey and managed from Pakistan”, created in 2017, 
Global Informers posted a link to PressTV, an Iranian propaganda outlet, with
the false claim that the novel coronavirus was created in a lab as a bioweapon, 
and to RT, the Russian propaganda outlet, claiming, without substantiation, that
the U.S. military started the pandemic.

(In this post, I will not provide a link to the misinformation itself, although 
you can find it on the NewsGuard website.)

Coming in at #2 is Rush Limbaugh (over 2.3 million Facebook Page “likes”), upon 
whom Donald Trump recently bestowed the Presidential Medal of Freedom, cited for
his false claims that the novel coronavirus was created in a lab as a bioweapon
and that it is similar to the common cold. Also speaking from the far right of 
the political spectrum, The Gateway Pundit (631,000 likes, but scoring 0 out of 
100 on NewGuard’s rating scale) posted false claims that the drug
hydroxychloroquine “has a 100% success rate in treating COVID-19”.

Not surprisingly, super-spreaders include websites shilling for unproven
COVID-19 cure-alls we’ve covered here on SBM, like colloidal silver, Vitamin C, 
and the aforementioned hydroxychloroquine, as well promoting debunked claims
that the virus is linked to 5-G technology and Bill Gates.

Two Facebook Pages affiliated with Ty Bollinger (whose promotion of cancer
quackery has been called out in SBM posts), The Truth About Cancer (sadly, with 
almost 1.2 million “likes”) and Cancer Truth, are cited for their false claims
that the virus was created in a lab as a bioweapon and that it is connected to
5G technology. NewsGuard’s evaluation of Bollinger’s The Truth About Cancer
website correctly describes it as one that “has repeatedly promoted unproven and
potentially dangerous cancer treatments.”

Another perennial SBM “favorite”, the National Vaccine Information Center (or,
as we prefer, the National Vaccine Misinformation Center), accurately described 
as a publisher of “articles with false and unsubstantiated claims about
vaccination”, is cited for its Facebook Page touting Vitamin C as prophylactic
against COVID-19.

Twitter trust issues

NewsGuard identified 10 Twitter super-spreaders, who reach a combined following 
of over 3 million. The list again begins with someone I’ve never heard of: Femi 
Fani-Kayode, who takes the number 1 spot with almost a million Twitter
followers. He’s identified as a former Nigerian politician (the Nigerian Prince,
perhaps?) “who has repeatedly shared misinformation about vaccines and 5G
technology”, including claims linking the latter to the pandemic.

Another unknown to me, David Icke, with over 310,000 followers, is a former
British football player, “who has repeatedly promoted conspiracy theories,
including the idea that the world is under the control of shape-shifting
aliens”. He tweeted both that the coronavirus does not exist and, in what would 
seem to be a mutually-exclusive proposition, that 5G technology is connected to 
its spread.

Into this illustrious group who should fall but Dr. Joseph Mercola, “an
osteopathic physician and alternative medicine advocate . . . who has published 
false claims about standard medical practices such as vaccinations”. (Not only
that, he actually funds the anti-vaccination movement.) Mercola has made
frequent appearances on SBM, going back at least to 2009, with the eponymous
post 9 Reasons to Completely Ignore Joseph Mercola, all the way up to a few days
ago, with a mention in a David Gorski post on COVID-19 and conspiracy theories.

Mercola, who has had frequent run-ins with regulatory authorities, made the
Twitter super-spreaders list by “suggesting that high heat, including from a
sauna or steam bath, can treat the coronavirus” and “promoting unproven herbal
remedies for COVID-19” to his almost 300,000 followers.

NewsGuard uses these super-spreader lists as a cudgel to beat Facebook and
Twitter over the head for not doing enough to remove this sort of misinformation
from social media, a legitimate criticism, along with a bit of self-promotion.

   Despite Facebook’s announced efforts to stop the spread of this type of
   misinformation, these pages continue to be allowed to use Facebook to publish
   blatant misinformation about COVID-19 — seemingly in violation of the
   platform’s content policies. In some cases . . . we found evidence of what
   appears to be “coordinated inauthentic behavior“, which violates Facebook’s
   policies. We also found that in a majority of the false posts we reviewed,
   Facebook did not provide any warning, fact-checking language, or links to
   more credible sources — despite the platform’s recent promises to do so. Of
   the posts we have identified so far publishing COVID-19 misinformation, 63%
   did not have any warning or fact-check link attached to the post . . .Whether
   or not a fact check was shown appeared to be random. Even for the posts that
   did have fact-checker warnings, those warnings would only have appeared
   after the hoax had been published. That lapse is exacerbated by Facebook’s
   policy of not providing information to its users that Facebook Pages like
   these have been known to publish misinformation or hoaxes in the past. This
   prior bad conduct is especially true of purveyors of COVID-19 hoaxes . . .

[Quotation reformatted for easier reading.]

NewsGuard aims similar criticisms at Twitter.

On the other hand,

   NewsGuard has found that 80% of the 174 COVID-19 misinformation sites we have
   now identified had already been rated Red by NewsGuard for publishing
   misinformation in the past.

In other words, don’t trust Facebook or Twitter; check it out on NewsGuard.

“Rated Red” is a reference to NewsGuard’s rating system, which “employs a team
of trained journalists and experienced editors to review and rate news and
information websites based on nine journalistic criteria” assessing credibility 
and transparency and assigning each a red or green rating indicating its
credibility. When NewsGuard is downloaded, these red and green (also, yellow for
satire and grey for not rated) icons appear next to news links on search
engines and social media feeds. Hovering over the icon will give you some
information on the rating, while clicking on the rating will take you to a
“Nutrition Label” for a more complete assessment of the site.

Altogether, NewsGuard has issued detailed ratings of more than 4,000 websites
which it claims account for 95% of online engagement with the news. Specific to 
the pandemic, the company, in addition to its super-spreader lists, debunks the 
most popular COVID-19 myths, such as

   Bill Gates plans to use COVID-19 to implement a mandatory vaccine program
   with microchips to surveil people.

It also created a Coronavirus Misinformation Tracking Center, including a list
of websites known to be posting false coronavirus information. The list includes
56 domains of the NaturalNews.com Network, another SBM frequent flyer, as well 
as WestonAPrice.org, whose “appalling legacy” Harriet Hall discussed, and
“natural health expert” Sayer Ji’s GreenMedInfo.com. Links are provided to
“Nutrition Labels” for these sites. (I’ve provided them here as well.)

I downloaded NewsGuard (normally $2.95/month, but available free until July 1
“with no strings attached”), mainly because I wanted to support its efforts to
combat misinformation on the internet, especially medical misinformation.
According to a 2019 STAT News article written by a former health news reporter
and now NewsGuard analyst,

   Americans consume an unhealthy diet of health misinformation. Of the sites
   analyzed by NewsGuard, 11% provide misinformation about health; in other
   words, more than 1 in 10 news websites accessed by Americans includes bad
   information about health.

   Of all the sites with red ratings, 37% publish false or unfounded health
   claims.

   These sites accounted for more than 49 million engagements (shares, likes,
   comments, etc.) on social media in the past 90 days — more than major news
   websites such as NPR, Business Insider, or Forbes. In a recent search on
   Facebook for “vaccines and CDC,” several of the top-page results were from
   NewsGuard red-rated websites.

    2. NewsGuard has come in handy when replying to emails from certain friends of 
      the family who are spreading COVID-19 nonsense or just dubious political
      “news” in general. Even if you don’t subscribe, nosing around the website 
      is interesting and, if you wish, you can suggest a site for review. I’m
      certainly going to.

Trump administration announces some COVID-19 tests can skip FDA review,
providing new opportunities for dubious lab tests

The Trump administration unexpectedly announced that the FDA will no longer
regulate some lab tests, including those for COVID-19. In addition to
potentially allowing unreliable COVID tests on the market, the decision creates 
an opening for more bogus CAM tests.

Jann Bellamy on August 27, 2020

Link



The U.S. Department of Health and Human Services (HHS) announced last week that 
the FDA can no longer require some lab tests, including tests for COVID-19, to
undergo FDA review prior to going on the market, a move that surprised many. The
announcement covers only laboratory-developed tests (LDTs), that is, tests
assembled and used within a single lab. This can include tests developed by
academic and medical center labs as well as testing behemoths like Quest,
Genova, and LabCorp. HHS did not exempt tests made by one company and sold to
other labs or commercial firms.

HHS also rescinded all previously-issued FDA guidance documents and informal
statements of policy concerning LDTs, taking the position that any FDA
regulation can be legally accomplished only through the process of notice and
rulemaking or new legislation passed by Congress, both of which can take years.

It is important to note that HHS’s decision covers all LDTs, not just those for 
COVID-19. As we’ll see later in this post, this not only has disturbing
implications for testing during the pandemic, it is also a boon to quacks and
fringe medical practitioners who were already exploiting the lax regulation of
LDTs to fabricate dubious diagnoses and sell bogus treatments to patients.

Before HHS rescinded the FDA’s authority altogether, the agency’s regulation of 
LDTs came in fits and starts. By way of background, the FDA regulates in vitro
diagnostic devices (IVDs), which analyze human samples (such as blood, saliva,
tissue, and urine) as medical devices. However, in the past, it did not use this
authority to regulate a particular type of IVD, the laboratory-developed test.

Instead, it focused on commercial test kits, which are broadly marketed to
laboratories or directly to the public. These tests have to undergo the same
pre-market approval process as other medical devices regulated by the FDA. In
some cases, this means clinical studies demonstrating that the device is safe
and effective for its intended use. An LDT could avoid this review, even when
it’s used for the same purpose as an FDA-approved test. For example, there are
both LDTs and FDA-approved tests for vitamin D. This has led to complaints of a 
double standard from labs facing the much stricter standard.

There is some oversight of labs that offer LDTs. A federal law, The Clinical
Laboratories Improvement Act (CLIA), requires assessment of whether a lab is
able to test according to instructions and detect what is intended to be
detected, that is, the test’s analytical validity. However, a key element is
missing in that evaluation: clinical validity. Does the test accurately diagnose
or predict the risk of a particular clinical outcome?

For example, Great Plains Laboratory sells the “IgG Food MAP with XMAP®
Technology”, an LDT, to health care practitioners. Because Great Plains is CLIA 
certified, this test, presumably, accurately “detects all food antibodies” as
advertised and is therefore analytically valid. But do the test’s results give a
clinician information to accurately diagnose or to predict risk? Not if the
clinician is practicing science-based medicine.

Historically, LDTs were developed by hospitals, researchers, and academic
medical centers for their own use. That is no longer true. In the past 15 years 
or so, there has been an explosion in the use of LDTs by commercial labs and
biotechnology companies. A few years ago, the FDA estimated that there were
about 11,000 LDTs offered by 2,000 laboratories, giving impetus to stricter
oversight of the burgeoning LDT market.

In 2014, the FDA announced it would henceforth use its medical device regulatory
authority to oversee LDTs. Then, in late 2016, the agency reversed course and
announced it would not finalize its draft guidance on LDTs, although it
maintained the agency retained the authority to regulate them (and took action
against LDTs based on that authority just last year). There were efforts in
Congress to come up with a regulatory solution via a new law, but those efforts 
have yet to bear fruit.

Prior to HHS’s pulling the FDA’s jurisdiction, labs wanting to market COVID-19
LDTs were required to get emergency use authorizations (EUAs) from the FDA.
Under this procedure, labs could begin using self-validated LDTs as long as they
submitted an EUA to the FDA within 15 days.

An FDA spokeswoman said in May that there were problems with some COVID-19 tests
whose developers had applied for an EUA, indicating that the requirement was
effective in weeding out bad tests. According to a New York Times report

   “Some of the laboratories didn’t do their validation properly, making it
   impossible to tell if they had a good test or not” [the agency spokeswoman]
   said. “Others included data that suggested the test did not perform well,
   likely missing far more positive cases than authorized tests.”

   Other laboratories, she added, had manufacturing problems such as
   contamination. And several made unsupported claims in their labels for home
   testing.

At the time HHS took action, over 170 labs had notified the FDA that they had
validated their own LDTs and were awaiting FDA authorization. HHS’s decision
mooted that necessity.

(Labs can still voluntarily seek an EUA, which will allow them to avail
themselves of the liability protection afforded by the PREP Act. Labs bypassing 
FDA pre-market approval will forego this protection.)

Pros and cons

According to the Washington Post, the move

   came as a surprise to many at the FDA and was a point of intense disagreement
   between HHS Secretary Alex Azar and FDA Commissioner Stephen Hahn . . .
   [who] vociferously opposed the change, arguing that the agency has the
   authority to regulate [LDTs] during a public health emergency like the
   current pandemic.

Public health experts told the Post that

   the shift could result in unreliable coronavirus tests on the market,
   potentially worsening the testing crisis that has dogged the United States if
   more people get erroneous results. They argued the change is unlikely to
   solve current testing problems, which at this point are largely due to
   shortages of supplies such as swabs and chemical reagents.

Former FDA Commissioner Scott Gottlieb, who served in the Trump Administration, 
was critical as well, telling Axios:

   We’ll see a plethora of DTC [direct-to-consumer] Covid tests enter the
   market, where tests ship directly to consumers and are processed in a central
   lab operating outside FDA oversight.

Dr. Michael Carome, director of Public Citizen’s Health Research Group told the 
New York Times:

   Suppose you get a Covid test and you actually have the infection and it comes
   back negative, . . . You may believe you’re OK and that may leave you in
   your home, exposing family and friends to the virus when you should
   quarantine.

Critics include former FDA officials Peter Lurie and Alberto Gutierrez, the
latter calling HHS’s action “Letting the Wild West be the Wild West”.

Others, however, supported the move as helping “new and more innovative tests to
market more quickly”, charging that the FDA’s review “sharply slowed testing”
at the beginning of the pandemic, according to the Washington Post.

   “This is what we needed and asked for five months ago,” said Melissa Miller, 
   director of the University of North Carolina Medical Center’s Clinical
   Molecular Microbiology Laboratory.

And:

   The emergency use authorization “requirement meant well. But in my opinion
   was a disaster,” Michael Mina, an epidemiologist at the Harvard T.H. Chan
   School of Public Health, wrote on Twitter.

FDA regulatory practitioners who had represented clients trying to obtain
COVID-19 test EUAs were critical of the FDA as well, charging that

   the lack of adequate testing at the outset of the pandemic can be directly
   linked to FDA’s controversial laboratory-developed test (LDT) policy . . .

Signaling the implications of the administration’s decision beyond the pandemic,
Jeff Allen, president and chief executive of Friends of Cancer Research, told
the Times

   “I think it’s quite alarming” . . . He noted that a growing number of tests
   are in development to help determine whether cancer patients are responsive
   to certain drugs. “It’s really important for the performance of those tests
   to be assured.”

   Mr. Allen and other critics also note that the new plan appears to leave the 
   F.D.A. with no knowledge of what lab-developed tests are being devised, much 
   less how they are performing.

It is unclear whether the FDA will now have the authority to remove an LDT
lacking clinical validity from the market. According to the Washington Post,

   Administration officials who defended the change said that the tests still
   will be subject to CMS regulation [that is, CLIA] and that the FDA will have 
   the authority to take a bad test off the market.

But it is not clear to me whether they are referring only to the agency’s
authority to take action under CLIA, which applies only to analytical validity. 
Or, are they saying the agency can still remove a test from the market for lack 
of clinical validity or other failings not covered by CLIA? Since HHS’s position
is that the FDA lacks authority to regulate LDTs at all, and it quashed all
existing FDA policy on the subject in the process, I don’t see how the FDA would
have jurisdiction to take action. In this opinion, I am joined by patient
safety activist Madres Tomes, CEO of Device Events and a former FDA manager, who
said HHS’s action

   removes the post-market oversight that is required for devices cleared or
   approved by the FDA. That oversight is critical in these times to ensure that
   providers are using the best tests available.

Dr. Gottlieb also noted that the FDA might not be able to “take needed
enforcement actions against bad tests” because of HHS’s decision.

A boon for quacks?

However COVID testing might be affected, I worry that HHS’s taking the FDA out
of the picture will embolden labs inventing dubious tests and marketing them to 
fringe practitioners and scientifically naïve consumers, a subject we have
addressed regularly here on SBM. As a journal article criticizing dubious lab
tests (covered in this SBM post) noted, there are now whole laboratories devoted
to CAM testing. CAM practitioners, such as naturopaths, “promote and sell a
wide range of tests, many of which are of dubious clinical significance”. Some
“have little or no clinical utility and are widely discredited”. Results “are
often accompanied by extensive clinical interpretations which may recommend, or 
be used to justify, unnecessary or harmful treatments”.

(As a warning to consumers, both Quackwatch and Naturopathic Diaries offer lists
of these dubious tests. It is important to note that while all non-standard
tests are LDTs, some are legitimate FDA-approved tests used for illegitimate
purposes.)

Among these are direct-to-consumer “personalized” dietary recommendations based 
on DNA testing, which David Gorski aptly characterized as “modern astrology”. As
well, autism charlatan Amy Yasko uses a “DNA Nutrigenomic Test” to make dietary
supplement recommendations (conveniently available for purchase from her
husband’s online store) to parents of autistic children. Although it had,
regrettably, not taken action against either of these tests, the FDA has now
lost all authority to do so. Labs know this and, I predict, will exploit this
regulatory void.

In a 2015 post, pediatrician John Snyder wrote poignantly about how dubious
tests exploit patients and complicate his medical practice:

   What I find to be a common theme with these patients is that they and their
   parents are summarily taken advantage of by their alternative care providers 
   when they are given a fictitious diagnosis and treated with a variety of
   useless potions, elixirs, and false hopes. Often, parents bring their
   children to these providers because they are frustrated by their child’s
   chronic complaints of fatigue, pain, or other somatic issues that have eluded
   a satisfactory diagnosis or treatment. Invariably, the diagnosis that has
   remained so elusive to me is quickly found and treated by these much more
   “holistic” and open-minded providers. In fact, I have never seen a
   consultation note from one of these providers indicating any uncertainty as
   to diagnosis or treatment regimen. Typically a large battery of expensive,
   inappropriate, and sometimes outright fraudulent lab tests is ordered, often 
   from equally questionable laboratories. Again, there are invariably
   interesting findings prompting tailored and bizarre treatments. In typical
   red-flag sCAM fashion, some of these providers have their own supplement
   store, available online only to their patients, prominently displayed on
   their website. These providers are perceived as being more holistically
   informed about health and wellness then “conventional” doctors like myself,
   as if there are two distinct ways of treating illness and maintaining
   health…as if there is truly such a thing as alternative medicine.

   It can be very difficult to manage patients who are being simultaneously
   “treated” by such providers. . .

[Emphasis added; links in original.]

As a possible solution, one lab trade group has called for a single regulatory
standard covering all diagnostic testing, LDTs and otherwise. That sounds like a
sensible solution, as long as it doesn’t include a get-out-of-jail-free card
for quack tests. It may take this pandemic to finally spur Congressional action.

FDA and FTC issue more warning letters citing products and services making
illegal COVID claims

The FDA and FTC have issued hundreds of warnings to companies selling products
and services claiming, without adequate evidence, that they can prevent or treat
COVID-19, but the possibility of government action doesn’t seem to be a
deterrence.

Jann Bellamy on November 19, 2020

Link



Since the beginning of the COVID-19 pandemic, the FDA and FTC have sent several 
hundred warning letters to companies and individuals allegedly selling products 
and services making misleading, deceptive, or scientifically unsupported claims 
about their ability to prevent, mitigate, or treat COVID-19, a topic we’ve
covered before here on SBM. Apparently undeterred by the possibility of
government action, advertising and selling of COVID-19 nostrums continues apace,
aided and abetted in some cases by laws that invite such nefarious activities
via lax regulation. Today we take a look at the government’s latest efforts to
pursue COVID scofflaws.

(The FDA has jurisdiction over false and misleading labels and labeling of
consumer products such as drugs, dietary supplements, and cosmetics. The FTC has
jurisdiction over unfair and deceptive advertising in all its forms. The
regulatory authority overlaps, hence warning letters are sometimes issued
jointly. You can report a product to the FDA here and a product or service to
the FTC here.)

Herbs, supplements, and other “natural” products

Dietary supplements, including herbal remedies, are only lightly regulated by
the FDA, creating a fertile field for unsupported claims. As easy at this is to 
pull off, some marketers apparently have not learned the trick of sticking to
claims that their products “boost the immune system“, thereby only implying that
they are effective against COVID-19, while avoiding direct statements that they
can prevent or treat it. Claiming the latter invites a warning letter from the 
FDA by making the product, in the eyes of the law, an unapproved new drug.

Per the FTC, a company cannot advertise that a product can prevent, treat, or
cure a disease unless it has competent and reliable scientific evidence,
including, when appropriate, well-controlled human clinical studies,
substantiating that the claims are true at the time they are made.

Only a handful of drugs have been shown to be effective in treating COVID-19
and, for now, there is no approved preventative on the market. This means that
sending warning letters to marketers touting preventatives and cures is somewhat
like shooting the proverbial fish in a barrel.

For example, Prairie Dawn Herbs, a Colorado firm, stepped over the line by
recommending its herbal formulas “to help protect the immune system and combat
symptoms of . . . covid . . .”, including Echinacea tincture, Echinacea
glycerite, thieves oil, eucalyptus oil, mentholated salve, skin heal salve, and 
chest tea. And, while the Chinese government is busy promoting TCM for COVID-19,
the U.S. government is not impressed. Thus, references to the fact that Chinese
hospitals are using herbs to treat COVID is, fortunately, not dispositive of
their effectiveness in the eyes of the FDA or FTC. This claim, among others,
earned Griffo Botanicals a warning letter:

   Did you know that hospitals in HuBei and WuHan published Chinese herbal
   guidelines for treatment of COVID-19 in its various stages and presentations?
   Griffo Botanicals has produced 4 new COVID formulas based on these
   guidelines. The intention of these formulas is to ease symptoms, while
   bringing the body back into balance. They promote recovery, improving both
   mild and moderate symptoms while reducing the inflammatory load on the lungs 
   and other organs that occur during Covid-19 infection. . . .

Perhaps due to the gravity of COVID-19, the feds are targeting even small
operators. The Tonic Therapeutic Herb Shop & Elixir Bar, of Shepherdstown, West 
Virginia, got a warning letter referencing an article that could be a tutorial
on how to make illegal claims:

   SARS-CoV-2 (COVID-19): HERBAL PROTOCOLS FOR THE TREATMENT OF INFECTION AND
   POST-CORONAVIRUS SYNDROME

The article recommends a plethora of unproven remedies to “help prevent
infection and reduce the severity of symptoms”, including Japanese honeysuckle, 
Chinese skullcap, elderberry, licorice, Cordyceps (“also known as caterpillar
fungus”), Astragalus, hyssop, thyme, elder flower, peppermint, red clover,
Calendula, violet, nettle, mullein, chickweed, and medicinal mushrooms.

Aside from the violations of federal law, it seems clear that this collective of
herbalists is treating disease, which, to my understanding, is limited to
licensed health care professionals like physicians and nurse practitioners under
West Virginia law. I could not find out whether West Virginia licenses the
practice of herbalism or that the state has a so-called “health freedom” law.

A warning letter to Beephothocary, another small company, demanded they stop
claiming its propolis, a substance produced by bees to build their hives, is an 
effective antiviral against COVID.

As you might imagine, the cure-all du jour, CBD, is also being monetized as a
COVID treatment. A Las Vegas outfit called Senior Living, LLC, and its website, 
blueribbonhemp.com, got a warning letter for claims that CBD and NAC (n-acetyl
cysteine) “Fight Viral Infections like Coronavirus”. Likewise, an Arizona
company named (with the apparent intent of exploiting America’s affinity for the
military) For Out Vets LLC, doing business as Patriot Supreme, was warned
against promoting CBD as a treatment for lung inflammation caused by COVID.

Another au courant medical marvel, salt therapy, was the subject of a warning
letter to a California firm, Oxford Medical Instruments, for claiming its salt
inhaler, which “involves the process of breathing salty air through high-quality
salt pipes that aids someone to reduce respiratory disorders especially during 
this era of coronavirus” can “ensure your respiratory tract is in the best
condition to effectively fight the coronavirus pandemic and keep you healthy
from other respiratory complications like pneumonia”.

Previous government warnings about claiming silver-containing products can
effectively treat COVID notwithstanding, companies continue to promote these
nostrums. Michigan company Spartan Enterprises (doing business as Watershed
Wellness Center) received a warning letter for saying:

   Today, Planes are arriving from China carrying one of the most deadly viruses
   every known, the Coronavirus. The best way to protect yourself against this 
   is with liquid angstrom silver.

And, even more expansively:

   Will silver, this kind of silver, kill that virus [i.e., the coronavirus]?
   Well yes! Silver will kill that virus. It will kill any virus, any bacteria, 
   yeast, mold, and fungus, nothing can survive it. So, this means when you take
   this, the virus will be killed, well it might kill some of it.

A company called Silveryguy, which advertises on Amazon, was warned against
hawking atomized colloidal silver, which “can be inhaled deep into the lungs,
the action of silver colloids getting on the lining of your lungs may prove to
inhibit the virus from replicating too quickly” and “may reduce your body’s
overreaction to the virus”. A Georgia-based outfit, Peterson Research
Laboratories, received a warning letter for making the following claim, which
nicely displays the sort of sciency-sounding nonsense beloved by supplement
pushers, plus a pitch to fringe practitioners who want to profit off selling
COVID nostrums to their patients:

   Simple Silver (Colloidal Silver) with ionic solubility technology is a
   dietary supplement that has ionic solubility that may supports the Immune
   system ability to fight off and kill nasty pathogens that can cause illnesses
   inside and outside the body such as: CORONAVIRUS (COVID-19) . . . Ideal for 
   dedicated health care professionals working with Covid-19 patients . . .

Failure to adequately address similar unlawful claims following warnings has
resulted in the FDA seeking injunctive and other relief in court. Most recently,
at the request of the FDA, the U.S. Department of Justice filed a civil
complaint for permanent injunction in a New Jersey district court against
Natural Solutions and individual defendants for selling a “nano silver product” 
that defendants claim can treat or cure COVID-19.

Finally, the aptly-named Predator Nutrition, a British firm, was told to stop
making COVID-related claims for its products, including salidroside, a bioactive
component of the plant Rhodiola rosea, the “potential” of which was couched in 
life-saving terms:

   . . . in ameliorating sepsis induced lung injury [footnote omitted], and
   protection against pulmonary fibrosis. [footnotes omitted] Attacking the
   lungs and causing pulmonary fibrosis is one of the most common symptoms seen 
   in those for whom Covid-19 turns severe or fatal.

Pharmaceuticals

“Natural” products aren’t the only ones in trouble for false COVID marketing.
The FDA recently went after companies selling pharmaceuticals as unproven COVID 
remedies.

According to the FDA, sales reps for Nephron Pharmaceuticals Corporation sent
emails promoting Budesonide, an FDA-approved drug for the treatment of asthma in
children, as a treatment for symptoms associated with COVID. In one email
quoted by the FDA, a sales rep said that:

   Over the last few weeks, doctors and researchers have touted the benefits of 
   using Budesonide as a treatment for symptoms associated with COVID-19. One
   physician, who went viral this month, called Budesonide a “silver bullet”.

Two internet pharmacies, Medication-house.com (China) and Extrapharma.com
(Russia), received warning letters in September regarding their sale of Arbidol,
an antiviral used in some countries for influenza treatment but not
FDA-approved in the U.S. because no application for approval has ever been
filed. Both websites claim that Arbidol is effective in preventing COVID.

Health clinics

“Wellness” practitioners received FTC warning letters as well. The FTC cited New
York City’s Tribeca Wellness Collective for promoting:

   Thymosin Alpha 1 peptide therapy, Endolaser IV therapy, high dose vitamin C
   IV therapy, ozone IV therapy, vitamin B12 injections, and supplements.
   [references added]

I was intrigued by the “Endolaser IV therapy”. An endolaser is a medical device 
used in eye surgery, so I couldn’t imagine what an IV Endolser was. Here’s an
“explanation” from Tribeca Wellness:

   So the reason that we use the IV Endolaser is because specifically the red
   light helps to support your body’s natural immune system. So it supports
   natural killer cells, T helper cells, and T suppressor cells, which are all
   cells that your immune system uses to keep you healthy, recognize foreign
   invaders, as well as kill them, and alert your body that you’re being
   invaded, and the appropriate response to that.

I must confess I still have no idea how this works. In any event, according to
the FTC, there is no reliable scientific evidence it works for COVID.

Park Avenue Skin Solutions, whose address is one floor above Tribeca Wellness
(and is therefore, in fact, not on Park Ave.) was cited in an FTC warning letter
for similar claims.

But for sheer volume of unsubstantiated COVID claims catalogued in an FTC
warning letter, I have not found anything to beat MD Beauty Labs in West Palm
Beach, Florida. MD Beauty Labs advises that

   It only makes sense that we should boost our immune system so that we can
   improve our chances to fight off disease.

How?

   In addition to Thymosin Alpha-1 there are several other IV Therapies and
   Supplements that are beneficial. [They are] IV Vitamin C Therapy – Helps the 
   immune system and possibly inhibit viral replication; IV Glutathione Therapy 
   – Powerful Antioxidant; IV Colloidal Silver Therapy – Antimicrobial and
   Immune Boost; AHCC- Japanese Medicinal Mushroom Extract – Supports Immune
   Function; Vitamin D3 – Helpful to enhance immune function; Path DS – Provides
   a powerful combination of herbs to naturally support a healthy immune
   system. Liposomal Vitamin C; Liposomal Glutathione; Liposomal Curcumin;
   Melatonin – Has been found to have anti-viral properties; Wellness Tonic- A
   blend of medicinal herbs that help boost the immune system; PRP spray –
   Purified Immunoglobulins from cow’s colostrum; Zinc – Supports immune system.
   We also have an Immune Support kit, containing mineralized D3, Liposomal
   Vitamin C, Zinc and Immuno PRP Spray. [Reformatted from original.]

The FDA and FTC have responded to the gravity of the pandemic by more
aggressively pursuing unlawful claims that products and services can treat or
cure COVID-19. It is unfortunate that they do not have the resources to mount
this type of campaign against more pedestrian bogus remedies, which remain on
the market to bilk the public.

COVID vaccine manufacturers should explore legal action against anti-vaxxers
spreading disinformation

Perhaps it’s time for vaccine manufacturers to consider defamation suits against
anti-vaxxers who spread false information about COVID vaccines. Lawsuits by
voting technology companies against Fox and others over false “rigged” election 
claims could serve as a template.

Jann Bellamy on May 6, 2021

Link



As has been widely reported in the media, voting technology companies Dominion
and Smartmatic have filed multi-billion dollar defamation lawsuits against Fox
News and others over false claims that voting machines were “rigged” to help
“steal” the 2020 presidential election. Perhaps it’s time for Moderna, Pfizer,
and Johnson & Johnson to follow suit, taking legal action against those who
spread disinformation about the safety and effectiveness of their vaccines.

An expert quoted in The Washington Post sees in the pending defamation suits the
possibility of curbing the spread of misinformation where other methods (like
actions taken by social media companies) have proven impotent:

   “We are seeing the way that libel has become a real battleground in the fight
   against disinformation,” said RonNell Andersen Jones, a law professor at the
   University of Utah. “The threat of massive damages for spreading probably
   false conspiracy theories on matters of public concern could turn out to be
   the one tool that is successful in disincentivizing that behavior, where so
   many other tools seem to have failed.”

Spreading false information about COVID 19, a matter of public concern for sure,
is exactly what “super-spreaders” like Joseph Mercola and Ty Bollinger have
been doing for over a year. “Disincentivizing” their harmful behavior with legal
action targeting their efforts to undermine the public’s confidence in vaccines
may be just what the doctor ordered.

With that possibility in mind, we’ll look at how the masterfully-crafted
complaints filed by Smartmatic and Dominion could serve as a template for
defamation suits brought by vaccine makers against those who endanger the
public’s health with their false claims. Although disinformation plagues all
vaccine manufacturers, today we’ll focus on COVID vaccines.

The defamation suits

The lawsuits center on alleged falsehoods about the companies’ voting machine
technology broadcast by Fox and its news personalities, including Lou Dobbs,
Maria Bartiromo, and Jeanine Pirro (and repeated on social media to millions),
including false statements made by lawyers Rudy Giuliani, Sidney Powell, and
businessman Mike Lindell, in interviews on various Fox programs following the
2020 presidential election. For our purposes here, we’ll concentrate on the
complaints’ allegations against Fox.

The tort of defamation is governed by state law, albeit with important First
Amendment implications, and can thus vary from state to state. However,
generally, the plaintiff must prove that the allegedly defamatory statements
were “of and concerning” the plaintiff, that the statements are ones of fact (as
opposed to, for example, an opinion) and are provably false, that they damaged 
the plaintiff’s reputation, and damages. Save a few statements that might be
regarded as opinion, Smartmatic and Dominion can likely prevail on these
elements.

If the plaintiff is a private figure, whether a person or business entity, they 
must show only that the statements were negligently made. But, if the plaintiff 
is a public official or public figure, they must prove, by clear and convincing 
evidence, that the defendant acted with actual malice or reckless disregard for 
the truth. The standard is a subjective one: the plaintiff must prove the
defendant had actual doubts about the veracity of his statements. This is a high
bar:

   The “reckless disregard” standard for public-figure plaintiffs is “rarely
   met,” said [law professor] Andersen Jones. “It is famously difficult to show 
   that someone knowingly lied, although Dominion has marshalled some powerful
   evidence on this front.”

Both Smartmatic and Dominion have obviously anticipated being deemed “public
figures” in drafting their complaints and have included allegations which they
believe will meet the actual malice/reckless disregard standard. Other
allegations go to show that Fox intended the statements to be understood as
factual, not opinion (a defense Sidney Powell has already invoked in her case). 
Key allegations include:

1. Fox and its news personalities repeatedly promoted themselves as providers of
factual information and a “trusted” source. They also used Giuliani’s and
Powell’s status as lawyers to create the impression they were reliable sources
of fact.

2. The falsity of their statements was easily verifiable from numerous sources,
including state and federal officials and agencies, voting experts, and the
plaintiffs themselves, none of whom were interviewed.

3. The way Fox claimed the voting machinery operated is inherently implausible and 
technologically impossible.

4. Fox urged viewers and readers to discredit and ignore what they heard from other
sources and suppressed facts that would counter its narrative.

5. Fox was aware of, but nevertheless violated, generally accepted journalistic
standards.

6. Fox’s motive was economic: it needed to placate angry viewers who migrated to
other media outlets after Fox called Arizona for Joe Biden early on, so it made 
Dominion and Smartmatic “villains” in the false narrative about a “stolen”
election.

Sound familiar?

SBM has extensively covered the firehose of falsehoods about COVID 19 vaccines. 
Let’s take a look at just a few of these posts, chosen for a particular reason, 
as you’ll see in a moment.

Just this past Monday, David Gorski, who has done some seriously heavy lifting
in shooting down COVID misinformation on all fronts, shredded a scientifically
illiterate claim, recycled from the anti-vaxx trope machine, that

   “shedding” of spike protein from the mRNA-based COVID-19 vaccines, such as
   the vaccines produced by Moderna or Pfizer/BioNTech, are making the
   unvaccinated sick and interfering with women’s menstrual cycles (or even
   causing miscarriages) . . .

Specifically called out, and rightly so, was anti-vaxx pediatrician Larry
Palevsky:

   Somebody get Dr. Palevsky a college-level introductory molecular biology
   textbook! Why? He seems not to know the difference between “genetic
   instructions”, mRNA, and proteins. He seems to think that an immune response 
   to an mRNA strand coding for a protein will attack the protein itself and any
   protein that looks like it, thus producing autoimmune disease. Truly, Dr.
   Palevsky needs a remedial course in basic biology and molecular biology.
   (Either that, or, again, he’s lying. Take your pick.)

Of course, no anti-vaccine falsehood would be complete without an attempt to
pre-empt truthful information from respected experts in the field, and Palevsky 
doesn’t disappoint, warning us not to listen to scientists who’ve dismissed, as 
the post describes it, his “incredibly improbable” claims “based on,
essentially, everything we know about molecular biology and immunology”.

Also skewered in his recent posts over their scientific malfeasance: Joseph
Mercola, Geert Vanden Bossche (aided and abetted by anti-vaccine propagandist
Del Bigtree), Robert F. Kennedy, Jr. , J. Bart Classen, and, of course, Natural 
News, among others.

Scott Gavura wrote a couple of posts on reports from the Center for Countering
Digital Hate (CCDH) that, conveniently for our purposes here, synthesize
anti-vaccine rhetoric and its sources. First,

   The Anti-Vaxx Playbook, that describes in detail how key members of the
   anti-vaccine movement are collaborating and partnering in new ways to exploit
   the COVID-19 pandemic, create consistent anti-vaccine messaging, and destroy
   confidence in vaccination.

Their strategy centers on three anti-vaccine themes:

1. COVID-19 is not dangerous. Talking points: There are few deaths, and death
reports are exaggerated. “It’s just the flu.” “It will just go away on its own.”

2. COVID-19 vaccines are dangerous. Talking points: “The vaccines were rushed.”
“The vaccines are killing people.” “Natural” immunity is better. Other
treatments (e.g., hydroxychloroquine) are safer and better. “Vaccines are
toxic.” “Vaccines will change your DNA/destroy your immune system.” etc. etc.

3. Vaccine advocates cannot be trusted. Talking points: “It’s politics over
health.” “It’s Big Pharma profits over health.” Vaccines are “too big to fail”
and manufacturers are “not liable for injuries.” “Bill Gates! Bill Gates! Bill
Gates!”

As described in a second post, another CCDH report outed the “disinformation
dozen”, just twelve anti-vaxxers responsible for almost two-thirds of all
anti-vaccine content on Facebook and Twitter. They include Joseph Mercola,
Sherri Tenpenny, Rashid Buttar, Kelly Brogan, and Christiane Northrup, all of
whom are either medical or osteopathic physicians. Another, Ben Tapper, is a
chiropractor.

This post referred as well to a third CCDH report, covering anti-vaccination in 
general, The Anti-Vaccination Industry, which identified four sub-communities of
anti-vaxxers, including these two:

1. Campaigners are full-time, anti-vaccine professionals who may be seen as
“experts”. They make a living based on promoting anti-vaccine sentiment and
ideas. Their examples include: Informed Consent Action Network (Del Bigtree),
Children’s Health Defence (Robert F. Kennedy Jr.), and the National Vaccine
Information Center (NVIC).

2. Entrepreneurs leverage and amplify vaccine fears to sell content, products and
services. Examples include Rashid Buttar, Ty and Charlene Bollinger, David
Wolfe, Judy Mikovits, and the biggest, Joseph Mercola.

One of the “campaigners” identified is Robert F. Kennedy, Jr., who was also
honored with a spot among the “disinformation dozen”.

   Kennedy’s most important role in the anti-vaccination movement is lending his
   credibility as an environmental campaigner and son of the Kennedy political 
   dynasty to other key figures by appearing alongside them at events or taking 
   part in interviews.

And with that, folks – a review of a few SBM posts – we’ve just checked off the 
entire list of key allegations against Fox:

1. Anti-vaxxers present themselves as credible “experts”, including the use of
their status as healthcare professionals, and therefore purveyors of trusted
“factual” information.

2. The falsity of their information is easily verifiable, from scientific experts
as well as the CDC, FDA, and the vaccine makers themselves, if they’d only
bothered to check.

3. Anti-vaxxers make scientifically implausible and biologically impossible claims.

4. In presenting their anti-vaccination misinformation, they fail to include
information that disagrees with what they are saying and try to discredit
reliable sources.

5. At least some of them are trained in science and the scientific method and
should (or do) know better.

6. Finally, by choosing anti-vaccination activism as a career or by shilling for
the nostrums they sell, or both, they have an economic motive to spread false
information.

If we can get here by reviewing a few SBM posts, imagine what a talented
defamation lawyer could do with an extensive review of, say, Mercola’s websites,
social media posts, books, transcripts of his media appearances, and FDA
warning letters.

As with the voting technology suits, proving the falsity of statements made by
various anti-vaxxers, or that they damaged the vaccine makers’ reputation,
shouldn’t be difficult. And while the defendants might try to fob everything
they have said off as “opinion”, that’s unlikely to fly.

Most crucially, as is true of the allegations against Fox, their actions
evidence, at the least, a reckless disregard for the truth. And it is here that 
the anti-vaccine movement goes the “rigged” election crowd one better. Key
players like Kennedy have amassed a years-long record of anti-vaccination
misinformation. Whole books (also here) have been written on the subject. In
fact, as David Gorski has so effectively shown, some of the COVID
anti-vaccination disinformation is merely recycled garbage from previous
anti-vaccination disinformation efforts. What a perfect means of demonstrating
actual malice.

Litigation is costly and time consuming, and there can be good business reasons 
not to employ it in any matter. Discovery, for one. These companies may not want
the defendants getting into their records (although there are guardrails, like 
protection of trade secrets). And, of course, not every bit of disinformation
broadcast by just anyone should be made the subject of a lawsuit. But, given the
relentlessness of the anti-vaxxers and the failure of social media companies to
stop them, defamation actions, especially against the “disinformation dozen”,
could be part of the solution. Even if monetary damages prove not worth the
pursuit, the plaintiffs could seek declaratory and injunctive relief,
prohibiting the defendants from repeating their misinformation.

Sending the likes of Mercola and Kennedy demands for retraction are a
possibility as well, setting out their false statements and explaining why they 
are false. (For this, they could just cut and paste any number of David Gorski’s
posts.) The demands may be ignored, but that is done at the risk of those
demands appearing in a complaint as evidence of actual malice – in other words, 
they kept it up even after being put on notice. (Both Dominion and Smartmatic
have set forth corrections they sought from Fox in their complaints.)

After Smartmatic demanded that right wing media outlet Newsmax retract its false
and defamatory statements, Newsmax posted a statement renouncing a number of
false claims about both companies, acknowledging “no evidence has been offered
that Dominion or Smartmatic used software or reprogrammed software that
manipulated votes in the 2020 election.” Imagine the satisfaction of hearing
similar statements retracting anti-vaccination lies.

“Health Freedom” group promotes legislation negating masks, other public health 
measures

National Health Freedom Action is promoting state legislation that would block
enforcement of public health measures (e.g., mask wearing and social distancing)
during epidemics and other emergencies. The organization and its allies embrace
junk science and have successfully passed laws protecting quacks.

Jann Bellamy on September 24, 2020

Link



An organization calling itself “National Health Freedom Action” (NHFA) is
promoting state legislation that would block public health measures designed to 
prevent the spread of communicable diseases like COVID-19. If enacted, the
legislation would prevent both government and private businesses from
instituting public health measures, like mask requirements and social
distancing, by making compliance with those measures voluntary.

Before we get to the specifics, let’s take a look at NHFA and its operations.

Under the rubric of “health freedom”, a legally meaningless term, NHFA supports 
several alternative medicine hobbyhorses. Their chief legislative success has
been passage of “safe-harbor” laws protecting quacks from being disciplined
under state health care practitioner licensing acts, thereby making it virtually
impossible for a state to combat the victimization of consumers by charlatans
and their nostrums. They and their allies have been instrumental in getting
these “Quack Protection Acts” passed in 11 states. One version is now pending in
Massachusetts; a Wisconsin bill came close to passing but, fortunately, failed.

In Maine, for example, an unlicensed practitioner providing “alternative or
complementary health care services” can diagnose and treat any disease or
condition (with very few exceptions), without informed consent and without any
obligation to refer the consumer to a physician. There is no requirement that a 
CAM practitioner keep patient records (of, say, symptoms and treatment) nor are 
there confidentiality protections for patient information. Unlike licensed
health care practitioners, such as physicians and nurses, there are no education
and training requirements; no criminal background checks; no prohibitions
against false advertising, conflicts of interest, or financial or sexual
exploitation of patients (at least those prohibitions established by the state’s
licensing laws); and no required reporting (e.g., of infectious diseases or
child abuse). They essentially practice medicine with no standard of care and
completely free of state regulation.

Concomitant with protecting quacks, NHFA opposes licensing of health care
practitioners like dietitians and massage therapists. They also oppose
vaccination mandates and support “personal and philosophical” exemptions,
including the virtually unchecked authority of health care providers to
underwrite vaccine exemptions. NHFA supports GMO labeling, “protection of access
to” dangerous raw, unpasteurized dairy products, and parental “rights” to
choose “alternative” health care for their children. (We’ve discussed the tragic
consequences for the child when parents exercise their “rights” a number of
times here on SBM, including here, here, and here.)

NHFA, with its sister organization, the National Health Freedom Coalition
(NHFC), promotes false information about COVID-19, including posts by
GreenMedInfo and the Weston A. Price Foundation, both on NewsGuard’s list of
websites known for spreading COVID-19 misinformation. For example, a post by
Weston A. Price Foundation founder (and English major) Sally Fallon Morell
opines, among other idiotic notions, that the rollout of 5G is somehow
responsible for the COVID-19 outbreak and that vaccines make people susceptible 
to it, both thoroughly debunked by David Gorski. (Morell has a book out
promoting this and other nonsense, such as “the disease called Covid-19 is not
contagious and scientists have not properly isolated and purified a virus
associated with the disease”.) Another post recommends the use of homeopathy,
falsely claiming that it “is very effective in epidemics”.

NHFC, in turn, hosts the United States Health Freedom Congress, which is
sponsored by COVID-19 misinformation “super-spreaders” mercola.com and the
National Vaccine Information Center (or, as we prefer here at SBM, the National 
Vaccine Misinformation Center), as well as companies selling various nostrums,
like EMF “protection” and homeopathic remedies.

The “Right to Refuse” model act

In sum, NHFA operates within an ecosystem of COVID-19 misinformation,
profit-making quackery promotion, anti-consumer legislation, anti-vaccination
hysteria, and all-around junk science. It is therefore unsurprising that NHFA is
spearheading an effort to pass legislation blocking public health measures
during the current pandemic. Billed as the “Right to Refuse” law, NHFA drafted a
model act for state legislatures, fresh off the presses, ready and waiting for 
introduction in your state’s next legislative session.

The “Right to Refuse” model act gives all individuals the “right” to refuse
health-related “countermeasures” including, “but not limited to”, refusing

  1. medical treatments or procedures;

  2. testing;

  3. physical or mental examination;

  4. vaccination;

  5. experimental procedures and protocols;

  6. collection of specimens;

  7. participation in tracking or tracing programs;

  8. the wearing of masks;

  9. the maintaining of measured distance from other humans and animals that is not
    otherwise unlawful;

  10. the involuntary sharing of personal data or medical information; and

  11. other recommended or mandated countermeasures.

All existing laws, regulations, and orders addressing outbreaks or potential
outbreaks of contagious, infectious, or communicable diseases, to the extent
they impose the disease countermeasures listed above, are overridden. More
broadly, if a law, regulation, or order was created in response to an emergency,
whether it relates to disease spread or not, including national security
emergencies and “any peacetime emergency”, provisions conflicting with the
“Right to Refuse” are also overridden.

Given the fact that unspecified “other recommended or mandated countermeasures” 
are forbidden, and the right to refuse is “not limited to” the listed
countermeasures, it is hard to imagine what might be left in the government’s
toolbox to combat a public health or national security emergency, other than
some confusing and contradictory measures we’ll get to in a moment. Ebola
epidemic? Too bad. Biochemical warfare? Too bad. Nuclear attack? Too bad,
because

   An individual who has been directed or ordered by a government . . . or
   public or private business entity, to subject to a directive or order
   [described in the list above] may choose to decline to comply, respond to, or
   participate with said directive or order.

Note that this would include hospitals, nursing homes, and other health care
facilities, which, during the current pandemic, would be prevented from barring 
individuals who refuse to wear masks, socially distance, or have their
temperature checked.

To emphasize the startling breadth of its prohibitions, under the heading
“Coercion”, the model act provides:

   The government or its designees, or other employers, businesses, non-profits,
   institutions, churches, travel carriers, or other public or private
   entities, may not infringe upon, put conditions on, restrict, or take away a 
   person’s ability to fully participate in necessary and important services and
   lifestyle choices and preferences including but not limited to education,
   daycare, employment, travel, religion, hobbies, entertainment, sports, and
   lifestyle preferences, based on a person choosing to decline countermeasures 
   as described [in the list above].

To ensure that we are all fully informed about our right to uninhibited
lifestyle choices and preferences, not to mention hobbies and entertainment, the
model acts requires anyone (government official and businessperson alike)
daring to direct, or even request, our compliance with the listed
countermeasures to read us our “rights” by reciting both the above-quoted
paragraph and the 11 countermeasures we can refuse, along with assorted other
verbiage, to the tune of almost 350 words. In addition, the person refusing the 
countermeasure (we’ll call him the “refusenik”) must be given a copy of the
section of the model act requiring this recitation of his rights. Then, the
reader of the recitation of rights has to “obtain a signature of acknowledgement
of receipt of notification” of the right to refuse by the refusenik.

By my calculation, this recitation of the right to refuse takes about 3 minutes.
(I have a Southern accent, your results may differ.) Then there’s the
additional time necessary to give out the written notification of the
requirement that one’s right of refusal be recited and get a signature. Given
the anti-mask sentiment in certain quarters, high-traffic government offices and
businesses would likely have to hire someone whose sole duty it is to read
refuseniks their “rights”, give them the written handout, and get it signed.
(Given their anti-regulation sentiment, query how many refuseniks are going to
stand there patiently while all of this takes place.)

But wait . . . there’s more, although it’s so poorly drafted it’s hard to make
heads or tails of it.

According to the model act, if our refusenik is actually infected, or reasonably
believed to be infected, or has been exposed to infection, he “may” (not
“must”, but “may”) participate in isolation or quarantine. However, if this
isolation or quarantine is truly optional, other provisions don’t make any
sense. For example, if our refusenik is “non-infected”, this apparently optional
quarantine must be based on “sufficient evidence of contact or close proximity 
with an infected person”. But why would this evidence be necessary if the person
is voluntarily choosing quarantine? Likewise, isolation and quarantine must
“include reasonable notice and due process”. Again, if the isolation or
quarantine is self-imposed, how would due process (that is, notice and an
opportunity to be heard) come into play?

If the restrictions are not voluntary, what means would the government have of
knowing a person is infected in the first place, given the right to refuse
requests for medical information and testing? In any event, even if the drafters
meant quarantine or isolation can be mandated, I’ll guarantee you the
refusenik’s attorney is going to argue that the “Right to Refuse” law says
otherwise; that “may” means it’s voluntary. (The thought occurs to me that this 
obfuscation could be intentional.)

Isolation or quarantine, whether mandated or self-imposed, “must be of the least
restrictive means possible” and includes the right to live in one’s home with
family or friends as well as a prohibition against removing minor children from 
the home. Testing, treatment, tracking, or prevention cannot be imposed as a
requirement of ending quarantine or isolation. And the drafters of this model
act, being who they are, included this:

   A person in isolation or quarantine has the right to utilize the health care 
   treatments of their choice. . .

One would like to think that a law undermining public health during a pandemic
has little chance of passing, but the facts suggest otherwise. First, there is
the anti-mitigation, anti-science, pro-quackery “leadership” coming from the top
echelons of our government. Second, a “right to refuse” law, similar but weaker
in its terms, already passed in Minnesota. Third, as mentioned, NHFA has been
successful in passing laws giving quacks carte blanche to prey on consumers by
eliminating state oversight. Fourth, state legislatures have shown themselves
more than willing to throw obstacles in the way of public health measures like
vaccination. Finally, state legislatures have also proven themselves incapable
of understanding science many times, having passed numerous laws licensing
quackery. In other words, don’t count them out.

Legislatures and litigation: anti-vaxxers continue attacks on COVID mitigation

Anti-vaxxers are attacking COVID-19 mandates in state legislatures and in court 
even as COVID-19 cases numbers and hospitalizations remain high among the
unvaccinated.

Jann Bellamy on June 3, 2021

Link



A so-called “health freedom” group is touting recently passed state laws
crippling government and private sector measures to mitigate the COVID pandemic.
Meanwhile, on another front, anti-vaxxers are attacking these measures in
court.

If their intent is to ensure that COVID-19 case numbers and hospitalizations
remain high among the unvaccinated, they are doing a good job. According to a
recent analysis by The Washington Post, while national case numbers and
hospitalizations are declining,

   adjustments for vaccinations show the rate among susceptible, unvaccinated
   people is 73 percent higher than the standard figures being publicized. With 
   that adjustment, the national death rate is roughly the same as it was two
   months ago and is barely inching down. The adjusted hospitalization rate is
   as high as it was three months ago.

For example,

   When current hospitalizations are spread across only the unvaccinated
   population, D.C. and Michigan have rates about twice as high as the adjusted 
   national rate. Pennsylvania, Maryland, Florida and Rhode Island have rates
   about 50 percent higher than the adjusted national hospitalization rate.

And in Washington state,

   unvaccinated seniors are 11 times as likely to get hospitalized than seniors 
   who got the shot. For unvaccinated people age 45 to 64, the chance of
   covid-19 hospitalization is 18 times higher.

Well done, anti-vaxxers.

“Right to Refuse”

National Health Freedom Action and its sister organization, National Health
Freedom Coalition, support your “right” to be bamboozled by charlatans with
their promotion of so-called “health freedom” laws or, as I prefer to call them,
Quack Protection Acts. These laws, passed in eleven states, prohibit the
prosecution of quacks for the unlicensed practice of medicine, leaving them free
to diagnose and treat the vulnerable and desperately ill with their dangerous
nostrums, confident in the knowledge that the state’s authority to hold them
responsible has been effectively neutered.

Apparently buoyed by the opportunity presented by the pandemic promote their
cause, NHFA has launched a “Right to Refuse” campaign aimed at aiding those who 
want to increase their chances of coming down with COVID-19 by refusing
vaccination. To ensure that their pro-pseudoscience propaganda is spread among
people attracted to their anti-public health campaign, “Right to Refuse”
includes tracts on how to successfully pass Quack Protection Acts. It also
refers readers to the notoriously anti-vaccine National Vaccine Information
[actually, misinformation] Center, funded by alternative medicine tycoon Joseph 
Mercola, for more know-how on anti-vaccination legislation in general.

In sum, a group that promotes dangerous and ineffective Gerson protocol quackery
for deadly cancers is also discouraging safe and effective immunization against
a deadly virus.

NHFC recently sent out an email blast congratulating NHFA and its “Right to
Refuse” campaign on its success in getting state laws passed designed to hog-tie
public and private efforts to combat both the current and future pandemics. (I 
wrote about a number of pending bills in a March post, some of which,
unfortunately, have now been signed into law.) They’ve even named these new laws
after themselves, calling them “Right to Refuse laws”. I’m not sure how much of
this “success” can actually be attributed to NHFA given the anti-science
proclivities among certain politicians eager to please their freedom-loving
base, but NHFC did include a handy summary of these freshly-passed state laws in
their email, from which I freely borrow.

Several the “Right to Refuse laws” concern so-called “vaccine passports”, that
is, written proof of vaccination.

In a new law that, on its face, applies to all immunizations, not just COVID-19,
Alabama prohibits state and local governments from issuing vaccine passports
and from requiring immunization as a condition of receiving government benefits 
or services. Likewise, businesses cannot refuse goods or services based on
immunization status. Fortunately, there are exceptions for health care providers
and hospitals. Alabama colleges and universities must provide exemptions from
vaccination requirements to any student or employee with a “bona fide medical
condition or religious belief that is contrary to vaccination”, and no student
or employee can be required to take a vaccine available only under an FDA
emergency use authorization, again with exceptions for those involved in health 
care.

In Arkansas, state and local government entities can no longer require proof of 
vaccination against COVID-19 “for any purpose”. In a separate section of the law
that does not specify who is governed by its prohibitions, proof of vaccination
“shall not be a condition for entry, travel, education, or services.”

Similarly, Florida (my state) will not allow businesses to require that patrons 
or customers show proof of vaccination or recovery from COVID, nor will it allow
educational institutions to require the same from students or residents. State 
and local governments cannot make “access to, entry upon, or service from” their
operations contingent on proof of vaccination. To the chagrin of “Right to
Refuse”, health care facilities are exempt and the prohibitions do not apply to 
employers vis a vis their employees, meaning that, in the kind of histrionic
language beloved by anti-vaxxers, “it appears employers may be able to choose to
require their employees to be injected”.

Although not mentioned in the NHFC email, the new Florida law also greatly
restricts local governments’ authority to require mitigation measures during a
public health emergency, including arbitrary times limits that are wholly
unrelated to the level of threat presented. The law bestows on the governor the 
authority to override local orders he personally finds unnecessarily restrictive
of “individual rights or liberties”. In turn, in rock-paper-scissors fashion,
the state legislature will be able to override a state of emergency declared by 
the governor.

Per Indiana’s new legislation, state and local governments can neither issue nor
require vaccine passports and proof of COVID immunization for driver’s licenses
and other state-issued IDs is prohibited. An Iowa law prohibits state and local
governments from requiring proof of immunization as well. Like Florida, Iowa
bans businesses from requiring proof of immunization for patrons or others
entering their premises, but this does not apply to their employees. Public and 
private health care facilities are exempt. Another Iowa law restricts the
ability of school boards and local governments to require face masks. Utah also 
exempts those engaged in health care activities from its recently enacted
prohibition against state and local governments requiring any COVID-19 vaccine, 
a prohibition that lasts only as long as the vaccine lacks full FDA approval.
Like Alabama, Utah also enacted a law aimed at student vaccinations required by 
institutions of higher learning, adding a personal belief exemption.
Unvaccinated students cannot be required to choose remote learning over
in-person classes.

Montana, in one of the more sweeping new laws, couches its prohibitions in terms
of “discrimination” and applies them to all immunizations except those required
by schools and day care centers. There is also a blanket prohibition against
requiring anyone to receive “any vaccine whose use is allowed under an emergency
use authorization or any vaccine undergoing safety trials”.

Thus, it is an “unlawful discriminatory practice” for any person or governmental
entity to refuse or deny anyone

   any local or state services, goods, facilities, advantages, privileges,
   licensing, educational opportunities, health care access, or employment
   opportunities based on the person’s vaccination status or whether the person 
   has an immunity passport.

Similar provisions apply to public accommodations.

Employers cannot require employees to be vaccinated or “discriminate” against
them regarding terms and conditions of employment based on vaccination status.
It is unclear whether the employer would be prohibited from inquiring whether
the employee is vaccinated or from requiring masks and other mitigation measures
of unvaccinated employees. That uncertainty alone could cause some employers to
forego any such requirements. Health care facilities are permitted ask whether 
employees are vaccinated, but only to the extent it is necessary to implement
“reasonable accommodation measures” for other employees, patients, and visitors 
to protect them from communicable diseases. Nursing homes are also exempt to the
extent they are required to comply with federal government guidelines.

Ohio also enacted sweeping new legislation, but with a different tack, making
virtually all emergency actions subject to legislative review, rescission, or
invalidation. Gov. DeWine vetoed the bill but the legislature overrode his veto.

The new law time-limits any state of emergency declared by the governor to 90
days, with extensions granted by the legislature, although the legislature can
end any state of emergency earlier if it wants. The legislature can rescind or
invalidate any rule issued by an administrative agency (the state health
department, for example) in response to a declared state of emergency.

The law also requires the governor and the state health department to report to 
the legislature every action they or their representatives take in response to
the state of emergency and any such action is immediately subject to legislative
review, rescission, or invalidation, in whole or in part. As well, it
significantly restricts, but does not eliminate, the authority of local health
departments regarding quarantine orders, school closures, and gathering bans.

In a resolution, Louisiana’s legislature declared that day care centers and
schools (including colleges and universities) must inform students that the
COVID-19 vaccine is authorized for emergency use only, has not been fully
approved by the FDA, and that they have a right to refuse the vaccine. Students 
must also be told, falsely that the vaccine is “experimental”. (A resolution
such as this can, at best, direct a state agency to take certain actions, but
does not have the force of law, so I’m not sure how effective this will be.)

In an even more legally meaningless (but undoubtedly base-pleasing) action,
falsely stating that “measures are being considered to mandate experimental
vaccination”, the North Dakota legislature passed a resolution urging Congress
not to issue vaccine passports or enact any law that would “restrain an
individual’s right to travel or participate in commerce, religious freedom, and 
education based on whether the individual has received a COVID-19 vaccine”.

Alaska’s legislature gave everyone a right to refuse the COVID-19 vaccination
“based on religious, medical, or other grounds”, with no exception that I can
find for employers requiring employee vaccinations or medical facilities.
Similarly, a new law in Kentucky provides religious and “conscientiously held
beliefs” exemptions to any immunization required by the state during an
epidemic.

Litigation threatened

In addition to the state legislatures, anti-vaxxers are turning to the courts to
attack COVID-19 vaccines. As reported in the Washington Post (in an article
well worth reading in its entirety), anti-vaccine careerists Del Bigtree and
Robert F. Kennedy, Jr. are chumming up cases to challenge employer and school
vaccine mandates, aided by a New York law firm, Siri & Glimstead. Bigtree’s
outfit, the Informed Consent Action Network (ICAN), which paid the firm nearly
$1.3 million in 2019, “has advertised Siri & Glimstad’s services and sought
plaintiffs for challenges to mandates”. Kennedy’s anti-vaxx group, the
Children’s Health Defense, is helping spread the word by running an ad:

   If you or anyone you know is being required by an employer or school to
   receive a covid-19 vaccine, ICAN is offering to support legal action on your 
   behalf to challenge the requirement.

Of course, employers like a county-owned skilled nursing facility in Wisconsin
and the Durham County (N.C.) Sheriff’s Department, both the subject of
litigation threats over their vaccination requirements for employees, can ill
afford budget-draining litigation, which may, as the article points out, lead to
their backing off. This, in turn, could have a chilling effect on other
employers who want their employees vaccinated against COVID.

Fortunately, Rutgers and Princeton are not so cowed. According to the Post, both
have received letters from Siri & Glimstead but are holding firm. Said a
Princeton rep,

   We conducted a careful review and are confident in our legal position.

The Post also reports that “ICAN’s legal team remains active on other
vaccine-related fronts”. Siri & Glimstead have filed a complaint on ICAN’s
behalf “asking a federal court to order Health and Human Services Secretary
Xavier Becerra to remove the finding that ‘vaccines do not cause autism’ from
all communications with the public”.

That one deserves its own SBM post. Stay tuned.

COVID-19 has exposed the toothlessness of state medical boards

A report in The Washington Post last week revealed just how badly state medical 
boards have been failing when dealing with physicians spreading COVID-19
misinformation and using quackery to prevent and treat the disease. None of this
is anything new, unfortunately. The pandemic has merely stress tested state
medical boards, and most have failed because of political choices made long ago.

David Gorski on July 31, 2023

Link



   You really think it’s all new.You really think about it too,The old man
   scoffed as he spoke to me,I’ll tell you a thing or two.

                                              The Clash, Something About England

Last week, The Washington Post published an investigation that, unfortunately,
jibes with much of what we at SBM have been writing about state medical boards
for over 15 years. Reported by Lena Sun, Lauren Weber, and Hayden Godfrey and
entitled Doctors who put lives at risk with covid misinformation rarely
punished, the story is a great overview of the shortcomings of state medical
boards that have been laid bare by the COVID-19 pandemic. However, as I will
discuss, the problems with the regulation of physician practice by state medical
boards go back long before the pandemic, which was a stress test on state
medical boards that, for the most part, they have failed miserably. My first
reaction to the story was a bit cynical, too, specifically some amazement that
as many physicians as were described in the story had actually faced
repercussions for their spreading dangerous misinformation about COVID-19 and
even practicing outright quackery claiming to treat or prevent it. That’s just
me, though. (Or maybe it isn’t.)

For the story, the three Post reporters did an analysis of disciplinary records 
of state medical boards for all 50 states, and in this case they don’t bury the 
lede:

   A Wisconsin doctor in 2021 prescribed ivermectin, typically used to treat
   parasitic infections, to two covid-19 patients who later died of the disease.
   He was fined less than $4,000 — and was free to continue practicing.

   A Massachusetts doctor has continued practicing without restriction despite
   being under investigation for more than a year over allegations of
   “disseminating misinformation” and prescribing unapproved covid treatments,
   including ivermectin, to a patient who died in 2022, according to medical
   board records.

   And in Idaho, a pathologist who falsely promoted the effectiveness of
   ivermectin over coronavirus vaccines on social media has not been disciplined
   despite complaints from fellow physicians that his “dangerous and troubling”
   statements and actions “significantly threatened the public health.”

   Across the country, doctors who jeopardized patients’ lives by pushing
   medical misinformation during the pandemic and its aftermath have faced few
   repercussions, according to a Washington Post analysis of disciplinary
   records from medical boards in all 50 states.

To say that this finding was…unsurprising…to me is an understatement. I’ve been 
writing about attempts to discipline dangerous physicians spreading COVID-19
misinformation and using quackery to treat the disease (the two very frequently 
go together hand-in-hand), and for every positive development that brings a ray 
of hope that state medical boards are beginning to understand I seem to find a
lot more signs, like the Post story I’ll discuss (which features some doctors
who have shown up on this blog before), for despair.

State medical boards and the failure to discipline physicians

State medical boards have long been a topic on SBM, dating back to the very
first year of this blog’s existence, when Dr. Kimball Atwood devoted a series of
posts about the pitfalls and failings in how state medical boards had been
growing more and more open to medical “pseudospecialties” or
“pseudodisciplines,” as we like to call them. He began by discussing how, as a
result of advocacy by groups representing naturopaths, several states had been
becoming more accepting of naturopathy, to the point of considering legislation 
that would legalize and regulate some of its quack treatments as though they
were legitimate—or even the specialty itself—in, for example, Minnesota,
Colorado, Massachusetts, and elsewhere. Unfortunately, the problem went beyond
just the political question of deciding whether to regulate naturopathy as
though it were a legitimate medical specialty, and to demonstrate this Dr.
Kimball followed up with discussions of state medical boards investigating
actual MD/DO licensed physicians who used actual quackery (e.g., intravenous
hydrogen peroxide and chelation therapy for anything other than the existing
very narrow conditions for which it is indicated), concluding with a discussion 
of how academic practitioners of what was then called “complementary and
alternative medicine” (CAM, now more frequently called “integrative medicine” or
“integrative health”) had been pressuring state medical boards to accept
outright quackery as being legitimate medical treatments. Jan Bellamy also used 
to write frequently about state medical boards and their shortcomings when they 
were faced with disciplining physicians, as well as about efforts by advocates
for medical pseudospecialties like naturopathy to persuade state legislatures to
pass laws legitimizing their quackery and even turning them into legally
recognized and regulated medical specialties. She even invented an apt term,
“legislative alchemy,” to describe the efforts of advocates to persuade
legislators to turn the lead of quackery (e.g., naturopathy and chiropractic)
into the gold of a recognized medical specialty.

I myself not infrequently wrote about the failings of state medical boards with 
respect to physicians practicing actual quackery. It began with the attempt by
the North Carolina Board of Medical Examiners to discipline Dr. Buttar for his
use of chelation therapy to treat autism and cancer. During the proceedings, Dr.
Buttar famously (to us, anyway) called the Board a “rabid dog.” Ultimately,
however, instead of permanently revoking Dr. Buttar’s medical license, the Board
gave him a slap on the wrist, telling him that he could no longer treat
children or cancer patients, rather than, as I put it at the time, “having his
medical license stripped from him, cut up in front of his face, and then the
fragments ritually burned,” which is the penalty that I thought he so richly
deserved. What ultimately happened, despite the minor restrictions placed on Dr.
Buttar’s practice was quite different.

Dr. Buttar, it turned out, was a significant “pioneer” of what became an
all-too-common and distressing tactic among quacks since COVID-19: Attacking
state medical boards and any other medical authority trying to rein in quacks
and misinformation. His was the template that COVID-19 disinformation spreading 
doctors followed. Most people combatting disinformation now don’t appreciate
just how influential Dr. Buttar was in terms of taking the war straight to state
medical boards. Indeed, he and his allies eventually persuaded the state
legislature to alter North Carolina state law to make it more quack-friendly by 
mobilizing public support to neuter the North Carolina Medical Board and prevent
it from disciplining doctors who practice quackery associated with “integrative
medicine.” Specifically, the 2008 law, passed due to the advocacy of the North 
Carolina Integrative Medical Society and Dr. Buttar, prevents the medical board 
from disciplining a physician for using “non-traditional” or “experimental
treatments” unless it can prove they are ineffective or more harmful that
prevailing treatments. In the end, Dr. Buttar basically won his battle with the 
North Carolina State Medical Board after losing what was in retrospect a
relatively minor battle.

Another case in particular led to my writing about the failure of state medical 
boards more than any other, that of Dr. Stanislaw Burzynski, the Polish expat
physician who has been making extravagant claims for his unproven treatment for 
cancer, something he calls antineoplastons, since the late 1970s and, at 80
years of age, is still practicing in Houston, TX. Indeed, after the multiple
hagiographies of a “brave maverick doctor” who’s “curing cancer” despite the
resistance of the medical establishment, he still appears to be thriving. I’ve
even seen the 2016 hagiography, Burzynski: The Cancer Cure Cover-Up, resurfacing
on many of the same sites promoting COVID-19 misinformation, leading me to
wonder if Burzynski has decided that antineoplastons are good for COVID-19 too. 
The main depressing point of my bringing up Burzynski is that, despite multiple 
attempts by the Texas Medical Board to discipline him for using unproven (and
ineffective) treatments while charging patients huge sums of money, the last
failed attempt in 2017, and attempts by the FDA to stop him, Dr. Burzynski is
still in business. I also like to note when I discuss Dr. Burzynski how he
pioneered many of the same misinformation techniques used today by doctors
promoting COVID-19 misinformation, including cultivating relationships with
sympathetic politicians and, above all, wielding believing patients as
sympathetic shields against attempts to discipline him.

I also used to comment about how infrequent it was for outright antivax quacks
who openly discouraged parents from vaccinating their children to face
discipline prepandemic, asking what we should do about antivax physicians.
Indeed, when such physicians did actually face discipline from their state
medical boards, it was frequently based on other problems, such as how
inadequate documentation brought down Dr. Bob Sears and use of homeopathy
brought down Dr. Paul Thomas. Much of the time, it’s other offenses, not the
quackery and antivax misinformation for which physicians were best known, that
finally pushed state medical boards to act.

Unfortunately, a lot of upstanding physicians practicing science-based medicine 
are unduly disturbed by even the suggestion that state medical boards should
discipline a physician for spreading misinformation about COVID-19. As much as I
argue that it is not “cancel culture” but rather quality control to do so,
political messaging has been successful in persuading all too many physicians to
view attempts by state medical boards to discipline COVID-19 misinformation
spreaders as potential threats to them.

How effective have state medical boards been? Not very

After the lede, the Post notes:

   State medical boards charged with protecting the American public often failed
   to stop doctors who went against medical consensus and prescribed unapproved
   treatments for covid or misled patients about vaccines and masks, the Post
   investigation found.

   At least 20 doctors nationally were penalized for complaints related to covid
   misinformation between January 2020 and June 2023, according to board
   documents, which The Post obtained by filing requests with state medical
   boards and reviewing public records. Five of those doctors lost their medical
   licenses — one had his revoked, while four surrendered theirs. Discipline is
   typically connected to patient care, not just what doctors say.

Again, I can’t help but expressing amazement that it was 20 physicians who were 
disciplined and five who actually lost their licenses to practice medicine. I
would have guessed smaller numbers, much smaller. I will note that the Post
nails the reasons why state medical boards often fail to act:

   But they [state medical boards] are barely able to keep up with the more
   mundane task of issuing licenses, doctors say, let alone monitor social
   media, where many of the false claims proliferate. Critics say the system is 
   not up to the task of overseeing the medical industry, and was particularly
   unable amid the explosion of misinformation that accompanied the pandemic.

   “We allow the profession to police themselves. And when they fail to do that,
   even in the most egregious cases, what they are abetting is the erosion of
   trust and respect for doctors,” said Wendy Parmet, director of Northeastern
   University’s Center for Health Policy and Law, who has written about the
   harms of covid misinformation.

And:

   Doctors don’t normally face discipline for promoting treatments that go
   against medical consensus because state boards are loath to tread on
   physicians’ medical judgment and First Amendment rights, according to doctors
   and members of medical boards. Physicians commonly prescribe drugs for
   conditions other than those they were approved for, a practice known as
   “off-label” use that boards do not want to curtail.

   “State boards can only do limited things,” said Humayun Chaudhry, president
   of the Federation of State Medical Boards, a nonprofit that represents the
   licensing agencies. “The most common refrain I hear from state licensing
   boards is they would like to have more resources — meaning more individuals
   who can investigate complaints, more attorneys, more people who can process
   these complaints sooner — to do their job better.”

As I’ve said many times over the years, state medical boards are often
underfunded and understaffed to the point where they can barely deal with
obvious cases requiring urgent intervention, such as cases of physicians
impaired by alcohol or other substance abuse disorders, grifting physicians
running prescription mills, or physicians engaging in outright fraud. Cases of
physicians practicing quackery—or, in the case of ivermectin and
hydroxychloroquine after 2020, when studies had definitively shown they don’t
work—as “off-label prescribing” are more difficult and resource-intensive to
pursue, if only because many of these quacks have significant resources to
afford top flight law firms to represent them in front of the board, indeed far 
more resources than the board itself often has. Then, when it comes to
misinformation, there’s always the issue of the First Amendment and the
reluctance to penalize a physician for what, misinformation spreaders will
claim, is Constitutionally protected speech. On the other hand, speech
frequently goes hand-in-hand with quackery. Misinformation-spreading physicians 
often base their treatment of COVID-19 patients on the misinformation, sometimes
with serious grifting, as when America’s Frontline Doctors were busted for
running an ivermectin telehealth prescription mill.

The point is, state medical boards, given their lack of resources, tend to go
after the “low hanging fruit,” cases they can win without the expenditure of a
lot of resources, cases like physicians impaired by substance abuse or
physicians sexually abusing patients under the guise of medicine. As I once put 
it years before the pandemic:

   …as Dr. Lipson pointed out, state medical boards are notoriously toothless.
   Think about it. How many times has the Texas Medical Board gone after
   Stanislaw Burzynski over the last 38 years and failed? Or what about the
   quack whose friendship with the town sheriff led to the identification of the
   nurses who complained about him and their suffering severe professional and 
   legal consequences as a result? Or what about the neurosurgeon who can’t
   operate and injured many patients? Or what about the oncologist who
   administered chemotherapy to patients without cancer and administered
   medically-unnecessary chemotherapy to patients with cancer? So bad was his
   behavior that a nurse interviewing for a job noticed that the chemotherapy
   was being mixed up incorrectly and complained to the state medical board with
   no result. This oncologist was only brought down when the feds investigated 
   massive Medicare fraud. Second, medical boards need a concrete complaint, and
   that concrete complaint usually has to be about the actual practice of
   medicine. The Arizona Board, for example, might list 49 definitions of
   unprofessional conduct, but try fitting speaking out about vaccines into any 
   of them. In Dr. Wolfson’s case, one might tag him under #19, “any conduct or 
   practice contrary to recognized standards of ethics of the osteopathic
   medical profession.” Maybe.

   The bottom line is that state medical boards tend to be toothless,
   underfunded, and overwhelmed. That’s why the only physician behaviors very
   likely to result in strong action consists of running a prescription mill,
   diddling patients, or practicing while impaired by abuse of alcohol or
   illicit substances. It’s a matter of resource allocation and prioritization. 
   State medical boards tend to react primarily to what they perceive to be the 
   most immediately and obviously dangerous behaviors. Practicing quackery
   rarely makes the cut, because medical boards are loathe to make value
   judgments about medical practice, and proving quackery is way harder and more
   resource-intensive than proving a doctor is an addict practicing while
   impaired or that he’s diddling patients. Even horrible surgeons like Dr.
   Duntsch, whose epic incompetence in the operating room resulted in multiple
   “clean kills” and so-alarmed colleagues that they actually took the rare
   action of complaining about him, all too often take a long time to take down.

Adjudicating whether a given treatment (or off-label use of an FDA-approved
drug) is quackery and sufficiently below the accepted standard of care or not to
warrant discipline is something that they are much more reluctant to do
because, again, quacks often have a lot of resources to argue, delay, and claim 
that their treatments aren’t quackery, as Drs. Buttar and Burzynski used to do
routinely decades ago.

Another point came up in the story’s discussion of the case of Massachusetts
physician Dr. John Diggs, who faced discipline for “prescribing ivermectin and
hydroxychloroquine to a patient with covid symptoms who died in 2022 after being
intubated”:

   The board alleged that Diggs prescribed the medications despite “clear
   evidence for the lack of any clinical benefit of hydroxychloroquine” and the 
   fact that “ivermectin has been proven ineffective.”

   The medical board accused Diggs of providing treatment to two patients that
   fell “below the standard of care.” It also accused him of “disseminating
   misinformation” on a Worcester, Mass., radio program in December 2020 when he
   promoted unproven coronavirus treatments touted by the alliance. At least
   two physicians lodged complaints in 2021 accusing him of “physician
   misconduct related to egregious COVID-19 misinformation and medical care well
   outside of the standard of care” and alleging “significant risk of patient
   harm,” board records show.

   In documents detailing his response to board charges, Diggs denied
   disseminating misinformation on the radio program but admitted to prescribing
   ivermectin and hydroxychloroquine and advocating for treatment of covid
   based on “studies from recognized medical professional organizations.” His
   lawyer, in the documents, accused the board of violating Diggs’s free-speech 
   rights by “attempting to inhibit the expression of his medical opinions.”

While I realize that it is a tricky line between professional and personal
speech, I have frequently argued that professionalism in medicine includes not
spreading misinformation. Of course, it is far less difficult to take action
against a physician practicing quackery than it is to do so against a physician 
simply spreading COVID-19 misinformation and not treating patients using
interventions based on that misinformation, and Dr. Diggs was, in my opinion,
treating patients with quackery, ineffective treatments against COVID-19, and
then trying to absolve himself of responsibility by disingenuously blaming
COVID-19 for their deaths, as if they were like patients who die in spite of
being given effective treatment rather than patients given false hope by his
promotion of ineffective treatments. This is a frequent theme among COVID-19
quacks:

   Some of the doctors cited in the misinformation-related complaints have
   defended their actions by saying they adhered to covid-treatment guidelines
   recommended by organizations that promote alternative therapies — guidelines 
   rejected by major medical societies and government agencies. They said
   patients died of covid — not because of misinformation or the therapies they 
   provided.

“Organizations that promote alternative therapies”? Does that sound familiar? It
should. It’s what we’ve been warning about for 15 years, fake medical societies
that promote unscientific or pseudoscientific quackery, or, as Dr. Atwood once 
called them, pseudomedical pseudoprofessional organizations (PPOs) back in 2008.
Since the pandemic, the PPO has, if anything, flourished more than any of us
could ever have predicted. Just as they were wielded by quacks in 2008 against
state medical boards and in favor of legalizing and regulating quack professions
like naturopathy, in the age of COVID-19 these PPOs have become major forces
for defending antivaccine misinformation and COVID-19 quackery against attempts 
to discipline doctors. Add to that the political polarization that has led those
largely of a certain political persuasion to side with the COVID-19 pandemic
minimizers, quacks, and antivaxxers, and state legislators are working to make
the jobs of state medical boards even more difficult by placing restrictions on 
their ability to consider disciplining COVID-19 misinformation spreaders,
decreasing their funding, and worse. One can understand how state medical
boards, particularly in states with legislatures controlled by physicians of
such a political bent, might be reluctant to risk incurring the wrath of the
government by pursuing cases against COVID-19 quacks and misinformation
spreaders, or, as the Post reports:

   As of June, medical boards in at least 14 states had taken disciplinary
   action against one or more physicians for misinformation-related causes, The 
   Post’s analysis shows. Nine of those states have Democratic governors,
   leaving more-conservative swaths of the country unprotected given that board 
   members are usually appointed by the governor, subjecting them to political
   head winds.

And:

   In the last two years, Missouri, North Dakota and Tennessee have passed laws 
   that would protect doctors from disciplinary actions for prescribing
   ivermectin, according to The Post’s review of more than 80 bills, including
   those identified by the Federation of State Medical Boards, the Association
   of State and Territorial Health Officials and the Center for Public Health
   Law Research at Temple University.

And:

   In addition, attorneys general in six states — Indiana, Kansas, Nebraska,
   Oklahoma, Tennessee and South Carolina — have issued opinions saying doctors 
   can prescribe ivermectin and hydroxychloroquine, with four of them
   determining doctors cannot be disciplined for off-label prescription to treat
   covid.

You get the idea. Moreover, the passage of laws designed to legitimize COVID-19 
quackery is nothing new either. We have been warning about the phenomenon since 
2008. For example, in California there was SB 577, a bill was passed and signed 
into law back in 2002 designed to regulate alternative medicine practitioners.
Basically, it allows the practice of medicine without a license, as long as the 
practitioner provides clients with a clear statement that he is not a licensed
physician, a list of services provided, and a description of training.
California is by no means alone, either. Jann Bellamy has pointed to bills and
laws that she refers to as the quack full employment act (Colorado) and “quack
protection law” (Nevada). Such are the fruits of the “health freedom” movement
and the increasing acceptance of pseudoscience that prosecutors, state medical
boards, and the police have a hard time prosecuting and convicting even the most
egregious quacks. Add to that an insufficiently-rigorous and poorly-funded
regulatory structure in most states, coupled with excessive deference to the
prerogatives of physicians, and what is happening now is no surprise to those of
us who have been documenting these problems for many years, particularly when
you consider that most state medical boards can’t even begin to investigate a
physician until and unless there is a complaint filed about that physician’s
treatment of a patient or patients.

The Post story includes a litany of doctors whom state medical boards in various
states have tried to hold to account for treating patients with ineffective and
unapproved treatments and/or spreading COVID-19 misinformation, including names
we’ve discussed here before, such as Dr. Maryl Nass, Dr. Ryan Cole, and Dr.
Steven La Tulippe, and others that we have not, such as the aforementioned Dr.
Diggs, as well as Wisconsin physician Dr. Edward Hagen and Nevada physician Dr. 
Medina Culver, the latter of whom brings me to a puzzling point.

Why don’t victims sue COVID-19 quacks?

I’ll finish by discussing Dr. Culver, who, according to the Post story, is
currently the defendant of a malpractice suit, something that is unfortunately
relatively rare when it comes to victims of quacks, be they COVID-19 quacks now 
or cancer quacks like Stanislaw Burzynski over the last four and a half decades:

   In Nevada, Jelena Hatfield and her husband, Jeremy Parker, did not believe
   what federal health officials said about the safety or effectiveness of the
   coronavirus vaccines and refused to get a shot.

   Instead, Hatfield said the couple sought what Trump had touted early in the
   pandemic as an alternative way to protect themselves: hydroxychloroquine.
   After Trump’s repeated promotion, the FDA issued an emergency-use
   authorization in March 2020 allowing the antimalarial drug to be used to
   treat covid. By early June of that year, however, virtually every published
   study reported that the medication was not effective in reducing death or
   illness, and the FDA revoked its authorization because of reports of serious 
   side effects, including heart problems.

   But a year later, Medina Culver, a family medicine physician in Henderson,
   Nev., prescribed hydroxychloroquine to Parker as a preventive treatment
   during a telehealth visit, Hatfield said. She said that Parker had connected 
   with Culver through America’s Frontline Doctors, which shot to prominence in 
   2020 by challenging pandemic health guidance, and that the doctor never
   performed a physical exam of her husband.

   In January 2022, Parker began having cold-like symptoms, assumed he had
   contracted covid and, unbeknown to his wife or Culver, took the medication
   that he had stashed away. The 52-year-old construction worker died within
   days, Hatfield said.

TIME Magazine reported on the case in May 2023, and it turns out that Jeremy
Parker was the victim of a telehealth grift run by America’s Frontline Doctors :

   The previous summer, Jelena discovered, Jeremy had started following AFLD
   online after listening to podcasts that promoted conspiracies about COVID-19.
   At the time, the group was producing slick videos on social media, falsely
   claiming that U.S. health agencies were withholding life-saving treatments,
   and that doctors refusing to prescribe them were like “good Germans who allow
   the Nazis to kill the Jews.” Jeremy, who worked as an industrial
   sandblaster, became convinced that hydroxychloroquine and ivermectin were the
   only effective treatments for the virus.

   On Aug. 26, 2021, Jeremy paid $90 for a consultation through AFLD’s online
   telemedicine portal. He was connected to a doctor named Medina Culver, 33, an
   osteopathic physician and Instagram influencer based in Henderson, Nev.
   Culver did not see or examine Jeremy. Over the phone, she prescribed him
   hydroxychloroquine for COVID-19 treatment or prevention, according to a
   receipt reviewed by TIME. Soon after, Jeremy received a prescription for
   200mg of hydroxychloroquine in the mail from Ravkoo, a Florida-based pharmacy
   chain partnered with AFLD. According to his widow’s lawsuit, he took those
   hydroxychloroquine pills the night he died.

   Jeremy’s family is suing both AFLD and Culver in Nevada district court for in
   excess of $30,000 in damages. The lawsuit, which was filed in February on
   behalf of his estate and cites TIME’s 2021 investigation, alleges that his
   death was linked to the falsehoods spread by AFLD as well as the doctor who
   prescribed it. “They didn’t even examine him. They gave him something that he
   used as they prescribed, and it killed him,” Jelena Parker-Hatfield says.
   “How can they not be held accountable for something? How in America can this 
   be a system that works, that everybody is okay with?”

This is a good question. After all, what is being described sounds an awful lot 
like the telehealth ivermectin and hydroxychloroquine prescription mill grift
that AFLD was running in 2021, right down to the use of the Ravkoo pharmacy
chain to fill the prescriptions and the $90 charge for a telehealth
consultation. It was a scam uncovered through investigations by TIME Magazine
and The Intercept in 2021. What is depressing, though, is that the family is
only suing for $30,000, which is not very much to AFD and many other grifting
COVID-19 quacks, many of whom have profited handsomely from their activities
during the pandemic, as documented by TIME Magazine.

As a physician, I will confess that I generally have a relatively dim view of
most malpractice suits, as there are many that are dubious. On the other hand,
I’m probably more open than a lot of other doctors to such suits when there is
legitimate malpractice, and to me recommending ivermectin or hydroxychloroqine
by telehealth instead of vaccination to prevent COVID-19 is definitely
practicing so far below the standard of care that it should qualify as
malpractice; so I fully approve when victims of quacks sue for malpractice. It’s
just that it so rarely seems to happen. This is an observation that is not just
true now but was true long before the pandemic.

Indeed, a discussion of this very issue came up in the comments after one of my 
posts about Stanislaw Burzynski and Robert O. Young as poster children for
failures of states to rein in quacks. In Burzynski’s case, there is a cap in
Texas on judgments on punitive damages above $250,000, making such cases less
attractive for attorneys to take on contingency. Bob Blaskiewicz, for instance, 
noted that Burzynski has settled out of court and that one of plaintiffs, being 
a patient with advanced cancer, unfortunately died before the case could go to
trial. Moreover, most malpractice suits are lost, and in the case of malpractice
suits against quacks it is likely to be difficult overcoming the likely
argument by the defense that the patient made the choice not to vaccinate and
instead choose “alternative” treatments like ivermectin and hydroxychloroquine. 
It is often difficult to determine what patients were and were not told about
such treatments, as well.

The bottom line is that now, as in years past, state medical boards are largely 
toothless when it comes to regulating the practice of medicine and stopping
dangerous doctors from endangering patients. The unfortunate bottom line is that
the long history of efforts by the health freedom movement to eliminate any
effective enforcement of the standard of care in medicine, the antivaccine
movement to shield antivax doctors and legitimize their quackery, and
right-to-try advocates to weaken the FDA have led to the current situation in
which most quacks, be they COVID-19 misinformation pushing quacks or old school 
quacks (the two becoming less and less distinguishable by the year) are pretty
safe from investigation or discipline by their state medical boards. This was
true before the pandemic, and I like to cite the example of Dr. Farid Fata, an
oncologist who administered chemotherapy to patients who did not have cancer in 
order to defraud Medicare and Medicaid to the tune of $35 million over several
years. It wasn’t the Michigan Board of Medicine that put a stop to his
intentionally misdiagnosing patients in order to justify treating them with
expensive chemotherapy; it was the feds investigating Medicare and health
insurance fraud.

Until there is the political will to empower state medical boards to go after
quacks, again be they COVID-19 quacks or any other quack, and provide the
resources to them to be able to do so without risking starving their other
important activities of funding, it unfortunately appears that a patient’s best 
defense is a healthy skepticism, as in “let the patient beware,” which is very
difficult given the differential in medical knowledge between physicians and
their patients, with the most likely means of punishing such doctors being to
sue them for malpractice after they have injured a patient. Even more
unfortunately, that is a hard road that frequently fails, and I don’t see the
political landscape changing any time soon to allow state legislatures to
properly empower and fund their state medical boards. We should be putting the
pressure on our representatives to do just that.

Consumer groups urge feds to act against Mercola and his false COVID-19 claims

Consumer rights organizations urge the FDA and FTC to take action against Joseph
Mercola and his businesses over their false, misleading, and dangerous claims
that their products will prevent, treat or cure COVID-19.

Jann Bellamy on August 13, 2020

Link



Consumer and social justice groups are asking the FDA and FTC to bring
enforcement actions against Joseph Mercola, D.O., and his companies
(collectively, the “Mercola Group”) for false, misleading, and deceptive claims 
that his products will treat, cure, or prevent COVID-19 infections.

In letters sent to the two agencies (FDA here and FTC here), dated July 21st,
the Center For Science in the Public Interest, Justice Catalyst, and the
People’s Parity Project charge the Mercola Group with capitalizing on the
coronavirus. Their deceptive marketing claims and “medical” advice, these
organizations say, pose a clear danger to the public,

   including the extraordinarily dangerous recommendation that individuals
   actually try to contract COVID-19 after using the supplements it sells to
   ameliorate the symptoms.

They’ve done their homework too. In 20-page letters (including extensive
footnotes) and an Appendix featuring photos of products, links to Mercola Group 
websites, and excerpts from Mercola podcasts, they document numerous threats to 
the public’s health posed by Mercola and his business interests.

Before we get to the details, a brief refresher on Mercola and his history of
quackery, a subject covered numerous times here on SBM.

Mercola, a doctor of osteopathy, is an alternative health tycoon, quackery
promoter, and marketer of a wide range of products, including dietary
supplements, protein bars, cookware, tanning beds, saunas, homeopathic remedies,
underwear, cosmetics, spices, books, and pet food. According to the Washington 
Post, he has donated millions of his $100 million fortune to the anti-vaccine
movement. One M.O. fueling his bank account is the promotion of dubious medical 
advice touting a remedy, then (surprise!) selling his particular brand of that
remedy via a Mercola-owned company, all the while pretending that his medical
counsel was never, ever intended for promotional purposes.

His quack health advice includes:

  1. Vitamin C as a viable option for measles prevention.

  2. Vitamin D for flu prevention.

  3. Thermography as superior to mammograms for breast cancer detection.

  4. Misinformation about screening colonoscopies, such as vastly overstating the
    complication rate.

  5. Tullio Simoncini’s cancer quackery, which claims that all cancer is really a
    fungus because it’s “always white” and that baking soda injections are an
    effective treatment.

David Gorski referred to that last one as “among the most ridiculous
‘alternative cancer cures’ I’ve ever seen”, which says a lot. As Harriet Hall
warns,

   the safest course is to assume that anything on [Mercola’s] website is false 
   unless you can verify it as true by consulting other sources that are
   reliable.

Mercola’s swindles have gotten him into trouble with the feds before. In one
settlement with the FTC, Mercola and his companies paid over $5 million and
agreed to stop selling tanning beds, which he claimed could reduce the risk of
skin cancer.

Apparently, Mercola is not one to learn from his experiences, nor does he have
any shame, which brings us back to his false and misleading COVID-19 claims. He 
was recently named one of the biggest social media “super-spreaders” of COVID-19
misinformation by NewsGuard, a company that evaluates and rates news and
information websites. Now, consumer groups are out to stop his mendacious
marketing, asking the FDA, with jurisdiction over unlawful claims that a product
can prevent, treat, or cure disease, and the FTC, with jurisdiction over false 
and misleading advertising, to take enforcement action against the Mercola
Group.

They argue that the Mercola Group is a danger to public health because it
“frequently disseminates false and deceptive claims”, which are consumed by a
substantial internet audience (Mercola.com “is viewed by ‘millions of people
daily'”) and fueled by robust sales (“millions of dollars in products
annually”).

He is, for example, preemptively downplaying the effectiveness of potential
COVID-19 vaccines, even warning the public that any potential vaccine would
likely be deadly. On a podcast posted April 5, 2020, Mercola told listeners
complete falsehoods about the risks of vaccines, saying:

   For every life being saved by a vaccine, you may have another 10, 20, 100
   people who are either killed or permanently injured as a result of that
   vaccine.

Mercola also endorsed his podcast guest’s incendiary assertion that people would
probably be dragged from their homes and vaccinated against their will.

Noting that their “false and misleading COVID-19 claims are really just a
thinly-veiled and self-serving attempt to sell its products”, the consumer
groups’ letters catalog the connection between Mercola’s “medical” advice, which
appear in website articles (e.g., “Nutrition and Natural Strategies Offer Hope 
Against COVID-19”) and in his podcast, and corresponding Mercola Group products 
which just happen to fill Mercola’s prescription.

Following this playbook, for example, Mercola wrote articles and spoke
extensively (and falsely) over the last several months about the effectiveness
of vitamin C to prevent and treat COVID-19, including his claim, without
evidence, that a Chinese study “is likely to show” that IV vitamin C will
successfully treat COVID-19-induced pneumonia. Mercola and his podcast guests
also told listeners, again without evidence, that “even a small amount of
vitamin C” reduces the risk of dying from COVID-19, “even in the most severe
cases”. As an alternative to IV C administered by a physician, Mercola and
guests suggested “liposomal” vitamin C tablets, which are (wait for it) featured
prominently in Mercola Group’s online store.

Blaming the media for hiding this information from consumers, Mercola advised on
his podcast that vitamin D, which he (dangerously) recommended in high doses,
will help prevent severe cases of COVID-19 when used in combination with vitamin
C and other dietary supplements. Mercola also told listeners that they should
use a test kit to determine current levels of vitamin D and proper dosage.
Needless to say, his online store sells a vitamin D test kit ($65) as well as a 
test kit for vitamin D and other nutrients ($165).

Mercola, or his podcast guests, have also touted, and the Mercola Group sells:

  1. Melatonin, which he claims is “proven to decrease the risks of COVID-19
    infection” and can treat COVID-19 as well.

  2. Glycyrrhizin, the active ingredient in licorice, which “could be a treatment
    for COVID-19” (as well as herpes, HIV, hepatitis, influenza, encephalitis,
    pneumonia, SARS, and several other viruses).

  3. Molecular hydrogen, which has, according to Mercola, “powerful and antioxidant
    and anti-inflammatory effects, making it potentially useful for COVID-19”
    and “preliminary results” from prominent doctors investigating its use “are 
    encouraging”. The most effective way to consume molecular hydrogen, he
    claims, is via tablets that are dissolved in water, the same form he sells.

  4. Astaxanthin, a derivative of microalgae, which, Mercola says, calms the immune
    system and thereby reduces the risk of sepsis, organ failure, and death.
    (Apparently, in addition to preventing the disease, Mercola aims to cover
    each and every symptom and complication of COVID-19 with a product he
    sells.)

  5. N-acetyl cysteine, which “may be effective at fighting the blood clotting and 
    strokes occurring in many COVID-19 cases as well as reducing the risk of
    acute respiratory distress syndrome.”

  6. Prebiotics, probiotics, and “sporebiotics”, based on Mercola’s notion that
    COVID-19 infections may enable Prevotella bacteria to colonize the lungs,
    causing severe symptoms associated with the disease. He especially touts the
    “sporebiotic” Bacillus spores, which, he suggests, may be even more
    effective than antibiotics at fighting the Prevotella.

  7. Saunas, which, Mercola told his podcast listeners, can raise your core body
    temperature, thereby “preventatively treat[ing] any lingering infection
    that’s just starting to go around.” (Sadly, Mercola Group saunas are
    currently unavailable due to a “redesign”.)

  8. Ozone, to which Mercola devoted an entire podcast: “ozone therapy appears to
    be even more effective than intravenous vitamin C and to me it’s tragic that
    no one’s touching that with a 10-foot pole to treat this.” The Mercola
    Group sells air purifiers touted as generating ozone.

  9. Elderberry extract, spirulina, beta-glucan, lipoic acid, and sulforaphane, all
    of which, according to the Mercola Group’s Coronavirus Resource Guide, “may
    be of particular benefit against COVID-19.”

As the consumer groups patiently explain, after each description of Mercola’s
mendacity, they “are not aware of any scientific evidence, let alone properly
conducted RCTs, that [the product in question] prevents or treats COVID-19
infection” or there is “no credible scientific evidence” to support his claims.

After discussing previous regulatory actions involving Mercola, they argue that 
prior cease and desist warnings “have been insufficient to prevent this fraud
and more action is needed”, up to and including warning letters followed by
compliance monitoring and, if necessary, enforcement actions in federal court
seeking permanent injunctions, civil penalties, and seizure of the offending
products.

Among the regulatory actions described was an investigation by Illinois
authorities and a call for revocation or suspension of Mercola’s medical license
by the Chief of Medical Prosecutions. How that matter was resolved is not
entirely clear and, as of June 25, 2020, Mercola’s medical licenses are still
active in Illinois and Florida, a shameful indictment of the Medical Boards in
those states.

There is something terribly wrong about a system that allows a multi-millionaire
charlatan, using his medical credentials as a badge of authority, to fleece the
public based on their understandable pandemic fears, all while his fellow
physicians are on the front lines treating COVID-19, with far less compensation 
and at great risk to their safety.

Courts should not order hospitals and physicians to administer ivermectin
against their will

Courts in several states have ordered hospitals to administer ivermectin to
COVID patients against the medical judgment of treating physicians. Patients
have no legal right to a particular treatment and health care providers should
not be forced to administer this drug.

Jann Bellamy on September 9, 2021

Link



Nine lawsuits have been filed recently seeking judicial orders forcing hospitals
to administer the controversial drug ivermectin to COVID patients against the
medical judgment of their treating physicians. In at least one case, in addition
to the hospital, the physicians themselves were named as defendants. Seven have
been successful, although one order was superseded by another judge, who ruled 
in favor of the defendant hospital. Hospitals are appealing other orders. In two
lawsuits, the hospital prevailed and the judge refused to order administration 
of ivermectin.

The rulings are an unsettling development because, as we shall see, patients
have no legal right to such a remedy. Indeed, in no case where I was able to
review the pleadings and orders (they were not available in all cases) did the
plaintiff cite any legal authority for the judge to act nor did their orders
cite any authority for doing so.

Today, after a brief review of ivermectin, we’ll take a closer look at the facts
of these cases. Then we’ll discuss the their ethical and legal implications.

Ivermectin, the alleged wonder drug

Ivermectin has been extensively covered here on SBM in posts by our own Scott
Gavura, DPharm, and Dr. David Gorski (also here and here), as well as in a guest
post by Dr. William Paolo. By way of background, here is some basic information
from those posts and other sources:

  1. Ivermectin is approved by the FDA to treat parasites in people and, in a
    different formulation, is used to prevent heartworm disease and treat
    parasites in animals. The FDA has not approved ivermectin to prevent or
    treat COVID, although off-label use for that purpose is not illegal.

  2. At this time, there is insufficient evidence of ivermectin’s effectiveness as 
    a COVID prophylactic or treatment and a growing body of evidence points to
    the conclusion that it is not effective for these uses. It can also have
    side effects. Some people have ingested the animal formulation and become
    seriously ill.

  3. The FDA, WHO, the AMA, the American Pharmacists Association, and the American 
    Society of Health-System Pharmacists all oppose the use of ivermectin to
    prevent or treat COVID outside of a clinical trial. According to the NIH
    COVID-19 Treatment Guidelines Panel, there is insufficient evidence to
    recommend its use. The CDC has issued a Health Advisory warning on
    ivermectin. Even Merck, the drug’s maker, recommends against using it for
    COVID.

  4. Despite all of this, and the availability of vaccines and effective treatments
    for COVID, some physicians, politicians, right-wing media personalities, as
    well as all-out quacks, continue to promote ivermectin. A group calling
    itself the Front Line COVID-19 Critical Care Alliance (FLCCC) aggressively
    promotes ivermectin with cherry-picked evidence and has created unproven
    treatment protocols that include it.

The facts

The nine lawsuits have similar facts so I won’t discuss each individually (for
one reason, it would make this post entirely too long). However, before we
begin, here’s a list of each patient for whom judicial intervention was sought, 
with links to more information about their cases, including media reports and
documents filed with the courts. (I’ll link to some of these again in referring 
to particular cases.)

  1. Randy Clouse (also here), Illinois

  2. Richard Cyganovich (also here), New York

  3. Glenna Dickinson (also here), New York

  4. Nurije Fype (also here), Illinois

  5. Michael Gangemi (also here), New York

  6. Pete Lopez (also here), Texas

  7. Judith Smentkiewicz, New York

  8. Jeffrey Smith (also here and here), Ohio

  9. John Swanson, New York

In a typical case, a patient contracts COVID and is hospitalized. In most cases 
the patient is in the ICU and some are on ventilators. A family member has read 
about ivermectin online, seen it discussed on Fox News or in other media, and/or
discovered the dubious advice of the FLCCC.

Because most of the COVID patients in these cases are incompetent to make their 
own decisions due to their illness, a spouse or other family member wants one of
the patient’s physicians to administer ivermectin. The physician and/or the
hospital refuse. Some family members then get prescriptions for ivermectin from 
physicians who do not have privileges at the hospital, but the hospital still
declines either to administer the ivermectin with its own staff or allow the
physician without privileges to do so. In the Texas case, the patient had been
prescribed ivermectin at a VA Medical Center but was admitted to the hospital
before he was able to take it.

The family member then files suit on behalf of the patient seeking to force the 
hospital to allow administration of ivermectin. In all but one case, the
plaintiffs are represented by New York law firm of attorney Ralph C. Lorigo. The
plaintiffs seek emergency relief, asking that the court enter an order
requiring the hospital to administer ivermectin immediately. The courts have
issued such orders before the hospital has had an opportunity to be heard and,
in at least one case, before the hospital was served with notice that the action
had commenced.

Favorable orders are usually based on documentary evidence filed by the
plaintiffs. Plaintiffs have submitted copies of the unproven FLCCC protocols,
supporting affidavits from physicians who prescribe or promote ivermectin,
studies purporting to show the effectiveness of ivermectin, and news articles
about similar cases in which courts have ordered hospitals to administer the
drug. In one case, Dr. Pierre Kory, president of the FLCCC and ivermectin
promoter extraordinaire, himself supplied an affidavit. In another, there is an 
affidavit from Dr. Fred Wagchul, one of the FLCCC’s founders. Needless to say,
this evidence generally presents a glowing picture of ivermectin’s effectiveness
as a COVID treatment.

In the cases won by the plaintiffs, the courts either ordered the hospital to
administer ivermectin to the patient (with, in some cases, the family delivering
ivermectin to the hospital from an outside pharmacy, which is against hospital 
protocol) or ordered the hospital to allow a physician who did not have
privileges at the hospital to administer the drug. The hospitals have appealed
at least two of these cases.

In several cases, according to media reports, patients have improved after being
treated with ivermectin, which their families, their attorney, and some doctors
interpret as evidence of the drug’s effectiveness.

One doctor said that Nurije Fype had been weaned off a ventilator and discharged
from the hospital after receiving small amounts of ivermectin for 20 days.
Judith Smentikeiwicz’s family thinks ivermectin saved her life, her son claiming
that, in less than 48 hours, his mother was taken off the ventilator,
transferred out of the ICU, and was sitting up on her own and communicating. Mr.
Lorgio, the attorney who obtained the order, said that Ms. Smentikeiwicz “was
on a ventilator, literally on her deathbed, before she was given this drug. As
far as we’re concerned, the judge’s order saved this woman’s life.” Mr. Lorgio
also claimed, in the case of John Swanson, that after one dose of ivermectin,
Swanson was breathing on his own and taken off the ventilator “and was making
great progress”.

Fortunately, for balance, some news reports about these seemingly miraculous
recoveries also quoted experts cautioning that correlation does not mean
causation and pointing out that there is still not enough evidence to support
ivermectin’s effectiveness for COVID.

In the case of Pete Lopez, who unfortunately passed away, the family is angry
because, they say, the hospital refused to administer ivermectin after being
ordered to do so by a court. The hospital has appealed the order and Mr. Lorgio,
the family’s attorney, is seeking to hold the hospital in contempt. In the Fype
case, Mr. Lorgio tried to get the judge to order the hospital to pay the
plaintiffs’ legal expenses and issue a $25,000 fine, but the judge refused,
saying the hospital had complied with the court’s order.

Hospitals have had some success in fighting these actions.

In Ohio, a judge, having given the hospital an opportunity to present evidence, 
ruled that it “bears no duty to honor a prescription” for ivermectin written for
COVID patient Jeffrey Smith (also represented by the Lorgio firm), superseding 
a previous order by a different judge requiring the hospital to do so.
Twenty-one days of ivermectin had been prescribed by Dr. Fred Wagshul, who (as
was revealed at the hearing) had never reviewed Mr. Smith’s clinical information
or discussed treatment with his physicians, is not board-certified in any
specialty, and has not worked in a hospital for 10 years. (At the time of the
hearing, Mr. Smith had received 13 doses.) Dr. Wagshul said that the
pharmaceutical industry and U.S. government have “smeared” ivermectin and
“‘censored’ its allegedly undeniable beneficial value”. (An odd claim in light
of the fact that the drug’s own manufacturer advises against its use.) He
nevertheless testified that “I honestly don’t know” if ivermectin had benefited 
Mr. Smith.

In an interview, Dr. Wagshul claimed that the science behind ivermectin is
“irrefutable”, that the CDC and FDA were in a “conspiracy” against the drug to
protect the FDA’s Emergency Use Authorizations for COVID-19 vaccines, that the
mainstream media and social media companies had been engaged in “censorship”
regarding ivermectin’s benefits, and that the government’s refusal to
acknowledge its benefits amounted to “genocide”. In the same article, another
physician called the FLCCA doctors “snake oil salesmen” and reviewed the
“serious problems” with organization’s research.

A physician testifying for the hospital said that “there is no conclusive
evidence to show enough benefit exists to outweigh [the drug’s] risks”. Mr.
Smith’s treating physician “disputed any notion that ivermectin demonstrably
helped his patient” and said there isn’t enough evidence to support its use. The
hospital’s chief of staff testified that a physician who is not board certified
would never be admitted to practice there and was concerned that Dr. Wagchul
had never seen the patient or reviewed his information.

The court, in ruling in the hospital’s favor, said that:

   While this court is sympathetic to the Plaintiff [Mr. Smith’s wife and his
   medical proxy] and understands the idea of wanting to do anything to help her
   loved one, public policy should not and does not support allowing a
   physician to try ‘any’ type of treatment on human beings . . .

The court found that ivermectin

   has not been shown to be effective at this juncture. The studies that tend to
   give support to ivermectin have had inconsistent results, limitations to the
   studies, were open label studies, were of low quality or low certainty,
   included small sample sizes, various dosing regiments, or have been so
   riddled with issues that the study was withdrawn.

In a New York case, last week a judge issued an order (via letter) refusing to
force the hospital to treat the patient with ivermectin, although he deferred a 
final ruling on the petition. The patient’s prescription, written by Dr. Ross
Nochimson, who specializes in “Interventional Pain and Regenerative Medicine”
and was not one of the patient’s treating physicians, read

   Take 5.5 pills by mouth once daily up to 5 days Depending [sic] on clinical
   symptoms and improvement.

As with the Smith case, there was nothing in the record to indicate that Dr.
Nochimson had ever “clinically observed” the patient or “reviewed his medical
record” or “what the pills are for; what are clinical symptoms and what would
constitute improvement”. On the other hand, “extensive affidavits” from the
patient’s treating physicians specified the “possible deleterious impact
Ivermectin may have” on the patient.

The record also included an affidavit from Dr. Pierre Kory extolling the virtues
of ivermectin, an affidavit to which the judge was apparently referring when he
noted that only doctors without personal knowledge of the patient’s medical
situation were advocating giving him the drug.

In a third case ruling in favor of a hospital, the prescribing physician, Dr.
Alan Bain, was also criticized by the hospital’s attorney for failing to perform
an adequate review of Randy Clouse’s medical history prior to prescribing
ivermectin and ignoring “widespread medical advice” on its use, charging that
Dr. Bain wanted to make Mr. Clouse (also represented by the Lorgio firm) “a
guinea pig”. The hospital, in rebuttal to the plaintiff’s description of Mr.
Clouse’s condition, filed documents showing that the patient was already
improving and that he no longer had an active COVID case. In any event,
according to the hospital, the patient’s physicians “believe administration of
ivermectin will likely result in kidney and lung damage, which can lead to organ
failure and death.”

In a testament to how widespread misinformation about ivermectin has become, the
patient’s wife, understandably upset, claimed that a ruling in her husband’s
favor “could have helped save the lives of ‘thousands of other people'”,
although she said she would not appeal.

Ethical and legal views

Noted bioethicist Arthur Caplan blasted the decisions forcing hospitals and
physicians to administer ivermectin in an Ars Technica interview. “There is no
standard of care saying you have to use [ivermectin]”, he said, and orders
forcing its administration were asking doctors to do something “unethical and
illegal”. Calling the original order (now overturned) in the Jeffrey Smith case 
“absurd”, Dr. Caplan said that if he were these doctors, he “simply wouldn’t do 
it”.

Unfortunately, from a legal standpoint, as has happened in some of these cases, 
refusing to follow a court’s order may result in the other side filing a motion 
to hold you in contempt.

As I said earlier, none of the cases in which I reviewed the pleadings and
orders cited any legal right to force a physician or hospital to administer a
drug against a physician’s medical judgment. This absence would be notable to
any lawyer because it is a basic rule of pleading one’s case, not to mention
winning it, that the plaintiff be able to point to some law – whether it be a
statute, administrative rule, a constitutional provision, or common law – giving
him a right to relief based on the facts of his case. So basic is this
principle that I began to wonder if there had been some drastic change in the
law since I was in active practice.

Fortunately, this has not happened. James M. Beck, an experienced litigator at
the international law firm Reed Smith LLP, and a drug and device law expert, has
done the heavy lifting in researching and analyzing the issue and recently
wrote about it in a blog post titled “More COVID Kookiness – Ivermectin
Lawsuits“, which gives you some idea of his thoughts on the subject.

   We are unaware of any legal basis for a court to order the off-label use of
   any medication over the objections of treating physicians and hospitals,
   whether or not some interloping non-staff physician might have prescribed it.

So there!

According to Mr. Beck, “precedent rejecting some sort of constitutional right to
‘medical’ use of unproven treatments goes back a long time”, as do cases
rejecting statutory and common law grounds. This includes Prohibition, when a
court refused to allow physicians to prescribe large amounts of alcoholic
“medicine”, as well as cases rejecting a right to use medical marijuana and the 
quack cancer drug Laetrile. He also cites the Abigail Alliance case, which, in
dispensing with the notion that a patient has a right to access experimental
drugs, helped fuel a movement that ended in the “Right to Try” laws. These do
not provide a right to access off-label drugs from unwilling physicians either, 
in part because these laws are “expressly voluntary”. Nor does the FDA’s
compassionate use program provide any legal basis for doing so.

Mr. Beck concludes:

   If a patient wants to self-medicate against COVID-19, whether by taking
   ivermectin, injecting bleach, or anything else, we’re not trying to stop
   them. Just leave a forwarding address for any Darwin Award. Nor would we
   object to a patient seeking off-label use of ivermectin as a COVID-19
   treatment being transferred to a facility willing to provide it. But beyond
   that, patients have no legal basis to go to court to force unwilling health
   care providers either to participate in an off-label use they do not believe 
   is therapeutic, or to force hospitals tolerate such a use in their
   facilities.

Hospitals and physicians would do well to cut and paste his blog post if faced
with a lawsuit seeking to force them to administer ivermectin.

I imagine the judges who ordered the administration of ivermectin were greatly
influenced by the dire straits of the patients who sought it and the
cherry-picked information filed in support of their petitions. Where hospitals
and physicians have been allowed to present their own evidence prior to the
court’s decision, defendants have generally fared better. And I imagine some of 
these orders will be overturned on appeal.

    2. However, in the face of overwhelming legal precedent holding that no patient
      has a right to a particular treatment, and especially in the face of
      stringent opposition by those who would be forced to provide it, these
      decisions are indeed troubling.

The “Natural Immunity is Real Act”: Real or an act?

Republican legislators have proposed a law requiring federal agencies to
acknowledge, accept, truthfully present and incorporate “consideration of
natural immunity” in their COVID regulations. It’s just political theatrics
based on a flawed understanding of infection-induced “natural” immunity.

Jann Bellamy on November 18, 2021

Link



A recent House Bill (H.R. 5590) and its Senate companion (S. 2846), both titled 
the “Natural Immunity is Real Act”, would require all federal agencies issuing
rules or regulations relating to COVID-19 to

   acknowledge, accept, agree to truthfully present, and incorporate, the
   consideration of natural immunity as it pertains to COVID–19 with respect to 
   the individuals subject to the applicable regulations.

As the bill helpfully explains, natural immunity means “immunity that is
naturally existing”. Natural immunity, of course, sounds so much more pleasant
and less scary than the CDC’s term: “infection-induced immunity”.

The sponsor of H.R. 5590, Rep. Diana Harshbarger (R-TN), appears to believe the 
evidence on natural immunity is settled and one’s level of immunity can be both 
accurately determined and used as an indication of sufficient protection from
the SARS-CoV-2 virus. Per her press release:

   I introduced this bill today because the Biden Administration must ‘follow
   the science’ and be open, honest and transparent about the millions of
   Americans who have natural immunity against the COVID-19 virus . . . .
   There’s ample scientific evidence from numerous peer-reviewed studies that
   natural immunity from previous COVID-19 infection is effective, durable and
   long-lasting.

According to a Tennessee TV station, Rep. Harshbarger thinks that unvaccinated
individuals could submit blood samples for antibody testing and, if antibodies
are found, they should not be subject to any vaccine mandate.

Some of the House bill’s co-sponsors, all fellow Republicans, seem to share her 
confidence that natural immunity can be measured accurately and that its
effectiveness against the virus is settled. Rep. Daniel Webster (R-FL) charges
that:

   Too many medical leaders [whom he accuses of “denying science”] are refusing 
   to publicly recognize what overwhelming data has already shown – protection
   afforded to individuals with natural immunity is real, robust and durable.

Rep. Chris Stewart’s (R-UT) comments suggest a belief that infection-induced and
vaccine-induced immunity are equivalent:

   The vaccine offers effective protection against COVID-19; natural immunity
   offers effective protection against COVID-19.

And, from Rep. Bill Posey (R-FL):

   No American should be forced to choose between getting the COVID vaccine or
   keeping their job, particularly when the Biden policy fails to recognize that
   millions of Americans have immunity because they’ve already had and
   recovered from COVID.

On the other hand, at least one co-sponsor, Rep. Jeff Van Drew (R-NJ),
acknowledges the science is not as settled as his colleagues make it out to be:

   We know vaccines work, but natural immunity could be equally or similarly as 
   effective in certain individuals. If the CDC would devote time into its
   research, we would have robust, evidence-based research that could help
   America finally move on from this virus.

In fact, the CDC has done just that, as you’ll see in a moment.

Indeed, the “numerous peer-reviewed studies” linked in Rep. Harshbarger’s
comment, which is actually a letter from Republican MDs and other health care
professionals in Congress to CDC Director Dr. Rochelle Walensky, takes a more
nuanced approach. Although the letter cherry-picks the studies it cites
supporting natural immunity’s effectiveness against the virus, it also admits
that the evidence is not all in:

   . . . we urge the CDC to harness available data and technology to . . . truly
   determine an individual’s level of protection against COVID-19. It may be
   the case that it is not medically necessary for an individual to receive a
   vaccination. It may also be the case that a sufficient level of protection
   may be produced from one dose.

Rep. Harshbarger is not anti-vaccination but is emphatically anti-vaccine
mandate. She is a Pharm.D who admirably, considering the enormous resistance to 
COVID-19 vaccination in her party, made a “get vaccinated” Public Service
Announcement, although in it she firmly states that the decision is up to the
individual. She’s also introduced bills prohibiting vaccine mandates and
“passports“.

That is not to say the anti-vaccination forces aren’t delighted with the
opportunity presented by the Natural Immunity is Real Act to further their
cause. The execrable National Vaccine Information Center “news” outlet, The
Vaccination Reaction (such a cute name!), which earlier this year ran a reprint 
of an American Institute for Economic Research (AIER) article questioning why
mainstream medicine was “downplaying or erasing natural immunity”, touted the
bill. The AIER, a libertarian think tank, has promoted “in essence, letting
COVID-19 rip through the ‘healthy’ population in order to achieve ‘natural herd 
immunity'”. As SBM’s Dr. David Gorski explained in his post on the subject,
“natural immunity” is a long-time anti-vaccine trope resurrected for COVID-19.

Other co-sponsors of the bill have not been shy about their anti-vaccination
sympathies. Rep. Mo Brooks (R-AL) pushed anti-vaccine talking points in a letter
to President Biden. Rep. Madison Cawthorn (R-NC) saw a prelude to confiscation 
of guns and Bibles in a proposed door-to-door immunization drive. Rep. Marjorie 
Taylor Greene (R-GA) also pushed misinformation about COVID-19 vaccines, saying 
falsely that the vaccines were “failing” and were ineffective in reducing the
spread of the virus. Rep. Lauren Boebert (R-CO) called researchers studying low 
vaccination rates “Needle Nazis” and spread vaccine misinformation, including
continuing to refer to approved vaccines as “experimental”. And, prior to the
pandemic, Rep. Mark Green (R- TN), an MD, and Rep. Bill Posey (R-FL) gave
credence to the widely discredited (mainly because it never existed in the first
place) vaccine-autism connection.

Meanwhile, back at the CDC . . .

Health experts have pushed back against the proposed law. Kenneth Goodman,
director of the University of Miami Miller School of Medicine Institute for
Bioethics and Health Policy and the Florida Bioethics Network, told the Orlando 
Sentinel that it is

   bad science, dangerous policy and saddest of all, ideology tricked out as
   ethics . . .

And in response to Rep. Daniel Webster’s claim to another Orlando news outlet
that the bill is “just saying there are other options than just a vaccine”,
pediatric pulmonologist Dr. Akinyemi Ajayi pointed out that, while there is some
natural immunity protection acquired from an infection, it is not clear how
long it lasts and that a verifiable way to determine natural immunity does not
currently exist.

An associate professor of medicine in the Division of Infectious Diseases at
University of Utah Health made similar points in a Deseret News article about
the proposed law:

   While there is some evidence natural infection provides strong immunity,
   there is variability from person to person and less predictability than
   vaccine immunity . . . . Clinical antibody tests available also are not great
   correlates of immunity to COVID-19 and have wide variability from test to
   test.

Meanwhile, it appears that the CDC has been doing pretty much what the proposed 
law dictates all along, only not with the result its backers would likely
prefer. On Oct. 29, 2021, the CDC published a Science Brief titled “SARS-CoV-2
Infection-induced and Vaccine-induced Immunity”, an overview of the current
scientific evidence regarding infection-induced and vaccine-induced immunity,
including both peer-reviewed and preprint publications, as well as unpublished
CDC data. In a signal that the CDC will continue to “consider” natural immunity,
the report says that “new data continue to emerge, and recommendations will be 
updated periodically”.

Key findings include:

1. Fully vaccinated and previously infected individuals both have a low risk of
subsequent infection for at least 6 months.

2. We don’t have sufficient data to determine an antibody titer threshold
indicating when an individual is protected from infection and no FDA-authorized 
test can reliably determine whether a person is protected.

3. There is a wide range of antibody titers from infection but vaccines (especially
mRNA vaccines) typically lead to a more consistent and higher-titer initial
antibody response.

4. More quality evidence exists regarding vaccine-acquired than infection-induced
immunity and, in fact, there is not enough evidence to apply what we know about 
the latter to children and those with a mild or asymptomatic infections.

5. Vaccination after infection significantly enhances protection and further
reduces risk of reinfection.

Thus, the CDC continues to recommend COVID-19 vaccination for all eligible
persons, including those who have been previously infected.

On the same day, the CDC issued a Morbidity and Mortality Weekly Report Early
Release, a study showing that COVID-19 was over five times more common among
hospitalized people who were unvaccinated and had a previous infection, compared
with those who were fully vaccinated and hadn’t had COVID-19 before. The study 
concluded that

   All eligible persons should be vaccinated against COVID-19 as soon as
   possible, including unvaccinated persons previously infected with SARS-CoV-2.

Although, technically, the bill (should it become law) would not apply to the
CDC’s report or study (because neither is a rule or regulation), it sure looks
to me like the CDC has acknowledged, accepted, and truthfully presented natural 
immunity and incorporated it into its recommendations.

Funny that the Representatives and Senators supporting the Act didn’t take the
time to ring the federal agency most responsible for COVID research and policy
and ask them whether they were “considering” natural immunity before blasting
the Biden Administration for failing to “follow the science” and introducing
legislation on October 18, 2021, a mere 11 days before the CDC’s report and
study came out. We can safely assume that neither was done in less than two
weeks, so obviously both were ongoing projects when Rep. Harshbarger’s press
release was issued and the bills introduced.

I can’t find that any of the bills’ sponsors have responded to the report or
study. Then again, I wonder if it matters to them. I suspect the House and
Senate bills were just a bit of political theater, designed to play to political
bases. If they really cared about “following the science”, one would think they
would have hailed the CDC’s recent publications as within the spirit of their
proposed legislation and urged constituents to follow the CDC’s recommendations.
But, of course, they didn’t, because it doesn’t fit their anti-mandate or
anti-vaccination narrative. The Act was an act all along.

UPDATE: In a special session called by Gov. Ron DeSantis, the Florida
Legislature just passed, and DeSantis signed, a new law:

   businesses are required to exempt employees from a [that is, the federal]
   mandatory vaccination policy if they have Covid immunity from prior
   infection, are tested periodically for the virus or choose to wear personal
   protective equipment provided by the company.

   ‘We recognize people who have natural immunity,’ DeSantis said. “Whatever a
   private employer wants to do, you’re automatically exempt because of natural 
   immunity.’

Here’s the actual language of the new law regarding “natural immunity”:

   To claim an exemption based on COVID-19 immunity, the employee must present
   to the employer an exemption statement demonstrating competent medical
   evidence that the employee has immunity to COVID-19, documented by the
   results of a valid laboratory test performed on the employee. The Department 
   of Health shall adopt a standard for demonstrating competent medical evidence
   of such immunity.

This should be interesting, considering that Florida’s new Surgeon General and
head of the state health department drafting the standard is Dr. Joseph Ladapo, 
a member of the kook anti-vaccine  America’s Frontline Doctors (or maybe former 
member, to my knowledge he hasn’t said one way or another). Stay tuned. e

Goodbye to the Novavax Vaccine? Our Flailing Medical Establishment Rejects
Medical Freedom and Refuses to Fund Gold-Standard Science.

Our current Medical Establishment doesn’t seem to grasp that they are no longer 
just Fox News and Twitter celebrities who can comment from the sidelines as if
they were passive observers.

Jonathan Howard on April 29, 2025

Link

Novavax may be the best COVID-10 Vaccine to date

Once upon a time, Dr. Marty Makary was a big fan of the Novavax vaccine. “It
uses a tried & true mechanism of action,” he said. It just needed a “better PR
firm,” he added, linking to an article titled The mRNA Vaccines Are
Extraordinary, but Novavax Is Even Better.

Under this administration, we are prioritizing the Gold-Standard of Science

Things are very different today. Dr. Makary no longer cares about tried-and-true
mechanisms of action when it comes to vaccines. With the assistance of Dr.
Tracy Beth Hoeg, a COVID-fabulist, sports medicine doctor, and political
appointee, Dr. Makary recently put the brakes on full approval for the Novavax
vaccine. As the article FDA Asks Vaccine Maker to Complete New Clinical Trial
for Delayed Covid-19 Shot reported, they are demanding a new
randomized-controlled trial (RCT).

On social media, Dr. Makary, who authors We’ll Have Herd Immunity by April 4
years ago, depicted himself as a champion of science and evidence-based
medicine. Although previous RCTs showed the Novavax vaccine was 90% effective
against preventing COVID, including 80% in adolescents, Dr. Makary now claims
that every tweak to it requires a fresh RCT.  He also depicted himself as
heroically standing up against Big Pharma. They were too greedy to run a new
trial.

They did not honestly study the issue

However, there is no reason why the NIH should not fund such vaccine RCTs. Dr.
Jay Bhattacharya agrees that RCTs are the only valid method for learning about
vaccines. Although he massively overhyped them in April 2021, promising they
blocked transmission and eliminated severe disease, in his article The Covid
Vaccine Trials: Failures in Design and Interpretation he blasted previous public
health officials for saying what he said. He wrote about “a mismatch between
the clinical trial endpoints and the public health needs” as well as a “failure 
in the interpretation of the trials, with a mismatch between what public health 
officials claimed and recommended and what the trials actually showed.”

Moreover, Dr. Bhattacharya clearly feels that running such trials is the
responsibility of the agency he now leads. In the video below, he excoriated his
predecessors for not running such studies of drugs like ivermectin. They
controlled “billions of dollars of funding,” Dr. Bhattacharya pointed out. “They
did not honestly study the issue in 2020,” he said. Dr. Bhattacharya feels Dr. 
Fauci and the NIH should have “definitively” studied these medications and done 
“high-quality trials.” He implied they refused to study them to hide that they
worked, and he also defended people’s right to take them. “Why would you not
permit people to take it,” he asked? In reality, Dr. Fauci and the NIH tried to 
study hydroxychloroquine and azithromycin in 2020 but couldn’t get anyone to
enroll.

There isn’t enough time between identification of strains included & release of 
vaccine

Unlike myself, Drs. Makary, Hoeg, and Bhattacharya did nothing to advance a
COVID-RCT before they were sworn into office. They merely called for others to
do RCTs and treated this as a genuine accomplishment. They made such trials
sound really easy and blasted their predecessors for their supposed failures,
the same way they are blasting Novavax today. There’s always a villain and it
can no longer be the Medical Establishment. Now, these doctors are the Medical
Establishment, with enormous power and resources at their disposal. Despite
this, they still feel it’s someone else’s job to run RCTs. They still feel their
role is to give TV interviews and send Tweets calling for other people to do
the Gold-Standard of Science. RCTs were for Francis Collins and Toni Fauci only 
apparently.

However, by refusing to fund and perform vaccine-RCTs, they are advocating for
Big Pharma to do the research that determines whether or not vaccines are safe
and effective. Our Medical Establishment doesn’t want independent agencies to
generate Gold-Standard of Science for the American public. They bash Big Pharma 
as greedy, but they expect people to trust the results of their studies.

Of course, we don’t have to play dumb about what’s actually happening here. Drs.
Hoeg and Makary are not demanding a new RCT to advance medical knowledge or
protect the America public, but rather to please their boss by sabotaging the
Novavax vaccine. As they surely know, a new trial might be “prohibitively
expensive“, and there is virtually no chance it could have actionable results
before the next variant emerged. As Dr. Tara Smith said:

Dr. Michael Osterholm, who recently launched the Vaccine Integrity Project to
safeguard vaccines the U.S. similarly said:

Since the season is only X number of weeks long, by the time they could get
vaccine approved with early season studies, it would be too late… to get vaccine
out. It makes no sense at all. Unfortunately, we’ve got a combination of
government scientists and public relations people who don’t understand what they
don’t understand. And this is potentially a very dangerous concern.

Doctors Who Performatively Fetishized RCTs Aren’t Out to Advance Medical
Research, But Rather to Sow Doubt & Mistrust

He’s, right, though this sort of methadolatry is an old anti-vaxx trick, which
we’ve written discussed often here at SBM. While it would be great if RCTs could
be whipped up in an instant, there’s a reason I titled one of my previous
articles Doctors Who Performatively Fetishized RCTs Aren’t Out to Advance
Medical Research, But Rather to Sow Doubt & Mistrust. Now, these merchants of
doubt have power, and they are using the same tricks, wielding RCTs as a weapon.

This is all part of a broader assault on vaccines. Dr. Makary is currently
downplaying measles, refusing to advise parents to get the MMR, and cheering for
the pediatric COVID vaccine to be taken away. Meanwhile, the headlines read US 
Halts Funding for New COVID-19 Vaccines and, Dr. Bhattacharya wants to pull
existing mRNA vaccines from the market. There is no reason to think that the
mRNA boosters will be treated different than the Novavax vaccine.

None of this surprises those of us who paid attention. Drs. Makary, Hoeg, and
Bhattacharya spread copious anti-vaccine misinformation over the past several
years. Today, they are threatening to take away all COVID vaccines under the
guise of protecting the American public from itself. They feel that they, the
Medical Establishment, knows what’s best for your health, and they want to use
government power to limit your choices.

A study of the Novavax vaccine, specifically funded by Novavax the company,
won’t convince anyone to get it. Moreover, absolutely no one who was going to
get the Novavax vaccine asked for a new RCT of it. They were satisfied with the 
existing data. Recent data from the company showed it has fewer side effects
than the mRNA vaccines, and its many fans are rightfully angry that our Medical 
Establishment is threatening their medical freedom. Apparently, the question
“Why would you not permit people to take it?” applies only to quack treatments, 
not to vaccines with a proven track record.

This Is Not How We Do Science, Ever

Our current Medical Establishment doesn’t seem to grasp that they are no longer 
just Fox News and Twitter celebrities who can comment from the sidelines as if
they were passive observers. They are in charge, and it’s their job generate
high-quality data, exactly like they demanded from their predecessors.
Similarly, the rest of us have the right to call for them to do RCTs and hold
them accountable for their failures. They signed up for this. Since Drs. Makary,
Hoeg, and Bhattacharya claim we need new RCTs of COVID vaccines, we should all 
call for them to do these trials themselves.

Yet, instead of providing the American public with the Gold-Standard of Science 
we deserve, our Medical Establishment is continuing the pattern they established
during COVID. For vaccines, they required the Gold-Standard of Science. They
felt it was necessary to protect the public from potential risks of the vaccine.
We must be very careful!

However, such none of this was necessary when it came to the virus. Listen to
what they said in summer 2021, when the virus was 1-year old, right before the
Delta and Omicron waves arrived. These confident pronouncements were not made
based on the the Gold-Standard of Science. There was no RCT that showed we had
herd immunity in May 2021 or that natural immunity to COVID was likely lifelong.
For the virus, vibes were just fine. There was no need for the Gold-Standard of
Science, and there was no need to be careful. Nothing’s changed, except who has
power and who is the Medical Establishment.

Today, these doctors are going to use our tax money to dredge private medical
records to “discover” the cause of autism and attack transgender people, with
the “results” known in advance. As Katherine Wu recently reported about this
inversion of the scientific method:

NIH officials found the memo’s directives appalling. “This is not how we do
science, ever,” one of them, who requested anonymity out of concern for
professional retribution, told me. “This is politicized research, exactly what
we were always told we would never do.”

For the past 5 years, the attitude of our Medical Establishment has been: RCTs
for thee, fishing expeditions for me. This is the quality of “science” they are 
going to give us today. We all know the “conclusions” in advance and because
it’s not the Gold-Standard of Science, we should reject the predetermined
results.


Misinformation

Physician Misinformation

Steven Novella on November 13, 2024

Link

When physicians spread medical misinformation, the potential harm to health is
far greater than their direct patient care. And yet, in a recent study, medical 
boards rarely discipline physicians for spreading misinformation.

The JAMA article looked at 3128 medical board disciplinary proceedings involving
physicians. Spreading misinformation to the community was the least common
reason, at 0.1%. Direct patient misinformation and inappropriate advertising
were tied for the next two least common reasons at 0.3%. This is an order of
magnitude or more less than other causes for disciplinary action.

The limitation of this study is that we do not know what the incidence of
spreading misinformation is. We also don’t know how many complaints are raised
that do not result in disciplinary actions, because pending or dismissed cases
are confidential and not made public. But, the authors write, there is evidence 
that such complaints are on the rise:

“The FSMB reported in December 2021 that about two-thirds of medical boards had 
seen an increase in complaints about physicians spreading COVID-19
misinformation.”

Many medical boards have also stated this is an increasing problem that they
intend to crack down on, and yet this is not reflected in the numbers. A few
questions are raised by this apparent disconnect. First, is it appropriate for
medical boards to police what physicians say to their patients and to the
public? Second, are medical boards the proper mechanism for dealing with
physician misinformation? And finally, if so, how can medical boards do a better
job?

Licensed professionals are generally given a lot of leeway in terms of
exercising their professional judgement, and we certainly don’t want to chill
discussion and debate about what the evidence says and best practices. However, 
a licensed professional carries and benefits from the imprimatur of authority
and legitimacy conferred by the state government. They may also be certified by 
a professional board. In other words, they can say (in some form) – listen to me
and trust me because I have MD after my name and I am a certified specialist.
If that means something, then it has to mean something.

In other words, it makes no sense for licensed professionals to have it both
ways – to benefit from a seal of professional approval without being held to a
professional standard. For those concerned about free speech, we can also look
at it this way. Physicians and other professionals are free to talk as a private
citizen about anything they wish. But when they are speaking in their capacity 
as a professional, their speech is part of their professional conduct, and it is
absolutely fair game to police that speech.

A physician speaking either directly to a patient or to the public on a health
issue is speaking, to a degree, on behalf of their profession. This is what the 
public generally assumes. State medical boards exist to uphold the standards of 
the professions they license.

The Federation of State Medical Boards, responding specifically to COVID-19
misinformation, had this to say:

“Physicians who generate and spread COVID-19 vaccine misinformation or
disinformation are risking disciplinary action by state medical boards,
including the suspension or revocation of their medical license. Due to their
specialized knowledge and training, licensed physicians possess a high degree of
public trust and therefore have a powerful platform in society, whether they
recognize it or not. They also have an ethical and professional responsibility
to practice medicine in the best interests of their patients and must share
information that is factual, scientifically grounded and consensus-driven for
the betterment of public health. Spreading inaccurate COVID-19 vaccine
information contradicts that responsibility, threatens to further erode public
trust in the medical profession and puts all patients at risk.”

The AMA (American Medical Association) also weighed in:

“State licensing and credentialing boards must use their authorities to
discipline clinicians who spread misinformation and to reinforce the nature and 
scope of professional and ethical obligations of government and nongovernment
clinicians. Individual clinicians must also play an important role by actively
and vigorously correcting misinformation disseminated by other clinicians.”

There is a broad consensus of relevant players that misinformation is dangerous,
spreading misinformation is unprofessional and potentially harmful, and it
should be policed and disciplined. And yet, it does not appear to be happening
at the state board level.

I could not find any information on how often specialty boards suspend or remove
certification for spreading misinformation. That is an even easier call – board
certification is a privilege that has to be earned an maintained, and a
specialty board can use whatever criteria they deem appropriate. This has
happened – there are reports of many cases of doctors losing their certification
for spreading misinformation, but there is no data to quantify this.

If there is a consensus that medical misinformation is harmful and violates
professional ethical standards and are an appropriate target for discipline, why
is action so uncommon? This gets to the second and third question – are medical
boards the best mechanism for dealing with physician misinformation, and how
can they do a better job?

The short answer to whether or not medical boards should be disciplining
misinformation is yes. In the US state medical boards are the primary mechanism 
for maintaining the standard of care and holding physicians to generally
accepted ethical and professional standards. That is literally their job. That
doesn’t mean there are no other layers of protection. As already stated,
specialty certification can and should be revoked for violating the high
standards of a certified specialist.

There are other layers as well. Hospitals can use their own criteria to
determine who can be on staff and who gets admitting privileges. They have
committee that regularly review all their physicians, including all complaints
and official disciplinary actions, and determines if action should be taken or
if privileges should be continued.

There is also a legal layer, which hopefully would be the last resort.
Professionals can be sued for malpractice that results in harm. It’s pretty
clear that directly giving a patient for whom you are caring false health advice
and misinformation is malpractice, and can result in harm. It’s less clear if
this would hold up for a physician spreading misinformation publicly.

Legal scholars have been weighing in on this issue. There appears to be a good
consensus that state medical boards can and should act when physicians spread
misinformation directly to their patients. There is no apparent consensus when
it comes to spreading misinformation to the public. There are first amendment
concerns, although many scholars argue that the first amendment does not prevent
medical boards from disciplining physicians for public misinformation.

However, many scholars argue that medical boards are simply not set up to police
public medical misinformation. Often issues are in the gray zone, and there is 
legitimate disagreement about what the science says. Medical boards don’t
necessarily have the proper expertise to judge what counts as misinformation and
where the draw the line. But again, if not the medical boards, then who?

Perhaps what needs to happen is that state medical boards establish the
infrastructure so that they can deal effectively with the physicians they
regulate spreading demonstrable misinformation. This will likely mean that they 
need to expand their resources. They may also need to partner with professional 
organizations. For example, specialty boards are generally in a better position 
to determine what is misinformation within their specialty, and already had a
history of putting together expert panels to review evidence and establish
practice guidelines.

What can, and likely should, happen, therefore, is that specialty boards turn
their attention to medical misinformation and establish practice guideline, not 
only for what physicians should do but what they should, and should not, say.
State medical boards would not need to duplicate this effort, but can simply
enforce it for physicians in their state.

It also should be noted that taking disciplinary action does not mean
immediately removing a physicians license. That is the most extreme action,
reserved for the worst offenses. In many instances a physician can simply be
given a warning, or be required to take CME credits in the relevant topic. A lot
of misinformation, in other words, can be dealt with through education.

For physicians who persist in spreading demonstrable misinformation despite
these efforts, increasing disciplinary action would be appropriate. Physicians
can be censored, their licenses can be suspended for a period of time, and they 
can ultimately be revoked. No one deserves an MD. If you are using your MD to
harm the public health, and the profession has a moral responsibility to protect
and advance the public health, then clearly action needs to be taken.

What is clear at this time is that physician misinformation is an increasing
problem, worsened by social media and perhaps also by political division. And
yet, the mechanisms we have in place for ensuring proper professional behavior
seem to be failing when it comes to spreading misinformation. There needs to be 
a robust discussion within the profession, and including legal scholars,
ethicists, and regulators, to improve our ability to ensure that the public is
getting the most accurate medical information from professionals.


The ABIM vs. medical misinformation: Better late than never?

Last week, the New England Journal of Medicine published an editorial by the
President of ABIM discussing how the board certification can be taken away from 
diplomates who spread medical misinformation. Is this too little, too late?

David Gorski on May 23, 2022

Link



Over its 14 years of existence, one of the core messages of Science-Based
Medicine has been very consistent. We have bemoaned how easily doctors who are
quacks, antivaxxers, and grifters not only manage to avoid professional
penalties and keep their medical licenses and board certifications, but often to
keep practicing more or less unimpeded by either state medical boards or the
private boards that certify them in their chosen medical specialties. Flowing
from this dismay, we have also advocated for change to empower state medical
boards and specialty boards to hold doctors accountable for professional
misdeeds, up to and including being able to revoke their medical licenses and
board certifications. After all, without a medical license, a physician cannot
practice, and without a board certification it is very difficult to practice, as
Medicare and Medicaid, as well as most insurance companies, require it to
reimburse a physician, and most hospitals require it to grant privileges. One
has only to consider the example of Texas cancer quack Stanislaw Burzynski, who 
“discovered” antineoplastons in the early 1970s and has been charging large
consultation fees to administer them since the late 1970s to treat cancer
patients despite no good evidence that they are effective. Over the more than 40
years of having plied his quackery on cancer patients, Dr. Burzynski had
managed to avoid significant sanctions from the Texas Medical Board (most
recently in 2017) and the FDA for his “clinical trials” that were designed
primarily as marketing tools to let him keep using antineoplastons rather than
actual clinical trials to determine if antineoplastons work. So it was with
great interest that I encountered an op-ed in The New England Journal of
Medicine by the President and CEO of the American Board of Internal Medicine
(ABIM) Richard J. Baron, MD, and the chair of its board of directors, Yul D.
Ejnes, MD, titled “Physicians Spreading Misinformation on Social Media — Do
Right and Wrong Answers Still Exist in Medicine?” Obviously, I think you know
how I (and SBM members) will answer, but first let me start with a little
context.

COVID-19: Old quacks revitalized and joined by new quacks spreading
disinformation

Burzynski arguably pioneered the technique that we see so much in evidence
today; he recruited his patients to use for PR and politics to spread
misinformation about cancer and “health freedom.” Basically, the techniques that
Burzynski used in the 1990s to pressure the FDA and Texas Medical Board were
the same techniques later used to pressure state legislatures and then the US
Congress to pass “right-to-try” laws in the name of “medical freedom”. The very 
same technique is being used to pressure legislatures to promote laws banning
COVID-19 vaccine mandates, making repurposed and ineffective treatments like
ivermectin available over-the-counter, and immunizing physicians against
penalties for using quackery to treat COVID-19.

When the COVID-19 pandemic hit, what we’ve been warning about since 2008 about
physicians promoting quackery and misinformation very quickly became a global
threat to public health. The usual physician suspects from the past, whom we had
long been writing about since back in the day (e.g., Rashid Buttar, Russell
Blaylock, Andrew Wakefield, Paul Thomas, Bob Sears, Sherri Tenpenny, Kelly
Brogan, various members of old crank medical organizations like the AAPS, etc.),
many of whom had been so forgotten that they were largely unknown outside of
the deepest, darkest circles of the antivax and quack Internet, soon found
themselves becoming relevant—even famous—again, along with the new generation of
quacks and cranks who arose to spread COVID-19 misinformation (e.g., Robert
“inventor of mRNA vaccines” Malone, Peter McCullough, Simone Gold, Vinay Prasad,
Marty Makary, Pierre Kory, Joseph Ladapo, Paul Marik, Vladimir Zelenko, Aaron
Kheriaty, and many others). There is now a veritable army of quacks, some of
whom are into serious grift (e.g., America’s Frontline Doctors running a
prescription mill for ivermectin), but all of whom are spreading dangerous
misinformation about COVID-19, vaccines, and unproven treatments for COVID-19
like ivermectin (which to me is now disproven), hydroxychloroquine, and many
others, all while doing their damnedest to promote “health freedom,” or, as I
like to put it, freedom from professional responsibility, government regulation,
or any consequences whatsoever for endangering patients.

Again, this was a problem that SBM had long written about going back to the very
beginning of this blog, namely how toothless state medical boards are, how
easily bad and even dangerous doctors can keep practicing, and how oblivious our
fellow physicians had been to the threat of medical misinformation before the
pandemic, a threat to which they have only fitfully been waking up. For example,
I noted at the end of 2020 how it had been a year of physicians behaving badly.
Before I discuss the NEJM op-ed, I think it’s worth quoting myself from nearly 
a year and a half ago:

   If anything, the COVID-19 pandemic has reinforced my opinion, first stated 12
   years ago, that medical practice itself is a sadly weak check on BS,
   particularly when the medical system is stressed. Just look at the list of
   examples that I’ve discussed in this post and realize that there are many
   more that I could have discussed if I didn’t mind having this post balloon up
   to 10,000 words or more. The point, of course, is that all too often we
   physicians view ourselves as relatively immune to being led astray by “BS”,
   certainly far more so than others. It is that arrogance that leads to doctors
   like Dr. Scott Atlas pontificating on areas of medicine that he doesn’t
   understand and then portraying himself as Galileo when criticized for it.
   Don’t believe me?

After listing a number of examples of physicians spreading dangerous COVID-19
misinformation, as well as historical examples, such as Stanislaw Burzynski,
Christopher Duntsch, and others, I concluded:

   The bottom line is that practicing medicine is a privilege, one of the
   highest privileges society can grant to any human being. It is not a right.
   Unfortunately, all too often the law treats it more like a right, with state 
   medical boards being loathe to strip quacks and other doctors practicing
   inarguably substandard medicine of their privilege to practice. That needs to
   change, and that change needs to include stopping physicians from abusing
   the privilege of their profession to spread disinformation that kills, as too
   many physicians did in 2020 and, sadly, are likely to continue to do in
   2021.

2021 has come and gone, and we’re not far from the halfway point in 2022. What’s
happened? The good news is that, as a result of the tsunami of misinformation
and disinformation being promoted by physicians, a disturbing number of whom are
vaccine-hesitant or outright antivax, nearly a year ago the Federation of State
Medical Boards asserted that spreading dangerous medical misinformation could
be grounds for a physician’s license to be suspended or revoked, although,
unfortunately, the FSMB has no statutory power and all state medical boards are 
governed by their individual state laws, which have been under assault by
“health freedom” antimaskers and antivaxxers not to discipline doctors for
spreading COVID-19 misinformation. As I’ve noted before, quacks and antivaxxers 
targeting state medical boards is nothing new. It’s long been a tactic of theirs
to target state medical boards legislatively, just as advocates for
pseudomedical “disciplines” like naturopathy, acupuncture, and the like have
long targeted legislators to achieve licensure in more and more states. In the
past, it was mostly quack-friendly legislators prodded by powerful
pseudomedicine interests. For example, in 2010, the aforementioned Buttar led a 
successful effort by the North Carolina Integrative Medical Society to persuade 
legislators to change state law to make it friendlier to practitioners of
alternative medicine. Now, North Carolina law prevents its medical board from
disciplining a physician for using “non-traditional” or “experimental”
treatments unless it can prove they are ineffective or more harmful that
prevailing treatments. The same thing is happening today, just on a scale I’ve
never seen before.

Other good news is that a new medical advocacy group, No License for
Disinformation (NLFD) has been formed and advocates to state medical boards and 
specialty medical boards to take misinformation seriously and even sanction
doctors who promote it. NFLD has been quite successful since it was formed in
garnering press and access to state medical board officials and specialty
boards. Unfortunately, much of the rest of medicine has been very resistant to
such efforts, apparently viewing them as an unacceptable assault on “freedom.”
Indeed, just over the weekend, I saw statements like this about a proposed
California law that would empower its medical board to discipline doctors who
spread misinformation.

If your dr is treating you for Covid or goes beyond the guidelines to save you, 
Appreciate him or her because these are the most trying times for drs. Not only 
do we have to stress about every lives we take on but now we have to fight
boards . This is coming I’m sure👇 pic.twitter.com/JC2m85dXmH

— sabine hazan md (@SabinehazanMD) May 19, 2022

You might remember Physicians for Informed Consent, a virulently antivax
physicians’ group.

With that background, let’s look at the NEJM editorial.

The ABIM weighs in…belatedly

It’s hard to argue with the opening of the NEJM op-ed on medical misinformation:

   Medicine has a truth problem. In the era of social media and heavily
   politicized science, “truth” is increasingly crowdsourced: if enough people
   like, share, or choose to believe something, others will accept it as true.
   This way of determining “truth” doesn’t involve scientific methods; it relies
   instead on “the wisdom of crowds,” which has particular power in a
   democratic society in which leaders and policies are chosen by the will of
   the group. Such choices anchor concepts like freedom and liberty. But they
   may not be helpful in determining whether a building will collapse, whether
   your brakes will stop your car — or whether a medication or vaccine works.

   Growing allegiance to crowd-endorsed “facts” poses a serious challenge for
   the institutions and structures that the medical enterprise has developed to 
   protect the public and ensure that people can tell who can or cannot be
   trusted as medical professionals or relied on for scientific knowledge. These
   structures include comprehensive medical education, licensure, and board
   certification, and leaders in all these areas are struggling to figure out
   how to respond to assertions by doctors on social media that are not
   supported by evidence and may harm patients. The Surgeon General has
   identified medical misinformation as a major public health threat, and many
   professional societies, including the American Medical Association, have
   called for action to combat it.

As much as I hate to say “I told you so”, I told you so, at least we’ve been
telling the medical profession, state medical boards, etc., so for over 14
years. None of this is anything new, and SBM has been warning about it since
2008, with some of its member having been warning about it years before. Indeed,
one of our bloggers, Val Jones, even coined a term for the attitude of
physicians about alternative medicine quackery, medical misinformation,
antivaccine pseudoscience, and the like, describing most physicians who didn’t
take it seriously as “shruggies”—and she did it in 2008, defining a “shruggie”
thusly:

   Shruggie (noun): a person who doesn’t care about the science versus
   pseudoscience debate. When presented with descriptions of exaggerated or
   fraudulent health claims or practices, their response is to shrug. Shruggies 
   are fairly inert, they will not argue the merits (or lack thereof) of
   complementary and alternative medicine (CAM) or pseudoscience in general.
   They simply aren’t all that interested in the discussion, and are somewhat
   puzzled by those who are.

Sound familiar? As hard as it is to believe, even more than two years into the
pandemic and the tsunami of dangerous misinformation and conspiracy theories,
there are still a lot of shruggies in the medical profession.

It hasn’t been just social media, either, which largely didn’t exist (at least
not at the massive scale it does now) when Steve Novella founded SBM in 2008.
The problem had been brewing years before on websites, blogs, Internet
discussion forums, Usenet, and old-fashioned email lists. It had also been
brewing in our very profession of medicine, with the rise of “complementary and 
alternative medicine” (CAM), later “rebranded” as “integrative medicine,” which 
was based on the “integration” of outright quackery into evidence-based
medicine. Let’s just put it this way. When there are academic departments in
medical schools that promote quackery such as reiki, naturopathy, homeopathy,
and even anthroposophic medicine, it’s little wonder that medical academia has
been reluctant to confront those in its ranks who promote COVID-19
contrarianism, misinformation, and even outright antivax views.

Baron and Ejnes then note:

   The issue of what physicians can and cannot say on social media has been
   hotly debated by legal scholars and in medical journals. Coleman has observed
   that “professional speech” is a legally contested domain between speech that
   can be regulated or prohibited by licensing boards and speech protected by
   the First Amendment. It is also unclear when physicians’ speech on social
   media constitutes “medical practice.”1 Mello has questioned why First
   Amendment protections should extend to harmful speech that leads to death
   from preventable disease, when some other forms of speech — such as
   fraudulent commercial speech, which may be less harmful — are prohibited.2

It’s true, too. No one, not even those of us at SBM who have advocated for
disciplinary actions that apply to physicians who use their status as trusted
professionals to give a patina of science and the authority of medicine to fraud
and conspiracy theories, have claimed that there is a bright line between
misinformation/disinformation and legitimate differences in scientific and
medical opinion. That being said, the ABIM does ask the right question, namely, 
“Do Right and Wrong Answers Still Exist in Medicine?” I’ll add a spoiler alert
by pointing out that the op-ed concludes, “There aren’t always right answers,
but some answers are clearly wrong.”

Exactly!

Certainly, at the very least I would agree with Baron and Ejnes that there are
indeed answers that are clearly wrong in medicine. They do exist. Cranks and
quacks like to wrap themselves in the observation that “medicine changes” as new
evidence comes in, all in order to argue that they are doing nothing more than 
engaging in “debate” and to claim that their views might be vindicated or that
they are at least plausible enough not to be immediately dismissed, but such
arguments are subterfuge, camouflage to fool the unwary. I also like the example
used by Baron and Ejnes, specifically how ABIM certifying exams are constructed
specifically the use of “distrators,” answers that are wrong but plausible
enough to trap those whose knowledge of the topic is insufficiently deep,
although I will argue that it is actually rather simplistic and naive as a
comparison to COVID-19 misinformation (and, indeed, medical misinformation and
quackery in general):

   Creating these exams involves bringing together academic and practicing
   expert clinicians from a particular field to write and critique
   multiple-choice questions that have a single best answer — a process that may
   provide a useful perspective on somewhat analogous efforts to assess the
   information that doctors and others disseminate through informal public
   channels such as social media. The challenge in writing multiple-choice exam 
   questions is not constructing a question with a right answer; rather it’s
   creating the “distractors,” the wrong but plausible answers. As anyone who
   has taken a multiple-choice exam knows, even someone with no knowledge of the
   relevant field can pass a test when the wrong answers are obviously
   implausible. An exam question measures something important only if someone
   acquainted with the field might believe the wrong answers are correct. The
   expert clinicians spend most of their time debating the distractors: Is that 
   answer really wrong? If anyone around the table can find a valid article that
   might support the choice of option C as correct, then option C can’t be used
   as a distractor. In these discussions, the experts are guided by
   peer-reviewed medical literature, not by “prevailing opinion” or what a
   committee member believes; they don’t take polls. They accept the methods
   underlying scientific studies as a safer guide to practice than the received 
   wisdom, intuition, or even “democratic process.” Informed by that literature,
   they conclude that some answers are definitively wrong.

There’s also quality control in such examinations. If, for example, certain
wrong answers are chosen at too high a frequency, the question or answers might 
be modified or dropped from future versions of the examination. The point,
though, is that there are answers that are plausible scientifically, but
nonetheless wrong.

There is a huge difference, though, between the example of exam questions and
distractors discussed above and the real world misinformation being promoted
about COVID-19, a disturbing amount of it by physicians. Specifically,
physicians tend to be really good at cherry picking (or even producing)
seemingly scientific papers published in the peer-reviewed medical literature to
support their misinformation. The problem of misinformation and disinformation 
is far more complex than there just being no papers to support a particular
answer. In addition, physicians can be really good at misrepresenting or
distorting the findings of legitimate scientific publications in the service of 
their disinformation, be it demonizing COVID-19 vaccines, claiming that masks
don’t work to slow the spread of COVID-19, or arguing that COVID-19 is not
dangerous. In this, I have always thought that Brandolini’s law (also known as
the bullshit asymmetry principle), which states that the “amount of energy
needed to refute bullshit is an order of magnitude bigger than to produce it” is
far too optimistic. I tend to think that it takes at least two—if not
three—orders of magnitude more time and effort to refute bullshit as it does to 
produce it, and disinformation spreading doctors are very good indeed at
producing and repackaging bullshit. Basically, the example used by Baron and
Unje is very simplistic and doesn’t recognize the full magnitude of the
misinformation problem. It is, however, a start, and I think they are starting
to “get it”:

   As the ABIM confronts the danger of medical misinformation, we recognize that
   there are many clinical issues on which physicians legitimately hold a
   spectrum of opinions, all supported by evidence; such justifiable positions
   would not make it as “distractors” on our exam, nor would they meet our
   definition of “false information,” as determined by experts consulting the
   literature. A whole range of statements with which many — or even most —
   physicians might disagree would therefore not trigger our disciplinary
   process. On the other hand, when someone certified by the ABIM says something
   like “the origin of all coronary heart disease is a clearly reversible
   arterial scurvy” or “children can’t spread Covid” or “vaccines don’t prevent 
   Covid deaths or hospitalizations,” we are not dealing with valid professional
   disagreement; we are dealing with wrong answers.

I like that Baron and Unje didn’t just mention false claims about COVID-19 and
included one about heart disease. It suggests that maybe—just maybe—they now
recognize that the problem of medical misinformation being spread as “health
freedom” and the “democratization” of medical knowledge is much broader than
COVID-19 and predates the pandemic by decades.

Also, conspiracy theories (e.g., that COVID-19 is a “plandemic” or “casedemic”
or that COVID-19 vaccines contain microchips or other tracking devices) should
easily fall into this category, as not even being plausible enough to be a
distractor in a multiple choice question. I am, however, a bit concerned. Again,
there is no bright line between a wrong answer that’s plausible enough to be a 
“distractor” and bullshit, given the talent a lot of physicians have for cherry 
picking the scientific literature, and I have to wonder if the experts in the
ABIM are up to the task of identifying certain claims as implausible. I say this
because I saw no mention of the ABIM consulting experts in conspiracy theories 
and disinformation to adjudicate cases. We’ve documented many times throughout
our 14 years of existence how physicians not acquainted with medical
misinformation and quackery are often flummoxed when they encounter many of
these claims. They just don’t have the background to adjudicate anything in the 
“gray areas” and sometimes struggle even with cases that to those of us who
study quackery and misinformation are obvious.

Difficulties aside, I applaud ABIM for starting to grapple with the issue of its
diplomates spreading medical misinformation and disinformation, even if they’re
late and appear to have a bit of a naïve view of what medical misinformation
and disinformation are. Basically, I hope that they will learn and suspect that 
they might have an easier time actually doing something meaningful than many
state medical boards will, given the politics in a distressing number of states.

Finally, although it’s the largest, the ABIM is but one of many boards
certifying various medical specialties. I, for instance, am certified by the
American Board of Surgery, which has not yet stepped up to the plate, and no
other board besides ABIM has yet gone as far. Certainly, I hope that a year from
now I will no longer be able to say that.

The American Board of Internal Medicine finally acts against two
misinformation-spreading doctors

Last week, I wrote about how COVID-19 has exposed the toothlessness of state
medical boards. Last week, the American Board of Internal Medicine announced
that it was going to permanently revoke the board certifications of two COVID-19
contrarian doctors, Drs. Paul Marik and Pierre Kory. Can medical specialty
boards make up for the failure of state medical boards, at least partially?

David Gorski on August 7, 2023

Link



Last week, I wrote what was basically a lament and jeremiad about the
longstanding failure of state medical boards to discipline quacks and antivax
doctors. It is, as I discussed, a failure that dates back to before the
pandemic, which is why I described how the pandemic had exposed the
toothlessness of most state medical boards. My observation was based on a recent
story published in The Washington Post by Lena Sun, Lauren Weber, and Hayden
Godfrey that described how few physicians spreading misinformation about
COVID-19 and vaccines had suffered anything in the way of discipline or
penalties, much less actually had their medical licenses revoked, despite the
unfortunately huge numbers of physicians who have made a name for themselves on 
social media for spreading fear, uncertainty, and doubt about public health
interventions, treatments, and vaccines for COVID-19, with many of them selling 
quackery such as “spike protein detox” instead. As you might expect, I pointed
out that this has been a longstanding problem with state medical boards, which
are often understaffed and underfunded, incentivizing them to deal with easy,
imminent threats, like doctors with substance abuse disorder, rather than cases 
where they have to adjudicate a standard of care an possibly devote large
amounts of their limited resources to take on well-funded quacks like Stanislaw 
Burzynski and Rashid Buttar.

Given that I had just written about the topic of holding misbehaving physicians 
accountable for the harm that they do, naturally it caught my attention when I
saw this Tweet on Friday from journalist Anna Merlan citing an email blast from 
the what is in my opinion a quack medical group, the Front Line COVID-19
Critical Care Alliance (FLCCC Alliance) about a decision apparently made by the 
American Board of Internal Medicine (ABIM) this week:

This has been coming for a while – we wrote about this battle last June.
https://t.co/Zyy8qIxwVb

— Anna Merlan (@annamerlan) August 4, 2023

Curious, I went to the FLCCC Alliance website and Substack, where I was greeted 
with headlines like Two Leading COVID-19 Doctors are Facing Accusations of
Spreading Misinformation by American Board of Internal Medicine (ABIM) Committee
and FLCCC Doctors Plan to Fight Board Decision. It didn’t take long for allies 
of Drs. Pierre Kory and Paul Malik to weigh in, in particular Sen. Ron Johnson:

Here's an example from @Covid19Critical of how one member of the COVID Cartel,
ABIM, uses their certification power to try to discredit two doctors who had the
courage and compassion to successfully treat COVID patients.
pic.twitter.com/iwu45BdGjB

— Senator Ron Johnson (@SenRonJohnson) August 4, 2023

Many of you will recognize the video as a brief “greatest hits” of COVID-19
misinformation, complete with the bogus “Pfizer whistleblower” conspiracy theory
and a bit at the end about “looking at the evidence for myself.” Regular
readers of SBM and my not-so-secret-other-blog know my opinion of FLCCC, namely 
that they’re a bunch of rank quacks who made their name selling ivermectin as a 
“cure” for COVID-19. Unfortunately, there are a lot of ideological useful idiots
in positions of power who have portrayed the FLCCC as a group of “brave
maverick doctors”—”truth tellers”—and tried to alter the law to shield them from
the consequences of the misinformation they spread and the quackery they
practice, even as they were part of a network creating a global market for
health fraud selling ineffective repurposed drugs like hydroxychloroquine and
ivermectin to treat COVID-19.

Indeed, in retrospect, I had noticed a rare email from ABIM sent to my work
address earlier in the week, which made me wonder if something was up. Here’s a 
rather generous excerpt, given that it’s an email blast:

   Second, I wanted to provide an update on our work around addressing medical
   misinformation. I’m sharing a piece just published in JAMA that I coauthored 
   with Dean Schillinger, MD, Professor of Medicine in Residence at the
   University of California San Francisco, titled “Health Communication Science 
   in the Balance.”

   In it, we explore how and why the NIH abruptly “paused” a new $154 million
   research program called Advancing Health Science Communication and
   Practice—which was 20 months in the making—with only a vague explanation that
   they needed to “reconsider the scope and aims in the context of the changing
   legal and regulatory landscape related to communication platforms.”

   It should be noted that this announcement was made June 6, 2023, just weeks
   ahead of a judicial order issued on July 4 in the Missouri v. Biden legal
   case that prohibits governmental agencies from talking with social media
   companies. Judge Terry A. Doughty’s order has been stayed temporarily by the 
   Appellate Court, but it appears to have already had an impact on federal
   officials.

   At a time when trust in the medical profession is at an all-time low, we know
   patients seek guidance about their health from a wide variety of other
   sources, including social media platforms. It is a tremendous disservice to
   patients everywhere when agencies like the CDC cannot even have a
   conversation with social media companies about how to ensure that
   evidence-based medical information is easily identifiable and distinguishable
   from snake oil.

   It also hampers our collective ability across all sectors of health care to
   collaborate on initiatives that may help mitigate misinformation and elevate 
   expert voices. I wrote about one such potential private-public partnership
   model in a piece in the Annals of Internal Medicine that you may have seen,
   called Addressing Viral Medical Rumors and False or Misleading Information.

   In closing, I’d also like to share a recent article in the Washington Post,
   where reporters Lena Sun, Lauren Weber (of the Post’s misinformation team)
   and Hayden Godfrey undertook a comprehensive investigation of disciplinary
   actions taken by medical boards across all 50 states, concluding that
   “doctors who jeopardized patients’ lives by pushing medical misinformation
   during the pandemic and its aftermath have faced few repercussions.”

   It’s truly a remarkable piece of journalism, and while it speaks specifically
   to the challenges that state medical boards are confronted with in our
   current environment, I’m sure we can all see aspects of ourselves and the
   organizations we serve in this story. It shouldn’t surprise any of us if this
   isn’t the last story we see like this.

First of all, the fact that political pushback seems to have shelved the $154
million research program called Advancing Health Science Communication and
Practice shows just how powerful the forces promoting misinformation and
resisting any effort to counter it have become. In its article listed above, the
ABIM asks, “What does the ‘current regulatory and legal landscape around
communication platforms’ refer to, and why does it matter?” I assume that these 
are rhetorical questions, as it is pretty obvious to me what they refer to and
mean—and why they, unfortunately, do matter. Basically, to me it sounds as
though the NIH caved to political pressure from Republicans like Sen. Ron
Johnson.

Be that as it may, I did wonder from the ABIM email blast whether something was 
up or not, given how seldom I’ve received these emails, and apparently I was
correct. The ABIM has apparently decided to take its first concrete action
against FLCCC members Dr. Paul Marik and Dr. Pierre Kory. But what does this all
mean? Let’s start with Merlan’s VICE article published a month and a half ago, 
Fringe COVID Doctors Say They’re Under Attack by Medical Certification Board.

The grifters’ “persecution” narrative

If there’s one thing that cranks, quacks, and grifters have long known, it’s
that somehow being able to portray oneself as a “victim,” as “persecuted,” is
the most effective way to rally followers and promote the grift, and FLCCC is no
different. As Merlan reported:

   In the ongoing saga of the ivermectin guys, who claim they alone hold the
   extremely dubious cure for COVID, it’s necessary to have an
   antagonist—someone they can say is threatening them for exposing the truth.
   Recently, it’s been the American Board of Internal Medicine, or ABIM.

   Two prominent vaccine skeptics and promoters of unproven COVID treatments,
   Drs. Pierre Kory and Peter McCullough, said on Twitter that the board is
   threatening them for their work. This narrative has speedily picked up speed 
   across the right-wing ecosystem, with one right-wing website claiming the
   board is going to “revoke their medical licenses,” which is not something the
   ABIM can do. The whole thing is a useful view into how mainstream medical
   bodies are struggling to deal with their still-certified but increasingly
   out-there colleagues. And it’s a very instructive example of how fringe
   medicine promoters—and their allies in Congress—immediately spin their
   tangles with the medical establishment into more fame and attention.

This strategy works even better if it’s coupled with pugnaciousness and a vow to
“fight” the “oppressor”:

I also got a letter from ABIM detailing multiple public statements I made as
misinformation (from whoever they hired to investigate me). I have massive
evidence to support each statement. Bring it on ABIM, err, I mean FBI. Didn’t
know investigating docs was part of your mission. https://t.co/9NC3dXkdnU

— Pierre Kory, MD MPA (@PierreKory) June 19, 2022

It was basically, the “Debate me, bro!” tactic so beloved of cranks, quacks, and
conspiracy theorists disingenuously employed. I say “disingenuously” because no
doubt Drs. Kory and McCullough know that the ABIM probably couldn’t do this
even if it wanted to, because it would be arguing an individual case in public. 
Just remember that this wasn’t a serious proposal. It was all performative, as
the clip from the movie Braveheart included by Dr. McCullough in his
quote-Tweeted Tweet above shows:

I suppose I should be grateful that Dr. McCullough refrained from using the clip
of Mel Gibson’s rendition of William Wallace’s inspirational speech to his
troops before battle with the English or maybe even of Wallace’s execution,
when, instead of taking the quick and merciful death promised him if he were
just to ask for “mercy,”  he cries out “Freedom!” as he is being tortured and
disemboweled. (I was half-tempted to issue a spoiler alert, but then realized
that the movie is 28 years old. Deal with it.) Basically, the martyr complex is 
an essential element to all good quack grifts. (Burzynski was a master of it,
for example.) It doesn’t matter that, in countering charges that they are
spreading misinformation, they spread misinformation:

   The current situation began when McCullough, a cardiologist formerly employed
   by Baylor Hospital who’s become a vocal vaccine skeptic, and Kory, a
   co-founder of the ivermectin-promoting Frontline Covid-19 Critical Care
   Alliance, or FLCCC, both said that they’d received threatening letters from
   the ABIM, saying it was considering disciplinary sanctions against the two
   men from promoting misinformation. This immediately became a fairly big deal 
   on the COVID-skeptical and ivermectin-promoting right, and the publication
   American Greatness immediately claimed that the body was threatening to
   “revoke the medical licenses” of both men.

   That is, as a point of order, both wrong and very dumb: The ABIM is a
   certification body, not a licensing one. The ABIM certifies doctors who
   specialize in internal medicine and other subspecialties; that certification 
   proves they completed a residency in their specialty and also passed a
   specialized exam.

This is a common misunderstanding among the public about the difference between 
medical licensure and board certification. In order to practice medicine, you do
have to be licensed by the state in which you practice. However, you can get a 
medical license after just medical school and one year of internship. In
general, however, to practice you also have to have completed an accredited
residency in a medical specialty. Board certification involves the board for
that medical specialty “certifying” that you have (1) successfully completed an 
accredited residency in the specialty and (2) completed a test that demonstrates
a basic level of knowledge and competency in the specialty. For my specialty,
the American Board of Surgery (ABS) required passing a written qualifying
examination, after which I then had to pass an oral certifying examination.
After that, I had to recertify every ten years by passing a written examination.
It is true that the ABS has, since my last recertification, created a new track
that doesn’t involve taking a test on all of general surgery, the way I did
twice before after my initial board certification but rather involves
self-learning, documentation of continuing medical education, case logs, and
smaller, specialty-focused tests every three years. (That is the track to which 
I will switch when my current ten-year board certification expires in a few
years.) In the medical specialties overseen by ABIM, the process of maintaining 
board certification can be much more involved, including submitting patient
evaluations, which has led to a fair amount of resistance and pushback from
physicians chafing under the requirements.

It is not my intention to comment on the process itself beyond this, but rather 
to explain what board certification is. Also, most hospitals will not provide
privileges to a physician who is not board-certified by an accepted, recognized 
board, nor will insurance companies reimburse for services provided by such
doctors. Of course, the wag in me can’t help but wonder why Drs. Kory and Marik 
are so upset given that they both appear to have abandoned traditional medical
practice in which they might want to have hospital privileges and bill insurance
companies and Medicare for their services in favor of the model preferred by
“brave maverick doctors” who don’t practice according to science-based
guidelines or scientific consensus: Cash on the barrelhead fee-for-service, no
insurance accepted. As far as their livelihood goes, even if the ABIM does
revoke their board certifications, the action is unlikely to have much, if any, 
financial impact on them. They even admit it in their response:

   The loss of ABIM certification will not impact Dr. Kory or Dr. Marik’s
   ability to practice medicine or conduct scientific research or educational
   work. Some hospitals and healthcare providers require ABIM certification for 
   employment, however the certification is not required by state medical boards
   or for a medical license anywhere in the U.S.

Of course it doesn’t! Neither of these doctors is practicing in an environment
where board certification is even required! However, the narrative of the poor
victim persecuted by big government, big tech, big pharma, and big medicine must
be maintained, hence the outrage from FLCCC Alliance and Drs. Kory and Marik.
Also, I’m pretty sure that there is also likely an element of pride involved, in
which the likelihood of soon having something as important as their board
certification revoked injures their massive egos.

In addition, Sen. Ron Johnson was at it again after the initial letter in June, 
publishing an open letter to the ABIM containing another “Debate me, bro!”
challenge to the ABIM, even inviting ABIM representatives to one of his COVID-19
“roundtables”:

   Unfortunately, the federal health agencies, public health experts and vaccine
   manufacturers did not accept my invitation to either event.   Rather than
   engage in a public dialogue in which information and perspectives can be
   openly exchanged and debated, the individuals and organizations responsible
   for our pandemic response continue to attack and discredit those with a
   different perspective by using the vague pejorative of “spreading
   misinformation”.

   It is well last time for the public to hear from many sides regarding
   COVID-19 in a public forum.  The purpose of this letter is to invite you,
   members of your Credentials and Certification Committee, and any other
   medical expert of your choosing to come to Washington and engage in an open
   and honest interchange regarding all aspects of COVID-19, without the threat 
   of reprisal by the ABIM or any other organization.  I request your
   participation in a public forum on one of the following dates: July 26, July 
   27, July 29, August 2 or August 3.

It is also telling that Dr. McCullough didn’t announce the ABIM letter himself
first, but rather appears to have just forwarded it to Sen. Johnson, who used it
as a tool to promote his misinformation-packed COVID-19 roundtable events.

Also, from the wording of the letter quoted by the FLCCC Alliance, the ABIM
hasn’t even actually officially revoked Dr. Marik and Kory’s board
certifications yet. Before concluding that, in “accordance with ABIM bylaws, Dr.
Marik and Dr. Kory will appeal the committee’s recommendation,” FLCCC rants:

   The ABIM Credentials and Certification Committee has recommended that FLCCC
   co-founders, Paul Marik, MD and Pierre Kory, MD, MPA should have their ABIM
   certifications revoked for spreading what the committee considers “false or
   inaccurate medical information.” The committee concluded that the published
   peer-reviewed, clinical, and observational data that create the foundation of
   FLCCC protocols, educational materials and public statements are not
   “consensus driven scientific evidence.” In reaching their recommendation, the
   committee cites NIH and CDC guidelines as well as several studies that have 
   been largely disproven or questioned for their glaring flaws, conflicts of
   interest or poor design. Additionally, the committee cites a National Public 
   Radio story that was later corrected for falsely reporting that overdosing of
   ivermectin was causing a surge in emergency room admittance.

   “What ABIM is doing is basically telling doctors that we need to take our
   orders from bureaucrats in Washington and certain medical journals instead of
   making treatment decisions based on our training and expertise,” said Pierre
   Kory, MD, MPA, president and chief medical officer of the FLCCC.
   “Threatening doctors the way the ABIM is doing, simply degrades the practice 
   of medicine to be something that is done out of fear rather than to heal our 
   patients in the best way we know how.”

And:

   “The ABIM is doing this to us and other doctors who didn’t follow what the
   committee is calling ‘consensus’ as a way to scare others into silence,” said
   Paul Marik, MD, chairman and chief scientific officer of the FLCCC.
   “Following the ABIM’s ‘consensus’ will only deprive patients of important
   treatments that have saved lives all over the world.”

   The ABIM committee continues to spread the myth that ivermectin is dangerous 
   without critically examining the scientific and clinical evidence. In its
   statement the committee cites false claims that ivermectin could be “fatal”
   while never mentioning the 99 controlled trials – 46 of them randomized
   controlled trials – that showed ivermectin is highly effective in treating
   COVID-19 with little to no reported side effects. These trials include over a
   hundred and thirty thousand patients successfully treated with no severe
   side effects, consistent with the WHO’s finding that ivermectin ranks higher 
   in safety than Tylenol or aspirin.

Ivermectin is indeed safe and effective when used to treat roundworm infections.
The problem, of course, is that it doesn’t work for COVID-19, those “randomized
controlled trials,” many of them fraudulent, not withstanding. It was always
predictable that ivermectin would be highly unlikely to work as a treatment for 
COVID-19 just on pharmacology. As I like to point out, the concentration of
ivermectin that inhibited the replication of SARS-CoV-2, the coronavirus that
causes COVID-19, in cell culture was 50- to 100-fold higher than what can be
safely achieved in the human bloodstream using “safe” ivermectin dosing. There’s
a reason that I’ve referred to ivermectin as the “acupuncture of COVID-19
treatments” and pointed to it as an example of why science-based medicine is
important not just for low plausibility alternative medicine treatments but for 
low plausibility treatments of all kinds—like ivermectin for COVID-19.

Also, what the FLCCC Alliance conveniently fails to mention is that the
promotion of ivermectin as a cure-all for COVID-19 has indeed led people to use 
veterinarian formulations designed for large animals like horses and cows. As I 
like to point out, equine ivermectin comes packaged in syringes with “1.87%
ivermectin paste. 6.08 g syringe treats up to 1,250 lbs. Safe for horses of all 
ages, pregnant mares, breeding stallions.” Another formulation comes as a 1%
solution to be given 1 ml/110 lbs of weight. Basically, in horses the dose of
ivermectin can be up to 1.200 mg, while the human dose recommended is only
around 3 mg. When ivermectin promoters state that ivermectin is “very safe” in
humans, they are correct, but only at the dose recommended for humans. As with
many drugs, toxicity increases with increasing dose, and when you take far more 
than the recommended dose your risk of serious side effects increases.
Fortunately, most of these side effects have been mild, but even mild side
effects are too much to risk for a drug that doesn’t work. Worse, promotion of
ivermectin for COVID-19 has, predictably, expanded to its being touted for
cancer and even autism. The FLCCC will, of course, claim that they have never
promoted ivermectin for such purposes, but their ally Tess Lawrie has. Promoting
a drug—any drug—as a near-miraculous cure for one life-threatening disease will
almost always lead other quacks to promote it for other conditions and
diseases.

Free speech versus board certification

I will conclude by discussing how the FLCCC is also bemoaning the recommendation
of the ABIM Credentials and Certification Committee to strip Drs. Kory and
Marik of their board certifications as an attack on “free speech.” This is, of
course, a lament that quacks throughout the decades that I’ve been writing about
science-based medicine vs. quackery nearly always invoke whenever they are
criticized or a medical authority tries to hold them accountable for their
quackery. The FLCCC is no different. Consistent with the narrative of their
conspiracy theories in which ivermectin is the “safe and effective” miracle cure
for COVID-19 that “they” don’t want you to know about, there must be nefarious 
forces seeking to silence the FLCCC’s two heroic doctors who are only fighting
for their patients. Seriously, I kid you not. You can buy merch on the FLCCC
website with images of Drs. Marik and Kory like these:

Dr. Marik as Superman?

Dr. Kory as Superman?

Seriously, this is a bit too much, even for me, and I’ve seen so many brave
maverick doctors portraying themselves as the heroes in an Ayn Rand novel.

It’s exactly the same narrative that Stanislaw Burzynski has employed for 45
years whenever the FDA or the Texas Medical Board made their feeble efforts to
hold him accountable and that Dr. Rashid Buttar used back in 2008, when he
called the North Carolina Medical Board a “rabid dog” for trying to “silence”
him. It’s the same claim that quacks make about bills designed to strengthen
state medical boards to act when physicians spread dangerous misinformation.

Unfortunately, it’s a very effective ploy. All too many of my colleagues chafe
at any suggestion that they can be told how to practice medicine. Even though
three years of a pandemic that’s killed over one million people in just the US
alone has finally awakened regulatory agencies like state medical boards and
professional societies to the the severity of the problem of doctors using their
professional status to spread misinformation, unfortunately, we as a profession
have a lot of members who either can’t or don’t want to see it as a problem and
for whom the FLCCC’s defense resonates. I suspect that the reason now is
similar to the reasons before the pandemic, involving our dislike of “being told
what to do” and an attitude that any of us could fall victim to a bogus
complaint to a state medical board or specialty board. (Ironically, I myself
have experienced exactly that, when several years ago a patient of Stanislaw
Burzynski reported me to my state medical board for my blog posts about her
case.) I get it. I also get that a lot of my colleagues and I have to make
medical decisions based on less than ideal evidence bases all the time (the
“art” of medicine). Unfortunately, too many of us extrapolate that to justify
what quacks do. Indeed, one mistake in framing that I see from the ABIM and
state medical boards is to emphasize too strongly “spreading misinformation” as 
a reason for action, rather than the quackery. What physicians say will always
draw a “free speech” defense. What they do—i.e., how they treat patients—is a
lot less defensible and more strongly a basis for state medical boards and
specialty boards to take action.

Professionalism, however, is essential to medicine, and one of the elements of
professionalism is not to practice quackery or to recommend quackery, and, if
there’s one thing I’ve observed, it’s that the practice and promotion of
quackery almost always go hand-in-hand. In other words, physicians promoting
medical misinformation (like the FLCCC) rarely just promote medical
misinformation. They almost always practice what they preach, so to speak; i.e.,
practice quackery. After all, FLCCC doesn’t just recommend ivermectin,
hydroxychloroquine, and its various and sundry “early treatment protocols” that 
don’t work, its members use them to treat COVID-19 patients—and are proud that
they do so! It is true that the First Amendment gives physicians like Drs. Marik
and Kory the freedom to say whatever they want about COVID-19 and its
treatment, no matter how quacky, but it doesn’t mean that they can do so without
consequences, which can be loss of board certification when their professional 
speech and actions wander too far outside of what can be justified with science.
Revoking the licenses and board certifications of such physicians is quality
control and consumer/patient protection, not “censorship.” These doctors are
still free to say whatever they want, no matter what the ABIM does.

I only wish that state medical boards would do something that would really make 
a difference: Take away their medical licenses. Yes, I said it, and I meant it: 
Take away their medical licenses.

The Federation of State Medical Boards vs. COVID-19 misinformation: A losing
battle so far

A few weeks ago, the Federation of State Medical Boards, which itself does not
have any regulatory power but advocates for state medical boards, issued a
statement that physicians who spread COVID-19 misinformation should be subject
to disciplinary measures. Unfortunately, a recent report found that not a single
US physician has had action taken against their medical license for doing this.
Why?

David Gorski on August 23, 2021

Link

My last post for 2020 was entitled 2020 and the pandemic: A year of (some)
physicians behaving badly. The reason was simple. The COVID-19 pandemic, which
first hit Wuhan, China in December 2019, was declared a pandemic by the World
Health Organization in March 2020, and shortly thereafter caused mass shutdowns 
and travel restrictions that led some physicians to reveal themselves to be very
bad actors indeed in terms of spreading misinformation, advocating quackery,
and outright grifting. Sure, the usual suspects (several of whom were ultimately
dubbed the “Disinformation Dozen” a few months ago) were involved, which is
exactly what one would expect. After all, what were doctors like Joseph Mercola,
Sherri Tenpenny, Kelly Brogan, and the like going to do during a pandemic
except switch their grift to the coronavirus and COVID-19 vaccines? This was
utterly expected. Years—even decades—before, I had wondered how doctors like
these could keep their state medical licenses.

I will admit, however, to being surprised at just how many doctors who had
previously demonstrated no history of this sort of activity took the opportunity
to dive head first into the COVID-19 misinformation pool. Even worse, as has
been documented here, even some highly respected doctors and academics have
become “COVID contrarians”. They minimize the risk of harm from the coronavirus 
(particularly in children), make risibly off-base predictions (e.g., “we’ll have
herd immunity by April“) and advocate against mask mandates (particularly in
schools) and vaccinating children—or even erroneously claim that respiratory
syncytial virus (RSV) is being misdiagnosed in children as COVID-19 and that
hospitalizations of children are being exaggerated. Worse, when corrected for
their mistakes, they almost never seem to have the humility to admit error and
move on; often they double down and act as though their statements were never
refuted.

I review all this because there’s a topic I’ve been meaning to write about (and 
have written about a bit at my not-so-super-secret other blog) regarding the
lack of professional sanctions against physicians who spread health
misinformation, be it about vaccines, masks, COVID-19, or anything else. Going
back to the case of cancer quacks like Dr. Stanislaw Burzynski, Dr. Rashid
Buttar, and beyond, I’ve long lamented how even the most obvious quacks seem to 
be able to keep their medical licenses and antivaccine doctors (e.g., Dr. Bob
Sears) get off with a slap on the wrist, even when their medical board actually 
investigates. True, there are occasional exceptions, such as Dr. Paul Thomas, a 
rising star in the antivaccine movement whose license was suspended because the 
Oregon Medical Board deemed his antivaccine practices a danger to his patients, 
Dr. Mark Geier, who subjected autistic children to a hormone blocker usually
used in children to treat central precocious puberty, based on the belief that
decreasing testosterone levels would allow the mercury from vaccines to be
chelated easier with his chelation therapy, and “Lyme literate” Dr John Lentz.
Basically, state medical boards seem to be (mostly) toothless when it comes to
intervening to stop such dangerous doctors. This is a topic that I’ve been
meaning to write about, and a few weeks ago the Federation of State Medical
Boards (FSMB) gave me an excuse.

The Federation of State Medical Boards enters the fray

Historically, state medical boards seem to have problems going after outright
quacks, much less physicians spreading dangerous misinformation during a global 
pandemic that has killed more than 600,000 people so far in the US alone. This
is why I was so heartened a few weeks ago to see this statement from the
Federation of State Medical Boards (FSMB), the organization that represents
state medical boards:

   Physicians who generate and spread COVID-19 vaccine misinformation or
   disinformation are risking disciplinary action by state medical boards,
   including the suspension or revocation of their medical license. Due to their
   specialized knowledge and training, licensed physicians possess a high
   degree of public trust and therefore have a powerful platform in society,
   whether they recognize it or not. They also have an ethical and professional 
   responsibility to practice medicine in the best interests of their patients
   and must share information that is factual, scientifically grounded and
   consensus-driven for the betterment of public health. Spreading inaccurate
   COVID-19 vaccine information contradicts that responsibility, threatens to
   further erode public trust in the medical profession and puts all patients at
   risk.

The fact that the FSMB issued such a statement stating that physicians spreading
misinformation and disinformation about COVID-19 risk disciplinary action was a
big deal, at least to me. However, my enthusiasm and approval were tempered by 
my knowledge of how state medical boards actually operate. They are, in general,
underfunded, have inadequate resources, and can only act when they receive a
complaints about specific instances of poor practice or patient injury. Indeed, 
when a state medical board actually does act against an antivaccine physician
(for instance), its penalties are often minimal, as was the case for Dr. Bob
Zajac in Minnesota.

Indeed, I’ve long lamented how rare it is for a state medical board to suspend
or revoke the medical license of outright quacks and how difficult it has been
on the occasions when a state has tried, having written more posts over the
years about this problem, both here and elsewhere. One good example that I like 
to cite (and did cite above but repeat here because I can’t emphasize his
example enough and feel it’s worth expanding on briefly) is cancer quack
Stanislaw Burzynski, who has been practicing his cancer quackery in Houston
since the late 1970s and, despite the occasional attempt of the Texas Medical
Board to put a stop to his activities, has managed to prevail, with only minor
impediments placed on his ability to practice, leading me to lament, “How is it 
that in 2018 cancer Stanislaw Burzynski is still preying on desperate cancer
patients?” I even lumped him together with correspondence school naturopath and 
“pH Miracle Living” quack Robert O. Young as examples of how poorly many states 
regulate medical practice. (Of course, Burzynski practices in Texas, and Young
used to ply his quackery in Florida, two of the worst states for this problem.)

Elsewhere, I’ve discussed the problem before a number of times. The problem is
that state medical boards tend to be reluctant to go after doctors who use
unscientific treatments like “detoxification” and colon cleanses because it
forces them to enforce a standard of care, because such cases are harder to
prove, and because there is so much pushback. State medical boards are generally
good at going after doctors who commit easily identified, clear-cut breaches in
trust, such as substance abuse, defrauding insurance companies, or diddling
patients. When it comes to making judgment calls about doctors practicing
outside of the standard of care, they’re a lot more reluctant to do so. That’s
why the only physician behaviors very likely to result in strong action consists
of running a prescription mill, sexual improprieties with patients, or
practicing while impaired due to abuse of alcohol or illicit substances. It’s a 
matter of resource allocation and prioritization. State medical boards tend to
react primarily to what they perceive to be the most immediately and obviously
dangerous behaviors. Practicing quackery rarely makes the cut, because medical
boards tend to be loathe to make value judgments about medical practice, and
proving quackery is way harder and more resource-intensive than proving that a
doctor is an addict who has been practicing while impaired or has sexually
abused patients.

This applies to even horrible surgeons like Dr. Christopher Duntsch, whose epic 
incompetence in the operating room coupled with alcohol abuse resulted in
multiple “clean kills” and paralyzed patients. He was rare in that his bungled
operations so alarmed colleagues that they actually took the even rarer action
of complaining about him to the Texas Medical Board. Even so, all too often it
took a long time to take down. Ultimately, Dr. Duntsch, who had major substance 
abuse problems in addition to his epic incompetence in the operating room,
finally did lose his medical license and is now serving a life sentence in a
Texas prison for multiple counts of aggravated assault relating to 33 botched
surgeries over two years, including two that resulted in patient death. Indeed, 
Dr. Duntsch’s case was so remarkable that he is now the subject of an eight part
series on Peacock entitled Dr. Death: The Undoctored Story, which I’ve been
meaning to watch:

The good thing about the case of Dr. Duntsch is that doctors as sociopathic as
he are rare. The bad thing about the case is that it took a really long time for
his colleagues (who knew his reputation and had had to try to salvage his
disastrous complications) and the Texas Medical Board to act.

Which brings us to COVID-19 misinformation, which can kill. Are state medical
boards actually doing anything? While it’s true that it has been less than a
month since the FSMB issued its statement, I thought I’d look into this.

“No physicians disciplined for COVID falsehoods”

Earlier this week, a reader made me aware of a story published in MedPage Today 
that looked into the question of whether state medical boards have been
investigating physicians making false COVID-19 claims. Its findings were not
reassuring:

   Despite a national call to sanction doctors who spread COVID-19
   misinformation, a MedPage Today investigation found that not one of 20
   physicians who’ve peddled such falsehoods has been disciplined by their state
   licensing agency for doing so.

   That’s not to say that complaints haven’t been filed, or that investigations 
   haven’t been launched. These elements are confidential in most states,
   including the 10 contacted by MedPage Today who license the physicians.

   But that means physicians who have advanced false COVID information —
   including Simone Gold, MD, JD; Scott Atlas, MD; Joseph Mercola, DO; Lee
   Merritt, MD; Sherri Tenpenny, DO; and Stella Immanuel, MD — are free to
   continue to misinform their patients and the public, even as the Delta
   variant surges.

   “Our statement is a reminder to physicians that words have consequences and
   during a public health emergency like COVID-19, those words can mean life or 
   death for patients,” Joe Knickrehm, vice president of communications for the 
   Federation of State Medical Boards (FSMB), told MedPage Today via email.

Obviously, Dr. Joe Mercola is well-known to readers of this blog, my having
featured him in a post last month describing his copious spreading of online
COVID-19 misinformation. He is what I have long referred to as a quack tycoon,
given that his net worth is north of $100 million, thanks to his online
supplement and quackery sales supported by his website, which has spread
antivaccine misinformation for close to 25 years. As I mentioned before, of
course he pivoted to COVID-19 misinformation and antivaccine fear mongering
targeting the COVID-19 vaccines, including false claims that the flu vaccine
makes you more susceptible to COVID-19, that mRNA-based COVID-19 vaccines are
“gene therapy” that can “permanently alter your DNA”, that the vaccines will
cause global depopulation, and that ivermectin is a miracle cure for COVID-19
whose “suppression” is the “crime of the century.”

I also can’t help but note that the reporters seem not to be aware that Mercola 
recently moved from Illinois to Florida and appears to not be licensed in
Florida. Also, he hasn’t practiced medicine for over a decade, which makes
asking the Illinois Department of Financial and Professional Regulation strike
me as a bit off-target, given that the only thing Mercola would lose if he lost 
his medical license would be prestige. (His ability to grift would remain
intact.) Still, here’s the statement from the story:

   In a statement, the Illinois Department of Financial and Professional
   Regulation said that if the agency “determines a licensee committed
   violations against the Act that regulates their profession, an appropriate
   course of action will be taken. Complaints filed with and investigations
   undertaken by IDFPR are confidential, unless and until a public complaint or 
   discipline is issued by the Department.”

The largest number by far of doctors featured in this story hold medical
licenses in California: Simone Gold, MD, JD; Scott Atlas, MD; Dan Erickson, DO; 
Artin Massihi, MD; Jeffrey Barke, MD; Jennings Ryan Staley, MD; Brian Tyson, MD.
Several of these doctors are familiar. For example, Simone Gold is a prominent 
member of the Frontline COVID-19 Critical Care (FLCCC) Alliance, which has been 
promoting ivermectin as the miracle cure for COVID-19 that “they” don’t want you
to know about. Unsurprisingly, last summer she was promoting hydroxychloroquine
as the miracle cure for COVID-19 that “they” don’t want you to know about.

As for the rest of the doctors in the list, last year around this time Hoover
Institution hack Scott Atlas, a radiologist with no expertise in infectious
disease or epidemiology, rose to become one of Donald Trump’s most trusted
medical advisors regarding the pandemic, even though he was very much for
“natural herd immunity“. Early in the pandemic Dan Erickson and Artin Massihi
published a highly dubious study that tried to estimate the prevalence of
COVID-19. Jeffrey Barke, whom I had never heard of before, has a concierge
practice in Newport Beach and appears to be an antimasker, having published a
book a year ago entitled Covid-19 A Physician’s Take on the Exaggerated Fear of 
the Coronavirus. And then there was this last September:

   His medically unorthodox opinions have become familiar among the voices
   claiming that the coronavirus has been politicized in an effort to damage
   President Donald Trump’s reelection campaign.

   Even despite Barke’s proactive omnipresence on social media, a video he
   posted Sept. 17 managed to create new shock waves – to the point that Hoag
   Hospital, with which Barke has a business relationship, publicly distanced
   itself from him.

   In last week’s video, Barke shares a split-screen with fellow anti-masking
   media star Peggy Hall. “What I do, Peggy, to protect you and to protect
   others when I’m in public – I think better than a mask – this is what I do,” 
   Barke asserts, suddenly brandishing a 9-millimeter handgun.

   “You know, I live in Orange County so I carry this wherever I go,” Barke
   continues, adding that he works for “a local sheriff’s department agency as a
   reserve deputy.”

   The next day, Hoag tweeted that Barke’s “radical views on COVID, masking and 
   hydroxychloroquine” are “diametrically opposite” from the hospital’s.

Well alrighty, then.

Then there’s Jennings Ryan Staley, who has his own mention on the US Department 
of Justice website:

   Dr. Jennings Ryan Staley, previously charged with one count of mail fraud,
   was indicted by a federal grand jury yesterday for additional crimes arising 
   from his business venture selling COVID-19 “treatment kits,” which he
   advertised to one potential customer as a “miracle cure.” Staley is a
   licensed physician and the former operator of Skinny Beach Med Spas in and
   around San Diego.

   According to the new charges, which became publicly available today, Staley
   agreed with a Chinese supplier to smuggle hydroxychloroquine powder into the 
   U.S., lying to U.S. Customs by mislabeling a shipment as “yam extract.”
   Staley is also charged with stealing the name and identifying information of 
   one of his employees in order to create and submit a bogus prescription for
   hydroxychloroquine on the employee’s behalf, in order to sell the drugs at a 
   markup to his customers.

   In late March and early April 2020, Staley marketed and sold his treatment
   kits to Skinny Beach customers. He described his product as a “concierge
   medicine experience,” which included hydroxychloroquine—an anti-malarial drug
   that Staley described to one potential customer as a “guaranteed” cure for
   COVID-19. Staley’s kits were priced as high as $3,995 for a family of four,
   while Staley himself paid roughly $1 per tablet of hydroxychloroquine.
   Staley’s marketing materials, per the indictment, stressed that recipients
   should “NOT BELIEVE THE REPORTS THAT HYDROXYCHLOROQUINE DOESN’T WORK!”

   During a phone call with a prospective customer, in reality an undercover FBI
   agent, Staley repeatedly promised that the drugs he was selling would cure
   COVID-19.

If he’s convicted, this should be a slam dunk, given that most states
automatically revoke the medical license of any physician convicted of a felony,
and another notice states that he pleaded guilty to “one count of importation
contrary to law, admitting that he worked with a Chinese supplier to try to
smuggle into the United States a barrel that he believed contained over 26
pounds of hydroxychloroquine powder by mislabeling it as ‘yam extract.'” (As a
side note, hilariously, this scammer got scammed, given that the shipment turned
out only to contain baking soda.)

Meanwhile, Dr. Brian Tyson appears to be a run-of-the-mill hydroxychloroquine
quack with an outsized social media presence, who is now promoting ivermectin as
part of a “multidrug therapy” for COVID-19:

Personally, I appreciated the FDA’s snark on this. Those of us who have
criticized ivermectin believers acknowledge that, when used for its intended
purpose, it’s a great drug. We just recognize that there’s no good evidence that
it is as much of a “miracle” drug for COVID-19 as it is for river blindness.

I could go on and on through the list, but why bother? Instead, let’s just
sample some of the responses from various state medical boards, starting with
California, given the number of offenders in that state:

   Carlos Villatoro, public information officer for the Medical Board of
   California, said in an email to MedPage Today that “publicly spreading false 
   COVID-19 information may be considered unprofessional conduct and could be
   grounds for disciplinary action. The Board will review complaints it receives
   about its licensees on this topic, as it does with all complaints. To date, 
   no accusation has been filed against a licensee regarding this issue.”

Let’s move on to nearby Idaho:

   Yvonne Dunbar, counsel for the Idaho State Medical Board, told MedPage Today 
   in an email, “Neither the Idaho Medical Practice Act nor the applicable
   administrative rules provide a basis for the Board to discipline licensees
   for statements made during a conference, to the media, or in any other public
   setting.”

   However, she said the board “does have authority to investigate and possibly 
   discipline its licensees for statements or behaviors which transpire in a
   health care setting … if it is established that they: ‘Engag[ed] in a pattern
   of unprofessional or disruptive behavior or interaction in a health care
   setting that interferes with patient care or could reasonably be expected to 
   adversely impact the quality of care rendered to a patient. Such behavior
   does not have to have caused actual patient harm to be considered
   unprofessional or disruptive.'”

Unsurprisingly, many of the docs who promote COVID-19 misinformation on social
media and old school media (TV, newspapers, etc.) often also practice according 
to that misinformation, discouraging masking, demonizing vaccines, promoting
“miracle cures” such as ivermectin and hydroxychloroquine (with zinc, and other 
drugs and supplements, of course!) as part of their treatment protocols.

I can’t resist quoting North Carolina (about, appropriately enough, Rashid
Buttar, who once famously referred to the North Carolina Medical Board as a
“rabid dog“):

   If the North Carolina Medical Board has information that a licensee may be
   spreading false or misleading information about COVID-19, it would
   investigate, said communications director Jean Fisher Brinkley. “Decisions
   about possible regulatory action would be based on the evidence gathered and,
   specifically, whether the Board has evidence that a violation of law or
   professional ethics occurred, a process that is consistent with the FSMB’s
   statement.”

There is a depressing similarity to all the responses, namely either that
medical board of the state where the physician in question practices hasn’t
received any complaints as of yet, that speech alone can’t be penalized, or that
they will “investigate” if there are complaints. When a bunch of readers sent
me a link to the FSMB complaint, I generally responded that I don’t expect much 
to come of it. More recently, I responded to those sending me this MedPage Today
article, “I hate to say I told you so, but I told you so.” But why? Why is
nothing happening?

The First Amendment vs. professional speech

To get an idea of why nothing is happening, I can’t help but point to the
reaction of some physicians to the FSMB statement, starting with the Association
of American Physicians and Surgeons (AAPS), a far right wing medical John Birch
Society camouflaged as a legitimate medical professional society. I’ve written 
about the AAPS a number of times, relating how it’s promoted antivaccine
pseudoscience blaming vaccines for autism, including a view that is extreme even
among antivaccine activists, namely that the “shaken baby syndrome” is a
“misdiagnosis” for vaccine injury. It’s worse than that, though. AAPS has
promoted HIV/AIDS denialism, blamed immigrants for crime and disease, promoted
the pseudoscience claiming that abortion causes breast cancer using some of the 
most execrable “science” ever, and not only rejected evidence-based guidelines
as an unacceptable affront on the godlike autonomy of physicians; the very
concept of a scientific consensus about anything. Let’s just put it this way.
The AAPS has featured publications by antivaccine mercury militia “scientists”
Mark and David Geier and many others. Unsurprisingly, in the age of COVID-19,
the AAPS has seamlessly pivoted to COVID-19 denial, antimask nonsense, and
antivaccine conspiracy theories.

As you might expect, the title of Dr. Tamzin Rosenwasser’s is “The Federation of
State Medical Boards Channels the Soviet NKVD“. (I suppose I should be grateful
that Nazis weren’t mentioned, at least in the title.) After quoting the FSMB
statement, Dr. Rosenwasser goes all anti-Communist, consistent with the AAPS’s
similarity to a medical John Birch Society:

   The FSMB has been described as a “private lobbying organization that
   represents the state’s attorneys who work for medical boards.” It does not by
   itself have the legal authority to take a doctor’s license but is highly
   influential.

   The NKVD, the People’s Commissariat for Internal Affairs, was the Soviet
   secret police agency, the precursor to the KGB.

Unsurprisingly, the editorial goes on to parrot antivaccine misinformation about
the COVID-19 vaccine and COVID-19 in general, continue the author’s confusion
on whether the FSMB are Communists or Nazis, and appeal to “free speech”,
portraying any effort to “censor” misinformation as an unconscionable assault on
free speech. It’s a very appealing argument, at least in the US, where free
speech protections are embedded in the Constitution. Doctors who are antivaccine
and/or promote COVID-19 misinformation often appeal to free speech (and, in the
US, the First Amendment) and portray any attempts by medical licensing bodies, 
whatever the state or country, to discipline them for their activities as
fascistic (or Communist) assaults on “free speech”.

Although there are certainly gray areas, these attacks are deceptive, for the
simple reason that professional speech by a physician licensed by the state is
not the same as some random fool on social media saying the same thing. When
physicians use the imprimatur of authority that society has bestowed on them to 
add the authority of their profession to their misinformation, that is arguably 
an abuse their status as a physician. These physicians spreading COVID-19
misinformation disingenuously ignore the simple fact that, if they were not
physicians, their misleading pontificating about how the vaccine doesn’t work or
is dangerous, how we’ll have “herd immunity by April”, or touting drugs that
don’t work as “miracle cures” for COVID-19 that are being “suppressed” by The
Man would not be taken nearly as seriously by the public.

As part of our professional role as physicians and surgeons we are granted
privileges unknown to non-physicians, including being allowed to ask patients
about their deepest and darkest personal matters, administering potentially
toxic drugs (such as chemotherapy for cancer), or, in the case of surgeons,
removing or rearranging body parts for therapeutic effect using sharp
instruments in a way that would be considered assault and battery if attempted
by a non-surgeon. We are granted these incredible privileges because society has
deemed us worthy after having completed four years of rigorous training in
medical school followed by anywhere from three years to a decade or more of
additional training in residency and fellowship. In the age of COVID-19, the
entire right-wing COVID-19 disinformation ecosystem, of which the AAPS is a
small but influential part on medical matters, will treat any physician whose
license is sanctioned by a state medical board as a free speech martyr. This is 
propaganda, however, not reality, because our professional status makes our
utterances on COVID-19 professional speech that is arguably part of our
profession as physicians, not just an exercise of free speech, and if we abuse
our professional speech, state medical boards should certainly be empowered to
investigate and discipline us.

After all, as a result of the privileges granted us, society also accords our
words on medical matters (and, let’s face it as ridiculous as it might seem, on 
many nonmedical matters too) much more weight than those coming from
nonphysicians. Physicians, in my experience, often both forget about that and
take advantage of it. Again, I like to emphasize that, were these physicians not
physicians, a lot fewer people would give a rodent’s posterior what their
latest take on COVID-19 or vaccines is. In other words, professional speech
misused can have deadly consequences, particularly during a pandemic. Contrary
to Dr. Rowenwasser’s ridiculous comparison to the repression carried out by the 
NKVD and appeal to the Nuremberg Code, it is entirely appropriate for the FSMB
to recommend going after the medical license of—or otherwise disciplining—any
physician promoting obvious COVID-19 and antivaccine misinformation and
conspiracy theories. That is not suppression of free speech. That is
professional oversight.

Advocates for science- and evidence-based medicine cannot help but be appalled
at how easily physicians practicing modalities that are clearly so far outside
the standard of care that they might as well be in another galaxy can continue
to do so with little or no oversight or even interference by state medical
boards. In essence, it takes mind-numbingly egregious offenses to motivate a
board to act, be it substance abuse by a physician resulting in obvious
impairment, non-science-based treatments resulting in the death or severe injury
of a patient, or blatantly illegal behavior, such as running a narcotic
prescription mill. Part of the problem is that the attitude among doctors seems 
to be that a medical license is a right, rather than what it really is: an
incredible privilege bestowed upon us physicians and surgeons by society that
takes an equally incredible commitment and skill to be allowed to continue to
keep. That same attitude among physicians also seems to lead them to think that 
they should be able to say anything they want about the pandemic, even though
their words are arguably professional speech (particularly given how many “COVID
contrarian” doctors use their status either to sell a product or to sell
themselves as “experts”).

Our patients deserve better. The vast majority of physicians are competent and
try their best to deliver the best evidence-based care they can to their
patients. However, doctors who consistently do not practice according to the
standard of care, be it because they are incompetent, dishonest, impaired by
substance abuse, or because they have come to believe in blatantly unscientific 
treatments that do not help and not infrequently harm patients, do not deserve
to be physicians. The same is true of physicians who abuse their status in order
to peddle misinformation about a virus causing a pandemic that has killed over 
600,000 in the US alone and millions worldwide—and is still sickening and
killing people at unacceptably high rates. I’m glad the FSMB said something
about revoking the licenses of physicians who spread misinformation, but I fear 
that in practice implementing such a policy will be well-nigh impossible.

The Ohio State Medical Board has finally suspended the medical license of
antivax quack Sherri Tenpenny

Last week, the Ohio State Medical Board suspended the medical license of Dr.
Sherri Tenpenny, a longtime antivax quack. The only question is: What took them 
so long, and why did it take the pandemic for them to act? Also, is there less
to this action than meets the eye?

David Gorski on August 14, 2023

Link



It always seems to happen whenever I’m on vacation. Last week, while I was
trying to relax at home and take care of some household business that work
always seems to interfere with, I got the news that the Ohio State Medical Board
had finally suspended the license of Dr. Sherri Tenpenny, a notorious antivax
quack practicing in the suburbs of Cleveland whose misinformation and quackery
I’ve been discussing intermittently here dating back to 2011 and whom I had been
discussing on my not-so-secret other blog since 2009, although I had mentioned 
her going back to at least 2007. Most people who have heard of Dr. Tenpenny
learned of her in 2021, when she became infamous for claiming that COVID-19
vaccines cause people to become magnetized:

   Two years ago, a Cleveland area physician strode into the House Health
   Committee room and told state lawmakers that COVID-19 vaccines magnetize
   their hosts and “interface” with cell towers.

   Her comments, the subject of widespread ridicule, triggered a swarm of 350
   complaints to the State Medical Board and a chain of events that led to the
   regulators indefinitely suspending the medical license Wednesday of
   anti-vaccine activist Sherri Tenpenny.

The term “chain of events” is important. The reason that the Board suspended Dr.
Tenpenny’s medical license actually has little to do with her decades-long
practice of rank quackery and promotion of antivaccine misinformation and more
to do with procedural issues:

   The board, charged with protecting the public and overseeing the licensure of
   Ohio’s doctors, yanked Tenpenny’s license on procedural grounds rather than 
   the substance of her comments. Board staff found she flouted investigators
   who came to visit, declined to answer written questions, and objected
   wholesale to the regulators’ inquiry.

   “Dr. Tenpenny, neither you nor any doctor licensed by this board is above the
   law, and you must comply with the investigation,” said Dr. Jonathan Feibel, 
   an orthopedic surgeon and medical board member. “You have not done so, and
   therefore, until you do, your license will be suspended.”

   Dr. Amol Soin, a pain management specialist and board member, said at the
   hearing that the suspension has nothing to do with vaccines, magnets, or cell
   towers, but about the board’s basic duty to oversee conduct of physicians
   and physicians’ responsibility to comply.

   “The license to practice medicine is not a right. It’s a privilege. A
   privilege that is earned, and a privilege that you have to uphold,” he said. 
   “And as you get that license, and as you obtain that privilege, you consent
   to certain reasonable things. And a reasonable thing you consent to… is to
   cooperate when someone complains about you. In this case, 350 complaints. It 
   is a very reasonable thing to cooperate in that scenario.”

Let me just say that I do like the statement about medical licenses being a
privilege, not a right. As a result of our education and training, society and
the state grant us physicians the privilege of practicing medicine, a privilege 
that, in my case as a surgeon, allows me to commit what under other
circumstances might be called assault and battery with the use of sharp
instruments to remover or rearrange parts of a human being’s anatomy in order to
treat cancer and other disease. It allows oncologists to administer toxic
substances to treat disease. It lets us legally ask the deepest and most
intimate questions about patients and their lives, all in order to diagnose and 
treat them. Too many of my colleagues forget what a privilege it is to be given 
these powers and come to treat their medical license more as a right than a
privilege, a viewpoint that, unfortunately, seemingly informs the law of some
states, allowing utter quacks to continue to practice, mostly unmolested by
their state medical boards. (Yes, I’m talking about Texas, but not just about
Texas.)

As I wrote in 2010:

   If there’s one area that SBM needs to do better in, it’s regulating our own. 
   To me, the license to practice medicine is a privilege, not a right. That I
   should even have to emphasize such a statement is bothersome to me, but all
   too often medical licenses, once obtained, seem to be treated as a right that
   can’t easily be taken away. That’s not to say that actually getting to the
   point of being licensed and board-certified isn’t difficult. It is. There’s
   the need to maintain excellent grades in college, after which there’s medical
   school and residency, both of which can be quite brutal. But once a
   physician is fully trained, board certified, and licensed, it seems that
   medical boards bend over backwards not to take away his license, seemingly
   even if he’s providing treatments so far outside the standard of care that
   they might as well be magic.

That brings me to what I’ve been emphasizing the last couple of weeks here on
SBM. Even if you have a problem with state medical boards or medical specialty
boards sanctioning physicians for promoting dangerous health misinformation, you
should have no problem with them sanctioning physicians who practice rank
quackery, as Dr. Tenpenny did. I’ll have more to say on this later, but I
thought that the case of Dr. Sherri Tenpenny would be worth discussing, if only 
to show how long before the pandemic she had been antivax, as well as to vent a 
little of my frustration over how it wasn’t her quackery that got her license
suspended but rather her refusal to cooperate with the Board’s investigation.

Dr. Tenpenny before the pandemic

As I said, I first mentioned Dr. Tenpenny in 2007, but I never really did a post
that was primarily about her until 2009. Also, the suspension of her medical
license last week reminded me that, compared to the likes of, for example,
Andrew Wakefield—or even Dr. Bob Sears—I haven’t written that much about her
over the years. Granted, she wasn’t a top tier antivax doc like Wakefield or
Sears or a number of the others about whom I routinely wrote (and sometimes
ranted) before the pandemic. She was second-tier. However, that doesn’t mean
that she was unimportant in the antivaccine movement. Indeed, she was important 
enough to be featured on a conspiracy cruise alongside Wakefield in 2016. Or
maybe that they were featured together on such a cruise was evidence of how far 
Wakefield had fallen by that time. I can be persuaded either way.

So who is Dr. Tenpenny? As I said, she’s been around for a long time and has
practiced antivax quackery quite a while. I always find it useful to check out a
quack’s website to see what the quack thinks of herself; so here is the
description from Tenpenny’s website:

   Dr. Sherri J. Tenpenny is an osteopathic medical doctor, board certified in
   osteopathic medicine, with a proficiency certification in Integrative
   Medicine. She was board certified in Emergency medicine from 1986 to 1998,
   when worked as a full-time Emergency Medicine physician and served as
   Director of a Level II Trauma center.

   The founder of Tenpenny Integrative Medical Center, a clinic located near
   Cleveland, Ohio, her clinic provides natural, holistic approaches to getting 
   well. Their success has attracted patients from all 50 states and at least 17
   countries.

   Dr. Tenpenny has invested 21+ years and far more than 40,000 hours
   researching, documenting, and exposing problems associated with vaccines. She
   is a frequent speaker at national and international conferences and a
   regular guest on radio shows, podcasts and on TV, sharing her highly
   researched information on why we should just say no to vaccines.

It is utterly unsurprising that Tenpenny is “certified” in Integrative Medicine,
what I like to refer to as a medical pseudospecialty that is based on
“integrating” quackery with medicine. I also like her claim to have spent 40,000
hours “researching, documenting, and exposing problems associated with
vaccines”. Does anyone ever bother to do simple division. Divide 40,000 hours by
24 hours/day, and you get just shy of 1,667 days (or 4.6 years) if you assume
that she’s working 24 hours a day, 7 days a week. That is, of course, totally
unrealistic. Let’s say that she was working 8 hours/day, and then that becomes
5,000 days (or 13.7 years), but that’s still unrealistic. No one works 7 days a 
week full time for that long. In any case, you get the idea. Her claim of having
spent 40,000 hours “researching, documenting, and exposing problems associated 
with vaccines” is such an exaggeration that it is utter BS.

Perusing her website, I saw once again that Tenpenny offers a variety of
evidence-free quack “detox” protocols. She touts one of them thusly:

   You’ve probably heard me say this countless times, almost all disease is a
   result of two things: Excess of toxicity and a lack of nutrients, especially 
   minerals. Mercury, aluminum, vaccine-related chemicals, and environmental
   poisons including arsenic, lead, cadmium, pesticides, and volatile organic
   compounds are just some of what we are exposed to every day. Imagine the
   damaging effects of heavy metals when they are injected into our bodies
   through vaccines?

This is, of course, a common trope shared among “integrative medicine” quacks
and antivax doctors, that “almost all disease” (at least she qualified it with
an “almost,” something not all such docs do) is due to “toxicity” or bad diet,
with—of course!—vaccines near the top of the sources of the “toxicity,” along
with pesticides and chemicals. So what is her solution? Zeolite (which, by the
way, cures cancer—that is, if you believe some of its proponents going back
decades). But not just any Zeolite. Oh, no. To her, “most zeolite products do
not work” because:

   To most from the gut and into cells, the zeolite must be nanosized and
   suspended in water molecule clusters. With that formation, this natural
   detoxifier can travel throughout the body and even cross the blood-brain
   barrier. You can start to see why this is important for those who want to
   detox from vaccines.

Actually, I can’t, but that’s because I practice science-based medicine.

Tenpenny claims that you have to use her preferred Zeolite, Clinoptilolite
Zeolite (whatever that is), which, conveniently enough, she sells on her
website:

   After doing extensive research, I discovered Pure Body Extra Strength
   manufactured and distributed by a company called Touchstone Essentials. They 
   use a cleansing and nanosizing technology that is hands-down the most
   advanced on the market. The particles that are contaminating the zeolite are 
   removed and the zeolite honey-comb is filled with alkalizing minerals. That
   way, the zeolite “swaps out” a beneficial mineral for a toxin it absorbs. The
   amount removed has been confirmed by a third-party independent laboratory.

Even better (if you believe Tenpenny):

   Nanometer-sized particles can get into cells and can “mop up” toxins within
   hours of administration. And because this form of zeolite is encapsulated
   within water molecule clusters, it can be administered as a liquid spray.
   That makes it easy to use: just take a few sprays, morning, noon, and night. 
   There is no odor, no taste, and no hassle.

So. Much. Water. Woo. (Plus Zeolite detox woo.) She’s also recommending
Nattokinase-based quackery, which I discussed not too long ago. I’m sure she
gets no kickbacks for selling this Zeolite and offers it only out the goodness
of her heart, for the good of her patients. Of course she is. She also
recommends a “parasite protocol” by Dr. Jason Dean. Unsurprisingly, “Dr.” Jason 
Dean is a chiropractor, not a real medical doctor. Meanwhile, on Amazon, you can
find books by her that indicate that she has been rabidly antivax for a long,
books with titles like Vaccines: The Risks, the Benefits, the Choices, a
Resource Guide for Parents (2006) and Saying No to Vaccines: A Resource Guide
for All Ages (2008).

You get the idea. But what about her antivax advocacy? First, let me quote
something that she wrote in 2007, and ask yourself whether it sounds familiar or
not:

   At the beginnings of ‘Public Health’ policy, efforts were made to convince
   persons to participate through cooperation. Since that late 1960s, the
   pendulum has swung from education and collaboration to heavy handed coercion 
   through advertisement campaigns designed to shame and terrorize parents into 
   believing the are neglecting their children by questioning, and at times
   refusing, vaccines. The current example of heavy handedly slapping of parents
   into “compliance” is a further example of how far our freedoms have eroded. 
   While we drop bombs and fire bullets around the world to ensure the freedom
   of others, we are incarcerating parents for doing what they believe is in the
   best interest of their children. Wake up, Americans. What will they be
   incarcerating us for next in the name of compliance?

Antivaxxers are nothing if not unchangingly consistent in their messaging. I
also can’t help but point out the consistency of the “Nuremberg” messaging among
antivaxxers, because that post reminded me that the Association of American
Physicians and Surgeons (AAPS), a fake medical society that I’ve been referring 
to as a medical John Birch Society since at least 2008, liked to use Nuremberg
comparisons about “informed consent” in 2007 (and likely for a long time before 
that):

   WHEREAS: Safety testing of many vaccines is limited and the data are
   unavailable for independent scrutiny, so that mass vaccination is equivalent 
   to human experimentation and subject to the Nuremberg Code, which requires
   voluntary informed consent; and

   WHEREAS: The process of approving and “recommending” vaccines is tainted with
   conflicts of interest;

   BE IT THEREFORE RESOLVED: That AAPS calls for a moratorium on vaccine
   mandates and for physicians to insist upon truly informed consent for the use
   of vaccines.

Truly, everything old is new again. But back to Sherri Tenpenny.

Does anyone remember what Tenpenny did in 2019, a few months before the
pandemic, in the midst of a deadly measles outbreak in Samoa that had killed
dozens of children? I frequently refer to what Robert F. Kennedy, Jr. did during
that outbreak, namely how he wrote to the Prime Minister of Samoa blaming the
MMR vaccine for the outbreak, rather than the dramatic decline in MMR uptake
that resulted because of a tragic error by two nurses mixing up the vaccine that
caused the deaths of two infants and how he and other antivaxxers swooped in to
fear monger about the MMR as children were dying. Well, Tenpenny was one of the
antivaxxers who swooped in, when she claimed that the outbreak had been related
to the delivery of over 100,000 doses of MMR to Samoa. She and Grundvig also
trotted out the old antivax trope about measles being curable with vitamin A.

Nor was this the first time that Tenpenny had spread antivax misinformation in
an underdeveloped country during an outbreak of a vaccine-preventable disease
that was killing children. Ten years before the deadly measles outbreak in
Samoa, Tenpenny did basically the same thing when children were dying of measles
in Zimbabwe. In response to reports that 30 children had died of the measles in
Zimbabwe at that point, Tenpenny wrote something that will likely sound very
familiar today:

   Study these numbers. We’ve had SARS, Bird flu and Swine flu. On average,
   approx. 190 children/year die from the flu. Considering there are about 62M
   kids under the 14 years of age in the US, this is NOT “statistically
   signficant” [sic] and should not even make the radar screen. See how they
   manipulate parents into vaccinations?

   Next year, PLEASE do not be afraid of the flu. Ever person here should pass
   this on to at least 25 people! Please pass this to at least 25 friends.

That’s right. To her 190 dead children were not “statistically significant,” and
she was using that number to downplay the deaths of children from measles. As I
asked at the time, can you imagine how Tenpenny and her ilk would descend upon 
me if I said that one case in a million of severe adverse reactions to
vaccination is “statistically insignificant”? (I’ve never said that, of course.)
Tenpenny would howl with outrage at my “insensitivity” and “callousness.” Note 
also how this very message has been increasingly echoed by “respectable”
physicians like Dr. Vinay Prasad about COVID-19, that it kills an
“insignificant” number of children. The message is the same; only the disease is
different. Also, 190 children dying of any one cause is a lot! Children aren’t 
supposed to die.

In case you’re wondering what other quackery she practices, just take a look at 
her Substack post about the Board hearing, in which she bemoans the Board’s
decision and lists what existing patients should do, which is to keep their
appointments and be seen by one of Dr. Tenpenny’s minions working at her
“integrative medicine” practice:

   If you are an existing or future patient at Tenpenny Integrative Medical
   Center (we’ve had patients from all 50 states and more than 18 countries),
   please continue with your appointments for with my team:

  1. SRT for allergies. Due for an annual tune up? Call today!

  2. Bio-identical hormones evaluation/treatment – ask for Sandi or Dr. Clapper

  3. Nutritional evaluation and supplement program – the entire team!

  4. Pain relief with mannitol injections – Carla can treat you

  5. Neuropathy relief wit Neurogenix – Mike knows all about this

  6. Nutritional IVs – we have many – ask Danielle and Laura

  7. Care of your unvaccinated children – ask Dr Jackson. She is trained in cranial
    manipulation for your babies who have crossed eyes or are struggling to
    nurse.

Regular readers of this blog will note that we have described how cranial
manipulation/craniosacral therapy is utter quackery (even more so when inflicted
upon infants); so are nutritional intravenous infusions and SRT for allergies, 
while the rest are, at best, unproven. SRT, in case you didn’t know, stands for 
Sensitivity Reduction Therapy for allergy elimination. Here’s a description of
what it entails:

   While you are in contact with the allergen, a series of acupuncture points
   along the spinal column are activated through pressure to open the energy
   channels connected to the central nervous system. A series of specific
   acupuncture points on the arms and legs are stimulated to open all the
   meridians flowing through the body. You will be asked to rest quietly on the 
   treatment table while holding the allergen for 15 minutes as part of the
   treatment. After your treatment, you will be asked to maintain a strict
   avoidance of that allergen for 3 hours. In addition, you will be told to
   avoid all food and beverage for 3 hours after the treatment. Water is
   generally allowed. Be sure to eat prior to each appointment. Each session
   lasts about 30 min.

   The actual treatment is painless and seems simple. However, it is EXTREMELY
   powerful and effective. There will be changes that affect your entire body’s 
   physiology. Side effects include body aches, headaches, sweating, and nausea.
   Even though these reactions are uncommon, if they persist more than 48
   hours, be sure to call the office for instructions.

You read that right. SRT, which apparently was invented by Dr. Tenpenny,
involves the patient holding the allergen—not a good idea if the patient’s
allergic reaction goes beyond hives and into, for example, anaphylaxis—while the
practitioner applies acupressure to acupuncture points. Given that acupuncture 
is mystical, prescientific nonsense whose history has been hopelessly retconned 
to portray it as “ancient wisdom”, SRT strikes me as not just quackery, but
potentially dangerous quackery.

It thus appears that, while her license is suspended (for however long that is),
Dr. Tenpenny will do just fine with income from her integrative medicine
practice. Moreover, the rest of the Substack entry asks for donations to her
legal fund, podcast subscriptions (which, she notes, “will become an important
part of my income too”), and other offerings. As is often the case for doctors
like this, it is likely that Dr. Tenpenny will continue to do just fine
financially. She might even prosper more as the latest “free speech martyr” and 
“brave maverick doctor” being subjected to “persecution”.

Sherri Tenpenny: Quackery meets hubris

Sherri Tenpenny has a history of antivaccine beliefs and practicing a wide
variety of quackery dating back to late last millennium; yet it took her making 
bonkers statements about COVID-19 vaccines magnetizing people and interacting
with 5G cell phone signals before the board actually tried to do anything.
Before that, apparently, she had been practicing more or less untouched by the
Ohio State Medical Board, selling her Zeolite quackery, refusing to vaccinate,
and practicing all manner of “integrative medicine” quackery in a quiet
Cleveland suburb. As I argued when I discussed the toothlessness of state
medical boards and the faltering attempts of medical specialty boards to deal
with physicians who spew misinformation, it is rare for advocacy of dangerous
health and antivax misinformation not to be coupled with the actual practice of 
quackery based on that misinformation. The two almost always go hand-in-hand.
For those who are uncomfortable with medical boards sanctioning physicians for
speech—even though I would counter that it is not censorship but rather quality 
control to provide consequences for physicians who endanger public health with
deadly misinformation—then surely advocates of science-based medicine who are
uneasy about the conflict between the First Amendment and sanctioning physicians
for spreading misinformation can get behind sanctioning physicians like
Tenpenny for practicing quackery.

Unfortunately, we never got the test, because hubris carried the day, with
Tenpenny, apparently under the instructions of her lawyer Thomas Renz, decided
to stonewall and refuse to cooperate. I have the PDF of the medical board’s
letter describing its actions, and the description of the stonewalling is truly 
amazing. It documents multiple attempts by Jason Alameda, a Board Enforcement
Investigator, to contact Dr. Tenpenny and then:

   On September 7, 2021, Ms. Pastrick mailed to Dr. Tenpenny the Board’s First
   Set of Interrogatories (“Interrogatories”). The Interrogatories were mailed
   to Dr. Tenpenny’s address of record by certified mail. (St. Ex. 2 at 2-24; St
   Ex. 9; Tr. at 18) Tracking information from the United States Postal
   Services shows that the Interrogatories were delivered on September 9, 2021. 
   (St. Ex. 2 at 25-26) The Interrogatories asked for information regarding Dr. 
   Tenpenny’s practice in general as well as asking specifically about her
   practice regarding recommendations concerning, and administration of,
   vaccines and whether any of her patients subsequently contracted certain
   illnesses. The Interrogatories also specifically ask how many doses of
   COVID-19 vaccines she had provided and whether she had personally received a 
   COVID-19 vaccine. (St. Ex. 2 at 7-16) The Interrogatories also asked Dr.
   Tenpenny what scientific evidence she had, and specifically asked that she
   cite her sources for this evidence, regarding COVID-19 vaccines causing
   people to become magnetized or creating an interface with 5G towers;
   regarding the COVID-19 vaccine not injecting a real virus but strips of
   genetic material and patients suffering complications such as abnormal
   bleedings, myocarditis, strokes, and neurological complications; and
   regarding some major metropolitan areas liquifying dead bodies and pouring
   them into the water supply. (St. Ex. 2 at 18-19) Dr. Tenpenny’s responses to 
   the Interrogatories were due by October 8, 2021. (St. Ex. 2 at 2-3)

Renz, however, responded:

   In a letter dated September 20, 2021, Thomas Renz, Esq., of Renz Law, LLC.,
   the only licensed attorney who signed the letter3, objected to the
   Interrogatories in their entirety, as well as an August 11, 2021 letter from 
   the Board regarding a method of investigation into a potential violation of
   R.C. 4731.22 which is not part of the Notice. (St. Ex. 3) While much of the
   letter addresses an issue which is not the subject of the current case, as to
   the Interrogatories, Mr. Renz, wrote, “The September 7th Interrogatories are
   invasive, irrelevant to any inquiry into (St. Ex. 3 at 3) Mr. Renz further
   wrote that Dr. Tenpenny would not respond to the Interrogatories and asserted
   that “[d]eclining to cooperate in the Board’s bad faith and unjustified
   assault on her licensure, livelihood, and constitutional rights cannot be
   construed as an admission of any allegations against her.” (St. Ex. 3 at 3)
   Mr. Renz also wrote that most of Dr. Tenpenny’s statements which were quoted 
   in the August 11, 2021 letter4 were “based on factual reports by third
   parties – including peer-reviewed studies published in mainstream medical
   journals.” (St. Ex. 3 at 2)

The letter also noted that Tenpenny and Renz had been informed that things
could…escalate…if Tenpenny didn’t respond, up to being subpoenaed to testify and
even having her license suspended:

   Please be advised that you are required by law to cooperate in an
   investigation conducted by the Board. Failure to appear for the office
   conference as scheduled may result in the issuance of a subpoena to compel
   your appearance at a deposition. Further, failure to cooperate in the Board’s
   investigation, including failure to appear and/or failure to answer
   questions truthfully at the office conference, constitutes legal grounds for 
   discipline that may potentially result in the denial, suspension, or
   revocation of your license to practice, as well as a civil penalty up to
   $20,000.00.

Unsurprisingly, when the Board did as it had warned and upped the ante by
subpoenaing Dr. Tenpenny, Renz responded:

   By letter dated October 31, 2021, Mr. Renz5 wrote, “. . . Dr. Tenpenny is in 
   no way obligated to and will not cooperate in the Board’s bad faith and
   unjustified assaults on her licensure, livelihood, and constitutional
   rights.” (St. Ex. 5 at 1) Mr. Renz incorporated the claims and defenses made 
   in his September 20, 2021 letter and made several additional legal arguments.
   He argued that there were no legal grounds for the Board’s investigation as 
   the Board had not presented the basis to Dr. Tenpenny, and he cited to R.C.
   4731.22(F)(1)6. Mr. Renz also argued that Dr. Tenpenny, as a party at a
   hearing, was entitled pursuant to R.C. 119.13 to have an attorney represent
   her and to have that attorney cross-examine witnesses7 and that the Board was
   attempting to mislead her on her rights by citing to R.C. 9.84 in its letter
   accompanying the subpoena8. (St. Ex. 5 at 1-2) Mr. Renz also alleged bad
   faith on the part of the Board:

   Bad faith is evident by your failure to present evidence that our client
   violated a provision of Chapter 4731, your erroneous and misleading citation 
   to R.C. § 9.84 regarding her right to counsel, your failure to communicate
   directly with our law firm regarding this subpoena, and your complete lack of
   any grounds whatsoever for continuing to harass Dr. Tenpenny.

   (St. Ex. 5 at 2)

   In addition, Mr. Renz wrote: For the foregoing reasons, the October 12, 2021,
   subpoena is demonstrably unlawful and unenforceable and, therefore, Dr.
   Tenpenny will not participate in the Board’s ongoing illegal fishing
   expedition. Declining to cooperate in the Board’s bad faith and unjustified
   assault on her licensure, livelihood, and constitutional rights cannot be
   construed as an admission of any allegations against her.

   Mr. Renz also wrote that further attempts to enforce the subpoena or obtain
   responses to the Interrogatories would result in a filing requesting
   declaratory and injunctive relief as well as any other available remedies.
   (St. Ex. 5 at 3)

First, note how Renz, invoking the sort of attitude that I decry, namely the
idea that a medical license is a right and not a privilege and couching his
response all in the language of rights. Even so, it is the height of hubris to
refuse to cooperate or answer legitimate legal demands of the State Medical
Board. To be honest, one could argue that Renz was not doing his client any
service in choosing this tactic, which he surely must have known would have a
high likelihood of ending up with the board suspending his client’s medical
license. I could be wrong, but I can only speculate that he did this precisely
because he knew that this would be the likely end result and that such a
suspension would allow him to portray his client as the “persecuted” victim of
medical board overreach and “censorship.” If that’s true, I can only further
speculate that such a tactic would be a last resort, something to invoke when
you know that, after an investigation, the board would likely still suspend his 
client’s medical license. My only question is whether Tenpenny understood this
and agreed to this hardball tactic, which the board dismissed thusly:

   As to Dr. Tenpenny’s claims that the Board was attempting to investigate
   statements which were public and/or political speech and therefore protected 
   by the First Amendment to the U.S. Constitution, Dr. Tenpenny has not
   provided sufficient evidence of what those statements were in order to enable
   a determination to be made of whether such statements were protected speech.
   Further, there is insufficient evidence to show that the Board’s
   investigation was initiated due to any protected speech.

Unfortunately, in the latter part of the letter, a lot is redacted, which I find
curious given that the investigation was the result of 350 complaints based on 
her public statements and not, apparently, individual patient complaints, where 
one would expect private information to be protected from public view. In any
event, I note that this suspension is not necessarily permanent. The Board’s
letter instructs Tenpenny and Renz:

   CONDITIONS FOR REINSTATEMENT OR RESTORATION: The Board shall not consider
   reinstatement or restoration of Dr. Tenpenny’s license to practice
   osteopathic medicine and surgery until all of the following conditions have
   been met:

  1. Application for Reinstatement or Restoration: Dr. Tenpenny shall submit an
    application for reinstatement or restoration, accompanied by appropriate
    fees, if any.

  2. Payment of Fine: Dr. Tenpenny shall have fully paid the fine as set forth in
    Paragraph B of this Order. In the Matter of Sherri J. Tenpenny, D.O. Page 17
    Case No. 22-CRF-0168

  3. Certification of Cooperation with Board Investigation: Dr. Tenpenny shall
    submit a written statement from the Board’s Enforcement Division that Dr.
    Tenpenny has fully complied with all subpoenas and interrogatories issued to
    her by the Board.

  4. Additional Evidence of Fitness To Resume Practice: In the event that Dr.
    Tenpenny has not been engaged in the active practice of osteopathic medicine
    and surgery for a period in excess of two years prior to application for
    reinstatement or restoration, the Board may exercise its discretion under
    Section 4731.222, Ohio Revised Code, to require additional evidence of her
    fitness to resume practice.

So, basically, what it sounds to me is that all Dr. Tenpenny has to do to get
her license back is to submit an application for reinstatement (plus fees),
promise to start cooperating with the Board, and pay her fines. Granted, the
Board will continue to investigate and there’s no guarantee that she would not
still have her license suspended, perhaps permanently, after the investigation, 
but I’m less optimistic. After all, this blog’s history is littered with reports
of utter quacks being disciplined by their state medical boards with, in
essence, slaps on the wrist involving fines plus mandated education and
supervision of their practices by the board for a specified period, which is
what happened in the case of Stanislaw Burzynski, a cancer quack who had been
practicing his quackery since the late 1970s.

In the end, this result is, as is too often the case, unsatisfying. As a friend 
suggested to me, we should take the “win” here (viewing this as a win), and
certainly it is a good thing that Dr. Tenpenny can no longer practice medicine. 
Unfortunately, if she decides to start cooperating with the Ohio State Medical
Board, she could well have her license reinstated while the investigation is
ongoing, and the ultimate penalty might be of the “slap on the wrist” variety
that I described above—or even nothing at all. In the meantime, she will be
portrayed as a free speech martyr, a “medical maverick” that “They” had to
“cancel” or “silence”. At least she won’t be able to inflict her quackery on
patients anymore for the foreseeable future. Given her decades-long history of
doing just that, I guess that I, too, reluctantly view the outcome of this case 
thus far as a “win”

State medical boards vs. COVID-19 misinformation, an update

The disinformation epidemic about COVID-19 has pushed state medical boards to
consider disciplining physicians who promote COVID-19 disinformation. How would 
that work? What are the obstacles? Is it even possible? It should be, but it
will be messy and complicated.

David Gorski on September 27, 2021

Link



A little over a month ago, I wrote about how the Federation of State Medical
Boards (FSMB) had recently issued a statement asserting that physicians who
spread COVID-19 misinformation should be subject to disciplinary measures by
their state medical boards up to and including revocation of their medical
licenses. Given that there have been some developments on that front since then,
I thought that now would be a good time for an update and a bit more discussion
on the general issue of what should be done about physicians who promote
misinformation not just about COVID-19 and COVID-19 vaccines, but medical
misinformation, antivaccine conspiracy theories, and pseudoscience in general.
At the time of my original post, I expressed major skepticism that the FSMB’s
statement would result in any action. The situation is perhaps not as bad as I
had predicted then, but it’s also not so great, either.

In that post a month ago, I started by pointing out how many physicians had been
behaving badly since the pandemic began 18 months ago. That was just in 2020.
In 2021, the prominence (and, I fear, number) of physicians promoting health
misinformation has only increased. In addition to the usual suspects jumping
onto the COVID-19 misinformation grift train (several of whom were ultimately
dubbed the “Disinformation Dozen“), there were academics who really should know 
better downplaying the pandemic and doubting the effectiveness of vaccines. Our 
very own Jonathan Howard even went so far as to point out how some of them have 
gotten to the point where, even though we know they are not antivaccine, their
bloviations need to be fact-checked as though they were antivaccine. Again, it
was no surprise that the usual suspects have been promoting COVID-19
misinformation. Grifters gonna grift, as I like to say, and COVID-19 was an
unprecedented opportunity for physicians like Joseph Mercola, Sherri Tenpenny,
Kelly Brogan, and the other usual quacks to pivot and switch their grift to the 
coronavirus and COVID-19 vaccines.

If it had only been the usual quacks and grifters who had jumped on the COVID-19
misinformation fraud train, possibly the situation now with respect to COVID-19
misinformation wouldn’t have deteriorated so much. After all, in contrast to
the academics who have turned COVID-19 contrarian, the usual quacks and grifters
are at best fringe figures with little influence outside their usual echo
chambers. So let’s briefly review some of the messages being promoted by
physicians who were once respected doctors and academics who have become what
Dr. Howard and I like to call “COVID contrarians”. They minimize the risk of
harm from the coronavirus (particularly in children), make risibly off-base
predictions (e.g., “we’ll have herd immunity by April“) and advocate against
mask mandates (particularly in schools) and vaccinating children—or even
erroneously claim that respiratory syncytial virus (RSV) is being misdiagnosed
in children as COVID-19 and that hospitalizations of children are being
exaggerated. During the recent discussion over myocarditis in children
associated with COVID-19 vaccination, none of them seem to be able to
acknowledge that COVID-19 actually harms children, while one physician whom I
used to respect whose results I used to write about on a regular basis has gone 
down the rabbit hole of conspiracy theories, repeating a particularly pernicious
one dating back to early in the pandemic that early intubation of COVID-19
patients was killing them. That physician, Dr. John Ioannidis, even went to far 
as to say that doctors, “not knowing how to use mechanical ventilation, just
going crazy, and intubating people who did not have to be intubated”. (Spoken
like a doc who has never taken care of critically ill patients in an ICU!) And
don’t even get me started on the physicians who wrote and signed on to the Great
Barrington Declaration, the pre-vaccine statement that advocated letting
COVID-19 rip through the “healthy” young community and using “focused
protection” to keep the elderly and those at high risk of severe disease and
death safe from the coronavirus.

Worse, when corrected for their mistakes, these “COVID contrarians” almost never
seem to have the humility to admit error and move on; often they double down
and act as though their statements were never refuted. Indeed, they often
characterize criticism as “cancel culture” and loudly claim victim status
whenever their efforts encounter serious pushback. We’ve recently seen an
excellent example of just that from our recent discussions of the VAERS analysis
looking at myocarditis after COVID-19 vaccination in teens by Tracy Beth Høeg, 
John Mandrola, Josh Stevenson, and Allison Krug that utterly misused the VAERS
database and didn’t put the findings into context. Predictably, they and their
defenders are crying “Persecution!” and blaming the blowback on “medical
tribalism“. So what’s new?

The medical boards in Mississippi and Washington weigh in

On Friday, I was made aware of this news story out of Washington, which reported
that the Washington Medical Commission can now discipline doctors who spread
COVID-19 misinformation:

   Doctors and physician’s assistants who spread misinformation about COVID-19
   in Washington could face disciplinary measures. That’s after action taken
   this week by the Washington Medical Commission, which monitors and enforces
   licenses of about 34,000 physicians and physician assistants here.

   During a special meeting, the commission formally adopted a position
   statement to that effect. The commissioners agreed unanimously that the
   treatment of COVID-19 must meet the same standard of care as other diseases.

   That’s after reports of a surge in unsafe alternative treatments such as
   ivermectin, an anti-parasitic drug often used in animals. It has off-label
   approval for human use in limited circumstances, but both the CDC and the FDA
   say there’s no convincing evidence it works to prevent or treat COVID-19.

The State of Mississippi has also made a move in the same direction:

   Physicians who spread misinformation about the COVID-19 vaccine could now
   have their license to practice medicine suspended or completely revoked,
   according to a new policy adopted by the Mississippi State Board of Medical
   Licensure.

   The policy, adopted on Sept. 7, says that doctors have an “ethical and
   professional responsibility” to practice medicine in the best interest of
   their patients and share factual and scientifically-grounded information with
   them.

   “Spreading inaccurate COVID-19 vaccine information contradicts that
   responsibility, threatens to further erode public trust in the medical
   profession and puts all patients at risk,” the policy reads.

   The policy says whether physicians “recognize it or not” they possess a high 
   degree of public trust due to their specialized knowledge and training. That 
   gives them “a powerful platform in society.”

   The policy specifically warns doctors against spreading misinformation on
   social media and strongly recommends physicians separate their personal and
   professional content online.

   “Physicians must understand that actions online and content posted can affect
   their reputation, have consequences for their medical careers, and undermine
   public trust in the medical profession,” it reads.

This is a step in the right direction, although I do wonder how these new
policies in Washington and Mississippi will be operationalized. Why do I wonder 
this? The article about the Washington Medical Commission alludes to it, but
doesn’t quite get to the point where we at SBM have been for a while:

   Dr. Yanling Yu, a research scientist from Lake Forest Park, serves as a
   public member of the commission. She expressed initial concern about
   following state law that protects alternative medicine, but then spoke in
   favor of the position statement on misinformation.

   “There is no valid science at all. … Like, ivermectin, there have been
   patients that have been harmed by it. So that is not scientific practice of
   medicine. And that needs to be stopped,” Yu said.

And there you have it, the exact issue that I’ve been writing about for well
over a decade, the powerlessness of state medical boards in the face of
quackery. Let’s take a trip down memory lane to explain what I mean.

COVID-19 misinformation and alternative medicine

Out of curiosity, I perused my personal blog to search for the first instance
when I wrote at length about the problem with state medical boards and found
that it was in 2008, when the North Carolina Board of Medical Examiners finally 
disciplined cancer and autism quack Dr. Rashid Buttar (who, unsurprisingly, is
today one of the usual quacks and grifters promoting COVID-19 and COVID-19
misinformation). Unsurprisingly, all Dr. Buttar got was the proverbial slap on
the wrist, even after having called the Board a “rabid dog“. All the Board did
was to restrict Dr. Buttar’s practice so that he was no longer permitted to
treat children or cancer patients. Why children and cancer patients
specifically? Simple. Dr. Buttar had been known for his antivaccine views that
blamed mercury in the thimerosal preservative in vaccines caused autism, and his
treatment was a “transdermal chelation therapy” that we disparagingly called
“Buttar’s butter“, and he was a cancer quack, to boot.

Two years later, Dr. Buttar was free to practice medicine again mostly
unencumbered. Basically, he signed a consent decree with the Board that
reprimanded him and ordered him (1) to provide informed consent to his patients 
as dictated by the Board; (2) to obey all laws, as well as rules and regulations
governing the practice of medicine in North Carolina; (3) to notify the Board
if he changes his address; and (4) to meet with the board periodically. The
informed consent forms were utterly worthless, as well. Basically, they stated
that Dr. Buttar made no claims for the efficacy of anything that he was doing.
It also pointed out that serious complications can occur from IV treatments. As 
I noted at the time, if I were to use an informed consent like this for surgery,
for example, in which I “make no specific claims” that the proposed surgery
will do anything therapeutic for the patient, sane practitioners would demand to
know why I was allowed to do this operation in the first place!

Of course, Dr. Buttar was one of many examples of the failure of state medical
boards to discipline outright quacks and antivaxxers. Worse, in one state,
whistleblowers who have reported dubious practices of physicians have even been 
prosecuted by law enforcement, as I described in depth in 2009. The state was
Texas, the same state whose medical board has been unable to shut down the
practice of Houston cancer quack Dr. Stanislaw Burzynski, who has been plying
his cancer quackery there since the late 1970s. Then there’s the case of Dr.
Christopher Duntsch, the substance abuse-impaired neurosurgeon who was so
incompetent that his fellow surgeons had seen nothing like it before. As I’ve
mentioned recently Duntsch is now the subject of a Peacock series Dr. Death. My 
own state is not immune. This might have nothing to do with alternative
medicine, but it took the FBI, not my state medical board, to finally stop Dr.
Farid Fata, the oncologist who gave chemotherapy to patients who didn’t even
have cancer. How did they stop him? They busted him for Medicare and Medicaid
fraud for having billed over $30 million for unnecessary treatments.

You get the picture.

It’s worse than that, though. As Jann Bellamy and others here at SBM have been
documenting, quacks like naturopaths, chiropractors, and other alternative
medicine practitioners have been playing the long game of pushing to change
state laws to legitimize their “professions”. She even has a term for it:
legislative alchemy, the process in which quacks try to turn the lead of their
professions into gold. She’s long documented the process for chiropractors,
naturopaths (among the most persistent and successful of the legislative
alchemists), acupuncturists, reflexologists, and practitioners of “integrative
medicine” who “integrate” quackery with their medicine. These bills take the
form of promoting bills mandating formal state licensure, expanding quacks’
scope of practice, and requiring Medicare and insurance companies to reimburse
quacks for their “services”. In Florida, a new law even forces doctors who don’t
support alternative treatments for pain to endorse acupuncture and other
quackery as “non-opioid treatments” for pain.

This brings me back to the State of Washington. Remember how that one quote
expressed concern about how the state could police physicians promoting COVID-19
misinformation when it has a law on the books that protects “integrative” (and 
therefore alternative) medicine practitioners? Remember how I discussed how
North Carolina handled the case of Dr. Buttar? One thing I didn’t mention then
but will mention now is this, quoted from a story that is no longer on the web
(and not in the almighty Wayback Machine at Archive.org), although the relevant 
parts are preserved in my post:

   The consent order, signed Friday, marks the end of a battle that Buttar had
   vowed to take to the U.S. Supreme Court. He said he has spent “hundreds of
   thousands of dollars” defending himself against the board’s allegations that 
   he exploited patients by charging exorbitant fees for unproven therapies that
   didn’t work and by arbitrarily ordering expensive tests to make more money.

   In recent years, Buttar led a successful effort by the N.C. Integrative
   Medical Society to get legislators to change state law to make it friendlier 
   to practitioners of alternative medicine.

This is another example of “legislative alchemy”, in which influential quacks
manage to persuade state legislatures to pass laws protecting “alternative
medicine” practices. So what is the relevance to the ability of, for instance,
the Washington Medical Commission? Simple. As we’ve documented here time and
time again, if there’s one consistent aspect of alternative medicine (besides
its lack of science), it’s antivaccine views. Naturopaths, chiropractors, and
acupuncturists, for example, tend to be overwhelmingly antivaccine, and many
even deny germ theory. If their views are “protected” somehow by state law, that
would put these new directives allowing state medical boards to discipline
physicians for spreading COVID-19 misinformation into direct conflict with the
laws protecting “alternative and traditional” medical practices.

So here’s what I mean when I ask: How will, for example, the Washington Medical 
Commission operationalize this new policy, particularly if it conflicts with a
law that protects alternative medicine practice? For example, if a doctor
promotes germ theory denial and antivaccine views about COVID-19 under the guise
of “integrative medicine” citing acupuncture (licensed) and naturopathy (also
licensed), how can the Washington Medical Commission do anything about it? The
state of North Carolina has also suggested that it might discipline doctors who 
promote COVID-19 misinformation, but how will it do so when its own law
privileges alternative medicine (hidden in “integrative medicine”) almost as
much as science-based medicine, thanks to the efforts of Dr. Buttar and his
fellow quacks? This is a general principle that applies to any state that has
legalized forms of “alternative medicine,” not just Washington or North
Carolina.

That’s aside even from the consideration of where to draw the line in terms of
professional speech. While it’s obvious that saying, for example, that COVID-19 
vaccines don’t work is misinformation or disinformation, what about physicians
who not-so-subtly raise doubts about the vaccines that rely on leaving out key
pieces of information? One way has been proposed in an op-ed by doctors, a
couple of whom should be familiar to regular readers here:

   It’s important to understand that the wrongdoing involved is not
   misinformation — that is, something that a person incorrectly but innocently 
   believes to be true. It is disinformation, which is information created and
   shared with the intent to deceive. For many months a well-coordinated network
   of disinformation doctors has been working to undermine mask-wearing and
   lockdowns, spread anti-vaccine conspiracy theories, and promote phony covid
   “cures” such as hydroxychloroquine and the horse-deworming drug ivermectin.

   The best known of these groups calls itself “America’s Frontline Doctors” —
   though many physicians in this group have never practiced emergency medicine,
   and some haven’t practiced any form of medicine for years. Amid the Trump
   administration’s disastrous handling of the pandemic, this group was ushered 
   into the public arena to discredit medical science. They began by trying to
   convince Americans that the potential for severe illness from covid-10 was a 
   hoax, in the interest of keeping the U.S. economy open and thus fueling
   Donald Trump’s reelection campaign. Through their social media platforms and 
   rallies, they continue to sow distrust of the Centers for Disease Control and
   Prevention and dissuade their audiences from following public health
   guidelines. In January, the group published a white paper denouncing
   vaccines. Its members have held rallies to spread their message in states
   including Florida, Texas and California — all of which are now experiencing
   covid spikes. Now, with the delta variant, those cases include a large number
   of very sick children.

They further note:

   But these physicians will not be dissuaded by strongly worded statements.
   Consider Simone Gold — a California physician and noted advocate of the
   hydroxychloroquine “cure.” In 2020 she was one of the founders of America’s
   Frontline Doctors; today, as NPR reported, Gold continues to spread
   disinformation, discourage vaccination and promote unproven treatments for
   covid (for which, NPR noted, she was offering to prescribe via a $90
   telehealth appointment). She was arrested after Jan. 6, when she participated
   in the incursion into U.S. Capitol, having come to Washington that day to
   speak at a “rally for health freedom.” Simone Gold is still licensed to
   practice medicine in the state of California.

The pessimist in me wonders if even losing their licenses would dissuade some of
these doctors, many of whom seem not to be in medical practice any more, having
gone into full time COVID-19 grifting. On the other hand, at least they
wouldn’t be able to be ivermectin prescription mills any more. The doctors
behind the op-ed cited above have gone beyond an op-ed and set up a website for 
reporting the worst disinformation peddlers, No License for Disinformation.

Let me finish on a more optimistic note. I’ve long said that professional speech
is not the same thing as free speech. Specifically, we as physicians have a
privileged status that is highly respected when it comes to our statements on
medical matters (and, oddly enough, even on nonmedical matters, as nonsensical
as that may seem). As a result, we have a particular professional responsibility
not to spread misinformation, and professional ethics demands that we do not
publicly promote quackery or disinformation. State medical boards should be
enforcing this, but traditionally have not, just as they have been very
reluctant to discipline outright quacks. They are understaffed and underfunded, 
which tends to disincentivize going after any but the most straightforward
cases, such as doctors running prescription mills, sexually abusing patients, or
suffering from substance abuse problems that impair their ability to practice
medicine safely. Traditionally, they’ve been reluctant to engage in judgment
calls on anything other than the rankest of quackery, and even then, as in the
case of Dr. Burzynski, their track record is uneven at best. Policing
professional speech about COVID-19 will be even more difficult.

    2. Even so, given the harm that physicians promoting misinformation cause, this
      is something that state medical boards need to undertake. If there could 
      be one good outcome from the pandemic, it would be enhanced power of state
      medical boards to discipline physicians promoting medical misinformation 
      and disinformation of all kinds, not just about COVID-19 or COVID-19
      vaccines. As No License for Disinformation puts it, “Everyone has the
      right to an opinion. Doctors, however, are bound by an ethical and legal
      obligation to do no harm”. Physicians promoting misinformation and
      disinformation betray that obligation.

State legislatures consider bills prohibiting COVID-19 vaccination mandates and 
other public health measures

Bills seek to prevent the states and private employers from mandating COVID-19
vaccines and other pandemic mitigation measures. Some proposed legislation would
severely handicap public health officials in combating future health
emergencies.

Jann Bellamy on March 11, 2021

Link



Although, to my knowledge, no government entity or employer has actually
mandated COVID-19 vaccination, legislation is pending in several states to head 
off any such attempts. Some of these bills attack mitigation measures like mask 
wearing as well, or provide religious and other exemptions to COVID-19
immunization. Other, more sweeping, bills tie the hands of public health
officials with overly-broad measures going well beyond the current pandemic and 
exhibiting little regard to what the future may bring.

The vast majority of bills, almost to the point of exclusivity, are sponsored by
Republican legislators. As is true of bills weakening or eliminating school
immunization requirements, anti-vaccination organizations like the Alliance for 
Natural Health, which assiduously protects your right to be bamboozled by fringe
medical practitioners and their nostrums, are busy lobbying state legislatures 
to make sure vaccination mandates and the like never see the light of day, or at
least permit generous exemptions.

While I don’t believe broad COVID-19 mandates are warranted in our current
circumstances, too many of these bills attack sensible public health measures
like mask wearing or ban mandates in situations where they may be appropriate,
like long-term care facilities. Bills broadly handicapping public health
officials without thinking through the consequences are downright dangerous.

Before we get to the pending legislation, let’s look briefly at how current
federal law addresses state and private employer mandates. The FDA allows
administration of the three COVID-19 vaccines currently available in the U.S.
under an Emergency Use Authorization (EUA) issued for each. Per the federal law 
allowing the FDA to issue EUAs, the Secretary of the Department of Health and
Human Services must specify whether individuals may refuse the vaccine and the
consequences for that refusal. Here, the FDA has made clear that anyone may
refuse a COVID-19 vaccination and requires that this information be disclosed to
the public. According to a recent JAMA Viewpoint article by public health and
health law experts, “mandating COVID-19 vaccines under an EUA is legally and
ethically problematic”.

However, at the end of last year, the Equal Employment Opportunity Commission
issued pandemic-related Q&As that “favor a voluntary vaccination approach, but
do not expressly prohibit a mandatory policy with appropriate ‘outs’ for
disability and religious accommodations.” As best I can tell, the advice was not
limited to vaccines with full FDA approval.

Where employees are unionized, a collective bargaining agreement could require
bargaining over the implementation of a mandate, or even consent-based
vaccination, to avoid violating federal labor laws.

In sum, federal law does not require vaccination of anyone but apparently does
not prohibit private-sector employers from mandating employee vaccinations.
(Please note: this is an SBM post, not legal advice. Consult a lawyer if you
have questions.)

With that, let’s turn to the pending state bills. As noted in my previous post
on school vaccination legislation, different states have different abbreviations
for legislation. To simply things (for me), I’m going to use whatever
combination of letters and numbers the particular state uses with a link to the 
legislature’s website, where you can find all the details.

Hog-tying public health

Legislators in several states have introduced bills curtailing the authority of 
health officials to implement mitigation measures in a public health emergency. 
These take various forms, some disallowing vaccination mandates altogether,
others adding that anyone refusing voluntary vaccination in an emergency cannot 
be quarantined or isolated, while others still create exemptions to vaccination 
mandates. Some bills are directed only at COVID-19; others cover all
immunization mandates. The titles of, and language used in, several bills give
us a hint as to their sponsors’ ideological leanings.

Maryland HB 17, the “Consent of the Governed Act”, is an especially ham-fisted
and poorly drafted reaction to the state’s handling of the COVID-19 pandemic.
Current Maryland law allows the Governor to declare a state of emergency and to 
issue orders to mitigate that emergency, such as Gov. Larry Hogan’s orders
restricting restaurant capacity, mandating mask-wearing, and similar measures.

No matter the emergency or its circumstances, HB 17 limits the duration of any
state of emergency to 14 days, with a 14-day extension if approved by a
two-thirds majority of the General Assembly, which must convene within 3 days of
the order. Oddly, an emergency order cannot apply at all to state legislators
or judges and the Governor cannot “threaten or arrest” legislators or judges for
violation of an emergency order.

The Governor cannot require

   any member of the public to remain indoors, wear a face covering, not
   congregate or assemble, close or limit capacity of a business, church, or
   school, or interfere with the right to obtain and try any medical treatment
   desired for any illness . . . or receive a vaccine or be forced under penalty
   of law to make any other health decision.

Private citizens would have the right to sue to enforce this proposed law and
could get an injunction and treble damages (and attorneys’ fees and costs) if
they can prove the emergency order is “unreasonable as applied” to them.

A similar effort to gut public health measures during emergencies is underway in
Missouri. HB 1144 tracks the language of a “Right to Refuse” Model Act promoted
by the “National Health Freedom Action” organization. As I described in a post 
last September, this group and its associates spread vaccine and COVID-19
misinformation and support laws shielding quacks, allowing the sale of
unpasteurized milk, and otherwise protecting pseudoscience and those who benefit
from its commodification.

HB 1144’s sweeping provisions handicap both the state government and individual 
business owners who try to institute protective measures such as mask wearing
and building capacity limitations, giving everyone the right to refuse such
measures and imposing absurd conditions on their implementation. For example, a 
shop owner who wants customers to wear a mask must read aloud portions of the
law granting the right to refuse this and other mitigation attempts to each
potential customer, give them a written copy of the law, and get a written
acknowledgement of its receipt.

In South Carolina, HB 3217 allows anyone to refuse a vaccination offered as
“part of any mass immunization project to protect against infectious disease, or
to prevent the spread of a pandemic or a contagious or possibly contagious
disease”. HB 3511 goes even further, providing that anyone who refuses a
vaccination in such circumstances “may not be denied any right or privilege of
citizenship”, which is defined to include “shopping”.

In another sweeping measure, South Carolina HB 3526 transfers the authority to
declare a state of emergency from the Governor to the state legislature and
removes “public health emergency” altogether (and well as other events) from the
list of circumstances permitting an emergency declaration. Declared public
health emergencies would still be allowed in some circumstances but the power to
mitigate them is reduced. For example, an infectious agent, chemical agent, or 
the like, posing “a substantial risk” of “widespread illness” would no longer be
a sufficient reason for a public health emergency, which would be limited to
risks of “a significant number of human fatalities” or “a serious economic
impact to the agricultural sector, including food supply”. The authority to
temporarily isolate or quarantine anyone is completely removed and a court order
required.

In North Dakota, HB 1320, which was, fortunately, soundly defeated, would have
banned any state vaccination mandate, in any circumstances, and prohibited
“making receipt of a vaccine a condition for entry, education, employment, or
services”, presumably pre-empting school vaccination mandates along with the
rest. It was strongly opposed by school officials and the science-based health
community and supported by a North Dakota “health freedom” organization and two 
chiropractors, among others.

In Oklahoma, a similar bill (SB 223), provides that any state entity, including 
school districts, cannot “through direct or indirect means, compel or coerce any
person . . . to receive any immunization”, seemingly eliminating all school
vaccination requirements as well. Likewise, Oklahoma SB 352 prevents any state
entity or from compelling or coercing anyone “to undergo any unwanted medical
procedure”, including immunizations and face mask wearing, with persons
violating the proposed law subject to misdemeanor conviction. (Private employers
are specifically excepted.)

In what appears to be an attempt to cover any and all situations that could
possibly arrive, Idaho HB 63, prohibits any state or local law or order that
mandates “vaccination, immunization, genetic modulation, or inoculation” (or, as
the bill refers to it, “forced or coerced vaccination”) in “any state of
disaster or emergency or any proclaimed state of extreme emergency,
insurrection, or martial law” and prohibits quarantining or isolation of those
who refuse vaccination. (I had to look up “genetic modulation“. The science is
beyond me but I am curious as to how it would come into play in an insurrection 
and such.)

With the preamble that a new law is required to “maintain the individual
liberty, parental rights, and free market principles of the citizens and
businesses of Nebraska”, LB 643 allows anyone to refuse vaccination during a
state of emergency declared by the Governor “or anytime thereafter” without
punishment, penalty, or “implication”.

A Florida bill (HB 6003) removes the authority of the state Public Health
Officer, in a public health emergency, to require quarantine of anyone refusing 
vaccination and to require vaccination of an individual who poses a threat to
the public health when quarantine is unavailable. Kentucky law currently allows 
the state’s health agency to require vaccination in any area where a pandemic is
declared. HB 36 (the “Ensuring Bodily Autonomy and Informed Consent Act”) and
SB 37 would repeal that authority.

In Tennessee, under current law, any person’s right to claim a religious
exemption from immunizations and medical procedures (presumably including
testing) is suspended when an epidemic threatens and an employee’s religious
exemption right is suspended when necessary to protect the health of others. HB 
10 (which failed in a subcommittee of the Health Committee) and SB 07 would
eliminate those suspensions as well as institute blanket religious and
conscience exemptions for all immunizations and medical procedures. The bills
would also eliminate misdemeanor charges for physicians who fraudulently provide
medical exemptions or certificates of vaccination. Specific to COVID-19,
Tennessee SB 187 and HB 13 provide that government entities “shall not force,
require, or coerce a person to receive an immunization or vaccination for
COVID-19 against the person’s will”, although, without a state COVID-19
vaccination mandate, they would not have any authority to do so in the first
place.

Washington HB 1006 creates “religious, philosophical, or personal” objections to
all state-mandated immunizations, including any that might be required for
state and day care center employees, and adds these exemptions to the
school-mandated MMR immunization, which is currently limited to medical
exemptions.

Virginia HB 2242 prohibits the state from requiring COVID-19 vaccinations and
prohibits discrimination based on vaccination status in a number of situations, 
including health insurance coverage and state employment, where vaccine refusal 
is accorded the same status as other traditionally protected classes in
employment discrimination law, like race, religion, and gender.

Although Wisconsin law permits health officials to mandate immunization in a
public health emergency, SB 4 and AB 23 would exclude COVID-19 vaccination from 
this law. New York A 4269 prohibits mandatory COVID-19 vaccinations as well. In 
Connecticut, proposed bills prohibit the state from mandating any vaccine that
has been given only an EUA (SB 405) and the COVID-19 vaccine in particular (HB
5401). Similarly, Virginia HB 2336 prohibits both public and private entities
from requiring any vaccine that is not FDA-approved, presumably including those 
with only EUA.

Should any state entity mandate COVID-19 vaccination for any purpose, such as
employment or school attendance, Washington SB 5144 allows “religious,
philosophical, or personal” exemptions. In Virginia, HB 2268 adds a religious
exemption to immunizations required by public health authorities during an
epidemic as well as removes the suspension of the religious belief exemption for
school vaccinations during an emergency or epidemic. Michigan HB 4008 adds
medical and religious belief exemptions to immunizations administered during a
pandemic, although parents are allowed to refuse consent for immunization of a
child on any ground.

Not all bills curtail the ability to act in an emergency. New York A 416 allows 
the governor, in consultation with state health authorities, to determine “by
clear and convincing evidence” that “the health of others is or may be
endangered” by an actual or suspected “case, contact or carrier” of a contagious
disease which “may pose a significant threat to the public health resulting in 
severe morbidity or high mortality”. Upon this determination, the “case, contact
or carrier” can be detained for at least 3 days, and for up to 60 days with
additional due process protections but, in any case, for no longer than they are
contagious. The order can be directed at an individual or a group, who can be
detained “in a medical facility or other appropriate facility . . . designated
by the governor”. In addition to detention, the governor can require quarantine 
and order testing, vaccination, and treatment, although no medication can be
required without a court order.

New York A 2081 adds COVID-19 vaccination to the list of required immunizations 
for residents and employees of long-term care facilities, with medical and
religious exemptions as well as the right to refuse “after being fully informed 
of the health risks” of refusal.

Employers restricted

A number of states have legislation proposed or pending that bar employers from 
mandating either vaccinations in general, or COVID-19 vaccinations in
particular, whether in certain circumstances or by banning them altogether.

Connecticut’s proposed HB 5402 prohibits any employer from requiring proof of
COVID-19 vaccination from employees, vendors and customers, presumably including
hospitals, long-term care facilities, and the like. It also bans public
officials from requiring proof of vaccination as a condition of using some
public facilities, like parks.

Mississippi HB 719 (which died in committee) and Wisconsin bills SB 5 and AB 25 
would prohibit any employer from requiring that employees be vaccinated against 
COVID-19, while Kentucky SB 37 and Oklahoma HB 1057 would prohibit employers
from requiring vaccination against any disease. All of these bills appear to
include hospitals, nursing homes, retirement communities, and similar
businesses.

In Minnesota, HF 261 requires that COVID-19 vaccines be made available to
teachers and other school employees but says they (and students) can’t be
required to take them. Similarly, Missouri HB 838 prohibits public employers
from requiring COVID-19 vaccination for public employees, no matter where they
work. North Dakota HB 1301, which was defeated, prohibited employers from
requiring vaccination of employees, with hospitals, long-term care facilities,
and the like excluded, although medical and religious exemptions were allowed.
Interestingly, even though the bill also contained protection against liability 
for the transmission of communicable diseases, it was opposed by the business
community, which wanted to retain the right to require employee immunization.
Conversely, Oregon SB 451 prohibits immunization requirements for registered
nurses and other medical staff as a condition of employment.

Pennsylvania HB 262 bars both private and state government employers from
requiring any immunization or “invasive medical test”, defined to include
providing tissue or bodily fluid samples (in other words, including COVID-19
testing). Employees can sue for treble damages if they are retaliated against or
otherwise penalized for their refusals. Indiana SB 74 grants employees medical,
religious and “conscience” exemptions from vaccinations required by an employer
and prohibits, upon pain of actual and punitive damages, any discrimination
against an employee claiming an exemption. Indiana HB 1488 prohibits
employer-required vaccinations if the vaccine has only emergency use approval
and bans the employer from inquiring into the employee’s reason for refusing the
vaccine.

Given the inevitability of future pandemics and other health emergencies, I
worry about how states will manage without the public health tools eliminated by
this year’s proposed legislation. Fortunately, some ill-conceived bills have
already been defeated. You can help ensure others suffer the same fate by
contacting your state representatives.

School mask mandate wars: Politics (Florida) v. Science (North Carolina)

Florida’s governor, Ron DeSantis, dictated a state-wide ban on school mask
mandates based on misinformation and pure politics, while North Carolina
officials took a bipartisan approach to masking based on science.

Jann Bellamy on August 26, 2021

Link



As schools reopen across the country, mask mandates are a hot button issue.
Today we look at how two conservative southern states handled mandates with
vastly different approaches. In one, North Carolina, decisions are based on
bipartisan compromise and science, while in the other, Florida, a dictate from
the governor relies on misinformation and raw politics. I happen to live in one 
(Florida), but (fortunately) spend a lot of my summer in the other (North
Carolina), giving me something of a front-row seat from which to view the
controversy.

North Carolina

As happened in many states, North Carolina’s students, teachers, and parents
were subjected to a shifting and sometimes confusing variety of studies, orders,
and directives related to K-12 school closures during the 2020-21 academic
year. But this past spring, after a protracted battle between the
Republican-controlled legislature and Gov. Roy Cooper, a Democrat, the
legislature unanimously passed, and the governor signed, a compromise bill, The 
Reopen Our Schools Act of 2021, paving the way for in-person  instruction for
the remainder of the school year.

Under the Act, local school boards could choose “Plan A” or “Plan B”, which
required different safety measures for reinstituting in-person instruction, with
Plan A offering expanded opportunities for reopening classrooms.

However, school boards choosing Plan A were also required to

   partner with the ABC Science Collaborative of the School of Medicine at Duke 
   University (ABC Collaborative) to allow the ABC Collaborative to collect and 
   analyze data from . . . students in Plan A in grades six through 12. A local 
   board shall both engage in robust contact tracing and report on requested
   information in the form specified by the ABC Collaborative.

By way of background, the ABC Science Collaborative describes itself as

   an initiative that extends across 13 states, connecting scientists and
   physicians with school and community leaders to help understand the most
   current and relevant information about COVID-19. The program helps school
   leaders and state policymakers arrive at informed decisions about returning
   to school using data from their own communities. . . The ABC Science
   Collaborative is coordinated by the Duke Clinical Research Institute at the
   Duke University School of Medicine and is funded through grants from the
   National Center for Advancing Translational Sciences, the National Institutes
   of Health, and the Food and Drug Administration.

The ABC Collaborative was to report interim results and a final analysis to the 
state, the latter by June 30, 2021.

Let me pause here to remark on how extraordinary I find this provision of the
Act, requiring a science-based collection and analysis of data by a reputable
institution in order to inform public health policy, and in a unanimously-passed
bipartisan bill to boot! With the caveat that I have not looked at legislation 
in any systematic way for similar provisions, in my decade-plus of posting here 
on SBM I cannot recall writing about a piece of legislation mandating the
legitimate collection and analysis of data on which to base public health
policy. In fact, although I admittedly focus on such subjects, what I regularly 
encounter is the wholesale incorporation of pseudoscience into state and federal
laws and policies affecting the public’s health. There outta be a law, and it
should look like this one.

From March to June, 2021, the ABC Collaborative, apparently expanding the reach 
of its original mandate, collected data from all North Carolina elementary,
middle, and high schools operating under Plan A, which included in-person
instruction, masking, and minimal physical distancing (3 feet or under). The
data represent 100 local school districts and 14 charter schools, comprising
more than 1,280,000 students and 160,000 staff.  As the lead authors of the
report explained in a New York Times Guest Essay, because there was a universal 
school mask mandate at the time of their data collection, they could not compare
masked to unmasked schools. They did, however, look to data from other
jurisdictions examining these situations.

The Collaborative’s final report concluded that:

   North Carolina schools were highly successful in preventing the transmission 
   of COVID-19 within school buildings and offers science-based learnings for
   the nation’s schools to limit COVID-19 spread.

In particular, the data showed that:

  1. Proper masking is the most effective mitigation strategy to prevent COVID-19
    transmission in schools when vaccination is unavailable or there are
    insufficient levels of vaccination among students and staff;

  2. With masking in place, Plan A – full, in-person instruction – is appropriate
    for all grades and all schools;

  3. Full-capacity bus transportation can and should resume, with the seating of up
    to three masked students per bus seat;

  4. Some within-school guidelines can be relaxed, e.g., quarantine can be modified
    for people who were exposed to COVID-19 but are either vaccinated or were
    appropriately masked when exposed; and

  5. Schools should examine safety protocols surrounding athletics. With proper
    safety protocols in place, particularly vaccination, schools could resume
    fall athletics while limiting the spread of COVID-19.

In addition to this report, the Collaborative has authored The Year in Review
and a Path Forward, described as offering “a road map for school leaders and
policymakers to use the latest science as they plan the path forward for K-12
in-person instruction”. (As you shall see, I know someone who could really use a
copy.)

For the current (2021-22) academic year, Gov. Cooper declined to issue a
state-wide mandate, opting instead to have each school district choose whether
to implement a mask requirement. The Raleigh News & Observer reports that, as of
August 24th, 27 of the 115 total districts have made masks optional. All of
those districts are in rural or “red” areas and many have low COVID vaccination 
rates. Eighty-eight districts, accounting for 78% of the state’s 1.5 million
public school students, have decided to require masking in school buildings and 
on busses; some will even require masks outdoors. At least 35 districts reversed
their original decision to make masks optional, some after Gov. Cooper sent
them a letter requesting the change. It is unknown how many of the state’s
charter and laboratory schools, accounting for 9% of the total student
population, will require masks.

According to the News & Observer, even where masks are required, a parent can
request an opt-out “if a medical or learning issue” prevents masking, but the
final decision on exemptions resides with each school.

Not everyone is happy with this plan, nor is everyone satisfied with the
districts’ individual decisions. A doctors’ group has a petition on change.org
urging Gov. Cooper to institute a statewide mask mandate for schools via
executive order. In Union County, where the school board voted to make masks
optional, local physicians urging the board to institute a mask requirement
asked a newspaper to keep their identities confidential due to fears of
retaliation. A school board member who voted to make masks optional reported
personal attacks on her character and the board to the same newspaper.

Nevertheless, in sum, in North Carolina, a bipartisan law created a plan to
collect and analyze data on which the state government and local school boards
could base their decisions. Some districts have apparently embraced the science,
while others have not. The net results is that, for now, over three-quarters of
North Carolina’s public school students are under a mask mandate which, while
not without some controversy, has maintained local control by decision makers
acting in what they believe is their constituents’ best interests, whether or
not we might agree with the results.

Florida

With this in mind, let’s turn to my home state, Florida

On July 30, 2021, Gov. Ron DeSantis issued an Executive Order that essentially
banned mask mandates in Florida public schools. (Technically, it directed the
state’s health and education agencies to develop rules “to ensure safety
protocols for controlling the spread of COVID-19 in schools”, but the results
are preordained by the Order.) He had previously ordered that all public schools
be open for in-person instruction five days a week.

Gov. DeSantis’s Order was chock full of cherry-picked evidence, unsupported
assertions, COVID myths, and downright falsehoods, all wrapped in a protective
coating of “parental rights” talking points designed to please his base. He
rested his authority to issue the Order on a new state law he signed in June of 
this year, the “Parents Bill of Rights”, which prevents the state and other
units of government

   from infringing on the fundamental rights of a parent to direct the
   upbringing, education, health care, or mental health of a minor child without
   demonstrating that such action is reasonable and necessary to achieve a
   compelling state interest and that such action is narrowly tailored and is
   not otherwise served by less restrictive means . . .

How this new law will affect cases, like this one, where parents choose
“alternative” remedies over science-based treatments remains to be seen. In the 
case of local mask mandates, my view is that they could meet even this tough
standard, but only if science is correctly applied to the matter, which, as you 
will see, is not part of the governor’s plan.

In the Order, the governor refutes the CDC’s mask wearing guidance as lacking “a
well-grounded scientific justification”, citing a Brown University study done
by an economist using now-outdated data, which Kaiser Health News concluded was 
“cherry-picked” by the governor and offered “little basis for his position and
includes a variety of elements that are not accurate.”  A pediatrics professor
at the University of Florida called DeSantis’s claim “patently false”.

The Order also says that there is “no statistically-significant evidence to
suggest that counties with mask requirements have fared any better than those
without mask requirements during the 2020-2021 school year”.  Of course, “fared 
any better” is vague. By what metric? Number of cases? Hospitalizations? Deaths?
We don’t know because the Order cites no evidence in support of this assertion.
And the general public (which is apparently who he is referring to) is not the 
same population as school students. However, we do know that modeling and
epidemiological studies (like that of the ABC Science Collaborative) support
masking in general and masking for school students in particular.

Again citing no evidence, the Order asserts that “masking children may lead to
negative health and societal ramifications” and that “studies have shown that
children are at a low risk of contracting a serious illness due to COVID-19 and 
do not play a significant role in the spread of the virus”. In fact, the most
you could say is that the evidence is uncertain regarding spread and, in any
event, it partly depends on the community rate, which is quite high in Florida
right now. And, if it was ever true that children are at low risk of contracting
COVID or experiencing serious symptoms, as SBM’s own Dr. Jonathan Howard has
explained, that is no longer the case.

Finally, the Order, ensuring that even more COVID mask myths are blessed with
the official imprimatur of state government, and once again without citing any
evidence, claims that masks “could inhibit breathing, lead to the collection of 
dangerous impurities including bacteria, parasites, fungi, and other
contaminants, and adversely affect communications in the classroom and student
performance.” No, masks do not interfere with breathing and no, they do not
collect “dangerous impurities” if you wear a clean mask (duh!). On the latter
point, it is interesting that the governor, who totally trusts parents to make
momentous decisions regarding their children’s health, suddenly finds they can’t
be trusted with basic hygiene measures, like keeping their children’s stuff
clean.

We simply do not have enough data to conclude one way or another on the effect
masks have on learning but, in the words of one research psychologist who
studies the cognitive and social development of children:

   Ultimately, how children feel about wearing masks at school, and how much
   they psychologically benefit from wearing them, is going to depend on how the
   parents, teachers and caregivers around them present the issue.

Certainly, we can well imagine that a child, too young to fully evaluate the
issue on his own, taken to a mask protest by his parents and told to hold up a
sign an anti-mask sign, might become anxious and confused when his school
district imposes a mask mandate.

The governor’s Order threatened local school districts with financial penalties 
for failure to comply, giving the Florida Commissioner of Education the
authority to pursue “all legal means available to ensure school districts” obey 
the his dictates, including withholding state funds from noncompliant school
boards.

In addition, in an incredibly irresponsible and undoubtedly
politically-motivated move, the Florida Department of Health’s “How do I prevent
and prepare for COVID?” webpage does not include mask-wearing, although it does
include a link to the CDC at the bottom of the page. The CDC does, of course,
advise to “wear a mask”, science-based advice the governor rejected.

This, I am pleased to report, has resulted in a coup against DeSantis by some
school districts, who have enacted varying forms mask mandates for students and 
faculty in open defiance of his Executive Order. As of Wednesday morning, ten
districts, including some of the largest, like Miami-Dade and Hillsborough
(Tampa), representing over half of Florida’s public school students, have these 
mandates in place.

In response, state officials have doubled down with the threats, promising to
dock the salaries of, and possibly remove, school board members who vote to
enact mandates. Officials are seeking compensation records of board members
voting for mandates in two districts, Alachua (Gainesville, home of the
University of Florida) and Broward (Ft. Lauderdale). (Three Broward teachers
recently died of COVID.) The state is expected to move against other board
members this week.

The governor’s office has also doubled down on the misinformation. Just
yesterday, a Washington Post news report quoted the governor’s press secretary
saying, again falsely,

   There is no empirical evidence to support the assertion that the benefits of 
   forced masking of schoolchildren outweigh the potential harms. Masking kids
   under 12 is not recommended in many EU countries, because their health
   authorities have found that the risks are not well understood — and the data 
   shows that forced masking of young children has a negligible impact on covid 
   prevalence and spread.

The Post dutifully reported that “public health experts dispute this”, quoting a
pediatric infectious disease physician from the Mayo Clinic who said that
“studies have unequivocally shown that there are no negative health effects on
children from wearing a mask.” As for what Europe is doing, the hypocrisy is,
once again, interesting. I’m pretty certain that Gov. DeSantis would reject
European public health authorities’ opinions on, say, gun control or universal
health care coverage. In any event, I did not check the mask policies in each of
the 28 EU countries, but reports from European health authorities like the
Association of Schools of Public Health in the European Region, the European
Academy of Paedatrics, and the European Centre for Disease Prevention and
Control show that they have (unlike the governor) fully evaluated the evidence
and recommend masking in school settings, depending on local conditions and with
exceptions for certain students (like those too young or the disabled).

The federal government has now joined forces with the renegade school boards,
with Pres. Biden and his Secretary of Education offering financial support and
threatening litigation. Parents have filed their own lawsuits against the state,
one of which is being tried in Leon County (Tallahassee) right now, with none
other than Dr. Jay Bhattacharya, of Great Barrington Declaration fame,
testifying on behalf of the state.

Florida’s “chaotic” school openings are playing out against Florida’s alarming
COVID stats, including its pediatric cases. (I am heartbroken that these include
the deaths of two children in my own community this month.) Just-opened schools
are having to shut down because of COVID, almost 30,000 students, teachers and 
staff are in quarantine, and health departments are backlogged on contact
tracing. Seventeen school employees, including teachers, have died of COVID just
since August 1st. At the same time, public opinion polls show support for both 
mask and COVID vaccine mandates for students and teachers.

To be fair, pediatric cases in North Carolina are on the rise as well, as they
are nationally, but I could not find that any schools had shut down, nor could I
find any statistics on the number of students and school staff in quarantine,
if any. School personnel have died from COVID in the state, although none
recently that I could find.

Compare and contrast

So, in states with comparable political climates, one, North Carolina, in a
bipartisan effort, looked to the data and science to inform decision-making on
mask mandates and left the issue to local control, resulting in over
three-quarters of public school students being under a mask mandate. In the
other, Florida, the governor dictated to local school boards what they must do
based on repeated misrepresentations of the evidence and is now threatening to
impose financial and other penalties on school board members who have been
elected to office by the citizens of their own communities, all in a state with 
some of the worst COVID stats in the country and in defiance of public opinion.

And here’s the really disturbing part: Gov. DeSantis’s Executive Order could
have, like North Carolina’s report, set forth the actual evidence and declared
parents should decide. In other words, the same result, just without the
misinformation. It wouldn’t be the result the scientific and educational
community might prefer, but at least the state wouldn’t be complicit in
spreading falsehoods. But he didn’t. He chose to manipulate parents, the ones he
claims he trusts to make the best choices for their children, with
cherry-picked and fabricated “facts” (and easily debunked at that) in order to
achieve the results he wanted.

Which approach do you think is best?

UPDATE: Judge throws out Gov. Ron DeSantis’ ban on mandatory masks in Florida
schools. Tallahassee Democrat, August 27, 2021.

Tennessee hamstrings medical board fight against COVID misinformation and
unproven treatments

A new Tennessee law hampers the state medical board’s efforts to rein in COVID
misinformation and will make disciplining physicians prescribing unproven COVID 
treatments impossible until the board goes through cumbersome rule-making
procedures, an effort that could outlast the pandemic.

Jann Bellamy on December 16, 2021

Link



Tennessee legislators have decided to encourage physician malpractice by
bullying the state medical board into rescinding its COVID anti-misinformation
policy and throwing huge bureaucratic obstacles in the board’s way before it can
discipline physicians who use unproven COVID treatments, including downright
quackery. Their blatant disregard for science, the details of which we’ll get to
in a moment, comes even as the medical profession calls for more vigilance
against disinformation and taking action against doctors who spread it, a
subject SBM has covered extensively, along with the quack COVID treatments
peddled by some physicians.

The Federation of State Medical Boards (FSMB) 2021 annual survey of member
boards found that

  1. 67% have experienced an increase in complaints related to licensee
    dissemination of false or misleading COVID-19 information;

  2. 26% have made or published statements about the dissemination of false or
    misleading COVID-19 information; and

  3. 21% have taken a disciplinary action against a licensee disseminating false or
    misleading COVID-19 information.

That last figure is encouraging news considering, as Dr. David Gorski lamented,

   how rare it is for a state medical board to suspend or revoke the medical
   license of outright quacks and how difficult it has been on the occasions
   when a state has tried . . .

In July, the FSMB issued a statement reminding physicians who spread COVID
misinformation that they risk disciplinary action. Since then, according to the 
FSMB, at least 15 boards published statements about false or misleading
information and at least 12 boards have taken disciplinary action against a
licensee. The FSMB is currently developing guidelines for medical boards to help
address the spread of disinformation.

It is not clear to me why the FSBM’s statement emphasizes disinformation only
and does not address the problem of physicians promoting unproven treatments
like hydroxychloroquine and ivermectin.

In any event, as Dr. Gorski optimistically pointed out:

   If there could be one good outcome from the pandemic, it would be enhanced
   power of state medical boards to discipline physicians promoting medical
   misinformation and disinformation of all kinds, not just about COVID-19 or
   COVID-19 vaccines.

Unfortunately, those who are hell-bent on protecting our “freedom” to thumb our 
collective noses at the common good and ignore public health measures as well as
our “freedom” to access quack treatments are ever at the ready to quash any
such efforts. It is thus that we find ourselves confronted with what the FSMB
calls “troubling legislation” introduced in a number of states making it more
difficult for licensing boards to discipline a licensee for spreading
disinformation. The FSMB say it

   strongly opposes any effort to restrict a board’s authority to evaluate the
   standard of care and assess risk for patient harm.

Which is exactly what the Tennessee legislature just accomplished in a new law
that also includes sweeping anti-public health measures. With that, let’s turn
to the specifics.

Tennessee: The Volunteer (to get COVID) State

The Tennessee Board of Medical Examiners, which regulates licensed physicians,
voted in September to adopt a policy, based on the FSMB’s statement, that would 
subject physicians who create or spread COVID vaccine misinformation to
disciplinary action.

According to the Chattanooga Times Free Press, at the time of the medical board 
meeting, at least 24 COVID-related complaints had been filed against health care
practitioners and a lawyer for the board asked for guidance on how to handle
three different types of these complaints:

  1. Physicians sharing their personal anti-vaccine or vaccine-hesitant opinions
    with their patients.

  2. Physicians sharing false information about vaccines in order to advise
    patients against vaccination.

  3. Physicians spreading misinformation or disinformation to multiple patients
    across their practice.

In response, the board decided that physicians who disseminate false information
about COVID vaccines (e.g., the myth that vaccines cause infertility) should
face formal discipline, although they debated “the degree to which physicians
should be allowed to express their personal opinions within the confines of the 
doctor-patient relationship.”

They ultimately agreed on a policy that physicians who “generate and spread
COVID-19 vaccine misinformation or disinformation” risk disciplinary action.
Physicians “must share information that is factual, scientifically-grounded and 
consensus-driven for the betterment of public health”.

In support of the policy, Dr. Melanie Blake, the boards’ president, said that

   It is painfully clear to the physicians who have served on the front lines of
   this pandemic that COVID-19 vaccine misinformation has caused undue loss of 
   life, loss of health, loss of jobs and other incalculable losses to our
   society. . . . I applaud the efforts to uphold our oath as physicians despite
   unprecedented challenges.

The new policy did not sit well state Rep. John Ragan (R-Oak Ridge) and some of 
his Republican colleagues. Ragan said that after the policy was adopted, “he
received phone calls from practitioners across the state who were afraid their
licenses would now be in jeopardy.” He complained that the policy did not define
“misinformation” and “disinformation” and took the position that the board had,
in effect, enacted a new rule without going through the formal rule-making
procedure required by state law.

Ragan sent letters pressuring the board to delete the policy or risk being
called before the legislature’s Joint Government Operations Committee. According
to The Tennessean, an attorney who works with the board warned board members
that Ragan had conveyed his “displeasure . . . in the strongest terms” and “made
clear he has no qualms about moving forward with dissolving the [board] and
reconstituting it with new members”, something he has “in fact done with another
state agency”.

My take on Ragan’s position is that he has made a highly questionable
interpretation of state administrative law and used it as a bludgeon to beat the
medical board into submission lest it take action against physicians giving
dubious advice about COVID, including vaccines, and promoting unproven
treatments. (When you see what the Tennessee legislature subsequently did, which
we’ll get to soon, I think you’ll agree with me.)

Ragan is correct that state law requires agency rules to go through a specific
procedure before they can become law. This procedure can be extremely cumbersome
and time-consuming, including notice to the public and an opportunity to be
heard, review by the attorney general and legislature, and challenges to the
rule that can take months, years even, to resolve.

But is the board’s policy a “rule”? I don’t think a fair interpretation of
Tennessee law supports Ragan’s claim that it is. Without getting too much into
the weeds of administrative law, a “rule” is defined by Tennessee law as an

   agency statement of general applicability that implements or prescribes law
   or policy or describes the procedures or practice requirements of any agency.

But, the definition of “rule” specifically excludes

   General policy statements that are substantially repetitious of existing law.

As board member Dr. Samantha McLerran correctly pointed out, under Tennessee law

   the board has the power to discipline physicians for “unprofessional,
   dishonorable or unethical conduct” as well as for “making false statements or
   representations . . . or being guilty of fraud or deceit in the practice of 
   medicine”.

She was of the opinion that the COVID misinformation policy fell under these
existing prohibitions.

I agree. The board was simply restating the prohibitions already contained in
state law as they applied to COVID, not promulgating a new rule. If Rep. Ragan’s
interpretation is correct, then every time a physician is disciplined for
infraction of the provisions cited by Dr. McLerren, whether or not
COVID-related, he could challenge the board’s action based on the absence of a
specific rule defining his conduct as unlawful.

Unfortunately, Rep. Ragan’s threats worked (sort of) and a special meeting of
the medical board was called “out of an abundance of caution” based on a new
state law signed by Gov. Bill Lee on November 12, according to board chair Dr.
Blake. At the meeting, the board voted 7-3 to remove the policy from its
website. However, displaying a lawyer-like talent for parsing words, Dr. Blake
said the only request the board received was to delete the policy from the
website, which it had done, but “our mission remains the same”. In other words, 
she confirmed that the policy itself remained in force. A Department of Health
attorney then recommended that the board conduct a second vote on whether to
rescind the policy outright, but the board declined and the meeting adjourned.

That “new law” (which is already being challenged in court) is sweeping
legislation preventing government agencies, schools, and private businesses from
imposing public health measures like vaccination and mask wearing, passed by
the Tennessee legislature in a special session in October devoted to COVID. (A
good summary can be found here.) It also creates a private right of action for
injunctive relief and compensatory damages, as well as attorneys’ fees, for
anyone “injured as a result of a violation” of the new law.

Per the Chattanooga Times Free Press, these measures

   stem from anti-vaccination efforts taken up by some legislators who are being
   egged on by groups such as Tennessee Stands

For those of you unaware, Tennessee Stands is a conservative group that opposes 
masks and vaccine mandates, among other public health measures, and reportedly
expressed support for the January 6th attack on the Capitol.

Specifically relating to physician discipline, during the special session, as
described by MedPage Today, Rep. Chris Todd (R-Madison County) and Debra Moody
(R-Covington) introduced bills limiting the medical board’s ability to
discipline physicians for substandard care in COVID cases:

   Rep. Todd’s bill, the Tennessee COVID-19 Treatment Freedom Act, would prevent
   the Tennessee Board of Medical Examiners from disciplining doctors for
   anything “solely related to the physician’s prescription, recommendation,
   use, or opinion relative to a treatment for COVID-19,” including treatments
   that aren’t approved by the state’s health department or the FDA.

   Rep. Moody’s bill would prevent . . . [disciplinary] actions “so long as the 
   physician exercised independent medical judgment and believes that the
   medical treatment is in the best interest of the patient,” and the patient
   consents.

The gist of these proposals, if not all of the language, made it into the final 
version of the legislation, which passed and was signed by the Governor despite 
what one law firm’s analysis described as “fierce opposition from the Tennessee 
business community, local school boards, health care providers, and other
stakeholders”. (As an aside, all this state and federal COVID legislation has
become essentially a full employment act for healthcare and employment lawyers.)

In a gigantic “screw you” aimed at the medical board, the new law requires both 
the medical and osteopathic boards to develop rules if they are to discipline
practitioners for prescribing COVID-19 treatments. This means each board must go
through the laborious and time-consuming process I briefly described earlier,
including a review of the rules by the legislature’s Joint Government Operations
Committee, co-chaired by none other than Rep. Ragan, before a physician can be 
disciplined for substandard prescribing. I assume that, until then,
practitioners can prescribe whatever they want, including ivermectin,
hydroxychloroquine, homeopathy, Black Oxygen Organics, Miracle Mineral Solution 
(bleach), herbs, dietary supplements, essential oils, and whatever else their
tolerance for pseudoscience will allow, without risking discipline.

The new law also addresses monoclonal antibodies, allowing practitioners to
prescribe and administer them as a treatment for or prophylaxis against COVID if
they “exercise independent professional judgment” and “notwithstanding any
guidance or advice from a governmental entity to the contrary”.

I am not sure where this gets the prescriber, other than the ability to
disregard governmental (such as FDA or CDC) guidance. Although I could find no
exact definition of what “independent professional judgment” means in medicine
(the term doesn’t seem to have an agreed-upon definition), I don’t believe it
means that you can toss medical science in making a treatment decision or that
it absolves the physician of failure to meet standard of care. Even if
government guidance would be excluded from evidence of malpractice in a
disciplinary action against a practitioner, the board could still consider other
evidence of standard of care, such as expert opinion and medical literature.
But, of course, no disciplinary action can proceed anyway until the medical and 
osteopathic boards go through the cumbersome agency rule-making process.

If the board trips up and violates the new COVID law, a practitioner could bring
a civil action against it per the law’s creation of a private right of action, 
complete with compensatory damages and attorneys’ fees. Whether this happens or 
not, the threat is certainly there, dampening any appetite to pursue
disciplinary action which might possibly subject the board to litigation.

Not all Republicans are on board with the new law. Sen. Richard Briggs
(R-Knoxville), a physician and the only Republican senator who voted against the
bill, said that doctors have a responsibility to be a “reliable source of
information”:

   The Government Operations Committee (which will review any board disciplinary
   rules related to COVID), should not be telling the Board of Medical
   Examiners, who (are) charged with protecting the public health and safety,
   that they can’t do something to a doctor that’s intentionally giving known
   misinformation.

Sen. Heidi Campbell (D-Nashville) agrees:

   Once we start as a legislature telling doctors how to practice medicine to
   the point we’re intervening in their ability to perform their duties, then
   we’ve got a big problem.

    2. She added that this “disdain” for science is putting Tennessee in “big, big 
      trouble”. I think she’s right, only it’s not just in Tennessee.

Florida Surgeon General declares single positive COVID test proves immunity
forever

Florida’s Surgeon General, Dr. Joseph Ladapo, continues to defy scientific
consensus with new rules declaring a single positive COVID test proves one has
“natural immunity” forever. This is but one example of recently enacted laws and
similar efforts gutting public health protections in Florida, thanks to Ladapo 
and his boss, Gov. Ron DeSantis.

Jann Bellamy on December 30, 2021

Link



Once again defying the science, Florida’s new Surgeon General, Dr. Joseph
Ladapo, recently issued an “emergency” rule basically declaring that a single
positive COVID test, no matter when it was taken, proves that one has immunity
from COVID in perpetuity.

Per legislation recently passed by the Florida Legislature and signed by Gov.
Ron DeSantis, this “natural immunity” will exempt employees from private
employer vaccine mandates. This is only one of several loopholes to private
employer mandates created via the new law, which also guts other public health
measures designed to protect Floridians from COVID infection.

The new legislation was passed in a whirlwind three-day special legislative
session convened by DeSantis in November, a mere two months from the start of
the regular session in January, 2022. In my view (shared by others), this was
yet another act in DeSantis’s base-pleasing COVID theater, there being no valid 
reason any of this couldn’t wait a couple of months, or was necessary in the
first place.

In addition to providing exemptions to private employer vaccine mandates, which 
we’ll return to in a moment, legislation passed during the special session:

1. Prohibits school districts from imposing mask or vaccine mandates for students
and allows parents to take legal action against districts that don’t comply, as 
well as recover costs and attorneys’ fees. (This codifies into law DeSantis’s
previously-issued executive order, and yet another Department of Health
“emergency” rule, banning mandates.)

2. Prohibits school districts from quarantining asymptomatic students or school
employees (even if exposed to COVID) unless they have a positive SARS-CoV-2
test.

3. Bans public employee vaccine mandates altogether (including K-12 schools,
state-run healthcare facilities, and the state university system) and authorizes
fines for failure to comply.

4. Removes the state health officer’s authority to require vaccination during a
public health emergency.

5. Allocates $5 million to the state Attorney General to investigate complaints of 
violation of the new law and to fight federal vaccine mandates, with which this 
new legislation conflicts.

6. Begins a process intended to transfer responsibility for worker safety from the 
federal OSHA to a state agency.

The Legislature gave the Florida Department of Health, headed by Great
Barrington Declaration supporter and (former?) member of the fringe grifter
group, Americas Frontline Doctors, Dr. Joseph Ladapo, the job of fleshing out
some of the new law’s provisions via the enactment of rules, hence the Surgeon
General’s decision that positive COVID tests “prove” immunity.

Before we move on, let me update you on Dr. Ladapo’s tenure as Florida’s Surgeon
General, as he’s been in the news near-continuously since he was introduced to 
SBM readers in September, where his casting doubt on vaccines, cheerleading for 
hydroxychloroquine and ivermectin, spreading misinformation about masks, and
dumpster-diving in VAERS was reported. Since then, Dr. Ladapo has packed quite a
bit of controversy into less than four months in office. Dr. Ladapo

1. got his Florida medical license in record time (two days) and then had a
complaint filed against him with the medical board speedily dismissed;

2. was awarded an annual salary of $437,000 (the highest ever paid), including tens
of thousands of dollars from the University of Florida’s medical school, where 
he was also hired, and given tenure, in record time (for teaching and research) 
on the suggestion of a wealthy DeSantis donor, although the press reports that
Dr. Ladapo has yet to show up for work there;

3. continued to spread misinformation;

4. been kicked out of a state Senator’s office for refusing her request to wear a
mask due to what she described to him as a “serious condition”, later identified
as breast cancer, for which she was undergoing treatment. He has yet to
apologize, instead making up a lame excuse about not be able to “communicate”
while wearing a mask; and

5. starred in a PSA that barely mentioned vaccines, left out testing and mask
wearing altogether, yet promoted treatments of questionable effectiveness
(again).

With that, let’s turn to the exemptions to private employer vaccine mandates
created by the legislature and Dr. Ladapo’s new rules implementing those
exemptions.

Private Employer Vaccine Mandate Exemptions

Although DeSantis bloviated about banning all vaccine mandates, the new law, as 
applied to private employers, instead creates exemptions so easily met, and
penalties so severe for violations, that it might as well be a ban. In fact,
anyone wanting to evade a private employer vaccination mandate but unable to
figure out how is probably unqualified for the workforce in the first place.
Thus, DeSantis and the Legislature can claim that they are respecting a private 
employer’s right to make decisions about how to run his or her business while
effectively gutting it.

Per the new law, if a private employer requires vaccination, an employee can opt
out with:

1. Medical reasons, including “pregnancy or anticipated pregnancy”, based on a
physician’s, P.A.’s, or nurse practitioner’s “professional opinion”, made after 
examining the employee, that vaccination “is not in the best medical interest of
the employee”.

2. Sincerely held religious beliefs.

3. “Competent medical evidence” that the employee has immunity, “documented by the 
results of a valid laboratory test”.

4. Regular testing, at no cost to the employee.

5. Unspecified “employer-provided protective equipment”.

The Department of Health was directed to enact “emergency rules” to implement
these exemptions within 15 days and to create forms for claiming them. Per
current Florida law, emergency rules can be adopted by an agency only when

   an agency finds that an immediate danger to the public health, safety, or
   welfare requires emergency action, [in which case] the agency may adopt any
   rule necessitated by the immediate danger . . .

The law also requires that the agency state

   the specific facts and reasons for finding an immediate danger to the public 
   health, safety, or welfare and its reasons for concluding that the procedure 
   used is fair under the circumstances . . .

In this case, the Legislature obviated these prerequisites, without ever saying 
exactly what the emergency was or telling us what threat to the public it was
supposedly alleviating, by simply declaring that “all conditions [for enacting
an emergency rule] are deemed met”. It also tossed the usual requirement that
emergency rules be in effect for only 90 days, allowing these very special
emergency rules to remain in effect until the Department of Health could go
through the regular rule-making process, which involves notice to the public,
possibly a hearing, and can take months, even years, to complete (and probably
won’t be completed anyway before this portion of the new law expires on its own 
terms on July 1, 2023).

With the usual protections for the public from government overreach conveniently
short-circuited, Surgeon General Ladapo promptly issued the required emergency 
rules and forms.

For one, the Department of Health (presumably with a lot of “guidance” from
DeSantis and Ladapo), relying on its well-known expertise in theology, decided
that “based on religious reasons” included “sincerely held moral or ethical
belief(s)”, an expansion that is questionable, in my view, based on the
Legislature’s specifically using the term “religious reasons” in the new law.
The rule also prohibits employers from inquiring “into the veracity of the
employee’s religious beliefs”. In any event, the practical result of this
exemption is that any employee can claim it, no questions asked.

Now, from theology we move on to the science component of the rules, or the lack
thereof.

Per the Legislature’s direction to elucidate just what it meant by the term
“anticipated pregnancy”, the Department decided that if the employee intends to 
become pregnant and is of child-bearing age, that’s an “anticipated pregnancy”
and the employee’s representation must be accepted. The rule does not eliminate 
the requirement that a healthcare professional “document” this “medical reason” 
for a vaccination exemption (nor presumably could it be eliminated, based on the
explicit wording of the law), leaving the employee in the curious position of
having to get her doctor to sign off on her declaration that she intends to get 
pregnant, although the doctor, unlike the employer, is not prohibited from
inquiring into the patient/employee’s statement of her intent.

More disturbingly, the Legislature, by including pregnancy and “anticipated
pregnancy” as a “medical reason” for a vaccination exemption, is ignoring the
advice of the CDC, the American College of Obstetricians and Gynecologists, and 
the Society for Maternal Fetal Medicine, among others, that COVID vaccination is
safe for women who are pregnant or intend to become pregnant. Indeed, according
to the CDC,

   people who are pregnant or recently pregnant are more likely to get severely 
   ill with COVID-19 compared with people who are not pregnant.

And in requiring a healthcare professional to “document an exemption based on . 
. . pregnancy or anticipated pregnancy”, the Legislature and the Department
appear to be co-opting the medical community into endorsing its scheme. Per the 
exemption form devised by the Department, a physician, P.A., or nurse
practitioner must declare that

   It is my professional opinion . . . that COVID-19 vaccination is not in the
   best medical interest of the employee.

To claim an exemption based on “immunity”, the Legislature requires that

   the employee must present to the employer an exemption statement
   demonstrating competent medical evidence that the employee has immunity to
   COVID-19, documented by the results of a laboratory test performed on the
   employee. The Department of Health shall adopt a standard for demonstrating
   competent medical evidence of such immunity.

Of course, the only problem is that there is no such thing as “competent medical
evidence” demonstrating immunity via a lab test. Therefore, the Department
adopted an “emergency rule” incorporating incompetent medical evidence to
demonstrate immunity, that being an FDA-authorized or approved positive
diagnostic test or a positive antibody test, even though, according to the CDC,

   At this time, there is no FDA-authorized or approved test that providers or
   the public can use to reliably determine whether a person is protected from
   infection.

Diagnostic tests are designed to tell you if you have a current infection.
Antibody tests look for antibodies in your immune system produced in response to
the COVID-19 virus. Having a current infection does not mean you are immune
from future infection. Having antibodies doesn’t mean they are sufficient to
protect against an infection nor is there any agreed-upon level of antibodies
that might confer protection or consensus about how long protection might last. 
And relying on a prior infection or the presence of antibodies to protect you
sans vaccination subjects you to a much greater risk of getting reinfected than 
if you were vaccinated following a case of COVID. That is why the CDC (and
pretty much everyone else) advises those who’ve had COVID to get vaccinated. Yet
here we are.

The Department also devised an exemption form, which simply requires the
employee to attach the lab test results, check a box indicating whether it is a 
PCR, antigen, or antibody test, and provide the test date.

Notably, there is no limitation on how old the test can be. So, if an employee
had a positive diagnostic lab test in, say, January, 2020, the first time tests 
were made public in the U.S. (that is, almost two years ago), he can still use
that result as “competent medical evidence” he has immunity.

Nor is there any limitation on how recent the test can be. Under the literal
terms of the new law and the Department’s rule, an employee could submit a
positive diagnostic test performed the same day, which means he should be
quarantining, and meet the criteria for immunity.

In sum, in defiance of the expert consensus, the Legislature and the Dr. Ladapo 
have decided that (1) prior infection provides “natural immunity” from future
infection in perpetuity, and (2) lab tests not designed to demonstrate “natural 
immunity” are a reliable way to determine this “natural immunity”.

I sense that even the Department itself is somewhat befuddled by its new rules.

   When asked whether the department’s rule is making the case that natural
   immunity lasts forever, a department spokesperson referred a reporter back to
   the rule.

To ensure that private employers know the Legislature and Gov. DeSantis mean
business, heavy fines can be imposed for terminating an employee for refusing
vaccination: up to $10,000 for employers with fewer than 100 employees and up to
$50,000 for those with greater than 100 employees. Employees can file
complaints, which the law protects from public view, against their employers,
triggering a requirement that the Attorney General investigate and, if she finds
it appropriate, impose fines, giving the whole thing a star chamber quality.

All of this has left Florida employers in a “tough spot” according to one
employment law expert, who notes that employers must now try to figure out how
to comply with Florida’s new law, while at the same time comply with conflicting
federal vaccine mandates per OSHA, the Centers for Medicare & Medicaid Services
(covering healthcare employees), and federal contractor rules.

2. Meanwhile, Florida’s COVID infection rate continues to climb, again landing our 
state case rate in the U.S.’s top 10.

State legislators dispense with standard of care for COVID treatment and
encourage medical misinformation

State legislatures are considering bills that protect doctors and other health
care providers from being held accountable for using unproven COVID-19
treatments and spreading medical misinformation.

Jann Bellamy on February 10, 2022

Link



Legislators in several states have introduced bills, some of which have passed, 
protecting physicians who prescribe unproven COVID-19 prophylaxes and treatments
(like hydroxychloroquine and ivermectin) from discipline by state medical
boards. Other bills hamstring efforts to prevent the spread of medical
misinformation.

Such proposals, typically sponsored by Republicans and supported in
Republican-led statehouses, substitute the judgment of legislators, who often
have no science background, for that of medical peers, and relieve physicians of
the burden of adhering to a standard of care. As noted bioethicist Arthur
Caplan told a reporter, this type of legislation is “purely ideology
masquerading as medicine”.

Today we’ll take a look (in no particular order) at some of these efforts to
sacrifice good patient care on the altar of political expediency as well as
welcome pushback from the medical profession.

One bill has already become law in Tennessee where, as I explained in a previous
post,

   the legislature bull[ied] the state medical board into rescinding its COVID
   anti-misinformation policy and [threw] huge bureaucratic obstacles in the
   board’s way before it can discipline physicians who use unproven COVID
   treatments, including downright quackery.

By way of background, as noted in that post:

   In July [2021], the FSMB [Federation of State Medical Boards] issued a
   statement reminding physicians who spread COVID misinformation that they risk
   disciplinary action. Since then, according to the FSMB, at least 15 boards
   published statements about false or misleading information and at least 12
   boards have taken disciplinary action against a licensee. The FSMB is
   currently developing guidelines for medical boards to help address the spread
   of disinformation.

Although the statement did not address the use of unproven therapies, this
crackdown sent physicians, under threat from being held to the standard of care,
running to their friends in state government for protection from medical boards
doing their job.

Like Tennessee, North Dakota has already taken action. A new law protects from
discipline physicians, nurse practitioners, and pharmacists who prescribe,
dispense, or administer ivermectin, although a regulatory board can still take
action on another basis, such as inappropriate documentation, substandard care, 
or “any basis that would in the board’s determination harm the patient”.

This is somewhat of an improvement over the original bill, which would have
shielded the prescription of any drug off-label for the treatment of COVID-19,
as well as

   distributing documented medical information, providing information regarding 
   the licensee’s professional experience or observations, or speaking against a
   public official.

Which would be a cover for, say, distributing information “documented” in
sketchy source material or relying on “professional experience” that flies in
the face of evidence-based medicine.

The legislation was opposed by hospital, medical, and pharmacy groups, to no
avail.

In a sign of just how far down the rabbit hole some legislators have gone, one
of the bill’s sponsors, Rep. Bill Tveit,

   responded to data showing that unvaccinated people die at a higher rate with 
   his own data: screenshots of a self-reported article from doctor Stella
   Immanuel, who in October 2021 claimed she and her team treated more than
   7,000 patients, of which “only eight precious souls,” who she wrote had
   advanced stages of COVID, died. Immanuel, who was briefly boosted by Donald
   Trump when he was president, has also contended that the US government is at 
   least partially run by reptiles.

Fortunately, despite rowdy constituents who appeared at a committee hearing to
support the bill, Virginia rejected a similar effort. The state legislature
recently voted down a proposal that would have protected doctors and pharmacists
who prescribed or dispensed ivermectin and other off-label COVID-19 treatments.

In a particularly ham-fisted attempt, a Colorado bill was introduced last year
that would shield physicians, nurse practitioners, and pharmacists who prescribe
or dispense any FDA-approved drug off-label for the treatment of COVID-19,
specifically including hydroxychloroquine and ivermectin, as long as the patient
gives “informed consent”. Not only could providers not be disciplined for
prescribing, no matter their degree of negligence or the harm caused, regulators
were forbidden from even initiating an investigation of such conduct. Happily, 
the bill failed.

A bill introduced in Pennsylvania, and now before the House Health Committee,
would prohibit regulatory boards from taking disciplinary action against
physicians (as well as other providers) for prescribing, with the patient’s
“informed consent”, or dispensing, any therapeutic drug

   for off-label use to the patient for prophylaxis or for at-home, early-stage 
   outpatient or hospital inpatient treatment of coronavirus infections [not
   just COVID-19] causing respiratory syndrome-related illnesses . . . absent a 
   showing of recklessness or gross negligence.

As originally filed, there were no circumstances under which a physician could
be held responsible for inappropriate prescribing. It was only in the amended
bill that recklessness or gross negligence was added to allow disciplinary
action. Legally, this replaces the usual negligence standard (that is, falling
below the standard of care, or what a reasonable physician would do in similar
circumstances) with a very high bar. Although state law can vary, recklessness
generally requires a showing that the physician was “so careless that it is
considered an extreme departure from the care that a reasonable [physician]
would exercise in similar circumstances”. Gross negligence “demonstrates
reckless disregard for the safety or lives of others, which is so great it
appears to be a conscious violation of other people’s rights to safety”.

In Wisconsin, a group of legislators recently unveiled a set of so-called
“medical freedom” bills that prohibit hospitals and other health care entities
and credentialing agencies (such as the state medical board) from taking action 
against a health care provider

   for ordering an innovative or novel therapy based on his or her assessment of
   the patient and any available clinical data supporting the innovative or
   novel therapy.

The bills are startling in their breadth. They would apply to the entire range
of licensed health care providers in Wisconsin including, in addition to
physicians and nurses, chiropractors and massage therapists. “Innovative or
novel therapy” is undefined and is not limited to drugs. Protection from
disciplinary or other adverse action is not confined to treatment of COVID-19
and presumably applies to any disease or condition.

Of course, “any available clinical data” would allow the provider to cherry-pick
the data to support his choice of therapies. This is evidenced by the
legislators’ citation to a dodgy website, the anonymous “c19early.com”, for
treatments they claim are “demonstrating clear signals of efficacy and robust
safety profiles”. This includes the decidedly inefficacious ivermectin, the drug
of choice among the conspiracy-minded, such as the legislators themselves, who 
say that

   [m]any continue to speculate as to the exact reasons why the efforts of these
   health care professionals have been actively suppressed by those who have
   assumed the responsibility of dictating the response to the COVID-19
   pandemic.

In another demonstration of utter cluelessness, the bills’ proponents depict the
Front Line COVID-19 Critical Care Alliance [FLCCC] as

   health care professionals with first-hand experience treating COVID-19
   patients through each phase of the disease [who] worked tirelessly to
   identify and utilize early treatment options . . .

FLCCC has made several appearances here on SBM, and not in a good way. As Dr.
David Gorski details, the “brave maverick doctors” of FLCCC have concocted
COVID-19 protocols using ivermectin, vitamins, melatonin, zinc, mouthwash and
other nostrums, but

   [n]one of these protocols has anything resembling solid evidence from
   randomized clinical trials to support it.

A third “medical freedom” bill would prohibit pharmacists from refusing to
dispense a prescribed drug unless there is an “absolute contradiction” to the
patient’s taking the drug. This amends current law, which allows a pharmacist to
refuse a prescription if there is simply a “contradiction”. “Absolute
contradiction” means that the drug is

   not safe to be used as prescribed under any circumstance because of the
   severe or potentially life-threatening risks involved.

This is necessary, according to the bill’s sponsors, because, citing
hydroxychloroquine and ivermectin as examples,

   big government, corporate media, and big pharma have waged a war of
   intimidation on pharmacists who distribute medicines in the treatment or
   prevention of COVID-19.

Fortunately, the medical profession and hospitals are pushing back. According to
the Wisconsin Hospital Association:

   This legislation removes the most fundamental tool hospitals use to ensure
   safe patient care through medical staff governance and privileging. This
   legislation circumvents an existing evidence-based process medical staff
   within a hospital use to maximize the health and safety of the patients and
   communities they serve.

And, from the Wisconsin Medical Society:

   [W]e believe these bills are not necessary. Further, the bills appear to
   undermine some basic safeguards now in place that help prevent care that
   might fall below minimal accepted standards.

A bill has been introduced in Indiana that permits physicians and nurse
practitioners to create “standing orders” allowing pharmacists to dispense
ivermectin without a prescription. Per the bill, ivermectin thus dispensed is,
ipso facto,

   considered to be issued for a legitimate medical purpose in the usual course 
   of professional practice.

The standing order must “specify a mechanism to document the screening performed
with the patient” and the dose dispensed in the patient’s medical record, as
well as a “plan for evaluating and treating adverse events”.

The pharmacist must give the person receiving ivermectin under a standing order 
“a standardized information sheet” that has to include “the importance of
follow-up care and health care referral information” but cannot discourage the
recipient from using ivermectin for the treatment of COVID-19. Physicians and
nurse practitioners cannot be disciplined if the pharmacist fails to follow a
standing order and pharmacists cannot be disciplined if there is a defect in the
standing order.

Frankly, I am not sure how all this would work. How would the pharmacist verify 
that the standing order is legitimate? (I’m assuming here that the patient keeps
the standing order until he wants to use it?) Does giving the patient accurate 
information about ivermectin, such as the overwhelming consensus that it is
ineffective and its risks, constitute “discouraging” the patient from using it? 
Can pharmacists refuse to participate? (I assume, for one thing, that screening 
and other procedures will take time the busy pharmacist may not have to spend on
this sort of thing.) Who is to execute this “plan” for adverse events?

In any event, this bill is identical in language to one introduced in New
Hampshire, which may mean there is some as-yet-unidentified group pushing it.
Fortunately, according to a local news report, multiple medical experts
testified against this bill in a recent committee hearing. Also encouraging is
the news that a “fact-based” coalition made up of “more than 50 business
leaders, healthcare institutions and advocacy groups” has been formed in New
Hampshire to educate legislators and the public about COVID-related issues.

Finally, my state of Florida, is not about to be left behind in this race to the
bottom. Companion House and Senate bills would allow the medical and other
health care practitioner regulatory boards to discipline health care providers
for misinformation (called “free speech” in the bill) posted on social media
only if the board can prove “beyond a reasonable doubt” (the evidentiary
standard required for conviction in criminal cases) that the “free speech” “led 
to the direct physical harm” of an actual patient of the practitioner.

This is, in effect, an impossible standard to meet. Nevertheless, boards could
be fined up to $1.5 million (a figure apparently pulled from nowhere) each time 
they try to discipline a practitioner for “free speech” but fail to prove their 
case beyond a reasonable doubt.

    2. I’m sure it was merely a coincidence, but the House bill was filed just as
      we were learning that a Florida physician had lodged a complaint with the 
      medical board against our infamous Surgeon General, Dr. Joseph Ladapo, for
      spreading false information. To no one’s surprise, the complaint that was
      promptly dismissed, no threat of a $1.5 million penalty required.

Federal employment rights agency inundated with thousands of COVID-related
discrimination claims

Thousands of workers have filed complaints with the EEOC alleging COVID-related 
employment discrimination. It may take years of litigation to sort out the
application of federal anti-bias laws to these claims.

Jann Bellamy on April 7, 2022

Link



The U.S. Equal Employment Opportunity Commission (EEOC) has been inundated with 
COVID-related claims brought by workers charging that employers discriminated
against them in violation of the Americans with Disabilities Act (ADA), Title
VII of the Civil Rights Act of 1964 (Title VII), and other anti-bias laws.

The ADA, as the name implies, prohibits employment discrimination based on
disability. Title VII protects employees against discrimination based on race,
color, sex, national origin and, most importantly for COVID-related claims,
religion. The EEOC is responsible for enforcing these and other federal laws
that make it illegal to discriminate against a job applicant or an employee.
Filing a charge with the EEOC is a prerequisite for workers who want to file
anti-discrimination law suits against employers. The EEOC can file its own suits
as well.

According to Bloomberg Law,

   Since April 2020 through December 2021, the U.S. Equal Employment Opportunity
   Commission has received roughly 6,225 Covid-related charges of
   discrimination under federal civil rights laws, the latest agency data show. 
   In addition, the commission received more than 2,700 vaccine-related charges,
   most of which were in 2021 when vaccine requirements were introduced. . .

   About 66% of the Covid-related charges raised ADA violations, totaling around
   4,125. Meanwhile, the ADA was cited in 300 of the 2,700 complaints tied to
   vaccines.

The EEOC has not said which of the other anti-bias laws were cited in the
vaccine-related claims but, as Bloomberg Law noted, companies have reported a
flood of religious exemption requests under Title VII.

The EEOC apparently views these developments as of a piece with the virus’s
adverse effects on disadvantaged groups in general. In a statement issued in
early March, the agency said:

   The COVID-19 pandemic has proved to be a civil rights crisis in addition to a
   public health crisis and economic crisis . . . As we heard at our public
   hearing last year, it has disproportionately impacted people of color, women,
   older workers, individuals with disabilities, and other vulnerable workers.

The ADA and Title VII require employers to provide a reasonable accommodation to
a worker’s disability or religion unless doing so would pose an undue hardship.
But employers can raise a “direct threat” defense to fire or refuse to hire a
worker if the worker’s disability poses a threat to the health and safety of
other individuals.

As one might surmise, the intersection COVID and employment discrimination law
raises many novel and difficult questions for workers and their employers,
including what qualifies as a “disability” or a “reasonable accommodation” and
what constitutes a “direct threat”. The EEOC previously issued guidance for
addressing these and other COVID issues.

   That guidance made clear, for example, that not every person with the virus
   will qualify as disabled, but said the virus’s aftereffects [such as long
   COVID] should be considered under the ADA’s three definitions for a
   disability. Those cover actual physical or mental impairments that
   substantially limit a major life activity; an employer’s perception that a
   worker has a disability; or the worker’s record of impairment.

As for a worker claiming a religious exemption to an employer’s vaccine mandate,
the EEOC’s guidance said that the employer must provide a reasonable
accommodation “for the religious belief, practice, or observance” that prevents 
the worker from receiving the vaccine under Title VII, unless that accommodation
poses more than a “de minimis” cost or burden.

   If, however, an employee requests a religious accommodation, and an employer 
   has an objective basis for questioning either the religious nature or the
   sincerity of a particular belief, practice, or observance, the employer would
   be justified in requesting additional supporting information . . .

Further complicating the issue, the EEOC advised that “religion” is not limited 
to established religions like Christianity, Judaism and Islam. It also includes 
“religious beliefs that are new, uncommon, not part of a formal church or sect, 
or only held by a small number of people”. As well, “nontheistic beliefs can
also be religious for purposes of the Title VII exemption as long as they
‘occupy in the life of that individual’ ‘a place parallel to that filled by. . .
God in traditionally religious persons'”. Thus, “the non-discrimination
provisions of the statute also protect employees who do not possess religious
beliefs or engage in religious practices”.

Anti-vaxxer misinformation campaigns notwithstanding, the EEOC guidance also
clarified that, since COVID-19 vaccines don’t use technology that impacts
employees’ DNA in any way, the Genetic Information Nondiscrimination Act (GINA),
also enforced by the EEOC, is not applicable to COVID-19 vaccine issues in the 
workplace. GINA prohibits employers from “using, acquiring, or disclosing
genetic information”.

As has been true since Title VII was enacted in 1964, the meaning of terms in
the federal anti-bias statutes has been fleshed out in litigation, a very
expensive way for employers to find out whether or not their conduct violated
the law. And it can be a long wait for a definitive ruling. It was not until
2020 that the U.S. Supreme Court decided that Title VII’s prohibition against
sex discrimination covered LGBTQ workers, an issue that had remained up in the
air for years and about which different presidential administrations (and thus
the federal agencies they control) held opposing positions.

We are now at the very beginning of a long slog through administrative rulings
and court decisions that will flesh out the application of employment
discrimination laws to COVID-19. Even when the pandemic fades, long COVID will
require workers and their employers to navigate this new territory.

So, off we go. Since the start of the COVID-19 pandemic, the EEOC itself has
brought at least three lawsuits related to disability bias and COVID.

In its first disability accommodation lawsuit connected to the COVID-19
pandemic, the EEOC alleged that a Georgia pharmaceuticals manufacturing facility
manager was fired after her employer denied her request to continue working
from home because a heart condition heightened her COVID-19 risk. According to
the complaint, other employees were allowed to continue working from home after 
the facility reopened but the manager’s request was denied and she was
terminated.

The EEOC also filed suits, against a pharmacy and a coffee house, in Texas.
According to the EEOC, a pharmacy discriminated against a pharmacy technician
who suffered from asthma. He asked to wear a face mask to help protect him from 
the virus as an accommodation to his disability. The complaint alleges that the 
technician was harassed because of this accommodation request, taunted and
humiliated for questioning management’s policy prohibiting masks, and sent home 
on at least two occasions after asking to wear a mask, all of which lead him to 
quit his job.

(We have to ask: What sort of pharmacy prohibits mask wearing? Not one I’d want 
to trade with.)

In the second Texas suit, the EEOC’s complaint alleged that a coffee shop
violated the ADA when it denied two baristas with disabilities reasonable
accommodations and terminated their employment. Rather than provide the disabled
employees reasonable accommodations to minimize customer contact, according to 
the EEOC, the baristas were not allowed to return to work until a vaccine for
COVID-19 was developed, despite the fact that they were ready and willing to
work.

According to one lawyer practicing in this area:

   Regardless of the outcome, the case serves as a reminder that wise employers 
   should not refuse to allow employees to work based in the hopes of protecting
   employees from illness. Employers must first ascertain whether there is a
   direct threat to the employee or others. Only where an employee would pose a 
   substantial risk of significant harm to his/ her own safety or the safety of 
   others that cannot be significantly reduced or eliminated by reasonable
   accommodations should an employer deny an employee with a disability the
   opportunity to work.

Great advice. But you can bet that for every defense expert who will testify
that a particular employee posed “a substantial risk of significant harm” that
“cannot be significantly reduced or eliminated by reasonable accommodations” you
can find a plaintiff’s expert willing to downplay the dangers the employee
presented to fellow workers (and vice versa). In fact, testifying as plaintiffs’
experts in anti-discrimination cases could be a whole new income stream for
Great Barrington Declaration types who make a living discounting the dangers of 
COVID-19.

In sum, long COVID won’t be the only lingering manifestation of the pandemic.
We’ll have long-lasting litigation (and attorneys’ fees) as well.

Mercola and Kennedy sue Sen. Elizabeth Warren for combating their COVID
misinformation

Quack tycoon Joseph Mercola and anti-vaccine crank Robert F. Kennedy, Jr., have 
filed a lawsuit against U.S. Sen. Elizabeth Warren claiming she violated their
First Amendment rights when she complained that Amazon was peddling COVID
misinformation, citing Mercola’s recent misinformation-filled book on COVID as
an example.

Jann Bellamy on January 27, 2022

Link



Quack tycoon Joseph Mercola and anti-vaccine crank Robert F. Kennedy, Jr., have 
filed a lawsuit against U.S. Sen. Elizabeth Warren (D-MA) claiming she violated 
their First Amendment rights when she complained that Amazon was peddling COVID 
misinformation, citing Mercola’s recent misinformation-filled book on COVID as
an example. Anti-GMO and anti-vaccine activist Ronnie Cummins and the book’s
publisher are also plaintiffs.

According to a letter sent by Sen. Warren to Amazon last September, Amazon’s
search and “Best Seller” algorithms consistently returned “highly-ranked and
favorably tagged books based on falsehoods about COVID-19 vaccines and cures”
when her staff performed searches for terms like “COVID-19” and “vaccine”.
Mercola’s windbag-titled book, The Truth About COVID: Exposing the Great Reset, 
Lockdowns, Vaccine Passports, and the New Normal, which Cummins co-authored and 
for which Kennedy wrote the introduction, topped the list. Amazon had also
tagged the book as a Best Seller and the #1 Best Seller in the “Political
Freedom” category.

Mercola, Sen. Warren notes in her letter, has been identified as “the most
influential spreader of coronavirus misinformation online” and is apparently
using his book to drive sales of supplements, despite the fact the FDA warned
him to stop selling these supplements “for the unapproved and unauthorized
treatment of COVID-19”. She unfavorably compared Amazon’s lack of effort in
combating misinformation to that of fellow internet behemoths Facebook and
Twitter, who have more aggressively supervised their content.

Sen. Warren’s letter charged that Amazon had engaged in a “pattern and practice”
of spreading falsehoods and selling inappropriate products, conduct she deemed 
an “unethical, unacceptable, and potentially unlawful course of action”. She
asked that Amazon perform “an immediate review” of its algorithms and report on 
the extent to which they are directing consumers to books and other products
containing COVID misinformation.

In response, Amazon basically said that the algorithms worked as described
because that’s the way they are set up.

   As a retailer, we respect that our customers want access to a wide variety of
   viewpoints on the matter, which is why we continue to list the books in
   question.

Or, Sen. Warren characterized the response:

   they can eliminate misinformation if they want to do it—but they won’t.

And apparently they didn’t, because Mercola’s book, as of yesterday, has a
five-star rating based on over 5,000 reviews, is the #2 Best Seller in the
“Political Freedom” category and #1 in both the “Propaganda and Political
Psychology” and “Politics of Privacy and Surveillance” categories. Among the
tens of millions of titles Amazon sells, it ranks #1,153 in Books. Amazon did,
however, notify the publisher that it would no longer run ads for the book,
although Amazon did not cite Sen. Warren’s letter as the reason. Barnes & Noble 
decided not to sell the book, a decision it later reversed. Again, there is no
evidence linking the bookseller’s actions to Sen. Warren’s letter to Amazon.

Mercola and Kennedy are well-known to readers of this blog, but here’s a short
summary of their nefarious activities.

Mercola is a scofflaw osteopath who built a multi-million-dollar empire selling 
dietary supplements and various other nostrums, which he promotes by fomenting
distrust in “conventional” medicine and regulatory authorities, deceptively
presenting his products as the safer, more “natural” alternative. His false
claims for these products have gotten him in trouble with the FDA, as Sen.
Warren noted. He is also rabidly anti-vaccine and has donated generously to
anti-vaccine organizations. He is prolific spreader of misinformation on COVID
and well as other health topics, which aids his trafficking in quackery when
consumers buy into his rhetoric and his pricey products. This book is, in my
view, just another means of profiting off the pandemic.

Kennedy, in my opinion, has probably done more to sow distrust in vaccines,
including routine childhood vaccinations that have saved millions of lives, than
just about any other person living today. (The despicable Barbara Loe Fisher
and Andrew Wakefield are his chief competitors for the all-time record.) The
pandemic has presented him a golden opportunity to traffic in lies and
distortions about COVID and COVID vaccines, and he’s made the most of it,
earning himself a spot (along with Mercola) among the Disinformation Dozen as a 
major source of COVID misinformation. Just this past Sunday, Kennedy (employing 
a common anti-vaccine trope) compared vaccine mandates to laws in Hitler’s
Germany and invoked the name of Anne Frank. This “moral and intellectual decay” 
was rightly called out by the Auschwitz Memorial, among many others. Kennedy
later “apologized“.

Ronnie Cummins, Mercola’s co-author, is the leader of the Organic Consumers
Association, also funded by Mercola, which the Genetic Literacy Project calls
“one of them most aggressive of North America’s anti-GMO groups”. The group is
also anti-vaccine and republishes misinformation from highly unreliable sources 
like Mike Adams and Alex Jones.

I have not read Mercola’s book and do not plan to. Fortunately, Jonathan Jarry
of McGill University’s Office for Science and Society has, thereby giving us a
reliable source as to its contents. So, before we move on to the details of the 
lawsuit, let’s see what he has to say about The Truth About COVID (etc. etc.).

   Summarizing the book is, in effect, summarizing the misinformation
   surrounding COVID-19. In short, Mercola and Cummins argue that the SARS-CoV-2
   coronavirus was engineered in a laboratory in Wuhan, China, and its escape
   was capitalized on by every cabal, government, and corporation you can think 
   of to scare people into looking away while they stole most of the world’s
   financial resources for themselves. None of the diagnostic tests, treatments,
   or public health measures can be trusted; rather, the disease is mild and
   protection is afforded to smart people who have no health conditions, eat the
   right food, and load themselves up with the right supplements.

   Fact-checking the book’s thousands of erroneous claims would require weeks
   and, I suspect, the publication of a two-tome book.

Jarry does take a stab at pointing out some of the book’s factual errors and
exaggerations. For instance, the book insists that pandemic restrictions will be
“permanent” even as those restrictions are being lifted. It touts a supplement 
(quercetin, which Mercola conveniently sells) based on a computer simulation,
not an actual in-vivo study, that is a preprint and not peer-reviewed to boot.
Mercola’s fevered conspiracy mindset sees a pandemic preparedness simulation as 
evidence that the whole thing was planned.

So, in sum, people who have spent years profiting off misinformation with little
consequence have filed a lawsuit claiming their freedom to speak out has been
impaired. With that, let’s turn to some of the particulars.

The complaint, filed in the U.S. District Court for the Western District of
Washington (because that is where Amazon is) incorrectly styles Mercola an
“M.D.” (he’s a D.O.) and describes him as a “board-certified and licensed
physician”, itself a sad commentary on the unwillingness of medical
organizations and boards to sanction egregious conduct harmful to the public’s
health. Kennedy is described as “prominent lawyer and professor and the founder 
and CEO of Children’s Health Defense Fund”, the innocuously-titled but
vociferously anti-vaccine organization

The complaint quibbles with Sen. Warren’s characterization of the book as
containing “false and misleading” information, including content disparaging
COVID vaccines, which they defend as merely asserting that the vaccines’
effectiveness “has been wildly exaggerated and major safety questions have gone 
unanswered”. They attempt to support this by claiming

   many renowned scientists have questioned the safety and efficacy of the COVID
   vaccines and thousands of physicians have asked for more openness to
   alternative COVID treatments.

The “renowned scientists” they cite are physician and anti-vaccine conspiracy
theorist Robert Malone and former Trump advisor Peter Navarro, an economist,
writing in a Washington Times op-ed. The “thousands of physicians” are
signatories to a Great Barrington Declaration-type online manifesto that anyone 
can sign. To give you an idea of where that is coming from, Robert Malone
himself and yet another anti-vaccine MD, Peter McCollough, have signed on.

In any event, the plaintiffs contend, it doesn’t matter whether what they say is
truthful or not, their book is protected by the First Amendment and Sen.
Warren’s implication that Amazon’s conduct might be unlawful, as well as her
previous threats bust up Amazon on anti-trust grounds (unrelated to this
incident), could cause Amazon to take behind-the-scenes action to suppress their
views. Suing her in both her official capacity as a U.S. Senator and
individually, they seek a declaration that Sen. Warren has violated their
constitutional rights, a preliminary and permanent injunction against her doing 
so in the future, and damages.

The U.S. Attorney for the Western District of Washington, representing her in
her official capacity, filed opposition to the motion for preliminary
injunction, a Motion to Dismiss (which basically says that, even if everything
the plaintiffs allege in their complaint is true, they still don’t have a viable
claim) and a Motion for Summary Judgment (which says that, based on all the
undisputed facts, she wins).

She is represented in her individual capacity by election law expert and
Democratic operative Marc Elias, who joined in the U.S. Attorney’s arguments.

The trouble with the plaintiffs’ claims, the U.S. Attorney points out, is that
the plaintiffs don’t allege, nor have they presented, any evidence that Amazon
or anyone else has taken any action against anyone because of Sen. Warren’s
letter. In response, the plaintiffs say they don’t need any such evidence, that 
what they characterize as her “threat” to Amazon alone is sufficient as a matter
of law.

Other defenses are raised as well, such as sovereign immunity and the Speech or 
Debate Clause of the Constitution, but we won’t get that much into the weeds,
except to note a recent interesting case she cites, Association of American
Physicians & Surgeons v. Schiff.

The Association of American Physicians & Surgeons (AAPS) sued Rep. Adam Schiff
(D-CA ) after he, similarly to Sen. Warren, sent letters to Amazon, Google, and 
Facebook, encouraging them to use their platforms to prevent inaccurate
information on vaccines and requesting information about what the companies were
doing to prevent misinformation. He also, in an unrelated Congressional
hearing, questioned certain legal privileges these companies enjoyed. At no time
did he mention the AAPS.

SBM’s Dr. David Gorski called out the AAPS way back in 2008 as an organization
that

   tries to represent itself as a legitimate medical professional society, but
   in reality it promotes antivaccine views, HIV/AIDS denialism, and an Ayn
   Randian view of the world in which doctors are supermen, Medicare is
   unconstitutional, and the government should never interfere with physicians’ 
   prerogatives.

It is unsurprising, then, the AAPS has been promoting dubious COVID information.
In the lawsuit, the AAPS complained that, among other things, “Amazon removed
from its platform for streaming videos the popular videos Vaxxed and Shoot ‘Em
Up: The Truth About Vaccines“, both rank anti-vaccine propaganda.

When Amazon and other companies took action, resulting in the diminished ability
of AAPS and others to spread misinformation, the AAPS took umbrage and sued
Rep. Schiff although they, like Mercola et al., had no evidence that their
downfall had anything to do with him.

In a February, 2021, decision, the court granted Rep. Schiff’s Motion to Dismiss
the complaint based, in part, on the alternate grounds (1) that the plaintiffs 
had failed to allege anything but an “implied” connection between Rep. Schiff’s 
actions and that of the tech companies and (2) his immunity under the Speech or 
Debate Clause, which provides that

   for any Speech or Debate in either House, [Members of Congress] shall not be 
   questioned in any other Place.

The clause protects Members of Congress and Senators from lawsuits arising from 
their conduct during official legislative functions, such as hearings, as well
as when they engage in other activities in service to their elected office, such
investigations and gathering information.

    2. Whether or not she prevails on the Speech or Debate Clause defense, as
      pointed out in Sen. Warren’s argument in support of her motions,
      government officials are free to try to convince private parties to remove
      content protected by the First Amendment that they find dangerous to the 
      public’s health, but they are not free to coerce that removal through
      threat of legal action or government sanction. In her view, and mine, Sen.
      Warren’s letter falls far short of “coercion”. We’ll see if the court
      agrees, if it reaches this question at all, and otherwise how the case is 
      decided. Stay tuned.

Why are physicians threatened by efforts to report doctors to their state
medical board for COVID-19 misinformation?

It’s not “cancel culture” to delicense physicians promoting dangerous
misinformation about COVID-19. It’s quality control. Why do so many physicians
think it is?

David Gorski on January 17, 2022

Link



We at SBM have long lamented how physicians can practice quackery and promote
pseudoscience while spreading medical conspiracy theories and only rarely do
state medical boards do anything concrete to stop them. Indeed, so uncommon is
it for a state medical board to suspend or revoke the license of even the worst 
quacks that, when a quack does suffer sanctions from his state medical board, we
tend to write about it here. Examples include when Florida revoked the license 
of a “Lyme literate” doctor and New York sanctioned other promoters of the fake 
diagnosis that is “chronic Lyme disease“. (Of note, one of those New York
doctors sued Jann Bellamy and the editors of SBM, also naming some of us who had
long ago left or retired from this blog, for having written about him.)
Surprisingly to me, even pediatricians and other doctors who are leaders of the 
antivaccine movement have largely escaped discipline from their state medical
boards, to the point that it is noteworthy when they are actually disciplined,
with the example of Dr. Bob Sears and Dr. Paul Thomas coming to mind.

Counterexamples also come to mind, such as Dr. Rashid Buttar, who treated
autistic children and cancer patients with chelation therapy and referred to the
North Carolina Medical Board as a “rabid dog“. Two years later, he was free to 
practice again (mostly) unencumbered, having signed a consent decree with the
Board that reprimanded him and ordered him (1) to provide informed consent to
his patients as dictated by the Board; (2) to obey all laws, as well as rules
and regulations governing the practice of medicine in North Carolina; (3) to
notify the Board if he changes his address; and (4) to meet with the board
periodically. And don’t even get me started on cancer quack Dr. Stanislaw
Burzynski, who has been treating patients with his ineffective “antineoplastons”
for 45 years now, with at least three attempts by the Texas Medical Board
failing to stop the harm, the most recent attempt ending with a consent decree
in 2017 after four years. Meanwhile, doctors peddling COVID-19 misinformation,
such as Dr. Lee Merritt, COVID-19 quack Dr. Simone Gold, and long-time antivax
“leader” Dr. Sherri Tenpenny, are easily renewing their medical licenses.
(Tenpenny has long referred to vaccines as a method of “mass destruction” and
“depopulation” and more recently actually claimed that COVID-19 vaccines make
you magnetic, if you remember that gem from last year.) Worse, COVID-19 denying 
and quackery-friendly legislators are trying to hamstring state medical boards.

In the months after the pandemic first hit in 2020, many of my colleagues were
shocked to see the number of physicians promoting outright misinformation and
even antivaccine quackery about COVID-19. They shouldn’t have been. This was
completely foreseeable if only they had been paying attention. So was the shock 
expressed by colleagues that, for example, America’s Frontline Doctors (the ones
pushing hydroxychloroquine in 2020 and ivermectin last year whose number
included the infamous “demon sperm” doctor) didn’t suffer any consequences.
Quite the opposite, in fact. One of them, Dr. Joseph Ladapo, was nominated to
take charge of the public health bureaucracy in Florida, where he is now
implementing all manner of unscientific and dangerous COVID-19 policies. That’s 
why I was heartened to see colleagues wake up to the threat of misinformation
and the promotion of quackery, as manifested by the formation of No License for 
Disinformation, founded by Dr. Nick Sawyer and colleagues, whose goal is to
change the current situation, in which doctors promoting COVID-19-related
disinformation have faced virtually no consequences so far. Of course, I have
argued that NLFD doesn’t go far enough and that this effort shouldn’t be
primarily restricted to just COVID-19 misinformation and quackery, but do
welcome the baby steps towards a more general effort to hold quacks accountable.

You’d think that the vast majority of doctors would approve of a renewed effort 
to purge our profession of dangerous doctors practicing COVID-19 quackery and
promoting harmful misinformation. I like to hope that you’d be right, but lately
I’ve been seeing a number of doctors who are very disturbed by NLFD and have
been expressing their unease in op-eds and on social media. I’ve been seeing
more and more of this after a Maine physician named Dr. Meryl Nass had her
license suspended for promoting COVID-19 disinformation, although certainly
there are doctors who agree with me:

Regulatory action for physicians who spread #COVID #misinformation:

Maine is right! This needs to become standard. We witness the routine ruining of
lives & families that occurs when people are victims of misinformation and
scientific untruths.

Boundaries must protect. #Safety https://t.co/NRVlXfMQb4

— WesElyMD (@WesElyMD) January 13, 2022

There were others who were—shall we say?—much less enthusiastic about this
development. Why is this? Why are some doctors so uncomfortable over the idea of
state medical boards sanctioning doctors who promote COVID-19 disinformation?
Doctors, after all, hold a special high status in society. Because of our
medical expertise, physicians’ medical credentials lend credence to their
pronouncements and, when physicians promote pseudoscience and quackery, their
assumed expertise is trusted by much of the public.

“Cancel culture” vs. quality control

So what do I mean by doctors who come across as threatened by an effort to hold 
COVID-19 disinformation-promoting doctors accountable? Of course, there were
predictable responses like this from non-physicians, which were easy to dismiss:

Maine’s medical licensing board. How much were they paid to do this? They are a 
disgrace. Free speech is dead America. Wake up

— delete (@coffeejones123) January 13, 2022

You seem blissfully unaware that pretty much everything written off as a
conspiracy theory has been subsequently proven to be correct.

Maybe a little less righteous indignation and more critical thinking would be a 
good thing for you.

— Bob Johnston (@Lunatic__Fringe) January 13, 2022

I do so love how conspiracy theorists love to claim that every conspiracy was a 
“conspiracy theory” that was later shown to be correct. One key difference
between conspiracies and conspiracy theories is that conspiracies have strong
evidence to support that there was an actual conspiracy.

There were, however, reactions like this from doctors:

Should doctors lose their license for misinformation? Sure, if you can
distinguish between science and morality https://t.co/1XG6AyRbFA

— Saurabh Jha (@RogueRad) January 12, 2022

To be honest, I wasn’t sure what Dr. Jha’s point about this was. Moral arguments
can be just as misleading if they use pseudoscience, conspiracy theories, and
quackery to support them. In any event, Dr. Jonathan Howard and I responded:

Dr. Daly calls it “cancel culture”; I call it quality control.

— David Gorski, MD, PhD (@gorskon) January 13, 2022

Doctors who promote misinformation have long hidden behind the First Amendment
and “free speech” dating back to long before the pandemic. One prominent example
includes the Association of American Physicians and Surgeons (AAPS), which is, 
in essence, a medical John Birch Society camouflaged as a legitimate medical
professional society. I’ve written about the AAPS a number of times, relating
how it’s promoted antivaccine pseudoscience blaming vaccines for autism,
including a view that is extreme even among antivaccine activists, namely that
the “shaken baby syndrome” is a “misdiagnosis” for vaccine injury. It’s worse
than that, though. AAPS has promoted HIV/AIDS denialism, blamed immigrants for
crime and disease, promoted the pseudoscience claiming that abortion causes
breast cancer using some of the most execrable “science” ever, and not only
rejected evidence-based guidelines as an unacceptable affront on the godlike
autonomy of physicians; the very concept of a scientific consensus about
anything. Indeed, in August an AAPS member likened the recent statement by the
Federation of State Medical Boards (FSMB) endorsing disciplining doctors for
spreading COVID-19 misinformation to the Soviet NKVD, which led me to quip that 
at least he didn’t invoke Nazis.

I mention the AAPS for two reasons, first to contrast it with the doctors
expressing extreme reserve about NLFD and second to disabuse readers of the
concept that there aren’t a lot of crank MDs and DOs. It’s easy to make fun of
the AAPS, because it is truly a home for little but medical conspiracy theorist 
“brave maverick doctors” who “don’t follow the herd” even when the herd is
actually correct, hence the antivax and HIV/AIDS denial that has flowed from it.
However, the doctors expressing reservations most assuredly are not cranks.
(Although I didn’t recall ever having interacted with Dr. Daly before, I
actually rather like Dr. Jha.)

What is interesting is why doctors who practice science-based medicine would
react negatively, to the point of unironically echoing the whole “cancel
culture” talking point, leading to a continuation of the conversation:

And they should be perhaps the echo chamber of Twitter is affecting me. Battling
quackery and censorship is a challenging dual mandate.

— Ryan P. Daly, MD (@DrRyanPDaly) January 13, 2022

Actually, “Mr. Bond” makes an excellent point that echoes what we at SBM have
been saying for a long time.

Then there was this:

Who decides on what is mis-information?

— Terry Maratos-Flier (@Maratosflier) January 13, 2022

A flippant response would be to ask: If state medical boards can’t be tasked at 
determining what is quackery and misinformation, then who can? The response,
though, isn’t so flippant if you think about it, particularly in the context of 
my periodic laments over the last two decades over how state medical boards so
rarely ever actually discipline outright quacks like Dr. Buttar or Burzynski.
And if state medical boards can’t enforce even a minimal standard of
professional behavior, both in terms of treating patients and public health
messaging by licensed doctors, then what good are they? Sure, getting rid of
doctors who are impaired due to substance abuse disorders, who assault patients,
or who defraud third party payers and patients is good and necessary, but it’s 
not sufficient, nor is it “cancel culture” for state medical boards to sanction 
misinformation-spewing physicians.

Let’s take a look at the common concerns expressed by non-quack physicians about
NFLD.

Start with an “easy” example

In considering the whole issue of “cancel culture” and physicians’ reactions to 
Dr. Nass’ suspension by Maine, let’s start with the article that Dr. Jha cited, 
“Physicians React: Should Docs Lose Their Licenses for Spreading False COVID
Information?” The article breaks down physician responses on social media into
two categories, Yes, Those Doctors Are Doing Wrong and No, Those Physicians Have
a Right to Speak Their Beliefs. Since I am arguing the first point, I’ll be
focusing more on the arguments for the second, most of which boil down to a fear
that “science and controversial thought” were being “muzzled.” Interestingly,
these sorts of arguments came from perspectives that could be considered both
right and left wing. For example, here’s one who based opposition on distrust of
big pharma:

   Another clinician claimed the “truth is very difficult to discern from
   less-than-truth in a country running on a profit-oriented economic ideology.”

While, from the other side:

   “Who can determine exactly what is truth?” asked another clinician. “For
   sure, the ‘Federal Government,’ who ‘is here to help you,’ is not qualified
   to make such determinations, and who are you to make such a suggestion as to 
   remove someone’s license because they disagree with you. Give me a break!”

“What is truth?” How, very, very deep! (Really, most doctors are pretty crappy
at philosophy.)

While it is true that big pharma doesn’t have the greatest track record in terms
of its messaging, it does not follow from that history that it is impossible to
discern good science from bad or quackery from science-based medical care, nor 
do past errors by the federal government imply the same thing. Similarly, it is 
the state governments who set up state medical boards, which are made up of
physicians and stakeholders from the public, and no one—no one—is saying that
the federal government (or a state government) should take away a physician
license.

This is where my “easy example” comes in, specifically naming physicians who
deny germ theory and use that denial to spread antivax misinformation, something
I did last week on Twitter:

And, lest you claim that no doctor would ever deny germ theory, just let me say 
that I can provide a number of undeniable examples to you of just such doctors
(e.g., Kelly Brogan), along with the receipts. (I've been writing about this
sort of thing for nearly two decades.)

— David Gorski, MD, PhD (@gorskon) January 13, 2022

This, of course, is an “easy example” if you don’t overthink it. I’m not talking
about, for instance, the relative contribution of host susceptibility versus
the microbe to the development and severity of disease. I’m talking about the
very basic concept of whether “germs” cause disease at all, the denial of which 
is a longstanding belief in large swaths of alternative medicine and the
antivaccine pseudoscience spawned by it. I’m talking about people like Dr. Kelly
Brogan:

And there are many more like her out there. State medical boards rarely do
anything about them.

— David Gorski, MD, PhD (@gorskon) January 13, 2022

We at SBM have written about Dr. Brogan before. Recall that she was denying germ
theory years before the pandemic. Unsurprisingly, she continues to deny germ
theory when it comes to COVID-19. As I’ve said many times before, if there’s one
thing that those of us who have been struggling to counter medical
misinformation, quackery, and antivaccine pseudoscience frequently encounter,
it’s medical professionals and scientists who have a hard time believing us when
we describe just how unscientific, pseudoscientific, and just plain
conspiracy-addled various beliefs underlying alternative medicine and
antivaccine pseudoscience are. Surely, they seem to think, there’s no way anyone
could actually believe that in 2022! How wrong they are, and among the
alternative medicine beliefs that provoke the most disbelief among my colleagues
(and among educated lay people) is germ theory denial. Few doctors believe me
when I say there are people (and doctors) who deny basic germ theory. I have to 
show them the evidence.

Generally, most physicians expressing discomfort over medical board sanctions
for spreading health misinformation will agree that a physician like Kelly
Brogan, who denies basic germ theory, should face sanctions from her state
medical board. Certainly Dr. Daly did. Therein lies the trap. By conceding that 
promoting one very obvious sort of medical misinformation should be sanctionable
by a state medical board, the naysayers concede my main point, that state
medical boards should have the power to sanction physicians who promote
misinformation. The rest is just “haggling over the price” (to echo a famous
joke); i.e., determining what specific sorts of misinformation should be
sanctionable.

That’s when these doctors usually retreat into complaining that “dogma will
prevail” if sanctioning doctors on the basis of their spreading misinformation
becomes widespread. Then, even as they concede that misinformation coming from
doctors can be dangerous, they won’t take a stand on where to draw the line,
leading to exchanges like this:

So what misinformation would you say is worth pulling a license for?

Vaccines are full of graphene and hydra that will blow up your head when 5g
comes online?

— Ryan Bedell (@ryanbeed) January 14, 2022

Notably, Dr. Ryan never answered Mr. Bedell’s very reasonable question about
real world examples. Presumably he does not support sanctioning speech promoting
conspiracy theories like that, but maybe I’m wrong. He never answered the
question. Those of us who are trying to fight disinformation do not have the
privilege and liberty of not taking stands on these questions. No one is saying 
that these questions are easy in general, but sometimes they are. Kelly Brogan
and physicians who deny germ theory are not difficult cases, at least
conceptually. I concede that implementing standards for misinformation that
rises to the level of being dangerous is not easy.

“Settled science,” Or “What about scientific debate?”

Another common complaint by physicians over the move to sanction doctors
promoting misinformation is that no science is “settled” and that such
sanctioning will somehow inhibit “scientific debate”. For instance, here’s an
example from the Medscape article:

   However, many physicians worried that science and controversial thought were 
   being muzzled.

   “Absolutely no,” a doctor stated. “Who judges what is misinformation in this 
   age where debate is canceled? Science advances with challenge and it’s not
   about an authority dictating the allowable opinion.”

Again, I also quote Dr. Daly, who asks the questions:

Clearly. That’s a black and white example as can be. Not the slippery slope.
What theories are challengeable? Or is all science settled ?

— Ryan P. Daly, MD (@DrRyanPDaly) January 13, 2022

And appeals to the “art” of medicine:

That’s not the gotcha you think it is. I’ve literally been writing about this
very topic for nearly two decades. I’m manager of a blog devoted to these sorts 
of discussions.

— David Gorski, MD, PhD (@gorskon) January 13, 2022

This is, of course, a very common straw man fallacy frequently invoked whenever 
professional and scientific sanctions against physicians spreading
misinformation are advocated. Here are a couple of more examples from the
Medscape article:

   One specialist warned that if disinformation doctors are held responsible,
   then “that means a lot of doctors” will be “gone” because “almost anything
   that is written or said about COVID can be contested.”

   Another physician warned his colleagues about suppressing new ideas: “To
   condemn what we didn’t try, or purposefully ignore a different approach
   because [it] doesn’t agree with our opinion is suppression of information.”

Here we go again with “What is truth?”

My response is simple. No one is suggesting, much less arguing, that “all
science is settled” or that state medical boards should strip doctors of their
medical licenses for taking medical or scientific positions that are reasonably 
debatable from a scientific standpoint. Certainly, I’ve never made that claim,
nor have I argued anything like this. I do, however, argue that there are
certain scientific conclusions in medicine that are as close to being “settled” 
as one can imagine, to the point that not accepting them is unscientific
quackery. Basic germ theory is one. That homeopathy is physically impossible is 
another. As I like to say about homeopathy, for homeopathy even to have a chance
of working would require not just that huge swaths of very well-established
theory in physics and chemistry be wrong, but that they be spectacularly wrong. 
Another way of putting it is that to provide sufficient evidence to make
homeopathy physically plausible would require a level of evidence that can
topple major theories undergirding our current understanding of chemistry and
physics. I generally conclude by saying that all theories are “challengeable”,
but that simply denying them based on no evidence (or on highly dubious
“evidence” and conspiracy theories) is not a “challenge” that professional
societies and medical boards are obligated to take seriously as “scientific
debate”.

Similarly, just because the science of COVID1-19 is rapidly evolving, having
started out with us knowing little about the coronavirus, its mechanism of
activity, its transmissibility, and the like, contrary to the claim that “almost
anything that is written or said about COVID can be contested”, it’s not as
though we know nothing about it. Even in the early days of the pandemic we knew 
a lot about coronaviruses, of which SARS-CoV-2, the coronavirus that causes
COVID-19, was a novel example. For example, as early as January 2020, I could
say with a great deal of confidence that SARS-CoV-2 was not a result of a
vaccination campaign in China against the flu vaccine.

To sum it up, rapidly evolving science and a lack of knowledge do not mean no
knowledge or that we cannot with a high degree of certainty know what is not
true or recognized science denial and conspiracy theories when we see them. It
doesn’t mean we can’t know quackery when we see it. Moreover, it’s now nearly
two years since the pandemic hit the US. The “fog of war” argument about the
lack of scientific knowledge regarding COVID-19 and SARS-CoV-2 is much less
compelling now than it might have been in March 2020.

Aside from that, doctors also often express fears that such sanctions will shut 
down “nuance”:

There is tremendous multi-faceted COIs in medicine, hype, and misinterpretations
of what trials actually inform us – just see poop-show of nutritional science. 
Let none of my comments be thought of as anti-vax, I’m pro-nuance. And Pro-vax.

— Ryan P. Daly, MD (@DrRyanPDaly) January 13, 2022

Here’s the problem. We are not dealing with “nuance,” and the fallacy that we
are talking about here is not anything resembling “scientific debate”. It’s
denialism. On a conceptual level, it’s no different than the denial of, for
example, climate science, evolution, or that HIV causes AIDS. Indeed, germ
theory denial is a form of denialism, as is antivaccinationism. Physicians who
express concern that holding physicians who are promoting denialism to account
will somehow shut down scientific debate are doing exactly what brothers Mark
and Chris Hoofnagle warned about years ago, mistaking denialism for debate. It’s
exactly the trap that disinformation peddlers want you to fall into. Denialism 
generally involves at least more than one of five things: conspiracy theories,
fake experts, cherry picked evidence, impossible expectations (and moving
goalposts), and, of course, logical fallacies.

Speaking of logical fallacies…

“It’s a slippery slope”

Another oft-expressed concern is that if state medical boards start sanctioning 
doctors promoting COVID-19 misinformation, it’ll be a slippery slope to their
sanctioning all sorts of other things. In other words, they express fear that
“gray areas” will end up being sanctioned. Examples include (and I don’t mean to
keep picking on Dr. Daly, who seems sincere and dedicated to evidence-based
medicine, but he sums up the common arguments rather succinctly). Here’s another
invocation of the “slippery slope”:

Yes clearly. Not my larger point. There’s a role for sanctions and quality
control. For each egregious example there’s is a grey zone one. Or uncommonly
something we’re just frankly wrong about as a profession. Blackswans.

— Ryan P. Daly, MD (@DrRyanPDaly) January 13, 2022

And:

Not sure we are arguing the same argument here. And likely agree on many points.
Arguing dualMandate of balancing quackery and censorship is a hard one with a
slippery slope. Not an all or none arguement

— Ryan P. Daly, MD (@DrRyanPDaly) January 13, 2022

Again, no one claims that this is an all-or-none argument. I’ll also point out
that, contrary to what some argue, a slippery slope argument is not always a
logical fallacy, conceding that there can be occasional valid uses of it. The
are, however rare, and I agree that is it almost always a logical fallacy that
avoids the specific question at hand and instead distracts with extreme
hypotheticals, all without any evidence that the action proposed will lead to
the chain reaction suggested, ultimately resulting in the undesirable
consequences proposed, which become increasingly improbable the farther along
the chain reaction of consequences one drifts. It’s an appeal to fear, not
reason.

At its essence, the slippery slope argument, whether the person deploying it
realizes it or not, is always an argument to do nothing, based on invoking the
fear of some inevitable awful consequence somewhere down the line if a first
step is taken.

This wasn’t a doctor who said this, but it is a more extreme example of what I’m
talking about:

What's next? The gulag for her? This is all disturbingly similar to Stalin's
Soviet Union.

— Swamp_Yankee (@BenFranklin1171) January 13, 2022

And:

It's not the vaccine , a flu shot never gave us a yearly card, we saw health
cards in nazo Germany, lest we forget.history can repeat itself. They could
easily have bred and trained covid sniffing dogs to eradicate covid they chose
not to

— nashville kittens12 (@Happycats678) January 13, 2022

None of the doctors that I encountered went as far as putting Nazi Germany or
the Gulags at the end of their slippery slope, but at their core their arguments
were not far removed from this.

Whataboutism

The final sort of argument that I’ve seen involves something known as
“whataboutism” or “whataboutery”. In brief, whataboutism is a logical fallacy
and rhetorical technique of distraction in which a person responds to a
criticism with a counter-accusation in order to divert attention to a different 
topic. The origin of the term goes back to the Cold War, where it was coined to 
describe the oft-used technique by the Soviet Union to counter various charges
made against it. The following is a classic example:

   One clinician suggested enforcement against health food, drug company
   commercials, and talk shows: “What about all the [misinformation] at the
   health food stores and the like. Doctors of natural-whatever? Those
   info-commercials on tv. How many faxes do I get to ‘approve’ because
   ‘patients request’ braces and pain-treating expensive compounds advertised on
   TV? We tolerate those…. What about Dr Oz and the docs on talk shows claiming
   BS?”

This bit of whataboutism is not nearly the “gotcha” that physicians (and others)
making this argument think it is, at least not to me. I’ve been arguing to do
something about all of these things for a very long time, as has everyone here
at SBM. Need I remind you how often we have written about the licensure of
quacks, Dr. Oz, and quackery in pharmacies? And that’s just a small sample.

State medical boards vs. COVID-19 (and other) misinformation

State medical boards are in a difficult situation that has only become more so
with the rise of quacks promoting COVID-19 misinformation. I’ve long lamented
how reluctant they are to discipline doctors practicing quackery and promoting
antivaccine conspiracy theories and other dangerous misinformation, even before 
the pandemic. It was a problem that few seemed to appreciate or have much desire
to do anything about. Worse, whenever state medical boards actually did
something about it, it became obvious that quacks had considerable political
pull in some states. The example that I like to cite the most often is that of
Dr. Rashid Buttar, whom I mentioned earlier. Buttar led a successful effort by
the North Carolina Integrative Medical Society to get legislators to change
state law to make it friendlier to practitioners of alternative medicine.

Then the pandemic hit, and finally the severity of the problem of doctors using 
their professional status to spread misinformation is being appreciated, perhaps
for the first time. Unfortunately, we as a profession have a lot of members who
either can’t or don’t want to see it as a problem. I suspect that the reason
now is similar to the reasons then, involving our dislike of “being told what to
do” and an attitude that any of us could fall victim to a bogus complaint to a 
state medical board. (Ironically, I myself have experienced exactly that, when
several years ago a patient of Stanislaw Burzynski reported me to my state
medical board for my blog posts about her case.) I get it. I also get that a lot
of my colleagues and I have to make medical decisions based on less than ideal 
evidence bases all the time (the “art” of medicine). Unfortunately, too many of 
us extrapolate that to justify what quacks do.

    2. That needs to change, and we need to work to clean up our own profession.
      Before the pandemic, I wouldn’t have cared so much where we started, with 
      quacks like Stanislaw Burzynski or with antivaxxers like Paul Thomas.
      Given that we are still in the middle of a pandemic that’s killed
      northward of 800K in just the US alone, starting with doctors promoting
      COVID-19 misinformation makes a lot of sense. As imperfect as it is and
      even if it doesn’t go far enough for my tastes, NLFD is as good a strategy
      to start with as any. Again, this is professional quality control, not
      “cancel culture”, and, even if it were, not all “cancel culture” is a bad 
      thing.

Heritage Covid Commission Wants China Accountable… What About Trump?

The Heritage Foundation’s COVID-19 Commission Calls for Chinese “Accountability”
for US Pandemic Damage

Allison Neitzel on July 14, 2024

Link



On July 8, The Heritage Foundation released a report from their own
‘Non-Partisan Commission on China and COVID-19’ and held an event bearing the
same name as the report’s title: “Holding China Accountable for Its Role in the 
Most Catastrophic Pandemic of Our Time: COVID-19.” This commission, from the
organization behind Trump’s Project 2025, lays out recommendations for legal and
policy strategies for the White House and Congress to take against China.

.@JohnRatcliffe and the @Heritage Nonpartisan Commission on China and COVID-19
have built a blueprint to hold China accountable for Covid-19.Read the
commission's recommendations 👉 https://t.co/VWupKcOud3
pic.twitter.com/VS6SiMWL85

— Heritage Foundation (@Heritage) July 9, 2024

Doubling down

I previously discussed Heritage’s “Road Map for COVID-19 Congressional
Oversight” that the decidedly partisan House Select Subcommittee on the
Coronavirus Pandemic (HSSCP) appears to be following. It embraces Trump’s
“censored” herd immunity-pushing doctors and promotes the evidence-lacking lab
leak origin theory. Unsurprisingly, this new Heritage report doubles down on the
lab leak as part of their arguments to hold China accountable for U.S. pandemic
damage.

HSSCP Chairman Rep. Brad Wenstrup (R-OH) gave introductory remarks at the July 8
event hosted by Heritage president Kevin Roberts. Also featured were:

  1. John L. Ratcliffe, a former Republican Congressman, the Director of National
    Intelligence under Trump, and a Heritage visiting fellow

  2. David Feith, an adjunct senior fellow at the Center for a New American
    Security and former Deputy Assistant Secretary of State for East Asian and
    Pacific Affairs in the U.S. Department of State

  3. Jamie Metzel, founder of OneShared.World who served on the U.S. National
    Security Council and in the State Department in the Clinton administration

  4. Dr. Robert Redfield, the Director of the Centers for Disease Control and
    Prevention (CDC) under Trump

Metzel and Redfield have both promoted the lab leak theory and testified before 
the HSSCP during a March 2023 hearing on COVID-19 origins as guests of the
Republican subcommittee majority.

Who are these people?

Redfield, a controversial figure from the HIV crisis, has been sharply
criticized for his CDC’s handling of the pandemic outbreak. Under his
leadership, the CDC rejected the World Health Organization’s COVID-19 test in
favor of creating a more complicated one, which faltered and wasted crucial
early weeks in the U.S. response.

Later, the public messaging of Redfield’s CDC was commandeered by the Trump
administration. An October 2022 report from the HSSCP’s Democrat-led
predecessor, the House Select Subcommittee on the Coronavirus Crisis (HSSCC),
detailed the unprecedented political control exerted over their gold-standard
Morbidity and Mortality Weekly Reports during a time of crisis. While Redfield
broke with Trump over the importance of masks, he was largely seen as submissive
to the then-president.

Another controversial COVID-19 character from the former president’s
administration, Dr. Robert Kadlec, who served as Assistant Secretary for
Preparedness and Response in the Department of Health and Human Services (HHS)
under Trump, is listed as a “commissioner” of the new Heritage report. Going
into the pandemic, Air Force veteran Kadlec was said to have been more focused
on bioweapons than his public health-focused Obama era predecessor Dr. Nicole
Lurie.

In May 2020, Dr. Rick Bright, who Kadlec had removed from his position as head
of the Biomedical Advanced Research and Development Authority the previous
month, filed a whistleblower complaint against Kadlec and the HHS (settled the
following year) and testified before Congress about the lack of leadership and
plan within the pandemic response.

Trump’s Big HCQ Lie

Bright claimed he was ousted over his raising concerns about the Trump
administration’s embrace of the anti-malarial drug hydroxychloroquine (HCQ) as a
COVID-19 cure and their desire to make it publicly available outside of
clinical trials. Trump’s promotion of HCQ as a “game changer” forced his chief
medical advisor Dr. Anthony Fauci to publicly counter the president, damaging
their working relationship. HCQ would prove ineffective against the virus in a
major trial by early June 2020.

An August 2022 HSSCC report details Trump insiders’ behind-the-scenes “knife
fight” with the Food and Drug Administration over HCQ and their relentless (but 
ultimately failed) attempts to get its COVID-19 emergency use authorization
reapproved after it had already proven ineffective. At the same time, a group of
right-wing physicians, America’s Frontline Doctors (AFLDS), was brought
together in coordination with the Trump 2020 reelection campaign to publicly
push the MAGA-endorsed, scientifically disproven pandemic miracle drug and
instill faith in reopening the U.S. economy before a vaccine was available.

Pot, meet Kettle

Troublingly, Heritage continues to uphold Trump’s Big HCQ Lie. Pharmacist and
Heritage fellow David Gortler testified before the HSSCP in March, stating that 
those who prescribed HCQ or its follow-up GOP “cure” ivermectin were correct to 
do so. They were not, and Heritage and the HSSCP have been working to protect
Trump and the GOP by distracting from pandemic leadership failures and
gaslighting the public.

“To the countries, physicians, & pharmacists who prescribed ivermectin or
hydroxychloroquine…you were right.” – Dr. David GortlerWe’ll never forget those 
who gaslit Americans about COVID treatments and tried to force Americans to take
the vaccine. pic.twitter.com/UJInVqdSdb

— Heritage Foundation (@Heritage) July 10, 2024

The new Heritage report opens by quantifying the U.S. pandemic damage, citing
the 1.1 million American death toll and their calculation of $18 trillion in
economic losses. While the report “does not rule out that many other
governments, institutions, and individuals may have played contributing roles in
the pandemic,” it asserts that “China has been in a league uniquely of its own 
in its active and aggressive opposition to honesty, transparency, and
accountability regarding the virus and its spread.”

The seriousness with which the Heritage report takes the damage wrought by
COVID-19 must be contrasted with the actions of public health-antagonizing and
publicly non-transparent Trump during the early days of the pandemic. Despite
privately confiding in journalist Bob Woodward that COVID-19 was “deadly stuff” 
in early February 2020, Trump tweeted that the situation was “very much under
control in the USA” and referred to the virus as the Democrats’ “new hoax”
during a rally later that month.

The Coronavirus is very much under control in the USA. We are in contact with
everyone and all relevant countries. CDC & World Health have been working hard
and very smart. Stock Market starting to look very good to me!

— Donald J. Trump (@realDonaldTrump) February 24, 2020

Casualties of politics

As Fauci recently recounted, the former president – who was focused on his 2020 
re-election campaign and desperate for the pandemic to disappear – went from
embracing HCQ as a pandemic quick fix to bringing in contrarian advisors like
Dr. Scott Atlas who told him what he wanted to hear, science be damned.

Heritage’s “Road Map” highlights Great Barrington Declaration authors turned
HSSCP “experts” Drs. Jay Bhattacharya and Martin Kulldorff, who are subjects of 
a June 2022 HSSCC report on their “dangerous and discredited herd immunity via
mass infection strategy”, insinuated themselves into the Trump White House with 
Atlas. Their work was done behind the back of White House Coronavirus Response
Coordinator Dr. Deborah Birx, who testified to the HSSCC in 2022 that Atlas’s
presence “destroyed any cohesion in the response in the White House itself.”

Birx stated that failure to deliver “concise, consistent communication about the
seriousness of the pandemic resulted in inaction early on across our agencies” 
and “created a false sense of security in America.” She claimed this federal
mismanagement led to 130,000 preventable COVID-19 deaths before the vaccines
were available.

The GOP – and groups like AFLDS – would wage war on the life-saving vaccines,
creating massive public confusion leading to 232,000 preventable unvaccinated
COVID-19 deaths during the delta and initial omicron waves and an increased
death rate among Republican voters compared to their Democrat counterparts by
2022.

Look! Over there!

While the Heritage report claims to “lay the groundwork for holding accountable 
those whose negligence or overt actions exacerbated the pandemic’s severity,”
this only extends to China. Through their HSSCP “Road Map,” Heritage has laid
the groundwork for Trump and the MAGA GOP’s evasion of accountability for lack
of leadership and exacerbation of the pandemic’s severity in the U.S. While the 
commission has wrangled some individuals with Democrat pedigrees in order to
call themselves “non-partisan,” this report must be viewed in the context of
Heritage’s other work.

There is agreement throughout the scientific community and across the political 
aisle that China has not been forthcoming with information regarding the
COVID-19 outbreak. There should be calls for accountability for this, but not in
the absence of calls for accountability for our nation’s own failures in 2020. 
China is not responsible for Trump’s dereliction of duty.

All over the World the CoronaVirus, a very bad “gift” from China, marches on.
Not good!

— Donald J. Trump (@realDonaldTrump) May 28, 2020

There must be an understanding that China’s lack of cooperation and transparency
in investigating how COVID-19 came to upend global life does not make it any
more likely that the virus emerged from a lab leak at the Wuhan Institute of
Virology. The consensus amongst the majority of virologists is still that the
COVID-19 pandemic most likely occurred as a result of animal spillover, as has
been the case in previous pandemics.

Bring in the scapegoat

But the lab leak narrative generates emotion and buzz. And, in addition to
distracting from Trump’s failures, it has had the added benefit of being a
narrative the HSSCP could weaponize against MAGA Public Enemy #1 – former
director of the National Institute of Allergy and Infectious Diseases Anthony
Fauci — via questions regarding US funding of viral research in Wuhan. Thus
far,however, the HSSCP’s attempts to smear Fauci with this have fallen flat and 
garnered the now retired doctor support from both Democrats and the public

The same cannot be said for Peter Daszak. As the president of EcoHealth Alliance
– an organization that conducts federally-funded global research into viruses, 
which has included work at the WIV – Daszak has been the target of a years-long 
unfounded attack originating under Trump, who was quick to push the lab leak
narrative. Most recently, this has seen Daszak dragged before the HSSCP and
debarred from funding, putting the organization’s future at risk.

EcoHealth has a decades-long track record of important work researching viral
epidemics and attempting to predict and thwart viruses that pose a risk to human
life. This must be understood as a form of international security. Shutting
them down for a short-sighted political strategy or a geo-political agenda only 
harms us.

What’s to be done?

In the calls for accountability for the Trump administration’s mishandling of
the pandemic outbreak and MAGA’s subsequent vengeful war on science, we must
include the atrocious treatment of our own scientists over the last few years.
And we must not let the deeply politically compromised Heritage Foundation drive
this discussion on pandemic accountability.

The Oregon Medical Board suspends the medical license of antivax pediatrician
Dr. Paul Thomas

Late last week, the Oregon Medical Board suspended the licenses of two
physicians, one for bragging about not wearing a mask around his patients, the
second being Dr. Paul Thomas, an antivaccine pediatrician, whose continued
practice was deemed a threat to his patients. It’s time for more state medical
boards to step up, as Oregon’s has.

David Gorski on December 7, 2020

Link



If there’s one thing that the COVID-19 pandemic has made all too painfully
undeniable, it’s that there are a lot of healthcare professionals out who are
very awful people, with very awful, unscientific beliefs about the pandemic,
pushing awful unproven treatments, unscientific treatments, or even just plain
quackery (often based on conspiracy theories) to prevent or treat COVID-19,
while denying the efficacy of public health interventions such as masking and
social distancing, using bad science to deny the severity of the pandemic, and
even participating in the ongoing disinformation war against COVID-19 vaccines
being waged by antivaxxers. Sadly, more than a few of these disinformation
spreaders are physicians, with some of the usual antivax physician suspects
jumping on the COVID-19 denial grift train so effortlessly. Sadly, physicians
behaving badly is nothing new, as there are antivaccine pediatricians(!) like
Dr. Bob Sears and Larry Palevsky, and many have been the times that I’ve
bemoaned the seeming inability of state medical boards to act to take away the
licenses of quacks like Stanislaw Burzynski (who’s managed to keep practicing in
Texas since the late 1970s despite peddling nonsense) and antivaxxers who
endanger their patients—or even of just run of the mill utterly incompetent
surgeons.

That’s why I was so elated over the weekend to see a medical board doing what
medical boards should do. I’m referring, of course, to the Oregon Medical Board,
which recently decided to act against the licenses of two doctors spreading
disinformation about medicine and thereby endangering their patients and the
public, Dr. Steven LaTulippe and Dr. Paul Thomas, the latter of whom will be the
main topic of this post, for reasons that will become apparent as you continue 
to read. I will, however, mention first why the Oregon Medical Board suspended
Dr. LaTulippe’s license first:

From a local news story:

   The Oregon Medical Board suspended the license of an Oregon doctor who said
   he refuses to wear a mask in his clinic while also encouraging others to not 
   wear masks.

   Dr. Steven LaTulippe told a pro-Trump rally in November that neither he nor
   his staff wears a mask while working in their Dallas, Ore. clinic. That
   violates a state order requiring health care workers to wear a face-covering 
   in health care settings.

   Members of the medical board voted Thursday evening to suspend LaTulippe’s
   license immediately. According to a statement on the Oregon Medical Board
   website, the suspension was issued “due to the board’s concern for the safety
   and welfare of licensee’s current and future patients.”

   The indefinite suspension prevents LaTulippe from practicing medicine
   anywhere in the state. LaTuilippe ran a family practice clinic called South
   View Medical Arts in Dallas, Ore.

I found it particularly amusing that it was the Oregon Republican Party that
posted the video that led to the spotlight being shone on Dr. LaTulippe’s crank 
beliefs and ultimately to his license being suspended:

Nice job, Oregon Republicans! More videos like this, please, so that we can
identify other COVID-19 denying quacks for the Oregon Medical Board to examine! 
There’s so much disinformation in just Dr. LaTulippe’s brief remarks, including 
his claims that SARS-CoV-2, the coronavirus that causes COVID-19 is rapidly
mutating and has already mutated into something else (not true), meaning that
COVID-19 is “over” (whatever that means). Someone like him should not be let
anywhere near COVID-19 patients, and not just because he believes so much
nonsense but because his failure to adhere to infection control protocols (like 
facemasks) will facilitate the spread of the virus, possibly to his other
patients.

The Oregon Medical Board suspends the medical license of antivaccine
pediatrician Dr. Paul Thomas

I’m more interested in the story of Dr. Paul Thomas, than that of Dr. LaTulippe.
The reason is that Dr. Thomas is an antivaccine pediatrician whom I’ve been
covering for nearly three years at my not-so-secret other blog but who, for
whatever reason, has only been briefly mentioned in passing here on SBM. He is, 
like Dr. Bob Sears, a pediatrician. Like Dr. Sears, he has also made a name for 
himself promoting antivaccine pseudoscience, propaganda, and disinformation,
even writing a book, like the one written by Dr. Sears, that promotes an
“alternative” vaccine schedule not based in science. Unlike Dr. Sears, he has
claimed to do “science” to support his assertions that unvaccinated children are
healthier than vaccinated children. (More on that later.) From my perspective, 
it appears that Dr. Thomas is much more into “integrative pediatrics” woo than
Dr. Sears, which puts him on a similar level with another antivaccine
pediatrician, Dr. Lawrence Palevsky, who showed up in the news a year and a half
ago during all the measles outbreaks in Brooklyn and Rockland County, NY
spreading antivaccine pseudoscience to Orthodox Jews.

The suspension of Dr. Thomas’ license last week by the Oregon Medical Board
provides me with the perfect pretext to discuss him, as he’s been a rising star 
in the antivaccine movement since around 2017 or 2018 and recently made waves
with a really awful “vaxxed/unvaxxed” study that claimed to find that
unvaccinated children are healthier. More importantly, it provides me with the
opportunity to discuss my belief that antivaccine physicians should lose their
medical licenses because, by definition, they are practicing so far below the
standard of care that they endanger their patients.

Here’s a PDF of the Oregon Medical Board’s order, issued on December 3. Let’s
take a look at some key passages. First, however, note how the order points out 
that Oregon law allows its medical board to temporarily suspend the license of a
physician without a hearing when the “Board has evidence that indicates that
Licensee’s continued practice constitutes an immediate danger to the public” or 
finds that “that Licensee’s continued practice of medicine by a physician
presents a serious danger to the public health or safety”. This is important in 
that I don’t recall any previous cases in which a quack or antivaxxer had their 
license suspended because their state medical board viewed them as such a threat
to patients or public health.

Let’s get to the meat of the findings, shall we?

   The Board finds that Licensee’s conduct has breached the standard of care and
   has placed the health and safety of many of his patients at serious risk of 
   harm. It is therefore necessary to emergently suspend Licensee’s license to
   practice medicine. The acts and conduct that support this Order for Emergency
   Suspension follow:

   3.1Licensee has published an alternative vaccination schedule that decreases 
   the frequency of many recommended vaccines and omits others, including
   rotavirus. Licensee promotes his unique, “Dr. Paul approved” schedule as
   providing superior results to any other option, namely improved health on
   many measures, and fraudulently asserts that following his vaccine schedule
   will prevent or decrease the incidence of autism and other developmental
   disorders. Licensee uses this claim to solicit parental “refusal” of full
   vaccination for their children, thereby exposing them to multiple potentially
   debilitating and life-threatening illnesses, including tetanus, hepatitis,
   pertussis (whooping cough), rotavirus, measles, mumps, and rubella.

   Licensee’s promotion of this alternative vaccination schedule exposes
   patients to the risk of harm in violation of ORS 677.190(1)(a), as defined by
   ORS 677.188(4)(a).

This, of course, is nothing new. Dr. Thomas published his book (co-authoring it 
with another rising star in the antivaccine movement, Jennifer Margulis), The
Vaccine-Friendly Plan: Dr. Paul’s Safe and Effective Approach to Immunity and
Health- from Pregnancy Through Your Child’s Teen Years, nearly five years ago.
That, of course, brings up the question of why the Oregon Medical Board
considered it necessary to suspend Dr. Thomas’s license on an emergent basis,
before a full hearing. The most serious (to me) of Dr. Thomas’ “unprofessional
or dishonorable conduct which exposed his patients to the risk of harm, as well 
as gross or repeated acts of negligence in violation of ORS 677.190(13)” listed 
by the Board in its order of emergency suspension was this one:

   3.3.3Patient D, a now 9-year-old male, was completely non-immunized. Patient 
   D sustained a large, deep scalp laceration at home in a farm setting on
   August 8, 2017, and was treated with colloidal silver and with his parents
   suturing the wound independently. Patient D subsequently developed acute
   tetanus requiring intubation, tracheotomy, feeding tube placement and an
   almost two- month ICU stay at Doernbecher Children’s Hospital. Patient D was 
   then transferred to Legacy Rehabilitation. Licensee saw Patient D for
   follow-up in clinic on November 17, 2017. Licensee’s notes documented a
   referral to a homeopath, recommendation of fish oil supplements, and
   “phosphatidyl seine.” He did not document an informed consent discussion
   about the risk/benefit of immunization for a child who had just sustained and
   still had sequelae of, and remained vulnerable despite prior infection, to
   tetanus, a life-threatening and disabling disease that is preventable by
   proper vaccination. Licensee’s care placed Patient D at serious risk of harm 
   and constitutes gross negligence.

The standard of care, of course, after a laceration resulting in what must have 
been a grossly contaminated wound in a child (or adult) who has either not had a
tetanus vaccination or whose tetanus vaccination status is unclear or in doubt 
is to recommend a tetanus booster plus tetanus immune globulin (TIG). Colloidal 
silver won’t cut it, being quackery. Homeopathy certainly won’t cut it, being
The One Quackery To Rule Them All. (I note that Dr. Thomas’ practice is an
“integrative pediatrics” practice, which of course goes along with his general
antivaccine bent.) Basically, if the facts of this case are as stated by the
suspension order, this is gross malpractice of the most negligent kind, in my
not-so-humble opinion. It’s even worse than that, because he did it twice! Not
only did he not recommend tetanus vaccination (and, apparently, TIG) once when
the child first presented with his laceration, but he did it a second time, not 
recommending it during a followup visit after the child’s hospital discharge!
Tetanus infection doesn’t make you immune to a second infection, because it’s a 
toxin produced by Clostridium tetani, the bacteria tetanus that causes tetanus, 
that is dangerous. The child was still susceptible to tetanus when Dr. Thomas
saw him after discharge.

That’s not all when it comes to preventable disease due to Dr. Thomas’ medical
negligence, though. For instance, there were children who were hospitalized with
rotavirus infections, including a ten year old girl and twins born at 35 weeks 
gestation, who developed rotavirus gastroenteritis at ten months of age and
required hospitalization for five days. For these latter patients, the Board
does note this:

   Licensee’s clinic chart contains documentation of parental refusal of
   vaccines, but they are inconsistent regarding specific vaccines and their
   timing. In addition, Patient G and Patient H’s mother stated during
   hospitalization that she thought her children had received rotavirus vaccine.
   Failure to adequately document specific parental refusal and lack of
   providing parental clarity constitute acts of negligence.

Correct. These cases demonstrate extreme medical negligence, and there is no
excuse. Similarly, so is placing the fake diagnosis of chronic Lyme disease on a
girl and then not following the standard of care to work up her symptoms:

   3.3.5Patient F is a 7-year-old female who Licensee followed in clinic for
   constipation, food allergies, mold allergies and possible “chronic Lyme
   disease. Review of her chart from Licensee’s clinic reveals that she was
   nonimmunized. Licensee ordered repeated IgE allergy panels and recommended
   elimination diets, vitamin supplements and provided antibiotics for acute
   infections. Licensee failed to provide an appropriate referral to a pediatric
   gastroenterologist to exclude a diagnosis of malabsorption or celiac
   disease, a referral to pediatric allergy/immunology or to pediatric
   nutrition. Licensee’s neglect to seek consultative support and oversight, and
   his failure to address Patient F’s lack of immunizations, placed the health 
   of this patient at serious risk and was grossly negligent.

Not doing a proper, science-based medical workup to rule out potential medical
and physiological causes of a patient’s symptoms and instead treating them for
fake diagnoses constitute malpractice in my book.

There are also cases described in which Dr. Thomas measured antibody titers for 
measles, mumps, and rubella, using those levels to decide not to give the
additional doses of the vaccine recommended. Never mind that, as the Board put
it, except for “rare cases of suspected immune deficiency, there is no clinical 
indication for assessment of antibody titers” and regardless “of antibody
titers, the standard of care requires a second dose of the recommended MMR
vaccination”.

Then, as one might expect for an antivaccine pediatrician, there were cases in
which the child developed a vaccine-preventable disease, such as an 11-year-old 
boy who was on Dr. Thomas’ delayed schedule and developed pertussis. One case
like this involved not just failure to vaccinate, but gross patient
mismanagement:

   3.3.2Patient C is a now 7-year-old male. He was admitted to Randall
   Children’s Hospital in August 2013 at approximately 10 weeks of life with
   fever and a diagnosis of Kawasaki’s disease. Licensee saw Patient C in clinic
   for three days in clinic with fever. Though Dr. Thomas reevaluated Patient C
   daily and sent repeated labs, he made a clinical decision to treat a febrile
   child a less than 3 months old with intramuscular ceftriaxone on the basis
   of a “bagged” and not catharized urine sample and in the absence of blood
   cultures. Any child of this age is at higher risk for serious bacterial
   infection (late onset group B strep, pneumococcal bacteremia, urinary tract
   infection, pneumonia, meningitis) as well as inflammatory illnesses such as
   Kawasaki’s disease. Licensee breached the standard of care by failing to
   refer Patient C to the Emergency Room or hospital for definitive lab testing 
   (guided bladder tap, blood cultures done with bedside ultrasound, possible
   lumbar puncture) and observation. Licensee’s management of Patient C’s
   illness in clinic breached the standard of care. Patient C remained non
   immunized for pertussis and subsequently contracted pertussis when his older 
   brother, Patient C, became ill with pertussis on September 24, 2018.

Even I know that you have to take a persistent fever in an infant under three
months old a lot more seriously than Dr. Thomas did, and I’m not even a
pediatrician or internist.

Here’s a particularly interesting finding by the Board. I’ll preface this
finding by noting that “integrative doctors” like Dr. Thomas almost always tout 
their supposedly superior ability to “listen to patient concerns” and to “work
with patients”. They tout their “respect” for their patients’ wishes, negatively
contrasting it with, apparently, the cold, unfeeling, dismissive behavior of
science-based physicians. It turns out though, that if the following allegations
recounted in the Board’s order are true, Dr. Thomas is not so respectful of
parents who are pro-vaccine and want the standard vaccine schedule:

   3.2Licensee is insistent and direct in his communication with parents and
   guardians that they should accept his alternative vaccine schedule.

What does the Board mean by that? It provides two examples:

   3.2.1A patient’s mother sought subsequent treatment by Provider X after
   having been “reduced to tears” by Licensee’s “bullying” her into his personal
   vaccine schedule against her express wishes for full vaccination for her
   child.

   3.2.2Patient A’s mother requested polio and rotavirus vaccinations for
   Patient A according to CDC Recommendations, but Licensee did not have those
   vaccines in the clinic, and Patient A would therefore not be able to get
   them. Patient A’s mother reported that the Licensee questioned why she wanted
   Patient A to get the polio vaccine and asked whether they were traveling to 
   Africa. During the appointment, Licensee continually connected vaccines (not 
   specific) with autism. Licensee asked her how awful she would feel if Patient
   A got autism and she could have prevented it.

So Dr. Thomas reduced one mother to tears because she wanted to follow the
standard, science-based CDC-recommended vaccine schedule for her child, as he
tried to bully her into accepting his unproven “alternative vaccine schedule.”
(Funny, but doesn’t this sound like a common description by antivax mothers of
pediatricians and nurses trying to persuade them to accept the CDC vaccine
schedule, that of bullies.) He also tried to guilt another mother into not
giving her child recommended vaccines using a false claim that vaccines cause
autism, an antivaccine claim that has been tested time and time and time again
through numerous studies, none of which has produced any scientifically
convincing evidence that vaccines cause or even are associated with an increased
risk of autism. I guess that Dr. Thomas is understanding, empathetic, and
willing to work with parents, as long as the parents do what he wants them to
do, rather like the caricature of science-based physicians recommending the
standard CDC-recommended vaccine schedule. The word “projection” comes to mind
here.

And I do love what the Board wrote here:

   3.1Licensee has published an alternative vaccination schedule that decreases 
   the frequency of many recommended vaccines and omits others, including
   rotavirus. Licensee promotes his unique, “Dr. Paul approved” schedule as
   providing superior results to any other option, namely improved health on
   many measures, and fraudulently asserts that following his vaccine schedule
   will prevent or decrease the incidence of autism and other developmental
   disorders. Licensee uses this claim to solicit parental “refusal” of full
   vaccination for their children, thereby exposing them to multiple potentially
   debilitating and life-threatening illnesses, including tetanus, hepatitis,
   pertussis (whooping cough), rotavirus, measles, mumps, and rubella.

And here:

   Licensee’s false claims regarding the safety of the CDC Recommendations, his 
   failure in following these Recommendations absent unsolicited parental
   refusal of vaccines, his failure to document any such refusal, and his
   failure to adequately vaccinate children is grossly negligent in violation of
   ORS 677.190(13) and exposed his patients to the risk of harm in violation of
   ORS 677.190(1)(a), as defined in ORS 677.188(4)(a).

Because making demonstrably false claims about vaccines in order to dissuade
patients from vaccinating or parents from vaccinating their children is fraud
and malpractice, as far as I’m concerned, and should be grounds to suspend or
even permanently revoke a physician’s license. Dr. Thomas’s antivaccine grift
has real health consequences for children, and his popularity in the Portland
area has real public health risks. Indeed, he was peddling his message during a 
measles outbreak nearly two years ago.

Dr. Thomas: A rising star in the antivaccine movement

As I said near the beginning of this post, Dr. Thomas has been a rising star in 
the antivaccine movement ever since he first published his book touting his
“alternative vaccine schedule”. Unsurprisingly, in his promotion of his book,
one can easily find all sorts of red flags for antivaccine pseudoscience,
including favorite quack tropes about “blindly following your doctor’s
recommendations” or “counting on some government agency to have your best
interests first,” coupled with a sales pitch for his book, his videos, and,
above all, his nutritional supplements. Supplements, did I say? Oh, yes. Dr.
Thomas sells lots and lots of supplements, in particular “Dr. Paul Approved
Nutraceuticals” (vitamins, minerals, herbs and more) that are “selected to
maintain optimal cellular function and to restore optimal cellular function for 
those individuals with unique dietary requirements and sensitivities”.

Because of course he does.

Unsurprisingly, Dr. Thomas has, like Dr. Palevsky, jumped on the COVID-19 denial
grift train with his new book, COVID-19: Life-Saving Strategies The News Media 
Will Never Tell You. Here’s a rule of thumb. Whenever you see a book title about
how “They” don’t want you to know something, like Kevin Trudeau, run. It’s
almost certainly a scam or, at best, misinformation. I can tell just from the
blurb:

   Are you worried that you or a loved one might die from COVID-19? It is your
   healthy immune system that protects you and keeps you alive. In COVID-19:
   Life-Saving Strategies the News Media Will Never Tell You, Paul Thomas, M.D. 
   provides possible solutions backed by sound science and his experience in his
   own clinical practice. In this book, you will discover:

  1. The best type of immune-boosting diet.

  2. Why a ventilator should only be used as a last resort.

  3. 6 essential dietary supplements that support immunity and lung health (Hint:
    It’s not just about vitamin C).

  4. 1 possible way to get a conventional doctor to administer vitamin C while
    you’re in the hospital.

  5. Many other easy-to-implement key action steps to strengthen your immune
    system.

   This book provides a way to take your destiny into your own hands and
   dramatically increase your chances of staying healthy. The many scientific
   references included in the book also make it an ideal resource for health
   care providers.

Hard pass.

But how did Dr. Thomas get to where he is now? Certainly, he has followed the
same sort of path that Dr. Sears did, publishing a book with an “alternative
vaccination schedule” that delays and omits certain vaccines based on
fear-mongering antivax pseudoscience claiming that vaccines cause autism,
autoimmune disease, and all sorts of other problems, but that’s not all. He’s
also been good about getting favorable press coverage from local and national
media figures who are prone to “false balance” when it comes to vaccine stories,
as he did with Genevieve Reaume, a reporter for KATU, the Portland, OR ABC
affiliate, a year and a half ago. Her story went beyond false balance and, in
the midst of an MMR outbreak in Portland and Washington, basically lionized
Thomas as a “brave maverick doctor” being “persecuted” by The Man for his views.
The basis of the story was Dr. Thomas’ claim that he is doing “studies” of the 
15,000 patients in his practice and that then those studies “showed” that
unvaccinated children are rarely diagnosed with autism. Unsurprisingly, it used 
poor study design and incorrect statistical analyses.

As I pointed out at the time, there are issues where there are not two sides to 
the story. Whether the MMR vaccine causes autism is one. Worse, when it comes to
conspiracy theory-based movements like the antivax movement, facts don’t
matter, and presenting antivaccine pseudoscience side-by-side with science does 
falsely elevate the pseudoscience, no matter how much refutation to antivax
pseudoscience is included. Dr. Thomas was engaging in information warfare, and
it’s asymmetric warfare. He continues to do so. What do I mean?

First, Dr. Thomas has teamed up with James Lyons-Weiler, whom you might recall
attacking a study that found that autism is primarily genetic and using risibly 
incompetent science to try to demonstrate early in the pandemic that SARS-CoV-2,
the coronavirus that causes COVID-19 (which at the time was still called
2019-nCoV) was not natural and had been engineered. A while back, Dr. Thomas
teamed up with Lyons-Weiler to do antivaccine “science”. One of the early fruits
of that collaboration (if you can call such a rancid piece of rotten science a 
“fruit”) was an incompetent study, published as the COVID-19 pandemic was
getting started in China, that demonized aluminum adjuvants using some really
incompetent pharmacokinetic modeling. It was a wonder to behold in its
awfulness. The other “collaboration” between these antivaccine cranks involved a
“vaxxed/unvaxxed” study.

What is a “vaxxed/unvaxxed” or “vaccinated/unvaccinated” study? I’ll remind
those who might be unfamiliar with the concept or don’t remember it. It’s any
study that compares health outcomes between a vaccinated cohort of children and 
those of an unvaccinated cohort. In its purist form, it is a randomized,
double-blind, placebo-controlled study comparing “vaxxed” to “unvaxxed.” Of
course, such a study would be highly unethical because, by its very design, it
would require that a group of children be intentionally placed in a control
group that would be left vulnerable to vaccine-preventable diseases because the 
control group would only receive placebo vaccines. Antivaxxers don’t like it
when that simple fact is pointed out to them, of course, because they really and
truly believe that vaccines do more harm than good. Of course, it never occurs 
to them that their belief would make such a randomized, controlled clinical
trial unethical as well, because they would be intentionally placing children
into a group who would be—to them—being exposed to something they view as a
grave threat to their health, vaccines. (After all, they believe that vaccines
are toxins-laden interventions that cause autism, autoimmune diseases, obesity, 
alter DNA, render females infertile, and have created the “sickest generation”
of children—and in some cases even kill.) True, their belief is erroneous, but
intent matters. It all comes down to clinical equipoise, which is the genuine
uncertainty over whether an intervention is on balance beneficial, harmful, or
without detectable effect. A randomized controlled trial (RCT) of
“vaxxed/unvaxxed” children violates clinical equipoise.

As a result, some of the savvier antivaxxers, who know that a “vaxxed/unvaxxed” 
RCT would be highly unethical (or who are at least willing to concede that the
overwhelming view of physicians and scientists who do clinical trials is that a 
“vaxxed/unvaxxed” RCT would be highly unethical) have retreated back to
suggesting observational “vaxxed/unvaxxed” studies, such as retrospective and
epidemiological studies. The whole idea is that vaccines cause autism, the
obesity epidemic, and in general the “sickest generation” of children, even
though there is no evidence that they do. Of course, doing such a study is a
hell of a lot more difficult than antivaxxers think, given how difficult it is
to account for confounders and how many subjects are needed to provide
sufficient power to detect differences in a condition whose prevalence is in the
low single digit percentage range. Still, none of this has stopped antivaccine 
“scientists” and physicians from trying to do such studies. Unsurprisingly, the 
results are always dismal in that the studies are inevitably positive (i.e.,
claim to find that unvaccinated children are healthier than vaccinated children)
but so poorly designed and executed that they are singularly uninformative and 
their conclusions are not supported by their data and design. Examples abound,
unfortunately, such as risibly incompetent “vaxxed/unvaxxed” studies by Brian
Hooker and Neil Z. Miller, studies by Anthony Mawson that were retracted and
republished and retracted, Internet surveys by quacks about vaccinations, and a 
number of others that I could reference.

The even more rancid “fruit” of that collaboration, Thomas and Lyons-Weiler’s
“vaxxed/unvaxxed” study, was published right before Thanksgiving. I’m not going 
to go into detail over why it was so bad, which you can just read here for the
gory details. I will give you the Cliffs Notes version, which is that the study,
apparently unable to find a statistically significant difference in health
outcomes between vaccinated and unvaccinated children in Thomas’ practice using 
standard methods, Thomas and Lyons-Weiler invented a metric, the Relative
Incidence of Office Visit (RIOV) and then did what sure looks to me like a lot
of p-hacking to find statistically significant differences in the numbers of
office visits for various diagnoses between the two groups as determined by
billing records over 20 years. RIOV appears to have been designed to crank up
sensitivity over specificity, thereby finding “differences” that might or might 
not mean anything (or even be real).

Worse, Thomas and Lyons-Weiler promise a “follow-up” study soon. I do wonder,
though, how feasible that study will be given that Dr. Thomas can no longer
treat patients, at least until there is a hearing before the Oregon Medical
Board and possibly forever. (Obviously, I’m rooting for the latter possibility.)
There will probably no effect, given that this has been a retrospective study. 
In any event, you can see how Thomas has teamed up with other antivaccine
grifters to produce “science” to demonize vaccines.

Cry persecution!

Unsurprisingly, the reaction of antivaxxers to this news was to cry,
“Persecution!” and “Freedom!” with a touch of “Fight forced vaccination!”
conspiracy mongering. Indeed, on his website, Dr. Thomas posted this:

   Dr. Paul now faces attacks on three fronts:

  1. Providence Health Plans, the largest local insurance company terminated all
    contracts.

  2. The State of Oregon terminated all contracts.

  3. BREAKING NEWS, the same week his data is published and CHD Defender posts
    about it comes:

   “By order of the Oregon Medical Board, the license of Paul Norman Thomas, MD 
   to practice medicine is hereby suspended, effective December 3, 2020, at 5:15
   p.m. Pacific Time. As of this date and time, Licensee must stop practicing
   medicine until further order of the Board.”

   Integrative Pediatrics and our providers are fighting to preserve your right 
   to direct your child’s medical care with Providence Health Plan (PHP) and
   with those covered by OHP (Oregon Health Plan). PHP and the Oregon Health
   Authority (OHP) intend to terminate our provider contracts in an effort to
   restrict your provider choices and force you and your children into
   compliance with CDC vaccine “recommendations.”

   In an unprecedented move the Oregon Medical board suspended my license
   without a hearing potentially endangering countless patients.

   Dr. Paul and Integrative Pediatrics have secured a team for legal action,
   civil lawsuits, and a class-action lawsuit against patients’ wrongful
   abandonment by PHP and OHA / OHP and the Oregon Medical Board.

Of course, the part about patients being “abandoned” or “endangered” is
nonsense. After all, as this news story notes, Dr. Thomas has eight doctors and 
nurse practitioners who work for him. Surely his partner or the docs who work
for him can see his patients while his license is suspended. Unsurprisingly,
although his practice does very well and he is anything but poor, Dr. Thomas has
started a legal defense fund, the better to milk his antivaccine fans for cold 
hard cash. Meanwhile, antivaxxer Robert F. Kennedy, Jr. was also rallying the
antivaccine troops before this order was published:

   In recent years, the Oregon Health Authority has targeted Dr. Thomas by
   removing his access to the CDC’s Vaccines For Children program, which pays
   for vaccines for low income families. Providence Health Plan and the Oregon
   Health Authority’s Oregon Health Plans, which are major health plans, have
   threatened to drop Dr. Thomas’ insurance coverage, claiming that the
   practice’s low vaccination rate signifies inferior care. These maneuvers
   could trigger a domino effect, closing down Dr. Thomas’ practice and leaving 
   thousands of families with no pediatric care.

My response to this is that the closing of Dr. Thomas’ pediatrics practice would
not be a bad thing. Quite the contrary. As for the Oregon Health Authority
having removed his access to CDC’s Vaccines for Children program, I can’t help
but wonder why Dr. Thomas cares, given how little enthusiasm he has for
vaccinating according to the CDC schedule.

Meanwhile, Dr. Thomas’ “collaborator” took to video on Facebook:

Unsurprisingly, he starts his rant with COVID-19 disinformation, such as the
“casedemic” before pivoting to ranting about the Oregon Medical Board’s action, 
bragging about their awful aluminum study and RIOV study. Even less
surprisingly, he portrays the Board’s action as “a clear retaliation for daring 
to do science in the United States”. I must admit, I laughed out loud when he
said that, given how utterly awful Dr. Thomas’ and his “science” was, but, hey, 
conspiracy mongerers gonna conspiracy monger. The Medical Board didn’t even
mention the studies in its order, and state medical boards generally don’t take 
action regarding physician licenses based on their publications to peer-reviewed
literature, no matter how awful or unethical the study. That’s not their
charge, unless something in how the study was done could be proven to be a
danger to patients or the public. Lyons-Weiler also pulls the “other patient”
gambit because Dr. Thomas also practices—believe it or not!—addiction medicine, 
a truly frightening thought to me, given that he is an “integrative pediatrics” 
quack who is antivaccine.

Lyons-Weiler also portrays the suspension of Dr. Thomas’ license as a threat to 
their trial, to which I was tempted to say, “Good! It’s a scientifically crappy 
trial designed to generate propaganda and disinformation for the antivaccine
movement”. What I’ll say instead is: How? It’s a retrospective study. The data
are already there and just need to be analyzed in the manner the investigators
stated that they would do. Given that there are 20 years’ worth of data,
stopping now is unlikely to make any difference in the number of subjects in the
study. Of course, likely Lyons-Weiler knows that, but realizes that his
audience does not. He needs a threat, and he needs a hook to ask for money.

You get the idea.

State medical boards: More please!

What the Oregon Medical Board has done with Dr. Thomas (and Dr. LaTulippe) is a 
very rare occurrence. All too often, after being obtained for the first time
medical licenses end up in practice being more like a right rather than a
privilege, and it often takes incredible effort on the part of state medical
boards to suspend or revoke a physician’s medical license, even quacks like
Stanislaw Burzynski, who still has a Texas medical license after 40 years of
Texas Medical Board efforts to stop his quackery. Look at Dr. Bob Sears, who did
have his license restricted with the condition that he practice under the
supervision of the Medical Board of California for three years. The list goes
on.

Basically, it’s very difficult in most states (some more than others) for the
state medical board to suspend or revoke a physician’s license, which is why
many medical boards, by and large, tend to go after mainly the easiest, most
obvious cases. That’s why the physician behaviors most likely to result in
strong action against a medical license include running a prescription mill,
sexual improprieties with patients, or practicing while impaired due to
addiction to alcohol or illicit substances. It’s a matter of resource allocation
and prioritization. State medical boards tend to react primarily to what they
perceive to be the most immediately and obviously dangerous behaviors; most
importantly, though, behaviors that can be definitively proven. It’s worse than 
that, though. In some states, Quacks like Dr. Rashid Buttar still practice and
even have enough political influence among legislators to get state laws
rewritten to be more favorable to quacks.

That’s why, seeing what the Oregon Medical Board did last week, suspending the
licenses of two dangerous doctors in rapid succession, I can only say: More,
please.

Personal Belief Exemptions for Vaccines

Steven Novella on March 4, 2015

Link

Positive change not only requires a valid argument, it requires political will. 
My colleagues and I have been pointing out for years that vaccines are safe and 
effective, and the anti-vaccine movement, which is built largely on
misinformation, threatens the public health by eroding herd immunity. These
arguments are no more valid today than they were five or ten years ago (except
that new scientific evidence continues to support our conclusion).

We also predicted that it will likely take the significant return of
vaccine-preventable diseases to muster the political will to effectively push
back against the anti-vaccine movement. Parents need to be more afraid of
infectious disease than the false fearmongering surrounding vaccines. We, of
course, did not want this to happen, we just thought this was a likely scenario.

I did not think, however, that it would be so sudden and dramatic. The
Disneyland measles outbreak created an undeniable media and popular backlash
against the anti-vaccine movement. Recent evidence for this is the Jimmy Kimmel 
segment in which he blasted anti-vaxxers and showed a fake PSA in which real
doctors express their frustration over vaccine refusers. Anti-vaxxers replied
with their usual shrill nonsense, comparing Kimmel’s statements to hate speech
and falsely accusing him of attacking autistic children. Kimmel responded with
still more ridicule, making a mockery of anti-vaxxer tweets attacking him. Being
the butt of late night comedian jokes is a reasonable sign of popular backlash.

Popular opinion, which is turning against vaccine refusers for threatening the
public health, translates into political will. In the case of vaccines there is 
a specific focus for this political will – state laws allowing exemptions from
the requirement for children to be up to date on their vaccines in order to
attend public school.

All 50 states require vaccines to enter public school, and all 50 states allow
for medical exemptions. Medical exemptions are not controversial; some children 
have medical conditions that do not allow them to be vaccinated. Their numbers
are small enough that they can be protected by the herd if a sufficient number
of the rest of the population are vaccinated. In fact, these sick children
depend upon herd immunity.

Every state except Mississippi and West Virginia allow for religious exemptions.
In the 1944 Prince v. Massachusetts case, the Supreme Court ruled:

   The right to practice religion freely does not include liberty to expose the 
   community or the child to communicable disease or the latter to ill health or
   death.

Ideally there would be no non-medical exemptions to vaccines. There is no legal 
requirement for such exemptions, and I think there is a solid case that such
exemptions are not ethically defensible. Politically, however, religious
exemptions specifically will be difficult to eradicate.

Twenty states allow for exemptions from vaccines based on personal belief
(called philosophical or personal belief exemptions). These laws create a very
low bar for parents to obtain an exemption. Often they simply have to check a
box stating they don’t want to vaccinate their children, and that is sufficient.
States with philosophical exemptions have 2.5 times the vaccine refusal rate as
states with religious exemptions only. Essentially, the easier it is to obtain 
a vaccine exemption, the lower the vaccination rate. We have 50 data points
showing this correlation. The state with the highest vaccination rate is
Mississippi, which is close to 100% and allows for no vaccine exemptions beyond 
medical exemptions.

It would therefore aid vaccine compliance and herd immunity to make obtaining a 
vaccine refusal as difficult as possible, or simply impossible by removing them 
altogether. We seem to have reached a critical level of public understanding of 
this issue, and state lawmakers are responding by introducing bills that will
reduce or eliminate non-medical vaccine exemptions. This would be a concrete
step that would directly protect the public health.

Here is a list of 14 states that have recently introduced bills that would
reduce or eliminate vaccine exemptions (the list may not be exhaustive). Among
them is the home state of Disneyland – California. State Senator Richard Pan,
who is a medical doctor, introduced the bill, which now has 26 sponsors, which
apparently means it is likely to pass. As the law is currently written it would 
eliminate all non-medical exemptions. This may change, however, before the bill 
is passed.

Anti-vaxxers, of course, are firing back. The tide is turning heavily against
them so they are turning up their shrillness generators to maximum. Fortunately 
I think this is serving only to marginalize them even further, as the Jimmy
Kimmel episode demonstrates. One of their strategies is to characterize vaccine 
requirements as “forced vaccinations.” They want to conjure images of officers
pounding down your door, holding down your child, and vaccinating them by force.
This, of course, is absurd. Vaccinations are only required to attend public
school. Parents can still avoid vaccination by homeschooling their children or
sending them to private school (although some states require vaccinations for
homeschooling as well).

Arguments based on parental rights are losing steam as the public realizes that 
children with medical exemptions from vaccines and their parents also have
rights. Parents are saying, “your right to think that you know better than the
medical community does not trump my right to protect my child from communicable 
diseases.” Again, humor is a good barometer of public opinion. The satirical
paper, The Onion, captured this feeling perfectly with an article titled “I
Don’t Vaccinate My Child Because It’s My Right To Decide What Eliminated
Diseases Come Roaring Back.”

Even worse, anti-vaccine “paleo” doctor, Jack Wolfson displayed the callous face
of the anti-vaccine movement when he had his 15 minutes of fame. In an
interview he stated:

   I’m not going to sacrifice the well-being of my child. My child is pure. It’s
   not my responsibility to be protecting their child.

If asked if he would feel bad if a sick child with a medical exemption caught
measles from his child and died, he replied:

   I could live with myself easily. It’s an unfortunate thing that people die,
   but people die. And I’m not going to put my child at risk to save another
   child.

His words did a better job of exposing the anti-vaccine movement for what it is 
than any commentary or criticism from the medical community.

Now is therefore the time to increase our efforts. Public opinion and the
political will are there to reduce vaccine exemptions, increase vaccination
rates, and protect the public health. Public and political will, however, is a
fickle thing.

Stanislaw Burzynski

Stanislaw Burzynski: Using 1990s techniques to battle the FDA today

In the 1990s, cancer quack Dr. Stanislaw Burzynski and his lawyer Richard Jaffe 
perfected a PR strategy in which patients who believed that Burzynski had saved 
their lives would protest and, often aided by friendly legislators, beg the FDA 
(or whatever regulatory body was trying to stop Burzynski’s abuses at the time) 
not to let them die. It was very effective political theater, which is why
Burzynski is using the same strategy today against the FDA.

David Gorski on January 20, 2014

Link

It figures that I couldn’t go three weeks into 2014 without the topic of
Stanislaw Burzynski rearing its ugly head. I had hoped to make it to February or
even beyond before feeling the gravitational tug of the wretched hive of
ignominious and unethical behavior, but here we are, only 20 days into the new
year. So be it.

2013 finished with serious setbacks for Stanislaw Burzynski and his unproven
cancer treatment that he dubbed “antineoplastons” (ANPs) way back in the early
1970s. As you might recall, in November, two things happened. First, the FDA
released its initial reports on its inspection of the Burzynski Clinic and
Burzynski Research Institute (BRI) carried out from January to March 2013. They 
were damning in the extreme, pointing out the shoddy operating methods of the
institutional review board (IRB) used by the BRI to approve and oversee
Burzynski’s “clinical trials” (and I use the term loosely) of ANPs. Violations
included using expedited approvals to review single patient protocols, something
so far outside the purview of what the expedited approval process was intended 
for, namely approving minor tweaks to human subjects research protocols without 
requiring a full meeting of the IRB, that the FDA called Burzynski out for it.
Other violations included failure to report serious adverse events (SAEs) and
adverse events (AEs) to the FDA and/or the IRB, failure to follow proper
informed consent procedures, failure to determine that risks to subjects were
minimized and that risks to subjects were reasonable in relation to anticipated 
benefits, if any, and a lot of other violations, which are listed in my previous
post on the subject.

Later in November, Liz Szabo of USA TODAY published a fantastic expose of
Burzynski entitled “Doctor accused of selling false hope to families,” in which,
in addition to many of the violations revealed by the FDA, it was further
reported that the child whose death in the summer of 2012 triggered the FDA
investigation was Josia Cotto, and that the child died of hypernatremia
(elevated sodium levels in the blood) caused by ANP therapy. In response to the 
reports of shoddy record keeping, lack of ethics, and contributing to the death 
of a child, Burzynski was his characteristically cuddly self, referring to his
critics as “hooligans” and “hired assassins,” while claiming that they “pretend 
they got sick and would like to extort money from us.” When last I wrote about
Burzynski in November, his empire was struggling to strike back. Eric Merola,
the film maker responsible for two pro-Burzynski propaganda movies Burzynski:
Cancer Is A Serious Business and Burzynski: Cancer Is A Serious Business, Part
2, likened USA TODAY to everything from Nazi propaganda under Joseph Goebbels,
to slave masters, and to the Westboro Baptist Church protesting at the funerals 
of gay soldiers killed in the line of duty. Meanwhile Burzynski himself tried to
answer the FDA findings and failed miserably, nor did his poster presentation
of singularly unimpressive results at the Society of Neuro-Oncology Meeting
right before Thanksgiving help. The year ended with the Texas Medical Board
using the FDA’s findings as part of the basis of charging Burzynski with false
advertising, meaning that Burzynski will be spending a lot of time defending
himself against the TMB in 2014.

Unfortunately, beginning in December, Burzynski and his allies decided to go
back to the future, so to speak (or maybe just back to the 1990s) and resurrect 
the campaign that worked so well for them the last time Burzynski’s back was
against the wall. Unfortunately, this strategy, rooted as it is in using cancer 
patients to lobby Congress to force the FDA to allow Burzynski to use
antineoplastons, could work. Pro-Burzynski forces, in a nod to the past, have
even hired the same lobbyist who, or so it is claimed by the pro-Burzynski
forces, succeeded so brilliantly in the mid-1990s in persuading Rep. Joe Barton 
(R-TX), then the chair of the House Subcommittee on Oversight and
Investigations, to “investigate” the FDA’s “harassment” of Burzynski.

Using patients as human shields and missiles

If you want to understand Burzynski’s new strategy to keep using ANPs, you have 
but to go back and examine his previous strategy, which was to milk dying cancer
patients for every bit of human sympathy they can evoke from lawmakers and the 
public. I realize that the way I chose to phrase that might be offensive to some
readers, but how Burzynski has cynically exploited the sympathy we all feel for
children dying of incurable brain tumors offends me, and he’s at it again. For 
example, there is the case of MacKenzie Lowe, a 12-year-old girl with an
inoperable brain tumor whose story, entitled Child Cancer Patient Petitions For 
Brain Tumor Treatment Not Yet Approved By The FDA was published in The
Huffington Post at the end of November:

   Last Thanksgiving, 12-year-old McKenzie Lowe was diagnosed with an inoperable
   brain tumor. Her family is petitioning New Hampshire’s governor to allow
   McKenzie to undergo Antineoplastons therapy, a treatment not approved by the 
   FDA. The FDA has allowed 471 “compassionate use” exemptions to date, and
   McKenzie’s grandfather, Frank LaFountain, hopes she’ll be next in line.

   “We’ve talked to survivors of this drug, who had the same condition McKenzie 
   has,” he told HuffPost Live host Nancy Redd. “People say there aren’t any,
   but we know them. We’ve talked to them, and that’s what makes us so
   passionate about getting her this particular drug.”

And here’s the video:

Only a heartless bastard could fail to be moved by McKenzie’s story, which is,
sadly, typical for pediatric patients with brain cancers. HuffPo pulled out all 
the stops to emphasize McKenzie’s cuteness and what a nice girl she is, while
buying completely into the propaganda line that the Burzynski Clinic promotes.

It pained me to watch that video. It really did. But it also made me angry. Once
again, Burzynski is offering false hope to families of cancer patients, and
HuffPo deserves nothing but opprobrium for promoting the Change.org petition,
which Eric Merola, producer of two propaganda “documentaries” for Burzynski is
also promoting. As desperate as McKenzie’s situation is, Burzynski can’t help
her. However, her family can help him, most likely unwittingly, by changing the 
narrative from a doctor without any training in internal medicine or oncology
who is utterly unqualified to treat patients with advanced cancer who has
cynically sidestepped the FDA and the Texas Medical Board for nearly 37 years
while abusing the clinical trial process to keep giving a toxic, almost
certainly ineffective chemotherapeutic agent to patients. And, make no mistake
about it, antineoplastons (ANPs) are chemotherapy, no matter how much Burzynski 
tries to claim otherwise.

The Change.org petition for McKenzie Lowe, as well-meaning as its sponsors seem 
to be, is exceedingly misguided. The Friends of McKenzie Lowe are petitioning
FDA Commissioner Margaret Hamburg to grant a compassionate use exemption for
McKenzie so that Burzynski can treat her with ANPs. Recall that one of the very 
offenses that got Burzynski into hot water with the FDA was his investigational 
review board’s (IRB) history of playing fast and loose with single patient use
protocols, in which patients were approved through the expedited approval
process, which was never intended to be used for this purpose. Putting patients 
on compassionate single patient use requires full approval by the entire IRB. In
essence, this petition is asking the FDA Commissioner to ignore those findings 
and let Burzynski do it again for McKenzie Lowe. One also wonders whether the
Lowes know other things about Burzynski. For instance, the FDA found that he had
destroyed original patient records and, most importantly of all, misclassified 
partial and complete responses. Suffice to say, Burzynski’s explanations are
underwhelming and unconvincing.

Finally, there is the oft-repeated claim that Burzynski is the only person who
has ever cured the cancer that McKenzie has. These days it is Burzynski’s
favorite line, a line often parroted by his minions, particularly Eric Merola.
Would that it were true! What Burzynski proponents can’t understand is that I
would be very happy if there were a treatment that could actually cure children 
with diffuse intrinsic pontine glioma (DIPG). As I’ve discussed many times
before, nearly all of Burzynski’s “cancer cure” testimonials, when examined more
closely, are highly dubious with respect to whether it was actually ANPs that
cured the tumor, with not a single one of them being particularly convincing
when examined closely. Either there’s insufficient information (i.e., the
timeline is vague), or there exists the possibility of misdiagnosis, or the
mistaking of the natural reversal of pseudoprogression for an actual antitumor
effect. Moreover, brainstem gliomas in children are a heterogeneous group of
tumors. Moreover, many of these tumors aren’t biopsied because of their
location, and are usually diagnosed by their appearance on MRI. However, MRIs,
as discussed in the case of Tori Moreno, can sometimes find masses that look for
all the world like tumors but aren’t. Moreover, contrary to Burzynski’s claim, 
there are occasional long-term survivors, some of whom received little or no
therapy, such Connor Frankenberg, a child from Germany, and two patients who
underwent spontaneous remission. (Yes, I know that one of the children listed is
a Burzynski patient, Tori Moreno. One notes that the DIPG Registry does not
mention Burzynski or ANPs at all.)

The DIPG Registry concludes that, although the vast majority of children with
DIPGs do poorly:

   The bottom line is: 1) we really don’t understand DIPGs, and 2) there are
   children who have been diagnosed with DIPGs-based on the incomplete knowledge
   that we currently have- who truly have had spontaneous regression of their
   tumors and 3) most of the children with reports of spontaneous regression
   have been very young.

The big problem is that, like many dubious cancer doctors, Burzynski appears not
to keep good enough records to demonstrate one way or the other whether he can 
cure DIPG, and we already know he misclassified partial and complete responses. 
In brief, DIPG is a horrible disease, with only 10% surviving beyond two years, 
and there is no convincing evidence that Burzynski can do any better than
conventional oncology, much less cure DIPG, as much as he repeats the claim that
he can. Worse, he hasn’t published a single one of his completed phase II
clinical trials, even though he’s had well over 15 years to complete them. With 
tumors this lethal, most such trials should be completed within five years.

Unfortunately, Mackenzie Lowe isn’t the only such patient being used by
Burzynski’s minions. Unfortunately, now there are now at least two more.

First up, there is a Jewish boy in Houston named Raphael Elisha Cohen:

   Then, the unthinkable happened. A series of symptoms in the couple’s young
   son, Raphael Elisha, led to the diagnosis of medulloblastoma, an aggressive
   form of cancer of the brain and spine. Initially, the now-6-year-old
   underwent surgery to remove as much of the brain tumor as possible, followed 
   by radiation and chemotherapy.

Unfortunately, Cohen’s tumor recurred in September 2012. After this, the story
became sadly familiar. Well-meaning people set up a fund to send Raphael Elisha 
to Houston for treatment by Stanislaw Burzynski, as described in this article:

   The Cohen family, of Houston, TX, is facing a battle none of us should have
   to go through – aggressive brain cancer in their 6-year old son Refael
   Elisha. Having recently received the devastating news from their doctors that
   “there is nothing more we can do for him,” the Cohens are turning to a last 
   resort – Antineoplaston Therapy at the Burzyinski clinic. However, the FDA
   pulled their approval for this treatment in 2012 pending further clinical
   trials. We are told that the FDA is nearing approval to resume this
   treatment, but Refael Elisha does not have time to wait.

   The FDA has the power to approve a “compassionate use exemption” so Refael
   Elisha can undergo this therapy to try and save his life.

   We are asking the FDA to grant this exemption so we can continue to fight for
   his life.

Several other stories were written, including this story and a blog post by
Ariela Davis for the Times of Israel that gave Cohen’s story international
attention. Here’s the Whitehouse.gov petition, which uses language very similar 
to what is quoted above.

This sort of thing infuriates me, because it really does appear as though the
Cohen family is being lied to. According to this editorial, the Cohens are aware
of Burzynski’s reputation. However, obviously either Burzynski, Eric Merola, or
someone from the Burzynski Patient Group has been feeding them “success
stories.” As I’ve explained time and time again, these “success stories” appear 
compelling on the surface, but if you look at them with a knowledge of how
cancer progresses and how cancer treatments work it rapidly becomes apparent
that they are not evidence that Burzynski’s antineoplastons can do any better
against deadly cancers than conventional therapy. Think Hannah Bradley and Laura
Hymas. Think Mary Jo Siegel. Think Tori Moreno. It seems as though Burzynski
cured these patients, but he almost certainly did not.

In addition, Burzynski has apparently been telling patients that the FDA is
“nearing approval to resume” his clinical trials almost ever since the FDA
imposed a partial clinical hold on Burzynski’s antineoplaston trials in the
summer of 2012. That partial clinical hold meant that no further children could 
be enrolled on any of Burzynski’s clinical trials. Later, in early 2013, that
partial clinical hold was extended to adults. Patients who were already
receiving antineoplastons could continue to receive them, but no new patients
could be enrolled in Burzynski’s clinical trials. Ever since then, Burzynski’s
been dangling the hope that the FDA would lift the partial clinical hold. Now,
apparently, he’s using those patients to try to get the attention of the White
House, and in Cohen’s case he has been very successful.

Raphael Elisha is not alone, however. There’s an adult who is also going down
the same road. This adult happens to be the wife of Sammy Hagar’s drummer. She
is 46 and was diagnosed with an inoperable brainstem glioma. Her name is Liza
Cozad, and to send her to the Burzynski Clinic there’s a Give Forward campaign. 
Her Change.org petition asks for the same thing as MacKenzie Lowe and Elisha
Cohen’s families are asking:

   Six months ago, Liza was diagnosed with a deadly brainstem tumor – called a
   DIPG – it rarely strikes in adults (only about 20 in the U.S. each year) but 
   is unfortunately common among brain tumors in children – and just as deadly –
   a year to a year and a half to live. No doctor can perform surgery to remove
   due to its location, chemo has consistently shown to be ineffective on
   Liza’s type of tumor, and even the radiologist tells her her best case
   scenario with radiation is it would return in 1-2 years, more aggressively,
   and they could no longer radiate. There is one drug that could save Liza’s
   life. The drug – ANP – has been approved for Phase III clinical trials by the
   FDA. This means it has been deemed safe (Phase I trials) and effective
   (Phase II trials). The FDA has continually denied Liza’s request for the
   treatment under a Single Patient Protocol (the FDA format under which she
   could be approved), saying they have questions for the manufacturer about the
   drug based on one patient out of hundreds’ response to sodium levels. They
   have cotinued [sic] with this for a year – each time the manufacturer answers
   all their questions, the FDA keeps coming back with more – all the time
   denying any new patients – including Liza – from receiving this drug the FDA 
   has itself acknowledged to be safe and effective. This precious and caring
   young woman has been fighting her fight since April, but her health is
   declining. This drug has a documented 27% success rate on her exact kind of
   tumor – which is 27% better than her odds with all standard therapies – and
   with some children still cancer-free over 20 years later.

Recently Cozad and her husband posted a video appeal to YouTube:

There is, of course, no evidence that Burzynski has a 27% success rate in
treating DIPG, but the video is heartbreaking. Her story is depressingly
familiar to those of us who know about the Burzynski saga. After being given the
diagnosis and told that radiation would only delay progression of the tumor,
she went on the Internet and, as all too many patients with inoperable brain
tumors do, found Stanislaw Burzynski. In her desperation, as all too many cancer
patients have, Cozad latched on to the false hope that Burzynski offers. As so 
many of Burzynski’s patients have done, they talked to Burzynski’s “success
stories,” who, being convinced themselves that Burzynski saved their lives when 
he almost certainly didn’t, convinced Cozad and her husband that Burzynski was
the only one who could save her life.

These are the patients are petitioning various Senators and Representatives to
lean on the FDA to grant the compassionate use exemption. This is what those of 
us who want to protect cancer patients from this sort of predation are against, 
parents of children with cancer who have been convinced that Burzynski is their 
family member’s only hope. What human being doesn’t have difficulty saying no to
such an appeal, even when he knows the family’s desperation has led them down a
dark path to viewing Burzynski as the only man who can save their loved one?
That they are wrong is almost beside the point. What politician can say no to
such an appeal? At the very least, they will look into it and put pressure on
the FDA. Meanwhile those of us who stand up and say no, who try to point out
that Burzynski can’t save these patients, that they are being used by him so
that he can re-open his ANP clinical trials, are pummeled with arguments like
the one by Randy Barnes that we should “respect the parents’ choice.” After
pointing out that he is “not a fan” of the Burzynski Clinic, and “agrees with
many of the criticisms leveled at Stanislaw Burzynski and his treatments,” he
asserts that “Raphael Elisha’s parents are the only ones with the right and
responsibility to make the best decisions they can in a horrible situation that 
no one who has not faced the loss of a child can possibly understand.” He then
concludes:

   If you choose not to sign the petition that is fine, but please, allow the
   Cohens the dignity they deserve by respecting their right to make the choices
   they deem fit for their child. Publicly fighting the Burzynski Clinic in
   Raphael Elisha’s name will only bring more pain to an already suffering
   family.

This is the argument we’re up against as well, an argument that is every bit as 
invalid as when it is used to defend, for example, the family of Sarah
Hershberger for relying on quackery instead of chemotherapy to treat a deadly
lymphoma. We can respect the parents’ decision, to the extent that they are the 
parents. We can try to understand the desperation that led them to it, even
though they are aware of all the criticisms of Burzynski. Most parents can only 
imagine how they would react under similar circumstances. Even I couldn’t
guarantee that I wouldn’t be tempted by the blandishments of Burzynski and his
followers if I were in the same position as the Cohens. However, sympathy and
respect do not equal agreement, nor do they require us to acquiesce and just
“shut up” when the Cohen’s grief and desperation lead them to do something
profoundly harmful to public health, to use the power of their story to persuade
lawmakers to call off the FDA.

The Alliance for Natural Health joins the fray

Right after the holidays, one of the most prominent pro-quackery advocacy groups
in the country, scourge of any legislator trying to regulate supplements or
“natural medicine,” the Alliance for Natural Health USA (ANH-USA) launched a
series of articles urging its members and followers to write to their
legislators to lean on the FDA to allow Burzynski to treat patients under
compassionate use protocols:

  1. Exclusive: Inside USA Today’s Smear Campaign Against Dr. Burzynski

  2. Dying Patients Denied Access to Dr. Burzynski’s Potentially Lifesaving
    Treatment

If you want to understand how much contempt the ANH-USA has for its audience,
I’ll show you briefly through one passage from one of these articles. The
ANH-USA complains that Liz Szabo:

   Cites the lack of published random-controlled trials (RCTs) as evidence of
   antineoplastons’ uselessness, while omitting the fact that the efficacy of
   the treatment has recently been confirmed by a randomized, clinical trial by 
   Japanese researchers. And of course ANH-USA has repeatedly had to point out
   that RCT’s are enormously expensive. Nobody but drug companies can afford
   them, and they will usually only undertake them if the treatment is under
   patent and therefore a government enforced monopoly. In addition, there is
   growing evidence that RCTs, particularly in the context of individualized
   treatments, should no longer be considered the “gold standard” for drug
   efficacy.

Of course, this is the same nonsense Burzynski’s been peddling for the last
couple of years about a vaporware randomized clinical trial carried out by
Hidaeki Tsuda in Japan. This trial featured prominently in Eric Merola’s second 
movie. Unfortunately, although the trial sounds interesting as described in
Merola’s movie, it has not yet been published. Now take a look at the article
linked to in the ANH diatribe. It was published in Oncology Reports (not the
greatest of cancer journals) entitled “Demethylation effect of the
antineoplaston AS2-1 on genes in colon cancer cells”. Do you notice something? I
did, immediately. More accurately, I didn’t notice something, and that
something was a clinical trial. This is nothing more than yet another in vitro
study, and it’s not even that compelling of one, given that it uses enormous
concentrations of AS-2, 2 mg/ml, way higher than is likely to be achievable in
the bloodstream, even using the massive doses of ANPs that Burzynski advocates
using. Yes, Burzynski really does have that much contempt for you that he tries 
to pass off an in vitro study as a clinical trial.

The rest of the ANH-USA’s attacks are largely nothing more than regurgitations
of past Burzynski excuses and attacks. For example, in one article the ANH-USA
twists the cases of Liza Cozad and McKenzie Lowe to its own ends, all but saying
that the FDA is evilly laughing and twirling its metaphorical mustache as Cozad
and Lowe die, as USA TODAY dutifully promotes the agenda of its pharma masters 
and the FDA. Hilariously, there was a third article claiming that the FDA
violated patient privacy by providing Szabo with medical records of a patient
without the parents’ permission. If you click on the link now, there’s nothing
there. The article has apparently been taken down. There are, however, multiple 
links to it elsewhere, for example, here, here, here (our old friend Merola) and
here. The article still shows up on the ANH sitemap, but there’s nothing there.
Apparently, the ANH took it down, which is probably because it was full of
misinformation and lies. I only wish I had saved a screenshot or web archive of 
the article. My mistake.

Bringing it all together: The ANP Coalition

It’s taken nine months since Burzynski supporters revealed in a video of the
panel discussion after a screening of Eric Merola’s movie that various Burzynski
patient groups were planning to form an organization to lobby Congress for fast
track approval of ANPs. Indeed, Merola and his merry band of Burzynski
sycophants were quite open about wanting fast track approval for ANPs so that
Burzynski could then prescribe them off-label for virtually any cancer and
presumably could also sell them to any doctor who wanted to use them for
whatever purpose. Of course, advertising a drug for off-label uses is against
the law, which is why the FDA takes such a dim view of it, but “word of mouth”
and ANP-friendly groups like the ANH would make sure that word got around fast. 
Unfortunately for Stash, with the deficiencies of the procedures of the
Burzynski Clinic and BRI with respect to running clinical trials having been
laid bare in Liz Szabo’s article in USA TODAY, fast track approval for ANPs for 
glioblastoma is, at best, highly unlikely. So Burzynski’s allies have fallen
back on lobbying Congress to lean on the FDA to allow single patient protocols, 
sometimes called “compassionate use” protocols, to allow Burzynski to treat
patients with ANPs even though his clinical trials are shut down. To do this,
they have formed a group called the ANP Coalition:

   It is our fundamental belief that the discovery of Antineoplastons (ANP) can 
   and will herald a new age of medical science and subsequent advancements in
   the treatment of previously incurable diseases. This benign yet effective
   drug contradicts the paradigm that cancer treatments have to be harmful to be
   effective, and redirects modern medicine back to its salient principal
   Primum non nocere, “first, do no harm”.

   How does the ANP Coalition intend to accomplish our mission?

   We will accomplish our mission by focusing on four main goals:

  1. To educate the public as to the importance and benefits of ANP.

  2. To advocate for patients who need access to ANP for medical conditions.

  3. To expedite regulatory approval for ANP thereby making it available to all.

  4. To further research and development of ANP.

Consistent with a lot of the rhetoric used by Eric Merola and the Burzynski
Patient Group, the rhetoric on the ANP Coalition site is apocalyptic, painting
the battle as nothing less than one of good versus evil:

   This is not a time for all good men to act; it is a time when all good people
   must act. We live in an age of awareness, where technology has become the
   great equalizer. With technology comes communication, and through
   communication we can educate! Once armed with education, propaganda withers
   and dies!

   This website is designed with the sole purpose of educating the public and
   exposing the truth. The battle starts here in cyber space, but the war is won
   in the real world, by real people who participate in real ways. It will be
   won by you!

   We are no longer an organization of patients connected by a cure; we are the 
   collective who will not allow evil to triumph.

I can provide a hint of why the rhetoric is so amped up. One has only to look at
who owns the ANPcoalition.org. The domain is registered through Domains By
Proxy, which makes one wonder why the ANP Coalition would want to hide who owns 
the domain. First of all, the pictures on the Contact page reveal several old
friends, including Ric Schiff, whose wife Laura, not coincidentally, owns a
related domain, theotheranpcoalition.org, and registered it under her real name 
and also appears on the Contact page. (A screenshot has been saved, of course.) 
Also there is Mary Jo Siegel and her husband Steve. These are the people behind 
ANP Coalition, just as they are heavily involved in the Burzynski Patient Group.
In fact, in July 2013, Ric Schiff was elected to the board of directors of the 
BRI, which makes his involvement in this effort a massive conflict of interest.

Predictably, Elisha Cohen, Liza Cozad, and Mackenzie Lowe are featured as the
stories used to drive petitions to lawmakers and the FDA to allow compassionate 
use of ANPs. In addition, there are two new patients, of whom I haven’t heard
before, Laura Nowosad, a 7 year old girl from Canada with a DIPG whose story is 
sadly familiar to anyone who covers Burzynski:

   Her parents, Janusz and Mira, are an amazing couple whose lives got shattered
   in an instant. Laura is their only child and their whole world. They
   couldn’t believe that this is happening to their little girl; they were
   hopeful that the doctors made a wrong diagnosis and went for a second
   opinion. Unfortunately, this diagnosis was confirmed. Words cannot explain
   the feelings of hopelessness, frustration, and terror they felt when they had
   to be faced with the truth.

   Janusz and Mira are not giving up hope! They have taken Laura to The
   Burzynski Clinic in Houston, Texas. This clinic has seen significant
   improvement in patients facing similar diagnosis as Laura, using alternative 
   therapies not available in Canada. However, the treatment is very expensive. 
   The initial visit costs $25,000 and each month after is $30,000.

On the same page is yet another desperate family being used by Burzynski’s
minions as well, that of Isaac DeHerrera, a five year old boy whose tale is
presumably so new that there isn’t yet a fundraising website that I could find
or a petition to let Burzynski treat Isaac with ANPs on a compassionate use
protocol. I’m sure there will be more families added as soon as Burzynski and
his minions can find them. Clearly Ric and Laura Schiff and Steve and Mary Jo
Siegel believe that they can duplicate the success Burzynski patients had in the
1990s, which was the last time Burzynski was in a comparable amount of trouble,
with demonstrations featuring patients chanting, “FDA go away! Let me live
another day!” and the intense political pressure brought to bear by a compliant 
Senator or Representative, the way they persuaded Joe Barton to drag then-FDA
director David Kessler in front of his committee four times over two years to
explain why the FDA was “harassing” Burzynski. Only this time, they have the
Internet, which was only in its infancy as an organizing tool back in 1995,
which allows them to produce a “Meet the Miracles” section, which, presumably,
will be full of glowing testimonials of Burzynski Patient Group patients. So
far, there is only Jessica Ressel, who was featured in the first Burzynski movie
and whose testimonial is not convincing, as I described in detail in my review.
No doubt she believes Burzynski saved her, but it is almost certainly the case 
that he did not, which is the only reason I can forgive her regurgitating
Burzynski Clinic talking points.

Perhaps the most concerning aspect of the ANP Coalition is that it’s hired a
lobbyist named Antonio C. Martinez II:

   His experience with ANP extends more than 18 years back when he represented
   the Burzynski Patient Group in 1995 and 1996, organizing numerous patient
   demonstrations and a Congressional Hearing on February 29, 1996 before the
   U.S. House of Representatives Energy & Commerce Subcommittee on Oversight &
   Investigations. These efforts helped Burzynski patients obtain access to ANP 
   through Phase II clinical studies.

This isn’t cheap. Unless Martinez is serving pro bono, his hourly rates are $250
to $400. I have no reason to doubt the claim that he worked on organizing the
Congressional Hearing in 1996 at which Burzynski patients vented at the FDA, but
I wonder. I’ve read both Richard Jaffe‘s Galileo’s Lawyer: Courtroom Battles in
Alternative Health, Complementary Medicine and Experimental Treatments and
Thomas D. Elias’ The Burzynski Breakthrough: The Most Promising Cancer Treatment
and the Government’s Campaign to Squelch It. Both books describe the
Congressional hearings in which Burzynski patients testified from a very
pro-Burzynski standpoint. I don’t recall seeing Mr. Martinez’s name being
mentioned even once, and a quick flip through the indices and relevant sections 
of these books did not change that assessment for me. If Martinez were so
important to the 1996 hearings, one would think that Jaffe and/or Elias would
mention him and at least briefly describe his role in their books. They didn’t, 
as far as I can tell.

So what does the ANP Coalition want to accomplish? Its list of demands is long
and some are completely unrealistic. For example, on its page where it tells
people how they can help, it asks people to write to Wikipedia to:

   …demand removal of the “Burzynski Clinic” webpage, since it has been high
   jacked by a paid group who identify themselves as “The Skeptics”, and is no
   longer open for public contribution. The Wikipedia page on “Burzynski Clinic”
   is filled with untrue statements, statements taken entirely out of context, 
   cherry-picked information, sources that do not qualify as sources under
   Wikipedia rules, fake sources—you name it.

The Wikipedia team has already noticed the ANP Coalition’s attempts to astroturf
its article on the Burzynski Clinic.

Others, however, are not unachievable. Certainly organizing petitions and
getting people to write to their lawmakers are achievable aims, and that’s what 
concerns me: How do we respond? In the absence of sound scientific information
showing that ANPs almost certainly don’t work and are very toxic, Burzynski’s
claims notwithstanding, legislators and politicians are going to go with the
sympathetic story; i.e., the stories told by Burzynski supporters of children
with deadly brain tumors who will die soon if they aren’t allowed to have ANP
therapy. That’s why it infuriates me to see how Burzynski so cynically uses
patients with deadly cancers in his battle with the FDA. Make no mistake, that
is exactly what he is doing here. He dangles false hope in front of patients
like Eliza Cozad, Raphael Elisha Cohen, and McKenzie Lowe, and their families do
the rest for him. Even in the case that a legislator understands the lack of
evidence, he might well go with a “What’s the harm?” attitude, not appreciating 
that the harm can be appreciable given how toxic ANPs are, not to mention the
financial harm done to the family raising tens or hundreds of thousands of
dollars for an ineffective treatment. That’s why information to show why, as
much as we sympathize with the plight of these patients and their families,
legislators should not overrule the FDA’s decision regarding antineoplastons.
Indeed, the real investigation should be into why the FDA has allowed Burzynski 
to get away with what he’s gotten away with all these years.

I also appeal to you, our readers, for help and ideas. Visit Bob Blaskiewicz’s
appeal and take action. In the meantime, let’s hear ideas for how to counter
this latest initiative.

The Texas Medical Board vs. Stanislaw Burzynski, 2014 edition

Here we go again. I’ll give the Texas Medical Board credit for one thing. It’s
persistent. It’s going after Stanislaw Burzynski’s medical license again. Will
this finally be the time the TMB puts a stop to Burzynski’s abuse of the
clinical trial process and patients? Or will this be a replay of the 1990s, with
Burzynski slithering away yet again?

David Gorski on July 14, 2014

Link





Stanislaw Burzynski: 40 years of failure to prove that his antineoplastons are
effective against cancer.

As I begin this post, I’m on a miserably crowded, hot, stinky flight winging my 
way home from TAM. This puts me in the perfect mood to write about my bête noire
to conquer all bêtes noires, namely Stanislaw Burzynski, the Polish expat
doctor who claims to have much better results treating deadly brain cancers than
conventional oncology, even though he is not an oncologist and has never even
completed the prerequisite training for an oncology fellowship, namely an
internal medicine residency. Actually, I don’t mean that in the way that you
probably think I mean it. This time around, unlike the last time around, writing
about Burzynski will put me in a better mood to endure being slapped into a
sardine can in coach, barely able to move, barely able to type, but needing to
get a blog post out on Monday.

If you remember, the last time I wrote about Burzynski, the Food and Drug
Administration (FDA) had caved, and by “caved” I mean that it had lifted the
partial clinical hold on Burzynski’s clinical trials. As is usual with the long 
and winding saga that is Burzynski, I feel compelled to give a brief review for 
any newbie who might encounter this post. Old hands at this story can skip ahead
or just skim.

Two years ago, a child named Josia Cotto died of hypernatremia (elevated sodium 
level in the blood) due to receiving treatment for a brain tumor from the
Burzynski Clinic using Burzynski’s “miracle drug” antineoplastons. Hypernatremia
is a known complication of ANP treatment, and, as a result of this child’s
death, the FDA put a partial clinical hold on Burzynski’s clinical trials for
pediatric patients, which meant that he could continue to treat children already
enrolled in his clinical trials but could not enroll any new patients. Six
months later, this partial hold was extended to all of Burzynski’s clinical
trials, and in early 2013 the FDA inspected the Burzynski Clinic and Burzynski
Research Institute (BRI).

The reason why the FDA’s decision late last month to lift this clinical hold is 
so puzzling is because the results of the FDA’s inspection were so damning. In
particular, the FDA found that Burzynski exaggerated responses to therapy using 
inappropriate criteria, didn’t have original scans of many patients, and played 
fast and loose with the rules regarding enrolling patients onto clinical trials 
under single patient INDs (otherwise known as compassionate use exemptions).
Let’s just say that Burzynski’s institutional review board (IRB), the committee 
whose charge under the Common Rule (which clinical trials meant to be used as
the basis for FDA approval of a drug must follow) wasn’t exactly rigorous about 
following federal regulations or protecting patient rights and safety, and let’s
further say that Burzynski’s response was…less than convincing. More puzzling, 
this is not the first time that the FDA has investigated Burzynski and found the
very same sorts of violations by the BRI IRB; it’s a pattern that goes back to 
at least 2001 and continued at least until the FDA inspection. Let’s just put it
this way. IRBs are supposed to be as independent as possible, and Burzynski’s
IRB has been (and still is) chaired by Carlton F. Hazlewood, PhD, who just so
happens to be on the board of directors of the Burzynski Research Institute. The
conflict of interest and lack of ethics are astounding. Yet the FDA still
lifted the partial clinical hold, a breathtaking failure to protect cancer
patients.

That was the bad news.

The Texas Medical Board tries to do the right thing

During this time, the Texas Medical Board, which has tried and failed to strip
Burzynski of his medical license on multiple occasions over the last four
decades, has decided to take another whack at the piñata. I’m glad it did, even 
though, as has been discussed before with respect to multiple cases, including
Rolando Arafiles and Christopher Duntsch, the TMB is toothless by design, thanks
to an anti-regulatory bias that has led to laws that have vastly weakened its
already-weak regulatory authority. That’s why, although I’m not optimistic that 
this time the TMB will prevail where in the past it has not, I’m glad it’s
giving it the old college try, which is what it has done with an amended
complaint against Burzynski dated July 10, 2014. I warn you: It’s over 200 pages
long, but the spacing and repetition are such that I was able to read most of
it even though I was busy with TAM. It’s a devastating document that, if the
allegations are proven in court, should finally end Burzynski’s career. I’ll
apologize if I’m a bit pessimistic, though. Burzynski has slithered out of
tighter spots before.

Still, it’s worth discussing the allegations. Because of the length of the
document, I can only hit the high points, but the complaint is there for you all
to read if you are so inclined. If you’ve been following the Burzynski saga
it’s definitely worth taking the time to do so. The introduction sets the stage:

   Board Staff alleges that Respondent created a medical practice model based on
   marketing his proprietary anti-cancer drugs to patients without adequate
   measures for patient safety and therapeutic value. Respondent misled patients
   knowingly by promoting these drugs as an attraction to bring patients to his
   medical practice when Respondent was aware that he could not legally include
   most of those patients in FDA-approved Phase 21 clinical trials of his
   proprietary anti-cancer drugs. Respondent further misled patients into paying
   funds as a retainer prior to receiving any evaluation, diagnosis or
   treatment. Respondent further misled patients into: (1) paying exorbitant
   charges for drugs and medical services; (2) accepting care from unlicensed
   persons while Respondent and Respondent’s employees misrepresented those
   unlicensed persons to be licensed medical doctors in Texas and the United
   States of America; and (3) accepting care from health care providers who had 
   little advanced education or training related to cancer treatment while
   Respondent and Respondent’s employees misrepresented those health care
   providers to be doctors with significant advanced education or training
   related to cancer treatment.

Having followed the Burzynski saga for three years now, I’m always heartened to 
see when a regulatory or law enforcement body “gets it” the way this paragraph
demonstrates that the TMB appears to “get it” now. This is in sharp contrast to 
the weaselly justifications by the FDA for unleashing Burzynski’s bogus clinical
trials—which, recall, his own lawyer characterized as “an artifice, a vehicle
we and the FDA created to legally give the patients Burzynski’s treatment” so
that Burzynski “would be able to treat almost any patient he would want to
treat!”—on unsuspecting desperate cancer patients again. The new allegation that
I hadn’t been aware of was the part about using health care providers with
little or no education or skill and representing them to patients as being
doctors. Now that’s really bad by any stretch of the imagination, and a profound
betrayal of the cancer patients whose desperation led them to Burzynski.

Patient A

Several of those desperate cancer patients are described in the complaint. I’m
not going to go through all the cases, because there’s a depressing similarity
to them in terms of the allegations of Burzynski’s wrongdoing, but it’s worth
discussing at least a couple of them. I’ll start with Patient A, not only
because it’s the first patient listed but because it’s a different story than we
normally see at the Burzynski clinic. This patient had suspected colon cancer. 
I say “suspected,” because at the time he first presented to Burzynski he had
not had any biopsies.

Patient A presented to the Burzynski clinic with a diagnosis of “sigmoid colon
carcinoma metastatic to the liver.” This diagnosis was made on the basis of
imaging studies that showed lesions in the liver suspicious for metastases and a
colonoscopy that showed a “polypoid mass consistent with high-grade dysplasia
and suspicious for invasive adenocarcinoma.” This, unfortunately, is not an
uncommon presentation of colon cancer, except for one thing. Usually, there’s a 
biopsy done. A cardinal rule for treating cancer patients is that you do not
initiate treatment without a tissue diagnosis from a biopsy. This tissue both
proves that the patient has cancer and identifies the kind of cancer it is.
Indeed, these days, when molecularly-targeted therapy is being increasingly
used, the tissue also allows analysis of gene expression patterns that can guide
the choice of treatment. The situations in which it is considered acceptable to
begin treatment of presumed cancer in the absence of a tissue diagnosis are
very uncommon and boil down to rare cases where the imaging is pathognomonic of 
the kind of cancer suspected and the clinician judges that a biopsy would be too
risky.

Basically, patient A should have had a biopsy of both his sigmoid colon lesion
and one or more of his liver lesions. There was no reason not to do this, as
colonoscopic biopsies and needle biopsies of the liver are in general low risk
procedures and the treatment of colon cancer is, increasingly, being guided by
newer gene tests. Now, in fairness, Patient A had refused to undergo a biopsy
when his local physician had recommended it and also refused to consider
chemotherapy with FOLFOX3 with Avastin after a biopsy, which is within the
standard of care. However, if that’s the case then Burzynski should have refused
to treat him. Not only is it considered a gross breach of the standard of care 
not to have a tissue diagnosis before treating a patient, but nearly all
clinical trials for cancer treatments absolutely require a tissue diagnosis,
which means that this patient was ineligible for any of Burzynski’s clinical
trials. Instead, without even recommending a biopsy, Burzynski began to treat
patient A with anticancer medications.

Now here’s the kicker:

   9. At the time Patient A first met with Respondent and the other employees of
   the Burzynski Clinic, Respondent allowed Tolib Rakhmanov, a person who is
   not a licensed physician or health care provider in Texas or elsewhere in the
   United States of America, to represent to Patient A that Tolib Rakhmanov was
   a licensed medical doctor practicing medicine in Texas. Respondent and the
   other Burzynski Clinic employees under Respondent’s supervision and control
   continued to represent to Patient A and Patient A’s fiancee or to allow them 
   to believe that Tolib Rakhmanov was a licensed medical doctor practicing
   medicine in Texas throughout Patient A’s treatment at the Burzynski Clinic.

   10. Respondent and the other Burzynski Clinic employees under Respondent’s
   supervision and control referred to Tolib Rakhmanov as “Dr. Rakhmanov” in
   Patient A’s and Patient A’s fiancée’s presence. Respondent knew or reasonably
   knew that Tolib Rakhmanov signed documents, many of which were also signed
   by Patient A and Patient A’s fiancee, in manners that identified Tolib
   Rakhmanov as a medical doctor. Patient A and Patient A’s fiancée reasonably
   believed that Tolib Rakhmanov was a medical doctor licensed to practice
   medicine in the state of Texas. Respondent was responsible for the false,
   misleading and deceptive representation to Patient A and Patient A’s fiancée 
   that Tolib Rakhmanov was a medical doctor licensed to practice medicine in
   the state of Texas.

Rakhmanov also performed tasks and services that obviously constitute the
practice of medicine, including diagnosing and evaluating Patient A’s medical
condition, making treatment recommendations, on numerous occasions (with all the
dates listed). The TMB further alleges that Burzynski “directed and/or
reasonably knew and allowed Tolib Rakhmanov, a person who is not a licensed
physician or health care provider in Texas or elsewhere in the United States of 
America, to perform medical tasks that constituted the practice of medicine in
the state of Texas in the evaluation, diagnosis and treatment of Patient A.”

Burzynski also promised the patient that he would receive ANPs and the
FOLFOX/Vectibix treatment he desired, after which he demanded a large retainer
for treatment. This is interesting, because Vectibix (generic name: panitumumab)
is a targeted therapy that is only useful in cancers with a gene called KRAS
that is not mutated. (KRAS is gene that is frequently mutated in colorectal
cancer.) This is what I mean about how gene testing is becoming more important
in colorectal cancer. Most colorectal cancers these days are tested for KRAS
mutations to determine if Vectibix is an appropriate therapeutic regimen.
According to the company’s website, Vectibix is “not indicated for the treatment
of patients with KRAS-mutant mCRC [metastatic colorectal cancer] or for whom
KRAS mutation status is unknown.” In other words, it was unequivocally not
indicated for Patient A. That’s even leaving aside the issue of ANPs.

Actually, Patient A never received FOLFOX/Vectibix or ANPs. Instead, he received
something else from Burzynski without his “adequately explaining to Patient A
the difference in safety and efficacy between the therapy requested by Patient A
and the therapy provided by Respondent and the employees of the Burzynski
Clinic under his supervision and control.” Instead, Burzynski initiated
treatment with phenylbutyrate. Remember phenylbutyrate? It’s the orphan drug
that Burzynski touts as an ANP prodrug. Patient A also received a “partially
FOLFOX equivalent regimen” consisting of oral Xeloda and intravenous Avastin,
which I consider kind of a half-assed treatment that isn’t FOLFOX. Apparently
Patient A improved for a while, which is quite possible given that he was
receiving Xeloda (capecitabine), for which there is some evidence of efficacy,
as well as Avastin, which is why it’s sometimes used as an alternative to
FOLFOX. It’s unlikely that the phenylbutyrate did anything. I do have to note,
however, that there is a passage in which “shrinkage” of a brain tumor is
mentioned, which makes me think the TMB made a mistake and mixed up part of
Patient B’s story with that of Patient A.

For some reason, Burzynski started changing drugs without adequate rationale.
Eventually, the tumors started growing again, and the patient left Burzynski’s
care, having paid an enormous amount of money, including a $4,500 monthly case
management fee and a charge of $360 for 500 mg of sodium phenylbutyrate. During 
the course of Patient A’s treatment, Burzynski also used very expensive drugs
that are not indicated for colorectal cancer, such as Afinitor (everolimus),
which inhibits a protein called mTOR and is primarily used for kidney cancer and
breast cancer, and Votrient (pazopanib), a tyrosine kinase inhibitor that
blocks tumor growth, inhibits angiogenesis, and is used for renal cell carcinoma
and soft tissue sarcoma.

The story is all very familiar if you’ve been following Burzynski and very
depressing. There’s more, just in the case of Patient A, including failure to
assess the patient’s mental status when recommending treatments, failing to
provide anything resembling adequate informed consent, and having an ownership
interest in the pharmacy dispensing the drugs Burzynski used, among other
violations, but let’s move on to Patient B.

Patient B

Patient B is an interesting case, because part of it isn’t clear to me. In
December 2010, Patient B had a diagnosis of brain cancer, which was successfully
removed by craniotomy, which was followed by imaging studies that showed
complete removal of the tumor. Post-operative chemotherapy and radiation therapy
were recommended. Now here’s a part where it’s hard to understand what
Burzynski did wrong if you don’t know a lot about him. The complaint alleges
that Burzynski didn’t get a biopsy to confirm the existence of cancer before
initiating anticancer treatment. Yet, conventional doctors had recommended
postop chemotherapy and radiation, even though as far as they could tell the
cancer had been completely removed. The difference is in intent. The
chemotherapy and radiation therapy were being recommended as adjuvant
treatments, in other words, treatments designed to decrease the risk that the
tumor would recur, given that microscopic disease is almost always left behind. 
My guess (and it’s only a guess) is that Burzynski didn’t document that he was
undertaking treatment for adjuvant purposes but rather made it sound in the
medical record as though he were treating for therapeutic purposes for an
existing cancer.

Later in the complaint it is alleged that “Respondent and/or employees under his
direction and control failed to inform Patient B about the FDA-approved
criteria for treatment with antineoplastons in one of Respondent’s sponsored
clinical studies.” None of Burzynski’s trials that I can find are for the
adjuvant treatment of brain cancer. They are, instead, for the treatment of
existing brain tumors, most often recurrent or refractory brain tumors. Thus,
Patient B almost certainly wasn’t eligible for any of Burzynski’s ANP clinical
trials, because he had what we in the biz like to call “no evaluable disease,”
often abbreviated NED, meaning that there wasn’t any currently detectable tumor 
whose response to therapy could be followed.

Next, we see the same depressing litany for Patient B as well, including lack of
informed consent, failure to document treatment rationale, and, again,
Burzynski Clinic staff who are not physicians being represented as such,
including Tolib Rakhmanov and Larisa Tikhomirova. There again was the
requirement for a large retainer to begin treatment. There was again the “bait
and switch” in which Burzynski lured Patient B in with the promise of his ANP
therapy and then used something different, including—of course!—phenylbutyrate, 
plus the usual witches’ brew of targeted drugs that we’ve seen before and that
are not indicated in most brain cancers. It’s what I’ve referred to before as
the “everything but the kitchen sink” approach.

In actuality, Patient B’s story in the complaint is poorly written and very
confusing. I had trouble making heads or tails of part of it. It says that
Patient B didn’t have any detectable tumor when he first consulted Burzynski in 
December 2010 and nails Burzynski for that, but then it describes Burzynski
beginning treatment in February 2011 and an MRI scan:

   On or about March 17, 2011, an MRI of Patient B’s brain revealed moderate
   decrease in the size of the brain lesion.

My guess, but I can’t be sure from the muddled and confusing description in the 
TMB complaint, is that this brain “lesion” was probably the inflammatory
reaction to the patient’s surgery, which would have been expected to get smaller
over the next three months anyway. A better way to say it would have been to be
very clear from the start what the radiological findings were when the patient 
first approached Burzynski. If there was a lesion there, then it should have
been pointed out whether it was suspicious for residual disease or whether the
radiologists thought it was just normal postoperative changes. We can infer from
the description that Patient B’s doctors must have thought that there was no
residual disease, but then what is this “brain lesion” that was showing moderate
decrease in size on March 17, 2011? I’m a cancer doctor who’s followed
Burzynski, and even I’m not entirely sure what happened based on the
description.

Be that as it may, many of the same complaints made against Burzynski for his
treatment of Patient A apply to Patient B as well, and Patient B suffered
considerable toxicity:

   Respondent and other health care providers under Respondent’s direction and
   control treated Patient B without regard to the potential combined toxicities
   of drugs used pursuant to Respondent’s recommendations and directions.
   Respondent and other health care providers under Respondent’s direction and
   control referenced the case reports of other physicians not associated with
   the Burzynski Clinic as support for combined use of the drugs recommended and
   administered to Patient B. In those referenced case reports of physicians
   not associated with the Burzynski Clinic, however, those drugs were only used
   individually or in other combinations besides the combinations of drugs used
   for Patient B by Respondent and other health care providers under
   Respondent’s direction and control. In this regard, Respondent and other
   health care providers under Respondent’s direction and control violated the
   standard of care for reasons including:

   a. Patient B suffered considerable toxicity affects.

   b. Respondent violated the standard of care by failing to have an adequate
   medical rationale for this simultaneous use of these agents in anti-cancer
   therapy.

   c. Respondent violated standards of adequate documentation by failing to
   document an adequate medical rationale for this simultaneous use of these
   agents in anti-cancer therapy.

   d. Respondent also failed to adequately inform Patient B of this increased
   risk.

Same as it ever was. I note that Patient D’s case is a lot like Patient C’s
case, one difference being that Sheryll Acelar was one of the non-physicians
allegedly represented to the patient as a physician. Another name that came up
as a Burzynski Clinic employees who was falsely represented to patients as being
physicians was Lourdes DeLeon.

Patient G

Patient G is different in that Patient G was actually enrolled on one of
Burzynski’s phase II clinical trials for a malignant astrocytoma of the optic
nerve. For this patient, not only were there many of the same violations as
listed for Patients A through F, but there were added allegations based on
Burzynski’s treatment of the patient as part of this clinical trial:

   14. Respondent failed to comply with federal regulations, the Burzynski
   Research Institute’s agreement with the FDA regarding the clinical study
   program for administration of antineoplastons and the approved protocols for 
   the approved clinical study in which Patient G was enrolled. Such failures
   included Respondent’s direction and allowance for Patient G to be charged for
   the antineoplaston therapy and Respondent’s direction and allowance for
   these charges to be characterized as something else, “chemo prolong infuse” .
   This characterization was false, misleading and deceptive.

And:

   40. The federal regulatory requirements for approval of single patient
   protocols for Phase 1 or Phase 2 clinical studies require that the
   investigator ensure that risks to patient/subjects are minimized and
   reasonable in relation to anticipated benefits.

   41. Respondent, as principal investigator and as sponsor of the clinical
   study of antineoplaston therapy for Patient G, had a responsibility to ensure
   that risks to Patient G were minimized and reasonable in relation to
   anticipated benefits.

   42. Ensuring that risks to patient/subjects are minimized and reasonable in
   relation to anticipated benefits requires (1) review of the subject’s medical
   records (history and physical examination) and (2) clarifying any
   outstanding issues with respect to the suitability of treating the
   patient/subject prior to granting institutional review board approval.

   43. Respondent, as principal investigator and as sponsor of the clinical
   study of antineoplaston therapy for Patient G, failed to do the following to 
   protect Patient G who was a patient/human subject in the clinical study of
   antineoplastons; (1) Respondent failed to take adequate measures to minimize 
   risks to Patient G; and (2) Respondent failed to ensure that the risks to
   Patient G were reasonable in relation to anticipated benefits and the
   importance of the generalizable knowledge that may be expected to result.

   44. Respondent’s failure, as principal investigator and as sponsor of the
   clinical study of antineoplaston therapy for Patient G, to ensure that risks 
   to Patient G were minimized and reasonable in relation to anticipated
   benefits violated the standard of care, federal regulations, the Act and
   Board Rules.

This is the first time I’ve ever seen the TMB go after Burzynski for violating
federal clinical trial regulations and human subjects research protections. I
would like to see more of this. Another aspect of this case is unusual in that
the TMB notes that the patient’s parent was allowed “to open an account whereby 
the public could read about Patient G’s medical and financial crisis and
contribute money to that account.” The TMB alleges that Burzynski and his staff 
“reasonably were aware that the website that hosted this contribution account
would provide any donations directly to the Burzynski Clinic to pay for the
costs of Patient G’s treatment and that such costs had already been paid in
advance by Patient G’s parent.” Patient G’s parent had a billing dispute with
the Burzynski Clinic in which Burzynski refused to accept those donations as
credit on Patient G’s account at the Burzynski Clinic and returned all the
donations to the website that had acted as an intermediary for the donations.
Burzynski also received significant reimbursement payments from an insurance
company for Patient G’s care and refused to refund Patient G for benefits paid.

In other words, it’s all about making money from the dying and desperate.

And all the rest…

The TMB complaint also describes something that people who’ve been following the
Burzynski case are well aware of, namely his advertising claims for ANPs, which
are illegal under federal law because he made specific health claims for them
and they are not yet FDA-approved for any indication. This is one thing that I
haven’t been able to figure out. If a drug company did this, all the “natural
health” advocates who defend Burzynski tooth and nail would howl bloody
murder—and rightly so. But Burzynski does it, and he’s a hero being “persecuted”
by the FDA and TMB. Ditto Burzynski’s failure to meet criteria for human
subjects protection again and again, which are detailed very carefully in the
last 30 pages or so of the complaint.

So what does it all mean? At the very least, it means that the TMB is serious
this time. Does it mean that finally—finally—Burzynski is going down? I
certainly hope so. Unfortunately, there’s no guarantee, and Burzynski has been
found not guilty of similar charges before. Whatever happens with this case,
thirty-seven years are too many, and no other cancer patient should pay hundreds
of thousands of dollars for an ineffective treatment.

Stanislaw Burzynski’s propaganda victory on antineoplastons: The FDA really
caves

Once more, the FDA fails to shut down Stanislaw Burzynski’s clinic and
antineoplaston manufacturing operation. Cancer patients will suffer as a result 
of the FDA’s failure.

David Gorski on July 1, 2014

Link

It’s been a while since I wrote a substantive post for this blog about the
Houston cancer doctor and Polish expat Stanislaw Burzynski who claims to have a 
fantastic treatment for cancer that blows away conventional treatment for
cancers that are currently incurable. The time has come—and not for good
reasons. The last time was primarily just a post announcing my article about
Burzynski being published in Skeptical Inquirer. When last we saw Stanislaw
Burzynski on this blog, it was a post that I hated to write, in which I noted
that the Food and Drug Administration (FDA) had caved to patient and legislator 
pressure and allowed compassionate use exemptions (otherwise known as single
patient INDs) to continue. The catch? Cynically, the FDA put a condition on its 
decision, specifically that no doctor associated with Burzynski nor Burzynski
himself could administer the antineoplastons. This set off a mad scramble among 
Burzynski patients wanting ANPs to find a doctor willing to do all the paperwork
and deal with Burzynski to administer ANPs. The family of one patient, McKenzie
Lowe, managed to succeed.

It’s hard for me to believe that it’s been almost three years since I first
started taking an interest in Burzynski. Three long years, but that’s less than 
one-twelfth the time that Burzynski has been actually been administering an
unproven cancer treatment known as antineoplastons (ANPs), a drug that has not
been FDA-approved, to patients, which he began doing in 1977. Yes, back when
Burzynski got started administering ANPs to patients, I was just entering high
school, the Internet as we know it did not exist yet (just a much smaller
precursor), and disco ruled the music charts. It’s even harder for me to
believe, given the way that Burzynski abuses clinical trial ethics and science, 
that I hadn’t paid much attention to him much earlier in my blogging career.
After all, I’m a cancer surgeon, and here’s been this guy treating patients with
advanced brain cancers using peptides that, according to Burzynski, do so much 
better against what are now incurable tumors than standard of care while
charging huge sums of money to patients on “clinical trials.” It might be a
cliché to quote the Dead this way, but what a long, strange trip it’s been.
Because there has been a major development in this saga whose context you need
to know to understand, I’m going to do a brief recap. Long-time regulars, feel
free to skip the next couple of paragraphs, as they just try to bring people up 
to date and include a lot of links for background, or, if you haven’t already,
read this summary of Burzynski’s history published earlier this year in
Skeptical Inquirer. Newbies, listen up. Read the next two paragraphs. You need
to know this to understand why I’m so unhappy. 

Incidents that I never blogged about here (but fortunately a certain “friend” of
mine did on another blog) that have occurred since the FDA caved and (sort of) 
lifted the partial clinical hold on ANPs included:

  1. For the first time in 37 years, Burzynski published what was purported to be
    the complete results of one of his phase I/II clinical trials. The results
    were—shall we say?—underwhelming.

  2. Before that Burzynski had published 42.5% of one of his phase I/II trials,
    with even more unconvincing results.

Meanwhile, since he received that warning letter from the FDA late last year, in
addition to making unconvincing claims excusing the issues described in the FDA
warning letter, he’s been trying to enlist patients, both cute children and the
semi-famous, to persuade legislators to pressure the FDA to let his clinical
trials open again after they had been put on a partial clinical hold in the wake
of the death of a child from hypernatremia (too much sodium in the blood), as
reported by Liz Szabo in USA TODAY. All the while Burzynski has continued to
charge patients large sums of money, while bragging that he didn’t charge for
the actual ANPs. For those unfamiliar with the story, a partial clinical hold
means that Stanislaw Burzynski can’t enroll any new patients on clinical trial
but can continue to treat patients already enrolled.

Yes, three months ago—has it been that long already?—I noted with dismay that,
under the onslaught of sympathetic cancer patients who understandably but
incorrectly believe that Burzynski is their last chance to live, the FDA did
indeed cave, although in the most weaselly way imaginable, stating that
Stanislaw Burzynski could again enroll patients under compassionate use
exemptions (also known as single patient INDs), even though the FDA warning
letter had found gross deficiencies in the Burzynski Research Institute
Institutional Review Board (BRI-IRB), which is run by an old crony of
Burzynski’s who just so happens to be chair of the board of directors of the BRI
and was found to be negligent in protecting patients by playing fast and loose 
with the regulations for enrolling patients on single patient INDs. The
condition was that Burzynski himself or anyone working for him couldn’t be the
physician treating the patients, leaving the patients to find a doctor willing
to oversee the administration of ANPs.

And so it was for three months, with desperate patients with terminal brain
tumors scrambling to find some doctor willing to do the paperwork to get the FDA
to allow him to administer ANPs and also willing to work with such a
disreputable character. McKenzie Lowe’s family, for instance, managed to find a 
retired family practitioner named Terry Bennett to agree to this. (More on this 
later.) Then, last week, this bombshell landed, courtesy of Liz Szabo again, in 
a story entitled “FDA gives controversial doc green light to restart work“:

   The Food and Drug Administration has given a controversial Houston doctor the
   green light to resume administering experimental cancer treatments.

   The FDA has lifted restrictions on a clinical trial run by Stanislaw
   Burzynski, who was the subject of a USA TODAY investigation last year.
   Burzynski, 70, has wrangled with state and federal medical authorities for
   nearly 40 years over his claims that he has discovered natural substances
   that can fight certain cancers.

You might think that my reaction upon reading this would be “WTF?” It wasn’t.
However, that was only because I had had that reaction a week ago, when I read a
press release from the BRI, “Burzynski Research Institute, Inc. Announces
Lifting Of The FDA Partial Clinical Hold – Phase 3 Clinical Study Agreed Upon“:

   The Burzynski Research Institute, Inc. (BRI) announced today that U.S. Food
   and Drug Administration (FDA) has notified the company that its partial
   clinical hold on its IND for Antineoplastons A10/AS2-1 Injections has been
   lifted. The FDA has determined that under its IND the Company may initiate
   its planned Phase 3 study in newly diagnosed diffuse, intrinsic, brainstem
   glioma. The Company is continuing discussions with the Agency in an effort to
   finalize additional details of the phase 3 study protocol for the potential 
   clinical trial.

   The FDA’s decision to lift the clinical hold marks an important step in the
   development of Antineoplastons for the treatment of various forms of brain
   tumors in the US. At the same time, the Company is evaluating possible next
   steps for the Antineoplastons clinical program given the current progress and
   anticipated resource requirements of the ongoing program.

That was when I had my “WTF?” moment. However, noting the obviously
intentionally vague language of the press release, I decided to wait until I
could learn more and obtain confirmation rather than to blog the press release. 
For one thing, Burzynski could have just been spinning furiously, and there
could have been a lot less to this press release than met the eye. It wouldn’t
be the first time. Also, I just couldn’t believe that the FDA would so
horrifically fail patients with brain cancer yet again the way it now has. I
could sort of see why the FDA issued its previous ruling that allowed other
doctors to enroll patients in single patient INDs of ANPs. At the time, the FDA 
was under a lot of pressure from legislators being contacted by constituents
about families in their state or district with brain cancer who wanted to be
treated by Burzynski. Its cynical solution must have seemed downright Solmonic
at the time to the administrators who thought of it. But this? There’s nothing
in the press release that says that the conditions that led to the partial
clinical hold were resolved. Yesterday, however, there was this in Szabo’s
story:

   In a statement issued Wednesday), the FDA confirmed that it has lifted its
   restrictions on Burzynski because he answered all of their questions. In
   particular, Burzynski addressed “common and serious (and in some cases fatal)
   adverse drug reactions, as well as accurate information on how often tumors 
   shrink after treatment with antineoplastons.”

Notice something missing? I did. The FDA said nothing about the BRI-IRB, which
was soundly chastised for approving single patient INDs without full meetings of
the committee. It also said nothing about the massive conflicts of interest
that exist in the IRB and how it can’t possibly be independent. Sure, if
Burzynski talked the talk adequately, I might see how the FDA might be either
snowed or too tired to fight any more. I could see how it might be tempted to
let him open his bogus clinical trials again—but only if Burzynski were forced
to use a truly independent IRB, not his crony-packed IRB that basically rubber
stamps whatever it is he wants to do with no questions and no evident effort to 
protect the welfare and rights of clinical trial subjects. Any IRB worth its
salt will refuse to approve a clinical trial now and then and/or issue warnings 
to principal investigators for inadequate documentation, too many adverse
events, etc. Has the BRI-IRB ever done this? Not as far as anyone I know can
tell. Of course, it’s not really up to the FDA to oversee the function of IRBs. 
Rather, it’s more a function of the Office of Human Research Protections (OHRP).
Long have I wondered: Where the heck has the OHRP been all these years?

It’s not as though Burzynski isn’t up to his old tricks again, either. Even with
another physician overseeing the treatment of McKenzie Lowe, he’s managing to
find ways to charge patients huge sums of money, even as he isn’t charging them 
for the ANPs. Indeed, the other day, Dr. Bennett, the physician who is
overseeing the treatment of McKenzie Lowe whom I mentioned near the beginning of
this article, was featured in an article in a local newspaper “Dr. feels misled
in cancer treatment costs“. The money quotes are here:

   But there was something Bennett didn’t know.

   Bennett’s decision was based, in part, on a newspaper article that said
   Burzynski had agreed to donate the medicine required for McKenzie’s
   treatment. But what Bennett didn’t know is that Burzynki [sic] planned to
   charge the family for the clinical costs associated with the therapy.

   LaFountain said the first month’s bill is expected to be $28,000. Every month
   after that is expected to cost $16,000. The treatment usually lasts eight to
   12 months.

   And health insurance won’t cover a dime of it.

And here:

   Bennett says a representative of the Burzynski Clinic called him on that date
   seeking payment for the first month of McKenzie’s therapy. Prior to that,
   Bennett, who is donating his services, thought Burzynski was doing the same.

   Instead, said Bennett, “I’m supposed to be the bag man for all of this. They 
   want me to collect the 30 grand for the family and send it to Burzynski.”

Elsewhere, Bennett said, “It [the Burzynski Clinic] meets all the criteria for a
bait and switch operation.” Yes, even Dr. Bennett found out the hard way how
the Burzynski Clinic operates. None of this is anything new. Burzynski has been 
trying to dodge this tactic for years by saying that he doesn’t charge patients 
for his actual drug, the ANPs, giving the impression that he’s not charging them
much of anything. However, the reality is that costs can rapidly add up to
hundreds of thousands of dollars, which is why fundraisers by families of
Burzynski patients have been a feature surrounding the Burzynski Clinic
operation for decades, as has been documented time and time and time again.

This is a doctor who wants to help and is willing to take risks, even if
inappropriately in this case, and he feels used by Burzynski. Indeed, his
comparing himself to a “bag man” is a particularly apt metaphor, because that’s 
what he is in this: A bag man. It’s his job to collect the cash from the family 
of a dying child and ship it to Burzynski. Ironically, this news story appeared 
on the very same day as Burzynski’s press release, and, of course, Szabo’s story
appeared yesterday. Did the FDA know Burzynski was doing this? It strains
credulity to think that the FDA didn’t know about this abuse of a desperately
ill child’s family, given that information regarding how it will be paid for is 
part of a single patient IND application, indeed part of all clinical trial
applications. Indeed, that Burzynski gets away with this is yet more evidence
that his IRB is nothing more than a rubber stamp, because any independent IRB
would ask some very hard questions about such an arrangement. Very hard
questions indeed. It’s painfully obvious that the BRI-IRB has never asked hard
questions any IRB should be asking about any clinical trial Burzynski has
proposed or about how his clinical trials are being carried out.

It’s even worse than that, though. Check out what I found on a website devoted
to penny stocks, “Burzynski Research Institute (BZYR) Reignites On FDA
Approaval” [sic]:

   Focusing since 1967 on the isolation of various biochemicals produced by the 
   human body as part of the body’s possible defense against cancer, the penny
   stock of Burzynski Research Institute, Inc. (BZYR) has exploded on the scene 
   thanks to the efforts of CEO and President Stanislaw R. Burzynski, M.D.,
   Ph.D. After notification that the U.S. Food and Drug Administration lifted
   its partial clinical hold on its IND for Antineoplastons A10/AS2-1
   Injections, shares of BZYR stock begun to trade and are putting on a good
   show thus far. Although only around 25 million shares issued and outstanding 
   do not belong to the founder who is determined to treat of various forms of
   brain tumors, the large jump upwards has made this little biotech
   burz-worthy.

You know, with all the typos and English that sounds as though it were written
by someone who isn’t a native English speaker, this made me suspicious that
Burzynski or someone from Burzynski’s clinic wrote it. Either that, or the web
page is written by non-English speakers, which seems likely given that I found
the same sorts of weird-sounding sentence constructions in other articles and I 
know Burzynski’s people can produce serviceable English prose when they need to.
Be that as it may, I have little doubt that the Burzynski clinic is trying to
take advantage of the FDA decision to bolster its flagging finances, which have 
been reportedly hurting since the partial clinical hold was placed. Whether this
article on a website hawking penny stocks has anything to do with it, I don’t
know, but its appearance right around this time sure doesn’t seem coincidental
to me.

So what happened? Why did the FDA cave so ignominiously? How could it ignore 37 
years of Burzynski’s therapeutic misadventures and abuse of science and the
clinical trial process? I have a few ideas, but none of them are satisfying, and
all of them are speculation, ranging from educated to, well, just speculation. 
Back in the 1990s, it was powerful legislators like Joe Barton leaning on the
FDA to let Burzynski be Burzynski. Today, there are no visible and obvious
champions in Congress for Burzynski. Even so, that doesn’t necessarily mean that
such congressional patrons don’t exist, given the campaign waged by patient
families and the Burzynski clinic to get people to write their Congressmen and
Senators. Another likely possibility is that the FDA is just tired. If it shuts 
Burzynski down, it will be portrayed for years as the bad guy denying patients a
chance at life, and there will be an enormous court battle. If it decides to
fight, the FDA could end up with years of litigation, and, given the FDA’s
unfortunately limited budget, it has to pick its battles. Does it help the FDA’s
mission overall if it drains so many resources fighting what it likely views as
small fry like Burzynski that it finds late in the fiscal year that it can’t
afford to go after a large drug company over lack of resources? I don’t know,
but given how long Burzynski’s been at it, the FDA’s decision is still an
extreme dereliction of its duty to the public.

Whatever the reason that the FDA caved, we’ll probably never know. We can make
FOIA requests, but the FDA is notoriously tight with the information it permits 
to be releases because it’s forbidden from releasing information that might
endanger trade secrets of the companies it regulates and it appears to take a
fairly expansive view of what constitutes such information. At least, we’ll
probably never know unless we can get a powerful Senator or Congressman (or two)
interested and as outraged as we skeptics are. A Congressional investigation,
as unlikely as that sounds, is probably the only thing that will get to the
bottom of the FDA’s utter failure. It’s clear that in this case the FDA is no
longer able or willing to protect the safety, finances, or rights of patients
with advanced cancer.

The Center for Inquiry weighs in on the FDA’s mishandling of Stanislaw
Burzynski’s clinical trials

The Center for Inquiry points out how what Stanislaw Burzynski is doing corrupts
the clinical trial process and harms patients.

David Gorski on July 3, 2014

Link

We interrupt our usually scheduled post for an important announcement. OK, we do
nothing of the sort. Scott Gavura’s post will go live a little later this
morning. In the meantime, here’s a public service announcement about a frequent 
topic of mine, Stanislaw Burzynski, that I’d like you to read.

As you recall, last week, the FDA inexplicably decided to lift the partial
clinical hold on Stanislaw Burzynski’s bogus clinical trials of antineoplastons,
which he’s used since the 1990s as a pretext to charge huge sums of money for
“case management fees” to patients for a treatment whose efficacy he has never
demonstrated. Yesterday, the Center for Inquiry laid in, and has sent a letter
to legislators:

   “We are frankly stunned to hear that the clinical hold against Dr. Burzynski 
   has been lifted,” writes CFI in its letter. For decades, Dr. Burzynski and
   the Houston-based Burzynski Research Institute have been trafficking in
   unproven and scientifically baseless cancer treatments based on compounds
   known as antineoplastons, derived from human urine, which Burzynski claims — 
   without evidence — can target and destroy cancer cells. He has taken
   advantage of desperate patients who are at their most vulnerable, and willing
   to pay any price.

   After the death of a six-year-old patient in 2012, the FDA placed a hold on
   Burzynski’s trials with children, followed by a hold on trials with adults in
   2013, prohibiting him from taking on new patients on whom he could
   experiment and from whom he could extract more money.

   Over several decades, his clinic has proven it is unable to properly protect 
   patient rights, adhere to basic ethical or scientific protocols, or even
   maintain correct patient records. It has also shown it is willing to exploit 
   desperate cancer patients and their families, milking them out of enormous
   sums of money. But it has yet to show even a shred of evidence that its
   cancer treatments have any positive effect whatsoever.

   “We struggle to see why the FDA continues to enable this deceptive,
   antiscientific, and unethical medical adventurism and profiteering, even for 
   patients who are terminally ill,” writes CFI. “Given the behavior of Dr.
   Burzynski and the Burzynski Research Institute over the course of nearly
   three decades of failed research and trials, and in the face of a complete
   lack of scientific evidence demonstrating the efficacy of their expensive and
   dangerous antineoplaston treatment, we find the FDA’s decision perplexing
   and profoundly disturbing.”

The full text of the letter can be found here.

If only groups like the American Cancer Society would write similar letters.
Cancer patients have been taken advantage of for nearly four decades, and
Burzynski has made a mockery of the clinical trial process for nearly 20 years. 
It’s gone on way too long.

Stanislaw Burzynski and Robert O. Young: How two quacks of a feather illustrate 
how poorly states regulate medical practice

David Gorski on November 23, 2015

Link





Stanislaw Burzynski (upper panel) and Robert O. Young (lower panel), two quacks 
whose activities reveal the weaknesses in how the practice of medicine is
regulated.

One of the weaknesses in our system of regulating the practice of medicine in
the United States is that, unlike most countries, we don’t have one system. We
have 50 systems. That’s because the functions of licensing physicians and
regulating the practice of medicine are not federal functions, but state
functions. Each state sets its own laws and regulations governing the practice
of medicine, making for wide variability from state to state. Some states are
lax in their regulation (cough, cough, I’m talking to you, Texas), others are
not so lax.

Given how often state medical boards and the other enforcement bodies states use
to protect the public from professional misconduct and quackery, I thought I’d 
take this opportunity to update our readers on two men who have been frequent
topics of discussion on this blog, Stanislaw Burzynski and Robert O. Young. The 
reason is that, through some bizarre confluence of events, both of them faced
justice last week, in the form of a hearing due to action against Burzynski by
the Texas Medical Board, and in the form of the trial of Robert O. Young in
southern California.

What these two quacks share in common is that they’ve gotten away with their
cancer quackery for a very long time, two decades in the case of Robert O. Young
and nearly four decades in the case of Stanislaw Burzynski, with attempts by
the law to bring them to heel having been largely ineffective. They are
different in that one is a physician (Dr. Burzynski) and one is not (Young) and 
therefore different legal considerations come into play. Young, for instance, is
a self-proclaimed naturopath known for his “pH Miracle Living” cure, which, he 
claims, can be used to cure basically any disease by “alkalinizing” the body.
After two decades of running, he is being tried for practicing medicine without 
a license, and, of course, fraud. Burzynski, although not an oncologist, is a
licensed physician in Texas and has been administering an unproven and almost
certainly ineffective “natural” treatment consisting of substances derived from 
blood and urine that he dubbed “antineoplastons” (ANPs) back in the 1970s. He is
also different in that he’s gotten away with this largely through abuse of the 
clinical trial process, which is regulated at the federal level through the FDA 
and the HHS. It is not, however, the federal government that is pursuing action 
against Burzynski, but rather the Texas Medical Board (TMB). Thus, while Young
is on trial and could go to jail if he loses, if Burzynski loses he will only
lose his license to practice medicine in the state of Texas.

Despite their differences, both Stanislaw Burzynski and Robert O. Young
illuminate major shortcomings in how the legal system deals with quacks.

The Texas Medical Board Versus Stanislaw Burzynski, Round 4 (at least)

Last week as I contemplated what to write about this week, realized that it’s
been a long time since I’ve written about Stanislaw Burzynski, the expat doctor 
who fled Poland in 1970 and for six years actually did legitimate cancer
research at the Baylor College of Medicine. Convinced that he had made a major
breakthrough in cancer treatment with his discovery of antineoplastons and
apparently frustrated with the difficulties involved in doing legitimate
clinical trials, Burzynski left Baylor and started treating patients with his
home brew concoction in a private clinic. Since then, despite the fact that he
has no training in medical oncology, Burzynski has treated thousands of cancer
patients with ANPs beginning around the time he left Baylor and established over
the intervening decades a reputation as a “miracle” cancer doctor who can cure 
deadly brain tumors that current conventional medicine cannot. He has managed
this feat despite the fact that he’s never even come close to showing that ANPs 
are effective and safe against the cancers for which he uses it. Even so, the
FDA has, with a brief interruption two years ago, continued to let him do his
clinical trials, and the Texas Medical Board, despite at least three attempts
since the early 1980s, has failed to strip Burzynski of his medical license. The
best it managed to do was to put him on probation between 1994 and 2004.

It’s not because there hasn’t been a lot happening, either. Over a year ago, the
Texas Medical Board decided to have another go at Burzynski. Over the last 16
months, what a long, strange trip it’s been. This week, the beginning of the
climax of this effort was upon us. Indeed, what reminded me that the climax of
this struggle is approaching was an e-mail from one of the several quack email
lists to which I subscribe (in this case, The Truth About Cancer), which urged
its members to support Burzynski:

   As we’ve shared many times before, actually curing cancer would be
   detrimental to the pharmaceutical industry. So much so that they’re willing
   to do whatever it takes to silence the doctors as to keep their poisons as
   the only solutions.

   They’re trying to do that now with Dr. Burzynski by revoking his medical
   license and we need your help.

   We’re asking for volunteers in the Austin area to go to the State Office of
   Administrative Hearings on the morning of Nov 19th and exercise their right
   to protest these absurd charges and hearings.

   It’s 9:00am on Thursday, November 19, 2015, at 300 West 15th Street, Fourth
   Floor, Austin, Texas. Hearings will continue through November 25, 2015,
   before recessing until January 19, 2016, when it will reconvene at 9:00am and
   continue through January 29, 2016, if necessary.

   There will be a lot of media attention and we need to show how powerful our
   voices are and that we will NOT be silenced.

   Please arrive at 8:30am and bring signs that read “Dr. Burzynski saves lives”
   or “Stop persecuting Dr. Burzynski” or whatever else you’re inspired to
   write.

   Unfortunately, I personally will not be able to travel and be in Austin but
   I’m doing my best to tell everyone I can and I’m hoping you will too. Even if
   you can’t make it in person, please tell everyone you can on Facebook and
   other social media sites.

   Hopefully, if you’re in Austin (or inspired to travel there) you can go and
   represent our movement in a powerful way.

   Thank you for your consideration.

   Ty Bollinger

Meanwhile, other Burzynski supporters were also rallying. Eric Merola, the film 
maker who made two massively deceptive “documentaries” (which I like to call
Burzynski I and Burzynski II: Electric Boogaloo, because those are far less
awkward titles than the multiple-subtitled ones Merola actually gave the movies)
that amounted to the equivalent of hagiographies portraying Burzynski as the
“brave maverick doctor” persecuted by the medical profession because he doesn’t 
play by its rules and can cure cancer where conventional oncologists cannot.
Truly, it is not for nothing that I like to refer to Eric Merola as Stanislaw
Burzynski’s own personal Leni Reifenstahl, even at the risk of going Godwin and 
even though Reifenstahl herself, were she still alive today, would recognize
Merola for what he is: A talentless hack. Not surprisingly, the Alliance for
Natural Health USA has also been trying to drum up support.

The whole situation is like a replay of the 1990s. If there’s one way Burzynski 
is very predictable it’s in his response to investigation and criticism.
Whenever Burzynski is in trouble or the law actually threatens his practice, he 
cynically uses desperate cancer patients as “human shields” against government
investigation. He did it in the 1990s, when Burzynski was being prosecuted for
75 counts of insurance fraud and violations of the Food, Drug, and Cosmetics
Act. It was cynical political theater featuring media appearances of the weeping
parents of children with deadly brain tumors, national press stories about
demonstrations by patients chanting, “FDA go away! Let me live another day!” It 
worked back then, although I note that at the time Rep. Joe Barton (R-Dallas)
was also putting intense pressure on the FDA, dragging then-FDA Director David
Kessler in front of his committee multiple times to harangue him about his
“persecution” of Burzynski. The FDA told Burzynski that he could administer
ANPs, but only under the auspices of an approved clinical trial. So, urged by
his lawyer Richard Jaffe, Burzynski cynically submitted 72 clinical trial
protocols to use ANPs to treat pretty much any cancer he wanted to treat, and
the FDA approved them all. In the intervening 16 years from 1997 to 2013,
Burzynski enrolled patients on his clinical trials and charged them enormous
“case management” fees for the privilege, even though doing so is completely
unethical.

Of course, two years ago, Burzynski’s clinical trials were placed on partial
clinical hold after the death of Josia Cotto of hypernatremia (very high sodium 
levels in the blood, a known complication of ANP treatment). In the wake of that
decision, Burzynski went back to the tactic that had served him so well,
mobilizing his patient base to do the same thing it did in the 1990s. Not long
after that, the FDA gave in and let him begin his clinical trials again, albeit 
with conditions. Specifically, Burzynski had to provide ANPs for free, and he
couldn’t be the one administering the cocktail. Then, last year, the FDA lifted 
all restrictions on Burzynski’s clinical trials. Burzynski had won again, but
not long after that, the Texas Medical Board acted to strip Burzynski of his
license.

The TMB’s 200 page complaint documents the charges that Burzynski misled
patients by:

  1. Making patients pay a retainer before receiving any diagnosis or treatment.

  2. Performing unnecessary tests and “non-therapeutic treatment” with no potential
    to help them.

  3. Imposing “exorbitant charges” for drugs and lab tests, without telling
    patients that he also owned the pharmacy and lab being used.

  4. Allowing unlicensed staff to treat patients, while describing the staff as
    doctors.

Burzynski was also charged with prescribing unapproved combinations of toxic
chemotherapy, which is quite ironic. Burzynski has been treating patients with
an unapproved cancer drug (antineoplastons) for nearly four decades, but that’s 
not the heart of the case. Rather, the heart of the case appears to be
Burzynski’s off-label use of what I like to call Burzynski’s “make it up as you 
go along” cocktails of expensive targeted therapies that he touted as
“personalized, gene-targeted therapy” and I more accurately described as
“personalized, gene-targeted therapy for dummies.”

The Houston Cancer Quack has a nice (and, unlike one of my typical posts, brief)
summary of what’s been happening to Burzynski’s case over the last several
months. Basically, as is commonly the situation in cases like this, there have
been a number of motions and countermotions. In March, the judge rejected a
large number of Burzynski’s motions to suppress evidence brought by the TMB,
including testimony by FDA inspectors, FDA inspection documents, and the
testimony of a former employee, the last of which looked to be particularly
damaging to his defense.

Perhaps the most interesting and unexpected aspect of this whole case occurred
over the summer, and when I say “unexpected,” I really mean it. Remember Richard
Jaffe, whom I mentioned earlier and who was the architect of Burzynski’s wildly
successful strategy of submitting over 70 clinical trials to the FDA, a
strategy that served as the basis for Burzynski’s reputation and increasing
wealth over the better part of the last 20 years? It was a strategy that didn’t 
start to fall apart until the partial clinical hold was placed on his clinical
trials and Burzynski was forced to substitute his far less popular “personalized
gene-targeted therapy.” The reason it was far less popular is because ANPs, for
whatever reason, were viewed among the alternative cancer cure crowd as being a
“natural” treatment for cancer (presumably because they were originally
isolated from urine and blood) while Burzynski’s “personalized gene-targeted
therapy” consisted of cocktails of expensive targeted therapies made by
pharmaceutical companies. It turns out that Jaffe is no longer Burzynski’s
lawyer, even though he had been working for Burzynski for decades. As Skeptics
for the Protection of Cancer Patients drolly noted, those of us trying to expose
Burzynski’s quackery all thought that Jaffe would be buried in the Burzynski
family crypt, so tight had Burzynski and Jaffe been for so many years.

Apparently not any more.

How this shocking situation came about is not entirely clear, but it appears to 
involve—gasp!—enormous unpaid legal bills. Basically, a new lawyer, Dan Cogdell,
started filing motions for Burzynski. It turns out that Cogdell was part of
Burzynski’s legal team before. In any case, the judge became concerned that it
was late in the game to be switching lawyers; so another administrative law
judge heard Jaffe’s explanation in private and ruled that Jaffe had to withdraw 
from the case. Per Judge Suzanne Marshall’s finding, Jaffe’s continued
representation would violate the mandatory withdrawal provision of Rule 1.15.
This provision reads:

   A lawyer ordinarily must decline employment if the employment will cause the 
   lawyer to engage in conduct that the lawyer knows is illegal or that violates
   the Texas Disciplinary Rules of Professional Conduct. Rule 1.15(a)(1); cf.
   Rules 1.02(c), 3.01, 3.02, 3.03, 3.04, 3.08, 4.01, and 8.04. Similarly,
   paragraph (a)(1) of this Rule requires a lawyer to withdraw from employment
   when the lawyer knows that the employment will result in a violation of a
   rule of professional conduct or other law. The lawyer is not obliged to
   decline or withdraw simply because the client suggests such a course of
   conduct; a client may have made such a suggestion in the ill-founded hope
   that a lawyer will not be constrained by a professional obligation. Cf. Rule 
   1.02(c) and (d).

So apparently Jaffe withdrew because he was concerned that his continued
representation of Burzynski would somehow result in his violating a rule of
professional conduct or other law. What could this mean? The explanation came
when Jaffe withdrew from representing Stanislaw Burzynski’s son, Greg Burzynski 
and gave the following reason:

   Respondent is a vice president and an employed physician at the Burzynski
   cancer clinic in Houston. The clinic is owned by Respondent’s father,
   Stanislaw R. Burzynski. Undersigned counsel had represented Stanislaw
   Burzynski in a related SOAH board case.

   Undersigned counsel is taking legal action against Respondent’s employer
   which might have a material adverse effect on Respondent’s interests as an
   officer and employed physician at the clinic. As a result of such action,
   undersigned counsel will likely have a conflict of interest with Respondent, 
   at least until the anticipated legal action is resolved.

In other words, Jaffe is suing Burzynski. But why? It turns out that Burzynski
owes Jaffe nearly a quarter of a million dollars, and Burzynski hasn’t paid. In 
fact, Jaffe appears to be suing to force Burzynski into involuntary chapter 7
bankruptcy.

I tried not to go into too much detail in this post (which, as regular readers
know, is hard for me) because a lot of the legal wrangling and back-and-forth
comes across too much as “inside baseball.” It doesn’t help that I’m not a
lawyer and don’t understand a lot of it. What I do understand is that, this week
and in January, the TMB is doing its best to finally put an end to Stanislaw
Burzynski’s cancer quackery, and I wish them the best in this endeavor.

To me, it’s a good sign that, for whatever reason, this time around the
political theater that surrounded Burzynski’s 1997 trial is minimal to
nonexistent, although there are some rather laughable letters being sent to the 
TMB. I have yet to see photos of terminally ill cancer patients with signs
trying to shame the TMB, although there is a Change.org petition with over
13,000 signatures petitioning the TMB to “Save Doctor Burzynski’s Life-Saving
Cancer Treatment,” complete with a video showing Hannah Bradley as one of
Burzynski’s “success stories,” even though she was almost certainly saved by
conventional treatment, not Burzynski. Thus far, news coverage of the
disciplinary hearing has been minimal outside of local news media. I also hope
that, with the rift between Burzynski and his former consigliere and architect
of the strategy that has allowed Burzynski to abuse the clinical trial process
for so many years to charge patients exorbitant sums to enroll in his clinical
trials, Burzynski will finally fall.

Robert O. Young finally faces justice

Robert O. Young is a quack whom I’ve written about more on my
not-so-super-secret other blog than here. Basically, Young is a naturopath (or
claims to be one), two of whose seemingly-impressive degrees came from diploma
mills and whose degree in naturopathy came from Clayton College of Natural
Health, a nonaccredited correspondence school that taught a panoply of quackery.
For twenty years he’s been plying his cancer quackery (and quackery for HIV and
other serious diseases) at Rancho del Sol, an avocado and grapefruit ranch in
Valley Center, California that he’s turned into a plush retreat called the pH
Miracle Center, where he offers juicing, cleanses, and all manner of dubious and
bogus treatments. He even has a coaching program in which he trains other
quacks in his method and offers “group cleanses.” (Eewww!)

When I took note of Robert O. Young’s arrest in January 2014, I experienced not 
a small amount of schadenfreude, for which I felt no guilt in this case. Seeing 
quacks hauled before a judge makes me happy. Even so, as much as I enjoyed the
sight of Young in a prison jumpsuit—if only it were orange instead of blue!—I
nonetheless asked at the time: Will it stop him? During the nearly two years
since his arrest, his arrest and impending trial for practicing medicine without
a license and fraud seemed not to deter him in the least. He still did his “pH 
Miracle” cruises. (What is it with cranks and cruises these days? Is this a
thing?) He still has his “pH Miracle” retreats planned in Como, Italy in
December and January. (I wonder what will happen if he’s convicted.) He still
runs his pH Miracle Center at the Rancho del Sol. He’s been promoting the
“world’s first functionally structured alkaline water kiosk” and accepting
awards from International Association of Colon Hydrotherapy. His blog, Twitter
feed, and Facebook page have remained active this week promoting his activities,
with nary a mention of his trial. Indeed, when I was first made aware that
Young’s trial had begun last week, it caught me completely by surprise, given
how little I had heard about what was going on since early 2014:

   The author of a popular series of books espousing an alkaline diet as a way
   to improve health began standing trial this week in a Vista courtroom on
   charges that he practiced medicine without a license and took money under
   false pretenses.

   In opening arguments Wednesday, prosecutor Gina Darvas described the
   defendant, Robert O. Young, as the proverbial “man behind the curtain,”
   making money peddling pseudoscience to desperate, dying people. Defense
   attorney Paul Pfingst said Young is under attack for espousing alternative
   views to traditional medicine.

   Young, 53, faces nine charges linked to his work at his posh Valley Center
   compound, The pH Miracle Living Center, where people came for $2,000-a-day
   retreats. He is charged with seven counts of practicing medicine without a
   license — including inserting intravenous lines into people — and two counts 
   of grand theft.

The trial is slated to last approximately four weeks, and thus far it hasn’t
seemed to stop Young’s social media activity, although he makes no mention of
his trial. No doubt he’d love to, in order to paint himself as the victim being 
persecuted by The Man (and Big Pharma) to keep his natural medicines from the
people (which is always good for quack business), but I’m guessing his lawyer
probably nixed that idea.

For those of you not familiar with Robert O. Young, a brief recap is in order.
For this, a picture (or in this case, a PowerPoint slide that I’ve used before
in various talks about cancer quackery) is worth a thousand words (not that
that’ll stop me from using a thousand words to describe Young if I deem it
necessary).

Basically, to Young, acid is the cause of all disease, to the point that he
states that “overacidification” is the cause of all disease, an overarching
theory of all disease that he has dubbed The New Biology, and about which he
frequently states that “the pH Miracle Lifestyle and Diet is a program focuses
on the foundational principal that the body is alkaline by design and yet acidic
by function. This makes this program the ultimate program for preventing and
reversing aging and the onset of sickness and dis-ease. I would say that the pH 
Miracle Lifestyle and Diet is the diet for immortality.” (Note that another of
Gorski’s rules, besides the rule that health practitioner who invokes Béchamp
over Pasteur is to be avoided like the plague, is that anyone who uses the term 
“dis-ease” instead of “disease” is to be similarly shunned.)

For example, after a beautiful aspiring young Brazilian model named Mariana
Bridi da Costa died of sepsis after a urinary tract infection so severe that she
had had to have her hands and feet amputated in a desperate bid to save her
life, Young wrote a post entitled “Ignorance Caused Sepsis or Systemic Acidosis 
That Took The Life of a Young Brazilian Woman“, in which he blamed “acidic
lifestyle choices, including acidic food, drink, and drugs” and proclaimed,
“Most people believe that sepsis or acidosis is an infection. It is not!” He
explicitly denies germ theory to the point where he has written posts like “The 
Illusion of Germ Theory“, in which he refers dismissively to “Pasteurian
scientific dogma,” challenges “everything in the modern construct of immunology 
and what is said to be the immune system,” and characterizes viruses as
“molecular acids.”

Oh, and so is cancer. Well, not exactly. Cancer is…well, let me just quote Young
to give you an idea:

   The following is a summary of understanding cancerous tissues:

   Cancer is not a cell but a poisonous acidic liquid.

   A cancer cell, is a cell that has been spoiled or poisoned by metabolic or
   gastrointestinal acids.

   A tumor is the body’s protective mechanism to encapsulate spoiled or poisoned
   cells from excess acid that has not been properly eliminated through
   urination, perspiration, defecation or respiration.

   The tumor is the body’s solution to protect healthy cells and tissues.

   Cancer is a systemic acidic condition that settles at the weakest parts of
   the body – not a localized problem that metastases.

   Metastases is [sic] localized acids spoiling other cells much like a rotten
   apple spoiling a bushel of healthy apples.

   There is no such thing as a cancer cell. A cancer cell was once a healthy
   cell that has been spoiled by acid.

   The tumor is not the problem but the solution to protect healthy cells and
   tissues from being spoiled from other rotting cells and tissues.

   The only solution to the acidic liquids that poison body cells causing the
   effects that medical savants call cancer is to alkalize and energize the
   body.

   In conclusion, the human body is alkaline by design and acidic by function!
   If we desire a healthy body we must maintain that alkaline design.

This is, as they say, so wrong it’s not even wrong. Worse, as I described before
when Young was arrested, his quackery can be blamed for at least one
preventable death, that of Kim Tinkham, the woman who became briefly famous when
she went on television with Oprah Winfrey, shocking even Oprah with her
assertion that she was so inspired by The Secret that she had decided to go her 
own way and treat her stage III breast cancer with Robert Young’s “alkaline
diet.” She didn’t reveal that it was Young until later, when she did
testimonials for Young and appeared in an interview that was on YouTube but has 
since vanished down the memory hole. (True fact: I happened to have saved that
video from YouTube and was therefore more than happy to provide a copy to the
San Diego County District Attorney’s office last year.) Ultimately, Tinkham died
of what was almost certainly metastatic breast cancer.

Based on his “alkaline diet,” Young ran a very lucrative quack spa business,
both at Rancho del Sol and “on the road,” so to speak, as far away as Italy. Add
to that his numerous courses and speaking engagements, and Young did quite
well. Ironically, what tripped him up was not his claim that he could treat
patients with diet alone, but, as is the case with many quacks, overreach.
Basically, he started offering other treatments. Investigators ran a sting
operation on him using officers posing as cancer patients, and Young made bogus 
diagnoses and offered bogus treatments. Two years later, we will see if Young is
convicted.

The problem with state medical regulation

Whenever I come across egregious cases of misconduct by physicians, be they
quacks like Robert O. Young or incompetent surgeons like Christopher Dunstch, I 
note the problems with how state medical boards function. First and foremost
most state medical boards are understaffed and have too few resources for the
tasks that they are charged to carry out. They are also made up of physicians,
which means that (1) they tend to be reluctant to question another physician’s
judgment unless the case is so far beyond the pale that no physician would fail 
to consider it a gross violation of the standard of care and (2) physicians tend
to sympathize with other physicians and not to want to deprive them of their
means to earn a living by taking their licenses away. This problem is magnified 
in Texas, where the TMB, by design and statute, is weak and doctors’ rights are 
strongly protected in their interactions with the TMB. Consequently, they tend
to stick to the most egregious, easily provable cases, such as physicians who
are substance-impaired, commit fraud, or diddle patients. Outside of that, in
Texas it is enormously difficult to take away a physician’s license to practice.
In other states the situation is not as bad, but the same considerations apply.
Add to that how expensive it is to prosecute a case like the one against
Burzynski, who has up until now been able to afford the best lawyers and who has
had significant political pull, and it’s a wonder that the TMB decided to act. 
The current TMB is to be commended for this. Even though the outcome is nowhere 
near certain and the disciplinary proceeding might well fail, the TMB is doing
the right thing at significant cost.

The bigger failure in the Burzynski case is that of the FDA. Burzynski has been 
running his bogus clinical trials for more than 17 years now, and it took the
death of a six-year-old before the FDA shut him down, even though the FDA had
investigated him multiple times before that. Worse, the shutdown was temporary. 
All Burzynski had to do was to file a remediation plan sufficiently convincing
to the FDA that he was cleaning up his act, and he was free to enroll patients
again. Whenever I see quacks ranting about the “fascistic” FDA, I roll my eyes, 
given how the FDA suffers from many of the same problems as state medical
boards. It’s chronically underfunded, and given the current antiregulatory bent 
of Congress that situation is unlikely to change any time soon, even as
legislators try to weaken the FDA in the name of “innovation” with misguided
bills like the 21st Century Cures Act. One day, the story of why the FDA failed 
so monumentally in the Burzynski case will come out. I just hope I’m alive to
see it, because it’s the biggest question I have remaining about him.

The law has nearly as much difficulty stopping non-physician quacks like Robert 
O. Young from taking advantage of desperate patients. Notice how Young could
have gotten away with practically anything as long as he only recommended
dietary changes to treat cancer, and it took him hiring physicians to prescribe 
dubious treatments to trip him up. It also doesn’t help that so many states are 
licensing quack specialties like naturopathy, where there is no standard of care
and, let’s face it, even treatments and ideas like those advocated by Young are
not beyond the pale.

Then there are even more misguided “health freedom laws” and far too much
deference shown to quackery. For example, in her opening statement, prosecutor
Gina Darvas said that Young’s trial “is not an attack on alternative medicine.” 
When I read that, my first thought was: Why the hell not? Alternative medicine
for cancer costs patients’ lives!

It won’t be, though. In California, for instance, there is SB 577. This bill was
passed and signed into law back in 2002 and was designed to regulate
alternative medicine practitioners. Basically, it allows the practice of
medicine without a license, as long as the practitioner provides clients with a 
clear statement that he is not a licensed physician, a list of services
provided, and a description of training. Because of this, I feel for Darvas. I
don’t know what her evidence includes, but based on SB 577, my guess is that her
best bet will be to get Young on the fraud charges because convicting him for
practicing medicine without a license is going to be difficult. The California
legislature intentionally made it that way 13 years ago.

California is by no means alone, either. Jann Bellamy has pointed to bills and
laws that she refers to as the quack full employment act (Colorado) and “quack
protection law” (Nevada). Such are the fruits of the “health freedom” movement
and the increasing acceptance of pseudoscience that prosecutors, state medical
boards, and the police have a hard time prosecuting and convicting even the most
egregious and long-practiced quacks, like Robert O. Young. Add to that an
insufficiently-rigorous and poorly-funded regulatory structure in most states,
coupled with excessive deference to the prerogatives of physicians, and you have
physician-quacks like Stanislaw Burzynski getting away with administering
unproven cancer treatments since the 1970s. Worse, even if the TMB is successful
in its action, the worst that Burzynski will suffer is the loss of his medical 
license.

Let the patient beware!

The Texas Medical Board lets Stanislaw Burzynski off lightly: A cautionary tale 
of the failure of regulating medicine

After three years and countless twists and turns, the final decision by the
Texas Medical Board on the sanctions to be imposed on Houston cancer quack Dr.
Stanislaw Burzynski were announced on Friday. Sadly, they were not enough. The
Burzynski saga should serve as a cautionary tale that the regulation of
physicians and medicine is too lax, not too strict.

David Gorski on March 6, 2017

Link



Dr. Stanislaw Burzynski awaits the decision of the TMB regarding his medical
license.

I’ve been blogging here fairly regularly about Houston cancer quack Dr.
Stanislaw Burzynski since 2011, and now the story is over…sort of.
Unfortunately, as you will see, the ending is not satisfactory. It is, however, 
somewhat better than I had feared it would be. What I’m referring to, of course,
is the final ruling of the Texas Medical Board (TMB) regarding Dr. Burzynski,
the Houston cancer doctor who has been a frequent topic of this blog because of 
his practices of charging desperate cancer patient tens (or even hundreds) of
thousands of dollars for his “antineoplastons” (ANPs) and, later, what he refers
to as “personalized, gene-targeted cancer therapy” (or, as I like to call it,
making it up as you go along). Over the course of the last several years, a
credulous filmmaker by the name of Eric Merola contributed to Burzynski’s
reputation in the alternative medicine world as a “brave maverick doctor” with
two blatantly deceptive “documentaries”, Burzynski The Movie: Cancer Is A
Serious Business and Burzynski: Cancer Is A Serious Business, Part 2, or, as I
like to call it, Burzynski 2: Electric Boogaloo.

Burzynski’s is a long and tangled story, one that I’ve blogged about many times.
The details up to early 2014 are covered in an article I wrote for Skeptical
Inquirer entitled “Stanislaw Burzynski: Four Decades of an Unproven Cancer
Cure.” Burzynski has been selling cancer quackery since roughly 1977, which is
around the time he left Baylor University to set up his own private practice and
manufacturing facility to make and administer his ANPs for big bucks to
desperate cancer patients, many of whom had terminal brain cancers like
glioblastomas. The TMB and then, beginning in the 1990s, the FDA have been
trying to shut him down ever since, all with only temporary success, as when the
FDA managed to put a partial clinical hold on Burzynski’s clinical trials in
2013. It was initially issued for children but then extended to adults and was
based on the death of a six-year-old boy named Josia Cotto the year before, of
hypernatremia (too much sodium in the blood, a known complication of ANPs
delivered at the doses Burzynski uses). The success was short-lived, as the
partial clinical hold was lifted a year later, because, according to the FDA,
the Burzynski Clinic answered all its questions and concerns.

Most recently, in 2014 the TMB, after a long investigation, decided once again
to initiate legal action to strip Burzynski of his medical license. (It had
tried and failed back in the 1980s and 1990s to do just that.) Unfortunately,
the final ruling came in on Friday, and Burzynski was put on probation. He still
has his medical license. Yes, there are conditions and TMB oversight that he’ll
have to abide by, and yes, he was fined $60,000, but I view the sanctions as
not a lot more than a slap on the wrist. Once again, the TMB has failed to shut 
Burzynski down. Before I discuss the latest ruling, let me step back a moment,
for the benefit of those unfamiliar with Burzynski and those who might not
remember enough to put this ruling into context, and provide a bit of background
about why I consider him a cancer quack and how he’s shown the inadequacy of
the TMB and the FDA in dealing with such brazenness.

Stanislaw Burzynski: The early years

On the surface, it’s easy to mistake Stanislaw Burzynski’s story for that of a
classic riches-to-rags-to-riches story. Born in 1943 in Lublin, Poland, just as 
the Holocaust in Poland was entering its most deadly phase, Burzynski was
fortunate enough to have been born to a mother whose family was wealthy and was 
therefore mostly sheltered from the horror of Nazi-occupied Poland. Of course,
he wasn’t even two and a half yet by the time the Third Reich fell, but that
occupation was soon replaced with another one almost as bad and much more
enduring, that of the Soviet Union. After the war, when Burzynski was five, his 
older brother Zygmunt was killed fighting the newly installed Communist regime, 
which affected him his whole life. Basically, he idolized the idea of fighting
authority.

Very little is known about the next couple of decades, other than that Burzynski
was a good student, and that he got into medical school. By 1970, he was a
promising researcher and was recruited by the Polish Communist Party. He refused
to join, and in retaliation the Party saw to it that he was drafted into the
Polish Army. So Burzynski fled to the US “with only $20” in his pocket in 1970
to stay with an uncle. He soon found a research position in the Department of
Anesthesia at the Baylor College of Medicine in a laboratory headed by Georges
Ungar, a Hungarian refugee with whom he immediately hit it off. Ungar was famous
at the time for proposing that memory resided in peptides in the brain and for 
his experiments to “transfer” memory by transferring the putative “memory”
peptides from one mouse brain to another. It was a hypothesis that seemed to be 
supported by his experiments but soon faded from favor. At Baylor, Burzynski
split his time between working on Ungar’s projects and studying his
antineoplastons. He appeared to be well on his way to becoming a successful
cancer researcher, securing an NIH grant in 1974 and publishing several
peer-reviewed papers.

Basing his concept on cybernetic systems and information theory, Burzynski
hypothesized the existence of ANPs as the mediator or regulator of information
exchange in autonomous systems that carried information about differentiation to
the cells and began to look for peptides in the blood of cancer patients that
might correct the abnormal differentiation of cancer. I don’t need to go into
detail here about the whole story. However, if you’re so disposed, you can delve
into the details in my SI article, a famous The Cancer Letter article, and the 
NIH website. In brief, based on his hypothesis, Burzynski used gel filtration of
blood and urine fractions and tested them for activity against cancer cells.
Although there were many fractions initially, these days “antineoplastons”
generally refer to AS-2.1 (also known as Astugenal or Fengenal) and A-10 (also
known as Atengenal or Cengenal). Basically, AS-2.1 is the sodium salt of
phenylacetic acid (PA), a potentially toxic chemical produced by normal
metabolism and detoxified in the liver to phenylacetylglutamine (PAG). To boil
ANP chemistry down to its essence, AS-2.1 is primarily a mixture of PA and PAG, 
and AS-10 is primarily PA. Of note, PA had been studied as a potential
anticancer agent years before Burzynski discovered it and, although it has been 
studied intermittently for fifty years, it has shown little promise against
brain tumors. More recently, Burzynski has hijacked an orphan drug for urea
cycle disorders, sodium phenylbutyrate, because it is a prodrug that is
metabolized into PA.

In 1976, though, when he wanted to begin his clinical trials, his ANPs weren’t
even fully chemically characterized, and only one of them had been tested in
mice. It didn’t work, but Burzynski excused that failure by saying that ANPs
were species-specific. Earlier, in 1973, Burzynski had gotten his Texas medical 
license. Even though he had not done a fellowship in oncology or even a
residency in any medical specialty, by 1976 he thought himself uniquely
qualified to do a clinical trial of ANPs. Again, all the details are discussed
elsewhere, but Burzynski managed to do a case series, although it’s not clear if
it ever had ethical approval, and, when the Baylor ethics board refused to
approve a clinical trial, managed to get a nearby hospital to approve it.
Ultimately, he left Baylor and formed his own practice, to administer ANPs to
patients, setting up his own manufacturing facility, first to isolate the
peptides from gallons of urine and then to synthesize them once their chemical
identities had been worked out.

As I’ve recounted before, from the late 1970s to 1998, Burzynski was under
nearly constant investigation by medical authorities, beginning with the Harris 
County Medical Society in 1979 and continuing with the TMB and the FDA. Indeed, 
before this most recent ruling, the TMB has tried to strip Burzynski of his
license to practice twice, failing to do so in 1993 and 2012. The latter time,
Burzynski got off on a technicality.

Why I view Burzynski as a cancer quack

It is my educated opinion that Burzynski is a cancer quack. I do not make that
charge lightly and will back up my opinion. Beginning in the late 1970s, he
began administering ANPs to cancer patients without their having been
demonstrated to be safe and effective in well-designed clinical trials. The
“brave maverick doctor” that he is, he just knew they worked, and, like many
cancer quacks, over the years he accumulated what seemed like “success stories.”
However, as I’ve discussed many times over the last 6 years, if you look at
them more closely, these “success stories” can almost always be explained by the
conventional treatment patients have undergone before they turned to Burzynski.
Examples abound, patients such as Hannah Bradley, Laura Hymas, Tori Moreno, and
Mary Jo Siegel, and Sheila Herron. I note that, of these, Laura Hymas featured 
prominently as a success story, only to die of recurrent cancer a year after the
second Burzynski movie featured her so prominently. Particularly memorable was 
a scene in which audio was played of her and her family trying to persuade her
NHS oncologist to do routine tests as part of Burzynski’s clinical trial and him
trying to explain to her that he can’t do that because his was an unapproved
treatment and his clinical trial was not approved by the NHS. As a fellow
physician, I really felt for that oncologist, who was put in a very difficult
position. These are but a few of the patients. Fellow skeptic Bob Blaskiewicz
maintains a blog, The Other Burzynski Patient Group, patterned on a website set 
up by Burzynski patients to tout the “success stories,” that documents just how 
many of these patients have died.

More importantly, the website documents the suffering, both physical and
financial, of patients who are lured to the Burzynski Clinic by promises of
cures, most often promoted by Burzynski believers like Eric Merola. (Indeed, his
Burzynski movies have probably generated more business for the Burzynski Clinic
than anything else in Burzynski’s 40 year history.) Basically, Burzynski
charges exorbitant fees for his services. He likes to claim that he charges
nothing for his ANPs, and, after the FDA cracked down on him, that was true.
However, he charges huge “case management” fees. For example, Pete Cohen, Hannah
Bradley’s husband, documented why his fundraising target to get his
then-fiancée treated in Houston was £200,000 (approximately $246,000 at
yesterday’s exchange rate, a lot more back in 2012), estimating her monthly
costs to be £8,600. Moreover, £200,000 wasn’t even that high for a Burzynski
patient. The prodigious fundraising required to afford Burzynski’s treatments
has been documented at TOBPG and all over the blogosphere and includes cases
such as that of Seán Ó’Laighin (who did not survive), Rene Louis, Jesse Bessant,
Rachel Mackey, Luna Petagine, Wayne Merritt. and Chiane Cloete. A lot of these 
people came from the UK, and perhaps the most famous two included Billie
Bainbridge, whose family raised hundreds of thousands of pounds and got
celebrities to help in order to travel to Houston, and Amelia Saunders, a lovely
child who was unfortunate enough to be diagnosed with a brain tumor whose
parents raised over £200,000 in 12 weeks in order to pay for Burzynski’s
treatments and who was featured as a great “success story” by Merola and
Burzynski. What really angered me (even more than a typical Burzynski story) is 
that Burzynski told the father that the formation of cysts in the tumor was the 
tumor dying because of treatment when in reality it is quite common for tumors
to outgrow their blood supply, leading to the death of cancer cells in the
middle. Sadly, Amelia also ultimately died.

Here’s where Burzynski is different—and worse—than typical cancer quacks, such
as those in Tijuana. Basically, unlike the vast majority of other cancer quacks,
Burzynski has had clinical trials open, lots and lots of them, and he has used 
them as a tool to continue to be able to administer ANPs. Worse, he charges
patients enrolled in his clinical trials, a practice that is very much frowned
upon and considered, with very few, defined exceptions, to be unethical.

Here’s how he pulled it off. It was the prosecution brought against Burzynski by
the FDA during the 1990s that spawned the oft-touted “six dozen” clinical
trials. In the fall of 1995, a grand jury indicted Burzynski for seventy-five
counts of insurance fraud and violations of the Food, Drug, and Cosmetics Act.
As part of this process, Judge Simeon Lake of the U.S. District Court for the
Southern District of Texas, ruled that Burzynski’s “continued pretrial release” 
was contingent upon his administering his drugs exclusively through FDA-approved
clinical trials. During the trial in the 1990s, Burzynski’s PR defense against 
prosecution established and has remained constant ever since. When threatened,
he rallies his patients around him to accuse whatever regulatory agency is
pursuing Burzynski this time of cruelty and wanting to let them (or their family
members die). More recently, thanks to his newfound fame after Merola’s movies,
he’s taken to dispatching celebrities like Suzanne Somers, Fabio Lanza (whose
sister suffered from end stage ovarian cancer), and Sammy Hagar (whose drummer’s
wife suffered from a terminal brain tumor) to defend him. He’s also cultivated 
powerful political allies, such as Representative Joe Barton (R-Texas), who held
a series of hearings featuring cancer patients who were, quite understandably, 
terrified that Burzynski would be convicted. (Remember, these patients were
completely convinced that Burzynski was the only person who could save them.) He
also used to routinely drag the FDA Commissioner in front of his committee to
castigate him for “persecuting” Burzynski.

As a result, the FDA entered negotiations to let Burzynski set up clinical
trials, and Burzynski’s then-lawyer Richard A. Jaffe decided to take advantage
of Judge Simeone’s ruling and the political pressure on the FDA, saying, in
essence, “If the judge wants clinical trials, we’ll give him clinical trials.”
So that’s just what they did. Prosecutors pleaded with the FDA not to give in
because it would undermine their case, but the FDA overruled them. First,
patients already being treated were enrolled in  a wastebasket trial known as
“CAN-1”, a retrospective trial looking at all patients then being treated at the
Burzynski Clinic. Of this trial, Jaffe (2008) wrote:

   . . . As far as clinical trials go, it [CAN-1] was a joke. Clinical trials
   are supposed to be designed to test the safety or efficacy of a drug for a
   disease. It is almost always the case that clinical trials treat one disease.
   The CAN-1 protocol had almost two hundred patients in it and there were at
   least a dozen different types of cancers being treated. And since all the
   patients were already on treatment, there could not be any possibility of
   meaningful data coming out of the so-called clinical trial. It was all an
   artifice, a vehicle we and the FDA created to legally give the patients
   Burzynski’s treatment. The FDA wanted all of Burzynski’s patients to be on an
   IND, so that’s what we did.

I always repeat these quotes by Jaffe because they demonstrate the cynicism
behind Burzynski’s actions. It gets worse, though. The FDA also permitted
Burzynski to set up nearly identical phase 2 trials for every cancer that he
wanted to treat. Burzynski claimed these were based on a protocol used in a
trial done by the National Cancer Institute in the early 1990s when the NCI had 
tried to work with Burzynski. (This effort failed because of strife between the 
NCI and Burzynski, who viewed the NCI as trying to sabotage the trial. These
trials had but one purpose, to allow Burzynski to continue treating patients
with ANPs, as Jaffe himself boasted (2008):

   CAN-1 allowed Burzynski to treat all his existing patients. That solved the
   patients’ problems, but not the clinic’s. A cancer clinic cannot survive on
   existing patients. It needs a constant flow of new patients. So in addition
   to getting the CAN-1 trial approved, we had to make sure Burzynski could
   treat new patients. Mindful that he would likely only get one chance to get
   them approved, Burzynski personally put together seventy-two protocols to
   treat every type of cancer the clinic had treated and everything Burzynski
   wanted to treat in the future.

The prosecution was undermined, and the first trial ended in a hung jury in
1997. A second trial on a subset of the original charges resulted in Burzynski’s
acquittal. Since then, Burzynski has practiced (mostly) untroubled by the FDA, 
other than intermittent inspections and warning letters. The TMB tried to take
away his license in 2012 and failed on the slimmest of technicalities.
Basically, the TMB went after Burzynski based on the doctrine of vicarious
liability, which means in essence that the TMB was arguing that Burzynski was
responsible for the actions of the physicians working for him who had actually
cared for the patients at the heart of the TMB’s case against Burzynski. In
response, Burzynski moved to dismiss and/or strike TMB allegations against him
to the extent that the allegations were based on the actions of other physicians
working at his clinic. His attorney’s argument was that, under administrative
law, there is no vicarious liability for the actions of others. This is
apparently different from tort law (for example, medical malpractice), where the
physician can be held liable for the actions of physicians working under his
control or supervision in some circumstances. The bottom line is that the
administrative judge ruled in Burzynski’s favor. Basically, by throwing his
fellow physicians working for him under the bus, Burzynski walked. Meanwhile,
since 1998 he’s been enrolling patients on clinical trials, charging them, and
not publishing his full results for a long time. Recently, he has published a
few reports, but they’ve all been in bottom-feeding journals and/or don’t report
the whole trial. The closest thing he had to a decent publication showed that
ANPs didn’t work against colorectal cancer metastatic to the liver. He even just
did it again last month.

Then, in 2014 the TMB decided to try again.

The Texas Medical Board vs. Stanislaw Burzynski, Round ∞: The charges

In the summer of 2014, I learned through readers that the TMB was gearing up to 
take another go at Burzynski. I was surprised and cheered that the Board would
be willing to try again so soon after its last defeat, but I remained
pessimistic that anything would actually happen. The original complaint was over
200 pages long, but basically the TMB charges fell into three main categories:

  1. Creating a “medical practice model based on marketing his proprietary
    anti-cancer drugs to patients without adequate measures for safety and
    therapeutic value.”

  2. Misleading patients knowingly “by promoting these drugs as an attraction to
    bring patients to his medical practice when he was aware that he could not
    legally include most of those patients in FDA-approved Phase 2 clinical
    trials of his proprietary anti-cancer drugs” and “into paying funds as a
    retainer prior to receiving any evaluation, diagnosis or treatment.”

  3. Misleading patients into: “(1) paying exorbitant charges for drugs and medical
    services; (2) accepting care from unlicensed persons while Respondent and
    Respondent’s employees misrepresented those unlicensed persons to be
    licensed medical doctors in Texas and the United States of America; and (3) 
    accepting care from health care providers who had little advanced education 
    or training related to cancer treatment while Respondent and Respondent’s
    employees misrepresented those health care providers to be doctors with
    significant advanced education or training related to cancer treatment.

Anyone who has paid attention to Burzynski should be able to tell that charges
#1 and #3 are very provable. As for Charge #2, as I’ve discussed before, the
Burzynski Clinic’s trials were on partial clinical hold, Burzynski did appear to
be doing a “bait and switch,” where ANPs drew the patients in, and then he’d
give them his jury-rigged “gene-targeted personalized” therapy consisting of
cocktails of very expensive targeted therapies that were not known to be safe
and effective when administered together. To prove these charges, the TMB
described 12 patients (labeled Patients A through L) whose treatment did not
live up to the standard of care in one or more of these three areas. For
instance, the TMB charged that Burzynski treated Patient A with ANPs for colon
cancer even though the patient had never had a biopsy and that non-physicians
represented themselves as physicians to them. For Patient C it was a similar
story; Burzynski treated the patient for mesothelioma without biopsy
confirmation and without “adequately documenting Respondent’s medical
rationale.” Patient G, for example, was charged for her treatment even though
she was on a clinical trial, and there were multiple failures to follow FDA
regulations about human subjects.

The Texas Medical Board vs. Stanislaw Burzynski, Round ∞: The proceedings

The TMB proceedings have been going on against Burzynski for well over three
years now, and during that time, Burzynski has been pulling out all the stops
and using all the old propaganda tactics he’s used since his patients swarmed
the courthouse during his trial in the 1990s. Sadly, he’s even had some success 
in that journalists who should know better fell for the “false balance” trope
over a patient who was being denied ANPs because an FDA inspection of his
manufacturing facility had turned up serious issues. That the proceedings have
dragged on this long shouldn’t be a surprise; Burzynski is an old master at
this, as was his lawyer Richard Jaffe. Of course, the amusing thing is that
during the proceedings Jaffe actually withdrew as Burzynski’s attorney (and his 
son Greg Burzynski’s attorney) and apparently sued him for $250,000 in unpaid
legal bills, further delaying the proceedings. Then, in December 2015, Burzynski
informed the Board that he had had a heart attack and wouldn’t be able to
proceed for a time, delaying the second phase of the proceedings for several
months.

Then, in October 2016, there was a major setback when administrative law judges 
issued a proposed decision dismissing the bulk of the charges against Burzynski,
largely because of gross incompetence on the part of the TMB. For example,
instead of local cancer experts from, for example, M.D. Anderson and Texas
Children’s Hospital, you know, the doctors who have to clean up the mess when
one of Burzynski’s patients suffers the complications of his incompetence and
the toxicity of his ANPs, the TMB relied on outside experts. In fairness, we
can’t know for sure why the TMB didn’t use local experts because its
spokesperson wouldn’t say. Given Burzynski’s famously litigious nature and his
tendency to use his patients as shields and spears against his enemies, it could
well be that local oncologists were cowed and didn’t want to speak out the way 
Dr. Jeanine Graf, director of the pediatric intensive care unit (PICU) at Texas 
Children’s Hospital did to the producers of the BBC news magazine Panorama when 
Panorama did a story about Burzynski, stating ,point blank, that she’s never
seen a Burzynski patient survive.

Here’s what we got instead:

   What we got, instead, was Dr. Cynthia Wetmore, who seems to have done a
   decent job in most aspects, but screwed up royally when it came to someone
   referred to as “Patient D.” The judges noted that Wetmore claimed that
   Patient D “did not receive the standard of care and was exposed to
   medications that are not documented to cross the blood brain barrier.”

   The only problem with that, per the judges, was that “contrary to Dr.
   Wetmore’s testimony and report, Patient D received no treatment or therapy at
   the Clinic.” They wrote that “such inattentiveness to the accuracy of her
   report raises concerns about her credibility.”

This is one thing that utterly infuriated me. Burzynski is an old hand at this. 
He’s been slithering away from judgments by the TMB and FDA since the late
1970s. You cannot take him down with such inattention to detail. You have to
have all your ducks lined up in the proverbial row. Your case has to be airtight
and rock solid. On the other hand, the Chief Administrative Law Judge Lesli G. 
Ginn was not without fault, because she also accepted a lot of Burzynski
propaganda as well. For instance, I’ve written many times how the Burzynski
Institutional Review Board (IRB), the committee that is responsible for
protecting human subjects and examining the ethics of any proposed clinical
trial being carried out by an institution receiving funding from the federal
government or any company or entity doing the clinical trial to gain FDA
approval for a treatment or drug, is hopelessly compromised and packed with
Burzynski cronies. Yet Ginn wrote, apparently with a straight face:

   Dr. Burzynski testified that IRB was also created in 1983, but it is a
   separate entity from BRI. IRB was created to supervise the ethical conduct of
   clinical studies by approving or disapproving clinical trial protocols; to
   collect data on the toxicity and the response of the investigational agent;
   and to evaluate data on the efficacy of the investigational agent ANP.22 IRB 
   is not in the business of practicing medicine.23 Neither Dr. Burzynski nor
   any of the Clinic’s employees is a member of IRB. The IRB consists of 14
   members. Carlton Hazelwood, M.D., a retired professor of pediatrics and
   physiology at the Baylor College of Medicine, is IRB’s chairman.24 Dr.
   Burzynski testified that he had no role in the selecting the board members.25

Wrong. Carlton Hazlewood is on the board of directors of the Burzynski Research 
Institute, as has been pointed out many times.

So things looked bad in October, but fortunately this was only a proposed
judgment. What did the final judgment say?

The Texas Medical Board vs. Stanislaw Burzynski, Round ∞: The Ruling

On February 15, the TMB issued a proposed decision in which Burzynski would be
fined $360,000, required to pay $20,000 restitution to a patient. Unfortunately,
although the proposed decision included the revocation of Burzynski’s medical
license, the revocation was stayed, with Burzynski to be placed on probation
with a public reprimand. In addition to the fine and his probation with
reprimand, the TMB would require that Burzynski meet these conditions:

  1. The billing practices of the Burzynski Clinic must be monitored and patient
    records reviewed.

  2. Burzynski must complete a Physicians Ethics program and undergo continuing
    education to obtain credits of completion in several topics of medical
    research. (I laughed at this one. Burzynski knows medical research
    regulations; it’s how he’s so good at skirting them.)

  3. Burzynski must submit his informed consent forms to the Board for review to
    show that they comply with relevant regulations and laws, and each patient
    must receive and sign these new forms before treatment.

  4. Burzynski must inform his patients that he owns the pharmacy requires them to 
    use. Ownership interest disclosure must be submitted to the Board for
    review.

  5. Burzynski must pass a Medical Jurisprudence Exam.

Overall, this struck me as a fairly substantial penalty, but far less than he
deserves. Worse, Burzynski would have the opportunity to submit a
counterproposal, and that’s what resulted in the final decision issued on
Friday, which is even less severe:

   The board’s staff had originally recommended that Burzynski pay a $360,000
   fine and $20,000 in restitution to a patient. They also wanted Burzynski put 
   on probation, with the power to automatically revoke his medical license if
   he violated the terms.

   Instead on Friday, the board opted for a lesser penalty that included a
   five-year probation with more lenient terms, a public reprimand, more
   training and oversight, along with $60,000 in fines and restitution.

   Burzynski’s attorneys called the decision a win.

   “It means that he gets to continue medicine. He gets to continue to save
   lives,” attorney Gregory Myers said.

That $60,000 includes $40,000 in fines and the aforementioned $20,000 in
restitution to a patient. If Burzynski’s attorneys consider this decision a
“win,” then for patients it is clearly a loss. Unfortunately, I haven’t been
able to find the final final decision yet; so I don’t know exactly how the terms
of his probation are more lenient.

Still, even though Burzynski can continue to practice, I have some hope. For one
thing, Burzynski is no spring chicken any more. He’s 74, and he had a heart
attack a little more than a year ago. The terms of his probation will likely
take him through most of the rest of his 70s, and, at his age, can he really
stand to practice with even more stringent monitoring? He’s always been stubborn
and arrogant, and I can’t picture him tolerating the regular monitoring of his 
billing practices and patient charts that will occur with much equanimity at
all. Will he actually complete courses on Physician Ethics and study for a
medical jurisprudence exam”? I’m not sure I can see it happening. Maybe he’ll
retire.

Or maybe not. That’s the problem. Burzynski is nothing if not expert at evading 
the spirit of constraints placed on him to continue to sell his unproven
treatments to patients for exorbitant sums of money.

The failure of the FDA and state medical boards to protect the public from
quacks

With the election of Donald Trump as President, I and my SBM co-conspirators
have been warning about the consequences of the sort of massive deregulation
that Trump wants. For instance, just this week, Jann Bellamy warned about
efforts to remove impediments to “right-to-try” laws, shield wrongdoers, and
hide adverse events, and Steve Novella has warned about Trump’s plan to
deregulate pharmaceuticals. Before that I had been beating the drum about how
every single candidate for FDA Commissioner under consideration by the Trump
administration, such as Peter Thiel Crony Jim O’Neill, and honest-to-goodness
pharma shill Scott Gottlieb, favor massively decreasing the amount of evidence
for drug approval, when in fact the FDA functions pretty well given its
underfunding and an argument can be made that the evidence bar for approval is
actually too low.

Contemplating the case of Stanislaw Burzynski worries me. Consider that the FDA 
using its current guidelines has only been intermittently able to temporarily
put a halt to Burzynski’s preying on patients in the name of clinical trials.
Meanwhile, state right-to-try laws could be a boon to practitioners like
Burzynski, who, indeed, has already taken advantage of the Texas right-to-try
law. It’s not just Trump, though. The majority of the states are solidly held by
Republicans, and, as I’ve pointed out many times before, state medical boards
are generally underfunded and outgunned. That doesn’t even consider the “quack
protection” and “quack full employment” laws regularly discussed by Jann Bellamy
and others here that would license and protect naturopaths, chiropractors, and 
other quacks, all in the name of “health freedom,” a recurring theme among
Trump’s candidates for FDA commissioner which is used as a justification for
“right-to-try” laws.

The failure of the TMB strip Burzynski of his medical license reminds me that,
if anything, the laws and regulations protecting the public from quacks are too 
weak, not too strong. I fear they will become a lot weaker soon.

Mandatory breast density reporting legislation: The law outpaces science, and
not in a good way

David Gorski on June 8, 2015

Link

Over the years, our bloggers here at Science-Based Medicine have written time
and time again about the intersection of law and science in medicine. Sometimes,
we support a particular bill or law, such as laws to protect children against
religion-inspired medical neglect; laws making it harder for manufacturers of
homeopathic “medicines” to deceive the public; or California Bill AB 2109, a
bill whose intent was to make it more difficult for parents to obtain nonmedical
exemptions to vaccine mandates but whose implementation after being passed into
law was profoundly sabotaged by Governor Jerry Brown. or, more recently,
California SB 277, a bill currently wending its way through the California
legislature that would eliminate nonmedical exemptions to school vaccine
mandates and has, not surprisingly, engendered extreme resistance from the
antivaccine crowd, including by Robert F. Kennedy, Jr. In the vast majority of
cases we explain how the law lets us down when it comes to science in medicine, 
and, unfortunately, examples are many: Naturopathic licensing laws; supplement
regulation (or, more appropriately, lack of regulation); misguided, deceptive,
and patient-hostile “right-to-try” laws; state laws regulating medical practice 
that allow quackery to flourish unchecked; laws regulating pharmaceutical cost
transparency that ask the wrong question.

The case I will discuss here is unusual in that it is a case of the law getting 
ahead of what the science says in a manner that will likely do little, if any,
good for patients, cause a lot of confusion until the science is worked out
better, and end up costing patients money for little or no benefit. I am
referring to laws mandating the reporting of high-breast-density to women with
dense breasts undergoing mammography. These laws are sweeping the country
(albeit not as rapidly as “right-to-try” laws), with a total of 22 states having
passed them as of today since Connecticut became the first to do so in 2009.
The most recent of these laws went into effect in my own state of Michigan
exactly one week ago:

   Women with dense breast tissue — the sort that can hide potentially deadly
   tumors from routine mammograms — must be notified in writing and encouraged
   to consider additional tests under a new state law that is effective Monday.

   While mammograms remain the gold standard for detecting breast tumors,
   they’re less reliable in almost half of women with dense breast tissue. Dense
   or fibrous tissue shows up as splotches of white on a mammogram — so do
   tumors.

   That will likely surprise many of the millions of women who rely on
   mammography for catching the earliest signs of cancer, said Nancy Cappello.
   The Connecticut woman was shocked in 2004, when her gynecologist found a lump
   — advanced cancer that had already spread to her lymph nodes — just months
   after a mammogram deemed her cancer-free.

Yes, mammography is imperfect, and we here at SBM have not shied away from
describing its imperfections (or the difficulties in general with screening
asymptomatic patients for any disease) including one large study that found no
reduction in breast cancer-related mortality that was relentlessly (and falsely)
attacked as fraudulent by a prominent radiologist. Regular readers know that
the sensitivity of mammography is not optimal, and that it likely results in
significant overdiagnosis and overtreatment, particularly of the pre-cancerous
entity known as ductal carcinoma in situ (DCIS). All these issues aside, a
review by the World Health Organization (WHO) International Agency for Research 
on Cancer (IARC) of mammographic screening hot off the presses last week in the 
New England Journal of Medicine nonetheless concluded that, for women between
the ages of 50 and 74 at least, there is sufficient evidence to conclude that
mammographic screening results in a significant reduction in the risk of dying
of breast cancer, although the same report affirmed doubts about the adequacy of
evidence for women between the ages of 40 and 49 that the USPSTF originally
used in 2009 to base its recommendation that mammographic screening not begin
until age 50 for most women. In other words, mammography, as imperfect as it is,
does reduce the risk of death from breast cancer in women over 50.

Breast density, mammography, and cancer risk

It has long been known that mammography tends to be less effective in women with
dense breasts. What is causes “density” on mammographic imaging is the high
level of fibrous and glandular tissue relative to fatty tissue compared to
breasts that are not considered dense. The reasons why mammographic screening of
dense breasts might be less effective are fairly simple to understand.
Mammography is basically an X-ray of the breast taken in a specified, highly
standardized manner. As such, the image rendered shows up as areas of white and 
dark, with the white representing denser tissue and the dark less dense tissue, 
usually fat, which lets X-rays pass through easily. Lesions suspicious for
breast cancer manifest themselves as a density that stands out among the darker,
less dense tissue, of which there are two kinds: a tissue density or
calcifications. I could ramble on and on and on about what characteristics make 
a tissue density or an area of calcifications suspicious and another area of
tissue density or calcifications benign-appearing (or at least much less
suspicious). The details aren’t important for purposes of this post. What is
important for purposes of understanding the effect of mammographic density on
the ability to detect cancer is that it depends on the contrast between the
denser lesions that are suspicious for cancer and the surrounding breast and
fatty tissue. The less contrast there is, the harder it is for the radiologist, 
even with computer-aided detection, to differentiate between suspicious lesions 
and normal breast tissue. That’s why mammography works really well in breasts
that are largely replaced by fatty tissue, as is the case in many postmenopausal
women, in whom dense breast tissue is less common than in premenopausal women. 
Basically, as estrogen and progesterone levels plummet, over time the glandular 
tissue in postmenopausal breasts becomes replaced with fatty tissue.

Just to give you an idea, here are images of breasts of low, intermediate, and
high density on mammography:



Breast density measurements

And here is an example of what microcalcifications look like:



Microcalcifications

And of how breast cancers appear on mammography:

You can see how it would be more difficult to see these lesions in dense
breasts, especially when they are more subtle and not as obvious. Indeed, the
National Cancer Institute (NCI) points out on its website that the “main cause
of false-negative results is high breast density.” In any case, the reason why
mammography is more problematic in women aged 40 to 49 boils down to the fact
that most premenopausal women have denser breasts due to higher levels of
hormones and the incidence of breast cancer is lower, such that a positive
finding is much more likely to be a false positive than a true positive than it 
is in older women. As I’ve explained before, for a screening program to be
effective, the disease being screened for has to be sufficiently common for this
not to happen. There’s a reason why even the most zealous supporters of
mammography don’t recommend that routine screening begin before age 40; breast
cancer incidence is just too low in this age group.

So far, so clear (I hope). However, recent science has thrown a new wrinkle into
the equation. That science is the consensus that has emerged over the last
couple of decades, based on numerous studies, that breast density is an
independent risk factor for the development of breast cancer. In other words,
women who have dense breasts, all other clinical characteristics being equal,
have a higher risk of developing breast cancer. According to a recent review
article, women with the highest breast density have a risk that is 2 to 6 times 
higher than women with the lowest breast density, and that as many as 30% of
postmenopausal women still have dense breasts. Breast density correlates with a 
number of factors, including age (negative correlation), serum and tissue
hormone levels (positive correlation), genetics, and body mass index (negative).
Paradoxically, although high BMI is correlated with decreased breast density,
obesity is correlated with an increased risk of breast cancer in postmenopausal 
women.

Because breast density is an independent predictor of breast cancer risk,
naturally, the question has been asked what the biology is behind this and
whether it is a modifiable risk factor. (Indeed, in the interests of full
disclosure, I have been involved in a study that asks that very question and
uses a new ultrasound technology to quantify breast density.) It is known, for
instance, that Tamoxifen can decrease breast density, and it is also known that 
Tamoxifen can decrease the risk of breast cancer significantly in women at high 
risk. Are the two related? Does Tamoxifen’s ability to decrease breast cancer
risk have to do with its ability to decrease breast density? We don’t yet know. 
Does the decrease in breast density due to Tamoxifen cause the decrease in risk 
or is the decreased breast density an epiphenomenon associated with the
decreased risk? We don’t yet know. Does reduction in breast density over time
correlate with decreased breast cancer risk? Yes, to some extent. A recent case 
control study, for instance, found that women who did not develop breast cancer 
showed a decrease in mammographic density between first and second prediagnostic
mammogram compared to women who did develop breast cancer, who did not.

In other words, it’s complicated, and the science is far from settled. We know
that breast density is associated with an increased risk of breast cancer, but
the biology is not well understood, we don’t yet know if it’s a modifiable risk 
factor, and we don’t know the molecular basis. All we know are factors that are 
associated with increased breast density and that increased breast density is an
independent risk factor for breast cancer. Research is ongoing and likely will 
be ongoing for quite some time before answers start to become clear.

Mandatory breast density reporting

It’s impossible to discuss mandatory breast density reporting laws without
discussing the woman who started the movement, Nancy Cappello, PhD, and her
organization Are You Dense? Advocacy, whose mission is described as:

   To ensure that women with dense breast tissue have access to an early breast 
   cancer diagnosis. To that end, women need to be informed of their breast
   density, the limitations of mammography to find cancer in dense breast tissue
   and the increased risk factor of dense breast tissue.

As described in the story I first cited above, Cappello’s gynecologist found a
lump months after she had had a “negative” mammogram in 2004, and she was
diagnosed with stage IIIC breast cancer. As she herself relates in a recent
article, “Decade of ‘Normal’ Mammography Reports–The Happygram“:

   I ate healthy, exercised daily, examined my breasts regularly, and underwent 
   yearly mammography. I had no family history of breast cancer. In 2003, my
   annual screening mammogram was reported as normal, just as the decade of
   reports before 2003. I was faithful to my health care regimen; my routine
   annual gynecologic examination was 6 weeks later. As my physician was
   examining my breasts, she felt a ridge in my right breast and ordered
   diagnostic mammography and ultrasound. The diagnostic mammogram revealed
   nothing, but the ultrasound examination revealed a 2.5-cm mass. A breast
   biopsy confirmed invasive cancer, which was later verified as stage IIIC
   breast cancer. At the time of diagnosis, my tumor was more than 1 inch in
   size, and it had metastasized to 13 lymph nodes. The American Cancer Society 
   reports the 5-year survival rate for stage IIIC breast cancer as 49%,
   compared with stage I at 88% [1]. I expected, in the event of a cancer
   diagnosis, an early stage because of my faithful program of annual screening 
   mammography. I questioned my doctors as to what had happened. This was the
   first time that I was told that I had extremely dense tissue and that, as
   breast density increases, the sensitivity of mammography decreases.

   I was stunned that my doctors knew about dense breast tissue and its impact
   on the effectiveness of mammography but had never informed me. I also
   discovered that my physician received reports generated by radiologists that 
   included more details about my mammographic results and, as in most reports, 
   my breast tissue composition. This information is usually not reported in the
   patient’s “happygram” report. My decade of radiologists’ reports, unknown to
   me, read, “Patient has extremely dense breasts…no change from prior exam.”
   My radiologist knew that I had dense breasts. My doctor knew that I had dense
   breasts. The only person who did not know was me: the woman with the dense
   breasts.

Regular readers who have been paying attention to my posts on mammography and
screening know that there is a huge misconception in this story, namely the
belief that catching a cancer earlier results in a better chance of survival.
It’s a common misunderstanding, even among physicians. Clearly, Cappello doesn’t
understand the concept of lead time bias, but she’s in good company. Neither do
a lot of physicians. Basically, earlier detection can make survival after
diagnosis seem longer even if the treatments used have no effect at all. It
seems an opportune time to explain why this is by resurrecting one of my
favorite explanations for lead time bias, by Aaron Carroll:

   Let’s say there’s a new cancer of the thumb killing people. From the time the
   first cancer cell appears, you have nine years to live, with chemo. From the
   time you can feel a lump, you have four years to live, with chemo. Let’s say
   we have no way to detect the disease until you feel a lump. The five year
   survival rate for this cancer is about 0, because within five years of
   detection, everyone dies, even on therapy.

   Now I invent a new scanner that can detect thumb cancer when only one cell is
   there. Because it’s the United States, we invest heavily in those scanners. 
   Early detection is everything, right? We have protests and lawsuits and now
   everyone is getting scanned like crazy. Not only that, but people are getting
   chemo earlier and earlier for the cancer. Sure, the side effects are
   terrible, but we want to live.

   We made no improvements to the treatment. Everyone is still dying four years 
   after they feel the lump. But since we are making the diagnosis five years
   earlier, our five year survival rate is now approaching 100%! Everyone is
   living nine years with the disease. Meanwhile, in England, they say that the 
   scanner doesn’t extend life and won’t pay for it. Rationing! That’s why their
   five year survival rate is still 0%.

As I’ve said before, I don’t think screening for breast cancer is useless.
Neither does the WHO. It’s just that the relationship between screening, finding
cancer earlier, and increasing cancer survival is not simple. Would finding
Cappello’s cancer earlier have increased her chance of survival? There’s no way 
of knowing because she was one of the lucky ones who survived stage IIIC cancer.
In fairness, her treatment probably would have been less brutal, but it’s
impossible to know in any single case whether early detection would have made a 
difference.

So Cappello became an advocate, and a successful one. Over the last several
years, she and her collaborators have successfully gotten notification bills
passed in 22 states. The new law in Michigan is typical. In the case of a
finding of increased breast density, it mandates that the patient receive a
letter that states:

   Your mammogram shows that your breast tissue is dense. Dense breast tissue is
   very common and is not abnormal. However, dense breast tissue can make it
   harder to find cancer through a mammogram. Also, dense breast tissue may
   increase your risk for breast cancer. This information about the result of
   your mammogram is given to you to raise your awareness. Use this information 
   to discuss with your health care provider whether other supplemental tests in
   addition to your mammogram may be appropriate for you, based on your
   individual risk. A report of your results was sent to your ordering
   physician. If you are self-referred, a report of your results was sent to you
   in addition to this summary.

So what’s wrong with this? More information is always a better thing, right?
Even if it’s vague and just tells the patient to discuss the matter with her
health care provider? There’s more wrong than you might think.

The problem with mandatory breast density reporting laws

There are a number of problems that these laws produce. The most difficult to
navigate problems include what to recommend for these patients and how to
reassure them. The reasons are simple. First, there is as yet no standardization
for determining breast density, and, indeed, measuring density is still a
fairly subjective process that radiologists do, with rather high interobserver
variability. It is true that there are now automated systems designed to
estimate breast density using image analysis, such as Volpara (there are other
competing software systems), but most breast centers don’t yet have them and
still use the American College of Radiology BI-RADS lexicon. My breast center
does (it’s an NCI-designated Comprehensive Cancer Center, after all), but most
mammography centers do not. Over time, no doubt the whole process will become
much more standardized, but until then there will remain a lot of subjectivity
in breast density assessments.

More importantly, indeed, most importantly of all, there is no consensus as to
what to do next. As described in an editorial by Marcia Javitt, Section Editor
for Women’s Imaging Director of Medical Imaging, Rambam Healthcare Campus in
Israel, no large randomized clinical trials have shown that breast cancer
mortality is reduced by alternative screening and “although the use of
alternative imaging techniques, such as breast ultrasound, breast MRI, digital
breast tomosynthesis, and molecular breast imaging (MBI) may enable the
detection of mammographically occult cancers in patients with increased breast
density, refinement and validation are required for successful large-scale
supplemental screening.” The American Cancer Society guidelines call for MRI
screening in addition to mammography for women at high lifetime risk (20-25%) to
develop breast cancer, but states there is “insufficient evidence to recommend 
for or against MRI screening” in women whose mammographs indicate extremely
dense or heterogeneous breast tissue. Javitt also notes that the potential
number of women who would need to be considered for additional imaging after
being informed of having heterogeneously or extremely dense breast tissue could 
be huge, adding that “if all of these women opt for adjunct screening
procedures, a staggeringly high number of alternative screening studies in the
United States could overwhelm the available resources.”

One of the most commonly suggested alternative additional modalities to use,
whole breast ultrasound, is highly operator-dependent and has never been shown
to decrease breast cancer mortality, although it can increase the detection rate
in dense breasts, but at a cost. For example, the American College of Radiology
Imaging Network (ACRIN) 6666 trial showed that using breast ultrasound to
supplement mammography in women with dense breast tissue and increased risk for 
breast cancer resulted in improved cancer detection (an additional 4.3 cancers
per thousand women screened) at the cost of an increased recall rate, a large
increase in the false positive rate, and reduced positive biopsy rate. Also,
there was no control group, and the study only evaluated women at increased risk
of breast cancer, not women of average risk. (Once again, in the interests of
full disclosure, my cancer center has developed a 3D ultrasound imaging
technology that we have high hopes for.)

And I forgot to mention: The vast majority of these laws do not mandate that
insurance companies pay for additional screening, which is a big problem, since 
most insurers don’t cover additional imaging for women with “clean” mammograms. 
The Affordable Care Act doesn’t require it, and, with the exception of
Connecticut, Illinois, New Jersey, and Indiana, states with these mandatory
reporting laws don’t require it. So, in most states that have passed these laws,
women who get these notices are faced with the choice of just living with it or
paying out of pocket for additional testing that has not been validated as
being able to decrease their risk of dying of breast cancer. For some tests, MRI
for instance, that expense could be quite high.

Finally, not all dense breasts are created equal, if you’ll excuse the cliché.
Some are truly high risk, and some are not. At a website set up by radiologists 
to try to navigate the vagaries of these laws, BreastDensity.info, there is a
flow sheet that informs us that:

  1. If the report states her density is heterogeneously dense, this is associated 
    with minimal risk above average (RR=1.2 compared to average breast density).

  2. If her density is extremely dense (also sometimes called simply dense), this
    factor doubles her risk of breast cancer compared to average density,
    similar to the risk associated with a family history of breast cancer in a
    mother, sister, or daughter. For example, having extremely dense tissue on
    its own raises the 10-year risk of breast cancer in the average 50 year old 
    woman from 1 in 42 to 1 in 21.

It also goes on to point out that, in the absence of other risk factors
associated with breast cancer, elevated breast density alone does not put a
woman at high risk for breast cancer. For instance, a recent prospective cohort 
study with over 365,000 women found that, in the absence of other risk factors
for breast cancer, high breast density alone has a rather modest effect on
breast cancer risk, leading the authors to warn:

   Breast density should not be the sole criterion for deciding whether
   supplemental imaging is justified because not all women with dense breasts
   have high interval cancer rates. BCSC 5-year risk combined with BI-RADS
   breast density can identify women at high risk for interval cancer to inform 
   patient–provider discussions about alternative screening strategies.

The study also found that about half of all women with heterogeneously or
extremely dense breasts did not meet the threshold for high rates of interval
breast cancer and that the threshold of screening all women with heterogeneously
dense breasts required 1,124 supplemental tests per additional cancer case
detected. In other words, an emphasis on breast density alone is probably
ill-advised based on what we know now.

I can understand why women like Nancy Cappello become activists. I really can.
They think they’ve been wronged by the medical system and that they’ve
discovered something that doctors either aren’t aware of or didn’t think
important enough to tell them. Unfortunately, in the case of breast density that
something is information that is both unreliable and does not as yet have a
consensus about it over what to do. As a result, what they’ve done is advocate
for laws that are ahead of where the science is, but not in a good way.

Bait and switch in Oregon: Substituting quackery for opioids for Medicaid
patients

The Oregon Health Authority is on the verge of passing a radical policy that
would require chronic pain patients receiving Medicaid to have their opioids
tapered to zero while covering “nonpharmacologic treatments for pain” that
include primarily acupuncture, chiropractic, massage therapy, and other
“alternative” treatments. Not surprisingly, the Oregon Chronic Pain Task Force, 
which is responsible for this proposed infliction of quackery on the most
vulnerable, has three acupuncturists and a chiropractor sitting on it.

David Gorski on August 30, 2018

Link



[Editor’s note: Due to a personal issue, Jann Bellamy was unable to write a post
for today. As a result, I filled in. Some of you might have seen this before
elsewhere, but I thought the topic was important enough to discuss here on SBM
as well.]

I’ve described in the past many times how advocates of “integrative medicine”
(or, as I like to call it, “integrating” quackery with conventional medicine)
like to co-opt science-based treatments as somehow being solely within the
bailiwick of their favored unholy hybrid medicine offspring bred of a forced
marriage between science and magical thinking. There are many potentially
harmful aspects of this shotgun marriage, not the least of which is the dilution
of the scientific basis of medicine in favor of pseudoscience. One area,
however, that doesn’t get enough attention (except from me) is how integrative
medicine tries to claim all “nonpharmacologic treatments for pain” as its own.
I’ve described how quacks have done this.

My thinking on this issue first started to gel a couple of years ago, when the
National Center for Complementary and Integrative Health (NCCIH) published its
five year strategic plan for 2016-2021. In this plan, NCCIH prominently featured
researching and promoting the “nonpharmacologic treatment of pain” as one of
its most pressing goals. Later that year, it published a really bad review
article, one based on horrible studies and huge extrapolations from weak data,
that basically claimed all nonpharmacological treatment of pain as part of
“complementary and alternative medicine” (CAM, now known as “integrative
medicine”). Basically, although I had been getting the vibe that integrative
medicine advocates were trying to claim all non-drug treatments for pain as
their own before this, these two publications by NCCIH made it incredibly
obvious to me that this was the new propaganda direction that integrative
medicine advocates would be taking, and take it they did. It wasn’t long before 
JAMA joined in, followed by the American College of Physicians, the Academic
Consortium for Integrative Medicine and Health (of course!), and the FDA which, 
in response to lobbying by acupuncturists and chiropractors, has a draft
proposal outstanding to encourage physician education about acupuncture and
chiropractic as “therapies that might help patients avoid prescription opioids.”
Never mind that there is no good evidence that either can accomplish this goal.
Meanwhile, acupuncture advocates have been busy lobbying various states to have
their Medicaid programs cover acupuncture.

Which brings us to Oregon.

Oregon: The “nonpharmacologic treatments for pain” scam

There was a story last month that I had meant to write about but somehow had
gotten lost in the piles and piles of links in my “to be blogged folder” about
the potential horrible consequences for patients that this co-optation of
nonpharmacologic treatments for pain could have for chronic pain patients, in
essence sanctioning their torture. (I don’t think I’m exaggerating, or if I am
it’s not by much.) It came in the form of an AP story, “Oregon officials
consider limiting opioid prescriptions“:

   A proposed change to the state’s Medicaid program aims to reduce the
   overprescribing of opioids, which has caused an epidemic of overdoses, Oregon
   officials said.

   The proposal would limit coverage for five broad chronic pain conditions to
   90 days of opioid pain relievers, The Bulletin reported Wednesday.

   It would also taper off patients who have been taking opioids long-term from 
   those medications within a year.

   In turn, it would introduce alternative treatments previously unavailable
   under the Oregon Health Plan.

“Alternative” you say? What does that mean? If you read this blog, I bet you
know exactly what that means. From The Bulletin, a central Oregon newspaper:

   Oregon could have some of the country’s strictest limits on opioids for
   chronic pain patients under a proposal being considered for the state’s
   Medicaid program. The proposed change would limit Oregon Health Plan coverage
   for five broad chronic pain conditions to 90 days of opioid pain relievers
   and would force patients who have been taking opioids for longer to be
   tapered off those medications within a year.

Yikes! Forced tapers for chronic pain patients beginning in 2020? What, pray
tell, will replace the opioids? You guessed it: yoga, acupuncture, massage,
chiropractic, or physical therapy. Or, as an Oregon Health Authority
spokesperson put it:

   “We are in an opioid crisis in Oregon,” said Jonathan Modie, an OHA
   spokesman. “Over prescribing has been the main driver of overdose and death. 
   We want to make sure patients have more non-pharmacological options such as
   acupuncture, massage therapy and chiropractic care.”

Well, yes. There is an opioid crisis. Deaths due to opioid overdose are at an
unacceptably high level. Something needs to be done. Unfortunately, the
imperative to “do something, anything” is driving some truly awful policies that
will harm patients. For example, in my state, as of June 1, physicians have to 
run a search on every patient for whom they prescribe opioids beyond a three day
course for acute pain (as in postoperative prescriptions) and document that
search on a special opioid prescription form. We also have to have patients sign
a consent form warning them that opioids can be addictive and can even kill
them. Will this policy reduce opioid overdoses in this state? Hell if I know!
There’s no good evidence to say that it will, but it might just accomplish that 
by making it so onerous to prescribe and get opioids, even for patients who need
them, that fewer patients get opioid prescriptions and therefore fewer die. The
price, of course, is a lot of patients in pain who don’t need to be. Of course,
the Oregon proposal is so much worse. At least the Michigan proposal has a
little bit of prior probability based on callousness: Let patients suffer by
making it harder for them to get opioids and maybe overdoses will decline. It
might work if as a state official you don’t mind treating some chronic pain
patients with needless cruelty. The Oregon proposal, on the other hand, can’t
work because it proposes encouraging the use of quackery instead of opioids.

Now that’s cruel.

Three acupuncturists and a chiropractor

Where, you might wonder, did such an incredibly non-evidence-based and, to put
it quite bluntly, dumb proposal come from? It takes a little explaining,
explaining that’s easier to do just by quoting:

   The proposed change came out of the Chronic Pain Task Force, an ad hoc
   committee created to provide guidance on reducing opioid use under the Oregon
   Health Plan. The Oregon Health Plan has a unique structure among state
   Medicaid programs, relying on a prioritized list of health services ranked by
   experts in order of importance to patients. State lawmakers then decide
   where in the prioritized list to draw the line between covered and uncovered 
   services.

   Currently, the five conditions being discussed — fibromyalgia, chronic pain
   syndrome, chronic pain due to trauma, other chronic postprocedural pain and
   other chronic pain — fall below the line, and thus treatments for those
   conditions aren’t covered by the Oregon Health Plan. But according to the
   Oregon Health Authority, many patients with those five conditions are being
   prescribed opioids. The Oregon Health Plan has no way of knowing whether
   those patients are being prescribed opioids for those chronic pain conditions
   or for covered services and, therefore, cannot decline to cover those
   prescriptions.

   By establishing a new entry in the prioritized list above the cutoff line,
   the Oregon Health Plan would then cover alternative treatments, such as yoga,
   acupuncture or physical therapy, but would try limit the use of opioids.

I’m all for evidence-based guidelines for just about every condition in medicine
with sufficient scientific and clinical evidence upon which to base guidelines,
but the key is how these guidelines are developed. Using Google to try to find 
various reports of the Oregon Chronic Pain Task Force, I found this Health
Evidence Reviews by the Chronic Pain Task Force dated January 23, 2018 and June 
7, 2018. I could see the problem right away as I perused these documents.
Basically, the problem was that the review of evidence listed in the reports
tended to cite the same unconvincing studies that acupuncture and integrative
medicine advocates like to cite. They cited follow-ups to the infamous Vickers
meta-analysis (or, as I like to call them, Son of Vickers, Bride of Vickers, and
the like), the granddaddy of acupuncture meta-analyses and the one most often
touted as the gold standard “proving” that acupuncture works for chronic pain.
It didn’t, no matter how much acupuncture advocates strained to say it did.
Then, of course, the Task Force cited the systematic review by the NCCIH that
really didn’t show that acupuncture or other CAM (rebranded as “nonpharmacologic
treatments for pain”) has any effect on chronic pain distinguishable from
placebo.

You can listen to the panel itself debating the opioid taper at its meeting of
June 7. It’s cringe-inducing. They admit there’s no evidence, and basically
admit that the figures they’re bandying about for length of time for the taper
to zero have basically been pulled from their nether regions:

Notice the obsession with being consistent with the “prior guidelines”. What
prior guidelines, you ask? Well, in 2016, Oregon imposed similar restrictions on
patients with chronic back pain. At one point, they assert that this program is
working, but there’s no evidence presented that it is, nor could I find any
evidence that it’s doing what is intended. Basically, they want to expand their 
forced taper to a much larger group of patients.

It didn’t take me long to figure out why the Chronic Pain Task Force is so
“open” to alternative treatments. There are three acupuncturists (Ben Marx,
David Eisen, and Laura Ocker) and a chiropractor (Mitch Hass) on the committee. 
Yes, you read that right. Four of the members of the Oregon Chronic Pain Task
Force are quacks. They’re cruel quacks, too, as they want to force patients to
taper their opioids in favor of their fraudulent “nonpharmacologic treatments
for pain”.

Ocker, for one, is a high-ranking and influential quack, too. She was President 
of the Oregon Association of Acupuncture and Oriental Medicine from 2012-2013
and has been active promoting acupuncture legislatively in Oregon at least since
2009. Indeed, our old friend John Weeks interviewed her admiringly in May 2017,
claiming that “Evidence opens Medicaid in Oregon to acupuncture,” where we also
learn that Ben Marx has been one of her colleagues at the Oregon College of
Oriental Medicine also working to promote acupuncture reimbursement in Oregon:

   Ocker has also made available multiple documents that can guide interested
   parties more deeply into how to engage such a process. These include the
   recent Oregon Health Plan remarkable decision, following the ascendency of
   the opioid crisis, to “prioritize therapies such as chiropractic and
   osteopathic manipulation, physical therapy, acupuncture, cognitive behavioral
   therapy, graded exercise therapy, interdisciplinary pain management, yoga,
   and massage—and a treatment plan to stay active and return to previous
   function—over ineffective surgeries and narcotics.” Ocker believes that the
   looming opioid crisis has been wind at their backs during the entire process.

In other words, at least two of the acupuncturists on the Chronic Pain Task
Force are not just acupuncturists. They’re advocates for acupuncture and federal
and state reimbursement for acupuncture services and have been active
politically for quite some time working for just that. In addition, Amber Rose
Dullea is a fibromyalgia sufferer and licensed massage therapist, as well as a
“coach, speaker and author.

I couldn’t help but wonder: Are there any physicians on this task force? It
turns out that there are. There are two anesthesiologists (Dr. David Sibell),
one of whom is a pain specialist (Dr. Kevin Cuccaro). I must admit, after
perusing Dr. Cuccaro’s website, I was left with the distinct impression of woo, 
as I read of the “Pain Triangle”. At the very least, his publications and
podcast go on about the “Pain Management Business–A multi-billion dollar empire 
motivated by what is profitable rather than what is best for patients”. In
episode #39 of his podcast, he starts right out going on and on about the
“powerful placebo,” a dead giveaway for someone whose mind is so open that his
brain falls out when it comes to woo. After all, placebo effects figure
prominently in the central dogma of alternative medicine. The others include a
fairly unremarkable assortment of specialties, including Dr. Tracy Muday, Chief 
Medical Officer of Southwest Oregon Independent Practice Association and
Advanced Health, Coordinated Care Organization administering Oregon Health Plan 
benefits to enrollees in Coos and Curry counties; Dr. Holly Jo Hodges, Medical
Director at WVP Health Authority; and Dr. Ariel Smits, a family medicine doctor 
in Portland.

It certainly looks as though the doctors barely outnumber the quacks on this
panel, and might even have the upper hand. Why is this panel like this? An
Oregon Health Authority spokeswoman justified it by saying that the task force
composition aimed “to represent the variety of clinicians who would be involved 
in the management of chronic pain.”

Here’s the actual text and the changes from previous policy on the use of
opioids for chronic back pain from 2016 (yes, that was the precursor to this
cursed policy):

And what is this taper process? This:

My reaction: WTF?

The backlash

Not surprisingly, groups representing chronic pain patients are not happy about 
these proposed guidelines. A story in STAT News from last week described how
patients in Oregon are protesting, having shown up to an August 9 meeting of the
Value based Benefits Subcommittee (VbBS) and the Health Evidence Review
Commission (the latter of which includes a naturopath, Angela Senders, as one of
its members) to make their concerns known, especially since the HERC is the
committee that has to vote on the proposal, after it’s screened and approved by 
the VbBS. And, boy, did they ever!

   The controversy has brought together an unlikely crew of protestors,
   including many in wheelchairs and in walkers, who, at 7:15 on a recent
   Thursday morning, erected a tidy encampment outside the windows of a
   community college lecture hall here. A security guard eyed them warily from
   inside, where an obscure committee would soon hear the state’s proposal to
   end coverage of opioids for chronic pain.

   Among their signs: “Death with dignity is a law: What about LIFE with
   dignity?”

And:

   Each used their time in the lecture hall to offer impassioned speeches,
   accented alternately with tears, shouts, shakes of a pill bottle, uniformly
   opposing the policy change.

   Again and again, they reminded the committee members that they had not yet
   fully grappled with the question central to their proposal: Is continued
   reliance on opioids for chronic pain more dangerous than forcing patients off
   them?

And that’s the point:

   Experts say the science supporting either argument is extremely limited.

   “What is notably missing is any review of any literature regarding the
   centerpiece of their proposed policy: Forced opioid taper to zero for all
   persons,” said Dr. Stefan Kertesz, a pain and addiction specialist at the
   University of Alabama, Birmingham, School of Medicine.

Indeed, a group of pain physicians, academics, and patient advocates wrote a
letter to Oregon Health officials pointing out just how wrong-headed and harmful
this proposal is. The full text of the letter can be found here, but a key
quote is worthy of noting:

   An across-the-board denial of opioid therapy for the huge umbrella category
   of chronic pain is as destructive as is liberally prescribing opioids for all
   types of chronic pain,” the letter warns. “The denial of coverage to the
   Medicaid population, in particular, is likely to have a disproportionate
   impact on individuals with disabilities, on the sickest patients and those
   with multiple chronic conditions.”

Precisely. They also note that, although opioid prescribing has been declining
since 2012, that decline has not correlated with a decline in opioid overdose
deaths. Indeed, the authors note that opioid deaths have skyrocketed during that
same period because “crisis has evolved to feature heroin and illicitly
manufactured fentanyl and its analogs” and even “most deaths that involve a
prescription opioid are polypharmacy—often including illicit drugs,
benzodiazepines and other CNS depressants, and alcohol—and most misuse is
non-medical.”

The danger of “integrating” quackery into medicine

Let’s just put it this way. Even “integrative medicine” pain specialists were
appalled. The Academy of Integrative Pain Management submitted a statement.
While the statement lauds the intent to make acupuncture and chiropractic (as
well as other non-evidence-based treatments) “above the line” and thus
reimbursable, even “integrative medicine” practitioners were horrified at the
thought of forced opioid tapers. The statement also sarcastically notes Oregon’s
first foray into this sort of nonsense by pointing out that it’s “in the 20th
month of a similar 12-month plan to forcibly taper patients with back and spine 
pain off their opioid pain relievers” and then goes on to point out that this
policy “is not a rousing success, yet you appear to be willing to impose it on
another large group of patients.”

This proposal by the Chronic Pain Task Force in Oregon is also incredibly
unethical. The reasons are simple. There is no evidence that forced opioid
tapers—particularly a forced taper to zero opioids—is of any benefit for chronic
pain patients, but there is considerable anecdotal evidence of potential harms,
up to and including suicide. Indeed, Department of Veterans Affairs data
suggests that opioid discontinuation is not associated with overdose mortality
but is associated with increased suicide mortality. Moreover, denial of coverage
for opioids in these patient groups will almost certainly have a
disproportionate impact on patients with disabilities, on the sickest patients
and those with multiple chronic conditions. These are the patients who
frequently wind up on Medicaid after they can no longer work. Worse, the
evidence that the modalities that will be covered and will be recommended as
replacements for opioids are effective is weak to nonexistent. Indeed, the
highest quality evidence shows that acupuncture, for instance, is no more than a
theatrical placebo. It does not work.

If you want to see the danger of “integrating” quackery with medicine, as
integrative medicine does, look no further than Oregon. Here, because of the way
that integrative medicine has so successfully rebranded quackery like
acupuncture as “nonpharmacologic treatments for pain” and tarted them up as
being evidence based when they are not, a large state is seriously considering a
policy that, if implemented, would leave an large number of the most vulnerable
patients suffering unnecessarily, all because there are four quacks and at
least some quack-sympathetic doctors and advocates on a panel. The opioid crisis
is truly driving not just bad solutions born out of the desire to “do
something”, but is being used as a “wedge” to drive more pseudoscience into
medicine. Unfortunately, the fix seems to be in. There’s going to be a vote as
early as October, and I’d be willing to bet—sadly—that Oregon will approve this 
patient-hostile policy. Then, moralizing about those who need opioids combined
with magical thinking like acupuncture will leave untold patients suffering
unnecessarily—all because we have to “do something”.

Don’t say I didn’t warn you this was coming somewhere, sometime. I also predict 
that, if Oregon gets away with this, it won’t be long before more states decide 
to punish chronic pain patients in the name of helping them with
“nonpharmacologic treatments for pain.

Significant Ruling Against Conversion Therapy

Steven Novella on February 11, 2015

Link



The standard features of quackery are all there. Proponents of this particular
therapy claim that a normal condition is a disease. They make false claims about
the cause of this disease. They then charge thousands of dollars for their fake
treatment to cure the fake disease, and claim success rates that are not backed
by any statistics.

In this case the fake disease is homosexuality, for which there is now a solid
consensus that it is a normal variation of human sexuality. The fake treatment
is conversion therapy. Recently a New Jersey judge ruled that conversion
therapists cannot claim that homosexuality is a disease or disorder. The
Southern Poverty Law Center reports:

   Superior Court Judge Peter F. Barsio Jr. found that it “is a
   misrepresentation in violation of [New Jersey’s Consumer Fraud Act], in
   advertising or selling conversion therapy services, to describe
   homosexuality, not as being a normal variation of human sexuality, but as
   being a mental illness, disease, disorder, or equivalent thereof.”

Further:

   The judge also ruled that [New Jersey conversion therapy provider Jews
   Offering New Alternatives for Healing (JONAH)] is in violation of the
   Consumer Fraud Act if it offers specific success statistics for its services 
   when “client outcomes are not tracked and no records of client outcomes are
   maintained” because “there is no factual basis for calculating such
   statistics.”

Anytime there is a ruling or new law or regulation that essentially makes it
illegal to make fraudulent health claims, that is a win for the consumer. Health
care consumers, including those for mental health services, are particularly
vulnerable. Further, most consumers assume that such protections are already in 
place, and therefore have a (frequently false) sense of security that others
cannot make fraudulent health claims.

(Note: I recognize that sexual orientation and gender identity are complex and
represent spectrums, rather than clean dichotomies. However, since the dubious
treatment and the current ruling address “homosexuality” I will use that term as
a representative label.)

Homosexuality has been a target for many decades. By coincidence, a character in
this season of Downton Abbey (which takes place in the 1920s), Thomas Barrow,
is undergoing dubious and apparently dangerous medical treatments for his
homosexuality.

Early psychiatrists differed on their views of homosexuality. Freud actually
thought it was a natural variation of human sexuality, while others, such as
Sandor Rado, argued that it was pathological. The pathological view prevailed,
and the dominant theory was that homosexuality results from abnormal sexual
development or even early childhood trauma and abuse. In the first half of the
20th century what little research was done supported the pathological
hypothesis, but in retrospect this research was highly biased.

The turning point came with the research of Evelyn Hooker beginning in 1957. Her
research into homosexuality addressed the inherent biases of earlier research. 
She studied subjects who were not already psychiatric patients. She also
performed blinded evaluations in which personality traits were assessed by
evaluators who did not know the sexual orientation of the subject.

With these biases eliminated, she found that homosexuals did not have any
greater chance of having mental illness or poor adjustment than heterosexuals,
which was a fatal blow to the view that homosexuality was a mental pathology.
Her research was replicated by others, with similar results. A new consensus was
forged around these more rigorous research results.

In 1974 homosexuality was removed from the DSM as a mental disorder. Now, forty 
years later, this remains the robust conclusion of psychological research, that 
homosexuality is part of the healthy spectrum of human sexuality and there is no
evidence that justifies the conclusion that it is a disorder or disease.

Similarly, there is no evidence to support the claim that homosexuality results 
from early childhood trauma or abuse. Sexuality is a complex behavior, and there
is no simple cause that can be identified. However, researchers have identified
two significant contributors.

The first is genetics. While there is certainly no “gay gene”, studies have
identified a genetic predisposition to homosexuality. This means that there are 
likely many genes that play a role, and no single gene (or even the totality of 
relevant genes) is deterministic.

The second biological factor is the hormonal environment in the womb, which has 
a known effect of brain development. There are several independent lines of
evidence supporting this conclusion, from birth order effects to differences in 
brain scans.

The genetic and development research, however, overall is not definitive and
both larger, more representative, and more nuanced research is considered
necessary. The Harvard Kennedy School LGBTQ Policy Journal concludes:

   Issues of sample size and selection bias, however, also plague these studies.
   Those who are willing to undergo brain scans, or have their brain examined
   upon autopsy (Swaab and Hofman 1990), may have a special and unique
   relationship with their sexuality. It would be more informative to study
   individuals across a range of sexualities and gender identities. While such
   studies would be unlikely to produce the striking results we currently see in
   the literature, they would better reflect the diversity of the human
   population and shed light on what differences may actually exist between
   people who identify as LGBT and those who do not.

Regardless of these finer points, it is clear that variations in sexual
orientation and gender identity are not the result of childhood trauma or abuse,
as is claimed by the conversion therapy industry.

Does conversion therapy (also called reparative therapy) work? The burden of
proof, of course, is on those making claims for efficacy. The research, however,
is scant and problematic. Most famously, in 2003 Spitzer published a case
series in which he concluded that reparative therapy was effective. He wrote:

   Either some gay men and lesbians, following reparative therapy, actually
   change their predominantly homosexual orientation to a predominantly
   heterosexual orientation or some gay men and women construct elaborate
   self-deceptive narratives (or even lie) in which they claim to have changed
   their sexual orientation, or both. For many reasons, it is concluded that the
   participants’ self-reports were, by-and-large, credible and that few
   elaborated self-deceptive narratives or lied.

The first sentence summarizes the difficulty with this research. Subjects are
self-selected and they self-report their own outcomes. There are good reasons to
believe that the social pressures that led them to seek out reparative therapy 
in the first place also motivate them to construct a narrative of efficacy. The 
problem was in Spitzer’s second sentence, concluding without adequate
justification that the self-reports were not self-deception. In 2012 Spitzer
then recanted this conclusion.

Conclusion

Sexual orientation and gender identity are complex behavioral traits that
exhibit the full spectrum of possible manifestations and even flexibility.
Decades of research suggest that the full spectrum is part of human sexual
variation, and does not represent a pathological or disease state, nor any kind 
of disorder. They are not associated with any pathology, specifically with
childhood trauma or abuse. Rather, sexual orientation appears to have a clear
but complex biological component.

Claims for efficacy of conversion or reparative therapy are not supported by
adequate clinical evidence.

The recent ruling in this ongoing case in New Jersey is encouraging, essentially
ruling that practitioners of dubious conversion therapy cannot make fraudulent 
claims regarding the medical status of homosexuality or the efficacy of their
treatment.

Lyme Testimony

Mark Crislip on May 15, 2015

Link





The black-legged tick, responsible for spreading Borrelia burgdorgeri, the
bacteria that causes Lyme disease

As the saying goes, when you do not have the facts, argue the law. This tried
and (?) true approach was successful in New York where a law was passed
protecting those who are, shall we say, creative in treating patients with Lyme 
and ‘chronic’ Lyme.

The bill protects those from investigation of misconduct:

   based solely on treatment that is not universally accepted by the medical
   profession.

The major bone of contention has been extended courses of IV antibiotics for
‘chronic’ Lyme, but there are a wide variety of treatments that may be used by
so called “Lyme literate” doctors.

The number of therapies divorced from reality that are offered to Lyme patients 
is remarkable. I do not know if chronic Lyme patients have greater use of
pseudo-medical therapies than other pseudo-diagnoses, but I am impressed by the 
offerings in a recent review:

   Results. More than 30 alternative treatments were identified, which fell into
   several broad categories: these included oxygen and reactive oxygen therapy;
   energy and radiation-based therapies; nutritional therapy; chelation and
   heavy metal therapy; and biological and pharmacological therapies ranging
   from certain medications without recognized therapeutic effects on Borrelia
   burgdorgeri to stem cell transplantation. Review of the medical literature
   did not substantiate efficacy or, in most cases, any rationale for the
   advertised treatments.

   Conclusions. Providers of alternative therapies commonly target patients who 
   believe they have Lyme disease. The efficacy of these unconventional
   treatments for Lyme disease is not supported by scientific evidence, and in
   many cases they are potentially harmful.

Why a legislature would want to abandon consumer protections and protect those
providing useless and potentially dangerous therapies eludes me.

There was a nice summary in the discussion which in many ways sums up the entire
history of the Science-Based Medicine blog and its entries:

   Two common themes characterized the websites referenced in this study. One
   was the reliance on anecdotes and testimonials from patients. The second was 
   the veneer of scientific credibility, ranging from the medical credentials of
   the service providers to the use of seemingly technical terminology. In
   virtually all cases, these testimonials and scientific expositions were used 
   promotionally to sell therapeutic services and products. Our review of the
   medical literature did not yield evidence to support these health claims.

Sadly, I suspect that the above paragraph will remain relevant for as long there
is an internet. Plus ça change, plus c’est la même chose.

The malignant success in NY has inspired others to have similar laws metastasize
to other states. They call me Dr. Metaphor for a reason. Oddly there is no
super-hero or villain with that name. And here I though all the good names were 
taken.

In Oregon there was a similar bill before the legislature, which read:

   Permit professionals regulated by the boards to diagnose and treat, in
   manners consistent with the standards of care guidelines developed by the
   International Lyme and Associated Diseases Society, Lyme disease and
   associated viral, bacterial and parasitic diseases; and

   (b) Establish disciplinary procedures that consider as mitigating factor
   whether, in diagnosing or treating Lyme disease or associated diseases, a
   professional who is facing discipline followed evidence-based diagnosis and
   treatment guidelines not recognized by the boards.

I suspect similar laws will be showing up in your state. As part of the
legislative process in Oregon, there are public hearings where anyone can
testify for or against a bill. I thought it would be interesting to look at some
of the testimony in favor of the bill for insight into the rationalization
behind supporting the bill.

There was but one letter opposing the bill from the Oregon Health Authority.
Otherwise it was all testimony in favor.

Of the 58 exhibits, 35 were from patients. They have a similar theme: odd
symptoms, a diagnosis of Lyme by one non-standard test or another, refusal of
Oregon doctors to recognize and treat the patients for Lyme for what are
probably nefarious reasons, and occasionally some improvement with alternative
therapy delivered in other states.

As an IDSA-sort-of-doctor, the suffering is compelling (although not due to
Lyme). The lack of precise information about testing and treatment is
aggravating, making an assessment of the validity of the patient stories
impossible. I am well aware of unreliability of patient histories, especially
when they have a dog in the fight.

Most appear to be patients who have received creative care from the alternative 
Lyme world. An example (bold are my additions):

   Ashley to the East Coast, where she was examined, tested, and found to have
   Lyme disease, along with Babesia and Ehrlichiosis (three diseases almost
   nonexistent in Oregon). Her Lyme doctor was shocked that her absolute
   classical presentation was ignored by her doctors and specialists. She
   improved using the ILADS standard of care.

   This doctor worked with Ashley’s PCP’s who could do supportive care in
   Oregon. Over the next several years, we and our daughter went through a
   cyclical routine of Oregon support doctors discontinuing her ILADS Lyme
   treatment and telling us residual symptoms were not Lyme. However, the
   symptoms recurred, and positive blood tests, including 2 positive PCR (DNA)
   tests (unreliable) indicated she was still infected.

   When we asked the East Coast and California Lyme specialists why she was so
   difficult to treat they said because she went for 9 years without any
   treatment, and the bacteria had penetrated bone marrow and brain (not).

   Ashley stabilized to an almost normal life routine by age 20, but she missed 
   having anything resembling a normal childhood and teen years. At this time,
   she is happily married and has 3 healthy children.

   Our family was terribly impacted. Our “vacations” were often spent traveling 
   to out-of-state doctors. Our children missed out on many normal family
   activities. We can never get back those years. We’ve spent approximately
   $185,000 out of pocket

That is a lot of money. No wonder the Lyme literate doctors want legislative
protection from their treatments. And they say we are shills.

Some of the diagnoses and clinical courses are quite fantastical, although from 
the spotty information given in the testimony a true analysis is not possible.
It would be interesting to compare the testimony with the whole medical record, 
but that is unlikely to occur.

Many were diagnosed for Lyme and other diseases using testing that may be
suspect. Igenex is a popular but questionable lab, used rather than the standard
two step testing. The CDC test, as they call it, has been validated by the gold
standard: culture positive patients. I cannot find where Igenex has been
validated, if it is on PubMed I could not locate it. The closest I could find
was a report that:

   IGeneX was rejected by New York three times for Lyme tests in the past decade
   for not having enough documentation to prove the tests worked.

And:

   Several Lyme laboratories said they stood by their tests, but the process to 
   get FDA approval was too cumbersome.

   “You need a ton of documentation,” time, and money, said Jyotsna S. Shah,
   vice president of IGeneX Inc., a Palo Alto, Calif., lab that performs more
   than 25,000 Lyme tests a year for hundreds of dollars each…

   …In contrast, government and academic scientists contend that the IGeneX
   method is highly sensitive but not adequately specific, meaning it probably
   returns positive readings for many people without Lyme.

   Sitting in a small conference room in a nondescript building near Stanford
   University, Shah said IGeneX’s testing is backed up by solid science and that
   the company has been open about its methods. She pointed to two papers on
   its methods, a 2007 paper published in an alternative medicine newsletter and
   a 2010 paper in a journal that appears to be defunct. Neither publication is
   widely read or cited by other scientists.

The patients put a lot of faith in the validity of the alternative testing
despite a lack of rigorous published evaluation. Perhaps because it provides the
answer they want, motivated reasoning at its finest.

   The most common of all follies is to believe passionately in the palpably not
   true. It is the chief occupation of the Lyme literate.— H. L. Mencken.
   Almost.

Reading the patient testimony made me sad. People suffering (I never deny the
suffering of patients, only that the suffering is from Lyme), being diagnosed
with multiple infections with unreliable tests and spending enormous amounts of 
time and money chasing the chimera of alternative treatments for their mythical 
illness.

More striking is that if the testimonies are correct, it documents medical
treatments by the Lyme literate doctors that are, in my opinion, truly bizarro
by my understanding of infectious diseases. Why such horrible medical care needs
protection is understandable. Such care certainly cannot be justified by the
best medicine and science.

Many of the patients noted that Lyme is an under recognized epidemic; I saw an
epidemic of inappropriate tests, testing and treatment.

This was brought home by the opening testimony of the Oregon Lyme Disease
Network.

They note many times more false Lyme diagnoses than real Lyme diagnoses in
Oregon:

   CLIA certified laboratory with CDC proficiency ratings, reported 166 CDC
   positive results on either Western Blot IgG or IgM test for Oregonians in
   2014

   Currently in Oregon Support Groups 817 patients, a combination of clinical
   diagnosis with supportive laboratory testing.

   Patients currently in Support groups or in email connection with SG around
   the state: 817

While:

   The State of Oregon, Cases of Selected Notifiable Diseases for 2014 —
   reported a total of 38 probable cases and 21 confirmed in Oregon for the
   year.

It is the kind of weasely statements that obscure the truth with misdirection.
Lots of positive tests by labs that are certified but note they fail to mention 
if the tests are validated. In my opinion there are a staggering numbering of
patients misdiagnosed and mistreated with Lyme.

The Oregon Lyme Disease task Force also says MDs (emphasis added):

   Reject IgeneX laboratory telling patients it’s a bad lab (not sure why they
   say this)

Really? You really can’t discover why MDs might find Igenex questionable? It
took me less five minutes to find why the non-standard Lyme testing is
questionable.

No MDs testified in favor of the bill. I can see why. If the patient stories are
any judge, the doctors who provided the care as mentioned in the patient
narratives have reason to worry. I tend to be fairly liberal in patient care as 
often the what and how of patient care has uncertainty, but in the case of these
testimonies? Gave me the heebie-jeebies.

There was a ND who did mention the benefits of naturopathic practice in Lyme:

   I am indeed fortunate that I hold a license as a Naturopathic physician and
   as a consequence have a board that allows me to practice without the threat
   of losing my license if I choose to treat a patient diagnosis with Lyme
   disease.

As has been pointed out elsewhere, being a naturopath means never having to say 
you have standards.

So that was the testimony in favor of the bill. Patient stories of creative
diagnosis and treatment and the need for those who provide those treatments to
be protected and paid. Some disingenuous cherry picking from the Lyme
organizations. A seeming lack of understanding why the ILADS guidelines and
alternative testing are suspect and what constitutes best evidence. From my
viewpoint, the testimony was a compelling argument for increased investigation
into the practice Lyme literate doctors to protect patients. They did their
cause little benefit.

There is a lot more information in these testimonials that would make
interesting analysis if I had the time.

Despite all the testimony in favor of the bill, or perhaps because of it, the
bill was amended to instead read:

   The Oregon Health Authority, the Oregon Medical Board and the Oregon State
   Board of Nursing shall study clinical guidance regarding Lyme disease and the
   health outcomes related to the clinical guidance and shall report findings
   to the appropriate committees of the Legislative Assembly no later than March
   1, 2016.

I am a newbie in the legislative arena and had a late start in the 2014–15
legislative session when Oregonians for Science-Based Medicine was started as
part of SfSBM. I hope next season to start earlier and more comprehensively.
That being said, Ore4SBM sent a letter opposing the bill to the Committee as
well as a modified (snark free) version of my SBM post on Lyme.

The committee members also received a letter opposing the bill, written and
orchestrated by yours truly, signed by 18 Oregon Infectious Disease doctors.

Did those actions have any effect to change the bill? No idea. But I like to
think it did.

For now the standard for the treatment of Lyme will remain gold rather than the 
tin of the initial bill. It will not last. I have no doubt that further SCAM
protection bills will be presented to Oregon, and other, legislatures.

Florida revokes medical license of “Lyme literate” doctor

Florida finally revoked the medical license of “Lyme literate” doctor John
Lentz, who honed his diagnostic skills and treatments in ILADS seminars and
treated “chronic Lyme” for almost a decade. Why does the system allow this?

Jann Bellamy on December 22, 2016

Link



The Florida Board of Medicine revoked the medical license (warning: very large
PDF file) of John Lentz, MD, who operated Lentz Lyme Clinic in Destin, on
November 4, 2016, by a unanimous vote. In doing so, it adopted the
recommendation of an Administrative Law Judge (ALJ), issued in July of this
year, following a 4-day hearing in January. The Board voted against the ALJ’s
recommended imposition of a $30,000 fine.

The very presence of a “Lyme clinic” in Florida is an anomaly indicating
something might be amiss. As noted by the ALJ, while it is not impossible to
contract Lyme disease in Florida, it is not prevalent in the state. According to
the CDC, in 2015, Florida had 0.6 confirmed cases per 100,000 population, a
total of only 116 cases. Most people diagnosed in Florida were likely infected
elsewhere while traveling.

But a Lyme clinic makes perfect sense, economically at least, when one
understands the transmogrification of real Lyme disease into “chronic” Lyme
disease and of the real specialty of infectious diseases into the “specialty” of
“Lyme literate” doctors.

Real practicing infectious disease specialists go through internal medicine
residencies, followed by infectious disease fellowships, take the American Board
of Internal Medicine certification exam in infectious diseases, and are members
of the Infectious Diseases Society of America (IDSA). “Lyme literate” doctors
do residencies in any area and gain their Lyme “literacy” through seminars where
no actual patient care may be involved. They are members of the International
Lyme and Associated Diseases Society (ILADS), an organization that advocates
very different standards than the IDSA for the diagnosis and treatment of Lyme
disease and whose guidelines are based on “very low quality evidence.”

Without getting into the weeds (where ticks may be hiding) too much, real Lyme
disease is an infectious disease transmitted by a tick bite. Its symptoms are a 
rash, fever, headache and fatigue, although not all symptoms may appear. It is
diagnosed by medical history, physical exam and sometimes a blood test. It can
take 4 to 6 weeks for the immune system to make antibodies against Borrelia
burgdorferi, the organism responsible for the disease, and show up on a blood
test. Anyone who has symptoms for longer than 6 weeks and who hasn’t been
treated with antibiotics is unlikely to have Lyme disease if the blood test is
negative, according to the IDSA.

A diagnosis of “chronic” Lyme, which is not recognized by medical science, is
based on a collection of vague, non-specific symptoms that could be attributed
to any number of things (or nothing):

   Lyme is a multi-systemic illness, and may affect every part of the body
   causing fatigue, stiff neck, headaches, light and sound sensitivity, tinnitus
   (ringing in the ears), anemia, dizziness, joint and muscle pain, brain fog, 
   tingling, numbness and burning sensations of the extremities, memory and
   concentration problems, difficulties with sleep (both falling asleep and
   frequent awakening), chest pain and palpitations and/or psychiatric symptoms 
   like depression and anxiety.

Non-standardized and unvalidated tests are thrown into the diagnostic mix,
presumably to add credibility to the diagnosis, while evidence-based testing is 
rejected. Standard treatment for “chronic” Lyme includes long-term antibiotics, 
which is both not evidence-based and potentially dangerous. Case reports in the 
medical literature describe the ill-effects of long-term antibiotics.

A “specialty” based on a few seminars

Lentz did a family practice residency and was board-certified in family practice
until 2009, but currently holds no board certification. He graduated from
medical school in 1975 and practiced in South Carolina, but moved to Florida in 
2001, where he worked in a variety of practice settings, including working as an
emergency room doctor in several hospitals. In 2007, he opened the Lentz Lyme
Clinic. His education and training for this enterprise, according to his hearing
testimony, was attendance at four courses, each lasting three to four days. He 
testified that the first course he took, put on by ILADS, was not until 2009.
Another, also put on by ILADS, was in 2010. It featured Eva Sapi, PhD. According
to information on the ILADS website, Sapi’s

   recent research shows that Borrelia burgdorferi is capable forming a
   protective layer around itself ??” [sic] called biofilm ??” [sic] which could
   render it to be very resistant to antibiotics and provide a logical
   explanation as to why extensive antibiotic treatment for patients with a
   tick-bite history could fail.

This research has been parlayed into new testing and treatment regimens for
“chronic” Lyme by dubious medical clinics.

The two remaining courses were taught by Dr. Carol Ann Ryser, a pediatrician
whose Kansas City clinic treated, among other things, “chronic” Lyme disease.
Ryser surrendered her medical license and shut down her clinic as part of a plea
agreement with the feds over fraud and tax evasion charges in 2013. She was
also the subject of numerous malpractice actions, one of which reveals her as a 
devotee of the idea that “bugs” could hide in one’s “biofilm,” necessitating
lengthy antibiotic treatment.

The findings

The Department of Health’s case against Lentz involved his treatment of seven
patients, as alleged in three administrative complaints consolidated for
hearing. Lentz’s courses in “chronic” Lyme diagnosis and treatment were
well-reflected in his practice. According to the ALJ’s Recommended Order,
Lentz’s falling below the standard of care included the following:

Diagnosed Lyme disease without objective laboratory tests results from ELISA or 
Western blot tests.

Lentz testified he based his Lyme diagnoses on clinical presentation and CD57
blood panels. As the ALJ noted, the CD57 panel itself carries a disclaimer
stating it is for investigational purposes only and should not be used as a
diagnostic procedure without confirmation of the diagnosis by a medically
established diagnostic product or procedure. He also used other unvalidated
tests, even though at least one other had a disclaimer stating it was for
research use only.

While the ALJ found that performing other tests in conjunction with the
CDC-recommended ELISA and Western blot tests is not a per se departure,

   the standard of care requires either ordering the ELISA and where necessary, 
   the Western blot, or reviewing these tests previously obtained by the patient

where the exposure to the disease occurred four weeks or more in the past. In
other words, just what the IDSA says. She rejected the testimony of Dr. Michael 
Cichon, Lentz’s infectious disease expert, who testified that the ELISA and
Western blot tests had “little value” as “not credible.” ILADS also takes the
position that ELISA is “unreliable” and that the Western blot test is too narrow
in its reporting.

Diagnosed babesiosis and bartonellosis without appropriate testing.

This is another popular “Lyme literate” diagnosis, rejected by IDSA but given
support by ILADS. The ALJ noted that both are uncommon infections and that even 
an infectious disease specialist might never see a case in his or her entire
career, yet Lentz diagnosed several patients with these infections and treated
them.

Prescribed inappropriate and excessive antibiotic therapy without medical
justification.

For example, without proper testing, Lentz diagnosed one young woman who had
multiple orthopedic problems (and therefore pain) with Lyme and babesiosis. He
referred her for venous port placement for administration of IV antibiotics. He 
prescribed at one visit alone:

  1. Acetaminophen-oxycodone 300 mg – 7.5 mg oral tablets, three times a day

  2. Cymbalta 30 mg orally, once a day

  3. Flagyl 500 mg oral tablets, 3 weeks on, 1 week off

  4. Heparin, 5,000 units/ml injectable solution, once a day

  5. Omnicef 300 mg oral capsules, once a day

  6. Interfase Plus Prothera, a supplement

  7. Boluoke lumbrokinase, a supplement

At a subsequent visit, he ordered a Fry test for bartonellosis and prescribed IV
vancomycin for bartonellosis, even though she had yet to be diagnosed with that
disease. Fortunately, this patient saw a real infectious diseases doctor at
some point, who advised her to immediately stop the therapy prescribed by Lentz 
because it “was unsafe.”

If you are a medical professional, you are likely saying to yourself at this
point: Heparin? Why heparin? Read on.

Prescribed the anticoagulant heparin in the treatment of Lyme, babesiosis and
bartonellosis, without medical justification.

Lentz prescribed heparin for several patients. He testified that heparin was
“very therapeutic for biofilm” and that it “coats the babesia so when the
babesia protozoan enters the red blood cell” it “protects the red blood cells
from actually allowing babesis to enter them,” a bit of pseudoscience one
imagines he learned in the courses he attended.

The ALJ had a different view. She concluded that not only was its prescription
in these cases a departure from the standard of care, it

   was a dangerous choice for this or any other patient who did not have a need 
   for a blood thinner.

Failed to obtain complete medical histories, failed to perform adequate physical
examinations and failed to keep adequate medical records.

On some patients, he performed no history and physical, but ordered non-standard
tests for Lyme disease based on e-mails sent to him by people he’d never seen
in person. Reading between the lines, it appears some of his correspondents were
actively seeking “Lyme literate” doctors based on information on the internet
or recommendations from friends. With others, his history and physical were
inadequate. For instance, he did not inquire about travel history, to see if the
patients had been to Lyme-infested areas. As the ALJ said, Lentz

   seems so focused on Lyme disease and its possible co-infections that he seems
   to pay no attention to other symptoms or complaints the patient may have.

The ALJ also found Lentz prescribed antiparasitic medication, antimalarial
medication, antacids, laxatives, enzyme formulations, and supplements, without
medical justification. In addition, he failed to comply with a state law
requiring the immediate reporting of “diseases of public health significance,”
including Lyme disease, to the Department of Health.

The ALJ did not agree with the Department of Health that Lentz’s failure to
refer patients to an infectious disease specialist was below the standard of
care:

   the evidence was not clear and convincing that a primary care physician could
   not diagnose Lyme disease or babesiosis, assuming that he or she took an
   appropriate history, conducted a thorough physical examination, and, where
   warranted, ordered the appropriate objective laboratory tests.

Based on her finding that Lentz was guilty of “repeated malpractice,” the ALJ
recommended revocation of his license and the fine. Because the Board of
Medicine agreed with the ALJ’s findings of repeated malpractice, it had no
discretion to impose a lesser penalty than revocation. In 2004, Floridians
overwhelmingly approved a proposed amendment to the state constitution,
subsequently enacted into Florida law via enabling legislation, dubbed the
“Three Strikes Rule.” The law prohibits physicians with three or more incidents 
of medical malpractice, proven by clear and convincing evidence, from being
licensed to practice medicine. Because Board proceedings require proof by “clear
and convincing evidence,” the adjudication in this case met the statutory
requirements. According to the audiotape of the Board proceedings, this is the
first “three strikes” case the Board has considered, although I could not
confirm this. Of course, one hopes the Board would reach the same conclusion
even without the Three Strikes Rule if presented with this egregious case.

What happens next?

Lentz had 30 days to appeal the Board’s revocation to the state court of
appeals. As of yesterday, I could not find that a notice of appeal had been
docketed on the court’s website, but that isn’t conclusive as to whether one has
been filed. If he appeals, he has a right to a stay of his license revocation
“upon such conditions as are reasonable” unless the Department of Health can
convince the court of appeals that a stay “would constitute a probably danger to
the health, safety, or welfare of the state.”

Should he appeal, the appellate court cannot substitute its judgment for that of
the Board (which is based on the ALJ’s decision) as to the weight of the
evidence on any disputed finding of fact. It can, however, determine that a
particular finding is “not supported by competent, substantial evidence in the
record.” In this case, the ALJ repeatedly rejected the testimony of Lentz’s
expert as not credible on issues such as appropriate testing and use of
antibiotics. The Department of Health, on the other hand, presented the
testimony of an expert in infectious diseases and family practice in support of 
its case. Several ID doctors who treated patients after Lentz also testified as 
to how they rejected Lentz’s diagnoses and took patients off his regimens. This 
should give Lentz little hope of overturning the Board’s decision.

In sum, starting in 2007, Lentz, an older, peripatetic family practice
physician, opened a clinic specializing in diagnosing and treating certain
infectious diseases, based on his having taken a few seminars. As a consequence,
his patients were diagnosed with diseases they did not have by any credible
assessment of their symptoms, using unvalidated tests that plainly stated they
were not for diagnostic purposes, and subjected to expensive, ineffective,
painful, and possibly dangerous treatments. This went on for almost a decade
before the state medical board revoked his license, thus assuring (barring
overturning the Board’s decision on appeal) that he will never have this
opportunity again.

Yet, because of pressure from misinformed advocacy groups and physicians who
eschew science, these appalling practices are being put beyond the reach of the 
authorities. Had Florida a law like, for example, New York’s, which greatly
inhibits the medical board from taking action against “Lyme literate”
physicians, Lentz might well be exonerated. Something is wrong with this system.

Another “Chronic Lyme” VIP disciplined by NY medical authorities: Bernard Raxlen

Another “Lyme literate” NY physician is on probation and under orders to clean
up his act. Will other physicians treating “chronic Lyme” take note?

Jann Bellamy on November 9, 2017

Link



Bernard Raxlen, MD, who devotes more than 90% of his practice to the treatment
of so-called “chronic Lyme” disease, is on a three-year probation imposed by the
New York State Board for Professional Medical Conduct (BPMC). Raxlen agreed to 
probation and a lengthy list of practice requirements last month following
allegations, filed in September, of negligence, incompetence, gross negligence, 
gross incompetence, and failure to maintain adequate patient records. In doing
so, he becomes the second “Lyme literate” VIP disciplined by the NY medical
authorities this year. Based on similar charges of professional misconduct,
David Cameron, MD, was also put on probation with numerous practice restrictions
in June.

Who is Bernard Raxlen, MD?

Raxlen is a psychiatrist and solo “chronic Lyme” practitioner in New York City
who says he’s “successfully treated” over 3,500 cases of tick-borne disease in
the past 15 years. (He named his practice “Lyme Resource Medical of New York.”) 
He touts a “total comprehensive treatment program which utilizes both oral and
intravenous (IV) antibiotic treatment.” It doesn’t come cheap, either. An
initial visit with Raxlen costs $1,200 with follow-up visits between $600 and
$700. A PICC-line insertion (presumably for long-term antibiotics) is $750 and a
“nutritional IV” is $150. He does not accept public or private insurance.

Raxlen has a history of disciplinary actions against him in two states
stretching back almost 20 years. In Connecticut, where he was formerly licensed,
he was reprimanded and paid a total of $35,000 in civil penalties in two cases 
arising out of his refusal to provide patient records to the Health Department
and insurance companies, even though patients had signed releases. He was also
disciplined for inappropriate prescribing and failing to maintain malpractice
insurance. Because these infractions constituted professional misconduct in New 
York as well, he was subject to two disciplinary actions in that state,
resulting in censure, reprimand and a $2,500 fine.

According to the Chicago Tribune, Raxlen had other professional misconduct
charges brought against him by Connecticut authorities but they were ultimately 
dropped. The Tribune reported that, in one case, Raxlen was charged with telling
a patient with Lou Gehrig’s disease (ALS) that she had Lyme disease and
treating her with an illegal drug from Germany. He told the reporter that the
relationship between ALS and Lyme was “unclear,” even though ALS experts
concluded that there was no evidence of a connection.

Per his New York State Department of Health physician profile (just type his
name into the search engine), Raxlen completed residency training in psychiatry 
and lists his specialty as psychiatry, but he is not board certified in any
specialty. He did not train in internal medicine, family medicine or pediatrics 
(although he treats pediatric patients), specialties that normally treat routine
Lyme infections. Nor did he train in infectious diseases, experts to whom
patients with more complicated cases of Lyme would normally be referred by other
practitioners.

Yet, he is described by the International Lyme and Associated Disease Society
(ILADS) as a “leader in Lyme disease treatment and research.” In fact, he is a
founding member of ILADS, former Secretary of the Board, and has taught a number
of ILADS courses. He was a co-author of the original ILADS guidelines for the
treatment of tick-borne diseases. Despite their troubling disciplinary status,
both he and David Cameron are scheduled to speak at the ILADS Annual Scientific 
Conference, which starts today in Boston.

How can this be? How can one be a leading light in ILADS with a disciplinary
history like Raxlen’s and no graduate medical education in infectious diseases?

“Lyme literate” physicians like Raxlen have fabricated a disease they call
“chronic Lyme,” which they regularly “diagnose” and treat with long-term
antibiotics, sometimes for months to years. Board-certified infectious diseases 
doctors and other “conventional” physicians all agree that “chronic Lyme” is not
a valid diagnosis and rely on well-conducted trials showing that long-term
antibiotics do not substantially improve the outcome for patients diagnosed with
so-called “chronic Lyme.” Long-term antibiotics can, in fact, result in serious
harm, including death, a subject our good friend Orac covered recently over on 
Respectful Insolence. Orac’s post nicely summarizes the differences between real
Lyme disease and “chronic Lyme,” “a prototypical fake medical diagnosis,” and
the dangers of long-term antibiotics, as have posts on SBM, here, here, here,
and here.

The CDC, the Infectious Diseases Society of America (IDSA), the American Academy
of Pediatrics, the American College of Physicians, the Medical Letter and the
American Academy of Neurology all reject the notion that “chronic Lyme” exists
and that long-term antibiotics are an appropriate treatment. There is something 
called “post-treatment Lyme disease syndrome,” but responsible medical
authorities do not equate this syndrome with the nebulous symptoms and
unvalidated lab tests of “chronic Lyme” and specifically reject the utility
long-term antibiotic treatment based on well-conducted clinical trials. None of 
this is to say that patients who’ve been told they have “chronic Lyme” are not
truly suffering, a fact that makes “Lyme literate” practices all the more
reprehensible.

None of this stopped “Lyme literate” doctors from banding together to form ILADS
and issuing their own guidelines for the diagnosis and treatment of “chronic
Lyme,” guidelines based on very low levels of evidence that are accepted only by
themselves and, in contrast to the IDSA guidelines, no other professional
medical organization. ILADS teaches physicians and other practitioners how to
become “Lyme literate.” ILADS, again in contrast to IDSA, is not an
ACCME-accredited provider of continuing medical education although, for some
inexplicable reason, the Westchester [County, NY] Medical Society has teamed up 
with ILADS and is using its accrediting authority to grant CME credit for some
of the talks (also here) at the ILADS Scientific Conference.

Despite the lack of evidence that “chronic Lyme” is a valid diagnosis, and the
lack of efficacy as well as the risks of long-term antibiotic treatment, ILADS
healthcare providers currently treat more than 100,000 patients with “chronic
Lyme” and tick-borne diseases in the USA and around the world. Given media
reports that patients can spend $10,000 to $35,000 for treatment, “Lyme
literacy” translates into millions of dollars for practitioners.

While it may be profitable, “Lyme literate” doctors risk running afoul of state 
medical boards. Raxlen is just one among ILADS-trained, “Lyme literate”
physicians who have had their medical practices questioned by their peers, up to
and including discipline imposed by state authorities (also, here and here).

With that background, let’s look at the allegations against Raxlen and the terms
of his probation.

The BPMC v. Raxlen

New York’s medical misconduct procedures do not require the physician charged to
stipulate to any particular acts of misconduct as a condition of settling his
case. The physician can, as Raxlen did here, simply state he is unable to
“successfully defend against at least one of the acts of misconduct alleged” and
agree to the imposition of sanctions. This means the allegations in the state’s
Statement of Charges were never proven, as it was unnecessary to reach a
decision on the factual issues once Raxlen agreed to a settlement. However, per 
the Office of Professional Medical Conduct’s (OPMC) standard procedures, the
allegations were based on expert review of Raxlen’s patients’ records and they
remain uncontested by him.

The allegations of misconduct arise out of Raxlen’s care of eight patients. As
is typical of “chronic Lyme” diagnosis and treatment, patients (whose identities
are protected) presented with a variety of disparate symptoms, such as:

  1. Patient A: freezing, burning, air hunger, weakness, fatigue, neck pain and
    intestinal pain.

  2. Patient E: fatigue, migraines, neck pain, joint pain, numbness and tingling,
    irritability, sound, light and temperature sensitivity and nonrestorative
    sleep.

  3. Patient G: back pain, abdominal pain, feet pain, extremity weakness, anxiety, 
    depression and mood swings.

  4. Patient H (who got the Hickman catheter and numerous antibiotics mentioned
    below): mouth, teeth and jaw pain, confusion, forgetfulness, irritability
    and mood swings.

Diagnosis and treatment of “chronic Lyme” is never mentioned, a wise decision on
the part of the BPMC prosecutors in light of the ill-conceived New York law
protecting “Lyme literate” doctors from prosecution

   based solely upon the recommendation or provision of a treatment modality by 
   a licensee that is not universally accepted by the medical profession,
   including but not limited to, varying modalities used in the treatment of
   lyme disease and other tick-borne diseases.

Instead, the BPMC focused on the fact that Raxlen had failed in the most basic
tenets of good medical care, although the fingerprints of “chronic Lyme”
diagnosis and treatment, such as failure to consider alternative diagnoses,
prescribing IV antibiotics and using a Hickman catheter, are all over the
charges. The charges included:

  1. Repeatedly failing to perform or note in the patient’s chart a comprehensive
    history and appropriate physical exam, including (despite his being a
    psychiatrist) a psychiatric history, neuropsychological testing and mental
    health status exam.

  2. Failing to construct a differential diagnosis and pursue a thorough diagnostic
    evaluation prior to instituting a treatment plan.

  3. Inappropriate prescribing, including prescribing Rifampin for a patient on
    Tamoxifen and prescribing addictive medications prior to a making a
    diagnosis and without considering non-addictive treatment.

  4. Inappropriately relying on Applied Kinesiology (which is quackery) to
    formulate a diagnosis.

  5. Placement of a Hickman catheter without medical necessity.

  6. Inappropriately administering antibiotics, including intravenous Invanz,
    Clindamycin, Flagyl, Rifampin, Minocycline, Mepron, Plaquenil and Bactrim,
    all of these for one patient.

  7. Failure to present or note in the patient’s chart potential risks, benefits,
    side effects and safe use of prescribed medications.

  8. Failure to appropriately identify, address, and/or follow-up on potential side
    effects.

  9. Treating inappropriately with an ongoing and/or escalating medication regimen 
    without appropriate physical exams and clinical reassessment for
    consideration of alternative diagnoses and treatment.

  10. Poor record-keeping.

These allegations resulted in charges of negligence, incompetence, gross
negligence, gross incompetence, and failure to maintain adequate patient
records. As noted, Raxlen agreed to a three-year probation in addition to the
imposition of conditions on his practice. He must, among other things:

  1. Communicate to patients the nature of his medical role, whether it be a
    primary care physician responsible for the patient’s general medical
    condition, or for a defined or limited purpose, and/or as a practitioner of 
    a particular medical specialty.

  2. Obtain written informed consent addressing all aspects of treatment and
    document same, including documentation of all discussions with the patient
    about the nature and scope of his evaluation and treatment and the patient’s
    need to pursue “conventional medical care elsewhere.”

  3. Document all histories and physicals.

  4. Refer patients to primary care physicians, specialists or consultants for
    further evaluation and/or treatment where medically warranted and provide
    these physicians with all relevant patient information.

  5. Cooperate fully with the state in enforcing the Consent Order and timely
    respond to all state requests for written periodic verification of his
    compliance and all documents.

What now?

Based on a birthdate of 1938 in his state physician profile, Raxlen is either
already, or soon will be, 79 years old. One wonders whether he will continue his
practice in face of these new sanctions, although his website is still trying
to attract patients.

Sadly, the “chronic Lyme” lobby responsible for passing the law protecting “Lyme
literate” doctors has its sights set on even greater rewards. Several bills are
pending in the NY legislature which would force insurers to cover “chronic
Lyme” treatment (Assembly Bill 114, Senate Bill 4713, Senate Bill 670). Other
bills give them the opportunity to argue in yet another venue for insurance
coverage. (Assembly Bill 4863, Senate Bill 2168, Assembly Bill 6927).

In any event, it is commendable that the Board for Professional Medical Conduct 
has not let New York’s unfortunate law get in the way of its prosecuting
physicians who take advantage of patients with a diagnosis of “chronic Lyme,” no
matter how they frame the specific charges. With two leading NY “Lyme literate”
physicians now on probation and under strict orders to clean up their acts, it 
remains to be seen what effect this might have on other “Lyme literate” doctors 
in the state.

State Medical Boards should not recognize board certification in “Integrative
Medicine”

Integrative medicine is not a real specialty in medicine. Let’s not treat it as 
though it were.

Jann Bellamy on December 8, 2016

Link



There are a number of things about so-called “integrative medicine” (or, “IM”)
we don’t know, such as

  1. Whether IM really offers the best of conventional medicine and CAM.

  2. Whether IM produces better outcomes.

  3. Whether IM is effective in the area of prevention, including obesity and
    cardiovascular risk.

  4. Whether IM has anything to offer preventive medicine.

  5. Whether future IM research will yield beneficial results.

  6. Whether IM has a positive impact on utilization clinical preventive services, 
    smoking cessation, diet, and physical activity.

  7. Whether IM is cost effective.

We don’t even have a working definition of “integrative medicine,” although
experience tells us that incorporating diagnoses and treatments with
insufficient evidence of safety and effectiveness is an acceptable element of
integrative practice, as is rebranding “conventional” practices as
“integrative.”

Normally, these substantial deficiencies would get in the way of declaring that 
IM is anything like a real specialty in medicine. Indeed, as David Gorski has
pointed out, IM is more of a brand than a specialty. Yet, as we do know,
integrative medicine considers itself exempt from the rules. Thus, a few years
ago, Andrew Weil, MD, an early adopter in incorporating pseudoscience into
medical practice, announced his desire to create of a board certification in
integrative medicine. No doubt aware that IM couldn’t fulfill the requirements
of the American Board of Medical Specialties (ABMS), he turned to the American
Board of Physician Specialties (ABPS), whose requirements for Board recognition 
are more forgiving. For example, the ABPS is willing to credit work experience
as a prerequisite to board certification, as opposed to residency and fellowship
training. Sure enough, a few years ago, the ABPS formally accepted
board-certification in IM via the ABPS’s recognition of the American Board of
Integrative Medicine (ABOIM).

Board certification is not required for medical practice in any state. However, 
some hospitals and insurance companies do require it as a credential. State
medical boards, which regulate the practice of medicine in the U.S., also have
rules on which recognizing agencies they approve. The oldest (est. 1933) and
most prestigious is the American Board of Medical Specialties, whose 24 boards
and 147 subspecialties, covering 750,000-plus physicians, are universally
accepted by state medical boards, hospitals and health insurers. (Statistics are
from 2010.)

The American Board of Physician Specialties started its board recognition
program in 2005. In 2010, the ABPS recognized 16 certifying boards, representing
5,000 plus physicians. According to its website, there are now 20 boards
recognized by the ABPS. Some, like orthopedic surgery, family medicine, and
emergency medicine, have competing boards, one recognized by the ABMS and the
other recognized by the ABPS. Others, like urgent care and disaster medicine,
have only ABPS recognition. The ABPS has encountered some difficulties in
gaining state medical board approval as a recognizing agency, centered on the
lack of requirement of formal training in a specialty for board certification.
There is a third recognizing agency, the American Osteopathic Association, which
has 18 certifying boards representing about 25,000 osteopathic doctors. (Again,
2010 figures.)

Most, but not all, state medical boards, allow a physician to advertise an
ABPS-recognized board certification or are neutral on the subject. (California, 
for example, does not.) However, because the First Amendment protects truthful
advertising statements, as long as there is nothing misleading or false in
claiming board certification, state medical boards can’t prevent a physician
from stating he is board certified even if the recognizing agency doesn’t have
board approval, although some states, like Florida, require the physician to
post a disclaimer stating that the specialty certification is from a private
agency and is not one approved by the medical board.

Interestingly, there is nothing to prevent a medical board from approving some, 
but not all, of a recognizing agency’s board certifications. Thus, even in
states where ABPS boards are otherwise recognized, the state medical board could
refuse to recognize a particular board that did not meet its criteria. For
example, the Florida Board of Medicine has imposed additional requirements on
holding oneself out as a board-certified dermatologist, even though it
recognizes both the ABMS and ABPS, each of which has its own dermatology board
certification.

Because the American Board of Integrative Medicine has no publicly available
standards for board certification in IM, and, indeed, we don’t even know who
runs the ABOIM, state medical boards should not allow physicians to claim they
are board-certified in IM, at least without a disclaimer. From what little
information is publicly available about the ABOIM’s requirements, we can
conclude IM does not warrant state-sanctioned board certification.

Who controls the ABOIM and what are its standards?

In the first place, who are these people? The American Board of Physician
Specialties has a staff list, but does not reveal who its officers and directors
are. We are told that the ABPS is

   composed of the Chair of each of the governing specialty boards, the
   President, President-Elect and Secretary/Treasurer of AAPS [American
   Association of Physician Specialists] and up to two public members.

But we aren’t told who they are. We are also given this rather cryptic chart.

We know even less about the American Board of Integrative Medicine. According to
the ABPS website:

   Complete eligibility requirements, application and examination information
   are available at www.aboim.org.

But if you enter that URL you are simply directed back to the ABPS website.
Thus, we have no clue as to who is actually on the board of the ABOIM or who its
officers or staff members are.

We also learn from the ABPS that

   Each specialty board establishes its own standards although the ABPS oversees
   proposed changes in standards for appropriateness and adherence to standards
   to which all Boards must comply. All proposals by specialty boards regarding
   organization, structure and certification standards are first reviewed by
   the ABPS and then forwarded to the AAPS Board of Directors for final
   approval.

So, what are the ABOIM’s standards for organization, structure and
certification? We don’t know. Nothing on the ABPS website tells us.

Compare this to the American Board of Medical Specialties, which tells us not
only who is on its Board of Directors but also gives us links to all member
specialty board websites, each of which has information on governance and
standards.

Integrative Medicine is, until December 31, 2016, one of the ABPS-approved board
certifications which doesn’t require formal training, except for having
completed a medical residency, which can be in any specialty. Until a few days
ago, the deadline was December 1. However, the ABPS just announced that

   In response to the overwhelming interest for the ABOIM Limited Time
   Eligibility Option, ABPS has extended the deadline to submit applications to 
   the end of the month [Dec. 31, 2016].

The E-Z way to IM board certification will cost you another $200 in addition to 
the regular $750 fee, which was itself bumped up from the original $500 fee if
you waited until after Oct. 15 to apply.

Thus, for all its lip service about patient-centered care, holism, and the like,
physician specialists who rarely come in contact with an actual patient
(radiologists, pathologists) are nevertheless allowed to sit for the board exam 
in integrative medicine. All they need is to be board certified or board
eligible in anything, have a license to practice medicine, and rack up 500
points of “documented training and experience,” which has to include at least
one year of clinical experience in integrative medicine. Clinical experience is 
worth up to 250 points, depending on how long one had been practicing IM. The
rest can be gotten by taking continuing education courses.

Clinical practice can be documented with a couple of letters. One is to verify, 
from an independent source (like a partner or office manager), the number of
years the physician has been practicing IM. The other

   will be needed to document the integrative elements of the practice. This
   letter should be about 1-2 pages and should provide details about the
   integrative practices regularly used with patients.

(What we would give to see these letters!)

Apparently, there is some concern among potential applicants about just what
constitutes practicing integrative medicine for purposes of the point system.
After all, as best I can tell, there are no criteria provided for what does and 
does not count as IM for purposes of claiming that mantle via the E-Z route.
Given the fact that IM regularly purloins elements of “conventional” medicine
and just as regularly discounts evidence of effectiveness as a criterion, we
must imagine the list of what was acceptable as IM practice is quite liberal.
Nevertheless, this confusion called for guidance from ABPS, which, unhelpfully, 
basically tells applicants to take a stab at it and see what happens:

   Q: Can I submit documentation to ABPS staff to see if it qualifies as
   Integrative?

   A: Unfortunately, only the Board can judge if the eligibility criteria
   [whatever they might be] have been met. ABPS staff is happy to provide
   guidance based on previous board decisions. The Board will not “pre-screen”
   applicants or partial applications.

After December 31, the ABOIM will require an MD or DO to complete a “fellowship”
in IM unless he or she has also graduated from a naturopathic, chiropractic or 
oriental medical school, in which case he can go straight to the exam. You can
still be board-certified or board-eligible in any specialty. This presents some 
interesting possibilities. The following combinations would be eligible for
board certification under ABOIM rules:

  1. ND/DO with board certification in anesthesiology

  2. DC/MD with board certification in radiology

  3. MD with board certification in pathology who completes an IM residency

The many stylings of IM fellowships

As befits IM in general, which has yet to settle on the basics, the IM
fellowships listed on the ABPS website are an odd lot. (Come to think of it,
that’s yet another thing we don’t know about IM in medical education: costs and 
return on investment.) First, it appears there are no common admission
requirements. The Santa Rosa Family Medicine Residency and the University of
Michigan take only those who’ve completed family practice residencies. The
University of Arizona admits non-physician fellows: pharmacists, nurses and
physician assistants, and physicians from all specialties are admitted. As we
will see below, one fellowship program admits naturopaths, chiropractors and
traditional Chinese medicine practitioners along with MDs and DOs.

There is no core curriculum or standard format for an IM fellowship. Arizona has
a two-year “distance learning” IM fellowship. The University of Kansas IM
program follows the more traditional format of clinical education and research. 
Stamford Health requires both: completion of the Arizona program plus a 300-hour
acupuncture course as well as providing clinical care in a family medicine and 
an integrative clinic. The University of North Carolina has a fellowship in
research in integrative medicine. I couldn’t find that Ohio State University,
which is listed as having an IM fellowship program, offers one.

One program has a connection with questionable medical organizations. The George
Washington School of Medicine & Health Sciences Integrative Medicine program
advertises that it’s “curricula were developed in collaboration with the
Metabolic Medical Institute (MMI).” MMI also claims it is “educationally
associated” with George Washington, as well as the University of South Florida
Morsani College of Medicine, and the American Academy of Anti-Aging Medicine, or
“A4M” as it likes to call itself.

A4M is on Quackwatch’s list of questionable organizations. (More information on 
A4M here and here.) I contacted the University of South Florida by email,
inquiring about the claimed link between the A4M, MMI and the USF medical school
and providing links to relevant MMI and A4M websites. According to a USF Health
Communications representative:

   I asked the Vice Dean of our Morsani College of Medicine’s Graduate Medical
   Education program about this and he had never heard of it.

I sent the same email to George Washington University, whose rep said she would 
get back in touch with me, but never did.

MMI offers its own self-styled “fellowships” (offered to nutritionists and
chiropractors as well) in Metabolic & Nutritional Medicine, Integrative Cancer
Therapies (taught by a Florida physician who, according to information he
provided to the Florida Department of Health, is board-certified in emergency
medicine but does not have any education and training in oncology), and Stem
Cell Therapies (uh-oh). Perhaps taking a page from the chiropractic “diplomate” 
playbook, these “fellowships” are taught in hotel conference rooms.

The newest IM fellowship program, perhaps the apotheosis of the fetishization of
alternative medicine by IM proponents, is the Academy of Integrative Health &
Medicine Fellowship in Integrative Medicine and Health. The director is Tieraona
Low Dog, MD, formerly of Weil’s University of Arizona IM program. The assistant
director is a naturopath. The program’s “academic partner” is the Oregon
Collaborative for Integrative Medicine, which consists 5 schools, only one of
which has a medical school, Oregon Health & Science University. The rest teach
acupuncture and traditional Chinese medicine, chiropractic, and naturopathy. The
curriculum was developed in conjunction with the Academic Collaborative for
Integrative Health, an organization consisting solely of institutions devoted to
naturopathy, chiropractic, TCM and acupuncture. It is open to physicians,
naturopathic “physicians,” chiropractic “physicians,” TCM practitioners, and
acupuncturists, as well as assorted other health care professionals.

We are given only the most abbreviated information about the curriculum,
although we do know that it is mostly online. Faculty include “naturopathic
oncologist” Lise Alschuler, whose Arizona clinic offers quack treatments for
cancer and “detoxification” programs, and  Jeffrey Gladd, an MD who prescribes
“bioidentical hormones” and sells dietary supplements and other products to his 
patients. Mimi Guarneri, MD, whose LaJolla clinic offers biomat therapy, cranial
sacral therapy, and a “medical intuitive” course taught by a woman who also
teaches a course in speaking with the dead, is also on the faculty.

According to the AIHM,

   The AIHM Interprofessional Fellowship was unanimously approved by American
   Board of Integrative Medicine (ABOIM) committee in 2015.

If I were a medical board member considering whether to recognize board
certification in integrative medicine, I’d certainly want to know just who is
doing this approving and what their standards are.

Given the paucity of information available on IM board certification, state
boards might well want to look at what IM clinics affiliated with IM fellowship 
programs actually offer in the way of treatments. What they will find is an
array of pseudoscience and unproven interventions:

  1. Santa Rosa Family Medicine Residency: treatment of “adrenal fatigue“

  2. Middlesex Hospital (also here): reflexology and reiki

  3. University of Kansas Medical Center: IV high dose vitamin C,magnesium and
    glutathione

  4. Maine Medical Center: homeopathy

  5. Harvard’s Osher Center: cranial sacral therapy

  6. University of Michigan: anthroposophic medicine

  7. University of Wisconsin (also here): healing touch and heavy metal
    detoxification

One characteristic these IM fellowships do share is that none are accredited by 
the Accreditation Council for Graduate Medical Education (ACGME), which requires
compliance with published standards for faculty, program content, clinical and 
research requirements for participants, accountability, and oversight by
ACGME-approved institutions, among other means of assuring a quality program.

Conclusion: Definitely cause for concern

State medical boards should be deeply concerned about recognizing a board
certification in an ill-defined “specialty” run by unidentified parties with no 
published standards. Those standards, whatever they may be, are apparently loose
enough to allow physicians to simply summarize their practices in a page or two
and take CME courses to qualify for the board exam. Or, as of January 1, 2017, 
complete on-line, unaccredited fellowships offered, in some cases, by
organizations of dubious educational provenance. This is the system that brought
us Kenneth Woliner, MD, board certified integrative physician, who recently had
his medical license revoked by the Florida Board of Medicine after a patient
under his care died from untreated cancer. Woliner asserted before the Board
that there is a distinct standard of care for integrative medicine
practitioners, one that absolved him of the patient’s death. Woliner’s case
should serve as a cautionary tale for all medical boards.

Is there a distinct standard of care for “integrative” physicians? The Woliner
case

We at SBM argue that there should be a single, science-based standard of care in
medicine. Unfortunately, with the rise of “complementary and alternative
medicine” (CAM) also called “integrative medicine,” there is a separate standard
emerging that allows CAM practitioners to get away with using unproven and
disproven treatments. The case of Dr. Kenneth Woliner illustrates this problem.

Jann Bellamy on October 13, 2016

Link





Board certification in family medicine and “integrative” medicine: different
standards of care?

Florida Atlantic University student Stephanie Sofronsky was diagnosed with
Hodgkin’s lymphoma in 2011, after review of her case by oncologists and
pathologists at Moffitt Cancer Center in Tampa, the NIH/National Cancer
Institute, and the Mayo Clinic in Jacksonville. By June of that year, a PET scan
showed the cancer had progressed to her pelvic region. She decided to be
treated locally by oncologist Neal Rothschild, MD, and met with him to discuss
chemotherapy and ongoing management of her cancer. At this point, with Stage III
Hodgkin’s lymphoma, she had an 80-85% chance of being in complete remission
with appropriate treatment.

Unfortunately, at the same time, Sofronsky was also seeing Kenneth Woliner, MD, 
a family medicine practitioner. Despite the fact that world-renowned cancer
specialists agreed that Sofronsky had Hodgkin’s lymphoma, and knowing that she
was about to start chemotherapy, Dr. Woliner told Sofronsky that cancer was “low
on his list” of possible medical concerns and that increased lymphoctyes shown 
in her tests were not indicative of cancer, insinuating that oncologists “often 
overreact” to the presence of lymphocytes and recommend chemotherapy before
making an actual diagnosis. Dr. Woliner suggested instead that Sofronsky have
her house tested for mold, which could be causing allergies, and therefore her
symptoms. Convinced, Sofronsky pursued treatment for her allergies and cancelled
her follow-up appointment with Dr. Rothschild.

Sofronsky complained repeatedly to Dr. Woliner of symptoms that were, as our
good friend Orac points out, consistent with progressing lymphoma – back pain
and pain and swelling in her lymph nodes, abdomen and legs, to the point of
having to use a cane. Yet, Dr. Woliner, over the next couple of years, continued
to attribute her symptoms mostly to her allergies and also thyroid issues and
some other minor illnesses. On February 7, 2013, at her last visit to his office
and in significant distress from pain and severe leg swelling, he ordered a 100
mg shot of iron, despite the fact that her blood tests showed she was not iron 
deficient. She rapidly decompensated and died in the hospital three days later
of from complications of untreated Hodgkin’s lymphoma.

In 2015, the Florida Department of Health filed a complaint against Dr. Woliner 
alleging medical malpractice, failure to keep legible medical records,
exploiting a patient for financial gain, and accepting or performing the
professional responsibilities of an oncologist that he knew, or should know, he 
was not competent to perform. A hearing was held before an Administrative Law
Judge (ALJ) in February of this year. The ALJ issued a Recommended Order in
April, and, based on the facts she found, some of which I’ve set out above, she 
concluded:

1. Dr. Woliner fell below the standard of care in treating Sofronsky, by failing to
timely refer her to an oncologist, educating and counseling her on the risks,
including death, of not treating her cancer, and by failing to appropriately
attribute her symptoms to her lymphoma.

2. He failed to keep legible medical records providing an adequate medical
justification for his diagnoses and treatments.

3. He exercised influence over his patient in such a manner as to exploit her for
financial gain by scheduling appointments, selling and administering drugs, and 
obtaining blood work when he knew or should know that none of these would
reasonably alter her medical condition, treatment or life expectancy.

4. He practiced beyond the scope permitted by law by minimizing, if not outright
rejecting, Sofronsky’s diagnosis of Hodgkin’s lymphoma, because he is not an
oncologist nor was he qualified to give any advice regarding treatment of her
cancer.

The ALJ recommends that his medical license be revoked, a $16,000 fine, and
repayment of the money Sofronsky paid him to her estate as well as the state’s
costs of prosecuting the case. The Florida Board of Medicine will make the final
decision, although it has very limited legal authority to reject the ALJ’s
findings of fact. It can, however, independently decide all legal issues,
including the penalties.

The standard of care for “integrative” medicine, if any?

Given my interest in the intersection of science-based medicine and the law (or,
more usually, the lack of intersection), I find one of the defenses presented
by Dr. Woliner particularly fascinating. He argues that, even though he is
Board-Certified in family practice, he is an “integrative” physician and, as
such, is not held to the same standard of care as a “conventional” doctor.

And integrative he is. Dr. Woliner’s website, which advertises his board
certification in family practice and calls itself “Holistic Family Practice,”
also notes he is Board Certified in Integrative Medicine, certified by the
American Board of Integrative Holistic Medicine, and certified in Functional
Medicine. He sells patients Metagenics-brand dietary supplements and his website
has an online store. His specialty list includes candida, thyroid conditions
(even though he is not an endocrinologist or an ENT), food allergies (even
though he is not an allergist) and “bioidentical hormones” (a marketing, not a
medical, term). If you click on any of these headings expecting to find more
information on the topic, you won’t. Instead, you’ll find anecdotes describing
cases in which Dr. Woliner was able to figure out what was really wrong with the
patient and how he successfully treated that condition, usually after other
doctors had failed.

Woliner’s charming anecdotes are a perfect lesson in how unsuccessful cases are 
excluded from testimonials, one reason they are worthless as evidence of safety 
and effectiveness.

I imagine he won’t be adding the Sofronsky case to his list. You’ll also not
find, under “Thyroid Conditions,” his 2005 settlement with the Board of
Medicine, in which he admitted he had, among other things:

1. diagnosed a patient with Hashimoto’s thyroiditis who had no indication thereof
clinically or biochemically,

2. diagnosed the patient with adrenal insufficiency who showed no biochemical
indication,

3. overdosed the patient on thyroid medication, making him hyperthyroid, and

4. failed to consult with an endocrinologist instead of “treating conditions that
did not exist.”

Ironically, as part of his settlement with the Board, he was required to take a 
course on keeping adequate medical records.

The Department of Health presented two expert witnesses at the hearing. One, an 
oncologist, testified to the scope of practice of oncology, which was necessary 
to establish that Dr. Woliner practiced outside of his, whether it be family
practice or integrative medicine. The other, a board-certified family practice
doctor, testified to the standard of care for that specialty, and that Dr.
Woliner fell below it.

Dr. Woliner argues that neither expert’s testimony should be admitted because,
as an integrative physician, only a “qualified” integrative physician can
testify to the appropriate standard of care. For Dr. Woliner, that expert is
Stephen Silver, MD, a Boca Raton doctor, who, interestingly, does not claim on
his website (“HealthSmart MD: Private Family Medicine and Medi-Spa”) that he is 
an integrative specialist and actually says he follows the same standard of care
as the traditional medical community. However, he does offer, among other
services, “anti-aging” medicine, IV vitamins, and medical astrology. As he, um, 
explains,

   Astrological Medical and Psychological constitution are determined at birth, 
   affording a skilled Medical Astrologer a valuable tool when diagnosing and
   treating patients. . . . A Natal Chart is constructed utilizing your
   birthday, birth time (call mom) and birth location. Astrological Philosophy
   states that each soul incarnates at a precise time and in a precise place to 
   best predispose the native to fulfill his/her life purpose. This chart
   describes in accurate detail the twelve (12) spheres of mundane (earth) life 
   and your basic drives and motivations in these areas . . . I use the natal
   chart as invaluable tool to better understand myself, my patients and the
   energy flow between people. I am delighted to perform an Astrological chart
   analysis and profile upon request . . . The Astrological Signs and Planets
   are correlated with the anatomy, physiology and disease potential of the
   human body and provide an excellent basis for “Energy Medicine”.

Because, when your medical license is at stake and you need an expert to testify
on the standard of care for integrative medicine, you call only the best. I
wonder what the standard of care is for medical astrology?

Unfortunately, while the transcript of the hearing and many other documents are 
available online (although excruciatingly hard to find; hint: see pages
8900-10592) from the Board of Medicine, Dr. Silver’s testimony (submitted by
deposition) is not included for reasons that are unclear. However, from the
ALJ’s Recommended Order we learn that Dr. Silver opined Dr. Woliner’s role was
that of an out-of-network, adjunct holistic doctor,

   more comparable to an acupuncturist or a Reiki specialist than a medical
   doctor . . . [and] suggested that Respondent should not be held to the same
   standard of as other family medicine doctors providing primary care services.

In other words, an integrative physician has no duty to refer a patient with
cancer to an oncologist, no duty to explain to her the grave consequences of her
decision to forego chemotherapy, no duty to correctly attribute her symptoms to
Hodgkin’s lymphoma. Doesn’t say much for integrative medicine doctors, does it?

The ALJ ultimately rejected Dr. Silver’s assertion that a different standard of 
care should apply, as well as Dr. Woliner’s claim that he wasn’t acting as
Sofronsky’s PCP, which she found “specious.” In response to Dr. Woliner taking
exception to the ALJ’s determination, the Department of Health notes, correctly,
that Dr. Silver never said what this purportedly different standard actually
was.

It is ironic that a physician with Dr. Woliner’s disdain for “conventional”
medicine would argue that he is somehow held to a lower standard of care than a 
conventional physician. (I realize he doesn’t explicitly argue that the standard
is lower, but that is in essence what he is saying.) Here’s what he has to say 
about you “traditional” doctors in an issue of Aventura, a local “lifestyle”
magazine:

   What is different about holistic medicine from traditional medicine?Holistic 
   medicine requires the assessment of the whole person, body, mind and spirit, 
   in the quest for optimal health and wellness. While traditional allopathic
   medicine often relies on looking at individual symptoms and covering up those
   symptoms with prescription drugs, a holistic approach looks for functional
   imbalances and seeks to treat the underlying causes of illness.

As Harriet Hall, MD, said, “this stupid CAM mantra is a vile, false accusation,”
and it is a dangerous one too. Dr. Woliner’s smug attitude about “conventional”
medicine led him in both this case and his previous run-in with the Board of
Medicine to reject the superior education and training of specialists in two
complex fields, oncology and endocrinology, in favor of his own supposed
expertise as an “integrative” physician. He even used the “if the only tool you 
have is a hammer” analogy with Sofronsky’s mom when describing oncologists. Yet,
he was so blinded by that pet all-purpose bugaboo of integrative medicine –
allergies – that he kept insisting that her obvious symptoms of spreading cancer
were caused by them.

Not a different standard – a lower standard

Integrative medicine gives a physician permission to lower the standard for
evidence of safety and effectiveness. After all, alternative medicine that’s
been proven to work is just medicine. But, it is not only in their employment of
quackery that integrative physicians are a menace to patients, it is this
disdain for conventional medicine too. That disdain came through loud and clear 
in Dr. Woliner’s testimony, where he defined “mainstream medicine” as
“patentable drugs and surgery.”

In one final, sad irony, here’s what Dr. Woliner says on his website about “the 
ideal candidate for holistic medicine”

   Anyone who is interested in actually fixing the cause of their medical
   problems, rather than merely attempting to cover up symptoms, is the ideal
   candidate for holistic medicine.

Chemotherapy had a great chance of “fixing” Sofronsky’s “medical problems” but
that chance was squandered on “holistic medicine.” I hope the Board of Medicine 
accepts the ALJ’s recommended penalty and revokes Kenneth Woliner’s medical
license. He shouldn’t get a third chance to choose arrogance over “conventional”
medical treatment for his patients.

“Fauci Files” and Florida’s Grand Jury Investigations Fail to Deliver

Although multiple antivaccine investigations have failed to deliver any
substantive evidence of alleged crimes, the latest antivax flops won’t flip
anyone.

Mallory Harris on June 13, 2024

Link



In the past few months, multiple anti-vaccine investigations have unsurprisingly
failed to produce any substantive evidence of alleged crimes warranting massive
tribunals. In response, one might expect conspiracy theorists to come to the
realization that maybe Covid-19 vaccines weren’t actually a mass depopulation
plot and stop calling for public hangings. Unfortunately, I don’t see that
happening anytime soon. To understand why, I unfortunately think we need to
return to Hillary Clinton’s emails.

A bit of history

In the weeks leading up to the 2016 Presidential election, WikiLeaks began
publishing emails from the hacked email account of John Podesta, Hillary
Clinton’s campaign chair. To be sure, those emails shed light on some shady
aspects of Clinton’s charitable foundation, her ties to big money, and her
candidate’s operations. Yet for those who believe that she is a cold-blooded
reptilian who orders executions of her political enemies and  drinks children’s 
blood to maintain her youthful vibrancy, the emails at first appeared
underwhelming.

A lot of the emails centered around boring logistics: Podesta making plans to
pick up his wife’s prescriptions, giving cooking advice to his co-workers,
meeting up with his brother for dinner, and getting invited to fundraisers. The 
latter two emails happened to involve pizza, including mention of the
now-infamous restaurant “Comet Ping Pong Pizza.” And so the Pizzagate conspiracy
theory was born. In brief, adherents believed that every mention of cheese
pizza in the emails was code for child pornography and Comet Ping Pong Pizza was
actually hosting Satantic ritual abuse of children in its basement. This all,
of course, culminated in an armed man showing up at the pizzeria to liberate the
kids from the basement. But there was no abuse, no pornography, and no
imprisoned kids; in fact, there wasn’t even a basement.

All this is to say that conspiracy communities do not necessarily need evidence 
for their claims. In fact, the very lack of evidence can often be the most
galvanizing. They thrive on the idea of secret knowledge and investigations, but
are not necessarily interested in what the resulting documents actually look
like. And lately, leaders of anti-vaccine and Covid conspiracy theory movements 
have really been failing to deliver results, yet their followers don’t seem to
care that their bold promises of future revelations keep falling flat.

The “Fauci Files”

One of my favorite examples in this genre was the release of the “Fauci Files,” 
a subplot of the larger “Twitter Files” manufactured news cycle. For those
unaware, the Twitter Files consisted of Elon Musk giving a group of people
access to internal documents on Twitter prior to his purchase of the company,
which they then proceeded to misread and misrepresent in long threads. In
December of 2022, Musk began to promote the forthcoming release of an
installment focused on former NIAID Director Anthony Fauci.

The project ran into a few hiccups, with Musk stating a month later that it had 
to be delayed because a “key researcher can only travel to Twitter in early
Feb.” But surely it would be worth the wait. After all, Musk at the time implied
that legal action should be pursued against Dr. Fauci. A case (Murthy v.
Missouri) was also working itself up to the Supreme Court alleging that the
government, including Dr. Fauci specifically, was running a massive censorship
regime to oppress oppositional voices on Twitter. So, to reiterate, the stakes
were extremely high to give us something good.

Here’s what “key researcher” Paul Thacker finally came up with in April, four
months and two trips to Twitter later:

The Epoch Times took this as evidence that Dr. Fauci lied under oath, quoting
Great Barrington Declaration co-author and Murthy v. Missouri plaintiff Martin
Kulldorff who called this finding “explosive.” As someone who has helped run
social media accounts for several organizations and individuals, I found this
quite amusing. Please don’t tell them about all of the times that Nancy Pelosi
has texted me to ask for a donation while she was simultaneously on the floor of
the House giving a speech. Or the time that Herman Cain posted a tweet
downplaying the dangers of COVID-19 12 days after he died of it. And, even if
Dr. Fauci did help draft a couple of tweets, pointing that out does nothing to
establish his alleged involvement in a mass social media censorship campaign
(again, a key claim in a case that was recently heard by the United States
Supreme Court).

It is unclear to me why Thacker needed to travel to Twitter to find this
publicly available information, although maybe he needed multiple visits to
uncover this one email from a former Twitter employee where she says something
positive about Dr. Fauci.

Incidentally, Musk stated a full week prior to the Fauci Files’ release that it 
was time to “move on” from the Twitter Files as “there’s not a lot…that’s left,”
so users like @pepedownunder and @TruthWarrior_77 may be excused for missing
the Fauci Files’ publication and inquiring about them a full nine months after
their release.

Florida Man

And it’s not just Musk’s coterie overhyping an imminent epic reveal of public
health malfeasance and then (much more quietly) coming back months or years
later with nothing to show for it. Around the same time that Musk was teasing
the Fauci Files, Florida Governor Ron DeSantis announced that he was calling for
a grand jury to “investigate crimes and wrongdoing committed against Floridians
related to the COVID-19 vaccine.”

Fourteen months later, the Grand Jury released its first report, a 33-page
document that includes “vaccine” and related words exactly 29 times:

1. 21 times in the introduction, to explain the charge of the grand jury and how it
examined whether there was “criminal activity or wrongdoing” with respect to
COVID-19 vaccines

2. 2 times to explain assumptions underlying mathematical SIR models of disease
transmission and note that COVID-19 vaccines may be assumed to both reduce
susceptibility and risk of severe disease

3. 2 times to highlight how some nonpharmaceutical interventions disrupted
administration of international vaccination programs against diseases like
measles

4. 3 times to discuss the CDC’s changing guidelines about masking (in response to
new data about infection and transmission amongst vaccinated people as the delta
variant began to spread)

5. 1 time in the conclusion, to note that “[t]here is a case to be made
that…lockdowns enabled others in high-risk groups to ‘bridge the gap’ until 2021
when they had access to vaccines.” Notably, this claim (which the report
suggests the Grand Jury may follow up on at a later date) would mean that both
lockdowns and vaccines helped to save lives in Florida.

Everything else in this report is pointedly not about vaccines: It rehashes old 
grievances about shelter-in-place orders, masks, and other nonpharmaceutical
interventions. Even those who agree with the gist of this report (that COVID-19 
wasn’t as deadly as they said and that the measures implemented to prevent its
spread were not worth their costs) should agree that it doesn’t remotely address
the particular concerns that Governor DeSantis seemed to think it would. To be 
fair, the grand jury is expected to make multiple reports and has requested an
extension through the end of this year to complete their investigation, so they 
may just be waiting on those to get to the alleged mass criminal conspiracy.

But it does seem worth comparing this pretty weak showing to Florida grand jury 
reports on, for example, the Parkland shooting (which called for the removal of 
four members of Broward County school board members) or federal immigration
policies (which concluded that crimes were being “enabled by government
agencies”). Even the 2006 grand jury investigation into Jeffrey Epstein, which
culminated in a plea deal that has been panned as “completely unprecedented” in 
its leniency, led to a prostitution charge.

Much ado about nothing

In this case, we’re talking about the (purported) crime of the century, ranging 
from fraud that killed millions to the most egregious case of governmental
censorship in US history. One of the richest men in the world gave internal
company documents to his idea of a top investigative journalist and the Governor
of one of the most populous states deployed state resources — all to get to the
bottom of this. And there is still nothing.

As someone who always believed these theories were a load of hogwash, I may be
biased, but I find the anti-climactic outcomes of these investigations to be
pretty compelling evidence that there is no there there. Still, the absence of
evidence isn’t evidence of absence. I think there are two other explanations
that adherents to anti-vaccine conspiracy theories are likely to gravitate
toward.

The first is that the grand jury and Fauci Files flopped because the folks
involved didn’t do a good enough job. In fact, David Gorski of Science-Based
Medicine has pointed out that Musk’s hand-picked journalist has a history of
errors. At least one Covid conspiracy theorist, Trump HHS science advisor Paul
Alexander, was thinking along these lines when he republished a Substack post
calling the Florida grand jury “a grift, a clown show, which was set to
fundraise off ‘health freedom’ sentiment for [Desantis’] political run.”
(Alexander added his own commentary involving something about “moma [sic] breast
milk teat suckers”). So here is one thing that Alexander and I agree on: The
influencers in the Covid conspiracy movement do not deserve your money and do
not have your best interests at heart. But I also think that won’t be the
takeaway for their biggest fans.

The other option is one that can keep the conspiracy alive and keep powering its
influencers: Maybe the people behind these crimes are just too good at covering
everything up. After all, the grand jury report notes that the CDC, FDA, and US
Army all declined to participate in the proceedings. So we need to keep
digging, and we need you to keep doing your part at home. Members of the
anti-vaccine community can stay engaged and connected with one another as they
trade theories to fill in the (numerous) evidentiary gaps.

Keeping it real

Like the doomsday cult members who double down when the clock hits 12:01 and the
flood is nowhere to be seen, true believers will only become more convinced
when combing over Thacker’s thread or skimming the findings out of Florida, if
they even saw those. Even so, it’s important that we follow up as anti-vaccine
investigations continue to fall apart — especially when they were publicized
prior to any findings being released by mainstream news outlets, with little to 
no coverage of their laughably null and irrelevant conclusions. It’s also
important to remain clear-eyed that the latest flops from the anti-vaccine
movement likely will not change many minds. In fact, they may just strengthen
existing convictions that were never based on evidence in the first place.

Government watchdog to investigate politicization of CDC and FDA during COVID-19
pandemic

Based on numerous reports of White House interference, a government watchdog
will investigate politicization of the CDC’s and FDA’s actions during the
coronavirus pandemic.

Jann Bellamy on October 22, 2020

Link



The Government Accountability Office (GAO) announced last week that it would
review whether the CDC’s and FDA’s scientific integrity and communications
policies have been violated, as well as whether those policies are being
properly implemented to assure scientific integrity throughout the agencies. The
review is being conducted at the request of several U.S. Senators “in light of 
public reports that the Trump Administration has improperly exerted political
influence on the CDC and FDA” since the onset of the COVID-19 pandemic.

As Senators Elizabeth Warren (D-MA), Gary Peters (D-Mich), and Patty Murray
(D-WA), told the GAO in their request:

   The CDC’s and FDA’s independence as scientific agencies is crucial to
   safeguarding the public health and saving lives. These agencies must be able 
   to develop, review, and disseminate public health data, guidelines, and other
   information that are based on science, facts, and medical principles – not
   the political imperatives and moods of a president and his advisors.

Yet, they charge that

   the Trump Administration has reportedly pressured the CDC and FDA throughout 
   the COVID-19 pandemic, repeatedly applying political pressure and imposing
   orders on career scientists that undermine the agencies’ credibility and
   independence.

Citing reports from major media organizations, agency announcements, and Mr.
Trump’s Twitter account, the Senators’ letter catalogued numerous instances of
putative political interference in CDC and FDA decision-making, interference
they say “seeds confusion, erodes public confidence, and diminishes the
agencies’ credibility”. (SBM’s David Gorski lamented this erosion of trust in a 
recent post, “In the age of COVID-19 pandemic, can we trust the CDC and FDA
anymore?“, citing a number of the same public reports relied upon by the
Senators in their request to the GAO.)

Offenses against scientific integrity on the Senators’ list include:

  1. The White House’s allegedly overruling CDC officials who wanted to recommend, 
    in March, that elderly and physically fragile people not fly on commercial
    airlines due to the coronavirus.

  2. Reported interference, in April, by Vice President Pence, and again by the
    White House this month, in an extension of the CDC’s “No Sail” order
    prohibiting cruise ship voyages, despite evidence that cruise ships have
    been a major source of outbreaks.

  3. The Department of Health and Human Services (HHS, of which the CDC and FDA are
    a part) political appointees’ reported “significant efforts to edit, water 
    down, and caveat CDC’s Morbidity and Mortality Weekly Reports”.

  4. In May, the White House’s blocking the publication of the CDC’s “Opening Up
    America Again Framework”, eventually published only after the White House
    required substantive changes.

  5. HHS officials accusing the CDC of “undermining the President” when it released
    information on pregnant women and COVID-19.

  6. HHS political appointees excoriating a CDC official for remarks she made about
    the U.S. needing to take its virus response seriously, accusing her of
    being “duplicitous” and undermining the President.

  7. In July, the White House ordering the CDC to stop collecting certain COVID-19 
    data, “instead filtering the data through a third-party contractor at HHS”
    resulting in “significant issues with the quality, completeness, and
    transparency of data”. [Although it was not cited in the list, NPR has
    reported on apparent irregularities in HHS’s awarding the contract and the
    contractor’s financial connections to Mr. Trump.]

  8. Mr. Trump and Mr. Pence exerting “considerable public pressure on the CDC to
    revise its guidelines for schools”. This resulted in new guidance, which the
    White House reviewed and substantially edited.

  9. The appearance of “highly-criticized” testing recommendations for asymptomatic
    patients (since reversed) on the CDC website, not written by CDC scientists
    but dropped there by HHS, “flouting the agency’s strict scientific review
    process” and containing “elementary errors”.

  10. The FDA’s Emergency Use Authorization (EUA) for hydroxychloroquine (since
    revoked), a drug highly touted by Mr. Trump for COVID-19 but widely
    criticized for lack of quality evidence.

  11. In August, Director of the National Institute of Allergy and Infectious
    Diseases, Dr. Anthony Fauci, and National Institutes of Health head Dr.
    Francis Collins reportedly voiced concerns that data did not support the
    FDA’s EUA for convalescent plasma and the authorization was put on hold. Mr.
    Trump called Dr. Collins and told him to “get it done by Friday” and
    suggested to reporters that the FDA wanted to limit its use until after the 
    election. On August 23, the FDA issued an EUA for convalescent plasma.

  12. HHS Secretary Alex Azar allegedly overruling the FDA when he revoked the
    agency’s ability to regulate lab-developed diagnostic tests, including
    COVID-19 tests.

  13. In August, Mr. Trump made a “clearly spurious” claim that the “deep state” at 
    the FDA is delaying potential COVID-19 treatments and vaccines until after
    the election.

  14. After remarks by the lead career official in charge of FDA vaccine review
    suggested that the FDA’s forthcoming guidance will set a higher bar for a
    vaccine EUA, Mr. Trump said it “sounds like a political move” and that the
    White House “may or may not” approve the guidance. After a news report that 
    the White House had actually blocked the guidance, the Administration
    reversed course.

The review is grounded in the GAO’s jurisdiction to investigate and evaluate, at
the request of Congress, federal programs and activities, and provide
“information, analyses, options, recommendations, and other assistance to help
the Congress make effective policy, funding, and oversight decisions”. The GAO
has already issued three reports on the federal government’s response to the
pandemic, the most recent of which criticizes the CDC on an issue raised by the 
Senators’ letter — guidance on reopening schools:

   Portions of CDC’s guidance on reopening K-12 schools are inconsistent, and
   some federal guidance appears misaligned with CDC’s risk-based approach on
   school operating status. CDC should ensure that its federal guidance on
   reassessing schools’ operating status is cogent, clear, and internally
   consistent.

In this case, authority for the GAO review is grounded in the CDC’s and FDA’s
policies on scientific integrity and the premise that those policies are being
violated by the Trump Administration. According to the request, the CDC’s
“Guidance on Scientific Integrity” requires that CDC employees “affirm a
commitment to ensure that research and services are based on sound science, meet
real public needs, and help achieve public health goals” and states that the
“CDC has a responsibility to conduct the best science and is committed to
disseminating scientific findings and results without being influenced by policy
or political issues”. Likewise, according to the FDA’s policy on scientific
integrity, the agency promotes an environment where “scientific decisions are
protected from political influence”. The FDA policy requires “shielding the
agency’s science and its scientific staff from political influence” and
“maintaining a firm commitment to science-based, data-driven decision-making”
and is “committed to a culture of openness with the media and public that values
the free exchange of ideas, data and information”.

The GAO is asked to audit the implementation of these policies and “understand
the extent of any undue political influence at the CDC and FDA”, an issue which 
raises “a larger concern about independence of CDC, FDA, and other public health
agencies”. It is also asked to identify “current structures . . . in place at
these agencies to allow them to independently carry out their missions” and
recommend “additional structures or steps . . . to enhance the agencies’
abilities to independently carry out their missions, free from political
influence”.

The review will not happen quickly. According to the GAO, “the required skills
will be available to initiate an engagement in about three months”.

Interestingly, in a poll just out, 36% of respondents said they trusted health
officials’ COVID-19 information at agencies such as the CDC and FDA, with 26%
saying the same about their state or local governments. Sixteen percent trusted 
information from Mr. Trump “a great deal or quite a bit”.

Meanwhile, the revelations continue. A day before the GAO’s letter agreeing to
the review, Pro Publica published an extensive exposé of the CDC’s failures
during the coronavirus pandemic headlined “Inside the Fall of the CDC“. It
reports the White House’s rejection of the CDC’s guidance on reopening houses of
worship, including elimination of a warning about the dangers of singing. Part 
of the Administration’s meddling included a call from the Vice President to a
CDC infectious disease expert, telling him that the White House’s edits to the
guidance were not optional and the CDC’s failure to use them was
“insubordinate”.

On October 14, Science ran its own in-depth news report on plummeting confidence
in the CDC, titled “The inside story of how Trump’s COVID-19 coordinator [Dr.
Deborah Birx] undermined the world’s top health agency”, including the charge
from CDC insiders that Dr. Birx “flouted science and undermined the agency to
placate the president”. As well, CDC head Dr. Robert Redfield “has quietly
complied with many of the administration’s demands”.

According to Science, many CDC execs and professionals plan to leave the agency 
if Trump is re-elected as public confidence in the agency has eroded.

   In 2015, CDC was viewed favorably by 70% of the public, the highest for any
   agency measured. But in March, the percentage of the public that held a
   “great deal” of trust in CDC dropped to 46%. In September, it was only 19%.

Also last week, The Wall Street Journal [paywall] and Axios [free] reported that
an open letter from current and former CDC Epidemic Intelligence Officers,
first published in May, topped 1,000 signatures. The letter begins:

   We hereby express our concern about the ominous politicization and silencing 
   of the nation’s health protection agency during the ongoing COVID-19
   pandemic. In previous public health crises, CDC provided the best available
   information and straightforward recommendations directly to the public. It
   was widely respected for effectively synthesizing and applying scientific
   evidence from epidemiologists and biomedical researchers at CDC and
   worldwide. Its historic credibility was based on incomparable expertise and
   70+ years of institutional memory. That focus and organization is hardly
   recognizable today.

Saying the “absence of national leadership on COVID-19 is unprecedented and
dangerous”, the signatories “urgently call upon the American people to demand
and our nation’s leaders to allow CDC to resume its indispensable role”.

All of this was before Mr. Trump, this week, called Dr. Fauci a “disaster”,
claiming that people were “tired” of hearing about the virus from Fauci and
“these idiots, all these idiots who got it wrong” and complaining that Fauci
“loves being on television” and has made “a lot of bad calls”.

A GAO investigation into improper political influence at two of the nation’s top
scientific agencies may be the least of Mr. Trump’s worries, but hopefully it
will result in new safeguards against politicians meddling in science, part of a
larger effort to mend the guardrails of democracy this Administration has all
too easily blown through.


Note to Readers: If you are eager to learn more about the government’s COVID-19 
mismanagement you can follow along on American Oversight’s COVID-19 Oversight
Hub.

Is Australia’s Planned Vaping Ban A Good Idea?

Australia’s planned ban on recreational vaping has a solid base in current
evidence.

Steven Novella on May 3, 2023

Link



Australia plans to ban recreational vaping in a move designed to head off what
they fear is an industry that will get a new generation of young people addicted
to nicotine. Part of the justification for the ban is concern over the health
risks of vaping, or e-cigarettes, which use heat to turn a liquid into a vapor
which is then inhaled. Often the liquid contains nicotine and may also be
flavored, a practice critics argue is targeted at children.

Vaping was initially promoted as a safer alternative to smoking, and a way for
smokers to quit their nicotine addiction. But at the same time non-smokers have 
been taking up vaping. The Australian ban seeks to eliminate this latter path,
so-called recreational vaping, while making it easier for smokers to get
prescriptions for vaping as a method of quitting. Australia also seeks to
regulate the contents of vaping fluid, including nicotine content and flavoring.
There is also concern that a ban might simply turn users toward the black
market in vaping products.

Regardless of the ultimate regulatory strategy, what is the current evidence on 
the health effects of vaping? While there is concern that the evidence is still 
preliminary, there have been enough studies to spawn a number of systematic
reviews. A 2021 review – Vaping and lung cancer – A review of current data and
recommendations, found:

   E-cigarette devices and vaping fluids demonstrably contain a series of both
   definite and probable oncogens including nicotine derivatives (e.g.
   nitrosnornicotine, nitrosamine ketone), polycyclic aromatic hydrocarbons,
   heavy metals (including organometal compounds) and aldehydes/other complex
   organic compounds. These arise both as constituents of the e-liquid (with
   many aldehydes and other complex organics used as flavourings) and as a
   result of pyrolysis/complex organic reactions in the electronic cigarette
   device (including unequivocal carcinogens such as formaldehyde – formed from 
   pyrolysis of glycerol).

This study is essentially looking at hazard, the presence of known and possible 
cancer causing agents in vaping fluid. The reason to take this approach is that 
there is likely a 20 year delay between exposure and diagnosis with cancer, so
by the time there is clear evidence for an actual increase in lung cancer we
will already have a new generation addicted to vaping nicotine. But still, this 
kind of data has to be put into perspective – it is a hazard, a potential risk.

Because of this delay in terms of developing cancer, some studies focus on acute
or short term lung damage. A 2021 review of these studies, E-Cigarette or
Vaping Product-Associated Lung Injury: A Review, finds:

   Since March 2019, there has been an ongoing epidemic of acute lung injury
   secondary to the use of e-cigarettes, with over 2600 cases and 60 deaths
   reported all over the United States.

   A significant proportion of patients hospitalized with e-cigarette- or vaping
   product-associated lung injury have required admission in the intensive care
   unit, with mechanical ventilation needed in up to one-third of patients.

This acute injury is treatable, with generally (but not universally) good
outcomes, but the concern is that these acute lung injury cases are the tip of
the iceberg. They represent cases with symptomatic acute lung injury, which
raises the possibility of chronic, asymptomatic, or mildly symptomatic lung
injury. Again, this type of injury may take decades to fully appreciate.

Another 2022 review, Vaping-Associated Lung Injury: A Review, gives this
summary:

   Adolescents who use e-cigarettes commonly report an increased cough and
   wheeze, and studies have shown an association with e-cigarette use and asthma
   exacerbations. However, it is not yet clear if chronic e-cigarette use by
   itself can cause COPD in a clinical setting or if the substitution of
   e-cigarettes for combustible tobacco products can prevent or slow the
   development of COPD. There is also data to support a correlation between
   e-cigarette use and impaired host defence. It appears viral responses are
   compromised, and bacterial clearance by macrophages and neutrophils appears
   to be reduced. This allows increased adhesion and colonisation of bacteria
   and possibly an impaired infection-fighting ability.

A 2020 review,  A review of toxic effects of electronic cigarettes/vaping in
adolescents and young adults, also includes extrapulmonary effects.

   Additionally, there have been more recent studies showing extrapulmonary
   effects including cardiovascular, immunologic and neuro-developmental
   effects. Many of these effects are likely dose-dependent.

A 2021 review of studies looking at periodontal effects found:

   This study concluded that there is not enough evidence to fully characterize 
   the impacts of vaping on periodontitis. However, within the limitations of
   our review and the selected included studies, the available results point to 
   increased destruction of the periodontium leading to the development of the
   disease.

If we take a risk-vs-benefit approach to vaping, we can review the evidence of
whether or not it works as a smoking-cessation tool. From the 2022 review above:

   E-cigarette use has grown exponentially, particularly amongst adolescents.
   While they were originally marketed as a smoking cessation tool, evidence for
   a role in smoking cessation has been inconclusive. There is some evidence
   that nicotine-containing products may have a role in risk reduction for
   active smokers but, conversely, may encourage the initiation of cigarette
   smoking in non-smokers.

The evidence for benefit is mixed and unclear. Using vaping as a nicotine
delivery alternative does seem to help some smokers quit, but the number is low 
(18% in one study) with a high relapse rate, perhaps higher than other methods
of quitting. Meanwhile vaping leads some non-smoker to take up tobacco use, and 
some smokers become dual-users, with demonstrated increased toxicity. Therefore,
just in terms of smoking cessation, it is unclear if there is a net benefit to 
vaping, which likely means that there is no large benefit.

Meanwhile, vaping is leading to a dramatic increase in younger people taking up 
vaping directly. There is clear evidence at that point of toxicity, exposure to 
hazardous materials, acute lung injury, periodontal injury, and some
extrapulmonary effects. It is still unclear what the long term risks are,
because there simply hasn’t been enough time to see these effects and gather
that data. Also, as with smoking, we can’t ethically do a randomized controlled 
trial, so we must infer the risks from toxicity and epidemiological data.

The evidence clearly shows that we should not be complacent about the risks of
vaping. There is legitimate cause for concern about a product that is addictive,
may lead to more harmful behavior (smoking), and targeted toward children with 
sweet flavoring and attractive packaging, a practice that the evidence shows is 
clearly working. Whether or not Australia’s ban is effective or the best
approach, time will tell. But the justification is reasonable.

Medical debt vs. universal health insurance: The interface between SBM and
policy

This blog has long argued that the best medicine is science-based medicine
(SBM). The problem is that in the US SBM is often not accessible, except at
ruinous cost, which is why I argue that we have to broaden our definition of SBM
to include the systems that deliver it and pay for it.

David Gorski on June 20, 2022

Link



The name of this blog is Science-Based Medicine, because we seek to champion
medicine that is based on rigorous science as the safest and most effective
medicine. Before the pandemic, much of what we used to write about was the
infiltration of pseudoscientific medicine and medicine based far more on
prescientific or religious ideas than science, although common threads even
since the pandemic remain. These include, but are not limited to, the
antivaccine movement, COVID-19 minimization/denial (much like germ theory denial
that undergirds a lot of alternative medicine and antivaccine beliefs),
resistance to public health measures, and, of course, the promotion of quackery,
in the case of the pandemic (among many other things) the promotion of drugs
that were unproven but are now disproven as effective treatments for COVID-19;
i.e., ivermectin, hydroxychloroquine, and others.

However, there’s more to SBM than rigorous basic and clinical science, a
Bayesian approach to evaluating evidence that considers prior plausibility based
on basic science, randomized clinical trials, and epidemiology. The most
effective science-based treatments will do no good if they are not available to 
patients who need them, for whatever reason, and this is where, unavoidably,
social sciences and politics come in. I’ve long said that we at SBM are not
apolitical, although we do strive to be as nonpartisan as individuals can be
given their biases. After all, opposing the licensing of quacks, the continued
sale of homeopathic products without the requirement by the FDA that they
demonstrate safety and efficacy, and agreeing that physicians who spread medical
misinformation should face sanctions from state licensing boards (for example) 
are far from apolitical. In some cases they aren’t even nonpartisan, given how
it was prominent Democrats who championed the National Center for Complementary 
and Integrative Health (NCCIH) that we have long advocated dismantling, and
these days the Republican Party that is promoting resistance to public health
measures designed to mitigate the impact of the pandemic. That being said, SBM
will never be as effective in ameliorating human suffering if public policy
considerations are not taken into account and also based as much as possible in 
science. What that means is that SBM cannot—and I now argue, should not—avoid
social science and politics. Of course, as difficult as it is to deconstruct
antivaccine misinformation, various alternative medicine pseudoscience, and
false claims about COVID-19, I am well aware that looking at SBM at a more macro
level in which it interacts with society at large and its political and
economic systems adds even more complexity to the mix, but we do need to
consider these problems—and consider them more.

What got me thinking about these issues, which I had been meaning to bring up,
were two news reports about studies. I listened to one of these on NPR on the
way to work on Thursday morning, a story about how 100 million people in the US 
live with medical debt (based on the KFF Health Care Debt Survey) that also
featured brief stories about individuals who make up that figure. The second was
a series of stories about a study that concluded that single payer universal
health insurance (which we in the US still do not have, “Obamacare”
notwithstanding) could potentially have saved hundreds of thousands of lives
during the pandemic. Obviously, the two stories are related, because the cause
of so much medical debt in the US is clearly the lack of universal health
insurance. Many families who are uninsured or underinsured face financial
catastrophe.

Medical debt: Deferring or foregoing SBM due to financial constraints

While on my way to work last Thursday, I was flipping radio stations in my car
and landed on NPR, only to hear:

   Elizabeth Woodruff drained her retirement account and took on three jobs
   after she and her husband were sued for nearly $10,000 by the New York
   hospital where his infected leg was amputated.

   Ariane Buck, a young father in Arizona who sells health insurance, couldn’t
   make an appointment with his doctor for a dangerous intestinal infection
   because the office said he had outstanding bills.

   Allyson Ward and her husband loaded up credit cards, borrowed from relatives,
   and delayed repaying student loans after the premature birth of their twins 
   left them with $80,000 in debt. Ward, a nurse practitioner, took on extra
   nursing shifts, working days and nights.

   “I wanted to be a mom,” she said. “But we had to have the money.”

   The three are among more than 100 million people in America ― including 41%
   of adults ― beset by a health care system that is systematically pushing
   patients into debt on a mass scale, an investigation by KHN and NPR shows.

   The investigation reveals a problem that, despite new attention from the
   White House and Congress, is far more pervasive than previously reported.
   That is because much of the debt that patients accrue is hidden as credit
   card balances, loans from family, or payment plans to hospitals and other
   medical providers.

Again, SBM can do some truly amazing things and save lives that would have been 
lost even a couple of decades ago. However, it can’t help if people can’t afford
to access it, and it will be much less effective if people suffer such major
financial consequences for having accessed it.

The number is truly staggering, given that the poll found that in the past five 
years, more than half of US adults report they’ve gone into debt because of
medical or dental bills, with a quarter of people with health care debt owing
more than $5,000 and about one in five with any amount of debt said they don’t
expect ever to be able to pay it off. I’m sure that our European and Australian 
readers will facepalm at these findings, but they track. As the poll and news
story noted, even though the Affordable Care Act (ACA) did dramatically reduce
the percentage of Americans who are uninsured, an unfortunate problem with it is
that a lot of the health insurance policies sold in the ACA marketplaces have
high deductibles, making it very possible for less affluent people to go deeply 
into debt even though they ostensibly have health insurance. It’s the
deductibles that get them.

Worse:

   Perhaps most perversely, medical debt is blocking patients from care.

   About 1 in 7 people with debt said they’ve been denied access to a hospital, 
   doctor, or other provider because of unpaid bills, according to the poll. An 
   even greater share ― about two-thirds ― have put off care they or a family
   member need because of cost.

   “It’s barbaric,” said Dr. Miriam Atkins, a Georgia oncologist who, like many 
   physicians, said she’s had patients give up treatment for fear of debt.

This last example strikes close to home, given my surgical specialty. I will
admit that it’s been rare in my practice for a patient to be reluctant to
undergo surgery for breast cancer. However, what is often not appreciated is
that surgery is actually likely the least expensive part of the
multidisciplinary care of this disease. Totalled up, the chemotherapy tends to
cost a lot more, particularly when newer drugs are used, such as immune
checkpoint inhibitors or the newer HER2-blocking drugs.

Indeed, the story includes the example of Cheyenne Dantona, who is now 31 but
was diagnosed with a blood cancer while in college:

   The cancer went into remission, but when Dantona changed health plans, she
   was hit with thousands of dollars of medical bills because one of her primary
   providers was out of network.

   She enrolled in a medical credit card, only to get stuck paying even more in 
   interest. Other bills went to collections, dragging down her credit score.
   Dantona still dreams of working with injured and orphaned wild animals, but
   she’s been forced to move back in with her mother outside Minneapolis.

   “She’s been trapped,” said Dantona’s sister, Desiree. “Her life is on pause.”

   Desiree Dantona said the debt has also made her sister hesitant to seek care 
   to ensure her cancer remains in remission.

Another example:

   Sherrie Foy, 63, and her husband, Michael, saw their carefully planned
   retirement upended when Foy’s colon had to be removed.

   After Michael retired from Consolidated Edison in New York, the couple moved 
   to rural southwestern Virginia. Sherrie had the space to care for rescued
   horses.

   The couple had diligently saved. And they had retiree health insurance
   through Con Edison. But Sherrie’s surgery led to numerous complications,
   months in the hospital, and medical bills that passed the $1 million cap on
   the couple’s health plan.

   When Foy couldn’t pay more than $775,000 she owed the University of Virginia 
   Health System, the medical center sued, a once common practice that the
   university said it has reined in. The couple declared bankruptcy.

   The Foys cashed in a life insurance policy to pay a bankruptcy lawyer and
   liquidated savings accounts the couple had set up for their grandchildren.

Most oncologists who practice in areas like Detroit (where I practice) have
observed this phenomenon firsthand. I daresay that even oncologists who practice
in more affluent areas have also seen it.

One aspect of this problem not included in the story because it is not about
patients’ debt is the massive infrastructure devoted by insurance companies to
prior authorizations. Again, prior authorization is a concept foreign to many
other nations and refers to the requirement by an insurance company that it
authorize a proposed treatment before that treatment can be undertaken and
reimbursed. Failure to get prior authorization will usually mean that the
insurance company won’t pay for it; so providers’ offices and hospitals are very
careful to obtain prior authorization to begin treatment. Unfortunately, as
known by any physician, NP, or nurse who has to deal with insurance companies’
prior authorization departments, obtaining prior authorizations can quickly
descend into truly Orwellian depths of language denying them. The process is so 
bad that it’s often lampooned in cartoons and videos, for example, the
ever-amusing Dr. Glaucomflecken.

Lest you think that the good doctor is exaggerating, I included a response with 
a video of an actual prior authorization call:

real life https://t.co/lOjmW6c0IN

— Amy Walsh, 〽️D (@doctordirectmd) June 16, 2022

Given how difficult and bureaucratic the entire approach to prior authorizations
has become, hospitals now have significant infrastructure devoted just to prior
authorizations, and small, private practice offices end up devoting ridiculous 
amounts of time that could be devoted to patient care just trying to make sure
they can be paid for their services. I won’t dwell on this any more—nor will I
even mention it again in this post—because our inconvenience as physicians
dealing with insurance company bureaucracy pales in contrast to the suffering of
patients who have difficulty accessing care or face the specter of going into
major debt if they become ill. I merely mention it briefly to bolster the point 
that the current health insurance system in the US is designed not to facilitate
SBM care, but to profit, and one way to profit is to deny more expensive care
whenever possible. (Thus endeth the whining about this.)

To get an idea of what people give up because of medical debt, here’s a graph
included with the story:



What people forego because of medical debt in the US.

In addition:

   But the medical debt on credit reports represents only a fraction of the
   money that Americans owe for health care, the KHN-NPR investigation shows.

  1. About 50 million adults ― roughly 1 in 5 ― are paying off bills for their own 
    care or a family member’s through an installment plan with a hospital or
    other provider, the KFF poll found. Such debt arrangements don’t appear on
    credit reports unless a patient stops paying.

  2. One in 10 owe money to a friend or family member who covered their medical or 
    dental bills, another form of borrowing not customarily measured.

  3. Still more debt ends up on credit cards, as patients charge their bills and
    run up balances, piling high interest rates on top of what they owe for
    care. About 1 in 6 adults are paying off a medical or dental bill they put
    on a card.

Not only is the current system apparently designed to slow or deny SBM care, it 
is also a medical debt machine. In fact, one thing that I hadn’t appreciated
that was reported in this story is how medical debt has become big business in
the US. The story first notes that in the past, medical debt on this scale was
unheard of because of two reasons. First, in the past doctors and hospitals
often made informal arrangements for patients to pay off medical debts; for
example in the 19th century male patients at New York’s Bellevue Hospital had to
ferry passengers on the East River and new mothers had to scrub floors to pay
their debts. Second, and more importantly, physicians often wrote off debts that
patients couldn’t afford to pay, as historian Jonathan Engel was quoted saying,
“There was no notion of being in medical arrears.”

Now, efforts to collect often have horrific effects:

   Edy Adams, a 31-year-old medical student in Texas, was pursued by debt
   collectors for years for a medical exam she received after she was sexually
   assaulted.

   Adams had recently graduated from college and was living in Chicago.

   Police never found the perpetrator. But two years after the attack, Adams
   started getting calls from collectors saying she owed $130.58.

   Illinois law prohibits billing victims for such tests. But no matter how many
   times Adams explained the error, the calls kept coming, each forcing her,
   she said, to relive the worst day of her life.

This sort of horror is the result of a system that has sprung up that makes
medical debt—and collection of that debt—big business. It’s a business that
hospitals, including university hospitals and nonprofits, now partake of:

   Now, a highly lucrative industry is capitalizing on patients’ inability to
   pay. Hospitals and other medical providers are pushing millions into credit
   cards and other loans. These stick patients with high interest rates while
   generating profits for the lenders that top 29%, according to research firm
   IBISWorld.

   Patient debt is also sustaining a shadowy collections business fed by
   hospitals ― including public university systems and nonprofits granted tax
   breaks to serve their communities ― that sell debt in private deals to
   collections companies that, in turn, pursue patients.

   “People are getting harassed at all hours of the day. Many come to us with no
   idea where the debt came from,” said Eric Zell, a supervising attorney at
   the Legal Aid Society of Cleveland. “It seems to be an epidemic.”

I realize that some of our readers might be unhappy that I ventured into this
territory or maybe think that it is an inappropriate subject for SBM. I’m also
sure that someone will be unhappy that I didn’t include their favorite issue
with our healthcare system as currently constituted (e.g, for-profit big pharma 
companies distorting clinical trial results and driving up costs). Fair enough, 
but that is not the topic for today. Maybe in the future.

In the meantime, I understand, but now disagree that considering the more “meta”
issues of how a political system regulates and provides SBM to its citizens is 
any less of a topic for this blog than discussing why the latest trial for
homeopathy is bogus. Over the last few years I’ve increasingly realized that, as
fantastic as SBM is at alleviating suffering, saving lives, and restoring
health, it’s no good if people can’t access it without worrying about being
bankrupted or incurring debts that that take years to pay off. Moreover, guess
who is most affected by medical debt? While the story does note that nearly half
of households making $90,000 or more a year have incurred medical debt in the
last five years, it also notes that it is the poor and disadvantaged who most
fall prey to this system and suffer the most under it. Quite simply, the
strongest predictor of medical debt is the prevalence of illness. Indeed, US
counties with the highest share of residents with multiple chronic conditions,
such as diabetes and heart disease, tend to have accumulated the most medical
debt. That makes illness a stronger predictor of medical debt than either
poverty or insurance. This system also exacerbates racial disparities in health 
and medical care as well, with Blacks 50% more likely and Hispanics 35% more
likely than whites to owe money for care. My cancer center is home to an
excellent Population Studies and Disparities Program; so I have been aware of
racial and socioeconomic disparities in cancer outcomes and burden for quite
some time, having increasingly appreciated the issue over the 14 years since I
accepted my current employment. I now therefore argue that understanding
disparities in SBM care and how to eliminate them is part of SBM.

This brings me to one area for change and improvement. Certainly, there are
other needed changes to make SBM more available to all, but I’m going to start
with this one.

Health insurance and the pandemic

The story that I just discussed includes this quote:

   “The No. 1 reason, and the No. 2, 3, and 4 reasons, that people go into
   medical debt is they don’t have the money,” said Alan Cohen, a co-founder of 
   insurer Centivo who has worked in health benefits for more than 30 years.
   “It’s not complicated.”

Put this way, the reason for the problem might not be complicated, but the
solution is. Again, this is where the interface between SBM and society gets
messy. Still, let’s look to a PNAS study published a week ago by a group led by 
the Center for Infectious Disease Modeling and Analysis, Yale School of Public
Health, and including investigators from the University of Florida, University
of Massachusetts, Amherst, and Syracuse University. The study asked the
question: What would the effect of universal health insurance have been on
mortality in the US from the pandemic? Its conclusion is that universal health
insurance is pandemic preparedness, and it concludes that ~212K who died of
COVID-19 could have been saved in 2020 alone and that, overall, from the
pandemic’s beginning until mid-March 2022, universal health care could have
saved more than 338K lives from COVID-19 alone. In addition, the study estimates
that single payer universal health care would also have saved the US government
roughly $106 billion in health care costs associated with hospitalizations from
COVID-19—plus an estimated $438 billion that could be saved in a nonpandemic
year.

The methodology of the study was as follows. The authors calculated elevated
mortality attributable to loss of employer-sponsored insurance and to background
rates of being uninsured, summing with increased COVID-19 mortality
attributable to low insurance coverage. Demographics and age-specific mortality 
rates due to COVID-19 were estimated, as well as prepandemic mortality, leading 
the authors to estimate that 338K deaths from COVID-19 alone could have been
prevented over the two year period from March 2020 to March 2022. They then
argue that Medicare-For-All could have saved these lives through a combination
of:

  1. Improved access to primary care and reduction in comorbidities.

  2. Early diagnosis and access to life-saving medical care.

  3. Facilitation of COVID-19 preventative measures (e.g., vaccination).

  4. Alleviating pressure on hospitals during a pandemic.

There’s a large evidence base supporting the conclusion that health outcomes
tend to be better with universal health care. However, I tend to agree with this
analysis by Dylan Scott that points out a number of issues with the study
above, not the least of which is its assumption that a single-payer universal
health care system is the be-all and end-all of systemic solutions for improving
health outcomes, decreasing disparities, and eliminating medical debt. For
instance, it is very much true that COVID-19-associated mortality was very high 
in the US. We have 4% of the world’s population, but suffered 16% of the
mortality burden due to COVID-19. It is also true that COVID-19 mortality was
lower in countries with universal health insurance, in some cases a lot lower.
However, there is the outlier of the UK, which, despite having single-payer
universal health care (in the form of the National Health Service, or NHS), had 
a COVID-19 mortality rate almost as bad as the US.

Also:

   All of these countries do have universal health care, but they do not all
   have a single-payer system in the vein of Sanders’s Medicare-for-all
   proposal. Taiwan does. But Australia utilizes a hybrid program where some
   people depend on public health insurance and other people use private plans. 
   The Netherlands and Germany rely on private health insurance, heavily
   regulated and subsidized by the government. The UK’s National Health Service 
   goes beyond single-payer and is fully socialized: The government not only
   pays for care for everyone but also runs hospitals and employs doctors
   directly.

I’ve often said elsewhere that universal health insurance does not have to be
single-payer to be effective, and that was the main thing that irritated me
about this Yale study; it assumed that only Medicare-For-All would be the answer
to save all these lives from COVID-19, an assertion that it did not back up
with evidence, mainly because it didn’t really seriously consider or compare
other universal health insurance systems. (Also, one notes that even Medicare,
which was examined in this study, only covers 80% of costs—after the deductible 
is met—unless one gets a Medigap policy or signs up for a Medicare Advantage
plan.) Germany, for instance, has one of the oldest universal health insurance
systems that dates back to the 1880s and survived the Nazi regime. It is what’s 
called a universal multi-payer health care system and encompasses both statutory
health insurance for people who earn less than a certain salary, as well as
private health insurance for those who earn more and choose to purchase their
own. Moreover, clearly there have been other factors besides just universal
health insurance.

As Scott notes:

   Other factors might be in play beyond the specific type of health care
   system. As Damien Cave wrote for the New York Times in Australia, social
   trust seems to have been a decisive difference between the American and
   Australian experiences during the pandemic. The two nations share a lot of
   sociocultural DNA, but Aussies have much deeper trust in people in general,
   and their health care system specifically, than Americans do, Cave wrote.
   When I was reporting on South Korea’s successful Covid-19 response, Korean
   sources pointed in part to people there having a generally high level of
   trust in the government.

   This also makes some intuitive sense. It follows that people in societies
   with more trust would be more likely to wear masks or stay home or get
   vaccinated not only for their own benefit but for the health of the people
   around them and society at large.

This brings us to the final point. SBM alone is not enough.

SBM versus values and politics

I’ve lost track of how many times when, as I discussed potential randomized
controlled clinical trials (RCTs), I pointed out that sometimes the key value of
SBM, namely doing best science possible to determine if a treatment works (a
double-blind, placebo-controlled RCT) is not always possible because it
conflicts with another value, specifically values of fairness and clinical
equipoise as laid down by medical ethics. For example, I’ve long pointed out how
doing a double-blind placebo-controlled RCT of the childhood vaccination
schedule in the form of a “vaxxed/unvaxxed” study that some antivaxxers have
periodically called for to “prove” that vaccines cause autism would be
completely unethical because it would leave the control group unprotected
against common childhood diseases. As a result, we have to rely on
epidemiological studies to show that vaccines are not associated with autism.

The same principle operates on a much larger scale when it comes to a country’s 
willingness to institute public policies designed to bring SBM to as many people
as possible, as Scott points out quite well:

   Universal health care is a choice, a reflection of a country’s values. When
   reporting the Everybody Covered series, I found this quote from Princeton
   health care economist Uwe Reinhardt. It was in his most recent book Priced
   Out, which was published after he died in 2017:

   Canada and virtually all European and Asian developed nations have reached,
   decades ago, a political consensus to treat health care as a social good.

   By contrast, we in the United States have never reached a politically
   dominant consensus on the issue.

   While traveling in Taiwan or the Netherlands, people would ask me about US
   health care and I would have to tell them that millions of Americans were
   uninsured and that people could be charged thousands of dollars for medical
   care. That was unfathomable to the people I met. They lived in a country
   where people agreed such things should never be allowed to happen.

   America has never made that collective commitment to providing everyone with 
   health care. The country paid the price for that shortsightedness during the 
   pandemic, as this new study helps demonstrate. Whatever form it took, a
   universal health system would have likely prevented tens of thousands of
   deaths from the novel coronavirus.

As important as demonstrating how harmful medicine based on bad science and
pseudoscience has been to patients and to the healthcare system in general, as
well as how it has degraded standards of evidence in a manner that (I argued)
facilitated the promotion of, for example, ivermectin as a miracle treatment for
COVID-19, SBM in isolation is not enough. The system in which SBM is utilized
is part of SBM, for better or worse. It can’t be repeated enough that SBM is
much less useful if people can’t access it or the cost of accessing it is
prohibitive. I’m therefore coming to the conclusion that not only is SBM
necessarily political, it must be political, in order to find ways to change the
dominant values in our political system in order to spark change that allows
SBM to be accessible to all without ruinous cost. Unfortunately, these days we
seem to be going in the wrong direction.

Legislative alchemy and abortion: How the fall of Roe v. Wade will degrade
science-based medicine

The U.S. Supreme Court overturned Roe v. Wade on Friday, eliminating the federal
right to an abortion. What does that mean for science-based reproductive health
and science-based medicine in general? Hint: It’s not good, even for areas of
medicine outside of reproductive health.

David Gorski on June 27, 2022

Link



I had another topic all teed up for today. It was yet another dubious study of
COVID-19 mRNA vaccines that’s been going round the antivaccine
misinformationsphere, notable not so much for anything other than that a rather 
famous and well-respected statistician (one whom I have personally cited before)
signed on. If it continues to gain traction, there is time to come back to that
study, either here or at my not-so-super-secret other blog. Unfortunately,
something more urgent arose. On Friday, the US Supreme Court released its
decision on Dobbs v. Jackson Women’s Health Organization, not only upholding
Mississippi’s 15-week abortion ban but also ruling that there is no
Constitutional right to an abortion, basically striking down the 49 year old
decision that had ruled that there was such a right. While much ink, both print 
and digital, has been expended already on this monumental shift in US law and
women’s rights, I’m going to look at it from the perspective of a longstanding
topic on this blog: Law vs. science-based medicine, a topic that our recently
retired contributor and legal expert Jann Bellamy used to refer to as
“legislative alchemy“. In her honor, I was tempted to refer to this decision as 
“judicial alchemy”, but in reality what this decision unleashed even before it
was announced was legislative alchemy in a huge number of states.

It’s no secret that I was raised Catholic and as a result was taught throughout 
my grade school and high school education (eight and a half out of thirteen
years of which, counting kindergarten, were in Catholic schools, including an
all-boys Catholic high school) that abortion is an absolute evil. I even
believed it until well into my early adulthood. Medical school, however, coupled
with my gradual drift away from religion, led me to appreciate that abortion is
a necessary and integral part of reproductive health care. Although this post
is a typical length for me, it’s far from an exhaustive discussion. In the
spirit of full disclosure and so that no one tries to accuse me of hiding an
agenda (although I’m sure someone will anyway), I will state my bias from the
beginning, even though this post will not be primarily invoking arguments based 
on rights and I will try to stick mostly to SBM. Consistent with Roe v. Wade,
women should—but no longer do—have the right to control their bodies. Leaving
aside arguments of rights and when a fetus should be considered a “person”,
however, I am struck by just how much the arguments of the anti-Roe forces
resemble those that we at SBM have been deconstructing for nearly 15 years in
their appeals to bad science and pseudoscience.

The current frenzy of abortion bans—and, make no mistake, it is a frenzy—being
considered in various states represent an assault on science-based medicine
every bit as non-evidence-based as bills to license naturopaths. In the very
best case, these laws will make practicing science-based medicine much more
difficult (and not just in reproductive health care) but in some cases
impossible, forcing doctors and their patients into choices that they should
never be forced to make. Many of these new laws are based on the idea that human
life begins at conception, which means that embryos are human lives and that
fetuses are legal persons, with all the rights of persons under the law, to the 
great detriment of the pregnant. (Indeed, if it becomes law that embryos have
legal personhood, one can only imagine the effect that it will have on in vitro 
fertilization, which often involves the generation of multiple embryos, some of 
which end up being discarded. What will become of the millions of unused embryos
sitting in liquid nitrogen tanks in fertility clinics across the US?)

In this post, I will attempt to discuss some of the outcomes that we are likely 
to see and that OB/GYNs are dreading. Make no mistake either, the effects are
likely to go beyond the realm of reproductive health, as I will also discuss.

Think about it this way. Ideologues have long pressured legislatures to foist on
doctors types of care that are not based in science, to legalize outright
quackery, to require insurance companies and government payors to cover
quackery, or to outlaw science-based standards of care based on their ideology. 
More recently, laws have been passed to make it easier for quacks to prescribe
ineffective treatments for COVID-19 like ivermectin and to ban public health
interventions against the disease. Abortion bans as draconian as the ones
spreading throughout the country as a result of the fall of Roe v. Wade are no
different in terms of ideology trumping science and evidence. As I contemplated 
what to write (or even whether to write) about the fall of Roe v. Wade and what 
it means for SBM, I came to the conclusion that it is useful to look at this
decision and the laws that will flow from it through the lens of ideologues and 
believers overruling SBM based on their beliefs.

Let’s look at some not-so-potential consequences. We don’t have to speculate
what the consequences of these laws will be for SBM. We know from history and
other countries.

“The life of the mother”

Proponents of abortion bans always point to exceptions for “the life of the
mother” included in every abortion ban in order to claim that such bans are not 
contrary to science- and evidence-based medicine and won’t harm the pregnant.
But what does “the life of the mother” actually mean in practice? To the lay
person, it might seem very clear: If continuing the pregnancy endangers the life
of the mother, then termination is allowable even under these bans. It turns
out that there are many cases where it is not that clear, and that, even in
cases where it is very, very clear indeed, such bans tend to lead to situations 
in which optimal science-based treatment is impossible.

In fact, we don’t even have to speculate what is likely to happen. We already
know, as a story published in The New Yorker over a month ago by Jessica Winter 
describes. It begins with a horrific anecdote from Ireland:

   Savita Halappanavar’s water broke just after midnight on October 22, 2012, in
   a hospital in Galway, Ireland, in her seventeenth week of pregnancy. This
   meant two things: the fetus could not possibly survive, and Halappanavar was 
   at risk of infection if the fetus was not immediately expelled or removed.
   She begged doctors to terminate her pregnancy—or, put another way, to treat
   her miscarriage—but they refused. A fetal heartbeat could still be detected, 
   and the Eighth Amendment to Ireland’s constitution effectively banned
   abortion. After two days, Halappanavar developed sepsis; on October 28th, she
   went into cardiac arrest and died, at the age of thirty-one. An inquest into
   Halappanavar’s death found that even as her temperature and heart rate
   soared, even as she was entering septic shock, doctors continued to monitor
   the fetal heartbeat. “They were worried that, if they did a termination, they
   might be accused of performing an illegal act by not complying with the
   Eighth Amendment,” the doctor who led the inquest later said. A national
   outcry over Halappanavar’s death catalyzed a movement to repeal the
   amendment, which Ireland’s voters accomplished by referendum in 2018, with a 
   two-thirds majority.

The science-based standard of care in such a case is, sadly, quite clear.
Terminate the pregnancy before sepsis can set in. At the very least, such a ban 
on abortions will lead to fear and second-guessing by doctors faced with
situations in which termination would be the standard-of-care to treat a given
health condition in the pregnant. At the very worst, we will have cases like
that of Savita Halappanavar. Clearly, hers was a dramatic case, but I included
it to make a point. Exceptions to abortion bans to treat medical emergencies in 
order to “save the life of the mother” do not in practice protect the pregnant
nearly as much as those citing them claim that they do.

The New Yorker article nicely summarizes the medical issues involved with
exceptions for “the life of the mother”:

   If, as expected, the Supreme Court abolishes the constitutional right to
   abortion in its forthcoming decision in Dobbs v. Jackson Women’s Health
   Organization, scenarios such as the one that killed Savita Halappanavar will 
   become more likely to occur in the United States. Twenty-six states are
   likely to ban or criminalize abortion if Roe is overturned, including
   thirteen with “trigger bans.” These typically include a “life of the mother” 
   exception, but the language of these exceptions varies in its scope and
   specifics state to state. Texas’s current six-week ban—its proponents call it
   the “heartbeat bill”—allows exceptions for “a medical emergency.” North
   Dakota would permit abortion “to prevent the pregnant female’s death.”
   Louisiana invokes “death or substantial risk of death,” or “permanent
   impairment of a life-sustaining organ,” but also requires “reasonable medical
   efforts under the circumstances to preserve both the life of the mother and 
   the life of her unborn child.”

   The questions implicit in these phrases—What constitutes an “emergency”? How 
   does one define “substantial” or “reasonable”?—are left unanswered. “These
   laws presume a certainty that doesn’t exist in medicine,” Cara Heuser, a
   maternal-fetal-medicine physician in Salt Lake City, said. “How
   ‘life-threatening’ the situation has to be—I don’t know what that means.”

   “In states where abortion becomes illegal, and particularly in states where
   there are criminal penalties for doctors or anyone who assists in an
   abortion, I fear that it will send a chill through the entire medical
   community,” Audrey Lance, an ob-gyn in Michigan, said. “People are going to
   be scared to intervene until the last minute or perhaps until it’s too late.”

Where does this fear among doctors come from? It comes from the criminalization 
of health care and a therapeutic operative procedure.

D&C vs. D&E for miscarriages

In addition to the very difficult medical and ethical issues that naturally come
with reproductive health care doctors will now be forced to weigh, in any case 
in which termination of a pregnancy is the science-based standard-of-care
treatment for a life-threatening condition during pregnancy, the good of the
patient versus some very serious potential consequences to themselves. Why? As
The New Yorker article points out, as many as 22 states are “likely or certain” 
to make abortion a felony, with potential penalties including jail time and
fines to doctors who do the procedure. The result will be this:

   A doctor who is inclined to provide an emergency termination would have to
   weigh her medical judgment against the possibility of criminal charges,
   losing her license, and never being able to practice medicine again. “There’s
   a very real fear: Will they force people to prove that they really had a
   miscarriage?” Heuser said.

We already know the answer to that question, I fear. In fact, we’ve long had
examples even during the 49 years of Roe v. Wade, because Catholic hospitals
have shown us, one in my very own state. This is not for someone seeking to
terminate the pregnancy, but, as a Dallas OB/GYN is quoted in the article said, 
“This is not a person who comes to you and says, ‘I want to end this pregnancy.’
This is a person who is saying, ‘I am having a pregnancy complication, and I
need you to help me.'”

Unfortunately, in the presence of punitive abortion bans:

   That cry for help often goes unheeded in the presence of a fetal heartbeat,
   even if the demise of the pregnancy is inevitable. In 2015, the A.C.L.U.
   filed suit on behalf of a Michigan woman, Tamesha Means, against the United
   States Conference of Catholic Bishops, the body that writes the religious and
   ethical directives that must be followed by Catholic hospitals, which, as of
   2016, accounted for about fifteen per cent of acute-care hospitals
   nationwide. The directives state that abortion is “never permitted,” barring 
   “a proportionately serious pathological condition of a pregnant woman.”
   Means’s water broke at eighteen weeks, but she was sent home from a Catholic 
   hospital, Mercy Health Partners, mid-miscarriage—twice—despite excruciating
   pain and possible infection.

At 18 weeks, the fetus is not viable outside of the uterus, and the risk of
infection of the sort that killed Savita Halappanavar in Ireland after a
premature rupture of membranes is very high. The science-based standard of care 
in nearly all such cases is to terminate the pregnancy, as described by an
OB/GYN:

   “Yes, there are absolutely certain medical conditions that warrant us to very
   urgently encourage a woman to have an abortion,” said Stacey Beck, MD and
   Assistant Professor at the Department of Obstetrics, Gynecology, and
   Reproductive Sciences, Maternal Fetal Medicine at the University of
   Pittsburgh Physicians

   “One of the most common reasons I help women to terminate their pregnancy is 
   because their water broke [early in pregnancy] and they have an infection,”
   Beck said.

   If there’s a clear sign of infection, the condition can be life threatening, 
   “because there is an extremely high risk that the infection inside of the
   uterus spreads very quickly into her bloodstream and she becomes septic. If
   she continues the pregnancy it comes at a very high risk of death.”

   “Typically, if a woman breaks her water before 20 weeks into her pregnancy,
   it is usually strongly recommended by medical professionals that she
   considers an abortion,” Beck said.

It’s not just Catholic hospitals, either. Before the fall of Roe v. Wade, a
number of nonreligious hospital systems would not permit their doctors to
perform “abortions” as long as the fetus still had a detectable heartbeat, with 
predictable results:

   Several physicians told me that hesitation to provide emergency-miscarriage
   care is not peculiar to Catholic or other religious institutions. Even in
   states where abortion rights are broadly intact, many hospital systems do not
   permit terminations for any reason; patients in need must be transferred
   elsewhere. Heuser, who serves as a consultant for general ob-gyns across her 
   hospital system in Salt Lake City, told me, “I have got calls from the E.R., 
   saying, ‘This patient is bleeding, but there’s still a heartbeat—I don’t know
   what to do.’ And I have had to say, ‘You are allowed to treat the patient.
   You need to save the patient. This is a medical emergency.’ If you hem and
   haw because you aren’t sure about the law or the rules—that’s dangerous for
   patients.”

   Leilah Zahedi, a maternal-fetal-medicine physician in Tennessee, told me
   about a recent referral. “The patient was eighteen or nineteen weeks
   pregnant. She came in almost fully dilated and bleeding heavily, but the
   fetus still had a heart rate. The provider who transferred her was prohibited
   from giving her care, per the statutes of the hospital—it would have been
   considered an abortion. She transferred her to us because I am the only
   provider who is trained to do D. & E.s” in the area, Zahedi said. “When the
   patient reached us, within two minutes she lost 500 cc.s of blood. I said,
   ‘We’re done.’ I took her to the O.R. Her case was done in five minutes. She
   ultimately lost 2,500 cc.s of blood and needed a blood transfusion.”

That last case was what we in the biz call a near-miss. The patient could well
have died and was certainly not served by all the delays due to the uncertainty 
at the referring hospital and then all the mechanics of being transferred to a
hospital that was allowed to actually deal with the medical emergency. I would
also argue that the uncertainty and fear that leads to doctors hesitating to
take care of their patients according to science-based standards-of-care in
these situations are a feature, not a bug, of many of these abortion bans.

Supporters of abortion bans will claim that there is a difference between an
elective abortion and a therapeutic abortion (e.g., to treat a miscarriage or
uterine infection after premature rupture of membranes). Here’s the problem.
Both employ the same surgical procedure, and state bans in general do not
distinguish between the two. To cite The New Yorker article again:

   The two procedures also employ the same tools and techniques, depending on
   the stage of the pregnancy and the health of the pregnant person: medication 
   or dilation and curettage (D. & C.) for early abortions; and dilation and
   evacuation (D. & E.) or induced labor for later abortions. (In his draft
   opinion reversing Roe, Justice Samuel Alito refers to D. & E. as “a barbaric 
   practice.”)

Is a D&E still a “barbaric practice,” though, when it is used to save the life
of someone who is dying from bleeding or about to go into septic shock? It’s a
science-based life-saving surgical procedure. Proponents of banning abortion
bans will swear up and down that it is not their intention to prevent
life-saving medical and surgical care of life-threatening conditions like this
in the pregnant, but it is irrefutable that abortion bans do just that. Under
the best of circumstances, they insert more uncertainty, doubt, and
second-guessing into the process; at worst, they force doctors to abandon SBM
out of fear of prison and wait to intervene until much later in the
life-threatening process, when the success rate of interventions are lower and, 
even when successful, come at a higher cost of complications.

What about other life-threatening conditions?

I know what some of you out there are saying now: “But, but, but those are
extreme examples!” And so they are. I chose to lead with extreme examples
because they illustrate most clearly the consequences of abortion bans with
criminal penalties. Again, the cases described above are not even close calls
from an SBM standpoint, nor were they meant to be. These patients were clearly
going to die—and soon!—without surgical intervention in the form of a pregnancy 
termination. Even so, I’m brought back to the quote from Dr. Heuser about how
these laws “presume a certainty that doesn’t exist in medicine” and her
question: How life-threatening does the situation have to be to trigger an
exception to the ban “for the life of the mother”?

One such condition is preeclampsia early in the pregnancy (less than 24 weeks). 
Preeclampsia is a disorder of pregnancy that usually develops later (after 20
weeks) and includes hypertension, severe headaches, kidney dysfunction (usually 
evidenced by protein in the urine), among other health issues. Major risk
factors include diabetes, hypertension, kidney disease before pregnancy,
autoimmune conditions (e.g., lupus or antiphospholipid syndrome), or having had 
high blood pressure or pre-eclampsia in a previous pregnancy. Other risk factors
include a family history, age over 40, more than 10 years since a previous
pregnancy, non-singleton pregnancy (twins and above), or a body mass index (BMI)
of 35 or higher. Most of the time, pre-eclampsia is treatable through a
combination of close monitoring and medications, although it is not “cured”
until the fetus is delivered, usually at 37-38 weeks, sometimes by caesarean
section.

Early severe preeclampsia, however, is more of a problem, because, again, the
only treatment for preeclampsia is delivery, and the consequences of prematurity
versus the risks to the mother (and fetus) of continuing the pregnancy must be 
carefully weighed, and sometimes when the preeclampsia is severe enough and
happens long enough before fetal viability, pregnancy termination is the safest 
way to treat it and prevent complications such as stroke or kidney failure. Even
later in pregnancy, it can sometimes be necessary:

   But she says there also are cases after viability in which an abortion is
   safer than an induced childbirth or surgical delivery.

   Cecily Kellogg, 44, a writer who lives near Philadelphia, says that was the
   situation she faced when she was nearly six months pregnant with twin boys in
   2004 and developed severe preeclampsia. One fetus had already died and “my
   liver had shut down, my kidneys had shut down and they were expecting me to
   start seizing at any minute,” she says. The doctors said they had to quickly 
   dilate her cervix and perform an abortion to save her. “I fought it,” she
   says. “But they told me I would die — that it was either me and my son or
   just my son.”

The bottom line is that there are well-described science-based indications for
therapeutic abortions. By conflating elective abortion with these situations,
abortion bans will result in deaths. Indeed, one recent study estimates that
banning “all wanted induced abortions,” by increasing exposure to
pregnancy-related mortality, could result in a 21% increase in
pregnancy-associated deaths overall, with an even more whopping 33% increase
among Blacks, which is unsurprising given that due to racial disparities in
health care maternal mortality is already much higher among Black women in the
US.

And don’t even get me started on legislators claiming that it is possible to
“reimplant” ectopic pregnancies, for which the treatment is always surgical
removal.

Before I move on to a broader discussion, I will mention one more horrific
effect of these laws based on this Tweet:

Arkansas, your legislature says that it is the government’s job to legislate how
mothers grieve the loss of their babies.

We are forcing women whose babies will *certainly* die to endure pregnancy and
childbirth, and then to watch their babies die inevitable, painful deaths.

— Rep. Nicole Clowney (@NicoleClowneyAR) June 24, 2022

That’s right. Some of these laws do not have exceptions for cases of pregnancies
in which it is discovered that the fetus has unsurvivable anomalies; the sole
exception in Arkansas is now to save the life of the mother in a “medical
emergency” (undefined). States with such laws would prevent the science-based
standard of care, termination of pregnancies in which unsurvivable fetal
anomalies are present, requiring such pregnancies to be carried to term, with
all the attendant risks of complications and death. In Arkansas, apparently,
pregnancies involving anencephalic fetuses (a fetal anomaly when the brain fails
to develop) must be carried to term. Ditto fetuses with severe anomalies such
as a lethal form of skeletal dysplasia.

Beyond reproductive healthcare

If you think that the fuzziness over what constitutes a true danger to the “life
of the mother” just affects science-based healthcare decisions in reproductive 
health, think again.

Saturday on Twitter:

Same. (I am a breast cancer surgeon.) It doesn't happen that often, but I do
take care of pregnant patients with cancer from time to time, probably more
often than the average breast surgeon because I'm at an NCI-designated
comprehensive cancer center.

— David Gorski, MD, PhD (@gorskon) June 25, 2022

It’s true, too. Cancer during pregnancy is an issue that comes up from time to
time among breast cancer surgeons, medical oncologists, and radiation
oncologists. What do we do when a breast cancer is diagnosed during pregnancy?
For example, if a pregnant patient presents with a breast cancer that needs
chemotherapy before surgery, it is possible to administer it relatively safely
during the second and third trimesters (although long term data regarding
outcomes in the children delivered after chemotherapy during pregnancy are still
lacking). However, during the first trimester chemotherapy is most definitely
not safe due to the teratogenic (mutation-causing) characteristics of the
chemotherapy used, as this guidance from the American Cancer Society describes. 
It is often possible and reasonably safe to delay treatment until the pregnancy 
is into the second trimester—but far from always. There are cases that are
sufficiently urgent that waiting to start chemotherapy will definitely result in
a much higher risk of death from the cancer.

The American Cancer Society states:

   Treatment choices can become complicated if there is a conflict between the
   best known treatment for the mother and the well-being of the baby. For
   example, if a woman is found to have breast cancer early in her pregnancy and
   needs chemotherapy right away, she may be advised to think about ending the 
   pregnancy. A counselor or psychologist should also be part of your health
   care team to help give you the emotional support you may need.

   Some older studies found that ending a pregnancy in order to have cancer
   treatment didn’t improve a woman’s prognosis (outlook). Even though there
   were flaws in these studies, ending the pregnancy is no longer routinely
   recommended when breast cancer is found. Still, this option may be discussed 
   when looking at all the treatment choices available, especially for
   metastatic (stage IV) or aggressive cancers that may need treatment right
   away, such as inflammatory breast cancer.

It’s not just breast cancer, either, of course. These considerations are in play
for any cancer diagnosed in during pregnancy that will require chemotherapy for
definitive treatment. Although I’m not an oncologist, hematologic malignancies 
like leukemia come to mind right away. Moreover, as a physician on Twitter
described the situation, there’s no bright line. The situation is complicated:

The idea of that we just automatically “know that someone will die” from
something imminently is not realistic, and at that point may actually be too
late.

Medicine, as with life, does not exist in black and white, but varying shades of
gray.

— Taylor Nichols, MD (@tnicholsmd) June 26, 2022

Surgeons know this too, as to OB/GYNs. Dr. Nichols also correctly added that we 
shouldn’t “for a second think the same extremists who wanted to overturn Roe
don’t also want to dramatically narrow the scope here as well.”

Again, abortion is part of healthcare, and, contrary to frequent claims from
those seeking to criminalize it that it is “never necessary” to save the life of
the mother, which brings us to my final section.

Is abortion ever “medically necessary”?

Some advocates of abortion bans go beyond banning it for anything other than
“emergencies” in which death is imminent, an exception that, as narrow as those 
supporting abortion bans try to make it, is still an exception that they
concede. Some refuse to admit to any exceptions and go on to deny that abortion 
is ever “medically necessary”. Some of these people are even doctors. For
example, the American Life League circulated a statement that a disturbing
number of physicians (although still under 500) signed:

   I agree that there is never a situation in the law or in the ethical practice
   of medicine where a preborn child’s life need be intentionally destroyed by 
   procured abortion for the purpose of saving the life of the mother. A
   physician must do everything possible to save the lives of both of his
   patients, mother and child. He must never intend the death of either.

   There is never a reason in law or in practice to advocate a “life of the
   mother” exception for abortion. We base this statement on testimony of many
   pro-life physicians over the years, including John F. Hillabrand, M.D.,
   Herbert Ratner, M.D., and Bernard N. Nathanson, M.D.

I would counter that any physician who signs such a statement have fallen prey
to magical thinking that is as non-reality-based as that among antivaccine
physicians, ivermectin pushers for COVID-19, and those who become naturopaths.
There’s a reason (many reasons, actually) why the American College of Obstetrics
and Gynecologists released this statement:

   The science of medicine is not subjective, and a strongly held personal
   belief should never outweigh scientific evidence, override standards of
   medical care, or drive policy that puts a person’s health and life at risk.

   Pregnancy imposes significant physiological changes on a person’s body. These
   changes can exacerbate underlying or preexisting conditions, like renal or
   cardiac disease, and can severely compromise health or even cause death.
   Determining the appropriate medical intervention depends on a patient’s
   specific condition. There are situations where pregnancy termination in the
   form of an abortion is the only medical intervention that can preserve a
   patient’s health or save their life.

   As physicians, we are focused on protecting the health and lives of the
   patients for whom we provide care. Without question, abortion can be
   medically necessary.

I haven’t even discussed a large number of other medical situations in which
abortion might be necessary to save the patient’s life, such as one that you
might not even have considered, hyperemesis , the mental health effects of being
forced to carry a nonviable pregnancy to term, which is associated with a high 
risk of suicide, or situations in which surgery for a life-threatening condition
is unsafe during pregnancy. The list goes on and includes healthcare that you
might not realize. For example, the “abortion pill” misoprostol has many other
uses besides as an abortifacient; indeed, in a 2021 research paper on
misoprostol use in Francophone Africa, medical sociologist Siri Suh described
misoprostol as “widely recognized as an essential obstetric medication,” yet
lamented that “the stigma of abortion stalls its integration into routine
obstetric care and availability to the public.” In addition, the related drug
mifepristone can be used in the management and treatment of fibroids and
Cushing’s syndrome by blocking progesterone. Again, the list goes on. Nor have I
touched much on the many other adverse effects that such restrictive abortion
bans will have on health, and I would be remiss if I didn’t take an opportunity 
before the end of this post to emphasize how much carnage will likely result
from unsafe “underground” abortions that those desperate to end their
pregnancies will seek out.

Regardless of one’s position on the morality of abortion as a form of birth
control (and, although I am no longer of a Catholic belief system regarding
this, I can still to some extent understand), it should be clear that the strict
bans that will soon be part of life in probably more than half the states are
ideological, not scientific. The arguments being used to justify them are every 
bit as reality-challenged as those made in support of laws licensing
chiropractors, acupuncturists and naturopaths, legislative efforts to protect
doctors who practice quackery and those who promote the use of disproven drugs
like ivermectin to treat COVID-19 from regulatory sanctions, and laws preventing
public health departments from instituting measures to slow the spread of the
pandemic.

New Florida law forces physicians to endorse pseudoscience

A new Florida law forces physicians to endorse chiropractic, acupuncture, and
massage as non-opioid alternatives for pain, even if the physician disagrees
with that advice.

Jann Bellamy on September 12, 2019

Link

Billed as an effort to combat the opioid crisis, a new Florida law requires
physicians and other healthcare practitioners to endorse pseudoscience and give 
patients misleading information about non-opioid alternatives for the treatment 
of pain. It is yet another attempt at co-opting the opioid epidemic to boost
so-called complementary/alternative/integrative medicine at the expense of
science-based medicine.

The law imposes several requirements before a healthcare practitioner (except a 
pharmacist) can prescribe, order, dispense or administer a Schedule II opioid
drug for pain treatment. Before we get to those requirements, it’s worth noting 
the first version the bill was entirely different. As originally introduced,
House Bill 451 would have required the Department of Health to create a
“non-opioid directive form” which patients could sign, indicating their desire
not to be prescribed or administered an opioid. Any physician treating the
patient could be disciplined for failing to comply with the directive.
(According to one legislative analysis, similar laws have passed in several
states.) The Florida Medical Association (FMA) objected and worked with the
bill’s sponsor to completely revise the bill. While their concerns about
disciplinary action are understandable, the version that passed is, in my view, 
a worse result for evidence-based medicine and good patient care.

This new law adds to the already substantial statutory and regulatory control of
controlled substance prescribing in Florida. However, unlike the rest of
Florida’s statute to which the new requirements were added [as Sec. 456.44(7)], 
it does not exempt cancer pain, terminal conditions, palliative care or certain 
traumatic injuries.

As of July 1, 2019, before prescribing, ordering, dispensing, or administering a
Schedule II opioid drug for the treatment of pain, a physician or other
healthcare provider must (except in the provision of emergency care):

  1. Inform the patient of non-opioid alternatives for pain treatment, which may
    include, non-opioid drugs, interventional procedures, acupuncture,
    chiropractic treatments, massage therapy, physical therapy, occupational
    therapy, or any other appropriate therapy as determined by the health care
    practitioner.

  2. Discuss the advantages and disadvantages of non-opioid alternatives.

  3. Provide the patient with an educational pamphlet published by the Department
    of Health.

  4. Document the non-opioid alternatives considered in the patient’s record.

Interestingly, as originally drafted, this new version did not mention
chiropractic, acupuncture, or massage therapy. They were added later, a
legislative staff analysis citing two documents in support of their inclusion.
One, the CDC’s “Nonopioid Treatments for Chronic Pain“, does not actually
mention any of these treatments. The second, The Joint Commission’s
“Non-pharmacologic and non-opioid solutions for pain management”, relies on the 
recommendations of the American College of Physicians for acupuncture and
massage therapy for acute and chronic low back pain, all based on low quality
evidence. The Joint Commission also recommends spinal manipulative therapy,
based on one systematic review and meta-analysis and one Cochrane Review,
neither of which was exactly a ringing endorsement. “Chiropractic treatments”
are not mentioned and, of course, chiropractors are not the exclusive providers 
of spinal manipulation.

In any event, physicians need not discuss options that are inappropriate for the
patient, either because they just don’t apply to the patient’s condition or
they are not evidence-based. Unfortunately, the same discretion is not available
to physicians in complying with the rest of the law.

The Department of Health (DOH) was directed to create a pamphlet on its website 
“regarding the nonopioid alternatives for the treatment of pain”, including, at 
a minimum, information on available non-opioid treatments and the advantages and
disadvantages of using them. The physician must provide patients with this
pamphlet before prescribing/ordering/administering opioids. The law is unclear
on whether the patient has to be given the pamphlet at each administration,
resulting in multiple pamphlets being handed to, for example, the same hospital 
patient prescribed a Schedule II opioid every 6 hours post-surgery. (The FMA has
requested guidance from the Florida Board of Medicine on the issue.)

The content of the DOH’s pamphlet is unobjectionable in many respects. It urges 
patients to work with their healthcare providers in deciding on the best course 
of treatment for pain and talk about the advantages and disadvantages of all
options. It warns that some options may not be covered by insurance and may be
ineffective for severe pain. It lists cold and heat, exercise, OTC meds,
physical and occupational therapy, and behavioral interventions, among others,
as treatment options. Unfortunately, the pamphlet’s recommendations also
includes chiropractic, acupuncture, and massage therapy.

I’ll leave to others a discussion of whether physicians and other prescribers
need to be second-guessed by legislators in their attempt at what one critic has
described as “opiophobia”. My particular problem with the new law is that, by
mandating the distribution of this pamphlet, healthcare providers are forced to 
essentially endorse treatments with, at best, questionable evidence of safety
and effectiveness. At worst, they are forced to endorse pseudoscience
administered by Florida-licensed healthcare providers whose practices will
subject patients to quack remedies. Ironically, the authority to treat patients 
with pseudoscience was bestowed on these licensed providers by the very
Legislature that is so keen to protect patients from evidence-based
practitioners. That is not to say that physicians and others have not
overprescribed opioids or that some corrective action is unnecessary. But
pseudoscience is not the solution; it is, in fact, a problem the Legislature
itself created and is doing nothing to stop.

Chiropractic, acupuncture, and massage

With that, we’ll turn to a discussion of the three problematic recommendations.

From the DOH pamphlet:

   Chiropractic: Chiropractic physicians practice a hands-on approach to treat
   pain including manual, mechanical, electrical and natural methods, and
   nutrition guidance. Can help with pain management and improve general health.
   Aching or soreness in the spinal joints or muscles sometimes happens—usually
   within the first few hours after treatment.

But here’s how Florida law defines the “practice of chiropractic”:

   a noncombative principle and practice consisting of the science, philosophy, 
   and art of the adjustment, manipulation, and treatment of the human body in
   which vertebral subluxations and other malpositioned articulations and
   structures that are interfering with the normal generation, transmission, and
   expression of nerve impulse between the brain, organs, and tissue cells of
   the body, thereby causing disease, are adjusted, manipulated, or treated,
   thus restoring the normal flow of nerve impulse which produces normal
   function and consequent health by chiropractic physicians using specific
   chiropractic adjustment or manipulation techniques . . .

This is nonsense, of course; pseudoscientific gobbledygook, invented by an
uneducated “magnetic healer” in the late 19th century and dutifully incorporated
into Florida law by the Legislature. There is no such thing as the chiropractic
“subluxation”. Consequently, it cannot interfere with “nerve impulse” or “cause
disease”, nor can it be “adjusted” to “restore normal flow of nerve impulse”
and “consequent health.”

Some chiropractors, such as now-retired Florida D.C. Sam Homola (a guest
contributor here at SBM) do limit themselves to evidence-based treatment of
musculoskeletal conditions with spinal manipulation. On Chirobase, Dr. Homola
gives advice on how to locate a good chiropractor, but also admits “it’s not
easy to find a good, properly-limited chiropractor” and warns that

   “Straight” chiropractors use only spinal adjustments to treat the gamut of
   human illness. They are dedicated to locating and correcting (imaginary)
   vertebral “subluxations,” which they find in everyone’s spine. “Mixer”
   chiropractors offer manipulation with other methods, including such bogus
   methods as homeopathy, megavitamins, colon irrigation, and acupuncture. Both 
   types might attempt to treat organic ailments—one using only spinal
   adjustments and the other using spinal manipulation along with vitamins, etc.
   Both might recommend “maintenance therapy” to prevent the development of
   “subluxations.”

“Chiropractic”, an ambiguous term that encompasses the entire spectrum described
by Dr. Homola (for an overview, see here and here), has been the subject of
numerous posts here on SBM describing, among other things, their many
unsubstantiated claims in preventing or treating diseases and conditions such as
ADHD, bedwetting, ear infections, colic, SIDS, concussions, reflux, autism,
Alzheimer’s, Tourette’s, cancer, asthma and allergies, as well as the dangers of
chiropractic treatment, including stroke, the use of unvalidated diagnostic
testing, and opposition to vaccination. We have also discussed their aggressive 
efforts to promote themselves as primary care physicians, even to the point of
creating the ersatz “specialty” of “chiropractic internist”.

Unfortunately, the physician who is forced by law to provide his or her patient 
with the incomplete and misleadingly benign description of chiropractic will
appear to have endorsed chiropractic practices unless they take the time out of 
an already burdened schedule to disclaim the pamphlet’s contents. Whether the
state can constitutionally mandate a physician to communicate information he or 
she feels is not truthful is a question we’ll return to in a moment.

Again, from the DOH pamphlet:

   Acupuncture: Acupuncturists insert thin needles into the body to stimulate
   specific points to relieve pain and promote healing. Can help ease some types
   of chronic pain: low-back, neck and knee pain, and osteoarthritis pain. Can 
   reduce the frequency of tension headaches. Bleeding, bruising and soreness
   may occur at insertion sites.

Where to begin? First, “acupuncture” is an imprecise term. What kind of
“acupuncture”? By the reckoning of (sadly) former SBM blogger Dr. Mark Crislip
there are

   over 30 different types of acupuncture with many different modes of operation
   and fantasy explanations for their claimed effectiveness.

Second, the traditional Chinese medicine concepts on which acupuncture is based 
are pseudoscience. There are no meridians, no “qi” and “specific points”, i.e., 
“acupuncture points”, do not exist. Third, the evidence simply does not support 
the conclusion that acupuncture “can ease some types of chronic pain.” In fact,

   Acupuncture is a theatrical placebo.

Specifically, there is insufficient evidence to unqualifiedly recommend
acupuncture’s effectiveness for low-back, neck (also here), knee pain,
osteoarthritis pain (also here), and tension-type headaches, especially when
prior probability is considered.

Fourth, the side effects of acupuncture are not limited to “bleeding, bruising
and soreness” as this overview of systematic reviews (available at the time DOH 
composed the pamphlet) concludes:

   Minor and serious AEs [adverse events] can occur during the use of
   acupuncture and related modalities, contrary to the common impression that
   acupuncture is harmless. Serious AEs are rare, but need significant attention
   as mortality can be associated with them.

There are three provider choices for acupuncture treatments in Florida: a
licensed acupuncturist, a physician providing “medical acupuncture”, and
chiropractors, who can be eliminated from consideration based on our previous
discussion.

The licensed acupuncturist’s scope of practice in Florida should give any
healthcare practitioner pause:

   “Acupuncture” means a form of primary health care, based on traditional
   Chinese medical concepts and modern oriental medical techniques, that employs
   acupuncture diagnosis and treatment, as well as adjunctive therapies and
   diagnostic techniques, for the promotion, maintenance, and restoration of
   health and the prevention of disease. Acupuncture shall include, but not be
   limited to, the insertion of acupuncture needles and the application of
   moxibustion to specific areas of the human body and the use of
   electroacupuncture, Qi Gong, oriental massage, herbal therapy, dietary
   guidelines, and other adjunctive therapies, as defined by board rule.
   [Emphasis and link added.]

Acupuncturists can also practice “Oriental medicine”, defined by Florida law as:

   the use of acupuncture, electroacupuncture, Qi Gong, oriental massage, herbal
   therapy, dietary guidelines, and other adjunctive therapies.

The Florida Board of Acupuncture, through rulemaking, has expansively
interpreted the scope of practice to include, among other diagnostic methods and
treatments: auricular, hand, nose, face, foot and/or scalp acupuncture,
moxibustion, cupping, [unspecified] thermal methods, magnets, gua-sha scraping
techniques, reflexology, tongue diagnosis, five element correspondence, German
electro acupuncture, Kirlian photography, and homeopathic remedies.

Query whether one would want to put one’s patient in the hands of someone who
can employ, without limitation as to disease or condition, such a vast array of 
pseudoscience and quackery. Further caution may be warranted when one is made
aware that acupuncturists graduate from acupuncture and Oriental medicine
schools that do not require a college degree, an admissions test, or a minimum
GPA for admission.

“Medical acupuncture” is, according to the American Academy of Medical
Acupuncture, practiced solely by MDs and DOs, who choose treatments “based on
traditional principles such as encouraging the flow of qi”, or “modern concepts 
such as recruiting neuroanatomical activities in segmental distributions, or a
combination of these two principles.”

I have no idea what “recruiting neuroanatomical activities in segmental
distributions” means. The “traditional principles” are based on pseudoscience,
which undermines any notion that “medical acupuncture” is evidence-based. And,
in fact, it took only a few minutes on the internet to find evidence
contradicting the Academy’s claims of acupuncture’s effectiveness for a number
of conditions, including insomnia, asthma, arthritis (also here and here), IBS, 
dysmenorrhea and pelvic pain, abdominal distension/flatulence, and persistent
hiccups.

Finally, briefly,

   Massage therapy: Massage therapists manually manipulate muscle, connective
   tissue, tendons and ligaments. Can relieve pain by relaxing painful muscles, 
   tendons and joints. Can relieve stress and anxiety—possibly slowing pain
   messages to and from the brain. At certain points during a massage, there may
   be some discomfort— especially during deep tissue massage.

Like acupuncture, massage therapy is a non-specific term and the evidence for
effectiveness of massage for pain is actually quite limited. (See also here.)

However one feels about massage therapy, health care practitioners forced to
hand out the DOH pamphlet should be aware that, in addition to traditional
massage, massage therapists push a number of unproven and frankly fantastical
treatments like reflexology, pranic healing, cranial-sacral therapy, zero
balancing, reiki, and polarity therapy, making claims of effectiveness that go
beyond relief from musculoskeletal pain.

Constitutional?

While an extended legal analysis is beyond the scope of this post, I question
the constitutionality of the new law in that it essentially forces physicians to
endorse medical advice with which they may disagree, either on grounds of the
lack of evidence for its safety and efficacy, or on the grounds that a
particular type of health care providers’ practice is so infused with
pseudoscience that it would be irresponsible to recommend it, whether or not
there is evidence of safety and efficacy of any particular treatment.

For example, on Tuesday, a federal judge blocked North Dakota from enforcing a
new law requiring physicians to inform patients it may be possible to reverse a 
drug-induced abortion. The judge ruled that the requirement violated the
doctors’ First Amendment protections against compelled speech. Noting that the
American College of Obstetricians and Gynecologists had rejected the law’s
claims about “reversal” treatments as unsupported by evidence, the judge stated

   State legislatures should not be mandating unproven medical treatments, or
   requiring physicians to provide patients with misleading and inaccurate
   information.

(You can find further discussion of the First Amendment and compelled speech by 
a constitutional law scholar here.)

The State of Florida has gotten in trouble with this sort of thing before when
it tried to interfere with physicians’ discussions of gun safety with patients. 
(Covered here prior to the most recent decision by the 11th Circuit en banc,
which overturned previous decisions upholding the law.) Physicians and their
fellow healthcare providers who oppose being forced to give their patients
ill-conceived state-mandated medical advice should bring the issue up with their
professional associations and regulatory boards.

Florida strikes out against Brian Clement

Jann Bellamy on May 28, 2015

Link





CBC interview with Brian Clement.

Brian Clement is a charlatan. Unfortunately, that doesn’t seem to be a problem
for the State of Florida. I made two (which turned into three) attempts to get
the state to take action against Clement or the Hippocrates Health Institute,
where he serves with his wife Anna Maria Gahns-Clement as co-director. All of
them failed. Brian Clement slithered through the cracks in Florida law each
time.

Before we get into the details of Florida’s failure to act, a bit of history
(and there is plenty of it) is in order.

In recent months, Clement’s sordid cancer quackery has been well-documented in
the media as well as in the science “blogosphere”. (I’ve listed what I hope is a
— but almost certainly isn’t — complete blog archive at the end of this post.
Many of the Canadian Broadcasting Corporation [CBC] and other news reports are
linked in these posts.) Most of the coverage has centered on two Canadian girls 
suffering from lymphoblastic leukemia whose parents pulled them from
conventional cancer therapies, which gave them an excellent chance of survival, 
in favor of treatment at the Hippocrates Health Institute (HHI), a sprawling spa
in West Palm Beach, Florida, licensed as a massage establishment by the state.

Clement gave a talk in Canada, in 2014, claiming “we’ve had more people reverse 
cancer than any institute in the history of health care.” (“We” is the operative
word here, because it later served as Clement’s ticket to avoid prosecution by 
the Florida Board of Medicine, as you shall soon find out.) The girls’ families 
were impressed.

Sadly, one of the girls, Makayla Sault, died earlier this year. The other,
identified only as “JJ” in the media because of a publication ban, has returned 
to conventional treatment. However, her mother apparently remains under the
influence of Clement: JJ is restricted to a raw foods diet and is still being
followed, if that is the right word, by HHI.

Other cancer patients have been lured by the false hope Clement and Hippocrates 
offer: Stephanie O’Halloran, a young Irish woman, the parents of Anael
L’Esperance-Nascimentol, a three-year old Canadian boy who went for treatment
there, Laurie Ann Prince, Kathyrn Tachell and Kim Curry, also Canadians and all 
fairly young, and Lajos Tringer. (Tringer is also considering treatment by
another cancer quack, Stanislaw Burzynski.) Most of these either drained their
own resources or raised funds, or both, to pay the considerable expense of going
to Hippocrates. Unfortunately, we know that Stephanie, Kathryn and Kimhave
died. I’ve been unable to discover the fate of Aneal and Laurie Ann. Lajos is,
as far as I know, still living, but very ill.

Orac, in his inimitable way, has described the services (for lack of a better
term) offered at Hippocrates as “cancer quackery on steroids.”

   Let’s take a look again at the sorts of treatments offered by Brian Clement
   as part of HHI’s “Life Transformation Program“. They include:

  1. Superior nutrition through a diet of organically-grown, enzyme-rich, raw,
    life-giving foods

  2. Detoxification

  3. Wheatgrass therapies, green juice, juice fasting

  4. Colonics, enemas, implants

  5. Exercise, including cardio, strength training and stretching

  6. Far infrared saunas, steam room

  7. Ozone pools, including: dead sea salt, swimming, jacuzzi and cold plunge

  8. Weekly massages

  9. Bio-energy treatments

  10. Med-spa & therapy services

Laughably, Clement claims to be a researcher who is “constantly in a position
where I’m addressing medical conferences and universities,” and has “a body of
evidential science” which demonstrates why he’s observed “tens of thousands of
people recovering from catastrophic disease.” Oddly enough, even though HHI has 
“the number one ratio of having people reverse the aging process and reverse
disease than any other organization in the history of man,” a search of PubMed
does not disclose a single journal article published by Clement. Really, Mr./Dr.
Clement, we implore you, let the rest of the world in on your ground-breaking
discoveries. Publish in a top-flight, peer-reviewed science journal, so more
lives can be saved. He also claims that “we’re in the middle of a study with the
University of California to disprove genetics.” Maybe that research will show
up soon in the medical literature. We can only hope.

With that background, we’ll turn to the State of Florida and its failure to stop
Brian Clement, who, as we shall see, has embarked on yet another international 
speaking tour.

Strike one: Operating a healthcare facility without the appropriate state
license

I filed a complaint against Hippocrates Health Institute with the Florida Agency
for Health Care Administration (AHCA) for operating a health care facility
without the proper state license. (Regrettably, none of the AHCA or Florida
Department of Health documents I mention in this post are available online.)
AHCA licenses health care facilities, such as health clinics and hospitals. As I
did with my complaint against Clement, which we’ll get to in a minute, I
informed AHCA that these allegations were not based on personal knowledge, but
rather upon Canadian media reports. However, in light of what I had read, I felt
an obligation to report Clement and Hippocrates to the state. It appeared to me
that the health of these girls and others was at stake and that it was
appropriate for the state investigate what was going on.

According to a January 28th email from AHCA:

   After some additional Agency research, unfortunately this “Health Center”
   does not meet the definition of a Health Care Clinic, see [Florida Statutes] 
   Section 400.9905(4),

   “Clinic” means an entity where health care services are provided to
   individuals and which tenders charges for reimbursement for such services,
   including a mobile clinic and a portable equipment provider.

   Since this institute is a cash-only business, it does not fall under AHCA’s
   regulation. The only recommendation I have, is to file complaints with the
   Department of Health (Board of Medicine) against the individual doctors,
   thanks.

In other words, since Hippocrates doesn’t get reimbursed by third party payers, 
such as health insurance companies, it does not need a license and AHCA had no
jurisdiction to do anything about the clinic.

A Senate bill was introduced this year in the Legislature to eliminate this
loophole in the health care licensing law.

According to Sen. Eleanor Sobel, one of the bill’s sponsors,

   flimflam artists and snake-oil salesmen have escaped state scrutiny by
   running clinics that accept only cash.

Like Clement and Hippocrates, for example.

It wouldn’t matter anyway. Hippocrates would have been exempted if the bill had 
become law (it died in committee). The licensing law exempts non-profits. The
IRS has granted Hippocrates tax-exempt status as a Section 501(c)(3) charitable 
organization. A non-profit that, according to its 2013 tax return, paid Brian
Clement and his wife, Anna Maria, together about $1 million dollars in salary,
bonuses and other unspecified income, has $30 million in assets, and took in
over $17 million in revenue.

What Hippocrates does have is a massage establishment license issued by the
Board of Massage Therapy, for which it pays the paltry sum of $100 per year. The
law seems designed to prevent houses of prostitution from operating as
fictitious massage parlors, but rank quackery doesn’t appear to be a problem as 
far as licensing goes.

Strike Two: Department of Health v. Brian Clement, Case No. 2014-19139

On November 13, 2014, I filed a complaint with the Florida Department of Health 
against Clement for practicing medicine without a license. (The Medical Quality 
Assurance [MQA] division of the Department investigates unlicensed practice
complaints as well as complaints against licensed health care practitioners.) I 
explained to the MQA that I didn’t have any personal knowledge about Clement’s
conduct, but was reporting him based on news stories covering Makayla’s and JJ’s
treatment at Hippocrates, including the report that his degrees were from
diploma mills and the fact that he is not a state licensed health care
practitioner, although he says he’s an NMD on HHI’s website. I specifically
included his statements about “reversing cancer,” Makayla’s grave medical
condition at the time (I later reported that she had died) and the fact that HHI
was continuing to provide care by analyzing the child’s blood test results
which are sent by mail. Later, I spoke to an investigator with MQA and gave her 
links to the HHI website and to a number of Canadian media reports.

On February 10, 2015, the Department of Health issued a “Notice to Cease and
Desist” in the case, stating that:

   the Department has probable cause to believe that Brian Clement of
   Hippocrates Health Institute . . . is not licensed by the Department or the
   Board of Medicine and is practicing medicine without a license. . . .

   Wherefore, . . . Brian Clement . . . is hereby notified to cease and desist
   from practicing medicine in the State of Florida unless and until Brian
   Clement is appropriately licensed by the Department.

The Department also ordered Clement to pay a fine of $2 500 and costs of $1 238.

On February 16th, an “Unlicensed Activity Investigative Report” was issued by
the Department. As investigations go, it seems pretty cursory. It contains
copies of only two of the many news reports and one of the many blog posts. Also
attached are printouts from the HHI website detailing the appalling quackery
offered there, which seems to have bothered exactly no one at the Department.

An investigator went undercover to an appointment with Clement, which elicited, 
as might be expected, only quack recommendations (including the sale of
merchandise from HHI) but no smoking gun statements to the effect that Clement
is an MD or specific medical diagnoses or treatments.

The report says that the investigator did not attempt to obtain a release of
patient information authorization from the Canadian girls because “their names
were not provided or noted in the Canadian News Release,” even though Makayla’s 
name is clearly given in one of the news stories attached to the investigative
report itself, as well as in links to other information provided by me. And it
seems that the Department could have at least attempted to discover the identity
of JJ through contacting the Canadian government. After all, the ban is on
publication of her name, not giving it to the authorities in another
jurisdiction doing an investigation of alleged criminal activity. (Practicing
medicine without a license is a felony in Florida and, according to the
Department, the Sheriff’s Office was notified, although I have a feeling that
one will go nowhere too.)

Another person not contacted was Steven Pugh, RN, who is suing the HHI and
Clement over his being fired for refusing to follow Clement’s orders. According 
to a CBC news report, published well before the investigative report was issued,
Pugh maintains he could not legally do what Clement told him because the orders
were not issued by an MD. Pugh also reported to the CBC that Clement told
patients he could “cure” them, prescribed treatments for them, would overrule
what their physicians told them and used the term “Dr.” with patients (as he
formerly did on the HHI website). Most disturbingly:

   They (Clement and his wife) also placed restrictions on when staff could call
   an ambulance to take patients for emergency medical care at local hospitals,
   according to Pugh and other former staff.

According to this same news story, the CBC has interviewed both past and present
employees who are disturbed by the Clements’ treatment of cancer patients. It
also reports that a former HHI physician is suing for breach of contract,
alleging he was terminated after he documented concerns that what he was being
asked to do at HHI could be illegal.

A search of the public records (in this case, of the 15th Judicial Circuit
Court) would have revealed Pugh’s suit, along with two others, against HHI.
You’d think a decent investigation would, at the very least, include a search of
the public records of the state doing the investigating.

All of this leads me to conclude that the Department should hire the CBC to do
its investigations. They do a much better job.

Much to my surprise, I learned from – you’ll not be surprised – the CBC, that
the Department, citing insufficient evidence, had dropped all charges against
Clement. I called the Department for more information but my call was never
returned. Later, when I called about the Department’s second complaint against
Clement (see “Strike three,” below), I was told by a Department official why
they couldn’t prosecute Clement for the unlicensed practice of medicine. He
explained that HHI has a physician on its staff and, by Clement always using the
collective “we” (as in, “we can reverse cancer”), he personally was not
practicing medicine.

Since we’re on the subject, HHI has a new physician as Medical Director, Tina
Discepola, MD. I wondered what sort of physician would associate herself with an
operation like HHI and a guy like Clement, especially in light of their
well-publicized troubles. Even if you fully believed in what they were doing,
you’d have to be wary of stepping into the hornet’s nest of litigation and
on-going investigations by the Department of Health. (Pugh has filed his own
complaint against Clement.)

In any event, Dr. Discepola is certainly well acquainted with, shall we say,
unconventional medical practices. According to her HHI bio, although
board-certified as an emergency medicine doctor, she formerly practiced
Functional Medicine in New York. She is also into acupuncture and cranial sacral
manipulation. She is a Diplomate of the American Board of Integrative Holistic 
Medicine, Andrew Weil’s brainchild, a Diplomate of the American Board of
Anti-Aging Medicine (also, here) which is not recognized as a specialty board by
any of the medical specialty-credentialing organizations, and is an “active
member” of the American College for the Advancement of Medicine, ditto.

Curiously, while she holds an active license to practice medicine in Florida,
according to the Department of Health’s Practitioner Profile, she still lists
New York as her residence and states that she does not practice in Florida. I
understand that Dr. Discepola is new to Florida, and is likely unfamiliar with
the laws and regulations governing medical practice in this state, but she may
want to review them, including the state’s rules on physician advertising.

Dr. Paul Kotturan, the former Medical Director, is still on staff, running the
“Vida Building” operation, which must surely contain more quackery per square
foot than any other building in the state, including, for example, the Aqua Chi 
ionic detox footbath, which, if it works as advertised:

   Your meridians are permeated and re-aligned back to their original strength
   and placement.

If there is a medical device equivalent of homeopathy, the detox footbath is it.

Strike three: Dietetics & Nutrition Practice Council v. Brian R. Clement, Case
No. 2014-19150

In a letter dated March 24, I learned that this complaint had been reviewed by
legal staff and recommended for submission to the next Probable Cause Panel. The
complaint was another surprise from the Department for me, because I didn’t
even know this particular complaint had been filed until the Department sent me 
an earlier letter.  This time, according to the complaint, it was because
Clement illegally used the initials “NMD,” which stands for “Naturopathic
Medical Doctor.”

Clement is a licensed nutritional counselor in Florida, but is not a licensed
naturopath. (Florida used to licensed naturopaths, but stopped issuing licenses 
in the 1950s, although the state allowed those with ND licenses to continue
their practices. To my knowledge, none of these licensees are still practicing.)
As with all types of health care practitioner licensing, nutritional counselors
are required to follow certain laws and administrative rules. The complaint
alleged Clement violated three separate provisions in advertising himself as an 
NMD.

Based on this, one might say that the Department of Health is charging Clement
with practicing quackery without a license, but that’s not how they see it.

“Nutrition counselors” are no longer licensed in Florida either, but those like 
Clement and his wife who hold nutrition counselor licenses, can still practice. 
The state now licenses only registered dietician/nutritionists, who must meet
more rigorous requirements than nutrition counselors. (Both are regulated by the
Dietetics & Nutrition Council, which operates under the auspices of the Board
of Medicine.) Neither of the Clements have the qualifications for the newer
license, at the least because they didn’t graduate from an accredited school nor
have they taken the current licensing exam.

Nutrition counselors are, by law, limited in their practices to advising people 
on appropriate nutrition intake by integrating information from an evaluation of
nutritional needs, using appropriate data to determine those needs, and making 
appropriate nutrition recommendations.

It is striking to me that, given the reams of material documenting Clement’s
inappropriate nutrition advice, it never occurred to the Department to add a
count or two to the complaint for substandard practice as a nutritional
counselor. What about wheatgrass, which, as Orac points out, Clement seems to
regard as a virtual panacea, and raw foods diets? And what about wheatgrass
enemas? Is that an “appropriate” nutrition recommendation?

In the Department’s investigative report, mentioned earlier, we learn that the
investigator reviewed the Hippocrates website and confirmed that Clement was
using the title NMD. (Gee, notice anything else, Mr. Investigator?) The report
notes that Clement had been issued an informal Notice to Cease and Desist in the
past for advertising and using the title NMD on the website. Later, when the
undercover investigator revealed his true identity, Clement denied using the
title “Naturopathic Medical Doctor” on the Hippocrates website, despite all the 
evidence to the contrary.

Brian Clement no longer uses the honorific “Dr.” nor does he list the initials
“NMD” on the website. He still uses PhD on his bio page, and the covers of books
advertised at the bottom of the page identify him as being an NMD. He says
nothing about where he earned any of the claimed degrees. He has been referred
to as “a naturopath” or “Naturopathic Medical Doctor” in a couple of news
reports, information they must have gotten from somewhere. (Also: “a formally
trained biochemist.”)

Clement has variously claimed his degrees came from University of Science, Arts,
and Technology (USAT), where he says he earned his PhD and NMD, and Lady Malina
Memorial Medical College, where he says he earned a post-grad degree.
(Interestingly, for both Brian and Anna Maria, no undergraduate degree is ever
mentioned.) But those institutions have been called out as diploma mills in both
a CBC report and academic literature. The president of USAT denies Clement was 
granted an NMD degree by his school.

Anna Maria Ghans-Clement’s HHI bio say she has a PhD in nutrition from “Denmark 
University” but I could not find that any such institution exists. It refers to 
her as “working on her nursing degree,” implying that she has one, but does not 
say whether the degree requirements were completed. Her book covers also show
her as having an NMD and one of her book covers shows the book as being authored
by “Dr. Anna Maria Clement.”

Nevertheless, once again, the Department backed off. According to the
Department’s letter to me of May 20, the probable cause panel determined that
probable cause existed to support prosecution of Clement for allegations set
forth in the complaint. However:

   after the finding of probable cause, the Department discovered correspondence
   from [Clement’s] counsel that was not available to the probable cause panel 
   during consideration of the case. As a result of this new information, the
   Department dismissed the Administrative Complaint due to insufficient
   evidence to prosecute.

They don’t say what information was “discovered” in this letter. A Department
official did tell me in a phone conversation that Clement does, in fact, have an
NMD degree and that, while he can’t practice as a naturopath, he is not
prevented from using those initials after his name. I informed the official
that, to my knowledge, he does not have an NMD degree, information that seemed
to surprise him. In fact, the denial was reported by the CBC (yes, them again)
in 2014, well before the Department acted.

So, where in the world is Brian now? According to his busy speaking schedule he 
is, at this moment, at the “Real Truth About Health” conference in Orlando where
he is identified as an NMD. Then he is off to New York to lecture. (At the
Manhattan lecture, attendees will get 10% off HHI’s three-week “Life
Transformation Program,” a “$600 value.” Which means, if you do the math, the
three weeks normally costs $6,000.) After that, it’s Europe: Norway, Sweden, the
UK (he’s still a naturopath according to one of the London announcements),
Ireland, Germany (“Dr. Clement”), France, Switzerland and Holland. The
announcements indicate Clement is being circumspect about what he says, but who 
knows what he’ll do when he actually gets there. Clement doesn’t seem like the
type who can resist grandiose pronouncements regarding his many self-proclaimed 
talents. And, of course, once within the confines of the vast acreage of the
privately owned (but taxpayer supported) Hippocrates campus, he is virtually
free from scrutiny.

The Brian Clement/Hippocrates Health Institute blog archive

Science-Based Medicine

  1. Ontario fails to protect the life of a first nations girl with cancer

  2. Brian Clement and the Hippocrates Health Institute finally under the
    spotlight, but will it matter?

  3. An aboriginal girl dies of leukemia: Parental “rights” versus the right of a
    child to medical care

  4. Florida tells Brian Clement to stop practicing medicine

  5. Florida strikes out against Brian Clement

  6. Brian Clement claims Hippocrates treatments “reverse” multiple sclerosis

Respectful Insolence

  1. When false hope leads well-meaning people astray

  2. An Ontario court dooms First Nations girl with cancer

  3. An Ontario court dooms a First Nations girl with cancer: Who’s to blame?

  4. A tale of two unnecessarily doomed aboriginal girls with leukemia

  5. J.J. has a chance to live!

  6. Brian Clement and the Hippocrates Health Institute: Cancer quackery on
    steroids

  7. Finally, the State of Florida acts against Brian Clement and the Hippocrates
    Health Institute

  8. Wheatgrass quack Brian Clement returns to the scene of the crime in Six
    Nations

Society for Science-Based Medicine

  1. Canadian reporters cover Florida health scam ignored in US

  2. Florida retracts cease and desist order and fine against Brian Clement

  3. Florida files second complaint against Brian Clement

  4. Cancer quack Brian Clement: canceled in Ireland, protested in the UK

  5. Cancer quack Brian Clement’s Scadanavian tour goes south

Other blogs

  1. The Seduction of Cancer Quackery

  2. Hippocrates Health Institute: Five reasons not to spend $4,000

  3. Staff of controversial Florida alt med spa sues claiming illegal and unethical
    practice

Florida tells Brian Clement to stop practicing medicine

Jann Bellamy on March 5, 2015

Link





Screenshot of the Hippocrates Health Institute’s website

Note: Also posted today is a brief profile of a new blog, Naturopathic Diaries: 
Confessions of a Former Naturopath, by Britt Marie Deegan Hermes, a trained
naturopath who became disillusioned with her profession. I encourage you to have
a look!

The State of Florida has finally taken action against Brian Clement.

David Gorski, Orac, and the Canadian media, especially the Canadian Broadcasting
Corporation (CBC), have done an excellent job of chronicling the activities of 
“Dr.” Clement. All have reported on Florida’s taking action against Clement.
I’ll give a brief background here, most of which comes from Dr. Gorski’s most
recent post, as well as add some information and observations to theirs.

Hippocrates Health Institute, located in West Palm Beach, Florida, is licensed
as a massage establishment by the state and run by Brian Clement and his wife,
Anna Maria Gahns-Clement. Clement and Hippocrates came to the attention of the
Canadian media when, last year, the families of two Canadian aboriginal girls
withdrew their children from conventional cancer treatment, including
chemotherapy. Prior to that, Clement had basked in the glory of fawning reports 
from local media, one of which described him as having an “inimitable, engaging 
style.” Another described him as coming “fresh from a detoxifying sauna” to the 
interview.

Had they completed conventional treatment, both girls had a very good chance of 
survival. The families opted instead for traditional medicine as well as
“alternative medicine” at Hippocrates. Each paid a reported $18,000 for
participation in a “Life Transformation Program” there. This included, for at
least one of the girls, cold laser therapy, vitamin C injections and a strict
raw vegetable diet.

Sadly, one of the girls, Makayla Sault, died in January. The other girl cannot
be identified due to a court-ordered publication ban, but is referred to as “JJ”
in news reports. As of last November, Hippocrates was still providing care for 
JJ by analyzing blood test results sent by mail. According to her mother, JJ
must maintain a raw diet for two years with absolutely no sugar, presumably at
Clement’s direction.

In previous statements, Makayla’s and JJ’s mothers identified Clement’s
assurances of successful treatment at Hippocrates as the reason they decided to 
stop conventional cancer treatment. After all, why would any parent pay that
kind of money and take her child out of the country had she not been convinced
by someone that this considerable effort offered a real possibility of saving
her daughter’s life? However, they are now walking back from those statements.
The families are claiming that the girls’ trips to Hippocrates were a “family
vacation.”

Clement has been fudging on his credentials, referring to himself variously as a
naturopathic doctor, an NMD [naturopathic medical doctor] and a Ph.D. He has
used the honorific “Dr.” (as recently as last November, on the HHI website) and 
called himself a “scientist.” But his degrees are from diploma mills. He is
correct in claiming he is licensed by the state a nutritionist, a matter we’ll
return to in a moment. His bio on the Hippocrates website is more circumspect
since his troubles started. He still claims he is a Ph.D and is LN (licensed
nutritionist).

Clement has made some wildly exaggerated claims about the effectiveness of
treatments offered at Hippocrates. He’s asserts that “thousands and thousands”
of people have “reversed” their cancer via Hippocrates treatments. He was
recorded on video as saying:

   We have the longest history on the planet Earth, the highest success rate on 
   the planet Earth, of people healing cancer.

In response to the question “What ailments have you cured by putting your
patients on a vegan diet?” posed on another video, he said:

   Every known disease. Of course, we’re most notable for all of the people that
   have healed cancer.

And, in another video:

   We’ve seen thousands and thousands of people reverse stage-four catastrophic 
   cancer.

Medical experts have been widely quoted in news accounts debunking various
nostrums offered there. David’s post last week thoroughly deconstructs these
treatments:

   They include almost every imaginable form of cancer quackery, including
   “detoxification,” colonics, wheatgrass, ozone pools, “bio-energy treatments,”
   the aforementioned “Cyber Scan,” and, of course, the Aqua Chi “detox
   footbaths.” One particularly silly treatment offered by HHI is called a
   “wheatgrass implant”, which, it turns out, are actually wheatgrass juice
   enemas. Indeed, if you believe the hype on the HHI website, there’s nothing
   that wheatgrass can’t do. If the HHI is to be believed, wheatgrass can
   increase red blood cell count, decrease blood pressure, cleanse the blood,
   organs and GI tract of “debris,” stimulate the thyroid gland, “restore
   alkalinity” to the blood, “detoxify” the blood, fight tumors and neutralize
   toxins, and many other fantastically beneficial alleged effects. Basically,
   combine a raw vegan diet with a veritable cornucopia of other kinds of
   quackery, and you have the HHI.

Unlicensed practice

Practicing any licensed health care profession without the appropriate license
is a third-degree felony in Florida, with a penalty of up to 5 years in jail and
a $5,000 fine. It is subject to administrative sanctions as well, such an order
to cease and desist and a fine. According to the Florida Department of Health
(DOH):

   The Unlicensed Activity (ULA) program protects Florida residents and visitors
   from the potentially serious and dangerous consequences of receiving medical
   and health care services from an unlicensed person. The ULA unit
   investigates and refers for prosecution all unlicensed health care activity
   complaints and allegations.

   The ULA unit works in conjunction with law enforcement and the state
   attorney’s offices to prosecute individuals practicing without a license. In 
   many instances, unlicensed activity is a felony level criminal offense. More 
   importantly, receiving health care from unlicensed people is dangerous and
   could result in further injury, disease or even death.

And:

   investigations involving the unlicensed practice of a healthcare profession
   are criminal investigations that require the development of sufficient
   evidence (probable cause) to present to law enforcement or file charges with 
   the State Attorney’s Office in the county of occurrence.

Florida law defines the practice of medicine as:

   the diagnosis, treatment, operation, or prescription for any human disease,
   pain, injury, deformity, or other physical or mental condition.

Last November, I filed a complaint against Brian Clement for the unlicensed
practice of medicine with the DOH. I also filed a complaint against Hippocrates 
Health Institute with the Florida Agency for Health Care Administration (AHCA)
for operating a health care facility without the proper state license. AHCA
licenses health care facilities, such as health clinics and hospitals. As I
stated in the complaints, these allegations were not based on personal
knowledge, but rather upon Canadian media reports. However, in light of what I
had read, I felt an obligation to report Clement and Hippocrates to the state.
It appeared to me that the health of these girls and others was at stake and it 
was appropriate for the state investigate what was going on.

The AHCA complaint was resolved first, with a surprising result. According to a 
January 28th email from AHCA:

   After some additional Agency research, unfortunately this “Health Center”
   does not meet the definition of a Health Care Clinic, see [Florida Statutes] 
   Section 400.9905(4),

   “Clinic” means an entity where health care services are provided to
   individuals and which tenders charges for reimbursement for such services,
   including a mobile clinic and a portable equipment provider.

   Since this institute is a cash-only business, it does not fall under AHCA’s
   regulation. The only recommendation I have, is to file complaints with the
   Department of Health (Board of Medicine) against the individual doctors,
   thanks.

In other words, since Hippocrates doesn’t get reimbursed by third party payers, 
such as health insurance companies, it does not need a license and AHCA had no
jurisdiction to do anything about the clinic.

Interestingly, by not accepting insurance, Hippocrates avoids the usual
limitations on insurance reimbursement for unproven treatments, typically deemed
“experimental” in insurance policies and therefore not covered. It is thus able
to escape any scrutiny a health insurer would normally apply to the treatments 
offered there, scrutiny that might otherwise raise suspicions among its clients 
when their insurance claims were denied.

The other complaint against Clement met with more success. On February 10th, I
learned that DOH had taken action. First, DOH issued a Notice to Cease and
Desist, saying

   The Department has probable cause to believe that Brian Clement of
   Hippocrates Health Institute . . . is not licensed by the Department or the
   Board of Medicine and is practicing medicine in violation of [state law]. The
   practice of medicine without an active, valid license or permit is strictly 
   prohibited [by law] and constitutes a crime.

   Wherefore, in accordance with [state law], Brian Clement . . . is hereby
   notified to cease and desist from practicing medicine . . . unless and until 
   Brian Clement is appropriately licensed by the Department.

An event that, we can safely assume, won’t take place.

It goes on to state that, if he violates the Notice, DOH can seek a court order 
to stop the violation and recover attorneys’ fees and costs.

DOH also issued a citation in the amount of $3,738 ($2,500 fine plus costs) for 
practicing or attempting to practice medicine without a license.

There is no right of appeal from the cease and desist notice but he can
challenge the citation. Clement can request an administrative hearing within 30 
days. This means he would have an opportunity to introduce testimony and
evidence on his behalf before an Administrative Law Judge. The state, of course,
would introduce testimony and evidence supporting the citation. If he loses, he
can file an appeal to a state appellate court. If he does not challenge the
citation, he would not get a hearing and the citation becomes a final order of
the agency. However, he can still get another crack at it by filing an appeal,
although his ability to argue against his being cited would be greatly limited.

According to Clement’s PR person, to whom we’ll return in a moment,

   We deny these allegations from the Department of Health in their entirely and
   are vigorously contesting these allegations through the administrative
   process.

So it looks like Clement will be requesting a full administrative hearing.

DOH also notified Clement that

   THE CITATION DOES NOT PREVENT OTHER ADMINISTRATIVE, CIVIL OR CRIMINAL
   PROSECUTION INVOLVING THE SAME FACTS AS USED IN THIS AGENCY ACTION.

And indeed, the investigative report states that DOH notified the Palm Beach
County Sheriff’s Office about the matter on February 13th. Prosecution would be 
handled by the State Attorney.

In the investigative report accompanying the citation and notice, we learn that 
the DOH investigator reviewed the Hippocrates website and confirmed that Clement
was using the title NMD. The report notes that Clement had been issued an
informal Notice to Cease and Desist in the past for advertising and using the
title NMD on the website.

The report says that the investigator did not attempt to obtain a release of
patient information authorization from the Canadian girls because “their names
were not provided or noted in the Canadian News Release.” This omission is
curious because Makayla’s name and location were in several news reports and I
mentioned her as well in my communication with DOH.

We also learn that a DOH investigator, who also reviewed the website and media
reports, went undercover to Hippocrates on February 10th for an appointment with
Clement, using an assumed name. He discussed his (unidentified) medical
condition with Clement who gave him a “menu.” Based on the exhibit referred to
in the report, this menu is a handwritten list, as follows:

   Lifegive [a brand sold by Hippocrates] internal cleanser

   2 AM, 2 PM

   Mon, Wen, Fri, Sun

   Lifegive B12

   1 every morning

   Pollen, teaspoon AM, PM

   Quinoa Burger

   Rice Pasta

   Non Soy Burgers

   Amy [brand?] Dinners

   All Grains

Clement asked the investigator to provide a copy of his blood screen results;
presumably, the blood screen was done prior to the appointment. Clement also
gave the investigator a “specimen collection box” and told him to forward a
sample to the company listed on the box. An attached exhibit shows a “fecal
collection specimen box.” According to the report, Clement didn’t diagnose the
investigator but said that the Hippocrates “medical team would review” his file.

Later, when the investigator revealed his true identity, Clement denied using
the title “Naturopathic Medical Doctor” on the Hippocrates website despite his
earlier run in with DOH for that exact thing.

A letter from DOH dated February 23rd notified me that “Dietetics & Nutrition
Practice Council v. Brian R. Clement” was under review and, after an
investigation, the DOH’s attorneys would look at the case and make a
recommendation to the probable cause panel of the Council. (The Council operates
under the auspices of the state medical board.) Although it is not clear, it
appears as if DOH views me as the complainant in that case as well although my
complaint did not include any allegations specifically regarding his nutritional
counselor license.

Clement does hold a “clear/active” license to practice as a nutrition counselor.
Florida no longer licenses nutrition counselors but they were grandfathered in 
under a newer law licensing dietetics/nutritionists, who have a broader scope of
practice. Because they are no longer licensed, the statute does not tell us
what the original educational and training requirements were.

By law, nutrition counselors can evaluate a person’s nutrition needs:

   using appropriate data to determine nutrient needs or status and make
   appropriate nutrition recommendations.

One would assume that “Lifegive internal cleanser” and pollen are not an
“appropriate” nutrition recommendation but I do not know if that is the basis of
the complaint. It could be that his credentials were not in order when he
applied.

Other legal problems and a PR offensive

According to media reports, Clement’s troubles with DOH are not his only legal
problems. A complaint filed against Hippocrates with the Federal Trade
Commission remains open. Several former employees, including the former director
of nursing and an MD, are suing him over allegations that they were fired when 
they expressed concerns about Clement and other employees practicing medicine
without a license. One RN alleges he was fired for refusing to follow Clement’s 
orders, which could be legally given only by an MD.

It is interesting that the Board of Directors of Hippocrates has not, to my
knowledge, asked Clement to step aside pending resolution of these legal
troubles, if not outright fire him. They would certainly be within their rights 
to do so absent some contractual arrangement with Clements that nixes his being 
ordered to stop practicing medicine as a firing offense, which is unlikely. It
makes one wonder how closely the Board is overseeing the operations at
Hippocrates.

Clement and/or Hippocrates have hired a top Florida PR firm to help handle the
media heat. One can hardly blame them, considering the fact that Clement’s media
interviews were just making him look like, well, like himself. Vicki Johnson,
the PR firm’s VP, accused the Toronto Star of taking Clement’s “thousands and
thousands” statements “out of context.”

   As (Clement) has repeatedly emphasized, what Hippocrates does is educate
   people about the benefits of raw foods and exercise, and how a healthy
   lifestyle arms the body to fend off disease and in many cases heal itself.

Johnson might want to consider relying on medical information from someplace
other than Hippocrates before she speaks to the media.

Johnson claims that all blood tests are administered by a medical professional
and reviewed by the medical director. All Clements and his wife do is review the
“guest’s” health history, including blood tests, to make nutritional
recommendations. She says the medical director is responsible for all medical
decisions. As the article points out, Hippocrates houses as many as 100 people
at a time but has only one licensed medical director, Dr. Paul Kotteran. Sounds 
like a busy guy.

Johnson also challenged criticisms from a former Hippocrates employee who
accused Clement of getting “as much money as possible” from deathly ill people:

   He has dedicated his life to the health and well-being of his guests . . .
   Hippocrates grants thousands of dollars’ worth of scholarships to guests on
   an annual basis.

Lucky them.

Clement himself has also denied as “erroneous” a 2013 tax return filed with the 
IRS reporting his income as $529,000 and his wife’s at $432,000. We’ll see if an
amended tax return is filed, as is required by federal law.

Clement and Hippocrates are clearly in the sights of the media and the
blogosphere. The lawsuits by employees, the FTC action, the Florida Department
of Health’s continuing investigation and the possibility of criminal charges
will all be followed. Too bad Clement and Hippocrates have been able to
successfully rake in millions of dollars by scamming so many people, some of
whom died after they withdrew from conventional treatment, before the state
decided to act.

What will be the actual effect of the Notice to Cease and Desist and Citation on
Clement? That remains to be seen. Neither requires that the quack treatments or
sales pitches to gravely ill people and their families be stopped. Hippocrates 
can continue to operate as a “massage establishment.” Clement will not suffer
any penalty (other than the citation) for what he has done unless the FTC or
state attorney take action. Any recovery in the suits brought by employees would
go to them, not to the families of those who stopped treatment and died.
Hopefully, the FTC and the state attorney will act to ensure more people don’t
die because they abandoned conventional treatment for quackery.

UKs Phased Smoking Ban

Steven Novella on April 17, 2024

Link



UK MPs have just passed the Tobacco and Vapes Bill by a 383 to 67 vote. If the
measure becomes law it will ban the sale of tobacco products to anyone born
after January 1, 2009. This is not just an age limit – this is a permanent
phased ban. If the law passes and stands, anyone born after that date will never
be able to purchase tobacco products in the UK.

The measure has sparked another round of the endless debate regarding the role
of the government in protecting people from themselves. Even ardent defenders of
SBM can have good faith disagreements on this issue, as ultimately it is a
value judgment regarding competing principles. Personally I find the arguments
in favor of the ban far more compelling, but I can understand those who choose
to prioritize individual liberty and worry about government overreach into our
personal lives.

Such debate should at least be based on some shared understanding of the facts, 
so let’s review some of them. In 2024 we shouldn’t have to spend too much time
defending the overwhelming consensus of scientific opinion that smoking is a
significant health risk, but here’s the data. I’ll give some UK and US numbers
for comparison.

In 2022, 12.9% of adults 18 and over in the UK were current smokers. In the US
the percentage is 11.5%. The health impacts are significant. “There were 506,100
hospital admissions due to smoking in 2019/20, and in 2019 there were 74,800
deaths attributed to smoking among adults aged 35 and over.” In the US,
according to the CDC, “Cigarette smoking kills more than 480,000 Americans each 
year.” This makes smoking the leading preventable cause of death.

What about the cost to society? Again from the CDC – “Cigarette smoking cost the
United States more than $600 billion in 2018, including more than $240 billion 
in healthcare spending and nearly $372 billion in lost productivity.” In the UK 
– “Smokers’ need for health and social care at a younger age than non-smokers
also creates costs, with smoking costing the NHS an additional £2.4bn and a
further £1.2bn in social care costs.”

Smoking, therefore, has a significant cost to society in both money and lost
health, and it is entirely preventable. Much of this cost is born by the
government, which gives it a legitimate interest in reducing this cost.

Do smoking bans work? The short answer is yes. Social bans on smoking reduces
smoking and its health consequences, as does taxes on tobacco products. There is
also evidence that bans on smoking in public places reduces the negative health
effects of second-hand smoke.

From what I can see so far, the debate over the phased ban in the UK is focusing
on the issue of liberty, not contesting the science. This is good as that is
where the debate should focus, because the science at this point is fairly
clear. Tobacco use is a demonstrable health risk, it is very costly to
individuals and society, and laws that make smoking more difficult are effective
at reducing the behavior, improving health, and saving money. So the only
questions that really remain are those surrounding personal liberty.

But there is one more science-based consideration that impacts the question of
liberty – the addictive potential of nicotine and smoking. Nicotine acts upon
the same dopaminergic system as other addictive drugs, in the nucleus accumbens.
But it has neurological effects beyond dopamine, affecting the “GABAergic,
serotonergic, noradrenergic, and brain stem cholinergic” systems.  

Further, because of the mechanism of drug delivery, nicotine can affect the
brain within 20 seconds of inhaling. This strongly reinforces the
pharmacological addiction and also the behavioral addiction. The consensus is
that nicotine is as addictive as heroine, opioids, and cocaine, and some argue
it may be more addictive.

About 68% of adults who smoke report that they would like to quit but find it
difficult because of addiction. In 2018 55% of smokers made an attempt to quit, 
but only 7.5% did. Further, most people who regularly smoke began smoking by the
time they were 15 years old. This significantly complicates the argument that
smoking bans are an infringement on the liberty of adults.

Essentially people start smoking when they are teenagers, and their ability to
control their behavior and make strategic life decisions is not yet fully
developed. They then become addicted to nicotine and smoking, which locks in
this behavior into adulthood. When they are ultimately old enough to decide that
they do not want to smoke, they are already addicted and find it extremely
difficult to quit. It is highly problematic to defend this scenario as the
liberty of informed adults to make decisions for themselves.

Even worse, there is evidence that the tobacco industry targeted teenagers,
specifically because they understood the above dynamic. We are now seeing this
cycle repeat with vaping.

This is an interesting more general question – how does addiction affect liberty
and personal choice? Is a decision that someone makes under the influence of
biological and psychological addiction truly a free choice and an expression of 
their individual liberty? I think there is a strong case to be made that the
answer is no. But people generally don’t like to think of themselves as
biological machines, or that our freedom can be so mechanistically compromised.

There is still room for debate about the proper role of government and where we 
draw the line on micromanaging individual behavior. But I don’t think
superficial platitudes about “liberty” are sufficient. Any discussion has to
account for the health effects of tobacco, the cost to society, and the role
that addiction plays in individual behavior.

Framing is also important here. We can simply frame the issue as one of consumer
protection. Tobacco is a harmful and addictive product. If something similar
were introduced today, it’s difficult to see that it would garner regulatory
approval.

State Attorneys General pursue consumer protection law claims against stem cell 
clinics

State Attorneys General are pursuing stem cell clinics offering unproven
therapies and engaging in fake clinical trials using state consumer protection
and false advertising laws, seeking monetary penalties and injunctive relief.
Until there is rational, comprehensive stem cell regulation, these actions can
help fill the regulatory gap.

Jann Bellamy on March 24, 2022

Link



State Attorneys General have recently filed actions against stem cell clinics
whose outsized claims for their treatments far outstripped the evidence. Today
we’ll look at several of these cases and see how the states are helping fill the
gap caused by the lack of effective regulation for these relatively new
therapies.

Stem cell clinics are ubiquitous in the U.S. and, unfortunately, too many make
claims of effectiveness that are not backed by sufficient evidence for any
number of conditions, including Parkinson’s disease, ALS, stroke, traumatic
brain injury, and spinal cord injuries. In addition to overstating the success
of their treatments, some clinics enroll patients in what are essentially fake
clinical trials, charging thousands of dollars to participate. Both financial
and physical harms (for example, blindness) from worthless stem cell treatments 
have resulted.

Because stem cell therapies are relatively new, regulation is playing catch up. 
Some therapies are considered drugs or biological products by the FDA and are
therefore regulated as such. Others are not. Where to draw the line between the 
two is a point of contention between stem cell clinics and the FDA.

The Federal Trade Commission (FTC), with its jurisdiction over “unfair or
deceptive acts or practices in or affecting commerce”, including advertising
claims, can also serve as a means of regulating stem cell clinics, although
unfortunately after-the-fact. Rather than haggling over whether or not a therapy
is subject to FDA regulation, the FTC asks, more simply: “Are your claims
backed by competent and reliable scientific evidence?” Because evidence of
effectiveness is limited, or nonexistent, for the vast majority of conditions,
this may prove a more efficient route to shutting down dubious clinics, or at
least hitting them with big financial penalties.

States, too, have their own consumer protection laws, typically enforced by the 
states’ Attorneys General (AGs). Under these laws, as well as specific false
advertising statutes, state AGs are permitted to initiate and conduct
investigations and bring lawsuits on behalf of the states’ citizens. Once a
lawsuit is initiated, liability for consumer protection act-based claims for
false advertising can be found without a showing that anyone was actually harmed
or defrauded by the false advertising — the law merely requires that deception 
was likely. Such a low threshold makes these state laws particularly potent
tools for state AGs seeking to hold companies liable for false or deceptive
advertisements.

States sanction stem cell scams

New York

Last November, New York Attorney General Letitia James announced a $5.1 million 
judgment against a New York City stem cell clinic (now defunct) and its managing
physician, Joel B. Singer, MD, for fraudulently advertising their stem cell
therapies, settling a 2019 lawsuit brought for scamming patients out of
thousands of dollars each for unproven and potentially harmful treatments. The
defendants were also enjoined from fraudulent and deceptive marketing of their
stem cell treatments.

The clinic advertised widely that it could treat a variety of serious medical
conditions using patients’ own stem cells, including erectile dysfunction,
cardiac/pulmonary disease, neurological diseases (such as Parkinson’s disease), 
autoimmune diseases (like lupus), and orthopedic conditions.

The clinic falsely claimed in advertising that stem cells “represent a medical
breakthrough in the treatment of many chronic medical conditions”, that there
was a “great deal of excitement” about using stem cells to “treat currently
incurable diseases”, and that their stem cell treatments could “treat the entire
body not just the injured part”. The defendants represented stem cells as
“magical” or “miraculous” cells that could help diabetes patients avoid
amputation and even help people suffering from rheumatoid arthritis to “throw
away crutches and get younger”. Of course, as the AG noted, there is currently
no adequate scientific substantiation that stem cells can effectively treat any 
of these conditions.

Treatments were promoted using testimonials from well-known individuals like
Guardian Angels founder Curtis Sliwa and NFL player Darrel Reid without
disclosing that they did not pay for these treatments, in effect compensating
them for their endorsements without letting the public know. The defendants also
falsely claimed that their procedures were FDA-approved and had been endorsed
by several scientific and medical organizations and that patients were
participating in an established research study.

The defendants charged consumers nearly $4,000 per procedure, with several
consumers paying over $20,000 for multiple procedures. Most of the procedures
involved adipose stem cells, derived from a patient’s own fat tissues.

Georgia

Earlier last year, in August, the Georgia Attorney General joined the FTC in
filing an enforcement action in federal district court against Regenerative
Medicine Institute of America, doing business as Stem Cell Institute of America,
and several other corporate and individual defendants, for violations of the
Georgia Fair Business Practices Act and the FTC Act.

The complaint alleges that the defendants made false and misleading claims about
stem cell therapies offered to consumers in Georgia, aggressively marketing and
selling these therapies, mostly to older adults. They allegedly advertised to
the public and to healthcare practitioners that their therapies cure, treat, or 
mitigate a variety of orthopedic diseases and health conditions, and that they
are comparable or superior to conventional treatments for these conditions.
According to the complaint, these claims are not backed by competent and
reliable scientific evidence.

Two of the defendants, Physician Business Solutions and Stem Cell Institute of
America, according to the complaint, generated millions of dollars in revenue by
training and advising chiropractors and other health care practitioners on how 
to add stem cell therapy to their practices. Another defendant, Superior
Healthcare, allegedly generated revenues by selling these products directly to
consumers and by contracting with clinics throughout the state to administer
injections in exchange for a fee. These therapies cost approximately $5,000 per 
joint injection, with patients often receiving more than one injection.

The complaint reveals the creative way in which chiropractic “adjustments”
gibberish, unproven stem cell treatments, and anti-“allopathic” medicine
propaganda were rolled into one convenient package for chiropractors looking to 
earn an extra buck. From promotional material used in luring chiropractors to
join the scheme, quoted in the complaint:

   Stem cells help to rejuvenate the joints, allowing your adjustments to really
   take hold and the alignment process to occur. . .

   Stem cell and regenerative therapies have recently shown incredible results
   with conditions that, up until now, were only treated with dangerous,
   unreliable surgeries or masked with pain drugs. But with these therapies,
   patients are experiencing seemingly miraculous outcomes. Chiropractors can be
   integrated with a [sic] MD or DO to offer these protocols in merely 60 days.
   Yet these therapies keep with the spirit of the chiropractic soul, i.e.,
   avoiding allopathic health care, major surgery or pain drugs.

So, in sum, the way to help patients avoid allopathic health care and its
attendant dangers is to team up with an allopathic practitioner to administer
unproven, risky therapies.

The lawsuit, which is still pending, seeks injunctive relief, consumer
restitution, disgorgement of ill-gotten gains, and civil penalties which, under 
Georgia law, are doubled for violations committed against elderly or disabled
persons.

A similar suit was filed in 2020 by the Georgia AG against Elite Integrated
Medical and other corporate and individual defendants seeking injunctive relief,
consumer restitution, and civil penalties. According to that complaint, Elite
made over $6.4 million by using aggressive marketing techniques and
high-pressure sales tactics to convince consumers, most of whom were elderly
and/or disabled, to purchase expensive, unproven stem cell treatments that are
not covered by Medicare or health insurance. The AG alleges that

   Elite represents that it has a staff of medical doctors who provide its
   products to patients, when in fact, medical doctors administer a very limited
   number of product injections. The vast majority of patients interact only
   with chiropractors and nurse practitioners, and most of the injections are
   administered by nurse practitioners.

As best I can tell, the suit is still pending in a Georgia state court.

Washington State

Finally, last week the Washington State Attorney General filed a civil action in
state court against Seattle-based US Stemology and its owner, Tami Meraglia,
MD, for deceptively marketing stem cell therapies for COVID-19 and dozens of
other serious medical conditions, including asthma, lupus, Parkinson’s disease, 
congestive heart failure, and MS, in violation of the state’s Consumer
Protection Act. The complaint alleges that there is no reliable clinical
evidence that stem cell therapies can effectively treat these conditions. Dr.
Meraglia began the stem cell clinic out of the basement of her “medispa”, which 
mostly performed aesthetic and cosmetic treatments.

According to the complaint, the defendants charged patients as much as $10,000
to participate in the clinic’s purported “patient funded research” and claimed
they were treating patients as part of clinical trials. These “clinical trials” 
were under the supervision of an Institutional Review Board (IRB) operated by a 
company called the International Cell Surgical Society. Two of the primary
“researchers” listed on US Stemology’s trials were also principal officers of
the company operating the IRB when it approved the trials, an obvious conflict
of interest.

Per the AG’s press release,

   the trials themselves did not follow accepted standards of research. For
   example, the trials did not use a control group or a standard course of
   treatment for each patient, and relied solely on patient surveys to assess
   results. Typically, legitimate clinical trials pay patients — not charge them
   thousands of dollars — for agreeing to undergo experimental treatments.

In what should be an inspiration to us all to report such nefarious activity,
the AG’s office was first alerted to the clinic’s false claims that it could
prevent and treat COVID-19 by a concerned citizen. When investigators looked
into the complaint, they found claims that the clinic’s stem cell therapies
could treat dozens of other conditions, claims for which no reliable scientific 
evidence existed.

The lawsuit seeks injunctive relief preventing the clinic from making the
allegedly false and deceptive claims, restitution for patients, and civil
penalties which could, according to the AG, total in the millions of dollars.

Conclusion: A good start for individual states

Until there is a comprehensive regulatory scheme in place, unscrupulous
practitioners and their associates will continue to abuse patients for profit
with unproven stem cell therapies and bogus clinical trials. In the meantime,
the states can help deter these greedy charlatans by vigorously pursuing stem
cell scofflaws in court using state consumer protection and false advertising
laws.

For reputable stem cell therapy information, an excellent source is The Niche
blog, published by Paul Knoepfler, PhD, a stem cell scientist (and SBM guest
blogger).

Good faith doctoring or greedy drug dealing? SCOTUS hears opioid prescribing
cases

Physicians running opioid “pill mills” were convicted of violating the
Controlled Substances Act and given substantial prison sentences. The U.S.
Supreme Court will soon decide whether they were entitled to a “good faith”
defense at trial.

Jann Bellamy onM arch 10, 2022

Link



Dr. Xiulu Ruan and Dr. John Patrick Couch, licensed physicians, owned and
operated a medical clinic in Mobile, Alabama, along with a connected pharmacy
solely engaged in the business of dispensing drugs prescribed at their clinic.
In a little over four years, they wrote nearly 300,000 prescriptions for
controlled substances. In fact, they were among the top prescribers nationally
of transmucosal immediate-release fentanyl (TIRF), which is FDA-approved for
breakthrough cancer pain. Though no more than 15% of their patients had a cancer
diagnosis, they prescribed more than 475,000 doses of TIRF to over 1,000
patients, which at times was more than double the number of TIRF prescriptions
written by the next highest U.S. prescriber.

Drs. Ruan and Couch invested over $1 million in the pharmaceutical company
making Abstral, a particular brand of TIRF, at the same time “massively”
increasing their prescriptions of the drug. They collected “substantial”
speaking fees from the maker of a different TIRF drug, Subsys, and were paid to 
host weekly programs promoting the drug, a gig intended to influence their
prescribing practices according to a drug rep. This strategy apparently worked. 
Their clinic ranked among the top 10 prescribers of Subsys nationally.

All of this caught the attention of the federal Drug Enforcement Agency (DEA).
During an investigation, an agent was easily able to obtain prescriptions for
controlled substances from the clinic without an adequate examination and from
clinic personnel who were not licensed to prescribe them, using prescriptions
that appeared to be pre-dated and signed by Dr. Couch.

Drs. Ruan and Couch were indicted and, after a jury trial in an Alabama federal 
district court, were each convicted on multiple counts, including violations of 
the Controlled Substances Act, health care, mail, and wire fraud, and
racketeering conspiracy. Dr. Ruan was sentenced to 21 years in prison, Dr. Couch
to 20 years.

Dr. Shakeel Kahn, also a licensed physician, operated a clinic in Arizona where 
he “routinely” prescribed controlled substances, including oxycodone and
alprazolam, with a perfunctory examination or, in some case, no exam at all. He 
doctored medical records to show, falsely, that he had seen patients in person, 
completed assessments, made referrals, and collected samples for testing.

Dr. Kahn priced his services, mostly cash-based, according to the number of
pills he prescribed: the more pills, the greater the charge. For patients who
could not afford his services, he prescribed fewer pills or refused to write a
prescription. Some patients who referred others to Dr. Khan were given
discounted fees. At times, his clinic manager would meet patients in the parking
lot to exchange prescriptions for cash.

When area pharmacies started refusing to fill his prescriptions, he opened a
second practice in Wyoming, where his prescriptions were more easily filled,
inviting his Arizona patients to follow him there. In 2015, Dr. Kahn wrote a
high-dose prescription for oxycodone and other controlled substances for a young
woman who paid him $1,250. After filling the prescriptions, the patient died
two days later of an oxycodone overdose.

After a DEA investigation, which revealed he charged a $500 minimum for writing 
prescriptions, Dr. Kahn was indicted and tried before a jury in a federal
district court in Wyoming. At trial, experts testified that that Dr. Kahn’s
prescriptions were issued outside the usual course of medical practice and not
issued for legitimate medical purposes. He was convicted of one count of
conspiring to dispense and distribute controlled substances resulting in death, 
along with a number of other controlled substances offenses. He was sentenced to
25 years in prison.

At trial, in both cases, the defendant physicians requested that the judge
instruct the jury on a subjective “good faith” defense – in essence, that they
could not be convicted if they sincerely and honestly believed that that their
prescriptions were for a legitimate medical purposes and within the usual course
of professional practice. Their jury instruction requests were denied. They
appealed and, in both cases, their convictions affirmed (save for one
racketeering conspiracy count in the Alabama case, which was overturned but is
not relevant here).

Dr. Ruan and Dr. Kahn each petitioned the U.S. Supreme Court for a writ of
certiorari and both were granted, the Court consolidating the two cases. Oral
arguments were heard on March 1.

The federal Controlled Substances Act (CSA) makes it illegal to knowingly or
intentionally distribute a controlled substance “except as authorized”, such as 
when a physician prescribes a drug for a patient. DEA regulations promulgated
pursuant to the CSA require that controlled substance prescriptions, to be
legal,

   must be issued for a legitimate medical purpose by an individual practitioner
   acting in the usual course of his professional practice.

As succinctly explained by health care lawyers in a Lexology post,

   In 1975, the Supreme Court held that doctors could be convicted under the CSA
   when “their activities fall outside the usual course of professional
   practice.” But in the decades since, courts have interpreted that decision
   differently. Some have adopted a subjective good-faith standard and hold that
   practitioners cannot be convicted if they sincerely and honestly believe
   that their prescriptions were within the usual course of professional
   practice. Others have adopted an objective good-faith standard and hold that 
   a practitioner cannot be convicted if they “reasonably believed” that their
   prescription was within the usual course of professional practice. A minority
   of courts have rejected any consideration of good faith and found it
   irrelevant to criminal liability.

   Given that the [CSA] statute requires the “knowingly or intentionally”
   unauthorized distribution of a controlled substance, the Supreme Court is
   expected to permit the good-faith defense. The only question remains: To what
   extent? If a doctor honestly believed the prescription was for a legitimate 
   medical purpose, should that absolve the conduct, or should the belief be
   judged on an objective standard?

[Footnotes omitted.]

Unsurprisingly, the defendants argue that the Court should adopt a subjective
good faith defense.

Some interesting friends

The consolidated cases attracted no less than a dozen amici curiae (“friend of
the court”) briefs, although some specifically stated they had no interest in
the outcome of these defendants’ cases one way or another. Rather, they were
participating solely to argue how the CSA should be interpreted in general.

Many amici, including a group of Professors of Health Law and Policy and the
National Association of Criminal Defense Attorneys, argue that some federal
appellate courts are interpreting the CSA in a manner that essentially
criminalizes conduct that deviates from accepted medical standards (that is,
conduct that is basically malpractice) without considering whether the
practitioner acted without a legitimate medical purpose. This, according to the 
health law professors’ brief, will

   criminalize mistaken or negligent prescribing for which there are already
   myriad civil [e.g., malpractice], administrative [e.g., medical board
   complaints], and even lesser criminal remedies.

The ask the Court to

   clarify that the CSA’s reach only extends to practitioners who prescribe
   knowingly or intentionally (i.e., not in good faith) without a medical
   purpose outside the usual course of professional practice.

They also argue that the criminalization of prescribing practices usurps the
states’ authority to regulate the practice of medicine.

Two patient advocacy groups filed amicus briefs: Compassion & Choices, which
describes itself as “committed to improving care and expanding choice at the end
of life” and advocating “for high quality end-of-life medical care and
educate[ing] the public about available end-of-life options”, and the National
Pain Advocacy Center, “an organization dedicated to improving the health and
protecting the rights of people living with pain”. Both argue that denying a
good faith defense to practitioners will have a chilling effect on the
willingness of physicians to prescribe opioids to patients in pain and those who
are at life’s end. (The National Pain Advocacy Center has been criticized for
failing to disclose funding from opioid manufacturers, from whom it accepted
over half a million dollars over a five-year period. Its chairman received
$170,000 from Insys, the maker of Subsys, which featured in the convictions of
Drs. Ruan and Couch.)

Of note to regular SBM readers, representing the “brave maverick doctor” faction
of the medical community, the Association of American Physicians and Surgeons
(AAPS, who we have met before) filed an amicus brief which, contrary to the
neutral stance of some amici, most assuredly takes up the cause of Dr. Ruan,
portraying him as someone who received a “21-year imprisonment for medicating
pain” and describing him as having “acted in good faith”. This statement in
AAPS’s brief caught my eye:

   Most innovative physicians advance medical practice contrary to “generally
   recognized and accepted” treatments . . .

Yep, like the crank members of the AAPS, who promote antivaccine pseudoscience
and HIV/AIDS denialism, blame immigrants for crime and disease, and claim that
abortion causes breast cancer. Innovative indeed.

The health care lawyers, in a second Lexology post following oral arguments,
opined that

   the majority of the justices seemed prepared to adopt a subjective good-faith
   standard that would protect practitioners from criminal prosecutions if they
   sincerely and honestly believe their prescriptions were for a legitimate
   medical purpose and within the usual course of professional practice.

A decision is expected in June.

I am not sure how a physician could “seriously and honestly believe” his
prescriptions “were for a legitimate medical purpose” if his belief is not
objectively reasonable, that is, within acceptable medical standards. To me,
this implies that the physician has no duty to inquire as to what the standard
of care is when prescribing. In fact, any attempt to discern the standard of
care could undermine his argument that his beliefs were “serious” and “honest”, 
counseling that he best avoid trying to find out, lest he undermine his own
“beliefs”.

In any event, should the convictions of Drs. Ruan and Kahn be overturned and
they are retried, I doubt any jury would buy into the n

Plexus: MLM Strikes Again

Many health-related products are sold through multilevel marketing (MLM); now
the FTC is warning them to stop making false claims about COVID-19. The tactics 
that MLMs use to promote all their products are deceptive and are a variation on
the old Ponzi scam.

Harriet Hall on September 15, 2020

Tweet





Why pyramid schemes are a scam. If you could recruit 11 tiers of distributors
below you to provide you income, the number of distributors would have to exceed
the US population.

Multilevel marketing (MLM) companies have a terrible reputation, so bad that
Quackwatch devotes a whole section to “MLM Watch“. Now that we are in the midst 
of a pandemic, MLM schemes have been quick to take advantage of public fears and
are offering bogus products alleged to prevent or treat COVID-19. Quackwatch’s 
Consumer Health Digest reported on September 6, 2020, that Plexus and five other
MLM companies have been warned by the FTC about false health and/or income
claims related to the coronavirus pandemic. The other companies are Youngevity, 
Vivry, Melaleuca, Isagenix, and Juice+. More false claims and more FTC warning
letters will surely follow.

What does MLM mean?

No, MLM doesn’t stand for “Marketing Lies and Misinformation”, but it might just
as well. Is it ever legal? Basically, it’s OK for a company to reward you for
selling their products, but if it rewards you for recruiting other people who
have to pay you, it’s an ethically and legally questionable version of an old
scam, the Ponzi scheme or pyramid scheme. Ponzi schemes are named after Charles 
Ponzi, a businessman who paid profits to early investors from funds obtained
from later investors, telling the early investors that the money they received
was earnings from their own investments. It was a system for robbing Peter to
pay Paul, and when it collapsed, the Peters lost all the money they had
invested. Today, typical MLM Pauls get the Peters to do the recruiting for them.
More and more Peters recruit yet more Peters in order to get a portion of the
commissions earned by the Peters below them in the pyramid. Eventually, the
Pauls at the top of the pyramid get rich, while the Peters further down the
pyramid lose money.

How it works

The company offers an overpriced, difficult-to-sell product, often a dietary
supplement, with grandiose claims that it is the best of its kind and will help 
customers lose weight or provide other health benefits. Think about it. If they 
had a good, reasonably priced product, why would they resort to MLM schemes?
Reputable products can be (and are) sold profitably in stores everywhere.

A trusted friend or relative persuades you individually or invites you to a
group presentation in their home, sort of like a Tupperware party on steroids.
They offer amazing testimonials, offer to sell you products, and tell you that
you can become a distributor too and earn lots of money effortlessly from home. 
You will start earning royalty payments after you buy a large inventory of their
products (which you soon discover you are unable to sell), but the real money
comes as you recruit other distributors and get a percentage of their
commissions and get your recruits to recruit even more distributors. If you
recruit a large enough stable of distributors, you theoretically might make a
lot of money, but the reality is that the vast majority of recruits lose money. 
Only a few individuals at the top of the pyramids actually benefit. And there is
a high social price, as friends and family realize they have been defrauded.
Early enthusiasm deteriorates into disillusion, disappointment, customer
complaints, and often regulatory actions and lawsuits against the company.
Remember Amway, Herbalife, Young Living, and DoTerra. Episode 1 of the (Un)Well 
documentary series that I reviewed in August covered two disreputable MLMs that 
sell essential oils.

The FTC’s warning letters remind companies of three pertinent laws:

  1. It is unlawful to make unsupported claims of product efficacy

     It is unlawful under the FTC Act, 15 U.S.C. § 41 et seq., to advertise that a 
    product can prevent, treat, or cure human disease unless you possess
    competent and reliable scientific evidence, including, when appropriate,
    well-controlled human clinical studies, substantiating that the claims are
    true at the time they are made.

  2. It is unlawful to misrepresent earnings claims

     …representations about a business opportunity, including earnings claims,
    violate Section 5 of the FTC Act, 15 U.S.C. § 41 et seq., if they are false,
    misleading, or unsubstantiated and material to consumers. Express and
    implied earnings claims must be truthful and non-misleading to avoid being
    deceptive, which means that claims about the potential to achieve a wealthy 
    lifestyle, career-level income, or significant income are false or
    misleading if business opportunity participants generally do not achieve
    such results. Even truthful testimonials from participants who do earn
    significant income or more will likely be misleading unless the advertising 
    also makes clear the amount earned or lost by most participants. Your
    business opportunity participants and representatives must immediately cease
    making all express and implied earnings claims that would be false or
    misleading to current or prospective participants.

  3. MLM companies are responsible for what its representatives say

     You are responsible for the claims of your business opportunity participants
    and representatives. As the FTC stated in the January 2019 Business Guidance
    Concerning Multi- Level Marketing, the compensation structure of a
    Multi-Level Marketing entity (“MLM”) may create incentives for its
    participants to make certain representations to current or prospective
    participants. As a consequence, an MLM should (i) direct its participants
    not to make false, misleading, or unsubstantiated representations and (ii)
    monitor its participants so they don’t make false, misleading, or
    unsubstantiated representations.

Warning letters to Plexus failed to lead to corrective action

     On June 5, 2020, the FTC sent Plexus a warning letter saying that the company 
    and its representative had published false claims on social media alleging
    that their products could prevent or treat COVID-19. They gave specific
    examples and asked the company to review the claims, to stop making claims
    that weren’t supported by evidence, and to respond within 48 hours
    describing the actions they had taken to address the FTC’s concerns.

     Truth in Advertising found that after the June 5 letter, Plexus distributors
    continued to make unsubstantiated claims that the “Kids Essentials Combo”
    (comprised of MegaKids Microbiome and XFactor Kids), would help:

    1. boost children’s’ immune systems

    2. possibly keep them virus free

    3. a host of health conditions that affect children including asthma, eczema,
      ADHD, GI issues

Earlier violations

     Before the current pandemic focused attention on coronavirus claims, Plexus
    had received earlier warnings about its products. An FTC warning letter in
    2014 mentioned specific claims on their website that promoted their products
    as drugs, in violation of FDA regulations for dietary supplements. The
    products targeted were Fast Relief, Probio5, and Biocleanse. For example,
    Probio5 was said to typically provide results for jock itch, migraine
    headaches, recurrent cystitis, and vaginal infections. And Biocleanse
    claimed that many people were in a low oxygen state that allowed microbes to
    thrive and cause diseases such as flu, Candida, and chronic fatigue;
    Biocleanse was said to kill these microbes by increasing the oxygen level
    around them.

     These claims meant the products were new drugs that were misbranded. And:

     The introduction of a misbranded drug into interstate commerce is a violation 
    of section 301(a) of the Act [21 U.S.C. § 331(a)].

     Those claims have been removed from the website. The company website no longer
    makes specific disease claims but only “support and function” claims, which
    are allowed under the Dietary Supplement Health and Education Act (DSHEA). 
    But Plexus distributors have continued to make disease claims in person and 
    on social media, and the company has done nothing to stop them.

Conclusion: A typical MLM company, not trustworthy

     Plexus is typical of so many other MLM companies that defraud their
    distributors with false promises of easy income and allow distributors to
    make claims for their products that the company itself can’t legally make,
    claims that are not supported by acceptable evidence. Legitimate products
    don’t need to resort to MLM schemes to make profits.

     Stephen Barrett has investigated over 150 MLM companies with health-related
    products. He says:

     Every MLM company I have looked at has made false or deceptive claims in its
    promotional materials. The products that have nutritional value (such as
    multivitamins and low-cholesterol foods) are invariably overpriced and
    usually not needed. The products promoted as remedies are either bogus,
    unproven, or intended for conditions that are unsuitable for
    self-medication. In addition, none of companies I investigated gave a really
    clear picture of how difficult it is to earn money selling health-related
    MLM products…distributors must persuade prospective customers that their
    product is superior even though it is not and may even be identical to
    competing products that cost less. This requires misrepresentation.

The National Council Against Health Fraud recommends that consumers avoid
health-related MLM products altogether. I think that’s excellent advice.

Decision Against Spelling to Communicate – A Small Victory for Science

Spelling to Communicate is just another form a facilitated communication, an
invalid technique that was disproved decades ago but refuses to die.

Steven Novella on December 18, 2019

Link



Some pseudosciences will simply not fade away. They just keep reinventing
themselves over and over again. This is partly due to the fact that snake oil
peddlers don’t care about science or evidence. But also, knocking down
pseudoscience does not usually result in fixing the underlying problem – a lack 
of sufficient critical thinking skills in the relevant population. So even
well-meaning practitioners can repeat the mistakes of the past. That is why
advocating for science and critical thinking will always be partly a game of
whack-a-mole. Still, we can celebrate the occasional solid whack.

A recent court decision in Pennsylvania is a good victory for science in public 
school education for children with disabilities, but it also reveals a deep
problem of pseudoscience that won’t go away. The decision relates to a technique
called Spelling to Communicate, which is essentially a form of facilitated
communication (FC).

FC was introduced in the 1980s, and was popular until the early 1990s. The
technique is designed to help those with either poor communication or even a
complete inability to communicate due to autism or some neurodevelopmental
disorder. The basic concept is that such children may have greater intellectual 
capacity than is reflected in their ability to communicate, which may in turn be
limited by purely motor deficits. In order to bypass these motor deficits and
access the child’s inner thoughts, facilitators will hold the child’s arm while 
they point to letters on a letter board. Suddenly children thought to have been 
severely cognitively limited were writing poetry, and reading and writing at an 
advanced level.

The extreme implausibility of such results should have prompted immediate
skepticism in the speech therapy community, and indeed some were skeptical, but 
the allure of a transforming method was just too great, and many more therapists
embraced the method. FC became popular before critical research was done
(always a mistake), and when that research was finally completed it
unequivocally showed that the facilitator, not the client, was doing all the
communication. Sometimes children were not even looking at the board, as the
facilitator rapidly and precisely moved their hand across the letter board or
keyboard. Facilitators were largely falling prey to the ideomotor effect,
subconscious small movements of their own that were guiding (rather than merely 
facilitating) the hand movements.

When it became undeniably obvious that FC was nothing but self-deception, it
moved rapidly to the fringe. But it never completely went away. It continues to 
be used by some practitioners, who simply deny the evidence, champion anecdotes,
or cherry pick studies that are not designed to determine who is doing the
communication.

The lessons from FC are clear, and should stand as a cautionary tale for every
practitioner.

  1. First, do not accept and widely use a technique that has not yet been
    validated by adequate research. The research should come first. Until then, 
    new techniques should be treated as experimental.

  2. When something seems too good to be true, be especially skeptical. It is the
    duty of every professional to do due diligence, and make sure they are not
    harming their clients. So don’t get caught up in a “miracle” treatment or
    intervention – be skeptical.

  3. The research that matters most are studies designed to rigorously answer the
    question – is the phenomenon real? This kind of research requires proper
    blinding. In the case of FC (like many deceptive pseudosciences) the alleged
    effect vanished under proper blinding.

  4. Listen to the research. Do not make excuses for negative results, or simply
    ignore it in favor of lesser research that is not capable of disproving your
    preferred method.

  5. Do not underestimate the potential for self-deception.

Many people simply did not learn these lessons. They continue to champion FC.
Also, as time goes by new generations of practitioners come up who may not have 
learned the history of FC, and so repeat the mistakes of the past. For example, 
in 2010 a prominent neurologist and coma researcher fell for a clear case of FC.
They were simply not aware of the history and were fooled. To their credit,
they eventually performed the kind of blinded test they should have done at
first, and exposed the FC as invalid. Look at the video here. It is a dramatic
example of how impossible it would be to actually communicate using this method.
The facilitator is moving the clients hand over the letter board at an
impossible speed.

Another way in which such pseudosciences survive is to simply rebrand
themselves. In the case of FC we now have virtually identical methods, known as 
Rapid Prompting Method (RPM) and Spelling to Communicate. These methods also use
a facilitator to help a client point to letters on a board. With the Spelling
to Communicate method, the facilitator holds the board, rather than the clients 
hand, but this still allows for the ideomotor effect. Why not have a stationary 
board?

The facilitators often have to direct clients, ignore incoherent spelling, and
“reset” them if they are not giving a meaningful response. Videos remind me of
the Clever Hans effect – clients pointing at seemingly random letters until they
hit the “correct” letter, which is then counted. Now of course clients exist on
a spectrum, and some do have the cognitive ability to communicate but may be
non-verbal or have impaired communication. So it is possible to cherry pick
examples of clients who can actually communicate with a letter board, as if that
validates the process itself. Such cases are not representative, and do not
validate the specific techniques used, or justify the lack of proper controls.

The American Speech-Language-Hearing Association (ASHA) has reviewed the
evidence for RPM and Spelling to Communicate and warned against their use. They 
conclude there is no evidence that the clients are actually doing the
communication. They write:

   According to Davis-McFarland, such positions have been and continue to be
   marked by deep concern about a range of potential serious harm that includes 
   “reduced access to effective and appropriate treatment, denial of the human
   right to effective communication, and victimization of individuals with
   disabilities and their families with false hope and wasteful use of personal 
   and professional resources.”

So officially such techniques are not evidence-based or professionally
sanctioned. That does not stop private companies from using their own brand of
FC in order to prey (whatever their intentions) on desperate parents. Often
school systems become involved, because parents might demand that the school
system uses and pays for these methods. This is where the recent courtroom
victory comes in. A recent Pennsylvania court decision (ODR File Number: 21855 /
18 – 18AS, link not yet available) denied parents compensation for their
private use of a company providing Spelling to Communicate.

The ruling hit many important themes. It concluded that the technique is not
recommended by the ASHA because it is not scientifically valid. But further, it 
reaffirmed that parents cannot demand of a school system that a specific method 
is used. This is important because otherwise pseudoscience could be foisted onto
public institutions at public expense.

This principle has broad implications. It is increasingly a problem that
insurance companies are forced by legislatures to cover pseudoscientific
treatments, for example. Rather proper experts should dictate the standard of
care based on the best current scientific evidence available.

But also this small case reflects another reality – there is constant pressure
from countless pseudosciences to infiltrate academic, scientific, professional, 
and public institutions. Guarding against such harmful and wasteful intrusions
requires constant vigilance on the part of experts and professionals. But this, 
in turn, requires that professionals are properly educated about the history of 
specific pseudoscience, and the methods necessary to ward against them. No
physician, or therapist, or speech pathologist, or similar professional should
be able to get through their training without learning about basic scientific
methodology, critical thinking, the pitfalls of self-deception, and the methods 
used by charlatans and snake-oil peddlers.

Otherwise we’ll be playing a losing game of whack-a-mole.

Washington bills: Christian Science no longer an excuse for denying medical care

Jann Bellamy on February 5, 2015

Link



All states try to protect children from neglect, abandonment and mistreatment,
such as deprivation of clothing, shelter, food and medical care. This includes
civil laws which permit the removal of a child from the home and other
protective interventions. Criminal laws protect children as well by, for
example, making nonsupport a misdemeanor or criminal neglect a felony.

Washington State law prohibits criminal mistreatment of children and other
vulnerable persons, such as the frail elderly, by their caregivers. Criminal
mistreatment is defined as the “deprivation of the basic necessities of life:”

   food, water, shelter, clothing, and medically necessary health care,
   including but not limited to health-related treatment or activities, hygiene,
   oxygen, and medication.

Mistreatment can be either a misdemeanor or felony, depending on whether the
defendant’s conduct amounts to criminal negligence or recklessness and the
degree of harm caused to the victim. Punishment ranges from 90 days in jail and 
a $1,000 fine to 10 years in jail and a $20,000 fine.

Unfortunately, parents and other caregivers in Washington have what amounts to
an almost literal “get out of jail free” card if the mistreatment takes the form
of “treatment” by “duly accredited” Christian Science practitioner:

   It is the intent of the legislature that a person who, in good faith, is
   furnished Christian Science treatment by a duly accredited Christian Science 
   practitioner in lieu of medical care is not considered deprived of medically 
   necessary health care or abandoned.

In other words, if a parent negligently or recklessly fails to get adequate
medical care for his diabetic child, the parent could be prosecuted for criminal
mistreatment. But if the parent calls in a “duly accredited” Christian Science 
practitioner to pray over the child instead, his conduct may be excused, even if
the child suffers “great bodily harm,” in the words of the criminal
mistreatment statute.

Washington law also requires the reporting of suspected child abuse or neglect
to child protective services and law enforcement, who can take action to protect
the child and institute criminal proceedings against the alleged abuser. Abuse 
or neglect includes activity that presents a danger to the child’s health,
welfare or safety. Here, again, parents who employ Christian Science
practitioners are given a legal pass:

   A person who is being furnished Christian Science treatment by a duly
   accredited Christian Science practitioner will not be considered, for that
   reason alone, a neglected person for the purposes of this chapter.

Two bills currently pending in the Washington Legislature would repeal this
special treatment for parents and caregivers who deny their children and other
vulnerable people proper medical care by hiding behind a religious exemption.
We’ll return to those bills in a minute.

The Christian Science political juggernaut

Christian Science is a small, secretive denomination that holds beliefs unique
to Christianity and whose operations fulfill several requirements for
characterization as a cult. Its association with the illness and death of
children due to withholding medical care is well chronicled. Save for a few
other small, fringe sects, no other Christian denomination so thoroughly rejects
medical care or views faith healing and medical care as mutually exclusive. In 
fact, no other religious denomination period endorses these strange beliefs. It 
is therefore a testament to the Christian Science political lobby that its
influence so outstrips its ability to deliver votes.

Even though religious exemptions from medical care, including immunization, are 
not constitutionally required, Christian Scientists enjoy legal exemptions that 
are exclusive to their religion in a number of states, such as Washington. In a 
majority of other states, they and the parents who employ them are protected by 
virtue of numerous state laws exempting faith healing from civil and criminal
liability.

Christian Science lobbyists have had outsized success in gaining insurance
coverage of their services as well. Jerry Coyne has written a good summary of
health insurance coverage, including Medicare, Medicaid, and federal employee
insurance benefits for Christian Science “nursing” and faith healing. Your tax
dollars at work!

Hypocritically, Christian Science lobbyists have, at the same time, sought to
exclude their believers from purchasing health insurance. The reliably
pseudo-science-friendly Sen. Orrin Hatch and Sen. John Kerry supported an
amendment to the original Affordable Care Act bill prohibiting an insurer from
denying benefits for “religious or spiritual health care” that is recognized as 
deductible by the IRS. (Sen. Kerry represented Massachusetts, where the
Christian Science “Mother Church” is located, in Boston.) A similar amendment
was included in the House bill. Fortunately, due in part to intense lobbying by 
CHILD (Children’s Healthcare is a Legal Duty) and other organizations, the
amendments did not survive. And, yes, that’s another benefit faith healing
enjoys: religious or spiritual health care is a deductible medical expense under
federal income tax regulations.

Failure in their first go-round has not stopped the Christian Scientists from
lobbying for amendments to the ACA. In the last Congress, bills were sponsored
at their behest to exempt everyone with “sincerely held religious beliefs” from 
the ACA’s mandate to purchase insurance. While the House bill passed, the Senate
bill did not. Efforts to pass similar bills in this Congress may prove more
successful in the Republican-controlled Senate.

Whatever you may think of the ACA, it does give children a defined set of
insurance benefits, including preventative services, provided without cost to
the insured. These preventative services include vaccinations. No doubt the
anti-vaccination crowd will be thrilled to see those benefits denied to children
whose parents chose to duck their responsibility via claiming “sincerely held
religious beliefs,” an excuse they also employ in states granting immunization
exemptions for religious reasons. And parents who choose “pediatric
chiropractic” or naturopathy for their children wouldn’t have to pay for
coverage of other evidence-based “allopathic” preventive services or care their 
CAM practitioner doesn’t offer.

Repealing special privileges for faith healing

Washington Senate Bill 5408 would repeal provisions of state law giving
Christian Science practitioners and their clients special privileges. First, the
bill repeals the statement of legislative intent, quoted earlier, shielding
those who deprive children and other vulnerable persons of adequate medical care
from a charge of criminal mistreatment. Providing faith healing from a “duly
authorized” Christian Science practitioner will no longer be considered an
excuse. This doesn’t mean these parents will necessarily be criminally liable,
just that they won’t receive special consideration other parents charged with
criminal mistreatment of their children don’t get.

Second, the bill removes the provision, also quoted above, granting special
consideration to parents who choose faith healing over medical care in cases of 
suspected child neglect. No longer will the fact that the child is being
“treated” by a Christian Science practitioner be a barrier placed between a
legitimate determination that a child is being neglected and the ability to take
action to protect the child. Again, this doesn’t mean that child authorities
will necessarily intervene or that parents will face charges; they will simply
be treated the same as other parents in the same situation.

The bill received a unanimous “do pass” from the Senate Committee on Human
Services, Mental Health and Housing on February 2. It is now before the Rules
Committee, which will decide whether it goes to the floor of the Senate for
discussion. I am cautiously optimistic as several of the bill’s sponsors are on 
the Rules Committee, including one who is the Democratic Caucus Vice Chair, a
leadership position. There is also a companion bill, House Bill 1476, with
bipartisan sponsorship but it has not yet been heard in the Judiciary Committee,
where it will make its first stop.

One wonders at Christian Scientist lobbying successes considering the weak
testimony opposing the bill, summarized here in the Human Services, Mental
Health and Housing Committee’s Report [PDF]:

   The existing language was put into law after working with the Attorney
   General’s Office. Proponents are working under false premises, not all
   religions are created equal. Spiritual healing is the premise of Christian
   Science so if this language is repealed, what do the Christian Scientists
   have left? Concerns raised involved another church that does not have a good 
   record with faith healing. Christian Scientists have practiced faith healing 
   for generations. Getting medical help doesn’t ensure a better outcome.

Perhaps there is an RCT in the published literature, of which we are unaware,
comparing Christian Science faith healing, the faith healing of “another
church,” and “medical help” reporting statistically significant “better
outcomes” for Christian Scientists. If you’ve got the citation, please post it
in a comment.

(You can watch the committee testimony here starting at the 1:43:50 mark of the 
2-hour hearing.)

Another provision of Washington law governing Christian Science practitioners
won’t be repealed by this bill, but it is a good one. Along with other
practitioners, day care centers, child welfare workers and the like, they have a
statutory duty to report child abuse and neglect, including withholding of
medical care, to the authorities. My interpretation of this is that they would
have a duty to report their clients if the circumstances require.

Along with Rita Swan and the terrific folks at CHILD, these bills are endorsed
by the State Medical Association, State Hospital Association, Washington Chapter
of the American Academy of Pediatrics, and the Washington Association of
Prosecuting Attorneys. I sense a general public weariness with claims of
religious privilege when it adversely affects children. Perhaps the Disneyland
measles epidemic has found the upper limits for tolerance of religious belief as
a means of granting carte blanche to put the health of your children and others
at risk.

You can voice your support for Senate Bill 5408 and House Bill 1476, although
these comments appear to be limited to Washington residents. Otherwise, you can 
call or write the legislators. Contact information for Senators is here and for 
Representatives here.

Ezekiel Stephan: Another Pediatric Death by World View

Clay Jones on March 11, 2016

Link



Reports of a disturbing chain of events that ended in the likely preventable
death of a 19-month-old Canadian child have made the rounds this week. The case 
was discussed by friend of Science-Based Medicine Orac (who I believe is some
kind of a protocol droid) on Respectful Insolence two days ago. But even if
you’ve read that excellent post, please continue reading as I have updated
information and, I believe, additional insight into this unfortunate outcome.

If this is your first encounter with the story, prepare to be angry and
frustrated but don’t presume to know everything that happened. The numerous news
reports, beginning back in 2013 when the parents were first charged and the
case went public, are not all well-written and there are discrepancies between
accounts. Add to that the announcements and fundraising efforts by the family on
Facebook and various other crowdfunding websites, and their alleged side of the
story as reported by disreputable sources steeped in pro-woo/anti-vaccine bias,
and we have one confusing mess of facts and a heap of conspiracy claims to
boot. The only aspect of this case that is completely irrefutable is that a
child suffered and died, and that he was failed by people who should have known 
better. 

The making of a tragedy

On March 18th, 2012, physicians at Alberta Children’s Hospital made the
always-difficult decision to remove 19-month-old Ezekiel Stephan from life
support after five days under their care. Carrying the diagnosis of brain death,
there was sadly no life to support at that point. The events that led to his
tragic death are currently the focus of a trial where Ezekiel’s parents stand
charged with “failing to provide the necessaries of life.” I’m no lawyer, but it
appears that if convicted they would face up to five years in prison, a length 
of time that would be unlikely to placate most folk’s demands for justice. They 
also stand to lose custody of their remaining children.

On February 13, 2013, Canadian news outlets first began reporting on the death
and the fact that Ezekiel’s parents were being charged after a year-long
investigation. The trial finally began this week and has been covered by a
variety of news sources ranging in quality, with some showing clear signs of
bias (Health Impact News). I have tried my best to piece together what happened.
Take it all with a grain of salt considering the frailties of human memory as
it passes through time and the filters of our personal biases, but some of this 
information was culled from taped interviews given at the time of Ezekiel’s
hospitalization four years ago.

Here goes.

In late February of 2012, Ezekiel’s parents noticed that he wasn’t feeling well.
He wasn’t objectively febrile or extremely ill-appearing, at least not yet. He 
just wasn’t as active as usual and he had a runny nose. Although not explicitly 
stated, he must have had some degree of cough because his family at first
thought that he had croup, a common viral illness in toddlers that targets the
upper airway and results in a characteristic “barking” cough. Most kids with
croup don’t need medical care. So far so good.

Ezekiel’s parents, proponents of “natural” therapies and wary of conventional
medicine, treated him with a variety of herbs and other home remedies.
Horseradish for example. Over the next several days his condition worsened, with
Ezekiel becoming “achy” and more tired, so the family contacted Lethbridge
Naturopathic Medical Clinic (website is down so I can’t review it) to ask for
something to help “boost Ezekiel’s immune system.”

Rather than a Naturopathic practitioner at the clinic, the family spoke to a
woman “who fills holistic prescriptions.” She has now testified that they
specifically mentioned the possibility that Ezekiel might have viral meningitis.
According to the family, they researched meningitis online and did not think
that he had symptoms consistent with a bacterial infection, a clinical
distinction that can be challenging even for a seasoned clinician. In a toddler,
we generally would need a sample of cerebrospinal fluid to make that call.

When asked if Ezekiel had been evaluated by a medical professional, his family
claimed that a nurse had come to their home. The nurse, or midwife depending on 
which news report you read (many are both), was actually a friend of the family 
that had come at their request and she has also now testified in the trial. She 
stated under oath that while she did not believe that Ezekiel was seriously ill,
she did mention the possibility of meningitis and that he should be seen by a
medical doctor.

Two or three days later, Ezekiel was brought into the same naturopathic clinic
where Dr. Tracey Tannis recommended a “tincture of echinacea.” According to a
taped March 15th, 2012 interview of his father, Ezekiel was so stiff that they
were unable to put him into his car seat, so they laid him flat on a mattress in
the back of their vehicle for the ride to the clinic. According to more than
one report, Dr. Tannis did not examine Ezekiel.

Later that evening, despite initially believing that Ezekiel was responding to
the new remedy, he was found to be unconscious and not breathing. The family
notified emergency medical services, initiated CPR, and drove to meet the
ambulance in an attempt to save time. Ezekiel was transported to a nearby
hospital in Lethridge and airlifted to Alberta Children’s where he ultimately
was found to be dead. According to the family, the hospital allowed a few days
for them to try both oral and IV “natural remedies” to no avail. Of course his
physicians are unable to discuss protected medical information publicly so who
knows what really happened in the hospital.

What killed Ezekiel Stephan?

As reported by the media as well as in the alleged family account linked to at
the onset of the post, the autopsy on Ezekiel revealed meningitis, which is
typically an infection related inflammation of the covering of the brain and
spinal cord. I can’t find confirmation of the organism but it is exceedingly
likely that it was bacterial rather than viral given the severity of his
presentation. Not that viral meningitis can’t be deadly, it just usually isn’t
in an otherwise-healthy older child.

The fact that Ezekiel, like his older sibling, was not vaccinated, further
increases the likelihood that he died from bacterial meningitis. The most common
cause of bacterial meningitis in a toddler, Streptococcus pneumoniae, as well
as the bug that used to be, Haemophilus influenzae type b, are both exceedingly 
deadly if not treated in a timely fashion. They can cause severe neurologic
injury and death even when they are.

Both infections can be prevented with a safe and effective vaccine. I’ve
diagnosed zero cases of HiB meningitis and only one case of pneumococcal
meningitis in 13 years of practice. Prior to these vaccines, pediatricians that 
far out of medical school would have seen hundreds of cases considering that 1
out of every 200 children used to suffer invasive Hib disease alone.

Not that the ultimate cause matters in this case, because a critically ill child
is a critically ill child. The question jurors are being asked to answer is not
whether or not Ezekiel’s parents knew what was wrong but if they failed to
respond appropriately to his severe illness. Should two medically naïve parents 
have recognized that their child needed emergent evaluation by a trained medical
professional? Did they simply make a fatal mistake or were they biased by their
world view? The parents have pleaded not guilty.

Who is to blame for Ezekiel’s death?

The parents may be the focus of the trial, but are they the only parties
potentially at fault for their son’s death? What about the nurse who came to the
house at the parents’ request to take a look at Ezekiel? In general, I consider
it to be risky, even acting as a “friend of the family not there to give a
diagnosis,” to provide medical advice outside of a professional capacity at
work. This is not to say that I haven’t done it in certain situations, but the
more ill the child, the less of a good idea it probably is. In addition to the
possibility of impaired judgement, there are also numerous cases where
physicians have been sued for malpractice by friends and family members after
giving requested medical advice.

I do not know if the same potential legal issues would apply in a case where the
advice was given by a nurse rather than a medical doctor. But in her defense,
it does appear that she recommended that the family seek appropriate medical
care. If she suspected medical neglect, one could argue that she is a mandated
reporter as she was potentially acting in a professional capacity. That would be
an interesting case in itself. But she testified that the child did not seem
that sick at the time, which could be true. It is also possible that she didn’t 
do that thorough of an assessment, or any assessment for that matter. You can’t 
tell asleep from obtunded visually or with a stethoscope.

What about the Naturopathic provider? Here it is considerably clearer. I can see
only one of two possible explanations for this aspect of the case, unless you
consider that maybe they left Ezekiel in the car. Actually I wouldn’t discount
that if he was as uncomfortable as stated in his father’s interview three days
before he died. So three possible explanations.

One possibility is that this particular practitioner is so incompetent that even
when primed by the parental concern of possible viral meningitis she did not
recognize a toxic child on visual assessment or during her examination. A child,
I remind you, that was in such pain from infection of his meninges as to be
unable to tolerate any stretching of his neck or back, and who was laying right 
in front of her while she prattled on about tinctures, or balms, or whatever
nonsense she conveniently sells from her clinic dispensary. Either that or, as
has been reported, she discussed Ezekiel’s case with the family without so much 
as laying a hand or stethoscope on him.

It seems very likely that an opportunity to save Ezekiel’s life was missed when 
he was brought to the naturopathic clinic. So far, it appears that the clinic
and Dr. Tannis should face disciplinary action at the very least. They are a
danger to their community and whatever worthless license the government has seen
fit to bestow upon them should be burned to ashes and the ashes divided up and 
buried in separate locations in order to avoid any chance of it reconstituting.

It’s interesting that the “Health Nut News” article I linked to at the beginning
of the post, which supposedly described the events as related by the family,
did not include any mention of a call or visit to a naturopath. Maybe they
forgot, although that is unlikely. Or perhaps they realize that it may be taken 
as evidence that they knew exactly how sick poor Ezekiel was. This alleged
family account also describes how Ezekiel had improved dramatically and was in
fact well enough for his worried mother to leave his side to attend church, only
to suddenly and unexpectedly stop breathing. This is inconsistent with a
diagnosis of meningitis resulting in complete cardiopulmonary arrest only a few 
hours later.

Ultimately, in regards to Ezekiel’s parents, I think application of a reasonable
parent standard is probably appropriate. At what point would a reasonable
parent seek out medical evaluation for their ill toddler, particularly when
already concerned about the possibility of meningitis? It is perhaps a difficult
assessment in this particular case, because there is so much we just don’t
know, but not impossible.

Did the nurse friend really assess him at the house and find him not that
ill-appearing, or did she just look at him lying there asleep/altered and think,
“What are the odds he is really sick?” Did he truly improve prior to crashing
suddenly like that, or was that just denial and wishful thinking? Was he really 
afebrile this entire time or were they just not taking his temperature? Was
Ezekiel able to drink and maintain hydration? At what point did he truly become 
stuporous or comatose? It’s frustrating to not have more details.

In my mind, I keep coming back to the father’s taped statement on March 15,
2012. Ezekiel was so stiff they could not even sit him in a car seat. They had
to place him on a mattress in the back of the car for transport to the
naturopathic clinic. They already suspected possible meningitis. If that doesn’t
meet the reasonable parent standard for accessing emergency medical care, what 
the hell does?

They did seek assistance, however. They accessed what in their biased world view
counted as medical care but was in reality a hopelessly inadequate medical
cargo cult, the world of naturopathy. But in my opinion a reasonable parent
would have called 911 at that point or at the very least immediately driven him 
to the nearest emergency department.

It is possible, but unlikely, that the events on the day of his arrest went down
as allegedly described by the parents in the Health Nut article. But he
probably suffered for days without even Tylenol or ibuprofen for his severe head
and neck pain, gradually slipping into an unconsciousness from which he would
never recover. His parents, like so many before them, probably did what they
thought was best in their warped reality, and kept hoping that he would
eventually turn the corner.

From the minute it became clear that they had waited too long to seek real help,
they probably began doing what all humans do, rationalizing and unintentionally
altering their memory via the process of repeated recollection. Their memories 
being sent over and over again through a filter that slowly removes aspects that
call into question their parenting skills or love for their child. Memories
that might cast doubt on their ability to protect their child from harm were
eventually replaced by conspiratorial outrage.

Conspiracy!

From the very beginning of this saga there have been claims of conspiracy from
the family. In the initial news reports, Ezekiel’s grandfather questioned the
charges, raising the ridiculous concern that they had something to do with his
company, which goes by Truehope. Truehope’s main product is a supplement called 
EMPowerplus, which they claim is effective in the treatment of a variety of
mental health conditions, such as depression and bipolar disorder, but also
fatigue and autism.

Here’s the supposed connection between the charges against Ezekiel’s parents and
Truehope. The Canadian government tried, and failed, to shut the company down
for making bogus health claims over a decade ago and they haven’t forgotten
about it. Big pharma is also upset about losing profits to his family’s
miraculous supplement, so much so that they have managed to interfere with their
online fundraising accounts as punishment. The father compares himself to
Gandhi, accuses the Canadian Broadcasting Company of being out to get them, and 
claims that thousands of people committed suicide when EMPowerplus was
temporarily confiscated by wicked Mounties. It’s all here and here. But wait, it
gets worse.

As I mentioned above, Ezekiel’s parents did not vaccinate their children. Some
known anti-vaccine pseudo-journalism entities, namely Health Impact News, have
taken this fact and come up with the absurd conclusion that the Canadian
government is making an example of the Stephan family. Because they are limited 
in their ability to force parents to vaccinate their children, they are
attempting to scare people into doing it by threat of prosecution.

Essentially, they claim, parents of unvaccinated children will be held to a
higher standard in regards to accessing medical care because they will face
criminal charges if their child has a bad health outcome. The implication is
that the government will see to it that these children are diagnosed with a
vaccine preventable disease so that the “failing to provide the necessaries of
life” charge will stick. The Stephan family has endorsed this concern on
Facebook, writing that their family is being “offered up on the sacrificial
alter of the vaccine industry.”

Conclusion: Distractions from a tragic and avoidable death

Ultimately we will probably never know exactly what happened in the home of
Ezekiel Stephan. As I hope I’ve made abundantly clear, my take on the situation 
is a medically informed speculation. I believe, based on the available
information, that Ezekiel’s parents should have sought appropriate medical care 
far sooner than they did, and that there is a good chance he would have survived
had they done so. I also believe that the naturopathic clinic and Dr. Tannis,
and to a much lesser degree the family friend called upon because of her nursing
background, share some of the blame.

Ezekiel Stephan is not the first child to die because of an anti-medicine world 
view, and he certainly won’t be the last. This is also not the last time that
claims of conspiracy will be used in an attempt to distract us from a tragic and
avoidable death. We don’t cover cases like this on Science-Based Medicine in
order to kick grieving parents while they are down, and I have no doubt that
Ezekiel’s family loved him and would probably give anything to undo what
happened. We discuss these cases in order to shed light on modifiable risk
factors for these outcomes and gaps in the public understanding of science and
medicine.

When all is said and done, I find myself at a bit of a loss for words believe it
or not. A child has suffered and succumbed to a preventable and/or treatable
illness. Nothing will change that. But as I and my SBM colleagues struggle to
push this boulder, knowing full well what the future holds once we crest the
hill, thoughts of Ezekiel and others like him will serve as inspiration to press
on.


Last minute update

A forensic pathologist has now testified regarding the autopsy findings. Dr.
Adeagbo concluded that Ezekiel died from both bacterial meningitis as well as
pneumonia with an accompanying empyema. Empyema is typically diagnosed in the
setting of a bacterial pneumonia when pus collects within the lining of the
lung.

So what does this mean? It certainly makes sense from a clinical perspective.
Ezekiel likely developed bacterial pneumonia caused by infection by either S.
pneumo or HiB, which went untreated and developed into an empyema. At this point
surgical drainage is usually necessary for recovery in addition to appropriate 
antibiotic treatment. His bloodstream was repeatedly showered with the
pathogenic bacteria, which eventually made its way to the child’s brain.

This new information adds to my suspicion that Ezekiel was much more
ill-appearing than described by his parents and the nurse who visited the
family’s home. Although there may have been some degree of waxing and waning of 
his symptoms, particularly with the fever he almost certainly developed during
the course of his illness, I am very skeptical of claims that he had any
significant recovery just prior to his arrest. This also makes it more likely
that he suffered a great deal prior to his death.

Parents Convicted in Death of Toddler

Steven Novella on April 27, 2016

Link

v


David and Collet Stephan, parents to the now-deceased Ezekiel Stephan.

This is a very sad and tragic case, and I have great sympathy for the extended
family of Ezekiel Stephan, the 19-month-old who died of meningitis four years
ago. In my opinion, there are many victims in this case.

The jury, apparently, agreed. Yesterday they returned a guilty verdict for
Ezekiel’s parents, David and Collet Stephan, who now face sentencing for failing
to provide the basic necessities of life to their son. It is reported that many
of the jurors were crying when the verdict was given – clearly this was a
difficult and emotional case.

Just the facts

As is often the case, there are different narratives of what happened, depending
on your perspective. It is likely the jury had access to more facts than the
public, and so their verdict, which was clearly difficult, needs to be taken
seriously. Here are the basic facts as being reported:

In March of 2012 Ezekiel became ill with flu-like symptoms. His parents report
that they thought this was a normal childhood illness and would pass. His mother
reported to police that she thought he had croup. They treated him with natural
remedies, mostly supplements.

Of importance is the fact that David Stephan is vice-president of Truehope
Nutritional Support Inc., a natural remedies company founded by his father,
Anthony Stephan. According to a police interview shortly after Ezekiel’s death, 
David Stephan said:

   “Do we have a formal education? No. Are we educated in it? Absolutely,” he
   said. “Has it worked for us in every single scenario in the past before this?
   Yes.”

   “And then when he was sick there, we were giving him, above and beyond that, 
   the olive root extract, which is an antifungal, antiviral, it’s a very
   powerful one,” he told Bulford.

Ezekiel was sick for 2½ weeks, during which time his parents treated him only
with supplements. According to reports at one point they consulted a neighbor
who is a nurse, and who told the parents Ezekiel might have meningitis. At one
point Collet Stephan searched online for treatments for meningitis. She also
consulted a naturopath, and picked up Echinacea as a treatment.

Ezekiel’s condition worsened until he became acutely ill, at which point his
parents rushed him to the hospital. At that point they were giving him fluids
through an eye dropper because he could not eat or drink. Also, he was so stiff 
from the meningitis that he could not sit in the car and had to be laid flat.
Ezekiel was not breathing on arrival at the hospital. He was put on a breathing 
machine but never recovered, and was pronounced dead five days later.

Dueling narratives

Those defending the Stephans argue that they did what any parent would do, treat
their child as if he had an ordinary illness until it became clear he was
seriously ill at which time they sought emergency care. Some blame the Canadian 
system saying it was difficult to get a doctor’s appointment, and that the
ambulance was delayed and did not have the proper equipment to intubate him.

They also go as far as to argue this is a witch hunt against the natural
remedies community.

Critics of the Stephans argue that they unreasonably and irresponsibly delayed
proper medical care for Ezekiel because of their misguided reliance on
supplements and natural medicine. Clearly the jury, after hearing all the
evidence, concluded that this latter narrative is closer to the truth.

During my medical education I have been on the receiving end of many parents
with sick children, including children who ultimately died of meningitis. We see
many children in the emergency room who are just a little sicker than a usual
cold, perhaps lasting more than a day or two, or who are cranky or might be
dehydrated. We rule out meningitis with a workup even in these mild and
potentially early stages, because that is not a diagnosis you can afford to
miss.

A child who is so stiff that they have to be laid flat is way past the point
where they should have received definitive medical attention, in my opinion.
This suggests that the Stephans waited longer than typical parents, until the
severity of Ezekiel’s illness was undeniable.

Who’s to blame?

In tragic cases such as this there is often plenty of blame to go around.
Clearly Ezekiel’s parents have the primary responsibility for his care, for
providing the basic necessities of life, and a jury has now found that they
failed to do so.

The prosecuting attorney had this to say:

   “They definitely, definitely loved their son but as stated in our closing
   arguments, unfortunately sometimes love just isn’t enough,” Weich said
   outside court. “Parents still have to follow a standard of care as set by
   criminal law.”

The “standard of care” is a critical concept for any modern society. For me,
that is what this case (and others like it) is really about.

The Stephans are also simultaneously victims. They consulted a naturopath, and
naturopaths are licensed in Canada (and, unfortunately, in many US states). We
have written extensively about naturopaths here, showing that they do not base
case on a scientific standard. They use an eclectic variety of dubious and
unscientific treatments, from homeopathy to “water cures,” that only seem to
have in common that they are not based on scientific evidence.

Therefore, how much blame does Canada have for licensing a profession of,
essentially, fake medical providers? Governments that legitimize such
professions are failing in their duty to their citizens in the same manner that 
the Stephans failed Ezekiel. Ezekiel’s death is therefore on the heads of the
naturopathic profession and the Canadian government as well.

There is also a much more diffuse blame, but still clear, on the entire
alternative medicine community. The Stephans did not exist in a vacuum: they are
a product of a cultural movement that seeks to legitimize what was considered
health fraud just a generation ago. This is what happens when you abandon
rigorous science as the basis of a medical standard of care, when you water down
that scientific standard, try to subvert the proper functioning of medical
science, and lobby for regulations that allow for pseudoscience and just plain
bad science in medicine.

The Stephans are not an anomaly – they are a symptom of the intellectual
bankruptcy and deception of the alternative medicine movement.

I am glad to hear a lawyer talk about the standard of care, but the irony of
this statement is not lost on me either. Governments have been slowly abandoning
the defense of the standard of care, and in a way it is hypocritical of them to
condemn parents for doing what they have implicitly sanctioned.

Conclusion: Parents Nobody can ignore the basic standard of care

Given the facts as presented, I agree with the jury for convicting the Stephans.
This case sets an important precedent: parents cannot ignore basic standards of
care for the children under their charge because of their ideology. It doesn’t 
matter that you truly believe Echinacea can help with a serious infection (it
can’t), you still have a responsibility to provide actual health care to sick
children.

When such tragic cases occur, it is always my hope that they will help advance
the discussion about what a standard of care in health care actually means, and 
everyone’s responsibility for upholding it. The public’s memory is short,
however, and the alternative medicine propaganda machine is tireless.

Unfortunately, Ezekiel probably will not be the last victim of the lies and
deceptions of alternative medicine quackery.

ADDENDUM: Orac has also discussed this case.

The Supreme Court of Canada orders a new trial for parents convicted in Ezekiel 
Stephan’s death

The Supreme Court of Canada has ordered a new trial for David and Collet
Stephan, who had been convicted in the meningitis death of their son. The
Stephans say they’re vindicated. The facts say otherwise.

Scott Gavura on May 17, 2018

Link






Ezekiel Stephans’ parents, who attempted to treat his vaccine-preventable
meningitis with hot sauce, horseradish, and naturopathic remedies.

In 2016, David and Collet Stephan were found guilty of failing to provide the
necessaries of life for their 19-month-old son, Ezekiel, who died of bacterial
meningitis. The Stephans had ignored obvious signs that the son was seriously
ill, and instead used vitamins, supplements, hot pepper, horseradish, and
remedies from the family’s own home business, Truehope Nutritional Support.
Ezekiel had never seen a physician in his life. He had received no vaccinations,
including vaccination against Haemophilus influenza type b (Hib), a vaccine
which protects against bacterial meningitis. And as he lay dying, the parents
chose to use an Echinacea tincture recommended by a naturopath, who never
examined the boy. His body was so stiff, he couldn’t sit in his car seat, and
had to lie in a mattress in their car. The Stephans eventually called 911, but
the toddler still died, and the cause of death was subsequently identified as
bacterial meningitis.

David Stephan was sentenced to four months in jail. Collet Stephan was ordered
to spend three months under house arrest. The Stephans appealed, but the
conviction was upheld by the Alberta Court of Appeal in November 2017. However, 
because the ruling was not unanimous, there was an automatic right of appeal to 
the Supreme Court of Canada. The Stephans exercised that right.

Monday, the Supreme Court of Canada ordered a new trial. Are the Stephans
vindicated? No, not even close.

Ezekiel’s last days

The Canadian Press has a concise summary of Ezekiel’s tragically short life:

   August 20, 2010: Ezekiel Stephan is born at home with the assistance of
   birthing assistant Terry Meynders, who is also a registered nurse.

   February 27, 2012: Ezekiel takes ill at the family home in Glenwood, Alta.
   His mother describes him as having a cold, stuffy nose and trouble breathing.
   “The sound he was making was heartwrenching. This isn’t the kind of sound
   you want to hear from your child,” she testifies later at the trial.

   February 28-March 5, 2012: Ezekiel is treated for what his parents believed
   to be croup, an upper airway infection that leads to a barking cough. In
   addition to regular smoothies, they give the boy olive leaf extract, garlic, 
   hot peppers and horseradish. They also attempt to help his breathing with
   cool air and a humidifier.

   March 5, 2012: Ezekiel seems to improve. His father says the boy is not 100
   per cent, but he no longer has any difficulty breathing and is able to go to 
   preschool. He plays with his toys and manages to eat some solid food.

   March 6, 2012: Ezekiel suffers a setback. He is “unusually lethargic,” lies
   in bed the entire day and his only response is to moan unhappily. He doesn’t 
   eat or drink and is exhibiting unusual neurological symptoms.

   March 7, 2012: Ezekiel seems to improve again. His abnormal movements stop
   and he can watch TV, but still isn’t playing normally.

   March 8-10, 2012: Ezekiel’s parents note he seems to be gradually improving. 
   He regains a bit of his appetite, but is not active or playful.

   March 11, 2012: Ezekiel’s symptoms worsen again. He refuses to eat or drink
   and is lethargic. His parents notice his body is very stiff.

   March 12, 2012: Ezekiel’s body is so stiff that his back is arched. He is
   getting fluids through an eyedropper because he will not drink on his own.
   Meynders comes to the home and checks his vitals. She suggests he could
   possibly have viral meningitis and says she tells the mother she should take 
   the boy to a doctor. “It did not jump out at me that he was that seriously
   ill,” Meynders testifies.

   March 13, 2012: The Stephans head to Lethbridge to pick up an echinacea
   mixture from a naturopath. Ezekiel is too stiff to sit in his car seat and
   has to lie on a mattress in the vehicle. Back at home that evening, the boy
   stops breathing on a couple of occasions before his parents leave home to
   meet an ambulance. The breathing equipment in the ambulance it too large to
   properly help a small child. The boy is taken to hospital in Cardston and
   then to Lethbridge for transport to Calgary by air.

   March 14, 2012: Ezekiel arrives at Alberta Children’s Hospital in Calgary
   where doctors tell the parents the boy is showing very little brain activity 
   and the prognosis is bleak. He is put on life support.

   March 16, 2012: Ezekiel dies.

The facts seem clear in this case. Ezekiel was seriously ill with bacterial
meningitis, a vaccine-preventable disease. Had he been seen by medical
professionals promptly, he might be alive today. His parents endangered his life
by ignoring clear signs that he was seriously ill. A registered nurse
recommended a physician assessment. The parents ignored this advice.

The Supreme Court of Canada’s decision

The appeal was heard Monday, May 14. The court made the following assessment:

   The Supreme Court heard arguments from the couple’s lawyer and the Crown
   before making the unusual move of ruling immediately from the bench.

   Justice Michael Moldaver, speaking for the high court, said the trial judge
   did not properly instruct jurors on what would be a marked departure from
   reasonable behaviour “in a way that the jury could understand.”

   “Accordingly we would allow the appeal, quash the convictions and order a new
   trial.”

   Karen Molle, lawyer for the Stephans, had argued the trial judge didn’t
   instruct the jury properly to determine whether the Stephans acted
   differently than other reasonable parents.

   “This jury charge gave this jury little choice but to convict,” Molle said.

   Julie Morgan, representing the Crown, said the trial judge’s language was
   generalized but it was enough for the jury to understand the case.

   “The jury would have understood what their job was,” she told the court.
   “They found that the appellants did not meet the community standard, when
   they failed to take their child to a doctor when he had meningitis, and that 
   endangered his life.”

And from the CBC:

   The Stephans’ defence lawyer, Karen Molle, told the Supreme Court judges that
   due to the significant “polarization of evidence” and “overabundance of
   medical evidence,” the charge from Alberta Court of Queen’s Bench Justice
   Rodney Jerke did not supply jurors with the tools they needed to properly
   decide the case. In the decision, Supreme Court Justice Michael Moldaver said
   the panel agreed that the trial judge conflated two elements of the offence 
   to be decided by the jury and failed to sufficiently explain the concept of
   marked departure in a way the jury could apply and understand it.

And:

   The two elements the judges believe were combined by the trial judge are
   actus reus and mens rea. Actus reus, Latin for guilty act, raises the
   question of whether the Stephans failed to provide their son with the medical
   attention that was necessary in the circumstances. Mens rea, Latin for
   guilty mind, raises the question of what level of risk could objectively be
   foreseen by a reasonable person. The concept of marked departure was
   explained by Crown Julie Morgan as actions removed from what a reasonable
   person would do in a specific situation, in this case meaning not taking a
   child displaying symptoms of meningitis to the hospital.

Now I’m a pharmacist, not a lawyer, so I will defer to experts for their
assessment of the court’s ruling. What it effectively means today is that the
Stephans now face another trial:

   A spokeswoman for Alberta Justice said the file will return to Lethbridge
   Court of Queen’s Bench to set a new trial date.

   “The Crown has an obligation to continually assess the evidence/file against 
   the prosecution standards of a ‘reasonable likelihood of conviction’ and if
   it is ‘in the public interest to proceed’ with a case,” said spokeswoman
   Katherine Thompson.

   Although David Stephan said the prospect of a new trial is “deeply
   uncomfortable for us,” he rejoiced in the Supreme Court’s decision.

   “Praise be to the Lord God Almighty!!” Stephan wrote on Facebook.

What is this whole truth that David Stephan says is being withheld or destroyed?
Just after the trial, he elaborated a bit – in a clip he described on his
Facebook page as “Mainstream Media’s agenda begins to shine through”:

No surprise, David Stephan is as unrepentant as ever. Right from the beginning
of the criminal charges, there have been claims of “conspiracy” that have
continued through this week. To David Stephan, it’s all about “freedom” versus
“Big Pharma” and their agenda…which appears to be, if they do have an agenda,
it’s preventing children from dying from meningitis by selling a vaccine that
prevents meningitis.

No choice for children harmed by pseudoscience

This is a horrible tragedy, and we haven’t seen the end of the story.
Astonishingly, as a glance at the Stephans’ Facebook page shows, there is no
shortage of supporters for the Stephans’ actions. Yet no matter how far the
Stephans will continue to spin this, they are not victims. Ezekiel, who was
denied proper medical care through the Stephans’ neglect, is the only victim. He
had no voice, and no choice. If society has a duty to protect children, is it
doing enough to prevent cases like these? We will see what the courts have to
say.

       s

The Verdict is In: There is No Justice for Ezekiel Stephan

Ezekiel Stephan died from bacterial meningitis and his parents’ failure to seek 
appropriate medical care in 2012, and now they have been acquitted after the
Supreme Court of Canada ordered a new trial. It appears that there may be no
justice for Ezekiel.

Clay Jones on September 20, 2019

Link



In March of 2016, I wrote about the tragic 2012 death of Ezekiel Stephan.
Ezekiel, who was not vaccinated, died from a preventable case of bacterial
meningitis. As he suffered, being described as so stiff that he could not even
be put into his car seat, his parents treated him with useless herbs and sought 
care from a naturopathic doctor. His parents also ignored advice from a
medically trained family friend to seek appropriate medical care. Finally, as
his body became overwhelmed with bacterial sepsis and his lungs and brain were
developing collections of pus, his parents called emergency medical services but
he had no real chance of recovery.

The Stephans were ultimately convicted of failing to provide the necessaries of 
life and sentenced to a few months of jail and house arrest, but were released
early pending the outcome of an appeal. Ezekiel’s parents repeatedly
demonstrated a lack of repentance, and his father took to claiming that they
were the victims of a government (and Big Pharma) conspiracy. The Court of
Appeals rejected the appeal, but because it was a 2-1 decision it was kicked up 
to the Supreme Court of Canada who would eventually order a new trial.

Yesterday, this new trial concluded with the acquittal of the Stephans. Despite 
an extremely consistent clinical presentation, the finding of diffuse
inflammation/pus around the brain and spinal cord, and positive bacterial
cultures in a child who was already not breathing (and almost certainly beyond
any chance of recovery) by the time his parents finally chose to call for
appropriate medical help, Queen’s Bench Justice Terry Clackson found that
Ezekiel had viral meningitis. Furthermore, Clackson found that Ezekiel had died 
because the ambulance didn’t have the appropriate size oxygen mask and that the 
Stephan’s didn’t know he had meningitis, two patently absurd assertions clearly 
refuted by the facts of the case.

   The medical examiner who did the autopsy testified that Ezekiel died of
   bacterial meningitis, but a pathologist called by the defense said the child 
   died from a lack of oxygen to the brain when he was in an ambulance

The pathologist called by the defense was Dr. Anny Sauvageau, Alberta’s
controversial former Chief Medical Officer who also disagreed with the same
medical examiner in another recent high profile case. Concerns that Sauvageau
might be biased were raised in the initial 2016 trial, during which she
“promised to be neutral”. More concerning to me is that her disagreement with
the medical examiner in this case appears to be based only on a reading of the
medical examiner’s report and a 911 call which she cites as evidence that the
child was asphyxiated. In a 2018 trial involving another case of parental abuse,
she similarly contradicted the findings of a different medical examiner using
questionable logic.

The Crown has the right to appeal this ruling, although they have not made any
announcement yet in this regard. I hope that they do because I truly believe
that the judge is mistaken. I don’t believe that justice has been served in the 
case of poor Ezekiel Stephan. And his father is already crowing about being
vindicated and how this is a win for parental rights. I’ll close with this
chilling quote from Judge Clackson:

   Ezekiel was indeed sick, but the law does not impose a duty to seek medical
   attention for every sick child.

I can’t imagine many things more heartless and ignorant than that. Ezekiel
wasn’t merely sick. He was in agony. He was intermittently seizing, his head
pounding and his neck and back searing as pathogenic bacteria spread from his
lungs to his brain through the bloodstream. He didn’t have the developmental
capability to understand why, but you can be confident in the fact that he
suffered as he slipped into a comatose state from which he would not recover.

Ezekiel, and all the children who have died at the hands of their parents’ world
views, deserved better.

Deconstructing Justice Terry Clackson’s outrageous acquittal of David and Collet
Stephans for the death of their son Ezekiel

On September 19, in a retrial ordered by the Supreme Court of Canada, Alberta
Justice Terry Clackson issued a ruling acquitting David and Collet Stephan of
failing to provide the necessities of life to their son Ezekiel, whose bacterial
meningitis they had chosen to treat with quackery instead of medicine, leading 
to his death in 2012. The news reports showed that this was a very bad decision,
but you have to read Justice Clackson’s actual decision to see that it’s an
even worse decision than the news reports indicate, full of bad medicine, bad
science, and even a hint of racism.

David Gorski on September 30, 2019

Link



Last week, Clay Jones wrote about the tragic case of Ezekiel Stephan,
specifically how the ruling issued by Justice Terry Clackson a week and a half
ago was a massive miscarriage of justice. Ezekiel, you might recall, was the
19-month-old son of David and Collet Stephan. He lived in Alberta with his
parents David and Collet until his death from bacterial meningitis in 2012. He
was a child who very likely would have lived had it not been for the fact that
his parents were (and still are) heavily into alternative medicine. After he
fell ill, his parents tried to treat him with “natural remedies”, his wife at
one point briefly consulting with a naturopath’s office, until, by the time they
sought conventional medical care, Ezekiel was in extremis, at death’s door.
Basically, Ezekiel had been ill for a couple of weeks and getting sicker and
sicker, but the parents didn’t seek conventional medical care until he stopped
breathing, which led them finally to call an ambulance. But it was too late.
Ezekiel made it to the hospital, but ultimately died.

As a result, David and Collet Stephan were tried and convicted in 2016 under
Section 215 of the Criminal Code which deals with “failing to provide the
necessaries of life”. David Stephan was sentenced to four months in jail, and
his wife was ordered to spend three months under house arrest. Meanwhile, the
Stephans’ appeal went on. (Because the decision to convict hadn’t been
unanimous, the Stephans’ case could automatically be appealed to the Supreme
Court of Canada.) At the time, I was actually somewhat surprised at the verdict 
in the first trial, as courts in the US and Canada appear to give parents
wide—too wide—latitude for making decisions about what is best for their
children, and great deference is generally granted to parental authority and
parental “rights.” It is this deference that can cause a problem in protecting
children from their parents’ belief in quackery when they become seriously ill. 
Before the verdict was announced, I had half expected that to happen in this
case, the more so because David Stephan is a prominent member of his community, 
belonging to a family that runs a large nutritional supplement company, Truehope
Nutritional Support. Of course, Stephan’s entire business and worldview were
(and still are) inextricably linked to what happened, with his belief in
“natural healing” having led to Ezekiel’s unnecessary death. That’s one reason
why Dr. Jones in an earlier post had explained how Ezekiel’s death was in
essence a “death by world view”.

Consistent with the Stephans’ world view believing in quackery, reports from the
trial indicated that David Stephan tried to use Truehope supplements to treat
his son. As far as David Stephan’s business goes, Health Canada once launched an
unsuccessful court case in 2004 to stop the distribution of the company’s
product Empowerplus, a product that the company claimed to be able to manage
mental illnesses. The case ended in 2006 when the company was found not guilty
of distributing the supplement without a drug identification number. Not
surprisingly, the Stephans are antivaccine, too, and that quite possibly also
had a role in Ezekiel’s death, as you will see.

Unfortunately, the 2016 Stephans’ conviction was overturned on appeal based on a
technicality (if you want the gory details, which involved a conclusion that
the jury hadn’t been correctly instructed before deliberating, go here), the
Supreme Court of Canada ordered a new trial, and on September 19 the Stephans
were acquitted after a trial before Justice Terry Clackson. Clay’s post a week
and a half ago was about the expressed justified anger, dismay, and puzzlement
over the judgment of Justice Clackson. As a CBC news report put it, the Stephans
will face no responsibility:

   An Alberta couple who treated their son’s illness with natural remedies
   rather than take him to a doctor have been found not guilty in the toddler’s 
   death after a retrial.

   David and Collet Stephan were tried on charges of failing to provide the
   necessaries of life to 19-month-old Ezekiel, who died in 2012.

   Supporters in the courtroom cheered and Collet Stephan cried as she hugged
   her husband.

   Court of Queen’s Bench Justice Terry Clackson spoke to the court in
   Lethbridge, Alta., for only four minutes on Thursday before releasing his
   written decision in the judge-alone trial.

Yes, these parents let their child suffer for days and finally die, thanks to
their medical neglect, and they’re going free, although the Crown can appeal.
Even worse, after the verdict they’ll now be heroes to the alternative medicine 
crowd in Canada (and, let’s face it, the world), for having been “falsely
accused” of child neglect, being “persecuted” by the system, but finally having 
beaten the charges and found to be “innocent”. Yes, they’ll be heroes. Even
worse still, David Stephan can go back to doing what he does best: Grifting in
the service of his company’s Truehope supplements and making money by appearing 
at “natural health” expos, the latter being a revenue stream that his conviction
had cut into severely, as expo organizers, facing very negative publicity,
dropped him like the proverbial hot potato.

You might wonder why I’m writing about this case again, given that Dr. Jones
covered it so recently. The answer is simple. When Dr. Jones wrote his post,
Justice Clackson’s full ruling hadn’t yet been published. Now it has been,
allowing me to examine in more detail the “reasoning” (such as it is) that led
to what is one of the most head scratching, cringeworthy miscarriages of justice
I’ve ever seen. At the time, news reports described Justice Clackson’s
rationale thusly:

   The judge ultimately sided with the defence’s medical experts in finding the 
   boy had viral not bacterial meningitis and ultimately died of a lack of
   oxygen.

   Speaking with the media after the decision was handed down, David Stephan
   called the last seven years an “emotional roller-coaster.”

   “We didn’t know what to expect coming into today, and it’s the right
   decision, and it’s shocking because it’s been seven years of our life
   fighting this so it’s become part of our identity,” he said.

   “It’s a beautiful thought that we can move on with our lives.”

   Stephan said his case “helps protect parental rights” so that parents won’t
   be held criminally liable if they choose alternative treatments for their
   sick children.

This is a boy who at autopsy was found to have pus on his brain and an empyema
(pus in the pleural cavity surrounding the lungs). You don’t get this from a
virus, at least not in the brain. (You can, of course, get a bacterial pneumonia
complicating a viral respiratory infection.) Also, as Dr. Jones described in an
earlier post, by far the most likely diagnosis was haemophilus influenza, type 
B (HiB), to which, of course, Ezekiel was vulnerable because he hadn’t been
vaccinated. (Indeed, although the medical examiner was unable to culture the HiB
bacteria, PCR did apparently detect HiB DNA.) It’s just another indication how 
the parents’ world view not only predisposed Ezekiel to catch a deadly
infection, but greatly diminished his chances of surviving that infection once
he had caught it.

Justice Clackson and “accents”

The retrial basically ended up boiling down to a “battle of the expert
witnesses”. In the Crown’s corner was Dr. Bamidele Adeagbo, a former medical
examiner in Calgary who testified that Ezekiel’s autopsy showed Ezekiel had
clearly died from bacterial meningitis. In the defense’s corner was Dr. Anny
Sauvageau, who was registered as Anatomo-Pathologist in Quebec until 2011 and is
currently not licensed. As Alheli Picazo notes, Dr. Sauvageau’s credentials
have also come under scrutiny before. She is not boarded in forensic pathology, 
either, and does not have a license to practice in Alberta. Nor did she at any
point examine the child, basing her conclusions on reading the autopsy report
and listening to the 911 calls. In addition, Dr. Sauvageau is suing Alberta
Justice for wrongful dismissal, alleging that her position was not renewed after
she stood up to political pressure to change a contract for transporting bodies
for the Office of the Chief Medical Examiner of Alberta. Indeed, given her
pending civil litigation, the Crown’s prosecutor asked how she could be
impartial. She claimed that her lawsuit is irrelevant and promised to be
neutral.

Of course, I highly doubt Dr. Sauvageau’s “neutrality”. She appears to have a
history of being a hired gun (excuse me, “expert witness”) for negligent
parents. It turns out that the Stephans aren’t the only dangerously neglectful
parents for whom she’s come up with—shall we say?—”creative” alternative
explanations for the death of the neglected child. For instance, there was the
case of John Clark in Calgary, a child who had been born at home, had never been
vaccinated, was not fed properly and had never seen a doctor until the day
before he died. Her testimony in the case brought against John’s parents Jeromie
and Jennifer Clark was only somewhat less ridiculous than her testimony in
defense of the Stephans. John was brought to the hospital malnourished with a
clinical picture most consistent with sepsis, and Dr. Sauvageau claimed that it 
was an overly aggressive correction of the child’s hyponatremia (low sodium)
that killed him, not the malnutrition and sepsis. While this story is marginally
more plausible (overly aggressive correction of hyponatremia can indeed cause
seizures), when taken in context with the whole picture, I have a hard time
taking her testimony in this case seriously, either. For instance, Dr. Sauvageau
also claimed that John wasn’t septic because there were never any positive
blood cultures. This to me indicates that, at the very least, Dr. Sauvageau is
well behind the times in her understanding of the pathophysiology of sepsis. In 
fact, you can be septic and still have persistently negative blood cultures.
Indeed, the definition of sepsis no longer even requires a blood culture
positive for bacteria, as positive blood cultures are no longer even part of the
diagnostic criteria for sepsis. She also claimed that John’s small size was due
to a hormonal condition, not malnutrition, based on his “body proportions”.

You get the idea.

Before I delve into Justice Clackson’s defective reasoning in terms of medicine 
and science, there is an issue that came up late last week that I feel obligated
to deal with briefly first. Let’s take a look at Clackson’s characterization of
Dr. Adeagbo. It was so bad that there was a complaint of racism:

   A group of professors has sent a six-page letter to the body that oversees
   federally appointed judges, saying language used in a recent ruling that
   acquitted two parents in the death of their toddler could be perceived as
   racist.

   “We believe that Justice (Terry) Clackson’s choice of words is inappropriate,
   shocks the conscience, and speaking for ourselves, undermines our confidence
   in the administration of justice,” says the letter to the Canadian Judicial 
   Council and signed by 42 professors of medicine and law from across Canada.

Dr. Adeagbo is African, Nigerian specifically:

   In his ruling, Clackson devotes an entire section to complaining about the
   way Adeagbo spoke. He says that he is, in part, summarizing the concerns the 
   defence had about Adeagbo’s expertise as a witness but also that he had
   concerns with the doctor’s garbled enunciation, dropping his Hs and
   mispronouncing vowels, and his failure to use the appropriate definite and
   indefinite articles and correct endings for plurals and past tenses.

   “Justice Clackson harshly mocked Dr. Adeagbo’s manner of speech and accented 
   English, and thereby inappropriately implicated his national or ethnic origin
   as a person of African roots,” say the professors in their complaint. “It is
   hard to imagine that if Dr. Adeagbo, who is of African origin, had spoken in
   a typically American, Australian, British, or other more familiar accent,
   Justice Clackson would have been so scathing…”

   While Clackson concludes, in the end, the way Adeagbo spoke had no real
   effect on his credibility as a witness, the letter’s signatories say the
   judge “formed an inappropriate view that one’s spoken expression, as rooted
   in one’s national or ethnic origin, is relevant to the weight of one’s
   testimony.”

If Dr. Adeagbo’s accent as a non-native speaker of English was “irrelevant” to
how Justice Clackson viewed his credibility as a witness, then why did Clackson 
spend so much verbiage basically snarking on his accent? Let’s go to the ruling 
itself:

   Dr. Adeagbo’s evidence was replete with technical medical jargon. His
   vocabulary was extensive. His ability to articulate his thoughts in an
   understandable fashion was severely compromised by: his garbled enunciation; 
   his failure to use appropriate endings for plurals and past tenses; his
   failure to use the appropriate definite and indefinite articles; his repeated
   emphasis of the wrong syllables; his dropping his Hs; mispronouncing his
   vowels; and the speed of his responses. In addition, his answers were not
   always responsive and he would on occasion embark upon a mission to educate
   the parties and the Court. As a result, there were many instances when it was
   necessary to have Dr. Adeagbo: repeat his answers; slow down his delivery;
   focus on the question asked; and accept that, despite our ignorance, the
   question asked need to be answered. The Transcripts of his testimony are
   replete with many examples of the foregoing. All of this was exacerbated by
   the use of a video link as an accommodation to Dr. Adeagbo. However, even
   when present in person, as he was the final two days of his testimony, the
   problems I have identified, continued. Nevertheless, the profound difficulty 
   all the participants experienced in comprehending Dr. Adeagbo’s evidence,
   does not form a basis for a realistic concern that he was biased or partial. 
   In my view, all of those problems are best considered in the Cost-Benefit
   Analysis and, if his testimony is admitted, in the weight to be given to his 
   evidence.

How nice of Clackson to conclude that his difficulty with English doesn’t mean
that Dr. Adeagbo was biased. In any event, does anyone think that Justice
Clackson would have written a paragraph like the one above if Dr. Adeagbo were
white and had trouble with English because he came from a European country and
English was his second language? Wait, we already know. Dr. Sauvageau, I’m told,
is French-Canadian and speaks with an accent as well.

Dr. Clackson didn’t stop there, though:

   [21] Dr. Adeagbo demonstrated all of the following behaviours and attitudes
   over the six days of his testimony. He was calm, rationale, reasonable,
   arrogant, petulant, exasperated, combative, argumentative and angry.

   [22] Those attitudes were demonstrated not just verbally but also in Dr.
   Adeagbo’s movements, body language and physical antics. Again, these
   behaviours were more prevalent during the video-link presentation.
   Unfortunately, the Transcript does not adequately capture some of the
   behaviours I have described. Suffice to say that they were not the behaviours
   usually associated with a rational professional imparting opinion evidence
   for the benefit of the Court.

Look, I get it. Dr. Adeagbo might not have been the most likeable witness on the
stand, and clearly it’s the prosecutors who messed up if that was the case.
Even if he wasn’t the best performing expert witness, I also feel for Dr.
Adeagbo. I’m sure being cross-examined by David Stephan (who represented
himself) and Collet Stephan’s lawyers for six days was painful and frustrating
in the extreme, given how they’ve tried to twist the science and evidence into
pretzels of pseudoscience and conspiracy theories and how judges often grant
defendants who are representing themselves wider leeway than they do lawyers.
I’m also puzzled. Dr. Adeagbo was a medical examiner. Surely he must have
testified in dozens of cases. That’s part of the job of a medical examiner, to
be the prosecution’s expert witness on cause of death. Has any other justice
ever complained about him like this before? I didn’t see any such complaints in 
the original case. In any event, I can totally understand why he might have
gotten frustrated, but obviously wish he hadn’t. Even so, I have a hard time not
strongly suspecting that Justice Clackson is racist, given how much verbiage he
expended snarking on Dr. Adeagbo’s difficulty with English and his “uppity”
manner and how he believed the risibly ridiculous testimony of the defense’s
primary expert witness, Dr. Anny Savageau, instead. Also, Dr. Adeagbo was damned
if he did, damned if he didn’t. Justice Clackson in essence complained that Dr.
Adeagbo used too much jargon and then complained that he kept trying to educate
the parties and the court.

The Stephan retrial ruling

Now that that has been dispensed with, let’s look at the balance of Justice
Clackson’s ruling itself in which he didn’t concern himself with how annoying he
found Dr. Adeagbo’s accent and demeanor. The summary tells the tale, and it’s a
horrible one:

   [3] The evidence plainly establishes that Ezekiel had meningitis. The main
   issues in dispute are:

  1. Whether he had bacterial or viral meningitis;

  2. Whether his death was the result of meningitis, or the result of hypoxic
    injury;

  3. Whether the Stephans knew he had meningitis; and

  4. Whether knowing that, they ought to have sought medical intervention.

   [4] I have concluded that Ezekiel did have meningitis. The Stephans did not
   know the Ezekiel had meningitis but were alert to the possibility and
   monitoring for symptoms. The meningitis Ezekiel had was viral and he did not 
   die from meningitis but from the lack of oxygen. Therefore, I have concluded 
   that the Stephans are not guilty of the charge.

Before I get into the weeds a bit more, let me simply say that the entire
premise of Justice Clackson’s ruling is a steaming, heaping pile of fetid
dingo’s kidneys. Basically, he’s buying into the Stephans’ nonsense that
conflates the final, most proximate cause of death (hypoxia because the child
had stopped breathing) with the cause of death (the meningitis that made Ezekiel
so sick that he stopped breathing). How did Ezekiel get to that point? He got
to that point because his parents didn’t take him to the doctor after he got
very sick and instead watched him get worse. True, from previous testimony, we
know that Ezekiel did make some improvements, but it’s not unusual in the case
of a serious disease for the course not to be an unrelenting downward spiral. It
is, however, obvious from previous court cases that Ezekiel’s course was,
overall, a downward spiral, with occasional brief improvements. We can argue
about how sick a child has to be before the parents have a duty to take him to a
doctor, but we already knew quite clearly that not only did the Stephans at
least strongly suspect that Ezekiel had developed meningitis, but that they had 
asked advice of a naturopath. Indeed, here’s testimony quoted in Judge
Clackson’s ruling:

   Q And during your conversation with Ms. Meynders, did she ever stress that
   meningitis was an urgent thing that you would have to take him to the doctors
   for immediately?

   A I’m trying to recall our conversation of what she had said. I believe with 
   the one that she was in contact with that few weeks ago was the bacterial,
   and she had expressed that with bacterial, it – well, if I remember right,
   she expressed that meningitis was hard to diagnose, and that the bacterial is
   more concerning than the viral. And when I was looking at the symptoms and
   reading on that page, it had — it said the same thing that– that she was
   implying.

   Q And when you were reading about the page and comparing, I take it, you
   compared what Ezekiel was going through to what you found on the page; is
   that correct?

   A Yes.

   Q And how did Ezekiel stack up, if at all?

   A So when looking at the symptoms, even on the viral meningitis, he just had 
   that achy slash stiff, so, like, the tension of the flu, but he didn’t have
   any of the other symptoms on the viral. So in my mind, I’m thinking, Well, if
   it – out of the two, he would — he would be closer to have a viral
   meningitis rather than bacterial, but at that time, like, it was uncertain.

   Q So why didn’t you take him to the doctor at that point?A Because he didn’t 
   really have any symptoms that was listed under the viral and the bacterial
   meningitis.

Then, as Dr. Jones noted:

   Two or three days later, Ezekiel was brought into the same naturopathic
   clinic where Dr. Tracey Tannis recommended a “tincture of echinacea.”
   According to a taped March 15th, 2012 interview of his father, Ezekiel was so
   stiff that they were unable to put him into his car seat, so they laid him
   flat on a mattress in the back of their vehicle for the ride to the clinic.
   According to more than one report, Dr. Tannis did not examine Ezekiel.

Neck stiffness is a sign of meningitis, and neck and spine stiffness so bad that
the parents couldn’t put Ezekiel into his car seat should be an incredibly
worrisome sign to parents that the child is very sick.

What about the issue of whether the meningitis was viral or bacterial? As Dr.
Jones described in his earlier post, viral meningitis tends to be significantly 
less severe than bacterial meningitis and is rarely deadly in an otherwise
healthy child. Even so, my first reaction was: Why on earth should it matter?
Yes, bacterial meningitis is deadlier but also easier to treat because it can
respond to antibiotics, and viral meningitis has to run its course. Seriously,
though. It’s part of the Court’s “reasoning” based on its erroneous conclusion
that Ezekiel “only” had viral meningitis that the parents weren’t neglectful in 
not taking him to a doctor or hospital? Judge Clackson should realize that
supportive care, such as being placed in a pediatric intensive care unit (PICU),
would have maximized Ezekiel’s chances to ride out the a severe case of viral
meningitis, and would have allowed a bacterial meningitis to be properly
treated.

The Court also ruled that the child died of “lack of oxygen”. Well, yes, that’s 
what we all die of! It’s basically the common final cause of every death on the 
planet! The real question should have been: What had caused Ezekiel to stop
breathing leading to the “lack of oxygen” that killed him? It’s clear that it
was bacterial meningitis! Again, Ezekiel’s death could have been prevented by
putting him in the hospital, in the PICU if necessary, for supportive care up to
and including mechanical ventilation if it were to become necessary plus
appropriate antibiotics, assuming the meningitis was bacterial. Justice Clackson
conflated the proximal cause of Ezekiel’s death with the overall cause.

Let’s look at how Justice Clackson came to the conclusion that Ezekiel had viral
meningitis, as it reveals even more intellectual bankruptcy. First, he was
annoyed by Dr. Adeagbo doing what any responsible doctor would do:

   [23] Again, however, while concerning, distracting and unprofessional, none
   of those attitudes demonstrate a bias or partiality. Rather, all may be
   attributed to the fact that in Dr. Adeagbo’s opinion, Ezekiel so obviously
   died of bacterial meningitis that it is a complete waste of time to even
   consider anything else. Accordingly, those attitudes do not raise a realistic
   concern that Dr. Adeagbo is not an appropriate expert. Those attitudes are
   however, relevant in the Cost-Benefit Analysis.

Well, yes, the child had pus on the brain and in his pleural spaces, but, by all
means, hearing the hoofbeats, Dr. Adeagbo should have looked for zebras! What
do I mean? In medical jargon, a “zebra” is an unexpected, much less common
diagnosis relative to the more common ones fitting a given clinical
presentation. There’s a saying in medicine that goes something like this:

  1. When you hear hoofbeats look for horses not zebras.

  2. If you hear hoofbeats in the distance don’t expect a zebra.

  3. When you hear hooves think of horses before zebras.

The idea is that common diagnoses are far more likely to explain appropriate
clinical presentations than uncommon or rare diagnoses. Sure, there are times
when doctors do have to go “zebra hunting“, but from the testimony from the
previous trial that I’ve read (and this one), Ezekiel’s was not one of those
cases, given the purulence on the brain and in the pleural cavity, plus the
presence of HiB bacterial as documented using PCR. In this clinical setting, by 
far the most likely diagnosis was HiB pneumonia and meningitis, with viral
meningitis very much less likely.

Unfortunately, Justice Clackson let Dr. Sauvageau cast doubt on that diagnosis.

   [47] Dr. Adeagbo testified that a sample of the right lung tissue across the 
   empyema noted in the pleural cavity was taken and the Gram stain process
   disclosed Gram negative bacilli which is consistent with bacterial infection.
   All of which confirmed his opinion that the meningitis had been caused by
   bacterial infection. He plainly believed the empyema was part of the same
   bacterial infection which caused the meningitis.

   [48] He ignored the presence of enterovirus in the nasal swab/wash.
   Supposedly, chalking that up to something common in us all.

The pleural cavity is normally sterile. There should be no bacteria there.
Moreover, empyema literally means pus in the pleural cavity. As for enterovirus?
That’s such an obvious deflection that I think I hurt the bridge of my nose
from driving my glasses into it from all the facepalming that I did.

Then there’s this:

   [50] Dr. Adeagbo also confirmed his diagnosis of bacterial meningitis by the 
   presence of certain types of white blood cells. Again, Dr. Sauvageau came to 
   a different conclusion. Although her evidence in the 2016 trial on this
   subject appears less certain then she was before me, I accept her conclusion 
   that the relative prominence of lymphocytes excludes bacteria as the agent of
   infection.

   [51] In result, I was left unconvinced that the meningitis was bacterial.

   [52] Dr. Sauvageau explanation for why the meningitis was viral is consistent
   with what was observed on autopsy, the history of Ezekiel’s illness, the
   radiology reports, and was logically compelling. As well, Dr. Adeagbo said
   hemophilus influenza, which is the bacterial agent he concluded had caused
   the meningitis, is very rare. That fact, plus the fact that the vast majority
   of meningitis cases are viral in origin (para 62 infra), further supports
   Dr. Sauvageau’s conclusion.

   [53] In result, I am satisfied the meningitis was viral.

Yes, lymphocytic meningitis in the absence of bacteria (so-called aseptic
meningitis) is usually viral. However, in the presence of pus on the brain, that
consideration goes out the window. Moreover, that lymphocytes predominated does
not rule out bacterial meningitis, as it took me all of a minute to find
Googling and doing PubMed. For instance:

   The CSF findings typical of aseptic meningitis are a relatively low and
   predominantly lymphocytic pleocytosis, normal glucose level, and a normal to 
   slightly elevated protein level (Table 5). Bacterial meningitis classically
   has a very high and predominantly neutrophilic pleocytosis, low glucose
   level, and high protein level. This is not the case for all patients and can 
   vary in older patients and those with partially treated bacterial meningitis,
   immunosuppression, or meningitis caused by L. monocytogenes. It is important
   to use age-adjusted values for white blood cell counts when interpreting CSF
   results in neonates and young infants. In up to 57% of children with aseptic
   meningitis, neutrophils predominate the CSF; therefore, cell type alone
   cannot be used to differentiate between aseptic and bacterial meningitis in
   children between 30 days and 18 years of age.

And it didn’t take me long to find a paper describing acute bacterial meningitis
with lymphocyte predominance in 14 out of 103 cases of documented bacterial
meningitis, noting that cerebrospinal fluid lymphocytosis was “significantly
more common in neonates and in those without meningismus, but occurred in all
ages and without any clear identifying clinical characteristics.” (Meningismus
refers to the symptoms of meningeal irritation, like stiff neck.) The authors
concluded, “It [CSF lymphocytosis] is therefore of little value in
differentiating bacterial meningitis from viral, fungal, and tuberculous
meningitis.” A review article notes that “WBC differential may be misleading
early in the course of meningitis, because more than 10 percent of cases with
bacterial infection will have an initial lymphocytic predominance and viral
meningitis may initially be dominated by neutrophils.” The Royal Children’s
Hospital in Melbourne, for instance, explicitly states that a “predominance of
lymphocytes does not exclude bacterial meningitis.”

Yet, risibly, Justice Clackson believed Dr. Sauvageau’s testimony over that of
Dr. Adeagbo and even accused Dr. Adeagbo of confirmation bias:

   [25] I accept that insight as a reasonable proposition which can be
   manifested by an expert in the steps he or she takes to defend or explain the
   opinion reached. In this case, I prefer to apply the label confirmation bias
   because the cross-examination of Dr. Adeagbo proceeded on that footing. In
   the cross-examination of Dr. Adeagbo, it was established that he was sure
   from the beginning that Ezekiel had died from bacterial meningitis. The
   testing done, post autopsy, was done to confirm that conclusion. There was no
   specific testing done to rule out viral or fungal causes for the meningitis.
   Despite records which could tend to support hypoxic injury and hyponatremia,
   no specific steps were taken to confirm or refute either possibility. These 
   actions are consistent with Dr. Adeagbo’s assertion and attitude, that
   Ezekiel’s death was a crystal clear case of bacterial meningitis. He had no
   doubt on the subject. In that circumstance, testing for anything other than
   the bacteria which caused the meningitis was a waste of time. Dr. Adeagbo
   said, and I accept that his additional efforts to identify the bacterial
   agent were not done to support his opinion but done because he wanted to
   identify the infectious agent as he felt it was his duty to do so in the
   discharge of his responsibilities to the Stephans and the general public. The
   duty to keep them safe from a similar fate.

I’m sure any other physicians out there, especially pathologists, are laughing
(or crying, or both) at this paragraph. This is how medicine is done. If
clinically the case is crystal clear, as it was in Ezekiel’s case, it is a waste
of time and resources to do a lot of low yield testing. Moreover, by letting
himself get drawn into the “viral versus bacterial” weeds, Justice Clackson
again ignored the true cause of Ezekiel’s death: The parents waited until far
too late to take him to a doctor, and that’s why he died. Trying to diagnose him
on the Internet isn’t enough. Seeking advice from a naturopathic quack (who
didn’t even examine him) doesn’t count. At the very latest, when Ezekiel became 
so stiff that the Stephans couldn’t put him in his car seat, they should have
taken him to the nearest emergency room.

But what about all the incriminating things that David and Collet Stephan said
to police and first responders, as documented in the first trial? Judge Clackson
basically made them all disappear by saying the Stephans were under stress:

   [81] That is in stark contrast to the various statements they gave to police 
   and medical staff about their observations and actions.

   [82] I have concluded that I cannot rely on any of the statements to the
   medical staff or the police beyond what Mr. Stephan and Ms. Stephan told 911 
   Dispatch, the paramedics and Dr. Clark. All of those recorded exchanges are
   consistent with the circumstances I have just described and the Stephans’
   evidence before me.

   [83] I do not have evidence as to why honest people commit themselves to
   false facts, but the case reports confirm it can occur.

   [84] Perhaps, as the defence has argued, the combination of stress,
   suggestion, confusion, lack of sleep, lack of nourishment and the
   overpowering urge to help save their child, all contributed to the content of
   the statements they made, in those fateful six days. In any event, I am of
   the view that those statements are not reliable.

How convenient for the Stephans. Not only did Judge Clackson buy their false
narrative and let their obfuscations lead him astray, but he basically magically
waved away all their previous statements to police and others about how sick
Ezekiel had been.

Reading through the transcript, I got the distinct impression that Clackson had 
decided that he really didn’t like Dr. Adeagbo and didn’t want to accept his
testimony, preferring that of Savageau instead. There are whole sections on voir
dire and “cost-benefit” analysis in which he came up as many dubious reasons to
discredit and discount Dr. Adeagbo as possible. Why? Was it racism? Possibly.
It could also have possibly been because her testimony wasn’t technically beyond
his ability to comprehend or because he just didn’t like Dr. Adeagbo’s manner, 
which he made abundantly clear in a way that stands out strikingly. This ruling 
is so bad that I really do think that Justice Clackson was not unbiased; he bent
over backwards to find a way to rule for the defendants.

This isn’t the only time Justice Clackson has come under fire, either. He has
been the subject of media attention and criticism since 2018, when the Supreme
Court ordered a retrial after finding that Justice Clackson had relied on rape
myths and stereotypes when acquitting a stepfather of sexual abuse charges:

   The man, known only by the initials A.R.J.D. ( his name and his
   stepdaughter’s were under a publication ban) had initially been acquitted at 
   trial by Alberta Court of Queen’s Bench Judge Terry Clarkson .

   Clarkson let him go based on his assessment the stepdaughter didn’t do enough
   to avoid being alone with A.R.J.D, and didn’t display any changes in
   behaviour such as experiencing nightmares or losing interest in school.

Why is Justice Clackson still a judge?

“Parental rights”: License to kill

Not surprisingly, the Stephans were ecstatic over having been acquitted:

David Stephan speaking now pic.twitter.com/hqj1lniX2l

— Meghan Grant (@CBCMeg) September 19, 2019

Ah, yes, “parental rights,” the all-purpose justification that quackery-loving
parents everywhere use to justify medical neglect of their children, be it
treating diabetes with prayer instead of insulin, refusing chemotherapy for
their children with cancer, refusing to vaccinate their children against
potentially deadly diseases, and many other ways that parents abuse and neglect 
their children by subjecting them to treatments not supported by science. I
always note when I come across people like the Stephans invoking “parental
rights” that these parents always make it about them and their rights and
somehow never seem to bother to consider their children as a separate,
autonomous being with rights of his own, which encompass the right to good
medical care and not to be subjected to medical neglect. Children are not
extensions of the parents’ bodies. The parents do not own their children. They
are supposed to be the guardians of the children, and in that role society gives
them very wide latitude in deciding how to raise the children (too much, if you
ask me). When parents medically neglect their children, then the state has to
step in to protect the child’s rights.

Senator Rand Paul once said about school vaccine mandates, “The state doesn’t
own the children. Parents own the children, and it is an issue of freedom.” This
is the attitude of far too many parents about their children, that they own
them. Sadly, it’s not just in the US where there is a widespread view that
parental rights are absolute or near absolute and people react with outrage
against the state and sympathy for the parents whenever the state tries to
intervene. I see this in every single case of medical neglect that I write about
on this blog; public opinion is almost always on the side of the parents.
Sadly, prosecutors and child protective services know this too, which can’t help
but restrain them. As a result, in some places, even parents who justify not
treating their children with anything resembling science-based medicine using
their religious beliefs have pretty much carte blanche to do whatever they want,
to subject their children to whatever treatment or lack of treatment they want.
The result? Lots of dead children.

If you want to see just how bad things are in the US, at least, I will briefly
recount a case that I’ve discussed several times before, that of Kent Schaible, 
whose parents Herbert and Catherine Schaible chose prayer instead of antibiotics
to treat Kent’s bacterial pneumonia. Their son, two years old at time, had been
suffering from a respiratory illness for two weeks. It worsened and developed
into pneumonia, as his parents prayed. The parents were convicted of involuntary
manslaughter and child endangerment, were sentenced to ten years of probation, 
and had to promise to take their children to a doctor when they were ill (i.e., 
“pretty please, promise not to do it again””). That was 2009. Guess what
happened in 2013? They did it again! Their 7-month-old son Brandon Scott died of
bacterial pneumonia and dehydration, and once again Herbert and Catherine
Schaible did nothing but pray as their child’s condition deteriorated until he
finally died. It is not exaggerating in the least to say that it took two dead
children, both of whom died under similar circumstances, before the state
finally acted to protect the Schaible’s other children by taking their children 
away and sentencing the Schaibles to several years behind for third degree
murder. It was nowhere near enough.

We can see this misguided deference to “parental rights” writ large in Justice
Clackson’s decision:

   [100] It is perhaps helpful to explain this result somewhat differently.
   Ezekiel was sick. Section 215 of the Criminal Code does not impose a duty to 
   seek medical attention for every sick child. For that duty to arise there
   must be a risk to the child. In this case, the risk is particularized as a
   risk to Ezekiel’s life. The cause of that risk is further particularized as
   resulting from meningitis.

   [101] The evidence before me does not establish that the viral meningitis
   Ezekiel had constituted a risk to his life. Therefore, the duty to seek
   medical attention did not arise.

   [102] Did the duty to seek medical attention arise because Ezekiel had
   meningitis and his parents were aware that it was possible he had some type
   of meningitis and aware that some meningitis can be life threatening?

   [103] One suspects that many parents when faced with the scenario which
   presented itself to the Stephans on March 12 would have been perfectly
   justified in feeling their child needed medical attention.

   [104] However, as I said when addressing what the Crown must prove in Element
   6, this is not a civil action. The objective analysis of what prudent
   parents in the circumstances would have done are captured in the other
   elements of this offence. The duty to act only arises on this charge, as
   framed, if medical intervention would have saved Ezekiel’s life. That it
   could have saved his life was not, in my view, sufficient.

This time, the facepalming not only bruised my nose, but it broke my glasses. I 
wonder if I can bill Judge Clackson for a replacement pair.

Note the argument, though. Justice Clackson seems to be saying that if there was
any doubt that getting a child to a doctor would have saved his life, then
that’s “reasonable doubt” and that Crown has failed to prove its case. I would
counter: There is no reasonable doubt that failing to take Ezekiel to a doctor
dramatically lowered his chances of survival to near zero. Even though I’m not a
lawyer, even I get the feeling that Justice Clackson’s verdict appears to have 
been made on a matter not before the court, death as a result of negligence, not
the actual charge of failure to provide the necessaries of life.

Also, the law does not impose a duty to seek medical attention for every sick
child? Perhaps not—but only if the illness is obviously minor to a reasonable
layperson. That was clearly not the case here. Ezekiel was, as we say in the
biz, sick as snot and circling the drain. Not to take him for medical evaluation
and to opt for treating him with witchcraft was child abuse at its most naked, 
in my not-so-humble opinion. As for the claim that Ezekiel died of oxygen
deprivation because the first ambulance didn’t have the right equipment, it was 
pretty clear from the medical evidence that it almost certainly wouldn’t have
mattered if it had. By the time the parents called EMS, Ezekiel was almost
certainly too far gone to be saved. Even if he could have been saved, what about
the suffering and long-term sequelae he would have suffered from bacterial
meningitis treated too late?

The bottom line is that Justice Terry Clackson issued an utterly nonsensical
judgment so divorced from science, medicine, and reality that I would laugh at
it if the consequences weren’t so horrific. He believed the testimony of an
unqualified doctor who never actually did the autopsy on Ezekiel and used only
the autopsy report and the audio recordings of the 911 call and the EMS response
over that of a forensic pathologist to acquit David and Collet Stephan. His
ruling will both allow David Stephan to continue his grift peddling his useless 
supplements, which are promoted to treat real diseases and whose use are likely 
to lead to preventable deaths, and, worse, will likely demoralize child
protective service officials and prosecutors, who are likely to think twice
prosecuting medical neglect. There will be blood on Justice Clackson’s hands.

I hope that the prosecutors appeal. This ruling must be appealed. Unfortunately,
I fear that the prosecutors will look at the multiple legal proceedings, the
fact that it’s now seven years since Ezekiel’s death, and public opinion, and
decide it’s not worth it.

Washington State’s Unconscionable, Unconstitutional Child Protection Law

Harriet Hall on January 28, 2014

Link

I recently wrote about the conflict between child protection and the religious
freedom of believers in faith healing. That issue has reared its ugly head again
in the state of Washington.

Washington law currently denies the children of Christian Scientists equal
protection under the law governing child abuse and neglect, and it grants a
special exemption from criminal prosecution for abuse and neglect to that one
specific religion and not to any others. Even if you supported religious
exemptions in principle, there would be no excuse for the preferential treatment
of one single religion. This law is clearly unconstitutional.

Zachery Swezey didn’t need to die

This law was challenged in the Swezey case. Zachery Swezey was 17 when he died
in Spokane, Washington of a ruptured appendix in March 2009. He received no
medical treatment because his family belonged to the Church of the First Born, a
faith-healing sect that has been responsible for a number of other avoidable
deaths of children. See here for links to several of those cases. With medical
care, Zachery would almost certainly be alive today. Appendicitis is one of the 
things conventional medicine is very good at treating; patients rarely die from 
it anymore; reported death rates are only a fraction of 1%.

Zachery’s parents were tried for manslaughter. The defense argued that the law
exempted one faith-healing religion (Christian Science) from prosecution, and
there was no rational basis for denying another faith-healing religion (Church
of the First Born) the same exemption. The judge ruled that the law had a
rational basis because Christian Science practitioners are licensed by the state
and required to report child abuse and neglect. The judge was demonstrably
wrong. Practitioners are not licensed or accredited by the state and they are
not on the state’s list of mandated reporters. There was a hung jury on the
manslaughter charges. The parents agreed to a plea deal to avoid jail on the
other charges. They will not appeal, so there will be no formal challenge to the
law’s constitutionality.

Proposed bill

State Senate bill 6295 was introduced by Sen. Mark Mullet (D) and three other
Democratic senators on January 20, 2013, and was referred to the Committee on
Human Services and Corrections. Its progress can be followed here.

It proposes to amend RCW 9A.42.005 and3 26.44.020; and to re-enact and amend RCW
26.44.030. The laws were enacted to protect children and dependent persons from
abuse and neglect by requiring reporting of abuse and neglect and imposing
criminal penalties on those found guilty of such abuse or neglect. The new bill 
strikes out these sections:

   It is the intent of the legislature that a person who, in good faith, is
   furnished Christian Science treatment by a duly accredited Christian Science 
   practitioner in lieu of medical care is not considered deprived of medically 
   necessary health care or abandoned.

and

   A person who is being furnished Christian Science treatment by a duly
   accredited Christian Science practitioner will not be considered, for that
   reason alone, a neglected person for the purposes of this chapter.

It adds this section:

   Cultural and religious child-rearing practices and beliefs that differ from
   general community standards do not, in and of themselves, create a duty to
   report under this section unless there is reasonable cause to believe the
   practices and beliefs pose a danger to the child’s health, welfare, or
   safety.

The language being struck out was not even in the original bill as passed by the
House and Senate, but was added by a conference committee (6 people charged
with reconciling differences between the House and Senate versions of the bill) 
and was never debated but simply accepted pro forma.

How could anyone object to a state child protection law that requires all
parents to provide medical care for seriously ill children? It should be a
no-brainer. I wrote to my state senator, Bruce Dammeier (R), asking him to
co-sponsor the bill, since bipartisan support would increase its chance of
passing. I received no answer, and the bill was introduced with no Republican
co-sponsors.

Religious shield laws that exempt members of faith-healing sects from child
protection laws and from criminal prosecution for child neglect and manslaughter
must be repealed. Adults have the right to reject treatment for themselves, but
society has a duty to protect children from parents who would withhold
lifesaving treatment and allow their children to die unnecessarily. Society’s
duty is widely recognized. Just to give one example, it has long been common
practice for courts to intervene and mandate lifesaving blood transfusions for
the children of Jehovah’s Witnesses whose religious beliefs prohibit them.

Which way Washington?

It remains to be seen if Washington will go the way of its neighbor Oregon or
its other neighbor Idaho. Oregon repealed its religious exemptions; the death
rate among faith-healing sects promptly dropped, and parents have since been
successfully prosecuted for manslaughter. Idaho maintains its exemptions; its
cemeteries are filling up with the graves of children who died without medical
care, and the parents are not being prosecuted.

A favorite tactic of the antivaccine movement: When science doesn’t support you,
use the law

David Gorski on August 5, 2013

Link

As I’ve joked about before, I’m a bit like Dug the Dog from the movie Up
whenever a squirrel goes by. In other words, I’m easily distracted by things
that interest my primal urge to chase pseudoscience. I originally had a
cancer-related topic in mind for this week’s foray into science-based medicine, 
but then on Friday our favorite group of antivaccine activists over at the
antivaccine crank blog Age of Autism induced a squirrel to run in front of me,
and the rest is history, at least for the moment. I’ll try to get back to my
original topic either as a bonus post later this week or as next week’s post
(unlike the topic of today’s post it’s not really particularly time sensitive). 
In the meantime, I’ll chase this squirrel. Sorry about that. But Dug’s gotta do 
what Dug’s gotta do. Besides, the topic I had in mind for this week is
sufficiently complex that my ultimate post will probably end up being much
better if I have a few more days to a week to think about it. At least, that’s
what I keep telling myself.

If there’s one thing I’ve learned over the years opposing the antivaccine
movement, it’s that these days its “Holy Grail” (well, a “holy grail”) is to
have a “vaccinated versus unvaccinated” study performed, or, as it’s frequently 
abbreviated, a “vaxed verus unvaxed” study. The reason they want such a study so
badly is not because they think there’s a scientific question that genuinely
cries out for an answer. Rather, they believe it will confirm their fixed,
unalterable belief that vaccines are the root of nearly all chronic health
conditions children suffer today, particularly autism and autism spectrum
disorders. In particular, they believe that a “vaxed versus unvaxed” study would
demonstrate once and for all that vaccines are the cause of the “autism
epidemic.” Hilariously, a few years back, the antivaccine group Generation
Rescue tried to do such a study. It was more an utterly incompetently
administered and analyzed telephone survey than anything else, and, ironically, 
its results actually were just as consistent with the conclusions that vaccines 
protect against autism as that they predispose to autism. And don’t even get me 
started on an even more hilariously incompetent vaxed versus unvaxed study by a 
German antivaccine homeopath (I know; “antivaccine homeopath” is redundant) that
antivaccinationists were touting a while back. That took attempts to ape
science to depressingly ridiculous extremes.

Meanwhile, other than incompetently performed studies by antivaccinationists
(this one, for instance) many large, well-performed epidemiological studies have
failed to find even the suggestion of a link between vaccines and autism or
between mercury in the thimerosal preservative that used to be in childhood
vaccines and autism, such that the Institute of Medicine reaffirmed this finding
just this year. Yet, antivaccinationists remain undeterred. True, they seem to 
have accepted that their original Holy Grail, namely a prospective randomized,
placebo-controlled trial in which one group is vaccinated and another is not, is
considered highly unethical because it would intentionally leave one group of
children unprotected against vaccine-preventable diseases. (I say “considered”
because antivaccinationists are so convinced of the harm done by vaccines that
they do not accept that a randomized controlled trial of vaccinated versus
unvaccinated children would be unethical in the extreme.) Unfortunately,
however, that doesn’t stop them from demanding other forms of vaxed versus
unvaxed studies, even though such a study would be difficult, bias-prone, and
unlikely to provide a definitive result, as I explained in detail before.

Well, they’re at it again. Antivaccinationists are trying to legislate where
they have utterly failed to convince using science. It’s a standard tactic of
cranks, but unfortunately there are nearly always credulous legislators who will
be duped into going along or who are cranks themselves and therefore go along. 
Remember Dan Burton? He was antivaccine to the core and used his position as a
Representative from Indiana to cause a lot of mischief with hearings on
vaccines. Fortunately he’s retired now, but there are still Representatives who 
are either antivaccine themselves or easily duped into carrying
antivaccinationist’s water.

Here’s what I mean. The other day, posted on the antivaccine crank blog, was a
call for help by the antivaccine group SafeMinds to support a resolution by the 
House of Representatives, specifically HR 1757, The Vaccine Safety Study Act:

   What is HR1757? – Also known as “The Vaccine Safety Study Act,” this bill,
   introduced by Rep. Bill Posey (R-FL) and Rep. Carolyn Maloney (D-NY), directs
   the National Institutes of Health to conduct a retrospective study of health
   outcomes, including autism, of vaccinated-versus-unvaccinated children, and 
   to determine whether exposure to vaccines or vaccine components is associated
   with autism spectrum disorders, chronic illnesses, or other neurological
   conditions.

   Currently before the US House Committee on Energy and Commerce, the bill, if 
   implemented, “should bring an answer to this decades-long question,” Rep.
   Posey stated on the House floor.

No. It. Won’t. It would be expensive, and it would be highly unlikely to provide
an answer, for the reasons I pointed out before. Moreover, contrary to the
claims in the SafeMinds press release reposted by AoA, there is no compelling
scientific rationale for such a study. There are no preclinical data or
epidemiological observations that would mandate (or even justify) such a study
from a scientific standpoint. Before such a study would be mandated, there would
have to be strong evidence of a problem with vaccine safety or indication that 
vaccines cause autism and chronic health problems. There is no such indication. 
Fevered dreams of antivaccinationists don’t count.

SafeMinds cites “findings” discovered through a Freedom of Information Act
(FOIA) request claiming that “risks of autism, ADD, sleep disorders and
speech/language delay were consistently elevated in the more exposed group:
Increased autism risk in one-month-old infants with the highest exposures ranged
from 7.6 to 11.4 times higher than zero-exposure infants.” No links are
provided, but my best guess is that SafeMinds is referring to Verstraeten et
al., which is a very old gambit on the part of the antivaccine movement that has
no validity but is frequently used to try to provide the impression of a
conspiracy and government cover-up. There wasn’t. It’s Simpsonwood all over
again, eight years later. Safeminds then cites another study that claims that
unvaccinated children had significantly lower emergency room visits. The
implication is that unvaccinated children are healthier, but, as has been
pointed out before, despite what Brian Hooker says, the study shows nothing of
the sort. Indeed, let’s look at what the investigators themselves said about
this result:

   These results suggest inherent health care–seeking behavioral differences
   between the 2 groups of parents. For example, published survey data31-32 have
   shown that parents who choose not to have their children vaccinated are less
   likely to trust health care professionals and more likely to use
   complementary/alternative medicine providers than are parents who have their 
   children fully vaccinated. It is therefore possible that parents who delay or
   refuse immunizations are less likely to use the traditional health care
   system when their children contract minor acute illnesses but will seek
   medical care when their children become seriously ill. Such differences could
   create a selection bias in studies that attempt to examine the risk of
   potential adverse events following vaccination.

Emphasis mine. There was nothing in the study that claimed to show that
unvaccinated children use the ER less because they are healthier.

So what about the bill itself? The introduction and background (called the
“Findings”) in HR 1757 start out paying lip service to the importance of
vaccines and then move on to a whole bunch of antivaccine tropes before getting 
to the “meat” of the bill. The bill itself is sponsored by Rep. Bill Posey
(R-FL), who appears to be vying for Dan Burton’s position as the most
antivaccine member of Congress, so much so that he even participated in a
“Congressional panel” at this year’s antivaccine quackfest Autism One in May,
following in the footsteps of prior years’ Autism One quackfests.

But what about the bill’s co-sponsor, Rep. Carolyn Maloney (D-NY)? Well, it
turns out that she’s very much into antivaccine pseudoscience as well. A quick
Google search of her name plus the term “vaccines” brings up a plethora of
embarrassment (from a scientific viewpoint that is), much of it right on her
very own website. For instance, here she touts Dan Olmsted’s incompetent and
incomplete series of news stories claiming that the Amish don’t vaccinate and
don’t get autism from back when he was actually a reporter (they do, and they
do; it’s a myth that they don’t). She has also been known to grill CDC officials
about vaccines, as shown in this YouTube video:

The above video comes from a hearing held by by the House Oversight and
Government Reform Committee, chaired by Rep. Darrell Issa (R-CA). One notes that
Darrell Issa is not exactly known for being a fan of science. Besides being an 
anthropogenic global climate change denialist, he’s prone to meddling in peer
review and trying to micromanage the National Science Foundation. He’s also at
the very least sympathetic to antivaccine views, holding a hearing about the
“autism epidemic” and “environmental causes” (translation: it’s the vaccines)
last November, a month before Rep. Dan Burton (R-IN) retired. Dan Burton, the
chair of the same committee in the 1990s and into the 2000s, used it for no end 
of antivaccine legislative mischief when he was in control, and Darrell Issa
appears to be taking up the antivaccine mantle left behind now that Burton has
retired.

In any case, Maloney begins by complimenting Dan Burton for “doing such a fine
job” back in the day. She then demands to know why autism prevalence has gone
from 1 in 10,000 to 1 in 88, dismissively saying that she “doesn’t want to hear 
that we have better detection” and claiming that detection would not account for
a jump from 1 in 10,000 to 1 in 88. That is, of course, a straw man argument.
As I’ve pointed out many times, screening programs, broadening of diagnostic
criteria, diagnostic substitution, and better detection can easily account for
huge increases in the prevalence of a condition. My favorite example is ductal
carcinoma in situ, whose incidence increased 16-fold in 30 years just because of
mammographic screening. Other examples include hypertension and
hypercholesterolemia. In reality, the prevalence of autism is probably not
higher (or at least nowhere as much higher as the antivaccine movement would
like you to believe) than 30 years ago. When careful studies are done, it is
found that autism prevalence is the same now as it was then. So, right off the
bat, we know that Maloney doesn’t want to hear the science-based answer, namely 
that diagnostic substitution, broadening of the diagnostic criteria, and more
intensive screening programs have led to a massive increase in autism prevalence
without a real, biological increase. She’s convinced that the vaccine program
or some other environmental factor is causing an “autism epidemic,” and she
falls for the “too many too soon” trope beloved antivaccinationists.
Unfortunately, Colleen Boyle, the hapless CDC official who had to answer,
appears completely unprepared for the hectoring about vaccinations to which
Maloney subjects her.

I also learned that Rep. Maloney marched with Jenny McCarthy in her infamously
pointless antivaccine Green Our Vaccines rally in 2008. I think that says it all
about Rep. Maloney. Well, maybe not all. Her performance in last year’s hearing
shows that she values anecdote above scientific evidence; she attacks straw men
explanations for the increase in autism prevalence (i.e., that it’s just better
detection, when it’s a combination of factors); she makes spurious and
downright dumb analogies between vaccine manufacturers and tobacco companies;
and she’s just plain scientifically ignorant. In other words, she fits the very 
picture of being antivaccine. The video above demonstrates it beyond debate.
Sadly, she is not alone among our legislators.

Rep. Maloney’s clearly the Democratic counterpart to the Republican antivaccine 
fringe represented by Rep. Posey and former Rep. Dan Burton and has been pushing
the dubious vaxed versus unvaxed study resolution for a long time. Indeed,
she’s been doing this for years. I do give her some credit for making at least
one change from previous versions of the bill, namely pointing out that “Nothing
in this Act shall be construed to authorize the conduct or support of any study
in which an individual or population is encouraged or incentivized to remain
unvaccinated.” One also notes a quack-friendly clause that “To facilitate
further research by the Secretary or others, the Secretary shall ensure the
preservation of all data, including all data sets, collected or used for
purposes of the study under this section.” One wonders whom the “others” are,
one does. Does anyone want to take any bets that this clause is designed to make
sure that antivaccine groups like SafeMinds have access to the complete data
set of such a study to use and abuse for their ideological purposes? One wonders
who provides her with these anecdotes, one does. Could it be SafeMinds, The
Canary Party, and Age of Autism? Sure, it could.

But what about this time around? Amusingly (if you can ignore the waste of
taxpayer money and the antivaccine impetus behind HR 1757), the bill itself
demands that the each investigator of the required study:

  1. is objective;

  2. is qualified to carry out such study, as evidenced by training experiences and
    demonstrated skill;

  3. is not currently employed by any Federal, State, or local public health
    agency;

  4. is not currently a member of a board, committee, or other entity responsible
    for formulating immunization policy on behalf of any Federal, State, or
    local public health agency or any component thereof;

  5. has no history of a strong position on the thimerosal or vaccine safety
    controversy; and

  6. is not currently an employee of, or otherwise directly or indirectly receiving
    funds from, a pharmaceutical company or the Centers for Disease Control.

One notes that requirements #3 through #6 pretty much destroy any chance the NIH
have of being able to find an investigator who meets requirement #2. As an
aside, it’s also amusing to note a reaction to HR 1757 from our old buddy, now
the antivaccine Robin to the crazed “health freedom” Batman (Patrick “Tim”
Bolen) after having been the Boy Blunder at the antivaccine crank blog Age of
Autism before he betrayed AoA and SafeMinds, Jake Crosby, who rants No More
Federal Research Fraud – OPPOSE HR1757! His reason for opposing HR 1757 (other
than because SafeMinds and AoA are for it)? Because he doesn’t trust the NIH:

   In other words, this bill aims to mandate the National Institutes of Health
   (NIH) to conduct a vaccinated vs. unvaccinated study of autism and other
   disorders before the NIH and other federal agencies are forced to clean up
   their act and stop engaging in the institutional research misconduct that
   causes the vaccine-autism cover-up to persist. Although the initiatives of
   congressional representatives like Bill Posey and Carolyn Maloney to
   investigate malfeasance by government agencies should be commended, HR1757
   only helps to legitimize and facilitate federal research misconduct by
   agencies like NIH, while distracting from efforts to expose government
   corruption. Autism Investigated supports vaccinated versus unvaccinated
   research conducted by independent researchers at academic institutions, but
   not conducted by federal agencies that merely pursue predetermined results.
   NIH is one of those agencies.

Poor Jake. Back when he was in high school and maybe even college I could (sort 
of) forgive such ignorance, but he’s a graduate student now. Unfortunately, it’s
now utterly clear that he is utterly clueless about how the NIH works, which
could be a real problem for him if he ever becomes an epidemiologist and wants
to apply for research funding. Note that HR 1757 says that the NIH “shall
conduct or support” such a study. That means the NIH, if so instructed, could
simply issue an RFA (request for applications) for a grant to do a vaxed versus 
unvaxed study. In fact, that is almost certainly what would happen if this
unscientific bill passed; the NIH almost certainly wouldn’t do the study itself;
it’s not really well set up to do such a study, but, more importantly, by the
very language of the bill it couldn’t. Indeed, perhaps the most amusing part of 
Jake’s tirade is the lack of insight into this very point. He clearly didn’t
even bother to read the bill. Note the clause listed above that the
investigators can’t be “currently employed by any Federal, State, or local
public health agency.” Here’s a hint for Jake: The NIH is a federal agency.
Seriously, I think that Jake’s just phoning it in these days.

I rather suspect that antivaccinationists are so deluded that they don’t realize
that this bill actually is against their interests. What do I mean? Easy? Look 
at criteria #1, 2, and 5 required of any investigators recruited to do such a
study. The bill states that any such investigator must (1) be objective; (2) be 
qualified; and (3) have “no history of a strong position on the thimerosal or
vaccine safety controversy.” These three criteria alone completely rule out any 
investigator that would be acceptable to SafeMinds, as none of their favored
investigators fit any of them! I’m also going to emulate Matt Carey the next
time I see an antivaccine study and ask if the investigators have a history of a
strong position on the thimerosal or vaccine safety controversy. I presume that
I can just dismiss studies based on this reason alone; after all fair’s fair.
That’s often the main reason why antivaccine groups dismiss the plethora of
studies failing to find a link between vaccines and autism.

No, I’m all about the science; so I couldn’t do that.

Antivaccinationists have been trying to legislate science for a very long time
now, and Rep. Maloney is just ignorant or antivaccine enough to be willing to be
their contact person. Meanwhile, Bill Posey seems to be relatively new at the
antivaccine game, but he’s clearly up and coming, and, given that the House is
currently controlled by the Republican Party, he’s more likely to do more damage
in the short term because he’s part of the majority party. Either way, although
I realize that this bill has little chance of passing and that the lack of
appropriations for the study suggest that even Reps. Maloney and Posey know it, 
skeptics and supporters of science-based medicine should still fight fire with
fire, I say. I’m willing to bet that there are a lot more science-based people
out there than antivaccinationists; so I’ll finish echoing exactly what AoA
said. Only, do it from the science-based perspective and use the same tactics to
oppose HR 1757:

  1. First identify your own Representative in the House by clicking here:
    http://www.house.gov/representatives/find/.

  2. Call and schedule a meeting at their district office and urge them or their
    staff to sign on to this absolutely critical bill.

  3. If they will not commit, indicate you will call back in one week to check on
    progress and check with Rep. Posey’s office to confirm their commitment to
    co-sponsor.

  4. After Labor Day confirm everything has happened and thank them for their
    support.

  5. Also, let SafeMinds know! Answer the few simple questions on our online survey
    at: https://www.surveymonkey.com/s/HR1757

At the very least, write letters to your Representatives, real letters on real
paper, and to Bill Posey and Carolyn Maloney as well. (E-mails are easier to
ignore.) I plan on doing that much at least, even though I’m not a big fan of my
current Representative (to say the least). I realize that HR 1757 is a
resolution, and I realize that it probably doesn’t have a lot of support. I also
realize that it appears to be stuck in committee. Let’s do our best to keep it 
that way. Never underestimate the antivaccine movement.

Finally, I’m serious about that last bullet point. After all, we’d like
SafeMinds to know that they’ve inspired us to stand up for science, wouldn’t we?

CAM Docket: Kardashian Diet Products Klass Action

Jann Bellamy on June 13, 2013

Link

Kim, Khloe and Kourtney Kardashian permit the use of their names and images of
their curvaceous bodies to promote “QuickTrim” diet products, a line of dietary 
supplements making overblown claims typical of the weight loss supplement
industry. Their personal testimonies and formidable publicity machine (Kim alone
has over 13 million followers on Twitter), “has reportedly generated $45
million in revenue since they struck the deal with New Jersey-based Windmill
Health Products in 2009,” according to the N.Y. Post. Naturally, the sisters are
paid for their efforts, although how that amount is calculated or how much they
receive apparently is not a matter of public record.

Some Quick Trim consumers who are not as enthused about the products as the
Kardashians filed two class action lawsuits last year alleging violation of
consumer protection and other state and federal laws. One is pending in New York
and the other in California. The judge in the California suit issued a
preliminary approval of a settlement in March, a subject we’ll get to in a
minute.

Keeping up with the Kardashians

For those of you lucky enough to live in a corner of the planet where news of
every Kardashian family spat, marriage, divorce, pregnancy, baby and assorted
other details of their extensively chronicled lives are not forced upon you via 
every popular media delivery device available, a bit of background is in order. 
Kim, Khloe and Kourtney Kardashian are sisters and stars of their own popular
American TV reality show, Keeping Up With the Kardashians. The sole premise of
the show appears to be that there are a lot of people extremely interested in
keeping up with the Kardashians and that premise appears to be correct.

The show, which also features their mother, Kris Jenner, wife of Olympic gold
medalist Bruce Jenner (who is not the sisters’ father) and various Kardashian
husbands, ex-husbands, boyfriends . . . well, you get the idea. The show
generated several reality show spinoffs, Kourtney and Khloe Take Miami, Kourtney
and Kim Take New York, and Khloe & Lamar, Lamar being Khloe’s husband, NBA
player Lamar Odom. These shows, as well as product endorsements and other
commercial activities, have made the sisters multi-millionaires. Apparently
these folks employ an army of publicists who ensure that the media, and you, are
kept well informed of pretty much everything they want you to know about
themselves, which is an awful lot. In short, the Kardashians are famous for
being famous.

The New York Lawsuit

Several people who purchased QuickTrim in a number of different states brought
suit in New York federal district court seeking compensatory and punitive
damages in an amount greater than $5,0000,000 (but not otherwise specified), as 
well as injunctive relief, on behalf of themselves and a class of other
QuickTrim product purchasers. Cowan et al. v. Windmill Health Products, LLC et
al., Case No. 1:12-cv-01541-VM-AJP (S.D.N.Y.) has not yet been certified as a
class action by the court. The Kardashian sisters, as well as companies involved
in the manufacture and sale of QuickTrim products, including GNC, the retail
and on-line dietary supplement seller, are named as defendants.

The suit alleges statements made by the Kardashians in advertising and the
products’ labels are false and misleading, in violation of various state and
federal consumer protection laws. In addition, the suit alleges that QuickTrim’s
individual product weight loss and appetite suppression claims and the whole
QuickTrim system, which is touted as working “synergistically” to promote weight
loss and weight control, are actually drug claims within the meaning of the
Food, Drug and Cosmetic Act. Because the products do not have FDA approval,
plaintiffs claim their distribution also violates the Act.

The “Quick Trim Weight Loss System” includes:

  1. QuickTrim Extreme Burn

  2. QuickTrim Fast Cleanse

  3. QuickTrim Burn & Cleanse

  4. QuickTrim Hot Stix (“an antioxidant rich, delicious berry drink mix”)

  5. QuickTrim Sugar & Carb Cheater

  6. QuickTrim Fast Shake

  7. QuickTrim Satisfy (a “chocolate fudge soft chew” to “help satisfy between meal
    cravings”)

  8. QuickTrim Celluslim (a “body sculpting gel” to fight cellulite, smooth tone
    and firm, and spot-treat problem areas)

QuickTrim’s claims of easy weight loss and “detoxification” sound depressingly
familiar. With apologies for the lengthy quote, the complaint alleges the
following product misrepresentations, lifting language directly from product
labels and ads:

   QuickTrim’s labeling and advertising represents that QuickTrim products (a)
   are effective for “weight loss,” (b) use “research proven ingredients,” (c)
   “safely work to help burn calories [and] curb cravings,” (d) that the
   “sustained release formula allows for greater absorption and controlled
   release of nutrients providing optimum calorie burning,” (e) are
   “synergistically designed to work together” with other QuickTrim formulas,(f)
   “Help Cleanse and Detoxify,” (g) “Help Jump-Start Weight Loss,” (h) “Help
   Reduce Belly Bloating,” (i) “Help Jump Start Your Weight Loss,” (j) “Help
   Burn More Calories by Day,” (k) will “Flush Out [your] System Overnight,” (l)
   “stimulate metabolism to burn more calories and fat through the day,” (m)
   “help to release and burn stored fat,” (n) “help to remove toxins and
   impurities out of your system,” (o) “help remove excess water from under the 
   skin,” (p) “Help Block Excess Sugar & Carbs,” (q) “Help Curb Carbohydrate
   Cravings,” (r) “increase the body’s ability to burn stored fats and decrease 
   the appearance of cellulite while helping increase firmness and elasticity,” 
   (s) “Increase lipolytic effect by 630%,” (t) “Release stored lipids at
   adipocytes 1064%,” (u) “Reduce indentation by 9.5%,” (v) “Reduce roughness by
   32.4%,” (w) “Decrease fat deposits by 33%,” (x) “Help increase circulation
   to problem areas,” (y) “Help tone, smooth and firm skin,” (z) “attack
   cellulite by breaking down excess fat stored in the cells,” (aa) “[are]
   scientifically designed and clinically shown to work with your body naturally
   to help increase your ability to burn calories,” and also to “reduce
   carbohydrate cravings,” (bb) “ha[ve] been clinically tested and shown to
   increase metabolism by burning 278 calories (on average) per day”.

(I’ve removed some of the attorney’s editing, which is necessary for quotations 
in a document filed with the court but which also makes the quote harder to
read.)

I searched the FDA website and could not find that the agency has issued a
warning letter to any of the defendants or taken any other regulatory action
regarding the QuickTrim products.

Interestingly, according to the complaint, the Kardashian sisters represented
that they personally formulated and tested QuickTrim products “to make sure that
this was something that really works.” I guess they are scientists in addition 
to being reality TV stars.

These products are not cheap. You can buy them online for between $12 to $30 a
package, depending on the product and the amount supplied, but there is a hefty 
shipping and handling charge for most sellers, up to $14 per product. A package 
will last you, again depending on the product, up to 30 days.

The defendants deny any wrongdoing in their answers to the complaint.
Specifically, the Kardashian sisters state in their answer

   . . .that they have used QuickTrim products, and that they base their
   statements about QuickTrim products (including on Twitter and Facebook) on
   their honest opinions, experiences and beliefs about the products.

In a U.S. News & World Report article about QuickTrim and the New York lawsuit, 
registered dietitian Keri Gans and Adriane Fugh-Berman, a physician and
associate professor in the complementary and alternative medicine master’s
degree program at Georgetown University Medical Center (sigh), criticized
several QuickTrim products and their unproven ingredients. (The reporters said
QuickTrim did not respond to repeated requests for comment.)

According to the article, the “Burn and Cleanse 14 Day Diet System” contains
products for both morning and evening which provide a total of 400 milligrams of
caffeine per day, the equivalent of about 4 cups of coffee, as well as piperine
(black pepper) and white willow bark extract, both of which can increase the
potency of caffeine.

   ‘It irritates me that they’re not saying how much caffeine is in these
   pills,’ Fugh-Berman says. ‘Too much caffeine can make you jittery and
   increase your blood pressure and pulse. If you pop a couple of these pills
   with your Starbucks coffee, that’s not good; you could get caffeine
   poisoning, which can cause heart arrhythmias.’

“IsoCleanse and Flush Herbal Complex,” the evening product, is a combination of 
“natural” stimulants and bulk laxatives, designed to increase the movement of
food and liquid through the body. This is fine, said Fugh-Berman, if you are
constipated. If you’re not, “you’ll get diarrhea.” In addition, “stimulant
laxatives, of which IsoCleanse is chock-full, can cause your intestines to
become dependent on them for stimulation, causing constipation if you stop.”

“Fast Cleanse,” a “48-hour Super Diet Detox,” is a drink rich in fiber ingested 
four times a day between meals of clear soups, gelatin, fruits and vegetables.
This may cause you to drop of few pounds, but Fugh-Berman says you’ll be
“putting them right back on.” “Sugar & Carb Cheater” is designed for dieters
concerned “that their sugar and carbohydrate intake is keeping them heavy.” I
suppose a sensible solution would be to reduce one’s sugar and carb intake, but 
that’s just me. For those seeking a less taxing solution, the “Cheater” contains
chromium, fenugreek seed, bilberry fruit, and vanadyl sulfate and is touted to 
keep carbs from turning into fat by blocking the enzyme that causes the
conversion. To Gans, the registered dietician, “scientifically, it doesn’t make 
sense . . . It’s offering people false hope.”

Fugh-Berman doesn’t think anyone should take these products. Healther Mangieri, 
a spokeswoman for the American Dietetic Association added, “The good news is
that these products are absolutely not necessary for weight loss. My suggestion 
is to leave them on the shelf.” Good advice all around.

In March, the judge stayed the New York suit pending the outcome of a proposed
settlement in the California case. If the settlement gets final approval, the
plaintiffs in the New York suit would be included in the class of QuickTrim
product purchasers in the California suit, because its scope is nationwide,
unless they opt out of the class, which they say they will do. However, unless
their suit covers a different time period than the California action (product
purchases made between August 14, 2009 and March 1, 2013), the New York
plaintiffs will be able to pursue their claims only as individuals, not as
representatives of a class of purchasers, barring some highly unlikely
circumstances.

The California Lawsuit

So let us move from the East Coast to the West and to Anaya v. Quick Trim, LLC, 
et al., Case No. CIV VS 1201177, pending before the Superior Court of the State 
of California, County of San Bernardino. The same defendants are named, plus
Kris Jenner, Jenner Communications, Inc., and additional sellers of QuickTrim
products, the CVS pharmacy chain, Walmart, Amazon.com, and Drugstore.com. Also
named is Vitaquest International, a New Jersey company that formulates, develops
and manufactures dietary supplements for its clients. (I can just imagine the
Kardashian sisters in their crisp white lab coats formulating and testing
QuickTrim products in the Vitaquest laboratories.) Finally, three corporations
with the cutie-pie names Kimsaprincess, Inc., Khlomoney, Inc. and 2Die4Kourt,
Inc., are named as defendants.

(And here I will switch, for reasons of economy, from the actual documents filed
in the New York action, which can be viewed as they appear in the court’s files
for a reasonable charge, to the information available on a website set up by
the California settlement administrator, which can be viewed for free.  Viewing 
the actual documents from the California court’s files costs up to $50 per
document.)

Like its New York counterpart, this suit seeks certification as a class action
on behalf of purchasers of the same eight QuickTrim products. The California
state court has issued a preliminary approval of a class action settlement, the 
details of which can be found on the website, although not nearly as much
information as is available in the New York case.

The plaintiff alleges that improper statements were contained on the product
labels and in advertisements, and that these statements violate state consumer
protection laws and various other state and federal laws. She seeks, among other
remedies, damages and injunctive relief. As is usual in such settlements, the
defendants deny any wrongdoing.

If the settlement is approved, plaintiff’s counsel will get $250,000 in fees and
costs and the named plaintiff, Teresa Anaya, will get $2,500. QuickTrim will
have to “redesign its labeling and packaging to restate the nature of its
products and its benefits.” Members of the class who file a claim (other than
those who opt out of the settlement) receive different amounts depending on
where they bought the product and whether they have proof of purchase.
Basically, they can get either a refund or a coupon good towards purchase of
another QuickTrim product. In other words, the defendants have managed to turn
the settlement into a product promotion event.

We’ll have to wait until August, when the settlement proposal will have a final 
hearing, to find out what happens.

Conclusion

This is yet another tale of outlandish dietary supplement claims, testimonial
“evidence” of effectiveness and the failure of the DSHEA to adequately protect
consumers by preventing this sort of thing from happening in the first place. As
I have said before, lawsuits are not the ideal way of bringing supplement
companies and their enablers to justice. But until the federal law is amended,
these suits remain the best way to apply some brakes to the runaway dietary
supplement industry.

CAM Docket: Functional Endocrinology

Jann Bellamy on November 15, 2012

Link

One of the signature abilities of CAM practitioners is the creation of new
diagnostic methods and treatments which convincingly demonstrate they have only 
a superficial understanding of human physiology. Here at SBM, posts have
addressed such sterling examples of this phenomenon as cranial sacral therapy,
applied kinesiology and chiropractic neurology. Now we have a new one on the
horizon: functional endocrinology.

I don’t know who thought up this idea, but a primary promoter appears to be a
Colorado chiropractor, Brandon Credeur, a 2002 graduate of Parker Chiropractic
College in Texas. In additional to operating the Functional Endocrinology Center
of Colorado, in Denver (where he practices with his wife, Heather Credeur,
D.C.), he sold (and may still be selling) practice-building courses on
functional endocrinology to other chiropractors.

What is functional endocrinolgy?

That’s a great question. Credeur’s website doesn’t give much of an explanation, 
although perhaps it is a new “specialty” within “Functional Medicine.” He spends
most of his web video presentation on the subject talking about how M.D.s are
simply prescribing drugs and not getting to the “root cause” of endocrine
disorders, such as diabetes. Or, as he says, M.D.s are simply “bully[ing] the
body’s physiology.” He, on the other hand, is able to ferret out what is
actually causing these problems by determining exactly why your body is not
producing enough hormones and proceeding to make your body produce them on its
own, without drugs. He does not tell us specifically what the root cause is, how
he finds it, how it his treatments supposedly work, or statistics on his
results. (Testimonials, but no statistics.)

Credeur and his clinic have been the subject of a good deal of media scrutiny in
the last two years, most notably from Denver’s ABC affiliate, Channel 7, which 
give some insight into how he operates, including patient interviews, an
interview with Credeur, and a video of practice-building seminar.  In addition, 
the Colorado Board of Chiropractic Examiners complaint against him includes
copies of his ads.

According to these sources, here is what was going on: Credeur was attracting
patients with seminars and “gourmet dinners,” advertised in the newspaper, where
diabetics were advised “how you too may be able to reverse your diabetes and
put your health on a totally new trajectory” and, like others he’s treated,
“walk away from diabetes.” At these events, diabetics were told, a “clinical
model for successfully reversing diabetes” would be “revealed.” He also used
television commercials promising free consultations.

Some patients said they had no idea Credeur was a chiropractor and thought he
was an endocrinologist. According to one, she was told by office staff that
Credeur was in fact an endocrinologist and another said his office was “lined
with certificates about endocrinology.” His functional endocrinology treatments 
were described by a patient as “a diet outlined in a book given to all patients,
supplements, [and] chiropractic adjustments,” which, as a Channel 7 report
pointed out, all Colorado chiropractors are licensed to do.

Another patient reported that she was attracted to Credeur’s free consultations 
because she had lost her job. She wanted someone to look at a lump on her neck. 
Creduer told her that it was probably a “thyroid disorder” and said he would get
her on a healthy lifestyle and diet. Fortunately, the woman was able to see
doctors at a Denver health center and the University of Colorado Hospital, where
she was diagnosed with Stage 2, B-cell lymphoma and hospitalized. She too
thought Credeur was an endocrinologist.

Credeur’s functional endocrinology is not cheap either. Patients reported paying
thousands of dollars. A Channel 7 producer was quoted a fee of $8,600 for six
months treatment, all paid up front.

The Colorado Board of Chiropractic Examiners alleged in its complaint that
Credeur and other chiropractors under his supervision at the clinic violated
state law and regulations by:

  1. False and misleading advertising

  2. Failure to take a history and do physicals on patients

  3. Diagnosing patients with diseases (diabetes and celiac disease), which is
    beyond the scope of chiropractic practice

  4. Telling patients that they could reduce their medications

  5. Failure to consult with patients’ physicians

  6. Making promises of cures and guaranteed results

  7. Failure to keep adequate records

  8. Substandard practice

In addition to the state’s complaint, a number of patients are suing Credeur in 
a civil action. Trial is set for April, 2013.

As well as making money from his clinic, Credeur was conducting functional
endocrinology practice-building seminars for chiropractors, who were told in one
seminar ad: “Discover How to Attract More Sick Patients With Real Organic &
Visceral Illnesses.” His website, HelpMorePatients.com, is no longer available, 
but a screen shot can be viewed courtesy of the “Way Back Machine” and a video
of his practice-building techniques is posted on Channel 7’s website. In it, he 
brags about taking in over $300,000 a month in cash and advises fellow
chiropractors to avoid calling themselves “chiropractors” and to remove
chiropractic paraphernalia from their offices.

So what happened to Credeur? We’ll leave that question for later.

Meanwhile, over in Utah

One of Credeur’s chiropractic functional endocrinology students and Parker
Chiropractic College classmate, Utah chiropractor Brandon Babcock, has also been
the subject of media attention, mostly from the Salt Lake Tribune (here, here, 
here and here).  Babcock makes the same claims about his ability to “reverse”
diabetes and the State of Utah brought charges similar to those against Credeur.
Here we’ll go into a bit more detail about individual patients to demonstrate
what functional endocrinology looks like in operation. (Part of Babcock’s
charges have to do with his using a credit scheme to finance thousands of
dollars’ worth of treatments, but we won’t go into those here. Patients are
referred to by their initials.)

BB: 79 year old female with Type II diabetes, polio, recent heart valve
replacement, saw ad that Babcock could reverse her diabetes and signed up for
his program. Babcock did not examine BB, ask her about other meds or consult
with her physicians, but did tell her to cut back on insulin and diabetes meds. 
BB called Babcock’s office to report declining health and legs swelling. He
never called her back.

TL: 71 year old male suffering from Parkinson’s disease, dementia, thyroid
problems, and diabetes. Was given supplements and prescribed “cleasing”
techniques, even though he was on a strict diet at health care facility where he
lived.

DO: 65 year old male, suffers from diabetes, high blood pressure and high
cholesterol, had open heart surgery two years prior to seeing Babcock. Babcock
told DO he could get DO off all meds, including heart med. Ordered $2,000 tests 
(spit DNA and stool) for DO but wouldn’t discuss results. Told DO after 2 months
to stop Simvastion and reduce Metforman. When subsequent checkup at Veteran’s
Administration health facility showed DO was much worse and cholesterol at
dangerous levels, Babcock told DO “Not to worry. Your body is just going through
a change.”

TH: 69 year old male diabetic, told by Babcock program could reduce or eliminate
his insulin. Several months later TH admitted to hospital for kidney failure
and pneumonia and there told to get off program’s diet and supplements.

RK: 83 year old male diabetic, told by Babcock he could reverse his diabetes and
get blood sugar down to 110. Ordered same DNA and stool sample as DO. Told RK
that without the program RK could have his foot cut off or go blind while
driving.

DZ: Elderly female. Without any testing Babcock told her she had Hashimoto’s
disease and leaky gut. Upon DZ telling Babcock she was suffering from swollen
legs and cramps, he told her to eat more fish. Did not do further exam.

In addition to state administrative charges Babcock is, like Creduer, being sued
by former patients, who are trying to get a class action certified of all his
elderly patients treated by him for diabetes. In a newspaper report, their
attorney said that her clients were charged $6,000 for supplements that cost
less than $200 on-line. Babcock has also been charged by the District Attorney
with 11 felony counts, 10 counts of exploitation of a vulnerable adult and one
count of communications fraud.

What’s happened so far

We’ll get to a status report on these cases, but first, a look at chiropractic
scope of practice.

In Colorado,

   ‘Chiropractic’ means that branch of the healing arts that is based on the
   premise that disease is attributable to the abnormal functioning of the human
   nervous system. It includes the diagnosing and analyzing of human ailments
   and seeks the elimination of the abnormal functioning of the human nervous
   system by [adjustment or manipulation]. . . and the use of . . . nutritional,
   and physical remedial measures for the . . . restoration of health . . . and
   the treatment of human ailments.

Colorado chiropractors cannot prescribe medications, but can prescribe dietary
supplements.

Under Utah law,

   Practice of chiropractic means a practice of a branch of the healing arts . .
   . that involves examining, diagnosing, treating, correcting or prescribing
   treatment for any human disease, aliment, injury, infirmity, deformity, pain,
   or other condition, . . .

They can advise patients regarding exercise and diet and prescribe dietary
supplements, but cannot prescribe medications, although they can advise patients
about the possible side effects of medications.

In one Salt Lake Tribune article, Mark Steinagel, director of the state’s
Division of Professional Licensing, was quoted as saying that “diabetes
treatment is within the scope of a chiropractor.”

The Utah Division of Occupational and Professional Licensing initiated an
Emergency Adjudicative Proceeding against Babcock,

   upon evidence that the continued practice of Brandon Babcock as a
   chiropractic physician represented an immediate and significant danger to the
   public health, safety, and welfare, and that the threat required immediate
   action by the agency.

The Division made findings of fact, which I briefly summarized above, and
suspended Babcock’s license until further hearing. That case remains pending, as
do the civil suit and criminal case. His preliminary hearing on the felony
charges is set for November 20.

In July of this year, Brandon Credeur entered into a stipulation with the
Colorado Board of Chiropractic Medicine (as did his wife) which completely
resolves his administrative case. The Board and Credeur stipulated that Credeur 
did not “completely document his patient interactions in certain records
reviewed by the Board” so he agrees to a Letter of Admonition and to future
adequate documentation.

That’s it. But the stipulation also says (emphasis added):

   The Board affirms that the scope of chiropractic practice includes diagnoses 
   and treatment of human ailments, including those affecting the endocrine
   system. [Credeur] and the Board expressly agree that it is appropriate for
   [him] to use the term ‘functional endocrinology’ in his practice name and to 
   describe his services provided that he continues to disclose his credentials 
   ‘D.C.’ when referring to himself as “doctor” to make clear that he is a
   chiropractor and that his services are provided pursuant to his chiropractic 
   credentials.

The civil suits are still pending. Credeur’s website remains up and running and 
still advertises functional endocrinology, including his claim that it can
reverse diabetes “in as little as three weeks. ”

How ironic that the Babcock, the pupil, got his license suspended temporarily
and 11 felony charges, while Credeur, his teacher, got off with a slap on the
wrist and a confirmation that his practice of functional endocrinology is
perfectly legal. Why the difference in result with similar factual allegations
and similar scope of practice statutes?

A bright spot: Texas

Fortunately, M.D.s are on the case in Texas. The Texas Medical Association (TMA)
has aggressively pursued chiropractors’ attempts to expand their scope of
practice in lawsuits and complaints to the Texas Board of Chiropractors (TBCE). 
In one recent example, in August the TBCE voted against adopting rules
recognizing “chiropractic neurology” as a specialty after the TMA complained.
According to a Salt Lake Tribune report, the TMA is also concerned about
chiropractors claiming, in TV ads similar to ones appearing in Utah, that they
can treat diabetes. While a spokesperson for the TBCE said that chiropractors
could “co-manage” diabetes with diet and exercise, the Board is reported to be
working on a rule expressly banning chiropractors from treating thyroid
disorders and diabetes. However, no such rule has been enacted or is currently
proposed according to the TBCE’s website.

Confused?

It is shocking enough that chiropractors think they have the education and
training to diagnose and treat endocrine disorders, which simply points up how
poorly some of them are educated and trained. In other words, they don’t know
enough to know they don’t know enough. It is even more shocking that a state
would permit this.

These cases also highlight the mystery surrounding just what it is chiropractors
claim they can do, and, more importantly, what are they competent to do. Are
they primary care doctors, able to diagnose and treat all comers? Are they
musculoskeletal specialists, like physical therapists? Are they limited to
“detecting and correcting subluxations?” Can they specialize, as with
“chiropractic neurology,” “pediatric chiropractic” and “functional
endocrinology?” There is no agreement among chiropractors and no agreement among
the states regulating them. If they don’t know, how is a patient supposed to
know? Until all of this is resolved, the harm (financially and physically) to
patients will go on and chiropractors will continue to profit.

For an update, see CAM Docket: Functional Endocrinology Update

GSK Pays $3 Billion Fine

Steven Novella on July 4, 2012

Link

The following article is reposted from NeuroLogicaBlog. Happy Independence Day
to all our American readers.

The pharmaceutical giant, GlaxoSmithKline, has agreed to pay three billion
dollars in fines to settle three charges of fraud brought by the FDA. This is
the largest health fraud settlement in US history. What are the implications of 
this settlement for how the pharmaceutical industry is regulated in the US and
for the role that “Big Pharma” allegedly plays in US health care?

The three fraud charges admitted to by GSK include promoting the off-label use
of two anti-depressant drugs – Paxil and Wellbutrin. In the US drugs are
approved for specific indications, and they can only be marketed for those
indications. So-called off-label use of drugs, however, is very common.
Off-label does not necessarily equate to bad medicine, or to lack of scientific 
evidence or rationale. Often there is solid basic science and clinical evidence 
to support a specific use of a drug that is not approved by the FDA. That simply
means the manufacturer did not apply to the FDA for that indication, which
could simply be because they did not feel they would recoup the millions of
dollars they would need to spend to get approval for the additional indication. 
In other words, FDA approval for secondary indications is as much about
marketing and finance as it is about the science.

Regardless of whether or not a specific use is evidence-based, however, the
rules regulating pharmaceutical companies are very clear – they cannot market a 
drug for a non-approved use. Doing so breaks the law. GSK broke the law.

The second charge was that GSK held back data and made unsupported claims
regarding its diabetes drug Avandia. The third charge is that their sales force 
used inappropriate tactics to get doctors to prescribe their drugs, including
various forms of “high-priced entertainment” and large speaking fees. This
practice has come under heavy scrutiny in the last decade and rules regulating
what pharmaceutical reps can give to physicians have been significantly
tightened. According to the settlement GSK violated those rules, not to mention 
basic ethical behavior.

Mark Crislip summarizes the concerns well in an article for Science-Based
Medicine. He concludes that pharmaceutical companies give misleading and biased 
information to physicians, who are influenced by their contact with
pharmaceutical reps, and that the best policy is for practicing physicians to
keep a healthy distance from reps (no free lunches, no sponsored lectures, no
free gifts). This has become voluntary policy in many institutions, including
Yale where I work. Access of pharmaceutical reps to physicians is strictly
limited.

The debate continues, however, about whether or not there can be a healthy
relationship between doctors and pharmaceutical companies, or whether we need an
absolute wall of separation between the two. One recent article, for example,
found that doctors who have no access to pharmaceutical reps were up to four
times slower to adopt new medications than physicians with some access to reps. 
In addition, they were also four times slower to stop using a drug that has a
new black box warning, meaning that negative information about safety has come
to light. It seems, therefore, that pharmaceutical companies can be a useful
conduit of information to physicians, but that also comes with a lot of baggage.
It seems to me that we have two choices. Either we develop new ways of quickly 
spreading the word about new valuable drugs and new warnings about existing
drugs (pushing critical information to physicians), and/or we need to carefully 
monitor and regulate the pharmaceutical company distribution of this
information.

The GSK settlement, in my opinion, is just the most recent evidence that
industry cannot be left to their own devices without proper monitoring and
regulation. There is a certain efficiency and motivation for innovation in the
private sector approach to drug development. That seems worth preserving. But
companies are chiefly motivated by profit, and when billions of dollars are at
stake there is a huge motivation to bend the rules. We take for granted that
companies are going to distort information when marketing their products to the 
public. Experienced and savvy consumers view all commercial and marketing
activity with a skeptical eye and we do need to take some personal
responsibility for protecting ourselves (let the buyer beware).

At the same time the public largely expects that with health care issues the
government will play some role in protecting the public from fraud,
misinformation, unsafe and ineffective products and services. The stakes are
just too high to make every consumer fend for themselves in a completely
unregulated wild west of health care. In addition the science behind health care
products and services is complex, and it is not reasonable to expect the
average citizen to be able to sift through complex technical medical research.
That is essentially the reason for the existence of the FDA.

I think that with careful, thoughtful, and evidence-based regulations we can
have the best of both worlds. We can have a dynamic and innovative
pharmaceutical industry that is also regulated to protect the public from
misinformation and fraud and to ensure a minimum standard of scientific evidence
for safety and effectiveness.

What this recent settlement indicates, in my opinion, is that companies will
bend the rules to maximize their own profits, and that effective regulation can 
bring them into line and protect the public. I also think this settlement is a
significant piece of evidence against the typical “Big Pharma” conspiracy theory
that government is in the hands of industry. It’s hard to dismiss $3 billion
dollars as a slap on the wrist. This was a clear statement.

I hasten to add that everything I said above is also true of other private
segments of the health care industry, including the supplement industry (which
has large and increasing overlap with the pharmaceutical industry), and the
alternative medicine industry. They like to promote this false dichotomy between
the business end of medicine they decry and the “holistic” practitioners who
just want to help people. This is a fiction. The people most loudly playing that
card are also the ones making the most money off of selling their products,
services, and information. Supplements and CAM are big business. They routinely 
misrepresent scientific information, make unsupported claims for their
treatments, ignore data about lack of safety or effectiveness, and personally
attack anyone who will dare disagree with them. And they are doing this to sell 
treatments that are scientifically dubious or even disproved, yet they have been
remarkably successful in eliminating regulations designed to protect the public
from their own fraud.

It is hypocritical to simultaneously call for more pharmaceutical company
regulation and less supplement and alternative medicine regulation, but that is 
what they do. Rather, I think we need fair and consistent science-based
regulation across the board. No double standards, no false dichotomies. I agree 
that GSK should be heavily fined for making unsupported claims for its products.
And so should every company selling herbs, supplements, fanciful treatment, and
dubious products with unsupported claims. Instead they are shielded by industry
friendly and anti-consumer laws crafted by the industry itself.

GSK Investigated for Bribing Doctors

Steven Novella on April 16, 2014

Link

The BBC reports that 11 doctors and a GlaxoSmithKline regional manager in Poland
have been charged with alleged corruption. The apparent scheme was simple — GSK
sales reps are given targets for new prescriptions for whatever drugs they are 
promoting. In order to meet those targets, it is alleged that one sales rep
agreed to pay doctors £100 to give educational lectures to patients. The
lectures never took place, and it was understood that in exchange for the
payment the doctors would prescribe more of the rep’s drug.

The case is still under investigation but one doctor has already admitted guilt,
stating that the £100 was simply too tempting.

Assuming the charges are upheld, such cases are very damaging to public
confidence in the system. This is similar to cases of researchers faking their
published research — I cringe every time I read about such cases.

There are some important questions, however: how common are such occurrences?
And is this the isolated corruption of these individuals, or is it endemic in
the system? The first question is difficult to answer. We can only know about
exposed cases. Given the number of physicians and drug reps in the world,
however, and the fact that the number of such cases that come to light are
relatively few it would seem that such cases are the exception rather than the
rule.

The second question is a bit easier to answer, but of course there can always be
hidden corruption. GSK, for their part, states that such behavior is against
their policy. I certainly hope this is true. GSK has been caught in scandals
before. As the BBC reports:

   In 2012, GSK paid $3bn (£1.9bn) in the largest healthcare fraud settlement in
   US history after pleading guilty to promoting two drugs for unapproved uses 
   and failing to report safety data about a diabetes drug to the Food and Drug 
   Administration.

These cases involved illegal activity at the corporate level. The current case
most likely represents corruption at the level of the individuals directly
involved.

While drug reps are certainly in sales, I have only personally seen a drug rep
step over the line on one occasion. A new rep, who was clearly green, actually
said to me and my colleague, “What would it take to get you to prescribe more of
this drug?” I don’t think he was suggesting anything like bribery, but the
statement was clearly inappropriate.

Our response was to end the encounter, and then call his company to report the
incident and instruct them never to send that rep to Yale ever again.

There is no way to completely prevent isolated corruption. But we should ask
about which policies would best minimize the incentives and opportunities for
corruption. One approach, which is gaining favor, is to simply limit access of
drug reps to doctors. This has already happened quite a bit. Drug
company-sponsored lunches and talks have essentially vanished. Now my
interaction is limited to signing for samples.

An even more draconian approach would be to eliminate the sales divisions of
pharmaceutical companies. I am not suggesting this, but this would certainly
eliminate any problems resulting from sales.

There is a potential downside to this also. There is benefit to be had from the 
flow of information between professionals and the private sector. Sometimes the 
goals of sales and good medicine align, when a new drug will improve health
outcomes but is underprescribed because word has not penetrated the field yet.
Companies can help get the word out and improve health outcomes.

The trick is to provide objective information, not information that is skewed in
favor of the drug company. This can be accomplished by simply supporting
education and outreach on the part of academics, who themselves will control the
content. In my experience this is what happens most often, but obviously there 
are opportunities for drug companies to put their thumb on the scale, for
example by their choice of academics — choosing those whose views happen to
align with the company’s goals.

There are also advantages to academics advising private industry, to help them
spend their research dollars in a way that is most likely to bear fruit and to
meet unmet needs.

There are plenty of other measures that can be taken to minimize corruption
short of a total ban on interactions between industry and practitioners and
researchers. Perhaps the biggest measure is to manage the culture of the sales
division. This flows from the top down — if companies want to keep their names
out of the scandal pages and avoid big fines, they need to systematically train 
their sales reps to follow appropriate behavior, and swiftly and definitively
discipline those who stray.

However, no matter what a company tells their employees during retreats and
seminars, if the company sets up incentives that encourage corruption, it will
still happen. GSK has already stated in response to the current episode that
they will end direct payments to doctors for promotional talks, and also that
they will eliminate sales goals for their reps.

Conclusion

No matter how a system is configured there is the potential for corruption. Even
if the entire pharmaceutical industry were nationalized, there would still be a
great deal of money exchanging hands, and this creates the incentive and
potential for corruption.

It is critical, therefore, to identify and eliminate systemic corruption or any 
elements in the system that encourage or make it easy to hide corruption. This
is especially important in vital industries, such as pharmaceuticals.

I do think we have been moving in the right direction in the last two decades.
The tendrils of drug companies’ sales divisions have been slowly removed from
academia and doctors’ offices. Gone are the previously ubiquitous drug lunches, 
branded gifts, and sponsored trips. There are further steps to be taken, such as
those above, to maximize transparency and minimize both actual corruption and
the appearance of corruption.

Exposing cases as they come to light, and shaming drug companies into taking
corrective action, is an important part of this progress.

Food fights in the courtroom

Jann Bellamy on July 24, 2014

Link

What’s in a name? Will sugar by any other name taste as sweet? Well, yes, but
calling sugar “evaporated cane juice” in an ingredient list may get food
manufacturers into trouble. Consumers in several class action suits allege that 
companies are trying to disguise the amount of sugar in their products by
calling it something else.

Robin Reese filed a class action suit against Odwalla, a subsidiary of
Coca-Cola, saying use of the term “evaporated cane juice” instead of sugar
fooled her into thinking she was getting a healthier product when she purchased 
Odwalla juice. Odwalla told the judge the suit should be dismissed because it’s 
up to the FDA to decide the issue. The FDA issued draft guidelines, in 2009,
taking the position that the term “evaporated cane juice” should not be used
because it’s not a “juice” as defined in the Federal Regulations. For unknown
reasons, no final guidelines were issued and food companies seem to be honoring 
the draft guidance more in the breach. The FDA reopened the draft guidelines for
comment in March of this year, for 3 months, but still hasn’t decided.
Meanwhile, similar class actions against other companies were dismissed or
stayed pending the FDA’s making up its mind.

So what’s the difference, if any, between the two? Sugar company Florida
Crystals told NPR the two are not the same and that evaporated cane juice is a
“natural sweetener with ‘dark golden hues’ and a ‘sweet sugarcane flavor.’”
Competitor U.S. Sugar begged to differ. Its rep said they are basically the same
thing: “white sugar is stripped of all traces of molasses, while evaporated
cane juice still has some little flecks of molasses that give it a darker
caramel color.” According to this rep, from a health standpoint, there’s no real
difference.

While Odwalla and other food companies may be trying to run from the word
“sugar,” makers of high fructose corn syrup should be so lucky. The Corn
Refiners Association asked the FDA to allow use of the term “corn sugar” instead
of “high fructose corn syrup,” which, in some circles, is the equivalent of
saying “poison” on the label. The FDA said no.

It’s only natural. Or not.

“Evaporated cane juice” is small potatoes compared to the food fights over
“natural” ingredients. The biggest problem here is that no one really knows
what” natural” means, even though it is ubiquitous in food product labeling and 
advertising.

The whole issue aggravates synthetic biologist Terry Johnson:

   “Natural” is a word that has been used in so many contexts with so many
   different meanings that it’s become almost impossible to parse. Its most
   basic usage, to distinguish phenomena that exist only because of humankind
   from phenomena that don’t, presumes that humans are somehow separate from
   nature, and our works are un- or non-natural when compared to, say, beavers
   or honeybees.

   When speaking of food, “natural” is even slipperier. It has different
   meanings in different countries, and in the US, the FDA has given up on a
   meaningful definition of natural food (largely in favor of “organic”, another
   nebulous term). In Canada, I could market corn as “natural” if I avoid
   adding or subtracting various things before selling it, but the corn itself
   is the result of thousands of years of selection by humans, from a plant that
   wouldn’t exist without human intervention.

Johnson’s comment is part of a terrific list titled “Ten Scientific Ideas that
Scientists Wish You Would Stop Misusing” (including “quantum” and “gene”) which,
in my opinion, which should be required reading for everyone.

In the last few years, dozens of class action lawsuits have been filed alleging 
food and other consumer products are labeled “natural” when, according to the
plaintiffs, they contain synthetic ingredients. Many consumers believe that
“natural” equates with “healthier” so they seek out and purchase products
alleged to be made partly or wholly from natural ingredients. Mintel, a market
research firm, did a consumer survey reported in a publication called Natural
Foods Merchandiser. 60% of consumers read nutrition labels regularly and 51%
look for “all natural” on the product label. One suit (over tortilla chips)
cited a survey by Consumers Union which found that 86% of consumers understand
the term “natural” to mean that the product doesn’t have any artificial
ingredients in it.

My source for information on these lawsuits (including the “evaporated cane
juice” cases) is a website called “Top Class Actions.” Motto:

   Connecting Consumers to Settlements, Lawsuits and Attorneys

For example, here’s a “top class action” from July 11th, titled “Flushmate
Toilet Class Action Settlement.”

   The manufacturer of the Flushmate toilet flushing system has agreed to pay
   $18 million to resolve multiple class action lawsuits accusing the company
   selling a defective product that causes toilets to explode. If you own or
   owned a toilet equipped with a Series 503 Flushmate III Pressure-Assist
   Flushing System, you may be eligible to claim money from the class action
   settlement.

Of course, this suit has absolutely nothing to do with natural products, except 
in the broadest sense, but I couldn’t resist. To get to the suits we’re
discussing in this post enter “natural” in the Top Class Actions search box.

WARNING: This website is not for use by drug and device manufacturers, consumer 
products manufacturers, financial institutions, publicly traded companies, large
employers, or any other persons likely to have issues with the plaintiffs’ bar.
Viewing this website may cause a dangerous spike in blood pressure, insomnia,
depression, gastrointestinal upset, apoplexy and other symptoms of extreme
aggravation.

The “natural” American meal: pizza, soda and cupcakes

My sympathies don’t lie with either side in this fight. One the one hand, it is 
simplistic to believe that “natural” and “healthier” are synonymous. On the
other hand, companies shouldn’t be allowed to get away with false advertising.
But is it false? After all, what does “natural” even mean? That’s a question
we’ll return to in a minute.

And I have to wonder whether some of the consumers who file these suits are all 
that concerned about healthier eating. Take a look at the type of products they 
allege are mislabeled:

  1. Waffles

  2. Shakes

  3. Cookies

  4. Crackers

  5. Snack bars

  6. Enchiladas

  7. Pizzas

  8. Sodas

  9. Ice cream

  10. Cinnamon rolls

  11. Buttermilk biscuits

  12. Cheese

  13. Pretzels

  14. Chips

  15. Bean dip

  16. Baking mix

  17. Pie

  18. Cupcakes

Other consumer products have also been sued in class actions over the “natural” 
claim as well, including toothpaste, baby wash, sunscreen, shampoo, conditioner,
shaving gel, diapers and deodorant.

Products containing GMOs are the subject of several lawsuits, including one
against Heinz, alleging its distilled white vinegar is made from GMO corn, which
is not really natural. Other suits allege that products containing Vitamin B12,
Vitamin D2, niacin, iron, riboflavin, folic acid and ascorbic acid should not
be labeled “natural.” Go figure.

The financial reward in these suits is not great, at least not for the members
of the plaintiff class. While the total amount of the settlement can range from 
several hundred thousand to several million dollars, costs and attorneys’ fees
must come out of that amount. To recover, individual consumers must file a claim
with the court and generally receive only a few cents to a couple of dollars
per product purchase, with a limit on the total reward, depending on whether the
claimant has a proof of purchase or not. (Who saves grocery receipts in
anticipation of a possible consumer lawsuit?) To add insult to injury, a claim
will sometimes be rewarded with a voucher for more of the defendant’s products. 
If the settlement fund is not sufficient to pay all claims, each claim can be
reduced pro rata.

For example, in a class action over claims of “natural” ingredients involving
several dozen Kashi products, class members will get $0.50 per product, but
those without proof of purchase will be capped at $25 total. The total
settlement fund is $5 million. (As in all such settlements, Kashi denies
plaintiffs’ claims.)

Attorney’s fees can sometimes eat up a substantial chunk of the settlement fund.
In a recent class action against the maker of Nutella, plaintiffs claimed the
product was misleadingly advertised as a “healthy breakfast food.” The case was 
settled with an agreement to alter Nutella’s label and advertising as well as a 
settlement fund of $1.5 million. About two thirds of that went to the attorneys.
Three class members challenged the fee amount, arguing that such awards were
generally limited to 25%, but a federal appeals court refused to overturn the
lower court’s approval of the settlement.

Common sense

Not all plaintiffs have been successful.

An Alabama federal district judge tossed out a class action suit against Citrus 
World, Inc., makers of Florida Natural orange juice. The plaintiff’s complaint
alleged that the juice was mislabeled as pure and natural when, in fact, it is
“heavily processed, stored and flavored” before it is put on store shelves. In
effect, the judge told the plaintiff to use a little common sense in the grocery
store.

   The plaintiff makes much ado about believing the packaged containers of
   orange juice contained ‘fresh squeezed’ orange juice. As a matter of common
   sense, whatever is in a container on a store shelf with an expiration date
   some weeks hence cannot contain ‘fresh’ anything. . . The fact that the
   plaintiff may have believed defendant hired individuals to hand squeeze fresh
   oranges one by one into juice cartons, then boxed up and delivered the same 
   all over the country does not translate into a concrete injury to plaintiff
   upon his learning that beliefs about commercially grown and produced orange
   juice were incorrect.

Class action lawsuits have also been filed alleging orange juice made by
Coca-Cola, under the name “Simply Orange,” and Tropicana, is not actually 100%
juice nor is it natural. Plaintiffs claim that these companies use “flavor
packs” to add back flavor and fragrance that is lost in processing.

So, what is “natural” anyway? That’s a question the plaintiff in a lawsuit
against Nestle USA, Inc., couldn’t answer.

The complaint alleged the plaintiff bought Buitoni’s Three Cheese Tortellini and
Spinach Cheese Tortellini believing that “all natural” meant they didn’t
contain any unnatural, artificial or synthetic ingredients, when, in fact, they 
contain certain ingredients that aren’t “natural:” xanthan gum, soy lecithin,
sodium citrate, maltodextrin, sodium phosphate, disodium phosphates, and ferrous
sulfate. She would not have bought them had she known this, according to the
complaint. The judge didn’t buy it.

The question before the court (on a motion to dismiss for failure to state a
claim) was whether a reasonable consumer would likely to be deceived by the “all
natural” claim. The plaintiff’s problem was that she could not provide an
objective definition of just what “all natural” means. Basically, if you don’t
know how to define it, you can’t say you were deceived by thinking a product
failed to live up to the definition of “all natural.” This failure was not for
lack of trying.

First, she tried the dictionary definition of “natural:” “produced or existing
in nature” and “not artificial or manufactured.” The judge rejected this
attempt, saying that consumers are obviously aware that Buitoni pastas aren’t
“springing fully-formed from Ravioli tress and Tortellini bushes.”

So she tried again. This time, she argued that none of the ingredients in
“natural” products can be “artificial” as that term is defined by the FDA. But
the FDA’s definition applies only to flavor additives, not any of the
ingredients plaintiff alleged were “unnatural.”

Finally, the plaintiff argued that none of the ingredients in a “natural”
product are “synthetic” as defined by the National Organic Program (NOP). Two
problems with that argument. First, the pastas weren’t labeled organic, so the
NOP didn’t apply. Second, the ingredients plaintiff claimed were “synthetic” are
actually permitted in products labelled “organic.”

The judge found, as a matter of law, that the description “all natural” was not 
deceptive because the actual ingredients were clearly disclosed on the label,
quoting from another case where the plaintiff claimed “all natural” was
misleading:

   Because the labels clearly disclosed the presence of the [allegedly unnatural
   ingredients] it is not plausible that Plaintiffs believed, based on
   Defendant’s ‘[o]nly natural ingredients’ or ‘all natural’ representations,
   that the [product] did not contain [the challenged ingredients]

In other words, read the ingredients list on the label. That’s what it’s there
for.

Undermining the regulation of stem cell therapies in Italy: A warning for the
future?

David Gorski on May 6, 2013

Link

Stem cells are magical.

At least, if you listen to what docs and “practitioners” who run stem cell
clinics in various parts of the world, usually where regulation is lax and money
from First World clientele is much sought after, that’s what you could easily
come to believe. Unfortunately, it’s not just Third World countries in which
“stem cell clinics” have proliferated. For instance, they are not nearly
uncommon enough in Europe. The example that is most troubling right now is
Italy, and the reason is that there is currently a law being considered that
would greatly weaken the regulation of stem cell therapies, so much so that on
Friday I saw something that’s fairly rare: a major scientific journal published 
a pointed editorial about this new law. Specifically EMBO Journal published a
commentary by an international group of scientists warning about the path that
the government of Italy is considering entitled Regulation of stem cell
therapies under attack in Europe: for whom the bell tolls.

Stem cell quackery is a very popular form of quackery these days because, well, 
stem cells are so magical-seeming. You can now find stem cell treatments offered
for autism (one of which, offered at a clinic in Costa Rica, I’ve discussed
before and involves injecting “stem cells” into the cerebrospinal fluid of
autistic children for a cool $15,000). Kent Heckenlively, the man who took his
daughter to the aforementioned Costa Rica clinic for this treatment, is not
alone in subjecting his autistic child to such unproven uses of stem cells. Just
a couple of months ago, a broadcast journalist in the Philippines named Karen
Davila took her autistic son to the Villa Medica Clinic in Germany, which offers
variants of stem cell therapy. One is known as “fresh cell therapy” and
involves harvesting cells from lamb fetuses and injecting them into the patient.
The other is called fat stem cell repair therapy, which is claimed to involve
harvesting fat from the patient’s abdomen or thigh and then isolating “stem
cells” from them to be injected back into the patient’s body.

There’s also a variation on this “stem cell” theme in China, discussed by Steve 
Novella a few years ago, in which Dr. Hongyun Huang runs a clinic in which he
injects “stem cells” claimed to be derived from olfactory sheath cells taken
from aborted fetuses into the cerebrospinal fluid of patients suffering from
spinal cord injury or motor neuron disease like amyotropic lateral sclerosis
(Lou Gehrig’s disease), claiming what can only be referred to as miraculous
cures, sadly credulously reported by the press. He’s a little more expensive, in
that he charges $20,000 (or at least he did back in 2008, when Steve wrote his 
post).

It’s not just neurological diseases and conditions for which stem cell
treatments are offered, though. Dubious “stem cell” treatments can be easily
found for virtually any disease that is currently incurable, chronic, or only
treatable with great effort and not-so-great success. The list of diseases and
conditions include, in addition to developmental disorders such as autism,
neurological injury, and degenerative neurological diseases such as multiple
sclerosis, diseases as diverse as heart disease, autoimmune diseases,
respiratory disease, HIV/AIDS, diabetes, hypertension, cancer, and, of course,
anti-aging. Truly, there is seemingly no disease for which some clinic,
somewhere in the world (usually in Central America and China, but sometimes in
Germany and the former Soviet Union) won’t be claiming miraculous cures with
“stem cells.”

One example, a clinic in the Ukraine called EmCell, advertises its wares with
slickly-produced infomercials, chock full of impressive-appearing graphics and
animations:

It’s hard not to note that 1994, the year that this clinic came into existence, 
was long before legitimate stem cell therapy, other than bone marrow
transplantation, had progressed to anywhere near being a viable therapy. Notice 
the claims of patents, mostly in Russia and the Ukraine, but a few European
patents and a couple of US patents as well. I looked at one of the US patents.
All it is, is a method to prepare a “cell suspension” from human embryos that,
or so it is claimed, is suitable for treating HIV. You know what you don’t see
on the website? Solid evidence from randomized clinical trials. There are,
however, many testimonials. It doesn’t help that well-known antivaccinationist
and autism quack (in my opinion) Jeff Bradstreet is apparently the US contact
for EmCell.

Of course, EmCell is far from alone; it’s just one of the older and slicker
“stem cell” clinics. There are many others, such as the Stem Cell Institute in
Panama, the Bio-Cellular Research Organization in Ireland, the Regenerative
Medicine Institute in Tijuana, among many others. Astute readers might have
noticed that I use scare quotes when I discuss stem cells in the context of
these clinics. That’s because it’s very much in doubt in most of these clinics
whether what is being administered actually consists of stem cells. That’s where
the need for regulation comes in most acutely. It’s also why what is going on
in Italy right now is of great concern.

Attacking regulation of stem cell therapies in Italy

It’s been a bad year for Italian science thus far. Just last month, animal
rights activists broke into the animal facility at the University of Milan and
occupied it. During the occupation, they stole animals and rearranged all the
cage cards so that scientists didn’t know which group of animals were which
anymore, rendering their work uninterpretable and ruining years of research. Now
this. If you think that the “health freedom” movement is limited just to the US
and its more libertarian-leaning groups, think again. The EMBO article, by
Bianco et al, starts out describing how this proposed law came to be. Noting
that this is the first case in which unproven “stem cell” treatments are
recognized as legitimate therapy without having been tested in rigorous clinical
trials and based only upon flimsy preclinical evidence, “to be made part of a
publicly funded, public health care system,” Bianco et al write (note that “MSC”
= “mesenchymal stem cell”):

   Patients with disparate, severe neurological diseases were and are being
   treated, and will continue to be treated in a major public hospital in Italy,
   by intravenous and intrathecal infusions of ‘MSCs’, purportedly prepared
   according to a unique, novel method of isolation in culture, and in vitro
   differentiation into neurons. This activity had previously been taking place 
   in Trieste. In Brescia, an official agreement had been stipulated between the
   public hospital and a private foundation, whereby the foundation was granted
   permission to prepare cells with the purportedly proprietary method. Cells
   for infusion into patients were prepared within a GLP lab (not stringent
   enough for growing cells in culture before use in patients), intended for the
   handling of bone marrow and cord blood-derived haematopoietic cells.
   Patients were being treated in the hospital. Patient care in public hospitals
   in Italy is paid for by the Government.

More information can be found in these news reports in Nature from March and
April. Here’s what happened. Apparently, Italy’s health minister, Renato
Balduzzi, has been impressed by the blandishments and claims regarding adult
stem cell therapy and on March 21 decreed that that a controversial (actually,
let’s be honest, a quack) stem cell therapy can continue in 32 terminally ill
patients, mostly children, even though the stem cells were not isolated
according to Italy’s safety standards. This decision followed a prolonged
campaign and media pressure to authorize the compassionate use of the therapy.
As noted in this Nature report, hundreds of people protested in Rome on March
23, including a naked woman with pro-stem cell slogans painted on her body.

This particular therapy is marketed by the Stamina Foundation and has been
banned multiple times. However, this time the Stamina Foundation has found a
winning public relations message, pushing for “compassionate use” of its
unproven therapies:

   Stamina Foundation president Davide Vannoni, a psychologist at the University
   of Udine, says that the publicity around the treatment has won him 9,000 new
   patients. He hopes that further modifications to the law will allow him to
   expand the therapy.

   A month ago, an investigatory television programme, The Hyena, reported that 
   children with incurable diseases such as spinal muscular atrophy were being
   denied supposedly important treatment, and Italian show-business
   personalities joined the call to relax rules on stem-cell treatment.

As is my wont, I wandered over to the Stamina Foundation website. Unfortunately,
it’s in Italian, and I don’t speak Italian. However, a little Google Translate 
allowed me to get the gist of what the Stamina Foundation is selling. For
instance, this page touts MSC for everything from heart disease, to Parkinson’s 
disease, to multiple sclerosis, to kidney damage, to type I diabetes, to
Alzheimer’s disease, to Huntington’s chorea, to spinal injuries, and just about 
anything else you can think of. That, in and of itself, should be a massive red 
flag, of course, coupled with the fact that in the news reports Vannoni admits
that he’s never published his outcomes. Moreover, the only published outcome, a 
small trial involving five babies with type I spinal muscular atrophy treated
with Vannoni’s MSCs was published in October and was entirely negative, leading 
the authors to conclude:

   More generally, our findings highlight the risk that the combination of
   newspaper ‘hype’ and parental ‘hope’, with the support of courts that are
   sympathetic to families with children with severe disorders, may produce
   shortcuts in the design of clinical studies that would need more rigorous
   preclinical information and more accurate safety and efficacy measures and
   may actually put patients at risk of potential side effects of therapy.

Vannoni’s response? He claimed that the therapy didn’t work because the
clinicians did not use his exact cocktail of cells.

Indeed, I can’t help but compare Vannoni unfavorably to Stanislaw Burzynski, who
at least has published a few papers and case reports. They might be crappy
papers, case reports, and incomplete clinical trials that, when examined
closely, don’t support his claims, but he has published. Vannoni, on the other
hand, seems not to care about even the appearance of not being a quack.

One aspect that Vannoni does share with Burzynski, however, is his willingness
to cynically use desperate patients to try to get approval for his unproven
therapies. Indeed, public hospital Spedali Civili of Brescia has been permitting
the Stamina Foundation to administer MSC treatment for various
neurodegenerative treatments, despite it not being one of the 13 authorized
Italian stem cell factories. After an inspection in 2012, the Italian version of
the FDA ordered an immediate halt to these treatments, and that’s when the
protests began:

   But the halt sparked protests among patients’ families who believed the
   treatment was working. Some appealed to the courts, and as a result a few
   patients were allowed to go ahead with the therapy. On 15 March, a group of
   13 Italian stem cell researchers published an open letter to the country’s
   Minister of Health, Renato Balduzzi, asking him to shut down all of the
   Stamina Foundation’s treatments at the hospital.

The open letter urged Balduzzi not to succumb to the wave of emotion and pointed
out that there was no evidence that MSCs can do what Vannoni and his patients’ 
parents claim they can do. They also argued that “compassionate use” exemptions 
shouldn’t be used as a means of weakening regulation of completely unproven
therapies. Indeed, it’s worth citing a couple of passages, conveniently
translated into English here:

   The decision seems to be dictated by emotions raised by public opinion rather
   than by scientifically based reasons. No scientific evidence whatsoever has 
   been produced suggesting that mesenchymal cells may have any effect on those 
   diseases for which it is claimed they could be employed. Moreover, no
   scientific description has been given of the method by which it is claimed
   these cells may be obtained. This seems a real subversion of the scientific
   and moral foundations of medicine, denying both the dignity and the traumatic
   experiences of patients and their relatives. We are aware of these issues
   and they profoundly motivate the scientific community to generate and
   guarantee accepted, visible and public data that will change any potential
   scientific hypothesis into an accepted curative procedure.

The scientists also addressed the health freedom issue head on:

   The freedom of any citizen to adopt any personal health decision, including
   the wish to refuse any cure, does not imply that the Government is obliged to
   authorize all medical procedures that anyone may suggest as appropriate. In 
   fact, although the individual choice to use an imaginary or inappropriate
   therapy complies with the rights of individual citizens, such therapies
   should not necessarily be approved by the Government and provided by public
   or private health structures. It is not the Government’s role to respond to
   pressure from patients to translate an individual choice into a therapeutic
   option for ready use in any health structure. Media campaigns should not
   become instrumental in adopting decisions on medical or health procedures.
   The right of single individuals to adopt snake oil as a freely chosen drug
   does not mean that snake oil has to be prepared in hospital pharmacies as a
   result of Government-authorized procedures.

In other words, the Italian government is on the brink of giving free rein to
stem cell quacks, but it’s worse than that. This order, as the scientists point 
out, in essence allows government-funded facilities to collaborate with stem
cell quacks and facilitate their treating patients.

One point that the scientists didn’t really nail, and that’s the issue of
informed consent. One notes that Vannoni’s stem cell quackery has no evidence
for it published in the peer-reviewed biomedical literature nor any compelling
clinical trial results. Consequently, if claims are being made for this
treatment it is impossible to give informed consent because there is no evidence
upon which to base even a rough estimate of the chances for success weighed
against the risks of the treatment. Even worse, we don’t even know that these
are really stem cells. Seriously. As the scientists point out, there is no
transparency, and if there’s an area of clinical research where transparency is 
essential, it’s stem cell research.

Sadly, the scientists’ words fell on deaf ears. In fact, Balduzzi had called a
scientific review committee to examine the cases and make recommendations. It
recommended against authorizing further use of the Stamina Foundation’s stem
cells in a public hospital, but Balduzzi ignored the recommendations of his own 
panel and permitted use of the Foundation’s procedure in a terminally ill three 
year-old. Indeed, Balduzzi signed the order allowing the bogus MSC therapy to
continue at a public hospital. On April 10, the Italian Senate amended
Balduzzi’s ministerial decree with a clause that would redefine stem cell
therapy as tissue transplantation, thereby releasing it from any regulatory
oversight by the government. If this decree is passed by the other parliamentary
chamber in Italy, the Camera dei Deputati, then dubious stem cell therapies
will be out of reach of Italian drug regulators. One notes that this will be in 
marked contrast to European Union and US standards, which treat cells removed,
treated, and reinfused as drugs, although sadly one also has to note that the
attempt to redefine cell therapies as not being drugs but surgical procedures or
“tissue transplantation” is not unique to Italy. Regulations for stem cell
therapies are in a perpetual state of catch-up.

It’s also hard not to note that the Catholic Church apparently played a role in 
this scientific debacle. As noted in Nature, Vannoni’s stem cell treatments are 
not embryonic stem cells; they are claimed to be MSCs; i.e., “adult stem cells.”
Because of its opposition to the use of embryonic stem cells, the
“scientifically naïve” Vatican is enamored of the sorts of treatments offered by
the Stamina Foundation, and indeed even held its Second International Vatican
Adult Stem Cell meeting from April 11 to 13, described as “a shamelessly
choreographed performance” in which “sick children were paraded for television, 
sharing the stage with stem-cell companies and scientists desperate to hawk a
message that their therapies must be speeded to clinical use” and was framed as 
a “fight for reason and fairness against an uncaring and intransigent scientific
community.”

If you go to the Stem For Life website, you’ll find a lot of anecdotes, some
preclinical science described, but not a whole lot of actual compelling
evidence. One anecdote in particular is as manipulative as any I’ve ever seen
anywhere else. Don’t get me wrong. I do believe that eventually that stem cells,
be they adult or embryonic, will be used for more and more therapies and that
they will eventually allow the treatment of diseases that we currently cannot
treat, but we have to be realistic and understand what is and is not known about
adult and embryonic stem cells before they are used as therapies.

Why the Stamina Foundation’s stem cell treatment is highly dubious

All of this brings us back to the EMBO article. I really do have to give the
authors credit for a well-written, clear explanation of why MSCs are not ready
for prime time yet and therefore why deregulating them, as the Italian
government appears to be on the verge of doing, is madness. They pull no
punches. First, they argue in a manner that I approve of heartily (and
paraphrasing Tim Minchin) that “regenerative medicine must be medicine.” In
other words:

   Stem cells are not a homogeneous class of cells; ‘stem cells’ are not
   one-size-fits-all cures. There are different kinds of stem cells in different
   tissues, and even when the appropriate stem cell is selected for an
   indication it takes years of research to learn how to administer the stem
   cell safely and effectively, as demonstrated by the decades of research that 
   was required to transplant bone marrow safely and effectively. The use of
   stem cells in medicine must remain cognizant not only of the true biological 
   nature of the type of cells considered for use, but also of the biology of
   the diseases being targeted. Treating patients with disparate neurological
   diseases with intravenous or intrathecal infusion of MSCs, which is being
   done in Italy, has no medical rationale.

You can tell a lot about a purported stem cell therapy by how the “stem cells”
are isolated and administered. If the physician doing the therapy can’t tell you
what specific kind of stem cells he’s using, give a good technical description 
of how they are isolated and purified, show preclinical evidence demonstrating
that they are, in fact, stem cells, and describe how he is going to target them 
to the correct area, then chances are good that the therapy is dubious. As
Bianco et al point out:

   In the case of systemic administration of mesenchymal stem cells (MSCs),
   cells are introduced into the bloodstream, which is not their natural
   environment. They are infused in the hope that they will reach target organs 
   that do not normally contain MSCs. There is a wealth of knowledge about their
   function in their natural site (the bone marrow) and a wealth of knowledge
   on the properties they exhibit in a tissue culture dish. But it is not clear 
   how exogenous MSCs will behave in the brain, kidney, or the lung. As
   inherently osteogenic and adipogenic cells, MSCs could generate bone or fat
   in the wrong organs if transplanted in sufficient numbers (Breitbach et al,
   2007). MSCs can also embolize in the lungs and damage the local
   microcirculation. Allogeneic MSCs can trigger an adverse reaction (instant
   blood mediated inflammatory reaction, IBMIR; Moll et al, 2012), which leads
   to activation of the coagulation and complement cascades, and to the death of
   the infused cells. IBMIR can result occasionally in thromboembolism, but we 
   were unaware until recently that IBMIR could be triggered by MSCs. This
   exemplifies why infusion of MSCs must necessarily be studied in rigorously
   controlled and monitored clinical trials before such therapies can be
   considered safe in patients.

In other words, you can’t just inject the cells either into the bloodstream or
the cerebrospinal fluid, and hope like hell that they “home in” to the right
place and know what to do. It’s not that simple, unfortunately. Adult stem cell 
therapy works for bone marrow transplantation because progenitor cells are made 
in the bone marrow and they tend naturally to stay there when the circulation
takes them through the marrow. We also have 30 years of experience using adult
stem cell therapy for bone marrow transplantation. Bianco et al recount a little
history about this pointing out that the first trial using bone marrow
transplant between unrelated patients resulted in the deaths of all the
recipients in the trial. Indeed, Donnell Thomas, we are told, spent 14
additional years in the laboratory figuring out why donors had to be matched to 
recipients before transplant, observing that “This illustrates how even the
simplest and most promising cell therapies must be studied in depth to be
delivered safely and effectively to patients.” He also notes that the situation 
becomes much more complex for cell therapies in which the scientific rationale
for whom they might work is not known, unclear, or unproven.

Basically, it turns out that to date there are very few examples of proven stem 
cell therapies. There is bone marrow transplantation, of course. There are also 
corneal resurfacing procedures with limbal stem cells and skin regeneration with
epidermal stem cells. There is also decent preclinical evidence and a few case 
reports for bone regeneration, and it is not unreasonable to hypothesize the use
of specific types of stem cells for cardiovascular disease, although progress
in this area has been disappointing.

Then, as I’ve pointed out, there’s the whole issue of exactly what kind of cell 
is being used. Just because someone says they are isolating and using “stem
cells” does not mean that what is being isolated and used are, in fact, stem
cells. Indeed, Bianco et al get almost downright sarcastic (at least as
sarcastic as I’ve seen in a scientific review article) and refer to mesenchymal 
stem cells as “most suspicious cells,” stating:

   Cells that have become known as ‘MSCs’ are locally transplantable,
   system-specific and self-renewing perivascular progenitors of skeletal
   tissues, including the haematopoietic microenvironment (Sacchetti et al,
   2007). They are found in the bone marrow and have significant potential in
   medicine and unique biological appeal. It is therefore perhaps not surprising
   that multiple cases of unauthorized stem cell treatments being offered
   directly to the public before any approval or evidence of efficacy are
   centred on the use of the so-called MSCs. Lack of scientific rigour, although
   not unique to the MSC subfield, has flourished therein. Loose definitions
   and poor assays have disseminated across the scientific community as ‘gold
   standards’ (Dominici et al, 2006), creating huge confusion and opening the
   way to the completely erroneous belief that any culture of cells from any
   kind of connective tissue is a culture of stem cells. The apparent ease of
   isolation and culture, and the conceptual confusion between a stem cell as a 
   physical and functional entity, and a culture of cells originating from stem 
   cells ex vivo (Caplan and Correa, 2011), have contributed to the widespread
   use of such cells worldwide. Their nature as ‘adult’ stem cells has granted
   license and exemption from unwanted ethical controversy. Pressure towards
   development of therapies from all funding bodies around the world, a general 
   climate dominated by the need to develop treatments (‘translational
   medicine’, Zerhouni (2005)) and the very existence of multiple companies
   ready to commercialize ‘MSCs’ have contributed, in turn, to making this
   particular biological object prone to misuse in the clinic and user-friendly 
   for ill-intentioned salesmen.

This cannot be repeated often enough. Whenever a stem cell clinic claims to be
using “stem cells,” are they really? What is their scientific rationale? What
are their preclinical data? Do they really support the use of these cells? In
the vast majority of cases, including that of the Stamina Foundation, the answer
is no.

Finally, we should think of these cells in the same way we think of any
“complementary and alternative therapy”—or any therapy, for that matter—and I
have yet to find a better paragraph, even one of mine, arguing for the
importance of there being at least a plausible mechanism:

   Complementary to empirical clinical trials, a number of studies have been
   conducted, claiming ‘beneficial effects’ of systemically infused MSCs in
   animal models. The conceptual design of these studies as ‘clinical trials in 
   a mouse’ is often flawed, detracting from the power of such studies to
   highlight a robust rationale for subsequent clinical use. Typically, a
   pharmacological effect is measured, without measuring the dose, kinetics and 
   dynamics of the active principle, unknown at the outset. A putative active
   principle is often identified ex post through ex vivo reductionistic
   experiments. These arbitrarily single out a putative ad hoc molecular
   mechanism out of a maze of possible, pleiotropic, interlocking mechanisms. An
   arbitrary hypothesis that fits the results is pursued and alternative
   hypotheses are ignored. In vivo effects are often interpreted in a biased way
   (e.g., in studies on ischaemic heart disease, size of post-infarct scars is 
   equated to extent of necrosis; effects of cardiac remodelling are ignored).
   Even though these studies sometimes specifically record the vanishing of
   infused cells, they fail to relate any claimed effect to kinetics of cell
   survival. ‘Clinical data in the mouse’ are descriptive and insufficient to
   offer mechanistic insight. Mechanistic insight is not a dispensable
   intellectual luxury. It is specifically required to develop effective
   therapies. It is to this end that we need mechanisms and rationale. MSCs are 
   thought to have a role in treating GvHD and arthritis alike (Keating, 2012), 
   owing to their generic ‘known immune modulatory effects’. The specific immune
   modulatory effects are not known. We have no way to model and measure them
   effectively in vitro or in vivo. We have, therefore, no way to distinguish
   those operating in GvHD from those operating in arthritis, or to tell whether
   they are the same or different. We have no way to tell whether these effects
   are unique to MSCs or shared with other kinds of cells, and which ones.
   While potentially crucial to advance therapies that harness immune
   modulation, these issues are mostly neglected. Meanwhile repetitive,
   expensive, small, uncontrolled phase I–II trials with i.v. infusions of MSCs 
   continue to be pursued as useful.

I love two of the sentences in that paragraph; so I will repeat them again:
Mechanistic insight is not a dispensable intellectual luxury. It is specifically
required to develop effective therapies. Live them. Learn them. Love them. I
do, and I try to live by them in my research.

The same admonition could be directed at, say, acupuncture, except that at least
MSCs have more plausible mechanisms. However, as Bianco et al point out,
preclinical data and understanding are critical to designing clinical trials
that can actually give the answer that is being sought. Just taking a bunch of
ill-defined cells and willy-nilly injecting them into small groups of patients
with wildly disparate conditions with wildly differing mechanisms of disease is 
likely to be no more informative than taking some needles and sticking them
willy-nilly into patients with wildly disparate conditions with wildly differing
mechanisms of disease and hoping we’ll gain therapeutic insight.

There can be no compassion without safety and efficacy

One of the most potent arguments for Balduzzi’s decision in Italy is an
emotional one: Look at the suffering children! They are dying! How can we
possibly deny them this therapy? My response would be to rephrase that a bit by 
adding specific therapies other than stem cell therapies.

For example: Look at the suffering children! They are dying! How can we possibly
deny them MMS enema (bleach enema) therapy?

Or: Look at the suffering children! They are dying! How can we possibly deny
them homeopathy?

Or: Look at the suffering children! They are dying! How can we possibly deny
them bloodletting?

Sounds ridiculous when put in those terms, doesn’t it? But, even though some day
they might turn out to be wonderful treatments, right now stem cells are in the
same boat. We do not know if they are effective and safe, and there is an
incredible paucity of preclinical evidence to show that they do anything for the
deadly diseases for which they are being used in Italy. The argument is that
these severely ill children have nothing else going for them, no other
therapeutic alternatives; so safety concerns can be thrown out the window.
However, terminally ill patients need more safety and protection, and exposing
them to unknown risks in a therapy with no evidence of efficacy is, as Bianco et
al, put it, ethically unacceptable. Most people would accept the contention
that someone who is severely or terminally ill has the right to take risks in
search of treatment, but their willingness to take such risks because “they have
nothing to lose” makes them vulnerable to any number of unproven treatments or 
even outright quackery. Without some sound evidence that a treatment might be
effective, they are in essence taking all risk with at best an unknown and
likely very small chance of benefit and at worst no benefit at all for all the
risk. While personal freedom might give them the right to “roll the dice” and
take large risks for minimal chance of benefit, neither physicians nor the
government are obligated to facilitate their taking such risks. In fact, quite
the contrary for physicians, who are ethically bound to give proper informed
consent and obligated not to provide treatments without evidence of efficacy. As
Bianco et al put it, “There can be no compassion without safety and efficacy.”

One can only hope that the Italian government figures that out before the Camera
dei Deputati takes up the minister’s decree.

Nigeria Court Ruling on Benzene in Soft Drinks

A Nigerian court condemned the current level of benzene found in local soft
drinks. Was this decision reasonable given the evidence? Is there something else
going on here?

Steven Novella on April 5, 2017

Link

A recent ruling by a Nigerian high court judge has sparked a round of online
discussion about the safety of certain soft drinks. The ruling actually only
affects the Nigerian Bottling Company (NBC) and their manufacturing of certain
Coca-Cola products, Fanta and Sprite. Before I get to the court case, here is
the background science.

Benzene in soft drinks

Benzene is a known carcinogen. Long term exposure increases the risk of certain 
cancers, such as leukemia and myeloma. It is therefore the goal of regulatory
and health agencies to minimize human exposure to benzene to levels that carry
an insignificant risk.

The World Health Organization reports:

   Because of the unequivocal evidence of the carcinogenicity of benzene in
   humans and laboratory animals and its documented chromosomal effects,
   quantitative risk extrapolation was used to estimate lifetime cancer risks.
   Based on a risk estimate using data on leukaemia from epidemiological studies
   involving inhalation exposure, it was calculated that a drinking water
   concentration of 1 µg/litre was associated with an excess lifetime cancer
   risk of 10-6 (10 µg/litre is associated with an excess lifetime risk of 10-5 
   and 100 µg/litre with an excess lifetime risk of 10-4) (15).

A “µg/litre” is a microgram per liter, which is equal to one part per billion
(ppb). So regular exposure to benzene in 1 ppb had an increased lifetime risk of
cancer of 10-6, which is one addition case per million people.

We are exposed to benzene in gasoline fumes, tobacco smoke, fumes from other
products that contain benzene, and a small amount gets into our food and water. 
Smokers have 3-6 times the exposure to benzene than non-smokers. The WHO also
reports that the amount from drinking water is a small overall contribution:

   Exposure to benzene may vary considerably. For nonsmokers, the estimated
   average daily intake is 200–450 µg/day. The estimated contribution from food 
   is 180 µg/day but, as information on benzene levels in food is very scanty,
   this background level should be considered only as an approximate reference
   point. For smokers, the intake levels are increased by a factor of 2–3 (urban
   areas) or 2–6 (rural areas). The levels commonly found in drinking-water are
   minimal compared with the intake from food and air (3).

Benzene is not directly added to soft drinks, although there may be a tiny
amount from the water used to manufacture the drinks. However, benzene can form 
from a combination of benzoic acid, which is added as a preservative, and
ascorbic acid (vitamin C). This reaction is increased by heat and light and
inhibited by sugar and EDTA.So, how much benzene gets into soft drinks and how
much is allowed? The various regulatory agencies around the world limit benzene 
from 1 to 10 ppb. At one ppb, if you drank one liter of the soft drink you would
consume 1 microgram of benzene. In one review of 28 soft drink products the
mean benzene levels detected were 0.45 ppb. In that survey two citrus
fruit-based drinks (so they contained benzoic acid and ascorbic acid) exceeded
1ppb.Another survey of 199 soft drinks found:

   The vast majority of beverages sampled contained either no detectable benzene
   or levels below the U.S. Environmental Protection Agency’s drinking water
   limit of 5 ng/g. Beverages found to contain 5 ng/g benzene or more were
   reformulated by the manufacturers. The amount of benzene found in the
   reformulated beverages ranged from none detected to 1.1 ng/g. [1 ng/g is also
   equal to 1 ppb – SN]

Soft drinks therefore have a very low level of benzene, with the vast majority
being lower than the legal limit, but a few having just above the more stringent
limits. Now, let’s put this level of exposure into context. Again, 1 ppb would 
give you one microgram from a liter of soft drink. Let’s use a high estimate of 
5 micrograms per day from soft drinks, assuming someone drinks 5 liters a day of
a soft drink at the limit of 1ppb.

The WHO, as stated above, estimates that the average person is exposed to
250-400 micrograms of benzene per day. You will inhale 32 micrograms when you
fill up your car, and 40 micrograms from driving for one hour. Smokers inhale
2-7 thousand micrograms a day, and passive exposure to smoke contributes an
estimated 50 micrograms per day.

Total contribution from food and water is estimated at between 1 and 3
micrograms per day, which is a small contribution to overall exposure.

The Nigerian case

The recent court case decision (the case itself was filed 10 years ago and took 
this long to get a decision) dealt with a lawsuit from an exporter. They
attempted to export Fanta and Sprite bottled in Nigeria by the NBC to the UK.
The product was tested on import into the UK and found to exceed their limit on 
benzoic acid (note – this refers to benzoic acid, not benzene):

   The UK standards limit benzoic acid in soft drinks to a maximum of 150 mg/kg.
   Both Fanta and Sprite have benzoic levels of 200 mg/kg which is lower than
   the Nigerian regulatory limit of 250 mg/kg when combined with ascorbic acid
   and 300 mg/kg without ascorbic acid and also lower than the 600 mg/kg
   international limit set by Codex.

So the product was compliant with Nigerian and international limits, but over
the stricter limit for the UK. The case focused on whether or not the NBC and
the Nigerian regulatory agency (National Agency For Food and Drug Administration
and Control – NAFDAC) was negligent in allowing these higher limits. NBC
claimed that they bottle soft drinks for local distribution and comply with
local regulations, and their product is not intended to export. The judge,
apparently, did not buy this argument:

   In her judgment, Justice Oyebanji said: “It is imperative to state that the
   knowledge of the Nigeria Bottling Company that the products were to be
   exported is immaterial to its being fit for human consumption. The court is
   in absolute agreement with the learned counsel for the claimants that soft
   drinks manufactured by Nigeria bottling company ought to be fit for human
   consumption irrespective of color or creed.

   “It is manifest that NAFDAC has been grossly irresponsible in its regulatory 
   duties to the consumers of Fanta and Sprite manufactured by Nigeria Bottling 
   Company. In my respective view, NAFDAC has failed the citizens of this great 
   nation by its certification as satisfactory for human consumption products,
   which in the United Kingdom failed sample test for human consumption, and
   which become poisonous in the presence of Ascorbic Acid ordinarily known as
   Vitamin C, which can be freely taken by the unsuspecting public with the
   company’s Fanta or Sprite.”

I’m no legal scholar, but that seems like a massive overreaction to me. It
sounds like the judge had a political point to make. They are claiming that
these products are poisonous and not fit for human consumption because they
contain 200 mg/kg of benzoic acid, when the international limit is 600 mg/kg,
but the UK’s limit is 150. Further, all the evidence suggests that even at the
higher limit the amount of resulting benzene would be well below safety limits
and an insignificant contribution to overall benzene exposure.

As always, the dose makes the poison. And, when considering overall exposure,
individual sources should be put into the proper context of how much they
contribute. Benzoic acid and resulting benzene from soft drinks is a non-issue. 
Overall the levels are extremely low, and are a minor contributor to overall
benzene exposure. The Nigerian court decision has more to do with political
maneuvering than the actual science.

Medical Malpractice Lawsuits

Harriet Hall on July 22, 2014

Link

We hear a lot about medical malpractice suits and how they affect the practice
and the cost of medicine. Doctors sometimes get the feeling that a lawyer is
looking over their shoulder as they interact with patients, and sometimes they
practice “defensive medicine,” ordering unnecessary tests and doing what they
think would look best in court rather than what is really in the patient’s best 
interests. One of my colleagues in the Air Force, a psychiatrist, said at his
retirement ceremony that he considered his career a success because he had never
been sued. That struck me as a sad commentary on what it means to practice
medicine today.

Some of my preconceived ideas on the subject of malpractice were challenged by a
recent survey. Medscape asked 3,480 U.S. physicians about their experience with
malpractice suits. 60% of responding physicians reported they had never been
named in a lawsuit, 31% had been sued in conjunction with other defendants like 
hospitals, and only 9% were sued as individuals.

Among those sued, the specialties most represented were internal medicine (15%),
family medicine (13%), ob/gyn (9%), psychiatry (8%), gastroenterology (6%),
cardiology (6%), and pediatrics (5%). Allergy/immunology was the lowest at 0.4%.
Part of the variation is likely a reflection of the numbers of doctors
practicing each specialty.

Reasons for the lawsuit: failure to diagnose (35%), failure to treat (17%),
informed consent (4%), and other (45%, some legitimate and some clearly
opportunistic). One respondent was sued after a laparoscopy by a patient who
complained that she could no longer eat big meals and enjoy steaks; she
neglected to reveal that between the laparoscopy and the suit, she had a gastric
bypass and stomach stapling.

23% of respondents said the experience of being sued was horrible, one of the
worst experiences of their lives. Some described harassing phone calls, a
near-divorce, and a decision to stop practicing OB.

1% expected the lawsuit, 24% suspected there might be a lawsuit, and 74% had no 
inkling they would be sued.

We hear the horror stories about huge judgments, but most lawsuits don’t even go
to trial. In 5%, the case went to trial but was settled prior to a verdict; in 
16% the case went to trial and a verdict was rendered. In the rest of the cases,
the suit was dismissed or settled out of court, either before or after
depositions.

Even if the case didn’t go to trial, being sued was time-consuming. 28% of
doctors spent more than 40 hours meeting with attorneys, gathering records, and 
preparing for depositions.

The length of the entire lawsuit process was most likely to be 1-2 years (39%); 
28% lasted 3-5 years, and 11% went on for more than 5 years.

Outcomes: voluntarily dismissed by plaintiff (22%), dismissed by the court
(13%), settled before trial (35%), settled at trial (3%), jury returned a
verdict in favor of the doctor (13%), jury returned a verdict in favor of the
plaintiff (2%).

Monetary award: None (57%), up to $500,000 (34%), up to $2 million (9%), over $2
million (2%).

62% thought the result of the lawsuit was fair. Only 7% thought saying “I’m
sorry” would have helped. One who didn’t think so commented that a patient’s
wife had interpreted his apology as an admission of guilt and a reason to sue.
In most cases, defense lawyers were provided by the insurer. 70% were completely
satisfied with their lawyers, 1% thought they were incompetent and destroyed
the case. Some insurance policies have a “required to settle” clause; doctors
were required by their insurer to settle in 9% of cases and encouraged to settle
in 21%. Insurance covered the entire payout in most cases. Patients’ reactions 
to lawsuit: 91% said their patients didn’t know about it or didn’t mention it;
in only 1% of cases, some patients left the doctor’s practice. Long term
effects: 29% said they no longer trust patients and treat them differently, 6%
left the practice setting, 63% reported no effects.

When asked about the worst thing about the trial, emotions came through loud and
clear. One doctor was asked to “list the date, publisher, and title of every
book, magazine, journal you own and/or subscribe to.” One complained that the
plaintiff’s attorney lied; another said the judge fell asleep during the trial.

Advice to avoid lawsuits:

  1. Follow up even when you don’t think you have to

  2. Practice more defensive medicine (One commented that “It is perfectly
    legitimate to order every test that you feel is acceptable to prevent
    another suit.”)

  3. Document more often, more thoroughly; document even cursory conversations.

  4. Get rid of rude, demanding, noncompliant patients.

I don’t know if we should believe the Medscape study, since it was based on
physicians’ voluntary responses to a questionnaire and may not have been a
representative sample of the physician population. A 2011 study in The New
England Journal of Medicine was based on more objective data from a large
liability insurer and it got rather different results. It found that 7.4% of
physicians are sued every year, with the highest rates among neurosurgeons
(19.1%), cardiothoracic/vascular surgeons (18.9%), and general surgery (15.3%), 
and much lower rates for family medicine (5.2%), pediatrics (3.1%), and
psychiatry (2.6%). It estimated that by the age of 65 years, 99% of physicians
in high-risk specialties and 75% of physicians in low-risk specialties have been
sued. 78% of malpractice cases did not result in payments to claimants; when
they did, the median payment was $111,749. The highest mean payment was in
pediatrics, over $500,000. Recently there has been a trend to decreasing
amounts, not increasing.

According to some reports the number of malpractice suits and the cost of
malpractice insurance are both decreasing. One source estimates that the average
insurance premium for surgeons is $10,000; for internal medicine specialists,
$4-6,000. But premiums vary widely by location, insurer, specialty, and type of 
coverage. The standard rate for a neurosurgeon practicing in Long Island in New 
York State is $331,295.

Various studies estimate that malpractice coverage and defensive medicine
account for 2-11% of total health care spending.

I don’t question that patients should be compensated for injuries due to
physician malpractice, but unfortunately the “system” tends to hurt some good
doctors who are practicing good medicine, and some doctors who should lose their
license get away with egregious malfeasance because they are able to inspire
loyalty from their patients. I remember hearing about a surgeon whose patient
returned complaining of pain. He did an x-ray, saw that he had left a surgical
clamp in her abdomen, and instead of apologizing or even admitting that he had
done anything wrong, he told the patient “I think that clamp has just about
finished doing its job now, and we can take it out.” He charged her full price
for a second surgery; she remained oblivious and was grateful for what she
thought was his thorough, attentive care.

I wonder if there isn’t some better way. Hospital M&M (morbidity and mortality) 
conferences do a good job of not only identifying errors but of helping doctors 
learn from them. Judges and juries aren’t as capable of understanding the
intricacies of the medical issues involved. In an ideal world, some independent 
body of medical experts could determine whether standard medical practice was
followed and whether the physician made a mistake, and could advise the courts
on the medical merits of the case. In the real world, doctors will just have to 
keep paying those insurance premiums, documenting everything, improving
communication, and earning their patients’ trust. And lawyers will not lack for 
business.

Enbrel for Stroke and Alzheimer’s

Steven NovellaonMay 8, 2013

Link

A recent article in the LA times tells of a husband’s quest to find a treatment 
for his wife’s Alzheimer’s disease. This is a narrative that journalists know
and love—the brave patient or loved-one who won’t accept the nihilism of the
medical establishment, who finds a maverick doctor willing to buck the system.

The article itself at least was not gushing, it tended toward a neutral tone,
but such articles do tend to instill in the public a very counterproductive
attitude toward science and medicine. I would have preferred an exposé of a
dubious clinic exploiting desperate patients by peddling false hope. That is a
narrative in which journalists rarely engage.

The story revolves around Dr. Edward Tobinick and his practice of perispinal
etanercept (Enbrel) for a long and apparently growing list of conditions. Enbrel
is an FDA-approved drug for the treatment of severe rheumatoid arthritis. It
works by inhibiting tumor necrosis factor (TNF), which is a group of cytokines
that are part of the immune system and cause cell death. Enbrel, therefore, can 
be a powerful anti-inflammatory drug. Tobinick is using Enbrel for many
off-label indications, one of which is Alzheimer’s disease (the focus of the LA 
Times story).

The Dubious Health Clinic

Before I go into the details of Tobinick’s claims, let’s review the typical
features of what we commonly call the “quack clinic” or the dubious health
clinic. I wrote about this in 2009, and listed the following features:

  1. The clinic often has an impressive name, such as “The Institute Of,” but lacks
    any formal affiliation with an established institution, like a university
    or hospital, and was founded and may even continue to be operated by one
    person.

  2. The clinic claims to treat or cure one or more diseases that is currently
    believed to be incurable. Their claims sound too good to be true.

  3. There is only one clinic in the world that can perform their special procedure
    or that uses their proprietary treatment. Sometimes the treatment offered
    is new and experimental.

  4. The clinic claims to cure a variety of diseases, all with different causes and
    pathophysiology, with a single treatment – the “one cure for all diseases” 
    approach.

  5. The clinic is often located in a country with little or no regulation.

  6. The clinic claims that it is the victim of repression. Typically they will say
    that either Big Pharma, the medical establishment, the insurance industry –
    or some other convenient villain—is trying to suppress their revolutionary 
    treatment. Alternatively, the “medical establishment” is simply
    closed-minded to their paradigm-shifting ideas.

  7. Testimonials are used to promote the treatments offered by the clinic, but
    they have not published appropriate research in legitimate peer-reviewed
    journals.

  8. When challenged by professional organizations, the clinic defends itself by
    appealing to politicians, using the testimonies of previous patients who
    believe they have been helped by the clinic and the accusation of a
    conspiracy of those trying to protect their monopoly.

The Institute of Neurological Recovery

Now let’s take a look at Tobinick’s clinic. It has an impressive name—a one-man 
institute.1 The website proclaims:

   The Institute of Neurological Recovery (INR®) is pleased to provide this
   introduction to its pioneering medical concepts, research, and treatment
   programs. INR designates a group of separate medical practices that utilize
   innovative, patented, off-label medical treatments developed by Edward
   Tobinick M.D. These treatment methods are designed to target a number of
   neuroinflammatory conditions with unmet medical need.

Many of the features of a dubious clinic are right there—the impressive name,
claim to treat many conditions with one treatment, emphasis on how innovative
the treatments are. The website also claims that his treatments are patented.

This is an interesting side issue, worthy of its own post. There has been a
surge in the US in recent years in medical procedure patents. However, the first
(and I think only) infringement lawsuit lost its case. Medical procedure
patents are generally opposed by medical organizations as counterproductive
profiteering and are banned in 80 countries. They are still legal in the US but 
there has been a number of legislative effort recently to limit or ban them.

The patented procedure (even if not enforced) seems like just another way to
market the uniqueness of the treatments offered by the dubious clinic.

The list of conditions for which Tobinick claims or even has patented use of
Enbrel include Alzheimer’s, stroke, traumatic brain injury, Parkinson’s disease,
carpal tunnel syndrome, brain tumor, spinal cord injury, and back pain. That
quite impressive for a doctor who isn’t even a neurologist. Tobinick is an
internist who, prior to curing a long list of neurological diseases, specialized
in laser hair removal.

The LA Times reports:

   But his claims about the back treatment led to an investigation by the
   California Medical Board, which placed him on probation for unprofessional
   conduct and made him take classes in prescribing practices and ethics.

Tobinick has since moved his practice to Florida,2 which is a very
quack-friendly state.3  Its “health care freedom” law effectively shields
dubious practitioners from pesky medical boards.

Plausibility and evidence

When considering just the notion that Enbrel, a TNF inhibitor, might have a
broad range of applications, this is entirely plausible. It is common for
immunosuppressive drugs to gain an FDA approved indication for one specific
condition, such as transplant rejection or rheumatoid arthritis, and then to be 
used off-label for many other autoimmune conditions.

This is very tricky, however, as the immune system is complex. There are
different components to the immune system, and different aspects of immunity are
involved in different auto-immune conditions. Therefore there is no one
immunosuppressant drug or treatment for all auto-immune conditions.

When a new immune-suppressing drug comes on the market it is common for it to be
tried in a variety of conditions—but practice then follows evidence. Initially 
we might see some case reports, followed by a case series. If the drug shows
promise, then a double-blind placebo-controlled trial would ultimately determine
its effectiveness.

This is definitely a gray area of off-label use. How much evidence is necessary 
to justify an off-label use of a drug—and how far off label? Sometimes the
popularity of a new off-label use of a drug gets ahead of the evidence. In most 
cases, however, eventually the research is done and practice conforms to the
evidence.

The claims of Tobinick, however, are not in the gray area—they are leaps and
bounds ahead of the evidence. Further, the conditions he claims to treat are not
clearly immune-mediated diseases. It’s one thing to use an immune-suppressing
drug to treat a disease that is known to be caused by immune activity, and
probably the kind of immune activity suppressed by the drug.

Tobinick, however, is claiming that a wide range of neurological conditions not 
known to be immune mediated are treated by a specific immunosuppressant.

On his website he cites many studies, but none of them establish the
effectiveness of Enbrel for any of the conditions he is treating. Most of them
are simply identifying that TNF is increased in the condition. This is very weak
evidence, however, as markers of immune activity are frequently increased in
diseases that are not caused by immune activity. The immune system is very
reactive — it reacts to disease with inflammation (often what we refer to as the
cleanup crew). The inflammation is not causing the disease, it is simply the
body’s reaction to it.

Tobinick has also started to publish case series — little more than
retrospective case series reporting on his own patients.  This is weak evidence 
even when coming from an established researcher within their own area of
expertise. It is all but worthless coming from clinic like Tobinick’s.

This is where his lack of expertise is especially relevant. Such arguments are
often portrayed as elitist, as if a mere internist cannot have a valuable
insight into how to treat neurological disease. But medicine and research are
complex and there are many pitfalls. Unless you have expertise dealing with
strokes or dementia, including how to properly research these conditions, you
are likely to fall for these pitfalls.

For example, in his recent case series he writes:

   Significant improvement was noted irrespective of the length of time before
   treatment was initiated; there was evidence of a strong treatment effect even
   in the subgroup of patients treated more than 10 years after stroke and TBI.

This, if anything, is evidence that the observed treatment effect is mere
placebo. It is very implausible that stroke or TBI deficits will be equally
responsive to an anti-inflammatory treatment (or any treatment) regardless of
time since the stroke or trauma.

Stroke researchers are also very familiar with what is known as the “cheerleader
effect.” Take any patient with chronic deficits, give them any intervention and
then encourage them to function better, and they will function better. This can
result simply from trying harder, or even just the incidental physical therapy 
benefit of engaging in a treatment and being evaluated.

Unless all these factors are controlled for with proper blinding, no conclusions
about the treatment effect are possible. Tobinick is providing the kind of
evidence that is guaranteed to be positive, but not the kind of evidence that
would determine if his treatments are effective or not.

Conclusion

If you strip away the gratuitous narrative in the LA Times story and just look
at the facts presented, a very different narrative emerges. Ken Chiate brought
his wife to Tobinick’s clinic for 165 injections of Enbrel over four years, at a
cost of $800 each (that’s $132,000).4 During that time there were questionable 
subjective effects from the treatment, typical of placebo-only effects.
Meanwhile his wife continued to relentlessly progress, as is typical of the
disease, until she finally died in 2011.

According to the article, the treatments gave Chiate a sense of purpose and of
hope — a false hope, it turned out. He still clings to the idea that Enbrel may 
be an effective treatment for Alzheimer’s disease — even though Tobinick himself
has apparently moved on to treating stroke.

In my opinion, the story documents exploitation of a well-meaning and desperate 
husband at the hands of a dubious practitioner, practicing at the fringes of
medical ethics and evidence, making bold claims without adequate justification. 
The story also documents the utter failure of the regulatory system to prevent
(or even properly react to) such exploitation. Florida in particular appears to 
be a haven for such activity.


Update April 2, 2015

1 Dr. Tobinick objects to this characterization on the basis that his practice
includes multiple staff and other physicians. I maintain that this
characterization is appropriate because his “institute” is merely his private
practice of which he is the only significant component. The “institute’s”
websites are found at tobinick.com, strokebreakthrough.com, nrimed.com,
painbreakthrough.com, and alzheimerbreakthrough.com. Despite having several
websites, his is the only bio that appears on any of them (and he so testified
in court). No other physicians are featured on the INR website, nor any of the
“Institute”’s other websites.

2 Tobinick objects to the fact that the original text stated that he moved his
clinic to Florida. However, the clinic did not move to Florida, Dr. Tobinick
himself moved to Florida where he opened an additional clinic, where he now
works, but kept his a California clinic open also.

3 Dr. Tobinick objects to my characterization of Florida as “Quack Friendly.”
However, as I pointed out in the text, Florida has a healthcare freedom law that
specifically shields practitioners from having action taken against their
license simply because they are practicing below the standard of care. In fact I
was involved in a case where the court concluded a neurologist was practicing
below the standard of care, but they appealed based upon Florida’s health care
freedom law and the claim that they could not be held to the standard of care,
and they won on appeal.

4 Dr. Tobinick disputes this figure, claiming that the LA Times story is
incorrect. He claims that he charged Chiate a total of $71,000 for the
treatments. However, other news sources state that he charges thousands of
dollars for the initial treatment.

Lying for the State

Peter Lipson on March 30, 2012

Link

Quacks lie.  In some ways, that’s what separates us from them.  Real doctors are
stuck with the messy truth: with bad news, with uncertain outcomes.  It’s this 
reliance on the truth which gives us much of our credibility.

Laws forcing doctors to lie to patients take me back to reading Kundera in the
80s; the hovering fear that everyday actions might bring the authorities to your
door. These feelings affect every portion of your life, whether you are a
patient or a doctor.  Lying in service of the state is pervasively oppressive.  
Laws requiring doctors to lie have become a popular tactic in the abortion wars.

Let’s look at Texas’s law, it’s requirements, and internal contradictions.

   Sec. 171.012. VOLUNTARY AND INFORMED CONSENT.

   (a) Consent to an abortion is voluntary and informed only if:

   (1) the physician who is to perform the abortion informs the pregnant woman
   on whom the abortion is to be performed of:(A) the physician’s name;(B) the
   particular medical risks associated with the particular abortion procedure to
   be employed, including, when medically accurate:(i) the risks of infection
   and hemorrhage;(ii) the potential danger to a subsequent pregnancy and of
   infertility; and(iii) the possibility of increased risk of breast cancer
   following an induced abortion and the natural protective effect of a
   completed pregnancy in avoiding breast cancer;(C) the probable gestational
   age of the unborn child at the time the abortion is to be performed; and(D)
   the medical risks associated with carrying the child to term;

We have encountered a problem.  Informed consent is a medical term d’art that
protects both the patient and the doctor. To the extent possible, a doctor must 
communicate risks and benefits of a proposed procedure in a way the patient can 
understand and acknowledge. These risks and benefits are not set in statutes but
found in the medical literature.  Statistics such as complication rates of
various procedures are usually easy to find and to cite.

The statute does not use the medical definition of informed consent but it’s own
concoction.  It throws in “…when medically accurate…” but then insists that the
doctor state information that is counterfactual (that is, a lie).  In this
section, the most glaring lie is that abortion is associated with breast cancer.
It most certainly is not. And where are the “benefits” in “risks and
benefits”? It is implied that there are none.

What about the next section?

   (2) the physician who is to perform the abortion or the physician’s agent
   informs the pregnant woman that:(A) medical assistance benefits may be
   available for prenatal care, childbirth, and neonatal care;(B) the father is 
   liable for assistance in the support of the child without regard to whether
   the father has offered to pay for the abortion; and(C) public and private
   agencies provide pregnancy prevention counseling and medical referrals for
   obtaining pregnancy prevention medications or devices, including emergency
   contraception for victims of rape or incest;

The above section is slightly murkier.  It looks superficially to be innocent
enough, perhaps even compassionate. This makes the lie even more dangerous.  The
section infantalizes the woman seeking an abortion, assuming that she needs
this information to make her choice.  Likely, she’s already made her choice. 
It’s not up to a doctor to give information that is clearly designed to topple
the patients autonomy.  It’s also only somewhat factual.  “Medical assistance
may be available…” (emphasis mine).  I’m sure that’s very comforting, a real
promise of assistance (sarcasm mine). I’m sure that the state can hunt down the 
father and find a way to make him pay child support (additional sarcasm),
assuming the patient feels this is wise, safe, and desired (although the
patient’s desires aren’t taken into account here).   And then there are
“referrals” to agencies that provide pregnancy counseling (often thinly-veiled
anti-abortion offices) and to “emergency contraception” for rape and incest.  If
they are seeking an abortion, it’s a bit late for Plan B. And why only for rape
and incest?  According to the law, the crime must be reported in order to avoid
some of this law’s consequences. This is problematic in ways that would take
another full post.

This section assumes that it is economics or assault driving the patient to
choose an abortion, that it is not a well thought-out choice by an adult who
wishes control over her own body.  It makes the woman invisible, except for her 
womb.

The following section goes on to delineate exactly how the doctor is to perform 
the state-mandated rape of the patient with an ultrasound probe*.  This
violation of trust between the physician and patient is too obvious to mention, 
but mention it I will.  It’s bad enough to demand we lie, but to demand we
commit rape is, it would seem, obviously bad.

The statute also requires the doctor to give the patient a booklet full of
misinformation about abortion with trumped up descriptions of risks, and no
discussion of benefits.

The statue does a lot of bad things I haven’t listed, as do similar statues
being passed in other states.  The point here is not that statues that
essentially outlaw abortion, infantalize and shame women, and require forcible
penetration are bad.  Any sensible person knows this.

The other consequence is the complete destruction of the doctor-patient
relationship. If the state can compel a doctor to lie to a patient in one
circumstance, it can in any circumstance, and patients will no longer be able to
believe anything a doctor says.  They would be fools to trust us.

When the state can demand that we violate our basic responsibility to our
patient—that of delivering the truth—we are no better than quacks, and deserve
no better than quacks.

________________________*

Here is the ultrasound part of the statue for your revulsion:

   (A) the physician who is to perform the abortion or an agent of the physician
   who is also a sonographer certified by a national registry of medical
   sonographers performs a sonogram on the pregnant woman on whom the abortion
   is to be performed;(B) the physician who is to perform the abortion displays 
   the sonogram images in a quality consistent with current medical practice in 
   a manner that the pregnant woman may view them;(C) the physician who is to
   perform the abortion provides, in a manner understandable to a layperson, a
   verbal explanation of the results of the sonogram images, including a medical
   description of the dimensions of the embryo or fetus, the presence of
   cardiac activity, and the presence of external members and internal organs;
   and(D) the physician who is to perform the abortion or an agent of the
   physician who is also a sonographer certified by a national registry of
   medical sonographers makes audible the heart auscultation for the pregnant
   woman to hear, if present, in a quality consistent with current medical
   practice and provides, in a manner understandable to a layperson, a
   simultaneous verbal explanation of the heart auscultation;(5) before
   receiving a sonogram under Subdivision (4)(A) and before the abortion is
   performed and before any sedative or anesthesia is administered, the pregnant
   woman completes and certifies with her signature an election form that
   states as follows:“ABORTION AND SONOGRAM ELECTION

   (1) THE INFORMATION AND PRINTED MATERIALS DESCRIBED BY SECTIONS
   171.012(a)(1)-(3), TEXAS HEALTH AND SAFETY CODE, HAVE BEEN PROVIDED AND
   EXPLAINED TO ME.(2) I UNDERSTAND THE NATURE AND CONSEQUENCES OF AN
   ABORTION.(3) TEXAS LAW REQUIRES THAT I RECEIVE A SONOGRAM PRIOR TO RECEIVING 
   AN ABORTION.(4) I UNDERSTAND THAT I HAVE THE OPTION TO VIEW THE SONOGRAM
   IMAGES.(5) I UNDERSTAND THAT I HAVE THE OPTION TO HEAR THE HEARTBEAT.(6) I
   UNDERSTAND THAT I AM REQUIRED BY LAW TO HEAR AN EXPLANATION OF THE SONOGRAM
   IMAGES UNLESS I CERTIFY IN WRITING TO ONE OF THE FOLLOWING:___ I AM PREGNANT 
   AS A RESULT OF A SEXUAL ASSAULT, INCEST, OR OTHER VIOLATION OF THE TEXAS
   PENAL CODE THAT HAS BEEN REPORTED TO LAW ENFORCEMENT AUTHORITIES OR THAT HAS 
   NOT BEEN REPORTED BECAUSE I REASONABLY BELIEVE THAT DOING SO WOULD PUT ME AT 
   RISK OF RETALIATION RESULTING IN SERIOUS BODILY INJURY.___ I AM A MINOR AND
   OBTAINING AN ABORTION IN ACCORDANCE WITH JUDICIAL BYPASS PROCEDURES UNDER
   CHAPTER 33, TEXAS FAMILY CODE.___ MY FETUS HAS AN IRREVERSIBLE MEDICAL
   CONDITION OR ABNORMALITY, AS IDENTIFIED BY RELIABLE DIAGNOSTIC PROCEDURES AND
   DOCUMENTED IN MY MEDICAL FILE.(7) I AM MAKING THIS ELECTION OF MY OWN FREE
   WILL AND WITHOUT COERCION.(8) FOR A WOMAN WHO LIVES 100 MILES OR MORE FROM
   THE NEAREST ABORTION PROVIDER THAT IS A FACILITY LICENSED UNDER CHAPTER 245
   OR A FACILITY THAT PERFORMS MORE THAN 50 ABORTIONS IN ANY 12-MONTH PERIOD
   ONLY:I CERTIFY THAT, BECAUSE I CURRENTLY LIVE 100 MILES OR MORE FROM THE
   NEAREST ABORTION PROVIDER THAT IS A FACILITY LICENSED UNDER CHAPTER 245 OR A 
   FACILITY THAT PERFORMS MORE THAN 50 ABORTIONS IN ANY 12-MONTH PERIOD, I WAIVE
   THE REQUIREMENT TO WAIT 24 HOURS AFTER THE SONOGRAM IS PERFORMED BEFORE
   RECEIVING THE ABORTION PROCEDURE. MY PLACE OF RESIDENCE
   IS:__________.________________________________________SIGNATURE DATE”;

Another Lawsuit To Suppress Legitimate Criticism – This Time SBM

Steven Novella on July 23, 2014

Link



I suppose it was inevitable. In fact, I’m a bit surprised it took this long. SGU
Productions, the Society for Science-based medicine, and I are being sued for
an article that I wrote in May of 2013 on Science-Based Medicine. My SBM piece, 
which was inspired by an article in the LA Times, gave this summary:

   The story revolves around Dr. Edward Tobinick and his practice of perispinal 
   etanercept (Enbrel) for a long and apparently growing list of conditions.
   Enbrel is an FDA-approved drug for the treatment of severe rheumatoid
   arthritis. It works by inhibiting tumor necrosis factor (TNF), which is a
   group of cytokines that are part of the immune system and cause cell death.
   Enbrel, therefore, can be a powerful anti-inflammatory drug. Tobinick is
   using Enbrel for many off-label indications, one of which is Alzheimer’s
   disease (the focus of the LA Times story).

The claims and practice of Dr. Tobinick have many of the red flags of a dubious 
medical practice, of the sort that we discuss regularly on SBM. It seems that
Dr. Tobinick does not appreciate public criticism of his claims and practice,
and he wants me to remove the post from SBM. In my opinion he is using legal
thuggery in an attempt to intimidate me and silence my free speech because he
finds its content inconvenient.

Of course, we have no intention of removing the post as we feel it is critical
to the public’s interest. This is what we do at SBM – provide an objective
analysis of questionable or controversial medical claims so that consumers can
make more informed decisions, and to advance the state of science in medicine.

We also feel it is critical not to cave to this type of intimidation. If we do, 
we might as well close up shop (which I suspect the Tobinicks of the world would
find agreeable). Defending against even a frivolous lawsuit can be quite
expensive, but we feel it is necessary for us to fight as hard as we can to
defend our rights and the work that we do here at SBM.

An interesting wrinkle of this suit is that Tobinick is claiming that my blog
post is an “advertisement.” This is a legal maneuver as the threshold for
forcing someone to remove an advertisement is much lower than the threshold for 
suppressing their free speech. I can only assume that he and his attorneys are
not bothered by the fact that blog posts on SBM are blatantly not
advertisements.

In the case of the Enbrel article he had to make the absurd claim that the post 
(which does not mention my own practice) was an advertisement for my neurology
practice at Yale, designed to attack a “competitor.” He would have us believe
that Yale neurology in Connecticut is concerned about a distant clinic. Further,
Yale Neurology is an academic practice. Our problem is too many referrals and
long wait times, not competitors. To see how desperate the claim is, he argued
that because I use Botox, which can be used to treat symptoms following stroke, 
that his treatments for stroke represent a competitor. However, I don’t use
Botox to treat stroke patients. I mostly use it to treat migraines, as I am a
headache specialist.

Perhaps he feels that my 18-year career promoting science, critical thinking,
and science-based medicine is just a cover so I can occasionally attack distant 
tangential “competitors.”

In any case, the fight is on. Here is a review of the salient points of my
criticism of Tobinick:

Tobinick is not a neurologist, and yet he feels it is appropriate for him to
treat multiple neurological conditions with an experimental treatment. It is
generally considered unethical for physicians to practice outside of their area 
of competence and expertise. He is trained in internal medicine and dermatology 
and is certified in those specialties. He has never completed a neurology
residency nor is he board certified in neurology.

Despite his lack of formal training and certification, he feels he has ushered
in a “paradigm shift” in the treatment of Alzheimer’s disease – a disease that
has proved challenging for actual neurologists for decades.

His treatment of choice is perispinal etanercept (Enbrel), which basically is an
immunosuppressant drug. He is using this treatment for not only Alzheimer’s
disease, but neurological deficits following stroke, traumatic brain injury, and
pain resulting from vertebral discs. He therefore claims that the neurological 
deficits in these various conditions result from active inflammation
(specifically tumor necrosis factor – TNF) and by inhibiting TNF “rapid
improvement” in neurological function is possible.

These claims are highly implausible, and in my opinion reflect his lack of
training and expertise as a neurologist. Strokes cause ischemic damage to the
brain – brain cells in severe stroke die. Inflammation following stroke is
incidental, not causative. Yet Tobinick claims that 10 years following a stroke,
long after any neurological recovery would have occurred, patients can improve 
by inhibiting TNF.

He makes the same claim for Alzheimer’s disease, despite the fact that this is a
neurodegenerative disease resulting in loss and destruction of brain cells. An 
anti-inflammatory drug is not going to bring back dead brain cells, yet he
claims “rapid improvement” is possible.

The simplest explanation for the apparent response to his treatments is simply
placebo effects. Stroke neurologists, for example, are acutely aware of the
so-called “cheerleader” effect. Take a patient with chronic deficits, get them
off the couch, give them any treatment and tell them it will make them better,
and they will likely demonstrate increased functionality simply because they are
making an effort they had not made for a while.

The only way to really know if the treatment itself is having any neurological
benefit is with careful double-blind placebo-controlled clinical trials.
Tobinick, however, has not produced such evidence. He has a long list of
publications – all case series, observational studies, pilot studies, case
reports, and reviews. I could not find a single double-blind placebo-controlled 
trial establishing the efficacy of his treatment for any of the conditions I
listed above. (There are small studies for disc herniation showing conflicting
results.)

At best his treatment should be considered experimental. I think the
plausibility of the effects he is claiming is extremely low. It’s possible that 
an anti-TNF effect may be of some use, but given the type of evidence we have it
is likely we are seeing mostly (if not completely) placebo effects.

Despite the preliminary nature of his evidence, the “paradigm shift” such claims
would represent, and his lack of formal training in neurology, Tobinick has
obtained a number of use patents for his treatments. Use patents for medical
procedures are still legal in the US, although they have been banned in many
other countries, and many consider them unethical. The AMA has this to say:

   The intentional withholding of new medical knowledge, skills, and techniques 
   from colleagues for reasons of personal gain is detrimental to the medical
   profession and to society and is to be condemned.

The case highlighted in the LA Times story involved Ken Chiate, who brought his 
wife who was suffering from Alzheimer’s disease to Tobinick’s clinic for 165
injections of Enbrel over four years, at a cost of $800 each (that’s $132,000). 
During that time there were questionable subjective effects from the treatment, 
typical of placebo-only effects. Meanwhile his wife’s condition continued to
relentlessly progress, as is typical of the disease, until she finally died in
2011.

I am not the only one to have concerns about Tobinick’s practices. The Medical
Board of California filed an accusation in 2004, amended in 2005 and 2006,
stating:

  1. From about 2000 to 2002, Tobinick, owned and operated a medical practice under
    the name “Institute for Neurological Research” in Los Angeles and Newport
    Beach.

  2. During those years, Tobinick promoted and advertised a new off-label use for
    an FDA-approved drug, etanercept (Enbrel). He referred to his drug as
    DiskCureÂ® [sic] and advertised it as “a new and innovative approach for
    back or neck pain without surgery,” and as a “breakthrough” in the treatment
    of disc-related back and neck pain.

  3. Enbrel is a genetically engineered protein and immune response modifier
    approved by the FDA for treating several types of arthritis but not for back
    pain. Tobinick’s treatment involved injecting it near the spine.

  4. Until May 2002, there had been no published, peer-reviewed, scientific studies
    showing the effectiveness of the treatment for back pain in humans. Nor had
    there been an approved, pending, or investigational drug application for
    this use of etanercept.

  5. Tobinick’s advertisements for DiskCure constituted unprofessional conduct
    under the California Business and Professions Code.

  6. Tobinick had also failed to obtain a fictitious name permit for the Institute 
    for Neurological Research as required by law.

Tobinick agreed to serve one year on probation during which he was required to
complete courses in ethics and prescribing practices and have his practice
monitored by another physician or complete a professional enhancement program.

But now he is not only up to his old tricks, but he has greatly expanded the
scope of his Enbrel claims and practice. He has his own “Institute for
Neurological Recovery” in which he shows videos of select patients to promote
his patented treatments.

This is all, unfortunately, a far too common pattern, one with which we at SBM
are very familiar. There is definitely a need here to provide critical analysis 
of such extraordinary medical claims. That means, also unfortunately, that we
will occasionally need to spend our time and resources defending our right to do
so.

Update on the Tobinick Lawsuit

Steven Novella on April 1, 2015

Link



Last year Edward Tobinick sued the Society for Science-Based Medicine, SGU
Productions (the producers of the Skeptics’ Guide to the Universe podcast), Yale
University, and me personally for libel and (of all things) false advertising. 
I am frequently asked how the suit is going so here is an update.

Background

The lawsuit involved an article I wrote on Science-Based Medicine on May 8,
2013. Dr. Tobinick’s practice involves giving perispinal etanercept to treat
sciatica, Alzheimer’s disease, traumatic brain injury (TBI), and chronic
deficits following stroke. He claims that he can reverse the symptoms of these
various conditions within minutes. He uses highly emotional videos and anecdotal
evidence to promote his treatments.

Further, he has medical use patents on these and other treatments and charges
other physicians a substantial fee for training and a royalty simply for
treating patients with his methods. Medical use patents are considered by the
AMA and other medical organizations to be unethical and are banned in 80
countries (but not the US).

My original article was highly critical of Tobinick’s practice. I emphasized the
fact that he is making dramatic clinical claims, which he himself characterizes
as revolutionary, without ever having conducted a single double-blind placebo
controlled trial. In my opinion none of these uses of etanercept are supported
by adequate clinical evidence. In fact, there are no published double-blind
placebo-controlled trials of etanercept for post-stroke symptoms or TBI. There
are some studies for sciatica, but a 2013 systematic review concluded:

   There was insufficient evidence to recommend these agents when treating
   sciatica, but sufficient evidence to suggest that larger RCTs are needed.

There is a single pilot study of etanercept for Alzheimer’s – a phase II trial
with 41 subjects total. That’s it – this is hardly sufficient evidence on which 
to revolutionize the treatment of multiple complex neurological disorders. In
fact, during the hearing, his own expert testified that we are “not there yet.”

Libel suits in the US are highly problematic, in my opinion, as there is a
strong potential for them to be used as a strategic lawsuit against public
participation (SLAPP). Even if a case essentially has no merits, it takes tens
of thousands of dollars to defend and can be a tactic for silencing critics
based on the burden of mounting a defense. In other words, unless you have lots 
of disposable cash or can raise it quickly, someone with money can use the legal
process to chill your freedom of speech (more on this below).

Updates

Here are some updates in the case: Yale University was quickly dropped from the 
case, which is unsurprising as they had no connection to the article at all. SGU
Productions was also dropped from the case.

A few weeks ago the Society for SBM won a summary judgment motion, and so they
are therefore out of the case also. In the summary judgment the judge ruled that
the original article was not commercial speech, as alleged by Dr. Tobinick.
This was good news because it not only let SfSBM out of the suit, it boded well 
for the same issue in my case.

For background, Tobinick is alleging that my article here on SBM was “commercial
speech.” The claim is absurd on its face, and so I am not surprised that the
judge is not buying it. However, whether or not the claim makes sense there
needs to be a specific legal basis for ruling on the claim. The judge, in the
ruling for the SfSBM summary judgment, laid out the three criteria by which
speech constitutes commercial speech, and the article did not meet any of those 
criteria. However, because the motion was brought by SfSBM the judgment on that 
motion applied only to them, not to me.

Just yesterday there was another update on the case. We completed a two-day
hearing on Tobinick’s motion for injunctive relief. Essentially this is a motion
asking the judge to order me to take down several articles and an SGU podcast
in which I discuss Tobinick and the case (I’m taking bets on whether he is going
to add this one to the list), pending the final outcome of the case.

Yesterday the hearing concluded and the judge ruled from the bench, denying the 
motion. More importantly, the judge specifically rejected Tobinick’s commercial 
speech claim (among other things).

This is all very good news. However, the case will still go forward (unless
Tobinick comes to his senses). It will likely take many more months for the case
to play itself out.

Unfortunately, even though it seems that Tobinick’s case has no merit, the
overall cost of defending my right to express my opinion on the pages of SBM has
already been substantial and will continue to grow.

Libel reform

This experience has certainly been an eye-opener. One reaction, however, is that
my attorney, the SGU, and myself, are beginning a serious effort for libel
reform. What we need is to get effective anti-SLAPP legislation passed is as
many states as possible. I have already received a score of e-mails from readers
and listeners willing to help with this effort, and we will be discussing it
further at NECSS in a week and a half.

We have model anti-SLAPP legislation and can send it to anyone who wishes to
help by contacting their state legislature and looking for someone to sponsor
the bill. E-mail me if you want more details.

Another Tobinick update

Another interesting update is that I recently learned that Tobinick is the
target of another claim by the state of California Medical Board. In November
2014 they filed a complaint against him for false and/or misleading advertising,
deceptive advertising, unprofessional conduct, and gross negligence. Here is
one key part of the claim:

   …he has disseminated or caused to be disseminated false and/or misleading
   statements and/or claims for the purposes of or that are likely to induce,
   directly or indirectly, the rendering of professional services with
   connection with his professional practice, which contained misrepresentation 
   of facts, were likely to mislead or deceive, created false or unjustified
   expectations, and/or make scientific claims that cannot be substantiated by
   reliable, peer reviewed, published scientific studies.

These are devastating accusations, and echo my criticisms of Tobinick. Tobinick 
was subject to a very similar complaint that was settled in 2006.

I will continue to give updates when anything significant happens, but it may be
half a year or more before there is anything to report.

Meanwhile, let’s fight together for libel reform and protect the freedom of
speech on which our entire movement depends.

Lawsuit Update

Steven Novella on June 10, 2015

Link



The First Amendment of the United States of America, guaranteeing freedom of
speech

For those of you following the defamation lawsuit against me by Dr. Edward
Tobinick, there has been a significant and positive update. For quick
background, Dr. Tobinick filed a suit against me personally, the Society for
Science-Based Medicine, Yale University and SGU Productions for an article I
wrote here critical of his claims that perispinal etanercept can treat a variety
of neurological conditions. All the defendants but me have since been removed
from the case.

There are three plaintiffs in the case; Dr. Tobinick himself, his California
corporation, and his Florida LLC. Last year I filed a motion to strike some of
the claims as they apply to the California corporation under that state’s
anti-SLAPP statute. The update is that last week the judge in the case ruled in 
my favor on this motion. These are public documents, so you can read the entire 
decision here. It concludes:

   For the foregoing reasons, it is hereby ORDERED AND ADJUDGED that Steven
   Novella’s Special Motion to Strike (Anti-SLAPP Motion) [DE 93] is GRANTED.
   Tobinick M.D.’s claims for unfair competition under 28 U.S.C. § 1338(b)
   (Count II), trade libel (Count III), and libel per se (Count IV) are STRICKEN
   from the Amended Complaint.

As important as the decision itself are the judge’s reasons for the decision.
She writes:

   The Court concludes that (1) Tobinick M.D. is a limited public figure subject
   to the actual malice requirement, and (2) Tobinick M.D. has failed to
   establish a probability of demonstrating, by clear and convincing evidence,
   that Novella made the statements at issue with actual malice. Therefore,
   Tobinick M.D.’s unfair competition, trade libel, and libel per se claims must
   be stricken.

In other words, Tobinick cannot win his suit on the merits. This also means:

   As a prevailing defendant, Novella is entitled to recover his attorney’s fees
   and costs under the anti-SLAPP statute. Cal. Civ. Proc. Code § 425.16(c)(1).
   He may seek to recover his fees and costs by separate motion.

This applies to only a portion of the case, as it entails only one of the three 
plaintiffs and only some of the claims. It is an important victory, but the case
may be far from over. I will keep you updated.

The decision also highlights the importance of anti-SLAPP laws. “SLAPP” stands
for strategic lawsuit against public participation and refers to the notion that
some libel suits are filed not because they have merit but as a way of
silencing free speech and participation in public discourse. As I have now
learned first-hand, it can cost an incredible amount of money to assert your
free speech. Anti-SLAPP statutes serve the purpose of protecting free speech
from oppressive or harassing SLAPP suits. Effective anti-SLAPP laws allow for
defendants to shut down meritless cases early, before ruinous expenses are
incurred, and also allow for the recovery of fees.

This is why the SGU, myself, and my attorney are lobbying for effective
anti-SLAPP laws in every state and at the federal level. We need people in every
state to contact their legislature. We have a model anti-SLAPP law we can
provide and will be coordinating efforts. There are also groups like the Public 
Participation Project supporting anti-SLAPP legislation.

Recently the Speak Free act of 2015 was introduced in the House of
Representatives. This would be a fairly effective anti-SLAPP law that applies to
federal cases, and may also provide protections for cases in state court as it 
has a provision that allows defendants to avail themselves of the federal
anti-SLAPP protection. Read about it and contact your representative in support 
of this bill.

Right now the laws governing libel cases are broken (in most states),
representing a significant infringement on our free speech. There is a clear
fix, however – effective anti-SLAPP laws. We just need a political push to get
these laws passed.

Tobinick Lawsuit Update – Justice Has Prevailed

sbmadmin on October 6, 2015

Link

On September 30, the U.S. District Court for the Southern District of Florida
granted Dr. Novella’s motion for summary judgment, ending the lawsuit against
him by Dr. Edward Tobinick and two of his companies. Earlier in the case, all of
the other defendants had filed successful motions to dismiss or for summary
judgment and were no longer parties to the case.

That he won the remaining issues in the case on a motion for summary judgment is
highly significant. Summary judgment motions are granted sparingly by the
courts. In granting his motion, the judge was required by law to view the facts 
in the light most favorable to Tobinick and the other plaintiffs and draw all
reasonable inferences from those facts in their favor.  Dr. Novella had to
convince the judge that there was no dispute as to any of the relevant facts and
that those undisputed facts entitled him to prevail. Because of this ruling,
the case will not go to trial.

For a quick background, Tobinick filed a suit against Dr. Novella, the Society
for Science-Based Medicine (SFSBM), Yale University and SGU Productions. The
subject of his suit was an article Dr. Novella wrote here critical of his claims
that perispinal etanercept can treat a variety of neurological conditions, as
well as a second article, posted after suit was filed.

There were three plaintiffs in the case: Tobinick himself, his California
corporation, and his Florida LLC. Last year Dr. Novella filed a motion to strike
some of the claims brought by the California corporation under that state’s
anti-SLAPP statute. In June, the judge ruled in his favor. He was awarded
attorneys fees and costs as well.   The judge concluded:

   For the foregoing reasons, it is hereby ORDERED AND ADJUDGED that Steven
   Novella’s Special Motion to Strike (Anti-SLAPP Motion) [DE 93] is GRANTED.
   Tobinick M.D.’s claims for unfair competition under 28 U.S.C. § 1338(b)
   (Count II), trade libel (Count III), and libel per se (Count IV) are STRICKEN
   from the Amended Complaint.

A post on the Anti-SLAPP ruling is here, and here is a subsequent update. In the
latter, it is mentioned that, in November, 2014,  the Medical Board of
California had filed a complaint against Tobinick for false and/or misleading
advertising, deceptive advertising, unprofessional conduct, and gross
negligence.  That complaint has been dismissed.

Following the court’s Anti-SLAPP decision, Tobinick and the Florida LLC
voluntarily dismissed their libel claims because of the likelihood that they
would fail.  All that remained in the case, therefore, were two counts: Count I 
for violation of the Lanham Act, and Count II for unfair competition.

The plaintiffs claimed that Dr. Novella’s posts were “false advertising” under
the Lanham Act. They argued that the posts constituted “personal advertising or 
promotion” misrepresenting Tobinick’s treatments. To win, the plaintiffs had to 
show that what was said fell within the definition of “commercial speech.”  They
tried to get the judge to buy their argument that, because SBM and SGU have
advertising, memberships, and sell merchandise, the speech contained in those
outlets is commercial speech.

Or, as the judge herself described it, the plaintiffs were claiming that Dr.
Novella, in cahoots with others, had concocted:

   an interrelated scheme to ‘funnel money’ to Defendant Novella personally, and
   that the Articles [that is, the posts] are commercial speech in furtherance 
   of this scheme.

This has always been, in our opinion, an absurd legal argument. If this were
true, then every article appearing in every newspaper that has advertising is
commercial speech, which means the First Amendment would be effectively gutted.

Significantly, the judge specifically rejected this view of the evidence. She
found that

   [b]oth Articles clearly state their intent to raise public awareness about
   issues pertaining to Plaintiffs’ treatments.

Later in the Order, she repeated this point:

   . . . the content of the Articles is directed toward raising public awareness
   of scientific issues, rather than promoting an economic interest.

Our position has always been that Science-Based Medicine represents science
communication (technically journalism), is largely based on professional
opinions and analysis, and the purpose of which is public education and consumer
protection.

The judge had already spelled out, in her earlier decision granting SfSBM’s
motion for summary judgment, established precedent determining exactly what
constitutes commercial speech. Dr. Novella’s blog posts did not meet any of
these criteria. The judge repeated this interpretation of the law when she
denied the plaintiffs’ motion for injunctive relief. In that decision she wrote:

   The Court concludes that Plaintiffs have failed to demonstrate that there is 
   a substantial likelihood that they will be able to show that the speech at
   issue in the two articles is commercial in nature. Accordingly, Plaintiffs
   have failed to demonstrate a substantial likelihood of prevailing on the
   merits.

Despite having twice been denied relief based on the extraordinary theory that
the articles constituted commercial speech, Tobinick continued to make this
argument. In fact, rather than accept the inevitable, he became creative in
trying to expand the case.

In August, he filed a motion for permission to amend the complaint with yet
another theory, that Dr. Novella violated the Florida Deceptive and Unfair Trade
Practices Act by publishing an unfair review of Tobinick’s practice. He
essentially compares SBM to the Better Business Bureau, and, repackaging his
original claims, argues that the review was unfair and not objective. The judge 
denied his motion.

Nevertheless, he tried to amend the complaint yet again, this time with a
bizarre conspiracy theory involving Dr. Novella and two other neurologists.
Tobinick argued that Dr. Novella was the ringleader at the center of a web of
conspiracy against him. He argued that the three  neurologists were against him 
because they “hate innovation,” a transparently absurd claim.  The judge denied 
leave to amend this time as well.

Having ruled against the plaintiffs on the Lanham Act, the judge was able to
quickly dispose of unfair competition. Because the state law unfair competition 
claim, like the Lanham Act claim, was based on a theory of false advertising,
that claim failed as well.

As all the plaintiffs’ claims had been resolved by the court in favor of the
defendants, the judge directed the Clerk of Court to close the case.

The SBM Editorial Board

References:

Order granting the Society for Science Based Medicine summary judgement. 

Order denying Tobinick’s motion for injunctive relief.

Order granting Dr. Novella his motion to strike (Anti-SLAPP).

Order granting Dr. Novella his motion for summary judgement.

Other public documents on the case. 

Politics

The “CAM” Consumer: Misled and Abused

Jann Bellamy on April 5, 2012

Link

There is a disturbing lack of protection for the consumer of “complementary and 
alternative” products and services. I can think of no other area of commerce
where misleading, as well as out and out false, information is so regularly
employed, without consequence, to entice the consumer into forking over his
hard-earned cash. Nor do I know of any other manner of goods or services where
giving consumers patently false information is protected by law.

Consider first the fact that nonsensical gibberish is enshrined in state law in 
the form of “CAM” practice acts, which give practitioners of implausible, if not
wholly discredited, diagnostic methods and treatments carte blanche to ply
their trades. For example, as has been discussed before on SBM, state law
defines chiropractic as the detection and correction of subluxations, which, as 
many chiropractors themselves admit, do not exist. State practice acts define
acupuncture in such pseudoscientific terms as “modulation and restoration of
normal function in and between the body’s energetic and organ systems and
biomechanical, metabolic and circulation functions using stimulation of selected
points.”

As well, naturopathy practice acts allow “mixing and matching treatments
including traditional Chinese medicine, homeopathy, herbalism, Ayurvedic
medicine, applied kinesiology, anthroposophical medicine, reflexology,
craniosacral therapy, Bowen Technique, and pretty much any other form of
unscientific or prescientific medicine that you can imagine.” State practice
acts also permit the indiscriminate use of the term “doctor” and “physician.”
Scope of practice is broadly defined as “primary care.”

To add insult to injury, state law generally gives the Boards governing these
practices exclusive authority to regulate their “professions.” This has resulted
in rules which incorporate even more pseudoscientific nonsense into the scope
of practice. In Florida, for example, a Board of Acupuncture rule allows
aromatherapy, electric moxibustion, color therapy, homeopathy, ion pumping
cords, iridology, kirlian photography, magnet therapy, photonic stimulation and 
sonopuncture.

These Boards usually have exclusive jurisdiction to adjudicate complaints
against practitioners. Thus, the unfortunate consumer who complains to a “CAM”
provider Board that a practitioner failed to disclose the scientific
implausibility and lack of evidence of effectiveness of a particular therapy is 
likely to get a frosty reception. Unfortunately, even the Medical Boards may
turn a deaf ear to consumer complaints about the use of “CAM” due to the squishy
double standard for “CAM” versus “conventional” medicine adopted by the
Federation of State Medical Boards.

And then, there’s the feds

All those problems and we haven’t even scratched the surface of federal law yet.

Although the U.S. Food and Drug Administration is charged with regulating
dietary supplements, a 2009 Government Accountability Office report found

   surveys and experts indicate that consumers are not well-informed about the
   safety and efficacy of dietary supplements and have difficulty interpreting
   labels on these products. Without a clear understanding of the safety,
   efficacy, and labeling of dietary supplements, consumers may be exposed to
   greater health risks associated with the uninformed use of these products.

And pity the poor consumer lulled into complacency by the knowledge that the FDA
has regulatory authority over homeopathic products. As a federal district court
recently concluded:

  1. “Unlike non-homeopathic OTC drugs, homeopathic OTC drugs . . . are not
    evaluated by the FDA at all.”

  2. “The Court is unaware of what standards, if any, exists to ensure that
    homeopathic OTC drugs are safe and effective.”

  3. “[T]he FDA has largely abdicated any role it might have had in creating
    standards for homeopathic OTC drugs, and has instead attempted to delegate
    this authority to the non-governmental . . . .”

  4. “[T]he FDA explicitly states that it makes no guarantee about the safety or
    efficacy of homeopathic OTC drugs . . . .”

Lessons from the financial meltdown

The 2008 financial debacle highlighted the need for enhanced protection for
consumers of financial products and services. This resulted in the passage of
the Dodd-Frank Wall Street Reform and Consumer Protection Act in 2010. The law
created the Consumer Financial Protection Bureau (CFPB), operating under the
auspices of the Federal Reserve and responsible for regulating consumer
financial products. The CFPB will consolidate existing consumer protection
programs now scattered across several agencies, which were widely criticized for
doing a poor job in the past.

The Bureau has the power to make and enforce rules for banks and other financial
services providers which aim to protect consumers from deceptive and abusive
loans and other financial products and services. According to the CFPB website, 
part of this responsibility will be to ensure that “consumers are provided with 
timely and understandable information to make responsible decisions about
transactions involving consumer financial products and services.”

The Bureau also has the authority to conduct examinations of financial services 
providers and collect and tract consumer complaints about them. For example, if 
you have a gripe with your credit card company, you can go on the CFPB website
right now and file a complaint.

Perhaps it is time to grant similar protections for consumers in the “CAM”
marketplace. In spite of the fact that many people would rank their health as
more important than their financial condition, their purchase of financial
services and products now appears to be far more protected from unfair,
deceptive, or abusive practices than their purchase of “CAM” products and
services.

Despite considerable political wrangling over the CFPB’s start up, last fall the
Bureau published a Supervision and Examination Manual on its website detailing 
how the CFPB will oversee consumer financial service providers. This includes
guidance on unfair and deceptive acts and practices.

In some respects these guidelines are similar to those already in place at the
Federal Trade Commission. Yet Congress, in creating an agency specifically
overseeing the consumer financial industry, obviously saw a need not met by
current FTC regulation – as well as other existing regulatory protections – in
the consumer financial markets.

One could come to the same conclusion regarding CAM – that even though some
state and federal regulation is already in place (such as the FDA’s authority to
regulate dietary supplements) it is inadequate to address the specific abuses
of CAM practices and products in the consumer marketplace. In fact, as we have
seen, in some instances these abuses are actually facilitated.

How it works

Let’s take a closer look at how consumer financial regulation might inform
consumer CAM regulation. According to the CFPB’s Manual, an unfair act or
practice is one that

  1. Causes or is likely to cause substantial injury to consumers,

  2. Is not reasonably avoidable by consumers, and

  3. Is not outweighed by countervailing benefits to consumers or to competition.

Significantly, an act or practice causing a small amount of harm to a large
number of people (think of, for example, a purchase of a homeopathic product)
can meet the test for “substantial injury.” Actual injury is not required in all
cases – a significant risk of concrete harm is sometimes sufficient.

According to the CFPB, a representation, omission of information, act or
practice is deceptive when

  1. It misleads or is likely to mislead the consumer,

  2. The consumer’s interpretation of the misrepresentation (etc.) is reasonable
    under the circumstances, and

  3. It is likely to affect the consumer’s choice or conduct (in legal parlance, it
    is “material”).

“Materiality” is presumed in some cases. Express claims about a product or
service are presumed material, as is information about their basic
characteristics, like costs or benefits.

The CFPB can also go after “abusive” practices and products. While the agency
has yet to issue guidance on how it will enforce this authority, the Dodd-Frank 
Act defines an “abusive” act or practice as, among other things, one that takes 
advantage of the consumer’s reasonable reliance on the seller of financial
products or services to act in the consumer’s interest.

Could it work for “CAM” consumers?

If federal law protected consumers of CAM products and services as it now
protects consumers of financial products and services, and created a Consumer
CAM Protection Bureau (“CCPB”), how might consumers benefit? (I don’t know what 
our new law would be called, although we can be fairly certain it won’t be the
Hatch-Burton-Harkin CAM Reform and Consumer Protection Act of 2012.)

For one thing, instead of being spread among numerous federal and state
agencies, we would have a single agency focused solely on looking over the
collective shoulder of CAM product and service providers, a group that sorely
needs some additional supervision.

For another, I imagine mere knowledge that one is being watched might jump start
the Herculean task of shoveling all the crap out of CAM practices and products.
(Of course, whether anything might be left at the end of the clean – up is
subject to speculation. As has been noted on this blog before, if it is
plausible and works, it’s plain old science-based medicine, not “complementary
and alternative” or “integrative” medicine.)

CAM consumers would have access to accurate and reliable information about CAM
products and practices, including the meaning of terms (to the extent they have 
any meaning) used in selling them to the public. Financial consumers can find
out answers to questions such as “What is a ‘daily periodic rate’?” and “What is
the difference between a fixed APR and a variable APR?” Why shouldn’t CAM
consumers be entitled to similar accurate and unbiased information presented in 
an easily understood manner, such as:

Q:  What is a chiropractic subluxation?

A:  The chiropractic subluxation is allegedly a misalignment of the spinal
vertebrae purported to interfere with “nerve flow” between the brain and other
organs, thereby causing disease. However, in reality it doesn’t exist and the
detection and correction of subluxations will not do you any good.

Or:

Q:  Does acupuncture work?

A:  No. It is highly implausible and many studies show that it is no more
effective than placebo.

If this seems somewhat silly, I ask you: why shouldn’t consumers have this
information prior to purchasing CAM products and services? If a consumer needs
to know what a variable APR is before deciding to borrow money, is it any less
important to know whether acupuncture is beneficial before spending money on
acupuncture services?

A prohibition against unfair and deceptive acts or practices, if defined in same
manner as the Dodd-Frank Act, and given its own dedicated oversight and
enforcement bureau, would go a long way toward halting the sale of nonsense. For
example, I think there is little doubt the CAM Bureau would take a dim view of 
a reiki practitioner telling a consumer that reiki will relieve pain (or that
reiki can do anything, for that matter) because, as we know, this would mislead 
the consumer into thinking that reiki is effective, when we in fact know that it
is both highly implausible that it would work and that it does not in fact
work.

If reiki were offered by an M.D. we might well find ourselves spilling over into
the category of “abusive” practices, as, of course, any consumer would
reasonably believe that her M.D. is acting in her best interest.

In fact, over time, I imagine these measures would leave few CAM products or
practices standing. Given access to accurate and unbiased information about CAM,
I’ll wager that not many consumers who reviewed that information would choose
to purchase it. For those who do seek it out, sellers would be prohibited from
misleading folks about what exactly it is they are selling, which, we might
guess, would lead to severely diminished sales.

Conclusion

The financial services industry is far larger than the business of CAM and
creating a whole federal bureau to fight its abuse of consumers is likely
overkill. But the fact remains that the patchwork of state and federal
regulation now in place is inadequate to the task. Perhaps a smaller unit within
a federal agency (the FTC might be a candidate) would be sufficient if it were 
solely dedicated to protection of CAM consumers and given adequate authority by 
Congress to make and enforce rules governing unfair and abusive practices and
handle consumer complaints.

The regulation of nonsense

Jann Bellamy on May 17, 2012

Link

   The most meticulous regulation of nonsense must still result in nonsense.

— Edzard Ernst, M.D., PhD., professor, Complementary Medicine, Peninsula Medical
School, University of Exeter, UK

One necessity of licensing so-called “complementary and alternative,” or “CAM,” 
practitioners is to spell out exactly what is encompassed in the CAM scope of
practice. This is unfortunate for the practitioners because it forces an exposé 
of the nonsensical precepts underlying their claims. For example,

   ‘Acupuncture’ refers to a form of health care, based on a theory of energetic
   physiology that describes and explains the interrelationship of the body
   organs or functions with an associated acupuncture point or combination of
   points located on ‘channels’ or ‘meridians’. . . Acupuncture points are
   stimulated in order to restore the normal function of the aforementioned
   organs or sets of functions.

(Delaware acupuncture practice act.)

   [Chiropractic is] the science of adjusting the cause of the disease by
   realigning the spine, releasing pressure on nerves radiating from the spine
   to all parts of the body, and allowing the nerves to carry their full quota
   of health current (nerve energy) from the brain to all parts of the body.

(North Carolina chiropractic practice act.)

   The practice of naturopathic medicine includes, but is not limited to, the
   following services:. . . ordering, administering, prescribing, or dispensing 
   for preventive and therapeutic purposes: food, extracts of food,
   nutraceuticals, vitamins, minerals, amino acids, enzymes, botanicals and
   their extracts, botanical medicines, herbal remedies, homeopathic medicines, 
   dietary supplements and nonprescription drugs as defined by the federal Food,
   Drug, and Cosmetic Act, glandulars, protomorphogens, lifestyle counseling,
   hypnotherapy, biofeedback, dietary therapy, electrotherapy, galvanic therapy,
   oxygen, therapeutic devices, barrier devices for contraception, and minor
   office procedures, including otaining specimens to assess and treat disease. 
   . .

(Minnesota naturopathic practic act.)

Licensing also brings into sharp focus exactly how broad those claims are.

   ‘Acupuncture’ means a form of primary health care, based on traditional
   Chinese medical concepts and modern oriental medical techniques, that employs
   acupuncture diagnosis and treatment, as well as adjunctive therapies and
   diagnostic techniques, for the promotion, maintenance, and restoration of
   health and the prevention of disease.

(Florida acupuncture practice act, emphasis added.)

   Any chiropractic physician who has complied with the provisions of this
   chapter may examine, analyze, and diagnose the human living body and its
   diseases by the use of any physical, chemical, electrical, or thermal method;
   use the X ray for diagnosing; phlebotomize; and use any other general method
   of examination for diagnosis and analysis taught in any school of
   chiropractic.

(Florida chiropractic practice act, emphasis added.)

In addition to prescribing a scope of practice, licensing imposes basic
education requirements, testing, board oversight, continuing education
requirements, and other measures supposedly designed to protect the public
health and welfare.

Perhaps this is why there is no movement by other CAM therapists, such as reiki 
practitioners, crystal therapists, iridologists, and the like, to seek
licensing. While having one’s own licensed health care practice act conveys a
huge advantage in terms of protecting one from unlicensed practice of medicine
prosecutions, it also means that one must set out one’s gibberish in a form that
state legislators can be persuaded to pass into law. That this is not hard to
do is evidenced by the above examples of naturopath, acupuncturist and
chiropractic licensing. Still, having to take tests to demonstrate one’s command
of the gibberish and having to attend continuing education classes to remain
abreast of advancements in practices that never advance is burdensome. Besides, 
the medical boards don’t seem to be particularly interested in stopping the
spread of CAM practices through prosecution for the unlicensed practice of
medicine, so why bother? In fact, M.D.s themselves are joining in the fun via
“integrative medicine.”

Nevertheless, it is interesting to contemplate what enlarging the pantheon of
licensed CAM health care practices might look like. Just how far might the state
legislatures willing to go in their Legislative Alchemy? After all, practices
such as reiki, crystal therapy and iridology are no more implausible and have no
less a claim to effectiveness than subluxation-based chiropractic, homeopathy
and acupuncture.

May the force be with you

Let’s take reiki for example. Here’s an explanation of reiki (so to speak) from 
The International Center for Reiki Training:

   We are alive because life force is flowing through us. Life force flows
   within the physical body though pathways called chakras, meridians and nadis.
   It also flows around us in a field of energy called the aura. Life force
   nourishes the organs and cells of the body, supporting them in their vital
   functions. When this flow of life force is disrupted, it causes diminished
   function in one or more of the organs and tissues of the physical body.

   The life force . . . becomes disrupted when we accept, either consciously or 
   unconsciously, negative thoughts or feelings about ourselves. These negative 
   thoughts and feelings attach themselves to the energy field and cause a
   disruption in the flow of life force. This diminishes the vital function of
   the organs and cells of the physical body.

   Reiki heals by flowing through the affected parts of the energy field and
   charging them with positive energy. It raises the vibratory level of the
   energy field in and around the physical body where the negative thoughts and 
   feelings are attached. This causes the negative energy to break apart and
   fall away. In so doing, Reiki clears, straightens and heals the energy
   pathways, thus allowing the life force to flow in a healthy and natural way.

(I apologize for the lengthy quotes throughout this post. However, I find it
very difficult to summarize nonsense. Besides, the actual language is so
entertaining.)

As Steve Novella pointed out, reiki is simply another form of vitalism, a
long-discredited, pre-scientific notion that a spiritual energy animates all
living things. As he says, “[t]he notion of vitalism was always an intellectual 
place-holder, responsible for whatever aspects of biology were not currently
understood.” It is the same concept that underlies subluxation-based
chiropractic, where it is known as “Innate Intelligence,”or, more recently
“nerve flow.” In acupuncture, this “life force” is called “qi.” In therapeutic
touch, it is “energy,” as it is sometimes referred to in reiki. In craniosacral 
therapy, this force is the craniosacral rhythm. Like those practices, there is
no good evidence that reiki has any effect beyond placebo, nor is there any
evidence that such a “life force” exists.

The practice of reiki, as does chiropractic, therapeutic touch, acupuncture and 
other CAM methods, depends on the practitioner convincing the patient that he
(or she) can influence this “life force” via some action on his part. In reiki,

   . . . energy flows from the practitioners hands into the client. . . The
   practitioner places her/his hands on or near the client’s body in a series of
   hand positions.

Treatment sessions last between 30 and 90 minutes. According to one website, it 
costs about a dollar a minute, which is a lot to pay for anything and especially
a lot for nothing.

As might be expected from a treatment that purports to affect all organs and
tissues of the body, the advertised benefits of reiki appear to be virtually
limitless. Here are some I found on the internet:

Stress relief, improves well being, minimizes discomfort from acute or chronic
pain conditions, reduces recovery time from injuries, sets new habits, promotes 
emotional healing, reduces side effects of medical treatment including
chemotherapy, post operative pain and depression, improves the rate of healing, 
reduces time in hospital, relaxation, improves sleep, accelerates the body’s
self-healing abilities, reduces blood pressure, breaks addictions, adjusts the
energy flow of the endocrine system, reduces side effects of drugs, postpones
the aging process, aids spiritual growth, increases the vibrational frequency of
the body, accelerates healing from bruises, aids mental/emotional imbalance,
benefits pregnant women and their unborn children, relieves back problems, PMT, 
menstrual problems, sinus problems, head or stomach aches, bee stings, colds,
flu, tension and anxiety, heart disease, cancer, leukemia, asthma and eczema.
And, of course, it cleanses the body of toxins. As an added bonus, it can
benefit both animals and plants. All in all, “reiki always helps and in some
cases people have experienced complete healings . . .”

Oddly, though, the reiki practitioner “will not offer any diagnosis or
prognosis.” Hmmm. If the practitioner doesn’t diagnose or prognose, then how
does he know what the patient is suffering from and how can he tell that there
has been an improvement in the patient’s condition? After all, reiki
practitioners claim that reiki is always beneficial. One puzzles at this
contradiction.

Are there side effects? As it turns out, yes.

   . . . sometimes a person will have what is called a healing crisis. As a
   person’s vibration goes up, toxins that have been stored in the body will be 
   released into the blood stream to be filtered by the liver and kidneys and
   removed from the system. When this happens, sometimes a person can get a
   headache or stomach ache or feel weak. If this happens, it is a good idea to 
   drink more water, eat lighter meals and get more rest. The body is cleansing 
   as part of the healing process so this is a good sign.

Despite its magnificent success rate, reiki is pretty easy to learn. In fact,
even children can be taught reiki.

   A beginning Reiki class is taught on a weekend. The class can be one or two
   days long. I recommend that the minimum time necessary be at least six to
   seven hours. Along with the attunement, it is necessary that the student be
   shown how to give treatments and also to practice giving treatments in class.

For the uninitiated, an “attunement”

   . . . is the process by which a person receives the ability to give Reiki
   treatments. The attunement is administered by the Reiki Master during the
   Reiki class. During the attunement, the Reiki Master will touch the students 
   head, shoulders, and hands and use one or more special breathing techniques. 
   The attunement energies will flow through the Reiki Master and into the
   student. These special energies are guided by the Higher Power and make
   adjustments in the student’s energy pathways and connect the student to the
   source of Reiki. Because the energetic aspect of the attunement is guided by 
   the Higher Power, it adjusts itself to be exactly right for each student.

Licensed Reiki Masters?

Assuming, arguendo, that the claims of reiki practitioners are true, then we can
fairly state that:

  1. Reiki improves, and in some cases fully resolves, a wide, perhaps unlimited,
    range of human and animal (and plant) illnesses and conditions.

  2. Reiki requires training which includes establishing a minimum proficiency in
    giving treatments.

  3. Reiki can have side effects.

  4. Reiki practitioners say that they do not make diagnoses or prognoses. However,
    they necessarily employ some type of diagnosis in the form of measuring
    improvement in the patient’s condition. (Otherwise they could not claim
    effectiveness.)

  5. Reiki is essentially based on the same principles (vitalism) as two other
    licensed health care practitioner types, chiropractors and acupuncturists.

States have the inherent power to regulate the practice of medicine, as well as 
other health care practices, to protect the public’s health, safety and welfare 
(called the “police power”). Based on the characteristics of reiki shared with
other licensed health care providers, I conclude, by analogy, that the state
could constitutionally regulate the practice of reiki by enactment of a reiki
practice act, defining a scope of practice, authorizing oversight by a Board of 
Reiki, and instituting minimum requirements for training and continuing
education requirements, whether the reiki practitioners desired such regulation 
or not.

We could go through the same exercise for any number of CAM practices, such as
craniosacral therapy, Kirlian photography, iridology, crystal therapy, aroma
therapy, angel therapy, Matrix Energetics®, reflexology and polarity therapy, to
name a few. Just imagine – a Board of Polarity Therapy! A licensed and
regulated Iridologist! Crystal Therapy continuing education! A Matrix
Energetics® scope of practice act! Given the fact that all that is necessary to 
create a new CAM practice is to make something up, state legislatures would be
working year-round just to draft and pass practice act legislation accommodating
the seemingly endless varieties of CAM.

If all of this seems silly – and it most certainly is – it raises an important
question: why do the states license any form of CAM practice? Homeopathy is no
more plausible or effective than Matrix Energetics®. Subluxation-based
chiropractic is no more plausible or effective than crystal therapy. Acupuncture
is no more plausible or effective than iridology. If the prospect of licensing 
Matrix Energetics® practitioners, crystal therapists and iridologists is
ridiculous, then why isn’t licensing homeopaths (or naturopaths who practice
homeopathy), subluxation-based chiropractors, and acupuncturists equally
ridiculous? What’s the difference?

In fact, the next time you find yourself in a discussion with an acupuncture
proponent, heartily agree with him (or her) that of course acupuncture should be
a licensed health care profession, available to everyone, as should angel
therapy. When he demurs on the ground that angel therapy is totally absurd, ask 
him to explain exactly how acupuncture is any different.

Dr. Ernst is entirely correct. The regulation of nonsense must still result in
nonsense. Rather than fooling themselves into thinking they are protecting the
public with CAM practitioner licensing, state legislators should concentrate on 
protecting the public from CAM.

The new Surgeon General nominee and CAM: Is there a problem here?

David Gorski on November 20, 2013

Link

Our fearless leader, Steve Novella, has informed me that he is traveling today. 
Unfortunately, I am preparing a talk for later today, and no one else seemed
able to come up with a post; so I decided to adapt a recent post from my
not-so-super-secret other blog and see what a different readership thought of
it. I realize that I’m risking subjecting you all to Gorski overload, but, hey, 
if the world needs more Mark Crislip, why wouldn’t the world need more David
Gorski too? Steve will return next Wednesday, as usual.

I don’t normally give a lot of thought to the Surgeon General because, quite
frankly, in recent years it hasn’t been a position of much authority or
influence. That’s why I didn’t noticed late last week that President Obama had
nominated a new Surgeon General. Normally, my failure to notice isn’t such a big
deal, because there really hasn’t been a Surgeon General who has really been
particularly well-known or had much of an impact since Dr. C. Everett Koop,
although back when President Obama first took office Dr. Sanjay Gupta’s name was
floated as a possibility for the position. Obviously, he didn’t get it. (I’m
guessing that being a neurosurgeon and CNN’s chief medical correspondent
probably pays much better than being Surgeon General.) To be honest, I didn’t
even know that the prior Surgeon General had stepped down, but apparently she
did in July, leaving the position filled by an interim Surgeon General until a
new one could be nominated.

The other day, I learned whom President Obama nominated to be her successor, Dr.
Vivek Murthy, a faculty member at the Harvard Medical School:

   President Obama will nominate Dr. Vivek Murthy of Harvard Medical School and 
   Brigham and Women’s Hospital as surgeon general of the United States, the
   White House announced Thursday night.

   Murthy is a hospitalist at the Brigham and is co-founder and president of
   Doctors for America, a Washington, D.C.-based group of 16,000 physicians and 
   medical students that advocates for access to affordable, high quality health
   care and has been a strong supporter of the Affordable Care Act.

   If he’s confirmed by the Senate, Murthy would replace acting surgeon general 
   Boris Lushniak. The surgeon general serves a four-year term and the post is
   essentially a bully pulpit to speak out on public health issues.

The official White House biography of Dr. Murthy reads:

   Dr. Vivek Hallegere Murthy is the Co-Founder and President of Doctors for
   America, a position he has held since 2009. Dr. Murthy is also a Hospitalist 
   Attending Physician and Instructor in Medicine at Brigham and Women’s
   Hospital at Harvard Medical School, a position he has held since 2006. In
   2011, Dr. Murthy was appointed to serve as a Member of the Advisory Group on 
   Prevention, Health Promotion, and Integrative and Public Health. Dr. Murthy
   has been the Co-Founder and Chairman of the Board of TrialNetworks, formerly 
   known as Epernicus, since 2007. Dr. Murthy co-founded VISIONS Worldwide in
   1995, a non-profit organization focused on HIV/AIDS education in India and
   the United States, where he served as President from 1995 to 2000 and
   Chairman of the Board from 2000 to 2003. Dr. Murthy received a B.A. from
   Harvard University, an M.B.A. from Yale School of Management, and an M.D.
   from Yale School of Medicine.

So far, at least on the surface, there doesn’t appear to be anything
particularly alarming about Dr. Murthy. He’s very accomplished for his age,
which is only 36. The group he leads, Doctors for America, seems to have fairly 
conventional moderate-to-left views and has lobbied for Medicaid expansion, to
protect Medicare, and to support the Affordable Care Act. In general, it
supports expanding access to health care coverage to the entire population. Of
course, no one would expect President Obama to nominate a doctor for Surgeon
General who doesn’t support the ACA, and, since it’s the law of the land now,
one would expect the Surgeon General to support it.

Although opponents of the ACA might not like Dr. Murthy’s staunch advocacy for
the ACA, that’s not a problem for me. If anything, it’s a point in his favor.
What worries me about Dr. Murthy is his connection to so-called “complementary
and alternative medicine” (CAM), otherwise known these days as “integrative
medicine.” My skeptical antennae started twitching when I saw that Dr. Murthy
has been serving on the U.S. Presidential Advisory Council on Prevention, Health
Promotion, and Integrative and Public Health since 2011, along with Dr. Dean
Ornish. (Come to think of it, it’s disturbing that President Obama would have
appointed Ornish to such a committee.) Also on the council is Janet R. Kahn,
PhD, who is described as a having been a “Faculty Preceptor in the Fellowship
Program in Complementary, Alternative, and General Medicine at Harvard Medical
School” since 2000 and having served on the National Advisory Council for
Complementary and Alternative Medicine at the National Institutes of Health
since 2009. You know who also serves on that particular advisory council? Brian 
Berman. There’s also an acupuncturist, Charlotte Kerr, on the U.S. Presidential 
Advisory Council on Prevention, Health Promotion, and Integrative and Public
Health.

OK, OK, none of this proves anything about whether or not Dr. Murthy has far too
much credulity towards quackademic medicine. After all, there are also
perfectly respectable science-based health care practitioners on that council,
although it is truly disquieting to see an acupuncturist there, even more so
than Dean Ornish. Ornish, after all, has managed to make himself seem scientific
to the point where many physicians don’t realize how far down the road of woo
he has traveled. In contrast, there’s no excuse for an acupuncturist to be on a 
President’s health care council—any President. Annoyingly, the advisory council 
has issued reports that cite the problematic section 2706 of the ACA that
mandates nondiscrimination of health plans to urge consistency between state and
federal law. Translation: The council wants the ACA to be interpreted to
guarantee that any quacks that states license (like chiropractors and
naturopaths) count as valid health care providers whose services should be
reimbursed by insurance companies selling policies through the government
exchange. Meanwhile, the 2011 National Prevention Strategy, which Dr. Murthy
contributed to, emphasizes “evidence-based” CAM, an oxymoron if ever there was
one.

More concerning is what Dr. Murthy said in this article, published in Harvard
Magazine in 2003:

   Murthy’s combined expertise in medicine and business (and he still might
   pursue an advanced degree in public health) makes him well qualified to
   follow through with one of his dreams: to develop a system that provides
   proven, affordable, integrated (traditional and alternative) healthcare in a 
   standardized fashion.

   His interest in alternative medicine stems from his own cultural
   background—both his parents emigrated from India. Although he grew up in
   Miami, Murthy’s frequent visits to his parents’ homeland allowed him to
   witness that country’s ancient art of healing, Ayurveda (Sanskrit for “the
   science of life”). “I have tried various alternative medical therapies
   myself,” he reports, “and I have found that many alternative modalities are
   based in principles that make sense, and seem to frequently be effective with
   patients.” Research in recent years has made important strides in
   investigating alternative medicine in the United States, Murthy says, but
   much more needs to be done, and he would like to be a part of that process.

Oh, dear. “Based on principles that make sense?” That’s the sort of thing no
physician whose practice is science-based should ever utter about Ayurveda or
other “alternative medicine.” He also seems to have been prone to the same sorts
of deficits in reasoning that lead all too many people to confuse correlation
with causation or placebo effects for real effects.

In fairness, I realize that this is a ten year old interview, and Dr. Murthy was
very young at the time, but it’s concerning nonetheless, although elsewhere, in
a book entitled The Yale Guide to Careers in Medicine and the Health
Professions, Dr. Murthy was quoted as a fourth year medical student as being
interested in integrative medicine. Has Dr. Murthy followed through with his
youthful interest in “integrative medicine,” or, as I like to call it,
integrating quackery with real medicine? Is he practicing and/or supporting CAM 
or integrative medicine? It’s hard to tell. There’s not much that can be found
about him with regards to this question on the Harvard Medical School or Brigham
Women’s and Children’s Hospital websites. I’ve also been Googling my little
brain and fingers off, and I haven’t been able to find any “smoking gun” that
indicates that Dr. Murthy is still as enamored of quackademic medicine as he was
10 to 15 years ago, although there are niggling little indications. But who
knows? Maybe he’s reformed himself.

In my perfect world, if I were a Senator asking Dr. Murthy questions, I wouldn’t
ask so much about Medicaid, Medicare, the ACA, or other health policy. Well, I 
would, but that wouldn’t be my primary line of questioning. I figure that Dr.
Murthy has political views compatible with those of President Obama, otherwise
President Obama wouldn’t have appointed him. Presidents rarely appoint people
with highly incompatible views to theirs to positions that are very public, like
that of the Surgeon General. What concerns me more is that the Surgeon General 
should be a voice of science-based medicine, even if it means bucking the
prevailing views, existing government policies, the pharmaceutical companies,
whatever. Think of the Surgeon General in 1964 warning that cigarettes cause
cancer, even though cigarettes were popular (not to mention extremely
profitable) and the tobacco companies were doing everything they could to bury
or counter the developing body of evidence linking smoking tobacco to lung
cancer and heart disease. What we don’t need is a Surgeon General who will be a 
voice in favor of the ongoing pollution of science-based medicine with quackery.

If Dr. Murthy is that kind of doctor—and there are far too many of these doctors
around—then to me he should be disqualified from being the Surgeon General.
Perhaps what’s more distressing is that the President’s Advisory Group on
Prevention, Health Promotion, and Integrative and Public Health has Dean Ornish 
and an acupuncturist on it. It’s just another example of how much quackery has
“integrated” itself into legitimate medicine.

Surgeon General nominee Dr. Casey Means and functional medicine: Legitimizing
quackery

Surgeon general nominee Dr. Casey Means is an advocate of “functional medicine.”
She, MAHA, and a new “board certification” will falsely legitimize quackery.

David Gorski on October 20, 2025

Link

Ever since antivax activist turned independent Presidential candidate Robert F. 
Kennedy Jr. suspended his Presidential campaign to bend the knee to Donald Trump
in return for a high-ranking position in his administration should he win,
coining the term “make America healthy again” (MAHA) as a direct riff on Trump’s
“make America great again” (MAGA) slogan, we’ve been faced with the
consequences the possibility, later becoming the reality, of putting a
conspiracy mongering, antivax, alternative medicine crank in charge of all
non-military federal medical, public health, and biomedical research programs.
Now that RFK Jr. is Secretary of Health and Human Services, we have seen the
consequences of letting RFK Jr. “go wild on health,” “go wild on the food,” and 
“go wild on the medicines,” as Trump promised during the campaign, and it’s not 
good, particularly for vaccines, as I’ve written about extensively. However,
what I haven’t written about so much is how the other vibes-based, unscientific 
ideas behind MAHA could end up reshaping medicine. For example, leaving aside
the extreme antivax views of our HHS Secretary—and, make no mistake, he is
antivax to the core and coming for your vaccines—one aspect of MAHA is its
embrace of a form of alternative medicine known as “functional medicine” (FM),
as embodied in one of RFK Jr.’s key allies in MAHA, previously little-known
physician named Dr. Casey Means, who is Donald Trump’s nominee for Surgeon
General.

It’s been a long time since I’ve written about functional medicine, which used
to be a common topic on this blog back in the pre-MAHA ancient past. However,
given that our next Surgeon General is likely to be a functional medicine quack,
I thought that now was as good a time as any to revisit the topic of functional
medicine, in particular because Means is not the only force that is likely to
work to legitimize functional medicine. Before I write about Dr. Casey Means,
what functional medicine is, why it’s quackery, and why MAHA likes it so much,
let me point to an announcement from last month by the Institute of Functional
Medicine (IFM). Here’s part of the press release:

The Institute for Functional Medicine (IFM) today took the next step in the new 
Functional Medicine Certification Program™ by announcing the formation of the
International Board of Functional Medicine Certification (IBFMC)™. Established
by a formal resolution of the IFM Governing Board of Directors (BOD), IBFMC™ is 
the first-ever certifying board for functional medicine and operates
autonomously to oversee and set standards for the Functional Medicine
Certification Program™ (Certification Program).

“Aligned with IFM’s mission to ensure the widespread adoption of functional
medicine, the IFM Governing Board of Directors is proud to establish this
autonomous body to lead the new Certification Program,” said Dr. Gail C.
Christopher, chair of IFM BOD. “IBFMCTM ensures proper oversight on the
assessment of practitioner competencies in functional medicine through their
successful completion of the industry-leading Certification Program for the
field of functional medicine.”

I always laugh when I read something like this. After all, how does one
determine what the core competencies and core knowledge are in a quack
specialty? (Imagine the same thing for homeopathy.) Some of you out there might 
think I’m being unfair and too harsh throwing around the q-word as I’ve been
doing, but, as you will see, while FM does include some science- and
evidence-based bits (as in some of the stuff about nutrition), these morsels of 
non-quackery mostly serve as seasoning to disguise the flavor of all the massive
overtesting, overtreatment, and embrace of quackery like homeopathy and
acupuncture, all in the name of “holistic” medicine. Moreover, as we’ve long
documented here at SBM, one of the favored techniques that quacks use to slather
on a patina of seeming legitimacy onto an edifice of quackery is the formation 
of what Dr. Kimball Atwood dubbed way back in 2008 “pseudo-professional
organizations,” some of which form pseudo-professional boards in order to grant 
practitioners of quackery pseudo-certifications in various quack practices.
(Naturopathy as a “specialty” has been particularly effective using this
technique.) This “board certification” for FM is just the most recent of which
I’m aware, and, truth be told, when I learned about the IFM certification, I was
rather surprised that the IFM had never done something like before.

I note here, as I do whenever I see one of these “wholistic” or
“integrative”-style “board certifications,” that this is not a board
certification granted by one of the boards falling under the American Board of
Medical Specialties, such as the American Board of Internal Medicine or the
American Board of Surgery. It is mainly certifications from boards that fall
under the ABMS that are recognized by hospitals, insurance providers, etc. as
allowing a physician to be considered “board certified” in a specialty.

Let’s start with who Casey Means is and how she embraced functional medicine
before I explain why that is a problem and what her elevation to surgeon general
and the MAHA embrace of FM could mean for medicine.

Casey Means, MD: A conversion story

As is the case for many conventional doctors who “go rogue” and embrace
“wholistic” medicine that is largely not science- or evidence-based, Dr. Means’ 
story sounds a lot like a religious conversion story. I find it useful to go to 
her website and quote it from the horse’s mouth, so to speak. Here is how Dr.
Means describes her journey, in which she quit her otolaryngology residency
during its final year in order to embrace “wholistic” medicine, when she was
just months away from being board-eligible as an otolaryngologist:

After completing four years of surgical residency in Otolaryngology–Head and
Neck surgery, Dr. Means resigned from her residency in late 2018 to focus on
reforming the “sick care” paradigm in American healthcare. Her work centers on
introducing a systems-thinking perspective to clinical medicine, highlighting
the interconnected physiological root causes of many of the most common Western 
chronic diseases. After being awarded a full medical license in Oregon in 2018, 
she opened a private practice in Oregon in early 2019 focusing on holistic
health and functional medicine, called Means Health.

In an aim to scale functional medicine principles and nutritional awareness to a
wider population, she co-founded the health company Levels in late 2019, which 
empowers individuals to monitor and understand their key metabolic biomarkers,
aiming to increase awareness of factors that contribute to the most common and
preventable diseases in the United States. The company’s stated mission is to
“reverse the metabolic disease epidemic,” and since 2022 has undertaken an
Institutional Review Board-approved research study of over 10,000 participants
to characterize glucose patterns in a non-diabetic population to better
understand the transition from healthy glucose levels to overt metabolic
dysfunction.

I can’t help but cringe at some of the language, which should be very familiar
to readers of this blog. As you will see, FM docs love to claim that they are
engaging in “systems-level thinking” (as opposed, obviously, to those of us who 
supposedly engage in that horrible “reductionist” scientific thinking) and
addressing the “interconnected physiological root causes of many of the most
common Western chronic diseases” (as opposed to those of us who supposedly only 
treat the symptoms and not the “root cause” of diseases). It’s a false dichotomy
that I’ve long detested: The alternative medicine claim that one must embrace
woo in order to practice “wholistic” medicine. True, she doesn’t say this
(exactly) in this passage, but the attitude is there. Unlike the unimaginative
and boring doctors trying to apply evidence-based medicine to patients, she is
the bold maverick embracing a much more complex and “systems-level” way of
thinking. In her bio, she brags repeatedly at her scientific accomplishments,
and, I must admit, they are indeed impressive for a young investigator. However,
as is almost always the case with “brave maverick” doctors like Means, pretty
much all of these impressive accomplishments took place before she left
conventional medicine to embrace FM.

In addition, in her book Good Energy, Means recounts the story of her mother’s
death from pancreatic cancer, as described in this New Yorker article:

The second was the death of Gayle Means, in January, 2021, at the age of
seventy-one, from what Casey calls a “preventable metabolic condition,” also
known as pancreatic cancer. Casey depicts her mother as active and watchful of
her health: she got her preventive tests at the Mayo Clinic, saw doctors at
Stanford, ate mindfully, and exercised regularly. But she was also a former
smoker, and, like many seniors, took metformin to manage her blood sugar and a
statin for cholesterol. On the eve of the pandemic, mother and daughter visited 
Sedona, the New Age destination in Arizona, for what Casey describes as “‘Dr.
Casey’s Bootcamp’ of proven actions to improve metabolic health: extended
fasting, cold plunging, exercise, morning sunrise hikes.” Gayle, her daughter
says proudly, “was actually very much on the same page about, sort of, holistic 
health as me.”

About a year later, according to Casey, her mother felt fatigue and stomach pain
while on her daily hike. After getting blood work and a CT scan, she received a
diagnosis of Stage IV pancreatic cancer, via text message. Casey got a FaceTime
call from her mother, she writes, in which “she told me that she was dying,
that she had to leave me, and that she would not meet my future children.” She
had “softball-sized tumors all throughout her belly.” Thirteen days later, Gayle
Means died. In “Good Energy,” Casey rues the fact that her mother “didn’t have 
the resources to make sense of her biomarkers.” Still, her final days, Casey
said in 2022, added up to “a very beautiful, transformational experience”—a
“spectacular two weeks” for the Means family, in which Gayle experienced “pure
joy.”

A physician should know that, alas, there are no reliable “biomarkers” that will
allow pancreatic cancer to be diagnosed early. Sadly, the majority of
pancreatic cancer patients present late, like Casey’s mother Gayle. However, in 
the story you can see the regret, the very real human physician’s belief that if
only she had done something different maybe her mother would still be alive. I 
myself have experienced that same feeling thinking back over the death of my
father this year and the ongoing deterioration of my mother’s health. Again, the
above stories are the sorts of stories we hear frequently from physicians who
convert to alternative medicine and quackery, that “something” led them to see
all that is supposedly wrong with evidence-based medicine, a realization that
led them to convert to something that they saw as better, more “holistic,” more 
able to take care of patients. Here is how she further characterizes her
“conversion” to FM:

   As her residency progressed, however, Means grew increasingly disillusioned
   with the reactive “sick care” model she encountered in her clinical practice.
   This shift in perspective led her to take time away from her surgical
   training to explore the intersection of holistic health and surgery.
   Extensive documents and emails from this period show a prolonged effort to
   merge her surgical work with a holistic and “root cause” approach, securing
   meetings with the Chief Wellness Officer at Cleveland Clinic, faculty from
   National University of Natural Medicine, the Casey Health Institute (which
   has developed an integrated approach to healthcare blending complementary and
   conventional therapies), and many other experts for guidance on
   opportunities to design and foster a more proactive and holistic practice
   within the surgical ecosystem. Ultimately, she felt so disillusioned with the
   practice and incentives of surgical care that she chose to resign and work
   on reform from outside the “system.”

   She summarizes this in her book Good Energy,

   I deeply respect doctors, but I want to be very clear on something: at every 
   hospital in the United States, many doctors are doing the wrong things,
   pushing pills and interventions when an ultra-aggressive stance on diet and
   behavior would do far more for the patient in front of them. Suicide and
   burnout rates are astronomical in health care, with approximately four
   hundred doctors per year killing themselves. (That’s equivalent to about four
   medical school graduating classes just dropping dead every year by their own
   hand.) Doctors have twice the rate of suicide as the general population.
   Based on my own experience as a young surgeon, I think a contributor to this 
   phenomenon is an insidious spiritual crisis about the efficacy of our work
   and a sense of being trapped in a system that is not working but seems too
   big to change or escape.

   Two weeks after resigning from residency, Means participated in a business
   retreat for physicians with Dr. Pamela Wible focused on designing an “Ideal
   Medical Practice,” beginning on October 14th, 2018. In December 2018, she
   obtained her unrestricted medical license with the state of Oregon, and
   incorporated her medical practice, “Means Health,” in January 2019, to
   implement a holistic and functional medicine approach in clinical practice.
   She began training with the Institute for Functional Medicine (IFM),
   completing the foundational “Applying Functional Medicine in Clinical
   Practice” on March 8th, 2019 and completing further coursework with IFM, and 
   started giving talks on Functional Medicine and “food as medicine” in
   Portland, Oregon.

In other words, she had come to a “revelation” that somehow what she was doing
in her surgical residency were the “wrong” things and that, instead of surgery
and medications, she should be pushing an “ultra-aggressive stance on diet and
behavior,” justifying her conversion by citing statistics showing that
physicians and other health care professionals have a higher rate of death by
suicide than average and attributing it to an “insidious spiritual crisis.”
Whenever I see that sort of language coming from a surgeon, I always wonder:
What did you expect going into a surgical specialty? Surgery is only sometimes
preventative. It’s most frequently a treatment for something that’s already gone
wrong, sometimes catastrophically wrong, that can best be fixed by removing or 
rearranging pieces of human anatomy. If a doctor is interested in holism and
prevention, she should go into primary care or internal medicine rather than
into a surgical subspecialty.

Unsurprisingly, reporters who have looked into what actually happened in 2018
that led Dr. Means to abandon her surgical residency so close to finishing have 
found that the story is…more complex…than what Means relates on her website and 
in her interviews. There’s an excellent report in Vanity Fair by Katherine Eban 
entitled “She Was Tearful About It”: The Nuances of Casey Means’s Medical Exit
and Antiestablishment Origins, in which Eban interviewed fellow residents and
her department chair about what had happened to lead Means to abandon her
residency so close to the finish line. Remember, although there is attrition
among surgical residents, it’s very uncommon for a surgical resident to quit in 
her last year, other than for health challenges or switching specialties, and
even then the vast majority of attrition happens in the first couple of years.

There does, however, appear to be a grain of truth in Means’ characterization of
her departure. Remember that part about suicides among physicians? According to
the Vanity Fair article and an LA Times article, the reason that Means departed
was largely due to stress and anxiety.

From the LA Times:

Dr. Paul Flint, a former chair of Otolaryngology/Head and Neck Surgery at Oregon
Health and Science University, said Means resigned from the residency because
of anxiety.

After four years of training, Means came to him and Dr. Mark Wax, the residency 
program director, and said she wasn’t sure it was the right job for her.

“She wasn’t even sure she wanted to be in medicine,” Flint said. “She wanted to 
do something different. She wanted to resign.”

Flint and Wax urged Means to think about it more and offered her three months
paid time off.

“She was under so much stress,” he said. “She did that, came back and decided
she wanted to leave the program. She did not like that level of stress.”

Flint said Means was competent, a good resident. “But there was a lot of anxiety
around this,” he said of the role of the surgeon. “You become much more
responsible the more senior you get.”

Don’t I know it! That’s also one very understanding department chair, to offer
her three month’s paid leave to “think about” her decision, although in her book
Means also says that she took the leave also to deal with neck pain.

From the Vanity Fair report:

Two former residents she served alongside offer a version of her departure from 
the program that matches with Flint’s. They say that contrary to Means’s
oft-told version of events, she exited due to her inability to handle the
admittedly high pressure. They describe her as being deeply unhappy and fearful 
of harming patients, and say she took a leave of absence before departing
altogether. The former residents also tell VF that they do not recognize the
version of events laid out in the book. In their view, Means misrepresented her 
residency training and proclaimed a medical conspiracy against good health that 
simply doesn’t exist. (Both former residents have asked not to be named because 
they fear retaliation from the Trump administration.)

Another resident, who was one year ahead of Means in the program and has asked
not to have his name used due to restrictions imposed by his current employer,
says, “I thought she handled the stress of the program exceedingly well, and
that’s one of the reasons why people wanted her to stay and see it through.” He 
adds, “The way she explained it to me at the time, she felt it wasn’t the best
fit for her, the residency in general and otolaryngology in particular. It
wasn’t as fulfilling or rewarding as she expected.”

I’m about to do something a bit unexpected here and express some empathy with
Means about this. I myself came very close to quitting my general surgery
residency during my third year due to the stress. I even went so far as to
investigate what it would take to transfer, for instance, into the pathology
residency program at the hospital where I was training. With the help of an
understanding chair and residency director, I didn’t resign and managed to
finish my residency with good marks, but I fully understand the stress, maybe
even more so, given that I trained in the era before resident work hour
restrictions. It does take guts to realize so close to the finish line that you 
had made a mistake in your specialty choice and then actually do something about
it. If Means had just said that she had changed gears because she was stressed 
out and unhappy with practicing otolaryngology, I’d be fine with that; I might
even admire her for her choice, other than that she chose FM as her specialty.

Unfortunately, according to the Vanity Fair article:

After she left, the two former residents grew increasingly skeptical of her
public claims. “I did not witness a spiritual awakening,” the former junior
resident says. “It felt more and more like she was preying on the less educated 
and using the MD she had to tout these pseudoscience things.”

The other former resident observes, “She’s a good person and does care for
people and wants what’s best. But it feels disingenuous, demonizing your
training. She didn’t make it through.” The former resident adds, “By trying to
question our entire field and sowing distrust in medicine, it’s hard to ignore
that she may benefit from that.”

Indeed. However, sowing distrust in medicine and “reinventing” one’s “journey”
to sound a lot more altruistic than it actually was are key components of any
“brave maverick” doctor’s journey, as regular readers know. As you will see,
that first junior resident quoted sounds pretty spot-on. For one thing, Means’
actual functional medicine practice didn’t last very long. It wasn’t long at all
before she pivoted to sales of products to treat “metabolic health” and raising
venture capital to do so. Since then, she has bragged about appearing on Joe
Rogan’s and Tucker Carlson’s podcasts to promote her viewpoint that the chronic 
disease epidemic is “metabolic” and that diet and lifestyle are the answer. Part
of that evangelism (and business) involves her forming a company that markets, 
among other questionable products, continuous glucose monitoring devices to
everyone, not just people with diabetes or pre-diabetes, as a near-panacea for
monitoring diet. (More on that later.)

Finally, like a lot of other “brave mavericks,” Means’ reaction to criticism, as
included in her bio on her website, is very much of the “poor, poor persecuted 
me” variety, just like “brave mavericks,” COVID contrarians, and any others who 
portray valid science-based criticism as an attempt to “silence” or “cancel”
them:

Responses to this widespread backlash from legacy media included articles
criticizing mainstream media for their biased framing of her work, including
“Rise of the “Woo-Woo” Woman: The Witch Hunt for Dr. Casey Means” by Lauren Lee,
which stated that “the backlash against Trump’s pick for Surgeon General isn’t 
about science — it’s about a country terrified to confront its own spiritual
collapse.”

Means is considered controversial because her work challenges the economic and
cultural foundations of U.S. healthcare, agriculture, and food systems. She
criticizes “sick care” medicine for profiting from disease management, calls for
reform of the Farm Bill, pharmaceutical incentives, food culture, and
industrial agriculture, and integrates spirituality, ecology, and patient
empowerment into her philosophy—departures from conventional frameworks that
have led some outlets to label her “unscientific.” Legacy media critics often
dismiss her credibility because her message exposes institutional failures and
calls for disruption, and her career trajectory has included periods without
direct one-to-one patient care while pursuing work in preventative health that
has reached tens of millions. Some critics cite her work as an entrepreneur and 
health-technology co-founder as incompatible with public health leadership,
overlooking Levels’ large-scale research collaborations with academic
institutions and the complex management and operational skills required to build
a high-growth company. Others argue she oversimplifies chronic disease and
places too much responsibility on individuals, failing to recognize that her
approach explicitly advocates for both bottom-up empowerment—equipping
individuals with the knowledge to understand their own bodies—and top-down
systemic reform that makes healthy choices affordable, accessible, and the
cultural default. Finally, her stances on medications and emerging therapies
such as vaccines, oral contraceptives, and psychedelic therapies have drawn
intense scrutiny, though her consistent position on each of these therapies has 
strongly emphasized informed consent, medical freedom, and ending corporate
liability shields and conflicts of interests that often distort research
findings and prioritize profit over patient well-being.

You get the idea. Like so many quacks, she portrays criticism of her as not
being about the science but being because she, brave maverick that she is,
“challenges the economic and cultural foundations” of medicine, “criticizes
“sick care,” and “integrates spirituality, ecology, and patient empowerment into
her philosophy.” I’m also amused by how she is clearly stung by criticisms of
MAHA, which are quite justified, that it undermines public health and ignores
the social determinants of health in favor of a model in which health is
entirely a matter of one’s personal choices, where good health is a consequence 
of “virtue”; i.e., eating the “right” diet, engaging in the “correct” behaviors,
and the like. Then, of course, she’s not anti-medicine or antivaccine; she’s
just for ending “corporate conflicts of interest” and for “informed consent” and
“medical freedom.” In fairness, I’m not yet sure if she’s antivaccine, if only 
because of some of the highly negative reaction of some prominent antivaxxers to
her nomination, although a recent Washington Post article by Lauren Weber and
Rachel Ruben notes that she has started questioning “the cumulation of the
childhood vaccine schedule and the hepatitis B vaccine” and has asked on Joe
Rogan’s podcast, ““I bet that one vaccine probably isn’t causing autism, but
what about the 20 that they are getting before 18 months?”

Yes, she’ll come the rest of the way over to RFK Jr.’s antivax views soon
enough.

It occurs to me right here that advocating continuous glucose monitoring devices
for almost everyone as a means of improving health is so very, very functional 
medicine. Indeed, the entire program offered by her company Levels, is very much
the epitome of functional medicine quackery. (Let’s just say that the highest
“Level” program, costing $1,499 a year, involves twice a year measurements of
“100+ health markers,” two months of continuous glucose monitoring, and a lot
more.

On to functional medicine.

Functional medicine: The worst of conventional and alternative medicine

Over the years, I’ve frequently referred to the kludge that is known as
“functional medicine” as the “ultimate misnomer” in medicine and “worst of both 
worlds.” What I mean by that is that FM combines the worst elements of
conventional medicine, overtesting and overtreatment involving reams of
questionable lab tests and imaging studies (many not reimbursed by health
insurance), with the worst elements of alternative medicine, specifically
embracing quackery like naturopathy and acupuncture and “integrating” them with 
medicine. Indeed, I’ve often riffed a major punchline in a famous Mitchell &
Webb comedy sketch about homeopathy and referred to FM as “reams of useless
tests in one hand, a huge invoice in the other.” Even if you don’t know anything
about FM, you can get the feeling that overtesting is a key component of it
just from realizing that Means’ plan offers to look at 100+ biomarkers drawn
twice a year. Unsurprisingly (to anyone who knows anything about FM) this sounds
very similar to a panel of 100+ tests offered by one of the longtime gurus of
FM, Dr. Mark Hyman, who himself was (prepandemic, at least) a frequent topic of 
this blog. Unsurprisingly, Dr. Hyman is himself tight with RFK Jr., a longtime
buddy, and promoting FM as part of MAHA.

But what is functional medicine itself? It is a “specialty” that was
“pioneered”—actually more or less made up of whole cloth—by Dr. Jeffrey Bland,
who co-founded IFM, and then championed by people like Dr. Mark Hyman, who is
quoted as characterizing FM thusly:

Dr Hyman, a medical doctor, says FM is “a rigorous system for assessing chronic 
illness using new advances in systems biology and systems thinking”.

“Functional Medicine is not about a test or a supplement or a particular
protocol,” he adds. “It’s really a new paradigm of disease and how it arises and
how to restore health. Within it there are many approaches that are effective, 
it’s not exclusive, it doesn’t exclude traditional medications, it includes all 
modalities depending on what’s right for that patient.”

We’ve asked (and tried to answer) the question of what FM is many times on this 
blog going way, way back to Wally Sampson’s posts explaining why FM is quackery.
(Even 17 years later, I like his characterization of FM as an “indecipherable
babble and descriptive word salad.“) Basically, FM invokes “systems” thinking in
order to make it seem as though it is more “holistic” than conventional
medicine. Oddly enough, however, when Dr. Hyman used to discuss the systems
biology of autism, he made no sense and mangled the science; ditto for cancer.

Is that too harsh? I don’t think so. I’ll explain why by first taking a look at 
the “functional medicine model.” Hopefully longtime readers will forgive me if
this is a bit repetitive of what I’ve written before, but I do feel the need
every so often to reiterate our objections to functional medicine without
forcing you to click on multiple links. In other words, every few years I like
to lay out why FM is quackery in another post. Looking over the IFM website, I
can’t help but note that a lot of what used to be public information is now
either restricted content on members-only pages or otherwise unfindable. A lot
of it seems to have been incorporated into a series of courses, some free, most 
paid. So I will use Archive.org when needed, for example, to refer to this page 
What Is Functional Medicine? First, here are FM’s main principles:

Functional medicine is personalized medicine that deals with primary prevention 
and underlying causes instead of symptoms for serious chronic disease. It is a
science-based field of health care that is grounded in the following principles:

  1. Biochemical individuality describes the importance of individual variations in
    metabolic function that derive from genetic and environmental differences
    among individuals.

  2. Patient-centered medicine emphasizes “patient care” rather than “disease
    care,” following Sir William Osler’s admonition that “It is more important
    to know what patient has the disease than to know what disease the patient
    has.”

  3. Dynamic balance of internal and external factors.

  4. Web-like interconnections of physiological factors – an abundance of research 
    now supports the view that the human body functions as an orchestrated
    network of interconnected systems, rather than individual systems
    functioning autonomously and without effect on each other. For example, we
    now know that immunological dysfunctions can promote cardiovascular disease,
    that dietary imbalances can cause hormonal disturbances, and that
    environmental exposures can precipitate neurologic syndromes such as
    Parkinson’s disease.

  5. Health as a positive vitality – not merely the absence of disease.

  6. Promotion of organ reserve as the means to enhance health span.

In pretty much every post about functional medicine that I’ve ever written, I
feel compelled to remind our readers that the very first principle is, in
essence, functional medicine’s “get out of jail free” card for basically
anything its practitioners want to do. FM docs can always find reasons, whether 
science-based or not, to justify any form of treatment, be it science-based or
quackery, simply by invoking the “biochemical individuality” of the human being 
they are treating. I feel compelledto remind my readers yet again of my favorite
retort to this claim: Yes, human beings are individuals, and each human being
is unique. However, we’re not so unique that our bodies don’t all work pretty
similarly. In other words, in terms of biology, physiology, and yes, systems
biology, we human beings are far more alike than we are different. If that
weren’t the case, modern medicine, developed before we had the tools to probe
our genetic, metabolic, and biochemical individuality, wouldn’t work as well as 
it does.

FM fetishizes “biochemical individuality,” not so much because humans are so
incredibly different that each one absolutely has to employ a totally different 
treatment for a given disease or condition in any given individual. We’re not.
Nor am I arguing that the insights scientists have derived from genomics,
metabolomics, and proteomics, which have revealed different system-level
biochemical and metabolic pathways in physiology, don’t matter. They do. We’re
just not as radically “individuals” on a biochemical basis as FM docs try to
argue. In essence, FM fetishizes biochemical “individuality” because emphasizing
such “individuality” distinguishes functional medicine as a brand distinct from
conventional science- and evidence-based medicine and, I suspect, because it
makes its practitioners feel good, like “total” doctors who are never at a loss 
for an explanation for a patient’s symptoms or clinical condition and can always
think of more tests to figure out a problem. It also patients feel special and 
that their every bit of “individuality” is being catered to. As for the last bit
about FM being a “science-using” profession, FM “uses” science more as a means 
of justifying whatever its practitioners do rather than guiding them to
scientifically-proven treatments.

Also, functional medicine is all about the “imbalances”:

Functional medicine is anchored by an examination of the core clinical
imbalances that underlie various disease conditions. Those imbalances arise as
environmental inputs such as diet, nutrients (including air and water),
exercise, and trauma are processed by one’s body, mind, and spirit through a
unique set of genetic predispositions, attitudes, and beliefs. The fundamental
physiological processes include communication, both outside and inside the cell;
bioenergetics, or the transformation of food into energy; replication, repair, 
and maintenance of structural integrity, from the cellular to the whole body
level; elimination of waste; protection and defense; and transport and
circulation. The core clinical imbalancesthat arise from malfunctions within
this complex system include:

  1. Hormonal and neurotransmitter imbalances

  2. Oxidation-reduction imbalances and mitochondropathy

  3. Detoxification and biotransformational imbalances

  4. Immune imbalances

  5. Inflammatory imbalances

  6. Digestive, absorptive, and microbiological imbalances

  7. Structural imbalances from cellular membrane function to the musculoskeletal
    system

Imbalances such as these are the precursors to the signs and symptoms by which
we detect and label (diagnose) organ system disease. Improving balance – in the 
patient’s environmental inputs and in the body’s fundamental physiological
processes – is the precursor to restoring health and it involves much more than 
treating the symptoms. Functional medicine is dedicated to improving the
management of complex, chronic disease by intervening at multiple levels to
address these core clinical imbalances and to restore each patient’s
functionality and health. Functional medicine is not a unique and separate body 
of knowledge. It is grounded in scientific principles and information widely
available in medicine today, combining research from various disciplines into
highly detailed yet clinically relevant models of disease pathogenesis and
effective clinical management.

Functional medicine emphasizes a definable and teachable process of integrating 
multiple knowledge bases within a pragmatic intellectual matrix that focuses on 
functionality at many levels, rather than a single treatment for a single
diagnosis. Functional medicine uses the patient’s story as a key tool for
integrating diagnosis, signs and symptoms, and evidence of clinical imbalances
into a comprehensive approach to improve both the patient’s environmental inputs
and his or her physiological function. It is a clinician’s discipline, and it
directly addresses the need to transform the practice of primary care.

No. It is not a clinician’s discipline, and it does not address the “need to
transform the practice of primary care.” Also, does the focus on “imbalances”
remind you of anything? How about “imbalances” in the four humors? Or
“imbalances” in the Five Elements in traditional Chinese medicine. Basically,
functional medicine also fetishizes “balance” in a way that sounds very much
like both ancient Asian and European medicine. Indeed, if you read much about FM
from its advocates, you’ll soon find images like this one:

Functional Medicine practitioners like to make patients think that thisdiagram 
actually means something.

Or this one:

Can you see why I sometimes compare FM to the four humors in humoral medicine or
the Five Elements in traditional Chinese medicine?

In fairness, here I generally mention that there are some things that functional
medicine (sort of) gets right, although these things tend to be no different
than the sorts of things every primary care doctor should be getting right
anyway, such as emphasizing healthy lifestyles, good nutrition, enough exercise,
adequate sleep, cessation of habits known to be deleterious to health (e.g.,
smoking and being sedentary). Functional medicine also claims to emphasize
prevention, which is a good thing as far as it goes, but again something that
good primary care doctors do anyway. Moreover, the functional version of
“prevention” isn’t always in line with the SBM version of prevention. Where
functional medicine doctors go so very wrong is in what Grant Ritchey once
described as a major unstated premise. That premise is that functional really
does address the root causes of disease better than conventional medicine. (It
does not.) Worse, FM also encompasses a lot of quackery, such as acupuncture,
chiropractic adjustments, naturopathy, and especially “detoxification” programs.
FM medicine also includes a slew of fake diagnoses, like adrenal fatigue,
chronic Lyme disease, and “heavy metal toxicity.”

Basically, FM is a triumph of marketing over science, which is why it seems so
appealing on the surface. Means, like Hyman before her and Bland before him,
portrays FM as a new paradigm in medicine, tossing around catchphrases and
buzzwords like “systems-level,” “biochemical individuality,” the body’s
“operating system,” “empowerment,” and the like, all while demonizing
conventional medicine. Unfortunately, the marketing has paid off, with Hyman
having founded a functional medicine institute at The Cleveland Clinic, and FM
finding its way into “integrative medicine” programs at academic medical
centers.

Casey Means and functional medicine

Now that you know a bit about FM, I hope you can see why continuous glucose
monitoring for even non-diabetics is the ultimate in the FM paradigm. It
provides reams and reams of measurements of blood glucose that might or might
not mean anything or be actionable to improve health. Basically, Means’ Level
program is FM on steroids. It includes a panel of over 100 biomarkers that
includes standard labs (e.g., electrolytes and complete blood counts) plus a
raft of tests that are normally only ordered when a condition is suspected. Then
it adds the continuous glucose monitoring to measure basal glucose, glucose
variability, and post-meal glucose dynamics. This is all fed into an artificial 
intelligence program that supposedly provides actionable “advanced AI insights” 
by way of a proprietary smartphone app.

As you might imagine, there is evidence that continuous glucose monitoring (CGM)
can be beneficial in patients with type 1 and type 2 diabetes, as well as in
patients with prediabetes. When it comes to the use of this technology (which is
not cheap) in nondiabetics, as you might imagine, the evidence is a lot more
mixed, confusing, and far from compelling, despite Means’s selling it thusly:

Over the past few years, however, interest has grown in the use of CGM among
people without diabetes, driven by a desire to avoid prediabetes and Type 2
diabetes (conditions of high blood sugar), as well as to gain insights about how
diet, sleep, and activity influence blood sugar levels.

For people without diabetes, a CGM offers real-time feedback on how foods and
other lifestyle factors affect your glucose levels. This information can help
you aim for more stable blood sugar to boost energy, improve focus, aid weight
loss, prevent and manage chronic disease, and even foster longevity. Here, we
explain what a CGM is, how it works, why people without diabetes might want one,
and how you can get one.

“Even foster longevity”? Sounds awesome, right? But is there any good evidence
for these claims for the use of CGM in healthy nondiabetics? The answer, in
brief, is: Not really, with the possible exception of people at high risk for
diabetes and prediabetes. The American Diabetic Association, for instance,
explicitly states that there is insufficient evidence to support the use of CGM 
for screening or diagnosis of prediabetes or diabetes, and that FPG, HbA1c, and 
OGTT remain the standard of care for these purposes. Even in patients with
prediabetes and metabolic syndrome, evidence is mixed, as this recent systematic
review of personalized nutrition strategies points out. There is also some
scattered evidence that CGM can improve cardiovascular outcomes in nondiabetics 
by guiding lifestyle and dietary interventions, but, again, as the ADA points
out in its recommendations, CGM is a lot more expensive than the standard
screening blood tests. For a discussion of CGM targeted at the lay audience, I
recommend this article in NPR, which notes some of the promise of CGM while also
cautioning:

Many people find the data confusing and unhelpful.

“Many people come to me and say, ‘I have been using the device for three or even
12 months, and I have all this data, but I don’t know what it means. I don’t
know how to lower my blood sugar or improve it,'” Kennedy says.

People really need to be educated about what the data means, Popp agrees. But
that education will go only so far because at this point, some of the data is
still mysterious to scientists and doctors.

If you’re staying within a normal range, say about 70 mg/dL to 140 mg/dL,
scientists still don’t understand what the peaks and troughs mean.

“There’s no real standard guidelines about what’s a good peak or a bad peak in
nondiabetics,” Popp says.

Emphasis mine.

Perhaps I should write a more detailed post about CGM in the future, as this
post is already long and CGM is not the main topic, but rather an indication of 
Means’ proclivities for FM and FM-adjacent overtesting. It is these proclivities
that will, if she is confirmed—which is not entirely certain at this point,
given that Sen. Bill Cassidy, who so woefully failed as a physician and a
legislator by voting twice in favor of RFK Jr., once to send his nomination out 
of committee and to the full Senate and then voting to confirm him, seems
leery—give her the strongest voice yet to promote FM quackery as the answer to
all of America’s problems in public health, chronic disease, and diet, while
supporting the faux legitimization of FM as a specialty by the IFM’s
pseudo-board certification.

And so the process of “integrating” quackery into medicine that began nearly 35 
years ago will continue apace, only turbocharged by President Trump, MAHA, RFK
Jr., and, yes, Casey Means. Her conversion is, as I have described above, every 
bit a religious one, and, like many converts, particularly “medical apostates,” 
Means appears to revel in being seen as a “heretic.” Again, note her frequent
characterization of standard evidence-based medicine as more of another
religious sect than anything else. This is incredibly common language used in
these spaces by advocates of FM, naturopathy, homeopathy, acupuncture, and lots 
of other forms of alternative medicine, as is the citation of a “spiritual
crisis” as a reason for abandoning evidence- and science-based medicine. They
don’t call it that, of course. Means, as does MAHA in general, seems to think
that she’s following “gold standard science.” Means’ medical worldview is also
largely based on fear, as so aptly described by Jessica Winter in the same New
Yorker article that described Means’ reaction to her mother’s death:

The health-care system, she has claimed, is rife with “fear-based thinking,” and
doctors “weaponize fear of death” in order to force harmful drugs and
procedures on patients. A flawless commitment to diet, exercise, and sleep
hygiene means nothing, she writes in “Good Energy,” if stress and anxiety are
present, because a “cell living in a body experiencing chronic fear is a cell
that cannot fully thrive.”

And yet, for long stretches of “Good Energy,” the prescription appears to be
fear. Fear of Smartfood popcorn and Ben & Jerry’s ice cream. Fear of progestin
pills and dryer sheets and unfiltered shower water. Fear of your glucose levels,
or of not knowing what your glucose levels are at any given moment. Fear of
your mother’s sub-optimized mitochondria, which she passed down to you. Fear of 
the takeout dinners and late nights that Gayle Means enjoyed as a
twentysomething living in the West Village half a century ago. (Casey cites
these youthful habits as possible causes of her mother’s “metabolic
abnormalities.”) The Good Energy message, in the main, is that if you’re afraid 
of everything you have nothing to fear. You cannot eat your way out of death,
but you should follow the Calvinist urge to try.

Any religious conversion has to include a devil that the religion will protect
you against. Unfortunately, we’re probably about to find out how much she can
proselytize as Surgeon General, as well as the extreme limitations in how much
FM can protect one against the demons that drive Dr. Means’ fears.



EcoHealth Alliance Fights Back

The organization scapegoated by the lab leak-promoting GOP-led House Covid
subcommittee publishes its defense

Allison Neitzel on October 31, 2024

Link


As I have recently discussed, the evidence-lacking COVID-19 lab leak origin
theory has been part of a right-wing partisan effort pushed by the GOP-led House
Select Subcommittee on the Coronavirus Pandemic (HSSCP), the Heritage
Foundation, and established pandemic political bad actors. Recommendations on
lab leak talking points were featured in the April 2020 “Corona Big Book”
published for Republicans by the strategic communications firm O’Donnell &
Associates. Around this time, Trump began pushing the theory and has repeated it
on the campaign trail as recently as a few weeks ago.

This attention-grabbing narrative has stoked mistrust in science and distracted 
from the Trump administration’s horrendous mismanagement of the pandemic
outbreak. EcoHealth Alliance, an organization that conducts federally funded
virology research which has included work at the Wuhan Institute of Virology,
has been made the scapegoat and erroneously accused of being responsible for the
deadly pandemic – amid MAGA’s all-out war on science.

The quest for a villain

In May, EcoHealth president Peter Daszak was dragged before the GOP-led HSSCP
(full transcript here) and received a concerning lack of support from Democrat
subcommittee members, despite saying in his opening statement, “Our
organization, staff, and even my own family were often targeted with false
allegations, death threats, break-ins, media harassment, and other damaging
acts.” Daszak has frighteningly found himself, his wife, and children on a “kill
list” on 4chan.

The HSSCP did not have evidence to substantiate their lab leak claims – and they
certainly did not have proof to show a coordinated cover up of a lab leak
including the likes of Dr. Anthony Fauci, who Democratic subcommittee members
were quicker to defend.

While the lab leak narrative dates back to the early days of the pandemic under 
the Trump administration, those who have pushed it have failed in the last 4+
years to provide proof needed to make such extreme accusations. Publications in 
favor of the lab leak have relied on a great deal of speculation and
cherry-picking – yet this has been sufficient for the GOP and complicit media to
run with in their quest for a villain figure.

How low can they go?

The sole point the GOP-led subcommittee had against EcoHealth involved a
progress report that was filed late, which EcoHealth asserted was due not to
negligence on the part of the organization but an issue with the National
Institutes of Health’s (NIH) website. Regardless, barring a scientist from NIH
funding for filing a late report may be unprecedented. Subjecting him to a
congressional grilling for doing so seems bizarre in the extreme, especially
given EcoHealth’s decades-long track record at the forefront of important
ecological research.

Following the hearing, EcoHealth was recommended for debarment for future
federal funding by the subcommittee. Shortly after, Health and Human Services
(NIH’s parent organization) announced movement to debar EcoHealth, citing the
work of the HSSCP. HSSCP chairman Rep. Brad Wenstrup (R-OH) made public comments
about debarring Daszak personally – a display of how low the subcommittee was
willing to stoop in their scapegoating – and the HHS obliged, filing a personal 
suspension and proposed a debarment notice to Daszak.

This drew strong criticism from members of the scientific community, including
vaccine expert and disinformation fighter Dr. Peter Hotez, who has also found
himself on the receiving end of harassment from the HSSCP.

EcoHealth responds to HSSCP accusations

At the May hearing, Daszak asserted the accusations made against both EcoHealth 
and him personally could and would be disproven. After months of work with
lawyers – a process that was likely quite costly – EcoHealth has now published a
146-page response on its website, fighting back at the congressional and public
smearing.

For years, EcoHealth Alliance (EHA) has received intense scrutiny from the
federal government, culminating in a Congressional hearing on May 1, followed by
a Suspension and Debarment notice issued by the Department of Health and Human 
Services. (1/3)

— EcoHealth Alliance (@EcoHealthNYC) September 24, 2024

This comes on the heels of the publication of a major paper in Cell on the
genetic tracing of wildlife at the Wuhan wet market where the COVID-19 pandemic 
is believed to have emerged. While the paper did not reveal the exact mechanism 
of spillover, it showed the presence of animals and virus in the section of the 
wet market where most of the positive samples were collected.

One of the paper’s authors, virologist Dr. Angela Rasmussen explained the
significance of their paper:

This is one more piece on top of a mountain of evidence supporting a zoonotic
origin. We have the pandemic beginning at the same time as the virus began
circulating at the market, we have the earliest known cases expanding outward
from the market and not a lab, we have the samples within the market testing
positive in the same place where live animals were sold, and now we have
evidence that susceptible animals were actually there. These data can’t be
explained in any kind of realistic laboratory or research-related scenario.

Dogs with a bone

Unfortunately, it is unlikely that the GOP and their allies will drop the
narrative anytime soon. After all, the HSSCP has been propping up the authors of
the anti-public health, pro-economy Great Barrington Declaration, which was
never a viable strategy, and proponents of the failed COVID-19 early treatment
drugs pushed by Trump and his allies.

Wrong. The entire body of evidence indicates that COVID-19 did not originate
at a lab in China. It originated in nature & emerged into humans via the live
animal trade at the Huanan Seafood Market.“Deficiencies in @NIH’s oversight”
refers to a progress report submitted late. https://t.co/xufr6WyJCn

— Dr. Angela Rasmussen (@angie_rasmussen) October 25, 2024

Additionally, a recent and concerning Stanford conference hosting COVID-19
minimizing contrarians – some of whom have been majority expert witnesses at the
HSSCP – featured a panel on the lab leak with individuals involved with the
problematic organization Biosafety Now. The panel was moderated by a senior
editor from the Epoch Times, a “global conservative multimedia company
championing former President Donald Trump and conspiracy theories.” The Epoch
Times has published numerous pieces targeting Daszak and EcoHealth Alliance.

As Rasmussen said,

In my opinion, my professional field owes EcoHealth our gratitude for their
contributions to our scientific field. And from the people outside our field who
have persecuted them relentlessly for political reasons, they are also owed an 
apology.

Death Returns From Holiday

This picture invariably brings tears to my eyes. It could be the logo, literally
and metaphorically, for current health care policy.

Mark Crislip on March 17, 2026

Link


To predict the future, look at the past.

One of my wife’s favorite observations.

I spent most of my career in acute care hospitals, where people often die with
and of infectious diseases. So, sad to say, I saw a lot of death. I think I
remember them all, as death does make an impression on you. I’m not a fan.

The first corpse I ever saw was our cadaver for dissection in gross anatomy.
Between the smell of preservatives and what those preservatives did to tissues, 
the cadavers didn’t look like a dead person, more a statue made of pungent beef 
jerky. Still, I was oddly moved by the discovery that her last meal had included
French cut green beans.

The first acute death was during my first rotation in the hospital. Late at
night I went to use the restroom. The door opened about a foot and stopped for
no reason. So I gave it a shove and found a twenty something bearded man on the 
floor, dead from an overdose. He was unsuccessfully resuscitated, also my first.
Then we had to get the body up on a gurney. I took the wrists and my resident
the legs, and on three heaved the body up. As the arms came together under the
weight of the body, the air remaining in the lungs forced out and the body gave 
a huge groan. I actually screamed and let go. Fortunately, the momentum carried 
the body onto the gurney. For the rest of my career, I opened the bathroom doors
in the hospital cautiously. I think everyone in health care has mild PTSD from 
training and education.

I remember the first time I had to declare a person dead, a young black woman
with metastatic breast cancer. 3 a.m. on a freezing Minnesota winter. I remember
the cold and the frost on the windows. A year earlier, I had sat in with the
(dirtball) oncologist who had repeatedly used the word cure. Pisses me off to
this day.


The first autopsy on one of my patients. Unexpected undiagnosed melanoma around 
the heart. Unfortunately, not the last patient whose diagnosis would remain
unknown until autopsy. I retain the memory of the smell of the open body of the 
recently dead. There is no smell quite like it.

The young female with cardiomyopathy with a cardiac arrest who, after a
45-minute code, was declared dead. I broke the news to the family, and left to
write a note. A nurse came running up saying she has a pulse of about 10. What
do we do? We repeated the resuscitation and she survived another 24 hours.
Talking with the family was, let me say, a unique experience.

But that was residency. I went on to an infectious disease career, and after
that virtually all the deaths were due to, or complicated by, infectious
diseases. Not often. Most of my patients were a cure. But not always, and I
think I remember them all.

When the current administration’s policies are said to increase deaths, I know
exactly what that means. I have seen the deaths from infections and they are not
pretty.

Take the USAID, which

From 2001 to 2021, USAID programs were estimated to save between 4.1 and 4.7
million lives per year, including between 1.2 and 1.7 million children under
five.

Now funding has been gutted and as a direct people have and will die:

A study published in June 2025 estimated that funding cuts and the abolition of 
the agency could result in at least 14 million preventable deaths by 2030, 4.5
million of which could be among children under 5 years old. Another estimate (by
epidemiologist and health economist Brooke Nichols) is that, over a period of
one year from when they began, the cuts will result in the deaths of as many as 
262,915 adults and 518,428 children.

Big numbers. How to wrap your head around 518,000 dead children (the population 
of Kansas City), much less 4.5 million (the population of Kentucky)? It is
impossible. But I have witnessed many a death from infection, so while I may not
be able to comprehend all of Kansas City dying, I certainly understand how each
individual will die. And I can multiply.

People have and will die of AIDS, tuberculosis, malaria, infectious diarrhea,
starvation and more.

No surprise, I have never seen a human die of starvation, a dreadful way to die.
And malaria is uncommon in the Pacific NW, although I have had a few patients
get very close to dying from malaria. The shaking chills, drenching sweats and
prostration for a week or more is miserable.

Tb? Unfortunately, tuberculosis is not the good death that we all hope full. To 
not see the bullet coming, to die in our sleep like my dad, not screaming in
terror like the passengers in his car. Yep. Went there.

The old term from Tb was consumption, as patients wasted away from the
infection. There is the misery of tubercular meningitis. The worse TB cause of
death is a ruptured Rasmussen’s anyerism, where a pseudoanyerim in a tubercular 
lung cavity ruptures, filling the lungs with blood, drowning the patient
relatively slowly. I saw two deaths from that complication. One patient refused 
treatment, and I remember his body in the ICU, leaning forward, clutching his
blood drenched pillow.

My career coincided with the onset of the AIDS epidemic. Early in the epidemic
we could little to slow the progression of the disease. Young men have good
cardiovascular systems, so most of the infections that eventually killed them
were slow and painful, often taking weeks and months of unremitting suffering
before death from a variety of infections.

The first AIDS death, after months of diarrhea and fevers, who on autopsy had
more MAC than human cells. Those who slowly suffocated from refractory PCP.
Months of migraine level headaches from Cryptococcal meningitis. Blind from CMV.
Wasting away from uncontrollable diarrhea. And on and on. So many ways to die, 
all of them horrible. At least in the West we could lessen the suffering
somewhat with medications. Not so in the areas served by USAID.

I suppose the good news, he says with deep sarcasm, is the severe starvation
will likely hasten the deaths from infectious diseases, shorting the duration of
suffering. I keep in mind that pain and suffering is currently a feature, not a
bug, of the administration.

Musk and Rubio have insisted no one has died from the USAID cuts. I do not
doubt, from their perspective, they are telling the truth: No one who matters
has died.

The big beautiful bill cut health care funding for millions, and death will
follow.

Before Obama care, I was involved with patients who could not afford health care
and let their diabetes, hypertension, and AIDS go untreated, with fatal
results. Most common for my practice was the uninsured diabetic who could come
to the hospital with progressive gangrene of the leg or perineum and sepsis.
Another smell you don’t want to encounter. Too often fatal because they
presented with advanced disease. Having your leg and groin rot off is not a good
death. All preventable with routine health care.

Expect a return of death from lack of insurance in the years to come. I once
noted that the three most dangerous words in medicine were In My Experience, but
in truth they are I Lack Insurance.

Then there are vaccines, or the lack thereof.

I saw no end of influenza and COVID deaths, although most were sedated on a
ventilator and didn’t see the bullet coming. Still, we all want time to get
affairs in order, say our goodbyes, and exact our revenge when we know the end
is nigh. It is sad these patients were denied those opportunities and it
compounds the family’s grief.

As an adult doctor (who I cared for, not necessarily how I behave) I rarely took
care of vaccine-preventable childhood infections. Those I saw were often
disasters.

Chicken pox? The worst case was an unvaccinated pregnant patient who caught
chicken pox from her unvaccinated child. Not good. Pregnancy makes progressive
varicella pneumonia, a rare complication, more likely. The mother died after a
month in the ICU of refractory lung failure. Never saw another case, but I
expect there will be others. And a couple of cases of necrotizing fasciitis
complicating adult unvaccinated chickenpox, one of whom lost a breast from the
infection.

Of all the diseases whose routine vaccination is on the chopping block, the one 
I most feared for my kids was Meningococcus, because of the rapidity with which 
it kills. I took care several cases where the young woke up fine and was brain
dead by dinner due to meningitis. Whenever my children had a fever, I
continuously looked for the rash associated with the disease so there would be
minimal delay in therapy.

And meningococcus, along with a few other bacteria, can cause purpura fulminans,
where there is massive clotting leading to the death of arms, legs, noses and
ears. I saw several cases due to the pneumococcus who lost parts of their
extremities from this complication. There was a child often seen at the hospital
who lost both her arms and legs from meningococcus. Awful diseases.

I have noted in the past the ID is like birding, only interesting. There are all
these pathogens that can infect people (I estimated 1300 or so common
pathogens) and you have a life list of diseases you have seen. Some, like plague
or measles or smallpox, you do not really want to take care of. No one wants to
be an unusual or interesting case for an ID doctor.

But any number of usual infections will be making a comeback with resultant
morbidly and morality. All those lucky doctors who get to see diseases that I
considered as only of historical interest: measles and H. influenza and
diphtheria and whooping cough and more, all emptied from the dustbin of history.
More needless death and suffering, much of it preventable.

Many will see the statistics for these unnecessary infections and deaths. A few 
will map those numbers on to the patients they cared for and know how they died.
And remember the immense suffering of these preventable deaths.

I do have a solution. Declare all humans to be a fetus and lack of health care
and vaccinations a form of abortion. Those who cannot even recognize what a war 
is will certainly fall for the ruse, to the benefit of society.

For Whom the Bell Tolls 2026 Edition

I am an island,Entire of myself.You are a piece of the continent,A part of
them.A clod to be washed away by the sea, I couldn’t care less.I will not
vaccinate.Or support healthcare outside of a manor of thine ownOr fret of
thine friend’s medical needs.Each man’s death? Doesn’t bother me,For I don’t
care for mankind.Therefore, send not to knowFor whom the bell tolls,No
concern of mine.John Donne


MAHA

How Unbekoming! The central delusion of MAHA

The antivax movement has a central conspiracy theory, but there is also a
central delusion behind MAHA, revealed by a blogger with the ‘nym Unbekoming.

David Gorski onMay 25, 2026

Link


A long time ago, in—seemingly—a galaxy far, far away (or at least a time that
now seems very far, far away indeed), I coined a term, the central conspiracy of
the antivax movement. In brief, this conspiracy theory posited that vaccines
are harmful, causing autism, autoimmune disorders, cancer, etc., and that
“They”—the medical profession, the CDC, the FDA, state governments, and the
federal government—know they are causing massive harm but are covering up
evidence of that harm. The motivations for the “coverup” vary according to the
weaver of the conspiracy theory and generally involve one of or a combination of
motivations involving greed, ideology, and control, but the central conspiracy 
theory has long remained the same. Vaccines are evil; “They” know vaccines are
evil; and “They” are covering up and/or actively suppressing the evidence
uncovered by the brave maverick doctors and rag-tag vaccine “resistance”
conclusively demonstrating that vaccines are evil. Now that longtime rabid
antivax activist Robert F. Kennedy, Jr. is Secretary of Health and Human
Services and thus in charge of all non-military federal medical, public health, 
and biomedical research programs, from Medicare/Medicaid, to the Centers for
Disease Control and Prevention, to the Food and Drug Administration, to the
Public Health Service, to the National Institutes of Health, we are seeing the
“unbekoming”—I’ll explain shortly—ideas behind that conspiracy theory become
policy under the banner of the “make America healthy again” (MAHA) movement, to 
the detriment of public health in the US and, more broadly, the world.

This central conspiracy theory of the antivax movement goes beyond just the
antivax movement, of course. Its more general version, that there are “natural” 
cures to diseases that “They” don’t want you to know about, dates back
generations and has long been a key feature of the various movements that have
existed around alternative medicine, “health freedom,” New Age woo, and the
like. Unsurprisingly, this sort of conspiratorial thinking now underlies much of
RFK Jr.’s MAHA movement, but there is also an associated central delusion that 
now underlies the MAHA movement, after having long been a core feature of
alternative medicine. Nowhere do I recall having seen it laid out more clearly
than in a recent post on a Substack that I recently discovered. The Substack is 
entitled Lies Are Unbekoming. (I really hate that cutesy stylistically spelling 
of “Unbecoming.”) The post is entitled You Are Born Defective™: An Essay. (Yeah,
whoever the pseudonymous writer of this Substack, who goes by the ‘nym
“Unbekoming,” is, they’re clearly very full of themselves.) In this “essay,”
Unbekoming claims that the main problem with medicine is that it views human
beings as having been “born defective” and in need of correcting.

Unbekoming is clever, though. Here’s how the post is introduced:

This essay operates in two registers. When the medical system’s claims are being
examined, the system’s own language is used — vitamin K deficiency, immune
system, mutation, cholesterol threshold. This is the establishment being
prosecuted in its own words, using its own evidence. When the position the essay
actually holds is being stated — that the body is self-healing,
self-regulating, and intelligent — the language shifts. The body’s lymphatic and
cleansing network is not an “immune system” of warriors and defenders. The
MTHFR polymorphism is not a “mutation.” Cholesterol is not a “danger” the body
inflicts on itself. The dual register is the structure of the argument: the
establishment’s framework is allowed to speak so its contradictions can be
heard, and then the terrain framework names what is actually being observed.

There is a huge “tell” in this mass of pseudoprofound, pseudointellectual
blather that reveals clearly where Unbekoming is really—if you’ll excuse the
term—coming from, and that’s the use of the term “terrain framework.” I’ll
discuss that in bit more detail later, but for the moment, “terrain theory” is
the 19th century idea championed primarily by one of Louis Pasteur’s
competitors, Antoine Béchamp, that it’s not the viruses, bacteria, etc. that are
causing disease, but rather that disease is caused by the “terrain” being
somehow “damaged” or otherwise hospitable to the outside invaders or causes of
disease. It’s an idea that is not entirely untrue. After all, the elderly, the
debilitated, those with immune systems that are not functioning properly,
whether due to inherent disease or to chemotherapy, are more prone to infection.
However, alternative medicine believers—and now MAHA stans—frequently vastly
overplay this relationship to argue that the microbes don’t matter much, if at
all.

Unbekoming starts with birth and the vision of a human baby that is, well,
basically perfect, or nearly so.

Unbekoming: Birth, vitamin K, and vaccines

Unbekoming’s central straw man argument is that conventional science-based
medicine views humans as “born defective,” and from that flows the second straw 
man that medicine must “correct” all these “defects.” To illustrate this,
Unbekoming cites the example of the routinely recommended neonatal dose of
vitamin K, portraying it in the most “unnatural” and “chemical” language
possible, which I will quote in full, even though it’s long, so that you can see
clearly what is being done, namely how Unbekoming claims to be “allowing” the
“establishment’s framework” to “speak,” which is not actually what is happening 
here:

The baby is minutes old. The cord has been cut — too soon, but that is another
story. The mother has not yet finished holding the child against her chest. A
nurse approaches with a syringe.

The syringe contains 1mg of synthetic phytonadione suspended in polysorbate 80, 
propylene glycol, and a preservative system that has changed several times over 
the decades the injection has been administered.¹ The dose is roughly 20,000
times what the newborn would receive in a day of feeding on colostrum.² The baby
is healthy by every visible measure — pink, breathing, alert, gripping a finger
when one is offered.

The injection goes into the thigh muscle. The baby cries. The mother is told
this is routine. She is rarely told what the injection is correcting.

What the injection is correcting, the medical system maintains, is a defect. The
newborn, in the first days of life, produces clotting factors at levels lower
than adult reference ranges. This lower level is called “physiologic
deficiency”³ — a term whose internal contradiction passes without examination.
The body is producing exactly what its own developmental program calls for, and 
this is described as a deficiency.

Within the first hour of life, the medical system has identified something wrong
with the baby and acted to correct it. This is the first transaction. The baby 
has been told, on its first day, that the body it arrived with is inadequate.

Note the framing here. The infant is “healthy,” and the evil (and/or deluded)
medical system is insisting on ripping it from its mother’s breast to inject it 
with unnecessary artificial chemicals to correct a what is portrayed as a
nonexistent “defect.” (Never mind that babies aren’t ripped from their mother’s 
breast to be injected with vitamin K. The recommendation is simply that the
newborn infant receive an intramuscular dose of vitamin K before leaving the
hospital.) The neonatal vitamin K shot is then represented as the first of many 
“transactions” in which the medical profession portrays the body as inherently
“defective” and offers a “correction,” or, as Unbekoming puts it:

There is a paradigm operating beneath modern medicine that is rarely stated as a
paradigm, because to state it would be to expose it. The paradigm is that the
human body, as it arrives, is defective. It produces too little of some
substances and too much of others. Its immune capacities are insufficient. Its
genetic code carries errors. Its measurements drift, with age, into pathological
ranges. Each of these defects is the basis for a product or procedure that
corrects it.

This passage literally made me chuckle out loud, given that this verbiage, minus
the portrayal of ripping a baby from its mother’s arms to inject it with toxic 
chemicals, describes the very foundation of a branch of alternative medicine
much favored by MAHA and practiced by MAHA bigwigs like former Surgeon General
nominee Dr. Casey Means and Dr. Mark Hyman, namely functional medicine (FM). FM 
basically does what Unbekoming spends the Substack post accusing modern medicine
of doing, but on massive doses of steroids. Basically, FM involves massive
overtesting for diseases and conditions in the asymptomatic or “worried well,”
with some FM panels involving hundreds of blood markers. Abnormalities in these 
panels of tests, often repeated at least once a year, are then “corrected” by
selling supplements targeting every abnormality, whether clinically relevant to 
anything or not. Functional medicine, as I like to say, is based on reams of
useless tests in one hand and a huge invoice in the other. Unsurprisingly,
Unbekoming loves functional medicine to death.

How’s that for allowing Unbekoming’s own contradictions to be revealed by simply
quoting what is written?

Vitamin K is an essential factor for one arm of the clotting system in mammals. 
As we have explained many times over the history of this blog when discussing
vitamin K fear mongering by antivaxxers, the reason for the vitamin K injection 
is that neonates can be relatively deficient in vitamin K because it doesn’t
easily cross the placenta and is relatively deficient in breast milk, which can 
leave infants relatively deficient until they start eating other foods at around
six months of age. As Steve Novella noted six years ago, one dose of
intramuscular vitamin K at birth “significantly reduces that risk (relative risk
in that study was 0.19, with a number needed to treat of 74),” immediately
increasing “vitamin K levels, with most of the vitamin being stored in the liver
where it is slowly released over the next six months.” He also notes that the
risks are minimal. In an earlier post, Steve noted that recent studies looking
at infants who developed VKDB showed that most or all of them did not receive
vitamin K prophylaxis. For a more in-depth discussion of why a routine neonatal 
dose of vitamin K is safe and effective, Dr. Clay Jones has you covered. Yes,
these posts are several years old, but, seriously, the arguments made by people 
like Unbekoming against the routine vitamin K dose for neonates haven’t changed,
nor has the evidence supporting this practice, other than more data showing it 
to be safe and effective.

Unbekoming does at least admit that the condition that the neonatal vitamin K
injection is designed to prevent, namely Vitamin K Deficiency Bleeding (VKDB),
is real; so there’s that. It’s even acknowledged that there are three subtypes
of VKDB:

  1. Early onset VKDB (within 24 hours): Rare; usually associated with maternal
    medications (e.g., anticonvulsants, warfarin).
  2. “Classic VKDB” (days 2–7): The most common form without vitamin K prophylaxis;
    GI bleeding, umbilical bleeding, or post-circumcision bleeding.
  3. Late onset VKDB (weeks 2–12): The most dangerous form — intracranial
    hemorrhage occurs in 30–60% of cases and carries significant mortality and
    neurological morbidity. Exclusively breastfed infants are most at risk.
It’s even acknowledged that vitamin K prophylaxis eliminates the risk of late
onset VKDB, which is cited as having an incidence of between one in 14,000 and
one in 25,000 infants. (Hint: There are roughly 3.6 million births per year in
the US, which, if you accept Unbekoming’s numbers, would translate into
potentially 144-257 cases of late onset VKDB, a catastrophic condition, per
year. There used to be a time when we thought that preventing hundreds of dead
or severely neurologically injured infants was a good thing, but apparently not 
to MAHA’s way of thinking anymore. (RFK Jr. and HHS have backed away from
routinely recommending neonatal vitamin K injections, and more parents are
refusing the shots.)

But it’s all so “unnatural.” Unbekoming goes on and on about the excipients used
for intramuscular vitamin K injections:

The injection is not vitamin K alone. It contains polysorbate 80, a surfactant
shown in animal studies to alter blood-brain barrier permeability¹⁰; propylene
glycol, which the FDA itself has warned about in neonates¹¹; and benzyl alcohol,
which has been associated with “gasping syndrome” and infant deaths.¹² The
product carries a black box warning — the FDA’s most serious — that reads
“severe reactions, including fatalities, have occurred during and immediately
after intravenous and intramuscular injection,” noting that “some patients have 
exhibited these severe reactions on first receiving phytonadione.”¹³ A 1992
study from the British Medical Journal reported an association between
intramuscular vitamin K and childhood cancer.¹⁴ Subsequent studies disputed the 
finding. The dispute is unresolved. The injection continues.

First of all, phytomenadione is simply vitamin K1. Second, the dispute is not
“unresolved.” Since the study mentioned, epidemiological studies have
consistently failed to find an association between the birth dose of vitamin K
and increased risk of any cancer. The purported “risk” at this time is purely
hypothetical and therefore far outweighed by the benefits of the neonatal
vitamin K injection.

As for polysorbate-80, unmentioned is that the animal studies cited used large
doses of polysorbate-80, far above what a human infant receives in a vitamin K
injection. (Indeed, the quantities of excipients like propylene glycol and
polysorbate-80 in current vitamin K injectable formulations in the US are
minuscule, making this attack just another variation of the “toxins” gambit
beloved of antivaxxers.) Most were studies of polysorbate-80 in the diet, and
most recent studies of polysorbate-80 and the blood-brain barrier that I could
find involved using polysorbate-80 in lipid nanoparticles designed specifically 
to target the blood-brain barrier. Indeed, the study cited by Unbekoming to
support the fear mongering about polysorbate-80 is a 1985 study in which levels 
of chemotherapeutic agents were measured in the brains of mice when dosed with
and without polysorbate-80 included in the mice’s diet. Surely, if this were a
major concern, they could have come up with a more relevant (and recent) study. 
At least, if I were trying to make the same argument, I’d find something less
than four decades old that directly addressed the claim. Ditto benzyl alcohol,
for which the reference cited comes from 1982 and looked at doses 100 times
higher than what is in vitamin K shots, and even if parents are concerned about 
the presence of this chemical in the shots there is a preservative-free version 
of intramuscular vitamin K. Not that any of this stops Unbekoming from citing
the litigation-driven antivax pseudo-“study” the Control Group as evidence for
the dangers of vitamin K injection.

[NOTE ADDED AFTER PUBLICATION: Ironically, after I finished this post, I noticed
that antivax physician Suzanne Humphries showed up on the website of the
antivax org founded by RFK Jr. parroting basically the same claims about benzyl 
alcohol, the now disproven elevated risk of childhood cancer from the shot, and 
even the claim that the lower vitamin K levels in neonates is “by design” for a 
purpose. Yep. Unbekoming is parroting old antivax nonsense about vitamin K
shots.]

Finally, Unbekoming asks what they must think to be a reasonable question: Why
not just give the vitamin K orally in divided doses, as though it were pure
ideology—”the hospital workflow is built around injection”—and grift that led
the American Academy of Pediatrics to recommend one intramuscular dose of
vitamin K1 in 1961 and reaffirm the recommendation in 2021. In reality, a single
intramuscular dose provides protection for months. In contrast, oral regimens
require multiple doses and have a higher failure rate, particularly for
late-onset VKBD. If you listen to Unbekoming, though:

The newborn is not deficient. The newborn is producing vitamin K at the level
the newborn’s developmental program calls for, in a body whose clotting system
is calibrated to that level. The “deficiency” is defined against an adult
reference range that has no biological relevance to a three-day-old infant. A
genuine clinical bleeding risk exists in a small subset of infants with
underlying pathology, and that risk is real and serious. The response is to
inject every newborn, mask the signal that would have identified the at-risk
subset, and accept the toxic burden of the carrier substances in exchange for
protection against a condition most infants would never have developed.

The reason that the deficiency is defined the way it is is because at the lower 
level of vitamin K in neonates, the clotting system doesn’t work as well, and
there actually is a risk of catastrophic bleeding. I also wonder what “signal”
that would identify the “at-risk subset” is being “masked” by a universal
neonatal vitamin K dose. What would that “signal” consist of? What action would 
Unbekoming recommend when an “at-risk” infant is identified? This is basically
the same sort of MAHA appeal to “individualized” care that is, in reality, an
excuse for undermining public health interventions.

Unsurprisingly, Unbekoming moves on to make the same sort of “appeal to perfect 
nature” to argue against the childhood vaccine schedule, portrayed this way:

The premise of the schedule is that the child’s lymphatic and cleansing network 
cannot adequately respond to childhood exposures without injected antigens,
adjuvants, and excipients. Stated baldly, this is implausible. Children have
been having childhoods for as long as there have been children. The lymphatic
system, the fascial network, the mucosal surfaces, the liver, the kidneys —
these are not new structures awaiting pharmaceutical activation. They are the
body’s cleansing and adaptive architecture, refined across the entire arc of
human existence.

“Implausible.” You keep using that word. I do not think it means what you think 
it means. Yes, children have been having childhoods as long as there have been
children, and children have been dying of infectious diseases as long as there
have been children. In the 19th century, huge numbers of children died of what
are now vaccine-preventable infectious diseases, to the point where it was
common for families to lose one, two, three, or even more of their children
before they grew up. It’s a straw man to say that the child’s immune system
“can’t” adequately respond to childhood exposures. The problem is that the
immune system needs training. If it hasn’t seen an antigen before, it will not
do as well dealing with that antigen as it will if it has seen it before.
Vaccines do nothing more than prime the immune system by letting it see antigens
of potentially dangerous disease-causing microbes in a safe manner that doesn’t
cause disease, so that it “remembers” them when it encounters them for real.

The rest of Unbekoming’s section on vaccines consists of a lot of well-worn,
common, and easily debunked antivax talking points, such as the “toxins” gambit,
the “no saline placebo” gambit, the false claim that unvaccinated children are 
healthier than vaccinated children, and a truly brain-dead analogy:

The injection volumes themselves are worth pausing on. A two-month-old infant
weighing roughly 5kg may receive, in a single visit, vaccines totalling around
2.5ml of injected material. Scaled to the body mass of a 70kg adult, the
equivalent volume would be approximately 35ml — over two tablespoons of injected
pharmaceutical product in a single visit.²⁹ No adult medical protocol
approaches this density. The infant receives it in a body still building the
structures the substances are delivered into.

Here’s a hint: Vaccines are not like standard pharmaceuticals. The doses do not 
scale linearly with weight; that’s not how the immune system works. Moreover, 35
ml is not a large fluid volume for an adult, just as 2.5 ml is not a large
fluid volume for a two-month-old infant. Whether Unbekoming doesn’t know
these—i.e., is just ignorant—or does know these things but knows that their
audience doesn’t—i.e., is lying—I don’t know. Take your pick.

Either way, Unbekoming’s fallacy is the same for both vitamin K and vaccines:

Both pillars rest on the same proposition: the body is defective at baseline.
The proposition is not stated this way in medical literature. It is implicit in 
the structure of every intervention. Each procedure, each prescription, each
diagnostic threshold rests on the same foundation — that the body, as it arrives
and as it ages, fails to meet a standard the medical system has the authority
to set and the products to address.

There is another paradigm. It is older than germ theory. It survived the
institutional capture of the early twentieth century only at the margins, in the
work of Béchamp, Bernard, Tilden, Shelton, Price, and their inheritors. The
paradigm holds that the body is a self-healing, self-regulating, intelligent
organism. It maintains its own equilibrium. It does not make mistakes. It does
not attack itself. It responds to insult — toxic, nutritional, electromagnetic, 
emotional — with intelligent processes aimed at restoring balance. Symptoms are 
not malfunctions; they are the body’s response to conditions that warrant a
response. Disease arises from terrain conditions, not from baseline defects.

There it is, as expected, the appeal to terrain theory. While it’s true that
terrain theory was a legitimate competitor to Pasteur’s germ theory of disease
in the mid-19th century, the bottom line was that it lost the race. It was a
hypothesis that seemed reasonable at the time, given what was known about
medicine, but ultimately failed to be validated as science progressed, just like
so many other hypotheses and theories over the history of medicine and science.
Scientific evidence and experiments increasingly supported Pasteur and did not 
support Béchamp. Yes, it’s true that “terrain” contributes to one’s
susceptibility to disease, but unfortunately people like Unbekoming seem to make
like Bill Maher and claim that if one’s “terrain” is maintained through diet,
exercise, and other “virtuous” behavior with respect to health practices, then
they are not susceptible to disease and don’t need vaccines. Bob Costas had the 
perfect retort to such arguments: “Oh, come on, Superman!“

As for the body being “self-healing,” “self-regulating,” and “intelligent,”
there is some truth to that, but, like quack-lovers everywhere, Unbekoming
massively overstates the case. The body can “self-heal” and “self-regulate,” but
there are definite limits, and the system doesn’t always work correctly (e.g., 
in the case of auto-immune diseases and cancer). As for “intelligence,” the
brain produces intelligence, but the body’s homeostatic systems are more akin to
algorithms than intelligence.

Naturally, all of this “reasoning” (if you can call it that) leads to the
conspiracy theory that science-based medicine promotes vitamin K and vaccines
for infants and children because it is creating “diseases” or “deficiencies” of 
the oh-so-perfec human body in order to profit, which, again, is truly rich
given how much quacks and, more recently, MAHA have promoted supplements for
nonexistent diseases:

This paradigm has no product line. It generates no patents. It cannot be billed.
A body that needs only to be supported — through clean food, clean water, low
toxic burden, low stress, sunlight, movement, sleep — produces no revenue. The
medical system as currently structured cannot operate on this paradigm. It
requires the other.

Oh, you sweet summer child! (Either that, you know damned well that a body that 
“needs only to be supported” can be monetized by selling it products that
allegedly help it with “clean food, clean water, low toxic burden, low stress,
sunlight, movement, sleep.”)

Into the adult world

I’m not going to spend as much time on the two adult examples that Unbekoming
uses to try to make the same “argument” (such as it is), specifically
methylenetetrahydrofolate reductase (MTHFR) mutations (referred to as
“defective” genome) and statin treatment for hypercholesterolemia (referred to
as “the defective adult”). Once again, I chuckled out loud when I saw that
Unbekoming was going to “go there” when it comes to MTHFR mutations, given that 
testing for such mutations has become such a cottage industry among quacks,
MAHA-aligned and otherwise, that eight years ago genetics experts at the
Cleveland Clinic called out all the dubious tests for MTHFR mutations being
marketed. Most of the time genetic testing for MTHFR mutations.

Just to remind readers, folic acid is not metabolically active itself. It must
first be converted to dihydrofolate (DHF) and then to tetrahydrofolate (THF)
through enzymatic reduction, a reaction that is catalyzed by the enzyme DHF
reductase (DHFR). After that, THF can be converted to the biologically
active l-methylfolate by the enzyme methylenetetrahydrofolate reductase (MTHFR).
This key conversion is necessary to provide l-methylfolate for the one-carbon
transfer reactions needed for purine and pyrimidine synthesis during DNA and RNA
assembly, for DNA methylation, and to regulate homocysteine metabolism. Thus,
MTHFR is the critical enzyme for almost all biologic processes that involve the 
metabolism of folate and methionine.

Here’s a diagram illustrating its role:

Formation of l-methylfolate from folic acid. CH2, methylene; CH3, methyl group; 
DHF, dihydrofolate; DHFR, dihydrofolate reductase, F, folic acid; H, hydrogen;
SHMT, serine hydroxy-methyl transferase; THF, tetrahydrofolate.
To be honest, I almost think that Unbekoming might be calling out the quacks
here, because, seriously, most science-based medical professionals aren’t going 
to be routinely ordering MTHFR mutation testing for patients, certainly not for 
patients complaining of “fatigue,” but a whole lot of MAHA-aligned quacks,
particularly functional medicine quacks and naturopath quacks, will. I wanted to
assume that, but in reality this whole example serves mainly as an excuse to
attack folic acid supplementation as “artificial” and “toxic,” a “chemical” that
wasn’t synthesized until 1943. Meanwhile, two common variants, C677T and
A1298C, are portrayed as totally “natural” and harmless because approximately
40% of the population carry them.

In reality, this is all a pretext for nothing more than attacking the addition
of folic acid to foods—referred to, tellingly, as being “added through
industrial fortification”—and the recommendation that people who are pregnant or
who plan on becoming pregnant supplement with folic acid. I’m not going to go
into gory detail on this topic, because, unsurprisingly, it’s a lot more nuanced
than Unbekoming portrays it:

A patient is told they carry the mutation. They are told it predisposes them to 
cardiovascular disease, pregnancy complications, neural tube defects,
depression, autoimmune conditions, and detoxification impairment. They are told 
they must supplement with methylated folate — 5-MTHF — for life, because they
cannot adequately process folic acid.³¹

Yes, the most dreaded pregnancy-related consequence of folate deficiency is
neural tube defects in the developing fetus, which is why folic acid
supplementation has been routinely recommended during pregnancy. Interestingly, 
the reference cited doesn’t actually say this. It’s all about folate metabolism 
and how supplementation with folic acid prevents all the bad things that can
happen with folate deficiency, such as birth defects and other adverse pregnancy
and health outcomes. What does it say about L-methyfolate?

Not much:

Although folic acid supplementation to supraphysiologic levels has demonstrated 
many of the benefits to pregnant women and fetuses noted above, the potential
risk of high-dose folate supplementation must also be considered. First, folate 
supplementation can mask vitamin B12 deficiency (pernicious anemia) and care
must be taken with susceptible individuals to avoid missing this diagnosis.
Also, concerns have been raised about the potentially untoward effects of
unmetabolized synthetic folic acid with regard to cancer, depression, and
cognitive impairment. 52 With all these concerns, early data suggest
supplementation with l-methylfolate rather than folic acid may mitigate these
risks.53

See what I mean? (Note that L-methylfolate and 5-MTHF are the same substance.)
All this review says is that using 5-MTHF instead of folic acid might mitigate
potential effects of unmetabolized folic acid and that “newer research in this
area has focused on supplementation with l-methylfolate rather than folic acid
as a means of preventing folate-related pathology,” not that the standard
recommendation is that if you have an MTHFR variant that interferes with folate 
metabolism you will definitely need to take 5-MTHF for the rest of your life. Of
course, this review is from 2011—Unbekoming seems incapable of citing newer
literature—and so I looked up some newer literature. As of November 2024, the
American College of Medical Genetics, for instance, recommends against routine
screening for MTHFR polymorphisms/mutations and that “women of childbearing age 
should take the standard dose of folic acid supplementation to reduce the risk
of neural tube defects as per the general population guidelines.” As for the
general population, it recommends that “MTHFR positive individuals may decide to
take vitamin B and folic acid supplements. Although safe (toxicity is rare),
evidence is lacking on whether such supplements reduce the risks associated with
hyperhomocysteinemia or MTHFR genotype status.”

That sure doesn’t sound like how Unbekoming is portraying modern medicine and
how it deals with MTHFR mutations. What Unbekoming describes sounds a lot more
like how functional medicine quacks and naturopaths deal with MTHFR variants. Be
that as it may, Unbekoming concludes here:

The genome is not defective. The diet is. The defect-claim has been moved from
the food supply, where it belongs, to the patient’s DNA, where it absolves the
food supply and creates a permanent customer for the supplement industry. The
genome, which existed long before the synthetic compound it is being declared
inadequate to process, is now held responsible for the inadequacy of the
synthetic compound.

The funny thing is, the medical consensus with respect to MTHFR variants seems
to be similar: that these are not “defects” and that, unless you’re trying to
become pregnant, you probably don’t need to do anything other than eat a good
diet with green, leafy vegetables. If you are trying to become pregnant,
supplement with folic acid to prevent neural tube defects and other defects in
your baby.

The next example, “the defective adult,” is basically your standard anti-statin 
nonsense. Pretty much everything written by Unbekoming is nonsense of the sort I
once wrote extensively about when COVID quack Pierre Kory started to embrace
statin denial; so I won’t go into much detail regarding the claims, although I
do love a claim like this:

In 1984, the cholesterol threshold for treatment in adults was 240 mg/dL.³⁴ In
1993, it dropped to 200 mg/dL. In 2001, the threshold for high-risk patients
dropped to 100 mg/dL. In 2004, it dropped again to 70 mg/dL for very high-risk
patients. The 2004 update was authored by a panel of nine members, eight of whom
had financial ties to statin manufacturers.³⁵ Each threshold reduction expanded
the eligible patient population by tens of millions. Statin prescriptions in
the United States exceeded 200 million annually by the 2010s, generating revenue
in the tens of billions.³⁶

Yes, and blood pressure thresholds for the diagnosis of hypertension have
dropped through the decades as well. It’s what happens as more epidemiological
and clinical evidence accumulates and guideline organizations realize that there
is a benefit to intervening at lower values, which Unbekoming misrepresents by 
discussing a hypothetical patient with elevated cholesterol who was prescribed a
statin:

The doctor does not mention that the threshold he now fails was lowered by a
committee in which eight of nine members held financial ties to the
manufacturers of the drug he has just been prescribed.

Here we go with the conspiracy theories again.

This leads Unbekoming to repeat what is, after the previous three examples, a
now-familiar refrain adapted for cholesterol and statins:

Cholesterol is not dangerous. It is required. The body manufactures it in the
quantities the body requires. When measurements are taken and compared to
thresholds, the thresholds are being moved to expand the patient population, not
to track a biological change. The “high cholesterol” of a healthy adult is the 
cholesterol level a healthy adult produces. Treating it with a drug that
interrupts a biosynthetic pathway producing multiple essential compounds is not 
correction of a defect. It is induction of a deficiency.

Again, it never occurs to Unbekoming that the body might actually malfunction,
that it might make too much of a substance and that too much of that substance
might actually cause health problems. Given this framework, I have to wonder why
the article didn’t mention type 2 diabetes, with the argument that impaired
glucose metabolism is normal for the person with type 2 diabetes and that
metformin and GLP-1-based drugs are all a big scam to induce a glucose
deficiency.

What ties them all together? According to Unbekoming:

The four pillars share an architecture. A measurement is taken or a category is 
named, a threshold is set or a defect is claimed, a product is offered. The
threshold is positioned as biology; the product is positioned as correction.

In each case, the body is held to a standard the body did not set. The newborn
is measured against an adult reference range with no biological relevance. The
child is measured against an immune theory that requires injected substances to 
function. The adult is measured against a synthetic compound invented in 1943.
The aging adult is measured against a threshold lowered by a committee paid by
the manufacturer.

In each case, the actual cause of the symptoms or risks the intervention claims 
to address is foreclosed. The newborn’s bleeding risk, where it exists, is from 
underlying pathology that the universal injection masks. The child’s chronic
disease load is from the toxic burden of the schedule itself, alongside diet and
environment. The adult’s MTHFR symptoms are from a diet built around fortified 
processed food. The adult’s cardiovascular risk is from inflammation driven by
diet, stress, toxic exposure, and metabolic dysregulation — not from cholesterol
levels the body itself maintains.

In each case, the patient becomes a customer for life. The newborn injection
initiates the relationship. The schedule extends it. The MTHFR diagnosis cements
it. The statin completes it. From the first hour to the last, the body has been
a revenue stream, and the defect-claim has been the mechanism by which the
revenue stream was constructed.

There it is, the central delusion of MAHA, that the body is this all-knowing,
(nearly) all-powerful self-healing machine and that the only thing that prevents
it from healing itself of virtually anything are the “toxic load” of chemicals 
and pharmaceuticals that the medical profession nefariously hooks you on by
declaring your body to be less than perfect, full of “deficiencies” that must be
corrected for the rest of your life. Given that viewpoint, it should not
surprise anyone that Unbekoming is a virus denier, basically claiming that
viruses don’t really exist in posts such as What Is Ebola? and What Is Hepatitis
C? Amusingly, Unbekoming argues that Ebola doesn’t really exist, that it is
really arsenic poisoning, much as antivaxxers did for the polio virus in the
past, and “poisoning” due to other industrial toxins related to mining.
(Everything old is new again.) Meanwhile, hepatitis C isn’t due to a virus, but 
just “toxins” that are “poisoning” the liver. (Everything old is new again.)

As Unbekoming shows us, the central delusion of MAHA now (and a lot of
alternative medicine in the past that has now glommed onto MAHA) is that the
body is basically perfectly functional, even when it’s not. The lower level of
vitamin K in the neonatal bloodstream is exactly as nature intended, and the
neonatal birth dose is an abomination that “masks” those who are truly “at risk”
for VKDB at the cost of exposing all babies to supposedly horrific “toxins.”
Your immune system is already exactly as nature intended it to be, and vaccines 
only interfere with that perfection, again at the cost of exposing the body to
horrific “toxins.” Your genome is also exactly as nature intended it to be, and 
food alone is enough to prevent neural tube defects if you happen to have an
MTHFR variant that leaves you deficient in folate. If you have elevated
cholesterol, it’s just as nature intended and not at all harmful, even though
medical research tells us that there is increasing risk of cardiovascular
disease with elevated levels of LDL and cholesterol.

This delusion leads to a single answer to nearly all medical problems related to
chronic disease. A medically virtuous diet and lifestyle will fix everything
and prevent all diseases—I only exaggerate slightly—and you don’t need
pharmaceuticals or vaccines. Would that this were true, but unfortunately we
live in the real world. Our bodies are not perfect. Far from it. Most of us will
need medical care at some point in our lives, often at many points. The central
delusion of MAHA is to deny this essential reality.


Donald Trump won. Now what for science-based federal health policy?

Last week, Donald Trump defeated Kamala Harris and will return to the White
House in January. What does this mean for science-based federal health policy?
Hint: Nothing good. Just like the rest of the government, the worst people are
likely to be in charge of health and science policy.

David Gorski on November 11, 2024

Link

Last week, the day before the election, I described Robert F. Kennedy, Jr., who 
in return for abandoning his quixotic and bizarre campaign for the Presidency as
an independent to bend the knee and swear everlasting fealty to former
President Donald Trump had been promised control over the entire federal health 
policy apparatus, as an “extinction-level threat to federal public health
programs and science-based health policy” as I pointed out what RFK Jr. had been
saying and promising all these years. Unfortunately, for federal science policy
and public health, last Tuesday Donald Trump won not only well over the 270
votes in the Electoral College needed to become President but a clear majority
of the popular vote (and all seven swing states) to defeat Kamala Harris and
become President-Elect again. As a result, on January 20, 2025 he will be sworn 
in as the 47th President of the United States, which means that that
extinction-level threat to public health is now less than two and a half months 
away. It thus behooves me to follow up last week’s post by taking a look at what
form—many forms, actually—that threat might take.

So, even as I deal with a hectic weekend (my father is in the hospital), let me 
try to lay out some of my thoughts and speculation. In many cases, I hope that
I’m wrong, but fear that I’m actually not alarmed enough. I’ll start with
vaccines. Why? Because antivax is what RFK Jr. is known for, and, despite his
denials that he’s antivax, antivaxxer Del Bigtree is closely associated with
him, Bigtree and now chief executive of MAHA Action, a new organization named
after Kennedy’s “Make America Healthy Again” slogan that is also proposing
appointees to RFK Jr.

According to Bigtree:

No confirmation has come from Trump’s presidential team on which position
Kennedy will fill. He may only become an adviser, according to the Kennedy
campaign’s former director of communications, Del Bigtree.

“President Trump is giving him two years to show success,” Bigtree said.
“President Trump is keenly interested in the selections that Bobby Kennedy
thinks would get the job done.”

He also said that Kennedy would recommend doctors who have no “conflicts of
interest” with Big Pharma companies involved in vaccine and drug production.

That will be interesting, as any doctor who believes as RFK Jr. and Del Bigtree 
believe about vaccines pretty much all have conflicts of interest. They’re all
selling or promoting quackery to treat either COVID-19 or “vaccine injury.”
Bigtree himself has a massive conflict of interest, given that he has a podcast 
that makes money promoting antivax disinformation and conspiracy theories and
runs ICAN, which he is paid to run and which exists to sue governments and
pharmaceutical companies over vaccines and vaccine policy.

Worse:

Bigtree is involved in proposing appointees to Kennedy, having become the chief 
executive of the Make America Healthy Again Action organization, which seeks to 
follow on Kennedy’s healthcare campaign pledges.

Meanwhile, Reuters is reporting that RFK Jr. is reviewing resumes for top Trump 
health jobs.

Will Trump let antivax activist RFK Jr. “go wild” on vaccines (and health), as
promised?

To someone who has been writing about RFK Jr. for nearly two decades (as I have)
since he first outed himself as an antivaxxer on the national stage with his
publication of a conspiracy-mongering “investigation” co-published by Salon.com 
and Rolling Stone. In the article, Deadly Immunity, RFK Jr. falsely implicated
the mercury-containing preservative thimerosal that had been used in a number of
childhood vaccines until around 2002 as the cause of an “epidemic” of autism,
the first question that comes to mind is: What role will RFK Jr. have in the
second Trump administration? You might recall that at his Madison Square Garden 
rally two weeks ago, Donald Trump promised, mentioning Elon Musk:

And we also have somebody that is great. And look, we’re not going to let him go
too crazy, Elon, with the oil and gas stuff. Because Robert F. Kennedy cares
more about human beings and health and the environment than anybody. And he’s
going to be absolute. Having him is such a great honor. I’ve been friends of his
for a long time. And I’m going to let him go wild on health. I’m going to let
him go wild on the food. I’m going to let him go wild on medicine. The only
thing I don’t think I’m going to let him even get near is the liquid gold that
we have under our feet. I don’t know, Elon. He might not like liquid gold. It’s 
oil and gas. Sometimes referred to as oil and gas. J. D. , I think we’re going
to have to keep him away from the oil and gas. What do you think, Howard? Yes?

As I noted last week, it is very telling that Trump promised to let RFK Jr.
“Make America Healthy Again” (an obvious nod to Donald Trump’s “Make America
Great Again,” or MAGA), but only if he doesn’t go too far and actually do
something about one of the most serious threats to public health, environmental 
pollution, particularly if that pollution is a result of the fossil fuel
industry. By “telling,” I mean telling about both men: Trump for being willing
to embrace antivax “wellness” grift but not anything that would harm the
business interests that support him, and RFK Jr. for being willing to forget
about his pre-antivax crusade as an environmentalist in the service of achieving
power and declaring MAHA “war” on the FDA while trying (and failing) to hide
his true antivax nature.

Of course, RFK Jr. does share one trait with Donald Trump. He is a malignant
narcissist, and two malignant narcissists generally don’t mix very well
together. Generally, whoever is the more powerful narcissist will get rid of or 
punish the less powerful one. This is why I was amused to see stories like this 
last week:

HAHAHAH https://t.co/NCFmGVBhbP

— Professor (@professor_TopK) November 7, 2024

If only…

Let’s just say that, at least for the moment, I don’t think that we can count on
Trump getting so fed up with RFK Jr.’s showboating that he reneges on his
promise to appoint him to a high-ranking position on health in his
administration. I have little doubt that, at some point, Trump and RFK Jr. will 
butt heads, even have a falling out, but I doubt that it will happen soon enough
to prevent massive damage to the federal health policy infrastructure, and,
even if it does, anyone waiting in the wings to replace RFK Jr.’s influence
would be just as bad—or even worse.

In any event, according to the story above:

Donald Trump’s team appeared to be quietly distancing itself from Robert F
Kennedy Jr in the immediate aftermath of the election amid speculation that the 
former presidential candidate could be handed control of US public health
agencies.

Advisers to the president-elect questioned whether Mr Kennedy, a vaccine sceptic
who has also been the subject of a series of bizarre stories involving animals,
would make it through a security check for a cabinet position.

It raises questions about what role, if any, Mr Kennedy would be given in the
Trump administration, as the Republican’s transition team sets about filling
thousands of federal posts for his return to the White House.

Mr Kennedy had previously said that Mr Trump had “promised” him control of the
Department of Health and Human Services and public health agencies like the Food
and Drug Administration (FDA).

However, there is disquiet in the Trump team about media attention on the former
independent candidate after he was pressed in a post-election interview with
NBC about his vaccine scepticism.

Dammit, reporters. RFK Jr. is not a “vaccine skeptic.” He is antivax. If you
can’t call him antivax, at least don’t misuse the word “skeptic.” Call him
instead a vaccine misinformation spreader and/or conspiracy theorist, or
something like that. I’ll stop now, but that’s long been one of my pet peeves
about reporting on the antivaccine movement, and I couldn’t resist mentioning
it.

But what, exactly, did RFK Jr. say in his NBC News interview, given the day
after the election? I suspect that it was an attempt to reassure people after an
interview before the election with the co-chair of Trump’s reelection campaign,
Howard Lutnick, who stated that RFK Jr. wanted “access to federal health data
so he can show vaccines are unsafe and lead to them being pulled from the market
in a second Trump administration.” Now that Trump has won, RFK Jr. is trying to
sound more “moderate” in an interview with NBC News reporter Vaughn Hillyard:

RFK Jr. once again lying about not being antivaccine.

Here’s the key part. I will quote at length, so that you don’t have to watch the
video above if you don’t want to and to discuss things that were left out of
the news reports on this interview, which included only brief quotes and left
out RFK Jr.’s whole mendacious antivax schtick, in which he tries to claim he’s 
“never been antivaccine” (even though he most definitely is and has been rabidly
antivax for nearly two decades, with a long history of antivax conspiracy
mongering and misinformation) and that he won’t endanger anyone (he most
definitely will). As an aside, I will mention my frustration at how news
organizations never seem to produce a full transcript of interviews like this
(if there is one, I couldn’t find it), leaving me to use YouTube’s AI transcript
generator (which puts time stamps in the transcript that need to be deleted and
makes a lot of mistakes) and my painstakingly watching the video to produce
this:

HILLYARD: You have been a crusader on questioning vaccines. Are there specific
vaccines that you would seek to take off the market?

RFK JR: Oh, I’m not going to I’m not going to take away anybody’s vaccines. I’ve
never been antivaccine I’ve just…

HILLYARD (interjects): You will not…you will not take any vaccine that is
currently on the market?

RFK JR: I’m not. If somebody, if vaccines are working for somebody, I’m not
going to take them away. People ought to have choice and that choice ought to be
informed by the best information. So I’m going to make sure scientific safety
studies and efficacies are out there and people can make individual assessments 
about whether that product is going to be good for them.

HILLYARD: Would that include covid vaccines that are currently on the market?

RFK JR: I, I want the best science for every vaccine.

HILLYARD: It is part of that, in, during the pandemic, the height of the
pandemic, you were questioning the FDA and calling them out for approving the
emergency authorization of the COVID vaccines if you had been in charge of the
FDA at that time would you have blocked the authorization of the COVID vaccines 
like you were suggesting publicly?

RFK JR: What I was saying at that time is the vaccines are not going to prevent 
transmission, which they were telling the public that they would. They were
saying you need to take this vaccine in order to protect Grandma. I knew in May 
of 2020 that the vaccines were not going to protect against transmission,
because I was actually reading the monkey studies…

HILLYARD (interjecting): But you would not have told the FDA to block the
authorization of the vaccine…

RFK JR: I would have been honest with the American people and…

HILLYARD (interjecting): So you wouldn’t, you wouldn’t have blocked it?

RFK JR: I wouldn’t have directly blocked it I would have made sure that we had
the best science and there was no effort to do that at that time.

Translation: RFK Jr. most definitely would have blocked the mRNA COVID-19
vaccines if he had been in charge in 2020. As for his having “read the monkey
studies,” my response is that it doesn’t take much looking to find articles
about how COVID-19 vaccines might not block transmission but that many vaccines 
don’t. What we want from a vaccine is, first and foremost, to prevent severe
disease and death, which COVID-19 vaccines most definitely accomplished. If a
vaccine blocks transmission, so much the better; that’s icing on the cake.
That’s why my response to drivel like this is: So what? RFK Jr. does not have
significant scientific expertise in medicine, immunology, molecular biology,
virology, epidemiology, public health, or any relevant specialty to assess the
safety and efficacy of COVID-19 vaccines in a science- and evidence-based way.
What he does possess is expertise in conspiracy mongering, data dredging, cherry
picking and misrepresenting studies, and, in general, being a disinformation
agent, expertise that he’s honed over the last two decades since Deadly
Immunity.

In the interview above he’s also spreading the usual antivax tropes about
“choice” and “consent.” Remember, as I’ve long said, when an antivaxxer like RFK
Jr. invokes informed consent, what he really means is misinformed refusal (a
term that applies not just to vaccines but to all rejection of evidence-based
treatments) based on a totally warped risk-benefit assessment in which potential
risks are exaggerated far beyond what the evidence supports, while the benefits
are downplayed to the point where there are none. I’ve frequently said that, if
I actually believed the assessments of someone like RFK Jr. regarding the
risk-benefit ratios of vaccines I’d be antivaccine too. That’s why I’ve always
found RFK Jr.’s claim that he’s “not antivax” or that he is even “fiercely
pro-vaccine” to be transparently disingenuous and risible as hell. After all,
RFK Jr. has a nearly 20-year history of comparing vaccines to the Holocaust,
twisting science (with examples too numerous to mention here), and conspiracy
mongering. The bottom line is that RFK Jr. is either lying to you or lying to
himself when he claims he’s “not antivaccine.”

All of this is just my usual prolonged introduction to a spoiler alert: If he
becomes Trump’s “health czar” or Secretary of Health and Human Services (HHS),
RFK Jr. will most definitely start targeting vaccines currently approved, if he 
can, to try to prove them “unsafe,” no matter how much he and his minions have
to distort science and lie to accomplish this, all as a pretext for eventually
taking them off the market, all the bromides about “choice” notwithstanding,
likely starting with the mRNA COVID-19 vaccines and then proceeding to vaccines 
like the MMR vaccine and the hated (by antivaxxers) HPV vaccines. If there’s one
thing I’ve learned about antivaxxers (and, indeed, the “health freedom
movement”) over the last quarter century, it’s that, when they invoke “health
freedom,” what they really mean is freedom for them and people who believe what 
they believe and make the same decisions that they want to make. Those of us who
try to champion science-based medicine and health policy don’t count, nor do
people who try to take care of their health following science- and
evidence-based medical recommendations. Be afraid. Be very afraid.

Hillyard, to his credit, followed up with a very pertinent question:

HILLYARD: And if there was another pandemic that were to strike, why should the 
American public have confidence that you would allow a vaccine to be made
available through the market even it’s…

RFK JR: Well, I mean, let me point this out. They should not have confidence and
the people who are managing our pandemic we had the worst record of any country
in the world so we had 16% of the covid deaths in the United States of America 
we only have 4.2% of the globe’s population so whatever we were doing in this
country was the worst of every country in the world…

First off, as bad as the US did as a nation handling COVID-19, for COVID-19
mortality on a per-capita basis it was not the worst. Peru was. Unfortunately,
that’s cold comfort, as the US still did very poorly in terms of deaths per
100,000 people due to COVID-19 and fell in the middle of the pack in terms of
case fatality ratio.

Be that as it may, one can’t help but point out who was in charge for most of
the first year of the pandemic. (Hint: It was not Joe Biden, who didn’t assume
office until January 20, 2021. By the time Biden took office, the disordered
response to COVID-19 led by Trump had become so baked in that his administration
had to spend his first year trying to fix the mess that he’d been left at
federal public health agencies) Yes, the man to whom he has bent the knee,
Donald Trump, was President when the pandemic first hit. He’s the President who 
downplayed and mostly ignored the warnings in December 2019 and January 2020
that the mysterious new viral respiratory disease due to a novel coronavirus
then spreading in Wuhan, China could well result in a major pandemic. He’s the
one who constantly interfered with the CDC and FDA response to the pandemic,
promoted ineffective repurposed drugs like hydroxychloroquine (which was granted
emergency use authorization by Trump’s FDA based on far, far less data than
what were used to grant COVID-19 vaccines their EUAs).

And what’s RFK Jr.’s answer to the problem of pandemic response? He follows the 
above exchange by saying that he’d get rid of “corruption” at the FDA and CDC,
bragging about how he has a PhD in corporate corruption, and then going on a
bizarre tangent about Fruit Loops supposedly having only three ingredients in
Canada while having 19 ingredients in the US—”Why do we have Fruit Loops in this
country that have 18 or 19 ingredients and you go to Canada and it’s got two or
three?”—in order to justify getting rid of the FDA nutrition department.

That’s not all, though. RFK Jr. doubled down on his bad idea to recommend—”on
day one”—that states stop fluoridating their water, citing the usual
cherry-picked studies and ranting about “corruption” at the EPA under the Obama 
administration. This is, of course, a very bad idea, as Steve Novella just wrote
last week, given that fluoride is safe and effective and water fluoridation
programs represent one of the greatest public health achievements of the 20th
century. While it is true that states, not the federal government, make policy
decisions on water fluoridation, it’s not difficult to imagine some
Republican-led states using such a recommendation as a reason to stop their
water fluoridation programs.

What would RFK Jr. actually do?

One thing that’s puzzled me ever since RFK Jr. bent the knee to Donald Trump in 
return for a role in his administration is the question of what, exactly, he
would do, Bigtree’s pronouncements quoted earlier in this post (which don’t
clarify things at all) notwithstanding. What would RFK Jr.’s role be? Nothing
that I’ve read so far has really clarified that. I’ve heard speculation that he 
might be named HHS Secretary, but I’ve had discussions in which people have said
that, even in a Republican Senate (which we will have in January), he is
“unconfirmable,” based his past and the likely difficulty he would have gaining 
a security clearance from his previous behavior, which includes photos
documented in this news article, such as the famous interview this year when he 
admitted to having dumped a bear carcass in Central Park ten years ago:

These photos don’t even include when RFK Jr. beheaded a beached whale and
transported the head home on top of his car.

Even with these photos and RFK Jr.’s history I’m not so sure that he’s
“unconfirmable” anymore, given what’s become of the GOP, but I do know that RFK 
Jr. doesn’t have any experience running a bureaucracy as huge as HHS. I also
suspect that he would chafe under many of the mundane details that come with
running a bureaucracy as huge as HHS, particularly given his lack of experience.
So I rather suspect that he’ll likely take on an advisor or “czar” role that is
relatively undefined and work behind the scenes to pick who runs HHS, the FDA, 
the CDC, and NIH, while letting the picks know just what he wants them to do.

One of the names that I keep seeing popping up to be FDA Commissioner is Dr.
Martin Makary, although sometimes I see his name popping up to lead the CDC.
Makary is a well-published surgical oncologist at Johns Hopkins, which is why I 
frequently joke (as a fellow surgical oncologist) about needing to put a paper
bag over my head when I see some of his pronouncements. You probably recall that
we at SBM don’t think much of Makary, who first came to my attention as one of 
the foremost promoters of the myth that medical errors constitute the third
leading cause of death in the US, all based on a risibly incompetent study that 
used unjustifiable extrapolation from small numbers to conclude that 250,000
deaths occur each year in hospitals due to medical error. As I pointed out at
the time, whenever you see an estimate of how many deaths are “deaths by
medicine,” it’s very helpful to compare that estimate with what we know to
assess its plausibility. According to the CDC in 2016, of the 2.6 million deaths
that were occurring every year in the U.S., 715,000 occurred in hospitals,
which meant that, if Makary’s estimates were correct, 35% of all hospital deaths
were due to medical errors. But the plausibility of Makary’s estimate was worse
than that. Remember that the upper estimate used by Makary and Daniels was
400,000 inpatient deaths due to medical error. That was 56%—yes, 56%—of all
inpatient deaths. It was never anywhere near plausible that one-third to over
one-half of all inpatient deaths in the US were (or are) due to medical error.

Since then, Marty Makary started out semi-reasonable on COVID-19 but was, as our
very own Jonathan Howard has long documented, quick to be captured by his
audience and fully embrace the “let ‘er rip” approach to the pandemic in a
futile effort to achieve “natural herd immunity,” which, he promised, was always
no more than six months away, after which he rapidly pivoted to fear mongering 
about COVID-19 vaccines. I can’t decide whether he would be more of a disaster
heading up the FDA or the CDC, given his ideology and lack of qualifications for
either.

Another name I keep seeing popping up as possible CDC Director is Dr. Joseph
Ladapo. However unsure I am about just how bad Dr. Makary would be at CDC, I
know that Dr. Ladapo would be an unmitigated disaster, given his track record in
Florida, where he as Surgeon General has been in charge of the Florida
Department of Health since 2021. This, of course, was never unexpected given
that Dr. Ladapo was a founding member of America’s Frontline Doctors, which made
a name for itself in that horrible first summer of the pandemic by touting
hydroxychloroquine as a miracle cure for COVID-19 and later turned to telehealth
grift selling prescriptions for ivermectin to cure COVID-19, and a signatory of
the Great Barrington Declaration, the document published by contrarian
scientists brought together by a right-wing think tank to advocate a social
Darwinist “let ‘er rip” approach to the pandemic with poorly defined “focused
protection” for those most at risk for severe disease and death from the
pandemic. Last year, he was busted for altering a Florida Department of Health
study for lying with statistics to make it look as though the vaccine was more
dangerous than COVID-19 for men under 40. Earlier this year, consistent with its
inclusion in this “guidance,” Dr. Ladapo was parroting bad science that
massively exaggerated the problem of DNA contamination of the vaccine. I
discussed not too long ago just how bad he would be as a potential pick at the
federal level, namely plenty bad, man. He’d be an utter disaster, no matter what
agency he was placed in charge of CDC, FDA, or whatever.

And then I remembered a Washington Post article that I had seen before the
election but forgotten, reporting that Ladapo is on the shortlist to become HHS 
Secretary, although he might end up being Surgeon General, given that HHS
Secretary is a position that requires Senate confirmation and Surgeon General is
not. We can only hope it’s not HHS Secretary, as, unlike the case of being
Surgeon General in Florida, which has considerable power, the post of Surgeon
General of the US is more a bully pulpit, with little actual political power.

Then there’s Dr. Vinay Prasad, who before the election and even more so since
the election seems to be furiously angling for a position in the Trump
administration by kissing up to RFK Jr. and appears to be angling for a high
ranking job at NIH. (He’s clearly too junior to be NIH Director, but I have
little confidence that that would stop Trump from appointing him.) For example:

The NIH is a failure. It has never tested how to give grant money. We have no
idea if the current system is better than modified lottery or other proposal. It
has no interest in data transparency, publishing in timely fashion, and
reproducibility. The agency also needs a hair cut, and a leader who understands 
these concerns.

While the NIH has problems, some of which I have even written about, in these
areas, I’ve seen nothing in Dr. Prasad’s Substack and public utterances to
suggest that he has clue one what to do to address these problems through
modifications in policy and operation. Some of the other things that he mentions
are problems that RFK Jr. notes that are actually problems, such as too many
conflicts of interest in certain agencies and a revolving door between
government and industry, but I have zero confidence that RFK Jr. or Prasad has
any workable ideas on how to correct these problems, particularly given how
gullible Prasad was in agreeing that RFK Jr. had a point when he claimed that
the childhood vaccine schedule is unsafe because not all vaccines have been
tested against saline placebo, a distortion that I’ve discussed a number of
times. Basically, Prasad has been good at weaponizing the evidence-based
medicine paradigm against public health. One also wonders what he thinks of RFK 
Jr.’s MAHA plan to devote half the NIH budget to studying “integrative” health
and chronic disease.

Finally, there’s Dr. Jay Bhattacharya, co-author in 2020 of the Great Barrington
Declaration, which advocated a “let ‘er rip” approach to the pandemic, with
“focused protection” of those at highest risk for severe disease and death, in
order to achieve “natural herd immunity,” while not spelling out what, exactly, 
was meant by “focused protection.” It’s an approach that never would have worked
and whose advocates devastated (and continue to devastate) public health. What 
position is his name popping up for? CDC Director, of course.

A number of pundits and apologists have been trying to reassure the public that 
it isn’t that bad, that what RFK Jr. can actually do is fairly limited given
that much of the current construction of HHS and the agencies that make it up is
defined by statute and would require an act of Congress to change too
dramatically. True enough, but that doesn’t mean that RFK Jr., through the
appointment of his buddies, couldn’t do enormous damage anyway. Let’s look at
one example, the Advisory Committee on Immunization Practices (ACIP). This is
the committee that advises the CDC on vaccination policy and which vaccines to
include on the childhood and adult schedules, which is why it has long been a
target of ire for antivaxxers. In August, Dr. Paul Offit wrote about what sort
of mischief that could be done to ACIP by antivaxxers in a Trump administration,
although he focused on The Heritage Foundation’s Project 2025 and the desire to
basically eliminate the CDC as a recommending body for vaccines. I don’t think 
that even RFK Jr. would do that.

First, Dr. Offit describes ACIP and its history:

During the 1940s and 1950s, the United States Public Health Service (USPHS)
relied on committees that met intermittently to address various vaccine issues. 
For example, in 1955, the USPHS convened experts to determine who should get
Jonas Salk’s polio vaccine. By the early 1960s, with the licensure of new
vaccines, it became evident that these committees needed to meet regularly. In
March 1964, the Surgeon General created the Advisory Committee on Immunization
Practices (ACIP), which was composed of experts in virology, immunology,
microbiology, pediatrics, epidemiology, public health, and preventive medicine. 
The charge to the ACIP was clear: “The Committee shall concern itself with
immunization schedules, dosages and routes of administration and indica­tions
and contraindications for the use of these agents. The Committee shall also
provide advice [to the CDC] regarding the relative merits and methods for
conducting mass immunization programs.”

Since 1964, ACIP experts have recommended many safe and effective vaccines.
Prior to these recommendations, every year in the United States polio caused
20,000 cases of paralysis and 1,500 deaths; measles caused 48,000
hospitalizations and 500 deaths; mumps was the most common cause of acquired
deafness; rubella (German measles) caused 20,000 cases of congenital birth
defects; rotavirus caused 70,000 hospitalizations from severe dehydration; and
bacteria such as pneumococcus and Haemophilus influenzae type b (Hib) caused
tens of thousands of cases of pneumonia, sepsis, and meningitis and hundreds of 
deaths. Thanks to vaccines, and the clear, strong recommendations by the ACIP
and CDC, these diseases have been dramatically reduced or eliminated. Indeed, in
a recent report published on August 8, 2024, researchers found that among 117
million children born between 1994 and 2023, CDC-recommended vaccines prevented 
about 500 million illnesses, 32 million hospitalizations, and 1.13 million
deaths.

All of this is true, which is why I don’t think RFK Jr. would eliminate ACIP,
even though he could. (The ACIP charter expires if it isn’t renewed every two
years.) Rather, more likely he would subvert ACIP. The Secretary of HHS picks
the members of ACIP, after a nomination and selection process. These members
serve staggered terms, and the current roster has four members, including the
chair Dr. Helen Keipp Talbot, whose term expires June 30, 2025, four whose terms
expire in 2027, with the rest expiring in 2028. (The reason for this is that,
for whatever reason, the Biden administration left a number of ACIP committee
positions vacant after the members’ terms had expired and then appointed several
new members in February.) By the end of a Trump administration, all members of 
ACIP could be replaced. Now imagine putting, say, RFK Jr. or his designee in
charge of vetting potential new ACIP Members, a process that could be used to
place four antivax and/or contrarian “scientists” and physicians on the
committee next June, qualifications that prospective members be “acknowledged
experts with an outstanding record of achievement in their own field and an
understanding of the immunization issues covered by ACIP” be damned. Then in
2027, he could add four more, followed in 2028 by replacing the eight remaining 
voting members appointed this year.

Regular readers can only imagine the disaster that would be. Likely no new
vaccines would be added to the CDC-recommended schedule, while some might even
be removed, as committee members harass CDC and FDA scientists to torture the
safety and efficacy data to make it “confess” that vaccines are unsafe and
ineffective. I shudder at the thought. Of course, one thing that I do know about
ACIP is that its conflict of interest reporting requirements are quite
rigorous. That might keep the worst grifters off the committee, but I can’t
guarantee that.

Can RFK Jr. succeed in destroying federal public health policy and programs?

There are many contradictions inherent in the MAHA movement that RFK Jr. has
forged with Donald Trump. For example, RFK Jr. rails against the FDA as being
too beholden to drug companies and quick to approve products without adequate
evidence of efficacy and safety, while also wanting to lower the bar for the
approval of the various quack treatments that he espouses, such as ivermectin
for COVID-19 and cancer. He wants to make the FDA more strict and accountable,
which, even if one could trust him to do this right, would run headlong into the
interests of big business supporters of Trump in big pharma. One might easily
see Trump being swayed to rein in or get rid of RFK Jr. because billionaires
running pharmaceutical and medical device companies don’t like him interfering
with their business. Given Trump’s history, who do you think Trump will listen
to, his billionaire supporters or RFK Jr., whom he only took on as his health
advisor (whatever position he ends up occupying) as an expedience, to get rid of
a potential threat to his election?

Even so, and even considering that it will take years to accomplish what RFK
claims to want to accomplish, be afraid. Be very afraid. Even if RFK Jr.
accomplishes only a fraction what he promises, the damage to public health, the 
vaccination program, the FDA drug and device approval process, and federal
science-based health policy in general, especially public health, will be
incalculable. Previously controlled or even conquered vaccine-preventable
infectious diseases are likely to return, although it might take a few years, by
which time Trump will be out of office and his successor will be blamed. As for
the rest, RFK Jr. will not “make America healthy again.” Far from it. He will
jeopardize the health of Americans by making them vulnerable to infectious
disease, keeping the FDA from approving safe and effective medications while
encouraging it approve quackery of which he approves, and subjecting them to
foodborne illness in the pursuit of the “natural,” like raw milk. And I haven’t 
even gotten into how he could change the rules at CMS to force it to pay for
quackery under Medicare and Medicaid.

The next four years will be a disaster for science-based health policy and
programs. The only question is: How bad? Again, my thought is: Plenty bad, man.


RFK Jr. is now an extinction-level threat to federal public health programs and 
science-based health policy

A week ago, Donald Trump said that, if elected, he would let Robert F. Kennedy, 
Jr. “go wild” on healthcare. RFK Jr. has said that he’d immediately remove
fluoride from drinking water, while surrogates say he’d work to prove vaccines
unsafe. This is why a Trump Presidency could represent an extinction-level event
for science-based federal health policy.

David Gorski on November 4, 2024

Link

Prelude: A shift in the political center of gravity of antivax and quackery

It’s the day before the 2024 election, and, contemplating what to write today, I
realized that there was really only one topic that I could address. I’ve said
many times that this blog strives to be nonpartisan but not apolitical. After
all, promoting science-based medicine is not just a scientific and medical
endeavor; it is also a political endeavor, given that the federal government
regulates and funds healthcare, drug approval, and national public health
programs, while state governments regulate the practice of medicine, as well
determining vaccine requirements for school and a number of other medicine- and 
public health-related requirements and local governments have their own laws and
regulations. Indeed, that is why Jann Bellamy (and I) frequently wrote about
“legislative alchemy” designed to provide the imprimatur of the state on
pseudoscientific and quack medical practices and specialties and, before the
pandemic, we used to write regularly about efforts to weaken or eliminate school
vaccine mandates and the “right-to-try” movement, which was custom-designed to 
weaken the power of the Food and Drug Administration.

I will admit, however, that it’s become increasingly difficult to remain totally
nonpartisan, given the events of the last decade, but, even more, events since 
the pandemic hit nearly five years ago. While there are still crunchy lefties
promoting various woo, including alternative medicine, antivaccinationism,
unwarranted fear mongering about pesticides and “chemicals” in food, and false
beliefs that, for instance, cell phone radiation causes cancer, by and large
it’s difficult not to notice that the ideological center of gravity in terms of 
hostility to science-based medicine and science-based health policy has shifted 
far to the right. I’ve described how it’s a process that I first started
noticing 10-15 years ago, as more and more antivaxxers started promoting
conservative and right-leaning candidates; accelerated beginning in 2015, when
opposition to California law SB 277, which eliminated nonmedical exemptions to
school vaccine mandates galvanized the antivaccine movement to successfully use 
the rhetoric of “freedom” and opposition to government overreach to attract
conservatives; infested the Republican Party during the 2016 Presidential
primaries and the 2018 midterms; and became (if you’ll excuse the term)
turbocharged after the pandemic, when opposition to non pharmaceutical public
health interventions like masking or school and business closures, vaccine
mandates, and basically any non-voluntary public health interventions resulted
in the fusion of the antivaccine movement with right wing resistance to what it 
saw as “tyranny.” As we’ve written about and the Conspirituality Podcast has
documented over the last five years or so, basically a lot of the New Age
“spirituality” and quackery, including the antivaccine movement, has shifted far
to the right, to the point that we see lots of pseudoscience and conspiracy
theorists who used to be perceived as being on the left now fully MAGA and
aligned with Donald Trump. Whether this is because the grift is better there or 
because of a genuine ideological shift or both, it’s happened, and I still
haven’t decided what the biggest factor was fueling this shift.

RFK Jr. and Donald Trump teaming up to “MAHA” (I guess).

One such example is Robert F. Kennedy Jr. When I first started writing about RFK
Jr. nearly two decades ago, he had just “come out” as an antivaxxer, publishing
his deceptive conspiracy-fest of an article Deadly Immunity in Salon.com and
Rolling Stone promoting a conspiracy theory falsely claiming that the
mercury-containing preservative thimerosal, which had been used in many
childhood vaccines until around 2001-2, was responsible for an “epidemic” of
autism that the CDC was covering up. (My deconstruction of the article was my
first blog post ever to go viral.) It might be hard for our younger readers to
recall that, when RFK Jr. first launched his antivax crusade in 2015, he
explicitly linked it to his previous environmentalist activism fighting
pollution and mercury contaminating water supplies. It was just the start of
many years of demonizing vaccines and promoting antivaccine pseudoscience and
conspiracy theories. Although I could see signs of this in him before the
pandemic, the pandemic led RFK Jr. to embracing far right movements. As you
probably know, in 2023 RFK Jr. announced that he was running for President.
However, by August, he suspended his campaign and embraced Donald Trump, who
promised him a major role in his administration overseeing health policy. By
September, RFK Jr. had coined the term “Make America Healthy Again” (MAHA), an
obvious homage to Donald Trump’s longstanding slogan “Make America Great Again” 
(MAGA), although in his MAHA manifesto he hid his antivax proclivities, which
his antivax followers did notice and were dismayed.

They shouldn’t have been. Over the last week it’s become very clear that, were
RFK Jr. to be put in charge of the federal health apparatus, either as Secretary
of Health and Human Services (HHS) or in some “czar” role, it would be an
extinction-level threat to science-based federal health policy, which would be
replaced with pseudoscience, quackery, and conspiracy theories. When I first
wrote about RFK Jr.’s antivax conspiracy-fest of an article two decades ago,
never in my worst nightmares did I envision that he might be on the cusp of
being put in charge of the nation’s healthcare policy, regulatory, and research 
apparatus. Worse, the mask is coming off, and it’s becoming terrifyingly clear
what this might mean.

Donald Trump: Letting RFK Jr. “go wild” on health?

Last week, I wrote about what the “health freedom” movement and its takeover of 
the Republican Party in terms of anything having to do with medicine and public 
health might mean after I had come across a post by RFK Jr. on X, the hellsite
formerly known as Twitter, saying that he would “declare war on The FDA”:

The full version of what this might entail can be found here; the CliffsNotes
version follows. Basically, it would mean the dismantling of a regulatory and
public health apparatus built up over decades that, while flawed, has mostly
successfully improved the health of Americans and protected them from unsafe
medications and foods. No one, least of all I, is saying that the system
couldn’t use significant improvement, possibly even major reform, but that’s not
what RFK Jr. is about. What he is about is tearing the system down.

Donald Trump addressing the crowd at Madison Square Garden.

The night before that post went live, Donald Trump held a rally at Madison
Square Garden that made the news because of the racist comments of some of his
surrogates. Less reported was something that Donald Trump promised his
followers:

And we also have somebody that is great. And look, we’re not going to let him go
too crazy, Elon, with the oil and gas stuff. Because Robert F. Kennedy cares
more about human beings and health and the environment than anybody. And he’s
going to be absolute. Having him is such a great honor. I’ve been friends of his
for a long time. And I’m going to let him go wild on health. I’m going to let
him go wild on the food. I’m going to let him go wild on medicine. The only
thing I don’t think I’m going to let him even get near is the liquid gold that
we have under our feet. I don’t know, Elon. He might not like liquid gold. It’s 
oil and gas. Sometimes referred to as oil and gas. J. D. , I think we’re going
to have to keep him away from the oil and gas. What do you think, Howard? Yes?

But where is Robert? He’s around. He gave a beautiful speech. And it’s an honor.

I must admit that one consolation in all this, as minor as it is, is that I do
find it rather amusing that RFK Jr. willingly signed on to be part of a campaign
in which Trump explicitly states that he can’t address the environment—you
know, where his roots were—if it interferes with the profits of the fossil fuel 
industry. Given that so much of public health is related to the environment,
that is a rather large no-fly zone for RFK Jr. I suppose, in his lust for power,
he considers it an acceptable price to pay, but who knows? Be that as it may,
what do “go wild on health” and “go wild on medicine” mean in this context?

When I originally started writing about RFK Jr.’s having joined Team Trump, I
feared that he would want to be HHS Secretary, because the Department of Health 
and Human Services oversees the vast majority of the federal health and medical 
apparatus, including Centers for Medicare & Medicaid Services (which oversees
the massive Medicare and Medicaid programs), the Centers for Disease Control and
Prevention, the Food and Drug Administration, the National Institutes of
Health, and more. However, a discussion with a knowledgeable person suggested to
me that he would be “unconfirmable.” My retort was that, yes, if somehow the
Democrats retained control of the Senate he would not be confirmable, but if
Republicans took control I would not be the least bit confident that he wouldn’t
be confirmed. That being said, apparently he will not be HHS Secretary. Rather,
as a recent news report in The Washington Post suggests, he would be more of a 
“health czar”:

Robert F. Kennedy Jr. is poised to have significant control over health and food
safety in a potential Trump administration, with discussions about some Cabinet
and agency officials reporting to him, according to four people familiar with
the planning process who spoke on the condition of anonymity to detail private
conversations.

Kennedy has been privately meeting with Trump transition officials to help draw 
up an agenda for a new administration, which could involve the longtime
anti-vaccine activist taking a role as a White House czar rather than attempting
to win Senate confirmation to lead an agency, the people said. Kennedy and his 
advisers have also been drafting 30-, 60- and 90-day plans for what they would
like to accomplish after Trump is inaugurated, according to one person familiar 
with the planning process.

“The president has asked me to clean up corruption and conflicts at the agencies
and to end the chronic disease epidemic,” Kennedy said in an interview
Wednesday. “He wants measurable results in two years and to return those
agencies to their long traditions of gold-standard evidence-based science and
medicine.”

And:

Kennedy told his own supporters in a Zoom call Monday that Trump has promised
him “control of the public health agencies,” singling out the Department of
Health and Human Services and its subagencies, and also naming the Department of
Agriculture. The agencies are collectively responsible for implementing food
and public health regulations; approving vaccines, medications and health-care
devices; enforcing safety measures in food-processing facilities; steering
billions of dollars in federal research initiatives; and overseeing Medicare,
Medicaid and the Affordable Care Act, among many other responsibilities.

“Long traditions of gold standard evidence-based science and medicine”? Anyone
who’s paid attention to RFK Jr. over the years knows that RFK Jr. is pretty much
the opposite of evidence-based science and medicine. He has been spreading
antivaccine misinformation, disinformation, and conspiracy theories for close to
20 years now, and, more recently, has increasingly entered the “wellness” grift
side of things. To envision him in charge of so much of the health policy,
science, and research apparatus of the federal government should truly terrify
you. Certainly it terrifies me.

Accordingly, RFK Jr. has apparently been suggesting picks for key posts who are 
in line with his “thinking,” such as it is. The list will include some names
that should be familiar to our readers:

Kennedy has been working to identify possible personnel for a future Trump
administration, a list that Trump advisers say includes Casey and Calley Means, 
siblings and health-care entrepreneurs who have become close advisers to
Kennedy; Marty Makary, a Johns Hopkins University physician who advised the
Trump White House on health-care price transparency; and former Trump health
officials such as former Centers for Disease Control and Prevention director
Robert Redfield and former Department of Health and Human Services spokesman
Michael Caputo.

The Means siblings, Makary, Redfield and Caputo have been working with Kennedy
to roll out his “Make America Healthy Again” (MAHA) platform, an initiative to
tackle chronic disease and childhood illnesses — and a deliberate riff on
Trump’s “Make America Great Again” (MAGA) slogan. None of them responded to
questions about their potential roles in a future Trump administration, with
several declining to comment.

Dr. Martin “Marty” Makary was, before he became a COVID-19 contrarian who has
appeared frequently on right wing media outlets minimizing the pandemic and
advocating a “Great Barrington Declaration”-style “let ‘er rip” approach to the 
pandemic claiming that “we’ll have herd immunity any day now” while fear
mongering about the vaccines, first made a name for himself publishing some of
the most risibly bad science I’ve ever seen. Sadly, that awful science, which
claimed that medical errors are the third leading cause of death in the US (they
aren’t—far from it), “stuck,” to the point that it’s become a commonly cited
(and totally erroneous) factoid that even people who should know better
sometimes casually cite when discussing the shortcomings of our medical system. 
Basically, like RFK Jr.’s resistance to vaccines, the viewpoint promoted by
Makary and his allies has devastated public health—and didn’t work. Truly, given
that Dr. Makary is, like me, a surgical oncologist, whenever I discuss him I
feel like Sylvester Jr. in the old Looney Tunes cartoons, putting a paper bag
over my head in extreme embarrassment and shame due to his father.

“For shame.”

Casey and Calley Means, of course, I have discussed before. They’re a
brother-sister team. Calley is an “entrepreneur” who runs a business based on
attracting federal health savings funds to purchase alternative medicine
treatments. His sister Dr. Casey Means is a physician who trained to become an
otolaryngologist, but dropped out of her residency in her final year. (Who does 
that, so close to the finish line?) In any case, her company promotes “metabolic
health” as the answer to all diseases. From my perspective, they are simply
health grifters who have seized upon the shift of the political center of
gravity of the wellness movement in order to latch themselves onto Donald Trump 
and make money selling their wares to (mostly) the right. As for Dr. Redfield,
he started out semi-reasonable (and provaccine) when he served as CDC Director
during the Trump Administration, but has of late gone further and further down
the MAGA conspirituality rabbit hole, promoting doubt about COVID-19 vaccines
and, of course, lab leak conspiracy theories. Finally, back in 2020, Michael
Caputo, who at the time was Assistant Secretary of Public Affairs at HHS,
publicly stated some bizarre conspiracy theories, such as accusing the “Centers 
for Disease Control and Prevention of harboring a ‘resistance unit’ determined
to undermine President Trump, even if that opposition bolsters the Covid-19
death toll,” led “efforts to warp C.D.C. weekly bulletins to fit Mr. Trump’s
pandemic narrative,” promoted disinformation about COVID-19 vaccines, and is
perhaps best known for having written an email in which he stated that “we want 
them infected” in order to pursue “natural herd immunity.”

It’s quite a motley crew, a rogues’ gallery of COVID-19 antivax disinformation. 
But what would they do?

A dagger aimed at federal health policy and public health

So now we know a bit about the proposed role for RFK Jr and about some of the
characters he might bring in to run HHS, the FDA, the CDC, the NIH, and CMS, but
what would it mean? One indication came in the form of a post like this:

On January 20, the Trump White House will advise all U.S​. water systems to
remove fluoride from public water. Fluoride is an industrial waste associated
with arthritis, bone fractures, bone cancer, IQ loss, neurodevelopmental
disorders, and thyroid disease. President…

— Robert F. Kennedy Jr (@RobertKennedyJr) November 2, 2024

…which were discussed in stories published over the weekend, like this one:

As president, Mr. Trump would not have the power to order states and
municipalities to remove fluoride from their water supplies; fluoridation is a
matter of local control.

But a presidential pronouncement would inject the White House into a debate that
stretches back to the 1950s, when conspiracy theories swirled around
fluoridation, with critics claiming it was a Communist plot to poison Americans’
brains — a view that was memorably parodied in Stanley Kubrick’s film “Dr.
Strangelove.”

I like that the reporter mentioned one of my favorite movies of all time, and,
really, we know 60 years ago, when this movie was released, that this
anti-fluoride fear mongering of the kind that RFK Jr. is now resurrecting was a 
conspiracy theory not based in evidence. Fluoride is safe and has been one of
the most effective public health interventions ever. Again, states determine
whether to fluoridate their water and what concentration to use, but a federal
official recommending against it would likely lead to states whose current
governments are aligned with the MAGA movement deciding to stop fluoridating
their water, likely with predictably bad outcomes in terms of dental health of
their populations, especially children.

Unfortunately, unlike regular readers of this blog, there are a lot of people
who don’t know a lot about RFK Jr., haven’t paid attention to his antivax
activism, and were maybe even reassured by his intentionally not mentioning
vaccines in his MAHA manifesto, even if his own followers weren’t and were
dismayed. Remember, in 2019, a mere three months before a pandemic was declared 
by the World Health Organization, RFK Jr. directly contributed to vaccine fear
mongering in Samoa even as a measles epidemic that would claim the lives of over
80 children was raging. Before that he used to routinely compare vaccines and
the vaccination program to the Holocaust. That is, of course, why his followers 
were so disappointed when he first published his MAHA manifesto that left out
any mention of vaccines. If you were in any way reassured by that, you shouldn’t
be.

For example, over the weekend stories like this one have been published:

Florida’s top health official, whose tenure has been marked by his warnings
against vaccines, threats to TV stations for running abortion ads and frequent
clashes with public health experts, has emerged as a candidate to run the
Department of Health and Human Services in a potential Trump administration,
according to two people familiar with the process.

Joseph A. Ladapo is on a list of HHS secretary candidates being assembled by
Robert F. Kennedy Jr., who has been charged with helping select staff for the
nation’s health and food agencies if Donald Trumpwins office, according to the
people, who spoke on the condition of anonymity to describe the planning
process. HHS is responsible for overseeing Medicare, Medicaid and the Affordable
Care Act; approving vaccines, medications and health-care devices; coordinating
responses to disease outbreaks; and numerous other priorities across its nearly
$2 trillion budget.

Ladapo, who has served as Florida’s surgeon general since 2021, has repeatedly
defied public health practices — such as failing to urge parents to vaccinate
their children or keep unvaccinated students home from school during a recent
measles outbreak — drawing scorn from public health experts who say his
decisions have imperiled Florida residents.

We’ve been writing about how bad Dr. Joseph Ladapo has been regarding vaccines
going back a few years. You might remember that Ladapo first came to prominence 
during the early days of the COVID-19 pandemic as a founding member of America’s
Frontline Doctors, which made a name for itself in that horrible first summer
of the pandemic by touting hydroxychloroquine as a miracle cure for COVID-19 and
later turned to telehealth grift selling prescriptions for ivermectin to cure
COVID-19, and a signatory of the Great Barrington Declaration, the document
published by contrarian scientists brought together by a right-wing think tank
to advocate a social Darwinist “let ‘er rip” approach to the pandemic with
poorly defined “focused protection” for those most at risk for severe disease
and death from the pandemic. In 2021, Florida Governor Ron DeSantis appointed
Ladapo Surgeon General, a position that put him in charge of the Florida
Department of Health, where he proceeded to do everything in his power to impede
public health responses to the COVID-19 pandemic and to spread fear and
uncertainty about COVID-19 vaccines, even if he had to cook the numbers and lie 
with statistics to do it. In the meantime, he continued to promote COVID
misinformation, even going so far as to refuse to recommend COVID-19 vaccines to
almost anyone this year, the first time, as far as I’m aware, that a state
government health department failed to recommend an FDA-approved and
CDC-recommended vaccine against anything. I feared and speculated that Ladapo
might score a high ranking federal position related to health policy if Donald
Trump were elected. Ladapo is, after all, one of the golden docs in the MAGA
antivax movement. Now, if Trump wins, that fear is likely to become reality:

The prospect of a vaccine skeptic such as Ladapo in a national health role has
alarmed public health experts, pointing to his decision to warn Florida
residents against the mRNA coronavirus vaccines while citing debunked claims. No
other state public health officer has followed his lead.

It’s worse than that, though:

A co-chair of Donald Trump’s transition team said Trump supporter Robert F.
Kennedy Jr. wants access to federal health data so he can show vaccines are
unsafe and lead to them being pulled from the market in a second Trump
administration.

Howard Lutnick echoed a number of Kennedy’s debunked anti-vaccine talking points
in a CNN interview Wednesday, including falsehoods about the vaccine schedule
and the disproven theory that vaccines cause autism. Trump has talked often
about how Kennedy, who suspended his own presidential bid and endorsed him in
August, will have a big role to play if the former president returns to the
White House.

While Lutnick said Kennedy would not be chosen as secretary of health and human 
services, he was not specific about what Kennedy’s role might be. Lutnick made
the comments the same day that Kennedy told NewsNation that Trump asked him to
“reorganize” agencies including the U.S. Centers for Disease Control and
Prevention, the National Institutes of Health, the Food and Drug Administration 
and some agencies under the Department of Agriculture.

If you’ve read this blog and/or my not-so-secret other blog, you know that
antivaxxers use data from vaccine safety databases the same way that a drunk
uses a light pole: For support, not illumination. Just look at Steve Kirsch and 
his increasingly ridiculous torturing of any data that he can get his hands on, 
all designed not to determine if vaccines are safe, but rather to prove, by any 
means necessary, including torturing the data, that vaccines are dangerous and
ineffective. You can be sure that, should RFK Jr. gain access to federal vaccine
and medication safety databases, what will follow will be a tsunami of poor
quality and misleading studies designed to demonstrate that vaccines cause
autism, childhood chronic health problems, and all manner of health issues, and 
that they don’t work. Count on it. That’s what his antivax org Children’s Health
Defense has done for years. Why would it be any different if RFK Jr. gains
power over the massive federal health apparatus. Trump’s own co-chair for his
transition team has told you what RFK Jr. wants to do. He wants to “prove” that 
vaccines are unsafe, as a prelude to taking all of them off the market:

Lutnick, the CEO of the financial services company Cantor Fitzgerald, told CNN
that Kennedy wants access to data “so he can say these things are unsafe” and
that will stop the sales.

“He says, if you give me the data, all I want is the data and I’ll take on the
data and show that it’s not safe. And then if you pull the product liability,
the companies will yank these vaccines right off of the market. So that’s his
point,” Lutnick said.

It was unclear what data Lutnick was referring to since extensive data and
research on vaccine safety is publicly available.

Seriously, the title of an article published the other day by NBC News is not an
exaggeration: Trump team fully embraces RFK Jr.’s vaccine skepticism. If
anything, it’s an understatement, because RFK Jr.’s antivaccine views are not
“vaccine skepticism.” (I hate it when editors and journalists describe his
antivax conspiracy theories that way.) More appropriate is this headline for an 
article published over the weekend in The Intelligencer, a section of New York
Magazine, Trump Transition Chair Blurts Out Plan to End All Vaccines: Kook
Robert F. Kennedy Jr. to steer Trump public health:

In the interview, Lutnick calmly repeated a series of vaccine-skeptic talking
points. He did not even limit his vaccine skepticism to the COVID-19 vaccine,
which is safe and effective, but to all vaccines, which he painted as
unregulated, dangerous, and part of a for-profit conspiracy between the
pharmaceutical industry and the federal government. The steps he proposed would 
be to give Kennedy data about vaccines, and if Kennedy decides they are not
safe, which he already has, the FDA could pull approval.

Exactly. If Trump is elected, RFK Jr. might finally have the opportunity to
realize his longtime dream of eliminating vaccines from the market. Sure, he’ll 
deny that that’s what he wants and claim that he’s “not antivaccine” or, even
more risibly, that he’s “fiercely provaccine,” even though his history
demonstrates that he is neither.

And:

What is far more likely, Semafor notes, is that Kennedy could be an “adviser or 
czar, positions that would not require Senate confirmation. That sort of post
would allow Kennedy to wield influence over the broad swath of agencies he has
taken an interest in (he has named CDC, FDA, NIH, USDA, and “others”). Kennedy
couldn’t shape policy in all these agencies from any one cabinet position, but
he could do so as an adviser or czar with a broad portfolio.

The sort of havoc this arrangement could wreak is almost impossible to fathom.
The federal government plays an essential role in authorizing vaccines and
pharmaceuticals. It is true that the government’s scientific authority is not
omniscient, and there are enough cases in which scientific authorities have
imposed political judgment in place of evidence to raise ample grounds for
treating any of their pronouncements with some skepticism.

But justified skepticism is one thing. Subjecting public-health decisions to RFK
Jr.’s cracked worldview is something else altogether. And the process Lutnick
proposed to Collins — that the FDA could withdraw approval for a suite of
life-saving vaccines because Kennedy decides the data is insufficient — is a
glimpse into a public-health nightmare.

It’s more than just vaccines and fluoride, though. If Trump wins and RFK Jr.
gains the power he seeks, the entire federal public health establishment could
be reorganized and recast, to the detriment of public health everywhere:

Project 2025 describes the C.D.C. as “perhaps the most incompetent and arrogant 
agency in the federal government,” and calls for it to be divided into two
entities.

One would be responsible only for publishing data gathered from states and other
sources. The other would retain a “severely confined ability to make policy
recommendations” under the auspices of political leaders.

“He’ll go down the path that he started, which is to fully politicize the
C.D.C.,” said Lawrence Gostin, the director of the W.H.O. Collaborating Center
on Global Health Law, referring to a second Trump administration.

Exactly. The article mentions that a lot of this would require Congressional
approval and that “moderate Republicans” might balk at going so far, but there
is a widespread belief in the GOP that the CDC has “gone too far,” which has led
to a desire to “pare it back” to stop it from investigating or intervening in
legitimate public health issues whose findings are not in line with MAGA
politics, such as gun violence and the like.

Worst of all, however, RFK Jr. would have huge influence over the CDC,
particularly given that the HHS Secretary appoints the members of the Advisory
Commission on Immunization Practices (ACIP), the committee that formally
recommends the childhood and adult vaccine schedule. While it is true that
states determine which vaccines are included in school vaccine mandates,
generally they take the CDC’s lead, following its recommendations, which are
made and periodically updated by ACIP. One can imagine an HHS Secretary under
Trump appointing antivaxxers to ACIP, which would wreak havoc with our
vaccination program.

Whether it’s perceived as partisan or not for me to say it, I’m going to say it 
anyway Trump wins the election tomorrow and actually keeps his word to give RFK 
Jr. the portfolio and influence that he’s claiming (which is, given Trump’s
history, not a given), it will be an extinction-level threat to public health in
the US. If Trump wins and RFK Jr. manages to accomplish only a fraction of what
he wants to accomplish in terms of policy with respect to vaccines, fluoride,
drug regulation, and public health, in four years, Americans will be less
healthy and sicker. Far from “making America healthy again,” RFK Jr.’s MAHA
would have the potential to make us sicker than ever.

One of my favorite pundits, the great Charles Pierce, riffing on my
aforementioned beloved movie Dr. Strangelove, put it best: “Deny these people
your essence, America.”


RFK Jr. vs. the NIH: Say goodbye to the greatest engine of biomedical research
ever created

President-Elect Donald Trump has nominated antivaccine activist and anti-pharma 
conspiracy theorist Robert F. Kennedy, Jr. to be Secretary of Health and Human
Services. I’ve written about the damage he will do, if confirmed, to the CDC and
FDA, but what about NIH, the greatest engine of biomedical research ever?

David Gorski on November 18, 2024

Link

Shares

Ever since antivaccine and pharma conspiracy theorist and enemy of public health
Robert F. Kennedy, Jr. suspended his quixotic campaign for the Presidency to
bend the knee to Donald Trump, in return for the promise of a high-ranking
position in Trump’s administration related to health policy—and especially since
Donald Trump won the election two weeks ago—I’ve been writing about what a
horror he could be for public health, regardless of the position to which he
ended up being appointed. Then, over a week ago, we learned that President-Elect
Trump plans to appoint him as Secretary of the Department of Health and Human
Services, something that I had been speculating as a strong possibility and
likely the worst-case scenario, given that the HHS Secretary is in charge of
basically all non-military medical and health policy and oversees the critical
health infrastructure in the department, which includes the Centers for Disease 
Control and Prevention (CDC), the Food and Drug Administration (FDA), the
National Institutes of Health (NIH), and the Centers for Medicare and Medicaid
Services (CMS). Truly, RFK Jr., if confirmed by the Senate—which he might well
be even in spite of his antivax conspiracy-mongering and stories about his
having had a brain worm, dumped a road-kill bear cub in Central Park ten years
ago, and decapitated a dead whale to take the head home—will be a catastrophe
for federal health policy and medical research. (Sadly, the only thing that I
see maybe tripping up his confirmation is his past strong support for abortion
rights.)

Given his antivaccine background, burbling from the Trump campaign that RFK Jr. 
wanted access to federal vaccine safety databases in order to “prove” vaccines
are unsafe as a pretext for taking them off the market, and his threat to
“declare war” on the FDA, at first I concentrated mainly on the FDA and the
Centers for Disease Control and Prevention, in particular the damage that he
might do to the CDC’s vaccination program, but equally important is what he
might do to the National Institutes of Health, arguably the greatest engine of
biomedical research ever created. When I saw news stories floating around this
weekend that high on the list of candidates for NIH Director is a name familiar 
to our readers, namely Dr. Jay Bhattacharya, coauthor of the Great Barrington
Declaration, that famous anti-public health manifesto calling for a “let ‘er
rip” approach to the pandemic—in October 2020, before there was a vaccine!—with 
the futile goal of achieving “natural herd immunity,” with a poorly defined
strategy of “focused protection” that would supposedly keep those most
vulnerable to severe disease and death from COVID-19 while the presumably young 
and healthy died at a much lower rate than the elderly and ill as the virus
rampaged through the population. It was a tendentiously libertarian and
profoundly social Darwinist approach to “open up the economy” at the expense of 
disease and death that never would have worked and ultimately caused enormous
damage to public health.

I knew when I saw these stories that I had to discuss the consequences to the
NIH of having an antivax conspiracy theorist who wants to devote half of NIH
resources to “chronic diseases” in charge of the department under which NIH
falls and a director likely handpicked by him. Spoiler alert: It won’t be good. 
At all.

How the NIH doles out money

Over 80% of NIH funding goes to funding extramural research grants
(extramural=not funding labs at the NIH itself). Contrary to the conspiracist
vision of Anthony Fauci—or any other Institute director at NIH, or even the NIH 
director him or herself —personally viewing every grant application and deciding
who gets those sweet, sweet NIH dollars and who does not, there is a
long-defined, rigorous, and codified process used by the NIH to evaluate grants 
applications. It begins with the submission of a grant to the NIH. Before I
discuss what happens next, I will note that the NIH has a number of granting
mechanisms designed for different purposes. For example, the R21 grant is
designed for preliminary work, often the “higher risk” studies that the brave
mavericks demand, and doesn’t require a lot of preliminary data. (The claim that
it can require no preliminary data, however, is generally nonsense. You need at
least some data.) R21s can fund up to two years and cannot be renewed.

In contrast, the granddaddy of them all, the “gold standard” grant for an
individual investigator, small groups of co-investigators, or collaborators, is 
the R01, which can be funded for up to five years (it’s also one of the only
grant mechanisms where the investigator can propose basically anything, rather
than having to address a particular topic or question). At the end of that time,
the investigator can apply for a competitive renewal, which can extend the
grant for up to another five years, and so on ad infinitum. There are a number
of other grant mechanisms, which include training grants for graduate students, 
center grants (e.g., for cancer centers), larger multi-investigator grants, and 
more targeted grants—Wikipedia has a nice list here—but in general all of them
are scored by groups of scientists with the relevant expertise in a review group
called a study section, of which there are dozens in the NIH arranged by topic 
into Review Branches at the Center for Scientific Review. Many of these study
sections are permanent, but the NIH can and does set up temporary study sections
for topics of special interest at the time.

NIH grants generally undergo two levels of review, first the study section and
then advisory councils. To guide the reviews, the NIH has five criteria that it 
uses to evaluate grant applications:

  1. Significance

  2. Investigator(s)

  3. Innovation

  4. Approach

  5. Environment

Other considerations include “Additional Review Criteria”:

As applicable for the project proposed, reviewers will evaluate the following
additional items while determining scientific and technical merit and in
providing an overall impact score, but will not give separate scores for these
items.

  1. Study Timeline (specific to applications involving clinical trials)

  2. Protections for Human Subjects

  3. Inclusion of Women, Minorities, and Children

  4. Vertebrate Animals

  5. Biohazards

  6. Resubmission

  7. Renewal

  8. Revision

Additional Review Considerations. As applicable for the project proposed,
reviewers will consider each of the following items, but will not give scores
for these items and should not consider them in providing an overall impact
score.

  1. Applications from Foreign Organizations

  2. Select Agent

  3. Resource Sharing Plans

  4. Authentication of Key Biological and/or Chemical Resources

  5. Budget and Period Support

Grants undergo anonymous peer review, and usually each application is reviewed
by three or four reviewers, with one of them being a statistician where
appropriate. Those assigned to do the detailed reviews score each of the above
areas from 1-9, although in this case low scores are better, denoting high
impact/priority, and then assign an overall impact score to the grant
application. During the study section meeting, the study section member assigned
as primary reviewer starts the discussion with a summary of the grant
application, the score assigned to it, and why that score was assigned. Then the
others who evaluated each grant application do the same, after which the whole 
study section discusses the application. At the end, every member assigns an
overall impact score to the grant under discussion before moving on to the next 
application. After the study section meeting, all the impact scores are used to 
calculate a final overall Priority Score assigned to the grant application.
Also, the membership rosters of the study sections are public knowledge, as they
are published on the CSR website; so it’s not uncommon for investigators who
got a bad review among their reviews to make a good guess about who was
responsible.

Although I’ve never served as a permanent member of an NIH study section, I have
served as an ad hoc member for specific expertise. (Ad hoc members generally
serve for only one or a handful of grant review cycles, rather than being
assigned for multi-year stints.) As such, I can only comment on the dynamics of 
study sections in which I’ve participated. One thing that I’ve noticed is that
it only takes one highly negative review from a reviewer who is outspoken to
tank an application. I’ve also noted that someone who really likes a grant
application can sway others to score it higher, but the effect seems a bit
weaker than “negative campaigning,” which seems more effective in getting others
to lower their scores.

When an individual grant application hits the NIH, it will be assigned to a
study section. Investigators can influence this process by suggesting study
sections, and, unsurprisingly, some study sections have reputations for being
harsher than others. Once a grant is assigned to a study section, that study
section’s Scientific Review Officer (SRO) will read it, decide if it’s
appropriate for the study section, and assign reviewers:

Assignment of Applications to Specific Reviewers: The SRO assigns applications
to particular reviewers by matching the science in the application to the
reviewer’s expertise. Assignment considerations include: reviewer knowledge
about, and interest in, the goals of the project; expertise in the techniques
proposed; reviewer workload; and real or perceived conflicts of interest. The
SRO encourages reviewers to let him/her know of any concerns that they have
about their assignments. This would include conflicts of interest, concerns
about the appropriateness of the assignment, or the need for additional
expertise.

The SRO also recruits scientists to serve on the study section, thusly:

Identifying and Recruiting Reviewers: Possibly the most important role of the
SRO is to ensure that the reviewers present at the study section meeting have
all the needed expertise to evaluate the applications under review.

In choosing regular members for study sections, it is essential that the SRO
recognizes current trends in the field and ensures that the membership reflects 
where the field is now and where it is going. It is also critical that the
expertise of each nominee complements that of the other members and strengthens 
the study section as a whole.

As you can see, the SRO is a big deal.

The SRO also runs the study section meeting, collates the reviews, takes notes, 
and from those notes and the overall reviews produces a Summary Statement that
includes the overall Priority Score assigned (with a percentile measurement
denoting the percentage of grant applications that were scored higher than the
applicant’s), comments about the discussion at the study section, and the
original “raw” reviews from each study section member who reviewed the grant.
Note that now generally only grants that score in the top one-third to one-half 
receive overall Priority Scores and Summary Statements, because any grant with
higher (and therefore worse) scores are so unlikely to be funded as to make it
not worth the SRO’s effort to put the documents together. These investigators
do, however, still receive the reviews carried out by individual study section
members. SROs also handle appeals from applicants who question whether their
review was fair or whether one or more of the reviewers had the requisite
expertise.

The second level of review occurs through committees formed at each Institute
and Center (IC) at the NIH called Advisory Councils:

The Advisory Council/Board of the potential awarding Institute/Center performs
the second level of review (See Advisory Councils or Boards). Advisory
Councils/Boards are composed of scientists from the extramural research
community and public representatives (NIH Federal Advisory Committee
Information). Members are chosen by the respective IC and are approved by the
Department of Health and Human Services. For certain committees, members are
appointed by the President of the United States.

Now here’s the part where the conspiracy might come in:

Recommendation Process

  1. NIH program staff members examine applications and consider the overall impact
    scores given during the peer review process, percentile rankings (if
    applicable) and the summary statements in light of the Institute/Center’s
    priorities.

  2. Program staff provide a grant-funding plan to the Advisory Board/Council.
    Council members have access to applications and summary statements pending
    funding for that IC in that council round.

  3. Council members conduct a Special Council Review of grant applications from
    investigators who currently receive $1 million or more in direct costs of
    NIH funding to support Research Project Grants (see NOT-OD-12-140). This
    additional review is to determine if additional funds should be provided to 
    already well-supported investigators and does not represent a cap on NIH
    funding.

  4. The Advisory Council/Board also considers the Institute/Center’s goals and
    needs and advises the Institute/Center director concerning funding
    decisions.

  5. The Institute/Center director makes final funding decisions based on staff and
    Advisory Council/Board advice

It’s that last part that the conspiracy theorists harp on. In theory, an
Institute director like Anthony Fauci could override all the peer review to fund
a grant, but in practice it almost never happens. Why? Because the NIH set up
this process in order to minimize the possibility direct involvement of its
leaders in picking and choosing grant awardees based on personal whim. The whole
system exists to try to ensure as much as possible that grant selection is
based on scientific merit, and few other considerations.

I won’t go through the whole appeals process, other than to say that appeals
rarely succeed. I also won’t say that politics and the personal preferences of
various Institute/Center (IC) directors never play a role in grant funding
decisions, but I will say that the system is set up to minimize such biases
playing a significant role in funding decisions. Also, often the people who most
characterize NIH funding decisions as the personal doling out of funding by
directors are the same ones who have no compunction about trying to shut down
research they don’t like themselves—and have been for a long time.

Add to this efforts by the NIH to minimize repetitional bias, in which, all
things being equal, more highly ranked universities and researchers are more
likely to be funded than researchers with a lower reputation or at a university 
with a lower reputation, and the system is complex, full of safeguards, and
designed to work as close to a meritocracy as possible. It is imperfect, of
course, and often doesn’t achieve that goal, but reforming the system so that it
comes closer is clearly not what RFK Jr. is about, given that he’s described
big pharma as a “criminal enterprise,” with the NIH, FDA, and CDC all in cahoots
with it.

RFK Jr.’s plans for NIH

Before I get to discussing why Jay Bhattarcharya (or, likely, any nominee that
RFK Jr. could propose and persuade President-Elect Trump to agree to) would be
such a dumpster fire as NIH Director, let’s take a look at what RFK Jr. has been
saying about NIH and his plans for it. Last week, for instance, RFK Jr. was
quoted as saying:

At an event late last week in Arizona, anti-vaccine activist and Donald Trump
transition team member Robert F. Kennedy Jr. said he’d fire and replace 600
people from the National Institutes of Health on day one of a second Trump term.
The NIH is one of the public health agencies Kennedy loathes the most—and
despite still lacking any defined role in a new administration, he’s clearly
relishing the opportunity to promise retribution against them.

In comments that were first reported by ABC News, Kennedy declared, “We need to 
act fast, and we want to have those people in place on January 20, so that on
January 21, 600 people are going to walk into offices at NIH and 600 people are 
going to leave.”

Of course, RFK Jr. loathes the NIH. Besides its having been the longtime
employer of his nemesis Dr. Anthony Fauci, who ran the National Institute of
Allergy and Infectious Diseases from the 1980s until his recent retirement, one 
key strength of the NIH over its entire existence has been its general
independence from partisan politics and focus on the best science and medicine, 
which automatically excludes RFK Jr. No one is saying NIH is perfect, certainly 
not I, but it is about as close as one can get to a genuine scientific
meritocracy in a federal agency as one can imagine. Moreover, whatever
complaints one might have about its system for determining which research grant 
applications receive funding as being too “safe” or conservative, complaints
resurrected by COVID-19 contrarians during the pandemic, it does try to adhere
to a very rigorous process of scientific peer review by its study sections to
score grants and rank them for funding priority. Could the process be improved
to be made fairer, more rigorous, and more open to less “safe” ideas? Yes. Does 
RFK Jr. have clue one how to do that? No. It’s not even what he’s about, which
is to direct some of that sweet, sweet NIH grant money to his antivax quack
cronies, whom he views as having been unjustifiably “silenced.”

What RFK Jr. seems to be proposing here is to replace directors, managers, and
scientists whom he doesn’t like with political loyalists. This statement is also
yet more evidence that he doesn’t have clue one how NIH operates. There are
only around 200 political appointees in the entire HHS and just a handful at
NIH. At the NIH, most employees are the scientists and physicians who do
biomedical research and oversee the review process for deciding which grant
applications are funded, as well as the support staff to assist them and to
administer yearly grant allocations and the reporting requirements for those
receiving NIH grants. Again, the NIH has long been one of the most apolitical
and nonpartisan agencies in the entire federal government, which has been its
traditional strength. Moreover, there is a culture there that very much resists 
attempts by legislators and politicians to influence its scientific decisions,
even at the National Center for Complementary and Integrative Health, which does
research most aligned with RFK Jr.’s stated priorities.

Given Kennedy’s history, you know that his picks will all be hacks, quacks, and 
conspiracy theorists. It is also not at all clear that he can do this, given
federal civil service protections. It is clear how he wants to realign research 
priorities at the NIH as well:

Calley Means, a self-described health care reform activist who played a role in 
Kennedy’s independent presidential run sat alongside him for part of the
interview. He framed the MAHA movement as “kicking the special interests and the
Deep State” out of government, calling the NIH “an orgy of corruption.”

Kennedy made other eyebrow-raising claims during the interview, for instance
claiming that “pilot studies” showed that anorexia could be cured with a “keto
diets and other kind of diets.”

“NIH won’t do those studies because they don’t want to know the source or the
cure or the treatment of chronic disease,” he declared. He also returned to his 
hobby horse, claiming links between vaccines and a spread in autism.

“I never saw anybody who was autistic when I was a kid,” Kennedy claimed.
“Never.” He added that men his age—Kennedy is 70—don’t have “full blown autism,”
which he defined as “wearing helmets” and “not being toilet trained” and
“head-banging, stimming, toe-walking.”

We’ve written about the brother-sister duo of Calley and Casey Means before.
Casey Means is a former otolaryngology resident who quit in her last year of
residency to peddle “alternative health,” while her brother runs a business that
facilitates people using health savings accounts to purchase quackery. No one
should be surprised at anything that Kennedy said here. It’s just RFK Jr. being 
RFK Jr., the same nonsense that he’s been spewing at least since 2005 about
vaccines causing autism. As always, he continues to confuse correlation with
causation and blame vaccines for a phenomenon that reflects far more on
broadening of the diagnostic criteria for autism spectrum disorders in the
1990s, increased screening and surveillance, and a better understanding of the
underlying neurodevelopmental contributors to autism than any biological basis
for an increase in measured prevalence.

RFK Jr. vs. “conflicts of interest”?

A couple of months ago, not long after he had bent the knee to Donald Trump, RFK
Jr. published an op-ed in The Wall Street Journal entitled entitled Trump Can
Make America Healthy Again, which was subtitled, “Chronic diseases have reached 
crisis proportions, and Kamala Harris seems uninterested in the issue.” In it,
RFK Jr. laid out a 12-point plan to “make America healthy again,” which spawned 
MAHA, to go along with MAGA (“make America great again”). I discussed his plan
in depth then, noting how assiduously RFK Jr. hid his antivax proclivities given
that vaccines weren’t mentioned even once in the plan (something his antivax
supporters noticed immediately and did not like). Suffice to say that the plan
was a lot of the same ol’ same ol’ about supposed corruption at the FDA; his old
claim, at best highly dubious and exaggerated and at worst false, that children
today represent America’s “sickest generation” (and a lot of it is due
to—cough, cough—vaccines); rants about pesticides; and the usual pharma
conspiracy mongering. While it is true that one part of his proposal, finding
ways to decrease conflicts of interest among scientists and doctors tasked with 
regulating health, was fairly mainstream, the devil is in the details, and we
all know that RFK Jr.’s definition of a “conflict of interest” is very different
from the standard definition; at the very least he has a double standard,
identifying involvement with pharma as a COI but ignoring massive COIs among his
favored quacks, most of whom make their living selling nostrums, quackery, and 
supplements.

Let’s revisit, however, what RFK Jr. wrote in his September WSJ op-ed describing
what he wanted to do with the NIH, first:

Change federal regulation so that NIH funds can’t go to researchers with
conflicts of interest. A 2019 ProPublica analysis of disclosures going back to
2012 found that over 8,000 federally funded health researchers reported
significant financial conflicts of interest.

I asked at the time: According to RFK Jr.’s definition, what constitutes a
“conflict of interest” for an NIH-funded researcher? Once again, I remind our
readers that many of these researchers are trying to translate their findings
into actual medical products that benefit patients, be they new drugs, devices, 
or other treatments designed to prevent and treat specific diseases. To do so,
they often either form companies themselves or partner with existing companies
to continue to develop their findings from the basic science and preclinical
stages into an FDA-approvable, marketable product ready to undergo randomized
clinical trials for FDA approval. There are even NIH grant mechanisms
specifically designed to assist this process, like the Small Business Innovation
Research (SBIR) and Small Business Technology Transfer (STTR) programs,
collectively the Small Business Programs, also known as America’s Seed Fund.

Last year, during an interview with Lex Fridman, RFK Jr. pontificated about what
he meant when it came to NIH “COIs”:

From around the 7:00 mark:

In fact there’s a word for those kind of scientists who take money for their
opinion and the words by biostitutes and they are very very common and you know 
and I’ve been dealing them with, with them my whole career. You know, I think it
was Upton Sinclair who said that it’s very difficult to persuade a man of a
fact if the existence of that fact will diminish his salary and I think that’s
true for all of uf. If they, you know, we find a way of reconciling ourselves
the things that are the truth that actually and world wiews and actually benefit
our our salaries.

Now NIH, um, NIH has probably the worst system which is that scientists who work
for NIH—NIH itself which used to be the premier gold standard scientific agency
in the world. Everybody looked at NIH. Today it’s just an incubator for
pharmaceutical drugs, and, and, you know, that is that gravity of economic
self-interest because if you’re, um, if NIH itself collects uh royalties, they
have margin rights for the patents, on all the drugs that they work on. So, with
the Moderna vaccine which they, promoted incessantly and NIH on 50% that
vaccine is making billions and billions of dollars on it, and there are four at 
least four scientists that we know of and probably at least six at NIH who
themselves have margin rights for those patents. So if you are a scientist who
work at NIH you work on a new drug you you then get margin rights and you’re
entitled to royalties 150,000 a year forever from that forever—your children,
your children’s children. As long as that, uh, product’s on the market you can
collect royalties. So you have you know the modern vaccine is paying for the top
people at NIH, you know some of the top regulators is paying for their boats
it’s paying for their mortgages paying for their children’s education and you
know you have to expect that the uh that in those kind of situations the
regulatory function would be um subsumed beneath the mercantile ambitions of the
agency itself and the individuals who stand to profit enormously from getting a
drug to market. Those guys are paid by us the taxpayer to find problems with
those drugs before they get to Market but if you know that drug is going to pay 
for your mortgage you may overlook a little problem and that we’re even a very
big one and that’s the problem.

A couple of points in response: First, I hate the term “biostitute.” It’s a term
that RFK Jr. has long used to describe scientists and physicians whom I admire 
for their pro-vaccine and pro-science advocacy, especially Dr. Paul Offit.
Second, and more importantly, what planet is RFK Jr. living on? His description 
of how things work bears little resemblance to how things actually work with
respect to royalties to the NIH from pharmaceutical companies who use NIH-funded
research to develop marketable products. One of the better debunking of this
conspiracy theory was published this June in Science, in response to its being
claimed by Rep. Marjorie Taylor Greene, who claimed that the NIH had pocketed
$710 million in royalties from COVID-19 vaccines and that Fauci had personally
collected millions.

In reality:

A series of laws passed by Congress starting in the 1980s that aimed to spur
innovation and sharing of technology allows federal employees to receive a
limited share of the royalties. But NIH scientists can legally only earn up to
$150,000 a year in royalties, which Andrzejewski tells ScienceInsider he knew, 
although it wasn’t disclosed in his article. And the reality that almost all of 
the $710 million went back to the U.S. government is also easy to verify on a
long-standing, public NIH website about royalty distributions from technology
transfers.*

In one exchange with Fauci, Malliotakis asked whether he thought that “any of
those royalties, this nearly billions [sic] of dollars, should be going back to 
the American taxpayer, not in the pockets of the scientists?”

In fact, NIH said most of the royalty income that comes to institutes and
centers “supports additional research,” noting that U.S. law stipulates how it
may be used, including a requirement that money be given to the U.S. Department 
of the Treasury if the amount exceeds 5% of an agency’s annual budget.

It is true that the NIH does not routinely disclose how much in royalties
individual scientists receive. If all RFK Jr. wanted to do was something like
the  the Royalty Transparency Act, a bill with broad bipartisan support that
would require the NIH to disclose this information, I could be on board with
that. However, somehow I doubt that’s what he has in mind, given that he is
lying about the situation. Yes, I say “lying,” because as a lawyer RFK Jr. knows
all the information cited above and that how royalties to the NIH from
pharmaceutical companies using its research are distributed is mandated by law. 
Indeed, he must know that the vast majority of the payments in the report
commonly cited by cranks like RFK Jr. predate the pandemic.

Also:

Fauci’s payments came from Santa Cruz Biotechnology, a company that develops
products for biomedical research. Santa Cruz Biotechnology made 13 other
payments to Fauci from 2010 to 2019.

When the Associated Press wrote in 2005 about previous royalties paid to Fauci, 
and how the payments raised concerns about potential conflicts of interest,
Fauci said he planned to donate all royalties that he receives to charity. He
told the AP that he tried to refuse the royalties, but was told that he was
legally obligated to accept the money.

Again, one can argue that the royalty payments mandated by law for the last few 
decades are a problem. One can argue that perhaps they should be curtailed or at
least more fully disclosed, but consider this. RFK Jr. is also lying about the 
NIH. The NIH has no regulatory function when it comes to drug approval; its
scientists are not taking royalties from pharmaceutical companies whose products
they are approving. RFK Jr. knows that, but he also knows that most Americans
don’t know that. So he lies.

No one, least of all I, will argue that COIs shouldn’t be reported. Moreover,
the NIH does require its investigators to report any financial COI that involves
more than $5,000/year. (I know this because as faculty at a university that
receives NIH funding, every couple of years I have to do online training about
COIs). If the goal of NIH-funded research is to lay the groundwork for drugs,
treatments, and devices that are ultimately turned into products it is
counterproductive to ban NIH funds from going to anyone who has a financial
interest with a pharmaceutical, medical device, or food company. One can
reasonably argue about policies designed to minimize harmful influences due to
financial COIs and how to make sure that all COIs are reported and findable by
the public, but to ban researchers with interest in a company related to the
research that they are carrying out would likely have the unintended consequence
of seriously hampering further research. The issue is, of course, complex,
predictably RFK Jr. has presented an oversimplified version of it designed to
imply that most NIH researchers are in the pocket of big pharma, all as a
pretext towards, likely, undertaking a witch hunt for scientists with COIs that 
he thinks he can fire.

The NIH and chronic disease

Next up, from RFK Jr.’s MAHA manifesto published in the WSJ:

Devote half of research budgets from the NIH toward preventive, alternative and 
holistic approaches to health. In the current system, researchers don’t have
enough incentive to study generic drugs and root-cause therapies that look at
things like diet.

I note once again that the NIH already has a fairly well-funded center to
examine these questions, the National Center for Complementary and Integrative
Health (NCCIH), formerly the National Center for Complementary and Alternative
Medicine (NCCAM). Of course, research into the “preventative, alternative, and
holistic approaches to health” funded by NCCIH includes rank quackery such as
acupuncture and highly dubious treatments like chelation therapy for
cardiovascular disease. This proposal sounds as though RFK Jr. wants to expand
NCCIH to take up half of the NIH budget, which would, of course, be a disaster
for public health. I also note once again that one of the most efficacious and
safe preventative approaches to health is vaccines. I’d love it if the NIH put
more resources into vaccine research, but somehow I suspect that RFK Jr. isn’t
including vaccines in the category above.

In fact, in a recent interview:




View on Threads




View on Threads




View on Threads

I have been trying to locate the full version of this video in order to find the
context (even though just this 24 second clip is bad enough), thus far without 
success. Apparently it was some sort of Tik Tok townhall done earlier this year,
before RFK Jr. suspended his campaign:

TikTok served me an RFK town hall. He spent 10 minutes talking about vaccines,
implied they cause autism; then said that he wasn't anti-vax, just anti- all
vaccines we currently have, and says as POTUS he'd stop research on drug
development and infectious diseases for 8 years. pic.twitter.com/PKAzZ56Mn8

— Jacob Rubashkin (@JacobRubashkin) June 21, 2024

I also note that RFK Jr. didn’t mention cancer in this video clip, which is
rather why I want the whole video to examine. Finally, “functional medicine”
quack Dr. Mark Hyman is in on this discussion, because of course he is. In any
case, in the video RFK Jr says:

I’m going to go to NIH my first week, and I’m going to call all the division
heads and I’m going to call all the division chiefs, and I’m going to say: We’re
going to give drug development and infectious disease a break, a little break, 
a little bit of a break, for about eight years, and we’re going to study chronic
disease.

This is an incredibly stupid and dangerous idea. For one thing, it’s a false
dichotomy. Some infectious diseases are chronic diseases or produce chronic
diseases. Hepatitis B and C come to mind, which can both result in chronic liver
failure. For another thing, infectious diseases don’t care about your ideology.
During that eight year “pause,” we could face another pandemic. The overall
budget for the National Institute of Allergy and Infectious Diseases (and
allergies are also chronic diseases) is just over $6.5 billion, out of a $47
billion total NIH budget. It’s minuscule in the scheme of things. Moreover, we
are increasingly approaching a crisis due to bacteria resistant to our most
powerful antibiotics, with the World Health Organization declaring that
antimicrobial resistance (AMR) is “one of the top global public health and
development threats. It is estimated that bacterial AMR was directly responsible
for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths
(1).”

Moreover, the NIH already does fund research into chronic diseases. Here are the
budgets for the last five years:

Look at how much goes to National Heart, Lung, and Blood Institute, to study
heart and lung diseases, most of which are chronic. Ditto the National Institute
of Diabetes and Digestive and Kidney diseases, the National Institute of Mental
Health, and the National Cancer Institute. (Cancer is now a chronic disease for
many people, and the HPV vaccine, for example, can prevent cervical cancer.)

Those of you who have been reading SBM for a while know that what RFK Jr. is
really referring to when he talks about researching “chronic disease” is
researching diet, exercise, and all sorts of woo as the be-all and end-all of
preventing and curing such diseases. What he’s really advocating is that we
should “pause” drug development and infectious disease research in favor of
research of the sort carried out by the National Center for Complementary and
Integrative Health (NCCIH).

Enter Dr. Jay Bhattacharya

I realize that Dr. Jonathan Howard just wrote about how Dr. Jay Bhattacharya,
whose role in promoting the Great Barrington Declaration and, more recently
spreading pandemic misinformation and fear mongering about COVID-19 vaccines,
has floated to the top of the list of potential candidates for NIH Director.
Previously, speculation had been that he was a top candidate for the post of CDC
Director.

Never mind that:

Bhattacharya, who holds a medical degree and PhD from Stanford, has never held a
senior government position, nor any role overseeing a large bureaucratic
organization. While that might have stymied his candidacy in prior
administrations, Kennedy and his allies view his inexperience as a positive,
saying they are seeking reformers willing to battle the bureaucracy.

Yes, putting someone who’s never run a large organization before in charge of a 
large organization always ends well. In any event, putting Bhattacharya in
charge of the CDC or NIH would be bad, with the potential to damage public
health for a generation, and I’m still not quite sure which would be worse.
Whichever is worse, it looks like a fair bet now that he will be nominated for
NIH to replace Francis Collins, and to that end he has been furiously sucking up
to RFK Jr. in posts like RFK Jr Will Disrupt the US Medical Establishment. If
you want to see how far Bhattacharya’s nose is up RFK Jr.’s rectum (far enough
to be able to see his uvula from the inside), try not to gag or laugh too hard
as you watch Bhattacharya swallow what’s left of his scientific pride in order
to dismiss RFK Jr.’s 20 year history of bonkers quackery, antivax conspiracy
mongering and pseudoscience, and just plain wrongness:

Left-leaning outlets, such as the Atlantic, Washington Post, PolitiFact, and
Forbes— as well as the predominantly Left-leaning medical establishment — were
quick to lambast the choice, using selective quotations and a narrow focus to
smear Kennedy. But establishment mandarins who focus on his sometimes eccentric 
scientific claims, from vaccines to AIDS, overlook the single most important
factor in his success: the anti-science, authoritarian policies of the Covid
years. As a result, they miss what matters most in the Kennedy phenomenon: his
broadly appealing, and thoroughly centrist, reform agenda.

And:

The central argument against Kennedy from the medical establishment pertains to 
some of his scientific claims, for example about vaccines, wireless radiation
and cancer, raw milk, and neurodevelopmental disorders caused by water
fluoridation. Kennedy is not a scientist, but his good-faith calls for better
research and more debate are echoed by many Americans. If he remains true to
this promise, scientists will be able to work to address the challenges of
evidence in ways that previous administrations have not. The status quo is not
working for the public interest or patients. If the medical establishment
becomes obsessed with resistance, it will marginalise itself and lose what
little trust the public currently places in it.

Translation: Never mind all the dangerous antivax quackery RFK Jr. has promoted,
you know, his “sometimes eccentric claims” that were “selectively” quoted.
Never mind his 20 year history of promulgating conspiracy theories about
cellphone radiation and cancer, water fluoridation, and raw milk. Don’t worry
about them! Forget about it! After all, RFK Jr. isn’t a scientist; so it’s all
good. He can be taught. (No, he can’t. We’ve been trying to teach him for two
decades, and he only gets worse and worse.) To this, I would add something that 
Bhattacharya must surely know but can’t admit: RFK Jr.’s calls for “better
research” are not in good faith. He has already said that there are no vaccines 
that he considers safe and effective and that basically nothing can change his
mind. His standard of evidence is very much a double standard. He demands
impossible standards of evidence for what he fears (vaccines, pharma drugs) but 
accepts what he likes (“functional medicine,” and quackery for chronic disease) 
based on flimsy to nonexistent evidence.

But what would Bhattacharya do? According to this news article:

Bhattacharya has long called for changes to NIH and other government agencies in
critiques that began before the pandemic. In a 2018 working paper, Bhattacharya
and co-author Mikko Packalen, an economist at the University of Waterloo, wrote
that NIH could “do more to promote innovative science,” arguing that scientific
and political considerations may have led the agency to inadequately fund
exploration into new ideas. Two years later, Bhattacharya and Packalen concluded
in another working paper that scientific breakthroughs had stagnated because
scientists were wrongly focused on being cited by other researchers.

The devil, of course, is in the details. Many are the brave maverick scientists 
who have castigated NIH for being “too conservative” in deciding who gets
funded. I’ve discussed this issue a number of times, most recently when
Bhattachary’s Stanford colleague John Ioannidis (who’s also a Great Barrington
Declaration believer) complained about the NIH supposedly promoting “mediocrity”
and “conformity.” His arguments were, as is often the case, exaggerated. First,
most of the time, the examples cited of science that led to innovative
treatments whose investigators initially had difficulty getting NIH funding are 
often exaggerated and full of hindsight bias, in which now it seems obvious how 
brilliant the ideas were but at the time they were being considered it wasn’t at
all obvious. I will note, as I always do, that whenever NIH funding decisions
become more conservative, it is usually be cause money is tight and study
sections and advisory councils don’t want to make risky bets. The answer to that
is to provide more funding. Does anyone want to take a guess whether Donald
Trump will significantly increase NIH funding? More likely it will be quite the 
opposite.

One frightening thing about Bhattacharya is that he mistakes the criticism that 
he justly received for being “silenced” and wants revenge. Indeed, in 2022, he
wrote about how he wanted to hold “lockdowners” accountable:

And I don't mean in an even slightly conspiratorial way.Jay Bhattacharya was
just vague-posting about this being like the Civil War.
pic.twitter.com/fQUZMKZjrV

— Noah 🧡 (@Michigan_Noah) February 10, 2022

He made allusions to the Civil War, envisioning himself on the victorious side:

And I don't mean in an even slightly conspiratorial way.Jay Bhattacharya was
just vague-posting about this being like the Civil War.
pic.twitter.com/fQUZMKZjrV

— Noah 🧡 (@Michigan_Noah) February 10, 2022

I observed at the time that Dr. Bhattacharya’s frequent invocation of the
“laptop class” as COVID-19 bogeymen unconcerned about the harms their
interventions were causing always struck me as a combination of a straw man so
enormous that if set on fire it could be seen from space plus breathtaking
hypocrisy. After all, no public health official advocating business closures and
shelter-in-place orders early in the pandemic denied potential harms. (It’s not
their fault that governments didn’t adequately support those whose livelihoods 
were impacted by such orders.) Moreover, Dr. Bhattacharya himself is most
definitely part of the “laptop class.” Although he is an MD, he’s a Stanford
University academic and researcher, not a clinician. He never did a residency
and, as far as I can tell, never practiced clinical medicine after medical
school, which means that he has never treated a COVID-19 patient, nor has he
struggled (for example) to provide care to cancer patients (as I have), due to
the effects of the pandemic overwhelming hospitals and, now, due to severe
staffing shortages now affecting my hospitals and many others. He could easily
do most of his work from home, and I’d be willing to bet that in 2020 and
through much of 2021 he did.

Yet, having been ensconced in his ivory tower and home office, in October 2020
he joined his fellow GBD authors Martin Kulldorff (then a professor at Harvard) 
and Sunetra Gupta (a professor at Oxford) at the headquarters of the libertarian
“free market” think tank American Institute for Economic Research (AIER) for a 
confab with like-minded AIER officials, reporters, and scientists to discuss a
“natural herd immunity” approach to the pandemic, ending “lockdowns,” and using 
“focused protection” for the elderly and those at high risk of severe disease
and death from COVID-19. The result was the GBD, which advocated a “natural herd
immunity” approach to the pandemic, ending “lockdowns,” and using “focused
protection” for the elderly and those at high risk of severe disease and death
from COVID-19.

Also, as Dr. Howard mentioned just yesterday, Bhattacharya has spend the last
four years portraying himself as the “canceled” outsider, whom The Man crushed
for his “scientific heresy” and how he has spent the past four years portraying 
himself as a total outsider, even though he had advised presidents and governors
and become a “dissident” scientific rockstar among the right doing so. Given
what he’s written, I suspect that, although Bhattacharya might share RFK Jr.’s
“eccentric” beliefs with respect to COVID-19, masking, public health, and
COVID-19 vaccines, he fears being associated with RFK Jr.’s utterly
reality-divorced views with respect to vaccines in general, his conspiracy
theories, and all the quackery that he supports. I also suspect that he thinks
that, as a “reasonable” scientist, he can rein RFK Jr. in from his more bonkers 
beliefs and do what he wants to do with the NIH without all the collateral
damage that would come from RFK Jr. getting his way.

How well did that work out with Donald Trump? Not very, and I predict that it
won’t work out either for Jay Bhattcharya or any of the other contrarian doctors
who tried to downplay just how conspiracist, pseudoscientific, and full of
quackery RFK Jr.’s views on health are. He will become complicit in damaging or 
destroying the greatest engine of biomedical research and discovery in the
world, the NIH.

So it begins: Robert F. Kennedy Jr. is confirmed as HHS Secretary and
immediately starts dismantling US federal science infrastructure

The nightmare has come true. Robert F. Kennedy Jr. has been confirmed as HHS
Secretary and didn’t wait long to start dismantling federal science and health
programs. The White House even formed a “MAHA commission” to draw up a battle
plan.

David Gorski on February 17, 2025

Link

Three months ago, after Donald Trump had won the 2024 election—and even before
he had chosen longtime antivax activist Robert F. Kennedy, Jr. as his nominee
for Secretary of Health and Human Services (HHS)—I characterized RFK Jr. as an
“extinction-level threat to federal public health and science-based health
policy.” The reason was simple. Last summer, RFK Jr. had abandoned his quixotic 
and doomed campaign for President as an independent and bent the knee to Donald 
Trump. As a result, he was rewarded with a promise to be, in essence, Trump’s
health policy czar and to have a prominent role in health policy in his
administration if he won. During the campaign, RFK Jr. even came up with a
slogan that riffed on the long familiar Trump slogan “Make America Great Again” 
(MAGA) by changing it to “Make America Healthy Again” (MAHA). Cleverly, he said 
nothing at all about vaccines in his “MAHA manifesto“—an absence that his
antivax minions noticed right away and were dismayed by—instead planning to
“reform” the FDA, emphasize healthy food (depending on your definition), and
legalize psychedelics and stem cell clinics. A couple of weeks after the
election, President-Elect Trump nominated RFK Jr. for HHS, a nomination that I
referred to as a “catastrophe for public health and medical research.”

Of course, RFK Jr. was “controversial” (translation: a batshit) nominee. I will 
even admit that, after RFK Jr.’s disastrous confirmation hearings, in which he
lied repeatedly and blatantly about being “pro-vaccine” and in which Sen. Bernie
Sanders embarrassed him over the organization that he founded, Children’s
Health Defense, selling baby onesies with antivax slogans on them—asking RFK Jr,
“Are you supportive of these onesies?“—and Sen. Elizabeth Warren pointed out
how much money he makes assisting a law firm suing vaccine manufacturer, I
briefly held out a tiny hope that a few Republicans would vote against him,
denying him the nomination, but I soon realized that none of it mattered and
that he would definitely be confirmed.

Sometimes I hate being right. I might not be right all the time, but this is one
time where I would have been happy to be spectacularly wrong.

So, on Thursday, the Senate confirmed RFK Jr. as HHS Secretary, with only one
Republican, Mitch McConnell (who is a polio survivor), voting against his
confirmation. On Friday, RFK Jr. wasted no time beginning to do what he had
promised to do all along, going back to 2023, namely mass firing scientists at
the CDC and NIH. Of course, as I wrote last week, President Musk Trump and the
“department of government efficiency” (DOGE) hadn’t waited for RFK Jr. to be
confirmed as HHS Secretary or for Dr. Jay Bhattacharya to be confirmed as NIH
Director to cancel study section meetings and travel by NIH scientists to
present their findings, all in the name of attacking DEI (diversity, equity, and
inclusion) and, soon after, to start gutting payments to universities for
indirect costs with no warning, thus threatening biomedical research at a large 
number of US universities, who could not easily make up the shortfall. That a
federal judge quickly issued a temporary restraining order to block the policy
doesn’t mean that it won’t ultimately go into effect, either.

Then RFK Jr. arrived on Friday.

Scientists at the CDC, NIH, and FDA on Thursday, awaiting RFK Jr.’s attack.

So it begins

Surprising no one other than those who hadn’t been paying attention while
portraying RFK Jr. as “not that bad” or even as potentially good, RFK Jr.
started his tenure as HHS Secretary with what some have called the “St.
Valentine’s Day Massacre,” namely firing scientists en masse:

President Donald Trump’s administration today moved to fire 5200 workers at the 
Department of Health and Human Services (HHS), using supervisors across the vast
agency to warn probationary employees that they would soon receive termination 
notices. It also fired the director and much of the staff of the Advanced
Research Projects Agency for Health (ARPA-H), a $1.5 billion agency created 3
years ago to fund high-risk, high-payoff research.

The move came on the first full day in office of HHS Secretary Robert F. Kennedy
Jr., who had promised to eliminate hundreds of jobs at federal health agencies 
“on Day 1.”

This is pure irony. Remember how sycophants, toadies, and lackeys of RFK Jr.—I’m
talking to you, Dr. Vinay Prasad—lambasted the NIH for supposedly funding
useless “safe” research that didn’t advance science? Here we see RFK Jr.
defunding and moving to eliminate ARPA-H, a program designed to address that
perceived problem by funding high risk, high payoff research projects. But what 
else? Nothing good.

It wasn’t just the NIH, of course, but the hated CDC too:

At the U.S. National Institutes of Health (NIH), where institute directors were 
hastily summoned to a meeting this morning to alert them of the imminent
firings, some 1500 employees were initially scheduled to be let go; at the
Centers for Disease Control and Prevention (CDC) the number was 1269.

It turns out that 50 of the fired CDC scientists were members of the first-year 
class of the Epidemic Intelligence Service, the CDC’s prestigious “disease
detective” training program for young epidemiologists. Moreover, three division 
directors in the National Center for Emerging and Zoonotic Infectious Diseases, 
a key front in pandemic prevention, were also on a list of targeted employees.
It’s almost as though RFK Jr. is trying other make us less prepared for another 
pandemic. No, strike that. He is, just because he hates what the CDC said about 
COVID-19, nonpharmaceutical interventions (e.g., masks, social distancing,
business closures) to slow the spread of the virus, and, above all, vaccines.

It was the NIH that suffered the most from the initial round, however:

At NIH, many of those fired were junior employees. But the vast cull also took
out senior employees who had been recently converted to staff positions after
years as contractors—as well as division directors at NIH who were new to their 
positions. In some cases, the directors had to call junior staff to inform them 
of their impending firings while knowing they, too, were about to be terminated.

“This will decimate our ability to function as an institution,” says one senior 
NIH scientist who had to notify staff that HHS was firing them. “Whatever the
opposite of government efficiency is, this process will take us there.”

Indeed. It is frequently a mantra among CEOs like Elon Musk that all they’re
cutting is fat, that they can “do more with less,” but when the cutting is
indiscriminate, basically anyone still on probation, regardless of their
performance or the importance of their work, what will happen is that the work
of the NIH will be degraded. For example, scientific studies, once halted, are
often difficult or impossible to resurrect, and even the ones that are
successfully resurrected usually end up costing more, not less. Worse, this cull
is affecting senior employees recently promoted who, as a result of their new
position, were on probation, thus removing institutional knowledge that helps
large organizations with continuity.

In case you wondered what was happening with research grants to universities,
given the pause in study section meetings and the attempt to slash university
indirect cost rates to 15%, it’s not good either:

Also among those slated for termination at NIH were grants administration and
program officers, who ensure the smooth disbursement and functioning of more
than $30 billion in grants to university scientists. The NIH grants process has 
already ground to a halt because study sections and advisory councils are not
meeting because of a Trump ban on posting required notices about upcoming
meetings in the Federal Register.

“Over the past year, NIH has brought in some spectacular people who are critical
for programs. It will be a great loss,” former NIH Director Monica Bertagnolli,
who stepped down last month, told Science.

Lest you think that intramural clinical trials and translational research
(research done at the NIH itself, rather than at universities funded by NIH
grants) won’t suffer:

The imminent terminations included many of NIH’s 483 research fellows. Some of
its roughly 260 clinical fellows were initially on lists of targeted employees
Friday morning, although at least some were spared later in the day. (The
Clinical Center, where hundreds of clinical trials are underway, would have to
“shut down” if the clinical fellows and nurses with probationary status were let
go, one source who asked not to be identified told Science.) But animal care
staff were among those fired.

Again, here’s some irony. You might recall that Dr. Prasad did an oncology
fellowship at the National Cancer Institute and the NIH Clinical Center. I don’t
know what happened there, but he came out very bitter about the NIH, a
bitterness that grew with his apparent failure ever to obtain NIH funding as a
principal investigator. Is he rejoicing at the potential firing of all the
fellows? What about all the research fellows, who took what in the past would be
considered a fantastic opportunity to do research training at the NIH, only to 
have the rug pulled out from under them this way?

The likely result will be, as described by former NIH Director Monica
Bertagnolli:

“We’re going to lose the next generation, that is the most difficult loss. This 
just sends, sends a chill,” Bertagnolli told STAT in an interview Saturday on
the sidelines of the American Association for the Advancement of Science annual 
meeting in Boston. “It’s hard work, to get an education and be a scientist. Some
of the fellows trained for so many years, and it’s a mission that requires
great, great dedication. We’re very worried that our brilliant next generation
isn’t going to want to do that, if they’re not very, very clearly supported.”

Indeed. Imagine that you’ve spent a couple of years doing a research project at 
the NIH, only to have a conspiracy theorist like RFK Jr. come in and fire you
just as you’re getting results.

Meanwhile:

It is negligent to report firings at HHS as “an attack on science.”FACT:
Career leaders at the HHS have overseen a breakdown of science, where corporate 
interests took over the FDA, NIH, CMS and CDC and American health has
plummeted.It would be irrational not to make changes.
pic.twitter.com/1EesnbLNcd

— Calley Means (@calleymeans) February 15, 2025

Nope. It’s an attack on science.

Unfortunately, this is clearly only the beginning. On Thursday afternoon, right 
after RFK Jr. was confirmed, the White House posted an executive order
establishing the President’s “Make America Healthy Again” Commission. It’s full 
of misinformation and represents a blueprint for dismantling US public health
and medical science policy and efforts in favor of the sort of quackery that RFK
Jr. prefers.

The MAHA Commission

Let’s take a look at the executive order establishing the President’s MAHA
Commission. The first thing I noticed is that it starts out with the usual MAHA 
tropes:

American life expectancy significantly lags behind other developed countries,
with pre‑COVID-19 United States life expectancy averaging 78.8 years and
comparable countries averaging 82.6 years.  This equates to 1.25 billion fewer
life years for the United States population.  Six in 10 Americans have at least 
one chronic disease, and four in 10 have two or more chronic diseases.  An
estimated one in five United States adults lives with a mental illness.

The wag in me can’t help but note that, of all the things that the MAHA
Commission goes on to suggest as contributors to the lagging life expectancy, a 
problem that has been much discussed, very little is mentioned about poverty and
nothing is mentioned about how our lack of a government-funded universal health
insurance plan is one big difference between the US and the “comparable
countries” cited and doesn’t suggest expanded health insurance for anything
other than supporting “beneficial lifestyle changes and disease prevention,”
which, if science-based (doubtful) would be good but not enough.

The second thing I noticed about this executive order is that, under the first
section (Purpose), it trots out a lot of statistics, none of which are
referenced and some of which I know are completely wrong. For instance, it
claims, “Further, from 1990-2021, the United States experienced an 88 percent
increase in cancer, the largest percentage increase of any country evaluated.”
All one has to do is to look at last month’s American Cancer Society annual
report on cancer statistics to demonstrate this, specifically Figure 2, which
presents age-adjusted rates of cancer incidence and mortality in the US:

Do you notice anything? First of all, cancer incidence has not increased by 88% 
since 1990, or even since 1975. Indeed, cancer incidence is the same as—or only 
slightly higher than—it was in 1975, adjusted for age and delays in reporting. I
rather suspect that whoever wrote this executive order used raw numbers that
were not age-adjusted, but, again, no reference is provided. (I tried a bit of
Googling to try to find the reference, but gave up.) The population, after all, 
is aging; so it would be expected that cancer incidence would climb just from
that, as many cancers, particularly malignancies arising from organs like colon,
breast, etc., tend to be, in essence, diseases of aging.

Did you notice anything else? It’s something that I like to point out any time I
give a talk on cancer. Specifically, mortality rates from cancer have been
steadily declining since 1990. I also point out that this is mortality from all 
cancers, because there are cancers for which the mortality and incidence rates
have fallen more rapidly than the chart, and there are some cancers whose
incidence and mortality have increased. The overall picture, though, is very
different from what RFK Jr. and the Trump administration paints. There are
challenges to be met and progress to be made, but the situation with respect to 
cancer has actually been improving over the last three decades. It might not
seem like it because the population is aging and many cancers are much more
likely in old age, thus producing the illusion “on the ground” that there is
more cancer and death from cancer, but when you look at statistics adjusted for 
age it’s true.

The White House further claims, “Across 204 countries and territories, the
United States had the highest age-standardized incidence rate of cancer in 2021,
nearly double the next-highest rate.” Again, there is no reference, but this
too is easily disproven. For example, if you look at Our World In Data, it shows
that, yes, the US does have the highest age-standardized incidence of cancer,
but barely and that other countries have had higher incidences in the past. For 
example, I picked some developed industrialized countries and used the tool on
the site to create this graph:

Seriously, MAHA. It’s easy to look this stuff up. No wonder there are no
references.

Notice how the US has very similar cancer incidence to New Zealand, France, The 
Netherlands, and Australia. Notice, also, that the difference in
age-standardized incidence of cancer is nowhere near two-fold different between 
the US and other countries. For some, it’s barely distinguishable. Further note 
that the age-adjusted incidence of cancer in the US is not climbing. It’s
actually falling slightly. I suspect that whoever wrote this dreck simply
compared US cancer incidence to that for the world (which I included in the
graph), not noting that many countries have cancer incidence similar to that of 
the US, mainly wealthy industrialized countries. Of course, this is not a new
observation that people in wealthy industrialized nations tend to have a higher 
cancer incidence; it is, however, profoundly deceptive to claim that this is
somehow a uniquely American phenomenon, with no country even close to our cancer
incidence.

The same sort of exaggeration is apparent for the claim that in 2021 “asthma was
more than twice as common in the United States than most of Europe, Asia, or
Africa.” While it’s sort of true, when you look at individual countries, there
are a lot of them with asthma prevalence similar to that of the US. Poland and
the UK, for instance, have very similar asthma prevalence rates. Again, from Our
World In Data:

Asthma prevalence, of course, is correlated with environmental factors, such as 
animal hair and dander, pollen, and mold (fungal) spores, food allergens,
tobacco smoke, or other pollutant exposures. If MAHA were really serious about
reducing asthma burden, it would have to look at environmental pollutants,
particularly air pollution, something that I don’t see the Trump Administration 
acting to decrease any time soon, if ever.

Then, of course:

Autism spectrum disorders had the highest prevalence in high-income countries,
including the United States, in 2021.  Similarly, autoimmune diseases such as
inflammatory bowel disease, psoriasis, and multiple sclerosis are more commonly 
diagnosed in high-income areas such as Europe and North America.  Overall, the
global comparison data demonstrates that the health of Americans is on an
alarming trajectory that requires immediate action.

This concern applies urgently to America’s children.  In 2022, an estimated 30
million children (40.7 percent) had at least one health condition, such as
allergies, asthma, or an autoimmune disease.  Autism spectrum disorder now
affects 1 in 36 children in the United States — a staggering increase from rates
of 1 to 4 out of 10,000 children identified with the condition during the
1980s.  Eighteen percent of late adolescents and young adults have fatty liver
disease, close to 30 percent of adolescents are prediabetic, and more than 40
percent of adolescents are overweight or obese.

Of course, we here at SBM have written about the increasing prevalence of autism
and its causes (not vaccines) on a number of occasions, most recently here.
It’s an old antivax narrative that “something” must be causing this increase
other than the causes that scientists have identified, such as the broadening of
diagnostic criteria in the 1990s, increased screening and recognition,
decreased stigma, and the like. I could trot out yet again my example of a
condition that whose diagnostic criteria hasn’t changed much in 50 years but
whose incidence has increased 16-fold just due to screening; you can read about 
it here if you’re interested. As for obesity and diabetes in children, that is a
complex topic oversimplified by RFK Jr. (as usual). For instance, the US
actually has rates of childhood obesity that are similar to that of other
industrialized countries and lower than some outliers. For example, according to
the Global Obesity Observatory, the US is actually ranked #22 in the percentage
of obese children, with countries like Samoa, Qatar, and others having higher
rates. This is not to say that childhood and adult obesity are not a
problem—indeed, the US does lead the world in adult obesity, although Australia,
New Zealand, the United Arab Emirates, and the United Kingdom aren’t far
behind—or that they haven’t been increasing. It is simply to say that there is
nothing uniquely American about this phenomenon, as RFK Jr. wants to imply.

Now note the pivot to implying that correlation equals causation:

These health burdens have continued to increase alongside the increased
prescription of medication.  For example, in the case of Attention Deficit
Disorder/Attention Deficit Hyperactivity Disorder, over 3.4 million children are
now on medication for the disorder — up from 3.2 million children in 2019-2020 
— and the number of children being diagnosed with the condition continues to
rise.

This poses a dire threat to the American people and our way of life. 
Seventy-seven percent of young adults do not qualify for the military based in
large part on their health scores.  Ninety percent of the Nation’s $4.5 trillion
in annual healthcare expenditures is for people with chronic and mental health 
conditions. In short, Americans of all ages are becoming sicker, beset by
illnesses that our medical system is not addressing effectively.  These trends
harm us, our economy, and our security.

Vaccines weren’t mentioned, but I’m sure that RFK Jr. knows that his fans will
know that they are implied, along with medications for ADHD. It’s also implied
that way fewer people are exercising, but, by coincidence, I happened to have
listened to a recent episode of the Conspirituality podcast where they discussed
this very thing:

Now, what about exercise? Available data says that about 24% of Americans
exercised regularly in the 1960s. And today, about the same, 24% meet
recommended levels of aerobic exercise plus strength training.

But an impressive 46% get sufficient aerobic exercise alone. I can’t find a stat
for that in the 1960s. They probably weren’t thinking about it that way because
so much of this has been culturally sort of emergent.

But commercial gyms, yoga studios, cycling apps and jogging clubs may be a more 
contemporary phenomenon because more of the population got their exercise from
physically demanding jobs in the 1960s. But you know what else was different?
42% of Americans were smokers back then.

And it’s a little bit controversial, but smoking has been repeatedly shown to be
correlated with lower BMI due to appetite suppressant and metabolic effects. A 
2015 study showed that only 30% of smokers are overweight or obese. So that’s
one way to make America healthy again, I guess.

I don’t want to belabor this point, because there are some real problems with
obesity, type II diabetes, and other chronic health problems. It’s just that RFK
Jr. oversimplifies and implies that a lot of it’s due to vaccines and
pharmaceuticals.

What to do? Well, if you didn’t know RFK Jr., you’d think that this next part
sounds pretty good:

To fully address the growing health crisis in America, we must re-direct our
national focus, in the public and private sectors, toward understanding and
drastically lowering chronic disease rates and ending childhood chronic disease.
This includes fresh thinking on nutrition, physical activity, healthy
lifestyles, over-reliance on medication and treatments, the effects of new
technological habits, environmental impacts, and food and drug quality and
safety.  We must restore the integrity of the scientific process by protecting
expert recommendations from inappropriate influence and increasing transparency 
regarding existing data.  We must ensure our healthcare system promotes health
rather than just managing disease.

Of course, we know that RFK Jr.’s “fresh thinking on nutrition, physical
activity, healthy lifestyles, over-reliance on medication and treatments, the
effects of new technological habits, environmental impacts, and food and drug
quality and safety” involves a lot of pseudoscience and quackery, as well as a
hostility to psychiatric drugs as nasty as the anti-psychiatry beliefs held by
any Scientologist; for example, he has recently characterized antidepressants as
addictive and the cause of violent behavior, such as school shootings and has
even proposed the creation of “wellness farms”:

…Kennedy said he planned to dedicate money generated from a sales tax on
cannabis products to “creating wellness farms—drug rehabilitation farms, in
rural areas all over this country.” He added, “I’m going to create these
wellness farms where they can go to get off of illegal drugs, off of opiates,
but also illegal drugs, other psychiatric drugs, if they want to, to get off of 
SSRIs, to get off of benzos, to get off of Adderall, and to spend time as much
time as they need—three or four years if they need it—to learn to get
reparented, to reconnect with communities.” The farm residents would grow their 
own organic food because, he suggested, many of their underlying problems could 
be “food-related.”

It sounds a lot like Mao’s “down to the countryside” initiative, doesn’t it? The
problem thus identified, the executive order moves on to policy and the MAHA
Commission.

RFK Jr. and “science”

So let’s first see what the policy is that RFK Jr. wants:

It shall be the policy of the Federal Government to aggressively combat the
critical health challenges facing our citizens, including the rising rates of
mental health disorders, obesity, diabetes, and other chronic diseases.  To do
so, executive departments and agencies (agencies) that address health or
healthcare must focus on reversing chronic disease.  Under this policy:

(a)  all federally funded health research should empower Americans through
transparency and open-source data, and should avoid or eliminate conflicts of
interest that skew outcomes and perpetuate distrust;

(b)  the National Institutes of Health and other health-related research funded 
by the Federal Government should prioritize gold-standard research on the root
causes of why Americans are getting sick;

(c)  agencies shall work with farmers to ensure that United States food is the
healthiest, most abundant, and most affordable in the world; and

(d)  agencies shall ensure the availability of expanded treatment options and
the flexibility for health insurance coverage to provide benefits that support
beneficial lifestyle changes and disease prevention.

Again, this all sounds great on the surface. However, I know what RFK Jr. really
means, which is why I think I will provide a translation:

It shall be the policy of the Federal Government to aggressively combat the
critical health challenges facing our citizens, including the rising rates of
mental health disorders, obesity, diabetes, and other chronic diseases.  To do
so, executive departments and agencies (agencies) that address health or
healthcare must focus on deprioritizing science-based medicine with respect to
chronic disease.  Under this policy:

(a)  all federally funded health research should empower Americans through
transparency and open-source data, and should avoid or eliminate conflicts of
interest that skew outcomes and perpetuate distrust, in order to allow
antivaxxers and quacks to manipulate the data to show that vaccines and
FDA-approved drugs are dangerous, some even addictive;

(b)  the National Institutes of Health and other health-related research funded 
by the Federal Government should prioritize gold-standard research on the root
causes of why Americans are getting sick that will exclude anything having to do
with actual science or science-based medicine that doesn’t comport with our
preconceived conclusion that vaccines, pharmaceuticals, and “bad food” is the
cause of all chronic disease;

(c)  agencies shall work with farmers to ensure that United States food is the
healthiest, most abundant, and most affordable in the world (even as we deport
all the undocumented agricultural workers); and

(d)  agencies shall ensure the availability of expanded treatment options and
the flexibility for health insurance coverage to provide benefits that support
beneficial lifestyle changes and disease prevention; i.e., we don’t care about
universal national health insurance, just that existing insurance transfers
coverage away from drugs, vaccines, and surgery to woo.

But what about the MAHA Commission? It will be chaired by RFK Jr., of course,
and be co-charied by the Assistant to the President for Domestic Policy serving 
as Executive Director (Executive Director). Committee members will include
Secretaries of Agriculture, Housing and Urban Development, Education, and
Veterans Affairs, as well as the administrator of the EPA and the Directors of
OMB, the National Economic Council, NIH, CDC, and Office of Science and
Technology Policy, plus the Chairman of the Council of Economic Advisors and the
Commissioner of the FDA—oh, and “other members of my Administration invited to 
participate, at the discretion of the Chair and the Executive Director.”

Let’s look at some of the biggest red flag items that this commission is tasked 
with. First, with respect to childhood chronic disease, the commission is tasked
to:

(a)  study the scope of the childhood chronic disease crisis and any potential
contributing causes, including the American diet, absorption of toxic material, 
medical treatments, lifestyle, environmental factors, Government policies, food 
production techniques, electromagnetic radiation, and corporate influence or
cronyism;

A few translations:

  1. Absorption of toxic materials = vaccines, pharmaceuticals, and “chemicals”

  2. Environmental factors = “chemicals,” whether shown to be harmful or not

  3. Electromagnetic radiation: “Cell phones and wifi cause cancer and other
    diseases!” (They don’t.)

  4. Corporate influence and cronyism = vaccines and big pharma, but not
    supplements, alternative medicine and what I now like to call “big wellness”

Next up:

(b)  advise and assist the President on informing the American people regarding 
the childhood chronic disease crisis, using transparent and clear facts; and

(c)  provide to the President Government-wide recommendations on policy and
strategy related to addressing the identified contributing causes of and ending 
the childhood chronic disease crisis.

Translations:

  1. Transparent and clear facts = Cherry picked studies and data that show what we
    want them to show.

  2. Strategy related to addressing the identified contributing causes of and
    ending the childhood chronic disease crisis = Get rid of vaccines,
    pharmaceuticals, and science-based interventions that we don’t like, all in 
    favor of woo.

Seriously. I know you, RFK, Jr. You don’t fool me with:

…assess the threat that potential over-utilization of medication, certain food
ingredients, certain chemicals, and certain other exposures pose to children
with respect to chronic inflammation or other established mechanisms of disease,
using rigorous and transparent data, including international comparisons;

Spoiler alert: The MAHA commission will find that we vaccinate too much, use too
much “artificial” ingredients in foods, that wifi causes cancer and chronic
disease, while the “rigorous data” will be cherry picked and/or gathered by
hand-picked crank scientists and doctors in order to come to preordained
conclusions.

Also:

…assess the prevalence of and threat posed by the prescription of selective
serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and
weight-loss drugs;

See what I mean? RFK Jr. is coming after psychiatric medications in addition to 
vaccines. I know, I know. He says nothing about vaccines in this document, but, 
once again, given how much he was grilled on vaccines during his confirmation
hearings and how he’s been playing coy with the question of vaccines ever since 
he bent the knee to Trump and came up with “MAHA,” does anyone doubt that he’s
coming for vaccines? I’ve been following him and documenting the antivax
misinformation that he’s promoted since 2005. For him not to go after vaccines
using deceptive science, conspiracy theories, and cherry-picked data would be so
unlike him as to strain credulity, as demonstrated by his two decade track
record in this sphere, so much so that I absolutely do not believe him when he
says he won’t go after vaccines.

Similarly:

…restore the integrity of science, including by eliminating undue industry
influence, releasing findings and underlying data to the maximum extent
permitted under applicable law, and increasing methodological rigor; and

…establish a framework for transparency and ethics review in industry-funded
projects.

If RFK Jr. were really about eliminating “undue industry influence,” I could
actually get behind that, depending on the details. That’s not what he is about.
What he is really about is shifting allowable “undue industry influence” away
from big pharma to big wellness, away from companies that at least try to
develop treatments rooted in science to companies that sell outright snake oil. 
Similarly, “increasing methodological rigor” will involve, at least for vaccines
and pharmaceuticals, impossible standards for safety and efficacy.

Again, everything that I know about RFK Jr.’s history, studied over the last two
decades, tells me that this is what he will do and what he really means. I will
give RFK Jr. and whoever else wrote this credit. They are very good at couching
what they really mean in language that on the surface seems unobjectionable. If
you don’t know RFK Jr.’s history or are sympathetic to parts of his message
that you want to believe that he’s being sincere rather than disingenuous, you
might be swayed. Certainly, I expect RFK Jr. apologists and cheerleaders like
Dr. Prasad to enthusiastically embrace this document, taking it at face value
and selling it that way. Unfortunately, I know RFK Jr.’s MO all too well, and I 
know what is really behind this document, as likely do most of our readers.

This is:

President Donald Trump on Friday signed an executive order that would strip
schools of federal aid if they mandate COVID vaccines, a pool report said — a
largely symbolic move considering that no states currently require them.

The order applies to students and not to teachers or staff.

“People wanted that very badly,” Trump said.

In a fact sheet provided to reporters, the White House said the order was
necessary because COVID vaccine mandates were “threatening educational
opportunities for students.”

And so is this:

Louisiana’s health department “will no longer promote mass vaccination”,
including using media campaigns or health fairs to promote vaccines against
preventable illnesses, according to an internal memo issued by the surgeon
general in the state of 4.5 million people.

The memo from surgeon general, Dr Ralph Abraham, immediately ignited fears of
lower vaccination rates leading to increased sickness, hospitalization and death
– as well as a return of diseases such as measles and polio that had all been
mostly eradicated by vaccines.

Appointed to his position in June by Louisiana’s extremist Republican governor, 
Jeff Landry, Abraham wrote that the state would continue to “encourage each
patient to discuss the risks and benefits of vaccination with their provider”.
But, characterizing it as a matter of personal choice, Abraham said the state’s 
health department would do away with promoting the practice of mass vaccination 
– even as Louisiana has grappled with a surge in influenza, for which vaccines
are offered seasonally.

Yes, I know. It’s a state government, not the federal government, giving up
promoting the most effective public health intervention against infectious
disease ever discovered. The initiative, is, however, very much in line with
MAHA ethos, which is starting to metastasize beyond RFK Jr. and the federal
government. Basically, this is an example of a populous Trump-supporting state
giving up on public health and instead framing public health as a matter of
“personal choice.” Nor will Louisian be the only state to do this, I predict (an
unfortunately easy prediction to make). I’m only surprised that Florida didn’t 
beat Louisiana to a policy like this, given that its health department is run by
COVID-19 contrarian Dr. Joseph Ladapo, who’d better get cracking now.

Meanwhile:

Bill Cassidy, the Republican US senator, has said his home state of Louisiana’s 
recent decision to cancel the promotion of mass vaccination against preventable 
diseases is a disservice to parents who want to keep their children healthy.

And:

Cassidy on Friday joined the chorus of detractors questioning the wisdom of the 
policy unveiled by Abraham, who has been in his position since June. He issued a
statement saying the policy’s removal of vital vaccine-related resources “is
not a stand for parents’ rights”. Rather, “it prevents making health care more
convenient and available for people who are very busy”.

The senator said the health fairs shelved by his state had been a boon for
parents who “suddenly realize their child needs to be immunized and they can’t
get in to see the doctor”.

“It may be six weeks or longer for a routine visit,” Cassidy’s statement said.
He added that was why, in his prior career as a physician, he had run
“large-scale immunization programs to bring health care and immunizations to the
patient”.

“Things like vaccine fairs keep a child from having to miss school and a mother 
from having to miss work,” Cassidy said. “That is the reality of today’s
medicine. To say that cannot occur and that someone must wait for the next
available appointment ignores that reality.”

He continued: “Advertising the benefit of vaccines and where to get them helps
parents improve the health of their child. It’s important information they may
not have known or needed to be reminded of.”

Sen. Cassidy is, of course, quite correct about all of this. Unfortunately, it’s
way too little, way too late. Not only that, but his words belie his recent
actions. Yes, he’s speaking out about antivaccine policies in his state, but,
really, what is happening in Louisiana is completely of a piece with the
realignment of the Republican Party to embrace antivaccine tropes. Moreover,
before this Sen. Cassidy had just exhibited willful blindness and, through his
failure to live up to what he said was his conscience, helped to install the
most (in)famous antivaxxer in the world (with the possible exception of Andrew
Wakefield) as head of all non-military federal health, public health, and
biomedical research programs. Sen. Cassidy could have stopped RFK Jr.’s
nomination dead in its tracks, by voting against its being forwarded to the full
Senate for a vote. He chose not to, even after he had acquitted himself well
during the confirmation hearing by grilling RFK Jr. about his antivax views,
giving him many opportunities to recant his oft-stated belief that vaccines
cause autism. that RFK Jr. awkwardly refused, dodging and weaving. Yet, in the
end Sen. Cassidy still voted to forward RFK Jr.’s nomination to the full Senate.
The vote was 14-13. Had Sen. Cassidy voted no, the nomination would not have
advanced. Then Cassidy voted again to confirm RFK Jr. when the nomination came
up for a vote by the full Senate. As I said above, Sen. McConnell was the only
Republican to vote against confirmation.

Worse, Sen. Cassidy voted for confirmation after having given this self-serving 
obsequious speech to the full Senate in support of the nomination, in which,
from my perspective, he basically admitted to having been duped by more of RFK
Jr.’s lies. I’m going to quote it at length, because his statement really
is…something; that is, something nauseating to any physician who supports public
health, science-based healthcare, and, as a result, vaccines:

Now, Mr. Kennedy and the administration reached out seeking to reassure me
regarding their commitment to protecting the public health benefit of
vaccination.

To this end, Mr. Kennedy and the administration committed that he and I will
have an unprecedently close collaborative working relationship if he is
confirmed. We will meet or speak multiple times a month. This collaboration will
allow us to work well together and therefore to be more effective.

Mr. Kennedy has asked for my input into hiring decisions at HHS, beyond
Senate-confirmed positions. This aspect of our collaboration will allow us to
represent all sides of those folks that were contacting me this weekend.

He has also committed that he would work within the current vaccine approval and
safety monitoring systems, and not establish parallel systems. If confirmed, he
will maintain the Centers for Disease Control and Prevention’s Advisory
Committee on Immunization Practices without changes. CDC will not remove
statements on their website pointing out that vaccines do not cause autism. Mr. 
Kennedy and the administration also committed that this administration will not 
use the subversive techniques employed under the Biden administration, like sue 
and settle, to change policies enacted by Congress without first going through
Congress.

Mr. Kennedy and the administration committed to a strong role of Congress. Aside
from us meeting regularly, he will come before the Committee on a quarterly
basis, if requested. He committed that the HELP Committee Chair, whether it’s me
or someone else, may choose a representative on any board or commission formed 
to review vaccine safety.

If he is confirmed, HHS will provide a 30-day notice to the HELP Committee if
the agency seeks to make changes to any of our federal vaccine safety monitoring
programs, and HELP Committee will have the option to call a hearing to further 
review.

These commitments, and my expectation that we can have a great relationship to
make America healthy again, is the basis of my support. He will be Secretary,
but I believe he will also be a partner in working for this end.

If Mr. Kennedy is confirmed, I will use my authority as Chairman of the Senate
Committee with oversight of HHS to rebuff any attempts to remove the public’s
access to life-saving vaccines without ironclad, causational scientific evidence
that can be defended before the mainstream scientific community and before
Congress. I will carefully watch for any effort to wrongfully sow public fear
about vaccines between confusing references of coincidence and anecdote.

But my support is built on assurances that this will not have to be a concern
and that he and I can work together to build an agenda to make America healthy
again.

Cowardice, thy name is Senator Cassidy, who betrayed his Hippocratic oath as a
physician. Seriously, he seems to think that he will be HELP Chair indefinitely.
I also have to ask rather pointedly: If Sen. Cassidy was too cowardly to buck
Trump by voting against forwarding RFK Jr.’s nomination out of committee to the 
Senate and voting against the nomination directly, how can he honestly expect us
to believe him when he bloviates that he’ll be this bulldog, this unstoppable
watchdog, who will make sure that RFK Jr. doesn’t do what he’s been promising
his followers that he’d do if ever given power over the CDC, namely carrying his
antivaccine crusade to the halls of power and doing his damnedest to destroy
the federal vaccination program? Does Sen. Cassidy seriously believe that RFK
Jr. won’t change ACIP, as I predicted he would, stacking it with antivaxxers?
Does he really believe that the CDC will leave intact statements that vaccines
don’t cause autism and not at least add qualifying statements or equivocations
to them that make the statements a lot less definitive?

I suppose that RFK Jr. probably won’t develop parallel systems to monitor
vaccine safety, but that will be because he won’t need to. He’ll be able to
change and distort existing systems, bending them to his will to twist data in
any way necessary for him to “prove” that vaccines are “unsafe” and cause autism
(not to mention all sorts of other conditions and diseases). If RFK Jr.’s
testimony was a tour-de-force study in disingenuousness, Sen. Cassidy’s
performance was a tour-de-force performance in either gullibility or cowardice, 
likely both. I’m sure it didn’t hurt that apparently Vice President J.D. Vance
leaned on him as well.

I’m not Sen. Cassidy, and I know that RFK Jr. can’t be trusted when he lies and 
lies and lies and lies about being “pro-vaccine,” no matter how much the media
sanewashes him as being seemingly reasonable and no matter how much they try to 
call him a “vaccine skeptic” rather than what he is, an antivaccine activist.
Because of my two decades studying RFK Jr.’s antivax propaganda, pseudoscience, 
and conspiracy theories, unlike Sen. Cassidy, I know what RFK Jr. is really
saying, and I know what the executive order establishing the MAHA Commission is 
really saying, what it really means, and what it is hiding, I will conclude by
noting that the executive order ends by tasking the MAHA commission to draft a
report of its findings and recommendations within 180 days of the date of the
order. Because I can translate RFK Jr.-speak, I therefore know that, whatever
horrors come between now and summer, August will be an “interesting” month, and 
by “interesting” I mean truly alarming, because the MAHA commission report will 
be RFK Jr.’s roadmap for dismantling science-based public health, medical, and
biomedical research policy. He’s already begun in a haphazard way, but this will
give him the appearance of an evidence-based plan.


How Robert F. Kennedy Jr. will undermine and ultimately destroy US vaccination
programs

When Robert F. Kennedy Jr. was nominated to be Secretary of Health & Human
Services, I called him an “extinction-level threat” to public health. Here’s how
he will attempt to make vaccines extinct in the US.

David Gorski on February 24, 2025

Link

The day before Donald Trump won the 2024 Presidential election, I wrote a post
describing his health advisor, longtime antivaccine activist Robert F. Kennedy
Jr., as an “extinction-level threat” to federal public health and science-based 
health policy, if Trump were to win. Unfortunately for those who care about
public health, Trump did win the election and two weeks later nominated RFK Jr. 
to be Secretary of Health and Human Services. Soon to follow RFK Jr. in joining 
the Trump administration were a collection of antivaxxers, grifters, and quacks 
nominated to take over various federal health agencies. Ultimately, as we all
unfortunately know, RFK Jr. was confirmed by the Senate, thanks largely to the
cravenness of Senator Bill Cassidy (R-Louisiana), who could have stopped RFK
Jr.’s confirmation in committee, but instead voted both to forward his
nomination to the full Senate and then, after a nauseatingly self-serving
speech, voted to confirm him. However, even before RFK Jr. was confirmed, the
Trump administration started attacking federal science by postponing NIH study
sections with no warning, suddenly barring NIH investigators from traveling to
give talks or present their research at scientific meetings, and attempting to
slash indirect costs attached to NIH grants to universities with no warning, in 
essence, a massive, immediate, and unexpected budget cut to universities that do
a lot of NIH-funded research. The day after RFK Jr.’s confirmation as HHS
Secretary by the Senate, the administration began mass firing NIH employees,
jeopardizing intramural research and clinical trials.

There are a lot of ostensibly “pro-vaccine” physicians out there who, because
they like how RFK Jr. includes an emphasis on “chronic disease” in his dubious
“Make America Healthy Again” (MAHA) slogan, have been willing to ignore RFK
Jr.’s 20 years of rabid antivaccine activism, in which he has consistently
promoted pseudoscience, quackery, misinformation, and conspiracy theories and
support him. They chose to believe RFK Jr.’s claims that he is “not
antivaccine,” or even that he is “pro-vaccine,” or, even more risibly and
unbelievably, that he is “fiercely pro-vaccine,” the last of which being a claim
that he’s made for over a decade. However, as I like to say, whenever RFK Jr.
says he’s “not antivaccine,” he is lying. Whenever he claims to be
“pro-vaccine,” he’s lying even harder. Finally, when he claims that he “won’t
take away anyone’s vaccines,” he’s lying harder still and assuming that his
audience has a lot of useful idiots in it who will believe him.

So, to those physicians, like the most useful and idiotic of useful idiots, Sen.
Bill Cassidy, who believe RFK Jr. when he says he won’t take away anyone’s
vaccines or think that they system will prevent him from doing much damage to
federal vaccination programs, I’m here to school you. Here, I will predict,
based on my having followed RFK Jr. and debunked his antivax misinformation for 
two decades, as well as my knowledge of how vaccines are approved by the FDA and
recommended by the CDC, as well as of current science and vaccine safety
monitoring systems, how RFK Jr. will go about dismantling the federal vaccine
program and, ultimately, seriously hobbling state and local vaccination
programs. Unlike certain contrarian physicians, if, two or four years later,
events show that I am mistaken in this, I will happily admit it because I want
to be mistaken. I desperately want to be mistaken and don’t want my predictions 
to come true. Unfortunately, I suspect that I will get more right than wrong,
but time and history will be the judge of that, and you can even call me out on 
it in 2028—or even sooner, if you like.

It’s very fortuitous that Jonathan Howard wrote his post yesterday about
policy-based evidence-making, because that will be a key strategy that RFK Jr.
will use to upend the vaccination program. I’ve long noted that this is how RFK 
Jr. does things, although I had, amazingly, been unaware of this pithy little
sarcastic name for putting the cart before the horse by taking a desired policy 
and then cherry picking and manufacturing evidence to cloak that policy in the
illusion of being evidence-based and thereby providing a justification for
implementing it. What I do like to point out is that lawyers, like RFK Jr., tend
to approach data and studies very differently than scientists. While scientists
test a hypothesis by doing experiments and studies to test it, potentially
falsifying it—i.e., they care if the hypothesis is actually aligned with nature 
and reality and will reject it if it fails to stand up to experimental
testing—lawyers are trying to make a case for they position that they are
defending. To that end, they will cherry pick evidence to support their case and
look for any way to denigrate or discredit evidence that does not. This is
exactly what RFK Jr. will do, but even more so. Now that he controls the CDC and
NIH, he will be in a position to fund new research and cherry pick existing
research that results in “evidence”—no matter how dubious—to support his
policies, namely undermining confidence in vaccines and removing them from the
market, and that is exactly what he will do.

So let’s dig in. This is how RFK Jr. will greatly hobble or even destroy federal
vaccination programs. Suffice to say, he will definitely take away at least
some of your (and your children’s) vaccines, or do his damnedest to take them
away, no matter how much his supporters ignoring his antivax stances try to
delude themselves otherwise. Two main federal agencies now controlled by RFK Jr.
in his role as HHS Secretary will be the focus of his efforts, the Centers for 
Disease Control and Prevention, which oversees public health efforts, vaccine
safety, and and the Food & Drug Administration. Also, HHS is intimately involved
with the Vaccine Court that operates under the National Vaccine Injury
Compensation Program. Let’s start with the CDC.

CDC: Policy-based evidence making to fuel antivax messaging

The CDC has long been a hated target of the antivaccine movement going back to
before the time when I started paying attention to and writing about the
antivaccine movement over two decades ago, mainly because it is the epicenter of
public health in the US and antivaxxers are hostile not just to vaccines but to
public health in general. There are many functions carried out by the CDC
relevant to vaccines, including communications, the CDC-recommended vaccine
schedules for children and adults, vaccine safety monitoring through systems
such as the Vaccine Adverse Events Reporting System (VAERS) and the Vaccine
Safety Datalink (VSD), and the Vaccines for Children program, which provides
vaccines to children whose parents might not be able to afford them.

It didn’t take long before RFK Jr. asserted control over communications, the
most prominent example being its cancelation of the CDC’s Wild-to-Mild campaign:

The agency’s Wild to Mild initiative, launched at the start of the 2023–24 flu
season, aimed to inform the public that while getting immunized against the flu 
doesn’t guarantee you won’t catch an influenza virus, it can protect you from
severe illness, hospitalization, and death. With the catchphrase “A flu vaccine 
can take flu from wild to mild,” the campaign’s marketing materials featured
hulking, wild animals juxtaposed against domesticated, sometimes stuffed,
counterparts, such as a blowfish versus a goldfish. Wild to Mild targeted
high-risk groups in particular, including children and pregnant people, whose
vaccination rates had suffered during the COVID-19 pandemic.

The CDC, part of the Department of Health and Human Services (HHS), ditched the 
campaign Feb. 19, as first reported by NPR. That is, six days after the Senate
confirmed outspoken vaccine skeptic Robert F. Kennedy Jr. as President Donald
Trump’s health secretary. National Center for Immunization and Respiratory
Diseases leaders broke the news to CDC staff following an HHS review of the
campaign, NPR reported.

The death of Wild to Mild also coincides with the worst flu season the nation
has seen in nearly 30 years. The percentage of outpatient and emergency
department visits involving patients with influenza-like illness hit 7.79% the
week ended Feb. 8—the highest percentage recorded since at least the 1997–98 flu
season, CDC records show. The previous high was during the H1N1 swine flu
pandemic: 7.72% the week ended Oct. 24, 2009.

Wild-to-Mild was, of course, a very reasonable messaging campaign. It didn’t
make overblown claims, such as saying that if you are vaccinated against the flu
you won’t get the flu, and instead concentrated on the real benefits of
seasonal influenza vaccines, that they can both prevent the flu and, even when
they fail to prevent the flu, greatly decrease the severity of disease. The
press release announcing the campaign, oddly enough is still available, and it
says:

The intent of the Wild to Mild campaign is to reset public expectations around
what a flu vaccine can do in the event that it does not entirely prevent
illness. Participants found this information useful and even motivational in
consumer testing. For pregnant women, the information about how vaccination
during pregnancy could not only protect the pregnant woman but also her baby for
several months after birth was particularly persuasive.

To me, this sounds as though the CDC did learn some of the lessons of the
COVID-19 pandemic, when the messaging around COVID-19 vaccines might arguably
have been too definitive in claims of efficacy of preventing transmission.

RFK Jr. and HHS officials are denying that they had anything to do with the
nixing of the Wild-to-Mild campaign, with HHS spokesperson Andrew Nixon telling 
reporters, “”Unfortunately, officials inside the CDC who are averse to Secretary
Kennedy and President Trump’s agenda seem to be intentionally falsifying and
misrepresenting guidance they receive” and HHS denying that the removal of the
campaign was intentional. If you believe that, I have a bridge or two that I’d
like to sell you, but let’s assume, for the moment, that Nixon isn’t lying. (As 
someone who was alive in the 1970s that phrase cracks me up.) Even so, one could
easily see how pulling the Wild-to-Mild campaign could have been the result of 
anticipatory obedience.

Whatever the true story regarding the cancelation of the Wild-to-Mild program,
RFK Jr. wants to “refocus” CDC messaging about vaccines on a very common antivax
trope about vaccines, “informed consent”:

The Centers for Disease Control and Prevention was ordered to shelve promotions 
it developed for a variety of vaccines, including a “Wild to Mild” advertising
campaign urging people to get vaccinated against flu, two sources familiar with 
the decision told STAT.

The Department of Health and Human Services’ assistant secretary for public
affairs informed the CDC that HHS Secretary Robert F. Kennedy Jr. wanted
advertisements that promote the idea of “informed consent” in vaccine
decision-making instead.

With the likely result:

Shifting the framing of advertising for vaccines that the CDC has long
recommended — like flu shots — to put more focus on the possible risks of
vaccines could undermine people’s willingness to get vaccinated, or to have
their children immunized.

There you have it: This is almost certainly the reason RFK Jr. ordered some
existing CDC advertising campaigns, like Wild-to-Mild, to be canceled. He wants 
to change CDC messaging to a very deceptive framing of “informed consent” that
has long been a favorite of the antivax movement ever since I first started
writing about it and likely long before that. There’s a reason, for instance,
that an antivax physicians group named itself Physicians for Informed Consent
and so many antivax groups include something about “informed consent” in their
names and/or propaganda. In actuality, “informed consent” is anything but
informed. When I first noted antivax framing of “informed consent,” I renamed it
to “misinformed consent.” Sadly, it took me nearly six years to realize that
“misinformed consent” wasn’t really quite right as a descriptor, because to
antivaxxers it’s not about the consent for vaccines, but rather the refusal of
vaccines. That’s why I now refer to antivax “informed consent” (not to mention
tropes about “informed consent” by quacks for other forms of medicine) as
“misinformed refusal.” The idea behind misinformed refusal is simple: Vastly
exaggerate the potential harms of vaccines beyond what any evidence can support,
while simultaneously minimizing or denying the benefits, weaving a story that, 
if believed, would lead any reasonable person to refuse to be vaccinated because
the message they get is that it’s a big probability of harm and a
low-to-nonexistent probability of benefit.

Yes, the CDC is going to pump out antivax messaging that seems reasonable on the
surface. No doubt my physician colleagues who like the MAHA message so much
that they desperately need reasons to ignore RFK Jr.’s long history of
antivaxxers messaging will find the focus on “informed consent” compelling. This
brings us to the next part of how the CDC will be turned into an antivaccine
organization. The problem with informed consent misinformed refusal is that
there needs to be evidence to support vaccines’ harms and lack of efficacy. Of
course, antivaxxers are very good at cherry-picking evidence and studies to
weave a false narrative of dangerous and ineffective vaccines, but imagine what 
they could do if they had control of the research apparatus of the CDC! Well,
you don’t have to imagine anymore. Soon you’ll see!

Let me go back in time to, the very first antivax conspiracy theory about the
CDC that I tackled. It was promoted by RFK Jr. himself in 2005, when he
published the conspiracy-fest of a “revelation,” Deadly Immunity, in which he
claimed that the mercury-containing preservative thimerosal used in some
CDC-recommended childhood vaccines until around 2001 was the cause of an “autism
epidemic” and that the CDC tried to cover it up at a meeting in 2000. What was 
really happening is that the raw data in the study at the center of RFK Jr.’s
conspiracy theory did show a correlation between thimerosal-containing vaccines 
and autism but that that correlation went away as the data were corrected for
appropriate confounders. To RFK Jr. and antivaxxers, of course, this was a
conspiracy by the CDC to “cover up” evidence that vaccines caused autism, rather
than epidemiologists doing what epidemiologists do with their data and
adjusting for factors likely to produce misleading correlations. Unsurprisingly,
evidence produced over the intervening several years failed to support a link
between mercury in vaccines and autism; it is a dead hypothesis that, these
days, even antivaxxers don’t harp on much anymore.

The second big CDC conspiracy theory that I discussed was the so-called
“CDC-whistleblower” conspiracy theory, whose creation and spread I first
witnessed in 2014, when an antivax scientist named Brian Hooker secretly
recorded several phone calls with a disgruntled CDC vaccine scientist named
William Thompson, who had started calling him to voice his unhappiness with a
2004 study for which he was a co-author. I won’t go into the specifics much,
other than that Williams accused the CDC of scientific fraud, with no basis for 
such charges and include some relevant links. For example, the transcripts of
Thompson’s conversations with Hooker (and why they don’t show what antivaccine
activists claim they show) have been discussed in detail here. Thompson also
gave a large number of documents to Rep. Bill Posey (R-FL), a number that is
sometimes claimed by antivaxers to be “100,000 documents” but in reality was far
fewer. (A detailed discussion of these documents can be found here, here, and
here.) I’ll also point out links to some of my writings and delving into how
Thompson became the “CDC whistleblower.” Ultimately, Del Bigtree and Andrew
Wakefield produced a successful antivax propaganda film disguised as a
documentary, VAXXED, that promoted the conspiracy theory nine years ago. (Has it
really been that long since I reviewed that dreck?) In any event, antivaxxers
have periodically funded “studies” designed to show that vaccines cause autism
or are in some way dangerous. They tend to backfire. this time around it will be
the federal government funding such studies through the CDC or even the NIH.

Now, imagine that RFK Jr. were in charge of HHS and the CDC when the two studies
at the heart of the Simpsonwood conspiracy theory and the CDC whistleblower
conspiracy theory were being readied for publication. I think you get the idea. 
He could easily respin the studies in the way that antivaxxers wanted,
emphasizing, for instance, the raw data in one that showed a correlation between
thimerosal-containing vaccines and autism and the unadjusted data in Thompson’s
paper that showed a correlation between MMR vaccination and autism risk in a
subset of African-American boys. But wait! Surely CDC scientists wouldn’t go
along with this? Perhaps. Some probably wouldn’t and as a result would either
quit or be fired. Likely they would quickly be replaced by antivax “scientists” 
chosen by Dr. Dave Weldon, the antivaxxer who has been nominated to be CDC
Director but not yet confirmed. Others might go along to save their jobs.

Let me point you to an already existing example: The Florida Department of
Health, which did have competent and talented scientists when Gov. Ron DeSantis 
appointed ivermectin- and hydroxychloroquine-promoting quack Dr. Joseph Ladapo
as Florida Surgeon General to head it. The Department soon started publishing
dubious studies not-so-subtly “massaged” to produce the result desired by the
state’s new Surgeon General, namely the claim that COVID-19 vaccines are more
dangerous than effective and “natural herd immunity” is all. If you think the
same thing can’t happen at the CDC, all I can say in response is, “Oh, you sweet
summer child” and move on to the NIH, before coming back to the CDC and,
finally, the FDA.

The NIH: Directing research grants to antivaxxers

The NIH is under HHS as well, and the nominee to be NIH Director is Dr. Jay
Bhattacharya. He was, as readers recall, one of the co-authors of the Great
Barrington Declaration, which—before there even was a vaccine—advocated a “let
‘er rip” approach to the COVID-19 pandemic, the better to reach “natural herd
immunity” within 3-6 months, with an ill-defined strategy of “focused
protection” that would supposedly keep those vulnerable to severe disease and
death from the coronavirus safe while all the “young and healthy” people bravely
caught the bug and opened up society again. It was an impossible strategy that 
never would have worked and did massive damage to public health, as well as a
profoundly social Darwinist idea that basically threw the most vulnerable to the
corona-wolves. As I’ve documented before, RFK Jr. has said that he wants an
eight year “pause” on research on infectious disease and drug development, the
better (supposedly) to shift effort to studying “chronic disease.” You can bet
that any research on new vaccines will be included under that ban, if it ever
happens. You can also bet that funding studies of “vaccine injury” as a cause of
chronic disease will become a focus of the NIH, because his claim that the
current generation of children is the “sickest generation” assumes that vaccines
are one of the major root causes of chronic disease in children (and adults).

The obvious retort to that is that the NIH has a system of peer review, which
takes place in committees called study sections. These committees consist of
scientists with appropriate expertise, statisticians, and other relevant experts
who review incoming grants and assign them a priority score based on the
scientific impact, merit, and feasibility of each proposal. These scores are
then used by higher level committees called scientific councils to determine
which grants actually make the cut to receive funding. Surely, you might
reassure yourself, study sections are going to keep obvious bad science such as 
what antivaxxers generally propose, from receiving funding. All I can say again 
is: Oh, you sweet summer child.

This is where I must point out how so many MAHA- and MAGA-adjacent scientists
and physicians, such as Dr. Vinay Prasad, have been castigating NIH funding
mechanisms as promoting “mediocrity.” The basic attack, which goes back years
and years, claims that NIH study sections do not choose the most scientifically 
meritorious applications, but rather “safe” science. It’s a narrative I’ve been 
hearing over and over going back 15 years. While there is a grain of truth to
the narrative, a lot of the examples cited by, for instance, Dennis Slamon and
John Ioannidis are subject to retrospective bias, in which those making such
arguments know that the projects that had difficulty funding were successful and
assume that it was always obvious that they would be, all while forgetting that
at the time it was not nearly so obvious that these projects would succeed, not
to mention ignoring all the other similarly risky projects that didn’t succeed.
My retort to such complaints has always been to acknowledge that the NIH
becomes more conservative as paylines get tighter, meaning that the best
solution would be to increase the NIH budget, so that it can fund more grant
applications.

In any event, while attacking study sections as unable to pick the most
meritorious grants, these people are advocating for new systems to pick grants
to be funded that would make it potentially easier for antivaxxers to receive
NIH grants. How? By diminishing the role of study sections—or eliminating them
altogether—as gatekeepers. How? Think about the proposals, which I’ve discussed 
in depth here and here, to add a “modified lottery” element to the system
whereby grant applications are chosen for funding. The overall ideas here range 
from scoring grants, taking twice as many of the best-scored applications as
there are funds to support, and then making final funding determinations by
lottery. That’s not so scary, but other proposals involve almost total
randomness, with a fairly perfunctory review of grant applications to make sure 
they check all the boxes, after which they are funded according to lottery.

It’s worse than that, though. After all, lotteries are too unreliable,
especially when less than there is funding for less than 10% of grant
applications. That brings us to ideological purity tests being proposed and
touted by people like—you guessed it—Jay Bhattacharya and Vinay Prasad:

And yes, just as NIH grants currently consider the university’s ability to
provide lab space, and central core laboratory facilities, NIH grants should
consider a university’s ability to provide an environment of open inquiry. FIRE 
rankings or a modified alternative may serve as a starting point. Creating an
NIH hotline to report instances of academic freedom being threatened, perhaps
anonymously, would also discourage universities from these actions.

In short, there is nothing “outlanding” about Jay Bhattacharya considering
academic freedom alongside other facilities and opportunities present at
universities in deciding whether federal funding should be invested. We already 
ensure universities treat women fairly, lest they loose funding. We already
ensure universities have the physical space to conduct the work that is being
funded. We now ask only that universities offer the intellectual environment
that is conducive to free and open thought. That is not only in the interest of 
universities, it is directly in the public interest as well.

Guess who will determine what constitutes an adequate commitment to “academic
freedom”? No doubt such “commitment” will involve refusal to call quackery
quackery, bad science bad science, and pseudoscience pseudoscience, at least
with respect to ideological beliefs about COVID-19, masking, public health, and 
vaccines to which RFK Jr. clings. Remember, to science deniers, appeal to
“debate” is a shield against criticism and a grievance to which they can point
when the scientific community knows that what they are promoting is not worthy
of debate because it has no basis in evidence and/or is an obvious conspiracy
theory. For them, “debate” is performative, more designed to impress what they
view as the rubes with a false narrative that their pseudoscience is worthy of
serious consideration by actual scientists.

A long time ago, I wrote about the antivax view of NIH funding. Actually, it’s a
view of NIH funding held by many quacks, pseudoscience pushers, and cranks.
Specifically, it’s embodied in the narrative during the pandemic that suggested 
that Anthony Fauci, as the Director of the National Institute for Allergy and
Infectious Diseases, personally doled out grant funds to reward scientists and
universities that “toed the line” with respect to COVID-19, while punishing
contrarians not because their science was poor but rather because they didn’t
toe the line. Basically, the narrative portrayed Fauci (or the NIH Director) as 
akin to Michael Corleone at the end of The Godfather, when all the capos came to
kiss his ring and pledge their fealty to him as the new Boss, with Corleone
doling out favors to reward loyalty. I’ve long suspected that the origin of this
misconception about how NIH grants are funded is based on projection.
Basically, antivax conspiracy theorists who portray the NIH as doling out grant 
funds to reward supporters and withholding them to punish “dissidents” is
exactly how antivax conspiracy theorists would determine whose research is
funded and whose is not, leading them to assume that this is how the NIH has
always done it. With RFK Jr. in charge of HHS and Jay Bhattacharya soon to be in
charge of the CDC, there is now a chance for antivaxxers and “contrarians”
opposed to public health science to modify NIH funding mechanisms to resemble
more closely what I now call the Godfather model; i.e., adding a component to
grant funding decisions based on the ideology and loyalty of the scientists
applying.

As I’ve long said, whatever its flaws (and there are many), the study section
mechanism by which the NIH makes its grant funding strives to be as close to a
true meritocracy as any human organization can attain. If RFK Jr. gets his way, 
look for the NIH to pivot away from vaccines and infectious disease to whatever 
RFK Jr. designates as “chronic disease.” In fact, I can’t help but think that
the pseudoscience- and alternative meidcine-promoting National Center for
Complementary and Integrative Health is likely due for a huge budget increase
under him, in addition to grant mechanisms to study “vaccine injury.”

Having described the policy-based evidence-making by CDC and NIH that RFK Jr.
will likely begin as soon as he can, assisted by Dr. Jay Bhattacharya as NIH
Director and Dr. Dave Weldon as CDC Director as soon s they are confirmed by the
Senate, I now must move not to what scientific evidence produced as a result of
that process will be used for, supporting antivax policy. The first strategy to
do that will be through the Advisory Committee on Immunization Practes

RFK Jr. will control and thereby co-opt ACIP for the antivax movement

One of its most important functions, if not the most important function, of the 
CDC with respect to vaccine policy is its recommended schedule of childhood and 
adult vaccines. These CDC-recommended schedules are used by states to determine 
which vaccines will be required for school enrollment and which vaccines must be
covered under law by health insurance companies, Medicaid, Medicare, and
insurance plans under the Affordable Care Act is the CDC Advisory Committee on
Immunization Practices (ACIP), the committee that formally recommends the
childhood and adult vaccine schedules. He who controls ACIP controls the
CDC-recommended vaccine program. RFK Jr. has long known this.

And now RFK Jr. controls ACIP.

Soon after RFK Jr. suspended his independent campaign for President in August,
Dr. Paul Offit wrote about what sort of mischief that could be done to ACIP by
antivaxxers in a Trump administration, although he focused on The Heritage
Foundation’s Project 2025 and its plan to eliminate the CDC as a recommending
body for vaccines. At the time, I said that I didn’t think that even RFK Jr.
would do that. I stand by that assessment because controlling the
CDC-recommended vaccine schedule is a far more powerful tool than giving up that
CDC power. In that light, I note that the Februarty meeting of ACIP was
abruptly postponed (although ACIP workgroups did apparently meet as scheduled
this month) and reports have suggested that RFK Jr. is planning to replace the
existing ACIP members with antivax fake vaccine “experts.” (More on that in a
moment.) In a rather…interesting…twist:

The fresh scrutiny comes as a meeting scheduled for next week of the CDC’s
external vaccine committee was canceled, according to a person familiar with the
decision. HHS spokesperson Andrew Nixon said the meeting is being “postponed to
accommodate public comment in advance of the meeting.”

The federal public comment portal for the meeting — which was set to be open
from Feb. 3 through Feb. 17 — was never activated, a contributing factor to the 
postponement. The public historically has had an opportunity to comment on the
meeting agenda and request time to make oral statements.

Incompetence or malevolence? To be honest, I’m not sure which is the
explanation. Normally, I like to go by the adage, “Never ascribe to malevolence 
what can be explained by incompetence.” However, with RFK Jr. and Donald Trump, 
I’m having a difficult time hewing to that rule of thumb. I’ll assume for now
that it’s convenient incompetence. Why is ACIP so important, though?

First, Dr. Offit describes ACIP and its history:

During the 1940s and 1950s, the United States Public Health Service (USPHS)
relied on committees that met intermittently to address various vaccine issues. 
For example, in 1955, the USPHS convened experts to determine who should get
Jonas Salk’s polio vaccine. By the early 1960s, with the licensure of new
vaccines, it became evident that these committees needed to meet regularly. In
March 1964, the Surgeon General created the Advisory Committee on Immunization
Practices (ACIP), which was composed of experts in virology, immunology,
microbiology, pediatrics, epidemiology, public health, and preventive medicine. 
The charge to the ACIP was clear: “The Committee shall concern itself with
immunization schedules, dosages and routes of administration and indica­tions
and contraindications for the use of these agents. The Committee shall also
provide advice [to the CDC] regarding the relative merits and methods for
conducting mass immunization programs.”

Since 1964, ACIP experts have recommended many safe and effective vaccines.
Prior to these recommendations, every year in the United States polio caused
20,000 cases of paralysis and 1,500 deaths; measles caused 48,000
hospitalizations and 500 deaths; mumps was the most common cause of acquired
deafness; rubella (German measles) caused 20,000 cases of congenital birth
defects; rotavirus caused 70,000 hospitalizations from severe dehydration; and
bacteria such as pneumococcus and Haemophilus influenzae type b (Hib) caused
tens of thousands of cases of pneumonia, sepsis, and meningitis and hundreds of 
deaths. Thanks to vaccines, and the clear, strong recommendations by the ACIP
and CDC, these diseases have been dramatically reduced or eliminated. Indeed, in
a recent report published on August 8, 2024, researchers found that among 117
million children born between 1994 and 2023, CDC-recommended vaccines prevented 
about 500 million illnesses, 32 million hospitalizations, and 1.13 million
deaths.

All of this is true, which is why I don’t think RFK Jr. would eliminate ACIP,
even though he could. Rather, it is far more likely that he will subvert ACIP.
The Secretary of HHS picks the members of ACIP, after a nomination and selection
process. These members serve staggered terms, and the current roster has four
members, including the chair Dr. Helen Keipp Talbot, whose term expires June 30,
2025, four whose terms expire in 2027, with the rest expiring in 2028. (The
reason for this is that, for whatever reason, the Biden administration left a
number of ACIP committee positions vacant after the members’ terms had expired
and then appointed several new members in February.) By the end of a Trump
administration, all members of ACIP could be replaced; that is, if RFK Jr. were 
to wait until the terms of existing members expire. He could easily decide not
to wait and replace the entire committee now. Such is the power he now holds. In
any event, RFK Jr. can now decide who is in charge of vetting potential new
ACIP Members, or even vet them himself, a process that could be used to place
four antivax and/or contrarian “scientists” and physicians on the committee,
qualifications that prospective members be “acknowledged experts with an
outstanding record of achievement in their own field and an understanding of the
immunization issues covered by ACIP” be damned.

Regular readers can only imagine the disaster that would be. Likely no new
vaccines would be added to the CDC-recommended schedule, while some might even
be removed, as committee members harass CDC and FDA scientists to torture the
safety and efficacy data to make it “confess” that vaccines are unsafe and
ineffective. (Remember my discussion of policy-based evidence-making above.
There’s its relevance!) RFK Jr. might well be working on doing what I feared and
replacing real vaccine experts on ACIP with antivax quacks and
pseudoscientists, as reported by Politico:

HHS Secretary Robert F. Kennedy Jr. is preparing to remove members of the
outside committees that advise the federal government on vaccine approvals and
other key public health decisions, according to two people familiar with the
planning.

Kennedy plans to replace members who he perceives to have conflicts of interest,
as part of a widespread effort to minimize what he’s criticized as undue
industry influence over the nation’s health agencies, said one of the people,
who were granted anonymity to speak freely. Kennedy has long argued that
drugmakers have too much sway over the approval of their products.

Unsurprisingly, in his first speech to the HHS, RFK Jr. invoked rooting out what
he perceives as “conflicts of interest”, saying:

“We will remove conflicts of interest from the committees and research partners 
whenever possible or balance them with other stakeholders,” he said on Tuesday. 
“We will shut the revolving door.”

The shake-up is likely to target the Centers for Disease Control and
Prevention’s Advisory Committee on Immunization Practices (ACIP), which makes
recommendations for the licensing and administration of vaccines.

The whole appeal to “conflicts of interest” with Big Pharma is a longstanding
antivax trope. HHS already has very rigorous requirements for ACIP members to
report their financial conflicts. Moreover the members with direct interests in 
vaccines tend to be nonvoting members. I’m referring to representatives of
pharmaceutical companies, as well as advocacy groups such as the American
Academy of Pediatrics, the AMA, and Pharmaceutical Research and Manufacturers of
America (PhRMA).

As I like to say, I consider it rather telling how RFK Jr. seems only to
consider it a financial “conflict of interest” if it’s Big Pharma. As I also
like to say, I support transparency when it comes to all financial conflicts fo 
interest. One wonders if RFK Jr. will be so rigorous when it comes to enforcing 
COI reporting requirements when the COI is with Big Supplement, Big Wellness, or
Big Antivax (I’m looking at you, RFK Jr., with your massive COIs with respect
to suing pharmaceutical companies that manufacture vaccines, so expertly called 
out by Sen. Elizabeth Warren during your confirmation hearings), all of which I 
consider to be under the umbrella of Big Quackery. Somehow—just somehow—I
suspect that he won’t. That’s the idea. He’ll just shift ACIP COIs from Big
Pharma to Big Quackery.

In any event, one can’t help but note:

There was also a discussion scheduled for the HPV vaccine, a product known as
Gardasil that’s the subject of personal injury litigation on which Kennedy has
worked.

Quelle surprise. But don’t worry! RFK Jr. has a reassuring answer to that:

In a revised ethics pledge, the secretary said he would direct to his son any
proceeds won from the lawsuit over Merck’s vaccine and to which he’s entitled
through a referral arrangement with the law firm Wisner Baum.

Well, that makes it no longer a COI, doesn’t it? (Yes, that’s sarcasm, in case
that wasn’t painfully obvious.) I’m reassured. Aren’t you?

Meanwhile, RFK Jr.’s old antivax org Children’s Health Defense—you know, the one
that he had founded and run for several years and then tried to disavow when
Bernie Sanders asked him about the onesies with antivax slogans it’s selling—is 
salivating at the prospect of RFK Jr. replacing ACIP members, unsurprisingly
echoing RFK Jr.’s claim of “conflicts of interest” and quoting other
antivaxxers:

Once a vaccine is included on the childhood schedule, the drugmaker is protected
from liability for any injuries associated with the shot. The combination of
school vaccine mandates and no liability guarantees a steady revenue stream for 
vaccine makers.

“Most ACIP members have a financial conflict of interest with the pharmaceutical
companies,” Dr. Meryl Nass, internist, biological warfare expert and long-time 
ACIP watchdog, said.

“Their decisions almost always appear to reflect pro-industry bias,” she said.
“Although they are there to protect the public, few decisions seem to take the
public interest into account as the primary concern.”

Meryl Nass, of course, is an antivax quack. I’ll also translate from
antivax-speak what “pro-industry bias” means, namely any decision based on solid
science, clinical trials, and epidemiology, rather than on antivax
pseudoscience, conspiracy theories, and fear mongering. Interestingly, they
quote another antivax and pro-quackery activist Sayer Ji, who cites the outgoing
Biden Administration’s appointments to ACIP as justification for getting rid of
ACIP members:

“This postponement raises questions about whether there are internal conflicts
or strategic recalibrations underway at the CDC,” said Sayer Ji, founder and
editor of GreenMedInfo.

“Given that the outgoing administration stacked ACIP with staunchly pro-vaccine 
appointees, one could speculate that the postponement is a stalling tactic to
ensure continuity of their agenda. Alternatively, it could reflect an effort to 
re-evaluate and possibly restructure ACIP under new leadership.”

In its final days, the Biden administration quietly stacked ACIP with several
new pro-vaccine members, a move intended to “insulate the scientific integrity
of the panel from the incoming administration,” STAT News reported.

The outlet said these appointments were a direct response to President Donald
Trump’s nomination of Kennedy to head HHS. However, Kennedy could override or
otherwise bypass these selections.

Actually, as I wrote the last time I discussed what RFK Jr. might do to ACIP, I 
noted that the Biden administration had, for whatever reason, left a number of
ACIP committee positions vacant after the members’ terms had expired and only
eventually appointed several new members last February. In other words, the
picture is more complicated. If anything, I blame the Biden administration for
not keeping up-to-date with ACIP appointments and keeping the committee at full 
strength.

Unfortunately, now RFK Jr. controls ACIP, the single most important decider when
it comes to which vaccines are on the CDC-recommended schedule, because,
although the CDC Director isn’t required to accept ACIP recommendations, he
almost always does. ACIP is also the single most important watchdog regarding
existing vaccines on the schedule that decides when a vaccine shows too much
evidence of being unsafe to remain on the schedule. Remember, too, that More
importantly for this discussion, such health insurance plans are not required to
pay for vaccines not on the schedule.

Who controls ACIP controls the CDC-recommended schedule and controls the choice 
of science used to justify the CDC schedule. Over time, with antivaxxers on
ACIP, the accumulation of policy-based “evidence” falsely showing vaccines to be
unsafe, to cause autism, and to be ineffective could lead to the slow drip of
vaccines coming off the recommended schedule, one by one.

Then there’s the Vaccine Court.

RFK Jr. will influence the Vaccine Court

In 1986, because of a wave of litigation against vaccine manufacturers that
threatened to force vaccine manufacturers to flee the US market, Congress passed
the National Childhood Vaccine Injury Compensation Act of 1986, which set up
the National Vaccine Injury Compensation Program (NVICP) and the Vaccine Court. 
Basically, the law says that claims for vaccine injury must go through the
Vaccine Court first, the court funded by an excise tax on every dose of vaccine.
There are many advantages to complainants, not the least of which is that they 
can recover reasonable court costs, win or lose, and the standard of evidence
tends to be less onerous. There are also “table injuries” for which automatic
compensation is granted. Antivaxxers hate the system because it does try to be
science-based (although occasionally it tends to err on compensating injuries
not caused by vaccines); antivax lawyers really hate it because they can only
collect hourly rates and can’t gamble on obtaining a huge settlement and taking 
their huge contingency fees out of it. Here’s the thing. HHS controls what is on
the list of table injuries and has a large role in recommending settlements to 
the Department of Justice, as the process for seeking compensation is described 
on the website for the NVICP:

   What is the process?

  1. An individual files a petition with the U.S. Court of Federal Claims.

  2. The U.S. Department of Health and Human Services medical staff reviews the
    petition, determines if it meets the medical criteria for compensation and
    makes a preliminary recommendation.

  3. The U.S. Department of Justice develops a report that includes the medical
    recommendation and legal analysis and submits it to the Court.

  4. The report is presented to a court-appointed special master, who decides
    whether the petitioner should be compensated, often after holding a hearing 
    in which both parties can present evidence. If compensation is awarded, the 
    special master determines the amount and type of compensation.

  5. The Court orders the U.S. Department of Health and Human Services to award
    compensation. Even if the petition is dismissed, if certain requirements are
    met, the Court may order the Department to pay attorneys’ fees and costs.

  6. The special master’s decision may be appealed and petitioners who reject the
    decision of the court (or withdraw their petitions within certain timelines)
    may file a claim in civil court against the vaccine company and/or the
    health care provider who administered the vaccine.

You can see where this is going. With antivaxxers in ACIP and, over time, all
over the relevant HHS offices, you can see HHS medical staff adding conditions
that vaccines definitely don’t cause (e.g., autism) to the list of table
injuries and recommending compensation at step #2 for more and more conditions, 
whether caused by vaccines or not. You might further envision that the
policy-based “evidence” created by RFK Jr.’s minions could be used to justify
greatly broadening the list of conditions viewed as “vaccine injury,” thereby
bankrupting the fund that supports the Vaccine Court and building pressure to
take certain vaccines off the CDC schedule. Manufacturers might take the most
targeted vaccines off the market.

RFK Jr. will control vaccine safety monitoring systems VAERS and VSD

Speaking of policy-based evidence-making, it won’t just be the CDC and NIH that 
RFK Jr. will be able to weaponize to produce “evidence” that portrays vaccines
as unsafe and causing conditions (like autism), diseases (like “the various
autoimmune diseases antivaxxers like to attribute to vaccines “turbo cancer”),
and complications that current evidence shows them not to cause. Although they
are not the only vaccine safety monitoring systems, VAERS and VSD are the two
primary ones. Other active monitoring systems include the Clinical Immunization 
Safety Assessment (CISA) project and the FDA’s Post-licensure Rapid Immunization
Safety Monitoring System (PRISM).

VEARS is a passive reporting system, which relies on vaccinees, families, and
healthcare professionals to report suspected adverse events after vaccines.
Thus, as a system, VAERS was never intended to provide an accurate estimate of
the frequency of AEs related to vaccines, but rather to serve as an early
warning system, a “canary in the coal mine”, if you will, for possible new
vaccine-related AEs. In other words, VAERS is a hypothesis-generating, not a
hypothesis testing, system, and its hypotheses are tested using better systems, 
like VSD, CISA, and PRISM. In contrast to VAERS, these systems are active
reporting systems in that electronic health records are actively monitored for
AEs after vaccination in order to identify potential signals; there is a lot
less bias that way and a lot less potential for misreporting. Indeed, the main
problem with using VAERS to estimate the frequency of AEs after vaccination is
that, in essence, anyone with access to the Internet, mail, or the telephone can
report anything to VAERS, as was demonstrated by bloggers years and years ago
when one autism advocate filed a report claiming that the flu vaccine had turned
him into The Incredible Hulk and another claimed a vaccine had turned his
daughter into Wonder Woman. Moreover, going back 25 years, antivaxxers have
flooded the database with claims that vaccines cause autism, in order to support
litigation.

RFK Jr., however, as HHS Secretary, will have access to the unfettered raw data 
from all of these systems, given that they are all maintained by agencies under 
his purview. If he wishes to commission “analyses” of data from VAERS, VSD,
CISA, or PRISM, he can. If he wishes to commission antivax “scientists” like
Brian Hooker, Anthony Mawson, or even Andrew Wakefield to “reanalyze” the data
from these systems, he can. Antivaxxers have long gone “dumpster diving” into
VAERS to find all manner of correlations that they use to blame vaccines for
horrible adverse events, a process that accelerated after COVID-19 vaccines were
granted an emergency use approval. Antivaxxers have long abused VAERS data.
Imagine what they could accomplish with unfettered access.

As for the VSD, you might remember that around 21 years ago, the antivax
father-son team of Mark and David Geier were granted access to the VSD database 
to explore the hypothesis that thimerosal in vaccines cause autism. At that
visit, they were busted trying to merge databases in a manner that could
compromise patient privacy and reveal protected health information (PHI) for
patients whose health data were contained within the database. As a result,
their IRB approval was revoked and their access to VSD terminated. Now imagine a
whole horde of Geiers, given permission by RFK Jr. himself, swarming over the
VSD database. You get the idea. None of this even considers changes in the VAERS
or VSD systems that RFK Jr. could potentially make that would degrade the
reliability of the systems in the name of “improving safety.”

Of course, to RFK Jr., that likely will not be enough. Even if all the
policy-based “evidence” that he and his minions make lead to many vaccines no
longer being covered by insurance and to more and more people being so afraid of
vaccines that they refuse to use them, vaccines will still be legal. They will 
still be available to people who have the resources. Yes, I know that, were RFK 
Jr. to stop there, he could in essence have mostly destroyed the US vaccination 
programs without, technically, having “taken away” anyone’s vaccines. I predict 
that he won’t be able to stop there, however. That’s where the FDA comes in and 
where the policy-based evidence will be particularly useful.

FDA: Recalls, bans, and black box warnings

The FDA is also part of HHS and therefore now controlled by RFK Jr. As most
people know, the FDA exists to assure the safety of food and the safety and
efficacy of drugs and medical devices. As a result, vaccines must be licensed by
the FDA for market before ACIP will even consider adding them to the schedule. 
(Yes, I know, in the case of the COVID-19 mRNA vaccines, emergency use approval 
by the FDA was enough to have ACIP consider the vaccine, but the idea stands.
Any vaccine must be approved, either provisionally or fully, by the FDA before
it can be added to the schedule.

Before even considering any other aspect of the FDA as it relates to vaccine
approval, I predict that the approval of new vaccines by the FDA under RFK Jr.
will grind to a halt. At the very minimum, in the name of his “concerns” about
their “safety,” RFK Jr. will call for re-reviews of the data and applications
for any vaccine in the approval pipeline, thus bogging things down, even if the 
FDA has already accepted the evidence for safety. I also predict that he will
find ways to make the standards for vaccine approval more and more onerous
beyond what is called for by science and reason, all while requiring, similarly,
ever more onerous post-licensure monitoring. As a result, given that most
vaccines are not exactly profit centers for pharmaceutical companies anyway,
there will be a lot less financial incentive to develop vaccines for the US
market and likely there will be few if any new vaccines submitted for FDA
approval while RFK Jr. is HHS Secretary.

As ACIP is the key committee for determining which vaccines are in the CDC
schedule, the key committee for vaccine approval by the FDA is its Vaccines and 
Related Biological Products Advisory Committee (VRBPAC), which is under the
purview of the Center for Biologics Evaluation and Research (CBER). The VRBPAC
charter describes its duties and functions thusly:

Objectives and Scope of ActivitiesThe Committee advises the Commissioner or
designee in discharging responsibilities as they relate to helping to ensure
safe and effective vaccines, allergenics, and related biological products for
human use and as required, any other product for which the Food and Drug
Administration (FDA) has regulatory responsibility.

Description of DutiesThe Committee reviews and evaluates data concerning the
safety, effectiveness, and appropriate use of vaccines, allergenics, and related
biological products which are intended for use in the prevention, treatment, or
diagnosis of human diseases, and as required, any other products for which the 
FDA has regulatory responsibility. The Committee also considers the quality and 
relevance of FDA’s research program which provides scientific support for the
regulation of these products and makes appropriate recommendations to the
Commissioner of Food and Drugs.

Unlike ACIP, however, VRBPAC members are selected by the FDA Commissioner or his
designee, in this case (assuming he’s confirmed by the Senate), Dr. Martin
Makary.

To obtain FDA approval for a vaccine, a manufacturer submits a Biologics License
Application (BLA) to the FDA. BLAs include preclinical and clinical data and
information, as well as details of the manufacturing process and facilities. The
FDA then examines the application and data submitted and decides whether to
approve and license the vaccine. As for VRBPAC:

In some cases, FDA seeks the input of its Vaccines and Related Biological
Products Advisory Committee (VRBPAC). This committee is comprised of a panel of 
outside, independent, technical experts from various scientific and public
health disciplines that provide input on scientific data and its public health
significance in a public forum. The FDA will consider, but is not bound by, the 
input received from the VRBPAC when determining whether to approve a vaccine.

As you can see, there are multiple levels of review for any vaccine for which a 
manufacturer is seeking FDA approval. Now, imagine that Dr. Marty Makary, who
has not yet been confirmed as FDA Commissioner but who will be working for RFK
Jr. Jonathan Howard once asked what Dr. Makary would do if RFK Jr. pressured him
to revoke the licensure of various vaccines and was not confident at all that
Makary would do the right thing, even if it meant being fired. Neither am I,
even when it comes to resisting the coming machinations of RFK Jr. and his
cronies to game the approval system for vaccines.

Also, Makary will soon have the power to appoint members to VRBPAC. Imagine the 
policy/ideology-directed scientific evidence and studies that RFK Jr. and his
minions will be cooking up being used as pretexts to bring “concerns” about the 
safety of specific vaccines to VRBPAC, which they will do. Also remember, VRBPAC
is the committee that meets every spring to examine data about the flu strains 
circulating in order choose which flu strains should be used to produce vaccines
in the late summer and fall that year, based on its predictions of which
strains will likely be circulating in North America. Indeed, now that I think of
this aspect, one can easily see a scenario where whatever VRBPAC picks will not
be a “good enough” choice and flu vaccine production is hampered, leading to
shortages and fewer people receiving the vaccine.

Finally, even if RFK Jr. can’t use the CDC, NIH, and FDA to manufacture and/or
cherry pick “scientific evidence” falsely portraying specific vaccines as so
unsafe that the FDA has to revoke their licensure, I can easily see a scenario
where such dubious “science” can be used to produce just enough “evidence” to
lead a compliant FDA to issue a “black box” warning for specific vaccines. Black
box warnings are the FDA’s most stringent warning, alerting the public and
health care providers to serious side effects, such as injury or death, from a
drug, device, or biologic. In such an event, RFK Jr. will have, again
technically, “not taken away” anybody’s vaccines, but will have ginned up so
much fear of the vaccines, also while possibly inducing health insurance
companies not to cover them, that the effect will be almost the same delicensing
them.

Will RFK Jr. succeed in destroying the US vaccine program?

I realize that this post is long, even by Gorski standards. The reason is
simple. As I thought more and more about what RFK Jr. can do to undermine the
vaccine program as HHS Secretary, I kept thinking of more and more horrible
things, things that I know RFK Jr. has undoubtedly already thought of. The more 
I thought of, the more I had to write about, and the longer this post became. I 
make no apologies, though. I’m hoping the sheer length and depth will convince
you just what a dire threat RFK Jr. is to public health and the vaccination
program as HHS Secretary.

From my perspective, even if the rest of MAHA aside from vaccines weren’t mostly
a sham, what RFK Jr. will try to do to the vaccine system will far outweigh any
potential good he could do in terms of public health by encouraging healthy
eating and directing more research money to chronic disease. To my fellow
physicians who, just because they like the superficial MAHA message RFK Jr.
promotes about food, obesity, and chronic disease have in essence been in denial
about how antivaccine RFK Jr. is and how much damage he can do to public
health, I urge you: Wake up. You have been played. Nearly three months ago I
characterized RFK Jr. as an “federal public health programs and science-based
health policy.” Unfortunately, I fear, that extinction is nigh; that is, unless 
we resist.


HHS is weaponizing evidence-based medicine to falsely portray vaccines as unsafe

Last week, HHS announced that all “new vaccines will undergo safety testing in
placebo-controlled trials.” Sounds good? Not so fast. This is really a deceptive
weaponization of evidence-based medicine to undermine confidence in vaccines
and eliminate at least some of them.

David Gorski on May 5, 2025

Link

Having a man who has for the last two decades arguably been America’s most
famous and intellectual antivax activist in charge of the Department of Health
and Human Services (HHS) has been exhausting. Every week, I say that I’m not
going to write about whatever new horror Robert F. Kennedy Jr. is inflicting on 
US federal health, public health, and biomedical research, but then every week
he comes up with something new that, to those of us paying attention, is not
really new at all. Last week, it was this announcement showing up in all sorts
of news stories, for example, The Washington Post:

Health and Human Services Secretary Robert F. Kennedy Jr. intends to shift the
way vaccines are tested, a move that the agency said will increase transparency 
but that medical experts fear could limit access to vaccines and undermine the
public’s trust in immunization depending on its implementation.

The potential change outlined in a statement says all new vaccines will be
required to undergo placebo testing, a procedure in which some people receive
the vaccine and others receive an inert substance — such as a saline shot —
before the results are compared.

“All new vaccines will undergo safety testing in placebo-controlled trials prior
to licensure — a radical departure from past practices,” an HHS spokesperson
told The Washington Post in response to questions about Kennedy’s comments on
the measles vaccines and general vaccine policy.

As soon as I started reading these stories and seeing them pop up on TV in news 
reports, I realized that this was simply the implementation of something that
antivaxxers and COVID-19 contrarians had been doing all during the pandemic,
riffing on an antivax trope that long predated the pandemic. Indeed, less than a
year and a half ago, I wrote a post about it entitled 2023: The year that the
evidence-based medicine (EBM) paradigm was weaponized against vaccines and
public health. Sadly, I never thought I’d be doing an update to this post in
which I felt the need to explain that this weaponization of the EBM paradigm is 
now federal vaccine policy—and, no doubt, soon to be policy regarding all public
health—but here we are.

Think I’m overreacting? Here’s the “tell” from the HHS statement:

In recent weeks, the Trump administration has injected uncertainty into the
annual process for approving an updated coronavirus shot traditionally offered
in the fall, indicating there may need to be more data.

“Except for the COVID vaccine, none of the vaccines on the CDC’s childhood
recommended schedule was tested against an inert placebo, meaning we know very
little about the actual risk profiles of these products,” HHS said in its
statement.

This is a straight-up antivax trope, one that I’ve written about a number of
times, specifically the claim that none of the vaccines on the CDC’s childhood
recommended vaccine schedule was tested against an “inert placebo.” Usually the 
antivax version of this specifies a saline placebo as The Only One True Inert
Placebo permitted, but, whatever the term, the trope remains. It’s a trope long 
repeated by RFK Jr. and Aaron Siri, an antivax lawyer with whom RFK Jr. has
frequently worked, and therefore one that I’ve written about before,
specifically how the trope is based on a deceptive half-truth based on on a
misuse of EBM that I like to call methodolatry.

Before I discuss why that is, I also have to note that it’s a straight up lie to
claim that “none of the vaccines on the CDC’s childhood recommended schedule
was tested against an inert placebo” (emphasis mine). The HHS statement itself
even concedes that the COVID-19 vaccine, which is currently—although probably
not for much longer—on the CDC’s recommended childhood vaccination schedule was 
tested against placebo. That actually surprised me, given the RFK Jr.’s
propensity to lie about vaccines. In any case, it’s easy to see that the
varicella vaccine, for example, was tested against saline placebo.

I’ll start by defining “methodolatry,” after which I’ll explain why it is,
depending on your point of view, either a weakness of the EBM paradigm that is
baked in or a fundamentalist version of EBM that ignores medical ethics in favor
of supposed scientific rigor. Then I’ll discuss why this new HHS diktat,
although represented as “gold standard science”—a term RFK Jr. and his minions
love to throw around and something they claim to be “restoring” to federal
vaccine policy—is, in actuality, a strategy to undermine trust in vaccines by
portraying vaccines on the current CDC childhood schedule as inadequately tested
and potentially unsafe. It is also a strategy that, depending on how “new
vaccine” is defined, could prevent the approval of updated COVID-19 and flu
vaccines and even provide a seeming “gold standard science” rationale for
delicensing some currently licensed vaccines, all while falsely claiming the
scientific high ground in doing so.

Think of it this way. The reality-challenged insinuation that the current
childhood vaccine schedule is unsafe because its constituents haven’t been
tested in placebo controlled RCTs notwithstanding, placebo-controlled RCTs
demonstrating efficacy and safety have always been required for new vaccines
against diseases that currently have no licensed vaccine.

Methodolatry: EBM fundamentalism that ignores ethics and practicality

Way, way back in the day in 2009, I came across the term “methodolatry” in a
blog post by a senior epidemiologist who blogged under the ‘nym “revere,” who
during the H1N1 influenza pandemic, called out a hagiography published in The
Atlantic of Dr. Thomas Jefferson, an EBM guru at the Cochrane Collaborative
known for having cast doubt on the efficacy and safety of flu vaccines, setting 
up his use of the term thusly:

Brownlee and Lenzer rely upon (and romanticize as a martyr and truth-teller) Dr.
Thomas Jefferson, someone who is fast establishing himself as an “Evidence
Based Medicine” (EBM) crank who who courts notoriety by being a contrarian. The 
kind of EBM practiced by the likes of Jefferson and some other randomized trials
zealots is far from the judicious weighing of the evidence envisaged by its
early proponents.

Sound familiar? Let’s just say that EBM fundamentalist zealots like Drs. Vinay
Prasad, John Mandrola, and Adam Cifu are nothing new. Indeed, they are simply
the latest generation of methodolatrists, “intellectual”—if you can call it
that—descendants of, for example, Tom Jefferson and Peter Gøtzsche, who used it 
to cast doubt on the safety of Gardasil. (Never mind that the existence of long 
term studies like this one that did compare HPV vaccines to saline placebo
controls rather undermines this particular antivaccine talking point.) The
difference, of course, is that that Prasad and colleagues have way less
experience in actually doing EBM. But what is methodolatry? Heed the words of
revere, nearly 16 years ago:

There is nothing judicious about Jefferson, whose problem was described by one
of my colleagues as “methodolatry,” the profane worship of the randomized
clinical trial as the only valid method of investigation.

The very first comment after revere’s post describes the consequences of
methodolatry, or what I sometimes also call EBM fundamentalism:

Even if in his case the agenda might be “That’s sufficient evidence?”, which if 
thoroughly applied would declare many treatments to be not effective and
ultimately—if you follow the logic of EBM—not approved or allowed?

My specific point is that we have here a concrete example of the misuse of EBM
that is having real world effects, perhaps to the point that one or more people 
will die from novel H1N1 because this article convinced them the benefit of
getting inoculated is so low it doesn’t outweigh the perceived risks.

Again, does this sound familiar? It’s exactly what has been done by COVID-19
contrarians deceptively claiming the scientific high ground by demanding
randomized controlled clinical trials (RCTs) on everything from mask mandates to
other nonpharmaceutical interventions, while almost never actually proposing
how one would do such a trial in the middle of a pandemic. As our very own Dr.
Jonathan Howard has frequently pointed out, it’s all performative, designed to
cast doubt on existing evidence and demand a standard of evidence that in the
real world is often impossible to attain for whatever interventions they don’t
like, be they COVID-19 boosters, masks, or whatever.

As I wrote at the time, you could take a number of articles citing the lack of
RCTs about various non-pharmaceutical interventions for COVID-19 or for COVID-19
boosters or for a number of issues that have come up during the pandemic and
change the words “novel H1N1” to “novel coronavirus” or “COVID-19,” and revere’s
observations are just as valid today as they were in 2009. The only difference 
today is that far more EBM gurus seem to be promoting the same simplistic and
misleading message that Tom Jefferson was back then; worse, the same idea is
metastasizing from COVID-19 to the childhood vaccination schedule. If you doubt 
me, must look at how Vinay Prasad, eager to suck up to RFK Jr., suggested that
the childhood vaccination schedule should undergo a “a multi-arm, factorial
RCT…before public distrust gets too out of control,” without, as I pointed out, 
ever actually saying how such a massive trial could be done ethically. (Hint: It
can’t, for reasons that I will explain.) Indeed, Dr. Prasad is prone to
proposing RCTs for questions that are not even medical, such as testing various 
methods of deciding which grant applications are funded by the NIH.

Why is methodolatry so deceptively appealing? In brief, the way it is being used
now by HHS under RFK Jr. depends on a very simplistic version of EBM as
promoted by EBM/RCT zealots and understood by those knowledgeable enough to be
aware of the basic tenets of EBM but who do not understand EBM sufficiently well
to know the caveats; i.e., when we have to do with “lesser” evidence.

At this point, it’s useful to briefly explain the EBM paradigm that puts RCTs
near the very top of the EBM pyramid—or hierarchy—of evidence, with the only
evidence ranking higher being systematic reviews and meta-analyses of multiple
RCTs. First, though, keep in mind these two bedrock principles of bioethics, the
first relevant to all human subjects research including RCTs, the second being 
more relevant to RCTs:

  1. No subject should receive anything less than current standard-of-care
    medicine, be it the intervention being tested or any other medical
    intervention that they might undergo during the trial.

  2. There must be genuine clinical equipoise between all groups, including control
    groups, in any RCT. Clinical “equipoise” means that there must be genuine
    scientific uncertainty regarding whether the experimental intervention is
    truly better than what the control group receives. Obviously, physicians
    don’t carry out clinical trials if they don’t think that the intervention
    being tested is likely to be at least as good as the control group, and one 
    can argue about what constitutes an adequate level of “uncertainty” to
    justify an RCT, but clinical equipoise is one bedrock principle that
    determines if an RCT can be ethical. In other words, you can’t ethically
    randomize human subjects to an experimental group that you know to be an
    inferior treatment.

Keep these principles in mind as I discuss how the EBM paradigm can become
methodolatry. I will then describe how the HHS diktat could easily be
methodolatry, depending upon how it is operationalized.

The EBM paradigm vs. methodolatry

The EBM paradigm is often described in terms of the “evidence pyramid,” in which
types of scientific evidence applied to medicine are ranked thusly:

EBM pyramid of evidence. Note that anything that is not an RCT is automatically 
considered “lower quality” evidence and that the highest form of evidence of all
is meta-analyses and systematic reviews of RCTs.

Randomized controlled clinical trials are just that: clinical trials in which
subjects are randomized to receive either the intervention or a control (such as
a saline placebo) and then followed to determine which group has better
outcomes, which are prespecified in the clinical trial protocol. The reason for 
randomization is to ensure that the two groups being compared resemble each
other as closely as possible in characteristics relevant to the outcomes being
tested. For example, if you’re testing a drug to treat hypertension, you would
want the groups to be matched as closely as possible for, among other
characteristics, age, race, sex, severity of hypertension, and relevant risk
factors for poor outcomes. Ideally, these RCTs are then double-blinded, so that 
neither the subjects nor the doctors or medical personnel administering the
drugs and assessing outcomes know which group any given subject is in. Moreover,
such clinical trials have strict inclusion and exclusion criteria, which ensure
that those being treated actually have the disease, do not belong to a group
that might be harmed by the drug, and are subjects who are likely to benefit if 
the drug does have efficacy; i.e., does work.

As you can see in the image above, in the EBM paradigm RCTs are ranked near the 
top of the pyramid for strength of evidence. Actually, as far as original
clinical studies go, they are at the top. It is true that systematic reviews and
meta-analyses of RCTs are ranked higher (i.e., as more rigorous), but remember 
that these are syntheses of existing RCTs, not original experimental clinical
studies in which one intervention is tested against placebo or another
intervention. Moreover, it is also true that, for certain questions, RCTs truly 
are the gold standard, as an RCT is the design that best minimizes bias, thanks 
to randomization and careful matching of the experimental versus the control
group, plus blinding, which when done properly minimizes bias due to
observation.

Let’s look at a concrete example that I like to cite, the strict EBM paradigm as
applied to whether the MMR vaccine causes autism. (RFK Jr. has been saying for 
many years now that he believes it does.) Regular readers of SBM likely already 
know that in reality the evidence base of studies examining the question of
whether vaccines cause autism is very large and has failed to find even hint of 
a whiff of an association between MMR (or MMRV) and autism. Yet, because the
bulk of these studies consists of epidemiology, including one that encompassed
537,303 children representing 2,129,864 person-years of study, the certainty of 
the evidence behind the conclusion of the relevant Cochrane review that the MMR 
vaccine does not cause autism can never be more than “moderate” because by the
very definition of the EBM paradigm and its ranking of sources of evidence,
epidemiological studies always rank below RCTs. Note that it will never be
possible to do an RCT to answer the question of whether vaccines like MMR
increase the risk of autism because such a trial would be inherently unethical, 
not to mention also very impractical, as defenders of science-based vaccine
requirements were explaining 15 years ago.

I discussed the nitty gritty of EBM levels of evidence the last time around,
including some newer definitions and acknowledgment that certain questions can’t
be answered by RCTs, if only for ethical reasons. I’ve also discussed how the
EBM paradigm can “inspire” those who take it too far to want to argue that RCTs 
are the only valid method of investigation, even for questions for which they
are ill-suited. I also note that EBM fundamentalists frequently ignore the
precept that “if RCTs are impractical or unethical,” then cohort and case
control studies must suffice. While it’s always difficult to tell whether EBM
fundamentalists are true believers or are intentionally misusing the EBM
paradigm of RCTs über alles, in the case of RFK Jr. I am willing to say that it 
is almost certainly intentional misuse of the paradigm. Let me explain through
the example of the childhood vaccination schedule and the longstanding antivax
half-truth that childhood vaccines have never been tested in proper RCTs.

RFK Jr: Weaponizing EBM fundamentalism against the childhood vaccination
schedule

The idea that the vaccines in the childhood vaccination schedule have never been
tested in “proper” RCTs for safety and efficacy is an old antivax trope, long
championed by Aaron Siri, a shyster—IMHO, of course!—who’s long worked with
antivax activists RFK Jr. and Del Bigtree and his antivax organization ICAN
harassing various governments and companies with—again, IMHO—frivolous lawsuits 
designed to cast doubt on the safety and efficacy of vaccines. It was the
central subject of an antivax book, Turtles All the Way Down, whose title
appears to be an analogy to the actual situation with the childhood vaccination 
schedule, as you will see, particularly if you look at the book’s cover art:

Notice the turtles piled up on top of turtles going down ad infinitum. Besides
being an allusion to Hindu mythology, in this case it’s referring to vaccines in
the CDC childhood vaccine schedule and RCTs, as you will see.

The central premise of Siri and RFK Jr.’s claim that most childhood vaccines
have not been tested against a saline placebo—rephrased in the HHS statement as 
“inert placebo”—has also been misrepresented as a “placebo pyramid scheme”:

Aaron Siri Exposes the 'Placebo Pyramid Scheme' Used to License Childhood
Vaccines"What Dr. Offit wrote is 'all vaccines are tested in
placebo-controlled trials before licensure'…The problem is that is not true…He
is dead wrong in making that claim…As an example the… pic.twitter.com/W2T5xtLpp9

— Chief Nerd (@TheChiefNerd) August 12, 2023

Or, as Dr. Vincent Iannelli at Vaxopedia represented it

It is, of course, true that many of the current vaccines in the childhood
vaccine schedule were never tested an RCT vs. saline placebo, but there is a
very good reason for that. Go back to the first ethical principle of human
subjects research that I listed above. I’ll repeat it again for emphasis:

No subject should receive anything less than current standard-of-care medicine, 
be it the intervention being tested or any other medical intervention that they 
might undergo during the trial.

Why is this principal of clinical trial ethics so important regarding the
childhood vaccination schedule? Simple. Consider first the case of a disease for
which there is no existing FDA-licensed safe and effective vaccine; i.e., a
first generation vaccine. To test an experimental first-generation vaccine, it
is ethical to do an RCT, because there currently exists no vaccine that is
licensed and standard-of-care, and that’s exactly what is required of such a new
vaccine. In fact, that is what has always been required for new first
generation vaccines. It’s the reason why, to be approved for use in children,
the COVID-19 vaccines were required to undergo an RCT in children. Even the HHS 
statement conceded that COVID-19 vaccines had undergone placebo-controlled RCTs 
in children before being licensed.

Now let’s consider the case of a new vaccine for a disease for which there
already exists a licensed vaccine that is safe and effective and considered by
pediatricians to be standard-of-care, for example, vaccines against measles;
i.e., a second, third, or even fourth generation vaccine. (I’ll call these
second generation vaccines, for brevity’s sake.) Alternatively, consider the
development of multivalent vaccines; i.e., multiple existing vaccines against
different diseases combined into one shot for convenience of administration,
such as measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV).
In the case multivalent vaccines combining approved vaccines and of second
generation vaccines, there already exists a vaccine licensed as safe and
effective against an specific disease (or safe and effective vaccines against
specific diseases) that are considered standard of care by pediatricians and
other relevant medical specialties.

In these cases, other than rare cases, doing an RCT with a saline or “inert”
placebo would be completely unethical because it would require randomizing a
number of subjects to be in a group that receives less than the standard of care
with respect to vaccines and who would therefore be intentionally left
vulnerable to the diseases prevented by both the old vaccine and the new vaccine
being tested. In the case of, for example, a new vaccine against a disease, the
only ethical way to carry out an RCT of a second generation or of a new
multivalent vaccine would be to test the new vaccine against the existing
vaccine for that disease in order to determine that the new vaccine is at least 
as effective and safe as the old vaccine. This is called a non-inferiority
trial. Even if a non-inferiority trial doesn’t show that the new vaccine is
better than the old at preventing disease, there might still be reasons to favor
the new vaccine even if it is only “as good as” the older vaccine. Reasons for 
favoring the new vaccine might include, for example, that it’s cheaper, easier
to dose, or has a more tolerable side effect profile. Of course, ideally, we
would prefer to be able to show that the new drug is better than the existing
standard-of-care, but this is often very difficult to do, which is why
noninferiority trials are more common.

In addition, remember the second ethical principle I mentioned. Regardless of
the scientific rigor of the trial, randomization requires clinical equipoise;
i.e., the existence of genuine uncertainty based on existing science and
evidence about which group, control or experimental, will do better. Clinical
equipoise is not just a requirement, but absolute requirement for randomization 
of clinical trial subjects to be considered ethical. Note that clinical
equipoise does not mean that there is no evidence that a treatment works or is
better than existing treatments. After all, the reason we do clinical trials is 
to find drugs that work where there currently are none and to find drugs that
work better than current therapy, and there has to be compelling preclinical
evidence from laboratory and animal studies, as well as preliminary early stage 
clinical trials, to justify testing a drug or vaccine in an RCT. There also has 
to be genuine scientific uncertainty, even if, as is usually the case,
investigators think that it is more likely than not that the experimental group 
will do better than the control group. Absent that legitimate uncertainty, an
RCT to test an intervention is unethical, as is the case in randomizing a child 
to be left unprotected against measles to test a new measles vaccine or
formulation of vaccines that includes the measles vaccine.

I note that these two principles are general principles governing all clinical
trial ethics as well. In my area of specialty, for instance, oncology, we don’t 
test new chemotherapeutic drugs against placebo if there already exist effective
chemotherapy regimens with a side effect profile deemed tolerable. Instead, we 
either add the new drug to the existing chemotherapy regimen and test it against
the existing chemotherapy regimen without the new drug, or, in the case where
the existing chemotherapy regimen is only marginally effective, it can sometimes
be ethical to test the new chemotherapy against the existing chemotherapy
regimen. The principle to be remembered is that in no case should any human
subject enrolled in the clinical trial ever receive anything less than the
existing science-based standard-of-care. To do otherwise would be unethical.
Indeed, this is codified in a multinational set of guidelines to which the FDA
has adhered. I cited above and that could be fit into the FDA regulation that
allows an active treatment concurrent control:

The use of a placebo control group does not imply that the control group is
untreated. In many placebo-controlled trials, the new treatment and placebo are 
each added to a common standard therapy (so called add-on studies, see section
2.1.5.2.1).

Coming back to the childhood vaccine schedule, the true situation is that, in
any cases for which a current vaccine in the schedule wasn’t tested against
placebo, if you go back far enough you will inevitably find that the original
vaccine against that disease was tested in a placebo-controlled RCT. As friend
of the blog Skeptical Raptor put it:

So, let’s be clear here. Any new vaccines that replace older vaccines will
probably not use a true placebo-controlled group. The new vaccine will almost
always be compared against the older version of the vaccine, but there may be a 
way around that; I don’t see it.

Nor do I. As Dr. Stanley Plotkin puts it:

Stanley Plotkin, a pioneer in the field who developed the rubella vaccine, said 
that when scientists test vaccines against a new disease, they typically look
for evidence that the vaccinated individuals do not get a disease, compared with
those who received a placebo. This is how the coronavirus vaccines were tested,
in 30,000-person trials in which half of the participants received saline
shots.

But when a disease is already well understood, scientists can look for evidence 
that vaccines induce a biological response that has been scientifically shown to
protect against the disease — what scientists call “a correlate of protection.”

In the case of diseases that cause serious illness and can even be fatal, if
there are existing interventions, the use of placebos is often not considered
ethical.

“Ethics must be taken into account when you set up a study,” Plotkin said. “Can 
I ethically agree to having people acquire the disease because they receive a
placebo?”

Precisely.

Moreover, as vaccine scientist and advocate Dr. Paul Offit pointed out, even
doing RCTs for new vaccines against diseases for which there is currently no
safe and effective vaccine has an ethical price. Pointing to the original RCT of
Jonas Salk’s original vaccine against polio in the 1950s, he called it the
“casual cruelty of placebo-controlled trials,” because 34 of the 36 children
paralyzed by polio in that study were in the placebo group.

Over on Threads, Dr. David Higgins provided some comparisons to give you an idea
why requiring placebo-controlled RCTs of second generation vaccines instead of 
the case now, trials comparing the new vaccine to existing vaccine, is so
off-base:




View on Threads

I’ll also point out that the way that HHS emphasizes “inert” placebos is another
antivax trope. To the likes of RFK Jr., Del Bigtree, and Aaron Siri, the only
acceptable placebo is saline. This emphasis of “inert”—cough, cough,
saline!—placebos is another strategy to falsely delegitimize the RCTs used to
license some vaccines because, for example, some RCTs use something other than
saline. For example, the original HPV vaccine trial used a placebo that
contained the same aluminum adjuvant as the vaccine, because it made it very
difficult for subjects and their doctors to see any difference in local skin
reactions between placebo and vaccine. Sometimes vaccine trials will use the
diluent used for the vaccine, minus the antigen(s) used to provoke the immune
response, in order to make the two as similar as possible other than the “stuff”
that provokes immunity.

The real purposes of the HHS vaccine placebo diktat

With that background in mind, I turn my attention to what I view as the real
purpose of the HHS diktat that, henceforth, all new vaccines will be tested
against “inert” placebo before they can be licensed. You won’t be surprised to
learn that my conclusion is that the purpose of this diktat is, first of all, to
suggest that the current CDC childhood vaccination schedule is somehow unsafe
and not evidence- or science-based, when it most certainly is. Again, the “tell”
is how the HHS statement claims that none of the current vaccines, save
COVID-19 vaccines, have been tested in what RFK Jr. considers “real”
placebo-controlled RCTs. If HHS had simply said that all new vaccines will be
tested against inert placebo, I probably would have shrugged my shoulders and
said, in essence, “That’s how they’ve always been tested.” HHS stating that
vaccines in the current childhood vaccine schedule tells me that this diktat is 
at least about casting doubt on the safety and efficacy of childhood vaccines.

I’d argue, though, that the HHS diktat has a more sinister, more explicitly
antivax purpose that will depend upon how HHS operationalizes it and defines
“new vaccines.” Multiple actions and statements by HHS made me suspect this more
sinister purpose. The first occurred month ago, when the date of April 1 came
and went without the reformulated version of Novavax being fully licensed, as
previously planned by FDA before President Donald Trump and HHS Secretary RFK
Jr. took over. Worse, in a highly unusual step, the FDA is now requiring that
the new Novavax formulation go through a large RCT before licensure. The new FDA
Commissioner, Dr. Marty Makary, who has sworn up and down during the pandemic
that he isn’t antivax, is fully on board as well, even to the point of parroting
RFK Jr.’s line of “gold standard science”:

Question: if a new formulation is required every year (as is the case with flu
vaccines), will new double blind randomized trials be required as if it is a
totally new product with no knowledge about it?Even if by the time the trial
is complete, the information is obsolete…

— Prof Jeffrey S Morris (@jsm2334) April 26, 2025

Note how Makary capitalized “Gold Standard of Science.” Ugh.

Or, as Tara Smith put it:

Not to mention that requiring such an RCT will be insanely costly and therefore 
make it financially not worth it to try to. apply to the FDA to license this
vaccine in the US. That’s the idea.

This happened shortly after it looked as though the FDA was going to grant full 
licensure to the new Novavax formulation, after all. Worse:

“It’s now been years since COVID has presented the threat it once did, and the
urgency to rush approval of boosters without normal oversight no longer exists,”
said Andrew Nixon, a Health and Human Services spokesman, in a statement.

Prof. Morris is correct. The only difference between the updated Novavax vaccine
and the original version of the vaccine is that the company is updating the
COVID-19 strains in the vaccine to reflect better what is circulating now. In
addition, given that the mRNA vaccines have been treated the same way as Pfizer 
and Moderna have updated the strains included in them to reflect better the
COVID-19 strains in circulation, does the FDA plan on applying a similar logic
to COVID-19 vaccines? Note that the administration is using the claim that
COVID-19 is supposedly no longer a threat as justification for this move.

Interestingly, in response to concerns about whether or not this precedent will 
be applied to influenza vaccines, HHS responded:

Nixon, the HHS spokesman, suggested the policy might not apply to the flu shot, 
“which has been tried and tested for more than 80 years.”

This sounds to me like nothing more than a sop to the old guard, or something
that Dr. Makary can say for now in order to reassure himself that he isn’t just 
a figurehead carrying out RFK Jr.’s assault on vaccines in the US. (Hint: He
most definitely is nothing more than a useful idiot chosen to serve as the face 
of the dismantling the FDA, no matter how much he tries to deny it.) Under RFK
Jr. and the spineless Makary, I have little doubt that reasons will be found to 
expand this requirement for RCTs for “new vaccines” to seasonal flu vaccines by 
simply redefining each season’s flu vaccine as a “new vaccine.” That’s all it
would take to make flu vaccines unavailable in the US, and I have little doubt
that this is part of RFK Jr.’s endgame. Indeed, my prediction is that the
delicensing of vaccines begins with Novavax, will expand to include mRNA
vaccines against COVID-19, and then further expand to end seasonal flu vaccines.
Think I’m exaggerating? The administration has arguably been at war with mRNA
technology since Trump was inaugurated, as evidenced by the NIH defunding grants
to study the technology and the promised increased scrutiny on such vaccines.
As for flu vaccines, these have long been the target of antivaxxers as the
“low-hanging fruit,” given how their efficacy varies so much from year to year
based on how accurately scientists are each year at predicting in the winter the
strains that will be circulating the following fall and winter.

The second thing that made me suspect a more sinister purpose to this diktat has
been RFK Jr.’s characterization of current vaccine safety monitoring systems.
For example, a Fox News story about the “placebo only” diktat, included this
statement about vaccine safety monitoring:

HHS also claimed that the CDC has not been monitoring vaccine complications
adequately, and criticized its current surveillance system.

“The CDC’s former practice of suppressing information about vaccine injuries has
badly eroded trust in our public health agencies,” the agency said.

“The CDC’s own research has shown that the post-licensure surveillance system,
VAERS, captures fewer than 1% of vaccine injuries,” the HHS spokesperson said.
“It’s a system that was designed to fail. The Vaccine Safety Datalink (VSD) —
intended as a backup to VAERS — is virtually unusable for serious research. Both
systems have become templates of regulatory malpractice.”

Antivaxxers have frequently attacked the Vaccine Adverse Events Reporting System
(VAERS) database and/or weaponized it to give a false picture of the safety of 
vaccines. Indeed, the weaponization of VAERS against COVID-19 vaccines started
almost before COVID-19 vaccines had received emergency use authorization (EUA)
in December 2020. (Read here for details. It’s a subject that I’ve written about
more times than I can remember, going back to 2006.)

But what about VSD? Why is RFK Jr. attacking the Vaccine Safety Datalink (VSD), 
which, if you believe what he says about a vaccine safety monitoring system,
should be about as close to the “Gold Standard Science” that he claims to want? 
After all, unlike VAERS, VSD is an active, rather than passive reporting system,
that surveys the electronic health records of several large health care
organizations, including Kaiser Permanente in California. Last week, a story was
published in NBC News, The little-known database at the heart of Kennedy’s
vaccine conspiracy theory, that gives an indication why:

Kennedy now oversees the Centers for Disease Control and Prevention — including 
the Vaccine Safety Datalink — and one of his first initiatives as health
secretary was to launch his long-dreamed-of study using the VSD to investigate
the link between childhood vaccines and autism. It’s a theory that has already
been disproven in dozens of studies, many using VSD data.

“We’re going to be able to get into these databases and give answers to the
American public,” Kennedy said last month. He told President Donald Trump at
recent Cabinet meeting that he would reveal the cause of autism by September.

But:

Without evidence, anti-vaccine lawyer Aaron Siri and activist Del Bigtree have
claimed on the internet show “The HighWire” that the CDC scattered the vaccine
safety data after Kennedy took office, making it unavailable for Kennedy’s team 
to examine. The goal, according to Siri, was to “thwart the ability for the
current administration to actually conduct a study in the VSD.”

Not exactly:

There’s one thing that Bigtree and Siri have right: The data in the VSD is not
actually housed at the CDC — but that’s not a recent change.

The VSD is a collaboration between a small team at the CDC’s Immunization Safety
Office and 11 private health care organizations. Since the 1990s, it’s been
used to monitor vaccine safety and conduct studies of rare side effects.

“These studies that use the VSD are able to tell the difference between a
condition that coincidentally happens after vaccination and a condition that may
actually be the result of vaccination,” said Dr. Joshua Sharfstein, vice dean
for public health practice at the Johns Hopkins Bloomberg School of Public
Health.

The health care organizations used to send their anonymized medical data to the 
CDC each year for analysis, but since 2001, the organizations have kept the data
on their own servers, to ensure it stays secure.

That’s what’s likely upsetting RFK Jr. He can’t snap his fingers and have
immediate access to the data in VSD to torture until it confesses that vaccines 
cause autism because the data are stored not on CDC or FDA servers, but on the
servers of the individual healthcare organizations that contribute to the VSD.
Worse for him, although outside researchers can get access to VSD data, they
have to go through the institutional review board of Kaiser Permanente, which,
unlike the CDC, NIH, and FDA is not controlled by RFK Jr. and therefore can’t be
tampered with. You might remember that in 2003 Mark and David Geier, the latter
of whom was hired by NIH to do RFK Jr.’s study to look at vaccines as a risk
factor for autism, got busted for trying to merge datasets in a manner that
could compromise protected health information (PHI) in violation of HIPAA and to
copy some of the data, both of which violated their IRB-approved protocol. The 
news story notes that David Geier has viewed that as “oppression” and “coverup”:

For the Geiers, the experience was one of oppression. At anti-vaccine
conferences, they presented PowerPoints alleging that the CDC had “restricted”
their access to data and “attacked” their findings.

At the same conferences, Kennedy, who has consistently praised the Geiers, told 
a similar story.

“Oh, they’ve hidden it, and they won’t let anybody in it, except their own guys 
who cherry-pick and design these fabricated studies and change the protocols
constantly to try to use it to defend vaccines,” Kennedy said in a 2017 keynote 
at AutismOne, an anti-vaccine conference for parents of autistic children where 
the Geiers also presented. “It’s being used instead to craft these fabricated,
fraudulent studies,” he said, “to fool the public about vaccine safety.”

Far be it from me to say that better postlicensure safety monitoring for
vaccines—for all pharmaceuticals, really—wouldn’t be desirable and an
objectively good thing. (Indeed, I’ve argued the opposite.) However, also far be
it from me to fall for RFK Jr.’s claim that all he wants to do is to improve
vaccine safety monitoring. Indeed, he is the last person I would put in charge
of vaccine safety monitoring; sadly, the same was not true of President Trump,
and here we are, with RFK Jr. overseeing the agencies that are in fact
responsible for vaccine safety monitoring. Until RFK Jr. is no longer in charge,
the best that can be done is to try to protect, as much as possible, the
integrity of existing vaccine safety monitoring systems. In any event, it’s
clear that what RFK Jr. really wants is access to the data to cherry pick in a
manner to “prove” a connection between autism and vaccines or to blame vaccines 
for all the things that antivaxxers like to attribute falsely to vaccines.

Finally, the last (or at least he most recent) tell that RFK Jr. is working to
eliminate vaccines also appeared news stories with titles like Kennedy Orders
Search for New Measles Treatments Instead of Urging Vaccination.

Basically:

“Secretary Kennedy will be enlisting the entire agency to activate a scientific 
process to treat a host of diseases, including measles, with single or multiple 
existing drugs in combination with vitamins and other modalities,” the HHS
spokesperson said in a statement to CBS News.

The statement said the CDC effort would involve working with universities “to
develop protocols, conduct testing, and pursue approval for new uses of safe and
effective therapeutics that meet the highest scientific standards.”

While the CDC is continuing to recommend vaccination “as the most effective way 
to prevent the disease,” the statement says they recognize some Americans “may
choose not to vaccinate.”

“Our commitment is to support all families — regardless of their vaccination
status — in reducing the risk of hospitalization, serious complications, and
death from measles,” the statement said.

Unfortunately, as is the case with most viral diseases, the only treatment for
patients who have been infected is supportive care. True, in children who are
malnourished—which is not the majority of American children—treatment with
vitamin A could have some beneficial effects but is useless for most children,
but nothing beats vaccination to prevent the disease in the first place. While
it might sound benevolent and high-minded to say that he’s supporting “all
families regardless of vaccination status,” what RFK Jr. is really doing is, as 
he’s been doing all along, paying lip service to the MMR vaccine (grudgingly)
while deemphasizing it in favor of quackery and unproven treatments like the
steroid inhaler budesonide. It’s the same playbook that COVID-19 deniers used
with COVID-19: Tout hydroxychloroquine and ivermectin, neither of which have any
therapeutic activity against COVID-19, the implication being that you don’t
need to get vaccinated because there is an effective, safe, and inexpensive cure
that you can use if you contract the disease.

The future looks grim

As I was writing this, it was difficult not to note that, at 935 cases, the
number of measles cases in the current outbreak continues to climb. Fortunately,
there have been no further deaths (yet) since the second child died a month
ago. However, the number of children who have died of influenza thus far has hit
216, the most since the H1N1 pandemic in 2009-2010, thanks to declining
vaccination rates. That’s not all, however. The number of whooping cough cases
is also skyrocketing, with 8,400 cases already reported thus far, which is
double what was reported this time last year, which was double what was reported
in 2023 at this time. (In my own state of Michigan, cases have surged by nearly
1,800%.

As I like to say, measles tends to be the canary in the coal mine when it comes 
to declining vaccine uptake, if only because it’s the most contagious. It almost
always comes back first, because the highest level of population immunity
(a.k.a. herd immunity) is required to keep it in check. Then, as vaccination
rates continue to fall, next up we would expect to see the return of pertussis, 
which is also very contagious and for which the vaccine is not as effective.
Then we have influenza, for which not enough children were vaccinated even
before the pandemic resulted in the turbocharging of antivax misinformation and 
conspiracy theories. it was also just last week that I discussed a modeling
study that shows the catastrophic possibilities if vaccination rates continue to
fall, with measles becoming endemic and even polio returning. Even if RFK Jr.
were removed and replaced with a pro-vaccine HHS Secretary today, sadly, I fear 
that a huge resurgence of vaccine-preventable diseases is inevitable, given how 
much time it will take to reverse the mistrust fueled by the pandemic and the
devastation that RFK Jr. has already in less than three months inflicted on the 
CDC and FDA.

But wait, I hear RFK Jr. apologists saying, what about the new $500 million
next-generation universal vaccine platform announced last week? Let’s just say
that it’s a lot less than it seems:

That HHS and NIH are going to continue to invest in efforts to make vaccines
that could reduce the impact of future pandemics was good news, many thought.
But why spend so much money on using whole killed viruses — an approach
pioneered in the last century — as the basis of the vaccines?

“I was confused by the messaging, because it is a 70-year-old technology,” said 
one scientist who works in vaccine development, noting this was the method used 
by Jonas Salk to create the world’s first polio vaccine in the early 1950s.

Another scientist familiar with the scope of research that is being done to try 
to develop a so-called universal flu vaccine to protect against a range of
dangerous strains — like H5N1 bird flu — was blunt. “There is incredible work
going on. This is not it.”

Of course, our new NIH Director Dr. Jay Bhattacharya portrays using whole-virus 
vaccines as a “preserve the virus’s structural integrity while eliminating
infectivity,” even though whole virus vaccines were how flu vaccines were made
for decades before newer technologies arose, and the influenza virus still
managed to evolve quite handily to avoid preexisting immunity. Truly, everything
old is new again, as is the likely grift, given that this project is totally
in-house and therefore bypasses traditional peer review, likely to funnel money 
to favored researchers. Color me unimpressed; in reality this initiative strikes
me as a way of deflecting from the rejection of the mRNA platform that produced
COVID-19 viruses.

A couple of months ago, I wrote a post speculating on what RFK Jr. might do to
undermine the US vaccination system at the federal level, and, make no mistake, 
that is what he is about, his lies that he is “not antivaccine” and only wants
to improve trust and make vaccines safer notwithstanding. Disturbingly, he’s
actually doing more than I had predicted. Although I foresaw, for instance, his 
changing CDC—and HHS—messaging on vaccines, meddling with the Advisory Committee
on Immunization Practices, promoting research aligned with antivaxxers, and the
like, I should have foreseen this shift to requiring placebo-controlled trials 
for basically everything.

I fear that this move is a prelude that lays the groundwork for RFK Jr. to start
delicensing vaccines. He’ll start first by refusing to approve any new COVID-19
vaccines without large placebo-controlled RCTs, and then likely move on to
doing the same for flu vaccines, probably not this year but next year or the
year after. In the meantime, he’ll look at vaccines on the childhood schedule
for ways he can justify delicensing them—or at least taking them off the CDC’s
recommended vaccine schedule so that insurance is no longer required to pay for 
them—and requiring new, large RCTs to license them again, likely starting with
HPV vaccines and the birth dose of hepatitis B vaccine. He’ll weaponize VAERS
and, if he can get his hands on it, VSD, in order to create apparent adverse
reactions attributable to specific vaccines, in particular autism, in order to
justify delicensing them and requiring new, long term RCTs to relicense them. In
the meantime, vaccine-preventable diseases will come roaring back, as they
always do whenever vaccination rates fall. Children will die, as well adults. I 
hope I’m wrong, but I really do fear that this is what RFK Jr.’s “make America
healthy again” will mean in practice.



MAHA: Echoes of The Secret

When you look at Robert F. Kennedy, Jr.’s “Make America Healthy Again” movement,
there is a notable echo of an idea once promoted by Oprah Winfrey, namely The
Secret, combined with antivax and alt-med tropes.

David Gorski on February 3, 2025

Link

Last Wednesday, antivax conspiracy theorist and crank Robert F. Kennedy, Jr.
testified before the Senate Finance Committee as nominee to become President
Donald Trump’s Secretary of the Department of Health and Human Services. It just
so happened that Wednesday is a day when I have no scheduled clinical
responsibilities other than to round on patients in the hospital when I have any
(which isn’t that often given my specialty). Fortunately (or unfortunately, I’m
not sure), that meant that I was doing charts in my office and writing a grant 
proposal, meaning that I was able to fire up my iPad and have the Senate
confirmation hearing going in the background. As someone who has been debunking 
the antivax misinformation, pseudoscience, conspiracy theories, and outright
lies that RFK Jr. has been promoting for close to 20 years, even I found it
painful to listen, and I recognized a lot of old tropes that RFK Jr. has been
repeating for two decades (e.g., “Ralph Nader was pro-safety for cars, but no
one called him anti-car; I was anti-mercury in fish, but no one called me
anti-fish”). Then I came to an exchange between RFK Jr. and Senator Bernie
Sanders. After I saw this exchange, everything about MAHA started to come into
perspective in a way that, frankly, I’m embarrassed that it hadn’t before, given
how often I had written about the idea that undergirds alternative medicine, an
idea that I called the central dogma of alternative health, namely a variant of
“The Secret,” or, as I like to call it, “wishing makes it so,” or, more
recently, the idea that a virtuous lifestyle with respect to health will ward
off all disease.

Let me explain by going over some testimony, although first I have to point out 
one part of the proceedings that led me to laugh out loud.

Although I do like some of what he has to say, in general I haven’t usually been
a big fan of Bernie Sanders, and, indeed, had feared that he might be one
non-Republican who might vote to confirm RFK Jr., based on his disdain shared
with RFK Jr. for big pharma and his belief (also shared with RFK Jr.) that not
enough is devoted to promoting healthy living. However, I do have to give Sen.
Sanders credit for hammering RFK Jr. on his antivax views. The best example was 
what became a viral moment, when Sen. Sanders hammered RFK Jr. about onesies
with antivax slogans sold by Children’s Health Defense, the antivax organization
founded by RFK Jr. Sen. Sanders kept asking RFK Jr. if he would stop the sale
of these onesies, sarcastically adding “now that you’re provaccine.” Predictably
RFK Jr. dodged by saying that he was no longer associated with the organization
and had resigned from its board of directors after being nominated for HHS
Secretary. Sen. Sanders was ready for that dodge and asked RFK Jr. repeatedly
whether he supported the message on the onesies, “now that you’re pro-vaccine.” 
Before I go on, I just have to show you this clip, because it’s very revealing:

Basically, this ambush by Sen. Sanders was a thing of beauty that, sadly, will
probably have little bearing on whether RFK Jr. is confirmed or not. I show it, 
though, just to emphasize how dishonest RFK Jr. is. Yes, he might no longer be
affiliated—officially—with CHD, but if he called them up and told them to stop
selling these onesies, I’m sure they would comply.

MAHA: Health as a result of virtue?

The most important part of the exchange between Sen. Sanders and RFK Jr., the
part that inspired the idea for this post and got me to thinking about The
Secret and MAHA, came here:

SANDERS: Do you agree healthcare is a human right?RFK Jr: I can't give you a
yes or no answer pic.twitter.com/z10JyGeM16

— Aaron Rupar (@atrupar) January 29, 2025

The key part of the exchange that caught my ear was this part of RFK Jr.’s
answer to the question, which occurred after he had dodged and weaved in order
not to give a definite yes/no answer:

Free speech doesn’t cost anybody anything, but in health care, if you smoke
cigarettes for 20 years and you get cancer you are now taking from the pool. Are
you guaranteed the same right?

Does this sound familiar? It’s a recurring theme that we hear from believers in 
alternative and “natural” medicine, namely the victim-blaming idea of lifestyle 
über alles in medicine, the judgmental mindset that if you are ill it is your
fault. (Never mind, for instance, that nicotine is a highly addictive substance 
that makes it incredibly difficult to quit smoking once you start. Never mind
that whole industries exist to promote and sell tobacco.)

If I were to sum up the idea succinctly, it is the concept that virtue equals
health and that, if you are not healthy, you must not be virtuous. In this
context, “virtue” means leading a “virtuous” lifestyle with respect to health;
i.e., eating a healthy diet, exercising, not indulging in habits that contribute
to chronic disease, etc. Consequently, if you develop lung cancer or heart
disease as a result of your having smoked cigarettes for 20 or 30 years, somehow
you are less deserving of healthcare. It’s a concept that suffuses the antivax 
movement too, with claims that diet and healthy living can prevent disease
better than any vaccine.

The prototypical example of this attitude that I like to cite is one that I
first wrote about quite a long time ago. It comes from Bill Maher, the formerly 
seemingly “liberal” comedian and pundit who has always leaned antivax and
pro-quackery but during COVID-19 really let his contrarian freak flag fly high
and also “come out”—if you will—as anti-trans. The exchange occurred way back in
2009 when Bob Costas was a guest on his show. Somehow the subject of the
influenza vaccine came up. Maher claimed that, because he lived the “right”
lifestyle—never mind all that marijuana, right?—his immune system was superior
and he would not catch flu on an airplane, leading him to say, “I would never
get the flu on an airplane,” presumably because his immune system is so healthy 
and there is no “swamp” there for the virus to breed in.

An exasperated Bob Costas retorted brilliantly, “Oh, come on, Superman!”

It turns out that this same attitude underlies much of the “Make America Healthy
Again” (MAHA) movement, namely that health virtue equals health. Now, far be it
from me to say that you shouldn’t live a healthy lifestyle (based on science), 
eat a healthy diet (based on science), exercise, maintain a healthy weight, or
to claim that doing so doesn’t maximize your chances of being (and remaining)
healthy. That’s not the problem. The problem is the dark underbelly of this
belief, namely that if you aren’t healthy you must not be sufficiently
“virtuous,” which leads to a punitive idea, such as the one insinuated by RFK
Jr. in his testimony, that you don’t deserve the healthcare necessary to treat
the disease, be it chronic or not, resulting from your lifestyle. It leads to
RFK Jr. having a very hard time agreeing with the concept that basic healthcare 
should be a human right, because he sees some humans less deserving than others,
to the point that he couldn’t answer yes but knew that answering no would look 
very, very bad.

Now, let’s consider RFK Jr.’s testimony in light of something that his current
communications director, TV producer turned antivax activist Del Bigtree, said
early in the pandemic, around June 2020, six months before COVID-19 vaccines
became available. I was pointing out his hostility to public health, shared
among antivaxxers, in which public health is portrayed not as a collective
enterprise but as individual responsibility. At the time, it had become clear
that the biggest risk factors for severe disease and death from COVID-19 were
old age and various chronic health conditions, such as diabetes, heart disease, 
chronic obstructive pulmonary disease, and the like. This led him to a rant that
I have cited and repeated a number of times because it illustrates the attitude
that I’m talking about far better than I ever could by just describing. Here is
the episode, and here is the relevant segment (starting at about 2:23:28) which
I long ago transcribed. I’m quoting a lengthy excerpt because it is so perfect 
a distillation of the MAHA ideal, with Bigtree claiming that for most of us
COVID-19 was “just a cold” and that those of us without chronic diseases should 
“catch that cold” in order to get to herd immunity faster. If you’ve read this
before in previous posts, feel free to skip past it, but I actually do think
it’s worth reading again in order to see how much this sounds like MAHA:

What is the group that is really at risk? Let’s be honest about this and say
something that might get me some trouble here, but let’s be honest. That group
is very well known. It’s people over the age of 65—not just because you’re over 
the age of 65, but you’re sick with other diseases. You have heart disease. You 
have COPD. You have diabetes. You have issues, many of those issues coming from 
the fact that you didn’t treat your body very well while you were on this
planet. And I want to talk about this for one minute as we close this down. That
0.26% are the most sick among us, and I have nothing against you. Go ahead and 
bubble wrap your house. Lock yourself in your basement. Go and do what’s
necessary.

But here’s the problem. When you were my age, you were most likely eating food
and fast food and Doritos and drinking Coca-Cola, which you’ll never find in my 
home. You were eating that all the time. You probably were drinking a lot of
alcoholic beverages and really liked to party and enjoyed your cigarettes and
said to yourself, “You know what? It’s more about the quality of my life right
now. I don’t care if I live to be 100 years old. I want to enjoy my life right
now. I like the finer things in life. I like good rich food. I like smoking a
cigarette once in a while. I like to drink my drinks.” And you know what? Good
on you! That’s the United States of America. No problem, that, some of my best
friends think like that. It’s great, and they’re fun to hang out with. That’s
perfectly OK.

But here’s what’s not OK. When you reach that point in your life where now your 
arteries are starting to clog up, your body is shutting down, and the alcohol is
eating up your liver, and you have diabetes, or you have COPD, you have asthma,
you can’t breathe, all the cigarette smoking has finally caught up with you,
you have heart disease because of the way you decided to live your life in the
moment, here’s what you are now. You are pharmaceutical-dependent. You did that 
to yourself, not me. You decided that the moment mattered, and now you find
yourself pharmaceutical-dependent, which is really what that 0.26% is, and
that’s OK too. Thank God there’s drugs out there! There’s drugs that allow you
to eat the Philly cheesesteak even though your body knows it hates it, but, go
ahead, take the Prilosec. What difference does it make? Drug yourself! Drug
yourself! Get through the day! Don’t exercise! Maybe just attach an electrode
and see if a little electricity to the stomach will give you the abs you want.

Come on! Grow up! You made choices! And now that you’re
pharmaceutically-dependent, here’s what you don’t get to do. You don’t get to
say I have to take a drug to protect you. That’s what this is. You don’t get to 
say I have to wear a mask and suck in my own CO2 to protect you. You don’t get
to say I have to lock myself in a basement and destroy my career and take away
my own ability to feed children because you are pharmaceutical-dependent. You
lived your life. You made your choice. And thank God we live in the United
States of America so you don’t have to worry about grocery police standing
outside a grocery store saying, “Really? You really need four liters of
Coca-Cola? You really need four bags of Doritos or Chitos or Fritos or whatever 
the heck it is, little cupcakes with synthetic icing on them? You really need
all that?” Because we could go there. We could go there. If we’re really going
to get into each other’s schiznit, that’s what we could do.

Or could we live and let live? Eat all the Twinkies you want! Drink all the
bourbon you want, and smoke as many cigarettes as you want, and when you find
yourself pharmaceutical-dependent I will go ahead and say thank God the drug
companies are there for you, but you do not get to make me
pharmaceutical-dependent. You do not get to put me in the way of Heidi Larson,
who wants to eradicate natural health and natural immunity and make us all
pharmaceutical dependent.

And when you find yourself pharmaceutical-dependent, I will go ahead and say
thank God the drug companies are there for you. But you do not get to make me
pharmaceutical-dependent. You do not get to put me in the way of Heidi Larson,
who wants to eradicate natural health and natural herd immunity and make us all 
pharmaceutical-dependent. No, she only gets to rule your life because you lived 
in a way that you are going to need drugs to survive. And by the way, if you’re 
wearing a mask right now, if you’re locked in your basement, if you’re at a
grocery store and you’re scowling at me and you aren’t pharmaceutical-dependent,
and you are living a decent life, you may want to think about taking that mask 
off. You may want to think about coming out in the sunshine and getting some
vitamin D. Because you know what? I do care about my pharmaceutical-dependent
friends. And the only thing I can do for them, you know, beyond wishing for a
vaccine unicorn, is to actually catch what is just a common cold. Oh my God I
got you, right. You’re going nuts right now, you’re saying, wait. He said common
cold. I thought people would compare this to the flu. No, let me be perfectly
clear. This is not even a flu.

For 99.74% of us, you won’t probably even have a fever or a cough, because as
it’s described, this is one of the most mild illnesses there is. So mild, you
are probably what is called an asymptomatic carrier, you don’t even know you
have it. That’s how mild this is. It’s a common cold for 99.74% of us. The
non-pharmaceutical-dependent people. So here’s what we do. Let’s go outside.
Let’s take off our mask. We’re not on drugs, and we don’t need to be on drugs.
Let’s catch this cold. Whether or not it’s just the 20% of us or maybe we’re not
even in that category, let’s give it a college try to catch this cold, so that 
we can protect the pharmaceutical-dependent amongst us. That though they lived
our lives, we still love them, and they need us to establish herd immunity,
quick, before we destroy the world we live in and can’t do anything for anybody.
So join me. Let’s save the world, shall we? I’m up for a cold. Grab your
vitamin C, tour vitamin D, your magnesium, your zinc.

Notice two strains of “thought” here. First, there is the self-righteousness,
the victim-blaming, which led Bigtree to rant about how all these people with
chronic diseases brought it on themselves and the faux “thanks” to the
pharmaceutical companies for bailing them out with drugs to keep them going by
keeping their heart disease, diabetes, lung disease, etc. under control.
(Bigtree uses the term “pharmaceutical-dependent” in the same way that a
fundamentalist preacher uses the word “sinner.”) Second is the hostility to any 
concept of public health, to collective action to protect the vulnerable. (“Go
ahead and bubble wrap your house. Lock yourself in your basement. Go and do
what’s necessary.”) Notice Bigtree’s attitude, which I’ll paraphrase: “Just
because you’re chronically ill and “pharmaceutical-dependent” (due to your
lifestyle choices) doesn’t give you the right to make me
‘pharmaceutical-dependent.'” Of course, by “pharmaceutical-dependent,” what
Bigtree meant was his being required to take a hypothetical COVID-19 vaccine,
which didn’t even exist yet at the time. This focus is particularly striking
because, even though the first safe and effective COVID-19 vaccine did roll out 
a mere six months after this podcast, at the time neither Bigtree nor anyone
else could have known that the vaccine would be developed that fast. In June
2020 we all assumed that a vaccine would probably be years away; that is, if one
was successfully developed at all. After all, that’s what the experts were
telling us at the time. Yet, here Bigtree was, worrying about being made
“pharmaceutical-dependent” on a vaccine that, for all he knew, might never be
successfully developed.

Of course, one can’t help but contrast the “catch that cold” narrative above
with RFK Jr.’s frequent claim that 60% of Americans have at least one chronic
disease. If that claim is true, then Bigtree’s tirade makes no sense, because
RFK Jr.’s estimate of 60% of us with chronic disease would have implied that
most people were (and are) at for severe disease from COVID, not the tiny number
that Bigtree claims. Similarly, the stance of anti-mask activists has generally
been the false narrative masks don’t work at all to prevent transmission of
COVID-19 but do cause all sorts of horrible problems. Here, at least, Bigtree
seemed to be acknowledging that masks actually do work to prevent transmission, 
given that he told his listeners to take their masks off and “catch this cold,” 
all in order to promote “natural herd immunity.” Of course, no one ever claimed 
that Bigtree was big on consistency, at least not if mutually contradictory
arguments can seem to bolster his misinformation-packed narratives. He is, after
all, first and foremost, a propagandist.

One other thing that I like to point out whenever I see this übermensch concept 
bubble up in alternative health, particularly with respect to COVID-19, is that 
there’s one risk factor for serious disease and death from the coronavirus that 
no one can control, and that’s getting older. You don’t have any control
whatsoever when you were born and therefore how old you were when COVID-19 hit. 
It wasn’t your fault if you were over 70, which is one of the high risk groups. 
Oddly enough, neither RFK Jr. nor Del Bigtree has ever seemed to care much about
that particular major risk factor—or even to acknowledge it much, other than in
passing—because age is a non-modifiable risk factor.

It’s not just COVID-19 where this judgmental idea that virtue equals health and 
poor health must imply a lack of virtue is prominent among MAHA. For example,
what is HIV/AIDS denial, which RFK Jr. has promoted, but the idea that it isn’t 
a virus that causes AIDS, but lifestyle choices of which the denialist
disapproves, mainly homosexual sex and use of poppers? Notably in his book The
Real Anthony Fauci: Bill Gates, Big Pharma and the Global War on Democracy and
Public Health, RFK Jr. proclaimed himself “neutral” regarding whether HIV is the
cause of AIDS, stating that he takes “no position on the relationship between
HIV and AIDS” and later declaring that HIV could be “one cause” of AIDS but that
there are many others, in particular:

Duesberg and many who have followed him offered evidence that heavy recreational
drug use in gay men and drug addicts was the real cause of immune deficiency
among the first generation of AIDS sufferers. They argued that the initial signs
of AIDS, Kaposi’s sarcoma and Pneumocystis carinii pneumonia (PCP), were both
strongly linked to amyl nitrate—poppers—a popular drug among promiscuous gays.

RFK Jr. published this book in 2021, not the 1980s, by the way, and the idea
that amyl nitrate had anything to do with the immunodeficiency observed in AIDS 
patients was debunked nearly 40 years ago.

RFK Jr. also flirts with germ theory denial. Like many antivaxxers, he very much
likes the ideas of 19th century scientist Antoine Béchamp, who posited that it 
wasn’t microbes that caused disease but, rather, that the microbes were a
manifestation of an unhealthy or disordered “terrain,” which is the real cause
of illness. Béchamps was a contemporary of Louis Pasteur, and his ideas

Germ theory aficionados, in contrast, blame disease on microscopic pathogens.
Their approach to health is to identify the culpable germ and tailor a poison to
kill it. Miasmists complain that those patented poisons may themselves further 
weaken the immune system, or simply open damaged terrain to a competitive germ
or cause chronic disease…When a starving African child succumbs to measles, the 
miasmist attributes the death to malnutrition; germ theory proponents (a.k.a.
virologists) blame the virus.

See what I mean? It’s of a piece with RFK Jr.’s activities during a deadly
measles outbreak in Samoa in 2019 that killed over 80 children. While the
outbreak was due to decreased uptake of the MMR vaccine that was the result of a
tragic medication mishap in which two nurses mixed up a vial of MMR with a
muscle relaxant than the correct diluent that led to plunging trust in vaccines,
RFK Jr. did his best to throw gasoline on the existing fire of vaccine
hesitancy, attempts to gaslight you about the true history in order to absolve
RFK Jr. notwithstanding.

But what does this all have to do with The Secret?

MAHA, alternative health, and The Secret

Does anyone remember The Secret? Back in the day, I used to write about it
fairly often, because Oprah Winfrey had promoted this New Age concept on her
then-immensely popular daytime television show. You might even remember that
around 18 years ago, Oprah’s promotion of The Secret made the news. Around the
same time, I noted that Oprah’s “Secret” had enticed a woman with breast cancer 
named Kim Tinkham to abandon science-based treatment and embrace the “pH miracle
living” quackery of Robert O. Young. Oprah even invited Tinkham to appear on
her show and seemed genuinely appalled to learn that Tinkham had decided to
reject conventional medicine and surgery in order to “heal herself.” As a
result, Tinkham died of metastatic breast cancer in 2010.

One notes that it is probably not entirely a coincidence that Donald Trump also 
nominated Oprah’s protégé “America’s Quack,” Dr. Mehmet Oz, to be Administrator 
for the Centers for Medicare & Medicaid Services (CMS), the government agency
that administers the federal government’s largest healthcare programs, including
Medicare, Medicaid, and the insurance programs under the Affordable Care Act.
But what is The Secret? As peddled by Oprah Winfrey, The Secret is:

The secret of The Secret was something called the Law of Attraction. As Oprah
put it on the show, “It says that the energy, that the thoughts and feelings
that you put out into the world, both good and bad, are exactly what is always
coming back to you, so you have the life that you have created.” Oprah and the
teachers of The Secret, as they call themselves, did not mean this
metaphorically. They explained that the universe and everything in it are made
of vibrating energy, and by thinking positively we can actually “attract” the
positive vibrations of the universe and bend them to our will. “You’re a field
of energy in a larger field of energy,” one of The Secret’s teachers said. “And 
like attracts like, and that’s very, very scientific.”

By harnessing this powerful science, they said, we can have anything we
want—happiness, love, fabulous wealth. This was so inspiring to Oprah that she
devoted three shows to the product and appeared on Larry King to talk it up
more. She said it encapsulated everything she believes. “I’ve been talking about
this for years on my show,” she said. “I just never called it The Secret.”

The similarity between this concept and much of alt-med should be obvious and
embodied in the idea, which I’ve seen so many times on so many alt-med websites,
that you – yes, you! – are completely responsible for your own health by your
own lifestyle choices. All it takes is living the right way, doing the right
things, and you can be not just healthy, but virtually immune to serious
diseases up to and including cancer. This sort of concept is inherent in the
antivaccine world in which RFK Jr. has been a highly influential voice for two
decades, in which it is frequently stated that vaccines are unnecessary because 
healthy people don’t get sick. It’s also inherent in the germ theory denialism
so common in alt-med systems such as naturopathy and homeopathy. This denialism 
most often takes the form of the 21st century embrace by antivaccinationists and
alternative medicine mavens of Antoine Béchamp‘s idea that it is the “terrain,”
not the microbes, that make us sick. Never mind that in the influenza pandemic 
of 1918 it was the younger people who tended to die at a higher rate and the
pandemic got its start in the U.S. in a military barracks. The basic concept is 
that the terrain is all, and, of course, you control the “terrain” with your
thoughts.

As with The Secret, there is a germ of truth in the concept that your thoughts
can make you healthy, just not in the way implied by RFK Jr., his MAHA
followers, and the conspirituality writers who have embraced right wing politics
over the last several years. Again, if you have a genuine desire to be healthy,
it is more likely that you will exercise, lay off unhealthy habits such as
drinking to excess or smoking, and eat a healthy diet. However, as reasonable
people know, it’s a matter of probabilities; diet and a healthy lifestyle are no
panacea. Worse, as I’ve already written above, the corollary of the central
dogma appears to be that if you are chronically ill it is your fault for not
having the right “intent,” attitude, and thoughts and therefore not doing the
right things and/or not believing hard enough.

Whenever I encounter this idea, I like to point to my parents, neither of whom
drank to excess, consumed unhealthy diets, or led what even RFK Jr. would
consider an unhealthy lifestyle, aside from my mother not exercising much. (My
dad was a sports fanatic and played basketball and softball, continuing to golf 
until he was in his 80s and his back no longer allowed him to do it.) Yet both
of them developed chronic diseases, my father hypertension and heart disease and
my mother suffering a major stroke two years ago. My grandmother was a highly
accomplished amateur athlete, statewide tennis star who continued to play until 
well into her 70s. Yet she still developed heart disease and suffered a stroke. 
The implication behind MAHA and the alternative medicine “Secret”-like mindset
behind it is that they brought these fates on themselves.

The key idea behind RFK Jr.’s MAHA is that Americans are unhealthier than ever, 
with most adults suffering from chronic diseases, nearly all a result of a
combination of lifestyle, vaccines, pharmaceuticals, and “poisonous” processed
food. Similarly, he is known for having proclaimed the current generation of
children to be the “sickest generation,” due to—you guessed it!—vaccines,
processed food, pesticides, and lack of exercise. As I’ve pointed out before,
RFK Jr. used the most inclusive possible definition of “chronic disease” to come
up with a figure of more than half of children suffering from chronic disease
and ignores changes in screening and diagnostic criteria that tend to increase
the number of diagnoses of many of these conditions, but that’s par for the
course for him. Indeed, I like to cite Vaxopedia for an estimate the real
situation, where Dr. Vincent Iannelli brings the data to show that “not only are
54% of children not in poor health, with chronic health problems, 90% of
today’s parents describe their children’s health as excellent or very good!” He 
also brings the pain to RFK Jr.’s claim by pointing out that while, yes,
prevalence of some conditions are increasing, including ADHD, type 1 diabetes,
obesity, and most autoimmune diseases, overall the health of today’s children
compares favorably with children in the 1990s. Moreover, the largest threats to 
children’s health is gun violence, something that neither RFK Jr., MAHA, nor
Donald Trump say anything about.

Like any New Age guru or alternative medicine quack, he has the cure, which is
to make people live virtuous lifestyles, whether they really want to or not. I
do have to admit to being amused that even RFK Jr.’s fans saw right through this
and (partially) correctly characterized it. For example, antivaxxer Sasha
Latypova, who wrote:

Make Chronic Illness Your Own Fault Again! At a minimum, it’s the fault of those
bad farmers that need to be regulated harder into low-yield/high price food
making practices. It’s not because you and your child have been injected
gazillion times with non-self proteins, and now have an allergy to your normal
environment, no. NO. You are not allowed to discuss THAT reason.

Any reason but THAT ONE.

Drop it, and put your digital choke collar back on! You are supposed to shut up 
about that, and get on board with the Uniparty pushing for more government
regulation in agriculture and food, i.e., making the food scarcer and less
affordable, just like the Agenda 2030 all-inclusive package envisions
-Pestilence, War and Famine.

Where Latypova is correct is that, at its heart, MAHA is mostly “make chronic
illness your own fault again.” Where she is obviously incorrect is that vaccines
are the real reason Americans are so unhealthy. Moreover, it’s not about
healthcare as a “right,” as RFK Jr. made very clear in his response to Sen.
Sanders. It’s very much an Orwellian Animal Farm construct, in which, “All
animals are equal, but some animals are more equal than others.” Alternatively, 
you could view this as all humans being equal, but some are less equal than
others, those less equal ones being the ones whose lifestyle choices contributed
to their chronic disease(s) and who are therefore deemed less “worthy” of
healthcare; that is, unless they are sufficiently affluent to pay for healthcare
themselves, given RFK Jr.’s reference to smokers with cancer “taking from the
pool.” Basically, health equals virtue, and lack of health equals a lack of
virtue, never mind genetics. However, in this worldview, wealth also equals
virtue.

Basically, MAHA flows from a viewpoint that equates health with virtue, leading 
to hostility to the very concept of public health, as evidenced by RFK Jr.’s
frequent claim that he “won’t take vaccines away” from those who want them and
his shoulder shrug that says, in essence, go ahead and get vaccinated (and
vaccinate your children) if you want to. Moreover, other than addressing (sort
of) food and diet, I see little in the MAHA agenda that would actually address
the four main drivers of the most common preventable chronic diseases (diabetes,
heart disease, and respiratory diseases), specifically physical inactivity,
poor nutrition, tobacco use, and excessive alcohol consumption. (Seriously,
other than food and dubious science about food dictating what to do as far as
our food supply goes, can anyone tell me how MAHA addresses tobacco use,
physical inactivity, and alcohol use?) The whole MAHA agenda is a clever
bait-and-switch that denies government responsibility or any collective action
and, other than food, dumps responsibility for health entirely on the
individual.

Indeed, Amanda Marcotte summed it up well:

…Kennedy stuck to his shtick of reframing health as a matter of private virtue
rather than public concern. Over the course of the hearing, it became clear why 
this lifelong Democrat has switched to the GOP. His view that sick people did it
to themselves and deserve what’s coming to them offers a nifty justification
for Republicans‘ long-standing desire to deny health care to millions of
Americans. Kennedy may dress this up as “prevention” or concern for children,
but the message came through loud and clear: Medical patients are parasites who 
suck up resources from better, more responsible people.

Coming back to the example of smoking and cancer:

Instead, Kennedy blamed “chronic disease,” a vague category that encompasses a
cornucopia of ailments like “autoimmune diseases, neurodevelopmental disorders, 
asthma, Alzheimer’s, ADHD, depression, addiction” and, with special emphasis,
diabetes. I’ll leave it to the experts and fact-checkers to explain how badly he
misrepresented the diverse causes of these conditions. What matters here is the
rhetorical purpose “chronic disease” plays: Blaming the victims, and creating
the pretext for taking their health care away.

And:

When asked how he would implement “prevention” for Medicare and Medicaid
patients, Kennedy replied that it was about “making them accountable for their
own health care, so they understand the relationship between eating and getting 
sick.” He argued that people on food assistance should have their options
reduced so they can’t buy processed foods. That’s designed to sound vaguely
positive while doing nothing to help people. No living person believes that
Oreos are better for you than apples. Lecturing them about it and restricting
their food budget will do nothing to reduce their medical costs, but it does
creates an excuse to deny health care by claiming that they made themselves
sick.

Marcotte is correct, but I would quibble mildly. I would rephrase her assessment
to say that what RFK Jr. wants to do also includes promoting access to
healthcare that is not science-based but is rather the sort of quackery that
alternative medicine practitioners believe in. After all, remember that part of 
the MAHA agenda is to Make Quackery Great Again, with RFK Jr. declaring war on
the FDA:

As an aside, speaking of hyperbaric oxygen therapy (HBOT), in my neck of the
woods, a five-year-old boy was recently killed at a quack clinic when an HBOT
chamber he was in exploded. No information was provided about what it was that
he was being “treated” for, but I bet that it wasn’t any of the handful of
indications for which there is good evidence that HBOT is effective. Look for a 
lot more tragedies like this dead five-year-old, and not just from HBOT
quackery, if RFK Jr. is confirmed.

As for the rest, as I said before, the FDA doesn’t “suppress” exercise, “clean
foods,” sunshine, or nutraceuticals. It does regulate the rest because there is 
no good evidence base for any of them, especially hydroxychloroquine and
ivermectin, neither of which treat or prevent COVID-19. Raw milk, in particular,
is a particularly nasty public health threat given that it can carry all manner
of diseases, including H5N1 bird flu. There’s a reason Pasteurization was
invented. Moreover, stem cell clinics have become quite the profit center at
quack clinics that use stem cells (and charge large amounts of money for them)
to treat all manner of diseases for which there is yet no good evidence for
their efficacy. (Remember Gordie Howe and his stroke?)

It’s a MAHA world now, unfortunately

As I was writing this post, I realized that it’s a bit too simplistic to
describe MAHA as just another manifestation of The Secret as the central dogma
of alternative medicine, but that doing so does touch on a simple truth. MAHA is
a “manifestation” of alternative medicine and health applied to government
policy, and there will be disastrous results if RFK Jr. is confirmed. It’s not
for nothing that I referred to RFK Jr. at HHS as an “extinction-level” threat to
public health.

Specifically, MAHA embodies the idea of health being due, above all, to personal
will, virtue, and efforts, rather than public health efforts, but it also
embodies the idea that science-based medicine and nutrition are not just
ineffective but actively harmful. In that way, it is also manifestation of what 
I like to call the cult of purity that is behind so much of alternative medicine
and so many antivaccine beliefs, namely that anything “unnatural” will
contaminate you and lead to a degradation in your health, especially vaccines
and pharmaceuticals. Although MAHA pays lip service to lack of physical activity
and exercise as one major driver of chronic disease, while proposing basically 
nothing to reverse that tendency in the population to physical inactivity, it
mixes science-based ideas with quackery when it comes to food and diet as
drivers of chronic disease. In parallel, MAHA says little or nothing about
alcohol or tobacco, two other major drivers of chronic disease, other than RFK
Jr. implying that someone who gets cancer as a result of smoking “draws from the
pool” and doesn’t deserve taxpayer-funded healthcare.

MAHA is a con designed to distract from what will undoubtedly be RFK Jr.’s war
on vaccines and science-based regulation of food and drugs. What makes it so
appealing is what makes The Secret and the central dogma of alternative medicine
so appealing, the idea that you, and you alone, control your destiny when it
comes to health. Would that were the case, but no one can escape their genetics,
and many can’t escape their environment, both of which, science-based medicine 
tells us, have enormous effects on overall health. I don’t know if RFK Jr. will 
be confirmed or not—sadly, I suspect that he probably will—but I do know that if
he is, public health and science-based regulation as we currently understand
the concepts will be under a threat unlike any faced before. I also know that,
even if RFK Jr. fails to win confirmation as HHS Secretary, President Trump will
likely nominate someone almost as bad, but just not as obviously a
conspiracy-mongering antivax crank.

Antivaxxers, grifters, and quacks: RFK Jr.’s MAHA takes over federal health
agencies

President-Elect Donald Trump has now announced most of picks to lead critical
federal health agencies. These picks predictably prioritize grift, quackery, and
antivax ideology.

David Gorski on November 25, 2024

Link


Ever since longtime antivaccine activist, supporter of “natural health”
quackery, and fear mongered about food ingredients Robert F. Kennedy Jr.
suspended his quixotic Presidential campaign and bent the knee to Donald Trump
in exchange for a high-ranking health-related position in the Trump
administration, should Trump win, I’ve been trying to warn my readers what it
would actually mean if RFK Jr. were to gain influence. Unfortunately for health 
policy and biomedical science in the US, Donald Trump did eek out a narrow
popular vote victory (49.9% to 48.3% thus far, and counting), with an Electoral 
College victory that hinged on a small number of votes in the usual swing
states. After the election was declared, speculation was rampant over what role 
RFK Jr. would hold in the second Trump administration and what he and Trump
would do. By September, RFK Jr. had coined the term “Make America Healthy Again”
(MAHA), an obvious homage to Donald Trump’s longstanding slogan “Make America
Great Again” (MAGA), although in his MAHA manifesto he hid his antivax
proclivities, which his antivax followers did notice and were dismayed.
Eventually, Trump announced that he was going to nominate RFK Jr. for the most
important health-related cabinet position, Secretary of Health and Human
Services (HHS), where, if confirmed by the Senate, RFK Jr. would oversee a
sprawling and massive department with a $2.86 trillion budget, as well as key
agencies that fall under HHS, including the Centers for Disease Control and
Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug
Administration (FDA), and the Centers for Medicare and Medicaid Services (CMS). 
Ten days ago, I outlined how having an antivax crank like RFK Jr. in charge of
HHS would be a catastrophe for public health and biomedical research.

At the time, however, we did not yet know whom Trump would appoint to lead key
agencies like the CDC, FDA, CMS, and NIH, as well as whom he would appoint
Surgeon General. We now know his nominees for four of these posts—and strongly
suspect that he will ultimately nominate Dr. Jay Bhattacharya, COVID-19
minimizer and coauthor of the social Darwinist “let ‘er rip” COVID-19 “natural
herd immunity” manifesto, the Great Barrington Declaration—all thanks to a
flurry of announcements last week. These announcements included Trump’s naming
America’s Quack, Dr. Mehmet Oz, as CMS Administrator. (Thanks yet again, Oprah, 
for foisting this quack upon America all those years ago!) I will admit to
having been somewhat surprised at this nomination, as I hadn’t really thought
much about Dr. Oz since his failed campaign to be the carpetbagger elected to
the Senate for Pennsylvania two years ago, given that he mostly dropped out of
the public eye after his defeat. As for the CDC, Trump’s pick is a real blast
from the past for me, a man about whom I had almost forgotten after having
written a couple of times a decade ago about his role as one of the go-to
Representatives in Congress for the antivax movement. I’m referring to former
Florida—of course!— Representative Dave Weldon, a clear signal that the CDC is
about to be led by a die-hard antivaxxer with no relevant public health
qualifications other than that he’s a physician. (Make no mistake, Dr. Weldon is
an antivaxxer who was all-in on RFK Jr.’s conspiracy theory that the
mercury-containing preservative thimerosal that was in several childhood
vaccines until around 2001 had been the cause of an “autism epidemic.” More on
that later in this post.) Next, to no one’s surprise, Trump nominated COVID-19
minimizer and frequent Fox News pundit, Johns Hopkins surgical oncologist Dr.
Martin Makary, while, finally, to my surprise given that I don’t recall much
about her, he chose Fox News contributor Dr. Janette Nesheiwat for Surgeon
General.

While I won’t comment on what Donald Trump might do outside of health and
science policy, at least not here, make no mistake, by electing Donald Trump
again, Americans have shot themselves in the foot with respect to medicine,
public health, and biomedical research. Let’s start with the antivaxxer
nominated to be CDC Director, and then work our way down. Let’s put it this way.
Dr. Weldon for CDC makes Dr. Oz for CMS look like not so bad a choice, and
that’s saying a lot. I will expend more verbiage describing him than any of the 
other picks by Trump because he’s probably the worst of the lot, but, even more 
importantly, likely the most obscure given that he’s been out of the public eye 
for a decade, ever since he left Congress.

Dr. Dave Weldon: An antivaxxer to run CDC

As I just said, I never expected Trump and RFK Jr. to pick Dr. Dave Weldon to
run CDC, although I did expect them to pick someone who was at least
antivax-sympathetic, if not outright antivax. It looks as though they went with 
outright antivax.

Many of you have probably never heard of Dr. Dave Weldon. I must admit that,
when I first heard about his nomination, I had forgotten about him and actually 
had to remind myself who he was and what he did and said back in the day by
looking up some posts on my not-so-super-secret other blog. In brief, back in
the day when I was he, along with Florida Rep. Bill Posey and Indiana Rep. Dan
Burton, were among the antivax movement’s go-to legislators in Congress. You
might remember that back in the 1990s and early 2000s, Rep. Burton, based on his
belief that vaccines had rendered a grandchild of his autistic, used his
powerful position chairing the House Oversight Committee to drag CDC Directors
and scientists before him to be interrogated and harassed about what the CDC was
doing to “study” the (nonexistent) link between vaccines and autism and abused 
his position to try to influence the Autism Omnibus hearings, among other
antivax activism. Rep. Bill Posey, for his part, was intimately involved in
promoting the “CDC whistleblower” conspiracy theory of disgraced CDC scientist
William Thompson who claimed that the CDC had covered up a finding that the MMR 
vaccine was associated with a four-fold increase in the incidence of autism in
African-American boys in the Atlanta area. It was a big nothingburger, but the
conspiracy theory did end up playing a central role in the 2016 antivax
propaganda film disguised as a documentary, VAXXED (directed by the godfather of
the 21st century antivax movement, Andrew Wakefield, and produced by antivax
propagandist who’s currently working with RFK Jr., Del Bigtree), whose second
sequel, VAXXED III: Authorized to Kill, has been promoted heavily by—you guessed
it!—RFK Jr.

But what about Dave Weldon? First of all, he is utterly unqualified for the
position of CDC Director. Yes, he is a physician, but he has no relevant
experience in public health, epidemiology, infectious disease, vaccination, or
any other science that might qualify him to run an organization like the CDC.
And, of course, he is antivaccine. Per this news report on his nomination:

President-elect Donald Trump has tapped former Florida Rep. Dave Weldon, a
physician and vaccine safety skeptic, to lead the Centers for Disease Control
and Prevention.

While in Congress, Weldon introduced legislation to move oversight of vaccine
safety from the CDC to an independent agency within HHS. He has also repeatedly 
voiced serious reservations about the independence of the federal government’s
vaccine safety review process, and previously suggested that a mercury-based
preservative once commonly used in vaccines, thimerosal, is linked to a rise in 
autism.

“Federal agencies charged with overseeing vaccine safety research have failed.
They have failed to provide sufficient resources for vaccine safety research.
They have failed to adequately fund extramural research. And, they have failed
to free themselves from conflicts of interest that serve to undermine public
confidence in the safety of vaccines,” Weldon said in a statement at the time.

Weldon, who served in Congress for nearly two decades, has also raised concerns 
about the safety of the measles, mumps and rubella vaccine and Gardasil, the
vaccine that girds against the papillomavirus virus, which can lead to cervical 
cancer.

“Vaccine safety skeptic.” May I once again ask your indulgence as I rant yet
again about clueless reporters and editors insisting on calling antivaxxers
“vaccine skeptics” or “vaccine safety skeptics.” They are none of these, as
skepticism implies critical thinking, knowledge, and careful reasoning about a
topic, none of which Weldon (or his boss-to-be RFK Jr.) has ever displayed.
Similarly sanewashing Weldon is this headline at STAT News, whose editors should
know better, Trump selects Dave Weldon, former congressman with ties to vaccine
critics, to lead CDC. Of course, that’s why RFK Jr. likes Weldon and no doubt
why he was chosen by Trump! In any event, given that Weldon was primarily a
“thimerosal” antivaxxer, the two did have a lot of contact back in the day:

Starting in the early 2000s, Weldon had a prominent part in a debate about
whether there was a relationship between a vaccine preservative called
thimerosal and autism. He was a founding member of the Congressional Autism
Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior
attorney for the Natural Resources Defense Council, believed there was a tie
between thimerosal and autism and also charged that the government hid documents
showing the danger.

“Debate.” You keep using that word. I do not think it means what you think it
means. Try: Conspiracy theory. That’s a more accurate description of the belief 
on RFK Jr. and Weldon’s part that the CDC had “covered up” a link between
vaccines and autism.

From an interview with RFK Jr. published on the website of his antivax
organization Children’s Health Defense:

The CDC is a subsidiary of the pharmaceutical industry. The agency owns more
than 20 vaccine patents and purchases and sells $4.1 billion in vaccines
annually. Congressman Dave Weldon has pointed out that the primary metric for
success across the CDC is how many vaccines the agency sells and how
successfully the agency expands its vaccine program—regardless of any negative
effects on human health. Weldon exposed how the Immunization Safety Office,
which is supposed to ensure vaccine efficacy and safety, has become subsumed in 
that metric. The scientists in that part of the agency should no longer be
considered part of the public safety sector. Their function is to promote
vaccines. As Dr. Thompson has attested, they are routinely ordered to destroy,
manipulate and conceal evidence of adverse vaccine reactions in order to protect
that ultimate metric. The CDC shouldnot be the agency that we are relying on
for oversight of the vaccine program. It’s the hen guarding the wolf house. It’s
not just the CDC. Virtually all the institutions that are supposed to stand
between a rapacious industry and vulnerable children have been compromised.

First off, that reference to Dr. Thompson is yet another reference to the CDC
whistleblower conspiracy theory. More importantly, though, the CDC does not
authorize or license vaccines. That is the FDA’s responsibility under its powers
to regulate drugs, medical devices, and biologics. It is true that the CDC,
based on recommendations of its Advisory Committee on Immunization Practices
(ACIP), does contract the recommended vaccine schedule for children and adults. 
The committee holds three public meetings every year, to allow public input
regarding its deliberations about proposed additions and changes to the
recommended vaccine schedule. But what do Weldon and RFK Jr. mean when they say 
that the CDC purchases and sells $4.1 billion in vaccines annually? Most likely,
they are referring to Vaccines for Children, a program that has provided free
vaccinations to uninsured and underinsured children for three decades:

The VFC program was established by Congress in 1994 in response to measles
outbreaks in 1989–1991. The program provides all recommended vaccinations
against 19 different diseases at no cost to eligible children and helps ensure
all U.S. children are protected from life-threatening diseases. Anyone age 18
years or younger who is Medicaid-eligible, uninsured, underinsured,* or American
Indian or Alaska Native can receive vaccines from VFC program providers at no
cost. CDC currently funds 61 state, local, and territorial immunization programs
to implement the VFC program.

This interview is several years old, and Weldon left Congress in 2009. I looked 
it up, and the 2024 budget for VFC was around $7.2 billion:

The Vaccines for Children (VFC) program (FY2024 estimate: $7.213 billion)
provides vaccines to enrolled health care providers to vaccinate eligible
children.20 As authorized in SSA Section 1928 (42 U.S.C. §1396s), the HHS
Secretary can purchase vaccines as necessary for eligible children at a
federally negotiated discounted price and then distribute vaccines to
participating state and local health departments. State and local health
departments then distribute a portion of the supply to participating health care
providers and also administer vaccines through their own programs. In addition,
some of the annual VFC funding is awarded to states and other jurisdictions for
program operations and administration.21 VFC is financed by a Medicaid
appropriation within the HHS Centers for Medicare & Medicaid Services (CMS) and 
is administered by CDC.22 Like other Medicaid programs, VFC is an appropriated
entitlement, meaning that VFC funding is provided through LHHS appropriations
acts, but the funding level is determined based on budget projections for
meeting the funding needs of the program as required by the program’s
authorization law.23

Those nefarious “deep state” pharma operatives! Imagine the sheer evil of their 
buying discounted vaccines for poor children and then distributing them to the
states! All with your tax dollars! The horror! Personally, the only horror I now
have is imagining Weldon being in charge of administering these funds from 2025
on.

The point, of course, is that, contrary to antivax conspiracy theories, there I 
nothing nefarious about the VFC program, Weldon and RFK Jr.’s best attempts to
make it sound like as sop to big pharma notwithstanding. The idea behind the
program has been—and still is, at least for the moment—to make sure that
uninsured and underinsured children do not suffer unnecessarily from
vaccine-preventable illnesses on the basis of their parents not being able to
afford the standard childhood vaccines, as well as to protect the health of
everyone through keeping vaccination rates high enough for herd immunity.
Moreover, in the $6 trillion-plus federal budget, the amount of funding provided
to VFC is a real pittance, some of the best-spent money in Washington, and,
worse, funding for state vaccination programs through VFC has already been cut.

But what about Weldon’s past?

During his 14 years in Congress, Weldon funneled his belief in an “autism
epidemic.” He also apparently believed in the thimerosal-autism link, to the
point of promoting highly dubious studies and attacking decent studies examining
whether mercury in childhood vaccines had been responsible for such an
“epidemic.” Back in the day, he even spoke at antivax “conferences” falsely
billed as scientific conferences:

Understanding autism and searching for a cure is a passion that I will continue 
to carry with me. In 2004, I delivered an address at the Defeat Autism Now
Conference and the keynote address to the Autism One Conference in Chicago
regarding the autism epidemic affecting one in 163 children. I challenged public
health officials to direct the funding to defeat this epidemic. Today, autism
affects one in 88 children. America can’t afford further delay in autism
research.

Defeat Autism Now! was the umbrella organization for a lot of antivax quacks
abusing children with “autism biomed” treatments to “cure” them of the “vaccine 
injury” blamed by antivaxxers for their autism, while the Autism One conference 
was the longstanding fake medical conference held in Chicago annually for many
years that showcased all forms of antivax and autism quackery. For those of you 
not familiar with Autism One, It was at the 2013 Autism One conference that RFK 
Jr. likened vaccines to the Holocaust, at least to my knowledge, and where Kerri
Rivera described feeding bleach to children in 2012 to treat their autism.

Back in 2003-2004, Weldon used his position in Congress to write letters to
then-CDC Director Julie Gerberding demanding an “investigation” of supposed
links between vaccines and autism. Basically, the letters made the same claims
that RFK Jr. made in his 2005 conspiracyfest Deadly Immunity. Recall that the
central claim in RFK Jr.’s article, co-published by Rolling Stone and Salon.com 
(to their eternal shame), something I like to call an example of the Central
Conspiracy Theory of the Antivaccine Movement, was that there was evidence that 
thimerosal in vaccines was associated with a highly elevated risk of autism in
children but that the CDC, at a meeting in 2000, “covered it up.” This is a
claim that I like to call the Simpsonwood conspiracy theory, after the
conference center where the meeting was held, an example of the central
conspiracy theory of the antivaccine movement (at least in the US), one
I’ve deconstructed in the past. Basically, Weldon, even though he’s a physician,
fell for the Simpsonwood conference conspiracy theory, promoted a year and a
half later by antivaccine crank Robert F. Kennedy, Jr., hook, line, and sinker. 
The first letter basically regurgitates the “concerns” being promoted by the
antivaccine movement at the time. The second letter turned up the heat, trying
to persuade Gerberding to postpone an important Institute of Medicine conference
until the “concern” about the Verstraeten study had been addressed. As we all
know, the IOM conference did go on and the IOM report strongly stated that there
was no correlation between the MMR vaccine and autism. Once again, antivaxxers 
were deceptively looking at standard epidemiological and statistical techniques 
to account for confounders as something nefarious, as they misrepresented how
the observed “association” between thimerosal and autism risk declined and
disappeared as appropriate confounders were accounted for as the CDC
intentionally “covering up” an association, and Weldon was the Congressional
spearhead for this conspiracy theory.

Truly, the vaccination program and public health efforts by the CDC are in
serious jeopardy, even worse than I had imagined. I suppose I should be happy
that Trump didn’t appoint Andrew Wakefield as CDC Director.

Oz turning CMS into…Oz?

What can be said about Dr. Mehmet Oz that we haven’t said before many, many
times here on this blog (and that I haven’t said many times before on my
not-so-super-secret other blog)? As a result, this section will be relatively
short compared to the section about the horror that is Dave Weldon for CDC.
That’s not to say that Dr. Oz is in any way a good pick. My longtime readers
here and elsewhere might remember that back in the day I routinely liked to
refer to Dr. Oz, the once promising cardiac surgeon turned advocate of
“integrating” quackery into medicine (i.e., “integrative medicine“) turned Oprah
Winfrey’s go-to physician for dubious medicine, turned daytime “medical” talk
show host (and I use the term” medical” loosely), as “America’s Quack.” I don’t 
know whether I coined the term or not, given that adding the term “quack” was a 
very obvious riff on the title of “America’s Doctor” bestowed on him by Oprah
and that Dr. Oz even trademarked the term “America’s Doctor,” but it sure feels 
like it. So what the heck? As I’ve done for years, I’ll go with it and say that 
I coined the term, unless and until someone shows me otherwise.

In fairness, whenever I discuss Dr. Oz, I note that over three decades ago, he
was a legitimate phenom in academic surgery, a true rising star. In any
timeline, I have to note that between 1988 and 1991, Dr. Oz won the prestigious 
Blakemore Research Award four years in a row, no mean feat. Also dating back to 
the 1990s and his early days as an academic surgeon, Dr. Oz holds 11 patents for
inventing methods and devices to assist in heart surgeries and transplants,
including helping to research and develop the left ventricular assist device, or
LVAD, which helps keep people alive while they’re awaiting a heart transplant. 
Indeed, Dr. Oz played a major role in growing Columbia’s LVAD program into one
of the biggest in the world. Around the same time, though, in the early 1990s,
the seeds of Dr. Oz’s heel turn into America’s Quack were being sown as well:

In the early ‘90s, according to Argenziano, Oz could often be found in his lab, 
studying “alternative medicine, hypnosis, Eastern medicine, all that stuff —
guided imagery, acupuncture.” Argenziano added, “That was 10 years before he
ever went on TV.”

By later in the 1990s:

They [Dr. Oz and his collaborator, certified perfusionist and registered nurse
Jery Whitworth] also used audiotapes to try to subconsciously relax patients
before surgery and brought reiki — or “energy medicine” — into the operating
room. Reiki, an ancient Japanese healing art, has never been shown in scientific
studies to alter the outcomes of patients. One high-quality study on the effect
of reiki on pain in women after C-sections showed that it had no effect.
Science-based thinkers have wondered whether it’s ethical to continue studying
reiki, given that we know it works no better than a placebo and we may be
diverting funds from treatments that could actually help people.

Oz’s work with the center drew critics. One Mount Sinai physician told the New
York Times in 1995: “I call practitioners of fraud practitioners of fraud. It’s 
my feeling that the [center] has been promoting fraudulent alternatives as
genuine.”

Fast forward to the early 2000s, just before Oprah Winfrey discovered Dr. Oz and
plucked him from mainstream obscurity:

In the early 2000s, he worked with a reiki healer named Raven Keyes. She told me
recently, “My reiki master is the archangel Gabriel. All I have to do is ask
Gabriel to activate all the angels, and everybody’s angels come to life.” In the
operating room, she said, she’d perch on a stool behind the anesthesiologist
and transfer her good energy. “I’m connecting with the divine light within me
and allowing myself to absorb the divine light in myself so it expands outward.”

Raven attributed Oz’s experimentation with reiki to his desire to help people
and to understand “energy medicine.” Oz, in turn, endorsed Keyes by writing the 
introduction to her book, The Healing Power of Reiki.

Of course, here at SBM and elsewhere, I and my fellow SBM contributors have long
been pointing out how much dubious medicine and outright quackery Dr. Oz has
promoted over the years. I’m not talking “soft” quackery either. I’m talking
quackery as bad as The One Quackery To Rule Them All (homeopathy) and even faith
healing, as well as the promotion of the antivaccine views of Robert F.
Kennedy, Jr., and even psychic scammers like John Edward and Theresa Caputo. In 
addition, he’s promoted unproven (and almost certainly nonexistent) links
between cell phones and breast cancer, GMO fear-mongering,  By 2014, Dr. Oz’s
reputation for quackery had gotten so bad that he was increasingly facing less
than adoring press and was hauled before Senator Claire McCaskill’s (D-MO)
committee for his unscrupulous boosterism for unproven weight loss supplements, 
where he was soundly humbled. It got so bad that not long ago Dr. Oz’s social
media people tried to do an “Ask Dr. Oz” segment on Twitter under the hashtag
#OzsInbox. Let’s just say that it backfired spectacularly and hilariously.

More recently, during the pandemic, Dr. Oz also boosted quack tycoon Joe
Mercola, who’s now (hilariously) in the thrall of a psychic medium claiming to
channel Bahlon, an “ancient and wise high-vibration entity from the Causal
Plane,” and as a result now thinks he’s a “new Jesus” who will save the world.
(He’s even started abandoning old friends in the antivax movement.) His
promotion of COVID-19 misinformation started early too. During the early weeks
of the pandemic in 2020, Dr. Oz, enamored of Didier Raoult‘s horrendously awful 
science, promoted Didier’s protocol using hydroxychloroquine and azithromycin,
as a cure for COVID-19. Meanwhile, as he was angling to run as a Republican to
be one of Pennsylvania’s Senators, he started embracing the minimization of
COVID-19, in particular becoming critical of school closures. Indeed, he went so
far that he was forced to apologize for having suggested that reopening schools
was a “very appetizing” opportunity because it was estimated that reopening
schools might “only” increase the total number of COVID-19 deaths by 2-3%:

DR OZ: "Schools are a very appetizing opportunity. I just saw a nice piece in
The Lancet arguing the opening of schools may only cost us 2 to 3%, in terms of 
total mortality. Any, you know, any life is a life lost, but … that might be a
tradeoff some folks would consider." 😳 pic.twitter.com/aifMeKTsIv

— Aaron Rupar (@atrupar) April 16, 2020

His apology came too late to avoid the appearance of memes like this:

Unfair? Maybe a little, but Dr. Oz’s blithe dismissal of how 2-3% additional
mortality would translate into thousands of additional deaths was quite tone
deaf.

I also can’t help but note that Dr. Oz had Donald Trump on his show in September
2016 during the election, and the two got along so famously that I referred to 
it as a “huckster bromance.”

So what might we expect from having Dr. Oz in control of the sprawling
bureaucracy that is CMS, which controls Medicare, Medicaid, and the Affordable
Care Act insurance exchanges? Nothing good would be my guess. First, I would
expect that he will likely do his damnedest to get the sorts of quackery that
he’s promoted all these years paid for by Medicare, Medicaid, and ACA insurance 
plans, all in the name of promoting RFK Jr. and Trump’s MAHA agenda in the form 
of “preventing chronic disease” and encouraging the use of various “natural”
interventions that quacks like him cloak in woo. In this, he is totally in line 
with Casey and Calley Means, the sibling duo who’ve been advising President
Trump and working with RFK Jr. Look for a significant degradation of
science-based standards with respect to “holistic,” “complementary,” and
“integrative” medicine; in other words, I expect a lot more “integration” of
quackery with science-based medicine.

Indeed, just look at this editorial that he cowrote last year, Longer life
expectancy can solve our busted budget. The idea is that more years of healthy
life might alleviate the budget deficit, which might be somewhat true, but it’s 
definitely exaggerated. The other thing to consider is that Dr. Oz has no
experience running an organization this large. He was never even the chairman of
the surgery department where he worked for decades. CMS is huge. Bending it to 
your will requires bureaucratic and leadership skills that Dr. Oz probably does 
not have. That might be the only good thing about this nomination. His own lack 
of experience is likely to stymie his ability to make major changes.

Marty Makary: What will he do with the FDA?

Marty Makary is, of course, familiar to readers of this blog, given how much Dr.
Jonathan Howard and I have written about him. As you might recall, Makary is a 
well-published surgical oncologist at Johns Hopkins, which is why I frequently
joke (as a fellow surgical oncologist) about needing to put a paper bag over my 
head when I see some of his pronouncements. You probably recall that Jonathan
and I don’t think much of Makary, who first came to my attention as one of the
foremost promoters of the myth that medical errors constitute the third leading 
cause of death in the US, all based on a risibly incompetent study that used
unjustifiable extrapolation from small numbers to conclude that 250,000 deaths
occur each year in hospitals due to medical error. As I pointed out at the time,
whenever you see an estimate of how many deaths are “deaths by medicine,” it’s 
very helpful to compare that estimate with what we know to assess its
plausibility. According to the CDC in 2016, of the 2.6 million deaths that were 
occurring every year in the U.S., 715,000 occurred in hospitals, which meant
that, if Makary’s estimates were correct, 35% of all hospital deaths were due to
medical errors. But the plausibility of Makary’s estimate was worse than that. 
Remember that the upper estimate used by Makary and Daniels was 400,000
inpatient deaths due to medical error. That was 56%—yes, 56%—of all inpatient
deaths. It was never anywhere near plausible that one-third to over one-half of 
all inpatient deaths in the US were (or are) due to medical error.

Since then, Marty Makary started out semi-reasonable on COVID-19 but was, as our
very own Jonathan Howard has long documented, quick to be captured by his
audience and fully embrace the “let ‘er rip” approach to the pandemic in a
futile effort to achieve “natural herd immunity,” which, he promised, was always
no more than six months away, after which he rapidly pivoted to fear-mongering 
about COVID-19 vaccines. I can’t decide whether he would be more of a disaster
heading up the FDA or the CDC, given his ideology and lack of qualifications for
either.

As little as I think of Makary, putting him at FDA might be one of the “least
bad” choices made by Trump. The FDA approval process is codified by law and
longstanding regulations that would take a lot to roll back, including
legislation. Moreover, my perception of Makary is that he is an opportunist. I
don’t know that he is generally antivaccine, except anti-COVID-19 vaccine
because his political fellow travelers became anti-COVID-19 vaccines, which is
likely mostly why he became anti-COVID-19 vaccine.

Here’s what Trump said on Truth Social announcing the nomination:

As I’ve noted before, though, there is a profound disconnect between the
competing goals of MAHA. On the one hand, RFK Jr. claims to want to make the FDA
approval process more rigorous for pharmaceutical drugs because he thinks the
organization is captured by big pharma and, as a result, too lenient on its
products. On the other hand, he wants the FDA to loosen or eliminate regulations
on raw milk, stem cell treatments, ivermectin for COVID-19, peptide therapies
(does he know that most vaccines would be considered peptide therapies?), and
the like. Makary will have a difficult time reconciling those competing plans.

A Fox News pundit for Surgeon General? Why not?

I must admit that I hadn’t even heard of Dr. Janette Nesheiwat. I guess I just
don’t watch much Fox News, and, for some reason, she’s never shown up in a story
that caught my attention enough to blog about. Trump announced her appointment 
on Truth Social thusly:

To be honest, I don’t know what to think of Dr. Nesheiwat. It will be
interesting to see how she fits in, given that, whatever her beliefs on COVID-19
public health matters, she does not appear to be antivaccine. This Newsweek
story contrasted her to RFK Jr. thusly:

In contrast, Nesheiwat has previously described the COVID vaccine as a “gift
from God.”

“I’m optimistic we are on our way to ending the needless loss of lives starting 
with the nothing short of miraculous coronavirus vaccine and the development of 
therapeutics,” she wrote in an opinion piece published on Fox News in 2021.

“We have many vaccines in existence that treat a variety of non-life-threatening
diseases but to have a COVID vaccine, i.e. a Pfizer or Moderna mRNA that will
actually save you from dying is a gift from God.”

She has also said that the measles, mumps and rubella vaccine is highly
effective.

“The measles, mumps and rubella vaccine has been around for many many years, at 
least 50/60 years, and it’s highly effective. It’s about 97 percent effective in
preventing you from catching measles, mumps and rubella, and this is really
important, because it is the most contagious vaccine-preventable disease out
there,” she said during a Fox News interview in January.

On the other hand, Dr. Nesheiwat does talk the talk with respect to vaccine
mandates, as well as the manufactured controversy over gender dysphoria and
gender-affirming care of trans youth. She also sells supplements, because of
course she does:

Nesheiwat, who specialized in emergency and family medicine, has supported
vaccines that Robert F. Kennedy Jr., Trump’s nominee for HHS secretary, has cast
doubts about.

But she at times seemed to criticize the CDC’s guidance about Covid vaccines,
saying earlier this year that for many Americans, especially young people, the
vaccine’s risks would outweigh the benefits — while acknowledging that risk is
small for the majority of patients. Nesheiwat has been critical of government
mandates through the pandemic.

She has also called into question the standards of care for youth with gender
dysphoria from the American Academy of Pediatrics.

She regularly contributes to Fox News and other outlets, has written a book
about “miracles in medicine” and promotes dietary supplements she formulates,
according to her website.

Linked to from her website:

Now that’s more like what we expect from a Trump nominee!

I take that back. I think I’m starting to understand more and more why Trump
nominated her, despite her previous praise of vaccines, including even the
COVID-19 vaccine. Even so, Dr. Nesheiwat is probably the least bad of the picks 
for anything, if only because Surgeon General doesn’t really have much in the
way of real power other than the power that her platform provides.

And so it begins…

We now know most of the team that will be tasked with implementing RFK Jr.’s
MAHA manifesto. In our Bizarro World, we will, if RFK Jr. and Dr. Weldon are
confirmed, have longtime antivaxxers running HHS and the CDC, respectively, an
opportunistic pandemic minimizer and exaggerator of the harms of modern medicine
running the FDA, a TV grifter and quack running CMS, and a Fox News personality
who, although seemingly provaccine, sells overpriced vitamin supplements from
her website. None of these people has demonstrable qualifications or competence 
to do the actual jobs tasked to them, and three of them (RFK Jr., Dave Weldon,
and Marty Makary) are downright hostile towards the agencies and departments
that they’ve been chosen to lead. Look for a brain drain due to a mass exodus in
which those in these HHS agencies who can get out do get out, rather than face 
years of hostility and the hollowing out of the core missions of these agencies.
(Who could blame them, either?) They will, of course, be replaced by MAHA
loyalists, this degrading US health policy and science even further, damage that
it could take a generation to undo, if it can be undone at all.

As the great Charles Pierce likes to say, “This is your democracy, America.
Cherish it.” As for me, I’ll echo Pierce again by adding that I’ll be back next 
week for whatever fresh hell awaits in SBM’s bailiwick. Also: What, no Joseph
Ladapo? Yet?

How bad is it? RFK Jr.’s extinction-level threat to science-based federal health
policy and public health is here

Five months ago, I called RFK Jr. an “extinction-level” threat to US biomedical 
science and public health. That extinction is under way.

David Gorski on April 14, 2025

Link

After learning that, in return for his having suspended his independent
Presidential campaign to bend the knee to Donald Trump, Trump had said that he’d
appoint longtime antivax activist Robert F. Kennedy Jr. to an important
health-related position in his administration and “let him go wild on health,”
“go wild on the food,” and ‘go wild on medicine,” I wrote a post with an
intentionally rather inflammatory title, RFK Jr. is now an extinction-level
threat to federal public health programs and science-based health policy. Some, 
of course, considered me alarmist. Some of the usual suspects who had been
attacking public health and vaccines during COVID-19 even suggested that doctors
should “stop worrying and learn to love MAHA,” MAHA standing for RFK Jr.’s
slogan, “Make America Healthy Again,” which was a clear nod to Donald Trump’s
longstanding slogan, “Make America Great Again” (MAGA). As we all know, Donald
Trump won the 2024 election and has since appointed RFK Jr. as Secretary of
Health and Human Services, in addition to appointing a wretched collection of
grifters, antivaxxers, and quacks (most of whom have long been discussed on this
blog) to important positions in HHS.

I hadn’t wanted to write about RFK Jr. again. Really, I hadn’t. Believe it or
not, I get tired of his antics, grift, and conspiracy theories, having written
about them on a regular—or semi-regular—basis for nearly 20 years now.
Unfortunately, he’s doing so much damage to US health and science policy in such
a short period of time that it’s difficult for me to ignore. Also, there was an
impetus by fellow SBM blogger Dr. Jonathan Howard:

The free website publishes accurate information from doctors who’ve been
tracking this stuff for decades. The one that has to pander to its paid
subscribers publishes propaganda from political doctors. @ScienceBasedMed versus
@Sensible__Med https://t.co/wVgaZSK9BJ pic.twitter.com/PO3fIuuyjv

— Jonathan Howard MD (@19joho) April 13, 2025

Damn, I thought. Maybe I should revisit that post, now that we’re nearly three
months into the Trump Administration, and see how well it aged. Fortunately for 
me—and unfortunately for us as a nation—I find that it has aged pretty well. In 
fact, rereading it and reflecting on what has happened during the last five
months since I posted that, I realize that, if anything, I arguably
underestimated the damage that would be done in such a short period of time. I
note that a month and a half ago I also discussed how RFK Jr. would likely
undermine and destroy vaccine policy in the US and over the last two weeks noted
how MAHA is the new Lysenkoism, not to mention at least “soft” eugenics, based 
on RFK Jr.’s response thus far to the large and growing measles outbreaks in
this country.

The article cited above by Dr. Howard shows RFK Jr. spewing a number of common
antivax tropes, including these two:

There is malnutrition in West Texas, in Gaines County, and in the Mennonite
community. The doctors that I’m talking to on the ground, the leaders in the
community are reporting that the people who are getting sick are people who are 
umm and the little girl who died, where malnutrition may have been an issue in
her death. There’s a lot of poverty in that area and the food is kind of a food 
desert. The best thing that Americans can do is to keep themselves healthy. It’s
very very difficult for measles to kill a healthy person.

And:

If you are healthy, it’s almost impossible for you to be killed by an infectious
disease in modern times because we have nutrition, because we have access to
medicines. It’s very, very difficult for any infectious disease to kill a
healthy human being.

Of course, these are the sorts of things that RFK Jr. has been saying all along.
First, his idea that measles is a harmless disease if you are healthy is just
plain wrong. Don’t get me wrong, I’m not arguing against good nutrition, but
good nutrition is not going to make it less likely that an unvaccinated child
will catch measles and is not a silver bullet to prevent death. The second part 
is so wrong that RFK Jr. is not even wrong. It is, however, a common MAHA
talking point that frames health as an issue of private virtue with respect to
health-related behaviors and implies, if not outright states, that if you live
the “correct” lifestyle, consume the “correct” diet, and do the “correct” amount
of exercise, infectious diseases can’t harm you.

It’s the same mindset that Bill Maher exhibited in 2009 when he claimed that he 
lives a lifestyle that basically made him immune to influenza, leading his guest
Bob Costas to retort sarcastically, “Oh, come on, Superman!” One need only
point to the historical fact that one of the earliest outbreaks of influenza
during the 1918 pandemic occurred in an Army barracks in Kansas, where the
recruits were, presumably, young, healthy men. There are, of course, many other 
examples from history. The whole point of vaccination is that an immunologically
naive population can’t fight off a pathogenic bacterial or viral infection
because they’ve never been exposed to it before. A healthy immune system needs
priming, not nutrition. If that priming is by infection, there will be suffering
and death as the price to pay for immunity, rather than a sore arm and maybe
some fever, aches, and/or chills.

Let’s take a look at some of the things that RFK Jr. and his minions have done
since taking office as HHS Secretary. I’ll go by critical agencies and provide
an overview of what’s happening, because this post is already too long and going
into detail would make it still longer. Again, let’s just say that, if
anything, I understated the danger when I called RFK Jr. an extinction-level
threat to US federal science-based programs in health, public health, and
biomedical research.

RFK Jr. at the FDA: Beware the “deep state”!

Last week, Politico and others reported on a visit to the Food and Drug
Administration by RFK Jr. and the new FDA Commissioner, Dr. Marty Makary, where 
an “all hands” meeting was held. Dr. Makary, you might recall, rose to infamy by
popularizing the myth that one-third of all deaths in the US are due to medical
errors each year. It’s a myth that has become so pervasive that it’s a common
sound bite on stories about the subject, despite the absolutely awful “science” 
by Dr. Makary on which it was based. (Suffice to say that the true absolute
number of deaths attributable to medical error is at least 10- to 20-fold
smaller than the inflated figure that Makary estimated.) Later, of course, Dr.
Makary became a “COVID-19 contrarian” and, as frequently documented by Dr.
Howard, did his damnedest to minimize the severity of the disease, rail against 
public health interventions, and making failed prediction after failed
prediction about herd immunity. Still, I almost felt sorry for Dr.
Makary—almost!—as I read about what went down at that “all hands” meeting, as
Dr. Makary tried to claim, against all reality, after the massive staffing cuts 
instituted at FDA:

The cuts came during FDA Commissioner Marty Makary’s first full week in charge
of the agency. Makary acknowledged the staff cuts as he introduced Kennedy and
pledged that scientists, reviewers, inspectors and administrative staff would
have the resources they needed to do their jobs.

“There have been some changes as all of you are extremely aware of,” Makary, a
Johns Hopkins surgeon and former Fox News contributor, said. “Thank you for your
patience in those changes.”

Seriously, even if you believe that Dr. Makary is sincere in his stated desire
to tighten up the FDA’s regulatory standards for approving drugs and devices (a 
need for which I’ve had sympathy and some agreement in the past), it’s going to 
be mighty difficult to accomplish that now that the agency’s staff have been
decimated. It’s also going to be difficult to communicate clearly, write product
safety sheets, or in general explain things to the public given that nearly all
the FDA communications staff have been fired. One wonders if Dr. Makary
realizes that he’ll be the fall guy when needed drugs fail to be approved and
unsafe drugs get approved or when there are outbreaks of food-borne illness that
could have been prevented with more staff.

For someone who keeps claiming that he’s “not antivaccine” (although he’s
definitely anti-COVID-19 vaccine), I wonder if Dr. Makary realizes that, most
likely, no new vaccines will be approved as long as RFK Jr. is HHS Secretary.
Perhaps he doesn’t care. After all, he brought in Dr. Tracy Beth Høeg, who as a 
special assistant to him will serve as dual purpose, apparently. First, in her
previous life, she was a sports medicine quack who offered unproven stem cell
therapies in her practice., a perfect fit, given RFK Jr.’s desire to deregulate 
stem cell quackery. Since COVID-19, she’s basically aligned with Dr. Makary’s
contrarian views (the two are friends now), opposing nonpharmaceutical
interventions (NPIs) such as “lockdowns,” business closures, school closures,
and masking while also opposing vaccinating children against COVID-19. While not
as antivax as RFK Jr. clearly is, she has echoed common antivax talking points,
such as “questioning” the need for certain childhood vaccines, such as
immunizations against flu, rotavirus and varicella, for children not known to be
at high-risk for severe illness.

To get an idea why Dr. Høeg’s appointment is worrisome, just consider this
story, which shows direct political interference in a licensing decision:

The US Food and Drug Administration was slated to transition Novavax’s COVID-19 
vaccine from emergency use authorization to full licensure on April 1, when
Principal Deputy Commissioner Sara Brenner intervened, asking to take a look at 
the application, per multiple sources familiar with the matter.

Brenner enlisted Tracy Beth Høeg, who recently joined the FDA as a special
assistant to the commissioner, to help look at the application again, a source
said. Brenner announced Høeg’s arrival at the agency on 2 April at Commissioner 
Martin Makary’s introductory all-staff meeting.

Høeg has promoted incorrect information about COVID-19 vaccines, including
misinterpreted data, multiple people with vaccine expertise said.

“Having senior political staff stepping on and potentially overrule decisions
made by FDA experts raises a big red flag,” said Aaron Kesselheim, director of
the Program on Regulation, Therapeutics and Law at Harvard Medical School. “It
is perhaps worse that none of this is being done transparently.”

Although it’s not unheard of for the FDA Commissioner’s office to intervene in
the decision whether or not to approve individual products, it is rare and
nearly always problematic. What I see here is a signaling that Dr. Makary will
indeed bow to the MAHA antivax agenda, as Dr. Scott Gottlieb, former FDA
Commissioner, notes:

Scott Gottlieb, FDA commissioner during Trump’s first term, said 2 April at
Politico’s 2025 Health Care Summit that he expects some very early tests “of how
much [Makary] is going to establish independence in decision making, not just
on policy, but on product-specific things related to vaccines or how much he’s
going to be pressured by the secretary to do certain things that are clearly
evidence of political decision-making in the scientific and review process.”

Gottlieb said it is typical for commissioners to guard against outside political
pressure.

“We all got it, although I was fortunate,” Gottlieb said. “I mean Alex Azar in
many ways was exceptional. He understood that it was important to maintain the
independence of FDA and he guarded that.”

Remember, Trump 2.0 is not the same as Trump 1.0. This time around, there are no
guardrails. My expectation is that Dr. Makary will either bend the knee and
serve as RFK Jr.’s vassal, a political hack, or he won’t last long, nor will he 
succeed in his stated aim of making the FDA approval process more rigorous.
After all, while RFK Jr. might want “more rigor” for vaccines and
pharmaceuticals, he clearly wants to loosen standards for stem cells and many
other unproven treatments that MAHA likes.

Basically, I didn’t say a lot about the FDA in my original post from November,
but speculated that the FDA could pull approval from already approved vaccines
and/or issue black box warnings for potential side effects that don’t exist.
Nothing I see thus far tells me that these are not possibilities. Moreover, the 
first test of whether Dr. Makary will try to exercise some independence from HHS
and RFK Jr. will likely be, as Dr. Howard predicted, the first time that RFK
Jr. tells FDA to revoke the approval for a long-approved vaccine, which I
predict that he will do this year or, at the latest, next year. Dr. Howard
predicted that Dr. Makary will capitulate, rather than risk being fired or
forced to resign. There’s nothing in his history to suggest that he will do
otherwise. I agree with Dr. Howard that, if this happens, Dr. Makary will live
in infamy as the doctor who most enabled vaccine-preventable diseases to return 
and ravage our children. Meanwhile, we’re treated to headlines like FDA’s New
Commissioner Marty Makary Signed Off on Peter Marks Ouster, FDA Commissioner
Marty Makary Gets Off To A Bruising Start As Agency Is Wracked By Layoffs, and
The FDA Is ‘Finished’ as Firings Sweep Health Agencies. Drug Stocks Are Falling.

Of course, it’s very likely that nearly everyone with any scientific integrity
left will leave the FDA, especially after RFK Jr.’s rambling speech last week in
the aforementioned “all hands” meeting about how the “deep state” is real, the 
FDA has been hopelessly captured by industry to the point of being a “sock
puppet,” and referenced referenced the CIA’s Project MKUltra — a notorious human
experimentation program from the 1960s — and the Milgram experiment, a
well-known study meant to test people’s willingness to obey authority even if it
meant inflicting pain on others, and also:

But in his first visit to the FDA, he offered little in the way of a vision for 
how the agency would come away from the layoffs stronger — instead devoting much
of his speech to railing against the agency’s past failings and repeating his
assertions that the U.S. was far healthier during his childhood than it is now.

“This whole generation is damaged,” Kennedy said, according to the transcript,
claiming that rising rates of chronic disease, allergies and other illnesses are
the result of some “environmental toxin.”

“The information is out there,” he said. “But those studies aren’t done because 
they may offend the financial interests of powerful entities.”

RFK Jr.’s concern about environmental toxins must be why the CDC told the
Milwaukee health department that it couldn’t help them investigate elevated lead
levels in the city’s public schools because the CDC personnel who would
normally offer such help had all been fired. RFK Jr.’s response to being asked
about this?

It was basically, “Oopsie!”:

Two days later, asked about the cutting of the CDC’s lead poisoning prevention
and surveillance branch, US Department of Health and Human Services Secretary
Robert F. Kennedy Jr. suggested that the program might be reinstated.

“There are some programs that were cut that are being reinstated, and I think
that’s one of them,” he said April 3, noting that “there were a number of
instances where … personnel that should not have been cut were cut.”

Truly, I had underestimated the malignant incompetence of this administration
and RFK Jr. This is far from the only example of mass firings that had to be
undone. Moreover, it’s clear that the message in the chaos will be that you must
toe the line or be fired. Dr. Peter Marks, the FDA’s Director of the Center for
Biologics Evaluation and Research (CBER) and therefore in charge of vaccine
approval, was recently forced to resign and left with a banger of a resignation 
letter, in which he noted that he had tried to work with RFK Jr. but that it had
“become clear that truth and transparency are not desired by the Secretary, but
rather he wishes subservient confirmation of his misinformation and lies.”

The NIH is already in dire straits

I didn’t make much in the way of specific predictions about the NIH, but let me 
just say right now that what’s going on at the NIH is far worse than my worse
nightmares last year. What I rather expected is that the NIH would stop funding 
grants that went against RFK Jr.’s MAHA and antivax views or the views of the
administration. One thing that I did not expect was that Elon Musk and his
“Department of Government Efficiency” (DOGE) would try to slash indirect costs
on grants to 15%, thus kneecapping universities with the most NIH grants. What I
did not expect was that there would be an ideologically targeted and
vengeance-motivated mass cancellation of NIH research grants, which began before
the new NIH Director Dr. Jay Bhattacharya was even confirmed. RFK Jr. made sure
that the NIH started unilaterally canceling grants that had passed peer review 
through NIH study sections as scientifically worthy of funding and then been
funded—and canceling them without warning, thus utterly disrupting research.

They started with grants to study vaccine hesitancy, then moved on to grants to 
study and develop the mRNA technology used in the Pfizer and Moderna COVID-19
grants for use in other ways, such as vaccines against other pathogens and as
cancer treatments. Then, “reasoning” that the “pandemic is over,” they moved to 
cancel grants to study COVID-19 itself, followed by instituting their disbelief 
in climate science to cancel grants studying the health effects of climate
change. No, seriously, HHS literally said:

The NIH did not respond to Nature’s queries about the grant terminations or
scientists’ concerns about them. Its parent organization, the US Department of
Health and Human Services (HHS), told Nature that “the COVID-19 pandemic is
over, and HHS will no longer waste billions of taxpayer dollars responding to a 
non-existent pandemic that Americans moved on from years ago”.

The updated documents that Nature obtained (see Supplementary Information below)
were sent on 25 March to ‘grants-management specialists’ — NIH staff members
who oversee the business side of awarding funding. This document includes
COVID-19 on a list of “research activities that NIH no longer supports”, in
addition to research on China, DEI, “transgender issues” and vaccine hesitancy. 
The latest guidance also says that grants related to South Africa and climate
change should be terminated.

The document also outlines a new category of research that should be terminated:
any project on a list sent by the NIH director or the HHS, which is currently
helmed by long-time anti-vaccine advocate Robert F. Kennedy Jr.

In other words, if RFK Jr. doesn’t think your science matters, you won’t get
funded. As Nature notes, the scope of the cancellations is totally
unprecedented:

Such large-scale grant terminations are unprecedented; the agency typically
cancels only a few dozen projects each year in response to serious concerns
about research misconduct or fraud — and does so only as a last resort, after
taking other actions such as suspension.

Grants-management specialists will be tasked with identifying and terminating
projects, because the NIH’s current leadership considers its scientific staff
members too biased to make these determinations, says an NIH official who
requested anonymity because they weren’t authorized to speak to the press.

Lysenkoism 2.0 indeed, as I feared. Only research approved by Dear Leader HHS
Secretary RFK Jr. is real science! After all, remember how both Dr. Steve
Novella and I recently wrote about how the NIH has hired longtime antivax hack
“scientist” David Geier to oversee a study of vaccine safety to determine if
vaccines cause autism. (Spoiler alert: He’ll use crappy science to conclude that
they do.) As we both noted—and Dr. Howard, too!—you don’t hire someone like Mr.
Geier unless you want a predetermined result and know that rigorous science
won’t support it.

Speaking of predetermined outcomes, apparently the NIH will lead an autism
initiative announced last week by RFK Jr.:

Robert F. Kennedy Jr., the nation’s health secretary, pledged on Thursday to
seek out experts globally to discover the reasons for the increasing rates of
autism in the United States.

“We’ve launched a massive testing and research effort that’s going to involve
hundreds of scientists from around the world,” Mr. Kennedy announced at a
cabinet meeting held by President Trump. “By September, we will know what has
caused the autism epidemic and we’ll be able to eliminate those exposures.”

“There will be no bigger news conference than that,” Mr. Trump replied.

And:

He said the Centers for Disease Control and Prevention would soon release data
showing that the autism diagnoses had now increased to one of every 31 children.
Many scientists and doctors attributed the rise in autism rates over the last
several decades in part to growing awareness of the disorder and to expanded
diagnoses along a spectrum.

“We are launching requests to scientists from all over the country and all over 
the world,” Mr. Kennedy said in an interview on Fox News. “Everything is on the 
table: our food system, our water, our air, different ways of parenting, all the
kind of changes that may have triggered this epidemic.”

As I’ve been saying on social media about this story, spoiler alert: The study
will conclude that it was the vaccines. There, I saved five months and tens of
millions of dollars! Don’t believe me? Oh, come now:

In the interview, Mr. Kennedy also said an important part of the effort would be
to compare autism rates in vaccinated and unvaccinated children. It’s an angle 
that many scientists dismiss, saying that parents who vaccinate their children
are also more likely to get a diagnosis, given higher rates of interaction with 
health providers.

Of course, I shouldn’t need to repeat again that vaccines don’t cause autism; we
have copious evidence from many large epidemiological studies dating back a
quarter century or more supporting that conclusion. What does RFK Jr. have?
David Geier, the hack nonscientist who’s spent the last 25 years doing bad
research to “prove” that mercury in vaccines. But what about the rest?
“Different ways of parenting”? WTF does he mean by that? Is he resurrecting the 
long-discredited “refrigerator mother” hypothesis? How does one even study
“different ways of parenting” as a risk factor for autism, anyway?

Moving on, let’s just take a look at the scope of the carnage being inflicted on
NIH grants. It is truly unprecedented. I’ve been applying to the NIH for
various grants, training to young investigator, to bigger grants, since the late
1990s, and I’ve never seen anything like it. Neither have researchers more
senior than I am whom I’ve asked. As of April 7, according to Nature, 770
research grants have been canceled, mainly these topics:

If you think that Trump and RFK Jr. will stop with just these subject areas, I
have a bridge I’d like to sell you.

And:

You might ask how the NIH can do this. Although most NIH grants are longer than 
a year, with the “gold standard” NIH R01 grant typically being for five years,
they are funded one year at a time. After each year, the investigator must
submit a progress report, and, based on that, the next year’s funding is
granted. In the past, the progress report would have to be really bad for the
NIH to consider cutting off the next year’s funding, but now the NIH is
basically just stopping grants cold because they are, from the administration’s 
point of view, outside of goodthink or are even doubleplusungood, either. The
overall effect is to utterly change how scientists view the NIH, which has for
eight decades been very trustworthy as a funder:

In the past, the termination of grants has been exceedingly rare, reserved only 
for gross misconduct, poor performance or fraud, says a former senior employee
at the NIH, who requested anonymity out of fear of retribution. Even in those
cases, institutions are often given the opportunity to remedy the situation, the
former worker says.

“Up until now, grant recipients have been able to assume that, as long as they
do good work and don’t do anything stupid, they’ll have five years of funding,” 
they add. “Now, that’s gone.”

This uncertainty, combined with the hostility toward institutions of higher
education, is already having a deep chilling effect: more than 75% of
respondents to an informal Nature poll of readers who are scientists said that
they were considering leaving the United States.

And that’s not even when the administration is canceling grants in order to
punish specific institutions, like Columbia, and make them obey:

Last month, White House began to pressure Columbia over its handling of
anti-Israel protests and other allegations of antisemitism at the university,
saying it was killing $400 million in federal grants to the school, including
the NIH money. NIH terminated approximately 400 grants to Columbia on 12 March
and ordered their researchers to stop work on them.

They’ve also threatened NIH funding for major universities if they did not
eliminate DEI (Diversity, Equity, and Inclusion) programs. Embarrassingly, my
alma mater, both undergraduate and medical, the University of Michigan, caved
under such threats. As Gregg Gonsalves accurately described it, this is all a
purge of a generation of knowledge and expertise:

What we are seeing is a purge—of the administrative state, of the universities, 
of expertise—that is consistent with events like the Cultural Revolution in
China in the 1960s and ’70s, or the dismantling of the tsarist civil service
after the Bolshevik Revolution in 1917. Just because this moment isn’t
associated with the intense political bloodshed of those eras doesn’t make the
comparison any less apt. In one way or another, the goal is to get rid of an
entire set of people and institutions in the service of a radical ideology.

And what is rising in its place is also recognizable from history. From the
Covid contrarians running the National Institutes of Health and the Food and
Drug Administration to the anti-vaxxers down at HHS headquarters, we have our
21st-century Lysenkos propped up not by the strength of their ideas but by their
political patrons in the White House.

While the short-term effects of the administration’s policies have been
well-articulated, the long-term ones are just as chilling. In less than 100
days, President Trump has created a lasting legacy: We have lost a generation of
expertise, of systems built up to care for our nation and provide for our
collective future in terms of scientific advances.

And I haven’t even gotten to the CDC yet.

Like the case for Dr. Makary, I wonder if Dr. Jay Bhattacharya knows that he’s
being set up to be the fall guy for when these initiatives all go wrong. Either 
that, or he will, along with Dr. Marty Makary, be remembered as the physician
face of the effort to destroy biomedicine and public health in the US. As
Alt-NIH put it, Trump and RFK Jr. are attacking the NIH and universities because
they want them to knuckle under and obey:

American universities are a shining star of America’s economic power, a magnet
for talent that attracts people from all over the world. So why do movement
conservatives want to destroy universities? It’s an important question right
now, one that many scientists are just waking up to. The answer is that
conservatives hate universities because they are bastions of free thought, which
leads them to self-organize into liberal places. Smart people, whether they are
center-right, center-left, or left, generally support core liberal values of
intellectual freedom, fairness, and the rule of law. That leads people in
academia, including scientists, to oppose today’ authoritarian conservatism —
today’s autocratic and oligarchic US Republican party.

Universities also occupy a privileged place in public debate. Scholars at
universities get quoted in the press; scientists at universities weigh in on the
truth and validity of oil CEOs’ climate claims, and on COVID deniers’ public
health claims. In other words, universities are independent arbiters of truth in
a free society. They are institutions that can push back on autocrats. That’s a
major reason Rufo and Vance hate universities so much: universities limit the
power of autocrats. So Trump and Republican elites are now seeking to
politicize, damage, and corrupt NIH — they want to take over the science
grantmaking system to destroy US universities.

So does Dr. Bhattacharya, apparently. Funny how much he complained about
supposedly being “canceled,” which in his case consisted of being sharply
criticized and having his feelings hurt because in 2020 former NIH Director
Francis Collins referred to him in a private email as a “fringe epidemiologist” 
while now enthusiastically embracing canceling whole areas of scientific
investigation and knowledge. I would also add that I only half-agree with Dr.
Collins. Dr. Bhattacharya is indeed quite fringe, but he is not an
epidemiologist. He is a health economist, and it showed. The Great Barrington
Declaration, which he co-authored, advocated for a “let ‘er rip” approach to the
pandemic among the “healthy” in order to achieve “natural herd immunity”
faster, while weakly suggesting “focused protection” of high risk populations
without any actual concrete strategies to do so. The document was truly about
economics and opening the economy back up, the human toll be damned.

The CDC is being destroyed

I noted in my original post that RFK Jr. would have huge influence over the CDC,
particularly given that the HHS Secretary appoints the members of the Advisory 
Commission on Immunization Practices (ACIP), the committee that formally
recommends the childhood and adult vaccine schedule. While it is true that
states determine which vaccines are included in school vaccine mandates,
generally they take the CDC’s lead, following its recommendations, which are
made and periodically updated by ACIP. One can imagine an HHS Secretary under
Trump appointing antivaxxers to ACIP, which would wreak havoc with our
vaccination program. To my knowledge, RFK Jr. has not as yet appointed
antivaxxers to ACIP, but the February meeting was delayed until next week.

There is a conspiracy theory that I’ve dubbed the “central conspiracy theory of 
the antivaccine movement” (at least the US antivaccine movement), which posits
that vaccines cause autism and all sorts of horrible health outcomes and that
the CDC “knew” but covered up the data. That conspiracy theory was at the heart 
of RFK Jr.’s “coming out” party when he published his antivax conspiratorial
screed Deadly Immunity back in 2005, and nothing in his world view has changed. 
It was also at the heart of Del Bigtree and Andrew Wakefield’s antivax
propaganda film disguised as a documentary, VAXXED and has continued to be the
main driving antivax conspiracy theory through the COVID-19 pandemic. RFK Jr.
fully believes in these conspiracy theories, and, as a result, the CDC is
suffering a similar destruction of its mission and corruption of its values and 
science.

Examples abound, the most recent of which occurred last week when RFK Jr. told
the CDC to stop recommending that states fluoridate their drinking water. Of
course, before that, RFK Jr. had stopped advertising that promotes vaccination, 
wanting instead to emphasize “choice” and “informed consent,” while temporarily 
and abruptly shutting down the CDC’s weekly scientific publication, the
Morbidity and Mortality Weekly Report (MMWR), which CDC’s primary way of
publishing and communicating important data for public health. Then, of course, 
Trump appointed Dr. Dave Weldon, an antivax blast from the past, to be CDC
Director, although Weldon’s nomination was abruptly yanked at the last minute
when it became clear that he wasn’t going to win confirmation. Not that it
mattered. When it came to the deadly measles outbreaks, the largest of which is 
in west Texas, RFK Jr. only grudgingly recommended vaccination with MMR, burying
the recommendation in nonsense about using vitamin A and steroids to treat
measles, even after two children have died of measles. Despite the so-far
disastrous response of CDC and HHS to the measles outbreak under RFK Jr.’s
leadership, he’s crowing that the CDC has done an “amazing job” getting the
measles outbreak under control, even though the measles outbreak is definitely
not under control yet and, as Dr. Paul Offit wrote, RFK Jr. should apologize:

When RFK Jr. attends the funeral of yet another child who has died from measles 
unnecessarily, he should apologize to the family. Apologize for his inaction.
Apologize for his continual spread of misinformation about the disease and the
vaccine. Apologize for his failure to strongly support the importance of
vaccinating children during an epidemic. And apologize for cutting funds for
immunization clinics in areas with low vaccination rates. The frankly dismissive
mantra of “thoughts and prayers” doesn’t cut it here.

Meanwhile, the CDC has slashed funding to community health departments and to
programs designed to encourage childhood vaccination, leading, predictably, to
outcomes like:

In Dallas County, Texas, the health director said the cuts compelled the
cancellation of 50 community vaccination events — including many in schools with
low measles vaccination rates amid a rising outbreak.

In Minnesota, the Health Department announced it would lay off 170 employees
after losing more than $220 million in federal funds. Among the casualties is
the state’s immunization registry, which will no longer be upgraded — leaving
Minnesota with one of the most outdated tracking systems in the country.

In California, the Health Department said in a federal filing that it would be
unable to provide childhood vaccines, including for measles, to millions of
children, roughly half of the state’s youth.

And in Washington state, the Health Department announced that in response to $20
million in grant cuts targeting immunization programs, it would furlough or lay
off 46 workers and suspend its mobile clinic operation, known as the
Care-a-Van. The 104 canceled clinics were expected to administer 2,000 vaccines 
to vulnerable kids, including those in rural areas and homeless populations.

And:

The National Association of County and City Health Officials survey captured
further impacts: A department in Ohio said it plans to halt training on vaccine 
hesitancy. One in Indiana will lose two nurses who travel to schools to
vaccinate children, so parents don’t have to miss work. A Texas agency will not 
be able to replace old equipment as planned.

The cuts also threaten a less visible but critical part of the vaccine
infrastructure: the data systems that public health departments use to record
and share immunizations. Vaccines for Children relies on these systems to order 
doses, approve and track distribution, and monitor safety.

It’s almost as though the HHS is now intentionally trying to destroy federal
vaccination programs. Scratch the word “almost.” That’s exactly what it is
doing. I could continue to go on, but Dr. Howard has collected a whole bunch of 
links to news stories documenting the carnage.

US public health, medicine, and science are in deep trouble

Looking above at what I’ve written, I just realized that I haven’t even
mentioned that America’s Quack, Dr. Mehmet Oz, now runs the Centers for Medicare
& Medicaid Services (CMS), which is in charge of our largest health programs,
including Medicare, Medicaid, and Affordable Care Act insurance plans. Maybe
another time. Now I’m too tired.

I’ll conclude by riffing on Gregg Gonsalves, who notes the consequences of this 
rapid destruction of generations of institutional and scientific knowledge:

These resources won’t just spring back if Trump is gone. Senior figures outside 
the government are seeking other opportunities. Students and trainees are
missing the chance right now to take up their chosen profession; they’re not all
going to wait around indefinitely for the political winds to change. The rest
of the human, administrative, and physical infrastructure for science, public
health, and healthcare is starting to wither away as well. In government, in
addition to the mass dismissals, we have people like Peter Marks—central to drug
development and regulation for years—walking away from the FDA in disgust and
protest. If you needed more evidence of the central punitive nature of these
purges, some agency officials are getting told they can go work in remote rural 
locations in Alaska or Montana and remain in federal service. At least they are 
not getting a bullet to the head as they are marched out to the countryside. But
they are indeed facing a kind of exile.

This is basically Nuremberg 2.0, the fantasy that many antivaxxers and COVID-19 
contrarians held that one day they could punish those whom they viewed as
responsible for all the “horrors” in policy instituted to control COVID-19. The 
problem is, this time it’s no fantasy. Indeed, Jeffrey Tucker, who played a
major role in bringing together the three “dissident” scientists to write the
GBD and later founded the right wing antivax and anti-public health think tank, 
the Brownstone Institute, has even stated as much recently at the Independent
Medical Alliance (IMA; Previously FLCCC) Annual Conference:

But my highlight of the weekend was Tucker’s plenary talk, in which he
summarized his worldviews – anti-lockdown, pharma controls the world, etc – and 
then revealed the reason for HHS cuts in the form of a theatrical skit. “And
this is why there is upheaval going on in Washington,” he said. “Nobody says it,
but this is why.” “How come you just fired twenty thousand people from the
HHS?” “Oh, cost cutting…” – he looks down, pretending to be a coy government
spokesperson, then pauses to give the audience time to come to their own
conclusion. “It’s not cost cutting. It’s JUSTICE. It’s JUSTICE.” (I later asked 
Tucker and Mansdoerfer whether this is the view of the White House as well –
they said No).

See for yourself:

Nice guy, that Tucker. Never mind that he’s a Neo-Confederate far right wing
propagandist who was largely responsible for bringing together authors of the
social Darwinist Great Barrington Declaration in 2020. Note the glee with which 
he contemplates tens of thousands of HHS workers losing their jobs, rather like 
Elon Musk.

Arguably, before Trump and RFK Jr., Mr. Tucker did more to destroy public health
by first enabling and then promoting the GBD. As an aside, if you believe their
account, the FLCCC/IMA had a lot to do with getting RFK Jr. confirmed, as their
speakers bragged about how they had “carpet-bombed” Sen. Bill Cassidy’s
district in Louisiana, calling thousands of constituents and transferring them
directly to Cassidy’s phone lines, thus ensuring his tie-breaking committee
vote. An opening video apparently also showed Senator Ron Johnson holding a
stack of “65 thousand letters” in support of Kennedy during the hearings – also,
if you believe them, the work of IMA Action.

Depressingly, I’m with Gregg Gonsalves:

We’re in deep trouble. The midterms, the 2028 elections, should they change the 
balance of power in Congress or who is in the White House, all come too late.
The patient is bleeding out in the waiting room. American science, public
health, and healthcare will be damaged for a generation or more.

I’m at least as pessimistic. The damage has already been done, and it will only 
get worse the longer Trump and RFK Jr. remain, in effect, unopposed in this
sphere. Lysenkoism 2.0 is upon us. How much damage will be done? Will it take us
decades to recover, as it did the Soviet Union? I don’t know, but I’m afraid to
learn the answers as the months roll by. Five months ago, I called RFK Jr. an
“extinction-level” threat to US biomedical science and public health. That
extinction is well under way. If my old post hasn’t aged well, it’s because I
was not pessimistic enough and exhibited a failure of imagination regarding just
how far President Trump and RFK Jr. would go and how fast.


MAHA Gave Us MAGA 2.0.  Remember the Enablers.

When the history of this sad era is written, MAHA doctors will be disgraced
pariahs and cautionary tales.  Everyone else should be remembered based only on 
whether they tried to put the brakes on MAHA/MAGA however they could or whether 
they slammed the accelerator.

Jonathan Howard on January 23, 2026

Link


Public health wasn’t always a dystopian hellscape intent on using police and
military power to maximize compliance… But it is now!

We’ll never know, but it’s entirely possible that without the unholy union of
MAHA and MAGA in the summer of 2024, Trump might not be in power today. As such,
it’s important to understand how MAHA came to be. While that’s a long,
complicated story I’ve explored in two books and nearly 300 essays here, SBM
readers know that disinformation doctors played a crucial role in elevating
Kennedy, and thus Trump.

Although MAHA doctors described themselves as “medical scholars” who based their
opinions on a “sober assessment of available evidence”, in reality, they were
content creators first and foremost. They rose to prominence via their
emotionally manipulative social media output, and their videos, podcasts,
Tweets, Fox News clips, and blogs were deliberately designed to stoke fear and
rage regarding COVID mitigations.

In their telling, COVID threatened only grandma, and plagiarizing from
pre-pandemic anti-vaxx agitprop, they depicted public health officials not as
people struggling to stop a new virus from overwhelming hospitals and morgues,
but as diabolical totalitarians who would gleefully send masked police in the
street to terrorize innocent civilians.

Pre-pandemic anti-vaxx propaganda

In this video for example, set to ominous music and footage of police in riot
gear, Dr. Jay Bhattacharya, the current head of the NIH, hysterically warned of 
a “biomedical security state” should another pandemic arise. The alternative he 
offered was “a liberal democracy, with enlightenment norms guiding science.” 
“Those are the stakes going forward,” he said. He wasn’t wrong about that.

Dr. Jay Bhattacharya warns of a “biomedical security state.”

Dr. Vinay Prasad, a top FDA official today, sounded similar themes on social
media by writing:

Public health wasn’t always a dystopian hellscape intent on using police and
military power to maximize compliance with interventions that are based on 0
RCTs. But it is now!

He elaborated on this delusion in a video and essay titled How Democracy End: 
COVID19 Gives A Road Map for Political Control, which also warned of a police
state ushered in by fascists who might seek to contain a future pandemic. Dr.
Prasad wrote:

The pandemic events of 2020-2021 outline a potential pathway for a future
democratically elected President of the United States to systematically end
democracy…  During the COVID19 pandemic, some of the most ardent calls for
strong restrictions came from members of the political left… When democratically
elected systems transform into totalitarian regimes, the transition is subtle, 
stepwise, and involves a combination of pre-planned as well as serendipitous
events.  Indeed, this was the case with Germany in the years 1929-1939, where
Hitler was given a chance at governing, the president subsequently died, a key
general resigned after a scandal and the pathway to the Fuhrer was inevitable.

Dr. Vinay Prasad warns of military in the streets.

Elsewhere, Dr. Prasad rejected calls for “forgiveness.”  “These pieces of shit
are still lying”, he said in his typical vulgar, vengeful manner. “They are
still fucking lying.”

Although this was theatrics, an imagined, paranoid, fantasyland conjured to
spread anger and doubt, it was very effective in warping public opinion. Many
people are now convinced that the only problem with COVID was that Nazis from
the “political left” tried to limit its carnage.

God gave us two arms. One to vote for Donald Trump, the other to give thumbs up 
to RFK Jr.

However, this histrionic fearmongering regarding COVID mitigations served a
larger purpose beyond deliberately infecting people with SARS-CoV-2. Despite
claiming to be apolitical scientists, MAHA doctors were open about their
political leanings and ambitions. Brushing off January 6th and dead children in 
Samoa, MAHA doctors openly campaigned for both Trump and Kennedy, who himself
compared vaccine mandates to Nazi Germany.  This too was effective- Kennedy and 
Trump are in power- and none of it was hidden. MAHA doctors were loud and clear 
about their loyalties and intentions.

Dr. Jay Bhattacharya speaks at a Kennedy presidential rally.

Dr. Vinay Prasad directs his audience to vote for Trump and support Kennedy.

Vinay Prasad is divisive, opinionated — and usually right

However, MAHA doctors could not have triumphed on their own. They had a
formidable public relations team that amplified, normalized, and defended their 
message every step of the way. While many of us desperately tried to alert
people to their obvious risks, these enablers gave MAHA doctors a platform to
disseminate both COVID disinformation and MAHA/MAGA propaganda.

The enablers invited MAHA doctors to speak, published their articles, promoted
them on social media, appeared on their podcasts, defended them in newspapers,
and berated anyone who corrected their disinformation. MAHA doctors told the
world that Trump was the key to preserving liberal democracy and that Kennedy
would be the savior of vaccines, and this cadre of collaborators told the world 
that the men behind such messages were wise, principled, and trustworthy.

While the enablers provided a safe space to MAHA doctors, they deliberately
undermined those of us who stuck our necks out to warn of them, mocking us as
hysterical, dishonest, nasty, woefully ignorant, and a stain on the academy.
Only we were “political.” Only we had to watch our “tone.”

The list of enablers is very long and includes not just obvious bad-faith
actors-  malignant tech oligarchs, MAGA doctors, pundits, and politicians,
contrarian podcasters such as Lex Fridman Jordan Peterson and Gad Saad,
supplement salesmen and wellness influencers, juvenile pseudo journalists, crank
medical organizations, Fox News, Epoch Times, Brownstone Institute, Heritage
Foundation, and Bari’s Weiss’s grift the Free Press–  but also shadowy
right-wing dark money organizations and cartoonish villains, including a
cape-wearing, pro-tobacco, child-labor advocate with Neoconfederate ties.
Predictably, these people are thrilled with the news today. Things are going
mostly as they hoped and planned.

But these malevolent forces are just a small part of the story. The list of
enablers includes many venerable individuals and institutions who found common
cause with the the right-wing disinformation machine in their promotion of MAHA 
doctors. This list includes a world-renowned scientist, Princeton political
scientists, a “civil rights attorney”, a famous “skeptic”, a Nobel Prize winner,
public health professors from UC Irvine and Johns Hopkins, “medical
conservatives”, a podcasting neuroscientist, the former dean of the Brown School
of Public Health, a contributing editor for Vanity Fair and a former NYTimes
columnist, a podcasting economist, a YouTuber cosmologist, a leading
libertarian, a formerly respected vaccine-advocate, an “acclaimed” independent
journalist, a Rutgers molecular biologist, a Rutgers geneticist, a contributing 
editor to City Journal, a UCLA surgeon and former JAMA editor, a Bernie Sanders 
acolyte, a legendary conservative pundit, a Johns Hopkins cardiologist, a toxic 
media-hungry British biologist, a doctor who writes for the Washington Post, a
concierge internist from Washington DC, a guitar-playing oncologist, a UCSF ID
doctor, a UCSF geriatrician, a Yale law professor, a Cornell internist, a former
Harvard Medical School dean, a current Harvard ID doctor, the president of
prestigious medical societies, a department chair, and a university President.
One of Dr. Prasad’s business partners, a prestigious professor from the
University of Chicago, said that Dr. Prasad- who likened leftist public health
workers to Nazis and endorsed Trump and Kennedy the solution– was “divisive,
opinionated — and usually right”. 

The list also includes the Cato Institute, The Foundation for Research on Equal 
Opportunity, Technology Policy Institute, Biosafety Now, Labroots, Independent
Institute, Salem Center for Policy, The Fund For American Studies, The Fund for 
American Studies, Family Research Council, The Atlas Society, New Books Network,
Buckley Institute, University of Chicago Federalist Society, Manhattan
Institute, and Hoover Institution. It includes publications such as The
Atlantic, New York Times, City Journal, Spectator, USA Today, US News and World 
Report, Newsweek, Wall Street Journal, UnHerd, Politico, Reason Magazine, The
Hill, Tablet Magazine, Persuasion, Washington Post, STAT News, MedPage Today,
and even medical journals such as JAMA and the BMJ.  It includes universities
such as Harvard, Emory, UCSF, Johns Hopkins, Stanford, and Washington
University.

All this on behalf of MAHA doctors who claimed they were silenced and censored.

Under President Trump’s leadership. We are just getting started!

Fast forward to today and MAHA doctors are loathed and ridiculed by workers at
the institutions they purportedly lead. Diseases are spreading, and everyone
knows they are untrustworthy. No one can make the affirmative case that the FDA 
are NIH thriving under their leadership.

However, MAHA doctors haven’t just given us censorship, purges, and vandalism of
vaccines, public health, clinical trials, and basic research, they also are key
members in an authoritarian regime that is gleefully sending masked police to
the streets to terrorize innocent civilians, including young children and in
hospitals. Their dystopian fantasy is now our dystopian reality.

While MAHA doctors faked a concern about a dystopian hellscape intent on using
police and military power to maximize compliance in order to spread COVID and
catapult themselves to power, they now literally stand behind the corrupt, mad
king responsible for the real thing today. Dr. Bhattacharya, for example, now
says it is “ridiculous slander” to say that Trump is anything but a champion of 
science. “What the president is doing is very, very healthy”, he said. No MAHA
doctor has resigned in protest thus far. Neither Trump nor Kennedy has crossed
any of their red lines.  None of this is new, of course. There are ample
historical precedents of doctors lending the legitimacy of the medical
profession to authoritarian, anti-science regimes, and it never ends well for
those involved.

Anyone seeking to grasp how this nightmare came to be in the U.S. needs to
understand not just the role of MAHA doctors, but everyone who elevated them
along the way. Even if many of these venerable individuals and institutions are 
now shocked and horrified by what they helped unleash on us all, their cowardly 
capitulation helps explain how we got here, and we don’t need their permission
to remember that. Instead of having the integrity to simply be honest about the 
threat back when there was a chance of containing it, they collaborated to
elevate MAHA doctors, and thus Kennedy and thus Trump. While none of these
individuals and institutions alone are to blame, like an individual shooter in a
firing squad, they are collectively responsible for the end result.

When the history of America’s self-immolation is written, MAHA doctors will be
disgraced pariahs and cautionary tales for future medical students. They made
their choice and sealed their fates.  Everyone else made their choices too and
should be remembered based only on whether they at least tried to put the brakes
on MAHA/MAGA or whether they slammed the accelerator.

We are all along for their ride whether we like it or not, and unfortunately Dr.
Bhattacharya wasn’t wrong when he said that under Trump, they are just getting 
started.

A year full of wins at @NIH under President Trump’s leadership. We are just
getting started! 💪#MAHA pic.twitter.com/wG2YFpvg9R

— Jay Bhattacharya, MD, PhD (@NIHDirector_Jay) January 20, 2026


RFK Jr. Sacks Entire CDC Vaccine Committee

Steven Novella on June 11, 2025

Link

I’m sure you are as sick of reading about RFK Jr. as we are of writing about
him, but this is the world we live in. We cannot let outrage fatigue cause us to
take our eye off the ball. If nothing else, SBM needs to chronical every
anti-science move that this administration makes.

As most people, and certainly most readers here, certainly know, RFK Jr. is a
dangerous anti-science and specifically anti-vaccine crank who is now the
secretary of Health and Human Services (HHS). This puts him in charge of health 
care policy at the federal level, with a directive from Trump to “go wild on
medicine”. That’s what he is doing.

RFK Jr. is a particular kind of crank. He is a lawyer who knows how to start
with a desired conclusion, then cherry pick and twist evidence to suit that
conclusion. He has apparently operated that way for so long, he behaves as if he
truly believes that is how science and logic work. Of course, that is precisely
how pseudoscience works. RFK is also the master of “I am not anti-vaccine, I am
pro-safe vaccine” coyness. It is a toxic mix of anti-intellectual deception
that is now running roughshod through American health care.

The latest outrage was completely predicted here by David Gorski. In February he
wrote:

“The Secretary of HHS picks the members of ACIP, after a nomination and
selection process. These members serve staggered terms, and the current roster
has four members, including the chair Dr. Helen Keipp Talbot, whose term expires
June 30, 2025, four whose terms expire in 2027, with the rest expiring in 2028.
(The reason for this is that, for whatever reason, the Biden administration
left a number of ACIP committee positions vacant after the members’ terms had
expired and then appointed several new members in February.) By the end of a
Trump administration, all members of ACIP could be replaced; that is, if RFK Jr.
were to wait until the terms of existing members expire. He could easily decide
not to wait and replace the entire committee now. Such is the power he now
holds.”

RFK went with the worst-case scenario – he just fired the entire ACIP panel at
once. He was not content to wait until their staggered terms were up. An again, 
in typical RFK style, he has a ready-made pretext for this extraordinary move.
In his WSJ editorial announcing the move, he begins:

“Vaccines have become a divisive issue in American politics, but there is one
thing all parties can agree on: The U.S. faces a crisis of public trust. Whether
toward health agencies, pharmaceutical companies or vaccines themselves, public
confidence is waning.”

This is part of his justification – he needed to take this unprecedented action 
because of waning public trust in the CDC and vaccines. This is an old-school
strategy often used by anti-vaxxers, conspiracy theorists, and pseudoscientists 
– do everything you can to undermine public trust or to create questions, then
use waning public trust as justification for taking action. Perhaps no
individual has done more to undermine public trust in vaccines, so it’s rich
that he is using that to justify attacking the vaccine infrastructure. Of
course, this is all by design.

RFK is also using another pretext for his sacking of the entire ACIP panel, one 
that was also anticipated by David, because this is also something cranks do –
citing conflicts of interest. This is part of a general strategy to weaponize
methods of quality control within science and medicine to achieve a
predetermined outcome. We see this in the recent executive order by Trump
ostensibly to promote “gold standard science”. He too writes: “Over the last 5
years, confidence that scientists act in the best interests of the public has
fallen significantly.” And then he uses this as pretext to direct the heads of
agencies to institute certain standards, including that government science be
“without conflicts of interest”.

Superficially, setting such standards, and the standards themselves, are
reasonable. They use all the right phrases, promoting standards we support here 
as SBM. The problem is, none of this is a sincere effort to improve the quality 
of science. RFK’s sacking of ACIP and Tump’s executive order represent the
weaponization of science standards to achieve predetermined ends.

Getting back to conflicts of interest – Kennedy cites that many of the ACIP
panel members have had connections with the pharmaceutical industry. Of course
they have – they are vaccine experts. The pharmaceutical industry produces all
vaccines, and they require experts to do this. There is a collaboration among
government, universities, the medical profession, and industry. Scientific
research informs policy, and also feeds into translation into products by
industry. This kind of relationship exists in all industries heavily based on
science and technology.

But Kennedy sees this all as a conspiracy. He even acknowledges that individual 
members of the panel may not have specific conflicts of interest (panel members 
are vetted very carefully for this) – but they are all part of this
collaboration with industry, which biases their recommendations. In other words 
– they’re vaccine scientists and experts. So who is Kennedy going to get to
replace them? Where are the experts that have never had even a brush with a
pharmaceutical company?

RFK’s real beef with the panel is that they make recommendations he personally
doesn’t like, because he is an anti-vaccine crank. Like all cranks, he
interprets the fact that actual experts disagree with him as a conspiracy, not
as a reflection of the fact that they are experts and he is not. The system
disagree with him – so he undermines the system, spreads misinformation and
conspiracy theories, and then uses that as pretext to dismantle the system.

What will come next? I think we all know. RFK will appoint a panel of cranks who
will proceed to weaken vaccine recommendations. This in turn will affect
messaging about vaccines, and will even affect insurance company coverage of
vaccines. We can expect no new vaccines to get approved by RFKs hand-picked
panel of cranks.

For those keeping score – since RFK has been secretary of HHS he has weakened
CDC public messaging on vaccines, reversed recommendations for specific
vaccines, pulled funding for vaccine research (such as developing a bird-flu
vaccine), and has now wiped out the CDC panel that makes official vaccine
recommendations.

This is American Lysenkoism. Lysenko’s crank agricultural science, which became 
the official science of the Soviet Union, ultimately resulted in the death of
millions of people. The only question now is – will RFK Jr surpass Lysenko with 
a higher body count? The smart money is on yes.


MAHA Doctors Promised Kennedy Would be the Savior of Vaccines. What Happened
Next?

It was a mistake to treat bad faith political actors as wise medical sages.
Cildren are paying the price today.

Jonathan Howard on June 12, 2026

Link


“Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy”

As MAHA loomed in the fall of 2024, we at SBM warned of its obvious risks.
However, two prominent doctors, auditioning for roles in new administration,
made a bold claim at the time. Although Robert F. Kennedy Jr. had been the USA’s
anti-vaxx disinformation superspreader for 20 years, they argued that elevating
him to the most powerful position in American medicine was required to restore 
confidence in vaccines.

Dr. Vinay Prasad wrote an article titled Sabotaging RFK Jr’s Confirmation Will
Increase Vaccine Hesitancy that said:

At this point, the best way to curb vaccine hesitancy is to approve RFK Jr, and 
redirect his energies to generating more data. More data will answer the key
questions that remain unanswered: which childhood immunization program is
optimal. The worse (sic) thing we can do is tank his nomination. Then vaccine
hesitancy will explode.

Dr. Martin Kulldorff wrote a nearly identical article titled The Cure for
Vaccine Skepticism that said:

The only way to restore public trust in vaccination – which has taken a big hit 
since the lies attending the rollout of the COVID-19 vaccine – is to put a
well-known vaccine skeptic in charge of the vaccine research agenda. The ideal
person for this is Robert F. Kennedy Jr., who has been nominated to lead the
Department of Health and Human Services…

We won’t restore vaccine confidence by preaching to the choir. After the COVID
debacle, Kennedy’s stated goal is to return to evidence-based medicine free from
conflicts of interest. Letting him do that is the only way that skeptics will
trust vaccines again, and those of us who trust vaccines have no reason to be
afraid of that.

As a reminder, at the same time Drs. Prasad and Kulldorff were arguing that
Kennedy was the “only way to restore public trust in vaccination“, he was
showing the movie Vaxxed III: Authorized to Kill. This is the sophisticated
analysis and intellectual integrity they brought to the conversation.

“Hospitals See Diseases Resurge as Vaccinations Decline”

Enough time has passed that we can judge the validity of their promises. Has
Kennedy returned to evidence-based medicine free from conflicts of interest? Has
he generated more data to determine which childhood immunization program is
optimal? Has he restored public trust in vaccination? Here are some headlines
from this month alone:

US Hits A Scary Mark For Total Number Of Measles Cases — For The Second Year In 
A Row

The number of U.S. measles cases surpassed the 2,000 mark this week for the
second time in two years, federal data shows. There have been 30 new incidents
resulting in 2,030 confirmed cases so far this year, the U.S. Centers for
Disease Control and Prevention said Thursday. That’s inching closer to last
year’s total of 2,288 cases, the agency noted. Before 2025, America’s yearly
measles cases had not surpassed 2,000 since 1992. The highly infectious virus
was largely considered eliminated in the U.S. in 2000 due to the preventative
measles-mumps-rubella vaccine, but falling vaccination rates have helped the
disease to spread again.

CDC: Only 1 In 10 Hospital Patients Early In The West Texas Measles Outbreak Had
Underlying Conditions

A new study in Morbidity and Mortality Weekly Report from scientists with the
Centers for Disease Control and Prevention (CDC) and their state partners
analyzes the patients hospitalized during the first two months of the measles
outbreak that swept through West Texas in 2025, finding that nearly all were
unvaccinated children, only 11% had preexisting conditions, and respiratory
complications were common.

From January 20 to March 18, 2025, 325 measles cases were reported in the
region, and 60 patients—roughly one in five—were hospitalized. Of the 54
hospitalized patients with available medical records, all were either
unvaccinated or had unknown vaccination status. The vast majority (49; 91%) were
younger than 18 years, and 48 (89%) had no underlying health conditions. One
patient died.

Poison Center Reports Rose 39% For A Common Supplement — After It Was
Incorrectly Touted As A Measles Cure

Just because you can grab it off a drugstore shelf doesn’t mean it’s harmless.
As the US confronted a major resurgence of measles last year, poison control
centers reported a sharp spike in calls involving children exposed to a widely
available supplement. Around the same time, new research shows internet searches
surged for whether that same vitamin could be used as an alternative treatment 
for the potentially deadly disease. That spike in attention came after several
prominent figures — including Health Secretary Robert F. Kennedy Jr. and
podcaster Joe Rogan — discussed the nutrient as a possible tool in fighting the 
virus.

With Measles Roaring Back, the Search for a Treatment is On

As vaccination rates decline, biotech companies see a potential new market for
measles drugs. Just this year, two U.S. biotechnology companies announced they
would begin testing antibody treatments, one of them citing “measles incidence
reaching levels not seen in decades.”

Anguished Parents, Crying Doctors: Life Amid Utah’s Measles Outbreak

“I wish that people could see what I see,” said Nathan Money, a hospital
pediatrician in Utah whose eyes welled up with tears as he described children he
has treated for measles struggling to breathe. “This train is going in the
wrong direction, and it can feel like a helpless situation, because we’re just
not seeing the public messaging and leadership that’s needed to turn this
around.”

Hospitals See Diseases Resurge as Vaccinations Decline

Doctors around the country say they are seeing more cases of serious, sometimes 
life-threatening illnesses that vaccines have long kept at bay, including
whooping cough and bacterial infections that can cause pneumonia or meningitis.

The concern among doctors comes on the heels of a resurgence of measles
nationwide, fueled by distrust in vaccines that grew during the Covid-19
pandemic, and that Health Secretary Robert F. Kennedy Jr. and President Trump
have amplified. Public health experts have long seen measles as a harbinger:
Because it is so exceptionally contagious, it can be the first disease to spike 
as vaccination rates broadly decline, and a sign of more to come.

Source: Johns Hopkins Bloomberg School of Public Health

Things don’t seem to be going well to me, and the man whom Drs. Prasad and
Kulldorff marketed as the only person who could prevent these headlines is
responsible for creating them. Kennedy claimed that “the (measles) outbreaks are
actually declining” when in fact they were just ramping up, and that the MMR
“causes deaths every year… encephalitis, blindness“. He said that only “very,
very sick kids should die from measles“, and that “it’s very hard to tell” if
measles kills kids at all. He blamed doctors for the death of their patients,
saying that “children, healthy children, should not die of measles and there’s
no reason they should if doctors know how to treat at the hospital, that will
not happen.” He’s never acknowledged that measles can hurt children without
killing them, even though it caused encephalitis in children in South Carolina
this year. He’s touted vitamin A as a cure-all, and now people are getting sick 
from it. All this has occurred since he assumed power last year, as anyone with 
at least two functioning neurons could have predicted.

Meanwhile, during Dr. Prasad’s disastrous tenure at the FDA, he falsely claimed 
the COVID vaccine killed 10 children. He censored vaccine studies whose results 
he didn’t like. He fear-mongered about ultra-rare vaccine side-effects, even
mere MRI abnormalities. He promised new vaccines RCTs and failed to deliver
them. He personally rejected successful vaccine RCTs.

For his part, Dr. Kulldorff is working behind the scenes at the CDC to advance
Kennedy’s anti-vaxx agenda. He beclowned himself-“we are rookies”– during his
embarrassing turn leading the now defunct ACIP and has sought to decimate the
vaccine schedule simply to copy Denmark.

Neither doctor used their voice and authority to encourage vaccines. As measles 
spread under their watch, they sat back and said nothing.

“Brilliant, analytically rigorous, prolific, and passionate about improving the 
way we generate and apply medical evidence.”

How did we get here?

The answer isn’t just that doctors like Drs. Prasad and Kulldorff debased
themselves by spreading mind-blowing absurdities to obtain power- only Kennedy
can save vaccines!– it’s that the medical profession let them. Most medical
“leaders” yawned and looked away, while others spread mind-blowing absurdities
to glorify MAGA/MAHA doctors. For example, an editorial in the NJEM last year
described Dr. Prasad as:

Brilliant, analytically rigorous, prolific, and passionate about improving the
way we generate and apply medical evidence.

That was obviously false, and like predictions that Kennedy would save vaccines,
it was bound to age poorly. MAGA/MAHA doctors were overt political
propagandists above all else, and that’s how they should have been treated by
the medical community. A failure to do helps explain how got here.

Moving forward, MAHA/MAGA doctors will be disgraced pariahs for the rest of
their lamentable careers. They made their choices and those are the
consequences. They will be remembered for their COVID disinformation, their
incompetence in public office, and their responsibility for the entire MAGA/MAHA
regime, but no one will care about their oh-so controversial hot takes once
they are out of power and can’t do any more damage. However, this irrelevance
should have been their fate long ago. Medicine failed to police its own, and
children are paying the price today.

There are still years left to go.


The Trashing of Science by Robert F Kennedy Jr

If confirmed, Kennedy will keep trashing science and will continue exploiting
the trashed science he helps create for his own benefit.

Christopher Hickie on February 4, 2025

Link

Last week brought us two days of US Senate confirmation Hearings involving Mr.
Kennedy. It went as many of us here suspected: Tough questions from (mostly)
Democratic senators and fawning adulation by (mostly) Republican Senators.
Kennedy was questioned in both the Senate Finance and Senate Health Committees
regarding vaccines, Medicaid, Medicare, NIH research, abortion, and drug prices.
Not surprisingly Mr. Kennedy worked mightily in his effort to reconcile his
decades of anti-vaccine activism with his now hard-to-believe claims that he is 
all for vaccines. The Senate Finance Committee will meet Tuesday February 4th at
10 AM to vote on whether Kennedy advances to a full Senate vote.

Near the end of the second day (in the Senate Health Committee), Kennedy pulled 
a backhanded maneuver using what he thought was the ace up his sleeve — he cited
as “other science” a newly published vaccinated versus unvaccinated (vax-unvax)
study claiming (of course) unvaccinated children have fewer neurodevelopmental 
disorders (read: autism) than vaccinated. Here is the exchange between Dr.
Cassidy and Kennedy starting at 2:53:44

[Cassidy]: You’re a smart guy. You’re reading the medical literature and you’re 
coming up with the recent medical literature on certain issues. But here is both
an older article summarizing lots of older articles that have come out since
the original refute of Wakefield article in the Lancet regarding measles and
autism. And here’s somebody who you know it’s he said he said but somebody who
said that previously you’ve had this presented to you. So back to me. I’m a doc.
Trying to understand. If, how, convince me that you will become the public
health advocate but not just churn old information so that there’s never a
conclusion, as Senator Hassen suggested. But that will become the influencer for
people to believe; know there’s 1.25 million kids studied and there’s no autism
associated with measles. How, you tell me, you see what my question is in
there.

[Kennedy]: I’m going to be an advocate for strong science. You show me those
scientific studies and you and I can meet about it. And there are other studies 
as well. I’d love to show those to you. There’s a study that came out last week 
of 47,000 9 year-olds in the Medicaid system in Florida by a Loui — I think a
Louisiana scientist called Mawson that shows the opposite. There are other
studies out there, I just want to follow the science. And I will do if the
science says that I am wrong about what I’ve said in the past as I said I will
publicly apologize.

This did not sit well with Senator Cassidy who had endured Kennedy’s evasive
responses for both hearings. Cassidy, being committee chair, passed the
discussion to Senator Bernie Sanders while he looked at that study. Later
Cassidy (at 3:08:57) remarked he had looked at the Mawson paper, but that it
“seem to have some issues”. Time did not permit Dr. Cassidy to elucidate
further.

“Some issues”

“It had some issues” is an understatement regarding Kennedy’s “other science” of
Mawson’s paper, which has so many fatal flaws that it should never have been
published (more on that later). What completely disqualifies this paper,
however, is an undisclosed conflict of interest (COI) with Albert Dwoskin who,
up until 2019, was a wealthy funder of anti-vaccine research and a partner of
Kennedy’s anti-vaccine organization, Children’s Health Defense (CHD). In a
nutshell, DEVEXI — which supplied a filtered version of the Florida Medicaid
data to Mawson — was funded by a wealthy anti-vaccinationist (Dwoskin), without 
Mawson’s disclosure in his paper. THAT should have been disclosed, especially as
Mawson could have obtained his data directly through the State of Florida
instead of this nebulous third-party anti-vaccine-funded database.

I will also look at Mawson in the context of two other papers by
anti-vaccinationists: (1) a December 2024 paper co-authored by Brian Hooker
(CHD’s Chief Science Officer (CSO)) and Karl Jablonowski, and (2) a retracted
November 2020 vax-unvax paper by Lyons-Weiler and Paul Thomas, an Oregon MD who 
surrendered his medical license in 2022 rather than face the Oregon Medical
Board’s numerous charges against him for his anti-vaccine activities. The take
home lesson is Mr. Kennedy and CHD claim they follow science, but all they
really do is trash science.

Mawson’s Study

This new study was conveniently released a mere 7 days before this hearing. I
suspect this was to thwart efforts at debunking. But even on such short notice, 
two researchers, Jessica Steier, DrPH, PMP and Andea Love PhD, laid bare on
their Substacks many serious flaws in this paper (here and here). Among them: no
correction for healthcare seeking behavior (which is always less in
unvaccinated), an incomplete data set (by Mawson’s own admission), and an
inability to track all vaccines received by the 47,000 nine-year-olds in the
study. Any of these concerns would have torpedoed this vax-unvax paper on a
legitimate editor’s desk. But the editor who published this is James
Lyons-Weiler, who runs a web site pretending to be a medical journal (it isn’t) 
made for laundering retracted studies by anti-vaxxers. Because of this, Mawson’s
article will never face the slightest test of actual science or scientists.

Conflicts of Interest

Kennedy could be confirmed as soon as this week as Secretary of the US
Department of Health and Human Services, giving him absolute control over the
NIH, FDA, CDC and vaccine review committees. If confirmed, Kennedy could easily 
modify or even gut the US vaccine program while himself profiting handsomely
from tilting the vaccine landscape into the hands of his vaccine litigation
colleagues who could make many billions from vaccine lawsuits and kicking back
10% to him in referral fees. Thus, this undisclosed COI for Mawson has
importance as it turns Kennedy’s “other science” into non-science that Kennedy
promoted to advance Kennedy’s own self-serving interests in becoming HHS
Secretary.

Let’s look at this undisclosed COI.

Per Mawson, the Mawson paper used DEVEXI — “an integrated health and medical
research platform for generating epidemiological studies” as the source for
Florida Medicaid data. Mawson states in citation 24 of his paper that DEVEXI “is
no longer in existence” and that they last accessed DEVEXI in 2022. Consistent 
with this, DEVEXI’s web site is gone and their last Virginia Corporation
Commission activity was in 2021. DEVEXI’s prior web presence still exists and
notes:

DEVEXI is a powerful, intuitive health and medical research platform linking 22 
years of de-identified, HIPAA-compliant medical and dental claims data for
approximately 11 million patients. This platform links data from medical and
dental treatments, prescribed drugs and vaccines, exposures and short and
long-term health outcomes to provide researchers with the data and unique
analytics capability for groundbreaking, longitudinal epidemiological studies
never before possible. This Web-based health research platform seamlessly
integrates 100 national datasets on a range of important environmental,
behavioral and socioeconomic exposures. DEVEXI enables researchers to improve
the quality and cost effectiveness of healthcare across the industry including
medical schools, public health programs, teaching hospitals, insurance payers,
government health agencies and pharmaceutical companies.

So, yes, DEVEXI is a company that had access to health data for outcomes
research. DEVEXI was also noted by the NIH in 2020 to be a TPWA (third party
website application).

Follow the Money

While searching DEVEXI’s history (created in 2016), an entity named DEVEXI ADJ
LLC, (created in 2015) was found. The key here is this earlier LLC is an adjunct
to DEVEXI LLC and it listed Albert Dwoskin as its organizer and agent. This was
almost certainly done so Dwoskin could bankroll DEVEXI, but even if not, he was
involved in DEVEXI.

Dwoskin’s involvement in the creation of DEVEXI is not disclosed by Mawson. It
should have been. Why? Two big reasons:

  1. Albert Dwoskin (when DEVEXI started in 2016) was ½ of the Dwoskin Family
    Foundation, DFF. The other half of the DFF being now ex-wife Claire
    Dwoskin). DFF, at the time of DEVEXI starting, funded numerous anti-vaccine 
    activities and research including the Children’s Medical Safety Institute
    (CSMRI), which funded (of course) Mawson’s first vax-unvax study in 2017.
    DFF has shared the same address ( 3201 JERMANTOWN RD STE 700, FAIRFAX, VA,
    22030) since 2019 with DEVEXI ADJ LLC, which has the same address as DEVEXI 
    LLC. For completeness (and fairness), Mr. Dwoskin became pro-vaccine (likely
    concurrent with the Dwoskin’s 2018 divorce) and the current incarnation of 
    the DFF is now pro-vaccine (but it was not when DEVEXI started).

  2. CSMRI, which the Dwoskin’s also funded at the time of DEVEXI’s existence, was 
    a coalition partner with CHD (CSMRI ended with the Dwoskin’s’ divorce).

Thus, this “other science” by Mawson that Kennedy cited in his testimony to Dr. 
Cassidy came from Florida Medicaid data processed through an anti-vaccine-funded
corporation, instead of being directly obtained from the State of Florida (as
it could have been, shown below). On top of that, there is a coalition
partnership between CHD and the person funding DEVEXI. And none of this was
disclosed. Yet Kennedy still wants to hold this study up to Dr. Cassidy as
“other science”. No, Mawson’s study is invalid.

I could end here with this. It’s damning enough. But two other papers show just 
how deep the trashing of science is for the “other science” that Kennedy and CHD
love to cite.

The 2024 Hooker Paper

Let’s now look at that 2024 paper by Hooker and Jablonowski, which looked at
HibTITER vaccine effects on children in the State of Florid Medicaid database.
Sound familiar? Anti-vaccinationists love Florida Medicaid data. Near the end of
Hooker’s paper, a “Data Availability Statement” notes:

All data used is publicly available through the Agency for Health Care
Administration (https://ahca.myflorida.com/) …

This is why I stated earlier Mawson did not need to use DEVEXI, at least
according to Hooker. But here is where it gets truly bizarre: Hooker didn’t get 
his data directly from the State of Florida; instead, Hooker, like Mawson used
DEVEXI. Yes, he did that even though Hooker did not disclose it in his paper.
This is disclosed in a December 2024 podcast/video on CHD where Hooker
interviews co-author Karl Jablonowski. Here is what Hooker and Jablonowski said 
starting at 3:55:

[Hooker]: I’ve literally thrown a large supercomputer at you that I knew nothing
about and said, ‘Hey Karl, make this sing’, and you did. And tell us a little
bit more about the data that you mined for this particular project is from the
Florida Medicaid database. Tell us about that specific database you know, how
many entries? How large is the database? You know, how is it organized and, and,
I will tell you we did get this really kinda in a sort of a wink wink sideways 
way um it was actually it obtained from a politician in Florida and then it
became the heart of a software package called DEVEXI. DEVEXI is now out of
business but at the same time that DEVEXI got the database I was able to obtain 
a stack of CDs or DVDs I don’t know there were some D’s. that we were able to
then get this database, and I had this data um and finally one day loaded it up 
on drop box but tell us a little bit more about you know besides the back story 
what is in there.

[Jablonowski]: Yes so, it’s um it’s about 2 decades worth of Medicare data
coming out of the state of Florida and it contains um pretty much all of the
diagnoses and all of the medical procedures that were performed on individuals. 
It’s one of the largest medical databases I’ve worked with. And so, it was
really a beast to get into. It’s biased information in so much as all
information has a bias to it. it’s medical coded data, so you have your pitfalls
— are the doctor or entity that’s entering the codes for the data they are
after money so they are going to code for things that will give them profit and 
if a particular diagnosis doesn’t yield any profit, they may not even bother to 
code for it.

Incredible. Hooker admits to using DEVEXI and then portrays how they obtained
DEVEXI as not being above board. Ethics anyone? Apparently not for CHD and
Hooker when it comes to scoring a data hit (wink, wink, you know). This Hooker
paper, like Mawson’s, is no longer valid due to failing to disclose the COI with
DEVEXI. As an aside to show you how bad this paper otherwise was, go listen
from 32:30 to 34:30 where Hooker and Jablonowski talk about how their paper was 
rejected by twelve journals before being accepted. That could be a record.

Hide the DEVEXI

Hooker’s use and concealment of DEVEXI in his paper leads me to this assertion: 
CHD/Hooker supplied DEVEXI to Mawson, in order to finish his study, but then hid
it (by not disclosing DEVEXI’s use in Hooker’s paper) because Mawson’s study
needed to appear independent of CHD to make it “other science”. Mawson states in
his paper that he last accessed the DEVEXI platform in 2022; so, this paper
took two more years to come out since last DEVEXI access? I’ll wager Mawson
wasn’t done doing data analysis and needed to access the remnants of DEVEXI held
by Hooker. This is consistent with Mawson’s admission of incomplete data (cited
in “Limitations of the Study” #4 and noted by Drs. Steier and Jones in their
debunkings).

But most damning is that Hooker claimed to use direct access to Florida Medicaid
data, when in truth he used DEVEXI. Hooker does not want DEVEXI linked to CHD, 
but clearly it is. One can only conclude DEVEXI existed solely as a faux-legit
modifier of Florida Medicaid data for the purpose of guaranteeing vaccine
research favorable to anti-vaccinationists, especially given the only two known 
papers that have used DEVEXI are those by Mawson and Hooker. And again, Mr.
Kennedy has the nerve to sit there in front of the US Senate Health Committee
and cite Mawson’s study as legit “other science”. It is not.

How Convenient

Mawson’s study appeared just in time for Kennedy to cite it in his testimony.
The paper was submitted in October 2024 and approved December 2024, yet Mawson
was working on it way back in 2018 as noted in the Discussion section of his
paper which states in “Strengths of the Study” #7:

The authors were the first users to test and operate the initial version of
DEVEXI (Personal communication from Mitch Praver, co-founder of DEVEXI,
07/19/2018).

So, the work on this paper started 6 ½ years ago and only just now one week
prior to Kennedy’s testimony it just coincidentally gets published. I think not.
This was done to minimize any chance such execrable vax-unvax research could
get debunked and refuted.

CHD’s Undisclosed Reach Into Other Vax-Unvax Studies

Now let’s look at the third paper — the now-retracted vax-unvax study by
Lyons-Weiler and Thomas. In a recent January 24 NBC News article, investigative 
journalist Brandy Zadrozny finally showed why Kennedy was in Samoa in June 2019 
— he went to perform a prospective “vax-unvax” study on the children of this
island nation that had seen its MMR vaccination rates drop precipitously from
2018 to 2019, in part due to the efforts of Kennedy’s allies. Regarding
Kennedy’s Samoa visit, Zadrozny reports information relevant to this SBM post:

Kennedy wasn’t alone at the dinner. He brought the Children’s Health Defense’s
new chief information officer [CIO], Dr. Michael Graven, a lauded neonatologist 
known for creating information systems that tracked and improved health outcomes
in the world’s poorest countries…

…In 2019, Graven was analyzing the data for a study that would be published in
2020 by two prominent anti-vaccine activists, scientist James Lyons-Weiler and
Oregon pediatrician Paul Thomas, whose license would be suspended the same year 
— in part for his failure to adequately vaccinate patients — and then
voluntarily relinquished two years later.

Comparing health outcomes of Thomas’ patients, the study concluded that
unvaccinated children in his practice were healthier than vaccinated ones. It
was retracted a year later following an investigation that “raised several
methodological issues and confirmed that the conclusions were not supported by
strong scientific data.”

The Puppet Master

Zadrozny refers here to the same retracted Lyons-Weiler and Thomas paper I cited
above. Dr. Graven really was CHD’s CIO, as seen on page 7 of CHD’s 2019 IRS
form 990 (but also confirmed by Zadrozny in interviews of Graven’s family and
friends). Graven was also involved in this now-retracted Lyons-Weiler and Thomas
paper, as Thomas himself notes in Chapter 1 of his new book “Vax Facts”:

In January of 2019, I received a letter from the Oregon Medical Board saying
that I needed to prove the vaccine-friendly plan was as safe as the CDC vaccine 
schedule. While their letter didn’t convey an overt threat, my attorney advised 
me that failing to comply with their demands, even when they were unreasonable, 
could cost me my license. So, we did. I hired an independent consultant (a
pediatrician, neonatologist, and informatics expert) and tasked him with pulling
the data on every baby born into my practice from the day we opened our doors
(June 1, 2008) to the day he closed that dataset in February 2019. We had 10.5
years of data on many health outcomes. The analysis of the data was published…

Thomas verifies Graven was an unnamed “independent” consultant involved in his
retracted paper where Thomas describes him as a neonatologist and informatics
expert. Given Graven was CIO of CHD at the same time he was pulling Thomas’
data, Graven was not at all “independent”. Lyons-Weiler and Thomas should have
disclosed it. They did not.

Earlier I asserted CHD was involved without disclosure in the new Mawson study. 
I assert here that Kennedy’s CHD — without disclosure — was deeply involved in
the creation of the Lyons-Weiler and Thomas vax-unvax paper as well. Kennedy/CHD
is behind multiple “other sciences” they love to cite as independent research
and they are not willing to disclose it. Wakefield all over again, anyone?

What It All Means

Kennedy, throughout the two days of hearings, repeatedly refused to acknowledge 
the vast amount of valid, peer-reviewed research showing vaccines are not
associated with autism. We now know he will never do that, given he straight up 
cited invalid science as valid to Dr. Cassidy. If confirmed, Kennedy will keep
trashing science. He will not become the public health advocate Dr. Cassidy
encouraged him to be. He will never apologize for being wrong about what he’s
said, indeed he will never admit to being wrong. Instead, Kennedy will continue 
exploiting the trashed science he helps create for his own benefit. He will
further drive down US vaccine rates like happened in Samoa. We will see
outbreaks of measles, pertussis and meningitis that will hospitalize and kill
our infants and children. And it will be horrible.


HHS To Cut Funding for Vaccine Research

Steven Novella on August 6, 2025

Link

I get it. I am as tired of writing about RFK Jr.’s dismantling of the
evidence-based federal medical infrastructure as you are of reading about it. I 
have tried to focus on anything else, as you can see from my recent articles
here. There is still a lot of bad medical science and misinformation out there
that needs dealing with. But I couldn’t let this one pass.

As David predicted not too long ago, RFK Jr., the Secretary of Health and Human 
Services, has pulled $500 million in federal funding from research to develop
mRNA vaccines for respiratory viruses. His justification for this move is
straight-up misinformation. It is a reckless act that is highly likely to cost
American lives down the road, although it will be impossible to tally exactly
how many.

Kennedy claims that “mRNA technology poses more risks than benefits for these
respiratory viruses”. He also said that his team, “reviewed the science,
listened to the experts, and acted.” Translation – his clown car of anti-vaxxers
reached a predetermined anti-vaccine decision and will now try to justify it
with misinformation.

For review, mRNA technology uses messenger RNA, which incorporates into the
muscle cells, to produce viral proteins which elicit an immune response. In
other words, instead of injecting the proteins, you inject the RNA code to
produce the proteins. One of the main advantages of mRNA vaccines is that this
platform can develop new vaccines and track strains very quickly, which is part 
of the reason why we were able to to quickly develop COVID-19 vaccines. mRNA
vaccine so far have proven very safe and effective.

Kennedy’s claim that they pose “more risk than benefit” is a very specific
empirical medical claim. This is not a matter of judgement or opinion, but
rather of data and math. It is also provably wrong. The most comprehensive
review we have to date looked at 99 million doses of mRNA COVID-19 vaccine
internationally and found that the benefits far outweigh the risks. The study
really just confirmed what previous research had also found.

Kennedy also said, “To replace the troubled mRNA programs, we’re prioritizing
the development of safer, broader vaccine strategies, like whole-virus vaccines 
and novel platforms that don’t collapse when viruses mutate.” This is the line
he is taking – there are better vaccines. Specifically he says he wants a
universal vaccine which, “It could be effective — we believe it’s going to be
effective — against not only coronaviruses, but also flu.”

Researchers have been working on a universal flu vaccine for decades. This is
still a worthy line of research, and such a vaccine would be highly useful. But 
this has proven to be a tough nut to crack. Yet Kennedy is confident for not
only a universal flu vaccine but one that also covers coronaviruses. So he wants
to kill a proven and extremely promising technology that is only getting
better, with clear advantages, for a unicorn. A cynical person might wonder if
he is trying to divert attention to a low probability goal so he can continue to
pretend to be pro-vaccine while scuttling vaccine research. Or maybe he is just
the idiot that everyone thought he was.

Kennedy further claims that mRNA vaccines don’t track variants and lead to
mutations which causes the vaccine’s efficacy to “collapse”. No current vaccines
track variants. You have to develop new versions targeting the new variants.
Here the mRNA platform is an advantage because developing new versions is much
quicker than other vaccine platforms.

The mRNA vaccines do not cause the virus to mutate – they do that all on their
own, even without vaccination. What causes new variants to arise more quickly is
allowing a virus to spread uninhibited throughout a population – the more it
replicates, the more opportunities there are for new mutations. Widespread
vaccination therefore decreases new mutations and variants.

Also, efficacy does not just “collapse” – it slowly fades away as new variants
get farther and farther away genetically from the variant the vaccine is based
on. With the flu, there are also pre-existing variants that wax and wane over
different flu seasons. And again this is not different for any vaccine platform 
– unless you have a universal vaccine, which we don’t have for these respiratory
viruses.

Put simply, Kennedy is simply wrong here. He is making decisions based
(charitably) on his overconfidence misunderstanding of science, and he appears
to only be listening to the voices that already agree with him. Meanwhile,
actual experts are horrified at this move:

“I don’t think I’ve seen a more dangerous decision in public health in my 50
years in the business,” said Mike Osterholm, a University of Minnesota expert on
infectious diseases and pandemic preparations.

Does RFK Jr. have the authority to cut this funding? Yes, unfortunately.
Congress appropriates the funds, but the executive branch can direct it to
specific priorities. However, congress still has the power to act. The simplest 
way would be to pass new legislation which specifically restores the funding. I 
don’t see this as very likely to happen – but perhaps if there is sufficient
outrage from the public (write your congressman and senators) something might
happen. I’m not holding my breath.


“Make America Healthy Again”: The new Lysenkoism

Trofim Lysenko was a Soviet scientist whose dogmatic science denialism led to
mass famine when his ideas were applied to agriculture. Robert F. Kennedy Jr. is
a lot like Lysenko in his science denial. Will his results be as disastrous?

David Gorski on March 31, 2025

Link

Trofim Lysenko (1898-1976).

I’ve been thinking about Trofim Lysenko (1898–1976) a lot, ever since it was
announced that longtime antivaccine activist Robert F. Kennedy Jr. had been
nominated to become Secretary of Health and Human Services. Many regular readers
will know why if they are familiar with Lysenkoism, the disastrous political
campaign led by Lysenko against science-based agriculture based on Lysenko’s
rejection of Mendelian genetics in favor of Lamarckism (more on that later). In 
brief, during his time as Josef Stalin’s favorite scientist, Lysenko and his
version of biology that came to be known as Lysenkoism led to the persecution of
biologists who stuck to science-based views regarding agriculture that
conflicted with Lysenko’s, up to and including imprisonment and, even in some
cases, execution. Worse, his ideas applied to Soviet Agriculture led to crop
shortfalls and worsened famines, to the point where Although no one has been
imprisoned or executed yet, under the reign of President Donald Trump and HHS
Secretary RFK Jr., the suppression of politically incorrect science and purges
of the ideologically impure or suspect have already begun, most recently Peter
Marks, the FDA’s Director of the Center for Biologics Evaluation and Research
(CBER), who was forced to resign last week:

Dr. Peter Marks, the Food and Drug Administration’s top vaccine regulator, has
resigned, an official at the Department of Health and Human Services said
Friday.

“If Peter Marks does not want to get behind restoring science to its golden
standard and promoting radical transparency, then he has no place at FDA under
the strong leadership of Secretary Kennedy,” a spokesperson at HHS said.

A person familiar with the matter told NBC News that Marks was forced out of his
position.

No doubt. After all, remember that RFK Jr. promised purges of the CDC, FDA, and 
NIH even back when he was running for President as an independent, long before
he bent the knee to Donald Trump in return for a prominent role in shaping the
Trump administration’s health policies, which unfortunately is turning out to be
as HHS Secretary. Now he’s delivering. Marks isn’t the first, and he’s far from
the last. Why, however, did his resignation lead me to think of Lysenko more
than ever? You have to read his resignation letter, which basically lays it out 
way more bluntly than the typical resignation letter does.

Peter Marks' departure is a significant moment for FDA’s biologics division. His
leadership and contributions will be deeply missed in the field.

— Lukas Jäger-Meister (@OncoAdvLukas) March 29, 2025

Although Marks doesn’t explicitly say it, RFK Jr. is the new Lysenko in that,
with him, ideology trumps science every time. It’s especially ironic given that 
Marks held that role during 2020 and was largely responsible for Operation Warp 
Speed, the accelerated effort that led to the development of COVID-19 mRNA
vaccines:

Early in the pandemic, Marks, the director of the Food and Drug Administration’s
Center for Biologics Evaluation and Research, took the highly unusual step of
engaging with multiple drug manufacturers—companies that are typically
competitors—to discuss what would be needed for a successful vaccine to receive 
an emergency use authorization.

Marks recognized that the drug companies’ proposed timeframes were faster than
any previous vaccine development, but “still completely inadequate to meet the
exploding public health need,” said Dr. Cynthia Dunbar, a research scientist at 
the National Institutes of Health’s National Heart, Lung and Blood Institute.

“By the time we landed in April of 2020, it was clear we were going to need some
heroic effort,” Marks said. “Every month we could shave off development could
save a lot of lives.”

An avid “Star Trek” fan, Marks called this initiative Operation Warp Speed
because the scale of the effort seemed so “improbable and difficult” as to be
almost like science fiction, Dunbar said.

The project represented an unprecedented collaboration between government and
the private sector to vaccinate the people of this country as quicky and safely 
as possible. The task became more urgent as millions were getting sick and tens 
of thousands were dying from the coronavirus across the nation. Now, more than a
year later, thanks in large part to Marks’ efforts toward the onset of the
pandemic, U.S. vaccination rates are faster than almost any other country in the
world and confidence in the vaccines’ safety and efficacy remains high.

Truth be told, I never realized that Marks had come up with the name “Operation 
Warp Speed.” That was probably his biggest mistake, because to a lot of people
the name implied that speed trumped everything else, including safety and
efficacy, making it easy to weaponize against the vaccines, even though the FDA,
if anything, resisted pressure from the first Trump Administration—remember who
was in charge during most of the first year of the pandemic!—to approve the
vaccines faster:

After standing up Operation Warp Speed, Marks returned to his full-time role
overseeing the FDA’s approval process for vaccines and biologics. He believed
this process would not only help the country produce and administer vaccines
more quickly, but also inspire public confidence that any vaccines approved were
safe and effective. He also wanted to make sure that the FDA based its
decisions on science, not politics.

“He just kept making it clear that he could not be persuaded, influenced,
shamed, guilted or threatened into acting in any way other than where the
science led him,” [Arthur] Caplan said.

[…]

“That was extremely unpopular at the White House at the time, but it was the
right thing to do,” [Francis] Collins said. “And he withstood a great deal of
criticism and pressure.”

Of course, now that RFK Jr. and his “make America healthy again” (MAHA) ideology
rule HHS, there is no room left for someone who follows the science wherever it
goes. I’m not saying that everything Marks did was perfect. It was a crisis
situation, and at the very least the name for the effort was problematic in
terms of messaging. However, now an antivaxxer is in charge, and, make no
mistake, RFK Jr. is not a “vaccine critic” or a “vaccine skeptic.” He is
antivaccine.

First, let’s take a look at Marks’ resignation letter and why it led me to think
of Lysenko more than ever. Then I’ll take a look at what’s happening in the
rest of HHS, including the NIH, CDC, and FDA that reinforces my conclusion that 
RFK Jr. is the new Lysenko, even though he isn’t even a scientist.

Marks vs. Kennedy

Marks is quite blunt about why he is resigning. After touting his successes in
improving the safety of the blood supply, he mentions the rapid development of a
vaccine for COVID-19, noting:

In the last of these, during the COVID-19 pandemic I had the privilege of
watching the vision that I conceived for Operation Warp Speed in March 2020 in
collaboration with Dr. Robert Kadlec become a reality under the leadership of
HHS Secretary Azar and President Trump due to the unwavering commitment of
public servants at FDA and elsewhere across the government. At FDA, the tireless
efforts of staff across the agency resulted in remarkably expediting the
development of vaccines against the virus, meeting the standards for quality,
safety, and effectiveness expected by the American public. The vaccines
undoubtedly markedly reduced morbidity and mortality from COVID- 19 in the
United States and elsewhere.

Basically, Marks’ crediting President Trump as a strong collaborator for
Operation Warp Speed is ice cold, particularly while also pointing out how the
FDA had made sure that the vaccines met expected standards for safety and
efficacy. Here, however, is the money quote:

Over the past 13 years I have done my best to ensure that we efficiently and
effectively applied the best available science to benefit public health. As you 
are aware, I was willing to work to address the Secretary’s concerns regarding
vaccine safety and transparency by hearing from the public and implementing a
variety of different public meetings and engagements with the National Academy
of Sciences, Engineering, and Medicine. However, it has become clear that truth 
and transparency are not desired by the Secretary, but rather he wishes
subservient confirmation of his misinformation and lies.

Having followed and written about RFK Jr. for nearly 20 years, I am hard-pressed
to come up with a better concise description of his approach to vaccines and
science. Like Trofim Lysenko, RFK Jr. is an ideologue whose “science” flows from
his preconceived notions about vaccines, public health, and chronic illness.
Like Lysenko, RFK Jr. is not swayed by evidence, science, or reason. After all, 
many have tried to persuade him that vaccines do not cause autism using
scientific evidence, and he still fervently believes it.

Let’s take a break for a little history lesson, shall we?

Trofim Lysenko: What happens when an ideological scientific crank becomes very
powerful

Before I come back to RFK Jr. and his parallels with Lysenko, I would like Ethan
Siegel describes how Lysenko burst onto the Soviet scientific scene in the late
1920s thusly:

Lysenko’s work on vernalization was transformative for Soviet agriculture.
Normally, most crops that are successful in Russia-like climates require the
signal of a cold, long winter coming to an end to begin flowering. However,
Lysenko (correctly) realized that one could artificially induce those
conditions, triggering the crops to flower even in the absence of a cold, long
winter. This advance, known as vernalization, offered the promise of
dramatically improving the crop yields of the entire country. His publication
from way back in 1928 catapulted him to fame, prominence, and political power
within the USSR.

However, there was a problem: while Lysenko’s method worked for a couple of
particular crops, that same method didn’t universally apply to all crops, as
many in the USSR hoped it would. In fact, as other scientists quickly showed,
Lysenko’s papers contained flaws in both his ideas and his reasoning, rendering 
his conclusions suspect. Although he did experience some mild success with
vernalizing two crops specifically — peas and wheat — his ideas behind why these
plants were yielding successful crops were wrongheaded, and demonstrably so.

Lysenko rejected Mendelian genetics on ideological grounds, and developed his
own wild ideas that were interesting, compelling, profound, and also entirely
incorrect. He claimed that organisms within a species, such as the same crop of 
plant, would instinctively work together for the good of the collective
population; an ideology in line with communist propaganda, but at odds with
genetics. His rejection of Darwinism was again ideologically based, not
scientifically, and he admitted as much, stating:

“Even when Darwin’s teaching first made its appearance, it became clear at once 
that its scientific, materialist core, its teaching concerning the evolution of 
living nature, was antagonistic to the idealism that reigned in biology.”

That last quote made me chuckle. Funny how conservative Christian creationists
and die-hard Communists can somehow sound very much alike. After all,
creationists often rail against what they see as the “materialism” at the core
of evolutionary biology. In any event, Lysenko’s initial successful results,
which soon became suspect, led him to spearhead a campaign to reject Mendelian
genetics in favor of a pseudoscientific hypothesis of environmentally induced
heredity. This campaign lasted from the late 1920s into the early 1960s and
Lysenko’s ideas about genetics and heredity came to be known as Lysenkoism.

In essence, Lysenkoism is warmed-over Larmackism, or soft inheritance, a concept
named after French biologist Jean-Baptiste Lamarck (1744-1829), who championed 
the hypothesis that notion that an organism can pass on to its offspring
physical characteristics that the parent organism had acquired through use or
disuse during its lifetime. The classic example often taught in high school
biology class is that of the giraffe, whose long neck, Lamarckism postulates,
came about through successive generations of giraffes ancestors stretching their
necks to reach the leaves on ever-higher branches of trees. In contrast,
according to Darwinian evolution, a wide variety of neck lengths originally
existed in a population of giraffe ancestors, and then a food scarcity at low
elevations selected against the short necked giraffes, leaving only the giraffes
with the genes for long necks as the survivors.

Lysenko’s ideas were explicitly based on Marxist doctrine:

Officials eventually put Lysenko in charge of Soviet agriculture in the 1930s.
The only problem was, he had batty scientific ideas. In particular, he loathed
genetics. Although a young field, genetics advanced rapidly in the 1910s and
1920s; the first Nobel Prize for work in genetics was awarded in 1933. And
especially in that era, genetics emphasized fixed traits: Plants and animals
have stable characteristics, encoded as genes, which they pass down to their
children. Although nominally a biologist, Lysenko considered such ideas
reactionary and evil, since he saw them as reinforcing the status quo and
denying all capacity for change. (He in fact denied that genes existed.)

Instead, as the journalist Jasper Becker has described in the book Hungry
Ghosts, Lysenko promoted the Marxist idea that the environment alone shapes
plants and animals. Put them in the proper setting and expose them to the right 
stimuli, he declared, and you can remake them to an almost infinite degree.

Based on his ideas, Lysenko proposed that he could “educate” Soviet crops to
sprout at different times of the year by soaking them in freezing water and
using other interventions, going on to claim that future generations of the
crops would then remember these cues and inherit the beneficial traits. He had a
number of other crackpot ideas as well. For example, in addition to claiming
that plants could pass on traits acquired during life to their offspring,
Lysenko denied the existence of DNA and genes and claimed that plants selected
their mates. He also espoused the idea that some plants choose to sacrifice
themselves for the good of the remaining plants. Based on these Ideas, Lysenko
believed he could revolutionize Soviet agriculture, boosting crop yields and
boost crop yields and transforming the empty Russian interior into vast farms.
The result was catastrophic:

Such claims were exactly what Soviet leaders wanted to hear. In the late 1920s
and early 1930s Joseph Stalin—with Lysenko’s backing—had instituted a
catastrophic scheme to “modernize” Soviet agriculture, forcing millions of
people to join collective, state-run farms. Widespread crop failure and famine
resulted. Stalin refused to change course, however, and ordered Lysenko to
remedy the disaster with methods based on his radical new ideas. Lysenko forced 
farmers to plant seeds very close together, for instance, since according to his
“law of the life of species,” plants from the same “class” never compete with
one another. He also forbade all use of fertilizers and pesticides.

Wheat, rye, potatoes, beets—most everything grown according to Lysenko’s methods
died or rotted, says Hungry Ghosts. Stalin still deserves the bulk of the blame
for the famines, which killed at least 7 million people, but Lysenko’s
practices prolonged and exacerbated the food shortages. (Deaths from the famines
peaked around 1932 to 1933, but four years later, after a 163-fold increase in 
farmland cultivated using Lysenko’s methods, food production was actually lower 
than before.) The Soviet Union’s allies suffered under Lysenkoism, too.
Communist China adopted his methods in the late 1950s and endured even bigger
famines. Peasants were reduced to eating tree bark and bird droppings and the
occasional family member. At least 30 million died of starvation.

Does Stalin’s backing of Lysenko remind you of anything, such as Trump’s backing
of RFK Jr.? Lysenko, having Stalin behind him, was also quite ruthless about
getting rid of critics and competition:

Unable to silence Western critics, Lysenko still tried to eliminate all dissent 
within the Soviet Union. Scientists who refused to renounce genetics found
themselves at the mercy of the secret police. The lucky ones simply got
dismissed from their posts and were left destitute. Hundreds if not thousands of
others were rounded up and dumped into prisons or psychiatric hospitals.
Several got sentenced to death as enemies of the state or, fittingly, starved in
their jail cells (most notably the botanist Nikolai Vavilov). Before the 1930s,
the Soviet Union had arguably the best genetics community in the world. Lysenko
gutted it, and by some accounts set Russian biology back a half-century.

Nikolai Vavilov, by the way, was a true scientific pioneer. By the late 1920s,
as director of the Lenin All-Union Academy of Agricultural Sciences, Vavilov had
amassed the largest seed collection in the world. He worked hard, he enjoyed
himself, and drove other eager young scientists to work just as hard to make
more food for the people of the Soviet Union. As plant biologists Ian Godwin and
Yuri Trusov put it in 2017, Vasilov “worked hard, he enjoyed himself, and drove
other eager young scientists to work just as hard to make more food for the
people of the Soviet Union.” They also note:

The Lysenko vs Vavilov/Mendel/Darwin argument came to a head in 1936 at the
Conference of the Lenin Academy when Lysenko presented his “-ism”.

In the face of scientific opinion, and the overwhelming majority of his peers,
Pravda declared Lysenko the winner of the argument. By 1939, after quite a few
scientists had been imprisoned, shot or “disappeared”, including the director of
the Lenin Institute, there was a vacancy to be filled. And the most powerful
man in the country filled it with Trofim Lysenko. Lysenko was now Vavilov’s
boss.

Within a year, Vavilov was captured on one of his collection missions and
interrogated for 11 months. He was accused of being a spy, having travelled to
England and the United States, and been a regular correspondent with many
geneticists outside the Soviet Union.

It did not help his cause that he came from a family of business people, whereas
Lysenko was of peasant stock and a Soviet ideologue. Vavilov was sent to a
gulag where, tragically, he died in 1943.

The embrace of Lysenkoism in the Soviet Union also destroyed what had been one
of the best genetics research programs in the world in the 1920s:

   Examples of the false claims put forth under Lysenko are numerous and
   extraordinary. They include:

  1. The false claim that rye could transform into wheat and that wheat could
    transform into barley, even though they cannot.

  2. The false claim that weeds can transmute into food grains, even though they
    are distinct organisms.

  3. The false claim that nature always exhibits natural cooperation between
    different species, even though competition and natural selection are most
    commonly observed instead.

   From the late 1920s, when Lysenkoism was first adopted, until the death of
   Stalin in 1953, scientific research into genetics suffered a decades-long
   stagnation in the Soviet Union. During those 25 years, from 1928-1953, more
   than 3000 mainstream biologists were removed from their scientific and/or
   academic positions. Moreover, many were sent to the gulags and a number of
   them were even executed.

   Why? Because all of these decisions were part of a campaign, orchestrated by 
   Lysenko himself, to suppress those who opposed him. If opposition happened to
   come from mainstream biologists who were actually conducting scrupulous work
   whose conclusions were unpalatable to him, so be it.

One also notes that, even after Stalin’s death, it took nearly a decade to
discredit Lysenko and Lysenkoism sufficiently that it fell from favor. Indeed,
Stalin’s successor as ruler of the Soviet Union, Nikita Khrushchev, for a time
fell under Lysenko’s spell, and the Great Chinese Famine that resulted in part
from the adoption of Lysenko’s methods occurred from 1959-1961. In fact, it
arguably took until the 1990s before Soviet science and genetics had truly
purged themselves of Lysenko’s influence, even though Lysenko died in 1976.

On the other hand, there was recently an attempt to rehabilitate Lysenko’s
reputation. Can you guess the basis of this attempt to “rethink” Lysenko? Yes,
it’s the rise of epigenetics, the science that shows that there are acquired
characteristics that can be inherited through the epigenetic alteration of DNA. 
(Unsurprisingly, quacks love to invoke epigenetics to justify their woo, and in 
their hands it might as well be magic.) Of course, one can’t help but note that 
Lysenko claimed that genes didn’t exist, while epigenetics take genes as a
given. They are, after all, what is being turned on or off by the epigenetic
modifications. Moreover, while epigenetic changes can occasionally pass from
parent to child, the changes always disappear after a few generations. Unlike
Lysenko’s claims, the changes are not permanent.

Ironically, although biologists who opposed Lysenko routinely lost their jobs,
were imprisoned, or “disappeared,” some opponents of Lysenkoism during Stalin’s 
lifetime escaped this fate, namely members of the small community of Soviet
nuclear physicists. According to Tony Judt, “it is significant that Stalin left 
his nuclear physicists alone and never presumed to second guess their
calculations. Stalin may well have been mad but he was not stupid.”

As I said, no one has been sent to prison…yet. Nor has anyone been executed…yet.
I would also point out that the lack of scientists being sent to prison or
executed is not due to a lack of desire among some parts of the MAHA movement.
Remember “Nuremberg 2.0“?

Yet, as I have said, the purges are well underway. They come in two forms.
First, there is a purge of science that does not conform to the new
administration’s ideology; second, there is a purge of personnel.

RFK Jr. and Donald Trump: Lysenko and Stalin revisited?

Steve Novella and I have both written about one example of ideology overriding
science with respect to vaccines; specifically the appointment of David Geier to
be in charge of a study examining vaccine safety in general and the question of
whether vaccines cause autism in particular. As an aside, I wondered why RFK
Jr. didn’t choose David’s father Mark Geier, who was the brains behind the
father-son team and also an actual physician, to do the study, but it turns out 
that Mark Geier had died on March 20 at the age of 76. In any event, as both of 
us have pointed out, David Geier has no skills that make him remotely qualified 
to carry out such a study; indeed, he and his father were notorious for their
“Lupron protocol,” in which they misdiagnosed autistic children with precocious 
puberty and then treated them with a powerful puberty blocking drug, Lupron, to 
lower testosterone levels, the rationale being that testosterone binds mercury
and makes it easier for chelation therapy to eliminate it. One characteristic
that David Geier does share with Lysenko’s acolytes, whom he hired to work on
Soviet agriculture, though: He believes in the antivax ideology and lacks
anything resembling competence in science.

The most obvious and dramatic examples of the purges going on at HHS, however,
are occurring at the NIH, where hundreds of research grants are being summarily 
canceled without warning because they do not “further administration aims.” For 
example, last week the NIH began canceling grants studying COVID-19 because “the
pandemic is over.” I kid you not:

The White House appears to have a new target for its cuts to research funding:
Grants linked to COVID-19, which President Donald Trump and his appointees have 
decided are a waste of money because the pandemic is over.

Science has learned that grant termination letters went out last night to
principal investigators of 29 awards made by the National Institute of Allergy
and Infectious Diseases (NIAID), including nine grants that were part of a
program hoping to deliver antiviral drugs to prevent future pandemics. “The end 
of the pandemic provides cause to terminate COVID-related grant funds,” the
notification states. “These grant funds were issued for a limited purpose: to
ameliorate the effects of the pandemic. Now that the pandemic is over, the grant
funds are no longer necessary.”

Oh, and researchers whose research is being defunded are “encouraged” not to
fight the decision:

According to the grant termination letter Rice and colleagues received, the
researchers were told they could appeal but were discouraged from trying to
fight the termination. “Although ‘[the National Institutes of Health] generally 
will suspend (rather than immediately terminate) a grant and allow the recipient
an opportunity to take appropriate corrective action before NIH makes a
termination decision,’ no corrective action is possible here,” the termination
notice said. “The premise of this award is incompatible with agency priorities, 
and no modification of the project could align the project with agency
priorities.”

These terminations come complete with updated guidance. Let’s just say that
COVID-19 research is not the only “forbidden science” under RFK Jr. and Donald
Trump:

The updated documents that Nature obtained (see Supplementary Information below)
were sent on 25 March to ‘grants-management specialists’ — NIH staff members
who oversee the business side of awarding funding. This document includes
COVID-19 on a list of “research activities that NIH no longer supports”, in
addition to research on China, DEI, “transgender issues” and vaccine hesitancy. 
The latest guidance also says that grants related to South Africa and climate
change should be terminated.

The document also outlines a new category of research thatshould be terminated: 
any project on a list sent by the NIH director or the HHS, which is currently
helmed by long-time anti-vaccine advocate Robert F. Kennedy Jr.

Also, the NIH is terminating grants to study long COVID (although some have been
restored). It has also been suggested that soon research involving fetal cell
lines will be defunded, as have research into preventing HIV/AIDS; managing
depressive symptoms in transgender, nonbinary and gender-diverse patients;
intimate partner violence during pregnancy; and how cancer affects impoverished 
Americans.

I’ve been a researcher since the early 1990s and a principal investigator with a
laboratory since 1999. Although I’ve never been a permanent study section
member, I have served as an ad hoc member on a number of NIH study sections over
the years. I can assure you, nothing like this has ever happened before going
back as long as I can remember. I’ve asked colleagues even more senior than I
am, and they assure me that nothing like this has ever happened during their
careers either. Never has the NIH suddenly canceled such a large number of
grants. Indeed, the NIH rarely cancels grants, and then usually only for
malfeasance, such as misappropriation of funds or scientific fraud, and then
only after an extensive investigation. What is happening here is that grants
that have, in essence, “banned words” in their titles, abstracts, or other
documents are being targeted for cancelation. Indeed, RFK Jr., also appears to
be coming for any grants funding research into new vaccines or therapies using
mRNA technology:

The NIH confirmed in a statement to the Guardian that it made a “data call” to
learn more information about the funding of mRNA vaccine grants. Nature, the
scientific journal, first reported the data call, and said it had been conducted
by the acting NIH director, Matthew Memoli, on 6 March. Scientists were given
one day to report the information, and NIH collected information about 130 mRNA 
grants as a result.

Many of the scientists, public health experts and medical researchers
interviewed by the Guardian spoke on the condition of anonymity, fearing that
they might be targeted if they expressed concerns publicly.

One former senior NIH official who resigned recently said what was happening
inside the organization was “not understandable”.

“So far, any attempt at reasoning with people has fallen on deaf ears.
Everything is being run by the department [Department of Health and Human
Services] or the White House,” the person said. KFF Health News separately
reported that all grants involving mRNA research were to be reported to Memoli, 
for referral to the office of the health secretary, Robert F Kennedy Jr, and the
White House.

Yes, it sounds as though RFK Jr. is going to personally review every mRNA grant 
and decide whether its funding should continue. As a result, surprising no one, 
scientists are frightened and intimidated. They’re also looking for anyway they 
can to game the system and avoid scrutiny by avoiding any words that might
trigger an ideology-based review. Basically, what is happening at HHS under RFK 
Jr. is that the NIH is no longer basing its funding decisions solely on
scientific merit; rather, it’s imposing the broadest ideological test to
prescreen grant applications and reject those that do not align with RFK Jr.’s
ideology. Lysenko must be smiling. The incompetence is also amazing, as
evidenced by one researcher who was funded by the NIH to study whether the
shingles vaccine could reawaken the virus in the eye whose grant was terminated.
She found that it could. This is exactly the sort of research that RFK Jr. says
that he wants, but because the grant got flagged, likely because it was about
vaccines.

Meanwhile, scientists working on such projects are finding themselves
unemployed:

What really makes Acharya sad is the effect of the funding cuts on her
colleagues.

“I can’t save them,” she said. “I’m trying to call people and try to get jobs
for them. I’m trying to set up interviews and stuff, but it’s really hard.”

Universities have lost so much federal research funding that many are coping
with their own grant cancellations and doing their own belt-tightening. There’s 
a hiring freeze at UCSF.

“It’s not these people’s fault that they ended up being in a research group that
was good, it was so promising, and their careers would have been made, and now 
it’s gone, and they’re gonna be out of a job,” she said.

Which, I suspect, is the point. RFK Jr. wants to force scientists into not
studying what he doesn’t want them to study and into studying what he does. Very
Lysenkoist of him!

Then, of course, RFK Jr. is planning on purging 25% of HHS employees across all 
agencies, to go from 82,000 employees to 62,000, including:

  1. 3,500 jobs at the FDA, which inspects and sets safety standards for
    medications, medical devices and foods.

  2. 2,400 jobs at the CDC, which monitors for infectious disease outbreaks and
    works with public health agencies nationwide.

  3. 1,200 jobs at the NIH, the world’s leading public health research arm.

  4. 300 jobs at CMS, which oversees the Affordable Care Act marketplace, Medicare 
    and Medicaid.

Moreover, like any authoritarian regime, its pettiness knows no bounds. The new 
administration has even removed a mural at the NIH featuring Dr. Anthony Fauci
making an inspirational statement, ““Science is telling us that we can do
phenomenal things if we put our minds and our resources to it.” Rep. Jamie
Raskin called it just right, too: “This is the kind of treatment that scientists
get in totalitarian societies like Stalinist Russia if they don’t toe the
political line of the leaders.” Indeed, there are echoes of Lysenko in the
termination letters, which frequently say things like: the researcher’s project 
is “antithetical to scientific inquiry” and “harms the health of Americans.”
Like Lysenko, RFK Jr. is claiming the mantle of science as he attacks, purges,
and defunds actual science.

Moreover, Trump and RFK Jr.’s lackey Jay Bhattacharya, who has just taken over
as NIH Director, seems down with the whole purge. One of his first acts upon
taking over the NIH was to instruct his staff to compile a list of grants and
contracts related to “fighting misinformation or disinformation.” This has been 
the first step under this administration in identifying grants that they want to
terminate.

That’s not all, either. HHS is suppressing any results that RFK Jr. might not
like:

Leaders at the Centers for Disease Control and Prevention ordered staff this
week not to release their experts’ assessment that found the risk of catching
measles is high in areas near outbreaks where vaccination rates are lagging,
according to internal records reviewed by ProPublica.

In an aborted plan to roll out the news, the agency would have emphasized the
importance of vaccinating people against the highly contagious and potentially
deadly disease that has spread to 19 states, the records show.

The bureaucratese tells me that RFK Jr. was almost certainly behind this:

When asked what role, if any, Kennedy played in the decision to not release the 
risk assessment, HHS’ communications director said the aborted announcement “was
part of an ongoing process to improve communication processes — nothing more,
nothing less.” The CDC, he reiterated, continues to recommend vaccination “as
the best way to protect against measles.”

This is about the most mundane observation and recommendation I can imagine, but
since it involves vaccinating people at risk for measles, RFK Jr. doesn’t like 
it. Such is the new “science” at HHS.

Are we witnessing the destruction of science in the US?

Obviously, as those of you who have been paying attention to the news—perhaps
even closer attention to the news than I—know, I’ve barely scratched the surface
here. I haven’t even discussed the Trump administration’s attempt to slash
indirect costs on NIH grants here, mainly because I discussed it in depth when
it first happened. Similarly, I haven’t discussed the reorganizations of huge
swaths of HHS being proposed, such as the creation of a new Administration for a
Healthy America, which will “consolidate the OASH, HRSA, SAMHSA, ATSDR, and
NIOSH, so as to more efficiently coordinate chronic care and disease prevention 
programs and harmonize health resources to low-income Americans. Divisions of
AHA include Primary Care, Maternal and Child Health, Mental Health,
Environmental Health, HIV/AIDS, and Workforce, with support of the U.S. Surgeon 
General and Policy team.” (These acronyms stand for Office of the Assistant
Secretary of Health, the Health Resource and Services Administration, Substance 
Abuse and Mental Services Administration, Agency for Toxic Substances and
Disease Registry, and the National Institute for Occupational Safety.)

On the surface, this wouldn’t necessarily sound so bad were it not for the
massive cuts in personnel and that the cuts will only save $1.8 billion out of a
total HHS budget of $2 trillion. Just this weekend, the news broke that RFK Jr.
had terminated the entire Office of Infectious Disease and HIV/AIDS Policy,
whose stated mission of the OIDP is “to provide strategic leadership and
management, while encouraging collaboration, coordination, and innovation among 
federal agencies and stakeholders to reduce the burden of infectious diseases.” 
This includes implementing various national plans to prevent and control
infectious diseases. For example, there’s the National HIV/AIDS Strategy,
Vaccines National Strategic Plan, Viral Hepatitis National Strategic Plan and
the Sexually Transmitted Infections National Strategic Plan. The OIDP also
directs different initiatives, such as initiatives to end the HIV epidemic in
the U.S., prevent healthcare-associated infections and control tick-borne
diseases.

Basically, any government entity dealing with acute diseases caused by
infectious agents (plus HIV/AIDS, which is a chronic disease that, untreated,
takes years to kill) seems to be in RFK Jr.’s crosshairs because of his
Lysenko-like ideological belief that chronic disease is all that matters. In a
rambling video describing the reorganization, RFK Jr. alternated between
praising his employees and blaming them for harming America’s health:

I love how he mentions how low the US ranks in terms of various health measures 
compared to other wealthy industrialized countries and, instead of blaming it on
lack of universal health insurance (which a major contributor), he blames it on
the “sprawling bureaucracy” of HHS. Meanwhile, just two months into President
Trump’s term and less than a month into RFK Jr.’s reign as HHS Secretary, morale
among biomedical scientists in the US is rock-bottom, as evidenced by this
survey by Nature:

The massive changes in US research brought about by the new administration of
President Donald Trump are causing many scientists in the country to rethink
their lives and careers. More than 1,200 scientists who responded to a Nature
poll — three-quarters of the total respondents — are considering leaving the
United States following the disruptions prompted by Trump. Europe and Canada
were among the top choices for relocation.

The trend was particularly pronounced among early-career researchers. Of the 690
postgraduate researchers who responded, 548 were considering leaving; 255 of
340 PhD students said the same.

I realize that this was not a scientific poll, but it echoes sentiment that I’m 
hearing. I also can’t blame any of the respondents who are thinking of leaving
for thinking that way. I’d be lying if I said that I hadn’t had similar
thoughts. Unfortunately, I’m too close to retirement and basically tied to my
current location by family obligations. I am, however considering giving up
research and going all clinical, given that the director of the NIH knows my
name and thinks I’m a “threat to science.” It’s that bad out there.

Lysenkoism destroyed genetics as a science in the Soviet Union for several
decades. The USSR went from a nation with a top-flight research program in the
then-new science of genetics to a laughingstock has-been, in the process letting
many more of its own people die of famine than had to, all because Stalin liked
Lysenko’s ideas because they were based on Marxist ideology and tried to make
science conform to that ideology. The problem, of course, is that science
doesn’t care what your ideology is, and it will be no different for RFK Jr. New 
pathogens will arise. Diseases once under control will reemerge if vaccine
uptake plummets. There will be more unsafe drugs and medical devices if there
are fewer scientists to evaluate them.

In fact, RFK Jr. scares me more than Lysenko. Lysenko limited his pseudoscience 
and suppression of science mainly to genetics and agriculture. RFK Jr. is not so
limited. His pseudoscience, science denialism, and conspiracy theories
encompass all areas of medicine, health, and public health. Lysenko’s grip on
Soviet science arguably killed millions. How many will die as a result of RFK
Jr. as HHS Secretary? It’s impossible to predict now, but I shudder to think
about it. My guess is that the toll will be huge.


Lysenkoism 2.0 and the dismantling of the NIH

Robert F. Kennedy Jr.’s “make America healthy again” is basically Lysenko 2.0.
It’s come to the NIH and is destroying the crown jewel of US biomedical research
with ideology and cronyism.

David Gorski on May 12, 2025

Link

There’s an old adage or curse that comes to mind nearly every day since Donald
Trump won the 2024 Presidential election. Hard as it is to believe, it’s been
less than four months since Trump was inaugurated, and nearly every day since
then has greeted me with new assaults on the federal infrastructure overseeing
biomedical science, medicine, and public health. It’s an assault that began
before longtime antivax activist Robert F. Kennedy Jr. was nominated to be
Secretary of the Department of Health and Human Services but has only
accelerated massively since then. Last week, the main themes with respect to
medicine were the worsening damage done to the National Institutes of Health,
Food and Drug Administration, Centers for Disease Control and Prevention, and
public health through the lens of a disastrous interview with the new NIH
Director (and Great Barrington Declaration co-author) Dr. Jay Bhattacharya, the 
appointment of hostile anti-mask antivax methodolatrist Dr. Vinay Prasad to
replace Dr. Peter Marks as head of the FDA’s Center for Biologics Evaluation and
Research (CBER), which oversees vaccines and blood products as well as gene and
cell therapy products, and the appointment of RFK Jr. friend and “make America 
healthy again” (MAHA) booster Dr. Casey Means. That made it a difficult decision
what to discuss. In the end, I thought that what’s going on at the is most
emblematic of the damage MAHA is doing to federal medicine, public health, and
biomedical research programs. It all hangs together, but the assault on the NIH,
perhaps more than anything else, demonstrates the practical effect of what I
called the “new Lysenkoism” inherent in MAHA will have on US science.

Trofim Lysenko (1898-1976).

I wrote about the new Lysenkoism of MAHA over a month ago. If you want to go
into detail, you can read my previous post, but I’ll lay down the CliffsNotes
version. Trofim Lysenko was a Soviet scientist with a number of pseudoscientific
views, most prominent of which was his embrace of a form of warmed-over
Larmackism, or “soft inheritance,” a concept named after French biologist
Jean-Baptiste Lamarck (1744-1829), who championed the hypothesis that notion
that an organism can pass on to its offspring physical characteristics that the 
parent organism had acquired through use or disuse during its lifetime, instead 
of Mendelian genetics, in which inheritance is passed from parents to offspring 
by genes. Because Josef Stalin found Lysenko’s ideas attractive, Lysenko became 
more and more influential in Soviet agriculture, to the point where agricultural
scientists who went against him could find themselves out of a job, sent to the
gulags, or even killed. His views of agricultural science dominated the Soviet 
Union for more than three decades, from the late 1920s to the early 1960s, and
even metastasized to China, contributing to or causing famine wherever they were
applied to crop production. Basically, Lysenkoism destroyed Soviet agricultural
science for more than a generation and stands as perhaps the most prominent
historical example of what can happen when ideology infuses science to the point
where ideology trumps science.

You can see where I’m going with this: I view MAHA as a new form of Lysenkoism
applied to medical science, except with a Trumpian twist, that twist being the
grift. Basically, what appears to be happening is that, from my perspective, it 
appears that Trump, with the enthusiastic assistance of RFK Jr., is changing the
system used by the NIH to distribute grant money from the current system, which
relies on rigorous peer review of grant applications by study sections to score
them, with the best-scoring grants being funded, to one that is very much more 
based on ideological tests, patronage, and grift, combined with the massive
shrinking of the NIH budget; that is, if the administration gets its way.

Dr. Jay Bhattacharya: Enthusiastic MAHA supporter or useful idiot?

Observing what has been happening to the NIH since the Trump administration took
over, in particular the sudden mass cancellations of grants based on an
“anti-DEI” (diversity, equity, and inclusion) rationale, I had been thinking
along these lines for a while. Then I saw a disastrous interview with the new
NIH Director Dr. Bhattacharya published in Science last Monday, and by
“disastrous,” I mean just that, at least for his reputation among actual
scientists. I’m sure it played well with MAHA and MAGA, given that he was
confrontational and full of excuses.

First, note that Dr. Bhattacharya didn’t appear alone. He appeared to require a 
handler:

But the day before that budget was released, Bhattacharya sat down for an
interview with this Science reporter. He was joined by NIH Chief of Staff Seana 
Cranston, a former congressional staffer who replaced John Burklow, a 4-decade
NIH communications veteran. The encounter was brief, sometimes confrontational, 
and even personal.

I note that the appointment of a nakedly political appointee like Cranston was a
major change from the longtime practice at NIH of appointing a career
professional as chief of staff to the NIH Director. Moreover, given how poorly
Dr. Bhattacharya did during the interview, you’ll see why he needed a handler:

When I asked about low morale at NIH following two waves of firings, and about
concerns at academic institutions about funding delays and grant cuts,
Bhattacharya wanted to know whom I had talked to. After I mentioned past NIH
Director Harold Varmus, he noted that the Nobel Prize winner had “attacked me
pretty viciously” in an op-ed. He complained about my past coverage of a
nonprofit group, the EcoHealth Alliance, that used NIH funding for virus studies
in China that some scientists and Republican politicians claim caused the
COVID-19 pandemic.

Very Trumpian, all grievance, all wanting to know who was complaining, the
better to attack them. However, here’s what I found to be one very telling part 
of the interview:

On a Nature news article reporting that NIH planned to suspend subawards for
foreign collaborations:

“No, that’s false. There’s going to be a policy on tracking subawards. The NIH
and the government should be able to see where the money’s going.”

“I’m really uncomfortable with this conversation, because you’re like, actually 
spreading rumors that you don’t know anything about. … Nature also is spreading 
rumors. Halt foreign collaborations, that’s not true.”

“We’re working on the policy, Jocelyn. You shouldn’t be reporting rumors. I know
there’s leaks all over here, but the leaks don’t actually reflect what’s
happening. Don’t write about rumors. It actually makes the things that you and I
care about worse. Like it spreads panic.”

Later that day, NIH released a policy that halted future subawards to foreign
scientists and said they will need to apply directly for money under a system
still in development.

I saw two likely possibilities, which are not necessarily mutually exclusive.
Either Dr. Bhattacharya was lying (or deluding himself), or he genuinely didn’t 
know, implying that political operatives like RFK Jr. and DOGE were the ones
making major decisions about how NIH grants will be disbursed without consulting
him. In other words, Dr. Bhattacharya is not driving the clown car that the NIH
is fast becoming; he’s in way over his head, a useful idiot for MAHA.

I’m thinking the latter possibility is closer to the truth, if only because Dr. 
Bhattacharya is clearly utterly unqualified even strictly based on his utter
lack of experience running an organization even a thousand times smaller than
the NIH. Much of his interview consisted of excuse-making and responses that
boiled down to, in essence, “It wasn’t me” or “I had nothing to do with that,”
asserting, for instance, that he “arrived the day that the RIF [reduction in
force] happened” and “had nothing to do with it.” Basically, he comes across as 
a figurehead with no real power. After all, you’d think that a responsible
administration would have consulted with its nominee to head an agency regarding
planned reductions in force in that agency. Here’s another example:

“They’re canceled because they’re DEI [diversity, equity, and inclusion]-based
science … [which does] not actually have anything to do with promoting the
health of the American people. I’m not sure why you’re switching to HIV.”

“I think the scientific priorities of the NIH ought to focus on improving the
health of the American people. Politicized science doesn’t do much to advance
the health status of anybody.”

“I don’t personally review grant lines and say, ‘I cancel this grant. Don’t
cancel that grant.’ That’s not what I do. … There’s a process. It’s not me
personally, but I mean, the best I can tell, most of those were canceled before 
I even got into office.”

In fairness, it is true that the NIH Director doesn’t personally review every
grant. It’s also true that a lot of the grants that were canceled were canceled 
before he was confirmed as NIH Director. Even so, here Dr. Bhattacharya is
dodging responsibility. If he objected to what is going on with his agency, he
could advocate against it. If he had any major problem with it, he could resign 
and go back to Stanford, refusing to be part of it. He didn’t and won’t. When he
complained about the “politicization” of science, like everyone else in the
Trump administration, what he really meant is that he doesn’t like
“politicization” that doesn’t align with his beliefs, and, when he complained
about “censorship,” what he meant by the word “censorship” was criticism of
views and science that he didn’t like. Everything that he’s said and done since 
his nomination to be NIH Director clearly indicates that Dr. Bhattacharya is
more than happy to “censor” science based on nakedly political beliefs that have
nothing to do with science, such as hostility to “DEI.” Again, he must have
seen what DOGE and the Trump administration were doing before he was confirmed. 
If he objected and didn’t want to be part of it, he could easily have asked to
have his nomination withdrawn.

Instead, when asked about the withholding of grant funds from universities like 
Columbia solely based on alleged antisemitism, Bhattacharya was more than happy 
to justify it:

“Those decisions are not up to me, but I do notice these institutions ought to
obey the civil rights laws, and I think eventually they will. … There’s a lot of
excellent science that goes on in these places. It’s very difficult to do
excellent science, though, in a place that doesn’t have basic civil rights
laws.”

“Free speech, for instance, [was] really important during the pandemic. Many,
many of the academic institutions in this country, including some of the places 
you’ve mentioned, make it very difficult for free speech, for scientists to
dissent.”

“Free speech.” You keep using that term. I do not think it means what you think 
it means. Actually, Bhattacharya is so on board, that he makes a hilarious
contortion to justify what’s happening, even though his past research involved
what the administration might term “DEI”:

“I want to distinguish studies that make appropriate distinctions between people
based on their age, race, sex, all that, that have biological consequences that
are important. Scientists should be able to look at that, and we’re not
canceling any grants around that, as far as I know.”

“[On the other hand] politicized, DEI kinds of ideology, essentially race
essentialism, that has nothing to do with science, as far as I’m concerned, and 
has no capacity to improve the health of the American people.”

Imagine my relief. (Hint: I have co-authored a few papers on health disparities 
in breast cancer.) Of course, health disparities are a very important area of
research, but MAHA tends to be very hostile to such research because health
disparities imply that there are systemic, environmental, and racial influences 
that individuals can’t control that have huge impacts on their health, risk of
disease, and treatment outcomes. I’ve argued that MAHA is an unholy combination 
of social Darwinism and soft eugenics, in which nature is allowed to cull the
“unfit” (e.g., no vaccines) and the individual is viewed as entirely responsible
for their own health, with health being due solely to virtue. If, however,
science shows and describes influences on health that individuals can’t control,
that rather undermines the entire idea in MAHA that health is a result of
personal virtue with respect to “healthy living” in terms of diet, exercise, and
lifestyle.

Basically, this interview with Bhattacharya made it clear that he’s all-in on
punishing ideological opponents of the Trump administration, punishing
universities that don’t sufficiently toe the line with respect to the
administration’s preferred ideology, and refusing to support scientists whose
science doesn’t align sufficiently with the prevailing ideology of the
administration—just as the Soviet Union with anyone who opposed Lysenko. Will
the gulags be next? Probably not, but certainly the NIH is being—shall we
say?—repurposed to serve the ideological goals of the administration in a way
that no administration has ever done before.

The mass defunding of grants

Although the carnage started almost immediately, the most prominent
implementation of a Lysenko-like regime at the NIH has been the mass defunding
of already awarded grants, preceded by an attempt to slash indirect funds.
Remember, as I’ve described many times, the NIH distributes most of its grant
funding through a system in which scientists submit detailed grant applications 
to the NIH, where they are reviewed by groups of scientists in committees called
study sections, scored, and then ranked. Final funding decisions are made by
scientific councils, the best-scored grants first and working their way down the
list until the money runs out. It’s certainly not a perfect system. No system
designed and run by humans is. Despite its deficiencies, the NIH is, however,
about as close to a meritocracy as one can imagine in the government, and
funding decisions tend to be, by and large, pretty closely aligned with
scientific merit, even if one can always find sporadic examples where it is not.

Indeed, the system has functioned pretty well for many decades and contributed
to the US becoming the leader in biomedical research. Administrations, both
Democratic and Republican, have generally not meddled much with how the NIH
functions. Certainly, never before has an administration done anything like what
the Trump administration has done, namely the mass defunding of grants based on
ideology, eliminating science that its ideology rejects or that is being done
at universities that do not sufficiently toe the line with respect to the
administration’s ideology.

It’s very clear that the mass defunding of grants is based primarily on
ideology, too. Making that very clear was the second thing I read last week that
made me lament what’s happening at NIH was in LinkedIn. It was written by
Brittany Charlton, Associate Professor at Harvard Medical School & Harvard Chan 
School of Public Health; Founding Director of the LGBTQ Health Center of
Excellence. Harvard University, as you might recall, has resisted the
administration’s blackmail in the form of withdrawing federal grants and thus
has been the target of particular opprobrium from Trump and his allies. The
Trump administration is targeting anything it can represent or misrepresent as
“DEI” (diversity, equity, and inclusion), as well as anything related to mRNA
technology (which its supporters hate and fear because of the fearmongering
about COVID-19 vaccines during the pandemic), to LGBTQ health research
(especially anything related to gender-affirming care or transgender
healthcare), vaccine hesitancy, and combatting misinformation. Charlton is not
silent about it on LinkedIn:

Here’s what I’ve built in the last few years: I’ve mentored 75+ faculty,
postdocs, & leaders. Published 100+ papers in top journals like JAMA, Journal of
the American Medical Association & BMJ. Been cited 2,600+ times — because facts
matter. Launched the LGBTQ Health Center of Excellence <1 year ago. Our mission
is to advance health equity by training future leaders, driving innovative
research & informing public policy. I had secured continuous NIH funding for
almost 2 decades — 15+ grants, including a rare early-career R01. With a proven 
track record of winning & managing NIH grants, I had built what should have been
a lasting academic center. To put it in perspective: I rank as the 51st most
highly funded NIH investigator compared to the nearly 500 faculty across Harvard
University’s 13 schools — including Harvard Med School, Harvard Chan School of 
Public Health, & Harvard College.

Charlton is Associate Professor at Harvard Medical School and Harvard Chan
School of Public Health, as well as the Founding Director of the LGBTQ Health
Center of Excellence. At almost any university other than Harvard, she would be 
a full professor. In this case, she lost her grants due to Trump’s feud with
Harvard, which has refused to buckle under his demands, which has led to grant
terminations, a threat to revoke Harvard’s tax-exempt status, and a statement
last week that Harvard will receive no new federal research grants.

Meanwhile, the Association of American Medical Colleges (AAMC) published a brief
describing how many grants have been defunded since Trump took office, and
include grants supporting research involving HIV/AIDS, vaccine hesitancy, mental
or behavioral health, COVID-19, vaccines, substance abuse, and, shockingly,
cancer. Many of the grants are supporting clinical trials:

Canceling grants supporting clinical trials is particularly wasteful, because
not only does it prevent funded trials from accruing new patients, but it makes 
it impossible to follow and collect data on the patients already in the trial.
Basically, much, if not all, of the data already collected is wasted because the
trial, unless near the end of accrual, will not have enough patients to produce
a statistically significant result.

Meanwhile, as reported in Nature, the FY2026 budget proposal sent to Congress by
the administration contains massive budget cuts:

US President Donald Trump’s proposed budget for fiscal year 2026 calls for
unprecedented cuts to scientific agencies that, if enacted, would deal a
devastating blow to US science, policy specialists say. On 2 May, the White
House released a budget document for the upcoming fiscal year, which starts on 1
October. The proposal is a ‘skinny budget’ that is light on details, but calls 
for disproportionately large cuts to federal science funding. According to the
White House document, the proposal would cut all non-defence spending by 23%,
but it targets the US National Science Foundation (NSF) for a 56% funding
reduction, and would slash the budget of the US National Institutes of Health
(NIH) by roughly 40%. The Environmental Protection Agency (EPA) would be hit by 
a 55% cut as the administration seeks to eliminate what it calls “radical” and
“woke” climate programmes. On the day the budget was released, the EPA announced
plans to dismantle its primary research division. Later this month, the
presidential administration is expected to release a more detailed budget.
Observers warn that Trump might still seek cuts to money already allocated by
Congress for fiscal year 2025.

One notes that, as part of the CDC budget, the Trump administration proposes to 
eliminate programs aimed at preventing chronic diseases. So much for “make
America healthy again.” The same is true of the proposed 55% cut to the
Environmental Protection Agency.

Again, remember. The grants being defunded were all awarded after a rigorous
peer review process. They are not being defunded based on lack of scientific
rigor, no matter how much the administration, Dr. Bhattacharya, and RFK Jr.
claim otherwise. They are being defunded based on ideology. Unfortunately, there
are a number of scientists who are willing to go along with this. For example, 
on LinkedIn, I found a bit of a rant by someone named P. Greg Czyryca, PhD, CSO 
at a company called Allosterix, who is happy about the grants being terminated
because he thinks that “soft” science and DEI are keeping funding away from
where he thinks it all belongs, “hard” science:

The list of recently canceled NIH grants is a must read for people who were
unable to secure funds for legitimate scientific research or after-postdoc
academic positions. You were not able to get $500,000 for your cancer research? 
That was the “proper grantsmanship”, silly: “Testing the effect of anti-tobacco 
message framing on polytobacco use in lesbian gay bisexual and transgender young
adults”, and here comes $858,221. You were unable to get $300,000 for HIV drug 
discovery? Refocus your work, silly, on “Intersectional Approaches to
Population-Level Health Research: Role of HIV Risk and Mental Health in Alcohol 
Use Disparities among Diverse Sexual Minority Youth”, and here comes
$2,017,111.68 of taxpayers’ money. Not enough? Try “Harnessing the power of text
messaging to reduce HIV incidence in adolescent males across the United States”
– $4,180,423.00 And so on. You have sent 100 applications, with innovative
science proposed in your research plans, and got no interview invitations? Guess
who has been sitting on the selection committees.

Later, in the comments, he adds:

Note that all this recent noise about cutting NIH spending is padded with
examples of authentic societal benefits of cancer research, vaccine research
etc. The authors of such posts know PERFECTLY WELL what they owe to the
taxpayers. NOBODY quotes actual examples of huge grants awarded for DEI social
engineering, or for ideological aspects tangential to healthcare (such as
“fighting disinformation”). Oh, they know what they owe. Yet they hide the
quackery, the fraud and their “right” to distribute academic welfare as they
please behind examples of legitimate research.

Notice the hostility towards the social sciences, which Czyryca views as
insufficiently “hard” science and thus unworthy of funding. (One wonders if
Czyryca has some sour grapes over grants that he’s applied that weren’t funded
because their science wasn’t as rigorous as he thought.) Truth be told, there
was a time many years ago when I was sympathetic to this sort of viewpoint, but 
if age and experience combatting misinformation have taught me anything, it’s
that social sciences are just as important as all that “hard” science and that
the “hard” sciences aren’t always as rigorous as people like Czyryca seem to
think. In any event, solution is not to defund social science, but to assure
enough funding for both social sciences and the “hard” sciences. Both are
needed. Certainly dealing with antivax propaganda and misinformation as well as 
combatting health misinformation has taught me that. Also, dude. Most NIH grants
don’t involve “interview invitations,” just an application, evaluation and
scoring by study section, and secondary review at council meeting if the score
is in the fundable range.

In any event, what Czyryca is saying is little different than what RFK Jr. and
the Trump administration are doing. Like Lysenko, they are punishing scientists 
whose science doesn’t fit within the government’s prevailing ideology. Lysenko
2.0 roles on, but it’s more than that. There is a Trumpian twist on an old
theme. First, there is the thirst for punishment and revenge.

Gregg Gonsalves reports in The Nation that the mood at the NIH is…not good. In
fact, he reports that there’s a “climate of fear as the Trump administration
takes a hatchet to its core functions,” calling the whole situation a
“bloodbath,” the man most responsible for the bloodbath apparently Russell
Vought, director of the Office of Management and Budget. Worse, Vought is
someone whose family benefited directly from the results of NIH research,
specifically Trifakta, a drug to treat cystic fibrosis, leading his wife Mary to
post on social media, “Today our little one starts #trikafta. Beyond grateful
for this miracle drug.… We’re extremely grateful to live in a nation that leads 
the way on medical innovation.”

Now:

But if the Voughts could once be described as symbols of the good that
government can do for public health, Russell Vought has now become a symbol of
just the opposite.

Metraux told the story about the Voughts because Russell had just been appointed
as the director of the Office of Management and Budget, and one of his first
priorities was to attempt to gut indirect funding for research institutions from
the NIH—the same kind of funding that produced the drug helping Vought’s own
child. The Cystic Fibrosis Foundation responded with criticism, stating that
discoveries like that of Trikafta depend on this critical infrastructure
support, support that Mr. Vought was now putting in jeopardy.

Just a little over 100 days later, it is clear that Russell Vought was just
getting started on dismantling biomedical research in the United States. The
NIH, when Vought gets through with it, will be a shell of its former self. It’s 
clear that for the Voughts, gratitude or even any sense of Christian charity is 
trumped by political sadism. “We want the bureaucrats to be traumatically
affected,” Vought said in private talks, recorded on video in 2023 and 2024, and
uncovered by ProPublica and Documented, “When they wake up in the morning, we
want them to not want to go to work, because they are increasingly viewed as the
villains. We want their funding to be shut down.… We want to put them in
trauma.”

What a lovely guy. At this point, enter Vought’s collaborator in destruction
Matthew Memoli, Memoli’s scientific collaborator Jeffery Taubenberger, and the
last Trumpian twist on Lysenkoism 2.0.

“It’s all cronyism going forward”

When it comes to MAHA, antivax, and the like, I often say something along the
lines of: Yes, it’s the ideology, which comes first, but it’s always also about 
the grift, which inevitably follows. Enter Matthew Memoli, who has been guiding 
Vought through the inner workings of the NIH, the better to dismantle it, as
reported by Gonsalves:

If DOGE needed a guide to the inner workings of the agency, Memoli would have
the knowledge to provide. And it is Memoli who pulled the trigger on the cuts to
indirect costs, the pausing of grants, their terminations, the decision to
slow-walk study sections and council meetings, and the purging of senior staff
at the agency, from second-in-command Larry Tabak to numerous institute
directors. Memoli is now the principal deputy director at the NIH (fellow Covid 
skeptic Jay Bhattacharya has taken the top job), but he seems to still be
leading the MAGA charge.

It wouldn’t surprise me if, given how hapless Bhattacharya has been, Memoli is
the one who is really running the NIH at the moment. He is also being rewarded. 
This is where I bring in Generation Gold Standard, a new $500 million initiative
to develop vaccines against influenza and potential “pandemic-prone” viruses.
At this point, you might think, “Great! Maybe RFK Jr. isn’t as antivax as he
seems.” Maybe. Or maybe this is both a way to give the appearance of not being
antivaccine and to reward RFK Jr.’s hatchet man and mole at the NIH.

First of all, the choice of platform is curious, namely using chemically
inactivated whole virus as the antigen, leading scientists to be puzzled at the 
choice. This platform is, quite literally, just a variation on last century
technology, having been in use since the 1940s to produce influenza vaccines.
Yet, the press release sells it as cutting edge:

“Generation Gold Standard is a paradigm shift,” said NIH Director Dr. Jay
Bhattacharya. “It extends vaccine protection beyond strain-specific limits and
prepares for flu viral threats – not just today’s, but tomorrow’s as well –
using traditional vaccine technology brought into the 21st century.”

It’s basically just using chemical used since the the 1950s to inactivate the
influenza virus. As one scientist said:

“This is not a next-generation vaccine,” said Rick Bright, who led HHS’
Biomedical Advanced Research and Development Authority, or BARDA, in the first
Trump administration. “It’s so last-generation, or first-generation, it’s
mind-blowing.”

And:

If the mRNA-based covid shots produced by Moderna and Pfizer-BioNTech
represented the cutting edge of vaccine technology, applying ultra-sophisticated
approaches never before seen in an inoculation, the approach by Taubenberger
and Memoli represents a blast from the past.

So why? Why would RFK Jr.—and you just know he’s behind it—funnel this money to 
a project using 70 year old technology and an idea that’s at least 80 years old 
and then sell it as “cutting edge technology.” It’s not. Moreover, contrary to
the way it’s being sold, it’s not any sort of lock to develop a universal flu
vaccine. (After all, did scientists manage to develop such a vaccine last
century? They did not.) I rather suspect that the main reasons this technology
was chosen are two-fold. First, its’ a reaction to the opposition to what is
really cutting edge technology, mRNA vaccines, stirred up by all the
fearmongering during the pandemic leading to Trump’s base being suspicious and
fearful. I also suspect that it’s easy for RFK Jr. to view inactivated whole
virus vaccines as somehow “more natural” because they are the entire virus,
rather than selected peptides used as antigens, produced either by recombinant
DNA technology or by mRNA technology.

Never mind that the technology is associated with more, not less, adverse
events.

The second reason is to reward Memoli and his collaborator Jeffery Taubenberger.
As reported in The Atlantic by Sarah Wu:

Memoli and Taubenberger’s vaccine technology could end up yielding an effective 
product. It relies on a type of vaccine composed of whole viruses that have been
chemically inactivated; at least one of the vaccines under development has
undergone safety testing, and has some encouraging preliminary data behind it.
But flu viruses mutate often, hop frequently across species, and are tricky to
durably vaccinate against; although scientists have been trying to concoct a
universal-flu-vaccine recipe for decades, none have succeeded. When the goal is 
this lofty, and the path there this difficult, the smartest and most efficient
way to succeed is to “fund as broadly as you can,” Deepta Bhattacharya, an
immunologist at the University of Arizona (who is unrelated to Jay
Bhattacharya), told me. That strategy has long been core to the mission of the
NIH, which spends the majority of its budget powering research outside the
agency itself.

So, yes, the technology could result in a new vaccine or new vaccines. After
all, it was the mainstay of vaccine technology for decades. It’s just that there
is nothing new here. Come to think about it, it is very Trumpian, selling old
technology as though it were something new and shiny.

As Wu concludes:

Kennedy, a longtime anti-vaccine activist, does not appear to have sought out
vaccine research to fund, though. Memoli “is really the one who has pushed this 
ahead,” one NIH official told me: A few weeks ago, he dispatched Taubenberger to
brief Kennedy on the pair’s work. (Memoli did not respond to questions about
this briefing or about how he had solicited so much of Kennedy’s support.) No
matter the instigator, though, the outcome sends an unsettling message to the
rest of the American research community—“the only way to overcome HHS priorities
is to be part of the inner circle,” the University of Arizona’s Bhattacharya
told me. One NIH official put it more bluntly: “It’s very clear it’s all
cronyism going forward.”

Lysenkoism 2.0. It’s all there: ideology trumping science, scientists not buying
into the new scientific dogma losing favor, being fired, or even otherwise
punished, while scientists who do are rewarded, sometimes richly. I predict that
MAHA will end up changing the way that research grants are disbursed to
scientists to emphasize rigorous scientific review by expert study sections less
and emphasize ideology, loyalty, patronage and cronyism. The Trumpian
innovation to Lysenko’s legacy is the cronyism and, I expect in the future,
grift.

Trofim Lysenko examines grain with Soviet farmers.


It’s a madhouse! Public health under the heirs to Lysenko (and Dr. Zaius) in
2025

As 2025 barrels towards its depressing conclusion, I look back at the damage
federal science and medicine have sustained thus far under Donald Trump and
Robert F. Kennedy Jr. through the lens of a classic film. Truly, it’s a
madhouse, in which our federal science apparatus is run by Lysenko’s heirs.

David Gorski on December 29, 2025

Link


As I approached the task of doing my overview of the year, I couldn’t help but
think of one of my favorite movies of all time, Planet of the Apes (the original
1968 film starring Charlton Heston, not the far inferior 2001 remake). In the
movie, as you might recall, three astronauts awake from deep
hibernation/cryosleep after a space journey as their ship is out of control and 
about to crash into a mysterious planet. The leader, George Taylor (played by
Charlton Heston) estimates that they are 300 light-years from home and, because 
of time dilation at near-light speed, have wound up in the year 3978, their
having aged only a year. Most readers, I assume, will be familiar with much of
what happens next, as Taylor and the other two surviving astronauts of the four 
original crew members encounter humans who are mute and living as prehistoric
hunter-gatherer/scavengers. Soon after, they fall prey to intelligent talking
apes who are hunting the humans down to kill or capture. In the ensuing melee
Taylor is wounded, shot in the throat so that he can’t talk. Captured and
separated from the other astronauts, Taylor finds himself held as an animal in a
society of intelligent apes whose level of technology is at a preindustrial
level; i.e., no electricity and horses being the primary means of
transportation, although they do have rifles. He is nursed back to health by a
married couple of chimpanzees, Zira (played by Kim Hunter) and Cornelius
(memorably played by Roddy McDowell), who are, respectively, an animal
psychologist and an archeologist.

One of the most memorable moments from the film occurs when, after having been
captured trying to escape, Taylor snarls at his captors through the netting
ensnaring him (as only Charlton Heston could snarl), “Get your stinking paws off
of me, you damned dirty ape!” The shocking revelation (to the apes) that Taylor
could speak results in his being removed from the Ministry of Science and
Zira’s hands and placed under the control of the military, which views him as a 
freak of nature and, not incorrectly, a threat to ape society. While in
captivity, one guard in particular delights in punishing Taylor by spraying him 
with a high-pressure water hose, which leads to another memorable moment from
the movie, in which Taylor cries out:

“It’s a madhouse! A madhouse!”

Let’s just say that I’ve been feeling this scene all year, given a world turned 
upside down from a science-based medicine perspective in which the quacks are in
charge and real scientists treated not unlike the way the guard treated Taylor 
in the movie.

Now here’s the thing. I originally thought of this clip and image solely as an
excuse for a clever title for my year-end post. However, as I started thinking
about the plot and world of Planet of the Apes, I started seeing more and more
parallels between the movie and our current government, not the least of which
is the denial of science and the fusion of religion and science. That’s because 
ape society as portrayed in the film is a theocratic militaristic authoritarian 
state. Indeed, the main antagonist, Dr. Zaius, is an orangutan who serves not
just as the Minister of Science but as Chief Defender of the Faith and sees no
conflict at all between his two roles. (Sound familiar?) That faith was first
laid down by a figure known as the Lawgiver, who taught that god had created
apes in his image and urged apes not to let humans “breed in great numbers, for 
he will make a desert of his home and yours,” to “shun him,” and to “drive him
back into his jungle lair, for he is the harbinger of death.” (Sometimes, when
I’m in one of my more cynical and disconsolate moods, I have to admit that the
Lawgiver had a point.)

Even more chilling to me, as far as parallels between the movie and real life in
2025, Dr. Zaius is terrified by what the discovery of a talking human like
Taylor might mean for his society and religion. He presides over a hearing into 
Taylor’s origins that is obviously meant to suppress scientific findings that
cast doubt upon the religion of the apes, concluding that Taylor was either
created by a mad scientist or that he was of a tribe of human mutants living
beyond his people’s borders. Cornelius and Zira free Taylor and, seeking to
clear themselves of heresy, flee to Cornelius’ archeological dig in a region
near Ape City in a region dubbed the Forbidden Zone. Pursued by Dr. Zaius and
soldiers, Taylor and his chimpanzee allies are cornered at the entrance to the
dig, but Taylor holds off the soldiers with a rifle. He manages to trick Dr.
Zaius into thinking he was seriously wounded, allowing him to grab Zaius as a
hostage and threaten to kill him to keep the ape soldiers at bay. Under duress, 
Dr. Zaius agrees to enter the cave. There, Cornelius shows Dr. Zaius artifacts
from a society of intelligent humans that predated apes, including a human doll 
that talks, which is the one artifact that Dr. Zaius couldn’t attribute to apes.
I’ll discuss what happened next and its relevance near the end. The immediate
point is that exploring this movie led me down a deeper rabbit hole than I had
expected in terms of parallels to the current administration.

Basically, an idea that started as a bit of a lark ended up confronting me with 
a bit more complex a post and metaphor than I had intended. Don’t get me wrong. 
The parallels between ape society in Planet of the Apes and the destruction of
science and medicine at the federal level that we’re seeing now are nowhere near
perfect, and I’ll mention a couple of glaring differences near the end of this 
post. However, they are close enough to have made me think of how, right now in 
2025 and through 2028, we are ruled by the heirs of Lysenko and, to come back to
my science fiction analogy, Dr. Zaius. The two are similar in many ways, but
there’s one big difference that I will explore, as it divides RFK Jr. and his
sycophants, toadies, and lackeys into two different categories.

Lysenko 2.0

Of course, we don’t need to look to dystopian authoritarian theocracies
portrayed in science fiction novels and movies to know that it is not uncommon
for humans—and particularly their authoritarian leaders—to value ideology and/or
religion over the cold, hard findings of science, nor is it uncommon for them
either to co-opt and misrepresent science to falsely make it appear to support
their ideology or, failing that, to suppress “inconvenient” science that casts
doubt on the teachings of their faith and ideology. We just have to look to
history and even today’s politics. That’s one big reason why I’ve reiterated
multiple times in 2025 that the “Make America Healthy Again” (MAHA) movement
that is now in power is, in fact, “Lysenkoism 2.0.” Of course, the Lysenkoism in
this administration goes far beyond what Trofim Lysenko himself might have
imagined. After all, Lysenko only ruled government agricultural science and
genetics. Trump- and RFK Jr.-branded Lysenkoism taints all areas of
government-supported science, including medicine, public health, and biomedical 
science, as well as climate science, environmental science, and even NASA.

Trofim Lysenko (1898-1976).

But what do I mean by dubbing 2025 the year of new Lysenkoism? For those who
don’t remember who Trofim Lysenko was, I’ll briefly remind you, although I did
discuss him in depth back in March. In brief, Lysenko was a Soviet scientist who
gained Josef Stalin’s favor after publishing work that, when boiled down to its
essence, was basically warmed-over Lamarckism, or soft inheritance. Lamarckism 
is a concept named after French biologist Jean-Baptiste Lamarck (1744-1829), who
championed the hypothesis that an organism can pass on to its offspring
physical characteristics that the parent organism had acquired through use or
disuse during its lifetime. The classic example often taught in high school
biology class is that of the giraffe, whose long neck, Lamarckism postulates,
came about through successive generations of giraffe ancestors stretching their 
necks to reach the leaves on ever-higher branches of trees. In contrast,
according to Darwinian evolution, a wide variety of neck lengths originally
existed in a population of giraffe ancestors, and then a food scarcity at low
elevations selected against the short-necked giraffes, leaving only the giraffes
with the genes for long necks as the survivors. Lysenko basically fused his
warmed-over Lamarckism with his view of Communism to deny the increasing
knowledge of genetics based on experimentation from scientists all over Europe, 
including Lysenko’s colleagues in the Soviet Union. (Prior to Lysenko’s rise,
Russia had some of the best agricultural scientists in the world, such as
Nikolai Vavilov, who was later imprisoned as a result of Lysenko’s power.)

Based on his ideas, Lysenko proposed that he could “educate” Soviet crops to
sprout at different times of the year by soaking them in freezing water and
using other interventions, going on to claim that future generations of the
crops would then remember these cues and inherit the beneficial traits. He had a
number of other crackpot ideas as well. For example, in addition to claiming
that plants could pass on traits acquired during life to their offspring,
Lysenko denied the existence of DNA and genes and claimed that plants selected
their mates. He also espoused the idea that some plants choose to sacrifice
themselves for the good of the remaining plants. Based on these Ideas, Lysenko
believed he could revolutionize Soviet agriculture, boosting crop yields and
transforming the empty Russian interior into vast farms. The result was
catastrophic. Not only did he fail to prevent crop failures and famine, but his 
ideas clearly made the famines worse. When China adopted Lysenko’s methods in
the late 1950s, along with its forced collectivization of farms, it too
experienced worsened famines. Yet, after being put in charge of Soviet
agricultural science in the early 1930s, Lysenko’s grip on power continued for
three decades. Although his iron power declined after the death of his patron
Stalin in 1953, his powerful influence continued until 1965. Even after that, it
took Soviet science decades to recover.

I’m sure you can see where I’m going with this. While likening President Donald 
Trump to Stalin might be opposite of the politics to whom we normally liken him,
what matters here more is the authoritarian impulse and worship of ideology,
which reject any inconvenient science in favor of pleasant pseudoscience from
people like Lysenko that strokes the ego of the leader. In this, 2025 has been
the year of Lysenko’s heirs and the sycophants, toadies, and lackeys who abase
themselves to serve him and his patron Donald Trump in return for power and
revenge against scientists who had criticized them during the COVID-19 pandemic.
The result has been a redirection of many areas of federal science as well as, 
most Lysenko-like, the purging of scientists who oppose the changes or even are 
simply not on board with science driven more by ideology and grievance than by
actual scientific data.

Trofim Lysenko examines grain with Soviet farmers.

Lysenko’s primary heir: Robert F. Kennedy, Jr.

If there’s one person who most embodied Lysenkoism in 2025, it has to be Robert 
F. Kennedy Jr. Moreover, there’s no way that President Trump didn’t know this
when he nominated him to be Secretary of Health and Human Services, although RFK
Jr. represents a slightly more complex figure in that he is simultaneously a
true believer in one form of pseudoscience and quackery, like Lysenko, but
clearly compromised his other scientific advocacy for power. Before RFK Jr.
outed himself as antivax in 2005, to become the American equivalent of the
United Kingdom’s most famous antivaxxer, Andrew Wakefield, he had been an
environmental lawyer. Indeed, it was a twisted version of RFK Jr.’s advocacy
against mercury in water that led to its accumulation in fish that humans
consume that led him to be receptive to mothers who in the 1990s had come to
believe against all evidence that mercury in the thimerosal preservative that
was used in several childhood vaccines until around 2001 had caused their
children’s autism. And the rest, as they say, is history.

In 2005, RFK Jr. published his infamous screed Deadly Immunity simultaneously in
Salon.com and Rolling Stone, positing a vast conspiracy by the CDC to cover up 
evidence implicating mercury in vaccines as a cause of autism, thus popularizing
a conspiracy theory that I’ve called the Simpsonwood conspiracy theory to a
much wider audience than the group of fringe antivaxxers who had previously been
spreading it. Since then and before his elevation to HHS Secretary, RFK Jr. had
spent nearly 20 years promoting antivaccine disinformation and conspiracy
theories, even to the point of capitalizing on a deadly measles outbreak in
Samoa in 2019 to spread antivax misinformation to people whose children were
dying of measles. I could go on and on and on about how much RFK Jr. promoted
his ideology that vaccines are harmful and cause autism in the face of huge
volumes of strong science that contradict his ideology. I’ve been writing about 
RFK Jr. and his antivax crusade for over 20 years. If you don’t believe me, just
search for his name and “vaccines” both here and at my not-so-super-secret
other blog. Also, consider that a number of scientists and physicians, including
Dr. Paul Offit, have tried over the years to personally educate RFK Jr. about
the actual scientific evidence base behind vaccines, including scientific
studies supporting vaccine safety and refuting a link between vaccines and
autism, as well as explanations why the studies that RFK Jr. likes to cite to
support his views are so flawed as to be useless. Unsurprisingly, RFK Jr. has
steadfastly refused to listen to them, rather like Trofim Lysenko did with his
critics before his power over Soviet agriculture had become near-absolute.

Which brings us to the true parallel between Lysenko and RFK Jr.

As soon as he was confirmed, RFK Jr. did what he had been promising to do for a 
long time, first during his independent run for President in 2024 and then after
he had bent the knee to endorse Donald Trump in return for power; namely, he
started to purge HHS agencies, such as the CDC, FDA, and NIH of scientists with 
actual expertise. Of course, to do this, he eagerly colluded with Trump’s Office
of Management and Budget (OMB) Director Russell Vought to rescind funding for
projects not deemed to be in line with administration goals. The administration 
wasn’t even subtle about it, either, as huge numbers of NIH scientific grants
were terminated because they did not align with administration priorities.
Thousands of HHS employees were let go under “reduction in force” orders. (So
haphazard were the layoffs that in October the Trump administration was forced
to admit that it had laid off twice as many HHS employees as intended.)

This purge, almost more than anything else, aligns RFK Jr. with Lysenko, who
himself purged Soviet science of scientists who opposed him or even just
disagreed with his warmed-over Lysenkoism. For example, let’s look at the case
of Lysenko’s mentor Nikolai Vavilov, a Russian and Soviet agronomist, botanist, 
and geneticist. Before his run-in with Lysenko, Vavilov had been renowned in the
world of science for having identified the centers of origin of cultivated
plants and created the world’s largest collection of plant seeds, having made
contributions to the study of genetic diversity of crop plants across the world,
the Darwinian problem of speciation, plant breeding, and a geographical
approach to studies of crops, as well as the law of homologous series in
variation. Among his honors for scientific achievements before Lysenko, Vavilov 
had been the youngest member of the Academy of Sciences of the Soviet Union and 
a member of the USSR Central Executive Committee. He had received the Lenin
Prize and was president of the All-Union Geographical Society. Outside of Russia
and the USSR, Vavilov was respected among scientists abroad as well, having
been elected a fellow of the Royal Society and of the Royal Society of
Edinburgh. So what happened to Vavilov? After becoming increasingly marginalized
by Lysenko, by 1936 he had lost the favor of Stalin and was sacked from his
position as director of the Institute of Plant Industry. In 1940 he was arrested
by the NKVD (Soviet secret police) and thrown into prison for opposing Lysenko,
later being accused of spying for the British and degrading Soviet agriculture.
After a forced false confession, he was found guilty in 1941 and sentenced to
death, although his sentence was commuted to 20 years’ imprisonment. He died in 
prison in 1943 due to the harsh conditions.

Although it is unknown precisely how many scientists were purged, imprisoned,
and even executed as a result of their opposition to Lysenko, estimates are that
over 3,000 agronomists and geneticists were fired, many of whom ended up being 
imprisoned in Gulag labor camps. Numerous scientists were executed as “enemies
of the state,” examples including Isaak Agol, Solomon Levit, Grigorii Levitskii,
Georgii Karpechenko, and Georgii Nadson. It didn’t take long for scientists to 
realize that criticism of Lysenko and his crackpot theories was the equivalent
of a death sentence, or at the very least an invitation for an indefinite
“vacation” in a Gulag, and dissent was suppressed. All research into genetics in
the Soviet Union came to a halt.

RFK Jr. is not literally Lysenko, but one can’t help but see the echoes of
Lysenko in his actions. It must be acknowledged that the purges began
immediately upon Trump’s re-assumption of power and before RFK Jr. was confirmed
as HHS Secretary, but he enthusiastically continued the purges and added a few 
targeted purges of his own in which he replaced those purged with loyalists,
just as Lysenko did. For example, here are but two related examples:

  1. RFK Jr. purged all the members of the CDC Advisory Committee on Immunization
    Practices (ACIP), the committee that has long produced the CDC-recommended
    infant, child, and adult immunization schedules, to replace them with
    antivaxxers. The result has been chaotic incompetence and chipping away at
    the vaccine schedule, starting with COVID-19 boosters and moving on, most
    recently, to the birth dose of the hepatitis B vaccine.

  2. RFK Jr., after having personally “handpicked” her to be Director of the CDC,
    persuaded President Trump to fire Dr. Susan Monarez when she wouldn’t
    unquestioningly go along with his plans to change the vaccine schedule.
    Basically, she refused to go along with RFK Jr.’s attempts to promote
    unscientific and pseudoscientific policies at the CDC and would not fire the
    people he wanted her to fire. Her firing led to a mass resignation of
    several key CDC managers.

This didn't age well pic.twitter.com/8MMwceCv5S

— The Real Truther (@thereal_truther) August 27, 2025

Unsurprisingly, there are many reports out there that RFK Jr. does not consult
with or listen to scientists with expertise in vaccines, infectious disease,
epidemiology, and public health policy, preferring instead his own stable of
cranks and quacks, some of whom he’s elevated to high positions in the CDC, FDA,
and NIH. For example, over at the FDA, COVID-19 contrarian and antivaxxer Tracy
Beth Høeg is now acting director of the Center for Drug Evaluation and
Research, the branch of the FDA responsible for approving and regulating
prescription drugs. Never mind that Høeg has no experience running randomized
clinical trials or developing regulations for drugs—or anything else.

Meanwhile programs targeted for reductions in force (RIFs), planned RIFs, or
even outright elimination include:

Three employees — two of whom received layoff notices on Tuesday — told Capital 
B Atlanta that the CDC’s labor force reductions in Atlanta were concentrated in 
areas of health study that have an outsized impact on Black people, including
HIV/AIDS, tuberculosis, gun violence, and youth violence.

An internal memo provided to Capital B Atlanta by a CDC employee appears to show
a list of agency departments and divisions that were downsized on Tuesday. In
addition to divisions related to areas of research in which Black people are
overrepresented, the memo also lists research divisions primarily affecting
women and other minority groups.

Here’s the memo from April:

A partial list of CDC programs targeted for RIFs, some for elimination.

See what I mean? Any science not in favor with the powers that be is being
targeted for reduction or elimination. In addition, beyond the CDC, layoffs and 
budget cuts were directed primarily at areas of science that the administration 
and RFK Jr. found conflicting with the MAHA and MAGA ideology. Examples include 
anything having to do with gender studies or the gender-affirming care of trans 
people, mRNA vaccine development, environmental causes of disease, and so much
more.

Meanwhile, more and more, cranks who align with RFK Jr. are being hired,
starting with David Geier, a longtime antivax activist hired as a senior data
analyst, clearly to “prove” that vaccines cause autism. He was joined by Lyn
Redwood, a former head of an anti-vaccine group founded by Kennedy, who is now
listed as an expert at HHS. William Thompson (remember him?), the CDC scientist 
at the heart of the “CDC whistleblower” conspiracy theory at the heart of Andrew
Wakefield and Del Bigtree’s 2016 antivax propaganda film disguised as a
documentary, VAXXED, has been elevated to a senior supervisory role (GS-15)
overseeing research on adverse childhood experiences, including adverse vaccine 
reactions.

That’s not all, however. All branches of HHS, including CDC, FDA, and NIH have
embraced purges, censorship, canceled clinical trials, and shuttered labs, using
a combination of techniques, including firings (RIFs), massive budget cuts
proposed in the 2026 budget (such as a 40% cut to the NIH budget), and
weaponizing federal grants to force universities to comply with repression of
free speech and free academic inquiry. As a cancer specialist, I find it
particularly egregious that, as fellow SBM blogger Dr. Jonathan Howard pointed
out yesterday, such budget cuts disrupted 383 clinical trials, affecting 74,000 
trial participants, with some real horror stories about patients on clinical
trials out there:

The report indicated that approximately 1 in 30 NIH trials were affected by
funding disruptions between February and August 2025, for a total of 383 trials.
The cuts disproportionately affected trials involving the study of “infectious 
diseases, prevention, and behavioral interventions,” the JAMA report noted. For 
example, the cuts affected 118 cancer trials, 97 trials studying infectious
diseases, 18 trials studying cardiovascular diseases, and 48 trials studying
reproductive health, among others.

Patel and his co-authors also found that a greater percentage of NIH trials
conducted in locations outside the United States experienced funding
disruptions, compared to those conducted within the country. This corresponds
with other administration actions targeting international researchers.

And:

Disrupted trials also hurt patients. As Patel told Politico, the patients in the
trials “were exposed to the potential harms of treatment — whether that’s in
the form of drugs or devices or other interventions — but they didn’t receive
any benefit, which is what the entire purpose of the clinical trial is.”

Nothing like this has ever been done by any previous administration, certainly
not on this scale. Speaking among my colleagues, they complain that they now
feel like it’s Nineteen Eighty-Four, in which they have to self-police their
language in grant applications to avoid the censors and the AI scanners that are
looking for “forbidden” words. As I gear up to write and submit research grants
again in 2026, I’ve been thinking about that myself. Moreover, given how much
the powers that be at NIH now despise me, I have turned down an offer to serve
as an ad hoc reviewer in a study section simply because I don’t want to get the 
employee who invited me into trouble, should certain people find out that I’m on
a study section roster.

The heirs of Dr. Zaius

In Planet of the Apes, Dr. Zaius is a bit more complex than just a mindless
ideologue. Sometimes, he is even somewhat sympathetic. Although he is both
Minister of Science and Chief Defender of the Faith and publicly states that
there is no conflict, clearly he realizes that there is and chooses faith over
science because he believes that the science being uncovered by Cornelius is too
threatening to the established order. Indeed, after seeing products of a human 
civilization predating ape civilization, he orders the mouth of the cave to be
dynamited—and apologizes to Cornelius and Zira over their protestations as he
does so, as well as for the need for them to stand trial for heresy. In other
words, he knows what he is doing. He knows that the emerging science that
Cornelius has discovered in his excavations doesn’t support his religion, but he
suppresses it anyway, all to protect the existing power structure and because
he is afraid.

I realize that this is an imperfect analogy, but RFK Jr. is a true believer, at 
least in the antivax cause and MAHA pseudoscience, just as Lysenko was a true
believer in his preferred form of agricultural genetics-denying pseudoscience.
This is why RFK Jr. has, for the last two decades at least, cherry-picked
science, misrepresented science, and even tried to generate his own “science” to
support his ideology, the last of which he is doing with a vengeance at HHS.
Examples include an unethical study he has funded of the birth dose of hepatitis
B in Guinea-Bissau that I wrote about in detail earlier this month. This is
consistent with some of the things he had done before becoming HHS Secretary.
For instance, in the lead-up to the aforementioned measles outbreak in Samoa in 
2019, when vaccination rates had fallen due to a tragic accident involving MMR
vaccine that had resulted in the deaths of two infants, RFK Jr. sought to
capitalize on the plunging vaccination rates by running an unethical “vaxxed vs.
unvaxxed” “natural experiment“:

With a renowned health informatics expert in tow, Kennedy visited Samoa in 2019,
to pitch the prime minister and ministry of health on an information system
that would track the impact of medical interventions, including vaccines, on the
nation’s 200,000 citizens.

The study never happened, but it wasn’t long before plunging vaccination rates
demonstrated what happens to children who aren’t vaccinated against measles:

Months after Kennedy’s visit, the question of what would happen to Samoa’s
unvaccinated babies was answered. A measles outbreak swept the country,
sickening thousands and killing 83, mostly small children.

Something that we could already have predicted. It’s the same sort of crappy
science that Lysenko would have approved of though for an equivalently bad study
in agriculture and botany.

But back to the analogy (such as it is). As I’ve shown, Dr. Zaius knew that he
was peddling pseudoscience, but he did it anyway in return for power and because
he honestly believed that what he was doing was for the good of his society, to
protect it against the perceived threat of talking humans who might rise again.
A wrinkle here is that Dr. Zaius also knew that intelligent humans had arisen
before ape civilization and that they were responsible for the wasteland known
as the Forbidden Zone. Before the iconic big reveal at the end of the movie, if 
you looked at things from Dr. Zaius’ perspective, he knew that intelligent
humans capable of civilization had existed before the ape civilization in which 
he lived and that they had caused devastation, out of which intelligent apes had
arisen to found their own civilization, led by the Lawgiver. (I’m not going to 
go into subsequent movies and the TV series that revealed the whole story of how
this happened.) In other words, his ideology trumped inconvenient science.

Which brings me to he heirs of Dr. Zaius. Who are these heirs? They are the
collection of grifters, sycophants, toadies, and lackeys who know better, who
know MAHA is mostly pseudoscientific quackery, but who have signed onto MAHA to 
serve RFK Jr. and Trump in order to have power and to exercise their ideology to
reshape science because they fear what unfettered science will show and where
it might lead. Who are these people? I think you know. They all started out as
“COVID contrarians,” who made a name for themselves by downplaying the severity 
of the pandemic, attacking public health mitigations (which they called
“lockdowns”), and, later, casting doubt on the safety and efficacy of COVID-19
vaccines:

  1. Marty Makary MD (FDA Commissioner). Dr. Makary first came to my attention as
    one of the foremost promoters of the myth that medical errors constitute the
    third leading cause of death in the US, all based on a risibly incompetent 
    study that was a tour de force of bad math and using an unjustifiable
    extrapolation from small numbers to conclude that 250,000 deaths occur each 
    year in hospitals due to medical error. Basically, Dr. Makary started out
    semi-reasonable on COVID-19 but was, as our very own Jonathan Howard has
    long documented, quick to be captured by his audience and fully embrace the 
    “let ‘er rip” approach to the pandemic in a futile effort to achieve
    “natural herd immunity,” which, he promised, was always no more than six
    months away, after which he rapidly pivoted to fear-mongering about COVID-19
    vaccines. Amusingly and predictably, now that he is FDA Commissioner, after
    having long criticized pandemic mitigation strategies and vaccines as not
    being sufficiently evidence-based and calling for randomized controlled
    clinical trials on a variety of questions, whether RCTs were feasible or
    ethical or not, he has pivoted to accepting a more “fluid” standard of
    evidence for interventions RFK Jr. likes (e.g. stem cell-based therapies,
    many of which are currently offered in quack clinics without full FDA
    approval) while simultaneously moving towards embracing RFK Jr.’s deceptive 
    “no saline placebo controlled RCTs” myth about vaccines. Here’s the thing. I
    really do think that Dr. Makary knows better. He simply wanted the
    opportunity to impose his ideology at the FDA, and RFK Jr. gave it to him.
    The price for power? He had to embrace MAHA. Oh, and he also had to embrace 
    purges of FDA staff.

  2. Vinay Prasad, MD (Director of the FDA Center for Biologics Evaluation and
    Research). Dr. Prasad, of course, has been a topic on this blog for a long
    time. I first encountered him when I approved of his then reasonable
    suggestions for improving the rigor of randomized controlled trials of
    oncology drugs back in 2019. Unfortunately, before the end of that year, he 
    was mocking me and other physicians for supposedly wasting our time and
    intellect debunking homeopathy, jade eggs, and other quackery, sneeringly
    dismissing it as the equivalent of “dunking on a 7′ hoop.” When the pandemic
    arrived a few months later, it didn’t take him long to join Dr. Makary as a
    “COVID contrarian,” downplaying the risks of COVID and then later casting
    doubt on the safety and efficacy of COVID vaccines, all while demanding RCTs
    of public health interventions as well as different vaccine combinations
    and boosters, whether such trials were ethical or even feasible. Eventually,
    he started to sound more and more sympathetic to RFK Jr.’s antivax tropes, 
    even though at that time I didn’t think he had (yet) become antivax,
    although at one point he fully embraced the longstanding antivax message of 
    “do not comply” with COVID vaccine mandates. Amusingly, he soon ran into
    trouble with some MAGA/MAHA stans when he tried to apply his evidence-based 
    methodolatry to a treatment they liked, resulting in his “resignation,”
    although RFK Jr. somehow got him reinstated. Again, I am pretty sure that
    Dr. Prasad knows better, but he was just so eager for the power to impose
    his EBM methodolatry to the approval and regulation of vaccines that he’s
    willing to go full MAHA for the opportunity.

  3. Jay Bhattacharya, MD (NIH Director). Dr. Jay Bhattacharya is, of course, a
    coauthor of the Great Barrington Declaration, that famous anti-public health
    manifesto calling for a “let ‘er rip” approach to the pandemic—in October
    2020, before there was a vaccine!—with the futile goal of achieving “natural
    herd immunity,” with a poorly defined strategy of “focused protection” that
    would supposedly keep those most vulnerable to severe disease and death
    from COVID-19 while the presumably young and healthy died at a much lower
    rate than the elderly and ill as the virus rampaged through the population. 
    It was a tendentiously libertarian and profoundly social Darwinist approach 
    to “open up the economy” at the expense of disease and death that never
    would have worked and ultimately caused enormous damage to public health. As
    was posted in a lab research group on Reddit, “NIH director is usually
    someone that A) has an entire career dedicated to biological and medical
    research and B) is a leader in their field and has extensive administrative 
    experience. Bhattacharya has an MD but is health care economist, is
    appointed because he is a COVID skeptic, not because of his academic and
    research qualifications. Harold Varmus and Francis Collins changed the world
    of research and medicine, this guy posted on Twitter.” Unsurprisingly,
    since becoming NIH Director, Dr. Bhattacharya has signed onto everything
    President Trump and RFK Jr.’s MAHA agenda demand, including canceling
    hundreds of research grants on topics that don’t align with administration
    priorities, targeting especially anything having to do with mRNA vaccines,
    gender, gender-affirming care of transgender patients, and diversity, just
    as Lysenko would have done. He is also widely viewed as ineffective, with
    some staff giving him the divisive nickname of “Podcast Jay,” based on his
    seeming to care more about his podcast than actually running the NIH.

  4. Mehmet Oz, MD (Administrator for the Centers for Medicare and Medicaid
    Services). I long ago dubbed Dr. Oz “America’s Quack,” in a “nod” to Oprah
    Winfrey having declared him “America’s Doctor,” thus launching his TV
    career. It’s worth mentioning first how Dr. Oz routinely had antivaxxers
    like RFK Jr., Dr. Mark Hyman, and Mike Adams on his daytime TV show back in 
    the day. During the pandemic, Dr. Oz also boosted quack tycoon Joe Mercola, 
    who’s now (hilariously) in the thrall of a psychic medium claiming to
    channel Bahlon, an “ancient and wise high-vibration entity from the Causal
    Plane,” and as a result now thinks he’s a “new Jesus” who will save the
    world. His promotion of COVID-19 misinformation started early too. During
    the early weeks of the pandemic in 2020, Dr. Oz, enamored of Didier Raoult‘s
    horrendously awful science, promoted Didier’s protocol using
    hydroxychloroquine and azithromycin as a cure for COVID-19. Meanwhile, as he
    was angling to run as a Republican to be one of Pennsylvania’s Senators, he
    started embracing the minimization of COVID-19, in particular becoming
    critical of school closures. Indeed, he went so far that he was forced to
    apologize for having suggested that reopening schools was a “very
    appetizing” opportunity because it was estimated that reopening schools
    might “only” increase the total number of COVID-19 deaths by 2-3%. Dr. Oz
    also had Donald Trump on his show in September 2016 in the heat of the
    election season, and the two got along so famously that I referred to it as 
    a “huckster bromance.” Now here’s the thing. I’m pretty sure that Dr. Oz
    knows better too. He knows that a lot of MAHA is nonsense, and, even though 
    he was a “pioneer” (if you can call it that) in “integrating” quackery with 
    medicine, I’m pretty sure he realizes that the MAHA obsession with trans
    people is nonsense. That didn’t stop him from justifying blocking paying for
    “bottom surgery” for trans people with a bizarre speech in which he
    complained that it costs $150,000 to create a penis and $60,000 to create a 
    vagina.

It’s not a coincidence that all of these men are down with purges, censorship,
and vendettas to create an environment in which scientists fear to speak up at
the NIH and FDA. Of course, I would argue that the fictional Dr. Zaius, as wrong
as he might have been, was more honorable than any of these men. He more or
less stuck with actual science unless and until it conflicted with his religion.
In other words, in the movie at least, he was far more reactive than proactive.
He didn’t act to suppress inconvenient science until he could no longer ignore 
it and saw no choice but to act. In contrast, Trump’s minions are very
proactive, actively seeking at every turn to suppress and censor science that
clashes with their ideology and the evangelical religion that props it up.

Come to think of it, despite his prioritizing ideology and religion above
science, the fictional Dr. Zaius was far more honorable than any of the men
listed above who’ve signed on to the MAHA agenda in return for the chance to
impose their ideology on the agencies that they currently lead.

And that brings me to one last point. The big reveal at the end of Planet of the
Apes is deservedly famous, producing one of the most iconic closing images in
all of film history. This moment occurs when Taylor, riding a horse along the
ocean shoreline with the native human whom he’d fallen in love with after Dr.
Zaius had basically said, “Screw it!” and let him go, encounters this:

Taylor (on his knees in the foreground) makes a shocking realization. He is, to 
put it mildly, not pleased.

Yes, it’s the Statue of Liberty, the sight of which leads Taylor to realize that
he’s back on earth—he’s home—his ship having somehow circled around and come
back, over 2,000 years in the future, after an apocalyptic nuclear war that had 
destroyed human civilization and led to the current ape-dominated civilization. 
As Nova stands by looking confused, Taylor falls to his knees and pounds his
fist into the wet sand in despair crying, “You murders! You blew it up! Damn
you! Damn you all to hell!”

Sadly, I fear that this final image will be a metaphor for what US federal
medicine, public health, and biomedical science will look like by the time the
heirs of Lysenko and Dr. Zaius are through with it on January 20, 2029, with
proponents of science-based medicine in the role of Taylor as they survey the
wreckage.


The Lysenko-ization of federal science takes a big step forward

From the beginning, Trump science policy has been Lysenko 2.0, in which
ideology, not scientific promise and rigor, dictates federal grantmaking. OMB
Director Russell Vought’s proposed rules de-emphasizing peer review and placing 
political appointees in charge of final grantmaking decisions do Lysenko proud.

David Gorski on June 1, 2026

Link


Ever since Donald Trump was elected President for a second time in 2024, I’ve
been first warning about, and then lamenting, how his administration would
devastate US federal science problems. Specifically, it was very obvious that
President Trump, Project 2025, and the entire right wing establishment that
supports him wanted to transform US science policy, particularly biomedical
science policy, to make it conform to their ideology, regardless of what
rigorous, high quality science found, surrounding topics such as vaccines,
transgender people and gender-affirming care, public health, nutrition, climate 
science, and a number of other scientific topics. It’s a trend that I soon
started calling either “Lysenko 2.0” or the “Lysenko-ization” of the National
Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC),
the Food and Drug Administration (FDA), and other science organizations in the
US government. Indeed, I started calling the “make America healthy again” (MAHA)
movement promoted by Secretary of Health and Human Services—and long time rabid
antivax activist—Robert F. Kennedy, Jr. the “new Lysenkoism.”

For those not familiar with Lysenkoism, it’s a term inspired by the career of
Trofim Lysenko, a geneticist and agricultural scientists whose ideas regarding
agriculture and genetics appealed to Soviet dictator Josef Stalin. In brief,
Lysenkoism was the disastrous political campaign led by Lysenko against
science-based agriculture because of his rejection of Mendelian genetics in
favor of Lamarckism. (For a lot more detail on Lysenko’s career and purges of
scientists who tried to stick to actual science when it came to genetics and
agriculture, I recommend Ethan Siegel’s article detailing the history, as well
as my post on how MAHA is the new Lysenkoism.) In brief, during his time as
Josef Stalin’s favorite scientist, Lysenko and his version of biology that came 
to be known as Lysenkoism led to the persecution of biologists who stuck to
science-based views regarding agriculture that conflicted with Lysenko’s, up to 
and including imprisonment and, in some cases, execution. Worse, his ideas
applied to Soviet Agriculture clearly led to crop shortfalls and ended up
massively worsening famines. Although no one has been imprisoned (yet) or
executed, under the reign of President Trump and HHS Secretary RFK Jr., science 
policy is being transformed to look a lot more like agricultural science policy 
dictated by Trofim Lysenko in the 1930s and 1940s, when he was at the height of 
his power. We see this in the deceptive term “gold standard science,” the mass
cancellation of already funded NIH research grants because they mentioned
“diversity, equity, and inclusion” (DEI) or funded studies now-proscribed
topics, and how NIH Director “Podcast Jay” Bhattacharya wants to turn the NIH
into the “research arm of MAHA,” among other developments since Trump took power
again.

This week, the Director of the Office of Management and Budget (OMB) issued
proposed rules covering federal scientific grantmaking, publishing them in the
Federal Register under the title Regulation for Federal Financial Assistance,
with a deadline for public comment of July 13. It is the fruition of a process
that I first discussed last August, when President Trump issued an executive
order basically demanding just such changes in rules. If implemented, these
rules could spell the end of US science as an endeavor that’s been relatively
immune to partisan politics and the direct control of the party in power. It is 
a blueprint for the completion of the Lysenko-ization of US science.

Russell Vought codifies how the Trump administration will Lysenko-ize US science

The most obvious and blatant indication that the Trump administration wants to
Lysenko-ize federal science, however, has been its push to change the system of 
research grants at the NIH and other federal agencies that issue research
grants, such as the National Science Foundation (NSF) to de-emphasize peer
review and shift the real power in deciding which scientists and research
organizations receive federal grants out of the hands of career scientists at
the relevant organizations and into the hands of political appointees. I last
covered this topic in August, when Trump issued an executive order, Improving
Oversight of Federal Grantmaking, which claimed that “Federal grants have funded
drag shows in Ecuador, trained doctoral candidates in critical race theory, and
developed transgender-sexual-education programs. In 2024, one study claimed
that more than one-quarter of new National Science Foundation (NSF) grants went 
to diversity, equity, and inclusion and other far-left initiatives. These NSF
grants included those to educators that promoted Marxism, class warfare
propaganda, and other anti-American ideologies in the classroom, masked as
rigorous and thoughtful investigation.”

In the name of eliminating supposedly rampant waste that doesn’t exist,
eliminating all the supposed ideology described, and improving the quality of
federally-funded scientific research, gave several instructions to the Office of
Management and Budget (OMB) and others in charge of “discretionary” funding of 
research grants. Among these were instructions that:

  1. “Senior appointees and their designees shall not ministerially ratify or
    routinely defer to the recommendations of others in reviewing funding
    opportunity announcements or discretionary awards, but shall instead use
    their independent judgment.” Translation: Political appointees don’t have to
    defer to the recommendations of peer review panels, such as NIH study
    sections, in deciding which grant applications get funded if they don’t want
    to.
  2. “Discretionary awards must, where applicable, demonstrably advance the
    President’s policy priorities.” This one is self-explanatory. While it is
    true that Presidents and Congress have issued policy instructions to the NIH
    and other grant-issuing agencies regarding which scientific questions they 
    consider important, I do not recall ever having seen such a diktat before
    from any administration since I started my involvement in science in the
    1980s. Not even Ronald Reagan went this far.
  3. Discretionary awards. “Discretionary awards shall not be used to fund,
    promote, encourage, subsidize, or facilitate:” the usual cast of bogeymen,
    including “racial preferences or other forms of racial discrimination by the
    grant recipient”; “denial by the grant recipient of the sex binary in
    humans or the notion that sex is a chosen or mutable characteristic”
    (seriously, do even the “gender critical” scientists like Jerry Coyne
    support such a ban?); “illegal immigration”; or “any other initiatives that 
    compromise public safety or promote anti-American values,” “anti-American
    values,” apparently, being defined by the Trump administration.
  4. “Research grants should be awarded to a mix of recipients likely to produce
    immediately demonstrable results and recipients with the potential for
    potentially longer-term, breakthrough results, in a manner consistent with
    the funding opportunity announcement.” I wouldn’t necessarily be troubled by
    this requirement, if it weren’t this administration. Under this
    administration, I rather suspect that this diktat means that grantmaking
    agencies will be forced to operate under some “DEI” and fund, in addition to
    real scientists, cranks whose “science” is based on ideology more than
    science, such as climate science deniers, antivaxxers, and “lab leak”
    conspiracy theorists.
Trump gave the game away with this passage, however:

Nothing in this order shall be construed to discourage or prevent the use of
peer review methods to evaluate proposals for discretionary awards or otherwise 
inform agency decision making, provided that peer review recommendations remain 
advisory and are not ministerially ratified, routinely deferred to, or otherwise
treated as de facto binding by senior appointees or their designees.  Further, 
nothing in this order shall be construed to create any rights to any particular 
level of review or consideration for any funding applicant except as consistent 
with applicable law.

As I said, political appointees making the final decision on which grants will
be funded can listen to the peer review reports coming out of, for instance, NIH
study sections if they want to—nudge nudge, wink wink—but they really don’t
have to and are, in fact, being encouraged not to. The part about “provided that
peer review recommendations remain advisory and are not ministerially ratified,
routinely deferred to, or otherwise treated as de facto binding by senior
appointees or their designees” gives the game away. In contrast, members of the 
scientific councils at the NIH that finalize all grant funding decisions already
have a degree of latitude in how they rank grants for funding and can override 
priority scores determined by the NIH study sections’ peer review process, but
in general are, more or less, “routinely deferred to, or otherwise treated as de
facto binding by senior appointees or their designees.”

Which is as it should be if you want to fund the most promising and most
rigorous science.

Now let’s look at OMB Director Russell Vought’s proposed rules to implement
Trump’s executive order. In fairness, these rules, if implemented, would apply
to more than just scientific agencies in the federal government, as pointed out 
in the beginning:

A Proposed Rule by the Management and Budget Office, the Health and Human
Services Department, the Agriculture Department, the State Department, the
Agency for International Development, the Veterans Affairs Department, the
Energy Department, the Treasury Department, the Defense Department, the
Transportation Department, the Commerce Department, the Interior Department, the
Environmental Protection Agency, the U.S. International Development Finance
Corporation, the National Aeronautics and Space Administration, the United
States Agency for Global Media, the Nuclear Regulatory Commission, the
Corporation for National and Community Service, the Social Security
Administration, the Housing and Urban Development Department, the National
Science Foundation, the National Archives and Records Administration, the Small 
Business Administration, the Justice Department, the Labor Department, the
Homeland Security Department, the Institute of Museum and Library Services, the 
National Endowment for the Arts, the National Endowment for the Humanities, the 
Education Department, the Export-Import Bank, the Office of National Drug
Control Policy, the Peace Corps, the Election Assistance Commission, the Gulf
Coast Ecosystem Restoration Council, the Federal Communications Commission, the 
Consumer Product Safety Commission, the Delta Regional Authority, the Appraisal 
Subcommittee of the Federal Financial Institutions Examination Council, the
Marine Mammal Commission, the Millennium Challenge Corporation, and the National
Credit Union Administration on 05/29/2026.

The summary really is some great Orwellian Newspeak:

The Office of Management and Budget (OMB) proposes to revise the Guidance for
Federal Financial Assistance to improve government-wide policies and
requirements related to the management of grants, cooperative agreements, and
other forms of assistance. OMB is proposing revisions that would improve
transparency, accountability, and oversight for Federal awards across the
Federal Government. This includes ensuring that American tax dollars are not
wasted or misused, activities performed under Federal awards are consistent with
law and policy, and recipients are held accountable when they fail to meet
relevant standards. The revisions also aim to ensure that basic American
principles of equality and equal opportunity are upheld throughout all stages of
the award making process and that unlawful discrimination is no longer
permitted. Proposed changes also include providing further clarification on the 
regulatory status of the OMB requirements and on the process for future updates 
to the government-wide requirements. Finally, OMB also proposes changes to
reduce recipient burden. The listed Federal grant-making agencies propose
conforming changes to their respective adopting regulations, or, in the case of 
some agencies and other entities, establishing new adopting regulations or
policies. The proposed changes reflect the administration’s commitment to
transparency, accountability, and proper oversight for the Federal grantmaking
process. The proposed regulations seek to ensure that American tax dollars are
ultimately used to serve the needs of the American public.

All of this sounds reasonable on the surface. When you get into the weeds,
however, you’ll see that it’s basically Trump’s executive order warmed over,
with few changes, in which Vought makes it explicit right in the executive
summary that this is all designed to combat “wokeness”):

This lack of transparency, accountability, and proper oversight became
increasingly clear between 2021 and 2024. Federal awards were often used during 
those years to promote a “woke” policy agenda that did not reflect the values of
the vast majority of the American public.[2] For example, Federal programs and 
funding opportunities were designed to advance unlawful identity-based
“Diversity, Equity, and Inclusion” (DEI) policies and preferences across the
country.[3] These policies were inconsistent with basic American values and
civil rights laws, including the equal protection principles of the U.S.
Constitution.[4] They were also misaligned in many cases with underlying public 
purposes authorized by law.[5] Collectively, these policies wasted a great
amount of taxpayer resources and caused great harm to public trust in
government.

The White House Fact Sheet of August 7, 2025, describes examples of the types of
wasteful spending that occurred as a result of such policies. For example,
Federal grants funded unlawful DEI practices,[6] various anti-American
ideologies in American education,[7] non-replicable and highly misleading
studies,[8] labs engaged in gain-of-function research,[9] and AI-powered social 
media censorship tools.[10] More recently, another White House Fact Sheet of
January 8, 2026 provided examples of the rampant and pervasive problem of fraud 
in the United States, including under assistance programs in Minnesota.[11]

The “White House Fact Sheet” was really just propaganda justifying Trump’s
executive order from August. In any case, as I pointed out at the time, the
evidentiary basis behind these claims was really quite transparently poor. For
instance, reference 3 is a 2022 Heritage Foundation report entitled President
Biden’s `Equity Action Plans’ Reveal Radical, Divisive Agenda, which is hardly
what one would call anything resembling a nonpartisan, unbiased (or even not
that biased) source. References 4-8 go to Presidential executive orders whose
standards of evidence for backing up their claims are not what anyone would call
rigorous. And, of course, adding the reference to “pervasive” fraud involving
assistance programs in Minnesota is just the cherry on top of the propaganda
cake, particularly when used to justify cracking down on scientific grant
programs, which have a very low level of fraud.

Let’s first start with the proposed rules that flow directly from Trump’s
executive orders, and then move on to some equally problematic rules that are
related. The first and most obvious big one is that, consistent with Trump’s
executive order, the proposed rules want to make rigorous peer-review
non-binding and strictly “advisory”:

OMB proposes to revise § 200.205 to strengthen requirements for agency merit
review and to establish a new pre-issuance review process consistent with
Executive Order 14332. Under the proposed requirements for pre-issuance review, 
as part of the broader merit review process, agencies must ensure that proposals
selected for funding are consistent with applicable law, Federal agency
priorities, and the national interest. Consistent with the Executive order,
senior appointees must conduct these reviews and apply specific principles when 
evaluating proposals. These principles include ensuring that discretionary
awards advance the President’s policy priorities, prohibit the use of funds for 
discriminatory or otherwise impermissible purposes, and emphasize ensuring
compliance with applicable law. Additionally, the proposed revisions encourage
agencies to broaden the range of recipients, prioritize institutions
demonstrating rigorous and reproducible scholarship, incorporate benchmarks for 
measuring performance of “Gold Standard Science,” and direct agencies to weigh
institutional commitment to research integrity when making award decisions.
Proposed revisions in this section also clarify that peer review remains
advisory and does not replace agency discretion. Finally, the proposed revisions
clarify that agencies are not required to issue awards solely as a result of
issuing a NOFO. These proposed updates are intended to enhance consistency
across agencies, accountability, and alignment of Federal awards with
administration priorities, while also reducing the risk of award being made
contrary to statutory or policy requirements.

Again, this is very much in contrast with how the system currently works for
scientific grants, in which peer review scoring is the single most important
factor driving which grants are funded. Indeed, this is a full frontal assault
on the system used since World War II by federal scientific agencies including
the NIH, NSF, NASA, CDC, and the Department of Energy, in which peer review by a
panel of relevant experts has been the primary means by which scientific merit 
was assessed. Are these peer review processes perfect? Obviously not. I myself
have discussed the problems with NIH study sections and peer review a number of 
times on this very blog. However, ask yourself this: Is peer review by study
sections and panels made up of relevant independent experts, who produce a
report and scientific priority score for each grant application that is used as 
the primary—although admittedly not the only—measure determining which grant
applications are funded a better system than downgrading peer review to being
merely “advisory,” a suggestion that can easily be overridden on the whims of
political appointees? I would argue that it is.

I also have to wonder if Vought has thought this through. If his rules take
effect, what happens if Democrats take the White House in 2028? A future
Democratic President could use these rules to bend the grant approval process
politically to the left by defining all those “anti-American values” in a way
totally different from what the Trump administration does. True, a Democratic
President would have to issue new rules to get rid of the anti-DEI components of
the proposed rules, but a lot could be done without that. One wonders if the
administration is acting under the assumption that no Democrat will ever be
President again. Seriously, fear of what the other side would do while in power 
has long been a reason why Presidents of both parties have not tried to make
scientific grantmaking as nakedly political as the Trump administration wishes
to. Lysenko 2.0, indeed. Under these rules, presidential appointees will have
absolute veto power over funding any science that the administration doesn’t
like—or even science proposed by scientists whose political views it does not
like.

“Gold Standard Science,” Lysenko, and Humpty Dumpty

Ever since the administration coined the term “gold standard science,” I’ve
repeatedly pointed out how the term is very much akin to Humpty Dumpty’s view of
words in Lewis Carroll’s Through the Looking Glass, as epitomized by this
exchange between Alice and Humpty Dumpty. I’m going to quote liberally, because 
I don’t think that citing the shorter quote that most people cite when
referencing this “philosophy of words” quite gives the full flavor, and, believe
me, the Trump administration is going full Humpty Dumpty with “gold standard
science”:

Russell Vought’s inspiration, along with Trofim Lysenko.
`I don’t know what you mean by “glory,”‘ Alice said.

Humpty Dumpty smiled contemptuously. `Of course you don’t– till I tell you. I
meant “there’s a nice knock-down argument for you!”‘

`But “glory” doesn’t mean “a nice knock-down argument,”‘ Alice objected.

`When I use a word,’ Humpty Dumpty said in rather a scornful tone, `it means
just what I choose it to mean–neither more nor less.’

`The question is,’ said Alice, `whether you CAN make words mean so many
different things.’

`The question is,’ said Humpty Dumpty, `which is to be master– that’s all.’

Alice was too much puzzled to say anything, so after a minute Humpty Dumpty
began again. `They’ve a temper, some of them– particularly verbs, they’re the
proudest–adjectives you can do anything with, but not verbs–however, I can
manage the whole lot of them! Impenetrability! That’s what I say!’

`Would you tell me, please,’ said Alice `what that means?’

`Now you talk like a reasonable child,’ said Humpty Dumpty, looking very much
pleased. `I meant by “impenetrability” that we’ve had enough of that subject,
and it would be just as well if you’d mention what you mean to do next, as I
suppose you don’t mean to stop here all the rest of your life.’

`That’s a great deal to make one word mean,’ Alice said in a thoughtful tone.

`When I make a word do a lot of work like that,’ said Humpty Dumpty, `I always
pay it extra.’

`Oh!’ said Alice. She was too much puzzled to make any other remark.

Trust me, the Trump administration, Robert F. Kennedy, Jr., Russell Vought, and 
their ilk are definitely paying the term “gold standard science” extra. Note,
for instance, that nowhere in the rule is the term “Gold Standard Science” ever 
explicitly defined, although it is used five times. We can, of course, glean its
current meaning from the references, which link to prior executive orders,
including the document originally codifying the term “Gold Standard Science,”
namely last year’s “MAHA Report” and a May 2025 executive order. On the surface,
the definition sounds not unreasonable:

For the purposes of this order, Gold Standard Science means science conducted in
a manner that is:(i)     reproducible;(ii)    transparent;(iii)  
communicative of error and uncertainty;(iv)    collaborative and
interdisciplinary;(v)     skeptical of its findings and assumptions;(vi)   
structured for falsifiability of hypotheses;(vii)   subject to unbiased peer
review;(viii)  accepting of negative results as positive outcomes; and(ix)    
without conflicts of interest.

The problem is that the EO mandating “Gold Standard Science” was, as I
discussed, full of misrepresentations of existing science based on right wing
ideology. Again, if you just read the definition, it sounds peachy keen,
something few scientists could argue with. When you put it in context of the
“background” included attacking “DEI” and promoting pseudoscientific narratives 
about vaccines, “lab leak,” and public health, not to mention a biased reading
of the science downplaying the dangers of human-caused climate change and
promoting the use of fossil fuels, it becomes apparent how Orwellian—or Humpty
Dumpty-like—the term “Gold Standard Science” truly is. One also notes that there
is a direct inherent conflict between the part about Gold Standard Science”
being “subject to unbiased peer review” and the new diktat that peer review is
basically not to be taken as anything more than advisory, not that this
administration has ever cared about such contradictions. Neither did Lysenko,
and the topics for scientific research funded by the federal government that
this rule would outright ban is very much Lysenkoist. Basically, any grants that
“fund, promote, encourage, subsidize, or facilitate” any of the following are
verboten:

  1. “Gender ideology”
  2. Anything that has even a whiff of “DEI”
  3. Assistance with gender transition for anyone under 19 years old
Indeed, the proposed rule even goes so far as to remove any mention of Bostock
v. Clayton County, a US Supreme Court ruling that found that Title VII of the
Civil Rights Act of 1964 protects employees against discrimination on the basis 
of sexual orientation or gender identity, claiming that the decision is “legally
untenable and has harmed women.”

And:

Finally, OMB proposes to add a new paragraph (c) regarding non-discrimination
against faith-based organizations. The proposed paragraph (c) provides that
Federal agencies and pass-through entities may not discriminate against or in
favor of an applicant on the basis of the organization’s religious character,
affiliation, exercise, or lack thereof, nor on the basis of conduct that would
not be considered ground to favor or disfavor a similarly situated secular
organization. It also provides that faith-based organizations are eligible to
apply for Federal financial assistance on the same basis as any other
organization. It also explains that applicants that meet all eligibility
requirements may be considered for a Federal award under a notice of funding
opportunity.

Of course, discrimination based on religion is already illegal. So why insist on
adding passages like this? One can easily see how this might remove a barrier
to federal science agencies funding, for instance, studies in creationism based 
on creationism being bad science. (Creationists often claim “religious
discrimination” when their pseudoscience isn’t taken seriously.) One might also 
think of a number of other potential examples; e.g., reproductive health.

Meanwhile the proposed order states:

Additionally, OMB proposes a new provision that agencies may consider an
applicant’s affiliations with organizations engaged in activities that violate
Federal law, undermine public safety or national security, or advocate for the
overthrow of the United States Government.

Given how expansively this government defines “undermining public safety or
national security” and advocating for “the overthrow of the United States
government,” it’s not difficult to see how easily this provision could be used
to deny funding to researchers associated with civil rights organizations or
various public health or environmental advocacy organizations. Humpty Dumpty and
Lysenko strike again.

And all the rest…it’s bad, really bad

In addition to the above attacks on scientific merit and rigor as determinants
of funding, there are also a raft of restrictions on assembly and speech that
grantees use federal research grant money to engage in. For example:

OMB proposes to expand § 200.432 to add a requirement that costs for attending
conferences are allowable only if participation in the conference is expressly
approved by the agency and included in the terms and conditions of the award.
The revision would clarify that recipients are not authorized to attend
conferences using Federal funds that do not serve to advance program outcomes.

In other words, scientists can’t, as they have in the past, use grant money to
attend conferences without prior approval of the agency issuing the grant. This 
is a massive change that would give political appointees the power to dictate
which conferences scientists can attend to report their scientific findings;
that is, unless the scientist has other, non-federal funding to attend. Again,
it used to be assumed that it was a good thing for scientists to go to
conferences to report the findings of federally funded research, which is why
the instructions for grant applications allowed scientists to budget a certain
amount of funding for travel and attending scientific meetings to present the
findings of their grant-funded research. Under this rule, scientists can only
report the results of their grant-funded research at meetings if it’s
pre-approved or if they can pay for the expense themselves. (Many can’t.)

Also:

Except as provided in paragraph (b) of this section, publication costs
(including page charges, article processing charges (APCs), or similar fees such
as open access fees for professional journal publications and other
peer-reviewed publications) are unallowable under Federal awards. Printing costs
(including distribution and general handling) are allowable.

The only exceptions being:

The only exceptions to paragraph (a) of this section are for publication costs
that are specifically required by Federal statute or approved in advance by the 
Federal agency on a case-by-case basis. A general requirement to make results
publicly available must not be construed as authorizing publication costs.

Again, previously it was assumed that reporting and publicizing the findings of 
government-funded scientific research in the peer-reviewed biomedical literature
was a good thing, which is why grant applicants could include funds in their
budgets for page charges and open access charge costs. No more. As Elizabeth
Ginexi points out, this diktat directly conflicts with longstanding federal
mandates for open access reporting of the findings of federally funded
scientific studies, including the 2022 OSTP memorandum requiring that federally 
funded research be made publicly available.

This directly conflicts with longstanding federal open access mandates,
including the 2022 OSTP memorandum requiring that federally funded research be
made publicly available. Peer-reviewed publication is the mechanism by which
science is validated and shared. Making it financially prohibitive for federally
funded researchers to publish their findings would effectively suppress the
scientific record.

Then, of course, if you’re a researcher, you’d better not have collaborators in 
China or other countries deemed inimical to the interests of the US by this
administration:

The proposed § 200.220 establishes a government-wide baseline rule prohibiting
recipients and subrecipients from using Federal funds to support bilateral or
multilateral collaborations, agreements, programs, or activities with covered
foreign countries or covered foreign entities, unless expressly authorized by
Federal statute or approved by the Federal agency in accordance with the
proposed exception authority and applicable law. This provision is intended to
ensure that Federal financial assistance is not used, directly or indirectly, to
support activities that may pose a risk to U.S. national security, defense, or 
intelligence interests. Congress has expressly determined that such a risk
exists in the case of some agencies.

The prohibition would apply regardless of whether Federal funds are used for
direct programmatic activities, research, technical assistance, travel, or
indirect costs allocable to such collaborations. This approach would ensure that
restrictions on foreign collaboration—including those expressly required by
law—are not circumvented through the structure of funding mechanisms or cost
allocation practices.

While one might see the need for such a restriction in the case of militarily
secret and sensitive technologies and research, applying it to all scientific
endeavors funded by US federal grants, but the Trump administration proposes to 
go beyond that, basically saying that its “America First” slogan should apply to
science:

When designing research and development programs, and evaluating applications,
Federal agencies must apply a domestic-first framework, under which
international elements may be included only if the Federal agency determines
that such elements are justified, consistent with program objectives, and in the
national interest of the United States.

This passage suggests to me that, should the proposed rules go into effect, any 
research involving a significant international collaboration in which critical
parts of the research are carried out in countries other than the US (which
applies to a lot of research) will be at a major disadvantage in funding
decisions. In essence, by making it far more difficult for US researchers to
collaborate on research projects for which they need US federal agency funding, 
the Trump administration is siloing off US scientists from the rest of the
world, which in the long run will be yet another policy resulting in the
degradation of US science and making US science more prone to ideological
control by the administration.

Finally, one of the most chilling rule changes proposed is the ability of the
federal government to terminate any grant for basically any reason whatsoever,
or, as the proposed rule puts it, “terminate awards found to be inconsistent
with program goals or agency priorities.” Who dictates program goals and agency 
priorities? It used to be, for the most part, career staff, overseen by the
political appointees running the agency, and, in general, in federal science
agencies it was not political appointees making these decisions. Obviously, this
rule change was motivated by the pushback and lawsuits that resulted from the
mass cancellation of grants by the administration in the weeks immediately after
Trump reassumed power, to preclude legal recourse available to grantees whose
grants are arbitrarily canceled because the administration doesn’t like them.

The Lysenko-ization of federal science agencies is at hand

Science advocates have been warning of Lysenko 2.0 since Trump became President 
again, and everything that the current administration has done with respect to
science policy has shown that our warnings have been, if anything, not alarming 
enough. President Trump’s executive order from last August is now at the stage
where it will be codified in federal rules governing how federal science
agencies dole out grant funding, implementing key principles:

  1. Placing funding decisions squarely in the hands of political appointees
    instead of career federal scientists
  2. De-emphasizing rigorous peer review to give these political appointees
    “flexibility” to veto any scientific research that the administration
    opposes
  3. Implementing a Humpty Dumpty-inspired term “Gold Standard Science” that
    determines the scientific projects that will be funded and can mean whatever
    Humpty Dumpty the administration wants it to mean.
  4. Making it more difficult to publicize the results of federally funded science,
    both in peer-reviewed journals and at scientific conferences
  5. Providing the government with a powerful punitive tool to keep scientists in
    line, specifically the power to terminate any funded grant at any time for
    any reason whatsoever, just by declaring that it is inconsistent with agency
    goals and priorities or administration goals and priorities.
Since World War II, one of the greatest accomplishments of the federal
government has been the expansion of support for scientific research through
federal grants. Science advocacy groups, such as Stand Up For Science, are not
exaggerating when they say that these changes in federal rules would end
American support for science as we have known it for decades through the
administrations of Presidents of both parties:

Vought is trying to destroy American science as we know it. Here's what you can 
do to stop him:👉 Visit our action center: zurl.co/Hsflw👉 Donate to Fuel the
Fight for Science: zurl.co/mQlweLINK IN BIO

— Stand Up for Science! (@standupforscience.net) 2026-05-29T22:18:25.276Z

What this administration is proposing is no less than the permanent codification
of Lysenkoism as the defining trait of federal government-funded scientific
research, such that what is deemed to be good science worthy of funding is
determined not nearly as much by scientists and scientific peer review anymore
but will be increasingly determined by political operatives. Liberal,
conservative, Democrat, Republican, you should be able to see why this is a bad 
thing. For example, if you are Republican, just imagine American science under
these rules under the administration of a President Kamala Harris or Gavin
Newsom. Hopefully, regardless of political leanings, you can easily perceive how
disastrous these proposed rule changes will be for US science, if only because 
President Trump and his minions have made it very clear that they want to go the
way of Lysenko and put political appointees in charge of federal science, a
policy that is bad for science regardless of the party in power. If you support 
scientific funding that is as non-partisan and unbiased as a political system
can produce, a system that remains relatively stable and close to apolitical as 
achievable, regardless of who is in the White House, you know what to do.

ADDENDUM

Here are the instructions to start by commenting on the proposed rule, and here 
is the webpage to comment on the proposed rule changes, specifically docket
OMB-2026-0034. I like the first comment, and so far all the comments I’ve read
have been very negative. Good. Let’s add to them.


Lysenkoism 2.0 in action: Robert F. Kennedy Jr. abuses his power to bully
journal editors over a retraction

A journal editor decided to retract and remove a bad study by an antivaxxer
named Neil Z. Miller. RFK Jr. publicly demanded to know why. This is Lysenkoism 
2.0 in action in 2026.

David Gorski on June 22, 2026

Link


Those who’ve been reading SBM since at least 2024 know that, ever since Donald
Trump was elected President again, with respect to federal science policy I’ve
been referring to his second term as “Lysenkoism 2.0,” based on the
administrations immediate and aggressive efforts to alter federal science policy
to become dependent on ideology and politics, rather than rigorous science
peer-reviewed by more-or-less nonpartisan scientists. Trofim Lysenko, recall,
was the Soviet-era agricultural scientist whose ideas—which included the denial 
of Mendelian genetics in favor of a version of Lamarckism—Stalin liked because
they aligned with Soviet ideology. When put into practice, though, Lysenko’s
ideas were utterly disastrous for Soviet agriculture, worsening crop yields and 
turbocharging famines from the 1930s through the early 1960s. Yet, because his
ideas were ideologically in sync with the regime, particularly under Josef
Stalin, Lysenko yielded ruthless power over Soviet agricultural science for
decades, and scientists who dissented in favor of good science risked being
ostracized, fired, imprisoned, and in some cases even executed. This history is 
why the term “Lysenkoism” is now commonly used to refer the domination of
science by a pseudoscientific ideology, rather than evidence, experimentation,
and data.

Trofim Lysenko (1898-1976).
Despite being the product of politics, most federal science has escaped the
stain of Lysenkoism, particularly since World War II, when institutes such as
the National Institutes of Health (which I tend to discuss the most because I’m 
most familiar with it) rose to prominence. True, politicians decided funding
levels and would dictate priorities (e.g., Joe Biden’s Cancer Moonshot), but in 
general this was done in consultation with scientists, and it was career
scientists, not political operatives, making final funding decisions for
individual research grants. Most recently, earlier this month I described
proposed rules from Office of Management and Budget (OMB) Director Russell
Vought that, if allowed to take effect, would basically codify what the
administration has been doing already, specifically putting political operatives
in charge of granular decision-making over individual grants, with specific
policies enabling political appointees to decide on which grants to fund based
on whether they “align with administration priorities” or not, all while banning
swaths of research that have anything to do with the dreaded DEI (diversity,
equity, and inclusion) or “gender ideology.” Of course, the difference between
the original Lysenkoism and Lysenkoism 2.0 is that the original Lysenkoism was
(mostly) confined to agriculture and genetics, whereas Lysenkoism 2.0 has
metastasized to all federal medicine and science, with our current NIH Director 
“Podcast Jay” Bhattacharya exulting that the NIH would become the “research arm 
of MAHA” (make America healthy again), RFK Jr.’s pseudoscience- and
quackery-laden “health” movement.

Even all of that, however, is apparently not enough. You might recall recently
how the American Diabetes Association cravenly complied in advance by kicking
scientists critical of this administration’s NIH policy out of their yearly
scientific meeting. Witness our Secretary of Health and Human Services, longtime
antivax activist and conspiracy theorist Robert F. Kennedy, Jr. on X one week
ago:

I’ve been paying attention to federal health policy for literally decades now,
and I do not recall any HHS Secretary in my adult lifetime (or at least since
I’ve been paying close attention to federal health policy) ever having used the 
power of his office in this way with a clear intention to intimidate journal
editors over a retracted/removed study—or any study, for that matter. Prior to
this administration, it just wasn’t done. (If anyone remembers an example that I
might have missed, let me know, but I doubt that anyone will be able to.)
Unsurprisingly, as friend of the blog, UCSF law professor Dorit Reiss, pointed
out, he doesn’t have any regulatory power to do this:

Secretary Kennedy pretended in the past to support free speech.Now he is using
his position to bully a medical journal, in a way that's reminiscent of the
conduct the Supreme Court struck down here: https://t.co/k8EWHplU0qHe cites no
regulatory authority, and has none. https://t.co/pIhzGz4LUg

— (((Dorit Reiss))) (@doritmi) June 15, 2026

Not that any such niceties seem ever to stop this administration. I also note
that RFK Jr.’s demand to know which experts were consulted as part of the
journal’s investigation is clearly designed to frighten experts from agreeing to
participate in post-publication reviews of dodgy antivax papers for fear that
their identities will be revealed and they will be subject to harassment by RFK 
Jr. and his minions. Similarly, this concluding statement is obviously intended 
to intimidate the scientific publishing industry:

The public deserves to know how and if the scientific publishing industry is
taking its duty to ensure research integrity seriously and ethically.

I have my problems with the scientific publishing industry (and have written
about them periodically over the years), but what RFK Jr. is doing is not
intended to address any of those issues. He’s doing this because he doesn’t like
journal editors investigating, retracting, and removing pseudoscientific
“studies” that he uses to support his antivax crusade.

It wasn’t long before the usual sycophants, toadies, and lackeys joined in the
chorus, starting with evidence-based medicine (EBM) guru turned antivax crank
Peter Gøtzsche, who took to his Substack to declare Serious editorial
misconduct: unwarranted removal of an important vaccine study, even claiming
that the study “showed that infant deaths after vaccination are clustered in the
first three days.” (Given his tendency towards methodolatry, defined as the
profane worship of the randomized controlled trial as the only valid means of
clinical investigation, I’m surprised he so easily accepted this conclusion
based on anything other than a randomized controlled clinical trial. Actually,
no, I’m not.) Unsurprisingly, RFK Jr.’s buddy and sometimes legal collaborator, 
antivax attorney Aaron Siri joined in by complaining about this study’s removal 
and other investigations and retractions of typically awful antivax “studies” in
a post, The Targeted Assassination of Studies Showing Vaccines Cause Injury, in
which, with a total lack of self-awareness and/or intentional projection,
stated, “Since they can’t win on the merits, they’ve resorted to other tactics.”
(I know, I know. I laughed out loud reading that blurb, given RFK Jr.’s use of 
the considerable power of HHS to attack a journal.) Siri was also unhappy that
journal editors were investigating other antivax papers that never should have
been published, such as Hooker and Miller’s “vaxxed/unvaxxed” study from 2020
(deconstructed here).

The paper that was removed was a 2021 “study” (I hesitate to dignify this bilge 
by using that word, hence the quotes) by Neil Z. Miller. Who is Neil Miller?
He’s been featured in this blog a few times over the years—and even more often
at my not-so-super-secret other blog—because of his generally awful scientific
“studies” that always—and I do mean always—find horrible complications due to
vaccines. I first noticed him 15 years ago, when he and his frequent partner in 
crime against science, Gary S. Goldman, published a truly risible bit of
scientific dreck falsely claiming to have found a link between a larger number
of vaccines in a nation’s vaccine schedule with higher childhood mortality
rates, a study that they were flogging and defending 12 years later. I could go 
on, but recounting Miller’s list of antivax studies isn’t the point here.
Instead, one specific study of his, published in 2021, is, particularly given
that somehow I never wrote about it when it was first published, likely because 
that was the height of the pandemic and yet another study by a known antivax
crank “scientist” claiming to find a link between vaccines and sudden infant
death syndrome (SIDS) just didn’t rise high enough on my radar to trigger me to 
write about it, given the tsunami of COVID-19 misinformation we were drowning in
back then.

So let’s take a brief look at the study.

Neil Z. Miller: A hack dumpster dives into the Vaccine Adverse Events Reporting 
System (VAERS)

Whenever I’ve encountered an antivax study by Neil Z. Miller, I’ve always looked
to see if I could find what sort of credentials that he might have, and I never
find any. He is always listed as an “independent researcher,” while his
“collaborator” Gary S. Goldman lists himself as an “independent computer
scientist,” whatever that means. In the case of the removed study, the entry on 
Toxicology Reports, the journal in which the paper was originally published,
lists him as being affiliated with something called the Institute of Medical and
Scientific Inquiry in Santa Fe, New Mexico. Multiple searches failed to provide
me with an answer as to what, exactly, the “Institute of Medical and Scientific
Inquiry” is, but I do note that Miller is described as a “medical research
journalist” and director of the antivax ThinkTwice Global Vaccine Institute,
also based in Santa Fe. (The ThinkTwice website reminds me of web design
aesthetics from the 1990s/early 2000s.)

But what about the study itself? Although it’s been removed from the journal’s
website, it can still be found on PubMed Central, at least for now. As mentioned
above, it’s yet another antivax dumpster dive into VAERS, and that’s why I need
to briefly discuss VAERS yet again, as misusing VAERS to claim causation of
adverse events by vaccines has been a favorite tactic of antivax “research”
dating back to before I first started blogging in 2004. I’ve discussed several
times dating back to at least 2006 why the idea that VAERS is the be-all and
end-all of vaccine safety monitoring is wrong on a number of occasions, but I
always like to preface such remarks by simply noting something about discussions
of VAERS by antivaxxers. Notice how antivaxxers always cite VAERS and only
rarely, if ever, cite other, much better and more reliable, vaccine safety
monitoring databases, such as the Vaccine Safety Datalink (VSD), the Clinical
Immunization Safety Assessment (CISA) project, or FDA’s Post-licensure Rapid
Immunization Safety Monitoring System (PRISM) Antivaxxers also seem to like to
represent VAERS simultaneously as the best system to find adverse events (AEs)
from vaccines, even while also claiming it’s awful due to underreporting (as
above), which means (to them) that all the horrible things in VAERS are really a
lot more common than “they” want you to think.

VAERS is, of course, what is known as a passive reporting system in that it
relies on doctors, nurses, healthcare workers, and, yes, people receiving
vaccines (or their families) to report AEs after vaccines. As a system, it was
never intended to provide an accurate estimate of the frequency of AEs related
to vaccines, but rather to serve as an early warning system, a “canary in the
coal mine” if you will, for possible new vaccine-related AEs. In other words,
VAERS is a hypothesis-generating, not a hypothesis testing, system, and its
hypotheses are tested using better systems, like VSD, CISA, and PRISM. In
contrast to VAERS, these systems are active reporting systems in that electronic
health records are actively monitored for AEs after vaccination in order to
identify potential signals; there is a lot less bias that way and a lot less
potential for misreporting. I do note, however, that, now that RFK Jr. is HHS
Secretary and controls the government arm of the VSD, I am now very concerned
over antivaxxers misusing VSD to generate false studies claiming vaccine harm.
So far, the private health systems holding the data have resisted giving his
lackeys full access to VSD data, but can they hold out two and a half more
years?

But back to VAERS. The main problem with using VAERS to estimate the frequency
of AEs after vaccination is that, in essence, anyone with access to the
Internet, mail, or the telephone can report anything to VAERS, as was
demonstrated by bloggers years and years ago when one autism advocate filed a
report claiming that the flu vaccine had turned him into The Incredible Hulk and
another claimed a vaccine had turned his daughter into Wonder Woman. Both
reports were accepted. In fairness, ultimately someone from VAERS did contact
these people to ask about the reports, and the reports were removed. However,
had they refused, reports that vaccines might turn one into the Hulk or Wonder
Woman might still be in the database. Moreover, antivax lawyers have a long
history of contaminating VAERS with, for example, reports that vaccines cause
autism, something I’ve been pointing for 20 years after the first time I pointed
it out. All of these design features of VAERS make it at once useful for
hypothesis-generation but also, unfortunately, very useful to antivaxxers for
falsely claiming harms due to vaccines.

So what did Miller do in his study? He claims to have analyzed 2.605 infant
deaths reported to VAERS between 1999 and 2019, examining reports of infants
(defined as children < 1 year of age) who died within 60 days post-vaccination. 
He then claims to have analyzed the data thusly:

In the first analysis (All Mortality), VAERS was filtered to include all reports
of infant mortality regardless of whether “sudden death” or SIDS was listed in 
the report. In the second analysis (SIDS), the VAERS search was further
restricted to only include reports that mentioned “sudden death” or “sudden
infant death syndrome.” In both analyses, deaths were stratified by the onset
interval post-vaccination, that is, by the number of days that transpired
between vaccination and death (range = 1–60 days, with Day 1 = Day of
Vaccination). Pearson’s chi-squared test was utilized to determine whether there
was a statistically significant difference between the expected frequencies of 
infant mortality and the actual frequencies reported.

Of course, one notes that the peak incidence of SIDS is between 2-4 months of
age, with 95% of SIDS deaths occurring between those ages and the median age of 
an infant suffering SIDS being 11 weeks. This is a time when infants are
receiving a number of vaccines, such as at the 2, 4, and 6 month visits to the
pediatrician, a simple fact that explains why, even if you know nothing about
SIDS, it might appear that vaccines cause it. Unsurprisingly, Miller falls into 
this fallacy quickly with his two key “findings”:

Of the 2605 infant deaths, 58 % clustered within 3 days post-vaccination and
78.3 % within 7 days post-vaccination. The remaining deaths occurred between 8
days and 60 days post-vaccination, an average of 11 per day (564/53 days) as
compared to 760 infant deaths that occurred on Day 2 post-vaccination—a 69-fold 
increase (Table 2). If the 2605 deaths which occurred within 60 days of
vaccination were randomly distributed throughout this interval, one would expect
43.42 deaths per day or 304 per week. The excess of deaths on the day of
vaccination (43 were expected/440 occurred), within 3 days post-vaccination (130
were expected/1512 occurred), and in the first week post-vaccination (304 were 
expected/2041 occurred) were all statistically significant (p < 0.00001).

And:

Of the 1048 SIDS cases, 51 % clustered within 3 days post-vaccination and 75.5 %
within 7 days post-vaccination. The remaining SIDS cases occurred between 8
days and 60 days post-vaccination, an average of 4.8 per day (257/53 days) as
compared to 277 SIDS cases that occurred on Day 2 post-vaccination—a 57-fold
increase (Table 3). If the 1048 SIDS cases which occurred within 60 days of
vaccination were randomly distributed throughout this interval, one would expect
17.47 SIDS cases per day or 122 per week. The excess of SIDS cases on the day
of vaccination (17 were expected/131 occurred), within 3 days post-vaccination
(52 were expected/534 occurred), and in the first week post-vaccination (122
were expected/791 occurred) were all statistically significant (p < 0.00001).

Sounds damning, right? Wrong. As Prof. Jeffery Morris pointed out:

Sec Kennedy: The editor-in-chief already clearly explained the reason for the
removal in his notice (https://t.co/URhlHTKPLT), which was that there were
methodological flaws in the paper so serious that the conclusions were
unsubstantiated.I mention the specific methodological…
pic.twitter.com/uVBolDSDZL

— Prof Jeffrey S Morris (@jsm2334) June 15, 2026

Specifically:

The editor-in-chief already clearly explained the reason for the removal in his 
notice
(https://sciencedirect.com/science/article/pii/S2214750026000521?via%3Dihub),
which was that there were methodological flaws in the paper so serious that the 
conclusions were unsubstantiated.

I mention the specific methodological flaw here, which involves inferring
causality from the fact that VAERs reports clustered close in time to the day of
the shot, an inherent characteristic of passive reporting systems and not even 
close to sufficient to conclude causality or even an association:
https://x.com/jsm2334/status/2057919431519694866

Given this fatal flaw that was not detected by peer review, the entire argument 
in the paper falls apart, and the conclusion unsubstantiated.

Think about it. If something bad happens in close temporal proximity to
vaccination, of course it’s far more likely to be reported to a passive
reporting system like VAERS. The greater the time between vaccination and the
event, the less likely the event is to be reported. It makes intuitive sense
that this should be so, and, in this case, it just so happens that this is so.
Moreover, despite RFK Jr.’s insinuation that the editors never said why they
retracted and removed the paper, they most definitely did in the notice of
removal:

Following post-publication concerns raised by readers regarding potential
research errors and methodological flaws in this article, the journal initiated 
an investigation and contacted the author for clarification.

The Editor-in-Chief determined that the author’s response did not satisfactorily
address the concerns raised about this article. In particular, serious
methodological flaws were identified in the use of VAERS data to infer a
correlation between vaccination and sudden infant death syndrome (SIDS). Given
the inherent limitations of passive reporting systems, including the expected
temporal clustering of events independent of causality, the conclusions
presented in the article are not supported by the methodology employed. In light
of these concerns, and given the potential implications for medical practice,
the Editor-in-Chief has decided that the article should be removed. The author
disagrees with this decision and disputes the grounds for removal.

Apologies are offered to the readers of the journal.

As well apologies should be offered. This is an obvious example of a manuscript 
that should have been rejected with extreme prejudice. The flaws in this study
go far beyond just a flaw in methodology. It’s far worse than just that and
extends to a flaw in the conceptual design of the study, which ignores the
inherent characteristics of the database that is being analyzed and, in
particular, what must be done in order to try to account for the issue inherent 
in such an analysis that will produce clustering of events close to vaccination 
regardless of whether the events are caused by specific vaccines or not. Or, as 
Prof. Morris put it:

As a Biostatistics professor, it is obvious to me that this is not just a case
of suboptimal methods being used or the study being imperfect and having some
weaknesses and limitations. The methodology used completely depends upon false
assumptions, so is fatally flawed, and without this analysis the paper does not 
have any standing for publication.

Indeed, Prof. Morris includes a page from his recent white paper on vaccine
safety monitoring that illustrates this point well:

Nicely chosen examples, although I’m wondering why anyone is reporting abnormal 
dreams or sunburn to VAERS. There are, of course, a number of papers with
superior design that have failed to find a link between vaccines and increased
risk of SIDS, some of which I’ve mentioned in past posts on the topic, others of
which were helpfully summarized by Prof. Morris.

Prof. Morris also noted another obvious problem with the paper that I didn’t
notice myself (but should have):

Notably, the handling editor was Aristidis Tsatasakis, who has had other dubious
papers he’s handled retracted, including most notably one of his own in which
he was senior author and initially listed as the handling editor on his own
paper.

So, yes, Toxicology Reports appears to have an antivax problem, which now seems 
to have gotten glaring enough that its editor, Lawrence Lash, decided that he
needed to do something about it, although one wonders whether he will ever
actually do what really should be done and get rid of Tsatasakis.

The bottom line is that, RFK Jr.’s transparent attempt to use his power to bully
the journal editors notwithstanding, this is not even a close call as to
whether this paper should have been retracted. It is obvious dreck so fatally
flawed that the real investigation that the journal should have carried out is
how such garbage could have passed its peer review system and been published.
Indeed, one is tempted to suggest to RFK Jr. that he should be as interested in 
the identities of the original peer reviewers who let this paper pass as he is
in the identities of the experts consulted to help with the investigation of
this paper who concluded that it should be retracted and then removed, as well
as to harass another friend of the blog who deconstructed all the antivax
talking points in the introduction to the paper and called for the paper’s
retraction.

Enter RFK Jr.’s minions and apologists

I’ve written about how over several years Peter Gøtzsche, an EBM guru and former
head of Nordic Cochrane, has taken a heel turn from science to an antivax
apologist, first about HPV vaccines and then more generally. Indeed, a year
before the pandemic, he accepted an invitation to speak at the antivax
Physicians for Informed Consent and then was shamed into backing out of the
conference, afterwards whining about how badly treated he thought he had been.
More recently, Gøtzsche teamed up with Mary Demasi, an antivax influencer, to
exaggerate the claimed harms of COVID-19 vaccines. These days, Gøtzsche has been
reduced to writing a Substack and publishing articles for Jeffrey Tucker‘s
antivax Brownstone Institute.

First of all, Gøtzsche tries to refute Prof. Morris without mentioning him, and 
fails miserably:

Miller’s research design was appropriate. Looking for clusters of potential drug
harms in databases is a well-established method, which provided support to the 
suspicion that the HPV vaccines in rare cases cause serious neurological harms.3
And he concluded carefully that his findings did not prove that the vaccines
caused the deaths but were “highly suggestive of a causal relationship.”

So, basically, Gøtzsche wasn’t troubled by the methodology because it had been
used in the pass to suggest a causal relationship between neurological harms and
HPV vaccination. He also seems to be missing the point. No one said that
looking for clusters of potential drug harms in databases is inappropriate,
simply that the way this particular search for clusters of drug harms in a
database ignored a key conceptual issue that invalidated the study. The database
matters. If this were an active reporting system, like the VSD for instance,
that actively scans electronic health records for adverse outcomes related to
vaccines, Gøtzsche might have a point, but this is a passive reporting system.
Prof. Morris explained why the clustering observed occurs for adverse events
unrelated to vaccination.

The rest of Gøtzsche’s complaints are, quite frankly, embarrassing, and, rather 
than go through them one by one, I am simply going to cut to the chase and cite 
this paragraph, perhaps the most embarrassingly cringey defense of Miller that
I’ve seen:

Miller’s discussion section is very long, 8 pages, and I have several
reservations. It seems to me that he cherry-picked the references, which include
an unpublished lecture and book chapter I could not retrieve. Others are
unconvincing. Miller also left out some large studies that did not find an
association between vaccination and infant mortality. However, his methods and
his result, a clustering of deaths, are convincing.

So let me get this straight. After admitting that he thought that Miller had
cherry-picked the references used in his discussion of his results and that
Miller had also included unconvincing references and failed to cite and address 
large studies failing to find an association between vaccination and infant
mortality, Gøtzsche nonetheless has the temerity to conclude that Miller’s
methods and result are “convincing”? There is only one reaction appropriate to
this sort of a brain dead argument:

When Godzilla gives you the facepalm, you know the failure is monstrous.
(Someone needs to do a new Godzilla facepalm meme, with a newer version of
Godzilla. Speaking of Godzilla, I can’t wait for Godzilla Minus Zero to come out
this November.)
Gøtzsche then opines:

To put Miller’s findings in proper perspective, we need systematic reviews of
the randomised trials, including those that have compared early with late
vaccination, because his own research has shown that the death risk is smaller
in older children.5 Such trials exist.

Moreover, we need a systematic review of observational studies, with the various
biases in such research being addressed in the protocol and carefully assessed 
in the review.

Again, Prof. Morris discussed the evidence from much higher quality sources that
failed to find an association between vaccination and SIDS. Seriously, in the
scientific community it isn’t even controversial that vaccines are not a risk
factor for SIDS; the question has been studied many times. In any event, here,
Gøtzsche is just engaging in some methodolatry (demanding systematic reviews of 
RCTs, which actually exist and, if anything, suggest that vaccination might
actually be protective against SIDS) and ignorance about the actual
observational and epidemiological data already published addressing this
question. Again, Prof. Morris discussed these studies in his long X post,
concluding:

Bottom line: we don’t need VAERS for this. We have numerous population-level
studies, including multiple SCCS [self-controlled case series] built to detect
exactly this kind of short-term risk, and the evidence consistently shows no
increase in SIDS following vaccination.

The Miller retraction simply removes an erroneous result: one that was already
irrelevant next to the larger, more rigorous population-level studies, which
consistently show no increased SIDS risk after vaccination.

Seriously, after the passages I cited above from Gøtzsche, I started to check
out, as Gøtzsche continued to embarrass himself by primarily going after what he
likely viewed as an easy target, the pseudonymous Rosewind, another friend of
SBM, and complaining about PubPeer comments on the article, referring to it as
“PubSmear” and whining that such concerns should have been brought up in a
letter to the editor, which is rich given that he published his rant on
Substack. Dude, why didn’t you just write a letter to the editor of Toxicology
Reports?

Meanwhile, Aaron Siri claims that Miller has addressed all the criticisms:

Elsevier says it found “serious methodological flaws” and that the paper “may
pose potential risks to public health.” Author Neil Miller explains their
concerns were “either insignificant or plainly incorrect.” He has shared his
emails with Elsevier publicly, so you can be the judge. A copy of the study can 
still be found here.

Amusingly, the email exchange is being hosted on the website of Steve Kirsch,
the tech bro turned antivaxxer who is a master of challenging vaccine advocates 
to “debate me, bro” wagers, using LLM chatbots to make his antivax arguments,
and of mangling science beyond belief, as long as it serves an antivax agenda.
Also amusingly, nowhere in his email exchange does Miller directly address the
fatal flaw in his paper, that in a passive vaccine safety reporting system
adverse events will cluster closer to the time of vaccination irrespective of
whether there is a causal relationship between vaccination and the adverse
event, repeatedly retreating to stating variations of:

The article reports statistically significant temporal clustering of reported
events within defined post-vaccination windows. This is a recognized and
appropriate method for identifying safety signals. The manuscript does not claim
causation.

Yes, we know that, but the temporal clustering doesn’t imply causation, and,
even though technically he didn’t claim causation, the manuscript sure as hell
did its best to imply causation, even going so far as to speculate about
potential immunological mechanisms to explain the clustering, while citing
pretty much every dodgy study used to claim that vaccination causes SIDS, both
in his introduction and his discussion, and includes this gem of a passage in
the conclusion:

There are 130 official ways for an infant to die, as categorized in the ICD, and
one unofficial way for an infant to expire: from a fatal reaction to vaccines. 
When vaccine-related deaths are hidden within the death tables, it is difficult 
to monitor and prevent these deaths. In addition, parents are denied the ability
to ascertain honest vaccine risk-to-benefit ratios and true informed consent to
vaccination is not possible. This is why increased effort and transparency
toward achieving an accurate account of vaccine-related infant mortality is a
desirable goal.

The findings in this paper must be weighed against the strengths and limitations
of the available data and study design. While this paper does not prove an
association between infant vaccines and sudden infant deaths, it reveals unusual
patterns and safety signals highly suggestive of a causal relationship.
Additional investigation is warranted. Finding ways to increase vaccine safety, 
reduce inaccurate or inconsistent cause- of-death certification practices, and
support families in their quest to make genuinely informed healthcare decisions,
must be top priorities.

So, yes, Miller concedes—very grudgingly—that his results do not “prove an
association between infant vaccines and sudden infant deaths” but then claims
that they are “highly suggestive of a causal relationship.” It’s a game that
antivax “investigators” frequently play, basically conceding (barely) the
scientifically accurate assessment of their finding (no association between
vaccination and the adverse outcome examined) but nonetheless insisting that
their shoddy science is “highly suggestive of a causal relationship.” They know 
that the public will remember the “highly suggestive” and forget the “do not
prove.” Miller knows that. Siri knows that. Likely, so does Gøtzsche. They’re
not stupid people (well, maybe with the exception of Miller). It’s one reason
why the Miller study has been a favorite one among antivaxxers, often cited by
RFK Jr. and his sycophants, toadies, and lackeys to justify their antivax
stances.

RFK Jr.: Feeling the heat?

The Miller paper is not the only bad antivax paper beloved of RFK Jr. and his
antivax minions undergoing investigation, retraction, and removal. As The
Guardian reported earlier this month, there are at least three, and we know from
Siri’s Substack that there are, in reality, four. The papers include:

  1. Vaccines and sudden infant death: An analysis of the Vaccine Adverse Event
    Reporting System (VAERS) database 1990–2019 and review of the medical
    literature (Neil Miller, 2021). RETRACTED and REMOVED.
  2. Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997–2002 
    (Carolyn Gallagher & Melody Goodman, 2010). RETRACTED, and rightfully so.
  3. Analysis of health outcomes in vaccinated and unvaccinated children:
    Developmental delays, asthma, ear infections and gastrointestinal disorders 
    (Brian Hooker & Neil Miller, 2020). UNDER INVESTIGATION. This is another
    truly awful study that I deconstructed when it was published.
  4. Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in
    Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada
    (David Speicher, Jessica Rose, & Kevin McKernan, 2025). UNDER INVESTIGATION.
    Although I didn’t blog specifically about this paper, I have written about 
    the inappropriate techniques used by the likes of Speicher, McKernan, and
    Rose to fear monger about the dreaded “DNA contamination” in vaccines.
As The Guardian notes, RFK Jr. has relied on these studies (all of the above
minus Speicher et al), among others, to make his Lysenkoist arguments about the 
dangers of vaccines:

Robert F Kennedy Jr, the US health secretary who has been a leader in the
anti-vaccine movement for decades, relied on two of the studies that are now
facing scrutiny for a 2023 book he co-wrote that argued unvaccinated children
were healthier than children who had been vaccinated. The US Centers for Disease
Control and Prevention (CDC) cited one of the papers when it changed its
long-held position that vaccines do not cause autism, cutting against the
scientific consensus. And all three papers were cited by a lawyer, Aaron Siri,
who called for changes to the childhood immunization schedule before an
influential federal vaccine advisory panel. Siri is the managing partner of Siri
& Glimstad and has served as a lawyer for a prominent anti-vaccine group.

Remember how I laughed when Siri wrote, “Since they can’t win on the merits,
they’ve resorted to other tactics”? As I said, that is massive projection. So is
this quote from Siri:

Behind each of these attacks is a plain desire to wipe from the record any
evidence of vaccine harm and to chill the publication of any future studies that
report vaccine harm.

Every scientist who values scientific integrity should publicly denounce these
tactics. Anything less is not science. It is ideology.

Again, projection, thy name is antivaxxer. In actuality, what is happening is
that science, for all its flaws, is in this case engaging in the self correction
that RFK Jr. says he wants to champion with his “gold standard science.” It is 
not the journal editors investigating bad studies and correcting the record by
retracting and even removing them who are moved by ideology. It is RFK Jr. and
his minions, like Siri. Indeed, as vaccine scientist Dr. Paul Offit notes:

Kennedy’s efforts to get rid of studies he doesn’t like, or reinstate those he
does, are a function of his belief system, Offit said. He “has these fixed and
immutable beliefs — mostly anti-science beliefs — so he believes, for example,
that aluminum adjuvants in vaccines cause harm.”Offit pointed to a “paper
published not too long ago out of Denmark in the Annals of Internal Medicine —
it was an excellent study, a 23-year study involving more than 1 million
children — showing children could receive anywhere from 0 mg to 4.5 mg of
aluminum in vaccines, and it basically showed vaccines didn’t cause any harm.”

Kennedy then wrote a letter to that journal, “asking them to withdraw that paper
because it went against his bias. That’s who he is,” Offit noted.

Indeed it is. There’s a reason why RFK Jr. is the perfect person to implement
Lysenkoism 2.0 at HHS. He is an antivax ideologue, his claims to be “not
antivax” notwithstanding. He is most definitely coming for your vaccines, his
endgame being the elimination of all vaccines in the US, and he will let nothing
stop him. If a study finds vaccines to be safe and effective, he will use the
power of his office to try to get that paper retracted or withdrawn. If a bad
antivax study is retracted, he will use the power of his office to try to
intimidate and punish the editors into reversing their decision. If you are a
scientist at the CDC or other HHS agency and speak out for vaccines and against 
antivaccine pseudoscience, you risk losing your job, as the administration tries
to change the rules so that career civil servants can be fired for not
sufficiently aligning with the ideological goals of the administration.

This latest kerfuffle over Neil Z. Miller’s crappy antivax study would normally 
not be a big story, but in the age of Lysenkoism 2.0, it is a reflection of
where we are as a nation in 2026. Sadly, Lysenkoism isn’t just for government
science programs anymore. It’s now metastasizing to enforce ideology on
privately owned companies that do science and scientific publishing.

z

Lysenkoism 2.0 in action: Dismantling peer review at NIH

A recent report in Nature describes how the Trump administration is weakening
peer review in favor of ideology-based grant approval at NIH. Lysenkoism 2.0 is 
in full swing and getting worse.

David Gorski on June 29, 2026

Link


I must admit that I’m getting really tired of using the two images of Trofim
Lysenko in my posts again, but, unfortunately, this week it can’t be
helped…again. I’m also getting tired of reminding our readers who Trofim Lysenko
was, in case you happen to be encountering this blog for the first time or, for
whatever reason, haven’t read my past posts on Lysenkoism 2.0 and the
destruction of US federal science. So, before I launch into discussing how this 
administration, HHS Secretary Robert F. Kennedy Jr., his useful idiot NIH
Director Jay Bhattacharya, and the real powers behind the NIH throne, Office of 
Management and Deputy NIH Director Matthew Memoli and Office of Management and
Budget Director Russell Vought are furiously working to deprioritize rigorous
scientific peer review and prioritize the decisions of political operatives when
it comes to deciding which scientists receive NIH funding for their research,
here we go again. You can skip the next paragraph if you’re all too familiar
with Lysenkoism.

Trofim Lysenko (1898-1976).
Ever since Donald Trump was elected President again, with respect to federal
science policy I’ve been referring to his second term as “Lysenkoism 2.0,” based
on the administration’s immediate and aggressive efforts to alter federal
science policy to become dependent on ideology and politics, rather than
rigorous science peer-reviewed by more-or-less nonpartisan scientists. Trofim
Lysenko was a Soviet-era agricultural scientist whose ideas—which included the
denial of Mendelian genetics and Darwinian evolution by natural selection in
favor of a version of Lamarckism—Stalin loved not because of how scientific they
were, but rather because they aligned with Soviet ideology. Unfortunately, when
put into practice, Lysenko’s ideas were utterly disastrous for Soviet
agriculture (and, in one instance, Chinese agriculture), causing crop yields to 
plummet and turbocharging famines from the 1930s through the early 1960s, when
he was removed from power after his influence had slowly waned in the years
after Stalin’s death. Yet, because his ideas were ideologically in sync with the
regime, particularly under Josef Stalin, Lysenko yielded ruthless power over
Soviet agricultural science for decades, and scientists who dissented in favor
of good science risked being ostracized, fired, imprisoned, and in some cases
even executed. This history is why the term “Lysenkoism” is now commonly used to
refer to the domination of science by a pseudoscientific ideology, rather than 
evidence, experimentation, and data. History also shows that it took Soviet
agricultural science decades to recover after Lysenko had fairly been deposed.

Despite being the product of the political process, its priorities and budgets
decided by the President and Congress over the last several decades, most
federal science has escaped the stain of Lysenkoism, particularly since World
War II, when institutes such as the National Institutes of Health (which I tend 
to discuss the most because I’m most familiar with it) rose to prominence. True,
politicians decided funding levels and would dictate priorities (e.g., Joe
Biden’s Cancer Moonshot), but in general this was done in consultation with
scientists, and it was career scientists, not political operatives, making final
funding decisions for individual research grants. Most recently, earlier this
month I described proposed rules from Office of Management and Budget (OMB)
Director Russell Vought that, if allowed to take effect, would basically codify 
what the administration has been doing already, specifically putting political
operatives in charge of granular decision-making over individual grants, with
specific policies enabling political appointees to decide on which grants to
fund based on whether they “align with administration priorities” or not, all
while banning swaths of research that have anything to do with the dreaded DEI
(diversity, equity, and inclusion) or “gender ideology.” Of course, the
difference between the original Lysenkoism and Lysenkoism 2.0 is that the
original Lysenkoism was (mostly) confined to agriculture and genetics, whereas
Lysenkoism 2.0 has metastasized to all federal medicine and science, with our
current NIH Director “Podcast Jay” Bhattacharya exulting that the NIH would
become the “research arm of MAHA” (make America healthy again), RFK Jr.’s
pseudoscience- and quackery-laden “health” movement.

What, however, does this mean in practice? I’ve discussed it before, but the
features of how this administration plans on exercising ideological control over
the science funded by NIH are coming into view, as documented by a recent
report in Nature entitled Inside the new political screening that’s stalling NIH
grants and further described by an excellent post on Substack called 27 UNIHTED
by anonymous current and former NIH employees with experience in peer review,
The Quiet Attack On Science: Subverting NIH Peer Review. Unsurprisingly, there
are some apologists for the administration who are claiming that the changes
being ushered in by this administration are no big deal, that there’s nothing to
see here, such as Anthony LoSasso, PhD, who wrote a MedPage Today editorial, I 
Served on Grant Review Panels for 12 Years. Let’s Not Romanticize NIH Peer
Review, which, as you will see, boils down to a straw man that says, “Yes, the
administration’s proposals are bad for science, but all these scientists crying 
‘Lysenko!’ go too far and are romanticizing peer review.” I don’t know who was
doing that (certainly not the editors of the New England Journal of Medicine
editorial that provoked Dr. LoSasso’s reaction, The OMB and the Politicization
of Science, who correctly raised the alarm of Lysenkoism in the very first
paragraph, while praising NIH Director Jay Bhattacharya’s proposed “unified
strategy” for NIH priorities and accusing critics of the politicization of
science by this administration of lacking humility. (Hint: No one, and I mean no
one, claims that NIH peer review is perfectly objective and never tainted by
ideology, least of all I. What critics are saying is that the proposed “remedy” 
will make NIH peer review so much less objective and more tainted by ideology.

We’ll get to all that a little later. First, a word about my background. I have 
served on NIH study sections but, I admit, never as a standing member. I’ve only
ever served as an ad hoc reviewer, namely a reviewer brought in when there
aren’t enough standing members of a study section or the study section lacks
special expertise. (I might be doing so again, although I’m hesitant, given
what’s happening at the NIH.) When last I discussed this topic a month ago, it
was in the context of OMB Director Russell Vought’s proposed new rules that
would officially codify the politicization of NIH grant review that’s already
happening.

Stalling grant disbursement for political screening

On Friday, Nature published a report, Inside the new political screening that’s 
stalling NIH grants. The reporting is the result of an investigation carried out
by Nature based on internal emails and data, as well as interviews with senior 
NIH scientists. The picture is not pretty:

Hundreds of grant applications to the US National Institutes of Health (NIH) are
being held up at any given time by unprecedented scrutiny after peer review.
Some have been flagged by an algorithm for using terms, such as ‘gender’ and
‘climate change’, that have been deemed not to conform with the priorities of
the administration of US President Donald Trump.

These new layers of review have delayed delivery of funds to labs and research
institutions — and have even resulted in the outright rejection of some
applications that had been approved by outside and agency scientists. Before
2025, it was unheard of for grants that had received such approvals to be
rejected, says one of six NIH officials who spoke to Nature on condition of
anonymity. The extra scrutiny ramped up in early 2026 and is conducted by NIH
leaders and officials at the NIH’s parent agency, the Department of Health and
Human Services (HHS).

Say what you will about the NIH—and I have said plenty over the years—in
general, it has traditionally kept its funding decisions as apolitical as
humanly possible, dating back to just after World War II. Has it always
succeeded? Of course, not, but the intent has always been there, and it tries.
It is that drive to identify and fund the most rigorous and promising science
possible that has turned the NIH into the crown jewel of US science, the premier
funder of biomedical research in this country. Again, no one says that the NIH 
is completely apolitical. No institution created by politicians—or even human
beings in general—is ever completely apolitical. After all, Congress decides on 
the NIH budget, and the President sets its priorities, usually through the
person whom he appoints as NIH Director, although at times Congress can meddle, 
sometimes with bad results, such as when Sen. Tom Harkin (D-Iowa) added
provisions to create the National Center for Complementary and Alternative
Medicine (NCCAM), since renamed the National Center for Complementary an
Integrative Health (NCCIH), which has become a federal bastion of quackademic
medicine.

I’ve discussed in detail before the review steps that an NIH grant application
goes through before it is funded. For purposes of this post, I will note that,
once a grant receives a fundable score from the original study section to which 
it was assigned, the last step is generally review by the Scientific Advisory
Council, which generally looks at the pool of grants and their scores and then
funds as many of the top-scoring grants as funding will allow. True, sometimes a
grant that didn’t quite make the cut will be funded and a grant that did will
not be, depending on institute priorities, but in general NIH funding decisions 
have been a meritocracy, if you accept the premise that the priority score
determined by the NIH study section is a good estimate of the scientific promise
and rigor of a proposed project.

Now here’s what the administration has been doing:

The extra scrutiny has particularly affected researchers waiting for previously 
approved projects to be renewed. Most applications clear the supplemental review
in two weeks, but 10% of the grant-renewal applications that have entered this 
phase in the 2026 fiscal year have become stuck for more than seven weeks, and
some have been held up indefinitely, according to data and internal e-mails that
Nature has obtained (see ‘Holding pattern’).

This might not sound that horrendous, but remember that scientists tend to live 
or die by their funding, and a funding lapse of even 7-8 weeks can endanger a
scientist’s ability to keep a laboratory open. I’m also not particularly
reassured by the claim made by the NIH that there are no “banned words”:

In response to Nature‘s queries about the grant-screening process, an NIH
spokesperson said that “there are no ‘banned word’ lists at NIH, and funding
decisions are not based on specific words or phrases.” Internal documents
suggest that the agency does not ban these words, but projects that use them are
much more likely to be scrutinized by programme officers who use the tool and
by NIH and HHS officials reviewing the project.

Oh, well that’s OK then. Of course, if there is a list of words that trigger
scrutiny by program officers who will increasingly be political appointees, then
obviously scientists will be less likely to use those words or to propose
projects for which the use of those words is mandatory or very difficult to
avoid. That’s the intent. “Oh, no, we don’t have a list of ‘banned words,'” they
say, but those words might as well be banned if the real-world effect is that
their use triggers political appointees to go over a scientist’s grant
application with a fine-tooth comb to determine whether it “aligns with
administration priorities.” That’s the intent: a “soft” de facto ban, with
plausible deniability that it’s a ban. (Well, the deniability is only plausible 
to the general public, not to most scientists.)

You might remember the nightmarish first few months after the Trump
administration took over in January 2025, when the “Department of Government
Efficiency” (DOGE) started canceling NIH grants willy-nilly if some unskilled
tech bro didn’t think that it “aligned with administration priorities.” What’s
happening now is a less ham-fisted version of the same thing:

As DOGE’s influence in government waned, NIH leaders formalized a screening
process by creating an algorithm that checks applications for a list of
disfavoured terms (see Supplementary information). As of February, the list
included 235 terms, which serve as an “indicator that the grant likely needs, at
a minimum, a revision to align its terminology with NIH priorities”, according 
to one internal document.

The tool checks every application’s title, abstract and other summary sections
for terms including ‘racism’, ‘fossil fuel’, ‘queer’ and ‘sexual minorit’
(referring to all forms of the phrase ‘sexual minority’).

This algorithm is applied after applications have passed two rounds of peer
review, and after programme officials and the relevant institute director have
deemed them worthy of funding and in alignment with institute priorities (see
‘How an NIH grant is processed’).

If the application contains one of the 235 disfavoured terms, it is classified
as “not clean”. Programme officers are then instructed to renegotiate the
language or scope of the proposed project with the applicant, or to scrap it
altogether. Officers must also write a ‘decision memo’ that describes the
actions taken.

See what I mean? Then the NIH abuses a longstanding mechanism known as “Section 
19.” In brief, Section 19 status in the past referred to grants that have been
funded but are not yet active, usually because the contract with the institution
receiving the grant hasn’t been finalized yet. This Nature report also notes
that in the past the NIH has traditionally also “used this status to give
members of the US Congress advance notice of the projects being funded in their 
districts,” which is a pretty benign thing. Under this administration, however, 
Section 19 “gives NIH leaders and the “HHS counselor” an opportunity to review
all applications, according to internal documents that Nature reviewed.” Some of
the feedback was in the internal documents reviewed by Nature, and it is
revealing.

For example:

“Does [the institute] really want to fund this study? Seems likely to end up in 
a Congressional waste report,” reads one comment, referring to analyses that
highlight examples of allegedly improper federal spending.

And:

Applications are often sent back because they include disfavoured topics or have
foreign collaborators on projects that do not show a “clear benefit” to the
United States. Applications are also bounced back to programme officers for
alleged “lobbying activities”, a reference to projects that aim to inform
policy; or for containing “vague and non-specific language”, such as the phrase 
‘social determinants of health’, which is deemed not to include “measurable
concepts”, according to e-mails that Nature obtained.

I note that the term “social determinants of health” has a very definite
definition in public health that is not too difficult to comprehend. Remember
how I’ve long said that MAHA cares nothing for the social determinants of
health? This policy suggests that MAHA is downright hostile to such
determinants. In any event, this sort of review often results in:

In such cases, the application is sent back to the handling NIH programme
officer to remedy the issue, often requiring that they renegotiate the scope of 
the project with the applicant before resubmitting the grant for subsequent
rounds of Status 19 review. Sometimes, e-mails reprimand the people who
processed the applications: “There were a lot of problematic [National Institute
on Aging] grants in the queue this week”, says one e-mail from NIH leaders in
March. “Many of them had significant problems that should have been caught by
your staff.”

In some cases, such reviews result in the Section 19 study not being funded.
Meanwhile, the NIH program officers, who are now overworked and whose offices
are understaffed, become more and more demoralized:

“Just because the topic is something that makes some people uncomfortable
doesn’t mean we shouldn’t research it,” says one NIH programme officer, who adds
that the studies were deemed scientifically rigorous by multiple panels of
scientists before they were shut down.

“It’s demoralizing the number of hours we spend working up a grant that they
might kill at the last possible moment”, the officer says. “It’s a tremendous
waste of taxpayer dollars.”

This morass is also delaying processing of existing grants. What most people
don’t understand is that a five-year NIH grant isn’t really one grant. It is
five one-year grants, with renewal every year pretty much a given, as long as
the yearly progress report is adequate. These one-year grants are called
non-competing continuations or renewals, because the grant has already been
approved and the recipient is not competing with other applications for it. At
the end of the five years (or whatever year period covered by a grant), the
recipient can submit a competing renewal or continuation, which is competitive
and involves the scientist proposing another five years of work based on the
results of the previous five years. In any event, noncompeting continuations are
getting caught in the ideological dragnet, with intentional and predictable
results:

One NIH official analysed non-competing grant-renewal applications (those that
have been peer reviewed in the past and are soliciting their next year of
funding) that entered Status 19 between the start of the 2026 fiscal year on 1
October 2025 and early June 2026. They found that only 57% were approved within 
ten days. By comparison, in the same period over the previous three years, more 
than 95% of non-competing applications were approved within ten days.

Bureaucracy is the tool being used to Lysenkoize the NIH.

But that’s not all. As reported by anonymous NIH workers with experience in peer
review, the ideological politicization of NIH peer review and funding decisions
goes far beyond what Nature reported. It’s worth reading the whole thing, which
is rather long, but I’ll look at the items that most caught my attention. For
example, you might not be that bothered by the administration’s attack on
“diversity, equity, and inclusion” (the dreaded DEI), but it has more of an
effect on peer review than you might imagine:

Others have written of the damage that Bhattacharya has done to research on
chronic diseases, health equity, and the biomedical workforce. The
homogenization of study sections is a less apparent tool to achieve that end.
Less diversity on review panels will undercut the appreciation and evaluation of
research on health disparities and social determinants of health, as well as
overlooking important considerations for underrepresented populations in the
workforce. In addition, reducing diversity can indirectly impair the career
advancement of women and underrepresented minorities, leading to reduced
diversity in the scientific community at large. As has been discussed elsewhere,
there is ample evidence that reduced diversity of scientific teams reduces
scientific innovation and outcomes.

Another change “necessitated” by the staffing cuts made by DOGE is shorter
review meetings for study sections, leaving less time to discuss competitive
grants. Basically, after the government shutdowns that led to the cancellation
of 424 study section meetings in late 2025 that were rescheduled for 2026, the
Center for Scientific Review (CSR) faced a “logistical crisis.” Emergency
procedures were implemented, and the result will likely be:

The less discussion there is, the easier it is to reduce the importance of
reviewers’ evaluations and scientific staff reporting of the deliberations, and 
the easier it is to obscure funding decisions by political appointees. The less 
feedback there is, the less improvement there will be to the end product, which 
is ultimately the science.

Another change being implemented looks custom-made to obscure how much a funding
decision was based on scientific merit and how much it was based on ideology
and the input of political appointees. In the past, every NIH grant received a
priority score from 1-9, in which lower numbers represent better scores, and
these scores were included in the study section summary statements returned to
the applicants. These scores, as imperfect as they might be, allowed the
applicant an idea of how highly the study section thought of the grant
application and how close to fundable it is. Also, in general, the NIH would
fund grants with the highest percentile priority scores first, working its way
down the ranked list until the money ran out. Removing priority scores and
percentiles would, according to these NIH scientists, do this:

Removing scores from summary statements reduces transparency in peer review, as 
it denies applicants the knowledge of how their applications were viewed and
ranked by reviewers, and withholds valuable information from program staff who
integrate these peer review decisions into their funding recommendations to IC
directors. While ICs have used their discretion to fund grants out of score
order, they have done so in a limited capacity to address gaps in their
scientific portfolios and/or support emerging research areas. Greater influence 
by political appointees on funding decisions and pressure to circumvent score
order elicit concern from reviewers that the value of their efforts and
expertise has depreciated. This concern is largely dismissed by middle and upper
management at NIH. Although scientists are under greater pressure to obtain
funding that is compliant with the administration’s priorities, they also find
the time to advise NIH on the best scientific investments for taxpayer dollars. 
The declining respect for their efforts will likely convince scientists to
decline to review for NIH.

I suspect that the reason for this change is more to make it easier for
political appointees to put their finger on the scales deciding which grants are
and are not funded without leaving an obvious tell that that’s what happened,
such as a grant with a priority score of 1.2 and a 1.5 percentile ranking on the
social determinants of health not being funded while a grant with a priority
score of 4 and a 40th percentile ranking proposing to study RFK Jr.’s latest
favorite supplement receiving funding. The demoralization of scientists serving 
on study sections is just a happy byproduct of the policy to Russell Vought.

Overall, the fruits of Project 2025 are starting to be felt, and NIH funding
decisions are becoming less independent, more influenced by political
appointees, and, likely, poorer quality. This is all by design, in order to
solidify administration control over funding decisions to allow them to reward
the loyal and punish critics. After all, the right has long viewed the NIH as a 
source of patronage, thinking that NIH funding decisions should be like
everything else in their realm, transactional. Basically, people like Russell
Vought portrayed, for example, Anthony Fauci when he was the director of the
National Institute of Allergy and Infectious Diseases (NIAID) as a mob boss,
handing out grant money in return for COVID “orthodoxy” and loyalty to the
administration. Now that they are in power, they want to be that false vision of
how Anthony Fauci worked.

What the Trump Administration seems to think that the process of awarding grants
should be like, with President Trump (or Podcast Jay Bhattacharya) standing in 
for Michael Corleone.
Lysenkoism 2.0 continues apace.

Enter the sycophants, toadies, and lackeys

Unsurprisingly, there are a number of people who seem to be less troubled by
Russell Vought’s attack on DEI, scientific peer review as the primary driver of 
NIH funding decisions, and on any science that doesn’t “align with
administration priorities.” One such person is Anthony LoSasso, PhD, who penned 
an op-ed for MedPage Today entitled I Served on Grant Review Panels for 12
Years. Let’s Not Romanticize NIH Peer Review. As I said above, LoSasso seems far
less troubled by Vought implementing policies to bring NIH peer review under
political control than he is by critics calling that policy “Lysenkoism” and
not, in his estimation, pointing out the flaws in the current system. Now here’s
the hilarious thing. LoSasso writes:

That matters now because the Trump administration’s Office of Management and
Budget (OMB) has proposed having senior political appointees conduct a
“pre-issuance review” of every discretionary NIH grant. The proposal indeed
raises serious concerns. It would create a standing mechanism for political
officials to second-guess scientific awards before they are issued. Once built, 
such a mechanism would not belong only to this administration. It would be
available to every future administration, with whatever priorities, orthodoxies,
enemies, or enthusiasms it brings to power.

Right. This is pretty much what I wrote a month ago. LoSasso even pointed out
that political preissuance is a very bad “solution” to any problems with peer
review at the NIH that might exist. Fair enough. Too bad he couldn’t resist then
both-siding it in a big way:

But opposing political review does not mean we should pretend the current system
is pristine. That is where the editors of the New England Journal of Medicine
(NEJM), in their recent criticism of the proposal, missed an opportunity. They
are right to worry about political control of science. But they leaned on a
too-comforting account of how scientific funding works now.

The public story of NIH review is familiar. Objective experts, shielded from
politics, score each proposal on its scientific merits. The best applications
rise to the top. Funding follows the science. That story contains some truth,
but it is incomplete.

No one—and I mean no one—claims that the current system is perfect, or even
close to it. That is a straw man argument. What we do argue is that a system
like the one proposed by Russell Vought would not fix whatever flaws there might
be in the current system, but would make the system far more biased, opaque,
and capricious than it has ever been and, in the process, Lysenkoize US science.
Yes, as LoSasso says, there can be biases in NIH peer review, including
reputational bias in which the rich get richer, sometimes wide disparities
between review scores for a grant submitted by different peer reviewers, and
other issues. Unfortunately, what LoSasso seems most offended by is more the
comparison to Lysenko:

The trouble with hyperbole is that it crowds out the argument worth having. By
invoking Trofim Lysenko, the Soviet agronomist whose state-imposed theories
devastated Soviet biology, NEJM avoided the reform case it was especially well
positioned to make: that American science already has real problems of
hierarchy, risk aversion, incumbent advantage, and opaque decision-making. The
choice is not between pristine science and Soviet pseudoscience. It is between
repairing a flawed but indispensable system and replacing it with one that is
more openly vulnerable to political direction by this administration and the
next.

He concludes:

The scandal is not merely that politics may corrupt science. It is that a system
already too deferential to insiders may now become too deferential to
politicians.

How nice. How seemingly “reasonable.” Of course, conflating “insider bias” with 
deference to politics is just the sort of thing that someone in favor of the
administration’s approach might say, his denials and criticisms notwithstanding.
In any event, much of what LoSasso said is just another way of saying what I’ve
been saying. Moreover, the comparison to Lysenko is not an exaggeration.
LoSasso basically completely ignored the various factors discussed above that
suggest that the comparison to Lysenko is quite apt, given how the changes being
made that Russell Vought is trying to codify permanently in regulations all
have the effect of deemphasizing peer review and empowering political
appointees. Worse, he accepts at face value the “Unified Strategy” proposed by
“Podcast Jay” Bhattcharya last summer, when in fact, as I pointed out when it
was released, Bhattacharya’s plan cunningly wraps what are obvious Lysenkoist
ideological purity tests disguised as “academic freedom” and “unbiased peer
review” in seemingly reasonable proposals. (One wonders if LoSasso likes
Bhattacharya so much because they are both health economists.)

That’s why I like the response of Elizabeth Ginexi, PhD, who served as an NIH
Program Official. For example, she echoes my complaint about pay lines based on 
percentile scores, the rationale for which, as proposed by Bhattacharya, LoSasso
takes at face value:

The Unified Strategy also eliminated paylines — the objective score thresholds
that once determined which grants were funded. Previously, applications scoring 
above the payline had a strong likelihood of funding based on peer review merit.
This structural change removed the objectivity that once helped protect
meritorious science from political override.

By characterizing Bhattacharya’s approach as thoughtful reform based on calls
for “transparent” weighing of scientific merit alongside other factors, LoSasso 
accepts Bhattacharya’s language at face value. But he ignores what has actually 
occurred under his leadership: the systematic elimination of disfavored research
behind the language of continued support and scientific rigor. This is not
reform. It is redirection through administrative action.

Elsewhere, echoing LoSasso’s own words, Ginexi sarcastically notes that his
“characterization of what the Unified Strategy actually is and what has been
happening at NIH is incomplete.” (Nicely done.) She also sarcastically refers to
LoSasso’s complaint that study section members are never told which grants they
reviewed have been funded by pointing out that those “decisions are a matter of
public record, available to anyone through NIH Reporter, searchable by study
section, institution, or investigator,” adding sarcastically, “Perhaps he just
never looked.” She also notes that the NIH has mechanisms to try to decrease the
effect of the “luck of the draw,” when an application is assigned to a hostile 
reviewer or a reviewer who misses the point of the proposal:

Program officials are responsible for reviewing every peer review outcome. We
read every summary statement. We listen to the reviews. We know when reviewers
have missed the mark, when an assigned reviewer imposed their own methodological
preferences, or when a junior investigator got an unlucky panel draw. And when 
that happens, we advocate. I did this many times, making the case to branch
chiefs, division directors, advisory council members, and institute directors
that an application with a suboptimal score deserved a second look. The system
LoSasso describes as opaque is in fact a layered, accountable process staffed by
career scientists, exercising scientific judgment on behalf of the public.

Indeed. As for the comparison to Lysenko, I’ve already said why I think it’s
valid. Let’s see what Ginexi says:

LoSasso says the NEJM editors reached for Lysenko as a rhetorical shortcut. But 
the comparison is not hyperbole. It is a structural description of what is
currently happening at NIH. Lysenko replaced legitimate science with a
politically acceptable alternative, enforced by the state, and destroyed the
careers of scientists who practiced disfavored methods.

That structure is precisely what the data show happening today.

She then lists a number of examples, basically rubbing LoSasso’s face in the
receipts. I like it.

The bottom line is that what is happening at the NIH and every federal science
institute is Lysenkoism 2.0. Moreover, if Russell Vought’s proposed rule changes
that I wrote about four weeks ago are permanently codified into regulations,
this Lysenkoization will be very difficult to reverse by a science-friendly
future administration, if such an administration is ever elected again. Indeed, 
what worries me is that, even if a Democrat wins in 2028, he will like the
changes, and the Lysenkoization will simply shift politics depending upon who is
in office. That’s why I’m going to close by reminding our readers that the
proposed rules covering federal scientific grantmaking have been published in
the Federal Register under the title Regulation for Federal Financial
Assistance. The deadline for public comment is July 13. You know what to do.
This might be our last chance to stop Lysenkoism 2.0 from being how US science
operates.


The opposite of “transparency”: Sneaking Lysenkoism into NIH peer review

On Friday, the NIH released an RFI (request for Information) on a proposed new
format for reporting the scores of grant applications determined by study
sections. If implemented, this new system will make it easier to hide political 
manipulation of grant funding.

David Gorski on August 17, 2026

Link


Whenever I come across government announcements like this, I always wonder if
discussing them in depth is a bit too much “inside baseball” to be of interest
to SBM readers. For no topic is this more true than when I start discussing the 
nitty gritty of how the National Institutes of Health evaluates grant
applications in its peer review study sections to decide which ones will be
funded. The cited RFI (Request for Information NOT-OD-26-088) proposes to alter 
this peer review by altering how scoring results for NIH grant applications are 
reported to applicants in a manner that belies the ridiculous claims of this
administration to be the “most transparent in history.” (I’ll get into the
details shortly.) On the one hand, the details of how panels of scientists
evaluate and score grant applications and then how those scores lead to ranking 
the grant applications by percentile, (low percentiles are higher scored
grants), which then, with fairly uncommon exceptions, determines which grants
are funded tend to be technical and boring to the non-scientist (and even to
those with science-training who have never dealt with the NIH). On the other
hand, as I’ve said many times before, arguably the most important characteristic
of the NIH that has led it to being arguably the world’s foremost engine of
biomedical discovery over the last eight decades has been the incredible efforts
made to make grant review as fair and based on scientific merit as possible.

Is the NIH perfect at this? Of course not! However, say what you will about the 
NIH and its grant funding process, it can’t be denied that incredible effort has
been made over the last several decades to continually tweak the peer review
process to emphasize scientific merit, while also balancing policy goals that
are good for science policy in the US and that contribute to a stronger
scientific workforce, such as giving newly minted independent investigators a
chance to be NIH funded by carving out funds for them or giving them a leg up
when competing with long-established investigators and trying to ensure that
previously underrepresented groups receive funding. (Of course, it’s the latter 
efforts that have sparked a backlash and this administration’s war on “DEI.”)
Ever since the Trump administration took power over a year and a half ago, it
has been doing its damnedest to dismantle the science-based, reasonably
objective peer review process used by the NIH (and other federal science
agencies) to decide which external grant applications merit being funded. Before
I discuss the NIH RFI, it’s useful to look at what has occurred thus far on
this front.

Lysenko 2.0 arrives

Trofim Lysenko (1898-1976).
When last I wrote about peer review at the NIH, I noted that a recent proposed
change in federal rules by OMB Director Russell Vought was, in essence, a big
step forward in the Lysenko-ization of the NIH and Lysenkoism 2.0 in action. As 
most SBM readers know, Trofim Lysenko was a Soviet-era agricultural scientist
whose ideas—which included the denial of Mendelian genetics and Darwinian
evolution by natural selection in favor of a version of Lamarckism—Stalin loved 
not because of how scientific they were, but rather because they aligned with
his perception of Soviet ideology. Unfortunately, when put into practice,
Lysenko’s ideas were utterly disastrous for Soviet agriculture for decades (and,
in one instance, Chinese agriculture), resulting in crop yields plummeting,
turbocharging periodic famines from the 1930s through the early 1960s, when he
was removed from power after his influence had slowly waned in the years after
Stalin’s death. Yet, because his ideas were ideologically in sync with the
regime, particularly under Josef Stalin, Lysenko yielded ruthless power over
Soviet agricultural science for decades, and scientists who dissented in favor
of good science risked being ostracized, fired, imprisoned, and in some cases
even executed. This history is why the term “Lysenkoism” is now commonly used to
refer to the domination of science by a pseudoscientific ideology, rather than 
evidence, experimentation, and data. History also shows that it took Soviet
agricultural science decades to recover after Lysenko had fairly been deposed.

The Lysenkoism in Vought’s proposed rule changes for federal grantmaking was
easy to see. I wrote in detail about it here and here, but I’ll briefly recount 
the CliffsNotes version, because it’s important to your understanding of this
NIH RFI, and I don’t want to force you to have to click on links if you don’t
want to. In brief, the proposed rule changes included:

  1. De-emphasizing peer review as “advisory” only. In the past, the priority
    scores of grant applications was the primary way that grant applications
    were ranked for funding, with only occasional interventions by Institute
    directors to advance specific scientific priorities. Under the new rules,
    political appointees will be able to ignore peer review in order to
    accomplish the next aim.
  2. Grants must be consistent with and advance “administration priorities.” In
    other words, if these rules are implemented, political appointees will be
    empowered to overrule peer review to reject important projects based in
    rigorous science in favor of crap if they think those projects “advance
    administration priorities.”
  3. Grants must not “fund, promote, encourage, subsidize, or facilitate” the usual
    cast of right wing bogeymen, including “racial preferences or other forms
    of racial discrimination by the grant recipient”; “denial by the grant
    recipient of the sex binary in humans or the notion that sex is a chosen or 
    mutable characteristic”; “illegal immigration”; or “any other initiatives
    that compromise public safety or promote anti-American values,”
    “anti-American values,” apparently, being defined by the Trump
    administration.
There were other disturbing points in the proposed rule changes, but these are
the key three that stood out as designed to fuel Lysenko 2.0. It doesn’t take a 
scientist to see how such rules would, in essence, end scientific independence
of the NIH, allowing it to become, as its Director, Podcast Jay Bhattacharya
once promised, the “research arm of MAHA” (the Make America Healthy Again
movement). The other way that I like to put it is that the Trump administration 
tends to view science funding not as a public good that should be protected and 
nurtured to fund the best science out there, but rather as patronage not unlike 
something out of The Godfather, yet another bin of cash that can be doled out to
loyalists and withheld from the “disloyal.”

With that background, it will, I hope, be easy for you to understand how the
proposed changes in the reporting of peer review results will facilitate the
Trump administration’s clear desire to move the center of gravity in the peer
review carried out at NIH study sections away from science-based grantmaking
towards a more ideology-based grantmaking.

Proposed Changes to Reporting Outcomes from NIH Peer Review: Facilitating
Lysenko 2.0

Now we’re ready to discuss this RFI (NOT-OD-26-088, issued on August 14, 2026)
and entitled Request for Information (RFI) on Proposed Changes to Reporting
Outcomes from NIH Peer Review. First, the background:

In November 2025, NIH announced the Unified Funding Strategy, based in the
long-standing two-stage system of review NIH uses in making funding decisions.
The framework calls for NIH Institutes, Centers, and Offices (ICOs) to consider 
peer review outcomes in the context of their and NIH’s priorities, strategic
plans, and budgets, instead of relying on funding paylines to develop pay plans,
which over-emphasize numerical scores. Core tenets of this funding strategy
include that funding policies must “prioritize scientific merit; ICOs should
consider peer review information in its entirety.”

As a reminder, the Unified Funding Strategy purports to want all Institutes,
Centers, and Offices (ICOs) to follow these principles in peer review and
deciding which grants to be funded:

  1. Align with the NIH’s mission
  2. Prioritize scientific merit; ICOs should consider peer review information in
    its entirety
  3. Integrate a breadth of topics and approaches relevant to the ICO’s priorities
  4. Consider investigator career stage and promote sustainability of the
    biomedical research workforce
  5. Promote broad distribution and geographic balance of funding, considering the 
    total amount and type of NIH funding already available to each investigator
  6. Align with the availability of ICO funds
None of this sounds, at least on the surface, objectionable. In fact, it’s not
all that different from what the NIH has been doing for a while. Interestingly, 
the document cited in the quote above does not mention that ICOs should
emphasize funding administration priorities, although Podcast Jay’s precursor
document, Advancing NIH’s Mission Through a Unified Strategy, sure enough does, 
as I wrote at the time. One can even make an argument that current NIH funding
decisions might indeed overemphasize numerical scores, but here’s the rub.
Current funding levels (or, as we colloquially call them, paylines) for most
institutes are well under the 10th percentile, meaning that less than 10% of
grant applications per cycle are funded. Some are much lower. When the paylines 
are that tight, it almost forces the NIH to rely on numerical scores, because to
do otherwise interjects a lot of subjectivity into the decision-making process.

On the other hand, NIH priority scores and percentiles are a rather blunt
instrument, as I’ve discussed before while analyzing certain questionable
proposals for revamping how the NIH does peer review. For example, is a grant
that scored at the 3rd percentile substantially better than one that scored at
the 5th percentile? Probably not detectably so, and both are clearly fantastic
grants that greatly impressed the peer reviewers and the study sections that
evaluated them. Yet, if the payline is at the 4th percentile, one will be
funded, and the other will not be. Moreover, one reviewer who really hates the
grant (and assigns it unjustifiably low priority scores) can affect the overall 
averaged aggregate priority score just enough to move a fundable grant into the 
unfindable category. On the study sections where I’ve served on an ad hoc basis,
I’ve tended to observe, though, that the discussion tends to cause reviewers
issuing scores far outside range that includes other reviewers to move their
scores closer to the mean of those reviewers.

For all its flaws and imperfect objectivity, one aspect of the current system is
that it is fairly transparent. Sure, the actual discussions at the study
section are not revealed, but the peer review reports of the primary and
secondary reviewers, along with the priority scores issued by each, are returned
to the applicants. In the case of grant applications that are among the best
one-half or so, applicants also receive back a lengthy summary statement with
the individual priority scores for each criteria rated (Significance,
Investigators, Innovation, Approach, and Environment), the percentile ranking of
the grant, and a synthesis of the discussion of the grant application at the
study section meeting.

In fact, let me quote the RFI regarding the current system:

NIH uses a two-stage system of review in developing extramural funding
recommendations. In the first stage, scientific experts (peer reviewers)
evaluate the scientific and technical merit of grant applications. Each proposal
is assigned to a peer review group and is assigned to a minimum of three peer
reviewers from that group to prepare written critiques. Each written critique
addresses the likely overall impact of the proposed work, as well as strengths
and weaknesses guided by the review criteria in Section V of the relevant Notice
of Funding Opportunity. The assigned reviewers enter their individual scores
from 1-9 reflecting their preliminary assessment of the overall impact of the
proposal and criterion/factor scores for the review criteria. Generally,
applications with average preliminary overall impact scores in the top 50% of
applications assigned to the review group are discussed. After discussion, all
reviewers–assigned and not–enter their final individual overall impact scores,
which gets averaged into one final overall impact score.

The review outcome is currently reported as a summary statement which includes a
resume of discussion for discussed applications, the written critiques of the
assigned reviewers, criterion/factor scores from assigned reviewers, and a final
overall impact score averaged from all voting members of the panel.  The
principal investigator(s), applicant institution, NIH program staff, and the
members of the funding ICO’s advisory council have access to these review
outcomes.

NIH program staff examine proposals and consider the final overall impact scores
given during the peer review process, percentile rankings (if applicable), and 
the summary statements, in consideration of the ICO’s priorities. Program staff 
then provide a proposed funding plan to ICO leadership for award decisions.

This is more or less how funding decisions are made now, with final funding
decisions being made at the Advisory Council level. In brief, the Advisory
Council or Board for each Institute will examine the applications ranked on the 
basis of percentile scores, apply tests on criteria such as mission relevance
and maintaining a balanced research portfolio before finalizing funding
decisions. In practice, for the most part with relatively few exceptions,
percentile ranking determines which grant applications are funded, with most
Institutes funding the lowest percentile application first and then working
upwards through the applications until funds are exhausted.

Now here’s where the RFI gets most “un-transparent,” although the justification 
sounds benign enough:

In late 2025, a working group of NIH leaders was charged with recommending
changes in how NIH reports out peer review evaluations of scientific merit, to
facilitate the Unified Funding Strategy. Considerations for their work included 
the following: (1) funding decisions rely on qualitative peer review assessments
of merit, along with other important programmatic considerations; (2) peer
review scores are estimates with imperfect discriminative ability; and (3) peer 
review outcomes are multifaceted and contain valuable information beyond the
overall impact score. The group reviewed literature on the predictive value of
peer review scores for scientific outcomes, considered reporting approaches
utilized by other funding entities, and examined NIH peer review data.

Yes, this is all true (although in this administration I can’t help but read
“programmatic considerations” as “administration priorities), but, as you will
see, the changes proposed do not address these flaws in NIH peer review:

   The first-level peer review process is proposed to be modified to place an
   application in one of three overall impact categories:

  1. “Most competitive” (based on the top 25% of final overall impact scores),
  2. “Competitive” (based on the 26-50% of final overall impact scores), or
  3. “Not discussed” (scores >50%, or ND)
   With the exception of the reporting of final overall impact scores and
   percentiles, all other initial review group procedures would be retained. As 
   happens currently, all voting members of a peer review group would continue
   to enter individual overall impact scores for each application discussed. A
   final overall impact score would still be calculated for each discussed
   application for purposes of assigning the application to the appropriate
   category. The category assigned would be communicated to the principal
   investigator(s), applicant institution, NIH program staff, ICO leadership,
   and the relevant NIH Advisory Council. However, the final overall impact
   score or percentile on which the categorization was based would not be
   released to any of these parties.

   Other reporting procedures would be unchanged. Discussed applications would
   still receive a resume of discussion and all applications would still receive
   written critiques from the assigned reviewers, to include individual
   criterion/factor scores.

In other words, priority scores would still be issued, and percentile rankings
would still be generated, but investigators submitting grants would not receive 
any of them. They’ll just get the comments from the primary reviewers, the
summary statement if they aren’t in the “not discussed” group, and the
percentile group they are in.

Such a system is basically useless for grant applicants. Let me explain. Let’s
say that you submit a grant, and it’s not funded. You learn, however, that it
fell into the “most competitive” group, meaning somewhere in the top 25%. In
deciding whether to resubmit, think of this: When paylines are under the 10th
percentile, there is a huge difference between a grant application whose mean
overall priority score leads it to be ranked as 25th percentile versus one
ranked as, say, 11th percentile. The latter grant is in striking distance of
being funded on a resubmission, the first grant much less so. Moreover, what is 
being proposed is a lot less transparency, not more transparency. The “raw
data”—i.e., the raw priority scores and the percentile ranking—that led to an
application being grouped in one of the above three categories will, contrary to
past practices, be withheld from the grant applicant.

So how does Podcast Jay, who must have signed off on this RFI, justify this
proposal? Here’s how:

Reporting categorization as “most competitive,” “competitive,” and “not
discussed” in lieu of final overall impact score aligns with the Unified Funding
Strategy which encourages ICOs to actively balance many competing and dynamic
factors, including peer review, health priorities, scientific opportunities, the
workforce, availability of funds, and the wider research portfolio when
determining the most meritorious research ideas to support.  Categorizing
proposals in this way conveys valuable information about the assessed scientific
merit from peer review of without providing over-emphasis on overall impact
scores. Omitting a final overall impact score from what is reported will empower
program officials to utilize their substantial expertise, portfolio analyses,
and good judgment to make award recommendations that better incorporate ICO
strategic plans and NIH priorities.  The removal of final overall impact scores 
also supports a focus on substantive comments from the assigned reviewers and
the panel, elevating the role of scientific peer review. Finally, this change
would align NIH practices with those followed by other major funders such as the
National Science Foundation, Department of Energy, and U.S. Department of
Agriculture.

It is, of course, true that the NSF and Department of Energy for instance, do
use a more qualitative system that doesn’t include numeric scores, which does
inherently allow for more judgment and subjectivity on the part of program
managers/officers regarding funding decisions. it is also true that one huge
difference between the NIH and these other agencies is that the peer review
system used by the NIH is far larger and more formalized, with hundreds of
standing study sections, which each have members who serve for years plus some
ad hoc reviewers, all run through the Center for Scientific Review. In contrast,
the NSF and DoE, for instance, lack that infrastructure, with their program
managers or officers tending to send requests for peer review to ad hoc panels
of chosen experts. It should be noted, also, that the NIH disburses close to $40
billion a year in extramural funding (projects done outside of the NIH campus),
compared to one fifth as much or less by the NSF and the other agencies. It
therefore makes sense that the NIH has a more formalized, rigorous process.

One can readily see that the NSF, DoE, and USDA don’t need to be targeted this
way because the existing systems already allow for a lot of leeway in funding
decisions. The NIH, on the other hand, has a formal numerical system that, for
whatever flaws it might have, would make it a lot more difficult to hide the
hand of political appointees in boosting grant applications with lower scores
that “advance administration priorities” (or are to scientists aligned with the 
administration) and not funding high-scoring applications that contain the
dreaded buzzwords like “DEI” or “disparities” and/or would go to scientists who 
are critical of the administration. Indeed, perusing the NIH subreddit, I didn’t
even have to look for people who suspect exactly the same thing that I do,
namely that this proposed new scoring reporting system is a not-so-subtle way to
make it easier for political appointees to influence grant funding decisions.

For example, let’s quote some scientists who compete for NIH funding or work for
the NIH tell us what it’s all about:

   Commentbyu/nevernotdating from discussioninNIH

For those unfamiliar with NIH jargon, SRO = Scientific Review Officer.
CSR=Center for Scientific Review, the part of the NIH that runs study sections. 
IC = Institutes and Centers. SROs are the the backbone of the peer review
process, running the study section meetings, picking scientists to be on their
study section, and writing up the summaries of study section meetings.

And an excellent addition to the quote above:

   Commentbyu/nevernotdating from discussioninNIH

Oh, yes. Don’t think that which universities are favored or disfavored won’t
enter into political funding decisions.

And:

   Commentbyu/nevernotdating from discussioninNIH

And:

   Commentbyu/nevernotdating from discussioninNIH

And:

   Commentbyu/nevernotdating from discussioninNIH

Exactly. Under another administration without the history of the Trump
administration’s assaults on the NIH, I might have been less cynical and a bit
more open-minded about—or at least less hostile to—this RFI. I might have even
been open to the possibility that such a system might be worth trying out,
albeit with more categories than the three listed in the RFI. However, given the
recently proposed OMB rule changes designed to de-emphasize scientific peer
review and empower political appointees to have final say over which grant
applications are funded, it’s impossible for me not to take a much more alarmist
view of this proposed change. There is little doubt in my mind that the primary
intent of this proposed change in how NIH reports its scoring to applicants is 
to make it very difficult for applicants and outside analysts to identify very
high-scoring grants that were rejected for not aligning with administration
priorities or coming from institutions in disfavor, as well as grants that might
not have scored as well but are the sorts of MAHA-aligned “gold standard
science” that the current administration favors.

There is a 60 day comment period. If you are an scientist or academic,
particularly if you have or have had NIH funding in the past, there’s still time
to comment. The rule changes proposed by the OMB generated a tsunami of
comments, nearly all negative. Whether that will matter in the end, I don’t
know, but even this administration might find it difficult to ignore such
unpopularity. Perhaps the same can happen here.

Finally, remember this. Sometimes, “inside baseball” considerations matter—and
matter a lot. Changing technical procedures known to relatively few (e.g.,
scientists who submit grants to the NIH), such as how NIH peer review functions,
is but one strategy by which this administration is ushering in Lysenko 2.0 in 
a manner that the general public doesn’t see. Sadly, it seems to be noticed only
by academics like me who have knowledge of the issues involved. Worse, compared
to Donald Trump, Robert F. Kennedy Jr., and Russell Vought, Lysenko was a rank 
amateur. After all, he only turned Soviet agricultural science and genetics into
ideologically driven sciences. This administration is trying to do for all
science in four years what Lysenko did to just two over decades.

Denial of germ theory and the genetic basis of disease: Two pillars of MAHA

To understand MAHA, understand the specific science that it denies.

David Gorski on September 8, 2025

Link

As I sat down to write my weekly post, I had originally been thinking that, as
much as I say that I’m tired of writing about our Secretary of Health and Human 
Services (HHS), Robert F. Kennedy, Jr., I probably still had to write about the 
utter clown car of a fiasco that was his testimony last Thursday in front of the
Senate Finance Committee. Then I thought: What is left to say four days later? 
All you need to know is that the chair of the committee, Sen. Mike Crapo
(R-Idaho), rejected a request by ranking member Sen. Ron Wyden (D-Oregon) to
require RFK Jr. to testify under oath. This left RFK Jr. free to lie,
prevaricate, deflect, deny that he’d ever said things that he is clearly on
record as having said, and generally be RFK Jr. for three hours, which he
immediately proceeded to do with his usual combination of resentment at anyone
daring to question him and brazen shamelessness. As I thought about the
depressing task of going through three hours of this, I came across an article
in—of all places!—The Wall Street Journal by Sara Ashley O’Brien entitled RFK
Jr. Is Dismantling Public Health. A Fringe Theory May Explain Why. Intrigued, I 
read the tagline: The Health and Human Services secretary has long embraced
anti-scientific ideas that run counter to germ theory, the basis of treating
infectious diseases.

Wow. I was shocked. Someone at the WSJ actually gets it, and an editor let her
actually publish commentary about it! She even correctly identified the ideas:

Why do people get sick? Ask Robert F. Kennedy Jr., America’s highest-ranking
public-health official, and he may chalk it up to their terrain.

For centuries, doctors and scientists have agreed that germs are the underlying 
cause of infectious diseases. Someone coughs on you, you get a cold. Drink raw
milk, and you might end up with E. coli or listeria. This widely accepted truth 
is the basis of pasteurization, vaccines and antibiotics.

But Kennedy has long embraced ideas rooted in theories that run counter to germ 
theory and help explain his deep mistrust of vaccines and his efforts to remake 
the U.S. public-health system. Those efforts came to a head last week as the
Trump administration fired the head of the Centers for Disease Control and
Prevention and other top officials quit their jobs in the midst of disagreements
with Kennedy vaccine policy. On Thursday, Kennedy testified before a heated
Senate panel about the administration’s health agenda and the recent staffing
shake-ups.

And, here’s the kicker:

As chemist Louis Pasteur’s germ theory of disease was gaining traction in the
1800s, his rival Antoine Béchamp raised an alternative explanation: Disease, he 
said, was caused by the state of the body, which he referred to as the
“terrain.” In his view, a strong inner environment, bolstered by nutritional
food and a healthy lifestyle, could fend off illness.

Reading this, it occurred to me that now is as good a time as any to discuss two
key components of the “make America healthy again” (MAHA) movement. The first
is, as mentioned above, germ theory denial, as alluded to above. The second is
denial of genetics, as I will discuss. (Yes, I know there are other sciences
denied by MAHA, but I believe that these are the two main ones.) From my
perspective as well, MAHA is a loosely associated movement consisting of
“natural health” aficionados, “health freedom” activists, antivaxxers, and
fitness influencers that is rooted in a combination of alternative medicine and 
techno-utopianism. Obviously, nothing springs up from nothing. What is now
called “MAHA” predated RFK Jr.’s ascension to HHS Secretary but underwent a
rebranding when RFK Jr. coined his MAHA slogan soon after he had folded his
independent Presidential campaign in order to bend the knee to Donald Trump in
return for the promise of a powerful role in health policy,. When Trump won the 
2024 election, the position promised to RFK Jr. in return for kissing Trump’s
ring was revealed to be HHS Secretary.

Since then, although there have been predictable tensions between the extreme
antivax wing of MAHA and the more pragmatic antivax approach of incrementally
making vaccines harder to get until they are gone as well as the “right to try” 
movement and the weaponization of evidence-based medicine paradigms to make
vaccines more difficult to approve and market, MAHA is firmly in charge of HHS, 
which includes all non-military public health, medical, and biomedical research 
programs in the federal government; e.g., the Food and Drug Administration, the 
Centers for Disease Control and Prevention, and the National Institutes of
Health. That’s why I think it’s worth looking at what I now call two pillars of 
MAHA.

Terrain theory and MAHA

We at SBM have long been writing about how germ theory denial is at the root of 
so much of alternative medicine and the antivax movement, large swaths of which 
have found common cause under the banner of MAHA. Indeed, looking back through
our archives, I found that the first SBM post mentioning germ theory denial was 
by me in 2008. It was a post about antivaxxers and the human papillomavirus
(HPV) vaccine. A few months later Dr. Harriet Hall was the first to write a post
specifically germ theory denial and alternative medicine in 2008, sarcastically
riffing on the Mythbusters’ famously sarcastic tagline, “I reject your reality 
and substitute my own,” as she related the story of a chiropractor and a woman
whom she called a “raw food lady” (sound familiar?), both of whom confidently
told her that germs don’t cause disease. She then discussed various flavors of
germ theory denial before concluding, “I wish we could reject the reality that
germ theory deniers exist.” (So do I.) A couple of years later, I wrote one of
my typically long posts about germ theory denial and alternative medicine, in
which I discussed the Antoine Béchamp in the context of the history of germ
theory denial. Since then, we’ve updated our discussions of germ theory denial
to account for the new variants (if you’ll excuse the term) that have popped up 
since the COVID-19 pandemic, most recently earlier this year.

What I find interesting about germ theory denial inspired by terrain theory are 
two things, starting with how little it has changed since the 1800s. However,
equally interesting is how conveniently the modern version of terrain theory
leaves out certain aspects of Béchamp’s original ideas. Let’s start with the
modern incarnation of how Béchamp’s terrain theory is commonly invoked by
antivaxxers, quacks, and MAHA acolytes. I find it convenient to quote from the
WSJ article above, as it’s a succinct representation of how many MAHA acolytes
now present terrain theory:

Kennedy’s Make America Healthy Again movement has advanced fringe proposals such
as removing fluoride from public water and defying vaccine schedules.
Meanwhile, wellness influencers are promoting myriad “detoxifying” supplements
and treatments to their millions of followers. All of this has brought
long-debunked ideas about health back into the zeitgeist.

Actor Woody Harrelson, a vocal Kennedy supporter, asserted his belief in terrain
theory while appearing on Rogan’s podcast in February. “People’s immune system 
gets messed up from what they’re consuming,” he said. “And in a nutshell, that’s
why I believe in Béchamp’s theory as opposed to the germ theory. And, at least,
it’s got to be both.” Harrelson, who declined an interview request, also
discussed the theory on Bill Maher’s podcast in 2022, where Maher showed support
for the theory too.

In their remarks, Harrelson and Maher acknowledge that germs do exist—but that
healthy people tend not to be affected by them. “No serious person would contend
that terrain isn’t a factor in our health,” Maher said in a statement. “A
pathogen invading healthy terrain will have a harder time surviving. Terrain is 
a key factor among many.”

You’ll excuse me if, seeing Bill Maher mentioned in the context of terrain
theory and the antivax movement, I can’t resist yet another callback to one of
my favorite lines of all time. Back in 2008, Bob Costas was a guest on Maher’s
HBO show, Real Time with Bill Maher. Somehow, the topic of flu vaccines came up 
and how easy it is to catch it in crowded places like on an airplane, which led 
Maher to brag about how his “terrain” was so resistant to infection that he
didn’t need the flu vaccine and would “never get flu on an airplane.” Bob
Costas’ response was one for the ages: “Oh, come on, Superman!“

In any event, the modern-day invocation of Béchamp’s terrain theory tends to
emphasize claims that pathogens, be they viruses, bacteria, or other pathogenic 
organisms can’t make you sick if your “terrain” is made resistant, usually by
the now familiar combination of diet, exercise, and other health virtues, as
Maher said in that episode, “The model you have is wrong. You’re thinking that
the problem is the mosquitos, not the swamp. If there’s no swamp, the mosquitos 
can’t take root.” This is, of course, a commonly used metaphor. So is this:

Terrain theory in a fishbowl.

Of course, the idea that healthy people are more resistant to infectious disease
and, if they do become infected, are less likely to become severely ill or die 
from the disease is basically accepted science. After all, if you are
chronically ill, malnourished, elderly, and/ or debilitated, your immune system 
will not be able to launch as robust a response to a pathogen as someone who is 
“young and healthy.” Moreover, there is no incompatibility between germ theory
and acknowledging that your general health, which is impacted by lifestyle, can 
modulate your susceptibility to disease. That, however, is not what terrain
theory advocates are saying. Those who invoke terrain theory tend to emphasize
“the terrain” über alles as the be-all and end-all of preventing infectious
disease. What they are arguing is that pathogenic microorganisms and viruses
can’t make you sick if your terrain is “clean” and “pure.” There are, of course,
gradations of terrain theory, ranging from the more radical that denies that
germs can cause disease to more of a fusion that grudgingly admits that germs
can make you sick but places far too much power in the ability of interventions 
touted by alternative medicine to “clean the tank” and make the terrain
supposedly resistant to disease.

Variants of terrain theory were popular around the same time in the 19th
century, championed in different versions by Claude Bernard and Antoine Béchamp,
among others. Here’s where it gets interesting. The modern version of Béchamp
often conveniently leaves out a very critical part of Béchamp’s original terrain
theory that is obviously wrong. Béchamp, for example, strongly argued that
microorganisms were not the cause of disease but rather the consequence of
disease. Specifically, he argued that injured or diseased tissues produced the
microorganisms, and that it was the health of the organism that mattered, not
the microorganisms. In other words, the “terrain” was all. Bernard, for his
part, described what he called the milieu intérieur, the interstitial fluids
regarded as an internal environment in which the cells of the body are nourished
and maintained in a state of equilibrium, which he and others also called
terrain. Both men’s ideas, but in particular their shared concept of the
“terrain,” have been very attractive to germ theory deniers.

In, particular, let’s focus on Béchamp’s idea, given that MAHA stans tend to
invoke him rather than Bernard. Known as the pleomorphic theory of disease,
Béchamp’s hypothesis stated that bacteria change form (i.e., demonstrate
pleomorphism) in response to disease. In other words, they arise from tissues
during disease states, rather than invade tissue to cause disease. Béchamp
further postulated that bacteria arose from structures that he called
microzymas, which to him referred to a class of enzymes, that microzymas are
normally present in tissues, and that their effects depended upon the cellular
terrain. As our readers know, Pasteur’s theory won out over the ideas of Bernard
and Béchamp, based on evidence, but Béchamp was definitely very influential in 
the 19th century, and, given the science and technology of the time, his
hypothesis was not entirely unreasonable. It was, however, superseded by
Pasteur’s germ theory of disease and Koch’s later work that resulted in Koch’s
postulates.

That’s not to say that more extreme forms of germ theory denial that claim that,
for instance, viruses don’t exist don’t have influence, but the idea most
commonly cited by antivaxxers and MAHA tends to be a version of terrain theory, 
often disguised as a fusion of terrain theory that grudgingly acknowledges that 
germs can in fact cause disease, but only in those who are not healthy to begin 
with. We saw this a lot during the COVID-19 pandemic, and it’s an old idea that 
antivaxxers have long applied to measles, claiming that measles is a harmless
childhood disease that doesn’t kill healthy children, only children who are
unhealthy to begin with.

In addition, besides not fitting with the scientific evidence, Béchamp’s idea
had nowhere near the explanatory and predictive power that Pasteur’s theory did.
On the other hand, as I mentioned above, there is a grain of truth in Béchamp’s
ideas. Specifically, it is true that the condition of the “terrain” (the body) 
does matter when it comes to infectious disease. Debilitated people cannot
resist the invasion of microorganisms as well as strong, healthy people. There
is a twist, though, that modern day advocates of terrain theory almost never
mention; that is, if by “terrain” you mean mainly the immune system. We now know
that the “terrain” can facilitate the harmful effect of microorganisms in
unexpected ways. One well-known example is how certain strains of influenza (as 
in 1918 and H1N1) are more virulent in the young because the young can mount a
more vigorous immune response against them, which damaged tissues and made the
lungs more susceptible to bacterial infection.

RFK Jr. is totally down with these ideas, too, as described in the WSJ article:

As his political profile grew, Kennedy made his war on germ theory part of his
public platform. As a presidential candidate in 2023, he promised to tell the
National Institutes of Health to “give infectious disease a break for about
eight years,” NBC reported. On a 2023 episode of Joe Rogan’s popular podcast,
Kennedy said “it’s hard for an infectious disease to kill a healthy person with 
a rugged immune system”—an assertion that runs counter to modern medical
consensus. When Rogan said that wasn’t true of the 1918 Spanish flu, which
killed more than 50 million people globally, Kennedy replied: “Well, the Spanish
flu was not a virus.”

Naturally, RFK Jr. blamed the 1918 influenza pandemic on a flu vaccine. I’ve
discussed this conspiracy theory before in the context of a virus denier who
invoked it to deny that SARS-CoV-2, the virus that causes COVID-19, exists and
so will refer you here if you want more information.

Obviously, there are a number of attractive features of terrain theory if you
doubt modern medicine and are enamored of the ideas underlying “natural” health 
movements. First of all, if pathogenic microbes can’t cause disease when the
“terrain” is resistant—or never cause disease at all!—then vaccines are
obviously unnecessary. Even if you believe in a less absolutist version of
terrain theory that acknowledges that microbes can cause disease and even that
vaccines can work, you can easily be led to view even rare injuries due to
vaccines as resulting in a risk-benefit ratio that is unfavorable, allowing a
justification for instead opting for whatever health-virtuous lifestyle,
supplements, and “detoxification” (to eliminate the “toxins” supposedly
“poisoning” your terrain) instead. Second, if someone does become sick due to an
infectious disease, then one can comfort oneself by believing that that person 
must either be already ill or must not have been living a sufficiently virtuous 
lifestyle or is somehow “impure.” These latter consequences thus allow one to
indulge latent eugenicist beliefs combined with religious beliefs. (I’ve long
referred to antivax beliefs as a purity cult.)

Finally, if you believe that infectious diseases are a result of a “polluted
terrain” rather than pathogenic microbes, you can then justify treating such
diseases with all manner of supplements and magic. We saw this when during the
West Texas measles outbreak earlier this year RFK Jr. emphasized treating
measles with vitamin A (which was only ever shown to be beneficial in
underdeveloped nations where the children tended to be significantly
malnourished) and touted doctors using quackery, even steroids, to treat
children with measles.

If germ theory denial, in particular terrain theory, is a major piece of MAHA,
so is the denial of genetics.

Denial of genetics as a cause of disease: A second pillar of MAHA

If, as MAHA seems to preach, you can prevent nearly all disease if only you live
a sufficiently “virtuous” lifestyle with respect to health, one huge reality
check is the existence of genetic predispositions to disease. The prototypical
example is the marathon runner who drops dead of a heart attack at age 45 due to
a strong genetic predisposition to heart disease. Sure, without a supremely
healthy lifestyle, that marathon runner might have dropped dead at age 35
instead, but the curse of genetics meant that the odds of the runner ever living
to be 80 under any circumstances were always so close to zero as to be
practically indistinguishable from it. I use this example not to disparage
exercise and diet, but rather to point out that there are very definite limits
on what health as a consequence of a virtuous lifestyle can accomplish in the
face of genetic predispositions and that those limits are far more stringent
than anything a wellness influencer would want to admit.

Perhaps the best example of how MAHA denies genetic predisposition to health
conditions is autism. I’m just going to repeat it again right here. Autism is
primarily, but not exclusively, genetic in nature. The evidence for this
conclusion has been building for decades, and we’ve written about it a number of
times here on SBM dating back to 2010. Indeed, we now know that the genetic
contribution to autism and autism-spectrum disorders is approximately 65%-90%,
perhaps as high as 80%-90%. We know this from twin studies, population studies, 
and a number of other studies. None of this means that environmental factors are
not important, as they can influence risk. Indeed, the most well-characterized 
environmental risk factor for autism is prenatal rubella infection, although
more recent reappraisals have questioned how strong the link is.

You wouldn’t know that autism is primarily genetic in nature, however, from what
RFK Jr. says about it. Remember, he first “came out” as an antivaxxer in 2005
when he published an article in Salon.com and Rolling Stone entitled Deadly
Immunity. In it, he presented a conspiracy theory in which the
mercury-containing preservative thimerosal was the primary cause for the “autism
epidemic” but the CDC had met in 2000 at the Simpsonwood Conference Center to
strategize how to cover up this supposed link. Later, as evidence that
thimerosal-containing vaccines were not a risk factor for autism accumulated,
particularly after autism prevalence kept rising after thimerosal was removed
from nearly all childhood vaccines in 2001, he easily pivoted to the more
general antivax idea that it was vaccines, either specific vaccines like MMR or 
the idea of “too many too soon”, that cause autism. While it is true that some
antivax narratives suggest a “genetic susceptibility” to autism that is
triggered by vaccines, I still consider this to be genetics denial, as in these 
narratives the primary cause is never genetic. Rather, it’s the vaccines in
genetically susceptible individuals, which seems to be most children. Moreover, 
try as antivaxxers might, they have never actually identified specific genes
that somehow predispose to vaccine-induced autism.

As the Autism Science Foundation put it:

Autism doesn’t have a single cause. It is the result of a complex mix of
genetics and environment. We know that genetic factors play the biggest role:
hundreds of genes have been linked to autism, and inherited or spontaneous
changes in these genes can alter brain development. Environmental factors also
matter, especially during pregnancy, such as advanced parental age at
conception, prematurity or very low birth weight, and exposures that affect
brain development, like fever or illness during pregnancy.

Again, though, the predominant causes of autism appear to be overwhelmingly
genetic. Again, that doesn’t mean that environmental causes don’t impact the
risk, but if you listen to RFK Jr. and MAHA you can’t help but think that only
environmental exposures—cough, cough, vaccines—cause autism.

Finally, one can’t help but note what RFK Jr. did almost immediately upon
assuming the office of HHS Secretary, which was on April 16 to announce a study 
to find the causes autism. Nowhere in descriptions of that study does one see
mention of genetics. Rather, RFK Jr. explicitly said that by September “we will 
know what has caused the Autism epidemic and we’ll be able to eliminate those
exposures,” and, even more amazingly, promised to release preliminary results
this month, only five months after his announcement. Any real researcher knows
that a five month timeline for a project of this sort is impossible and likely
indicates that the results were preordained. Adding to this impression was the
observation that RFK Jr. had hired David Geier, the son half of the father-son
team of antivax autism quacks who two decades ago “pioneered” the Lupron
protocol, in which they treated autistic children with puberty blockers because 
they believed that testosterone bound to mercury and made it harder for
chelation therapy to bind to mercury and remove it, to head it.

Meanwhile, NIH Director Dr. Jay Bhattacharya announced a “real world platform”
look for causes of autism:

The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid 
Services (CMS) today announced a landmark partnership to enable NIH to build a
real-world data platform enabling advanced research across claims data,
electronic medical records, and consumer wearables.

This partnership will focus first on enabling research around the root causes of
autism spectrum disorder (ASD). In the long term, the partnership will link
real-world data, in a manner consistent with applicable privacy laws to protect 
Americans’ sensitive health information, for research on chronic conditions—a
core priority of President Trump and the Department of Health and Human Services
(HHS) Secretary Robert F. Kennedy, Jr.

“We’re using this partnership to uncover the root causes of autism and other
chronic diseases,” said HHS Secretary Robert F. Kennedy, Jr. “We’re pulling back
the curtain—with full transparency and accountability—to deliver the honest
answers families have waited far too long to hear.”

CMS and NIH will start this partnership by establishing a data use agreement
under CMS’ Research Data Disclosure Program focused on Medicare and Medicaid
enrollees with a diagnosis of ASD. Using ASD as the pilot research program,
teams at CMS and NIH will establish a secure tech-enabled mechanism to enhance
this data sharing with timely, privacy and security compliant data exchange.
This pilot research program will inform continued development of a landmark NIH 
platform to ultimately be used by researchers in understanding healthcare
utilization, chronic disease etiology and treatment, and the economic burden of 
chronic conditions.

Nothing to be worried about there, is there? I’m sure we’re all reassured by the
supposed appeals to “privacy.” Basically, this looks like one big fishing
expedition that will likely pull up a number of false positives.

Meanwhile, just last Friday, the WSJ reported that the HHS autism report
promised this month will link acetaminophen use during pregnancy and folate
deficiency to autism. I’m not going to go into detail about this, given that the
report hasn’t been released yet, other than to say that existing evidence does 
not support a link between acetaminophen use during pregnancy and autism. There 
are small studies that suggest a link, but they are confounded and small.
Indeed, just last year, a large Swedish cohort study encompassing nearly 2.5
million children born between 1995 and 2019 found no evidence of an association 
between prenatal acetaminophen use and elevated risk of autism spectrum
disorder, concluding:

Acetaminophen use during pregnancy was not associated with children’s risk of
autism, ADHD, or intellectual disability in sibling control analysis. This
suggests that associations observed in other models may have been attributable
to familial confounding.

The authors are referring to a handful of earlier studies that suggested a link.
In brief, again, the overall scientific consensus is currently that there does 
not appear to be a link between acetaminophen use in early pregnancy and autism 
spectrum disorders. Nor is there good evidence that folate use (or leucovorin
use) during pregnancy can prevent autism, although there is very good evidence
that folate deficiency can lead to neural tube defects, which is why folate
supplementation has long been recommended during pregnancy.

We’ll see what the report says later this month, of course. Speculation about
whether it will include vaccines as an “environmental cause” of autism is
rampant. It is, of course, is possible that RFK Jr. is saving vaccines for a
subsequent report and focusing first on a disproven link between acetaminophen
use during early pregnancy and autism and suggesting that leucovorin, because it
supposedly passes the blood-brain barrier easier than folate, can prevent
autism, the better to deflect against charges that he is antivaccine and that
the report had a predetermined conclusion. My guess is that RFK Jr. won’t be
able to help himself and knows that failure to mention vaccines in this first
report would cause a major row among his followers.

MAHA: Health as virtue

As I’ve discussed before, like the philosophies on which MAHA is based, MAHA
tends to deny external causes of disease that modern pharmaceuticals address,
such as pathogenic bacteria that can be treated with antibiotics and pathogenic 
bacteria and viruses that can be prevented with vaccines, in favor of the idea
that one’s health is nearly totally within one’s own control through one’s own
virtue. Similarly, it tends to deny internal causes of disease, such as genetic 
predispositions, because genetic predisposition to disease means that one cannot
be in near-total control of one’s own health through virtuous behavior, such as
consuming a healthy diet and avoiding unhealthy foods, exercising, and taking
the right supplements. To do this, large swaths of modern science must be denied
or minimized, which is why I have been referring to MAHA as Lysenkoism 2.0,
after Trofim Lysenko, whose lack of belief in genetics as science had come to
understand it in favor of a more ideological conception of agricultural science 
worsened famines across the USSR during his three decades as the preeminent
Soviet agricultural science. To this end, all agencies in HHS, including NIH,
are being what I like to refer to as Lysenko-ized in service of MAHA’s
ideological science.

Unfortunately, I fear that the results will be similar to those resulting from
Trofim Lysenko’s control of Soviet agriculture from the 1930s to the early
1960s, only worse. After all, Lysenko only controlled Soviet agricultural
science at the national level. RFK Jr. controls all non-military medical
science. The damage he has already caused will likely take a generation or more 
to repair; that is, if it is repairable at all. Certainly, I highly doubt that I
will live to see it repaired and will likely live long enough to see it get
much worse. This is what happens when someone hostile to science that he doesn’t
like is elected President and then promises to let an antivaxxer and germ
theory denier “go wild on health.” Unfortunately, “going wild on health” is
exactly what RFK Jr. is doing, and we will all suffer for it.


Doctors Who Fluffed RFK Jr.: Here’s What You Own So Far

“Just where is that extensive 5000 word longform apology from Adam Cifu over at 
Sensible Medicine, begging forgiveness for legitimizing Robert F. Kennedy, Jr?”

Jonathan Howard on April 4, 2025

Link

While I have not read all of RFK’s statements closely, my general impression is 
that he focuses on topics that are potentially important/relevant, and then
unfortunately often exaggerates or distorts the facts.

In a previous article titled If You Sanewashed RFK Jr., Or If You Sanewashed
Doctors Who Did, You Own the Next 4 Years, I discussed doctors who had either
written pro-RFK Jr. propaganda articles or profited from Substacks that did. 
Examples include:

  1. RFK Jr Will Disrupt the US Medical Establishment  by Dr. Jay Bhattacharya and 
    Kevin Bardosh

  2. Dr. Makary on RFK Jr’s Criticism of the ‘Medical Industrial Complex’: Saying
    Things ‘People Know Are True’   Dr. Marty Makary

  3. Why Doctors Should Learn to Stop Worrying and Love MAHA– by Dr. Joseph Marine

  4. Donald Trump Has a Plan to Make America’s Children Healthy Again. It’s a Good 
    One by Dr. Robert Redfield

  5. Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy by Dr. Vinay 
    Prasad

  6. The Cure for Vaccine Skepticism by Dr. Martin Kulldorff

  7. The Nomination of Robert F. Kennedy Jr. as Secretary of the Department of
    Health and Human Services: a New Beginning? by Dr. Frederik
    Schaltz-Buchholzer

That last article, by Dr. Schaltz-Buchholzer from the monetized misinformation
Substack Sensible Medicine, said:

While I have not read all of RFK’s statements closely, my general impression is 
that he focuses on topics that are potentially important/relevant, and then
unfortunately often exaggerates or distorts the facts.

That’s a profoundly embarrassing thing to have written. According to Dr.
Schaltz-Buchholzer, RFK Jr.’s belief that AIDS is not caused by HIV, but rather 
a “gay lifestyle” is “potentially important/relevant.” Saying that RFK Jr.
“exaggerates or distorts the facts” is like saying the Titanic was an unpleasant
boat ride. As people who actually bothered to read RFK Jr.’s statements closely
know, he is a paranoid, angry crank, utterly disconnected from reality, who
wants to take a wrecking ball to everything. Political actors with medical
credentials sought to obscure this obvious reality with the pro-RFK Jr.
propaganda.

RFK Jr. says measles vaccine routinely causes deaths. That’s not true

It’s no coincidence that the same doctors who spread absurdities about COVID-
just watch their old videos– also claimed that the man behind Vaxxed 3:
Authorized to Kill was the perfect guy to save vaccines and science in general. 
The same patterns are repeating.

Although RFK Jr. has been in office for under two months, we can begin to take
stock of what these doctors, some who are now part of this administration, now
own.

  1. US Measles Cases Jump 35% In a Week: Now Found In 12 States

  2. A Texas child who was not vaccinated has died of measles, a first for the US
    in a decade

  3. Remedy Supported by Kennedy Leaves Some Measles Patients More Ill

  4. RFK Jr.: It Would Be Better If ‘Everybody Got Measles

  5. RFK Jr. says measles vaccine routinely causes deaths. That’s not true

  6. Measles is back — and RFK Jr. isn’t taking it seriously

  7. Keeping With Kennedy’s Advice, Measles Patients Turn to Unproven Treatments In
    West Texas

  8. RFK Jr. Says Federal Vaccine Advisers Are Beholden To Industry. The Evidence
    Does Not Support Him

  9. FDA lays off bird flu leadership, among steep cuts to senior veterinarians

  10. FDA tobacco official is removed from post in latest blow to health agency’s
    leadership

  11. NIH To Terminate Or Limit Grants Related To Vaccine Hesitancy And Uptake

  12. FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled

  13. RFK Jr. Pauses Peninsula Company’s Oral Covid Vaccine Clinical Trial

  14. CDC Will Research Widely Debunked Link Between Vaccines And Autism

  15. Scientists Say NIH Officials Told Them To Scrub mRNA References on Grants

  16. RFK Jr.’s Prescription for Bird Flu on Farms: Let It Spread

  17. NIH to ax grants on vaccine hesitancy, mRNA vaccines

  18. Measles Cases in Texas Rise to 400 as U.S. Total Reaches Nearly 500 amid
    Worsening Outbreak, Officials Say

  19. The Expert Who Kept Eye Drops From Blinding You Was Fired Yesterday

  20. Trump Administration Shuttering Long Covid Office

  21. HHS taps anti-vaccine activist to look at debunked links between autism and
    vaccines, sources say

  22. Saying ‘pandemic is over,’ NIH starts cutting COVID-19 research

  23. Vaxart lays off 10% of staff after HHS unexpectedly demands halt to COVID
    vaccine trial

  24. CDC is pulling back $11B in Covid funding sent to health departments across
    the U.S.

  25. Trump cuts damage global efforts to track diseases, prevent outbreaks

  26. U.S. to End Vaccine Funds for Poor Countries

  27. DOGE moves to gut CDC work on gun injuries, sexual assault, opioid overdose
    data, and more

  28. CDC layoffs strike deeply at its ability to respond to the current flu,
    norovirus and measles outbreaks and other public health emergencies

  29. NIH sued over ‘ideological purge’ of DEI, Covid and vaccine research

  30. Trump administration says it will pull back billions in COVID funding from
    local health departments

  31. As Measles Continues to Rise, CDC Muffles Vaccine Messaging

  32. FDA Commissioner Marty Makary gets off to a bruising start as agency is
    wracked by layoffs

  33. US FDA Commissioner Makary Was Sworn In, Knew Of Plan to Push Out Marks,
    Sources Say

  34. ‘Bloodbath’ at NIH and Elsewhere at HHS Begins

  35. NIH Director Removes Four Main Scientists amid Massive Staff Purge

  36. Doctor Behind Award-Winning Parkinson’s Research Among Scientists Purged From 
    NIH

  37. Trump admin cancels NIH scientific integrity policy

  38. Trump administration cuts FDA staff handling bird flu outbreaks

  39. FDA layoffs described as “devastating” as mass cuts ensue across government
    agencies

  40. ‘One of the darkest days’: NIH purges agency leadership amid mass layoffs

  41. Gavi, the Vaccine Alliance, has its billion dollar grant cut by Trump
    administration

  42. H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics

  43. Vaccine critic’s apparent selection to head HHS autism study shocks experts

  44. Trump administration at ‘war’ with mRNA technology: scientists alarmed vaccine
    skeptics could kill research

  45. Texas children poisoned after RFK Jr touts vitamin A as measles treatment

  46. Trump’s War Against HIV Research and Care

  47. F.D.A. Layoffs Could Raise Drug Costs and Erode Food Safety

  48. How Kennedy is already weakening America’s childhood vaccine system

  49. Big cuts to US AIDS prevention feared as NIH axes HIV research grants

  50. Washington state vaccination clinic canceled after CDC funding cuts

  51. “The country is less safe”: CDC disease detective program gutted

  52. The CDC Buried a Measles Forecast That Stressed the Need for Vaccinations

  53. FDA’s top vaccine scientist is out, citing Kennedy’s ‘misinformation and lies’

  54. Doctors Blast RFK Jr After Vaccine Chief Forced Out: ‘Gutting of Expertise’

  55. Staff At CDC And NIH Are Reeling As Trump Administration Cuts Workforce

  56. RFK Jr. says he’ll cut 20,000 positions from Health and Human Services
    workforce

  57. Chaos and Confusion’ at the Crown Jewel of American Science

  58. ‘Taking away years of experience’: NIH probationary employees fired Friday

  59. HHS starts layoffs of thousands of workers across its agencies

  60. Experts Concerned as NIH Axes Critical Vaccine Study Funds

  61. Trump Cuts Target Next Generation of Scientists and Public Health Leaders

  62. Trump officials will screen NIH funding opportunities.

  63. FDA staff left ‘scrambling’ to complete product reviews after DOGE layoffs

  64. More NIH job cuts coming? Agency’s scientists already reeling after week of
    firings

  65. 5 High-Level CDC Officials Are Leaving in the Latest Turmoil for the Agency

  66. Here Are The Words Putting Science In The Crosshairs Of Trump’s Orders

  67. The CDC Has Been Gutted

  68. Dozens of free measles vaccine clinics close in Texas as federal funding is
    cut

  69. After RFK Jr.’s ‘radical transparency’ pledge, HHS shutters much of its
    communications, FOIA operations

  70. Inside yesterday’s anxiety-inducing, ‘crude and callous’ HHS cuts

  71. Fauci allies, Covid vaccine officials get ax at NIH

  72. Top Trump FDA official Brenner hits pause on Novavax Covid-19 vaccine decision

  73. RFK Jr. cuts 4,700 FDA and NIH jobs as HHS eliminates ‘an entire alphabet soup
    of departments’

  74. Research in Ruin: Slashing the NIH Will Stifle Development of Lifesaving
    Medical Treatments and Harm the Economy

  75. RFK Jr. lays off staffers who run FDA’s vaccine expert panel

  76. Widespread firings start at federal health agencies including many in
    leadership

  77. Johns Hopkins University To Slash 2,000 Jobs After $800M In Federal Cuts

  78. Stanford To Lose $160 Million In NIH Funding Change

  79. UCSF ‘Borders on Panic’ Facing Potential Trump Funding Slash

  80. Massive layoffs, purge of leadership underway at U.S. health agencies

  81. Layoffs begin at HHS agencies responsible for research, tracking disease and
    regulating food

  82. Trump Administration Has Begun a War on Science, Researchers Say

  83. ‘It’s a bloodbath’: Massive wave of job cuts began at US health agencies

  84. 75% of US scientists who answered Nature poll consider leaving

  85. FDA Is ‘Finished’ Amid HHS Firings. Drug Stocks are Dropping

  86. Trump administration orders NIH to eliminate $2.6 billion in federal contracts

  87. FDA planning for fewer food and drug inspections due to layoffs, officials say

  88. RFK Jr. purges CDC and FDA’s public records teams, despite “transparency”
    promises

  89. Young scientists see career pathways vanish as schools adapt to federal
    funding cuts

  90. NIH Cuts Will Devastate Disease Research, Say Senators and Scientists

  91. NIH removing outside scientific advisers who evaluate research

  92. NIH Director Removes Four Main Scientists amid Massive Staff Purge

  93. At NIH, ‘everyone is on edge’ as they brace for deep cuts and more centralized
    control

  94. All this is in crisis’: US universities curtail staff, spending as Trump cuts 
    take hold

Any one of those articles is basically enough to disqualify RFK Jr. as a leader 
of the HHS. As Dr. David Gorksi wrote here on Monday, “Make America Healthy
Again”: The New Lysenkoism.

Falling vaccine coverage over the years is a problem that likely increased due
to the failed COVID-19 policies you championed.

Despite all this, none of the doctors who authored pro-RFK Jr. propaganda pieces
have cared enough to look back. As with their false declarations of herd
immunity 4-years-ago, reality does not impede them a bit. Doctors who promised
that RFK Jr. would restore confidence in vaccines haven’t reflected on whether
or not that turned out to be the case. The author of Why Doctors Should Learn to
Stop Worrying and Love MAHA hasn’t explained to me why I should “love”
everything that’s happening now.

In fact several of these doctors are responsible for recent headlines of mass
purges and censorship. Their agencies are in complete disarray and their boss is
an anti-vaccine crank. This is what they signed up for. These doctors have
continued to lavish praise on their new boss. Dr. Bhattacharya recently said he 
“admires” RFK Jr. and that:

He wakes up in the morning asking, “How can I make the lives of children better?
How can we address the chronic health needs of the American people?” He has
ideas about what causes autism. But from a scientific point of view, there’s
been a tremendous increase in autism diagnoses… And we don’t know why. The
answer in that situation is to do excellent science so that we can find out what
causes it—and then we can address it in an informed way.

That’s going to age as well as Dr. Bhattacharya’s prediction that COVID would
kill 20,000-40,000 Americans.

Other pro-RFK Jr. doctors now claim that RFK Jr. is not responsible for the
actions of RFK Jr. In their telling, his 20-year history of anti-vaccine
disinformation was magically erased the moment he was sworn into office, and the
anti-vaccine disinformation he’s spread since then is also of no consequence.  
Desperate to absolve themselves of any responsibility for elevating RFK Jr.,
they have displaced his assault on science onto those of us who warned about it.
Like blaming meteorologists for hurricanes, they absurdly claim that myself and
those who warned of disinformation, are the reason parents in Texas are
refusing the MMR and poisoning their children with vitamin A. It’s all my fault.
If only I’d gotten behind the plan to mass infect unvaccinated people under age
70 to reach herd immunity in 3-6 months, none of this would be happening now.

RFK Jr. is blameless. It’s my fault that vaccine clinics are closing in Texas as
federal funding is cut.

Just where is that extensive 5000 word longform apology from Adam Cifu over at
Sensible Medicine, begging forgiveness for legitimizing Robert F. Kennedy, Jr?

These pathetic attempts to blame me and the always unnamed “failed COVID-19
policies” I supposedly championed aren’t going to work. My articles explaining
why death is worse than vaccine side-effects aren’t the reason kids are being
hospitalized with measles. In reality, doctors who fluffed RFK Jr. own RFK Jr.
As Pandemic Accountability Index (PAI) wrote in their harsh but fair article RFK
Jr. Fanboys Owe You An Apology:

I am writing to RFK Jr.’s fan club directly now. You now own this moment.

You can toss out the Substack draft, shut down the podcast recording equipment, 
and drop the tweeting device of your choice. Sure, you can say whatever you want
going forward – but it will be forever tainted by the stain that you got your
way, your boy wound up in charge – and faced with the basic responsibilities of 
the role you said he would excel at? RFK Jr. immediately failed. Now a child is 
dead as a result. There is absolutely zero pieces of media you can publish which
could change this fact. You will never wipe away this stain for the rest of
your pathetic lives.

The general public should hound you at every attempt of a public appearance you 
make in the future and remind you of what you championed. Your colleagues should
look upon you with scorn and embarrassment, that they’re forced to share a
workplace with such a useless, incompetent piece of trash. Professional
obligations with your name attached should be canceled with explicit
condemnations. You all owe the critics of RFK Jr. that you insulted as
“covidians” and other childish smears a massive, extensive apology. There is no 
“debate,” you are just wrong.

You got your way with Robert F. Kennedy, Jr. and he rushed to start treating
infectious disease outbreaks with fish oil supplements. With an innocent child
paying the ultimate price to entertain your perverted ideals of how science and 
medicine should function. Just how do you plan to hold The Medical
Establishment, which RFK Jr. is now a part of, accountable? Your ideals won out 
– and now a child is dead of measles because you wanted “revenge” on anyone who 
struggled to prevent pediatric COVID-19 deaths. RFK Jr’s critics were
immediately validated, and you have absolutely nothing to show for it in
response.

PAI also asked:

Just where is that extensive 5000 word longform apology from Adam Cifu over at
Sensible Medicine, begging forgiveness for legitimizing Robert F. Kennedy, Jr?
Do we have a clip from Real Time With Bill Maher featuring Bari Weiss from The
Free Press condemning contributor Vinay Prasad from UCSF for misleading her
audience about RFK Jr’s merits?…

Those of us who possess at least an incredibly basic understanding of medicine, 
science, and public health told you precisely how Robert F. Kennedy, Jr. as
Secretary of Health and Human Services was going to play out. We were
immediately proven correct. Don’t seem to see many apologies on social media,
however – isn’t that strange?

Those are fair and important questions, but those apologies won’t be coming. No 
matter how widely measles spreads, Dr. Vinay Prasad won’t apologize for his
pro-RFK Jr propaganda, and his business partners, Drs. John Mandrola and Adam
Cifu, won’t apologize for profiting from it.  If a miracle occurs and we are
healthier in 4 years, I will admit I was wrong about RFK Jr. However, as with
COVID, none of the doctors who celebrated RFK Jr. will ever take responsibility 
for their words. They used the pandemic to build their brand and achieve
political power. When RFK Jr. and his ilk threatened the foundations of American
science and medicine, they again prioritized their paid subscribers and need to
feel “heterodox”. Other people will suffer due to their actions, and it’s our
job to constantly remind these doctors of what they enabled, no matter how much 
they protest that the truth hurts their feelings. We are just getting started,
the repercussions will last for many decades, and many people will get hurt
along with way.

They told us to love it, and so they own it all.




RFK Jr.’s vaccine committee bloodbath: I hope you’re all up-to-date on your
vaccines…

…because the CDC schedule is about to start shedding vaccines the way antivax
newly appointed ACIP members think people vaccinated against COVID-19 shed spike
protein. Ground zero for RFK Jr.’s extinction-level event with respect to
public health is vaccines and the committee that recommends them for the CDC
schedule.

David Gorski on June 16, 2025

55Shares

55

0

0

Link

When SBM founder Dr. Steve Novella wrote last week about how our new Secretary
of Health and Human Services Robert F. Kennedy, Jr. last week had in essence
fired all seventeen members of the CDC’s Advisory Committee on Immunization
Practices (ACIP)—the committee that makes recommendations for which vaccines
should be included on the CDC immunization schedule, when people should receive 
them, and how many doses—starting his post noting that he was “sure you are as
sick of reading about RFK Jr. as we are of writing about him, but this is the
world we live in,” it’s incredibly difficult for me to disagree. I felt that
deep in my bones. After all, I’ve been writing about RFK Jr. since he first
“came out” as an antivax conspiracy theorist in 2005 with his unfortunately
influential article Deadly Immunity, co-published in Salon.com and Rolling
Stone, to the eternal shame of both outlets, a shame that they will never live
down and that I remind them of nearly every time I write about this topic.

As hard as it is for me to believe, tomorrow marks the 20th anniversary of the
very first time I ever wrote about RFK Jr.’s antivax conspiracy-mongering. Two
decades ago, I could never have imagined that such a fringe antivax conspiracy
theorist would be put in charge of the entire non-military health apparatus of
the US government. Who could have? Even a year ago, I could not have imagined
this outcome, but such are the times that we live in. Unfortunately, we can’t
ignore RFK Jr. given how he’s been systematically working to dismantle public
health and biomedical research efforts in this country ever since he assumed the
office of HHS Secretary four months ago. Moreover, Steve wrote his post before 
RFK Jr. announced eight picks to replace

I must admit that, although I foresaw that possibility that RFK Jr. might sack
every member of ACIP, to replace them with his cronies, I was far too
conservative in my estimation. ACIP members are appointed to staggered terms,
and I speculated that RFK Jr. would replace each member whose term expired with 
his own antivax cronies, which would have meant that by 2028 he could replace
the entire membership of ACIP. Again, although I envisioned the possibility that
RFK Jr. might get rid of all 17 members of ACIP, there was a distinct failure
of imagination on my part that he would be this bold. I won’t make that same
mistake again, although I do realize that I will have to avoid the opposite
mistake of going too far in the other direction.

This post will examine three things. First, I’ll look at the bogus rationale RFK
Jr. cited for sacking all seventeen members of ACIP. Then I’ll look at the
eight people chosen (so far) to replace them, at least two of which are antivax 
to the core—holy hell, one of them is Robert “inventor of mRNA vaccines” Malone 
and another of them is a member of Barbara Loe Fisher‘s antivax group National
Vaccine Information Center!—while others are problematic for a number of reasons
and could be veritable antivax Trojan horses. Finally, I’ll look at a couple of
reactions to RFK Jr.’s picks, which provide a window into how we got here, with
a rabid antivax conspiracy theorist and activist in charge of HHS.

A brief word about ACIP. The FDA licenses vaccines for use in the US, and
anything that ACIP does will not change the FDA-approved status of existing
vaccines. However, ACIP decides which vaccines are on the CDC-recommended
schedule, and that has a lot of influence, as health insurance companies not
required to cover vaccines not on the schedule (although they can choose to if
they think it cost-effective), and the the Vaccines for Children program does
not fund vaccines not on the CDC schedule. Thus, ACIP’s recommendations have
enormous influence and removing vaccines from the CDC recommended schedule has
the potential to make those vaccines much harder to obtain and, in essence, even
unavailable for many people.

Destroying ACIP to save it?

It’s rather amusing to note that RFK Jr., got the compliant right wing lackeys
running the editorial page of The Wall Street Journal to let him publish his
announcement in an editorial, saying that he’s doing it all in the name of
“restoring public trust in vaccines” and to “avoid conflicts of interest.” I
suppose that it’s fitting that the editorial is behind a paywall, given that he 
has been claiming that under his leadership HHS and all its component
organizations would be subject to “radical transparency.” Fortunately, I have
Apple News, which let me read the whole putrid wall of text for your
edification. RFK Jr. being RFK Jr., naturally he tried to deflect the blame,
justifying his action thusly:

Vaccines have become a divisive issue in American politics, but there is one
thing all parties can agree on: The U.S. faces a crisis of public trust. Whether
toward health agencies, pharmaceutical companies or vaccines themselves, public
confidence is waning.

Some would try to explain this away by blaming misinformation or antiscience
attitudes. To do so, however, ignores a history of conflicts of interest,
persecution of dissidents, a lack of curiosity, and skewed science that has
plagued the vaccine regulatory apparatus for decades.

No, “to do so” is entirely right and proper. Who but RFK Jr. himself has had an 
outsized role in undermining public confidence in vaccines over the last 20
years in the US? He is, after all, arguably the most famous antivax activist in 
the word, and he’s a Kennedy! Seriously, he’s a veritable giant in the field of 
spreading misinformation and antiscience attitudes that undermine public
confidence in vaccines. It’s what he does. It’s what he’s done for two decades. 
So are lying and breaking his promises, as RFK Jr. had had promised Sen. Bill
Cassidy that he would not tamper with ACIP:

In early February, when there was still some question as to whether or not the
Senate would confirm Robert F. Kennedy Jr. to lead the Department of Health and 
Human Services, Sen. Bill Cassidy delivered a closely watched speech on the
Senate floor. The Louisiana Republican, a physician by trade, not only endorsed 
the anti-vaccine conspiracy theorist during his remarks, he offered assurances
about the future.

“If confirmed, [Kennedy] will maintain the Centers for Disease Control and
Prevention’s Advisory Committee on Immunization Practices — without changes,”
Cassidy declared with confidence, pointing to assurances he’d received directly 
from RFK Jr.

This cartoon comes to mind:

I think you know which one, RFK Jr. or Sen. Bill Cassidy, isCharlie Brown and
which one is Lucy.

When it comes to RFK Jr. and the decline in public confidence in vaccines, I’m
reminded of this classic meme (click the link if you are unfamiliar with it):

Quoth RFK Jr. about the decline in public confidence in vaccines: “We’re all
trying to find the guy who did this.”

Having falsely claimed that it was “conflicts of interest,” rather than
exaggerations and misinformation about “conflicts of interest” and vaccine
science spread by the likes of RFK Jr. that were responsible for the decline in 
public confidence in vaccines, RFK Jr. proposes his “remedy”:

That is why, under my direction, the U.S. Department of Health and Human
Services is putting the restoration of public trust above any pro- or
antivaccine agenda. The public must know that unbiased science guides the
recommendations from our health agencies. This will ensure the American people
receive the safest vaccines possible.

Today, we are taking a bold step in restoring public trust by totally
reconstituting the Advisory Committee for Immunization Practices (ACIP). We are 
retiring the 17 current members of the committee, some of whom were last-minute 
appointees of the Biden administration. Without removing the current members,
the current Trump administration would not have been able to appoint a majority 
of new members until 2028.

That would have been so sad. Actually, ironically, I was very critical of the
Biden administration for having let the membership of ACIP languish after the
departure of some members and was actually happy that his HHS Secretary had
appointed new members to bring it back up to a full contingent before President 
Biden left office.

Unsurprisingly, to bolster his false claim that ACIP is rife with COIs, RFK Jr. 
cites “investigations” dating back to 2000, the most recent of which was 2009:

In 2000 the House issued the results of an investigation of ACIP and another
vaccine advisory committee under the U.S. Food and Drug Administration—the
Vaccines and Related Biological Products Advisory Committee. It found that
enforcement of its conflict-of-interest rules was weak to nonexistent. Committee
members regularly participated in deliberations and advocated products in which
they had a financial stake. The CDC issued conflict-of-interest waivers to
every committee member. Four out of eight ACIP members who voted in 1997 on
guidelines for the Rotashield vaccine, subsequently withdrawn because of severe 
adverse events, had financial ties to pharmaceutical companies developing other 
rotavirus vaccines. A 2009 HHS inspector-general report echoed these findings.
Few committee members completed full conflict-of-interest forms—97% of them had 
omissions. The CDC took no significant action to remedy the omissions.

These conflicts of interest persist. Most of ACIP’s members have received
substantial funding from pharmaceutical companies, including those marketing
vaccines. The problem isn’t necessarily that ACIP members are corrupt. Most
likely aim to serve the public interest as they understand it. The problem is
their immersion in a system of industry-aligned incentives and paradigms that
enforce a narrow pro-industry

It’s an old antivax claim that RFK Jr. has been peddling for years and years.
That “investigation,” such as it was, was carried out by Mark Benjamin at UPI.
Truth be told, it was one that I hadn’t seen before. My only excuse is that the 
year 2000 was four years before I started blogging regularly about antivaccine
propaganda. So I read his “investigation” with the perspective of my more than
two decades of having dealt with antivax propaganda, and I found it…typical.
Benjamin cited multiple antivax activists; e.g.,Rep. Dan Burton (R-Ind.) and
Barbara Loe Fisher, founder of the Orwellian-named National Vaccine Information 
Center (NVIC), a woman whom I like to refer to as the “grande dame of the
American antivax movement.” He rehashed the Simpsonwood conspiracy theory that
claimed that at a CDC meeting in suburban Atlanta in 2000 the CDC “covered up”
data showing that vaccines containing thimerosal (a mercury-containing
preservative) were associate with an elevated risk of autism. No such thing
happened.

In fact, in my first post that ever went viral, uncoincidentally the first post 
I ever wrote about RFK Jr.’s antivax conspiracy mongering, I deconstructed all
the misinformation and conspiracy mongering shortly after, as did others, who
noted that the entire Simpsonwood transcript was not at all consistent with any 
effort to “cover up” a link between mercury and autism, but rather included a
debate about how best to deal with confounders in a study by Verstraeten et al. 
(Of course, to antivaxxers, any adjustment for confounders that eliminates a
link between vaccines and whatever bad health outcome that they attribute to
vaccines is always a “coverup,” not science doing what science is supposed to do
and being rigorous.) Years later, I referred to this as the Simpsonwood
conspiracy theory and, sometimes, part of the central conspiracy theory of the
antivaccine movement, in which “They” (the CDC, government, FDA, medical
profession, big pharma, and who knows who else—aliens, possibly) “know” that
vaccines cause autism but actively work to cover up any incriminating evidence.

Let’s just say that I’m not at all impressed by the Benjamin report. I will give
RFK Jr. credit for one thing, though. Notice what he wrote about Rotashield:
“Four out of eight ACIP members who voted in 1997 on guidelines for the
Rotashield vaccine, subsequently withdrawn because of severe adverse events, had
financial ties to pharmaceutical companies developing other rotavirus
vaccines.” In the past, antivaxxers would claim that Dr. Paul Offit, for
instance, had a direct financial COI and had developed Rotashield. Personally,
if anything, hearing this story I’d wonder if those with financial ties to
pharmaceutical companies developing other rotavirus vaccines might have been
biased against Rotashield. After all, their companies were making competing
vaccines, and the first to market a vaccine for a disease for which no vaccine
exists usually has a huge advantage over competitors. Seriously, RFK Jr. can’t
even make sense in his insinuations of financial COIs from 28 years ago. Nor,
apparently, can he back up his claims that ACIP members today are hopelessly
compromised by their financial ties with pharmaceutical companies manufacturing 
vaccines, because of course he can’t.

Also, ACIP, as I’ve discussed before, has strict rules about conflicts of
interest, and potential members are rigorously screened for such conflicts, and 
stringent measures are taken not only to assure technical compliance with ethics
statutes and regulations regarding financial conflicts but also to address more
general concerns regarding any potential appearance of conflict of interest:

People with specific vaccine-related interests at the time of application are
not considered for appointment by the committee. Examples of such interests
include direct employment of the can- didate or an immediate family member by a 
vaccine manufacturer or someone holding a patent on a vaccine or related
product. In addition, before their names are submitted for final consideration, 
potential members are asked to resign for their term of member- ship from any
activities that are, or could be construed as, conflicts of interest. These
activities include provision of advisory or consult- ing services to a vaccine
manufacturer or acceptance of honoraria or travel reimbursement from a vaccine
manufacturer.

Members are required to file confidential financial reports every year with the 
Office of Government Ethics and to disclose publicly all vaccine-related
interests and work, including participation in clinical trials, at each meeting.
They must also declare conflicts at each meeting of a WG. Any single conflict, 
real or apparent, may serve to disqualify a participant from participating in a 
WG. WG members may receive confidential and proprietary information from the FDA
or others to assist them in their discussions. When appropriate, they are
therefore required to fulfill confidentiality requirements and, when required,
sign non-disclosure forms prior to receiving such information.

If, despite all these safeguards, a conflict exists, limited waivers allow
members to participate in committee discussions on con- dition that they are
prohibited from voting on matters involving the specific or competing vaccine
manufacturers. A member who develops an important conflict of interest during
the 4-year term is required to resign from the ACIP.

It’s basically an antivaccine myth that the ACIP is totally corrupt and
controlled by the pharmaceutical industry. I do suspect, though, that that will 
soon change given how many potential members favored by RFK Jr. have very real
COIs through their financial connections to antivax organizations and the sale
of supplements and various “treatments” for “vaccine injury.”

Unfortunately, in the intervening two decades since RFK Jr. took the Simpsonwood
conspiracy theory, which had previously only been seen in the deepest, darkest 
recesses of the antivax movement, and popularized it in mainstream press, RFK
Jr. has evolved from not just an antivax conspiracy theorist but to an
all-purpose conspiracy theorist, embracing (of course) lab leak conspiracy
theories, including one claiming that Ashkenazi Jews were immune to COVID-19 and
SARS-CoV-2, the coronavirus that causes the disease, because it was an
“ethnically targeted bioweapon.” As for being “not antivaccine,” I like to point
out how since at least 2014 he was likening vaccination to the Holocaust,
trying to persuade Samoan officials that the MMR vaccine was dangerous (in the
middle of a deadly measles outbreak!), and claiming that today’s generation of
children is the “sickest generation” (due to vaccines, of course!). Indeed, a
few years ago his own family even called him out for his antivaccine activism,
while, predictably, RFK Jr. has, as so many antivaxxers have done, gone all-in
on COVID-19 pseudoscience and conspiracy theories and become anti-mask,
“anti-lockdown,” and pro-quack treatments for COVID-19.

And now he’s HHS Secretary and gets to pick the members of ACIP.

Antivaxxers, Trojan horses, and the unqualified: RFK Jr.’s new ACIP thus far

Unfortunately, it didn’t take long for RFK Jr. to announce who the new members
of ACIP would be, at least some of them. Specifically, he took to X, the
hellsite formerly known as Twitter, to make the announcement:


Given that some of you probably don’t want to actually go to X to see his list, 
I’ll simply quote it here, along with how he describes each new member of ACIP, 
descriptions that are related to reality mainly by coincidence:

Joseph R. Hibbeln, MD, is a psychiatrist and neuroscientist with a career in
clinical research, public health policy, and federal service. As former Acting
Chief of the Section on Nutritional Neurosciences at the National Institutes of 
Health, he led research on immune regulation, neurodevelopment, and mental
health. His work has informed U.S. public health guidelines, particularly in
maternal and child health. With more than 120 peer-reviewed publications and
extensive experience in federal advisory roles, Dr. Hibbeln brings expertise in 
immune-related outcomes, psychiatric conditions, and evidence-based public
health strategies.

Martin Kulldorff, MD, PhD, is a biostatistician and epidemiologist formerly at
Harvard Medical School and a leading expert in vaccine safety and infectious
disease surveillance. He has served on the Food and Drug Administration’s Drug
Safety and Risk Management Advisory Committee and the CDC’s Vaccine Safety
Subgroup of the Advisory Committee on Immunization Practices, where he
contributed to national vaccine safety monitoring systems. Dr. Kulldorff
developed widely used tools such as SaTScan and TreeScan for detecting disease
outbreaks and vaccine adverse events. His expertise includes statistical methods
for public health surveillance, immunization safety, and infectious disease
epidemiology. He has also been an influential voice in public health policy,
advocating for evidence-based approaches to pandemic response.

Retsef Levi, PhD, is the Professor of Operations Management at the MIT Sloan
School of Management and a leading expert in healthcare analytics, risk
management, and vaccine safety. He has served as Faculty Director of MIT Sloan’s
Food Supply Chain Analytics and Sensing Initiative and co-led the Leaders for
Global Operations Program. Dr. Levi has collaborated with public health agencies
to evaluate vaccine safety, including co-authoring studies on mRNA COVID-19
vaccines and their association with cardiovascular risks. His research has
contributed to discussions on vaccine manufacturing processes, safety
surveillance, and public health policy. Dr. Levi has also served on advisory
committees and engaged in policy discussions concerning vaccine safety and
efficacy. His expertise spans healthcare systems optimization, epidemiologic
modeling, and the application of AI and data science in public health. Dr.
Levi’s work continues to inform national and international debates on
immunization safety and health system resilience.

Robert W. Malone, MD, is a physician-scientist and biochemist known for his
early contributions to mRNA vaccine technology. He conducted foundational
research in the late 1980s on lipid-mediated mRNA delivery, which laid the
groundwork for later developments in mRNA-based therapeutics. Dr. Malone has
held academic positions at institutions including the University of California, 
Davis, and the University of Maryland, and has served in advisory roles for the 
U.S. Department of Health and Human Services and the Department of Defense. His 
expertise spans molecular biology, immunology, and vaccine development.

Cody Meissner, MD, is a Professor of Pediatrics at the Geisel School of Medicine
at Dartmouth and a nationally recognized expert in pediatric infectious
diseases and vaccine policy. He has served as Section Chief of Pediatric
Infectious Disease at Dartmouth-Hitchcock Medical Center and has held advisory
roles with both the Centers for Disease Control and Prevention (CDC) and the
Food and Drug Administration (FDA). Dr. Meissner has been a voting member of the
CDC’s Advisory Committee on Immunization Practices and the FDA’s Vaccines and
Related Biological Products Advisory Committee, where he has contributed to
national immunization guidelines and regulatory decisions. His expertise spans
vaccine development, immunization safety, and pediatric infectious disease
epidemiology. Dr. Meissner has also been a contributing author to American
Academy of Pediatrics policy statements and immunization schedules, helping
shape national standards for pediatric care.

James Pagano, MD, is a board-certified Emergency Medicine physician with over 40
years of clinical experience following his residency at UCLA. He has worked in 
diverse emergency settings, from Level 1 trauma centers to small community
hospitals, caring for patients across all age groups, including infants,
pregnant women, and the elderly. Dr. Pagono served on multiple hospital
committees, including utilization review, critical care, and medical executive
boards. He is strong advocate for evidence-based medicine.

Vicky Pebsworth, OP, PhD, RN, earned a doctorate in public health and nursing
from the University of Michigan. She has worked in the healthcare field for more
than 45 years, serving in various capacities, including critical care nurse,
healthcare administrator, health policy analyst, and research scientist with a
focus on public health policy, bioethics, and vaccine safety. She is the Pacific
Region Director of the National Association of Catholic Nurses. She is a former
member of the Food and Drug Administration’s Vaccine and Related Biological
Products Advisory Committee and the National Vaccine Advisory Committee’s 2009
H1N1 Vaccine Safety Risk Assessment Working Group and Vaccine Safety Working
Group (Epidemiology and Implementation Subcommittees).

Michael A. Ross, MD, is a Clinical Professor of Obstetrics and Gynecology at
George Washington University and Virginia Commonwealth University, with a career
spanning clinical medicine, research, and public health policy. He has served
on the CDC’s Advisory Committee for the Prevention of Breast and Cervical
Cancer, where he contributed to national strategies for cancer prevention and
early detection, including those involving HPV immunization. With research
experience in hormone therapies, antibiotic trials, and immune-related
conditions such as breast cancer prevention, Dr. Ross has engaged in clinical
investigations with immunologic relevance. He has advised major professional
organizations, including the American College of Obstetricians and
Gynecologists, and contributed to federal advocacy efforts around women’s health
and preventive care. His continued service on biotech and healthcare boards
reflects his commitment to advancing innovation in immunology, reproductive
medicine, and public health.

Regular readers will immediately recognize some names; so I’ll start with them
and then work my way down the list to the less “famous.” Before I do that,
however, let me just note that only one of them has what one could accurately
characterize as in-depth subject-level expertise about vaccines and infectious
disease. Unfortunately, as you will see, despite that background he nonetheless 
associated himself with the right wing “free market” think tank, the American
Institute for Economic Research (AIER) and ultimately co-authored the Great
Barrington Declaration. The GBD was an October 2020 declaration that Kulldorff
co-authored with another of RFK Jr.’s picks that advocated a “let ‘er rip”
approach to the pandemic among the “young” and “healthy,” with a bogus “focused 
protection” of the elderly and those with chronic health problems that put them 
at high risk of complications and death from COVID-19. Unfortunately, there was 
no concrete plan for “focused protection,” and the GBD would never have worked. 
It did, however, do serious damage to public health in many ways. I referred to 
the plan from the beginning as profoundly social Darwinist/eugenicist, and I
stand by that. Another “tell” is that four of these members are given
acknowledgments in RFK Jr.’s conspiracy-fest of a book, The Real Anthony Fauci.

In any event, let’s start with Dr. Robert Malone:

Robert Malone MD. As I mentioned, Dr. Robert “inventor of mRNA vaccines” Malone 
is a scientist who has parlayed his apparent involvement 35 years ago in early
attempts to use liposomal vectors to introduce mRNA constructs into muscle and
induce muscle cells to make gene product into a career in the COVID-19
contrarian and later COVID-19 antivax crowd. I like to note that at around the
same time Dr. Malone was doing these experiments (late 1980s and early 1990s),
one of the graduate students in the lab where I did my PhD work was doing
similar experiments, but with DNA vectors. Since 2020 Dr. Malone has become a
rabidly antivax conspiracy theorist whose bruised ego over not getting the
credit that he thinks he deserves led him to claim that Wikipedia had “censored”
attempts to give him his due (including someone who turned out to be his wife) 
and to become rabidly anti-COVID-19 vaccination, leading him to claim repeatedly
that COVID vaccines have killed far more people than than COVID. Later, Malone 
became more generally antivax, saying at an antivax conference three years ago:

…I was not in any way endorsing our current vaccine schedule. For me as a
vaccinologist who has often assumed—has integrated—a belief system that I was
brought up in about the efficacy and utility of childhood vaccines, I had a
moment of epiphany when I sat down with Candace Owens and we talked about what
the temporal relationship has been with many of these classic pediatric diseases
and their quenching in the population, which was more concurrent with
implementation of modern public health and sanitation practices than it was with
implementation of vaccines. And yet the industry has taught me and many of us
that there was a causal relationship when in fact it was correlation, which is
one of the big flaws we’ve seen again and again, conflating correlation with
causation.

If you’re interested in just how far down the antivax conspiracy rabbit hole
Malone has gone, simply peruse his Substack, which is chock full of right wing
conspiracy theories about more than just vaccines and COVID-19. Just Saturday,
he published a post by Sofia Karstens entitled The Apex Predator of Captured
Science. Yes, it’s all about Malone and how, great hero that he is, didn’t want 
to take a position in the government but had to be persuaded, oh-so-reluctantly,
to join ACIP:

He didn’t seek a federal appointment, but when Kennedy asked him – with the
moral urgency of a country in collapse – Malone chose service over safety. He
strapped back into his armor not for ambition, but out of obligation. And that’s
precisely what makes him so dangerous to the institutional elite. He doesn’t
need them. He can’t be bought. And he knows how to beat them.

Dr. Malone’s appointment triggered a predictable media offensive, laced with
insinuation and omission. Major outlets, operating in lockstep, flooded the
digital landscape with headlines crafted to imply fraud without making refutable
claims. Phrases like “played an early role in mRNA development…” and “claims to
have invented…” flooded search results. They planted seeds of doubt without
offering substance – classic psyop strategy.

Let’s make this plain: the establishment isn’t reacting this way because Dr.
Malone lacks credibility. They’re reacting this way because he threatens
everything upon which they rely to maintain control.

No, as I’ve discussed a number of times both here and at my not-so-secret other 
blog, Malone is a full-fledged antivax conspiracy theorist with a grudge.
Indeed, I didn’t predict him because I thought he had become toxic due to a feud
he’s been having with a number of prominent antivaxxers over the last couple of
years, but clearly I erred there too, as RFK Jr. seems to have picked a side.
After all, Malone was one of the “brave maverick doctors” who got a shout-out in
the acknowledgments of his Fauci book.

Martin Kulldorff, PhD. Martin Kulldorff is a biostatistician and epidemiologist 
who is also, of course, one of the three authors, of the Great Barrington
Declaration, along with new NIH Director Jay Bhattacharya. Since I’ve already
discussed the GBD above, I’ll just add that Kulldorff has also become
anti-COVID-19 vaccine and has parroted antivax tropes about “natural immunity”
being superior to any vaccine-induced immunity. He has also posted images like
this demanding a “Nuremberg 2.0” against “lockdowners” and those who promoted
masking and vaccination:

What nice guys Martin Kulldorff and Jeffrey Tucker are!

He also likened efforts to combat misinformation and disinformation to the Salem
witch trials:


I suspect we know which way these guys will vote on COVID-19 vaccines and lots
of other vaccines. Malone, too, was one of the “brave maverick doctors” who got 
a shout-out in the acknowledgments of his Fauci book, and the next ACIP member
is a nurse who also got one.

Vicky Pebsworth, RN. I didn’t recognize Vicky Pebsworth at first, until I
realized that she was formerly known as Vicky DeBold. She is a longtime member
of the NVIC, arguably the oldest antivax organization that’s been continuously
in existence, having been formed in 1982, currently serving on its board of
directors and in the role of Director of Research and Patient Safety. Pebsworth 
has likely been antivax longer than RFK Jr. Embarrassingly, she comes from my
alma matter, the University of Michigan, having received her doctoral degree
there in 1999 from the School of Public Health (Health Services Organization and
Policy) and School of Nursing (Health Systems Administration). Her antivax
origin story is described thusly:

Her son — her only child — experienced serious, long-term health problems
following receipt of seven live virus and killed bacterial vaccines administered
during his 15-month well-baby visit which sparked her interest in vaccine
safety research and policymaking and chronic illness and disability in children.

She very much believes that her son was made autistic by vaccines.
Interestingly, Pebsworth was a “pioneer,” if you will, in fearmongering about
“DNA contamination” in vaccines. This quote, for instance, is from 2012:

Well, I think there’s a lot of danger, because we don’t know what portion of the
DNA can be incorporated into our own genome. We don’t know what portion could
be heritable to our children. We also don’t know what happens when the immune
system is exposed to DNA that has been recombined in lots of ways that the human
body, through the course of time, has never had any exposure to, and what
diseases – diseases of the immune system – may occur because of these exposures.

“What portion could be heritable to our children”? Tell me you don’t understand 
basic reproductive biology and the difference between somatic cells and germ
cells without telling me you don’t understand basic reproductive biology and the
difference between somatic cells and germ cells. (Hint: DNA that integrates
into somatic cells will not be heritable.)

Then, of course, she invoked “epigenetics”:

I think the use of foreign DNA in various forms has a potential to cause a great
deal of trouble. Not only because there is the potential for it to recombine
with our own DNA, but there is the potential for it to turn the DNA’s switches, 
the epigenetic parts of the DNA, on and off. I think that we’re still in a place
where there’s a lot of work that needs to be done to figure out what the short 
and long-term effects of this type of DNA are on people who have lots of
different genetic makeups.

Sound familiar? While clearly not understanding epigenetics, she was invoking
epigenetics as magic, the same way quacks do. Indeed, DeBold/Pebsworth was
protecting her child’s “essence” from contamination by those evil genetically
modified vaccines and organisms, a decade before the COVID-19 era antivaxxers
were declaring the unvaccinated to be Purebloods. Naturally, she’s been all-in
on antivax tropes about “autoimmunity” and autism as well:

We ask that the government begin to fund research that evaluates the effect of
vaccination, against no vaccines at all, on biomarkers of immunity, biomarkers
for metabolic dysfunction, neuro-developmental outcomes, including autism,
immune-mediated illnesses of all sorts, autoimmunity, allergies, asthma,
epilepsy, intellectual and learning disabilities, all the things that we know
are epidemic in our children. We ask for all of that

Of course she does. I think we know which way she’ll vote on pretty much any
vaccine recommendation.

Cody Meissner, MD. At first, I was puzzled—and even somewhat relieved—by this
choice, as on the surface he is the only member in RFK Jr.’s initial slate who
has the necessary subject-level expertise to serve on ACIP. Indeed, he’s
previously served on ACIP and the FDA’s Vaccines and Related Biological Products
Advisory Committee (VRBPAC), which advises the FDA Commissioner regarding which
vaccines and biologics should receive FDA approval and licensure. So why is he 
on ACIP again? One big hint should be that he, too, is listed among the brave
maverick docs who got shout-outs in RFK Jr.’s book, a strong indication that
he’s changed. But how?

One way that he’s made himself acceptable to RFK Jr. is that he’s argued against
vaccinating children against COVID-19 and, of course, he’s antimask:

He was an ACIP member of ACIP from 2008 to 2012 and has served on the FDA’s
Vaccine and Related Biologic Products Advisory Committee (VRBPAC) and as chair
of the HHS’s Vaccine Injury Compensation Program. During the pandemic, Meissner 
cowrote an editorial with FDA Commissioner Marty Makary arguing against masks
for children.

While he has credited vaccines for saving millions of lives and praised COVID-19
vaccines, he recently told Reuters that he supports Kennedy’s decision to not
recommend COVID-19 vaccination for healthy children and pregnant women. He also 
has characterized the US vaccine-event reporting system as “pretty good” and
praised Peter Marks, the FDA vaccine regulator ousted by Kennedy.

He is also against vaccinating the pregnant.

To me, Meissner looks like one of the “Trojan horses.” He seems reasonable on
the surface, but has clearly started to dip his toe into the ocean of COVID
misinformation about masking, vaccines, and the like. Also, as our very own Dr. 
Jonathan Howard pointed out, Meissner signed the GBD and was invited to the
White House in August 2020 by Dr. Scott Atlas to meet with President Trump about
the pandemic, along with GBD authors Jay Bhattacharya and Martin Kulldorff,
antivax crank and quack Joseph Ladapo,

Look for Meissner to be one of the “reasonable” voices on ACIP who is still
nonetheless supportive of the less radical antivax positions that children and
pregnant people shouldn’t receive COVID-19 vaccines, as well as GBD-related
positions like being anti-mask and anti-“lockdown.”

Retsef Levi, MD. Dr. Levi is an MIT risk-analytics professor, know for having
recorded a viral video that urged the “immediate suspension” of mRNA vaccines,
citing alleged cardiac death signals later debunked for methodological flaws.
Levi lacks formal training in immunology and faces an expression-of-concern on
one of his vaccine-mortality pre-prints. He has written several studies casting 
doubt on COVID-19 vaccines that were criticized by others. He’s known for having
published a bogus “study” full of methodological flaws based on Israeli data
that claimed to have detected a “death signal,” saying things like this on X:


Levi is definitely antivax:


His science is also pretty poor.

Now we get into the more obscure proposed members. I’ll start with one of the
most obscure.

James Pagano, MD. I had never heard of Dr. Pagano before, and, unlike many of
the other ACIP appointees, he has minimal online references and social media
presence. He is a retired emergency medicine physician, and his website is
http://jamesvpagano.com. His blog there has been fallow since 2017, and these
days he seems to be promoting music that he writes and thrillers that he has
authored, such as The Bleed and The Drain. The latter is about “money, medicine,
miracles, and a doctor’s pursuit of happiness in spite of all that.” His
X/Twitter account has some hot takes like:


And:


And:


Nice guy, right? Still, that’s not much information to go on. Nowhere could I
find any evidence of deep expertise in the topics regarding vaccines that ACIP
normally debates and decides. I have heard from others that he promoted
ivermectin to treat COVID-19, which, if true, would fit with his being chosen by
RFK Jr., but I haven’t been able to find evidence myself to verify this. If you
know of any, please post it in the comments! A final thought: If he really did 
promote the use of ivermectin to treat COVID-19, he is most definitely not a
strong proponent of evidence-based medicine.

Michael A. Ross, MD. I hadn’t heard of Dr. Ross, either; so I’ll quote a bit
about him:

…a physician in Virginia and a former professor of obstetrics and gynecology at 
Virginia Commonwealth University and a pediatrics professor at George Washington
University (GWU), earned his medical degree at GWU.

He has been a board member, advisor, and executive at a broad array of private
healthcare and life-science firms and health groups, mostly recently as chief
medical officer at the Maryland startup Manta Pharma. An operating partner at
the healthcare investment company Havencrest for the past 7 years, he was a
presidential appointee on the CDC’s Committee for Prevention of Breast and
Cervical Cancer, according to his company profile.

Ross has also advised LarreaRX, a supplement manufacturer, and worked for
India-based Cadila Pharmaceuticals, his LinkedIn profile says. He lists his
specialties as contact lenses, international business, healthcare and
pharmaceutical executive management, and pharmaceutical consulting.

His only publication in a scientific journal was a coauthored open letter to
JAMA flagging a study published in the journal that found that the drug
ivermectin didn’t speed time to symptom resolution in patients with mild
COVID-19 as “fatally flawed.”

The letter reads, in part, “We oppose this fixation on randomized controlled
trials at the expense of other clinical and scientific evidence and urge medical
policymakers to restore balance to the practice of medicine.”

Given the RFK Jr’s emphasis on a more “fluid concept of evidence,” selectively
applied to support conclusions that he agrees with, it sounds as though Dr. Ross
will fit right in. One does note that RFK Jr. is also rather selective in his
attacks on “conflicts of interest.” Apparently any COI involving big pharma is
bad, but COIs involving supplement companies and suing vaccine manufactures,
such as serving as expert witnesses for the plaintiffs in such lawsuits, is just
ducky. In any event, I’ve thus far failed to find any evidence that Dr. Ross
has any relevant qualifications to be on ACIP.

Also, per CBS News:

Ross is described by Kennedy as an obstetrics and gynecology professor at George
Washington University and Virginia Commonwealth University, though his name
does not appear on directories for either university.

“Dr. Michael Ross has not held a faculty appointment at the George Washington
University since 2017,” Katelyn Deckelbaum, a spokesperson for the university,
told CBS News in an email.

Deckelbaum said that Ross was previously a clinical professor, but stopped
teaching medical students or residents at the university.

It’s not that hard to be named a clinical professor at a medical school, as any 
medical school full time faculty member will know. Usually, all it requires is
being a licensed MD with a clean record with the state medical board and being
willing to have medical students rotate at your practice.

Joseph R. Hibbeln, MD. This is another appointee whom I hadn’t heard of before. 
On his LinkedIn, he describes himself as a psychiatrist and a “nutritional
neuroscientist.” He appears to be a career omega-3 researcher with zero
peer-reviewed publications related to vaccines that I can find. He also sits on 
the Seafood Nutrition Partnership’s advisory council, announced in this
Instagram post a couple of years ago:

Although I can’t say for sure, that bit about him practicing as a psychiatrist
could be innocent, or it could be a bit woo-ful. I’ll have to look into it more.
He did recently co-author a commentary arguing that current federal warnings
about mercury in fish are depriving children of neurolipids necessary for brain 
and eye development as well as a paper arguing that eating more fish did more
good than methylmercury in fish did harm, which, I admit, could be amusing with 
respect to RFK Jr.’s belief that mercury in vaccines pre-2001 was responsible
for an “autism epidemic.” Indeed, one wonders if RFK Jr. is even aware that his 
recent publication volume seems to argue that methylmercury is less dangerous to
children than it’s traditionally been viewed.

My impression is that Dr. Hibbeln is probably not antivaccine. Rather, he
strikes me as a “MAHA appointee” in that he seems to be big into nutrition as a 
treatment for neurological conditions. For example, he has co-authored a study
testing omega-3 polyunsaturated fatty acids as a preventative for bipolar
disorder. Ironically, it was a negative study. In any event, he has no relevant 
qualifications to be on ACIP that I can find, given that ACIP requires
“scientific knowledge of vaccines, immunization, and/or immunization programs.”

Come to think of it, the way to look at this new panel is that four (Pebsworth, 
Malone, Levi, and Kulldorff) are antivax, one is qualified but a COVID-19
contrarian (Meissner) who opposes vaccinating children and pregnant people
against COVID-19, and the remaining three (Ross, Hibbeln, and Pagano) are
utterly unqualified to be on ACIP.

Do any of these new ACIP members deserve the benefit of the doubt?

If there’s one thing that’s irritated me since the list of new ACIP members was 
announced last Wednesday, it’s bene the reaction of some usually science-based
scientists and doctors to the announcement. All of them acknowledge that Dr.
Malone and Ms. DeBold are antivax, but then they do mental contortions to tell
themselves that it could be alright. Indeed, I was shocked to see a longtime
hero of mine, Dr. Paul Offit, a man who’s championed vaccines since long before 
I was even aware that there was a large antivax movement, was quoted thusly in a
MedPage Today article about the new ACIP:

Paul Offit, MD, a vaccine expert at the Children’s Hospital of Philadelphia, was
most concerned about Pebsworth and Malone, who, he said, “is a clear
anti-vaccine activist.” As for the rest, “they seem reasonable — what they lack,
it seems to me, is the kind of expertise or experience in vaccines that was on 
that committee. I think we lost experience, expertise, and institutional memory,
and so I think we’ve taken a giant step backward in terms of the kind of advice
that we’re going to be getting. And I wonder whether the medical and scientific
community will look at this committee now and not trust their advice.”

Seriously, Dr. Offit, I admire you to death for your vaccine advocacy, but how
can you be unaware of what Kulldorff’s been saying and doing since the GBD was
published and how he was for a time the scientific advisor for the COVID-19
contrarian and antivax right wing think tank the Brownstone Institute, formed by
the now rabidly antivax (and neo-Confederate hack) Jeffrey Tucker? How could
you not be aware of Dr. Levi’s awful studies and his numerous postings on social
media fear mongering about COVID-19 vaccines as being more dangerous than
COVID-19? I realize that Dr. Meissner was once a respectable legitimate vaccine 
scientists, but how could Dr. Offit be unaware of Dr. Meissner’s heel turn
during the pandemioc into COVID-19 contrarianism, GBD “natural herd immunity”
approaches, and anti-masking? Dr. Offit is, of course, correct that, aside from 
Meissner, all of RFK Jr.’s picks are unqualified and will degrade the expertise 
and institutional memory of the CDC and ACIP, but his statement comes across as 
whistling past the graveyard, especially if he’s relying on gauzy memories of
the way things were a decade ago.

Even worse is Dr. Michael Mina’s post on LinkedIn:

His assessment on some of these people is so wrong that it’s not even wrong.
While, like Dr. Offit, he does realize that Malone and Pebsworth are antivax to 
the core, how the hell does he think that having them on ACIP might “force ACIP 
to sharpen and clarify its reasoning publicly” or “force open conversations
about hesitancy”? Has he not been paying attention to ACIP the last 20 years?
Vaccine hesitancy comes up frequently, particularly in the public comments. His 
post comes across like that of someone who superficially paid attention to the
antivax movement, but didn’t really pay attention.

As for the rest, Kulldorff “unfairly treated”? A “critical thinker”? “A bit of a
wild card but not unscientific”? Holy hell, has Mina read the sorts of things
Kulldorff has been writing and saying over the last four and a half years? If
Dr. Mina happens to read this post, I urge him to read my section above on
Kulldorff. I can provide many more examples. If anything, he was not treated
harshly enough, he is definitely not a “critical thinker” anymore, and he has
definitely become unscientific. In case anyone needs to be reminded, Martin
Kulldorff was every bit the driving force behind the GBD as Jeffrey Tucker and
the American Institute for Economic Research (AIER), the right-wing think tank
with which he was affiliated at the time before founding the Brownstone
Institute. Meanwhile, Levi was one of the first to promote fear mongering about 
vaccine-induced myocarditis from the vaccines through badly designed scientific 
studies that promoted the antivax “died suddenly” narrative. The rest, as Mina
himself notes, are utterly unqualified. They will not be “probably fine.” They
will likely be too ignorant of the relevant issues to push back against the
antivax fear mongering of the majority of the panel.

Even Atul Gawande fell for it, posting this after Dr. Mina had posted a version 
of his LinkedIn post to X:


Not really, Dr. Gawande. Still, in fairness, faced with massive criticism of his
take, Dr. Mina did back down, but only a little bit. He gets part right, but a 
lot wrong:




Yes, he does. RFK Jr. most certainly does plan to use the remaining three and a 
half years of the second Trump administration to do his utmost as HHS Secretary 
to undermine vaccines. In fact, I will go further than that. (See below.) At
least, Mina is correct that RFK Jr. is only getting started. After all, he could
name up to 11 more members to the panel, and it wouldn’t surprise me in the
least if he named antivaxxers like Brian Hooker, James Lyons-Weiler, William
Thompson, Paul Thomas, or Peter Doshi in the next round. (Hell, I wouldn’t even 
exclude the possibility that he might name Andrew Wakefield.) Hopefully, though,
Dr. Mina come around; at least he’s appears to have started the process, but he
clearly has a ways to go, if this comment he made on LinkedIn in response to
criticism of his being way too easy on Levi is any indication:

But I’m trying to look beyond Covid. A lot happened w Covid and a lot of
behaviors were out of the ordinary and wrt Covid remain out of the ordinary. I’m
getting a bit tired of the “establishment” judging many people’s entire careers
on their response to Covid. Especially since this is happening in a lopsided
way. If you had a view that didn’t fit everyone else’s view you are essentially 
damned. Outside if Covid, disagreements, even serious ones, have been celebrated
or at least encouraged. But god forbid someone has an idea that is outside the 
routine commentary for Covid… they must not be able to think and their entire
value as a critical thinker is thrown out the window.I saw this happen to me
and I was on the verge of everyone in my lab medicine discipline thinking I was 
insane for driving forward forward rapid tests because they were “bad”tests.
Thankfully for me people came around to what I was saying. But it didn’t have to
be that way. And there group think of academics could have swept me away.I’m 
going to start speaking out against this type of group think. It’s dangerous.
Whether Retsef or others can take on the position should be viewed through the
arc of their career.

To a point. Only to a point. When becoming COVID-19 “contrarian” and antivax has
taken over a scientist’s entire career and identity, as it has with Levi, then 
I really don’t give a rodent’s posterior if they had been awesome scientists for
many decades before they went quack. I’ve said it of Nobel Laureates like Luc
Montagnier, who went antivax several years before his passing, and of Linus
Pauling, who fell into the quackery claiming that vitamin C can cure cancer and 
the common cold. Let’s just say that Kulldorff, Meissner, and Levi are no
Montagnier or Pauling; they didn’t rate the same degree of respect before their 
heel turn with respect to science. Moreover, it’s not “groupthink” to call out
bad science, pseudoscience, and nonsense when you see it, and I refuse to accept
Mina’s framing, particularly the whiny part about how we supposedly celebrate
scientific disagreements in every other topic besides COVID-19 and vaccines. The
bottom line is that if you start to promote demonstrably false science and
conspiracy theories that are a danger to public health, you deserve to be
shunned by the scientific community.

What does this mean?

I wrote at the beginning of this post that I would try not to make the opposite 
mistake from the one that I made when I failed to predict that Malone would be
chosen or that RFK Jr. would be bold enough to fire every ACIP member and
replace them with his own sycophants, toadies, and lackeys, With that in mind, I
still think that this new ACIP is yet another tool that RFK Jr. will use to
eliminate every vaccine he can, and, if he can, all vaccines currently on the
CDC schedule. Half the panel is definitely antivax, and one has become COVID-19 
antivax-adjacent at least, while the remaining three are utterly unqualified and
therefore likely to be swayed by antivax arguments because they lack the deep
subject-level knowledge about vaccines, infectious disease, and epidemiology to 
recognize misinformation when they see it, all while likely being sympathetic—or
at least receptive—to the sorts of antivax arguments the antivax members of the
panel will make. Moreover, we do not know whom else RFK Jr. will appoint, as
the panel previously had 17 members and, if I remember correctly, can have up to
19 members.

I don’t think that I am making that opposite mistake when I leave you with this 
warning: Do not underestimate RFK Jr.’s determination to eliminate access to all
vaccines—yes, all vaccines. He is antivax to the core and has been so since at 
least 2005, no matter how much his stans try to latch onto what they like about 
his “make America healthy again” (MAHA) agenda, like the emphasis on tackling
obesity and unhealthy diets (never mind that it doesn’t really do even that) and
assiduously whistling past the graveyard when it comes to RFK Jr.’s two decade 
history of rabid antivax activism. Being antivax to the core, RFK Jr.’s endgame 
is to eliminate access to all vaccines or, failing that, to make access to them 
as difficult as possible and to stoke as much fear, uncertainty, and doubt about
them as he can, the goal being that people will fear vaccines more than they
fear the diseases that vaccines prevent, at least until these diseases come
roaring back as vaccine uptake plummets.

I hope everyone is up-to-date on their vaccines. I am now, having gone to my
primary care doctor on Friday and urged him to hit me up with any vaccine for
that I was eligible for or behind on. I urge our readers to do the same now,
while you still can, for yourself and your children. In the meantime, being
fortunate enough to live in the Detroit area and work at a hospital a mere two
miles from the Detroit River, where I can literally see Canada behind my
panoramic view of downtown Detroit, I am plotting ways to cross the border into 
Canada and pay to get the vaccines I need. The thing that depresses the hell out
of me is that I know my privilege. Most people do not have the advantages of
proximity to an international border and well above-average financial
wherewithal that I do. I know that, and I feel it.

And, no, I do not think that I am exaggerating. I’ve been predicting this ever
since RFK Jr. was appointed HHS Secretary, and he’s moving even faster and more 
boldly than I thought he would to implement his endgame of eliminating vaccines,
starting with COVID vaccines. He’s long claimed that vaccines do more harm than
good. Unfortunately, I fear that we are about to find out how wrong he is the
hard way.


“Autism biomed” is now in charge of the Eunice Kennedy Shriver National
Institute of Child Health and Human Development

The NIH announced that Dr. John Gaitanis, who has served as expert witness for
plaintiffs of “vaccine injury” cases and is affiliated with the autism biomed
quackery group MAPS, will lead the Eunice Kennedy Shriver National Institute of 
Child Health and Human Development. Lysenko marches on.

David Gorski on August 24, 2026

Link


Ever since longtime antivax activist and crank Robert F. Kennedy, Jr. bent the
knee to Donald Trump almost exactly two years ago during the 2024 Presidential
campaign and, in return, was rewarded by being named Secretary of Health and
Human Services by a year and a half ago, he has systematically engaged in the
degradation and destruction of public health, in particular federal vaccine
recommendations and programs. However, as I’ve been discussing ever since Trump 
assumed the Presidency for a second time, this administration’s attitude towards
federal public health, science, medical, and biomedical research programs is
very much like its approach to everything else, highly transactional, the idea
being that federal grant programs to fund biomedical and other scientific
research should be, more than anything else, a tool for patronage, in which
grant money flows to scientists not on the basis of solid science and scientific
promise, but rather on whether the work “advances administration priorities.”
That is why I’ve taken to referring to the era of federal support for science
that this administration wishes to usher in as “Lysenkoism 2.0,” the difference 
being is that Trofim Lysenko, the scientist whose ideological pseudoscience
ruled (and ruined) Soviet agriculture and genetics for over three decades, was a
rank amateur compared to these guys. After all, Lysenko turned only two
branches of Soviet science into ideological pseudoscience, while the Trump
administration is doing its damnedest to accomplish this for all federally
funded science in the US, by hook or by crook.

Consider this Friday announcement from the National Institutes of Health to be
yet another example of the flood of Lysenkoism unleashed by this administration:

National Institutes of Health (NIH) Director Jay Bhattacharya, M.D., Ph.D.,
announced the selection of John Gaitanis, M.D., as director of NIH’s Eunice
Kennedy Shriver National Institute of Child Health and Human Development
(NICHD). Dr. Gaitanis is set to begin his role on August 23, 2026.

As NICHD director, Dr. Gaitanis will shepherd the investment of NICHD’s
approximately $1.7 billion annual budget, facilitating research to advance
maternal, gynecologic, and child health, as well as the health of people with
intellectual and developmental disabilities. He will lead a staff of about 1,100
who either conduct research at NICHD or support some of the institute’s
approximately 2,300 research grants and projects at organizations throughout the
United States and internationally.

“With the burden of chronic disease on the rise, Dr. Gaitanis’s forward-thinking
approaches for NICHD research will help us adapt to the realities of today,”
Dr. Bhattacharya said. “We’re eager for research advances in prevention,
precision, and systems-level understanding to pinpoint root causes of these
conditions and yield transformative advances in clinical care to improve health 
for women, children, and people with disabilities.”

When I first saw that announcement, I didn’t recognize the name, but a quick
search of the blog revealed that he had been one of the candidates that RFK Jr. 
had wanted to appoint to the Centers for Disease Control (CDC) Advisory
Committee on Immunization Practices (ACIP) over a year ago, back when he had
first fired all the qualified scientists, physicians, and public health experts 
on ACIP to replace them with grossly unqualified antivax cranks and
antivax-adjacent or -sympathetic physicians and scientists. At the time, Dr.
Gaitanis was mentioned in a story in The Washington Post:

Six of the seven people who appeared to be on the list did not respond to
requests for comment. Pediatric neurologist John Gaitanis, who has been paid to 
be an expert witness on behalf of people alleging vaccine injuries, told The
Washington Post he declined to serve because of “prior professional
obligations.”

There’s the first huge red flag, that Dr. Gaitanis served as an expert witness
arguing for “vaccine injury.” As you will see, it turns out that he was paid
handsomely for his efforts in one case and also served as expert witness for the
complainants in two other cases brought before the Vaccine Court.

But it’s even worse than that, as was pointed out on Bluesky:

Let the shit show begin (actually continue)…www.nih.gov/news-events/…No NIH
experience at all as far as I can tell. No significant management experience.
Vaccine injury trial expert witness.

— Jeremy Berg (@jeremymberg.bsky.social) 2026-08-21T17:22:41.804Z

With a response:

I note that Dr. Gaitanis also received an award to study this:

I could be wrong, but this sure sounds like facilitated communication to me.
Actually, I’m not wrong. Spelled communication or “Spelling to Communicate”
(S2C) is just rebranded facilitated communication, and facilitated communication
is still pseudoscience.

Major red flags. Dr. Gaitanis is on the board of an organization that is the
successor organization to Defeat Autism Now! (DAN!), which for decades was the
premier (if you can call it that) organization promoting “autism biomed”
quackery and “certifying” quacks who treat autism with quackery, many, if not
all, of them rabidly antivaccine. I haven’t written about DAN! in a long time,
which is why I saw this appointment as a good chance to discuss DAN!, how it
became MAPS, what MAPS is and does, and who Dr. Gaitanis is and what he’s done. 
Suffice to say, Dr. Gaitanis is grossly unqualified to lead such a prestigious
Institute at the NIH, so much so that I have a hard time wondering if his
appointment is an intentional poke in the eye to the Kennedy family, which has
rebuked RFK Jr. multiple times for his antivax crusade. Certainly, Eunice
Kennedy Shriver, philanthropist that she was, must be doing backflips in her
grave.

Lysenko is taking over NIH

I’ve long contended that the National Institutes of Health is arguably the
greatest engine of biomedical research and discovery in history and that its
status as such derives from how well it has, until recently, been protected from
raw partisan politics, allowing it to fund what its scientist leaders view as
the most promising and rigorous science. The NIH was, of course, not perfect. It
not infrequently failed or even allowed pseudoscience into small sections of
its campus, thanks to political interference by powerful legislators (e.g., the 
National Center for Complementary and Integrative Health), but overall the NIH
was about as insulated from raw political influence as a government agency can
be and has long enjoyed strong bipartisan support. Moreover, this imperative to 
exert full political control over federal science and medicine comes from the
top. RFK Jr., as bad as he is, has merely agreed to sell what’s left of his soul
to be the instrument by which the Trump administration guts federal science,
all in return for the ability to eliminate as many vaccines as he can, as I’ve
been documenting since he was first nominated for HHS Secretary. He’s perfectly 
fine with Lysenko 2.0, even when it involves policies that he once opposed
regarding the environment, as long as he can place his little Lysenkos in charge
of everything else in HHS.

Although I was very much relieved to see that NIH Director Jayanta “Podcast Jay”
Bhattacharya‘s pick to lead the National Cancer Institute was not someone like 
Dr. Wafik El-Deiry, who was a respected researcher but of late has ruined his
reputation by endorsing the antivax pseudoscience blaming COVID-19 vaccines for 
a wave of “turbo cancers,” but rather a conventional and qualified pick, Dr.
Anthony Letai, other picks have been more disturbing. For example, it has been
reported that a lab leak conspiracy theorist whose—shall we say?—exaggerations
and distortions of molecular biology I wrote about back in the day is going to
be tapped to fill Dr. Anthony Fauci’s old spot as Director of the National
Institute of Allergy and Infectious Diseases (NIAID). Also, Bhattacharya picked 
a buddy of Vice President J.D. Vance, Kyle Walsh, to be Director of the National
Institute of Environmental Health Sciences (NIEHS), while Gaitanis’
second-in-command is a physician connected to Kennedy, endocrinologist Dorothy
Fink, who iwas appointed deputy director and acting director of NICHD before
Gaitanis was named.

Before I discuss Dr. Gaitanis, MAPS, and his expert witness work in depth, I
can’t result doing a “Dug the Dog” seeing a squirrel and briefly mention another
story that I consider highly relevant and that tells you all you need to know
about this administration’s attitude towards federal scientific agencies.
Specifically, I’m referring to the recent nomination of Dr. Heidi Overton to
replace Dr. Marty Makary as FDA Commissioner. Dr. Overton, like Dr. Gaitanis, is
grossly unqualified for the job for which she’s been nominated. She is,
however, politically aligned with the Trump administration:

The first thing to understand about Heidi Overton is what she is not. She is not
a career regulator. She has never run a drug approval division, managed a major
scientific organization, or overseen a workforce of the scale that the FDA
demands. What she does have is an MD from the University of New Mexico, a PhD in
clinical investigations from Johns Hopkins, and—most importantly for this White
House—a track record of political alignment that stretches back to her time as 
a White House Fellow during Trump’s first term.

The phrase “not a career regulator” is doing some heavy lifting. She has
basically zero experience in drug regulation at all, serving prior to her
nomination as Deputy Assistant to the President for Domestic Policy at the White
House and, reportedly, was one of the key drivers behind Trump’s recent
executive order ordering a decrease in the number of CDC-recommended vaccines
and increased research into links between vaccines and autism that our fearless 
leader called a “frontal assault on vaccines” and I called “gold-plated
nonsense,” reported thusly:

Earlier in 2026, HHS Secretary Robert F. Kennedy Jr. overhauled the childhood
vaccine schedule, cutting it from 17 recommended vaccines to 11. Medical groups 
sued, and a federal judge blocked the change in March. But the administration
revived the fight with the executive order, and Overton was there, in the room, 
urging “blue states” to adopt the new recommendations into state
law—recommendations that many doctors say are not supported by current science.

During the first Trump administration she served as a White House Fellow at the 
America First Policy Institute. In brief, her qualifications for the job of FDA 
Commissioner have nothing to do with a skillset necessary to actually do the job
well, but, rather, are purely political, and she’s proven this with a quote
that’s been going around:

Trump's pick to lead the FDA, Heidi Overton, says the FDA, CDC, and NIH need to 
be "reformed" to fund more "conservative-based" research instead of
peer-reviewed and evidence-backed medical science.#Trump #Overton #Science
#StandUpForScience #FDA

— Stand Up for Science! (@standupforscience.net) 2026-08-21T17:00:38.828Z

Her full quote:

We need publications in academic journals that are conservative-based. We need
research funding that is willing to say, “No, let’s fund these type of studies.”
That’s not happening at the NIH. The FDA isn’t prioritizing those kind of
decisions. The CDC certainly is not. So, all of those agencies have to be
reformed in how they fund and prioritize.

Lysenkoism 2.0 indeed. While Dr. Gaitanis is, as far as I can tell, not a purely
political appointee, he is an ideologically aligned appointee in that he has
deep roots in the “autism biomed” community and basically zero qualifications to
run an Institute at the NIH with a $1.7 billion budget. He is thus
ideologically aligned with RFK Jr. and Donald Trump’s quixotic desire to be the 
President whose administration solves autism. But how? First let’s look at
autism biomed, DAN!, and MAPS.

From DAN! to MAPS, “autism biomed” quackery over the decades

A little history is in order here. DAN! was a project of an organization called 
the Autism Research Institute (ARI), which was founded in 1967 by Dr. Bernard
Rimland “to conduct and sponsor research aimed at finding the causes and
developing treatments for autism.” To his credit, Rimland, who was a research
psychologist, did a lot to dispel the long-held view that autism was caused by
faulty mothering. Unfortunately, after dispelling one bad idea, came to embrace 
others. The ARI came to focus on “biomedical” causes of autism, whether
justified by science or not, whether there were clinical trials showing safety
and efficacy of its treatments or not, and ultimately became, in essence, an
organization promoting quackery for autism. In the 1990s, as the idea that
vaccines cause autism rose in prominence, ARI jumped on the bandwagon, with many
of its treatments—shall we say?—evolving to embrace treatments for autism as
“vaccine injury.” Indeed, Rimland incorrectly came to the conclusion that that
autism was caused by vaccines and could be treated with “detoxification” and
various supplements. A lot of this was based on parental surveys about what made
their autistic children better, almost always without followup rigorous studies
that actually tested whether these interventions were safe and efficacious.

Dr. Stephen Barrett, founder of Quackwatch, has provided a detailed history of
DAN!, and describes how it was launched in the 1990s, began thusly:

In 1995, ARI sponsored a 3-day meeting that was attended by about 30
professionals who discussed what they were doing and what they believed had
worked for them. These determinations were not derived from well-designed
studies but were based on clinical impressions, observations reported by parents
to the treating physicians, and responses to questionnaires that ARI had
collected. The meeting generated a consensus document—co-authored by Baker and
Pangborn—that was published in 1996 as Biomedical Assessment Options for
Children with Autism and Related Problems, but was often referred to as the DAN!
Clinical Manual” or DAN! Protocol.” In 2005, after undergoing five revisions,
the report was extensively rewritten, revised once more, and published by ARI as
a large book called Autism: Effective Biomedical Treatments. The original
version of the book covered 41 pages. The 2005 version, which I own, has about
330 pages and measures 8.25 x 10.75 inches [7]. I estimate that it contains
about 220,000 words.

The DAN! protocol was based on the idea that combination of lowered immune
response; external toxins from vaccines (of course!), and other sources; and
problems caused by certain foods, including:

  1. Nutritional deficiencies and special needs—these concern primarily Vitamins
    B6, B12, A and magnesium, calcium, selenium, zinc, and omega 3 fatty acids.
  2. Gut dysfunction due to multiple factors, including suboptimal nutrition,
    infections, antibiotics, and NSAIDs.
  3. Microbial overgrowth including viral infections in susceptible children after 
    a) certain vaccines, b) intestinal parasites, and c) bacterial and yeast
    overgrowths in the gut.
  4. Toxins, such as PCB’s, and particularly heavy metals, such as mercury from
    environmental sources and certain childhood vaccines.
  5. Food intolerance, including intolerance of gluten and casein (found in grains 
    and dairy), immunoglobulin-mediated food allergy (not always evident on
    skin-testing), intolerance of so-called Feingold foods and additives
    (phenolic compounds), and excitotoxins (certain flavor enhancers from the
    MSG family).
  6. Abnormalities in detox chemistry and immune function
  7. Benefits from secretin, intravenous immunoglobulin (IVIG), transfer factor,
    colostrum, and special digestive enzymes in many individuals with autistic
    symptoms
The DAN! protocol was basically a plethora of quackery and antivax nonsense.
However, it became very popular among parents of autistic children with
tendencies to seek out alternative therapies, and the list of DAN! doctors was a
big deal when I started blogging in 2004. Basically every one of these ideas
behind autism causation and treatment are still popular today and,
unfortunately, also very much embedded in the “make America healthy again”
(MAHA) movement.

ARI was what we like to call a pseudoprofessional medical organization; in other
words, an organization that is designed to appear to be a legitimate medical
professional organization but in reality is an organization designed to promote 
quackery and pseudoscience, and, sometimes, a highly political position. DAN!,
of course, was its more practical arm, which recruited and “trained” physicians 
to treat autism according to ARI’s pseudoscience. One example of a
pseudoprofessional organization that I’ve been writing about since 2006 is the
Association of American Physicians and Surgeons (AAPS), which promotes various
quackery and pseudoscience, especially antivax quackery, combined with extreme
libertarian views that proclaim Medicare to be unconstitutional and any
regulation of the medical profession by government an affront to physician
“autonomy.” Another example is the American College of Pediatricians, which is
often mistaken for the legitimate pediatrics professional organization the
American Academy of Pediatrics. It’s a small but loud organization that
advocates abstinence-only sex education and conversion therapy, and opposes
vaccines, vaccine mandates, pornography, abortion rights, and LGBT rights. It is
virulently transphobic and antivax. The Medical Academy of Pediatrics and
Special Needs (MAPS) is cut from the same cloth, and Dr. Gaitanis serves on its 
medical board.

So what happened to ARI and DAN! ARI, it turns out, is still around, but it has 
evolved. Dr. Rimland died in 2006, and a few years later, around 2011, ARI
phased out the DAN! registry and discontinued the program. DAN!, however, did
not die. Although I couldn’t find a detailed record of how DAN! became MAPS,
become MAPS it did in 2012, thanks to an autism biomed quack called Dr. Dan
Rossignol. The bottom line is that MAPS is a direct successor organization to
DAN!, and it shares the same quackery.

Dr. Gaitanis is on the medical board of MAPS, but who else is on the board?
Let’s go to the MAPS website:

Do any of those other names sound familiar? At least a couple of them should.
Elizabeth Mumper, for instance, is rabidly antivax and has been featured in this
blog before dating back to 2013. Here’s how the antivax blog Age of Autism
described her:

The latest example comes from Lynchburg, Va., and the pediatric practice of Dr. 
Elizabeth Mumper. She noticed a frightening rise in autism in the 1990s.
Concerned that vaccines and other medical interventions might be playing a role 
– concerned in other words that SHE was playing a role — Mumper changed course.
Fewer vaccines. Fewer antibiotics. No Tylenol. Breast-feeding. Probiotics.
Good, pesticide free diets. Since then, hundreds more children have been seen 
in her practice, Advocates For Children. But no more autism.

Unsurprisingly, RFK Jr. appointed her earlier this year to the Interagency
Autism Coordinating Committee.

Notice something else. All of these docs on the medical board list themselves as
FMAPS, or Fellow, MAPS. That’s because MAPS, like DAN!, offers “fellowship
training” in autism biomedical quackery, and physicians who complete that
“training” are awarded the title of Fellow. This is, as I will discuss shortly, 
a direct continuation of what the MAPS predecessor organization DAN! did
“training” physicians and maintaining a list of “DAN! doctors” for parents of
autistic children who wanted to use quackery to treat their children’s autism
and/or thought the autism was caused by vaccines could seek out.

As for the others, the President of MAPS, Dr. Neuenschwander, is
“board-certified in Emergency Medicine, Integrative and Holistic Medicine, as
well as Anti-Aging and Regenerative Medicine and been known to appear on
“vaccine skeptic” panels. He also offers CEASE therapy for autism, a therapy
based on homeopathy, and IV vitamin C and chelation therapy as well. Similarly, 
Dr. Singh has long been an autism biomed quack, I’ve encountered her before
being sued for a truly depressing and horrifying repertoire of autism biomed
quackery. Her topic? Autism biomed quackery, of course:

Dr. Anju Usman is director of True Health Medical Center in Naperville,
Illinois. She specializes in biomedical interventions for children with ADD,
autism, and related disorders. She has been involved in research regarding
copper/zinc imbalances, biofilm related infections, and hyperbaric oxygen
therapy. She serves on the boards for ASI, TACA, and Generation Rescue. She is
board certified in family practice and in integrative and holistic medicine.

I’m not familiar with Dr. Nancy O’Hara, but I did a bit of Googling, and found
that—surprise!—in addition to being an “integrative medicine” doctor, she’s a
practitioner of the quackery known as “functional medicine,” or, as I like to
describe it, reams of useless tests in one hand, a huge invoice in the
other—plus pure quackery! She’s also very big into Pediatric Autoimmune
Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), a 
condition that quacks frequently falsely attribute to vaccines, rather than its 
real cause, streptococcal infection.

If every single other member of the medical board of MAPS is an antivax quack,
what does that make Dr. Gaitanis? I suppose it’s possible that he is the lone
science-based physician among the sea of quacks. In one way, Dr. Gaitanis is
somewhat interesting in that has a legitimate clinical academic track history,
having previously served as Director of Pediatric Neurology at Brown
University’s Warren Alpert Medical School; before that, he was Director of
Pediatric Neurology at Tufts Medical Center/Floating Hospital for Children from 
2014 to 2022. He has over 30 academic publications on PubMed, although few as
either first or last author, the positions indicating primary responsibility for
carrying out a study. This part of Dr. Gaitanis’ bio is rather disturbing,
because from my perspective being affiliated with a group like MAPS should be
disqualifying to be director of any academic medical program—or even to be an
academic clinical professor.

Dr. Gaitanis also co-founded a telehealth platform called Meadow Health with
John C. Slattery and Candace McDonald.

Perusing the Meadow Health website, I found this statement about how Meadow
Health operates:

Meadow Health is different because we are physician-led, not coaching-only. We
focus on specific biological pathways that may be relevant to some children with
autism, not just behaviors. We use peer-reviewed science to guide care, offer
nationwide telehealth, provide access to a dedicated, high-quality supply chain 
for leucovorin free of additives, dyes, lactose, or other ingredients which can 
negatively impact children with ASD, and design care around the whole child, not
a one-size-fits-all model.

This sort of language is very typical of “autism biomed” quackery, in which all 
sorts of biological pathways that have at times been implicated in the
pathogenesis of autism and its symptomatology are supposedly “targeted” based on
science, whether there exists a robust base of human clinical trials validating
the treatment or not.

Of note, I also found a lot of promotion of Leucovorin at a cost of $249 a month
that includes:

  1. Initial consultation, and if prescribed, monthly medication delivery
  2. Ongoing follow-up and dose adjustments
  3. Secure clinician messaging
It’s all self-pay, of course, cash (or credit card) on the barrelhead. My main
reaction was that close to $3,000 a year is a rather steep price to be treated
with a drug that at best has some evidence for efficacy treating cerebral folate
deficiency (CFD), which is one potential contributor to autism spectrum
disorders and at worst is unproven. One can see a link, though, in that
President Trump, RFK Jr., and Dr. Mehmet Oz gave a press conference last
September, where they announced FDA approval of Leucovorin to treat CFD and
touted it as an autism breakthrough, described by Dr. Novella thusly:

They also wanted to use the news conference to announce a newly FDA approved
treatment for autism – leucovorin. Taken in isolation, this is just weird – why 
would the president and HHS secretary make such an announcement? Obviously this 
is just propaganda, trying to create the impression that they are doing
something about autism, even though neither of them or their policies have
anything to do with this. Leucovorin may be a legitimate treatment, but only for
a small subset of those with autism who have a folate metabolism disorder. It’s
really a treatment for cerebral folate deficiency, one of the manifestations of
which may be autism.

But more concerning – the FDA just gave approval for leucovorin for CFD without 
any new evidence. There was no new study, just a review of prior studies. The
evidence is generally considered to be preliminary. All of this makes the timing
– right before RFK’s big September deadline – highly suspicious. Others have
also noted that Dr. Oz, who was standing with Trump and RFK, holds a position in
a company that produces leucovorin, but this can be a coincidence.

It’s pretty obvious what is going on here. RFK needed something to announce in
September regarding autism, so he or his flunkies scraped the literature for
anything they can present as an identified exposure risk and a possible
treatment.

I note that the largest study of leucovorin in autism was retracted in February 
due to data inconsistencies and statistical issues. No wonder Dr. Novella
referred to this whole press conference as yet more Lysenkoism.

Of note, Dr. Gaitanis is also tight with the “make America healthy again” (MAHA)
movement, in particular the MAHA Institute. Indeed, he participated in a MAHA
Institute conference last September called Autism Roundtable: A National Call to
Action (YouTube). In addition to Dr. Gaitanis, panelists included Tony Lyons,
John Gilmore, Brian Hooker, Kim Mack Rosenberg, Katie Wright, Louis Conte, Mary 
Coyle, Sylvia Fogel MD, Honey Rinicella, James Lyons-Weiler, Richard Frye MD,
Andrew Downing, Gabrielle Traub, Elizabeth Horn, Tracy Slepcovic. Seriously, if 
you appear in any conference with rabid antivax activists like Brian Hooker,
Tony Lyons, Katie Wright, Louis Conte and James Lyons-Weiler, at the very
minimum you are antivax-adjacent, if not antivax-sympathetic, if not outright
antivax. No respectable scientist should, for instance, appear on a panel like
this moderated by James Lyons-Weiler:

I found an Easter egg in there too. Nearly a year before Dr. Gaitanis was
announced as the new Director of NICHD, antivax crank James Lyons-Weiler praised
him thusly (timestamp 2:48):

Dr. John Gatanis, I don’t know what happened. I started studying autism in 2014 
and I didn’t meet you until this year, and let’s just say I’m going to give you 
a commendation that was passed on to me. You should be in charge of a research
program on autism within the NIH, sir.

Alrighty then. Dr. Gaitanis was apparently recommended for this position by
James Lyons-Weiler. Not a good look for a science-based physician! In any event,
Dr. Gaitanis’ part of the panel consisted mainly of promoting leucovorin as the
cure for autism and attacking critics who said there wasn’t enough evidence,
while touting the press conference announcing FDA approval of leucovorin to
treat autism that had occurred a few days earlier.

But what about vaccines?

Is Dr. Gaitanis antivax? He’s at least antivax adjacent

In all the reading I’ve been able to find about Dr. Gaitanis, one thing that
he’s been very careful about is making public statements on vaccines. Given the 
company he keeps and the organization whose medical board he serves on, it’s not
at all unreasonable to wonder if he is antivax, given how much he buys into
dubious autism treatments and works with people who are undeniably antivax, like
Dr. Mumper. That’s why I was so interested in his expert witness work, reported
here:

Gaitanis has also served as a paid expert witness in a federal court where
families can claim neurological harm from childhood vaccines.

Just as Jeremy Berg said!

I really, really wanted to find his testimony to read. There are three cases
that I could find for which he served as an expert witness for the complainants,
with about all I could find about each:

  1. Hetrick v. HHS, No. 19-795V, 2025: “On May 30, 2019, Stephanie and Jonathan
    Hetrick (“petitioners”) filed a petition on behalf of their son, J.H.,
    pursuant to the National Vaccine Injury Compensation Program, 42 U.S.C. §
    300aa-10 et seq. 2 (“Vaccine Act” or “the Program”). Petitioners allege that
    the measles, mumps, rubella, and varicella (“MMRV”) and/or
    diphtheria-tetanus-acellular pertussis (“DTap”) vaccines J.H. received on
    May 29, 2018 caused him to suffer a Table encephalopathy, or alternatively, 
    an off-Table injury of Febrile Infection-Related Epilepsy Syndrome
    (“FIRES”). Petition, ECF No. 1. Petitioners now seek an award of interim
    attorneys’ fees and costs.”
  2. Rich v. HHS, No. 18-353V, 2021: “On March 7, 2018, Brianna and Jeffrey Rich
    (“petitioners”) filed a petition in the National Vaccine Injury Compensation
    Program on behalf of their minor child, S.G.R.2 Petitioners alleged that as
    a result of a diphtheria-tetanus-acellular pertussis vaccine administered
    on April 17, 2015, S.G.R. suffers from localizationrelated epilepsy.
    Petition at 1-2 (ECF No. 1). On February 2, 2021, the parties filed a
    stipulation, which the undersigned adopted as her decision awarding
    compensation on the same day. (ECF No. 57).”
  3. Davis v. HHS, No. 18-784V, 2021: “On June 4, 2018, Adriane and Sylvester Davis
    (“Petitioners”) filed a petition on behalf of E.D., their minor child, for 
    compensation under the National Vaccine Injury Compensation Program, 42
    U.S.C. § 300aa-10, et seq. 2 (the “Vaccine Act” or “Program”), for injuries 
    allegedly caused by the Hepatitis A, Varicella, and measles, mumps, and
    rubella (“MMR”) vaccinations E.D. received on June 24, 2016. ECF No. 1
    (“Pet.”) at 1.”
I could not find any rulings or any expert witness reports, even with the help
of friend of the blog Dorit Reiss. All we could find were judgments on
compensation for attorneys’ fees, expenses, and expert witnesses (linked above),
where I learned that, for Hetrick v. HHS, Dr. Gaitanis filed three initial
reports plus one follow report and had testified once, for which he received
$56,204.51 from the court. (He charged “$400 per hour for his work performed in 
2020, 2021, and 2022; $500 per hour for work in 2023; and $550 per hour for work
in 2024.”) For Rich v. HHS, the attorneys were awarded $13,521.56 in attorney
costs, the bulk of which appeared to be for Dr. Gaitanis’ expert witness work,
but it’s not listed how much Dr. Gaitanis himself received. For Davis v. HHS,
attorneys received “”$48,753.00 for Dr. Gaitanis’ reports and participation in
the entitlement hearing, and $990.00 for an ‘immunology consult.'”

Nice work if you can get it, but unfortunately, I have been unable to find any
of Dr. Gaitanis’ actual reports or testimony for any of these cases. All that we
could find were the rulings on attorney’s fees and expenses, including expert
witness expenses, which, recall, are paid, win or lose, by the National Vaccine 
Injury Compensation Program (NVICP). I just know that he received $105,857.51
for two cases and might have received as much as $13,000 more for the third
case, all in return, very likely, for coming up with a dubious idea of vaccine
causation of the injuries reported. From this, I stick by my conclusion that Dr.
Gaitanis is at least antivax-sympathetic or -adjacent and might be full
antivax. He’s just very clever not to say anything publicly about vaccines.

Lysenko rules supreme

Given what this administration has done to federal science in the less than two 
years that it’s been in power, it’s difficult not to conclude that we are
entering a new Age of Lysenko. I can easily see Dr. Gaitanis, now that he is in 
charge of NICHD, promoting an agenda of studying long disproven “autism biomed” 
quackery and dubious “theories” of autism causation, all because his ideology
aligns with MAHA and RFK Jr. Maybe I’m being unfair to Dr. Gaitanis—although I
think not given his associations and history—but one also can’t help but wonder 
if Dr. Gaitanis was put in charge of NICHD specifically to produce “evidence”
linking vaccines to autism that RFK Jr. can weaponize in the future against
vaccines.

Whatever the reasons for Dr. Gaitanis’ appointment, he is very much consistent
with the new Age of Lysenko, or Lysenkoism, 2.0. He is ideologically in sync
with the administration with respect to its dubious views and pseudoscience on
autism. At the very least, he is not pro-vaccine, as no pro-vaccine advocate
could work with the rabid antivaxxers on the medical board of MAPS, and he might
well be antivaccine. He is utterly unqualified to helm an institute with a $1.7
billion budget, having never received an NIH grant nor published truly high
impact science on autism or child health and development. Sadly, all of these
“qualifications” mean that he’ll fit right in with the dismantling of science
and medicine that RFK Jr. is doing at the bidding of his masters.


The CDC is lying to you about vaccines and autism

The CDC webpage about vaccines and autism now misrepresents the science and lies
to the public about vaccines and autism. It’s just part of HHS Secretary Robert
F. Kennedy Jr.’s continuing war on vaccines.

David Gorski on November 24, 2025

Link


The CDC is lying to you about vaccines and autism

The CDC is lying to you about vaccines and autism.

The CDC is lying to you about vaccines and autism.

If it bothers you that I sound, for the moment, like an antivax website c.2008
or an antivax Facebook or Twitter account c. 2015—or an antivax Tik Tok or X
influencer just a week ago, just be aware that last Wednesday or Thursday, a
mere five days ago, the next shoe dropped when it comes to Health and Human
Services Secretary Robert F. Kennedy Jr.‘s continuing war on vaccines. That’s
because, on November 19, 2025, the CDC updated its webpage about one of the
central antivax claims dating back to the 1990s, the false claim that vaccines
cause autism, a claim that originated in efforts in the 1990s by barristers to
sue vaccine manufacturers on behalf of parents of autistic children that
culminated in Andrew Wakefield’s fraudulent 1998 Lancet case series linking the 
MMR vaccine to autism. Here’s what I mean. Take a look screenshots of the last
version of the webpage saved in the Internet Archive’s Wayback Machine before
the change (an archive of the page when it was last updated on December 31, 2024
captured on October 11, 2025) and the webpage as it appears today:

CDC on vaccines and autism before November 19, 2025.

CDC on vaccines and autism since November 19, 2025.

Let’s compare. First, here are the CDC’s key points about vaccines and autism
before November 19:

  1. Studies have shown that there is no link between receiving vaccines and
    developing autism spectrum disorder (ASD).

  2. No links have been found between any vaccine ingredients and ASD.

Both of these are true, and the page goes on to describe why they are true, as
well as to look at supporting evidence that neither vaccination nor any vaccine 
ingredient has been associated with an increased risk of autism in large,
well-designed, well-executed epidemiological studies. It is a point that we here
at SBM have discussed more times than I can remember going back to the very
beginning of this blog in 2008 and that I myself have discussed going back to
early 2005 on my not-so-super-secret other blog, in particular how antivaxxers
publish bad science and misrepresent the scientific literature to try to cast
doubt on that. Indeed, I just wrote such a post about a recent misleading and
terrible “report” claiming that a link is plausible a mere two weeks ago. (More 
on that later, as it is relevant to the CDC’s rewriting of its webpage on
vaccines and autism.)

Now, here are the CDC’s misleading key points that lie to you about vaccines and
autism:

  1. The claim “vaccines do not cause autism” is not an evidence-based claim
    because studies have not ruled out the possibility that infant vaccines
    cause autism.

  2. Studies supporting a link have been ignored by health authorities.

  3. HHS has launched a comprehensive assessment of the causes of autism, including
    investigations on plausible biologic mechanisms and potential causal links.

You might wonder why the first heading still reads, “Vaccines do not cause
autism.” The new webpage explains:

The header “Vaccines do not cause autism” has not been removed due to an
agreement with the chair of the U.S. Senate Health, Education, Labor, and
Pensions Committee that it would remain on the CDC website.

Yes, as part of the deal that garnered him critical support for his nomination, 
RFK Jr. promised Sen. Bill Cassidy, the physician-politician and chair of the
Senate HELP Committee who betrayed his Hippocratic oath twice, first to send RFK
Jr.’s nomination for HHS Secretary to the full Senate and then to vote for his 
confirmation, that the CDC webpage continue to say that vaccines don’t cause
autism. Of course, what has really happened is that RFK Jr. has broken his
pledge not to change CDC messaging on vaccines and autism because he put an
asterisk next to the statement that vaccines do not cause autism and then added 
all sorts of antivax propaganda after it. Truly, when I consider Sen. Cassidy’s 
cowardly and perfidious betrayal and his ongoing attempts to “control” RFK Jr., 
I’m reminded of this cartoon:

Poor Sen. Bill “Charlie Brown” Cassidy! He took Robert “Lucy” Kennedy Jr.’s
reassurances that he wouldn’t turn the CDC into an antivax propaganda agency at 
face value. What a trusting fool!

Let’s take these points on one at a time. Why start with the last point? Because
it’s one part of the strategy by which RFK Jr. has been preparing the way to
force the CDC to pivot to messaging that, at the very least, will ignore three
decades worth of scientific evidence failing to find a hint of a whiff of a
correlation between infant and childhood vaccination and autism risk in favor of
bad science by ideologically motivated antivaxxers claiming a link to falsely
portray a link as at least plausible or, at worst, proclaim that the
aforementioned bad science by ideologically motivated antivaxxers claiming a
link demonstrates that there is a link. Here are key components the strategy
designed to cast doubt on vaccines:

  1. Falsely argue that the science showing no link between vaccines and autism is 
    uncertain and that therefore a link is still scientifically plausible.

  2. Bolster the deceptive claim that a link between vaccines and autism is
    plausible through wild speculation about biological mechanisms.

  3. Falsely argue that vaccines are inadequately tested clinically and
    epidemiologically; e.g., through the deceptive claim that vaccines aren’t
    tested against “saline placebo.”

  4. Manufacture evidence through bad science that vaccines are actually associated
    with autism.

I’ll start with the last CDC talking point (“HHS has launched a comprehensive
assessment of the causes of autism”), because I’ve written about it before and
it’s fairly quick. Then I’ll discuss the other two points, how antivaxxers are
now gloating and proclaiming victory, and where this all fits in when it comes
to RFK Jr.’s ongoing efforts to eliminate all vaccines. (And, yes, the
elimination of vaccines in the US is his endgame, no matter how many times he
lies and claims that he doesn’t want to take away people’s vaccines or that he’s
all about “personal choice,” “informed consent,” and “health freedom,” and
falsely reassures people that they will be able to be vaccinated (and to
vaccinate their children) if they desire.

Again, let me emphasize to you: The CDC is lying to you about vaccines and
autism, and this change in CDC messaging is part of a strategy to sow doubt and 
fear about vaccines in order to allow him to succeed in taking away your
vaccines.

“HHS has launched a comprehensive assessment of the causes of autism”? More like
the same ol’ same ol’ repackaged and made official policy

My first reaction to this statement was that it was typical of the way cranks
and quacks misrepresent science. How? Basically, it frames its new
“comprehensive assessment” as though it were something new, as though scientists
hadn’t been diligently researching the causes and potential treatments for
autism for, quite literally, decades and already know that autism is largely
genetic. Moreover, antivaxxers like RFK Jr. are so focused on vaccines as The
One True Cause of autism that they ignore the simple fact that arguably the
single most-studied potential cause of autism has been—surprise!—vaccines. And
guess what? Numerous large, well-designed studies from different countries and
different designs have failed to find an association between childhood
vaccination and an increased risk of autism. Let’s move on, though, to what,
exactly, RFK Jr.’s “comprehensive assessment of the causes of autism” is likely 
to entail and who will be doing the “research.”

Regular readers (and anyone paying attention to RFK Jr.’s “stewardship” of HHS
probably remember that in April he launched an effort to find the causes of
autism and, remarkably, promised to have results by September. In the meantime, 
he hired a veritable rogues’ gallery of antivaxxers to work on this question,
starting with (as far as we know) David Geier, the son half of the father-son
quack duo who blamed the mercury in the thimerosal preservative that used to be 
used in several childhood vaccines until around 2001 for an autism epidemic and 
ran a quack clinic and mail order pharmacy that claimed to treat autism with
chelation therapy and puberty blockers, with David Geier being prosecuted for
practicing medicine without a license. Unsurprisingly, Dr. Mark Geier (recently 
deceased) was a frequent expert witness for complainants to the Vaccine Court
back in the day. Evidence of Mr. Geier’s “skills” at epidemiological research
came from his violating the protocol approved by the institutional review board 
overseeing his proposed use of Vaccine Safety Datalink data to look for links
between vaccines and autism in 2003. Now he’s likely to do the same, just as an 
official employee of the NIH.

Joining Geier was Mark Blaxill, a longtime antivax activist with no medical
training who was also hired at the CDC as a senior advisor. Author of The Age of
Autism: Mercury, Medicine, and a Man-Made Epidemic with fellow antivaxxer and
blogger Dan Olmsted, Blaxill served for a long time on the board of directors of
the group of the antivax group SafeMinds and had a penchant for Holocaust
analogies referring to vaccination and autism. One of its most famous
publications was an article entitled Autism, A Novel Form of Mercury Poisoning, 
published in 2001—in Medical Hypotheses, naturally. Blaxill was also associated 
with another antivax group, Generation Rescue, and wrote prolifically for its
blog, Age of Autism, a frequent source for my blogging “inspiration” back in the
day. There, Blaxill wrote posts like There’s a Funny Thing About Evidence: More
Support for Autism-Mercury Link whose misinformation, bad science, and
pseudoscience I routinely used to lovingly deconstruct years ago.

That’s not all. Another antivax hire was Dr. Tracy Beth Høeg, who was hired as a
top advisor to Dr. Marty Makary, who is currently FDA Commissioner, who had
also become famous as a “COVID-19 contrarian” and slipped further and further
into COVID-19 vaccine “skepticism” as the pandemic wore on. Working for Dr.
Makary is also Dr. Vinay Prasad, an oncologist and COVID-19 “contrarian” who
eventually turned to parroting antivax talking points and is now in charge of
the FDA committee responsible for approving and regulating vaccines and
biologics. In addition, don’t even get me started on what RFK Jr., did with the 
CDC Advisory Committee on Immunization Practices (ACIP). There, he fired all the
experts on the committee, replaced them with antivaxxers and antivax-adjacent
or -sympathetic new members, resulting in a clown car of a spectacle as ACIP
incompetently tried to roll back current vaccine recommendations and made an
incoherent mess of recommendations for COVID vaccines. Interestingly, this
effort has failed to satisfy RFK Jr.’s most vehement supporters, and the most
that RFK Jr.’s new effort to prove that vaccines cause autism came up with in
September was a highly dubious claim that acetaminophen use during pregnancy is 
associated with autism. (It’s not.)

So what is HHS going to do under RFK Jr.? According to the newly rebranded
antivax CDC webpage:

HHS will evaluate plausible biologic mechanisms between early childhood
vaccinations and autism. Mechanisms for further investigation include the
impacts of aluminum adjuvants, risks for certain children with mitochondrial
disorders, harms of neuroinflammation, and more.

Regular readers will recall that all of these “plausible biological mechanisms” 
are actually not so plausible. Indeed, a lot of them are based on what I like to
call “biobabble” or “immunobabble,” names that I came up with in homage to
“technobabble,” a term used to describe a lot of the futuristic science-y
sounding dialogue about physics, biology, and other sciences in Star Trek: The
Next Generation and later series. (Public health scientist Jess Stier and
colleagues amusingly coined a term for the same phenomenon, “antivaccine Mad
Libs.”) Basically, antivaxxers love to do the same sort of speculative
handwaving about biological mechanisms behind autism that they think they can
relate to vaccines, using the sort of language that real scientists immediately 
recognize as fancy sounding scientific bullshit.

Indeed, this brings me back to the report that I mentioned in the introduction. 
Known as the McCullough Foundation Report, it was published in late October and 
widely debunked by many, including myself, for exactly this sort of speculative 
handwaving based on interpretations of basic science findings that have
consistently failed to be demonstrated in clinical and epidemiological studies
to be applicable in humans to the neurodevelopmental mechanisms that lead to
autism. It’s a longtime antivax technique, and there are a number of “tells” in 
the paragraph above that let me know that this is what the CDC is doing now, in 
particular invocation of mitochondrial disorders (shades of Hannah Poling and
Andrew Zimmerman in 2008!), adjuvants like aluminum (which do not cause autism),
and use of the term “neuroinflammation.” These were “mechanisms” featured
prominently in the McCullough Report.

In other words, this research effort being carried out by HHS agencies such as
the National Institutes of Health and the CDC is nothing more than using antivax
pseudoscientific ideas as the basis to design research programs to manufacture 
bogus scientific data to support the idea that vaccines cause autism.

“The claim ‘vaccines do not cause autism’ is not an evidence-based claim”?
Wrong.

Let’s circle back to first new CDC talking point, namely that the claim
“vaccines do not cause autism” is not an evidence-based claim “because studies
have not ruled out the possibility that infant vaccines cause autism.” This is a
complete misrepresentation or intentional misunderstanding of how
evidence-based medicine—and science in general—works. It is not my intention
here to relitigate the mountains of scientific evidence this century that have
failed to find conclusive—or even convincingly plausible—scientific,
epidemiological, or clinical evidence that infant vaccines detectably increase
the risk of autism, much less cause autism. I’ve discussed that evidence and
antivax attempts to attack it more times than I can remember. There are many
good reasons why the statement that vaccines do not cause autism is considered
very strong science by the scientific community, sufficiently strong that most
scientists studying autism and vaccines consider the issue to have been
scientifically settled, at least pending new and compelling evidence suggesting 
a link, evidence that antivaxxers can never seem to produce. Indeed, a large
chunk of posts on this very blog are deconstructions of the sort of bad science 
that antivaxxers routinely produce to try to “prove” that vaccines cause autism;
e.g., this study in 2017.

Instead, let’s address the bogus argument that the claim that “vaccines do not
cause autism” is not evidence-based, specifically because “because studies have 
not ruled out the possibility that infant vaccines cause autism.” It’s an
argument that is often weaponized in favor of alternative medicine quackery,
such as the scientific conclusion that homeopathy is physically impossible. What
I like to say in response to such arguments about homeopathy is that science
can never absolutely prove a negative. That’s just not how science works.
However, after a certain point, the weight of scientific studies reaches a point
where the odds that the negative finding is incorrect becomes so small as to
be, for all practical purposes, functionally and statistically indistinguishable
from zero.

Such has long been the scientific status of, for example, homeopathy, with the
added bonus that the mechanisms proposed by homeopaths for homeopathy to “work” 
would, if true, require that huge swaths of long-settled physics, chemistry, and
biology be not just wrong, but spectacularly wrong. Similarly, the evidence
from large studies looking for links between infant vaccination and autism have 
failed to detect an increased risk of autism attributable to vaccination or to
specific ingredients in vaccines, such as thimerosal (which is no longer in
childhood vaccines and hasn’t been in vaccines for close to a quarter of a
century) or aluminum salts used as adjuvants. I will conceded that biological
mechanisms proposed by antivaxxers for vaccines to cause autism are not quite as
fantastical as the claimed mechanisms behind homeopathy, but they’re still
incredibly implausible. (Does anyone remember “molecular mimicry” and
“homologous recombinaltion tiniker“?)

This is where the twin strategies of casting doubt on existing evidence because 
studies haven’t examined every possible scenario. As Matthiew Facciani put it on
Threads:




View on Threads




View on Threads




View on Threads

I mean, seriously: Do dogs cause autism?

This is all, of course, basically a rephrasing of what I’ve long written, but in
simpler terms, which is why I quoted it. Again, the weight of evidence that
fails to find even a hint of a whiff of an association between infant and child 
vaccination and increased autism risk is enormous, so enormous that, even though
we can never prove that the chances that vaccines cause autism in anyone is
truly zero, we can conclude from the evidence that this chance is so small that 
it is, for all intents and purposes, functionally indistinguishable from zero.
That is what the science shows, and that is why scientists say that vaccines do 
not cause autism.

Think of the change in wording on the CDC webpage on vaccines and autism as
being very similar in intent to the frequent claim by RFK Jr. that most
childhood vaccines have never been subjected to randomized controlled clinical
trials versus a saline placebo, a claim that RFK Jr.’s antivax propagandist bud 
Del Bigtree was touting this weekend on X, the hellsite formerly known as
Twitter:

Tell me you don’t understand the science and ethics of clinical trials and what 
constitutes an appropriate control without telling me you don’t understand the
science ands ethics of clinical trials and what constitutes an appropriate
control. https://t.co/9GHMPG89eQ

— David Gorski, MD, PhD (@gorskon) November 22, 2025

No, Del, it is you who are antiscience, not to mention in favor ofexperiments
that would violate medical ethics, specifically theDeclaration of Helsinki and 
the Belmont Report.

I’ve discussed in depth why this claim is deceptive. I’m not going to discuss
why in detail here because I’ve already discussed it multiple times, most
recently here (where I described why the “no saline placebo” claim is deceptive 
nonsense that doesn’t show that vaccines are unsafe) and here (where I discussed
how RFK Jr.’s HHS has deceptively weaponized and misapplied the principles of
evidence-based medicine, ignoring medical ethics, to cast doubt on vaccines and 
justify making influenza and COVID-19 boosters much more difficult to approve.

Again, what RFK Jr. is about is not science. It is not about medicine or public 
health. It’s about spreading doubt about the safety and efficacy of vaccines as 
a prelude to regulating them out of existence in the US. It’s no different than 
the “toxins” gambit antivaxxers used to love to employ back around 2008, blaming
formaldehyde (present in trace amounts in some vaccines) and the like for
autism. Every time a study exonerated one vaccine ingredients, antivaxxers would
shift to others to blame for autism. I used to like to say that “aluminum is
the new mercury” because, after studies increasingly exonerated mercury in
vaccines as a cause of autism, antivaxxers just shifted to blaming aluminum
adjuvants. Either that, or they shifted to “too many too soon,” the “hypothesis”
that it is the overall vaccine schedule that “overloads” the infant immune
system and somehow causes autism. Basically, every time science falsifies an
antivax “hypothesis” or shows that a proposed scientific mechanism by which
antivaxxers claim that vaccines cause autism, they easily and seamlessly shift
to another, more elaborate hypothesis or mechanism that is more difficult to
falsify. Indeed, citing unfalsifiable hypotheses is an antivax specialty, as
noted by Kristen Panthagani:

After three decades of research into the topic, with shifting rumors and
scientists doing more and more research trying to keep up, the rumor has still
not been satisfied. Now the rumor’s demands have shifted again — “but have you
studied every vaccine ever?” “What about the entire childhood vaccine series
altogether?” If scientists spend the next ten years painstakingly performing
these giant studies, the rumor would likely shift yet again — “ok but you added 
more vaccines to the childhood vaccine schedule, have you checked the updated
childhood vaccine schedule?” “What about this vaccine and this specific subtype 
of autism?  “What about parents who got the COVID vaccine?” “What about moms who
got multiple vaccines during pregnancy?” “What about these specific vaccine
ingredients during pregnancy?” “You’ve only done observational studies looking
into these 17 questions, where are the randomized controlled trials?” We could
go on and on forever like this, creating unending list of questions and demands.

This is what antivaxxers do. It’s what they’ve been doing ever since I started
really paying attention to them two decades ago.

As noted in an NPR article on the change in the CDC webpage:

“The Centers for Disease Control and Prevention website has been changed to
promote false information suggesting vaccines cause autism,” said Dr. Susan J.
Kressly, president of the American Academy of Pediatrics, in a statement. “Since
1998, independent researchers across seven countries have conducted more than
40 high-quality studies involving over 5.6 million people. The conclusion is
clear and unambiguous: There’s no link between vaccines and autism.”

And:

“The new statement shows a lack of understanding of the term ‘evidence,'” the
Autism Science Foundation said in a statement the organization provided to NPR, 
adding, “No environmental factor has been better studied as a potential cause of
autism than vaccines.”

Quite so. The single most-studied environmental factor as a potential risk
factor for or cause of autism is undeniably vaccines, and the studies have
consistently come up negative for a detectable association dating back nearly
three decades. The way antivaxxers have gotten around that simple fact about the
science is by continually misrepresenting the evidence base and shifting the
goalposts when science falsifies one of their fanciful hypotheses.

“Studies supporting a link have been ignored by health authorities”

I realize now that I should have dealt with this claim sooner, because, really, 
it’s fairly obviously bullshit. Scientists haven’t “ignored” studies supporting 
a link between vaccines and autism. They’ve read them, evaluated them, and
recognized them as poorly designed and executed studies that do not demonstrate 
what antivaxxers claim that they demonstrate. Moreover, as I’ve frequently
argued, scientists would not have persisted in doing study after study after
study looking for links between vaccines and autism, persisting in doing more
studies long after the vast preponderance of evidence had long ago shown that
the likelihood of ever finding such a link was functionally no different than
zero, were it not in service of a hopeless attempt to reassure hard core
antivaxxers that vaccines do not cause autism. I can’t help but also mention
that, every time such studies are published, antivaxxers are not reassured and
instantly do their damnedest to cast doubt on each study, even if they have to
attribute dubious methodological shortcomings to each study in order to convince
themselves. Again, I’ve written about such attacks more times than I can
remember over the last 20 years.

This HHS claim that the “studies are being ignored” is, at its heart, basically 
nothing more than the central conspiracy theory of the antivaccine movement,
namely that the “evidence is out there” that vaccines cause autism by “They” (a 
cabal of scientists, physicians, Big Pharma, the CDC, the FDA, etc.) are
“covering up” the real data and evidence. In essence, this statement is nothing 
different from what RFK Jr. wrote over two decades ago in Deadly Immunity, when 
he proposed a conspiracy theory that the CDC really did have the evidence that
the mercury-containing preservative thimerosal that used to be in several
childhood vaccines was the cause of the “autism epidemic” and convened a meeting
at the Simpsonwood Conference Center in suburban Atlanta in 2000 to find a way 
to cover it up. It’s no different from the more recent “CDC whistleblower”
conspiracy theory that claimed that the CDC had evidence that vaccines were
associated with a higher risk of autism in African-American boys but had
“covered it up.” As I like to say, all science denial, antivax vaccine denial
included, is a conspiracy theory.

As Dr. Peter Hotez put it:

Attacking scientists as dishonest and corrupt comes straight out of the
anti-vaccine playbook, said Peter Hotez, MD, codirector of the Texas Children’s 
Hospital Center for Vaccine Development, who also helped develop an affordable, 
unpatented COVID-19 vaccine.

“This is how the wellness influencer industry works,” Hotez said. “It’s not
enough to push the snake oil. You have to discredit mainstream biomedical
science and portray scientists as public enemies or cartoon villains, and that’s
what Kennedy’s seeking to do.”

Now the antivax arch-conspiracy theorist RFK Jr. is in charge of HHS, and the
CDC is well on its way to becoming, as we had feared after RFK Jr. bent the knee
to Donald Trump in the lead-up to the 2024 election, an antivax propaganda
outfit.

The CDC is lying to you and is no longer reliable

Unsurprisingly, antivaxxers are beside themselves with joy and celebration with 
the change in messaging on vaccines and autism from the CDC. For example:

🚨 BREAKING: CDC reverses 30 years of denial.The CDC website admits the claim
“Vaccines do NOT cause autism” was never evidence-based.Studies have NOT ruled
out infant vaccines as a cause of autism.Evidence has been ignored.HHS has 
opened a full investigation into… pic.twitter.com/o9sXInYBE7

— Children’s Health Defense (@ChildrensHD) November 20, 2025

CHD, as you recall, is an antivax organization founded by RFK Jr. Elswhere, here
are some samplings of the rejoicing from around the antivax influencer
crankosphere:

  1. The CDC Fold on Autism & Vaccines — What I’ve Been Saying for 25 Years (Sherri
    Tenpenny).

  2. BREAKING: CDC Finally Admitted They Cannot Claim Vaccines Do Not Cause Autism 
    (Lioness of Judah Ministry).

  3. Where Does the CDC’s Dishonesty Come From? Is a new era at last is dawning at 
    the CDC? (A Midwestern Doctor, whom I like to call A Midwestern Quack).

  4. CDC Retracts 30-Year Falsehood “Vaccines Don’t Cause Autism” Weeks After the
    McCullough Foundation’s Landmark Autism Report (Nicholas Hulscher). Note: I 
    don’t think it was a coincidence that the McCullough Foundation report was
    released a mere four weeks before this change to the CDC website. Indeed, I 
    think that the report was intended to provide the justification by throwing 
    up all sorts of dubious proposed scientific mechanisms (a.k.a. antivax Mad
    Libs) to give the impression of bolstering the claim that we can’t say that 
    vaccines do not cause autism.

  5. CDC’s Autism Reversal: Inside the Collapse of a 25‑Year Public Health
    Narrative (James Lyons-Weiler, because of course JLW is there to regurgitate
    antivax talking points).

I could provide many more examples, but I think you get the idea. The gloating
and rejoicing on the antivax side are truly epic. It also makes me wonder if the
growing dissatisfaction with RFK Jr. expressed by antivaxxers over their
perception by ardent antivaxxers that he hasn’t done much on vaccines also
prodded him to make this change.

I never thought I’d be writing these words, much less repeating them several
times in a single post, but the CDC is lying to you. It can no longer be
considered a reliable source of information about vaccines. Nor, depressingly,
am I alone in concluding that:

Instead of a global leader in science, the CDC has devolved into “a propaganda
machine for RFK Jr.’s fixed, immutable, science-resistant theories,” said Paul
Offit, MD, an infectious disease specialist at Children’s Hospital of
Philadelphia and co-inventor of the rotavirus vaccine. “The CDC is being
weaponized to promote RFK Jr.’s anti-vaccine point of view. So why should you
trust it?”

Many public health experts who spoke to CIDRAP News sounded sorrowful.

“Today is a tragic day for public health, for the US government,” said Michael
T. Osterholm, PhD, MPH, director of the University of Minnesota’s Center for
Infectious Disease Research and Policy (publisher of CIDRAP News). “Ideology has
replaced science as the means for addressing life-saving research and best
practices that save lives.”

Many physicians worry that the CDC’s new message will dissuade parents from
vaccinating their children.

That is, of course, exactly RFK Jr.’s intent. Meanwhile, those who remain behind
at CDC are increasingly demoralized and traumatized as the describe the changes
to the CDC webpage as “embarrassing” and “horrifying”:

While they declined to be identified for fear of retaliation, they all said that
they and their colleagues were shocked and dismayed by the misinformation put
forth on the new page. “It’s horrifying, it’s embarrassing, it’s scary, it’s
heartbreaking—it’s all of those things,” said a staffer at the CDC’s Injury
Center. “To see our agency being used to spread lies and misinformation is a gut
punch,” a CDC communicator with the National Center for Immunization and
Respiratory Disease wrote in a message. “People will be harmed by this—parents
will decide not to vaccinate their kids because of false information, and kids
will get sick and die as a result.”

Another longtime CDC employee who works in communications said, “The best way I 
can put it is it feels like we’re on a hijacked airplane.”

This is, of course, the intent, to make CDC scientists and staff who try to
stand up for vaccine science feel so demoralized and hopeless that they leave,
so that they can be replaced by antivax-compliant “scientists.”

As for my statement that we can no longer trust the CDC for reliable information
on vaccines under RFK Jr.:

When asked if the CDC was still a reliable source of public-health information, 
the employees said that most of the public-facing information remained
unchanged. A critical problem was that there didn’t appear to be a good way for 
the public to discern the difference between accurate and politicized messaging.
“I don’t know how they would distinguish that,” the Chronic Center staffer
said. “There’s not a disclaimer saying posts were approved by political
appointees and not by career scientists, so I don’t know.”

“It’s really easy from inside the agency to know what is real information and
what has just been added there for political reasons,” added the longtime
communications staffer. “But I can see that it would be really hard if you’re
outside the agency to know the difference.”

Again, that’s the intent. It’s all coming from the CDC, the remaining reliable
information and the ideological antivax propaganda. I can tell the difference,
but how on earth is the average person without scientific training going to be
able to tell the difference? Even some doctors who don’t have the experience of 
two decades of refuting antivax lies that I have accumulated might have
difficulty telling the difference in some cases.

As I have been warning, RFK Jr. is coming for your vaccines. Eliminating
vaccines is his endgame. It’s always been his endgame. What he’s done with ACIP 
and the FDA are just steps along the way. This change to a major CDC webpage on 
vaccines and autism is yet another part of RFK Jr.’s ultimate plan to eliminate 
vaccines.

And Sen. Bill Cassidy bears huge responsibility putting RFK Jr. in a position
where he can potentially achieve his aim.



Mark Blaxill: Robert F. Kennedy Jr. resurrects another washed-up antivax
activist

Last week, it was reported that Mark Blaxill had been hired at CDC. It looks
like RFK Jr.’s resurrecting every washed up antivax crony he can find to staff
HHS.

David Gorski on September 30, 2025

Link

As someone who has been writing about the antivaccine movement, its activists,
ts misinformation, and its conspiracy theories for well over 20 years, I have,
unfortunately, found myself recognizing the names of damned near every antivax
sycophant, toady, and lackey that longtime antivax activist Robert F. Kennedy
Jr. has been hiring to stock federal public health positions with, ever since he
was confirmed as the Secretary of Health and Human Services in February. Many
of the names have now become familiar, including those formerly not in RFK Jr.’s
orbit but who, sensing which way the wind was blowing during the pandemic, fell
under the spell of the American OG antivax crank of the 21st century. (In the
UK, the OG antivax crank of the 21st century is clearly Andrew Wakefield.). Now,
we have people like Jay “let COVID rip!” Bhattacharya in charge of the National
Institutes of Health (NIH), Marty Makary in charge of the Food and Drug
Administration (with Vinay Prasad in charge of vaccine approval), and “America’s
Quack,” Mehmet Oz, in charge of the Centers for Medicare and Medicaid Services 
(CMS). Most of these guys are what I like to call “new school” antivaxxers, who 
became antivax and radicalized during the pandemic, although Dr. Oz has long
flirted with, but not completely embraced, antivax pseudoscience. True, we
almost had old school antivaxxer Dave Weldon in charge of the Centers for
Disease Control and Prevention, but, oddly enough, his nomination was withdrawn.
It is also true that we have David Geier, one of the original antivaxxers whom 
I used to write about two decades ago, ensconced somewhere in NIH “reanalyzing” 
data to prove that vaccines cause autism. Now we have Mark Blaxill working at
CDC, apparently.

From MSNBC, courtesy of Brandy Zadrozny, He helped build the anti-vaccine
movement. RFK Jr. just hired him:

The Centers for Disease Control and Prevention has hired anti-vaccine activist
and author Mark Blaxill as a senior adviser, according to three current and
former senior CDC officials and an internal profile reviewed by MSNBC.

Neither a physician nor a scientist, Blaxill claims without evidence that every 
child who takes vaccines is in some way injured, and has written books and
articles promoting the disproven claim that childhood the shots cause a broad
range of health conditions and that autism is a consequence purely of
environmental exposures. Blaxill once helped lead the advocacy group, SafeMinds,
which funded research aimed at proving a link between vaccines and autism and
served as editor-at-large of the anti-vaccine website, Age of Autism. Blaxill
has long and wrongly blamed thimerosal, a preservative in some vaccines, for
what he calls an autism “epidemic.” His claims have been refuted by decades of
rigorous research. The Institute of Medicine officially rejected any causal
relationship between thimerosal-containing vaccines and autism in 2004.

Hoo boy. I’m having acid flashbacks to 2005, as RFK Jr. appears to be partying
like it’s 1999 (a few years later, actually).

Mark Blaxill: Another washed up antivaxxer resurrected by RFK Jr. to be
appointed as a senior advisor in HHS

As I said: Mark Blaxill. Now there’s a blast from the past! (Also, Blaxill has
zero qualifications to “track autism” as a public health scientist.)
Unfortunately. Blaxill is what I like to call a general in the mercury militia. 
Back in the day 20 years ago, there were two main branches of the modern antivax
movement. The British branch, as you might imagine, held up Andrew Wakefield as
its idol and blamed the measles-mumps-rubella (MMR) vaccine for autism, based
on a small case series that Wakefield had published in 1998 linking MMR
vaccination to what he called “autistic enterocolitis.” It turns out that the
study was fraudulent, which led to Wakefield being “struck off” (having his
medical license revoked) in the UK, but he continues to grift to this day
portraying the MMR as a major cause of autism and even a potential cause of a
mass extinction of humans. (Naturally, since COVID-19, he’s pivoted to that
sweet, sweet, COVID antivax grift.) Of note, when President Trump suggested last
week during the press conference when RFK Jr. announced that acetaminophen is
linked to autism risk based on bad science that the measles, mumps, and rubella 
components of the MMR should be separated and giving individually because of the
risk of autism from the combined MMR, that was an idea straight from Andrew
Wakefield, who, coincidentally, was developing his own measles-only vaccine.
(Yes, part of his fear mongering about MMR was to build a market for his new
vaccine.)

Across the pond in the US, we had the mercury branch of the antivax movement,
which many of us used to call the mercury militia back in the day, which
believed that the mercury in the thimerosal preservative that was in several
childhood vaccines was The One True Cause of Autism and were inspired by RFK
Jr., who started out as the US overlord of the mercury militia. Never mind that 
thimerosal was removed from childhood vaccines in 2001 and autism prevalence
kept climbing, about as slam-dunk a natural experiment as I can think of showing
that thimerosal is not associated with autism. There is, however, copious other
evidence that mercury at the doses used in vaccines before 2001 didn’t cause
autism, much less an “autism epidemic” or “autism tsunami,” but that never
stopped antivaxxers from still bringing it up every now and then. It did,
however, lead RFK Jr. to rebrand his antivax group the World Mercury Project as 
Children’s Health Defense.

In any event, Mark Blaxill was an old school antivax activist solidly in the
mercury militia camp, hence my labeling him a general in the mercury militia. Or
maybe RFK Jr. was the general, and he is more like a colonel. It doesn’t
matter, and my knowledge of military ranks is rudimentary. What does matter is
that he was a prominent antivaxxer back in the day and, like so many other
antivaxxers, started pivoting from “mercury in vaccines is bad because it causes
autism” to “all vaccines are bad because they cause autism” when the natural
experiment of removing thimerosal from vaccines failed to cause a dramatic drop 
in autism prevalence—or even a leveling off. He’s written a number of books
claiming a link between vaccines and autism, including The Age of Autism:
Mercury, Medicine, and a Man-Made Epidemic with fellow antivaxxer and blogger
Dan Olmsted.

I first became aware of Mark Blaxill in 2005 as a result of his activism with
the antivax group SafeMinds, noting his penchant for Holocaust analogies
referring to vaccination and autism. He was, in fact, on the board of directors 
of the group. SafeMinds, some of you might recall, started out solidly in the
mercury militia camp of antivaxxers. Indeed, one of its most famous publications
is an article entitled Autism, A Novel Form of Mercury Poisoning, published in 
2001 in Medical Hypotheses, naturally. This is why it makes sense that Blaxill
was also associated with Generation Rescue and wrote for its blog, Age of
Autism, which was a frequent source for my blogging “inspiration” back in the
day. Like SafeMinds, Generation Rescue was—is? I’m not sure if it still
exists—the antivax group founded by J.B. Handley and his wife and later headed
by model and comedienne turned antivax activist Jenny McCarthy that started out 
blaming autism on mercury in vaccines and later pivoted to the “all vaccines are
bad” stance that all antivax groups eventually arrive at, as well as massively 
downplaying the danger of COVID-19 and fear mongering about COVID-19 vaccines,
of course. (The group also appears to have pivoted to a more general “autism
biomed” grift about a year before the pandemic.) At Age of Autism, Blaxill wrote
posts like There’s a Funny Thing About Evidence: More Support for
Autism-Mercury Link whose misinformation, bad science, and pseudoscience I
routinely used to lovingly deconstruct back in the day.

If you really want to know how bad an antivaxxer Mark Blaxill is, though, you
have to go back about eight or nine years, to 2016 to 2017. Does anyone
remember? Does anyone remember a measles outbreak in a certain immigrant
community in Minnesota that happened? That’s right, thanks to antivaxxers,
including Andrew Wakefield, there were large measles outbreaks among Somali
immigrants related to antivax propaganda. You can read what Steve Novella and I 
wrote about these outbreaks at the time for more details if you like, but the
CliffsNotes version goes thusly.

Back in 2008, larger numbers of cases of autism were being diagnosed in the
children of the Somali immigrant community in Hennepin County, which led to news
stories asking if there was an autism cluster in this community and what might 
be going on. As you might imagine, these stories attracted the attention of
prominent antivaxxers, who blanketed the area. Most prominent among the
antivaxxers who made contact with the Somali immigrant community was Andrew
Wakefield himself. It’s not clear exactly when Andrew Wakefield first made
contact with the Minnesota Somali community, but I do know that Age of Autism
was on the case as early as August 2008 and that the founder of the antivaccine 
group Generation Rescue J.B. Handley published “An Open Letter to the Somali
Parents of Minnesota” in which he told them it was the vaccines and that they
can’t trust the local health authorities. He even went so far as to urge them to
declare a “state of emergency within your community and create a new vaccine
schedule for your kids.” Meanwhile, also as early as August 2008, David Kirby
had been writing stories like ‘Is Autism an “American Disease?” Somali
Immigrants Reportedly Have High Rates.’

I do know for sure from media accounts and triumphant blog posts in Age of
Autism that he met multiple times with the community and its leaders between
2010 and 2011 and that he appears to be still intermittently in contact. For
instance, here is one contemporaneous account in local media from 2010. It was a
time when he proposed as “study” of autism in Somali immigrants and promised to
raise funds for it, something he appears never to have done.

Among the antivaxxers making speaking appearances and contacts among the Somali 
immigrant community in Minnesota was—you guessed it!—Mark Blaxill. From a 2017
story in The Washington Post:

The presentation by anti-vaccine activist Mark Blaxill drew cheers and applause.
Blaxill, a Boston businessman whose adult daughter has autism, played down the 
threat of measles and played up local autism rates.

“When you hear people from the state public health department saying there is no
risk, that [vaccines] are safe, this is the sort of thing that should cause you
to be skeptical,” Blaxill said.

From MPR News in 2017:

Asia Dahir of Spring Lake is convinced that a measles shot her now 14-year-old
son Adam received as a baby is responsible for his autism. No scientific studies
have found proof of a connection. But Dahir says parents should make
inoculation decisions themselves — and not give in to what she says is
“bullying” by the medical establishment.

“If the consequences are greater than the benefits, it’s better to leave it
alone,” Dahir said.

Dahir was among 90 people — many of them also Somali-American — who came to a
Lake Street ballroom in Minneapolis Sunday night for a meeting organized by five
anti-vaccine groups. Their message: autism is the real epidemic, not measles.

For an hour they listened as businessman and vaccine skeptic Mark Blaxill
downplayed the risk of dying from measles. Blaxill, whose adult daughter has
autism, repeatedly emphasized the purported but discredited link between
vaccines and autism. And he claimed public health research on the matter is rife
with fraud.

“It is a fact that vaccines can cause autism,” said Blaxill. “That’s not the
controversy. The controversy is how many cases of autism are caused by
vaccines.”

Not true at all, says Dr. Andrew Kiragu of Hennepin County Medical Center.
Kiragu was one of at least three pediatricians who sat in the audience quietly
fuming as Blaxill clicked through his Powerpoint slides.

At the time Mark Blaxill spoke to the Somali community in Minnesota, the
community was in the midst of another measles outbreak.

I don’t have time to discuss the entire history of antivaxxers targeting the
Somali community in Minnesota, and so let’s just cut to the chase. The result of
the autism cluster and the resultant targeting of the Somalis.by antivaxxers,
including Mark Blaxill, MMR uptake in the Somali community plummeted, and there 
were multiple measles outbreaks between 2008 and 2017, one of which in 2011
involved 21 children, two-thirds of whom were hospitalized:

MMR uptake among Somali immigrants in Minnesota: This is theeffect of nearly a 
decade of antivaccine propaganda.

When Blaxill addressed Somali parents in 2017, the latest measles outbreak had
reached 34.

What has Blaxill been up to lately, though? As of this interview in 2024,
Blaxill was chief financial officer of the Holland Center, a “private autism
treatment center,” although according to Zadrozny’s report he’s the chief
financial officer of a “Minnesota company that buys and sells computer servers
and IT equipment.” In other words, for a while at least, if the blog post
containing the interview is correct, Blaxill oversaw the finances of a quack
“autism biomed” clinic, which makes sense. As an aside, basically the Holland
Center offers a combination of evidence-based treatment plus quackery like
functional medicine, hyperbaric oxygen therapy, and the like. Meanwhile, he
echoes the eugenicist rhetoric of RFK Jr. about autism:

Blaxill co-authored a peer-reviewed paper warning of an upcoming “autism
tsunami” as autistic children born in the 1990s and 2000s reach adulthood. The
paper, published in 2022 in a Springer journal, was retracted and subsequently
published in another journal.

“Those numbers are going to keep going up. … Over time, therefore, we’re going
to see a cost of disease evolution that’s dramatic and very concerning,” he
said.

Early in life, autism is very costly to parents, including mothers who often are
obliged to stay home and abandon their careers. “Over time, those costs shift,”
he said, as “the parents retire, the parents die.”

“Most autistic individuals in adulthood are unemployed and unemployable … Then
they’re going to have to be housed somewhere and they’re going to have to have
something to do during the day. Someone’s got to watch over them,” Blaxill said.

He also scoffs at neurodiversity and calls to celebrate autism:

Noting that the CDC stopped referring to autism as an urgent public health
concern, Blaxill said Most of what the agency talks about now is, “Oh, let’s
celebrate the fact that Black and Hispanic rates of autism are catching up to
the white rates of autism, and we’re doing as good a job discovering autism in
Black and Hispanic children.’”

Blaxill said that while he wants to celebrate his autistic daughter, he doesn’t 
want “to celebrate her disability or what happened to her because when I’m gone 
and when her mother is gone, there will be no one for her.”

“My daughter’s disabled for life. Don’t cheapen that disability by pretending
that the fact that you’re a little nerdy makes you autistic. No, it’s not,”
Blaxill said.

He also claims that every child who has been vaccinated is injured:

New: Ahead of an anticipated federal report that will "answer" autism, HHS
Secretary RFK Jr. has hired a new senior adviser to the CDC. Meet Mark Blaxill, 
an OG anti-vaccine autism activist who claims every single vaccinated child is
injured. https://t.co/UXix0FYfHw pic.twitter.com/sUwdOq3AsG

— Brandy Zadrozny (@BrandyZadrozny) September 26, 2025

Nice guy. He has zero qualifications to be working in public health, much less
in the Director’s office at the CDC. In fact, given his history, you might say
he has nothing but negative qualifications.

So what will Blaxill do at CDC?

So Mark Blaxill is yet another old school prepandemic antivaxxer who’s found
another career in RFK Jr.’s HHS. But what, exactly, will he be doing? Brandy
Zadrozny can’t say for sure in her news report:

Blaxill’s role and remit at CDC is unclear. The internal profile showed he will 
be working directly under CDC chief of staff Matthew Buzzelli. One of the senior
CDC officials said Blaxill’s name had been floated for weeks as a potential
leader for a program that tracks autism within the Center on Birth Defects and
Developmental Disabilities.

More importantly:

Blaxill’s quiet hiring is the latest in a series of staffing moves by Kennedy
aimed at reshaping federal vaccine policy by ousting experts and installing
former employees and longtime allies from the anti-vaccine movement.

“So Blaxill will join RFK Jr.’s inner circle,” said Dr. Paul Offit, director of 
the Vaccine Education Center at Children’s Hospital of Philadelphia, co-inventor
of a rotavirus vaccine and a vocal critic of Kennedy. “These are people who
believe what Kennedy believes, that want to to promote an agenda, that vaccines 
cause autism. And so Mark Blaxill will be perfect, right?”

Exactly. What we have is yet another antivax activist and conspiracy theorist
with zero relevant qualifications for any job in public health. Seeing Blaxill
hired now, after RFK Jr. cronies like David Geier, Lynn Redwood (who, according 
to Zadrozny, joined the CDC’s Vaccine Safety Office with the title of “expert”) 
and others, I’m left with a painful question: Who’s the next antivaxxer who’ll
be hired by RFK Jr.? The only reason I don’t think RFK Jr. will hire Andrew
Wakefield is because Wakefield’s ego is on par with RFK Jr.’s, and two egos that
large can’t coexist for long in the same organization, but who knows? I could
be wrong.

In any case, RFK Jr. is doing his best to turn the CDC, FDA, and NIH, as well as
the rest of HHS, into a tool to use in his quest to eliminate vaccines.



Science Based Satire: I Owe Several Doctors an Apology. I Was Wrong About RFK
Jr. They Were Right.

While my errors will be permanently memorialized here at SBM, so too will the
words of doctors who forevermore will be known for having gifted us Robert F
Kennedy Jr.

Jonathan Howard on September 5, 2025

Link

Like most people, it’s not easy for me to admit error. Many of my past articles 
were highly critical of Robert F. Kennedy Jr. and the doctors who promoted him. 
I was doubtful that he would restore trust in our public health infrastructure
as well as vaccines. That’s a part of my legacy.

However, watching Kennedy testify yesterday made me realize the how wrong I was 
about him, and the only way to restore trust in you, my readers, is to admit
this obvious truth. As he has for the past 6-months, Kennedy demonstrated a
nuanced, sophisticated understanding of complicated medical and scientific
issues, and his cool, calm demeanor highlighted his compassion and kindness.
It’s no wonder morale and confidence at the CDC, FDA, and NIH are soaring, while
vaccines are thriving. This is what happens when a mature, competent
practitioner of critical thinking and evidence-based medicine like Kennedy is
given a chance. Hospitals are emptying out and Americans are finally becoming
healthy again.

I doubted doctors who knew all along this would be the case. I was critical of
Dr. Martin Kulldorff and his essay The Cure for Vaccine Skepticism which said:

The only way to restore public trust in vaccination – which has taken a big hit 
since the lies attending the rollout of the COVID-19 vaccine – is to put a
well-known vaccine skeptic in charge of the vaccine research agenda. The ideal
person for this is Robert F. Kennedy Jr., who has been nominated to lead the
Department of Health and Human Services.

At the same time, we must put rigorous scientists with a proven track record of 
evidence-based medicine in charge of determining the type of study designs to
use. Two ideal scientists for this are Dr. Jay Bhattacharya and Dr. Marty
Makary, who have been nominated to lead the NIH and FDA, respectively.

Dr. Vinay Prasad made similar points in his article Sabotaging RFK Jr’s
Confirmation Will Increase Vaccine Hesitancy:

At this point, the best way to curb vaccine hesitancy is to approve RFK Jr, and 
redirect his energies to generating more data. More data will answer the key
questions that remain unanswered: which childhood immunization program is
optimal. The worse thing we can do is tank his nomination. Then vaccine
hesitancy will explode.

Obviously, Drs. Prasad and Kulldorff were right. The news reports are full of
parents who are finally confident that vaccines are safe and effective thanks to
Kennedy.

In their article RFK Jr Will Disrupt the US Medical Establishment Dr. Jay
Bhattacharya and Kevin Bardosh wrote:

His agenda will focus on decentralising power in America’s recalcitrant
scientific and medical institutions, offering an opportunity to allow true
scientific research and evidence-based policy to flourish. With his focus on
chronic disease and children, research priorities will realign with public
health ones. Kennedy also plans to confront the veil of secrecy and dishonesty
that inhibits transparency and integrity in public health and medicine. He
intends to strengthen checks and balances in Government health bureaucracies to 
confront groupthink and undue corporate influence. More than that, he is seeking
to ensure open public debate in medicine, recognising that science is
incompatible with censorship.

Censorship, especially at the NIH under the wise leadership Dr. Bhattacharya, is
a thing of the past, thankfully.

In his article Why Doctors Should Learn to Stop Worrying and Love MAHA, Dr.
Joseph Marine wrote:

I argue that we should embrace the Make America Healthy Again (MAHA) agenda and 
try to convince our medical leaders to work for major changes in our
dysfunctional health agencies and deteriorating health care system.

RFK Jr has tapped into a strong sense among the public that government health
agencies, and the health system at large, have been corrupted by corporate
interests that have become increasingly misaligned with the public interest, a
fact that was exposed by the disastrous authoritarian covid response.

It’s true that we had a “disastrous authoritarian covid response” and even
doctors like me, who vigorously opposed to Kennedy and MAHA, have learned to
love him.

In his article The Nomination of Robert F. Kennedy Jr. as Secretary of the
Department of Health and Human Services: A New Beginning? Dr. Frederik
Schaltz-Buchholzer said:

Our current system for testing, approving and regulating vaccines is inadequate,
and for the majority of the vaccines currently used, the importance of aspects 
such as the non-specific effects of vaccines, sequence, and co-administration
has not been adequately assessed. By all health outcome measures, US public
health is a complete failure and someone who thinks radically different is
needed.

Despite his shortcomings, RFK Jr. can be this person and it bows well that he
has surrounded himself with COVID-19 era heroes and evidence-based medicine
champions Bhattacharya and Makary.

Indeed, Kennedy has been this person, thanks to COVID-19 era heroes and
evidence-based medicine champions Bhattacharya and Makary.

In his article Donald Trump Has a Plan to Make America’s Children Healthy Again.
It’s a Good One | Opinion – Newsweek Dr. Robert Redfield wrote:

To heal our children, a president must see the possible and lead our nation to
act. After more than 40 years in the public health arena, it might surprise some
of my colleagues to know I think President Trump chose the right man for the
job: Robert Kennedy, Jr.

In an interview titled RFK Jr. is Saying Things People Know are True but Don’t
Want to Hear Dr. Marty Makary said:

[Kennedy Jr.] talked about guilt by association, that sort of modern-day
McCarthyism. He’s talked about how asking questions is not allowed. He asked a
lot of questions himself. But what’s interesting is people really don’t
criticize the details of what he actually said when it came to the COVID
pandemic. He’s been a skeptic, and he may have a different opinion, but he wrote
a 500-page book on Dr. Fauci and the medical industrial complex. 100% of it was
true. He said that [Biden’s] NIH nominee to direct the NIH … received $200
million from Pfizer for research. 100% true. So he’s saying things that people
know are true, but they just don’t want to hear it.

One thing RFK Jr. did is he would post true stories of children who died
immediately after the vaccine. These were otherwise healthy children. Social
media didn’t like that. Facebook, Instagram, LinkedIn, anyone who even
associated with him was censored. And in his hearing yesterday, what I really
appreciated is when he talked about the so-called toxic polarization of society 
and how we need to be kind to one another and restore civility. That is a
message people are hungry for in the medical community and I think at large.

Indeed, I was hungry for that message, and Kennedy and his team have quelched my
thirst. I was wrong. That wasn’t so hard to write after all. While my errors
will be permanently memorialized here at SBM, so too will the words of these
doctors, who forevermore will be known for having gifted us Kennedy.


Infection Control/Infection Prevention

Mark Crislip onJ une 17, 2025

Link

Summertime. And the living is easy. Janice Joplin has to be the best singer.
Ever. There may be those in the comments who disagree, but remember, within the 
context of the blog, what I write is canon. Which is not the same as being true.
Canon.

Any-who.

I spend summer on the front porch and rarely venture inside. Outside has had the
most empty summer nights I can remember. No insects buzzing the street light,
the porch light or bouncing on the window trying to go to the light. If bugs
have taught us anything, it is do not go towards the light.

Just a few depressed mosquitoes, going though the motions before being swatted
into oblivion, now remastered. If you are going to die, at least die with better
graphics.


Nothing for the birds and bats to eat, which perhaps explains why the
predominant birds of late are crows. Lots of crows. A murder if you will. It has
been ages since I saw a robin or a jay. At least the crows are sentinel
chickens for West Nile virus. Don’t you love language? A crow as chicken:

Some infected birds, especially crows and jays, are known to get sick and die
from the infection.

Crows start dying off, I’ll worry more about those desultory mosquitoes. And
perhaps bird flu if the crows start acting out:

Crows exhibited nervous symptoms following ingestion of HPAI H5N1 infected
carcasses.

Although, who can tell with crows?

Good news in hard times, at least not all the bugs are vanishing. As an aside, I
was colloquially called the bug doctor, although that was the Orkin man. And I 
was called the I and D doctor, which is actually the surgeon. For those not in
the biz, I and D is short for incision and drainage. I was the ID (infectious
diseases, not intelligent design) doc. Geeze, language can get convoluted.

Some bugs are thriving. Rubeola? Pertussis? COVID? It’s a good time to be a
pathogen. All you can eat buffets across the US. And even more opportunities for
growth are opening up for the discerning pathogen. Not cryptocoins. Nope.
Hospitals.

For the current administration, in its ongoing effort to make sure infectious
disease doctors have enough work, has disbanded The CDC Infection Control
committee, the Healthcare Infection Control Practices Advisory Committee
(HICPAC).

HICPAC has made 540 recommendations for infectious disease control, and 90
percent of its suggested measures were fully implemented by the CDC, NBC found.

The committee provided best practices for preventing and controlling health
care-associated infections. It shared guidelines on disinfection and
sterilization, environmental infection control and hand hygiene in health care
settings, among other areas of concern.

Why should you care? Because someday you are going to end up in a hospital, and 
hospitals are dangerous places, rife with infection, and other, risks. It takes 
tremendous effort to minimize these risks. Today, if you go to one of my
hospitals at least, the risk of infection is remarkably small. All thanks to the
infection control committee.

What does infection control, now infection prevention, do? Three main goals.

  1. Insure that patients with infectious diseases -measles, COVID, influenza,
    MRSA, etc.- are placed in proper isolation so that staff and other patients 
    are protected from the infection. Isolation is expensive, may not be good
    for the patient and a pain to do. But I was always of the opinion that if
    your day as a health care provider is not an inconvenient pain in the ass,
    you are not doing your job correctly.

  2. Investigate potential infection outbreaks. These happen at least once a year. 
    New technology, new techniques, and new organisms can lead to new
    infections. Generally, 2 to 3 unexpected infections of the same, often
    unusual, organism triggered an investigation. Sometime we found a reason;
    sometimes we didn’t and the problem just went away. We were the FEMA of the 
    hospital, and we know where FEMA is going.

  3. Infection prevention: applying interventions to prevent hospital-acquired
    infections: surgical wound infections, catheter infections, etc. No good
    deed ever goes unpunished and I learned early that any patient intervention 
    can have a fatal infectious complication. My first month as an intern, a
    patient had a cardiac arrest at home and successfully revived. The
    peripheral iv placed during the resuscitation became infected, the S. aureus
    seeded her stenotic aortic valve, which blew out and killed her all in 72
    hours. The worst kind of a Little Bug Went Ka-Choo.

For most of my career, I was the ostensible chair (although I sometimes thought 
I was the stool) of infection control for multiple hospitals. The infection
control practitioner did most of the real work, it was my job to back them up. I
will admit for the first 15 or so years I thought healthcare acquired
infections were the price paid for the treatments we gave our patients. How
could you not have the occasional infection from a ventilator, open heart
surgery, or a dialysis catheter?

Well, turns out almost every hospital/healthcare acquired infection need not
occur. If you follow the CDC/HICPAC guidelines, derived from too numerous to
count clinical studies, you can drive these infections to almost zero. It is, as
mentioned, a pain. And expensive. And you need a hospital administration
committed to doing the right thing, which I always had. Not everyone does, as in
private equity owned hospitals:

patients had a substantial increase in infections, falls, and other adverse
events.

Over the last decade or so of my career, health care infections went from common
to vanishingly rare, around one each a year.

And what was the origin of these studies and guidelines that lead to such a
dramatic decrease in iinfections?

CDC/HICPAC. Their infection control committee. Applying their guidelines has
prevented a tremendous amount of morbidity and mortality.

And now? So long, farewell.

Why? HICPAC was “unnecessary.”

Great. It is nice to know that going forward there will be no hospitalizations, 
surgery, central lines, or infectious diseases in the hospital. Looks like MAHA 
is a success. Of course, we all know the results of removing infection
prevention provided by “unnecessary” telephone sanitizers.

It was ever so nice to have experts pondering a complex literature and helping
guide care. Busy clinicians don’t have the time, or the expertise, that CDC
often provides. Provided. It is important to have science-based standards. Well,
it used to be anyway. While I understand the rationale for the name of this
blog, I think what separates SBM from the current Lysenco-ists is reality, not
science. I received reality based guidelines from the CDC. Moving forward?
Fictions, fantasy, lies and delusions. Ah well.

I suppose we can add more hospital acquired infections and the occasional
outbreak in the hospital to the list of future infectious disasters.

And more infections will mean more antibiotic use, accelerating the evolution of
antibiotic resistant bacteria.

Glad I am retired. Not so glad I am of an age where hospitalizations seem to
occur too frequently.

Yep. May not be bugs in my yard, but it is going to be hog heaven for bugs in
the hospitals.


Moth Trails by dbgg1979 https://www.flickr.com/photos/dbgg1979/3421345648/

Senator Hassan Sets Secretary Kennedy Straight

HHS Secretary Robert F. Kennedy’s reckless insistence on undermining confidence 
in vaccines and reckless elevation of the wholly unqualified David Geier to a
potentially influential role at HHS

Kathleen Seidel on  May 18, 2025

Link

At Wednesday’s hearing of the Senate HELP Committee, Secretary of Health and
Human Services Robert F. Kennedy, Jr. was questioned by numerous committee
members on the ongoing measles outbreak, drastic cuts in department staffing,
cancellation of ongoing studies and clinical trials, the evisceration of public 
health programs, cuts to the elimination of programs to monitor children’s lead 
exposure, and, most pointedly, his statements and actions regarding vaccines,
their ingredients, and their hypothesized risks.

In an exchange about vaccines with Connecticut Senator Chris Murphy, Kennedy
stated, “I am not going to just tell people everything is safe and effective if 
I know that there are issues”—“issues” loudly trumpeted by Children’s Health
Defense, the nonprofit organization he founded for the purpose of disseminating 
research that purports to demonstrate that vaccines are riskier than the
diseases they are intended to prevent.

The Chairman Sets Him Straight

After the Secretary stated that only the COVID vaccine had been subjected to
placebo-controlled testing, Senate HELP Committee Chairman Bill Cassidy
demurred:

The secretary made the statement that no vaccines except for COVID have been
evaluated against placebo. For the record, that’s not true; rotavirus, measles
and HPV vaccines have been, and some vaccines are tested against previous
versions. So just for the record, to set that straight. Next, Senator Hassan.

The Senator Sets Him Straight

Then, New Hampshire Senator Maggie Hassan spoke. Her exchange with Secretary
Kennedy bears repeating in its entirety, and a little commentary, too.

Senator Hassan: Thank you. Mr. Chair and Secretary Kennedy, thank you for being 
here. I’d like to start by talking about the current measles outbreak which I
know is a concern for all of us here today. Two children in Texas have
tragically died from measles this year, the first children to die from measles
in our country in more than twenty years. Measles is almost completely
preventable with the measles vaccine. As you know, it’s critical that families
hear directly and clearly from healthcare leaders about how they can best
protect their children. So, Mr. Secretary, I’d like to give you an opportunity
to say clearly here today to any parents who are watching that the best way to
protect their children from measles is to vaccinate them.Secretary Kennedy:
Yeah, I’ve said that that the best way to stop the spread of measles is through 
vaccination. I would say this: we have handled this measles outbreak. We get a
measles outbreak every year, we’ve handled this measles outbreak better than any
other nation.

Here, the Secretary minimizes the significance and threat of the ongoing measles
outbreak by falsely stating that “we get a measles outbreak every year.” This
year’s epidemic cannot be compared to previous outbreaks. Thanks to widespread
vaccination against measles, in 2000, the CDC declared the disease virtually
eliminated in the United States. Between 2000 and 2010, fewer than two hundred
cases were reported each year; spikes in 2014 and 2019 were followed by a return
to the average. However, in the first five months of 2025, measles has
afflicted over 1,000 individuals, mostly children and teenagers who were
unvaccinated or whose vaccination status is uncertain, and it continues to
spread across the United States.

A Request for Commitment

Senator Hassan then challenged the Secretary to make an unequivocal statement
encouraging parents to vaccinate their children against measles.

Senator Hassan: What I was interested in, you can say… what I asked you to do
was to say straight to the camera, as you did on social media, that it is your
position that the best way for parents to prevent their kids from getting
measles is to vaccinate them. And that is your statement today.Secretary
Kennedy: I said that.Senator Hassan: All right. Well, that is great, thank you.

Secretary Kennedy’s testy affirmation that he had stated that “the best way for 
parents to prevent their kids from getting measles is to vaccinate them” is also
undermined by his hotly defended public assertions that the measles vaccine was
never fully tested for safety (the inaccuracy corrected by Committee Chairman
Cassidy) and that the measles vaccine contained “fetal debris,” and his
statement that he would prefer to present the “pros and cons” of vaccines and
let parents “do their own research“ rather than unequivocally recommend
vaccination.

Scrutinizing a Staffing Selection

Senator Hassan then began to question the Secretary about his appointment of
David Geier to lead a study of autism and vaccines.

Senator Hassan: Now, you lead the nation’s health department, so let me ask you 
a couple of questions. Do you think HHS should employ anyone who has endangered 
the health of children?Secretary Kennedy: No.Senator Hassan: You hired David
Geier to lead autism research at HHS, an individual who fraudulently posed as a 
doctor and gave dangerous medications and medical tests to children with autism.
According to the state of Maryland’s investigation, David Geier, who has no
medical license or training, gave hormone blocker injections to children with
autism who were as young as 8 years old, which the Maryland Board of Medicine
said poses a substantial risk of harm. Secretary Kennedy, yes or no, will you
fire David Geier?

Senator Hassan was correct in her assertion that the Maryland Board of
Physicians found that David Geier had engaged in the unlicensed practice of
medicine. Although it wasn’t established that he had administered injections to 
his and his father’s young research subjects himself, it was established that he
had collaborated with his father in the promotion and administration of their
jointly-patented “Lupron protocol” to autistic children in a manner that
subjected them to substantial risk of harm, and that his responsibilities at his
father’s practice included holding children down for injections.

Doubling Down

The exchange continued, with the Secretary growing as flamingly indignant about 
the Senator’s criticism of his new hire as if he were David Geier’s personal
attorney.

Secretary Kennedy: First of all, what you’re saying is not true, and we did not 
hire David Geier to manage autism research at HHS.Senator Hassan: So what is
his job? What is his job, then?Secretary Kennedy: You just said some very
defamatory things about…Senator Hassan: Well no, I…Secretary Kennedy: … a
person who by the way…Senator Hassan: So, let me just be clear for the record…

The Secretary then directly accused the Senator of defaming David Geier. Senator
Hassan remained firm.

Secretary Kennedy: Those charges, Senator, I am going to correct the record on
this. You have defamed a person…Senator Hassan: Let me tell you what, let me
tell you what the record says, and then I will hear from you. Last week when Mr.
O’Neill was here in his confirmation hearing, I submitted for the record the
charge that the state of Maryland laid out. Now if you’d like also for me to
submit to the record with unanimous consent today the findings of the state of
Maryland, which fined him $10,000 for practicing medicine without a license–he
does not have a medical license–and for providing and instructing and giving
children hormone blockers. That is what the finding of the Maryland Department, 
the state of Maryland, its medical licensing board was, and I’ll submit that for
the record, I hope with unanimous consent.Secretary Kennedy: I’m assuming that
you don’t know what I’m about to tell you or you wouldn’t say something that
was so dishonest. You may or may not know that David Geier sued the
American…Senator Hassan: Oh I do know that; I do know that; that doesn’t change
the findings, nor does it change the experience of the parents who
testified.Secretary Kennedy: That finding was reversed by a court and he was
awarded $5 million against…Senator Hassan: That is not true.

The Secretary Conflates

Secretary Kennedy seemed, for a moment, to conflate Mark and David Geier’s
December 2012 lawsuit against the Maryland Board of Physicians with their
September 2005 lawsuit against the American Academy of Pediatrics and the
authors of Thimerosal-containing vaccines and autistic spectrum disorder, which 
raised questions about the provenance of certain data cited in the Geiers’
paper, Neurodevelopmental Disorders after Thimerosal-Containing Vaccines. In
that exchange, Senator Kennedy became as irate towards Senator Hassan as Mark
and David Geier had become towards the scientists who had critiqued their work
twenty years ago. The Complaint in the 2005 suit repeatedly referred to Mark
Geier and his 25-year-old son as if they were a single unit, of equal expertise 
and renown, so famous that the Pediatrics authors must certainly have been aware
of their reputation, so notorious that the Pediatrics authors must certainly
have intended to defame them, yet so vulnerable that even the most diplomatic
criticism would imperil their shared professional trajectory.

As a consequence of dedicating substantial time and resources to serving as
expert witnesses, the Geiers are dependent upon the compensation they receive as
expert witnesses as a significant source of income.

…Defendants were aware (or should have been aware) when they published the
Article that the Geiers will derive future income from those who would retain
the Geiers to appear as expert witnesses in National Vaccine Injury Compensation
Program proceedings and as expert witnesses in civil litigation

…It has been estimated that if thimerosal was determined to be a cause of the
various neurological disorders, civil damages for the injury to hundreds of
thousands of children could reach into the multiple billions of dollars, either 
paid for under the NVICP or in private civil litigation.

The suit was dismissed without prejudice due to their attorney’s health
problems, but was never refiled.

What really happened

Nine years later, Mark and David Geier filed a lawsuit against the Maryland
Board of Physicians. This action followed the online publication of a Cease and 
Desist order containing information about prescriptions written to Geier family 
members under Mark Geier’s license and their failure to promptly remove the
Order from their website. In their complaint and at trial, Mark and David Geier 
alleged that the Board acted with malice and deliberately sought to humiliate
them. The Board and its members sought to invoke their absolute immunity, and
resisted disclosure of documents pertaining to their internal deliberations.
However, Judge Ronald Rubin of the Circuit Court of Montgomery County, Maryland,
was so outraged by the Board’s actions that he prevented defendants from
rebutting charges of malice by announcing that he would “draw an adverse
inference” from anyone who sought to invoke immunity or who benefited from
someone else’s immunity.

Judge Rubin’s decision was highly prejudicial to the defendants; the Board
appealed the judgment, and the Court of Special Appeals eventually reversed the 
lower court’s decision, including the finding of malice, which would never have 
occurred had the lower court respected the defendants’ immunity claims. Although
some Board staffers may have been unprofessionally cheerful about the outcome
of their case against Mark and David Geier, it is understandable that
investigators who had gained in-depth knowledge of the unethical manner in which
the Geiers conducted their research and medical practice would be gratified
about having put a stop to it (if only temporarily). While the Board may have
deserved to be excoriated for their lapses, the Maryland Court of Special
Appeals held that the defendants were in fact entitled to immunity, and should
not have been held at fault for raising that defense.

Return to the Fireworks Display

Senator Hassan: Now, let me let me ask you, so I just want confirmation. David
Geier is still at HHS. I wrote you a letter ago and you have not
responded.Secretary Kennedy: Well, I apologize for that. That’s our bad, and I 
will respond. But David Geier is not managing autism research and…Senator
Hassan: What is his job?Secretary Kennedy: …I never said that he was.Senator
Hassan: What is his job at HHS? This is somebody who gave parents the impression
that he was a doctor and gave hormone blockers to children as young as eight,
telling them that hormone blockers would somehow magically, magically help their
kids with autism.Secretary Kennedy: His father is a very, was…Senator Hassan:
His father is a doctor but he is not, and his father was not in the room and
did not… and he faked his father’s signature, according to the state board of
medicine.Secretary Kennedy: And that ruling was overturned by a court. So what 
you’re saying is just wrong, it’s just a lie. They were actually… The court said
that the Maryland Board of Physicians was guilty of actual malice in
fabricating those charges against David Geier.Senator Hassan: Well, we will
pursue this.

The Pursuit of Accuracy

Let us pursue this here with some facts. Following lengthy evidentiary hearings 
and appeals, the Maryland Board of Physicians revoked Mark Geier’s license to
practice medicine, and sanctioned David Geier for practicing medicine without a 
license. Although both Mark and David Geier appealed the rulings, they were both
unsuccessful. The ruling by the Circuit Court of Montgomery County, however,
did not address these disciplinary rulings, let alone overturn them, and the
Court did not rule that the Maryland Board of Physicians had “fabricated” their 
extensively substantiated charges against David Geier.

Senator Hassan: Last, and I will submit for the record…Secretary Kennedy: So,
do you want to know why we brought David Geier in?Senator Hassan:
Sure.Secretary Kennedy: Because it wasn’t to run autism research. In 2002,
David, the… The CDC runs a Vaccine Safety Datalink, which is supposed to be the 
vaccine information for the biggest HMOs that are supposed to allow CDC to have 
a surveillance system for vaccine injury. It’s a backstop system. The CDC will
not let any physicians in there to look at it or any independent
scientist…Senator Hassan: He’s neither a scientist nor a physician.Secretary
Kennedy: Right. Congress ordered CDC to open it to the Geiers, so they are the
only scientists who have ever been in there.

Disregarded Protocols

The Secretary was correct in asserting that Mark and David Geier had previously 
been allowed to conduct research with the Vaccine Safety Datalink (VSD), a
program in which a consortium of managed care organizations share anonymized
patient data for vaccine research. In 2002, after being pressured by Congressman
Dan Burton to allow “independent researchers” to study the VSD, Mark and David 
Geier received approval to conduct their work at the secure Research Data Center
in Hyattsville, Maryland. However, that work was cut short after the Geiers
committed multiple breaches of research protocol. According to the CDC staffer
responsible for Institutional Review Board oversight of researchers:

The researchers asked how to merge datasets across studies to create a composite
data file. They were told the files were not set up for such a merger and that 
such a merger was not part of the approved analysis. Nevertheless, the
researchers ran a program which attempted to merge datasets, and the visit ended
with a cancellation of an SAS program that has been running for more than 45
minutes and was intended to have more than 8 million records in it (according to
the programmer).

By attempting to merge data files, the researchers would have created more
complete medical records on subjects, and if so, could have increased the risk
of a breach of confidentiality.

External researchers are provided with a copy of their SAS programs at the
conclusion of their visit to the RDC. On this occasion, the external researchers
attempted renaming data files with the “.sas” extension reserved for program
files. This would have allowed the external researchers to remove data files
from the RDC, contrary to the rules of the RDC. The violation was detected and
only the correct files were ultimately released. The programmer stated that the 
files were created by mistake.

A second trip by Mark and David Geier to the RDC, made in 2006 at the behest of 
the Petitioners’ Steering Committee (PSC) for the Omnibus Autism Proceeding,
yielded a similar result. As one PSC motion put it,

The CDC and the MCOs [Managed Care Organizations] refused to allow the
researchers involved in those ongoing studies to combine the datasets for
multiple vaccines, and in August 2006 the CDC terminated the ongoing research by
those investigators, seized work product already generated, and barred ongoing 
access to the VSD by the researchers.

What happens when you practice to deceive

In their reply to this self-serving characterization, attorneys for HHS
clarified that,

The PSC further fails to reveal the true nature of the course of events: that
its researchers had sought approval from the MCOs to alter their study design by
combining datasets; that the MCOs did not approve the request; that the
researchers combined the datasets anyway; and that when the RDC staff learned
that the researchers were acting outside the scope of their IRB approved
protocol, the RDC staff followed the instructions of MCOs and barred the
unapproved work.

More detail comes from the Declaration of Robert Krasowski, the RDC staff member
responsible for oversight of researchers working with data from MCOs. According
to the declaration, following their arrival at the RDC, Mark and David Geier
sought to modify their research protocol to expand the number of vaccines for
which they could search, and to link datasets so that they could conduct
searches across multiple vaccines. They were granted the former request and
denied the latter. Then, the SAS programmer who was assisting the Geiers got to 
chatting with an RDC staffer, who in turn got to chatting with Mr. Krasowski,
who was told that the Geiers had lied to their programmer about their research
protocol and the permissible scope of her work.

When my colleague told me about analyses being performed, I recognized that
searches across datasets were being conducted. I spoke with the programmer about
the work she was performing, and she indicated that she had specifically
requested a copy of the protocol from the Geiers and they had stated that there 
was none. Rather, they had informed her that there were no restrictions on the
analyses she could do. Finally, she stated that, had she known of the parameters
of the protocol, she would have never attempted analyses across datasets.

Mr. Krasowski then inspected the dataruns generated by the SAS programmer, which
revealed that Mark and David Geier were attempting to do exactly what they had 
been expressly prohibited from doing—to search for outcomes across datasets. On 
August 16, 2006, The MCOs responsible for safeguarding their patients’ data
terminated the Geiers’ access. In his Declaration, Mr. Krasowski concluded:

Although the PSC alleges that the CDC simply “terminated the ongoing research by
[the Geiers], seized work product already generated, and barred ongoing access 
to the VSD by the researchers”  these actions were taken in response to the
Geiers’ violation of the MCO-approved protocol and the express conditions of
their access to Data Sharing Program data.

The Omnibus Autism Proceeding tests cases were dismissed in 2009 and 2010, not
due to Mark and David Geier’s inability to conduct litigation-driven research at
the VSD without violating their approved research protocols, but due to
petitioners’ counsels’ inability to demonstrate that their clients’ autism was a
result of vaccinations.

Three-time offenders?

Mark and David Geier may even have been booted from the RDC a third time. In a
2015 talk at a conference of the International Academy of Oral Medicine and
Toxicology (an organization involved in anti-amalgam litigation), David Geier
complained in a conspiratorial tone about their access to the VSD being cut off 
again, sometime in the then-recent past.

We have had access for many years now to a database called the Vaccine Safety
Datalink or VSD database. This is a database that’s kept by the Centers for
Disease Control and Prevention or CDC. It’s completely secret from the public.
We’ve waged a campaign with lawyers, with parent activists and even members of
Congress to see this data and we’ve had an opportunity to examine it quite
thoroughly and be able to publish the first independent research examining this 
database.

And just add a neat little corollary: since we’ve been doing this, CDC is now,
or the people affiliated with CDC in this database have now suspended our access
to the data because we continue to publish data showing a link between mercury 
and vaccines and autism. They think that that’s been completely debunked and the
science that we’re doing is no good, so they’ve suspended our ability to see it
yet again.

Although David Geier alleged that the suspension of his and his father’s
research was the result of the machinations of a shadowy cabal opposed to their 
published findings, the more likely explanation would be yet another attempt to 
merge datasets and otherwise disregard their IRB-approved research protocol.

For the Record

Senator Hassan: But again, Mr. Geier is not a scientist. Thank you.Secretary
Kennedy: Independent scientist.Senator Hawley: Okay. Senator Hassan’s time’s
expired, but before we move on, did you have a unanimous consent request that I 
heard in there, Senator?Senator Hassan: Senator Hawley, I did—a unanimous
consent request for the printout of the website that shows Dr Geier is in… not
Dr Geier, that’s his father, Mr. Geier is employed, and also a unanimous consent
request for the finding from the board of licensing in Maryland.Senator
Hawley: Without objection to both of those.

A Few More Fact-Free Moments

Senator Hawley then afforded the Secretary a few more seconds to fulminate:

Senator Hawley: And now, Mr. Kennedy, before we get to my time, do you want… if 
you’d like to finish your response, go ahead and I’ll recognize
myself.Secretary Kennedy: David Geier is the only living independent scientist 
who’s seen the VSD inside. There’s been a lot of monkey business with the VSD,
including allegations of fraud. And he was hired by an independent contractor,
not as an HHS employee but by an independent contractor, to look at the
documents that we were getting to the VSD to see if they conformed with what he 
saw between 2002 and 2016. And that’s the only reason that he was brought in: to
see if there was… There’s so much information that has disappeared from that
database, the only way we could find out what information disappeared was
because he was the one guy who saw it.

Secretary Kennedy provided no support for his assertion that “there’s a lot of
monkey business with the VSD,” or for any allegations of fraud that have been
made against HHS staff or MCOs responsible for safeguarding patient data, or for
any allegations that data has “disappeared” from the VSD. Mark and David
Geier’s shenanigans at the VSD are supported by contemporaneous documentation,
and plenty of whining about the consequences in their published presentations.
MCOs have no legal or moral obligation to approve access to their patient data
by anyone who repeatedly fails to respect the legitimacy of rules and procedures
intended to protect patient confidentiality.

The Secretary’s statement that David Geier is not an HHS employee is belied by
the entry in the HHS Employee Directory, now entered into the hearing record,
indicating that he is.

Senator Hassan Has the Last Word

Senator Hassan: And just let the record show he’s not a scientist. Thank you
very much.

Many thanks to Senator Hassan, and to every member of the Senate HELP Committee 
who confronted Secretary Kennedy on his reckless insistence on undermining
confidence in vaccines, and on his reckless elevation of the wholly unqualified 
David Geier to a potentially influential role at HHS. There are plenty of
American citizens who have paid enough attention to developments in the field of
vaccines and autism to know exactly what sort of “science” he is likely to
produce. As former head of FDA’s Center for Biologics Evaluation and Research
Peter Marks stated in a recent interview on Face the Nation:

What I think we can expect is the expected: that there will be an association
determined between vaccines and autism because it’s already been determined.
This is not how science is conducted.


Measles, MAHA, and “soft eugenics”

I’ve long said that the antivax movement is borderline eugenicist (or at least
social Darwinist) in nature. Now that a second child has died of measles, it’s
time for me to take a look at the “soft eugenics” of the antivax movement.

David Gorski on April 7, 2025

Link

Saturday, a second child died of measles this year, a little more than a month
after the first death of a child of measles in two decades had been reported.
This brings the total number of measles fatalities so far this year to three,
and it’s only early April. Details are thus far scarce, but according to the New
York Times:

The measles crisis in West Texas has claimed the life of another child, the
second death in an outbreak that has burned through the region and infected
dozens of residents in bordering states.

The 8-year-old girl died early Thursday morning of “measles pulmonary failure”
at a hospital in Lubbock, Texas, according to records obtained by The New York
Times. It is the second confirmed measles death in a decade in the United
States.

The first was an unvaccinated child who died in West Texas in February. Another 
unvaccinated person died in New Mexico after testing positive for measles,
though officials have not yet confirmed that measles was the cause of death.

A Trump administration official said on Saturday night that the girl’s cause of 
death is “still being looked at.”

This measles outbreak, which is the largest, and other outbreaks in other states
are clearly associated with low vaccine uptake. I hate to have to repeat this
again, but measles is one of the most transmissible respiratory viruses, and
maintaining herd immunity/community immunity requires a high level of vaccine
uptake in a population, at least 90-95%. As for this case, from what we know
thus far, it sure sounds a lot like the first tragic measles death, in which the
child developed a superimposed bacterial pneumonia to which she succumbed. As
you might know, one of the ways that people die from viral respiratory diseases 
is that the virus weakens the lungs’ defenses sufficiently that a bacterial
pneumonia can gain hold. This is true for influenza, it’s true for COVID-19, and
it’s true for measles. Meanwhile, it’s being reported that, as of now (early
April), the US has seen twice as many measles cases as it did in all of 2024:

Texas’ outbreak began more than two months ago. State health officials said
Friday there were 59 new cases of measles since Tuesday, bringing the total to
481 across 19 counties — most of them in West Texas. The state also logged 14
new hospitalizations, for a total of 56 throughout the outbreak.

More than 65% of Texas’ cases are in Gaines County, population 22,892, where the
virus stated spreading in a close-knit, undervaccinated Mennonite community.
The county now has logged 315 cases since late January — just over 1% of the
county’s residents.

New Mexico announced six new cases Friday, bringing the state’s total to 54. New
Mexico health officials say the cases are linked to Texas’ outbreak based on
genetic testing. Most are in Lea County, where two people have been
hospitalized, and two are in Eddy County.

Elsewhere, there have been smaller outbreaks in New Mexico, Kansas, Oklahoma,
Ohio, and New Jersey, and the numbers cited above are likely significant
underestimates of the true number of cases, given that many parents are not
getting their children tested.

A few weeks ago, I wrote what to me was a frightening and
difficult-to-contemplate post in which I made some predictions about how our new
Secretary of Health and Human Services, longtime antivax activist Robert F.
Kennedy, Jr., might go about dismantling federal vaccination and public health
programs. It turns out that my imagination wasn’t expansive enough, as he’s come
up with ways that I hadn’t thought of, such as eliminating grant funding for
studies of vaccine hesitancy, COVID-19 vaccines, and COVID-19 itself. While this
current outbreak cannot be attributed to RFK Jr.’s policies given that he
hadn’t been confirmed as HHS Secretary yet when it began, I agree with Dr. Paul 
Offit that, thus far, RFK Jr.’s response has been abysmal. On the other hand,
the declining uptake of the measles-mumps-rubella (MMR) vaccine and other
vaccines driven by the distrust of vaccines stoked by the antivaccine movement, 
of which RFK Jr. has been the most prominent American voice since 2005, can be
laid right at RFK Jr.’s doorstep. Before he became HHS Secretary, he was a major
influential figure in the antivax movement and worked tirelessly to spread
fear, uncertainty, and doubt (FUD) about vaccines.

This time around, RFK Jr. planned to attend the funeral of the child who died
which was scheduled as of this writing for Sunday, perhaps in response to the
widespread criticism that he received for his reaction to the first pediatric
measles death and frustration from the Trump Administration that he has not been
more proactive in messaging around the outbreaks. When I heard about this, I
was immediately with Dr. Offit when he wrote:

When RFK Jr. attends the funeral of yet another child who has died from measles 
unnecessarily, he should apologize to the family. Apologize for his inaction.
Apologize for his continual spread of misinformation about the disease and the
vaccine. Apologize for his failure to strongly support the importance of
vaccinating children during an epidemic. And apologize for cutting funds for
immunization clinics in areas with low vaccination rates. The frankly dismissive
mantra of “thoughts and prayers” doesn’t cut it here.

Did RFK Jr. do any of this? Spoiler alert: No, he did not. What he did was
similar to what he did the last time a child died. Actually, what he did is more
defined by what he didn’t do rather than what he did, as you will see.

“Make America Healthy Again”: “Soft eugenics” and social Darwinism

RFK Jr.’s history of antivaccine activism is well known and has been well
documented, both here on this blog and over at my not-so-super-secret other
blog. I mentioned “soft eugenics” in the title of this post. Before I proceed to
explain, I have to give a hat tip to Derek Beres and Matt Remski at the
Conspirituality Podcast, specifically the March 8 episode, MAHA’s Soft Eugenics.
The reason that I feel obligated to mention them is because, although I’ve long
called, for example, the Great Barrington Declaration a “eugenicist” document
and referred to the eugenics-adjacent tendencies of the antivaccine movement, I 
had been a bit troubled, a bit concerned that perhaps I was overstating my case.
Eugenics, after all, implies the active removal of those thought to be
inferior, either through sterilization or outright killing, and, say what you
will about RFK Jr. and the antivaccine movement, it’s difficult to accuse them
of actively doing that. What the antivaccine movement does—and has always
done—is basically “let nature take its course”; i.e., let nature do the culling.
The child who survives was “fit,” and the child who doesn’t wasn’t. That’s why 
I like the term “soft eugenics,” which was defined in the episode thusly:

To be very clear, I don’t think Kennedy or any of the wellness influencers I’ve 
criticized are eugenicists in terms of advocating for the death of a group of
people or even suggesting fetuses with genetic problems should be killed. That’s
not what we’re discussing here. That type of language predominantly remains
over on the fringes of ethno-nationalism.

But it very much fits the bill of soft eugenics, which is more of a shrug and
sigh than a battle cry. We’ve been hearing this type of rhetoric from
anti-vaxxers and anti-maskers since COVID. But to be honest, it pervaded
wellness speak for generations.

When you hear an influencer claim that someone died with COVID, which is a
thoroughly debunked idea, instead of saying they died from COVID, you’re hearing
soft eugenics. When you hear someone, as I pointed out on Thursday’s episode,
talk about only malnourished children dying of measles and healthy children have
nothing to worry about. I mean, it’s an immunological rite of passage.

Of course, when the first child died of measles a month ago, I noted that all
the old measles tropes had come back (they had never really ever gone away, in
fact), in particular the claim that measles is a benign childhood illness that
rarely causes significant injury, disability, or death.

With that passage, it all crystallized in my head. I had heard a term that
accurately describes the antivaccine movement. Instead of an active removal of
the “unfit” from the gene pool, “soft eugenics” is more of a shrug, followed by 
an attitude of “let nature take its course.” The idea, of course, is that the
“fit” will easily survive the challenge—in this case, measles—and it’s only if
you’re “unfit” somehow that you have anything to worry about. What also caused
the lightbulb to go on in my head was the realization that there is a real point
here. It wasn’t just the antivaccine movement. It is huge swaths of MAHA, which
is derived from older, more general quackery. Thinking about “soft eugenics” in
the context of MAHA and the antivax movement led me to realize, however, that
MAHA is not just soft eugenics. After all, eugenics implies removing from the
gene pool, which fits the antivaccine movement and many of the ideas promoted by
“wellness” influencers if you’re talking about children who have not yet
reached reproductive age, but what about adults or the elderly?

It turns out that very similar ideas were behind the Great Barrington
Declaration, a document published by Martin Kulldorff, Sunetra Gupta, and our
new NIH Director Jay Bhattacharya that basically advocated a “let ‘er rip”
approach to COVID-19 in order to achieve “natural herd immunity.” But what about
those at high risk for hospitalization, complications, and death from COVID-19?
The authors of the GBD advocated for them “focused protection.” Unfortunately, 
this was never really well defined; it was basically an afterthought. The
overall document was at the very least social Darwinist, its central idea being 
that the “young and healthy” will be fine if they get COVID-19 and therefore
shouldn’t be expected to alter their lifestyle and participate in “lockdowns” in
order to protect the vulnerable.

See where the social Darwinism comes in? Admittedly, I’m not a historian
(although I do know a hell of a lot about World War II and Nazi Germany, given
an interest in WWII that dates back to junior high) nor am I an expert in these 
topics, but I know enough to know that eugenics is related to social Darwinism, 
and vice-versa. Eugenics tends to be more about actively trying to “improve the 
gene pool” by decreasing the fertility of people who are considered “inferior”
and/or promoting childbearing among people considered “superior.” Social
Darwinism can encourage such negative and positive eugenics, but doesn’t have
to. It is more like the “soft eugenics” in that it posits a worldview in which
the “strong” or the “fit” should have higher social status and the “weak” or the
“unfit” should be subservient or allowed to die. In a more individualistic,
laissez-faire societies (e.g., the US), the individual tends to be the unit of
selection, while in more nationalist movements it is the race or ethnic groups
(e.g., Nazi Germany). Social Darwinism tends to justify socioeconomic
differences as being a product of the “strong” rising and the “weak” being left 
behind, considering this to be “nature.” You can see how an attitude of “let
nature take its course” and “if he dies, he dies” can be compatible with this
worldview.

In any event, call it what you want, “soft eugenics” or social Darwinism, what
the antivaccine movement basically promotes is a deceptive appeal to nature, in 
which immunity from “natural infection” is always superior to “artificial”
immunity from vaccines (never mind that the same immunologic mechanisms are at
work) and infectious disease is nothing to worry about if you are “fit” and have
a “healthy immune system.” In that latter case, you will suffer briefly, but
come out fine on the other side, with all-powerful superior “natural immunity”
to the disease. When last I wrote about measles tropes, I pointed out how
desperately antivaxxers work to portray measles as a “harmless” disease, to the 
point where they like to refer to an old episode of The Brady Bunch in which the
kids all caught measles or episodes of The Flintstones or The Donna Reed Show
in which measles is played for laughs as evidence that, before the measles
vaccine arrived six decades ago, people didn’t view measles as much of a threat 
or big deal, contrary to today of course.

After the first measles death, RFK Jr. himself, under the guise of supposedly
recommending that parents get their children vaccinated with MMR, promoted such 
tropes, as I detailed. Read the post for the details, but examples included
emphasizing vaccination as a personal choice, saying that children died “with
measles” instead of “of measles,” doing his best to downplay the risk of
measles, and recommending vitamin A to treat measles, when the only evidence
that it helps comes from children in underdeveloped countries, where the
prevalence of nutritional deficiencies, including. Vitamin A, is high.
(Unsurprisingly, there have been cases of Vitamin A toxicity among the children 
of antivax parents seeking to prevent or treat measles with it.)

As Beres put it:

And if someone dies from natural infection, I’m gonna find a reason why they
couldn’t possibly be healthy in the first place, instead of recognizing that
measles is a vicious disease that can cause a lot of chronic disease, blindness,
and at the extreme, kill people, mostly young children. Like I said, a sigh,
but a rather pernicious one.

Indeed. Let’s take a look at an example, namely the first child to die. I expect
that it won’t be long before the second child and her parents are subject to
the same treatment.

How antivaxxers and MAHA react to deaths from measles

It represents a challenge for antivax messaging whenever a child dies of a
vaccine-preventable disease like measles, and antivaxxers know it. As a result, 
as soon as the news was announced, a number of the usual antivax suspects
started promoting familiar narratives. For example, some said that the child
died “with measles,” not “of measles,” because she had apparently died of a
superimposed bacterial pneumonia. A variant of that was that the child never had
measles at all, as Mike Adams tried to claim:

The recent media frenzy over a supposed measles outbreak has been met with
skepticism by health freedom advocates. Mike Adams, founder of Brighteon and
host of Brighteon Broadcast News, has called the panic a “total hoax.” He
highlights a recent case in Texas where a child reportedly died “with measles,” 
not “from measles.”

“The child died in a hospital, and the cause of death was likely something else 
entirely,” Adams explains. “They probably used a PCR test to claim the child had
measles, but that doesn’t mean measles was the cause of death. This is
fearmongering at its worst.”

Sound familiar? Brian Hooker, a chemical engineer turned incompetent antivax
“epidemiologist” (and the chief scientific officer of RFK Jr.’s old antivax
group Children’s Health Defense) opined:

Hooker said the lack of useful information about the current measles outbreak in
Gaines County, Texas, has been “extremely frustrating.” The West Texas county
has been home to a Mennonite community since 1977, according to the Seminole
Chamber of Commerce.

“People typically don’t just die from measles,” Hooker said. “We know it was a
child in the Lubbock, Texas, hospital — that’s it. No idea of comorbidities,
complications, course of disease, nothing.”

Notice the obvious underlying assumption that children don’t die of measles
unless they are somehow unfit less than healthy to begin with. Of course, if a
child actually does have a medical condition that predisposes them to severe
complications or death from measles, that’s actually all the more reason to get 
that child vaccinated!

Unsurprisingly, Del Bigtree also jumped on the bandwagon, interviewing mothers
of unvaccinated children who had contracted the measles and recovered, all of
them standing by their decision not to vaccinate using similar sorts of
assumptions, such as “natural immunity” being better, the vaccine being
“unnatural” or otherwise somehow inferior, and the disease itself not being that
serious. Of course, he featured a quack who claims to be able to treat measles 
with budesonide, an inhaled steroid that COVID-19 contrarians had touted as a
highly effective treatment for severe COVID-19, just showing how not only is
everything old new again but lots of new things are being repurposed for the
old, as in unproven COVID-19 treatments being applied to the new measles
outbreak.

CHD, for its part, decided to exploit the grieving parents of the girl who died,
neither of whom regretted not vaccinating, despite holding back sobs as they
described how their girl had gotten sick from measles, developed pneumonia, and 
then ended up on a ventilator in a hospital, where she eventually died. From a
local news report:

The couple, members of a Mennonite community in Gaines County with traditionally
low vaccination rates, spoke on camera in both English and Low German to CHD
Executive Director Polly Tommey and CHD Chief Scientific Officer Brian Hooker.

“It was her time on Earth,” the translator said the parents told her. “They
believe she’s better off where she is now.”

“We would absolutely not take the MMR,” the mother said in English, referring to
the measles-mumps-rubella vaccination children typically receive before
attending school. She said her stance on vaccination has not changed after her
daughter’s death.

“The measles wasn’t that bad. They got over it pretty quickly,” the mother said 
of her other four surviving children who were treated with castor oil and
inhaled steroids and recovered.

The couple told CHD that their daughter had measles for days when she became
tired and the girl’s labored breathing prompted the couple to take her to
Covenant Children’s Hospital in Lubbock. There, the girl was intubated and died 
a few days later. The other children came down with measles after their sister
died.

The parents also noted about their other children, “The measles wasn’t that bad.
They got over it pretty quickly.”

I watched as much of the actual video as I could stand, given the ghoulishness
of Brian Hooker and Andrew Wakefield’s old antivax friend Polly Tommey. Even
though Tommey oozes sympathy for the parents, her questions indicate that she
was looking for a reason to dismiss measles as the cause of this poor girl’s
death. More disturbing, the parents are still antivaccine and attribute their
daughter’s death to the will of God:

The couple, who are Mennonites, believe their daughter’s death was the will of
God. When Children’s Health Defense’s director of programming, Polly Tommey,
asked specifically about parents who heard their story and might be “rushing
out, panicking,” to get the measles, mumps and rubella (MMR) vaccine, the
parents rebuked the intervention that offered the best chance of preventing
their daughter’s death.

“Don’t do the shots,” the girl’s mother said. Measles, she added, is “not as bad
as they’re making it out to be.” She noted that her four other children all
recovered after having received alternative treatments from an anti-vaccine
doctor, including cod liver oil, a source of vitamin A, and budesonide, an
inhaled steroid usually used for asthma.

Again, everything old is new again and new is old again, including RFK Jr.’s
response. This time around, he did go to Texas to attend the funeral of the girl
who died:

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. visited the
epicenter of Texas’ still-growing measles outbreak on Sunday, the same day a
funeral was held for a second young child who was not vaccinated and died from a
measles-related illness. Kennedy said in a social media post that he was
working to “control the outbreak” and went to Gaines County to comfort the
families who have buried two young children. He was seen late Sunday afternoon
outside of a Mennonite church where the funeral services were held, but he did
not attend a nearby news conference held by the U.S. Centers for Disease Control
and Prevention about the outbreak.

Seminole is the epicenter of the outbreak, which started in late January and
continues to swell — with nearly 500 cases in Texas alone, plus cases from the
outbreak believed to have spread to New Mexico, Oklahoma, Kansas and Mexico.

The optimist in me likes to hope that encountering people who suffered
unimaginable loss due to a vaccine-preventable disease might change RFK Jr. Did 
it? Judging from his response, probably not. Characteristically, he posted his
response to X, the hellsite formerly known as Twitter:

Notice how RFK Jr. buried that statement about the “most effective way to
prevent the spread of measles is the MMR vaccine” almost as an afterthought,
after having touted how supposedly the growth rates for new cases and
hospitalizations have “flattened.” The overall message comes across to me as
grudgingly admitting that the MMR vaccine works but implying that it’s probably 
not that necessary anymore because things are getting better. (Hint: If an
another child dies, things aren’t getting better. Actually, just objectively,
the outbreak is not yet waning.)

While it might be a good thing that RFK Jr. sees the actual fruits of his two
decades of antivaccine fear mongering about vaccines, including the MMR, somehow
I doubt that it will change him, but his post did have its intended effect,
resulting in a number of news reports that took his statement at face value and 
ignored context, resulting in headlines like:

  1. ‘Most effective way’ to prevent measles is vaccination, RFK Jr. says, in most 
    direct remarks yet (STAT News)

  2. RFK: MMR vaccine is the “most effective way” to prevent measles spread (Axios)

  3. RFK Jr. consoles Texas family: MMR vaccine ‘most effective’ way to stop
    measles spread (The Hill)

Notice what RFK Jr. didn’t do? He didn’t do what past HHS Secretaries and CDC
Directors did in the face of measles outbreaks or outbreaks of
vaccine-preventable diseases. He didn’t urge families to vaccinate their
children. He didn’t mobilize mass vaccination efforts and public messaging
campaigns about the vaccine. He just said that the MMR is the “most effective”
way to prevent measles spread without actively encouraging vaccination. It’s
because he can’t. Even if he could bring himself to say explicitly that the MMR 
vaccine is safe and effective and doesn’t cause autism (or all the other things 
he’s claimed that it causes), MAHA has framed vaccination solely as an
individual choice without regard to society at large.

Meanwhile, Sen. Bill Cassidy posted:

Not publicly known if the child was vaccinated, but almost certainly not.
Everyone should be vaccinated! There is no treatment for measles. No benefit to 
getting measles. Top health officials should say so unequivocally b/4 another
child dies. https://t.co/iUbcspUlNn

— U.S. Senator Bill Cassidy, M.D. (@SenBillCassidy) April 6, 2025

We actually do now know that the child was, unsurprisingly, not vaccinated.

Too bad that Sen. Cassidy could have stopped RFK Jr.’s nomination in its tracks 
but was too cowardly to do so. He can try to assuage his conscience now by
playing at being the voice of science, but it’s too late.

Enter The Secret

The interesting thing about the soft eugenics of MAHA and the antivax movement
is that it isn’t just about “survival of the fittest” (or health of the
fittest); that is, unless you consider fitness to include will, as in triumph of
the will. Beres said it one way:

You’re hearing the language of soft eugenics. And when you hear the blaming of
chronic disease on fat people who don’t know how to control their urges, which
is something I’ve seen for years in the wellness landscape, yeah, you’re hearing
soft eugenics. It’s this moralizing of wellness, this idea that your health is 
only dependent on you.

And if you can’t achieve it, you’ve failed. Because there’s a level of
unacknowledged privilege that’s infected wellness for a long time. It might be
genetic privilege.

It’s often financial privilege. But what you’re really hearing is someone say,
you, you’re not me. And when you unpack that sentiment, it actually translates
to, I’ve had a set of opportunities and access that I’m blind to, because I just
assume everyone has the same opportunities and access.

That’s an excellent way of saying it. For example, I love to refer to Bill
Maher’s long-ago claim that his lifestyle was so healthy that he couldn’t catch 
the flu. The example that he used was that, were he to fly in an airplane in
which a lot of the passengers were coughing, he would not catch the flu. This
claim led to one of my favorite retorts, a retort so brilliant that, even 16
years after writing about it, I still remember it and still refer to it. It came
from, of all people, Bob Costas, who gave Maher serious side-eye and said
sarcastically, “Oh, come on, Superman!”

Perhaps the most blatant example of this attitude comes from an episode of The
Highwire with Del Bigtree posted in June 2020, when he dismissed the idea that
he is obligated to do anything for those susceptible to death or severe
complications from COVID-19, the frequency of whom he rates at 0.26%, completely
blaming the victim:

But here’s the problem. When you were my age, you were most likely eating food
and fast food and Doritos and drinking Coca-Cola, which you’ll never find in my 
home. You were eating that all the time. You probably were drinking a lot of
alcoholic beverages and really liked to party and enjoyed your cigarettes and
said to yourself, “You know what? It’s more about the quality of my life right
now. I don’t care if I live to be 100 years old. I want to enjoy my life right
now. I like the finer things in life. I like good rich food. I like smoking a
cigarette once in a while. I like to drink my drinks.” And you know what? Good
on you! That’s the United States of America. No problem, that, some of my best
friends think like that. It’s great, and they’re fun to hang out with. That’s
perfectly OK.

But here’s what’s not OK. When you reach that point in your life where now your 
arteries are starting to clog up, your body is shutting down, and the alcohol is
eating up your liver, and you have diabetes, or you have COPD, you have asthma,
you can’t breathe, all the cigarette smoking has finally caught up with you,
you have heart disease because of the way you decided to live your life in the
moment, here’s what you are now. You are pharmaceutical-dependent. You did that 
to yourself, not me. You decided that the moment mattered, and now you find
yourself pharmaceutical-dependent, which is really what that 0.26% is, and
that’s OK too. Thank God there’s drugs out there! There’s drugs that allow you
to eat the Philly cheesesteak even though your body knows it hates it, but, go
ahead, take the Prilosec. What difference does it make? Drug yourself! Drug
yourself! Get through the day! Don’t exercise! Maybe just attach an electrode
and see if a little electricity to the stomach will give you the abs you want.

What follows is Bigtree moralizing about those who had not been sufficiently
“virtuous” and now have chronic disease with respect to vaccine mandates, which 
he views as being forced to become “pharmaceutical-dependent”:

Or could we live and let live? Eat all the Twinkies you want! Drink all the
bourbon you want, and smoke as many cigarettes as you want, and when you find
yourself pharmaceutical-dependent I will go ahead and say thank God the drug
companies are there for you, but you do not get to make me
pharmaceutical-dependent. You do not get to put me in the way of Heidi Larson,
who wants to eradicate natural health and natural immunity and make us all
pharmaceutical dependent.

See what I mean?

I look at it slightly differently though. While it is true that MAHA seems to
view health as a result of virtue, as evidenced by virtuous behavior (as defined
by MAHA, of course), I hear echoes of The Secret in MAHA that I wrote about a
couple of months ago, inspired by—of course!—RFK Jr.’s answers at his
confirmation hearing, specifically:

SANDERS: Do you agree healthcare is a human right?RFK Jr: I can't give you a
yes or no answer pic.twitter.com/z10JyGeM16

— Aaron Rupar (@atrupar) January 29, 2025

Specifically, the key part of the exchange that caught my ear was this part of
RFK Jr.’s answer to the question, which occurred after he had dodged and weaved 
in order not to give a definite yes/no answer:

Free speech doesn’t cost anybody anything, but in health care, if you smoke
cigarettes for 20 years and you get cancer you are now taking from the pool. Are
you guaranteed the same right?

Does this sound familiar? It’s a recurring theme that we hear from believers in 
alternative and “natural” medicine, namely the victim-blaming idea of lifestyle 
über alles in medicine, the judgmental mindset that if you are ill it is your
fault. This is, of course, very much like what Beres was saying. If I were to
sum up the idea succinctly, it is the concept that virtue equals health and
that, if you are not healthy, you must not be virtuous. In this context,
“virtue” means leading a “virtuous” lifestyle with respect to health; i.e.,
eating a healthy diet, exercising, not indulging in habits that contribute to
chronic disease, etc. Consequently, if you develop lung cancer or heart disease 
as a result of your having smoked cigarettes for 20 or 30 years, somehow you are
less deserving of healthcare. It’s a concept that suffuses the antivax movement
too, with claims that diet and healthy living can prevent disease better than
any vaccine.

I’ve written more than once over the years about the central idea that
undergirds alternative medicine (which MAHA includes as a major part of what it 
is), an idea that I once called the central dogma of alternative health, namely 
a variant of “The Secret,” or, as I like to call it, “wishing makes it so.”
Recall that The Secret posits the universe will provide what you need and want
if only you want it badly enough. While it is true that if you want something
badly enough, you are far more likely to strive to get it, The Secret makes it
seem as though it is an ironclad law that if you want something badly enough,
the universe will provide. In the case of MAHA, it manifests—if you’ll excuse my
use of the word—as the idea that a virtuous lifestyle with respect to health
will ward off all disease, the flip side being that, if you’re sick, then you
must not have been living a virtuous enough lifestyle or wanted health badly
enough.

Bringing it all together, “fitness” in MAHA (and the antivax movement) thus
involves not just genetic fitness, but it also involves moral fitness, with
“moral” being whatever MAHA decides is virtuous with respect to health. It’s an 
attitude that underlies a lot of the unproven treatments and “biohacking”
promoted by MAHA, as Beres notes:

It’s often financial privilege. But what you’re really hearing is someone say,
you, you’re not me. And when you unpack that sentiment, it actually translates
to, I’ve had a set of opportunities and access that I’m blind to, because I just
assume everyone has the same opportunities and access.

And this is the mentality that often leads to assuming biohacking protocols and 
untested supplements are the keys to optimal health, not money or geography or
social status. And that blindness leads to a set of assumptions about health
that doesn’t reflect the biological, social, historical, or geographical factors
that all play into individual health. And if you’re that far off the mark with 
individual health, well, public health is definitely going to elude you.

That’s also what allows you to look at one of the greatest health interventions 
in human history and say, no, no, no, no, no, no, no. I’m not gonna believe
centuries of scientific rigor testing and yes, failures, to where we’ve come to 
today. Instead, I’m going to stand firm in my conviction that cod liver oil is a
better therapeutic than a vaccine.

Yes, I realize that I forgot to mention that RFK Jr. did indeed suggest that cod
liver oil could treat measles. At its core, MAHA, of which RFK Jr.’s
antivaccine activists is but a part (albeit a huge part), makes health an
individual responsibility, denying any sort of public or collective
responsibility and defining health as the result of individual willpower,
actions, and virtue with respect to health. It ignores social determinants of
health, how infectious diseases like measles cannot be controlled with a focus
on the individual alone and requires a public health effort, opting instead to
make all health and public health a matter of will and good ol’ American “do it 
yourself” doggedness and ingenuity.

It will be interesting—and likely in many cases tragic—to see what happens when 
the fantasy of MAHA meets the reality of dealing with healthcare policy on a
national level. In the case of measles, so far it hasn’t been a pretty sight, as
Dr. Offit and the recently ousted Dr. Peter Marks, the FDA’s recently ousted
Director of the Center for Biologics Evaluation and Research (CBER), head of
both note, but it won’t just be measles where reality will collide with fantasy,
particularly given the massive cuts to HHS that would hamstring RFK Jr. from
accomplishing much, even if he were competent and reality-based.



MAHA and “soft eugenics” revisited: The “autism tsunami,” Dr. Oz, and your
“patriotic duty” to stay healthy

Two weeks ago, I referred to the “soft eugenics” of RFK Jr. and MAHA. This week,
he and Dr. Oz provide new examples, one about autism, the other about public
health.

David Gorski on April 21, 2025

Link

I hadn’t intended to write about the longtime antivax activist who is,
tragically, now the Secretary of Health and Human Services for the US, namely
Robert F. Kennedy Jr. Truth be told, I’d love to forget about RFK Jr. for a
while, as I’m getting a bit of RFK Jr. fatigue (and, I suspect, so are you). I’d
love nothing more than to be able to do a post or two about standard-issue
quackery of the variety that I used to write about routinely back in the day. On
the other hand, I can’t ignore what’s happening every day around me. The
extinction-level threat to US federal biomedical and public health policy that I
predicted is here, and each week seems to bring new evidence that, if anything,
my first prediction five months ago when RFK Jr. first suspended his
independent Presidential campaign and bent the knee to Donald Trump in return
for a prominent role in his administration on health was insufficiently
pessimistic.

This time around, I want to revisit something that I wrote two weeks ago in
light of two developments that occurred last week. The first was RFK Jr.’s
horrendous press conference about the new autism prevalence statistics held last
Wednesday, in which longtime offensive antivax tropes about autistic people
that portray them as “damaged,” “diseased,” and hopeless, portraying autism as a
fate worse than death that must be prevented or cured took center stage as
official US government policy and research plans. The second development was
that the man whom I have long called “America’s quack,” Dr. Mehmet Oz, was
finally confirmed and sworn in as Administrator for the Centers for Medicare &
Medicaid Services (CMS), the massive agency that oversees not just the Medicare 
and Medicaid programs, but all health insurance plans under the Affordable Care 
Act. The two are related, but RFK Jr. got lots of press and outrage, while,
oddly enough, little was said about Dr. Oz’s remarks after his swearing in
ceremony. Yet both are related through what I referred to as the “soft eugenics”
of the “Make America Healthy Again” (MAHA) movement. (Hat tip again, to the
Conspirituality podcast for having coined that term. I hope that Derek Beres
doesn’t mind that I’ve appropriated it, with credit.)

Let’s start with RFK Jr.’s disastrous press conference last Wednesday.

The autism “tsunami”: RFK Jr. parties like it’s 2005

Last Wednesday, RFK Jr. held a press conference to announce the results of a new
CDC report issued by the U.S. Centers for Disease Control and Prevention (CDC) 
on April 17, Prevalence and Early Identification of Autism Spectrum Disorder
Among Children Aged 4 and 8 Years — Autism and Developmental Disabilities
Monitoring Network, 16 Sites, United States, 2022. Before I discuss the report
and the press conference, here’s a link to the video, for those who can stomach 
it:

As I listened, it didn’t take long for me to notice that I had heard all of this
before many, many times dating back to 2005. It was all there, calling autism
an “epidemic” (a term that I searched for in the transcript and found 20 times
in a 30-minute presser. At one point, the term “tsunami” came up. Amazingly, it 
was not RFK Jr. who used it, but rather Dr. Walter Zahorodny, an associate
professor of pediatrics at Rutgers New Jersey Medical School who directed the
New Jersey portion of the Autism and Developmental Disabilities Monitoring
(ADDM) study. Depressingly, for someone who has been researching autism as long 
as he has, Dr. Zahorodny seemed to be pretty much all-in with the narrative that
the increase in observed autism prevalence must be real and due to “something.”
(No doubt that’s why RFK Jr. included him; either that, or he pressured him.)
Indeed, at one point in the press conference, he even used the same language
that RFK Jr. and antivaxxers have long used:

So I would urge everyone to consider the likelihood that autism, whether you
call it an epidemic, a tsunami, or a surge of autism, is a real thing that we
don’t understand, and it must be triggered or caused by environmental or risk
factors. We need to address this question seriously because, in my opinion, for 
the last 20 years we’ve collected data but not made real progress in
understanding what causes autism or how to effectively prevent it or treat it
effectively.

At the very least, Dr. Zahorodny should never have used the term “tsunami,” as
it’s a term long used mainly by the antivax movement that many autistic
people—with justification, in my opinion—consider deeply offensive, as it
portrays them as something that engulfs, overwhelms, and destroys everything in 
its path, much as another term that antivaxxers often use, an “avalanche” of
autism. Indeed, it’s usually used to portray autistic people as a huge drain on 
society, as RFK Jr. did elsewhere in the press conference, under the guise of
sympathy:

These are kids that, this is a preventable disease. We know it’s an
environmental exposure. It has to be. Genes do not cause epidemics. It can
provide a vulnerability. You need an environmental toxin, and Irva
Hertz-Picciotto pointed out that because of this mythology, that the amount of
money and resources put into studying genetic causes, which is a dead end, has
been historically 10 to 20 times the amount spent by NIH and other agencies to
study environmental factors, to study exposures, to study external factors, and 
that’s where we’re going to find the answer.

This is an individual tragedy as well. Autism destroys families. More
importantly, it destroys our greatest resource, which are our children. These
are children who should not be suffering like this. These are kids who, many of 
them, were fully functional and regressed because of some environmental exposure
into autism when they were two years old, and these are kids who will never pay
taxes, they’ll never hold a job, they’ll never play baseball, they’ll never
write a poem, they’ll never go out on a date. Many of them will never use a
toilet unassisted, and we have to recognize we are doing this to our children,
and we need to put an end to it, and I think I’m going to have Walter Zahorodny,
who is the most senior researcher for this project, for ADDM, and who’s been
doing this for many years, to come up and say a little.

First off, autism is not a “disease.” Antivaxxers and “autism biomed” quacks who
abuse autistic children with chelation therapy and all sorts of other
treatments designed to “cleanse” them of “toxins” from vaccines, from
“parasites,” or whatever evil humors to which they attribute autism frequently
refer to autism as a “disease,” but it is a developmental disorder covering a
wide spectrum that can range from severe neurodevelopmental delay and
abnormalities to the relatively mild. In severe cases, the child can be
nonverbal and display a well-characterized set of behaviors, including
repetitive behaviors such as “stimming” (for example, hand flapping, making
sounds, head rolling, and body rocking.), restricted behavior and focus,
ritualistic behavior, and compulsive behaviors. In milder cases, less severe
compulsion, restriction of behavior and focus, and ritualistic behaviors do not 
preclude functioning independently in society, but such children and adults may 
have significant difficulties with social interactions and communication.
Because the autism spectrum represents a wide spectrum of neurodevelopmental
disorders whose symptoms typically first manifest themselves to parents between 
the ages of two and three, the idea that vaccines cause autism and ASDs has been
depressingly difficult to dislodge, even with copious evidence, and has been a 
large part of the fuel for the antivaccine movement 20-30 years ago and
continues to fuel it today. Add to that the rising apparent prevalence of ASDs, 
and, confusing correlation with causation, the anti-vaccine movement concludes
that vaccines must be the reason for the “autism epidemic.”

In the same manner that antivaxxers frequently do, RFK Jr. ignores the vast
majority of autistic people who are functioning members of society to emphasize 
the minority who don’t, all in order to portray autism as a fate seemingly worse
than death. Also, notice what’s hidden under the faux sympathy. What’s the
first thing that RFK Jr. mentions? What he leads with is telling: “…these are
kids who will never pay taxes, they’ll never hold a job…” (Emphasis mine.) Let
me say right here, this is some real, top grade, “useless eaters” rhetoric. If
RFK Jr. had said simply that many severely autistic children require lifelong
care and never be able to live independently, that would be one thing. It would 
simply be factual and relatively neutral statement of their situation. But no.
He had to say first that they’d never be productive taxpaying members of society
who can hold down jobs! Of course, none of this is unique to antivaxxers or
anything new. There has long been a eugenicist strain in psychiatry and
medicine. Moreover, the rhetoric about how those with “severe autism” “destroy
families” and how autism “destroys children” is very reminiscent of the sorts of
rhetoric used to justify the Aktion T4, the “euthanasia” program instituted by 
the Nazis around the start of World War II to eliminate those with serious
conditions that necessitated lifelong care in institutions.

Indeed, elsewhere RFK Jr. doubles down on the very same rhetoric:

There’s a recent study by Blacksell et al. and a team of other researchers that 
said that the cost of treating autism in this country by 2035, so within 10
years, will be a trillion dollars a year. This is added to already astronomical 
healthcare costs, and then there is an individual injury.

I was reminded of images like those below, from here and elsewhere:

It’s the same rhetoric being used to justify looking for the “environmental
causes” of autism. I wonder, though: What happens if observed autism prevalence 
keeps increasing during RFK Jr.’s tenure, despite his best efforts to “find” a
bunch of “environmental causes”?

This was so dark, that I have to insert a little levity right here. RFK Jr.’s
mention of autistic children never playing baseball let to some hilarious
responses on X, the social media hellsite formerly known as Twitter. If you need
to, hit the link just listed and peruse them for a palate cleanser before I
move on.

Besides the “useless eaters”-adjacent rhetoric, RFK Jr. is also promoting an old
and false narrative about autism. Its key components include the following.

#1. We know almost nothing about what causes autism.

Although no one would claim we have a definitive answer yet, it’s deceptive to
portray autism as a totally mysterious black box about which we know practically
nothing. In fact, we do know quite a bit about what causes autism. It’s just
that antivaxxers and quacks like RFK Jr. don’t like the answers. One reason that
they don’t like the answers because not only has science generated huge amounts
of data that have failed to find a link between vaccines and autism. Another
reason is, as I have been writing about for at least 15 years, science has
produced a lot of data and studies strongly implicating a largely, but not
entirely, genetic cause. As  Daniel H. Geschwind, MD, PhD, Senior Associate Dean
and Associate Vice Chancellor of Precision Health in the UCLA Health System and
David Geffen School of Medicine at UCLA (DGSOM), director of the UCLA Center
for Autism Research and Treatment (CART), and the Gordon and Virginia MacDonald 
Distinguished Professor of Human Genetics, Neurology and Psychiatry (who also
won a National Academy of Medicine prize for investigating autism’s genetic
underpinnings), puts it:

Autism is hereditary and therefore does run in families. A majority (around 80%)
of autism cases can be linked to inherited genetic mutations. The remaining
cases likely stem from non-inherited mutations.

There’s no evidence that children can develop autism after early fetal
development as a result of exposure to vaccines or postnatal toxins.

“Everything known to cause autism occurs during early brain development,” says
Dr. Geschwind.

Of course, if you accept the narrative that the cause of autism is totally a
black box, not genetic, almost totally unknown, then anything can be a cause and
must be worth studying, particularly in light of the next false narrative, that
autism is an “epidemic.”

#2. Autism is an “epidemic” (or “avalanche” or “tsunami”)

There is no doubt that observed autism prevalence has been increasing markedly
over the last quarter century. Indeed, every few years, when the CDC reports its
latest autism prevalence statistics, I’ve been writing about how the
antivaccine movement tries to spin the statistics to blame vaccines. Here’s just
a sampling, with the year that I wrote the post:

  1. Autism prevalence: Now estimated to be one in 88, and the antivaccine movement
    goes wild (2012)

  2. Autism prevalence: Now estimated to be one in 68, and the antivaccine movement
    goes wild (2014)

  3. Autism prevalence increases to 1 in 59, and antivaxers lose it…yet again
    (2018)

  4. Autism prevalence increases to 1 in 38, and antivaxxers blame vaccines without
    using the word “vaccine” (2023)

The most recent ADDM survey that RFK Jr. announced concluded that, among
children aged 8 years in 2022, autism spectrum disorder (ASD) prevalence is 32.2
per 1,000 children (one in 31) across the 16 ADDM sites, ranging from 9.7 in
Laredo, TX (one in 103) to 53.1 in California (one out of 19). Reasonable
readers not knowledgeable about autism or how medical conditions are diagnosed
might look at this and think: What’s going on there? After all, autism
prevalence was reported to be one in 88 just 13 years ago. This is why I
emphasize the term “observed autism prevalence,” which I will distinguish
between true autism prevalence. One must also remember that there is a
difference between incidence, which is the frequency of new cases diagnosed per 
a given time period (usually one year, normalized to population) and prevalence,
which is the frequency of cases in the population overall (normalized to
population), diagnosed and undiagnosed, encompassing everyone diagnosed earlier 
with the condition.

What one has to remember whenever looking at prevalence numbers like this about 
a condition or disease is that what we’re looking at is not necessarily the true
prevalence, but rather the number of diagnoses of that condition or disease
divided by the total relevant population. If a condition is underdiagnosed, for 
example, its observed prevalence could easily increase with increased awareness,
better screening, and decreased stigma in the case of conditions for which
there was formerly a stigma. In other words

Number of DIAGNOSES ≠ number of CASES

At least not necessarily. The number of diagnoses will only equal the number of 
actual cases if case ascertainment is 100%; that is, every patient with autism
or ASD is being detected and appropriately diagnosed with autism/ASD. Moreover, 
the number of diagnoses can be affected by the diagnostic criteria, which for a 
condition like autism and ASDs, have been periodically tweaked since at least
the early 1990s. Remember this when RFK Jr. expresses alarm and amazement like
this:

The ASD prevalence rate in eight-year-olds is now one in 31. Shocking. There is 
an extreme risk for boys. Overall the risk for boys of getting an autism
diagnosis in this country is now one in 20. And it’s high in California, which
has the best data collection. It probably also reflects the national trend, one 
in 12.5 boys.

This is part of an unrelenting upward trend. The prevalence two years ago was
one in 36. Since the first ADDM report in 1990, which was 1992 births, autism
has increased by a factor of 4.8, that’s 480% I believe. The first ADDM survey
was 22 years ago when prevalence was one in 150 children. In all the core
states, the trend is consistently upward.

Before I move on, let me just briefly revisit a couple of examples that I always
use whenever discussing autism prevalence. It’s an example of how screening
alone can increase the observed incidence/prevalence of a “hard diagnosis” that 
is based on pathology or a reliable measurement First, let’s look at ductal
carcinoma in situ (DCIS), a precursor to breast cancer that is often (and
probably erroneously) referred to as “stage 0 breast cancer.” Before 1975, DCIS 
was a very uncommon diagnosis. Now it is very common. Indeed, back in the early 
1900s, DCIS was rare because, by the time it grew large enough to be a palpable 
mass, it almost always had evolved into invasive cancer. Now, nearly fifty years
after mass mammographic screening programs were implemented and forty years
after they became standard of care, DCIS is a common diagnosis. Indeed,
approximately 40% of breast cancer diagnoses are DCIS, and a recent study found 
that DCIS incidence rose from 1.87 per 100,000 in the mid-1970s to 32.5 in 2004.
That’s a more than 16-fold increase over a 30 year period, and it’s pretty much
all due to the introduction of mammographic screening. That’s a similar time
period to that which RFK Jr. references with respect to autism, whose observed
prevalence only increased 4.8-fold during a roughly similar time period.

Moreover, unlike the case for autism and ASDs, the diagnostic criteria for DCIS 
remained pretty stable over that 30 year period. Pathologists in the 1970s and
pathologists in the 2000s would likely largely agree on what constitutes DCIS
looking at a slide of a breast biopsy. The same is true for other conditions.
Indeed, thyroid cancer comes to mind, a disease for which increased screening
with ultrasound has led to a massive increase in the number of diagnoses of
thyroid cancer, the vast majority of which are almost certainly overdiagnosis.
Actually, there are issues with changing criteria for the diagnosis of thyroid
cancer too. Indeed, diseases for which the prevalence is increasing often
involve both increased screening and changes in the diagnostic criteria.

Another example is hypertension. Before the 1920s doctors didn’t routinely
measure systolic/diastolic blood pressure ratios; so there were few, if any,
cases of hypertension because doctors weren’t looking for it and didn’t know how
to easily measure it. (If you don’t measure or look for something, you won’t
find it.) Even over the last decade, prevalence of hypertension has increased
(for instance, in Canada). Perhaps a better marker for hypertension diagnoses is
the percentage of adults who have been prescribed antihypertensive medications,
which has skyrocketed since 1950. Of course, over that time, the definition of 
what constituted “hypertension” has changed markedly, to lower and lower
diastolic and systolic pressures, as evidence showed that treating lower blood
pressures could prevent premature death, although that trend appears to have
leveled off. Amusingly, various denialists lambaste such broadening of
diagnostic criteria to claim that hypertension is an “engineered” epidemic. And 
don’t even get me started on hypercholesterolemia and hyperlipidemia.

Pointing out these basic facts to people like RFK Jr. leads to another common
antivax trope from two decades ago, the claim that anyone who tries to explain
the increase in observed diagnoses of autism and ASD is an “epidemic denier”:

One of the things that I think we need to move away from today is this ideology 
that the autism diagnosis, that the autism prevalence increases, the relentless 
increases, are simply artifacts of better diagnoses, better recognition, or
changing diagnostic criteria. If you look at Table 3 of the ADDM report, it’s
clear that the rates are real, that they are increasing in the last 10 years,
beginning with the first one. Year by year there is a steady, relentless
increase.

I looked at Table 3 and, quite frankly, was confused. You can visit the link,
scroll down, and at it for yourself. (The table is too large to easily just post
here.) Nothing in the Table demonstrates that these numbers can’t possibly be
due to more intense screening. Indeed, the Table doesn’t show increasing rates
of autism; it merely shows a snapshot of observed prevalence at 15 ADDM sites,
along with ages of diagnosis and IQ ranges, in 2022. Again, none of this rules
out a phenomenon for autism with respect to observed prevalence of the diagnosis
like that seen with DCIS, hypertension, thyroid cancer, or any of a number of
other diagnoses that have increased as a result of screening and other factors, 
such as changes in diagnostic criteria.

RFK Jr. then references two very old studies to bolster his point:

The baseline for autism in this country was established with the biggest,
largest epidemiological study in history, a study of all 900,000 children in the
state of Wisconsin, children under the age of 12. They found 0.7 percent, 0.7
children had autism in every 10,000. That’s less than 1 in 10,000, today we’re
at 1 in 31. That study also confirmed the 4 to 1 male to female ratio. There
were at that time just over 60 children in Wisconsin with autism, and today it’s
around 20,000.

This study was published in 1970. 1970! That was 55 years ago. One notes that
this was an exhaustive review of records from “nonduplicated cases coming to
attention or under treatment for a five-year period (1962 to 1967) in
Wisconsin’s community mental health clinics, state and county mental hospitals, 
colonies, and training schools.” Again, diagnostic criteria were much different 
then, and who knows what the case ascertainment rate was? Most likely it was
very low. None of that stops RFK Jr from jumping ahead 17 years:

In 1987, there was another exhaustive study, a peer-reviewed study in North
Dakota set out to count every child in the state with a pervasive developmental 
disorder, including autism. That study meticulously combed through every record,
every diagnosis, and it even conducted the in-person assessments of the entire 
population of 180,000 children under 18. The autism rate they found was 3.3 per 
10,000. So that’s in line with the 1 in 10,000 that was found in Wisconsin 17
years earlier.

For context, today the last number, 1 in 36, is 83 times higher. In 1987, out of
every 1 million kids, 330 were diagnosed with autism. Today, there are 27,777
for every million.

If you accept the epidemic denier’s narrative, you have to believe that
researchers in North Dakota missed 98.8% of the children with autism, and
thousands of profoundly disabled children were somehow invisible to doctors,
teachers, parents, and even their own study. The same researchers who followed
the original cohort for 12 years to double-check their number, they went back in
2000 and found that they had missed exactly one child.

Doctors and therapists in the past were not stupid. They weren’t missing all
these cases. The epidemic is real.

This is the study, and that last bit is a pure straw man argument. No one is
saying that doctors and therapists in 1970 or 1987 were “stupid,” any more than 
doctors who were recommending what were science-based treatments for breast
cancer 100 years ago were “stupid.” They were using the understanding of the
condition that they had at the time, which, yes, could lead to them “missing all
those cases,” at least using today’s diagnostic criteria. Seriously, the
incidence of DCIS was very low in the 1970s too!

Moreover, there have been a number of sets of major changes since 1970 in how
autism and ASDs are defined and diagnosed. For example, the the Diagnostic and
Statistical Manual of Mental Disorders-II (DSM-II), published in 1968, the term 
autism was used to describe the symptoms of three different conditions:
childhood schizophrenia (295.8), withdrawing reaction of childhood (308.1), and 
schizoid personality (301.2). Interestingly (and not coincidentally for purposes
of this discussion), the DSM-IV expanded the definition of autism to include
autism spectrum disorders. I said “not coincidentally” because it was during the
1990s that autism prevalence started increasing and also during the 1990s that 
the vaccination schedule was expanded. As I’ve been describing for many years,
correlation does not necessarily equal causation, but the science that has shown
that vaccines do not increase the risk of autism or ASD has struggled to
overcome the antivax narrative that it “must be” the vaccines.

Stephanie Pappas provides a bit more detail about this process in Scientific
American:

This period saw a number of changes in how autism was diagnosed, however. The
Diagnostic and Statistical Manual of Mental Disorders (DSM), which has lays out 
criteria for psychiatric diagnoses in the U.S., called autism “schizophrenic
reaction, childhood type” in its first edition and subsequently referred to it
as “schizophrenia, childhood type” until 1980, when the diagnosis changed to
“infantile autism.” The criteria then focused on external symptoms such as
delays in language development, resistance to change and attachments to objects.
In 1987 the criteria widened and encompassed three categories related to social
interaction, communication and restrictions in activities. In 1994 the
diagnosis of Asperger’s disorder appeared, only to be subsumed into a broadened 
“autism spectrum disorder” in the DSM’s fifth edition (DSM-5) in 2013. That year
was also the first in which autism and attention deficit hyperactivity disorder
could be diagnosed in the same child at the same time, Estes says. Prior to
that time, an ADHD diagnosis would preclude a child from getting an autism
diagnosis, even though researchers currently estimate that half or more of
autistic people also have ADHD.

She also correctly points out that there might be a genuine increase in the
prevalence of autism based on a number of factors, such as the delay in
childbirth, as children born to older parents have a higher risk of autism. The 
point to be emphasized that there is no good evidence to support the massive
increase in the true prevalence of autism that justifies calling it an
“epidemic” or “tsunami.”

Sadly, RFK Jr.’s expert, Dr. Walter Zahorodny, parrots the same line of
argument:

Autism prevalence has increased very dramatically. It’s increased in New Jersey,
where we have excellent resources and access to services, and it’s increased in
all the states in the network. It’s increased not only by the CDC, but by the
Centers for Disease Control and CDC, Adam Network, active surveillance
activities, but it’s increased according to federal IDEA statistics and
information from a multitude of surveys.

It is a true increase. There is better awareness of autism, but better awareness
of autism cannot be driving a disability like autism to increase by 300% in 20 
years. That’s what we saw in New Jersey. That’s what the CDC report of yesterday
indicates, and that’s what, in my opinion, future reports from epidemiologists 
will show.

Dr. Zahorodny really should know better. He’s attacking a straw man, just as RFK
Jr. did. No one is saying that just “better awareness” is driving the increase 
in observed autism prevalence. Moreover, one red flag that we are not (yet)
measuring the true prevalence of autism is the variability in prevalence
reported at the various ADDM sites, ranging from one in 103 at the Laredo site
to roughly one in 19 in California. Of course, antivaxxers like to point to such
variability as evidence that it must be an “environmental factor,” even though 
there is no good evidence to suspect such a strong effect. Naturally, RFK Jr.
almost certainly believes that it’s vaccines, even though he didn’t mention
vaccines once in the press conference, likely a tactical decision. In any event,
if you don’t want to believe that the cause of autism is mostly genetic, then
it’s easy to make the deceptive argument that you “can’t have a genetic
epidemic,” as RFK Jr. does repeatedly during the press conference.

#3. “Environmental causes”

It’s worthwhile at this point to mention that nowhere am I arguing that there
can’t be environmental exposures that might increase autism risk. We already
have some potential culprits, such as infections that are accompanied by fever
in the second trimester raise the risk of autism for their eventual baby. So
does exposure to fine particulate matter pollution in the third trimester of
development and the first year of life. The problem with pointing to these
studies is that the increased risk is modest. For instance, the odds ratio for
the first study was around 2-fold; for the second study it was 1.2 to 1.3, not
many-fold. Even combined, these would not explain the increase in diagnoses
observed. As far as environmental exposures and risk of disease or condition, I 
like to point out that a long-term smoking history “only” increases the risk of 
lung cancer around 10-fold, and that’s one of the strongest environment-disease 
relationships known.

My point is that, given that it’s not even clear that the true prevalence of
autism, as it is diagnosed now, using 2025 diagnostic criteria, has even
increased all that much and that the observed increase in prevalence isn’t due
to a combination of factors, including case ascertainment, diagnostic
substitution, more services, and less stigma. We’ve pointed to a number of
studies in the past that suggest that, using consistent diagnostic criteria, the
prevalence of autism hasn’t changed much, if at all, over the last few decades,
and how many factors could impact reported autism prevalence. As Stephanie
Pappas also added:

Kennedy downplayed diagnostic shift as a minor explanation for the increase in
autism cases, but researchers have found that changes in diagnosis probably
explain a majority of the increase. A 2015 study on children diagnosed as
autistic in Denmark, for example, found that 60 percent of the rise of autism
among children born between 1980 and 1991 was caused by changes in diagnostic
criteria and reporting practices. Another 2015 study examined students in U.S.
special education programs between 2000 and 2010. The number of autistic
children who enrolled in special education tripled from 93,624 to 419,647. In
the same time frame, however, the number of children labeled as having an
“intellectual disability” declined from 637,270 to 457,478. The shift of
children from one diagnostic category to another explained two thirds of the
increase in autism in this population, researchers say.

I must admit that I laughed out loud when RFK Jr. cited an EPA scientist who
dated the start of the “autism epidemic” to 1989, as well, leading him to
implicate (potentially) mold, food additives, air and water, medicines (of
course he means vaccines), and maternal ultrasounds, never mind that ultrasounds
have been looked at repeatedly as a contributor to autism risk, with a large
study finding as recently as 2023 no correlation. Unfortunately, instead of
following the science, RFK Jr. will fund studies to reinvent the wheel:

We’re going to issue grants the way that it’s always done to university
researchers and others. We’re going to remove the taboo. People will know they
can research and they can follow the science no matter what it says without any 
kind of fear that they’re going to be censored, that they’re going to be
gaslighted, that they’re going to be silenced, that they’re going to be
defunded, delicensed, and we’re going to give them permission to do this
research, and then we’re going to open it up to the research community, and
we’re going to task them with certain outcomes, and we’re going to have them
come and bid on how to do the research.

This is all being run by Jay Bhattacharya, and I think Martin Kulldorff may be
also working on this, on designing the grant proposals. So it’s going to be done
by credible scientists, by the most credible scientists from all over the
world, and we’re going to do it very, very quickly.

Imagine my relief. Two out of the three authors of the Great Barrington
Declaration, which advocated a “let ‘er rip” approach to the COVID-19 pandemic
in the hopes of reaching herd immunity in 3-6 months, while only offering a
perfunctory and ill-defined nod to “focused protection” for the elderly and
those at high risk of severe disease and death from COVID, will be in charge of 
this effort. I do note that RFK Jr. did back off a little from his promise to
find the cause of autism by September. Heck, the grants won’t even be funded by 
September; that is, unless the recipients have already been chosen outside of
the usual NIH competitive process, something that I don’t discount as being
depressingly possible under RFK Jr., with Dr. Bhattacharya as his willing
accomplice.

Before I move on, I will note that antivaxxers have noticed how RFK Jr. didn’t
mention vaccines at his press conference and are not pleased.

Bobby is going to have to say the V word at some point soon. And follow that up 
with bold and decisive action. And defend that action against the most intense
corporate backlash in history. Not sure when that’s going to happen but "the
only way out is through."

— Toby Rogers (@uTobian) April 17, 2025

RFK Jr.’s MAHA movement, as I have discussed, is a form of medical Lysenkoism
that equates health with virtue and purity with respect to diet, exercise, and
health habits and lack of health with either lack of virtue or some external
“contamination.” It preaches a message that you can make yourself healthy
through sheer force of will and virtue that leads to “good behavior,” but does
allow for external contamination by pharmaceuticals, the better to push a
message that big pharma is a temptation from the straight and narrow path of
health virtue. It’s disturbing how much of this is “soft eugenics” in that its
emphasis on the “natural” and demonization of vaccines and pharmaceutical drugs 
also carries the implication that nature—e.g., vaccine-preventable
diseases—should just be allowed to cull the “unfit” and that, if you aren’t
healthy, it is your own fault.

Which brings me to America’s quack, Dr. Oz, taking over as CMS Administrator.

Do your patriotic duty!

Speaking of MAHA and soft eugenics, let’s take a look at Dr. Oz’s remarks after 
being sworn in as CMS Administrator:

Just as RFK Jr. echoes “useless eaters” rhetoric of the past as justification
for his programs, so, too, does Dr. Oz do the same:

As we entered the the main building, the Humphrey Building, where Health and
Human Services is located, there’s a placard of Hubert Humphrey, and it says
that it’s a moral opportunity and moral obligation of government to take care of
people in the dawn of their life (the kids), in the twilight of their life (the
elderly), the mature (seniors), and those in the shadows of life those
struggling with disabilities. We want to provide America with access to great
care. We want to save the public health insurance programs of this country.

I immediately got the feeling that we’re looking at a “we must destroy the
village to save it” argument coming and that the real causes of our problems
won’t be addressed. I was not far off:

Now if we’re going to do that you’ve got to be honest with each other. And a
physician, President Trump, has to always do that, right? We’ve got to share
news—so do Presidents—that folks don’t want to hear, but it’s important for our 
well-being. So I’m going to give you four bullet points to remember. Bullet
point number one—and they’re all numbered in order for a reason—Medicaid is the 
number one budget item for many states, and it is crowding out education other
important social programs. The states are having a big problem and that’s with
the federal government paying most of the bill. Item number two healthcare
expenditures are increasing at 2% higher, higher than the economy is growing.
And because of that we spend more than two times per person on health care than 
any other country on the planet.

It never occurs to anyone there that much of this could be alleviated with
universal health insurance, rather than relying on for-profit insurance provided
through employers. That’s just an aside, though. After trotting out the myth,
turbocharged by the new FDA Commissioner Dr. Marty Makary in 2016, that medical 
errors are the third leading cause of death in America (they’re not), here comes
the soft eugenics:

What are we going to do? First we’re going to reduce chronic disease. How do you
do that? 70% of the health care expenditures of this country are driven by
chronic disease. But, and it is your patriotic duty—I’ll say it again—the
patriotic duty of all Americans to take care of themselves, because it’s
important for serving in the military but it’s also important because healthy
people don’t consume healthcare resources. The best way to reduce drug spending 
is to use less drugs because you don’t need them because you’re healthy. And it 
feels a lot better as well.

Here we go again. Yes, healthy habits can help you stay healthier, but in the
end biology and genetics always win. Healthy habits can help you maximize your
health as much as your genetics allow, and that’s a good thing, but one can’t
help but hear echoes of “useless eaters” rhetoric in what RFK Jr. is saying,
particularly the part about health being important for serving in the military
and for not consuming healthcare resources.

It’s not as though Dr. Oz hasn’t said things like this before going way back. A 
2013 speech recently resurfaced in which Dr. Oz said, well:

Dr. Oz said the uninsured “don’t have the right to health,” but should be given 
“a way of crawling back out of the abyss” with “15-minute physicals” provided by
the government “in a festival like setting.” pic.twitter.com/YMyhpZfEFI

— PatriotTakes 🇺🇸 (@patriottakes) September 7, 2022

From a January news report:

The physician, better known as the TV celebrity Dr. Oz, made the comment during 
a 2013 address to the National Governor’s Association. He told attendees that
uninsured people should be given “a way of crawling back out of the abyss of
darkness, of fear, over not having the health they need” in a “festival-like
setting” with physicians.

“You can screen thousands of people for almost nothing, and can you allow a
conversation to take place in more of a festival-like setting,” Oz said. “It is 
not scary … a lot don’t have insurance. Give them a way of crawling back out of 
the abyss of darkness of fear over not having the health they need and give them
an opportunity.

“Because they don’t have the right to health, but they have the right to access 
a chance to get that health,” he added.

Notice that he doesn’t say how those without health insurance will have a
“chance to get that health” if they can’t afford to pay for the healthcare they 
need. For example, what if that 15-minute health screening and exam picks up
serious heart disease or even just hypertension? How is someone without health
insurance going to be able to afford the science-based medical treatments and
preventative measures to address their health problems? Dr. Oz doesn’t say.

In fact, I could ask: If it’s one’s “patriotic duty” to take care of one’s body,
then shouldn’t the state make it as easy as possible to do so, with financial
support above and beyond the inexpensive screening physicals touted by Dr.
Oz—i.e., health insurance—to do so? Moreover, I’m rather surprised that there
hasn’t been more discussion of the concept of being “healthy” as one’s patriotic
duty. Why? There are direct echoes to a society that was more than “soft
eugenicist” in nature:

According to Nazi ideology, every member of the so-called Volksgemeinschaft
(German racial community) was like a single cell in the larger national body.
Each individual had a duty to stay healthy and strong so that the German nation 
could conquer other peoples and colonize their lands. These theories about
individual health and national strength were influential throughout Europe and
the United States in the early 20th century.

And:

The Nazi regime urged Germans to adopt healthy lifestyles and personal habits.
Like Weimar-era public health campaigns, Nazi health programs pushed the idea of
a wholesome and “natural” lifestyle as a remedy for many of the health concerns
in modern society. Nazi public health campaigns often promoted the importance
of fresh air and nutritious foods, as shown in the 1941 Nazi propaganda film,
“The English Disease.” A 1939 newspaper article titled “Nazis Hit Alcohol,
Tobacco” records Nazi health leaders’ declarations that rejecting tobacco and
alcohol in favor of a “wholesome life” was the “national duty” of all German
youth.4

There was one difference, though:

Nazi public health propaganda promoted a return to “natural” living, but Nazi
health officials also embraced modern medical innovations to prevent and treat
diseases in the so-called “Aryan” population. For example, the Nazi regime
organized mass X-ray screenings for cancer, tuberculosis, and other illnesses.
Nazi propaganda urged Germans to trust the advice of medical doctors over the
“hocus pocus” given by unqualified quacks offering miracle cures, as seen in the
1941 propaganda film on cancer treatment, “One in Eight.”5

Dr. Oz, RFK, and MAHA seem to discourage trusting the advice of qualified
medical doctors in favor of the “hocus hocus” given by unqualified quacks
offering miracle cures. Indeed, Dr. Oz has a long history of being one of those 
quacks! Meanwhile, even Dr. Marty Makary, who until now I had considered perhaps
the “least bad” of RFK Jr.’s picks, undermining his recommendation to vaccinate
children against measles with the MMR by adding how measles is not that
dangerous:

Quote:

At the same time we have to be honest about the facts about measles It has a
very low mortality rate extremely low There’s almost certainly a underlying coor
comorbid condition So again I’m not suggesting that people can skip it if they 
are healthy but we have to be honest with the data to people and that’s how we
rebuild public trust.

Dr. Makary appears to be embracing the soft eugenics of MAHA. I can’t help but
wonder what will happen the first time that RFK Jr. demands that approval for a 
vaccine or vaccines be revoked, and I know that’s coming, probably sooner than
you think. No doubt Dr. Makary, his protestations of being science-based
notwithstanding, will go along to avoid being fired.

Moreover, leave it to RFK Jr. to provide me yet more quotes consistent with
eugenicist views, whether soft or not-so-soft. Yesterday morning, he appeared on
a radio show—why is a supposedly good Catholic doing radio appearances on
Easter morning instead of being in church?—and once again doubled down:

The health and human services secretary made the comparison during a Sunday
interview with billionaire GOP donor John Catsimatidis on WABC 770 AM’s The Cats
Roundtable. Moreover, he claimed that the “pure economic cost of autism” will
cost the United States $1 trillion a year in lost “productivity” by 2035.

There you have it again, the purely economic argument, but, believe it or not,
it gets even worse:

“Autism affects children and affects them at the beginning of their lives, the
beginning of their productivity,” RFK Jr. said. “It dwarfs the COVID epidemic
and the impacts on our country because COVID killed old people.”

A more perfect match between the Great Barrington Declaration’s implication to
“let the elderly die of COVID-19” so that the young can go back to work and the 
economy can get moving again is hard to imagine. Again, notice how he says that 
autism affects children at the beginning of their lives and at the beginning of 
their productivity. Why does RFK Jr. keep saying that, or things like that? To
MAGA, it’s not about saving lives. Not really. No matter how much RFK Jr. claims
otherwise.

Seriously, he can’t help himself. He did it again in the same interview:

“Many of these kids are aging out and their parents worry every day. And I’m
talking about people with severe autism, what’s called profound autism, which is
about, which is about 26 percent of the total people who are diagnosed with
autism,” RFK Jr. alleged. “Those families, those children are non-verbal,
they’re non-toilet trained. They have all this stereotypical features of autism,
head banging, toe walking, stimming, agonizing gut pain and head banging. Those
kids are kids that will not hold jobs.”

He just can’t help himself.

MAHA and soft eugenics, revisited

Once again, when I say that there is a strain of what Conspirituality calls
“soft eugenics” in MAHA, I don’t mean that RFK Jr. will be actively killing the 
“unfit.” What I do mean is that a lot of the language of MAHA echoes that of
earlier eugenics movements. Remember, eugenics was hugely influential in the
late 19th and early 20th centuries and wasn’t discredited until after the world 
saw the results after the Nazis had violently put it into practice. Even then,
it never went away. Dr. Oz’s remarks reek of this “soft eugenics” or “social
Darwinist” attitude, especially this emphasis first on how taking care of the
body is an American’s “patriotic duty,” good for the military, and helpful
because it save the government money, rather than on its being about primarily
improving the health of the American public.

Indeed, there is an underlying attitude among the antivaccine movement that is
such a part of MAHA that “natural” is better and that if a child dies of a
vaccine-preventable disease like measles, it’s not because the measles killed
the child, but rather because the child was somehow “unfit,” the usual reason
being chronic disease, malnutrition, and the like. This makes the death of a
child from such diseases sad and regrettable, but, to the antivaxxer, probably
unavoidable because, of course, they believe that vaccines don’t work and are
actively harmful. Meanwhile, the “correct” parenting, “virtuous” parenting, in
which the children are raised the “right” way from a health standpoint (as
defined by MAHA) will make the children virtually immune to vaccine-preventable 
disease and chronic disease. Far be it from me to say that a good diet, lots of 
exercise, and enough sleep are not important to children. They most definitely
are. They are not, however, panaceas, nor are they a substitute for vaccines and
modern medicine. Children should have access to both.

Meanwhile, never does anyone in this administration consider the social
determinants of health or that universal health insurance would alleviate a lot 
of the problems. If you want to see the disconnect, just observe how recently
the CDC had to decline to help the health department in Milwaukee when they
requested that the CDC assist their investigation of elevated lead levels in
Milwaukee public schools. You’d think that MAHA would be all over a known,
science-based environmental toxic metal like lead, but, no, they fired all the
people at the CDC who could help. One can’t help but wonder if this lack of
concern stems from the likelihood that it is poorer communities and poorer
children in Milwaukee who are most affected by lead exposure. Depressingly, Dr. 
Michael Totoraitis, the Milwaukee health commissioner, was quoted as saying, “I 
can’t pick up and call my colleagues at the C.D.C. about lead poisoning
anymore.” That’s on top of the FDA gutting the departments responsible for
routine food and drug safety inspections. How is any of this “making America
healthy again,” given RFK Jr.’s “MAHA” emphasis on improving the healthiness and
safety of America’s food supply? The disconnect here is most telling.

One only wonders how long it will be before “soft eugenics” becomes not so soft 
anymore.

The MAHA Report: The Good, The Bad, and The Ugly (mostly the bad and ugly)

President Donald Trump and HHS Secretary’s MAHA report has landed. It’s a mix of
the good (a little), but mostly the bad and the ugly (a lot).

David Gorski on May 26, 2025

Link

Given that this is a holiday weekend, I had been considering taking a week off
to hang out, go on long bike rides, and do some yard work. Then—wouldn’t you
know it?—on Thursday, the Trump administration and his “make America healthy
again” (MAHA) antivax crank and toady, Robert F. Kennedy, Jr., dropped The MAHA 
Report, with a press release filled with the typical hyperbole and
self-congratulatory wankery that we’ve come to know and hate about RFK Jr.:

The Presidential Commission to Make America Healthy Again (MAHA) today released 
a groundbreaking assessment identifying key drivers behind the childhood chronic
disease crisis. Coming just 98 days after President Trump signed an Executive
Order, links to an external website establishing the MAHA Commission and tasking
it with delivering a “Make Our Children Healthy Again Assessment, links to an
external website,” the report exposes a range of contributing factors—including 
poor diet, accumulation of environmental toxins, insufficient physical activity,
chronic stress, and overmedicalization.

By examining these drivers, the assessment arms MAHA Commission stakeholders and
partners with clear evidence that will support the development of effective
policy interventions where they can deliver the greatest impact.

“We will end the childhood chronic disease crisis by attacking its root causes
head-on—not just managing its symptoms,” said U.S. Health and Human Services
Secretary Robert F. Kennedy, Jr. “We will follow the truth wherever it leads,
uphold rigorous science, and drive bold policies that put the health,
development, and future of every child first. I’m grateful to President Trump
for his leadership—and for trusting me to lead this fight to root out
corruption, restore scientific integrity, and reclaim the health of our
children.”

I debated not writing anyway, but, me being me, I couldn’t resist this big fat
juicy target dropped in front of me, even if I didn’t become aware of it until
Friday morning, thanks to a long day in clinic on Thursday followed by attending
to family business in the evening. Also, I had already discussed the executive 
order forming the MAHA Commission, the committee tasked with writing this report
in February. As I discussed then, the EO was full of health misinformation
about cancer, autism, and ADHD just by itself; so I wanted to see what the final
product ended up saying. Let’s just say, it’s a mixture of The Good (very
little but not nonexistent), The Bad and The Ugly (the vast majority of the
report.)

Hans Solo, “Hey, it’s me.” Yes, I know this isn’t the correct screenshot, but I 
like this one better, and it was hard to find a decent one of the correct shot
that wasn’t an annoying GIF. Also, I like to shamelessly mix my pop culture
references; so this time it’s a spaghetti western and Star Wars.

So let’s take a look at the report. I’ll start with its introduction, which is, 
predictably, full of RFK Jr.-inspired false premises. Then we’ll look at The
Good (which is invariably contaminated with The Bad and the Ugly), and then The 
Bad and The Ugly, discussion of which will take up the bulk of this post.

Membership

Any time one analyzes a report by a commission or a committee, it’s important to
look at who the members are, as who the members are will shape the report. So I
perused the list of members. Of course, RFK Jr. chaired the commission, as was 
expected based on the executive order.

MAHA Commission Roster

What really struck me, however, was how few of the commission members have any
expertise in medicine. For example, the only two members of the commission
trained in medicine are FDA Commissioner Dr. Marty Makary and NIH Director Dr.
Jayanta (“Jay”) Bhattacharya, the latter of whom never completed a residency and
has never practiced medicine since medical school. Dr. Makary is best known for
being a COVID-19 minimizer and anti-COVID-19 vaccination, as well as,
pre-pandemic, for having created the myth in 2016 that the third leading cause
of death in the US is medical error, basically putting a faux legitimate face on
longtime quack myths about “death by medicine.” Dr. Bhattacharya, of course,
was one of the authors of the Great Barrington Declaration, the October 2020
manifesto that proposed opening up society from “lockdowns” (which were largely 
already disappearing then anyway) through a “let ‘er rip” approach to the
pandemic, with a poorly articulated afterthought of “focused protection” of
those at high risk for severe disease and death from COVID-19, specifically the 
elderly and those with certain chronic medical conditions. Bhattacharya was well
known for his consistently wrong repeated claim that this approach would bring 
natural herd immunity in 3-6 months, a claim that Makary was totally happy to
parrot. In other words, they’re both down with the soft eugenics of MAHA.

The rest of the membership show little evidence of anything resembling expertise
in the subject areas necessary to “make America healthy again.” Stephen Miller?
Seriously? He’s known for his xenophobia and anti-immigration stances, rather
than any expertise in public health. Linda McMahon? She’s a former professional 
wrestling promoter and entrepreneur turned Secretary of Education. Michael
Kratsios? He’s a former businessman turned political operative. Russell Vought? 
He’s the Director of the Office of Management and Budget and believed to be more
the one behind all the budget cuts at HHS, as well as the defunding of so many 
previously awarded NIH research grants. Worse, he’s someone whose child
benefited from NIH research but who has since being appointed OMB Director
mercilessly hacked away at the NIH budget. Then, of course, many of the members 
have purviews in economic policy, rather than in medicine, research, public
health, or science.

A less competent group of individuals to “make America healthy again” is hard to
imagine, at least for me. I fear that it probably isn’t hard for RFK Jr. or
Donald Trump to imagine.

MAHA has glorious purpose! (And, yes, I added Marvel to the mix of my pop
culture references.)

Glorious purpose

If there’s one thing about MAHA (and MAGA in general), it’s that its adherents
can’t seem to view their mission with anything less than apocalyptic
Manichaeism, and good vs. evil dualism in which the triumph of evil would mean
the end of everything good and our children being doomed to unhealth forever.
Here’s an example from the statement of purpose:

It presents the stark reality of American children’s declining health, backed by
compelling data and long-term trends. More importantly, it seeks to unpack the 
potential dietary, behavioral, medical, and environmental drivers behind this
crisis. By examining the root causes of deteriorating child health, this
assessment establishes a clear, evidence-based foundation for the policy
interventions, institutional reforms, and societal shifts needed to reverse
course.

To turn the tide and better protect our children, the United States must act
decisively. During this administration, we will begin reversing the childhood
chronic disease crisis by confronting its root causes—not just its symptoms.
This means pursuing truth, embracing science, and enacting progrowth policies
and innovations to restore children’s health. Today’s children are tomorrow’s
workforce, caregivers, and leaders—we can no longer afford to ignore this
crisis.

After a century of costly and ineffective approaches, the federal government
will lead a coordinated transformation of our food, health, and scientific
systems. This strategic realignment will ensure that all Americans—today and in 
the future—live longer, healthier lives, supported by systems that prioritize
prevention, wellbeing, and resilience.

I can’t help but notice a number of things. First, notice the emphasis on how
“today’s children are tomorrow’s workforce.” Sound familiar? It’s just a softer 
version of what RFK Jr. said about severely autistic children, namely that they 
will never pay taxes, hold a job, get married, or play baseball. In other words,
it’s a “kinder, gentler” statement of “useless eater” rhetoric to describe
chronically ill children and is basically eugenicist. Am I being unfair? You
might convince me of that if this were the only statement like this from MAHA
leaders, but it’s simply another restatement of the same narrative, watered down
to make its eugenicist tendency less apparent. Also, don’t get me wrong. No
one—and I mean, no one wants children to suffer from chronic illnesses and
health conditions. We just differ on what the reasons behind childhood chronic
illness are, as well as the scope of the problem, which RFK Jr. has been
exaggerating and misrepresenting ever since his antivax org Children’s Health
Defense came up with the narrative of this generation being the “sickest
children.” (Hint: As I have explained, they are not.)

The Good, The Bad, and The Ugly

As I mentioned above, there are some reasonable parts to the MAHA Report, but
unfortunately even those good parts tend to be contaminated with exaggerated
and/or pseudoscientific MAHA narratives. In the introduction, The MAHA Report,
predictably, identifies four key problems responsible for this “crisis” of child
health, which sounds suspiciously like the language of the “sickest
generation.” Indeed, in the introduction, The MAHA Report even states:

Today’s children are the sickest generation in American history in terms of
chronic disease and these preventable trends continue to worsen each year,
posing a threat to our nation’s health, economy, and military readiness.

There goes the “soft eugenicist language” again. I note that the reference cited
to support the claim that today’s children represent the “sickest generation”
is this one, which does report that the percentage of children with chronic
conditions or functional limitations has increased from 22.6% to 30.2% from
1999/2000 to 2017/2018, as reported by the National Health Interview Survey. Of 
course, as I noted when I first addressed the “sickest generation” trope, this
survey likely undercounted many conditions in the past. For the moment, though, 
let’s accept that we have a problem with chronic disease in our children, which 
is undeniable. What would a science-based approach to addressing the problem
look like? Hint: Not like what The MAHA Report advocates.

Let’s start with the four main problems identified in the report:

  1. Poor diet

  2. Aggregation of environmental chemicals

  3. Lack of physical activity and chronic stress

  4. Overmedicalization

Right from the start, you can see the way that MAHA characteristically takes a
germ of truth and then throws in a lot of its usual nonsense. For example, there
is little doubt that many children suffer from poor diet and lack of physical
activity. Addressing those problems is undoubted worthwhile, but it depends on
how that is done. Similarly, overmedicalization can in some instances be a
problem, but, as you will see, part of The Bad and The Ugly is how MAHA is
basically anti-psychiatry and wants discourage the use of psychiatric
medications even when appropriate, as for depression, anxiety, and ADHD. Much
worse, as you will see, MAHA includes the childhood vaccination schedule under
“overmedicalization,” parroting the antivax narrative that the expansion of the 
childhood vaccine schedule since the 1990s as the cause of neurdevelopmental
conditions and chronic disease. Indeed, there is a long section on the childhood
vaccine schedule, full of common antivax tropes that RFK Jr. has long been
promoting. Many of the tropes will be very familiar to regular readers. In
addition, the report also includes under “overmedicalization” gender-affirming
care of children with gender dysphoria and trans adolescents, which is described
in unscientific terms, such as “child chemical and surgical mutilation.”

The MAHA Report plays the same game with environmental chemical exposures. For
example, it includes examples of chemical exposures for which there is
sufficient scientific evidence to be concerned about a possible health impact
from exposure, particularly in children, such as microplastics, PFAS,
biphosphenols, and the like. Fair enough, even if the cases as presented are
one-sided. To this, The MAHA Report adds fluoride, which is safe at the doses
and exposures used in drinking water and fluoride products, while ignoring the
benefits to dental health that come from fluoridated water and the use of
fluoridated dental products. It also includes, predictably, pesticides,
especially glyphosate, which is safe at the exposures users experience and is
mainly a concern in agricultural workers exposed to much higher amounts of it.

And get a load of what The MAHA Report says about electromagnetic radiation
(EMR):

…an exposure due to the proliferation of cell phones286, Wi- Fi routers, cell
towers, and wearables)287 Some studies have linked EMR exposure to reduced sperm
counts and motility but not quality.288 The NIH’s National Toxicology Program
identified “clear evidence” of DNA damage and increased cancer risk in rats.289 
However, a recent systematic review of over 50 studies found low to inadequate
evidence on impact in children and called for more high-quality research.290

We have written about the various overblown claims that EMR contributes to
cancer going back decades (most recently Steve Novella wrote about it in 2024), 
and I have specifically written about the awful study that claimed to show that 
EMR caused cancer in rats and its many deficiencies. Let’s just say that RFK Jr.
is being RFK Jr., mixing concerns about poor diet and sedentary lifestyle with 
overblown and unsupported claims about fluoride, vaccines, and the like.

Also tellingly, as others have pointed out, key drivers of poor health,
disability, and death among children are conveniently left out:

But as a governmental, “scientific” document, it omits some of the most common
causes of chronic disease and death among children, notably car crashes and
gunfire, the leading causes of death among young Americans. It never mentions
teenage smoking and alcohol or drug use. Or access to physical or mental health 
care. It prefers to criticize fluoride in drinking water (without discussing its
beneficial effects) than to take on less popular or profitable targets like
guns and social striations.

As I like to note, if you want children to eat healthier, you need to address
inequalities that lead large numbers of children to lack access to healthy food.
You need to address food deserts. Yet, nowhere in the report is any discussion 
of how to address this problem. Instead, there is a section discussing the food 
pyramid, even though the food pyramid was phased out by 2011 and hasn’t been a
thing as far as food recommendations go for a long time. Again, the part on
foods mixes the reasonable with the not-so-reasonable coupled with convenient
omissions, such as how it discusses how industry has influenced the Dietary
Guidelines for Americans (DGA). These issues are discussed with respect to
government food assistance programs, such as Supplemental Nutrition Assistance
Program (SNAP, formerly known as food stamps), the School Breakfast Program and 
National School Lunch Program (NSLP), and the Special Supplemental Nutrition
Program for Women, Infants, and Children (WIC), the latter of which is praised
as having a “proven track record for improving children’s health.”

Of course, if RFK Jr. wants to wield the power of the federal government to
encourage healthy eating, it is puzzling that the Trump administration is
proposing massive cuts to all of the above programs, including massive cuts to
SNAP and WIC.

And vaccines. Oh, yes, The MAHA Report is antivaccine.

MAHA vs. vaccines

I’m going to start by extensively quoting the section on childhood vaccines:

   Vaccines benefit children by protecting them from infectious diseases. But,
   as with any medicine, vaccines can have side effects that must be balanced
   against their benefits. Parents should be fully informed of the benefits and 
   risks of vaccines. Many of them have concerns about the appropriate use of
   vaccines and their possible role in the growing childhood chronic disease
   crisis.

  1. Since 1986, for the average child, by one year of age, the number of
    recommended vaccines on the CDC childhood schedule has increased from 3
    injections to 29 injections (including in utero exposures from vaccines
    administered to the mother). Of course, parents may choose to delay to a
    later age or forego one or more of these vaccines.454 455

  2. The number of vaccinations on the American vaccine schedule exceeds the number
    of vaccinations on many European schedules, including Denmark, which has
    nearly half as many as the U.S.456 457 458 Yet, no trials have compared the 
    advisability and safety of the U.S. vaccine schedule as compared to other
    nations.459

  3. Unlike other pharmaceutical products, vaccines are unique in that all 50
    states enforce some form of vaccine mandate for public school enrollment
    although almost all states allow exemptions for religious and/or personal
    reasons.460 In contrast, over half of European countries—including the UK—do
    not require childhood vaccination.461

Despite the growth of the childhood vaccine schedule, there has been limited
scientific inquiry into the links between vaccines and chronic disease, the
impacts of vaccine injury, and conflicts of interest in the development of the
vaccine schedule.

Sound familiar? These are basically the “too many too soon” trope beloved of
antivaxxers at least since Jenny McCarthy, as well as the implication that
childhood vaccine schedules are not evidence-based because they differ among
nations. As I wrote nine years ago, childhood vaccination schedules vary among
nations because different diseases are more prevalent in different countries and
different healthcare considerations come into play. None of that means that the
vaccine schedules recommended, by, say, European countries are more or less
evidence-based than the vaccination schedule recommended by our CDC. There are
more than one evidence-based way to skin the proverbial cat, so to speak, and
different countries choose different strategies based on the local relative
burdens of different vaccine-preventable diseases. Moreover, as Dr. Vincent
Iannelli pointed out in 2017, our vaccine schedule has been pretty similar to
those of other industrialized countries, including European countries and Asian 
countries like Japan. He does describe some differences, but the differences are
not always in favor of fewer vaccines or fewer doses of vaccines, for instance:

And in many European countries, even if you don’t get more vaccines overall, you
do get more dosages at an earlier age, often with two dosages of MMR and the
chicken pox vaccine by the time your child is 15 to 24 months old.

Some vaccines, like hepatitis A and chicken pox aren’t routine in every European
country, like Iceland and Sweden, but many countries give vaccines that we
don’t, like BCG and MenC. And even Iceland and Sweden have recently added the
HPV vaccine to their schedule and Sweden may soon add the rotavirus vaccine too.

Again, as I said, there are more than one evidence-based strategies to protect
one’s children against vaccine-preventable diseases, and they need to be
tailored to the diseases for which the population is at risk. You’d think MAHA, 
being all about “individualization and personalization,” would be all about
that, but you’d be wrong. As Dr. Iannelli adds, some European countries “give
more vaccines by 12 months because they also give meningococcal vaccines to
infants!”

As for “too many too soon,”The MAHA Report claims, for instance:

Since 1986, for the average child, by one year of age, the number of recommended
vaccines on the CDC childhood schedule has increased from 3 injections to 29
injections (including in utero exposures from vaccines administered to the
mother). Of course, parents may choose to delay to a later age or forego one or 
more of these vaccines.454 455

Once again, Dr. Iannelli explains why this is deceptive, not the least because
the inclusion of only injections before the age of one in 1986 left out the oral
polio vaccine (two doses) and pushes the MMR injection out of that one year
mark, given that in 1986 the MMR wasn’t given until 15 months. At the same time,
to get to 29 injections before the age of one, The MAHA Report, well, lies:

Infants do not get 29 injections, even if you include all the recommended doses 
that can be given to their mothers when they are pregnant.

To get to 29 injections, the MAHA folks are including the oral rotavirus
vaccines (not an injection!) and are doubling up on the RSV vaccine (either mom 
or baby get vaccinated, not both). They are also including all the vaccines that
infants could get after they are a year old, and they are going with the
maximum doses possible.

And since that still only gets you to 28, they must also be including the baby’s
vitamin K shot, something they would also have gotten in 1986!

So how many injections do infants really get?

You can see from the immunization schedule above that they can get as few as 17 
injections, including RSV, flu, and COVID shots by the time they are 12 months
old. Add in three more if mom got Tdap, flu, and COVID.

Moving on from the above trope, I almost hate to have to repeat this so often,
but the call for “clinical trials” of different countries’ vaccination schedules
ignores all that and represents “methodolatry” or, as I also call it,
evidence-based medicine fundamentalism being weaponized to undermine confidence 
in the vaccine schedule. The MAHA Report even trots out the “no saline placebo” 
trope that falsely insinuates that the childhood vaccination schedule is unsafe 
because some of the vaccines have never been tested against saline placebo. It’s
a trope that ignores medical ethics, which say that it’s unethical to test a
second or subsequent generation vaccine against placebo if a safe and effective 
vaccine already exists; in such cases, the new vaccine is tested against the
existing vaccine.

As for the related claims that vaccines undergo small trials and limited safety 
monitoring, Dorit Rubinstein included a link to a listing of why that is not
true:

In particular, there is this list of pre-licensure clinical trials of various
vaccines:

Table showing pre-licensure trial sizes and citations for vaccines: Rotavirus,
Pneumococcal, DTaP, HPV, Varicella, MMR, and Inactivated Polio. Each lists
thousands to hundreds of thousands of participants.

You get the idea.

The MAHA Report also trots out familiar antivax attacks on vaccine safety
monitoring systems, including the Vaccine Adverse Events Reporting System
(VAERS) and the Vaccine Safety Datalink (VSD). I won’t go into those in more
depth here, as I have discussed such tropes more times than I can remember
(particularly about VAERS), but readers will recognize the tropes, should they
decide to read the relevant section.

Corporate capture vs…what?

Another key disconnect that I see in The MAHA Report is a lot of discussion of
corporate capture. Again, this is an example of how RFK Jr. takes legitimate
concerns about science, medicine, and the pharmaceutical industry and weaponizes
them to his antivax, anti-psychiatry agenda. For example, it is not antivax or 
anti-psychiatry to question industry influence on regulatory bodies. However,
The MAHA Report goes far beyond that, for example::

In the United States, private industry funds five times as many clinical trials 
than all U.S. Federal agencies combined including the NIH.479 Since 1999, 97% of
the most frequently cited clinical trials received funding from industry480 The
number of citations is a measure of papers’ impact,481 suggesting nearly all of
the most impactful clinical trials have been funded by industry.

Let me just play Devil’s advocate for a moment and, for the purposes of
argument, accept these figures. What should be done, if the above were true.
Certainly one obvious response to this problem would be public funding of
clinical trials used for drug approval, and the NIH would be the institution
perfectly suited to fund such trials, either intramural (inside the NIH) or by
funding independent investigators through external grants to carry out such
trials. Alternatively, the FDA could require that industry pay for all or part
of the necessary clinical trials but pick independent investigators to carry
them out. That must be why the Trump administration budget proposal for FY2026
includes a massive 40% cut to the NIH budget and a 5.5% cut to the FDA budget.
One also can’t help but note that all the concern about environmental chemicals,
both where warranted and where unwarranted seems not to have filtered up to
actual budgetary policy. After all, the Environmental Protection Agency is
facing a 55% budget cut for FY2026, while the CDC, which also investigates
environmental contributions to disease and chronic diseases, is facing a budget 
cut of one-third.

As for The MAHA Report’s critique of the use of psychiatric meds, even though it
echoes concerns that some physicians and psychiatrists have expressed, let me
just cite Eric Reinhart, who wrote in February about RFK Jr.’s Mental Health
Bait and Switch, in particular the contrast between what physicians practicing
evidence-based medicine and research and RFK Jr. when it comes to concerns about
the number of people (including children) on psychiatric medications:

Despite the superficial resonance between MAHA and progressive critiques of
psychiatry, the differences between them could not be more pronounced—nor more
consequential. And an untold number of patients could get ground up in the gears
of these distinctions.

Today, roughly a quarter of all U.S. adults take at least one prescribed
psychiatric medication—a massive increase compared to prior decades, even as
there have been no notable improvements in the effectiveness of available
treatments, which remain disappointingly limited. Meanwhile, rates of death by
suicide, overdose, and alcohol continue to increase, with a striking 37 percent 
increase in suicide rates between 2000 and 2018—the same period  in which rates 
of antidepressant use in the U.S. more than doubled. Clearly, psychiatric
diagnoses and treatments are—by themselves—woefully inadequate responses to the 
sea of psychic suffering and accompanying nihilism plaguing American society.

Social and critical psychiatry respond to this reality by demanding investments 
in public systems for nonmedical social care that are significant enough to
prevent much of the current need for psychiatrists and psychiatric drugs. Trump 
and Kennedy, by contrast, respond to it by seeking to dismantle public care
systems altogether, plotting major cuts to Medicaid, the Indian Health Service, 
food assistance, and a plethora of other essential programs that threaten to
leave those in greatest need with nothing at all. This is a strategy to abandon 
the most exploited members of our society, exacerbating their suffering and
hastening their premature deaths.

Put bluntly, the MAHA agenda—irrespective of the varying intentions of its
supporters, who include millions of diverse people failed by our current
systems—is quickly being turned by the Trump administration into a eugenics
campaign in the guise of reform: a cynical strategy to grant symbolic
recognition of widespread pain and anger at failing U.S. mental health care as a
perverse means of enabling material redistribution of resources away from
redress of that suffering and instead into the pockets of the rich.

The MAHA Report is the policy embodiment of this contrast. It cherry picks
statistics and seems to take an attitude that treating mental illness is a
matter of will that can be accomplished without drugs, while deceptively
emphasizing that a lot of psychiatric drugs are prescribed “off-label” in
children, neglecting to mention the reasons. If you read the American Academy of
Child & Adolescent Psychiatry statement on off-label prescribing, you’ll see
that there are a number of quite scientifically defensible reasons why
psychiatric meds are so often used off-label in children, stating:

Off-label medication use is part of the standard of care in the treatment of
psychiatric disorders when: 1) there is a solid evidence base for the
medication; 2) an off-label medication has better efficacy and/or safety
evidence than an on-label one; 3) a child has symptoms that are not controlled
by, or experiences unacceptable side effects due to, an on-label medication; 4) 
a child has a disorder or comorbid conditions for which there is no FDA-approved
treatment; 5) adjunct medication is necessary for control of side effects of
another medication; and/or 6) a child is below the age for which an FDA approved
treatment is available.

Notice how that doesn’t sound nearly as scary as RFK Jr. makes it sound or The
MAHA Report portrays it. That’s not to say that overprescribing of psychiatric
medications isn’t a problem that should be addressed, but what The MAHA Report
implies echoes the same sorts of anti-psychiatry tropes spread by Scientology.
The situation is much more complicated, with some medications being arguably
overprescribed, while others are arguably underprescribed.

Gold Standard Science?

Of all the catchphrases and buzzwords to have come out of the Trump
administration, “gold standard science” and its variants are among the most
annoying; so naturally The MAHA Report ends with a section entitled Next Steps –
Supporting Gold-Standard Scientific Research and Developing a Comprehensive
Strategy. There, we see:

All of these are a mix of scientifically valid with the dubious. For example,
I’m not sure what the heck they’re talking about regarding post-marketing
surveillance here. We already do post-marketing surveillance, particularly for
vaccines. As for the replication crisis, I’ve long said that this was always an 
overblown “crisis.” As I like to say, there is a reproducibility problem, but
it’s not a crisis, and there are many reasons for it, and Steve Novella has
written more nuanced discussions on the issue, noting that the “problem with
findings that don’t replicate is not that the original study was a false
positive, or the new hypothesis was wrong,” adding that “these are unavoidable
and part of the scientific process.” My concern is less with the ten potential
“solutions” to the problems identified in The MAHA Report but rather how they
will likely be used.

Leave it to RFK Jr.’s boss President Donald Trump to sign an executive order
entitled Restoring Gold Standard Science on the day after The MAHA Report was
released. Declaring that “for too long, bureaucratic agendas, political
interference, and inconsistent standards have eroded the American people’s trust
in science,” Trump proclaims that this administration will use only “gold
standard science.” Basically, the declaration expands the concept of “gold
standard science” to all sciences, not just biomedical sciences, and he
misrepresents evidence in other areas, such as climate science and environmental
science, with a clear bias towards promoting fossil fuels and more fishing.
Don’t believe me? Read the Fact Sheet associated with the EO.

Of course, any term like “gold standard science” coming from this administration
clearly means science the way we want it, slanted to our ideological ends. As
vaccinologist and pediatrician Dr. Peter Hotez put it:

My view: this is gaslighting, implying that before science wasn’t conducted at
the highest “gold standard” but somehow RFK Jr’s pseudoscience based on a highly
corrupt health and influencer industry will fix everything with their
“appropriate” science. Lysenko said much the same.

I’ve been saying that, with this administration in general and RFK Jr. in charge
of HHS in particular, Lysenko 2.0 is here. It’s called MAHA, and it won’t make 
America healthy again. It’s a con.


If The Atlantic Wishes to Honestly Understand the Origins of MAHA, They Need to 
Investigate The Atlantic.

The Atlantic has some of the best writers around. But they were also eager to
launder right-wing talking points under the guise of a being liberal,
reasonable, and moderate publication, able to see all nuanced sides of complex
issues.

Jonathan Howard on November 28, 2025

Link


If I were to do this story right, Kennedy told me, I needed to talk with his top
deputies: Jay Bhattacharya, the director of the NIH; Marty Makary, the
commissioner of the FDA; and Mehmet Oz

The Atlantic recently ran a cover story on the rise of Robert Kennedy Jr. titled
Why Is Robert F. Kennedy Jr. So Convinced He’s Right? It said:

How, I asked him, did he explain going from scorned activist to the boss of the 
public-health apparatus?

“I would say in one word: providential,” Kennedy said.

The article discussed the prominent role We Want Them Infected doctors play in
Kennedy’s “providential” rise:

If I were to do this story right, Kennedy told me, I needed to talk with his top
deputies: Jay Bhattacharya, the director of the NIH; Marty Makary, the
commissioner of the FDA; and Mehmet Oz, the cardiothoracic surgeon turned TV
doctor known for having hyped dubious “miracle” cures, who is now running the
Centers for Medicare and Medicaid Services. All three of these physicians, like 
Kennedy, say that they were transformed by the pandemic, which they thought
public-health authorities had mishandled. They had dissented from government
edicts regarding vaccine mandates and masking. Although they do not embrace all 
of Kennedy’s views on vaccines, his deputies share his big-picture view that
America’s public-health system is broken.

Early in the pandemic, Bhattacharya, a Stanford University physician and health 
economist, co-wrote the 2020 “Great Barrington Declaration,” a document that
argued against universal COVID lockdowns in favor of allowing healthy people to 
gather while isolating only those groups at greatest risk of severe illness or
death, such as the elderly and the infirm. For this, Bhattacharya was ostracized
by colleagues at Stanford and the broader scientific community: An email that
later became public shows Francis Collins, then the NIH director, telling
colleagues that they needed a “quick and devastating published take down” of the
declaration. (Tens of thousands of Americans a month were dying from COVID at
that time; overstrained hospitals were at risk of collapse.) Death threats—a
recurring feature of public-health work these days—followed for Bhattacharya,
who now compares the COVID years to pre-Enlightenment Europe, when Galileo
Galilei was imprisoned by Catholic leaders for arguing that the Earth orbited
the sun.

In reality, the Great Barrington Declaration wanted “healthy people” to gather
because it claimed the mass infection of this population, none of whom were
vaccinated at the time, would lead to herd immunity in 3-6 months. However, it
is true that without WWTI doctors, Kennedy would probably not be in power today.
Myself and many others have been writing about this unholy alliance between
cranks and prominent doctors from prominent universities for some time. The
subtitle to WWTI was:

How the failed quest for herd immunity led doctors to embrace the anti-vaccine
movement and blinded Americans to the threat of COVID.

I intended the book as a warning.

My recent writing has sought to understand why such warnings were dismissed. How
did MAHA achieve power? Why were so many Americans blind to obviously dangerous
threats?

Your Unvaccinated Kid Is Like a Vaccinated Grandma

One source of blurry vision was The Atlantic itself. Here are some gems they
published from some familiar names.

  1. Emily Oster, October 2020: “Schools Aren’t Super-Spreaders“: It’s now October.
    We are starting to get an evidence-based picture of how school reopenings
    and remote learning are going (those photos of hallways don’t count), and
    the evidence is pointing in one direction. Schools do not, in fact, appear
    to be major spreaders of COVID-19.

  2. Dr. Monica Gandhi February 2021, “Overcaution Carries Its Own Danger to
    Children”: Incessant pessimism about the coronavirus is hard to kick, but
    the vaccines are banishing any doubt about reopening schools.

  3. Emily Oster, March 2020: “Your Unvaccinated Kid Is Like a Vaccinated Grandma“:
    Children are not at high risk for COVID-19. We’ve known since early in the 
    pandemic that they are much less likely to fall ill, especially seriously
    ill. Although scientists don’t quite understand why, kids seem to be
    naturally protected. As a result, you can think of your son or daughter as
    an already vaccinated grandparent.

  4. Drs. Tracy Beth Høeg, Lucy McBride, Vinay Prasad, and Monica Gandhi, May 2021,
    “American Kids Can Wait”: Allowing the export of doses would be not only
    effective vaccine diplomacy but also in Americans’ own interest. Gaining
    better control of the disease across the globe would prevent or slow the
    emergence of worrisome viral variants.

  5. Dr. Lucy McBride, August 2021, “Fear of COVID-19 in Kids Is Getting Ahead of
    the Data”: Shielding children from danger is a fundamental instinct.
    Tolerating risk for them is hard—but necessary—emotional work.

  6. Dr. Vinay Prasad, September 2021, “The Downsides of Masking Young Students Are
    Real”: Scientists have an obligation to strive for honesty. And on the
    question of whether kids should wear masks in schools—particularly
    preschools and elementary schools—here is what I conclude: The potential
    educational harms of mandatory-masking policies are much more firmly
    established, at least at this point, than their possible benefits in
    stopping the spread of COVID-19 in schools.

  7. Dr. Monica Gandhi, November 2021, “The New COVID Drugs Are a Bigger Deal Than 
    People Realize”: These miraculous drugs arrived with minimal fanfare but
    represent the biggest advance yet in treating patients already infected with
    COVID-19.

  8. Dr. Monica Gandhi, November 2021, “It’s Time to Contemplate the End of the
    Crisis”: Americans should be asking ourselves what else needs to happen
    before we can declare an end to the crisis phase of the pandemic. Although
    the coronavirus’s course remains unpredictable—and bad surprises are still
    possible—the Delta-variant surge that started in early July ushered in what 
    may have been the final major wave of disease in the United States.

This is how The Atlantic used seemingly credibly voices to trick its readers,
especially regarding to pediatric COVID. And today, Drs. Vinay Prasad and Tracy 
Hoeg are working at the FDA, where they are featured in articles titled How Two 
Top FDA Officials are Quietly Upending Vaccine Regulations and FDA Described As 
“Clown Show” Amid Latest Scandal.

The Case for Finding Common Ground With RFK

When manufactured rage over COVID led directly to MAHA, The Atlantic was there
to tell its readers not to worry about that either. In December last year, they 
published an article titled The Case for Finding Common Ground With RFK which
said:

Democrats need to build a bigger tent to be competitive. But building a bigger
political tent means compromising—and that compromise usually means making
someone inside your tent angry.

Take, for instance, Colorado Governor Jared Polis, who surprised many and
angered some by announcing that he was “excited” by the nomination of Robert F. 
Kennedy Jr. to lead the Department of Health and Human Services. Asking people
to hold off on mocking or disagreeing with RFK Jr., Polis pointed to issues like
pharmaceutical reform, nutrition policy, and the use of pesticides. After
facing backlash, Polis clarified that he was pro-vaccines, but it left me
thinking: What might it look like to open the Democratic tent to
vaccine-skeptical Americans, of which there are a growing number?

What might it look like to open the Democratic tent to vaccine-skeptical
Americans?  The answer is obvious. Whenever children are unvaccinated, some get 
sick and suffer. Some die. Viruses don’t care which political party you belong
to.

This spring, The Atlantic continued to minimize obvious dangers in an article
titled The Health Official Who Just Might Stand Up to RFK Jr. which said:

Marty Makary, Donald Trump’s pick for FDA commissioner, is undoubtedly qualified
for the job. A longtime Johns Hopkins surgeon and best-selling author, he has
advised the World Health Organization and been elected to the National Academy
of Medicine.

That was obviously false. Dr. Makary wasn’t qualified to lead the FDA no matter 
what fancy titles he had. He was a pandemic fabulist who confidently made things
up all the time. There’s an overwhelming amount of material, none of it is hard
to find. Dr. Makary also had no experience leading a large organization, and
predictably, things aren’t going well at the FDA today. “What to Know About the 
Collapse of the F.D.A“, read one typical headline. Predictably, Dr. Makary is
not standing up to Kennedy. Rather he is lending the legitimacy of the medical
profession to bolster Kennedy’s rank anti-vaccine disinformation.

Miranda Devine: “Are there too many vaccines that babies are being given?”Dr. 
Marty Makary: “A kid today can get 72 vaccines by the age of 18.”“In Denmark, 
it's half of that number and as a result, they get less than half the cumulative
aluminum exposure.”“In Germany, UK,… pic.twitter.com/sBdnB5qKc2

— MAHA Action (@MAHA_Action) November 26, 2025

This summer, The Atlantic published an article titled How Public Health
Discredited Itself. This absurd piece of COVID revisionist history said:

Early in the pandemic, a few prominent researchers echoed Henderson’s warning
that the unprecedented restrictions on liberty were not justified by the
scientific literature and could cause much more harm than the virus. But these
researchers—including Harvard’s Martin Kulldorff and Stanford’s John Ioannidis, 
Jay Bhattacharya, and Scott Atlas—were promptly vilified by colleagues, smeared 
in the press, and censored on social-media platforms. Other researchers became
afraid to openly challenge the establishment, so the officials promoting
lockdowns became the public face of scientific authority.

This was also obviously false, as I discussed in my article The Opinion Class:
Practicing Focused Protection From Reality. Like Dr. Makary, Drs. Kulldorff and 
Bhattacharya, whom The Atlantic portrayed as supermen stronger than COVID, are
also flailing now that they have real world responsibility for the first time.

The Atlantic had some of the sharpest, most insightful writers on the pandemic
and misinformation in general- Katherine Wu, Ed Young, Ben Mazer, and Charlie
Warzel come to mind- and I am glad it recognizes that without WWTI doctors,
Kennedy likely would not be where he is today. It’s important to honestly tell
the story of how MAHA triumphed. 

For that reason, it’s important to remember that The Atlantic was perfectly
willing to repeatedly deceive its readers and numb them to grave risks, both
COVID and MAHA. They were eager to launder right-wing disinformation that also
found a home at wretched outlets such as the Brownstone Institute and Children’s
Health Defense. What made The Atlantic exceptionally pernicious, however, is
that they did all this under the guise of a being liberal, reasonable, and
moderate publication, able to see all nuanced sides of complex issues.

If The Atlantic wishes to write more about the origins of MAHA, that will
require them to turn the spotlight on themselves, at least if they want to do
the story right.


Our Current Medical Establishment Would Have Botched COVID, The Same Way They
Are Botching Measles

Those of us who paid attention to their COVID wishcasting are not the least bit 
surprised that measles is killing and injuring children under their watch.

Jonathan Howard on April 25, 2025

Link

What would you have done?

Recently, an interviewer sympathetic to the Great Barrington Declaration (GBD)
listened to my criticisms of it and asked me: What would you have done? That
question has me bothered me ever since.

Unlike the doctors I critique, I never claimed to be a pandemic guru with all
the answers, and what I actually did is exactly what I would have done. There is
no alternate version of me where I was the was mayor of NYC or the dictator of 
some country. What I actually did is much more interesting than fantasies about 
what I would have done. I worked in a hospital. I was in a vaccine trial. I
corrected doctors’ misinformation. Moreover, just because someone says they
would have done something doesn’t mean they actually would have done it. It’s
trivially easy to write the words “I would have kept schools open” or “I would
have protected the vulnerable.” Anyone can do it.

While obviously anyone can voice their opinion on how we could have better
handled the pandemic, and it’s vital that we do that. However, the question
“what would you have done?” conjures a parallel universe where words become
reality, and both the virus and the public can be bent to one’s will.

Nonetheless, imagination time is fun, so here’s my answer:

I never would have let SAR-CoV-2 into the country. The moment the virus emerged 
in China, I would have sealed the border. If any COVID cases snuck in, I would
isolate them before the virus could spread. I’d launch a massively successful
vaccination campaign and ventilate indoor spaces. I’d create a culture where
people stayed home when they were sick and where mask-wearing was not unusual.
By keeping the virus out of the country, society could function normally, and
people would remain healthy.

A reasonable person would not be impressed by this. They’d expect to see a
detailed plan to keep COVID out of the country, and even then they would spot
its many flaws.

Yet, many people did not demand such a plan from the GBD, although their
proposal was as absurd as mine. They wanted 2/3 of the country live in a world
of pure COVID and 1/3 of the country live in a world of zero COVID. They said
this would end the pandemic in 3-6 months. Although though the virus shuttered
schools and killed a record number of people when they ran the show in Florida, 
they claim that if only we had listened to them, everything would have been just
fine.

Measles Surge in Southwest Is Now the Largest Single Outbreak Since 2000

While my plan of keeping the U.S. COVID-free is obviously superior to the GBD’s,
I will receive zero credit for it. In contrast, the authors of the GBD and
like-minded doctors received many accolades for merely saying what they would
have done. However, recent events reveal just how absurd this adoration was.

Doctors who became celebrities for saying what they would have done, parlayed
that game of make-believe into high positions in the Trump administration. They 
are the Medical Establishment now, and they no longer get to say what they would
have done on Twitter and Fox News. They have real-world responsibility, and
it’s a mess all around.

I don’t need to repeat all of the headlines of censorship and purges they are
generating, but one thing they are doing is letting children suffer and die from
vaccine-preventable diseases. Under our current Medical Establishment, the
headlines read Measles Surge in Southwest Is Now the Largest Single Outbreak
Since 2000, Texas Announces Second Measles Death in Unvaccinated Child, Texas
Measles Outbreak Surpasses 600 Cases With Most Among Children, Teens, Two
Infants Die of Whooping Cough in Louisiana as Cases Climb Nationally, and
‘Fighting to Breathe’: Whooping Cough Surges as Vaccination Rate Falters. We are
just getting started. Another recent headline declared Millions of U.S. Measles
Cases Forecast Over 25 Years if Shots Decline.

Despite these suffering children and the potential for many more to come, the
Medical Establishment is focused on other topics. The article Robert F. Kennedy 
Jr. to Launch Autism Registry Using Private Health Records provides a preview of
their creepy intentions, and in this unhinged screed, RFK Jr. says we need
healthy kids for the military. What could go wrong?

Our Medical Establishment is trying to pull the COVID vaccine for children- FDA 
Commissioner Says Pulling COVID Vaccine For Children Will be ‘Welcomed’ Dr. Jay 
Bhattacharya wants to get rid of mRNA technology all together. They are also
focused on fertility and testosterone levels in teenage boys. At this moment,
these are their priorities.

Yes, measles is still the most contagious virus there is, but it should be easy 
to handle compared to COVID. We have a near-perfect vaccine, and most parents
want it. Anti-vaxx disinformation is the only reason we are having measles
outbreaks today, and explained by the article Measles Misinformation Is on the
Rise — and Americans Are Hearing It, things are heading in the wrong direction. 
Allaying the fears of vaccine-hesitant parents should be a top priority for our 
Medical Establishment. That’s not happening.

The doctors who claimed they would have solved COVID are flailing with measles- 
amongst other things. Not only are the failing to correct anti-vaccine
disinformation, they are making things worse. In one recent interview, Dr. Marty
Makary, flanked by the Food Babe(!), twice refused to answer “YES!” when asked 
if parents should vaccinate their children against measles. In the video below, 
he said the bare minimum about the MMR. However, while saying “we have to be
honest,” he minimized children dying of measles with the same noxious myths he
used with COVID.

He said only vulnerable children are at risk of measles, he ignored its
non-fatal outcomes, and absurdly implied parents are not given any choice
regarding vaccines. He said that measles outbreaks are not unusual. He spread
misinformation about the hepatitis B vaccine for no reason. He said that RFK Jr.
had no responsibility for the current outbreak. He instead blamed “migrant
communities” and unspecified “government misinformation” about COVID, even
though the people who died of measles should have been vaccinated before the
pandemic. This is yet another example of our FDA director endorsing time travel.

It’s also an example of deflection. The current Medical Establishment doesn’t
want to take responsibility for what is happening under their leadership. Dr.
Makary doesn’t want to acknowledge the obvious truth about his boss, a crank who
lied about vaccines for 20-years and predictably botched this measles outbreak.
While the current Medical Establishment got famous by blasting the previous
Medical Establishment for their supposed dishonesty, they now seek to protect
themselves above all else and distract from their ineptitude with odd ramblings 
on teenage hormones.

Stanford Doctor Jay Bhattacharya Calls Dr. Fauci ‘Number One Anti Vaxxer’

Despite their grand pronouncements, our current Medical Establishment wouldn’t
have opened schools or protected the vulnerable when COVID was raging. Those
were empty boasts. Right now, they are demonstrating their complete inability to
keep people safe from a dangerous pathogens.

Yet, the problem isn’t just their incompetence, it’s their apathy. Our current
Medical Establishment does not care about keeping people safe from dangerous
viruses, though this is hardly breaking news. However, the strategy that
catapulted them to their current positions, downplaying COVID on Fox News, isn’t
going to work now that they are in charge. The media is paying attention to
these interviews now and will scrutinize their false claims- FDA Head Falsely
Claims no Scientists Laid Off, as Agency Shutters Food Safety Labs– something
they were generally spared previously. They can’t just wish measles away. Even
Megyn Kelly is asking about it. They will continue to be blamed for bad
headlines about is meals, which is appropriate. It’s their job now to stop it,
and the only way to do that is with vaccines.

Those of us on the outside have every right to treat our current Medical
Establishment as harshly as they treated public health officials regarding
COVID. Drs. Bhattacharya and Makary mocked them and depicted them as dishonest
imbeciles for not saying that COVID vaccines were a perfect panacea or that
natural immunity was this wonderful, powerful thing. We also have every right to
hold them the highest standards. After all, they set high expectations by
telling us all the amazing, incredible, wonderful things they would have done
with COVID.

Obviously, our Medical Establishment does not deserve credit for these imagined 
“accomplishments”. Rather, they deserve to be judged for the real-world
consequences of pandemic misinformation and everything that’s actually happening
right now. Those of us who paid attention to their COVID fantasies are not the 
least bit surprised that they shrug as measles kills and injures children under 
their watch.

In contrast, I deserve praise and glory. Unlike our inept, bumbling Medical
Establishment, I would have prevented this.



The tragic termination of the Diabetes Prevention Program Outcomes Study

An invaluable resource is being starved to death with no scientific or ethical
justification

David Weinberg on April 1, 2025

Link

On March 10, 2025, leadership of a research study known as the Diabetes
Prevention Program Outcomes Study (DPPOS) was notified that the grant supporting
the study had been terminated. The DPPOS and its predecessor the Diabetes
Prevention Program (DPP) have studied a group of patients since the inception of
the DPP in 1996. More than 3000 participants were enrolled, selected because
they were at high risk for developing diabetes. The studies have successfully
tested strategies to reduce the risk of diabetes and have continued to study the
same group of participants for nearly 30 years, looking at a variety of health 
outcomes in this aging cohort. The most recent focus is Alzheimer’s disease and 
dementia.

This is a multicenter study, involving 30 institutions across the USA. Due to
the way NIH structures this type of grant, the funding for the entire study
apparatus is managed through a central grant recipient. In recent years Columbia
University has become the funding center. Columbia receives the funds from NIH 
and distributes these to the various centers.

No official justification for the defunding has been given, but it was part of a
sweeping cancellation of federal grants to Columbia University. It is
speculated that Columbia was singled out because of the Administration’s
grievance regarding student protests and antisemitism on campus. Because
Columbia happens to be the funding hub, the result is a de facto defunding of
the entire DPPOS study.

Diabetes and its complications

If I had the power to wave a wand and eliminate one disease from the face of the
earth, diabetes would be a top candidate. Alzheimer’s disease would also be on 
the short-list. Diabetes is responsible for a great deal of premature death and 
disability–most notable are heart disease, kidney disease, stroke, and
blindness. There is a strong link between Type 2 diabetes and dementia.

Recent CDC data (2021) estimated that 38.4 million (11.6%) Americans have
diabetes. It is not only devastating for health, it is expensive. The costs of
diabetes (including medical costs plus lost work and wages) cost $413 billion in
2022. The prevalence of diabetes is growing. Nearly 98 million Americans have
prediabetes.

Every medical specialty sees and treats diabetic complications. As an
ophthalmologist, I dealt with the devastation caused by diabetic retinopathy.   
Much of what we know, and much of the progress we have made in treating diabetes
and managing complications are due to NIH sponsored studies. These studies are 
referred to by awkward initialisms like: DCCT, EDIC, and ETDRS. They are
canonical in the medical literature and have been profoundly impactful in the
day to day medical care of people with diabetes.

The Diabetes Prevention Program

Improving our treatment of chronic disease is important, but prevention is more 
impactful, both clinically and financially. Enter the Diabetes Prevention
Program (DPP).  The DPP was a randomized clinical trial conducted between 1996
and 2001 at 27 clinical sites in the US. 3,234 participants were enrolled. 
Study participants met predefined criteria identifying as high-risk for
development of Type 2 diabetes. Participants were randomized to one of three
groups (cut and pasted from the NIH website) below.

  1. Lifestyle Change Group – Group participants joined a DPP Lifestyle Change
    Program that provided intensive training. Participants tried to lose 7
    percent of their body weight and maintain that weight loss by eating less
    fat and fewer calories and exercising 150 minutes per week. Researchers met 
    with participants individually at least 16 times in the first 24 weeks, and 
    then every 2 months with at least 1 phone call between visits.

  2. Metformin Group – Group participants took 850 mg of metformin* twice a day and
    were provided standard advice about diet and physical activity.

  3. Placebo Group – Group participants took a placebo twice a day instead of
    metformin and were provided standard advice about diet and physical
    activity.

*Metformin is a first line medication for the treatment of Type 2 diabetes and
one of the most prescribed medications in the world.

Results of DPP

The DPP identified two strategies for at-risk patients to reduce their risk of
progressing to Type 2 diabetes. Compared to the placebo group, both intervention
groups demonstrated a reduced risk of progression to Type 2 diabetes. After 3
years, the Lifestyle Change Group lowered their risk by 58%. The metformin group
lowered their risk by 31%. These are large treatment effects. Given the
magnitude of diabetes in the US, any incremental reduction in the incidence of
new cases represents a huge public health benefit.

The Diabetes Prevention Program Outcomes Study

The Diabetes Prevention Program Outcomes Study (DPPOS) is an extension of the
DPP.  The study has proceeded in phases, focusing on different health outcomes
as the study population ages. Phase 1 demonstrated that lifestyle modification
and metformin continued to protect against the development of type 2 diabetes
after 10 years. Later phases have focused on other health outcomes including
cancer, heart disease, stroke, nerve disease, kidney disease, and retinopathy.
The DPP and DPPOS have been highly productive and highly prolific, producing
more than 200 publications.

There is a strong link between Type 2 diabetes and Alzheimer’s. The DPPOS is a
unique resource to study this association. The most recent phase of the study
has added dementia, including Alzheimer’s disease.  The current phase began in
2022 and is scheduled through 2027.

Consequences of defunding DPPOS

Last month I wrote an SBM article discussing the abandonment of more than 30
clinical trials due to defunding of USAID.  I discussed the direct and
collateral effects of the sudden, unplanned termination of these studies. These 
are equally applicable to the sudden unplanned defunding of the DPPOS.

I will discuss the consequences on 3 levels: the practical, the personal, and
the scientific.

The practical

Managing a clinical research study with the size and complexity of DPPOS is a
major feat. Thousands of patients seen at dozens of institutions across decades 
creates a logistical nightmare. As a result, studies like this have a complex
infrastructure. Study protocols must be written, communicated, and implemented. 
They are periodically amended.  Participants are recruited, consented, and
followed. Visits must be carefully coordinated to conform to specified
timelines.

Sites stay in contact with participants. Missed visits must be noted and
rescheduled. Participants must be notified of changes in the protocols. Data are
collected and communicated to coordinating centers, all constrained to protect 
participant privacy. Labs are collected analyzed and similarly forwarded.
Records must be stored in compliance with local and national regulations. Sites 
are audited. Data are collected, collated, and analyzed. Papers are written.
Study committees meet. Study-wide meetings must be organized. 

Suddenly cutting off funding, without a plan, effectively ends the study. The
sites may have enough funds to continue operations for a while, but institutions
cannot continue to assign personnel to studies without expectations that they
can pay them. Employees understand the writing on the wall and will move on to
more secure projects. Unless funding can be reestablished, day to day operations
will cease and decades of accumulated data will be wasted. The most recent
phase exploring Alzheimer disease and dementia will likely be abandoned, and
funds already invested will be wasted.

The personal

Research participants are volunteers. In order to qualify for a study, they must
endure a screening process to determine eligibility. If eligible, they go
through a rigorous informed consent process. If they accept the details of
consent, and agree to the terms of the study, they can enroll.  As a study
participant they agree to adhere to the study protocol, which often involves
visits, procedures, and investigations far in excess to what they would
experience in “usual care.”  There is no certainty that they will personally
benefit from their participation.

Participants are free to withdraw from a study at any time. Because DPP and each
phase of DPPOS are considered separate studies, participants were re-consented 
for and re-enrolled for each study. 85% of eligible patients transitioned from
DPP to DPPOS, considering this was a separate study, this is excellent patient
retention, a tribute to the trust and to the strength of the relationship among 
the study participants, the investigators, and the rest of the study staff.

Why do participants volunteer for studies? Motivations are varied. Many
participants have expressed to me their hope that information learned from the
study will be beneficial to others. To remain connected to a study and to a
group of researchers for decades reflects a powerful connection and commitment
to the project. At this point participants have little expectation of personal
benefit. Many persevere due to a to a valid sense that they are part of a team
and a hope that their participation will benefit others. The relationship
between participants and researchers is a powerful ingredient to the success of 
long-term studies like DPPOS. Regarding study staff, José Luchsinger, one of the
principal investigators at Columbia noted:

“They are the connection with the study participants…if we lose that connection,
it would be very difficult to resume the study in the future.”

The premature termination of this study limits the likelihood that the study
will produce additional data that will improve health. Imposing such limits is a
snub to the altruistic motivation of the volunteers who have been faithful to
the study for decades.

One long-term study participant expressed pride in contributing data to guide
professionals in advising patients with diabetes. Faced with the discontinuation
of the study: “Honestly, I wanted to cry,” she said.

The Scientific

DPP and the various phases of DPPOS were not launched arbitrarily. They were
evaluated on merit and priority. They were approved by appropriate ethical
review committees. Ultimately, they were awarded because they were expected to
answer important questions and to improve the outcomes of people with and at
risk for diabetes. They were approved by appropriate ethical review committees.

There can be justification for interrupting a study early. A study may be paused
if the interim results are definitive; if the risks of continuing the study are
too great; or if it becomes clear that the study has little to no potential to 
reach a meaningful conclusion. Often contingencies for these interruptions are
pre-specified in the study protocol and based on the advice of an independent
review committee which has access to the data. In each of these examples,
certain aspects of the study may be stopped or modified BUT, the study
participants are not abandoned. They will often be debriefed on the reasons for 
termination or modification of the protocol.  I am aware of no scientific or
ethical justification offered for the defunding/termination of DPPOS. 

The DPPOS is not just a series of research projects, it is an ecosystem. It is a
collection of experts teaming with a group of volunteers who have been studied 
for decades. These participants have been studied using standardized assessments
on a defined schedule. With a resource like this it is possible to look forward
and to look backward to answer important questions and to generate hypotheses
for future research. The longer funding is withheld, the more will be lost, and 
the more difficult it will be to resume. At some point there will be a loss of
too many participants, too many investigators, and too much data to resurrect
the study. The opportunity cost of dismantling this resource is impossible to
calculate. 

Backlash

The deconstruction of DPPOS seems particularly ironic considering current Health
and Human Services secretary Robert F. Kennedy Jr.’s assertion that current
research priorities are insufficiently addressing chronic illness.

An editorial in Medscape referred to the cancellation as a “Colossal Waste.”

The DPPOS investigators, The Endocrine Society and the American Diabetes
Association have all appealed to promptly resume funding of DPPOS. 

The Chairpersons of the Congressional Diabetes Caucus have written a letter to
the Secretary of HHS and the acting Director of the NIH urging them to take
action to reinstate funding of DPPOS.

David M. Nathan, MD, Chair of the DPPOS Research Group has written a letter
explaining the value of DPPOS, urging reinstatement ASAP, He concludes with this
paragraph:

Any continued interruption threatens the stability of the staff, the connection 
to the participants who have been a part of this work for more than 30 years,
and the potential to salvage the scientific integrity of the study. If this
decision is not reversed, it will undermine our nation’s best opportunity to
uncover the root cause of Alzheimer’s and Dementia, waste taxpayer’s
investments, and work against the Administration’s stated goal of Making America
Healthy Again. We urge you to take immediate action to call for reinstatement
of this funding to the study sites across the country through whatever means
necessary.

It is wasteful and sad that a resource like DPPOS is being starved to death
without justification.


Professor Stephen Macedo: How Does it Feel to Have Elevated MAGA/MAHA
Propagandists?

The fault is not yours alone. You were just a bit player in a larger
misinformation media ecosystem that was devoted to rewriting the history of the 
pandemic, numbing people to the grave risk We Want Them Infected doctors.


Jonathan Howard on WOctober 24, 2025

Link


Dear Professor Macedo,

I recently saw an interview where, under duress, you expressed dismay that Dr.
Jay Bhattacharya had cancelled research into mRNA vaccines.  I totally agree,
though this is just one of many ways Dr. Bhattacharya has shown he is utterly
unfit to lead the NIH.  It would take many pages to cover it all.  I am curious 
if you approve of any of his actions as NIH director.

This matters because you vouched for Dr. Bhattacharya to lead the NIH. In an
article titled, Restoring Trust in Public Health you and Francis Lee wrote:

If the country had had more scientific leaders like Dr. Jay Bhattacharya—and
more who were willing to listen to him—our policymaking could have been based
more on evidence and less on hubris. During the pandemic democracy’s
“truth-seeking” institutions were infected by politics, partisanship, and
dogmatism. What we need now is a strong dose of fresh thinking and institutional
reform from experts prepared to challenge the reigning consensus and renew our 
commitment to the basic values of science and liberalism.

I disagreed. In a previous article, A Review of “In Covid’s Wake”: According to 
Laptop Class Professors, the Heroes of the Pandemic Were Laptop Class
Professors, I reviewed a chapter of your book, where you glorified Dr.
Bhattacharya and other bumbling MAHA doctors- we are rookies– who are currently 
in positions of great power.

I found your work lacking in many ways, and I was not alone. The podcast If
Books Could Kill provided a devastating takedown, and the Pandemic
Accountability Index wrote an article titled Princeton’s Stephen Macedo and
Frances Lee Are Dishonest Frauds that said:

Comically enough, the authors are transparent about their ignorance, as two
“political scientists” who never treated a COVID-19 patient, nor studied the
virus and it’s impacts in a laboratory setting.

They’re right. In one interview you said:

I wanted to write a book on the current political moment and the highly
polarized politics that we are involved in now. Specifically, about how
progressives were not paying sufficient attention to conservative concerns on
certain issues in a way that was undermining the strength of progressive
arguments and positions. I was planning to focus on abortion, immigration, and
COVID. Of the three, COVID—and COVID policy—happened to be the subject I knew
the least about.

Not only did you write about the subject you “knew the least about,” but in a
pandemic where 1.2 million Americans died and millions more were injured, your
main concern was that progressives were not paying sufficient attention to
conservative concerns. Even though an estimated 232,000 people died because they
were tricked about vaccines, you felt that famous disinformation doctors and
advocates of herd immunity via mass infection didn’t get enough attention. You
were upset that the forces who are currently politicizing science, purging and
censoring scientists, had their feelings hurt by dastardly “progressives”.

My main criticisms of your book chapter were that you censored Dr.
Bhattacharya’s deluge of obvious disinformation- no, the flu did not kill more
children than COVID– and that you treated his pandemic proposals as genuine
accomplishments.

Dr. Bhattacharya marketed himself a superhero who could have bent the virus to
his will. He would have opened schools and protected the vulnerable, however he 
was thwarted by his predecessor at the NIH and YouTube. If it weren’t for those 
malicious, all-powerful villains, Dr. Bhattacharya and friends would have
swooped in and saved the day.

And you believed him.  It’s incredible.

I previously described this willful gullibility in an article titled The Opinion
Class: Practicing Focused Protection from Reality, in which I argued that
sheltered pundits like yourself existed in a fantasy world completely divorced
from what actually happened on the ground when the virus was allowed to spread
unchecked. It’s not clear to me that you interviewed any frontline doctors or
school administrators- you know, the people who actually had to deal with the
virus- in writing your book.

However, by treating Dr. Bhattacharya’s would have statements as actual
accomplishments, you erased the virus and treated mitigation measures as an
avoidable choice. This shows you misunderstood both COVID and Dr. Bhattacharya’s
critics.  It’s not that Dr. Bhattacharya uniquely wanted vulnerable people to
be protected and schools to be open while his detractors objected to these
laudable goals. Rather, when Dr. Bhattacharya claimed he would have accomplished
those wonderful deeds, his detractors knew these were empty boasts, meant to
spread doubt and rage about people with real-world responsibility.

By treating Dr. Bhattacharya’s imagination as real, you portrayed him a wise,
credible scientist, a man of extreme competence. However, we are all adults, and
we can stop pretending. Had Dr. Bhattacharya been in charge in 2020, he would
not have been more powerful than COVID. We do not need to speculate about any of
this or discuss him in the conditional tense. As with his tenure at the NIH, we
can examine his real-world track record. It turns out that Dr. Bhattacharya was
not more powerful than COVID. When he helped run the show in Florida, schools
closed and people died, “vulnerable” and “not vulnerable” alike. He didn’t do a 
single thing he claims he would have done, not that any of that mattered to you.

Of course, anyone can fantasize about what they would have done, but it’s what
they actually did that matters, and what Dr. Bhattacharya actually did while
COVID raged is write editorials and make podcasts/YouTube videos to fool people 
like you. He met with right-wing politicians, testified in courts and before
Congress. He was on Fox News many times. He spoke at the campaign events of Ron 
Desantis and Robert Kennedy Jr. He partnered with a pro-tobacco, child labor
advocate to write the Great Barrington Declaration, which was simply one-page
online petition, as Dr. Bhattacharya admits below. Dr. Bhattacharya was a
content-creator, and it was no magnificent achievement for him to merely write
that single page. He was also a political operative who stoked paranoid fears of
a “biomedical security state” to elevate himself into power.

You helped him.

Moving forward, every time you present Dr. Bhattacharya’s imaginary pandemic,
where he had superpowers and everything turned out just fine, your audience
should contrast that fantasy with his actual performance at the NIH today. He
can’t even handle a single meeting with disgruntled researchers in a
professional, competent manner, and people understandably stormed out of his
only town hall in protest. He is loathed and mocked by NIH staffers who rightly 
deride him “Podcast Jay.” As the NIH withers under his “leadership”, he is
currently spending his time on Twitter, reliving his glory days, having spats
about lockdowns from 2020. He is using his authority, not to protect vulnerable 
people, but to expose them.

Today, the COVID vaccine for healthy children and healthy pregnant women has
been removed from @CDCgov recommended immunization schedule. Bottom line:
it’s common sense and it’s good science. We are now one step closer to realizing
@POTUS’s promise to Make America Healthy Again. pic.twitter.com/Ytch2afCLP

— Secretary Kennedy (@SecKennedy) May 27, 2025

But hey, maybe I am wrong about all this, Professor Macedo.  Maybe Dr.
Bhattacharya is doing a really great job at the NIH, and science and research
are thriving in the U.S. today. Maybe scientists are finally free to speak their
mind without fear of retribution. Maybe Dr. Bhattacharya was right that Kennedy
is the savior of American science and medicine. Maybe they have restored trust 
in public health, and we are much better prepared to handle a pandemic than we
were in 2020. Maybe it’s good that COVID vaccines are harder to get. Maybe you
can convince me that the fictional version of Dr. Bhattacharya you praised
regarding COVID matches his real-world performance at the NIH today. 

However, if you can’t do that and you continue to portray Dr. Bhattacharya and
other MAHA doctors as censored superheroes, we need to be crystal clear that all
your doing is elevating MAGA/MAHA propagandists under the guise of being a
caring “progressive”, which is all you’ve ever done.

Indeed, beyond his deadly incompetence in Florida and his malevolence at the
NIH, Dr. Bhattacharya is all in on Trump and Kennedy. Listen as he says that
says Trump is “very pro-science” and that it is “ridiculous slander” to suggest 
otherwise. Listen as he expresses his deep admiration for Kennedy, portraying
him as a benign soul whose only motive is to make children healthy.

This is who you glorified and praised. The next time you performatively lament
the current state of science on some podcast, your listeners, as well as your
students and Princeton colleagues, should know that you helped unleash this on
the entire country.

Obviously, you alone are not to blame. From Bari Weiss and David Zweig to the
Wall Street Journal, Sensible Medicine, Reason, and countless others, you were
just a bit player in a larger misinformation media ecosystem that was devoted to
rewriting the history of the pandemic and numbing people to the grave risks of 
We Want Them Infected doctors. Every credulous mainstream news outlet that
allowed you to spin fairy tales about the fictional version Dr. Bhattacharya,
also owns this sad moment. Thanks to all of you, we are stuck with the actual
version of Dr. Bhattacharya and the entire MAGA/MAHA universe he represents.

We at SBM are content creators too. However, we used to our voice to desperately
try to warn people about the forces you celebrated. Unlike podcasting pundits
and Princeton political scientists, we also operate in the real world. If you
want to be a guest on my podcast, I’ll be happy to teach you all about it. And
in turn, I will listen quietly and respectfully while you teach me exactly why
you were right about this “Excellent appointment!” I have so much to learn from 
you.

Excellent appointment! https://t.co/wqVLuVHdvu

— Stephen Macedo (@stephen_macedo) November 27, 2024

.

“MAHA has fallen”? Antivaxxers are getting very impatient with Robert F. Kennedy
Jr.

Recently, antivaxxers have been expressing their impatience with HHS Secretary
Robert F. Kennedy Jr.’s progress eliminating vaccines. It was inevitable. Has
MAHA fallen?

David Gorski on November 17, 2025

Link 

One of the few things that can (sometimes) console me about the current
hellscape that federal public health, medical, and biomedical research policy
have become under the stewardship of longtime antivax activist Robert F.
Kennedy, Jr. as Secretary of Health and Human Services under President Donald
Trump is schadenfreude. I experience schadenfreude every time I see a story in
which arch conspiracy theorists like RFK Jr. who have come into power over
vaccine and health policy far beyond their wildest dreams find themselves the
victims of the very same tactics and rhetoric they’ve long weaponized against
conventional medicine, physicians, and scientists. So it was with great
amusement that, while perusing the usual antivax sites, I came across an article
in NaturalNews.com entitled Former MAHA director warns that COVID-19 vaccine
issues are intentionally hidden, as RFK Jr. is maneuvered into compliance. True,
the name on the byline was not Mike Adams himself, but rather one of his
disposable writing drones, Lance Johnson, who by this point might just be AI
slop, but that Adams would publish something like this is telling to me,
particularly about where RFK Jr.’s “Make America Healthy Again” (MAHA) movement 
is right now.

At this point, let me just interject that I still believe that RFK Jr. is
definitely coming for your vaccines. What he’s done at the CDC and FDA, as well 
as key committees overseeing vaccine policy, and his push to relitigate
scientific issues of vaccine safety and autism causation that have been well
studied continue to convince me that he definitely wants to eliminate all
vaccines. The schadenfreude that I’m experiencing is from the now undeniable
observation that the MAHA movement is getting very restless because they think
RFK Jr. is not doing nearly enough or moving fast enough to eliminate vaccines, 
as you will see.

OK, OK, I know it’s “MAHA attacks” and not “Mars attacks,” but the Martians
remind me of MAHA going after RFK Jr.

MAHA attacks, and reality bends!

It’s been quite a while since I’ve written much about anything Mike Adams has
published, largely because, now that RFK Jr. is in charge of HHS, his rantings
seem almost quaint and pre-pandemic by comparison. However, I do think it’s
worth starting out with the NaturalNews take on what’s happening before
exploring in a (slightly) less snarky manner just what the heck is likely to be 
going on and what it means for federal policy with respect to science-based
medicine and public health. The hilarious thing is that the very conspiracy
theories fueled by MAHA are now coming back to bite RFK Jr. Just look at the
introduction to the post:

The corridors of power at the Department of Health and Human Services are
echoing with a tense and unsettling silence, a forced quiet around the most
pressing medical scandal of our time: COVID-19 vaccine failure and vaccine
injuries. While new leadership under Secretary Robert F. Kennedy Jr. promised a 
revolution against the pharmaceutical machine, a disturbing pattern of internal 
censorship and managed narratives is emerging.

Whistleblowers from within are now revealing that the tough questions about
COVID-19 vaccine injuries, the relentless spread of the toxic spike protein, and
the ongoing harm to children are being deliberately suppressed. Instead of
confronting this public health catastrophe, the agency is being steered toward
trivialities like food dyes and contraceptive labels – a deliberate distraction 
from the genetic weaponry that was unleashed upon the world and its implications
for medical malpractice. Is RFK Jr. being maneuvered into silence? How deep
does the rot go, and who is truly in charge of an agency meant to protect the
people?

One thing that really struck me about this particular antivax narrative is how
much it’s a Bizarro World version of what is actually happening at HHS,
reminding me how every accusation from these conspiracy theorists is a
confession. In reality, RFK Jr. has purged the key advisory committee on
vaccines at the Centers for Disease Control and Prevention (CDC), the Advisory
Committee on Immunization Practices (ACIP), of scientific expertise, firing all 
its members and replacing them with nearly all antivaxxers, thus turning ACIP
into a clown car of incompetence and antivax nonsense; installed “COVID
contrarians” like FDA Commissioner Dr. Marty Makary (who himself is starting to 
find himself at the receiving end of such conspiracy theories, even as the
vultures swirl to reduce his role at the Food and Drug Administration to that of
a figurehead due to his incompetent hands-off and confrontational management
style) and Great Barrington Declaration co-author Dr. Jay Bhattacharya as NIH
Director, whose inexperience and utter lack of qualifications to run such a
large and important institution become more apparent by the day, leading to the 
Lysenko-ization of the NIH; hired long disgraced antivax “researcher” David
Geier, as well as longtime antivax activist Mark Blaxill to “research” vaccine
safety; and fired new CDC Director Dr. Susan Monarez because, as she stated, she
would not just sign off on his vaccine edicts, leading to a mass resignation of
key CDC leadership. It is not the MAHA-aligned staff at NIH, FDA, CDC, and all 
the other agencies at HHS who are being intimidated and living in fear of their 
jobs, thanks to RFK Jr. and the Director of the Office of Management and Budget,
Russell Vought. It’s the career staff who try to apply rigorous scientific,
medical, and clinical standards to their jobs, research, and policy making for
which they are responsible.

But, no, according to the conspiracy theory, it’s really RFK Jr. who has been
“compromised” and his MAHA stans who are supposedly living in fear of “speaking 
the truth” about vaccines, in particular COVID-19 vaccines, with Adams’s writer 
drone claiming that Former MAHA director Gray Delany was fired after “alleging a
culture of fear at HHS that prevents officials from discussing COVID-19 vaccine
harms”; Makary “justified keeping the vaccine emergency use authorization in
place specifically for immunocompromised children”; and, hilariously, that RFK
Jr. is “being ‘sequestered’ and ‘managed’ by his own staff, preventing him from 
receiving crucial information and acting on his stated convictions.” Why?
Because “they” are putting “immense pressure” on RFK Jr. to “maintain the status
quo on mRNA technology” because it’s so important Moderna, Pfizer, and all the 
companies developing the technology for more than just vaccines, but for
vaccines and treatments for cancer. (That must be why, right out of the gate,
the administration ordered the NIH to cancel $500 million in mRNA research
grants.)

Of course, one can’t help but see echoes of excuse making for leaders with a
cult of personality around them (like RFK Jr.) that paints their perceived
failure not as a personal failing but rather as due to underlings keeping them
from knowing the truth about the problems proliferating under their watch and
that, if the leader knew, he would put things to right. Adams’ minion even says 
so:

This paints a picture of a leader who knows he is being manipulated, but feels
powerless to break free. Delany suggested Kennedy is “humiliated” by the
situation and had “no choice” but to comply with the handlers around him. The
mission, therefore, becomes not one of policy, but of liberation: “We need to
somehow figure out how to break Secretary Kennedy free from this chokehold.”

If only RFK Jr. knew…

If only his underlings and the “deep state” weren’t keeping RFK Jr. in the dark…

If only RFK Jr. could “break free”…

Seriously, how does RFK Jr. go, in the minds of antivax conspiracy theorists,
from being so dynamic, powerful, and ready to shake up the status quo to being
so easily manipulated by those around him, by people like Principal Deputy Chief
of Staff/Senior Counselor to the Secretary Stephanie Spear and White House
Chief of Staff Susie Wiles? To me, the hilarious thing about these charges
coming from Delany is that he was the former Director of MAHA
Implementation—yes, that was his real title!—at HHS. Even more hilarious is that
he appears to have been the fall guy for the incompetent rollout of the
announcement regarding the cancellation of mRNA vaccine technology grants, which
had been announced “out of the blue,” catching the White House flat-footed,
leading to embarrassing questions from reporters about how eliminating support
for grants to develop mRNA technology squared with President Trump’s pride in
“Operation Warp Speed” during his first term. There was speculation that the
decision might be reversed, and Delany, MAHA and antivax to the core, did his
best to prevent that and ended up getting fired:

But Hatfill and Delany’s defiance had consequences. The night after Hatfill’s
Bannon interview, in a move that stunned the MAHA faithful, Delany was fired
after 52 days on the job. Spear had “lost confidence” in him.

“They covered up their own incompetence by firing the one guy that tried to pull
something together,” Bannon told me on a call hours after Delany was sacked.
“This has been a debacle.”

Delany and Hatfill declined a request for comment. HHS spokesperson Andrew Nixon
said in an email that Delany “is leaving HHS to contribute to the MAHA-MAGA
movement from outside the official sector.”

I guess he probably wanted to spend more time with his family, too. In any
event, you can see why this narrative is painting Spear as the bogey man (or
woman), because:

According to reporting by Brandy Zadrozny, RFK Jr’s Chief of Staff told Delany
not to go on MAGA shows and discuss the mRNA cancellation. They ignored her and 
went on Steve Bannon’s show, going against what RFK Jr. had originally claimed
and calling mRNA vaccines dangerous, citing a 181-page “evidence” list later
tied to the 2024 book Toxic Shot, which experts widely discredited. And then
Delaney was fired.

Here’s another hilarious thing. Delany is actually not far from correct when he 
accuses RFK Jr. of this:

In a recent and explosive interview, Gray Delany, the now-ousted director of
MAHA implementation, pulled back the curtain on the stifling atmosphere within
HHS. He described a workforce “scared of their own shadow,” operating under a
“self-fulfilling prophecy that you’re just not to bring up the vaccine issue.”
The strategy, he revealed, is to focus on “easy wins first,” like food dyes and 
hormone replacement, while indefinitely sidelining the urgent need to address
the documented dangers of the COVID-19 shots. This calculated diversion away
from mRNA vaccine failures and the widespread societal harms of this genetic
weaponry raises a critical question: who benefits from this silence?

Ah, “Cui bono?” indeed. Again, I call BS on the “workforce scared of their own
shadow,” not because the HHS workforce isn’t very frightened and intimidated,
but because the reason that they feel this way is not, contrary to the antivax
narrative, because they are afraid of speaking out against mRNA-based COVID-19
vaccines thanks to a shadowy cabal of advisors keeping RFK Jr. from knowing “The
Truth” and ruthlessly suppressing “dissent.” It’s because RFK Jr. and his
sycophants, toadies, and lackeys are promoting an environment that makes them
afraid of defending science and speaking out against pseudoscience and bad
science, while Russell Vought is doing his best to fire as many of them as he
can.

Of course, the charge of “going for the easy wins” as a distraction is not far
from the truth. I’ll discuss this more in the final section of this post. I also
find it amusing how outraged MAHA activists like Delany and fellow fired MAHA
official mentioned above, Steve Hatfill, have become, indeed, to the point of
doing interviews attacking Spears and Wiles:

Inside HHS: Featuring Steven Hatfill & Gray Delaney https://t.co/vlkvn9QmX3

— Mary Talley Bowden MD (@MdBreathe) November 12, 2025

The interview starts at approximately the 26 minute mark.

Leading, predictably, to speculations like:

And who is Spears’ handler? Wiles? Yeah.

— ApotheCarol (@KissMyCarol) November 13, 2025

Who, then would be Wiles’ “handler”? Amusingly, Dr. Paul “We Want Them Infected”
Alexander has taken to referring to Susie Wiles as “the Outlaw Josie Susie
Wales” and claiming that she “represents PHARMA’s interests, not that of
American people’s health and well-being.” Meanwhile, MAHA bloggers and
Substackers like Julian Gillespie the “2nd Smartest Guy in the World” are
writing articles about this with titles like MAHA has fallen and MAJOR MAHA
FAIL: RFK Jr. Defends White House Chief of Staff & BigPharma Lobbyist with Ties 
to the PSYOP-19 “Vaccine”, respectively. That second post was in response to RFK
Jr. taking to X, the hellsite formerly known as Twitter, to defend Susie Wiles 
and Stephanie Spear:

And, regarding my long-time friend, @StefanieSpear, Stefanie like many former
Democrats — myself included — drank the Kool-Aid of Trump Derangement Syndrome. 
Like me, she had a come-to-Jesus moment during the 2024 presidential campaign,
when we got to see the campaigns in action…

— Robert F. Kennedy Jr (@RobertKennedyJr) November 14, 2025

Too funny. In reality, RFK Jr. bent the knee to Trump in return for apromise of
a powerful health-related position in the administration,should Trump win, in 
2024. Now he’s referring to his supporters as“chaos agents.”

Predictably, a lot of MAHA stans were having none of it:

pic.twitter.com/VUJzR357Re

— Tony Seruga (@TonySeruga) November 15, 2025

And

Respectfully, the people calling out Susie Wiles are your own supporters, not
chaos agents. It’s insulting that you’d make that comment when many of us are 
rightfully concerned about the lack of progress on critical promises. In fact,
YOU called out the same corruption Susie… https://t.co/pBvBBi13gd

— Lauren Lee (@laurenlee) November 14, 2025

And:

So then by process of elimination it’s Trump and only Trump that is to blame for
the $70B to Albert Bourla & having Bill Gates/Mark Zuckerberg in the WH. Then
endorsing Democrat COVID Criminal Andrew Cuomo & promoting boosters. Massive
betrayals to get a Nobel Peace Prize. Wow!

— Ivan Raiklin (@IvanRaiklin) November 14, 2025

You know, Ivan is not wrong. It is OMB Director Russell Vought,working for
President Trump, who is behind this perceived“betrayal.”

Then I saw that Mike Adams himself had commented:

Disagree. Susie Wiles is best friends with Big Pharma and she was a high-level
executive at Mercury, which had clients among the big food giants that push
processed junk foods. Wiles is gatekeeping Trump and destroying MAHA and MAGA
credibility, in my view. Most of the movement…

— HealthRanger (@HealthRanger) November 14, 2025

I laughed out loud at that last response. When you’ve lost Mike Adams, you’re
hurting. Adams’ comment makes this as good a spot as any to pivot from X to what
MAHA activists on Substack are saying, for instance the self-proclaimed “2nd
Smartest Guy in the World“:

Susie Wiles is a RINO working on behalf of her NWO globopedo handlers against We
the People; she is the antithesis of all things MAHA and MAGA, and yet RFK Jr. 
was forced to publicly defend her.

Poor Bobby. Again, when you’ve lost the “2nd Smartest Guy in the World”…

If only this were really true! I’m guessing that the two women with hammers
poundingaway at the base of the statue are Susie Wiles and Stephanie Spears.
Also amusingto me is that RFK Jr. appears to be portrayed wearing an ancient
Roman toga.

Then there’s Gillespie, who brags about interrupting his break from writing to
compose MAHA has fallen, whichreads like a bad stream-of-consciousness rant and 
is barely comprehensible, but I think you’ll get the idea from this excerpt:

since the start of the year soon after we filed our Citizen Petition evidencing 
grossly excessive DNA contamination, and the FDA’s illegal role in not calling
the Covid vaxxines Gene Therapies, we have been suspicious of those working
alongside Bobby Kennedy Jnr .. particularly Bobby’s Principal Deputy Chief of
Staff, Stephanie Spear

Stephanie is a shadowy figure

.. Stephanie who, it turns out, controls ALL of Bobby’s messaging

.. messaging which to date has been disastrous and ineffective


like Bobby’s messaging on the Covid vaxxines

being effectively, nothing

.. despite the global evidence he knows about

and which has been presented to him

like our Citizen Petition


adding to the squeeze and gagging of Bobby are the efforts of Susie Wiles,
Trump’s Chief of Staff, who has been working overtime to preserve the illusion
of Operation Warp Speed having been a great achievment, of The Donald


when we all know OWS ushered in the genetic poisoning of a global population

.. with manifold vaxxine induced injuries and diseases

too many to name here

alongside millions of deaths


.. well, we all know these things, unfortunately

but what everybody now needs to know and hear about from those who were – until 
recently – within the inner circle of the MAHA administration, who were meant to
be working to help Bobby achieve everything he said he would, is how Bobby has 
been gagged, compromised, and rendered ineffective .. castrated


Bobby has been shut up

.. and MAHA does appear to have been taken over

by

Big Pharma


.. thus why the legal evidence we presented in our Citizen Petition is not
receiving the attention is should have, as soon as Bobby was sworn in as
Secretary of HHS


in circumstances where we received confirmation Bobby read the thing personally

and some of his advisors thanked us for getting the thing properly filed

so Bobby could use it as a legal basis for suspending the products


.. but .. to date .. nothing

Seriously, man. Get an editor. Also, you are not E.E. Cummings. Your lack of
capitalization and your rambling writing style are not artsy, clever, or even
stylistically interesting. They just come across as unhinged.

You get the idea, though. RFK Jr.’s antivax followers are very unhappy, based on
their perception of how little has been done thus far to get rid of mRNA-based 
vaccines, and they are expressing that unhappiness.

RFK Jr. and his high wire act

That RFK Jr. felt obliged to respond publicly to defend Spear and Wiles against 
the attacks coming from the hard antivax wing of MAHA over his handling thus far
of mRNA vaccines tells me that the discontent in the ranks of MAHA is starting 
to become a problem for him. Indeed, some mainstream media outlets are starting 
to notice, although I’m surprised at how few. One mainstream outlet that’s
published an article on the discontent in the MAHA ranks over Spear and Wiles’
supposed influence over RFK Jr. is POLITICO, which last week published an
article RFK Jr. calls for unity after supporters attack Trump aides, The story
doesn’t add much to what I’ve been describing, as it’s basically just a
superficial recounting the kerfuffle starting with RFK Jr.’s defense of Spear
and Wiles and the reactions to that defense without going into any depth.
There’s also an article in the right wing newspaper The Washington Examiner
entitled RFK Jr. defends Susie Wiles from attacks by MAHA base. Unfortunately,
it’s behind a paywall

Interestingly, the crank outlet TrialSiteNews (TSN) appears to describe what is 
really going on here, defending RFK Jr. in an article entitled MAHA in the
Crossfire: RFK Jr., Trump Aides, and the Battle for Narrative Control. After
noting that TSN has “challenged hit pieces on Ms. Spear, finding them
distractions from the true levers of power in the national health system” and “a
coalition built on challenging entrenched health orthodoxy is now grappling
with mistrust, factionalism, and ideological purity tests,” TSN observes:

A dismissed HHS advisor as TSN reported, Dr. Steven Hatfill, emerges as a
central figure. In an interview amplified by MAHA activists, Hatfill accused
Wiles and others of siding with “Big Pharma” to derail Kennedy’s agenda. This
claim is speculative; the only verifiable fact is Wiles’ past association with
Mercury, a lobbying firm whose client list includes Pfizer. Whether that
constitutes an ideological conflict is interpretation, not evidence.

HHS officials counter that Hatfill was terminated for overstating his authority.
Hatfill says he was punished for pushing MAHA reforms. This is a classic
bureaucratic clash—neither narrative is fully substantiated.

This is likely what is going on, at least with Hatfield. He was fired recently, 
and now he’s trying to get back at the person whom he views as having been
behind his firing. Hatfield has a rather interesting history, as he was long
under suspicion as the person responsible for the anthrax scare after 9/11. Last
month, I listened to a two-part episode on the Behind the Bastards podcast
about Hatfield, a former US Army Medical Research Institute of Infectious
Diseases (USAMRIID) researcher, who was accused of sending envelopes containing 
anthrax spores to a number of people in the wake of 9/11. Unfortunately for him,
the FBI investigated him for years even though there was little evidence and it
was becoming increasingly clear that he was the wrong man. True, Hatfield was
exonerated after nearly seven years, but his life was almost ruined. It’s just
interesting backstory, but it could partially explain why Hatfield is so hostile
to government science agencies. As for Delany, as I have mentioned above, his
firing seems to be due to his having gone against instructions regarding how the
Trump administration and RFK Jr. wanted the messaging about the canceled mRNA
contracts to be done.

TSN concludes:

MAHA’s internal cohesion is under pressure, and Kennedy is trying to keep a
fractious coalition intact. Politico’s framing leans toward portraying MAHA as
chaotic—a mainstream media tendency when covering outsider movements. At the
same time, a subset of MAHA enthusiasts amplify rumor, guilt-by-association
logic, and intra-movement suspicion.

Well, yes and no. It’s more than just a subset of “MAHA enthusiasts” who are
unhappy. The reason, of course, is because MAHA was born out of the antivaccine 
movement. I noted the internal tension in MAHA from the very beginning. For
example, when RFK Jr. first published his “MAHA manifesto” before the 2024
election, I noted one huge and glaring omission: Vaccines, which were not
mentioned even once in his WSJ MAHA declaration. Here was a man who had spent
the last 20 years as the nation’s most famous antivax activist writing a
manifesto about how to “make America healthy again,” but there was no mention of
vaccines in it—not a single one. Right then and there, I knew what RFK Jr. was 
up to. He was going to do exactly what critics cited above accused him of. He
was going to downplay his antivax conspiracy mongering in order to focus on
things that he could potentially sell, such as improving diet and exercise and
working on environmental toxins as a means of decreasing the prevalence of
chronic diseases, which became the total emphasis.

No one was fooled, least of all I. Even before the 2024 election, I wrote about 
how antivaxxers could easily see through the misdirection of MAHA. Some were
willing to go along with it as a pragmatic matter, trusting RFK Jr. to do what
they hoped. Others most definitely were not. One of those who was most
definitely not happy was actually Dr. Alexander, who wrote on his Substack, MAHA
(MAKE AMERICA HEALTHY AGAIN) is misdirection; McCullough is 100% correct! I am 
calling on Bobby Kennedy Jr. to FOCUS on failed OWS & Malone Bourla etc. mRNA
vaccine! MAHA is distraction, Sasha is CORRECT, see her last piece I promoted,
this MAHA sidelines the deadliness of OWS & Malone Bourla Bancel et al. mRNA
vaccine, come on Bobby Jr., I know Malone is cupping balls for a job but. (Yes, 
I do intentionally include the full headline and subtitle just to show you a bit
of Alexander’s “style,” such as it is. Classy guy, right?) In his Substack
Alexander cited—surprise! surprise!—Shannon Joy, referring to an interview
between her and Dr. Peter McCullough, antivaxxer and spokesperson for a COVID-19
antivax grift The Wellness Company, with the title Exclusive With Dr. Peter
McCullough: ‘The MAHA Movement’s Focus On FOOD Is A Dangerous Distraction’ From 
The REAL Cause Of Death & Disease, COVID Shots & CDC Recommended Vaccines!

I’m just going to quote Joy and McCullough again, first Joy:

On day one, Dr. McCullough, when RFK Jr. made his speech suspending his
campaign, I came on my show and I said, there are some very glaring omissions
here in this speech. And most importantly, COVID-19 lockdowns, the kill
protocols, Operation Warp Speed, the COVID-19 vaccines and the childhood vaccine
schedule, the mandated. And none of that is all food and pharma, food and
pharma.

Well, fast forward to MAHA and it seems as if it’s just getting worse and worse 
and worse. We’re seeing a complete omission of discussion on that, at least from
my perspective. And then there’s this whole new crap of characters.

McCullough, unsurprisingly, agreed with Joy:

We’re being poisoned. Somebody is poisoning us. So we look around us and we see 
people sick with myocarditis, or neuropathy, or blood clots.

Maybe we would think, no, it’s not the vaccine. We’re being poisoned with
something. When I first heard this, I said, oh my Lord, this is the biggest
deflection, misdirection campaign I’ve ever heard of.

And I was shocked it was coming from Robert F. Kennedy. And whether it’s
intentional or whether it’s just a byproduct of this new concern, it’s taking
eyes off of this COVID-19 vaccine debacle and then kind of deeper concerns about
the accelerating COVID-19 vaccines being added to the routine child’s schedule 
and the accelerating childhood schedule.

This tension between antivaxxers who want all vaccines, particularly COVID-19
vaccines, gone now and the more pragmatic elements of MAHA, who want to sell the
public on dubious diet and exercise interventions for chronic disease as a
gateway to becoming antivaccine, has been there at the very formation of MAHA as
movement. This tension continued. In January, less than a week before Donald
Trump was going to be inaugurated as President, antivaxxers were publishing
Substacks wondering if RFK Jr. would “betray us” and bemoaning reports about RFK
Jr.’s longtime collaborator, attorney Aaron Siri, being removed from the Trump 
transition team. Another antivaxxer named Sasha Latypova expressed her
unhappiness thusly:

Ok, I am just the messenger here… You can see the shitshow for yourself. The
cabal is pushing the “healthy food and exercise” and “vaccines are a political
loser” message. Which is what Trump himself voiced on several occasions.

In January, though, it was not Stephanie Spear and Susie Wiles who were the bad 
guys not letting RFK Jr. be RFK Jr. and not letting him fly his full antivax
freak flag high. Rather, it was Casey and Calley Means. Actually, Trump was not 
wrong about that. Despite all the inroads made by antivaxxers since the
pandemic, being antivax is still a political loser, at least for now. Even RFK
Jr. seems to recognize this, which is likely why he’s treading slowly. The
problem is, of course, that he’s been in charge of HHS for nine months now. His 
antivax followers are becoming more and more impatient. Indeed, one
manifestation of this impatience was on display earlier this month in the form
of a conference held in Texas and organized by the antivax organization founded 
by RFK Jr., Children’s Health Defense. There, RFK Jr.’s allies did let their
antivax freak flag fly high, starting with a man familiar to regular readers of 
SBM:

Health Secretary Robert F. Kennedy Jr. likes to say that he is not anti-vaccine,
he is “pro-safety.” But when 1,000 of his supporters gathered in Austin, Texas,
last weekend for a celebratory conference to chart the future of their
movement, they embraced a term — “anti-vax” — some once regarded as a slur.

“God is an anti-vaxxer, and he needs you to speak up,” declared Del Bigtree, a
close ally of Mr. Kennedy who served as his communications director during his
presidential campaign. Mr. Bigtree spoke during a session that looked back on
his 2016 documentary asserting that there was a cover-up of a link between
vaccines and autism.

That 2016 film was a propaganda pseudodocumentary disguised as a documentary,
VAXXED, which rehashed the 2014 CDC whistleblower conspiracy theory, which
falsely claimed that the CDC had “covered up” results of a 2004 study supposedly
showing an increased risk of autism in African-American boys vaccinated with
the MMR. Del Bigtree produced the film, with which the godfather of the 21st
century iteration of the antivax movement, Andrew Wakefield, made his directing 
review. (Wakefield was at the conference.)

As has happened over the last decade or so, what was once fringe is mainstream, 
and now, with RFK Jr. in charge of HHS, his old org is no longer antivax enough,
at least not according to the man who leads the MAHA Institute:

“I’ve come to this anti-vax conference with a message that we need to be more
boldly anti-vax,” said Mark Gorton, the president of the MAHA Institute, a group
that works to advance Mr. Kennedy’s “Make America Healthy Again” agenda. Mr.
Gorton assailed the website of Mr. Kennedy’s former nonprofit as “some pretty
weak anti-vaxxery.”

Children’s Health Defense, “some pretty weak antivaxxery”? I laughed out loud
reading that. CHD is and has been about as antivax as it gets. I found it very
telling that someone like Gorton would have the cojones say something like this 
about CHD at a MAHA conference, that was organized by CHD. It suggests to me
that CHD is the past and that more radical antivax groups are the present and
the future, which is profoundly depressing to think about. Indeed, just this
morning, The Atlantic published an article by Tom Barker entitled RFK Jr.’s
Cheer Squad Is Getting Restless, which is basically true. However, I was puzzled
that there was no mention of Bigtree’s boast about God being an antivaxxer or
of Gorton criticizing CHD for being “some pretty weak anti-vaxxery,” although
the reporter did mention that during an interview with Russell Brand, Brand
called him a Nazi.

Moving on, though, some antivaxxers do understand the strategy:

Kennedy’s Make America Healthy Again agenda, which has targeted ultraprocessed
food and chemicals along with vaccine safety, is both bold and strategic because
it offers something to both progressives and conservatives, said Bigtree.

“It’s very intelligent to start with food and moving chemical petroleum dyes out
of our food supply, getting lead and arsenic out of baby food, saying that you 
care about doing studies for safety,” Bigtree told POLITICO at the event. “All
of those things, I think, are making people realize on the liberal side, ‘This
isn’t the person that I expected. Oh, he’s not eradicating the vaccine program. 
He just wants safety testing.’”

Moving public opinion is key, he and others said, and in that sense sowing doubt
among Americans about the safety of vaccines is an accomplishment on its own.

That is, of course, what RFK Jr.’s game is really about: Use fear mongering
about food dyes, advocacy of diet as the cure-all for chronic disease, and
pushing more “natural” medicine as a gateway to antivax views. He knows as well 
as anyone else that alternative medicine is often a gateway to becoming
antivaccine, because doubt about anything portrayed as “unnatural” (as vaccines 
often are) can lead to doubts about vaccines. There’s a good reason why the vast
majority of naturopaths and chiropractors are antivax. Indeed, the emboldening 
of people like Del Bigtree, who after years of claiming to be “not antivaccine” 
but “pro-safety are now willing to openly proclaim that they are antivaccine to 
the point of saying that “God is an antivaxxer,” tells me that the strategy is
working. Ten years ago—or even a couple of years ago—you almost never saw
antivaxxers admitting, much less proclaiming proudly, that they are antivaccine.
Now you do.

So, has MAHA fallen? Sadly, it clearly has not—at least not yet—but RFK Jr. is
walking quite the dangerous tightrope. If he is too radically antivax and moves 
too fast to eliminate vaccines, he risks a backlash that might make him toxic
enough to President Trump to do something about him. Indeed, we saw some of that
a few months ago, when confusing and vague recommendations with respect to who 
should receive COVID-19 boosters led to widespread discontent among people who
wanted the boosters but either had a hard time finding them or could not get
their insurance to pay for them. On the other hand, if RFK Jr. is not antivax
enough, doesn’t move fast enough, and doesn’t get rid of the vaccines most hated
by antivaxxers (mRNA-based COVID-19 vaccines) soon, he risks alienating his
base, something that I perceive to be already happening. The attacks on Spear
and Wiles and outright antivax declarations like that of Del Bigtree represent
manifestations of that incipient alienation, as well as pressure from his base
to move faster to address their demands to get rid of vaccines.

I wish I could say that I know which way things will go, whether RFK Jr. will
manage his high wire act or fall to his (political) doom, but I don’t. One thing
that I do know is that the vast majority of his followers will stick with him
in the short term because of his two decade history of fighting for what they
believe in, the elimination of all, or nearly all, vaccines.


Every accusation is a confession (or a statement of intent): MAHA’s new Tuskegee
experiment

HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar
grant to researchers to carry out an unethical and scientifically unjustified
randomized clinical trial of the birth dose of the hepatitis B vaccine in
Guinea-Bissau. With MAHA, it’s Tuskegee all over again.

David Gorski on December 22, 2025

Link


When I read Steve Novella’s end-of-year post this Wednesday, one thing he wrote 
hit me a bit hard, although you might think that it’s for an odd reason.
Specifically, when he stated that he “honestly had to make a concerted effort to
avoid writing about RFK Jr., Dr. Makary, Vinay Prasad, and Jay Bhattacharya (my
colleagues here have it covered pretty well), in order to have some balance
here and continue to tackle some of the more classic topics at SBM” and that
“every week there is some outrage that deserves discussion on SBM,” it was like 
a slap in the face reminding me how tired and worn down I have become, thanks to
writing every week one of Steve’s aforementioned outrages of the week from this
administration attacking science-based medicine. Most of these attacks on
science-based medicine, public health, and biomedical research have been, of
course, orchestrated by longtime antivax activist turned Secretary of Health and
Human Services Robert F. Kennedy, Jr. Specifically, Steve reminded me that it’s
been such a long time since I myself have had a chance to write about one of
the more “classic topics at SBM,” so consumed have I been with the “Make America
Healthy Again” (MAHA) outrage of the week (or day). Indeed, it’s so bad that,
as the weekend approached, I looked for topics not related to this
administration, vaccines, or biomedical health policy, but I couldn’t. Then, as 
I started seriously thinking about today’s post for SBM, I couldn’t make up my
mind which outrage to write about this week. (There were at least three serious 
contenders.) ThenI learned about an incident that led me to throw out any hope
of writing about a “classic SBM topic,” at least this week. Specifically, RFK
Jr. appears to have quietly funneled $1.6 million of CDC funds to support an
unethical randomized controlled trial in Africa that reminded me of a modern
equivalent of the Tuskegee syphilis experiment.

The Tuskegee syphilis study, as many might recall, was an infamous experiment
carried out on conducted between 1932 and 1972 by the US Public Health Service
and the CDC on a group of nearly 400 African-American men with syphilis,
comparing them to a control group without syphilis, the goal being to study the 
effects of untreated syphilis. Although effective treatments for syphilis had
been developed in the 1920s, and an even more effective drug, penicillin, had
become widely available to treat the disease by 1947, the experiment continued. 
The Black men in the group with syphilis were not informed of existing
treatments, which were withheld from them. Moreover, the original experiment had
been designed to last only six months, which would have been ethically very
suspect but somewhat less horrifically unethical, but instead it continued for
40 years, ending only when a leak to the press led to its termination. By 1972, 
28 patients had died due to syphilis itself, while 100 had died from
complications related to the disease. In addition, 40 of the patients’ wives
were infected with syphilis, and 19 children were born with congenital syphilis.

So obviously and horrifically racist and unethical was this study that exposure 
of the Tuskegee syphilis study in the press ultimately led to the Belmont Report
in 1979, which became, after the Nuremberg Code in 1947, a foundational
document regulating medical ethics of HHS-funded human subjects research. Since 
then, ethical standards have tightened even more with the World Medical
Association Declaration of Helsinki, which is updated every few years. The
Tuskegee study is one reason among many—but a big reason—why there are now
extensive HHS regulations governing human subjects research codified under the
Common Rule (45 CFR 46) and requiring, among other things, informed consent,
voluntariness, approval and oversight by an ethics committee known as the
institutional review board, and protection of vulnerable populations from
exploitation, such as children and prisoners. With that background, in this post
I will attempt to show you why this study is unethical, not justified based on 
the science, and reeks of cronyism.

I’m not the only one to compare this $1.6 million award to the Tuskegee syphilis
study; Derek Beres of Conspirituality beat me to it. However, given how dubious
and unethical this funded study is, I don’t consider the comparison to be too
overblown. Let’s start by looking at the announcement of this award in the CDC
register and gleaning what we can about the study itself. I’ll then briefly
discuss the history of the antivax movement’s invocation of the Tuskegee study, 
to turn this around and demonstrate why this award reeks of a modern day
resurrection of Tuskegee, complete with additional corruption and cronyism.

A mysterious announcement appears

Last Thursday, an announcement from the CDC appeared in the Federal Register
entitled Notice of Award of a Single Source Unsolicited Grant To Fund University
of Southern Denmark (SDU). Fortunately, a number of researchers took notice, as
did some reporters, all of whom saw a number of red flags, to the point where
various news outlets started investigating. First, let’s look at what is so
concerning.

From Science:

Public health scientists are raising concerns following news of a $1.6 million
award from the U.S. Centers for Disease Control and Prevention (CDC) for a trial
of hepatitis B vaccines in newborn babies in the West African nation of
Guinea-Bissau. The funding is for an unsolicited proposal from a group in
Denmark whose work has emphasized the potential dangers of vaccination and has
frequently been criticized. Some researchers say the study raises ethical issues
and is unlikely to offer scientific insights into a vaccine already known to be
efficacious and safe.

The agency’s award comes on the heels of its controversial decision on Monday to
revoke a longtime recommendation that all U.S. newborns get their first dose of
the vaccine at birth. A CDC notice published today states that the 5-year study
will investigate “the optimal timing and delivery” of hepatitis B vaccines, and
collect data on “early-life mortality, morbidity, and long-term developmental
outcomes.”

I discussed the ACIP decision to drop the routine universal recommendation for a
birth dose of hepatitis B vaccine and why it’s so unjustified. However,
antivaxxers were going to do what antivaxxers do. Also, the hepatitis B vaccine 
has long been a bête noire of the antivax movement, and this study suggests that
MAHA is far from done with attacking the vaccine. Let’s shift now to what the
CDC notice says about the study:

The Centers for Disease Control and Prevention (CDC), located within the
Department of Health and Human Services (HHS), announces the award of
approximately $1,600,000 over a five-year period, in response to an unsolicited 
proposal that has been submitted by University of Southern Denmark (SDU). The
award will support a comparable study of the optimal timing and delivery of
monovalent Hepatitis B vaccinations on newborns in Guinea-Bissau. Activities
will include conducting a randomized controlled trial to assess the effects of
neonatal Hepatitis B vaccination on early-life mortality, morbidity, and
long-term developmental outcomes. The award is in response to an unsolicited
proposal.

I realize that the details are sketchy, and not much more information is
provided in the rest of the notice. Let’s just say that I would really, really
like to see the detailed research proposal and, most importantly, the protocol
for the randomized clinical trial itself. I’d also like to see the budget,
because, as you will see below, $1.6 million strikes me as grossly insufficient 
to run a study of the type proposed over five years. In any event, the
information provided is more than enough to raise serious alarm bells regarding 
the science and ethics of the proposed study that Science reported:

The proposed work being funded will support a single-blind, multi-center, phase 
IV randomized controlled trial enrolling over 14,000 neonates in Guinea-Bissau
to evaluate the impact of neonatal monovalent Hepatitis B vaccination (HBV0) on 
all-cause mortality, severe morbidity, and long-term developmental outcomes. The
study will also assess potential sex-differential effects of the vaccine. While
the World Health Organization (WHO) recommends three vaccines at birth in
low-income settings—Bacille Calmette Guérin (BCG), oral polio vaccine (OPV0),
and HBV0—there is limited evidence on the broader health effects of HBV0. This
study aims to fill that gap by rigorously evaluating the overall health impact
of HBV0 in early life.

At this point, readers who are not familiar with the issues of “nonspecific
effects” of vaccines might be scratching their heads, wondering what the heck
this study is proposing and perhaps even what is wrong with this study from an
ethical and scientific standpoint. I know that when I first read this
description, one thing stood out, from a strictly scientific standpoint: Nowhere
do I see among the primary outcomes to be tracked one that any vaccinologist
would consider to be the most important, namely the incidence of hepatitis B in 
infants receiving the birth dose versus those receiving the current dose at six 
weeks of age, you know, the disease that the vaccine is designed to prevent. Nor
do I find among any of the outcomes another critical outcome, namely the
incidence of chronic hepatitis B, which is the form of the infection that
produces an enormously elevated risk of liver failure and liver cancer during an
individual’s lifetime. Of course, by design, a five year study is far too short
to quantify beneficial effects of the birth dose of hepatitis B vaccination on 
long-term outcomes, which suggests to me that this study is clearly intended to 
generate data showing adverse health outcomes associated with the birth dose.
(This ain’t my first rodeo.)

But back to nonspecific effects of vaccines. It didn’t take long after the CDC
announcement hit the federal register for scientists, physicians, health
communicators, and reporters to figure out upon whom this CDC largesse will be
showered. Indeed, as soon as I learned of this news, I—and, to be fair, many who
follow vaccine-related issues—immediately guessed immediately who the
investigators most likely were. We were correct (ot that it was any great
insight to be correct), and soon news reports confirmed that the investigators
receiving this grant are Christine Stabell Benn and her husband, Peter Aaby, who
together lead the Bandim Health Project, a research site located in
Guinea-Bissau in West Africa.

Unsurprisingly as well, as has been reported in articles on various news and
commentary websites, there are ties between one of the investigators and FDA
officials that produce an acrid stench of cronyism. Specifically, Stabell Benn
is buds with Dr. Tracy Beth Høeg, who before the pandemic was a sports medicine 
physician with no experience in vaccinology but during the pandemic became a
prominent influencer by promoting COVID-19 contrarianism and anti-COVID vaccine 
misinformation. She is now a top advisor to FDA Commissioner Dr. Marty Makary
and acting director of the Center for Drug Evaluation and Research (CDER), the
FDA center in charge of approving all non-biologics drugs. Never mind that she
is utterly unqualified for this position, having never herself designed or run a
randomized controlled clinical trial of the sort required by the FDA to approve
a drug and being utterly lacking in relevant experience in drug regulation to
be the chief scientist in charge of drug approval and regulation.

STAT News describes this relationship between Stabell Ben and Høeg:

The two have co-hosted a podcast together called “Vaccine Curious” where they
compare vaccine policies in the U.S. and Denmark. Høeg is also the FDA’s
representative on the CDC’s ACIP panel, where she recently pushed for the U.S.
to reduce the number of vaccines it gives newborns.

Stabell Benn told STAT in April that she would like regulators to raise the bar 
on vaccines. She suggested asking companies to prove not only that their
products introduce antibodies or reduce the risk of the target illness, but that
they improve overall health.

“There is a misunderstood fear that if we start digging down and scrutinizing
vaccine effects on overall health, then we might reveal something that could
shatter confidence,” Stabell Benn said. “But it’s really not the way to deal
with uncertainty. To say that if we are so afraid of what we are finding, we
will just not study it. I can’t see any excuse.”

I find myself drifting back to the early 1980s to respond, “Gag me with a
spoon!” Seriously, this is the same schtick that every antivax-leaning
investigator invokes whenever they are criticized for promoting scientifically
unsupported speculations about harms from vaccines. That’s when they like to
quote Colonel Nathan Jessup (played by Jack Nicholson) in A Few Good Men: “You
can’t handle the truth!”

Seriously. We can handle the truth. It is, after all, scientists who study
vaccines who discover real potential adverse reactions due to them. What
irritates us are misinformation, disinformation, pseudoscience, and lies being
sold as “The Truth.”

This relationship also helps explain why it’s been reported that the topic of an
HHS press conference planned and canceled by RFK Jr. last Friday was to be to
announce that the US would be moving to a vaccine schedule much more like that
of Denmark, which vaccinates against far fewer diseases. This is not entirely a 
surprise to me given that two weeks ago I discussed how much current antivax
leadership at CDC and FDA fetishizes the Danish schedule as “best practices,”
while ignoring all the other things that Denmark does with respect to health,
most importantly its government-funded program of universal health insurance.
It’s a tendency that Angela Rasmussen pithily referred to as the the “vaccine
disinformation to descheduling pipeline,” adding, “Make America Denmark never.”

It is, however, a surprise that RFK Jr. moved that fast to implement such a
program. Indeed, there are a number of very good scientific and public health
reasons why the US vaccination schedule should not mirror Denmark’s,
particularly for hepatitis B vaccination. For example, Denmark has different
burdens of various vaccine-preventable diseases, and, importantly, Denmark has
universal health insurance and the US does not. As I’ve written before, there is
no “one size fits all” childhood vaccination schedule, and the vaccination
schedules of most countries, despite being different, are indeed science- and
evidence-based, because what is needed in each country is context-, population-,
and region-specific. Unfortunately, RFK Jr. and MAHA labor under the delusion
that there is just one best science- and evidence-based vaccine schedule,
and—surprise!—they always pick industrialized countries with the fewest vaccines
on their schedule (such as Denmark) as the “ideal” schedule. Fortunately, the
press conference has been postponed until January. Unfortunately, I’m sure that 
I’ll be writing about it in 2026.

But back to the study, such as it is, even given how little we know about it.

To give you an idea of Aaby and Stabell Benn’s dedication to scientific rigor,
let me just quote a bit more from the STAT News article, but first let me
provide context. Aaby’s desire to study nonspecific effects of vaccines seems to
have come out of a reasonable experience, as reported in Mother Jones.
Specifically, while studying malnutrition in Guinea-Bissau in 1979 during a
measles outbreak with horrific mortality, Aaby noticed that vaccinated children 
didn’t die from measles, which was unsurprising, but also had a lower all-cause 
mortality from any disease, which was surprising, especially the magnitude, a
three-fold decrease. This was actually one observation where Aaby’s work might
actually have been a legitimate contribution, as decades later it was discovered
that the measles virus can cause immune amnesia for up to three years after
infection, leading to an increased risk of infection and death from other
pathogens. Prevent measles, and you prevent that immune amnesia. Truly, the
measles vaccine does appear to protect against more than the measles.

Unfortunately, the discovery of immune amnesia from measles might have just been
Aaby getting lucky, as methodology of his later studies with his wife, some of 
which found negative nonspecific effects from vaccines, has been questionable.
For example, in 2017, Aaby and Stabell Ben published an observational study
using data from Guinea-Bissau during the 1980s that has been widely cited by
antivaxxers ever since, including RFK Jr. In brief, it was a “natural
experiment” in which they followed children after the DTP vaccine was introduced
to an urban area, reporting that receiving the DTP vaccine was “associated with
a mortality hazard ratio (HR) of 5.00 (95% CI 1.53-16.3) compared with
not-yet-DTP-vaccinated children.” I won’t deconstruct this study in detail,
because friend of the blog Skeptical Raptor took care of that at the time, as
did I. Let’s just say that it’s not a good study.

Now, look at what STAT News reports:

Kennedy has repeatedly cited their research in interviews, particularly an
observational study showing an increase in mortality among children who received
the DTP vaccine, which prevents diphtheria, tetanus, and whooping cough.

The couple has come under fire in the Danish press for failing to publish the
results of a separate randomized controlled trial they ran on the DTP vaccine in
2011, while touting the results of the observational study. Fellow Danish
researchers have expressed skepticism of the Bandim Health Project’s methods and
conclusions, according to articles from Weekendavidsen.

Where’s the RCT? Why doesn’t RFK Jr. want to see the results of the RCT? Could
it be because the RCT doesn’t show what the observational study using 40+ year
old data showed? I mean, just look at their excuse:

The couple told Weekendavidsen that they never published the results of the
randomized trial due to a Ph.D. student’s pregnancy and the death of her field
supervisor. The student “didn’t have time for long-term follow-up, and we didn’t
have new resources to continue,” they said.

When life happens, as in a key personnel becoming pregnant, generally the
principal investigator takes over until a replacement can be found—or just takes
over indefinitely. Let’s just say that the couple’s excuse sounds a lot like,
“The dog ate my paper.”

Worse, as Liz Szabo reported in CIDRAP:

In June, Kennedy used a single study by the Bandim group to justify canceling
more than $1 billion in funding for childhood vaccinations in developing
countries. The observational study found an increased risk of death in children 
who received a combined vaccine for diphtheria, tetanus and pertussis (DPT) that
hasn’t been used in the United States in three decades.

And, of course:

Yet Children’s Health Defense, the anti-vaccine organization Kennedy founded,
cites the Danish group’s research on multiple pages of its website. One article 
praises the Bandim Health’s founder, Danish anthropologist Peter Aaby, casting
him as a martyr who lost his funding when he suggested vaccines cause more harm 
than good.

Because of course he did.

I note that the person writing the article cited was none other than J.B.
Handley, founder of Generation Rescue, the antivax group that later persuaded
Jenny McCarthy to be its figurehead president back in the day. (I also note that
I deconstructed the misinformation in this very article back in the day.) Did I
also forget to mention that Peter Aaby isn’t even a vaccinologist, infectious
disease specialist, epidemiologist, or any specialty with training in running
clinical research? I have nothing against anthropologists; I find anthropology
fascinating and very difficult, given the limitations of applying scientific
methodology to the topics studied. It’s just that anthropologists are not one of
my go-to professions for carrying out studies on vaccine efficacy and adverse
events. Stabell Benn is, of course, a physician, but she seems to have drunk the
Kool-Aid with respect to claims that a number of vaccines having nonspecific
effects that are more harmful than their beneficial effects. Let’s just put it
this way. There’s a reason why antivaxxers love her and her husband. (Granted,
they don’t like their work showing that MMR has beneficial nonspecific effects, 
but they somehow ignore that part of the couple’s oeuvre.)

Indeed, Aaby and Stabell Benn’s studies have been widely criticized for their
poor methodology. A recent commentary and reanalysis of clinical trials
published earlier this month in Vaccine by Henrik Støvring et al in response to 
an article by Stabell Benn arguing that the evidence for adverse nonspecific
effects of vaccines is now so compelling that we should significantly change how
vaccines are approved and their safety monitored:

We have reached a point in time when we must rewrite our understanding of
vaccines. It is no longer tenable to maintain a narrow perspective on vaccines
as biological preparations that induce specific protection against a specific
disease. NSEs make life more complicated for both policy makers and regulators. 
However, the reward is the auspicious prospect of wiser vaccination programs
designed to protect against specific diseases and provide general immune
training with even bigger benefits than in current programs.

Let’s just say that Støvring et al were…less than impressed:

However, just as the commentary appeared in Vaccine, a series of Danish news
articles scrutinized the research practices of Drs Benn and Aaby. As external
experts in statistics and research methodology, we were asked to contribute
independent assessments of their conclusions from their own randomized
controlled trials. We were surprised to find several instances of questionable
research practices, such as unpublished primary outcomes, outcome switching,
reinterpretation of trials based on statistically fragile subgroup analyses, and
frequent promotion of cherry-picked secondary findings as causal, even when
primary outcomes yielded null results. Sample size calculations appeared to be
driven by unwarranted optimism regarding effect-sizes and event rates leading to
underpowered studies.

The commentary focused on results from randomized trials (RCTs) to motivate
policy changes. Yet, RCTs are only as good as the extent to which their analysis
and reporting practices can be trusted. As the risk of false positives
increases with the number of examined hypotheses, any findings from secondary,
presumably exploratory, analyses should be viewed with caution, when primary
outcomes fail to achieve statistical significance. Adjustment for multiple
comparisons then becomes essential to make meaningful inferences beyond the
primary endpoint.

In other words, Støvring et al found evidence that Aaby and Stabell Benn had
cherry picked secondary and subgroup outcomes in papers for which the results in
the primary outcome were negative, which is a no-no. Such results can be
hypothesis-generating, but, unless prespecified in the protocol and statistical 
analysis, should not be inferred as causation. In many of their papers, they
also apparently failed to do a basically statistical correction, namely to
correct for multiple comparisons. As Støvring et al note:

Strong scientific claims based on flexible reporting of secondary hypotheses can
be highly misleading [32]. When researchers explore data post hoc—after seeing 
the results—they may be tempted to highlight apparently interesting patterns or 
associations based on statistically significant findings. However, without
proper correction for the number of tests performed, these are at high risk of
being randomly occurring false positives. While explorative findings are
essential for generating new hypotheses, they become problematic when presented 
as if confirmatory.

It should be emphasized here that Guinea-Bissau is a poor nation in Africa with 
a very high childhood mortality rate, as well as a high level of hepatitis B
infection. As reported in multiple outlets, it is a country in which the
prevalence of hepatitis B infection approaches 20%. Moreover, given the poverty 
of the country, maternal testing for hepatitis B infection is sporadic, at best.
In other words, Guinea-Bissau is exactly the sort of country where the birth
dose of hepatitis B vaccine would be expected to do the most good. Now here’s
the wrinkle. As reported in STAT News and elsewhere, Guinea-Bissau plans to
implement the birth dose of hepatitis B vaccine in 2027, which is the
recommendation of the World Health Organization, changing its recommendation
from its current guidelines recommending vaccination at 6 weeks. In other words,
time’s running out for antivaxxers to do such a study in an underserved
impoverished population. They had to strike while they still could, while the
recommendation in the country still allows it.

I know what some out there might be thinking: What’s the big deal? The current
recommendation for childhood vaccination with hepatitis B in Guinea-Bissau is to
administer a dose at age 6 weeks. Could six weeks make that big a difference?
Why is this study so unethical? There are a number of reasons. First, there is
no strong scientific justification for the study, no preliminary data to lead
one to suspect that there are nonspecific effects, positive or negative,
associated with the birth dose of hepatitis B vaccination, as described by
Szabo:

Multiple researchers who spoke to CIDRAP News questioned the need for another
study of hepatitis B vaccines, which have been proven safe and effective in more
than 400 studies over 40 years.

“The data that supports the safety advocacy of the current hepatitis B vaccines 
is very robust,” said Amesh A. Adalja, MD, a senior scholar at the Johns Hopkins
Center for Health Security.

“Given the stance of the CDC under RFK Jr’s control, one can assume that the
results of this study will be preordained to be against the hepatitis B
vaccines,” Adalja said. “Continuing to do studies on a question that is already 
been answered sufficiently is a waste of resources that could better be used
answering new questions.”

Precisely. As much as RFK Jr. claims to be supporting “gold standard science,”
it’s not gold standard science to keep restudying an issue that has such a huge 
evidence base supporting one conclusion. It’s trying to generate an outlier
study to justify what you want to do anyway. Worse, this award was granted
through a completely opaque process in which Stabell Benn, a crony of Tracy Beth
Høeg and someone who likes RFK Jr, sent the CDC an unsolicited research
proposal, which was granted without any evidence that it underwent anything
resembling a rigorous NIH study section-style peer review. Worse, the study
intentionally takes advantage of an underserved, vulnerable population, namely
children in a poor country with a very high infant and childhood mortality rate,
to test a hypothesis that can’t ethically be tested in the United States or
Europe. Indeed, no institutional review board in the US would grant ethical
approval to a study like this, nor should any IRB do so. Ditto Europe. Moreover,
in the US and European countries, it is unethical to carry out a study on a
population in another country that would be considered unethical to do in the US
or Europe, and this study stinks to high heaven.

As Angela Rasmussen put it:

Rasmussen notes that it would not be ethical to provide a birth dose of the
hepatitis B vaccine to some babies but not others, given that doctors know the
immunization saves lives, both in the early newborn period and decades later.

Exposing thousands of babies to “a significant risk” of hepatitis B “in a
low-income country with limited health care resources” would be “wildly
unethical and a disgraceful use of American taxpayer money,” Rasmussen said.

Correct. And, as Dr. Jake Scott, a clinical associate professor of infectious
disease and geographic medicine at Stanford University School of Medicine, put
it:

Scott said the study’s announcement suggests that the CDC isn’t truly looking
for answers.

“In evidence-based policy, you gather data and then make a decision,” Scott
said. “This is the reverse. CDC made the policy decision and then funded
research to back it up. When you commission research after making a decision,
you’re not looking for answers—you’re looking for validation.”

And that’s exactly what RFK Jr. is doing here. It is, as our very own Dr.
Jonathan Howard put it, “policy-based evidence making.”

So where do comparisons to the infamous Tuskegee syphilis experiment come in?

The Tuskegee syphilis experiment: For MAHA, every accusation is a confession (of
intent)

As Derek Beres noted and as I have written about for ages and ages, the antivax 
movement in general and RFK Jr. in particular have loved to invoke the Tuskegee 
syphilis experiment with respect to vaccines in an attempt to portray vaccine
research as being as horrifically unethical as that infamous experiment. Just
for yucks, I searched this blog and my not-so-super-secret other blog for
“Tuskegee” and “vaccines.” (You can do the same search yourself, if so
inclined.) Let’s just say that, whenever antivaxxers, including RFK Jr., are
trying to demonize vaccines in front of an audience consisting primarily of
Blacks and other minority groups in the US, they just love to trot out the
Tuskegee syphilis study. Here are just a few examples:

  1. When antivaxxers descended on the Somali immigrant community in Minnesota, who
    had been in the news for the high prevalence of autism in their community, 
    in order fuel the flames of suspicion of vaccines as the cause, Andrew
    Wakefield invoked—of course!—the Tuskegee syphilis study.

  2. In 2018 at a chiropractic conference, RFK Jr. analogized the CDC whistleblower
    manufactroversy to the Tuskegee syphilis experiment on black men, an
    analogy he dredged up again in describing a California bill (which
    ultimately became law) tightening vaccine exemption requirements, all the
    while cozying up to the racist and anti-Semitic Nation of Islam.

  3. At an event targeting Black people in Compton, Andrew Wakefield and Del
    Bigtree nodded approvingly as a Black antivaxxer named Sheila Ealey invoked 
    the Tuskegee syphilis study, as well as the horrendous history of white
    physicians conducting painful and unethical experiments on enslaved people
    before the Civil War.

  4. Over one of the taped conversations with William Thompson (a.k.a. the “CDC
    whistleblower” of The CDC whistleblower conspiracy theory at the heart of
    Andrew Wakefield and Del Bigtree’s antivax propaganda film disguised as a
    documentary, VAXXED), Andrew Wakefield invoked the Tuskegee syphilis study
    because a dodgy subgroup analysis from the study in question was being
    misrepresented as having shown that the risk of autism induced by vaccines
    was most pronounced in Black boys, a four-fold increase. Note that just last
    week STAT News reported that Thompson been promoted to a high ranking job
    at the CDC to oversee research into adverse events due to childhood
    vaccines. Yes, that was another possible topic of this post in and of
    itself. (As an aside, Thompson recently sent me cease-and-desist emails
    about old posts about him written by me. I can post them if you like.)

  5. In a 2016 letter accusing the CDC of scientific fraud based on the “CDC
    whistleblower” conspiracy theory, Brian Hooker and Andrew Wakefield accused 
    the CDC of conducting another Tuskegee experiment.

  6. In 2021, RFK Jr. produced a film entitled Medical Racism: The New Apartheid
    for the antivax group that he had founded, Children’s Health Defense. The
    film leaned heavily into promoting false claims that COVID-19 vaccination
    efforts were part of a larger, sinister experiment on Black communities. The
    film mixed legitimate concerns about medical racism with conspiracy
    theories about COVID-19 vaccines as targeted medical experimentation on the 
    Black community akin to the Tuskegee syphilis study. In essence the film
    portrayed COVID-19 vaccination as part of the sad heritage of how white
    physicians have treated Blacks in the US, including the unethical Tuskegee
    study.

I could go on and on and on, but you get the idea.

This brings me back to the title of this post. With MAHA in general—and RFK Jr. 
and antivaxxers in particular—every accusation is a confession or, at least, a
confession of intent. The current study checks a lot of the boxes that the
Tuskegee syphilis experiment did. It’s arguably racist in that white
investigators from wealthy European countries and the US are targeting Africans,
as the Tuskegee study targeted African-Americans and was run by white
investigators. It targets a vulnerable population (children), as the Tuskegee
study targeted poor Black men with little education or access to high quality
medical care. It has not good scientific basis, just as the Tuskegee syphilis
experiment did not have a sound scientific rationale, and by its very design it 
is likely to intentionally expose one group to harm, just as the Tuskegee
syphilis experiment did. Indeed, after recent criticisms of Stabell Benn and
Aaby’s work, even the research base suggesting harmful nonspecific effects due
to vaccines has now been largely cast into extreme doubt, leaving even less of a
scientific rationale for this study.

In fairness, one does have to point out some differences. The Tuskegee study was
not randomized, as the proposed Stabell Benn and Aaby study is. However, it
remains a foundational principle of biomedical research ethics that human
subjects should not be knowingly randomized to a group that is more likely to
suffer harm, which is what this study is likely to do. One must also remember
that these are not neutral or benign actors. They have a history. Context
matters. After all, what RFK Jr. has kept demanding, RCTs of existing vaccines
versus saline placebo, is every bit as profoundly unethical as this study by
Stabell Benn being funded by the CDC. Now maybe—maybe—the study protocol will be
published, and I will have to eat crow, finding that there are no major ethical
issues. No doubt Stabell Benn and Aaby won’t believe me, but let me just say
that I even hope that that will be the case. However, I find it very difficult
to believe that outcome likely given what we know now about the study, the
history of its investigators, the hush-hush way it was funded and announced in
the federal register in a way clearly intended to make it less likely that
anyone would notice, and the obvious cronyism in how the award was granted.
(Fortunately, there were reporters on the case who noticed the announcement of
this study and now we all know.)

In the end, the reality of the situation is that neither MAHA nor antivaxxers
like RFK Jr. ever really had any major ethical qualms about randomized
controlled trials that randomize a group to likely harm, contrary to RFK Jr.’s
rants about “no saline placebo-controlled trials” of vaccines and his penchant
for comparing vaccine science to the Tuskegee syphilis study. Rather, led by RFK
Jr., MAHA just wanted to be the one to do their own versions of the Tuskegee
study—or to make sure that investigators who will do a 21st century Tuskegee
equivalent will receive the research funding to do so—in order to generate data 
that casts the safety of vaccines into doubt as part of his effort to eliminate 
vaccines. Also, being part of the Trump administration, RFK Jr. can’t resist
emulating his boss and treating research funding like patronage, funneling money
to ideologically aligned researchers (like Stabell Benn and Aaby, regardless of
science. Grift and unethical human experimentation are but two tools in the
MAHA playbook to chip away at vaccine science.



Pandemic Gurus: If You Can’t Defend MAHA Doctors Today, Then You Must Discard
Everything They Said Regarding COVID.

Had MAHA doctors been in charge in 2020, when COVID swamped our hospitals and
morgues, they would have brought the same level of malevolence and incompetence 
they are displaying today.

Jonathan Howard on February 3, 2026

Link

The Science and the Art of Gurometry.

I have a lot to say, but almost always on a few, restricted topics. I rarely
venture out of my comfort zone. The amazing podcast Decoding the Gurus teaches
about different sort of communicator, the secular guru. They are individuals,
usually of a certain demographic and with obvious political leanings, who
pontificate on everything, while doing nothing beyond making content, usually
with each other.

A good place to start is their episode The Science and the Art of Gurometry. It 
says:

The casual listener, who might possibly not be a loyal Patreon subscriber, or
might hypothetically not listen devotedly to every Gurometer scoring episode,
could conceivably be a little vague about what we mean by a secular guru(!). And
therefore might be tempted to make an ill-considered and poorly-informed
comment on Twitter or Reddit, thus exposing them to the devastating yet apropos 
riposte of a “You know nothing, Jon Snow” meme in reply. Don’t let it be you!

Here is a tutorial, a short illustrated primer if you will, on the Science and
the Art of ‘Gurometry’. No more will you have to live with the shame of not
knowing how many syllables there are in anti-establishmentarianism. Never again 
will you be liable to fall prey to the siren song of pseudo-profound bullshit or
fall foul of conspiracy mongers. Listen to it. Study it. Meditate on it. In no 
time at all you’ll be spotting gurus in the wild, categorising, and classifying 
them at will.

You’ll feel like an ornithologist who’s just been given a great big pair of
binoculars, a spotter’s guidebook, and a free afternoon to wander about a
National park. Impress your friends, family, and potential sexual partners with 
your intimate and subtle understanding of What It Means to Be a Guru. You’re
welcome.

This concept neatly describes the MAHA doctors I often write about. As I have
discussed countless times, they rose to power based on accomplishments that were
wonderful, but fictional. They were pandemic gurus. From the moment the virus
arrived on our shore, they spoke with complete confidence and absolutely
certainty about every aspect of the pandemic:

  1. The virus came from a lab

  2. It was less dangerous than the flu

  3. Herd immunity was inevitable

  4. Infections in young people were desirable

  5. Death was COVID’s only bad outcome

  6. New York and Sweden had herd immunity in June 2020

  7. One infection led to long term immunity

  8. Delta was nothing to worry about

  9. Omicron was nothing to worry about

  10. Vaccines blocked transmission and would end the pandemic

  11. Vaccines perfectly protected older people

  12. Long COVID was exaggerated

  13. Masks are useless and dangerous

  14. Vaccines are useless and dangerous

  15. We had herd immunity May 2021

  16. Children do not spread COVID

  17. Testing for COVID was useless

  18. It spared people under age 70

  19. Lockdowns were worse than COVID

This was their track record.

MAHA doctors also spoke confidently about education policy, pediatric mental
health, responsible science communications, the first amendment, social media
moderation policies, and literally everything related to pandemic. I can’t
recall an instance of them saying “I am not an expert in that, so I am not going
to comment.” Like all gurus, they knew everything, but aside from making
content, they didn’t do much. Though most treated 0 COVID patients, they claimed
that everything would have been fine, if only we had just listened to them.
MAHA doctors lectured us all about the importance of civility and humility, as
gurus do, but they never looked back on their own litany of failed predictions. 

ICE Halts “All Movement” At Texas Detention Facility Due To Measles Infections

However, history is now giving us a nasty but interesting natural experiment. 
What happens when gurus gain power?

For nearly a year, MAHA doctors have been the medical establishment they
previously railed against. They have had the opportunity to prove their real
world competency and dazzle us all. How are the gurus doing with actual
responsibility?  

Obviously, it would take another book to document their drama and destruction
thus far. There are many reasons that Dr. David Gorksi, Gregg Gonsalves, and
others call it Lysenkoism 2.0. We have years left to go.

However, I will remind SBM readers that I wrote two essays last year: Go Ahead, 
Make the Case that Science, Free Speech, and the NIH are Thriving Under Dr. Jay 
Bhattacharya and Go Ahead, Make the Case That Science, Free Speech, and the FDA 
Are Thriving Under Drs. Marty Makary and Vinay Prasad. No one has made that case
yet. I’ve not seen anyone make the affirmative case that things are going well 
in science and medicine and that MAHA doctors are respected, competent leaders. 

And this reveals something obvious, but important. Had MAHA doctors been in
charge in 2020, when COVID swamped our hospitals and morgues, they would have
brought the same level of malevolence and incompetence they are displaying
today. The headline ICE Halts “All Movement” At Texas Detention Facility Due To 
Measles Infections perfectly sums up what they have unleashed on us. We are very
lucky Kennedy and his crew were not in charge 6 years ago.

MAHA doctors hurt people with their COVID disinformation. It’s an important part
of the history of the pandemic. It’s vital to remember it for those reasons.

However aside from this, all of their COVID content should be discarded. All of 
their lofty opinion pieces, know-all Podcasts, omniscientYouTube videos,
boastful Tweets, absurdly confident Fox News appearances, blogs, roundtables,
Congressional testimony, fancy Declarations, and literally everything they said 
should be tossed away. Everything they argued for, proposed, called for, and
would have done regarding COVID, should be recognized as worthless opinions and 
imaginations in light of their real world performance today.

The same is true for the many books and articles defending the COVID track
record of MAHA doctors. These revisionist narratives from laptop class
historians endorsed a mythical universe where persecuted MAHA doctors would have
bent the virus to their will. This army of enablers elevated MAHA doctors to
power by treating their imagined accomplishments as genuine accomplishments.  In
2026, there is no reason for anyone to pretend this COVID-MAHA fan fiction has 
any value.

It should be clear to everyone now, that no, MAHA doctors would not have opened 
schools and they would not have protected the vulnerable had they run the show
in 2020. Those were always just empty boasts, and unless someone can make the
case that MAHA doctors are competent and thriving in 2026, we can abandon the
delusion that they would have been COVID superheroes 6 years ago.  

It turns out, in the real world, things go badly when gurus gain power. Who
could have predicted that?

Pandemic Revisionism Is a Pretext for MAHA Vandalism

My YouTube channel is a reliable history of the pandemic. The NY Times is not.

Jonathan Howard on February 6, 2026

Link


The NY Times recently published a lengthy interview with Dr. Jay Bhattacharya
titled A Plan to Restore Trust in Science From a ‘Fringe Epidemiologist, which
Dr. David Gorksi discussed in his article Lysenkoism 2.0 continues: Podcast Jay 
Wants to Turn NIH Into the “Research arm” of MAHA.  However, Dr. Bhattacharya
didn’t become Podcast Jay the moment he was sworn into the NIH.  He’s been
podcasting constantly for 6 years now, and I’ve saved a lot of it. Here, I will 
share 5 thoughts on Dr. Bhattacharya’s recent interview, using his own words to 
show how the NY Times is complicit in not just pandemic revisionism, but also
the MAHA attacks on science and medicine.

1. The Interview Was Revisionist History, Predictably

Today, Dr. Bhattacharya claims that his 2020 pandemic vision merely opposed
lockdowns, a word that appeared 11 times in the NY Times interview, and school
closures, a word that appeared 9 times. In reality, Dr. Bhattacharya believed
that COVID would kill 20,000-40,000 Americans and therefore wondered if
controlling it was “really worth it to suppress the economy.”  Watch for
yourself.

Notably, the word “immunity” was absent from the NY Times interview. However, a 
quick reading of the Great Barrington Declaration shows that it was all about
herd immunity via natural immunity, and Dr. Bhattacharya spoke about this often 
in 2020. Watch for yourself.

Dr. Bhattacharya felt that the best way to reach herd immunity was to let
countless millions of people “face the risk of the disease” in October 2020,
just 2 months before vaccines arrived.  Watch for yourself.

To numb people to the virus and further his pro-infection agenda, Dr.
Bhattacharya spread copious disinformation in 2020, claiming that COVID’s risk
kicked in at age 70 and that the flu killed more children than COVID, even
though the opposite was true.  Watch for yourself.

This is just a small sample of Dr. Bhattacharya’s disinformation in 2020, though
the NY Times didn’t mention any of it.

2. Dr. Bhattacharya Knows How to Destroy Trust, Not Rebuild It

The main theme of the NY Times interview was about trust, who broke it and how
to restore it.  It opened with this statement by Mr. Douthat:

I want to start with a general diagnosis of the collapse of public trust in the 
medical establishment in America and how I think the Covid-19 pandemic played
into it.

Dr. Bhattacharya himself said:

I just want to make sure people understand that I don’t want the public health
authorities to be discredited permanently. I want reform of the public health
authorities so that they become worthy of trust.

Of course, Dr. Bhattacharya was the “medical establishment”. He advised
Presidents and Governors. He testified before Congress and was omnipresent in
the right-wing disinformation media echo chamber. He was a pandemic celebrity
who was everywhere, except hospitals, and he used his megaphone to spread
distrust of scientists and doctors, claiming that they were liars and part of a 
“COVID cartel”.  Watch for yourself.

Elsewhere, Dr. Bhattacharya endorsed the myth that hospitals and doctors were
paid to put COVID on death certificates and therefore the death toll could not
be trusted. Watch for yourself.

Dr. Bhattacharya made multiple emotionally manipulative propaganda videos where 
he warned that measures to stop people from dying of COVID were evidence of a
“biosecurity state”. Watch for yourself.

To this day, Dr. Bhattacharya claims that “the engines of science were used for 
social control”, and this was “evil”.  Watch for yourself.

Though the NY Times didn’t tell its readers, Dr. Bhattacharya spent 6 years
relentlessly claiming that scientists and doctors were tyrants and liars. His
disingenuous blathering about repairing trust today is pure hot dog meme guy.

3. Pandemic Revisionism Is a Pretext for MAHA Vandalism

While keeping an accurate history of the pandemic is worthwhile in its own
right, this deliberate COVID revisionism serves a valuable purpose for MAHA. By 
constantly using the words lockdowns, school closures, and mask mandates, as Dr.
Bhattacharya made sure to do in the NY Times interview, Kennedy and his crew
seek to justify their vandalism today. For example, Dr. Bhattacharya claims that
lockdowns from spring 2020 are the reason the US is withdrawing from the WHO in
2026. Watch for yourself.

He also claimed that mandates are part of why he cancelled research into mRNA
technology. Watch for yourself.

By enabling pandemic revisionism, the NY Times is also enabling MAHA destruction
today.

4. “Bhattacharya should not be in charge of any scientific organization.”

Things are not going well for Dr. Bhattacharya at the NIH. While he is a
grandmaster at destroying trust, he has no clue how to build it and has already 
failed in his mission. He has tied his fate to both Trump and Kennedy, his old
allies have abandoned him, NIH leaders are quitting in protest, he is openly
mocked as “Podcast Jay”, and states and medical organizations are wisely
ignoring his anti-vaccine agenda.

The comments to the NY Times article revealed the depths of Dr. Bhattacharya’s
failure. Readers knew to judge him on his real-world performance today, not his 
imagined glories in 2020, and they knew that potential mistakes 6 years ago
don’t justify Lysenkoism 2.0 today.  The top comment was this:

Let me understand.  Mistakes were made during Covid so we should destroy
science?  Vaccines have decades of data to prove their effectiveness, we just
ignore them?  The US does NOT have a safety net healthcare system to treat
patients quickly like Denmark, yet we take their vaccine protocol but ignore the
lack of treatment we offer?  There is a difference between an “outsider” and a 
person with a predetermined agenda whose actions will kill people. Bhattacharya 
should not be in charge of any scientific organization.

My favorite comment, for obvious reasons, was:

Jay Bhattacharya is not an epidemiologist. He has no degree or training as an
epidemiologist, nor has he ever been a licensed practicing physician. In fact,
he never did a residency. He is an economist with an MD, who if one examines his
background and published research, has not only frequently criticized public
health, but has engaged in blaming the victim, as with his published papers on
the cost of insuring diabetic patients to employers, suggesting that employers
pass on the additional cost to their obese diabetic patients.

In fact, Jay was one of the most egregious disseminators of Covid disinformation
beginning in 2020 with the Great Barrington Declaration, which suggested that
prior to the development of vaccinations, the SARS-Cov-2 virus was no more
harmful than a common cold to the non-elderly population. Something we now know 
is completely false. He suggested that the US gov’t pay to protect all
vulnerable individuals prior to vaccination from Covid and then did nothing to
elaborate how this grand plan would take place. He repeatedly criticized the
efforts of public health to mitigate the transmission prior to vaccination of
COVID, including masking, school and work closures and public spacing, but never
offered any concrete or realistic alternatives.

For a comprehensive review of the anti-science approach that Jay Bhattacharya
communicated  during the first several years of the Covid pandemic, please see
Jonathan Howard’s excellent book “We Want Them Infected”.

Essentially all of the comments were like this, and not for the first time.
Though many people fell for Dr. Bhattacharya’s COVID-superhero fantasy in 2020, 
everyone sees through him today. No one can make the affirmative case that the
NIH is thriving under his competent leadership, and it’s no surprise he prefers 
to spend his time on X, celebrating the arrest of a journalist who called him
“names” and trying to convince strangers he was right about everything 6 years
ago.

5. My YouTube Channel is a Reliable History of the Pandemic.  The NY Times is
Not.

However, these wise readers knew to distrust Dr. Bhattacharya not because of the
NY Times, but despite the NYTimes, which is itself a major contributor to the
COVID amnesia project. It seems forbidden to acknowledge Dr. Bhattacharya’s plan
for herd immunity via natural immunity in 3-6 months, though this is what the
Great Barrington Declaration was all about. One guest writer even said this
about him:

His real dream is for the Covid and D.E.I. culture wars to wind down so he can
be the one to forge science’s new peace — to enact deep reform that brings new
purpose to the agency… Researchers who know him consistently told me that, sure,
he bucked the establishment on Covid, but was eminently sane about it, not a
rote contrarian.

Incredible.

In contrast to such fairy tales, my YouTube channel has become a mini library of
unassailable history. Even though the videos are a minuscule snippet of the
content MAHA doctors produced, collectively they reveal how pandemic
disinformation from 2020 led directly to MAHA demolition today. There’s a reason
prominent government officials tried to censor it. If the NYTimes wants to
honestly report on Dr. Bhattacharya’s dismal pandemic record for the first time,
I am happy to donate my collection so Podcast Jay can narrate it himself.

Watch for yourself.


MAHA Leaders Are Recycling COVID Myths to Minimize Measles

Once again, everything old is new again. The circle of disinformation is
complete.

Jonathan Howard on February 8, 2026

Link


Dr. David Gorski previously coined the phrase “everything old is new again” to
describe how disinformation agents plagiarized “old school” anti-vaccine
balderdash to minimize COVID. These techniques were dishonest, but effective. As
a result, people died of COVID, and MAHA doctors were catapulted to power.

However, with the geniuses who “would have” perfectly controlled COVID in
charge, the headlines read:

  1. 4 Times As Many Measles Cases In A Few Weeks Than Us Typically Averages In A
    Whole Year

  2. Measles Hits ICE Family Detention Center in Texas

  3. Measles Is Causing Brain Swelling in Children in South Carolina

Competent leaders would use their authority and soapbox to promote the MMR at
every opportunity. MAHA leaders are not doing that, and we are allowed to judge 
them on their silence now. Instead, they have been recycling COVID myths, which 
were themselves recycled from pre-pandemic anti-vaxx myths, to minimize measles 
and fear monger about the vaccine. Here are 6 examples.

1. People Die With COVID/Measles, Not of COVID/Measles

To minimize COVID then and measles today, disinformation agents spread the myth 
that people died with the virus, not from the virus.

2. Only Sick Kids Die

To minimize COVID then and measles today, disinformation agents spread the toxic
myth that only unhealthy children died from them, though death is not the only 
bad outcome from either virus.

3. It’s All Going Away

To minimize COVID then and measles today, disinformation agents prematurely
claimed the worst was over, and it was all going away.

4. The Vaccine is Dangerous

To minimize COVID then and measles today, disinformation agents treated vaccine 
side effects, both real and imagined, as a fate worse than death from a virus.

5. Doctors Are to Blame

To minimize COVID then and measles today, disinformation agents claimed that
incompetent doctors were to blame for the death of their patients.

6. Infections Are Beneficial

To minimize COVID then and measles today, disinformation agents claimed that
these viruses have potential health benefits. In his essay and video, I Am Going
To Mask Because I Want To Get Fewer Colds & Other Flawed Ideas Dr. Vinay Prasad
said:

It is natural to be infected repeatedly with respiratory viruses— if we got
fewer infections what would that mean for auto-immunity for cancer? We have no
clue. We have no idea if we would actually live longer or healthier lives trying
to dodge seasonal runny noses and coughs.

Once again, everything old is new again, again. The circle of disinformation is 
complete, and we are still just getting started. Though I can’t help but wonder 
if maybe we could have avoided everything that’s happening with measles today
had more people cared about COVID disinformation back then.



MAHA: Everything old is new again, except this time antiscience cranks (like
Stanislaw Burzynski) are in charge

Returning from my hiatus, I couldn’t decide on a specific new topic, mainly
because so much bad stuff happened in my absence. So, in this post I back up a
bit to reflect on how RFK Jr.’s “make America healthy again” is nothing new.
What is new is that the antiscience-cranks are in charge.

David Gorski on February 23, 2026

Link


I am returning from a two-week bereavement-related hiatus. Longtime readers
deserve to know that two weeks ago my mother died after a long illness, and the 
funeral was held on Saturday. Since my father died a couple of weeks before
Christmas 2024, I have been primarily in charge of my mother’s finances and
house since then. Over the last year and a half my sister and I visited my
mother several times a week and my sister from out of town would come in when
she could; quite frankly, I’m feeling a strange emptiness from not knowing what 
to do with those many hours a week spent with Mom as her cognition and health
declined. Coming back, I was seriously tempted to write a more personal post
about how, during the three years since my mother’s stroke that resulted in her 
developing vascular demential and the 14 months since my father’s passing at the
end of a long hospitalization, I as a physician have confronted the medical
system from the other side, discovering in the process just how much the US
healthcare system falls short and how much eldercare in this country stinks, but
it’s just too soon. One day I will do such a post, but today is not that day.
Feelings are still too raw. Maybe I’ll do it after the estate is taken care of.

Still, this blog beckons, and, although tempted, I really didn’t want to take a 
third week off because writing my weekly post will help me ease back into my
regular routine.

As I contemplated what to write about this week, I must confess to having faced 
the tsunami of nonsense that has occurred during the three weeks since I last
posted here and experienced an uncharacteristic feeling of being overwhelmed.
There are so many things that I could have written about. For example, I was
highly tempted to write about “Podcast Jay” Bhattacharya‘s having been appointed
acting director of the Centers for Disease Control and Prevention, that in
addition to his role as NIH Director. Let’s just say that his appointment as
acting director of the CDC confirmed to me what I have been saying all along.
Podcast Jay was never truly in charge of the NIH; he has been and continues to
be a figurehead under whom Russell Vought and Matthew Memoli will transform the 
NIH into a research arm of MAHA and a grant awarding system based, as part of
Lysenkoism 2.0, less on scientific merit than on patronage to reward friends of 
the administration and punish opponents. Similarly, Podcast Jay will not be in
charge of the CDC either. He will be the temporary figurehead under which the
longtime antivax activist who is currently our Secretary of Health and Human
Services, Robert F. Kennedy, Jr., will degrade and ultimately destroy much of
the CDC’s public health and vaccination programs. I just had to mention that in 
case I never get a chance to circle back around to this out in detail.

Instead, for some reason, I kept thinking about how there’s nothing new about
RFK Jr.’s “make America healthy again” (MAHA) movement, except that the
antiscience cranks, quacks and antivaxxers are firmly in charge. The led me to
reflect on one the longest-standing bête noire of pseudoscience, Polish expat
turned cancer quack Dr. Stanislaw Burzynski, and how his activities starting 50 
years ago and continuing into the 2020s, helped lay a lot of the groundwork for 
the tactics and tropes of MAHA. There is nothing truly new under the sun in
terms of quackery, other than that, even with my knowledge of medical history, I
am not aware of a time when not only are the cranks fully in charge but when
actual science-based medicine is in retreat.

The odd thing is, with MAHA ascendant and the ideological heirs of Burzynski,
such as William Makis, Pierre Kory, and Tess Lawrie (among, sadly, many others) 
promoting outright cancer quackery in the form of repurposed drugs and at least 
one legitimate scientist (Dr. Wafik El-Deiry) falling down the MAHA rabbit hole 
and giving them aid and comfort with his hand-waving cherry-picked science and
nonsense supporting the false view that COVID-19 vaccines cause cancer, we don’t
hear much about Burzynski these days. But he’s still around, having recently
celebrated his 83rd birthday still quacking loud and strong at his clinic in
Houston.

I’ve been writing a lot about how, starting very early in the pandemic, COVID-19
minimizers, cranks, and quacks have touted “repurposed drugs,” such as
hydroxychloroquine and ivermectin, for COVID-19. Then I noted how, as the
pandemic was finally starting to wane, they pivoted effortlessly to touting the 
same repurposed drugs for cancer. William Makis and Pierre Kory have been
particularly prodigious in this effort. William Makis, for instance, has been
promoting a treatment protocol for cancer involving repurposing drugs like
ivermectin and mebendazole, plus a variety of supplements, all while sharing
“miracle cure” anecdotes on his Substack (most behind a paywall, of course). He 
even briefly sucked cartoonist turned MAGA populist Scott Adams, who, sadly,
ultimately died of his metastatic prostate cancer last month, Even though he did
ultimately abandon Makis’ quackery, he found out that there is no cure for
stage IV prostate cancer. None of this stopped Makis from somehow securing a
Florida medical license earlier this month, because of course Florida granted
him a medical license. As for Kory, he’s been claiming miraculous results from a
cancer treatment protocol involving ivermectin for two years now. Let me just
remind you that, as good as a drug as it is for treating roundworm-related
disease, ivermectin doesn’t work against cancer, the NCI’s decision to reinvent 
the wheel by restudying the drug in vitro notwithstanding. We’ve known this
since 2021, at least, and I highly doubt that new studies will change that.

Again, all of these quacks are the 21st century heirs of Burzynski, who laid the
groundwork for them 50 years ago.

Stanislaw Burzynski: From science-based physician to cancer quack

One of the sometimes startling characteristics of the current generation of
cancer quacks and grifters who took their heel turn towards quackery during the 
COVID-19 pandemic is that some of them were pretty well-respected physicians.
Makis, of course, was not one of those doctors, as his heel turn occurred years 
before the pandemic, but Pierre Kory and his cohorts were. So was Wafik
El-Deiry. Longtime readers might recall that Stanislaw Burzynski was a highly
promising physician who did his training during the 1960s in Poland, which at
the time was under the control of a Soviet Communist puppet government. Born in 
Nazi-occupied Poland in the city of Lublin on January 23, 1943, as the Holocaust
in Poland was entering its deadliest phase, Stanislaw Burzynski was mostly
sheltered from the grim reality of Nazi-occupied Poland during his earliest
years because of his mother’s wealth. After the war, when Burzynski was five,
Stanislaw’s older brother Zygmunt was killed fighting the newly installed
Communist regime. In his hagiography The Burzynski Breakthrough: The Most
Promising Cancer Treatment and the Government’s Campaign to Squelch It, Thomas
Elias quoted Burzynski invoking his brother thusly, “The idea of fighting people
in authority became natural to me. I learned that you must never let them
defeat you in your own core.” This sort of determination could have been an
admirable trait—if only Burzynski had found a worthy cause to serve.

Sound familiar? This trait, of taking what can be a laudable thing (questioning 
authority) to extremes that lead away from science and into pseudoscience, seems
to be a defining trait of many of the new cancer quacks whose rise occurred
during the COVID-19 pandemic. Still, this alone is not enough of a similarity to
draw a line from Burzynski to ivermectin pushers. It’s a characteristic that
seems to have been found in abundance in quacks throughout history dating back
decades, if not hundreds of years. What is interesting to me is that in the late
1960s and early 1970s the young Burzynski seemed to be the real deal, an
academic physician who applied science to try to improve cancer treatment.

Indeed, by 1967 Burzynski was ready to work on his medical school doctoral
research project. He had become interested in differences in the amount and
types of peptides found in the blood and urine of renal failure patients and
cancer patients. He reported that some of these chemicals were found at high
levels in the blood of renal failure patients. He also found that cancer
patients had a low level of some of these substances, which were not, it turned 
out, peptides. Ultimately, his work in this area resulted in a thesis entitled
“Investigations on amino acids and peptides in blood serum of healthy people and
patients with chronic renal insufficiency.” There is some question that will
likely never be resolved about whether Burzynski’s doctoral degree is
legitimate, but for purposes of this post I don’t really care. What I care about
is what Burzynski has done since.

By 1970, Burzynski decided that he couldn’t stay in Poland anymore. Elias
reports that in 1970 Burzynski was being recruited to join the Communist Party
but refused to join. This was perhaps the first case, but definitely not the
only case, where his stubbornness caused him serious problems. Burzynski learned
he was going to be drafted into the Polish Army, where he would be sent to
wherever the Soviet Union needed him, but, thanks to the intervention of a
prominent scientist, managed to get a passport and get out of Poland before his 
draft notice was delivered. He arrived, as he has said so many times, at JFK
Airport with only $20 in his pocket.

Burzynski stayed with an uncle in The Bronx but soon managed to get a job at the
Baylor College of Medicine in the Department of Anesthesia, then headed by
Georges Ungar, a Hungarian refugee with whom he hit it off. Ungar was famous for
proposing that memory resided in peptides made by the brain, and he tried to
“transfer” memory by transferring those peptides from one mouse brain to
another. It’s a hypothesis that seemed to be supported by his experiments at the
time but faded from favor as more research failed to support it. Burzynski
split his time between working on Ungar’s project and working on his own
peptides, which he had finally dubbed “antineoplastons. He even managed, with
the help of an investigator at M.D. Anderson, to secure an NIH grant in 1974.
These years were productive for Burzynski, and he and Ungar published a lot of
papers. Burzynski apparently killed a lot of rats in his time at Baylor doing
Ungar’s research, which is something I can totally relate to, having dispatched 
hundreds of mice myself (and hated doing it) while doing angiogenesis research
in the 1990s. Basically, rats were trained at tasks by the hundreds, after which
they were killed and the peptides from their brains isolated. These peptides
were then injected into the brains of other rats in order to see if the
“knowledge” could be transferred with the peptides. Fun times!

One thing that seems to have pushed Burzynski to “buck the system” (and become a
quack) is similar to the sorts of things that seem to have pushed Kory, for
instance, to do the same nearly 50 years later. In 1973, after three years of
study, Burzynski had managed to pass the medical board examinations and obtain
his Texas medical license. However, as I’ve pointed out before multiple times,
he had no U.S. specialty training in oncology. In fact, he doesn’t appear to
have had any specialty training even in internal medicine, and an internal
medicine residency is a prerequisite to doing an oncology fellowship and
becoming a fully-trained oncologist. One thing I couldn’t figure out from either
book or any of my other reading is how Burzynski got a license to practice
medicine in Texas. Usually, getting such a license requires at least a year of
postgraduate medical training (usually an internship) in addition to medical
school and passing the national medical board examinations. I can only speculate
that whatever postgraduate clinical training Burzynski might have done in
Poland must have counted, because I can’t find any reference to him doing any
clinical training after arriving at Baylor. That’s not really the most important
issue here, but it is a curiosity to me as a physician.

It’s also indicative of the extreme arrogance that Burzynski exhibited at the
time. Elias recounts how in 1976 Burzynski thought that because he had obtained 
his medical license in 1973 he was then qualified to be the principal
investigator for the first clinical trial of antineoplastons. He didn’t want to 
let anyone else be in charge of such a trial, even though it is obvious to me
that at the time Burzynski was completely unqualified to run even a small phase 
I oncology trial. It’s rather instructive to look at what happened here from
three different perspectives, the narrative in Elias’ book, as well as the the
narrative in a chapter in the rather self-aggrandizing Galileo’s Lawyer:
Courtroom Battles in Alternative Health, Complementary Medicine and Experimental
Treatments by Richard Jaffe. (Note that Richard Jaffe is now serving as counsel
for Children’s Health Defense, the antivax organization founded by RFK Jr.
himself, and is lead attorney for at least one CHD lawsuit against vaccine
mandates.

So what did happen? From what I can gather from Elias and Jaffe, a confluence of
events conspired to push Burzynski towards his fate. Burzynski successfully
competed for an NIH grant to study antineoplastons in 1974, but was unable to
renew it in 1976; it expired in 1977. In 1976, apparently internal politics led 
to Ungar’s ouster from the Department of Anesthesia. According to Elias, the new
“boss of anesthesiology” (as Burzynski was quoted as putting it) was Lawrence
Schumacher, who wasn’t interested in peptide research and didn’t think much of
Burzynski. He also, arguably quite appropriately, didn’t think that Burzynski’s 
research was the sort of research that was appropriate to a department of
anesthesia. So Ungar ended up taking a job at the University of Tennessee, and
Burzynski had trouble renewing his grant. Apparently, if Burzynski is to be
believed, the new cancer research center at Baylor wanted to hire him and even
offered him a $30,000 start-up package (respectable at the time), but it also
imposed two conditions that were unacceptable to him. First, it wanted the
rights to his antineoplaston discovery. This has been common practice at
universities for a long time. If an investigator discovers something patentable 
while working for a university, usually the university will patent it and share 
a cut with the inventor. Burzynski, however, didn’t want to share. Similarly,
although Ungar offered Burzynski a position in Tennessee, Burzynski did not want
to follow his friend there because he was afraid that the University of
Tennessee would want his antineoplastons, too.

There was another condition, too, and it’s a problem that tells me that from a
very early time in Burzynski’s career he didn’t “play by the rules.” However, it
was more than that. Not only did he not “play by the rules,” but he didn’t much
care for those pesky regulations and ethical codes designed to protect human
subjects. Here’s where Elias and Jaffe diverge. According to Jaffe, shortly
after he got his medical license Burzynski started a private practice on the
side, and that practice became fairly lucrative. According to Jaffe, Burzynski
joined someone else’s practice part time. Actually, Elias is inconsistent on
this issue, at one point implying that it was Burzynski’s private practice and
at another point saying that Burzynski worked for someone named Dr. Walker.
Whatever the case was, both agree that before he even tried to undertake
clinical trials of antineoplastons at Baylor, Burzynski had been giving ANPs to 
patients at his private practice. Sound familiar? Many are the COVID quacks
turned cancer quacks who did just this.

Still, these similarities are not enough. Quacks in general behave this way. If 
they are not grifters, they tend to believe so strongly in their quackery that
they don’t think ethical considerations apply to them and twist medical ethics
to convince themselves that subjecting their quackery to clinical trials to
determine if they work and are safe and effective is actually the unethical
thing to do. Somehow, though, that doesn’t seem to stop them from charging their
patients huge sums of money for their unproven “cures.” As the 1970s careened
towards their end, Burzynski was just a quack who, although he had a respectable
academic background, had founded his own private clinic, where he charged
desperate cancer patients thousands upon thousands of dollars for his “cure.”

There was one unique thing about Burzynski even at this stage. His “cure,”
antineoplastons, were peptides isolated from the urine. In order to isolate and 
concentrate his antineoplastons, Burzynski needed 30 L of urine to isolate the
antineoplastons needed to treat one patient, and it had to be human urine. He
could also use human blood to isolate them. In his chapter on Burzynski, Jaffe
recounts some amusing anecdotes of Burzynski’s early years after leaving Baylor.
Back then, he really did isolate ANPs from blood and urine. Apparently before
he left Baylor, he got ANPs mainly from blood:

For the previous few years, he had been obtaining antineoplastons from human
blood in an unusual way. He got his raw material from the blood of his friends
and acquaintances. He would go to parties and public gatherings with IV lines
and bottles and beg and cajole his friends and colleagues to donate blood for
his research.

After a while, he noticed he was getting fewer and fewer invitations to parties,
and, when his friends would see him on campus or the street, they would turn
and walk away quickly, pretending they didn’t see him.

This is, of course, a reasonable response.

After he went into practice for himself, Burzynski’s need for raw materials
skyrocketed, and the only feasible way to get them was from urine. To get it,
Burzynski arranged to install urine collectors in public parks and the state
penitentiary system. Most amusingly of all, apparently Burzynski collected urine
from Gilley’s Bar, where Urban Cowboy was filmed. One wonders whether John
Travolta contributed to some of those early antineoplaston batches.

Burzynski the MAHA pioneer

While the little back story about how Burzynski isolated antineoplastons before 
he figured out how to synthesize them in the 1980s aside, how did Burzynski help
pave the way for MAHA? Some early hints can be found, in of all places, in
three issues of Penthouse published in the late 1970s. I first wrote about the
three-part story Penthouse feature written by longtime quackery promoter Gary
Null nearly 13 years ago, and these issues represent quite the time capsule into
the cancer-focused proto-MAHA movement. How this series came about probably has
to do with Penthouse publisher Bob Guccione’s belief in cancer quackery, which 
resulted in three articles published in successive issues of Penthouse: The
Great Cancer Fraud by Gary Null and Robert Houston; The Suppression of Cancer
Cures by Gary Null, which tells the story of Burzynski, c.1979; and  Alternative
Cancer Therapies by Gary Null and Anne Pitrone. You can either read the
articles yourself or read my summary of them from 13 years ago, but together
they portray Burzynski as a “brave maverick” whose cancer “cure” is being
suppressed by the American Cancer Society and big pharma (The Great Cancer
Fraud), and relating his antineoplastons to a longstanding bit of “folk
medicine,” namely urine therapy (The Suppression of Cancer Cures), all while
comparing Burzynski to Louis Pasteur, Ignaz Semmelweis, and Galileo.

Indeed, the myth-making and legend-building clearly had begun before Null wrote 
his article, the rest of which followed a script that was new back in 1979 but
has become old and tiresome now. Any time anyone or any professional
organization investigated Burzynski for unethical conduct, in this case
administering his antineoplastons to patients even though (1) they were not
approved drugs, (2) he hadn’t done any tests in animal tumor models yet, and (3)
he wasn’t doing proper clinical trials, all of which were indications for an
investigation, it couldn’t possibly have been because there were legitimate
concerns about his activities. Oh, no. To Burzynski and his supporters like
Null, it was (and still is) because the medical establishment was closing ranks 
to suppress a promising new cancer therapy.

The third article, Alternative Cancer Therapies, told a story of a number of
clinics, several of which still existed 13 years ago (34 years after the
Penthouse trilogy had been published) and several of which have found their way 
into MAHA, such as homeopathy and orthomolecular medicine (functional medicine
hadn’t been invented in the late 1970s), using protocols that could include
combinations of woo including laetrile, high dose vitamin C, and protocols
involving combinations of therapies, such as chelation therapy, various
nutritional interventions, “detoxification,” intravenous H2O2 (peroxide) and/or 
vitamin C.

While these are interesting as a historical interest, what caught my attention
was the emphasis on “health freedom” and a lack of concern for clinical trials. 
This is where Burzynski made his first key “innovations,” although these
advances in the proto-MAHA cause didn’t occur until the 1990s, with the help of 
Jaffe, who was Burzynski’s longtime lawyer until Burzynski stiffed him for legal
bills. Before I discuss this, let me point out that antineoplastons do not
work; there is abundant evidence of this that I reviewed in an article for
Skeptical Inquirer in 2014. Indeed, From the late 1970s to the turn of the
millennium , Burzynski was under nearly constant investigation by medical
authorities, beginning with the Harris County Medical Society in 1979, and
continuing with the Texas Medical Board and the FDA. Indeed, since the 1970s,
the Texas Medical Board tried to strip Burzynski of his license to practice at
least twice, failing to do so in 1993 and most recently in 2012.

To neutralize authorities, Burzynski “pioneered” three tactics in the 1990s.
First, he mobilized his cancer patients into a sympathetic and persuasive force 
that could be weaponized against legislators, the Texas Medical Board, and
federal regulatory agencies who were trying to hold him to account. Second, he
cultivated powerful allies in the Texas and federal legislatures including in
particular Representative Joe Barton (R-Texas), who held a series of hearings
featuring cancer patients who were, quite understandably, terrified that
Burzynski would be convicted. (Remember, these patients were completely
convinced that Burzynski was the only person who could save them.) Between the
cynical political theater, featuring weeping parents of children with brain
tumors, national press stories of demonstrations featuring patients chanting
“FDA go away! Let me live another day!” and the intense political pressure
brought to bear by Barton, who dragged then-FDA Director David Kessler in front 
of his committee four times over two years to explain why the FDA was
“harassing” Burzynski, the FDA ultimately relented and entered negotiations to
let Burzynski set up clinical trials. Taking advantage of the ruling and the
political pressure on the FDA, Burzynski and Jaffe decided, in essence, “If the 
judge wants clinical trials, we’ll give him clinical trials.” So that’s just
what they did.

Guess what? Burzynski was among the first to pervert and weaponize the clinical 
trial process in order to let him continue to ply his quackery unmolested. How
he did it in the 1990s was different than the weaponization of clinical trials
today, but he and Jaffe twisted clinical trials to their quack ends nearly 30
years ago. His patient groups and contacts in Congress allowed him to do this in
order to counter prosecution by the FDA for administering unapproved
medications. First, patients already being treated were enrolled in a
wastebasket trial known as “CAN-1,” a retrospective trial looking at all
patients then being treated at the Burzynski Clinic. Of this trial, Jaffe wrote:

The CAN-1 protocol had almost two hundred patients in it and there were at least
a dozen different types of cancers being treated. And since all the patients
were already on treatment, there could not be any possibility of meaningful data
coming out of the so-called clinical trial. It was all an artifice, a vehicle
we and the FDA created to legally give the patients Burzynski’s treatment. The
FDA wanted all of Burzynski’s patients to be on an IND, so that’s what we did.

The FDA also permitted Burzynski to set up nearly identical phase 2 trials for
every cancer that he wanted to treat. Burzynski claimed these were based on a
protocol used in a trial done by the National Cancer Institute in the early
1990s when the NCI had tried to work with Burzynski. (This effort failed because
of strife between the NCI and Burzynski, who viewed the NCI as trying to
sabotage the trial. These trials had but one purpose, to allow Burzynski to
continue treating patients with ANPs, as Jaffe himself boasted in his book:

The FDA also permitted Burzynski to set up nearly identical phase 2 trials for
every cancer that he wanted to treat. Burzynski claimed these were based on a
protocol used in a trial done by the National Cancer Institute in the early
1990s when the NCI had tried to work with Burzynski. (This effort failed because
of strife between the NCI and Burzynski, who viewed the NCI as trying to
sabotage the trial. These trials had but one purpose, to allow Burzynski to
continue treating patients with ANPs, as Jaffe himself boasted:

CAN-1 allowed Burzynski to treat all his existing patients. That solved the
patients’ problems, but not the clinic’s. A cancer clinic cannot survive on
existing patients. It needs a constant flow of new patients. So in addition to
getting the CAN-1 trial approved, we had to make sure Burzynski could treat new 
patients. Mindful that he would likely only get one chance to get them approved,
Burzynski personally put together seventy-two protocols to treat every type of 
cancer the clinic had treated and everything Burzynski wanted to treat in the
future.

The prosecution thus undermined, the first trial ended in a hung jury in 1997,
and a second trial on a subset of the original charges resulted in Burzynski’s
acquittal. Since then, Burzynski has practiced (mostly) untroubled by the law,
other than intermittent FDA inspections and warning letters, none of which
succeeded in shutting down his clinic. He also pioneered some MAHA cronyism. For
example, chair of the IRB at the Burzynski Institute was for a long time an old
Burzynski crony from Baylor and the current chair of the board of directors at 
the Institute, Carlton F. Hazlewood.

Of course, MAHA weaponizes clinical trials in the same and different ways. They 
do it the same way by using rather “fluid” requirements for clinical trial
evidence necessary to support approving therapies that MAHA likes (e.g., stem
cells, peptides, supplements, and the like), while invoking a fundamentalist
version of evidence-based medicine (EBM) to require unethical and impractical
clinical trials of new vaccines (and possibly even new versions of existing
vaccines, such as influenza vaccines) before approval. Before Burzynski, the
proto-MAHA movement just invoked the tired old quack trope about knowing that
the quackery worked and that the quacks were too busy curing patients to bother 
with those pesky old clinical trials. Post-Burzynski, quacks do sometimes invoke
that argument, but they often try to co-opt clinical trials to give the
appearance of efficacy—or at least to be able argue that what they are doing is 
legitimate experimental medicine. All of this is now bedecked with the glittery 
label of “gold standard science” or “best practices,” both terms used to justify
unscientific and pseudoscientific practices justified in large part by the
perversion of the clinical trial process. For MAHA as for Burzynski, clinical
trials are and always have been a means to an end: In Burzynski’s case, it was
to let him give ANPs to patients unmolested by the authorities. In MAHA’s case
in 2026, it is to serve as a scientific-seeming justification for FDA approval
of quackery and to give the FDA a pretext not to approve new vaccines.

There’s are two other favored tactics that Burzynski “pioneered,” and that’s
bullying. Robert Blaskiewicz documented many of the bullying tactics deployed
against critics, as did I. For example, in 2011 his representative threatened a 
UK high school student,Rhys Morgan, who wrote a skeptical blog, with a lawsuit
to silence him. Around the same time, other skeptical bloggers, including Andy
Lewis, Peter Bowditch, Popehat, and others also received pseudolegal threats
from the Clinic’s representative. The second tactic was the use of video and
social media to promote stories of “miracle” cures of cancers, in particular two
movies that portrayed him as a persecuted doctor who was curing cancer despite 
the best efforts of The Man to stop him, the first of which was responsible for 
attracting many desperate patients to the Burzynski Clinic in Houston, with the 
second movie buffing up Burzynski’s heroic image while also serving as an attack
on “The Skeptics.” I assume that this all sounds familiar. Indeed, Burzynski
took it even further, cultivating relationships with tabloid press, which touted
“miracle cure” stories breathlessly and, in the UK, used them to attack the NHS
for refusing to pay for antineoplastons for cancer patients, which had the
further effect of publicizing crowdfunding efforts by Burzynski patients to
afford the hundreds of thousands of dollars that his treatment could rapidly end
up costing.

Seriously, there was no end to this man’s perfidy with respect to treating
cancer patients, tactics emulated by legions of MAHA quacks, many of whom are
now in charge of the federal public health, medical, and biomedical research
establishment.

Unfortunately, MAHA owes a debt to Burzynski

Bringing it all together, it is clear that Burzynski was MAHA before there was
MAHA. Indeed, he “pioneered” a lot of the tactics and rhetoric used by MAHA,
including weaponizing patients, cozying up with legislators, perverting the
clinical trial process, attacking critics on social media, and producing
conspiracy-laden hagiographies that portrayed him as a persecuted brave maverick
who’s curing cancer but being unfairly attacked by skeptics, the FDA, big
pharma, and the law. To top it off, something I forgot to mention above is that 
he also was among the first quacks to use repurposed medical therapies. Indeed, 
around 13 years ago, he was promoting, in addition to his antineoplastons,
“gene-targeted” therapy as if he had invented the concept of genomic medicine,
an “innovation” that MAHA stans and quacks have taken as an example in their use
of “repurposed drugs” and other dubious cocktails used to treat everything from
COVID-19 to autism to cancer to the common cold. Basically, Burzynski learned
to hop on the latest promising modality for cancer, adopt and pervert it, and
then charge huge sums of money for it, in addition to his antineoplastons. Most 
recently, it’s immunotherapy.

Here’s the funny thing. At 83, even though he’s still quacking away, we hardly
hear anything about Burzynski. At least, I don’t. The last time I wrote about
him was in 2023, when I noted that his clinic was still operational and that he 
was still preying on desperate cancer patients. Looking at his clinic website
now, what I see is a rebranding in which antineoplastons are deemphasized and
various twisted versions of “personalized medicine” are front and center. Yes,
he now offers a “bespoke, patient-centered” concierge approach, because that’s
where the money is now. Just for yucks, I did multiple Google searches for
information on Burzynski that is less than a couple of years old and found
little. His clinic still exists, and, I must presume, continues to charge tens
to hundreds of thousands of dollars for his “bespoke” treatments (nearly all of 
which include antineoplastons).

It’s rather funny. As I said before, you’d think that Burzynski, who has a five 
decade history of recognizing trends in medical pseudoscience that will benefit 
him and then jumping on the wave at the right time, seems not to have gone MAHA,
something that I would have expected him to do. The further irony is that, even
though he was MAHA before there was MAHA, Burzynski seems not to be recognized 
as the pioneer in MAHA-style quackery that he truly is. As he enters the
twilight of his life, I have to wonder if that burns him, or if he’s just happy 
to keep quacking, keep representing himself as the brave maverick that The Man
couldn’t shut down, and, above all, to keep profiting.

Maybe it doesn’t matter to him, as long as MAHA cranks are in charge and leave
him alone to continue his half century of grift until he can’t grift any more.

Cancer quackery: Under MAHA, everything old is new again

A viral Instagram post claims that cancer is not a disease, but rather a defense
mechanism against “toxins.” Everything old is new again under MAHA.

David Gorski on August 10, 2026

Link


As seems to be the case almost every week, as I sat down to do my weekly post
for this blog, I had a hard time deciding what specific topic I should devote my
attention to, thanks to the hellscape that is our current government when it
comes to public health. News stories that Donald Trump is about to issue an
executive order on autism and vaccines, ordering more research into the already 
massively studied question of whether vaccines increase the risk of autism?
Let’s just say that if he had issued the order before this weekend, that would
have been my topic, but I didn’t see the point of speculating right now just how
bad it would be. News stories about how a notoriously bonkers “lab leak”
conspiracy theorist is on the short list to succeed Dr. Anthony Fauci as head of
the National Institute of Allergy and Infectious Diseases (NIAID)? I thought
about both, but then an Instagram post making the rounds (which appears to have 
been deleted since going viral and spawning a bunch of reaction videos) caught
my attention. Remember how during the pandemic I kept saying that everything old
is new again and that there is nothing new under the sun when it comes to
antivax narratives and lies? Unfortunately, under “make America healthy again”
(MAHA), the slogan repurposed by our current Secretary of Health and Human
Services, longtime antivax activist Robert F. Kennedy, Jr., the same is true of 
cancer, as I hinted at six months ago.

So, until we find out exactly how bad the predicted Presidential Executive Order
on vaccines and autism really is, I thought I’d revisit a more “classic SBM”
topic. Here are just a couple of the reaction videos to the original video that 
appears to be gone:






View this post on Instagram











       A post shared by Dr Idrees Mughal (MBBS, MRes, DipIBLM) (@dr_idz)





View this post on Instagram











                A post shared by James Cappola (@james_cappola)
Yes, it’s the revenge of the return of “cancer is not the disease but a body
defense mechanism” against X, X being “toxins” or some other external problem
caused by poor diet or external forces. And it’s all over social media again.
But that’s not all, as you will see. In any case, I haven’t dealt with this
particular claim in a long time, and so I thought it would be worth revisiting, 
given that it’s now seemingly everywhere. Truth be told, it never went away. No 
cancer quackery or misinformation ever does. Rather, it mutates, rather like the
genome of a cancer cell, in response to the environment in which it finds
itself.

Cancer is not the problem? (Robert O. Young)

It’s not difficult to find posts and content making this sort of claim, that
cancer is not the problem, but rather a survival mechanism that is trying to
protect the body, with the corollary claim that it is the medical treatments,
not the cancer, that cause complications and death from cancer, which, if you
believe the quacks, can be eliminated with “natural” interventions. Of course,
that leaves the question of why you would want to eliminate the cancer if it is 
a protective mechanism. The answer, obviously, is that you’re treating the “root
cause” or the “true cause” of the cancer, unlike that nasty surgery,
chemotherapy, radiation, immunotherapy, and targeted treatments that modern
oncology and surgery use now.

As I said before, the original Instagram post by Chelsea Chapman that inspired
the two reaction videos above appears to be gone. (If one of my readers has come
across it, let me know, as I’ve searched diligently and scrolled back through
way too much of Chapman’s Instagram feed than is good for my mental well-being
and been unable to find it.) However, here is a reel from a couple of years ago 
that says much the same thing:






View this post on Instagram











               A post shared by Onuche Edebo James (@onucheedebo)
And:






View this post on Instagram











         A post shared by Sinclair Fischer-Gray (@sinclairfischergray)
And:






View this post on Instagram











               A post shared by Neil Ryan Dumra (@neilryandumra)
The man in the video above is Leonard Coldwell, an old-school cancer quack whom 
I’ve mentioned before. From the first video:

Cancer is not a disease, it’s a survival mechanism. So cancer is not trying to
kill you, cancer is actually trying to save your life. Its creating a tumor, a
place for all those toxins to be so that they don’t spread to other parts of the
body. When you go to a doctor, the first thing they do is say okay, well let’s 
take a biopsy where they prick the tumor and they see if it was cancerous or
not। well first of all whether the tumor is cancerous or not, your passive
treatment is still the same so you don’t actually need; the biopsy. In fact,
most people don’t actually die from cancer. They die from the treatment of
cancer. Yes. And so so when they take that biopsy, remember that it we’re
dealing with health care, so there’s no money to be made off healthy humans. And
so when they prick the tumor, they’re opening it up and allowing the cancer
cells and all the harmful toxins to now spread throughout the body. So now you
go from having a tumor on biopsy, they come back, you know, a little bit later
and they say, “Okay, well now the cancer spreading all throughout your body.” So
we’re going to have to train uh you know, charge you more money and you’re
going to have to do more radiation, chemotherapy and all that…

In the spirit of how everything old is new again, this particular claim, that a 
cancerous tumor is not the disease but rather the body’s defense mechanism
against “toxins” is an old one. I first encountered it two decades ago, but it
predates that by at least three decades. In what context did I encounter this
claim? Does anyone remember Robert O. Young? I do, because it was in 2007 when I
first encountered a post by him entitled What is the cause of cancer? Is there 
a cure? Let’s see how familiar this sounds:

Cancerous tissue, above all other consequences of choice, has countless
secondary causes. But even for a cancerous condition there is only ONE PRIME
ORIGIN and CAUSE. I have simply summarized this origin and cause of cancerous
tissue in a few words. The prime origin and cause of cancerous tissue is the
over-acidification of the tissues then the blood due to lifestyle and dietary
choices. A cancerous tissue begins with our choices of what we eat, what we
drink, what we think and how we live. Cancer is a liquid and this liquid is a
toxic acidic waste product of metabolism or energy consumption.

According to Young, acid is the cause of cancer (of all disease, actually), and 
alkalinization is the cure in the form of what he referred to as “pH Miracle
Living.” But where does the tumor come in? Let’s take a trip down memory lane.
First, Young invokes the Warburg effect. I note that around 2007 was when
studying the metabolic causes of and contributors to cancer were all the rage.
After decades of being underappreciated, the Warburg effect became the focus of 
intense research because of observations demonstrating its importance. Indeed,
here’s a graph from a very good 2016 review on the Warburg effect showing the
explosion of scientific papers on the topic that started in the early 2000s:

For those who don’t remember, Otto Warburg won the Nobel Prize nearly 100 years 
ago for having discovered that many cancers switch from aerobic metabolism
(metabolism based on respiration with oxygen) to anaerobic metabolism, in
essence “choosing” (if you’ll excuse the anthropomorphizing of cancer) to use
glucose as their fuel. You don’t need to understand the details of the Warburg
effect to know that it posited that cancer was caused by metabolic derangements,
which is why a lot of the advocates of “natural” cancer remedies immediately
glommed onto it as justification for their claims that diet and lifestyle
interventions were better than surgery, radiation, and chemotherapy for “curing”
cancer.

Unsurprisingly, in the scientific literature, the debate is more along the lines
of, “Which came first, the chicken or the egg?” What I mean is: Was the
disordered metabolism observed in many cancer cells the result of the mutations 
which had caused the cancer, or were the mutations that caused the cancer a
result of disordered metabolism? Of course, we know from copious experiments
that there are single genes that can induce cancer, either by being
overexpressed (induced to make too much of their gene product) or silenced, by
themselves, but there is little doubt that there is a major metabolic
contribution to cancer. That’s part of why the current consensus is that somatic
mutations drive cancer and that the metabolic reprogramming is adaptive,
allowing faster growth, rather than a cancer-inciting event. That disordered
metabolism is the primary cause of cancer is very much a minority opinion in
oncology, although that doesn’t mean that targeting the metabolism of cancer
cells hasn’t proven to be useful for diagnosis, imaging, and some treatment.

But I digress. As I said, you don’t need to understand the Warburg effect to
understand why the following blather from Young is nonsense:

The following is a summary of understanding cancerous tissues:

Cancer is not a cell but a poisonous acidic liquid.

A cancer cell, is a cell that has been spoiled or poisoned by metabolic or
gastrointestinal acids.

A tumor is the body’s protective mechanism to encapsulate spoiled or poisoned
cells from excess acid that has not been properly eliminated through urination, 
perspiration, defecation or respiration.

The tumor is the body’s solution to protect healthy cells and tissues.

Cancer is a systemic acidic condition that settles at the weakest parts of the
body – not a localized problem that metastases.

Metastases is localized acids spoiling other cells much like a rotten apple
spoiling a bushel of healthy apples.

There is no such thing as a cancer cell. A cancer cell was once a healthy cell
that has been spoiled by acid.

The tumor is not the problem but the solution to protect healthy cells and
tissues from being spoiled from other rotting cells and tissues.

The only solution to the acidic liquids that poison body cells causing the
effects that medical savants call cancer is to alkalize and energize the body.

In conclusion, the human body is alkaline by design and acidic by function! If
we desire a healthy body we must maintain that alkaline design.

This is wrong on so many levels, particularly the part about cancer cells being 
healthy cells “spoiled by acid” but also including his claims that “alkalinizing
the body” will cure cancer. I also note that he claimed that viruses are
“molecular acids” (he claimed his “pH Miracle Living” could cure HIV/AIDS as
well) and that he is basically a germ theory denialist as well, having used the 
tragic death of a Brazilian model due to sepsis to claim that sepsis is not
caused by bacterial infection, but rather by “acidic lifestyle choices,
including acidic food, drink, and drugs – especially dextrose and/or antibiotic 
IV’s given at hospitals around the world.”

However, the case that made Robert O. Young most infamous was that of Kim
Tinkham. Tinkham, you might recall, was a woman diagnosed with breast cancer who
appeared on The Oprah Winfrey Show over 11 years ago. During the
interview, Tinkham told Oprah that she was not going to undergo surgery,
chemotherapy, or radiation but that, thanks to The Secret, she believed that the
universe would bring her healing, which was why she chose to use alternative
medicine to treat her cancer. (Often forgotten these days is that Oprah was
a big proponent of The Secret back then, which preaches that if you want
something badly enough, visualize something clearly enough, the universe will
manifest it for you.) Who was the quack that Tinkham chose? You guessed
it: Robert O. Young. As a result, Tinkham became a passionate advocate for
Young’s quackery, even recording YouTube videos with him to tout his “pH Miracle
Living.” Ultimately, Tinkham died of her disease, although it did take over
three years to happen. No one knows how many other cancer patients who didn’t
talk to Oprah Winfrey chose to trust Young, with the same results.

Cancer is not the problem? (Andreas Moritz)

Robert O. Young might have been the first quack that I encountered claiming that
cancer is a mechanism to protect the body against “spoiled” cells, but he is
far from the first to claim that cancer is not the problem, but a reaction to
the “real” problem. Around the same time, a cancer quack named Andreas Moritz
published a book entitled Cancer Is Not a Disease! It’s a Survival Mechanism.
(There’s even a chapter entitled “The Wisdom of Cancer.”) Here’s a taste of
Moritz’s “wisdom”:

If the body is designed to live and not to destroy itself, why then would it
suddenly allow the growth of extra cell tissue and kill itself? This does not
make any sense at all. The main obstacle to finding real cures for cancer is
that modern cancer treatment is rooted in the false assumption that the body
sometimes tries to destroy itself. Medical students are trained to understand
the mechanism of disease development, but they are left in the dark concerning
the origins of disease. Viewed superficially, to the students, an illness
appears to be something destructive and harmful to the body. Seen from a deeper 
perspective, however, the same illness is but an attempt by the body to cleanse 
and heal itself, or at least, to prolong its life. Since the medical textbooks
offer few insights into the true causes of illness, it is understandable that
the majority of doctors today believe that the body has self-destructive, and
even suicidal abilities or tendencies. Claiming to be non-superstitious and
objective, they inadvertently admit that certain cells suddenly decide to
malfunction, become malicious, and randomly attack other cells and organs in the
body. Based on this purely subjective and unsubstantiated belief, the doctor
and his patient alike become almost obsessed with trying to protect the body
from itself. Yet despite such undisputed notions of “truth,” none of this means 
that the body does, in fact, attempt or cause its own destruction. Would it
actually astound you if I told you that cancer has never killed a person?

The only thing that would astound me about this claim is just how much of a lie 
that it is. I have, sadly, seen many die of cancer, including at least two
family members thus far.

I love the whole argument from personal incredulity going on here. Just because 
Moritz can’t believe that the body would ever permit the growth of extra cells
that will lead to its destruction and death, he assumes that, in fact, the body 
does not permit the growth of extra cells that will lead to its death and
destruction. It is, of course, true that the body tries very hard not to allow
the growth of cancer cells that threaten it. There are lots of very complex and 
elegant homeostatic mechanisms to keep cells from “going rogue,” as well as
similarly complex and elegant immune surveillance mechanisms to destroy cells
that “go rogue” before they can progress to full-blown life-threatening cancers.
The error in thinking here is that these mechanisms are perfect, that they are 
foolproof, that they never, ever fail. Unfortunately, nothing in the world is
perfect and works 100% of the time. Our body’s defense mechanisms against cancer
are quite good, but they are unfortunately nowhere near perfect. They can and
do fail, and they fail more often as we get older and damage to the genome
accumulates.

Cancer is not the problem? (Ryke Geerd Hamer’s German New Medicine)

Still, Moritz didn’t think of the idea of cancer as a protective mechanism. Its 
origins go back at least a few decades earlier, to the late 1970s. Does anyone
remember Ryke Geerd Hamer’s German New Medicine (Die Germanische Neue Medizin)
and its bastard offspring, like the French version, Biologie Totale? Here’s the 
general idea:

THE GERMAN NEW MEDICINE provides us with illuminating explanations about the
origin, development and healing of both physical and mental disorders. In 1981, 
Dr. Hamer discovered that every DISEASE is caused by a shock experience that
catches us completely off guard. He found that this shock not only occurs in the
psyche but simultaneously in the brain and on the organ level. At the moment
the unexpected trauma takes place the shock impacts a specific area in the brain
causing a lesion that is clearly visible on a brain scan as a set of sharp
concentric rings. With the impact the affected brain cells communicate the
disturbance to the corresponding organ. Whether the organ responds with a tumor 
growth (cancer), with tissue degeneration, or with functional loss, is
determined by the exact type of conflict shock. Based on the analysis of over
40,000 case studies Dr. Hamer is the first to provide scientific proof that
cancer is not caused by a malfunctioning organism producing deadly cancer cells 
but is rather the result of an innate meaningful survival program that has been 
successfully practiced for millions of years. Since HEALING can only occur after
the conflict has been resolved, the GNM-therapy focuses on identifying and
resolving the original conflict. By understanding healing symptoms such as
painful swelling, infections, fever, or inflammation in their psychological,
biological and evolutionary context, we are able to liberate ourselves from the 
fear and panic that often come with the onset of an illness. Dr. Hamer’s
findings offer a completely new understanding of so-called diseases. His
scientific discoveries revolutionize entirely our view of medical conditions and
their causes.

The German New Medicine presents a comprehensive system that allows us to
understand what type of conflict causes the onset of a particular disease, how
the disease manifests itself in the conflict active phase, what can be expected 
in the healing phase, and how all the developments are connected to the brain,
verifiable with a brain scan.

See what I mean? The general idea is the same, except that it’s not “cells
spoiled by acid” or “toxins” or whatever that the cancerous tumor is protecting 
you from. It’s psychic trauma. In a way, Hamer’s conclusion is somewhat
understandable if you know his history. It turns out that Dr. Hamer’s son was
tragically shot in his sleep by Vittorio Emanuel, the last crown prince of
Italy. After a prolonged course requiring multiple operations, his son
unfortunately succumbed to his wounds, which undoubtedly caused Hamer immense
emotional trauma, as the sudden loss of a child always does. Three years later, 
Hamer developed testicular cancer. After that, in a perfect case of post hoc
ergo propter hoc reasoning, Hamer decided that it must have been the psychic
shock of his son’s death that had caused his cancer. Forget about all that
molecular biology. Forget about oncogenes and tumor suppressors. Forget about
increased mutation rates. Hamer, like many cancer quacks before him, preached
that everything that scientists thought they knew about the pathogenesis of
cancer was wrong. To him, cancer was (and is) really due to a “psychic shock,”
not genetic alterations in cells that lead to uncontrolled proliferation.

What about cancer patients who have lived happy lives devoid of “highly acute,
dramatic, and isolating shocks”? There’s no such person, according to Hamer. If 
you search back far enough, you will find such a shock, and if that fails, you
can always postulate some sort of birth trauma. As I always say when I discuss
the German New Medicine, I don’t mean to minimize the tragedy that Dr. Hamer
must have suffered because of the shooting of his son and the fact that the
killer got off with a slap on the wrist because of his title and wealth, nor am 
I claiming that mental stress doesn’t contribute to disease. Unfortunately,
Hamer took his tragic personal experience and generalized it to a ridiculous
extreme, even to the point of basing rather arrogantly named “biological laws”
on it. It’s as if the shock of losing his son unhinged his mind. I’m not going
to reiterate all five of his “Iron Laws” of cancer and other diseases other than
the First Law, a.k.a. the Iron Rule of Cancer, which is subdivided into three
criteria:

  1. The development of the conflict determines the exact development of the Hamer 
    Focus in the brain as well as the exact development of the cancer or
    cancer-equivalent disease in the organ.

  2. Every cancer or cancer-equivalent disease originates from a DHS (Dirk Hamer
    Syndrome), which is a serious, highly acute, dramatic and isolating shock
    that catches an individual completely off guard. The conflict shock occurs
    simultaneously in the psyche, the brain, and the corresponding organ.

  3. At the moment of the DHS, the content(s) of the conflict determine the
    location of the Hamer Focus in the brain and the location of the cancer or
    cancer-equivalent disease in the organ.

According to Hamer, every cancer patient has suffered DHS, and the evidence is a
lesion in the brain observable on CT scans called the Hamer Focus, visible “as 
a set of sharp concentric rings.” (HINT: No one has ever observed the Hamer
Focus in cancer patients.) You can read in detail about the rest of the “Laws”
that Hamer posited here, if you wish. Suffice to say that Hamer’s ideas were the
“inspiration” behind so much quackery. Indeed, one variant of the “cancer isn’t
the disease but the defense” is the risible claim by Tullio Simoncini that all 
cancer is a fungus.

One can argue that the basic germ of the idea that cancer isn’t really the
disease but the defense against disease goes back even further, to an idea held 
by a minority of conventional pathologists around 1900. Sometimes referred to as
the parasitic theory of cancer, the idea was that cancer was an attempt of the 
body to “encapsulate” pathogens. Of course, today we know that some cancers are 
indeed caused by infection, such as cervical cancer being caused by certain
strains of human papillomavirus and stomach cancer being caused by H. pylori
infection, but the mechanisms are nothing like what was proposed in the
parasitic theory of cancer. A related concept is Antoine Béchamp’s terrain
theory, which hypothesized that microorganisms were not the cause of disease,
but a manifestation of diseased tissue or a “terrain” that was not in
homeostasis.

Cancer is not the problem? Only if you don’t understand cancer!

These days, the idea that cancer is a protective mechanism nearly always posits 
unnamed “toxins” as the danger that cancer is supposedly trying to protect the
body against. Worse, these influencers nearly always claim that cancer is
completely—or almost completely—avoidable because it’s a consequence of
lifestyle choices, as Robert O. Young put it in 2007:

Cancer is not something we get it is something we do as a consequence of daily
choice of what we eat, what we drink, how we think and how we live. We either
have an alkaline lifestyle and diet and enjoy a fit and healthy body or we have 
an acidic lifestyle and diet and experience the aches, pains and suffering from 
metabolic acids.

And:

A cancerous condition is the consequence of choice. For example, if you want to 
reduce your risk for cancereous tissue of the lung by 100%, then stop smoking
and stop associating or working around people that do smoke.

Secondary smoke is just as acidic and damaging to the lung tissue.

If you don’t want a cancerous liver then stop drinking alcohol and carbonated
drinks.

If you don’t want a cancerous pancreas then stop eating the acid, sugar.

If you don’t want a cancerous bowel then stop eating protein.

It is that simple.

The only things in the above passage that are correct are that stopping smoking 
will reduce your risk of lung cancer and stopping drinking will reduce your risk
of liver cancer. Too bad Young comes to the right conclusions in these two
cases for the wrong reasons. The idea, however, is very much of a piece with
what MAHA has embraced, namely health as a consequence of virtuous health
behavior, in which you are damned near entirely responsible for your own health.
In this case, the health “reward” is freedom from cancer. Unfortunately, the
flip side of this idea of personal responsibility for one’s health is that, if
you aren’t healthy and are unfortunate enough to get cancer, then it must be
your fault for not living a sufficiently “virtuous” lifestyle.

Unfortunately, this answer resonates among those skeptical or hostile to
conventional medicine, leading to posts like this:

While I’m glad that this woman is apparently alive ten years after a diagnosis
of a stage IV cancer, her survival doesn’t mean that cancer was beneficial to
her and not trying to kill her.

Of course, we now know a lot about how cancer originates, progresses, evades the
immune system, and ultimately kills its host if left untreated. Unfortunately, 
we do not know enough to come close to curing all cancers, and some cancers
(e.g., pancreatic cancer) remain deadly and difficult to treat. We do, however, 
know enough that the death rate from cancer has been steadily declining for the 
last three and a half decades, having declined by approximately 34% since 1991. 
That’s what science can do, and deluding oneself into believing that cancer
can’t and won’t kill you won’t change that, other than to provide a reason to
blame cancer deaths on the treatment rather than the disease.

Sadly, there is nothing new about this. Everything old only seems new again
because, before MAHA and the rise of so many quack influencers, most people
hadn’t encountered quackery like the claim that cancer is not a disease, but a
defense mechanism used by the body to protect itself from toxins.



Alternative cancer clinics, distrust of medicine, and MAHA

Yesterday’s New York Times featured an article about a man with terminal lung
cancer who was enticed to chase cures that didn’t exist. He died before the
pandemic. Will MAHA turbocharge this sort of quackery in the US?

David Gorski on October 5, 2026

Link


I’ve been writing about dubious cancer clinics that provide unproven (and
disproven) cancer therapies, cash (or credit card) on the barrelhead, since the 
very beginning of this blog in 2008. These clinics tend not to be located in the
US, preferring more—shall we say?—regulation-poor countries like Mexico or
nations in Central America, Asia, and the former Soviet Union, or in certain
European countries with a lax attitude towards clinics such as the Hallwang
Private Oncology Clinic in Bavaria. That’s not to say that such clinics don’t
exist in the US. After all, I’ve been writing about Stanislaw Burzynski and his 
antineoplaston quackery for well over 15 years now, and his clinic still
functions in Houston, with Burzynski himself still quacking strong at age 83.
Ever since the pandemic and the rise of the “make America healthy again” (MAHA) 
movement, I’ve paid less attention to such clinics than I used to do before
2020. So, when I came across a story in the New York Times Magazine this weekend
by Trisha Thadani documenting how her father, Rajeev Thadani had been enticed
by just such a clinic to treat his stage IV lung cancer, I saw an opportunity to
revisit this subject. (Spoiler alert: Sadly, Mr. Thadani died of his disease.) 
I even approved of the title, something that is often not true as legacy media
like the NYT is often too cautious to be too blunt: Dying Patients Are Inundated
by Misinformation. My Dad Was One of Them, with the tagline: “Cancer patients
are being persuaded to spend tens of thousands on unproven treatments by
alternative-medicine clinics.”

Yes, they are. And they have been preyed upon this way for many decades. Indeed,
as I read the very sad story of Rajeev Thadani, I kept thinking that the clinic
where he went, Envita Medical Centers in Arizona, sounded very much like
Hallwang Private Oncology Clinic in Bavaria, only that it was trying even harder
to appear scientific in its approach, even though, right on its website, it
answers the question of whether it does clinical trials thusly:

Envita has done clinical trials in the past but does not do clinical trials
currently, due to several reasons. Dr. Dino Prato and Dr. John Oertle discuss
how clinical trials are important for the discovery of a new drug, but at Envita
Medical Centers and Center of Excellence, the focus is not on one single
therapy, drug, or treatment. The world class integrative center for precision
oncology aims to enhance treatment options for cancer patients by utilizing
cutting-edge combination treatments, which include immunotherapy, proprietary
interventional radiology procedures, genetically targeted chemo agents, and
integrative adjuvants. We aim to provide a greater selection of treatments based
on each patient’s genomics, as opposed to putting all our efforts and hopes
into a single drug to produce a response to care.

In other words, no. Envita doesn’t do clinical trials. Instead, the doctors
there “work towards providing a revolutionary treatment plan by going beyond the
limitations of large sample clinical trials that have a rigid framework of who 
can or cannot qualify for them” and utilize “a multi-pronged precision oncology 
plan based on the n-of-1 clinical trial model, as well as our advanced
algorithms which have been developed over the course of two decades in helping
late-stage cancer patients respond to care. Our proprietary precision testing
guides us to the most suitable agents for treating each patient’s cancer and its
microenvironment to help with their holistic recovery.” Sure, whatever. Because
some random clinic in Arizona has surpassed the greatest cancer centers in the 
world in developing these algorithms, which are so awesome that the doctors
there don’t think they can do clinical trials because they just know they’re
curing patients. This is, of course, my interpretation of what they are saying
based on many years of hearing very similar claims, including Burzynski’s own
touting of “personalized gene-targeted therapy” 15+ years ago.

And guess what? The clinic also states that it takes “advantage of the expanded 
right to try law to utilize the latest in conventional medicine, including drugs
and therapies that are still in the clinical trial phase, and combine them with
precision genomic chemotherapy, immunotherapy, and integrative agents,” doing
exactly the sort of thing I was warning about all those years ago when
right-to-try first reared its ugly head: Using it as a get-out-of-jail-free card
to justify using whatever “experimental” therapies they want to profit from.

I’ll get back to these issues that facilitate the existence of clinics like
Envita, and you’ll love their other justification for not doing clinical trials 
of their dendritic cell therapy. However, first let’s center this story on the
victim, Rajeev Thadani, and his story told through his surviving daughter. The
story, besides showing once again how these sorts of clinics exist and profit by
charging desperate dying cancer patients tens or even hundreds of thousands of 
dollars for unproven treatments, plus a lot of “alternative medicine.”

Rajeev Thadani: Modern medicine vs. “holistic” care?

Reading the story of Rajeev Thadani depressed the hell out of me, because I’ve
read so many similar stories and blogged on a number of them over the years.
That’s why I’m going to quote directly the first few paragraphs of the story:

My mom was making lunch when she heard a thump come from the bedroom. She ran
upstairs and found my dad face down on the carpet, blood seeping from a gash
under his eye.

For days, he had been feeling lightheaded and fatigued since receiving a round
of chemotherapy at Memorial Sloan Kettering Cancer Center. He was sitting on the
edge of the bed when suddenly, he told my mom, everything went black. Thump. As
my mom struggled to lift him from the ground, he vowed that he was done — done 
with Western doctors, who he said were “crooks” and “quacks”; done with
“poisons” coursing through his body; done with sickening treatments he didn’t
believe in.

“I’m going to die if I keep doing this,” he told her.

That evening, with a bruised eye and a stiff neck, my dad decided to book a
flight from New Jersey to Arizona so he could check out a clinic he had found on
the internet. On its website at the time, the clinic, Envita Medical Centers,
said that its unique protocol had helped patients “outperform other renowned
cancer centers for nearly two decades.” Its “proprietary” chemotherapy treatment
was “so gentle,” it said, “that many patients report being able to hike and
exercise” during care. My dad believed this outpatient clinic — which cost
nearly $10,000 a week — could save him from the Stage 4 lung cancer ravaging his
body.

How many times have I read variants of this sort of patient anecdote? I’ve lost 
track. Usually, they don’t start quite so dramatically, with a fall and a head
injury leading the patient to decide to go down the alternative cancer cure
path, but the beats are all there: a patient with a terminal cancer, tiredness
and hopelessness undergoing conventional therapies for their disease, and the
search for “alternatives” that leads to the patient finding the one clinic that 
gives him hope through patient testimonials. Also, the clinic charges huge sums 
of money for its treatments and doesn’t take health insurance. This narrative
sounds just like the narratives I’ve encountered for cancer patients such as
Pauline Gahan, a British woman who spent £300,000 at the Hallwang clinic to
treat her metastatic cancer, or any of the many patients attracted to the
Burzynski Clinic from the UK and US. It’s the business model of these clinics.
They offer “hope” to patients who have cancers that are not treatable for cure
using conventional therapies, cancers like stage IV lung cancer, although
Burzynski did seem to specialize in terminal brain tumors.

They also often offer something that, I’ve admitted many times, conventional
hospitals and clinics can lack: the human touch. In the US, the reason tends to 
be underpayment for services by third-party payers and our for-profit healthcare
system; in countries with universal health insurance, it tends to be because of
underinvestment in the healthcare system, as has been happening in Canada.
Thadani describes it herself, and I have experienced it dealing with my parents 
and the medical system when both of them were experiencing declining health
simultaneously in the months and years before they died. Her father was
initially treated at Memorial Sloan-Kettering Cancer Center, arguably the
premier cancer center in the US, if not the world, and this is what she
described in an accompanying interview with Adam Kushner, editor of the NYT The 
Morning newsletter:

I texted a friend at the time: “The staff has been so rigid and unpleasant”; a
doctor “made us feel like a burden”; “one nurse didn’t even look up from her
computer!” Those moments really add up. But I have to give a disclaimer that my 
dad was a difficult patient. He went into his oncology appointments after
spending hours researching alternatives. He did not want to be there and didn’t 
stay.

Who among us hasn’t experienced these little indignities, or even much worse,
when dealing with the healthcare system? Now contrast that to how Thadani
describes in the same interview what happened at Envita:

I was very skeptical, but I felt reassured as soon as we got there. During our
first visit, a naturopathic medical doctor sat with us for nearly four hours to 
explain their unique treatment regimen. It seemed so promising that I started to
think my dad would actually beat his disease. I was thrilled at how much better
my dad looked during his first weeks at the clinic. He finally had hope, and
that was having a real effect on his mood and energy.

Of course, stopping chemotherapy allows the adverse effects of the chemotherapy 
to wear off, and patients often feel better after that. Their cancer is still
growing, though. It just hasn’t hit the point where it’s causing horrendous
symptoms. Again, this is a very common feature of alternative cancer
testimonials. Also, the practitioners at such clinics spend lots of time with
patients, largely because they are able to because their payment doesn’t depend 
on what insurance companies or government payers like Medicare will reimburse
them for. The contrast with conventional medical facilities is often just that
jarring.

Moreover, Mr. Thadani was very much predisposed to distrust conventional
medicine, as is documented in the story:

The modern medical system reminded him of all he learned to fear from his own
father, an Indian homeopath, who worked at an alternative-medicine practice in
Midtown Manhattan. Patients traveled from across the country to see my
grandfather after finding him through televised interviews and a lecture series,
where he disseminated his views that vaccines are dangerous and American
children overmedicated. He also taught his audience about the healing power of
homeopathy, an unproven alternative medical practice developed in the late
1700s.

It was this distrust that led Mr. Thadani to ignore evidence of early-stage
cancer incidentally found on a CT scan done to screen for cardiac disease in
early 2019. You can picture the sort of man Mr. Thadani was, as I see elements
of my father’s behavior in him. According to the story, the only reason Mr.
Thadani agreed to get the scan was because his wife had basically forced him to 
do it after having heard from a friend how he had undergone such a scan and been
found to be at imminent risk for a heart attack. The results were:

The scan, which cost them each $750 out of pocket, revealed mostly healthy
hearts but showed a concerning image in my dad’s lungs: “interstitial lung
disease prominent in the lung apices” and “a nodule of ground glass lesion in
the superior segment left lower lung,” according to the report. The doctor
called five days later, on a Saturday morning, to implore my dad to get it
checked out. “Don’t ignore this,” my mom remembers him saying. My dad smoked
several Marlboro cigarettes a day for some 40 years, but with no symptoms at the
time, he dismissed the results as unnecessary hysteria from a doctor.

Given that Mr. Thadani had been a smoker for decades before, albeit a light
smoker who only smoked “several cigarettes a day,” you can see how such a
finding would be very concerning. Several months later, Mr. Thadani developed a 
dry cough and, instead of following up on the concerning findings on his chest
CT, went to his homeopath, who “initially suggested that he try rubbing castor
oil under his arms and also take Carbo Vegetabilis, a remedy typically used for 
indigestion.” Mr. Thadani’s symptoms continued to progress until he was unable
to make it all the way up a single flight of stairs without stopping to catch
his breath. This finally pushed him to see a pulmonologist, who did a
bronchoscopy and diagnosed multiple cancers in his lungs. His family managed to 
persuade him to go to MSKCC, although there’s an anecdote in the story about how
his wife woke up in the middle of the night and found him not in his bed, but
at the computer “looking for alternatives.”

Given this, it should perhaps not be surprising that, for all the effort Ms.
Thadani, her mother, and her brother put into persuading Mr. Thadani not to fly 
to Arizona to be treated at Envita, he only made it through one round of
chemotherapy, which led to him saying that he “felt so horrid that he vowed to
never go back,” after the incident that started the story, in which he fell and 
split open his scalp.

From here on out, I’m going to try to be a lot more strategic quoting the news
story, because you really should read it for yourself, but I will summarize Mr. 
Thadani’s story and course at Envita, first noting that Envita was not the first
clinic that had interested him. He was first interested in a clinic in Florida,
“whose treatment plan of ‘nontoxic’ alternatives cost $4,000 to $5,000 a week,”
but didn’t go when he learned that the clinic’s lead doctor would have multiple
complaints lodged against him beginning in 2021, ultimately losing his license 
in 2025. (Yikes! He must have been horrible, given how quack-friendly Florida
was and how much more quack-friendly it’s been since the rise of MAHA!)
Curiosity got the better of me, and I just had to do some Googling. The only
physician offering alternative cancer treatments that I could find whose license
was revoked in 2025 was Dr. Carlos M. Garcia of Utopia Wellness, whose license 
was revoked in March 2025 for using intravenous cesium to treat cancer, and I’m 
pretty sure that this is probably the doc and that Utopia Wellness was likely
the clinic.

But back to Envita.

Envita: Bespoke concoctions of approved drugs and delivery systems plus quackery

According to the story, it was the anecdotes that led Mr. Thadani to want to go 
to Arizona to be treated at Envita, one anecdote in particular:

But it was Envita, based in Scottsdale, Ariz., that he was most taken with. On
its website, the clinic said that it employed doctors “from a variety of
disciplinary backgrounds,” which included those with standard medical licensing 
and naturopaths. In an email, a patient coordinator told my dad that the clinic 
was “strategically” located in Arizona because the state “has the largest scope 
of practice for integrative medicine.” The clinic also claimed to have helped
“thousands” of patients from around the world.

My dad’s cousin happened to know a friend of a friend who went there for
late-stage cancer, and my dad was able to call him. He told my father that
before he went to Envita, he was emaciated from his cancer and sure he was going
to die. But now, he said, he was golfing, boating and enjoying time with his
children.

After that conversation, it was settled: My father knew that Arizona was where
he needed to be.

Ah, the old “friend of a friend of a cousin” anecdote. It gets ’em every time.
Whenever I hear stories like this, I can’t help but note that the actual patient
is almost never identified, which, of course, makes it impossible to check out 
the anecdote in order to determine whether it’s a plausible inference that
Envita helped the patient or not. So I looked at some of the testimonials that
Envita includes on its website. Many appear to be of the sorts that I’ve
described. For example, take this testimonial of a patient with stage IV
colorectal cancer metastatic to the liver, whose metastases had been discovered 
within a month of surgery. The conventional oncology plan was for him to undergo
a liver and gallbladder resection to remove the metastases, which is pretty
standard when the metastases are resectable, followed by chemotherapy, which is,
again, standard treatment. As I mentioned last week while discussing cancer
metastases, such treatment can result in long-term survival 25-35% of the time. 
Now here’s the kicker:

However, with Envita’s advanced precision integrative oncology options, which
combine the latest in conventional medicine with research-based natural
therapies, Christian experienced exceptional results. “After the two months in
Envita and such great results… the tumor in my liver had shrunk in half,” said
Christian.

With a much smaller tumor to remove, the outcome of his scheduled surgery after 
pursuing care at Envita proved to be significantly different from what was
expected. “We had to take out a lot less liver than we thought—less than 10
percent—did not have to take out the gallbladder, and with all the tests, I did 
not have to get the pump [for regional chemotherapy] … that’s radically
life-changing,” added Christian, while explaining how he benefited from Envita’s
precision-targeted care options.

Wow! Sounds fantastic, right? Here’s the thing. Neoadjuvant chemotherapy
(chemotherapy given prior to surgery with the intent of shrinking the tumor to
make an unresectable tumor resectable or to make the surgery to resect the tumor
less extensive) is an accepted treatment for potentially resectable metastases 
from colorectal cancer. However, it is usually reserved for tumors that are
borderline resectable. Reading between the lines, what Envita appears to have
done is simply to give its proprietary concoction of chemotherapy, which it
calls GTFC™ (Genetically Targeted Fractioned Chemotherapy), a “proprietary
treatment utilizing not only low doses of targeted chemo agents, but it also
enhances the impact on cancer cells by utilizing novel therapeutic windows
induced by natural and integrative medicine” that delivers “targeted
chemotherapy to the tumor by using a ‘Trojan Horse’ delivery mechanism.” A
“Trojan horse” delivery system attaches the therapeutic drug to a vehicle that
seems harmless to the body but delivers the drug to the cancer cells more
specifically. Such vehicles can include antibodies, modified immune cells,
nanoparticles, and viral vectors. Do we know how the drugs were delivered or
what drugs were used? Of course not! The mixture is proprietary!

GTFC™ is, however, likely chemotherapy, possibly mixed with immunotherapy. Does 
it work better than conventional chemotherapy? We have no way of knowing because
Envita didn’t publish any clinical trials testing GTFC™ versus standard-of-care
chemotherapy to determine whether it is more efficacious and less toxic. Could 
it work? Possibly, but, again, even if it does work, we don’t know how it
compares to standard-of-care. Its efficacy might have been similar to, lower
than, or greater than conventional chemotherapy. We have no way of knowing. In
any case, Christian is alive mainly because of conventional treatment,
especially the surgery, but, as is the case in most alternative cancer cure
testimonials, he attributes his good fortune to the “alternative” cancer
therapies that he had chosen to pay tens or hundreds of thousands of dollars to 
undergo.

The same likely applies to Envita’s other “proprietary” concoctions, including
PVM (Platelet Vesicle Medication) GTF™, whose delivery, if you believe Envita,
“is designed to selectively affect the inflammatory microenvironment of tumors
and cancer cells,” and Chemo Immuno Precision Injections (CIPI™), described as a
“minimally invasive proprietary treatment for deactivating tumors by deploying 
anticancer agents directly at the tumor site” using interventional radiology. I 
can’t help but note that we’ve tried injecting therapeutic substances directly
into tumors for literally decades, if not hundreds of years, and the track
record is, in general, poor. How is Envita’s CIPI™ any different? It’s not,
really, given its description as “customized immunotherapy treatments that are
combined with adjuvant agents and deployed directly inside the tumors of
concern.” Again, this sort of thing has been tried before with at best mixed
success many, many times, which makes it incumbent upon Envita to prove that its
protocol actually works.

Let’s take a look at a couple of tables Envita includes in its description,
first for GTFC™:

I love the almost Quack Miranda warning at the bottom of the table! (It lacks
the part about the treatment not being FDA-approved.)

And for CIPI™:

Yep. More weasel words at the end.

You can see how Mr. Thadani would have been impressed by such tables and such
descriptions of the treatments offered at Envita! They sound so much better than
what he had experienced undergoing just one round of the chemotherapy for stage
IV lung cancer that had been recommended. Add to that testimonials, such as
this one from a man with stage IV prostate cancer who was asymptomatic at the
time of his diagnosis and whose cancer was only discovered by PSA testing who
claims to have had his PSA return to normal under Envita care but does not say
whether imaging studies show his cancer to have regressed after the CIPI™
treatments; a woman with stage IV breast cancer metastatic to bone who, if her
cancer was estrogen receptor-positive (as 70% of breast cancer is) could
potentially survive quite a few years under conventional treatment but
attributes her doing so well to Envita; and a man with a cutaneous B-cell
lymphoma that was clearly very indolent given that he had survived “decades”
with it prior to Envita. One thing I noticed about these testimonials is that
they all rely on tumor markers to say that the cancer had responded to
treatment; I looked for descriptions of imaging studies and found almost
nothing.

Then there was this testimonial of a woman with “stage 2 triple negative breast 
cancer.” The first thing to note is that stage 2 breast cancer is treatable for 
cure. In the case of the triple-negative variety, a stage 2 cancer would be
treated first with neoadjuvant chemoimmunotherapy according to the KEYNOTE-522
protocol, followed by surgery and, if the breast is saved or there is found to
be tumor in the axillary lymph nodes on the side of the cancer, radiation. With 
such treatment, one can expect a five-year recurrence-free survival in the 80%
range. The neoadjuvant treatment produces a pathologic complete response rate
(no tumor found in the surgery specimen) higher than 60%. This is all very
standard. However, reading and watching the patient’s story, I found it hard to 
tell if she was being represented as metastatic. It’s not even clear whether she
ever underwent surgery or how long she has survived since her diagnosis.

The mouse-over reveals a real Quack Miranda warning, complete with the mention
that the treatment is not FDA-approved! No wonder, as in the video the patient
describes “low dose chemotherapy” with “high dose supplements.”

Basically, all the testimonials, as described on the Envita website, are pretty 
useless for determining whether Envita’s claims of efficacy are true. There’s
just not enough information provided.

So what did Mr. Thadani receive? I think it’s worth quoting again here, because 
it was a naturopathic quack who first went over the treatment plan and what it
would cost:

The naturopath turned to a whiteboard behind him to explain Envita’s
“proprietary” chemotherapy regimen ($2,315 per treatment), which included
lowering my dad’s blood sugar with insulin and delivering low doses of
chemotherapy into his body. The side effects would be minimal, he said, far less
than what my father felt with standard chemotherapy. Envita would also send him
to a clinic it operated in Mexico to receive a cell therapy ($125,000) that the
naturopath said would help his body fight off whatever cancer cells remained.

While I was sitting in his office, a nagging thought emerged: What if Envita
actually had the secret cure for my dad? Its treatment seemed sophisticated,
thoughtful and promising. The naturopath said his own father was successfully
treated at Envita — evidence of how much he trusted the protocol that he was
recommending for mine.

Those are the things that I remember, at least. Now, looking through my dad’s
medical records, I can also see that his treatment plan came with a battery of
what Envita calls “supportive” therapies. Many of them had little to no clinical
evidence supporting their use in cancer care. They included infusions of
hydrogen peroxide ($215 per infusion); a therapy that included adding
medical-grade ozone gas, a known toxin, to his blood (also $215 per infusion);
and coffee enemas, which carry side effects such as rectal burns and severe
infections. If the naturopath told us about these specific therapies with the
risks clearly outlined, I didn’t hear it. By that point, my skepticism had
largely fallen away, and I heard what I desperately wanted: that the clinic was 
safe and effective.

Here’s a hint about these clinics. If it sounds too good to be true, it is.
These clinics do not have “secret cures” for cancers that conventional
oncologists cannot treat for cure, but only palliation. Unfortunately:

It’s one thing for a doctor to inform you of all the clinical trials, the
rigorous scientific evidence, the percentage chance of one therapy working over 
the other. But it’s another to be looked in the eye by another human and told
that your suffering is real and that you will be OK, and to hear that there is, 
in fact, a secret cure, a magic bullet. Looking back on those desperate months
with my father, I can see clearly how much he valued the feeling of his care
above anything else.

This is precisely how these clinics lure their patients in.

Also, note the “supportive care.” As I’ve discussed many times right here on
this very blog, coffee enemas are pure quackery associated with the Gerson
therapy, and infusions of hydrogen peroxide are also not only unproven but
disproven. However, the business model of clinics like Envita and Hallwang is to
pitch “integrative care,” “the best of both worlds” that supposedly combines
the best of cutting-edge medicine that’s so cutting-edge that nothing about its 
efficacy or safety has been published or even subjected to clinical trials, plus
rank naturopathic quackery.

In fact, the cancer therapy is often quackery too. Did you notice that part
about “lowering my dad’s blood sugar with insulin and delivering low doses of
chemotherapy into his body”? That’s obviously a rebranded form of a cancer
quackery known as insulin potentiation therapy, which is known not to work and
is also potentially dangerous if a patient’s blood sugar is lowered too much.
(Read this article on Quackwatch about IPT if you want the details. In fact, it 
makes me wonder whether the GTFC™ therapy being sold by Envita is nothing more
than IPT in which the “low dose chemotherapy” is chosen in a
make-it-up-as-you-go-along manner based on various genetic tests.

The overall cost is a familiar story too:

At this point, the costs were staggering: around $200,000 since moving to
Arizona, a price that mostly included invoices from Envita. There were also
scans and outside therapies the clinic recommended, like “colon hydrotherapy,” a
treatment that supposedly cleansed toxins from his body (though there’s little 
scientific evidence to support it). This accounting does not include all the
supplements he needed to take, which at one point was 14 different pills, twice 
a day.

His Envita medical records from this time detail his lethargy, his cough and his
precipitous drop in weight. At certain points, the records show, Envita’s
doctors referred my dad to the emergency room or to an outside pulmonologist
when his symptoms got particularly bad. But there were also a few bits of good
news that my dad clung to. In January, he was told that there were some signs of
improvement in his lungs and that the lesions in his brain — which were being
treated by an outside radiation oncologist — were disappearing.

Any positive news contrasted with the person we were seeing — a man suffering
and shrinking, a husband and father wasting away. My mom, desperate to return to
her support system in New Jersey and horrified by my dad’s rapid decline,
suggested that they go back to Memorial Sloan Kettering — or, at the very least,
call the oncologist for a second opinion. But my dad refused, saying that
Envita’s treatments were just running their course.

Notice how Envita was falling back on conventional medical care to treat the
brain metastases and was trying to send him to the emergency room because he was
so obviously deteriorating. I note that, prior to this, according to the NYT
article, Mr. Thadani had done pretty well for a few months. He felt reasonably
well, and the environment at Envita when he went for his treatments was quite
pleasant, with an attentive staff. Again, this is not an atypical story after a 
patient stops chemotherapy and his cancer has not yet progressed enough to
worsen his symptoms. Ms. Thadani recounts how, when her father finally ended up 
in a nearby hospital in the ICU because his breathing and oxygen saturation had 
deteriorated so much, the ICU doctor asked where his cancer was being treated.
When informed that it was Envita, he told them that he saw patients like her
father “all the time” coming from Envita, concluding, “You wasted your money.”

I agree with Ms. Thadani that such a response from a doctor was quite callous
and totally inappropriate. On the other hand, even Ms. Thadani became more
understanding of that doctor when she did more investigating and found that
Envita had a long history of investigations and complaints about “selling
treatments ‘at a high cost to desperate subjects’ and administering unapproved
drugs to vulnerable, end-state cancer patients.” She also learned that Envita
was far from unique, noting that she had “found dozens of similar businesses
around the country that provide cancer patients with costly, unproven
treatments” and “spent months trying to figure out what kind of oversight exists
for such clinics, only to discover a confusing patchwork of laws that vary from
state to state.” From my perspective, that doctor’s response reminds me very
much of a news report from Panorama on the Burzynski Clinic in which an
interview with Dr. Jeanine Graf of the Texas Children’s Hospital, a pediatric
intensive care unit doctor, detested Burzynski and took care of many of his
patients who had deteriorated while being treated with his quackery.

At the risk of injecting myself too much into this story, which is really about 
how an alternative cancer clinic takes advantage of desperate patients, I can’t 
help but think that I wish she had discovered me and called me. I could have
helped her so much with her story. At least, I like to think that I could have, 
and I wish I could have, given how much the story of her father moved me, being 
so similar to a number of stories that I had written about and analyzed over the
years. My own self-absorption aside, one part really got to me. After noting
that “it felt as if there were two options: treatment at any cost or death and
how she “cannot remember a moment when the third option — acceptance — even
crossed our minds,” she describes deciding to take her father off his ventilator
and how he took much longer than expected to finally pass away, and how he kept
wanting fenbendazole to save his life, apparently having discovered “turbo
cancer” quack William Makis before his condition deteriorated, noting in the
accompanying interview that her “dad spent some of his final conscious moments
yelling at us to give him some.”

Moreover, this part of her story didn’t surprise me in the least:

Alternative treatment protocols like the one my dad received at Envita are often
not covered by insurance and can cost families tens — if not hundreds — of
thousands of dollars. My parents were able to shoulder the expense, but there
are many whose decision to seek care drives them into serious debt. I came
across hundreds of GoFundMe pages of people asking their communities for help
and spoke to several families whose loved ones sold off assets or ran through
their small savings to afford such treatments. Some claimed they were betrayed
or misled by their clinics but felt their only recourse was to write a bad
online review. (I would also later leave Envita a one-star review online.)

It’s just a fancier version of the Burzynski Clinic, and, yes, I’ve written a
lot of stories about desperate families using GoFundMe and other such
crowdsourced funding sites to pay for cancer quackery. It saddens me to see that
the situation remains basically the same as when I first discovered it 20 years
ago.

Will MAHA make things worse?

One point that Ms. Thadani makes that led me to start thinking about one of my
“favorite” topics again is about the mistrust of the medical establishment that 
her father had been harboring before his cancer diagnosis:

As this unfolded in the fall of 2019, I dismissed my dad’s choices as an extreme
reaction by someone who had long preferred natural remedies and didn’t like
going to the doctor. But that was before the pandemic eroded trust in the
medical system and the Make America Healthy Again movement elevated such
skepticism into the federal government. Now I look back on my dad’s aversion to 
conventional medicine and realize it was more than just personal eccentricity;
it was also an intimate preview of an ideology that was on the brink of going
mainstream.

As my dad was, patients today are inundated with misinformation spread by
alternative-medicine practitioners, social media influencers and public figures.
They are willing to experiment with unproven therapies, often at great physical
or financial risk, in part because they want more personalized and empathetic
care — an antidote to the famously harsh aspects of traditional medicine.

This tension is nothing new. “Integrative medicine” frequently advertises itself
by portraying conventional medicine as cold, bureaucratic, too scientific, and 
not caring about the individual patient, while wrapping itself in the human
touch. Unfortunately, thanks to the manner in which we as a society choose to
construct our medical system, there is more than a germ of truth in this. The
deception, whether self-deception or intentional, comes when alternative and
“integrative” medical practitioners try to claim that the only way to remedy
this lack of the human touch is to “integrate” quackery into medicine.

Now that MAHA is firmly in control of the federal government and likely to
remain so for at least the next couple of years, I fear that things will only
get worse. For example, I long ago warned about how “right-to-try” laws, which
give patients the “right to try” any experimental drug or therapeutic if it has 
passed the minimal safety bar of a phase I clinical trial, would eventually be
turned into profit centers, as Envita openly admits how it’s using right-to-try 
as the basis for its combining experimental therapeutics that haven’t been
FDA-approved yet with FDA-approved conventional therapies (although not
necessarily FDA-approved for the combination given or the cancer being treated).
It reminds me very much of clinics using 3-bromopyruvate a decade ago to treat 
cancer, even though it was not then FDA-approved.

Trisha Thadani describes a problem that is very old. As I like to say, there’s
nothing new under the sun. She also describes how the “coldness” of our current 
system, combined with the distrust of the medical system that people with her
father have harbored for a long time, can lead to the proliferation of
alternative clinics such as Envita that satisfy people’s emotional needs to be
treated seemingly as an individual, at least at first, but do so in service of a
business model that sells unproven and disproven cancer treatments, along with 
rank quackery like coffee enemas and intravenous ozone in the guise of
“supportive care.” MAHA has weaponized this distrust, and its ongoing project to
chip away at laws and regulations that protect patients, even as poorly as they
currently do, against alternative cancer clinics like this made it very likely 
that there will be many more Envitas forming and many more people like Rajeev
Thadani being victimized, leading surviving daughters like Trisha Thadani to
say:

Hope is a delicate thing in the face of a fatal disease: It can give a patient
like my dad the will to keep going, but it can also blur easily into false
expectations and questionable decisions. It’s a tricky balance that looks
different for every patient and family. Instead of chasing an elusive cure, I
wish my dad had taken more time to say goodbye and celebrate a life well lived.

Selling false hope is what these clinics do. It’s also what MAHA does, as long
as it can profit.



One year of Robert F. Kennedy Jr. as HHS Secretary: The Lancet reacts, and so do
I

Editors of The Lancet published an op-ed decrying RFK Jr.’s one year of failure 
at HHS. They’re correct about RFK Jr, but they are not blameless in what has
happened.

David Gorski on March 2, 2026

Link


On February 13, 2025, longtime antivaccine activist and promoter of quackery
under the guise of “make America healthy again” (MAHA), Robert F. Kennedy, Jr., 
assumed the office of Secretary of Health and Human Services (HHS), the largest 
cabinet-level department in the United States federal government. By any
standard, HHS is a behemoth of a department, with a budget of $1.8 trillion—yes,
trillion—in 2025. In fact, by budget it is the largest department in the
federal government, larger than even the Department of Defense. As HHS
Secretary, RFK Jr. was placed in charge of nearly all non-military US federal
programs in medicine, public health, and biomedical research. To give you an
idea of the scope of the department that RFK Jr. has headed for the last year,
think about this: Upon assuming office, he took charge of a number of critical
government agencies related to medicine and public health, including the Centers
for Disease Control and Prevention (CDC), the Food and Drug Administration
(FDA), and the National Institutes of Health (NIH), not to mention the Centers
for Medicare & Medicaid Services (CMS), the government agency responsible for
administering and regulating Medicare, Medicaid, and the implementation of the
Affordable Care Act (ACA, sometimes colloquially called Obamacare). Even now,
over a year later, it boggles my mind that such an addled conspiracy-mongering
antivax crank would ever be granted so much power in the US, even by a President
as irresponsible as Donald Trump.

You think I exaggerate? (I know that regular readers know that I’m not
exaggerating, but someone who just found their way here through a search or by
accident might.) Let’s just put it this way. Here are two recent videos posted
by RFK Jr.

Order yours today! pic.twitter.com/ucupfmhlf8

— Secretary Kennedy (@SecKennedy) February 26, 2026

This video is seriously cringey.

I mean, seriously. The video above looks as though it’s mocking RFK Jr. I know
it’s intended ironically, in the way that so much “make America great again”
(MAGA) content is, but this use of a 1990s-style toy ad aesthetic to promote
this message seems so mocking that maybe it will backfire? Then there’s this:

I’ve teamed up with @KidRock to deliver two simple messages to the American
people: GET ACTIVE + EAT REAL FOOD. pic.twitter.com/PkK8IfkPU4

— Secretary Kennedy (@SecKennedy) February 17, 2026

OK, this video was even more cringey.

Yes indeed, this is just what I’d want to watch to “inspire” me to exercise: A
shirtless RFK Jr. with a shirtless Kid Rock. Seriously, I thought RFK Jr. was
opposed to gender-affirming care, but, with a physique like that at age 72, he
sure looks as though he’s on more testosterone than the average trans male. And 
what’s with wearing jeans in the sauna and the cold plunge after?

But I digress.

These are just two recent examples among many others of the bonkers messaging
coming out of HHS these days, even as RFK Jr. works to systematically remove
access to as many vaccines as he can, undermine public health, turn the NIH into
just another grift as the “research arm of MAHA,” and realign the FDA to
approve quackery while making it more difficult to approve new vaccines, all
while aligning HHS policies with what can only be referred to as soft eugenics, 
thus turning health solely into a matter of personal responsibility in which
good health is viewed as being due to virtuous living and bad health due to
individual failure, with nary a mention (other than lip service) to the social
determinants of health and genetic predispositions to disease to be heard. In
this Brave New World, if your child dies of measles, it’s because the child was 
unfit, and if you have a chronic disease, it is your fault, which means that
nature should be allowed to take its course and cull you from the herd.

Of course, I was warning about the extinction-level threat to public health
represented by RFK Jr. even before the 2024 election, after then-candidate
Donald Trump promised to let RFK Jr. “go wild” on healthcare if elected and then
reiterated my warning after RFK Jr. had assumed his current position as HHS
Secretary. That’s why I’m torn whether to be gratified or annoyed that The
Lancet published an editorial late last week entitled Robert F Kennedy Jr: 1
year of failure. It’s a short editorial, only around 725 words (which is
basically barely enough for me to get started, at least here), but it does sum
things up fairly well while, of necessity, not being able cover a lot of the
carnage inflicted on US public health, medicine, and biomedical science in the
year since RFK Jr. took office. Amusingly, at least one antivaxxer didn’t like
it and said so, while a staunch pro-vaccine pro-science advocate, while
appreciating the message, noted the flawed messenger.

One year of failure after nearly 20 years of antivax messaging

As is the case with my fellow SBM blogger Dr. Jonathan Howard, one thing that
has irritated the crap out of me ever since it became apparent that Donald Trump
might win and then actually appoint RFK Jr. to a high ranking health-related
position in his administration, which everyone (correctly) assumed to be HHS
Secretary, so many “respectable” physicians, journalists, and pundits have bent 
over backwards to give him the benefit of the doubt, to “both sides” it. This
would generally take the form of positive (or at least noncommittal but hopeful)
takes on RFK Jr.’s MAHA emphasis on healthy food and exercise, coupled with
downplaying or almost downright ignoring his preceding two decades of bonkers
antivax conspiracy mongering—not to mention HIV/AIDS denial and any number of
conspiracy theories—elegating the bonkers to a throwaway comment about his
“controversial” views on vaccines or his vaccine “skepticism.” As I and others
have repeated many times, RFK Jr. is not and has not been a “vaccine skeptic”
for a long time. He is hardcore antivax and has been so since at least 2005.

So naturally, he was lying when, as The Lancet recounts, he promised to be good:

In his first speech as Secretary of the US Department of Health and Human
Services (HHS), Robert F Kennedy Jr laid out a plan to restore trust. The
COVID-19 pandemic saw public faith in Federal health and science plummet—between
April, 2020, and September, 2023, the percentage of polling respondents who
trusted coronavirus and vaccine information from the Centers for Disease Control
and Prevention (CDC) “a great deal” or “a fair amount”, fell from 83% to
63%—and the HHS employees to whom he was speaking were facing devastating mass
lay-offs and funding cuts. Although Kennedy did not mince words about the likely
fate of staff resistant to his ambitions, he promised open and honest
engagement with everyone willing to work towards making the USA healthy again.
To the Senate committee who confirmed his nomination, Kennedy promised a
receptive and collaborative relationship, and to the public from whom he claims 
his mandate, he promised a new era of unbiased science without hidden conflicts 
of interest, secrecy, or profiteering. Radical transparency, gold-standard
science, ethics, compassion, competency, and pride would restore to HHS the
unimpeachable authority that the USA needs and deserves.

Those of us who had been paying attention for nearly two decades before that
confirmation hearing and speech knew RFK Jr. was lying, but apparently too many 
people were like Charlie Brown in this famous series of comics, with RFK Jr.
playing the role of Lucy:

Charlie Brown could be Senator Bill Cassidy, who could have stopped RFK Jr.’s
nomination from advancing, but, coward that he is, chose not to.

As The Lancet drily notes:

Politicians are known to break promises, but Kennedy’s record, 1 year in, has
been a failure by most measures, especially his own.

That’s only if you assume that RFK Jr. was telling the truth about what he was
about and how he would measure success, and that the metrics for success that he
laid out were real. Unfortunately, by RFK Jr.’s likely real measures, RFK Jr.
has been depressingly successful; that is, if you support science-based public
health. He has reshaped the leadership of HHS, placing sycophants, toadies, and 
lackeys in key leadership positions, such as “Podcast Jay” Bhattacharya as NIH
Director, Marty “third leading cause of death” Makary as FDA Commissioner, and, 
recently, “Podcast Jay Bhattacharya” as acting director of the CDC, as if NIH
Director and CDC Director weren’t both very demanding full-time jobs that even a
highly competent and experienced manager and leader would likely struggle to do
well simultaneously. (Podcast Jay is neither experienced nor competent.)
Meanwhile, RFK Jr. appointed America’s Quack, Dr. Mehmet Oz, as CMS
Administrator, placing him in charge of all Medicare, Medicaid, and ACA
programs.

Podcast Jay, as you might recall, made a name for himself as co-author of the
Great Barrington Declaration, that public health-denying call for a “natural
herd immunity” solution to the pandemic published two months before the first
COVID-19 vaccines started trickling out first to healthcare professionals, in
which Podcast Jay promised “natural herd immunity” in 3-6 months if only nations
would “let COVID rip” (with, as an afterthought, “focused protection” of the
vulnerable). It was a profoundly eugenicist or social Darwinist strategy (take
your pick) that never could have worked, given that “natural herd immunity”
requires lifelong (or at least long-lasting) immunity and SARS-CoV-2, the
coronavirus that causes COVID-19, easily mutates to avoid pre-existing immunity,
and that wrecked public health. Meanwhile, Marty Makary first made his name in 
crankdom for doing a very bad “study” that was basically a ridiculous
extrapolation that claimed that medical errors are the third leading cause of
death, claiming 250,000 Americans a year. During the pandemic, he “graduated”
into pandemic minimization and antivax misinformation. Unsurprisingly, taking
their marching orders from President Trump and his OMB Director Russell Vought
and combining theme with RFK Jr.’s preexisting anti-public health proclivities, 
RFK Jr. and his minions have ushered in a new Lysenkoism—I like to call it
Lysenkoism 2.0—into all the scientific and public health establishments, all
while decimating workforces, withholding grant funding, and, well, I’ll let The 
Lancet summarize:

10 days after his speech about trust and openness, HHS rescinded a 54-year-old
policy of soliciting public comments for new rules and regulations, silencing
the voices of many of the stakeholders he pledged to serve. Kennedy has
summarily dismissed advisers and experts, communicated policy changes on
pay-walled media, fired a whistleblower, and overseen the revisions of
guidelines and recommendations, contradicting decades of established science,
often to the benefit of industries he formerly condemned. Under Kennedy’s
leadership, the National Institutes of Health (NIH) shuttered programmes
studying the health effects of air pollution, HHS withheld a report linking
alcohol consumption to cancer, and the Food and Drug Administration (FDA)
withdrew warnings of potential harm from consuming products (such as raw milk
and chlorine dioxide) falsely marketed as treatments for autism. His changes at 
CDC have driven 26 states to reject official guidance on vaccine policy, and in 
December the CDC awarded an unsolicited $1·6 million grant to conduct a vaccine 
study in Guinea-Bissau that raised so many ethical concerns—the design would
have risked exposing thousands of unvaccinated children to hepatitis B—that it
has been compared to the infamous Untreated Syphilis Study at Tuskegee.

HHS under Kennedy has made a habit of throwing good money after bad science.
Amid the Trump administration’s cuts to research funding and personnel there has
been a harmful shift in priorities. Cutting-edge discoveries and clinical
investigations—on subjects ranging from mRNA vaccines to diabetes and
dementia—are denied crucial resources while junk science and fringe beliefs are 
elevated without justifiable explanation. Under Kennedy’s leadership,
politicisation at the NIH, FDA, and CDC is imperilling the future of US science 
and innovation and throttling the public health enterprise that keeps the
country safe today.

As I said, Lysenkoism 2.0. As I like to say, RFK Jr. is definitely coming for
your vaccines, his goal being to eliminate all vaccines by the end of his term
if he can or, failing that, to eliminate as many as he can however he can. He is
also all about promoting his favored forms of quackery. For example, although
I’ve discussed on multiple occasions how RFK Jr. purged all members of the CDC
Advisory Committee on Immunization Practices (ACIP), to replace them with a
wretched collection of antivax cranks, quacks, and grifters, I haven’t really
written about the Interagency Autism Coordinating Committee (IACC), a Federal
advisory committee that coordinates Federal efforts and provides advice to the
Secretary of Health and Human Services on issues related to autism spectrum
disorder (ASD). Consistent with his longstanding belief that vaccines cause
autism, RFK Jr. transformed this committee, too, adding a collection of autism
cranks, quacks, and grifters, most antivax. Just look at the membership roster! 
It now includes Daniel Rossignol, Ginger Taylor, Toby Rogers, Lisa Ackerman,
Elizabeth Mumper, and Walter Zahorodny, among others. (I never thought I’d see
someone like Ginger Taylor, a particularly annoying old “friend” from the
antivax website Age of Autism, in such a position, for example.)

The Lancet also notes that measles and other infectious diseases are on the
upswing and that the US is in danger of losing its measles elimination status
that it’s had for over a quarter of a century, while RFK Jr. does little or
nothing about it, noting:

The destruction that Kennedy has wrought in 1 year might take generations to
repair, and there is little hope for US health and science while he remains at
the helm.

Correct, but, really, what did anyone expect when someone like RFK Jr. was
appointed to such a powerful position? Given his extreme antivax views, what has
been happening was largely predictable, and I was predicting a lot of what RFK 
Jr. would do before he did it. Kudos to The Lancet for calling out RFK Jr.,
albeit belatedly, complete with an article noting that the new dietary
guidelines that RFK Jr. pushed through are a recipe for poorer health.

Unfortunately, The Lancet‘s history intrudes.

The Lancet: Surgisphere or Andrew Wakefield?

When I first saw The Lancet‘s editorial, I wondered how RFK Jr.’s defenders
would respond. To that end, I headed over to the website of the antivax org
founded by RFK Jr, Children’s Health Defense. To my surprise, there was nothing 
there defending RFK Jr. I’m sure they’ll get around to that eventually. In the
meantime, the task of defending RFK Jr. from the depredations of science as
wielded by the editors of The Lancet was left to a second- or third-tier
antivaxxer, Jessica Rose, who took to her Substack to write The Lancet
(Surgisphere) smears the Secretary of Health and Human Services (HHS) RFK Jr.
Her attack begins:

   If you don’t know about the Surgisphere scandal, read about it here. In
   brief:

   The Surgisphere study, which claimed patients who received chloroquine or HCQ
   had 35% higher death rates, was retracted 13 days after publication, as its 
   data was determined to be fabricated.

   The Lancet journal was the apex predator in this scandal.

   Here, they smear RFK Jr.

I can’t help but laugh a bit. I will admit that I wrote about the Surgisphere
study at my not-so-super-secret other blog when it was first published and was, 
admittedly, a bit too credulous about it. Let’s just say that I was very
embarrassed afterwards for not having picked up on some of what should have been
fairly obvious red flags and wrote a long postmortem about how I screwed up and
vowed to do my utmost not to let it happen again. Suffice to say that I should 
have noted that what Surgisphere claimed to do seemed pretty implausible,
particularly given that the study was only published in late May 2020, only two 
and a half months after the World Health Organization had declared COVID-19 a
pandemic. Also note that The Lancet retracted the paper only 13 days after
publication, which in the world of publishing is lightning fast.

None of that stops our intrepid antivaxxer from ranting:

1 year of failure? Really Lancet? Really? If you define failure by standing up
to corporate bullies and pit vipers lurking in caves pining for your demise then
yeah, sure, he’s a failure at NOT succumbing to evil. This article is a hit
piece, plain and simple.

Funny, but Rose can’t name a single fact in the editorial that is incorrect or
provide evidence to show that it is incorrect. Instead, her entire rebuttal is
an ad hominem against The Lancet‘s editors. Admittedly, they didn’t exactly
cover themselves in glory by publishing the Surgisphere study, but they did
retract it pretty darned fast when its fraud was made plain. Still, let’s just
say that RFK Jr.’s “admirer” doesn’t cover herself in glory either, posting
nonsense regressions:

The most significant reasons! pic.twitter.com/eRkWgHpiLu

— The Real Truther (@thereal_truther) April 21, 2025

Actually, more intensive screening and awareness also contribute.

One is tempted to invoke the graph showing that the lack of pirates cause global
warming. She might as well have just posted that. Amusingly, she concludes by
saying, “And don’t get me started on glysophate,” to which I reply: Why not?

Seriously, though, there is a much more egregious offense for which The Lancet
richly deserves criticism. I thought of it immediately and then saw that Vince
Iannelli had beat me to writing about it in a post entitled A Reminder That The 
Lancet is Partly to Blame for the Destruction That Kennedy Has Wrought. Yes, The
Lancet arguably turbocharged the latest iteration of the antivaccine movement
when in 1998 it published Andrew Wakefield’s fraudulent paper relating the MMR
vaccine with an increased risk inflammatory bowel disease and autism, leading
Dr. Iannelli to produce this awesome parody of the cover of the issue of The
Lancet in which the editorial was published. I hope he doesn’t mind if I
“borrow” it:

Quoth The Lancet: Whoops!

Dr. Iannelli notes:

   No, I’m not saying that The Lancet is solely responsible for creating the
   modern anti-vaccine movement…

   “I cannot ask one who supports the controversial paper to read this posting
   and change your mind and unring the bell that the Lancet article clanged in
   1998. It would be naive of me to claim that no vaccine has ever been
   correctly associated with causing a particular disease. However, in this
   case, what Wakefield and Lancet did in 1998 is akin to screaming fire in a
   crowded theater. Without proper medical and scientific research to support
   his findings, he and Lancet acted irresponsibly by releasing such information
   without proper “fact-checking” as we call it these days.”

   Making Sense Of Dr. Andrew Wakefield Now

   But Andy Wakefield’s 1998 ‘study’ that was published in The Lancet, and the
   media frenzy that went with it, was certainly a big trigger.

Without a doubt. Andrew Wakefield is a foundational figure of the 21st century
antivax movement. So is RFK Jr., who first “came out” as an antivaxxer in 2005
with his conspiracyfest of an article Deadly Immunity. The two men formed two
pillars of the modern antivax movement, Andrew Wakefield popularizing the
fear-mongering pseudoscience falsely claiming that the MMR vaccine causes autism
and RFK Jr. popularizing the fear-mongering pseudoscience blaming autism on the
mercury-containing preservative thimerosal that was, until around 2001, in many
childhood vaccines. In the case of RFK Jr., Salon.com and Rolling Stone enabled
his conspiracy mongering by co-publishing his article. In the case of Andrew
Wakefield, The Lancet enabled his conspiracy mongering by publishing his
fraudulent case series. Which is worse? It’s bad when popular entertainment and 
news magazines publish pseudoscientific conspiracy theories, but it’s orders of 
magnitude worse when an academic journal enables pseudoscientific conspiracy
theories. Eventually, of course, as antivaxxers tend to do, RFK Jr. embraced
Wakefield’s pseudoscientific claims that MMR causes autism, and, of course,
Wakefield embraced RFK Jr.’s fear-mongering about thimerosal in vaccines causing
autism. I like to call this crank convergence, although Mark and Chris
Hoofnagle called it “crank magnetism.” Worse, these two men have arguably been
the most influential leaders of the 21st century antivax movement.

As Dr. Iannelli points out, too, The Lancet knew that Wakefield’s paper had a
lot of problems:

   But weren’t they fooled into publishing it too?

   “By publishing Andrew Wakefield and colleagues’ work purporting to show a
   link between MMR vaccination and inflammatory bowel disease and autism and
   related problems you give increased credence to their report. The Lancet is a
   prestigious, peer reviewed journal with high public profile. The profession,
   journalists, the public, and especially distressed parents of ill children
   suppose that a publication in your journal will be true. In this example you 
   print a commentary, which if it had been a peer reviewer’s report, should
   have led to the rejection of the paper.”

   Correspondence Autism, inflammatory bowel disease, and MMR vaccineAJ Beale

   Although Wakefield’s fraud wasn’t uncovered until later, we saw immediate
   criticism of the study!

And:

   The Lancet actually knew about all the problems with Wakefield’s study, and
   they published it anyway! Problems that were spelled out in a commentary,
   Vaccine adverse events: causal or coincidental?, that was published in the
   same issue. Not only that, but they doubled down on their decision to publish
   Wakefield’s study!

   “First, the decision to publish. There was no question in my mind that,
   subject to external peer review and editorial debate, we should publish this 
   work.”

   Autism, inflammatory bowel disease, and MMR vaccineEditor’s Reply

   But this was nearly 30 years ago…

   “Finally, what has been the outcome? In particular, has harm been done?”

   Autism, inflammatory bowel disease, and MMR vaccineEditor’s Reply

   Shouldn’t we just let it go by now?

As Dr. Iannelli said, “Not on your life!” Yes, it’s been 28 years, but the
damage persists.

One also notes that The Lancet didn’t formally retract Andrew Wakefield’s study 
until February 2010, a full twelve years after its publication, that despite
many criticisms and only after the UK General Medical Council ruled that
Wakefield had “acted ‘dishonestly and irresponsibly,’ and showed ‘callous
disregard’ for the suffering of children involved in his controversial
research.”

You might wonder: Why am I ragging on The Lancet 28 years after it published
Wakefield’s fraudulent paper and 16 years after it was finally dragged into
doing the right thing and retracting that paper? After all, it’s on the right
side of science now, isn’t it? In this case, yes it is. However, its editors
have never acknowledged their role in turbocharging what before Wakefield had
been a fringier than fringe movement by giving it the oxygen of seeming
scientific support and then taking years to rectify their mistake. The editors
of The Lancet are definitely correct in their characterization of RFK Jr. and
the damage that he’s done to US public health and biomedical research in just
one year, and for that I commend them. However, I do wish there had been some
acknowledgment that medicine itself, and also The Lancet itself, had enabled
this destruction.

Jessica Rose might attempt to discredit The Lancet‘s harsh evaluation of RFK
Jr.’s tenure as HHS Secretary thus far, but she chose the wrong failure by its
editors, and that leads me laugh at her. What I can’t laugh at is the Wakefield 
affair, a seminal event that helped shape the modern antivaccine movement and
provide it with the tools to be where it is today, with RFK Jr. in a position to
make vaccines increasingly scarce in the US based on bad science,
pseudoscience, and conspiracy theories.

MAHA Doctors Love Donald Trump

Every day they show up to work, with sweet declarations of love for Trump
pouring from their lips, they are further reaffirming their decision to bind
themselves to everything he does.  

Jonathan Howard on April 10, 2026

Link


“God gave us two arms, one to vote for Donald J. Trump”

To gain power and deflect criticism, MAHA doctors marketed themselves as neutral
scientists and cloaked themselves in science’s protective norms. They demanded 
to be treated with the utmost civility, as befits esteemed scientists, and felt 
entitled to have their pro-infection agenda debated in scientific forums. They
sanctimoniously warned others:

We can’t allow questions of science, medicine, and public health to become
captives of tribalized politics.

Of course, this was pure theater. Although MAHA doctors denied being political, 
even while speaking at political rallies, in reality they were primarily
political actors, and they didn’t hide this at all. The same doctors who faked a
concern about mixing politics and science openly campaigned for Trump and
hurled false, juvenile accusations against his perceived opponents in overtly
political forums. MAHA doctors didn’t spend the pandemic in labs or hospitals,
and an entire chapter of Everyone Else Is Lying to You was devoted to their
overt political activism, though this just scratched the surface.

“I just love him”

These performances worked though. Their auditions were successful. Trump won the
election and their advocacy on his behalf catapulted MAHA doctors to power.
Today, as their boss requires, they continue to behave like love-stricken
teenagers and lavish praise on Trump at every opportunity. 

In this video, Dr. Jay Bhattacharya, says “I just love him” while telling a
cutesy anecdote about Trump lying to the public about Tylenol in pregnancy. Dr. 
Bhattacharya found such deceptions from the POTUS amusing.

In this video, Dr. Bhattacharya says it is “ridiculous slander” to say that
Trump is anything but a champion of science.

In this video, Dr. Marty Makary says that his soon-to-be leaving CBER director, 
Dr. Vinay Prasad, “loves” Trump. “If you listen to his podcast, you’ll see he
has been an ardent supporter of everything Trump has done,” said Dr. Makary.  I 
couldn’t think of a worse insult to Dr. Prasad than this, but Dr. Makary is
right about Dr. Prasad’s podcasts.

Dr. Makary agrees with Dr. Prasad. In this video, he gushes over Trump saying:

He’s an amazing guy, a phenom really. He has more energy than anybody and
amazing instincts, better than some of the academic elites in America.

In this video, Dr. Mehmet Oz calls Trump an “excellent executive and superb
leader”.

In this video, Drs. Makary and Oz, along with Kennedy, nod along as Trump tells 
lies about Portland burning to the ground and boasts of ICE deployments.

“A whole civilization will die”

As our Mad King threatens to wipe out whole civilizations with MAHA doctors at
his back, I’d like to reiterate two points I’ve made previously. 

First, this explains why it was both dangerous for “respectable” doctors to
falsely portray MAHA doctors as “apolitical”, good faith actors and
reprehensible for them to mock those who warned of their obvious danger. These
sycophants did far more than disregard the COVID disinformation of MAHA doctors,
though that is shameful enough, they also legitimized their political
endorsements. When MAGA 2.0 and MAHA were on the rise, many of us stuck out our 
necks to sound the alarm bell. In contrast, the enablers rolled out the red
carpet, even if they are now oh-so horrified by what they helped unleash on us
all.

Second, not only will MAHA doctors be tied to Trump’s attacks on science, they
lent the legitimacy of the medical profession to his entire agenda. As such,
they will permanently be linked to it all. It doesn’t matter if they object or
think this is unfair. As public servants, they don’t get to choose how the
public judges and remembers them.  

However, they were not and are not without agency. No one forced them to confess
their infatuation for Trump and literally stand behind him as he spewed
dangerous lies. They chose to do this. No one is stopping them from resigning
today. Every day they show up to work, with sweet declarations of love for Trump
pouring from their lips, they are further reaffirming their decision to bind
themselves to everything he does.  

They only have 3 more years to go.  So do we all, sadly.

MAHA and science-based public health: Can’t we all just get along?

The answer is: Very likely not, at least not as long as MAHA embraces quackery
and antivax pseudoscience—not that that didn’t stop STAT News from ignoring the 
elephant in the room, vaccines, in search of a “kumbaya” moment between MAHA and
public health.

David Gorski on April 13, 2026

Link


One of the truly remarkable—and depressing—things that I’ve observed since the
longtime antivax activist who is now our Secretary of Health and Human Services,
Robert F. Kennedy Jr., first coined the slogan “make America healthy again”
whose abbreviation MAHA now stands for everything from antivax activism to
promoting lots of supplements and even cancer quackery, with a dollop of
science-based considerations of the effect of healthy diet and lifestyle as
determinants of health in order to disguise the stench of pseudoscience, has
been to watch how quickly MAHA has become normalized, to the point where a
usually good news outlet, STAT News, buys into the normalization.

What do I mean? Last week, STAT News published two op-eds, one from a public
health scientist and one from a MAHA activist, apparently in search of a
“kumbaya” moment asking not just “Can’t we all just get along?” but also, “What 
can public health learn from MAHA?” Don’t get me wrong. I’m usually all for
opponents listening to each other and trying to find common ground as a basis
for working together. Maybe there even is some common ground between MAHA and
science-based public health, although I would argue that it is a lot less
expansive than the editors of STAT News seem to think and almost completely
ignores the real problems with MAHA with respect to science. Unfortunately, the 
work of coming to an understanding with what have to this point been implacable 
foes involves very hard work that cannot shirk the real issues. Unfortunately,
as you will see, these op-eds help normalize MAHA by portraying the movement as 
just a bunch of people interested in healthy food, clean water, more exercise,
rather than a movement built around one of the most antivaccine of antivaccine
activists in our nation’s history, RFK Jr., as a cloak to shield his antivax
agenda in the guise of wanting to tackle chronic disease and champion more
“natural” and “healthy” food and lifestyle.

What STAT News editors have done is to commission two op-eds, one by Monica
Wang, ScD, MS, an associate professor of public health at the Boston University 
School of Public Health and one by Aaron Everitt, who is described as
a”freelance writer from Colorado who was active in the RFK Jr. presidential
campaign as a volunteer.” The articles are entitled:

  1. What public health can learn from the MAHA movement (Monica Wang). Tagline:
    Listening to MAHA advocates helped me realize what public health is missing.
  2. I’m a MAHA activist. I went into the public health lion’s den — and it changed
    how I think (Aaron Everitt). Tagline: Public health is not the enemy. The
    system is. Note that this is an edited version of a post that Everitt
    originally published in March on his Substack entitled Why MAHA Needs Public
    Health. (As you will see, the differences between the original article and 
    the edited STAT News version are important.)
The first thing I noticed about these articles is how assiduously they both
avoid the elephant in the room, vaccines. Wang only mentions vaccines once in
passing and medical misinformation as though it were not a primary element of
huge swaths of MAHA, while Everitt mentions vaccines not at all. In this, both
writers accept the frame that RFK Jr. tried so hard to encompass MAHA in right
from the beginning, namely that MAHA is not about vaccines (or that it is not
primarily about vaccines).

Let’s see how the messages go past each other. Again, I understand that dialogue
is necessary. What I have a problem with is the way the results of this
particular dialogue are being framed and how the dialogue appears to have
avoided the really hard issues that make MAHA so problematic in favor of a
narrative that ignores its antivax roots and activism.

Learning (mostly) the wrong lessons from MAHA

It is important to note right at the outset that Dr. Wang is the real deal as a 
public health scientist. As her university biography notes, she is Associate
Professor of Community Health Sciences at the Boston University School of Public
Health, an Adjunct Associate Professor of Health Policy and Management at the
Harvard T.H. Chan School of Public Health, and Executive Editor of Public Health
Post and has been principal investigator on “NIH and foundation-funded research
totaling more than $6 million, advancing efforts to improve nutrition and
support the health of children, families, and underserved communities.” Very
impressive indeed, certainly—and it doesn’t bother me to say this—considerably
more impressive than my academic career. So, right away, I have to take her
opinion seriously, even as I read a few seriously cringe-inducing passages in
her op-ed.

So, let’s let Dr. Wang tell us how this whole dialogue came about in her op-ed:

“I didn’t expect to find myself face to face with leaders and activists from the
“Make America Healthy Again” movement in respectful dialogue, or to consider
inviting one into a public health classroom. But that’s exactly where I found
myself this spring.

At a national public health meeting in March, I attended a session that brought 
together public health professionals, physicians, and MAHA leaders for a rare,
good-faith conversation. I went out of curiosity. I left with a level of clarity
I hadn’t expected — and a few unexpected connections.”

Mr. Everitt was similarly surprised, as he states in his companion piece:

Yet I found myself recently, and reluctantly, headed to the citadel of
arrogance: Washington (well, Arlington, Va., to be more specific). At the
invitation of Brinda Adhikari — one of the hosts of the podcast “Why Should I
Trust You?” — I attended the Association of Schools and Programs of Public
Health’s annual meeting, where I spoke on a panel about engaging in civil
conversation in a session called “A Dialogue Between Academic Public Health and 
MAHA.”

Curious as to who else was on the panel besides Mr. Everitt, I searched out the 
meeting website to look for the actual session, which I found here. (Dr. Wang
was an attendee, not a panelist or the moderator.) On the public health side,
the host was Sandro Galea, MD, MPH, DrPH, Margaret C. Ryan Dean, Eugene S. and
Constance Kahn Distinguished Professor in Public Health, and Vice Provost for
Interdisciplinary Initiatives, Washington University in St. Louis School of
Public Health. Joining him on the public health side, the panel also featured
Megan L. Ranney, MD, MPH, FACEP, Dean.,Yale School of Public Health, and Craig
Spencer, MD, MPH, Associate Professor of the Practice of Health Services, Policy
and Practice; Associate Professor of the Practice of Emergency Medicine;
Faculty Fellow at The Watson School of International and Public Affairs Brown
University School of Public Health. (I wonder what he thinks of his fellow Brown
University faculty, oncologist turned MAHA-curious and borderline antivax,
Wafik El-Deiry, MD.) In any event, both are what I’d call heavy hitters in the
world of public health. On the MAHA side, the panel featured Aaron Everitt and
Elizabeth Frost, the latter billed as “Political Consultant, Campaign
Strategist, and Co-Founder, Independent Force LLC.”

Moderating the panel was Tom Johnson, co-host of the “Why Should I Trust You?”
podcast (WSITY), a podcast that we’ve encountered before when it gave a softball
interview to then chair of the CDC Advisory Committee on Immunization Practices
(ACIP) Dr. Kirk Milhoan, allowing him to spew antivax disinformation largely
unchallenged. Let’s just say that it’s not necessarily a good idea to bridge
some divides “rebuilding trust.” Or maybe a better way of putting it is that
public health scientists and the press acquiescing to antivax narratives—or,
just as bad, sweeping them under the table in the name of this goal—is an
unacceptable price to pay to “rebuild trust” that will backfire.

My first impression looking at this lineup was that the representatives of MAHA 
were not anything I’d call top-tier MAHA. There was no Del Bigtree, for
instance, no Mark Gorton, no Tony Lyons, and none of the more prominent
MAHA-aligned activists. Mr. Everitt was a volunteer for RFK Jr.’s presidential
campaign before RFK Jr. dropped out to bend the knee to Donald Trump in return
for a promise to be allowed to “go wild on health” and have a high-ranking
health-related position in the administration. (And health-related positions in 
any Presidential administration don’t get any higher than HHS Secretary.) Ms.
Frost, on the other hand, runs Independent Force, a political consulting agency 
in Ohio. Her LinkedIn profile shows that she is on the board of directors of
MAHA Ohio; so I concede that would make her a leader in the MAHA movement, at
least at the state level, and she has appeared on the WSITY podcast with Del
Bigtree in which standard issue antivax disinformation was promulgated,
including old antivax tropes about “vaccinated vs. unvaccinated” and the
supposedly “suppressed” Henry Ford Study that was in reality just a bad study:

Let’s just say that being friendly with Del Bigtree indicates that, at minimum, 
rabid antivax stances don’t bother you. More likely, you are antivax. For one
thing, perusal of the transcript of the podcast suggests that she does appear to
buy into the “no saline placebo controlled studies” lie. There were even false 
claims likening vaccine mandates to being a violation of the Nuremberg Code, a
very old antivax trope.

So what is Dr. Wang’s take on the panel including public health scientists and
MAHA activists? She starts out:

“Each person shared a story about what drew them into this work. Listening, I
found myself toggling between two lenses: one grounded in communication, the
other in public health research. Through that first lens, something stood out
immediately: The MAHA speakers were strong storytellers.

One speaker began: “I grew up in Appalachia, and my community is often referred 
to as the bedrock of the opioid crisis.””

“I was hooked — and so was the rest of the room. She described how the opioid
epidemic had devastated members of her family and community, and how rural areas
like hers face overlapping barriers to health: limited health care access, lack
of healthy food, and economic disinvestment. She spoke about traveling for work
and struggling to find healthier food options beyond “a bottle of water and a
box of graham crackers.” She didn’t cite studies or statistics, and she didn’t
have to.

Her story connected the dots: the opioid crisis, distrust of pharmaceutical
companies, lack of access to health care and healthy food common to both rural
and urban communities across the U.S., and the search for alternatives that are 
affordable and accessible. In a matter of minutes, she built a narrative that
felt cohesive, human, and urgent — the kind that invites people not just to
understand, but to feel.”

My reaction to reading the passage above was simple. It must be acknowledged
that many MAHA activists didn’t come into the movement because of vaccines and
that it is certainly possible that Ms. Frost and Mr. Everitt are two such MAHA
activists. Here’s the problem. Downplaying the extreme antivax viewpoint that
birthed MAHA has been an intentional ploy ever since RFK Jr. first published his
Wall Street Journal editorial in 2024 in which he coined the MAHA slogan. As I 
observed at the time, the original twelve-point plan laid out in RFK Jr.’s WSJ
editorial intentionally sidestepped the issue of vaccines, noting further that
nowhere in his MAHA manifesto “RFK Jr. mention vaccines, not even once,”
something that didn’t go unnoticed by his antivax followers, even immediately.
Tech bro turned antivax activist Steve Kirsch, for instance, noticed. So did a
number of RFK Jr.’s other antivax allies. Indeed, in recent months, MAHA has
been becoming increasingly unhappy with President Trump and RFK Jr. because it’s
been reported that the White House, noting how very, very unpopular RFK Jr.’s
antivax moves have been over the last 14 months, has told him to cool it on
vaccines until after the midterm elections—and he has! MAHA unhappiness has
reached the point where President Trump felt the need to try to mollify MAHA
leaders in a closed-door session. A huge part of the reason why MAHA is unhappy 
is because its believers perceive that RFK Jr. has not acted fast enough to get 
rid of COVID vaccines (and other vaccines), although in fairness they were also 
very angry that President Trump decided to allow increased production of Bayer’s
Roundup weed killer.

Indeed, I’ve long argued that the main purpose of the MAHA movement is to
provide a mantle under which RFK Jr.’s rabidly antivax agenda could hide, mostly
disappearing under much more popular initiatives, such as promoting healthier
food and water and encouraging Americans to exercise. (Yes, I know that a lot of
what is being promoted in the name of addressing “chronic disease” and “diet”
is quackery, particularly the functional medicine quackery preferred by our
nominee for Surgeon General, Casey Means, but let’s for the moment accept this
frame—for purposes of discussion only.) Moreover, MAHA is a movement that can be
used as a recruiting tool for the antivax movement. As I used to say about
opposition to vaccine mandates, “Come for the freedom, stay for the antivax,” in
this case I’d repurpose it to say something like: “Come for addressing chronic 
disease, stay for the antivax.” Again, Dr. Wang’s take seems utterly oblivious
to something that has been completely obvious to those of us combatting antivax 
disinformation for a long time.

Part of Mr. Everitt’s post shows the divide:

My arrival at the hotel ahead of the conference had me wondering if I had made
the right choice. These were the adversaries who had frustrated me during the
pandemic. Despite my disappointment with the Trump administration on a host of
issues, I still believe that MAHA is a good movement and that public health and 
health care in general need a wholesale revision if they are ever to become
trusted institutions again. I also realized that many in the room were likely
the unfortunate recipients of the cuts that the Trump administration, under RFK 
Jr.’s leadership, had implemented. I felt an uneasiness about standing up in
front of a room that, in all likelihood, saw my advocacy for Kennedy as part of 
their own moment of tumult.

The next morning, on my way down to the lobby to get coffee, I walked past
former NIH Director Francis Collins. I recognized him instantly and couldn’t
help but trace my thoughts to Covid and all of the nefarious stories I
associated him with. For a moment, the scenes of lockdowns and vaccine mandates 
all flashed in my head. I don’t belong at this conference, I told myself.

I’d have probably agreed that he probably didn’t belong at that conference,
although in retrospect maybe he did. Note, however, that Mr. Everitt has clearly
been ensconced in the conspiracy theories about Dr. Collins and Anthony Fauci, 
as well as all the COVID-19 misinformation that was promoted during the
pandemic. This is another important point to consider. MAHA might be in part a
grassroots movement, but in reality it is a movement that was spawned by the
ruthless, constant, and intentional promotion of right wing anti-public health
and antivaccine messaging that reached a crescendo during the pandemic, but a
crescendo that never really faded as the danger did.

I know that the antivax movement was once considered a left wing movement, but, 
as I’ve related time and time again, along with the history of the rightward
shift of the political center of the antivax, now MAHA, movement, that time was 
long past four years ago. Be that as it may, failure to acknowledge this reality
is a blindspot. You can rebuild trust all you like with the odd individual MAHA
activist here and there or smaller groups of MAHA activists, but as long as the
misinformation flows so copiously from the firehose at the top, funded by a
whole ecosystem of dark money groups, that trust will be short-lived. It is,
after all, against the interest of the leaders of MAHA for MAHA believers to
trust science-based public health and medicine. Rebuilding such trust would
seriously cut into the ability of MAHA gurus like Casey Means and Peter
McCullough to sell unproven supplements.

This brings me to what was perhaps the most cringeworthy part of Dr. Wang’s
op-ed:

“Through my second lens of public health, that moment was both uncomfortable and
clarifying. Uncomfortable, because parts of the movement, particularly around
vaccines, run counter to established scientific evidence. It also exposed a gap 
we don’t often name: Public health has not always been as effective at
translating evidence into visible, tangible change in people’s daily lives. And 
clarifying, because I realized that what MAHA has built, in a relatively short
time, is social capital.”

“Parts of the movement…run counter to established scientific evidence”?
“Particularly around vaccines”? That’s like the proverbial, “Other than that,
Mrs. Lincoln, how did you like the show?” Going against established science is
the very raison d’être behind MAHA, particularly when it comes to vaccines.
That’s part of the reason why MAHA feels so obligated to cloak their
pseudoscience and opposition to science-based public health and medicine, using 
exaggerated terms such as “gold standard science” to describe what they want to 
do.

After correctly discussing the importance of social capital and how MAHA has
built such capital up more effectively than public health, Dr. Wang concludes:

“That panel conversation at the conference didn’t change my commitment to
evidence-based public health. But it did expand how I think about our work and
the importance and possibility of finding common ground. In the sciences,
communication is often treated as secondary, something to layer on after the
research is done.

But sometimes, communication is the work.”

Congratulations, Captain Obvious. It’s not as though science communicators
haven’t been saying this all along for decades. It’s not as though I haven’t
read article after article over the years by well-meaning public health
scientists saying the same thing. Another key point that Dr. Wang points out is 
how important stories are, how stories trump (excuse the use of the word)
evidence almost every time. Again, Captain Obvious, this is nothing that science
communicators haven’t been saying all along, going back two decades, when I
first started countering antivax misinformation on my first blog, and beyond.
Indeed, public health has long realized that stories are more effective tools
for persuasion than dry data and scientific studies and lamented antivaxxers’
ability to come up with more compelling stories because they are not constrained
by the truth. Don’t believe me? Here’s an example of a peer-reviewed article
addressing the use of stories to combat antivax misinformation. It was published
in 2013. Here’s a website devoted to stories of people suffering from
vaccine-preventable diseases.

The bottom line is that vaccine and public health advocates have long understood
the power of stories. So does Dr. Wang, who used her STAT News article to
promote her book, The Collective Cure, which describes how storytelling can be
used to promote evidence-based solutions. (I don’t begrudge her that, and
hopefully it’s a good book.) The devil, of course, is in the details. An even
bigger devil is: How does a science-based perspective penetrate the bubble of
misinformation and disinformation that MAHA activists and believers live in?
Stories can help, but if we can’t disseminate the stories nearly as well as the 
social media ecosystem captured by MAHA, how do we break through?

I’m not saying that there isn’t hope. For one thing, Mr. Everitt exults in just 
being listened to, and there is a potential lesson here:

But when the plenary session began, I sensed something really amazing: The room 
wanted to listen to what my fellow MAHA advocates and I had to say. I am certain
that the skeptics were scattered amongst the masses, but as we discussed the
challenges of public health interfacing with MAHA and the Kennedy leadership at 
HHS, the room seemed earnest, willing to hear what was being said.

It wasn’t a debate, and I wasn’t there to convince anyone that what I was saying
should become the new gospel of health. But I could see in the eyes of many in 
the crowd an acknowledgement that what had happened over the past decade,
particularly because of the pandemic, needed to be addressed.

We spoke for an hour, and when it was over, many audience members gathered
around the stage to talk to my MAHA colleagues and me and find out more. I was
thrilled to see it. No angry, in-your-face, Twitter-like battles were
instigated. There was a real sense that we should be learning from one another
in this moment, rather than building our bulwarks.

Far be it from me to argue that this is a bad thing, at least in this one case. 
Here’s the thing. You have to distinguish between listening to the foot
soldiers, the rank and file, of MAHA who aren’t diehard antivaxxers and
“listening” to the cranks, quacks, and grifters who lead the movement. There is 
utility in the former, because listening can potentially lead them back to
trusting science-based public health. There is no utility in the latter, other
than to educate yourself on the latest antivax talking points. You are not going
to change their minds.

Moving on, if you believe Mr. Everitt, there is nothing that he wants more than 
to be able to trust medicine again:

In my most honest of moments, what I want from the medical community is the
chance to trust it again. We need medicine to function in all the glory of its
artistry. Patient care is one of the most necessary and humane interactions in
all of humanity. So its politicization has been the worst possible outcome to a 
choose-your-own-adventure that never had to find its way down paths of distrust.

I so want to believe him here. However, I’m not sure that Mr. Everitt isn’t
deluding himself. As I’ve written about many, many times, MAHA is at its heart a
“choose your own adventure”-sort of medical ideology, which is likely precisely
why Mr. Everitt was attracted to it in the first place. It emphasizes the
primacy of the individual as the sole arbiter of ensuring individual health,
screw public health. Indeed, it goes beyond that into a philosophy that can only
be described as health as a result of personal virtue, with its frequent
messaging that you—yes, you!—are completely in control of your own health. What 
flows from that messaging is the idea that if you are healthy, you must be
living the “correct”—or virtuous—lifestyle.

Unfortunately, what also flows from the belief that health is solely the purview
of the individual is a “blame the victim” attitude in which, if you are not
healthy, then clearly it’s your fault for having lived a sufficiently virtuous
lifestyle, for having eten the right diet, for not having exercised enough, for 
not taking the right supplements. This is where we get into social Darwinism and
even soft eugenics. If it’s your fault for being sick, according to MAHA, then 
why on earth should society pay to take care of you? You can also see soft
eugenics in the messaging that infectious diseases like measles only kill
children who are unhealthy and that the healthy (i.e., the virtuous) have
nothing to fear from these diseases, messaging that during the pandemic was
applied to COVID-19. More than that, the suffering is said to make you
stronger—virtue, again!—with permanent lifelong “natural immunity,” unlike the
supposedly “unnatural” and inferior immunity that comes from vaccines. In fact, 
with its emphasis on health as a result of personal “health virtue,” MAHA very
much resembles prosperity gospel teaching, and that is not a coincidence,
because prosperity theology emphasizes wealth and health as manifestations of
virtue making a believer favored of God.

And MAHA leaders are the privileged who are favored by God. Most lower level
MAHA activists and believers are not so privileged, but they nonetheless buy
into the ideology.

The way forward

The first thing that must be understood is that MAHA is nothing more than a
manifestation of RFK Jr.’s worldview, laundered for “respectability” politically
and for consumption by the mainstream. That is why MAHA soft-pedals RFK Jr.’s
antivax beliefs, in particular how he is most definitely coming for your
vaccines and doing everything he can to eliminate as many vaccines as possible
during his time in office. That being said, that doesn’t mean that there aren’t 
common areas shared by MAHA and public health that, besides being good public
health policy, might peel some MAHA adherents away. I say this looking at Mr.
Everitt’s original version of the post and part that was edited out of the
version published in STAT:

The last few weeks have been nothing but discouraging for those of us who are
watching the generational political coalition that Donald Trump gathered
together in the election of 2024, be dismantled by a war, a silly executive
order on glyphosate, and a myriad of other mistakes, blunders and undoings that 
the Trump administration seems to be either fumbling their way through or
willfully marching toward. I’d be lying if I said that my heart hasn’t been bent
towards repentance for my part in the whole thing. I helped champion Bobby
Kennedy as a campaign volunteer, and when he joined up with Trump, I
reluctantly, yet calculatingly, decided that the tradeoffs were worth what I
believed Mr. Kennedy could advocate for within the walls of a Trump White House.

I will always adore Bobby Kennedy for his scrappy presidential run. From the
moment he signed on as a Democratic candidate, I was overwhelmed with a want and
desire to help him win the presidency. I thought he was the only way to restore
a sane approach to the democratic process, and after the Democrats trounced him
out of the primary process, his independent candidacy gave him the most runway 
to tell people the truth about what he thought would be the best fixes for a
very sick and broken nation. Yet, the last few weeks and months have been hard
to muster up a smile about what is going on. I have hung on to Mr. Kennedy’s
words at his campaign suspension event that he wanted the chance to argue and
debate robustly with President Trump, especially on the things they disagreed
about, but I was the fool for thinking the American bafoonery of thespianism,
that supposedly passes for the governance of a nation, would ever allow for such
a dynamism.

So you can see that Mr. Everitt is already unhappy with what MAHA has
accomplished thus far and even feels betrayed. This sense comes across much more
strongly in the original Substack version of the article than it does in the
version edited down to fit within the space constraints imposed by STAT News. He
goes on and on about how it is the system that is broken and how public health 
scientists are not MAHA’s enemy, although he can’t resist a dig or two about how
they work for the government. Then there is this passage:

But that room I was in was filled with the people who can make the outcomes I — 
we all — want. They are the ones who are interfacing with the most downtrodden
of our society, with the emergencies of bad choices, and the extraction that our
mercantile system perpetuates and celebrates in its boardrooms.

Those advocates are the ones who have to sit with a forlorn woman from
Mississippi and try to help her understand what is happening to her body, and
why she’s feeling sick. They are the ones who have to try to educate people
about junk food and processed fillers that are destroying their metabolisms and 
impeding their full flourishing capabilities. They are the ones who have to try 
to explain why it is their Medicare or Medicaid won’t help them pay for the
preventive measures they would benefit from, but only will allow them the money 
they need for a pill or a procedure once the disease has progressed too far.
These are the ground troops for a war that must be won, and MAHA needs them.

During the discussion, emergency physician Craig Spencer asked for a show of
hands.

“Who wants to eliminate processed foods for their children?”

“Who wants toxins to be out of our water and food supply?”

“Who wants good access to healthy, whole foods?”

There wasn’t a hand that didn’t raise.

The people of MAHA want those same things. They don’t want Kennedy relegated and
boxed into a corner, simply playing with his food dyes. The people of MAHA
actually want a government that acts as a watchdog against the enrichment of
corporations by the extraction of human capital through their cycles of
drug-chasing-drug remediation.

It is not a surprise to anyone involved in science-based public health that
public health scientists want to decrease the consumption of highly processed
foods, to remove toxins from water and food, to assure access to healthy food to
the population. However, MAHA itself has painted public health as being opposed
to—or at least indifferent to—these things. Where there might be a wedge to
make some MAHA believers start to question MAHA while finding common ground with
public health goes back to a huge disconnect at the heart of MAHA, something
Mr. Everitt seems to recognize, even if he doesn’t say so explicitly. One part
of that wedge is how, other than RFK Jr.’s crusade against vaccines, this
administration is not only not doing anything beyond the performative (e.g,
eliminating some food dyes) to make MAHA’s stated goals into policy, but it’s
actively implementing policies contrary to what MAHA claims to want, such as
allowing the use of glyphosate and loosening environmental regulations governing
pollution and clean water.

Another part is to go back to what Dr. Wang wrote about what surely must have
been Ms. Frost account of how she became MAHA in which she discussed the lack of
access to health care and healthy food common to both rural and urban
communities across the U.S. and the search for alternatives that are affordable 
and accessible. What, I would ask, are President Trump and HHS Secretary doing
to address these problems? Nothing! Worse than nothing, actually! They are
cutting funds to Medicare and Medicaid in order to fund the war in Iran. Those
cuts will endanger the viability of the rural hospitals that are, as Ms. Frost
knows, already grossly insufficient to meet the massive healthcare needs of
rural populations. Worse, the continued closure of the Strait of Hormuz likely
to make food more expensive because not just oil is being bottled up in.
Fertilizer currently can’t get through, either. President Trump’s tariffs are
hurting farmers, the end result of which will be—you guessed it—more expensive
food. Decreasing access to vaccines will make children, particularly poor
children, sicker. (I know, I know, the antivax contingent won’t buy that, but
maybe those in MAHA who came to the movement for reasons other than vaccines
might.)

As epidemiologist Katelyn Jetelina put it:

There’s a real difference between the leadership of MAHA, like RFK Jr., and the 
grassroots supporters drawn to the movement.

I don’t believe RFK Jr. is acting in good faith. His record is riddled with
contradictions and falsehoods. His tactics often erode trust under the guise of 
restoring it. Treating him as a serious partner would be a mistake.

But many people who support MAHA at the grassroots level are asking real,
good-faith questions. They’re responding to gaps and failures that public health
professionals recognize, too.

Indeed, I would argue that, from a “gold standard science” standpoint, the
single most effective strategy to address chronic disease, as MAHA claims to be 
all about, would be to institute universal government-funded health insurance
and that, if you truly want to improve the diets of poor people in Appalachia
(or anywhere else, such as urban areas with food desserts) the most effective
policy would be to increase food assistance benefits and institute policies that
actually encourage the production of healthier food and address the existence
of food deserts that lack stores selling fresh food. (Hint: Just removing a few 
food dyes ain’t such a policy, and close to 13% of the US population lives in
food deserts.) If you really want to encourage more people to be more active,
then policies mandating more walkable spaces in cities and suburbs would be one 
way to go. Is this administration doing any of these things? Of course not!
Quite the opposite, in fact!

Once again, it is undeniably true that MAHA was birthed from the antivax
movement. MAHA is antivax, and nearly all antivaxxers now appear to be MAHA.
This is a huge problem that, for whatever reason, Dr. Wang doesn’t acknowledge
other than very tangentially. Mr. Everitt, for his part, doesn’t even
acknowledge it at all in the STAT News version of his article, likely due to a
combination of intent and editorial control. (He does rail against vaccine
mandates in his Substack post.) RFK Jr. doesn’t want to endanger the antivax
focus of MAHA, except strategically and briefly. That explains why he is
currently refusing to talk about vaccines in public, at least until after the
midterms. The White House knows how unpopular his antivax stances are. None of
this is stopping RFK Jr. from, for instance, pushing through a new charter to
remake ACIP into a truly antivax committee by broadening the types of members
who can be committed and adding antivax groups like Physicians for Informed
Consent and the Association of American Physicians and Surgeons as liaisons.

I’m sure that Ms. Frost, as a board member of a state-level MAHA organization,
and Mr. Everitt, as a MAHA activist, know that the word from on high is to hide 
and deny the antivax rhetoric as much as possible, at least for the next six and
a half months until the midterm elections. That very restrain enabled this
messaging victory, with STAT News gamely providing the platform for two glowing 
op-eds about how MAHA and public health really might be able to work together if
public health would just pay no attention to all the quackery and antivax at
the heart of MAHA.

Still, there is enough potential here that something good might come of it. The 
problem is that the MAHA believers don’t appreciate that MAHA is, at its heart, 
an ideology that can only work for you (barring another pandemic) if you are
privileged and have sufficient resources to pay for what it advocates. They
further don’t appreciate that they are not among the privileged few. If more of 
them could be persuaded to understand that, they might be reachable by a
science-based public health approach. The problem is that MAHA and science-based
public health can never just “get along” as long as the antivax and quackery at
the heart of MAHA are not acknowledged and addressed in whatever dialogue
between MAHA and public health there is that might tackle shared interests. Any 
articles that fails to acknowledge the disinformation ecosystem that created
MAHA, how MAHA was spawned by RFK Jr. as a title to wrap his antivax beliefs in,
the better to hide them under the banner of “chronic disease,” better diet,
more exercise, and a hostility to big pharma is missing a huge part of the
point.


Does public health “need” MAHA? No more than medicine “needs” CAM

Last week, The Atlantic published an embarrassingly contrarian piece about how
public health “needs” the “make America healthy again” movement. Public health
needs MAHA only if it “needs” to integrate antivax and quackery into medicine
and public health. Sound familiar?

David Gorski on July 27, 2026

Link


Three months ago, I wrote a post for SBM entitled MAHA and science-based public 
health: Can’t we all just get along? Regular readers, even if they never
actually read that post, can probably predict my answer: No. At least, the
answer is no as long as MAHA continues to embrace outright quackery, massive
deregulation of medicine and drug approval, Lysenkoism 2.0, and antivax
pseudoscience, nor should the science-based medical community try to “get
along.” Indeed, ever since our current Secretary of Health and Human Services,
Robert F. Kennedy, Jr., a rabid antivax activist going back to at least 2005,
co-opted the slogan “make America healthy again” (MAHA) in order to make it his 
own after having suspended his Presidential campaign to bend the knee to Donald 
Trump in return for power, there have been colleagues and pundits telling us
that “MAHA is more than just antivax” and that “MAHA has tapped into something
real.” While the latter might be somewhat true, unfortunately you can’t separate
MAHA from the antivaccine movement, nor can it be separated from the motley
assortment of “health influencers,” quacks, antivaxxers, and grifters who see
the movement as a vehicle that will let them profit selling supplements,
unproven treatments (e.g., peptides), and “health freedom” to the masses.

Not that that keeps publications like The Atlantic and doctors like Dr. Craig
Spencer from trying.

Dr. Gorski, upon seeing this article in The Atlantic. Truly, sometimes he is Dug
the Dog.
This week is another one of those “Dug the Dog” moments, where, as the fictional
dog in the animated movie Up is easily distracted by a squirrel, I was
immediately distracted from the topic that I had originally been planning on
writing about by an article in The Atlantic by the aforementioned Dr. Spencer
entitled, Public Health Needs MAHA, in which it is argued that the “field must
swallow its pride and admit where the insurgent movement is right.” Just reading
the headline, I imagined the sound of thousands of eyes belonging to
science-based physicians, scientists, and public health experts all rolling at
once before thousands of palms hit thousands of faces. As I started to look
through this, I also realized that Dr. Spencer was one of the public health
experts who had appeared on the panel that I had discussed when I concluded that
science-based public health can’t really get along with MAHA. So here we go
again.

When Godzilla gives you the facepalm, you know the failure is monstrous.
Before I dive into the article, let me preempt the sorts of attacks that MAHA
apologists usually launch whenever I write an article like this. I’m not saying 
that some of what MAHA claims to stand for—e.g., healthy food, more exercise,
less environmental pollution, and the like—wouldn’t help to “make America
healthy again,” although I might leave off the word “again,” given that it’s
arguable that Americans were ever as healthy as MAHA stans try to claim back in 
the day. Let me put it more explicitly. MAHA is very much like a movement that
this blog has been documenting since 2008, namely “complementary and alternative
medicine” (CAM) or, as it’s now more commonly called, “integrative medicine,”
in which seemingly uncontroversial, unobjectionable precepts (like healthy food 
and more exercise) are blended with quackery and pseudoscience. The main
difference between the two is that MAHA is far more explicitly a political
movement than CAM/integrative medicine ever was, and the main similarity is
that, like CAM, MAHA tries to hide its quackery under a seemingly
unobjectionable set of ideas. Also, like CAM, MAHA often exaggerates what those 
unobjectionable health interventions can accomplish, the better to fuse them
with the quackery. Just like CAM/integrative health, MAHA tries to make those
unfamiliar with its history and the history of its precursor movements believe
that we can’t accomplish all those good things with the overall MAHA umbrella.

With this background, you’ll soon see why Dr. Spencer is so misguided.

Scientists are close-minded and MAHA isn’t antivax?

I knew that Dr. Spencer’s argument was going to cause my blood pressure to rise 
right from the very first paragraph, which frames the issue as one of
close-minded scientists not being open to what MAHA says, and he’s not very
subtle about it at all:

Since Robert F. Kennedy Jr. took office, more than a year ago, I’ve been trying 
to understand the MAHA movement from the inside. I’ve sat in on MAHA Institute
roundtables, roamed the conference halls of anti-vaccine gatherings, and talked 
with grassroots supporters across the country. They tell me their concerns about
toxic chemicals and ultra-processed foods and the worrying rise in childhood
chronic conditions. But when I share what I’m hearing with my colleagues in
medicine and public health, many chide that engaging with MAHA is completely
pointless. For them, the whole movement is nothing more than a subversive
anti-vaccine, anti-science syndicate.

Let’s just say that, even if they might ignore some of the reasonable concerns
that some in MAHA might have about public health and medicine in the US, Dr.
Spencer’s colleagues in public health and medicine perceive MAHA far more
clearly than he does and are far closer to the truth. Just look at the leader of
MAHA, the man who coined the slogan “MAHA”—actually, co-opted and claimed
it—RFK Jr. As I’ve been documenting for over 20 years, he is an antivax
ideologue who has demonized vaccines and, more recently, aligned himself with a 
veritable panoply of health influencers, grifters, and antivaxxers. Consistent
with that, he has spent the last year and a half trying to take away your
vaccines as he channels Trofim Lysenko in order to remake federal science into a
combination of a venture capital source and a slush fund for patronage to
reward supporters and punish opponents by placing scientific grant funding
decisions in the hands of political operatives charged with making sure all
science funding “aligns with administration priorities,” while de-emphasizing
peer review as solely advisory. Meanwhile, RFK Jr., working for the Trump
administration, has eagerly slashed the workforces of the NIH, CDC, and FDA, as 
he, for instance, stacked an FDA advisory committee with peptide advocates to
vote to allow compounding pharmacies to sell unproven peptides, going against
FDA scientists’ recommendations.

So, yeah, it’s not unreasonable of Dr. Craig’s colleagues to view MAHA that way,
not that that stops Dr. Pangloss Craig from opining:

That assumption is wrong. MAHA is an opportunity, and one the public-health
sector—academics, doctors, and leaders of advocacy groups—cannot afford to
squander. Yes, MAHA’s anti-vax wing is very loud and litigious. But for many in 
the MAHA movement, their top issues lie elsewhere: environmental pollutants, the
cost of health care, and a bone-deep conviction that health institutions have
been captured by the industries they’re supposed to regulate. These are not
fringe, unscientific concerns. They are concerns that millions of Americans have
been angry about for decades, long before the MAHA label even existed. And they
are concerns that many in public health share—if only they could see beyond
that label, and make common cause.

I suppose that, if you view every crisis as an opportunity, you might make this 
sort of argument, but I find this line of reasoning less persuasive because this
particular crisis was an entirely self-inflicted one. Reading the passage
above, I was seized with the desire to retort, “You sweet summer child!” Why?
Because public health has been concerned with environmental pollutants, healthy 
food, corporate malfeasance with respect to food and the environment, and the
like, long before MAHA ever existed. Dr. Spencer basically concedes that the
MAHA antivax wing is loud and litigious (because only an utter dolt would argue 
otherwise, given the evidence), but then pivots to try to convince you that it’s
just a fringe minority in MAHA. It’s not. It’s central to MAHA. Just four
months ago, the MAHA Institute, which, by the way, trademarked the terms “Make
America Healthy Again” and “MAHA” (just look at the bottom of the MAHA Institute
webpage if you don’t believe me) held a fear mongering “roundtable” called
“Massive Epidemic of Vaccine Injuries” (MEVI), which, as I documented at the
time, was full of longstanding antivax misinformation, bad science,
pseudoscience, lies, and conspiracy theories, touted by a mix of new
antivaxxers, useful idiots for the antivax movement, and old school antivaxxers 
like Del Bigtree, Mary Holland, Brian Hooker, Larry Palevsky, Toby Rogers, and
Elizabeth Mumper. Even if Dr. Spencer is correct that most MAHA supporters are
not antivax, the leadership of the MAHA movement most definitely is, and the two
cannot be easily separated.

Again, see the play? I agree that concerns about healthy food, lack of exercise,
and environmental pollution are not fringe concerns. I agreed with that premise
many times as I deconstructed the pseudoscience and quackery that is
“integrated” into CAM/”integrative medicine.” I agree with that premise now. The
problem is, MAHA is so loaded with antivax pseudoscience and conspiracy
theories promoted by grifters and outright quackery (as you will see) that these
are the proverbial turd in the swimming pool. They contaminate the whole thing 
irrevocably.

Not to Dr. Spencer, apparently, who strives mightily to convince us that MAHA
isn’t antivax:

That’s why a movement just two years old draws support from four in 10
Americans, according to polling from KFF. MAHA supporters cite the cost of
health care as their top priority, followed by restricting chemical additives in
food and limiting corporate influence in food policy. At the same time, nearly 
eight in 10 MAHA supporters consider long-established vaccines such as those for
measles, mumps, rubella, and polio safe, and only 4 percent cite vaccines as
their reason for supporting the movement. That disconnect alone shows that MAHA 
is not synonymous with a solely anti-vaccine constituency. It represents and
reflects something far larger.

“Long-established vaccines” is doing some very heavy lifting here. Let’s just
say that the wording is very careful, with two of the most established vaccines 
being carefully chosen. I would also argue that 80% of MAHA supporters believing
that these vaccines are safe is actually a very low number! It gets worse as
you read more of the conclusions of the KFF survey, where only half of
respondents were “very confident” that these two vaccines are safe. The survey
also discusses other vaccines:

MAHA supporters are among the groups least confident in the safety of the
COVID-19 vaccine for children (31%). However, a majority of MAHA supporters are 
confident in the safety of the polio vaccines (78%) and MMR vaccines (77%), and 
to a lesser extent heptatitis B (60%) and the flu vaccine (55%).

These are very bad numbers for vaccine support, but in his effort to portray
antivax views in MAHA as fringe, Dr. Pangloss Spencer cherry-picks the two best 
numbers. Here’s the chart from the KFF survey:

Again, these are horrendous numbers, given that high vaccine uptake is necessary
for herd immunity. For measles, for instance, 80% uptake is nowhere near high
enough to produce herd immunity. Uptake needs to be more like 90-95%. As a
public health physician and scientist, you’d think that Dr. Spencer would know
and acknowledge this. Also, as I like to say, antivax is a spectrum, not a
black-and-white division, in which antivaxxers are opposed to all vaccines.
While there certainly are “loud and proud” antivaxxers who believe all vaccines 
are harmful and that no one should be vaccinated, RFK Jr. being one of them even
as he does his best to portray himself as “not antivax.”

The bottom line is that antivaxxers are one of the core constituencies of MAHA
and always have been. They are foundational, and, indeed, they notice whenever
RFK Jr. soft-pedals the quest to eliminate vaccines and to prove that they are
responsible for autism and all manner of health problems and diseases;
antivaxxers notice and are always none too pleased. Some are getting impatient
because they don’t think that RFK Jr. has done enough to whittle down the
vaccine schedule. Anyone who thinks that antivax can be separated from MAHA is
living under a delusion. When Dr. Spencer opines that the number of MAHA
supporters who believe that “core vaccines are safe “shows that MAHA is not
synonymous with a solely anti-vaccine constituency, adding that it “represents
and reflects something far larger,” he might have a germ of a point, but he’s
ignoring how deeply entwined the antivax movement is with MAHA. It reminds me of
the famous adage, “Other than that, how did you like the play, Mrs. Lincoln?”
The allegedly “good” parts of MAHA are completely overshadowed and dominated by 
antivax, and you cannot separate them. Arguing otherwise shows a naïvété that I 
sometimes wish I had, but after 25 years of this, I cannot muster it.

At least MAHA “tries”?

One of the most bizarre and puzzling arguments made by Dr. Spencer in support of
his belief that science-based public health should engage with MAHA in the way 
that he thinks we should comes in this passage:

When I sat down with Nancy Fuller, a lifelong Democrat and, more recently, a
MAHA supporter, at a Christian coffeehouse in rural Ohio, she told me that what 
she likes about the movement is its willingness to try. Ever since her son was
diagnosed with autism, decades ago, she has wondered whether environmental
exposures or maybe vaccines were to blame, and she has spent years watching
health institutions dismiss parents like her as ignorant or uninformed. In her
view, public health steps up to the plate only when it already knows the
outcome. Whether the issue is autism, AI, or something else, MAHA swings at
anything and everything. That means more misses—and occasional hits—on issues
everyone else had decided were too complicated, too compromised, or too
politically inconvenient to touch. MAHA has never been shy about naming problems
loudly and promising to take them on, even—and sometimes especially—when that
means going after powerful corporations and other major institutions that others
had learned to work around.”

Regarding the baseball analogy used to argue that MAHA’s big swings will lead to
a lot of big misses, but also to the occasional hit, I agree with Melody
Schreiber when she asked:

Name ONE hit. In what ways has MAHA positively informed public health policy? I 
very much want to know!

— Melody Schreiber (@melodyschreiber.com) 2026-07-25T20:05:51.468Z

Notably, neither Nancy Fuller nor Dr. Spencer lists a single “big swing” by MAHA
that led to a “big hit” in terms of public health. The baseball fan in me can’t
help but point out that a team full of hitters who take “big swings” at
everything is not likely to be that successful because its batters will strike
out a lot and will probably not score a lot of runs. Sure, they’ll hit the
occasional massive home run, but, to carry this analogy nauseatingly forward,
nowhere in Dr. Spencer’s article does he or Ms. Fuller give even a single
example of a “big hit” from MAHA, even as he lists a lot of misses and
strikeouts. Even the “successes” that MAHA advocates like to point to are not
that impressive, ranging from the marginal (e.g., a couple of food dyes removed 
from products) to the harmful (trying to “make America Denmark” by whittling
down our vaccine schedule to be the same as Denmark’s). After a year and a half 
in power, MAHA has no big successes to go with its big swings. At best, it has a
couple of very modest successes, even on its own terms.

Moreover, given that public health interventions affect huge populations, I
would argue that, even if Ms. Fuller’s analogy were accurate, it’s actually a
good thing that science-based public health doesn’t come up to the plate until
it has a pretty good idea, based on scientific evidence, that what it is
planning will be effective. I don’t want public health to be reckless, and
apparently neither does Dr. Spencer. Why, then, does he defend MAHA and advocate
engaging with it on its own terms?

Also, why does he pivot to an even more head-scratchingly bizarre argument?
Basically, Dr. Spencer concedes that, sure, MAHA is reckless and a lot of it is 
not based in science, but at least it’s not “too timid,” like public health:

This is not a model public health should replicate wholesale. Many of MAHA’s
swings have been genuinely reckless—pushing unproven and often dangerous
wellness hacks, fabricating falsehoods about vaccine ingredients, and making
claims that run counter to all credible evidence. But public health has been too
cautious, setting the bar for evidence too high. On ultra-processed foods,
environmental toxins, and drug prices, public health’s problem was rarely
insufficient data. It was insufficient nerve.

So let me get this straight. Dr. Spencer acknowledges that much of what MAHA has
tried to accomplish is “reckless,” pushes “unproven and often dangerous
wellness hacks,” fabricates “falsehoods about vaccine ingredients” (if only
that’s all MAHA did in terms of antivax disinformation!, and makes “claims that 
run counter to all credible evidence,” but nonetheless still thinks that
science-based public health should engage with it? If public health sets the bar
for evidence “too high,” then how low is acceptable, Dr. Spencer, because
MAHA’s propagandistic “gold standard science” sets the evidence bar so low that 
it’s subterranean. Presumably, Dr. Spencer thinks there is a “golden mean”
somewhere that is appropriate? What is it? How can we tell? The discussion of
what the appropriate level of scientific evidence is to adopt a medical practice
is, after all, a large part of the reason that this very blog was created over 
18 years ago! I’d love to know.

Let’s say for the moment, however, that the problem with public health was
“insufficient nerve.” Public health cannot help but operate within the bounds
that science and, yes, politics permit, because the interventions to promote
public health often require government laws, policy, and action, thus making it 
impossible to separate them from politics and, in the US, partisan politics.
That is one reason why I laugh derisively whenever I hear one of my colleagues
opining that public health “should not be political” and want to ask: How,
precisely, would you accomplish that? Inevitably, the response tends to be that 
public health should “stay out of politics” and “be humble,” all while the
subtext is that it should also accept the political framing that public health
was too authoritarian during the pandemic and thus “lost the public’s trust”; in
other words, the MAHA framing. Moreover, “nerve” in the service of quackery and
pseudoscience, which is what MAHA appears to be, is not a good thing in
medicine or public health!

But, again, in some fantastical past, public health used to be “bolder.” What
does “bolder” mean? Here comes another head-scratchingly bizarre passage:

Public health was not always so timid. The field was born as a potent political 
force, arguing for safer workplaces, cleaner water, better housing. Somewhere
along the way, it shrank into the background, with many of its leaders
preferring to see themselves as a technical and technocratic enterprise that
operates outside the fray. The problem with invisible shields is that nobody
knows they’re there. When the field was forced out front, as it was during the
coronavirus pandemic, many Americans experienced public health not as a shield, 
but as a scold—speaking in acronyms and waving data-filled reports. In
COVID-19’s shadow, trust in essential health agencies including the National
Institutes of Health and the Food and Drug Administration has dropped to
all-time lows. Fewer than half of Americans now have confidence in the CDC to
carry out its core responsibilities, a nearly 40 percent drop from the start of 
the pandemic.

My first reaction was stated pretty well by, again, Melody Schreiber:

Was it public health who did that? Or was it politicians and opportunists?

— Melody Schreiber (@melodyschreiber.com) 2026-07-25T20:07:45.865Z

Indeed. Left out of this narrative of how public health lost the trust of the
populace, as is so often the case, is any mention of the powerful, well-funded, 
and relentless forces that arrayed themselves against public health beginning as
soon as any public health official or organization suggested that maybe, just
maybe, we should start taking collective action to try to mitigate the spread
and worst effects of COVID-19. Indeed, our current HHS Secretary was among those
forces himself, as were many of the sycophants, toadies, lackeys, and
incompetents now in power at HHS agencies such as the CDC, NIH, and FDA. I noted
very early in the pandemic how antivaxxers joined forces with pandemic
minimizers and deniers in an unholy alliance. Two years later, antivaxxers were 
rejoicing at how distrust of COVID-19 vaccines was leading to distrust of all
vaccines, and two years after that, the alliance of COVID-19 contrarians,
antivaxxers, “health freedom” advocates, cranks, quacks, and grifters formed the
basis of MAHA.

Now here’s the ironic thing. That link cited by Dr. Spencer about how public
health had been a potent political force 100 years ago goes to a 2021 article by
Ed Yong entitled How Public Health Took Part in Its Own Downfall. In the
article, Yong argues that the reason public health became less of a potent force
was:

By one telling, public health was a victim of its own success, its value
shrouded by the complacency of good health. By a different account, the
competing field of medicine actively suppressed public health, which threatened 
the financial model of treating illness in (insured) individuals. But these
underdog narratives don’t capture the full story of how public health’s strength
faded. In fact, “public health has actively participated in its own
marginalization,” Daniel Goldberg, a historian of medicine at the University of 
Colorado, told me. As the 20th century progressed, the field moved away from the
idea that social reforms were a necessary part of preventing disease and
willingly silenced its own political voice. By swimming along with the changing 
currents of American ideology, it drowned many of the qualities that made it
most effective.

In other words, Yong’s article basically argues for a more politically engaged
public health effort that advocates for social reforms that address social
determinants of health, which, unsurprisingly, MAHA all but ignores, paying mild
lip service to it. For example, MAHA has done nothing to address food deserts
or to ensure that everyone has adequate health insurance and access to care. It 
has basically ignored one of its supporters’ biggest concerns, with RFK Jr.
basically shrugging his shoulders when President Trump issued an executive order
entitled Promoting the National Defense by Ensuring an Adequate Supply of
Elemental Phosphorus and Glyphosate-Based Herbicides.

But, but, but… conflicts of interest! Dr. Spencer spends a lot of time lamenting
conflicts of interest in public health, singling out the American Academy of
Pediatrics, which, one notes, is not primarily a public health organization but 
rather a professional society for pediatricians:

One step to winning back the public’s trust would be a serious reassessment of
the field’s financial relationships. The AAP’s own donor page lists at least 10 
pharmaceutical companies as supporters, including six that manufacture vaccines 
the AAP recommends. And the six health organizations that sued HHS collectively 
received millions of dollars in donations from the pharmaceutical industry. Each
organization maintains that these gifts are used to fund education or advocacy 
programming, not to influence policy recommendations or approvals.

In a low-trust environment, however, the appearance of a conflict is still bad, 
and RFK Jr. has made this entanglement the centerpiece of his critique. Public
health’s refusal to acknowledge it has handed him an argument he doesn’t deserve
to keep winning. If these societies can accept money from anyone, it’s worth
asking why the donor pages are dominated by the very companies whose products
they evaluate and recommend. If public health wants to save vaccine
infrastructure in this country, it has to end these entanglements.

Dr. Spencer appears to single out the AAP because through legal action it
managed to stay the change in the CDC-recommended vaccine schedule that would
“make America Denmark” by removing six vaccines it and getting a court ruling
that RFK Jr.’s overhaul of the CDC Advisory Committee on Immunization Practices 
(ACIP) violated procedure, seemingly conflating AAP with the profession of
public health at large, which it is not. Sure, I’ll agree with him that it might
be better if the AAP wasn’t so heavily funded by large pharmaceutical
companies, but I’ll also add this retort. The AAP is far more transparent about 
its funding than MAHA is. Moreover, the wellness industry is now a huge industry
itself that is not shy about using its financial clout to advocate for its
interests. Indeed, when it comes to MAHA, just as his boss Donald Trump is for
MAGA, RFK Jr. is Grifter-in-Chief, with his antivax organization profiting
mightily off of its efforts, with RFK Jr. and his ally, antivax attorney Aaron
Siri, profiting off of their legal efforts against vaccines. Nary a peep is seen
in Dr. Spencer’s article about this, and I haven’t even gotten to the
supplement-industrial complex that is now highly influential among MAHA, which, 
it must be acknowledged, is rife with COIs.

Ironically, as you will see, Dr. Spencer appears to be arguing for the same
thing, but in such a way that ignores the realities of today, even as he
correctly lists the devastating actions that the Trump administration has
inflicted on American public health, medicine, and biomedical research:

Now essentially out of power, the public-health community has been justifiably
alarmed by what’s happened over the past year. The administration has
prioritized politics over sound public-health policy in determining what’s
approved by the FDA or what research is funded by the NIH. Severe staffing cuts 
at the CDC have weakened the response to health threats such as screwworm and
Ebola. Many key leadership posts at the agency remain empty—the CDC has had a
confirmed director for only 29 days of this administration. On immunizations,
RFK Jr.’s Department of Health and Human Services altered the childhood-vaccine 
schedule in ways that reflect ideology, not epidemiology. It also overhauled the
Advisory Committee on Immunization Practices, the expert body that has guided
U.S. vaccine policy for decades. In response, the American Academy of Pediatrics
distanced itself from the CDC and positioned itself as an independent,
evidence-based guide for childhood vaccinations. More than two dozen states have
already broken rank with the CDC’s recommendations. The result is a fracturing 
of vaccine guidance, a reflection of the fact that Americans no longer trust a
single institutional voice on vaccines.

And you say that public health needs MAHA because…exactly…why? I mean, these are
the sorts of actions by this administration that we at SBM have been bemoaning 
and analyzing ever since MAHA took control of all non-military federal medicine,
public health, and biomedical research programs. The record that Dr. Spencer is
describing sounds pretty horrendous to me. So, why MAHA?

Apparently this is why:

Public health must recognize there is opportunity in entropy. The path forward
for the field is simple, but requires public health to do something it has been 
reluctant to do: Show up. Visibly. Politically, but not in a partisan way. There
are fights that are strongly supported by both sides, including air quality in 
neighborhoods sharing zip codes with industrial facilities, lead and toxins in
the water kids are drinking, and the poor quality of the food Americans eat and 
its clear negative impact on our health. These are issues where public health
can stand next to communities, name what is harming them, and fight like it
means something. What MAHA understands—imperfectly and sometimes dishonestly—is 
that people do trust institutions, but not because those institutions have good 
data. They trust them because they feel like those institutions are on their
side.

Dr. Spencer, you sweet summer child!

The MAHA Administration has:-allowed coal plants to spew toxic
methylmercury-worsened climate change -dismantled public health & driven up
sickness/death from infections-rolled back food safety -cut funding to Gavi,
which will lead to an estimated 600,000 child deathsWe do not “need” MAHA

— Prof Gavin Yamey (@gavinyamey.bsky.social) 2026-07-26T16:16:37.307Z

Pretty much. I also can’t help but cite that KFF survey back at Dr. Spencer on
another issue. The single most important issue MAHA voters care about for the
midterms is not vaccines. It is not food dyes. It is not limiting pesticide use 
in agriculture. It is not food safety. It’s the cost of health care. Has MAHA
done anything to decrease the cost and expand access to high-quality health
care? Quite the opposite!

I suppose catastrophe, even self-inflicted catastrophe, can represent
opportunity, but if you’re not going to address the actual cause of the
catastrophe, it will be very hard to seize that opportunity. In the meantime,
let’s imagine that public health does what Dr. Spencer says it should do and
shows up, but “not in a partisan way.” What he is describing—advocating for
measures to improve air quality, food quality, and the like—are not going to be 
perceived as nonpartisan! In fact, they sound pretty “woke” to me, and we know
what this administration thinks of “woke.” For one thing, the industries that
would be impacted by such measures are all basically lined up with the
Republican Party now.

All of this brings me around to wondering why Dr. Spencer, who is a legit public
health researcher at Brown University with an impressive track record (and I’m 
not saying this just because he graduated from the medical school where I
currently serve as faculty, either), went down this particular rabbit hole. This
is, after all, a physician with an extensive history of volunteering for
Doctors Without Borders, even contracting Ebola himself in 2014. This is also a 
doctor who in 2023 wrote an article for The Atlantic, How to Lose a Century of
Progress in which he bemoaned rhetoric that was not called MAHA rhetoric at the 
time because MAHA in its current form had not yet come into existence,
concluding:

Armed with a growing array of treatments and diagnostic tools, medicine has
gotten much better at treating infections. But it can still do very little to
stop a novel pandemic, and in March 2020, its ability to save lives from COVID
wasn’t markedly better than during the 1918 influenza pandemic. America needs a 
robust field of public health to do what medicine cannot: keep people safe from 
emerging pathogens, environmental toxins, and gun violence. Medicine can treat
people who are sick, but only public health can preserve their health in the
first place.

And:

But Americans must make sure that public health keeps working, even if it
remains unnoticed. It’s how you know that the cauliflower at the supermarket
isn’t crawling with Cyclospora or that the water from your faucet won’t keep
your children from seeing their first birthday. We’re lucky we haven’t had to
think about it, but that doesn’t mean we can take it for granted.

As someone who lives near the epicenter of the Cyclospora outbreak that’s caused
thousands in my state to experience what the press calls “explosive diarrhea,” 
I found that last paragraph prescient. Here’s the problem. MAHA is not about
public health. It never has been. It’s about the individual über alles. In MAHA,
germ theory and the genetic basis of health are largely denied, and health is
viewed as a consequence of one’s virtue with respect to healthy behavior, and
lack of health as a moral failing. That is the exact opposite of public health.

MAHA is popular today largely because its leaders have (mostly) successfully
downplayed its antivax radicalism and its dedication to quackery, and that is
why it can be attractive to people like Dr. Spence. These people see the damage 
MAHA is doing and understand its generally unscientific worldview, but, because 
they like the part of the MAHA message that is relatively uncontroversial about 
better food, more exercise, and the elimination of environmental pollutants,
swallows his apprehensions, hold their nose, and warily embrace MAHA to the
point where someone like Dr. Spencer can even write that public health “needs”
MAHA. This reminds me of 20 years ago, when ostensibly science-based physicians 
could recognize a lot of the quackery at the heart of CAM/”integrative medicine”
but, because they liked the part of the CAM message that was relatively
uncontroversial about better food, more exercise, and the elimination of
environmental pollutants, were willing to hold their noses over all the
naturopathy, chiropractic, acupuncture, reiki, and other nonsense in CAM to
focus on the diet and exercise part, saying that medicine “needs” CAM.

As the late Dr. Harriet Hall used to say about naturopathy, what is good about
naturopathy is not unique to it, and what is unique to naturopathy is not good. 
Similarly, what is good about MAHA is far from unique to MAHA, and what is
unique to MAHA is not good. Unfortunately, in the case of CAM and MAHA, it is
impossible to separate the two, and that is by design, as MAHA is basically now 
the political arm of CAM, and I doubt that approaches like the one advocated by 
Dr. Spencer will peel off enough MAHA supporters to make much of a difference,
and certainly appearing on a podcast with real dishonest-to-goodness antivax
cranks like Dr. Robert Malone won’t help.


KevinMD platforms criticism of MAHA by a “functional medicine” practitioner

Although some of the criticisms of Robert F. Kennedy Jr.’s MAHA movement are
spot on, why did KevinMD platform a practitioner of functional medicine woo to
make them?

David Gorski on April 20, 2026

Link


The last few weeks have not been great for the “make America healthy again”
(MAHA) movement. MAHA, which is now so ubiquitous that I wondered whether I even
needed to define its acronym at the outset, is a movement designed to bring
antivax fanaticism under the same banner as the quackery-loving “health freedom 
movement.” It’s an acronym and slogan coined by Robert F. Kennedy Jr. (RFK Jr.),
the antivax activist who is now our Secretary of Health and Human Services
(HHS), as an obvious homage to President Donald Trump‘s longstanding slogan,
“make America great again” (MAGA) after he had abandoned his independent
campaign for President, to bend the knee to Donald Trump in return for a
promised high-ranking health post in the new administration, should Trump win.
Unfortunately, Trump won, and RFK Jr. is now our HHS Secretary, which means that
the health and medical bureaucracy of the federal government is now marked by a
combination of RFK Jr.’s antivax efforts to eliminate vaccines, the
administration’s Lysenkoism 2.0 applied to the National Institutes of Health,
and the increasing promotion of dubious treatments favored by wellness grifters,
including the nomination of a “functional medicine” quack named Casey Means as 
Surgeon General, a nomination that is, fortunately, stalled and faltering.

One indication of this last week was an opinion article that I saw on the
medical website KevinMD entitled Make America Healthy Again fails true
functional medicine, by functional medicine doctor Dr. Shiv K. Goel. It’s an
indication that the “integrative medicine” docs who had once been big fans of
RFK Jr. and MAHA are getting restless. Had this article appeared on a
MAHA-affiliated website, I probably would have taken no notice of it, but it was
published a week ago on KevinMD, which started out as a medical blog founded by
internist Dr. Kevin Pho in 2004 and became so increasingly popular and
well-trafficked that it soon partnered with MedPage Today, frequently publishing
co-branded articles on both sites. These days, KevinMD is branded as MedPage
Today’s KevinMD and “social media’s leading physician voice” and billed as the
“web’s leading platform where physicians, advanced practitioners, nurses,
medical students, and patients share their insight and tell their stories.”
Given who platformed Dr. Goel and what the message was—that MAHA isn’t quacky
enough for a functional medicine doctor—I couldn’t resist, in light of STAT
News’ rather clueless recent effort to ask why science-based public health and
MAHA can’t get along.

Before I move on to the article itself, I do want to point out that there have
also been a lot of other setbacks for MAHA in the last month or so. For
instance, The Lancet published a cover article on just what a disaster for
public health the last year-plus of RFK Jr. as HHS Secretary has been, and
ProPublica reported on how MAHA policies are contributing to a resurgence in
potentially deadly vaccine-preventable diseases—and not just measles.

More recently, there have been several news stories about how the MAHA base is
becoming disenchanted with RFK Jr. and the Trump administration because the
White House, realizing as the midterm elections fast approach that the antivax
policies that RFK Jr. had been promoting as HHS Secretary are wildly unpopular, 
has instructed RFK Jr. to cool it with the antivax and focus on the more popular
things about MAHA, such as promoting healthy food and lifestyle interventions
to combat chronic diseases. Meanwhile, a federal judge ruled against RFK Jr.’s
remaking of the Advisory Committee on Immunization Practices that turned ACIP
into an antivax messaging platform. These developments have led to pressure from
the antivax and quack wings of MAHA—which, let’s face it, make up the vast
majority of MAHA—on RFK Jr. and President Trump to cater to their desires and
legal shenanigans by MAHA allies designed to provide cover for RFK Jr. to
implement his antivax policies, to the point where Trump recently met with MAHA 
leaders to try to mollify them. Add to that RFK Jr.’s recent grilling in front
of Congress last week in which, in particular, his being raked over the coals
over his attacks on vaccines, the cutting of medical social safety net programs,
the administration’s attacks on “DEI” with respect to studying disparities in
health outcomes, and, most dramatically, a podcast appearance before he was
nominated in which he made the racist statement that black children on
psychiatric medications should be “reparented,” and it’s been a rough patch.
(RFK Jr. lied and claimed that he never said such a thing, demanding to hear the
recording. Let’s just say that it didn’t take long for a number of social media
influencers to post the audio.)

That’s not even counting the publication of a biography, RFK Jr.: The Fall and
Rise by investigative journalist Isabel Vincent, that revealed, among other
things, RFK Jr.’s numerous extramarital affairs documented in his diary with
ratings and an incident in which during a family trip he stopped the car so that
he could cut the genitals off of a raccoon that he had noticed dead on the side
of the road to “study them later.”

This brings me back to Dr. Goel’s article criticizing MAHA for failing to “true 
functional medicine,” and it’s a doozy. What drew me to this article was not
just the content of the criticism, either, but also the fact that it was
published in a publication as ostensibly as Dr. Pho’s MedPage Today-branded
KevinMD, the point being how mainstream medicine has allowed the language of
MAHA to be normalized to the point where KevinMD and MedPage Today would publish
an article criticizing MAHA for not having failed the quackery known as
functional medicine.

The critique begins

Unsurprisingly, Dr. Goel begins with the central trope at the heart of MAHA,
that the US is the “sickest” nation on earth, which is, of course, of a piece
with RFK Jr.’s false claim in 2019 that the current generation of children is
the “sickest generation” in history, a claim that arguably was one of the
earliest seeds that sprouted to become the MAHA movement. (Hint: RFK Jr. claimed
that the causes of chronic illness were vaccines, “environmental exposures,”
pesticides, and diet. Sound familiar?) Dr. Goel echoes this claim in the
introduction to his post:

I grew up in a family of nine in New Delhi, where scarcity was our daily
companion. We had no processed food, no artificial dyes, no glyphosate-laced
cereal aisles stretching into infinity. We ate whole foods, not by philosophy,
but by necessity. We moved our bodies, not by gym membership, but because life
demanded it. We slept when the sun went down and woke when it rose. Circadian
rhythm was not a wellness trend. It was simply life.

Then I came to America. I became a physician. And I watched, in examination room
after examination room, as a country drowning in abundance became paradoxically
the sickest developed nation on earth.

See what I mean? Dr. Goel, like RFK Jr. and other MAHA stans, invokes fallacies 
of a “lost golden age” and a more “natural time” in which everyone ate “healthy 
food” and exercised, and chronic disease was nowhere to be found (or at least so
uncommon as to be mostly negligible). Never mind that many of these chronic
diseases, such as heart disease and type II diabetes, tend to be diseases of
aging, and, as life expectancy increased and people lived longer, more people
are living to be old enough to be at a much higher risk of these diseases.

I’ll ignore that trope for the moment, because it’s interesting to point out how
Dr. Goel then likens MAHA to functional medicine:

So when Robert F. Kennedy Jr. stood up and said America’s chronic disease
epidemic was a crisis, when he pointed at ultra-processed food, at broken food
systems, at a health care model that treats symptoms instead of causes, I felt
something I had not expected: recognition. He was describing, in political
language, what functional medicine physicians have been saying in clinical
language for decades.

But recognition is not endorsement. And the story of Make America Healthy Again 
(MAHA) is, ultimately, a story of a real diagnosis attached to the wrong
prescription.

See what I mean? Dr. Goel loved MAHA because it spewed the same tropes beloved
of quacks for decades and decades, namely that science-based medicine only
treats “symptoms” instead of the “root cause” of illness and disease and that
that most chronic disease is caused by “contamination” (as I like to put it).
It’s not for nothing that I like to refer to alternative medicine and MAHA as a 
cult of purity, in which disease is due to “purity” being somehow “contaminated”
by the fruits of science, technology, and, yes, modernity. Worse, as we learned
during the pandemic, this “contamination” seems to be contagious, in which the 
“contaminated” (in this case by COVID-19 vaccines) can spread their evil humors 
to others and thereby make them sick too. Let’s just say that there’s a reason
why so much alternative medicine (including functional medicine) involves
“detoxification” and “purification” of those evil humors.

None of this is to say that environmental exposures do not impact health
negatively. No one would deny that pollutants and other exposures can’t
contribute to ill health. It’s just that MAHA takes it further, in essence
denying the genetic predisposition to disease while it also denies germ theory. 
The latter, of course, is perhaps the sole exception to MAHA’s emphasis on
environmental exposures as a cause of disease. After all, an infectious disease 
is nothing if not the result of an environmental exposure to a pathogenic
microorganism. No one ever said that consistency was a major emphasis of MAHA.

Now that we have the groundwork laid, Dr. Goel decides to lay out what, in his
opinion, MAHA gets right. Unsurprisingly, this includes, of course, the belief
that ultraprocessed food is the root of almost all health evil. One thing that I
like to note is that Dr. Goel references CDC reports and at least one study
but, shockingly, does not include the links to either. For instance, he states:

A landmark Lancet series confirmed what functional medicine practitioners have
long observed: Ultra-processed foods are associated with higher risks of heart
disease, diabetes, depression, kidney disease, and early death, and their
addictive properties rival those of tobacco.

I found the series, of course, because that’s what I do whenever I see a series 
or study referenced. Of the three papers in the series, it is mainly the first
paper in the series that lays out the evidence. (The other two are policy
papers.) Far be it from me to claim that ultraprocessed foods are good for our
health (or even neutral) or that, overall, they can cause harm. Our fearless
leader Dr. Steve Novella has written about this way more than I have, which is
why I will refer you to his posts on ultraprocessed foods, which point out that 
there isn’t even a clear definition of the term and that foods known to
contribute to obesity and poor health, namely calorie dense foods “higher in
fat, sugar, and salt, and lower in fiber and micronutrients” can contribute to
chronic diseases. Indeed, Dr. Novella also discussed the weaknesses in the
Lancet series on ultraprocessed foods soon after the three articles were
published. While noting that there is some truth to the claim that many
processed foods are also calorie dense, as well as high in sugars, fat, and
sodium, Dr. Novella argues that the case is more complex than that, stating, ” I
don’t think this story is as clear as the Lancet authors claim. There is likely
some real signal here in the data, but the details are fuzzy.” I tend to agree.
Again, no one is claiming that “ultraprocessed foods” are really good for you. 
What we contest is the representation of these foods as the be-all and end-all
of obesity and chronic disease, as if magically eliminating them would magically
eliminate obesity and its associated chronic diseases.

Naturally, Dr. Goel can’t resist, before shifting to his criticisms of MAHA,
making some magical claims for his beloved functional medicine:

As a physician who trained in functional medicine precisely because conventional
care was failing my patients, I believe in root-cause thinking. I believe in
food as medicine. I believe in the circadian rhythms, the gut microbiome, the
inflammatory pathways that ultra-processed foods disrupt at the cellular level. 
On those foundational truths, MAHA and functional medicine share common ground.

Note the outrageously stupid attack on conventional medicine, namely the
oft-repeated insinuation that science-based physicians don’t study and address
the “root cause” of disease, while “functional medicine” does. After all, what
is an antibiotic but an attempt to address the “root cause” of an infectious
disease. What is a vaccine other than an intervention designed to interfere with
the “root cause” of infectious diseases? Without being too hard on Dr. Goel, I 
will concede that, unlike MAHA, he appears not to be antivax. Indeed, one of his
complaints about MAHA is its antivax stance, and he devotes a entire paragraph 
to lamenting the resurgence of measles in the US as being due to decreased
vaccine uptake, concluding by complaining—quite correctly, I might add—that
“MAHA-aligned groups are simultaneously fighting against legislation that would 
tighten measles, mumps, and rubella (MMR) requirements for school entry” and
noting later in the article that “a movement cannot simultaneously claim to
protect children’s health while fighting vaccine mandates during a measles
outbreak.” I couldn’t have said that part better myself. Bravo! He even notes
what he thinks that “real transformation” of the healthcare system looks like

It looks like vaccine coverage that stays above 95 percent, because herd
immunity is itself a form of functional medicine, a community-level intervention
that protects the most vulnerable members of the biological ecosystem we all
share.

Given how antivax I’ve found functional medicine to be over the years, in
particular its tendency to embrace 19th century terrain theory over the germ
theory of infectious disease, I did rather roll my eyes at this statement, but
then I thought better of it and now applaud Dr. Goel for the sentiment. If only 
most other functional medicine doctors thought the same way about vaccines, even
as I note that conventional science-based medicine and public health has long
had the view that herd immunity is an intervention that protects the must
vulnerable members of society. There’s nothing unique to functional medicine in 
that.

Dr. Goel also perceives:

As a physician who has seen both the scarcity of New Delhi and the abundance of 
American illness, I recognize this pattern. It is the pattern of a movement that
has captured the language of healing without fully committing to its practice.

Or, as I would put it, MAHA cynically captured the language of healing, the
better to allow its supplement grift to proceed.

On the other hand, what did Dr. Goel expect? Was he unaware that RFK Jr. has
been a fanatical antivax activist for over two decades? Did he really expect
that, when RFK Jr. first introduced the acronym MAHA to the nation in 2024, he
would give up his longstanding antivax activism? (Hint: RFK Jr. did not.) Was he
honestly fooled by RFK Jr.’s assiduously avoiding any mention of vaccines in
the MAHA manifesto that he first published in the editorial pages of the Wall
Street Journal? RFK Jr.’s antivax followers were not fooled. They were
complaining about the lack of mention of vaccines in RFK Jr.’s MAHA call to
action as early as a few weeks after it had been published. They continue to do 
so. It’s the selective blindness of so many physicians (and not just functional 
medicine docs) who like what MAHA says about chronic disease, ultraprocessed
foods, exercise and lifestyle interventions, and environmental “toxins” and are 
so desperate to be onboard that they willingly overlook all the antivax quackery
that is at the very foundational heart of MAHA.

And now Dr. Goel is upset that RFK Jr. has, as I always predicted he would, sold
out the anti-pesticide activists, noting with extreme disapproval how RFK Jr.
is totally onboard with President Trump’s February executive order to increase
the production of glyphosate-containing herbicides, to promote national defense.
He is upset that MAHA has, as he put it, ignored the social determinants of
health:

And perhaps most critically: MAHA has nothing to say about the social
determinants of health. No mention of food deserts. No mention of the Medicaid
cuts that are stripping coverage from 11.8 million Americans, threatening to
close more than 400 hospitals. No mention of economic inequality, racial health 
disparities, or the communities, like the one I grew up in, where structural
poverty is the root cause that no seed oil ban can fix.

Correct, but, again, what the heck did Dr. Goel expect? He didn’t really think
that RFK Jr.’s MAHA was about actually addressing societal and population
determinants of health, did he? After all, as I’ve long pointed out, MAHA is
more about soft eugenics (particularly with respect to measles) and placing the 
entire burden of health on the individual, rather than society. Indeed, MAHA
emphasizes the primacy of the individual as the sole arbiter of ensuring
individual health, screw public health. Indeed, it goes beyond that into a
philosophy that can only be described as health as a result of personal virtue, 
with its frequent messaging that you—yes, you!—are completely in control of your
own health. What flows from that messaging is the idea that if you are healthy,
you must be living the “correct”—or virtuous—lifestyle. After all, MAHA was
born of an unholy union between the antivax movement, the anti-public health
movement that mobilized to oppose nonpharmaceutical interventions against
COVID-19 during the pandemic, and the “health freedom” movement that emphasizes 
the individual right to choose whatever treatment a person wants, regardless of 
whether it is scientifically demonstrated to be safe and effective or not, at
whatever price supplement hawkers can charge.

That’s why, even as I recognized this observation by Dr. Goel as right on the
money, I couldn’t help but eye roll again:

The movement that claimed to champion functional health has, in many
expressions, devolved into supplement grifting, fear-based marketing, and
conspiracy frameworks that erode the very institutional trust needed to reform
public health systems. As Newsweek noted, functional health is increasingly at
risk of becoming a luxury, costing up to $25,000 annually, accessible only to
affluent biohackers while the Americans who need it most are left out.

One suspects, one does, that Dr. Goel is more upset at the prospect of
functional medicine becoming unaffordable to all but the wealthy. Again, what
did he expect?

A brief interlude: What is functional medicine?

At this point, I think it’s worth revisiting exactly what functional medicine
is. I realize that I (and other SBM bloggers) have discussed functional medicine
in depth on several occasions, most recently last October, but whenever the
topic comes up I always deem it useful at least to discuss briefly what its core
tenets are. Even now, I like to reference Wally Sampson’s posts explaining why 
FM is quackery, especially his characterization of functional medicine
principles as an “indecipherable babble and descriptive word salad.“. To
describe functional medicine, I like to let the reader see what functional
medicine advocates themselves say about it, for instance on this page What Is
Functional Medicine? First, here are its main principles:

Functional medicine is personalized medicine that deals with primary prevention 
and underlying causes instead of symptoms for serious chronic disease. It is a
science-based field of health care that is grounded in the following principles:

  1. Biochemical individuality describes the importance of individual variations in
    metabolic function that derive from genetic and environmental differences
    among individuals.
  2. Patient-centered medicine emphasizes “patient care” rather than “disease
    care,” following Sir William Osler’s admonition that “It is more important
    to know what patient has the disease than to know what disease the patient
    has.”
  3. Dynamic balance of internal and external factors.
  4. Web-like interconnections of physiological factors – an abundance of research 
    now supports the view that the human body functions as an orchestrated
    network of interconnected systems, rather than individual systems
    functioning autonomously and without effect on each other. For example, we
    now know that immunological dysfunctions can promote cardiovascular disease,
    that dietary imbalances can cause hormonal disturbances, and that
    environmental exposures can precipitate neurologic syndromes such as
    Parkinson’s disease.
  5. Health as a positive vitality – not merely the absence of disease.
  6. Promotion of organ reserve as the means to enhance health span.
In pretty much every post about functional medicine that I’ve ever written, I
feel compelled to remind our readers that the very first principle is, in
essence, functional medicine’s “get out of jail free” card for basically
anything its practitioners want to do. FM docs can always find reasons, whether 
science-based or not, to justify any form of treatment, be it science-based or
quackery, simply by invoking the “biochemical individuality” of the human being 
they are treating. I feel compelledto remind my readers yet again of my favorite
retort to this claim: Yes, human beings are individuals, and each human being
is unique. However, we’re not so unique that our bodies don’t all work pretty
similarly. In other words, in terms of biology, physiology, and yes, systems
biology, we human beings are far more alike than we are different. If that
weren’t the case, modern medicine, developed before we had the tools to probe
our genetic, metabolic, and biochemical individuality, wouldn’t work as well as 
it does.

FM fetishizes “biochemical individuality,” not so much because humans are so
incredibly different that each one absolutely has to employ a totally different 
treatment for a given disease or condition in any given individual. We’re not.
Nor am I arguing that the insights scientists have derived from genomics,
metabolomics, and proteomics, which have revealed different system-level
biochemical and metabolic pathways in physiology, don’t matter. They do. We’re
just not as radically “individuals” on a biochemical basis as FM docs try to
argue. In essence, FM fetishizes biochemical “individuality” because emphasizing
such “individuality” distinguishes functional medicine as a brand distinct from
conventional science- and evidence-based medicine and, I suspect, because it
makes its practitioners feel good, like “total” doctors who are never at a loss 
for an explanation for a patient’s symptoms or clinical condition and can always
think of more tests to figure out a problem. It also patients feel special and 
that their every bit of “individuality” is being catered to. As for the last bit
about FM being a “science-using” profession, FM “uses” science more as a means 
of justifying whatever its practitioners do rather than guiding them to
scientifically-proven treatments.

I went into a lot more detail about this in previous posts, but FM is also all
about finding “imbalances” and then “correcting” them. I’ll illustrate this with
a diagram I frequently use, having found it on functional medicine websites:

I can’t help but point out that prescientific medical systems such as humoral
medicine and traditional Chinese medicine are also all about “correcting
imbalances.” When it comes to functional medicine, many of these “imbalances”
might as well be imbalances in humors, as in humoral medicine, or between
hot/cold, wet/dry, etc., as in traditional Chinese medicine. In practice,
however, functional medicine is the worst of both worlds. With its panels of
hundreds of lab tests that it recommends to screen asymptomatic people for
abnormalities and, of course to correct them with supplements, functional
combines the tendency of conventional medicine towards overtesting and
overtreatment with the quackery of alternative medicine, such as the embrace of 
naturopathy. There’s a reason that I wrote a post with the title, Functional
medicine: Reams of useless tests in one hand, a huge invoice in the other.
Peruse Dr. Goel’s website, and you will find similar reams of tests ranging from
standard to occasionally useful to nearly always useless except in very
specific circumstances.

And Dr. Goel is a functional medicine quack, and he lets his freak flag fly high
in the KevinMD article:

I practice functional medicine not because it is fashionable, but because it
asks the question that medicine too often skips: Why is this patient sick?

Let me just interject here that this quack trope really pisses me off, as it
implies that we science-based physicians are not interested in why patients are 
sick. That must be why physicians spend years and hundreds of thousands of
dollars studying biology, biochemistry, genetics, anatomy, physiology,
embryology, and pathology and why the NIH spends billions every year funding
scientists examining the causes of disease and how to treat disease. Again, “Why
are patients sick?” is just a rehashing of a longstanding trope that we
physicians just “treat the symptoms” and ignore the “root cause.” No! It’s more 
that the actual root causes of diseases tend to be the same as what functional
medicine doctors preach mainly by coincidence. Basically, functional medicine
doctors love to engage in what I like to call biobabble (like Star Trek
technobabble, but about human biology instead of physics). Don’t believe me?
Check out this next passage:

The answer is almost never one thing. It is a constellation, gut dysbiosis fed
by years of ultra-processed food, circadian misalignment from shift work and
blue light, cortisol dysregulation from chronic financial stress, hormonal
disruption from endocrine-disrupting chemicals, inflammatory cascades triggered 
by diets that never give the immune system a rest.

Root-cause medicine means looking at all of these threads simultaneously. It
means understanding that a child whose gut microbiome has been shaped by 62
percent ultra-processed calorie intake cannot be “fixed” by removing Red Dye No.
40 from Skittles, however symbolically satisfying that might be. It means
understanding that vaccine-preventable diseases like measles are not wellness
inconveniences, they are killers, disproportionately dangerous to
immunocompromised patients, infants too young to be vaccinated, and communities 
with compromised access to care.

I’ll give Dr. Goel a pass on vaccines, but notice the biobabble. Dr. Goel is
writing all this as though it actually meant something, when I reality it’s more
like a medical Mad Libs game about the “root cause” of disease, like this:

The circadian medicine principles I work with every day offer a compelling
example. America’s chronic disease epidemic is not only about what people eat,
it is about when they eat, when they sleep, when they move, and how profoundly
the structure of modern life has severed human biology from the natural rhythms 
it was designed to follow. Temporal biomarkers, cortisol curves, insulin timing,
sleep architecture, tell stories that no food label policy can fully address.
Healing requires structure, not just substitution.

Yes, medical Mad Libs coupled with a fallacious appeal to nature!

Personally, I couldn’t resist wondering what Dr. Goel does in practice, which
led me to his website, Prime Vitality Healthcare. Naturally, it didn’t take me
long to find this common narrative about combining the best of East and West,
with a twist:

Because of course Dr. Goel has added AI to functional medicine to “personalize” 
the treatments!
Unsurprisingly, Dr. Goel offers unproven peptide therapy, as well as IV vitamin 
drips (including NAD+, glutathione, iron, hydration, immunity, and custom
cocktails), and “detoxification.” (Of course the website insists that its IV
therapy isn’t a “spa drip bar,” but “physician-directed nutrient therapy
designed to correct deficiencies, accelerate recovery, boost immune function,
and support longevity — all verified by lab work and calibrated to your
biology.” Ri-ight.) Naturally again, he offers an artificial intelligence
service, Time Vitality AI, that claims to calculate your true biological age and
treat time as a “vital sign.” Intrigued, I hit a link called The Science and
was lead to this:

Silly me. I thought I might see some actual scientific articles, or at least an 
explanation of the alleged science behind the AI model, after hitting a link The
Science. Further down, it says that the model will sync with Apple Health,
Google Fit, Fitbit, Oura Rings, etc., as well as “HIPAA-compliant, HL7
FHIR-integrated platform connecting with Electronic Medical Records. Your health
data flows securely, creating a complete picture across providers.” I think
I’ll pass on feeding my health information into an unknown AI model run by a
“functional medicine” woo-meister.
Presumably, this is what Dr. Goel views practicing true functional medicine as
looking like, given that this is apparently how he practices functional
medicine. At least he’s not antivax. That’s about all I can say.

Wait, not quite all. What I can also say is that his concierge
integrative/functional medicine practice is pricey:

Over $2,400 to $7,200 a year for Dr. Goel’s concierge functional medicine plans?
Yikes! That’s not even counting the $499 to $1,499 initiation fees!
Why did KevinMD decide to publish this critique of MAHA?

Despite the fact that Dr. Goel is a functional medicine doctor, there was a lot 
right in this critique, especially its explicitly pro-vaccine retort to MAHA
antivax activism. Moreover, Dr. Goel correctly perceived that MAHA is, at its
heart, a vessel to enable grift involving supplements and unproven treatments,
such as peptides, stem cell treatments, and the like, and that MAHA as currently
formulated isn’t really about public health, given how it ignores nearly
completely the social determinants of health. Unfortunately, buried in Dr.
Goel’s critique of MAHA were some gems that destroyed yet another of my irony
meters, in particular his being unhappy about the supplement grift. After all,
Dr. Goel sells supplements too—lots of supplements—as well as unproven peptides 
and “IV boosters” that he claims to be definitely not from an IV drip spa. It
therefore amused me that he would criticize MAHA for promoting these modalities,
even as it undercut my ability to take his critique seriously.

What amused me less is that KevinMD would platform such a doctor practicing
unproven functional medicine as a credible critic of MAHA. Certainly, Dr. Goel’s
critique can never be truly science-based given his embrace of functional
medicine nonsense. Indeed, his critique comes across very much as, “I don’t want
to be associated with these quacks because I’m not a quack like them,” even
though Casey Means, the nominee to be Surgeon-General, does indeed practice the 
same functional medicine that Dr. Goel does and, yes, huge swaths of functional 
medicine are quackery, with some science-based medicine peppered in like gold
flakes in a cesspool.

Why would KevinMD platform someone like Dr. Goel, who practices “integrative
medicine,” which is, as I like to say, the “integration” of woo with
science-based medicine, the woo in his case being functional medicine? We at SBM
have been long complaining of the “integration” of quackery into medicine and
how it’s becoming increasingly normalized in medical academia and medicine in
general, and that, unfortunately, also includes MedPage Today and KevinMD. If
you want to see how MAHA has been able to co-opt messaging coming from
“respectable” and “mainstream” medical publications and websites, look no
further than MedPage Today and KevinMD.

The MAHA Amnesia Project

The same disinformation agents who are trying to erase the history of the
pandemic, are also trying to erase the history of MAHA.

Jonathan Howard on April 24, 2026

Link


“RFK Jr. Refuses to Say If He Takes ‘Any Responsibility’ for Measles Crisis”

The COVID Amnesia Project (CAP) is the deliberate effort to rewrite the history 
of the pandemic and erase the most basic facts about it. There are two reasons
why I have been writing about it recently. Most obviously, the truth matters. We
should accurately remember 2020. That’s why my articles are full of videos. We 
should also call out revisionist historians, the people who seek to prevent me
from sharing their videos.

However, we also need to recognize this is all an ongoing process. The
architects of the CAP are in charge today, and they didn’t suddenly morph into
men of honesty and integrity when they assumed office. The MAHA Amnesia Project 
(MAP) has already begun, and there will be a lot more it going forward. Although
MAHA is just a year old, we are already seeing their desperate attempts to
rewrite its pathetic history, and if we are not on guard against it, they may
succeed. The CAP has been very successful, after all.

Indeed, now that they have power, MAHA disinformation agents are using the same 
tricks and propaganda techniques that got them there in the first place. For
example, during his recent congressional testimony, an unhinged Robert Kennedy
Jr. blamed everyone else for his failure to control measles. According to the
article, RFK Jr. Refuses to Say If He Takes ‘Any Responsibility’ for Measles
Crisis:

Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday refused
to say whether he takes any responsibility for the surge in measles cases around
the country.

Kennedy, who has spent decades spreading disinformation about the safety of
vaccines, has been testifying to Congress for the past two days about President 
Donald Trump’s 2027 budget request. During that time, he repeatedly scoffed at
the idea that he deserved any blame for the measles outbreaks that spread on his
watch. Instead, he blamed Mennonites, immigrants at the border and other
countries for the nationwide crisis.

Kennedy repeatedly testified that because the measles outbreaks started before
he took office, he bore no blame for them. No one should remember him promoting 
the movie Vaxxed 3: Authorized to Kill right before he took office. In his
fantasy, he was born fresh in 2025, and his 20-year history of anti-vaccine
disinformation was erased the moment he was sworn in.

Notably, Kennedy never highlighted his efforts to vaccinate children during the 
outbreak. He never made the affirmative case he was doing a good job. He just
wanted to make sure no one thought he was at fault for starting the whole thing.
He was enraged that anyone expected him to defend his track record at the HHS, 
and it’s clear that no matter what happens moving forward, Kennedy and MAHA will
always find someone else to blame.

“Tell me one piece of misinformation I’ve ever said, one statement, just one.”

Beyond this, Kennedy incredibly said, “I’ve never been anti-vaccine” and
indignantly responded to one Senator who pointed out his history of anti-vaxx
disinformation by saying:

Tell me one piece of misinformation I’ve ever said, one statement, just one…
You’re just making things up, Senator, you are just making things up.

“There are adverse events from the vaccine It does cause deaths every year.”

OK, Bobby, challenge accepted, though finding examples of Kennedy lying about
vaccines is as difficult as finding sand at the beach. To pick perhaps the most 
egregious example, just last year, after Kennedy had been sworn into office and 
as measles was ramping up, he said:

There are adverse events from the vaccine It does cause deaths every year. It
causes — it causes all the illnesses that measles itself causes, encephalitis
and blindness, et cetera.

There! I’ve done it. I found one piece of misinformation Kennedy said about
vaccines! And remember, this is just one grain of sand.

But notice what’s happening. As with COVID, MAHA provocateurs are lying to our
faces about events we all remember and for which there is incontrovertible video
evidence. However, while such deceptions are utterly unsurprising from this
crew, the bigger problem here is that Kennedy is too addled to grasp a
fundamental fact about his current position in life, the one he chose for
himself.

He is the medical establishment now, and he’s responsible for everything that’s 
happening now. He’s not an outsider anymore. It’s not his job to throw red-faced
tantrums and litigate who started the recent measles outbreaks, though the
person responsible stares at him in the mirror. It’s his job to stop these
outbreaks now, and he’s failing. While he’s podcasting, children are suffering
and measles is spreading in ICE detention centers. That’s all that matters about
Kennedy and MAHA.

Conversely, it’s our job as honest, ethical citizens to get ahead of the MAHA
Amnesia Project, to accurately preserve its this history and to hold its leaders
accountable for their dishonesty, scientific vandalism, and gross incompetence.


“I’m Not Talking About 2020. I’m Talking About 2026.”

2020 is more than just a security blanket for MAHA/MAGA disinformation
superspreaders, it’s an indispensable tool for them. It is a distraction and a
reflexive excuse for their current failures.

Jonathan Howard on August 14, 2026

Link

“I’m not talking about 2020. I’m talking about 2026.”

In September 2021, as the devastating Delta wave was receding and the
devastating Omicron wave was lurking, Dr. Jay Bhattacharya hit his singular
note: everyone should stop worrying and talking about COVID. “The emergency
phase of the disease is over,” he said. “We should be treating COVID as one of
200 diseases that affect people.”

The world would be a much better place if Dr. Bhattacharya had followed his own 
instructions. However, rather than model the behavior he demanded from others,
he continued to treat COVID as the only disease that affects people, talking
about it constantly for years on end. Even today in August 2026, Dr.
Bhattacharya is desperate to return to his safe space and relitigate irrelevant 
battles from six years ago.

As a reminder, COVID overwhelmed hospitals and morgues in 2020, and Donald Trump
was president when America locked down. For his part, Dr. Bhattacharya
speculated that COVID had “one-tenth of the flu mortality rate” and that it
would kill 20,000-40,000 Americans that year. He also claimed that immunity to
COVID was long-lasting, that Sweden and New York had herd immunity, and that the
mass infection of unvaccinated people under age 60-70 would end the pandemic in
3-6 months.

Obviously, Dr. Bhattacharya doesn’t want his reminiscence of 2020 to include any
of that. An accurate remembrance of COVID’s victims, the politicians who
ordered lockdowns, and what people like Dr. Bhattacharya actually said is
strictly verboten in the MAHA/MAGA revisionist history fantasyland.

Although he won’t defend his own words, Dr. Bhattacharya’s core mission in 2026 
is to let everyone know he was right about 2020 all along. And so, like
Groundhog Day, he is once again on Fox News, spreading misinformation about
Fauci, lockdowns, and vaccines over and over again, as if he had no other
concerns or job to do.

There are multiple examples of him discussing 2020 this week alone. In the video
below, Dr. Bhattacharya’s interviewer, Margaret Brennan, knew it was 2026 and
begged him to focus on that. That’s like trying to get my dog to ignore tasty
treats, and predictably Dr. Bhattacharya only wanted to talk about the start of 
the pandemic.

MARGARET BRENNAN: Should parents trust that they can go vaccinate their kids
when their doctor tells them to do so for them to go back to school?

JAY BHATTACHARYA: Yeah, I think– I think that the– that parents, for most kids, 
especially for the measles vaccines, the DTP, all the standard childhood
vaccines, it’s very important that parents vaccinate their kids. As far as can- 
they feel confident sending them back to school? You know, I just– just to push 
back some. It was a tremendous mistake to cause parents to fear that– about
sending their kids to school during the Covid pandemic. The kids were better off
in school. We shouldn’t be scaring the public–

BRENNAN: I’m talking about what people do now. It’s August. About to be
September. Kids are going back to school. I’m not talking about 2020. I’m
talking about 2026.

BHATTACHARYA: Yes, but, Margaret, you’re talking about the– you’re talking
about– we’re talking about the why people have–

BRENNAN: Clarity from the federal government and the top health official…

BHATTACHARYA: Yes, OK, just so we’re clear. If you want clarity, let me give you
some clarity.

BRENNAN: Please.

BHATTACHARYA: The reason why you have this problem in public trust is because
what happened in 2020 has not yet been addressed. To be–….

BRENNAN: Yes. We want to send our kids to school.

BHATTACHARYA: I’m not– but now addressing what happened in 2020 is part of that.

BRENNAN: OK.

BHATTACHARYA: If you want to say why there’s this loss of public trust, you have
to really wrap your arms around that.

“The movement is responding to their current stress with fantasies about
bringing back the glory days. “

Dr. Bhattacharya is hardly the only MAHA/MAGA luminary stuck in a time warp. Dr.
Vinay Prasad, who wrote an article titled Should We Just Stop Talking about
COVID19? 2.5 years ago, still talks about COVID constantly. He’s back to making 
silly anti-Fauci YouTube videos, as if his own disgraceful tenure at the FDA was
some fever dream. So are Jeffrey Tucker, the pro-tobacco, child labor advocate 
behind the Great Barrington Declaration, and Dr. Scott Atlas, another advocate
of herd immunity via mass infection who treated zero COVID patients.

The old gang is back together, and the groupthink of the MAHA/MAGA hivemind is
on full display. They all want to keep spreading misinformation about Fauci,
lockdowns, and vaccines over and over again. That’s their happy place, and they 
all say the exact same things. According to the What’s Resonating newsletter:

Right-leaning accounts posted 2,300 times about Fauci yesterday—for comparison, 
that’s more post volume than the Super Bowl (1,900 posts for right-leaning
accounts, same for left-leaning accounts). The coordination is notable—Fauci was
mentioned in an astonishing 20% of all right-leaning posts yesterday, with
three entities mentioning him more than 75 times in a day.

In her article MAGA Has Pandemic Nostalgia, Amanda Marcott explains why the
disinformation superspreaders who spent years telling everyone else to “move on”
from COVID are constitutionally unable to do so themselves. “It was an era when
the GOP got to do what they love more than anything: play the victim as loudly 
as possible before huge audiences that were especially vulnerable to
disinformation,” she wrote. She continued:

Fascist movements have historically thrived in times of great social stress that
leave people vulnerable to misinformation and eager for scapegoats to blame,
and the pandemic era was no different. With people isolated and bored at home
during the lockdown, many were more willing to engage in conspiracy theory
content that runs rampant online. The pandemic was the peak of QAnon, sucking in
millions with elaborate fantasies that Trump was a savior out to defeat a
worldwide Satanic child cannibalism cabal. Many people, some of whom had even
identified as liberal in the past, were radicalized to the right. Fauci became a
favorite scapegoat for people who wanted to believe there was an evil
mastermind behind the virus, instead of viral replication and transmission. It’s
easy to forget it now, but Jan. 6 was fueled by Covid-19 and the sense of
disconnection that drove a lot of once-ordinary people to lose their intellect
and rationale.

Five years later, MAGA isn’t doing so hot. Between the Iran war and a faltering 
economy, Trump’s presidency is failing, and his approval ratings are in the
toilet. In this environment, it has become increasingly hard for conservatives
to play the victim when Trump has unleashed a secret police in the form of
Immigration and Customs Enforcement that is rounding up people and sending them 
to detainment camps. People aren’t as isolated; they are reconnecting with the
real world. MAGA media is fracturing, and their audiences are a small fraction
of what they had during the pandemic. Republican in-fighting has grown to the
point where podcaster Tucker Carlson, once a loyal Trump ally, is fueling
speculation that he’s going to start a third-party.

Right-wing politics has always been about escaping from contemporary problems by
hiding in nostalgia. After all, “Make America Great Again” is a painfully
literal version of that mentality. So it’s no surprise that the movement is
responding to their current stress with fantasies about bringing back the glory 
days. By reviving the harassment campaign against Fauci, the GOP has
inadvertently revealed the time they long to return to, an era that is
remembered by most people as miserable and deadly.

That sounds right to me.

Beyond this, there are many reasons why individuals like Dr. Bhattacharya are
nostalgic for their glory days of 2020. He rose to fame that year selling a
seductive fantasy where he was in charge, and we barely noticed the virus. He
marketed himself as a superhero who “would have” perfectly tamed COVID, and
powerful people believed him. Billionaires, MAGA politicians, and academics
lauded his imaginary accomplishments, and he didn’t have to do anything beyond
Tweeting and podcasting. He certainly never saw anyone die of COVID.

Things are very different today. Dr. Bhattacharya has a real job with real
responsibilities for the first time. He’s learned that it’s a lot easier to cast
stones from the outside than to deliver concrete results, and his superhero
narrative was punctured long ago. The people who once celebrated him are as
quiet as church mice about his performance in office. As MAHA crumbles, the
glowing praise has been replaced with scathing criticisms.

Today, he is required to nod along with Trump, Kennedy, and Stephen Miller as
they spew lies about vaccines, turning Wakefield’s fraud into policy. That’s his
job now. It’s no wonder he didn’t want to talk about this with Ms. Brennan.
2026 is not going well for him.

It’s also no wonder he wants to turn back the clock. However, 2020 is more than 
just a security blanket for Dr. Bhattacharya; it’s an indispensable tool for
him. It is a distraction and a shield, his reflexive excuse for his current
failures.

According to Dr. Bhattacharya, it’s not his fault measles and explosive diarrhea
are spreading under his watch. Fauci is to blame for that. The anti-vaxx
disinformation of his bosses, Trump and Kennedy, isn’t responsible for falling
vaccination rates. That’s Biden’s fault. Though Dr. Bhattacharya and his ilk
spent years spreading disinformation and doubt, he now claims ancient COVID
policies are responsible for the lack of trust today.

He’s hardly alone in blaming his predecessors for his current failures. Last
year, while in office, Kennedy lied and said the MMR causes encephalitis,
blindness, and kills children. Today, he wants us to believe that babies aren’t 
getting vaccinated because of what Fauci wrote in his diary in 2020. MAHA uses
2020 as their get out of jail free card for their incompetence in 2026. Their
mantra in power is “everything’s fine and don’t blame me anyway”.

“Only 50% of Americans say they trust the Centers for Disease Control and
Prevention’s recommendations to improve public health right now, down from 77%
last year.”

COVID created MAHA/MAGA doctors, and they’ll forever be trapped in pandemic
grievance. 2020 will never be over for them, and they’ll never stop using it as 
an excuse for their incompetence and malevolence.

The silver lining is that Dr. Bhattacharya’s old tricks aren’t working anymore. 
Droning on about 2020 just doesn’t generate the same rage as it did previously. 
Normal people moved on long ago, and we can all see through his charade today.
Everyone knows that he and Kennedy are the medical establishment, and although
neither of them will tell you this, they are responsible for everything that’s
happening now. No one can make the affirmative case they are succeeding, and the
American people have rightfully lost confidence in them. Cringe AI cutouts
won’t fix that.

Not long ago, when he was out of power and all he had to do was spitball
opinions on social media, Dr. Bhattacharya had big feelings about what failed
leaders should do in his situation.

It’s hard to argue with that.


Stanford President Jonathan Levin: You Should Host a Conference on the Job
Performance of MAHA/MAGA Doctors

In October 2024, you gave the introduction to a COVID Amnesia Project conference
that featured disinformation superspreaders and advocates of herd immunity
through mass infection. How do you feel these MAHA/MAGA doctors are doing today?

Jonathan Howard on August 7, 2026

Link


Dear President Levin:

In October 2024, just before the election, you gave the introduction at a
conference titled Pandemic Policy: Planning the Future, Assessing the Past. This
exemplar of the COVID Amnesia Project conference featured disinformation
superspreaders and advocates of herd immunity through mass infection, nearly all
of whom never treated COVID patients.

None of this bothered you, however.

You didn’t care that these laptop class doctors predicted that the virus would
kill 10,000 – 40,000 Americans.  You didn’t care about their false declarations 
of herd immunity. You didn’t care that they vastly overhyped vaccines in 2021,
helping to create distrust in them later on. You didn’t care that they
repeatedly botched basic facts – no, the flu didn’t kill more children than
COVID.  You didn’t care that they treated rare, temporary vaccine side effects
more seriously than literal death from COVID. You didn’t care that they falsely 
said children had “no serious risk” or that COVID’s risk kicked in at age 70.
You didn’t care that they mocked people who suffered from Long COVID or who
tried to avoid the virus in the first place. You didn’t care that they glorified
“natural immunity.” You didn’t care that they made rank propaganda movies in
which they falsely blamed prominent scientists for the origins of the virus. You
didn’t care about their overt political activism. You didn’t care about their
close associations with overt pro-tobacco, child labor advocates and paranoid
conspiracy theorists. You didn’t care that they dunked on masks, testing, and
vaccines, literally anything that slowed the spread of the virus. You didn’t
care that they tried to use unvaccinated people under age 60-70 as human shields
to theoretically protect the “vulnerable” and end the pandemic in 3-6 months.
There was many things that you didn’t care about.

Let’s call this what it is, toxic apathy. It was about life-and-death matters
and it was hardly unique to you. This indifference is utterly incomprehensible
to me, and prior to the conference I pleaded with you to simply show videos of
what these doctors actually said. I wrote:

I believe you are obligated to boost these doctors voices. The attendees and the
general public deserve to know what they said and the policies they pushed. The
speakers claim to have been “silenced”, and you have a unique opportunity to
remedy that injustice.

I thought it was important for the audience hear what the speakers had to say in
their own words.

You disagreed.

Instead, of simply showing the truth, you covered it up. You glorified the
speakers and sanctimoniously scolded their critics, the people who corrected
their factual errors. You said:

When I was invited to participate in this event a few months ago, it was with
the understanding that the goal was to bring together people with different
perspectives, engage in a day of discussion, and in that way, try to repair some
of the rifts that opened during COVID.

That struck me as a valuable goal, and the sort of goal we should aim for at
Stanford. So I agreed to give a few brief remarks to that effect.

What followed was disappointing. When I was invited, I asked around and indeed
the organizers were talking to some well-known people with quite different views
who were likely to speak. However, it was not so straightforward. Some invitees
weren’t able to make it, or withdrew, or didn’t want to participate in an event
with other speakers whose views and behavior they found attacking or abhorrent.

When an initial and partial agenda was posted, it was immediately perceived as
one-sided, and as I’m sure you all noticed became the subject of op-eds and
social media posts.

Ironically, instead of repairing rifts as intended and perhaps spurring fresh
thinking, the process seemed to reopen old and existing divisions.

As an observer and as the leader of this university, I found the episode
dispiriting, in a way that goes beyond the specifics of this particular event.

We have many issues today at Stanford, and on other campuses, where views are
divided, and in some cases, like this one, where feelings are raw.

Yet I believe we need to make every effort to get people who disagree, even
sharply, in dialogue with one another. I believe it’s essential for us to do
that as members of the faculty and university leaders – not just because it’s a 
way to advance knowledge, but because we need to model that behavior if we want 
to expect it from our students. And in today’s world, we absolutely need to ask 
and expect our students to be able to engage with, listen to, and debate with
people with whom they disagree. My view is that we need to err on the side of
talking to one another.

So I hope today’s conference will come off in a way that involves just that –
thoughtful and robust discussion across different perspectives. I hope it yields
some important insights about future pandemic policy – we certainly need that. 
Perhaps it does even bridge a few divides among those in the room.

And I hope even more that all of you will join in the larger project of trying
to make Stanford and other campuses forums for the type of robust and thoughtful
discussion that is at the heart of universities when we’re at our best.

A lot has happened since then. The doctors who spent the pandemic boasting on
Fox News and Twitter about all the amazing things they “would do” were given an 
opportunity to prove their mettle in the real world. Several of the conference
speakers, namely Drs. Jay Bhattacharya, Marty Makary, and Vinay Prasad, gained
great power in MAHA/MAGA, though only Dr. Bhattacharya remains. “I think he’ll
do an exceptional job in that role,” you said after Dr. Bhattacharya was
nominated to lead the NIH.

So, how do you feel they are doing?

Given your past comments, I think you owe it us all to weigh in on their job
performance. Have they proven themselves to be “exceptional” leaders? Are they
doing a good job containing contagious diseases? Is free speech thriving under
their leadership? What do you think about their efforts to decimate the routine 
vaccine schedule? How do feel about their censorship, both at the CDC and FDA,
of studies that cast COVID vaccines in a positive light. What about their
cancellation of research into mRNA vaccines? Do you agree with them that Trump
and Kennedy are defenders of science and the scientific method? What are your
thoughts about their disinformation in office- that Tylenol causes autism, that 
leucovorin cures it, and that the COVID vaccine killed children. How do you feel
about their continued efforts to blend science and right-wing politics? Have
these doctors restored trust? Is the future of American science and medicine
brighter thanks to their efforts? What do you think about respected scientists
being arrested, threatened, and abused by powerful MAGA politicians? Are we
better prepared for a pandemic under their leadership? That was a core theme of 
the 2024 conference, after all.

I’d also like to make a further suggestion. Given your previous endorsement of
MAHA/MAGA doctors, I think that you are obligated to host an updated conference 
on the state of STEM under their leadership. You should the invite scientists
they’ve censored and purged. You should invite public health workers who lost
their jobs and students who were forced to abandon careers in science. You
should invited the parents of children who suffered from measles and people who 
suffered from cyclosporiasis. You should invite Americans who were detained and 
locked down to contain Ebola and hantavirus. You should invite researchers whose
grants have been cut for political reasons and scientists who’ve left the
country. You should invite pediatricians who rightfully view the U.S. government
as a barrier to providing accurate information about vaccines.

You should also invite those of us who tried to sound the alarm bells two years 
ago. Former Stanford student Dr. Mallory Harris, for example, wrote a prescient 
article before the conference titled President Levin’s First Order of Business: 
Abandoning Academic Freedom that said:

Academic freedom actually does urgently need protection, at Stanford and across 
the country. Scientific researchers need legal protections, stable employment
that is insulated from outside pressure, security against violent threats and
assistance with debunking lies about their research. We deserve University
leadership that is able to recognize and rebuke these attacks, rather than a
president who endorses them.

Personally, I’d be happy to present the videos you refused to show. I’ll remind 
everyone the warning signs were out there for all to see. All anyone had to do
was care, which you, obviously, did not.

You previously claimed to value thoughtful and robust discussion across
different perspectives, and that’s exactly what I am proposing. Unfortunately, I
am all too familiar with these empty, vacuous words, always uttered in defense 
of MAHA/MAGA doctors, never in defense of their critics.

However, you have the opportunity to prove you were sincere back in 2024. Until 
then, you’ll be a poster child of a powerful academic who turned a blind eye to 
obvious disinformation agents, surrendered in advance to MAHA/MAGA, and made
others pay the price.


MAHA Fluffers Claimed MAHA Doctors Would “Restore Lost Trust.” I Disagreed. Who 
Turned Out to be Right?

The COVID Amnesia Project has seamlessly morphed into the MAHA Amnesia Project, 
and it’s up to us not to forget the sheltered sycophants and enablers whose
enthusiastic support of the pandemic’s worst disinformation superspreaders led
to this sad moment.

Jonathan Howard on May 29, 2026

Link


“Restoring Trust in Public Health”

From declaring that we had herd immunity 5 years ago to claims that immunity to 
COVID was “probably lifelong“, MAHA doctors made an overwhelming number of
preposterous predictions. Yet, they never looked back at them. As variants
repeatedly obliterated their farcical forecasts, they acted as if they simply
never happened.

Instead of humbly reflecting on their own errors, MAHA doctors launched a deluge
of vitriolic attacks on their predecessors, accusing them of being the biggest 
source of pandemic misinformation. Though these combined techniques of amnesia
and accusations were manipulative and dishonest, they were effective in
catapulting MAHA doctors to the pinnacle of the medical establishment.

However, MAHA doctors did not get there on their own. They had a robust support 
network of doctors, journalists, and prominent academics who normalized and
elevated them every step of the way. MAHA doctors said don’t worry about COVID, 
and their supporters legitimized this dangerous message by praising MAHA
doctors. MAHA doctors gained power with the help of these influential, trusted
people who yawned at their anti-vaccine disinformation, pro-infection agenda,
and overt right-wing political propaganda. This support network mocked and
sanctimoniously scolded those of us who disagreed- only we had to watch our
“tone”- while portraying MAHA doctors as benevolent souls whose competence and
wisdom would restore trust in medicine and public health. While many of us
desperately tried to sound the alarm bells about them, their supporters sought
to numb people to their obvious risks. Some examples are:

Drs. John Mandrola and Adam Cifu- Sensible Medicine Endorses Vinay Prasad for
Director of the Center for Biologics Evaluation and Research (CBER) at the US
FDA:

Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA.
He has our enthusiastic support. Prasad is slated to be the incoming CBER
director, where he will regulate vaccines as well as cellular and gene therapy. 
In our opinion, there is no better candidate… We can’t think of anyone more
qualified to lead the biologics division. Prasad’s lifelong commitment to
scientific rigor will help rebuild lost trust in regulatory bodies. 

Dr. John Mandrola- Can We Give the New FDA Leadership a Chance:

The public town hall conversations are both a huge step in the right direction
and a welcome change from the previous FDA leadership… I am excited and
optimistic about the new leadership at FDA. They speak with clarity, humility
and in a language the general public can understand. The transparency will begin
to restore some of the lost trust. Good on them.

Professors Frances Lee and Stephen Macedo- Restoring Trust in Public Health:

Educated elites bemoaning the return to power of Donald Trump would do well to
ask how they contributed to this outcome. Trust in institutions is down, perhaps
especially for those institutions charged with helping the public discern the
truth. Observers often blame the “information ecosystem”—in particular, the
internet—but elites have also undermined public faith by allowing science and
the wider pursuit of truth to be politicized. The incoming administration
presents the opportunity for a reset. To that end, Trump should nominate
Stanford University’s Dr. Jay Bhattacharya to lead the National Institutes of
Health. Bhattacharya exemplifies qualities that were lacking in our nation’s
scientific leadership during the pandemic. The ostracism and condemnation he
faced for his dissenting views provides a vivid illustration of elite failures
to live up to their own deepest values…

If the country had had more scientific leaders like Dr. Jay Bhattacharya—and
more who were willing to listen to him—our policymaking could have been based
more on evidence and less on hubris. During the pandemic democracy’s
“truth-seeking” institutions were infected by politics, partisanship, and
dogmatism. What we need now is a strong dose of fresh thinking and institutional
reform from experts prepared to challenge the reigning consensus and renew our 
commitment to the basic values of science and liberalism.

Dr. Andrew Noymer- Jay Bhattacharya Will Bring Much-Needed Transparency to NIH:

Dr. Jay Bhattacharya – the Stanford professor who is President-elect Donald
Trump’s nominee for the directorship of the National Institutes of Health – will
bring transparency to this government agency, which sorely needs it… I have
seen Jay’s commitment to hearing diverse and disagreeing viewpoints. Jay is not 
one to try to muzzle a dissenting opinion… Transparency is a principal (and
principled) solution to lack of public trust in institutions. I am confident
that Jay’s pursuit of transparency can restore public trust in NIH.

Dr. Leana Wen- The NIH and FDA Nominees Are Surprisingly Strong:

Then and now, I think that Bhattacharya and Makary were unfairly labeled “covid 
deniers” and unjustly ostracized in medical circles. During their confirmation
hearings, both spoke about open discourse, dissent and debate as cornerstones of
their tenures at NIH and the FDA. That’s a good thing. Scientific progress
hinges on challenging conventional thinking, and I appreciated hearing their
ideas for how things can be done differently…

Members of the scientific and medical community, including those who once
disparaged them as covid contrarians, should extend an olive branch. After all, 
Bhattacharya and Makary represent the country’s best chance to preserve its
vaunted biomedical infrastructure.

After Dr. Prasad was fired, the first time, Dr. Cifu wrote an article titled
Vinay Prasad Is My Former Student And Friend. His Departure from FDA Is a Loss
for American Medicine. “He is divisive, opinionated — and usually right,” it
began. It continued:

Vinay was also guaranteed to be labeled a hypocrite. Although his views on
evidentiary requirements have always been nuanced, many critics labeled him as
accepting only randomized controlled studies as adequate evidence. But that’s
not right. To function in his position, he would need to be open to a spectrum
of evidence, as all physicians must be — and he is. I applauded his appointment 
and his early work. His and Makary’s transparency was especially admirable.

In reality, Dr. Vinay Prasad was a juvenile vulgarian who repeatedly said “RCT
or STFU” to spread doubt and anger about mitigation measures. According to his
supporters, however, this meant he was nuanced and open to a spectrum of
evidence. Dr. Marty Makary claimed we had herd immunity in May 2021, immediately
before the Delta variant arrived. According to his supporters, however, he
spoke with clarity and humility. Dr. Jay Bhattacharya pushed for unvaccinated
people to face the risk of the disease in October 2020, just months before both 
vaccines and the pandemic’s deadliest month arrived. According to his
supporters, however, he acted based on evidence, not hubris.

Just watch some of these doctors’ videos to see their COVID disinformation and
pro-MAHA/MAGA agitprop. Though there’s an overwhelming amount of it, their
supporters weren’t bothered by any of it. They praised and celebrated it.

“Trust in CDC, FDA, NIH shrinks”

These videos also clearly showed that doctors who excelled in breaking trust
would struggle to rebuild it. Those are two entirely different skill sets, it
turns out, and breaking is always easier than building.

Enough time has passed to evaluate their real-world performance thus far. Have
they turned out to be surprisingly strong? Did Dr. Prasad’s lifelong commitment 
to scientific rigor help rebuild lost trust at the FDA? Were his public town
hall conversations with Dr. Makary a huge step in the right direction? Was their
transparency especially admirable? Has Dr. Bhattacharya renewed our commitment 
to the basic values of science and liberalism?  Have MAHA doctors fostered a
culture that values open discourse, dissent, and debate? Have they preserved our
vaunted biomedical infrastructure? Has their pursuit of transparency rebuilt
lost trust?

I sure don’t think so, though my own predictions as MAHA loomed weren’t
flawless. I correctly identified the threat, which was no great achievement,
however I greatly underestimated its magnitude. MAHA doctors sabotaged science
and medicine well beyond what I predicted and in ways I never could have
imagined. Their incompetence and malevolence surprised even me. However, at
least I did my best to warn about them, and I am fully prepared to defend my
writing. All of it.

It’s fair to ask those who rolled out the red carpet to MAHA to do the same. A
failure to hold people accountable is how we got here in the first place. As
such, I hope MAHA fluffers will either make the affirmative case they were
right, that MAHA doctors thrived in office and restored trust, or admit they
were wrong about all that.

“Welcome Back Vinay Prasad”

However, I doubt they will even have the integrity to even acknowledge their own
words. If history is any guide, they will claim it’s rude and uncivil for
anyone to merely remember them. Like past predictions of herd immunity,
predictions that MAHA doctors would “restore lost trust” will likely vanish into
the ether and be deliberately forgotten by the people who made them. Indeed
today, Drs. Mandrola and Cifu are writing articles titled Welcome Back Vinay
Prasad on their monetized Substack. It made no mention of his performance at the
FDA and said:

Vinay is returning with knowledge of the inner workings of the federal
government and US drug and biologic regulation, and will bring this perspective 
to his writing. He remains committed to the central question of our era: How do 
we ensure medical decisions are made by good and reliable evidence, at a time of
widespread excitement and innovation?

At least everyone can see through that nonsense these days.

The COVID Amnesia Project has seamlessly morphed into the MAHA Amnesia Project, 
and it’s up to us not to forget the sheltered sycophants and enablers whose
enthusiastic support of the pandemic’s worst disinformation superspreaders led
to this sad moment. Other people paid the price for their need to feel special
and “heterodox”, and I see no reason to trust their judgment on anything else
ever again.


MAHA Ruins Everything – Apeel Edition

Steven Novella on May 20, 2026

Link


About 30-40% of all food produced is wasted and not consumed. That is a stunning
figure – a third of produce goes to waste. That amount of food is grown on land
area the equivalent of China, uses 45 trillion gallons of water, and produces
about 3% of greenhouse gas emissions. An average American household of four
spends about $3 thousand a year on food they don’t eat. About 80% of wasted food
is perishable with an estimated two thirds due to spoilage.

Obviously, if we could slow the process by which perishable foods (such as
fruits and vegetables) spoil that could go a long way to reducing food waste. It
is already common practice to coat perishable food with edible wax after
cleaning at the packing house stage. The wax reduces moisture loss and protects 
against mold. However, this has limited efficacy – the spoilage statistics above
are with the existing use of such wax coatings.

In 2012 a small company called Apeel Sciences was launched, partly from a grant 
from the Bill and Melinda Gates Foundation. They developed a new produce coating
from plant-based mono- and diglycerides. These are natural, edible fat
compounds (lipids) extracted from the peels, pulp, and seeds of fruits and
vegetables. We already consume many such lipids so there is really no plausible 
health concern. The manufacturing process, of course, does involve some
solvents, but these remain in only trace amounts, orders of magnitude less than 
even cautious safety limits. For this reason the FDA has approved Apeel as GRAS 
(generally recognized as safe), and the EU has likewise granted approval as
safe.

The effect of the thin coating is to extend the freshness of produce by 2-3
times, reducing waste due to spoilage by up to 12%. This has impacts all along
the food chain, reducing the need for energy-intensive refrigeration, reducing
food spoilage, price, and environmental impact. And all of this is through a
thin coating made from natural plant products that are certified organic.

Despite all this, MAHA influencers managed to demonize this safe and effective
product through flagrant misinformation, almost destroying the company and
effectively removing the product from American shelves. The anti-Apeel campaign 
appears to have been started with two Facebook posts. This was enough – a new
product to fear-monger about in order to maximize clicks and drive customers to 
their own supplements and other products.

What did not happen was any careful investigation or fact-checking. That is not 
the influencer culture, and not what drives MAHA. They are driven by narratives,
and there are certain core go-to narratives – big industry are all villains
trying to kill you, Bill Gates is some sort of demonic supervillain, everything 
is a conspiracy and you can’t trust anything, especially the government. The
only thing you can trust are online mobs with virtual torches and pitchforks –
oh, and buy my supplements.

Some of the misinformation that was spread included confusing the Apeel food
coating with a completely different UK company also called Apeel which makes
cleaners, even listing the ingredients of the cleaner as if it were the
ingredients of the food coating. This Reddit post includes a lot of the typical 
propaganda – fearmongering about trace contents far below safety limits, falsely
claiming they contain heavy metals when they are only found in the same amounts
as all produce, which is absorbed from the soil (even less as the processing
removes some), and the false claim that Apeel is sprayed on about to spoil food 
to make it appear fresher. Wrong – Apeel is applied at the packaging level right
after harvest and is not purely cosmetic – it actually slows spoilage. There is
even a reference to Bill Gates (who had virtually nothing to do with the
company or product beyond initial grants).

Unfortunately fearmongering can be very effective. All you have to do is spook
the major food chains like Costco into thinking this will hurt their sales, and 
they will cheerfully proclaim that their produce is “Apeel free”. We see the
same thing with the “NON-GMO project” (which in my opinion is a scam). Companies
can’t be out-fearmongered from their competitors, which is why virtually all
pasta brands (for example) have the NON-GMO label despite the fact that there
are no GMO wheat products in existence – not to mention that GMOs are completely
safe and the anti-GMO campaign is built entirely on misinformation and
ignorance.

There is a slight bright spot in this story – Apeel Sciences sued some of the
influencers for defamation and won an undisclosed settlement which included a
statement that the prior claims were wrong. The damage, as they say, was done,
however. In addition to defamation, the suit was based partly on the Lanham act,
which I happen to be very familiar with because I and SBM were also once sued
under the Lanham act.

The Lanham act of 1946 establishes a national system for trademark registration 
and protects businesses and consumers from deceptive marketplace practices. What
this means is that if one business lies about another business in order to ruin
their competition, that is illegal and they can be sued for damages. The lawyer
for Apeel is quoted as saying: “Advertising laws should apply to influencers,” 
she said. “Otherwise, they don’t feel obliged to make truthful representations. 
And people trust what influencers say as fact, especially in health and wellness
marketing.”

I agree. But the complexity is in how the Lanham act is applied. The entity
making the alleged false claims must be a business – it does not apply to
non-commercial uses, such as political speech, news reporting, parodies, or
educational commentary. In fact my case, Tobinick vs Novella, is now a precedent
in how the Lanham act is applied. SBM is not a business, we are doing medical
journalism, commentary, and advocacy. Any fund-raising is incidental, used to
pay expenses, and that is not enough to trigger the Lanham Act.

In the Apeel case, the lawyers had a target-rich environment in terms of who
they could sue, and they were wise to choose an influencer who was clearly
running a business, Robyn Openshaw, a wellness influencer who markets herself as
GreenSmoothieGirl. Apeel claims in the suit: “Defendants’ reasons for
perpetuating these lies about Apeel are clear: They knew they could garner
attention on social media, gain notoriety, and generate engagement by smearing
Apeel, while simultaneously advertising their ownproducts. On information and
belief, Defendants’ smear campaign against Apeel has generated substantial
revenue for Defendants.” Specifically – Openshaw is reported to have sold a
guide to Apeel-free produce, so she directly profited from her fearmongering
about Apeel.

Because they settled this case does not create a legal precedent. But it was
enough to cause many other influencers to take down their anti-Apeel content.
Where does this leave us?

It certainly seems reasonable that “influencers” are a type of journalist, or at
least opinion columnist. This actually makes it difficult to sue them for
spreading misinformation – you have to prove defamation, which in the US is
difficult (I think appropriately so). All they have to do is couch what they say
as opinion and they are protected. Defamation requires writing things that are 
factual claims, false, you knew they were false or acted with reckless
indifference to whether or not they were true, and caused demonstrable harm.

The Lanham Act in some ways is a lower bar, but it requires that you are making 
money from your false statements. This can be a fuzzy standard, and the lines
are very blurry. I think it should be obvious that sites like SBM are not
primarily businesses. None of us make any money directly from our work here.
Other sites are clearly businesses, primarily selling products and services. But
many sites deliberately blur the lines, using sensational reporting to drive
engagement while selling stuff on the side. The question is, which of these
things is primary? Are they selling stuff so they can spread their opinions, or 
are they using their opinions to drive traffic to their store and sell product? 
Alex Jones is a great example of the latter, but many influencers are in the
gray zone. The courts will have to further work out exactly where this line is.

This case shows how powerful influencers have become. They can tank a company by
casually spreading disinformation. There has to be some accountability.

Should We Treat MAHA/MAGA Doctors as Serious Scientists or Political Actors?
Their Own Videos Provide the Answer.

Although MAHA/MAGA doctors wrapped themselves in the protective cloak of science
to stave off criticism, we are under no obligation to treat doctors who spread 
COVID disinformation and right-wing political talking points on TV as legitimate
and serious scientists.

Jonathan Howard on uly 3, 2026

Link


“Blaming credentialed, legitimate scientists can also backfire.”

On Tuesday, I discussed a paragraph in an article titled Misinformation Blaming 
and Labelling May Damage Health, Science and Policy Making by Dr. John
Ioannidis. I want to revisit it because I’m interested in how we got to this sad
moment, with MAHA/MAGA politicizing science and esteemed doctors enabling it
all.

One step on the path was the deceptive depiction of overt political actors as
apolitical, neutral scientists. Here again is Dr. Ioannidis’s paragraph:

Blaming credentialed, legitimate scientists can also backfire. Rigorous
organized scepticism and evidence-based questioning are quintessential for
science and desirable. Emotional pre-emptive rejection of scientific arguments
may suggest to the public that science is an authoritarian, even retaliatory,
process. Some scientists self-anoint themselves as “science-based” communicators
and obsessively blame other legitimate scientists with whom they disagree, even
without clear evidentiary basis for such accusations. They may attack opponents
as quacks. For the watching public, legitimate science becomes
indistinguishable from overt pseudo-science. Quackery can only benefit from
having serious scientists and serious arguments relegated to the same status.
Moreover, when sometimes “science-based” blamers are subsequently proven wrong, 
in retrospect their obsessive behavior becomes a total embarrassment for
science. Science is better served by elevating standards of reasoning and
methodological rigor than by engaging in rhetorical escalation or questionable
analogies.

Notice Dr. Ioannidis’s repeated emphasis on credentialed, legitimate, serious
scientists who made serious scientific arguments. He feels such exalted souls
need to be treated gently, with care, deference, and respect. Anything less
would be a “a total embarrassment for science.”

However, despite Dr. Ioannidis’s protestations, we are not required to treat
doctors who minimized COVID and openly pushed their policy objectives in the
media and to MAGA politicians as if they were conducting scientific research the
whole time. It turns out, the doctors who shared their policy opinions
regarding COVID on Fox News were not the ones who made scientific breakthroughs 
regarding COVID, and scientists who chose to enter the political arena this way 
have forfeited the right to be regarded as mere scientists.

“His arguments in a string of appearances on Fox News, CNN and other news
networks were seized on by right-wing firebrands seeking to discredit
public-health officials and reopen the economy.”

Indeed, while I was seeing a lot of people suffer and die at an overwhelmed NYC 
hospital in April 2020, Dr. Ioannidis was busy giving interviews to far-right
MAGA propagandists on Fox News saying COVID was overblown. “They vast majority
of them don’t even realize they have been infected,” he said after the host
listed his impressive scientific credentials. This is how he spent his time at
the start of the pandemic, minimizing COVID in front of a camera, utterly
indifferent to the experience of frontline doctors. This was not legitimate,
serious science.

Dr. Ioannidis produced an enormous amount of absurdly confident content like
this in 2020, and all of it aged horribly. Don’t take my word for it. Although
Dr. Ioannidis won’t do so, I urge you to watch it for yourself. It’s important
to remember exactly what he said during these media appearances because these
media appearances are why we criticized him for here at SBM. “I think there’s no
reason to fear,” he said. “We have data.” This virus had just arrived on our
shores when he said this in April 2020. This was not legitimate, serious
science.

Many others made rigorous criticisms of his scientific papers, namely the
infamous Santa Clara antibody study. According to statistics professor Dr.
Andrew Gelman:

I think the authors of the above-linked paper owe us all an apology. We wasted
time and effort discussing this paper whose main selling point was some numbers 
that were essentially the product of a statistical error. I’m serious about the 
apology. Everyone makes mistakes. I don’t think they authors need to apologize
just because they screwed up. I think they need to apologize because these were 
avoidable screw-ups. They’re the kind of screw-ups that happen if you want to
leap out with an exciting finding and you don’t look too carefully at what you
might have done wrong.

However, Dr. Ioannidis used this study to once again get himself in front of a
camera, where once again he minimized COVID and advocated for his favored
pandemic policies. COVID is in the “same ballpark as seasonal influenza” he
said. “I think the devastation can be extreme, and it can be far worse than
anything coronavirus can do,” he said about measures to contain the virus. This 
was not legitimate, serious science.

Rather than respond to his critics in good faith, Dr. Ioannidis acts as if the
mere act of disagreeing with the policies he pushed on TV fundamentally
undermines all of science itself. Apparently, anyone who criticizes what he said
on Fox News six years ago is guilty of a “pre-emptive rejection of scientific
arguments“- emphasis added. However, while Dr. Ioannidis now claims to have been
making “scientific arguments“, the truth is he used the cover of science to
advocate for his favored policies. For example, here he is saying we should
never lockdown again. That’s not science. That’s policy.

Dr. Ioannidis championed his favored policies all the time, always while
claiming to be conducting “scientific investigations”. An article from 2020
titled A Top Scientist Questioned Virus Lockdowns on Fox News. The Backlash Was 
Fierce discussed his media appearances, not his scientific discoveries. It said:

His arguments in a string of appearances on Fox News, CNN and other news
networks were seized on by right-wing firebrands seeking to discredit
public-health officials and reopen the economy…

He had appeared at least 18 times on major cable news networks, repeatedly
questioning the severity of the pandemic. He acknowledged that his statements
might have been exploited for political purposes but said the alternative —
silencing his doubts, or withholding them from certain audiences — is dangerous 
as well.

“I think it’s very scary when we try to suppress scientific thinking and
investigation, whatever the reason might be,” he said.

Dr. Ioannidis even made a vanity documentary where he discussed his pandemic
policy positions. “We took a lot of measures we should not have taken,” he said.
This was not legitimate, serious science.

Policy positions should be informed by science, but they are not themselves
science. Dr. Ioannidis is obviously free to express his policy positions on Fox 
News and anywhere else he wants, but no one should pretend these media
appearances are “scientific thinking and investigation.” Going on Fox News is
going on Fox News. No one forced Dr. Ioannidis to minimize COVID on Fox News,
and no one needs his permission to criticize him for this. It wasn’t legitimate,
serious science.

“In late March, as COVID-19 cases overran hospitals overseas, Ioannidis tried to
organize a meeting at the White House.”

Direct political advocacy is also not legitimate, serious science, and Dr.
Ioannidis was not above this either in 2020. According to an article from July
2020 by Stephanie Lee titled An Elite Group of Scientists Tried to Warn Trump
Against Lockdowns in March:

Stanford University scientist John Ioannidis has declared in study after study
that the coronavirus is not that big of a threat, emboldening opponents of
economic shutdowns — and infuriating critics who see fundamental errors in his
work

But even before the epidemiologist had any of that data in hand, he and an elite
group of scientists tried to convince President Donald Trump that locking down 
the country would be the real danger.

In late March, as COVID-19 cases overran hospitals overseas, Ioannidis tried to 
organize a meeting at the White House where he and a small band of colleagues
would caution the president against “shutting down the country for [a] very long
time and jeopardizing so many lives in doing this,” according to a statement
Ioannidis submitted on the group’s behalf. Their goal, the statement said, was
“to both save more lives and avoid serious damage to the US economy using the
most reliable data.”

Although the meeting did not happen, Ioannidis believed their message had
reached the right people. Within a day of him sending it to the White House,
Trump announced that he wanted the country reopened by Easter. “I think our
ideas have inflitrated [sic] the White House regardless,” Ioannidis told his
collaborators on March 28.

However, that White House meeting did happen in August 2020, the month after Ms.
Lee published her article, when We Want Them Infected doctors Scott Atlas, Jay 
Bhattacharya, Martin Kulldorff, and Joseph Ladapo met with Trump there. Listen
as they reminisce about meeting the world’s most powerful politician to push
their favored pandemic policies. This was not legitimate, serious science.

Dr. Ioannidis ended up being right about their ideas infiltrating the White
House, however. The next month, September 2020, Trump echoed their talking
points. Trump said:

With time it goes away. You’ll develop a herd mentality, it’s going to be herd
developed. That will all happen… I really believe we are rounding the corner… A 
lot of people do agree with me. You look at Scott Atlas, you look at some of the
other doctors from highly, from Stanford… They think maybe we could have done
that from the beginning.

This was not legitimate, serious science.

Several months later, pro-infection doctor Scott Atlas revealed how these
scientists influenced COVID policy at the White House. “This is the science,”
Dr. Atlas said. It wasn’t science, however.

Unfortunately, Dr. Ioannidis was hardly the only doctor who demanded to be
treated like a humble, apolitical scientist, while simultaneously pushing
political positions favored by “right-wing firebrands” on Fox News and to MAGA
politicians. The discussions below are a minuscule sample of these doctors’
overt political content, which vastly exceeded their scientific discoveries.

Dr. Vinay Prasad: Former Head of CBER

In 2023, Dr. Vinay Prasad published an article on Bari Weiss’s The Free Press
titled Why Was My Talk at a Medical Conference Canceled? The subtitle was “My
job is to terrify cancer cells. But apparently it’s not just malignant cells
that get uneasy around me.” He wrote about himself:

As a physician and medical scholar who has published over 450 academic articles 
and two books, my research team and I base our opinions on a sober assessment of
available evidence.

However. while Dr. Prasad portrayed himself as a medical scholar who based his
opinions on a sober assessment of available evidence, he didn’t behave that way.
He was immature, unprofessional, vulgar, and accusatory, and it’s no surprise
that during his dismal year at the FDA, STAT News published articles titled
Under Vinay Prasad, Employees At A Key FDA Center Fear Speaking Out, Look For
The Exits.

Dr. Prasad was also an overtly political actor who weighed in on pandemic policy
daily for years. He shared his political opinions in Reason Magazine and
fluffed Kennedy on podcasts hosted by far-right firebrands like Megyn Kelly.
“RFK Jr. has an important point” about vaccines not being properly studied, he
said in the middle video below. Dr. Prasad had every right to share his
political opinions, but no one has to pretend it’s legitimate, serious science.

Dr. Prasad openly endorsed Trump and Kennedy. It’s not subtle. It’s also not
legitimate, serious science.

Again, you don’t have to take my word for it regarding Dr. Prasad’s political
activism on behalf of Trump. Listen below as Dr. Marty Makary perfectly
described Dr. Prasad’s “love” for Trump. “If you listen to his podcasts for the 
past 4 years, you’ll see that he has been an ardent supporter of everything
President Trump has done and is trying to do.” That’s 100% true, and it wasn’t
legitimate, serious science.

Dr. Jay Bhattacharya: NIH and CDC

In a talk from 2024 titled Free Speech is the End of Science, Dr. Jay
Bhattacharya told the audience he was going to discuss “science that I did
during the pandemic.” “Science during the pandemic was distorted,” he said. He
spoke about the tragic fate of his social media content and the suffering of
“scientists who didn’t hold the orthodox views.”

However, Dr. Bhattacharya rose to fame not via his groundbreaking COVID
research, but rather via his failed plan for herd immunity via mass infection
and his association with Jeffrey Tucker, a proud pro-tobacco, child labor
advocate. Watch Tucker’s video with the “School sucks project.” You can’t make
this stuff up.

Despite not being a scientist, Tucker organized and contributed to the
composition of Great Barrington Declaration, Dr. Bhattacharya’s signature
achievement. “I was there while it was being drafted“, Tucker said. “I made a
couple of suggestions here and there.” These are the fringe political figures
with whom Dr. Bhattacharya associated, and today child labor laws are being
rolled back across the country, and the FDA is approving vaping products at
Trump’s urging.

While Dr. Bhattacharya portrayed himself as a serious scientist, he didn’t spend
his time in hospitals or labs. Rather he spent his time making slick, political
propaganda videos like this. Oh no! We might get a “biomedical security state.”
This was not legitimate, serious science, and it’s no surprise that he is
mocked today as “Podcast Jay”.

Dr. Bhattacharya was a star of Reason Magazine and the Wall Street Journal,
where he wrote articles such as Is the Coronavirus as Deadly as They Say? He was
#7 on the list The Dishonest Doctors Who Were Fox News’ Most Frequent Medical
Guests In 2021. He had 33 appearances that year where he openly expressed his
political views and made unprofessional accusations about people who disagreed
with his policy choices. “Maybe they like having children being developmentally 
held back,” he said in an interview with Pete Hesgeth. This was not legitimate, 
serious science.

Dr. Bhattacharya advised powerful right-wing politicians and joined multiple
presidential campaigns, both Ron DeSantis and Kennedy, where he shared his
political opinions while simultaneously portraying himself as an apolitical
scientist. “I work in public health,” he said. “I am deeply uncomfortable.
Public health should be equally suitable for Democrats. Republicans,
independents, and everyone alike,” he said at a political rally. This was not
legitimate, serious science.

Today, as the NIH director, Dr. Bhattacharya is still claiming to be apolitical 
while speaking at political events, like TPUSA and CPAC. “Science has no
politics,” he said at these right-wing political rallies. This was not
legitimate, serious science.

As NIH director, Dr. Bhattacharya continues to go on Fox News and NewsMax to
push his political views. Just listen as he says that Kennedy is “devoted to the
scientific method,” that he “loves” Trump, and that accusations that Trump is
against science are “ridiculous slander.” Today, it’s his job to advance their
political agenda at the NIH and CDC. This was not legitimate, serious science.

Dr. Marty Makary: Former FDA Comissioner

During his opening testimony as FDA commissioner, Dr. Marty Makary spoke about
his research. He said:

I’m grateful to Johns Hopkins for allowing me to have a dual career as both a
surgical oncologist, and a health care researcher. In addition to using FDA
approved devices and medications, my research has focused on patient safety, the
Orphan Drug Act, how the FDA evaluates devices, opioids, and how health care
has become too fragmented, too cold, and too corporate. My research on price
gouging and predatory billing turned into advocacy to call for price
transparency in health care.

Although Dr. Makary marketed himself as a “health care researcher” to one
audience, he too was a star of the right-wing media echo chamber. He wrote gems 
such as We’ll Have Herd Immunity by April for the Wall Street Journal and was
the #2 doctor in the article The Dishonest Doctors Who Were Fox News’ Most
Frequent Medical Guests In 2021, with 142 appearances. In the video below, from 
May 2021, Dr. Makary said public health leaders who disagreed herd immunity had 
arrived were “dishonest” and trying to “manipulate the public.” Dr. Makary made 
volumes of such content for years. This was not legitimate, serious science.

Dr. Makary was also an overtly political actor. Here he is endorsing Kennedy’s
vile lies about the COVID vaccine killing children on Fox News. “One thing RFK
Jr. did is he would post true stories of children immediately after the
vaccine,” Dr. Makary said. This was not legitimate, serious science.


Dr. Makary dunked on federal health agencies and glorified SARS-CoV-2 with MAGA 
figures like Jim Jordan. “Natural immunity adjusted for age and comorbidity is
27 times more effective than vaccinated immunity,” he said. This was not
legitimate, serious science.

Dr. Makary pushed right-wing talking points before Congress with Drs.
Bhattacharya and Kulldorff. “Public health officials were intellectually
dishonest,” he said. “They lied to the American people.” This was not
legitimate, serious science.

In 2026 as FDA commissioner, Dr. Makary gushed over Trump and expressed his
gratitude to him. Trump is an “amazing guy, he’s a phenom,” Makary said. Trump
has “more energy than anybody and instincts better than some of the academic
elites in America,” he added. Dr. Makary also did his best to enact Kennedy’s
and Trump’s agenda at the FDA. This was not legitimate, serious science, and
it’s no surprise that after his dismal year at the FDA, STAT News published an
editorial titled Why Marty Makary Was The Worst FDA Commissioner In 25 Years.

We at SBM didn’t do any of this. Not even close.

Yet, Dr. Ioannidis scolded us and portrayed us as the ones with some nefarious
agenda. He said we were a total embarrassment for science because we obsessively
criticized legitimate and serious scientists.

We don’t have to participate in his absurd fantasy, however. Although MAHA/MAGA 
doctors wrapped themselves in the protective cloak of science to stave off
criticism, we are under no obligation to treat doctors who spread COVID
disinformation and right-wing talking points on TV as legitimate and serious
scientists.

The obvious truth is that MAHA/MAGA doctors were primarily pandemic content
creators and political actors out to advance their own careers and the
Trump/Kennedy agenda.

They didn’t hide it, and we won’t deny it.


Dr. Joseph Marine: Defend Your Article “Why Doctors Should Learn to Stop
Worrying and Love MAHA”.

You owe it to Sensible Medicine readers to simultaneously to acknowledge the
state of STEM under MAHA and argue that you were right about it.

Jonathan Howard on July 5, 2026

Link


Dear Dr. Marine,

Though there have been countless reports describing the dismal state of STEM
under Kennedy and his crew, Drs. Jay Bhattacharya, Tracy Beth Hoeg, Vinay
Prasad, Marty Makary, and Martin Kulldorff, I’d like to draw your attention to
three recent articles about the total incompetence and dysfunction of MAHA from 
this month alone.

Kennedy Shows Minimal Engagement with Vast Health Portfolio:

Mr. Kennedy has shown little interest in managing the details of work in his
department, according to multiple colleagues… The secretary’s detachment from
much of the work of the agency, along with the administration’s deep staff cuts 
and his attacks on career staff, have driven down morale, they say. It’s a
dynamic that could threaten the department’s ability to protect Americans in a
crisis, according to public health experts and former secretaries.

Are MAGA and MAHA Heading for Divorce:

Over Kennedy’s 16-month tenure, while the MAGA White House has paid lip service 
to Kennedy’s agenda, its big-money alliances with tobacco, pesticide, and talc
companies have repeatedly undercut MAHA priorities, and have even taken Kennedy 
and his deputies by surprise. Meanwhile, Kennedy’s weak leadership skills,
drifting attention, and the operational naivete of his handpicked staff have led
to chaos so detrimental that agency lawyers have repeatedly warned officials
that their policy rollouts fail to comply with regulations, or will not survive 
legal challenges…

As the MAHA-MAGA compact has faltered over many months, Kennedy has reverted to 
stunts and marginalia: plunging into an ice bath wearing jeans, doing chin-ups
in an airport, and even delving into the question of extraterrestrial life with 
a visiting billionaire at an HHS meeting.

Has the MAHA Movement Given Up?:

It already seems clear that the resentful health libertarianism that bound the
movement together in podcast studios, social media groups and conferences stages
has no novel answer for new disease threats, even lesser ones.

You should read these articles in their entirety, and they should be of great
interest to you, because as MAHA loomed in the fall of 2024, you wrote an essay 
on the monetized Substack Sensible Medicine titled Why Doctors Should Learn to
Stop Worrying and Love MAHA. While we here at SBM desperately tried to sound the
alarm bells about MAHA, you wrote:

I argue that we should embrace the Make America Healthy Again (MAHA) agenda and 
try to convince our medical leaders to work for major changes in our
dysfunctional health agencies and deteriorating health care system.

RFK Jr has tapped into a strong sense among the public that government health
agencies, and the health system at large, have been corrupted by corporate
interests that have become increasingly misaligned with the public interest, a
fact that was exposed by the disastrous authoritarian covid response.

You concluded by saying:

This is the choice that physicians are going to have to make in the coming
months: stand with the corporate interests that the public and many doctors
increasingly see as harmful to their health and their lives or stand with
patients and public for major reform.

The right choice should be clear to everyone.

You followed this up with another Sensible Medicine gem titled The MAHA Report: 
A Seismic Shift in US Health Policy. Although much of the MAHA Report was AI
slop, full of fake citations, you were nonetheless impressed by it, writing:

The MAHA Report represents a seismic shift in US government healthcare policy.
It will form the foundation for US health policy for the next four years. Now
that the MAHA Commission has published its guiding principles, there are more
concrete ideas for physicians to engage with.

The sensible response for physicians will be to embrace its best ideas and
reflect on its criticism of our current medical and biomedical research models
and practices. We should embrace the opportunity for change.

A lot has happened since then, and you owe it to Sensible Medicine readers to
provide a thorough update on how MAHA is doing. You should be brutally honest
about the state of STEM today, and you should name the people who are
responsible for it. This includes large numbers of people at your own
institution who have lost their jobs.

After that, you should argue that you were right about MAHA in 2024. Taking into
account current events, you should make the affirmative case that MAHA has been
a smashing success, that it succeeded in restoring trust and promoting free
speech, and that doctors should “love” it today. That was your previous
instruction.

You could be the first person to write such an article. Again, I confess to
having asked ChatGPT about this, and here’s what it said:

I searched specifically for articles written by doctors or scientists who are
not themselves part of the MAHA movement and who argue that RFK Jr. and MAHA are
succeeding and doing a good job promoting science and medicine.

I could not find a meaningful list of such articles. The available evidence
points in the opposite direction: most physician/scientist commentary I found
was critical of MAHA’s scientific rigor or public-health impact.

Kennedy has boasted of his “wins” at least, warning us about food dyes in ice
cream and getting Steak and Shake to change the way they make French fries.
Maybe you can convince me that this will dramatically improve Americans’ health.
My mind is open, and I have so much to learn from your wisdom and nuance.

However, assuming you can’t honestly acknowledge what’s happening in STEM today 
and then defend MAHA, you should at least have the humility and integrity to
admit you vastly overestimated the abilities of MAHA doctors to deliver in the
real world. Their pitiful job performance has implications regarding your belief
about the “authoritarian covid response,” which was your main justification for
MAHA.

We can agree that beaches and hiking trails should have stayed open, but you
predictably portrayed all COVID mitigations as deliberate choices made by
malevolent people rather than the inevitable consequences of a deadly new virus 
repeatedly washing over us for years. I’ve described this previously as the
fantasy of the optional pandemic, where everything we hated about COVID, the
deaths and mitigations alike, could have been avoided if only sage MAHA doctors 
had been in charge.

They certainly weren’t humble about their imagined abilities. They claimed they 
could have delivered this COVID utopia, but pandemic bad guys- YouTube and the
NIH- got in their way. I can see why this was attractive, and something you’d
want to believe was possible. Their fantasy of the optional pandemic certainly
sounds a lot better than the awful actual pandemic. I admit it.

However, the purveyors of the optional pandemic are (or were) MAHA royalty. It’s
the exact same doctors. Today, Dr. Bhattacharya can’t fix a few broken windows 
at the CDC and Dr. Kulldorff can’t run a single meeting of the ACIP. They
shouldn’t get any accolades for their entirely imagined COVID glories in years
past. Dr. Vinay Prasad is correct that he Tweeted a lot about RCTs, but this is 
nothing to boast about, and no one should applaud him for it. He failed to
deliver RCTs when he had power, and his tenure at the FDA was a soap opera.
That’s what matters.

The counterfactual alternative histories, and there are many of them, where MAHA
doctors spared us the pandemic, depend entirely on these doctors being
individuals of great competence. They were the ones who supposedly “would have” 
opened schools and protected the vulnerable when COVID raged. In reality, they
delivered changes to the Shake Shack menu when given the opportunity to lead.

As such, if you can’t defend these doctors’ real-world performance today, then
you can’t plausibly claim they “would have” tackled COVID in 2020. Your fan
fiction about them can automatically be thrown in the bin along with all their
Great Declarations, editorials, podcasts, and Fox News appearances. It was all
just empty words.

The obvious truth is that COVID would have been a worse debacle had Kennedy and 
his crew been in charge in 2020. Anyone who still pretends otherwise in 2026 is 
just playing make-believe at this point.

Of course, MAHA doctors already had a real-world track record before assuming
office, and just because you ignored the warning signs doesn’t mean they weren’t
there. Indeed, Dr. Martin Kulldorff said about himself and Dr. Bhattacharya,
“One place where we had some success was Florida“. Here’s what Dr. Kulldorff
considered “success”:

  1. They failed to protect “vulnerable” people: “Florida Leads Nation in Number of
    COVID-19 Deaths of Nursing Home Residents and Staff,” August 2021.
  2. They failed to protect “not vulnerable” people: “Child Covid Deaths More Than 
    Doubled in Florida as Kids Returned to the Classroom,” September 2021.
  3. They failed to keep schools open: “School Closures Reported In Five Florida
    Counties; Districts ‘Drowning’ In COVID,” August 2021.
  4. They failed to protect educators: “15 Miami-Dade Public School Staff Members
    Die of COVID In Just 10 Days,” September 2021.
  5. They failed to achieve herd immunity: “Florida’s COVID Deaths Reach Nearly
    6,000 in 2024,” January 2025.
While we discussed these realities often at SBM, you didn’t care about them at
all, and the most recent addition to their list of “success” is Florida Reading 
Scores Fall to Last in the Nation, Report Says.  This is what MAHA doctors
accomplished when they had the opportunity to prove their pandemic mettle, and
I’m glad I never predicted they would thrive at the CDC, NIH, and FDA.

You could also admit you fundamentally misunderstood what the MAHA movement was 
all about. Let’s not forget you said, “MAHA is more than RFK and has little to
do with vaccines.”  I wrote an entire article about that absurd statement in
which I made several predictions of my own.

I predicted Kennedy would attack vaccines, and he has, though that was hardly
some brilliant insight on my part.  After all, Kennedy was showing the
propaganda move Vaxxed III: Authorized to Kill at the time, though you didn’t
care about that either.

My article concluded with a promise about myself and a prediction about you. I
wrote:

If I am wrong, and RFK Jr. leaves vaccines alone for the next 4 year, I will
happily admit it. If RFK Jr. relentlessly attacks vaccines, will Dr. Marine
admit error? I think we all know the answer.

Indeed, we all knew the answer. You haven’t admitted error yet, and based on my 
experience with Sensible Medicine doctors and their poor predictions, you never 
will. Being a Sensible Medicine doctor means never having to take responsibility
for your words. You won’t write a coherent, robust defense of MAHA, and you’ll 
refuse to even acknowledge how things are going in STEM today. As always, with
Sensible Medicine, unwanted news is unmentionable news, and I’m the true villain
for having the gall to remind you that you told doctors to “love” MAHA.

In contrast, we at SBM, the guys who accurately warned about Kennedy and his
ilk, are not afraid to honestly discuss what is happening to STEM with MAHA in
power. I do it every week, and you should feel free to ask me to defend any of
my prior essays, books, or podcasts. It’s totally fair and appropriate to hold
me accountable for things I’ve said.

I’m ready.

“Learn to love MAHA” vs. “how to make the CDC great again”?

MAHA apologist Dr. Joseph Marine recently wrote an article on how to make the
CDC great again. Wait, what? Trump’s been in office a year and a half, and the
CDC isn’t great?

David Gorski on July 13, 2026

Link


A (seemingly) long time ago in a galaxy (seemingly) far, far away, a Johns
Hopkins cardiologist named Dr. Joseph Marine wrote a(n) (in)famous post for the 
inaptly named Sensible Medicine blog entitled Why Doctors Should Learn to Stop
Worrying and Love MAHA. MAHA, for those who haven’t been paying attention,
stands for “make America healthy again,” a slogan co-opted by our current
Secretary of Health and Human Services Robert F. Kennedy Jr. in 2024 after he
had suspended his Presidential campaign and bent the knee to Donald Trump in
return for a promise of power, should Trump win the election and become
President again. Unfortunately for medicine, public health, and science, Donald 
Trump did win again, and RFK Jr. soon became what I described at the time as an 
extinction-level threat to public health. Nothing that has happened since I
first described the threat posed by this administration to science and public
health as “extinction-level” has led me to believe that I was exaggerating or
being histrionic at the time; quite the contrary, in fact. If anything, I lacked
the imagination in 2024 to see just how far this administration would go in
dismantling everything good about US federal science programs, such as, for
example, the National Institutes of Health, where Lysenkoism 2.0 is about to be 
codified into federal regulations.

So, given the dismantling of peer review at the NIH in favor of political
control of grantmaking decisions (with some MAHA advocates even calling for
“abolishing the NIH“), the systematic attack on US vaccination programs at the
Centers for Disease Control and Prevention and the Food and Drug Administration,
and the wholesale assault on evidence-based policy, it’s natural to wonder, as 
SBM contributor Dr. Jonathan Howard has, whether Dr. Marine is still supportive 
of MAHA or can continue to defend his original post, given what has happened
since Trump became President again, which led to this conversation on X, the
platform formerly (and better) known as Twitter:

Unfortunately, as of yesterday he had not produced his arguments. However, that 
doesn’t mean that, while we’re waiting, I can’t look at something that Dr.
Marine did write last week for the Brownstone Institute, which rose to
prominence during the pandemic as a far right wing anti-public health project of
one Jeffrey Tucker that has become one of the primary propaganda wings of the
populist, anti-expertise wing of the “make America great again” (MAGA) movement,
entitled How to Make the CDC Great Again. Besides, I’m sure that Dr. Howard
will be able to handle whatever apologia that Dr. Marine ultimately comes up
with for MAHA. In the meantime, as the title of this blog post implies, I’m
suffering whiplash between the Dr. Marine of 2024 chastising doctors (like me
and the rest of the SBM crew) for worrying about what MAHA would do with Donald 
Trump and RFK Jr. in power to now proposing how to make the CDC great again, as 
I said on X:

See what I mean? Dr. Marine is saying that we need to make the CDC great again
(whatever that means), but Trump has been in power a year and a half? Why isn’t 
the CDC great again, or at least clearly making progress towards being great
again? Even if “making CDC great again” is a long-term project, you’d think that
a year and a half would be enough time to get at least a decent start on it,
wouldn’t you? (I would.)

My whiplash aside, I think it’s instructive to look at what Dr. Marine actually 
wrote, to compare it with what’s actually happened since January 20, 2025, and
then with what Dr. Marine wrote about MAHA in 2024, to see how it all squares
up.

Ethics, censorship, and a MAHA apologist

Dr. Marine begins his article by letting the reader know that he is a Very
Important Person Indeed and, in fact, was under serious consideration to be the 
Director of the CDC. To a science-based physician like myself, that admission
tells me just how bad the situation is at CDC, as Dr. Marine is a cardiologist. 
Indeed, he subspecializes even more than cardiology; he’s an
electrophysiologist, which is the branch of cardiology concerned with heart
rhythm disorders, such as atrial fibrillation. There is nothing in his biography
or background that suggests that he is the least bit qualified to be CDC
Director. He does, however, have an impressive number of publications listed on 
PubMed. I’ll give him credit for that; he has five times the number of
publications that I do, and he’s considerably younger than I am. Unfortunately, 
none of his publications seem to indicate expertise in public health,
vaccinology, or infectious disease, although he did get a comment published in
the New England Journal of Medicine in 2023 about a study looking at universal
masking of children in school that showed an association between lifting mask
mandates in schools in Boston with increased incidence of COVID-19 among
students and staff. Naturally, Dr. Marine blamed unaccounted-for confounding.

In any event, let’s see how Dr. Marine leads off:

A few months ago, I was one of several candidates under consideration for
Director of the Centers for Disease Control and Prevention (CDC). While I did
not make the final cut, I was honored to be considered for such an important
position. The administration has nominated a highly qualified team to lead the
CDC and I wish them well. The experience gave me the opportunity to reflect on
what reforms I would like to see at the CDC as it faces a pivot point in the
history of medicine and public health. Here are six themes that I see as most
important and urgent.

Again, that the administration would even consider Dr. Marine for CDC Director
tells me just how little subject-specific expertise is valued by this
administration. That makes the ultimate choice of the administration to be CDC
Director all the more surprising, and in an actually pleasant way. Indeed, in
this one case the administration did choose a much better—and, shockingly, more 
conventional—candidate to run the CDC, Dr. Erica Schwartz:

Schwartz holds multiple academic credentials, including both medical and law
degrees. Her career has largely been spent in military uniform, including in a
leadership position at the U.S. Coast Guard where she oversaw the organization’s
system of 41 clinics and 150 sick bays.

She later served as deputy surgeon general, where she helped lead uniformed
medical and health professionals posted at the CDC and government health
agencies that serve the general public.

It almost makes me wonder if RFK Jr. had anything to do with this selection,
given that Dr. Schwartz has relevant experience and is not a crank. Indeed, it
amused me to see that everyone’s favorite antivax lawyer, Aaron Siri, was most
displeased when Dr. Schwartz’s nomination was announced:

But Aaron Siri, a lawyer and ally of Kennedy in attacking vaccines and
pharmaceutical companies, criticized Schwartz’s selection. In a social media
post, Siri lambasted Schwartz’s past promotion of vaccinations and said “she
lacks the basic ethics and morals to lead the CDC.”

I don’t know a lot about Dr. Schwartz, but if Siri doesn’t like her, the worst
that can be said about her is that she isn’t all bad, while the best is that she
is a real public health official and expert and, equally important, not an
antivax crank.

But back to what Dr. Marine thinks to be required to “make CDC great again.” I’m
going to take the liberty of jumping to one specific issue that he brings up,
because it is the most egregiously out of touch with reality. It is the one that
shows either his utter obliviousness to what has happened the last year and a
half or his utter disingenuousness. (Take your pick.) This item comes as a
bullet point under the first “theme” that Dr. Marine advocates. That theme
states:

Develop a new ethical framework for public health practice. Too often during the
pandemic, policies were justified by the intended effects with little attention
paid to the means used to reach those ends. The Hippocratic Oath and its modern
derivatives have served as that ethical framework for medical practice for over
2,000 years and they have made the health professions (until recently) one of
the most trusted institutions in our society. Public health practice needs its
own version and should adopt many of its principles…

I rolled my eyes at this, as you might imagine. Public health is a branch of
medicine. Many of the people who administer public health are physicians who
have taken the Hippocratic oath or one of its updated modern variants. Moreover,
at this point, Dr. Marine is just regurgitating standard COVID contrarian
talking points that falsely claim that public health officials never considered 
the consequences of the means they used to try to contain COVID-19. I’ll get
back to that in a minute, but let me jump down to the eighth bullet point under 
this theme:

Renounce and combat censorship. For the public to trust statements of public
health officials, they must believe that contrary viewpoints can be publicly
expressed and debated in the marketplace of ideas. Suppression of those
viewpoints by government actors may feed public mistrust and may suggest that
they are receiving an illusory consensus and propaganda rather than the best
available information. A previous administration embraced the dubious idea that 
“misinformation” was a “public health threat” and a “leading cause of death.”
The new public health framework must treat contrary viewpoints with respect and 
encourage open dialogue.

We can all agree that censorship is generally a bad thing in a democracy. On the
other hand, accepting that principle doesn’t mean that spreading misinformation
is or should be without consequences. After all, misinformation spreaders take 
advantage of the freedom of speech that our constitution ostensibly grants
citizens in order to promote their pseudoscience, conspiracy theories, and
disinformation as having equal purchase in the public dialogue with
science-based facts, policies, and opinions, all while proclaiming themselves as
victims of “censorship” if they face any sort of pushback or consequences for
exercising their freedom of speech to spread misinformation. When Dr. Marine
calls for treating “contrary viewpoints with respect and encourage open
dialogue,” I like to ask him what contrary viewpoints he’d treat with “respect” 
in his specialty. For instance, does he think homeopathy can effectively treat
atrial fibrillation? Should the viewpoint making that claim be treated with
“respect,” particularly when the person making that claim is selling homeopathic
products to treat atrial fibrillation? After all, homeopathy is basically
water, and using it to treat atrial fibrillation is the same as not treating the
atrial fibrillation at all. People could have strokes and even die as a result 
of untreated atrial fibrillation. I don’t want to harp on this point too much,
as I’ve discussed it more times than I can remember. This call for “respect” and
“open dialogue” is almost never anything more than a call to treat
pseudoscience, conspiracy theories, and misinformation as worthy of being
“debated” on the same plane as science-based medicine.

Instead, I want to point out something that Dr. Marine doesn’t mention at all
and, as far as I know, has not mentioned anywhere, namely: If he’s so much
against “censorship,” then why is he so chill with MAHA, given that the Trump
administration has done more than any previous administration to silence
scientists and punish those it doesn’t like, either by firing or making it
impossible for them to obtain research grants? Let’s start with a topic that
dominated my blog posts in June: what the current administration is doing at
NIH. First of all, does Dr. Marine approve of the new rules proposed by OMB
Director Russell Vought that would, in essence, relegate scientific peer review 
to an entirely advisory role in decisions over which research grant applications
to fund while giving the power to fund or veto research grants entirely to
political appointees, who have to be “aligned” with administration interests?
(There’s still time for public comment, by the way, but you’ll have to act fast.
The deadline is today.)

How about another example? Nature recently reported on how political screening
is holding up the disbursement of NIH research grants, and what’s happening is
really egregious and scary, as I discussed a couple of weeks ago. Does Dr.
Marine consider this “censorship” by the government? If not, why not? Does he
approve of political control of the research grant funding process? Before
answering that question, he should remember that, even if he likes this
particular administration’s politics, no administration lasts forever, and it is
(still) quite possible that a Democrat will be elected in 2028—or even a
Republican whose politics he doesn’t like. Does he feel comfortable given
political appointees such granular control over what science gets funded?

That’s not all, though. Some of the new proposed rules would require federally
funded scientists to seek permission to publish their results, suggesting that
the administration could bar them from publishing results that it doesn’t like. 
Ditto if a scientist wants to present the findings of federally funded research 
at a scientific conference. Yes, these rules will require preauthorization by
the government to present findings at a scientific conference. How are these two
policies not censorship of scientists? If these rules pass, the power of the
government to censor scientists and scientific findings will be permanently
codified in the federal register and very difficult to change! I don’t see Dr.
Marine being the least bit troubled by these issues; at least, if he is, I’ve
seen no indication in his writings or social media posts that he’s the least bit
troubled by this obvious government censorship. One wonders whether he’s fine
with it because it’s his side doing the censoring, one does. Or maybe he just
doesn’t know. What is the old saying? Oh, yes: There are none so blind as those 
who will not see, and, yes, this is happening now. For instance, Dr.
Bhattacharya blocked the publication of a study from the CDC that showed that
COVID-19 vaccines were effective and safe during the 2025-2026 winter
respiratory virus season.

Of course, Dr. Marine was untroubled. Hilariously, in this thread on X, he
basically dismissed the study as “a bigger piece of junk than I thought” but was
unable to describe in any coherent detail what, exactly, were the shortcomings 
that led him to conclude that, despite being asked again and again, eventually
just saying:

So, basically, Dr. Marine didn’t like the results and appears not to accept
epidemiological studies as ever being sufficiently rigorous to guide public
policy but, worse, doesn’t even care much about the actual results. Nor,
apparently, does he care that the government blocked the publication of the
results of government-funded and -administered science that had passed the usual
longstanding pre-publication peer review steps required by the CDC before
publication in its journal MMWR. Again, it’s difficult not to conclude that Dr. 
Marine is fine with the censorship of scientists, as long as it’s scientists he 
doesn’t like who are being censored and the censorship is being done by
officials whose policies he does like. Indeed, he has resorted to a truly
disingenuous argument:

Dr. Marine was so close to understanding why all the “censorship” against
misinformation was not, in fact, truly censorship at all in any real sense of
the world, but rather more akin to quality control and consequences for
exercising one’s freedom of speech for spreading bullshit. Again, though, when
establishment scientists do it, it’s 

Perhaps even worse, the new culture of censorship by the medical, public health,
and scientific authorities in the federal government is trickling down.
Recently, the American Diabetes Association called the police to kick out of
their yearly scientific conference several prominent members of the organization
who were doing nothing more provocative than quietly passing out reprints of an
article critical of NIH Director (and acting CDC Director) Dr. Jay
Bhattacharya, an op-ed that had originally been published in the official
journal of the ADA! Then it banned them from attending the rest of its official 
proceedings. Does that not bother Dr. Marine? When the government censors and
threatens punishment against critics, it’s not uncommon for some organizations
to start obeying in advance. True, the ADA did ultimately apologize, and some
heads among its leadership did roll, but that it ever served as the goon squad
to enforce the administration’s censorship in the first place is very
disturbing. I don’t recall Dr. Marine ever having said anything about that. I’m 
guessing that it doesn’t bother him.

Let’s just say I would take Dr. Marine a lot more seriously in his concerns
about “censorship” if he weren’t so blatantly one-sided in his criticisms. As it
is, to me his call against “censorship” reads more like saying that it’s
censorship when “they” do it, but when “we” do it it’s quality control.

Yet, under his third theme, Dr. Marine asserts that we must do this:

Embrace diversity in political viewpoints. A Washington Examiner column just
before the pandemic showed that >99% of political donations from CDC employees
went to one political party. That is a major problem. A CDC which is too biased 
toward one political philosophy or set of viewpoints will not be able sustain
long-term public support. While 50% + 1 may serve as a successful formula for
electoral politics, it is a prescription for failure in public health policy,
which necessarily blends science with public policy. A public health approach
which does not account for a range of political viewpoints will not be able to
garner the broad public health necessary for successful implementation,
particularly in times of crisis. CDC leadership must examine how certain
political viewpoints have been systematically excluded from the CDC and the
field of public health and work to broaden the base of political perspectives
within the field.

Can Dr. Marine honestly say that the CDC—or NIH or FDA or any agency in HHS, for
that matter—is “embracing diversity in political viewpoints”? Again, one of the
great bugaboos of this administration is the dreaded “DEI” (diversity, equity, 
and inclusion), and Trump is actively trying to crush any vestige of DEI
anywhere. At the NIH (again), even mentioning anything that sounds as though it 
might be even tangentially related to DEI is being suppressed. It is indeed rich
that Dr. Marine complains about the pre-Trump 2.0 CDC “systematically
excluding” certain political viewpoints from the CDC but says nothing about how 
Trump’s OMB Director

On a related note, as far as respecting diversity of scientific opinion, I would
point out that Trump’s first CDC Director, Susan Monarez, was fired because she
wouldn’t unquestioningly go along with RFK Jr.’s plans to change the vaccine
schedule. Basically, she refused to go along with RFK Jr.’s attempts to promote 
unscientific and pseudoscientific policies at the CDC and would not fire the
people he wanted her to fire. Her firing led to a mass resignation of several
key CDC managers. Moreover, there are many reports out there that RFK Jr. does
not consult with or listen to scientists with expertise in vaccines, infectious 
disease, epidemiology, and public health policy, preferring instead his own
stable of cranks and quacks, some of whom he’s elevated to high positions in the
CDC, FDA, and NIH. Does Dr. Marine think that RFK Jr. should listen to
scientists who might disagree with him?

He claims to in one of his bullet points:

Consideration of expertise of others: Public health is also public policy, not
just science. A public health program must include expertise in economics,
childhood development, psychology, and other fields which are not part of formal
public health training. Dr. Fauci famously disclaimed responsibility for
understanding the economic and social consequences of pandemic policies as being
outside his field of concern. This attitude is not acceptable in medicine or
surgery, where practitioners are expected to fully understand the consequences
of the treatments that they recommend. It should not be acceptable in public
health practice.

Let’s just say that this is not a fair representation of what Dr. Fauci actually
said. It’s a paraphrase of a Fauci quote that appears to have originated in an 
article in Reason commenting on an interview Dr. Fauci gave the New York Times. 
Here is what he actually said:

I certainly think things could have been done differently — and better — on both
sides. I mean, anybody who thinks that what we or anybody else did was perfect 
is not looking at reality. Nothing was done perfectly. But what I can say is
that, at least to my perception, the emphasis strictly on the science and public
health — that is what public-health people should do. I’m not an economist. The
Centers for Disease Control and Prevention is not an economic organization. The
surgeon general is not an economist. So we looked at it from a purely
public-health standpoint. It was for other people to make broader assessments — 
people whose positions include but aren’t exclusively about public health. Those
people have to make the decisions about the balance between the potential
negative consequences of something versus the benefits of something.

Certainly there could have been a better understanding of why people were
emphasizing the economy. But when people say, “Fauci shut down the economy” — it
wasn’t Fauci. The C.D.C. was the organization that made those recommendations. 
I happened to be perceived as the personification of the recommendations. But
show me a school that I shut down and show me a factory that I shut down. Never.
I never did. I gave a public-health recommendation that echoed the C.D.C.’s
recommendation, and people made a decision based on that. But I never criticized
the people who had to make the decisions one way or the other.

This is not an unreasonable stance. The purview of the CDC is public health, not
economics, although the two can intersect. In a functioning government, the CDC
would give its recommendations based on public health science, while, for
instance, the job of analyzing the economic impact of the recommendations would 
fall to the Council of Economic Advisors and maybe the Departments of Treasury
and Commerce, who would not be expected to comment on the scientific and public 
health recommendations. It would then be up to the President and the Cabinet,
along with Congress, to weigh these recommendations and act upon them, balancing
the costs with potential benefits. Dr. Marine is demanding that the CDC
undertake a task that it is ill-equipped to do simply because he didn’t like the
policies pursued by the first Trump administration and then by the Biden
administration to control the pandemic. Dr. Marine’s other claim that “US
pandemic leaders paid little or no attention to the massive collateral damage
caused by policies focused exclusively on preventing every possible Covid
infection” is also utter nonsense, nothing more than the usual claims that we’ve
been hearing since 2020. In reality, he’s referring to one interview with
former NIH Director Francis Collins, who said:

If you’re a public health person, and you’re trying to make a decision, you have
this very narrow view of what the right decision is, and that is something that
will save a life. Doesn’t matter what else happens, so you attach infinite
value to stopping the disease and saving a life. You attach zero value to
whether this actually totally disrupts people’s lives, ruins the economy, and
has many kids kept out of school in a way that they never might quite recover
from. Collateral damage. This is a public health mindset. And I think a lot of
us involved in trying to make those recommendations had that mindset — and that 
was really unfortunate, it’s another mistake we made.

I would, of course, argue that this statement from Dr. Fauci rather belies Dr.
Marine’s second theme, that we should “learn the mistakes of the COVID pandemic 
response.” No one—and I mean no one—argues that we should critically study the
pandemic response, what went wrong, what went right, and what were the
unintended consequences. Only someone who hasn’t been paying attention to the
medical literature or what public health officials have been saying over the
last couple of years could so blithely claim that there “is too little of this
happening on university campuses. The CDC could set the example for how to
undertake this kind of reexamination, opening the door for more open discussion 
and debate in universities and other scholarly venues.” I mean, seriously. There
has been a huge effort to understand what went wrong (and what went right)
during the COVID public health response. Given the Brownstone Institute
obsession with “lockdowns” as the root of all COVID evil, I can’t resist citing 
a systematic review of the unintended consequences of lockdowns from 2024 that
examined a total of 132 studies on this issue and found, among other things,
detrimental effects on mental health, obesity-related, and health-related social
need outcomes. Another scoping review looked at the failures of the World
Health Organization response.The research is being done. I myself made a modest 
contribution to this effort by co-authoring a study on the inaccuracies in the
early seroprevalence studies. It’s not being swept under the rug. However, it
serves the MAHA narrative that “They” won’t admit any error and that “They” are 
“hiding” the evidence of harm from lockdowns. If anything, the unrelenting
hostility of MAHA to science-based public health will hamper a sober assessment 
of failures and successes managing the pandemic.

I’m underwhelmed by the rest

The rest of the bullet points under this new “ethical framework” in Dr. Marine’s
first theme similarly read like the usual right wing talking points and claimed
victimhood of those who spread misinformation and portrayed any pushback as
“censorship” or “persecution.” Let’s take a look the rest of them briefly.
First, Dr. Marine demands “respect for individual rights,” stating that public
health practice in the US “must be consistent with our legal framework,
traditions, and Constitution, including the Bill of Rights.” (I’m not sure where
public health practice was not consistent with the Bill of Rights; Dr. Marine
doesn’t give examples.) He also demands “free, voluntary, and fully informed
consent for any medical or preventive treatment,” as if that were not already a 
principle of medical practice. Of course, how you define “informed consent” is
very important, and Dr. Marine appears to be either ignorant of or intentionally
ignoring a longstanding strategy of the antivax movement that I like to call
“misinformed refusal.” What I mean by this term is how antivaxxers try to
include in the “informed consent” nonexistent “risks” from vaccines, such as
autism and sudden infant death syndrome, all while downplaying the vaccine
effectiveness. The fact is, informed consent is already a bedrock principle of
medical practice. What antivaxxers and COVID contrarians like Dr. Marine don’t
like is that doctors are not required to include fantastical risks in their
discussions with patients.

Dr. Marine also pontificates about “acknowledging uncertainty” and, later,
“embracing nuance.” I laughed out loud when I read that, especially his
admonition to be “careful not to draw overly broad or definitive conclusions,
especially from studies of weaker design.” I mean, that’s what MAHA is all
about, making overly broad and definitive conclusions from studies of incredibly
weak design and execution. We’ve been documenting that sort of thing here for a
long time, for example here. I can’t help but point to Dr. Marty Makary
claiming that medical errors are the third leading cause of death based on a
study he did of such breathtakingly poor quality that it was basically an
insanely unjustified extrapolation from tiny numbers to the whole country. I
would argue that neither Dr. Makary nor MAHA acknowledged the uncertainty about 
that estimate.

Other recommendations include improving the rigor of science and data quality,
which is a recommendation that no one disagrees with. The devil, of course, is
in the details of what exactly is meant by this. The current regime coined a
term, “gold standard science,” that seems to mean whatever they want it to mean.
Dr. Marine bemoans “weak” studies being used to drive public policy during the 
pandemic, and that did in fact happen. However, as much as I hate to quote
former Defense Secretary Donald Rumsfeld, “You go to war with the army you have,
not the army you might want or wish to have at a later time.” In 2020, COVID-19
was a new virus, and not a lot was understood about it, other than what we
already knew about coronaviruses. The virus was washing over the world, and
waiting for better data was not an option. Later in the pandemic, after there
had been time to do better studies, then, yes, we should encourage better
evidence and only act on the highest quality evidence. Unfortunately, not
mentioned by Dr. Marine is how this administration’s gutting of the NIH and CDC,
its ideological purity tests to receive scientific funding, and its willingness
to censor and punish scientists who do not toe the administration line are not 
setting up the infrastructure to generate the highest quality evidence to help
us forestall the next pandemic or to deal with it when it eventually comes.

Finally, the pièce de résistance:

Put infectious disease in context and embrace MAHA. In most years, infectious
disease barely makes the top 10 causes of death in the US but plays an outsized 
role in public health policy and practice. The Make America Healthy Again (MAHA)
movement has questioned a medical and public health establishment that has
focused obsessively on the prevention of a few rare infectious diseases while
largely ignoring environmental root causes of declining population health.
Reconciliation can come through embrace of the key elements of the MAHA movement
and incorporation into public health practice and CDC policy. Building a
healthier population is an important component of pandemic prevention and
mitigation. The CDC has an underutilized National Center for Chronic Disease
Prevention and Health Promotion. The Center could be repurposed, reinvigorated, 
and redirected to facilitate this new preventive health agenda.

Of course, what MAHA (and Dr. Marine) neglect to mention is that a big part of
the reason that infectious diseases are not among the top causes of death in the
US anymore is because of a strong public health infrastructure and, yes,
because of vaccinations. Basically, what Dr. Marine appears to be doing is
parroting in a different form RFK Jr.’s proposal in 2023 during his ill-fated
Presidential campaign that he would tell the NIH to “give infectious disease a
break for about eight years.” While it is true that chronic disease can increase
susceptibility to infectious disease, MAHA always overplays what “building a
healthier population” can do in terms of resistance to infectious disease. After
all, the one historical counterexample is the 1918 influenza pandemic, which
originated in the US in army barracks full of healthy young men and tended to
kill the young.

In any case, while one can make arguments for and against the contention that we
haven’t paid sufficient attention to chronic disease, public health is all
about the “environmental root causes” of disease and declining population
health. In fact, the interest in the environmental causes of disease is about
the only good thing that MAHA might offer. I say “might” because MAHA tends to
exaggerate and to identify “environmental causes” not supported by science, such
as all the horrors that it attributes to vaccines, including autism,
neurological diseases, autoimmune diseases, cancer, and more. Basically, all Dr.
Marine is doing here, whether he realizes it or not, is paraphrasing a common
antivax trope that claims that healthy people don’t get sick from infectious
diseases and that children who die of, for example, measles cannot have been
healthy and must have had an underlying health condition. There’s a reason why I
refer to MAHA as “soft eugenics” or social Darwinism. Seriously, Dr. Marine
seems to think that the social determinants of health are actually important,
and for that, if for little else, I applaud him. However, that makes his embrace
of and apologetics for MAHA, which does its best to promote a highly
individualistic, “health hacking” view of health that denies or downplays the
social determinants of health, wildly discordant.

Dr. Marine is clearly a skilled cardiologist and well-published academic
physician. In fact, it is that very career history that makes him a particularly
good cautionary tale warning how none of that is sufficient to protect one
against going down the rabbit hole, be it the rabbit hole of MAHA or other
conspiracy theories. He probably thinks that he’s taking a reasonable “middle
ground” embracing MAHA because he agrees with its thesis that too much of the
health system has been, as he originally put it, “corrupted by corporate
interests that have become increasingly misaligned with the public interest.”
Unfortunately, what he doesn’t see is that MAHA isn’t really doing anything
about those corporate interests. Rather, it’s just adding the manufacturers of
supplements, snake oil, and “functional medicine” quackery to big pharmacy
interests, while peddling pseudoscience under the name of “gold standard
science.”


Guests on the “Why Should I Trust You?” Podcast Want to Hang Doctors. Why Should
I Trust It?

“The actual harsh truth about MAHA is that it is an anti-vaxx, anti-science,
pro-diarrhea conspiracy movement. It cloaks its arguments in abstractions about 
“big pharma” and “free speech” to generate the exact op-ed The Atlantic keeps
publishing. Movements like this need to be fought, not placated.”– Michael
Hobbes

Jonathan Howard on July 31, 2026

Link


“Anyone who believes in the right to bear arms. To stand up against your
government. I don’t know what you were saving that gun for then. I don’t know
when you planned on using it if they were going to take control of your own body
away. It’s now. Now’s the time.”

In January 2022 as the Omicron variant filled up pediatric hospitals, MAHA/MAGA 
royalty Del Bigtree had threatening words for those who tried to keep children
healthy. Speaking at a Defeat the Mandates rally, he threatened doctors,
Democrats, Fauci, Biden, and the “press” with Nuremberg style trials, after
which Nazi war criminals went to the gallows.

Over 10 years ago Dr. David Gorski wrote an article titled The Violent Rhetoric 
of the Antivaccine Movement. This was followed up by The Violent Rhetoric of the
Antivaccine Movement, Vaxxed Edition, The Violent Rhetoric of the Antivaccine
Movement: ‘Vaccine Holocaust’ And Potential Impending Attacks on Journalists,
and The Violent Rhetoric of the Antivaccine Movement Intensifies. Some of us
have been keeping track of these characters for years, and we know this was not 
Bigtree’s first time making such despicable threats. In the video below, from
2016, Bigtree compared his fate to Jews in Nazi Germany, a recurring theme, and 
said:

Anyone who believes in the right to bear arms. To stand up against your
government. I don’t know what you were saving that gun for then. I don’t know
when you planned on using it if they were going to take control of your own body
away.

It’s now. Now’s the time.

While normal people are appalled by such violent rhetoric, opportunistic content
creators sensed the potential for great theater and greeted Bigtree with a
smile and outstretched arms. Even though an anti-vaxx terrorist shot up the CDC 
and Fauci’s children needed bodyguards, Bigtree’s rageful threats weren’t a deal
breaker for the hosts of the Why Should I Trust You? podcast. These exemplars
of the Opinion Class provided him with a friendly forum which they marketed
thusly:

A longtime ally of Robert F. Kennedy Jr., Bigtree is a singular presence—an
expert communicator, storyteller, and filmmaker with a reach of tens of
millions. To fans and supporters, he’s a charismatic fighter taking on the
chronic illness crisis and exposing corruption. His critics say he is a spreader
of anti-vaccine misinformation.

We discuss politics, the future goals of MAHA, America’s vaccine policies,
bodily autonomy, and activism. It is a free-wheeling, occasionally raucous, but 
respectful conversation with one of the most important voices in MAHA today.

Of course, Bigtree’s critics say he is a spreader of anti-vaccine
misinformation, because he is a spreader of anti-vaccine misinformation. That’s 
his profession, and his views are well-known.

None of this was a bridge too far for the hosts of Why Should I Trust You?,
however. In their view Bigtree’s anti-vaxx propaganda, noxious exploitation of
the Holocaust, and vile threats could be overlooked because there was no higher 
value than the podcast itself. The free-wheeling, occasionally raucous, but
respectful conversation was the end-goal, infinitely more important than the
on-the-ground consequences of that “conversation.” Although hospitals need metal
detectors and children are getting measles encephalitis, that’s someone else’s 
problem. The show must go on!

“Consider for a moment the possibility that shunning them might only reinforce
the message they hear about you: that public health is elitist,
institutionalist, and doesn’t have your back.”

Just because the hosts of Why Should I Trust You? yawned at Bigtree’s menacing
threats, this does not mean they are unwilling to take a firm stand against
speech they deem problematic, however. They do have strict standards it turns
out, but only for critics of the MAHA/MAGA agenda.

Two of the podcast hosts, Brinda Adhikari and Tom Johnson, recently penned a
defense of Dr. Craig Spencer and his article Public Health Needs MAHA. (Dr.
David Gorski, Dr. Jeremy Faust, and the Pandemic Accountability Index wrote much
stronger responses.)

After listing some of the ways that Trump and Kennedy have attacked STEM,
Adhikar and Johnson got to their core point- the science-based community needs
to prioritize the feelings of the people who supported, enabled, and funded
those attacks. They wrote:

But what is also clear is that public health all too frequently equates the
millions of people who support some part of this movement with the actions of
the administration.

Adhikar and Johnson continued:

Let’s be clear. The Democrats abandoned them. Two former Democratic presidential
candidates have come on our podcast saying as much (Sen. Cory Booker and former
congressman Tim Ryan). The party decided that this movement of Americans had to
be stopped because of the anti-vaccine beliefs of some of its followers. That
meant the party lost potential allies in the fight for the environment,
healthier food, nutrition, access to preventive care, and against the systemic
causes of chronic disease….

What are you going to do, kick them out of your clinics? Remove them from your
conferences? Label them all anti-vaxxers and wait for them to leave the public
sphere? Pretend they don’t exist? Consider for a moment the possibility that
shunning them might only reinforce the message they hear about you: that public 
health is elitist, institutionalist, and doesn’t have your back.

Lashing out at a movement of people who have begun to break with this
administration, and enter a search for a new political and ideological home, one
that prioritizes many of the things you prioritize, seems to us like a mistake.
Definitionally, you need to demonstrate that you see a difference between MAHA 
leadership and supporters of an insurgent health movement that yes, maybe you
don’t totally see eye to eye with, but you recognize that they have tapped into 
something that we need to finally admit, the rest of us have not.

And rather than pile on a public health veteran who is calling for others in his
field to find common ground with MAHA where it is possible, while rejecting the
dangerous, unscientific elements, perhaps it is time to do a little mindset
change ourselves. We cannot afford to keep waiting for the exact right cast of
characters to come along in order to listen to the country as it is and fight
for them.

41% of the US population say they identify with the MAHA movement’s platform.
You can and should fight Trump’s and Kennedy’s destructive policies, while still
bringing these supporters into a dialogue. They are not a monolith. And neither
are you. It’s the smart thing to do.

Only professional podcasters could write something this ignorant. As those of us
who operate in the real-world know, there is a world of difference between how 
we strive to treat MAHA/MAGA patients in ERs and clinics- with professionalism, 
kindness, and understanding- versus how we treat MAHA/MAGA leaders, ideas, and
policies in the public sphere.

Furthermore, an obvious question emerges. Who exactly is “shunning” and “lashing
out” at MAHA/MAGA acolytes? Adhikar and Johnson don’t say, and they provided no
examples. It’s an article of faith amongst reactionary centrists that “elitist”
public health figures have ruthlessly attacked well-intentioned citizens and
thus the loss of trust in their field is both expected and well-deserved.

The obvious truth is that there’s been a well-funded, highly organized,
years-long campaign specifically to spread mistrust in public health. It
succeeded, and today Adhikar and Johnson blame public health officials for that 
success. Even though right-wing disinformation agents never hid their intention,
literally making videos titled Stop Trusting the Public Health Establishment,
Adhikar and Johnson give them a free pass. As Michael Hobbes said sarcastically 
about Dr. Spencer’s original article:

The piece also has a ton of victim blaming. It’s not the anti-science movement’s
fault that public opinion has shifted against public health, it’s the public
health authorities they’re constantly lying about!

Exactly.

However, instead of unequivocally calling out and exposing these merchants of
doubt, Adhikar and Johnson routinely invite them on their podcast. They had a
Special Episode: A Conversation with Dr. John Ioannidis and A Conversation with 
Dr. Jay Bhattacharya: On the NIH, CDC, Funding, DEI & His Vision For Doing
Science. Those are familiar names to SBM readers.

They promised an “honest, no-holds-barred conversation about the breakdown in
trust on all sides,” to promote their episode with crank Dr. Bret Weinstein,
another of their guests who has shared his hanging fantasies. All sides!
“Respectful dialogue can help rebuild trust in one another,” they added, without
providing a shred of evidence that their precious “dialogue” with vengeful
disinformation superspreaders has actually helped “rebuild trust”. They expect
us to just trust them about this.

While I am under no illusion that Adhikar and Johnson were specifically talking 
about SBM in their defense of Dr. Spencer, we are obviously familiar with the
issues they raise. Although they seem unaware of it, there’s been no shortage of
soul-searching and self-flagellation in public health and science
communication. It’s been going on for years, well before the pandemic, and we do
not reflexively circle the wagons when members of our profession espouse
disinformation or fail to protect the public against bad-faith actors.

Moreover, while we unsparingly call out professional anti-vaxxers, we generally 
have sympathy for their victims. We don’t “shun” or “lash out” at regular people
doing their best to navigate a confusing information landscape, one that is
confusing precisely because of honored guests on the Why Should I Trust You?
podcast.

This approach isn’t unique to SBM. Sure, there are some jerks out there, but
every prominent science communicator I can think of is similarly respectful
towards the victims of misinformation, and the mere existence of our content is 
an indication of that respect. We know people can learn and change their minds. 
To that end, we’ve created countless articles, YouTube videos, and podcasts that
refute misinformation and provide the facts in a neutral, judgement-free
manner. Most of us do this on our own time, for free, and we’ve been doing it
for years, even decades.

This is exactly the kind of outreach Adhikar and Johnson claim to value, but
don’t acknowledge, and it can be effective. For example, Heather Simpson, a
former anti-vaccine influencer who now promotes vaccines, had this to say about 
vaccine-champion Dr. Vincent Iannelli and his website Vaxopedia:

Was pediatrician Dr. Vincent Iannelli among the doctors who gave you the
information you needed?

Simpson: “Yes. He runs Vaxopedia, and I would absorb so much information off his
website. And I found out he was local. And so when we decided to get my
daughter vaccinated, we went to him first, and I was freaking out the whole
time.

“But he was very calm, and I think he told me, you know, ‘Reach out if she even 
hiccups weird,’ like, ‘We got you.’ I didn’t feel abandoned. I felt like, ‘Hey, 
this is not just to me. This is a community, you know, watching her,’ and I
joked that she had more energy and more of an appetite after her vaccine than
before.”

Adhikar and Johnson ignore all of that hard work. All previous efforts at
engagement and outreach mean nothing to them. They pretend MAHA/MAGA acolytes
were abandon to the wolves and there were no trustworthy voices to be found.
They say that we need to “listen to the country as it is and fight for them”,
though of course many us have been trying to do that for years, long before they
became interested in the topic. Instead of discussing the efforts to provide
people with accurate medical and scientific information, they become scolds
towards those people instead. They give great credence to the claim that public 
health is elitist, institutionalist, and doesn’t have your back.

This means however, that no one who falls for medical misinformation can claim
they lacked the resources to learn the facts. While we recognize that innocent
children are hurt by anti-vaxxers, their parents are not innocent children
themselves. We can acknowledge they were tricked by the anti-vaccine movement
without infantilizing them in the process. While shaming people purely to shame 
them should never be the goal, these parents were autonomous adults who made bad
decisions that harmed their children. Even after this, some of them are
encouraging others to make the same mistake. That’s appalling, and we don’t need
anyone’s permission to simply be honest about this.

Adhikar and Johnson don’t see it that way, however. They portray MAHA/MAGA
acolytes as blameless toddlers, without agency, without responsibility, passive 
victims of forces they don’t understand and can’t control. In their view,
MAHA/MAGA acolytes are simpletons who can’t possibly be asked to understand us, 
and conversely, their mental defects obligate us, the only ones with autonomy,
to constantly bend over backwards to understand and coddle them.

They assign no blame to the people who unleashed Trump and Kennedy on us all.
They have no responsibility for their actions, and no one should hold them
accountable or make them feel bad in any way. In fact, Adhikar and Johnson feel 
MAHA/MAGA enablers have to be pampered and catered to, specifically by those of 
us who were right about MAHA/MAGA the whole time. It’s our fault we tried to
warn them, and we have work to do to make it up to them.

Adhikar and Johnson have tasked us with demonstrating that we see a difference
between MAHA leadership and supporters of an insurgent health movement. It’s our
job to bring MAHA/MAGA supporters into a dialogue. While we need a little
mindset change, the people who unleashed Trump and Kennedy have no need to
introspect and reflect on how their choices impacted us all. Whereas Bigtree and
Weinstein can make violent threats against us, we must be ultracareful not to
“shun” their supporters.

Once again Adhikar and Johnson treat the discourse, rather than the real-world
consequences of that discourse, as the core value that must be protected at all 
costs. Sure, measles and explosive diarrhea are spreading, but what really
matters is not to hurt the feelings of the people who made this possible.

Everyone obviously says they support a clean environment, healthier food,
nutrition, access to preventive care, and children free of chronic disease.
MAHA/MAGA acolytes are not special boys and girls for simply claiming to care
about these issues, and they don’t have unique insights as Adhikar and Johnson
absurdly claimed – “they have tapped into something that we need to finally
admit, the rest of us have not”. As Melody Schreiber put it, “This is literally 
what public health already does.” MAHA/MAGA is trying to destroy what public
health already does, and many guests on Why Should I Trust You? podcast have
enabled that destruction.

As such, my willingness to find “common ground” with MAHA/MAGA acolytes requires
them to stop being MAHA/MAGA acolytes. Although Adhikar and Johnson didn’t
acknowledge it, those who abandon MAHA/MAGA, like the former anti-vaccine
influencer Heather Simpson, are greeted with open arms. They are not shunned or 
shamed. Good! No one needs to publicly abase themselves, and we should always
extend grace to people who have the courage to change their minds. They have a
valuable perspective and can likely reach people we cannot.

However outside of the exam room, I am not obligated to meet devoted MAHA/MAGA
acolytes where they are and cautiously tiptoe around their brittle emotions.
Trump’s and Kennedy’s obvious attacks on STEM are a deal breaker, and anyone who
claims these men have viable solutions in July 2026 is not someone who is going
to be convinced by anything I’ve got to say anyways. I’ve written two books and
nearly 350 articles here trying to convince them already. There is no magical
combination of words that I or anyone else can utter that will change their
minds. It’s all been uttered 1,000 times already.

At this point, we need to be clear that no matter what they say, anyone who
still supports MAHA/MAGA is working against a clean environment, healthier food,
nutrition, access to preventive care, and children free of chronic disease.
Those of us who genuinely support these goals, as opposed to making podcasts
about them, need to oppose MAHA/MAGA with everything we’ve got. Regardless of
its empty pablum about “gold standard science” and “eating real food“, the
horrific actions of MAHA/MAGA speak for themselves. That’s all that matters, and
we don’t need permission from podcast hosts to remember the bad faith actors
who empowered it. To again quote Michael Hobbes:

The actual harsh truth about MAHA is that it is an anti-vaxx, anti-science,
pro-diarrhea conspiracy movement. It cloaks its arguments in abstractions about 
“big pharma” and “free speech” to generate the exact op-ed The Atlantic keeps
publishing. Movements like this need to be fought, not placated.

Exactly. MAHA/MAGA is above all dangerous. Scientists are getting arrested, and 
they are being abused and threatened by powerful government figures. However, by
treating MAHA/MAGA as a curious plaything to be discussed and debated, the Why 
Should I Trust You? podcast numbs its listeners to that danger.

It turns out discourse isn’t the top priority after all, and sheltered pundits
who can’t recognize this aren’t worthy of your trust. I’d be happy to elaborate 
further on the Why Should I Trust You? podcast. However, while its hosts are
willing to politely embrace anti-vaxxers who profit by sickening children and
promoting violent revenge fantasies, something tells me their commitment to
“respectful dialogue” doesn’t extend that far.



Why is Sensible Medicine Selectively Silent Regarding MAHA/MAGA? Unlike Science 
Based Medicine, They Have Paying Customers to Please.

There is a long list of prolific pandemic pundits who have become totally silent
about the current events they enabled.

Jonathan Howard on August 21, 2026

Link

“Motivating biases need not be considered nefarious, only considered.”

In their foundational essay The Case for Being a Medical Conservative, Drs.
Vinay Prasad, Adam Cifu, and John Mandrola wrote eloquently about the need to
consider conflicts of interest in medicine. They said:

The medical conservative, therefore, is pragmatic about human nature and the
prevailing business model of medical science. To wit, content experts,
professional societies, or journal editors who too harshly criticize an industry
product jeopardize future funding. Motivating biases need not be considered
nefarious, only considered.

I agree and devoted an entire chapter to this topic in my book on cognitive
biases in medicine.

These doctors would go on to found Sensible Medicine, a Substack that was not
shy about discussing the issues of the day when COVID raged. When politicians
and public health leaders tried to stop people from dying of COVID, Sensible
Medicine talked about current events constantly, for years on end. They were not
neutral reporters, however. They had an agenda. Their goal to spread doubt and 
rage about the people tasked with containing the virus.

To pick one example amongst many, I previously discussed the bountiful
absurdities of an article that excoriated public health officials for not doing 
an RCT of hospital visiting policies in 2020. I later discussed the deluge of
hateful comments this article generated towards those public health officials,
which was its true purpose.

When MAHA loomed and in its early days, Sensible Medicine mostly cheered it on, 
publishing propaganda articles titled Why Doctors Should Learn to Stop Worrying 
and Love MAHA, The Nomination of Robert F. Kennedy Jr. As Secretary of The
Department of Health and Human Services: A New Beginning? and The MAHA Report: A
Seismic Shift in US Health Policy. According to that last article, by Dr.
Joseph Marine:

In conclusion, the MAHA Report represents a seismic shift in US government
healthcare policy. It will form the foundation for US health policy for the next
four years. Now that the MAHA Commission has published its guiding principles, 
there are more concrete ideas for physicians to engage with.

The sensible response for physicians will be to embrace its best ideas and
reflect on its criticism of our current medical and biomedical research models
and practices. We should embrace the opportunity for change. We should talk more
to patients about prevention and lifestyle modification and examine how we can 
change our own practices to align with its principles.

The sensible response for medical societies will be to engage with HHS and the
health agencies to understand and advance aspects of the agenda where they
intersect with their fields and missions.

In reality, the MAHA report was AI slop.

However, perhaps their most noxious article was Dr. Prasad’s abomination Is RFK 
Jr to Blame for the Samoa Measles Outbreak?. “We have to be honest when it comes
to health policy commentary,” said Dr. Prasad as he dishonestly absolved
Kennedy of his role in sparking a measles outbreak that killed dozens of
children. Kennedy has “some good ideas,” Dr. Prasad concluded.

Sensible Medicine also helped launch the brief, disgraceful tenures of Drs.
Marty Makary, Tracy Hoeg, and of course, Dr. Prasad himself at the FDA. In an
essay there titled Sensible Medicine Endorses Vinay Prasad for Director of the
Center for Biologics Evaluation and Research (CBER) at the US FDA, Drs. Cifu and
Mandrola ignored his anti-vaccine disinformation, overt MAHA/MAGA political
activism, and vulgar behavior to conclude:

We can’t think of anyone more qualified to lead the biologics division. Prasad’s
lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies.

“What Anthony Fauci Should Say to the American People”

Things didn’t work out that way. The FDA is approving untested peptides and
lettuce is dangerous, though you wouldn’t learn that from reading Sensible
Medicine. Instead of humbly reflecting on their own medical reversals, Sensible 
Medicine has moved on, as if MAHA/MAGA was all a distant dream. Drs. Prasad’s
anti-vaccine disinformation and censorship of vaccine research in office never
gets discussed, and any mention of his purges or unprofessional behavior at the 
FDA is strictly prohibited.

Similarly, when Dr. Jay Bhattacharya was nominated for the NIH, Sensible
Medicine said he was a:

Courageous, thoughtful, and deeply humane person who would make a great leader
of any of our US public health agencies.

Today, Dr. Bhattacharya nods along next to Stephen Miller, Kennedy, and Trump as
they spew Wakefieldian lies about vaccines in the middle of a measles outbreak.
If this monstrous betrayal of medical ethics bothers the doctors at Sensible
Medicine, they’ve kept it entirely to themselves, as they have with everything
MAHA/MAGA has done.

While they previously weighed in on current events, they are totally silent
about them today. They have zero criticisms of our current medical
establishment, and they are all done demanding RCTs from them. Those lofty
expectations were exclusively for previous public leaders who who had to
audacity to limit COVID.

As MAHA/MAGA ushers in American Lysenkoism, Sensible Medicine is busy publishing
articles such as Atrial Fibrillation and Symptoms – A Great Mystery, How I
Learned About Incontinence, and What Anthony Fauci Should Say to the American
People. Meanwhile their X feed is a toxic cesspool, desperately trying to
recapture the glory days of 2020 by sharing revenge fantasies against Fauci from
anti-vaccine luminaries and juvenile cranks. Even though Fauci is getting death
threats and threats of prosecution, they are perfectly willing to join the pile
on and enlarge the target on his back. This is the professionalism and ethical 
standards they bring to their work.

Sensible Medicine is fundamentally a dispatch from an alternative universe, a
time capsule from a gentler era where STEM was imperfect, but working to improve
and under no grave external threats. They refuse to even acknowledge anything
that is happening under MAHA/MAGA, and they are hardly unique in their see no
evil, hear no evil, speak no evil approach. They are just a small subset of
previously prolific pandemic pundits who freely expressed their criticisms
regarding COVID but have nothing to say about the current events they enabled.

While Dr. John Ioannidis was eager to undermine public health officials on TV in
2020, the only problem he has with MAHA/MAGA is that some of us have the
impudence to criticize it. He reserves his sanctimonious scolding exclusively
for us at SBM, powerless critics of our current medical establishment. Princeton
professors Stephen Macedo and Frances Lee have also slinked away into obscurity
after praising MAHA/MAGA doctors. Dr. Stefan Baral, who had many mighty
meltdowns because I warned about MAHA/MAGA, has nothing to say about its
actions, which include mass layoffs at his own department. There are many more
examples of previously vocal commentators who are now suddenly silent, and we
don’t need their permission to notice their silence at this moment.

This strategic silence is disturbing but also revealing. It shows how the COVID 
Amnesia Project, the deliberate attempt to rewrite the history of the pandemic, 
is seamlessly morphing into the MAHA Amnesia Project, the deliberate attempt to 
cover up how MAHA/MAGA vandalized and politicized STEM and public health. It’s
the same people, doing the same thing.

“Subscription Science: How Crowdfunding Has Become a Conflict of Interest”

There are several potential reasons for this selective mutism. The simplest is
that Sensible Medicine doctors haven’t voiced any objections to MAHA/MAGA
because they don’t object to it. They see what MAHA/MAGA is doing like everyone 
else, the political censorship of science and the cancelled clinical trials, and
they approve of it. In November 2024, Dr. Prasad had this to say in response to
masking young children:

I also said this in my latest YouTube video. I would fire at least ~10000 people
(1/4) in the CDC and everyone who touched this decision or didn’t stop it.
Anyone working from home should go, as well.

Fast forward to today, and the headlines read The CDC Has Zombie Programs.
Congress Funds Them, But Few People Are Left To Do The Work. That article said:

The Centers for Disease Control and Prevention still has an Alzheimer’s disease 
program. Congress appropriated $41 million to it this year. There’s just no one 
staffing it.

Then there’s the agency’s Office on Smoking and Health. Congress allocated $246 
million for that. Its staffers were cut, too.

Same for the epilepsy program. Its sickle cell disease data collection
operation. Its rape prevention unit.

Think of them as the CDC’s zombie programs — they appear to be alive, at least
according to legislation and congressional appropriations. But functionally they
are dead or nearly dead, because the CDC experts who did the work were laid off
by President Donald Trump’s administration or remain on leave — paid but not
allowed to do their jobs.

This is exactly what Dr. Prasad wanted, and he has every right to take a victory
lap. Why would he or anyone else at Sensible Medicine complain about it?

Sensible Medicine doctors have long been primarily political actors masquerading
as neutral scientists who merely want more robust evidence. Don’t take my word 
for it. Listen to Dr. Makary explain it better than I ever could. “Vinay Prasad 
loves president Trump,” he said.

If you listen to his podcast for the last four years, you’ll see he’s been
ardent supporter of everything President Trump has done and is trying to do.

That’s true, and there’s no reason to think that’s changed. A main goal of
Sensible Medicine has been to weaponize EBM to portray liberals as hysterics who
overreacted to threats– both COVID and MAHA/MAGA- which turned out to be very
real and very dangerous. The real threats in their telling were masks, vaccines,
and anyone who pointed out their disinformation. Our work was “unproductive“.
We had to watch our “tone“.

Conversely, there may be some reluctance on their part to comment on current
events. Were they to honestly acknowledge the state of STEM under MAHA/MAGA, the
Hot Dog Guy memes would fly, and they would invariably be accused of
complaining about everything they enabled. These obviously wouldn’t be baseless 
accusations, but rather an acknowledgment of basic reality. Sensible Medicine
doctors may feel damned if they do and damned if they don’t, which is an
appropriate fate for those who enabled MAHA/MAGA. No one forced them to do that.

Perhaps most importantly, however, Sensible Medicine doctors have “motivating
biases” of their own. They have paying customers to please, and this is no small
incentive. As Drs. Ben Mazer and Michael Rose wrote in their must-read article 
Subscription Science: How Crowdfunding Has Become a Conflict of Interest:

Crowdfunding has become another potent but overlooked source of revenue for
physicians who want to share their views on medical topics. Crowdfunding refers 
to payments that are voluntarily contributed by individuals who would like to
support an author’s work. Digital platforms such as Patreon, Substack, YouTube, 
and Twitter allow fans to offer recurring payments to healthcare professionals
who produce opinion articles, explanatory videos, and podcasts. Although
crowdfunding is often seen as a principled alternative to industry influence,
these payments may also create meaningful conflicts of interest.

Physicians do not always agree about which third party payments are
unacceptable. Yet two variables typically come into play: the size of the
payment and how strongly the payer is associated with a specific scientific
viewpoint. Crowdfunding poses a risk in both domains. For example, Substack, an 
online newsletter platform, is increasingly used by physicians to write medical 
commentary, with some newsletters reaching 10s of thousands of subscribers.
Substack estimates that 5-10% of readers will upgrade to a paid tier, and paid
subscriptions on the service cost a minimum of $5 per month. Although $5 sounds 
negligible, consider a newsletter with 10 000 total subscribers, 1000 of whom
pay a $5 monthly fee. After subtracting Substack’s 10% cut, a doctor could
expect $54 000 in annual payments. If physicians accrue 5000 backers, they can
expect $270 000 in revenue. This is greater than the $265 000 average salary of 
primary care physicians in the US.

Sensible Medicine subscribers don’t pay their hard-earned money to learn about
problems with MAHA/MAGA. They pay to escape into a fantasyland where MAHA/MAGA
isn’t worth mentioning, and the problems we face in 2026 are all because of what
Fauci did in 2020. Sensible Medicine’s business model necessitates their
current silence, and their refusal to even acknowledge current events sends a
clear message to their readers- Everything’s fine now. Nothing that is happening
under MAHA/MAGA is worth getting upset about.

Drs. Mazer and Rose concluded:

Doctors who wish to remain trusted arbiters of medical science, in all its
complexity and ambiguity, should seek to avoid any financial scheme that
explicitly or implicitly circumscribes the conclusions they reach.

Thankfully, Science Based Medicine is free. We don’t have to cater to paying
customers, which means we can write about whatever we want. Unlike Sensible
Medicine, we resist amnesia and are not afraid to acknowledge the basic reality 
of what is happening to STEM today. We’ve written about it multiple times this
month alone. We have no plans to stop, and if anyone is displeased they can
message me for a full refund.

Catastrophic Cost of Federal Research Cuts

The gleeful efficiency of an arsonist who mistakes the blaze for proof of his
power

Henry MIller on June 9, 2026

Link


There is a word for what the federal government has done to American science
during the past year and a half: sabotage. Not reform. Not streamlining. Not the
“realignment of priorities” the White House prefers to call it. Sabotage — the 
deliberate, systematic destruction of one of the most productive enterprises in 
the history of human civilization, inflicted at a time when the nation can least
afford it, for reasons that range from the ideological to the incoherent.

Let’s start with MIT. The Massachusetts Institute of Technology is one of the
foundational engines of American technological power, the place where radar was 
developed during World War II, where strobe photography was perfected, where the
modern internet took shape, where Nobel laureates mentor the scientists who
will produce the next generation of breakthroughs.

I experienced that education firsthand. As an MIT undergraduate in the 1960s,
two of my microbiology professors were Nobel laureates and three physics
professors were veterans of the Manhattan Project, which developed the atomic
bombs that ended WWII. As a graduate student (at the University of California,
San Diego), I was the co-discoverer of two important enzymes: Ribonuclease H,
which plays a critical role in DNA replication; and the RNA-dependent RNA
polymerase in influenza virus that enables it to replicate. Decades later, the
latter would be the target of anti-flu drugs.

“A striking loss”

When MIT’s president, Sally Kornbluth, stepped in front of a camera to address
her community in May, her message was not a complaint. It was a warning.
Federally funded research on campus is down more than 20 percent compared to a
year ago. New federal research funding has decreased by more than 20 percent.
Even accounting for non-federal sources — the industry partnerships and
philanthropic gifts MIT has scrambled to find — total campus research funding is
now 10 percent smaller than it was just twelve months ago. “That is a striking 
loss,” Kornbluth said, “for one of the most influential and productive research 
communities in the world.”

And it is only the beginning. Graduate student enrollment will decline by
roughly 20 percent in the coming academic year — approximately 500 fewer
students — because the funding that would support them has evaporated. Senior
faculty with decades of distinguished grant records are being forced to cut
doctoral students and postdoctoral researchers, and abandon entire lines of
inquiry. The damage is not abstract. It is being measured in the laboratories
that are going dark, in the careers that are being derailed, in the discoveries 
that will not happen, in the applications based on those discoveries that will
not materialize.

Ted Mitchell, president of the American Council on Education, listened to
Kornbluth’s remarks and lamented, “This is the first of many of these kinds of
alarms that will be ringing.” I concur. MIT, with its $27 billion endowment, is 
better positioned than nearly any other research university to absorb a shock
like this. If MIT is struggling, what is happening at the hundreds of schools
with fewer resources and smaller margins for error?

Cancelled funding

The numbers across the broader federal research enterprise are stunning. More
than 7,800 NIH and NSF grants were cancelled or suspended in 2025. The NIH
awarded 24 percent fewer grants last year than its recent ten-year average. The 
administration has proposed cutting the NIH budget from $47 billion to $27
billion — a 40 percent reduction. NSF funded 25 percent fewer new projects. The 
proposed cut to the NSF, relative to its 2023 funding, represents 61 percent.
The CDC would lose 44 percent of its budget. NASA’s science directorate would be
cut in half. The administration proposed returning non-defense research
spending to levels last seen in 1991 — erasing three decades of accumulated
capacity in a single budget cycle.

The cruelty of the cuts is matched only by their capriciousness. A study
reported in JAMA Internal Medicine in 2025 found that 383 NIH-funded clinical
trials lost their grant funding following the administration’s cancellations —
affecting more than 74,000 trial participants. The administration used keyword
searches to identify grants for termination — a method so blunt (and idiotic)
that grants were killed for containing the prefix “trans-” in terms like
“transgenic material” or “signal transduction.” Northwestern University’s Lurie 
Cancer Center, a national hub for cancer research and care, had $77 million in
funding frozen. The NIH cancelled subscriptions to Springer Nature journals —
home to more than 3,000 publications, including the highly respected flagship
journal Nature — with an HHS spokesperson calling them “junk science.”
Scientists at agencies across the government were fired in mass layoffs, or quit
through buyout programs, leaving a reported exodus of more than 25,000 federal 
science workers, many at the early-career stage.

Let’s talk about China

What makes this catastrophe particularly inexcusable is the geopolitical context
in which it is being inflicted. The administration claims to be hawkish on
China. It speaks constantly of competition, of national security, of “winning.” 
And then it methodically dismantles the infrastructure that would allow the
United States to compete. According to a March 2026 report from the Organization
for Economic Cooperation and Development, China’s investment in research and
development has now reached parity with that of the United States. In 2019,
China overtook the U.S. in its share of the most-cited scientific papers. By
2022, it led globally in most-cited papers overall. In 2024, it surpassed the
United States in total scientific publications for the first time since the U.S.
itself displaced the United Kingdom in 1948. Also in 2024, Chinese entities
filed roughly 1.8 million patent applications, compared to 603,000 from the
United States.

The scientific talent picture is equally dire. At least 85 established and
rising scientists working in the United States joined Chinese research
institutions full-time beginning in 2024, with more than half making the move in
2025, according to a CNN tally. In a 2025 Nature survey of 1,600 scientists, 75
percent said they were considering leaving the United States, with Europe and
Canada top destinations. The European Union launched its “Choose Europe for
Science” initiative, backed by €500 million in grants and fellowships explicitly
designed to attract scientists disillusioned by U.S. policy. The world is
watching what we are doing to ourselves and moving to capitalize on our
self-inflicted wounds.

Political spitefulness, fiscal irresponsibility

The administration justifies all of this with the language of fiscal discipline 
— cutting “waste,” redirecting money away from ideologically disfavored
research, and so on. But the fiscal argument collapses under even modest
scrutiny. Scientific investment is not a cost to be minimized; it is an engine
of national wealth. Federal research and development investments have accounted 
for more than 20 percent of all U.S. productivity growth since World War II. The
internet, mRNA vaccines, human gene therapy, GPS, the transistor — all emerged 
from the sustained public investment being dismantled today. The Information
Technology and Innovation Foundation estimates that a 20 percent cut to federal 
research spending would shrink the U.S. economy by nearly $1 trillion over the
next decade and reduce tax revenue by roughly $250 billion. The administration
is trading a trillion dollars in future prosperity for the political
satisfaction of slashing budgets that its base can be told represent elite
liberal excess.

Brain drain

What is being lost is not merely research output. It is the pipeline — the long,
slow accumulation of trained minds that makes discovery possible in the first
place. A doctoral scientist represents a decade or more of training. Laboratory 
knowledge lives in working research groups and the relationships among them. It 
does not reside in spreadsheets that can be reactivated when a future
administration changes course. Eric Lu, a third-year MIT PhD student in
bioengineering, put it simply: The United States has become “a pretty
unfavorable environment for students who see themselves as doing research in the
U.S.”

As a result, the U.S. is losing significant intellectual capital as students,
postdocs, and junior professors opt to go elsewhere.

MIT President Sally Kornbluth, who has navigated this crisis with admirable
diplomatic restraint, framed the bottom line plainly: “When you shrink the
pipeline of basic discovery research, you choke off the flow of future
solutions, innovations, and cures — and you shrink the supply of future
scientists.” This is as clear a statement of the stakes as any politician or
pundit could offer. And it is being articulated not by an activist, but by the
president of the institution that helped build the modern technological world.

Bonfire of the vainglorious

The United States did not become the world’s scientific superpower by accident. 
It took deliberate, sustained, bipartisan investment across decades — in
universities, in federal laboratories, in graduate education, in the culture of 
open inquiry. What the second Trump administration has done in under a year and 
a half is begin to dismantle that inheritance with the gleeful efficiency of an 
arsonist who mistakes the blaze for proof of his power. The fire is real, and so
is the carnage. And the scientists who might have rebuilt what burns are
already boarding planes for Beijing, Berlin, London, and Toronto.

History will assign responsibility clearly. The only question is how much
America will have lost before it does.


RFK Jr. is a Creepy Weirdo Obsessed with Teenagers’ Sperm

Kennedy’s sperm obsession combined with his desire for healthy “Trump babies” to
serve in a military led by a White supremacist, whom he believes to be a
divinely anointed, testosterone-filled übermensch can best be thought of a
corollary to soft eugenics. I’ll call it soft Lebensborn.

Jonathan Howard on June 19, 2026

Link


“Men had twice the sperm count as our teenagers do today. This is an existential
crisis for our country.”

On at least four occasions since taking over as head of HHS, Robert F. Kennedy
Jr. has used his authority and platform to express grave concern about the sperm
quality of teenage boys.  “Men had twice the sperm count as our teenagers do
today. This is an existential crisis for our country,” he said. An existential
crisis!

Unsurprisingly, Kennedy was wrong about this. A recent paper, Sperm
Concentration Remains Stable Among Fertile American Men: A Systematic Review and
Meta-Analysis, concluded:

In contrast to prior global studies, this analysis suggests no clinically
significant decline in sperm concentration among confirmed fertile men and the
general male US population without known infertility.

“Pronatalism: Just White Christian Nationalism in Disguise”

However, this is more than just another instance of Kennedy spreading medical
misinformation or being fascinated with male genitalia, both human and animal.
None of this is occurring in a vacuum, and it must be considered in light of
everything else that’s happening today.

Indeed, the pronatalist agenda a core part of MAGA/MAHA. JD Vance famously
mocked “childless cat ladies,” and an anti-abortion rally said, “I want more
babies in the United States of America.” Elon Musk said, “A collapsing birth
rate is the biggest danger civilization faces by far,” while Dr. Mehmet Oz
worried that Americans are “under-babied.” Dr. Oz also promoted fertility
medications saying they would lead to more “Trump babies.”

Though it’s hard to object to cute babies, Katie O’Conner wrote about the
movement’s unsettling beliefs in her article Pronatalism: Just White Christian
Nationalism in Disguise:

Scratch just beneath the surface of the so-called pronatalism movement—a
movement all over the pages of Project 2025 that’s based on the belief that
people need to have more babies because declining birth rates are a threat to
civilization—and you’ll find that it’s basically just white Christian
nationalism in disguise. The movement is full of ideological contradictions that
make it crystal clear: pronatalists’ desire for people to have more babies is
in service to their primary goal of reenforcing a system of religious, racial,
and gendered hierarchy that favors conservative white Christians.

This fits in well with the Trump administration- some recent headlines include
US Accepts Only White Refugees for Sixth Consecutive Month and Trump Calls
Somali Immigrants ‘Garbage’ As US Reportedly Targets Minnesota Community– though
Kennedy doesn’t care about this at all. He routinely gushes over Trump saying, 
“he’s got the highest testosterone level.” On multiple occasions Kennedy even
claimed divine intervention brought them together – “God sent me Donald Trump”- 
and Kennedy has thoughts on how children may be of use to Trump. He has
expressed concern about children’s health in relation to their fitness to serve 
in the military, as has Dr. Oz.

In contrast to these future soldiers, Kennedy has said only “very, very sick
kids should die from measles”, and that “children, healthy children, should not 
die of measles.” Derek Beres of the Conspirituality podcast coined the term
“soft eugenics” to describe this noxious attitude, which he defined thusly:

The idea that if you take away life-saving healthcare and services from the
vulnerable, then you can let nature take its course and only the strong will
survive.

Kennedy’s sperm obsession combined with his desire for healthy “Trump babies” to
serve in a military led by a White sfgupremacist, whom he believes to be a
divinely anointed, testosterone-filled übermensch can be thought of a corollary 
to soft eugenics. I’ll call it soft Lebensborn after the Nazi program to
encourage the breeding of “racially pure” children. When viewed with this
historical precedent and today’s current events in mind, Kennedy’s obsession
with teenagers’ ejaculate isn’t just creepy and weird, but dark and disturbing.


The Fox News Stars Got in Charge

When it comes to issues related to SBM, our fierce, mighty Secretary of War,
Pete Hegseth isn’t doing so well.

Jonathan Howard on September 11, 2026

Link


When it comes to issues related to SBM, our fierce, mighty Secretary of War,
Pete Hegseth, is failing at every level. This spring, he turned the camera on
himself and announced the flu vaccine would be optional for soldiers.
Immediately after this, the headlines read: Scores Fall Ill at Air Force Base
After Hegseth Makes Flu Vaccine Optional. Hundreds of people got sick, six were 
hospitalized, and one young airman lost his life. The policy was soon reversed.

Shortly after this, Hegseth again plopped himself in front of a camera and made 
a video titled The High-T Department of War, which mandated testosterone
screening for troops over 30. This unscientific policy was also rescinded soon
after this.

Elsewhere, Hegseth is punishing soldiers who have a mental health crisis.
According to the article Navy Sailor Who Jumped Off USS Lincoln Faces
Disciplinary Charges:

A sailor who jumped from the USS Abraham Lincoln this month in what his wife
described as a suicide attempt is now facing disciplinary action from the Navy, 
according to his wife and charging documents reviewed by MS NOW.

The wife, who was granted anonymity to discuss sensitive disciplinary actions,
said her husband is facing nonjudicial punishment for violating articles of the 
Uniform Code of Military Justice.

The charging documents, which were reviewed by MS NOW, show that the sailor has 
been accused of violating Article 83 for “malingering,” which is defined as a
service member “intentionally faking an illness or hurting themselves to avoid
work, duty or service,” and Article 86 for “absence without leave,” which means 
a service member failed to be at their required place of duty without proper
authority.

“I think they’re insane for doing this to people who need mental help,” the wife
told MS NOW. “Instead of giving them help, this is just another huge stressor.”

Hegseth is also teaming up with his MAHA brethren, who are also fond of making
videos. RFK has made some bizarre, topless videos, and a recent article read:
RFK Jr. Uses Military Aircraft as He Campaigns for GOP in Midterms.

Hegseth is also working with them to cast doubt on vaccines and carry out
financial shenanigans. A recent social media post said:

RFK Jr. and Pete Hegseth are investigating whether COVID vaccines caused deaths 
and injuries among America’s service members.

Army doctor Theresa Long has been tasked with examining military health data and
thousands of unverified death reports submitted after vaccination.

Nearly 9,000 service members were discharged for refusing the COVID vaccine
mandate.

Our troops were required to take these shots.

They deserve a full accounting of what happened afterward.

This investigation is long overdue.

Dr. Long has no relevant expertise on this topic and previously compared doctors
who vaccinated soldiers to Nazis who were sent to the gallows for experimenting
on prisoners.

Hegseth also partnered with Dr. Jay Bhattacharya to siphon hundreds of millions 
of dollars from the National Institute of Allergy and Infectious Diseases
(NIAID) to the Department of War, supposedly for biodefense projects. The
secretive transfer of funds came to light only thanks to a press release from
Congresswoman Rosa DeLauro, and according to an article titled Revealed: Inside 
the US Military’s Plan to Tap Huge Sums From the NIH:

Federal law does allow agreements between US agencies to share funding in some
circumstances, says Samuel Bagenstos, who until December 2024 was the top lawyer
for the NIH’s parent agency, the Department of Health and Human Services. But
“what’s not appropriate or legal is saying, ‘Look, DoD needs money, NIH has
money, we’re going to take money and send it to the DoD,’” he says. If the
administration is using NIH resources to cover shortfalls in the military
budget, “that would be illegal, because that would be using funding not to serve
the purposes of NIH, but to serve the purposes of DoD”.

Hegseth and Dr. Bhattacharya are old buddies who previously enjoyed spreading
doubt and disinformation on TV.

I think a useful framework to understand our current moment is to realize that
the content creators got in charge. That’s all these men really were, and across
our entire government, we are witnessing the incompetence, malevolence, and
insider dealing when Fox News stars gain power.

The EBM Gurus, RCT Zealots, & “Sensible” Doctors Who Gave Us Kennedy’s
Chemtrails, Wakefield’s Wins, Paxton’s Prosecutions, & Schwartz’s Study

Though these examples just scratch the surface, they are the end result of the
doctors I’ve written about previously, as well as the academic and media
ecosystems that promoted them.

Jonathan Howard on October 9, 2026

Link


Many of my prior articles have discussed the EBM gurus, RCT zealots, and the
“sensible” doctors whose efforts helped birth MAHA. Several recent events allow 
us to pause and take stock of exactly what they enabled.

Kennedy’s Chemtrails

While speaking at the Children’s Health Defense conference, the anti-vaccine
organization he headed and profited from, Robert Kennedy Jr. warned of
chemtrails. “We’re also looking at chemtrails and the impact of emissions from
aircraft, and those potential impacts on health,” he said to applause.

Wakefield’s Wins

At the same event, disgraced fraudster Andrew Wakefield was asked what three
recommendations he would have for Trump and Kennedy. The only interesting part
of his answer was its start. “I think they’ve already covered these issues,” he 
said.

He’s 100% right. Trump and Kennedy have covered his “issues.” Just like him,
they are lying about the MMR, claiming it is “lethal” and that splitting it into
separate vaccines will lower the rate of autism. Kennedy, along with Drs.
Mehmet Oz, Jay Bhattacharya, and Erica Schwartz, even opened a “vaccine injury
clinic” at the NIH this week. Meanwhile, measles is hospitalizing and killing
unvaccinated Americans for the first time in decades. Wakefield has every right 
to take a victory lap.

Paxton’s Prosecutions

Elsewhere, a recent article titled Texas Pediatricians Face Paxton
Investigations for Vaccinating Children reported on Ken Paxton, the Texas
attorney general and Republican Senate candidate. It said:

In December, Dr. Rachel received a letter from the attorney general’s Consumer
Protection Division demanding her vaccine purchase records over the past 10
years. “The division believes that you are in possession, custody or control” of
material, “involving potential misleading or deceptive acts regarding
incentives associated with the administration of childhood vaccines,” it said,
adding that such acts could be in violation of the state’s deceptive trade
practices law.

The letter also requested her practice’s vaccine policy, and said that it would 
not be sufficient to cite the childhood vaccine schedule recommended by the
Centers for Disease Control and Prevention.

Mr. Paxton has also implicated the nation’s largest organization of
pediatricians, the American Academy of Pediatrics, in the alleged conspiracy
over the workaday task of protecting children from polio, measles, meningitis
and more than a dozen other dangerous and sometimes life-threatening diseases.

“I will ensure that Big Pharma and Big Insurance don’t bribe medical providers
to pressure parents to jab their kids with vaccines they feel aren’t safe or
necessary,” he said when announcing the investigation in January, describing his
efforts as working “alongside President Trump” and Health Secretary Robert F.
Kennedy Jr.

“Together, we will Make America Healthy Again,” he said, using the rallying cry 
of a movement that helped elect Mr. Trump and propel Mr. Kennedy into the top
health position in the federal government.

Schwartz’s Study

Finally, an article by Katherine Eban titled CDC Is Moving Forward With a
Previously Shelved Controversial Hepatitis B Vaccine Study revealed the only
thing out MAHA medical establishment learned from the infamous Tuskegee
experiment is how to repeat it. She reported:

Two months after the Senate confirmed Dr. Erica Schwartz as the new director of 
the Centers for Disease Control and Prevention, her office has moved to allocate
new funds for a controversial clinical trial of the hepatitis B vaccine in
Guinea-Bissau…

The $1.6 million will be slated for a clinical trial in Guinea-Bissau seeking to
examine whether the birth dose of the hepatitis B vaccine, used safely for
decades, has potential negative health effects such as skin ailments or
neurodevelopmental disorders. The study would be led by Christine Stabell Benn
and Peter Aaby, married researchers at the University of Southern Denmark long
lionized by Secretary Kennedy for their controversial vaccine research.
Presently, they are facing accusations of scientific misconduct, unrelated to
the hepatitis B trial, that are under review by the Danish Committee on Research
Misconduct.

The study, should it proceed, would be a randomized controlled trial in
Guinea-Bissau that would give a birth dose of the hepatitis B vaccine to half of
the 14,000 newborn participants, but not to the other half, a step the
researchers justified as aligning with the standard of care in Guinea-Bissau,
where the birth dose of the vaccine is not routinely provided to newborns but
will be officially recommended there by 2028.  However, in a nation where one in
five adults have hepatitis B, the study design could result in some of the
newborn participants being infected but receiving no birth dose of the vaccine, 
clinical trial and infectious disease experts contend.

“It’s a wholly unethical trial, and it shouldn’t be allowed,” says Dr. Paul
Offit, a pediatrician and director of the Vaccine Education Center at the
Children’s Hospital of Philadelphia. “It saddens me to think that our country
would in any way participate in a trial where half of the children would be
receiving substandard care and thousands will be doomed to develop cirrhosis or 
liver cancer.”

These examples just scratch the surface of MAHA’s incompetence and malevolence. 
However, they are the result of the doctors I’ve discussed previously, as well
as the academic and media ecosystems that promoted them. They collectively
unleashed Kennedy’s chemtrails, Wakefield’s wins, Paxton’s prosecutions, and
Schwartz’s study on us all. That’s all that matters about them, no matter their 
empty demands for “nuance”, “rigor”, and “evidence” moving forward.


I Used to Wonder How the Tuskegee Experiment Could Have Happened. No More.

The cowards and sycophants who enabled, promoted, and normalized MAHA in any way
are collectively to blame for its attempt to do Tuskegee 2.0.

Jonathan Howard on  October 15, 2026

Link


“The men were not informed of the nature of the study, proper treatment was
withheld, and more than 100 died as a result.”

According to Wikipedia:

The Tuskegee Study of Untreated Syphilis in the Negro Male (informally referred 
to as the Tuskegee Experiment or Tuskegee Syphilis Study) was a study conducted 
between 1932 and 1972 by the United States Public Health Service (PHS) and the
Centers for Disease Control and Prevention (CDC) on a group of nearly 400
African American men with syphilis as well as a control group without. The
purpose of the study was to observe the effects of the disease when untreated,
to the point of death and autopsy. Although there had been effective treatments 
to reduce the severity of the disease since the 1920s, the use of penicillin for
the treatment of syphilis was widespread as of 1945. The men were not informed 
of the nature of the study, proper treatment was withheld, and more than 100
died as a result…

None of the infected men were treated with penicillin despite the fact that, by 
1947, the antibiotic was widely available and had become the standard treatment 
for syphilis. The study continued, under numerous Public Health Service
supervisors, until 1972, when a leak to the press resulted in its termination on
November 16 of that year. By then, 28 patients had died directly from syphilis,
100 died from complications related to syphilis, 40 of the patients’ wives were
infected with syphilis, and 19 children were born with congenital syphilis.

“Since the introduction of universal newborn hepatitis B vaccine in the United
States, vertical transmission rates have declined by 94%-98%.”

The core sin of the Tuskegee Experiment was withholding a proven treatment for a
devastating infection for “research” purposes and, like penicillin, the
hepatitis B vaccine is tried, true, and tested. According to the article The
History of Hepatitis B Vaccines and the Importance of Universal Vaccination in
Infancy:

The first hepatitis B vaccine, Heptavax, was plasma-derived and was approved by 
the Food and Drug Administration (FDA) in 1981. It was used in targeted
populations of high-risk individuals, including infants born to infected
mothers. In 1986, the FDA approved the first recombinant vaccine, Recombivax HB.
This vaccine was derived from yeast and was used for the same high-risk
populations.

In 1989, a second recombinant vaccine was approved, Engerix-B. Unfortunately,
the targeted vaccination strategy did not have an impact on reducing the overall
incidence of the disease. Efforts to identify high-risk individuals were
further complicated by data that showed 35%-65% of hepatitis B surface antigen
(HBsAg) positive mothers had no identifiable high-risk factors. Vertical
(mother-to-child) transmission was the most common route of infection.
Approximately 90% of babies born to mothers with hepatitis B become infected,
and an estimated 25%-40% die prematurely in adulthood due to complications such 
as cirrhosis or hepatocellular carcinoma. This led the Centers for Disease
Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) to
recommend the vaccine for all newborns, starting in 1991.

Since the introduction of universal newborn hepatitis B vaccine in the United
States, vertical transmission rates have declined by 94%-98%.

Not bad.

The article further explained the rationale for giving the dose at birth:

While hepatitis B screening is recommended for all pregnant individuals by the
CDC and the American College of Obstetricians and Gynecologists (ACOG), only
82%-86% have the screening performed, and just 35% of those who test positive
receive all recommended follow-up care. This leaves a gap for 2.9-3.1 million
infants per year who are born to mothers not screened for hepatitis B. The
universal hepatitis B vaccine dose serves as a critical safety net, providing
protection to infants born to hepatitis B infected mothers who were not
identified at the time of delivery.

In addition to being effective, the vaccine is safe. A recent review titled
Hepatitis B Vaccination at Birth: Safety, Effectiveness, and Public Health
Benefit found:

A comprehensive review of safety data from randomized and nonrandomized clinical
trials, cohort studies, national vaccine safety monitoring programs, and
systematic GRADE analyses demonstrated that the hepatitis B vaccine is safe and 
well-tolerated in all age groups.

“You are now enrolling newborns in a lottery to test a hypothesis.”

Despite this decades-long track record of proven success, MAHA/MAGA
disinformation agents want us to pretend none of that evidence exists. They
claim we need to start over with a new randomized-controlled trial (RCT) of the 
vaccine using children in Guinea-Bissau, a country with an extremely high
prevalence of hepatitis B. They argue that “many physicians don’t understand
clinical trial ethics” and this new trial is “ethical, feasible, practical and
would be quite useful“.

Jonathan Jarry called this deliberate ignorance the square one fallacy, and Dr. 
David Gorski discussed this proposed trial last year in his article MAHA’s New
Tuskegee Experiment. Its fate has gone back and forth, even this week alone, and
the latest update is that health authorities in Guinea-Bissau are refusing to
let their children be used for unnecessary research. Let’s hope that’s the end
of it.

However, even if this trial never gets off the ground, it is worth discussing
how it was even considered in the first place and to recognize that once again, 
White scientists are seeking to exploit Black bodies for unethical medical
experiments.

According to a recent article by Melody Schreiber titled Controversial Vaccine
Trial Touted by RFK Jr Gets Go-Ahead in Guinea-Bissau:

A controversial research trial that will withhold hepatitis B vaccines from some
African newborns was given approval to move forward this week… It is a central 
part of the vaccine vision for Robert F Kennedy Jr, the secretary of the US
Department of Health and Human Services (HHS) and a longtime vaccine opponent.

At an anti-vaccine conference last month, Kennedy praised the Danish researchers
behind the trial and touted US-supported research on hepatitis B in newborns as
exemplifying the Trump administration’s agenda for vaccines, which has included
slashing vaccine recommendations and casting doubt on the safety and
effectiveness of shots.

She further described the proposed experiment.

Danish researchers plan to enroll 14,000 infants in Guinea-Bissau in the trial, 
giving the hepatitis B vaccine to half of the babies at birth and withholding it
from the others for the first six weeks of life…

The researchers will now test mothers for hepatitis B before they give birth.
The babies of mothers who test positive will be given the vaccine and will not
be included in the trial. But the babies of mothers whose tests are negative may
be enrolled. The new protocol has not been shared publicly.

In previous research, half of children who contracted hepatitis B did so after
birth, through community exposures. “This virus can be transmitted casually,”
Offit said. It can live on surfaces for up to seven days, and it can be acquired
by sharing washcloths, toothbrushes and fingernail clippers. In addition, the
hepatitis B test has a 5% false negative rate, which could provide false
assurance that a birthing parent does not have the virus.

She quoted vaccine experts who were rightly appalled by this trial:

Kennedy “wants to make it so we don’t use a birth dose here in this country,”
said Paul Offit, an infectious disease physician at Children’s Hospital of
Philadelphia. “That’s the goal.”

Kennedy would never be able to do the trial in the US because of its significant
ethical concerns, Offit added. “He’s taking advantage of a developing country …
Is it because children in Africa are more expendable than children here?”

“Experts have decried the African experiment as ‘horribly unethical and cruel‘, 
‘neo-colonialist‘ and ‘damaging‘,” she reported.

She further revealed:

An ethics committee at the researchers’ home institution of the University of
Southern Denmark voted this week to proceed with the trial, and officials in
Guinea-Bissau have also greenlit the project, which the health minister, Quinhin
Nantote, initially said was suspended after international uproar earlier this
year.

Stig Børsen Hansen, a founding member who was one of two reviewers who presented
the study to the Danish committee, resigned from the group in protest on
Friday, citing major ethical issues with the study.

“You are now enrolling newborns in a lottery to test a hypothesis,” Hansen said.
The children who are randomly selected not to receive the birth dose of the
vaccine, those who “lost the lottery”, face in their earliest days the risk of
contracting hepatitis B, which can cause irreversible lifelong damage. “They
contract hepatitis B in the context of being part of a research project,” Hansen
said, which made their infection happen, in effect, “by design”.

Three other members of the committee have also resigned in protest.

Ms. Schreiber also reported that while the CDC planned to spend $1.6 million on 
this study:

It would cost approximately $13,200 to buy enough vaccines through Unicef and
Gavi, the Vaccine Alliance, to immunize all newborns in Guinea-Bissau each year,
Delawalla (a researcher and founder and CEO of the non-profit Stand Up for
Science) pointed out.

Everyone involved should work together to ensure that every baby in
Guinea-Bissau receives the birth dose of the hepatitis B vaccination, she added.
“This is not muddy water: we can use Black babies to further pseudoscience or
we can save children’s lives with a 20-cent shot.”

“It is a red flag when people don’t report the primary result of a randomized
trial.”

While this study would be abhorrent even if it were carried out by credible
researchers, that is not the case here. According to one article on the lead
researchers, Christine Stabell Benn and Peter Aaby:

Stabell Benn and Aaby are currently under investigation by Danish authorities
over allegations of “falsification” and “scientific misconduct” related to
previous vaccine research.

According to an article titled Controversial Danish Vaccine Research Group Faces
New Allegations:

A new paper levels fresh allegations of questionable scientific practices by the
Bandim Health Project (BHP), an embattled group led by researchers in Denmark
that has long studied vaccines in West Africa and has recently become
influential in U.S. health policy…

Benn’s group has been criticized in the past for what other researchers say are 
poor reporting practices—accusations her team denies. In a paper published today
in Vaccine, researchers allege problems at BHP go deeper. The authors say they 
were unable to find comprehensive data on primary outcomes—the effects a trial
was designed to investigate—for 10 of the group’s studies carried out over 2
decades. Together, the studies included tens of thousands of Bissau-Guinean
children.

The article continued:

“It is a red flag when people don’t report the primary result of a randomized
trial,” says Evan Mayo-Wilson, an epidemiologist at the University of North
Carolina’s Gillings School of Global Public Health who was not involved in the
new study. “We have an ethical obligation to participants in randomized trials
to report the results for the research questions that those trials were designed
to answer.”

Benn, who is affiliated with the University of Southern Denmark, told Science
the new paper is “substantially flawed in both content and interpretation,” but 
that she did not have time to respond in detail today.

Another article titled Randomized Trials Show no Evidence of Non-Specific
Vaccine Effects said:

For more than three decades, researchers Christine Stabell Benn and Peter Aaby
from the Bandim Health Project have conducted randomized trials involving
thousands of children in Guinea-Bissau and Denmark to demonstrate so-called
non-specific vaccine effects – that is, whether vaccines also protect against
diseases other than the one they are designed to prevent.

A new comprehensive Danish review now shows that the trials have been unable to 
demonstrate non-specific effects for the widely used vaccinations against
measles, tuberculosis, diphtheria, tetanus, and whooping cough.

“It is concerning that such a prominent research group has conducted so many
randomized trials over such a long period without finding real results.
Randomized trials are normally considered the gold standard in medical research,
so if they do not show anything, one should be very cautious about presenting
it as convincing evidence,” says Henrik Støvring from Steno Diabetes Center
Aarhus and Aarhus University, who led the new review.

Given this inglorious track record, it’s no surprise that:

Kennedy has repeatedly praised their work, which he says shows that after
vaccination, “you can have mass injuries, and catastrophic injuries, and they’re
hiding in plain sight.”

“I didn’t want to believe it.”

The Tuskegee Experiment ended only after it was exposed by a 28-year-old
whistleblower, Peter Buxton, who said:

I didn’t want to believe it. This was the Public Health Service. We didn’t do
things like that.

I had a similar reaction when I learned about the Tuskegee Experiment as a naïve
youth, and Buxton’s bravery only raises the question of why no one spoke up
sooner. How could such an atrocity be allowed to happen?

Today at least, I no longer have to wonder about such things. I just have to
read the news and recognize that the cowards and sycophants who enabled,
promoted, and normalized MAHA in any way are collectively to blame for its
attempt to do Tuskegee 2.0.

Vinay Prasad

Dr. Vinay Prasad “Sabotaging RFK Jr’s Confirmation Will Increase Vaccine
Hesitancy” & “Doctors Criticizing RFK Jr. Paved the Way for His Ascendancy”

Doctors who gushed over RFK Jr. made their bed, and they’ll lie in it.

Jonathan Howard on December 6, 2024

Link

Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy

I can forgive you for thinking that my article is satire. It is not. Dr. Vinay
Prasad actually published articles titled Sabotaging RFK Jr’s Confirmation Will 
Increase Vaccine Hesitancy and Doctors Criticizing RFK Jr. Paved the Way for His
Ascendancy.

In his article Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy,
Dr. Prasad argued:

The best way to curb vaccine hesitancy is to approve RFK Jr, and redirect his
energies to generating more data. More data will answer the key questions that
remain unanswered: which childhood immunization program is optimal. The worse
thing we can do is tank his nomination. Then vaccine hesitancy will explode.

It’s hard to know where to begin with something this asinine. According to Dr.
Prasad:

  1. Data about routine vaccines is currently lacking.

  2. All anti-vaxxers need to change their minds is “more data”.

  3. A “cluster RCT” of the routine vaccine schedule is both feasible, ethical, and
    a good use of resources.

  4. The ideal person to generate this data and reduce vaccine hesitancy is a crank
    who likened vaccines to the Holocaust and already has a body count of 83
    dead people in Samoa, mostly children.

  5. Keeping RFK Jr. from office would empower anti-vaxxers more than giving him
    power.

I won’t insult Dr. Prasad by pretending he actually believes any of this. He’s
not even trying to make coherent points anymore. It’s just bad-faith,
performative argumentation and nothing else.

Doctors Criticizing RFK Jr. Paved the Way for His Ascendancy

Dr. Prasad claims that in order to save vaccines, we must place America’s top
anti-vaxxer and his ecstatic henchmen in charge of our entire federal health
apparatus. These are the people behind Vaxxed III: Authorized to Kill.

However, Dr. Prasad also claims that he and other contrarian doctors had nothing
do with RFK Jr’s. rise, a position he made clear in his article Doctors
Criticizing RFK Jr. Paved the Way for His Ascendancy.

Although Dr. Prasad claimed that COVID vaccines offered 100% protection against 
severe disease, that they blocked transmission and would end the pandemic, he
now says that other doctors’ COVID pronouncements are to blame for mistrust in
vaccines. Dr. Prasad specifically said overselling the benefits of Paxlovid
paved the way for the rise of RFK Jr. If only doctors had been more circumspect 
about Paxlovid, we would not be in this predicament today.

Dr. Prasad is not alone in blaming everyone except himself and RFK Jr. for
increasing vaccine-hesitancy. Other pro-infection doctors, even those who
previously recognized the tragedy of Samoa, are now trying to get ahead of the
narrative and blame those who objected to their policies of mass infection with 
SARS-CoV-2. In this twisted narrative, heroes such as Peter Hotez and Paul
Offit, who have defended vaccines for decades at great personal cost, will be
responsible when measles returns. In contrast, RFK Jr. is just the man we need
to restore confidence in vaccines.

We can expect to be deluged with this upside down message as these doctors seek 
to proactively absolve themselves of all responsibility for what RFK Jr. might
do.

Why Doctors Should Learn to Stop Worrying and Love MAHA

However, I would argue something obvious- doctors who lauded RFK Jr. and
deliberately obscured his risk paved the way for his ascendancy, and they’ll own
everything that happens in the next 4 years.

The day after Dr. Prasad published his article blaming RFK Jr.’s critics for his
rise, his monetized misinformation Substack published an article titled Why
Doctors Should Learn to Stop Worrying and Love MAHA by Dr. Joseph Marine.
Predictably, Dr. Marine purposefully hid RFK Jr.’s anti-vaxx propaganda and
argued that “we should embrace the Make America Healthy Again (MAHA) agenda”.
Dr. Prasad claims this sort of material played no role in paving the way for RFK
Jr.

Indeed, Dr. Prasad spent the past year fawning over America’s top anti-vaxxer
while slinging juvenile taunts at pediatricians and anyone else who provided
accurate information about vaccines. The video below is one example amongst
many. Here’s what Dr. Prasad had to say:

I really think the way to engage with RFK is the way you’re doing actually, and 
the way I’m trying to do, which is not to insult him and to give credence to
what his root concerns are, which is really the concern of the corrupting
influence of money. That’s his root concern, how can I trust the system?  It’s
so corrupt with money that how can I trust that these vaccines are really best
for my children, and if there was a safety signal, you wouldn’t tell me anyway
would you?

Basically, “they” are hiding the harms of vaccines.

Perhaps Dr. Prasad thought he could make these oh-so edgy, controversial
statements without any consequences. He likely believed he could use RFK Jr. to 
build his “heterodox” brand, but that someone somewhere would surely prevent him
from gaining power. However, it turns out that the words of prestigious doctors
from prestigious universities with massive media footprints can actually
influence the real world. Important people believed these doctors when they said
RFK Jr. was right about his “root concern.”

Who could have imagined?

Along with the rest of us, Dr. Prasad had better hope the Senate blocks RFK Jr.,
because if he does to the U.S. what he did to Samoa, doctors who who have been 
sounding the alarm for about RFK Jr. decades will have a clean conscience. We
tried to warn you RFK Jr. was dangerous above all else.

In contrast, doctors who gushed over RFK Jr. will be tied to him for the rest of
their careers. They’ll forever be remembered for legitimizing an anti-vaxx
disinformation agent to pander to their paid subscribers and that’s it. Nothing 
else they’ll do professionally will count, no matter how much they try to
absurdly blame everyone else for RFK Jr.’s rise to power.

They made their bed, and they’ll lie in it.


Dr. Vinay Prasad Embraces Policy-Based Evidence Making

Policy-based evidence making means working back from a predefined policy to
produce underpinning evidence.

Jonathan Howard on February 22, 2025

Link


Unlike myself, Dr. Vinay Prasad did nothing to advance an actual COVID
randomized-controlled trial (RCT) as far as I know. Instead, of making any
real-world contribution, he created long lists of RCTs that he expected other
doctors to do. In his vision, it was a significant accomplishment to make
podcasts and “call for” for them to do RTCs.

In a previous article titled Doctors Who Performatively Fetishized RCTs Aren’t
Out to Advance Medical Research, But Rather to Sow Doubt & Mistrust, I described
how Dr. Prasad created these lists for one reason, to undermine mitigation
measures he opposed. It was trivially easy to take an unwanted measure and claim
that it was of no value because it hadn’t proven itself via an RCT. Obviously
RCTs are not the only way to learn about the world, and when these measures did 
prove themselves via RCTs, such as the pediatric and booster vaccines, Dr.
Prasad said these studies were too small or out of date.

Dr. Prasad started with his conclusions and always found some reason to discard 
unwanted data and to disparage those who disagreed as actively opposed to
high-quality evidence. Indeed he opposed the pediatric COVID vaccine months
before there was a pediatric COVID vaccine and called its supporters “idiots“.
Conversely, Dr. Prasad never demanded RCTs to push policies he preferred, namely
repeatably exposing unvaccinated children to SARS-CoV-2.

Though Dr. Prasad still starts with his conclusions, things are very different
now. Dr. Prasad’s ideological allies are in power or soon will be. As such, Dr. 
Prasad is done creating lists of endless RCTs for them to do. He has a very
different task for them today. He openly wants “researchers” to work backwards
to produce non-randomized “evidence” specifically to confirm his prior beliefs
and advance his political objectives. In his article Jay Bhattacharya is a
Superb Pick for NIH Director he tasked Dr. Bhattacharya with performing just one
RCT regarding NIH grants, and said:

Jay Bhattacharya will create a portfolio of funding to investigate the harms of 
lockdowns, school closures, vaccine mandates, and other unproven draconian
COVID19 measures. This will create a lasting body of scholarship which will
deter future public health tyrants.

That’s an amazing thing to write. Dr. Prasad doesn’t want to build a fair and
objective body of scholarship to help guide future public health leaders. Dr.
Prasad is done pretending that science is an objective method to investigate the
world. To him, it is a weapon. With his typical emotionally manipulative
language, he wants the NIH to “investigate… unproven draconian COVID19 measures”
for the singular purpose of deterring future public health “tyrants.” The term 
for this bastardization of science is policy-based evidence making. According to
Wikipedia:

Policy-based evidence making is a pejorative term which refers to the
commissioning of research in order to support a policy which has already been
decided upon. It is the converse of evidence-based policy making.

As the name suggests, policy-based evidence making means working back from a
predefined policy to produce underpinning evidence. Working from a conclusion to
provide only supporting evidence is an approach which contradicts most
interpretations of the scientific method; however, it should be distinguished
from research into the effects of a policy where such research may provide
either supporting or opposing evidence.

Unfortunately, Dr. Prasad is probably correct that Dr. Bhattacharya’s will
“investigate” COVID measures, and we all know what he will “discover”. They are 
both political actors who disguise themselves as neutral scientists, and Dr.
Prasad’s surprisingly honest admission leaves no doubt about that. The era of
policy-based evidence making making is upon on, and we should all be on guard
against it.


Dr. Vinay Prasad is Repeatedly Undermining RCTs. Why?

It’s quite the journey from “RCT or STFU” to “we will always have a place for
controlled clinical studies.”

Jonathan Howard on June 10, 2025

Link

There have been several examples of scientists trying to undermine randomized
trials— arguing they are not possible, not practical, or not useful.

In 2023 Dr. Vinay Prasad said that scientists who recognized the limitations of 
randomized-controlled trials (RCTS) were intentionally trying to undermine them.
Seeking to spread doubt and mistrust about them, he wrote an article titled The
Scientists Who Undermine Randomized Trials that said:

There have been several examples of scientists trying to undermine randomized
trials— arguing they are not possible, not practical, or not useful. All of
these arguments are false.

Despite not working on any RCTs himself, Dr. Prasad claimed his philosophy was
“RCT or STFU for all.”  Dr. Prasad also promised that RFK Jr. would be the
perfect guy to run RCTs and finally resolve longstanding “questions” on
vaccines. In his article Sabotaging RFK Jr’s Confirmation Will Increase Vaccine 
Hesitancy Dr. Prasad wrote:

The only path to vaccine trust is to create randomized trials and neutral
systems and to acknowledge the core concerns about vaccine safety.

Many previous SBM articles have described how these calls for RCTs weren’t made 
to advance actual research, but rather to spread doubt and mistrust about
vaccines and COVID mitigation measures. It’s been a favorite technique of
anti-vaxxers for decades.

Randomized trials are not always feasible, possible, or practical.

Now that he is in in power, however, Dr. Prasad has changed his tune rather
drastically, using the exact same language he previously lambasted- randomized
trials are not always feasible, possible, or practical. Not only is he
denigrating RCTs, but this has also become one of his core messages, starting on
his first day in office. In just one month, he has done so at least 5 times:

  1. Randomized controlled trials are not always necessary

  2. On other issues, we’ve talked about the importance of randomized-controlled
    trials, and sometimes people say to me “how come you don’t need
    randomized-controlled trials to take out the petroleum dyes”. And I say,
    this is just a simple teaching point, the evidence to take a medical product
    that’s supposed to make you better than to mitigate a potentially harmful
    substance.

  3. Randomized trials are not always feasible, possible, or practical.

  4. Trials vs. real world evidence? The answer to that is both. We will always
    have a place for controlled clinical studies, but we will also leverage the 
    incredible promise of real-world data.

  5. In the past, randomized clinical trials were the sole method used to determine
    if a product was safe and effective. But not all randomized trials are
    informative—some have poor control groups, unrepresentative populations, or 
    inadequate statistical plans.

It’s quite the journey from “RCT or STFU” to “We will always have a place for
controlled clinical studies.”

RFK Jr. Will ‘End The War’ Against Alternative Medicine at the FDA, From Stem
Cell Therapy to Chelation

Many people have noticed Dr. Prasad’s drastic medical reversal, now that he and 
other WWTI doctors have power, and it’s their job to generate gold-standard
evidence for the American public. It turns out, these doctors are only capable
of making YouTube videos “calling for” others to do RCTs. They are not capable
of doing any RCTs themselves.

However, Dr. Prasad’s statements are more than just rank hypocrisy. By
repeatedly undermining RCTs- and that’s exactly what he is doing- he is creating
a permission structure for the current medical establishment to do whatever
they want. They can make drastic changes based on “common sense,” as Dr. Prasad 
recently put it. While Dr. Prasad demanded the highest standards from his
predecessors, he believes the current medical establishment can embrace
Feelings-Based Medicine and restrict vaccines on this basis alone. Which RCT
shows that it’s wise to limit the COVID vaccine in pregnancy? There’s only
“common sense” from sheltered men who have no real-world responsibility for
dealing with the consequences.

Dr. Prasad is not the only member of our medical establishment who is
undermining RCTs. As Dr. David Gorski discussed Monday they are embracing
anecdotal evidence, and recent headlines give a clue as to what sort of
“real-world” data RFK Jr. plans to collect and how he plans to use it.

  1. Kennedy Says ‘Charlatans’ Are No Reason to Block Stem Cells,

  2. RFK Jr. Will ‘End The War’ Against Alternative Medicine at the FDA, From Stem 
    Cell Therapy to Chelation,

  3. Vaccine Opponent Hired by RFK Jr. Scours Official Records for Link to Autism

  4. RFK Jr. Purges Every Vaccine Adviser on CDC Panel, Will Pick Replacements

What will Dr. Prasad do when RFK Jr. orders him to approves stem cells to help
children recover from vaccine-induced autism? Will he resist and tell him “RCT
or STFU”? Or will he use his “common sense” and acquiesce to his every demand?
We may soon find out.

But no matter what decisions Dr. Prasad makes, we all have the right to reject
them unless they are backed by large, rigorous RCTs. RCT or STFU applies to him 
more than anyone. It’s too bad Dr. Prasad won’t take his own advice.


An Open Letter to Dr. Vinay Prasad

Please recognize that you are now influencing the national public health policy 
and understand that being in authority is a very different job than simply
questioning authority

Dr. Jonathan Storey on January 30, 2025

Link

Dear Dr. Vinay Prasad,

I knew you before COVID. Like you, I am a practicing medical oncologist. I first
discovered your name years ago when I stumbled upon your oncology podcast.
Later on, I proudly converted to Medical Conservativism after embracing your
mission statement: The Case for Being a Medical Conservative. I have read your
book as well. We have never actually met, but I have been following you across
various media formats for a long time. During my journey, I have been repeatedly
in awe of your ability to critically appraise the oncology medical literature. 
The methods that I have learned from you continue to inform the way that I
evaluate new data and teach my medical students.

While listening to you shred (a compliment) the latest oncology journal article 
on your podcast, I have often found myself wondering how you practice medicine
in your cancer clinic. With perhaps one exception, I have yet to hear you
whole-heartedly endorse a completed clinical study. Instead, you are quick to
point out methodologic flaws and second-guess the latest FDA approvals. If I
took every word literally, I would predict that you do not prescribe any of the 
cancer treatments that you have previously eviscerated on your podcast. But, I
know that is not reality.

I recognize your brand of frenetic bluster – you are a contrarian. Contrarians
are needed. In my oncology practice, I am inundated with pharmaceutical
salespeople and email advertisements promoting the latest oncology medications
(with new price tags upwards of $200,000 per year). You correctly point out when
there is only a marginal benefit to be obtained at very high societal cost. I
find value in questioning the status quo, even if it is only while listening to 
your weekly 30-minute podcast on my drive home. Listening to a contrarian
viewpoint every now and then does not paralyze me. In fact, I believe it makes
me a more well-rounded physician. My oncology patients continue to receive the
latest treatments even when the underlying study is partially flawed. I am sure 
that you treat your patients similarly.

More recently, I have watched you apply your brand of flippant contrarianism to 
COVID. As a result of your new content and continued flare for delivery, your
audience has grown well beyond the smaller world of medical oncology. You have
surely noticed that your new audience is now more likely to be politically
motivated than medically oriented. As a result, they may not be properly
equipped to place your indignation within the broader scope of traditional
medical opinion. For them, the script is likely flipped, with the contrarian
viewpoint replacing the standard of care.

While you might see that as a positive, I worry that hearing primarily
contrarian viewpoints can be paralyzing. How else does one explain the decreased
COVID vaccine uptake in the Red States? I respect the ability of my patients to
make informed decisions in my home state of Alabama. However, when that
decision process is cross-pollinated by politics my confidence wanes. By not
fully recognizing how your audience has changed, I fear that you may have
unintentionally contributed in some small way to these worse outcomes. 
Thankfully, there is still time to recalibrate your messaging for the next slate
of public health decisions.

As I write this, your influence is at a new high and the future looms large.
Your friends are accepting important government positions. You are likely
fielding some flattering and influential employment offers as well. Whether you 
change jobs or not, please recognize that you are now influencing the national
public health policy. Your role in the public square has evolved in a
significant way, whether you intended this or not. I hope you understand that
being in authority is a very different job than simply questioning authority.
You no longer have the luxury of being the bombastic underdog contrarian; your
audience is too large and the stakes are too high.

I am watching with interest to see how you will respond in your new role.
Unfortunately, the early returns are not great. An article you
recently penned in The Free Press attempts to “draw distinctions” on a multitude
of potential policies that Robert F. Kennedy, Jr may try to implement. You make
the reader aware that some of RFK Jr’s controversial recommendations are
currently implemented in other countries. On casual inspection of the article, I
do not see any overt factual errors. You correctly point out that “all European
countries recommend using MMR vaccines in children” and accurately state that
“no country I am aware of warns against using it because it leads to autism”.

Later in the article, the ground gets a little shakier when you make the
seemingly reasonable statement that “vaccines are like drugs. We need more
evidence.” But, the benefit of vaccines extend beyond the simple evidence-based 
calculation of number-needed-to-treat that you proselytize. Even in situations
where the individual benefit of vaccination is low, vaccines often have an
additional benefit – they keep our neighbors healthy, too. If I decide not to
take a cholesterol medicine, that decision only affects my risk of stroke and
heart disease. But, when someone declines a vaccine, it raises the risk of an
outbreak within the entire community. There is a public, and dare I say,
patriotic component to vaccination that makes it very different from the cancer 
therapies that you and I administer in our clinics.

And of course, we always “need more evidence” to inform our medical practice.
Like you, I am usually in favor of ethically collecting more data. However, we
must continue to care for our patients while we wait (indefinitely). As I
alluded to above, a lack of perfect evidence is not an excuse to be paralyzed
and do nothing. The inherent public health benefit of vaccines further raises
the stakes of inaction. I believe there is legitimate reason to hold each
vaccine to a lower evidence standard than the expensive and highly toxic
chemotherapy treatments that we prescribe. Of course, you know all of this
already. In “The Case for Being a Medical Conservative”, you list vaccines as
one of the penultimate examples of high-value care.

I suspect that you would counter that your article is not actually taking a
stance on vaccination or any of the other controversial topics. You may continue
to insist that “if other nations are doing it, we should be willing to look
into it”. I take issue with that seemingly benign sentiment as well, but will
let it pass for the time being.

Ultimately, it is not the existence of this article that surprises me. What
bothers me is that you are the author. I have never heard you parrot government 
public policy with the implicit assumption that if someone else is doing it, it 
might be okay. Where is the in-depth critical analysis of the evidence that you 
are so well known for?

Reading an article like this opens the door for me to question your biases and
perhaps even your motives. Because I used to see you as above politics, I
believe this article is beneath you.

Despite my ongoing admiration for you in the oncology space, I am now nervous.
Your vaccine communication and your latest article have given me pause. I always
thought that your superpower was unbiased critical appraisal of the medical
evidence. I hope that you can quickly rediscover your superpower and put it to
responsible use. Perhaps it will again lead you back to your evidence-based
roots as we confront a future of trying to fact-check Make America Healthy
Again.

Sincerely,

Jonathan Storey, MD

P.S.  Please beware falling victim to the human biases that you so astutely
identify in others. Specifically, I hope that you are being vigilant to avoid
motivated reasoning in the form of confirmation bias an audience capture.


Dr. Vinay Prasad is Now the Medical Establishment. It’s His Job to Run RCTs, and
It’s Our Job to Call Him a Lying Piece of $#!& if He Fails.

“I wish Vinay all the best for his new role. It’s a whole new state of play when
the buck stops with you.”

Jonathan Howard on May 9, 2025

Link

I also want them to admit they didn’t run any studies even though people told
them to

From claiming COVID vaccines were perfect and would end the pandemic to treating
rare, temporary vaccine side-effects, even abnormal lab values, as a fate worse
than death, Dr. Vinay Prasad spread copious COVID misinformation. It’s taken
volumes to begin to categorize his attempts to repeatedly infect unvaccinated
children with SARS-CoV-2.

As SBM readers know, one of the chief ways Dr. Prasad spread doubt and mistrust 
was via methodolatry. Except for vaccine side-effects, Dr. Prasad claimed that
only randomized-control trials (RCTs) could inform medical decisions and that
unwanted mitigation measures were useless unless they proved themselves via an
RCT for every variant and demographic subgroup.

Despite his professed love for RCTs, Dr. Prasad has not made a real-world
contribution to one as far as I know. Rather than do the hard work to advance
such research, Dr. Prasad sat on the sidelines and excoriated public health
officials for not doing every trial he imagined. On his many monetized social
media platforms, Dr. Prasad created long lists of RCTs they failed to do. He
said:

In the decades to come post COVID, the greatest failure will be a failure to
generate better data. It is forgivable to be ignorant in March 2020, but we
failed:

Zero randomized trials of school closure

Zero randomized trials business closures

Zero randomized trials on masking in schools

Zero randomized trials on masking kids

Zero randomized trials on masking in USA

Zero randomized trials of 3 vs 6 ft Zero randomized trials of cohorting

Zero randomized trials of installing HEPA filters

Zero randomized trials of masking, post vaccine

Zero randomized trials testing alternative dosing strategies of vax (post phase 
3)

Zero randomized trials of whatever foolishness we are doing on college campuses

Zero randomized trials of asymptomatic testing

Zero randomized trials of quarantine duration

Zero randomized trials of testing for preschool/ school

Zero randomized trials of plexiglass

Zero randomized trials of wearing your mask from the door to table, and table to
bathroom, but at no other points during your restaurant experience

Yet many of these things were wrongfully called parachutes by at least some
people who should know better. Leaving a pandemic as ignorant as we entered is
awful It is also why all of these issues have become political and not
scientific. Science should be ashamed of itself. In 100 years we will look as
primitive as the folks who survived the plagues of the middle ages.

Dr. Prasad made it sound like running RCTs was very easy, and he implied that
public health officials could have done them had they been willing. In a recent 
paper with Dr. John Ioannidis titled Evidence Base for Yearly Respiratory Virus 
Vaccines: Current Status and Proposed Improved Strategies, he said:

We propose a new research framework which would render results relevant to the
current or future respiratory viral seasons. We demonstrate that experimental
studies are feasible by adopting a more pragmatic approach and provide
strategies on how to do so. When it comes to implementing policies that
seriously impact people’s lives, require substantial public resources and/or
rely on widespread public acceptance, high evidence standards are desirable… 
RCTs are feasible and not prohibitively expensive if one incorporates pragmatic 
elements.

By saying that such RCTs are both feasible and necessary, Dr. Prasad portrayed
himself as a hero of evidence-based medicine, who was merely upholding rigorous 
standards.

In contrast, he depicted doctors who recognized the challenges and limits of
RCTs, even those of us who participated in them, as being careless and lax about
scientific evidence. He made his thoughts clear in an article titled The
Scientists Who Undermine Randomized Trials, in which he said:

In the last few weeks there have been several examples of scientists trying to
undermine randomized trials— arguing they are not possible, not practical, or
not useful. All of these arguments are false.

In less filtered moments- and there were many such moments– Dr. Prasad viciously
attacked these scientists with vulgar, juvenile, unprofessional slurs. “These
pieces of shit are still lying… they are still fucking lying,” he said. “I also 
want them to admit they didn’t run any studies even though people told them to,”
he added. Although Dr. Prasad didn’t do much the past 5-years, he was very
impressed with himself for having told them what to do. In his vision, typing
lists of RCTs on Twitter was hard. Actually doing them would have been easy. Had
Harris won, there is no doubt that Dr. Prasad would be demanding RCTs from the 
Medical Establishment.

RFK Jr. picks controversial doctor as top vaccine regulator

Well, guess what. Trump won and earlier this week, Dr. Vinay Prasad was named as
head of the Center for Biologics Evaluation and Research, which regulates
vaccines and gene therapist. Congratulations to him. As one person said on
social media:

I wish Vinay all the best for his new role. It’s a whole new state of play when 
the buck stops with you.

Indeed, it’s time for Dr. Prasad to stop telling other people what to do and to 
start doing those things himself. After years of profane rants against the
Medical Establishment, Dr. Prasad is now the Medical Establishment. It is his
turn to shine and deliver results for the taxpayers who pay his salary. Along
with the heads of the NIH and FDA, it’s his job to do everything he “told” his
predecessors to do. Dr. Prasad set a high bar for them, and he has a golden
opportunity to dazzle us all and succeed where they failed.

Corrupt Doctors

Conversely, those of us outside the Medical Establishment have the right to tell
Dr. Prasad what to do, just like he did with his predecessors. Measles and
whooping cough are spreading under his watch now, and I am telling him to loudly
refute his boss’s anti-vaxx disinformation. Until then, his silence will speak 
volumes. Additionally, we should all feel free to create lists of RCTs and tell 
Dr. Prasad to do them. Feel free to create your own list in the comments. I
obviously expect him to do the vaccine-RCTs he had previously demanded. After
all, he said they were “feasible by adopting a more pragmatic approach,”

It will not suffice for Dr. Prasad to again tell someone else- Big Pharma is the
bogeyman this time- to do these trials. The technique that catapulted him into 
power isn’t going to work now that he’s in power. Dr. Prasad has been reasonably
skeptical of pharma trials his entire career. He has since told the public that
vaccine companies make “garbage products” and that only conflicted, “corrupt
doctors” work for them. His message resonated with many people. If a Pfizer
trial found the Pfizer vaccine was a smashing success, many people would
distrust the results thanks to Dr. Prasad and his ilk. Is Dr. Prasad suddenly
telling us that only Big Pharma can be expected to generate evidence for the
American public? Is the Medical Establishment is suddenly off the hook?

Of course not.

That’s why it’s now his job to do these RCTs, and he needs to get started right 
away. Flu season is coming, and COVID boosters are waning. As he wrote, “phase
III trials may start early in the season and must be powered for clinically
relevant outcomes.” As things stand now, the Medical Establishment in
threatening to disregard our medical freedom by taking away the COVID vaccine
without an RCT showing us that is safe. That is unacceptable.

If Dr. Prasad fails to live up to the standards he set for his predecessors, I
can treat him the same way he treated them. If 4 years from now, he does not
have a portfolio of successful RCTs he has completed, his tenure will have been 
a total failure, and I can mock, berate, and humiliate him for this. I can write
articles about scientists like him who undermine randomized trials and I
supposed I can make childish, profane videos calling him and the rest of our
Medical Establishment lying “pieces of shit”.

After all, I’ve done the hard work already. I told him exactly what to do.

Addendum:


I Am Calling on Dr. Vinay Prasad, the Medical Establishment, to Break His
Silence on Vaccines as Measles And Pertussis Spread Under His Watch

For a brief period in 2022, Dr. Vinay Prasad faked a concern about routine
vaccines to infect unvaccinated children with COVID.

Jonathan Howard on May 17, 2025

Link



In 2022, as COVID was sending children to the hospital, Dr. Vinay Prasad instead
fretted about “truly dangerous diseases, like polio and measles.” He spoke
about the value of routine vaccines and said:

Measles can be a devastating childhood illness, but vaccination provides
durable, sterilizing immunity. When vaccination rates are high, measles
outbreaks can be averted.

Elsewhere he said “measles vaccine is sterilizing and high rates are needed to
halt spread.”

All this is 100% correct, and as vaccines are threatened as never before,
doctors should repeat this message loudly and clearly.

However, Dr. Prasad wasn’t motivated by a sincere concern for routine vaccines
at that time. Those sentences come from articles titled Covid Vaccines Shouldn’t
Be ‘Routine’ for Kids and A Pro-Con Debate: Should Doctors Encourage Healthy
Kids 11 and Under be Vaccinated Against COVID-19?. Dr. Prasad’s goal was to
promote the absurd myth that routine vaccines were in competition with the COVID
vaccine. His singular passion for the past 4 years has been to repeatedly
infect unvaccinated children with SARS-CoV-2, even if that required him to fake 
a concern about routine vaccines for a brief period in 2022.

Indeed, even though Dr. Prasad now has great influence and power as the head of 
the Center for Biologics Evaluation and Research, he’s said nothing about
measles, mumps, rubella, diphtheria, polio, and Haemophilus influenza type b
(Hib). He’s not uttered a word as his boss spread blatant anti-vaxx
disinformation. His silence is an implicit endorsement of these lies, even as
measles and pertussis spread, under his watch. Dr. Prasad didn’t start these
fires, but he is the Medical Establishment, and it’s his job to help put them
out.

Conversely, it’s our job to call on Dr. Prasad to do things, just like he did
with his predecessors. I am calling on Dr. Prasad to inform parents that
vaccines are safe and effective at preventing dangerous diseases. I am calling
on him to refute RFK Jr.’s disinformation. I am calling on him to do this on
camera and social media with the same passion he brought to his incessant
ramblings about rare, temporary vaccine side effects. This is the bare minimum
for someone in his position, like a fireman promoting smoke detectors or a
lifeguard promoting swim lessons.

As things stand now, Dr. Prasad is the only oncologist in the country who won’t 
say the image below is dangerous disinformation. What a pathetic place for a
once respected doctor to end up, though it is America’s children who will pay
the price for his cowardice and ambition.


Doctors Who Rose to Power Bashing the Medical Establishment Are Now the Medical 
Establishment. Good Luck With That.

“Almost all crank movements will eventually devolve to sectarian strife… It’s
the only upside of watching these idiots is knowing this fate.” Dr. Mark
Hoofnagle

Jonathan Howard on May 16, 2025

Link

And with that, any ounce of credibility @DrMakaryFDA may have had is out the
window

We here at Science Based Medicine will be keeping close tabs on our new Medical 
Establishment for as long as they are in power. We won’t be the only ones,
however. Though they have an entirely different agenda, anti-vaxxers and
crackpots of all sorts will be watching too, and their power and influence has
grown mightily over the past 5 years. Mainstream doctors relentlessly shared
their beliefs and talking points. In so doing, they validated and normalized
anti-vaccine thought, rhetoric, and techniques. Chief of these was spreading
fear, uncertainty, and doubt.

Dr. Marty Makary, for example, spent the past 4 years making common causes with 
such cranks and encouraging their mistrust of the Medical Establishment. In one 
particularly noxious speech, seated next to his fellow misinformation
superspreader Dr. Jay Bhattacharya, Dr. Makary said, “that the greatest
perpetrator of misinformation during the pandemic has been the United States
government.” He was upset that his predecessors didn’t join him in glorifying
“natural immunity” and treating vaccine side-effects as a fate worse than death.

Thanks in part to doctors like Dr. Makary, many people no longer trust the
Medical Establishment, and unsurprisingly the leopards that he validated and
enabled are already coming for his face. They are demanding that he remove all
COVID vaccines, and though he seems inclined to do so, this will appease them
for only so long. RFK Jr. is hiring cranks like David Geier to “discover” bad
things about vaccines. Their next targets will be the MMR, HPV, and other
routine vaccines. They’ll never be satisfied, and they’ll turn on him Dr. Makary
a heartbeat if he lets them down. The same will likely be true for Drs. Jay
Bhattacharya and Vinay Prasad. By pretending to take a “nuanced” and
“evidence-based” approach, they’ll end up pleasing no one and infuriating
everyone.

“It’s been a tough period, absolutely, and especially … for me.”

Already, the fragile coalition that brought our current Medical Establishment to
power is starting to fissure and fray. Today the headlines read: MAHA
Infighting Threatens to Derail RFK Jr.’s Health Revolution, Trump’s Surgeon
General Pick Pits MAGA Vs. MAHA, MAHA at War: RFK Jr’s Inner Circle Accusing
Each Other of Leaking False Info in Expletive-Ridden Phone Call, Trump’s Surgeon
General Pick Exposes Cracks in MAHA Movement, MAHA Civil War Erupts As Wellness
CEO Makes Bombshell Accusation Against Top RFK Jr. Adviser , and Wellness CEO
Files Ethics Complaint Against Top RFK Jr. Adviser. According to that last
article:

In a formal complaint to the Office of the Special Counsel and other agencies
filed Saturday and obtained by POLITICO, Gillooly accuses Calley Means of
abusing his position at HHS and violating the law prohibiting conflict of
interest in government services by threatening to involve Kennedy and National
Institutes of Health Director Jay Bhattacharya in the dispute.

“If one more thing happens, I’m going to go to Jay Bhattacharya and Bobby and
tell him that you and your cadre of Peter McCullough and Kelly Victory are
spreading lies and trying to fuck with him and hurt his administration,” Means
said, naming two members of the company’s medical board, in a recording of a
Saturday morning call between him and Gillooly obtained by POLITICO.

I’m glad I won’t have to spend the next 4 years dealing with middle school drama
like this. However, this is what our current Medical Establishment signed up
for. This is what their future holds. They’d better not upset Laura Loomer. They
cannot contract their boss, who is an anti-vaxx loon.

Dr. Bhattacharya at least seems to grasp that he is largely at the mercy of
forces beyond his control. His recent interview with Science reeked of
impotence. “Those decisions are not up to me… I had nothing to do with it… It’s 
not me personally,” he said. “It’s been a tough period, absolutely, and
especially … for me“, he said about having to purge scientists and other
dedicated NIH employees. “I don’t want to get in the middle of that
negotiation,” he said in another interview regarding potentially devastating
cuts to the NIH, as if he were a passive observer of the agency he purportedly
leads.

Some of us have been paying close attention to anti-vaxxers and conspiracy
theorists, and we’ve seen this story before. We could have warned these doctors 
that hitching their wagon to these characters was a dangerous game that wasn’t
going to end well for them. As Dr. Mark Hoofnagle said in response to these
headlines:

But this is the natural progression of cranks! First comes the magnetism, then
the repulsion. Almost all crank movements will eventually devolve to sectarian
strife, especially after the loss or humiliation of a figurehead. It’s the only 
upside of watching these idiots is knowing this fate. But think of any crank
community or movement, from 9/11 to 4chan.

It starts with bonding over mutual hates and love of being outside pissing in,
then, they inevitably they figure out people who think this way are intensely
unpleasant, narcissistic, rotten people so they turn on each other. Eventually
crank repulsion will destroy almost any movement and a few decades will go by
before some new crank comes along and picks up the pieces anew, then they’re
like Rife machines! Let’s cure space-aids with electricity! The circle of life.

There’s not going to be much to cheer about for the next 4 years. But watching
MAHA turn on itself and the doctors they empowered will provide an opportunity
to kick back, pull out the popcorn, and enjoy the circular firing squad.


Our Medical Establishment In Power Versus Our Medical Establishment Out of Power

Now that they have power, Drs. Marty Makary, Vinay Prasad, and Jay Bhattacharya 
have different standards than they set for their predecessors.

Jonathan Howard on May 29, 2025

Link

Dr. Marty Makary

When Dr. Marty Makary was out of power, he excoriated his predecessors for
supposedly recommending COVID vaccines without a vote from vaccine experts. In
an article titled Why America Doesn’t Trust the CDC he wrote:

If the CDC is curious as to why people aren’t listening to its recommendations, 
it should consider how it bypassed experts to put the matter before a Kangaroo
court of like-minded loyalists. The Biden administration should insist that we
return to the standard process of putting all major vaccine decisions before a
vote of the FDA’s leading vaccine experts.

However, Dr. Makary didn’t follow this “standard process” once he had the power 
to restrict vaccines for healthy people under age 65. Along with Dr. Vinay
Prasad and RFK Jr., he simply decreed it, and according to the article CDC
Blindsided As RFK Jr. Changes Vaccine Recommendations:

Health and Human Services Secretary Robert F. Kennedy Jr.’s surprise
announcement Tuesday ending coronavirus vaccine recommendations for healthy
children and pregnant women blindsided the agency that offers that advice,
according to current and former federal health officials. Officials at the
Centers for Disease Control and Prevention are scrambling to understand
Kennedy’s decision, announced in a 58-second video on X on Tuesday morning,
which took agency staff by surprise.

Dr. Vinay Prasad

When Dr. Vinay Prasad was out of power, he blasted his predecessors for not
studying every COVID mitigation measure via an RCT for every variant and
demographic subgroup. “My philosophy is RCT or STFU” he said in his typical
juvenile manner. Dr. Prasad created long lists of unwanted mitigation measures
and then claimed they were useless because other doctors hadn’t demonstrated
their value in a massive RCT.

Now, that he is in power and is expected to generate evidence for the American
public, Dr. Prasad created yet another medical reversal. During a recent
conversation with Dr. Makary about talc, which is grave danger to the American
public according to our medical establishment, he decided that, except for
vaccines, RCTs are no longer needed to guard against potential harms. “This is
just a simple teaching point,” he said, explaining why no one should expect him 
or anyone in the new medical establishment to do any RCTs. “RCT or STFU” was for
other people.

Dr. Jay Bhattacharya

When Dr. Jay Bhattacharya was out of power, he accused others of working for a
“censorship regime.” This was entirely about the fate of social media content,
some tweets and a YouTube video.

Now that he is in power, Dr. Bhattacharya has no problems working for an
administration responsible for these headlines: RFK Jr. Threatens To Bar
Government Scientists From Publishing In Leading Medical Journals, Medical
Journals Hit With Threatening Letters From Justice Department, and Top NIH
Nutrition Researcher Quits, Citing Censorship Under Kennedy.

And thus, it becomes clear. Aside from their anti-vaccine agenda, the only
principles guiding our medical establishment are their own power and
advancement. I also call it like I see it.


Our Medical Establishment is Flailing

It’s impossible to keep track of it all.

Jonathan Howard on June 6, 2025

Link

RFK Jr’s Team Adds New Errors To Its ‘MAHA’ Report, Making The Fiasco Worse

Writing for SBM these days is a bit like being in one of those cash grab
machines, though instead of money flying over the place, it’s bees and wasps.
Every week brings a fresh round of horrors that reveals our medical
establishment is flailing and in deeply over their heads. It’s impossible to
keep track of it all.

According to the article MAHA Report On Chronic Disease In Us Kids Includes Fake
Citations, Other Errors:

But the footnotes contain multiple errors. The false citations, first reported
yesterday by the news site NOTUS, include non-existent studies on anxiety in
adolescents, the impact of direct-to-consumer advertising on the prescribing of 
ADHD and antidepression medication for children, and overprescribing of oral
corticosteroids in children with asthma. Additional reporting by the New York
Times and the Washington Post found citations listing the wrong author,
published papers with the wrong journal listed, and inaccurate summaries of
correctly cited papers.

The Post also found that several citations appear to have been generated by
artificial intelligence

“This is not an evidence-based report, and for all practical purposes, it should
be junked at this point,” American Public Health Association Executive Director
Georges Benjamin, MD, told the Post. “It cannot be used for any policymaking.
It cannot even be used for any serious discussion, because you can’t believe
what’s in it.”

That was followed-up by an article title RFK Jr’s Team Adds New Errors To Its
‘MAHA’ Report, Making The Fiasco Worse that said:

It seemed hard to believe this debacle could get worse, but it did. NOTUS
reported in a follow-up article that several of the errors from the original
report have been edited or removed, but in the process, administration officials
have added new errors, including updated citations that “misinterpret
scientific studies.”

Undeterred by this embarrassing debacle, our medical establishment plans to use 
AI at the FDA. According to the article FDA Rolls Out AI Tool Agency-Wide, Weeks
Ahead Of Schedule:

FDA employees characterized the launch of the AI, called Elsa, as “rushed” and
expressed concern the agency is both over-inflating its capabilities and failing
to set guardrails.

Two employees familiar with the situation, speaking on condition of anonymity
for fear of retribution, told STAT that the tool is based on Anthropic’s Claude 
LLM and is being developed by consulting firm Deloitte. They also said that the 
tool has only been piloted in text summarization use cases, such as summarizing 
meeting minutes, and should only be used for daily administrative tasks, not
scientific ones.

“I’m not sure in their rush to get it out that anyone is thinking through policy
and use,” one employee said.

“Makary and DOGE think AI can replace staff and cut review times, but it
decidedly cannot,” the employee added, referring to the cost-cutting U.S. DOGE
Service. The FDA has cut thousands of employees since the new administration
began, and employees with AI knowledge have been particularly hard-hit.

We can all hope Elsa works, but there’s no reason to think that our bumbling
medical establishment will catch any errors it might make.

He’s so terrible during this interview that Brennan is left shaking her head as 
she wraps it up.

In addition to touting untested AI as the FDA’s savior, Dr. Marty Makary is
using his influence and authority to protect Americans from the grave dangers of
seed oils, talc, and COVID vaccines. He gave a cringeworthy interview to Face
the Nation, prompting journalist Aaron Rupar to say:

Margaret Brennan totally exposes FDA Commissioner Makary for making it up as he 
goes and making conflicting recommendations in order to cast doubt on covid
vaccines. He’s so terrible during this interview that Brennan is left shaking
her head as she wraps it up.

I encourage you to watch the whole thing.

In the interview, Dr. Makary called the latest COVID variant “the common cold,” 
just like he did with Delta and Omicron. With his typical childishness and
unprofessionalism, he called the Advisory Committee on Immunization Practices
(ACIP) a “kangaroo court,” and falsely said there is “no clinical data” on the
COVID vaccine for children. Dr. Makary posted a clip on social media where he
said:

We’re getting away from these blanket recommendations for healthy young
Americans. We don’t want to see kids kicked out of school because a 12-year-old 
girl didn’t get a fifth COVID booster shot.

Children aren’t being kicked out of school for not getting a fifth COVID booster
shot. Dr. Makary just made that up. That’s what he does. In contrast, some
children are missing school because of Long COVID. Our medical establishment
doesn’t care about them, however.

Dr. Makary also pointed to the vaccine’s unpopularity as a reason to ban it for 
heathy children, though of course his deluge of misinformation regarding
pediatric COVID is likely a reason why many parents decline the vaccine. Ms.
Brennan wisely responded by saying:

I don’t want to crowdsource my health guidance. You don’t go with popularity,
you go with data.

Ms. Brennan cited data that COVID is not benign for all children, including some
healthy ones, prompting Dr. Makary to claim that you can’t trust the CDC, a
disingenuous talking point I discussed here 4 years ago.

Ms. Brennan also pointed out that Dr. Makary had previously listed pregnancy as 
a risk factor for severe COVID, and he had no explanation as to why, along with 
RFK Jr. and Dr. Jay Bhattacharya, he planned to stop recommending the vaccine
for this population. In 2023, Dr. Makary spread doubt about the COVID vaccine in
pregnancy, writing articles such as Was the COVID Vaccine Safe for Pregnant
Women?– spoiler alert, it was.  However, during his interview, Dr. Makary
claimed that articles such as this had nothing to do with low vaccination rates 
in pregnant women.  Rather Dr. Makary said this was “probably because they want 
to see randomized trial data.” Dr. Makary presented no data to support his claim
that obstetricians’ offices are full of patients demanding RCTs. “When do they 
get the data you are promising,” Ms. Brennan asked. Dr. Makary had no answer.
Our medical leaders don’t feel it is their job the generate neutral, independent
data for the American public.

Dr. Vinay Prasad faired no better when he stepped outside of his safe space.
According to journalist Sarah Karlin-Smith, during a recent meeting Dr. Prasad
was asked about the headline RFK Jr May Block Government Scientists From
Publishing in Top Medical Journals. That prompted this exchange:

He says one of Kennedy’s issue is he wants govt papers publicly available –
someone in audience yells out this has been policy for 20 years.

Unfortunately for Dr. Prasad, he can’t block his critics in the real world.

Dr. Prasad also continues to create medical reversals regarding RCTs. Though he 
wrote an essay in 2023 titled The Scientists Who Undermine Randomized Trials,
now that he has responsibility for the first time, he sounds just like those
dastardly scientists. “There have been several examples of scientists trying to 
undermine randomized trials— arguing they are not possible, not practical, or
not useful. All of these arguments are false” he wrote back then. “My philosophy
is RCT or STFU” he said. Yet today, when discussing rare diseases, he said,
“Randomized trials are not always feasible, possible, or practical.”

Full video here  

RFK Jr. Says Matthew Buzzelli, A Lawyer With No Public Health Experience, is the
Acting CDC Director

Things are not also going well at the CDC, where the ineptitude and political
interference of our medical establishment is leading to resignations. According 
to the article CDC Official Overseeing COVID-19 Vaccine Recommendations Resigns:

A Centers for Disease Control and Prevention official said Tuesday she was
resigning from her role overseeing updates to the agency’s COVID-19 vaccine
recommendations, following an order by Health and Human Services Secretary
Robert F. Kennedy Jr. to force an update to the agency’s guidance.

“My career in public health and vaccinology started with a deep-seated desire to
help the most vulnerable members of our population, and that is not something I
am able to continue doing in this role,” Dr. Lakshmi Panagiotakopoulos wrote in
an email to the COVID-19 vaccines work group in the agency’s Advisory Committee
on Immunization Practices (ACIP)…

“More of us should be resigning in protest,” one federal health official told
CBS News, in response to the news of Panagiotakopoulos leaving her role.

Of course, it’s not really clear who is even running things at the CDC as Dr.
Jeremy Faust wrote in his article RFK Jr. Says Matthew Buzzelli, A Lawyer With
No Public Health Experience, is the Acting CDC Director. This may be a good
thing, however. As the article CDC Contradicts RFK Jr. on COVID Vaccine for Kids
explained, science-based employees there appear to be trying to stand against
anti-vaccine sentiment at other HHS agencies. Good for them.

“Out Of His Depth,” “Sold His Soul,” “Clueless”: NIH Staffers Speak Out About
Director Bhattacharya.

The NIH is faring no better. Some recent headlines are: Here Are the Nearly
2,500 Medical Research Grants Canceled or Delayed by Trump, As the Trump
Administration Slashes Federal Spending, Scientists Consider Leaving the U.S., A
Harvard Scientist Built A Database Of 2,100 NIH Grant Terminations. Then His
Own Funding Was Cut, and Why Trump’s Push For ‘Gold-Standard Science’ Has
Researchers Alarmed. Further budget cuts are promised as reported in the
article, White House Proposes Deep Cuts to HHS in FY2026 Budget, Reducing NIH to
8 Centers.

DOGE seems to be running the show there as described by the article NIH Killed
Grants on Orders From Elon Musk’s DOGE and The Shrewd Startup Founder Who Led
DOGE’s Cost-Cutting at HHS. In an interview with Science, the man who
purportedly heads the NIH, Dr. Jay Bhattacharya, refused to accept
responsibility the chaos and purges there, saying “I had nothing to do with it… 
It’s not me personally… Those decisions are not up to me.”

Journalist Walker Bragman published two devastating articles revealing how Dr.
Bhattacharya is perceived by NIH staffers. The first article, “I Believe It”:
Bhattacharya Pushes Lab Leak Conspiracy At Contentious NIH Town Hall As Staffers
Walk Out, shows dozens of NIH staffers walking out as his town hall. They also 
refused to applaud him when he walked out. The second article, “Out Of His
Depth,” “Sold His Soul,” “Clueless”: NIH Staffers Speak Out About Director
Bhattacharya, said:

“It’s a total shit show,” one agency staffer told Important Context, explaining 
that Bhattacharya seemed unaware of how NIH operated when he arrived. They said 
he had been promising reforms that were already part of the agency’s work.

“His attitude coming in has just been so condescending, and so like, ‘Oh, we’re 
going to make NIH great’… and ‘we’re going to make… science transparent, and
we’re going to introduce all of these programs’ that, mind you, already exist,” 
the staffer said. “Like, these are things we actively do… You fired people that 
do those things that you say you want to do.”…

Insiders described Bhattacharya as “arrogant,” “in over his head,” “out of his
league,” “out of his depth,” “clueless,” “weak,” and “full of shit.” The NIH
director did not respond to our requests for comment.

“In some ways, I do feel vaguely sorry for him, because he is clueless, and he
clearly does not know what he’s doing,” one staffer said. “But he’s also
arrogant, and he thinks that he can just come in and tell us how to do our jobs,
when he has no idea how science actually works.”…

The program officer speculated that Bhattacharya might be relying on “a lot of
mental gymnastics to contort himself into believing he’s doing the right/best
thing,” but said it ultimately did not matter because “either way, he is at
fault.”

“No matter what he tells himself to sleep at night, people will suffer and
potentially die because of the policies he’s allowing at NIH under his
leadership,” they said…

Another said that while Bhattacharya had once been “respected,” “now he sounds
like a joke, an ignorant political hack, every time he speaks… he comes across
as someone who has sold his soul.”

You’re saying that Moderna is doing the study on their own product?

Meanwhile, now that he is the medical establishment and expected to produce
results for the American public, RFK Jr. suddenly decided that Big Pharma
vaccine-trials are just fine after all. He said:

I want to address those of you who have anxieties about @US_FDA’s limited
approval of a new mRNA COVID vaccine for high-risk populations. Moderna has
agreed to a true placebo-controlled trial of the new vaccine, which is similar
to the existing mRNA vaccine but uses a smaller protein.

Predictably, his anti-vaxx base was not impressed by this plan to have Moderna
study the Moderna vaccine. A woman by the name of Nurse Brenda said:

Excuse me sir, you used the wrong word. It’s not anxiety we are feeling. It’s
betrayal. You’re saying that Moderna is doing the study on their own product?
Without a true placebo? After being approved for our most vulnerable population?
And yet artificial food dyes are banned on a whim. Common sense is dead, it
seems.

Someone named Fiona Rose Diamond told RFK Jr.:

You’re a far cry from the man I spoke to in 2020-23. Back then, you called these
mRNA shots “murder.” Now, you’ve either changed beyond recognition – or you
were never the man I thought you were. Whatever conviction you once had, it’s
gone. You’ve sold your soul, and God only knows what they’re holding over you to
make you fall in line.

No one is satisfied with our medical establishment and thinks they are doing a
good job. This is what they have to look forward to for the next 3.5 years.

Unfortunately, the rest of us are along for the ride.


Mockies: Doctors Who Mocked My Warnings About MAHA in 2024 are Copying Me Today.
Good.

The dangers of Kennedy and crew were blindingly obvious. Yet some doctors sought
to bolster MAHA by undermining and discrediting those who warned about it.

Jonathan Howard on October 7, 2025

Link

Looking back on my output last fall, I was pretty much a one-tricky pony. Along 
with countless others, I desperately tried to warn people about Robert Kennedy
Jr. and his crew of disinformation doctors. My SBM articles were titled:

  1. Robert Kennedy Jr. & His Doctor Friends May Just Be Getting Started

  2. Trusting RFK Jr. to Research Vaccines is Like Trusting a Hungry Python to
    Babysit a Kitten

  3. We Want Them Infected Doctors Sanewashed Robert F. Kennedy Jr. Will He Reward 
    Them With Appointments at the CDC, FDA, and NIH?  

  4. Dr. Marty Makary, What Are You Going To Do If RFK Jr. Demands That You Revoke 
    Approval For Vaccines?

  5. A Simple Challenge For Drs. Vinay Prasad and Tracy Hoeg: Denounce Robert
    Kennedy Jr. For Promoting The Movie Vaxxed 3: Authorized to Kill

Wendy Orent and I similarly sounded the alarm on our podcast last year, with
episodes titled:

  1. RFK Jr.’s Controversial Moves and the Future of Anti-Vaccine Politics

  2. The Perils of Pandemic Revisionism: RFK Jr. and the Threat to Public Health

  3. RFK Jr., Big Pharma, and Disinformation

  4. Election-Eve Anxiety: What RFK Jr.’s Public Health Control Could Mean for
    America

  5. RFK Jr.’s Anti-Vaccine Appointments: A Dangerous Future for Public Health

  6. RFK Jr., Medical Misinformation, and the Fight for America’s Future

None of this was brilliant or particularly insightful. I wasn’t breaking any
news or uncovering any secrets.  The risks of Kennedy and MAHA doctors were
blindingly obvious and out in the open. They broadcast their intentions for all 
to see. I merely paid attention and cared about their threat. I pleaded with
others to do the same.  This was a major theme of We Want Them Infected.

I was also quoted in a New York Times article at that time titled Trump Picks
Stanford Doctor Who Opposed Lockdowns to Head N.I.H. In it, I pointed out that
Dr. Jay Bhattacharya “bungled basic facts” and provided one of countless
examples. In March 2020, Dr. Bhattacharya predicted COVID would kill fewer than 
40,000 Americans. Things didn’t work out that way.  I thought that this was
important, and that most people, especially doctors, would share my concern
about our future NIH director.

I was wrong about that.

However, the problem was worse than just “shruggies”, a term coined here by Dr. 
Val Jones to describe doctors who are indifferent to pseudoscience. I am sure
many doctors saw my repetitious articles about MAHA last year, rolled their
eyes, and quietly moved on. That’s fine. However, several doctors, let’s call
them mockies, went out of their way to humiliate and belittle those who
corrected disinformation. Their core function was to bolster MAHA by undermining
and discrediting those who warned about it.

None of this was mockery unique to me, and many others had it much worse. 
However, one particularly illustrative example comes courtesy of a doctor I will
call Dr. Mocky, who thought my warnings were funny, an opportunity to make
jokes and boost their social media profile. They posted a screenshot of my quote
in the New York Times with the following comment.

What grave sin had I committed to deserve this spiteful tirade? I must have
quoted Dr. Mocky’s friends and explained why I disagreed with them.  I don’t
recall interacting with Dr. Mocky before, and there was no semblance of a good
faith argument from them. Predictably, they didn’t bother to point out anything 
I had gotten wrong, and they never will. Data, science, and evidence didn’t
matter to them. 

According to Dr. Mocky, I lacked the qualifications to critique someone of Dr.
Bhattacharya’s immense stature. In their vision, a lowly “psychiatrist” who
worked on COVID units in NYC and had written volumes exposing medical
misinformation had no right to critique a health economist who made podcasts
from his office listing all the amazing things he “would have” done.  While I
was just some blowhard on a plane, Dr. Bhattacharya was a titan, capable of
running the entire industry.  

Elsewhere, Dr. Mocky insulted me- they called me “fringe”-  and then incredibly 
accused me of doing nothing but insulting people. Apparently my books and 200
articles here are just thousands of pages of me slinging slurs. Predictably,
they didn’t bother to provide any examples of that either, and they never will. 

While Dr. Mocky faked a concern about my decorum, they were utterly indifferent 
to the fact that Dr. Bhattacharya insulted people and bungled basic facts.
Although I handed Dr. Mocky evidence of Dr. Bhattacharya’s duplicity on a silver
platter and it was staring them right in the face in their own screenshot, none
of that mattered to them. They simply brushed away the difference between
40,000 and 1.2 million deaths as my “strong feelings”. There were countless more
such examples of Dr. Bhattacharya absurdly minimizing COVID and spreading
obviously fake statistics. Dr. Mocky didn’t care at all. The countless real
people who suffered and died as a result of COVID disinformation didn’t bother
them in the slightest.  

The only thing that bothered Dr. Mocky about Dr. Bhattacharya’s plan for herd
immunity via natural immunity and his blatant anti-vaccine disinformation was
that I sought to counter it.   There was literally nothing I could have said to 
get them to take any of this seriously. It was all just a Twitter game to them, 
and they couldn’t seem fathom that some of us actually took medicine seriously
and cared about the victims of disinformation.

Fortunately, I’ll never meet any mockies, and I’ll survive their juvenile japes.
Of course it was decidedly unpleasant to be greeted with a deluge of childish
behavior from my peers for the sin of trying to alert them, which was their
goal. Mockies wanted to make me feel rotten, wear me down, and ultimately get me
to stop publicly criticizing MAHA doctors.

However, the problem isn’t that they were insulting and denigrating me, the
problem is that they were insulting and denigrating my warnings.  I wrote
serious articles- read them yourself- warning the world that Kennedy and his
crew were dangerous, and mockies told the world I was a “dishonest, nasty and
woefully ignorant” psychiatrist who spews “COVID hysteria nonsense” and
“ridiculous sensationist hyperbole”.  I brought facts, they brought grievance
and emotions.

Worst of all, they taunted me- and again, none of this was unique to me-
specifically to elevate and protect doctors who fluffed Kennedy. At the same
time I was begging people to pay attention to Kennedy’s threat, Dr. Bhattacharya
was singing his praises, glorifying him as the savior of American medicine and 
science. Dr. Bhattacharya had already spoken at one of Kennedy’s presidential
rallies, and in his article RFK Jr. Will Disrupt the U.S. Medical Establishment 
from November 2024 he said:

The American public voted for disruptors like RFK Jr in 2024, and academic
medicine now has an opportunity to atone for its Covid-era blunders. If it
engages constructively, it can participate in crafting and implementing reforms 
that would, indeed, make America healthy again.

As with COVID disinformation, Dr. Mocky wasn’t the slightest bit bothered by
this. In fact, Dr. Mocky specifically tagged Dr. Bhattacharya to let him know he
had his back.

Dr. Mocky also collaborated with Dr. Vinay Prasad last fall, back when he was
writing gems such as Sabotaging RFK Jr’s Confirmation Will Increase Vaccine
Hesitancy.  While Dr. Mocky said my warnings were “fringe,” he never objected to
Dr. Prasad’s vulgar MAHA/MAGA propaganda. That silence also sent a message.

Author note: My YouTube channel is back!

Today, in addition to the purges, censorship, attacks on universities, and
banned words, MAHA doctors are integral to Kennedy’s efforts to dismantle
vaccines in the U.S. Thanks to their efforts, Dr. Andrew Wakefield is taking a
victory lap. I’m glad that I at least tried to stop these malevolent actors.
Mockies can’t say that. When medicine and science were under attack, they rolled
out the red carpet.

My recent writing has been a record of how we got to this sad moment, and
mockies are part of that story. Their collective mockery played a role in
numbing people to a dangerous threat, and I don’t need their permission to
merely remember that. It wasn’t that long ago, and no one forced them to behave 
this way.  They chose to shield MAHA doctors. Obviously, in the scheme of things
Dr. Mocky’s single Tweet was a speck of dust, forgotten by everyone except me. 
However, there was a whole class of such influencers, who may not have spread
disinformation themselves, but nonetheless berated those who warned about it
with content-free taunts all just to preen on social media.

I also can’t help but wonder if things might have turned out differently had
more doctors had behaved with a modicum of professionalism and simply cared
about obvious disinformation when we had a chance to contain it. What if more
doctors reacted to Dr. Bhattacharya’s prediction of 40,000 COVID deaths with
shock and concern, instead of calling me a dumb dumb stupid head?  What if these
doctors had joined me, and many others, in sticking our necks out and taking
risks to warn about MAHA?  What if we had presented a unified front to oppose
disinformation?

Sadly, we’ll never know.

I also wrote several articles last fall discussing the many doctors who had
enabled MAHA doctors to that point.  They were titled:

  1. Anyone Who Supports Pro-RFK Jr. Doctors, Is Also Pro-RFK Jr.

  2. If You Sanewashed RFK Jr., Or If You Sanewashed Doctors Who Did, You Own the
    Next 4 Years, 

  3. If RFK Jr. Turns the CDC Into An Anti-Vaxx Propaganda Outfit, I Don’t Want To 
    Hear a Peep From Some “Respectable” Doctors

That last article said:

Hopefully Mr. Kennedy will never gain power. It’s bad enough that it’s a real
possibility. However, if it happens, I don’t want to hear a peep out of some
doctors.

I’ve done some thinking and changed my mind about that.  Although doctors
weren’t unified before, maybe we can be today. We should all work together to
oppose MAHA in any way we can. I won’t complain today, when they regurgitate our
warnings from before. Indeed, Dr. Mocky is saying things like this in 2025. 
Better late than never, I guess.

Mockies might even be useful today in a way I cannot. Unfortunately, another
article from me exposing MAHA won’t move the needle an inch. After all, a lot of
people think I am just a random fool on a plane. Doctors who previously
volunteered as defense attorneys for MAHA and have just now realized its risks, 
have no unique insights and nothing to teach those of us who recognized the
danger long ago.  However, after years of willful blindness, mockies’ newfound
opposition to the forces they previously championed might send an important
signal:  If even the doctors who laughed at COVID disinformation and its victims
are concerned, something must be seriously wrong.  

So while I encourage mockies to speak out today, I also feel they should do
something they’ve obviously never done before and actually read my writing, or
that of anyone who warned about MAHA previously.  We’ve done the hard work for
them, and if they honestly care about standing up for science and medicine, they
need to learn everything they’ve deliberately ignored the whole time.  I bet
they won’t find any of it funny. No one who has actually read my books has said 
laughed at them.


r. Vinay Prasad: Bodily Autonomy Applies to Raw Milk, Not Vaccines

This is what it looks like when disinformation doctors pretend to value data and
science to further their true objective, MAHA politics.

Jonathan Howard on July 4, 2025

Link

Robert F. Kennedy’s Point Is, He’s a Believer in Bodily Autonomy

Back when he was auditioning for his current role at the FDA and had to fluff
RFK Jr., Dr. Vinay Prasad recorded a video extolling the right of people to
drink law milk. The risks were “very low”, he said. The 7 in 100,000 risk was
“on par with risks we allow people to take every single day.” At least when it
comes to raw milk and vaccine-refusal, RFK Jr is a believer in “bodily
autonomy,” Dr. Prasad said. Raw milk lovers needed no justification for beyond
liking the taste.

Top F.D.A. Official Overrode Scientists on Covid Shots

Dr. Prasad’s gave a compelling performance and landed the role. Today, however, 
Dr. Prasad no longer believes in bodily autonomy, at least for those of us who
want COVID vaccines. On his own, in memos that he didn’t share with the American
public, Dr. Prasad made that decision on his own. According to the article Top 
F.D.A. Official Overrode Scientists on Covid Shots:

The Food and Drug Administration’s top vaccine official rejected broad uses of
two Covid vaccines, citing unknown risks or injuries despite assurances of
safety from dozens of staff experts, newly released documents show.

The decisions by the official, Dr. Vinay Prasad, the agency’s new chief medical 
and scientific officer, stunned agency veterans. Records show that the F.D.A.’s 
vaccine staff members had signed off on approving the Novavax vaccine, an
alternative to mRNA shots and weeks later on the next-generation of the mRNA
Covid shot by Moderna for anyone 12 and older.

Dr. Prasad overruled those recommendations by the end of May and instead advised
restricting the use of both Covid vaccines…

“Even rare vaccination-related harms, both known and unknown, now have a higher 
chance of outweighing potential benefits in non-high-risk populations,” he wrote
in the documents overriding the staff members on the Novavax shot…

About 30 staff scientists at the F.D.A. signed off on giving approval to the
Novavax vaccine for anyone 12 or older on March 28, according to the newly
released documents. Records show that they reviewed several studies, including a
clinical trial of the vaccine involving 30,000 people, and a safety database
with 45,000 adults and adolescents who got the vaccine.

In the large study, there were three cases of myocarditis within two weeks of
the second dose, compared with one case in the placebo group.

In a video explaining his decision to use his power to limit vaccines for
millions of Americans, Dr. Prasad cited a rate of vaccine-myocarditis of 8 per
1,000,000 overall and 27 per 1,000,000 for males age 12-24. This equates to a 1 
in 37,000 risk for this population, though Dr. Prasad expressed great concern
about late gadolinium enhancement on cardiac MRI and its potential harms in the 
future. I guess he feels we know everything about repeat COVID infections and
have no reason to at all worry about them.

Setting The Record Straight: There Is No ‘Covid Heart

Notably Dr. Prasad had previously discussed this late gadolinium enhancement in 
his article Setting The Record Straight: There Is No ‘Covid Heart’. Would you be
surprised to learn, he was unconcerned about it? When it came to COVID, he
said:

Even in the sickest of the sick, Covid-19’s effect on the heart appears to be
modest. A London-based team reported on a series of 148 patients who had
recovered from severe Covid-19. Cardiac magnetic resonance scans done during
convalescence showed that nearly half of the individuals had no major heart
abnormalities, and 9 out of 10 had normal heart function. These
researchers coined a new phrase for myocarditis seen on cardiac magnetic
resonance scans: they called it a myocarditis-like pattern because “we do not
know what is causing this.”

To sum up: The issue of Covid-19 induced cardiac problems was massively
overblown.

“People who have recovered from Covid-19 have no special reason to worry about
their hearts,” he concluded.

In reality, COVID myocarditis killed some young men, in contrast to the vaccine,
though COVID’s risks were never limited to myocarditis. However, while Dr.
Prasad was very worried about an MRI finding in people who feel fine with the
vaccine, he was quick to dismiss literal death from COVID as “rare anecdotes”.
According to our medical establishment, worrying about dead children is
“breathless,” while worrying about MRI abnormalities is “evidence-based.” This
is a continuation of a pattern I discussed previously where Dr. Prasad expressed
much more concern about abnormal lab values after vaccination than actual death
from COVID.

“Don’t Trust the Old FDA, Trust Us”

So let’s be clear what is happening here. When it comes to the COVID vaccine,
Dr. Prasad feels cardiac MRI abnormalities are “not a benign clinical finding”. 
With COVID, he said these exact same MRI abnormalities are “massively
overblown.” With raw milk, Dr. Prasad feels people have the right to bodily
autonomy, and that a risk of 70 per 1,000,000 is “very low.” With the COVID
vaccine, a risk of myocarditis of 27 per 1,000,000 only for young males, is
enough for him to ban the vaccine for every healthy person under age 65. These
people do not have the right to bodily autonomy. Even though the only risk I
face from a vaccine is a sore arm, the government, specifically Dr. Prasad,
feels entitled to impose his will on my medical freedom.

This is what it looks like when disinformation doctors pretend to value data and
science to further their true objective, MAHA politics. At least this is is
obvious to everyone to everyone now. On social media, podcasts, and readers’
comments, Dr. Prasad is rightly getting roasted by respected doctors- those who 
actually treat sick children- for his unscientific, medical authoritarianism. As
Dr. Paul Offit wrote in his article “Don’t Trust the Old FDA, Trust Us”:

By limiting use of the Covid vaccine to only those less than 65 who are in
high-risk groups, Makary and Prasad will make Covid vaccines less likely to be
insured and, therefore, less available for young people who have legitimate
reasons for receiving the vaccine. By requiring placebo-controlled trials before
licensure, they will likely make Covid vaccines more expensive. And by
insisting that both Pfizer and Moderna include a new, broader warning about
myocarditis on their label, they will make the vaccine more feared. This new
warning comes without the context that myocarditis following vaccination—in
addition to being self-limited, transient, and generally benign—has
virtually disappeared. Makary and Prasad are solving a problem that doesn’t
exist.

Dr. Prasad has picked up some new fans however. The makers of the movie
Plandemic are thrilled with his performance. That’s his tribe now and will be
for the rest of his career.


As Trust in our Medical Establishment Justifiably Collapses, They Are Making
Cheerful Propaganda Podcasts From Their Safe Spaces

Some of us believe in civil debate and discussion, even though Drs. Vinay
Prasad, Marty Makary, and Jay Bhattacharya do not.

Jonathan Howard on June 27, 2025

Link

In 2021, Dr. Vinay Prasad wrote an article titled At a Time When the U.S. Needed
Covid-19 Dialogue Between Scientists, Francis Collins Moved to Shut It Down. In
it, Dr. Prasad spoke about the value of “public dialogue between scientists”
and said that Dr. Francis Collin, then the head of the NIH, had an obligation to
have hosted “series of public discussions and dialogues” with advocates of herd
immunity via mass infection. “It is possible that through the heat of dialogue,
weak premises of the argument for focused protection might have been revealed,”
Dr. Prasad wrote.

Things are very different today. Dr. Collins is on the outside, giving
interviews titled Former NIH Chief Calls Research Cuts “Careless” and
“Heartless”. His replacement Dr. Jay Bhattacharya is reviled by NIH employees
and facing a mutiny about his censorship there. Instead of responding to their
concerns, Dr. Bhattacharya launched a quick and devastating takedown of a brave 
scientist who had the integrity to speak up about how NIH cuts are upending his 
cancer trials. So much for promoting a culture of dissent.

At the FDA, Dr. Marty Makary seems to be interfering with drug approvals for
political reasons and experienced professionals are being purged or resigning.
Even the staid BMJ published an article titled Appointment of FDA Critic Vinay
Prasad to Senior Role in Agency Prompts Departures. Fearful staff who remain
report that Dr. Prasad seems bored by his job when the cameras are off.
According to one news report:

Multiple agency employees, who requested anonymity to protect against
retaliation, told STAT that Prasad seemed uninterested in the administrative
work of being a center director. One CBER agency official said Prasad rarely
attends center meetings with office directors, and that their questions about
the budget, HR functions, and IT systems have gone unanswered. Prasad did not
consult career staff before unveiling a new regulatory framework for Covid-19
vaccines with Makary in May.

Meanwhile, at the rudderless CDC, vaccines are predictably under attack.
Responsible medical groups are looking to bypass the corrupted ACIP and form
their own science-based vaccine policies. Yet, Dr. Prasad, our chief vaccine
regulator, has nothing to say about any of this. Neither do Drs. Makary and
Bhattacharya.

Source: Acting CDER Head Becomes Latest in String of FDA Leaders to Leave Agency

Trust in our medical establishment is justifiably collapsing, however you
wouldn’t know any of this this from listening to the podcasts and videos they
are churning out. Drs. Makary and Prasad put out a regular program on X and Dr. 
Bhattacharya recently started his own podcast. Cheer and mirth abound and
everyone agrees each other. Amazing things are happening and everyone is happy. 
During the inaugural episode, Dr. Bhattacharya said:

Our goal is to support young scientists from all communities around the entire
country of the United States.

In reality, according to one young NIH scientist, in addition to terminating
their grants, Dr. Bhattacharya refuses to even meet with them.

Similarly, Dr. Makary repeated MAHA buzzwords in the typical drone-like fashion 
and recently said:

We’re combining efficiency and gold-standard science to ensure the U.S. remains 
the global leader in advancing medical cures.

Our medical establishment rose to fame saying everything was fine as COVID
overwhelmed morgues and hospitals. They are now doing the same thing with the
public health agencies they lead. Falsely reassuring people about grave threats 
is their greatest skill. The only difference is that they are no longer just
spouting off on social media and Fox News. They are creating state-sponsored
propaganda programs with our tax dollars.

While their disinformation fooled many people with COVID, it’s not working these
days, however. No one believes that everything is just fine at the NIH, FDA,
and CDC. The incompetence of our medical establishment is on full display every 
day, and the only way for them to restore trust is to take Dr. Prasad’s advice
and host a series of “public discussions and dialogues” with people who won’t
prioritize their feelings by reflexively praising their every utterance. The
American public deserves honesty and transparency from our medical
establishment, even if that requires them to venture outside their safe space
and answer a couple tough questions from time to time. They are welcome on my
podcast anytime, where Wendy Orent and I will treat them kindly and
professionally.

Some of us believe in civil debate and discussion, even though Drs. Prasad,
Makary, and Bhattacharya do not.


Read the Comments: “Just Do the Opposite of Whatever This Administration
Recommends!”

It’s obviously not good that people have lost trust in the FDA, NIH, and CDC.
However, since those once vulnerable institutions are now lead by naked
emperors, it’s good that the American public, at least those that read the news,
has uniformly recognized they have no clothes.

Jonathan Howard on November 29, 2025

Link


Our medical establishment rose to by power telling the American people that
Public Health Should be Distrusted and by claiming that they had the secret
sauce to “restore trust.” However, three recent articles show the leaders of the
FDA, NIH, and CDC have completely and justifiably lost the trust of the
American people.

Prasad is a very very dangerous and foolish man.

The first article was titled FDA to Impose Strict New Vaccine Requirements,
Claiming Child Covid Shot Deaths, which said:

The nation’s top vaccine regulator on Friday laid out a stricter approach for
federal vaccine approvals, citing his team’s conclusion, without detailing the
evidence, that coronavirus vaccines had contributed to the deaths of at least 10
children.

I didn’t read all 1,850 comments, but of the several hundred I read, 100% were
like this:

  1. The FDA has become increasingly unreliable. They now formulate a theory/
    conspiracy, and manufacture evidence to fit their agenda.

  2. The FDA is now setting the US up to lose tens of millions dead if the wild
    type bird flu mutates or recombines to spread human to human. Prasad is a
    very very dangerous and foolish man.

  3. “I remain open to vigorous discussions and debate,” Prasad wrote to his team, 
    adding that staff who did not agree with the core principles of his new
    approach should submit their resignations.” Hey Dingbat, you contradict
    yourself in this statement. I don’t love that you are in charge of anything 
    important.

  4. So, more people will die from preventable diseases because of some arbitrary
    bias of anti-vaccination nut-jobs. I’m grateful I have the resources to
    travel to Canada and/or Mexico and just pay for my vaccinations out of
    pocket. But, of course, the majority of Americans don’t have that option.
    What a sad place this country has become.

  5. Not only will more children needlessly contract or even die from Covid, due to
    lack of vaccination, but also, unvaccinated children will spread more Covid
    to their families, caregivers, teachers, classmates. Those cases will
    include cases in vulnerable people who then will die or suffer lasting
    damage, rack up vast medical bills, lose earning potential take up hospital 
    beds….This regime dies not understand how public health works. Worse, it
    does not care to know. Terrifying.

  6. I’m glad this guy wasn’t in charge when Covid hit. Millions would have died
    waiting for his slow-down-and-die approach to vaccine development and
    approval. Unfortunately, in his short tenure he has managed to do lasting
    damage to the process.

  7. CDC and FDA have tainted leadership who aren’t worthy of trust. Prasad is one 
    of them.

  8. this nightmare of trump and his cabinet needs to end. I read this stuff and am
    infuriated that these quacks and cruel people are allowed to operate the
    way they do.

  9. We must demand the proof relied upon for claiming the vaccine killed 10
    children. Vinay Prasad’s unsubstantiated claim is meaningless.

  10. This is what happens when you have a government that no longer depends upon
    experts. It’s so frustrating. We look like a bunch of idiots in this
    country. More than that many children are going to die because of this.

  11. How many deaths were the result of NOT being vaccinated?

  12. These loonies won’t be satisfied until we go back to using leeches to draw out
    the bad humours from patients.

  13. To think Covid vaccine is any more dangerous then the many other ultra safe
    childhood vaccines is so absurd I just want to reassure non medical folks
    please use the American academy of pediatrics recommendations for vaccines. 
    It is evidence based. Like it says in this article, these Trump appointees
    beliefs are not taken seriously at medical conferences

  14. This is untethered to any verifiable fact and misinformation. Kennedy and his 
    coven need to exit.

  15. If this team had been in charge in 2020, the death toll would have been
    unimaginable. I’m probably alive today because there were still people in
    the FDA and CDC then who believed in science. God help us if we get another 
    pandemic with a government that actively opposes vaccines and masks.

  16. I think the federal government is attempting to interfere with decisions that 
    should be made jointly by licensed doctors and parents of children. This is 
    the BIG GOVERNMENT that Trump and MAGAs claimed to oppose.

  17. Science denying fruitcakes. It’s no difference from a shoe salesman doing
    surgery on your feet. We still have 3 years, and 2 months left of Trump’s
    administration, and I wonder if we can survive.

  18. Nothing short of banning all vaccines is RFKjr’s goal. The best way to achieve
    it is to link each vaccine to at least one death the vaccine allegedly
    caused. Even “I vaccinated my child and the next day she drowned in the
    neighborhood pool” will do.

Batthacharya couldn’t carry Faunci’s water.

The second article was titled We Can’t Diet and Exercise Our Way Out of the Next
Pandemic. It said:

In the event of a sudden pandemic, what should we do? This month, Jay
Bhattacharya, the director of the National Institutes of Health, offered a
remarkably blunt answer: nothing.

I didn’t read all 587 comments, but of the several hundred I read, 100% were
like this:

  1. OK. America should not expect doctors, nurses, techs and other staff at the
    hospital to show up to work and risk their lives unsupported.

  2. RFK Jr.’s rhetoric about essentially, survival of the fittest—amounts to
    something more troubling than policy debate. It increasingly feels like a
    quiet endorsement of a system that lets the weakest among us fall through
    the cracks. I’m not saying there’s a secret plan. But I do wonder whether
    neglecting the vulnerable isn’t a flaw in the system—but the point of it.

  3. Yeah, the “just-be-a-healthy-individual” prescription worked so well during
    the Spanish Flu epidemic of 2018, which killed over a half million in the
    U.S. The virus targeted the young and healthy. I remember my grandfather
    telling me that a classmate could be in school one day, and dead and gone
    the next during that time.

  4. I can only hope that there is no significant medical emergency in the next
    1146 days == the duration of this administration’s anti-health,
    anti-prevention, anti-people perspective.

  5. Someone should remind these MAHA geniuses that the 1918 influenza pandemic
    preferentially killed those with the strongest immune systems. Because the
    virus had undergone a major antigenic shift our immune systems overreacted
    to it, causing sudden death in previously healthy young people.

  6. As a very fit and strong athlete eating healthy at 44, I was still struck by
    aggressive cancer. To assume a person maintaining excellent health will be
    protected from disease is nuts. Yes, it’s true that many people should try a
    bit harder for a healthy lifestyle. It’s also true that our food industry
    can push the worst foods into the market and the chemical industry can
    produce pretty much whatever they want and we all live in a world of
    environmental toxins. There’s already a lot of headwinds for our bodies to
    overcome, and now we’re supposed to fight off a pandemic disease by simply
    being “healthy”? The ignorance is beyond comprehension.

  7. This horrible pandemic slaughtered millions of perfectly healthy older
    Americans. I had a friend, a farmer, who was in very good shape, worked
    outside everyday, die from COVID after weeks in the hospitial. He got it
    teaching school in person, not weeks before the vaccine was available. These
    people do absolutely nothing but lie for their own self-aggrandizement and 
    probably profit (certainly profit for RFK Jr.). They could care less how
    many people their policies kill. I don’t believe that Bhattacharya believes 
    anything that he is saying right now. I guarantee he’ll be socially isolated
    at the next pandemic, and he’ll get the vaccine asap. This man is not
    stupid. He knows he’s full of nonsense. No one should ever fall into the
    trap of believing any of these shill believe in anything. They believe in
    what they can sell to gullible people who will make them richer and more
    powerful. That’s all there is to it. Trying to converse with such people
    rationally is a complete waste of time. I think that it is absolutely
    essential that we stop giving any of these people the benefit of the doubt. 
    They don’t believe the nonsense they blather. They could care less about
    America or the American People. They care about their own
    self-aggrandizement, and their own treasure. They are nothing but shills,
    and it is completely obvious when you listen to the constantly evolving word
    salad they spew.

  8. To be able to treat and recommend prevention methods for an infectious agent, 
    it is necessary to know what it is and where it is. The Trump Administration
    has basically destroyed the early warning systems for infectious agents
    that have been in place for decades. Imagine the United States deactivating 
    our early warning systems to warn us of a nuclear attack. The US has
    withdrawn from the World Health Organization, a critical sentinel that is
    part of the early warning system. The Centers for Disease Control and
    Prevention has lost 30% of its staff since the Trump Administration took
    over. State and local health departments have been severely impaired because
    of funding reductions and anti-public health sentiment. Hate is not a
    solution but if that’s all that remains in our collective public health
    sensibilities, then COVID could very well have been a small blip compared to
    what is possible in the future.

  9. So the new official approach is to assume that the next pathogen will cull the
    population of the aged and people with chronic illnesses? And that the
    young and healthy will survive? What if the next pathogen is one like that
    of the 1917 influenza epidemic? I seem to recall that one of the points that
    was made in the classic account of this pandemic was that the young and
    healthy fared at least as badly, if not worse. Soldiers were dying like
    flies and then spread the disease to the civilian population. How fast one
    forgets history!

  10. I’m a retired pediatrician who has experienced taking care of severely ill
    children and children who have died from terrible illnesses. Those of us who
    have experience dealing with dead bodies and their aftermath have a much
    more realistic viewpoint about taking care of each other. It’s great to have
    a sunny viewpoint that all of us should be able to survive while being
    happy and healthy. But life isn’t like that. Very difficult and ugly things 
    happen to good people all the time. When we have people like Batthacharya
    espousing these Ozzie and Harriet like warm and fuzzy pictures, I think it’s
    time they should be rehabbed into the soft underbelly of humanness, having 
    them spend serious time wiping up feces and vomit when good people become
    ill. A few months in the ICU and CCU bringing bodies to the morgue and then 
    taking care of the family’s’ aftermath should help turn around the sunny
    viewpoint that their magical thinking will not cover the bases. Life is
    difficult and not all bodies are made for the rigors of trying to reach the 
    mathematical life span. Anthony Fauci understood that life is both beautiful
    and cruel. He got us through the AIDS epidemic as well as anyone possible. 
    Batthacharya couldn’t carry Faunci’s water.

This is shameful. Andrew Wakefield’s fraudulent writings have been thoroughly
discredited by real scientists.

The third article was titled CDC in Turmoil After Agency Backpedals on Rejecting
Vaccines-Autism Link. It said:

The Centers for Disease Control and Prevention revised its website to contradict
the long-settled scientific conclusion that vaccines do not cause autism,
shocking career scientists, delighting anti-vaccine activists, drawing a rebuke 
from a key Republican senator and sparking an uproar among medical professionals
and autism advocates who questioned whether the agency’s credibility is now
gone.

The agency’s website on vaccines and autism, updated Wednesday, now makes
several false claims about a connection, echoing rhetoric fromHealth Secretary
Robert F. Kennedy Jr., who has a lengthy history of disparaging vaccines and
linking them to autism.

I didn’t read all 1,676 comments, but of the several hundred I read, 100% were
like this:

  1. The CDC used to be a leader in global health, protecting the US from global
    pandemics and containing communicable disease outbreaks in the US. Under
    Trump and his unqualified henchman RFKjr it has been reduced to a
    bullet-ridden shadow of its former self. The damage done to the CDC is
    permanent and irreversible loss to America. Thank you MAGA for electing
    these fools to “get the libs”. They have destroyed American society and the 
    result is a corrupt, incompetent and evil government representing only
    plutocrats and criminals.

  2. So a government web site outright has false information. Horrific.

  3. The diseases that vaccines prevent have killed hundreds of millions over the
    course of the centuries. There is not a creditable vaccines-autism link
    other than some of those hundreds of millions would have autism.

  4. Look up Lysenkoism—Soviet pseudoscience that caused tens of millions of deaths
    in Russia and China.

  5. Lies and mendacity. At the public expense.

  6. Lots of justly warranted incredulous indignation. How many will die because of
    this pseudoscientific dross? It is the stuff of nightmares, but in truth a 
    sign of the modern internet driven fantasy land we are all living in now.
    For this particular BS to be relegated to the padded cell it deserves along 
    with its proponents.

  7. What the current CDC is promoting will start huge outbreaks of diseases
    formally stamped out or receded to small numbers of infections. It’s already
    started in Texas and has spread to New Mexico and other states. This
    country could well be the reason for future pandemics. The utter lives and
    lack of medical knowledge and/or medical research knowledge is horrifying.

  8. I will do the opposite of what the current CDC advises. And when will the
    media stop soft peddling? These are lies, not false claims. Call them what
    the are.

  9. How long will it take for those of us who value impartial scientific advice
    based on peer-reviewed research to trust the CDC again?

  10. Jesus. Christ. I don’t have the words to describe what I’m feeling about this 
    insanity.

  11. These are horrible people that mock real science to no discernable end. Where 
    is the good in greater sickness and mortality?

  12. This is shameful. Andrew Wakefield’s fraudulent writings have been thoroughly 
    discredited by real scientists.

  13. What an extremely depressing time this is, when fiction and personal bias
    replaces scientific research.

  14. An official US government web site affirming pseudoscience. What’s next –
    references to a young earth and global flood on the USGS website? God help
    us.

  15. Another fine trustworthy American institute blown out of the water by Maga
    mayhem.

  16. The study that suggested a link between vaccines and autism was FABRICATED.
    That wasn‘t even “pseudoscience“ but blatant fraud and scientific misconduct

Perhaps the wisest comment was this, “Just do the opposite of whatever this
administration recommends!” It’s obviously not good that people have lost trust 
in the FDA, NIH, and CDC. However, since those once vulnerable institutions are 
now lead by naked emperors, it’s good that the American public, at least those
that read the news, has uniformly recognized they have no clothes.


Go Ahead, Make the Case That Science, Free Speech, and the FDA Are Thriving
Under Drs. Marty Makary and Vinay Prasad

Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my
“nuance” or claim to be a master of “clinical appraisal.” They have so much to
teach me.

Jonathan Howard on July 10, 2025

Link

Prasad’s lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies.

Whether it’s with COVID or RFK Jr., my writing is fundamentally about doctors
who spread misinformation to numb us to obvious but grave risks, while being
sheltered from the consequences of their words. In a previous article titled Go 
Ahead, Make the Case that Science, Free Speech, and the NIH are Thriving Under
Dr. Jay Bhattacharya, I invited doctors who assured us that Dr. Bhattacharya was
competent and qualified to make the case that they were right. So far, none
have done so.

With that in mind, we can turn to two “medical conservatives,” Drs. Adam Cifu
and John Mandrola, who run Sensible Medicine, a monetized Substack that
publishes propaganda such as Why Doctors Should Learn to Stop Worrying and Love 
MAHA. Not long ago, they wrote an article there titled Sensible Medicine
endorses Vinay Prasad for Director of the Center for Biologics Evaluation and
Research (CBER) at the US FDA. It said:

Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA.
He has our enthusiastic support. Prasad is slated to be the incoming CBER
director, where he will regulate vaccines as well as cellular and gene therapy. 
In our opinion, there is no better candidate…

We can’t think of anyone more qualified to lead the biologics division. Prasad’s
lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies.

Dr. Mandrola followed that up with an article titled Can We Give the New FDA
Leadership a Chance that said:

When Marty Makary and Vinay Prasad became leaders at FDA, many pundits worried
they would damage public health. Both had “anti-vax” tendencies, went the
narrative. Adam and I knew that was not true… I am excited and optimistic about 
the new leadership at FDA. They speak with clarity, humility and in a language
the general public can understand. The transparency will begin to restore some
of the lost trust. Good on them.

None of this was true of course. Drs. Makary and Prasad had an atrocious COVID
track and both of them behaved in a juvenile manner towards anyone who corrected
their basic factual errors. There was no reason to think either of them was
qualified for their current positions. Why would the author of We’ll Have Herd
Immunity by April be a competent steward of the FDA? Why would a doctor be able 
to restore trust when he treats lab values after vaccination more seriously than
literal death from COVID?

Prasad rarely attends center meetings with office directors, and that their
questions about the budget, HR functions, and IT systems have gone unanswered.

Drs. Makary and Prasad have been in the news a lot recently, and we can begin to
evaluate their performance so far. According to the article Vinay Prasad Named 
Chief Medical and Science Officer At FDA:

Multiple agency employees, who requested anonymity to protect against
retaliation, told STAT that Prasad seemed uninterested in the administrative
work of being a center director. One CBER agency official said Prasad rarely
attends center meetings with office directors, and that their questions about
the budget, HR functions, and IT systems have gone unanswered. Prasad did not
consult career staff before unveiling a new regulatory framework for Covid-19
vaccines with Makary in May.

Nearly every article about the FDA contains quotes from “agency employees, who
requested anonymity to protect against retaliation.” The reason they might feel 
this way are obvious. Thousands of FDA employees have already been fired, and
according to an article about a purged FDA expert, Dr. Nicole Verdun:

Verdun, and her deputy, Rachael Anatol, were placed on administrative leave by
Prasad, and escorted out of FDA headquarters on Wednesday, STAT reported
exclusively. Verdun told staff she was not given an explanation for the firing. 
She declined to comment for this story.

Longtime FDA employees noted that immediately escorting employees out of the FDA
is unusual, and was seen by some staffers as cruel. Multiple employees could be
heard voicing outrage over the move during a call Verdun convened to tell staff
of the news Wednesday, according to a recording that was obtained by STAT.

Marching employees out of their offices is a bigger deal than a private
organization canceling a single speech, isn’t it? Previously, this incident
warranted an hour-long Sensible Medicine podcast.

Another article titled FDA Layoffs Could Compromise Safety of Medications Made
at Foreign Factories, Inspectors Say said:

ProPublica spoke to 10 current and former FDA staff members and leaders in
recent weeks, including inspectors who said that the loss of support staff has
slowed critical investigations and that little relief has materialized. Most
declined to be named because they were not authorized to speak publicly or
feared backlash within the industry as they search for new jobs.

Another article titled FDA Head Falsely Claims No Scientists Laid Off, As Agency
Shutters Food Safety Labs said:

The head of the Food and Drug Administration has repeatedly claimed in recent
interviews that no scientists have been laid off at his agency, but one of the
scientists in a food safety lab shuttered by the FDA’s cuts says he is either
“blatantly lying” or “out of touch.”

“There were no layoffs to scientists or food inspectors,” FDA Commissioner Dr.
Marty Makary told CNN on Wednesday. Makary previously said in an April 17
interview with Megyn Kelly that there “were not cuts to scientists, or
reviewers, or inspectors. Absolutely none.”

“That just made me so mad, that he said no scientists were cut,” said one
laid-off FDA scientist, a chemist who had worked for the agency for years.

Another article titled Inside the Collapse of the F.D.A. said:

One thing that appeared not to have changed was the F.D.A.’s relationship with
drug makers. In June, Makary and his deputies began a six-city listening tour
with drug-industry executives that was, despite all the talk of radical
transparency, closed to the public. (According to Nixon, the communications
director at H.H.S., the tour was focused on industry stakeholders, and public
transparency would be preserved through other forums.) Later that month, Makary 
announced a voucher program that would shorten drug review times from 10 to 12
months to just one or two for companies whose products met certain criteria. He 
also laid out a new list of agency priorities in The Journal of the American
Medical Association that, for drugs, seemed to come down to two things: faster
reviews and more approvals. “Their paper reads like it’s straight from pharma’s 
playbook,” Ramachandran told me. “They criticized expedited drug reviews for
years, especially with respect to Covid vaccines, saying that it turned the
F.D.A. into a rubber stamp. But now they want to do the exact same thing for as 
many other drugs as possible.”

Reports from inside the agency remained bleak. Some of the civil servants fired 
in February and April were now being invited back (the office of generic drugs
had been reinstated), but most were not. Those who remained were being asked to 
volunteer for essential tasks for which there was now no dedicated staff.
Scientists and technicians still did not have ready access to the scientific
journals they needed to do their work. More than one drug review had been
delayed, and political appointees had interfered in several others. And,
ultimately, Vinay Prasad, the agency’s new chief medical and scientific officer,
overrode expert recommendations on the Novavax and Moderna Covid-19 boosters
slated for this fall. As expected — and perhaps as intended — many of the
F.D.A.’s remaining employees were now looking for jobs outside the government.

Another article titled Inside the Staff Exodus and Tanking Morale That Threaten 
Makary’s FDA said:

FDA employees are spooked by increasing political involvement in regulatory
decisions, frustrated by the impact of cuts to administrative staff who
supported drug reviews and inspections, and fed up with proclamations from the
commissioner’s office that they contend rarely take career staff’s expertise
into account…

The mood has plummeted in the drug and biologics centers in particular. Prasad, 
who has also been named the agency’s chief medical and scientific officer,
pushed out top gene therapy official Nicole Verdun and her deputy in June.
Shortly after, drug center director Jacqueline Corrigan-Curay announced that she
was retiring. Makary and Prasad bypassed career vaccine scientists to write a
new Covid-19 vaccine framework in May, and Prasad overruled staff to narrow the 
approvals of Covid shots from Novavax and Moderna…

Employees told STAT they wished Makary and other leaders would solicit more
input before announcing major initiatives to the public. There’s little
communication from Makary to staff outside of selfie video snippets he sends
trying to cheer up employees. Staff have been left out of key decisions in their
areas of expertise, like the development of the Covid-19 vaccine framework and 
a new priority review program…

As many as 600 reviewers have recused themselves from regulatory decisions due
to interviewing for work with pharmaceutical companies, former FDA Commissioner 
Scott Gottlieb said in April. STAT’s agency sources said a high number of
reviewers continue to be recused.

Leaders in charge of entire FDA centers, as well as those at the forefront of AI
policy, cybersecurity, cell and gene therapies, and drug safety surveillance
are gone, according to information compiled by STAT.

“I think anybody would be dumb not to be looking,” said a reviewer in the drug
center. “We could be paid more in the private sector and appreciated more.”

Dan Gold, president of life sciences recruiting firm Fairway Consulting Group,
said that in the past, he would receive unsolicited calls from interested FDA
employees once a year. Now, he speaks to someone from the FDA or the Centers for
Disease Control and Prevention every week.

Dr. Makary, along with RFK Jr. and Dr. Bhattacharya, is also being sued for his 
role in restricting COVID vaccines. According to the article Medical Groups Sue 
HHS, Kennedy Over COVID Vaccine Policy Changes.

The plaintiffs also include an unnamed pregnant doctor who has been barred from 
getting a COVID-19 booster, based on the recommendations that Kennedy announced 
unilaterally in May. The doctor contends that she is at high risk for exposure
to infectious disease due to her job working as a hospital-based physician. The 
groups that signed onto the lawsuit are the American Academy of Pediatrics
(AAP), the American College of Physicians (ACP), the American Public Health
Association (APHA), the Infectious Diseases Society of America (ISDA),
Massachusetts Public Health Alliance (MPHA), and the Society for Maternal-Fetal 
Medicine (SMFM).

The lawsuit mentioned Dr. Prasad, as well as Sensible Medicine author Dr. Tracy 
Hoeg, and an article titled Top F.D.A. Official Overrode Scientists on Covid
Shots shed some led some light on how Dr. Prasad worked behind the scenes to
impose his will on millions of Americans. It said:

Dr. Prasad overruled those recommendations by the end of May and instead advised
restricting the use of both Covid vaccines…

The Food and Drug Administration’s top vaccine official rejected broad uses of
two Covid vaccines, citing unknown risks or injuries despite assurances of
safety from dozens of staff experts, newly released documents show.

The decisions by the official, Dr. Vinay Prasad, the agency’s new chief medical 
and scientific officer, stunned agency veterans. Records show that the F.D.A.’s 
vaccine staff members had signed off on approving the Novavax vaccine, an
alternative to mRNA shots and weeks later on the next-generation of the mRNA
Covid shot by Moderna for anyone 12 and older.

So much for radical transparency.

However, this article wasn’t just noteworthy for its depiction of “stunned
agency veterans.” It had over 400 reader comments, nearly all of which blasted
Dr. Prasad for his unscientific intrusion on to their medical freedom and bodily
autonomy. Here are some samples:

  1. The vaccines should be available to everyone. Let people make the decision
    with their physician. Gatekeeping a vaccine is morally wrong.

  2. I have elderly parents and a best friend with a liver transplant. Who is this 
    guy to tell me I can’t protect my loved ones? Because I’m 10 years too
    young? I can’t work from home, I have to work from work and I could easily
    bring something home with me to my family.

  3. Was Vinay Prasad at the frontline in 2021 and 2022? No; he was making podcasts
    in which he claimed that the US response to COVID-19 was like the rise of
    Nazism in 1930s Germany.

  4. For those of us who know, Dr. Vinay Prasad from medical Twitter, none of this 
    is surprising. Childish taunts, vulgar insults, pseudoscientific nihilism,
    we’ve seen it all. Dr. Prasad was such a toxic character that an account was
    created entitled “blocked by Vinay Prasad” which had over 1000 examples of 
    medical professionals who were blocked. Having spent the past five years
    cheering for SARS CoV2 and the Covid contrarians, Dr Prasad is now moving in
    on US public health. We are doomed.

  5. It seems that refusing to approve a vaccine due to imagined possible
    consequences, when there are real consequences from not getting vaccinated, 
    is poor science.

  6. This is beyond frustrating. I am a “healthy young person” but am constantly
    around immunocompromised people in both my immediate family and at work. I
    want to continue getting vaccinated to keep my loved ones and students safe,
    however I don’t know how this will work if I myself do not have a medical
    reason to need to vaccine. If people want the vaccine, they should be able
    to get it without having to pay ridiculous amounts of money and jump through
    extra hoops.

  7. As someone who knew Dr. Prasad professionally, this does not surprise me. He
    is an extremely difficult person to work with and is widely disliked by his 
    colleagues, largely for his dismissive nature, arrogance, and constant need 
    for provocation as a tool for self-aggrandizement. He is not inherently a
    bad scientist (though he appears to have gotten this one wrong per the
    genuine experts quoted), but the problem is that you cannot know if his
    opinion is based on facts and data or is shaded by his need to be
    contrarian. I personally don’t know the data here well enough to have a
    defensible opinion but I know him and have no faith that his opinion is not 
    swayed by his opportunistic nature. It is clearly more politically
    advantageous in this administration to discourage vaccination. As a final
    aside, you know who wasn’t in the hospital seeing patients who were dying of
    Covid? The oncologist who is now in charge of our nation’s vaccine program.

Virtually no readers defended Dr. Prasad, and none of them did so in an
intelligent, coherent way.

This sort of criticism isn’t just limited to print journalism. Leading experts
such as Dr. Paul Offit, Michael Osterholm, and the hosts of This Week in
Virology routinely lambast Drs. Prasad and Makary. They have become objects of
scorn and ridicule amongst many doctors on social media as well. Conversely,
anti-vaxxers are furious with Drs. Prasad and Makary for not having banned COVID
vaccines altogether. Their attempt to be “nuanced” only led to no one trusting 
them at all.

Meanwhile, Drs. Prasad and Makary have nothing to say as their boss takes a
wrecking ball to vaccines, both domestically and internationally, and as measles
and pertussis spread under their watch. This will part of their legacy too.

They just cheerlead for the establishment

But hey, maybe I am wrong about all this. I have an open mind and am willing to 
learn. As such, I hope Drs. Cifu and Mandrola will have the integrity to defend 
their words. I hope they can explain why things are going great at the FDA, that
it’s a bastion of open debate, and that its leaders are restoring trust. Unlike
Drs. Cifu and Mandrola, I do not constantly boast of my “nuance” or claim to be
a master of “clinical appraisal.” They have so much to teach me.

If future news headlines report one success after another at the FDA, I will
happily share them. But something tells me Drs. Cifu and Mandrola will be as
silent as church mice about what’s currently happening there. As Dr. Prasad
informed us, there are some doctors- “motherfuckers” and “fucking morons”– who
“just cheerlead for the establishment.” He may have been premature in making
this vulgar accusation, but it turns out he wasn’t fundamentally wrong.


As Diseases Spread and Trust in the FDA Crumbles, Its Leaders Are Obsessed with 
an MRI Abnormality in 1 in 61,500 Males Ages 12-24

Our medical establishment told people to “Stop Trusting the Public Health
Establishment”. Now, almost no one trusts our medical establishment.

Jonathan Howard on July 18, 2025

Link

Most concerning, over a median follow-up of 159 days, 60% of individuals
(98/161) with initial late gadolinium enhancement

Things are not going well at the FDA. Recent headlines declare: Inside the Staff
Exodus and Tanking Morale That Threaten Makary’s FDA and Inside the Collapse of
the F.D.A. Meanwhile, dangerous diseases are spreading. Recent headlines
declare: Measles Cases in the U.S. Hit the Highest Total Recorded in More Than
30 Years, ‘Fighting to Breathe’: Whooping Cough Surges as Vaccination Rates
Drop, Pediatric Flu Deaths Hit Record High For Non-Pandemic Season, and CDC Says
COVID-19 Cases Rising in 25 States.

Yet, at this moment, with all that’s going on, the FDA’s leaders, Drs. Marty
Makary and Vinay Prasad, have devoted most of their time and energy to
protecting Americans from the grave “dangers” of COVID vaccines. Using their
government power to repeatedly override vaccine-experts and reject our medical
freedom has been their top priority. As Dr. Georgios Pappas put it:

The policy proposed by Prasad and Makary violates the right of individual
persons to protect themselves from an infection with considerable mid- and
long-term sequelae.

Drs. Makary and Prasad initially made their case in a widely panned NEJM
editorial, An Evidence-Based Approach to Covid-19 Vaccination. This was followed
this up by an official FDA warning and a JAMA editorial titled US FDA Safety
Labeling Change for mRNA COVID-19 Vaccines.

Their own data shows the absurdity of their concern. Drs. Makary and Prasad
revealed the COVID vaccine was totally safe for nearly everyone. They had to dig
deep to find a problem with it, and so they turned to their favorite topic,
vaccine-myocarditis. Drs. Makary and Prasad have been obsessed with this side
effect for 4 years, producing a deluge of spooky content to encourage COVID
infections in unvaccinated young people.

In their JAMA article, Drs. Makary and Prasad said vaccine-myocarditis occurred 
in males aged 12-24 years at a rate of 1 in 37,000. They revealed that nearly
all patients fully recover, something that’s been known for years, and that a
lingering MRI abnormality in 60% of them was the “most concerning” part about it
all. They wrote:

Most concerning, over a median follow-up of 159 days, 60% of individuals
(98/161) with initial late gadolinium enhancement (LGE) had persistence and a
minority (5% [5/98]) had worsening LGE and symptoms. A total of 4% of patients
(11/272) continued to have arrhythmias at a median follow-up of 31 days and 2%
required antiarrhythmic medications. These findings raise questions about the
benefit-risk assessment for COVID-19 vaccination in healthy male adolescents and
young adults.

This translates to 1 in 61,500 overall young men overall, or about 450 abnormal 
MRIs if every American male age 12-24 were to get the vaccine. Those are the
stakes. That’s what all the fuss is about. By way of comparison, at the peak of 
the Omicron wave in January 2022, nearly 1,000 children were being hospitalized 
with COVID every day.

Dr. Prasad also devoted an entire speech to this MRI finding. Listen to how
serious and sober he is as he discusses late gadolinium enhancement after the
vaccine. It is “not benign,” he said.

Breathless coverage of rare anecdotes of MIS-C & death in kids

Dr. Prasad didn’t always feet this way. In his article Setting the Record
Straight: There is No ‘Covid Heart’, he argued that late gadolinium enhancement 
after myocarditis was “no special reason to worry”. Is myocarditis dangerous or 
not? According to our medical establishment, myocarditis is dangerous only when 
it is caused by the vaccine.

In reality, COVID myocarditis killed some young people, while the vaccine has
not, and COVID’s harms are not restricted to myocarditis. However, our medical
establishment has a long history of treating vaccine side effects more seriously
than anything COVID could do. In their view, it was a “truly unacceptable” to
accurately report that vaccine-myocarditis was almost always “mild“, however it 
was “breathless” to even mention literal death from COVID. That was just “rare
anecdotes,” just 19 dead kids in a single month. He spoke in a vulgar,
unprofessional manner about anyone who disagreed.

While our medical establishment treated entirely hypothetical risks from the
vaccine with the utmost seriousness, nothing the virus did mattered them. Just
listen to how Dr. Prasad spoke about children going to the hospital with COVID
during the Delta wave versus how he spoke about “subclinical myocarditis“- which
is nothing more than an abnormal value in a kid who feels fine. He never
worried that repeat COVID infections might not be good for kids.

And this is all still going on today. Compare how Dr. Makary speaks about
“vaccine injuries” versus his casual dismissal of children dying of measles. “We
have to be honest with people,” he said as he embraced “soft eugenics” and
falsely claimed only children with underlying medical conditions were vulnerable
to measles.

The observed vaccine efficacy was 100%

While our medical establishment claims to value data and evidence, SBM readers
know this performative nonsense. Though both the virus and vaccine were new,
they greatly overhyped the vaccine in early 2021, promising it offered perfect
protection against severe disease, blocked transmission, and would end the
pandemic. When reality proved otherwise, they turned against the vaccine with a 
vengeance rather than admit error.

Our medical establishment always opposed vaccinating children, and Dr. Prasad
started his anti-vaccine campaign in January 2021 months before there was any
data about the pediatric COVID vaccine when he thought the pandemic was
“abating“. In the video below, from February 2021, Dr. Prasad spread obviously
fake statistics- COVID only kills 1 in a million children– and fear mongered
about mundane vaccine side effects such as headaches and fevers. There was no
data about the pediatric COVID vaccine at the time, but Dr. Prasad’s mind was
already made up.

The data from the randomized-controlled trial (RCT) in adolescents was released 
in March 2021 via a company press release. It was published in the NEJM in May
2021, and all 16 COVID cases occurred in the placebo group. The Delta and
Omicron variants arrived later that year causing unprecedented sickness in
children. The AAP says COVID hospitalized 234,000 children over all the first
four years of the pandemic. Unsurprisingly, dozens of observational studies have
since shown its value in limiting these rare, but grave COVID harms in
children. None of this mattered to Dr. Prasad. You can read his entire body of
work and not learn any of this. He didn’t feel his readers deserved to learn
these basic facts from him.

While Dr. Prasad never devoted a single thought to any child harmed by COVID, he
made an overwhelming amount of scary content like this.

Similarly, as Omicron loomed in December 2021, our medical establishment laughed
at and mocked anyone who wanted the first booster dose. Even though the results
were only available as a press release at the time, an RCT of 10,000 people
showed that it was safe and 95% effective at preventing COVID. It was published 
in the NEJM several months later, and it doesn’t take a genius to imagine a
vaccine dose that lowered infection rates would also lessen severe disease.

The results from a large observational study were also available when this
podcast aired. It found:

Vaccine effectiveness evaluated at least 7 days after receipt of the third dose,
compared with receiving only two doses at least 5 months ago, was estimated to 
be 93% (231 events for two doses vs 29 events for three doses; 95% CI 88–97) for
admission to hospital, 92% (157 vs 17 events; 82–97) for severe disease, and
81% (44 vs seven events; 59–97) for COVID-19-related death

None of this mattered to our medical establishment. No RCT, no observational
trial, no COVID variant, no packed pediatric hospital or dead child altered
their anti-vaccine ideology one bit. They never looked back. They didn’t care at
all.

It’s data from families that say their kids have been acting with bad behavior …
and they eliminate the petroleum-based food dyes and the behavior improves.
That is data.

In their JAMA article, Drs. Makary and Prasad predictably demanded new
“randomized controlled trials (RCTs) in these populations prior to issuing
further marketing approvals.” In contrast, when it comes to things they want to 
be true, anything goes. They are fine limiting vaccines without RCTs, and
commenting on another trivial risk, petroleum-based food dyes, Dr. Makary
recently said:

We have a lot of data and it may not necessarily be the traditional 50 year
randomized control trial follow up. It’s data from families that say their kids 
have been acting with bad behavior … and they eliminate the petroleum-based food
dyes and the behavior improves. That is data.

For our medical establishment, the drone-like phrase: gold-standard science and 
common sense, gold-standard science and common sense, gold-standard science and 
common sense, common sense and good science means: We will demand incredible
evidence for things we don’t want to be true and use vibes to justify things we 
want to be true. As Dr. Ben Mazer put it:

In the current health administration, we’re witnessing the birth of a new
medical philosophy: EBMOFCV Evidence-Based Medicine only for Covid Vaccines

This risk-taking approach may, in part, be responsible for widespread loss of
trust in public health and medicine

Despite their inglorious track record of failed predictions and pro-virus
disinformation, Drs. Prasad and Makary had the audacity to end their JAMA
article by speaking about trust. They wrote:

During the COVID-19 pandemic, broad, one-size-fits-all mandates were
aggressively pursued, requiring vaccines in populations with potentially
net-negative benefit-risk profiles. This risk-taking approach may, in part, be
responsible for widespread loss of trust in public health and medicine and
growing hesitancy against all vaccination. Public trust takes decades to build, 
but can be forfeited in a single action. The FDA’s class SLC action on mRNA
products represents one step toward rebuilding that trust.

I know whom I blame for the “widespread loss of trust in public health and
medicine and growing hesitancy against all vaccination” and it has nothing to do
with a rare, temporary vaccine side effect that was widely-publicized and
discussed.

Though it was recently scrubbed from the FDA’s website to make it seem as if it 
had been covered it up, the FDA warned about vaccine-myocarditis as early as
June 2021. So did the CDC. It was hardly some state secret. I’ve written
extensively on this side effect, starting in June 2021. So have many others. No 
one is just now discovering it thanks to the courage of Drs. Makary and Prasad, 
and they are the only ones who talk about it constantly today. Americans are not
breathing a collective sigh of relief because finally, they put an end to our
national nightmare of vaccine-myocarditis. No one thinks Drs. Makary and Prasad 
are heroes because they saved a narrow demographic group the minuscule risk of
an abnormal MRI after a voluntary vaccine.

The medical freedom community is calling for the resignation of podcaster
surgeon Marty Makary, the new FDA Commissioner.

Fortunately, it’s not my job to restore trust in the FDA. That is up to its
leaders, and it’s not going well for them. Prior to assuming office, Dr. Prasad 
gave interviews called Stop Trusting the Public Health Establishment, and many
people absorbed his message. Now, the knives are out for them from all
directions. Cranks are “calling for the resignation of podcaster surgeon Marty
Makary” because they haven’t banned all COVID vaccines, and a recent editorial
in the Washington Times titled Trump Agenda For Biotech Being Sabotaged From
Within was all about Dr. Prasad. It said:

An affinity for central planning is the hallmark of progressive thinking. Dr.
Prasad’s FDA is moving away from the America First principle of trusting parents
and doctors to make medical decisions back toward the failed Obama-Biden
approach, which lets unelected, unaccountable bureaucrats decide who gets a
chance at life. He wants the government to define what counts as “effective” or 
“appropriate” and force families to beg for permission from unelected elites in 
Washington.

Dr. Prasad’s rise is an example of what Mr. Trump means when he refers to “the
deep state.” He is a careerist insider, left-wing ideologue working from within 
to hollow out the president’s biotech revolution by ceding administrative and
regulatory power back to the bureaucrats and the woke elite. Mr. Trump should
remove him from his posts before he pushes his personal, anti-MAGA agenda any
further, causing irreparable harm to the American biotech industry.

Meanwhile, medical organizations with relevant expertise are suing them, and
vaccine experts are rightfully mocking them. They are utterly silent as their
boss does all he can to contribute to “growing hesitancy against all
vaccination.” They don’t really care about that at all.

Trust in our medical establishment is justifiably tanking, and 100 more articles
and podcasts about an MRI abnormality won’t fix that. Incredibly, ensconced in 
a bubble of their own creation, Drs. Makary and Prasad seem to actually have
fallen for their absurd notion that a rare, “mild” vaccine side effect was the
root cause of mistrust for millions of furious Americans. Once the FDA finally
comes clean about vaccine-myocarditis, everything will be just fine. I could
have told them they were high on their own supply and wrong about all that.

Drs. Makary and Prasad are the medical establishment now. It’s our right to hold
them accountable, and it’s their job to earn our trust. They are failing badly.
They signed up for this, and they only have 3.5 more years to go, though sadly 
the rest of us are along for the ride.

COVID-19 contrarian Dr. Vinay Prasad meets real world responsibility

Dr. Vinay Prasad parlayed his COVID-19 contrarianism into a high-ranking
position in the FDA. Now he’s facing real world responsibility, and knives are
out for him. Can he survive?

David Gorski on July 28, 2025

Link

In the current hellscape that is the US Department of Health and Human Services,
which is currently being run by a longtime antivax activist, Robert F. Kennedy,
Jr., and the resulting completely predictable ongoing demolition of core
aspects of federal medical, public health, and biomedical research programs, I
must admit to enjoying a bit of schadenfreude where I can find it. (Seriously,
given how bad the news regarding science, public health, and medicine has been
during the last six months, can you blame me?) For example, as SBM blogger Dr.
Jonathan Howard amusingly described in detail on Friday, Dr. Vinay Prasad, a
frequent topic on this blog because of his weaponization of the evidence-based
medicine (EBM) paradigm, is fast discovering that, now that he’s the head of the
FDA’s Center for Biologics Research (CBER) and the FDA’s Chief Scientific
Officer and thus has real world responsibility for approving vaccines and
biologics, the “RCTs or STFU” shtick that he used during the pandemic to cast
doubt on COVID-19 vaccines and public health interventions (as well as to build 
his brand to the point where he was high profile enough to score jobs at the FDA
for which he is manifestly unqualified) does not mesh well with reality. That’s
not to say that he and his boss, FDA Commissioner Dr. Marty Makary, haven’t
gotten on board with—shall we say?—the more “fluid concept of evidence”
necessary to be able to selectively apply a hyper-dogmatic application of EBM
(the aforementioned “RCTs or STFU) to hamper approval of things that RFK Jr.
doesn’t like—cough, cough, vaccines—and approve the things he does like (e.g.,
dubious stem cell therapies).

Vinay Prasad, MD, MPH, in a typical pandemic-era interview.

Clowns to the left of me, jokers to the right…

The current kerfuffle has resulted in right wing knives coming out for Dr.
Prasad. As Dr. Howard noted last week, the knives are out for Dr. Prasad coming 
from two directions. First, the “health freedom” community is unhappy as a
result of a recents decisions by Dr. Prasad. One such decision was to reverse at
a late stage in the process the accelerated approval for melanoma of
Replimune’s oncolytic virus vusolimogene oderparepvec and call for more data.
The second has to do with Dr. Prasad’s response to the death of a Brazilian boy 
who had received AAV Elevidys gene therapy from Sarepta. Ironically enough,
these are a couple of Dr. Prasad’s uncommon decisions that fall into a gray area
and are actually defensible. (More on that later.) Second, antivax activists
are very unhappy that the FDA is not banning COVID-19 vaccines and, even worse, 
that the FDA approved Moderna’s pediatric mRNA-based COVID-19 booster a couple
of weeks ago, an approval that ignited a minor social media storm, with
antivaxxers writing Substacks with titles like (to pick a few):

  1. Mothers Angered by FDA Rubber-Stamp Approval of Pediatric mRNA Boosters,
    subtitled Promise for Large Randomized Trials Broken, FDA Approves Spikevax 
    for Kids. (From antivax cardiologist and The Wellness Company grifter Dr.
    Peter McCullough.) Excerpt: “The medical freedom community is calling for
    the resignation of podcaster surgeon Marty Makary, the new FDA
    Commissioner.”

  2. Moderna Spikevax-FDA Post Mortem. (From Dr. Robert “Inventor of mRNA Vaccines”
    Malone.) Excerpt: “But who will speak for the injured? Who will protect the
    parents and their children?”

  3. FDA Commissioner Makary Went Behind RFK Jr.’s Back to Approve Moderna’s mRNA
    Shots for Infants. (From antivaxxer Karen Kingston.) Excerpt: “Fast forward 
    one week later, Emerald had me back on her show today when she broke the
    news that Makary went behind Secretary Kennedy’s back to grant full FDA
    approval to Moderna.”

I love that last one in particular, because it absolves the “sainted” (among
antivaxxers) RFK Jr. of responsibility, as “deceptive” underlings went behind
his back to do something they don’t like. (“If only RFK Jr. knew…”) It’s worse
than that, though, to antivaxxers given that the FDA has approved more than just
pediatric boosters:

“It’s shocking that three mRNA products have been approved by Robert Kennedy’s
FDA,” Shannon Joy, a self-described medical freedom advocate, told Endpoints
News. “It’s just astounding given his rhetoric, not only over the past three to 
four years, but over the past two decades of his career.”

Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy
group that has lobbied against mRNA shots, called for FDA Commissioner Marty
Makary, MD, MPH, to step down. “This is outrageous,” she wrote after the Moderna
COVID vaccine approval.

But HHS spokesperson Andrew Nixon justified the agency’s decisions, arguing that
the FDA Commissioner and Kennedy “are focused on strengthening public trust
through transparency.”

Dr. Prasad himself started catching some of the flack with his response to a
different issue, specifically a petition by antivaxxers calling for the
suspension of mRNA injections:

The U.S. Food and Drug Administration (FDA) has delayed its response to a formal
petition demanding the suspension of the mRNA Covid-19 injections, citing “the 
existence of other FDA priorities.”

In a letter dated 17 July 2025, Dr Vinay Prasad—recently appointed Director of
the FDA’s Center for Biologics Evaluation and Research (CBER)—acknowledged that 
the agency had “not yet reached resolution of the issues raised” in the
petition.

Filed on 20 January 2025, the petition alleges that Pfizer’s Comirnaty and
Moderna’s Spikevax were “unlawfully approved” in violation of federal regulatory
requirements.

It calls for an immediate halt to the injections, independent testing of
retained vials, and a full investigation into the approval process.

Note the data that the petition was filed: President Trump’s Inauguration Day.

I’m not going to further discuss the decisions made by the FDA regarding
COVID-19 vaccines. As bad as the FDA has been since RFK Jr. took over HHS, Dr.
Makary was appointed FDA Commissioner, and Dr. Prasad was appointed to lead
CBER, because these are uncommon instances where the FDA made more or less the
right decision. That is, of course, why RFK Jr.’s antivax supporters are so
outraged; after all, they want all mRNA-based COVID-19 vaccines suspended and
pulled from the market. (In actuality, they want all vaccines pulled from the
market, but COVID-19 vaccines are low-hanging fruit, a good test case for them
to use to agitate for their broader goals.)

I’m more interested in the decisions made by Dr. Prasad regarding Elevidys,
Replimune’s RP1 (vusolimogene oderparepvec) oncolytic virus treatment for
melanoma, and Capricor Therapeutics’ cell-based therapy for muscular dystrophy, 
Deramiocel. Why? Because the issues behind the decision are more nuanced, and
also because the outrage from the “make America healthy again” (MAHA) movement
that is being aimed at Dr. Prasad and his boss Dr. Makary over the FDA decisions
on vaccines was entirely predictable. Indeed, that outrage over decisions on
Elevidys, RP1, and Deramiocel is more interesting because it demonstrates how
Dr. Prasad’s longstanding criticisms of accelerated approval programs, with
which I mostly agreed before the pandemic, are running into the buzzsaw of an
alliance between understandable patient advocacy and the MAHA “health freedom”
ethos. This will help to illustrate how MAHA’s “health freedom” is highly
selective, given that its antivax contingent (e.g., 99% of MAHA) is more than
happy to take away the health freedom of vaccine advocates to receive vaccines
that are highly effective at considerably less risk than any of these therapies 
for which they advocate.

Before I discuss specifics, just for your amusement (and mine), let’s briefly
look at what Laura Loomer, a woman whom I consider a wingnut’s wingnut but who
is, sadly, very influential and very tight with President Trump, wrote a week
ago. Hilariously, in Meet Vinay Prasad: The Progressive Leftist Saboteur
Undermining President Trump’s FDA, she described Dr. Prasad as a “catastrophic
vetting failure that demands immediate action to protect Trump’s transformative 
healthcare agenda.” I can’t help but note that Dr. Prasad is indeed utterly
unqualified for the positions that he now holds, just not in the way Loomer
thinks. The real “vetting failure” was how the MAHA stans running HHS and its
agencies apparently didn’t think about how Dr. Prasad’s “RCTs or STFU” ethos
might impact issues other than its intended effect on amplifying antivax
messaging implying that vaccines are inadequately tested. They apparently didn’t
foresee the obvious, namely how that same ethos would impact issues such as
accelerated approval programs and “right-to-try” beloved of libertarian “health 
freedom” and “neuter the FDA” activists.

More Loomer:

More recently, Prasad has led arbitrary delays of gene and cell therapies from
Ultragenyx and Capricor not based on science, but on his own left-wing agenda.
These delays contradict Trump’s push for faster drug approvals, frustrating
patients and industry alike.

And:

Prasad’s regulatory philosophy is fundamentally anti-Trump. While the President 
has criticized the FDA’s “slow and burdensome” approval process, he has argued
for tougher reviews. Also, Prasad dismissed Republican pressure to streamline
approvals as misguided. He criticized Trump’s Right-To-Try policies, calling the
President “incorrect” and blaming pharmaceutical companies, not the FDA, for
delays in drug access. By publishing major policy changes in academic journals
rather than through transparent public comment portals, Prasad has reduced
opportunities for input from patients, providers, and industry, further eroding 
trust in the FDA.

Damn. Reading that he was totally against right-to-try, I almost like Dr.
Prasad! After all, I’ve been a far harsher critic of right-to-try than Dr.
Prasad has ever been, frequently characterizing it as a Trojan horse designed to
neuter the FDA, and, as I’ve noted before, I mostly agreed with his critique of
accelerated approval programs in oncology and the need to reform them. Of
course, that was before 2020, after which Dr. Prasad soon discovered the fame,
wealth, and power that came with being an obnoxious COVID-19 contrarian who uses
EBM fundamentalist methodolatry to undermine public health and vaccination.

The icing on the schadenfreude cake is Loomer’s long diatribe in that post
listing the times that Dr. Prasad has performatively declared himself a Bernie
Sanders/Elizabeth Warren liberal and a Joe Biden supporter in 2020, as well as a
“lifelong progressive” and “Bernie fan,” concluding that “Prasad must go before
he completely destroys the MAHA movement and all of the hard work President
Trump has put into his regulatory reform agenda.” (If only.) Of course, Loomer
left out Dr. Prasad’s more recent pivot to being simpatico with RFK Jr.’s views,
his gaslighting of RFK Jr.’s role in undermining support for vaccination during
the 2019 Samoan measles outbreak, and his echoing RFK Jr.’s antivax trope about
how the childhood vaccination schedule has supposedly never been tested against
saline placebo. That’s because, as we’ve long documented here, Dr. Prasad is
nothing if not a naked opportunist, which is why he eagerly hitched his wagon to
the MAHA movement and the far right wing politics that have aligned itself with
MAHA, a decision that paid off enormously for him, elevating him to positions
far beyond his talent and capabilities.

Let’s move on, however, to the most recent case that appears to have provoked
the most recent “health freedom” backlash accusing Dr. Prasad of being a
leftwing plant who’s undermining President Trump’s “health freedom” and RFK
Jr.’s MAHA agenda. There are other examples, but these two seem, more than
others, to have put Dr. Prasad on the radar of Trump supporters like Loomer and 
Rick Santorum:

More on the man destroying @POTUS legacy for helping patients. FDA’s Vinay
Prasad Stands with Progressive Health Policies https://t.co/4wQ3mRuA6U

— Rick Santorum (@RickSantorum) July 25, 2025

Dr. Prasad vs. accelerated approval

I’ll start with the less emotionally charged case of the two cases I will
discuss, specifically how Dr. Prasad appears to have intervened in the late
stages of the process for granting accelerated approval for RP1, the oncolytic
melanoma treatment being developed by Replimune, putting the brakes on and
demanding more data. Here’s a good description of just what RP1 is from Dr. Sean
Khozin:

RP1 is sophisticated biological engineering at the intersection of virology,
immunology, and cancer therapeutics. This modified herpes simplex virus carries 
two carefully designed genetic modifications: GM-CSF to recruit and activate
immune cells, and GALV-GP-R⁻ to enhance viral spread through tumor tissue.
Unlike traditional chemotherapy that indiscriminately kills dividing cells, or
targeted therapies that block specific molecular pathways, oncolytic viruses
like RP1 employ a dual strategy—directly destroying cancer cells while
simultaneously awakening the immune system to recognize and eliminate tumors
throughout the body.

Clever, right? For those unfamiliar with it, the accelerated approval process
was initiated largely in response to activism from HIV/AIDS patients to allow
for the approval for drugs that fill an urgent unmet need for the treatment of
serious conditions and allowed that approval to be based on what are known as
surrogate endpoints:

Drug companies are still required to conduct studies to confirm the anticipated 
clinical benefit. These studies are known as phase 4 confirmatory trials. If the
confirmatory trial shows that the drug actually provides a clinical benefit,
then the FDA grants traditional approval for the drug. If the confirmatory trial
does not show that the drug provides clinical benefit, FDA has regulatory
procedures in place that could lead to removing the drug from the market.

The FDA instituted its Accelerated Approval Program to allow for earlier
approval of drugs that treat serious conditions, and that fill an unmet medical 
need based on a surrogate endpoint. A surrogate endpoint is a marker, such as a 
laboratory measurement, radiographic image, physical sign or other measure that 
is thought to predict clinical benefit, but is not itself a measure of clinical 
benefit. The use of a surrogate endpoint can considerably shorten the time
required prior to receiving FDA approval.

Cancer therapies are generally evaluated using a number of endpoints. The most
commonly used include overall survival (OS), progression-free survival (PFS), or
recurrence-free survival (RFS). There are, of course, other endpoints related
to survival that are measured, but these three are the most relevant for this
discussion. Overall survival is what it sounds like: How long do patients
survive their cancer after diagnosis? Period. It’s hard for an endpoint to be
more objective than that: At a certain timepoint after diagnosis, either the
patient is alive or she is dead. This number is usually expressed in terms of
median survival, which is the period of time after which half of the patients
under study are still alive and half have died. It should be noted that OS
includes all causes of death, not just cancer. If a patient with cancer under
study dies of a heart attack that is not related to his cancer or his cancer
treatment, that counts.

Traditionally, OS has been the “gold standard” endpoint in measuring the
efficacy of a cancer therapy, because the primary goal has been to prolong
survival, the ideal case being prolonging survival to the point where it is
indistinguishable from life expectancy if the patient never had cancer in the
first place. PFS, on the other hand, is survival without progression; i.e., how 
long the patient with cancer survives without evidence that his or her tumor has
measurably grown or metastasized, with dying of other causes with disease
counting in the calculation. While PFS is often measured as well as OS, it’s
generally considered less useful because it is entirely possible for a treatment
to prolong PFS without prolonging OS. This sort of result can happen when the
treatment is effective at shrinking a tumor and/or slowing its progression but
its toxicities contribute to death from other causes. In such a case, PFS
improves with no improvement in OS. Finally, RFS (also called disease-free
survival, or DFS) is how long the patient survives without a recurrence of her
cancer after successful initial treatment. PFS and RFS are often used as
surrogate endpoints in cancer therapy clinical trials, although increasingly
there is one other. In neoadjuvant chemotherapy (chemotherapy given before
surgery), a pathologic complete response (pCR) has traditionally been considered
a good surrogate endpoint. A pCR occurs when, at surgery, there are no viable
cancer cells detectable in the specimen removed at surgery. In aggressive forms 
of breast cancer the correlation between pCR and improved overall survival is
high.

Other surrogate endpoints include response rate (RR), defined as the percentage 
of patients whose tumor shrinks significantly in response to the therapy
(usually 30% or more is the cutoff); and time to tumor progression (TTP, which
is the same as PFS but doesn’t include deaths; it just measures time until the
tumor detectably progresses). To these is being added a dizzying array of
molecular surrogate endpoints that are less accepted, and it’s hard not to be
tempted to pick your favorites if you’re an oncology researcher. The debate
about the use of surrogate endpoints in oncology has been going on as long as I 
can remember, dating back to before I entered the field of surgical oncology as 
a fellow back in the late 1990s

In my discussion I noted that one big problem with the accelerated approval
process wasn’t so much the use of surrogate endpoints as a basis for provisional
“accelerated approval.” Rather the problem was that the FDA wasn’t always so
rigorous about following up and demanding confirmatory phase 4 trials leading to
traditional FDA approval. I didn’t have any objections to the idea of an
accelerated approval process per se; my main problem with it was followup. That 
was where I thought reforms were needed. In that, I was for a time in agreement 
with Dr. Prasad. I like to point that out because, after all the rancor over
COVID-19 and Dr. Prasad’s embrace of COVID-19 contrarianism, fear mongering
about COVID-19 vaccines, and “natural herd immunity” approaches to the pandemic,
people forget that there was a time when I thought Dr. Prasad was doing
valuable work (for instance, his 2019 study that concluded that only around one 
in five treatments granted accelerated approval were later proven to show a real
clinical benefit in OS). That time ended in 2021 at the latest.

Be that as it may, here’s how the company put it in a press release last week:

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company
pioneering the development of novel oncolytic immunotherapies, today announced
that the U.S. Food and Drug Administration (FDA) has issued a Complete Response 
Letter (CRL) regarding the Biologics License Application (BLA) for RP1
(vusolimogene oderparepvec) in combination with nivolumab for the treatment of
advanced melanoma.

The CRL indicates that the FDA is unable to approve the application in its
present form. The FDA has indicated that the IGNYTE trial is not considered to
be an adequate and well-controlled clinical investigation that provides
substantial evidence of effectiveness. Furthermore, the FDA said the trial
cannot be adequately interpreted due to the heterogeneity of the patient
population. The CRL also states that there are items related to the confirmatory
trial study design which need to be addressed, including contribution of
components. Importantly, no safety issues were raised.

The Company will request a Type A meeting and expects it will be granted within 
30 days. Replimuneplans to urgently interact with the FDA to find a path forward
for the timely accelerated approval of RP1without which the development of RP1 
for advanced cancer patients with limited options will not be viable.

“We are surprised by this FDA decision and disappointed for advanced melanoma
patients who have limited treatment options as highlighted by the granting of
breakthrough status at the time we provided the IGNYTE primary data,” said
Sushil Patel, Ph.D., Chief Executive Officer, Replimune. “The issues highlighted
in the CRL were not raised by the agency during the mid- and late-cycle
reviews. Additionally, we had also aligned on the design of the confirmatory
study. We strongly believe that RP1 in combination with nivolumab can bring
substantial benefit to advanced melanoma patients.”

In brief, Replimune had been on track to be granted accelerated approval of RP1,
with no concerns having been raised by the FDA about its application during
mid- and late-cycle review. In other words, the company had played by the rules,
only to have a new CBER director yank the rug out from under them. We can, of
course, argue about whether the rules are appropriate from a scientific and
regulatory standpoint. In fact, I have discussed just that in my discussion of
accelerated approval for oncology treatments when I discussed the concerns that 
Dr. Prasad has long been raising about the program six years ago.

So what? You might say. It’s just one biological designed to treat melanoma.
What’s the big deal? Dr. Sean Khozin describes why it’s a big deal:

We all woke up today (July 22, 2025) to a sobering reality check. The FDA’s
complete response letter for RP1—Replimune’s oncolytic virus therapy—appears to 
signal the end of an era in oncology drug development, one where scientific
promise and unmet medical need could occasionally trump methodological
perfection.

Within hours of the announcement, Replimune’s stock had shed three-quarters of
its value, plummeting from over $12 to barely $3. Yet this dramatic market
correction merely reflects a deeper structural shift: the regulatory landscape
for cancer therapeutics is fundamentally changing, and the old playbook for
bringing innovative treatments to patients may soon become obsolete.

Of course, one can argue whether the accelerated approval program brings so many
“innovative treatments to patients” as Dr. Khozin seems to believe. I, for one,
am skeptical. My differences with biotech boosters aside, I have to point out
that Replimune did follow the current rules for the accelerated approval program
and quite reasonably expected that RP1 would be approved under that program;
that is, until Dr. Prasad changed the rules in mid-course, thus moving the
goalposts. It is, of course, within his power as CBER director to do that, but I
wonder if he appreciates that there will be consequences for him to pay, and
among those consequences, besides pissing off Replimune, the biotech industry at
large, and boosters of gene therapy, in the age of Trump, RFK Jr., MAHA, and
“right-to-try,” those consequences include political attacks from “health
freedom” advocates who want to burn down the FDA in order to get “cures” to the 
people faster, as Dr. Howard so amusingly documented and I’ll touch upon again
in the next section.

One can argue about what should be required in terms of surrogate endpoints for 
an application for accelerated approval, but that’s why companies and the FDA
meet extensively and agree beforehand what evidence the FDA will require, which 
is what Replimune and the FDA did. The IGNYTE trial studied 140 patients with
melanoma refractory to PD-1-targeted immunotherapy, a very bad subset of
melanoma with few treatment options, and showed that RP1 combined with nivolumab
achieved a 32.9% overall response rate and a 15% complete response rate. These 
outcomes compared favorably with existing standards of care, whose results in
this subset of melanoma is dismal. The study also was consisted with the
proposed biological mechanism, that RP1 appeared, as Dr. Khozin put it, “to
convert cold tumors to hot at injection sites,” while simultaneously triggering 
immune responses against metastases. He also notes:

By conventional measures of clinical benefit, RP1 appeared poised for approval
under the accelerated pathway, particularly given its breakthrough therapy
designation and the urgent need for new options in this patient population.

So why did Dr. Prasad put on the brakes? As Dr. Khozin explains:

The FDA’s rejection hinged not on the magnitude of clinical benefit but on the
interpretability of the evidence. In its complete response letter, the agency
concluded that the IGNYTE trial was not “adequate and
well-controlled”—regulatory language that carries precise legal meaning. The
core issue was attribution: because all patients received both RP1 and
nivolumab, and because this population had previously been exposed to PD-1
inhibitors, it became impossible to determine RP1’s independent contribution to 
the observed responses.

This distinction might seem academic, but it reflects a fundamental tension in
modern drug development. As therapies become more sophisticated and treatment
paradigms increasingly rely on rational combinations, the traditional regulatory
framework—designed for single agents with clearly measurable effects—struggles 
to accommodate biological complexity. The very features that made RP1
scientifically compelling—its multifaceted mechanism and synergy with checkpoint
inhibition—also made it regulatorily challenging to evaluate.

This is another case where Dr. Prasad might have a point, but it also might be a
case of where his EBM fundamentalist methodolatry (“RCTs or STFU”) might be
hamstringing the FDA and hampering innovation. There is a conflict inherent in
Dr. Prasad’s approach, as Dr. Khozin points out:

His appointment to lead CBER in May 2025 marked a philosophical shift toward
what might be termed “regulatory minimalism”—a framework that demands
compelling, interpretable evidence before approving new therapies, regardless of
theoretical promise or unmet medical need. This approach prioritizes internal
validity and methodological rigor over expedience or optimism about biological
mechanisms.

The doctrine is not without intellectual merit. Prasad’s academic work has
documented instances where accelerated approvals based on surrogate endpoints
failed to translate into meaningful patient benefit when subjected to randomized
controlled trials. His emphasis on confirmatory evidence and skepticism toward 
single-arm studies reflects legitimate concerns about regulatory capture and the
potential for marginal therapies to consume healthcare resources without
proportionate benefit.

However, this philosophy also creates tension with the innovation ecosystem that
has driven much of the progress in cancer treatment over the past two decades. 
Many breakthrough therapies—from CAR-T cell treatments to PD-1
inhibitors—initially gained approval based on dramatic single-arm trial results 
in desperate patient populations. The current regulatory environment might have 
delayed or prevented some of these advances, potentially costing lives while
pursuing methodological perfection.

This has always been the tension at the heart of the regulatory endeavor,
balancing innovation and getting new treatments onto the market, so that
patients can benefit from them, with methodological rigor necessary to assure
that approved products are safe and effective. CAR-T cells and PD-1 inhibitors
are good examples where such innovation occurred because of the accelerated
approval. PD-1 inhibitors, for instance, became standard-of-care for
triple-negative breast cancer in an astonishingly fast timeframe because of
their obvious benefits when the RCTs were done. The problem, as the second
example will illustrate more clearly, is that Dr. Prasad was chosen because RFK 
Jr. and the new medical establishment in charge at HHS believed that he would
use his EBM fundamentalist methodolatry to make the approval of new or updated
vaccines much, much more difficult, which he seems to be doing. What he forgets 
is that Donald Trump wants the illusion of cures flowing through the FDA to the 
people through decreased regulatory requirements and RFK Jr. wants dubious stem 
cell treatments to get the rubber-stamp of FDA approval that they wouldn’t have 
gotten under previous administrations.

Dr. Prasad’s putting the brakes on the accelerated approval of RP1 was just one 
incident, and probably one that those attacking him could have overlooked if not
for his decision on Elevidys.

Dr. Prasad vs. Elevidys

Last Friday, the FDA published a rather remarkable press release regarding
Elevidys, which is an adeno-associated virus (AAV)-based gene therapy for
Duchenne muscular dystrophy, a fatal genetic condition due to abnormalities in, 
or absence of, dystrophin, a protein that helps keep the body’s muscle cells
intact. The result is progressive muscle wasting that is ultimately fatal at a
young age. (This is the disease for which Jerry Lewis did his yearly telethons
for decades last century.) The AAV vector is designed to introduce a gene into
the body that leads to the production of Elevidys micro-dystrophin, a shortened 
protein (138 kDa, compared to the 427 kDa dystrophin protein of normal muscle
cells) that contains selected domains of the dystrophin protein present in
normal muscle cells. In brief, the press release stated that the FDA had placed 
the clinical trials for Elevidys on clinical hold:

The U.S. Food and Drug Administration today announced it has placed Sarepta
Therapeutics investigational gene therapy clinical trials for limb girdle
muscular dystrophy on clinical hold following three deaths potentially related
to these products and new safety concerns that the study participants are or
would be exposed to an unreasonable and significant risk of illness or injury.
The FDA has also revoked Sarepta’s platform technology designation.

The FDA leadership also met with Sarepta Therapeutics and requested it
voluntarily stop all shipments of Elevidys today. The company refused to do so.

“Today, we’ve shown that this FDA takes swift action when patient safety is at
risk.” said FDA Commissioner Marty Makary, M.D., M.P.H. “We believe in access to
drugs for unmet medical needs but are not afraid to take immediate action when 
a serious safety signal emerges.”

The three deaths appear to have been a result of acute liver failure in
individuals treated with Elevidys or investigational gene therapy using the same
AAVrh74 serotype that is used in Elevidys. One of the fatalities occurred
during a clinical trial conducted under an investigational new drug application 
for the treatment of Limb Girdle Muscular Dystrophy.

“Protecting patient safety is our highest priority, and the FDA will not allow
products whose harms are greater than benefits. The FDA will halt any clinical
trial of an investigational product if clinical trial participants would be
exposed to an unreasonable and significant risk of illness or injury,” said
Director of the FDA’s Center for Biologics Evaluation and Research Vinay Prasad,
M.D., M.P.H.

When I learned of this action, my first thought was that Dr. Prasad probably did
the right thing here, even if it turns out that the deaths weren’t related to
Elevidys. This was even after I learned some context from Dirk Haussecker at the
RNAi Therapeutics blog:

When Vinay Prasad was appointed to head CBER 3 months ago, it caused a sell-off 
in biotech stocks relying on accelerated approval pathways aimed to ultimately
provide patient choice in a timely manner.  Gene therapy companies in particular
rely on these pathways (e.g. biomarker-based, natural history comparisons) with
their ongoing programs and Prasad has been public with his disdain for the
Elevidys approval under Peter Marks.

In subsequent weeks and months, the investor and sector panic subsided as Vinay 
tagged along FDA Chief Makary advocating regulatory flexibility (approval at the
slightest sign of efficacy or plausible biological mechanism).  After recent
rejections of Capricor’s DMD cell and Replimmune’s oncolytic viral therapies and
now the controversy around Elevidys and Sarepta, this view is changing quickly 
again.

Unsurprisingly, Trump’s loyalty enforcer Laura Loomer has picked up the scent
and identified Prasad as a Bernie Sanders-style progressive, a wolf in sheep’s
clothing undermining Republican healthcare philosophy.

That being said, Haussecker also puts the deaths into perspective:

This death occurred and was reported to the FDA in early July.  To be clear, it 
was an unforced error by Sarepta to not publicly disclose that death for
transparency reasons as it claimed that it retiring most LGMD gene therapy
programs had nothing to do with safety.  It is, however, becoming increasingly
evident that pre-existing poor liver health such as cholestatic disease (à
XLMTM-related AAV gene therapy deaths) is the major risk factor for dying from
AAV-related liver failure.  The fact that none of the ~800 ambulatory and
therefore younger DMD subjects have died due to high-dose AAVrh74 gene therapy, 
but 3 out of ~140 non-ambulatory (à hepatic steatosis risk) patients treated
with AAVrh74 fits neatly, making it the hypothesis that needs to be disproven
first.

Reasonable people can disagree whether this is sufficient context not to have
placed a halt on the drug based on these recent deaths. The problem, of course, 
is that Dr. Prasad is in a bind of his own making. For example, compare Dr.
Prasad’s promise in June to make rare disease drugs available at the “first sign
of promise,” as well as Makary and Prasad’s embrace of a “more fluid concept of
evidence” for regulatory approval, to what seems to be a rather standard
regulatory action that most heads of CBER probably would have taken under
similar circumstances, and here we are. Indeed, this is one of the situations
where I would agree with Dr. Prasad that evidence for the drug’s actual clinical
efficacy is, from my perspective, fairly weak, as described in this New York
Times article:

The F.D.A. first approved the treatment under its accelerated approval program
for young Duchenne patients who do not use wheelchairs. That pathway is for
drugs that have had a successful study showing changes in the body but have not 
been proved to extend survival or markedly improve quality of life.

Dr. Peter Marks, who at the time was director of the F.D.A.’s vaccine and gene
therapy division, pushed the approval through, overruling staff scientists who
opposed the move.

The treatment had not been rigorously shown to improve patients’ motor
abilities, such as standing, walking and rising. But it had been shown in
clinical trials to increase production of a key protein, a signal that the
company said was predictive of meaningful benefits for patients. Some patient
groups applauded Dr. Marks’s decisions, saying they were willing to take a risk 
with such a devastating disease.

The article also notes that Dr. Marks agrees with the FDA decision:

In another interview on Friday evening, Dr. Marks said that he supported the
decision to step back and re-evaluate the safety of the medication.

“This is a different finding than what we originally made the benefit-risk
determination on,” he said. “So I don’t disagree with a statement that maybe it 
would be good to take a breather and look at what’s going on here, particularly 
given the potential implications for the larger field of gene therapy.”

Again, this is one decision that Dr. Prasad has made that I consider to be
pretty reasonable and one that almost any director of CBER probably would have
made, even if it turns out that the Sarepta’s conclusion that the Brazilian
boy’s death was “deemed unrelated to treatment” and, as Haussecker seems to
think, more likely due to the child’s immunosuppression.

Here’s the second part of the bind that Dr. Prasad has placed himself in,
through the fault of no one but himself. Even in the case of a making a decision
that was not unreasonable based on science and caution, one with whom his
predecessor who approved Elevidys agrees, some of Dr. Prasad’s other past
statements have come back to haunt him, and the attack article by Robert
Goldberg, Vice President of The Center for Medicine in the Public Interest, that
was cited by Rick Santorum takes full advantage of that:

Imagine telling a poor cancer patient they can’t access the same genomic test
their wealthier neighbor receives—not because it doesn’t work, not because it’s 
unsafe, but because a bureaucratic panel has declared the science behind it “not
pure enough.”

This isn’t a dystopian hypothetical. It almost happened in Oregon, where a
Medicaid board nearly blocked coverage for genetic testing that could guide
life-saving cancer treatment. At the helm of that chilling deliberation? Dr.
Vinay Prasad.

And:

Prasad’s hostility toward breakthrough therapies is not confined to policy
memos. He has dismissed Elevidys as “disgusting” because of its $3.2 million
price tag, decried its “unclear benefit,” and labeled it a “useless drug.” He
lumped it together with Sarepta’s earlier exon-skipping therapy Exondys 51,
calling its approval the result of “shenanigans” and “FDA politics” overriding
science.

To Prasad, the danger isn’t a fatal disease killing your child—it’s the prospect
that someone might get a new medicine he doesn’t think is worth using. In 2016 
he wrote: The case for rationing: Why we should limit public spending on cancer 
drugs.”

There’s no doubt that any director of CBER who made the difficult decision to
put a hold on shipments of a drug for a rare and fatal condition in order to
investigate reported deaths associated with it would have faced major heat from 
patient advocates. That just comes with the territory, because FDA leadership
positions are not just scientific and medical positions, but political
positions, with the key stakeholders being patients affected by regulatory
decisions, their families, and their doctors. Unfortunately, thanks to his
statements prior to becoming part of the medical establishment as CBER director,
Dr. Prasad has zero trust among muscular dystrophy patient advocates and
advocacy organizations. Why is that? It’s all because his past penchant for
shooting his mouth off didn’t involve just dumping on public health and vaccine 
advocates. Oh, no. Dr. Prasad was never shy about pontificating about FDA
decisions and making highly inflammatory characterizations of decisions with
which he’s disagreed. In this case, his past statements have really come back to
haunt him, because he talked a lot of smack about the accelerated approval of
Elevidys under Dr. Marks, as discussed above. Here’s another good example:

You could replace Peter Marks with a bobblehead doll that just stamps approval
and you would have the same outcome at FDA with lower administrative fees.
Maybe something DOGE should consider.

— Vinay Prasad MD MPH (@VPrasadMDMPH) March 20, 2025

Gee, one wonders why muscular dystrophy patients might nottrust Dr. Prasad to
make the right decision on Elevidys.

That Dr. Prasad said this a mere four months before he had to investigate deaths
potentially associated with Elevidys is—shall we say?—not a good look.
Seriously, even if Dr. Prasad’s decision turns out to have been 100% in the
right, he’s in a trap of his own making because, thanks to his past statements, 
his decision, right here right now, easily takes on the appearance of being
driven far more by his personal bias, his animus towards Dr. Marks, and, of
course, score settling, rather than science, patient protection, and public
policy. A different CBER director might have made the same decision, but have
been given more the benefit of the doubt by patient groups because a different
CBER director wouldn’t have spent the last decade Tweeting and writing
inflammatory things about, well, anything he disagreed with, including heaping
opprobrium on Elevidys and Dr. Marks for having overseen the approval of
Elevidys. (It’s one more reason why appointing obnoxious people like Dr. Prasad 
to a position like CBER director is not a good idea, even if they are qualified,
which Dr. Prasad is not.) A more politically adept, less obnoxious CBER
director might have been able to craft the FDA letter and press release in such 
a way as to mollify patient advocates for the moment and persuade them to give
him a chance to investigate and do the right thing. Unfortunately, Dr. Prasad is
not a less obnoxious, more politically adept CBER director,

There’s another element to this story as well. Remember, the people agitating
for Dr. Prasad to be removed are part of the right wing, anti-government
regulation, “tear down the FDA” wing of the Republican Party, the same wing that
agitated for several years to get “right-to-try” laws passed. Right-to-try, as 
you will recall, only requires that there be an open IND for an investigational 
drug and there be clinical trials open. For drugs that meet those conditions,
right-to-try states that terminally ill patients who want the drug get the drug.
Sen. Ron Johnson (R-Wisc), the sponsor of the final version of the federal
right-to-try bill that became law in 2018 made the real purpose of the law very 
clear, namely weakening the FDA:

As I made clear to my colleagues in the Senate and the House before each body
voted on S.204, this legislation is fundamentally about empowering patients to
make decisions in cooperation with their doctors and the developers of
potentially life-saving therapies. This law intends to diminish the FDA’s power 
over people’s lives, not increase it.

That was the only purpose of right-to-try, and guess what? Right-to-try
advocates are sharpening their knives for Dr. Prasad as well:

Prasad has long made clear that he would reverse what he sees as the FDA’s
leniency. “Their job is the safety and efficacy of drug products,” he snapped on
social media, listing Exondys, Aduhelm, and COVID boosters as examples of
supposed failure. “Now they want to tweet snark?”

But families aren’t asking for snark or leniency They’re asking for the same
moral urgency the Right to Try law was built upon—urgency that President Trump
understood viscerally. The 2018 law wasn’t just policy; it was a declaration
that in America, a desperate parent has more standing than a bureaucratic panel.
That a patient facing death deserves a shot at hope—even if the clinical
endpoint isn’t yet statistically significant.

Prasad rejected that vision outright. He mocked Right to Try as symbolic and
insisted it had no value. And now he sits atop the very agency that Trump sought
to unshackle from bureaucratic inertia.

This is no small irony, given that Prasad has become a darling of some
conservative commentators. A few vaccine-hesitant soundbites and critiques of
lockdowns, and suddenly he’s portrayed as a maverick ally of the populist right.
But don’t be fooled.

And:

They [patients] deserve better. From Sarepta. From the FDA. From a system that
promised them hope.

If the FDA wants to preserve its integrity, restore public confidence, and honor
the spirit of the President’s Right to Try vision, then Prasad must resign—or
at least recuse himself from all matters related to Sarepta and gene therapy
review.

Poor, poor, pitiful Dr. Prasad. The President’s flying monkeys are circling,
lead by Laura Loomer, and he has no one to blame but himself. He’s learning
painfully that, once you go into politics—again, any FDA regulatory leadership
position is a political position in addition to a scientific and medical
one—anything and everything you’ve ever said becomes fair game to attack and
discredit you, no matter what the context, no matter if you have since changed
your position (especially if you have since changed your position). My
schadenfreude comes from the realization that Dr. Prasad made this bed with his 
long history of arrogance and dismissiveness towards anyone who disagrees with
him, even those of us who have spent a long time combatting alternative medicine
quackery like homeopathy, as well as his hilariously performative claims that
he was a Sanders/Warren liberal, although, in fairness, I do think that his
original expressions of dislike of Donald Trump were genuine. Loomer and her
fellow flying monkeys are far better on the attack than Dr. Prasad ever was;
he’s strictly bush league when it comes to political attack, which is why I
suspect that Dirk Haussecker is likely correct in his assessment:

To me it is clear that this is coming down to a showdown between Sarepta, and in
particular its CEO Doug Ingram and Board of Directors, and Vinay Prasad.  The
company is taking the high road saying that it is working to resolve the
shipment halt ‘within the ordinary and well-established FDA channels and
procedures’.  You bet, however, that Sarepta is also working through unofficial 
political channels and Vinay Prasad has not taken into account how Sarepta got
to where it is today in the first place and, being tone deaf to patient concern,
certainly not the strength of DMD patient advocacy which clearly wants Elevidys
to remain a choice for them.  With Replimmune and Capricor showing that
Elevidys is part of a broader pattern, his fate has been sealed in my opinion.  
If not, expect a Jesse Gelsinger-type scenario for gene therapy.

Jesse Gelsinger, you might recall, was the young man who died undergoing
treatment in an early 

clinical trial of gene therapy in 1999, leading to a several year halt in gene
therapy development an d testing in the US.

It’s true. Now the deregulation- and big business-loving wing of the Republican 
Party is joining the flying monkey wing to attack Dr. Prasad. Indeed, just
yesterday, the Wall Street Journal published online two—count ’em,
two!—editorials attacking him:

  1. Vinay Prasad Is a Bernie Sanders Acolyte in MAHA Drag, subtitled A top FDA
    appointee who doesn’t think patients can be trusted to make their own
    healthcare decisions. I laughed out loud at the headline.

  2. The Sarepta Mugging and Drug Innovation, subtitled The Trump FDA tries to kill
    a therapy that has helped boys with a deadly diagnosis. This one is ironic,
    given that I actually sort of agree with Dr. Prasasd that the actual
    clinical evidence that this therapy really does much is rather weak. More
    amusing is how the WSJ editorial page was all for limiting mRNA-based
    COVID-19 vaccines over rare side effects, but now it’s defending Sarepta
    against the seeming depredations of Dr. Prasad. Double standard? Yes.

If you are featured in two WSJ attack editorials, you have well and truly
arrived. So, congratulations, Dr. Prasad!

Whether or not Dr. Prasad can survive the attacks on him coming from Loomer and 
her flying Trump monkeys, the big business/deregulatrion wing of the GOP, and
the biotech/pharmaceutical industry remains to be seen. Sadly, it’s the flying
monkeys who are probably more likely to bring him down than the legitimate
criticism from public health and vaccine advocates, I feel as though I must
conclude by shamelessly echoing Dr. Howard and asking Dr. Prasad how as part of 
the medical establishment he plans to rebuild trust with the public and the
muscular dystrophy patient advocacy groups. After all, time and time again
during the pandemic, he castigated the FDA, CDC, and NIH for having “lost the
trust” of the public and tasked them to rebuild it. Now he is the medical
establishment, and I task him similarly. He needs to rebuild trust. How will he 
do it?

Dr. Prasad reacts as Laura Loomer and her squadron of flying monkeysget closer.

This will be a task made so much more difficult in light of his history of
hostility towards Elevidys, the accelerated approval program, and Dr. Marks, all
of which is extremely is well-documented in his social media posts and all of
which make his decisions seem driven more by his own beliefs rather than
science, safety, and the law. I expect to experience more schadenfreude
observing him struggle. Even if he ultimately manages to hold on to his job, the
inherent contradictions between his “RCTs or STFU” ethos with respect to drug
regulation, which help him when applied to making the approval of vaccines more 
difficult, compared to the more fluid concept of evidence demanded by his boss
RFK Jr. to approve cell therapies, will likely ultimately do him in.

One can always hope. And get some popcorn, because there are some MAHA stans who
think that Laura Loomer and her ilk are in the pocket of big pharma and that’s 
why they’re attacking Prasad. Of course, they are just as unhinged as, or
arguably even more unhinged than, Laura Loomer.

When certain influencers took money from soda makers to trash MAHA, they were
immediately called out and apologized. The series of hit pieces on FDA's Vinay
Prasad coincide with his showdown with Sarepta Therapeutics over the death of
an 8-year-old boy on its drug, the THIRD… https://t.co/pjDX0RpTWX
pic.twitter.com/vGefSQkYPS

— Emily Kopp (@emilyakopp) July 27, 2025

As I said, get out the popcorn.

EBM “Boy Wonder” Vinay Prasad is toppled

Evidence-based medicine “Boy Wonder” Dr. Vinay Prasad was fired as CBER Director
after less than three months on the job. What can the kerfuffle surrounding his
ouster tell us about the FDA and doctors who enabled Robert F. Kennedy, Jr.?

David Gorski on August 4, 2025

Link

Last week, I wrote about a little dustup that Dr. Vinay Prasad, a frequent topic
of this blog and my not-so-super-secret other blog, had gotten himself into as 
the new director of the FDA’s Center for Biologicals Evaluation & Research
(CEBR) when he faced the tough real world responsibilities that the job entails.
I hadn’t intended to write about him again, for a while at least, but by last
Tuesday night, things had, as they say, escalated quickly.

How many Scaramuccis did Dr. Prasad last as Director of CBER? Less than eight?

What happened is that, less than two days after my post, Dr. Prasad—shall we
say?—resigned his position as CBER director, having held it less than three
months. Obviously, it must have been due to my awesome post, which must have
been the final straw. (I keed, I keed.) Truth be told, I was debating whether to
do a followup post realizing that Dr. Prasad’s unceremonious departure had
occurred nearly a week ago. In fact, I was going to write about it on my
not-so-super-secret other blog right after it happened. However, life once again
intervened, which turned out to be OK. I’m actually rather glad, given that I
now have a few days of obtuse reactions from the COVID-19 contrarian
crankosphere. More telling, though, are reactions by by doctors who like to
think themselves reasonable as they ignore the quackery and antivax in the “make
America healthy again” (MAHA) movement, even though the slogan was coined by
the longtime antivax activist who is, alas, now Secretary of Health and Human
Services, Robert F. Kennedy Jr., because they think it really is all about
chronic disease and poor diet. You might also recall the dismay that many of us 
expressed when, after Dr. Peter Marks, who was a longtime FDA regulator and
previous CBER director, was forced out, only to be replaced in early May by Dr. 
Prasad. By mid-June, Dr. Prasad had been appointed the FDA’s chief medical and
scientific officer. Truly, for our EBM Boy Wonder Dr. Prasad, the future seemed 
so bright that he’s gotta wear shades.

Sadly for him, it didn’t last.

Late last Tuesday, I became aware that Dr. Prasad had been unceremoniously shown
the door after a decision that he had made had provoked the ire of Laura
Loomer, the editorial page of the Wall Street Journal, and much of the
right-to-try movement, as well as another decision by him on COVID-19 vaccines
that had ticked off the antivax movement. As a result of the MAGA and “medical
freedom” pile-on, less than three months after being appointed CBER director and
a month and a half after being appointed chief medical and scientific officer, 
the future quickly became…less bright for poor Dr. Prasad:

Vinay Prasad, a top official at the Food and Drug Administration, has suddenly
departed after a series of controversial decisions about a treatment for boys
with Duchenne muscular dystrophy.

“Dr. Prasad did not want to be a distraction to the great work of the FDA in the
Trump administration and has decided to return to California and spend more
time with his family,” Health and Human Services Department spokesperson Andrew 
Nixon told STAT late on Tuesday. “We thank him for his service and the many
important reforms he was able to achieve in his time at FDA.”

Karma. I can’t help but think that maybe there is such a thing as karma. After
all, they sent Dr. Prasad packing not only with the classic bit about not
wanting to be a “distraction,” but also with the even more classic bit the
person who’s been fired wanting to “spend more time with his family.” These are 
two of the most classic tropes imaginable commonly used to announce the
firing—or “asking for the resignation” of—a political appointee who’s become too
controversial for his higher-ups. Indeed, hilariously, it turns out that
President Donald Trump himself had ordered the firing, apparently overruling HHS
Secretary Robert F. Kennedy, Jr. and FDA Commissioner Dr. Marty Makary, who had
only three days before his firing defended him.

FDA commissioner @MartyMakary defends Chief Medical and Scientific Officer Vinay
Prasad from criticism, calling him an “impeccable scientist." He talked to
our @DashaBurns about how partisan politics interact with his role on this
week’s episode of #TheConversation.Subscribe… pic.twitter.com/nu9cO49N4i

— POLITICO (@politico) July 26, 2025

The great Charles Pierce amusingly describes Politico as “TigerBeat on the
Potomac.”

Given the Lysenkoist hellscape that the HHS and pretty much all federal
scientific, medical, and public health programs are fast becoming under
President Trump, it’s difficult for me not to feel a fair amount of
schadenfreude. Even so, I was a bit more sympathetic to Dr. Prasad’s recent
plight—although most definitely not to his history of having played footsie with
the antivax movement that had won him his post—when I wrote about how he had
found himself in the crosshairs of not just one of Trump’s more unhinged MAGA
allies and her flying monkeys but of the “establishment” wing of the Republican 
Party as embodied by the editorial page of the WSJ. At the same time, it was
truly hilarious to read articles in the WSJ opinion page accusing Dr. Prasad,
ridiculously, of being a “Bernie Sanders acolyte in MAHA drag” who “doesn’t
think patients can be trusted to make their own healthcare decisions” and of
“mugging” the pharmaceutical company whose product had been suspended by Dr.
Prasad in the wake of three deaths that were being investigated.

I must admit that when I saw this headline last Sunday night I laughed out loud.

In fairness, it must be noted that any CBER director who makes a decision to
suspend shipments of a gene therapy for Duchenne’s muscular dystrophy can expect
to take heat from patient advocates and industry, but Dr. Prasad’s statements
on social media and elsewhere had provided Laura Loomer and right-to-try
advocates plenty of ammunition, particularly Dr. Prasad’s risibly performative
“he doth protest too much” claims of being a Bernie Sanders/Warren Elizabeth
progressive and some of his performative attacks on Donald Trump, all of which
he routinely deployed in a futile attempt to deflect criticism over how he had
been aligning himself with right wing antivaxxers and anti-public health
zealots. In other words, pay no attention to the times when Dr. Prasad went full
Godwin to characterize public health interventions as incipient Nazi-ism,
embraced the right wing message of “do not comply” with respect to vaccine
mandates, started gaslighting RFK Jr.’s role in spreading doubt about the MMR
vaccine during the deadly 2019 measles outbreak in Samoa, or echoed RFK Jr.’s
deceptive trope about childhood vaccines not having been adequately tested in
RCTs versus saline placebo, a trope that ignores vaccine history, not to mention
medical ethics.

Basically, Dr. Prasad had long courted the right wing outrage machine that went 
into overdrive over pandemic restrictions and mandates, and it was his very
brand that brought him down in the end. It’s a message that, unfortunately, has 
been lost on the very physicians who, along with Dr. Prasad, helped enable
Donald Trump’s war on expertise and science, as you will see from the reaction
of some of Dr. Prasad’s buddies and defenders.

Taped in a hallway of CBER’s office… pic.twitter.com/SczVZUVMkY

— Zach Brennan (@ZacharyBrennan) July 30, 2025

Ice cold…

The rise and fall of an opportunistic contrarian

Dr. Prasad has long been a frequent topic on this blog because of his
weaponization of the evidence-based medicine (EBM) paradigm. He is currently
best known for his “RCTs or STFU” shtick that he used during the pandemic to
cast doubt on COVID-19 vaccines and public health interventions (as well as to
build his brand to the point where he was high profile enough to score jobs at
the FDA for which he is manifestly unqualified). In brief, Dr. Prasad has long
used a very fundamentalist interpretation of the EBM paradigm, in which any
evidence that is not from randomized controlled trials (RCTs) is discounted as
being so poor quality as to be worthless, a use of EBM that I like to call
“methodolatry,” defined as the profane worship of the RCT as the only correct
method of clinical investigation, never mind if an RCT would be unethical,
completely impractical, or even not the best method to study a given hypothesis.
There were few better that Dr. Prasad at weaponizing methodolatry to give the
appearance that they were just asking for “more rigorous” science when in
reality they were doing was to cast doubt on the existing science behind
pandemic public health interventions, such as masking and school closures, and
vaccines.

Indeed, I immediately suspected that the very reason that Dr. Prasad had been
appointed CBER director was because of his methodolatry and receptiveness to the
antivax trope that would demand RCTs of every new version of a vaccine against 
saline placebo, when the only ethical way to do such trials, is to test second
generation vaccines against the old version of the vaccine in order to
demonstrate that the new vaccine is, at the very least, not inferior in terms of
safety and efficacy. Given his history, Dr. Prasad would be able to give RFK
Jr. cover in his war against vaccines as being someone who “just wants more
rigorous science,” or, to provide, as RFK Jr. and the “make America healthy
again” (MAHA) movement has been parroting, “gold standard science.” (“Gold
standard science” is aa deceptive trope that hides the production of doubt about
vaccines and anything else detested by MAHA under the appearance of a quest for
more rigorous science.) On the other hand, Dr. Prasad has always seemed a lot
more flexible when it came to standards of evidence showing vaccine harms,
implying a double standard that could have fit in well under RFK Jr.’s FDA.

As Dr. Angela Rasmussen put it:

During his brief tenure at FDA, Prasad wasted no time carrying out his masters’ 
bidding. He teamed up with Makary to write this odious position piece on
vaccines in the New England Journal of Medicine. This piece argues that US COVID
vaccine policy is patronizing and aggressive, and that vaccines have undergone 
insufficient testing. Prasad and Makary argued that all vaccines in healthy
people aged 6 months-64 years old would require a randomized clinical trial
(RCT) for FDA approval. This effectively means no more COVID boosters for most
people.

There is no reason to run RCTs for vaccines that have been in use for long
enough to evaluate outcomes. We don’t do this for seasonal flu shots because we 
know that these vaccines provide benefits that greatly outweigh the risks. If we
did RCTs for booster updates, we would never be able to use them during flu
season, when they matter. The same is true for updated COVID boosters. This is a
mechanism to limit or ban vaccines, despite Makary and Prasad’s claim that it
is “gold standard science.”

I immediately recognized the conflict that Dr. Prasad would face as director of 
CBER. On the one hand, he was tasked with casting doubt on vaccines by
weaponizing EBM fundamentalist methodolatry, thus making it much more difficult,
if not impossible, to approve new vaccines. However, CBER doesn’t just regulate
vaccines. It evaluates and approves biologics, which includes all stem cell and
gene therapies. Unfortunately, for Dr. Prasad, RFK Jr. had made it very clear
even before Trump was elected again that he wanted to “declare war on the FDA”
in order to approve more stem cell therapies, among other dubious and unproven
treatments and foods:

That fundamental tension between weaponizing fundamentalist EBM methodolatry
against vaccines and approving dubious biologics that RFK Jr. supports was why
Dr. Prasad and his boss Dr. Makary soon got on board with—shall we say?—the more
“fluid concept of evidence.” Such an embrace was necessary for them to be able 
to selectively apply Dr. Prasad’s usual hyper-dogmatic application of EBM (the
aforementioned “RCTs or STFU) to hamper the approval of medicines that RFK Jr.
doesn’t like—cough, cough, vaccines—and yet still be able to make it easier to
approve the things he does like (e.g., dubious stem cell therapies). It was also
that tension that tripped up Dr. Prasad so spectacularly.

I wrote about this in a lot of detail over at my not-so-super-secret other blog,
but I’ll provide the CliffsNotes version here before I move on to discussing
the fallout of Dr. Prasad’s dramatic ouster. The countdown to Dr. Prasad’s
downfall began on July 20, when Trump supporter Laura Loomer published an
article entitled Meet Vinay Prasad: The Progressive Leftist Saboteur Undermining
President Trump’s FDA, in which she described Dr. Prasad as a “catastrophic
vetting failure that demands immediate action to protect Trump’s transformative 
healthcare agenda.” (Talk about being hoist with your own petard!) At the time, 
I couldn’t help but note that Dr. Prasad was indeed utterly unqualified for the 
positions that he now holds, just not in the way Loomer thought. The real
“vetting failure” was how the MAHA stans running HHS and its agencies apparently
didn’t think about how Dr. Prasad’s “RCTs or STFU” ethos might impact FDA
regulation of medical treatments aside from its intended effect on amplifying
antivax messaging implying that vaccines are inadequately tested. They
apparently didn’t foresee the obvious, namely how that same ethos would impact
issues such as accelerated approval programs and “right-to-try” programs beloved
of libertarian “health freedom” and “neuter the FDA” activists. By July 25,
Rick Santorum was amplifying a post on RealClearHealth by Bob Goldberg entitled 
FDA’s Vinay Prasad Stands with Progressive Health Policies, not President Trump,
in which he attacked Dr. Prasad as having mocked right-to-try and as blocking
faster drug approval.

As I wrote last week, reading that he was totally against right-to-try, I
almost—almost!—liked Dr. Prasad! After all, I’ve been a far harsher critic of
right-to-try than Dr. Prasad has ever been, frequently characterizing it as a
Trojan horse designed to neuter the FDA, and, as I’ve noted before, I mostly
agreed with his critique of accelerated approval programs in oncology and the
need to reform them, in order to make sure that the surrogate endpoints used to 
grant accelerated approval to drugs actually do result in actual clinical
benefits to patients, something that Dr. Prasad found in 2019 happened only 20% 
of the time. In other words, even though Drs. Prasad and Makary had provoked the
ire of the antivax movement by approving a new version of a COVID vaccine (even
though they had narrowed its indications such that few could now access
boosters), what lead to Dr. Prasad’s downfall was his hostility towards the
FDA’s accelerated approval program in combination with what was actually a
defensible position of putting a temporary hold on shipments of a very expensive
gene therapy for muscular dystrophy (Elevidys, manufactured by Sarepta
Therapeutics) to investigate three deaths, which led to the knives coming out
for him:

More on the man destroying @POTUS legacy for helping patients. FDA’s Vinay
Prasad Stands with Progressive Health Policies https://t.co/4wQ3mRuA6U

— Rick Santorum (@RickSantorum) July 25, 2025

Again, I went into painful detail about this whole affair last week, but will
say that I didn’t see how any other CBER director could have done otherwise and 
point out that even Dr. Prasad’s ousted predecessor who had approved Elevidys
agreed (sort of) with the decision to pause shipping. The whole question of what
to do in a case like this is not always straightforward, and reasonable
physicians, scientists, and regulators can disagree. Any CBER director or FDA
Commissioner who made a decision like this was going to face some heat, though. 
The amusing thing is that Dr. Prasad’s social media history provided ample
examples of inflammatory statements that allowed Sarepta, MAGA activists,
patient advocates, and right-to-try advocates to cry bias. I won’t list them all
here, given that I’ve already listed a number, but I will post this one again
because of its temporal proximity and vehemence:

You could replace Peter Marks with a bobblehead doll that just stamps approval
and you would have the same outcome at FDA with lower administrative fees.
Maybe something DOGE should consider.

— Vinay Prasad MD MPH (@VPrasadMDMPH) March 20, 2025

That Tweet, by the way, was about the approval of Elevidys and made only a month
and a half before Dr. Prasad’s appointment as CBER director, making it easy for
MAGA, the health freedom and right-to-try movements, and patient advocates to
characterize his decision as biased and based more on settling scores than on
science. It is, of course, comparatively very easy to be a social media
influencer and Substack blogger pontificating from the sidelines about how the
FDA and CDC should do their jobs than it is to actually do the jobs. A more
politically adept CBER director without the baggage of Dr. Prasad’s long history
of criticism of accelerated approval, much of which was actually not
unreasonable if on could divorce it from his inflammatory attacks on Elevidys,
might have survived. Dr. Prasad, however, had no experience running a large
organization whose decisions could be politically charged. He was in way over
his head, and it showed. He should never have been appointed, and it is
satisfying that his downfall was so closely related to his overall brand and
persona.

Unfortunately, his apologists haven’t figured that out, as you will see. They
remain as clueless as they were before Dr. Prasad fell.

Physicians who helped enable the war against public health defend Dr. Prasad

Unsurprisingly, not everyone was happy about the attacks on Dr. Prasad or his
ouster. For example, Emily Kopp from The Daily Caller posted a defense claiming 
that the hit pieces on him were the product of Big Pharma, a claim that found
some traction in the MAGAsphere:

FDA is once again a paid arm of pharma.You can thank @LauraLoomer, Bob
Goldberg, @AllysiaFinley, and the folks at @WSJ.Pharma paid them to coordinate
and pull off the coup. https://t.co/hemECZ4RBX

— Kevin Bass PhD MS (@kevinnbass) July 30, 2025

Kevin Bass is not exactly what you would call…reliable.

LOL. 🤣 CMPI is a front group for pharmaceutical companies. Just look at its
donor list:https://t.co/5Kl2TBKuhIApparently, Santorum and other so-called
"conservatives" are opposed to Vinay since Vinay isn't anti-abortion enough for 
them.

— REGENETARIANISM תִּקּוּן עוֹלָם (@REGENETARIANISM) July 26, 2025

From Wikipedia page for “The Center for Medicine in the Public Interest:”
pic.twitter.com/5pkwZV8VdD

— Joseph Marine (@DrJMarine) July 26, 2025

Meanwhile, COVID-19 contrarian and the “pandemic’s wrongest man” Alex Berenson
echoed this line of defense in On Big Pharma’s demolition of Dr. Vinay Prasad,
one of the most honest people in medicine. So did Geoff Pain. Most hilariously
of all, Natural News ran a story entitled Vaccine truth-teller Vinay Prasad
FORCED OUT of FDA post as Big Pharma tightens grip on science. Let’s just put it
this way. When Mike Adams okays a post portraying you as a brave truth-teller, 
your medical and scientific credibility should be demolished for the rest of
your life. Not coincidentally, ever since Dr. Prasad was forced out of CBER,
I’ve been predicting that he will rebrand himself as even more of a “brave truth
teller” who was “forced out” by nefarious big pharma forces for trying to bring
The One True Version of EBM to the FDA approval process. I further predict that
he’ll likely go back to being a social media influencer and to tell his highly 
biased and embellished “inside story” of how behind the scenes is really run by 
big pharma.

That last person responding to Kopp is Dr. Joseph Marine a cardiologist and
electrophysiologist who appears to like Donald Trump. He definitely likes MAHA, 
talking the same talk (although it’s unclear whether he walks the walk). He’s a 
less frequent contributor to Sensible Medicine, the Substack founded by Drs.
Vinay Prasad, Adam Cifu, and John Mandrola that to me seems dedicated to
promoting not just COVID-19 contrarianism but also to the same sort of EBM
fundamentalist methodolatry that Dr. Prasad was known for. As it turns out, Dr. 
Marine published some embarrassingly bad posts for (not-so)-Sensible Medicine,
including, most infamously, Why Doctors Should Learn to Stop Worrying and Love
MAHA, as well as a credulous post entitled The MAHA Report: A Seismic Shift in
US Health Policy. It’s hard to argue that the MAHA Report isn’t a seismic shift 
in US health policy, but it is easy to argue against Dr. Marine’s apparent
belief that this shift is a good thing for medicine and patients. In any case,
Dr. Jonathan Howard deconstructed the first post, in particular Dr. Marine’s
ludicrous claim when criticized for his credulity towards MAHA:

See what I mean? Physicians like Dr. Prasad and his stans at (not-so)-Sensible
Medicine pretend that antivax quackery (not to mention a whole lot of other
quackery unrelated to vaccines) isn’t an integral part of MAHA, in favor of
deluding themselves that it’s all about getting Americans to exercise more, eat 
a healthier diet, and live a healthier lifestyle.

This brings us to the rest of the (not-so)-Sensible Medicine crew. Both Dr.
Mandrola and Dr. Cifu are so very, very unhappy that their Substack-mate Dr.
Prasad was treated so very, very horribly. Dr. Mandrola was first out of the
gate, publishing on his own Substack a post entitled Prasad Being Forced Out of 
FDA is a Sad Day for Evidence-Based Medicine. (Hint: It wasn’t.) Truly, Dr.
Mandrola is divorced from reality here:

Here are some initial thoughts.

Mainly I am sad.

Sad for Vinay because he told me how much he had learned in his short time. He
was happy doing a job that had incredible meaning. You could see how much this
new role meant to him in the FDA videos he did with Marty. It was a different
Vinay.

I only have to ask: If Dr. Prasad was so happy in his new role, why were there
news reports about how he frequently didn’t attend important directors meetings 
and about his seeming disinterest he showed in…oh, you know…actually doing the
administrative work of being CBER director?

From STAT News:

Multiple agency (FDA) employees, who requested anonymity to protect against
retaliation, told STAT that Prasad seemed uninterested in the administrative
work of being a center director. One CBER agency official said Prasad rarely
attends center meetings with office directors, and that their questions about
the budget, HR functions, and IT systems have gone unanswered.

That sort of stuff seems rather important to me, but apparently Dr. Prasad liked
overruling career scientists on vaccine recommendations more than putting in
the grunt work to make sure that CBER could actually run smoothly. Don Fink, a
former FDA employee, wrote on LinkedIn:

This begs the question: What has Dr. Prasad done in his Center Director’s role
at CBER to earn the support of managers (yes, earn, it’s not an entitlement)
when apparently he is filling this role ‘in absentia’?…Of the three hats
currently being worn by Dr. Prasad: (1) FDA Chief Medical Officer, (2) Chief
Scientific Officer, and (3) CBER Center Director, clearly he has little appetite
or enthusiasm for fulling the obligations and duties of the latter.

That hardly seems like a description of someone who was overjoyed to be doing
“important work” of running CBER and eager to learn how to do the job. Also, I
saw a couple of the videos that Dr. Prasad did with his boss Dr. Makary. The Dr.
Prasaad in the videos was the same Dr. Prasad, just toned down a fair amount
for an “official” government channel. One can’t help but think that Dr. Prasad
enjoyed making videos for the FDA far more than actually doing his job as CBER
director. Maybe Dr. Makary should have tapped him as the FDA’s social media
director.

In fairness, Dr. Mandrola is not entirely unreasonable—although he is clearly
rather oblivious—to note:

The question I have, and surely you do too, is why would political operatives
care about a specific drug for a rare disease.

Surely everyone (no matter the political affiliation) would want an FDA that
reacts cautiously to any drug that could cause death.

If only Dr. Mandrola had been paying attention all these years! (I mean,
seriously, how obliviously clueless can a physician be?) Is he not familiar with
the deregulatory fervor of the libertarian “health freedom” contingent that
birthed the “right-to-try” movement, which basically says that those with
terminal (or even serious) illnesses should be able to assume the risks of
taking any experimental therapy they want, as long as it’s passed phase I
studies? (There’s a reason why right-to-try Senator Ron Johnson joined the
pile-on. He was a sponsor of the 2018 right-to-try bill, which has been a
massive failure.) Are you not aware of the tech-bro libertarian contingent that 
wants to replace the current drug approval system with a “Yelp!”-like online
ratings system, a “Yelp! for drugs,” if you will? These forces happily teamed up
with patient advocates to portray Dr. Prasad’s decision as cruel and heartless.
As Dr. Rasmussen put it, “Prasad pissed off the ‘medical freedom’ component of 
the base that wants to be liberated from regulating drugs to ensure they are
safe and effective.”

Don’t get me wrong. I have little doubt that big pharma and Sarepta in
particular probably lent a hand to pushing Dr. Prasad out, but Dr. Mandrola
seems blissfully unaware of the even more powerful non-pharma political forces
that want to neuter the FDA, even to the point of approving drugs after they are
just shown to be safe and not requiring that pharmaceutical companies
demonstrate efficacy until after approval. These are the political forces of
which Dr. Mandrola appears blissfully ignorant. Moreover, as I’ve said before, a
more skillful CBER director who was not so arrogant and dismissive would have
maintained good communications with patient advocacy groups, so that when he had
to make a hard decision like the Sarepta decision they might be willing to give
him a chance to investigate. A more skillful CBER director would have crafted a
less tone-deaf announcement of the decision. Sadly, Dr. Prasad was not such a
CBER director—and, even if he had survived, would have been unlikely to mature
into one.

Dr. Mandrola did, if you’ll excuse the term, shred my irony meter here:

And if that were true, if industry could so easily extract an independent judge 
of evidence, then the only thing to feel is intense cynicism and hopelessness.

Gosh this is bad. I am not against medical industry. We have had great advances 
in this generation.

But society also needs independent judges to prevent profiteering of susceptible
people with serious illness. That we had one, and he was removed this easily is
simply awful. Trust is shredded.

Seriously, Dr. Prasad—and, to a lesser extent, Drs. Mandrola and Cifu as his
collaborators—has been shredding trust in medicine since 2021, if not earlier.
It is profoundly ironic that that same lack of trust led to Dr. Prasad’s ouster 
after less than three months on the job, right after he had to make his first
tough decision that might run afoul of the MAHA and right-to-try forces that
were important to his initial appointment.

Dr. Cifu followed soon after to lament Dr. Prasad’s “resignation,” publishing a 
post on (not-so)-Sensible Medicine entitled A Sad Day for EBM, which was
republished in a different form in STAT News as Vinay Prasad is my former
student and friend. His departure from FDA is a loss for American medicine, to
its shame. He begins thusly:

I do understand that he is … well … divisive. He has strong opinions, and he is 
not shy about sharing them. On social media, he has at times been brash, nasty, 
and insulting. Being opinionated and insensitive guarantees enemies, and he made
them in spades. I have many colleagues who confide that they greatly respect
his intelligence and productivity and agree with him on most issues, while being
seriously offended by his style.

This style, however, brought more attention to the issues he feels strongly
about than the scores of sober papers he published. It probably also played a
significant role in getting him appointed to a leadership position at the FDA, a
role that seemed tailor-made for him. In addition to being a leader, he was
rightly put in a position that required a workhorse.

“Divisive”? “Brash, nasty, and insulting”? Try saying that he’s an asshole,
which is a far better description that has long applied to him dating back to
well before the pandemic, when Dr. Prasad became, as Dr. Rasmussen termed it in 
reference to herself and him, “COVID famous.” (She also made me laugh out loud
by referring to Dr. Prasad as the “Steve Urkel of COVID Twitter.”) Dr. Howard
and others pointed out just how nasty and unprofessional Dr. Prasad has been,
for example, here:

Journalists writing on Vinay Prasad should share information about his maturity 
level and professionalism towards his predecessors.Your readers should hear
him in his own words.We all have the right to treat him this way
now.https://t.co/VuVWsDS6Wn

— Jonathan Howard MD (@19joho) May 6, 2025

LADIES AND GENTLEMEN: I PRESENT YOUR NEW FDA CBER DIRECTOR
pic.twitter.com/rvawsMVcej

— The Prasad Parody (@VpwndF) May 6, 2025

Dr. Prasad’s unprofessional and contemptuous behavior predates COVID-19, too. I 
like to relate a run-in that I had with Dr. Prasad a few months before the
pandemic, in which he dismissively attacked medical skeptics who took the time
to debunk quackery like homeopathy, Goop’s jade eggs, and various antivax
claims, portraying their efforts as not worth his massive brain power or even
the much lesser brain power (than him, of course) possessed by a typical MD.
Why? Because to him it was so obvious that homeopathy didn’t work and that
antivax was nonsense. He even urged me to “join him” in examining suspect pharma
clinical trials, apparently not realizing that the same skillset was necessary 
to show why all those seemingly positive homeopathy trials didn’t actually show 
that homeopathy works.

Also, Dr. Prasad’s being a “workhorse” apparently didn’t extend to his actually 
doing the less glamorous aspects of the job, such as actually attending meetings
and doing the administrative grunt work associated with the job, as I mentioned
above.

The greatest irony here is that it only took less than two years after that
encounter for Dr. Prasad to start praising a dumpster-diving study in the VAERS 
database (co-authored by Dr. Mandrola) looking for COVID-19 vaccine harms and
three years to be echoing RFK Jr.’s deceptive claim that childhood vaccines are 
not adequately safety-tested because they haven’t all been tested in RCTs
against saline placebo. Along the way, as I mentioned above, he echoed the
antivax claim of “do not comply” with COVID vaccine mandates and, most recently,
gaslit the role of RFK Jr. in undermining confidence in the MMR vaccine during 
the deadly 2019 Samoan Measles outbreak.

In the article, Dr. Cifu hilariously tries to argue that, contrary to his
frequent dismissal of non-RCT evidence and his contemptuous motto of “RCTs or
STFU for all” that revealed that he truly did not understand when RCTs were
unethical, impractical, or the wrong tool, Dr. Prasad was really, truly, and
actually open to more forms of evidence:

Vinay was also guaranteed to be labeled a hypocrite. Although his views on
evidentiary requirements have always been nuanced, many critics labeled him as
accepting only randomized controlled studies as adequate evidence. But that’s
not right. To function in his position, he would need to be open to a spectrum
of evidence, as all physicians must be — and he is.

If that were ever the case, Dr. Prasad never actually showed much, if any,
evidence of it in any of his publications or, in particular, his social media
statements and YouTube videos that I’ve ever seen. Seriously, maybe Dr. Cifu can
point me to any statements made by Dr. Prasad before he became CBER director
that showed that he seriously considered “lesser” evidence, given that his whole
schtick was weaponizing the EBM paradigm to cast doubt on public health
interventions against COVID, including vaccines. True, he did seem to embrace a 
“more fluid concept of evidence” after appointed, but I saw little evidence
before that he actually believed it. On the other hand, he did embrace some
pretty crappy studies that showed harms from vaccines; so maybe he could have
worked it out after all if he hadn’t stumbled so early.

I will give Dr. Cifu credit for noting the conflict at the very heart of Dr.
Prasad’s appointment, even as I laughed aloud reading the last sentence:

To succeed by what I know to be Vinay’s high standards, he was going to need to 
make difficult and unpopular decisions. The pharmaceutical industry would be
angered when therapies with poor evidence bases were withheld or more data were 
demanded. Any limit to vaccine availability would anger those who already
disagreed with him during Covid. Any support for vaccines would anger many in
health secretary Robert F. Kennedy Jr.’s camp, who seem unreasonably skeptical
of all vaccines.

“Seem unreasonably skeptical of all vaccines”? Seriously? How can anyone be that
clueless? They’re not “skeptical’; they’re antivax. RFK Jr. is not a skeptic;
he is antivax to the core and has been an antivax activist since at least 2005. 
Worse, as I pointed out above, Dr. Prasad has, likely without even realizing it,
been echoing common longstanding antivax talking points. Indeed, the position
described in that infamous opinion piece published in the New England Journal of
Medicine that Dr. Rasmussen so castigated implying that vaccines have undergone
unsufficient testing and that all vaccines in healthy people aged 6 months to
64 years old should require an RCT for FDA approval, represented an important
step towards realizing RFK Jr.’s vision of undermining and destroying the US
federal vaccination system.

Still, Dr. Cifu did perceive the inherent conflict. Dr. Prasad was brought in to
weaponize EBM fundamentalist methodolatry against vaccine approvals. Even
though he claimed to have embraced that more ‘fluid concept of evidence,”
however, that same methodolatry was bound to come into conflict with RFK Jr.’s
desire to approve dubious stem cell therapies, as well as the desires of
the”health freedom” movement and right-to try to let patients basically use
whatever they want and pharma to sell it to them, evidence for the most part be 
damned. In brief, Dr. Prasad was insufficiently antivax for MAHA and too strict 
an EBM advocate for “medical freedom.” That essential conflict guaranteed that
his tenure was never going to end well.

Worse, as a result of this dustup, RFK Jr. now seems to realize the inherent
problem that CBER presents him when it comes to realizing his twin visions of
making it all but impossible to approve new vaccines and making it much easier
to approve dubious MAHA-approved stem cell therapies. The two aims are in
fundamental conflict, which is why there is now talk of splitting vaccine
approval out of CBER into a new office at FDA. This would allow RFK Jr. to put
an antivaxxer in charge of vaccine approval while putting someone more —shall we
say?—open-minded in charge of approving stem cell therapies.

Finally, Dr. Cifu laments:

I am bewildered by political operatives who demand loyalty over effective work. 
I am disappointed that Vinay’s superiors apparently bowed to pressure over a
drug whose safety is more in question than that of any of the vaccines that the 
HHS secretary spends so much time criticizing.

That Dr. Cifu thinks it was just about this drug shows just how oblivious he has
been to the antiscience forces that I and people like Dr. Howard have been
warning about for years and years. These are the same forces that put an
unqualified hack like Dr. Jay Bhattacharya in charge of the NIH just because he 
has politically aligned with them and is willing to be the figurehead—the useful
idiot, if you will—to preside over the ideologically motivated dismantling of
the NIH. Similarly, Dr. Makary is the useful idiot chosen to preside over the
neutering the the FDA, and Dr. Prasad was the useful idiot in turn chosen by Dr.
Makary to demolish the vaccine approval process.

To sum it up, I’m with the Pandemic Accountability Index:

…nobody should let Vinay Prasad live this down. He wanted to become a celebrity,
appearing on countless podcasts and Youtube videos spewing unscientific garbage
to stand out and build a personal brand for himself. Now everyone knows him as 
the biggest clown in medicine, flaming out of the Trump Administration in a
matter of just a few weeks. Was it worth it, Vinay?

Dr. Prasad is shameless. I suspect that, if he can return to social media as a
martyr toppled by big pharma and can monetize that status, he will end up
answering yes. He doesn’t have to be respected by his colleagues to achieve
that. Don’t believe me? Just look at Dr. Mehmet Oz, America’s Quack.

Dr. Prasad and his shameless thirst for fame and influence aside, I will
conclude by observing that far too many of my colleagues have been oblivious or 
even blind to the forces of quackery and antivax pseudoscience that are now
firmly in control of the entire nonmilitary departments and agencies of public
health, medicine, and biomedical research in this country, all led by a raving
but clever antivax conspiracy theorist who wants to eliminate as many vaccines
as possible while giving quackery the imprimatur of FDA approval. These are the 
same forces that have contributed to the infiltration of the very alternative
medicine quackery (e.g., homeopathy) that Dr. Prasad considered a no-brainer to 
debunk into the bastions of academia, including the NIH and many academic
medical centers. Whether he knew it or not, Dr. Prasad was brought in to
weaponize EBM against vaccines while at the same time approving more stem cell
quackery. He tried navigate the choppy sea between the Scylla and Charybdis of
those imperatives but failed.

Don’t feel sorry for him, though. He chose this, and he’ll likely ultimately be 
fine. No doubt he’ll return to his career as a contrarian and obnoxious social
media influencer. Meanwhile, the destruction of public health and science-based 
medicine by the crew with whom he played footsie continues apace.


Dr. Vinay Prasad’s Legacy is Shattered Trust & 11 Other Thoughts on His Decision
to Spend More Time with His Family

Anyone who defends Dr. Vinay Prasad today is admitting he failed to restore
trust.

Jonathan Howard on August 5, 2025

Link

1: Dr. Vinay Prasad’s Hiring Should Have a Much Bigger Scandal Than His Firing

My first article here was a refutation of Dr. Vinay Prasad’s anti-vaccine
nonsense. Along with many others, I have have been chronicling his
disinformation for years, and it has taken volumes to do so. Even then, we are
just scratching the surface. There’s an overwhelming amount of it. Anyone who is
familiar with Dr. Prasad’s disgraceful pandemic record knows his hiring should 
have been more of a scandal than his firing. From COVID to RFK Jr., Dr. Prasad
relentlessly sought to numb people to grave risks, all to advance his personal
brand and political agenda.

Dr. Prasad was also a vulgar and unprofessional social media star who had no
experience running a large organization. As Dr. Bruce Lambert said:

He is a hostile and dismissive iconoclast, especially on social media. There’s
no ambiguity about why people were happy to see him leave. He had open contempt 
for the agency. I said when he was appointed that I thought he lacked the
emotional maturity and social skill needed to lead a large organization. Nothing
in his background suggested he had such skills. Managing a big bureaucracy is
not easy, and just being a smart is not enough to be successful. You have to be 
good with people, and he is clearly not.

Though Dr. Prasad never doubted himself for a moment, he was utterly unqualified
for his position, which seems to be a requirement for the Trump administration.
While his decision to “spend more time with his family” was unsurprising, in a 
sane world, an immature disinformation agent like him never would have been near
the levers of power in the first place.

2: The Leopards Came for Dr. Prasad’s Face

Donald Trump forced Dr. Prasad to resign. No matter who influenced Trump’s
decision, only he had the power to send Dr. Prasad packing. Even though Trump is
the kind of person who listens to vile propagandists like Laura Loomer, Dr.
Prasad repeatedly endorsed Trump (Never Forget: Vinay Prasad Loved Donald Trump)
and eagerly joined his administration. No one forced Dr. Prasad to do this. He 
chose it all.

Dr. Prasad also defended Trump’s right to fire anyone he wanted and fantasized
about being able to lead mass purges himself. Dr. Prasad spent the past four
years legitimizing the forces that came for his jugular. He bonded with them
over COVID disinformation, and incorrectly thought that would sustain him once
he joined the FDA. He never counted on these forces coming for him. However, Dr.
Prasad told people to stop talking about COVID and unfortunately for him, they 
did. The COVID coalition shattered and the leopards came for his face too. As
one person rightly said about Dr. Prasad’s downfall, “Live by the crank, die by 
the crank.“

3: The Circumstances Of Dr. Prasad’s Firing Were Bad and His Replacement Could
be Worse

If aliens teleported Vladamir Putin and Kim Jong Un off the planet, I would not 
feel sad for them one bit. However, I would be very concerned that aliens were
beaming away world leaders. While no one should shed a tear over Dr. Prasad’s
departure, it’s not necessarily a good thing that he is gone.

Dr. Prasad made a lot of people very angry in a short amount of time, and much
of that anger was sincere and understandable. Experts like Dr. Paul Offit also
criticized Dr. Prasad regarding vaccines, though this played no role in his
departure. No one in the Trump administration is listening to Dr. Offit,
unfortunately. I urge you to listen to this interview with a mother whose child 
has muscular dystrophy and is thriving on a treatment Dr. Prasad briefly removed
from the market. These parents felt that Dr. Prasad had not communicated with
them at all.

Other actors were not so pure of heart. I don’t need to repeat the details
behind Dr. Prasad’s firing, but the knives were out from all directions.
Right-wing propagandists and politicians, the biotech industry, the conservative
media, and advocates of right-to-try laws collaborated to sink Dr. Prasad. With
COVID in the rearview mirror, they rightly saw Dr. Prasad, their former ally,
as an anathema to their philosophy. The disinformation outlet the Free Press was
correct when it said “the right-wing attack machine revved into action” though 
of course, Dr. Prasad was a key part of that attack machine for many years.

It’s unambiguously bad that these forces can manipulate Trump to take down FDA
regulators. There is no question that Dr. Prasad’s firing, like his hiring, was 
political, and whoever replaces him will be keenly aware of this. The door is
open for RFK Jr. to install a crank who will reject vaccines and approve
quackery. As journalist Sarah Karlin Smith wrote:

My guess like I said last nice is this may be a sign of looser standards for
cell and gene therapy space and yet conversely an even tougher environment for
vaccines….

If that nightmare comes to pass, Dr. Prasad’s resignation paved the way.

4: Dr. Prasad’s Own Phony Words Took Him Down

Dr. Prasad woke-washed the pandemic, and these disingenuous performances came
back to bite him. Although he parroted right-wing talking points and elevated
right-wing figures, he feigned being a “progressive” to guilt liberals into
believing that COVID mitigations betrayed their core values. This phoniness
allowed Laura Loomer to weaponize his words against him. She absurdly portrayed 
Dr. Prasad as a “progressive leftist saboteur” to convince Trump that he had to 
go. This was the price Dr. Prasad paid for playing a character, the MAGA
progressive, for the past 4 years.

5: 7-Foot Hoops Matter

While Dr. Prasad was cozying up to the forces that took him down, we here at SBM
tried to sound the alarm bells about them. For example, Alysia Finely wrote an 
article an influential article in the WSJ titled Vinay Prasad Is a Bernie
Sanders Acolyte in MAHA Drag. I had pegged her as unreliable 3 years ago in my
article Science Fiction at the Wall Street Journal. Perhaps Dr. Prasad could
have avoided his sad fate had he spent less time dunking on SBM and more time
paying attention to our warnings about the dangers of 7-foot hoops.

6: Dr. Prasad is Not Off the Hook for RFK Jr.

In addition to fluffing Trump, Dr. Prasad relentlessly fluffed RFK Jr. To pick
one example amongst many, in December 2024, he wrote to an article titled
Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy that said:

The best way to curb vaccine hesitancy is to approve RFK Jr, and redirect his
energies to generating more data. More data will answer the key questions that
remain unanswered: which childhood immunization program is optimal. The worse
thing we can do is tank his nomination. Then vaccine hesitancy will explode.

Things didn’t work out that way, and just because Dr. Prasad is no longer in
power, that does not mean he is off the hook for RFK Jr.’s actions. RFK Jr. is
leading the HHS in part because “respectable” doctors like Dr. Prasad vouched
for him. Since taking office, RFK Jr. has predictably placed cranks like Dr.
Robert Malone into positions of power. Dr. Prasad, an EBM zealot, helped unleash
all the UFOers and chemtrialers on us. Dr. Prasad owns this and everything RFK 
Jr. else does moving forward.

Watch this video here

7: Dr. Prasad Did Not Shine in his Day Job or Impress His Co-Workers

Prior to entering the FDA, Dr. Prasad repeatedly dunked on his future employees 
with his typical childish profanity. That usually doesn’t end well, and it
didn’t end well.

Once at the FDA, Dr. Prasad had an actual job to do, and he did not shine at it.
According to an article titled Inside the Collapse of the F.D.A.:

Reports from inside the agency remained bleak. Some of the civil servants fired 
in February and April were now being invited back (the office of generic drugs
had been reinstated), but most were not. Those who remained were being asked to 
volunteer for essential tasks for which there was now no dedicated staff.
Scientists and technicians still did not have ready access to the scientific
journals they needed to do their work. More than one drug review had been
delayed, and political appointees had interfered in several others. And,
ultimately, Vinay Prasad, the agency’s new chief medical and scientific officer,
overrode expert recommendations on the Novavax and Moderna Covid-19 boosters
slated for this fall. As expected — and perhaps as intended — many of the
F.D.A.’s remaining employees were now looking for jobs outside the government.

People voted with their feet to get away from Dr. Prasad. Another article US
FDA’s Biologics Center Departures Grew Before More Than 100 RIFs Exited said
that the:

FDA’s biologics center reported 106 departures from Jan. 1 to June 30. These
numbers do not include those who were part of the reduction-in-force. FDA
sources estimate CBER lost another 100-150 due to the RIF.

I don’t know anything about the day-to-day life of FDA employees, but I imagine 
there are many vital but unglamorous duties. Meetings and tasks without cameras 
seemed to bore Dr. Prasad. According to the article titled Vinay Prasad Named
Chief Medical and Science Officer at FDA:

Multiple agency employees, who requested anonymity to protect against
retaliation, told STAT that Prasad seemed uninterested in the administrative
work of being a center director. One CBER agency official said Prasad rarely
attends center meetings with office directors, and that their questions about
the budget, HR functions, and IT systems have gone unanswered. Prasad did not
consult career staff before unveiling a new regulatory framework for Covid-19
vaccines with Makary in May.

Dr. Prasad also fired people himself. According to an article about Dr. Nicole
Verdun titled Top Gene Therapy Regulator Forced Out at FDA:

Verdun, and her deputy, Rachael Anatol, were placed on administrative leave by
Prasad, and escorted out of FDA headquarters on Wednesday, STAT reported
exclusively. Verdun told staff she was not given an explanation for the firing. 
She declined to comment for this story.

Longtime FDA employees noted that immediately escorting employees out of the FDA
is unusual, and was seen by some staffers as cruel. Multiple employees could be
heard voicing outrage over the move during a call Verdun convened to tell staff
of the news Wednesday, according to a recording that was obtained by STAT.

When Dr. Prasad suffered the same fate, there was no outrage. Rather his former 
co-workers put up this mocking photo, a technique Dr. Prasad employed himself.
Whoever takes over from Dr. Prasad will find the CBER and FDA in much diminished
shape compared to when he arrived in May, though at least Dr. Prasad’s
departure is said to have “improved morale“.

8: Dr. Prasad Had His Chance. He Failed.

Dr. Prasad got famous regarding COVID only because he “called for” the medical
establishment at the time to do many difficult things. He “called for” schools
to be open and for more RCTs to be done. It turns out podcasting about doing
things is easier than actually doing this. Yet, since his departure, several of 
his defenders have taken the attitude- Vinay Prasad cannot fail. He can only be 
failed.

This is false. There is no need to speak about Dr. Prasad in the conditional
tense or play imaginary games about what he “would have” done in some fantasy
world. He has a track record now. We don’t have to debate whether or not Dr.
Prasad “would have” restored trust. He didn’t. He was given the opportunity, and
he failed. Maybe he was treated horribly and unfairly and that shouldn’t have
happened, but it did. Trump fired him in record time. Perhaps there is a
parallel universe out there where Loomer doesn’t exist, Big Pharma is impotent, 
Trump is reasonable, and Dr. Prasad has a successful tenure at the FDA. But that
universe isn’t ours.

Any discussion about the wonderful, amazing things Dr. Prasad “would have” done 
presupposes an alternate reality where powerful forces were not aligned against 
him or where Dr. Prasad had the savvy to contain them. That’s like saying, I
would have been a major league superstar if I had been able to throw 100 MPH.

9: Propagandists are Censoring Dr. Prasad’s Pandemic Record to Rehabilitate his 
Image and Portray Him as a Victim

While science-based doctors were horrified at previous purges of scientists,
essentially no legitimate doctor was sad to see Dr. Prasad go. I’ve seen almost 
no one come to his defense. However, a very small number of doctors, Dr.
Prasad’s business partners and fellow misinformation superspreaders, cared only 
about his dismissal. They were silent when Dr. Prasad had Dr. Verdun frog
marched out the FDA, and in their view, Dr. Prasad is the first fired scientist 
anyone should care about.

To make their case, they immediately set to censor Dr. Prasad’s pandemic record 
and portray him as a heroic martyr. As Dr. David Gorski discussed yesterday, Dr.
Adam Cifu wrote a piece of absurd revisionist history titled Vinay Prasad is My
Former Student and Friend. His Departure From FDA is a Loss for American
Medicine. It said:

I do understand that he is … well … divisive. He has strong opinions, and he is 
not shy about sharing them. On social media, he has at times been brash, nasty, 
and insulting. Being opinionated and insensitive guarantees enemies, and he made
them in spades. I have many colleagues who confide that they greatly respect
his intelligence and productivity and agree with him on most issues, while being
seriously offended by his style.

This is absurd. Dr. Prasad’s “style” is not the reason he is divisive. We Want
Them Infected isn’t 400 pages of how I was “offended” by anyone’s “strong
opinions”. That Dr. Prasad called people “motherfuckers” and “fucking morons”
wasn’t his main problem. The main problem was that he directed this juvenile
fury exclusively at vaccine-advocates.

As Dr. Cifu surely knows, Dr. Prasad’s critics, objected to his fake statistics 
and pro-virus/anti-vaccine disinformation. We said that his articles Should We
Let Children Catch Omicron? and Sabotaging RFK Jr’s Confirmation Will Increase
Vaccine Hesitancy were dangerous, and we were completely right. It’s no surprise
that Dr. Cifu censored Dr. Prasad’s pandemic record. He doesn’t trust his
readers with the truth and wants them to think that Dr. Prasad’s critics were
just sensitive snowflakes who never made serious arguments.

Dr. Cifu also wrote:

Vinay was also guaranteed to be labeled a hypocrite. Although his views on
evidentiary requirements have always been nuanced, many critics labeled him as
accepting only randomized controlled studies as adequate evidence. But that’s
not right. To function in his position, he would need to be open to a spectrum
of evidence, as all physicians must be — and he is.

That’s totally false. “His views on evidentiary requirements have always been
nuanced” is pure gaslighting. In reality, Dr. Prasad spent the past 4 years
spreading doubt and rage about his predecessors precisely because they had to
“open to a spectrum of evidence”. Dr. Prasad’s “many critics” didn’t “label him 
as accepting only randomized controlled studies as adequate evidence”. Rather,
we accurately quoted Dr. Prasad, who accepted only randomized controlled studies
as adequate evidence. He wrote articles titled The Scientists Who Undermine
Randomized Trials and said that his motto was “RCT or STFU for all”. He was
guaranteed to be labeled a hypocrite because he changed his mind about this the 
moment he got into office. Dr. Cifu hid this from readers, of course.

Dr. Cifu also wrote:

Vinay is absurdly smart, hardworking, kind, willing to argue points — as he and 
I have done many times on Sensible Medicine — and will change his mind when he
is wrong.

While Dr. Prasad may be smart and hardworking, in reality he was unwilling to
argue points. I wrote dozens of serious articles here and an entire book
discussing the ways I disagreed his pandemic philosophy. So did many others.
Neither Dr. Prasad nor Dr. Cifu ever engaged with any of it in good faith. It
was impossible to have a discussion about science and data with either of them. 
I tried. They refused.

And Dr. Prasad was not kind about any of this. He was vicious and cruel to many 
people- read the article 120 Organizations, Institutions, Individuals, and Tools
that UCSF’s Vinay Prasad Has Attacked. He encouraged vulgar revenge fantasies
against his predecessors and other doctors, even those who needed bodyguards and
received death threats. None of this bothered Dr. Cifu, however, who instead
feigned concern about the “tone” of Dr. Prasad’s critics, such as myself, to
discredit us and avoid the content of our criticism. My tone mattered. Dr.
Prasad’s did not. Imagine the phony outrage if I made a meme like this with
pictures of doctors I didn’t like.

I expect Dr. Cifu will welcome back Dr. Prasad to their monetized Substack where
they share the “shocking inside story” of how he was taken down by Big Pharma. 
The drama, grievance, and revisionist history will continue.

10: Dr. Prasad’s Legacy is a Collapse of Trust

When it came to COVID, Dr. Prasad spent years intentionally spreading distrust
about the previous medical establishment. He made videos such as You’re Right
Not to Trust Public Health and wrote articles such as Trust in Doctors and
Hospitals is Down; Given the Extent of the Dishonesty, It is Still Too High. He 
drilled this message of doubt into the public consciousness daily for years. He 
told people that the medical establishment lied constantly, and they believed
him.

Incredibly, Dr. Prasad believed his own nonsense and thought he could fix the
problem he helped create simply by with incessant discussions of rare, mild
vaccine side effects. In an article about vaccine-myocarditis, he wrote:

This risk-taking approach may, in part, be responsible for widespread loss of
trust in public health and medicine and growing hesitancy against all
vaccination. Public trust takes decades to build, but can be forfeited in a
single action. The FDA’s class SLC action on mRNA products represents one step
toward rebuilding that trust.

That was never going to work. Vaccine-myocarditis was not the root cause of
mistrust after all.

Yet, instead of warning Dr. Prasad that he was headed down a dangerous path, his
“friends” enabled and encouraged him every step of the way. They too felt he
was the perfect guy to restore trust. When Dr. Prasad was appointed to run CBER,
Dr. Cifu, along with Dr. John Mandrola, wrote an article endorsing him that
said:

Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA.
He has our enthusiastic support. Prasad is slated to be the incoming CBER
director, where he will regulate vaccines as well as cellular and gene therapy. 
In our opinion, there is no better candidate…

We can’t think of anyone more qualified to lead the biologics division. Prasad’s
lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies.

Things didn’t turn out that way. However, after Prasad lost his job, Dr. Cifu
claimed he always knew how this would end. He wrote:

I am also unsurprised — this administration acted exactly how I expected it
would, with cowardice and short-sightedness — and angry.

While Dr. Cifu now claims he “expected it” all along, his words reveal that he
while he previously believed a competent doctor could succeed in the FDA, he too
has now lost trust. Dr. Mandorla feels the same way. In an article titled
Prasad Being Forced Out of FDA is a Sad Day for Evidence-Based Medicine he wrote
that:

But society also needs independent judges to prevent profiteering of susceptible
people with serious illness. That we had one, and he was removed this easily is
simply awful. Trust is shredded.

From claiming that Dr. Prasad would “rebuild lost trust” to “trust is shredded” 
in under 3 months is quite the medical reversal, but trust is indeed shredded
after Dr. Prasad’s 3-months in office. A diverse group people, from Sensible
Medicine doctors to Natural News, now view the FDA as nothing more than a pawn
of right-wing influencers, politicians, and Big Pharma.

By being Loomered, Dr. Prasad unintentionally lowered trust in the FDA even
further, and anyone who defends him today is conceding that his mission to
restore trust was an abject failure. Do you have more confidence in the FDA than
you did 3 months ago? Along with those hurt by his COVID disinformation, this
collapse of trust will be Dr. Prasad’s chief legacy.

11: How Long Will Marty Makary Last in the US Surreal Soap Opera

None of this is good for Dr. Marty Makary. Not only is he without his righthand 
man, but he must also be sure not to displease Laura Loomer, biotech companies, 
or the WSJ himself. Moreover, Dr. Prasad’s defenders, Dr. Makary’s former
friends and allies, are now claiming that “pharma lobbyists” are more powerful
than he is when it comes to staffing at the FDA. They have a strong case.

Like Dr. Prasad, Dr. Makary specializes in numbing people to grave risks. His
optimistic predictions- We’ll Have Herd Immunity– always end poorly, and today
he is speaking this way about the FDA- “We’ve got tremendous leadership.” He
insists that multiple news reports about Dr. Prasad’s departure are wrong. In
Dr. Makary’s telling, Trump didn’t fire Dr. Prasad. Rather, Dr. Prasad left of
his own volition because “the commute was brutal“. Moreover, Dr. Makary says
that Dr. Prasad is welcome to return at any time. Anything else would reveal who
is running the show at the FDA.

Almost no one trusts Dr. Makary now, not even his former Sensible Medicine
allies, and it is not clear how he can fix this. Although his job is to restore 
trust, he is spending his time talking about food dyes in ice cream and
spreading wild anti-vaccine anecdotes. Even anti-vaxxers are laughing at him
because of that.

12: A Not-So-Fond Farewell to Vinay Prasad

Our medical leaders, past and present, have created a soap opera. So it’s
possible Dr. Prasad will tire of his family and return to the FDA or makes the
news in some other outrageous way. Until then, I don’t think anyone should or
will care about his Substack articles or YouTube videos. I hope he returns to
patient care and his family and that he finds happiness and meaning in that.

However, as a public figure, he’s totally irrelevant, and he should be ignored. 
I wrote about Dr. Prasad many times previously because I knew that he was
dangerous and influential. That’s no longer the case, and unless that changes, I
see no need write about him ever again.

He was tragically ignorant about the forces he enabled, and he has nothing of
value to say about them now. He’s currently a pawn in a MAGA/MAHA Civil War, and
he will never be accepted into the good graces of academic medicine again. He
will remain a fringe figure the rest of his career, forever tainted by his
pandemic disinformation and willingness to debase himself to elevate Trump and
RFK Jr. Nothing he does moving forward will erase that, and it’s good that it’s 
all saved on video. I am confident his Sensible Medicine buddies will do their
best to deny that it ever happened.

His only usefulness is as a cautionary tale. Medical students should study his
sad trajectory as a warning and strive to be his opposite in every way. Dr.
Prasad had incredible potential, but he squandered it for power, fame, and paid 
subscribers. He surrounded himself in an echo chamber and never doubted himself 
or paused to consider if any of his critics had any valid points. As Dr. Angela 
Rasmussen wrote in her article A Not-So-Fond Farewell to Vinay Prasad:

Prasad may have been too incompetent at enabling fascism for the fascists, but
we should not forget that he volunteered to be part of that. He chose to support
people who are actively annihilating the American government and attempted to
prevent people from accessing lifesaving vaccines and medications. He is not a
colleague. His actions at FDA demonstrate that he is a traitor to our country
and we should never forget that. We should never let him forget it, either.

And while that sounds harsh, I’ve not yet heard any of Dr. Prasad’s critics
speak about him this way, thankfully. Tone is important, after all.


No One Believes Dr. Vinay Prasad Grew Tired of His Family. To Restore Trust, We 
Need an Honest Explanation From Our Medical Establishment. That’s Not Asking Too
Much.

The public deserves to the full story about Dr. Vinay Prasad’s temporary
resignation and how this might impact regulatory decisions moving forward.

Jonathan Howard on August 10, 2025

Link

It’s possible Dr. Prasad will tire of his family and return to the FDA

The TV show known as our Medical Establishment has a new plot twist, one I
suspected may be coming. In what I desperately hoped would be my last article on
Dr. Vinay Prasad, I wrote “it’s possible Dr. Prasad will tire of his family and
return to the FDA“. I wrote that not just because RFK Jr. and Dr. Marty Makary 
didn’t want Dr. Prasad to leave in the first place, but because the official
story was that he resigned voluntarily. HHS spokesperson Andrew Nixon said at
the time:

Dr. Prasad did not want to be a distraction to the great work of the FDA in the 
Trump administration and has decided to return to California and spend more time
with his family. We thank him for his service and the many important reforms he
was able to achieve in his time at FDA.

Predictably, Dr. Makary was eager to promote the narrative that Dr. Prasad left 
entirely of his own accord to be with his loved ones. He said it on camera
multiple times. Anything less would be an admission that staffing decisions at
the FDA were made for political reasons by a mercurial President under the
influence of nefarious actors. As such, he said:

He’s 42 years old, he gave us some of his time. He’s got family in California.
The commute was brutal. And then when he saw some of these sort of smear pieces,
he didn’t want to be a distraction.

Dr. Makary also said that idea that Dr. Prasad “was pushed out by anybody is
simply untrue.”

FDA official returns to agency after Loomer-led ouster

Well, that plot twist arrived, and Dr. Prasad is back. As I wrote previously,
his departure was not necessarily a good thing, and his return is not
necessarily a bad thing. Despite his litany of misinformation, juvenile conduct,
and reported disinterest in his job at the FDA, there are many worse choices
than Dr. Prasad, amazingly.

However, important questions remain. Did Dr. Prasad really tire of his family
that quickly? Did he change his mind about the commute? Is he no longer worried 
about being a distraction? Did Dr. Prasad actually have multiple, dramatic
changes of heart about his entire career in the span of one week?

No one believes this, of course. Multiple news outlets reported that Trump
demanded Dr. Prasad’s resignation and that he was influenced by a combination of
Laura Loomer, Big Pharma, the WSJ, patient advocates, the right-to-try folks.
All of Dr. Prasad’s defenders embraced this narrative. None of them believed Dr.
Makary, and they announced their disagreement with him in public for the first 
time. Dr. Makary’s anti-vaccine disinformation, fake statistics, and false
declarations of herd immunity didn’t bother them a bit, but spinning a fairy
tale about Dr. Prasad’s departure from the FDA was a bridge too far. That
demanded vigorous pushback!

I will be ramping up my exposes of officials with HHS and FDA

Of course, the return of Dr. Prasad doesn’t mean that things are fine and dandy 
at the FDA. Trust and moral at there are at an all-time low. Important staffing 
decisions seem to be made on a whim. As John Carol said:

And just like that, Vinay Prasad is back at the helm of CBER. From the convos
I’ve been having, it’s safe to say that no one in biotech understands which end 
is up at the FDA. The agency included a swipe at “the fake news” in making the
announcement. But a simple chronology of events underscores the turmoil at the
agency. One exec I talked with in recent weeks likened clinical research these
days to traveling a dirt road, with a drunk, gun waving sheriff in charge. Can
you imagine what it’s like working at the FDA now? Amateurs and antagonists.
Absurd.

Meanwhile RFK Jr. is devastating vaccines, as we knew he would, the FDA’s AI is 
hallucinating, deluded anti-vaxxers are shooting up the CDC, and CBER staff are 
likely not overjoyed that “boy wonder” is back. According to one news report:

FDA workers reacted to the decision to bring back Prasad with incredulousness,
according to one FDA staffer who said several coworkers were alternating between
being sad and concerned. Roughly a quarter of the 3,500 agency employees who
originally were given reduction-in-force notices earlier this year have been
reinstated, but staff morale remains low even as Makary tries to fill a
higher-than-average job vacancy rate among scientific reviewers.

No one, not even Dr. Prasad’s greatest supporters, can make the affirmative case
that things are going well right now.

It’s Drs. Prasad’s and Makary’s job to fix this, and they have a lot of work to 
do. They chose this. At a bare minimum, they owe us a full and honest accounting
of Dr. Prasad’s resignation and return. This isn’t just about drama and palace 
intrigue. Dr. Prasad isn’t returning to the same FDA he left, and it’s
inconceivable that his recent experiences won’t impact his future decisions.
Laura Loomer, Big Pharma, the WSJ, patient advocates, and the right-to-try folks
are still out there after all. We’ve all seen what they can do when they are
angered.

Link to original

Moving forward, how will Drs. Prasad and Makary navigate these treacherous
waters? Did they make assurances to the higher-ups in the Oval Office that they 
would be less stringent in their drug approvals? Can we be assured that they
will make their decisions based on science and evidence alone? Will they be
constantly looking over their shoulder? Can they keep this up for 3.5 more
years? Can Trump resist calls for their ouster for that long? How secure are
their jobs?

To restore trust, Drs. Prasad and Makary need to venture out of their safe space
and answer these basic questions from a tough but fair journalist. People
universally view Dr Makary as an unreliable reporter about major staffing
decisions at the FDA. I don’t know anyone, not one person, who believes his
version of events, and it’s a problem that no one trust our FDA leadership.
Maintaining the fiction that Dr. Prasad resigned and returned entirely on his
own, as I expect they will do, won’t fool anyone. Dr. Prasad said that “distrust
in public health is good” and now people don’t trust public health. Not only
does Dr. Prasad’s mission to restore trust remains unfulfilled, his main
accomplishment during his first 3 months in office was to make everyone
distrustful of the FDA.

Of course, everything Drs. Prasad and Makary say must be taken with a
wheelbarrow of salt. They have both been utterly untrustworthy for the past 5
years, falsely numbing people to grave risks of both COVID and RFK Jr. It’s
vital to remember their track record and past reliability when they discuss how 
wonderful things are at the FDA today.

Neither the White House nor HHS will allow the fake news media to distract from 
the critical work the FDA is carrying out under the Trump administration.

If I had any influence, Drs. Prasad and Makary would never have their current
jobs. Yet, if I could push a magic button and have them succeed at the FDA, I
would do so without hesitation. We all need safe food and medications. While I
will hold them accountable, I am not rooting for the FDA to crumble under their 
watch. If 3.5 years from now the FDA is widely trusted and viewed as competent, 
I will gladly write about it here at SBM.

However, I am not confident this will happen. Things don’t usually end well for 
employees of Donald Trump, and I don’t think 3.5 years from now I will be
writing about how Drs. Prasad and Makary overcame their doubters and turned the 
FDA into a well-oiled machine. Their first months in office have revealed their 
utter ineptitude- Inside the Collapse of the F.D.A.– and so far, instead of
leveling with the public about Dr. Prasad’s resignation and return, we’ve only
gotten rank gaslighting. According to that same HHS spokesperson Andrew Nixon,
Dr. Prasad’s brief absence imagined by “fake news media.” He said:

At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for 
Biologics Evaluation and Research. Neither the White House nor HHS will allow
the fake news media to distract from the critical work the FDA is carrying out
under the Trump administration.

It will be impossible to trust anything at the FDA going forward when all get is
tantrums and fabrications from spokespeople when they are asked important and
serious questions about Drs. Prasad’s and Makary’s leadership. Dr. Prasad does
not have to reveal any personal gossip about why he tired of his family so soon,
of course, but the American public deserves to the full story about his
temporary resignation and how this might impact his regulatory decisions moving 
forward. This is not an outrageous ask.

It’s just asking for honesty and transparency from our medical establishment.
That’s all.


Dr. Vinay Prasad’s Catch-22: The Only Way He Can Truly Succeed at His Job is to 
Get Fired Again

No matter what regulatory decisions Dr. Vinay Prasad makes moving forward, the
fact that he was willing to legitimize and quietly work for RFK Jr. in first
place means he will always be a failure in my book.

Jonathan Howard on August 15, 2025

Link

Catch-22

In Catch-22, Joseph Heller’s classic novel about WWII fighter pilots, a pilot
could avoid flying dangerous missions only if they were insane. However, anyone 
who asked to be grounded was by definition sane and therefore had to fly. As
Heller wrote:

There was only one catch and that was Catch-22, which specified that a concern
for one’s safety in the face of dangers that were real and immediate was the
process of a rational mind. Orr was crazy and could be grounded. All he had to
do was ask; and as soon as he did, he would no longer be crazy and would have to
fly more missions. Orr would be crazy to fly more missions and sane if he
didn’t, but if he were sane he had to fly them. If he flew them he was crazy and
didn’t have to, but if he didn’t want to he was sane and had to.

Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy.

With this in mind, we can turn our attention yet again to Dr. Vinay Prasad, who 
has become a lightening rod during his brief, tumultuous time at the FDA. The
drama has never been higher, and trust has never been lower. Back when he was
auditioning for his job, Dr. Prasad debased himself by relentlessly fluffing RFK
Jr., his future boss, claiming he was more reliable than vaccine-expert Dr.
Peter Hotez and that he would be the savior of vaccines. Dwell on that for a
moment. In order to gain power, Dr. Prasad was willing to write this article:

Things haven’t worked out that way.

After Vinay left, Marty and Bobby worked very, very, very hard through Susie
Wiles, the president’s chief of staff, to tell the president that Vinay was not 
anti-Trump

Once in office, Dr. Prasad made several controversial decisions about rare
diseases that landed him in hot water. However, while the patients affected by
these decisions shouldn’t be discounted, this is not what Dr. Prasad should be
primarily known for at this moment. Rather, Dr. Prasad should be chiefly known
what he isn’t saying. His silence about the dangers of the administration in
which he proudly serves affects the entire world.

As a reminder, Dr. Prasad is the country’s chief vaccine regulator and head of
Center for Biologics Evaluation and Research, which says its mission is to
“Protect and improve public and individual health in the United States and,
where feasible, globally.” Moreover, Dr. Prasad markets himself as a guru and
protector of EBM against ignoramuses who sometimes act based on less than
pristine evidence. Dr. Prasad was not shy about sharing his opinions. “RCT or
STFU!” he said to those who tried to limit COVID in any way. He said that anyone
who treated death more seriously than than rare, temporary vaccine side-effects
“motherfuckers” and “fucking morons”. Dr. Prasad was known for this juvenile
vulgarity, not his cautious restraint.

Yet now that he has power and responsibility, Dr. Prasad is quiet and invisible.
He has nothing to say as his boss spreads gross antivaccine disinformation and 
dismantles research in vaccines. Even though RFK Jr.’s disgusting rhetoric
inspired fatal violence at the CDC, and RFK Jr. continues to dunk on the people 
who work there, Dr. Prasad maintains his monk-like silence.

RFK Jr. is the literal chief of the Medical Establishment, and he is a
significant threat to the health of American children. Doctors across the
country have finally realized this, and they are aligned against him. Dr.
Prasad, however, is mute. This quiet acquiescence sends a clear message- If a
nuanced master of clinical appraisal like Dr. Prasad doesn’t think RFK Jr. is a 
problem, then why should anyone else?

From his immaturity to his disinformation, there are countless reasons why Dr.
Prasad is unqualified to be a leader at the FDA. However whatever decision he
makes about some future biotech drug, it’s all a secondary issue. None of those 
decisions will be more consequential than the initial one he made by agreeing to
work for RFK Jr. in the first place. That by itself is both indefensible and
irredeemable.

Moving forward, Dr. Prasad should be known mainly as a doctor who prioritized
his fancy job title, even though this required him to nod along politely while
his boss took a blowtorch to vaccines and science. Moreover, in order to get his
job back, Dr. Prasad had to grovel and prove he was a fan of Trump and
everything he is doing right now. According to one news report about his return:

“After Vinay left, Marty and Bobby worked very, very, very hard through Susie
Wiles, the president’s chief of staff, to tell the president that Vinay was not 
anti-Trump,” one of the senior administration officials said. “The MAHA movement
is an expansion of the MAGA, sort of, you know, big tent.”

History is full of these sorts of self-interested enablers, and Dr. Prasad can
avoid this disgraceful fate only if he is willing to be a responsible leader and
simply tell the truth about RFK Jr. It’s quite the Catch-22, but if someone
agrees to take a leadership role at the FDA under RFK Jr., that automatically
proves that person is fundamentally unfit for the job. And the only way Dr.
Prasad can have a successful tenure at the FDA is to be honest about RFK Jr. and
get fired again. Until then, the regulatory decisions he makes are
inconsequential compared to the fact that he was willing to legitimize and team 
up with RFK Jr. to begin with. Today, we should all pay attention to what he
isn’t saying.

Nothing else about him matters to me, and it shouldn’t matter to you either.


Doctors Who Glorified Trump Have Permanently Tied Themselves to Everything He
Does

The purges, censorship, and politicization in the worlds of medicine and science
are not distinct from the corruption and vandalism of the country writ large.
We Want Them Infected doctors are part of it all.

Jonathan Howard on October 17, 2025

Link

The purges, censorship, and politicization in the worlds of medicine and science
are not distinct from the corruption and vandalism of the country writ large.
It’s all part of the same horrifying, destructive process. One of the countless 
dangerous absurdities is Donald Trump’s insistence that Portland is a war zone
and that 4,000 people have been murdered in Chicago. In reality, Portland is not
on fire, and Chicago has recorded 339 murders this year, a decrease from
previous years.  Nonetheless, Trump is using these fictions as a pretext to send
violent federal agents, and possibly the military, to terrorize the populace.

Obviously, writing about Trump’s authoritarianism and detachment from reality
could fill a library.  However, during one recent foray into his imaginary
world, several doctors, namely Drs. Mehmet Oz and Marty Makary, were in the
background, smirking and nodding along.  Although they have no power in this
domain, their silence and acquiesce lent the legitimacy of the medical
profession to Trump’s threatening falsehoods.  They had the chance to tell the
truth but instead chose their power and positions.  

Drs. Oz and Makary may think that they operate in a distinct sphere from the
rest of the Trump administration and that what happens in these cities is none
of their concern. While this is the case for the countless anonymous public
workers who are quietly doing the same vital jobs they would have done had the
election gone the other way, this is not true for the celebrity doctors who
openly campaigned for Trump and whose propaganda elevates him to this day.
Listen below as Dr. Jay Bhattacharya, who did nothing but numb people to COVID, 
now says Trump is “very pro-science” and that it is “ridiculous slander” to
suggest otherwise. Where would anyone get that idea?

This is all especially loathsome coming from doctors who manufactured rage
regarding COVID to usher in Trump 2.0 and their own political appointments.
Watch these fearmongering propaganda videos by Dr. Bhattacharya, who warned that
measures to limit COVID deaths would lead to a “biomedical security state”and
Dr. Vinay Prasad, who said they could lead to the next Hitler. Their paranoid
fantasies of violent cops attacking peaceful citizens are a fair description our
current reality. Doctors who previously warned about a police state turned out 
to be pretty chill after all.

None of this is new. As Dr. Eric Reihart wrote in his article The Rise of
Medical Fascism:

Authoritarian regimes always enlist medical systems to ensure their control over
the means of life and death, but they do not do so overnight. Instead, medical 
fascism, by which I mean the integration of healthcare institutions and
professionals into autocratic systems of control, coercion, and repression,
rises gradually. It incrementally erodes professional ethics, co-opts health
institutions, discourages dissent, and provides incentives and ideological
support for participation in state violence. Rather than externally imposed,
these steps are typically carried out by actors already internal to the
field—usually by those doctors most eager for career advancement.

By prioritizing their career advancement, We Want Them Infected doctors have
permanently linked their fate to Trump and everything he does moving forward. 
They chose to do this, and they can always choose to resign. Until then, they
should be known for their COVID disinformation, glorifying Trump, and nothing
else.

They might object to this, but who cares?  Government doctors don’t get decide
to how the public judges and remembers them. We do, and we don’t need their
permission.


Dr. Vinay Prasad Doesn’t Realize He’s The Establishment. It’s His Job to Produce
Results for the American Public, Not Fluff Donald Trump.

Because he can masterfully feign concern over evidence and data, Dr. Prasad is
the Shohei Ohtani of spreading doubt and mistrust about vaccines. It’s no
surprise that under his “leadership”, diseases are spreading and Andrew
Wakefield is taking a victory lap.


Jonathan Howard on October 26, 2025

Link


I think the president is 100 percent correct

Although Dr. Vinay Prasad excoriated his predecessors for not holding “broad
debate among scientists” when COVID raged, he has sequestered himself in safe
spaces during his time in office. Instead of answering tough but fair questions 
about the purges and chaos at the FDA, Dr. Prasad is making juvenile podcasts
with Dr. Marty Makary and fielding softball questions from Bari Weiss, a
sycophantic promoter of disinformation and groupthink.

One recent interview with Ms. Weiss was titled Trump’s Vaccine Chief on
Childhood Vaccinations. In it, Dr. Prasad predictably said president Trump was
“100 percent correct”.  Fluffing Trump is the core job requirement for anyone in
this administration, and Dr. Prasad will do so no matter what Trump says about 
vaccines or anything else. Dr. Prasad said:

I think the president is 100 percent correct that it is prudent to take the
chicken pox shot (varicella) separately. MMRV is known to have an excess risk of
febrile seizures compared to getting them (MMR and V) separately. I also think 
the president and the ACIP (CDC’s advisory committee on vaccines) is right to
question when hepatitis B shots should be offered if a mother is negative for
hepatitis B, and notably, countries like Sweden and Denmark only offer it at
birth if a mother is hepatitis B positive, or a child is in a high-risk
category. For folks who argue that not all mothers are screened, or that hep B
surface antigen is not sensitive enough, I wonder why they don’t advocate for
better screening, including use of the highly sensitive polymerase chain
reaction or ultrasensitive quantitative antigen tests.

Dr. Prasad further claimed the “liberal media machine” and “liberal states”
would “go the other way” merely because they opposed Trump.

Dr. Prasad conveniently absolved Trump of all blame for disease outbreaks. In
response to the question “Do you draw a connection between vaccine hesitancy and
messages like the one just put out by the president?” Dr. Prasad answered:

The proximate cause of measles outbreaks is low rates of measles vaccination,
but the deeper causes are poverty, health illiteracy, distrust of the medical
system, and feeling like we lack agency over our lives and bodies. But the most 
destructive thing of the last 25 years, in my opinion, is the colossal
mishandling of the Covid-19 pandemic. In particular, mandating a vaccine that
could not halt transmission to low-risk populations has led to massive distrust 
that can’t be fixed. We will have more vaccine hesitancy for a generation. The
president’s comments are not the driver of what we are seeing.

Of course, thanks to people Trump and Kennedy, anti-vaccine sentiment was alive 
and well before 2021, when the COVID vaccines arrived, and it was Dr. Prasad and
his cronies who claimed that they halted transmission. To pick one example
amongst many, in May 2021 Dr. Prasad said:

For somebody who’s already been fully vaccinated, they can wear the mask out of 
solidarity or in a symbolic sense, but their wearing a mask indoors is not
benefiting anyone else. There’s an infinitesimally low probability of even
having an infection that can be detected on a PCR test, let alone being able to 
spread it to someone.

I never said anything like that, though this is not first time Dr. Prasad has
blamed others for his words.

I think the scientific establishment blindly defending the U.S. vaccine schedule
is incorrect.

However, beyond glorifying Trump, the most disturbing line in Dr. Prasad’s
interview was this:

I think the scientific establishment blindly defending the U.S. vaccine schedule
is incorrect.

In reality, no one defended the vaccine schedule “blindly”, and Dr. Prasad is
not the only doctor on the planet who cares about evidence and can see the world
clearly, free of bias.  A great deal of care and effort went into creating the 
vaccine schedule, and previously, it was constantly being refined by thoughtful 
experts. New vaccines were added only when there was compelling data, and
dangerous vaccines were occasionally removed from the market, as were
unnecessary doses. Those thoughtful experts are long gone, having been replaced 
by incompetent quacks who can’t even run a single meeting-  we are rookies– in a
professional, competent manner.

Moreover, different countries, with different populations and different
circumstances, should have different vaccine schedules. There is no single
“right” one, and as with Japan and the HPV vaccine, smart countries can make
stupid decisions. Medicine is not a popularity contest, and although Dr. Prasad 
mentioned Denmark 4 times in his brief interview, “Denmark” does not appear
anywhere on the EBM pyramid.

Beyond this, Dr. Prasad may be surprised to learn that he holds a key position
at the FDA, and that people he endorsed are running the NIH, FDA, and ACIP,
while Kennedy is in charge of the HHS.  They are the “scientific establishment”.

As such, it’s not enough for Dr. Prasad’s to sit on the sidelines and passively 
point out perceived problems, as he’s done for his entire career thus far, but
rather to fix them and deliver tangible results for the American public. The
techniques that catapulted Dr. Prasad to power don’t suffice any more. If Dr.
Prasad feels that it would be better to screen all mothers for Hepatitis B
(which is already recommended) than to vaccinate newborns, then it is the job of
the current establishment to make that happen. As he requested, I am
“advocating for” them to do this. Go ahead.

Similarly, if Dr. Prasad feels there are unresolved questions about the vaccine 
schedule, it is up to him and the rest of our establishment to provide the
answers, as they promised they would last year.  For example, in his article
Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy, Dr. Prasad
absurdly argued:

The best way to curb vaccine hesitancy is to approve RFK Jr, and redirect his
energies to generating more data. More data will answer the key questions that
remain unanswered: which childhood immunization program is optimal. The worse
thing we can do is tank his nomination. Then vaccine hesitancy will explode.

Where is that data? Why hasn’t vaccine hesitancy been curbed yet? Why hasn’t
there been a randomized-controlled trial to determine which childhood
immunization program is optimal? Although Dr. Prasad famously said on multiple
occasions, “RCT or STFU,” I can’t think of a single RCT our establishment has
done thus far. They’ve completely failed us.

Of course, the real problem now isn’t that children are getting too many
vaccines, it’s that confused parents are refusing them and diseases are
spreading. Today, the headlines read Alaska’s Whooping Cough Outbreak Infected
Hundreds, With Infants Suffering the Most, Measles Outbreaks Across the US
Spread As Vaccination Rates Fall, and Louisiana’s Deadly Whooping Cough Outbreak
is Now its Worst in 35 Years. Meanwhile, flu season is ramping up and COVID is 
still here. This is all happening under Dr. Prasad’s “leadership,” and he owns
it all.

However, instead of using his voice to clearly and unambiguously encourage
vaccines, as any competent public official would do, Dr. Prasad is again
undermining them. That’s his greatest skill. Because he can masterfully feign
concern over evidence and data, Dr. Prasad is the Shohei Ohtani of spreading
doubt and mistrust. It’s no surprise that with Dr. Prasad and friends in charge,
Andrew Wakefield is taking a victory lap today.

It’s only going to get worse from here, and those of us on the outside the have 
every right to hold our current establishment accountable. The first step is for
them not to deny who they are. Dr. Prasad is the establishment whether he likes
it or not, and any time he moans about a problem, he is simply admitting that
he his buddies have failed to solve it.


I am a Private Citizen Seeking to Hold My Government Accountable. Dr. Vinay
Prasad, a Government Doctor, Killed My YouTube Channel.

Americans do not need our government’s permission to remember the words of our
public officials, and I refuse to let them be silenced or censored.

Jonathan Howard on August 31, 2025

Link

Your YouTube channel has now been terminated

A core goal of my work has been to preserve the words of our current Medical
Establishment. While accurately remembering the past is valuable in its own
right, we need to remember their prior pronouncements to judge their current
credibility, even if they don’t want us to do that. A doctor who fluffed RFK Jr.
or spread blatant disinformation about a deadly virus is unlikely to be
trustworthy about anything.

To that end, I started a YouTube channel last year, which served as a repository
of what our current Medical Establishment said. I had accumulated about 350
videos, almost all of which were short clips of famous doctors saying absurd
things- that herd immunity had arrived in the spring of 2021 and that RFK Jr.
was an honest broker about vaccines, for example. I appeared in just a handful
of the videos, as a small face offering commentary in the corner, though I
hadn’t made a new video all year. I never promoted the channel and made no money
from it.

Although I was a YouTube nobody, my collection was extremely valuable, at least 
to me. I shared videos in almost all my articles here and I played them often on
my podcast. I used them to make important points, and as much as possible, I
want people to speak for themselves. It’s the best way to be fair to the doctors
I critique, and no one could argue with my videos. They were the definition of 
indisputable evidence. Collectively they revealed how credentialed, but
sheltered doctors spread misinformation to emotionally manipulate people and
numb them to grave risks.

And now, they are all gone.

I recently received the following email.

Censorship is bad, especially when the censor is WRONG

Have I been censored and silenced by a powerful government official? It sure
feels that way to me, and censorship is bad, especially when the censor is
WRONG.

To be clear, the loss of my YouTube channel is a trivial thing, and I promise
not to make it the center of my identify. I won’t make a Supreme Court case out 
of it or record lengthy videos about it- Prasad’s Lecture is Cancelled from ACCP
Conference b/c Online Haters. I won’t sit down for self-pitying interviews with
Bari Weiss, the Wall Street Journal, and Reason Magazine. I’ve been censored
before, and I am not dramatic about such things. After all, my YouTube channel
had 256 subscribers and its videos were typically seen by dozens of people,
DOZENS! Its loss is a speck of dust compared to what RFK Jr. is destroying, and 
on one level, it both really funny and pathetic that Dr. Prasad would care so
much about it.

On another level, it’s not funny at all. It’s no secret that the administration 
in which Dr. Prasad proudly serves- Vinay was not anti-Trump– is censoring
scientists and dissident voices. The termination of my channel is a small part
of that process, and so it’s OK to be clear about what seems to have happened
here. From his podcast Gmail account, Dr. Prasad filed a formal complaint that
video clips he had posted to Twitter had been uploaded to YouTube. YouTube
agreed and killed my channel. Dr. Prasad was not bothered by someone sharing his
videos on principle. For years, he’s been happy to let anti-vaxx disinformation
accounts share countless clips of his vulgar revenge fantasies. Dr. Prasad only
objected when I, someone who exposed his disinformation, sought to preserve and
share these exact same videos. Dr. Prasad wanted his own words hidden from you,
SBM readers.

🔥 Dr. Vinay Prasad Praises RFK Jr“On regulatory capture, on the COVID-19
vaccine, on the FDA being a corrupt entity that needs to be entirely renovated…I
completely agree with him, and I wish him well in that pursuit.”@VPrasadMDMPH
@RobertKennedyJr pic.twitter.com/MOTP7NQGH1

— Chief Nerd (@TheChiefNerd) October 30, 2024

🔥 Dr. Vinay Prasad Says No Amnesty for the COVID Tyrants"I don't believe in
forgiveness because in my opinion, these pieces of sh*t are still lying. I mean,
like if you want forgiveness, the first thing you have to say is what you
actually did wrong, and they're still f***ing… pic.twitter.com/FzHvsYxekF

— Chief Nerd (@TheChiefNerd) October 5, 2024

As a reminder, Dr. Prasad is a key leader of the FDA. He is the Medical
Establishment. It’s his job to be open and transparent with the citizens he
serves. And though he refuses to answer questions from journalists and skip
meetings with the industry he regulates, he has enough free time to seek out and
erase his videos from a barely visible YouTube channel.

I believe that Dr. Prasad’s past words are a vital guide to his current
credibility. It’s important for the public to know that he treated mere abnormal
lab values after vaccination as a fate worse than death from COVID, for
example. That is one of the reasons he is banning COVID vaccines today. We have 
every right to remember what key members of our Medical Establishment said when 
COVID raged and RFK Jr. loomed.

Dr. Prasad rejects this, however, and now, hundreds of such examples have been
erased from my channel, including multiple videos of him and others speaking in 
their official government capacity. I put many hours of effort into the videos I
narrated. Those are gone forever. Many of the links/references in my writing
are now duds, and instead of informative videos, my prior articles are now
filled with this ugly image.

Dr. Prasad’s is to blame for this. Rather than engage in professional “dialogue 
between scientists“, as he demanded of his predecessors, Dr. Prasad was so
desperate to silence his own voice, he chose to vandalize my work.

However, where there is loss there is opportunity. Already Dr. Prasad’s attempt 
to silence me has brought more attention to my YouTube channel than it ever
received previously- see Stephanie Kirchgaessner’s article Top FDA Official
Demands Removal of YouTube Videos of Himself That Criticized Covid Vaccines. I
am happy use the Streisand effect to try to draw some attention to some of my
writing, past and present. Who wouldn’t want to read the work of a censored,
dissident like me?

Unlike Dr. Prasad, I have no problem with anyone sharing my work. Feel free!
Much of it merely collects and curates what Dr. Prasad said the past 5 years,
including in the erased videos. None of this is lost, and I think it’s very
important that we don’t forget it. And even though my YouTube channel (RIP,
2024-2025) was assassinated by my own government, there are many ways to remind 
the world of what he said. I’ve already created another YouTube channel, and
this time every video will come with my commentary. It will be much better than 
the one that got erased, and hopefully it will be more widely viewed.

Americans do not need our government’s permission to remember their words and
inform the world about what our public officials said. I refuse to let Dr.
Prasad be silenced or censored. He should extend me the same courtesy. He is a
powerful government official. I am just a private citizen seeking to hold my
government accountable.



Dr. Vinay Prasad Rose to Power by “Calling For” His Predecessors to do Things.
How’s He Doing Now That He’s Had a Chance to Prove His Mettle?

I am calling for Dr. Vinay Prasad to manage the FDA in a mature, professional,
competent, transparent manner.  That’s just the bare minimum, and yet, he can’t 
even manage that. 

Jonathan Howard on November 7, 2025

Link

I want them to admit people didn’t run any studies even though people told them 
to

Previously, I discussed how Drs. Martin Kulldorff and Jay Bhattacharya became
pandemic celebrities not because of their genuine accomplishments, but because
they merely “proposed” things and listed the wonderful things they “would have” 
done. Though they portrayed themselves as superheroes who could have bent the
virus to their will, in reality, they were content creators. That’s it. Now that
they have power and a chance to prove their mettle, their utter incompetence
and ineptitude are obvious to all.  Had they been in charge in 2020, they
wouldn’t have opened schools, protected the vulnerable, or done any of the
things they “proposed.”  It was all just an elaborate game of make-believe.

They are hardly alone in this regard. Like them, Dr. Vinay Prasad achieved fame 
and power based on entirely imagined feats of glory. He didn’t run RCTs or open 
schools. Rather, he sent many Tweets calling for others to do these laudable
tasks and then made YouTube videos bragging that he “told” them what to do. In
the video below, for example, Dr. Prasad is childish, vulgar, and vaguely
threatening as he berates public health officials by saying, “I want them to
admit they didn’t run any studies even though people told them to.”

Of course, actually running studies is infinitely harder than simply “telling”
others to run them, and Dr. Prasad’s predecessors delivered multiple successful 
RCTs of COVID vaccines in record time. They were impressive people.

However, Dr. Prasad excoriated them not because he was genuinely motivated to
improve research, but rather to spread doubt and rage about people who, unlike
him, had real-world responsibility. To that end, he wrote articles such as The
Scientists Who Undermine Randomized Trials, which implied that anyone who merely
recognized the practical limitations of RCTs actively opposed them.  He wrote:

In the last few weeks there have been several examples of scientists trying to
undermine randomized trials— arguing they are not possible, not practical, or
not useful. All of these arguments are false, as I will detail. But more
interestingly, is that the attacks come from two sides: pro-corporation
entrenched interests, and left-wing public health. What does it mean that these 
two sides are joining?

Similarly, in Dr. Prasad’s telling, public health leaders could have kept
society running smoothly as COVID raged, but they either chose not to or were
too stupid figure this out. For example, after a COVID surge forced schools to
close in Alabama and Tennessee, Dr. Prasad said, “Covid is just a cold;
incompetent leaders forced schools to close.” Had he been in charge, apparently,
he would have kept schools open in ways that no one else figured out. He would 
have been a competent leader.

Dr. Prasad didn’t hide that his main purpose in all this was to undermine
“left-wing public health.” He was an overtly political actor who likened
mitigation measures to Nazi Germany and produced content titled Public Health
Should Lose Your Trust and You’re Right Not to Trust Public Health. His broader 
goal, of course, was to elevate Trump, Kennedy, and himself, into power.

He succeeded.

Under Vinay Prasad, Employees at a Key FDA Center Fear Speaking Out, Look for
The Exits.

Drs. Prasad’s ceaseless efforts to spread doubt and rewrite the history of the
pandemic were rewarded with a top spot at the FDA, and we can check in on how he
is doing now that he has an opportunity to demonstrate his prowess and
leadership abilities.

It’s not going well. There’s a lot of drama. He’s already been fired and rehired
once, and under his “leadership” we are all reading articles such as Under
Vinay Prasad, Employees at A Key FDA Center Fear Speaking Out, Look for the
Exits.  It said:

Dozens of scientists are considering leaving the Center for Biologics Evaluation
and Research, where Prasad serves as director, to escape a work environment
that eight agency officials described to STAT as rife with mistrust and
paranoia. These officials said staffers are terrified of pushing back on Prasad,
lest they face retaliation.

The fear has been fueled by Prasad pushing at least seven senior leaders out of 
their positions, employees told STAT, and offering no public explanations to
staff or the leaders’ supervisors. Some of his workers are fed up, and are
attempting to transfer to the FDA’s drug center. Prasad has tried to block these
transfers in apparent recognition that CBER can’t afford to lose many more
employees. The center has lost hundreds of employees since the start of this
year to retirements, layoffs, and resignations, and hiring conditions are
difficult.

CBER employees are concerned that the exodus of employees and the worsening
morale problems will affect the functioning of the center, which ensures the
safety and efficacy of vaccines and helps speed potentially lifesaving therapies
to rare disease patients.

“This is going to leave us with a workload problem that is crushing in the face 
of a morale problem that is circling the drain,” said one agency official, who
was not authorized to speak publicly…

Eight CBER employees said Prasad can be charismatic, and his passion for science
and evidence-based medicine is clear. But he is not a transparent,
communicative manager, they said, adding that his vision for the center, other
than applying additional scrutiny to vaccines, is unclear. His sudden removal of
senior leaders has not helped. Several employees have filed complaints about
Prasad’s management with human resources, four agency officials told STAT.
Investigations into those complaints are ongoing…

“He’s wreaking havoc with the staff,” one agency official said. “People are
terrified.”

In an environment where staffers are fearful to speak their mind, and where an
increasing number are trying to leave, the quality of CBER’s work may suffer.
The public, which relies on the FDA’s expertise to protect and promote their
health, may suffer too.

“When you talk about making sure your vaccines are safe and effective, or having
a safe blood supply, or developing the therapies of the future, you want the
best people in the world,” said Jesse Goodman, a former director of CBER. “To do
that, you want an environment where scientists want to work and are valued, and
where there can be free debate and discussion.”

The article also noted that Dr. Prasad barely shows up to work, appearing just
“two or three days every two weeks”, while another article on the downfall of
Dr. George Tidmarsh reported a message where Dr. Prasad said to an FDA employee:

Let me be clear. If you continue to choose not to do what I tell you. I will
spend all of my political capital gets [sic] you fired. Do not take people from 
my team. When I ask you to ask the reviewers a question you will do so.

None of his vindictive vitriol surprises me. When Dr. Prasad’s pathetic attempt 
to censor my miniscule YouTube channel was exposed, he baselessly smeared me in 
the press claiming:

All of Dr Prasad’s videos, that were illegally taken and published by another
party, remain available for all to watch on YouTube. Publishing someone else’s
videos without modification or commentary is a clear copyright violation. The
mission of Johnathan (sic) Howard was not medical transparency, but personal
profit by grifting and stealing someone else’s intellectual property.

None of this is true. In reality, Dr. Prasad profited from his social media
content, not me. My YouTube channel, with 327 subscribers, is too small to
monetize, even if I wanted to. Unfortunately, a prominent government official
blatantly lying about a powerless private critic and accusing them of illegality
is normal these days. Who knows what fabrications they’ll invent next?

Experts Worry FDA’s Credibility Is Being Shredded by Scandal And ‘Soap Opera’

However, while Dr. Prasad’s COVID disinformation and profane tantrums were often
greeted with yawns and shrugs unfortunately, the chaos he’s causing at the FDA 
is getting a lot of attention. According to an article Experts Worry FDA’s
Credibility Is Being Shredded by Scandal And ‘Soap Opera’ the FDA is an
embarrassing clown show that is in total disarray.  Some quotes are:

  1. Robert Califf, former FDA commissioner: None of the people there have managed 
    a large organization, and there are things that you learn when you do
    that…It’s certainly unprecedented stuff like this has been in the news.  I
    can’t say there haven’t been complex squabbles at FDA, but certainly, during
    my lifetime, there has been a view of the responsibility of the FDA to the 
    public that it practices highly principled corporate management. And this
    seems to be lacking.

  2. Brian Skorney, investment bank analyst: I think I have been consistently
    critical of parts of the FDA regardless of administration, but what’s
    emerged over the past few months is just reflective of complete and total
    disarray and a complete lack of functional leadership.

  3. Chanapa Tantibanchach, former FDA press officer: Now, we have FDA ‘Mean Girls’
    burn books happening out in the open.

  4. Anonymous portfolio manager at a large biotech fund: What’s happening at the
    top of the FDA is embarrassing. How am I supposed to convince people, other 
    investors, that this sector is doing important work when the leaders of the 
    FDA are acting this way?

  5. Anonymous venture capital investor: We are witnessing nothing less than a
    clown show at FDA right now. For the sake of patients, we need a stable and 
    consistent FDA!

  6. Anonymous FDA agency staffer:  It is impossible for dedicated career FDA staff
    to responsibly regulate new products, conduct groundbreaking research, and 
    manage FDA’s resources on behalf of the American public. The situation is
    not salvageable. We need our many stakeholders, legislators, and
    pharmaceutical companies to demand better and to insist on change now, from 
    the top of FDA and HHS down.

  7. Reshma Ramachandran, an assistant professor of medicine at the Yale School of 
    Medicine and a board member of Doctors for America:  The numerous incidents 
    and allegations at the FDA leave me very concerned about the agency’s
    ability to be a scientific regulator. Between the firing and departure of
    technical and expert staff, reported mismanagement of leadership, and
    decisions that are being made without real transparency and based on
    politics, I am deeply worried about the impacts this continued chaos will
    have on patients and clinicians.

Journalist Matthew Herpert said, “I’ve been covering the FDA for 25 years. And I
know about all sorts of internecine conflicts that we never got to report. And 
I can tell you this is pretty out of the ordinary stuff.” Another article titled
Scandal And Controversy Take Toll on FDA Credibility quoted a former FDA
staffer who said:

If they could get enough money elsewhere, if they could get remote jobs, if they
could get as much vacation, they would just leave. I don’t know that I’ve
talked to anyone who’s happy there.

Beyond his interpersonal toxicity, Dr. Prasad has failed to communicate the
reasons behind some of his tough, controversial decisions and has been accused
of changing regulatory standards in capricious, unpredictable ways. He skips key
meetings, and industry leaders are fed up. One CEO said:

You have leadership that has been absent, and that’s a problem. There’s numerous
issues going on, and it’s not just our company.

The Wall Street Journal has blasted him in articles such as Dr. Prasad, the
FDA’s Grim Reaper, The Spin Doctors at the FDA, and The FDA’s Meltdown
Escalates, while other articles, Drug Approvals Hit an FDA Wall and FDA Review
of Drugs Is Slowing While Application Delays Are Growing, Analysis Find, reveal 
the consequences of the dysfunction at the FDA. Dr. Prasad refuses to answer
tough but fair questions about any of this. While he’s fielded softballs from
safe space propagandists like Bari Weiss, he ducks interviews with actual
reporters like Lizzy Lawrence from STAT.

Other threats loom, especially as Kennedy ramps up his inevitable attacks on
vaccines. Professional anti-vaxxers, Kennedy’s base, don’t trust Dr. Prasad.
According to an article titled The Turmoil Inside MAHA Is About More Than Just
Vaccines:

“He gives too much blanket trust” to childhood vaccines, said Del Bigtree, a
Kennedy ally and top aide to his 2024 presidential campaign.

Another article reported:

An administration official granted anonymity to discuss Prasad’s role at the FDA
acknowledged there have been “some issues with his management style and his
communication style.”

“I wouldn’t say he’s in hot water, but I wouldn’t say he’s not in hot water,
either,” the administration official said.

That’s not exactly a ringing endorsement, and I can’t find anyone willing to
defend Dr. Prasad’s performance outside of his dronelike Sensible Medicine
sycophants. And though they are “ecstatic” that Dr. Prasad is “wreaking havoc”
and purging people at the FDA, even they can’t make the affirmative case that
it’s thriving under his tenure. No one can.

FDA Staff in Meltdown as RFK Jr. Chaos Triggers Mass Exit Fears.

Unsurprisingly, trust in our federal health agencies has cratered, and large
swaths of the country are ignoring Dr. Prasad and friends by forming their own
public health collaboratives. In July this year, the headlines read What to Know
About the Collapse of the F.D.A, and today they read FDA Staff in Meltdown as
RFK Jr. Chaos Triggers Mass Exit Fears. Meanwhile, confidence in vaccines is
dropping, and the doctors who “would have” mastered COVID can’t contain measles 
and pertussis. They’re not even trying.

This is what Dr. Prasad accomplished. This is what happened when he was given
the opportunity to prove his leadership skills and deliver concrete results for 
the American people. Along with his COVID disinformation, his ineptitude at the 
FDA- all to serve the broader MAGA/MAHA agenda– is the only thing that matters
about him.

It should be obvious to everyone now that when it came to COVID, Dr. Prasad was 
just spitballing opinions, and opinions are not accomplishments. No one should
be impressed that he spent years “telling” his predecessors what to do. He
deserves no praise or accolades because he sent Tweets “calling for” them to do 
difficult, often impossible things.

We also don’t have to pretend that Dr. Prasad would have been a capable of doing
those things himself had he been in power when a new virus swamped morgues and 
hospitals in a few weeks’ time. He wouldn’t have run RCTs. He wouldn’t have kept
schools open. He wouldn’t have done any of the things he “called for.” Based on
his abysmal performance thus far, it’s doubtful we would have gotten any COVID 
vaccines at all.

The establishment, the people who set the policies, they have to strive to get
things right. They need to do studies. They need to course correct. They have to
admit their errors. They need to be held to the highest standard.

Although Dr. Prasad is flailing, in over his head, and lashing out at critics,
we must continue to hold him accountable. As he said previously:

The establishment, the people who set the policies, they have to strive to get
things right. They need to do studies. They need to course correct. They have to
admit their errors. They need to be held to the highest standard.

Fair enough.

Now that Dr. Prasad is the medical establishment, those of us on the outside
have every right to treat him as he treated his predecessors. Obviously, no one 
should curse at him or threaten him. Such juvenile behavior debases the entire
profession. But we should all feel free to make countless YouTube videos and
social medial posts calmly “calling for” him to do whatever we want and publicly
branding him an “incompetent leader” if he fails to do everything we “told”
him. He asked for this.

Personally, I am calling for Dr. Prasad to do his job in a mature, professional,
competent, transparent manner. That’s just the bare minimum, and yet, he can’t 
even manage that.


Dr. Vinay Prasad Created Long Lists of Randomized Trials for Other People to Do.
Does That Make Him an EBM Guru?

“Just saying the same thing over and over again, whether in social media or in
medical literature, ain’t gonna get it done.”- Dr. Eliezer Van Allen

Jonathan Howard on September 25, 2026

Link


“How Not To Get Fooled by the Medical Literature”

Despite everything that’s happened, Dr. Vinay Prasad still feels entitled to
teach a 19-part online course titled How Not to Get Fooled by the Medical
Literature, along with his fellow “medical conservatives“. Dr. Prasad also has
many admirers who speak of his “lifelong commitment to scientific rigor” and
even today describe him as “smart, driven by evidence, fearless, unafraid to
take on the medical establishment“. Let’s examine his real-world contributions
to evidence-based medicine (EBM) to see if his course is worth taking and if
this high praise is justified.

“RCTs are feasible “

In 2024, along with Dr. Mariana Barosa and EBM luminary Dr. John Ioannidis, Dr. 
Prasad published one of his typical papers, an opinion piece titled Evidence
Base for Yearly Respiratory Virus Vaccines: Current Status and Proposed Improved
Strategies. They “proposed” the following:

Well-conducted experimental studies, particularly randomized trials, are
necessary to address persistent uncertainties about influenza and COVID-19
vaccines. We propose a new research framework which would render results
relevant to the current or future respiratory viral seasons. We demonstrate that
experimental studies are feasible by adopting a more pragmatic approach and
provide strategies on how to do so. When it comes to implementing policies that 
seriously impact people’s lives, require substantial public resources and/or
rely on widespread public acceptance, high evidence standards are desirable.

The key phrase here was “we demonstrate that experimental studies are feasible“.
Their paper had an entire section titled CLINICAL TRIALS ARE NECESSARY AND
FEASIBLE that said:

These cases demonstrate that RCTs are feasible and not prohibitively expensive
if one incorporates pragmatic elements… what is most needed is robust
effectiveness data on important clinical endpoints, such as severe illness,
hospitalizations and death.

By boldly asserting that such randomized-controlled trials (RCTs) were feasible,
Drs. Prasad and Ioannidis could then turn around and depict anyone who felt
otherwise as lacking “high evidence standards” and indifferent to “robust
effectiveness data on important clinical endpoints.”

Dr. Prasad explicitly stated this many times. In an article titled The
Scientists Who Undermine Randomized Trials, he said:

In the last few weeks there have been several examples of scientists trying to
undermine randomized trials— arguing they are not possible, not practical, or
not useful. All of these arguments are false, as I will detail.

Dr. Prasad repeatedly said his philosophy was “RCT or STFU for all” and claimed 
that anyone who disagreed must “hate EBM“. He felt his detractors, “left-wing
public health” in this case, weren’t just wrong; they deliberately undermined
RCTs.

In one of his many vulgar tirades, Dr. Prasad excoriated public health officials
and rejected “forgiveness” for them. He wanted them to “admit they didn’t run
any studies” even though he “told them to“. In yet another profane rant, Dr.
Prasad spoke with contempt for doctors who corrected his anti-vaccine
disinformation, blasting them as “fucking morons… who don’t know anything about 
evidence-based medicine.“

In Dr. Prasad’s telling, EBM was his domain, and the stakes couldn’t be higher. 
During a debate from before the election titled Which US Presidential Candidate 
is More Anti-Science?, Dr. Prasad argued that Kamala Harris was the larger risk.
His top reason was:

Harris will continue approving annual COVID19 boosters, including for kids as
young as 6 months old, without randomized trials.

As MAHA/MAGA loomed, Dr. Prasad claimed that the single greatest threat to the
scientific enterprise was COVID boosters without RCTs and that Trump and Kennedy
had to be put in charge to prevent this EBM catastrophe.

“I would conduct randomized experiments.”

While Dr. Prasad denigrated public health officials as incompetent buffoons who 
deliberately undermined RCTs, he claimed to be wiser and routinely boasted of
his entirely hypothetical accomplishments regarding EBM. “I would conduct
randomized experiments,” Dr. Prasad said about his imagined alter-ego.

I will disclose every time I use AI for an article here, and for this one I
asked ChatGPT to:

Scour Dr. Vinay Prasad’s tweets, articles, blogs, YouTube videos and make a
table of all the randomized trials (RCTs) he either “called for”, “proposed”,
“argued for” or claims he “would have” done.

Here was the result:

RCT / research question
Population / intervention
What Prasad said or did
School closure vs. reopening
Schools randomized to closure/reopening strategies
Explicitly said school closure/reopening could have been studied with randomized
trials
Business/workplace closures
Businesses/areas randomized to closure vs. opening
Listed absence of randomized trials of business closures as a major evidence gap
Community mask mandates
Communities/groups randomized to mask mandate vs. no mandate
Repeatedly called for cluster RCTs of community masking
Masking children
Children randomized to masking vs. no masking
Said a pediatric masking RCT should have been performed
Masking in schools
Schools randomized to masking strategies
Specifically listed masking in schools
Masking in the United States
Large-scale community masking
Listed masking in USA among trials that should have been done
Masking after vaccination
Vaccinated populations randomized to masking/no masking
Specifically called for post-vaccine masking RCTs
Masking of health-care workers indefinitely
HCWs randomized to continued masking vs. stopping
Used as an example of an RCT that could be done
Perfect mask compliance
Individuals randomized to continue vs. discontinue masking
Asked whether compliant people randomized to continued masking have better
outcomes later
Different mask strategies
Cluster RCT with multiple masking arms
Proposed testing different masking strategies
3 feet vs. 6 feet distancing
Groups randomized to different physical-distancing requirements
Specifically listed 3 vs. 6 feet
Cohorting
Schools/workplaces randomized to cohorting strategies
Specifically listed cohorting
HEPA filtration in schools/homes
Clusters receiving HEPA filtration vs. usual conditions
Said this should have been studied in cluster RCTs
CR boxes / portable air cleaners
Classrooms/locations randomized to filtration
Listed CR boxes among absent RCTs
Plexiglass barriers
Locations randomized to plexiglass vs. no plexiglass
Explicitly listed plexiglass
Hand sanitizer
Locations/groups randomized to sanitizer availability/use
Proposed as a component of a factorial NPI trial
Face shields
Groups randomized to face shields
Proposed as a component of a factorial NPI trial
Masks + sanitizer + plexiglass + partitions + shields
Factorial design testing combinations of NPIs
Proposed a factorial design to determine proportional benefit of individual
interventions
College-campus COVID measures
College populations randomized to different mitigation strategies
Listed college-campus interventions as lacking RCT evidence
Asymptomatic testing
Groups randomized to routine asymptomatic testing vs. not
Explicitly listed asymptomatic testing
Testing in preschool/schools
Schools randomized to testing strategies
Specifically listed preschool/school testing
Quarantine duration
Different quarantine durations randomized
Explicitly called for an RCT of quarantine duration
Restaurant masking rules
Mask only entering/leaving/bathroom vs. continuous masking
Used as an example of something that could have been randomized
Alternative COVID-vaccine dosing schedules
Different dose intervals/doses
Listed RCTs of alternative dosing strategies
Bivalent COVID booster vs. control
Randomized booster vs. appropriate control, severe-disease endpoints
Argued for clinical-endpoint RCTs
COVID boosters in low-risk/vaccinated people
Vaccinated/previously infected people randomized to booster vs. no booster
Repeatedly argued for clinical-endpoint RCTs
COVID vaccine in healthy children 5–11
Children randomized to vaccination vs. control
Said a large RCT should have been done
Paxlovid in vaccinated/previously infected people
Vaccinated/lower-risk adults randomized to Paxlovid vs. control
Argued for RCT evidence before extending EPIC-HR findings
Paxlovid in low-risk vaccinated people
Low-risk vaccinated adults randomized to treatment/no treatment
Identified as an RCT that should have been compelled
Paxlovid and long COVID
People with long COVID randomized to Paxlovid/control
Discussed need for randomized evidence
COVID anticoagulation strategy
Full-dose vs. intermediate vs. prophylactic anticoagulation
Said the question required RCTs
COVID vaccine/booster clinical endpoints
Randomized vaccine vs. control with hospitalization/severe disease/death
endpoints
Made clinical-endpoint RCTs a general regulatory requirement
Annual COVID vaccine updates
Seasonal vaccine vs. appropriate comparator
Advocated randomized studies to determine clinical benefit
Annual influenza-vaccine effectiveness
Flu vaccine vs. control, hard clinical endpoints
Said flu shots would benefit from more randomization
Multi-arm influenza-vaccine trials
Several vaccine formulations + control
Proposed repeatedly randomizing large numbers and advancing best-performing
formulation
Influenza-vaccine deployment
Randomized strategies for how/when vaccines are deployed
Explicitly proposed randomized trials of deployment
Influenza challenge trials
Controlled influenza exposure after randomized vaccination
Mentioned challenge trials as randomized studies
Routine childhood vaccination schedule: U.S. vs. Denmark
Regions randomized to U.S. vs. Danish-style schedule
Explicitly proposed a cluster RCT
Childhood-vaccine schedule: hospitalization
Same schedule RCT with hospitalization endpoint
Specifically proposed hospitalization
Childhood-vaccine schedule: all-cause mortality
Same schedule RCT
Specifically proposed all-cause mortality
Childhood-vaccine schedule: disease-specific outcomes
Same schedule RCT
Proposed measuring diseases targeted by additional vaccines
Childhood-vaccine schedule: neurocognitive development
U.S. vs. lower-dose schedule
Proposed routine neurocognitive testing
Teclistamab in relapsed disease
Teclistamab vs. observation/appropriate control
Used as example of a trial people incorrectly claimed could not be done
Smoldering myeloma treatment vs. observation
Treatment vs. observation, survival endpoint
Said this could/should be randomized
New cancer drugs powered for mortality
New cancer treatment vs. control with overall survival
Argued new cancer drugs could be tested with mortality endpoints
Free COVID tests
Free testing vs. no free testing
Used randomization to free COVID tests as an example
Coronary-artery calcium testing
CAC testing vs. no CAC testing
Said definitive test would randomize people to CAC testing vs. no testing
Routine CBC/BMP/CMP testing in healthy adults
Different testing frequencies vs. none
Said randomized studies should be conducted
Healthy-person primary-care visits
Different frequencies of routine primary-care visits
Pointed to randomized evidence and argued questions should be revisited
Whole-body MRI screening
Whole-body MRI vs. usual care
Proposed a large RCT powered for all-cause mortality
Prostate-cancer screening policy
No screening vs. screening vs. patient-choice approach
Suggested a randomized study comparing approaches
Alcohol consumption
Multi-arm randomized alcohol-consumption strategies
Explicitly proposed a multi-arm randomized trial
Vaccine coadministration
COVID + influenza + RSV vaccines together vs. separate/no coadministration
Called for RCTs examining safety and efficacy of coadministration
Vaccines in pregnancy
Vaccination vs. appropriate control with clinical endpoints
FDA framework called for premarket RCT evidence
Pneumococcal vaccines – clinical outcomes
Vaccine vs. control measuring pneumonia
Proposed requiring evidence of actual pneumonia reduction rather than antibody
titers
New vaccines/products – clinical endpoints
New products tested in randomized trials using patient-important outcomes
Proposed premarket RCTs assessing clinical endpoints for most new products
Expansion of vaccine indications
Existing vaccine in new population vs. control
Said populations should be included in premarket RCTs rather than extrapolated
using immunogenicity
Multiple vaccines administered simultaneously
Different combinations/timing of vaccination
Called for better randomized evidence for benefits/harms
If calling for RCTs were an Olympic sport, Dr. Prasad would win the gold every
year, though a clear pattern emerges from this. Dr. Prasad only called for RCTs 
for things he didn’t like, especially COVID mitigations and vaccines. However,
when these measures were studied via RCTs, such as boosters and the pediatric
COVID vaccine, including for babies and toddlers, Dr. Prasad didn’t care at all.
He just claimed these trials need to be repeated ad infinitum. I discussed the 
reason for this in my article Doctors Who Performatively Fetishized RCTs Aren’t 
Out to Advance Medical Research, But Rather to Sow Doubt & Mistrust.

Conversely, Dr. Prasad never called for RCTs for the policies and people he
supported. He never called for an RCT of “focused protection”, for example.
Advocates of herd immunity via mass infection never needed RCTs to back up their
agenda. He further lauded any and all observational studies that purported to
show vaccine harms, even claiming an awful VAERS dumpster dive was a “bombshell 
finding from dream team of authors“. Dr. Prasad made countless evidence-free
claims about SARS-CoV-2 itself, claiming it was “natural and healthy” for
children to contract it. While the vaccine was held to the highest standards of 
EBM, the virus was held to no standard at all.

Predictably, now that MAHA/MAGA is in power, Dr. Prasad is all done calling for 
our medical establishment to do RCTs. I asked ChatGPT about this too: Has Dr.
Vinay Prasad ever criticized Kennedy and MAHA for not doing more randomized
controlled trials? Here was the answer:

I found evidence that Prasad repeatedly called for RCTs while addressing
Kennedy’s agenda, but I have not found a clear instance in which Prasad publicly
criticized Kennedy/MAHA by saying, in effect, “you promised RCTs and haven’t
done enough of them.” I have not found a clear statement from Prasad saying
something like:

“Kennedy/MAHA are failing because they aren’t conducting enough RCTs.”

Though Dr. Prasad said, “RCT or STFU for all”, what he meant was “RCT or STFU
for you, but not for me”.

“We intend to stop the study due to slow enrollment and therefore the inability 
​to generate relevant post-marketing data.”

My final question to ChatGPT was whether Dr. Prasad had ever worked on any of
the RCTs he called for. The answer was “no.” Wiser souls than me figured this
out long ago. In 2018, Dr. Eliezer Van Allen said to Dr. Prasad:

You are an oncologist at an academic medical center. You clearly have knowledge 
& feelings about trial design. You even did some power calculations already. So…
write some grants, write some protocols, get some buy in, and do something to
be part of the solution.

Just saying the same thing over and over again, whether in social media or in
medical literature, ain’t gonna get it done.

He was right then, and except for Dr. Prasad’s career arc, nothing’s changed.
While his competent predecessors at the FDA delivered Operation Warp Speed, Dr. 
Prasad repeatedly promised new RCTs on FDA podcasts (here, here, and here) but
failed to deliver them. An RCT of the COVID vaccine failed to enroll enough
participants while Dr. Prasad led the FDA’s vaccine division. “We intend to stop
the study due to slow enrollment and therefore the inability ​to generate
relevant post-marketing data,” the companies said. Oh well! This was the exact
type of trial he and Dr. Ioannidis had previously deemed “feasible”. I guess
this means Dr. Prasad undermines RCTs and hates EBM.

As such, the question isn’t whether Dr. Prasad was correct about the value of
RCTs. The obvious truth is that no one tried to “undermine” them, and no one
“hates EBM”. Dr. Prasad just made that up to dodge substantive critiques and
discredit “left-wing” public health officials.

Rather, the question is whether Dr. Prasad was correct about the feasibility of 
RCTs and whether it was impressive for him to create long lists of RCTs for
other people to do.

I don’t think so, especially considering these lists, as well as his academic
papers must now be considered in light of his dismal performance at the FDA. Not
only did he fail to deliver the RCTs he promised, but he also single-handedly
rejected a successful Moderna flu vaccine RCT, a decision that wiser FDA
regulators later overturned. Unsurprisingly, vaccine companies announced their
intentions not to do further vaccine RCTs thanks to MAHA.

Meanwhile, his former bosses Trump and Kennedy are warning about chemtrails and 
gallivanting with Andrew Wakefield. They are promoting quack treatments, and
under their leadership the headlines read: NIH Grant Terminations Disrupt
Hundreds of Clinical Trials, Affecting More Than 74,000 Participants. Some
people “hate EBM” after all, and Dr. Prasad endorsed and empowered them. This is
his real-world contribution to EBM, and it’s the only thing that should matter 
about him.

Dr. Prasad’s sycophants and enablers don’t feel that way, however. They act as
if his failed tenure at the FDA was just a fever dream, and they excuse his
support for MAHA/MAGA. No big deal! They still lavish him with praise all
because he sent Tweets and made YouTube videos calling for RCTs. They claim that
by doing this, Dr. Prasad was bravely upholding the highest standards of EBM,
whereas his detractors either knew nothing of the subject, or were Philistines, 
indifferent to its principles.

It turns out, however, that writing the words “RCTs are feasible” is a lot
easier than doing RCTs. Some of us knew this all along, and we were never
impressed by all the amazing, wonderful RCTs Drs. Prasad “called for” and “would
have” done. We recognized that he glorified RCTs not to advance EBM, but rather
to weaponize it and advance his political agenda, something he didn’t hide at
all.

So no, I won’t sign up for Dr. Prasad’s course or laud him as an EBM guru. I say
all this as someone who values EBM so much that I volunteered to be in a
COVID-vaccine RCT in 2020. My contribution was small, but at least it was real, 
and not everyone can say that.

MAHA Government Doctors Feel Entitled to Falsely Smear Private Citizens in the
Press While Demanding That They Not Be Falsely Smeared in the Press

Our so-called public servants have one set of standards for themselves and
another for private citizens who dare to the challenge their government.

Jonathan Howard on March 5, 2026

Link

“Smearing officials with false allegations and then issuing a quiet correction
isn’t accountability. Your readers deserve better.”

On Friday, I wrote about Dr. Vinay Prasad’s dismal performance at the FDA and
his refusal to answer questions about it from credible journalists. Amongst
other things, I discussed a news report, originally in the Wall Street Journal, 
which claimed that Dr. Prasad was under investigation for berating staff,
retaliation, wasting taxpayer money, and sexual harassment.

On Monday evening, I saw on social media that the WSJ had retracted their
allegations of sexual harassment, a very significant correction. Dr. Prasad was 
falsely accused of wrongdoing in a major newspaper, and that’s a big deal. He
had every right to be upset and to want to set the record strait. HHS spokesman 
Andrew Nixon reacted with righteous indignation saying it was wrong to smear
“officials with false allegations”. It’s hard to argue with that.

We appreciate the @WSJ making this important correction but they should have
never published unverified hearsay in the first place. Smearing officials with
false allegations and then issuing a quiet correction isn’t accountability. Your
readers deserve better. https://t.co/qSRoUL5X6q

— Andrew Nixon (@AndrewNixonHHS) March 3, 2026

“Requesting a prompt update of your piece with a correction notice, please.
Also, would appreciate confirmation of receipt.”

Obviously, this single correction didn’t vindicate Dr. Prasad in any way. The
FDA is still a dysfunctional soap opera. Dr. Prasad is still under investigation
for creating a “toxic workplace” requiring external investigators to step in,
and no one can make the affirmative case the FDA is thriving under his
leadership.

Nonetheless, I knew that I had to immediately correct my article, and as I was
logging on to do so, an e-mail from an HHS representative appeared. It said: 

Jonathan, there is an issue in your posting on Mr. Prasad regarding “allegations
of sexual harassment”… The WSJ article has been updated to remove the false
accusation. Requesting a prompt update of your piece with a correction notice,
please. Also, would appreciate confirmation of receipt.

This was an entirely appropriate, though unnecessary request. I fixed my article
the moment I learned it contained a false allegation, and this wasn’t a hard
call. Leaving up such misinformation for even one extra minute would have been
incredibly dishonest. I’ve acknowledged other errors a couple times previously
and will always do so in the future when appropriate. Communicating accurate
information and treating people fairly is the top priority here at SBM.

“The mission of Johnathan (sic) Howard was not medical transparency, but
personal profit by grifting and stealing someone else’s intellectual property.”

The reverse is true for Dr. Prasad and his minions, however. Thanks to them, I
also know how unpleasant it is to face false accusations in a major publication.
However, while I was guilty of sharing someone else’s inaccurate reporting, Dr.
Prasad’s FDA deliberately lied to smear me in the press. When his pathetic
attempt to censor my YouTube channel was revealed, a mysterious, unnamed “FDA
spokesman” told The Guardian:

All of Dr Prasad’s videos, that were illegally taken and published by another
party, remain available for all to watch on YouTube. Publishing someone else’s
videos without modification or commentary is a clear copyright violation. The
mission of Johnathan (sic) Howard was not medical transparency, but personal
profit by grifting and stealing someone else’s intellectual property.

Dr. Prasad failed to make his case of copyright violation to YouTube and my
channel was restored. However, these dishonest accusations weren’t just a
message to me, but to anyone who might dare to criticize Dr. Prasad. He’ll say
anything to discredit you. He’ll make things up if he has to, including
allegations of illegality.

Unfortunately, these baseless allegations were very familiar to me. Despite his 
professed love for civil debate and dialogue, Dr Prasad never responded to me or
any of his many serious critics in a professional way. Not once. He only
responded with these sort of personal attacks and juvenile accusations. He had
previously sought to discredit We Want Them Infected– the entire thing- by
claiming I was “just trying to make money from selling a book😂.” According to
Dr. Prasad, the mere fact that I wrote a book demonstrated both its
worthlessness and my insatiable avarice. That’s the maturity and professionalism
he brought to the table.

Thanks to the incompetence of Dr. Prasad and MAHA, We Want Them Infected aged
very well, and I will defend every word in it. However, I didn’t write a dense
tome on medical disinformation expecting riches and fortune, and my minuscule
YouTube channel has 371 subscribers. Apparently, one needs 1,000 subscribers to 
monetize any channel, and I use the videos there to augment my articles here.
Its only use is “medical transparency”, and I’ve made $0 from it. I am confident
Dr. Prasad cannot say the same about his YouTube channel (196,000 subscribers),
Substack, and social media output. As usual, every accusation is a confession. 
Dr. Prasad has even written books, though unlike him, I see nothing inherently
wrong with that. 

Joseph you can't indulge someone just trying to make money from selling a book. 
🤣

— Vinay Prasad MD MPH (@VPrasadMDMPH) July 18, 2023

Measles is spreading and trust in the HHS is collapsing. There are much bigger
problems than false allegations against myself or Dr. Prasad, though it’s nice
to know that despite his responsibilities at the FDA, he carves out time to read
our tiny little blog. Still, we need to be clear about what happened here, as
these incidents reveals something important about the character of our current
medical establishment.

An HHS representative asked me, very fairly, to correct a significant false
allegation someone else initially reported. I was already in the process of
doing so. I agree with Mr. Nixon that it is wrong to smear people with false
allegations. In contrast, an anonymous “FDA spokesman” deliberately lied about
me in a major news outlet 6-months ago, and there has been no correction or
apology.

I immediately told the HHS representative that my article had been corrected.
However, I also told them, via email and a stern phone call, that I expected Dr.
Prasad and the FDA to publicly correct their absurd fabrications about me. I
too requested a prompt update with a correction notice.

That hasn’t happened yet, and I doubt it ever will. MAHA government doctors feel
entitled to falsely smear their critics in the press while demanding that they 
not be falsely smeared in the press. Our so-called public servants have one set 
of standards for themselves and another for private citizens who dare to the
question their government.

“Vinay Prasad Loves President Trump”. That, Plus 12 Other Thoughts on the End of
Dr. Vinay Prasad’s Sabbatical From UCSF

The bottom line is this: when given the opportunity to prove his real-world
prowess, Dr. Vinay Prasad failed.

Jonathan Howard on March 10, 2026

Link

1. “Letting fucking morons run public health is the greatest anti-vaccine
movement imaginable.”

Dr. Vinay Prasad rose to power as a COVID content creator, famous for his
opinions not his actions. He spent the pandemic “calling for” his predecessors
to do incredible, wonderful things and treating this a significant
accomplishment. However, as MAHA doctors are learning at our expense, calling
for things on social media and podcasts is a lot easier than actually doing
them. 

While it would take a dense tome to fully document the chaos and destruction at 
the FDA the past year, Dr. Prasad’s brief tenure was marked by endless personal 
drama, the normalization of quackery, and a justified collapse of public trust. 
The bottom line is this: when given the opportunity to prove his real-world
prowess, Dr. Prasad failed.

Dr. Prasad was sent packing twice in under a year, and though his Sensible
Medicine business partners claimed at the start of his tenure that “Prasad’s
lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies”, the opposite happened. Thanks largely to his efforts, the
headlines now read Americans Trust Fauci Over RFK Jr. and Career Scientists Over
Trump Officials. Morale at the FDA, especially in Dr. Prasad’s division, has
tanked and respected FDA regulators quit rather than work with him.

Despite his reputation as a staunch defender of EBM, Dr. Prasad’s FDA claimed
that Tylenol causes autism, removed warnings about some quack autism treatments,
and promoted others. The vaccine schedule was decimated under Dr. Prasad’s
stewardship as chief vaccine regulator, and multiple states and major medical
organizations are wisely ignoring this guidance. Instead of promoting the MMR as
measles injured kids under his watch, Dr. Prasad fretted mightily about
ultra-rare MRI abnormalities after the COVID vaccine. He was not wrong when he
said:

Although Dr. Prasad’s defenders portray him as a fearless doctor, willing to
tell harsh truths to powerful people, his tenure at the FDA reveals the reverse 
is true. It was easy for him to take on big bad Moderna with Kennedy as his
boss. But, when it mattered most, when Kennedy was going wild on our health, Dr.
Prasad was a passive and weak enabler, his silence lending the legitimacy of
the medical profession to Kennedy’s every act of scientific vandalism and
disinformation.

2. “How Vinay Prasad Came to Washington — And Why It Was Always Going to End
This Way”

There was no loud outcry of anger in the medical community when Dr. Makary
announced the end of Dr. Prasad’s sabbatical at the FDA. Very few doctors trust 
Dr. Prasad today. While cranks like the pro-tobacco, child labor advocate
Jeffrey Tucker mourned Dr. Prasad’s departure, there were a handful of doctors, 
all long-time defenders of Dr. Prasad, who are willing to stick up for him
today. In their telling, Dr. Prasad didn’t fail the American public, rather we
failed Dr. Prasad.

If only we had quietly genuflected to government doctors and unquestionably
accepted Dr. Prasad’s inherent integrity and wisdom, then his tenure at the FDA 
would have been a smashing success. Dr. Prasad’s defenders claim that he was a
helpless, blameless victim of nefarious forces, namely zealous patient advocacy 
groups, pharma, and the media. Dr. Prasad’s defenders never engage with the
reasonable objections doctors have to him.

Dr. Anish Koka, for example, wrote an obsequious essay titled How Vinay Prasad
Came to Washington — And Why It Was Always Going to End This Way that said:

Prasad couldn’t survive the combination. The rare disease advocacy community is 
not small, and it is not politically passive. The pharmaceutical companies
funding the stories are not without influence. And the media infrastructure
covering the beat has little institutional incentive to examine the science
carefully when the goal is to take scalps of the enemy.

Notably, outside of his boss Dr. Marty Makary, no one even tried to make the
affirmative case that Dr. Prasad succeeded at the FDA or that CBER is stronger
and more trusted now than this time last year, effectively conceding point, that
when given the opportunity to prove his real-world prowess, Dr. Prasad failed.

3. “Farewell Boy Wonder.”

Although Prasad’s defenders refuse to admit it, the obvious truth is that only
Trump, Kennedy, and Dr. Makary had authority over Dr. Prasad, and Dr. Prasad
relentlessly fluffed all of them to catapult himself into power. Whatever role
“pharma $$” played, these men sent Dr. Prasad back to UCSF. They are
responsible. No one else. 

Of course, the MAHA coalition was always unstable, composed of anti-vaxx
supplement salesmen, “right to try” libertarians, biotech investor bros, and
self-proclaimed EBM gurus like Dr. Prasad. The entire movement coalesced based
only on a mutual affinity for COVID disinformation and lacked a unifying
philosophy beyond this. Sitting at the top it all was their mercurial leader
Trump.

Dr. Prasad willingly threw himself into this morass, and only someone with deft 
political and interpersonal skills had a prayer of balancing these disparate
interests. That’s not Dr. Prasad. He never even tried, though it’s not clear
that he was cognizant of the internal tensions within MAHA. 

High on his own supply, he seemingly believed he could bend these forces to his 
will with the raw power of his sheer genius. In so doing, he managed to alienate
basically everyone, including the WSJ, vaccine-scientists, right-wing
politicians, left-wing politicians, pharma executives, and patient advocates.
His own FDA staff celebrated his first departure, and none have publicly
bemoaned his second departure. So much for rebuilding lost trust in regulatory
bodies.

.

4. “Vinay Prasad loves President Trump.”

At the start of the pandemic Dr. Prasad performatively lamented the mixture of
politics and medicine, writing:

Society faces a risk even more toxic and deadly than Covid-19: that the conduct 
of science becomes indistinguishable from politics. The tensions between the two
policy poles of rapidly and systematically reopening society versus maximizing 
sheltering in place and social isolation must not be reduced to Republican and
Democratic talking points, even as many media outlets promote such simplistic
narratives.

Fast forward a few years later, and Dr. Prasad had become an overtly political
actor. He routinely dunked on Biden and “Dems” and openly campaigned for both
Trump and Kennedy. “God gave people two arms… One to vote for Donald Trump, and 
the other one to give thumbs up to RFK Jr.”, he said back when he was
auditioning for his role at the FDA. He wrote patently absurd articles such as
Sabotaging RFK Jr’s Confirmation Will Increase Vaccine Hesitancy to numb people 
to the risks of MAHA, and just last month, in a desperate bid to save his
position, Dr. Makary insisted that:

Vinay Prasad loves President Trump… If you listen to his podcast for the last
four years, you’ll see he has been an ardent supporter of everything Trump has
done and is trying to do.

That’s an incredible accusation to make. Vinay Prasad loves President Trump!
It’s infinitely more damning than anything Dr. Prasad’s critics have ever said.

It’s also true. Dr. Prasad used to his voice to elevate MAGA/MAHA to power, and 
his responsibility for that doesn’t end when he leaves the FDA. He is on the
hook not just for everything that’s happened so far, but for everything that’s
going to happen moving forward. As the Lancet recently said:

The destruction that Kennedy has wrought in 1 year might take generations to
repair, and there is little hope for US health and science while he remains at
the helm.

Dr. Prasad helped unleash this on us all and thus should be linked to it all for
the rest of his career. As Dr. Angela Rasmussen wrote in her article A
Not-So-Fond Farewell to Vinay Prasad after his first departure:

Prasad may have been too incompetent at enabling fascism for the fascists, but
we should not forget that he volunteered to be part of that. He chose to support
people who are actively annihilating the American government and attempted to
prevent people from accessing lifesaving vaccines and medications. He is not a
colleague. His actions at FDA demonstrate that he is a traitor to our country
and we should never forget that. We should never let him forget it, either.

Things have gotten much worse since then.

It doesn’t matter if Dr. Prasad or anyone else objects to this. Public officials
don’t get to decide how private citizens regard and remember them.

5. “Prasad overruled FDA staff to reject Moderna’s flu vaccine application”

When Dr. Prasad arrived at the FDA, he promised to make “expedite the approval” 
of vaccines to high risk groups based on immunogenicity alone, the production of
antibodies. This turned out to be a false promise. He later ignored apolitical 
FDA scientists and initially refuted to review Moderna’s mRNA flu vaccine, even 
though it supported by a large RCT. Trump personally overruled him, apparently, 
landing the FDA’s leaders in hot water with the Dear Leader- Makary, Prasad
Under Fire as FDA Turmoil Reaches President Trump. Dr. Prasad made many
obviously bad decisions like this at the FDA. So bad that even Trump saw the
problem and had to right the ship.

6. “Rare Disease Advocates Fume Over FDA’s Mixed Signals.”

However, even if we pretend that all of Dr. Prasad’s decisions at the FDA were
scientifically unimpeachable, he refused to follow established procedure or
clearly communicate his rationale to relevant stakeholders. He was unpredictable
and guilty of regulatory whiplash, changing the rules at the last minute based 
on his whims and personal views. He never answered questions from journalists.
His FDA dunked on independent, outside advisory committees, and ignored
desperate patients and their families. An article titled Rare Disease Advocates 
Fume Over FDA’s Mixed Signals quoted Jeff Carroll, a Huntington’s researcher and
gene carrier, as saying:

I just wish one of them, somebody from the FDA, would be like, ‘Hi, my name is
Dr. Smith, and this is why I made this decision, and here’s the policy that
explains why and how you will have to jump in the future to get these kinds of
therapies done.’

On the rare occasions when he did speak, people wisely knew not to trust him.
The article also quoted Wilson Bryan, who previously directed the gene therapy
division at the FDA.

Bryan said he just ignores what Makary and Prasad say on stage. “Their public
statements are, to me, just like pharmaceutical company press releases,” he
said. “So, I don’t put any stock in what they say publicly. I just don’t think
it matters.”

Instead of quietly engaging with biotech companies as professionals at the FDA
did previously, he threw tantrums about them in the press.  As STAT News
journalist Adam Feuerstein reported:

Earlier today, the FDA held a media call with the same “senior FDA official” who
spoke to me (and other reporters) individually earlier in the week.

The call was set up obstensibly so that this senior FDA official could rail
against UniQure without going on the record. He did exactly this for 30 minutes,
repeating the same criticisms, claiming Uniqure’s Huntington’s therapy is a
failure, the sham surgery  would be blinded even if just small “nicks” in the
skin were made in a 30-minute procedure, dismissing the idea of formally
reviewing the therapy, disregarding outside scientific experts, and then
accusing the media of not adequately covering what the FDA (and this official)
have been doing.

Reporters from Bloomberg, STAT, NY Times, WSJ, Politico and other media
organizations were on the call.

The FDA was appropriately boring previously. Under Dr. Prasad, it was a high
school soap opera, too much for even his bosses.

7. “I want to write a children’s book about a bear who didn’t want to leave home
till it was perfectly safe. He never left and life passed him by.”

From mocking anyone who tried to avoid COVID, even during the deadliest wave in 
January 2021, to treating rare, temporary vaccine side effects as a fate worse
than death, Dr. Prasad was a fountain of pro-infection propaganda during the
pandemic. I’ve literally written volumes on the topic, though even this just
scratched the surface.

While his defenders will continue to frame this as “thinking differently”,
honest brokers recognize that nothing Dr. Prasad does will erase the
consequences of his fake statistics and failed predictions regarding COVID. It
should stain him for the rest of his career, and writers who discuss Dr.
Prasad’s tenure at the FDA while glossing over his deluge of pandemic
disinformation are failing their readers.

8. “I don’t believe in forgiveness because in my opinion these pieces of shit
are still lying.”

As a private citizen, Dr. Prasad was juvenile, vulgar, and even vaguely
threatening-I don’t believe in forgiveness because in my opinion these pieces of
shit are still lying. The Pandemic Accountability Index collected over 120
individuals and organizations he insulted, and Dr. Prasad was even happy to send
internet mobs to harass beleaguered vaccine-heroes who disagreed with his MAHA 
agenda.

This unprofessional behavior continued at the FDA, where he was accused of
berating and retaliating against staff, necessitating an external investigation.
He tried to shut down my puny YouTube channel and spread vile lies about me in 
the press when his pathetic attempt at censorship was revealed.

Today, Dr. Prasad’s defenders demand that he be treated with the maturity and
professionalism he denied to others. Fair enough. I’m pleased I’ve not seen any 
doctor debase themselves like Dr. Prasad, who called other doctors “fucking
morons.”

9. “At at least 10 children have died after and because of receiving COVID-19
vaccination.”

At the end of November, Dr. Prasad sent a “leaked” memo that the COVID vaccine
killed at least 10 children. Though his defenders had “faith” the proof would
soon arrive, Dr. Prasad has yet to provide a shred of evidence. I will be
skeptical if he releases any “evidence” before he departs, though cranks and
quacks claim Dr. Prasad’s words are proof enough. The damage has already been
done, as Dr. Prasad likely intended.

10. “Vaccine Makers Curtail Research and Cut Jobs.”

Prior to assuming office, Dr. Prasad routinely said “RCT or STFU“, though he
changed his mind the moment he gained power and responsibility. While his
predecessor at the FDA delivered Operation Warp Speed, Dr. Prasad delivered zero
RCTs. Although he promised that vaccine companies would do new RCTs under his
tenure, thus far the headlines read Vaccine Makers Curtail Research and Cut
Jobs. No matter what he says about the need for better clinical trials moving
forward, Dr. Prasad’s real-world contribution to the cause of EBM is curtailed
research and cut jobs, and that’s all that matters.

11. “I would fire at least ~10000 people.”

When he was out of power, Dr. Prasad dreamt of mass purges at the HHS- I would
fire at least ~10000 people– and he was able to partially enact his fantasy at
the FDA, having trusted regulator Dr. Nicole Verdun her deputy Rachael Anatol
escorted out of her office last summer, for example. Anyone who bemoans Dr.
Prasad’s dismissal should acknowledge that he gleefully inflicted this fate on
others.

12. “The FDA commissioner & his CBER director are breaking the law.”

Dr. Makary’s job security is likely tenuous and unless Dr. Rick Pazdur is
willing to return, I can’t imagine anyone reasonable would want to clean up
after Dr. Prasad at CBER. His replacement might be worse, someone ready to green
light all of Kennedy’s quackery and woo. Meanwhile, Rep. Jake Auchincloss has
said “The FDA commissioner & his CBER director are breaking the law” by
“disclosing trade secret information without legal authorization.” Senator Ron
Johnson, a true crank and former ally of Dr. Makary, is enraged by and
investigating Dr. Prasad’s decisions as well. Though Dr. Prasad will soon be
leaving, the real drama may just be getting started.

13. Why didn’t you do that when you were at the FDA?

Overall, Dr. Prasad’s trajectory is a sad one, and it didn’t have to be this
way. He is very smart and is a very skilled communicator. He previously made
many reasonable points, debunking Dr. Makary’s absurd claim that medical error
was the 3rd leading cause of death, for example.

However, he squandered it all, turning himself into a 7-foot hoop for power,
fame, and paid subscribers. He hurt a lot of people on the way, and his main
usefulness today is as a cautionary tale. Medical students should treat his
career arc as a warning and strive to be his opposite in every way. He
surrounded himself in an echo chamber and never doubted himself or paused to
consider if his critics had any valid points.

It turns out we had many valid points, and Dr. Prasad might be in a better place
today if he had the humility to listen to them. We knew who Kennedy was and
would have warned him not to hitch his star to that wagon. In contrast, his
so-called “friends” literally endorsed it all and pushed him along his ill-fated
path.

While they are welcoming Dr. Prasad’s return to the commentariat class, I would 
advise him to quietly find meaning in clinical practice and retreat from the
public eye. He’s not obligated to share his opinions on everything with everyone
once again. He should relish being out of the limelight, curing cancer.

But more importantly no one is obligated to take his opinions seriously if he
can’t contain them. No one is required to treat him as some sage EBM avatar
anymore. We should remember his COVID disinformation and judge him on his real
world performance at the FDA. That’s it. While it would be entertaining to hear 
him whinge about his treatment there, thus throwing Trump, Kennedy, and Dr.
Makary under the bus, no one needs to care about his oh-so-controversial hot
takes ever again. Someone who was MAHA royalty and still loves President Trump
can be dismissed out of hand today, especially by those of us who desperately
tried to warn about these forces. After all, I got my start here 5 years ago,
discussing Dr. Prasad’s budding anti-vaccine career.

And though I’d be happy to never write about him again, I doubt that Dr. Prasad 
will heed my advice. However, every time he “calls for” something moving
forward, the only response should be, “Why didn’t you do that when you were at
the FDA?”


Dear John Horgan, Fluff MAHA/MAGA Doctors Less, Bash War More

“A cancer expert I admire becomes a Trump collaborator. Should he be dead to
me?” That’s an easy question to answer.

Jonathan Howard on September 19, 2026

Link

“How can we not end war?”

I wasn’t there, but I first became aware of science writer John Horgan 10 years 
ago after he gave a talk to the Northeast Conference on Science & Skepticism
titled Dear “Skeptics,” Bash Homeopathy and Bigfoot Less, Mammograms and War
More. Horgan felt that conference attendees shouldn’t spend their free time in
ways they enjoyed or discuss topics that interested them. He said:

“The Science Delusion” is common among Capital-S Skeptics. You don’t apply your 
skepticism equally. You are extremely critical of belief in God, ghosts, heaven,
ESP, astrology, homeopathy and Bigfoot. You also attack disbelief in global
warming, vaccines and genetically modified food.

These beliefs and disbeliefs deserve criticism, but they are what I call “soft
targets.” That’s because, for the most part, you’re bashing people outside your 
tribe, who ignore you. You end up preaching to the converted.

Horgan had a much bigger assignment for these skeptics. He tasked them with
ending war. He said:

Meanwhile, you neglect what I call hard targets. These are dubious and even
harmful claims promoted by major scientists and institutions. In the rest of
this talk, I’ll give you examples of hard targets from physics, medicine and
biology. I’ll wrap up with a rant about war, the hardest target of all.

Indeed, Horgan ended his screed by saying:

I don’t expect you to agree with my framing of these issues. All I ask is that
you examine your own views skeptically. And ask yourself this: Shouldn’t ending 
war be a moral imperative, like ending slavery or the subjugation of women? How 
can we not end war?

In Horgan’s view, the cause of world peace would have been meaningfully advanced
if the attendees of a small skeptic’s conference ignored pseudoscience and
instead devoted themselves to ending war. Horgan portrayed these people, mostly 
science geeks, as having enormous power and influence. However, their talents
were being wasted on problems he deemed insufficiently important, such as global
warming and vaccines. He felt skeptics, who were simply enjoying a weekend
conference, were fundamentally apathetic and neglectful. How can they not end
war?

“Countering antivaccine misinformation is worthwhile and saves lives.”

Drs. David Gorksi and Steve Novella wrote powerful rebuttals at the time. Dr.
Gorski presciently wrote:

Countering antivaccine misinformation is worthwhile and saves lives. It’s also a
direct outgrowth of skeptical activism against alternative medicine, as many
antivaccine views derive from pseudoscientific health beliefs.

It’s certainly not Dr. Gorski’s fault that sanctimonious scolds like Horgan
deliberately undermined his warnings about the anti-vaccine movement. One study 
regarding COVID estimated that:

At least 232,000 deaths could have been prevented among unvaccinated adults
during the 15 months had they been vaccinated with at least a primary series.

According to Horgan, this was all a “soft target.”

Dr. Novella pointed out Horgan’s ignorance of skepticism, writing:

Here are almost 40 articles from science-based medicine on overdiagnosis in
mainstream medicine, including several articles on mammography. The pattern
should now be clear – Horgan gives a simplistic summary of an issue, showing
that he himself has a superficial understanding of the relevant points, accusing
skeptics of not dealing with such issues sufficiently. Meanwhile, there is
already an in-depth discussion of the issue in skeptical circles, which is much 
deeper that Horgan’s treatment.

Dr. Novella concluded:

The big lesson here is this – if you are going to criticize a movement,
discipline, subculture, science, or group from the outside, to the point of
telling them what they should be doing, you should at least have a working
knowledge of that group.

After reading his article, it is safe to say that Horgan does not have the first
clue about scientific skepticism. The result was a parade of straw men
supported by cherry picked and often misinterpreted examples.

Indeed, although Horgan accused skeptics of “tribalism” and rightly identified
Richard Dawkins, Stephen Pinker, Michael Shermer, and Lawrence Krauss as skeptic
royalty at the time, that is no longer the case, and we have been unafraid to
say so here at SBM.  So much for “tribalism.”

“I still find much to admire in Prasad. “

While Horgan was clueless in 2016, he’s either learned nothing or is simply
dishonest today. His most recent article was titled Vinay Prasad and Other
Complicated Experts, and it completely whitewashed the dismal record of some of 
the pandemic’s most egregious disinformation superspreaders and MAHA/MAGA
propagandists. He promoted his article on social media by asking:

A cancer expert I admire becomes a Trump collaborator. Should he be dead to me?

I’ve already answered that question- “There’s no reason to trust him or care
about what he says today” – and it was an easy question to answer. The answer
was obvious, at least for those of us who sincerely care about “hard targets”
with MAHA and MAGA in charge.

However, Horgan answered “no.”

Horgan did not criticize Dr. Prasad for his silence about the evils of war.
Unlike skeptics a decade ago, Dr. Prasad was magically exempt from this
requirement. He was free to speak about whatever he wanted without Horgan
policing his choices.

Instead, Horgan mostly lavished Dr. Prasad with praise, while failing to tell
his readers the truth about him. He wrote:

Prasad co-founded the site Sensible Medicine, which looks skeptically at medical
practices and takes seriously the Hippocratic dictum: First, do no harm.
Sensible Medicine reinforces my cranky anti-medicine perspective.

SBM readers will know this is false. In reality, Sensible Medicine is a
monetized misinformation Substack that published MAHA/MAGA agitprop such as Why 
Doctors Should Learn to Stop Worrying and Love MAHA, The Nomination of Robert F.
Kennedy Jr. As Secretary of The Department of Health and Human Services: A New 
Beginning? and The MAHA Report: A Seismic Shift in US Health Policy. Horgan
refused to share that with his readers and continued:

After the covid pandemic struck in 2020, Prasad accused federal officials of
overreacting. He challenged the benefits of masking, shutting down schools and
businesses and mandating covid vaccines (when those became available).

SBM readers will know this is false. In reality, Dr. Prasad treated rare,
temporary vaccine side-effects, even mere abnormal lab values, as a fate worse
than death, and published his article Should We Let Kids Catch Omicron during
the worst wave of the pandemic for children. That pro-infection article
advocated for the mass infection of unvaccinated children to have them
theoretically serve as human shields for more vulnerable adults. Horgan refused 
to share that with his readers however, and instead claimed, “Prasad was
applying First, do no harm to the pandemic.“

It gets worse. Horgan continued:

Prasad defended, sort of, Robert Kennedy, now Trump’s secretary of health.

SBM readers will know how this is false. In reality, Prasad openly campaigned
for Kennedy (and Trump), and in his article Sabotaging RFK Jr’s Confirmation
Will Increase Vaccine Hesitancy said:

At this point, the best way to curb vaccine hesitancy is to approve RFK Jr, and 
redirect his energies to generating more data. More data will answer the key
questions that remain unanswered: which childhood immunization program is
optimal. The worse (sic) thing we can do is tank his nomination. Then vaccine
hesitancy will explode.

Horgan refused to share that with his readers and concluded:

So here’s the question: Should I stop citing Prasad because he “collaborated”
(my term) with the Trump regime? Because he discerns upside in Trump and
Kennedy? I’m woke, Prasad is anti-woke. Shouldn’t this guy be dead to me? No. I 
still find much to admire in Prasad. He’s smart, driven by evidence, fearless,
unafraid to take on the medical establishment.

SBM readers will know how this is false. In reality, Dr. Prasad didn’t “take on”
the medical establishment, he is the medical establishment. He is a full
professor at a top medical school who spent a disastrous year as a top official 
at the FDA. While there, he continued to treat asymptomatic vaccine side effects
more seriously than literal death, refused to meet with patient advocates,
faked that the COVID vaccine killed at least 10 children, and was loathed by
staff for his abominable behavior. According to one article:

Prasad was mercurial, pushing at least 7 subordinates out of their positions &
repeatedly overruling career scientists to limit vaccine availability. Hundreds 
of workers left CBER during his tenure as morale slumped & he earned the ire of 
the rare disease community, rejecting at least five drugs.

Horgan refused to share this with his readers and instead falsely claimed Prasad
“welcomes pushback and debate.”  In Horgan’s view, Dr. Prasad did not fail at
the FDA, rather he was failed. The only story Horgan shared about Dr. Prasad’s
time at the FDA was to portray him as a victim, specifically of “Trump attack
dog Laura Loomer and biotech execs trying to make a buck”.

From this, an obvious question emerges- what could Dr. Prasad do to make him
lose Horgan’s admiration?  The answer, it seems, is nothing. Horgan didn’t care 
about Dr. Prasad’s COVID disinformation. Horgan didn’t care about Dr. Prasad’s
incompetence and malevolence at the FDA. Horgan didn’t care that Dr. Prasad
relentlessly fluffed Trump and Kennedy. Because Dr. Prasad scratched his need to
feel contrarian and heterodox, Horgan was willing to overlook it all. Even
though Horgan correctly acknowledged that Dr. Prasad was a Trump collaborator,
he nonetheless “admired” him.

“He’s smart, driven by evidence, fearless, unafraid to take on the medical
establishment.”- John Horgan

This was not a one-off. Horgan also had kind words to say about Dr. John
Ioannidis writing:

Ioannidis has been pointing out problems with the peer-reviewed scientific
literature for decades. When the covid pandemic struck, Ioannidis, like Prasad, 
argued that federal authorities were overreacting. He got bashed for airing this
view on conservative media. I continue to admire Ioannidis because I find his
analyses of the scientific literature sound.

SBM readers will know this is false. In reality, no one “bashed” Dr. Ioannidis
for merely appearing on conservative media. Rather, we justifiably criticized
him for what he said there and elsewhere. Dr. Ioannidis predicted COVID would
kill 40,000 Americans and then spread doubt and disinformation about the death
toll to avoid admitting error. Horgan refused to share that with his readers and
instead concluded:

I was at a weekend workshop with Ioannidis a while back, and I liked him. He
struck me not as an ideologue but as a modest, earnest researcher who goes where
data take him.

“All I ask is that you examine your own views skeptically.”

So, let’s be clear what happened here. In 2016, Horgan was full of condescending
scorn towards doctors who desperately tried to warn of Kennedy and his ilk.
Today, as measles spreads, Wakefield takes a victory lap, Kennedy warns of
chemtrails, and war worsens in the Middle East, Horgan, is full of glowing
praise for the doctors who helped enable all this.

This is what I mean by toxic apathy, and if Horgan disagrees, he can rewrite his
defenses of Drs. Prasad and Ioannidis and simply be honest about what they
actually said. That’s what we do here at SBM, and it doesn’t take any special
effort or skill, just integrity.

However, we also have the right to apply Horgan’s lofty 2016 standards to Horgan
in 2026. I don’t expect him to agree with my framing of these issues. All I ask
is that he examine his own views skeptically. I want him to ask himself this:
Shouldn’t ending war be a moral imperative, like ending slavery or the
subjugation of women? How can we not end war?

Put another way, Horgan should fluff MAHA/MAGA doctors less, and bash war more.


The Murray Hill Declaration

It’s the responsibility of our medical establishment to protect the vulnerable
and keep schools open.

Jonathan Howard on January 1, 2026

Link

Letting fucking morons run public health is the greatest anti-vaccine movement
imaginable

As SBM readers know, our medical establishment rose to power not because of
their genuine accomplishments, but rather because they were social media
celebrities who “proposed”, “argued for”, “called for”, and boasted that they
“would have” done countless amazing, wonderful things when COVID raged. Drs. Jay
Bhattacharya and Martin Kulldorff didn’t protect the vulnerable, but they
“proposed” it and claimed they “would have” done it.  Dr. Marty Makary didn’t
open schools, but he “argued for” this. Dr. Vinay Prasad didn’t run any RCTs,
but he “called for” them.

Fortunately, these doctors face many fewer challenges today than their
predecessors in 2020.  Despite not having to deal with a deadly new virus with
no vaccine, things are going horribly under their dismal “leadership.” Today,
familiar foes, the flu, measles, COVID, and pertussis are swirling, infecting,
and killing children. Meanwhile, vaccine rates are plunging, schools are closing
in multiple states, and students are absent and quarantined. Elsewhere,
hospitals are filling up and are once again forced to limit visitors and issue
mask mandates. It turns out that Dr. Prasad was totally right when he said:

The Murray Hill Declaration

Now that Drs. Prasad, Bhattacharya, Kulldorff and Makary are the medical
establishment, it’s their opportunity to dazzle us all with their real-world
prowess. But more than that, it’s fundamentally their job now do all the
incredible things they previously “proposed”, “argued for”, “called for”, and
“would have” done.  All of it. I have summarized their duties and obligations in
a document titled the Murray Hill Declaration, which borrows heavily from its
inspiration, the Great Barrington Declaration.

Protect the vulnerable

The  Great Barrington Declaration said:

Adopting measures to protect the vulnerable should be the central aim of public 
health responses. By way of example, nursing homes should use staff with
acquired immunity and perform frequent testing of other staff and all visitors. 
Staff rotation should be minimized. Retired people living at home should have
groceries and other essentials delivered to their home. When possible, they
should meet family members outside rather than inside. A comprehensive and
detailed list of measures, including approaches to multi-generational
households, can be implemented, and is well within the scope and capability of
public health professionals.

The Murray Hill Declaration recognizes that it’s now the job of our medical
establishment to implement these “comprehensive and detailed list of measures”
and protect anyone who is vulnerable to a dangerous virus. Since they are now
public health professionals, this is all well within their scope and capability.
Currently, their failure to deliver groceries and other essentials to retired
people living at home reveals their callous indifference to the fate of
vulnerable people.

Protect children’s right to a high-quality education

The Great Barrington Declaration said:

All children have a right to a high-quality education. Adults have a moral
obligation to make this happen.

The Murray Hill Declaration agrees. Our medical establishment are now the adults
with the moral obligation to protect children’s right to a high-quality
education. The Murray Hill Declaration calls for them to use vaccines,
ventilation, testing, masks, and whatever else is needed to make sure schools
remain open with healthy children learning from healthy teachers.  Every school 
closure or epidemic of absenteeism is now happening under their watch and
reflective of their indifference to high-quality education.

Monitor disease transmission at the local level and continuously communicate
this to the public in a nuanced way

The Great Barrington Declaration said:

It is essential for public health departments to monitor disease transmission at
the local level and continuously communicate this to the public. High-risk
individuals can make decisions and take precautions accordingly. This should
ideally be done using random population surveys. Information on hospitalizations
and mortality should also be tracked. Any monitoring system based on positive
test results must account for geographical and temporal variation in testing
practices.

This information should be conveyed to the population in a nuanced way that does
not induce panic but instead provides the basis for an accurate assessment of
each person’s risk based on their age and comorbid conditions.

The Murray Hill Declaration calls for our current medical establishment to
monitor disease transmission at the local level and convey this information to
the population in a nuanced way that does not induce panic but instead provides 
the basis for an accurate assessment of each person’s risk based on their age
and comorbid conditions. Unfortunately, instead of educating the public, they
are trying to relive their lost glory days of 2020, railing on social media and 
right-wing grift conferences about lockdowns and mandates that ended many years 
ago. Our medical establishment never mention headlines about the flu, pertussis,
or measles today. The Murray Hill Declaration calls for this to change.

Create a metabolically healthy population

In his latest one-page “pandemic plan”, Dr. Bhattacharya said:

We should learn from recent example: a metabolically healthy population,
physically active and eating nutritious food, will cope far better in the face
of a novel pathogen than a population facing a severe chronic-disease crisis…

Ultimately, public health agencies encouraging people to take whatever steps
they can to improve their health will have a dramatic effect during the next
pandemic. Whether simply by stopping smoking, controlling hypertension or
diabetes, or getting up and walking more, anything that makes the population
healthier will prepare us better for the next pandemic. The best pandemic
preparedness playbook for the United States is making America healthy again.

The Murray Hill Declaration strongly supports these healthy habits. It is now
the job of our medical establishment to get people to put down their cigarettes,
put on their walking shoes, and make sure Americans are metabolically healthy. 
Posting a cringey work-out video won’t move the needle an inch.

RCT or STFU

Dr. Prasad, famously said “RCT or STFU” and lambasted his predecessors for not
carrying out RCTs of every pandemic mitigation measure, claiming they
deliberately “undermined” RCTs. The Murray Hill Declaration remembers that that 
Dr. Prasad’s predecessors delivered multiple successful vaccine RCTs in 2020.
The Murray Hill Declaration strongly supports RCTs. Provided they don’t violate 
basic medical ethics by testing known vaccines against placebos, it calls for
our medical establishment to conduct RCTs and definitively answer every
lingering question regarding viruses and vaccines. Thus far, they’ve done zero, 
but refuse to STFU.

Hold a series of public dialogues

Despite being media superstars and advising presidents and governors, our
medical establishment claimed to have been silenced and censored. They also
claimed to value debate and discussion. Dr. Prasad, for example, lambasted the
previous medical establishment for not holding public dialogues with the authors
of the Great Barrington Declaration in 2020. He said:

A series of dialogues — even virtual ones — made available for the broader
scientific community, policy makers, and the public would have benefited us all.

It is now our medical establishment’s obligation to have a series of public
dialogues with myself and other signers of the Murray Hill Declaration. Anything
less would be censorship, though we already know they reject free speech.

The establishment, the people who set the policies, they have to strive to get
things right

I hope that you’ll sign the Murray Hill Declaration, an independent proposal
which, unlike the Great Barrington Declaration, wasn’t sponsored by a
pro-tobacco, child-labor advocate. I also view it as a living document. Feel
free to propose, argue for, or call for literally anything you want from our
medical establishment and claim that you would have done it if you had their
authority.  As Dr. Prasad said when he was out of power:

The establishment, the people who set the policies, they have to strive to get
things right. They need to do studies. They need to course correct. They have to
admit their errors. They need to be held to the highest standard.

The Murray Hill Declaration agrees with that 100%.


Who Cares About Dr. Adam Cifu’s Plan to Fix EBM in Theory, When in Reality, He
Elevated the MAHA Doctors Wrecking it Today?

No one forced Dr. Adam Cifu to volunteer as a defense attorney for MAHA doctors.
He chose to do that all on his own.

Jonathan Howard on November 14, 2025

Link

Prasad’s lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies.

Dr. Adam Cifu is a founder Sensible Medicine, a monetized misinformation
Substack that published gems such as Why Doctors Should Learn to Stop Worrying
and Love MAHA and The Nomination of Robert F. Kennedy Jr. as Secretary of the
Department of Health and Human Services: A New Beginning?  Sensible Medicine
also celebrated the appointment of Dr. Jay Bhattacharya by saying:

The recent news that Dr. Jayanta Bhattacharya is being considered for the post
of Director of the National Institutes of Health (NIH) was received with
enthusiasm by many of us who opposed the US pandemic response. Jay, a Professor 
of Medicine, Economics, Heath Research and Policy at Stanford, was a primary
author of the Great Barrington Declaration (GBD) and a consistent and articulate
opponent of unscientific, harmful, and ineffective covid policies. He is a
courageous, thoughtful, and deeply humane person who would make a great leader
of any of our US public health agencies.

That wasn’t true, and predictably things aren’t going well at the NIH today.

However, Dr. Cifu similarly lavished MAHA doctors with praise, especially his
friend Dr. Vinay Prasad. Sure, Dr. Prasad botched basic facts all the time- no
COVID did not kill just 1 in a million children– but who cares whether or not
doctors communicate accurate information about a deadly virus? Not Dr. Cifu,
apparently.

Dr. Prasad openly campaigned for Trump and Kennedy, and Dr. Cifu barely batted
an eye. He felt it was totally acceptable for doctors to elevate deluded
anti-vaxxers to the highest offices in the land under the pretense this was the 
best way to save vaccines.

Dr. Prasad was cruel, juvenile, and profane. He sought to enrage online mobs,
implying that beleaguered vaccine-hero Dr. Peter Hotez was indifferent to child 
sexual abuse, for example, and Dr. Cifu didn’t care at all. In fact, he thought 
it was funny that Dr. Prasad called doctors “motherfuckers” and “fucking morons”
for not treating rare, temporary vaccine side effects as a fate worse than
death from COVID.

While other doctors cited Dr. Prasad’s vulgar, vengeful, vitriol in articles on 
the fatal attack at the CDC, Dr. Cifu claimed this was effective, important
science communication. In an essay defending this “style”, Dr. Cifu wrote:

This style, however, brought more attention to the issues he feels strongly
about than the scores of sober papers he published. It probably also played a
significant role in getting him appointed to a leadership position at the FDA, a
role that seemed tailor-made for him.

Indeed, Dr. Cifu felt Dr. Prasad’s “style” and overt MAHA/MAGA activism meant
there was “no better candidate” to help lead the FDA. Along with another
misinformation superspreader, Dr. John Mandrola, Dr. Cifu endorsed him writing:

Prasad’s lifelong commitment to scientific rigor will help rebuild lost trust in
regulatory bodies.

That wasn’t true, and predictably things aren’t going well at the FDA today.

He’s wreaking havoc with the staff. People are terrified.

And we should be clear about the stakes here. Not long ago, Drs. Cifu and
Mandrola recorded an entire podcast with Dr. Prasad bemoaning a single canceled 
speech. With Dr. Prasad at the helm, many people’s entire careers have been
cancelled. His brief tenure has been marked by high school drama, anti-vaccine
fear mongering, purges, censorship, and outright lies about critics– namely
myself. He avoids journalists, skips key meetings, and barely comes into the
office. According to one article titled Under Vinay Prasad, Employees at A Key
FDA Center Fear Speaking Out, Look for the Exits:

Dozens of scientists are considering leaving the Center for Biologics Evaluation
and Research, where Prasad serves as director, to escape a work environment
that eight agency officials described to STAT as rife with mistrust and
paranoia. These officials said staffers are terrified of pushing back on Prasad,
lest they face retaliation.

The fear has been fueled by Prasad pushing at least seven senior leaders out of 
their positions, employees told STAT, and offering no public explanations to
staff or the leaders’ supervisors. Some of his workers are fed up, and are
attempting to transfer to the FDA’s drug center. Prasad has tried to block these
transfers in apparent recognition that CBER can’t afford to lose many more
employees. The center has lost hundreds of employees since the start of this
year to retirements, layoffs, and resignations, and hiring conditions are
difficult.

CBER employees are concerned that the exodus of employees and the worsening
morale problems will affect the functioning of the center, which ensures the
safety and efficacy of vaccines and helps speed potentially lifesaving therapies
to rare disease patients…

“He’s wreaking havoc with the staff,” one agency official said. “People are
terrified.”

I’m glad I played no role in respected scientists being marched out of their
office without explanation.

Another article, How Two Top FDA Officials are Quietly Upending Vaccine
Regulations, reported that Dr. Prasad is censoring research showing results he
doesn’t want to be true, namely that the COVID vaccine is beneficial.

In October, Prasad decided to withdraw the paper, which examined health outcomes
among patients with private health insurance who received Covid vaccines from
2023 to 2024. The paper concluded that there were no new safety concerns
following Covid-19 vaccination for people aged 6 months to 64, and that “the
benefits of vaccination outweigh the risks,” according to a copy viewed by STAT.

“The retraction of the study marks a choice by leadership away from transparent 
and comprehensive reporting of the results of these government funded studies
towards opaque and selective reporting of particular results,” a former employee
of an FDA contractor told STAT.

The article also noted that, “the deputy director in the office of vaccines,
quit the agency on Friday” and “The FDA, Prasad, and Høeg did not respond to
STAT’s requests for comment, or provide answers to a detailed list of questions 
sent by email.”

Here are some other articles we are all reading about the FDA:

  1. Experts Worry FDA’s Credibility Is Being Shredded by Scandal and ‘Soap Opera’

  2. Dr. Prasad, the FDA’s Grim Reaper

  3. FDA Described As “Clown Show” Amid Latest Scandal

  4. The Spin Doctors at the FDA

  5. Inside the Staff Exodus and Tanking Morale That Threaten Makary’s FDA

  6. The FDA’s Meltdown Escalates

  7. What to Know About the Collapse of the F.D.A

  8. FDA Leaders Are “Acting Political”, Says Ex-Agency Chief Counsel

  9. FDA Staff in Meltdown as RFK Jr. Chaos Triggers Mass Exit Fears

  10. Drug Approvals Hit an FDA Wall FDA Review of Drugs Is Slowing While
    Application Delays Are Growing, Analysis Find

  11. Fed-Up and Demoralized, FDA Staff are Leaving.

  12. Can Clinical Trials Withstand the New FDA?

  13. Inside FDA, Career Staffers Describe How Political Pressure Is Influencing
    Their Work

  14. FDA Chaos Threatens Medical Innovation — and Patients’ Health

  15. Chaos at the FDA Leaves Staffers Disturbed, Ready to Leave

Instead of rebuilding “lost trust,” confidence in our federal health agencies
has tanked, and large swaths of the country are wisely ignoring their
“guidance.” Talk about a medical reversal.

It’s nice to think there’s someone to blame, isn’t it?

While Dr. Cifu was happy to earn income from pro-Kennedy balderdash and fluff
MAHA doctors himself, he purposefully undermined those of us who warned of their
dangers. He repeatedly dunked on my writing, though he never even attempted a
coherent refutation of even a single word. Instead of thoughtfully engaging with
the arguments I made or the data I presented, he used haughty snark and sarcasm
to breezily dismiss it all. It was bad faith enagement all the way down.

“It’s nice to think there’s someone to blame, isn’t it?” he said to me- and only
to me- when I merely considered criticizing the authors of the Great Barrington
Declaration, two of whom now hold prominent positions in the Trump
administration. Apparently, influential advocates of herd immunity via mass
infection, backed by a pro-tobacco, child-labor advocate and current MAHA
powerbroker, deserved a safe space where they were shielded from even the
slightest criticism.

Elsewhere, Dr. Cifu morphed into a music critic, fretting mightily about
unspecified flaws in my “tone”. In a pandemic where over a million Americans
died, many due to the misinformation I warned about, my decorum is what mattered
most to him. “It is hard to engage when you feel like you’re being yelled at,” 
he said- again, only to me- without providing any examples. Imagine if I had
created a collage of prominent doctors to shame and mock them on social media.

Other times, Dr. Cifu put his words in my mouth to make me sound like a
blathering idiot and discredit my warnings about the threat of medical
disinformation. He said to me:

I think it’s wonderfully optimistic to think had it not been for Drs. X, Y, Z
everything would have gone swimmingly. You know our country as well as I do.

As people who’ve read my work know, I never said anything that stupid, though
Dr. Cifu is not such a person. In fact, he made a great show of publicly
refusing to even read an article of mine that corrected Dr. John Ioannidis’s
baseless, nasty accusation that frontline doctors killed our patients through
premature intubations. “It’s problematic when a paragon of evidence-based
medicine claims vaccines spread disease and amplifies internet rumors,” I wrote.
I stand by that. However, rather than even entertain the possibility that a
peon like me could critique a hero of his, Dr. Cifu said that he had to run to
clinic.

Trying to have a serious, mature conversation with him about evidence and
science was impossible. I tried. I failed. I tried again. I failed again. It was
like trying to teach a fish to ride a bicycle. It just wasn’t going to happen.

And while the disingenuous tone policing and deceptive straw man arguments were 
annoying, the core problem is that Dr. Prasad and I delivered very different
messages. I warned that Kennedy might turn the CDC into an anti-vaxx propaganda 
outfit. In contrast, Dr. Prasad called the FDA a “corrupt entity that needs to
be entirely renovated” and wrote articles such as Sabotaging RFK Jr’s
Confirmation Will Increase Vaccine Hesitancy.

However, according to Dr. Cifu, the vulgar doctor who glorified Kennedy had a
“lifelong commitment to scientific rigor” and deserved to lead CBER, while the
doctor who sternly warned about Kennedy could be scolded and dismissed out of
hand.

🔥 Dr. Vinay Prasad Praises RFK Jr“On regulatory capture, on the COVID-19
vaccine, on the FDA being a corrupt entity that needs to be entirely renovated…I
completely agree with him, and I wish him well in that pursuit.”@VPrasadMDMPH
@RobertKennedyJr pic.twitter.com/MOTP7NQGH1

— Chief Nerd (@TheChiefNerd) October 30, 2024

Evidence-Based Medicine Requires Urgent Reform, Physician Says

Given this background, Dr. Cifu recently gave a lecture that caught my eye. It
was summarized in an article titled Evidence-Based Medicine Requires Urgent
Reform, Physician Says. He’s right. Would Dr. Cifu be bold enough to discuss
what Kennedy and MAHA doctors are doing right now? Not according to the
article.  It said:

Evidence-based medicine faces fundamental challenges that threaten its core
mission of integrating clinical expertise with rigorous research, according to
Adam Cifu, MD, who delivered a lecture at a Toronto physicians’ meeting. His
analysis identified two competing explanations for what he calls evidence-based 
medicine’s failures: inherent design limitations predicted by early skeptics and
systematic corruption by special interests.

Dr. Cifu identified several flaws in EBM: foundational flaws in trial design,
post-randomization confounding, low positive predictive value, medical reversal 
phenomenon, and industry-influenced trial design.

The article concluded with Dr. Cifu’s proposed solutions:

Dr. Cifu outlined requirements for EBM restoration: “This demands unbiased
research. It demands trials that are actually designed by actual physicians,
practicing physicians, to answer important clinical questions that they
identify.”

From NASA to the National Institutes of Health, federal agencies conduct
research that universities cannot. Agency scientists speak out about the
irreplaceable facilities, institutional knowledge and training opportunities
that the country is losing.

Dr. Cifu’s talk, at least reported by the article, was mostly banal pablum, like
saying kittens are cute and papercuts stink. Who doesn’t want “unbiased
research?” and “trials that are actually designed by actual physicians”?

We all do, of course. The problem is that some of us can also read the news. We 
know what’s happening in science and medicine today and wonder who is going to
carry out this “unbiased research” moving forward. Unless one feels Americans
need to be protected from the grave threats posed by vaccines, food dyes in ice 
cream, wind farms, Tylenol, and chemtrails, we do not seem to be entering a
golden age of biomedical research.

Dr. Cifu didn’t acknowledge any of this, however. There was no mention of any
current events or the people responsible for them. His talk was a time capsule
from a more innocent age, when Kennedy was a powerless crank, Dr. Ioannidis
(whom Dr. Cifu positively referenced) was an unquestionable saint, and vital
medical questions could be definitively answered if only we summoned the
collective will to run the proper studies.

Dr. Cifu’s talk, it turns out, was just a dispatch from the pundit fantasy
world. I previously used this term to describe sheltered pundits who acted as if
all it took to open schools and protect the vulnerable was to utter the words
“open schools” and “protect the vulnerable”. Maintaining this illusion required 
them to actively deny what happened in the real world when COVID was allowed to 
spread unchecked. Unwanted news was unmentionable news.

It’s super wonderful that Dr. Cifu wants “unbiased research,” but how does he
feel things are going, not just at the FDA, but also the NIH and CDC? Can he
make the affirmative case that these agencies are thriving under the doctors he 
defended and promoted?

 If not, his complaints about the current state EBM should be viewed as a
searing indictment of their failed leadership. After all, they are the medical
establishment now, and they are to blame if they don’t deliver the “unbiased
research” Dr. Cifu claims to value. 

Perhaps I’ve missed it, but other than to deliberately distort Dr. Prasad’s
pandemic record- yes Dr. Prasad repeatedly said “RCT or STFU” to undermine his
predecessors- I’ve never seen Dr. Cifu seriously grapple with any of the
headlines about the state of science in the U.S. today. Unwanted news is still
unmentionable news.

Motivating biases need not be considered nefarious, only considered.

I have several proposals of my own to remedy this willful denial. Moving
forward, anyone who opines on problems with EBM should, at a bare minimum,
acknowledge what is happening to scientific research today and name the
individuals responsible for it. It’s not that hard to simply be honest.

Furthermore, speakers should disclose if they opposed or enabled the people
behind the headlines today, especially if they profited from articles like this.
Our audiences deserve to know such things. That is as relevant as any pharma
ties, and Dr. Cifu once wrote eloquently about the importance of considering
such “motivating biases.” I agree.

My disclosures would read that I volunteered for a vaccine-RCT. Though that was 
a small contribution, it was a real one, and I am proud of it. Additionally,
along with many others, I desperately tried to sound the alarm bells about
Kennedy and MAHA doctors. We failed, but at least there’s a clear record of us
doing everything we could to stop them.

I don’t think Dr. Cifu can’t say that.

As such, no one should care about his ideas to fix EBM in theory, when in
reality, he volunteered as a defense attorney for the MAHA doctors taking a
wrecking ball to it today. Though that was a small contribution, it was a real
one. Nothing else about him should matter, and his empty pleas for “unbiased
research” won’t change that.

And just to be clear, I totally agree with Dr. Cifu- tone is important. That’s
why I’ve never said anything like this. I don’t think it is unfair for me to ask
Adam to pause and reflect on that.


Suggested questions for Donald Trump’s health nominees during confirmation
hearings

It won’t be long before we’re treated to the spectacle of Senators grilling
antivax nominees like Robert F. Kennedy Jr. (HHS) and Dr. Dave Weldon (CDC). We 
exist to serve, which is why I’m suggesting some questions for Senators to ask
all of Trump’s health picks.

David Gorski on December 2, 2024

Link

Last week, President-Elect Donald Trump rounded out the list of his nominees for
health positions in his administration. Initially, he had nominated antivax
activist and all-around conspiracy theorist Robert F. Kennedy, Jr., whom given
his having bent the knee to Donald Trump before the election in return for the
promise of a high-ranking health position in Trump’s administration I had
previously characterized as an “extinction-level threat” to federal health and
biomedical science programs, to be his Secretary of Health and Human Services
(HHS), a truly awful and alarming pick, a veritable catastrophe for public
health and medical research. Likely on the advice of RFK Jr, Trump soon followed
up by nominating “America’s Quack” Dr. Mehmet Oz to be Administrator of the
Center for Medicare and Medicaid Services, a “blast from the past” antivaxxer
(and former Florida Representative) Dr. Dave Weldon to be Director of the
Centers for Disease Control and Prevention, as well as a veritable rogues’
caller of quacks and grifters, including Dr. Jay “the pandemic will be over in
six months” Bhattacharya to be NIH Director. The only somewhat tolerable nominee
was Dr. Janette Nesheiwat for Surgeon-General, given that she is definitely not
antivaccine (although she did eventually swear fealty to the “anti-mandate”
crowd.) She is, however, a Fox News pundit and does sell a self-concocted and
self-branded line of vitamin supplements, because of course she does. She also
was one of the directors of a chain of urgent care centers that settled a
lawsuit alleging fraud by the Department of Justice for fraudulently obtaining
government reimbursements for COVID tests from February 2020 to April 2022 by
submitting false claims to a COVID program for uninsured patients regardless of 
whether their patients had health insurance or not.

Let’s recap who the current nominees for key health positions are:

  1. Robert F. Kennedy Jr. for HHS Secretary. What else can we say about RFK Jr
    that we haven’t already said many times before? He first came out as antivax
    in 2005, when Salon.com and Rolling Stone co-published his conspiracy-fest 
    of an antivax article, Deadly Immunity, which claimed that the
    mercury-containing preservative thimerosal that was in a number of childhood
    vaccines until around 2001 had been responsible for an “epidemic” of
    autism—evidence overwhelmingly says that it wasn’t—and that the CDC had
    “covered up” that evidence. Since then, he has been nothing, if not
    consistent, in his demonization of mercury in vaccines, which ultimately
    grew to become demonization of all childhood vaccines as a cause of autism
    and all sorts of chronic illness, as well. as his becoming a fan of “autism 
    biomed” quackery to treat autism as “vaccine injury.” Unsurprisingly, when
    COVID-19 hit, RFK Jr. soon became antimask and opposed nonpharmaceutical
    interventions to slow the spread of the disease and, even less surprisingly,
    turned anti-COVID-19 vaccine as soon as mRNA-based vaccines appeared on the
    horizon. Oh, and he has characterized vaccines and the childhood
    vaccination program as a “holocaust“—repeatedly—all while risibly
    proclaiming himself “fiercely pro-vaccine,” starting with an appearance on
    Dr. Oz’s show. When he bent the knee to Trump, he proclaimed. that he and
    Trump would “make America healthy again” (MAHA), a nod to the longtime Trump
    slogan of “make America great again” (MAGA), assiduously avoiding
    mentioning vaccines while later declaring “war” on the FDA.

  2. Dr. Mehmet Oz for Administrator, Centers for Medicare and Medicaid Services.
    Here’s yet another one whom we’ve written about more times than I can
    remember and whom I long ago dubbed “America’s Quack,” in a “nod” to Oprah
    Winfrey having declared him “America’s Doctor,” thus launching his TV
    career. It’s worth mentioning first how Dr. Oz routinely had antivaxxers
    like RFK Jr., Dr. Mark Hyman, and Mike Adams on his daytime TV show back in 
    the day. During the pandemic, Dr. Oz also boosted quack tycoon Joe Mercola, 
    who’s now (hilariously) in the thrall of a psychic medium claiming to
    channel Bahlon, an “ancient and wise high-vibration entity from the Causal
    Plane,” and as a result now thinks he’s a “new Jesus” who will save the
    world. His promotion of COVID-19 misinformation started early too. During
    the early weeks of the pandemic in 2020, Dr. Oz, enamored of Didier Raoult‘s
    horrendously awful science, promoted Didier’s protocol using
    hydroxychloroquine and azithromycin, as a cure for COVID-19. Meanwhile, as
    he was angling to run as a Republican to be one of Pennsylvania’s Senators, 
    he started embracing the minimization of COVID-19, in particular becoming
    critical of school closures. Indeed, he went so far that he was forced to
    apologize for having suggested that reopening schools was a “very
    appetizing” opportunity because it was estimated that reopening schools
    might “only” increase the total number of COVID-19 deaths by 2-3%. Dr. Oz
    also had Donald Trump on his show in September 2016 during the election, and
    the two got along so famously that I referred to it as a “huckster
    bromance.”

  3. Dr. Dave Weldon for Director, Centers for Disease Control. I recently wrote
    about him. He was, I must confess, a real surprise, a “blast from the past,”
    an antivaxxer about whom I hadn’t thought in years. During his 14 years in 
    Congress, Weldon funneled his belief in an “autism epidemic.” He also
    apparently believed in the thimerosal-autism link, to the point of promoting
    highly dubious studies and attacking decent studies examining whether
    mercury in childhood vaccines had been responsible for such an “epidemic.”
    Back in the day, he even spoke at antivax “conferences” falsely billed as
    scientific conferences. Back in 2003-2004, Weldon used his position in
    Congress to write letters to then-CDC Director Julie Gerberding demanding an
    “investigation” of supposed links between vaccines and autism. Basically,
    the letters made the same claims that RFK Jr. made in the aforementioned
    2005 conspiracyfest Deadly Immunity. Recall that the central claim in RFK
    Jr.’s article, co-published by Rolling Stone and Salon.com (to their eternal
    shame), was that there was evidence that thimerosal in vaccines was
    associated with a highly elevated risk of autism in children but that the
    CDC, at a meeting in 2000, “covered it up.” This is a claim that I like to
    call the Simpsonwood conspiracy theory, after the conference center where
    the meeting was held, an example of the central conspiracy theory of the
    antivaccine movement (at least in the US), one I’ve deconstructed in the
    past. Weldon, even though he’s a physician, fell for the Simpsonwood
    conference conspiracy theory. No wonder RFK Jr. likes him.

  4. Dr. Jay Bhattacharya for Director, National Institutes of Health.  Dr. Jay
    Bhattacharya, coauthor of the Great Barrington Declaration, that famous
    anti-public health manifesto calling for a “let ‘er rip” approach to the
    pandemic—in October 2020, before there was a vaccine!—with the futile goal
    of achieving “natural herd immunity,” with a poorly defined strategy of
    “focused protection” that would supposedly keep those most vulnerable to
    severe disease and death from COVID-19 while the presumably young and
    healthy died at a much lower rate than the elderly and ill as the virus
    rampaged through the population. It was a tendentiously libertarian and
    profoundly social Darwinist approach to “open up the economy” at the expense
    of disease and death that never would have worked and ultimately caused
    enormous damage to public health. His appointment is symptomatic of the
    upending of the longtime bipartisan support that the NIH has enjoyed and a
    prelude to unprecedented political meddling. As was posted in a lab research
    group on Reddit, “NIH director is usually someone that A) has an entire
    career dedicated to biological and medical research and B) is a leader in
    their field and has extensive administrative experience. Bhattacharya has an
    MD but is health care economist, is appointed because he is a COVID
    skeptic, not because of his academic and research qualifications. Harold
    Varmus and Francis Collins changed the world of research and medicine, this 
    guy posted on Twitter.”

  5. Dr. Martin “Marty” Makary for Commissioner, Food and Drug Administration. Dr. 
    Makary first came to my attention as one of the foremost promoters of the
    myth that medical errors constitute the third leading cause of death in the 
    US, all based on a risibly incompetent study that used unjustifiable
    extrapolation from small numbers to conclude that 250,000 deaths occur each 
    year in hospitals due to medical error. Basically, Dr. Makary started out
    semi-reasonable on COVID-19 but was, as our very own Jonathan Howard has
    long documented, quick to be captured by his audience and fully embrace the 
    “let ‘er rip” approach to the pandemic in a futile effort to achieve
    “natural herd immunity,” which, he promised, was always no more than six
    months away, after which he rapidly pivoted to fear-mongering about COVID-19
    vaccines.

  6. Dr. Janette Nesheiwat for Surgeon General. Again, Dr. Nesheiwat is a physician
    and Fox News pundit. She’s generally pro-vaccine, although she did
    ultimately turn anti-mandate. She also sells her self-branded line of
    vitamins, because of course she does.

Wow. Reading summaries of all of Trump’s picks as a bulleted list just
reinforces how awful all but one of them are.

In any event, assuming that there are actually confirmation hearings—not a done 
deal yet, given Trump’s pressure on the Senate to let him appoint his cabinet
members by recess appointments—there is a possibility that one or more of these 
nominations will fail to win confirmation. For example, RFK Jr. isn’t exactly
popular, even among Trump’s Republican allies in Congress, which produces hope
(in me, at least) that there is a real possibility that he carries enough
baggage for his confirmation to fail. Of course, I fear that Trump probably has 
someone waiting in the wings, should RFK Jr.’s nomination fail, likely Dr.
Joseph Ladapo, the FLCCC quack who’s been Florida’s Surgeon-General since 2021, 
but that’s getting ahead of myself.

Let’s propose some questions for this rogues’ gallery of nominees. I’ll start
with questions that each nominee should be asked and then do a section for each 
individual nominee. Truth be told, the section listing questions that I think
all nominees should be asked will likely be the largest section, but certainly I
will have some “personalized” questions for the others. For instance, one can
ask Dr. Bhattacharya about the Great Barrington Declaration (which he
co-authored) and Dr. Makary about his repeated failed predictions that the
pandemic would end soon, as well as his risibly bad science about medical
errors. Also, if you have any suggestions, please add them in the comments!

Confirmation questions for all nominees

Here are some proposed questions for all nominees, with comments (as
appropriate). Note that, to be effective, Senators can’t let the nominee waffle 
and need to press the nominee for clear and specific answers. I’ll start with
some very basic questions that would help demonstrate whether a nominee believes
in conspiracy theories and pseudoscience and then proceed to more general
medical questions, some followed with additional brief commentary:

  1. What would you do about falling uptake of childhood vaccines, which is
    predisposing some states with particularly low uptake to the resurgence of
    once-controlled childhood diseases, like measles and whooping cough, with
    there even being a possibility that polio might return? Obviously, those who
    suggest that we should weaken school vaccine mandates would not help this
    problem.

  2. Based on your knowledge of the scientific evidence, do you believe that
    childhood vaccines cause autism, yes or no? Here’s a quick example where you
    can’t let someone like RFK Jr. waffle, because waffle he will, in spite of 
    his past comments. If any of them try to waffle, Senators need to bring the 
    receipts, which are easy to find for RFK Jr. and Dave Weldon. Heck, they’re 
    easy to find for all of them, save maybe Dr. Nesheiwat. Then follow up with…

  3. What is the explanation for the increase in autism diagnoses over the last
    three decades? Hint: The answer is not vaccines, as, when consistent
    diagnostic criteria are used, autism prevalence hasn’t changed in at least
    two decades. It’s likely a combination of diagnostic substitution, increased
    screening and awareness, and less stigma associated with a diagnosis of
    autism.

  4. Does SARS-CoV-2 cause COVID-19? Seriously, there are the usual virus denial
    conspiracy theories out there that SARS-CoV-2 doesn’t cause COVID-19, some
    of which claim that it’s a “misdiagnosed” bacterial pneumonia. A followup
    question would be: Is a positive PCR test for SARS-CoV-2 a reliable
    indicator that a patient has COVID-19?

  5. Was SARS-CoV-2 a bioweapon? If yes, where was it created and how did it get
    out of the lab? I realize that a lot of people think that “lab leak” is a
    plausible origin for SARS-CoV-2—it’s possible, but not very plausible at
    all—but even the “reasonable” lab leakers generally don’t “go there” when it
    comes to claiming that SARs-CoV-2 is a “bioweapon. If someone answers yes, 
    they’re a crackpot, pure and simple, and RFK Jr. has said that SARS-CoV-2 is
    an ethnically targeted bioweapon designed to spare Jews and Asians.

  6. Which vaccines do you generally recommend to everyone who doesn’t have a
    specific contraindication to them? This is one of my favorite questions to
    put antivaxxers on the spot. If they’re antivax, they’ll generally waffle or
    try to avoid giving a straight answer.

  7. What nonpharmaceutical interventions (e.g., masking, school closures, business
    closures) measures would you advocate instituting if a new pandemic caused 
    by a novel respiratory pathogen (e.g., bird flu that became easily
    transmissible between humans) for which there was no safe and effective
    vaccine? What would you do if the new pathogen was more severe than
    SARS-CoV-2, with an infection fatality rate of, say, 10%? What if hospitals 
    became overwhelmed with victims, to the point that they were in danger of
    having to shut down?

  8. How do you reconcile the MAHA imperative to decrease chronic diseases, some of
    which are environmental in nature, with the other imperative of the new
    administration to increase oil production, industry, and the like? By way of
    context, when saying he’d let RFK Jr. “go wild” on health at a rally before
    the election, DonaldTrump specifically excluded letting him do anything
    related to oil drilling, and I doubt that he’ll let you go after industrial 
    pollution given his promise to deregulate, particularly when it comes to
    environmental regulations.

I’m sure I’ve missed a lot of possibilities. Also, I realize that individual
Senators favoring science-based medicine and public health will have to pick,
choose, and prioritize, given how little time they each get to question
nominees. I also realize that they might end up choosing based more on political
considerations on what might most effectively discredit each nominee. With that
in mind, let’s move on to some individuals.

Robert F. Kennedy Jr.

I could come up with dozens of questions, but I’ll limit myself to just a few:

  1. Do you want to take away people’s vaccines? Then, when he predictably answers 
    no, follow up with…

  2. You have likened the childhood vaccination program to a “holocaust,” not just 
    once, but multiple times dating back to 2013, one time even likening the
    autism that you claimed vaccines cause to Nazi death camps. While it’s true 
    that you did apologize once, you’ve also said at various antivaccine
    conferences where you’ve spoken over the years that the CDC is a “fascist
    enterprise that knowingly hurt children”, likened its handling of data about
    vaccines to the Catholic priest pedophilia scandals, and called for the
    jailing of vaccine scientists and throwing away the key. Your apology for
    the “holocaust” remarks notwithstanding, do you still think the vaccine
    program is a “holocaust,” that being autistic is like being in a Nazi death 
    camp, and that the CDC is a fascist enterprise? Do you still think vaccine
    scientists should be jailed and the key thrown away? How about Anthony
    Fauci? How would you accomplish this as HHS Secretary? Would you, for
    instance, call for an investigation to put Dr. Paul Offit in prison, as you 
    said at an Autism One conference in 2013? How are these ideas consistent
    with the health mission of being Secretary of HHS?

  3. You have referred to yourself multiple times as “fiercely pro-vaccine,”
    starting with an appearance on The Dr. Oz Show a decade ago. Yet, it has
    been reported by people who have observed you for 20 years that they have
    never heard you say anything positive about vaccines. Indeed, recently you
    said, and I quote: “There’s no vaccine that is…safe and effective.” How is
    that not antivaccine, and please don’t use your previous risible response
    about how you “can say right now there’s no medicine for cancer that’s safe 
    and effective” and that ” It “doesn’t mean I’m against all medicines.”
    Instead, name a vaccine (or, preferably, several vaccines) that you consider
    sufficiently safe and effective that you recommend them in general to
    people who don’t have a contraindication.

  4. Given your previous views and that members of the CDC’s Advisory Committee on 
    Immunization Practices (ACIP) is appointed by the HHS Secretary, can you
    name some potential people whom you would pick to replace outgoing members
    of the committee? (Remember, one way that RFK Jr. could stop any new
    vaccines and start removing vaccines from the recommended schedule would be 
    to start putting antivaxxers on ACIP.)

  5. How will you prepare for a new pandemic? Let’s say that there is a pandemic
    due to a new virus that is transmitted like SARS-CoV-2 or the flu? Given
    that you have attacked masking, social distancing, and business and school
    closures, what strategies would you pursue to slow the spread of the
    disease?

  6. Does HIV cause AIDS? (There’s a lot of HIV/AIDS denial, in addition to antivax
    fear-mongering in RFK Jr.’s book The Real Anthony Fauci.)

  7. Do you still believe that SARS-CoV-2 is an “ethnically targeted bioweapon”
    designed to spare Ashkenazi Jews and Chinese people?

  8. What qualifies you to run an organization as large as HHS, which encompasses
    more than a trillion dollar budget and innumerable institutions, as well as 
    Medicare and Medicaid, given that you have never run an organization larger 
    than Waterkeeper Alliance or Children’s Health Defense before?

I’d be half tempted to ask RFK Jr. about the dead bear cub that he dumped in
Central Park a decade ago or the dead whale that he decapitated to take the head
home, but I’m sure those incidents will come up.

Dr. Dave Weldon

Again, make no mistake, Dr. Weldon was one of Congress’ go-to people for the
antivax movement back in the day, and there’s no evidence that he’s changed his 
stripes. Even so, in addition to the questions for everyone, because of his
distant profile, his most recent public activism being something like 15 years
ago, there are only a couple of questions for him:

  1. Your primary concern about vaccines and vaccine safety when you were in
    Congress was that the mercury-containing preservative thimerosal was
    responsible for an “autism epidemic.” Considering that thimerosal was
    removed from childhood vaccinations in 2001 and it is 23 years later, are
    you now satisfied that the vaccines on the childhood schedule do not cause
    autism? (Anyone want to bet that he isn’t?)

  2. Statisticians, scientists, and epidemiologists tell us that the studies
    showing no link between thimerosal-containing vaccines and autism were
    well-designed and turned out to be negative. What specific scientific,
    medical, and epidemiological expertise qualifies you to question their
    design or conclusions to the point of saying they are wrong?

  3. As has been noted, infectious disease is far from the only public health
    threat to Americans. Indeed, the number one cause of death among children is
    not infectious disease thanks to vaccines, but rather trauma, and not just 
    any trauma but gun-related trauma. What will you do to address the problem
    of childhood deaths due to gun violence?

  4. Your boss, RFK Jr., has said that the CDC is a fascist organization. Do you
    agree? If yes, what about it is fascist? If no, how will you protect the
    CDC’s independence from a boss who is so hostile to it and its mission?

  5. Another public health threat is environmental pollution. Yet your boss-to-be, 
    President-Elect Donald Trump, has put oil and gas drilling off-limits and
    promises to roll back environmental regulations. How will you deal with
    this? What would you say to President-Elect Trump to try to change his mind 
    about the importance of studying environmental pollution as a public health 
    threat?

  6. You say you are not antivaccine. Please list the vaccines that you personally 
    consider safe and effective enough to recommend generally to people without 
    specific contraindications to them.

Dr. Mehmet Oz

Dr. Oz is a bit of a difficult one. Superficially, he’s very slick, and there is
no doubt that he was once an accomplished academic surgeon before he turned
into “America’s Quack.” However, there are a few pointed questions that would
show his lack of qualifications:

  1. One of the missions of CMS is to ensure that the medical tests, treatments and
    services covered by Medicare and Medicaid are, at minimum, evidence-based
    and safe. In 2014, when The Dr. Oz Show was riding high in the cultural
    zeitgeist, a study was published examining 40 random episodes of your show
    that found that, for the recommendations on your show, evidence supported
    46%, contradicted 15%, and was not found for 39%. This is not a good record.
    How will you ensure that Medicare and Medicaid funds are used only on
    services with a strong evidence base supporting them?

  2. You have supported “alternative” medical therapies with little or no evidence 
    behind them and a lot of evidence against them, such as homeopathy, on your 
    show. Again, given your track record, how can we be assured that you will
    ensure that Medicare and Medicaid do not cover non-evidence-based treatments
    or even outright quackery? (Are you sensing a theme here?)

  3. You promoted hydroxychloroquine to treat COVID-19 early in the pandemic based 
    on some highly dubious studies by a man named Didier Raoult. We knew within 
    months of the pandemic’s start that hydroxychloroquine doesn’t work against 
    COVID-19. More recently, researchers representing sixteen French
    organizations wrote that Raoult and his subordinates engaged in “systematic 
    prescription of medications […] to patients suffering from Covid-19 […]
    without a solid pharmacological basis and lacking any proof of their
    effectiveness,” and that those drugs continued to be prescribed “for more
    than a year after their ineffectiveness had been absolutely demonstrated”,
    and a number of his papers have been retracted for ethical breaches. Once
    again, how can we trust you to make sure that CMS only endorses and
    reimburses services that are evidence-based, given that you clearly couldn’t
    identify poor quality and misleading studies then?

Dr. Marty Makary

Dr. Makary is being tasked to run the FDA. However, his track record on the
pandemic and various issues is not great. So let’s suggest a few questions:

  1. You estimated that medical error is the third leading cause of death,
    accounting for 250,000 deaths per year. However, the methods of the paper in
    which you came to that estimate have been sharply criticized. Critics noted
    specifically that, if your estimate were true, then 35% of in-hospital
    deaths would be due to medical error, which is highly implausible (and your 
    upper estimate was 400,000 deaths) while citing other studies showing that
    the true estimate, while still too high given that one error is too much, is
    likely at least ten-fold lower. First: Do you still believe that medical
    error is the third leading cause of death? Based on what, other than your
    flawed study, which is clearly a wild extrapolation?

  2. In February 2021, you published an article entitled “We’ll Have Herd Immunity 
    by April” and predicted that “Covid-19 will be mostly gone by April.”
    Clearly that was not the case, given the rise of the Delta and Omicron
    variants, neither of which stopped you from claiming that we were at herd
    immunity when we clearly were not. You repeatedly got it wrong about herd
    immunity. Why should we trust you to make sure that only the most rigorous
    evidence is used to determine drug approval?

  3. You are an executive in the telehealth company Sesame, which connects
    consumers to physicians who can prescribe compounded weight-loss drugs.
    Isn’t that a conflict of interest just like the ones you complain about with
    respect to pharma? After all, one might expect that you would be
    sympathetic to loosening regulations with respect to compounded drugs and
    compounding pharmaceutical pharmacies. What is your position with respect to
    compounding pharmacies, which are sometimes misused to sell inferior
    versions of FDA-approved medications?

  4. RFK Jr. has suggested that he wants a lower standard of evidence when it comes
    to interventions like stem cell therapies, peptides, botanicals, and the
    like. How will you resist political interference in the drug approval
    process?

  5. In fact, given that you advocate for a higher standard of evidence for FDA
    approvals and recommendations, how will you try to make sure that your boss 
    RFK Jr. doesn’t interfere in FDA approval deliberations on new vaccines to
    put requirements beyond reasonable scientific requirements under the
    Kefauver-Harris Amendments that require the FDA to demonstrate efficacy and 
    safety?

Dr. Jay Bhattacharya

I would ask Dr. Bhattacharya similar questions about herd immunity, but in
particular I would focus on his being a coauthor of the Great Barrington
Declaration, that October 2020 manifesto by three scientists brought together by
a right-wing think tank that recommended opening up the economy by letting the 
virus rip among the “young and healthy” population while offering vague
platitudes about the “focused protection” of the elderly and those at high risk 
for severe disease and death from COVID-19:

  1. You were a coauthor of the Great Barrington Declaration, published in 2020.
    This declaration recommended two things: first, to let the virus spread
    among the young and healthy, the better to reach “natural herd immunity”
    faster, specifically stating: “Those who are not vulnerable should
    immediately be allowed to resume life as normal. Simple hygiene measures,
    such as hand washing and staying home when sick should be practiced by
    everyone to reduce the herd immunity threshold. Schools and universities
    should be open for in-person teaching. Extracurricular activities, such as
    sports, should be resumed. Young low-risk adults should work normally,
    rather than from home. Restaurants and other businesses should open. Arts,
    music, sport and other cultural activities should resume. People who are
    more at risk may participate if they wish, while society as a whole enjoys
    the protection conferred upon the vulnerable by those who have built up herd
    immunity.” Elsewhere, the GBD made a couple of minor suggestions for
    “focused protection” of the elderly but blithely added that “a comprehensive
    and detailed list of measures, including approaches to multi-generational
    households, can be implemented, and is well within the scope and capability 
    of public health professionals,” while suggesting that herd immunity could
    be reached in 3-6 months. Yet you have denied that the GBD was a “herd
    immunity” strategy. What is the GBD if not a herd immunity strategy? (One
    has to be prepared to follow up when the usual dissembling occurs.)

  2. Given #1, why should you be put in charge of determining the sorts of research
    that the NIH will fund and do in order to determine how best to respond to 
    a new pandemic?

  3. You Tweeted in 2022, “Next, they [a coalition of regular people] will hold
    accountable the people who pushed the lockdowns to answer for the
    destruction they caused.” What, precisely, do you think this accountability 
    should entail? Trials? Imprisonment? I note that you were a senior scholar
    at the Brownstone Institute, which published an article calling for
    retribution against “lockdowners” that featured a menacing image of a
    guillotine. Do you support such calls for “retribution”?

  4. RFK Jr. has suggested that 600 people at the NIH would be fired on day one. Do
    you support this?

  5. RFK Jr. has suggested that there should be an eight year “pause” on drug
    development for infectious diseases. Do you support this proposal?

  6. The NIH is one of the few federal agencies that has long enjoyed strong
    bipartisan support. For example, its budget was doubled starting under the
    Clinton administration in the late 1990s, and the Bush administration
    completed that doubling in the early 2000s. Yet, you are perceived as highly
    political, associated with right-wing resistance to lockdowns and vaccine
    mandates. How will you keep the NIH as nonpartisan as possible and keep its 
    bipartisan support?

  7. RFK Jr. proposes making chronic disease 50% of the NIH budget. This would, of 
    course, require congressional approval in the 2026 budget, the first one you
    would be responsible for putting together as Director. How, specifically,
    would you define “chronic diseases”? And what diseases and Institutes would 
    you take money away from in order to shift it to the study of “chronic
    diseases”?

Dr. Janette Nesheiwat

To be honest, I don’t have much to ask her beyond the common questions for
everyone, other than:

  1. You have called the COVID-19 vaccine a “gift from God.” Do you still believe
    that? How do you reconcile your belief with the doubts about the vaccine’s
    safety and efficacy promoted by nearly all the other nominees, such as RFK
    Jr., Dr. Makary, and Dr. Bhattacharya? What would you say to them about
    their numerous statements casting doubt on the safety and efficacy of
    COVID-19 vaccines?

  2. You have said that the MMR vaccine is safe and effective. What would you say
    to RFK Jr. and Dave Weldon, who clearly don’t share that view, to try to
    persuade them that they are mistaken?

  3. As Surgeon-General, you will be in charge of the US Public Health Service
    (USPHS) Commissioned Corps, which consists of 6,000 uniformed officers who
    are public health professionals. What will you be instructing them to do in 
    terms of promoting vaccination and other public health imperatives?

As I said, the Surgeon-General doesn’t have much real power

Conclusion

I don’t pretend that my suggested questions are the best, but they can start a
conversation. (I hope.) I might add more questions later as I think of them, and
I encourage you to suggest questions in the comments. As for my part, I will
conclude by asking: Senators, there’s a whole crew of science-based scientists, 
physicians, and bloggers who are more than willing to assist your staffers in
writing probing questions. I hope you’ll take advantage of us. After all, RFK
Jr. and his antivaxxers, cranks, and grifters do indeed represent an existential
threat to public health in the US.

The attack on the NIH has begun

Donald Trump has been sworn in, and his new administration has immediately
turned its sights on the NIH. The danger to US biomedical research has never
been more acute.

David Gorski on January 27, 2025

Link

Not even two weeks after Donald Trump won the 2024 election, alarmed at what I
was hearing about the new administration’s plans for the National Institutes of 
Health, I wrote a post entitled RFK Jr. vs. the NIH: Say goodbye to the greatest
engine of biomedical research ever created. At the time, I crafted an
intentionally (somewhat) hyperbolic title, simply to emphasize the potentially
dire threat that the new administration posed to what is the crown jewel of
biomedical research in the federal government, the NIH, which has generally
enjoyed strong bipartisan support for many decades over many Presidential
administrations. The impetus that led me to write the post was President-Elect
Trump’s nomination of antivax activist and conspiracy theorist Robert F.
Kennedy, Jr. as Secretary of the Department of Health and Human Services (HHS), 
which I characterized—quite accurately, I think—as a catastrophe for public
health and medical research. Another impetus was the speculation at the time
that Dr. Jay Bhattacharya would be nominated as Director of the NIH, speculation
that turned out to be accurate. Recall that Dr. Bhattacharya was one of the
three co-authors of the Great Barrington Declaration, that October 2020
manifesto that called for letting SARS-CoV-2 rip through the “young and healthy”
population in order to reach “natural herd immunity” in 3-6 months, further
proposing that the elderly and those with chronic diseases that put them at high
risk for severe disease and death from COVID-19 could supposedly be kept safe
through a strategy of “focused protection.” It was, frankly, a social Darwinist 
strategy that never would have worked and was a disaster for public health.

At the time I wrote my post, I did wonder a bit whether I had been too harsh,
too alarmist. Now I’m not so sure, given what has happened just during the first
week of the new administration, which I’ll discuss in depth in a moment.
However, I did have at my disposal what RFK Jr. himself had written as well as
many of his “make America healthy again” (MAHA) cronies, such as RFK Jr. having 
said in 2023 (when he was still an independent Presidential candidate and before
he had bent the knee to Donald Trump) that he wanted to “pause” drug
development for infectious disease for eight years in order to focus on “chronic
disease.” (Some have said that he also wanted to pause cancer drug development 
as well, but I couldn’t find evidence of this in the clip frequently cited.)




View on Threads

TikTok served me an RFK town hall. He spent 10 minutes talking about vaccines,
implied they cause autism; then said that he wasn't anti-vax, just anti- all
vaccines we currently have, and says as POTUS he'd stop research on drug
development and infectious diseases for 8 years. pic.twitter.com/PKAzZ56Mn8

— Jacob Rubashkin (@JacobRubashkin) June 21, 2024

I pointed out that the NIH already does spend a lot of its budget for research
into chronic diseases and that it’s an incredibly stupid idea to pause drug
development in such a vital area, particularly given the current increasing
problem we have with antibiotic-resistant bacteria; indeed, antibiotics have
long been a neglected area of research, largely because antibiotics are not as
profitable as other drug categories.

That background aside (the details of which I covered in my previous post), what
is going on at the NIH since Donald Trump was inaugurated? Nothing good so far.

A gag order and travel ban

Anyone paying attention to the news knows that President Trump, upon taking
office, issued a huge flurry of executive orders (EOs) covering a wide range of 
issues. Two days after Inauguration Day, Science published an alarming account
of the new administration’s policies being implemented at NIH:

President Donald Trump’s return to the White House is already having a big
impact at the $47.4 billion U.S. National Institutes of Health (NIH), with the
new administration imposing a wide range of restrictions, including the abrupt
cancellation of meetings such as grant review panels. Officials have also
ordered a communications pause, a freeze on hiring, and an indefinite ban on
travel.

The moves have generated extensive confusion and uncertainty at the nation’s
largest research agency, which has become a target for Trump’s political allies.
“The impact of the collective executive orders and directives appears
devastating,” one senior NIH employee says.

Today, for example, officials halted midstream a training workshop for junior
scientists, called off a workshop on adolescent learning minutes before it was
to begin, and canceled meetings of two advisory councils. Panels that were
scheduled to review grant proposals also received eleventh-hour word that they
wouldn’t be meeting.

“This kind of disruption could have long ripple effects,” says Jane Liebschutz, 
an opioid addiction researcher at the University of Pittsburgh who posted on
Bluesky about the canceled study sections. “Even short delays will put the
United States behind in research.” She and colleagues are feeling “a lot of
uncertainty, fear, and panic,” Liebschutz says.

In fairness, the hiring freeze was government-wide. As for the panels scheduled 
to review grant proposals, those are commonly called study sections. Their
purpose is to review grant applications and assign them a priority score for
funding. That priority score is then used at the level of advisory councils,
which make the actual funding decisions based on the priority scores of the
grants and the priorities of the institutes of the NIH under which each grant
application falls. (I described the process in detail a few weeks ago.)

I’ve been around a while, and I don’t recall the NIH ever having mass-canceled
study section and advisory council meetings before when a new President took
over. I asked around among researchers even more senior than I am, and no one
could recall anything like this ever having been ordered by a newly inaugurated 
President before. Nor could any of them recall anything like this:

NIH travel chief Glenda Conroy sent an email to senior agency officials early
today notifying them of an “immediate and indefinite” suspension of all travel
throughout HHS with few exceptions, such as currently traveling employees
returning home. Researchers who planned to present their work at meetings must
cancel their trips, as must NIH officials promoting agency programs off site or 
visiting distant branches of the agency. “Future travel requests for any reason 
are not authorized and should not be approved,” the memo said.

The travel ban has left many researchers, especially younger scientists,
bewildered, says a senior NIH scientist who asked to remain anonymous. Today,
the scientist encountered one group of early-career researchers who were
scheduled to attend and present at a distant conference next week—presentations 
that are now impossible. “People are just at a loss because they also don’t know
what’s coming next. I have never seen this level of confusion and concern in
people that are extremely dedicated to their mission,” the scientist says.

Presenting at scientific meetings is the lifeblood of researchers, particularly 
fellows and early career researchers, and there are a lot of research fellows
working at NIH. I also wondered if the travel ban extended to travel to meetings
funded by NIH grants for extramural researchers (researchers funded by the NIH 
who are not based at the NIH). Most NIH grants have a modest travel budget
included to fund researchers presenting findings from the NIH-funded at
scientific meetings. Worse, this order smacks of ideological suppression of any 
scientific communication that doesn’t jibe with the new administration’s
ideology. Indeed, part of the order in the email referenced above states that
NIH employees must “refrain from participating in any public speaking engagement
until the event and material have been reviewed and approved by a Presidential 
appointee.” While brief communication freezes have been ordered by new
administrations before, again, to my knowledge such bans have never before
included presenting at scientific meetings.

Again, no one with whom I spoke could remember a travel ban this extensive ever 
having been ordered by a new President. One notes that this travel and
communications blackout covers all federal health agencies, including the FDA
and CDC. Indeed, for the first time in decades, the CDC did not publish its
weekly MMWR:

3. To understand infectious risks, you have to have good data, carefully sourced
and analyzed

Number 3 is why this week’s non-publication of the Morbidity and Mortality
Weekly Report (MMWR) came as such a shock. MMWR is the CDC’s primary way of
publishing and communicating important data for public health. It didn’t go out 
because of a communications pause at federal health agencies issued by the new
administration. The gap in publication marks the first time in its more than
60-year history that the CDC didn’t release a new issue.

And:

I put COVID-19 last because I strongly believe this is the primary motivation
for the communications pause issued by the new administration. The pandemic was 
so horrifically disruptive — so traumatic — to our society that we’re still
grappling with the best way to deal with it.

And one unfortunate coping mechanism is the urge to scapegoat individuals and
organizations for what happened. The CDC and its publications were often in the 
center of this storm, and some now want to blame them for all that they were
unhappy about.

Again, no new administration has ever done this before, as far as I have been
able to ascertain. I have little doubt that the “champions of free speech” in
the new administration are muzzling the CDC until they can find a way to control
the message. Remember, Trump’s nominee to head the CDC is Dr. Dave Weldon, a
former Florida Congressman and antivax activist from way back. One can easily
imagine that the administration is shutting down CDC communications until it can
install an antivaxxer as its director. Given that the CDC has been the focus of
anger and resistance among COVID-19 contrarians and antivaxxers, one cannot
help but wonder whether it is being targeted in retribution for that. Never mind
that President Trump was in charge for most of the first year of the pandemic
and that his administration instituted Operation Warp Speed, one of the
worst-named vaccine initiatives ever, at least if you want to inspire public
confidence in the vaccine or vaccines ultimately developed as a result. In any
event, it is likely that Trump and RFK Jr. are scapegoating the CDC here. It’s
also likely that they are scapegoating the NIH, given the outsized role that Dr.
Anthony Fauci played in pandemic management as longtime director of the
National Institute of Allergy and Infectious Diseases (NIAID), and, to a lesser 
extent, previous NIH Director Dr. Francis Collins. Consistent with this
interpretation is President Trump’s decision last week to cancel Dr. Fauci’s
security detail despite ongoing threats on his life.

The potential effects of these bans have, as you might imagine, been quite
concerning to scientists. The Science article notes:

Previous administrations have imposed communications pauses in their first days.
And the administration of former President Barack Obama continued a cap on
attendance at scientific meetings first imposed by former President George W.
Bush’s administration, which in some cases meant staff canceled trips to
meetings.

But an immediate, blanket ban on travel is unusual, says one longtime researcher
in NIH’s intramural program. “I don’t think we’ve ever had this and it’s pretty
devastating for a postdoc or graduate student” who needs to present their work 
and network to move ahead in their career, the researcher says.

Another consequence of the communications pause, according to an NIH staffer
involved with clinical trials at NIH’s Clinical Center, is that agency staff
cannot meet with patient groups or release newsletters or other information to
recruit patients into trials. Another unknown is whether NIH researchers will
still be allowed to submit papers to peer-reviewed journals.

The NIH administers two main types of research programs. Its intramural research
program consists of the scientists and physicians who work directly for the NIH
carrying out biomedical research and clinical trials; the extramural research
program, which is far larger, consists of the grants made to individual
researchers (more specifically, to their universities for them to use to carry
out the funded research). Again, as far as I can ascertain, no previous
administration has ever prevented intramural researchers at the NIH from
presenting their science or submitting abstracts for publication in the
peer-reviewed biomedical literature.

There also seems to be an unanticipated consequence of the communications ban.
Or maybe it was anticipated:

Scientists at the National Institutes of Health have been told the
communications pause announced by the Trump Administration earlier this week
includes a pause on all purchasing, including supplies for their ongoing
studies, according to four sources inside the agency with knowledge of the
purchasing hold.

The supply crunch follows a directive first issued on Tuesday by the acting
director of the Department of Health and Human Services, which placed a
moratorium on the release of any public communication until it had been reviewed
by officials appointed or designated by the Trump Administration, according to 
an internal memo obtained by CNN. Part of this pause on public communication has
been widely interpreted to include purchasing orders to outside suppliers. One 
source noted they had been told that essential requests can proceed and will be 
reviewed daily.

Researchers who have clinical trial participants staying at the NIH’s on-campus 
hospital, the Clinical Trial Center, said they weren’t able to order test tubes 
to draw blood as well as other key study components. If something doesn’t
change, one researcher who was affected said his study will run out of key
supplies by next week. If that happens, the research results would be
compromised, and he would have to recruit new patients, he said.

And:

While it’s unclear if the communications moratorium was intended to affect
purchasing supplies for NIH research, outside experts said the motivation wasn’t
all that important.

“It’s difficult to tell if what’s going on is rank incompetence or a willful
attempt to throw sand in the gears, but it really could be either, neither
reflects well on them,” said Dr. Peter Lurie, who is president and executive
director of the Center for Science in the Public Interest. Dr. Lurie was
previously an official at the US Food and Drug Administration.

The clinical center only has a few weeks of medication on hand, according to a
source who had knowledge of the pharmaceutical supply but was not authorized to 
speak with reporters.

Personally, I’m torn, wanting to fall back on the adage, “Never blame on malice 
what can be attributed to incompetence.” However, in this case I might make an
exception. Unsurprisingly, Trump fans who understand that halting cancer
research at the NIH campus, no matter how transiently, is politically not a good
look, are claiming that “bureaucrats” are purposely overinterpreting Trump’s
executive order to make Trump look bad; i.e., that holdovers from the previous
administration are trying to sabotage the Trump transition. Hilariously, Richard
“Lab Leak” Ebright thinks that not just the canceled purchasing is “sabotage,” 
but also the cancellation of meetings of study sections and advisory councils.

I tend to agree with this retort:

The “NIH Is sabotaging itself” idea makes no sense for two reasons:– it would
take 5 min after the story broke to issue a clarifying order. It’s been 5 days
and that hasn’t happened.– it would take 5 min to remove someone who wasn’t
following orders. That also hasn’t happened.

— Nick Mark MD (@nickmmark) January 26, 2025

Exactly. If the order wasn’t really intended to shut down study sections and
external ordering from intramural research programs, it would have been trivial 
to issue clarifying orders to exempt those activities. Again, is it incompetence
or malice? I suspect that it’s a little of both, as I’m quite sure that Trump
and his followers have a very specific kind of health research that they want so
desperately to stop the NIH from ever funding again that they were willing to
take radical action that risked making them look bad, with stories about cancer 
research being halted…excuse me, “paused.”

Worse, the EO canceling study sections will delay the awarding of research
grants:

Chrystal Starbird, a cancer researcher at the University of North Carolina
School of Medicine, had been preparing to serve on her first National Institutes
of Health (NIH) grant review panel at the end of January. On Wednesday, to her 
surprise, that meeting was abruptly canceled.

These NIH panels, or “study sections,” typically involve a group of about 20 to 
30 scientists who meet to assess research grant proposals within their areas of 
expertise. Most of the grants, Starbird says, range from about $2 million to $10
million. Once the group reviews and scores the projects, a separate NIH
“advisory council” decides which ones to fund.

The email Starbird received was vague. It came from her study section contact at
NIH, within the Trump administration, and it said the multiday meeting, set for
January 30 and 31, would not take place as planned. The message instructed her 
to save her files about the projects for the time being and thanked her for her 
service to the NIH. “I’ve never seen a complete pause like this as part of a
transition,” she told me.

Serving for the first time on an NIH study section is yet another milestone in a
research career. Besides allowing one to network, serving on study sections
helps a researcher learn what sorts of questions are most pressing in a field,
where the research is going, and how to present a research plan in the most
understandable, coherent manner possible.

More important, though, is how the delays could impact critical research. A
brief delay might not have too serious an impact, but if the “pause” continues
and more study sections fail to meet, it will start to have a huge impact on
biomedical research at universities all over the country. Research programs,
once “paused,” can be very difficult to restart again. (I have personal
experience with this.) As I’ve said before, the NIH is the crown jewel of the
entire biomedical research infrastructure of the federal government, an
institution that other nations envy and that has long helped to keep the US at
the forefront of biomedical research in the world.

Why? To help understand why Trump and the MAHA movement might target the NIH
this way, it’s helpful to look at one of RFK Jr.’s chief apologists, a medical
oncologist who once did somewhat interesting and useful research, before
attacking those of us debunking medical pseudoscience like homeopathy and
characterizing such efforts as being beneath his planet-sized intellect—e.g.,
“dunking on a 7′ hoop“—and then, during the pandemic, going full COVID-19
contrarian before embracing antivax talking points. Yes, I’m referring to Dr.
Vinay Prasad.

https://t.co/uH6ss8W11a

— Vinay Prasad MD MPH (@VPrasadMDMPH) January 23, 2025

Dr. Prasad: “Don’t worry, be happy” about the NIH under Trump

Given how much he clearly wants a position in the administration and, as a
result, has been sucking up to RFK Jr. and Donald Trump, Dr. Prasad naturally
published an article on his monetized Substack that should have been entitled
“Don’t Worry, Be Happy,” but instead was entitled Pausing NIH study sections is 
going to be fine, after which he added, “In fact, it’s a good thing. The NIH
needs reform.”

He begins by invoking—who else?—Dr. John Ioannidis, whom I used to admire but
have watched with increasing alarm as, starting very early in the pandemic, he
took a heel turn to become among the most contrarian of COVID-19 contrarians:

Panic unfolded yesterday as the NIH announced a pause in study sections. Study
sections are groups of mediocre scientists who decide which grants are funded.
You may bristle at my word choice of ‘mediocre’ but data support that claim.
Here is research by Ioannidis in Nature:

He looked at authors of papers with more than 1000 citations. These are highly
influential studies. I have published 530+ papers, but only one of mine fits
this bucket. As such, I would make this group, but I would not have 2 years ago.

He compares this to study sections members and you can see the poor overlap.
Ioannidis conclusion: conform and be funded. NIH seeks mediocre ideas that tread
along established lines and not highly novel views. It does a bad job of
funding people who do truly transformational work.

He included this image, but no direct citation:

I immediately recognized the paper cited by Dr. Prasad, as I had discussed it in
detail a long time ago. First, it was a commentary—not a research
paper—published in 2012 and entitled Conform and be funded. At the time
Ioannidis had joined the long line of contrarians complaining about the NIH’s
supposed funding and promotion of “mediocrity” and “conformity.” (Indeed, this
was the first indication that perhaps my admiration of Dr. Ioannidis might be
misplaced…nearly thirteen years ago!) His arguments were, as is often the case, 
highly exaggerated. First, most of the time, the examples cited of science that 
led to innovative treatments but whose investigators initially had difficulty
getting NIH funding are often full of hindsight bias, in which now it seems
obvious how brilliant the ideas were, even though at the time they were being
considered it wasn’t at all obvious that they would turn out to be so
transformative. (As we like to say in medicine, the retrospectoscope is 100%
accurate.) I will note, as I always do when discussing this topic, that whenever
NIH funding decisions become more conservative, it is usually be cause money is
tight and study sections and advisory councils don’t want to make risky bets.
The answer to that is to provide more funding. Does anyone want to take a guess 
whether Donald Trump will significantly increase NIH funding? More likely it
will be quite the opposite. Of course, those complaining about conservative
funding decisions at the NIH rarely provide workable solutions to try to correct
that bias. Dr. Ioannidis was no exception then, and Dr. Prasad is no exception 
now.

In addition to his Substack article, Dr. Prasad has posted a half-hour video,
which I had a hard time watching because his unrelenting smugness irritates me
so much:

Indeed, on X, the hellsite formerly known as Twitter, Dr. Prasad is using
scientists who have been affected by the administration’s actions to attack the 
NIH:

Every year, millions– No exaggeration– of human hours are wasted writing NIH
grants that are not funded. The NIH has never studied whether the method it
uses to give grants is optimal. Never It's important to have some broader
perspective. https://t.co/GVlhrzcYvs

— Vinay Prasad MD MPH (@VPrasadMDMPH) January 23, 2025

Worse, it was likely in response to a snitch tag:

@VPrasadMDMPH

— tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (@betaturn) January 24, 2025

I note that Dr. Prasad could have made the same point after expressing empathy
for Dr. Chuong, but he did not. Instead, he castigated the researcher for “not
having a broader perspective.” (Sure, don’t be upset that your chance to present
your proposal to the NIH for funding was canceled. It’s all for the greater
good.) In one other case, Dr. Prasad offers a bit of empathy—sort of, but it
comes across as fake. Why? Because he immediately launches into his usual
attacks:

It sucks to have NIH grants that arent funded. A huge waste of time. At the same
time, I think cutting DEI grants is a needed correction. Much of this work is
descriptive, and, at this point redundant, the few interventional studies are
often non randomized, or have poor control… https://t.co/ZM34cd0VkT

— Vinay Prasad MD MPH (@VPrasadMDMPH) January 26, 2025

Of course, no one is arguing that an enormous amount of time is spent writing
grant applications. I myself have written several in the last few years that
haven’t been funded, and it is frustrating. That’s not what this is about, as
you might get an indication when observing how Dr. Prasad’s fans leapt in:

I mean, she essentially invented certain Alzheimer’s and autism fMRI paradigms, 
but go off

— Diana Christine (@drdianencefalon) January 26, 2025

Back to Dr. Prasad’s Substack:

Trump has paused study sections to allow future NIH director Jay Bhattacharya to
revisit the priorities. This is completely normal and reasonable. Jay might
decide to run a randomized trial testing the current study section structure
against proposed alternatives, such as the modified lottery, and other ideas.

I tackled the whole question of modified lottery versus other methods of
determining who gets research grants in great detail, so much detail that I
suspect I’ve thought about the concept far more deeply than Dr. Prasad ever has.
In fact, I know that I have, as Dr. Prasad shows no sign of knowing much, if
anything, about the background data and research that already exist comparing
different systems for determining which grant applications are funded. Indeed,
after considering seriously Dr. Prasad’s promotion of “modified lottery” and the
evidence that exists for it, I concluded that NIH study sections are far from
the waste of time portrayed by Dr. Prasad and that they do distinguish
scientifically meritorious proposals from those that are lacking. The problem is
that they just aren’t a fine enough measure to reliably distinguish between
excellent proposals; e.g.., which of two clearly excellent proposals is better. 
Nor was I against adding the element of a lottery to choosing among proposals
that are highly meritorious whose success and output the current system doesn’t 
predict accurately. Again, improving the scientific rigor of the grant
application process is not what Dr. Prasad is about, however. He’s about
supporting Dr. Bhattacharya and pulling out of his nether regions unworkable
ideas for “randomized studies” of different systems for determining which grants
to award that sound profound but in reality are profoundly unserious. Of
course, he’s not making these proposals for an audience of scientists. He’s
making them for an audience of ideologues who don’t know how vaccine schedules
are constructed or how the NIH works.

Indeed, in his video, Dr. Prasad demonstrates more ignorance:

It’s even worse than that. NIH dollars come with massive indirects which make
researchers who have a lot of NIH dollars untouchable. Universities usually
overlook their errors and keep them on faculty because they get a lot of cash.
That cash is then laundered by universities given back to them in unrestricted
slush funds used for all sorts of purposes including lavish travel and parties
and going out for lab meetings. It’s wasted we don’t know what happens to all
that money.

Tell me you’ve never been awarded an NIH grant before without telling me you’ve 
never been awarded an NIH grant before. Yes, universities do sometimes give back
part of the “indirect costs” to researchers for a fund to help fund their lab, 
usually to buy equipment, particularly to well-funded researchers. (The NIH is
notoriously stingy funding equipment purchases.) By way of background for those 
not familiar with NIH grants, indirects are the costs over and above the dollar 
amount of direct costs that go to fund the research. Basically, the part of the 
budget for indirect costs goes to the university to help fund the infrastructure
used by its researchers. I would never deny that there is a legitimate argument
to be had over whether indirects can be excessive and add way too much to the
cost of research funded by grants. (In some cases, they can be 70% of the direct
costs added to the overall grant; also, indirect cost rates are periodically
negotiated by each university with the NIH.) That’s not what Dr. Prasad is
about, though. He’s trying to portray NIH funding and indirects as gross waste. 
The above is gross exaggeration that portrays well-funded researchers as, in
essence, fraudsters living high on the hog off of NIH grant money. To say that
this is divorced from reality is a massive understatement. Let’s just put it
this way. I haven’t had an NIH R01 in over a decade, and even back then it was
incredibly difficult to spend the funds on anything other than what the budget
said they would be spent on. If you wanted to change that, you had to file a new
budget and have it approved.

Even Dr. Wafik El-Deiry, a respected senior researcher whom I once admired but
who of late has been a little too credulous regarding antivax claims of “turbo
cancer” due to COVID-19 vaccines, found this hard to swallow:

It’s not OK. The comments are off base. The system needs reform but a sweeping
indictment is unfair to those who made important breakthroughs and helped people
all over the world. @NIH @theNCI @AACR @ASCO @theNASEM @AACI_Cancer
https://t.co/gYM4uUphKH

— Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) January 23, 2025

Then, of course, Dr. Prasad blamed the dreaded DEI (Diversity, Equity, and
Inclusion) initiatives so hated by Donald Trump and his followers, because of
course he did:

And what about diversity? The whole creation of the DEI state at universities is
in part due to NIH indirects. There are NIH diversity supplements that Trump
has argued that are going to get cut. So of course naturally a new
administration with new priorities an economist-physician coming to power will
look at this in a very different way and while he’s doing that there should be a
pause on grants. Tt’s not that big a deal. Science is not going to fall by the 
wayside. Universities have redundant budgets.

Here’s the thing. Previous administrations have had “new priorities” that they
wanted to implement at NIH. None of them stopped study section and advisory
council meetings dead in their tracks right after assuming power. Ironically, at
least Dr. Prasad recognizes that Dr. Bhattacharya is not a scientist, but
rather a physician who is also an economist. (I also note that Dr. Bhattacharya 
is also a physician who has never done a residency and hasn’t treated patients
since he graduated from medical school.) One wonders why the current
administration considers such an action so critical that it has done what, as
far as I can tell, no past administration has ever done before, and “paused”
study section and advisory council meetings until, if you believe Dr. Prasad, it
can shut down DEI supplements. It makes me think that this is what the pause is
really about, not increasing the scientific rigor of the NIH grant approval
process. (Thanks, Dr. Prasad, for being totally honest about what is really
going on and how much you approve!) Worse, from my limited anecdotal experience,
I’m beginning to think that universities have clearly gotten the message. I’ve 
heard through the grapevine reports of universities scrambling to rename any
office or research program that includes the words “equity” or “inclusion” in
its title to a name without those words in a frantic effort to avoid the
crackdown that is coming. And who can blame them? Unfortunately, I suspect that 
the thought police in the administration won’t take long to catch on to this
tactic.

One of the worst things about what is going on since Trump became President
again is that I see a real possibility that a very important area of medical
research, health disparities research, will be conflated with the dreaded “DEI.”
Indeed, it appears to be already happening, as Dr. Prasad gives away the game
with his extreme dismissiveness of current disparities research. While he
doesn’t attack health disparities research in his Substack post, he spends quite
a bit of verbiage in his video ranting about disparities research, simplifying 
it grossly and absurdly:

I got into a bit of a spat online today where someone was defending cancer
health disparities research. What did I say? My argument is simple. Do I think
poor people do worse than rich people? Yes. Do I think black people, Hispanic
people, do worse than white people? Yes, in part mediated because they tend to
be poor; so poverty is not good for having cancer. Being a minority is not good 
for having cancer. That’s been shown 1, 2, 12, 2,000, 1,000, 100,000—it’s been
shown 100,000 times in the literature. it’s been shown over and over again but
what can you do about it?

He then goes on to complain that we don’t need any more research showing
disparities because health disparities all boil down to basically the caricature
presented above. It’s a view so utterly simplistic as to be risible. Basically,
Dr. Prasad categorizes disparities research in its current form as a waste of
money because it doesn’t use what he considers sufficiently “rigorous” methods
to test interventions to overcome differences in outcome based on socioeconomic 
factors. (Yes, his “RCTs or it’s crap” evidence-based medicine (EBM)
methodolatry and fundamentalism are on full display here.) His arrogance, as
usual, is also on display. He thinks he knows more about health disparities
research than actual experts in health disparities, and, as a result,
characterizes it all as useless other than his very simplistic caricature of
what health disparities research tells us about how different racial, ethnic,
and socioeconomic groups fare much differently when suffering from different
diseases or about their overall susceptibility to disease. Basically, he’s
dismissing any research that doesn’t meet his arbitrary standards as not being
crap not worth funding or doing. He portrays nearly all disparities research as 
a big scam, a waste of money that furthers the careers of researchers more than 
it helps patients. While there might be a germ of a point under all the
opprobrium, it’s twisted, exaggerated, and filled with anger and contempt.

For example, here he’s not entirely incorrect that economics is a bit part of
disparities. The problem is…well, read:

Trump so far is doing a lot of good things. If you were objective about it and
actually thinking, does the NIH need someone to kick the crap out of it and
reform it? Absolutely. Does DEI and these modules got to go? Absolutely. Should 
diversity be funded to say that poor people do worse than rich people, black
people do worse than white, people over and over and over? No. We need
solutions. You’ve got to solve that problem and a lot of that solution is not
going to come from medicine it’s going to come from socioeconomics and from the 
economic and political sector.

Even if you accept Dr. Prasad’s premise, do you also accept that the Trump
administration is likely to do anything in the socioeconomic sector to address
health and healthcare disparities fueled by economic inequity? It boggles the
mind that anyone would believe this, given Trump’s long history of having no
interest whatsoever in these topics, other than as grievances. Personally, I
don’t think that even Dr. Prasad believes this. He just doesn’t like DEI and
views disparities research as useless.

MAHA vs. the NIH

It’s a very depressing time to be a biomedical researcher; that is, unless you
are aligned with the new administration. I’ve referred to what is being
advocated by the Trump administration as the new Lysenkoism. If you don’t
believe that, then why would an administration—any administration—shut
down..excuse me, “pause”… grant reviews in progress when no other administration
has done that before upon assuming power, even ones that wanted to “reform”
NIH? These proposals are about control. They are about punishing scientists who 
don’t toe the ideological line with respect to the science preferred by the
administration, which will be dictated by people who got nearly everything wrong
about the pandemic and whose ranks are populated with outright antivaxxers. The
proposals to “test” new methods of distributing grants strike me more as a
means of justifying doling out federal research dollars to researchers aligned
with MAHA and MAGA ideology, rather than truly increasing the scientific rigor. 
It’s all consistent with the antivax and quack conspiracy theory narrative that 
portrays the NIH as doling out grants the way Vito Corleone (and, later, his son
Michael) doled out favors to underlings in return for loyalty in the classic
mafia film The Godfather. It’s just that now there’s a new Godfather running
things, and he will dole out grant money favors according to the degree of
loyalty to anti-DEI initiatives. I fear that much-needed outcomes and
disparities research will fall victim to the anti-DEI meat grinder of this
administration.

And don’t even get me started on what might be in store for the CDC and the
entire US vaccination program. That might be a topic for a future post,
particularly given that RFK Jr.’s first confirmation hearing is this week,
although it would likely be an even more depressing post than this one.

DOGE vs. the NIH: Say goodbye to the greatest engine of biomedical research ever
created

Friday, the Trump administration slashed indirect costs associated with NIH
grants. What does this mean, and why could it be so disastrous for biomedical
research?

David Gorski on February 10, 2025

Link

A couple of months after Donald Trump won the 2024 election and right after he
had nominated conspiracy-mongering antivax activist Robert F. Kennedy, Jr. to be
Secretary of Health and Human Services, I wrote a post entitled RFK Jr. vs. the
NIH: Say goodbye to the greatest engine of biomedical research ever created. I 
admitted at the time that the title might seem a bit overwrought, but I wanted
to drive home the problem of putting RFK Jr. in charge of HHS, under whose
purview the National Institutes of Health lie. At the time, even I thought I
might have been exaggerating a bit, but something happened on Friday that makes 
me think that, if anything, I might have been a bit too mild, even after a
couple of weeks ago, when Trump’s minions started canceling NIH study section
meetings and putting a temporary pause on travel by NIH employees, even to
scientific meetings to present their science. This all happened happened before 
RFK Jr. has even been confirmed. It’s even before Trump’s awful nominee for NIH 
Director, the COVID-19 minimizing antivax-adjacent, conspiracy mongering Dr. Jay
Bhattacharya, who’s also the co-author of the Great Barrington Declaration, the
social Darwinist COVID-19 manifesto to “let ‘er rip” to reach “natural herd
immunity” (with poorly defined “focused protection” to protect the elderly and
vulnerable), has started confirmation hearings. Friday night, it got even worse.

Here we go.

Elon Musk and DOGE slash “indirect costs” (more formally F&A)

One of the gratifying things about writing for this blog is the ability to
explain how seemingly esoteric policies can affect medical research and
science-based medicine. For example, before Friday it certainly wasn’t on my
bingo card to write about indirect costs awarded to universities with NIH
research grants, but leave it to Elon Musk and his “department of government
efficiency” (DOGE, which isn’t a real department, hence my refusal to capitalize
its name) to unilaterally and without warning slash indirect costs associated
with NIH research grants. I’ll explain what indirect costs are in a moment. For 
now, just understand that indirect costs go to the university to support the
general infrastructure necessary to carry out NIH-funded research, including
grant administration. First, however, here’s the announcement, going under the
seemingly boring title Supplemental Guidance to the 2024 NIH Grants Policy
Statement: Indirect Cost Rates (Notice NOT-OD-25-068). Behind that seemingly
innocuous title lays potential devastation for medical schools and universities 
receiving NIH grants to do biomedical research under the guise of “providing
indirect cost rates that comport with market rates.” First, here’s the policy:

For any new grant issued, and for all existing grants to IHEs retroactive to the
date of issuance of this Supplemental Guidance, award recipients are subject to
a 15 percent indirect cost rate.  This rate will allow grant recipients a
reasonable and realistic recovery of indirect costs while helping NIH ensure
that grant funds are, to the maximum extent possible, spent on furthering its
mission.  This policy shall be applied to all current grants for go forward
expenses from February 10, 2025 forward as well as for all new grants issued. 
We will not be applying this cap retroactively back to the initial date of
issuance of current grants to IHEs, although we believe we would have the
authority to do so under 45 CFR 75.414(c).

Again, bear with me a moment. I will explain what indirect costs are. Just note 
that most universities have negotiated indirect cost rates between around
40-70%; so this is an immediate and unannounced cut. The rationale used? Whoever
wrote this announcement pointed to indirect rates offered by private
foundations that offer research grants, which max out at around 15% and then
claim that they’re being generous by “only” cutting indirects to 15%. The NIH
even posted this to X, the hellsite formerly known as Twitter, justifying its
cuts:

Last year, $9B of the $35B that the National Institutes of Health (NIH) granted 
for research was used for administrative overhead, what is known as “indirect
costs.” Today, NIH lowered the maximum indirect cost rate research institutions 
can charge the government to 15%, above… pic.twitter.com/FSUYpEGKsr

— NIH (@NIH) February 7, 2025

With Elon Musk himself proclaiming:

Can you believe that universities with tens of billions in endowments were
siphoning off 60% of research award money for “overhead”? What a ripoff!
https://t.co/RRTIMKTVYN

— Elon Musk (@elonmusk) February 8, 2025

So, are indirects the “ripoff” that Musk claims? I can tell right there that
“siphoning” off is a misunderstanding, whether intentional or disingenuous,
meant to make it sound as though universities are taking up to 60% off the top
for themselves. In reality, indirects are in addition to the direct costs of the
grant. If you have an indirect rate of 60%, that means that if your university 
is awarded an NIH grant for $1M, the university actually gets $1.6M. That means 
that, of the total grant, a 60% indirect cost rate is really only 37.5%. (See
Musk’s deception there?)

Basically, this is the justification in the announcement:

Indeed, one recent analysis examined what level of indirect expenses research
institutions were willing to accept from funders of research. Of 72 universities
in the sample, 67 universities were willing to accept research grants that had 
0% indirect cost coverage.  One university (Harvard University) required 15%
indirect cost coverage, while a second (California Institute of Technology)
required 20% indirect cost coverage. Only three universities in the sample
refused to accept indirect cost rates lower than their federal indirect rate.
These universities were the Massachusetts Institute of Technology, the
University of Michigan, and the University of Alabama at Birmingham.

The United States should have the best medical research in the world. It is
accordingly vital to ensure that as many funds as possible go towards direct
scientific research costs rather than administrative overhead.  NIH is
accordingly imposing a standard indirect cost rate on all grants of 15% pursuant
to its 45 C.F.R. 75.414(c) authority.  We note in doing so that this rate is
50% higher than the 10% de minimis indirect cost rate provided in 45 C.F.R.
75.414(f) for NIH grants.  We have elected to impose a higher standard indirect 
cost rate to reflect, among other things, both (1) the private sector indirect
cost rates noted above, and (2) the de minimis cost rate of 15% in 2 C.F.R.
200.414(f) used for IHEs and nonprofits receiving grants from other agencies.

This is next level ignorance. The reason why most universities are willing to
accept lower indirect cost rates is because private grants like the ones from
foundations listed in the announcement (e.g., the Bill & Melinda Gates
Foundation and the Rockefeller Foundation) is because most universities know
that foundation grants are often stepping-stones for younger investigators to
obtaining larger and more prestigious grants, especially from the NIH.
Basically, universities don’t like the lower rates, but accept them in order to 
help nurture younger investigators.

Also:

Many who advocate for cutting NIH’s indirect cost rate have long argued that
universities are willing to accept lower rates from philanthropic foundations.
Today’s NIH notice, for example, notes the Gates Foundation limits indirect
costs to 10%, while the Packard Foundation sets the ceiling at 15%. But such
reasoning is based on “perverse logic,” Corey says, because foundations use
their funds to increase the productivity of research infrastructure already paid
for by the federal government. And universities say they are often willing to
accept foundation grants that carry low overhead rates because those grants
amount to a relatively small fraction of their funding. Another key reason that 
indirects seem to be lower for foundation grants is that foundation grant
mechanisms tend to be more flexible in terms of what they allow investigators to
budget for in the direct costs, meaning that some of what is covered by federal
government indirects can be included in the direct costs budget for a
foundation grant.

Going back to 2017 again:

University officials, however, say comparing NIH and foundation overhead rates
is misleading. Gates, for example, is more expansive than NIH in defining direct
costs, meaning some overhead payments are wrapped in with the grant. The Trump 
proposal “does not reflect [the foundation’s] process for determining direct or 
indirect costs,” a Gates spokesperson says. Universities note that they are
often willing to accept foundation grants that carry low- or zero-overhead rates
because those grants amount to a relatively small fraction of their
funding—something they could not afford to do for major funders.

Everything old is new again.

Before I describe what indirect costs are and how they are calculated and
awarded, I would be the first to state that there has long been a widespread
recognition that indirects have gotten out of hand at some universities, with
some having argued that they need to be reined in, preferably to make more
dollars available to distribute to more researchers in the form of NIH grants,
particularly given how low the paylines have gotten (less than 10 percent of
grant applications funded). There’s definitely a policy discussion to be had
there, but such a discussion would have to include a sober, evidence-based
consideration of the trade-offs involved in shifting money from indirects to
more grants that would take months, if not years, and be phased in gradually so 
that universities and investigators would have time to adapt. Instead, what we
got was a hastily issued Friday night announcement that is causing massive
confusion and consternation at every university and research institute that
receives NIH grant funds. I never thought I’d see news reports like these about 
indirect costs, which are, again, an esoteric topic that few people outside of
universities, academic medical centers, research institutes, and policy wonks
know about, but here we are:

  1. NIH cuts billions of dollars in biomedical funding, effective immediately
    (Washington Post)

  2. Trump Administration Cuts Put Medical Progress at Risk, Researchers Say (New
    York Times)

  3. Research Universities Are Poised to Lose Billions Under Trump’s Sudden Cut
    (The Chronicle of Higher Education)

  4. NIH announces it’s slashing funding for indirect research costs (NBC News)

  5. Trump administration to cut billions from overheads in biomedical research
    (BBC)

  6. NIH slashes overhead payments for research, sparking outrage (Science)

Let’s go back to 2017, when the first Trump administration tried to slash
indirects:

The federal government has been adding indirect cost payments to research grants
since 1947. Today, each university negotiates its own overhead rate—including
one rate for facilities and one for administration—with the government every few
years. Rates vary widely because of geography—costs are higher in urban
areas—and because research expenses differ. Biomedical science, for example,
often requires animal facilities, ethics review boards, and pricey equipment
that aren’t needed for social science. The base rate for NIH grants averages
about 52%—meaning the agency pays a school $52,000 to cover overhead costs on a 
$100,000 research grant (making overhead costs about one-third of the grant
total). Universities usually don’t receive the entire 52%, however, in part
because some awards for training and conferences carry a lower rate, and because
certain expenses such as graduate student tuition don’t qualify.

At the time, political opposition scuttled this proposal.

Again, it is not unreasonable to argue that indirect cost rates have gotten too 
high; what is unreasonable is to think that suddenly slashing them without
warning, including on existing grants, won’t cause devastating harm to
universities.

Indirect costs (also called F&A): What are they and why are they so high?

Thus far, I have only given the broadest and simplest description of what
“indirect” costs are for NIH grants. It’s now necessary to discuss them in more 
detail.

Here we have to get into a little “inside baseball” talk with respect to the
NIH, much as I’ve done before when discussing, for instance, NIH study sections 
and how research grants are evaluated, ranked, and ultimately chosen (or
rejected) for funding. NIH grants are divided into two parts. The first is
direct costs, which include salaries, supplies, and other expenses associated
directly with doing the research proposed in the grants. The second part is what
is known as indirect costs, or, more formally, Facilties and Administration
(F&A). This is money that is provided to the university receiving the grant, in 
addition to direct costs, to help cover costs involved with the research, such
as building maintenance, office space, support staff, grant administration,
clinical trials administration, generally used equipment, and the like. While
often portrayed as a “slush fund” (and, yes, occasionally some universities have
abused F&A, in reality they are used as portrayed, as described here:

Here is how indirects work. A portion of a scientist’s NIH grant goes to the
university—not as a slush fund, but mostly to support research. Some of it even 
comes back to the researcher. Why? Because grants cover specific expenses, and
science often requires general funds.For…

— Alex Tabarrok (@ATabarrok) February 8, 2025

And:

What are “indirects costs” and why are they so high ?These are the
institutional costs that allow the research to be conducted across all studies
like:Utilities like heat, AC, water, electricity, phone & internet
costsFacilities costs like rent, costs of the building and…

— C. Michael Gibson MD (@CMichaelGibson) February 8, 2025

From the last time the Trump administration tried to slash F&A costs, here’s a
video:

It is, of course, a reasonable question to ask why universities aren’t paying
for these things themselves. To a significant extent, they are. Ask any dean of 
a medical school, and they’ll tell you that research is usually money-loser, not
a profit center, because the infrastructure to do research that can compete to 
win NIH funding is very expensive. From 2017 again:

Critics of the proposal predict that richer, private institutions, which often
have endowment income and fundraising prospects, would have an easier time
coping with lower overhead payments. But research facilities at some state
universities “would just become derelict,” predicts Mary Lidstrom, vice provost 
for research at the University of Washington in Seattle. “We would have to pick 
and choose what small number of grants we could support.”

But why are indirect costs formally called “F&A” (Facilities & Administration)? 
Let Michael Nietzel, a former college president, explain:

Indirect costs involve a myriad of necessary overhead expenses that universities
take on when they conduct research. They are typically divided into two
categories – “facilities” and “administration” — and include items like
maintenance of equipment, facility upgrades, the operation of labs,
depreciation, employment of support staff, accounting, research compliance,
legal expenses, and the salaries of key administrators in charge of an
institution’s research enterprise.

Universities depend on indirect cost reimbursement to defray a significant
portion of these expenses, and a cut of this magnitude will leave many of them
scrambling to fill the huge budget holes that it almost immediately creates.

Again, no one—and I mean no one—is claiming that indirects/F&A are sacrosanct
and should be immune from discussion and potential decreases in rates. Lots of
academics, scientists, and those involved with biomedical research have been
arguing that, for some institutions at least, they’ve gotten too high. Indeed,
periodically there have been efforts to rein them in, for example (again) in
2017:

Many universities have long complained that their negotiated rates don’t cover
true research costs. Congress and federal officials, for their part, have
repeatedly tried to rein in overhead payments. Most notably, in 1994 officials
capped the administration rate for universities at 26% after Congress became
concerned that schools were misusing the money. But for decades the share of
grants from funding agencies devoted to indirect costs has remained fairly
steady.

Note again, that Musk intentionally cherry picked institutions with the highest 
F&A rates negotiated with the government. (Incredible, I know.) Also:

President Barack Obama’s administration also floated setting an unspecified flat
rate, which economists said would increase efficiency and reduce paperwork.

This brings up an important point. F&A rates are negotiated individually,
university by university. Moreover, notice how DOGE and MUSK have targeted
universities that have negotiated the very highest F&A rates. For most
universities, the rate is a lot lower. Rates are affected by location and
expenses that vary by location (e.g., large urban areas versus rural locations),
as well as the sophistication of the infrastructure at each university. Even
more interestingly, it is not the NIH that negotiates these rates with
universities, as explained here:

F&A costs are determined by applying your organization’s negotiated F&A rate to 
your direct cost base. Most educational, hospital, or non-profit organizations
have negotiated their rates with other Federal (cognizant) agencies such as the 
Department of Health and Human Services or the Office of Naval Research. If you 
are a for-profit organization, the F&A costs are negotiated by the Division of
Cost Allocation (DCA), Division of Financial Advisory Services (DFAS) in the
Office of Acquisition Management and Policy, NIH.

Here’s why:

F&A cost rates for colleges, universities, nonprofits, hospitals, and state and 
local governments are established by the HHS Division of Cost Allocation or the 
Department of Defense’s Office of Naval Research. Once a federally-funded rate
is negotiated and established, it applies to all government funding agencies
that support your grantee institution.

NIH sets F&A cost rates only when the grantee is a commercial organization
(e.g., small businesses). In these cases, the Division of Financial Advisory
Services in NIH’s Office of Acquisition Management and Policy will set the rate 
for the grantee organization.

If a grantee institution does not have a negotiated rate at the time of its
award and it does not wish to pursue negotiations to establish one, it can elect
to receive a “de minimus” rate, which is 10 percent of Modified Total Direct
Cost (MTDC).

And:

NIH research funding supports both direct and F&A costs associated with
research. But non-research and research activities costs must stay separated
since NIH applies the F&A cost rate on the F&A costs associated with research
activities only.

Additionally, facilities costs are limited to the spaces that are used only for 
research. Separating direct and indirect costs helps ensure that the
reimbursements issued on NIH grants solely support the conduct of research.

The American Association of Medical Colleges provides a useful infographic:

F&A costs, in a nutshell.

All of the above is why, for instance, the indirect cost rate for a federal
research grant to researchers at a university will be the same, regardless of
whether the grant is funded by the NIH, National Science Foundation, or, for
example, the Department of Defense. (Yes, the DoD funds medical research. I
myself have had DoD grants in the past, which makes me wonder how long it will
be before DOGE realizes that indirects are paid on top of research grant direct 
costs by more federal agencies than just the NIH.) Also note that non-research
grants (such as fellowship or training grants) do not provide F&A costs, and
that there are a lot of limitations on what expenses F&A can be used to cover.

But why? Why did the government start paying indirect costs associated with NIH 
grants in the first place? Yale scientist Dick Aslin provides the historical
explanation, even asking whether we’re paying too much for biomedical research, 
explaining why the nation’s research effort is distributed among our
universities, rather than in research institutes set up by the government, not
just for biomedical research but for all scientific research supported by the
government. You might be surprised that the inspiration came from the Manhattan 
Project:

That geographic dispersal of research facilities was a brilliant decision made
by Vannevar Bush, the president of the Carnegie Institution and later appointed 
by FDR to direct the Office of Scientific Research and Development during World 
War II. In 1945 Bush published a report entitled “Science – The Endless
Frontier” in which he outlined an ambitious path forward to ensure that the U.S.
remained as the dominant science and technology power given what had just
transpired with the Manhattan Project. A key feature of Bush’s recommendation
was that the Federal government should invest heavily in basic and applied
research by capitalizing on the infrastructure already present in our
universities. That was clearly a success; for example, the Manhattan project
leveraged the existence of cyclotrons at the University of Chicago and the
University of Rochester to conduct research on plutonium – both its potential as
a military device and its biological consequences for those exposed to its
radiation.

Bush realized that to build dedicated research institutes from scratch would be 
hugely expensive and that a more cost-effective alternative would be to pay
indirect costs to universities to leverage their already existing (or easily
expanded) infrastructure. This also allowed biomedical research to be
geographically dispersed throughout the country to allow for easy access to
thousands of patients without transporting them to a single location. And to be 
clear, this university infrastructure is not just bricks and mortar. It is also 
the presence of scholarly information in libraries, the expertise of faculty
unrelated to any given grant such as mathematicians and statisticians, computers
and other shared items of equipment, and a highly educated workforce of
faculty, staff, and students all of whom are already located in the same place. 
Other countries opted for a different model, such as France with their CNRS labs
and Germany with their Max Planck institutes, which are not directly affiliated
with a university. But it took them decades to catch up to the Bush model in
the U.S.

So let’s be clear that indirect costs are not fluff. Moreover, they are
negotiated with NIH (or the relevant Federal funding agency such as NSF, NASA,
Department of Defense, etc) and, importantly, they are audited on a regular
basis to make sure that the government is not being overcharged (e.g., as the
mortgage on a building is paid off or utility rates go down). It should also be 
apparent that indirect costs differ by location – the cost of buildings,
utilities, and administrative salaries is not the same in Palo Alto as in Iowa
City.

Again, not to sound like a broken record (if people even remember what a broken 
record sounds like anymore), this is a very complicated issue and the current
system has evolved over many decades going back to the 1940s. There are sound
and understandable historical reasons why the government decided to fund science
using a model in which it paid investigators at universities across the country
to do the research, including indirect costs that the universities themselves
required to provide the necessary infrastructure and staffing to do the research
and administer the grants. And the system has been wildly successful, the
claims of some of DOGE’s fans notwithstanding. There’s a reason why US
biomedical research is the envy of the world.

Not that this administration seems to care. After all, to address the tradeoffs 
that would come from trying to cut F&A cost rates in order to shift money to the
direct costs of more new grants requires an actual understanding of the system,
knowledge of what F&A costs cover, and a study of potential downstream effects 
of the various solutions that have been proposed over the years. There is no
evidence that I can find that either Elon Musk, DOGE, or anyone in the Trump
administration has applied anything resembling through to this budget cut.

Think about it. It would be one thing if DOGE had announced that it would be
applying the new F&A rate only to new grants awarded after February 10. That
would have been difficult enough to deal with, but at least there would be some 
time for universities to adapt given that the new rate would only be applied to 
grants that they haven’t received yet. That’s not what happened. DOGE applied
this cut immediately to existing grants as well, starting, well, today. That
constitutes an immediate large budget cut to universities that do NIH-funded
research, an immediate huge shortfall that few universities will be able to
cover. (I know my university, which is a public university in an urban setting
and that does not have a large endowment, is unlikely to be able to.) Even those
with a large endowment might not be able to shift enough of the endowment over 
to covering expenses normally covered by F&A costs attached to their NIH grant
portfolio, and there are a number of reasons why their administrations might not
want to do that.

Likely outcomes include:

than 20% of my operational budget across all of these centers, so understand
that my thoughts on this topic have nothing to do with self-preservation or any 
sort of self-serving agenda. First, sweeping change of this magnitude is going
to cause great pain for thousands and 2/

— Putrino Lab (@PutrinoLab) February 8, 2025

these are going to be hardworking folks who put their faith in a system they
were told was stable. These are folks that were taught from the earliest points 
in their careers that if they sacrificed and followed the rules, they would
succeed. Now the rules have changed. But plz 4/

— Putrino Lab (@PutrinoLab) February 8, 2025

“pick me” b*tch of the highest order hoping to get an administration gig by
showing public support for a cruel policy move. Next, let’s talk about the
narrative of “let the institutions pay from their endowments”. Are you kidding
me??? Of course they won’t. If it doesn’t make 6/

— Putrino Lab (@PutrinoLab) February 8, 2025

just fine as soon as they make the necessary cuts and adjustments. It’s American
science and innovation that will suffer. You might tell me that regardless of
the harm, this is a necessary move – bloated indirect rates don’t make sense and
this will mean more money for science 8/

— Putrino Lab (@PutrinoLab) February 8, 2025

are the only ones that will lose out here? Have the decency to acknowledge the
disruption and pain this will cause. Also, I’ve heard a lot about dropping the
indirect rates, but precious little about how the NIH will make submitting
grants and engaging in contracting easier 10/

— Putrino Lab (@PutrinoLab) February 8, 2025

easier? Because that would actually offset many – not all – but many of the
administrative costs that are offset by indirects. I haven’t heard anything
about process improvement on the NIH side but I really hope it happens. Finally,
to my fellow scientists: hang tough, pivot, 12/

— Putrino Lab (@PutrinoLab) February 8, 2025

were in charge of scientific spending in countries abroad, I’d be investing in
talent leaving the U.S. right now: many countries have the opportunity to up
their rank scientifically with some infrastructure spending in a way that pay
off majorly in scientific innovation for 14/

— Putrino Lab (@PutrinoLab) February 8, 2025

That point about administrative costs being so high because of the bureaucracy
involved in submitting and administering NIH grants hits home. Dealing with
regulatory issues, the paperwork involved in submitting grant applications and
then yearly reports, as well as all the regulatory issues around animal
facilities, clinical trials, and the like are very time-consuming and expensive.
Some of that would be difficult to cut—for example, who wants to skimp on
safety regulations for clinical trials and IRBs?—but a lot of it could be
streamlined. As for gloating over good people, such as technicians, support
staff, secretaries, and the like, losing their jobs as a result of this, which
will happen, speaking of gloating, right on cue Dr. Vinay Prasad enters the
picture:

Good! This was the greatest slush fund ever created. It made researchers with
NIH dollars invincible. Universities shielding them at all costs, even when
research was fraudulent. This money was used to support initiatives, which
Americans rejected, like DEI training & admin… https://t.co/FtR1kiCmnA

— Vinay Prasad MD MPH (@VPrasadMDMPH) February 8, 2025

Hint: Very little of indirect costs goes to anything resembling “DEI.” Most of
it goes to mundane, boring functions like administration, grant reporting,
animal care facilities, clinical trial infrastructure, lab maintenance, and the 
like.

The reason that reforming the NIH is possible is that the average person in the 
public will not be sympathetic to 60% coming off grants used for university
mandatory training and hiring administrators. It is hard to lobby against
https://t.co/FtR1kiCmnA

— Vinay Prasad MD MPH (@VPrasadMDMPH) February 8, 2025

Again, 60% doesn’t “come off” of grants, as I explained above. This is a highly 
deceptive spin on the subject, and, I’m sure, Dr. Prasad knows exactly what he
is doing. The 60% is in addition to the direct costs of the grant awarded to the
grantees.

Bullshit. Lots of these indirects fund useless administrators to sit in their
office and think of ways to fuck doctors and nurses who actually work and pay
consultants to force all staff to complete dei training and other penance. It is
not spent on electricity. https://t.co/rLov317FKR

— Vinay Prasad MD MPH (@VPrasadMDMPH) February 8, 2025

The only “bullshit” I see above is what Dr. Prasad is saying. He’s either
ignorant or lying.

I do love Dr. Prasad’s civility, don’t you?

Once again, I can’t help but wonder how much of Dr. Prasad’s hostility towards
the NIH is due to his never having been funded by the NIH. Seriously, search NIH
rePORTER for his name. He’s never been the principal investigator of an NIH
grant, and it shows. One can’t help but wonder how much of his hostility towards
the NIH is sour grapes. On I, on the other hand, have been the PI on an NIH
R01. I also openly admit that my lack of success renewing the grant was probably
more my fault than any fault of grant reviewing system at NIH. Attacking that
which he hasn’t been able to successfully do is a pattern with him. For example,
Dr. Prasad, as someone who’s never won NIH funding and attacks the NIH, likes
to demand “RCTs” on everything, even though, as far as I can tell, he’s never
designed or carried out an RCT on anything or even really thought about what the
various RCTs of everything that he blithely calls for would actually entail,
much less whether any of them would be ethical. (Hint: He doesn’t care; he
proposes them whether they would be ethical or not, such as his “cluster RCTs”
of the childhood vaccine schedule. It’s as if he is utterly ignorant of the term
“clinical equipoise.”) In addition, it is important to note another thing. As
we know from his blog posts, Dr. Prasad completed a fellowship at the National
Cancer Institute (NCI). Clearly, something happened there that soured him on the
NIH, a hostility that’s only grown since the pandemic hit, although damned if I
can figure out what it was that triggered him as I read his rants.

Notice how Dr. Prasad has gone all-in on what the real motivation behind these
cuts are: an attack on “DEI.” Indeed, he’s been rewarded, too, for his diving
headfirst into culture war tropes:

The White House sent out an email to all reporters on its press list, calling
our story “fake news.”We stand by our story.

— Dan Diamond (@ddiamond.bsky.social) 2025-02-08T23:47:35.945Z

Wow! Quoted in an email press release from the White House! Thirsty as he’s been
for a position in the Trump administration, maybe Dr. Prasad has finally gotten
the attention of someone who might give him what he clearly wants so very, very
badly. As for his “defense” of this action, technically what he is saying is
true, namely that the overall NIH budget hasn’t been cut, it’s a deceptive spin.
Cutting indirects right now, with just a promise to move the money to funding
new grants in the future will definitely be a massive budget cut now. Indeed,
Dick Aslin, wag that he is, listed all the NIH Funding from the top ten states
that voted for Donald Trump in 2024 and found that they have a combined total of
$12.287 billion in NIH awards producing an economic impact of $31.7 billion:

This figure includes both direct and indirect costs, but a reasonable estimate
of the cut in funding if the 15% rate is upheld is $1.5 Billion. Many of the
public universities will be forced to terminate research grants because they
cannot, especially in the short run, balance their budget by quickly raising
state taxes by $1.5 billion. So the ripple effect will not only be layoffs of
staff, reducing the more than 150,000 employees supported by these grants, but
also how those employees spend their salaries to support the local economy – a
significant drop from $31.7 Billion – and the loss in tax revenue from these
salaries at the state and federal levels.

Let’s just put it this way. Not only would this immediate massive cut hobble
biomedical research used to improve science-based medicine, but the economic
impact will be potentially devastating. This is not how you solve a problem in a
manner designed to strengthen the system, improve the rigor of scientific
research funded by the NIH, and spread the pot of research money around to more 
investigators. It’s how you hobble the system for a generation, possibly even
destroying it. Is it “political” to say that? Yes, but again, as I’ve argued
many times, this blog has never been apolitical. Indeed, we’ve gone after
liberals and Democrats a lot in the past; e.g., Sen. Tom Harkin, who in the
1990s foisted the scientific abomination that is the National Center for
Complementary and Integrative Health on the NIH. I’d even say that if Trump
wanted to get rid of NCCIH, I’d be totally behind him on just this one issue. He
won’t, though, given how much “wellness” grift has become a favorite among his 
supporters. Moreover, never before since I started paying attention to these
issues has either party gone anywhere near as far as Trump has gone attacking
federal science infrastructure. Seriously, back when I first started writing
about RFK Jr. and the antivax movement was commonly viewed as more a left wing
rather than a right wing phenomenon, never in a million years would I have
envisioned him being nominated for HHS Secretary, much less being on the cusp of
being confirmed for the post this week. (He will be confirmed by the way.
Depressingly, that’s my prediction.)

Now let’s look at some reactions to this announcement.

Contrarians rejoice, spreading misinformation

Naturally, as I expected the moment I first read the NIH announcement, Dr. Vinay
Prasad posted to his Substack an article defending the action. Like his attacks
on NIH peer review and his calls for a “modified lottery” to distribute grants,
it’s immediately clear that he hasn’t thought very deeply about this and is all
about the rhetoric, not the policy, in NIH reduced indirects from 60+% to 15%: 
10 things you should know. Let’s just say that these ten things range deceptive 
spins on the announcement to half truths to outright nonsense, for example #1:

The NIH is now in line with many philanthropic associations that cap indirects
at 10-15%. See below. This is widely considered acceptable by universities.

I already dealt with that one above. The way the the rates are computed and
negotiated by the NIH are not comparable with how private foundations compute
and negotiate indirect rates. He should know this, being the recipient of Arnold
Ventures (a private foundation that issues research grants) largesse. (One can 
see the methodolatry and fetishization of randomized controlled trials in one of
its request for proposals, Strengthening Evidence: Evidence Support for RCTs to
Evaluate Social Programs and Policies. Arnold Ventures, not coincidentally I
believe, allows 15% indirect costs for university-based projects.)

Next up:

This will dramatically change academic incentives. Many universities have an
unspoken rule that you cannot become associate or full professor without NIH
funding. They claim that this rule exists because NIH funding means your work
has passed the highest hurdle— acceptance by peers—but that was always a bad
argument. If you publish papers, you have acceptance by peers. Instead, admin
made this rule because it enriches them.

Funny, but Dr. Prasad became a full professor at UCSF without NIH funding. In
fairness, he’s not entirely wrong about one thing. It’s definitely very
difficult to become a full professor at a medical school without NIH funding.
However, Dr. Prasad apparently managed it with just foundation funding—and
funding from primarily just one foundation at that! To be honest, I’m still
wondering how he pulled that one off. Personally, I don’t think it’s bad to
incentivize obtaining NIH funding, given that NIH funding tends to require the
most rigorous peer review compared to most foundations.

Next up, I cringed:

The university has become a bloated bureaucracy. Redundant admin, and excessive 
administrative hurdles to do research. Because money is fungible, this exists
because of indirects. This will force universities to fire many unessential
personnel. We need to make less paperwork to open trials. This might even
improve research, as we strive for efficiency.

Dr. Prasad wouldn’t know “unessential personnel” if they bit him on the
posterior. His is the sort of research that doesn’t really require much in the
way of regulatory approval, given that what he does is mostly critiquing
existing literature and clinical trials. He really appears to have little clue
how much work it is to administer clinical trials and to do basic and animal
research. Moreover, it’s impossible to “make less paperwork to open trials”
without changes in regulation from Washington, DC. The reason that it takes so
much paperwork to open a clinical trial is primarily due to those pesky human
subjects protection regulations and animal welfare regulations, as well as
health and safety regulations covering laboratories.

Next up, even more cringe:

Indirect costs are taxpayer money that vanishes. The NIH states, “Indirect costs
are, by their very nature, “not readily assignable to the cost objectives
specifically benefitted” and are therefore difficult for NIH to oversee.” We
don’t know what they money is spent on, but, because money is fungible, indeed
some of it is spent on things that Americas disagree with: mandatory DEI
training classes and modules and other programs of this nature. Some of it is
spent on alcohol at social events, business class international travel, and
lavish retreats. That’s the nature of money. How do you justify taxing the
plumber to pay for you to fly Business class to Singapore?

There you have it, the war on “woke” and “DEI.” As for alcohol at social
gatherings? Geez, it’s difficult for us to offer alcoholic beverages at
functions not funded by grants or indirects; our university has strict rules
about that, and I bet that UCSF does too. As for business class travel,
seriously? Travel to present at conferences is included as part of direct costs 
of NIH grants, not indirect costs. Seriously, you can budget travel into your
grant to allow you to present at scientific or medical conferences. I honestly
don’t know where Dr. Prasad got this one from, although I do applaud him for not
using an example of traveling business class to China, the better to
dogwhistle. That must have required some restraint on our part..

I mean, he basically repeats the same thing in a later bullet point (#7)
claiming inefficiency in the use of F&A costs,, “joking” that the “NIH is
spending 47 billion dollars for 5 grains of rice, and 2000 DEI training
seminars.” (That’s a joke, but you get my point).” Truly, Dr. Prasad is turning 
into a one trick pony.

Here it gets interesting:

At first, I believed that the NIH should have made this change more slowly.
Turned the indirects down year by year, but with a little more reflection, I
think the shock and awe approach has some virtue. It will scare universities to 
immediately work to lower their administrative costs. If they turned it down
slowly, changes may not occur.

Dr. Prasad should have stuck with his first instinct, which was far closer to
correct than his current schtick. Shock and awe will likely do nothing more than
cause a lot of good people to lose their jobs right now. Chaos and disruption
are not a good recipe for improving our nation’s biomedical research, the better
to improve science-based medicine with more effective treatments and better
understanding of disease mechanisms. Once you wreck something, it’s really
difficult to rebuild it at all, much less to rebuild it in a better form. On a
related note, in #8 he suggests that 15% is merely a “starting point for debate”
that could be “negotiated to 25% or something a little less immediately
painful,” while blithely dismissing all the pain it will cause with a jaunty,
“sometimes you have to open with a strong gambit.” I’m sure all the people who
stand to lose their jobs if this rate is not increased back to something closer 
to what it was before will appreciate such negotiating tactics.

Next up, more misunderstanding:

Universities never took their NIH indirects and tried to make research
reproducible. If universities, really cared about veritas, they could have used 
some of these funds to advance reproducibility— making sure published
experiments are able to be replicated. If an experiment cannot be replicated,
you did not learn anything true or enduring about the universe. Universities
have not made substantive efforts to tackle this problem— which means, they
largely don’t care about veritas. They are happy with the status quo. That’s why
I said this:

Dr. Prasad sure is one angry dude, isn’t he? I wonder why he’s so full of fury, 
given that he’s got a cushy tenured professorship at UCSF—and without ever
having to have obtained any NIH funding, at that!—lots of publications, lots of 
money coming in from his monetized Substacks, a huge megaphone to broadcast his 
contrarian message to lots of people, and now, it seems, the ear of the White
House. Why does he feel so “persecuted”? Why does he nurse such anger and
grievance? One also wonders: How reproducible is Dr. Prasad’s own research?
(Sauce for the goose, as they say.) Inquiring minds want to know, they do, and
Dr. Prasad never seems to show much concern about others reproducing his work,
at least not anywhere as much as he does about NIH-funded research and research 
that he doesn’t like.

Sarcasm aside, this is all ust another nice-sounding but empty Prasad trope. How
should universities take their indirects and make research reproducible? (As
usual, Dr. Prasad doesn’t say.) Remember, that’s not the purpose of indirects,
which go to support infrastructure needed for NIH research at a university.
There has been a widespread effort going back years and years to make research
more reproducible, but it doesn’t lend itself to easy soundbites of the sort Dr.
Prasad makes. Let’s just put it this way. It wouldn’t be a bad idea for the NIH
to devote more funding than it currently does to efforts to make scientific
research more reproducible, but that’s not the function and purpose of F&A
costs. Dr. Prasad knows that damned well, but he also knows that his audience
doesn’t know it. Take from that observation what you will.

After saying that decreasing indirects might make researchers more accountable
because universities don’t want to discipline researchers who bring in lots of
NIH grants (a point that might or might not be true), Dr. Prasad continues:

Cutting indirects might even mean more science. Less money spent on the
administration is more money to give out to actual scientists. I am shocked to
see researchers crying about how much money the university gets— it means more
grants can be given per cycle.

My response to this argument is simple: “Oh you sweet summer child. You really
believe that the money saved is going to go to more research grants to more
scientists?” Of course, that’s my response to people who make that argument
sincerely, not to pundits like Dr. Prasad. It is, of course, theoretically true 
that the result of cutting indirects could be to redirect that money to more
grants to more scientists or bigger grants to scientists. Given Trump (and
Musk’s) history, though, does anyone really believe that this isn’t just a way
to justify cutting the NIH budget next year? (I don’t.)

Indeed, one can look at a lot of this effort not so much as an effort to make
the NIH more efficient by decreasing “bloated” indirects as payback. Because
Anthony Fauci, Frances Collins, and the NIH funded research on COVID-19 and
messaging about public health interventions during the pandemic that the Trump
administration didn’t like, now Trump wants to make them pay. Because
universities are perceived by Trump and DOGE as hotbeds of “DEI,” they want to
make universities pay. I’ll give you an example:

In the past 48 hours, HHS canceled 62 contract worth $182 million. These
contracts were entirely for administrative expenses – none touched any
healthcare programs. This included terminating a $168,000 contract for an
Anthony Fauci exhibit at the NIH Museum. pic.twitter.com/EsZxflPS6w

— Department of Government Efficiency (@DOGE) February 7, 2025

So DOGE cut $168,000 budgeted to an exhibit in the NIH Museum about Anthony
Fauci? That’s not even a rounding error in the NIH budget! It’s minuscule, but, 
boy, did they get back at Anthony Fauci by stopping the NIH from adding an
exhibit on his career to the NIH Museum, even though Fauci headed NIAID for four
decades.

That’s where Dr. Prasad is coming from, whether he actually believes what he’s
saying or not or whether he is just saying what he needs to say to try to score 
an administration position. Personally I’m with Dick Aslin on one thing. If we
are truly going to stick with this brain-dead one-size-fits-all hack-and-slash
approach to indirect costs, then it should be applied to all federal grants, not
just NIH grants:

But if President Trump and his new NIH Director, Dr. Jay Bhattacharya, who has
not yet been confirmed, are determined to keep the indirect rate at 15%, surely 
we would be justified in asking that the same rate be applied to all government 
grants and contracts. This would include contracts to for-profit companies like 
SpaceX. I am not able to find (presumably proprietary) indirect cost rates for
defense contracts (although a Rand Corp. study in 2000 confirmed they are higher
than rates for universities), but I was able to find one example from a $404
million contract with Northrup-Grumman that spanned 7 years from 2019-2026. One 
of the differences between government grants (like those to non-profit
universities) and contracts (like those to Northrup-Grumman) is that the
salaries of the “key executives” who head up these contracts are included as
part of indirect costs. The Northrup-Grumman contract listed the salary of their
executive as $24 million. Even if this is spread out over 7 years, I can
guarantee you that no university researcher is being paid $3.4 million per year 
by NIH. In fact, NIH has a salary cap of $221,900 per year. I look forward to
the DOGE team reporting back to Congress about the indirect cost rate of SpaceX 
and the salary compensation Elon Musk is charging as part of NASA indirect
costs.

As do I, but I suspect I will wait long. I also note that the salary cap
described above is one reason why it’s difficult for universities to support
clinician-scientists, who, thanks to their clinical activity, tend to command
higher salaries than “pure” basic scientists. Any salary support for research
that can’t be covered by an NIH grant due to the salary cap must therefore be
covered by the university and/or from clinical revenue. Some universities can
manage to do that to support clinical and translational research; many cannot.

In any case, I suspect that I will wait long for bootlickers like Dr. Prasad to 
be consistent in their calls for fiscal responsibility and go after where the
real money is being spent on indirects. I realize there’s no way that’s ever
going to happen.

The attack on the NIH and science-based medicine continues

The bottom line is that cutting indirects to 15% across-the-board is clearly not
a well-thought-out policy. There is a policy discussion to be had on this
topic, but that’s not what DOGE and its cheerleaders (like Dr. Prasad) are
interested in. What they are more interested in is grievance, to punish
universities and the NIH because of grievances, mostly imagined. I fear what the
cost will be to biomedical research in the United States and to science-based
medicine in general as a result of these slash-and-burn tactics. It almost makes
me relieved that I’m probably only 5-8 years from retirement, but it also makes
me sad for all the hard working support staff who will lose their jobs and all 
the smart and ambitious young students and investigators with whom I interact,
whose career prospects look much less promising now. It makes me sadder for
patients, who as a result of ideology, grievance, and a lack of understanding of
the system necessary to institute reforms that would actually improve it, are
going to suffer as a result.

When I first said, “Say goodbye to the greatest engine of biomedical research
ever created,” I worried that my title might have been hyperbole. Now I fear
that it wasn’t alarmist enough. Worse, RFK Jr. hasn’t even been confirmed yet,
nor has Dr. Bhattacharya, and who knows what further “disruption” they’ll bring?


Dr. Nicole Saphier: “DOGE is Probably One of the Greatest Things to Happen in
U.S. History.”

I see no reason trust doctors who refuse to correct their errors.

Jonathan Howard on June 26, 2026

Link


“DOGE is probably one of the greatest things to happen in U.S. history”

In December 2021, just before the worst wave of the pandemic for children, I
wrote an article titled Incorrect Numbers that discussed an error made by Drs.
Marty Makary and Nicole Saphier, our Surgeon General nominee. They had penned an
opinion piece in the WSJ regarding the pediatric COVID vaccine but misread a
CDC slide set and therefore drastically understated the virus’s impact on
children. I wrote:

Having made them myself, I completely understand that doctors can make errors.
However, I can’t fathom why some of them don’t seem to care about correcting
them, especially considering the health of children is at stake.

Indeed, my article wasn’t about the incorrect number itself, but rather these
doctors’ total indifference to it. They were spreading fake statistics about a
serious disease in a prominent newspaper and didn’t care at all. That’s
inconceivable to me. I’ve misstated a few numbers here, and this still bothers
me. Although SBM is much less impactful than the WSJ, I’ve immediately fixed my 
errors and made a note of them.  It’s not that hard to do.

In contrast, the WSJ article remains uncorrected to this day, and this has
important implications for Dr. Saphier’s suitability as Surgeon General. I see
no reason trust doctors who refuse to correct their errors, and many such
individuals gained power under MAHA. Like Dr. Saphier, they also said ridiculous
things on Fox News. None of them ever admitted error.

When given a chance to prove themselves in the real world, they’ve performed as 
expected. Dr. Makary and his underlings left the FDA in disgrace, and things are
not going well at the CDC and NIH under the “leadership” of doctors with a
similar disregard for basic facts.

However, my concern about Dr. Saphier’s character and inability to admit error
extends to more than just a single number in a long-forgotten article. Dr.
Saphier said Kennedy Kennedy was “by far one of the best visionaries when it
comes to the healthcare industry” when he was nominated. She she profits from
selling supplements, and back when DOGE was ramping up in February 2025, Dr.
Saphier told worried cancer researchers “you just have to give it a pause right 
now.” 

Right after Elon Musk boasted that he had “spent the weekend feeding USAID into 
the wood chipper,” Dr. Saphier paid him homage. “DOGE is probably one of the
greatest things to happen in U.S. history,” she said. “Elon Musk and DOGE, I
truly believe, are doing great things.” She said it was “for the greater good of
things.”

“USAID Shutdown Has Led to Hundreds of Thousands of Deaths”

Enough time has passed to judge whether this was the case. Today the headlines
read NIH Killed Grants on Orders from Elon Musk’s DOGE and USAID Shutdown Has
Led to Hundreds of Thousands of Deaths. In his article How USAID Funding Cuts
Are Killing Kids, Dr. Vincent Iannelli listed the following ways DOGE hurt
children around the world:

  1. worsening of the Ebola outbreak in the Democratic Republic of the Congo (DRC) 
    and Uganda
  2. neglected tropical diseases, like lymphatic filariasis and onchocerciasis,
    coming back as drug distribution drives in high risk countries ended
  3. the shutting down of emergency ambulance services in many countries
  4. more cases of severe acute malnutrition, micronutrient deficiencies, with
    stunting, wasting, and deaths
  5. children contracting and dying with malaria because health centers have run
    out of mosquito nets and anti-malaria medicines
  6. deaths from cholera in South Sudan
  7. an end to programs targeting tuberculosis, which means a huge risk that drug
    resistant tuberculosis will emerge in many countries
  8. Rohingya refugees getting half of their usual rations of food
  9. an end to HIV prevention programs in Gaza and Mozambique, which has the
    second-largest AIDS epidemic in the world
  10. the closure of HIV treatment programs in many countries that covered over ten 
    thousand children and pregnant women
  11. the deaths of refugees at food distribution centers in Malawi because of
    severe hunger
  12. the loss of health services for children at a detention camp in Syria
  13. people in Uganda and Tanzania skipping or rationing doses of HIV medications
  14. deaths from increased violence in conflict prone areas
  15. the loss of healthcare and malnutrition treatment to children, pregnant and
    breastfeeding mothers in Yemen
  16. clinical trials being stopped or interrupted, including clinical trials for
    HIV vaccines, a malaria vaccine, and treatments for cholera and tuberculosis
  17. less money to the effort to finally eradicate polio!
I hope during her confirmation testimony, Dr. Saphier will have the integrity to
either explain why she believes this overwhelming suffering isn’t just good,
but one of the greatest things to happen in U.S. history– up there with the moon
landing and defeat of Nazi Germany.

Or, she can admit that she was wrong.

But something tells me she will chose option C and act as if it never happened, 
and claim it is rude for anyone to remind her of her own words. And therefore,
her credibility will be as dismal as all the other incompetent disinformation
doctors she’ll be joining in the MAHA circus.


Indiscriminate, Cruel, and Wasteful: Abandoning USAID clinical trials

The chaos and cruelty of its abrupt deconstruction are self-evident and already 
demonstrable

David Weinberg on February 25, 2025

Link

The United States Agency for International Development (USAID) was established
by President John F. Kennedy in 1961 and is responsible for overseeing foreign
aid and development assistance. The current Executive administration has
launched an assault on the Agency, beginning with an expansive freeze on foreign
aid, followed by specific attacks on the USAID itself. Most of the activities
have been halted. The majority of employees are slated for layoff or suspension.

If you familiarize yourself with the activities of USAID, the chaos and cruelty 
of its abrupt deconstruction are self-evident and already demonstrable. Workers 
who have dedicated their careers to serving needy communities are suddenly
adrift in a foreign land, cut off from communication with their peers, and
forbidden from even the most humane gestures toward the communities in which
they have worked and collaborated. The communities who have benefitted from the 
USAID are suddenly cut off from lifesaving food, medicine, and other resources
without the time to explore and implement alternative arrangements.

There is one particular casualty of the assault on USAID which hits close to
home for me. As reported by several media outlets including Science, the New
York Times, and others; more than 30 clinical trials have been interrupted and
likely terminated. The interruption or termination of these trials is tragic on 
many levels. It epitomizes the indiscriminate, cruel and wasteful nature of
these abrupt measures.

A word on clinical trials

A clinical trial is a research study in which people (study participants) are
assigned to some intervention(s) or strategy. Study participants are followed in
a prospective manner to assess the effects of those interventions. Often, this 
involves the direct comparison of 2 or more strategies, which may include
control groups (including placebos). As someone who has been involved in many
aspects of clinical trials,I will try to communicate consequences of these
sudden disruptions on a more personal basis.

There are aspects to clinical trials that outsiders may not fully appreciate.
Clinical trial participants are the unsung heroes of progress in biomedical
research. They are volunteers. In order to qualify, they undergo a screening
process and detailed informed consent. Study participants must accept that there
are risks, with no certainty of benefit. They typically commit to time,
testing, and inconvenience far in excess of conventional care. One of the key
motivations expressed by clinical trial participants is the hope that knowledge 
gained through their participation will benefit others.

Clinical trials may go on for months or years, and often involve dozens of
interactions with study participants. Research coordinators and other
team-members often spend hours with clinical trial participants and their
families. Speaking from personal experience, there is a special relationship
that develops between investigators, research staff, and participants in
clinical trials. Responsible investigators recognize the sacrifices and risks
that their study participants accept. I made a conscious effort to be especially
generous of my time and attention to clinical trial participants. Research
coordinators and support staff are ambassadors, communicators, schedulers, etc. 
Those with whom I have worked have been incredibly dedicated professionals. They
are the lubrication and the glue that make clinical trials run effectively. The
bond and trust that participants form with clinical trial staff is the “secret 
sauce” of successful clinical trials.

Reportedly, over 30 clinical trials have been abruptly halted. A complete
accounting of the trials is difficult because public records have been hidden.
Here is a sample of the interrupted study interventions:

  1. A device to prevent HIV transmission and pregnancy

  2. HIV vaccines

  3. Long-acting HIV prevention

  4. Malaria treatment in young children

  5. A malaria vaccine

  6. Treatment for cholera

  7. A screen and treat method for cervical cancer

  8. Multiple tuberculosis treatments

Indiscriminate

These trials were not launched recklessly or indiscriminately. They were
approved by appropriate ethical review committees. They were awarded based on
merit and priority. They were implemented because they were expected to answer
important questions. In contrast, the suspension/termination of these studies
was done indiscriminately, apparently without consideration merit or potential
benefit, and also without regard for the consequences of termination. None were 
spared.

Cruel

The indiscriminate termination of these studies was a cruelty imposed on the
study participants and to the investigators, but perhaps the greatest cruelty is
to the world at large, because potentially life-saving and health restoring
treatments will be delayed or permanently foreclosed.

The participants in each of these studies made a commitment to accept the terms 
of the study. The sponsors and investigators also made a commitment supervise
the trials ethically, including the commitment to protect the participants from 
unnecessary risk. Arbitrary termination of these trials is a betrayal of an
ethical commitment to the participants who volunteered.

Once enrolled, investigators are obligated to monitor participants for potential
harms from their participation, to mediate those harms to the best of their
ability. The stop-work orders prohibited the investigators from fulfilling that 
commitment, leaving study participants vulnerable. In one clinical trial, young 
women received implanted devices to prevent HIV transmission and pregnancy. On
termination of the study, it would be dangerous, cruel, and unethical to leave
the experimental devices in women who could no longer be monitored; yet the
stop-work order prohibited further contact. Complying with the order would
require abandoning the study participants. Investigators were given an
excruciating choice of honoring their ethical commitment to their study
participants or obeying the stop work order. This is cruelty to the women as
well as to the investigators.

Volunteers surely hope that they will benefit from their involvement, but they
enter clinical trials with the understanding that there are risks with no
assurance of benefit. They are often motivated by an altruistic hope that
knowledge gained through their participation will help others who are similarly 
afflicted. I have heard this over and over in my interaction with study
participants. If a study is terminated without scientific justification, the
study objective usually cannot be achieved. The primary question will not be
answered. For the participant, this will decrease the potential for personal
benefit, may increase the personal risk, and destroy the hope of vicarious
benefit to others and to society. These participants have endured the risk and
much of the benefit has been stolen. It is a betrayal to the volunteers on every
level.

Wasteful

Running a clinical trial is a little like building a bridge. A great deal of
planning takes place before construction of a bridge. Similarly extensive
planning takes place before beginning a clinical trial.

The conduct of the clinical trial is like the construction stage of building the
bridge. If construction stops prior to reaching the other bank, the bridge is
useless. It doesn’t matter how noble the intent, how elegant the design, how
flawless the construction, or how great the cost; the project has not achieved
its goal of providing a conduit from one side of the river to the other. If a
clinical trial is terminated prior to the prescribed end, the question the trial
was meant to answer will remain unanswered and much, if not all, of the
resources invested will have been wasted.

Here is where the analogy breaks down. Construction of a bridge may resume and
be completed at some time in the future without diminishing the designers’
intent. Not so for a clinical trial. Clinical trials are run according to strict
protocols. Compliance with a protocol is never perfect, but total abandonment
of the protocol, even for a limited time creates major problems. Once the study 
is stopped, it may not be possible to resume. Some participants may be
unreachable, some may decline to participate due to broken trust with the
investigators. Some may have taken medications otherwise engaged in activities
that would invalidate their results. Some may have died. Even if all the
participants could be assembled, interruption of the experimental treatment
would likely make the study outcomes uninterpretable.

There can be justification for interrupting a study early. A study may be paused
if the interim results are definitive, if the risks of continuing the study are
too great, or if it becomes clear that the study has little to no potential to 
reach a meaningful conclusion. Often contingencies for these pauses are
prespecified in the study protocol and based on the advice of an independent
review committee which has access to the data. In each of these examples,
certain aspects of the study may be stopped or modified BUT, the study
participants are not abandoned. They will often be debriefed on the reasons for 
modification of the protocol. They will continued to be monitored for safety,
and treated as appropriate.

For the USAID supported clinical trials, I am aware of no scientific or ethical 
justification for their termination. There is an excellent chance that the
results of these studies would have produced impactful results. That possibility
has been foreclosed. All resources that have already been used for these
studies have been wasted.

These trials were funded because they had potential to generate data that could 
improve health and reduce suffering. Running a trial on treatment of
tuberculosis in a country with a high rate of tuberculosis has certain
efficiencies and results of the study have the potential to improve the health
in that country. But the benefits do not stop there. The results may be quite
impactful elsewhere. Tuberculosis is prevalent across much of the world. Cases
are increasing in the United States. The largest outbreak of tuberculosis on
record was reported in Kansas City this year.

Trials in the USAID portfolio could have led to the prevention and/or more
successful treatment of diseases like tuberculosis, malaria, HIV, cervical
cancer, and cholera worldwide. Now they will not. This is the greatest cruelty
and waste of all.


Welcome to the Resistance UCSF Doctors

The many doctors who are just now realizing that misinformation wasn’t “COVID
hysteria nonsense” have a lot of catching up to do to understand how the forces 
they’ve legitimized the led to this moment.

Jonathan Howard on February 28, 2025

Link

Less money spent on the administration is more money to give out to actual
scientists

As the article Trump White House Cites Fringe Doctor to Defend Research Cuts
reported, Dr. Vinay Prasad was recently featured in a White House statement in
which he denied a Washington Post story about cuts to the NIH. The statement
said:

That is shameful and dishonest framing from the Post. Dr. Vinay Prasad, a
Professor of Epidemiology and Biostatistics and Medicine at the University of
California, San Francisco, praised NIH’s announcement.

Dr. Prasad wrote: “Cutting indirects might even mean more science. Less money
spent on the administration is more money to give out to actual scientists.”

However, when he’s not busy spreading Orwellian doublespeak, saying less money
is more money, Dr. Prasad is busy celebrating cuts to researchers, as well as
mass purges of scientists and the ascension of RFK Jr. Dr. Prasad, along with
his friends and ideological compatriots Drs. Jay Bhattacharya and Marty Makary, 
are now the embodiment of the medical establishment, and their vision is being
realized. They wanted RFK Jr. to “disrupt the US medical establishment” and
that’s what he’s doing.

Anyone who either legitimized these doctors or defended them by baselessly
smearing their critics contributed to this moment.

UCSF ‘Borders on Panic’ Facing Potential Trump Funding Slash

Not all of Dr. Prasad’s UCSF colleagues share his delight at the decimation of
scientific research and the triumph of anti-vaxxers. Dr. Monica Gandhi, for
example, recently said:

MEASLES: A child died from a vax-preventable disease in US. This is a national
emergency. We are throwing the baby out with the bathwater (e.g. stop some USAID
programs that are corrupt, not all; evaluate each vax in isolation- measles vax
works; “burn it all down” will kill)

She”s right. This is a serious moment. She was also featured in articles titled 
Court Orders Don’t Calm UCSF Researchers’ Nerves and ‘Devastating’: Trump
Research Funding Cuts Could Cost the Bay Area Billions. That last article
reported that UCSF could lose $138 million annually, and it quoted Dr. Gandhi as
saying:

People are acting like these schools are building palaces, but they’re
supporting direct research by giving us the infrastructure. There’s just so much
we would have lost, and that we could still lose.

People are acting like these schools are building palaces because her that’s
what her UCSF colleague is telling them.

Another article, UCSF ‘Borders on Panic’ Facing Potential Trump Funding Slash,
also quoted Dr. Gandhi. It said:

As the lead of the Center for AIDS Research at the University of California, San
Francisco, Dr. Monica Gandhi is spending the month in a world of devastating
“what-ifs.”

What would have happened if a federal judge had not, on Feb. 10, blocked the
Trump administration’s order to slash billions in biomedical research funding
from the National Institutes of Health? Monitoring the health of study
participants in biomedical research funded by NIH would be gone. Clinical trials
on patients would be stopped. Key services, like maintaining the lab equipment 
and keeping research data safe, would also vanish.

“All of that, as of Friday, is massively threatened,” Gandhi said.

That’s horrible, and I don’t blame her for panicking. However, I can’t help but 
wonder “what if” more doctors had cared about misinformation instead of
spreading it.

Four years ago, Dr. Gandhi was telling us not to panic in interviews such as
Pandemic Exit Interviews: Stop Panicking About The COVID-19 Variants, Says
UCSF’s Monica Gandhi. She also recorded a podcast titled The End Of The Pandemic
with Dr. Zubin Damania, “variants schmariants“, and The Motivation We Need to
Reach the End of the COVID-19 Pandemic with Dr. Monica Gandhi with Dr. Prasad.
Last summer, she shared a stage with Dr. Prasad, as well as Drs. Makary and Dr. 
Bhattacharya, during the infamous Stanford conference. When Dr. Bhattcharya was 
nominated to head the NIH, she said:

I can’t say I’m not nervous because our universities not only depend on this
money, but it’s not the time to, stop HIV research. We have a lot of work to do.
On the other hand, I think Dr. Bhattacharya is kind. He is gentle. He has had a
complete reputation of being respectful of listening to others and I think that
gives me a lot of hope about his leadership.

Hopefully, she is right, and Dr. Bhattacharya will arrive to save the day.

Meanwhile, seeking to enrage and emotionally manipulate his audience as usual,
here’s what Dr. Prasad is saying about worried researchers like Dr. Gandhi:

I have no sympathy for academic researchers and their staff who do shit science 
and live off NIH grants. I am sorry. Never have. Never will. They do work that
cannot be reproduced, just say the same empty slogans that are in vogue. During 
the pandemic they failed society and lied about the impact of school closure and
the viral origins. I can’t believe we tax plumbers and bus drivers who do real 
work to fund this bullshit. It’s a welfare program for upper middle class kids. 
Recently they were saying even a single drink of wine kills you. They should be 
completely defunded for using low quality science to insert themselves in
debates they don’t understand, or appreciate. It’s not even science. It’s
propaganda that’s government-funded masquerading as science.

Charming stuff.

Dr. Howard said Dr. Bhattacharya “bungled basic facts” about the pandemic

Dr. Gandhi is not the only UCSF doctor to suddenly started caring about the
consequences of misinformation in 2025. Dr. Eric Widera, who recently
collaborated with Dr. Prasad, now laments that RFK Jr. is in power. He recently 
said:

Does he even know what doctors and nurses do. He sounds like your weird uncle at
at Thanksgiving dinner telling you doctors will be replaced by (insert
anything) in the next year.

It takes competence to fix something or make it better. Any fool can break it
even further. RFK Jr. is in the latter group.

Dr. Widera was obviously correct, though RFK Jr. was confirmed by the Senate 2
weeks later.

Similarly, Dr. Anil Makam, who wrote an homage to anecdotal data in Dr. Prasad’s
monetized misinformation Substack, is not happy about the fate of an NIH grant 
he submitted. He said:

I too am unhappy because of silence on why and how long & have an R01 (an NIH
grant) that might be funded if council meets next week.

It’s awful that his hard work is stuck in limbo and may be lost forever.

However, not long ago these UCSF doctors berated me because I corrected the
factual errors of our new medical establishment. They felt our future leaders
deserved a space space where they are immune to criticism. Last fall, I was
quoted in a New York Times article titled Trump Picks Stanford Physician Dr. Jay
Bhattacharya to Head NIH. It said:

But Dr. Bhattacharya still provokes extremely strong feelings. Dr. Jonathan
Howard… who treated patients at Bellevue Hospital at the height of the pandemic,
has assailed Dr. Bhattacharya in a book, “We Want Them Infected.”

Dr. Howard said Dr. Bhattacharya “bungled basic facts” about the pandemic. In
March 2020, for example, Dr. Bhattacharya suggested in a Wall Street Journal
opinion essay that the pandemic was not as deadly as it was being made out to
be, and that the death toll might top out at 40,000 Americans; in the end, 1.2
million died.

Dr. Bhattacharya responded on social media by calling Dr. Howard “unhinged” and 
his book “inane,” advising him to “take an epidemiology class if you don’t want 
to keep embarrassing yourself.”

Dr. Bhattacharya’s outburst had nothing to do with my “inane” book. After
leaving his fake “review,” he later revealed he hadn’t read it. However, rather 
than lament Dr. Bhattacharya’s lack of maturity and professionalism, as well as 
his refusal/inability to engage with my ideas, Dr. Widera shared a screenshot
from the NYT article and decided to hurl more schoolyard taunts at me. He even
tagged Dr. Bhattacharya to make sure he knew that he was defending him against
my transgression. He said:

Sensing blood in the kiddie pool, his colleague Dr. Makam added:

Elsewhere, Dr. Widera tried to discredit me by calling me “fringe”. He said I
was merely a “loud voice on Twitter who by looking at his post history, mostly
insults people,” though he provided no examples.

These content-free tirades from Bay Area doctors, including Dr. Bhattacharya,
are not unusual and hardly worth writing about. But beyond the childishness, I
want you to notice something more disturbing. Look again at what these UCSF
doctors ignored:

Dr. Howard said Dr. Bhattacharya “bungled basic facts” about the pandemic. In
March 2020, for example, Dr. Bhattacharya suggested in a Wall Street Journal
opinion essay that the pandemic was not as deadly as it was being made out to
be, and that the death toll might top out at 40,000 Americans; in the end, 1.2
million died.

I provided a simple but vital piece of information about Dr. Bhattacharya, and
it was right there in the screenshot that Dr. Widera shared. I thought people
should care that our incoming NIH director drastically underestimated COVID and 
never looked back. Yet, these UCSF doctors didn’t care a bit. Whether or not Dr.
Bhattacharya bungled basic facts, which he did repeatedly, didn’t matter to
them at all. Data and evidence were entirely irrelevant to them. They
intentionally ignored the numbers I presented, and never thought, “Maybe it’s a 
problem that Dr. Bhattacharya and his ilk spread misinformation to numb people
to a deadly virus“.

While Dr. Bhattacharya was on Fox News (he’s #7 on this list of their most
“dishonest” doctors), I was working in the hospital. I didn’t predict 40,000
COVID deaths or spread fake statistics. I’ve been writing and warning about the 
anti-vaccine movement and RFK Jr. for years, even prior to the pandemic. And
yet, these UCSF doctors treated me with contempt and scorn. They just insulted
me and and accused me of just insulting people. In their telling, my 220
articles here and We Want Them Infected are thousands of pages of me calling
doctors silly names. In reality, I never called Dr. Bhattacharya “unhinged” or
“inane,” and I never left fake reviews of his work. I accurately quoted him and 
explained why I disagreed. These UCSF doctors felt that this was unacceptable,
and that frontline doctors like myself lacked the qualifications to critique a
laptop class, health economist like Dr. Bhattacharya.

And they did all this specifically to defend Dr. Bhattacharya, an anti-vaccine
advocate of herd immunity via mass infection. More recently, Dr. Bhattacharya
has called for mRNA vaccines to be removed from the market and validated core
anti-vaccine beliefs as Walker Bragman reported in his article Trump Pick for
NIH Director: Vaccines May Cause Autism, Alternative Schedules Okay. He also
pushed for cuts to the NIH and openly championed RFK Jr., even speaking at one
of his rallies with the dangerous anti-vaxx luminary Del Bigtree. That’s what
these UCSF doctors are now upset about.

However, until now, these UCSF doctors were just fine with all this. They told
the world Dr. Bhattacharya was reliable, while I was the “worst”. They sent a
clear message that only a hysterical, fringe, unqualified, insulting
psychiatrist would be concerned by the images below. According to UCSF doctors, 
indifference is the appropriate reaction when people suffer and die because of
misinformation.

“COVID hysteria nonsense”

In reality, I wasn’t hysterical enough. RFK Jr., whom Drs. Prasad, Makary, and
Bhattacharya all supported, has started his attack on vaccines and is spreading 
misinformation in the middle of a deadly measles outbreak. The same techniques
these doctors developed to numb people to children dying of COVID- “breathless“-
are now being employed with measles, and we are just getting started.

Though I underestimated the threat, I at least tried to warn people that
normalizing misinformation was dangerous and that we should be serious about the
threat. Indeed at the same moment UCSF doctors hurled their juvenile japes at
me, I recorded a podcast titled RFK Jr.’s Anti-Vaccine Appointments: A Dangerous
Future for Public Health, where I warned about much of what is happening now.
These were easy predictions to make for those of us who cared and paid
attention. I was nothing special. Countless others also sounded the alarm, only 
to be greeted with derision. There was nothing unique about my experience, which
was benign compared to many others. No one harassed me on my doorstep.

However, while the infantile slurs were easy to brush off, the purposeful apathy
was not. When medicine was under attack from within, these UCSF doctors
shrugged and yawned. They causally dismissed our warnings as “hysterical” and
said we were “insulting” people no matter what evidence we presented or what
arguments we made. They made a grand, public display of ignoring data, even when
it was right under their noses. They praised and amplified the forces they are 
currently whining about and simply did not care about misinformation until 2025.
Their deliberate indifference vanished only when its consequences hit close to 
home and after it was too late.

To be clear, I 100% agree with the UCSF doctors’ fears about the impacts of
these cuts. If I could push a magic button and restore their funding, I would. I
welcome them to the resistance. However, the many doctors, not only as UCSF,
who are just now realizing that misinformation wasn’t “COVID hysteria nonsense” 
have a lot of catching up to do to understand how the forces they’ve legitimized
led to this moment. This didn’t happen all of a sudden, and there were
countless opportunities to speak up along the way.

Fortunately, we at SBM can help. We cared deeply about misinformation, even when
it didn’t directly affect us. It’s clear these UCSF doctors have never read
anything we’ve written, and I suggest they start learning about what they’ve
missed over the past 5 years.



“Don’t Worry About the NIH” From the Same Doctors Who Brought You “Don’t Worry
About COVID.”

Although many doctors who spread COVID misinformation act as if its in poor
taste to bring it up today, we don’t need their permission to remember.

Jonathan Howard on February 15, 2025

Link

We have learned how to limit nosocomial spread.

According to Dr. John Mandrola:

Appraisal of medical evidence is just like a procedure or surgery It takes
practice, effort, desire and mentors. No shortcuts

Despite these lofty sentiments, Dr. Mandrola was a COVID fabulist, who spread
fake statistics, repeatedly said the pandemic was over, and treated rare,
temporary vaccine side-effects as a fate worse than death. In May 2020 alone, he
declared multiple absurd things to be true simply because he wanted them to be 
true. He said:

US Hospitals not close to being over-run. It’s the opposite in most places… We
have learned how to limit nosocomial spread. It’s May not March… No US hospital 
is now unprepared. It’s May, not March… May is different from March. People are 
not stupid. Public health surveillance is better. Hospitals are ready. NYC-like 
situations are unlikely now in the US.

Things didn’t turn out that way, though Dr. Mandrola never looked back. While
disguising himself as someone who cared deeply about “appraisal of medical
evidence“, Dr. Mandrola’s singular goal was to blind people to a dangerous
virus, and he was willing to say anything to do this.

COVID became a top killer of young people immediately after this article was
published

If NIH-supported studies like this decreased b/c of cuts, medical science would 
be fine.

Remembering why so many people failed to protect themselves against a deadly
virus is valuable it its own right, and Dr. Mandrola certainly won’t remind you 
of what he said in 2020. In fact, many doctors who spread COVID misinformation
act as if its in poor taste to bring it up today. In their view, 2020 was
ancient history, and they deserve a do-over.

However, we don’t need their permission. We are allowed to remember their track 
record and to take it into account when judging their 2025 commentary. The same 
biases and indifference to facts that led them to mislead people about COVID
haven’t vanished. To guard against current risks, it’s vital to remember who
spread misinformation and the techniques they used to falsely pacify people.
Unsurprisingly, the same doctors who made things up to numb people in 2020 are
making things up to numb people today. It’s all repeating itself, and it’s
likely to get much worse.

Dr. David Gorksi and myself have I already discussed this with regards Dr.
Mandrola’s Sensible Medicine business partner, Dr. Vinay Prasad, who has become 
a mouthpiece for the Trump administration, cheering their mass purges of
scientists. I’ve also previously discussed how doctors who minimized COVID, also
minimized RFK Jr. Meanwhile, Dr. Mandrola recently shared an observational
study and said:

No malice meant. I’m sorry in advance. But if NIH-supported studies like this
decreased b/c of cuts, medical science would be fine. Like coffee and blueberry 
studies, we could do w fewer nonrandom retrospective comparisons

While Dr. Mandrola was fine with “nonrandom retrospective comparisons” as long
as they purported to show harms of vaccines, even authoring a VAERS dumpster
dive himself, Dr. Mandrola wants people to think that cuts to the NIH will
affect only affect coffee and blueberry studies, but that real medical science
would be fine. This is as credible as his fabricated claim from May 2020 that
“we have learned how to limit nosocomial spread.” Moreover, Dr. Mandrola
predictably couldn’t even get basic facts right about the study he denigrated.
As Dr. Alok Khorana pointed out:

Except that this study is not funded by NIH. The investigators have NIH support 
outside of this study, which they are appropriately declaring.

Unfortunately, most people didn’t care that Dr. Mandrola and like-minded doctors
made things up in 2020. Maybe if they had, we wouldn’t be in such dire risk
today. Sadly, cuts to the NIH will affect a lot more than coffee and blueberry
studies, and even though “medical conservatives” don’t care, some of us value
RCTs and believe politicians shouldn’t meddle in science.

Read this article


Jay Bhattacharya Will Bring Much-Needed Transparency to NIH

J Howard Jun 20, 2024

Link


I was very familiar with Dr. Jay Bhattacharya’s pandemic record and had many
reasons to doubt that science and the NIH would thrive when his nomination was
announced. Other people saw it differently at the time. Dr. Andrew Noymer wrote 
an article titled Jay Bhattacharya Will Bring Much-Needed Transparency to NIH.
In it, he centered his own personal conference invitations and said:

Transparency is a principal (and principled) solution to lack of public trust in
institutions. I am confident that Jay’s pursuit of transparency can restore
public trust in NIH.

Zeynep Tufekci wrote an article in the New York Times titled Trump’s Pick to
Lead the N.I.H. Gets Some Things Right that said:

It’s a welcome sign that, unlike many of Donald Trump’s picks to lead parts of
the nation’s health system, his pick for director of the National Institutes of 
Health, Jay Bhattacharya, is actually qualified.

Dr. Leanna Wen wrote an article in the Washington Post titled The NIH and FDA
Nominees are Surprisingly Strong that said:

I think that Bhattacharya and Makary were unfairly labeled “covid deniers” and
unjustly ostracized in medical circles. During their confirmation hearings, both
spoke about open discourse, dissent and debate as cornerstones of their tenures
at NIH and the FDA. That’s a good thing. Scientific progress hinges on
challenging conventional thinking, and I appreciated hearing their ideas for how
things can be done differently.

COVID fabulist Dr. John Mandrola scolded Dr. Bhattacharya’s critics by saying:

There’s plenty to be worried about but the 100% partisan vote on
@DrJBhattacharya for NIH ranks high on the list. If you want to heal science,
how can 47 thinking humans vote against a proven academic and a Stanford
professor? Science should be apolitical. Come on, you all.

Although Dr. Bhattacharya participated in not one, but two presidential
campaigns in 2024, Dr. Mandrola depicted him as nothing more than “a proven
academic” and said it was “political” to oppose him in any way.

Dr. Monica Gandhi was also pleased. She said:

NIH DIRECTOR: Confirmation hearing of @DrJBhattacharya tomorrow- Dr.
Bhattacharya is going to do a great job as @NIHDirector and bring stability back
to this great medical research funding organization as demoralized at present; 
he will stabilize the NIH

Dr. Bhattacharya’s fellow laptop class professors were also eager to vouch for
him. Harvard President Alan M. Garber called him a “serious and dedicated
researcher who has always been well-intentioned,” while Stanford President
Jonathan Levin said, “I think he’ll do an exceptional job in that role.” Stephen
Macedo, the author of the revisionist history book In COVID’s Wake said,
“Excellent appointment!” Mark Hlatky, a Stanford professor of health policy and 
medicine said, “I do think Jay is a reasonable person, not an ideologue,” and
Dana Goldman, director of the University of Southern California’s Schaeffer
Center for Health Policy and Economics said, “If there’s anyone I wanted to be
making the case to the president about the value of science to solve problems
and contribute to economic prosperity, it would be Jay Bhattacharya right now.” 
Richard Vedder, a distinguished Professor of Economics Emeritus at Ohio
University wrote an article titled A Great Trump Appointment: Jay Bhattacharya.

Bari Weiss, a promoter of conformity and groupthink, fluffed him in a podcast
titled Jay Bhattacharya Was ‘Dangerous.’ Now He Leads the NIH. She said:

Jay has lived a remarkable life, and we get into all of it, including how his
faith allowed him to stick to his values—and even to pray for Francis Collins,
the old NIH director who called his ideas dangerous—the chutzpah it took to
fight the entire medical establishment, how he ultimately triumphed against his 
critics, and how he wants to put the National Institutes of Health on the front 
line in the war against chronic illness in America.

Juvenile pseudojournalist Paul Thacker wrote a fluff piece titled The COVID-Era 
Smearing – and Resurrection – of Trump NIH Appointee Dr. Jay Bhattacharya that
said:

Even as he seeks to advance medical research, Bhattacharya’s personal experience
will likely inform his pledge to clean up the NIH and clear the agency of some 
career civil servants who silenced dissenting scientific voices during the
pandemic and created national policies that were not always supported by the
public.  “Free speech is fundamental for science to function properly,” he notes
simply.

NIH Staff Lambaste Agency Head for Censorship of Science

Though Dr. Bhattacharya has been in office for just under 3 months, we now have 
some data points to evaluate his performance so far. Articles at the start of
his tenure spoke of “bloodbaths” and “purges.” DOGE seems to be running the
show, as explained by the article NIH Killed Grants on Orders from Elon Musk’s
DOGE. NIH staffers seem to revile and distrust him as explained by the
article “Out of His Depth,” “Sold His Soul,” “Clueless”: NIH Staffers Speak Out 
About Director Bhattacharya.

In addition to the news I shared in my article Our Medical Establishment is
Flailing, from just two weeks ago, here are some more recent headlines:

  1. Exclusive: NIH Documents Reveal Inconsistencies in Grant Terminations as
    Agency Reviews 3200 More

  2. More Than 70 Nutrition Scientists Call for Freedom from Censorship at NIH

  3. NIH Staff Lambaste Agency Head for Censorship of Science

  4. Reagan Appointee: Trump NIH Cuts Represent “Racial Discrimination” “Have we
    fallen so low? Have we no shame?” asked Judge William Young

  5. Several Hundred NIH Employees Sign a letter of Protest to the Agency’s
    Director

Meanwhile, during his recent Senate testimony, Dr. Bhattacharya acted as he were
a passive observer to the organization he purportedly leads and struggled to
answer basic questions about the future of clinical trials and research at the
NIH.

With all this in mind, I’d like to hear from those people who reassured us that 
Dr. Bhattacharya was both qualified to run the NIH and motivated to improve it. 
Let’s hear them make the affirmative case that research and free speech are
thriving under his leadership. I am sure they have a lot to teach us all.pork
butt

pork butt


Tell us Dr. John Ioannidis, Exactly Who is Waging This “War on Science”?

When science was under attack, Dr. John Ioannidis played the role of enabler.
Along with his copious COVID misinformation, that will be his permanent legacy.

Jonathan Howard on April 17, 2025

Link

I think that war on science, science surrendered immediately and the whole
country of science was torn

In a previous article, I discussed Dr. John Ioannidis and his supposed “biggest 
mistake”. He said:

So I think that science is about mistakes, it’s about making mistakes, but
trying to realize them and compare them with what might be better evidence and
hopefully correct them as quickly as possible. And I think my biggest mistake,
and I think that others can probably think about their mistakes, is that I
underestimated how much power politics and media and powers outside of science, 
could have on science. I think that I had no clue and no preparation for this
invasion of science.

I think that war on science, science surrendered immediately and the whole
country of science was torn apart among people with very different ideologies
and partisan beliefs with strong opinions, with power struggles, with the thirst
for power and dominance and conflicts and that’s something that I have not
witnessed before and I was not prepared for that and I think that I did my best,
but I was close to ridiculously poorly prepared for that.

I think my preparation had been for debates with other scientists with a few
scientists who might be knowledgeable in the field or are interested, and
sometimes very interested and are fighting for the truth, which is of course
evasive for all of us, but I was not prepared to have to fight with all of these
powers that had nothing to do with science. That’s something that I feel a
complete idiot about.

While I don’t think this was Dr. Ioannidis’ biggest mistake, I basically said
the same thing in my article I Confess My Sins: I Was Too Slow and Timid to Call
Out Propaganda For What It Is. I have been following cranks like RFK Jr. for
many years, and I greatly underestimated their threat. Not only is RFK Jr. is
taking a wrecking ball to everything, as the video below shows, he is also
plagiarizing misinformation spread by Dr. Ioannidis in 2020, absurdly claiming
that COVID wasn’t to blame for the deaths of people with underlying conditions. 
Everything that’s happening now is just a continuation of a process that began
in March 2020, when the misinformation started.

The only thing that’s changed is that the doctors who spread the misinformation 
are now in charge. They are now the Medical Establishment and they own
everything that’s happening right now. Their harm will reverberate for decades. 
Currently, things seem to be going very poorly for them and everyone around
them.

I discussed this and many similar myths spread by Dr. Ioannidis here.

BMJ had a strong bias in favour of authors advocating an aggressive approach to 
COVID-19 mitigation.

We at SBM have been agree that there has been a war on science and we have been 
crystal clear about about who is attacking it. Dr. Gorski wrote about this
Monday in his article How Bad Is It? RFK Jr.’s Extinction-Level Threat to
Science-Based Federal Health Policy and Public Health is Here and my article
Doctors Who Fluffed RFK Jr.: Here’s What You Own So Far, contained a long list
of horrific articles about the state of science and medicine in the U.S. today. 
We may be wrong- though our articles remain unrefuted- however we at SBM staked 
out an unambiguous position in this “war on science.” Their is no doubt about
where we stand and whom we blame.

Of course, none of this is any secret. In fact, it’s all over the news. It’s
impossible to miss.

Despite this, Dr. Ioannidis has only uttered bland platitudes about the “war on 
science” while remaining mostly silent about the battles and warriors. His
publication record provides a clue as to whom he believes the aggressors to be- 
his critics. His article Constructive and Obsessive Criticism in Science written
with pro-RFK Jr. propagandist Dr. Vinay Prasad, lamented harassment and
scientific bullying with “ad hominem aspects” saying:

Typical behaviors include: repetitive and persistent comments (including
sealioning), lengthy commentaries/tweetorials/responses often longer than the
original work, strong degree of moralizing, distortion of the underlying work,
argumentum ad populum, calls to suspend/censor/retract the work of the author,
guilt by association, reputational tarnishing, large gains in followers
specifically through attacks, finding and positing sensitive personal
information, anonymity or pseudonymity, social media campaigning, and unusual
ratio of criticism to pursuit of one’s research agenda.

Who specifically is guilty of this behavior? Dr. Ioannidis did not say, though
his co-author Dr. Prasad routinely launched juvenile, vulgar personal attacks,
compiled here by Pandemic Accountablity Index. To my knowledge, Dr. Ioannidis
has never complained about Dr. Prasad’s immature profanity or his calls for mass
purges of scientists. Dr. Ioannidis was also willing to found a new “journal”
with Dr. Martin Kulldorff, who sent out a guillotine Tweet along with an article
written by a child-labor advocate. This was not a bridge too far for Dr.
Ioannidis. He did not mind that Dr. Jay Bhattacharya campaigned for anti-vaxx
crank RFK Jr or that he made nearly $12,000 posting on Twitter, giving him a
financial incentive to keep his audience engaged and inflamed. He said nothing
when Dr. Marty Makary endorsed RFK Jr.’s most vile lies about vaccines. That was
not a deal-breaker for Dr. Ioannidis. None of this was part of the “war on
science,” apparently.

This is not to say Dr. Ioannidis didn’t have his pandemic villains. Last month, 
Dr. Ioannidis published an article titled COVID-19 Advocacy Bias in the BMJ:
Meta-Research Evaluation, which concluded that:

BMJ had a strong bias in favour of authors advocating an aggressive approach to 
COVID-19 mitigation. Advocacy bias may influence public opinion and policy
decisions and should be mitigated in future health crises in favour of open and 
balanced debate of different policy options.

In this moment, with all that’s happening, that is the hill he is willing to die
on. This seems to be this the “war on science” that Dr. Ioannidis had in mind. 
I got my start here debunking anti-vaccine balderdash from the BMJ. Should the
BMJ have published more of it? Did the BMJ owe space to Dr. Ioannidis simply
because of who he is? Is Dr. Ioannidis a causality in the “war on science?”

For the most part, I don’t think so. Dr. Ioannidis reported that he received
threats, which is of course abhorrent and completely unacceptable. However, he’s
healthy and employed, thankfully, and any dents to his reputation are his own
doing. He didn’t have to that claim the flu would be worse than COVID and that
it would kill 40,000 Americans. No one forced him to repeatedly minimize COVID
on Fox News.

However, when discussing the “war on science”, I can’t recall Dr. Ioannidis ever
lamenting the tragedy of young people who died due to anti-vaccine
misinformation spread by doctors he’s collaborated with. I’ve not seen seen him 
bemoan the attacks on universities, the mass purges, or the chaos and
dysfunction at the FDA and NIH. Given our mutual concern about this “war on
science,” I’d be curious to hear Dr. Ioannidis’ thoughts on these headlines and 
the men responsible for them. As far as I know, he’s said nothing. If there are 
examples, let me know in the comments and I will add them to this article.

Read these articles here and here.

Instead of recognizing this sad reality, Dr. Ioannidis continues to vaguely
worry about “science becoming a political battleground” as if that is something 
that might happen one day if we are not careful. “That’s not going to help
anyone. The winners and the losers, they’re both going to be losers,” he added
in a recent speech. In the video below he warns about “the wrong way to go”,
implying that things are OK now. Dr. Ioannidis is trying to warn us about a
potential dark future in a very serious and sober way, but he’s got nothing to
say about the present. In the same way headlines of mass morgues didn’t impress 
him 5 years ago, headlines about mass purges don’t seem to bother him today. One
wonders what would have to happen for him to care more about actual disasters
than theoretical threats.

Well, I have bad news for Dr. Ioannidis. We weren’t careful, science became a
political battleground, and the headlines leave no doubt as to whom is
responsible. Widespread indifference to misinformation spread by doctors for the
past 5 years directly led us to this moment. The same doctors who relentlessly 
spread fake COVID nonsense, are today pictured in articles about “purges” and
“firings.”

I suspect that if Dr. Ioannidis were to acknowledge this, he’d be forced to
confront the uncomfortable fact that he partnered with these doctors,
legitimized them, and shared their pandemic vision. He overlooked everything
they did. When science was under attack, he played the role of enabler. Along
with his copious COVID misinformation, that will be his legacy.

He’s right about some things though- science is the best thing that has happened
to humans, and when it becomes a political battleground, there are only losers.
All this is happening right now. Just read a newspaper.

Dr. John Ioannidis: To Protect Science and Keep it Apolitical, We Must Not
Resist MAHA.

Posing as an wise, elder statesman, a neutral guardian of science, Dr. Ioannidis
managed to pontificate mightily on COVID from a safe distance without ever
being forced to acknowledge the tragic realities on the ground. There is no need
for journalists to enable this charade today.

Jonathan Howard on December 28, 2025

Link


Unpredictable evolutions may ensue, including financial crisis, unrest, civil
strife, war, and a meltdown of the social fabric

In March 2020, Dr. John Ioannidis published a paper titled Coronavirus Disease
2019: The Harms of Exaggerated Information and Non-Evidence-Based Measures. In
it, he spoke with great confidence about a new virus that had already wreaked
havoc overseas. Despite this, Dr. Ioannidis wrote about about exaggerated
pandemic estimates, exaggerated case fatality rate, and exaggerated exponential 
community spread. He said a claim that 20%-60% of adults would be infected, was 
“substantially exaggerated.” He said, “China data are more compatible with close
contact rather than wide community spread being the main mode of transmission.”
He said that, “Even if COVID-19 is not a 1918-recap in infection-related
deaths, some coronavirus may match the 1918 pandemic in future seasons. Thus, we
should learn and be better prepared.”

He felt this coronavirus was a false alarm. He wrote that:

If only part of resources mobilized to implement extreme measures for COVID-19
had been invested towards enhancing influenza vaccination uptake, tens of
thousands of influenza deaths might have been averted.

While Dr. Ioannidis called for tranquility and calmness with regards to COVID,
he warned of dire consequences if we tried to contain it. In another essay from 
March 2020, titled A Fiasco in the Making? as the Coronavirus Pandemic Takes
Hold, We are Making Decisions Without Reliable Data. He speculated that COVID
could be less deadly than the flu and said:

If that is the true rate, locking down the world with potentially tremendous
social and financial consequences may be totally irrational. It’s like an
elephant being attacked by a house cat. Frustrated and trying to avoid the cat, 
the elephant accidentally jumps off a cliff and dies.

One of the bottom lines is that we don’t know how long social distancing
measures and lockdowns can be maintained without major consequences to the
economy, society, and mental health. Unpredictable evolutions may ensue,
including financial crisis, unrest, civil strife, war, and a meltdown of the
social fabric.

By the end of March, the headlines would read Surge in Deaths Overwhelms New
York’s Morgues, Hospitals and Shocking Video Shows the Bodies of NYC Coronavirus
Victims Being Forklifted into a Refrigerated Rruck Used as a Temporary Morgue.

Dr. Ioannidis was totally unmoved by what was happening in my hospital, however,
claiming in April that the “devastation” of COVID mitigation measures “can be
extreme and it can be far worse than anything that coronavirus can do.”

Dr. Ioannidis’s approach to risk was clear in spring 2020, and he never deviated
from it. While basically everything about COVID’s danger was exaggerated, the
real threat was an imaginary dystopia- financial crisis, unrest, civil strife,
war, and a meltdown of the social fabric– one that would be manifest into
existence by trying to limit COVID. Moreover, in order to contain the flu or
some future coronavirus, we needed to let this one rip.

Dr. Ioannidis made these claims in the name of data, evidence, and rigor, though
always without reference to what was happening in the real world at the time.
Headlines of overflowing hospitals and morgues didn’t count for him. In his
view, these obvious, present dangers, also known as reality, could be casually
brushed away in service of preventing hypothetical, future catastrophes.

We need some shaking up and we need that to happen rigorously. If we don’t, it
will be done with political means.

Though the threats are different today, Dr. Ioannidis’s approach to them hasn’t 
changed a bit. A recent article titled Will NIH’s New Director Reform His
Agency—or Destroy It? noted that there are “13 open directorships at NIH’s 27
institutes and centers” and said the following:

One longtime colleague and friend, who has kept in touch with the director since
he took the job, pleads for scientists—and reporters—to give him a chance. “I
do worry that taking the stance that ‘Everything was perfect, and now comes Jay 
Bhattacharya and destroys everything’ is very problematic,” says Stanford
physician-scientist John Ioannidis. “We need some shaking up and we need that to
happen rigorously. If we don’t, it will be done with political means.”

And there it is. In addition to a dishonest straw man- no one said everything
was perfect– Dr. Ioannidis is again claiming that our attempts to mitigate a
current danger, MAHA in this case, will end up leading to a worse catastrophe in
the future.

Again, Dr. Ioannidis conveniently disregards what is happening in the real
world. In reality, Dr. Bhattacharya openly campaigned for Ron DeSantis and
Kennedy last year and he continues to fluff Trump and give overtly political,
religious speeches at Turning Point USA to this day. Science doesn’t have to be 
dominated by the “political left” according to Dr. Bhattacharya.

Incredibly, Dr. Ioannidis claims that those who object to this rhetoric will be 
responsible for the future politicization of science. In his telling, Dr.
Bhattacharya is just here to shake things up, and he is doing so with rigor.
Everything is perfect, apparently, and Dr. Bhattacharya’s critics need to lay
off. They are “very problematic”.

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

In reality, no one needs Dr. Ioannidis’s permission to criticize Dr.
Bhattacharya or anyone else in our government and medical establishment.
However, perhaps the real lesson here is for journalists. What is the point in
interviewing Dr. Ioannidis when everyone already knows he is going to use bland 
bromides about data and rigor to shelter and defend the MAHA doctors he’s
promoted for years. Was there any chance he going to say, “Yeah, it turns out my
buddies Jay, Vinay, and Marty are screwing things up pretty badly.” Of course
not. As such, there is no need for journalists to seek his opinions further. He 
has nothing to contribute to our understanding of this sad moment, except as a
chief enabler of it.

Posing as an wise, elder statesman and a neutral guardian of science, Dr.
Ioannidis managed to pontificate mightily on COVID from a safe distance without 
ever being forced to acknowledge the tragic realities on the ground. There is no
need for journalists to enable his charade today. Moving forward anyone who
feels compelled to interview Dr. Ioannidis should do nothing but get his
reaction to the headlines about the current state of science and medicine. Given
that he feels we must embrace purges, censorship, canceled clinical trials, and
shuttered labs to protect science and keep it apolitical, he should be forced
to explain exactly why.


Dr. John Ioannidis Says Obsessive, Self-Anointed “Science-Based” Blamers Are a
Total Embarrassment for Science.

The anatomy of a DARVO.

Jonathan Howard on June 30, 2026

Link


While his COVID output and enabling of MAHA doctors should be remembered, it’s
not clear why anyone should pay attention to anything Dr. John Ioannidis says
moving forward. However, he recently penned an article that provides a good
opportunity to discuss a manipulative rhetorical technique known as DARVO. 
Though it was originally conceived to describe abusive relationships, DARVO has 
become a common tactic in supposed scientific debate and is worth discussing for
that reason.

According to one description:

DARVO is an acronym for manipulative communication: Deny, Attack, Reverse Victim
and Offender. Coined by psychologist Jennifer Freyd in the 1990s, DARVO
describes how individuals may evade accountability when confronted with their
wrongdoings.

DARVO combines elements of gaslighting and blame-shifting. Instead of addressing
the issue, perpetrators deny the facts, attack the accuser, and position
themselves as the true victim while portraying the original victim as the
aggressor.

DARVO is more than just “someone overreacting”—it’s a calculated narrative shift
often used by people who benefit from not being held accountable. It serves to 
evade responsibility, maintain power and control, discredit the person raising
the alarm, and centralize sympathy and attention back on the perpetrator.

Dr. Ioannidis’s article was titled Misinformation Blaming and Labelling May
Damage Health, Science and Policy Making, which prompted this response from
Kevin Kretsch:

Misinformation labelling may damage health, science, and policy making? Gee,
that sounds an awful lot like somebody wants misinformation to be left alone and
never called out. I wonder why that might be?

That was my reaction too, and Dr. Ioannidis’s article did not disappoint. It
contained the following paragraph:

Blaming credentialed, legitimate scientists can also backfire. Rigorous
organized scepticism and evidence-based questioning are quintessential for
science and desirable. Emotional pre-emptive rejection of scientific arguments
may suggest to the public that science is an authoritarian, even retaliatory,
process. Some scientists self-anoint themselves as “science-based” communicators
and obsessively blame other legitimate scientists with whom they disagree, even
without clear evidentiary basis for such accusations. They may attack opponents
as quacks. For the watching public, legitimate science becomes
indistinguishable from overt pseudo-science. Quackery can only benefit from
having serious scientists and serious arguments relegated to the same status.
Moreover, when sometimes “science-based” blamers are subsequently proven wrong, 
in retrospect their obsessive behavior becomes a total embarrassment for
science. Science is better served by elevating standards of reasoning and
methodological rigor than by engaging in rhetorical escalation or questionable
analogies.

At first blush, that sounds pretty reasonable. Let’s examine it one piece at a
time.

Blaming credentialed, legitimate scientists can also backfire. Rigorous
organized scepticism and evidence-based questioning are quintessential for
science and desirable.

I agree with all that. It’s atrocious that MAHA doctors berated and blamed
legitimate scientists for literally everything bad about the pandemic, even
though Dr. Anthony Fauci’s children needed bodyguards and Dr. Peter Hotez was
stalked at home,

These are not the credentialed, legitimate scientists whom Dr. Ioannidis is
defending however, and Dr. Ioannidis never directed such scolding at MAHA/MAGA
doctors, no matter what they did. They were except from such scolding.

Emotional pre-emptive rejection of scientific arguments may suggest to the
public that science is an authoritarian, even retaliatory, process. Some
scientists self-anoint themselves as “science-based” communicators and
obsessively blame other legitimate scientists with whom they disagree, even
without clear evidentiary basis for such accusations. They may attack opponents 
as quacks.

Is Dr. Ioannidis blaming the credentialed, legitimate scientists here at SBM? 
It sure seems that way to me, and his accusations of an “emotional pre-emptive
rejection of scientific arguments” perfectly describes his paragraph.

Notice, for example, his use of scare quotes to describe “science-based”
communicators. He did that to preemptively discredit us and trigger emotions in 
his readers. The same is true for his allegation that we “obsessively blame…
without clear evidentiary basis for such accusations.”  That makes us sound like
real jerks!

But is it true?  Do we make baseless, unfounded accusations?

Dr. Ioannidis provided no examples to support his claim. He didn’t quote us or
reference any of our essays. His lamentations were entirely content free. Rather
than actually debating the science, Dr. Ioannidis only ever wants to talk about
decorum and the format of some hypothetical scientific debate, one he refuses
to actually engage in. He previously made these exact empty complaints in an
article with Dr. Vinay Prasad. I guess that makes him “obsessive” too.

As Christopher Hitchens famously said, “What can be asserted without evidence
can also be dismissed without evidence”. While that alone would be enough to
dismiss Dr. Ioannidis’s accusations, fortunately we have an easily accessible
track record here at SBM and in my books. We eagerly invite people to read our
work and judge for themselves whether our criticisms are “without clear
evidentiary basis.”

I think we provide plenty of evidence.

For example, I emailed Dr. Ioannidis before I published my first essay on him
here to make sure I was representing his views fairly. He did not respond.
Nonetheless, that essay contained lengthy quotes of his combined with detailed
explanations of why I disagreed. That’s all I’ve done ever since, and it’s what 
I’m doing here too. I never just called him names.

Though he obviously has no obligation to do so, Dr. Ioannidis hasn’t responded
to any of our good faith criticisms in a good faith manner. While he parades his
hurt feelings, wags his finger, and sanctimoniously scolds us for our
“obsession,” not once has he raised any meritorious objections to our work, and 
SBM is not unique in this regard.

Despite his lofty words, praising “rigorous organized scepticism and
evidence-based questioning”, Dr. Ioannidis rarely, if ever, engages with his
critics in a serious, sober way.  Instead, he acts as if he’s our “opponent” in 
some game and absurdly implies that we’ve written dozens of lengthy articles
that do nothing but call him a “quack.” To Dr. Ioannidis, accurately quoting him
and disagreeing in any way constitutes an “attack”. Imagine his outrage if we
called him a “fucking moron”, “fucking liar” or “piece of shit,” like Dr. Vinay 
Prasad. Dr. Ioannidis apparently has no problem with this however. He referenced
their prior work on the value of civil discourse in his latest article.

If Dr. Ioannidis quotes our work and explains exactly where we he thinks we
erred, it will be the first time. Of course, I’ll keep an open mind to any
substantive criticism. Until then, we can recognize he is just obsessively
blaming legitimate scientists with whom he disagrees, even without clear
evidentiary basis for such accusations.

Simply put, he is attacking us while claiming to be attacked.

For the watching public, legitimate science becomes indistinguishable from overt
pseudo-science.

Not only do I agree with this, the disgraceful blending of legitimate science
with overt pseudo-science has been a core theme of my writing and of SBM long
before I arrived. Dr. Gorski wrote an article in 2018 titled Quackademic
Medicine and the Delusion of Being “Science-Based”, and the subtitle to We Want 
Them Infected warned about doctors who embraced the anti-vaccine movement.

As Dr. Gorski’s series on Lysenkoism 2.0 shows, we here at SBM talk about this
every week. In contrast, Dr. Ioannidis has nothing to say about Kennedy and MAHA
doctors. While he issues frequent vague warnings about potential, future
threats to science, he is silent about and unbothered by what is actually
happening to science today. I’ll confess I even asked ChapGPT about this. Here’s
what it said:

I could not find a public statement where Ioannidis specifically rebuked Kennedy
or called out his positions by name. If such a statement exists, it does not
appear to be widely documented.

So, assuming Dr. Ioannidis agrees with us that Kennedy is a quack, here are some
examples of prestigious professors from prestigious universities confusing the 
public by making legitimate science indistinguishable from overt pseudo-science.

  1. Dr. Martin Kulldorff, Harvard University: The Cure for Vaccine Skepticism
  2. Dr. Vinay Prasad, UCSF: Sabotaging RFK Jr’s Confirmation Will Increase Vaccine
    Hesitancy
  3. Dr. Jay Bhattacharya, Stanford University: RFK Jr Will Disrupt the US Medical 
    Establishment
  4. Dr. Marty Makary, Johns Hopkins University:  Dr. Makary On RFK Jr’s Criticism 
    Of The ‘Medical Industrial Complex’: Saying Things ‘People Know Are True’
While Dr. Ioannidis has only criticisms of SBM, he has only praise for such
MAHA/MAGA doctors. For example, not long ago he said:

I do worry that taking the stance that ‘Everything was perfect and now comes Jay
Bhattacharya and destroys everything’ is very problematic. We need some shaking
up and we need that to happen rigorously. If we don’t, it will be done with
political means.

Dr. Ioannidis has nothing to say about their actual performance in power, or the
state of science under MAGA/MAHA. He might be the only scientist in America
with no opinion on the matter.

Instead of honestly grappling with the news headlines he helped enable, Dr.
Ioannidis reserves his contempt and scorn for those of us who tried to warn
about them. Is his view, our tiny little blog is the big problem. We need to
stop being “obsessive.” We need to keep our mouths shut and lay off.

Dr. Ioannidis and MAHA/MAGA doctors

Quackery can only benefit from having serious scientists and serious arguments
relegated to the same status.

Of course, people cannot always be easily dichotomized into “quacks” and
“serious scientists.”  Plenty of serious scientists have made unserious
arguments, and despite Dr. Ioannidis’s protestations, they are not entitled a
lifetime free pass where they are forever immune from criticism. A Nobel Prize
winner who embraces quackery, and there have been several, deserves to be called
out for embracing quackery.

For me at least, any doctor who spread COVID misinformation and/or promoted,
amplified, and legitimized Kennedy/MAHA in any way has permanently forfeited the
right to be taken seriously as a serious scientist ever again, no matter their 
past scientific acumen or current homages to “rigor” and “evidence.”

Moreover, when sometimes “science-based” blamers are subsequently proven wrong, 
in retrospect their obsessive behavior becomes a total embarrassment for
science.

Once again, Dr. Ioannidis provided no examples of us “science-based’ blamers”
being proven wrong, and so once again we can dismiss his juvenile taunts out of 
hand.

While Dr. Ioannidis makes unfounded allegations about us being “proven wrong,”
he vastly overstates our power and influence by calling us a “a total
embarrassment for science“, as if with everything that’s happening in the world 
right now, the entire scientific community is reading SBM articles and shaking
their head in collective shame over our “obsessive behavior.”

Meanwhile, back in the real world, STAT News recently published an editorial
titled I’ve Spent 40 Years In Research. I Have Never Seen A Threat To Science
Like The New Grantmaking Rule. It didn’t mention SBM.

Of course, we are not perfect. I’ve readily acknowledged a couple goofs here and
there, though by far the biggest mistake we made was to underestimate the
threat to science.  I previously discussed how I bent over backwards too long to
give the benefit of the doubt to doctors who spread disinformation to trick the
public about COVID, advance their own careers, and promote the MAHA/MAGA
agenda.

These doctors are a total embarrassment for science and it is all they and their
enablers should be known for moving forward.

Science is better served by elevating standards of reasoning and methodological 
rigor than by engaging in rhetorical escalation or questionable analogies.

I agree with that too. Dr. Ioannidis can prove he means it by coming on my
podcast for some civil debate and discussion. There will be no rhetorical
escalation or questionable analogies. We’ll play lengthy clips of his 2020
pandemic pronouncements and provide examples of him boosting MAHA/MAGA
doctors. We will listen patiently, without interruption, while he defends his
words, and he is welcome to do ask me to do the same. I’m ready to defend it
all.

Something tells me his commitment to “elevating standards of reasoning and
methodological rigor” doesn’t extend that far, however. It’s a lot easier to
insult us as obsessive “science-based” blamers who are a total embarrassment for
science and then accuse us of attacking him.

DARVOs are attempt to silence people, and we aren’t going to let that happen
here at SBM.

Questions About Pandemic Preparedness

Steven Novella on December 4, 2024

Link

The theme at SBM this week is questions for Trump’s nominees for key health
positions within the federal government. David got the ball rolling with an
excellent summary of the nominees and questions for each. Jonathan followed up
with his own list of questions. I would like to continue the theme, focusing on 
our preparedness for the next pandemic.

It is arguably the defining feature of Trump’s first administration that he
bungled the response to the COVID19 pandemic. Even before the pandemic, Trump
disbanded the NSC directorate for global health and security and bio-defense, a 
unit dedicated to preparing for and responding to either bioweapons or a
pandemic. Trump himself fueled anti-masking misinformation and promoted false
cures like hydroxychloroquine. He denied the severity of COVID in the initial
phases and delayed an effective response.

As a result there have been over 1.1 million American deaths from COVID. The
pandemic was very disruptive to the US economy resulting in lost jobs and a
spike in inflation. We can never know what would have happened if there were an 
optimally effective US response, but we know that despite our wealth and
resources we faired worse than most other similar nations. Trump does get credit
for greenlighting an idea coming out of the FDA, Operation Warp Speed, to
accelerate the approval process for COVID vaccines. But then his administration 
bungled the roll out of the vaccine, again causing delay.

I know that for most people we would like the COVID pandemic to be a distant
memory, a time of shutdowns, masking, and fear. It feels like a
once-in-a-lifetime event, something to talk about to future generations like
living through the depression. I hope this turns out to be true, but it would be
folly to count on it. Already experts are warning of the potential for the bird
flu pandemic to spillover to humans. There are animal-to-human cases, but
currently no human-to-human transmission. But this is what spillover events are 
– viruses that can infect animals and humans mutating to trigger a human
epidemic or even pandemic.

To prepare for when (not if) the next pandemic hits, the Biden administration
created the Office of Pandemic Preparedness and Response Policy (OPPR). If you
are in the mood, you can watch two and a half hours of congressional testimony
about how we should be preparing for the next pandemic, and lessons learned from
COVID. What you will find are largely competent professionals getting deep into
the weeds of public health policy and pandemic preparedness.

In my opinion, a high priority for approving any Trump nominees for key federal 
health positions is their attitudes about COVID and how to prepare for and
respond to the next pandemic. These people might be the ones in charge when the 
next COVID hits. As we have seen, that response can save or cost hundreds of
thousands of lives, and dramatically affect all of society. So – here are some
questions for them:

Was it a mistake to shut down the NSC directorate for global health and security
and bio-defense? Do you support the OPPR and its mission?

What additional steps would you recommend to prepare for the next pandemic?

What should be the relationship between federal health policy and scientific
evidence, including academic, research, and professional institutions?

Given the COVID experience, how do you view the role of public health policy,
such as masking and isolation, as tools for controlling the spread of dangerous 
infectious diseases?

How do you view the role of public vaccination programs in managing pandemics?

Is it responsible to rely upon natural herd immunity as a primary measure of
managing a pandemic?

What background and experience prepares you for the responsibility of protecting
the public health, in general and in the face of potential future pandemics?

What steps would you take to foster public trust in government health
institutions and their recommendations?

These are all questions I would have loved to see asked of the candidates during
the campaign. Unfortunately, that is not the kind of media or culture we have
in this country. It is also amazing how quickly even big life-changing events go
down the public memory hole. You would think, just a few years after a massive 
pandemic, these would be key questions for any future executive.

At the very least, this should have been a major issue in the campaign. Who
would you want to have in charge if another pandemic hits over the next four
years? I may not have liked the collective answer that the US voting public
gave, but at least the question should have been asked. And so here we are,
facing a frightening line-up of nominees for key federal health positions,
presenting a spectrum of anti-science ideology and a concerning lack of
credentials.

Our one thin reed of hope is that senate Republicans will actually do their job.


Medical science policy in the U.S. under Donald Trump

The election of Donald Trump was unexpected. Given Trump’s history of
antivaccine beliefs and conspiracy theories, coupled with a fervor for
deregulation (a fervor shared by the Republican Congress), it is reasonable to
fear what will happen to medical science policy during the next four years.

David Gorski on November 14, 2016

Link





When Dr. Oz met Donald Trump: Somehow this photo just seemed appropriate for
this post.

Last week, in an unexpected upset, Donald Trump won the Presidential election in
the Electoral College while losing the popular vote and is now President-Elect.
Regular readers of my not-so-super-secret other blog know my opinion of this;
so I won’t belabor it too much here. If you’re curious, I have written about
Donald Trump’s antivaccine views here before in the context of last year’s
Republican debates, and, amusingly, I’ve even been at the receiving end of
criticism from an “integrative medicine” activist in which my snark was compared
to that of Donald Trump and my criticism labeled “Trumpism.” As you might
imagine, I was not pleased.

Leaving all that aside and leaving aside how we’ve now had two Presidential
elections out of the last five in which the candidate with fewer popular votes
became President (no, I’m not a fan of the Electoral College), Donald Trump won 
fair and square and will be our next President. As an advocate of science-based 
medicine, naturally I wondered: What can we expect in terms of medical science
under President Trump next year? Jann Bellamy already began the discussion on
this blog by undertaking a fairly comprehensive overview of the disturbing
anti-science positions Donald Trump and many now coming into his new
administration espouse. I’m going to do a bit of the same, but I’m going to
drill down and focus solely on medical science. While I agree that Trump’s
position on human-caused climate change and his stated intent to pull out of
important climate treaties and, in essence, cease any attempt to mitigate the
effects of human activity on climate change is a looming disaster that our
grandchildren and great-grandchildren and beyond will likely curse our
generation for, this blog is Science-Based Medicine.

So I’ll leave the discussion of climate science to people like Phil Plait. Also,
I would like to focus on a few issues that Jann either only touched on or
didn’t mention at all. I’m not going to focus on issues that are more political 
than scientific, like what will become of the Affordable Care Act (although I
suspect that Trump will find dismantling it far more difficult than he thought
it would be), but it’s impossible to avoid politics altogether when discussing
federal science and medical policy.

There have been a few articles in the scientific press speculating what the
election of Donald Trump means for science. Here is a sampling:

  1. Donald Trump’s Presidential Election Win Stuns Scientists

  2. What scientists should focus on — and fear — under Trump

  3. Richard Dawkins and Other Prominent Scientists React to Trump’s Win

  4. The ultimate experiment: How Trump will handle science

  5. What does Donald Trump’s win mean for science and medicine?

  6. Here’s some advice for you, President Trump, from scientists

Not surprisingly, the two primary reactions that come through loud and clear in 
these articles are fear and uncertainty. This is not surprising, given the
litany of antiscience positions that Trump articulated (if you can call it that)
during the campaign. The uncertainty comes from the fact that on a lot of
issues relevant to science, Trump hasn’t said much of anything and, as was
reported in Science, for the last 18 months the Trump team has had little
interaction with the scientific community. This means for a lot of medical
science policy issues, we really have no idea what he’ll do.

On Friday, Nature published an article, What scientists should focus on — and
fear — under Trump, that featured nine scientists expressing their fears and
hopes. One issue that stood out to me (and is one I haven’t seen covered before)
had to do with standards for drug approval.

Donald Trump, Mike Pence, and “right-to-try”

In a section of the article entitled Beware of plans to lower drug standards,
Douglas Sipp of the Riken Center for Developmental Biology, Kobe, Japan writes:

   Supporters of the idea that drugs should be tested for efficacy before being 
   sold are in for a long four years. In recent years, Republican majorities in 
   the Senate and in the House of Representatives have backed several bills that
   would drastically reduce the authority of the US Food and Drug
   Administration (FDA), and its ability to require that new medical products
   are demonstrated to be safe and effective before they are marketed.

One of the pillars of Republican belief these days is that nearly all regulation
of industry is bad, that it holds back the power of the free market. As I’ve
documented more times than I can remember, there is a strong Libertarian/right
wing bent to large swaths of what is known as the “health freedom” movement.
Basically, the “health freedom” movement loathes the FDA and views it as an
impediment to innovation. If you believe the narrative, the reason we don’t have
cures for cancer and many other diseases is the Draconian regulatory hurdle of 
the FDA. There is little doubt that Trump has imbibed deeply of this belief
system, and with both chambers of Congress under Republican control, there will 
likely be a deregulation spree shortly after Trump is inaugurated.

In case you doubt me about how much many conservatives detest the FDA, let me
remind you of something I came across last year when writing about the fear of
Ebola that was rampant in the US because of the outbreaks in Africa. There I
mentioned what is to me an iconic article articulating this point of view, Kill 
the FDA (before it kills again) by Nick Gillespie:

   As my Reason colleague Ronald Bailey has written, this means the FDA’s
   caution “may be killing more people than it saves.” How’s that? “If it takes 
   the FDA ten years to approve a drug that saves 20,000 lives per year that
   means that 200,000 people died in the meantime.”

Yes, there are some who quite literally (and mistakenly) believe that the FDA is
killing patients. As I wrote at the time, completely missing from Bailey’s and 
Gillespie’s equation is the number of drugs that the FDA doesn’t approve because
they don’t show efficacy and safety that could allow even more than those
20,000 people a year to die or even actively kill some of them. After all, it
was the FDA that prevented, for example, approval of Thalidomide in the US and
the rash of birth defects seen elsewhere in the world.

It’s this sort of attitude that leads to Sipp’s concerns:

   Most concerning is the Republican push for a federal ‘right to try’ law,
   which would indemnify companies and individual physicians that sell
   experimental drugs to dying patients after only preliminary safety testing.
   Similar laws have been enacted in 32 states. But these have had little
   impact, being superseded by federal code. A federal right-to-try law would
   effectively make phase I clinical trials (which test safety) the threshold
   for marketing new products. This would have profound consequences — on how
   new drugs are brought to market, and for clinical-trial enrolment. The
   right-to-try movement is making overtures overseas too. In Canada, for
   example, all members of its parliament received a coordindated e-mail calling
   on them to endorse such a law.

Although I was unable to find any statement by Donald Trump about “right-to-try”
laws, Mike Pence supported Indiana’s right-to-try law and in August responded
to the question of a child whose father has amyotrophic lateral sclerosis (Lou
Gehrig’s disease) about right-to-try thusly, “I’m very proud the state of
Indiana signed ‘Right to Try’ legislation into law, and I promise you, I promise
your dad, I promise Matt – we’re going to take your incredibly powerful,
courageous, inspirational example. We’re going to take it to Washington, DC, and
we’re going to get it done.” Support for a federal right-to-try bill is also
embedded in the Republican platform.

I’ve written many times before about “right-to-try” laws. As of now, there are
32 states that have passed such laws, an astounding accomplishment for the
proponents of these laws at the Libertarian think tank the Goldwater Institute, 
which began its promotion of these laws less than three years ago. Remember, the
first right-to-try law passed in Colorado in May 2014.

This success should not be surprising, because right-to-try laws give the
appearance of helping terminally ill patients. Passing right-to-try laws lets
legislators feel good about themselves without actually confronting hard
choices, not to mention to appear to be doing something helpful when they are
not. On the surface, they are very, very appealing, to the point where I’ve
grimly joked that opposing right-to-try appears akin to advocating disemboweling
puppies or being against mom, apple pie, and the American flag. I myself have
experienced some of that vitriol, and know from various private conversations
that university medical centers and pharma think these laws are a horrible idea.
Yet, it is very rare for an official representative to state outright
opposition to such laws. (Note: I do not represent my university or cancer
center in any way on right-to-try. See? Even I feel obligated to point that
out!)

In any case, right-to-try is a movement started by the libertarian Goldwater
Institute, ostensibly to give terminally ill patients the “right to try”
experimental treatments without interference from the FDA. Indeed, the Goldwater
Institute provided the template for these laws, and all right-to-try laws that 
I’ve examined hew pretty closely to this template (many even use the exact
language provided by the Goldwater Institute), with customizations intended to
make individual laws fit into the legal and regulatory framework of the state
passing them. In reality, right-to-try is a cruel sham.

There are several reasons why right-to-try laws are a cruel sham. First and
foremost, states do not have authority over drug approval. The FDA does, and
federal law trumps—if you’ll excuse the word—state law. Also, it’s incredibly
rare that an experimental drug will make the difference between life and death
in any given terminally ill patient. Yet it is that hope that supporters of
right-to-try laws, in particular the Goldwater Institute, have shamelessly
exploited to rally patient groups and to persuade legislators to pass these laws
all over the nation. Basically, the Goldwater Institute has sold patients and
legislators on a lie.

Unfortunately, that lie has power. Even though state right-to-try laws are
toothless—or are, as I like to call them, placebo legislation—they exist to put 
pressure on Congress. This year a federal version of a “right-to-try” law,
S.2912, The Trickett Wendler Right to Try Act of 2016, has been languishing in
Congress, apparently meeting the same fate that its predecessor did in 2014.
What S.2912 would do, if passed, would be: (1) to explicitly federalize each
state’s right-to-try law, in the process eliminating the FDA’s ability to
protect terminally ill patients from what could be dangerous or inappropriate
drugs; (2) eliminate all federal liability from physicians and drug companies
that offer a drug under right-to-try, meaning that if a patient suffers because 
of the inappropriate use of such a drug the patient (or, given that the patients
under this bill have terminal illnesses, the family) will have no recourse to
sue the manufacturer under federal law, in addition to having no recourse under 
state law; and (3) bar the FDA from using outcomes of patients using
experimental drugs or devices under right-to-try in its deliberations over
whether to approve them for sale. Basically, the Trickett Wendler Right to Try
Act of 2016 would not help terminally patients. It would endanger them.

The Trickett Wendler Right to Try Act of 2016 is almost certainly dead in 2016. 
Not much is going to happen in a lame duck session outside of essential
business, and President Obama would probably veto the bill anyway. However, I
expect this bill, or something very similar (and perhaps more alarming) to be
reintroduced next year in the new Congress. With Trump in office and Republican 
majorities in both chambers, who knows where it will go?

Sipp is utterly correct, though. If a federal right-to-try law like
Trickett-Wendler passes, it would effectively make phase I clinical trials the
threshold for marketing new products to terminally ill patients. Remember, phase
I trials are safety trials in which a handful of patients (often less than
three dozen) are given the drug at varying doses. They can only find the worst
adverse events, and they are not designed to test efficacy. Basically, a federal
right-to-try law would risk throwing us back to the pre-thalidomide FDA, at
least with respect to terminally ill patients, who are most vulnerable. Once
that door is unlocked, it’s also clear that right-to-try proponents will push
for liberalizing right-to-try to the “seriously ill,” as some state laws already
do and are likely to find a sympathetic ear in the White House.

Donald Trump and stem cell clinics

Sipp also notes:

   Then there’s the US REGROW Act. This seeks to lower standards for cell
   therapy products — such as stem-cell treatments — and has been stalled in a
   Senate committee since this spring. Major scientific groups have issued
   statements opposing the act, including the International Society for Stem
   Cell Research, the International Society for Cellular Therapy, and the
   Alliance for Regenerative Medicine. The bill’s prospects had seemed grim.
   Substantive amendments in recent months had, for instance, removed an
   alarming call for Congress to prohibit the FDA from requiring phase III
   clinical trials, typically the final hurdle for therapies to be approved for 
   market for most investigational cell therapy products. Now, under a
   Republican-dominated government, its dim chances seem to have brightened.

I’ve discussed the dangers of unregulated stem cell clinics before on several
occasions. Even under current FDA regulations, there is a large industry of stem
cell clinics in the US making scientifically unsupportable claims and selling
stem cell therapies as a panacea for aging, arthritis, chronic lung disease,
chronic heart disease, cancer, eye disease, and even autism. In the US, the
situation is not as bad as it is in overseas stem cell clinics, where literally 
almost anything goes, damn the consequences, even if it’s a tumor on a paralyzed
man’s spinal cord made up of stem cells. It’s an industry that blatantly uses
celebrities like Gordie Howe, in some cases even offering their $30,000 product 
for free, in order to promote their business. (Yes, I know that Gordie Howe was 
treated in Mexico, but the company that provided his stem cells and arranged for
his treatment outside of the US is an American company based in San Diego.)
Basically, such clinics engage in unethical for-profit human experimentation,
except that they seem not to keep records adequate to determine if their
treatments actually do any good.

These stem cell clinics use a hard sell technique, too, not unlike that of
salesmen selling time shares, complete with extravagant claims, high pressure
sales techniques, and “special” discounted prices that you can only get if you
sign on the dotted line and provide a check or credit card number right then and
there at the informational meeting. Basically, there’s a lot of shadiness and
quackery in just the US stem cell industry, which is why the FDA has been taking
a look at the plethora of dubious stem cell clinics in the US and preparing to 
propose new regulations that could shut down many of them.

It’s not clear if REGROW will now be passed, but given the anti-regulatory bent 
of the new administration, I wouldn’t be surprised if it, too, is reintroduced
in the new Congress and has a much higher probability of passing than before,
when even then it was viewed as too radical and dangerous, mainly because it was
and still is. Even before the election, there were powerful Senators talking
about reintroducing the bill or somehow folding it into a larger bill supporting
the NIH. If that happens, stem cell quacks will be given essentially free rein 
to sell whatever snake oil they please.

Will Donald Trump loosen drug approval standards?

Of course, right-to-try, although horrifying in how it would dismantle
safeguards to prevent drug companies from taking advantage of patients, is still
a rather special case. It applies only to terminally ill or “seriously ill”
(whatever that means) patients. Similarly, there are, at least now, relatively
few patients seeking unapproved stem cell therapies, in part because they cost
tens, if not hundreds, of thousands of dollars unreimbursed by insurance
companies. Perhaps of more concern is this, again discussed by Sipp:

   Other attempts at deregulation may also take advantage of the new,
   effectively one-party government. These include proposals to lower evidence
   standards for drug approval across the board, and to undermine FDA authority 
   over the promotion of ‘off-label’ uses of approved drugs.

This is the threat that is more likely to harm more people. As I pointed out
before, it is basically a religious tenet of Republican orthodoxy that the free 
market always does things better and that, if left to itself, the free market
will sort out everything. You might think I exaggerate, but I don’t, at least
not much.

I’ve already discussed the 21st Century Cures Act. It’s a bill that was proposed
last year, seemed not to go anywhere much, but is still very much alive and
still poised to endanger patients. Basically, it’s a bill that would
substantially increase the NIH budget (good), but couples that necessary
increase to some very bad ideas, such as doing exactly what Sipp warns against, 
letting the FDA approve off-label uses of drugs without a randomized clinical
trial. It would also weaken patient protections in clinical trials, increase the
number of things drug companies can pay doctors for without having to report it
to the government.

The central assumption behind the bill is that, for greater medical innovation
at a lower cost to let the medical advances flow to a grateful populace, the FDA
needs to be reined in. Of course, what the best level of regulation is to
balance cost and time to approval versus guaranteeing the safest, most
efficacious devices and drugs, is unknown. It’s such a seductive idea, and you
don’t have to be a nutty government-hating libertarian to feel the attraction.
The idea seems so…logical.

Here’s the problem. The premise is wrong. It turns out that such radical reform 
involving weakening the FDA is not needed. The FDA already has the tools to do
what the 21st Century Cures Act demands without weakening patient protections or
scientific rigor. In fact, the FDA, despite being underfunded, is actually
pretty efficient at new drug approvals, evaluating nearly all new drug
applications within 6 to 10 months, an impressive turnaround for such complex
assessments. It’s been pointed out that the FDA actually acts more rapidly than 
European regulatory agencies. Basically, there is no evidence that the FDA
hampers overall medical innovation, nor is there evidence that the FDA’s current
requirements lead to higher drug prices or cost lives. Unfortunately, the 21st 
Century Cures Act is cynical politics played to increase pharmaceutical company 
profits. It is not, nor has it ever been, about protecting patients. Although
its advocates genuinely believe that its purpose is to bring cures faster to
patients who need them, the 21st Century Cures Act will do no such thing, and
tying changes in the FDA regulatory framework to increasing NIH funding is the
ultimate cynical political ploy to gut the FDA and turn back the clock on drug
development at least 50 years.

I also look for the 21st Century Cures Act to be resurrected yet again in 2017. 
Yes, this is speculation, but educated speculation, I think, based on the
general anti-regulatory bent of the Republican Congress and Trump himself. As
for the NIH itself, last year Trump appeared on Michael Savage’s radio show,
where in response to Savage suggesting that if Trump wins he’d like to be
appointed head of the NIH (!) Trump said:

   Well, you know you’d get common sense if that were the case, that I can tell 
   you, because I hear so much about the NIH, and it’s terrible.

Even though it’s fairly obvious that Trump was probably either just joking about
appointing Savage as NIH director or just stroking his host’s ego, this is not 
the sort of statement that makes me, as a medical scientist, feel all warm and
fuzzy. Remember, Michael Savage weathered a controversy in 2008 in which he
blamed “99% of the cases of autism” on “lax parenting.”

Which brings us to vaccines.

Antivaccine activists petition Donald Trump

After the first Republican debate last year, I extensively documented Donald
Trump’s long history of making antivaccine remarks in which he stated some
variation of how it’s a “monster shot” that causes autism. Basically, I’ve been 
documenting Donald Trump’s antivaccine statements for close to a decade now,
since I first encountered him making such statements in 2007. I’ve frequently
said that, given how many times Trump has changed positions on so many issues,
his antivaccine views represent arguably his most consistent belief, one that
hasn’t changed since at least 2007.

Now take a look at this photo:

Yes, that is our President-Elect. according to antivaccine blogger Levi
Quackenboss (whom we’ve met before), in August, Donald Trump met with the most
famous antivaccine zealot in the world, Andrew Wakefield. (I’d say that Donald
Trump is the most famous antivaccinationist in the world, except that so few
people seem to be aware of his antivaccine views.) It also slipped by under my
radar when Wakefield posted this video to Facebook in August:

Yes, antivaccinationists—at least many of them—love Donald Trump. Love him. For 
example, our good buddy and antivaccine conspiracy theorist, Jake Crosby, whom I
like to refer to as Young Master Crosby (or, if I’m on Twitter, The Gnat), has 
been posting Hillary for Prison graphics, urging people to donate to the Trump
campaign, and generally worshiping the ground Donald Trump walks on. Before the 
election, he posted this Tweet about me:

Post-election @Gorskon and (S)Mellody Hensley. #MAGA pic.twitter.com/8akeCBZWNe

— Deplorable Jake, MPH (@JakeLCrosby) September 10, 2016

He then reposted it after the election:

@gorskon Over the wall you go. https://t.co/ZE5RXs22k8

— Deplorable Jake, MPH (@JakeLCrosby) November 10, 2016

He apparently didn’t realize that I had been in Mexico at the time on vacation. 
He also posted a gloating post, Deplorables prevail!!! Elsewhere, a man every
bit as deranged as The Gnat, Mike Adams, has been delivering a steady stream of 
pro-Trump propaganda, along with his other pseudoscience, quackery, and lies,
for several months now. Since the election, he’s been practically giddy with
glee over Trump’s victory.

You get the idea.

Here’s how Quackenboss characterized the meeting:

   The most important promise came at the end of their meeting when someone
   said, “Donald, you are the only one who can fix this.”

   And Trump said, “I will.”

   He will fix this.

   Fixing this is not rocket science. Hell, it’s not even vaccine science. He
   will fix this. It is entirely fixable, and he appreciates our advocates
   lending their assistance in getting it done.

   Friends, we have a direct route to stopping this madness. Can you imagine
   that for a second? Can you just imagine having vaccine education advocates
   getting face-time with the person who appoints the director of the CDC?

   Trump asked for a follow-up with our side. They are giving him advice on how 
   to help us.

Elsewhere, Kent Heckenlively, who normally blogs regularly over at the
antivaccine propaganda blog Age of Autism but now seems to be posting more over 
at a particularly nutty website, the one run by Patrick “Tim” Bolen, also
commented on the meeting between Trump and Wakefield. Basically, it’s a tease
for his latest book, INOCULATED: How Science Lost its Soul in Autism, a brief
excerpt. It doesn’t say explicitly, but it sounds as though the meeting with
Trump on August 11 in Florida was arranged by Gary Kompothecras, a Florida
chiropractor, who first met Trump at the Statesman of the Year dinner put on by 
the Sarasota Republican Party on August 26, 2012. Kompothecras is very wealthy
and has a history of using his wealth to promote antivaccine causes in Florida
and bullying Florida health officials on behalf of the father-son duo of
antivaccine “scientists,” Mark and David Geier. If Kompothecras and
Representative Bill Posey (R-FL), the latter of whom is known for promoting the 
“CDC whistleblower” conspiracy theory, were involved in setting up this meeting,
it would explain a lot.

After the election, Quackenboss gave voice to all the antivaccine activists
hoping that Trump will do what they want him to do, in the form of an open
letter, @realDonaldTrump A letter from parents of the vaccine injured.

Some key demands:

   1. Drain the swamp we call the CDC. Drain it of corruption, corporate
   influence, and public policies that fly in the face of health. Hell, drain it
   of all funding—you wouldn’t be the first to say it should be done. Nobody
   needs a billion dollars of Zika money in the United States. Nobody needs an
   ebola vaccine. The CDC has grown into a fear mongering monstrosity not worthy
   of having access to speak to the American people. Take vaccine safety away
   from the CDC and set up an independent agency to monitor it. If there is
   anyone who deserves to be grabbed by the private parts, it’s the CDC. At
   minimum, appoint a CDC Director who understands that health does not come
   from a needle and that food is medicine, and who is willing to build a
   national health foundation on giving access to truth.

Given Donald Trump’s famous penchant for eating McDonalds and Kentucky Fried
Chicken, so much so that during the campaign it was noted that he was hoping to 
become the nations “fast food president,” I couldn’t help but laugh out loud
when I read that last sentence. Be that as it may, though, the ignorance in that
paragraph is appalling. There is little evidence of any serious corruption at
the CDC. (Hint: Denying a vaccine-autism link and promoting vaccination are not 
signs of corruption. Science does not support a vaccine-autism link, but does
support vaccination as one of the best strategies to keep children healthy.)

As for setting up an independent agency to monitor vaccine safety, Quackenboss
really is living in a fantasy world. She thinks that starting a new bureaucracy 
is cheap and easy. However, the CDC has been tracking vaccine safety for
decades. It has the infrastructure. It has the expertise. It has the personnel. 
Under Quackenboss’ fantasy, there’d be a new federal bureaucracy, and she thinks
it could be set up without significant startup costs and a huge learning curve.
For what purpose? It is an article of faith among antivaccine activists that
the CDC is hopelessly compromised by pharmaceutical company influence. It’s a
massive exaggeration. No one is saying that the CDC is perfect or that it
doesn’t screw up from time to time. It’s an organization composed of human
beings. By and large, though, it works, and this is definitely a case of, “If it
works, don’t fix it.”

Then, of course:

   4. Publicly acknowledge the CDC Whistleblower investigation.

Yes, antivaccine activists are still flogging that conspiracy theory, the
subject of a film by Del Bigtree and Andrew Wakefield, VAXXED, an antivaccine
propaganda film disguised as a documentary, a film so unsubtle and over-the-top 
that that Leni Reifenstahl, were she alive, would likely say, “Genug!” or even
“Mehr als genug!” (I know, I use that joke too much, but, damn, it’s
appropriate.)

More dangerously, she also wants Trump to scale back the recommended vaccine
schedule and appoint antivaccine advocates to the Advisory Committee on
Immunization Practices (ACIP). Unfortunately for this trope, the ACIP, as I’ve
discussed before, has strict rules about conflicts of interest. Potential
members are rigorously screened for such conflicts, and stringent measures are
taken not only to assure technical compliance with ethics statutes and
regulations regarding financial conflicts but also to address more general
concerns regarding any potential appearance of conflict of interest.

Fortunately, I highly doubt that much, if any, of these demands will come to
fruition. The most important reason is priorities. President-Elect Trump and the
Republican Congress have far bigger fish to fry, such as “repealing and
replacing” Obamacare (which will turn out to be far more difficult than they
think), slashing taxes and spending, gutting environmental regulations, and the 
like. Even if Trump wants to do anything in line with his antivaccine beliefs,
it would be way, way down his list of priorities, so much so that he’d be
unlikely to get to it in the first two years, if ever. Also, government
bureaucracies, such as the CDC and HHS, are resistant to change. It would take a
concerted and prolonged effort to change the CDC in the way that Quackenboss
wants it changed. Again, fortunately, it’s highly unlikely that these issues are
high enough on Trump’s radar that he would want to spend the political capital 
necessary to accomplish it. Finally, vaccine mandates are the purview of the
states. No President can come into office and wave a magic wand to change them. 
Each state would have to do it on its own, which is highly unlikely to happen.

Still, it is disturbing that Trump holds these views and that he would meet with
an utter crank like Andrew Wakefield.

The upshot

There are lots of other health science related topics that could be impacted by 
Trump administration policies that I didn’t cover here, such as Mike Pence’s
opposition to embryonic stem cell research, statement that smoking doesn’t kill,
and lack of acceptance of the theory of evolution. Ditto the dire consequences 
of this election for women’s reproductive health. Those have been covered here
and elsewhere in detail. I intentionally focused on a handful of areas that I’ve
discussed the most in the past and that I haven’t seen discussed much
elsewhere.

My key concerns about the Trump administration focus on the potential for
neutering the FDA and leaving patients open to exploitation by drug companies
and bogus stem cell clinics and on whether Trump’s oft-stated antivaccine
beliefs will find their way into policy. My conclusions are, of course, educated
guesses at best, speculation at worst, but even so they worry me. I definitely 
believe that we are in for a weakening of the FDA and a loosening of drug
approval standards, both through the likely passage of a federal right-to-try
law and the sorts of policy embodied in the worst passages of the 21st Century
Cures Act. The only bright spot that I can see is that I doubt Trump cares
enough about vaccine policy to put any sort of sustained effort into tampering
with the CDC, although through his appointments to Secretary of HHS and the
director of the CDC he could still do serious mischief. Fortunately, school
vaccine mandates are state-level laws, and there is practically nothing he can
do about them unless he wants to invest serious political capital into passing
laws, for instance, tying federal funding to loosening of school vaccine
mandates, laws that even many Republicans would oppose vigorously.

We can’t yet know for sure what form Trump’s medical science policies will take,
but thus far they do not look good, and that’s even leaving aside what will
become of the ACA. Unfortunately, Donald Trump will be our President for the
next four years and will have a compliant Congress for at least the next two.
Those who advocate for science and public health should be very, very afraid.

On the other hand, maybe Dr. Harold Bornstein will be our new Surgeon General:



Dr. Harold Bornstein: Donald Trump’s doctor and next Surgeon General? (I keed, I
keed.)

That, at least, would be good for a few laughs to temper the pain medical
scientists and physicians will likely feel.

“Donald Trump’s presidential election win stuns scientists”

Jann Bellamy on November 10, 2016

Link



Scientists in the U.S. and from around the world are weighing in on Donald
Trump’s election as the next president of the most powerful country on earth:

   Trump will be the first anti-science president we have ever had . . . The
   consequences are going to be very, very severe.

Michael Lubell, director of public affairs for the American Physical Society in 
Washington, DC:

   I am simply stunned. . . Trump’s election does not bode well for science or
   most anything else of value.

Neal Lane, a Democrat who led the National Science Foundation and served as
White House science adviser under President Bill Clinton, now a physicist and
university professor at Rice University in Houston, Texas:

   It’s going to be critically important for researchers to stand up for
   science.

Jennifer Zeitzer, director of legislative Relations at the Federation of
American Societies for Experimental Biology in Bethesda, Maryland:

   I do breast cancer research for my PhD . . . Scared not only for my future
   but for the future of research and next years @NIH budget.

Sarah Hengel, a graduate student at the University of Iowa in Iowa City:

   This is terrifying for science, research, education, and the future of our
   planet . . . I guess it’s time for me to go back to Europe.

María Escudero Escribano, a postdoc studying electrochemistry and sustainable
energy at Stanford University in California:

   It’s going to badly tarnish the image of the United States . . . Roughly half
   of the population has voted for somebody who by almost any measure is unfit 
   to serve as president.

David Victor, a political scientist at the University of California, San Diego:

   The Paris Agreement without the US would live on, but the spirit and the
   international focus on one of the defining challenges of our time could get
   lost. And the economic opportunities for the US will get lost too . . . Not a
   good outcome for the US in that respect. Not a good outcome for the climate.
   Too early to tell how bad it will be, though. One can hear the world gasping
   for air.

Malte Meinhausen, senior researcher in climate impacts at the University of
Melbourne and the Potsdam Institute for Climate Impact Research:

   The result of the US presidential election is very worrisome on many counts, 
   including of course for climate negotiations. . . . The outcome of this
   election is clearly not the end of the world but the consequences for
   humanity are potentially dreadful.

Prof Jean-Pierre Gattuso, professor of biological oceanography at the Centre
National de la Recherche Scientifique, Sorbonne University and the Institute for
Sustainable Development and International Relations:

   To quote James Hansen, I fear this may be game over for the climate.

Michael. E. Mann, distinguished professor of atmospheric science at Penn State
University

Even the Chinese feel sorry for us:

   I feel sad for the United States and its scientists, and would like to
   welcome good scientists to work and live in China.

Yi Rao, a neuroscientist at Peking University.

[For more reactions from scientists, see here and here.]

Trump’s science-free campaign

According to Science, there has been almost no interaction between the
scientific community and the Trump campaign over the past 18 months and the
campaign didn’t do any outreach to the scientific establishment. Scientists say 
that one of Trump’s most important appointments will be the head of the White
House Office of Science and Technology Policy (OSTP). Dr. Neal Lane said that
this person will be influential in filling other science-related positions in
government, such as head of the Environmental Protection Agency (if it
survives), the Department of Energy, NASA, the National Institutes of Health,
National Oceanic and Atmospheric Administration (NOAA) and the National
Institute of Standards and Technology. All of these require Senate confirmation.
(The National Science Foundation head, France Cordova, has a six-year term,
which does not expire until 2020.)

Robert Cook-Deegan, a research professor at Arizona State University in Tempe,
is pessimistic about what the appointment to OSTP might (or might not) mean:

   For Trump, I’m not sure [the appointment] would matter, because there won’t
   be any ‘policy’ apparatus, but only traffic cops and damage control fire
   brigades. Science won’t get much attention, except when it gets in the way or
   bolsters support for a political priority.

STAT reports that former presidential candidate Dr. Ben Carson, who also wants
to repeal the Affordable Care Act, has called for the overturning of Roe v.
Wade, and disputed the theory of evolution, is a top candidate for head of
Health and Human Services in the Trump administration. Also in the running is
Newt Gingrich, who is not a scientist at all, and who is reportedly being
considered for Secretary of State as well. Politico confirms that Dr. Carson is 
a favored candidate to head HHS.

Dr. Cook-Deegan’s and his fellow scientists’ concerns are well-founded. How has 
President-elect Trump demonstrated his ignorance of science in general and his
denigration of medical science in particular? Let us count the ways.

Vaccination

Both David Gorski and our good friend Orac have done a masterful job of keeping 
up with Trump’s anti-vaccination rhetoric over the years, his belief in the “too
many, too soon” gambit, his promotion of the non-existent connection between
vaccination and autism, and the adulation of anti-vaccination cranks bestowed on
Trump. Despite all scientific evidence to the contrary, Trump has said he has a
“theory” that

   a little baby that weighs 20 pounds and 30 pounds gets pumped with 10 and 20 
   shots at one time, with one injection that’s a giant injection, I personally 
   think that has something to do with it

The “it” being autism. (The “10 and 20 shots at one time” is a perfect example
of how Trump simply fabricates the data to suit his whims.) He has said (or,
more likely, the staffer who filled out a questionnaire, said) that “we should
educate the public on the values of a comprehensive vaccination program,” but,
given his consistent anti-vaccination rhetoric and poor understanding of
immunization science, what a Trump “comprehensive vaccination program” would
look like is anyone’s guess.

Climate change

Trump has called climate change a “hoax” and a “money-making industry,” although
he does believe “there’s weather.” He has used scare quotes around the term
“climate change.” He has said he would dismantle the Environmental Protection
Agency, and “cancel” the Paris Agreement on climate change, a move that drew an 
open rebuke from several hundred top scientists. He vowed to repeal key EPA
regulations, including those on ozone pollution, the Clean Power Plan, and part 
of the Renewable Fuel Standard Program. He has said “perhaps” we should invest
in alternatives to fossil fuels and access to clean water. But he hates wind
turbines and greatly overestimated their effect on birds. He said that “Science 
will inform our decisions on what regulations to keep, rescind or add,” but
contradicts himself in the very next sentence by claiming that the “free market 
system will regulate the private sector.” In a 2012 tweet, Trump claimed,
falsely, that energy-saving light bulbs cause cancer.

According to Environment & Energy Daily, Trump has selected climate change
skeptic Myron Ebell to head his transition plans for the EPA and, such is his
devotion to ridding government of political insiders, Koch Brothers lobbyist
Mike McKenna to head the Department of Energy transition team.

Public health

According to the Kaiser Family Foundation, Trump does not have a position on
funding for Zika or on public health preparedness. In 2014, he tweeted that the 
U.S. should immediately stop all flights from Ebola-infected countries “or the
plague will start and spread” in this country. In fact, medical experts said
that suspending flights would hamper relief efforts and make controlling and
monitoring the flow of people to and from infected regions more difficult.

Trump’s promised repeal of the Affordable Care Act would leave approximately 22 
million Americans without health insurance. The ACA requires health insurers to 
cover many preventive services (such as vaccinations) without copays. Whether
Trump’s health plan would require preventive services at all, and, if so, under 
what conditions, is unknown.

He supports health savings accounts, which, unlike traditional health insurance,
have no controls over their use for unproven diagnoses and treatments. Previous
HSA bills introduced in Congress by Sen. Orrin Hatch, and supported by Sen.
Marco Rubio, have been larded with corporate welfare for the dietary supplement 
industry.

Reproductive health

Trump opposes abortion except to save the life of the woman or in the cases of
rape or incest; supports laws that would limit access to later term abortions;
would defund Planned Parenthood and make the Hyde Amendment permanent law.
Although he walked back his position that women who have abortions should be
punished, he has not changed his view that physicians who perform abortions
should be punished. He has said he will appoint U.S. Supreme Court justices who 
will overturn Roe v. Wade. He claimed that American women are getting abortions 
days before birth, a claim refuted by OB/GYNs.

Bogus health products

Trump started The Trump Network in 2009, a multi-level marketing scheme to sell 
nutritional supplements and weight-loss products. He promoted the scheme to
those affected by the economic meltdown as “an opportunity for you to make as
much money as you want.” Key to success, however, was not so much in selling his
dubious products, but in recruiting other sellers and earning commissions.
Trump’s “health” products included a multi-vitamin supposedly customized to the 
consumer’s needs based on an unvalidated mail-in urine test. There was also a
weight-loss program developed by a naturopath but exposed by a real registered
dietician as expensive and unhealthy. Trump sold The Trump Network in 2012.

Research

Scientific American reports that, while Trump has offered few details on
biomedical research policies, he said last year that he heard “terrible” things 
about the NIH. He has no clear position on stem-cell research, although Mike
Pence, the Vice President-elect thinks embryonic stem cell research is
“unconscionable” and “offensive” and has claimed, incorrectly, that the
usefulness of embryonic stem cell research is “obsolete.” Pence, of course,
famously denied a causal connection between smoking and cancer.

Immigration

Trump’s immigration policies, including a proposed ban on Muslims entering the
U.S. and plans to build a wall along the Mexican border, has researchers
concerned that foreign scientists could be dissuaded from working or studying
here. Kevin Wilson, director of public policy and media relations at the
American Society for Cell Biology, said that “at the very least it would put a
chilling effect on the interest of scientists from other countries coming here.”

Conclusion

It is indeed unfortunate that we will have scientific illiterates as our
president and vice-president for four years. Whatever actually happens during
his term, it remains incontestable that Donald Trump’s abysmal record of
ignoring and disparaging science, scientific evidence and scientific
institutions was there for all to see, and people voted for him anyway. It is
especially discouraging that some medical doctors supported a candidate for
president who so clearly disparages medical science and proven public health
measures. Some measure of his regard for physicians can be gleaned from the
“patently ludicrous” letter written by his oddball gastroenterologist declaring 
him the “healthiest individual ever elected to the presidency,” a declaration
met with widespread ridicule. Medicine is just part of the con for Trump.

Andrew Rosenberg, of the Union of Concerned Scientists and former senior
official at NOAA, says that, after this election:

   [s]cientists need to stand up and be heard . . . They can’t just hunker down 
   in their labs and say that they won’t get involved because the election
   didn’t go the way they wanted it to.

He’s right, and it’s not just scientists who need to “stand up and be heard”
when Trump, Pence and their anti-science allies trash science. We all do. The
defense of science and science-based medicine are more important than ever.
We’ll be watching.

Medical science policy in the U.S. under Donald Trump eighty days in

A week after Donald Trump was elected, I speculated about how he would affect
medical science policy. Now, 80 days into the Trump administration, we have some
observations.

David Gorski on April 10, 2017

Link



From the moment that Donald Trump was unexpectedly elected President, I couldn’t
help but be concerned about what President Trump would mean for medical science
and science in general. I was not alone in my concerns. Of course, now, five
months later, we know that such concerns were quite valid. If funding is a
primary indicator, then, if anything, my concerns expressed last November were
understated. For example, in his first budget, Trump proposed cutting the
National Institutes of Health (NIH) budget by 19%, and, then, not content with
that, proposed cutting $1.2 billion from this fiscal year’s NIH budget, even
though the fiscal year was half over at the time. None of this even takes into
account the massive proposed cuts at the Environmental Protection Agency (EPA)
and many other agencies responsible for federal science policy. It looks as
though we are entering a grim time for US science funding. Even though there is 
almost no Congressional support for massive cuts to the NIH, the Trump
administration has signaled its intent, and there likely will nonetheless still 
be pain.

There are three places where the “rubber meets the road” when it comes to health
and science policy. One is the director of the Centers for Disease Control and 
Prevention (CDC), but Trump hasn’t appointed one yet. I know that when Robert F.
Kennedy, Jr. announced that he had met with Donald Trump the first fear I had
was that Trump was going to tap him for the CDC. Fortunately that didn’t happen,
but the fact that I briefly feared that Trump might have picked RFK, Jr. gives 
you an idea how much Trump’s long, sordid history of antivaccine emanations
coupled with his having met with antivaccine activists like Andrew Wakefield and
RFK Jr. actually worries those of us who promote science-based medicine. Given 
that last week the Senate held confirmation hearings on Dr. Scott Gottlieb,
Trump’s nominee for FDA commissioner, I thought that it was a good time to
revisit the topic of health and biomedical science policy as it’s shaping up
under Donald Trump. Any such policy first involves a brief discussion of the
Department of Health and Human Services (HHS), because the federal agencies
devoted to health and biomedical science policy fall under its purview. What we 
can expect, based on the rhetoric coming out of the Trump administration and
Congress, as well as Trump’s picks for key agencies, is increasing deregulation.
I’ll then look at the FDA and Scott Gottlieb again in light of recent
developments.

Whither HHS under Trump?

HHS is a sprawling Department, with a budget of over $1 trillion. Most of that
budget derives from the fact that HHS is the department that administers
Medicare and Medicaid, but HHS also encompasses such critical agencies as the
FDA, NIH, CDC, Agency for Healthcare Research and Quality (AHRQ), and Health
Resources and Services Administration (HRSA). Also, the HHS is the department
that administers the Affordable Care Act (colloquially called Obamacare) that
Republicans promised to “repeal and replace” but failed to do so.

Unsurprisingly, President Trump tapped an ultraconservative Congressman, Dr. Tom
Price, to run HHS. Price, as you might recall, belongs to an ultraconservative 
physician advocacy group masquerading as a professional society, the Association
of American Physicians and Surgeons (AAPS). The AAPs, you might recall,
fetishizes physician “autonomy” and the “patient-physician relationship” above
all else, which doesn’t sound bad on the surface, until you realize that this
stance is married to an extreme anti-regulatory stance that opposes nearly all
constraints, particularly government constraints, on physician “autonomy” and a 
free market fundamentalist approach to health care that views government funding
and regulation as illegitimate or even unconstitutional. The AAPS also
encourages “brave maverick doctors” to “challenge” the scientific consensus,
even if it means quackery and pseudoscience.

This is easily demonstrated by perusing its official “journal” (if you can call 
it that), the Journal of the Association of American Physicians and Surgeons
(JPANDS). As I’ve discussed many times before, JPANDS publishes a wide variety
of antivaccine pseudoscience, including the vile claim that shaken baby syndrome
is a misdiagnosis for “vaccine injury.” Indeed, it also has published papers in
support of a link between abortion and breast cancer, a link that is not
supported by science, as well as papers promoting HIV/AIDS denialism. Indeed, as
Kathleen Seidel noted, the descriptors of articles published in JPANDS are
often quite indicative of the political and ideological stance of the
organization: Criminalization Of medicine, eco-imperialism, government
arrogance, incremental socialism, left illusions, medical herdology, physician
slavery, police state of medicine, and, of course, socialized medicine. Indeed, 
AAPS very much views itself as an organization of doctors who don’t “follow the 
herd,” and heaps scorn on anything it views as following the herd, viewing
evidence-based medicine in such terms and rejecting physician peer review as an 
unacceptable affront to physician autonomy.

Unfortunately, worshiping not “following the herd” leaves the organization open 
to a lot of pseudoscience, and it hasn’t stopped. Indeed, in the Winter 2016
issue, JPANDS featured an outrageous bit of antivaccine pseudoscience, and its
most recent issue features a new article promoting the debunked link between
abortion and breast cancer, an article very similar to one I deconstructed seven
years ago.

To be fair, I must point out that just because Dr. Price belongs to the AAPS
does not necessarily mean that he ascribes to its views. Indeed, during his
confirmation hearings he appeared to reject the claim that vaccines cause
autism, but he was perhaps less forceful than one would like to see in a nominee
for HHS Secretary:

   “Do vaccines cause autism?” Menendez asked Price during Tuesday’s hearing,
   the first time the issue had been raised with the HHS nominee during his
   confirmation.

   “I think the science in that instance is that they don’t,” Price said. He
   went on: “But there are individuals in our country who are very —”

   Menendez cut him off.

   “I’m not asking about individuals,” he said. “I’m asking about science.”

So, yes, Dr. Price knows the words to speak, but he couldn’t resist trying to
talk about anecdotes and the parents who fervently believe that vaccines cause
autism. The press immediately portrayed this as reassurance that Price is not
antivaccine, but I’m not so reassured. I’ve seen antivaccine-sympathetic
physicians say basically the same thing, as in, “The science says that vaccines 
don’t cause autism, BUT…”

Since then, Price seemed to waffle a bit on the issue of requiring vaccines:

   In an interview with CNN Wednesday night, Tom Price was asked, “should it be 
   required, measles, mumps, those kinds of immunizations?”

   “I believe it’s a perfectly appropriate role for the government, this happens
   by and large at the state-government level, because they’re the ones who
   have the public-health responsibility … to determine whether or not
   immunizations are required for a community population.”

On the one hand, as has been noted, this could be interpreted as a simple
statement of fact, because states are responsible for passing laws on school
vaccine requirements. On the other hand, most states use the guidelines
published by the CDC to determine the vaccine requirements for school entry; so 
Price’s answer could also be interpreted as a bit of a dodge, which is how I
interpret it, because he basically pointedly omitted support for any federal
role.

Just yesterday in his weekly Daily Beast column, Dr. Paul Offit also noted that 
one of Dr. Price’s answers during his confirmation hearing testimony suggested
that he was open to further weakening the already weak regulation of
supplements:

   On January 18, 2017, then Congressman Tom Price (R, Georgia) testified before
   the Senate Health, Education, Labor and Pensions Committee. Price was Donald
   Trump’s pick to serve as Secretary of the Department of Health and Human
   Services. Not surprisingly, most of the questions—and most of the media’s
   attention—centered on Price’s views on the Affordable Care Act. One question 
   and answer, however, went entirely unnoticed.

   “One of the essential duties of the HHS Secretary is to be diligent and
   thoughtful when considering if federal regulation is necessary,” said Orrin
   Hatch (R, Utah). “Do you recognize dietary supplements in helping reach and
   maintain healthy lifestyles?” Price answered without hesitation.
   “Absolutely,” he said.

   Given his efforts on behalf of the dietary supplement industry two decades
   earlier, Hatch’s question was predictable.

Orrin Hatch, as I have noted, is basically the supplement industry’s lapdog,
which should not be surprising given that Utah is the supplement manufacturing
capital of the US. So is Rep. Jason Chaffetz, by the way, as he also comes from 
Utah.

In any event, Dr. Offit rattles off a long list of how even the weak regulation 
of supplements by the FDA mandated in the Dietary Supplement and Health
Education Act (DSHEA) is inadequately enforced and has resulted in harm,
concluding:

   Most people assume that when it comes to dietary supplements, someone is
   watching. But they’re not. And until the FDA regulates this industry, people 
   purchasing dietary supplements from a health food store are doing so at their
   own risk.

   Tom Price, the new Secretary of Health and Human Services, which includes the
   FDA, could do something about this if he chooses. Unfortunately, given his
   response to Orrin Hatch’s question during his confirmation hearing, it
   doesn’t sound like he’s interested.

So when it comes to health policy, the person in charge of the vast majority of 
what the federal government does in this area is someone whose commitment to
science is questionable, as evidenced by his wishy-washy answers about vaccines 
and his apparently enthusiastic buy-in to the idea that supplements are
wonderful for health. Granted, he could just have been currying favor with Sen. 
Hatch, but that he wouldn’t even include a little bit of skepticism in his
remarks suggests otherwise.

Of course, the FDA is where any changes in policy and regulation will be
crafted. So let’s revisit Scott Gottlieb, Donald Trump’s pick for FDA Secretary.

The least bad pick for FDA: A real, honest-to-goodness pharma shill

When I last discussed the candidates under consideration by the Trump
administration for FDA Commissioner, I reserved most of my alarm for the two who
are cronies of technolibertarian Peter Thiel, a man known for his belief in a
technological singularity and all the woo that goes along with it, including
parabiosis, to which Steve Novella has referred as “the next snakeoil.”
Basically, it’s another “fountain of youth,” that postulates that the blood of
the young (or, in this case, plasma) will reinvigorate and reverse aging in the 
old. The two candidates favored by Thiel included Balaji Srinivasan, CEO of
bitcoin start-up 21.co, and Jim O’Neill, the managing director of investment
firm Mithril Capital Management. O’Neill is on record as having suggested that
the FDA should not require evidence of efficacy before approving drugs, only of 
safety. In other words, O’Neill wanted to party like it’s 1959, which was three 
years before the Kefauver amendment to the law covering the FDA that said drugs 
must be proved safe and effective before they can be sold. Unfortunately, Balaji
Srinivasan out did O’Neill in the deregulation department, having argued on
Twitter that a “Yelp for drugs” would be a great way of ensuring that marketed
drugs are safe and effective. It’s hard to imagine anyone more deluded when it
comes to how the FDA functions and has stated that the FDA has been responsible 
for “many deaths” due to overregulation. Srinivasan quickly fell out of favor
because he was too out there even for Trump.

So, not surprisingly, when Trump ultimately decided to tap the ultimate pharma
shill, Scott Gottlieb, to be the FDA commissioner, there was a collective sigh
of relief in the press and pharma, given Trump’s previous statements accusing
pharma of “getting away with murder” by charging high drug prices and, of
course, the fact that Jim O’Neill and Balaji Srivinasan were under
consideration. Truly, my fears about the Trump effect on medical science were
not unfounded. On the other hand, the FDA definitely dodged a bullet, as
behind-the-scenes Thiel had been pushing hard for O’Neill, Srivinasan, or
another radical pick to remake the FDA:

   Behind the scenes, the process leading to Gottlieb’s selection was far more
   colorful than the announcement suggested.

   Trump supporter Peter Thiel, an iconoclastic billionaire, had been pushing
   hard for a far more radical pick to head the FDA.

   Thiel had Trump’s ear, and pitched him on two Silicon Valley libertarians who
   had publicly questioned the core mission of FDA. (One suggested the FDA need
   not ask for proof that a drug worked before releasing it onto the market.
   Another mused that the agency could perhaps be replaced with a consumer
   review site, a sort of Yelp for drugs.)

   The Trump team seemed to toy with the idea of turning the agency on its head 
   with such a pick.

In fairness, Gottlieb is the sort of nominee that might be expected of any
conservative Republican administration, a very industry-friendly and
regulation-unfriendly sort of bureaucrat who’s served in the FDA before as
Deputy Commissioner for medical and scientific affairs under the George W. Bush 
administration. During his actual tenure at the FDA as Deputy Commissioner, he
had so many financial conflicts of interest with pharma companies that he had to
recuse himself from resource planning for a potential bird flu epidemic because
of his financial ties to Sanofi-Aventis, as well as work related to Eli Lilly, 
Proctor & Gamble, and, yes, five—count ‘em, five!—other drug companies. After
leaving the FDA, the situation has only gotten murkier, with Gottlieb’s now
having ties to at least 25 pharmaceutical companies, including GlaxoSmithKline, 
Bristol-Myers Squibb, and Vertex Pharmaceuticals. If that’s not a real pharma
shill, I don’t know what is. If that’s not enough to convince you, then take a
look at some of Gottlieb’s activities when last he was in a position of
authority at the FDA:

   When three people in a multiple sclerosis drug trial lost blood platelets and
   one died, he called stopping the study “an overreaction” because the disease
   not the drug might be to blame.

   And when FDA scientists rejected Pfizer’s osteoporosis drug candidate Oporia,
   forecast to earn $1 billion a year, underlings received accusatory emails
   from Gottlieb.

   His on-to-Wall-Street approach succeeded in rushing Chantix, Pfizer’s stop
   smoking drug, varenicline, to market but a string of 2006 suicides and the
   violent death of Dallas musician Carter Albrecht leave many asking if that
   was such a good thing.

   “The truth is, the FDA’s required trials reveal limited information,”
   Gottlieb wrote presciently in an oped in the Chicago Tribune in 2005. “In
   many cases, it is only afterdrugs are on the market for many years and given 
   to thousands of patients that their true benefits (sic.) are revealed.”

Which is, of course, true, but not an argument for less rigorous pre-approval
evidence but rather more rigorous post-approval surveillance. Indeed, Gottlieb
is very much in favor of loosening regulations regarding off-label marketing of 
pharmaceuticals and has a history of arguing for such marketing during his
previous stint at the FDA, even going so far as to refer to regulations against 
off-label marketing as an affront to the free speech of corporations. The term
“off-label” refers to marketing a drug for an indication for which it is not
FDA-approved but for which there is evidence of efficacy and safety. Physicians 
not-infrequently prescribe off-label. Although there is a debate about whether
off-label prescribing is appropriate and when, there is also little doubt that
in some cases it is justified. What is less controversial is that drug companies
should not be allowed to advertise off-label uses of their products; indeed,
off-label marketing is illegal. Not surprisingly, pharmaceutical companies have 
found ways to get around the prohibition on off-label marketing and continue to 
push against the prohibition with some success.

As I said, Gottlieb is probably the “least bad” choice of the options under
consideration for the job of FDA Commissioner, and big pharma appears to love
him, as does a group known for being closely aligned with the interests of big
pharma, the food industry, and the chemical and pesticide industries that sees
“chemophobia” even where it doesn’t exist, the American Council on Science and
Health (ACSH), whose president Hank Campbell and senior fellow of biomedical
science Alex Berezow fell all over themselves in a column in USA TODAY praising 
Gottlieb:

   The tougher regulations drag out approval times, increasing research and
   development costs. All the while, the patent clock is ticking. Once FDA
   approval is granted, companies must charge as much as possible to recoup
   their investment, driving up drug prices.

   The higher regulatory cost also prevents the growth of startup biotechnology 
   and pharmaceutical firms. Today, startups that are developing a promising new
   drug simply cannot afford clinical trials, so they hope to be bought up by a
   larger company. The result maintains the status quo in the marketplace,
   stacking the deck in favor of Big Pharma.

   Gottlieb’s instinct toward deregulation could help reverse this trend,
   evening the playing field for new companies. His commitment to science-based 
   policies is another reason to applaud his nomination.

I’ve pointed out before that it’s a myth that deregulation evens the playing
field for new companies. In actuality, smaller companies prefer a strong FDA
because they can’t compete in marketing muscle. They can, however, compete once 
they obtain FDA approval.

Also, as I’ve discussed many times before, it’s a myth that the FDA is slow at
approving drugs or that its requirements are particularly onerous compared to
other industrialized countries. Indeed, I’m not the only one to have pointed out
that the FDA in general approves drugs faster than Europe. President Trump’s
promise to cut 75% of FDA regulations is frightening in this context, but
fortunately likely too radical to be accomplished even with a Thiel crony in
charge.

Gottlieb, at least, appears more conservative, not politically, but in how he
will do things. Even so, there are other reasons for concern. For instance, one 
aspect he shares with Jim O’Neill is a belief that drugs should be approved
based on their effects on surrogate markers. However, as I’ve described,
surrogate markers often don’t correlate with efficacy. FDA data bear this out,
as described in a BMJ feature article last week:

   The FDA report on 22 case studies, however, though primarily concerned with a
   defense of phase III trials, also includes a strong rebuttal to Gottlieb’s
   portrayal of the power of surrogate endpoints.

   “While biomarkers have many important uses in clinical practice and product
   testing, most have not been shown to reliably predict clinical outcomes.”
   They cite six cases, noting that “promising biomarker data in phase II do not
   necessarily translate into effective product performance.” One such case was
   torcetrapib, a drug Pfizer called the “most important new development in
   cardiovascular medicine in years.”20 Phase II studies had shown that it
   increased “good” high density lipoprotein cholesterol levels and lowered
   “bad” low density lipoprotein cholesterol. A phase III study confirmed these 
   findings. But Pfizer ended its development program after another phase III
   study with over 15 000 participants found that those receiving torcetrapib
   “were 25% more likely to suffer a major adverse cardiac event, and were 58%
   more likely to die from any cause,” than those taking placebo. Both results
   were statistically significant.

   Joseph Ross, associate professor of medicine at Yale University, concurs with
   the FDA report, noting that though some surrogate markers, such as viral
   load for HIV therapies, have proved reliable, many others are problematic.
   “Those used for regulatory approval of therapies for diabetes, cardiovascular
   disease, cancer, and many more have only been found to be weakly, or even
   not all, predictive of clinical outcomes after further study. If the FDA is
   going to continue to allow regulatory approval based on trials using
   surrogate markers of disease, there must be strong post-market requirements
   placed on manufacturers to complete studies that use clinical outcomes in
   order to ensure the clinical community understands the true benefits and
   risks of any approved therapy,” he says.

The FDA report basically describes 22 cases where phase II trials weren’t
confirmed by the results of phase III trials. The bottom line is that, while
some surrogate markers are very useful, in general surrogate markers are too
unreliable an outcome upon which to base drug approval.

This brings up other questions of how to speed up drug approval in the age of
molecularly-targeted therapies. To this end, Gottlieb has heaped love on
adaptive clinical trials. Such trials are designed so that the protocol can be
altered based on data collected during the trial. I’ve described one such trial 
before, the I-SPY trial, and the 21st Century Cures Act encourages adaptive
designs. Unfortunately, for all the buzz about adaptive trials, they are not a
panacea. In particular, biostatisticians fear:

   A recent survey of researchers’ attitudes toward adaptive trials—part of a
   National Institutes of Health and FDA-funded project on which Berry and
   Barsan collaborated—also found that biostatisticians were also generally less
   optimistic than other stakeholders about the validity of conclusions from
   adaptive trials. Some fear that dropping arms or changing randomization rules
   based on data in the trial will introduce problematic bias to the results,
   Berry says, though study conclusions can be adjusted to take potential bias
   into account.

In fairness, not everything about Gottlieb is questionable. If there’s one area 
where he shines it’s vaccines. Indeed, he’s quite pro-vaccine and has no truck
with antivaccine pseudoscience falsely linking vaccines to autism. Indeed,
antivaxers are referring to him as the “FDA vaccine stooge,” which leads me to
feel schadenfreude, given how much hope that antivaxers had had in Donald Trump 
after he was elected. Assuming Gottlieb is confirmed, my main consolation will
be responses like this:

This is Ginger Taylor, and antivaccine activist with whom I’ve butted heads
periodically over the last decade, citing the Twitter feed of a disappointed
Trump supporter. There is no need to worry that Gottlieb will pander to
antivaccine pseudoscience, and that’s a good thing. Whether that’s worth all the
other baggage is debatable. Still, it could have been much worse. On the other 
hand, Gottlieb also appears to support the cruel sham that is right-to-try, a
topic I’m likely to have more to say about next week or the week after.

The answer to everything: More deregulation and more ties with business

It is now five months after I expressed my concerns about what would happen to
federal health and biomedical science policy under President Trump. At the time 
I was very much afraid that much of what would happen would not be based on
science. In fairness, I will mention right now that thus far my worst fears
about vaccine policy have not been realized. Trump’s FDA pick is solidly
pro-vaccine, for instance, and even though Trump did meet with RFK Jr. there has
been no evidence that the “vaccine commission” about which RFK Jr. bragged is
anywhere near coming into being. On the other hand, the CDC director hasn’t been
appointed yet, and there’s still a part of me that fears it will be someone
like Andrew Wakefield or RFK Jr. I know that even Trump probably wouldn’t do
something like that, but I still can’t help but wonder. In any case, thus far
vaccine-related changes have not been as I feared. Thus far. On the other hand, 
we now know that deregulation is the order of the day for…pretty much everything
health-related. It probably won’t be as bad as I feared at the FDA with Scott
Gottlieb at the helm, and the FDA certainly dodged a bullet when Peter Thiel
failed to inflict his favored candidates on it, but there will be
pharma-friendly deregulation.

Even for the NIH, this attitude permeates the administration. For example, the
name of Dr. Patrick Soon-Shiong, the richest man in Los Angeles, a doctor and
entrepreneur who is worth an estimated $11 billion, had been floated to be NIH
director. (His name has also been floated for other science-related positions,
as well.) He’s undoubtedly a brilliant man. There’s no doubt about it. However, 
the myth making about him appears to have gotten ahead of his actual success
against cancer. For example, a couple of years ago he was profiled by 60 MINUTES
in what appeared to be more hagiography than profile, complete with a groaner
like, “A cancer is not what people think, cells growing. Cancer is actually the 
inability of the cells to die.” The way 60 MINUTES treated this statement as
some sort of brilliant, radical new insight into cancer was downright
cringe-inducing. The idea that defects in apoptosis (programmed cell death) are 
integral to cancer has been mainstream since before I was in graduate school 25 
years ago. Indeed, many of Soon-Shiong’s “radical” ideas are conventional,
something Matt Herper pointed out. That’s not to say that he might not be on to 
something with his computational approach to cancer, but whether he is or not
remains to be seen. He’s a philanthropist, too, but the main target of his
philanthropy appears to be companies and entities that he owns. He’s apparently 
no longer under consideration for the NIH, but it appears likely that he’ll have
some role in the administration.

To be honest, though, what concerns me more than the ideology that deregulation 
über alles will fix everything that ails medical research and drug regulation,
is the idea that the budgets of science agencies can be subjected to massive
cuts and still function adequately. For instance, in total dollars the NIH has
had budgets that have been flat or only slightly increasing for years, but in
inflation-adjusted dollars the NIH budget has decreased approximately 25% since 
2003. Similarly, I’ve often argued that there are no problems with the speed of 
FDA drug approval that couldn’t be greatly ameliorated with more money. Given
how important the FDA is, it’s been criminally underfunded for years.
Unfortunately, based on the first two and a half months of the Trump
administration, I fear that we are in for a rough time in biomedical science and
ensuring that our drugs and food are safe.

On the other hand, I can still hope that the new NIH director will be John
Ioannidis, can’t I?

Every accusation was a confession of what they wanted to do if they were to
attain power

On Friday, President Donald Trump signed an executive order that would shift
power over grantmaking away from career scientists to political appointees.
Lysenkoism 2.0 has been made official policy, and science in the US is in deep
trouble.

David Gorski on August 11, 2025

Link

I lamented in the comments of Steve Novella’s post this week how, every time I
sit down to write my weekly SBM post, I swear I will to try to write about
something else—anything else, like homeopathy, cancer quackery…anything!—but
inevitably something will have happened that compels me to write yet again about
the current administration, in particular our Secretary of Health and Human
Services Robert F. Kennedy Jr., and some new assault on science-based medicine, 
public health, and vaccination programs. It was tempting to write one more post 
about Dr. Vinay’s Prasad‘s troubled (and very brief) tenure as the FDA’s
Director of the Center for Biologics Evaluation and Research CBER), his downfall
and forced resignation, and, over the weekend, his seemingly miraculous
reinstatement as CBER Director, but then there was this story in Nature on
Friday:

US President Donald Trump issued an expansive executive order (EO) yesterday
that would centralize power and upend the process that the US government has
used for decades to award research grants. If implemented, political appointees 
— not career civil servants, including scientists — would have control over
grants, from their initial solicitation to their final review. The order is the 
latest move by the Trump administration to assert control over US science.

The new EO, titled “Improving Oversight of Federal Grantmaking”, orders each US 
agency head to designate an appointee to develop a grant-review process that
will “advance the President’s policy priorities”. Those review processes must
not fund grants that advance “anti-American values”, but prioritize funding for 
institutions committed to achieving Trump’s plan for ‘gold-standard science’.
(That plan, issued in May, calls for the US government to promote “transparent, 
rigorous, and impactful” science, but has been criticized for its potential to
increase political interference in research.)

Impacts might be felt immediately: the latest order directs US agencies, such as
the National Institutes of Health (NIH), to halt new funding opportunities,
which are calls for researchers to submit applications for grants on certain
scientific topics. They will be paused until agencies put their new review
processes in place.

You might recall that during the pandemic, the lament among contrarian
scientists and doctors was that any criticism of what they said or professional 
consequences that came about due to their promoting dangerous misinformation
represented not normal consequences for their words and behavior, but rather
their being “canceled,” “repressed,” or even “persecuted.” You might remember
the wailing and gnashing of teeth as these COVID-19 contrarians lamented that
their “freedom of speech” was somehow being “suppressed” and science hopelessly 
politicized by The Left. In particular, our new NIH director, Dr. Jay
Bhattacharya, long complained bitterly that his “freedom of speech” and
“inquiry” were being somehow violated when someone like Dr. Anthony Fauci
correctly perceived the document that he’d co-authored in October 2020, The
Great Barrington Declaration, as a scientifically unsupportable call for a “let 
‘er rip” approach to the pandemic in a futile bid to reach “natural herd
immunity” in 3-6 months that never would have worked (and didn’t work, despite
the revisionist history of Dr. Bhattacharya and his supporters claiming it did).
You might even remember that Dr. Bhattacharya has proclaimed loud and long that
he wants nothing more than “free speech” and “open debate” about science.

To that, I will say: With these people, every accusation was a confession of
what they wanted to do if they were ever to attain power. Moreover, in response 
to the contrived, self-proclaimed victimhood of such people, I like to answer
with a quote from Robert Evans, who does the Behind the Bastards podcast:

Yes. It sucks actually being oppressed, but pretending to be a victim of
censorship is great because you get all of the benefits of being a victim. You
get that sympathy, you get to feel like a hero, you get to make grand speeches
about how you won’t be silenced.

But you don’t actually have to face any consequences for any of your shitty
behavior, right?

Right, except in this case Jay Bhattacharya, Marty Makary, RFK Jr., et al are
facing the consequence of now being firmly in control of all non-military
federal health and biomedical science programs.

In fact, none of these “silenced” or “canceled” free speech warriors were really
“silenced” or “canceled.” Moreover, as you will see, with these people, every
accusation during the pandemic was in reality a confession of what they wanted
to do if they ever achieved power. They claimed that science was being
politicized, but, as this EO is the latest indication, now that they’re in power
they’re politicizing US science more than any other administration, Republican 
or Democratic, has ever done before. This is just the latest, though, given that
this administration immediately started canceling grants that funded science
that it did not like, again, something no administration has ever done before.

Remember, every accusation was (and is) a confession. I will be repeating that
mantra throughout this post.

It starts with a bogus rationale

I’m just going to emphasize again that this EO is bad. Very bad. At this point, 
I’m half-tempted to riff on the passage from The Hitchhiker’s Guide to the
Galaxy about how big space is, in order to emphasize how bad this EO is, but
I’ll leave that to Douglas Adams fans. Basically, this EO, if fully implemented,
would for the first time put political appointees entirely in charge of the
grant making process and completely subordinate career staff and peer review to 
political appointees. Don’t believe me? I will quote extensively from the
preamble to the EO:

By the authority vested in me as President by the Constitution and the laws of
the United States of America, and to improve the process of Federal grantmaking 
while ending offensive waste of tax dollars, it is hereby ordered:

Section 1. Purpose. Every tax dollar the Government spends should improve
American lives or advance American interests.  This often does not happen.
Federal grants have funded drag shows in Ecuador, trained doctoral candidates in
critical race theory, and developed transgender-sexual-education programs. In
2024, one study claimed that more than one-quarter of new National Science
Foundation (NSF) grants went to diversity, equity, and inclusion and other
far-left initiatives. These NSF grants included those to educators that promoted
Marxism, class warfare propaganda, and other anti-American ideologies in the
classroom, masked as rigorous and thoughtful investigation.

Let’s just say that the rationale used here is based on some rather questionable
sources. One notes that nowhere does this EO actually provide references for
these claims, although one can’t help but note that the usual non-science-based 
right wing hostility to transgender medicine is there. A bit of Googling quickly
revealed that the basis of the claim that one-quarter of new NSF grants went to
“DEI” programs was not as “study” at all, but a highly politicized report by
U.S. Senate Commerce Committee Ranking Member Ted Cruz (R-Texas). As for funding
“drag shows in Ecuador,” it is true that a small USAID grant ($20,600) was
awarded to Centro Ecuatoriano Norteamericano (CEN) in 2022 as part a public
diplomacy program. Whatever the policy merits or lack thereof that you might
perceive in such a grant, whose purpose was, according to the State Department, 
to “promote tolerance” and “provide new opportunities for LGBTQI+ Ecuadorians to
express themselves freely and safely,” I can’t help but note the obvious
overgeneralization (not to mention, a bit of a bait-and-switch). Basically, the 
administration is generalizing a tiny grant that was not a peer-reviewed science
grant as representative of huge swaths of federal science grants. Moreover,
USAID has been essentially disbanded, and this was a tiny grant. Again, even if 
you don’t think federal dollars should be spent on such programs, you must
realize how deceptive the rationale for this EO is.

Need more? How about this:

The harm imposed by problematic Federal grants does not stop at propagating
absurd ideologies.  An unsafe lab in Wuhan, China — likely the source of the
COVID-19 pandemic — engaged in gain-of-function research funded by the National 
Institutes of Health.  The NSF gave millions to develop AI-powered social media 
censorship tools — a direct assault on free speech.  Taxpayer-funded grants have
also gone to non-governmental organizations that provided free services to
illegal immigrants, worsening the border crisis and compromising our safety, and
to organizations that actively worked against American interests abroad.

First of all, notice the lie that accepts a version of the “lab leak” conspiracy
theory as though it were established historical and scientific truth. It is
not. It remains, despite years of advocates trying to put scientific varnish on 
a nasty conspiracy theory, nothing more than a conspiracy theory. As for
“AI-powered social media censorship tools,” one notes that the previous
administration was desperate to slow the spread of pandemic misinformation of
the sort spread by those now in charge of the entirety of the non-military US
medical, public health, and biomedical research infrastructure, which had been
turbocharged by social media algorithms. So what’s their answer? To abandon all 
attempts at controlling misinformation and then engaging in a vast censorship
effort of their own. As for that part about “illegal immigrants,” that has
nothing to do with scientific research and is just another bait-and-switch in
which grant-making policies that have nothing to do with science are used as a
pretext to bring scientific grant-making under the political control of the
administration, thus conflating grants given to further political policies with 
NIH grants that have traditionally been based on finding the best science
through peer review.

True, it does add:

Nothing in this order shall be construed to discourage or prevent the use of
peer review methods to evaluate proposals for discretionary awards or otherwise 
inform agency decision making, provided that peer review recommendations remain 
advisory and are not ministerially ratified, routinely deferred to, or otherwise
treated as de facto binding by senior appointees or their designees.  Further, 
nothing in this order shall be construed to create any rights to any particular 
level of review or consideration for any funding applicant except as consistent 
with applicable law.

Somehow, this does not reassure me, as it the EO is saying to do what federal
agencies that award scientific grants do: Routinely defer to study section
reviews and scores and treat them for the most part as de facto binding by
political appointees and their designees, which is how grants should be
reviewed. That’s how the NIH has emphasized funding the highest quality science.
Is the current system perfect? Of course not. Does it sometimes fund science
that isn’t the greatest? Obviously yes. Is what is being proposed more likely to
decrease the problem of funding science that might not be the greatest? That’s 
not just a “No,” but an “Oh, hell no!”

While one can read this EO in a way that doesn’t sound too horrible (with
difficulty), to me such a view is whistling past the graveyard of US science.
This EO is basically the formalization of what I’ve been calling the science and
medical policies of this administration: Lysenkoism 2.0. You remember Trofim
Lysenko, don’t you? He promoted a sort of Lamarckian version of genetics that
aligned with his belief in Communist ideology but, alas, did not actually align 
with the real science of genetics and, because Josef Stalin liked him and his
“science,” became so powerful that his view of genetics predominated in the
Soviet Union for three decades, leaving famines in its wake. As I’ve argued, RFK
Jr.’s “make America healthy again” (MAHA) movement is pure Lysenkoism; i.e,,
science whose underpinning is ideology rather than, you know, actual science.
The only difference now is that, in contrast to the one Trofim Lysenko running
Soviet agricultural science, we now have many Lysenkos running many areas of our
federal health and medicine infrastructure, and they do not limit themselves to
one area of science.

What’s happening at HHS goes far beyond the fears that I expressed when I first 
saw proposals for how to “reform” the NIH peer review process, as it
subordinates peer review to the political, making it purely advisory, to be
ignored completely if political appointees don’t like the research proposed.
Let’s start by reviewing how peer review has traditionally worked in
grant-making. I will use the NIH as the prototype, if only because, unlike the
case for the NIH, I have never applied for or garnered a National Science
Foundation grant, nor have I sat on a study section to participate in peer
review of NSF grant applications. Thus, I know a lot more about NIH grants and
the peer review process used at the NIH than I do the NSF, as I have directly
experienced it as an applicant, grant holder, and peer reviewer.

How the NIH actually reviews grant applications vs. President Trump’s executive 
order

I know I’ve written about this before, but I think it’s good to go over this
process again every now and then when it’s appropriate to the topic. At the very
least, it’s useful to compare and contrast how the NIH decides which grant
applications are funded now, compared to how the Trump administration appears to
want such decisions to be made.

I’ll start by reiterating that approximately 80% of NIH funding goes to funding 
extramural research grants (extramural=laboratories and research sites that are 
not part of the NIH, mostly universities and private research institutes).
Contrary to the conspiracist vision of Anthony Fauci—or any other Institute
director at NIH, or even the NIH director him or herself —personally viewing
every grant application and deciding who gets those sweet, sweet NIH dollars and
who does not, there is a long-defined, rigorous, and codified process used by
the NIH to evaluate grants applications. (Here’s another area where every
accusation was a confession, as you will see, given that the Trump
administration seems to want to convert the NIH grant process into political
patronage, with his underling Jay Bhattacharya, doling out the Godfather’s
favors in the form of grant money.)

The process begins with the submission of a grant to the NIH. The NIH has a
number of granting mechanisms designed for different purposes. For example, the 
R21 grant is designed for preliminary work, often the “higher risk” studies that
the brave mavericks demand, and doesn’t require a lot of preliminary data. (The
claim that it can require no preliminary data, however, is generally nonsense. 
You need at least some data.) R21s can fund up to two years and cannot be
renewed.

In contrast, the granddaddy of them all, the “gold standard” grant for an
individual investigator, small groups of co-investigators, or collaborators, is 
the R01, which can be funded for up to five years (it’s also one of the only
grant mechanisms where the investigator can propose basically anything, rather
than having to address a particular topic or question). At the end of that time,
the investigator can apply for a competitive renewal, which can extend the
grant for up to another five years, and so on ad infinitum. There are a number
of other grant mechanisms, which include training grants for graduate students, 
center grants (e.g., for cancer centers), larger multi-investigator grants, and 
more targeted grants—Wikipedia has a nice list here—but in general all of them
are scored by groups of scientists with the relevant expertise in a review group
called a study section, of which there are dozens in the NIH arranged by topic 
into Review Branches at the Center for Scientific Review. Many of these study
sections are permanent, but the NIH can and does set up temporary study sections
for topics of special interest at the time.

NIH grants generally undergo two levels of review, first the study section and
then advisory councils. To guide the reviews, the NIH has five criteria that it 
uses to evaluate grant applications:

  1. Significance

  2. Investigator(s)

  3. Innovation

  4. Approach

  5. Environment

Other considerations include “Additional Review Criteria”:

As applicable for the project proposed, reviewers will evaluate the following
additional items while determining scientific and technical merit and in
providing an overall impact score, but will not give separate scores for these
items.

  1. Study Timeline (specific to applications involving clinical trials)

  2. Protections for Human Subjects

  3. Inclusion of Women, Minorities, and Children

  4. Vertebrate Animals

  5. Biohazards

  6. Resubmission

  7. Renewal

  8. Revision

Additional Review Considerations. As applicable for the project proposed,
reviewers will consider each of the following items, but will not give scores
for these items and should not consider them in providing an overall impact
score.

  1. Applications from Foreign Organizations

  2. Select Agent

  3. Resource Sharing Plans

  4. Authentication of Key Biological and/or Chemical Resources

  5. Budget and Period Support

Grants undergo anonymous peer review, and usually each application is reviewed
by three or four reviewers, with one of them being a statistician where
appropriate (which is usually). Those assigned to do the detailed reviews score 
each of the above areas from 1-9. In this case low scores are better, denoting
high impact/priority. Reviewers also assign an overall impact score to the grant
application. During the study section meeting, the study section member
assigned as primary reviewer starts the discussion with a summary of the grant
application, the score assigned to it, and why that score was assigned. Then the
others who evaluated each grant application do the same, after which the whole 
study section discusses the application. At the end, every member assigns an
overall impact score to the grant under discussion before moving on to the next 
application. After the study section meeting, all the impact scores are used to 
calculate a final overall Priority Score assigned to the grant application.
Also, the membership rosters of the study sections are public knowledge.

Although I’ve never served as a permanent member of an NIH study section, on a
number of occasions I have served as an ad hoc member for specific expertise.
(Ad hoc members generally serve for only one or a handful of grant review
cycles, rather than being assigned for multi-year stints.) As such, I can only
comment on the dynamics of study sections in which I’ve participated. One thing 
that I’ve noticed is that it only takes one highly negative review from a
reviewer who is outspoken to tank an application. I’ve also noted that someone
who really likes a grant application can sway others to score it higher, but the
effect seems a bit weaker than “negative campaigning,” which seems more
effective in getting others to lower their scores.

When an individual grant application hits the NIH, it will be assigned to a
study section. Investigators can influence this process by suggesting study
sections, and, unsurprisingly, some study sections have reputations for being
harsher than others. Once a grant is assigned to a study section, that study
section’s Scientific Review Officer (SRO) will read it, decide if it’s
appropriate for the study section, and assign reviewers:

Assignment of Applications to Specific Reviewers: The SRO assigns applications
to particular reviewers by matching the science in the application to the
reviewer’s expertise. Assignment considerations include: reviewer knowledge
about, and interest in, the goals of the project; expertise in the techniques
proposed; reviewer workload; and real or perceived conflicts of interest. The
SRO encourages reviewers to let him/her know of any concerns that they have
about their assignments. This would include conflicts of interest, concerns
about the appropriateness of the assignment, or the need for additional
expertise.

The SRO also recruits scientists to serve on the study section, thusly:

Identifying and Recruiting Reviewers: Possibly the most important role of the
SRO is to ensure that the reviewers present at the study section meeting have
all the needed expertise to evaluate the applications under review.

In choosing regular members for study sections, it is essential that the SRO
recognizes current trends in the field and ensures that the membership reflects 
where the field is now and where it is going. It is also critical that the
expertise of each nominee complements that of the other members and strengthens 
the study section as a whole.

As you can see, the SRO is a big deal.

The SRO also runs the study section meeting, collates the reviews, takes notes, 
and from those notes and the overall reviews produces a Summary Statement that
includes the overall Priority Score assigned (with a percentile measurement
denoting the percentage of grant applications that were scored higher than the
applicant’s), comments about the discussion at the study section, and the
original “raw” reviews from each study section member who reviewed the grant.
Note that now generally only grants that score in the top one-third to one-half 
receive overall Priority Scores and Summary Statements, because any grant with
higher (and therefore worse) scores are so unlikely to be funded as to make it
not worth the SRO’s effort to put the documents together. These investigators
do, however, still receive the reviews carried out by individual study section
members. SROs also handle appeals from applicants who question whether their
review was fair or whether one or more of the reviewers had the requisite
expertise.

Now, imagine if SROs were to be political appointees whom the administration
could hire or fire at will and/or have to report directly to political
appointees. That is one consequence that I can foresee if this EO stands.

The second level of review occurs through committees formed at each Institute
and Center (IC) at the NIH called Advisory Councils:

The Advisory Council/Board of the potential awarding Institute/Center performs
the second level of review (See Advisory Councils or Boards). Advisory
Councils/Boards are composed of scientists from the extramural research
community and public representatives (NIH Federal Advisory Committee
Information). Members are chosen by the respective IC and are approved by the
Department of Health and Human Services. For certain committees, members are
appointed by the President of the United States.

Unsurprisingly, the Trump administration recently moved to dismiss new advisory 
council members appointed by the previous administration and instructed NIH
directors to nominate new members who will be aligned with the priorities of the
Trump administration, nominations that can be overruled by political
appointees, apparently not caring about this:

The researchers up for dismissal, who are based at academic institutions across 
the country, were all nominated during the administration of Trump’s
predecessor, Joe Biden, through a process that has been used for decades, but
had not yet taken up their positions. The move will leave advisory councils at
most of the NIH’s institutes understaffed, leaving them without a breadth of
expertise in making final decisions about which research projects the agency
funds.

The move throws away all the effort put into vetting those reviewers, says Eric 
Green, who was director of the NIH’s National Human Genome Research Institute
(NHGRI) for more than 15 years, until March, when his tenure was not renewed.
The NHGRI had 7 advisory council members vetted under Biden who have been
awaiting final approval, Green says. Without them, the institute’s panel will
have only 6 out of its potential 18 members. It’s unclear how long it will take 
to install new members. In the meantime, “to have it be that small is atrocious 
— you want these advisory groups to be robust because they’re taking the final
look at everything going to be funded”, Green adds.

In other words, the Trump administration is politicizing US science, and Dr.
Bhattacharya, for all his complaints about the politicization of science and
being in favor of “free speech,” will be the useful idiot who oversees this
process. Once again, every accusation was a confession of what they wanted to
do.

Now here’s the part where the conspiracy might come in:

Recommendation Process

  1. NIH program staff members examine applications and consider the overall impact
    scores given during the peer review process, percentile rankings (if
    applicable) and the summary statements in light of the Institute/Center’s
    priorities.

  2. Program staff provide a grant-funding plan to the Advisory Board/Council.
    Council members have access to applications and summary statements pending
    funding for that IC in that council round.

  3. Council members conduct a Special Council Review of grant applications from
    investigators who currently receive $1 million or more in direct costs of
    NIH funding to support Research Project Grants (see NOT-OD-12-140). This
    additional review is to determine if additional funds should be provided to 
    already well-supported investigators and does not represent a cap on NIH
    funding.

  4. The Advisory Council/Board also considers the Institute/Center’s goals and
    needs and advises the Institute/Center director concerning funding
    decisions.

  5. The Institute/Center director makes final funding decisions based on staff and
    Advisory Council/Board advice

It’s that last part that the conspiracy theorists harp on. In theory, an
Institute director could override all the peer review to fund a grant, but in
practice, thankfully, it almost never happens. Why? Because the NIH set up this 
process in order to minimize the possibility direct involvement of its leaders
in picking and choosing grant awardees based on personal whim. The whole system 
exists to try to ensure as much as possible that grant selection is based on
scientific merit, and few other considerations. What President Trump’s EO seems 
to be doing is to set up, at minimum, institute directors to feel free to
override peer review and fund grants with poor scores or refuse to fund grants
with high scores, all based on political considerations, or, as the EO puts it, 
to fund proposals that are “consistent with agency priorities and the national
interest” and that ” demonstrably advance the President’s policy priorities.”

Repeat again after me: Every accusation was a confession.

To sum it all up, at the NIH the system is set up to minimize the possibility of
personal and political biases playing a major role in funding decisions. Going 
along with the theme of this post, I will note that this is not new. Often the
people who were most prone even decades ago to characterizing NIH funding
decisions as the personal doling out of funding by directors are the same ones
who have no compunction about trying to shut down research they don’t like
themselves—and have been for a long time.

Add to this efforts by the NIH to minimize reputational bias, in which, all
things being equal, more highly ranked universities and researchers are more
likely to be funded than researchers with a lower reputation or at a university 
with a lower reputation, and the system is complex, full of safeguards, and
designed to work as close to a meritocracy as possible. It is imperfect, of
course, and often doesn’t achieve that goal, but you can’t convince me that
anything in this EO will reform the system to make it closer to a meritocracy,
rather than closer to a kakistocracy.

But, but, but… supporters of Trump might say, pointing to this part of the EO:

Even for projects receiving Federal funds that serve an ostensibly beneficial
purpose, the Government has paid insufficient attention to their efficacy.  For 
example, a significant proportion of the results of federally funded scientific 
research projects cannot be reproduced by external researchers.  Even at Harvard
and Stanford, once considered among America’s most prestigious universities,
senior researchers have resigned following accusations of data falsification.  A
substantial portion of many Federal grants for university-led research goes not
to scientific project applicants or groundbreaking research, but to university 
facilities and administrative costs.

Yes, President Trump went there, but you can be sure that a concern about the
“reproducibility crisis” is not why this rationale has been added. It’s barely
mentioned after this, with only one bullent point in the EO addressing it:

To the extent institutional affiliation is considered in making discretionary
awards, agencies should prioritize an institution’s commitment to rigorous,
reproducible scholarship over its historical reputation or perceived prestige.  
As to science grants, agencies should prioritize institutions that have
demonstrated success in implementing Gold Standard Science.

As we have discussed, Gold Standard Science is a buzzword that this
administration came up with and that its useful idiot appointees, from Dr. Marty
Makary to Dr. Jay Bhattacharya to Dr. Mehmet Oz to everyone else involved in
the dismantling of US federal scientific infrastructure parrots as though it
means anything. It certainly doesn’t mean what it sounds like it means; i.e.,
actual “gold standard science.” As for the reference to the “replication crisis”
or “reproducibility crisis,” I have long argued that it’s not a “crisis,” but a
problem that is often overblown in order to cast doubt upon science that is
supported by strong evidence and experimentation. Don’t misinterpret us; we
don’t deny that it’s a problem and that more effort should be devoted to
ensuring reproducibility of scientific findings, findings that are the result
particularly taxpayer-funded scientific research. It’s just that we see through 
the transparent attempt by this administration to weaponize problems with
replication in the service of dismantling and politicizing US science under the 
guise of only being about “gold standard science” (which I refuse to capitalize 
the way everyone in the Trump administration does).

We are witnessing the destruction of the NIH, NSF, and US federal science

Back in November, a couple of weeks after Donald Trump won the Presidential
election and soon after RFK Jr. was named his nominee to head HHS, I predicted
that we would get here, that what RFK Jr. wanted to do was to “replace
directors, managers, and scientists whom he doesn’t like with political
loyalists.” I don’t claim any great insight or ability to see the future; it’s
just that Trump, RFK Jr., and all their sycophants, toadies, and lackeys had
been making it crystal clear exactly what they intended to do for many months
before the election. Now, nine months after the election, the Trump
administration is doing exactly what I predicted. Again, this is not a surprise,
given that the entire infrastructure of debate bros, COVID-19 contrarians,
climate science denialists, antivaxxers, and wellness grifters who had glommed
onto Donald Trump’s campaign had been signaling that they wanted to do exactly
this for a long time before, even as they lamented to high heaven that their
speech was being “suppressed,” that they were being “canceled,” and even that
they were being “persecuted,” likening themselves to, of course, Galileo and
Semmelweis.

In reality, they were not for free speech or scientific freedom at all. They
were just unhappy that they were not in power and therefore were not able to
suppress speech and science that they didn’t like. Now that they are in power,
they’re going farther and faster than any administration has ever done to defund
grants supporting science they don’t like, to require grants to align
themselves with the priorities of the President, and to suppress dissent.
Indeed, recently I was asked to be an ad hoc reviewer for an NIH study section. 
Not wanting to get the SRO in trouble for having appointed me, given how much
Jay Bhattacharya dislikes me—he’s called me a “threat to science”—I pointed the 
SRO to the article by Paul Thacker portraying Dr. Bhattacharya as “silenced” and
“persecuted” for being the brave maverick COVID-19 contrarian. I never heard
back, and that’s OK. Again, I didn’t want to get anyone in trouble, as much as I
love being on NIH study sections.

To conclude once again, every accusation from antivaxxers and the opponents of
public health during the pandemic was a confession, and we’re now seeing this
administration do exactly what its useful idiots had been accusing scientists,
physicians, and “progressives” of doing. I only wonder if the administration’s
useful idiots have figured out yet that they are, in fact, nothing more than the
useful idiots chosen to be the face of the dismantling of US support for
rigorous science in favor of turning federal grant programs for medicine and
science into grift and patronage to be doled out as rewards to political
loyalists. They probably don’t, at least not yet, but sooner or later they will.

Lysenkoism 2.0 is here, and I fear that I will not live long enough to see the
damage that’s already been done repaired, if it is ever repaired at all.


The Scientific Integrity Act: Protecting science from politics

The proposed federal Scientific Integrity Act supports science and the
scientific process as the basis of public policy and aims to protect it from
politics, ideology, and financial conflicts of interest.

Jann Bellamy on October 10, 2019

Link



The Scientific Integrity Act, introduced earlier this year in the U.S. House of 
Representatives (H.R. 1709) and Senate (S. 775), aims to protect science and
scientists from political interference.

The Act begins with a “Sense of Congress” resolution that science and the
scientific process should be the basis of public policy, including public health
and environmental protection, and that the public must be able to trust this
process, which should be free from politics, ideology, and financial conflicts
of interest.

The proposed legislation covers all federal agencies funding, conducting, or
overseeing scientific research, as well as federal employees and contractors
involved in “scientific activities” (a term that is not defined), including
analysis and public communication of the results of these scientific activities.
It also covers the use of scientific information in making policy, management, 
and regulatory decisions.

The Act is comprehensive in its prohibitions. These federal employees and
contractors cannot

  1. Engage in dishonesty, fraud, deceit, misrepresentation, coercive manipulation,
    or other scientific or research misconduct;

  2. Suppress, alter, interfere with, or otherwise impede the timely release and
    communication of, scientific or technical findings;

  3. Intimidate or coerce an individual to alter or censor, or retaliate against an
    individual for failure to alter or censor, scientific or technical
    findings; or

  4. Implement institutional barriers to cooperation and the timely communication
    of these findings.

Federal employees and contractors would be free to disseminate scientific and
technical findings in scientific conferences and peer-reviewed journals,
although there is a 30-day window for pre-publication agency review for
technical accuracy. They would also be free to sit on scientific boards, join
scientific councils and other professional organizations, act as journal editors
and peer-reviewers, and otherwise “participate and engage with the scientific
community”.

They would have the opportunity to review public statements regarding their
research for technical accuracy and require revision if necessary. They could
also respond to media inquiries without agency approval and present their expert
or personal opinions, if clearly presented as such, but must disclose actual or
potential conflicts of interest.

To accomplish all of this, the Act requires all federal agencies that fund,
conduct, or oversee scientific research to put in place systems to prevent and
address attacks on science. These agencies would have to designate a scientific 
integrity officer, develop a scientific integrity policy, and provide employees 
with scientific integrity and ethics training.

At a July hearing on H.R. 1709 before the House Science, Space, and Technology
Committee, the bill’s main sponsor, Rep. Paul Tonko (D-NY-20), aimed for
bipartisan support by presenting the issue as transcending one party or
administration:

   The [entirely predictable] abuses directed by this president [Trump] and his 
   top officials have brought a new urgency to the issue, but the fact remains
   whether a Democrat or Republican sits in the speaker’s chair or the Oval
   Office, we need strong scientific integrity policies.

[Bracketed words added.]

He added:

   Allowing political power or special interests to manipulate or suppress
   federal science hurts, and hurts all of us. It leads to dirtier air, unsafe
   water, toxic products on our shelves, and chemicals in our homes and
   environment. And it has driven federal inaction in response to the growing
   climate crisis . . .

Although some federal agencies have already undertaken scientific integrity
initiatives following 2010 guidelines issued during the Obama administration,
Committee chair Rep. Eddie Bernice Johnson (D-TX-30), said that legislation was 
necessary because these policies were

   proving unable to counter the Trump administration’s manipulation and
   oppression of science.

This “manipulation and suppression” was partially quantified by the Union of
Concerned Scientists (USC), in their 2018 survey of more than 63,000 federal
government-employed scientific experts, conducted in partnership with the Center
for Survey Statistics and Methodology at Iowa State University. According to
the USC:

   The results should be disturbing to anyone who believes that government
   science has a crucial role to play in making the United States a safer,
   healthier nation. Federal scientists describe a broad range of problems,
   including workforce cuts, censorship and self-censorship, political
   interference, and undue industry influence. Unsurprisingly, these problems
   have taken a toll on morale, making it hard for scientists to do their jobs
   effectively.

While there is some Republican support for “rigorous policies on scientific
integrity, research misconduct, conflict of interest, and data transparency”,
per Rep. Jim Baird (R-IN-4), Rep. Tonka’s appeal to bipartisanship has
apparently fallen short. The 216 co-sponsors of H.R. 1706 and 11 co-sponsors of 
S. 775 are all Democrats.

Rep. Tonko also introduced a Scientific Integrity Act in the previous Congress, 
again with many Democratic co-sponsors, as did former Sen. Bill Nelson (D-FL),
in the Senate. Neither got so much as a committee hearing, so there is some
progress.

Brennan Center report on scientific integrity

The need to protect science and scientists from political interference was
underscored in a just-released report issued by the bipartisan National Task
Force on Rule of Law & Democracy, a project of the Brennan Center for Justice at
New York University Law School. According to the Brennan Center, the Task
Force, led by former U.S. Attorney (S.D. N.Y.) Preet Bharara and former New
Jersey Governor and EPA administrator Christine Todd Whitman,

   proposes legislative reforms to reinforce the norms and unwritten rules that 
   once ensured that these government functions were carried out without
   excessive politicization.

A previous report laid out a series of proposals to strengthen government ethics
and the rule of law; the second, in addition to addressing scientific
integrity, outlines recommendations for fixing what the Task Force sees as a
broken presidential political appointments process.

The Task Force’s latest report notes that all recent administrations have
manipulated scientific research, retaliated against government researchers for
political reasons, asked special interest groups to shape research priorities,
undermined and sidelined scientific advisory committees, and suppressed research
from public view.

The report contains an interesting history of the government’s attempts to
establish science as basis for policymaking, counteractions to undermine that
process, and remedies undertaken by Congress and prior administrations to
prevent these counterattacks, none of which have been completely successful.
This history of scientific misconduct includes Lyndon Johnson’s imposing a
political test, based on attitudes toward the Vietnam War, in selecting members 
of the President’s Science Advisory Committee, and George H.W. Bush’s White
House altering proposed congressional testimony of NASA climate expert James
Hansen to emphasize scientific uncertainties about climate change.

However, with the Trump administration, the Task Force says,

   we are at a crisis point, with almost weekly violations of previously
   respected safeguards.

The current administration not only politicizes scientific research, it
“undermine[s] the value of objective facts themselves.”

Some examples from the report:

  1. The acting White House chief of staff reportedly instructing the Secretary of 
    Commerce to have NOAA issue a misleading statement in support of President
    Trump’s false assertion about the path of Hurricane Dorian, with the
    Secretary reportedly threatening to fire NOAA officials in pressuring them
    to act. Gov. Whitman refers to this incident as “Sharpiegate.”

  2. The Department of Agriculture relocating economists across the country after
    they published information about the financial harms of the administration’s
    trade policies to farmers.

  3. The Interior Department reassigning a top climate scientist to an accounting
    job after he highlighted the dangers of climate change.

  4. The EPA adopting rules preventing experts from serving on science advisory
    boards, while encouraging participation by industry-affiliated researchers.

An “Appendix of Scientific Integrity Issues” contains a more complete list of
troubling interference with scientific research and scientists, the vast
majority of which are from the Trump administration. Categories include

  1. Threats to Scientific Integrity

  2. Contacts Between Political Officials and Career Experts That Undermine
    Scientific Integrity

  3. Retaliation and Threatened Retaliation Against Career Experts

  4. Attacks on Science Advisory Committees

  5. Restriction of Public Access to Government Research and Data

  6. Politically Motivated Interventions in Nonpolitical Expert Regulatory Analysis
    Underlying Regulatory Actions

To remedy this abuse, the Task Force recommendations include legislation

  1. establishing scientific integrity standards for agencies and policies to
    guarantee them;

  2. establishing clear standards for interactions between political officials and 
    career researchers;

  3. prohibiting politically-motivated suppression of research and data;

  4. prohibiting retaliation and discrimination against government researchers;

  5. protecting scientific advisory committees;

  6. requiring disclosure of government research and data;

  7. requiring disclosure of nonpolitical expert analysis underlying agency
    policymaking.

As the report itself notes, several of these recommendations are already
contained in the Scientific Integrity Act. The Center for Inquiry has
information on contacting your Representative and Senators if you are interested
in urging them to support this legislation. I hope you will.

The seven dirty words the CDC won’t be able to say any more (in budget requests)

On Saturday, The Washington Post broke a story that Trump administration will
prohibit officials at the CDC from using a list of seven words or phrases —
including “transgender,” “evidence-based,” and “science-based” — in official
documents being prepared for next year’s budget. As much as we like the title of
our blog, this is not the sort of recognition we at SBM want. It’s also an
ominous indication that the Trump administration will attempt to impose ideology
on the most important public health agency in the federal government.

David Gorski on December 18, 2017

Link



Ever since Donald Trump’s unexpected victory in the Presidential election last
year, many of us who advocate for the view that medicine and public policy
should be based on the best evidence and science have been increasingly
disturbed by just how little science and evidence mean to the Trump
administration. Our concern began well before the actual election, based on the 
dangerous antivaccine politics on display in the Republican primary races, in
which several of the candidates seemed to be competing over who could best
pander to the antivaccine fringe. Trump himself, of course, has a long and
sordid history of expressing a number of antivaccine views that he’s expressed
on Twitter and in interviews many times dating back at least to 2007 and
encompassing—of course!—the scientifically discredited view that vaccines cause 
autism. So when Donald Trump was nominated and then when he was elected, a
number of physicians and a huge number of scientists were appalled—and rightly
so, as it turns out.



Who knew that George Carlin’s immortal routine about the seven dirty words you
can’t say on TV would become the basis for government policy, only substituting 
different “dirty words”?

Donald Trump bans “seven dirty words” at the CDC

I was reminded of that fear and what was likely to be the result of electing
someone like President Trump on Saturday morning, when The Washington Post broke
a story, “CDC gets list of forbidden words: Fetus, transgender, diversity“:

   The Trump administration is prohibiting officials at the nation’s top public 
   health agency from using a list of seven words or phrases — including “fetus”
   and “transgender” — in official documents being prepared for next year’s
   budget.

   Policy analysts at the Centers for Disease Control and Prevention in Atlanta 
   were told of the list of forbidden terms at a meeting Thursday with senior
   CDC officials who oversee the budget, according to an analyst who took part
   in the 90-minute briefing. The forbidden terms are “vulnerable,”
   “entitlement,” “diversity,” “transgender,” “fetus,” “evidence-based” and
   “science-based.”

Here’s a brief video:

And more:

   At the CDC, the meeting about the banned terms was led by Alison Kelly, a
   career civil servant who is a senior leader in the agency’s Office of
   Financial Services, according to the CDC analyst, who spoke on the condition 
   of anonymity because the person was not authorized to speak publicly. Kelly
   did not say why the words are being banned, according to the analyst, and
   told the group that she was merely relaying the information.

   Other CDC officials confirmed the existence of a list of forbidden words.
   It’s likely that other parts of HHS are operating under the same guidelines
   regarding the use of these words, the analyst said.

And still more:

   The longtime CDC analyst, whose job includes writing descriptions of the
   CDC’s work for the administration’s annual spending blueprint, could not
   recall a previous time when words were banned from budget documents because
   they were considered controversial.

   The reaction of people in the meeting was “incredulous,” the analyst said.
   “It was very much, ‘Are you serious? Are you kidding?’”

Never put it past the Trump administration to leave an easy opening for
ridicule. It had to pick a list of seven words to ban. Not six. Not eight.
Seven. Seven allows me to channel George Carlin and refer to them as the “seven 
dirty words” that the CDC can’t say on TV (or anywhere else). I had thought of
giving this post the title, “The Science-Based Vulnerable Entitlement of the
Transgender Fetus for Evidence-Based Diversity,” but, damn if someone on Twitter
hadn’t beaten me to it:

Just for spite, I am going to write a play entitled "The Science-Based
Vulnerable Entitlement of the Transgender Fetus for Evidence-Based Diversity."
#BannedWords #CDC7words #cdcbannedwords #theatre #drama #newplay #Resist

— Samuel Yates (@SamuelYates) December 16, 2017

George Carlin is more appropriate for someone of my generation, anyway, given
that I grew up with him and one of his classic routines, “The Seven Words You
Can Never Say on Television,” more commonly referred to as the “seven dirty
words.” Besides, as managing editor of this blog, in particular I was appalled
that the terms “science-based” and “evidence-based” were on the list. After all,
what the hell else is the CDC supposed to base its policy, research, and
regulations upon? How can one request funds for scientific research on, for
instance, transgender health issues without using the word “transgender”? Or,
more pointedly, how does one request funds for research on microcephaly caused
by the Zika virus without using the term “fetus”? Of course, the very idea of
banning the word “fetus” is, quite obviously, to force the CDC to use the word
“baby” or “developing baby” in its official budget requests, thus not-so-subtly 
influencing any health or scientific issue where abortion might be a relevant
consideration.

I also fear for the “longtime CDC analyst,” as it is probably very obvious to
the White House who leaked word of the ban to The Washington Post. I fear that
that analyst is not long for the CDC. I also suspect that that analyst knew the 
consequences of leaking the information from the meeting but did it anyway. Good
for him or her.

Mockery: The inevitable reaction to scientific censorship

Not surprisingly, the Internet exploded at this edict. Indeed, as I write this, 
I’m hoping that the outcry and mockery will cause the Trump administration to
back down before this post even goes live. There are indications that it might
be backing down in that the FDA has explicitly denied that it has been forbidden
to use the seven dirty words. Also, the Department of Health and Human Services
(HHS), while not exactly denying ban on the ban on the seven dirty words at the
CDC, claims news stories have “mischaracterized” it, which is what bureaucrats 
always say when caught by the news media attempting to implement an obviously
awful policy. (Censoring the words scientists can use in their funding requests 
is always bad policy.)

One meme created by Kevin Folta summed up the reaction quite well:

New Proposed Science Terms for the @CDCgov. Effective Jan 1, 2018.
pic.twitter.com/cSxsBQ5W08

— Kevin Folta (@kevinfolta) December 16, 2017

I’m half-tempted to rename the blog “Confirmicated Medicine,” but will resist
the temptation…for now. I couldn’t do it without Steve Novella’s permission
anyway, but I could always do it at my not-so-secret other blog, although how
I’d mesh the new name with all the cheesy images from a 36 year old obscure
British science fiction TV show remains to be seen.

“Science-based”: One of the “seven dirty words”?

Be that as it may, the Trump administration gave precious little guidance
regarding replacement terms, other than for “science-based.” It sounds benign,
but really isn’t, as you will see:

   In some instances, the analysts were given alternative phrases. Instead of
   “science-based” or ­“evidence-based,” the suggested phrase is “CDC bases its 
   recommendations on science in consideration with community standards and
   wishes,” the person said. In other cases, no replacement words were
   immediately offered.

We use the term “science-based medicine” because we recognize that medicine is
not a science, at least not strictly. For instance, patient values can have a
huge role in deciding which science-based treatments to use or whether to forego
treatment altogether, among other examples. We do, however, argue that medical 
treatments should be based in science. As Steve Novella put it in the very first
post ever on this blog, now nearly ten years ago:

   The philosophy of this blog, at its core, is simple: Safe and effective
   health care is critical to everyone’s quality of life; so much so that it is 
   generally considered a basic human right. The best method for determining
   which interventions and health products are safe and effective is, without
   question, good science. Therefore it is in everyone’s best interest for
   health care to be systematically evaluated by the best science available.

Now, some of you out there might be wondering: What’s the difference?
“Evidence-based,” “science-based,” aren’t they basically the same thing as
basing recommendations on “science in consideration with community standards and
wishes.” The difference is one of emphasis. I view this as a Trojan horse
designed to open the door to the CDC making non-science-based recommendations,
as long as it’s considered the science. In other words, rather than science
being the prime driver of health-based recommendations of the CDC, “community
standards” and “community wishes” are now elevated to be equal to science in
recommendations.

There are a number of situations where this sort of a wishy-washy “alternative” 
can be very problematic. Tara Smith points a couple out:

   Soak that up. This opens the door for official CDC documents to support, say,
   abstinence-based education in conservative areas as a “recommendation based 
   on science in consideration with community standards and wishes.” In other
   words, not science-based at all, even though many communities support it
   *despite* the scientific evidence. Or anti-vaxxers in Oregon who believe
   vaccines are “toxic” to have that now become a CDC recommendation based “on
   science in consideration with community standards and wishes.”

It’s that latter example that came to my mind right away. For instance,
“community wishes” might be that more funding is channeled to studying the
scientifically discredited idea that vaccines cause autism. Science says that a 
link between vaccines and autism has never been demonstrated in well-designed
epidemiological and scientific studies. Or what about nonmedical exemptions to
school vaccine mandates. The science is very clear that easily obtained
nonmedical exemptions are associated with lower vaccine uptake and greater
likelihood of outbreaks of vaccine-preventable disease, while banning nonmedical
exemptions or at least making them harder to obtain are associated with
increased vaccine uptake. If “community standards and wishes” are taken into
account, maybe my home state legislature’s boneheaded attempt to keep the
Michigan Department of Health and Human Services from implementing science-based
recommendations to increase vaccine uptake could be acceptable to the CDC.

Now consider the above “recommended replacement” terms in the context of what
Donald Trump has done with respect to vaccines and the CDC. Right before the
election, an antivaccine blogger couldn’t resist blurting out that Donald Trump 
had met with antivaccine activists in Florida in August 2016, including the
patron saint of the antivaccine movement, discredited gastroenterologist Andrew 
Wakefield, the man whose fraudulent case series in 1998 gave birth to the most
recent iteration of the antivaccine movement in history. During the presidential
transition period, Trump also met with Robert F. Kennedy, Jr., one of the most 
active and famous antivaccine activists, a man who recently raised close to
$50,000 to meet with every legislator to promote antivaccine pseudoscience. It’s
not clear exactly what they discussed. RFK Jr. claimed that they discussed his 
chairing a “vaccine safety commission.” This claim was quickly denied by the
Trump transition team, but that didn’t stop RFK Jr. from sending an e-mail to
members of the Waterkeepers Alliance, which Kennedy leads, announcing that he
would leave the environmental group if the commission actually comes to be. More
recently, RFK, Jr. issued the most spectacularly dumb “vaccine challenge” since
Jock Doubleday. Basically, like many antivaccine activists, RFK, Jr. dons the
mantle of a “vaccine safety activist,” even though he’s anything but, his
risible oft-repeated claim to be “fiercely pro-vaccine” notwithstanding.

Do you see why I was concerned about CDC vaccine policy?

Then there’s the new CDC Director, Dr. Brenda Fitzgerald. While her previous
record as the Georgia Public Health Commissioner was reassuring for her vigorous
pro-vaccine stance, she is not exactly the sort of doctor who is likely to
stand up to political meddling in public health affairs. For one thing, she is
not a scientist and hasn’t even done clinical or epidemiological research, two
previously very desirable qualifications in any CDC Director. Worse, before she 
became Georgia Public Health Commissioner, she sold quack anti-aging treatments 
from her private practice and had even been a Fellow in Anti-Aging Medicine. As 
I noted before when I first discussed her peddling of anti-aging quackery, Dr.
Fitzgerald’s case suggests that you can be pro-vaccine and still be a quack.
More importantly in the case of the ban on seven dirty words, not being a
researcher grounded in science, Dr. Fitzgerald is in danger of not being able to
distinguish pseudoscience from science when antivaxers come calling (and they
will come calling) to demand an “investigation” into issues relevant to
vaccines. I also hoped that she would listen to CDC scientists, but, even if she
does, I doubt she’ll have the spine or smarts to stand up for science and
resist this ban on the seven dirty words.

It’s very clear that the Trump administration does not value science and wants
to control the narrative and research about science as much as it can. It’s also
clear that the administration favors extreme deregulation and free market
fundamentalism, given that two of the names floated to head the FDA were cronies
of über-Libertarian Peter Thiel, one of whom wanted to roll the FDA back to
only requiring evidence of safety and not efficacy before approving drugs and
another who wanted to substitute online reviews for science as evidence to be
used in drug approval applications. Ultimately the Trump administration settled 
on the “least bad” option for the FDA, Scott Gottlieb, who is as close to a
real, honest-to-goodness pharma shill as there is in existence. Then there was
Tom Price, a Georgia Representative and orthopedic surgeon, who was appointed to
head HHS but lasted only a few months before scandal consumed him. He belonged 
to the ultraconservative free market fundamentalist group of physicians
masquerading as a medical professional society, the Association of American
Physicians and Surgeons (AAPS). AAPS is rabidly antivaccine and antiscience in a
number of ways, as well as very Ayn Randian in its view of medicine. While
there is no good evidence that Price was antivaccine, one does not belong to
such an organization without being sympathetic to its views.

These are the sorts of people the Trump administration has been appointing to
posts involving science and medicine. Sure, Trump kept Francis Collins as NIH
Director, but that’s about the only sound choice he’s made. Of course, the
desire of the Trump administration to control the narrative with respect to
science extends far beyond health. This is not even the first time that the
administration has tried to censor scientific terminology. As Winston Smith was 
tasked with doing at the Ministry of Truth to news stories that no longer jibed 
with the version of history mandated by the totalitarian regime in which he
lived in George Orwell’s novel Nineteen Eighty-Four, the administration has been
throwing references to human-caused climate change down the old memory hole,
even at NIH. Basically, any science that conflicts with the Trump administration
ideology is being systematically purged from the government, as much as the
administration can manage, while appointing people like Scott Pruitt, a man who 
made his name suing the agency and who opposes the agency’s mission, to head the
Environmental Protection Agency.

What about the other words?

I can speculate about why the Trump administration might want to ban words like 
“entitlement” and “vulnerable.” First of all, it’s clear that the current
administration is hostile to “entitlements,” although I am unsure why it would
matter in terms of banning the word for budget requests, although I can guess
that it might not want the CDC doing research on how “entitlements” (Social
Security, Medicare, etc.) impact health.

Reasons for banning the word “vulnerable” are easier to see. In epidemiology and
medicine, “vulnerable” populations are defined as populations more at risk for 
disease, poor health outcomes, and death because of age (children are considered
a vulnerable population), sex, access to health care, and socioeconomic status,
among other factors. In general, vulnerable populations can be described
thusly:

   Vulnerable populations include the economically disadvantaged, racial and
   ethnic minorities, the uninsured, low-income children, the elderly, the
   homeless, those with human immunodeficiency virus (HIV), and those with other
   chronic health conditions, including severe mental illness.2 It may also
   include rural residents, who often encounter barriers to accessing healthcare
   services.3 The vulnerability of these individuals is enhanced by race,
   ethnicity, age, sex, and factors such as income, insurance coverage (or lack 
   thereof), and absence of a usual source of care.1,4-8 Their health and
   healthcare problems intersect with social factors, including housing,
   poverty, and inadequate education.2

Given the policies of the Trump administration, one can easily see why it would 
want to ban the CDC from using the word “vulnerable” in its budget requests.

It’s even easier to see why the Trump administration would want to ban word like
“transgender” as a sop to the conservative evangelicals who supported him.
After all, there is no good substitute term, not even one as convoluted and
unbalanced as the one proposed for “science-based.” The overall effect is to
make it harder to discuss scientific research having anything to do with
transgendered people through language. Human nature being what it is, any
roadblock placed in the way of doing research on a subject will make it less
likely that scientists will want to jump through the necessary hoops to do it.
Also, banning “transgender” is a clear signal to the CDC and other government
agencies, whether they have to hew to the same ban or not, that the
administration will not be receptive to budget requests for research in this
area.

But what about “fetus”? As I alluded to above, banning the word “fetus” forces
the CDC to use words like “baby” or “developing baby,” and changes the framing
of any discussion of abortion. Why not ban the word “abortion” too? Good
question. My guess is like that of Emil Karlsson, namely that banning “fetus”
can “serve to crack down more broadly about research related to pregnancy and
other issues related to reproductive health for women.”

Finally, “diversity” is a strange word to ban, although not surprising given the
Trump administration’s oft-expressed hostility towards policies intended to
promote diversity and equality. However, one wonders about unintended
consequences. In medical science, the word “diversity” is used to describe far
more than just racial and sexual diversity in human populations, the usual use
of the word in policy and social science. As Karlsson also notes, “diversity” is
a scientific term frequently used in biology and medicine; e.g., diversity can 
refer to genetic diversity of pathogens or hosts, diversity of animal
populations, and the like. Will the Trump administration allow these latter uses
of the word but not uses of the word related to human racial and ethnic
populations, for example, and will the censors be scientifically savvy enough to
tell the difference?

The predictable non-denial denial

On Sunday, Dr. Brenda Fitzgerald, CDC Director, took to Facebook and Twitter to 
deny everything.

First Facebook:

Here she is on Twitter, saying basically the same thing:

You may be understandably concerned about recent media reports alleging that CDC
is banned from using certain words in budget documents. I want to assure you
that CDC remains committed to our public health mission as a science- and
evidence-based institution.

— Dr Brenda Fitzgerald (@CDCDirector) December 17, 2017

CDC has a long-standing history of making public health and budget decisions
that are based on the best available science and data and for the benefit of all
people—and we will continue to do so.

— Dr Brenda Fitzgerald (@CDCDirector) December 17, 2017

HHS statement addressing media reports, continued: "HHS also strongly encourages
the use of outcome and evidence data in program evaluations and budget
decisions.”

— Dr Brenda Fitzgerald (@CDCDirector) December 17, 2017

I was not reassured. This is a non-denial denial.

Note that that HHS statement was nothing more than the same statement quoted by 
a STAT News article published on Saturday, specifically a statement issued by
HHS spokesperson Matthew Lloyd. Also note that I remain unimpressed by Dr.
Fitzgerald using the terms “evidence-based” and “science-based” in a Tweet.
Remember, the news reports stated that use of these terms was to be banned in
budget requests. I also note that even Dr. Fitzgerald doesn’t exactly deny it.
Let’s look again at the key Tweets:

You may be understandably concerned about recent media reports alleging that CDC
is banned from using certain words in budget documents. I want to assure you
that CDC remains committed to our public health mission as a science- and
evidence-based institution.

— Dr Brenda Fitzgerald (@CDCDirector) December 17, 2017

Notice how carefully Dr. Fitzgerald is not to deny that these words were banned 
in CDC budget requests. It’s very careful phrasing that denies nothing while
appearing to deny the reports. If these words were not actually banned in budget
requests, why not say explicitly that these words are not banned in budget
requests? Yet Dr. Fitzgerald does not do so. Instead, she hides behind carefully
crafted sentences.

I call BS. I am now more convinced than I was when I saw the first story that
the Trump administration did indeed ban these words, particularly in light of a 
follow-up report describing how officials from other HHS agencies revealed that 
they, too, had been given similar lists of banned words, and then some. The
reporters also checked in with the CDC analyst who provided them the original
story:

   At the CDC, the briefing was led by a senior career civil servant in the
   office that oversees formulation of the agency’s budget. She opened the
   meeting by telling participants not to use the words “vulnerable,”
   “entitlement” and “diversity” because documents containing those words were
   being “flagged” by others higher up the chain in the budget process, and
   documents were being sent back to CDC for corrections.

And:

   The CDC analyst said it was clear to participants that they were to avoid
   those seven words but only in drafting budget documents.

   “What would you call it when you’re told not to use those words?” the person 
   said. “If that’s not a ban, maybe I need to improve my vocabulary.”

No, the analyst doesn’t need to improve his vocabulary, and it doesn’t matter
that, this year, the ban only applies to budget requests. The chilling effect is
the same. Administration officials might now be claiming that this is only
about the budget and how to win funding from Congress, words matter, and using
the correct words matters.



Insoc Logo. By Nirwrath – Made in Inkscape 0.48.4.1, CC BY-SA 3.0,
https://commons.wikimedia.org/w/index.php?curid=25354838

1984 has arrived 33 years later than Orwell predicted

In this case, invoking George Orwell’s dystopian novel is not inappropriate.
Orwell understood what all totalitarian governments know, namely controlling
language and narrative is an essential tool to controlling populations. That’s
why in Nineteen Eighty-Four, Orwell portrayed unwanted news and history being
thrown down the “memory hole” and inconvenient people becoming “unpersons”
(i.e., erased from existence), the term in a language he called Newspeak for
eliminating all references to them. The Trump administration policy is not quite
a memory hole, but this attempt to ban “inconvenient” words at the CDC is
uncomfortably close to Newspeak.

The intent is clear. The pretext might be about the budget process, but, no
matter how much Trump administration officials claim it’s just about winning
funding from Congress, it’s about more than that:

   Dr. Ashish Jha, director of the Harvard Global Health Institute, worries
   about the ban’s broader impact.

   “It sends a signal to people in the agency that this is not just about the
   budget process,” Jha told STAT. “There’s as much of a risk of self-censorship
   that comes out of this than actual direct censorship … This is the part
   that’s much more pernicious than any direct pronouncement.”

   “So of course the administration and its defenders are going to argue that
   this is only about what goes into the budget,” Jha said. “But we know that
   the signal to the agency is much stronger than that. And it’s going to change
   behavior of people who work there. And that’s much more damaging than any
   direct censorship.”

Exactly.

Science and ideology often butt heads, and this tension is not infrequently
apparent between Presidential administrations and government agencies devoted to
science. However, the great strength of the US federal government’s science
programs dating back many decades has traditionally been just how little
political considerations can usually interfere with the scientific efforts of
these agencies. Indeed, it has been impressive just how little difference
changes in administrations have usually made in the day-to-day operations of
federal agencies tasked with funding scientific research and using scientific
findings to develop policy options. That’s not to say that previous
administrations haven’t tried before to influence the scientific mission of
agencies like the EPA (probably the most frequent target of political meddling),
NIH, NSF, or CDC. However, as far as I can tell, the Trump administration’s
edict to the CDC is unprecedented. Never before has a list of words, “seven
dirty words” or others, been explicitly banned for use in budget requests.

This attempt at censoring scientific discourse, even limited as it is to one
agency for 2019 budget requests, provides grave reason for concern, as it is not
likely to be limited. Yes, right now HHS is denying that this is a policy for
any agency other than CDC, and, yes, the FDA has stated that it “hasn’t yet
received or implemented a policy to avoid certain words in budget or policy
work.” The key word is “yet.” If this censorship of science isn’t nipped in the 
bud at the CDC, there’s no reason to expect that the CDC will be the only agency
affected. As Tara Smith notes:

   If this policy is allowed at the CDC, there’s no reason to think this will
   stay in that agency, either. Imagine all of HHS, NASA, NOAA, the Department
   of Education, and many others requiring similar definitions of
   science/evidence-based. It’s programmatic approval of the idea that facts are
   anything you want them to be.

   It’s literally turning “truthiness” into Federal policy.

Dr. Fitzgerald and scientists at the CDC need to resist this obvious attempt to 
censor “inconvenient” scientific discussion. Scientists need to speak out and
resist. You and I need to speak out to our elected officials. This new policy at
the CDC is not normal. It is a violation of norms accepted by both parties over
many decades. It must not stand.

The ICEmen Cometh

The potential effects of the current ICE actions on public health

Peter Lipson on February 10, 2026

Link


Why would a blog about medicine and science need to address what appears to be a
purely political question? Promotion of science-based medicine shouldn’t be
obscured by unnecessary forays into partisan politics. But our current political
crisis affects every facet of our public health environment.

Public health is always political, but does not have to be partisan—there is
clear evidence that the current public health policies are broadly unpopular
across the political spectrum. While we may disagree on policy goals and
methods, we do seem to agree that masked secret police operating with complete
impunity is a bad thing. And whatever the political consequences, it is bad for 
public health. And we have the science to back that up.

The ICE crackdowns affect public health directly, indirectly, and
synergistically with other policies. They aren’t separate from the
administration’s attacks on public health. It may seem strange at first to link 
ICE activities with the dismantling of our public health infrastructure by
Kennedy et al. but these are inseparable. The gutting and politicization of the 
CDC and NIH cannot be separated from violent immigration enforcement and
policing. For example, if the CDC and NIH don’t track data related to law
enforcement violence, it’s hard to study. And if people are scared away from
seeking healthcare due to immigration actions (and I had to stop myself from
typing “Aktions”) people will sicken and die.

Shock and confusion

Since the Trump Administration’s transformation of ICE into a masked secret
police force, much of (white) America has stared at their screens in shock.
Nothing that has happened has surprised minority communities that have always
been subject to police abuses. But the egregious and unpredictable scenes of
masked, militarized forces invading peaceful neighborhoods have awakened even
the most complacent among us. At the same time, Americans are wondering where to
turn for health data, vaccinations, and reliable advice as the usual sources
are torn down and/or turned into Kennedy’s private playground. For now, let’s
focus on the potential effects of the current ICE actions on public health.

Police violence is an established public health issue, with its associated
experts and academic literature. There are many barriers to studying police
violence, perhaps the biggest being the lack of mandatory reporting. Most
importantly, when the state that perpetrates violence is also responsible for
collecting public health data, there is an inevitable conflict of interest, and 
as recent events have shown us, public health is very much subject to political 
censorship. Again, the gutting of public health and violent policing are a
mutually dependent part of our current political situation.

Our modern life in which everyone has a camera makes it hard for the state to
hide. Pictures of chemical weapons being used outside of schools, children being
torn from their parents, people being murdered in what amount to concentration 
camps, and (white) people being murdered and vilified have made our current
crisis hard to ignore. (As an aside, this one hit home since he is a fellow
healthcare worker. But Trump’s policies were already harming my colleagues. Many
of our hospital nurses and ancillary staff are immigrants and therefore under
threat. Many of our doctors are immigrants—so many that many of our hospitals
could not survive without them. And the US does not produce enough doctors to
fill the gap.)

You’re not from around here, are you?

Recent ICE crackdowns take invasive policing to a new level. There is plenty of 
social science literature showing the negative effects of invasive policing on
individual and population health. Before the current crackdown, there were about
75,000 hospitalizations caused by interactions with police every year, and
about 600 deaths.

Digging deeper, a 2016 study looking especially at “Terry Stops” (snagging
people for “looking suspicious”) showed significant negative health effects not 
only for those who were subject to “stop and frisk” but also those living in the
neighborhoods where this sort of policing is used. Another systematic review
showed adverse outcomes on Black youth who had contact with police.

Knowing this, we should be able to infer the negative effects of so-called
“Kavanaugh Stops” where ICE officers (I consciously stopped myself from typing
“goons”) are supposedly allowed to stop anyone who they think may look like an
“illegal immigrant”. The Supreme Court decision that allows this is either
supremely naive, intentionally oppressive, or both. The results were completely 
predictable based on both data and common sense, and our doom-scrolling
certainly highlights the inevitable abuses. Kavanaugh’s decision in Noem v.
Vasquez Perdomo implies that ICE grabbing up “suspicious” people is not
particularly harmful:

[A]s for stops of those individuals who are legally in the country, the
questioning in those circumstances is typically brief, and those individuals may
promptly go free after making clear to the immigration officers that they are
U.S. citizens or otherwise legally in the United States.

—Noem V. Vasques Perdomo

The news belies this as we see citizens and non-citizens alike hauled off in a
typically not-so-brief way. And public health research shows us wider harms.

[D]irect exposure to police physical, psychological and sexual violence is
associated with multiple health-related harms, including suicide attempts and
suicidal ideation, psychotic experiences, anxiety, depression, distress, and
post-traumatic stress symptoms, and can adversely impact health-related
behaviors.

—Haile, et. al.

Violence breeds fear

As noted above, we know that invasive policing affects not only those who have
direct interactions with police but also the larger community. This probably
happens in a number of ways but there are some specific harms that we see. And I
want to state explicitly, again, that these practices disproportionately harm
people and communities of color. It is now, when the effects are “bleeding over”
into the majority community that it makes headlines.

Aside from harms from direct physical assault and incarceration, how does police
violence harm the health of communities and individuals?

The most obvious effect of state violence is injury to the individual. As noted 
above, hundreds of people die at the hands of law enforcement annually and tens 
of thousands are hospitalized. But there are broader effects.

It seems obvious that if you are afraid that going to the hospital will get you 
snatched up by ICE, you’ll stay away, and studies back this up. Immigration
actions (ugh, again I almost typed “Aktions”) deter people from seeking health
care. This could lead to, for example, worsening of diabetes, hypertension,
heart disease, and other common health problems. It can also lead to the spread 
of infectious diseases. For example, justice-involved youth were less likely to 
be vaccinated against COVID-19 during the height of the pandemic.

The myth that immigrants are the problem

Immigrants in general are at risk of under-vaccination. Many of the current
leaders at CDC and NIH are, in fact, directly responsible for discouraging
vaccination in immigrant communities. (Their good friend Andrew Wakefield who,
incidentally, is not a great friend of SBM, helped start a measles outbreak in
Minnesota.) If you pair avoidance of vaccination in marginalized populations
with increasing attacks on vaccination from the current administration, you can 
see where this will lead.

Which leads me to a healthcare myth I hear nearly every day: “Doc, we need to
stop these immigrants from bringing all these diseases here.” No, immigration,
legal and otherwise, is not responsible for disease outbreaks in the US. Take,
for example, tuberculosis (TB). Most cases are in immigrants. However:

As it stands, incident TB among migrants is less likely to be associated with
local disease outbreaks than TB arising among US-born individuals, and the large
majority of new non-US-born TB cases arise from [latent TB] reactivation rather
than recent infection.

—Menzies et al.

TB may enter the country with migrants, but most outbreaks belong to us.

Measles

And then there’s measles. Imported cases have been steadily dropping—around 90% 
of measles cases are in US residents. Measles outbreaks often occur when a
traveler to the US (resident or otherwise) comes into contact with an
under-vaccinated community, which, thanks to years of attacks on vaccination by 
our current NIH and CDC leadership, is most of us.

And now we see measles emerging as a direct result of US immigration crackdowns.
It was recently announced that there is a measles outbreak in one of the
immigrant crackdown detention centers.

When you build warehouses and camps to imprison tens of thousands of ordinary
folks, you not only create fear, you also create epidemics. This is a perfect
storm—an administration that doesn’t believe that measles vaccines are a good
thing, and shoves people together under terrible conditions—this is how
epidemics launch. What are the chances that ICE would make sure everyone they
imprison is healthy and vaccinated?

The government announced that they have basically locked down the prison but
this won’t stop measles—it’s too contagious for that. It will cause worsening
morale and worsening health as people are confined to cages and cells and can’t 
move around. And guards will take it home with them.

A History Lesson

This is all going to get much, much worse before it gets better.

During World War I in the US, men were crushed together in half-built army bases
and then sent overseas. Flu spread like wildfire. In the “Spanish flu” pandemic
of 1918, about 5% of the world’s population died of flu. Try to wrap your head 
around that one.

In the Nazi labor and concentration camps (but not the death camps), about
30-40% of people killed died of disease due to deliberate overcrowding,
starvation, and poor sanitation.

We know how these things work. If you institutionalize people in poor
conditions, they start to sicken and die. It doesn’t matter if it’s in a Soviet 
gulag, a US army base, or a Nazi concentration camp–dead is dead. It’s a matter 
of degree–for the Soviets and Nazis, death and disease was a feature, not a bug.

When an antivaccine government imprisons an already under-vaccinated population 
under conditions that are perfect for spreading disease, well, you get the idea.

My patients are not well

It would be too easy to end up going on a Gorski-length analysis. But I’m driven
to write this, after a very long absence from the blog, because of what I am
seeing in my clinic. My patients are not well. Every day, I hear fear—not
necessarily fear of personally being deported, but the over-arching sense of
unease and danger from knowing that the current administration not only doesn’t 
want to protect you from disease but promotes it; not only from direct
interactions with ICE but just knowing that families are being torn apart and
people tortured and murdered all in our name.

So while this is not a political blog, politics is part of public health, and
the current political landscape is very, very unhealthy.


Dr. Remington Nevin: Michigan’s own RFK Jr. or Dr. Joseph Ladapo?

Dr. Remington Nevin is a the director of a county health department in Michigan 
but is poised to become Michigan’s very own Dr. Joseph Ladapo, a MAHA crank put 
in charge of a state’s public health apparatus.

David Gorski on September 7, 2026

Link


Regular SBM readers are no doubt familiar with Dr. Joseph Ladapo, Florida’s
Surgeon General and head of the state’s Department of Health since 2021. Dr.
Ladapo first rose to prominence in 2020 in the early months of the pandemic as a
prominent member of the group of crank physicians and pandemic minimizers known
as America’s Frontline Doctors. It’s hard to believe it, but it’s been six
years since this group first made a splash in the news by promoting
hydroxychloroquine as a cure for COVID-19, even as rapidly arranged clinical
trials were showing that it did not work, leading me to call it the “Black
Knight of treatments for COVID-19,” a nod to the infamous Black Knight scene
from the movie Monty Python and the Holy Grail. Uncoincidentally, Dr. Ladapo was
also a signer of the Great Barrington Declaration, that “declaration”
co-authored by our current NIH Director and orchestrated by a right-wing think
tank and neo-Confederate conspiracy theorist Jeffrey Tucker that called for a
“let ‘er rip” strategy for dealing with the pandemic, claiming that such a
strategy would lead to “natural herd immunity” in 6 months. Never mind all those
people at high risk of hospitalization and death due to the virus. They just
got “focused protection,” the GBD never bothering to provide details regarding
how we protect them from a virus that was spreading among the rest of the
population. At its heart, the GBD was a profoundly social Darwinist
document that, in essence, advocated abandoning the weak to the virus so that
the strong could “open up” the economy again. Basically, the GBD could never
have worked, as one of its supporters implicitly admitted, but it managed to
do devastating damage to public health due to its influence. I bring up Dr.
Ladapo because, with the upcoming gubernatorial election in Michigan, I worry
that if the Republican candidate John James wins, we might have our very own Dr.
Ladapo placed in charge of the Michigan Department of Health and Human
Services. I’m referring to Dr. Remington Nevin, who is currently the medical
director in St. Clair County and has been referred to as “Michigan’s RFK Jr,”
after our current antivax Secretary of Health and Human Services, Robert F.
Kennedy, Jr.

I first encountered Dr. Nevin when he emerged as a key figure in a recent
political win by antivaxxers in Michigan that weakened a requirement that
parents who want to claim a personal belief exemption to school vaccine mandates
for their children must first attend an educational session at their local
health department. To recap why he is being called “Michigan’s RFK Jr.,” since
joining the St. Clair County health department in 2023, Dr. Nevin has made it
easier for parents to opt their children out of school-based vaccine mandates in
his county, supported parents in trying to opt out of state immunization
tracking, been on record of being in favor of removing fluoride from drinking
water, ended the county’s participation in the state’s school-based health
clinic program after a county commissioner raised concerns that her 12-year-old 
daughter had been exposed to concepts of transgender identity, homosexuality and
emergency contraception at Port Huron High School’s teen health center, and
declared solar farms a “possible threat to public health.” Let’s just put it
this way. News reports routinely describe Dr. Nevin as having given St. Clair
County’s public health department a “MAGA makeover.”

What originally brought Dr. Nevin to my attention, besides his role in watering 
down Michigan’s requirement for a personal belief exemption to school vaccine
mandates, was another case in which he spectacularly intervened in the case of
Andrew Eberly and his children:

Last fall, a dispute over the waiver process involving a St. Clair County family
blew up into a local controversy, and school officials asked local law
enforcement to get involved.

Although the family lived in St. Clair, the children attended high school in
neighboring Macomb County. Macomb had already switched to the hybrid model, but 
the parents didn’t want to file any documents at all, because they didn’t want
their children’s vaccination status to be known by local health officials.

The father, Andrew Eberly, said in November at a St. Clair County public health 
meeting that getting a certified waiver “forces parents like me to register
personal health decisions” with the state, which he doesn’t trust.

Unsurprisingly, Dr. Nevin landed firmly on Eberly’s side and even provided him
with a vaccine exemption letter himself. Dr. Nevin also worked to make it easier
for parents to opt out of vaccine tracking involving vaccination doses being
entered into Michigan Care Improvement Registry, commonly just called MICR. For 
details on that, I refer you to my first post mentioning Dr. Nevin, lest I
repeat myself more here than I already have (although I will point out that RFK 
Jr.’s old antivax organization, Children’s Health Defense, loves him). Before I 
move on to discuss Dr. Nevin some more, I’m just going to quote this bit from
CHD:

Kevin Watkins, a nurse and president of the Port Huron branch of the NAACP, told
the AP that Nevin’s policies are “anti-vaccine” and “anti-public health.”

Nevin pushed back on Watkins’ claims. “Nothing about this is anti-vaccine. It’s 
pro-choice and it’s pro-trust,” he said. “Vaccines remain available to every
family that wants them.”

You get the idea. Dr. Nevin is one of those antivaxxer or antivax-adjacent
ideologues who hides his antivax and anti-public health beliefs under the guise 
of being “anti-mandate” and “pro-freedom.”

So where did he come from?

Who is Dr. Remington Nevin?

As I mentioned the last time I wrote about him, there are a number of aspects of
Dr. Nevin’s past that set my skeptical antennae twitching when I first read
about them. First, though, let’s look at how Dr. Nevin describes himself on his 
own website:

Dr. Remington Nevin is a physician epidemiologist and expert consultant board
certified in Public Health and General Preventive Medicine and in Occupational
Medicine by the American Board of Preventive Medicine and certified in public
health by the National Board of Public Health Examiners.

A former U.S. Army Major and Preventive Medicine Officer and faculty associate
in the Department of Mental Health at the Johns Hopkins Bloomberg School of
Public Health in Baltimore, Maryland, Dr. Nevin now serves as Medical Director
of the Quinism Foundation.

Dr. Nevin’s research has focused primarily on the adverse effects of quinoline
antimalarials. Dr. Nevin’s work has been instrumental in improving policymakers’
understanding of the potential for long-lasting and permanent neurologic and
psychiatric effects from quinoline antimalarials, as exemplified by a recent FDA
“black box” warning.

This all struck me as very strange, given how Dr. Nevin has behaved since being 
appointed as medical director in St. Clair County in 2023. Stranger still was
that Dr. Nevin appears to run a consulting and expert witness business based on 
this entity of “quinism.” Out of curiosity, I did a quick PubMed search for the 
term, having never encountered it before and wanting to know what the scientific
literature says about it. The search returned 14 articles. Two were prostate
cancer-related, for reasons that appear to be related to the use of drugs from
the quinoline and quinazoline families being researched for use in prostate
cancer. Of the remaining 12 articles, 11 were single-author, with Dr. Nevin as
sole author, and one included him as a co-author of a paper on Trichomonas
vaginalis infection and prostate-specific antigen levels. Let’s just say that
when a diagnosis (like “quinism”) is used by just one investigator, that’s
usually an indication that it is not a widely accepted diagnosis. If it were,
lots of investigators would be using it in their published papers. I did,
however, find a 2013 review article by Nevin and two co-authors that discusses
the psychiatric side effects of mefloquine. Most likely it didn’t show up in my 
search because it predates Nevin’s coining of the term “quinism.”

In fairness, the FDA did add a black box warning for a drug called mefloquine in
2013 that stated:

The U.S. Food and Drug Administration (FDA) is advising the public about
strengthened and updated warnings regarding neurologic and psychiatric side
effects associated with the antimalarial drug mefloquine hydrochloride. A boxed 
warning, the most serious kind of warning about these potential problems, has
been added to the drug label.  FDA has revised the patient Medication Guide
dispensed with each prescription and wallet card to include this information and
the possibility that the neurologic side effects may persist or become
permanent. The neurologic side effects can include dizziness, loss of balance,
or ringing in the ears.  The psychiatric side effects can include feeling
anxious, mistrustful, depressed, or having hallucinations (For a more complete
list of potential side effects, see Additional Information for Patients).

Neurologic side effects can occur at any time during drug use, and can last for 
months to years after the drug is stopped or can be permanent.  Patients,
caregivers, and health care professionals should watch for these side effects.
When using the drug to prevent malaria, if a patient develops neurologic or
psychiatric symptoms, mefloquine should be stopped, and an alternate medicine
should be used.  If a patient develops neurologic or psychiatric symptoms while 
on mefloquine, the patient should contact the prescribing health care
professional.  The patient should not stop taking mefloquine before discussing
symptoms with the health care professional.

On the Quinism Foundation website, Dr. Nevin states:

The term “quinism” may seem new, but the symptoms of poisoning from mefloquine
(previously marketed as Lariam®), tafenoquine (marketed as Krintafel® and
Arakoda®), chloroquine (marketed as Aralen®), and related quinoline drugs are
all too familiar: Tinnitus. Dizziness. Vertigo. Paresthesias. Visual
disturbances. Gastroesophageal and intestinal problems. Nightmares. Insomnia.
Sleep apnea. Anxiety. Agoraphobia. Paranoia. Cognitive dysfunction. Depression. 
Personality change. Suicidal thoughts.

These symptoms are not “side effects”. They are symptoms of poisoning from a
class of drug that is neurotoxic and that injures the brain and brainstem. This 
poisoning causes a disease, and this disease has a name: Chronic quinoline
encephalopathy — also known as quinism.

So I started searching PubMed for this term and variants. The result was
thousands of articles unrelated to the term, along with a notice that the term
was not recognized in the phrase library of PubMed, further implying that it is 
not a generally accepted diagnosis. After doing some digging, it turns out that,
as far as I can tell, Dr. Nevin coined both terms, using them in a book chapter
[Nevin RL. “Neuropsychiatric Quinism: Chronic Encephalopathy Caused by
Poisoning by Mefloquine and Related Quinoline Drugs.” In: Ritchie EC, Llorente
M, eds. Veteran Psychiatry in the US. Cham, Switzerland: Springer Nature; 2019. 
DOI: 10.1007/978-3-030-05384-0_20.

Unfortunately, my institution does not have access to this paper, so I couldn’t 
get a copy, and I wasn’t willing to shell out $29.95 to Springer for a copy, not
even for SBM. However, what I did learn is that “quinism” is a term that is not
used in the medical literature and is almost exclusively used by advocacy
groups attributing neurological symptoms to quinine drugs used to treat and
prevent malaria. As proposed, it encompasses symptoms such as nightmares,
insomnia, anxiety, depression, tinnitus, cognitive dysfunction, dizziness, and
paresthesias persisting after the drug has been discontinued. This diagnosis
construct has not been validated in clinical trials or adopted by regulatory
bodies, medical societies, or expert evidence-based guidelines. That is not to
say that neurological symptoms have not been linked to mefloquine sufficient
that the FDA added a black box warning. However, reports of these neurological
and psychiatric complications rest largely on uncontrolled clinical observations
and pharmacovigilance reports.

Also, in that chapter, at least from what I’ve been able to glean from summaries
of it, Dr. Nevin appears to repurpose the term “quinism,” previously referred
to as cinchonism (a classic toxic reaction to quinine/cinchona-derived drugs
that includes tinnitus, headaches, and visual disturbances) to describe a
broader proposed array of disorders caused by quinoline-class drugs generally.
He also introduces another term, “neuropsychiatric quinism,” to describe a
chronic, long-lasting variant. The chapter’s central claim is that the
“unrecognized effects of neuropsychiatric quinism in veteran populations are
likely to have confounded a significant body of military research and clinical
diagnosis”; i.e., that a substantial portion of existing PTSD/TBI research in
veterans may actually reflect misdiagnosed drug toxicity due to quinolines. He
further calls for screening veterans for quinoline exposure.

So, at this point, I didn’t see anything particularly nefarious, other than Dr. 
Nevin perhaps going beyond what the evidence shows. We know mefloquine can cause
neurological symptoms. Indeed, there’s a Cochrane review from 2017 that
summarizes what was known then about the potential side effects and adverse
reactions due to mefloquine, which include:

Mefloquine has not been shown to have more frequent serious side effects than
either atovaquone‐proguanil (low‐certainty evidence ) or doxycycline (very
low‐certainty evidence).

People who take mefloquine are more likely to stop taking the drug due to side
effects than people who take atovaquone‐proguanil (high‐certainty evidence), but
may be equally as likely to stop as people who take doxycyline (low‐certainty
evidence).

People taking mefloquine are more likely to have abnormal dreams, insomnia,
anxiety and depressed mood during travel than people who take
atovaquone‐proguanil (moderate‐certainty evidence ) or doxycyline (very
low‐certainty evidence ). Doxycycline users are more likely to have dyspepsia,
photosensitivity, vomiting, and vaginal thrush (very low‐certainty evidence).

So, yes, mefloquine can cause psychiatric side effects. However, the Quinism
Foundation goes far beyond that. For example, in a 2020 press release warning
against using mefloquine to treat COVID-19—shades of hydroxychloroquine!—Dr.
Nevin is quite blunt:

The Quinism Foundation has warned of a risk of sudden and lasting
neuropsychiatric effects from the use of antimalarial quinolines against
COVID-19, the disease caused by the novel coronavirus, and has urged policy
makers, physicians, and members of the public to be alert to such effects.

“The same endosomotropic properties that likely underlie the effectiveness of
quinoline antimalarial drugs such as chloroquine and hydroxychloroquine against 
the virus may also underlie their dangers, ” said Dr. Remington Nevin, MD, MPH, 
DrPH, a Johns-Hopkins trained psychiatric epidemiologist and drug safety expert 
and former U.S. Army public health physician, who now serves as Executive
Director of The Quinism Foundation. “These are not safe drugs.”

“Tonic water is a prescription medication masquerading as a cocktail mixer,”
said Dr. Nevin. “It should not be used against COVID-19.”

“In susceptible individuals, these drugs act as idiosyncratic neurotoxicants,
potentially causing irreversible brain and brainstem dysfunction, even when used
at relatively low doses,” said Dr. Nevin. “This drug-induced dysfunction causes
a disease of the brain and brainstem called quinoline encephalopathy, or
quinism, which can be marked acutely by psychosis, confusion, and risk of
suicide, and by lasting psychiatric and neurological symptoms.”

“Symptoms of chronic quinoline encephalopathy include tinnitus, dizziness,
vertigo, paresthesias, visual disturbances, nightmares, insomnia, anxiety,
agoraphobia, paranoia, cognitive dysfunction, depression, personality change,
and suicidal thoughts, among others, ” said Dr. Nevin. “Particularly among
military veterans, in whom these drugs have been widely used for decades as
prophylactic antimalarials, these symptoms can mimic and be mistaken for those
of post-traumatic stress disorder and traumatic brain injury.”

As much as it amused me to see someone who would later go all-in on COVID
contrarianism attacking hydroxychloroquine as a treatment for COVID in March
2020, you can see how what Dr. Nevin says does not align with what much more
careful assessments of the evidence, such as by the Cochrane Collaboration.
Later in the press release, he misrepresents what the National Academy of
Sciences (NAS) published, saying that its report on side effects of antimalarial
drugs identified a “critical need” for more research into psychiatric adverse
events, when in reality NAS found “insufficient evidence to determine whether
there is an association between antimalarial use and neurologic and psychiatric 
outcomes, including anxiety, depression, and the development of symptoms that
mimic post-traumatic stress disorder (PTSD),” and concluded that “research is
warranted because existing studies are limited in their design.” Basically,
there isn’t much in the way of compelling evidence to support Dr. Nevin’s
assertions. Moreover, Dr. Nevin clearly knows that his view is not mainstream.
In a press release announcing that his foundation is now offering disability
evaluation services to US veterans, Dr. Nevin states:

“Veterans disabled as a result of their exposure to these neurotoxic drugs
should not claim quinism or chronic quinoline encephalopathy directly,” said Dr.
Nevin. “Neither should they claim synonymous conditions, such as ‘mefloquine
poisoning,’ or ‘mefloquine toxicity,’ as the VA does not yet recognize these
formally as medical conditions.”

“Instead, veterans should claim that the service-connected use of the quinoline 
drug, such as mefloquine, was the cause of another medical condition, such as a 
drug-induced psychiatric disorder, or a drug-induced neurologic disorder, or a
physical disorder, such as sleep apnea, linked to one or more such psychiatric
or neurologic cause.”

Let’s just say that the level of certainty regarding the existence of “quinism” 
or a syndrome resembling it expressed by Dr. Nevin and the Quinism Foundation
does not align with the actual existing high quality scientific evidence, which 
I interpret as indicating that mefloquine and related drugs can cause
psychiatric symptoms as part of their side effect profile but that there is as
yet little evidence for a chronic “disease” or “syndrome” with serious symptoms 
persisting long after discontinuation of the drug. Dr. Nevin also offers his
services as a consultant and expert witness related to the pseudodiagnosis of
“quinism” that he had invented.

Dr. Nevin and St. Clair County

From what I could learn, Dr. Nevin relocated from Vermont to Michigan after his 
father died in order to be closer to family. One rather odd thing about Dr.
Nevin and his situation in St. Clair County is that the medical director is
currently a part-time position.

Nevin took the St. Clair County job in 2023 during a period of significant
change at the local health department, which had drawn fire for mask mandates
during the pandemic.

County commissioners decided to split the health department’s leadership between
a medical director role, which Nevin would eventually assume, and a health
officer position to oversee the organization.

And:

Despite that, St. Clair County commissioners are considering recombining the
health department positions once again, but haven’t specified how.

Some residents say Nevin should be given more authority to enact his vision for 
the county. Others say they’re concerned about Nevin’s moves to curtail standard
public health guidelines.

Because of his “make America healthy again” (MAHA) cred and his actions as
medical director of St. Clair County, Dr. Nevin has drawn praise from a lot of
Republican state legislators, including a 2025 legislative tribute from Rep.
Jaime Greene, “Rep. Greene recognizes Dr. Remington Nevin of St. Clair Health
Dept. with legislative tribute,” and a June 2026 tribute from St. Clair County
GOP legislators Reps. Joseph Pavlov, Jamie Greene, and Jay DeBoyer. It is highly
unusual for legislators to notice, much less issue public proclamations
praising, a part-time county health official. Both proclamations emphasize his
“vaccine choice” and anti-fluoride stances, for example:

“Dr. Nevin has been a phenomenal local leader serving in the St. Clair Health
Department, and his impact on our community cannot be overstated,” Greene said. 
“We are all incredibly fortunate to benefit from not just his skill as a medical
practitioner, but also his character and leadership. He has consistently been
at the forefront of fights for science-backed medical policies that still
respect individual freedom, even when those policies have been unpopular in the 
medical community. That kind of courage and moral clarity is exactly what we
need from our civic leaders, and I wanted to do some small part in recognizing
it with a legislative tribute.”

Dr. Nevin has worked to align St. Clair County’s vaccine exemptions with
Michigan law in order to ensure parents and families seeking exemptions for
medical or religious reasons are not met with hostility from their local health 
department. Greene, who has been an outspoken advocate for vaccine choice and
individual freedom, praised Dr. Nevin for his efforts to improve the county’s
vaccine exemption process. Greene’s tribute also lauds Dr. Nevin’s bold,
science-based approach to fluoride in public water systems and the unexamined
health risks of industrial-scale solar energy development.

From a science-based perspective, these are all reasons why Dr. Nevin is so
problematic. You can see why I am concerned about him rising further to become
Michigan’s Joseph Ladapo if John James wins the governorship. On the other hand,
there have been allegations of sexual harassment and fostering a toxic work
environment in the county health department. A report from the Hotline Review
Committee to the St. Clair County Board of Commissioners noted that 12 employees
had come forward, with four written statements, along with emails and letters. 
Among the findings, Dr. Nevin demonstrated persistent demeaning behavior to
women, refused to communicate with others based on perceived lack of
qualifications, declaring himself the “smartest person in Michigan,” delaying
effective treatment for TB and ignoring safety guidelines dealing with TB
patients, and made “discriminatory comments to or about patients regarding their
immigration status, income status, parental status, sexual orientation.”

The report concluded:

Overall, when reducing these concerns to paper, they appear to be unreasonable. 
After speaking at length with the staff, the constant bombardment of demeaning
and condescending behavior; the arrogant presentation of himself to colleagues
from State and County government; the disregard for the safety of staff and
patients; and the disdain and prejudice toward the community he was hired to
serve is untenable long term. State and local community partners are questioning
our choice of medical director and as a result various partners have
discontinued providing or working with SCC public health.

Sounds like a hell of a leader, doesn’t he?

Most recently, Michigan Advance reported a few days ago:

A St. Clair County Board of Commissioners committee decided on Thursday night to
table a decision to launch an independent investigation into the county medical
director, Dr. Remington Nevin — an investigation that public health nurses in
the county have been requesting  for months.

Nevin is facing complaints of a toxic workplace, including reports of unfair
labor practices like retaliation as well as sexual harassment allegations, from 
nurses since he took over leadership of the department in 2024.

A December 2024 report from the county’s Hotline Review Committee detailing
anonymous complaints submitted through the county’s Human Resources hotline
included many of those concerns, which members of the local nurses union say
have only escalated in the nearly two years since.

“After speaking at length with the staff, the constant bombardment of demeaning 
and condescending behavior; the arrogant presentation of himself to colleagues
from state and county government; the disregard for the safety of staff and
patients; and the disdain and prejudice toward the community he was hired to
serve is untenable long term,” the report states.

Given that all of the county commissioners in St. Clair County are Republican
and most are MAGA, the nurses bringing the complaints are very suspicious that
the Board of Commissioners is “choosing to promote their own political agenda by
keeping Nevin in his role, instead of exerting proper oversight over a county
official.”

So there you have it. We in Michigan have our very own Dr. Joseph Ladapo, only
worse, as I am unaware that Dr. Ladapo has ever been credibly accused of sexual 
harassment. I must admit, though, the findings of the Hotline Review Committee
do make me think that, unfortunately, the comparison between Dr. Nevin and RFK
Jr. is all too on point.

I have no specific knowledge of whether Dr. Nevin is currently under
consideration for MDHHS, should James win the governorship. However, the
attention of powerful Republican state legislators heaping praise on him will
definitely put him in the discussion, if not on the shortlist, of candidates for
the post, especially given his ideological alignment with stated positions of
the James campaign, including “vaccine choice” and his stated desire “protect
informed consent” and to reform MDHHS influence over county health departments
(his CLEAR Initiative). The question is: If Republicans do succeed in retaking
the governor’s mansion in November, will the charges of misconduct against him
be enough to keep Dr. Nevin from ascending to become the director of MDHHS?
Normally, I would say yes. In this era, I am no longer so sure. What I am sure
of is that Dr. Nevin is definitely a crank, and his expansion from “quinism” to 
basically all things MAHA is an excellent demonstration of crank magnetism. He
shouldn’t be running a medical practice, much less a county health department,
much less a state health department.

Hidden in Plain Cite: HHS backs Teen Pregnancy Program priorities with phantom
references

David Weinberg on September 22, 2026

Link


This story came to my attention through mainstream headlines noting that a
federal judge accused HHS of using fake and/or AI-generated references:

So I decided to take a close look at the references myself.

These dubious references appeared in two Notices of Funding Opportunity (NOFOs) 
issued by the Teen Pregnancy Prevention program (TPP), administered by the
Office of Population Affairs (OPA). The references were intended to support the 
agency’s strategy and priorities for these grants, a strategy that has shifted
significantly under the current administration.

I will not render an opinion on whether or not the strategy/policy changes are
justifiable. I will also not opine on the legal case. In both instances, I am
neither prepared nor qualified to do so. This will be an analysis of the
scholarship used to justify HHS’s modification to the program.

Teen Pregnancy Prevention program

The Office of Population Affairs (OPA) is one of the less familiar offices
within Health and Human Services. According to their website:

The Office of Population Affairs (OPA) advances reproductive health outcomes and
adolescent health and wellbeing by supporting high-quality clinical services,
evidence-based and innovative programs, rigorous research and evaluation, and
the engagement of communities and partners to inform policy.

Regarding the Teen Pregnancy Prevention program (TPP), the HHS website states:

The HHS Office of Population Affairs (OPA) Teen Pregnancy Prevention (TPP)
program is a national, evidence-based grant program that funds diverse
organizations working to prevent teen pregnancy across the United States. OPA
invests in the implementation of effective TPP programs and provides funding to 
develop and evaluate new and innovative approaches to prevent teen pregnancy,
prevent sexually transmitted infections (STIs) among adolescents, and promote
positive youth development.

A shift in priorities…

TPP has issued roughly $100 million in grants annually since Congress
established it in 2010. In 2026, the funding priorities for TPP have been
modified to align with the MAHA agenda.

These new priorities are reflected in two different NOFOs. A NOFO is a public
document issued by a government agency to announce the availability of
competitive grant funding. It includes details such as eligibility rules,
funding amounts, application instructions, important deadlines, etc. TPP funds
Tier 1 and Tier 2 projects. Tier 1 funds programs that replicate established
strategies to achieve the goals of TPP. Tier 2 funds investigations into new
strategies.

…applied retroactively

The new priorities will not only be applied to incoming grant applications;
previous awardees were scrutinized as well. Of the still-active grants funded in
previous cycles, 53 of 66 were abruptly canceled in 2026 by HHS.

Some grantees and communities served by these grants were understandably unhappy
about the shift in priorities of TPP, and a lawsuit was filed to try to stop
their implementation. The plaintiffs were two counties and two nonprofits:
Hennepin County, Minnesota; King County, Washington; Planned Parenthood of the
Heartland, Inc. (in Iowa); and Sexuality Information and Education Council of
the United States. The named defendants were the U.S. Department of Health and
Human Services and Robert F. Kennedy, Jr.

The lawsuit alleges that implementation of the new standards is contrary to
Congress’ intent and unlawful. In a recent ruling, District Judge Christopher R.
Cooper issued a ruling temporarily enjoining implementation of the new policy
for incoming grant applicants, but fell short of reinstatement of the terminated
grants. This is not a final ruling on the merits of the case, just a temporary 
delay of implementation of certain aspects of the policy.

This ruling made the news largely because the judge alleged that many of the
references cited by HHS were fictitious and possibly AI-generated. In the
ruling, the judge stated:

On the topic of body literacy, the notices (remarkably) reference public health 
studies that appear either not to exist or not to support the propositions for
which they are cited—a hallmark of AI-generated citations.

The judge made the headlines, but the allegation of fictitious references
originated with the plaintiffs themselves. The methodology used by the
plaintiffs to vet the references is described in detail here (scroll down to
Document 14-6, Declaration of Kate Talmor). The plaintiffs concluded that 5 of
the 7 articles could not be found as cited in the NOFO. Two of these seemed
totally fictitious. Three did not match the NOFO citation but had titles similar
to articles in different journals. This analysis was referenced in Judge
Cooper’s opinion and is the source of the “fake” studies allegation.

An independent exploration of the references

The plaintiffs in the lawsuit have made a serious allegation, namely that the
government used fictional references as a justification for a change in funding 
criteria. The references in question are in the Tier 1 and Tier 2 NOFOs. Both
documents are publicly available, so I decided to take a look at them myself.

Fully indexed back issues of each of the relevant journals are available online.
For each reference, I searched the journal and looked at the specific year,
issue, and page number as listed in the NOFO reference. If there was no match, I
performed PubMed and Google Scholar searches using the first author and
keywords from the title of the article to see if I could find a close match. If 
there had been a typo or transcription error in the details of the reference,
these search engines are quite effective in tracking down articles with
incomplete information.

My Findings

There are six references in the Tier 1 NOFO, discussed in the order they are
cited:

Hall, Kelli S., et al. “Understanding Factors Contributing to Unintended
Pregnancy.” American Journal of Public Health, vol. 102, no. 3, 2012, pp. 1–8.

This article does not exist as cited. There are 4 peer-reviewed articles with
author KS Hall and “unintended pregnancy” in the title. None match the remainder
of the title, the journal, or year of publication.

Polis, Chelsea B., and Laurie Zabin. “Missed Conception: Fertility Knowledge and
Pregnancy Risk.” Contraception, vol. 85, no. 4, 2012.

This article does not exist as cited. There are no articles authored by C Polis 
or CB Polis with “missed conception” or “fertility knowledge” in the title.

Manhart, L. E., Aral, S. O., Holmes, K. K., & Foxman, B. “Sex Partner
Concurrency: Measurement, Prevalence, and Correlates Among Adolescents.”American
Journal of Public Health, vol. 101, no. 10, 2011, pp. 1896–1902.

This article did not exist as cited. I found one article with the same authors, 
similar title, different year, different journal. This article explicitly was a 
study of 18- 39-year-olds, NOT adolescents. There were 3 other articles
co-authored by Manhart with “sex partner concurrency” in the title but with
different co-authors, journals, and years of publication.

Klaus, H. M. Abstinence and Teen Fertility Awareness: Behavior Outcomes Among
At-Risk Youth. Life Issues Institute, 2004

This is not a valid citation. There is no peer-reviewed Journal called “Life
Issues Institute.” Google and PubMed searches with Author “Klaus” and “Teen
Fertility” in the title found no matches. A Google search for “Life Issues
Institute” found this website, a pro-life educational organization. On their
home page is a tab titled “Research,” but I could not find this article or one
resembling it.

HM Klaus likely refers to Hanna Klaus, MD. Dr. Klaus was an OB-GYN and a
Catholic nun. She promoted natural family planning as approved by the Church.
She founded Teen Star, a sex education curriculum for teens and young adults
based on the doctrine of the Catholic Church.

It is unclear if a document written by HM Klaus with this title exists. It does 
not appear to be in an accessible, peer-reviewed source. I could not locate such
a document for review.

Sinai, I., et al. “Fertility Awareness–Based Methods of Family Planning: A
Review of Effectiveness for Avoiding Pregnancy.”Journal of Midwifery & Women’s
Health, vol. 57, no. 6, 2012, pp. 547–554.

This article does not exist as cited. There are a few articles published by
Author “Sinai” with “fertility awareness” in the title. The closest was a very
similarly titled paper published in a different journal, different year. Sinai
was a coauthor, but not the first author.

O’Donnell M. Definition of Health Promotion 2.0: Embracing Passion, Enhancing
Motivation, Recognizing Dynamic Balance, and Creating Opportunities. American
Journal of Health Promotion. 2009;24(1): iv-iv.

This article does exist. In context, it’s a confusing reference. It’s a note
from the Editor of The American Journal of Health Promotion, a brief commentary 
on a previous Editorial (by the same author) proposing a revision to the
Journal’s definition of the term “health promotion.” It contains no original
data and links to no peer-reviewed data or reviews.

The reference is used to support this statement: “Lifestyle change can be
facilitated through a combination of learning experiences that enhance
awareness, increase motivation, build skills, and provide access to environments
that make positive health practices the easiest choice.” It’s noteworthy that
this is an almost word-for-word quote of the final sentence from the editorial. 
The article is attributed by the citation, but the verbatim sections are not in 
quotes.

There are three references in the Tier 2 NOFO:

Manhart, L. E., Aral, S. O., Holmes, K. K., & Foxman, B. “Sex Partner
Concurrency: Measurement, Prevalence, and Correlates Among Adolescents.”American
Journal of Public Health, vol. 101, no. 10, 2011, pp. 1896–1902.

Sinai, I., et al. “Fertility Awareness–Based Methods of Family Planning: A
Review of Effectiveness for Avoiding Pregnancy.”Journal of Midwifery & Women’s
Health, vol. 57, no. 6, 2012, pp. 547–554

You may recognize the first 2 articles from the Tier 1 NOFO. As noted above,
neither exists as written.

Hebert-Beirne, Jennifer M. et al. (2017) A Pelvic Health Curriculum in School
Settings: The Effect on Adolescent Females’ Knowledge. Journal of Pediatric and 
Adolescent Gynecology, Volume 30, Issue 2, 188 – 192

This article does exist and is a peer-reviewed research report.

This study tested the “basic pelvic anatomy and functional knowledge” in a group
of “female adolescents.” Students completed a standardized questionnaire at
baseline. An intervention group received 6 weekly 1-hour teaching sessions on
relevant subject matter. When administered the same questionnaire, these
students demonstrated improved scores. This type of study is common in
validating an experimental teaching strategy, but far from groundbreaking or
priority-altering research.

Within the NOFO, this study is cited in support of the sentence: “Adolescents
with greater understanding of their bodies may be more confident in managing
changes and making informed health decisions.” Notably, the study did not
explore confidence or competence in making informed health decisions among these
students.

Summary

Between the 2 NOFOs, there are seven references to explain/justify the pivot in 
priorities of the TPP grant funding. The majority of the references (five of the
seven citations) were not an accurate representation of a legitimate article.
The NOFO references listed combinations of publication dates, journals, titles, 
and authors. The authors were real people with published work in relevant
subject matter. The journals were real. The titles often borrow elements from
real articles. It is as if these nuggets of information were confabulated into
chimeric pseudo-references, Mad-Libs style. This has led the plaintiffs and the 
judge to speculate that these were AI-generated references.

This leaves only two of the seven NOFO references as extant, properly cited
articles in biomedical journals. One (O’Donnell) is an editorial that contains
no original data and does not directly address any subject matter relevant to
public policy on teenage pregnancy.

The other legitimate article (Hebert-Beirne) is relevant subject matter and does
contain original, peer-reviewed research. It is a specific assessment of a
specific teaching program. But it does not support the statement for which it is
cited. As the only extant relevant article, it is hardly of the scope and depth
to justify a sharp pivot in funding priorities or the interruption of
previously approved and ongoing projects.

In summary, of the seven references cited in the two NOFOs: five don’t exist or 
can’t be located as cited; one exists but is an editorial with dubious
relevance; and one is a legitimate relevant study but does not support the
proposition for which it was cited.

Comparisons to the plaintiffs’ analysis

The plaintiffs’ analysis reached a similar finding. They determined, as did I,
that 5 of the 7 articles did not exist as cited in the NOFOs. They further
determined that 2 were completely fake, and 3 corresponded with similarly titled
articles in other journals. This may be true but, in my opinion, does not
materially change the problem. Each of the 5 articles can be linked, in some
way, to a similarly titled or similarly authored, thematically related article. 
In every case, the related article was in a completely different journal,
published in a different year, different page numbers, and other bibliographic
details.

The plaintiffs concluded (Document 14-1, page 33):

Given that five out of seven articles cited in the NOFOs do not exist at all, do
not exist in the journal HHS cited, and/or provide no support for HHS’s
proposition, it is reasonable to infer these mistakes likely resulted from the
use of artificial intelligence to draft the NOFOs.

Previous Citation Problems from HHS

This is not the first time Health and Human Services has used problematic
citations. They have repeatedly been found to use low-quality, misrepresented,
and fictitious references in the communications created to justify positions and
policies.

FAQ to Congress

In May 2025, HHS modified the vaccine schedule to exclude healthy children and
pregnant women. In a FAQ communication to Congress, the modified vaccine
schedule was explained using several citations from the medical literature.
Consistently, low-quality studies exaggerating the risks were cited, while
higher-quality, safety-affirming studies were ignored. The citations included
one study that had not been peer-reviewed, and another bearing an “Expression of
Concern” from the publisher, noting “potential issues with research methodology
and conclusions and author conflicts of interest.” The findings from other
cited papers were misrepresented or fabricated. One notable example was a paper 
cited to support the assertion: “Yet another study showed an increase in
placental blood clotting in pregnant mothers who took the vaccine.” Curiously,
the cited study had nothing to do with pregnancy and had no mention of placental
blood clotting.

Advisory Committee on Immunization Practices (ACIP)

ACIP is a committee of experts convened periodically to advise the CDC on
vaccine policy. Early in his tenure as HHS Secretary, RFK Jr. dismissed and
replaced the entire membership of the ACIP. In advance of the first meeting of
the new ACIP, a PowerPoint to be presented by Lyn Redwood, a former leader of
Children’s Health Defense, was posted on the CDC website. Redwood’s presentation
was a review of Thimerosal in vaccines. Both RFK Jr. and Redwood have advocated
for a long-discredited link between thimerosal in vaccines and
neurodevelopmental issues.  In that presentation, she cited a reference
supporting neurotoxicity of thimerosal. Eagle-eyed observers, as well as the
putative author of the paper, noted that the reference was fictitious.

The MAHA Report

President Trump issued an executive order instructing the Make America Healthy
Again (MAHA) Commission, chaired by RFK Jr., to deliver a report focusing on
childhood illness in the US. The MAHA Commission delivered the report (often
referred to as the MAHA report) on May 22, 2025. News outlets quickly noted
problems with the references used to justify the conclusions of the report. Some
citations were incorrect, and several were completely fictitious. 37 references
were entered multiple times. Results of many of the studies were
misrepresented, as attested by the authors of those papers. The text string
“oaicite” in the URLs of some of the citations is strong evidence that large
language models were used in constructing the report. The use of LLM’s in such
an ambitious publication is not surprising, but the persistence of confabulated 
references and “oaicite” in URL’s indicates insufficient human oversight.

Why this matters

The CDC FAQ to Congress regarding COVID vaccine guidelines, the MAHA report, and
now the NOFOs from TPP have been littered with references that cannot be found 
and/or have been misrepresented.

These documents purport to provide scientific support for priorities and
policies of HHS and its subsidiaries. Teen reproductive health and pregnancy
prevention are far outside of my realm. I lack subject-matter expertise needed
to make informed opinions. However, I do have some expertise in reading and
interpreting medical literature and in judging the strengths and weaknesses of
scientific arguments. I should be able to read an informational publication by
HHS and be provided with actual information to assess.

Are these errors due to poorly-supervised AI use (as speculated by the
plaintiffs and the judge), carelessness, indifference, incompetence, or some
combination? In the end, it doesn’t matter. The fact is, this HHS has fallen
short of the “gold standard science” and transparency we were promised.

I do not expect to agree with every decision of any administration. But when
invoking scientific literature to explain public policy, the literature should
exist, the citation should be accurate, and the evidence should support the
claim. Sadly, these conventional standards of scientific communication do not
seem to be a priority for this HHS.


NCCAM

   Senator Tom Harkin: “Disappointed” that NCCAM hasn’t “validated” more CAM

                                  David Gorski

                                      Link

Senator Tom Harkin (D-Iowa) owes me a new irony meter.

I’ll explain in a minute, but first you have to know why I even care about what 
Harkin says or does, given that he’s not my Senator. As you may recall, arguably
no single legislator in the U.S. has done more to harm to the cause of
promoting science- and evidence-based medicine than Tom Harkin. That’s because
it was primarily through Harkin’s efforts that the National Institutes of
Health, despite the fact that its scientists were not agitating for it, had the 
National Center for Complementary and Alternative Medicine (NCCAM) rammed down
its throat in 1992, first as the Office of Alternative Medicine (OAM), then in
1998, when NIH Director Harold Varmus tried to place OAM under more scientific
NIH control, by elevating OAM to a full and independent Center within the NIH.
Thus was NCCAM born.

I’ve complained many times about how NCCAM funds studies that, let’s face it,
are of pseudoscience and quackery (homeopathy, anyone?) and even more about how 
it promotes unscientific medical practices. I’ve argued time and time again that
there is no research that is funded by NCCAM that couldn’t be dealt with as
well or better by other Centers or Institutes within the NIH. I’ve even argued
that NCCAM should be defunded and dismantled, allowing CAM grant applications to
be evaluated by the most appropriate center, as has our fearless leader Steve
Novella. Most vociferous of all has been my fellow SBM blogger Kimball Atwood,
who has made similar arguments at even greater length. I’ve also pointed out
Harkin and other CAM-friendly legislators created and managed to increase the
funding of NCCAM to the tune of $120+ million a year not for the purpose of
rigorous scientific evaluation of CAM practices, but rather to promote CAM and
ultimately “integrate” it with scientific medicine. At this they have been
enormously successful.

Let me clarify. What I meant is that NCCAM, along with the Bravewell
Collaborative, has been very successful in popularizing CAM in medical academia;
at “proving” that CAM works, not so much. Evidence that this is so comes from a
recent observation that Senator Tom Harkin is very, very unhappy with NCCAM
these days and has publicly said so recently, as pointed out by Lindsay
Beyerstein, daughter of the late, great skeptical psychologist Barry Beyerstein.
On Thursday, Harkin told a Senate panel, Integrative Care: A Pathway to a
Healthier Nation, that he was disappointed that NCCAM had disproven too many
alternative therapies. (His remarks begin about 17 minutes into the video on the
webpage to which I linked.) In addition, Harkin’s statements have also been
posted to his Senate blog:

   “I am pleased to co-chair this morning’s hearing with Senator Mikulski. And I
   am eager to hear our distinguished witnesses’ ideas on using integrative
   care to keep people healthy, improve healthcare outcomes, and reduce
   healthcare costs.

   “It is fashionable, these days, to quote Abraham Lincoln. So I would like to 
   quote from his 1862 address to Congress – words that should inspire us as we 
   craft health care reform legislation. Lincoln said, “The dogmas of the quiet 
   past are inadequate to the stormy present. The occasion is piled high with
   difficulty . . . . As our case is new, so we must think anew, and act anew.
   We must disenthrall ourselves, and then we shall save our country.”

   “Clearly, the time has come to “think anew” and to “disenthrall ourselves”
   from the dogmas and biases that have made our current health care system –
   based overwhelmingly on conventional medicine – in so many ways wasteful and 
   dysfunctional.

I note that on the video, Harkin does not say “conventional medicine.” In fact, 
he says “conventional allopathic medicine.” And, as any regular reader of this
blog knows, anyone who uses the term “allopathic” in such a contemptuous manner 
to describe conventional scientific medicine has clearly drunk the Kool Aid.
But, consistent with how I’ve warned that CAM advocates would do their best to
hijack any effort on the part of the Obama administration to reform the health
care system by trying to link all manner of unscientific woo to “prevention,”
Harkin goes on to do just that:

   It is time to end the discrimination against alternative health care
   practices.

   “It is time for America’s health care system to emphasize coordination and
   continuity of care, patient-centeredness, and prevention.

   “And it is time to adopt an integrative approach that takes advantage of the 
   very best scientifically based medicines and therapies, whether conventional 
   or alternative.

   “This is about giving people the pragmatic alternatives they want, while
   ending discrimination against practitioners of scientifically based
   alternative health care. It is about improving health care outcomes. And,
   yes, it is about reducing health care costs. Generally speaking, alternative 
   therapies are less expensive and less intrusive – and we need to take
   advantage of that.

Note the false dichotomy. It is not necessary to embrace pseudoscience in order 
to reform the health care system to emphasize “coordination, continuity of care,
and prevention.” Nor, I would argue, is it necessary to use placebo medicine as
a coequal to scientific medicine in order to reduce costs (unless, of course,
your goal is to reduce costs by not treating patients adequately), and, let’s
face it, placebo medicine is what the vast majority of the hodge-podge of
unscientific and pseudoscientific practices that fall under the rubric of CAM
are.

Most tellingly, Harkins makes the agenda of CAM advocates to hijack health care 
reform in order to get their foot in the door as “preventative” medicine as
plain as can be, exactly as I described recently. Harkins first prefaces his
remarks by explaining how he decided he wanted to write the legislation that
brought into existence the OAM and, later, NCCAM. Not surprisingly, it was based
on an anecdote about a friend of his from the House of Representatives who had 
a serious illness, tried “alternative” approaches, and supposedly got better.
Then, Harkins makes a startling admission:

   One of the purposes of this center was to investigate and validate
   alternative approaches. Quite frankly, I must say publicly that it has fallen
   short. It think quite frankly that in this center and in the office
   previously before it, most of its focus has been on disproving things rather 
   than seeking out and approving.

Note what Harkin first says here. He doesn’t say that the purpose of NCCAM was
to investigate alternative approaches and determine if they work or not,
regardless of what the results turned out to be. Rather, he states plainly that 
the purpose of NCCAM was to investigate and validate alternative approaches. His
concept for NCCAM is that it would prove that his favored woo works. That’s why
he’s so disappointed that the vast majority of the studies coming out of NCCAM 
are actually negative. Moreover, he clearly doesn’t understand how science
works. Hypothesis testing involves designing experiments or clinical trials that
can be falsified; i.e., “disproved.” If an experiment or clinical trial can’t
falsify the hypothesis that is being tested, then it is not really science.
Falsification (attempting to disprove the hypothesis) is at the heart of how the
scientific method works. But Tom Harkin does not want NCCAM to work by the
scientific method. Not really. He has claimed that he does, but his statements
above make it very clear that he only likes the scientific method when its
results are what he wants them to be. Under NCCAM, many studies have been
performed by believers under conditions quite favorable to producing apparently 
“positive results”; yet few and far between are any results resembling anything 
postive when it comes to NCCAM-funded studies, and they’re firtually nonexistent
for studies funded by NCCAM for the major favored CAM modalities, such as
“energy healing,” acupuncture, therapeutic touch. Only studies of herbs produce 
positive results, and such studies are nothing more than pharmacognosy, which
could be done in virtually any Institute, depending upon what natural product is
being studied. A special center for herbalism is not needed, and all the other 
CAM practices have, by and large, failed to stand up to even the favorable
scrutiny of NCCAM-funded studies.

In any case, now Senator Harkin is unhappy because NCCAM isn’t proving what he
wants it to prove. So what’s his new strategy? Why, to “integrate” these
therapies that have failed thus far to stand up to scientific scrutiny with
scientific medicine! In fact, he makes it very clear that he plans on yoking any
health care reform that President Obama tries to pass through the Congress to
the addition of integrative medicine:

   Since 1992 the field has evolved and matured. Today, we are not just talking 
   about alternative practices but also the integration between conventional and
   alternative therapies in order to achieve truly integrative health. We need 
   to have practitioners talking with each other, collaborating to treat the
   whole person. And this is the model we intend to build into our health care
   reform bill.

   On several occasions, I have laid down a public marker, saying that if we
   pass a bill that greatly extends health insurance coverage but does nothing
   to create a dramatically stronger prevention and public health infrastructure
   and agenda, then we will have failed the American people.

   Well, this morning, I want to lay down a second marker: If we fail to seize
   this unique opportunity to adopt a pragmatic, integrative approach to health 
   care, then that, too, would constitute a serious failure.

That, my dear readers, is what we are dealing with. A very powerful, senior
Senator invites “luminaries” of the CAM movement to testify in front of his
Senate committee and states openly that he will consider any health care reform 
that doesn’t include “integrative medicine” to be a failure. Funny, but as an
advocate of science- and evidence-based medicine, I would consider a health care
reform package that does include the integration of unproven health care
modalities, many of which are based on a pre-scientific understanding of
illness, with science- and evidence-based medicine to be a catastrophic failure 
of health care reform.

I encourage our readers, particularly the ones who are registered voters in
Iowa, to comment on Senator Harkin’s statement using the link at the bottom of
his blog entry.

Senator Tom Harkin and Representative Darrell Issa declare war on science-based 
                                    medicine

                                  David Gorski

                                      Link

In discussions of that bastion of what Harriet Hall likes to call “tooth fairy
science,” where sometimes rigorous science, sometimes not, is applied to the
study of hypotheses that are utterly implausible and incredible from a basic
science standpoint (such as homeopathy or reiki), the National Center of
Complementary and Alternative Medicine (NCCAM), I’ve often taken Senator Tom
Harkin (D-IA) to task, as have Drs. Novella, Lipson, and Atwood. That’s because 
Senator Harkin is undeniably the father of that misbegotten beast that has
sucked down over $2.5 billion of taxpayer money with nothing to show for it.
NCCAM is the brainchild of Senator Harkin, who foisted it upon the National
Institutes of Health not because there was a scientific need for it or because
scientists and physicians cried out for it but rather because Senator Harkin,
who believed that alternative medicine had healed a friend of his, wanted it,
and he used his powerful position to make it happen, first as the Office of
Unconventional Therapies, then as the Office of Alternative Medicine, and
finally as the behemoth of woo that we know today as NCCAM. The result has
included a $30 million trial of chelation therapy in which convicted felons were
listed among the investigators and a totally unethical trial of the Gonzalez
therapy for pancreatic cancer. It’s not for naught that Wally Sampson called for
the defunding of NCCAM, as have I and others. Not surprisingly, alternative
medicine practitioners are appalled at this idea.

Most recently, Harkin has been most disturbed by the observation that NCCAM’s
trials have all been negative, going so far as to complain that NCCAM hasn’t
produced any positive results showing that various alternative therapies
actually work. This is, of course, not a surprise, given that vast majority of
the grab bag of unrelated (and sometimes theoretically mutually exclusive)
therapies are based on pseudoscience. One of the only exceptions is the study of
herbal remedies, which is a perfectly respectable branch of pharmacology known 
as pharmacognosy. Unfortunately, as David Kroll showed, in NCCAM the legitimate 
science of pharmacognosy has been hijacked for purposes of woo. Meanwhile,
earlier this year, Senator Harkin hosted a hearing in which Drs. Dean Ornish,
Andrew Weil, Mehment Oz, and Mark Hyman (he of “functional medicine“) were
invited to testify in front of the Senate. Add to that other powerful
legislators, such as Representative Dan Burton (R-IN), trying to craft
legislation in line with his anti-vaccine views and pressure the NIH to study
various discredited hypotheses about vaccines and autism. Clearly, when it comes
to quackery, there are powerful legislative forces promoting pseudoscience and 
studies driven by ideology rather than science.

When politicians play politics with peer review

What brought this to mind (and led to my regurgitation of two paragraphs of
history about this) are two very disturbing pieces of news that surfaced on
Friday. They come from the opposite sides of the political spectrum. One, as you
might imagine, involves Senator Harkin. One involves a Republican. What they
share in common is that they serve to illustrate how perilous it is when
legislators try to insert their ideology into science and medicine funded by the
federal government.

Before I go on, I should point out that, in any endeavor funded by the federal
government, the insertion of some politics will be inevitable. It can’t be
otherwise, and I’m not sure that it should be. Legislators who write the laws
funding, for example, the NIH, the National Science Foundation (NSF), Medicare, 
and other federally-funded research are accountable to their constituents for
how taxpayer money is spent. However, poltics and science are all too often a
contentious mixture, which is why it is desirable to place as much buffers
between direct involvement meddling of legislators in the science as possible.
Part of the genius of how the NIH and NSF are set up is that scientists can
apply for funding for virtually any project they wish to do, and their proposals
will be considered seriously through careful peer review. In other words, it is
scientists, not politicians and bureaucrats, who decide what work is and is not
funded “in the trenches” on a day-to-day basis. Meanwhile, elected
representatives decide the overall broad picture of what is and is not funded
through legislation funding various agencies and through Presidential
appointment and Congressional confirmation of Directors of various agencies,
such as the NIH and NSF, who then hire the leadership of these agencies and
decide how they will run and what science they will emphasize. All in all, for a
product of the messy democratic process, it works pretty well, and the track
record of NIH- and NSF-funded research is the envy of much of the world (well,
except for NCCAM, but nobody’s perfect).

Of course, none of that stops legislators from periodically trying to insert
themselves into the process by passing laws targeting specific research
proposals, and that’s just what happened late last week through the passage of
hte so-called Issa Amendment to the FY 2010 Labor, Health and Human Services and
Education Appropriations bill. Specifically, Representative Darrell Issa (R-CA)
offered an amendment to rescind funding for three currently funded,
peer-reviewed NIH grants that that focus on HIV/AIDS prevention, and the the
House of Representatives passed the amendment by voice vote, and Issa is crowing
about it on his website:

   “It is my mission to hold the federal government accountable for its spending
   and the NIH is no exception, especially during the current economic crisis” 
   Issa said.  “These studies are clearly not high priorities for U.S. citizens,
   suffering from disease here at home, who could benefit from the $5 million
   the NIH plans to spend on foreign alcoholics and prostitutes.  We need to get
   the NIH’s priorities in line with those of the American people.”

Here are the grants that are targeted for de-funding through the Issa Amendment:

  1. Substance Abuse Use and HIV Risk Among Thai Women (1R21 DA026324): The
    proposed collaboration study between Ms. Usaneya Perngparn, Chulalongkorn
    University, Thailand and Dr. Nemoto, Public Health Institute, California,
    will investigate the sociocultural contexts of HIV risk behaviors and drug
    use among Thai female and male-to-female transgender (kathoey) sex workers
    in Bangkok. Research is currently needed to develop and adapt HIV prevention
    models that take into account sociocultural factors so that the further
    transmission of HIV and sexually transmitted infections can be averted.
    Participation in these types of studies also can provide a way for persons
    suffering from the health consequences of illicit sexual activity to receive
    treatment while contributing to our knowledge of prevention and treatment
    outcomes in these populations.

  2. HIV Prevention for Hospitalized Russian Alcoholics (5R01 AA016059):
    nvestigators are adapting a prevention approach that has been demonstrated
    to be effective in decreasing high-risk HIV related behaviors in the U.S.
    for use in Russia, a country with a rapidly expanding incidence of HIV.C2
    The approach, called Health Relationships Intervention, involves the
    development of a plan of action for each client to increase social support
    and reduce high-risk behaviors. This includes the disclosure of information 
    to family and friends on the client’s health, social needs and condition
    thereby assisting the client in maintaining low risk behaviors.

  3. Venue-based HIV and Alcohol Use Risk Reduction Among Female Sex Workers in
    China (1R01 AA018090): Research has provided evidence linking
    alcohol-related, high risk sexual behavior with HIV and other
    sexually-transmitted infections. Research has also provided rich
    descriptions of social, cultural, and economic contexts in which people
    engage in alcohol-related sexual risk behaviors. More specifically, alcohol 
    use characteristics (e.g., binge drinking) have been linked with sexual
    risk-taking that occurs in a range of high risk environments. The
    investigators have proposed a 5-year study to develop, implement, and
    evaluate a theory-guided, multiple components, and venue-based HIV and
    alcohol use risk reduction intervention among commercial sex workers (FSWs) 
    in China.

As an NIH-funded researcher and a taxpayer (of quite a bit of tax), I’m very,
very disturbed by this, and you as taxpayers should be too. Remember, these are 
grants that were submitted to the NIH for peer-review. Remember that the NIH
peer-review process is the gold standard. Thousands of grant applications per
year are evaluated by the study sections charged with reviewing them. In the
last three or four years, thanks to the flat NIH budget, which, thanks to
biomedical inflation (which is higher than the base rate of inflation), has led 
to an actual decrease in the purchasing power of the NIH budget allocated for
research gratns, as few as 10% of these new applications have been funded,
depending upon the Institute. This is a drastic decline compared to the five
year time period (FY 1998 to 2003) during which the NIH budget doubled. In those
halcyon times, up to 25% or even somewhat more of new grant applications were
funded. What this means is that the three grants that Issa is trying to de-fund 
were considered the cream of the crop as far as HIV/AIDS prevention. They likely
had to be at least in the top 15% of grant applications reviewed. What this
means is that Representative Issa is intefering with science based on ideology, 
not because the grants above represent bad science.

Unfortunately, studies like this are easy to ridicule if taken out of context of
the broader public health effort. As Dr. Andrew Tartarsky points out:

   Given that HIV/AIDS is a global epidemic that has already killed more than 25
   million men, women, and children and 33 million are currently living with
   HIV, it is clear that prevention of HIV infection should be a priority area
   of research funding.

   The research is easy to ridicule if it is taken out of its public health
   context. The fact is, scientists need to explore a range of research avenues 
   in vulnerable populations around the world to learn the best ways to control 
   the transmission of HIV. In response to previous congressional concerns about
   whether sexual health research should be funded by the agency, NIH reviewed 
   the entire NIH sexuality portfolio in 2004.

   That investigation found that all of the NIH grants in areas of sexual health
   met the rigorous standards of scientific and ethical quality, that they were
   not funded out of proportion to the public health burden of these diseases, 
   and that the merit review system had been followed.

Efforts by politicians like Rep. Issa to meddle in the peer review process and
second guess NIH peer-reviewers represent a threat to science-based medicine
every bit as profound as that of Sen. Harkin’s championing of pseudoscience. If 
Rep. Issa can force his ideology on the NIH (and let’s face it, this is almost
certainly about conservative religious views more than anything else), then
what’s to stop any other Representative (of which there are 435) or Senator (of 
which there are 100) from doing the same thing? Nothing. It’s also profoundly
demoralizing to scientists, as Drugmonkey points out:

   Great isn’t it? There you are, fighting to get your project funded,
   surmounting the usual procedural hurdles in the grant process. Finally, you
   get the grant funded and can get down to the business for which you are
   employed- doing good science in the interests of national, nay worldwide,
   public health. And some politician wants to prevent further funding of your
   project in the middle of the award period for naked political posturing
   purposes. Grand.

Grand indeed. There is a long history of various legislators trying to make
political hay out of NIH- and NSF-funded grants that are easy to ridicule if you
don’t know the science or the broader context of the research. It frequently
involves studies of sexuality, too. For example, back in 2003, then
Representative Pat Toomey (R-PA, who was also said to be planning to challenge
Arlen Specter for his Pennsylvania Senate seat) tried to shut down NIH grants
R01 HD043689 R03 HD039206, R01 DA013896, and R01 MH065871, all of which were
focused on sexuality. (Surprise.) Fortunately, his efforts were shot down
(narrowly, alas) and resulted in the formation of the Coalition to Protect
Research, part of whose mission is to educate legislators on the importance of
the peer review process. We can only hope that the horrible Issa Amendment is
removed from the final bill passed after a House-Senate Conference Committee.
You can help by contacting your Congressional Representatives to urge them to
remove the Issa Amendment.

Finally, let’s not forget the late Senator William Proxmire’s (D-WI) Golden
Fleece Award. Although the award often served to highlight truly wasteful
government spending, all too often as collateral damage it targeted in a
breathtakingly ignorant fashion scientific studies funded by various government 
agencies because they sounded funny to non-scientists. One researcher, after
having received such an honor, went through a rather nasty ordeal:

   This silliness went on for many years. The news stories began to swirl around
   like some kind of toxic cosmic dust. Senator Proxmire would return to
   Madison on a Sunday (to attend a Badgers’ football game); he’d take that
   opportunity to appear on a local TV show denouncing (sigh!) love research. I 
   would be asked to reply. On Monday, one of Senator Proxmire’s comic writers
   would issue a devastatingly funny press release (inaccurate but beguiling)
   about the inanities of our love and sex research. By Tuesday morning, I’d be 
   reeling from its aftershock. On Wednesday, the fallout would be settling in
   near Tokyo. Stories would appear in the Asahi Shimbun, Mainichi Shimbun, and 
   Yomiuri Shimbun. A few weeks later, The Bangladeshi Standard‘s Geiger
   counters would be clicking out the news. Each time an editor in Japan,
   Bangladesh, or Mozambique translated the story, a name would get misspelled
   here, a word altered there, and the next thing you know, the Wisconsin State 
   Journal would have picked up the challenge or comic riff yet again. The news 
   story would be so altered and so sensationalized—by now, Dr. Hatfield, the
   mad doctor of love, would be caught slipping women dime bags of marijuana,
   asking students to confess their darkest secrets while both were doing
   God-knows-what in their bedrooms— that the Journal would assume that somehow 
   they’d missed a heck of a story. Then once more the dust would start swirling
   around the earth, entering newer and higher orbits with each new news cycle.

   I got to know the postman very well indeed as he dragged in mail by the
   bagful…Crazy persons’ letters, with blood curdling threats. Spiky letters,
   painstakingly, tremblingly constructed. Letters written in Day-Glo colors.
   Words marching in an orderly way across the top of the page, down the sides, 
   and along the bottom, but then they began to sprawl in upon themselves,
   growing smaller and smaller as they whirled around the page. At the vortex,
   the microscopic calligraphy ended in a sinister inkblot. Letters filled with 
   pain and suffering. Most people, of course, wanted to know how they could
   scam some of the US government’s “loot” for themselves. When they discovered 
   they would have to dash off a grant—and actually get that grant reviewed—they
   were irate.

Imagine if the Internet had been as easily available in the 1970s as it is now.

I well remember in my youth hearing stories from Senator Proxmire of
government-funded studies looking at bear sperm or some other equally
ridiculous-sounding research (or so it seemed to me at the time). I’d chuckle
and wonder just what those scientists were smoking. Now that I am a scientist, I
realize just how toxic Senator Proxmire was when he targeted scientific
studies. Fortunately, however, as far as I know Senator Proxmire never tried to 
insert himself directly into the NIH and NSF peer-review process by directly
trying to stop one of these studies. These days, legislators are not content
with just making political hay by issuing press releases and awards. They want
to stop ongoing research projects.

When politicians impose their ideology on science-based policy

Then there’s Senator Harkin.

I’ve already gone on a bit of a rant about how Sen. Harkin wants to hijack
President Obama’s health care reform initiative in order to let alternative
medicine into the range of “services” funded by any new government health plan
by hiding it in the Trojan horse of “prevention” and “healthy living”
initiatives. Of course, Harkin and his fellow travelers co-opt diet and
exercise, both of which are science-based interventions, as somehow being
“alternative” and then use them as the “foot in the door” to introduce all sorts
of other “alternative” medical modalities that represent themselves as being
“prevention.”

Now, it appears, that Sen. Harkin has made his desire explicit, as described in 
an article that appeared in the Boston Globe on Friday:

   Naturopathic doctors, herbal healers, mind-body specialists, and
   acupuncturists often have been scorned by the US medical establishment, but
   growing numbers of Americans are seeking such care, and now an influential
   group of US senators believes the time has come to embrace an array of
   alternative therapies.

   Senator Tom Harkin, an Iowa Democrat who is a longtime supporter of
   nontraditional medicine, is at the forefront of the effort to win insurance
   coverage for such providers as part of national healthcare legislation.

   “It’s time to end the discrimination against alternative healthcare
   practices,’’ Harkin said at a congressional hearing.

   Harkin is the cosponsor of an amendment that says healthcare plans will not
   be allowed to “discriminate’’ against any healthcare provider who has a
   license issued by a state, an amendment Senate aides said was designed to
   provide coverage for alternative medicine.

Here’s the language that Sen. Harkin has slipped into the 615 page Senate
version of the health care reform bill:

   HEALTH PROFESSIONALS.—The term “health professionals” includes—

   (A) dentists, dental hygienists, primary 25 care providers, specialty
   physicians, nurses, nurse practitioners, physician assistants, psychologists 
   and other behavioral and mental health professionals, social workers,
   physical therapists, public health professionals, clinical pharmacists,
   allied health professionals, chiropractors, community health workers, school 
   nurses, certified nurse midwives, podiatrists, licensed complementary and
   alternative medicine providers, and integrative health practitioners;

Such a tiny passage in a huge bill, yet it has potentially enormous
consequences. If this part of the bill remains unchanged in whatever legislation
makes it through Congress later this year then any “alternative health care
provider” licensed by any state in the union will be entitled to compensation
for his services from the government and health insurance companies.

What does this mean? Let’s consider some examples. Acupuncturists are licensed
in 44 states; so in those states acupuncturists will be able to bill the
government and insurance companies for their services. Naturopaths are licensed 
in 15 states; so in those states naturopaths will be able to bill for their
services. Combine this with recent push by naturopaths to be considered “primary
care physicians,” and you can see the potential disaster looming. Remember,
naturopathy is the cornucopia of woo. Many of them include in their practice
supplements, acupuncture, reiki, and even homeopathy, which is considered to be 
within the normal scope of naturopathic practice. To them it’s all good as long 
as it’s “alternative.” Now that I mention homeopathy, let’s not forget that some
states actually license “homeopathic physicians,” states such as Arizona,
Connecticut, and Nevada. If Harkin has his way, these homeopathic physicians
will be able to bill the government and insurance plans for treating their
patients with water. Of course, if this bill passes with Harkin’s amendment
intact, you can then expect agitation by naturopaths and homeopaths in other
states in which they are not licensed to set up licensure, so that they can
equal their fellow woo practitioners fortunate enough to live in Arizona,
Connecticut, or Nevada or the 14 states that license naturopaths. It would only 
be fair, right?

Politics as a threat to science-based medicine

In an ideal world, scientists and physicians wouldn’t have to worry about the
intrusion of non-science-based ideology into the conduct of scientific research 
or science-based medicine. However, we do not live in an ideal world. Someone
has to fund science, and in the U.S. one major funder of biomedical and other
basic research is the federal government. Charities and philanthropic
organizations also fund research, but their funding is nearly always targeted
far more narrowly at the causes that are the raison d’être of individual
organizations. Pharmaceutical companies also fund considerable research, but
their priorities are profit-driven. In other words, if a given research project 
doesn’t have the potential to result in a marketable drug or product,
pharmaceutical companies are highly unlikely to fund it.

Which brings us back to the federal government, where support for woo is
bipartisan:

   The two main sponsors of the Senate amendment were Harkin and Senator Barbara
   Mikulski, a Maryland Democrat. Republicans, including the ranking member on 
   the Senate health committee, Senator Mike Enzi of Wyoming, also backed the
   amendment. The Senate committee on Health, Education, Labor and Pensions
   agreed to the measure, but it will be left to the Senate Finance Committee,
   which is working on companion legislation, to write crucial language
   regarding potential reimbursement, Senate aides said. The matter will then be
   debated on the Senate floor, and a similar amendment is expected to be
   offered in the House.

Moreover, the problem goes far beyond just biomedical science. Any endeavor of
the federal government which contains a large component based on science is fair
game, be it climate policy, the environment, the space program, or others.
Worse, as is the case with these others, the forces arrayed against
science-based medicine tend to be well-funded, more savvy politically, and
certainly more motivated than scientists are. Sen. Harkin, for example, knows
that few other legislators will understand the significance of the few lines he 
slipped into the healthcare reform bill and few of their constituents will
understand or care. The same is true of Rep. Issa regarding his naked attempt to
invalidate NIH peer review. Both also know that their fellow legislators are
highly unlikely to hold up such huge bills and that the President is highly
unlikely to veto them over such tiny amendments. Indeed, Sen. Harkin knows that 
health care reform is President Obama’s signature issue and that Obama
desperately wants to pass a major health care reform bill before the end of the 
year.

Unfortunately, as distasteful as it is, if we as physicians and scientists,
along with citizens who support science-based medicine, want to stop these sorts
of attempts to impose ideology-based, rather than science-based, medicine upon 
health care reform, we’re going to get involved in the political process. We’re 
going to have to contact our Senators and Representatives and tell them that we 
don’t want them interfering in peer review of individual competitive scientific 
grants and that we don’t want our taxpayer dollars going to pay for quackery.

Tom Harkin, NCCAM, health care reform, and a cancer treatment that is worse than
                                    useless

                                 David Gorski’

                                      Link

PRELUDE: SOME BAD NEWS FOR ADVOCATES OF SCIENCE-BASED MEDICINE

It was a bad week for science-based medicine. It was a good week (sort of) for
science-based medcine.

First the bad.

There has been a development that anyone who supports science in medicine and
opposes quackery will likely find disturbing. Do you remember Senator Tom Harkin
(D-IA)? We’ve written about him extensively over the last several months on
this blog. First of all, he is the man most responsible for the creation of that
government-sanctioned, government-funded bastion of pseudoscience, the National
Center for Complementary and Alternative Medicine. He’s also one of the men
most responsible for the Dietary Supplement Health and Education Act (DSHEA) of 
1994, which has done more to protect the supplement industry from making dubious
health claims than any other piece of federal legislation. More recently,
Harkin has made a name for himself in the health care reform debate currently
ongoing by inviting advocates of “integrative” medicine (IM), which in essence
integrates quackery and the pseudoscientific with scientific medicine, to
Capitol Hill as a means of trying to persuade his fellow legislators to include 
a CAM/IM version of “wellness” care as part of any bill that might pass this
fall. In essence, he is trying to hijack any health care reform bill to include 
government sanction of unscientific medicine. Meanwhile, he has been chastising 
NCCAM because it hasn’t “validated” enough “alternative medicine” for his taste.
(Actually, it’s validated none, because virtually none of it is likely to be
valid.)

This is the man who, according to reports, will almost certainly be taking over 
the chair of the Senate Committee on Health, Education, Labor, and Pensions
(HELP) after the death of its former chair, Senator Edward Kennedy. This
committee is among the most important for government health policy and will be
in the thick of the final negotiations and battles over any health care reform
that may arise from Congress this fall.

The existence of powerful supporters of pseudoscience in the highest eschelons
of government has real consequences. As I’ve described before, NCCAM, being
based entirely on studying highly–even ridiculously implausible–notions about
disease and how to treat it, has resulted in the infiltration of quackery into
academia, where ideas once rightly dismissed as quackery are respectfully given 
deference and studied as though they were anything other than Tooth Fairy
science, a process that Dr. R. W. Donnell has amusingly termed “quackademic
medicine.” One result was the expenditure of $30 million on an unethical, poorly
designed, and corrupt trial of chelation therapy for cardiovascular disease.
Another result was an even more unethical trial of an even more scientifically
implausible remedy for a deadly cancer. Although the fact that the trial was
even done is a horror, at least last week we finally found out the results,
which had been suppressed for nearly four years, namely that this protocol is
not just useless, but worse than useless. It’s a Pyrrhic victory for
science-based medicine and cold comfort to patients with pancreatic cancer who
may have continued to use this protocol during those four years, but at least we
finally know.

Let’s take a look at the study. But first, a little background.

PANCREATIC CANCER AND THE GONZALEZ PROTOCOL

Pancreatic cancer sucks.

There’s no other way to put it. It’s one of the most lethal, if not the most
lethal, cancer there is. There are several reasons for this. Less than 5% of all
patients diagnosed with pancreatic cancer are alive five years after diagnosis.
To put it another way, pancreatic cancer is the tenth most commonly diagnosed
cancer but number four in the list of cancer killers. That’s because most (at
least 80%) are diagnosed with unresectable and/or metastatic disease, for whom
surgery cannot be performed. Given that the only currently known possible chance
of long term survival in pancreatic cancer comes from a complete surgical
resection of the cancer with negative surgical margins (i.e., no tumor at the
margins of the surgical specimens and a rim of normal tissue between the margin 
and the tumor), any pancreatic cancer patient who is not a candidate for surgery
has incurable disease. Of the minority of patients who do have their cancer
completely resected surgically, the five year survival rate is better, perhaps
in the range of 15-20% or so, but still the vast majority will be dead within
five years, usually much less. Moreover, known as a pancreaticoduodenectomy or
Whipple procedure, the surgery necessary to remove a pancreatic cancer in the
head of the pancreas (the most common location) is a huge operation that
involves removing the head of the pancreas and the duodenum and then
reconstructing the connections between the bile and pancreatic ducts and the GI 
tract and establishing continuity between the stomach and small intestine. It’s 
a tour de force operation that often takes 8 hours or more and is fraught with
the potential for complications, both short term and long term. However, for
someone with a potentially resectable pancreatic cancer in the head of the
pancreas, it is the patient’s only hope. Even so, after surgery, median survival
times still only range from 12 to 19 months.

Because the outlook for pancreatic cancer, particularly unresectable pancreatic 
cancer is so grim (the median survival has barely budged from less than six
months for decades. Median survival for untreated metastatic pancreatic cancer
is on the order of 3-4 months, although gemcitabine chemotherapy regimens
combined with radiation) can result in median survivals of six months or more.
For locally advanced pancreatic cancer that cannot be resected but has not
metastasized, the median survival is on the order of 6-12 months depending on
the study. Thus, we can rightly say that pancreatic cancer is one of those
cancers for which science-based medicine has frustratingly little to offer that 
can cure it. That’s not to say that science-based medicine doesn’t have a lot to
offer for palliation, but no one wants just palliation. We all want to live to 
a ripe old age, not just have our pain and nausea palliated for a few months
before cancer claims us. Even scarier is that pancreatic cancer usually produces
few or no symptoms until it is fairly advanced. Usual symptoms include vague
upper abdominal discomfort, loss of appetite, and post-prandial nausea from
intermittent gastric outlet obstruction, you know, the sorts of symptoms that
nearly of us have from time to time and that primary care doctors see in their
practice every day. By the time a pancreatic cancer causes severe pain or
obstructs the bile duct leading to jaunice, it’s usually unresectable or
metastatic. (Often the reason it causes such severe pain is because it invades a
plexus of nerves just posterior to the pancreas.)

It is the very deadliness of pancreatic cancer and the lack of effective
life-saving or life-prolonging treatments for it that make pancreatic cancer a
ripe condition for quackery. Rising above most other quackeries to attract a lot
of attention about a decade ago is a quackery known as the Gonzalez protocol.
It is described on Dr. Nicholas Gonzalez’s website as involving dietary changes,
supplements, the replenishment of pancreatic proteolytic enzymes, and
“detoxification,” including coffee enemas. It is not an easy therapy to undergo.
For example, Dr. Gonzalez states:

   Overall, cancer patients will consume 130-175 capsules a day, including
   nutrients as well as enzymes. Non-cancer patients might consume in the range 
   of 80-100 capsules a day, the exact number depending on their health status
   and medical problems.

I know of no science-based cancer protocol that requires a patient to consume
150 pills a day. There are also the dietary alterations that can be quite hard
to follow, as well as the frequent coffee enemas. All in all, the Gonzalez
protocol is an arduous regimen for a debilitated pancreatic cancer patient to
follow. Still, for some reason, it gained some popularity in the “complementary 
and alternative medicine” (CAM) community, so much so that, based on poorly
designed case series of eleven patients, Dr. Gonzalez managed to get a clinical 
trial funded by the NIH to study his method versus standard chemotherapy, a
sordid story that Dr. Atwood has chronicled in detail in a long series of blog
posts. That trial ended in 2005.

So why is it 2009 before we have the results of this trial, which show that the 
Gonzalez protocol is worse than useless? The trial, begun in 1999, is known
formally as Prospective Cohort Study of Gemcitabine Versus Intensive Pancreatic 
Proteolytic Enzyme Therapy With Ancillary Nutritional Support (Gonzalez Regimen)
in Patients With Stage II, III, or IV Adenocarcinoma of the Pancreas. The
results were finally reported in an E-pub ahead of print manuscript for the
flagship journal of the American Society of Clinical Oncology, the Journal of
Clinical Oncology, and entitled Pancreatic Proteolytic Enzyme Therapy Compared
With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer,
written by John A. Chabot, Wei-Yann Tsai, Robert L. Fine, Chunxia Chen, Carolyn 
K. Kumah, Karen A. Antman, and Victor R. Grann.

A CLINICAL TRIAL STUDYING FAIRY DUST VERSUS CHEMOTHERAPY

One reason why we emphasize prior probability so much here at SBM is because it 
matters. Nowhere have I seen it matter quite as much as in the genesis of a
trial of the Gonzalez protocol for pancreatic cancer. The reason is that the
“scientific” rationale behind these megadoses of supplements and pancreatic
enzymes plus “detoxification” by coffee enemas is what Harriet Hall terms “Tooth
Fairy science.” The Gonzalez treatment is basically a modification of a
protocol known as the Kelley Treatment, which in turn was very similar to the
Gerson protocol. Chabot writes in the introduction to this study:

   The Scottish embryologist John Beard first proposed pancreatic proteolytic
   enzyme treatment in 1906 and soon after published a monograph, entitled The
   Enzyme Therapy of Cancer. In 1981, Nicholas Gonzalez began to evaluate the
   use of proteolytic enzyme therapy. Twelve years later, in 1993, he was
   invited to present a series of cases at the National Cancer Institute (NCI), 
   which led him to undertake a case series of alternative medical therapy that 
   included proteolytic enzymes, diet, nutritional supplements, and
   detoxification procedures. Among 11 patients with inoperable, biopsy-proven, 
   stages II to IV pancreatic adenocarcinoma, he reported 81% survival at 1 year
   and 45% at 2 years. Four of the 11 patients survived for 3 years.

This is the very example of an implausible hypothesis. True, it’s not as
implausible as homeopathy (few hypotheses are), but it goes against everything
we know about cancer in general and pancreatic cancer in particular. There is no
evidence that pancreatic enzyme deficiency has anything to do with pancreatic
cancer, for example. Nor is there any evidence that this discription of the
rationale behind the Gonzalez protocol, cribbed straight from the NCI website,
has any relationship to reality:

   Two major concepts underlie use of the Gonzalez regimen in cancer treatment. 
   The first concept is that the pancreas, like the liver, is an organ that
   performs a detoxification function and that pancreatic enzymes help the body 
   eliminate toxins and help normal cells repair damaged cells.[2] The second
   concept is that cancer and most other human illness are related to
   physiological imbalances created by environmental toxins either consumed in
   food or contacted in the environment.[2,3]

   Proponents of the Gonzalez regimen believe that toxins from sources such as
   processed foods and environmental pollution are responsible for human
   cancers. These toxins are thought to accumulate in tissues and over time
   create imbalances in the autonomic nervous system, diminish the normal immune
   response, and give rise to cellular damage that can lead to cancer.[2,3] If 
   these toxins could be neutralized and eliminated from the body, proponents
   believe, both early and established cancers would be halted, and general
   health would be restored.[2,3]

Here’s the problem. These “toxins” are never identified, nor is there any
evidence that the Gonzalez regimen actually removes them. It’s not that
environmental exposures don’t have an effect on cancer susceptibility. Smoking
can cause lung cancer and, ironically enough, increase the risk of pancreatic
cancer as well. “Detoxification” quackery like the Gonzalez protocol takes
science and turns it into Tooth Fairy science by giving near magical
characteristics to these “toxins.” In any case, cancer is primarily a genetic
disease. Even heavy smokers who smoke for 50 years “only” have about a 25%
lifetime risk of developing lung cancer, which means more smokers don’t get lung
cancer than do. In any case, think about it: Let’s say there is this host of
unnamed, undefined “toxins” that give you pancreatic cancer. Remember, the
toxins from tobacco smoke that predispose to lung cancer are largely known and
quantifiable. Why would one think that coffee enemas would remove those
“toxins”? Certainly there is no scientific basis to think that the special diet,
the dozens of capsules of supplements and pancreatic enzymes, or the other
aspects of the regimen would “detoxify” anything. Basically, the Gonzalez
protocol appears to derive from a prescientific notion of disease that is almost
religious in its nature blaming “contamination” as the cause of all disease and
that one must “purge oneself” of this “contamination” to cure the disease.

But, say Gonzalez supporters, what about the case series of 11 patients with
stage II to IV pancreatic cancer from the 1990s reporting 81% survival at 1 year
and 45% at 2 years, with 4 of the 11 patients surviving for 3 years? As Dr.
Atwood pointed out, this was a nonconsecutive case series, a so-called “best
case” series. Basically, it’s a cherry-picked series, and I’ve criticized “best 
case” series before because they in essence intentionally look at outliers for
whom the therapy may or may not have made a difference. Some patients with
pancreatic cancer do survive longer than a year. Indeed, actor Patrick Swayze is
one such patient, who has now been alive over a year and a half since being
diagnosed with stage IV pancreatic cancer with liver metastases. Without knowing
the denominator (i.e., how many patients Gonzalez treated to produce those 11
patients with significantly better than average survival for pancreatic cancer),
his case series is meaningless. Indeed, back in my old Usenet days in the late 
1990s and early 2000s, I would frequently comment that if I were to apply for a 
grant at the NIH to fund a clinical trial based on such a thin gruel of
preliminary data, my application would have found its way to the cylindrical
file. The trial for the Gonzalez protocol did not. Selection bias is a wonderful
thing if you’re peddling unscientific cancer therapies, where patients who
actually could undergo the rigorous Gonzalez protocol would be more likely to be
doing better and thus more likely to continue to do better than average,
therapy aside.

So what was this trial? These were the objectives:

  1. Compare the survival of patients with stage II, III, or IV adenocarcinoma of
    the pancreas treated with gemcitabine versus intensive proteolytic enzyme
    therapy and adjunctive dietary and nutritional support.

  2. Compare the quality of life in patients treated with these regimens.

The two arms of the study were described thusly:

This is an open-label study. Patients are stratified according to stage (II or
III vs IV), performance status (0-1 vs 2) and nutritional status (well nourished
or moderately malnourished vs severely malnourished). Patients are entered into
1 of 2 treatment arms at their choice:

   Arm I (Nutritional Arm): Patients receive pancreatic enzymes orally every 4
   hours and at meals daily on days 1-16, followed by 5 days of rest. Patients
   receive magnesium citrate and Papaya Plus with the pancreatic enzymes.
   Additionally, patients receive nutritional supplementation with vitamins,
   minerals, trace elements, and animal glandular products 4 times per day on
   days 1-16, followed by 5 days of rest. Courses repeat every 21 days until
   death despite relapse. Patients consume a moderate vegetarian metabolizer
   diet during the course of therapy, which excludes red meat, poultry, and
   white sugar. Coffee enemas are performed twice a day, along with skin
   brushing daily, skin cleansing once a week with castor oil during the first 6
   months of therapy, and a salt and soda bath each week. Patients also undergo
   a complete liver flush and a clean sweep and purge on a rotating basis each 
   month during the 5 days of rest.

   Arm II (Chemotherapy Arm): Patients receive gemcitabine-based chemotherapy.

   Quality of life is assessed at 0, 2, 6, and 12 months and then yearly
   thereafter.

   Patients are followed at 1, 3, 7, and 12 months and then yearly thereafter.

Arm I is the very epitome of Tooth Fairy science.

A word needs to be said about the design of this study. It is not randomized,
and it is not double-blinded. It was originally designed as a randomized but not
blinded study, given the difficulty in blinding which group is getting coffee
enemas, for example, and which were not. (I can see how placebo enemas would be 
a problem.) Even so, because placebo effects would not be evident in the
objective outcome, namely survival, this would not be a major problem in a study
of this sort, although the lack of blinding could conceivably affect the
quality of life measurements. Unfortunately, investigators could only accrue
three patients between 1999 and 2001; so in 2001, the trial protocol was
converted from a randomized phase III design to an open label observational
design. Basically, patients picked which therapy they wanted, and the
investigators prospectively studied how they did. The figure below shows the
ultimate flow of patients:

One serious problem with a nonrandomized design like this is the likelihood of
selection bias. In this case, it would be “self-selection” bias in that
investigators would have to worry whether patients who were either worse off or 
better off might opt preferentially for one arm of the trial over the other. I
will address that point after we look at the results, which are quite striking:

In words:

   At enrollment, the treatment groups had no statistically significant
   differences in patient characteristics, pathology, quality of life, or
   clinically meaningful laboratory values. Kaplan-Meier analysis found a
   9.7-month difference in median survival between the chemotherapy group
   (median survival, 14 months) and enzyme treatment groups (median survival,
   4.3 months) and found an adjusted-mortality hazard ratio of the enzyme group 
   compared with the chemotherapy group of 6.96 (P<.001). At 1 year, 56% of
   chemotherapy-group patients were alive, and 16% of enzyme-therapy patients
   were alive. The quality of life ratings were better in the chemotherapy group
   than in the enzyme-treated group (P <.01).

Moreover, the quality of life, as measured by standardized surveys, was actually
worse for the Gonzalez therapy group:

   Patients in the two groups responded similarly to the questionnaires on
   quality of life before initiation of therapy, but the overall FACT-PA scores 
   during 12 months decreased more in the enzyme group than in the gemcitabine
   group (Fig 3). Twenty-four percent of total measurements were missing.
   Quality of life scores of both groups were significantly different (P<.01).
   During the first 6 months of the study, pain scores increased in the enzyme
   group, but they decreased in the chemotherapy group (P <.05); however, few
   patients reported on use of analgesics. (Table 2).

In all my years in medicine, surgery, and surgical oncology, I have never seen a
study with such a striking difference in outcome between the two groups. No
wonder the Office for Human Research Protections (OHRP) issued a determination
letter stating that it was appropriate to terminate the study before the full 72
patients were enrolled due to the study having reached its “predetermined
stopping point.” These days, clinical trials are designed with periodic
assessment of results and predetermined stopping points. These stopping points
are invoked to shut down the trial in the event that one group is doing so
significantly better than the other that enrolling the remaining patients could 
not possibly change the result. The purpose of such a stopping point is to
protect clinical trial subjects from being enrolled in a study that no longer
has clinical equipoise; i.e., the groups can no longer be predicted to have
roughly equivalent outcomes based on what we know. Usually, it’s the
experimental group that does better than the control group. At least that’s the 
intent. Sometimes, however, as in the case of the Gonzalez protocol, it’s the
experimental group that did much worse, so much so that the study was halted
before reaching its full accrual.

But it’s even worse than that. Not only was the median survival of patients in
the Gonzalez therapy group worse than it was for the standard chemotherapy
group, it was three times worse. At one year, 56% of the chemotherapy patients
were alive; only 16% of the Gonzalez protocol patients were. But it’s still even
worse than that for the Gonzalez therapy. Not only did Gonzalez therapy
patients do worse than those receiving standard therapy, but they did worse than
the “average” pancreatic cancer patient as determined by the survival curve
derived from data from the SEER Database. The most likely reason to explain such
a result is that the Gonzalez therapy is not just inferior to gemcitabine but
is probably completely biologically inactive against pancreatic cancer. What we 
are looking when we examine the survival curve for the Gonzalez protocol group
is, most likely, indistinguishable from a survival curve of untreated pancreatic
cancer versus treated.

Is this study a slam dunk? Is the Gonzalez therapy, for all intents and
purposes, dead? For the most part, yes, but there are a few problems. Of course,
the nonrandomized nature of the trial makes it possible that biases crept in.
As I mentioned before, that is always a potential problem with a nonrandomized
study design. Fortunately, the patients in each group ended up being reasonably 
well matched in age, gender, and other demographics. There was, however, at
least one relevant difference that no one discussed. Indeed, I’m surprised that 
the investigators didn’t mention it, as it could have at least partially
suggested a reason why the Gonzalez group might have done so poorly early on.
It’s unlikely to have made a difference big enough to have explained the huge
difference between patient groups, but it would at least have been a straw to
grasp at. Specifically, the serum albumin levels in the Gonzalez group were
statistically significantly lower than they were in the control group. Albumin
is a rough estimate of nutrition (although there are better parameters) and we
surgeons know that lower albumin levels are associated with increased early
mortality in pancreatic cancer. I doubt that this is anywhere near enough to
explain such a huge difference in mortality between the two groups, especially
since the difference between the albumin levels in the two groups was relatively
small (4.3 g/dL versus 4.0 g/dL), with the Gonzalez group still having albumin 
levels within the normal range, but it is one difference that caught my eye. It 
is also likely (but not well explained) that there were differences in
supportive care, such as the rate of inserting biliary stents to relieve bile
duct obstruction or aggressively treating infections such as ascending
cholangitis, which is one of the most common causes of death in pancreatic
cancer patients. The obstructed bile duct causes bile to back up; the bile gets 
infected; and the patient develops a life-threatening infection. The primary
treatment is biliary drainage, either through a tube inserted endoscopically
into the bile duct or inserted through percutaneously into the bile ducts in the
liver. Antibiotics are necessary, too, of course, but they don’t do much good
without biliary drainage. Also, if there was a difference in palliative care
between the two groups, that, too, would be yet another example of the unethical
nature of this trial.

The one thing that surprised me about this study was not so much that the
Gonzalez group had the same mortality and median survival as, in essence,
untreated pancreatic cancer patients (which they are), but rather that the
survival in the gemcitabine group was so long (14 months). This is better than
most studies of gemcitabine-based regimens from the time period during which
patients accrued to this study (although results of more recent trials have been
better). This suggests a possibility of some unexpected selection bias.
Alternatively, it could be that this is simply an outlier group. However, it’s
highly unlikely that it invalidates the study. Given the striking difference
between the two groups and the fact that the Gonzalez group did more poorly than
historical controls, from this study we can confidently say that the Gonzalez
protocol is almost certainly no better than no treatment.

In fact, it’s probably worse. Go back to Dr. Atwood’s post on this issue and
consider the story of an unfortunate 40 year old man who enrolled in the trial
and chose the Gonzalez protocol arm. This man was told to have his fillings
removed and afterward tried as hard as he could to continue the regimen to the
letter and suffered horribly as he did. At one point he was even told that
increasing pain might be an indication that his tumors were “dissolving.”
Although it may be that the Gonzalez protocol didn’t make his pain worse, it’s
quite clear that the man’s pursuing the therapy kept him from persuing effective
palliative care that might have made his last few months on this earth a lot
less unpleasant. Indeed, this makes me wonder what the investigators did after
the trial was closed. From an ethics standpoint, every patient in the Gonzalez
arm should immediately have been informed of these results and been strongly
encouraged to give up the Gonzalez protocol and undergo standard gemcitabine
chemotherapy.

Finally, the most disturbing issue that this trial raises is the question of why
it took nearly four years after the trial was stopped to publish the results.
Dr. Atwood has speculated why this might be the case, namely to cover up the
results that were unfavorable to Gonzalez. There is now no doubt that this trial
was completely unethical right from the very beginning, but that lack of ethics
was compounded by not having the results reported right away. In this, after
having had a few days to think about it, I am going to have to strongly disagree
with my co-blogger Dr. Atwood when he asserted, “A compelling argument can even
be made that the JCO should not have published the report—as paradoxical as
that sounds.” I can understand where he’s coming from. This study clearly
violates the Helsinki Declaration, to which JCO requires the clinical trials
that it publishes to adhere. However, I find an it equally, if not more,
compelling to take the view that the patients who suffered in the Gonzalez group
will have suffered in vain if the results of this trial were not published. I
also tend to take the view that shining a light on such a trial, in the form of 
publication, is a good thing in this particular case because it eliminates the
uncertainty over whether the results were as bad as we know them to be. Let’s
put it this way: If the results were not published in a peer-reviewed journal
but rather announced or mentioned in a report, they would seem less credible to 
shruggies. It is these people who need these bad results rubbed in their noses, 
the better to let the stench waft into their nasal passages and make them retch.
When they ask, “What’s the harm,” we can tell them in no uncertain terms what
the harm is. The same would apply if they were simply announced on
ClinicalTrials.gov or mentioned in a report. It’s just not the same as a
peer-reviewed publication in one of the highest impact oncology journals there
is. This is truly a case where the greater good can be served by disseminating
this data far and wide as soon as possible by the most scientifically credible
means necessary.

One thing that is most remarkable is that this study was released without any
fanfare whatsoever. You can bet that, had the results been positive, it would
have been trumpeted with press releases. I bet that even if the results had
shown that the Gonzalez protocol was no worse than “conventional” therapy, it
would have been trumpeted as “Gonzalez therapy as good as conventional
chemotherapy!” to the press. Yet, here we have exceedingly striking results, and
what do we hear? Nothing.

TOM HARKIN, NCCAM, AND HEALTH CARE REFORM

I now return to the issue of Tom Harkin’s likely taking over Senator Kennedy’s
old chair and why it matters. The reason it matters is because Tom Harkin is not
a science-based man. He is the man most responsible for the creation of NCCAM
and has in 2009 been doing his best to infiltrate coverage for CAM in any
government health care reform legislation that may come. Yet that doesn’t stop
organizations like The Foundation for the National Institutes of Health,
Research!America, and the Albert and Mary Lasker Foundation from awarding Harkin
a “Champions of Research” award. While it’s true that Harkin seems a strong
supporter of the NIH on the surface, at the same time he is a corrosive
influence, inserting his belief in CAM/IM into the NIH and pushing to promote
it. Without NCCAM, Tom Harkin, and Dan Burton, the latter of whom in particular 
pushed the NIH to fund the Gonzalez protocol, this pseudoscientific and highly
unethical study is highly unlikely ever to have been funded.

Now Tom Harkin, who has “distinguished” himself by trying to hijack health care 
reform to give undeserved legitimacy to therapies like the Gonzalez protocol and
even to have the government pay for such quackery, is now in charge of one of
the key committees involved with government health policy. I fear he’ll do for
health care reform what he did for the NIH through NCCAM.

Be afraid. Be very afraid.

REFERENCE:

John A. Chabot, Wei-Yann Tsai, Robert L. Fine, Chunxia Chen, Carolyn K. Kumah,
Karen A. Antman, & Victor R. Grann (2009). Pancreatic Proteolytic Enzyme Therapy
Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic
Cancer Journal of Clinical Oncology : 10.1200/JCO.2009.22.8429 (E-pub ahead of
print).

Congress will soon lose its foremost supporter of quackery, but will it matter?

David Gorski on January 28, 2013

Link



Tom Harkin, the NCCAM’s biggest supporter.

I don’t much like Senator Tom Harkin (D-IA), and, I daresay, neither do any of
my fellow bloggers here.

The reason should be painfully obvious. Arguably, no single elected official
currently serving today (or ever) has done more over a longer period of time to 
promote quackery in the United States. I make this harsh assessment because
Senator Harkin was the legislator who created the National Center for
Complementary and Alternative Medicine (NCCAM) and has been its most powerful
patron, promoter, and protector. It’s a center in the National Institutes of
Health (NIH) of which we at this blog have regularly been quite critical, right 
from the very beginning, when I pointed out how our taxpayer dollars were being 
wasted on pseudoscience and quackery, while Wally Sampson provided some
perspective on how this situation came to be and I gave a bit of history of
NCCAM. Since then, we’ve been hammering away at NCCAM as a blight on the the
science of the NIH, whether intramural or extramural.

Three years ago, we even managed to attract the notice of Josephine Briggs, the 
current director of NCCAM, who invited us to Bethesda for a meeting. It was a
very cordial meeting, as described by Steve Novella and myself. Unfortunately,
in the name of “balance,” Dr. Briggs turned right around and met with a bunch of
homeopaths and then drew a false equivalency between us “skeptics” and
proponents of quackery as represented by the homeopaths. Clearly, she didn’t get
it, or, if she did get it, her position was such that she couldn’t bite the
hand that feeds NCCAM. A year after that, NCCAM published a five year strategic 
plan, which I characterized as “let’s do some rigorous science for a change,”
given that that’s about all it said. It’s a nice sentiment. We’ll see if it
actually happens, although I doubt that it will. Although studying herbs is
nothing but a form of pharmacognosy (natural products pharmacology) and studying
lifestyle interventions is science-based medicine, neither of them are actually
“CAM” per se, because there is nothing “alternative” about them other than
their having been co-opted as a “foot in the door” grafted onto the more serious
woo. Like a stray limb grafted onto Frankenstein’s monster, they don’t belong
and don’t fit.

But I digress. NCCAM has that effect on me.

A Congressional champion of quackery decides to quack no more (after 2014,
anyway)

It turns out that over the weekend, Senator Harkin announced that he will not
seek a sixth term as a Senator:

   U.S. Sen. Tom Harkin said Saturday he will not seek a sixth term in 2014, a
   decision that eases some of the burden the national Republican Party faces in
   retaking the Senate.

   Harkin, chairman of an influential Senate committee, announced his decision
   during an interview with The Associated Press, saying the move could surprise
   some.

   The 73-year-old cited his age — he would be 81 at the end of a sixth term —
   as a factor in the decision, saying it was time to pass the torch he has held
   for nearly 30 years, freeing a new generation of Iowa Democrats to seek
   higher office.

   “I just think it’s time for me to step aside,” Harkin told the AP.

   Harkin, first elected in 1984, ranks seventh in seniority and fourth among
   majority Democrats. He is chairman of the Health, Education, Labor and
   Pensions Committee, and chairman of the largest appropriations subcommittee.

So, after his 30 years in the Senate promoting quackery, after January 3, 2015
we at SBM won’t have Tom Harkin to kick around anymore. This comes hot on the
heels of the retirement of the other biggest promoter of quackery in Congress,
Representative Dan Burton (R-IN), who declined to run for re-election last year 
and went off into the sunset a few weeks ago when the new Congress was sworn in.
He’s been a fairly frequent target of criticism, albeit less so than Tom
Harkin, on this blog as well, in particular for his promotion of his antivaccine
views, his defense of the supplement industry against the FDA, his key role in 
the the Dietary Supplement Caucus, and his role in instigating one of the most
unethical, wasteful clinical trials of all time, the randomized trial of the
Gonzalez therapy for pancreatic cancer, a trial that was not just negative but
showed that patients undergoing the Gonzalez therapy actually did considerably
worse than patients undergoing standard treatment.

The ironic thing about Tom Harkin is that, if you ask researchers and officials 
at the NIH, they’ll tell you that Harkin is a major supporter of the biomedical 
research in general and the NIH in particular. In addition, organizations like
The Foundation for the National Institutes of Health, Research!America, and the 
Albert and Mary Lasker Foundation, and others from declaring Harkin a “champion 
of research.” For instance, the National Alliance on Mental Illness declared him
a “champion of neuroscience research,” and an organization to which I belong,
the American Association for Cancer Research, recently awarded him an AACR Award
for Distinguished Service and Global Impact in Cancer and Biomedical Research. 
These are just the most recent awards and recognitions of many over the years.
While it’s true that Harkin seems a strong supporter of the NIH on the surface, 
at the same time he is a corrosive influence, inserting his belief in CAM (or,
as it’s increasingly being called, “integrative medicine”) into the NIH and
pushing to promote it. Losing him is not going to be an unalloyed good in that
the NIH and biomedical research will lose a champion just as much as the quacks 
will.

Harkin and Herbalife: Two great woos that woo great together

The question, of course, is: Why now? Why is Harkin retiring now? Sure, it might
have something to do with his stated reasons. He might be tired. He’d be 81 at 
the end of another term, and maybe he wants to relax. On the other hand, the
history of the Senate is replete with octogenarians and nonagenarians like Strom
Thurmond and Frank Lautenberg serving until they’re carried out feet first.
Compared to them, Harkin is a mere pup. He could potentially serve another two
terms at least, given the propensity of senators to keep legislating until they 
drop.

Maybe this story, published around the same time as Harkin’s announcement, might
at least partially explain his puzzling decision. Basically, it’s the story of 
how Senator Harkin has been the biggest patron of Herbalife, so much so that the
title of the story refers to Harkin as “(D-Herbalife):

   Harkin has served as Herbalife’s chief patron in the federal government for
   decades. Harkin attended the company’s “New Orleans Extravaganza” in June
   2002 to speak to Herbalife officials and distributors about “the status of
   preventative healthcare in the U.S.” Harkin also spoke at the company’s 25th 
   Anniversary “Atlanta Extravaganza” in April 2005. “Il Senatore Tom Arkins”
   addressed a confab of some 35,000 Herbalife consultants about a bill he
   sponsored to make “good nutrition available to everyone,” according to an
   English translation of a report from Leonardo di Paola, an Italian Herbalife 
   distributor.

   An interview of Harkin in Herbalife’s internal newsletter illustrates the
   symbiotic relationship.

Indeed it does. In the interview, Harkin expresses pride for having been one of 
the chief architects of the Dietary Supplement Health and Education Act (DSHEA) 
of 1994. This law, which is about as bad a law as you can imagine, basically
gives supplement manufacturers a nearly free pass in marketing and selling their
supplements. As long as they don’t make specific health claims for their
supplements, they can sell practically anything, or, as Peter Lipson put it,
“sell whatever you want, just don’t let us catch you.”

As for Harkin’s relationship with Herbalife, let’s just say that it’s been
longstanding and mutually profitable. Harkin gets campaign cash (Herbalife has
been Harkin’s top donor for many years now) and now gets cash for his new policy
institute, while Herbalife gets legislation favorable to its interests (such as
the DSHEA) and a champion in Congress in the form of a very senior senator who 
has a history of fighting tooth and nail against any attempt to pass laws
imposing meaningful science-based regulations on the supplement industry while
trying his best to insert coverage for CAM therapies in the 2009 Patient
Protection and Affordable Care Act (PPACA). It also gets quality face time with 
the Senator, as described in the story in The Iowa Republican:

   In the summer of 2011, when most Hawkeye State politicians spent sweaty
   sessions with constituents in Iowa’s communities, Sen. Tom Harkin (D-Iowa)
   sat down to a steak dinner with a team of corporate lobbyists and executives 
   in Beverly Hills, Calif.

   Harkin, along with Jeremy Gold, the finance director for his 2014 Senate
   campaign, met Herbalife International executives at the Four Seasons Hotel at
   8 p.m. on Aug. 16. Before Harkin’s rendezvous with Herbalife’s high command,
   he took a meeting with Hollywood mogul and Democratic donor Steve Bing,
   according to Harkin’s official schedule, which was provided to
   TheIowaRepublican.com by a source in Harkin’s Washington, D.C. office.

   After Harkin’s meeting with Bing, whose company donated $250,000 to Majority 
   PAC, Senate Democrats’ so-called super PAC, he met with Herbalife
   executives—CEO Michael Johnson, chief legal officer Brett Chapman and chief
   lobbyist John Venardos. The fivesome dined at CUT Restaurant, the “classic
   steakhouse” designed by chef Wolfgang Puck, where a steak can set you back
   $160. The “chic spot in the heart of Beverly Hills… has become the place to
   see and be seen,” according to CUT’s website.

   Harkin and Herbalife officials chatted about America’s obesity epidemic,
   which Herbalife aims to combat with its line of weight-loss products, and
   Federal Drug Administration regulations, Venardos said. The 32-year-old
   company sells its products through independent distributors in more than 80
   countries.

   In Oct. 2011, two months after the swank supper, Venardos pledged $100,000 on
   behalf of Herbalife to the Harkin Institute of Public Policy at Iowa State
   University in Ames. He is the company’s senior vice president of worldwide
   regulatory, government and industry affairs, but he is not registered as a
   federal lobbyist (he terminated his registration in 2007).

The wag in me can’t help but note that this meeting among “natural health”
advocates didn’t take place in a vegan—or even vegetarian—restaurant, but in a
steakhouse, and a very expensive and swanky one at that. I suppose that those
Herbalife products must protect very well against the health consequences of
eating all that fatty red meat. In any case, given Harkin’s advocacy of
positions beneficial to Herbalife, it’s not surprising that the company would
see value in not just donating to his campaign but in donating to his policy
institute as well.

It’s been noted that this arrangement is not illegal. It does, however,
understandably raise ethical issues, as it’s obviously a method by which a donor
can further ingratiate himself with a legislator. As a representative for the
Center for Responsive Politics put it, an institute named after a politician
“helps to cement the lawmaker’s image as a substantial person,” and donations to
the institute help bolster the institute’s strength and visibility.

Also more than a bit fishy is the way this institute came into being. It turns
out that Harkin’s wife sits on the Iowa Board of Regents, which created and
oversees the Harkin Institute of Public Policy, which will be housed at Iowa
State University in Ames. It further turns out that Harkin’s wife appears to
have used her influence to bypass opposition:

   The Harkin Institute has been dogged by controversy since its inception.

   Mrs. Harkin rushed the institute’s approval through the Iowa Board of Regents
   in April 2011 before two of the senator’s allies on the board rotated off.
   She excluded two “conservative Republicans” from internal board discussions
   about the institute, according to current board president Craig Lang, because
   they might not have supported the institute.

And:

   The Iowa Board of Regents voted to prohibit future institutes from being
   named after an active politician after it approved the Harkin Institute.

Which strikes me as a good idea. Otherwise, powerful politicians with
connections on the Board of Regents might use that influence to create such
policy institutes. Oh, wait. That’s what the Harkins did. Too bad such a policy 
wasn’t in place two years ago.

Whither NCCAM (and Senator Harkin)?

The shenanigans that produced the Harkin Institute and the further shenanigans
that led Herbalife to donate to it aside, I must admit that I was pleasantly
surprised by a detailed description of how Harkin drove the creation of NCCAM:

   In 1992, Harkin appropriated $2 million to establish the Office of
   Unconventional Medicine, which was later renamed the Office of Alternative
   Medicine. At a congressional hearing, Harkin claimed that bee pollen cured
   his allergies, according to a report by Stanford University emeritus
   professor of medicine Wallace Sampson. Harkin appropriated $200,000 to Royden
   Brown, who sold Harkin the bee pollen, to study the remedy, according to
   “Natural Causes: death, lies and politics in America’s vitamin and herbal
   supplement industry,” a book by journalist Dan Hurley. Roydon was later fined
   the same amount ($200,000) by the Federal Trade Commission for making false 
   claims. Harkin then blasted OAM for its science-based research guidelines,
   which he described as “the unbendable rules of randomized clinical trials.”
   Harkin packed OAM’s council with his cronies, such as a travel agent from the
   Bahamas, where Harkin owns a vacation home.

   When then-NIH director Harold Varmus tried to place stricter scientific
   research standards on the agency, Harkin changed the agency’s status so it
   would no longer have to answer to NIH and increased its appropriations to
   $104 million per year by 2002, an increase of 5,130 percent in ten years. In 
   fiscal year 2012, it’s budget was $128 million, a 22 percent increase from
   2002.

And so it continues. NCCAM is basically untouchable, thanks to its powerful
patron. Any move by an NCCAM director to try to increase the scientific rigor of
the center is virtually guaranteed to provoke a rebuke from Senator Harkin,
with the implicit threat being that Harkin can easily seek (and get) the removal
of an NCCAM director who pursues research or policy changes he doesn’t like.
After all, when Harold Varmus ran the NIH and tried to rein in NCCAM, holding it
to tighter scientific standards, Harkin’s showed him.

Another important thing to remember is that NCCAM was not created in response to
a perceived scientific need or public demand. It was not, as I have said
before, the result of a groundswell of support among physicians and scientists
who saw all this quackery out there and said, “Hey, we really ought to study
homeopathy (or reiki, or therapeutic touch [or: INSERT FAVORITE QUACKERY HERE]) 
to see if there’s anything to it.” Instead, NCCAM was created primarily through 
the effort of a single person, Senator Tom Harkin, a woo-friendly legislator who
believed that bee pollen had somehow cured his allergies. It’s worth fleshing
out yet again the historical background of NCCAM in the above article
documenting Harkin’s Herbalife connections.

NCCAM, as befits the subject matter to which it is dedicated, is a bizarre
beast. Ostensibly charged with the rigorous investigation of modalities
considered “alternative,” NCCAM all too often applies state of the art science
to what is at its heart, prescientific mysticism, such as various “energy
healing” techniques, acupuncture, and even homeopathy, a practice that Harriet
Hall once aptly dubbed “Tooth Fairy science.” As was pointed out above, it was
Harkin who first assigned $2 million of his discretionary funds to establish the
Office of Unconventional Medicine in 1992. The OUM was soon renamed the Office 
of Alternative Medicine (OAM). Then, as detailed in Wally Sampson’s classic
article Why the National Center for Complementary and Alternative Medicine
(NCCAM) Should Be Defunded, the first director of OAM resigned under Senator
Harkin’s pressure because he quite properly objected to nominees to the OAM
Council who had been involved in Laetrile and Mexican cancer clinic scams. In
1998, then NIH Director Harold Varmus tried to bring the OAM under tighter NIH
scientific control to make its studies more rigorous and was stymied when Harkin
introduced legislation to elevate OAM to an independent Center.

Although it’s been discussed on multiple occasions on this blog, it’s worth
repeating any time the topic of NCCAM comes up, NCCAM is constituted so that
even its director is hamstrung in what she can do. The reason is that charter of
the National Advisory Council for Complementary and Alternative Medicine
(NACCAM), the committee that oversees NCCAM’s activities, requires that council 
members be chosen from practitioners and “leaders” in the CAM field, for
instance a former president of the American Association of Naturopathic
Physicians. In other words, true believers control the agenda, and it is
difficult for even scientifically inclined NCCAM directors like Dr. Briggs and
her predecessor Dr. Stephen Strauss to keep NCCAM from wasting precious grant
money investigating the more ludicrous and implausible CAM “therapies” out
there–like reiki or homeopathy. The bottom line is that by design there just
isn’t that much an NCCAM director can do to change the way NCCAM operates, at
least in terms of how it awards its grants and how it disburses its training
grant money. Caught between the Scylla of scientists and physicians practicing
science-based medicine and the Charybdis of her alt-med constituency, led by her
center’s powerful Congressional patron, Dr. Briggs (or any NCCAM director who
wants to support decent science) really is in a virtually no-win situation. All 
of this is due largely to Senator Harkin.

NCCAM history makes the allegations about the relationship between Senator
Harkin and Herbalife all the more interesting, because if there’s one constant
about NCCAM it’s that, in addition to the research it funds, NCCAM also funds
“educational” programs that promote unscientific practices and, in particular,
supplements. There’s a reason why the supplement industry in general (and
Herbalife in particular) love Tom Harkin, and it’s not because they think he’s
such a nice guy. It’s because Harkin fights for causes they believe in, namely
laws like the DSHEA that hamstring the FDA, preventing it from interfering too
much with the business of selling supplements with a “wink, wink, nudge, nudge” 
about the many health claims that are made to sell them, all with the
not-so-plausible deniability of the Quack Miranda Warning that’s so ubiquitous
on the websites and in the literature used by supplement manufacturers to sell
their wares. It’s because Harkin is a true believer. Indeed, my favorite quote
of all time from him about NCCAM demonstrates this quite nicely:

   One of the purposes of this center was to investigate and validate
   alternative approaches. Quite frankly, I must say publicly that it has fallen
   short. It think quite frankly that in this center and in the office
   previously before it, most of its focus has been on disproving things rather 
   than seeking out and approving.

Clearly, Harkin doesn’t understand the nature of science, which involves trying 
to falsify hypotheses. To him, NCCAM was (and is) clearly intended as a vehicle 
to produce studies that support the unscientific treatments he believes in. I
suppose I should take comfort in Senator Harkin’s bitter disappointment that
NCCAM hasn’t validated any of the quackery it studies, even after a couple of
billion dollars and 20 years. It’s not for lack of trying, though.

In any case, given the integral nature of the relationship between Harkin and
NCCAM, the natural question in wake of Harkin’s announcement is: Whither NCCAM? 
What will happen in a little less than two years, when NCCAM’s most powerful
champion retires, riding off into the sunset to his policy institute and, very
likely, a position on the Herbalife board of directors? One also has to wonder
whether Harkin will try to do some mischief before he leaves, much as
Representative Dan Burton did with his one last antivaccine hurrah in November.

The question as I see it is whether there will be a window beginning in 2015
when there is a possibility that NCCAM might actually be dismantled. After all, 
two of the most powerful supporters of NCCAM (Representative Dan Burton and
Senator Tom Harkin) will be gone from Congress. That just leaves Senator Orrin
Hatch (R-UT), who, as I’ve documented before, is a huge champion of the
supplement industry. There’s also Representative Jason Chaffetz (R-UT), who is, 
not surprisingly, also from Utah, which is the capital of the supplement
industry in the U.S. He’s a former supplement company executive turned U.S.
Representative and co-chair of the Dietary Supplement Caucus. Then there’s
Darrell Issa (R-CA), who is known for attacking the NIH for funding studies he
doesn’t like. Would it be possible to dismantle NCCAM in the wake of Harkin’s
departure?

Alas, I have to conclude: Probably not. While the retirement of Senator Harkin
will leave a huge hole in Congressional support for NCCAM, given that he has
defended and nurtured it for 20 years and neither Orrin Hatch, Darrell Issa,
Jason Chaffetz, nor any other members of the supplement caucus seems
particularly interested in NCCAM, except as a political tool, the other side of 
the equation is lacking. There appears to be no one in Congress with the “fire
in the belly” for science-based medicine willing to do what it would take to
dismantle NCCAM and distribute its component parts back to the appropriate
institutes and centers of the NIH that could do the job better. On the other
hand, perhaps in these days of budgetary concerns and deficit reduction, maybe
the case could be made that wasting $125 million or so a year to study fairy
dust is not an expenditure that the government should be making when that money 
would do so much more good funding the rest of the NIH.

A guy can hope, can’t he?

Harkin’s folly, or how forcing insurers to cover CAM undermines the ACA

Jann Bellamy on May 29, 2014

Link



Bloodletting: a good reason to discard disproven therapies

All of us at SBM have repeatedly expressed frustration at the continuing influx 
of pseudoscience into the health care system. Judging from comments posted on
this site and private communications we receive, our readers share this
frustration but are at a loss to figure out how to get through to legislators
and other policy makers. Unlike naturopaths and chiropractors, we don’t have the
money to hire professional lobbyists. Fortunately, an opportunity to sound off 
against SCAMs has presented itself, completely free of charge.

How?

Now that the Affordable Care Act enrollment debacle is dying down, the
Department of Health and Human Services (HHS) is turning its attention to
divining just what the heck Section 2706 of the ACA, the non-discrimination
provision, means. (Actually there are other federal agencies involved; to
simplify things, here we’ll refer to them collectively as “HHS.”) HHS has opened
the issue to public comment, but only until June 10. Let’s take a look at why
this is important and what you can do about it.

(There are providers other than chiropractors, naturopaths and acupuncturists
involved in this fight. For example, you’ll see public comments from nurse
anesthetists and nurse practitioners. But I’m not worried about providers who
stick to science.)

I’ve discussed Section 2706 before, but a brief review is in order. Here’s what 
it says:

   (a) PROVIDERS.—A group health plan and a health insurance issuer offering
   group or individual health insurance coverage shall not discriminate with
   respect to participation under the plan or coverage against any health care
   provider who is acting within the scope of that provider’s license or
   certification under applicable State law. This section shall not require that
   a group health plan or health insurance issuer contract with any health care
   provider willing to abide by the terms and conditions for participation
   established by the plan or issuer. Nothing in this section shall be construed
   as preventing a group health plan, a health insurance issuer, or the
   Secretary from establishing varying reimbursement rates based on quality or
   performance measures.

Section 2706 was inserted into the ACA under the stewardship of Sen. Tom Harkin,
whose CAM-friendly inclinations are well known. It was not in the original ACA 
bill but became part of the Senate’s version without the benefit of any sort of 
committee hearing. Perhaps that was by design.

Via a set of “FAQs,” HHS issued its interpretation of Section 2706’s
requirements for the guidance of insurance companies devising ACA-compliant
health care benefits:

   to the extent an item or service is a covered benefit under the plan or
   coverage, and consistent with reasonable medical management techniques
   specified under the plan with respect to the frequency, method, treatment or 
   setting for an item or service, a plan or issuer shall not discriminate based
   on a provider’s license or certification, to the extent the provider is
   acting within the scope of the provider’s license or certification under
   applicable state law. The FAQ also states that section 2706(a) of the PHS Act
   [that is, the ACA] does not require plans or issuers to accept all types of 
   providers into a network and also does not govern provider reimbursement
   rates, which may be subject to quality, performance, or market standards and 
   considerations.

Sen. Harkin was not pleased. Here’s what HHS was told by a Senate Committee:

   The goal of this provision is to ensure that patients have the right to
   access covered health services from the full range of providers licensed and 
   certified in their State. The Committee is therefore concerned that the FAQ
   document issued by HHS … advises insurers that this nondiscrimination
   provision allows them to exclude from participation whole categories of
   providers operating under a State license or certification. In addition, the 
   FAQ advises insurers that section 2706 allows discrimination in the
   reimbursement rates based on broad ‘market considerations’ rather than the
   more limited exception cited in the law for performance and quality measures.
   Section 2706 was intended to prohibit exactly these types of discrimination.

HHS is asking for your help in resolving this dilemma:

   Pursuant to this [Senate] report, the Departments are requesting comments on 
   all aspects of the interpretation of section 2706(a) of the [the ACA]. This
   includes but is not limited to comments on access, costs, other federal and
   state laws, and feasibility.

But, again, you have to comment by June 10, so get going.

How the state legislators got us into this mess

First, I suggest that HHS and the public be made aware of the extent of damage
Section 2706 might do as it has been interpreted by Sen. Harkin’s committee.
They need background, and you are just the person to give it to them.

Of course, CAM providers have always depended on government largesse to survive,
whether it be NCCAM-funded studies (none of which CAM practitioners apparently 
paid the least bit of attention to), state licensing, Medicare coverage (of
chiropractic, for the detection and correction of subluxations), state insurance
coverage mandates and Medicaid coverage. (Washington just became the third
state to include naturopaths in Medicaid. Naturopaths are also lobbying for
Medicare coverage, a subject I’ll return to in a later post.) There are also
government-backed student loans, as well as DSHEA and the legalization of
fraudulent homeopathic remedies. Section 2706 is just another example of
substituting political clout for the rational application of science to health
care practices. Or, put another way, it pours the public’s money into the
coffers of practitioners of pseudoscience.

As we’ve talked about before, chiropractors, naturopaths and acupuncturists are 
all claiming, to some degree or another, that they are primary care physicians. 
(Both Harriet Hall and I have discussed the deficiencies of chiropractors as
PCPs, and Mark Crislip took on the naturopaths.) Acupuncturists seem sort of
half-hearted about it, but DCs and NDs are dead serious, especially the latter. 
And it is here that the profligacy of the state legislatures in defining DC, ND 
and acupuncturists‘ scope of practice comes home to roost.

In para materia

First and foremost, Section 2706 must be read as one part in a larger whole.
(Or, as the lawyers would say, in para materia with the entire ACA.)

In interpreting Section 2706, HHS must keep in mind the overarching purpose of
the ACA, as well as the fact that it is but one paragraph in nearly 1,000 pages 
of text. As the U.S. Supreme Court said in National Federation of Independent
Business v. Sebelius:

   The Act aims to increase the number of Americans covered by health insurance 
   and decrease the cost of health care. The Act’s 10 titles stretch over 900
   pages and contain hundreds of provisions.

Obviously, Section 2706 does nothing to fulfill the Act’s intent of increasing
the number of covered Americans. But its provisions can be judged against the
goal of decreasing the cost of health care. Of course, decreasing costs must be 
measured against outcomes. As Harriet Hall has pointed out, eliminating health
care altogether would reduce costs to zero. What we are really seeking here is
cost effectiveness.

For example, the Patient-Center Outcomes Research Institute (PCORI)’s purpose is
(as described by the Urban Institute Health Policy Center, citations omitted):

   There are a number of other provisions in the ACA that have the potential to 
   contain costs. The ACA authorizes the establishment of a nonprofit
   corporation, the Patient-Centered Outcomes Research Institute, to conduct and
   broadly disseminate comparative-effectiveness research. This research effort
   is intended to inform “patients, clinicians, purchasers, and policy-makers
   in making informed health decisions” regarding relative health outcomes,
   clinical effectiveness, and appropriateness of medical treatments and
   services.

A mechanical application of Section 2706 without considering cost effectiveness 
sacrifices the larger goals of the Act for the private gain of individual
practitioners and political ideology. Which brings up an interesting
possibility. What if there is no evidence that chiropractors, naturopaths or
acupuncturists can deliver cost-effective care? What happens then?

In one sense, forcing inclusion of CAM providers is already undermining the
market-oriented managed competition strategy employed by the ACA. Insurers are
already offering ACA-compliant plans, as required by law, under the assumption
that CAM providers need not be included. To the extent these plans do not
include chiropractors, naturopaths and acupuncturists, it reflects a decision by
insurers that these practitioners are not able to offer health care services
required by the Act at the best price for the result achieved. Obviously, were
that not the case, CAM practitioners would have been included in provider
panels. Mandating inclusion will send insurers scrambling to recalibrate plan
benefits and costs, another glitch in the system we don’t need.

Essential health benefits

The ACA’s tying cost reduction, in part, to improved health outcomes, is based
on the theory that healthier people will utilize fewer health resources and that
catching a problem early reduces the need for more expensive treatment down the
line. In order to achieve these goals, the ACA requires coverage of “essential 
health benefits:”

  1. Ambulatory patient services

  2. Emergency services

  3. Hospitalization

  4. Maternity and newborn care

  5. Mental health and substance use disorder services

  6. Prescription drugs

  7. Rehabilitative and habilitative services and devices

  8. Laboratory services

  9. Preventive and wellness services and chronic disease management

  10. Pediatric services, including oral and vision care

The ACA centers the delivery of these services on the patient’s “medical home,” 
which is headed by a primary care physician, who coordinates the patient’s care.
Chiropractors and acupuncturists, despite claims to the contrary, cannot
provide the full scope of primary care required by the ACA. Naturopaths claim,
falsely, that they have the education and training to practice as PCPs and they 
are, in fact, licensed as primary care practitioners in a handful of states,
although they do not have hospital privileges. They are covered Medicaid
providers in three states but are not covered by Medicare.

The fact that naturopaths are licensed as PCPs in a few states does not override
the ACA’s primary concern with reduced costs and improved outcomes. The truth
of the matter is that naturopaths do not practice evidence-based medicine and
the majority of their treatments are not supported by an acceptable level of
evidence or, for that matter, any evidence at all. In fact, some of the
mainstays of naturopathic practice are thoroughly discredited, such as colonic
irrigation homeopathy, the use of dietary supplements to manage many diseases,
and the like. There is evidence, however, that naturopathic care results in
worse outcomes. Most disturbing is the naturopaths’ opposition to vaccination,
an opposition that sees its logical outcome in the association between
naturopathic care and undervaccination, as well as an increased risk of
acquiring a vaccine-preventable disease.

In short, despite their claims otherwise, there is simply no evidence that
naturopaths can safely and effectively (much less cost-effectively) diagnose and
treat the undifferentiated patient, a basic skill necessary for all primary
care practitioners. (Basically, the undifferentiated patient is any person of
any age with any condition who might walk in the door.) In fact, there is only
one study in all of the medical literature which purports to show a benefit to
naturopathic care. Even there, patients were under the care of a medical doctor 
and naturopathic care was in addition to usual care, and, in fact, there was
nothing in their care that was uniquely naturopathic or could not have been
provided by any other medical professional.

Even where specialty care is concerned, chiropractors and acupuncturists suffer 
from a similar dearth of evidence and the risk that patients will be exposed to 
unproven and disproven diagnoses and treatments. For example, some chiropractors
continue to diagnose and treat “subluxations”, a thoroughly discredited
prescientific notion that the human spine requires “adjustments” to “misaligned”
vertebrae to maintain health. (This has been a huge cost burden on Medicare.)
To be fair, other chiropractors limit themselves to evidence-based treatment of 
musculoskeletal problems. However, insurers would do well to institute a
detailed vetting process to choose only those willing to stick to the evidence.

There is simply no reliable evidence that acupuncture is effective for any
condition. Even the National Center for Complementary and Alternative Medicine
admits acupuncture may be no more than an elaborate placebo. (Actually, that is 
exactly what it is.) Yet, given their full range of options under state practice
acts, acupuncturists subject their patients to all sorts of prescientific
practices like moxibustion and “Kirlian photography.”

Harkin’s folly

Thus the folly of Section 2706’s premise – that simply because a state has given
a particular type of practitioner a broad scope of practice, those
practitioners can deliver safe and cost-effective health care commensurate with 
their practice act – is fully revealed. We already have a substantial body of
evidence (some of it from the federal government itself, via NCCAM) that the
services CAM providers offer do not improve health outcomes, yet Section 2706
forces insurers to include these practitioners. Given this, insurers must be
given wide latitude to exclude practices that do not benefit, and may in fact
harm, the insured. Yet, this remedy itself poses its own problems.

Another cost control measure imposed by the ACA is a limitation on the
percentage of administrative costs an insurer can include in premiums. When
contracting with medical doctors and allied health professions such as nurses
and physical therapists, insurers can rely on a body of medical literature that 
either includes or excludes diagnoses and treatments based on the current
evidence. Chiropractors, naturopaths and acupuncturists, however, have the
liberty of simply creating new diagnoses and treatments out of whole cloth,
unhindered by basic scientific plausibility, much less published literature
supporting or rejecting it. It is thus that CAM providers have come up with such
novel diagnoses and treatments as IV vitamins for flu prevention and other IV
“cocktails”, functional endocrinology, chronic yeast overgrowth, adrenal
fatigue, green tea suppositories for cervical dysplasia, treatment of disease
with homeopathy, organ repositioning, applied kinesiology, food “intolerance”
testing, cranial sacral therapy and moxibustion to name just a few.

If all insurers are forced to include CAM practitioners in their provider
panels, they will have to be eternally vigilant in excluding these exotic
creations, thereby simply adding to administrative costs. They must already do
this to a certain extent due to state insurance mandates, but Section 2706
simply compounds the problem by increasing the number of CAM providers which
must be included. (While chiropractors often have insurance mandates in their
favor, naturopaths and acupuncturists generally do not. There are exceptions,
however, such as Washington state.)

Given all of this, it is clear that Section 2706 undermines the very purposes of
the ACA and should be repealed. But we don’t get to decide that, nor does HHS. 
The best we can go for at this point is damage control. Here’s what I recommend:

  1. Issue a report setting forth the dilemma caused by Section 2706 (see above)
    and use this as a basis for stringent limitations on coverage of CAM
    provider services.

  2. Allow insurers to require that all providers sign an agreement that they will 
    employ evidence-based practices. Breach of the agreement is grounds for
    exclusion from the provider panel.

  3. Further allow insurers to require that all providers advise patients to follow
    CDC-recommended schedules for vaccination and prohibit them from advising
    patients not to vaccinate based on discredited reasons. Again, failure to
    follow the rules should be grounds for exclusion from the panel.

  4. Make it clear that chiropractors, naturopaths and acupuncturists cannot advise
    patients to ignore their medical doctors’ advice unless there is an
    evidence-based reason for doing so.

  5. Make it clear that no medical doctor is ever required to compromise his or her
    judgment by referring to a practitioner when he or she feels that doing so 
    is not in the best interest of the patient. For example, medical doctors
    should be free to refer to physical therapists instead of chiropractors.

  6. Allow insurers to institute preventive measures to combat the bundling of
    unproven treatments with covered services. For example, make it clear that
    treatment of a cold by a naturopath will not be covered if the naturopath
    uses that time to advise patients to use (or sells) unproven treatments like
    homeopathy, dietary supplements and herbs.

Feel free to comment on the HHS’s website by using any, all or none of this
post. (You can certainly add your own reasons.) Even if you don’t think HHS will
pay a bit of attention, you’ll feel so much better afterwards. Click here to
proceed.

Healthcare reform should ditch mandated coverage of CAM providers

Forced insurance coverage of chiropractic, naturopathic, and acupuncture
services is not consistent with the goals of either the ACA or the AHCA.
Whatever happens to Obamacare in the U.S. Senate, Section 2706 of the ACA should
be repealed.

Jann Bellamy on May 25, 2017

Tweet





Legislative Alchemy

Should health insurers be forced to cover the services of chiropractors,
naturopaths, acupuncturists and massage therapists? The Affordable Care Act
(ACA, or “Obamacare”) says “yes” and the American Health Care Act of 2017 (AHCA,
but apparently not “Trumpcare”), recently passed in the U.S. House of
Representatives by a narrow margin, agrees. The legislation is now in the hands 
of the Senate, where it’s passage in its current form appears doubtful. Whatever
the end result, this reconsideration of Obamacare affords an opportunity to
ditch mandated coverage of CAM providers, for two reasons: (1) health insurance 
coverage should be limited to evidence-based practices, necessarily excluding
pseudoscience, and (2) CAM providers do not have sufficient education and
training to competently provide the vast majority of covered benefits and, where
they do, insurers cover them anyway.

Despite President Trump’s oft-repeated promise to repeal Obamacare on “Day One,”
vowing to call a special session of Congress if necessary, the American Health 
Care Act of 2017 actually amends the Affordable Care Act and does not repeal it 
outright. In doing so, the AHCA retains a number of the ACA’s provisions.
Unfortunately, one of those is Section 2706 of the ACA (42 U.S.C. Sec. 300gg-5),
which prohibits “discrimination” in insurance coverage against health care
providers practicing within the scope of their state license.

Section 2706 says:

   A group health plan and a health insurance issuer offering group or
   individual health insurance coverage shall not discriminate with respect to
   participation under the plan or coverage against any health care provider who
   is acting within the scope of that provider’s license or certification under
   applicable State law.

It adds that it is not an “any willing provider” law and that varying
reimbursement rates can be based on quality or performance measures, a subject
we’ll return to in a moment.

I have argued that forcing insurers to cover providers they would not otherwise 
choose to include is at odds with the ACA’s emphasis on cost-effectiveness and
evidence-based practice. If we take the Republican architects of the ACHA at
their word (and not everyone does) the putative reforms embodied in the AHCA are
based on a free-market approach:

   What we want to do is have a viable market where the insurers can offer a lot
   of different competing plans that are more affordable.

And:

   You need to have an individual market where people care about what things
   cost, where people have real freedom, where those providers of health care
   services, be they insurers, doctors or hospitals and everybody in between,
   compete against each other for our business based on value, based on price,
   based on quality, based on outcome.

If the free market is going to determine coverage, why does the AHCA force
insurers to cover CAM provider services?

History of Section 2706

By way of background, Section 2706 was not part of the U.S. House of
Representatives version of the ACA, but was included in the Senate version
(which ultimately passed) under the guidance of the now-retired Sen. Tom Harkin 
(D-Iowa), a great friend of alternative/complementary/integrative medicine and
chief architect of the National Center for Complementary and Integrative Health 
(formerly the National Center for Complementary and Alternative Medicine), whose
mission is, in Sen. Harkin’s view, to “validate” CAM. It was heavily lobbied by
the American Chiropractic Association and other “CAM” providers, as well as
some “conventional” providers like nurse anesthetists and optometrists. The
legislative history (reports, committee minutes, floor debates and the like
which precede a vote on a bill) indicates it was specifically included to
prevent “discrimination” against CAM providers.

Section 2706 was rolled out with much fanfare by CAM enthusiasts, who thought it
would mean instant coverage. As former American Association of Naturopathic
Physicians Board member and Vermont naturopath Loirlee Schoenback, sunnily
predicted:

   If the law is implemented as intended NDs in 16 states [where they were then 
   regulated] will immediately be covered by insurance.

“Implemented as intended,” Schoenback said,

   suggest[s] that if insurers cover a health condition, they must pay any
   providers are licensed to treat that condition. If the insurer covers a
   service provided by medical doctors . . ., for example, it must also cover
   that service when provided by another legal provider, such as NDs,
   acupuncturists or chiropractors.

Consistent with the push for rebranding chiropractors as primary care physicians
(a subject we’ve covered extensively on SBM), a chiropractic organization
issued a White Paper asserting that chiropractors could act as PCPs in
patient-centered medical homes, a care-improvement strategy adopted by the ACA. 
CAM proponents also pushed for inclusion of chiropractors, Oriental medicine
practitioners, massage therapists, and naturopaths in Accountable Care
Organizations, another key component of the ACA.

Back in 2013, the Department of Health and Human Services (HHS) issued guidance 
on just what was to be expected of insurers under Section 2706. According to
HHS, insurers would be allowed to use:

   reasonable medical management techniques specified under the plan with
   respect to the frequency, method, treatment or setting for an item or service
   . . . [Sec. 2706] does not require plans or issuers to accept all types of
   providers into a network and also does not govern provider reimbursement
   rates, which may be subject to quality, performance, or market standards and 
   considerations.

[Emphasis added.]

This brought a stinging rebuke from Harkin’s Senate Committee, who told HHS to
go back to the drawing board:

   The goal of this provision is to ensure that patients have the right to
   access covered health services from the full range of providers licensed and 
   certified in their State. The Committee is therefore concerned that the FAQ
   document issued by HHS … advises insurers that this nondiscrimination
   provision allows them to exclude from participation whole categories of
   providers operating under a State license or certification. In addition, the 
   FAQ advises insurers that section 2706 allows discrimination in the
   reimbursement rates based on broad ‘market considerations’ rather than the
   more limited exception cited in the law for performance and quality measures.
   Section 2706 was intended to prohibit exactly these types of discrimination.

[Emphasis added.]

In other words, unless insurers could point to some performance or quality data 
allowing them to exclude reimbursement to chiropractors, naturopaths,
acupuncturists or the like for services covered by a health plan, refusing
reimbursement would violate the ACA. Of course, “performance or quality” data is
notoriously lacking on CAM practices, leaving insurers in a precarious
predicament: If this hard performance or quality data justifying the exclusion
of CAM practitioners from providing covered services didn’t exist, would they be
forced to pay up just because some state legislature had foolishly passed a
licensing bill giving chiropractors, naturopaths or acupuncturists a broad scope
of practice?

The Senate Committee’s rebuff led HHS to issue a request for public comment on
“all aspects of interpretation” of Section 2706, which drew over 1,500 comments.
While the previous guidance was withdrawn, no new guidance was forthcoming,
except to say that the federal government would not take action against insurers
“using a good faith, reasonable interpretation” of Section 2706, while it
continued to try to figure this whole mess out.

CAM proponents push for broad implementation of Section 2706

The Integrative Health Policy Consortium, an organization promoting the
wholesale integration of naturopaths, chiropractors, homeopaths, and
acupuncturists into the healthcare system, takes the position:

   that commercial insurers must allow all types of licensed providers to
   participate in their networks . . .

[Emphasis added.]

Thus, in the IHPC’s view, all insurers must reimburse for chiropractic care
because chiropractors are licensed in all 50 states. Insurers in states
licensing naturopaths and acupuncturists should be forced to include them in
their coverage as well.

Insurers disagree. State benchmark plans still exclude certain types of
providers, especially massage therapy and naturopathy.

IHPC launched a “Cover My Care” campaign designed to assist patients in lobbying
for coverage. Unfortunately, nurse practitioner, physical therapy, marriage and
family therapy, and other “conventional” health care practitioner organizations
have allied with the IHPC, the American Association of Naturopathic Physicians,
the American Chiropractic Association and the American Association of
Acupuncture & Oriental Medicine to push for greater insurance coverage of their 
services, in an organization called the Coalition for Patients Rights (CPR).

The ACA requires insurers to cover certain “essential health benefits,” or
“EHBs,” such as maternity care and an annual wellness exam. Under the AHCA, EHBs
are retained, but states will be able to apply for waivers excluding particular
EHBs from required coverage.

CPR created a chart promoting CAM practitioners as competent providers of the
ACA’s required essential health benefits. This includes acupuncturists as
providers of maternity and newborn care, rehabilitative services, mental and
behavioral health, and preventative and wellness services, even though there is 
no evidence that acupuncture is effective for any of this (also here).

The CPR says “chiropractors and chiropractic physicians” can provide pediatric
services, even though “chiropractic pediatrics” is chock full of
anti-vaccination beliefs and ineffective subluxation-based treatments for
children. (SBM’s own pediatrician, Clay Jones, MD, has covered a number of
these: brachial plexus injury, newborn care, craniosynostosis, colic, shaken
baby syndrome, SIDS, Tourette syndrome, bedwetting, and gastroesophageal
reflux.)

According to the CPR, chiropractors can also provide “preventive and wellness
services,” even though in chiropractic parlance this often means “maintenance
care,” the idea that non-existent subluxations must be regularly “detected” and 
“corrected” to prevent adverse health consequences.

The CPR promotes “naturopathic physicians” as providers of EHB preventive and
wellness services and ambulatory patient care, even though their education and
training is insufficient (also here) and they eschew evidence-based practice,
using instead dubious diagnostic tests and quack treatments like homeopathy,
craniosacral therapy, and colonic irrigation, a subject we’ve discussed many
times here on SBM. (See, for example, Scott Gavura’s Naturopathy vs. Science
series and David Gorski’s both hilarious and disturbing take on naturopaths
discussing patient care, also here.) Former naturopath Britt Hermes extensively 
covers these subjects on her blog, Naturopathic Diaries, as well. (For an
appalling look at how naturopaths diagnose and treat endocrine disorders, check 
out the latest post.) Under the ACA, preventive services must include pediatric 
and adult vaccinations. Given the anti-vaccination stance of most naturopaths,
it is a public health risk to advocate naturopaths as providers of preventive
healthcare.

Practice acts are not based on science and evidence

Of course, insurers can fight back by excluding particular tests and treatments 
from coverage. For example, Aetna limits or won’t cover a whole slew of
chiropractic, acupuncture, and other CAM treatments (and, therefore, a lot of
what naturopaths do) because they aren’t evidence-based. But Section 2706
muddies the waters by focusing on whether a particular service is within a
practitioner’s legal scope of practice, not on whether the service can be safely
and competently provided by a particular type of practitioner, and certainly
not whether there is any evidence supporting the practitioner’s care.

In the case of chiropractors, naturopaths, and acupuncturists, state practice
acts, which define the scope of practice, actually incorporate pseudoscience
into the law. Chiropractic scope of practice in all states includes the
detection and correction of the putative subluxation. Acupuncture practice acts 
treat the mythical “qi” as a real phenomenon. For example, in New Hampshire:

   Oriental medicine means the distinct system of health care that diagnoses and
   treats illness, injury, pain, or other conditions by controlling and
   regulating the flow and balance of energy to restore and maintain health.

Nevada is even more expansive in its definition of Oriental medicine, which
includes both the practice of acupuncture and herbal medicine. “Oriental
medicine” is:

   that system of the healing art which places the chief emphasis on the flow
   and balance of energy in the body mechanism as being the most important
   single factor in maintaining the well-being of the organism in health and
   disease.

“Acupuncture” is defined as:

   the insertion of needles into the human body by piercing the skin of the body
   to control and regulate the flow and balance of energy to cure, relieve, or 
   palliate: (a) Any ailment or disease of the mind or body; or (b) Any wound,
   bodily injury or deformity.

Naturopathic practice acts frequently define naturopathy as support and
stimulation of the patient’s “natural healing capacity” i.e., vitalism, a
long-discredited pre-scientific notion that a supernatural force controlled
bodily function. They specifically permit discredited practices like homeopathy,
colonic irrigation, visceral manipulation, treatment of disease with unproven
dietary supplements, and unvalidated diagnostic testing.

In sum, there is a total disconnect between science and scope of practice in
state CAM practice acts. Given the use of evidence-based medicine as a means of 
cost control in the typical health insurance policy, Section 2706 sets the stage
for inevitable conflict between providers and insurers should the government
ever decide to enforce the law in the manner apparently intended by Sen. Harken 
and organizations like IHPC and CPR.

In addition to the conflict between science and pseudoscience, the issue of
competency to perform covered services is troubling. As naturopaths and
chiropractors push for primary care physician status (something naturopaths have
fully achieved in Oregon), the fact that they are not sufficiently educated and
trained in primary care will conflict with their state practice acts, which
deem them primary care physicians nevertheless. Oregon insurers have fought this
by instituting more rigorous credentialing requirements for naturopath PCPs,
but this strategy to insure competent care is under attack in the state
legislature via a bill forbidding them from doing so.

And consider this bill, which just passed in the Tennessee General Assembly and 
is now before the Governor for consideration. This legislation rewrites the
traditional “detection and correction of subluxations” definition of
chiropractic practice, adding to chiropractic scope of practice:

  1. The differential diagnosis of human ailments through examination and
    evaluation of patients and through the ordering and performance of
    appropriate diagnostic procedures necessary to clinically correlate a
    physical examination to a diagnostic impression.

  2. The ordering of X-rays, advanced diagnostic imaging, and other diagnostic
    procedures, and the performance of X-rays and other diagnostic procedures
    for which the chiropractic physician has received training.

  3. The collection of bodily fluids and specimens for analysis.

Does this mean that Tennessee insurers will now have to cover the annual
“wellness exam” provided as an essential health benefit under the ACA (and
covered by the AHCA) even if performed by a chiropractor and even if though most
of the preventive services mandated as EHBs are not within the chiropractic
scope of practice? I think chiropractors have a good argument under the law that
the answer is “yes.”

Section 2706 is consistent with neither the implementation of evidence-based
cost-effective health insurance coverage nor the “free market,” which loathes
any sort of government mandate. Whatever plan the Senate comes up with, it
should “repeal and replace” Section 2706.

Note: Many thanks to David Gorski for graciously taking my usual Thursday post
on May 11th.

Health Savings Accounts: a tax-sheltered way to pay for quackery

Jann Bellamy on February 18, 2016

Link

If you want money to pay for pseudoscience, but your pesky health insurance
company is getting in the way, a Health Savings Account might be just the
solution. And if the Health Savings Act of 2016, sponsored by the Big
Supplement’s own Senator Orrin Hatch, becomes law, your opportunities will be
greatly expanded.

First, let’s take a look at Health Savings Accounts and explore how they can be 
used to pay for quackery. Then we’ll see how Hatch’s Senate Bill 2499 (and
companion House Bill 4469) would essentially force taxpayers to fund consumer
purchases of unproven and potentially unsafe dietary supplements and “The One
Quackery To Rule Them All,” homeopathy. Finally, we’ll look at how all of this
might affect the presidential race.

What are Health Savings Accounts?

A Health Savings Account (HSA) is a personal account created exclusively to pay 
for current or future health care expenses. They have significant tax
advantages:

  1. Contributions to HSAs are tax deductible;

  2. Withdrawals are tax-free as long as they are used to pay for qualified medical
    expenses;

  3. Interest earnings accumulate tax-free and the balance in the account at year’s
    end can be rolled over into the next year with no tax penalty.

HSAs predate the Affordable Care Act but survived its individual health
insurance mandate as a means of paying for health care costs not covered by a
high deductible plan. Here’s how it works: An individual pays his own medical
expenses out of his HSA until he meets the calendar-year deductible of his
high-deductible plan. Once that coverage kicks in, the HSA can still be used to 
pay for non-covered expenses. There are limits on yearly tax-deductible
contributions to an HSA, and eligible high deductible plans must also meet
certain limits, all set by the IRS each year. For example, in 2016, an
individual HSA holder under 55 years of age is limited to $3,350 in deductible
contributions to his HSA.

(At this point, SBM’s Canadians are rolling their eyes at the insanity of the
U.S. healthcare system and thinking how glad they are they don’t live here.)

HSAs are touted for their tax advantages as well as, in combination with high
deductible plans, being lower in cost than traditional health insurance. They
also allow the consumer to pay for health care costs that are not covered by
other insurance plans, such as vision and dental, a feature we’ll return to
shortly. While this post is not a debate on the pros and cons of HSAs, I should 
note that the HSA/high deductible insurance plan combination has its critics,
including Consumers Union and the American Public Health Association. Critics
say that HSAs favor the wealthy and healthy at the expense of those with lower
incomes and in poorer health. These plusses and minuses are reflected in
consumer opinions.

Tax-free distributions from an HSA must be used for “qualified medical
expenses.” (If not, you have to pay taxes on the distribution and, possibly, a
penalty.) What qualifies as a “qualified medical expense?” Here’s where it gets 
really interesting.

Eligible Health Savings Account expenses

Eligible HSA expenses are defined by the IRS. You can use your HSA for some
expenses that are not direct medical care, such as long-term care premiums and
some other types of health-related medical insurance premiums. For healthcare
itself, the expense must be for “medically necessary” purposes only. According
to the IRS, “qualified medical expenses” are those expenses “that would
generally qualify for the medical and dental expenses deduction.” In other
words, you go by the same rules as if you were taking medical expenses as an
itemized deduction on your tax return.

As it turns out, in some respects, those rules are much more generous than your 
average health insurance company’s limitations coverage of medical care. For
example, the list of allowable deductions (and therefore allowable distributions
from your HSA) includes contact lenses, contact lens solutions, and radial
keratotomy, all of which are typically not covered by traditional health
insurance without a purchase of a specific vision plan, and are not required by 
the ACA (for adults), although some companies do offer discounts.

This liberality extends to so-called “complementary and alternative medicine.”
According to the IRS, amounts you pay to acupuncturists, chiropractors and
Christian Science practitioners for “medical expenses” are eligible for payment 
via HSA tax-free disbursements. “Medical expenses” are defined as

   the costs of diagnosis, cure, mitigation, treatment, or prevention of
   disease, and the costs for treatments affecting any part or function of the
   body. These expenses include payments for legal medical services rendered by 
   physicians, surgeons, dentists, and other medical practitioners. They include
   the costs of equipment, supplies, and diagnostic devices needed for these
   purposes. Medical care expenses must be primarily to alleviate or prevent a
   physical or mental defect or illness. They don’t include expenses that are
   merely beneficial to general health, such as vitamins or a vacation.

While chiropractic “wellness care” probably wouldn’t make the grade,
chiropractic “adjustments” for all manner of health conditions (otitis media,
allergies, asthma, ADHD) would seem to qualify, as would acupuncture and
Christian Science prayers. (Sadly, dancing lessons are specifically excluded,
although, to my mind, they would be far more beneficial to one’s health than
chiropractic, acupuncture, or Christian Science.)

In contrast, chiropractic services are not considered essential health benefits 
under the ACA, and health insurance plans that do offer chiropractic coverage
generally limit the number of visits, the conditions covered (usually
musculoskeletal pain) and require demonstrated improvement of the patient’s
condition. For example, Blue Cross/Blue Shield of Alabama specifically excludes 
spinal manipulation for any non-musculoskeletal condition. Coverage of
acupuncture is similarly limited, although, as with any coverage that is not
deemed an essential benefit under the ACA, plans can vary.

As explained in a CHILD (Children’s Healthcare is a Legal Duty) newsletter, the 
IRS takes the position that the providers’ qualifications are irrelevant to
deductibility. If, as the IRS states, it is importing its standards for medical 
expenses deductibility into the rules on HSAs, we can assume the same is true of
payments for medical care from an HSA.

   Since the 1950s the IRS has allowed bills sent by Christian Science
   practitioners for their prayers to be deducted from federal income tax as
   medical care expenses. . . . In 2000, the IRS wrote that the “experience,
   qualification, or title” of the person rendering the services is irrelevant
   to whether they are allowed as a deductible medical care expense. Whether
   anyone besides the person paying for the service thinks it is medical is also
   irrelevant. . . . Thus, the only real criterion was that the person paying
   for the service believes its primary purpose is to heal, prevent, relieve, or
   diagnose disease. If the customer believed that, then the service was
   deductible medical care.

Homeopathy and naturopathy are not specifically mentioned by the IRS, but would 
certainly be eligible if you could get a physician to sign a letter of medical
necessity. (One can quickly see the potential for a mutually-beneficial referral
relationship here between an “integrative” medical doctor and a naturopath or
homeopath.) Health insurer Cigna’s interpretation of the IRS’s HSA regulations
is:

   Expenses paid to alternative providers for homeopathic or holistic treatments
   or procedures are generally not covered unless to treat a specific medical
   condition. Naturopathic procedures or treatments using natural agents such as
   air, water or sunshine are generally not reimbursable. Member’s explanation 
   of necessity required.

Not surprisingly, homeopaths and naturopaths take a more liberal view of the
matter. According to the California Association of Naturopathic Doctors,

   Money in your HSA can be used to pay for qualifying medical expenses,
   including medical appointments with your naturopathic doctor, lab tests,
   prescribed supplements, over-the-counter products, and other medically
   necessary prescribed services (for instance, massages for back pain). Some
   HSAs provide a debit-like card, others require you to submit receipts for
   reimbursement. You may ask your doctor for a Letter of Medical Necessity
   detailing your dietary supplement prescriptions for reimbursement.

Thus, the CAND is of the opinion that not only office visits, but also lab tests
ordered, and dietary supplements prescribed, by the naturopath, would be
covered the same as for a medical doctor. As well, they believe that the
naturopath’s signing a Letter of Medical Necessity would be sufficient to
support the legitimate use of HSA funds if questioned by the IRS. Given that
naturopaths make fake diagnoses, use a number of quack lab tests, and prescribe 
(and sell) dietary supplements of questionable efficacy, the HSA would appear to
be a real boon to naturopathic practice, paying for diagnostic tests and
treatments that would never be covered under traditional health insurance.

Individual naturopaths appear to agree with this expansive reading of the IRS
rules. One Connecticut naturopath, who practices “functional medicine“,
“encourage[s] patients to use HSAs for lab tests as well as natural medicines
provided by your doctor.” In contrast, she says, “functional lab testing is
often not covered by your [conventional health] insurance.” (Which is
undoubtedly true, since it is considered quackery by responsible medical
practitioners.) This Minnesota naturopath offers similar advice, as does a
California naturopath. At least one HSA guide, HSA Resources, takes the position
that “homeopathic care” can be paid for out of an HSA, while “homeopathic
treatment” is covered if used to treat a “specific illness.”

But who’s looking anyway? You decide whether any particular expense is
appropriate. While the taxpayer must attach a form to his 1040 showing his HSA
contributions and deductions, and is required to keep (but not file)
documentation of expenses, nothing will be questioned unless the taxpayer is
audited by the IRS. And the chance of that is minuscule, especially if your
income is less than $200,000 per year.

Health Savings Act of 2016

The ostensible purpose of The Health Savings Act of 2016, Senate Bill 2499 (and 
companion House Bill 4469) is to greatly expand the use of Health Savings
Accounts. But tucked in at the very end of the bill are some big-ticket goodies 
for the multi-billion dollar dietary supplement and homeopathic remedies
industries, as well as the sporting equipment and weight-loss industries.

First, the main event. The bill would rename “high deductible health plans” as
“HSA-qualified health plans” and remove a number of restrictions that prevent
consumers from creating and using HSAs. It would also allow consumers who use
health care sharing ministries to use HSAs, a move that is curiously at odds
with the whole idea that such arrangements place one’s health care choices
outside government purview. (Ironically, HSAs can be used to cover abortion
costs.) Users of direct primary care service arrangements could also use HSAs.

Unfortunately, the appeal of these provisions might propel Senate Bill 2499 and 
House Bill 4469 to passage, although Gov.Track actually gives both poor odds of 
being enacted. Still, it is a valuable addition to Sen. Hatch’s rap sheet of
offenses against the public’s health through his unwavering support of the
dietary supplement industry, which are well documented in the press (also here
and here), the medical literature, by  advocacy groups, here on SBM, and over at
our good friend Orac’s Respectful Insolence. As is the industry’s generous
support of him in return.

Which brings us to the offending provisions. If you flip way back to the end of 
the bill, starting on page 35, you’ll find the following:

   (13) Nutritional and dietary supplements.

   (A) In general. The term ‘medical care’ shall include amounts paid to
   purchase herbs, vitamins, minerals, homeopathic remedies, meal replacement
   products, and other dietary and nutritional supplements

In other words, all consumer purchases of these products (up to a generous limit
of $1,000 annually) would be treated as medical care, without a prescription
and without any demonstration whatsoever that they are “medically necessary,”
and HSA funds could be used for their purchase. (A feature this extremely
complementary Forbes piece on the bills failed to note.) This would be true even
though

  1. Homeopathic remedies do not, and cannot, work.

  2. Except for certain populations or those with demonstrated deficiencies, no
    dietary supplement has been proven effective for any health care need, and
    may even be harmful.

  3. Herbs are not only unnecessary, they are often adulterated, as are dietary
    supplements, which has been the subject of several posts on SBM.

In fact, about the only time “medical care” has any relationship to dietary
supplements, herbs and homeopathic remedies is when these products are used in
lieu of real medical care, with some unfortunate consequences, or they actually 
create the need for medical care because of their unsafe contents.

Naturally, if you will, the supplement industry is tickled pink with this latest
gift from Sen. Hatch. In this nearly fact-free statement, Daniel Fabricant, who
went out the revolving door of the FDA and into his current position as CEO and
Executive Director of the Natural Products Association, a trade industry
organization, said,

   The Health Savings Act would make necessary changes to dietary supplement
   coverage, allowing families to lead healthier lives, provide more freedom in 
   Americans’ personal healthcare choices, and lower overall healthcare costs.

In another tax-payer funded boondoggle for a specific industry (and also found
at the very end of the bill, starting at page 31), the term “medical care” would
be redefined to include

  1. Equipment for use in a program of (including a self-directed program) of
    physical exercise or physical activity;

  2. Instruction or participation in a program of physical exercise, nutrition, or 
    health coaching, again including a self-directed program; and

  3. Membership at a fitness facility

As with dietary supplements, there is a $1,000 annual limit and an item of
sports equipment can’t cost more than $250. You can’t include your Air Jordans
or your lululemons either – footwear or apparel does not qualify.

So, what might this have to do with the presidential election?

One of the sponsors of Sen. Bill 2499 is current presidential candidate Sen.
Marco Rubio. Could it possibly prove an embarrassment to Sen. Rubio that he is
supporting such obvious corporate welfare? Or alternative medicine? As to the
latter, it is unlikely. Bernie Sanders is a longtime proponent of naturopathy
and Hillary Clinton is in the thrall of Functional Medicine guru Dr. Mark Hyman,
but no one seems to think a thing about it. On the other hand, Ben Carson did
get a drubbing over his shilling for a supplement company, but I imagine he was 
going to flame out anyway. And Donald Trump’s anti-vaccination nonsense was duly
criticized, although he doesn’t seem to have suffered any ill effects from it
(or anything he says, for that matter). Rand Paul and Chris Christie also
pandered to the anti-vaccination movement, but they’re out of the running now.

Back in the day, Congress investigated quackery as a social ill. Today, Congress
pushes tax deductions for its purchase. And presidential candidates freely
support medical pseudoscience. What a shame.

Health misinformation now has powerful allies

Misinformation and conspiracy theories about health had long been a growing
problem before the pandemic, but it took COVID-19 to get the government and
researchers to take it seriously. Now, a new report in The Washington Post adds 
to previous reporting from multiple sources describing how allies of
misinformation—and not just health misinformation—are striking back under the
guise of defending “free speech.”

David Gorski on September 25, 2023

Link



It turns out that health misinformation and disinformation and the “freedom” to 
promote them now have very powerful allies, as a report in the Washington Post
published on Saturday demonstrates:

   Academics, universities and government agencies are overhauling or ending
   research programs designed to counter the spread of online misinformation
   amid a legal campaign from conservative politicians and activists who accuse 
   them of colluding with tech companies to censor right-wing views.

   The escalating campaign — led by Rep. Jim Jordan (R-Ohio) and other
   Republicans in Congress and state government — has cast a pall over programs 
   that study not just political falsehoods but also the quality of medical
   information online.

Obviously, the sort of misinformation that this blog has been most involved in
combatting is health misinformation. Indeed, over the last three years, the
tsunami of misinformation and disinformation about COVID-19 and COVID-19
vaccines has become a primary focus of our work. While it is true that, as the
pandemic has subsided somewhat, we have increasingly returned to our
pre-COVID-19 subjects, COVID-19 is never far from our concerns. However, the
problem described in the Post report goes beyond health misinformation:

   Facing litigation, Stanford University officials are discussing how they can 
   continue tracking election-related misinformation through the Election
   Integrity Partnership (EIP), a prominent consortium that flagged social media
   conspiracies about voting in 2020 and 2022, several participants told The
   Washington Post. The coalition of disinformation researchers may shrink and
   also may stop communicating with X and Facebook about their findings.

This is, of course, exactly the desired result of such campaigns, which
intentionally target those who research misinformation, how it is created, how
it spreads, and how to combat it, portraying such research as inherently biased 
against them and an attack on “freedom,” in particular “free speech.” When such 
campaigns come from powerful legislators (virtually all of whom are right wing
Republicans), the end result is this sort of reaction:

   The National Institutes of Health froze a $150 million program intended to
   advance the communication of medical information, citing regulatory and legal
   threats. Physicians told The Post that they had planned to use the grants to
   fund projects on noncontroversial topics such as nutritional guidelines and 
   not just politically charged issues such as vaccinations that have been the
   focus of the conservative allegations.

   NIH officials sent a memo in July to some employees, warning them not to flag
   misleading social media posts to tech companies and to limit their
   communication with the public to answering medical questions.

   “If the question relates in any way to misinformation or disinformation,
   please do not respond,” read the guidance email, sent in July after a
   Louisiana judge blocked many federal agencies from communicating with social 
   media companies. NIH declined to comment on whether the guidance was lifted
   in light of a September appeals court ruling, which significantly narrowed
   the initial court order.

This is, of course, another consequence of the simple fact that the government
funds a lot of science research. Two of the greatest triumphs of science in the 
US have been the National Institutes of Health and the National Science
Foundation. Neither are perfect or completely free from potential biases, but I 
have in the past argued that the methods by which they review, rank, and fund
grant applications come as close to a meritocracy as one is likely to find, with
grants being reviewed by panels of scientists with expertise in the subject
matter of the applications picking the applications over with a fine tooth comb 
before giving them a priority score from 1-9 (at the NIH, with which I’m most
familiar), lower scores being better. Even more surprising, for the most part,
the grants with the lowest priority scores are the ones that are funded,
regardless of the conspiracy theories of antivaxxers and COVID-19 cranks that
have sought to portray funding decisions as a quid pro quo of: “You support
Anthony Fauci and the government’s ‘censorship,’ or your research won’t be
funded.”

Purists frequently argue that science and medicine should be apolitical, a
position that I have never taken. In years past, I used to argue that supporting
science-based medicine is inherently political because government regulates
medicine and quacks have long tried to use the the political process to weaken
the scientific basis of medicine not just in academia but in the government
regulatory sphere. Examples of the interface between politics and medicine
include what retired SBM contributor Jann Bellamy used to refer to “legislative 
alchemy” in which the lead of pseudoscience and quackery (e.g., naturopathy,
reflexology, chiropractic, and unregulated supplements) are through the
legislative process turned into gold through laws turning pseudomedical
specialties into specialties recognized and regulated by the government in much 
the same way that medical practice by those who actually graduated from real,
accredited medical schools and residencies is. Other include laws like one in
North Carolina that bars the state medical board from disciplining physicians
for using alternative medicine unless it can prove that the treatments utilized 
are ineffective or more harmful that prevailing treatments. (Note the reversal
of the standard of evidence. The quack doesn’t have to prove the treatment is
effective or less harmful than prevailing treatments; rather the state medical
board has to prove that it is ineffective and/or more harmful than prevailing
treatments.) This is a law that was passed in 2010, a full decade before the
pandemic, and Jann had a good term for these “health freedom” bills and laws
too: Quack protection acts.

As a result of the rather obvious interface between politics, medicine, and
public health, traditionally I’ve always said that science-based medicine (the
movement and this blog) is not apolitical (nor should it be) but rather should
strive to be nonpartisan. Unfortunately, even before the pandemic this stance
had become more and more difficult to maintain given how much the center of
gravity of health misinformation in general, and the antivaccine movement in
particular, had shifted to the right. Indeed, by 2015 I was noting with alarm
how much the antivaccine movement had shifted to the right, to the point that
Republican candidates for President were using antivaccine talking points
cloaked in the rhetoric of “freedom,” opposition to mandates, and vaccine
safety, while by 2019 certain state legislators had become rife with antivax
legislator that antivaxxers were bragging about it. As early as 2018 I was
declaring that Republican Party had become the antivaccine party. (It still is, 
Robert F. Kennedy Jr.‘s campaign for the Democratic nomination for President in 
2024 notwithstanding.) I took no pleasure in saying this, because I’d long
feared the consequences that could follow if the one area of public health and
medicine about which there had been broad bipartisan consensus, school vaccine
mandates, were to become hopelessly politicized, something I was warning about
in 2017. I had no idea what was to come.

There are two incidents that the Post story primarily focuses on. Both are
intended to shut down government effort (or even government funding of efforts) 
to study and combat misinformation and disinformation, but one is more of a
slam-dunk than the other as far as egregiousness of intent goes. The worst
example is Rep. Jordan’s effort to shut down the NIH’s program to fund research 
into misinformation and how to combat it; the second is Missouri v. Biden, a
case now before the Supreme Court seeking to block a ruling from the U.S. Court 
of Appeals for the 5th Circuit that found that the White House, FBI and top
federal health officials had likely violated the First Amendment by improperly
influencing tech companies’ decisions to remove or suppress posts on the
coronavirus and elections. It’s a case that is not without some reasonable,
albeit still fairly weak, arguments that the Biden Administration might have
gone too far with respect to government compelling speech. Unfortunately, it’s
also a case that likely had significant influence on the NIH’s decision to
scuttle—for now—its misinformation research program,

Politicians vs. the NIH and NSF

What Rep. Jordan is doing in terms of trying (and, unfortunately, apparently
succeeding) in influencing the NIH to eliminate—or at least make much less
robust—its program to study misinformation and how to combat is truly alarming. 
It goes beyond the NIH, too. According to the Post:

   In September 2022, an NIH council greenlit a $150 million program to fund
   research on how to best communicate health issues to the public.
   Administrators had planned the initiative for months, convening a strategy
   workshop with top tech and advertising executives, academics, faith leaders
   and physicians.

   “We know there’s a lot of inaccurate health information out there,” said Bill
   Klein, the associate director of the National Cancer Institute’s Behavioral 
   Research Program at a meeting approving the program. He showed a slide of
   headlines about how online misinformation hampered the response to the
   covid-19 pandemic, as well as other public health issues, including gun
   violence and HIV treatment.

   The program was intended to address topics vulnerable to online rumors,
   including nutrition, tobacco, mental health and cancer screenings such as
   mammograms, according to three people who attended a planning workshop.

   Yet in early summer 2023, NIH officials contacted some researchers with the
   news that the grant program had been canceled. NIH appended a cryptic notice 
   to its website in June, saying the program was on “pause” so that the agency 
   could “reconsider its scope and aims” amid a heated regulatory environment.

Remember that memo to NIH employees about contacts with social media companies
and warning them not to flag misinformation on social media platforms? That’s
almost certainly as a result of Missouri v. Biden. I’m not going to comment on
the suit itself much—I am, after all, not a lawyer—other than to note that on
September 8, the Fifth Circuit ruled against the federal government, stating
that it had “coerced or significantly encouraged social media platforms to
moderate content”, which violated the First Amendment. The Court, however, also 
ruled that the preliminary injunction had been too broad because it blocked
legally allowed content between the government and social media services. The
Fifth Circuit Court narrowed the ruling to cover only the government
“threatening, pressuring, or coercing social-media companies in any manner to
remove, delete, suppress, or reduce posted content of postings containing
protected free speech.”

Whether you agree or not that there is a First Amendment issue here, there was
one thing that stood out to me as I perused some of the filings for the case.
Take a gander at this one from the State of Missouri dated July 4, 2023:

   The Court heard oral arguments on this Motion on May 26, 2023 [Doc. No. 288].
   Amicus Curiae briefs have been filed in this proceeding on behalf of
   Alliance Defending Freedom,3 the Buckeye Institute,4 and Children’s Health
   Defense.5

Children’s Health Defense? That’s RFK Jr.’s antivax organization!

But, again, even if you think that Missouri v. Biden is based in legitimate
First Amendment concerns about the Biden Administration using the power of
government to coerce speech, either by removing or inhibiting it or by
encouraging it, I would argue that what Rep. Jordan is about has far less to do 
with protecting freedom of speech than it does with protecting freedom of speech
by those espousing viewpoints with which he agrees and with suppressing freedom
of speech by those who espouse viewpoints that he detests. For example, take a 
look at what he’s doing to Stanford researchers, which is ironic given how much 
health information comes from Stanford faculty like Dr. Jay Bhattacharya when in
June he did this:

   Republican House Judiciary Chairman Jim Jordan and his allies in Congress are
   demanding documents from and meetings with leading academics who study
   disinformation, increasing pressure on a group they accuse of colluding with 
   government officials to suppress conservative speech.

   Jordan’s colleagues and staffers met Tuesday on Capitol Hill with a frequent 
   target of right-wing activists, University of Washington professor Kate
   Starbird, two weeks after they interviewed Clemson University professors who 
   also track online propaganda, according to people familiar with the events.

   Last week, Jordan (Ohio) threatened legal action against Stanford University,
   home to the Stanford Internet Observatory, for not complying fully with his 
   records requests. The university turned over its scholars’ communications
   with government officials and big social media platforms but is holding back 
   records of some disinformation complaints. Stanford told The Washington Post 
   that it omitted internal records, some filed by students. The university is
   negotiating for limited interviews.

As much as Jordan and his allies cloak this in the rhetoric of the First
Amendment and preventing government “censorship” of right wing voices, there is 
one purpose behind actions like this. It’s the same purpose that abusive Freedom
of Information Act (FOIA) requests have when weaponized at scholars working for
the government or for state universities where faculty emails are subject to
FOIA: to dig for dirt to “expose” and weaponize against academics doing research
that they don’t like and thereby to intimidate them either to silence or to
tone down their work.

It’s not just the NIH, either. According to this weekend’s report in the Post,
Jordan’s committee is going after researchers who have received NSF funding to
study misinformation and how to counter it, with the intended results:

   Some NSF grant recipients who have not received requests from Jordan’s
   committee say they are facing a barrage of online threats over their work,
   which has prompted some to buy services that make it harder to find their
   addresses, such as DeleteMe.

I’ve been subject to harassment, a libel suit, and abusive FOIA requests just
for editing this blog and running my own personal pseudonymous blog, and that
was bad enough. I can only imagine what these academics are going through. Let
me disabuse you, though, of one idea. This is not just about the NIH and NSF.
It’s about using the power of government to silence academics.

Politicians vs. academics

In fact, this is not just about the NIH or the NSF, but about academics in
general, as can be seen by further reporting:

   Connie Moon Sehat, a researcher-at-large for the group, said she and other
   researchers have faced online attacks including threats to reveal personal
   information and veiled death threats. She says members of her team are at
   times under high levels of stress and having ongoing conversations about how 
   to elevate accurate information on social media, as some platforms become
   increasingly toxic.

   “We are double- and triple-checking what we write, above what we used to, to 
   try to communicate our good intentions — in the face of efforts that
   willfully misconstrue our work and desire to serve the public,” Sehat said.
   “And I worry more broadly that we researchers may self-censor our inquiry, or
   that some will drop out altogether, to stay safe.”

Again, that is precisely the intended result of these “inquiries” into what
people like Rep. Jordan are now calling the “censorship-industrial complex.”
(Cute.) Those undertaking them want to punish academics whose research threatens
them or, failing that, at least make them so afraid that they constantly
second-guess themselves, tone down their findings, or even just leave the field 
altogether.

It isn’t about funding by the NIH or NSF, either. Private groups have been
targeted:

   Jordan’s committee has sent records requests to a number of universities and 
   independent research groups that worked on the Virality Project, which
   monitored anti-vaccine narratives across social media platforms after
   coronavirus vaccines became available, according to a person familiar with
   the matter who spoke on the condition of anonymity because of not being
   authorized to speak publicly.

   Groups that received demands for information include the Stanford Internet
   Observatory, the University of Washington, the National Conference on
   Citizenship, and New York University’s Center for Social Media and Politics
   as well as its Tandon School of Engineering, the person said.

   In one letter obtained by The Post, Jordan alleges strong ties between the
   Virality Project and federal government agencies, most notable being the
   Office of the Surgeon General and the Centers for Disease Control and
   Prevention. The letter seeks years worth of communications between employees 
   at those organizations and representatives of the executive branch and social
   media companies.

In case you’re wondering what the Virality Project is, it’s a “global study
aimed at understanding disinformation dynamics specific to the COVID-19 crisis.”
Also, rather interestingly to me, it’s about more than disinformation
spreaders:

   We have a unique opportunity to address several outstanding research
   questions:

     Tactics: How do governments leverage the full scope of media and social media 
    capabilities – overt and covert – to spread particular narratives? What can 
    we learn about state information capabilities from this crisis?

     Priorities: What do government information operations tell us about their
    geopolitical priorities?

     Actors: What role do groups that are partially aligned or not aligned with
    governments, such as groups opposed to vaccination, play in these
    information operations? To what extent do these groups coordinate?

     Interaction between government narratives and local communities: What is the
    relationship between government narratives, user-generated content,
    participatory dissemination, and mass media?

Also, most importantly, the work is being funded by private sources:

   This work is being funded by pre-existing grants by Craig Newmark
   Philanthropies and the Hewlett Foundation. Funding bodies interested in
   supporting this work are encouraged to reach out to [email protected].

All of this does, of course, risk angering those whose power and careers depend 
on spreading misinformation, and the techniques of harassment should sound
familiar to longtime readers of this blog:

   As the field of disinformation research has grown more politically
   contentious, researchers say that records requests, subpoenas and lawsuits
   have become tools of harassment. The fear of being targeted is profound
   enough that several researchers spoke on the condition that they not be
   named, and one prominent professor asked to be removed from the story
   entirely, citing concerns about his family’s safety.

   “The set of techniques used to harass people online has gotten more
   sophisticated,” said Alice Marwick, an associate professor of communications 
   at the University of North Carolina at Chapel Hill. “Right now, there’s a lot
   of bad actors who are using freedom of information requests to harass
   academics working at public universities. And that wasn’t something we saw
   until a few years ago.”

Neo, not really. Those of us who have been combatting the antivaccine movement
and various forms of quackery for a long time recall that abusive FOIA requests 
were “pioneered” many years ago and had become pretty common by the time the
pandemic hit. I myself have been subject to at least three. I will say that the 
most recent of these abusive FOIA requests did have an amusing aspect to it. An 
antivaxxer wanted any correspondence between the NIH and me. While I have had
NIH collaborators and a PubMed search will find several papers on which I’m
co-author that involve NIH researchers, in reality the amount of correspondence 
that I have with NIH researchers is rather limited. I am, however, on several
NIH listservs, which means that I have hundreds, if not thousands, of emails
from those listservs. Since the crank who had subjected me to the abusive FOIA
did not specify to exclude listserv results, I suggested that the university
counsel send him everything. While this made only a little more work for the
lawyer, because those making FOIA requests have to pay, it increased the expense
of the request. I am hoping that I got a little bit of revenge that way.

Academics respond

Unfortunately, my bit of fun with one harasser is just one minor time when I
feel as though I might have returned the favor in terms of causing inconvenience
to a tormentor. The vast majority of the time, the academic targeted has no
recourse other than to hunker down and hope the harassment blows over, combined 
possibly with either abandoning the targeted line of research or making their
research somehow less threatening. In fact, it’s getting so bad that academics
are considering this:

   Many academics, independent scholars and philanthropic funders are discussing
   how to collectively defend the disinformation research field. One proposal
   would create a group to gather donations into a central fund to pay for
   crisis communications and — most critically — legal support if one of them
   gets sued or subpoenaed in a private case or by Congress. The money could
   also fund cybersecurity counseling to ward off hackers and stalkers and
   perhaps physical security as well.

This is a good start. Certainly, back in the day, when Dr. Paul Offit was
receiving death threats, complete with harassing phone calls indicating that the
caller knew the names of his children, where they went to school, and where his
family lived in response to his defense of vaccines and pushback against
antiavax misinformation, things were a lot less organized. Fortunately for Dr.
Offit, he was on the CDC’s Advisory Committee on Immunization Practices, which
meant that he had a physical guard whenever he attended, and his university was 
supportive and willing to expend the resources to screen his mail. Still, two
decades ago, cases like his were anomalies. They aren’t anymore. They’re much
more common, victims of an intentional tactic to silence.

Another idea that sounds as though it might work but won’t is:

   University academics are also mulling ways to rebrand their work to attract
   less controversy. One leader in a university disinformation research center
   said scholars have discussed using more generic terms to describe their work 
   such as “information integrity” or “civic participation online.” Those terms 
   “have less of a bite to them,” said a person, who spoke on the condition of
   anonymity to speak on the private discussions. Similar conversations are
   occurring within public health agencies, another person said.

Superficially, this sort of approach seems reasonable. However, you can bet that
right wing defenders of misinformation like Rep. Jordan will not be mollified
by a rebranding or renaming of the research. They won’t be mollified by anything
less than cessation of such research or changing the research so that it
exonerates their allies who are promoting conspiracy theories and misinformation
about health and so many other areas. It’s why the far right, assisted by Rep. 
Jordan and his committee, has targeted the Center for Countering Digital Hate
(CCDH). It is all part of a coordinated strategy.

I realize that misinformation is not just being spread by the right and the
Republican Party. Indeed, back in the day, it was much easier to be political in
my advocacy for SBM while remaining, for the most part, nonpartisan. 15 years
ago, there was some truth to the common stereotype of the antivaccine movement
as being primarily made up of crunchy granola munching lefties. (The stereotype 
was always an exaggeration, but let’s just say that the leftwing component of
the antivax movement was much more prominent in those days.) Here and now, in
2023, it can no longer be denied that, however much misinformation might emanate
from left wing sources, the sheer volume of misinformation and disinformation
that emanates from right wing sources far exceeds it. The recent volley coming
from Congress is nothing more than the latest chapter in the long-running saga
of the war on science-based regulation of medicine and public health in which
the pandemic has served as a convenient event to push quacks and right wing
activists and politicians who view all government regulation as the enemy into
bed together. It is a conflict that goes back 200 years.

I am far less optimistic about the outcome than I used to be.

Supplements, Lies, and a Lengthy Transcript

Jann Bellamy on May 26, 2016

Link



Thanks, Congress, for making bull testicles available as a dietary supplement!

On October 21, 1993, there was a hearing before the U.S. Senate Committee for
Labor and Human Resources, with the long-winded title:

   Examining How the Federal Government Should Regulate the Marketing and Use of
   Dietary Supplements and Related Measures, Including S. 784, To Strengthen
   Federal Standards with Respect To Dietary Supplements.

S. 784, sponsored by Sen. Orrin Hatch, would eventually be enacted as the
Dietary Supplement Health and Education Act of 1994 (DSHEA).

I discovered this bit of Congressional theater when doing research for my recent
talk at NECSS. Scott Gavura and I joined forces to present “Natural Disaster:
Dietary Supplements.” Scott focused on pharmacology, while I talked about FDA
regulation of dietary supplements (or lack thereof). Thanks to him, I now have a
rudimentary knowledge of pharmacokinetics, the science behind how a drug or
supplement works (or doesn’t) in the body. If you haven’t read his post from
last week explaining this, and more, you should.

Reading the lengthy hearing transcript (well, ok, a lot of it) confirmed my
suspicions that the fix was in even before the gavel went down to begin the
hearing. What I had not realized was, at least according to some proponents of
DSHEA, part of the deal was that consumers would have access to accurate
information backing efficacy claims made for supplements and their safety. Nor
had I realized that the weaknesses of DSHEA, which have become painfully obvious
in the 20-plus years since the law was passed, were anticipated from the get-go
and that Congress was well-informed of what they were. Finally, I was not
previously aware of the provenance (shall we say) of the “experts” asked to
testify at the behest of Sen. Hatch.

First, let’s set the stage on which this drama plays out, according to two
excellent books on dietary supplements, Natural Causes and Vitamania. In 1991,
Congress passed the Nutrition Education and Labeling Act (NELA). Most famously, 
NELA, for the first time, required that all foods bear the now-familiar
nutrition label. It also required that any health claims made for foods be
backed by “significant scientific agreement.” Rep. Henry Waxman and others
wanted the same standard applied to dietary supplement health claims. After all,
if food companies had to meet a certain standard to make health claims for,
say, calcium in their products, why shouldn’t claims for the health benefits of 
calcium in dietary supplement form be held to the same standard? But the
supplement industry knew it couldn’t survive under such stringent rules and Sen.
Hatch made sure it didn’t happen. All parties agreed to let the FDA decide what
standard should be required of supplement health claims and left it at that.

Lo and behold, the FDA turned right around proposed a regulation that dietary
supplement health claims would be held to the same “significant scientific
agreement” standard. This could be met in one of two ways. The supplement
company could submit the evidence to the FDA for review or show that the claim
was backed by a statement from a recognized scientific authority, like the
National Academy of Sciences. (Actually, this is still the standard for health
claims, but DSHEA did away with the necessity of making health claims. The
nebulous “structure/function” claim and the “substantiation” standard for
evidence obviated the need go to all the trouble.)

Sen. Hatch and the industry were not amused. The industry started an absolutely 
false rumor that the FDA was out to “ban” or “take away” consumers’ supplements.
Thus riled up, hundreds of thousands of people wrote and called Congress
demanding that something be done. With that, let’s turn to the hearing itself.

Where’s the evidence?

Rep. Bill Richardson (D-NM), who sponsored the House version of S. 784, led off 
the testimony. Rep. Richardson framed the issue as one of “freedom of choice.”
If consumers could “choose dietary supplements that will help them prevent
illness and disease,” the “safe use of supplements could save this country
billions of dollars in health care costs each year.” How? By giving consumers
“adequate information” using labels and “pamphlets.” (This is before the age of 
Google U and widespread use of internet sales.) And,

   I also believe that health claims must be truthful, nonmisleading, and based 
   upon the totality of scientific evidence . . . [M]anufacturers of supplements
   must be allowed to make truthful and nonmisleading claims when there is
   scientific evidence to back those claims. Let’s allow science to be the
   determining factor for the validity of health claims for supplements and any 
   questions involving safety. This should be our goal as we move forward.
   [Emphasis added.]

The importance of consumer access to the evidence was emphasized by the
Commission on Dietary Supplement Labels, which was created by DSHEA. The
largely-forgotten Commission, which included industry representatives, was
charged with making recommendations for

   the regulation of label claims and statements for dietary supplements . . .
   [T]he Commission shall evaluate how best to provide truthful, scientifically 
   valid, and not misleading information to consumers so that [they] may make
   informed and appropriate health care choices.

The Commission’s 1997 Report said that the supplement industry has a
responsibility to provide a synopsis of the scientific evidence regarding
statements of nutritional support and product safety to potential buyers and
health professionals. These synopses should indicate how health professionals
can obtain access to the studies and evidence that support these statements,
which would facilitate the ability of health professionals and consumers to
evaluate them.

Later in the hearing, Sen. Tom Harkin, of NCCAM/NCCIH fame, steps up to the bat,
teeing off (badly scrambled sports metaphor noted) with his infamous story
about how bee pollen cured his allergies. To that he added an anecdote about how
someone gave him a traditional Native American substance (never identified) to 
chew on and it cured his sore throat, practically instantaneously. He then
wanted to know why supplement companies shouldn’t be able to tell consumers that
some people have been “cured of allergies,” for example, by a dietary
supplement. However, to his credit, Sen. Harkin ends up agreeing with David
Kessler, then head of the FDA and a witness at the hearing, that “significant
scientific agreement” would be an appropriate standard.

Science and the Senator

As might be expected, the supplement industry’s protector-in-chief, Sen. Orrin
Hatch, who dominated the mic, spent most of his time lambasting the FDA,
including a downright abusive confrontation with Dr. Kessler. (Fortunately, Sen.
Katzenbaum, for the record, stepped in and established that the rumors about
the FDA “banning” supplements were encouraged by the industry and absolutely
false.)

For their part, Dr. Kessler and other FDA officials present at the hearing tried
to warn the committee about the dangers of supplements and the lack of evidence
of their efficacy. Their points:

  1. Many products sold as dietary supplements – amino acids, herbs and botanicals,
    and other non-vitamin and non-mineral products, have no established role in
    nutrition, have been associated with serious adverse reactions, and
    frequently bear unsubstantiated claims to prevent or treat disease.

  2. If no scientific standard is imposed, the market will be filled with
    unsubstantiated claims, putting the public’s health at risk, including
    diverting people from proven medical treatments.

  3. The lack of reported adverse events doesn’t mean they don’t happen, because
    there is no system for reporting them.

  4. Although some botanicals are derived from well-known culinary herbs, most are 
    not and have no known nutritional value or history of use as foods. Dietary 
    supplements containing herbs and botanicals are not standardized, making
    testing them for efficacy or safety problematic. The FDA’s testimony
    specifically discussed the risks of germander, comfrey, chapparal, yohimbe, 
    lobelia, Jin Bu Huan, Stephania/Magnolia, Ma Huang (ephedra), and willow
    bark.

And, finally, in Dr. Kessler’s own words,

   The proposed legislation would permit companies to make the initial judgment.
   A claim could be made as long as it accurately described the state of the
   scientific evidence, which under the bill as written could include a complete
   lack of evidence. Thus, a claim could be based on mere belief or on one
   small preliminary study that in no way established the nutrient-disease
   relationship, as long as the label statements accurately portray the state of
   the evidence.

[I am not sure what he is referring to by “accurately portray the state of the
evidence” as there is no such requirement in DSHEA.]

In yet another session of lambasting Dr. Kessler and the FDA, Sen. Hatch makes
two statements confirming my initial impression that either Sen. Hatch does not,
or does not want to, understand science-based, or even evidence-based,
medicine. First, he asks, in essence, “what’s the harm?” If a supplement doesn’t
hurt someone, why not let it remain on the market, even without evidence of
efficacy:

   The fact of the matter is that many people get well because they take
   placebos because in a large sense they believe they are doing something that 
   helps them, and psychosomatically it does.

And,

   [what] you have been advocating for . . . is basically that they [the
   supplement companies] have got to prove every claim that they make before
   they can put the claims out there. And, if they do not, they cannot do it.
   Therefore, a lot of products that basically are helping people like Senator
   Harkin . . .

Sen. Hatch then trails off into the “bee pollen anecdote” but his message is
clear: anecdotal evidence is sufficient and supplement companies should not have
to have any valid evidence before making claims.

He also said, in questioning a representative of the Center for Science in the
Public Interest,

   I have seen estimates where just if people would take Vitamin E that we would
   save about $25 billion a year in health care costs on the reduction of
   cardiovascular disease. You could just extrapolate that out with Vitamin C,
   beta carotene, Vitamin A. You could just go right through it. The American
   people would be much better off.

He does not explain exactly how one can “extrapolate” the alleged evidence for
the efficacy of one vitamin to prove the efficacy of other vitamins, but such is
the scientific prowess of our elected representatives in Congress.

Sen. Hatch’s “experts”

Sen. Hatch’s remarks were not without humor, although that certainly wasn’t his 
intent. The good Senator thanked a number of luminaries from the alternative
medicine industry “who have worked closely with us during our consideration of
this issue.” These included “Citizens for Health,” now run by James Turner,
“neutraceutical” litigator and lobbyist, and supported by the Weston A. Price
Foundation and the National Health Freedom Coalition, on whose board the late
homeopathy enthusiast Rustum Roy sat.

Also recognized were a number of “helpers” with obvious ties to the supplement
industry. And:

   Another individual who has been a great help to me is Dr. Julian Whitaker, a 
   noted physician, author of the monthly newsletter, “Health and Healing,”
   President of the American Preventive Medical Association.

I laughed out loud when I came to this point in the transcript. We’ll all have
to agree that Dr. Whitaker is “noted,” just not in the way Sen. Hatch had in
mind. He is an anti-vaccinationist who debated our very own Steve Novella. And, 
if that weren’t enough, he is a supporter of cancer quack Stanislaw Burzynski,
claims he can cure diabetes “naturally,” thinks antibiotics don’t work, and
prescribes chelation therapy for this patients. The American Preventive Medical 
Association, now the American Association for Health Freedom, was described by
SBM’s Kimball Atwood as part of “what is probably the largest and most insidious
family of organizations hyping implausible practices and the ‘freedom’ to
peddle them.”

Dr. Whitaker did not personally appear, but submitted written testimony touting 
the benefits of saw palmetto, calling it more effective than Proscar.
Apparently, Dr. Whitaker was the source of Sen. Hatch’s claim that we could save
“billions” by taking Vitamin E. He extrapolated from two observational studies 
that by taking Vitamin E there would be a 23% reduction in the U.S. heart
disease rate.

Another of Sen. Hatch’s experts at the hearing was Michael Janson, MD, who,
according to his website, is past president of both the American Preventive
Medicine Association and the American College for Advancement in Medicine,
another pseudomedical pseudoprofessional organization. Quackwatch, which lists
the ACAM among “Questionable Organizations,” complained to a website about it’s 
referring readers to ACAM for advice on “alternative medicine” that

   referring readers to ACAM members is like referring people who want to borrow
   money to Mafia loan sharks.

Dr. Janson also described himself in his testimony as a charter member of yet
another pseudomedical professional organization, the American Holistic Medical
Association, whose members include such luminaries as Christiane Northrup, MD.

Dr. Janson seemed to enjoy his position as medical advisor to Sen. Hatch, a
position of authority one doubts comes his way all that often. He refers to the 
“vast medical literature” substantiating the use of dietary supplements for
health. He describes supplements as “safer than water.” His claimed that saw
palmetto reduces enlarged prostates, heart attacks are preventable by taking
vitamin C, and that antioxidant supplements are beneficial. He also sets up a
giant straw man by displaying, in a chart, adverse reactions to drugs. He used
the opportunity to promote one of his books by handing out free copies.

Although he didn’t personally testify, a letter from Linus Pauling to President 
Bill Clinton was included in the record. He opined that “vitamin C can help
prevent the common cold” (it can’t) and that “a whole range of vitamins, known
as antioxidants, can also prevent chronic illnesses including the nation’s two
largest killers, heart disease and cancer.” (Vitamin supplementation may
increase cancer mortality.)

Of course, if you’re pushing for a law like DSHEA, these are just the sort of
“experts” one would want as advisors.

On the other hand, Bruce Silverglade, from the Center for Science in the Public 
Interest, presented the views of that organization and the American Cancer
Society, American Heart Association, American Association of Retired Persons,
American College of Physicians, American Institute for Cancer Research, American
Nurses Association, Association of State and Territorial Public Health and
Nutrition Directors, Citizens for Public Action on Cholesterol, Consumer
Federation of America, Public Voice for Food and Health Policy, and the Society 
for Nutrition Education. With all due respect to Mr. Silverglade and his
excellent testimony, having one person present the opinion of so many different 
organizations was a tactical error. Given the influence of the supplement
industry and its powerful protector, I doubt it would have made any difference
in the outcome, but it would have at least made the outcome look worse.

Mr. Silverglade said, in a statement overly generous in its interpretation of S.
784, that the bill would allow health claims “so long as manufacturer disclosed
the state of the evidence supporting the claim, even if it was minimal.” This
concerned him because

   Manufacturers could hype products on the basis of preliminary, shaky, and
   inconclusive scientific evidence that would preclude consumers from making an
   informed choice, and a [sic] uninformed choice is tantamount to no choice at
   all.

He also warned against making health policy based on the “sole assumption that
because a product has been used for many years that it is safe.” As well, he
thought the level of proof required for removing products from the market –
“substantial and unreasonable risk of injury or illness” – was too stringent and
that the “amount and type of evidence needed by a supplement manufacturer to
substantiate safety is insufficient.”

So, who was right?

How has DSHEA worked out? Splendidly, for the dietary supplement industry. Sales
of dietary supplements were at $4 billion annually in 1994. In 2014, they were 
just under $37 billion.

For the rest of us, not so much. Over 20 years later, we know that some of the
testimony at the hearing was prescient. Some of it proved dead wrong.

  1. Consumers and health care professionals have never received the promised
    evidence for safety and efficacy. In fact, the industry fought legislation
    which would make them tell us what evidence they have backing their claims, 
    even though they are required to have substantiation. And when the
    Department of Health and Human Services Office of Inspector General looked
    into whether a sample of the industry was complying with the
    “substantiation” requirement, they were not. The prediction that supplements
    would be put on the market with flimsy evidence behind them came true.

  2. Placebos have yet to make anyone “get well.” But, as we know, there are
    dangers of thinking you are better because you feel better. For example,
    choosing alternative medicine over effective asthma treatment because
    placebo responses lead to feeling better without altering the underlying
    illness, could very well lead to preventable asthma deaths.

  3. The supplements touted by Julian Whitaker and others at the hearing have not
    held up to further scrutiny, for Vitamin E and cardiovascular disease, for
    saw palmetto and prostate problems, for Vitamin C and colds or heart
    disease, or for antioxidant supplements. In fact, a 2012 systematic review
    of randomized, placebo-controlled clinical trials led the authors to
    conclude

     With the possible exceptions of Vitamin D and omega-3 fatty acids there is no 
    data to support the widespread use of dietary supplements in Westernized
    populations; indeed, many of these supplements may be harmful.

  4. The evidence that the health care system has saved “billions” of dollars
    annually due to the public’s taking dietary supplements never materialized.

  5. The standard for getting supplements off the market has proven problematic.
    Only one ingredient, ephedrine alkaloids, has been banned by the FDA, and
    that took a decade to accomplish. The other supplements Dr. Kessler and the 
    FDA warned the committee about are still available and still have serious
    adverse effects: germander, chapparal, comfrey, Jin Bu Huan, yohimbe,
    lobelia, stephania, magnolia, and willow bark. Yet, because DSHEA does not
    require warning labels, consumers may not know of the risks.

  6. Anecdotes weren’t evidence then, and they still aren’t.

  7. Not knowing about adverse events doesn’t mean they aren’t happening. Through
    investigation of one manufacturer, we learned that the company withheld over
    13,000 adverse events from the government. It was not until 2008 that a
    reporting system was imposed, although it is only for serious adverse
    events.

  8. Recently, as Dr. Kessler predicted, the disturbing possibility that use of
    dietary supplements might actually result in rejecting an effective medical 
    intervention was raised when researchers discovered a correlation between
    CAM use, including supplements, and chemotherapy refusal among breast cancer
    patients.

Conclusion: DSHEA is still a terrible law that harms consumers

The real experts, those who hew to the standards of evidence-based medicine, are
vocal in their condemnation of DSHEA and the profligate use of dietary
supplements. (For example, here, here, here, here, here, here and here.) But as 
long as Orrin Hatch remains in the Senate and the dietary supplement industry
continues to rake in billions, regulatory reform is unlikely.

The Congressional Dietary Supplement Caucus

The Congressional Dietary Supplement Caucus, an officially-recognized
Congressional Membership Organization, operates as an in-house mouthpiece for
the dietary supplement industry. Both the caucus and the rules allowing it
should be reformed to prohibit this.

Jann Bellamy on August 17, 2017

Link




Legislative Alchemy

If you were thinking from the title that this might be another facetious SBM
post (a la Clay Jones) in which I fabricate an officially-recognized
organization within the U.S. Congress devoted to the dietary supplement
industry, you would be wrong. There really is an official organization of the
U.S. Congress, called the Congressional Dietary Supplement Caucus, and it is
devoted, in every sense of the word, to the dietary supplement industry. Its job
is feeding your elected representatives a steady diet of industry-friendly
talking points and protecting the industry from meaningful regulation, all
skillfully orchestrated by the industry itself.

I am not particularly sanguine about the U.S. Congress to begin with, but I must
admit that, despite over a decade of dealing with quackery and its many
deceits, even I was taken aback to find what is essentially a lobbying arm of
the dietary supplement industry imbedded in the institution itself. To be fair, 
there are other special interests with their own caucuses (beef, bourbon, and
cement, for example). I have not investigated the extent to which those and
other industries with dedicated caucuses have the same degree of industry
control over their message as the Congressional Dietary Supplement Caucus. If
they do, don’t expect the beef, bourbon or cement industries to be reformed
anytime soon.

Before we put the two together, let’s take a brief look at dietary supplements
and caucuses separately.

Just yesterday, Steve Novella’s post reviewed yet another article in the press
decrying the lack of effective regulation of dietary supplements and the
unfortunate misconception in the public’s mind that supplements are safe and
effective, when, in fact, the evidence is to the contrary. (You can find other
articles here, here and here.) As he pointed out,

  1. Routine supplementation with vitamins and minerals (sometimes sold in dosages 
    far exceeding the recommended daily allowance) is unnecessary for the vast
    majority of the public.

  2. Herbal remedies are essentially unpurified drugs with unfavorable risk-benefit
    ratios and are not intended to supplement the diet in any event (which is
    how “dietary supplement” is legally defined).

To this list, I’d add desiccated animal glands, another category of dietary
supplement also used as drugs (also here), but (like herbal remedies), without
the pre-market testing and post-market level of surveillance pharmaceutical
drugs must undergo.

The root cause of the supplement con, as Steve correctly names it, is the
Dietary Supplement Health and Education Act of 1994 (DSHEA), which eschews
premarket testing for product safety and efficacy in favor of a post-market
catch-the-bad-guys-if-you-can regulatory scheme enforced by a severely
understaffed and underfunded FDA: 26 government employees and a $5 million
budget versus a $41 billion-a-year dietary supplement industry, of which Big
Pharma owns a large chunk.

In addition to its own profits, the dietary supplement industry is an economic
engine of the vast pseudoscience market. Naturopaths derive significant income
from selling patients dietary supplements they prescribe. Gwyneth Paltrow and
her apologist, Dr. Aviva Romm, “functional medicine” guru Dr. Mark Hyman,
“integrative medicine” inventor Andrew Weil, right wing conspiracy theorist Alex
Jones, and President Donald Trump all have (or, in the case of Trump, had)
their own branded dietary supplements they want to sell you.

None of these will easily give up their profits. And, if their pals in
Congressional Dietary Supplement Caucus have their way, they won’t have to.

A “caucus” is formally known as a Congressional Member Organization (CMO),
formed by members of Congress “to pursue common legislative objectives.” CMOs
must register with the House Committee on Administration and are governed by its
rules. They are not publicly funded per se, although caucus members can use
certain publicly-funded resources to carry out the legislative objectives of the
caucus, including staff help, communications resources, space on an official
website, and preparation of materials for dissemination. Representatives and
Senators can use their personal funds to support caucus activities, but the
Administration Committee’s rules provide that:

   Neither CMOs nor individual Members may accept goods, funds, or services from
   private organizations or individuals to support the CMO.

As of 2014, according to an article in The Atlantic, there were almost 700 CMOs,
up from about 100 in the early 1990s. You can find the current list here. (I
didn’t count them, but feel free.)

The Dietary Supplement Caucus

With that background, let’s turn to the Congressional Dietary Supplement Caucus.
According to the United Natural Products Alliance (UNPA), an industry trade
association, the Dietary Supplement Caucus (DSC) was formed in 2006 and:

   serves as a bipartisan congressional group of legislators, who promote
   discussions among lawmakers about the benefits of dietary supplements;
   provide tips and insights for better health and wellness; and promote
   research about the health care savings these products provide. In a recent
   letter confirming the DSC to the Committee on House Administration, the DSC
   writes, ‘The caucus seeks to enhance Congressional attention to the role of
   supplements in health promotion, disease prevention and address the
   regulation of the supplement industry.’ The DSC sponsors regularly scheduled 
   luncheon briefings on Capitol Hill for members of Congress, their staffers,
   the media and the public.

Apparently, any consideration of meaningful industry reform via legislation to
protect the public from the deleterious health and financial effects of dietary 
supplements is not on the agenda. Other industry reps were even more blunt in
their assessment of the DSC’s purpose. In congratulating Rep. Mia Love (R-UT) on
her ascension to co-chair of the DSC following Rep. Jason Chaffetz’s (R-UT)
resignation from Congress, here’s what the President of the American Herbal
Products Association had to say:

   ‘We greatly appreciate Rep. Love volunteering her valuable time and expertise
   to lead this Caucus in representing the regulated dietary supplement
   industry on Capitol Hill,’ said Michael McGuffin, president of the American
   Herbal Products Association. ‘Rep. Love’s leadership will help the Caucus
   continue to educate policymakers about this growing industry’s significant
   and positive impact on consumer health and the U.S. economy.’

Yep. That’s Job #1 of the DSC: “representing the dietary supplement industry on 
Capitol Hill.”

And this from the head of the Council for Responsible Nutrition, another
industry trade group:

   As more than 170 million Americans take dietary supplements each year, the
   Dietary Supplement Caucus serves as an important resource to ensure
   legislators and their staff learn more about the wellness benefits of dietary
   supplements and the regulatory complexities of our booming industry . . .

Of course, as mentioned, the “wellness benefits” of dietary supplements overall 
are extraordinarily modest compared to their risks, so much so that major health
institutions advise against their use. The actual research demonstrates that:

   Most supplements do not prevent chronic disease or death, their use is not
   justified, and they should be avoided. This message is especially true for
   the general population with no clear evidence of micronutrient deficiencies, 
   who represent most supplement users in the United States and in other
   countries.

Yet, according to a rep from the UNPA, the DSC has its work cut out for it:
making sure Americans take even more unnecessary and potentially dangerous
dietary supplements.

   Loren Israelsen, president of the United Natural Products Alliance, which is 
   based in Salt Lake City, said, ‘UNPA is thrilled that Rep. Love is taking on 
   this important new leadership role. We look forward to working with her to
   help grow the $41 billion national dietary supplement industry, which
   includes more than $13 billion in supplement business activity in Utah. The
   dietary supplement industry is a positive and powerful economic engine that
   creates thousands of jobs while helping Americans support their healthy
   lifestyles.’

Rep. Love, for her part, is all in:

   ‘I’m excited to begin work on behalf of the more 68 percent of Americans who 
   take dietary supplements every year, ‘ Love said. ‘The industry is also a
   crucial part of Utah’s economy. Not only do dietary supplement companies
   provide jobs and opportunities in my state, they give consumers the
   opportunity to make educated choices to fill critical nutrient gaps and
   achieve better health.’

(Once again, no, they don’t.)

In fact, when the DSC reauthorized itself with the House Committee on
Administration this year, a Senior VP of the Council for Responsible Nutrition, 
Mike Greene, made it clear just who was behind the effort:

   In the past, it used to take us months to reform the caucus, which has to be 
   done each two years. This year was relatively quick.

And:

   Normally at the beginning of every Congress we refile the caucus. It used to 
   be that we had to reach out to each individual to see if they wanted to
   continue to be a member; now we tell participants they will continue to be
   carried as members unless they affirmatively opt out.

“Us?” “We?” In other words, the supplement industry isn’t just getting its
messaging out via the DSC, it’s dictating the terms of membership in the caucus 
and taking a proprietary role in its administration.

The Dietary Supplement Caucus seems to have taken a liberal view of the rule
against accepting “goods, funds, or services from private organizations or
individuals.” An announcement imploring other members of Congress to join the
DSC, sent out by the Council for Responsible Nutrition, conveniently provides
the names and contact information of Congressional staffers for those wanting
more information. Or, your elected representative was told, he or she could just
contact the CRN’s own “DSC industry liaison” for more information on joining
the DSC. That seems a bit cozy, as well as a clear indication that the industry 
has no reason to fear that the DSC might present anything other than
pro-supplement fodder to its members. (Current members of the Dietary Supplement
Caucus are listed on the announcement. If you see one of your elected officials
there, you might want to contact him or her and give them your thoughts on
belonging to this group.)

The DSC has co-hosted a number of luncheons and briefings for members of
Congress and their staffs “in cooperation with” (also here, here, here, here,
here, and here) the four major industry associations: the American Herbal
Products Association, the Council for Responsible Nutrition, the Natural
Products Association and the United Natural Products Alliance. One can guess who
picked up the tab.

In fact, Daniel Fabricant, executive director of the Natural Products
Association (and former director of the FDA’s Division of Dietary Supplement
Programs), has been remarkably frank about the industry’s role in running the
show:

   If you look at the history of the caucus, it has been the best way to educate
   Congress about dietary supplement issues. At these meetings, we can bring in
   speakers . . .

Yes, “we” can and “we” do.

You’ll not be surprised, by the way, to learn that Sen. Orrin Hatch (R-UT) is a 
member of the Dietary Supplement Caucus, nor that he is again sponsoring a bill 
to permit people with Health Savings Accounts to purchase dietary supplements
and homeopathic remedies with their triply-tax-exempt funds. (A companion bill
has been filed in the House.) We at SBM have criticized Sen. Hatch for blocking 
needed reforms in dietary supplement regulation. Perhaps we have been remiss in 
giving him too much credit. Looks like he’s got plenty of help from his fellow
DSC members.

Any organization that is essentially part of Congress and operated with
taxpayer-funded resources should not function as the in-house lobbying arm of an
industry special interest group, nor should Congressional rules allow this to
happen. As presently constituted, the Congressional Dietary Supplement Office is
simply a shill for Big Supp. Both the caucus and the rules should be reformed
to prevent this.

Dietary supplement industry says “no” to more information for consumers (again)

Jann Bellamy on October 3, 2013

Link

Once again, the dietary supplement industry is fighting efforts to give
consumers more information about the safety and effectiveness of dietary
supplements.

Big Supp is very clever. It sells consumers on the phony idea that they need
dietary supplements for good health. Even as the evidence continues to mount
that consumers don’t need supplements and shouldn’t take them, the industry
continues to convince the public otherwise. And in 2011 they raked in $30
billion.

The state and federal governments have served as handmaidens to the industry in 
this clever marketing strategy. Congress’s gift to the supplement industry, the 
Orwellian-named Dietary Supplement Health and Education Act (DSHEA) “effectively
excludes manufacturers of these products from virtually all regulations that
are in place for prescription and over-the-counter drugs, and puts the
requirement to demonstrate harm on the FDA, rather than the onus on the
manufacturer to show a product is safe and effective,” as SBM’s Scott Gavura
pointed out. DSHEA allows supplements to make “structure and function” claims,
although no one seems to know what that means, including the FDA.

States have done their part in granting chiropractors and naturopaths the
authority to give “nutritional” advice and recommend dietary supplements,
sometimes on the basis of dubious diagnostic testing purporting to reveal
imagined nutritional deficiencies. This gives them carte blanche to sell
supplements to their patients, a clear conflict of interest.

And when proposed regulation threatens their profits, the dietary supplement
industry and its surrogates enlist the very public it duped to join the battle. 
The industry convinces the public that someone is trying to take away their
access to supplements they never needed in the first place. This threat is
dressed up in terms designed to push all the buttons of a public already primed 
to be leery of “the government” – their “health freedom” may be taken away.
Actually, freedom to choose among health care practices is most threatened by
withholding readily-available information which would adequately inform health
care decisions.

Sen. Durbin wants more information for consumers

Sen. Dick Durbin (D-IL) has (once again) introduced legislation with some
perfectly reasonable requirements designed to help consumers make informed
choices about whether to use supplements. (The Dietary Supplement Labeling Act, 
S. 1425) Sen. Richard Blumenthal (D-CT) joins him in this effort. I’ve
criticized Sen. Blumenthal for his support of a Connecticut law forcing
recognition of a disease that does not exist – Chronic Lyme Disease. I don’t
know if he’s seen the scientific light and now wants to protect consumers or
simply doesn’t realize that the dietary supplement industry and “Lyme literate” 
doctors are employing variations of the same marketing strategy: selling the
public on a need and then selling the public products or services to fulfill
that illusory need.

In support of the bill, Sen. Durbin refers to yet another government report on
the health risks of supplements. A recent Government Accounting Office report
noted that between 2008 and 2011, the FDA received 2,100 reports of health
problems associated with dietary supplements. However, the GAO suspects
underreporting of adverse events because most consumers call poison control
centers, not the FDA. (To be fair, a reported adverse event may or may not be
caused by taking a dietary supplement.)

The latest report is just one of many warnings about the dangers of supplements 
and pleas for adequate regulation. Recently, the American College of Medical
Toxicology and the American Academy of Clinical Toxicology had this to say in a 
joint statement:

   There is a lack of stringent quality control of the ingredients present in
   many herbal and dietary supplements. Reliable evidence that these products
   are effective is often lacking, but substantial evidence exists that they may
   produce harm. Indirect health risks also occur when these products delay or 
   replace more effective forms of treatment or when they compromise the
   efficacy of conventional medicines.

Sen. Durbin’s bill would at least partially address some of these problems.
Here’s what the bill would do:

  1. Beef up the registration requirements for supplement manufacturers. In
    addition to registering, manufacturers would be required to provide the FDA 
    with a description of each dietary supplement they make, a list of its
    ingredients and a copy of the label. The companies already have all of this 
    information – at least, I certainly hope they do. This information would be 
    available to the public.

  2. Require the FDA to compile a list of dietary supplement ingredients (or blends
    of ingredients) it determines could cause potentially serious adverse
    events, drug interactions, contraindications or risks to subgroups such as
    children and pregnant or breastfeeding women. (But not to the general
    public.) The Institute of Medicine would evaluate dietary supplement
    ingredients and provide this information, at no cost to the supplement
    companies.

  3. Require dietary supplement manufacturers to provide substantiation for their
    claims of health benefits, such as “structure and function” claims.
    Currently, manufacturers are supposed to have substantiation but need not
    give it to the FDA. Again, information the companies already have in their
    records, or should have.

  4. Give the FDA authority to clear up the distinction between dietary supplements
    and food and beverages with additives.

Big Supp doesn’t want them to have it

In sum, the bill would give consumers some of the tools necessary to do a proper
risk-benefit analysis in deciding whether to take a dietary supplement. It
accomplishes this with information the companies already have or which the
government will provide free of charge. But the supplement industry (once again)
does not want consumers to have this information. Here’s what Michael McGuffin 
of the American Herbal Products Association (AHPA), an industry trade group, has
to say about the bill:

   There are numerous authoritative references already available to provide
   safety information on dietary ingredients, including AHPA’s Botanical Safety 
   Handbook for herbal ingredients . . . Instead of using taxpayer funds to
   reinvent the wheel, the existing resources should be recognized.

Of course, consumers would need a paid subscription to access much of this
research, if it exists, including the AHPA’s Handbook, which provides
information only on botanicals. As pointed out by the toxicology experts, many
of these supplements have never been fully researched. And one would need a
background in pharmacy or medicine to fully understand the information provided 
in the Handbook.

Personally (if I took supplements, which I don’t) I’d rather have the Institute 
of Medicine doing my research instead of a trade organization. For example,
let’s compare what the AHPA says about St. John’s wort to the analysis of St.
John’s wort available from Natural Medicines Comprehensive Database, which also 
requires a subscription. (For brevity’s sake, I’ve omitted the references.)

AHPA Handbook:

   Pregnancy and Lactation

   Studies on the effect of prenatal consumption of St. John’s wort on pregnancy
   in mice and rats were generally associated with normal gestation and
   offspring development. A limited number of human case reports indicated
   healthy pregnancies and infants when St. John’s wort was used prenatally.

   In studies of nursing mothers, the compound hyperforin was detected in low
   concentrations in mother’s milk while the compound hypericin was not detected
   in milk.

Natural Medicines Comprehensive Database:

   PREGNANCY: POSSIBLY UNSAFE …when used orally. Anecdotal evidence suggests
   that St. John’s wort might be safe for use during pregnancy; however, animal 
   model research has produced contradictory findings. Other preliminary
   research suggests that constituents of St. John’s wort might have teratogenic
   effects. Until more is known, St. John’s wort should not be taken during
   pregnancy.

   LACTATION: POSSIBLY UNSAFE …when used orally. Nursing infants of mothers who 
   take St. John’s wort can experience colic, drowsiness, and lethargy; avoid
   using.

Whose advice would you follow?

According to Steve Mister, from another industry trade group the Council for
Responsible Nutrition, the supplement industry does not support legislation

   that directs FDA to require warning labels for products or ingredients that
   ‘could cause’ adverse events or potential risks as this is a case of the
   precautionary principle run amok. While the premise may be well intentioned, 
   in practice this requirement would lead to confusing and unnecessary label
   instructions likely to deter consumers from using beneficial dietary
   supplements based on uncommon or miniscule risks.

But that’s not what this legislation says. It plainly states that labels would
have to warn only of “potentially serious adverse events, drug interactions, or 
contraindications, or potential risks to subgroups” like pregnant women and
children. And “beneficial”? If the industry has good evidence that using dietary
supplements is beneficial why not share it with the public?

In other statements, Mister seems to want to shift the focus to supplement
manufacturers and sellers who aren’t complying with DSHEA and urges more
resources for the FDA to address those problems. I certainly agree with giving
the agency more resources, but that doesn’t really address the issues raised by 
this legislation: insufficient information about health benefit claims all
manufacturers are touting and knowing the health risks of taking any dietary
supplement, not just those sold by companies who are out of line.

Sen. Durbin’s bill has been referred to the Senate Committee on Health,
Education, Labor and Pensions. Unfortunately, according to GovTrack, it has zero
chance of passing.

Politics of Public Research Funding

Steven Novella on May 1, 2013

Link

A great deal of science is funded by the US government. The total research
funding for 2009 was 54.8 billion dollars (much more if you include all R&D). A 
breakdown by agency of total R&D shows that the NIH (National Institutes for
Health) funding is 28.5 billion while the NSF (National Science Foundation) is
4.1 billion.

There is general agreement that this expenditure is an investment on critical
intellectual infrastructure for our nation and is vital to our competitiveness
and standard of living. The government certainly has the right, and in fact the 
duty, to ensure that this money is well-invested. Government oversight is
therefore understandable. Inevitably, however, politics is likely to intrude.

Representative Lamar Smith has been developing legislation that would in effect 
replace the peer-review process by which grants are currently given with a
congressional process. Rather than having relevant scientists and experts decide
on the merits of proposed research Smith would have politicians decide. It is
difficult to imagine a more intrusive and disastrous process for public science 
funding.

Superficially some of the language of the bill may seem benign and reasonable.
The draft bill calls for all research to be:

   (1) is in the interests of the United States to  advance the national health,
   prosperity, or welfare,  and to secure the national defense by promoting the
   progress of science;

   (2) is the finest quality, is ground breaking,  and answers questions or
   solves problems that are of  utmost importance to society at large; and

   (3) is not duplicative of other research projects  being funded by the
   Foundation or other Federal science agencies.

The first two criteria sound reasonable at first – that the research is of some 
practical use. What this is, however, is a broadside against all basic science
research. For optimal effect, scientific research needs to be balanced between
speculative research, basic science research, translational research, and
practical research. You can’t have all research be designed to lead directly to 
a practical application. You need sufficient basic science research to feed into
that last step in the development process.

It can be difficult, however, for non-scientists to understand the relevance of 
abstract basic-science research. Often it is not even clear how such research
might translate into a practical application – scientists sometimes are just
curious and want to figure out how things work. It is often exactly this kind of
research that leads to unexpected advances with very practical applications.

I have noticed, however, that researchers have become reflexively good at making
up plausible-sounding possible applications for their basic science research – 
as if they have to constantly justify their research. Every basic-science study 
that looks at viruses, therefore, may one day cure the common cold. Anything
dealing with cell replication may be a cure for cancer. Any materials advance
will lead to supercomputers or superlight vehicles. All brain research,
apparently, might one day cure Alzheimer’s disease.

I would love for a scientist to say something to the effect of “I have no idea
what, if any, practical use this research might lead to, but the knowledge is
really cool”. I guess you just don’t say that to a grant committee, however.

When those providing the funding insist on an immediate practical application,
they put their thick thumb on the scale and affect the balance of research,
shifting it away from basic science. This may have the effect of actually
slowing scientific progress. Resources (researchers, institutions, subjects,
etc) follow the funding. They have no choice. It’s appropriate to have broad
goals for research funding, but it’s counterproductive to dictate how those
goals should be achieved.

This can happen with private funding as well. I have seen it happen with disease
research. Private charitable organizations raise money to research a disease.
The organizers want that money to go to research that will directly benefit
patients (who are often their primary donors). But if this prematurely pushes
researchers toward clinical studies when we don’t have the basic science
sufficiently worked out yet, you end up wasting a lot of time and resources on
dead ends.

The third criterion may sound like a way to avoid waste, but it is hopelessly
naïve about how science progresses. Duplicative research is a good thing. One
reason is that independent replication is vital to scientific advance. That
provision looks like it was written by someone who thinks that a single study is
sufficient to establish a scientific finding.

Second, it often makes sense to tackle a problem simultaneously from multiple
angles and theories. Non-scientists should not put themselves in the position of
picking scientific winners and losers before the research is even completed.

The bottom line is that there is no easy formula or algorithm for deciding what 
research to fund. You can have criteria, but applying those criteria requires
intimate knowledge of the research area, of research in general, and the
background science. Peer-review by a panels of experts is the best method for
making such decisions.

As expected the NSF was very critical of the proposed legislation to replace
this process with a more political one. In addition to the draft bill, Smith has
written to the NSF requesting information on specific grants with which he has 
issue.

Representative Eddie Bernice Johnson, who also sits on the science committee,
wrote a letter to Smith complaining about this request:

   In the history of this committee, no chairman has ever put themselves forward
   as an expert in the science that underlies specific grant proposals funded
   by NSF. I have never seen a chairman decide to go after specific grants
   simply because the chairman does not believe them to be of high value.

She hits the nail directly on the head – oversight of science-funding by
politicians does not mean that they present themselves as scientific experts
above actual experts in the field.

Optimally efficient and effective scientific research requires a certain degree 
of intellectual freedom. It is legitimate to require transparency and
accountability, but not micromanagement. There needs to be a certain insulation 
between the political process and the scientific process.

The worst aspect of this proposed bill is that it would throw the door wide open
for political intrusion into public science funding. Every Senator or
Representative with an ideological ax to grind could harass and impede funding
of undesirable research.

Let’s hope this bill dies an early death.

NIH Director Francis Collins doesn’t understand the problem with CAM

David Gorski on January 16, 2012

Link

As the sole cancer surgeon among our stable of Science-Based Medicine (SBM)
bloggers, I’m probably the most irritated at the infiltration of pseudoscience
into academia (or, as we sometimes like to call it, quackademic medicine) in the
realm of cancer. Part of the reason, of course, is that cancer is so common and
that the consequences of adding pseudoscience to cancer therapy are among the
most devastating. Witness, for instance, the use of Gonzalez therapy to treat
pancreatic cancer, a form of quackery that harms patients and resulted in
incredibly unethical and disastrous clinical trial of Gonzalez quackery versus
chemotherapy whose results were entirely predictable, given the lack of prior
plausibility of the treatment: Gonzalez protocol patients did worse, with no
evidence that the therapy impacted the natural history of the disease and the
Gonzalez patients scoring lower on quality of life measures. Or look at what
happens when patients with breast cancer choose quackery over science-based
therapy.

I realize that “complementary and alternative medicine” (CAM) or, what
quackademics like to call it now, “integrative medicine” (IM) is meant to refer 
to “integrating” alternative therapies into SBM or “complementing” SBM with a
touch of the ol’ woo, but I could never manage to understand how “integrating”
quackery with SBM would do anything but weaken the scientific foundation of
medicine. Moreover, weakening those foundations would have more consequences
than just “humanizing” medicine; weaker scientific standards would allow not
just ancient quackery like traditional Chinese medicine (TCM) into academia, but
it would also provide an opening for drug and device companies to promote their
wares under less rigorous requirements for evidence. There’s also perhaps a
touch of personal embarrassment involved. After all, oncology and cancer surgery
tend to be specialties that are the most steeped in science. If I had to rank
specialties for how science-based they are, I’d certainly put oncology near the 
top, which is why I tend to come down so hard on “integrative oncology” and,
even worse, “naturopathic oncology.”

Consequently, I was doubly disturbed several months ago when I learned that the 
director of the National Institutes of Health, Francis Collins, had agreed to be
the keynote speaker at the Eight International Society for Integrative Oncology
Conference in Cleveland, OH. I say “doubly” disturbed because it disturbed me
that Francis Collins would agree to speak at such a function and, perhaps even
more, because the host institution was Case Western Reserve University, the
institution where I both completed my surgery residency and my PhD in Physiology
and Biophysics. Sadly, it now appears that my old stomping grounds at
University Hospitals has been thoroughly infiltrated with quackademic medicine, 
as evidenced by this clinical trial of reiki for psoriasis that’s making the
rounds of news services and the offering of acupuncture, reiki, and even
reflexology at various UH facilities through the University Hospitals Connor
Integrative Medicine Network. Let me tell you, there was none of this
pseudoscience going on when I finished my residency there in 1996. Seeing it
there now provokes a reaction in me not unlike Sylvester Junior’s reaction when 
his father Sylvester embarrasses him, particularly when I noted that the
director of the CWRU Comprehensive Cancer Center, Dr. Stanton L. Gerson, was to 
give one of the keynote talks, entitled, “The Future of Integrative Oncology.”
(Hint for those of you not familiar with classic Looney Tunes cartoons: A paper 
bag is involved.) I guess that by expressing my extreme disappointment and
embarrassment that the institution where I learned to become a surgeon has
during the last 15 years gone woo, I’ve probably just killed any opportunity I
might have to work at the Case Comprehensive Cancer Center ever again. Oh, well,
add it to the list, along with Beth Israel and my alma mater the University of 
Michigan.)

Back when I first learned about it, I thought about blogging the meeting, but
without much concrete to go on, given the copious other SBM-related topics to
blog about, all I could do was to write a critical open letter to Dr. Collins
about his decision to accept the offer to be the keynote speaker at the Society 
for Integrative Oncology (SIO). Then yesterday I saw popping up in my e-mail a
notice from the American Society of Clinical Oncology (ASCO), along with a link 
to a story in its publication The ASCO Post entitled NIH Director Calls for
Rigorous Evaluation of Integrative Medicine to Provide Evidence of Efficacy.

Et tu, Dr. Collins?

Francis Collins “gets it” about as well as Josephine Briggs

We here at SBM have written frequently and copiously about the National Center
for Complemnatary and Alternative Medicine, a.k.a. NCCAM, a.k.a. the Barad-dûr
to SBM’s Minas Tirith. OK, I exaggerate. Just a bit. NCCAM director Josephine
Briggs is a real scientist, and I have no doubt that she wants to make NCCAM
more scientifically rigorous than it has been in the past. Unfortunately, the
recent five year strategic plan she developed, along with her reaction to having
met with Steve Novella, Kimball Atwood, and me in 2010, leads me to believe
that she either doesn’t understand or refuses to acknowledge the problem at the 
very core of NCCAM: namely, that it is charged with studying treatment
modalities that are inherently unscientific, being as they are based on
prescientific or demonstrably incorrect understandings of human physiology and
disease. “Rebranding” CAM as “harnessing the power of the placebo effect” will
only go so far in putting lipstick on that pig, and trying to emphasize natural 
products begs the question of why a separate “CAM” institute is needed to do
pharmacognosy research.

Be that as it may, NCCAM is a political, not a scientific, construct, because
CAM is an ideological, not a scientific, construct. There is nothing tying
together the disparate “disciplines,” treatments, and woo lumped together under 
the rubric of CAM/IM other than that they either (1) have not been
scientifically demonstrated to have efficacy; (2) have been demonstrated not to 
have efficacy; or (3) are diet and exercise or other interventions that should
fall under the purview of SBM but have been co-opted by CAM/IM believers along
with the woo because they are modalities that have proven health benefits and
including them along with all the pseudoscience makes the pseudoscience seem
more plausible. It’s not for nothing that I frequently refer to diet, nutrition,
and pharmacognosy as the “Trojan horses” of CAM. These modalities have more
than a modicum of plausibility (although it should be pointed out that the way
they are represented by CAM often does not, vastly overselling the benefits or
fusing science-based recommendations with pseudoscience). “Energy healing,”
acupuncture, reiki, the vast majority of TCM, Ayurveda, and many other
modalities that fall under the CAM umbrella do not, and that is the problem.

Unfortunately, it’s quite obvious that Collins does not “get” this. Although he 
changed the title of his talk from the original title of “Faith, Spirituality
and Science in Oncology,” the actual talk he gave, entitled “Seeking Out the
Most Effective Interventions for Cancer Prevention and Treatment,” still falls
hook, line, and sinker for one of the favorite arguments of CAM proponents, the 
argumentum ad populum (i.e., appeal to popularity):

   “Many new frontiers exist in integrative medicine,” NIH Director Francis
   Collins, MD, PhD, stated in his keynote address at the Eighth International
   Conference of the Society for Integrative Oncology (SIO) in Cleveland. “The
   evidence is overwhelming that these approaches are being used by many
   individuals in the United States, including those with cancer,” he said. “For
   wellness, immune function, and pain-related symptoms, there is a significant
   increase in interest among cancer survivors compared to other people who use
   complementary and alternative medicine.”

   Survey data show that over a lifetime, complementary and alternative medicine
   (CAM) is used by “65% of cancer survivors vs 53% of noncancer respondents,” 
   he said. When questioned about motivations to use CAM, cancer survivors “are 
   more likely to be using this because they are unhappy that medical treatments
   have not helped them or because it has been recommended by the provider,” he
   noted.

As Steve Novella has pointed out, the appeal to popularity is the most
ubiquitous argument used in CAM apologetics. In brief, it argues that, because
CAM is seemingly popular, there must be something to it and we should study it. 
If you look at the figures, on the surface Collins’ figures appear to be
correct. However, such figures are hugely inflated by inclusion of things like
massage, vitamins and supplements, yoga, and prayer. That’s how studies of tai
chi in fibromyalgia, for instance, make it into the New England Journal of
Medicine labeled as “CAM” when in fact they are merely studies that demonstrate 
that gentle exercise appears to be helpful in alleviating fibromyalgia symptoms.
As Steve also pointed out, most hard-core CAM modalities are actually used by a
very small percentage of the population, with most falling in single digit
percentages. For example, acupuncture use is around 6.5%; Ayurveda, 0.6%;
chelation therapy, 0.3%; energy healing, 1.7%; naturopathy, 1.5%; and
homeopathy, 3.7%. These are hardly impressive numbers. In addition, these
numbers are not significantly different from numbers reported 10 or 20 years ago
– belying the claim that CAM use is increasing. In any case, the number I
usually see for the percentage of cancer patients reporting having used CAM is
less than 50%. I don’t know where Collins got his figure of 65%.

In fact, while looking for the source of Collins’ information, I found this
recent meta-analysis that, while claiming to find that CAM usage among cancer
patients is increasing, still only estimated it at 40% in American patients, way
lower than the 65% claimed by Dr. Collins. It’s actually a fairly maddening
study in that the definition of CAM therapies for purposes of inclusion in the
various studies is not listed in the paper. Rather, it’s listed in an online
supplement mentioned in the paper that I couldn’t find. In any case,
particularly interesting to me was this passage in the discussion:

   Surveys that restricted CAM use to certain categories or treatments yielded
   lower prevalence estimates than surveys that did not. This is exemplified by 
   the study from Abu Realh et al,120 who confined their definition of CAM use
   to mind-body approaches, counseling, and attendance to self-help groups and
   found that 12% of respondents were “CAM users.” Accordingly, studies with
   broad definitions of CAM use tended to inflate estimates: for example, many
   of the included surveys with very high usage rates had integrated prayer and 
   exercise defined as CAM, and the usage rate would have been approximately
   halved if these therapies had not been included. We planned to systematically
   address the question of how different definitions for the term CAM would
   influence the results in surveys. However, this was not feasible because
   authors seldom stated how they defined CAM for the purpose of their study.
   Moreover, even in studies from the same country, in which the same type of
   definition was used, the CAM treatments included varied substantially.

It’s a shame that Dr. Collins apparently either doesn’t recognize such
distinctions or was too unconcerned to look more in depth into whether claims of
CAM use in cancer patients by CAM advocates are accurate. They are, as Steve
and I have pointed out, hugely inflated by the inclusion of modalities that
aren’t really medicine (prayer, for instance) or through the inclusion of of
modalities that are arguably not CAM, such as vitamin use (which might or might 
not be science-based depending upon the specific use), exercise, and nutrition. 
Even sensationalistic news coverage comes up with lower estimates than Collins
did. Next up on Collins’ hit parade is a citation of a study from M. D. Anderson
Cancer Center that reports that 52% of cancer patients are using CAM during
phase I trials, but that 23% don’t disclose that information to trialists. This 
is indeed a disturbing figure, but it is not a justification for NCCAM, a
specialty known as “integrative oncology,” or CAM itself. Rather, it’s a figure 
that tells us that we should do more research in drug interactions with natural 
products, something that could easily be done under the auspices of non-CAM
funding mechanisms in the NIH.

In fact, I find this whole line of argument confusing. Collins went on to
proclaim how the goals of NCCAM are “very much aligned” with those of the SIO
and then used the following as his examples:

   “We need to do this research, not only to find out what works, but to find
   out what interventions actually may be harmful,” no matter how unlikely that 
   may seem, Dr. Collins commented. For example, he pointed to the story of
   beta-carotene in cancer prevention. In the 1980s, epidemiologic evidence
   suggested that beta-carotene might decrease lung cancer risk. Double-blind
   clinical trials were initiated, and in the 1990s, those trials showed that
   “not only is beta-carotene not protective, it actually increased lung cancer 
   risk—16% in one study and 28% in another—and so the studies were halted.” A
   follow-up study in 2004 corroborated those results.

This is, of course, a massive straw man coupled with a non sequitur. No one
seriously argues that scientists shouldn’t try to find out what works and what
doesn’t. In addition, the examples Collins cites are not in any way
“alternative,” “integrative,” or “complementary.” Beta-carotene is a chemical
found in some foods that can act as a drug or nutrient. There was preliminary
epidemiological evidence suggesting that beta-carotene might decrease the risk
of lung cancer. Scientists then did what scientists do: They performed
randomized, double-blind clinical trials to test the hypothesis, which seemed
plausible when the trials were initiated. Unfortunately, the results of these
clinical trials turned out not to be what had been anticipated; not only did
beta-carotene not prevent lung cancer, but it increased the risk of dying of
lung cancer in smokers. How this relates to “CAM” or “IM” is tenuous at best.
This is SBM at work. The same is true of the other example cited by Collins,
that of vitamin E and selenium as preventatives for prostate cancer that, when
tested in randomized clinical trials, actually slightly increased the risk of
prostate cancer. So, while I agree with Collins that “That’s the kind of data we
need if we are going to be giving rational recommendations to patients and
providers about how to practice better prevention and treatment,” I disagree
that such studies are in fact “integrative” or “alternative” or “complementary” 
or whatever CAM proponents like to call such supplementation these days. They
are, in fact, SBM. Beta-carotene and the vitamin E/selenium combination are
simply proposed therapies that had a modicum of plausibility to them as a
preventative strategy for different cancers that failed when tested in rigorous 
randomized clinical trials. This happens all the time in SBM; it’s why we do
clinical trials.

In essence, whether he knows it or not, Collins has fallen for the old “bait and
switch” of CAM/IM, just as NCCAM director Josephine Briggs has.

“Personalized” medicine and CAM

I’ve written many times before about how CAM co-opts the idea of “personalized
medicine” for itself when in fact what “personalized medicine” means in CAM
tends to involve practitioners “making it up as they go along” and the co-opting
of the term as a strategy to attack evidence-based medicine as being “one size 
fits all.” Some, such as Dr. Stanislaw Burzynski, co-opt the term as a
science-y-sounding way to make his very own “make it up as you go along”
mish-mash of targeted cancer therapies, antineoplastons, and chemotherapy sound 
as though he knows what he’s doing.

Collins, disappointingly, buys into this frame. Whether he does this knowingly
or unknowingly, I don’t know. (I suspect the latter.) First, he touts NIH
initiatives, such as the Cancer Genome Atlas, a project that will sequence the
genomes of many cancers and try to draw conclusions about the genetic
abnormalities that drive cancer growth and determine responsiveness to various
therapies. It’s an ambitious (and risky) project that has almost nothing to do
with CAM, although CAM proponents have tried to claim such projects as their
own, the most hilariously off-base example being so-called Ayurvedomics. This is
a strategy that appears to be echoed in one of the talks given at the SIO
conference by Jeffrey A. Dusek, PhD, entitled, “Mind-Body Strategies and
Epigenetics.” In any case, Collins points out how “big numbers” are needed to be
able to draw any useful correlations and understandings of patterns of genetic 
derangements in various cancers. No doubt this is true, but it is also
irrelevant to CAM, as is this example he cites:

   As “a dramatic example” of the new targeted, personalized approach to cancer 
   treatment, Dr. Collins described the case of a woman, a nonsmoker who was
   diagnosed with very aggressive, stage IV non–small cell lung cancer in both
   lungs about 4 years ago. Following standard chemotherapy, she participated in
   a clinical trial with crizotinib (Xalkori). Prominent lung metastases shown 
   on x-ray in July 2009 “were essentially gone by November 2009,” Dr. Collins
   reported. “So she has had a dramatic response, and she continues to do
   extremely well,” he added.

   “Of course this drug doesn’t work for everybody with this kind of lung
   cancer. So what’s the difference? It depends on whether the particular cancer
   has a fusion involving the ALK gene,” Dr. Collins explained. “Crizotinib was
   not developed with that particular target in mind, but it turned out after
   the fact that this was going to be a very responsive situation.” The success 
   of crizotinib when used in a targeted personalized approach led to its
   approval by the FDA several months ago. Yet the drug may not have been
   approved if it “had been tried on thousands of people with lung cancer
   without having stratified them by the specific molecular findings,” Dr.
   Collins said.

Triumphs such as these are promising harbingers of a potential new age of
personalized medicine and illustrate the potential power of such approaches.
They do not, however, illustrate anything about CAM. Neither does the other
example cited, that of a promising new approach of modulating the immune system 
to stimulate a patient’s own cells to attack cancer cells in chronic lymphocytic
leukemia. This sort of science-based immunotherapy is related to claims of
“boosting the immune system” promoted by CAM aficionados only by coincidence or 
in the way that the germ theory of disease as understood today is related to
miasma theory from 200 years ago. Yet Collins seems to think that these
promising avenues in the science-based treatment of cancer are somehow related
to “integrative oncology.” In fact, he falls for the “bait and switch” even
harder:

   “We also have great excitement about a new era in therapeutics based on
   natural remedies,” Dr. Collins said. The NCI has an ongoing program looking
   for anticancer activity in extracts from plants, marine invertebrates, and
   microbes. “We are also seeking opportunities by looking at traditional
   medicines, many of them from China, for how we can decrease the side effects 
   of treatment.”

All of which is pharmacognosy, not “CAM,” As David Kroll pointed out not too
long ago:

   But pharmacognosy – the study of natural products – is *not* alternative
   medicine. It is, in fact, the basis for at least 25% of our prescription
   drugs and up to 60% of some classes of over-the-counter drugs.

And:

   What worries me more is how pharmacognosy is approached by NCCAM and how
   damaging their supported studies can be in leading us to dismiss potentially 
   useful botanical medicines. In attempting to show political supporters the
   benefits of alternative medicines, NCCAM seems to spend a disproportionate
   share of their appropriation on expensive clinical trials. My concern has
   been that clinical trials are warranted when sufficient basic science has
   been conducted. However, the rush to clinical trials has instead led to
   multiple clinical trials failures.

The problem, of course, is that NCCAM and “integrative oncology” are not about
pharmacognosy, other than “rebranding” it and fusing it with pseudoscience. They
are about magical thinking and what Harriet Hall likes to call tooth fairy
science. Dr. Briggs might have brought more scientific rigor and a more true
pharmacognosy-like approach to NCCAM for the moment, but she will not be NCCAM
director forever. One day she will retire or move on. When that happens, the
institutional inertia will likely cause NCCAM to revert to its old ways.

What Francis Collins doesn’t know about “integrative oncology”

One of the reasons that quackademic medicine can flourish is that respected
scientists like Francis Collins do not understand what it is about. That’s
because in general they are unaware of what “integrative medicine” is all about,
and many quackademics are quite good at cloaking their woo in
convincing-sounding scientific language. Certainly, they have donned the
language of evidence-based medicine and of “patient-centered” care like the
proverbial cloak of invisibility in the Harry Potter novels and movies to hide
the pseudoscience, as Kimball Atwood so eloquently described and I reiterated in
my open letter to Dr. Collins and my post entitled “Integrative” oncology:
Trojan horse, quackademic medicine, or both? I won’t retread old ground other
than to point out that “integrative” oncology in reality means “integrating”
quackery and pseudoscience into science-based medicine. I will, however, take a 
look at the agenda for the SIO meeting at which Collins was the keynote speaker.

A brief perusal of the SIO meeting program reveals a few tidbits, in no
particular order, some with and some without my comment:

  1. Gillian Flower; Kieran Cooley; Dugald Seely. Adjunctive cancer care at the
    Canadian College of Naturopathic Medicine: A prospective, longitudinal,
    observational cohort study. One notes that “naturopathic oncology” includes 
    homeopathy and a variety of other forms of quackery. Too bad the abstract is
    not online. In any case, one notes that the lead author Gillian Flower
    offers acupuncture, high dose intravenous vitamin therapy, acupuncture, and 
    bogus “electrodermal testing” in her practice.

  2. Garrett Sullivan; Qi Chen; Ping Chen; Julia Chapman; Mark Levine; Jeanne
    Drisko. Prospective randomized phase I/IIa pilot trial to assess safety and 
    benefit administering high-dose intravenous ascorbate in combination with
    chemotherapy in newly diagnosed advanced stage III or Stage IV ovarian
    cancer. That’s high dose intravenous vitamin C, people.

  3. Lucille Marchand, Diana Wilkie, Jun Mao, Kimberly Fleisher (Discussant:
    William Collinge). Moderated panel 6. Massage and Energy Therapy Research.

  4. Alejandro Chaoul; Kelly Bieger; Tenzin Rinpoche; Amy Spelman; Christina
    Meyers; Deborah Fry; Ideen Zeinali; Banu Arun; Janna Taylor. Tibetan Sound
    Meditation Improves Cognitive Dysfunction, Mental Health, and Spirituality
    in Women with Breast Cancer.

  5. Barrie Cassileth; Amy Matecki; K. Simon Yeung; Carmencita Mercado-Poe; Marci
    Coleton; Lisa Bailey; James Lozada; Martha Tracy; Gary Cecchi. Safety of
    Acupuncture for Upper Extremity Lymphedema in Breast Cancer Patients:
    Lessons from two major Medical Centers. Define “safety.” As a surgeon who
    sees a fair number of patients with lymphedema due to breast cancer surgery,
    the thought of sticking needles into the lymphedematous limb causes me to
    shudder, given how prone limbs with lymphedema are to infection and
    how—shall we say?—unconcerned about sterile technique most acupuncturists
    are. (Just ask Mark Crislip if you don’t believe me.)

I could go on, given that there is a lot more there, but I’ll wind up with my
favorite session of all, one that I might have actually been interested in
attending. Yes, I’m talking about the Integrative Tumor Board. For those of you 
not familiar with what a tumor board is, it’s a meeting where all the relevant
specialties are together in one room to discuss the cases of individual cancer
patients in order to formulate the best evidence-based treatment plan that the
multidisciplinary team can come up with. Of course, this tumor board has a
bit…laxer definition of “specialty.” This tumor board includes two medical
oncologists (one of whom is the medical director of the M.D. Anderson
Integrative Medicine Center), an MD/acupuncturist, a naturopath from Bastyr
university, a nutritionist from Nutritional Solutions (now there’s an idea for a
future post!) and a nurse who is interested in “mind-body” medicine. One notes 
that there are no surgeons, no radiation oncologists, and no genetics
counselors, most of whom tend to be on tumor boards, depending upon the tumor
type. One wonders what sorts of cases this tumor board discussed and what
recommendations its members gave for the cases chosen to be presented.

It’s extremely disappointing that Dr. Collins agreed to appear as the keynote
speaker for the SIO conference, but it’s even more disappointing that, instead
of using his forum to challenge the SIO to abandon pseudoscience, he instead
fell right into their frame of co-opting science-based modalities as being
somehow “alternative.” He even bragged about how much support the NIH has given 
to such research, pointing out that the Office of Cancer Complementary and
Alternative Medicine (which has the unfortunate acronym OCCAM) in the National
Cancer Institute has a budget even larger than that of NCCAM and saying:

   While NCCAM is an important focus of efforts at NIH, other institutes within 
   NIH also have initiatives in complementary and alternative medicine, Dr.
   Collins noted. “The NCI has the largest one by far,” he said, and “the budget
   for CAM in the NCI is actually slightly larger than the entire budget of
   NCCAM. The total investment that NIH makes in complementary and alternative
   medicine research in 1 year is about a half-billion dollars. I wish it was
   more, but I wish everything we are doing in biomedical research could be
   more,” he said.

As I’ve said before, I wish it were less, as in zero, and all the money wasted
on pseudoscience or putting a pseudoscience spin on what should be SBM
distributed to the rest of the NIH. There is nothing that NCCAM or OCCAM does
that requires a special, dedicated office or center in the NIH. Unfortunately,
Collins uses the dire funding situation of the NIH to make the wrong argument
about CAM research funding:

   “The opportunities for medical research have never been greater than they are
   right now, and yet the threat to the support of biomedical research has—in
   the memories of anybody who is currently working in the field—never been
   greater either,” Dr. Collins stated. He noted that in fiscal year 2011, “for 
   only the second time in 40 years, the NIH budget sustained a real cut.” If
   the failure of the Joint Select Committee on Deficit Reduction (the so-called
   supercommittee) to cut $1.2 trillion from the budget results in sequestering
   of discretionary budgets, “a dramatic downturn in support for biomedical
   research” could occur in fiscal year 2013, Dr. Collins said.

We now know, of course, that the supercommittee did fail to come to an agreement
and that sequestering of discretionary budgets is all but assured in 2013. To
me that’s all the more reason that waste such as NCCAM and OCCAM should be
rooted out of the NIH, in order to make the best possible use of the remaining
funds. Look at it this way. Only the top 7% of new research grant applications
to the NCI are currently being funded, down from the top 16% back when I got my 
R01 in 2005, with no improvement in sight. In some NIH institutes, I’ve been
told, it’s only the top 5% being funded. Meanwhile, investigators used to have
two opportunities to revise and resubmit rejected proposals; now they can only
revise and resubmit once. When funding gets this tight, there are lots of
innovative projects, chock full of good science, that don’t make the cut and
don’t get funded. I fully agree with Dr. Collins that the case for funding
medical research has never been stronger and that the threat to the NIH has
never been greater. At least 20 years ago, which was the last time funding was
so tight, there appeared to be hope that an end was in sight. Not so today.

I realize that Dr. Collins was tailoring his address to his audience. I also
realize that Collins is not just a scientist and administrator, but a
politician. He has to be to have become director of the NIH and to have held all
the other prominent leadership positions he has held during his career. Even
so, it’s hard not to come to the conclusion that, like so many physicians and
scientists, he just doesn’t “get” the problem of CAM and pseudoscience
infiltrating medicine. At least, I hope that’s the case. What would be worse is 
if he either didn’t care or supported it.

Funding CAM Research

Steven Novella on May 2, 2012

Link

Paul Offit has published a thoughtful essay in the most recent Journal of the
American Medical Association (JAMA) in which he argues against funding research 
into complementary and alternative therapies (CAM). Offit is a leading critic of
the anti-vaccine movement and has written popular books discrediting many of
their claims, such as disproved claim for a connection between some vaccines or 
ingredients and risk of developing autism. In his article he mirrors points we
have made here at SBM many times in the past.

Offit makes several salient points – the first being that the track record of
research into CAM, mostly funded by the NCCAM, is pretty dismal.

   “NCCAM officials have spent $375,000 to find that inhaling lemon and lavender
   scents does not promote wound healing; $750,000 to find that prayer does not
   cure AIDS or hasten recovery from breast-reconstruction surgery; $390,000 to
   find that ancient Indian remedies do not control type 2 diabetes; $700,000
   to find that magnets do not treat arthritis, carpal tunnel syndrome, or
   migraine headaches; and $406,000 to find that coffee enemas do not cure
   pancreatic cancer.”

The reason for the poor track record is fairly simple to identify – by
definition CAM includes treatments that are scientifically implausible, which
means there is a low prior probability that they will work. If the treatments
were scientifically plausible then they wouldn’t be alternative.

CAM proponents argue that the treatments they advocate, like acupuncture,
certain herbal remedies, and homeopathy, are not implausible, they are just
neglected by mainstream medicine because they don’t fit into the narrow (and
profitable) paradigm of “Western” medicine.  This argument, however, is
demonstrably wrong. Homeopathy is rejected by the mainstream because our current
understanding of physics, chemistry, and biology tell us that it is impossible 
for homeopathic potions with extreme dilutions to have any physiological effect.

I admit that one benefit of all the research that the NCCAM has funded is to
test these two versions of reality. Are CAM modalities scientifically
implausible or are they just not being given a fair shake by modern medicine? If
the former then research into CAM modalities should be largely negative, if the
latter than we should regularly be finding CAM diamonds in the rough. Well,
after 1.6 billion dollars of research any score of studies the NCCAM has left
behind it a trail of negative studies, such as those listed above. This strongly
supports the SBM view that “alternatives” to science-based treatments are not
science-based.

CAM research, therefore, is like playing the lottery – the chance of winning is 
so small it is not significantly different from zero, but if you get really
lucky perhaps you may hit upon something. As a society we have to decide if this
is a worthy investment of our limited research dollars. To continue this
analogy, financial advisers often recommend a range of investments from
conservative to risky, but I don’t think they would consider buying lottery
tickets part of a sound financial plan.

The first major criticism against doing research into CAM, therefore, is that it
is simply a waste of resources – not just research money but all the components
of the infrastructure of research. This includes access to sick patients. 
Patients who enter into a clinical study of a low-probability CAM modality may
therefore not be available to enter into a study of a more plausible treatment.

That most of the studies funded by NCCAM are negative raises another point
discussed by Offit – the value of negative studies. Offit acknowledges that
negative studies in medicine can be very valuable. It is important to know what 
doesn’t work, especially if it is a treatment that is already being used. In
fact I and others at SBM have argued that journal editors need to make more room
in their journals (or at least in the online versions) for negative studies
(and also for replications, but that is a separate issue), in order to limit the
“publication bias” toward positive studies.

This, I feel, is the one legitimate argument for doing CAM research – the value 
of solid scientific evidence for lack of efficacy of a treatment that is being
promoted, even on the fringe. But Offit raises a very important point – does
this negative evidence have any effect on the practice of those who are
promoting or using CAM modalities? The answer is largely, no. He gives as
examples many supplements, like gingko biloba or echinacea, that continue to
have robust sales even after large rigorous studies found they do not work.

There is some wiggle room in the data to spin it in more than one way. NCCAM
director Josephine Briggs has argued that negative studies from the NCCAM have
decreased the sales of specific herbal remedies, like echinacea. This is true,
but the decrease was modest and temporary. Sales figures indicate that echinacea
remains a popular herb and overall herbal product sales continue to increase
(over $5 billion dollars in the US in 2009).  The relative popularity of
specific herbs is affected by large published studies that gain some media
attention – but not dramatically.

The real problem is that regulation of herbs and supplements are not adequately 
tied to scientific evidence. Aggressive marketing can therefore have a greater
long term effect on the popularity of a CAM treatment than a published study
that the public soon forgets. Also, the media often does a poor job of putting
published scientific studies into a proper context. For every large rigorous
negative study, there are many small, preliminary, and positive studies. In the 
media, therefore, the positive will tend to get more headlines and more overall 
attention, even though their relative scientific value is much lower. The media 
just reports – “a study showed.”

There are also other issues of concern with CAM research. One is ethics – the
ethics of biomedical human research is such that we owe it to people we
experiment on to maximize the probability that the experimental treatment will
be safe and effective. That is why there is the need for a great deal of
pre-clinical and preliminary clinical studies before going to a large human
trial. Researchers also have to justify their treatment with sound science that 
indicates it is plausible, that it is likely to be of benefit to the study
subjects.

The entire notion of plausibility, however, was thrown out by the very concept
of CAM. Offit argues that many CAM modalities “border on mysticism.” I would
argue that many of them are mysticism or thinly veiled versions of faith
healing. Not only is there no known mechanism, but there is no known way they
can possibly work. It is one thing to not know what receptor is the target of
interest for a specific effect of a drug, it is another to violate basic
concepts of physics and chemistry.

In other words, some CAM modalities are the equivalent of magic. Is it ethical, 
therefore, to study magic therapies on human subjects? Does this violate the
ethical requirement of informed consent? Even worse, in some cases there is
already adequate evidence for lack of efficacy (such as the chelation trial that
Kimball Atwood has been criticizing).

Conclusion

There is much to criticize in the funding of medical research into highly
implausible treatments – they are a waste of resources with little probability
of resulting in effective treatments, while negative evidence is useful, users
of unscientific treatments don’t listen very much to the evidence, and there are
significant ethical concerns.

I propose that as a society we strike a bargain with the proponents of so-called
CAM. We will fund and conduct research into CAM modalities where it is
reasonably ethical to do so, but in exchange treatments for which there is
evidence of lack of efficacy will be abandoned. Further, regulations for health 
products (like herbal remedies) will better reflect the scientific evidence. I
would prefer that evidence of safety and efficacy would be required before
marketing, but failing that the FDA should have the power to remove a product
from the market after research shows that it is ineffective (right now the FDA
must meet a difficult burden of proof of harm to do so).

So, if the evidence shows that homeopathy does not work, the homeopathic
industry will vanish. If a rigorous study shows that chiropractic manipulation
does not work for asthma then chiropractors will condemn the practice and stop
doing it.

However, if scientific evidence does not significantly affect practice or
product sales, then why should we pay for it? Further, if CAM continues to be
disconnected from scientific evidence, why should it enjoy any legitimacy?

Taxpayers Fund Scientology Research on Gulf War Veterans

Harriet Hall on August 25, 2015

Link



The “Hubbard protocol” is Scientology’s religion-based, pseudoscientific
“detoxification” treatment used in its Narconon program to treat drug addiction.
It was dreamed up by a science fiction writer with no medical training. Now it 
is being studied as a treatment for veterans suffering from Gulf War illness.
Our limited public money for research is being wasted on a study with no
scientific merit. Whether or not you consider this a church/state conflict, the 
study is clearly ill-advised.

The study: $600K worth of sweat

A description of the study is available online in the government’s clinical
trials registry. The DOD funded this study to the tune of $633,677. The subjects
are veterans with Gulf War illness characterized by persistent memory and
concentration problems, headaches, fatigue, and muscle and joint pain. The
illness has not been well defined, and its cause has not been determined; but
the researchers are working on the assumption that toxins are the cause and that
the treatment will relieve symptoms by removing toxins from the body.

The control group will get only “usual care.” The experimental group will get:

   A four to six week regimen consisting of daily, supervised, mild-moderate
   exercise as tolerated for 20 minutes, supervised, intermittent Finnish saunas
   (at about 140’F) sauna time with breaks and showers, gradually increased as 
   tolerated to approximately 4 hours, dietary supplements including immediate
   release niacin in gradually increasing doses from 100 mg to a maximum of 5000
   mg per day, salt and water, other vitamins, minerals and oils per Hubbard
   protocol.

Subjects are randomized to the treatment or control group but are not a random
sample of veterans with Gulf War illness. They are a “convenience sample” of
veterans who reside in the local area and “show interest in the study,” whatever
that means.

The outcomes they measure are quality of life, symptoms as reported on
questionnaires, performance on neurocognitive tests, and physical health as
measured by standard medical examination and blood tests (metabolic panel, lipid
profile, hormones).

Toxins? What toxins?

They describe the intervention they are testing as a detoxification program, but
they have no way of knowing whether toxins are responsible for the patients’
symptoms, they don’t identify the toxins, and they don’t demonstrate that any
toxins have actually been removed.

One of the participants said, “I was going to be done today, but…I had some more
junk come out of my legs. Some black stuff. So I’m going to do one more day and
see if I can clean it all out.” The program director, Dr. Crystal Grant, shows 
off towels with various colored stains (pink, blue, brown, purple, orange, light
yellow) that she calls evidence that the program rids the body of nasty toxins.
It is no such thing! It is reminiscent of the bogus claims for those
detoxification foot baths. It is evidence that something colored the towels, not
evidence that the program removes toxins.

One of the participants said by the end of the study she was taking two large
canning jars of vitamins a day (!) along with a few spoonfuls of peanut oil.

Scientology’s “Purification Rundown”

The Hubbard protocol is also known as the “Purification Rundown,” and is based
on the belief that toxins affect both the body and the soul, and that they can
be eliminated from the body by exercise, saunas, and supplements. L. Ron Hubbard
believed the regimen would take humans to a higher plane of existence, improve 
their IQ, and allow them to survive nuclear fallout in World War
III.Scientology’s Narconon program uses this regimen to treat drug addiction. 
Numerous deaths have been attributed to it, and Scientology has been responsible
for deaths from its other programs. Its most famous victim is probably Lisa
McPherson, who died during an “introspection rundown” treatment for her mental
illness. The Wikipedia article provides a handy summary with links to original
sources.

The lead investigator, David Carpenter, is a professor of environmental health
at the University of Albany who has been embroiled in controversy because of his
research on the questionable diagnosis of electromagnetic sensitivity. He was
approached by Scientologists and asked to do this study. A Scientology group is 
providing the therapy; it charges $2,000 per participant, a discount from the
usual rate of $3,000. The vitamins they dispense are labeled with a picture of
Scientology leader David Miscavage’s personal chiropractor, who has now gone
into the supplement business.

Co-investigator Kathleen Kerr is a prominent Scientologist who has appeared in
advertisements for the church and served as chair of Narconon Toronto’s board of
directors in 2010.

The lead investigator, David Carpenter, was unaware of her conflict of interest 
until he read about it in The Daily Beast.

Scientology is behind organizations that purport to give impartial advice about 
drug rehabilitation programs but that actually use detailed scripts to inveigle 
prospective customers into paying exorbitant amounts for Narconon treatment and 
subject them to Scientology influence.

Sure, the treatment seems to work

Patients report feeling better, but that could be from a combination of
exercise, enjoyment of saunas, and suggestion. They are subjected to an
elaborate, time-consuming regimen and have to work at it. The Hawthorne effect
of just being in a study may come into play. There is a natural resistance to
thinking one’s time and effort have been wasted. It is only natural that
participants will believe it has helped them. They are suffering. They want it
to work. They expect it to work. They need it to work. A “usual care” group is
not a valid control group; it does not control for confounding factors.

When used as a treatment for hyperlipidemia, niacin causes a number of side
effects in 92% of patients. It must be started slowly to minimize problems like 
“niacin flush,” an uncomfortable warmness and redness of the skin. Study
participants may interpret these side effects of niacin as a sign that the
detoxification is working. It’s not just a matter of innocuous flushing. High
dose niacin in the amounts used in the Hubbard protocol can sometimes cause
liver failure and death.

Proponents have claimed that niacin releases fat stores into the blood stream to
remove toxins stored in fat. In reality, niacin is used clinically to treat
hyperlipidemia by decreasing blood lipid levels.

Public funds have been used for this before

Utah has used public funds to “detoxify” cops with the Scientology protocol
after they raided meth labs. Public funds have also been spent on “detoxifying” 
9/11 workers with the Scientology protocol. This effort has been severely
criticized by scientists.

The sins of Scientology

I have written previously about Scientology’s war on medicine. They discourage
medical treatment, although medicinal doses of vitamins are part of the Hubbard 
protocol. Scientology is a religious cult invented by L. Ron Hubbard, a science 
fiction writer. There is a Deadly Devotions episode that provides insight into
how people become attracted to Scientology’s promises of a better life and how
they are gradually indoctrinated into bizarre beliefs, persuaded to spend their 
money on a series of self-improvement courses, and let the church take over
their life. It tells the true story of Elli Perkins, a woman who reached a high 
place in the church hierarchy, refused medical treatment for her paranoid
schizophrenic son, was misled by a doctor who was a fellow Scientologist who
told her son only had a yeast infection and needed treatment with vitamins and
isolation. The story ends in tragedy and then attempted cover-up to protect
Scientology’s reputation.

Conclusion: A predictable propaganda win for Scientology

In my opinion, this study is ill-advised from a scientific standpoint. It will
do nothing to elucidate the cause of Gulf War symptoms or to credibly test the
effectiveness of the Hubbard protocol. We can predict that more subjects will
report improvement with the treatment than with usual care. That will not be
strong enough evidence of its effectiveness to convince scientists; but it will 
be enough to bolster Scientology propaganda, to provide pseudoscientific support
for their lucrative drug rehab business, and to help entrap suffering people in
a dangerous cult.

The Center for Inquiry (CFI) has issued a strongly worded protest against
spending public money on a pseudoscientific/religious practice and using our
veterans as guinea pigs in a treatment that does nothing to address their
plight. They went so far as to call this study obscene. They wrote a letter to
the Secretary of Defense urging him to immediately halt the study and open an
investigation into how it came about. I would love to see him do just that, but 
I am not optimistic.

                                 The Scam Scam

                                 Steven Novella

                                      Link

In 1994 Congress (pushed by Senators Harkin and Hatch) passed DSHEA (the Dietary
Supplement Health and Education Act). As regular readers of SBM know, we are
not generally happy about this law, which essentially deregulated the supplement
industry. Under DSHEA supplements, a category which specifically was defined to
include herbals, are regulated more like food than like medicinals.

Since then the flood-gates opened, and there has been open competition in the
marketplace for supplement products. This has not resulted, I would argue, in
better products – only in slicker and more deceptive claims. What research we
have into popular herbals and supplements shows that they are generally
worthless (except for targeted vitamin supplementation, which was already part
of science-based medicine, and remains so).

A company can essentially put a random combination of plants and vitamins into a
pill or liquid and then make whatever health claims they wish for their
product, as long as they stay within the “structure-function” guidelines. This
means they cannot claim to cure or treat a specific disease, but this has proven
to be an insignificant limitation on marketing supplements.

It has been fascinating to watch the evolution of supplement marketing claims
and strategies. One new twist caught my eye – what I am calling the “scam scam.”
Some companies realize that the internet is the primary battle ground for the
marketing of their product. Many companies also probably know that their claims 
are largely scientifically baseless – if you’re in the meeting where the claims 
are crafted and the marketing strategy developed, it would be hard to be
delusional about their scientific validity. I suspect most companies just don’t 
care about the science or understand it, and you can find some justification to 
cherry pick for most any supplement claim you wish with just a little Googleing.

It also appears that many companies are starting to realize that “those meddling
skeptics” are starting to cramp their style, at least a little bit. If you
search on the name of a supplement product, you are likely to get a link for a
consumer protection or skeptical site revealing the claims to be a scam, or at
least scientifically dubious. Invariably when I write about a specific product
in a blog post a company marketing rep will show up in the comments to claim
that I was unfair and that they do have evidence for their claims. Of course,
when asked for the evidence it rapidly becomes clear that they don’t have any,
outside a worthless in-house study or two.

Companies cannot silence the scientific analysis of their claims. Some have
tried using the libel laws, but that has generally not worked out well for them.
That approach instantly raises the visibility of the criticism by orders of
magnitude, and the companies or individuals generally lose in the end.

So now some companies have hit upon a different strategy – if you cannot silence
the skeptics, then bury them with fake skeptics of your own. That way at least 
their websites won’t appear on the first page of Google searches (at least
that’s the hope). One product, Shakeology, seems to be marketed entirely as
“Shakeology Scam” (trek2befit (dot) com/shakeology-scam). The website starts out
saying – “Do Not buy Shakeology” with “Skakeology Scam” in big letters. Of
course, when you read down even a little bit you find:

   Ok, I couldn’t let this question linger any longer. I’ve got to tell you
   right now, that it’s not a scam. Why, and how do I know? Because I’ve had
   first hand experience with this product.

Then you get a standard sales pitch – but it’s more believable, because the
person making the pitch started out as a skeptic – right? What do these magic
shakes do? The claims are typical – lose weight without food cravings, have more
energy, and they throw in that they will lower your cholesterol. What are in
these shakes:

   - Antioxidants: Will help to boost your immune system to prevent you from
   getting sick. Antioxidants will also help to lower free radical damage which 
   can lead to stroke, heart attacks, high blood pressure, and heart disease.

   - Prebiotics AND Probiotics: Will help to support your immune and digestive
   health.

   - Phytonutrients: Will help to support healthy immune function. They also
   have anti-inflammatory properties, and antioxidant properties.

   - Vitamins and Minerals: Will help you to maintain optimal health.

   - Whey Protein: Will help you to lose weight, build muscle, supports brain
   functions, as well as keeps your bones and skin healthy.

   - Digestive Enzymes, Fiber and More…

Antioxidants are of no proven benefit, and may actually be associated with a
higher death rate. Prebiotics and probiotics are of no benefit when taken
routinely, and of dubious benefit (and only if taken very early and in
sufficient amounts) for antibiotic-associated GI syndromes. Phytonutrients and
routine vitamin supplementation – again, no proven benefit. Whey protein is
protein, and you can get this a lot cheaper by drinking Yoohoo. And again,
digestive enzymes are of no proven benefit for routine use. Fiber is good, but
you don’t need to buy expensive shakes to get it.

The claims are typical and you can find them on thousands of websites selling
all sorts of supplements. But the “scam scam” marketing is a nice twist. I
especially like the glowing comments at the bottom that read like ad copy.

I have encountered this strategy before also – with some of the “superfood”
products. Specifically, there has been an acai scam marketing campaign going on.
If you search on “acai scam” you will find sites with headlines like, “Acai
Berry Scam – the Untold Truth about Acai Berry Scams.” Once again, when you read
the copy you find that an “independent reporter” investigated the alleged scam 
and found that that a particular acai berry product was not a scam and really
worked. Some are formatted as if they are news sites, complete with stock photos
of fake reporters.

So don’t be scammed by the scam scam. It’s all just another marketing ploy in
the wild west of the supplement marketplace.

“Obama Promises $156 Million to Alzheimer’s…But where will the money come from?”
That’s easy: the NCCAM!

Kimball Atwood on February 9, 2012

Link

The quoted language above is part of the headline of this story in today’s The
Scientist:

   Citing the rising tide of Americans with Alzheimer’s—projections suggest 10
   million people will be afflicted by 2050—the Obama administration and top
   National Institutes of Health officials are taking action. On February 7,
   they announced that they will add an additional $80 million to the 2013 NIH
   budget for the Alzheimer’s research program.

The problem is that there ain’t no such thing as a free lunch:

   However, Richard Hodes, director of the NIH’s National Institute on Aging,
   told Nature that the 2013 dollars still have to be approved by Congress in
   the next budget and, if not, existing programs may need to be cut. And this
   year’s $50 million is likely to bump other projects, perhaps at NIH’s
   National Human Genome Research Institute. “If there’s a finite budget
   anywhere, once there’s more of something, there is less of something else,”
   he said.

Often such budget compromises are difficult, because there is no ready way to
choose between two or more competing recipients of taxpayers’ money, each of
which might be comparably worthy. Thus it is with a great sense of relief that
in this case, we in the biomedical community can assure President Obama that no 
such dilemma exists. This is one of those occasional decisions that requires no 
hair-pulling whatsoever. The obvious solution is to defund the National Center
for Complementary and Alternative Medicine (NCCAM), which, at about $130
million/yr, would solve the problem of funding Alzheimer’s research and take the
heat off other worthy programs such as those mentioned by Richard Hodes.

Defunding the NCCAM would serve yet another worthy purpose: to end the period of
nearly two decades during which the National Institutes of Health (NIH) has
been bullied into acting as though pseudoscientific health claims ought to be
taken seriously, thus embarrassing itself and medicine, endangering human
subjects for no justifiable purpose, contributing to erroneous content in
medical school courses, bankrolling ‘integrative medicine’ centers when there is
no evidence that these are useful, and adding to the widespread scientific
illiteracy of the American public. Here is a smattering of more articles making 
those points over the years, only some of which have been written by the authors
here at Science-Based Medicine:

  1. The politics of alternative medicine —Science 1994

  2. Lobbying Blitz Attacks Alternative Medicine —Science 11 July 1997: 277 (5323),
    169. [DOI:10.1126/science.277.5323.169e]

  3. Let’s Abolish the Office of Alternative Medicine at the National Institutes of
    Health —North Carolina Journal of Medicine 1998.

  4. Why the National Center for Complementary and Alternative Medicine (NCCAM)
    Should Be Defunded —Quackwatch 2002

  5. The Ongoing Problem with the National Center for Complementary and Alternative
    Medicine —Skeptical Inquirer 2003.

  6. Science and government. Review for NCCAM is overdue. —Science 2006

  7. The National Center for Complementary and Alternative Medicine (NCCAM): Your
    tax dollars hard at work —Science-Based Medicine 2008

  8. Let President-Elect Obama know that NCCAM should be defunded! —Science-Based
    Medicine 2009

  9. President Obama – Defund the NCCAM —Science-Based Medicine 2009

  10. Yes We Can! We Can Abolish the NCCAM! —Science-Based Medicine 2009

  11. Save NIH $$$: eliminate “alternative” medicine —Genomics, Evolution, and
    Pseudoscience  2010

  12. Update on Josephine Briggs and the NCCAM —Science-Based Medicine 2011

  13. Measuring Mythology: Startling Concepts in NCCAM Grants —Skeptical Inquirer
    2012 Preview available here.

It is clear that things have not improved much, in spite of the two most recent 
NCCAM Directors, Stephen Straus and Josephine Briggs, having previously been, at
least on paper, legitimate scientists. The explanation for that paradox is
two-fold: the very language that spawned the NCCAM makes it impossible for more 
than a smattering of useful, legitimate science to be done; the two Directors
have been company (wo)men first, scientists second.

Regarding the NCCAM mandate, consider these passages in the law that established
the Center (emphasis added):

   (a) In General.–The general purposes of the National Center for Complementary
   and Alternative Medicine…are the conduct and support of basic and applied
   research…and other programs with respect to identifying, investigating, and
   validating complementary and alternative treatment, diagnostic and prevention
   modalities, disciplines and systems…(b) Advisory Council.–The Secretary
   shall establish an advisory council for the Center in accordance with section
   406, except that at least half of the members of the advisory council who
   are not ex officio members shall include practitioners licensed in one or
   more of the major systems with which the Center is concerned, and at least 3 
   individuals representing the interests of individual consumers of
   complementary and alternative medicine.(c) Complement to Conventional
   Medicine.–In carrying out subsection (a), the Director of the Center shall,
   as appropriate, study the integration of alternative treatment, diagnostic
   and prevention systems, modalities, and disciplines with the practice of
   conventional medicine as a complement to such medicine and into health care
   delivery systems in the United States.(d) Appropriate Scientific Expertise
   and Coordination With Institutes and Federal Agencies.–The Director of the
   Center, after consultation with the advisory council for the Center and the
   division of research grants, shall ensure that scientists with appropriate
   expertise in research on complementary and alternative medicine are
   incorporated into the review, oversight, and management processes of all
   research projects and other activities funded by the Center...(e) Evaluation 
   of Various Disciplines and Systems.–In carrying out subsection (a), the
   Director of the Center shall identify and evaluate alternative and
   complementary medical treatment, diagnostic and prevention modalities in each
   of the disciplines and systems with which the Center is concerned, including
   each discipline and system in which accreditation, national certification,
   or a State license is available.(f) Ensuring High Quality, Rigorous
   Scientific Review.–In order to ensure high quality, rigorous scientific
   review of complementary and alternative, diagnostic and prevention
   modalities, disciplines and systems, the Director of the Center shall conduct
   or support the following activities:(1) Outcomes research and
   investigations.(2) Epidemiological studies.(3) Health services research.(4)
   Basic science research.(5) Clinical trials.(6) Other appropriate research and
   investigationalactivities.

That language is anti-scientific for many reasons. I’ll explain a few; feel free
to look here for more discussion. Paragraph (a) guarantees a cherry-picking
approach to the topic: start with a treatment claim that has no scientific
basis, assume that it works for something, then try to find a ‘something’ that
seems to ‘validate’ it. This is the opposite of the way clinical research,
including that done by most NIH-sponsored trials, proceeds. Paragraph (b) is
self-explanatory: if the ‘major systems’ have no scientific validity—and no
system other than modern, science-based medicine does—the NCCAM Advisory Council
will certainly not be expected to acknowledge that fact, and it hasn’t.
Paragraph (c) begs the question and betrays the real agenda of the NCCAM’s
creators.

Paragraph (d) presumes that there are scientists “with appropriate expertise in 
research on complementary and alternative medicine.” There actually are a few
such people, such as Edzard Ernst, but the NCCAM has not “incorporated” them.
Rather, it has incorporated pretenders to science such as those quoted in this
recent post. Paragraph (e) guarantees that the NCCAM will cotton to quacks who, 
regrettably, have been licensed to practice in one or more states. Paragraph (f)
predicts that various implausible ministrations will inevitably be found to
“work,” relying as it does on “outcome studies”—a form of Cinderella Medicine—as
the first choice in testing.

Regarding my second assertion, that Directors Straus and Briggs forsook their
scientific (and ethical) roots in favor of a perceived mandate to go along with 
the company gag, I can offer numerous pieces of evidence in addition to those
already linked above: here, here, here (my response to that is here), here (Dr. 
Briggs’s contribution to this), and here (circling the wagons in response to
this), for example.

Which makes me wonder: if Dr. Briggs were really honest with herself, would she 
think that taxpayers’ money is better spent on the NCCAM than it would be on
Alzheimer’s research? A cheap shot, you say? I don’t think so: once there’s more
of something, there is less of something else.

A final note to the president: as easy as this decision is, there’s yet another 
easy one. You can double your (our) money by defunding the rest of NIH ‘CAM’
research! You’ll find most of that at the National Cancer Institute (NCI).

Foolishness or Fraud? Bogus Science at NCCAM

Ben Kavoussi on June 8, 2012

Link

   Voodoo science is a sort of background noise, annoying but rarely rising to a
   level that seriously interferes with genuine scientific discourse… The more 
   serious threat is to the public, which is not often in a position to judge
   which claims are real and which are voodoo. Those who are fortunate enough to
   have chosen science as a career have an obligation to inform the public
   about voodoo science.

   — Robert L. Park, PhD, 20001

Imagine you are an ordinary person with limited knowledge of science and
medicine, and you see this 2010 video on tai chi and qi gong by the National
Center for Complementary and Alternative Medicine (NCCAM) — one of the agencies 
that make up the National Institutes of Health (NIH). I am certain that the
solemn voice of the Director of NCCAM, Dr. Josephine Briggs, talking about
“rigorous scientific research” and “accurate, authoritative information on
complementary and alternative medicine,” will leave you with a strong sense of
confidence in her message.

In addition, despite the fine-print and the disclaimer, the appearance of Dr.
Briggs in the video could be broadly viewed as a sign of tacit endorsement.
Often, the very fact that a treatment is associated with the government is
already a de facto stamp of approval and a warranty of efficacy. For instance,
the publication below by the California Department of Consumer Affairs states
that the NIH formally “endorses” acupuncture, simply because in 1997, a panel of
scientists assessed its use and effectiveness for a variety of conditions.
Since 1997 the scientific review of acupuncture by NIH has become synonymous
with its endorsement, despite the fact that as a federal research agency, the
NIH does not endorse any product, service, or treatment.

In October 26, 2011, a few weeks after Steve Jobs’ death, Josephine Briggs
decided to do something she has never done before: she put an explicit
disclaimer on her blog:

   When making treatment decisions, unproven “alternative medicine” approaches
   should not replace conventional medical care approaches known to be useful or
   helpful. Simply put, the evidence is not there (emphasis added).2

Three paragraphs down the page, she goes on — with a candor rarely seen from her
— that given the recent news about Steve Jobs’ choices for cancer treatment,
all health decisions “should be guided by the best available evidence.”If you
recall, Jobs put off surgery in favor of juice fasts, cleansing, acupuncture,
herbal medicine and other remedies he found online. Job’s biographer, Walter
Isaacson, writes that he also followed a doctor who ran an alternative medicine 
clinic.3 Obviously, Dr. Briggs’ new-found skepticism did not get to him on-time.

Josephine Briggs’ sudden confession actually raises more questions than answers:
did she have an enlightenment, an “Aha moment” in October 2011, and she
suddenly realized that the evidence was not there? Or perhaps she knew all
along, and while her institute was spending over $2 billion of US taxpayers’
money, she conveniently looked the other way? The question is pertinent because 
— despite the overwhelming criticism from the scientific community — Briggs and 
her staff have refused to admit that most research in alternative medicine is a 
reprehensible waste of public funds. If she has willingly looked the other way, 
then we are dealing here with bad faith and the betrayal of the public’s trust.

And waste and betrayal, there is. Skeptics Eugenie Mielczarek and Brian Engler
write in the January/February 2012 issue of the Skeptical Inquirer that since
1992, there have been over 1000 monetary awards by NCCAM to fund hundreds of
clinical trials. None of them has revealed anything new that would justify the
current annual expenditure of $134 million. Some of these funded studies are
beyond absurd: $250,000 was wasted to determine whether waving hands over fatty 
rabbits will decrease their cholesterol. Did it? Almost ten years later, we
still don’t know! Public funds were also wasted to study the efficacy of prayer 
to cure AIDS or to hasten recovery from breast-reconstruction surgery. Other
funded studies involved the use of ancient Indian remedies for type 2 diabetes, 
magnets for arthritis, carpal tunnel syndrome or migraine headaches, and coffee 
enemas for pancreatic cancer. It is not surprising that none of these studies
showed any efficacy beyond the placebo effect.4

After examining hundreds of grants, dozens of scientific papers, 12 years of
documents and advisory council meeting minutes, the Chicago Tribune also reports
that NCCAM has spent millions of taxpayer dollars on studies with “questionable
grounding in science.” The Tribune cites a grant for $374,000 to find out if
inhaling lemon and lavender scents would improve wound healing. NCCAM has also
wasted funds in studies of various forms of energy healing, including one based 
on the ideas of a self-described “healer, clairvoyant and medicine woman” who
says her children inspired her to learn to read auras. The cost to the taxpayer 
was $104,000.5

All that is proven by these studies is that that most alternative “cures” work
no better than placebo. It is also the case for acupuncture: a 3-arm randomized 
clinical trial on chronic back pain with 638 subjects showed that both
acupuncture and sham control were better than usual care in managing low-back
pain. However, the acupuncture regimen was not found to be more effective than a
sham procedure that did not penetrate the skin. In other words, there is no
difference between any type of acupuncture, and a placebo control procedure that
does not involve real needles. This study was published in 2009 in the Archives
of Internal Medicine.6

Well, here’s Josephine Briggs’ reaction to this acupuncture study:

   This adds to the growing body of evidence that there is something meaningful 
   taking place during acupuncture treatments outside of actual needling.

In other words, Briggs states that a treatment is useful because something
meaningful is taking place outside of the treatment itself! But, isn’t this the 
very definition of the placebo effect? Based on her outlandish argument,
needling voodoo dolls should also be considered as treatment — and perhaps
qualify for funding — because something meaningful is taking place outside of
actual needling!

But now that acupuncture, herbal remedies and a vegan diet did not help an
American icon, Josephine Briggs is having an Aha moment, and is suddenly
realizing that the evidence is not there! Why didn’t she admit to it earlier?
Why did her agency omit credible evidence against the efficacy of these remedies
for over a decade? Is her forced admission — or rather confession — some kind
of proactive measure? These questions remain unanswered. But what is now
certain, is the fact that NCCAM’s claim of being “dedicated to exploring
complementary and alternative healing in the context of rigorous science,” is in
flagrant conflict with its actual practices-on-the-ground.

Besides, let’s also not forget that this conflict is first and foremost
politically motivated.7 It is the work of “alternative-medicine purveyors” and
their powerful allies who seek to legitimize their anti-science agenda through a
federal agency, and to maintain government funding for the promotion of
“willful ignorance.”

Willful ignorance is certainly the hallmark of some of NCCAM’s Advisory Board
members. Take a good look at their credentials and you will notice one element
universally lacking: rigorous scientific training. Even worse, some have been
entirely dishonest about their credentials or have a record of disregard for
science- and evidence-based medicine, altogether.

Since 2009, Kimball Atwood, has written several posts on this site about the
former member of NCCAM’s Advisory Council, the “AltMed Superstar,” Ted J
Kaptchuk. According to Atwood’s investigation and also documents obtained from
the California Acupuncture Board, Kaptchuk not only does not have real academic 
training, but he also has grossly misrepresented his credentials. Atwood
suggests that Kaptchuk may have violated federal law by lying about his
credentials when applying for federal grants.

Atwood adds in his November 11, 2011, comments that:

   The revelation that this degree never existed now undermines all of those
   things, with ramifications that go way beyond Kaptchuk himself. The lie is so
   fundamental that it casts suspicion on all of his trial reports, for
   example. That affects all of his co-authors.

Be noted that even real credentials are not necessarily indicative of aptitude
for scientific inquiry. Consider another former member of the Advisory Council, 
Adam Burke, PhD, MPH, MS, LAc. Despite what reads like a string of illustrious
credentials, Burke doesn’t have any biomedical training: his graduate degrees
are from UC Santa Cruz and UCLA in Social Psychology and Health Education. His
healthcare “degree” doesn’t even come from an academic institution: it’s from
the American College of Traditional Chinese Medicine in San Francisco (a private
vocational school, where he is presently on faculty).

Here’s testimony to Adam Burke’s contempt for science:

   If you biomedicalize it all, my big fear and this is why I’m in the
   university and one of the reasons why I went back to the university is if we 
   strip the history and the philosophy and the understanding of that, we have
   shut out millennia of understanding of human illness that could enrich our
   understanding of healing people.

What follows is just crazy talk:

   Distant healing — They don’t know how, but some of the people at the
   Institute of Noetic Sciences, which was founded by an Astronaut up in Marin, 
   they are doing research on distant healing. Their principle investigator is a
   physicist — they are getting their research published in the best physics
   journals in the United States.

   — Adam Burke, California Acupuncture Board Meeting Minutes, June 20, 2008

Burke also boasts the rather awkward honor of serving as Editor-in-Chief of The 
American Acupuncturist, the official publication of the American Association of 
Acupuncture and Oriental Medicine (AAAOM). Here below is a photo of AAAOM
representatives meeting with Director Josephine Briggs in 2008:

Image 1. Front Row (L-R): Will Morris, Josephine Briggs, Martin Herbkersman, and
in the back Row (L-R) Partap Khalsa, Misha Cohen, Adam Burke, Rebekah
Christensen. Image Source: The American Acupuncturist, Fall 2008.

It is certainly not due to their concern for “rigorous science” that the above
met with Josephine Briggs. It is because in this New Age of ignorance,
hocus-pocus is big business, and getting the government involved can create the 
false perception of endorsement for any nonsense. This is a common charade that 
has been played by alternative-medicine purveyors for decades, with the public’s
safety at stake.

But no matter — what we see recorded here is a 2008 meeting between an advocacy 
group and NCCAM. They were assembled to present Briggs a wish-list that included
an increase in herbal research; grants to support AAAOM conferences; and the
placement of acupuncturists on university research, grant review teams, and
research advisory panels. The wish-list also requested “the expansion of the
NCCAM Advisory Board to include individuals versed in mixed research methods,
including qualitative, population-based research, quality and other
approaches.”8

Now fast forward to 2010, about two years after the photo, and AAAOM’s
candidate, Adam Burke, is appointed to NCCAM’s Advisory Board. Immediately
after, the AltMed wizards from the above picture write in the January 2010 issue
of Qi-Unity Report:

   We look forward to the in-depth professional and research acumen Dr. Burke
   will bring to the NCCAM Advisory Council and to the benefits that will accrue
   to the AOM profession as our medicine transitions into the mainstream of
   U.S. health care delivery.

“In-depth professional and research acumen” and “our” medicine?! I just cannot
refrain from laughing out loud.

But this is no laughing matter. The NCCAM budget for 2011 was $127.7 million.9
They requested a $3.4 million increase in funding for 2012.10 This is over
$131.1 million taken away from serious medical research. Fortunately, Adam Burke
was not re-nominated in 2012, and cannot influence the channeling of funds for 
“herbal research” or “grants to support AAAOM conferences” — especially now that
we know the evidence is not there.

But despite Dr. Brigg’s disclaimer, many key questions still remain unanswered. 
How much more money is NCCAM going to waste for studying remedies where
something meaningful is taking place outside of the actual treatment? How many
more self-proclaimed experts with fabricated or unfit credentials are going to
feed off the taxpayer? How many more Steve Jobs need to die before we realize
that alternative medicine is in essence foolishness?

In my opinion, none, absolutely none. Once we become aware that the evidence is 
not there, a transgression takes place; this is when a legal line is finally
crossed, and — as Robert Park has argued — foolishness becomes fraud.

With many thanks to Daniel Bederian-Gardner, Kristen Koster, Dawn Martin,
Eugenie Mielczarek and Robert Slack for their valuable comments. The opinions
expressed here are the author’s.

REFERENCES:

  1. Park RL. Voodoo Science: The Road from Foolishness to Fraud. Oxford University
    Press. 2001. Return to text

  2. Briggs JP. A Role for Complementary Medicine? NCCAM. 26 October, 2011.
    Retrieved 8 April 2012. Return to text

  3. Isaacson W. Steve Jobs. Simon & Schuster; First Edition edition. 2011. Return 
    to text

  4. Mielczarek EV, Engler BD. Measuring mythology: startling concepts in NCCAM
    grants. Skeptical Inquirer. Volume 36.1, January/February 2012. Return to
    text

  5. Tsouderos T, Federal center pays good money for suspect medicine. Chicago
    Tribune. December 11, 2011. Return to text

  6. Cherkin DC, Sherman KJ, Avins AL, Erro JH, Ichikawa L, Barlow WE, Delaney K,
    Hawkes R, Hamilton L, Pressman A, Khalsa PS, Deyo RA. A randomized trial
    comparing acupuncture, simulated acupuncture, and usual care for chronic low
    back pain. Arch Intern Med. 2009 May 11;169(9):858-66. Return to text

  7. Mielczarek EV, Araujo DC. Power Lines and Cancer, Distant Healing and Health 
    Care. Skeptical Inquirer. Volume 35.3, May/June 2011. Return to text

  8. AAAOM Meets with the National Center for Complementary and Alternative
    Medicine (NCCAM). American Acupuncturist. Volume 45 FALL 2008. Return to
    text

  9. NCCAM Funding: Appropriations History. NIH. 12 September 2011. Retrieved 8
    April 2012. Return to text

  10. Fiscal Year 2012 Budget Request. NIH. 12 September 2011. Retrieved 8 April
    2012. Return to text

NCCAM on “integrative medicine”: What’s in a word?

David Gorski on July 2, 2012

Link

I don’t know how I’ve missed this, given that it’s been in existence now for a
month and a half, but I have. Regular readers (and even fairly recent readers,
given that I write about this topic relatively frequently) know that I’m not a
big fan of the National Center for Complementary and Alternative Medicine
(NCCAM). (Come to think of it, neither is anyone else writing for this blog.)
Just search this blog for “NCCAM” if you don’t believe me. I’ve explained the
reasons many times, but the CliffsNotes version is that NCCAM is an enormous
waste of taxpayer money, dedicated as it is to the study of modalities that are 
at best highly implausible and at worst break well-established laws of physics
(i.e., “energy healing”). I do concede that, since the latest NCCAM director
(Dr. Josephine Briggs) took over, there has been a noticeable attempt to bring
more scientific rigor to NCCAM, and to some extent Dr. Briggs has succeeded. At 
the very least she is a legitimate scientist with an impressive pre-NCCAM track 
record, and I do fear who will succeed her when she moves on or retires given
that there is enormous pressure from the CAM community to appoint one of their
own as director.

Unfortunately, as rigorous a scientist as Dr. Briggs was in her former life,
since coming to NCCAM she has gradually been assimilated into the culture of the
place. Indeed, although it is good that NCCAM has backed away from studying woo
like homeopathy and distance healing, the co-optation of science-based
modalities such as exercise, diet, and natural products pharmacology has
continued apace. Worse, the recently released five year strategic plan for NCCAM
admitted that the science funded by NCCAM in the past was crap and, in essence,
promised to do some real science for a change. That’s why on occasion I’ve
jokingly said that we should take off and nuke NCCAM from orbit. It’s the only
way to be sure. On the other hand, no doubt someone would think I seriously mean
that we should nuke NCCAM. Of course, I’d never advocate that! NCCAM is located
right smack dab in the middle of the NIH campus. The collateral damage would be
unacceptable.

I keed. I keed. I’m not kidding, though, when I echo the questioning of why
NCCAM still exists.

What’s in a word?

But back to the new initiative by NCCAM that I started out the post with. I’m
referring to the new NCCAM researchblog. Dr. Briggs welcomes readers to the blog
in the first post:

   Like all of the NIH, our mission is to conduct the highest quality biomedical
   research to improve the health of the Nation. NCCAM’s special charge is to
   bring rigorous science to the broad array of health practices that have
   arisen from outside of mainstream medicine. This covers a lot of tough
   territory! Not surprisingly the conversation about complementary and
   alternative health practices has often become polarized, with competing views
   about what makes good sense. I hope to use this blog as a place for a
   conversation about these challenges.

Sounds like a plan! It’s also one reason why I encourage SBM readers to take
part in that conversation, both here and on the NCCAM blog (although you should 
note that the comments on the NCCAM blog are moderated). I also thank Dr. Briggs
for providing me with additional blogging material. In particular, I’d like to 
join the discussion started in the very first substantive post after her
welcome. It’s about the word, “integrative,” which Dr. Briggs discusses in her
second blog post, “Integrative” — What Is in a Word? It’s a very good question, 
although probably not in the way that Dr. Briggs intended it. What is in the
word “integrative”? I’ve discussed the use of this word many times before, in
particular how “integrative medicine” is a brand rather than a specialty, but
before we get to my blather, let’s take a look at Dr. Briggs’ blather. Fair’s
fair, after all.

First, Dr. Briggs tries to have it both ways, being a good skeptic but still
accepting the CAM framing of science and language:

   That seems simple enough but there are a lot of rough edges at the interface 
   between conventional medicine on the one hand and use of
   complementary/alternative health approaches on the other, and “integrative”
   can get caught in a highly polarized debate. From one end, “integrative
   medicine” offers a holistic, gentle, patient-centered approach that will
   solve many our Nation’s most pressing health care problems. At another end,
   “integrative care” represents an evasive rebranding of modern equivalents of 
   “snake oil” by practitioners who raise unrealistic hopes and promote
   approaches that are not sensible, supported by evidence, or proven safe.

This is the classic false equivalency. Notice how Dr. Briggs characterizes
“integrative medicine” on the one hand as being all soft and fuzzy, the
equivalent of mom and apple pie. Who could argue with “holistic, gentle,
patient-centered” approaches? Well, actually, I can, because the word “holistic”
is meaningless in this context. A good science-based primary care doctor is
“holistic.” You don’t need to buy into woo to be a holistic doctor. Similarly,
you don’t need to buy into woo to be patient-centered in your approach. In
addition, as I’ve pointed out before, “patient-centered” is a wonderfully
flexible term that can mean so many things to so many people, and the
woo-meisters have certainly taken advantage of that in order to promote the idea
that patient-centered care necessarily involves their favored quackery.

Now here’s the false equivalency. Dr. Briggs equates the above wonderfully
Orwellian verbal prestidigitation that describes CAM (or “integrative medicine” 
or whatever you want to call it) as the path to holistic care with skeptics who 
point out that integrating quackery with real medicine makes no sense. As Mark
Crislip so famously put it, “If you integrate fantasy with reality, you do not
instantiate reality. If you mix cow pie with apple pie, it does not make the cow
pie taste better; it makes the apple pie worse.”

And if you “integrate” pseudoscience with science, it does not make the science 
more rigorous. If you mix quackery with real medicine, you do not make the real 
medicine better—or even more “holistic.” Much of “integrative medicine”
represents, more than anything else, a return to pre-scientific beliefs, such as
vitalism, miasmas, and illnesses being caused and cured by, in essence spirits 
or gods or magic. After all, reiki is nothing more than a form of faith healing,
and most energy medicine is nothing more than magic, the belief that if you
wish for something really, really hard, you can bend the universe to do your
bidding and provide you with that thing, in this case, healing.

Dr. Briggs then asserts three “very well documented facts.” Unfortunately, none 
of these facts are unequivocally true—or even that particularly well documented.
I’ll show you what I mean.

Here’s “fact” one:

   Individuals, their health care providers, and their health care systems are
   all, on a large scale, incorporating various practices which have origins
   outside of mainstream medicine into multi-pronged treatment and health
   promotion approaches.

Well, yes and no. First the no. As I’ve explained many times, the evidence for
this assertion is weak at best. Most surveys of CAM use include spirituality and
prayer, which artificially inflates the numbers. It also includes exercise and 
meditation, both of which are arguably not from “outside the mainstream.” As
I’ve pointed out before, when you look at the hardcore woo, such as homeopathy
and the like, the numbers of people who use them are actually quite small and
haven’t changed that much over the last decade. Now the yes. It is true that
quackademic medicine has infiltrated medical schools and that many hospitals
whose leaders should know better have embraced it.

Now here’s “fact” two:

   This “integrative” trend among providers and health care systems is growing. 
   Driving factors include perceived benefit in health or well-being, emerging
   evidence in at least some cases that perceived benefits of integrative are
   real and/or meaningful (e.g., management of chronic pain), and marketing of
   “integrative care” by health care providers to consumers.

OK, I’ll give Dr. Briggs this one—partially, anyway. The reason, however, is
because Dr. Briggs cleverly worded it. Note how she refers to “perceived”
benefit rather than actual benefits. She’s also right that the marketing of
“integrative care” plays a large role in its current popularity. As I’ve pointed
out before as well, “integrative medicine” is a marketing term, not a term that
describes anything real. It’s more about keeping the customer satisfied rather 
than actually helping the patient. It’s a sham. It’s also quite arguable whether
in the case of the management of chronic pain the perceived benefits of
“integrative care” are real or meaningful. Indeed, some “integrative” modalities
touted as effective are in fact science-based treatments, such as exercise and 
lifestyle interventions.

This leads to “fact” three:

   With few exceptions, data to guide evidence-based decision making about
   safety and efficacy are at best preliminary.

No, no, no, no. With few, if any exceptions, data to guide science-based
decision making about CAM or “integrative medicine” are negative. They do not
work, by and large. As Kimball Atwood so famously described CAM modalities:

   A spectrum of implausible beliefs and claims about health and disease. These 
   range from the untestable and absurd to the possible but not very intriguing.
   In all cases the enthusiasm of advocates vastly exceeds the scientific
   promise.

Unfortunately, Dr. Briggs remains inordinately impressed with the concept of
“integrative” medicine, calling it “simple” and “pragmatic” while declaring it a
“very useful construct” that “focuses on major trends in 21st century health
care.” In actuality, most CAM modalities focus on major trends in 17th or 18th
century health care or even earlier. They are modalities steeped in
prescientific beliefs because they have their origins in a time before we
understood enough about how the body works and how health and disease occur not 
to attribute disease and health to mystical concepts. That is the reality of
what CAM “integrates” with science-based medicine.

Oh, the pain, the pain…

One notes that Dr. Briggs emphasizes multiple times “nonpharmacological
approaches” to pain management. No doubt this is because pain management is
where placebo effects are most common. Be that as it may, she’s already produced
one post on pain management. She begins by exulting about the science presented
NIH Pain Consortium 7th Annual Symposium on Advances in Pain Research, which
she attended, mentioning various targets and promising new pharmacological
therapies. What impressed her inordinately (much as the word “integrative”
appears to do) were the potential nonpharmacological approaches that, of course,
fall under the rubric of complementary and alternative medicine (CAM). The
reason she uses to justify this promise is recent data that find a serious
problem with the abuse of prescription pain medications. This is indeed a
serious problem, although one notes that in fields such as mine (cancer) there
is considerable evidence that many patients are undermedicated for their pain as
well. Be that as it may, this is how Dr. Briggs views the landscape:

   Clearly, drugs are, and will remain, critically important in managing pain,
   but drugs alone are not enough. There is another important piece to pain
   management—patients also need strategies for self-care and ways to harness
   the huge impact that context, attention, emotional state, and reassurance can
   have on pain. NCCAM is bringing a special contribution to pain research by
   pursuing promising, nonpharmacological approaches to pain management; about
   30 percent of our total research budget is focused on pain. Our research is
   built on evidence, still incomplete, that various mind and body approaches,
   such as meditation, guided imagery, yoga, tai chi, massage, and spinal
   manipulation, may have value as adjuncts in pain management. Some of these
   techniques are being integrated into pain management in health care
   facilities around the country. And, while there is a growing evidence base
   for their value, and a number of “real world” testimonials, there are still
   many areas of uncertainty. It’s my belief that NCCAM, by funding the kind of 
   research that builds a critical, rigorous evidence base, can truly have an
   impact on pain management.

I find it rather revealing that NCCAM spends one-third of its budget on pain
research. After all, pain is one symptom where placebo effects play a huge role.
Consequently, if there’s an area where CAM modalities would be most expected to
appear to show an effect, it would be in treating pain. Of course, if there’s
one research area where it’s really hard to separate placebo effects from real
effects it’s in pain research as well. Without really rigorous research design, 
any clinical study looking at the effect of a CAM modality on pain, particularly
chronic pain, will be prone to many confounders, such as recall bias,
regression to the mean, placebo effects, various biases that can creep into the 
design of clinical trials, and the like. Note how Dr. Briggs points out how
there are a “number of ‘real world’ testimonials” supporting the efficacy of CAM
modalities. No doubt there are. There always have been. Unfortunately, as we’ve
documented time and time again for CAM modalities, in particular acupuncture,
when CAM modalities are tested under truly rigorous conditions with appropriate 
controls the result is nearly always that they are indistinguishable from
placebo.

There’s another consideration, and it goes to the heart of why NCCAM should even
exist. Once again, there is nothing inherent in pain research that requires a
separate institute dedicated to CAM, or “integrative medicine,” or whatever you 
want to call it. NCCAM is completely unnecessary for this sort of research;
worse, it’s counterproductive. The reason is that it overlays woo on what should
be rigorous scientific research. Worse, if the next blog post is any
indication, NCCAM doesn’t even really want to do truly rigorous research.

Reversing the progression

If the pain research carried out at or funded by NCCAM were indeed highly
rigorous, then I wouldn’t have much problem with it. I’d still argue that NCCAM 
as a center is completely superfluous, but I’d be more willing to accept its
continued existence. Unfortunately, if the most recent post on the NCCAM blog is
any indication, Dr. Briggs’ promise of building a “critical, rigorous evidence 
base” is a lot of hot air. This post was not written by Dr. Briggs, but rather
by Richard Nahin, Ph.D., M.P.H., who is Senior Advisor for Scientific
Coordination and Outreach at NCCAM and is entitled Observational Studies and
Secondary Data Analyses To Assess Outcomes in Complementary and Integrative
Health Care. I’m guessing that from the title alone you’ll be able to tell where
this is going. You won’t be wrong. Dr. Nahin wants to encourage “pragmatic”
trials of CAM modalities. It’s rather sad to see his rationale because he
describes well the problems with observational trials and then concludes that
they’re useful anyway:

   Although observational studies cannot provide definitive evidence of safety, 
   efficacy, or effectiveness, they can: 1) provide information on “real world” 
   use and practice; 2) detect signals about the benefits and risks of
   complementary therapies use in the general population; 3) help formulate
   hypotheses to be tested in subsequent experiments; 4) provide part of the
   community-level data needed to design more informative pragmatic clinical
   trials; and 5) inform clinical practice.

   The main difficulty with causal inference in such observational studies has
   to do with the fact that participants or their providers choose which
   therapies the participants receive. Invariably, this “choice” means that
   participants choosing one therapy may not have the same characteristics as
   participants choosing another therapy; one or more of these differences may
   be the true cause of any observed effects rather than the use of one therapy 
   or another. This is, of course, very different than a well-designed
   randomized clinical trial of sufficient size, where the same process that
   randomly assigns participants to one treatment or another also helps to
   balance the characteristics of individuals in each group.

Here’s the problem. Nahin is putting the cart before the horse, as so many CAM
apologists do. Pragmatic “real world” trials can be useful, particularly in
terms of comparative effectiveness research, which will be more and more
important in the coming years. There’s a caveat, though. It’s only useful to do 
pragmatic or observational trials after treatments have already had their
efficacy and safety demonstrated in well-designed randomized clinical trials. In
other words, for comparative effectiveness studies, there’s no point in
comparing the “real world effectiveness” of two studies that haven’t yet been
shown to be efficacious in randomized clinical trials. “Pragmatic studies,”
which try to examine the “real world” effectiveness of a treatment are pointless
if the treatment under study hasn’t actually been demonstrated to be
efficacious yet in rigorous randomized clinical trials. And observational
studies are right out, as we say, when randomized clinical trials of a modality 
have already failed to demonstrate efficacy, as is the case for the vast
majority of CAM treatments that have been subjected to randomized clinical
trials.

None of this deters Nahin. He proposes a number of methods to try to control for
treatment self-selection, such as regression modeling or employing propensity
scores or instrumental variables to match samples. Don’t get me wrong; I have
nothing against these methods when they are appropriately used. However, they
are utterly unnecessary for the sorts of questions that Nahin apparently wants
to ask. They could just do randomized clinical trials, which would be less prone
to the biases and shortcomings that necessitate all that statistical
prestidigitation in the first place.

Steve Novella has made an excellent point multiple times on this blog and on his
own about the normal progression of clinical trials. Usually, what happens is
that clinical observations are made (or something is discovered in the
laboratory and tested in preclinical models). Next come small pilot trials in
humans. If those are promising, then larger, rigorous clinical trials are
performed. These are the classic randomized clinical trials, either with placebo
control or comparing the new therapy to standard of care therapy. Once large
randomized clinical trials demonstrate efficacy, then, and only then, are
“pragmatic” trials indicated in order to examine “real world” effectiveness.
Indeed, frequently, as we have found out, treatments are less effective in the
“real world” than they are under the idealized conditions under which randomized
clinical trials are carried out. CAM advocates, however, tend to flip the
order. Basically, when more rigorous randomized clinical trials fail to
demonstrate efficacy, they tend to start advocating things like “pragmatic”
trials because such trials are far more likely to be confounded by placebo
effects and the various biases that randomized, double-blinded trials are
designed to try to avoid. That appears to be exactly what Nahin is doing here.

In a way, I’m rather happy that NCCAM has a blog now, and it’s not just because 
it provides me with extra blogging material. The reason is that, even after just
four posts, this blog demonstrates the very problems with “integrative”
medicine (or CAM) in general and how NCCAM does research in particular. Despite 
Dr. Briggs’ attempts to portray NCCAM as doing only the most rigorous research
and even though to some extent Dr. Briggs does appear to have succeeded in
tightening up the scientific rigor of the center, in this blog we still see that
NCCAM is steeped in the pseudoscientific attitudes that underlie so much of
CAM. Dr. Briggs buys into the language of CAM, which is one of the most potent
tools CAMsters have to make it seem as though they are not quacks, and the
scientific leadership clearly buys into the idea that it’s acceptable to put the
cart before the horse and do pragmatic trials and “real world” observational
studies before they’ve actually demonstrated that CAM modalities can actually do
anything above and beyond placebo.

All of this is why, more than ever, NCCAM should be dismantled, defunded, and
its personnel absorbed into the rest of the NIH, where they could do some good.

What’s in a name?: NCCAM tries to polish a turd

David Gorski on May 19, 2014

Link

   What’s in a name? that which we call a roseBy any other name would smell as
   sweet;So Romeo would, were he not Romeo call’d,Retain that dear perfection
   which he owesWithout that title. Romeo, doff thy name,And for that name which
   is no part of theeTake all myself.

                          William Shakespeare, Romeo and Juliet, Act II, Scene 2

   You can clean up a pig, put a ribbon on its tail, spray it with perfume, but 
   it is still a pig.

                        A 1980 article from the Quad-City Herald in Brewster, WA

   You can paint a turd red, but it’s still a turd.

                                                                      Jason Bray

There’s a colloquial phrase commonly used to describe an effort to sell or
promote something that is so inherently awful or at least so flawed as to be
unsalvageable without either a radical rethinking or such a major overhaul that 
it would be impractical or impossible to do: Polishing a turd. In this,
advocates of so-called “complementary and alternative medicine” (CAM) have been 
very successful. Mark Crislip, in his usual inimitable fashion, just reminded us
why CAM is a turd that needs polishing. Unfortunately, on Friday, I learned
that the National Center for Complementary and Alternative Medicine unveiled a
proposal to help it be more efficient in polishing the turd that is CAM through 
the clever use of language, and it wants your feedback. There were lots of other
things that happened over the last few days that tempted me to write about them
that will likely have to appear over at my not-so-secret other blog, but this
one caught my attention and held it, given that it goes to the very heart of the
deceptive use of language that is at the heart of giving CAM the appearance of 
legitimacy. In this specific case, NCCAM wants a new name. Dr. Briggs wants to
rename NCCAM the National Center for Research on Complementary and Integrative
Health (NCRCI). (I have no idea why the abbreviation of the proposed new center 
name isn’t NCRCIH.) Here’s Dr. Briggs explaining the rationale for the proposal 
and urging feedback by June 6 at http://nccam.nih.gov/about/offices/od/comments.
I urge you to watch the whole video, or at least read the transcript:

Thus does Dr. Briggs propose polishing the turd that is NCCAM.

The power of language in CAM

That we at the Science-Based Medicine blog aren’t exactly fans of NCCAM is not
exactly a secret. So confident am I of this contention that I daresay that I
speak for us all at SBM when I point out that NCCAM is a source of research
funding that has been dedicated to pointless studies of quackery, “rebranding”
science-based modalities, such as diet and exercise, as somehow being CAM, and
“educational” grants clearly designed to promote CAM. After all, several of us
have at various times called for its dismantling, with its potentially useful
components (for example, the study of natural products pharmacology currently
disguised as studying herbal medicines and supplements, to be absorbed back into
various Institutes and Centers of the NIH more appropriate to study them.

A couple of years ago, in response to Dr. Briggs’ discussing the same matter,
albeit without the discussion of a potential name change, I asked a simple
question with respect to NCCAM: What’s in a word? In fact, I asked that question
in response to the very first blog post that Dr. Briggs wrote, in which she
welcomed readers to the new NCCAM researchblog and, more importantly (and
tellingly), her second post “Integrative — What’s in a Word?” At the time, I
thought it was a very good question, albeit not in the way that Dr. Briggs
intended. The reason was that advocates of so-called “complementary and
alternative medicine” (CAM), despite having been the ones to have coined the
term in order to soften the negative connotation of the word “alternative”
applied to medicine, are no longer happy with the term “CAM.” Indeed, government
entities being government entities and tending to move slowly, I’m only
surprised that it took NCCAM so long to want to change its name to be more in
line with the new, hipper thinking (if you can call it that) that says that
there’s nothing “alternative” in CAM. If we’re to believe CAM advocates, CAM
involves it’s “integrating” only the good stuff from CAM, the stuff that
allegedly can be proven scientifically. Never mind that much of it is what Dr.
Crislip called type 1 CAM: pure fantasy, which might be useful if CAM
practitioners could admit that the only studies such modalities are useful for
is to demonstrate the noise inherent in the clinical trial process and to
measure placebo effects, which have, not surprisingly, been “rebranded” as
“powerful mind-body effects.”

So let’s take a look at Dr. Briggs’ justification for this proposed name change.
In it, you will see the misuse of language, the clever verbal prestidigitation,
that underlies so much of CAM. I don’t think that Dr. Briggs’ is doing this
intentionally, but, after six years at the helm of NCCAM, she seems to have
imbibed deeply of the culture of CAM and its chosen word use that it’s now
second nature to her:

   Today, I’m asking for your input regarding the name of our Center. In the 16 
   years since NCCAM was established, we have funded more than 3,800 research
   projects examining the safety, efficacy, and use of a very wide array of
   interventions and practices with origins outside mainstream medicine. At the 
   same time, large population-based surveys have reinforced the fact that the
   use of true alternative medicine—that is, the use of unproven practices in
   place of treatments we know to be safe and effective—that that is rare. Also 
   during this time, the field of research has progressed, and a much more
   defined set of research opportunities has emerged. We see the growth of
   integrative health care within communities across the US, including
   hospitals, hospices, and military health facilities. With these changes in
   the research and practice landscape, we believe that our current name no
   longer accurately reflects our Congressional mandate, which is, in part, to
   study the integration of these practices as a complement to conventional
   care.

   We also recognize that our current name is not explicit about our research
   mission, and that it may be misconstrued as advocacy or promotion of unproven
   practices.

   And so, we are proposing that the name of our Center be changed to “NATIONAL 
   CENTER FOR RESEARCH ON COMPLEMENTARY AND INTEGRATIVE HEALTH.” The goal of
   this change is to better align the Center’s name with the evolution in health
   care and our research focus, and thus best address our Congressional
   mandate.

I don’t know whether Dr. Briggs knows it or not, but this is the very same
rationale that’s been used since time immemorial (or at least over the last 30
years or so that has seen the rise of CAM and quackademic medicine) every time a
name change for “alternative” medicine has been proposed. As I once put it in
far more detail three years ago, once upon a time—maybe three decades ago—there 
was quackery. Physicians, actually caring about prior plausibility based on
basic science considerations, intuitively “grokking” Bayesian thinking without
necessarily having had any formal training in it, recognized that modalities
such as homeopathy, reflexology, and various “energy healing” methodologies were
based on a combination of prescientific vitalism, magical thinking, and/or
science that was incorrect, distorted, misunderstood, or misrepresented.
Physicians weren’t afraid to call a quackery quackery, quacks quacks, and
charlatans charlatans. The first step for advocates to change this perception
clearly involved language.

Arguably, the first ill-fated attempt to change the language landscape of
quackery was to start referring to it as “alternative medicine,” medicine that
was (and still is) medicine that does not fit into the current scientific
paradigm, a term used to describe medical practices not supported by science and
evidence, and were used instead of effective therapies. As Dr. Crislip reminded
us just last Friday, there is no alternative medicine. There is only
scientifically proven, evidence-based medicine supported by solid data or
unproven medicine, for which scientific evidence is lacking. “Alternative
medicine” was not a rubric that could long stand, at least not in a form that
would ever gain credibility in mainstream medicine.

Thus was born, around 20 or 25 years ago, the term “complementary and
alternative medicine” (CAM). The arguments used for the name change were
virtually identical to those that Dr. Briggs is using in favor of her name
change: Almost no one uses alternative medicine instead of science-based
medicine, thus making it not “alternative.” That’s the very reason why the word 
“complementary” was added to the term “alternative medicine” in the first place.
Alternative medicine would “complement” conventional medicine, not replace it! 
As before, CAM was (and is) medicine that does not fit into the current
scientific paradigm, including treatments that are not supported by evidence and
are ineffective and/or potentially harmful. The difference? As the name
implied, CAM therapies are used in addition to rather than instead of real
medicine. Over a relatively brief period of time, the name change had its
intended effect. No longer did many physicians automatically view modalities
that were once considered quackery, later considered “alternative,” and now
considered “CAM” as quackery, and those that still did were dismissed as
close-minded, stubborn, and dogmatic, relics who were trying to swim against the
coming wave of wonderful CAM magic.

Into this world, with this then-new nomenclature in ascendance, the precursor
office to NCCAM, the Office of Alternative Medicine (OAM), was reborn as a full 
center, the National Center for Complementary and Alternative Medicine, with an 
abbreviation almost as pithy as “CAM,” namely NCCAM. That name has endured for
16 years. Ironically, the name has endured as CAM has moved on. The reason CAM
has moved on, with the word “CAM” increasingly being shunned by its former
advocates, is simple. The word “alternative” is still there. The very name of
CAM still implies that its treatment modalities will forever be considered not
quite right, not quite in the mainstream, not quite “real” medicine. At the very
least, the word “complementary” implies that CAM is not the real medicine, that
it only “complements” real medicine. Medicine was the cake, and their wares
were just the icing. That this is simultaneously both a correct and incorrect
perception—most CAM is not real medicine, but it also “complements” nothing—is
irrelevant to CAM advocates. They believe; so they want a name that eliminates
that inference. They craved respect. They wanted to be co-equals with physicians
and science- and evidence-based medicine.

Thus was born the term “integrative medicine.” The term “integrative medicine”
(IM) served their purpose perfectly. No longer were CAM/IM treatments merely
“complementary” to real medicine. Now they were “integrating” their treatments
with those of science- and evidence-based medicine! The implication, the very,
very, very intentional implication, was that alternative medicine was co-equal
to science- and evidence-based medicine, an equal partner in the “integrating.”

As I said before, I’m only surprised that it took the NCCAM Advisory Board and
Dr. Briggs so long to decide that a name change is in order for NCCAM.

Polishing the turd to a high gloss

Of course, the appeal to “integrative” health and denial that anyone uses CAM
instead of real medicine are not the only arguments that Dr. Briggs uses. She
also uses the logical fallacy known as argumentum ad populum, the appeal to
popularity, which argues in essence that because something it popular there must
be something to it. In this case, in addition to the claim that CAM is not
“alternative,” Dr. Briggs is arguing that the popularity of CAM justifies the
name change, in which “we see the growth of integrative health care within
communities across the US, including hospitals, hospices, and military health
facilities.” Even if true (and, unfortunately, the infiltration of quackademic
medicine into both medical academia and community hospitals like so much kudzu
is a fact), how that justifies a name change, I don’t know, but apparently to
Dr. Briggs it does.

The other point that Dr. Briggs makes that caught my attention was her statement
that “the field of research has progressed, and a much more defined set of
research opportunities has emerged.” When I heard her utter that phrase, I
started thinking. What on earth was she talking about? NCCAM has a hard time
even defining what “CAM” is, which makes me wonder how the definition of its
mission will change when the term “CAM” is no longer even part of its name.
First, let’s look at NCCAM’s definition of CAM:

   Defining CAM is difficult, because the field is very broad and constantly
   changing. NCCAM defines CAM as a group of diverse medical and health care
   systems, practices, and products that are not generally considered part of
   conventional medicine. Conventional medicine (also called Western or
   allopathic medicine) is medicine as practiced by holders of M.D. (medical
   doctor) and D.O. (doctor of osteopathic medicine) degrees and by allied
   health professionals, such as physical therapists, psychologists, and
   registered nurses. The boundaries between CAM and conventional medicine are
   not absolute, and specific CAM practices may, over time, become widely
   accepted.

   “Complementary medicine” refers to use of CAM together with conventional
   medicine, such as using acupuncture in addition to usual care to help lessen 
   pain.

Can any of you tell from this what practices would and would not be CAM? I
can’t, other than that by this standard certain things that are considered CAM
shouldn’t be, such as diet and exercise, as well as herbal medicine, the latter 
of which is, as I’ve repeated more times than I can remember, nothing more than 
the old and respected branch of pharmacology known as pharmacognosy, or natural 
products pharmacology. NCCAM further divides CAM into these five categories:

  1. Alternative medical systems: Complete systems outside of mainstream medicine
    based on concepts that vary widely depending on the whole medical system.
    Includes: Homeopathy, traditional Chinese medicine, Ayurvedic medicine,
    Native American medicine, naturopathy.

  2. Mind-body interventions: Influencing physiology through influencing the mind. 
    Includes: Meditation, yoga, guided imagery, deep breathing exercises,
    progressive relaxation, and tai chi.

  3. Biologically-based treatments: Use of substances found in nature, including
    diet. Includes: Herbal medicines, dietary supplements, probiotics, nutrition
    and diet manipulation.

  4. Manipulative and body-based methods: Manipulation of musculoskeletal
    structures to affect physiology. Includes: Osteopathy, chiropractic,
    craniosacral therapy, massage therapy.

  5. Energy therapies: Manipulation of “life energy” fields, sometimes called
    “biofields.” Includes: Therapeutic touch, reflexology, rolfing, reiki,
    acupuncture, qi gong.

Lifestyle interventions, such as exercise, clearly fall under “mind-body” while 
diet and natural products clearly fall under biologically based therapies. Yet
all of these can be and, when not infused with CAM magic, are science-based.
There is no need for a separate “complementary,” “alternative,” or “integrative”
category to account for them. Doing so does nothing other than ghettoize these 
modalities by making them seem less than respectable because they’ve become
associated with pseudoscience. Of course, one thing I noticed while doing the
web research for this post is that it’s actually hard to find a table of CAM
subtypes on the actual NCCAM website, although lists and tables are common
elsewhere. The most recent CAM Basics brochure from NCCAM lists only natural
products, mind and body medicine, and manipulative and body-based practices,
while relegating energy therapies and alternative medical systems to “other.”

To be honest, I fail to see what Dr. Briggs means when she says that “a much
more defined set of research opportunities has emerged.” The snarky skeptic in
me can’t help but wonder whether this “much more defined set of research
opportunities” came about as NCCAM was so continually embarrassed over the years
because of its funding of studies into what can only be described as magic and 
mysticism, such as homeopathy, reiki, therapeutic touch, and distance healing
that under Dr. Briggs’ leadership the most blatant of these have been (mostly)
discarded. As I put it when discussing the recent five-year strategic plan for
NCCAM for 2011 through 2015, this amounts to saying, “Let’s do some real science
for a change!” In other words, let’s concentrate on modalities like diet,
pharmacognosy (excuse me, herbal medicine and supplements), and exercise, where 
we might actually find something, rather than on type 1 CAM like energy
medicine, which even CAM practitioners at some level seem to recognize as pure
fantasy and magical thinking. Of course, if that’s what NCCAM does, then the
need for NCCAM disappears, because there is nothing inherent in any of these
things that requires a separate center or institute within the NIH to study it. 
NCCAM was created through Senator Tom Harkin’s (D-IA) efforts to study magic
like energy medicine, not mundane, science-based interventions that have been
“rebranded.”

Finally, Dr. Briggs claims that the proposed name change is necessary because
NCCAM’s current name “may be misconstrued as advocacy or promotion of unproven
practices.” The problem is that there is nothing “misconstrued” here. NCCAM has 
promoted unproven practices, particularly through educational grants to teach
CAM, the teaching of which is almost always done not in a science-based fashion 
but in a credulous fashion that assumes CAM works. Indeed, it was an NCCAM grant
that funded the initial effort to “integrate” such credulous CAM education into
the standard medical school curriculum at Georgetown and other medical schools,
even up to encouraging the partnering of real medical schools with schools of
naturopathy.

No doubt this “rebranding” of NCCAM is intended as the first step in developing 
its next five-year strategic plan for 2016 to 2020. After all, the current NCCAM
five year plan has only a year and a half left to go.

So what should we call NCCAM, anyway?

I was half-tempted to make this post about proposing names for NCCAM that would 
be better than the proposed new name National Center for Research on
Complementary and Integrative Health. While the proposed name is a perfect
example of the move away from acknowledging anything “alternative” or
less-than-evidence-based about CAM, it does not describe what NCCAM really is
about, whether its director and the officials who run it will acknowledge it or 
not. Observing some discussions where this has come up, I’ve seen proposed names
such as the National Center for Research on Supplements, Complementary and
Alternative Medicines (SCAMs), the National Center for Research on Tooth Fairy
Medicine (I like this one), National Center for Research on Snake Oil and
Science Denial, National Center for Unprovable Therapies, and National Center
for More Research is Needed (I would suggest a slight alteration to this one to 
National Center for More Research Is Always Needed). Personally, I like Harriet 
Hall’s suggestion, seen on the HealthFraud mailing list, of Center for Studying 
Things Scientists Wouldn’t Otherwise Bother Studying. I don’t mind if you try to
outdo these suggestions in the comments, but let’s not do just that. NCCAM,
unfortunately, isn’t going anywhere any time soon, so I urge all SBM readers to 
head on over to the link for public comments regarding the proposed name change 
and submit your thoughts to Dr. Briggs. Feel free to cite this post. Remember,
you only have until June 6.

The bottom line, however, is that it really doesn’t matter that much what NCCAM 
is called. Sure, removing “alternative” and adding “integrative” somewhere in
the name might make it less offensive to its stakeholders, the alternative
medicine practitioners whose purpose it serves, and more palatable for a
different reason to science-based physicians, but unless the underlying mission 
and structure are changed radically, it’ll just be putting lipstick on a pig or 
polishing a turd, or whatever metaphor you like for trying to make something
that is fundamentally flawed beyond easy redemption seem attractive.

Speaking of polishing a turd, Adam Savage and Jamie Hyneman once demonstrated on
their most excellent television show MythBusters that it is indeed possible to 
polish a turd to a high gloss. However, doing so takes a lot of work:

Basically, polishing a turd requires breaking the turd down into a slurry,
completely remolding it into a sphere, and letting it dry, followed by many
hours of constant buffing. The current leadership of NCCAM appears not to want
to go that far, which, if we carry the metaphor a bit further, would involve
actually breaking NCCAM down to the proverbial slurry and reforming it,
something that is highly unlikely to happen. Until the day that NCCAM is either 
completely rethought on a basis of science informed by prior plausibility that
would eliminate completely the magic or dismantled, there’s nothing to do except
polish the turd to a brighter sheen and hope no one notices the smell.

The National Center for Complementary and Alternative Medicine (NCCAM): Your tax
                              dollars hard at work

                                  David Gorski

                                      Link

What’s an advocate of evidence- and science-based medicine to think about the
National Center for Complementary and Alternative Medicine, better known by its 
abbrevation NCCAM? As I’ve pointed out before, I used to be somewhat of a
supporter of NCCAM. I really did, back when I was more naïve and idealistic.
Indeed, as I mentioned before, when I first read Wally Sampson’s article Why
NCCAM should be defunded, I thought it a bit too strident and even rather
close-minded. At the time, I thought that the best way to separate the wheat
from the chaff was to apply the scientific method to the various “CAM”
modalities and let the chips fall where they may.

Two developments over the last several years have led me to sour on NCCAM and
move towards an opinion more like Dr. Sampson’s. First, after its doubling from 
FY 1998-2003, the NIH budget stopped growing. In fact, adjusting for inflation, 
the NIH budget is now contracting. NCCAM’s yearly budget remains in the range of
$121 million a year, for well over $1 billion spent since its inception as the 
Office of Alternative Medicine in 1993. Its yearly budget contains enough money 
to fund around 75 to 100 new five year R01 grants, give or take. In tight
budgetary times my view is that it is a grossly irresponsible use of taxpayer
money not to prioritize funding for projects that have hypotheses behind them
that have a reasonable chance of being true. Scarce NIH funds should not be for 
projects that have as their basis hypotheses that are outlandishly implausible
from a scientific standpoint. Second, I’ve seen over the last few years how
NCCAM is not only funding research (most of which is of the sort that wouldn’t
stand a chance in a study section from other Institutes or Centers)) but it’s
funding training programs. Indeed, that was the core complaint against NCCAM:
that it facilitates and promotes the infiltration of nonscience- and
nonevidence-based treatments falling under the rubric of so-called
“complementary and alternative” or “integrative” medicine into academic
medicine. However, NCCAM cannot do otherwise, given its mission:

  1. Explore complementary and alternative healing practices in the context of
    rigorous science.

  2. Train complementary and alternative medicine researchers.

  3. Disseminate authoritative information to the public and professionals.

If, in fact, NCCAM actually did devote itself solely to “rigorous science” with 
regard to “alternative” healing practices, I would have much less problem with
it than I do. However, it broadly interprets the second and third parts of its
mission. For example, it views part of its mission as promotion, rather than
study: “Supporting integration of proven CAM therapies. Our research helps the
public and health professionals understand which CAM therapies have been proven 
to be safe and effective.” This would be all well and good if NCCAM had as yet
actually proven any CAM therapies to be at least effective, but it has not.
Worse, it has not even managed to demonstrate any of them to be ineffective,
either, thus leading to endless studies of modalities that either do not work or
at the very least would have marginal efficacy.

Still, I thought; All questions of promotion of CAM modalities aside, least
there’s the science. Surely, under the auspices of the NIH, NCCAM must be
funding some high-quality studies into CAM modalities that couldn’t be done any 
other way. That thought died when NCCAM announced last week the studies that it 
had funded during FY 2007.

Before I discuss the studies, it’s useful to explain briefly for the benefit of 
those not familiar with NIH grant mechanisms (in other words, the vast majority 
of our readers) just exactly what the alphabet-number soup describing the types 
of NIH grants means:

  1. R01. The gold standard of NIH research awards, this mechanism describes
    investigator-initiated multiyear grants (usually four or five years) to
    study whatever the investigator wants to study, provided that he or she can 
    convince a study section of the worth of the project and that the project is
    related to the program interests of one of the NIH Institutes. As such,
    they generally require a fairly large amount of preliminary data and a
    well-defined research plan to study a clear and scientifically reasonable
    and interesting hypothesis.

  2. R21. These grants are usually one or two year exploratory rewards designed to 
    investigate more risky hypotheses. As such, they require much less, if any, 
    preliminary data.

  3. P01 and P50. P-series awards are known and program project grants and are
    intended to fund large, multi-investigator projects (P01), often
    encompassing more than one institution, or research centers (P50).

  4. K-awards. These awards are intended to fund the development of junior faculty 
    and are also known as career development awards. The idea is that these
    awards, which require a mentor to support and guide the applicant, are
    supposed to be a bridge to independent funding.

  5. Small Business Research Awards (R41, R42, R43, R44). These are granted to
    small businesses to fund the development of (usually) biotech and related
    projects.

  6. T32. T32 and related grants fund training and fellowship programs. For
    example, my surgical oncology fellowship was funded by a T32 award, and our 
    cancer institute has a T32 to fund medical oncology fellows who want to
    spend two years in the lab.

These by no means encompass all of the funding mechanisms of the NIH, but they
are the most common and ubiquitous across Centers and Institutes. Now, let’s
look at the breakdown for NCCAM:

It should also be noted that the NIH funds its grants by the fiscal year.
Consequently, a five year grant is, in reality, made up of five one-year awards.
The difference is that investigators do not have to compete for the renewal of 
their grants during the years encompassed by them. Rather, they simply have to
submit progress reports, and, if reasonable progress is being made, the NIH will
usually rubberstamp the renewal of the grants. These are called “noncompetitive
renewals,” appropriately enough. The suffixes (-01, -02, -03, etc.) tell us
which year of the grant is represented. At the end of the grant period, for R01 
and other mechanism, (but not, for example, R21 grants, which are meant to be
followed up by other mechanisms), the investigator can either submit a
competitive renewal for a continuation of the grant or let the grant lapse.

We see from the above chart that NCCAM funded two new and nine ongoing P01
grants and 14 new and 47 ongoing R01 grants, but a more illuminating analysis
comes when we look at the breakdown of general topics being covered in the P01, 
R01, R21, and training grants. I’m going to take the liberty of concentrating on
studies of herbal remedies or dietary supplements or manipulations (mainly
because these are the grants that could easily be funded by one of several other
NIH Institutes), other modalities that are considered “alternative” for unclear
reasons (such as studies of various light therapies on different diseases),
studies of CAM usage (many of which seem designed to promote CAM usage), true
“alternative therapies” (homeopathy, chiropractice, etc.), and then funding for 
training programs. A caveat is that not everyone will agree with which studies I
chose for each group, but the relative numbers are such that minor quibbles on 
a few studies will not change the overall trend. Finally, I’m going to
concentrate mainly on the R01, P01, and training mechanisms:

What we can see from this is that by far the largest category of NCCAM grants
for research not related to small businesses is a topic that could just as
easily be funded by numerous other Institutes or Centers within the NIH: the
study of herbal remedies, which, when you come right down to it is nothing more 
than the study natural products, and studies of dietary manipulations to treat
disease and improve health. If you peruse the list, you’ll see numerous studies 
of chromium supplementation, gingko bilova, saw palmetto, various dietary
manipulations, and similar studies. Since when did the study of natural products
and diet become “alternative”? There is no good reason why these sorts of
proposals need a special “CAM” Center to fund them or why they could not be
evaluated by the appropriate study sections in the appropriate disease-specific 
Institute of the NIH.

Then there are a number of other studies (you may disagree with me about the
specific studies chosen) that examine physical treatments that are considered
“alternative” for unclear reasons, studies such as near infrared therapy or the 
effects of blue light on alertness. There’s no reason why such these studies
need to be under the rubric of “alternative” or “complementary” medicine,
either. These are the same sorts of studies that “conventional” physicians have 
been doing for decades. Indeed, when it comes to natural products and herbal
remedies, I suspect some pharmacologists, dieticians, and medicinal chemists
probably look at NCCAM as easy money (or, in this disastrously tight NIH funding
environment, at least less torture to get) if they just slap together a project
to study the most popular herb du jour. Finally, there are the 28 grants
funding either fellowships or large collaborative CAM centers or projects and 13
funding studies that either examine CAM usage or seem custom-made to promote
CAM usage, such as this study of the effect of increased coverage of CAM
therapies by insurance companies.

That just leaves approximately 61 P01- , R01, or R21-level grants that seem to
look at therapies that might truly be called “CAM” (at least by NCCAM’s
definition). These are, not surprisingly, weighted towards acupuncture or
accupressure (17 grants), mind-body interactions (15, with a huge emphasis on
“mindfulness,” a distinctly religious concept), and then assorted miscellaneous 
CAM therapies that constitute a grab-bag of mostly unrelated modalities. There
are also some rather disturbing grants here, a few of which look as though they 
couldn’t get through an Institutional Review Board (IRB) review. For example,
there is actually a grant to fund the study of acupuncture for acute spinal cord
injury. I wish I were joking. It even pulls the usual acupuncture trick of
including electrical stimulation (which, by the way, is not acupuncture, but
rather transcutaneous electric nerve stimulation, a decidedly conventional
therapy that has been well-studied to treat chronic pain) as part of it.

Worst of all, there are two grants to study arguably the most scientifically
implausible of all CAM modalities, homeopathy. For instance, there is an R21
grant funding a study called Polysomnography in Homeopathic Remedy Effects. Yes,
you have it right. Your tax dollars are going to fund at least a study this
year on homeopathic remedies (a.k.a. water). But it’s even worse than that.
There was actually awarded an R21 grant to study homeopathic dilution and
succussion and how they affect the dose-response curve of homepathic remedies.
This latter grant actually proposes to study whether succussion (the vigorous
shaking done with each homeopathic dilution) that, claim homeopaths, is
necessary to “potentize” their remedies affects the dose-response
characteristics of homeopathic remedies up to 30C dilution (30 times 100-fold,
or a dilution factor of 1 x 10-60). This is a dilution factor many orders of
magnitude larger than Avagaddro’s number, which is makes a 30C homeopathic
remedy nothing but water. Period. In fact, the investigators are actually going 
to compare stirring with succussion to see whether succussion, as homepaths
claim, improves the dose-response curve. It beggars the imagination that such a 
project was actually seriously considered and then scored highly by a study
section. There can also be found grants studying seriously dubious modalities
such as craniosacral therapy, prolotherapy, and even qi gong for treating
cocaine addicition. Truly, it’s like studying whether eye of newt or pixie dust 
is more efficacious in curing cancer!

Here’s another thing to consider: An NIH-funded grant is the pinnacle of
external funding mechanisms to universities, largely because the government
gives the universities additional “indirect costs” of around 50 cents on the
dollar to administer the grants and maintain their infrastructure. In the eyes
of universities (and probably the public) it doesn’t matter whether that grant
came from NCCAM, the NCI, NHLBI, NIAA, NIDDK, or whatever. Universities will be 
just as happy if investigators get grants from NCCAM as from any other agency
within the NIH. More insidious still are the grants to fund fellowship and
training programs. It’s easy enough to laugh at grants being offered to study
whether homeopathic succussion does anything other than aerate the solution, but
when I see how much NCCAM is laying out for the promotion of non-evidence-based
medicine through “education” grants, I find it truly disturbing. There are
grants to fund fellowships in CAM at the University of North Carolina Chapel
Hill, the Weill Medical College of Cornell University, the University of
Virginia, Harvard University, the University of Arizona, Oregon Health and
Science University, UCSF, and a naturopathic college (Bastyr University). Most
of these centers are not there to look at CAM from a truly scientific or
skeptical viewpoint. Most are run by believers, and their NIH-funded existence
lends a patina of undeserved scientific credibility to the enterprises,
particularly since most of them are housed in academic medical centers.

As two of my co-bloggers Wally Sampson and Kimball Atwood IV have pointed out,
NCCAM was created not because of any groundswell of support from the scientific 
community. Rather, it was CAM-friendly legislators who foisted it upon the NIH
and made sure that its budget skyrocketed–at least until the recent flattening
and decline of the NIH budget put the brakes on. It doesn’t seem to matter if a 
bona fide scientist is placed in charge, either. For example, Dr. Stephen
Strauss was the Director of NCCAM from 1999 to just last year, and he was a
hardcore scientist who promised to “explore CAM healing practices in the context
of rigorous science, to educate and train CAM researchers and to disseminate
authoritative information about CAM to the public.” Yet that is not what has
happened. Recently, it was announced that Dr. Strauss’ replacement would be
Josephine Briggs, MD, another accomplished researcher with a strong CV making
similar promises. Can she deliver on them?

It’s highly unlikely.

Here’s why. First, she has only minimal control over who is appointed to the two
councils charged with advising the Director on matters related to research
funding and clinical trials, and, in any case, the Council is mandated to be
constituted as follows:

   Of the 18 appointed members, 12 shall be selected from among the leading
   representatives of the health and scientific disciplines (including not less 
   that 2 individuals who are leaders in the fields of public health and the
   behavioral or social sciences) relevant to the activities of the NCCAM,
   particularly representatives of the health and scientific disciplines in the 
   area of complementary and alternative medicine. Nine of the members shall be 
   practitioners licensed in one or more of the major systems with which the
   Center is involved.

In other words, they must be CAM practitioners and “leaders” in the field. It’s 
unlikely that such a group will support rigorous science that might threaten
their livelihood, and indeed they don’t. In fact, its stated mission
notwithstanding, NCCAM was never originally intended as a means of rigorously
investigating CAM therapies but was rather as a government agency to give these 
therapies the patina of credibility and respectability that they can’t earn
through the science. Dr. Strauss may have tried to do what he said he would do
during his tenure, but it clearly just didn’t work. He couldn’t change NCCAM.
Moreover, no matter what he did, he couldn’t win either way. On the one hand, he
was criticized by scientists and physicians who support science- and
evidence-based medicine (like me) for allowing highly dubious studies to be
funded, while on the other hand he was castigated for being too scientifically
rigorous and not being a CAM practitioner because CAM advocates didn’t like his 
emphasis on determining whether their therapies worked or not. The same thing
appears to be true of Dr. Briggs. Indeed, I found an open letter to Dr. Briggs
from a CAM supporter that is most revealing, from which I draw a key excerpt:

   Your predecessor, Stephen Straus, MD, also had no experience in complementary
   and alternative medicine. He told the New York Times during his tenure that 
   he had no plans to experiment. I always thought that an odd waste of human
   imagination. This is not cancer, or renal failure we’re typically talking
   about. These are therapies and approaches which many view as particularly
   valuable for creating health and vitality – often altering the course of
   disease, or a person’s experience of disease, in doing so. Why spend 7 years 
   as an “investigator” and never personally investigate?

   Now, a decade later, the NIH has done it again. Director Zerhouni appointed
   you, despite the fact that you too have no visible professional experience in
   the field that you were selected to lead. Of your 125 publications, none
   appear to touch on the kinds of interventions which will be on your desk at
   your new job.

The writer of this letter, John Weeks, then tries to give Dr. Briggs some
advice, most importantly to “go get yourself some experience of complementary,
alternative and integrative practices.” He then goes on a rant against NCCAM
for, in essence, not being friendly enough to the CAM practices he supports
because it does not spend as much as he would like on “whole systems” and “whole
practice” approaches. Even worse, from his perspective, NCCAM actually is out
of compliance with the mandate that 50% of NACCAM members be licensed in the
specialties studied by NCCAM in that only 25% are so licensed. (Actually, if
true, this was the only heartening information I found during my research). Mr. 
Weeks goes on:

   I spoke with a conventional academic medicine colleague and researcher
   yesterday who is a close NCCAM watcher. He said he was “flabbergasted – not
   in a positive way” by your appointment. His gut feeling was that “the
   appointment makes it very clear that the NIH wants to bury NCCAM.” He
   wondered why you took the job, given your career path. Did you just want to
   be on the NIH director’s Council? Is it, for you, merely a step in dirty
   water, a post in Siberia on a career path which you hope will veer back into 
   other zones more prestigious in your view – a plum position in Moscow? – as
   soon as possible?

   My colleague told me he believes that, with all of the momentum in recent
   years, and the increased interest among employers and consumers, the field of
   integrative medicine is going to keep growing. The question on the table, he
   believes, is “whether NCCAM will provide leadership or become irrelevant.”

What this letter encapsulates to me is the attitude of CAM advocates towards
NCCAM. They don’t want truly rigorous scientific studies to determine if these
therapies work. They want studies that assume that these therapies work and then
simply look at utilization and cost-effectiveness. They want funding of
fellowships in CAM (taught, of course, by true believers). In brief, they want
CAM promotion.

This is why we can only hope that the NIH really is trying to bury NCCAM.
There’s nothing that NCCAM does, other than its advocacy for CAM therapies in
academic medicine, that couldn’t be done as well or much better by other
Institutes and Centers of the NIH appropriate to each question. This is
particularly true for the study of herbal remedies and dietary interventions,
neither of which are “alternative” except when claims are made that diet or
herbs can, for example, cure cancer.  Unfortunately, as protected as it is by
powerful legislators, the best we can hope for is a career scientist like Dr.
Briggs trying to slow NCCAM’s descent into pseudoscience. It can’t last forever,
though. Sooner or later a true believer will be appointed Director at NCCAM.
It’s virtually inevitable. The only thing keeping that from happening, I’d
guess, is that the most prominent CAM practitioners (like Andrew Weil, for
instance) make far too much money to be easily willing to take a huge pay cut to
work for NCCAM. When that day comes, any pretense of rigorous science taking
into account scientific plausibility will fly out the window.

   Utah Senator Orrin Hatch: A pit bull in defense of the supplement industry

                           Published by David Gorski 

                                      Link

The weakness and ineffectiveness of the law in the U.S. regulating dietary
supplements has been a frequent topic here on Science-Based Medicine, including 
the continued failure of efforts to address the serious shortcomings of current 
law and the illogic at its very heart. Indeed, over the last decade or so that
I’ve paid attention to relevant issues regarding supplements continually amazed 
at how much supplement manufacturers can get away with and for how long. For
example, one of the most recent atrocities against science occurred when Boyd
Haley, disgraced chemistry professor at the University of Kentucky and prominent
member of the mercury militia wing of the anti-vaccine movement, tried to sell 
an industrial chelator as a dietary supplement to treat autistic children. True,
that was too much even for the underfunded, undermanned FDA to ignore, but it
was amazing how long he got away with it. Apparently it takes someone trying to 
market a chemical compound that can’t by any stretch of the imagination be
characterized as a “nutrient” or “food” to be so obviously against even the
travesty of a mockery of a sham of a law regulating supplements (the Dietary
Supplement Health and Education Act of 1994, or the DSHEA) that the FDA could
take action.

Of course, here at SBM, we’ve written numerous posts on the shortcomings of the 
DSHEA. Basically, this law created a new class of regulated entities known as
dietary supplements and liberalized the sorts of information that supplement
manufacturers could transmit to the public. The result has been this:

   It [the DSHEA] also expanded the types of products that could be marketed
   as “supplements.” The most logical definition of “dietary supplement” would 
   be something that supplies one or more essential nutrients missing from the
   diet. DSHEA went far beyond this to include vitamins; minerals; herbs or
   other botanicals; amino acids; other dietary substances to supplement the
   diet by increasing dietary intake; and any concentrate, metabolite,
   constituent, extract, or combination of any such ingredients. Although many
   such products (particularly herbs) are marketed for their alleged preventive 
   or therapeutic effects, the 1994 law has made it difficult or impossible for 
   the FDA to regulate them as drugs. Since its passage, even hormones, such as 
   DHEA and melatonin, are being hawked as supplements.

One might wonder how such a bad law could survive for so long (seventeen years
now), but it has its defenders. One man, in particular, defends the DSHEA
against all regulatory threats, foreign and domestic. His name is Senator Orrin 
Hatch (R-UT), and he was just the subject of a writeup in the New York Times
last week referring to him as a “natural ally” of the supplement industry:

   A drive along mountain-lined Interstate 15 here shows why Senator Orrin
   G. Hatch is considered a hero in this region nicknamed the Silicon Valley of 
   the nutritional supplement industry.

   In the town of Lehi is the sprawling headquarters of Xango, where company
   officials praised Mr. Hatch, a Utah Republican, late last year for helping
   their exotic fruit juice business “operate without excessive intrusion” from 
   Washington.

   Up in Sandy, Utah, is 4 Life Research, whose top executives donated to
   Mr. Hatch’s last re-election campaign after federal regulators charged the
   company with making exaggerated claims about pills that it says helps the
   immune system.

   And nearby in West Salem, assembly-line workers at Neways fill thousands 
   of bottles a day for a product line that includes Youthinol, a steroid-based 
   hormone that professional sports leagues pushed to ban until Mr. Hatch
   blocked them.

And, as the article goes on to mention, Hatch was the principal author of the
DSHEA. Fast forward seventeen years, and these days any time the Obama
Administration tries to write rules to regulate supplements more strictly, Orrin
Hatch is there to do his damnedest to block them. Because Hatch is a very
senior (and therefore powerful) Senator, he nearly always succeeds. Indeed, as
the NYT article points out, the relationship between Hatch and Utah’s massive
supplement industry been a hugely mutually beneficial one, and the article also 
describes just how incestuous it has been as well. First of all, there’s an
enormous amount of campaign contributions that Hatch garners every election
cycle from supplement manufacturers, but the relationship goes so much more
deeply than that:

   His [Hatch's] family and friends have benefited, too, from links to the
   supplement industry. His son Scott Hatch, is a longtime industry lobbyist in 
   Washington, as are at least five of the senator’s former aides. Mr. Hatch’s
   grandson and son-in-law increase revenue at their chiropractic clinic near
   here by selling herbal and nutritional treatments, including $35 “thyroid
   dysfunction” injections and a weight-loss product, “Slim and Sassy Metabolic 
   Blend.” And Mr. Hatch’s former law partner owns Pharmics, a small nutritional
   supplement company in Salt Lake City.

   But many public health experts argue that in his advocacy, Mr. Hatch has 
   hindered regulators from preventing dangerous products from being put on the 
   market, including supplements that are illegally spiked with steroids or
   other unapproved drugs. They also say he is the person in Washington most
   responsible for the proliferation of products that make exaggerated claims
   about health benefits.

Many are the times that I’ve complained about a different Senator, namely
Senator Tom Harkin (D-IA) for his advocacy of pseudoscience that led hm to foist
the atrocity that is the National Center for Complementary and Alternative
Medicine (NCCAM) upon an unsuspecting nation. However, as bad as Tom Harkin is, 
he is nonetheless also widely appreciated as a staunch advocate of the National 
Institutes of Health and other funding for legitimate medical research. This has
been true for decades, and he has been honored as such more than once. The
problem is that, along with all that advocacy for the NIH, Harkin has a very
hard time distinguishing worthwhile medical research from quackery. Even so,
arguably he has supported enough good medical research that his unwavering
support of NCCAM can almost be forgiven. Almost. Hatch, on the other hand, has
no such redeeming quality to counterbalance his support for quackery and his
defense of supplement manufacturers against any government law or regulation, no
matter how reasonable, that might jeopardize their profits. Not surprisingly,
he denies that this is true in the NYT article. He even has the gall to claim
that he’s been a champion of regulating supplements, a claim that is so risible 
that it’s hard to believe he could make it with a straight face. I guess that’s 
why he’s a politician.

I am gratified, though, that the NYT didn’t forget to point out that there’s a
new Republican quackery supporter in town, and he’s out to unseat Hatch by–you
guessed it–sucking up to the supplement industry even more than Hatch does. His 
name is Jason Chaffetz, and he’s a former supplement company executive turned
U.S. Representative and co-chair of the Dietary Supplement Caucus. (Yes, there
really is such a thing.) I wrote about him not too long ago because of his
support for what I then termed the “wonderfully Orwellian” Free Speech About
Science Act of 2011 (FSAS). Boiled down to its essence, the FSAS would weaken
even more the already desperately weak DSHEA. Basically, under the auspices of
allowing “more free speech about food,” it would neuter the FDA with respect to 
claims about supplements, and it would do it through a very clever turnabout
regarding the use of peer-reviewed research in that it places the burden of
proof on the FDA to demonstrate that scientific studies used to bolster health
claims for food and supplements are not good research. One can see the obvious
problem with that. Supplement manufacturers could claim anything they wanted, as
long as they could pull out a scientific paper or two, and it would be up to
the FDA to have to refute them. Like the case for quacks, it wouldn’t be too
difficult for supplement manufacturers to produce a constant stream of dubious
research to point to, allowing the to make almost any claims they want to with
impunity.

Fortunately, that law appears not to be going anywhere right now, and I hope it 
doesn’t. However, it was only a year ago that Hatch demonstrated why he is the
master when it comes to protecting his supplement industry backers. That was
when John McCain tried to pass legislation to tighten the regulation of
supplements, Orrin Hatch and the supplement industry slapped him down in no
uncertain terms. Basically, McCain ended up groveling before Orrin Hatch seeking
absolution for his sins against the free market. The story is actually
mentioned in the NYT article, as is Hatch’s attempts to intimidate the Obama
Administration’s nominee for commissioner of the FDA, Dr. Margaret A. Hamburg.

So long standing and blatant has Hatch’s advocacy been that ten years ago
Stephanie Mencimer wrote a devastating article for The Washington Monthly
entitled Scorin’ with Orrin, an accurate description of Hatch’s activities then 
and now. To this day, Hatch remains in the pockets of the supplement
manufacturers, and he has served them well, passing the DSHEA, a law that has
been exploited by Utah companies like Xango:

   But Xango’s record illustrates how companies eager to exploit the law can
   go too far.

   In 2006, federal regulators warned Xango that brochures improperly
   promoted mangosteen juice as a disease cure, not just a healthy option. Xango
   is among more than a dozen Utah companies cited by federal regulators over
   the last decade for apparent violations of the law.

   Xango, whose executives are the single biggest Utah-based contributors to
   Mr. Hatch’s political campaigns and have drawn Mr. Hatch to its headquarters
   to down shot glasses of their juice, blamed a marketing company that had
   printed the brochures. The company also insisted that it was closely
   monitoring distributors to make sure they did not make inappropriate claims.

   But in his talk at Xango in March, Dr. Johnson — who lectures across the 
   country at other company events — used some of the same language the F.D.A.
   had cited in its 2006 warning letter, and he referred the sales agents to a
   nearby company that still sold brochures making the improper claims.

Amusingly, this NYT article also includes a truly mind-numbingly idiotic
statement justifying the activities of certain supplement companies from Dr.
Johnson, so much so that even our very own Steve Novella labeled it the “Dumb
Statement of the Week.” I think it has a real shot of winning far more than
that:

   One night in March, Dr. Vaughn T. Johnson, a Xango distributor, delivered
   part pep talk, part medical seminar, in describing extraordinary powers
   attributed to mangosteen. Studies showed, Dr. Johnson said, it was
   “anti-tumor,” “anti-obesity,” “anti-aging,” “anti-fatigue,” “antiviral,”
   “antibiotic” and “antidepressant.”

   “How do I know this isn’t just snake oil?” Dr. Johnson, an osteopathic
   physician, asked. “It’s a really simple answer. A company that is selling
   snake oil is not going to stay in business for almost 11 years and grow as
   fast as this company is growing.”

In other words, because his supplements sell well, they must work. Anyone
familiar with evidence- and science-based medicine knows that this is utter
nonsense on steroids (which adulterate quite a few supplements, by the way).
Placebo effects, confirmation bias, expectancy effects, and a number of other
nontherapeutic effects can lead to the success of a product. Before the FDA
existed, there were countless useless patent medicine products sold in this
country that were quite popular. Heck, homeopathy is still popular in some parts
of the world, and it’s just water!

It is with great irony that, having read this NYT article, I note how advocates 
of unscientific modalities frequently love to bash big pharma and insinuate that
legislators are in the pocket of the drug companies. While it is true that
pharmaceutical companies are heavy contributors to a number of legislators and
wield considerable influence, pro-CAM apologists frequently contrast what they
paint as big, soulless, corporations with local, mom & pop “natural medicine”
businesses that big pharma is supposedly trying to crush, all in a nefarious
plot to protect its obscene profits. However, as Orrin Hatch demonstrates, in
the wake of the DSHEA of 1994, in the U.S. supplement manufacturers have
themselves become quite a force to be reckoned with themselves. In states like
Utah, supplement manufacturers can become far more powerful than pharmaceutical 
companies. One reason is that there isn’t much in the way of a pharma presence, 
big or otherwise, in Utah. There are, however, lots and lots of supplement
manufacturers pushing all manner of poorly supported health claims to sell their
products. Because these supplement manufacturers are very profitable and have a
lot of money to throw around, it’s not surprising that they now also have a
very powerful patron, too, in Orrin Hatch. As long as Hatch is in office, you
can be quite sure that the DSHEA will stand, and, if Hatch has his way, sooner
or later its remaining tooth will be pulled.

The question then becomes: What will happen after Hatch retires? He is, after
all, in his late 70s. Clearly, it’s likely (although not a lock) that Jason
Chaffetz will succeed him. If that happens, he will be even more in the pocket
of the supplement manufacturers than Hatch has been over the years. Chaffetz
will, of course, not have the seniority and long years of having built up
political power and capital that Hatch has right now; so at first he is unlikely
to be nearly as effective a protector of the supplement industry as Hatch has
been. Still, that might offer a window of opportunity. The only time supporters 
of more science-based regulations of supplements will have a chance to do away
with the DSHEA will be in the immediate wake of Hatch’s retirement or death,
before his successor can accumulate clout.

Even at that time, I’m not optimistic that the DSHEA will ever be repealed.

NCCAM Criticism from a Not-Quite-Opponent

David Kroll on December 23, 2011

Link

The demographic of SBM readers are likely to remember the early Miller Lite beer
television commercials where sports personalities debated as to whether the
beverage “tastes great” or was “less filling.” In one classic version, New York 
Mets’ Marv Throneberry breaks the shouting match to level his decision: “I feel 
strongly both ways.”

My colleagues at Science-Based Medicine have generally been opposed completely
to the existence of the NIH’s National Center for Complementary and Alternative 
Medicine (NCCAM). The primary objection is that the Center awards roughly $125
million per year in taxpayer dollars to studies that are generally not based on 
a strong scientific foundation or, in some cases, absolutely no scientific
basis. On the other hand, the best NCCAM-supported studies have provided
fruitful results, if not negative with regard to clinical outcomes.

The recent series of articles by Trine Tsouderos at the Chicago Tribune (1, 2,
3, 4) has reignited a national debate as to whether NCCAM is needed at all.
After all, NCCAM was not because of science but because of politics,
particularly the efforts of Senator Tom Harkin and Representative Dan Burton.
And other NIH institutes, such as the National Cancer Institute, seem to do a
much more rigorous and science-based job of funding studies of alternative
cancer therapies through their unfortunately-named Office of Cancer
Complementary and Alternative Medicine, or OCCAM.

In fact, I have long argued that if alternative therapies are to be investigated
rigorously, they should be done so under each of the specific NIH institutes
and centers (ICs) that have been established to focus on organ systems (National
Institute of Diabetes and Digestive and Kidney Diseases; NIDDK) or a class of
related disorders (National Institute on Drug Abuse; NIDA).

As it stands now – and take away any objections to the poor scientific
foundation of some of the modalities studied – NCCAM is like having a NIH IC
assigned to study experimental medicine: all possible modalities against all
possible diseases. Even if approaches tested were based on some scientific
validity, you’ve got a relatively poorly-funded IC here that is charged with
reviewing grants across a huge swath of medicine, basic and clinical.

Co-opting classical pharmacognosy as alternative medicine

Many pixels have been spent here and at other blogs, as well as Trine Tsouderos’
articles, on the least plausible of so-called complementary and alternative
medicine. As egregious as that work is, I’m more concerned about the most
legitimate, fact-based science that is often considered as “alternative
medicine.”

A common tactic of alternative medicine practitioners is to take some approaches
of medical validity – such as nutrition, exercise, stress reduction – and
combine them with utter nonsense, such as energy healing, to provide some
legitimacy to a package that includes some outright deceptive and unethical
approaches.

When NCCAM was established, many investigators in the natural products field
were encouraged that some of the hardcore chemistry and biology of herbal
medicines and other natural medicinal sources would have a home for focused
funding. What many of us learned was that NCCAM’s charge was to investigate
traditional botanical products as they are used by the public and not to study
the individual components.

Around 2000, I wrote a NCCAM grant proposal while at the University of Colorado 
to study the potential of a component of St. John’s wort in potentially
antagonizing the chemotherapeutic effectiveness of drugs such as etoposide
(VePesid) and doxorubicin (Adriamycin). The basis for this work was eventually
published in Biochemical Pharmacology in 2001 from my cobbling together other
funds.

I sought to investigate whether complex St. John’s wort extracts would have a
similar effect. Moreover, I hypothesized that different St. John’s wort products
would vary in their drug interaction liability based on the content of the
products since they are produced in different parts of the world by a spectrum
of chemical extraction procedures.

I discussed some of the following story here at SBM in 2009. My initial attempt 
at getting funding for this new idea returned a priority score of 228. In the
old form of NIH grant review scoring, the range was 100 to 500 where, as in
golf, the lower score was better. A major criticism was that I as a
pharmacologist lacked the chemical expertise to truly interrogate complex
botanical extracts.

Fortunately, I was spending the 2000 calendar year doing a sabbatical at Duke
University and was fortunate to meet the legendary co-discoverers of taxol and
camptothecin, Drs. Monroe Wall and Mansukh Wani, at the nearby Research Triangle
Institute. Who better to enlist as collaborators than the team that isolated
and solved the structure of these two important drugs using the technology
available in the 1960s and early 1970s. (Taxol itself became a prescription drug
and has been followed by Taxotere/docetaxel; camptothecin never became a drug
itself by gave rise to the semisynthetic FDA-approved drugs Camptosar/irinotecan
and Hycamtin/topotecan).

When we resubmitted the grant application, my score became worse: 345. Yes,
enlisting true scientific legends to help a little old pharmacologist
investigate herbs was viewed as “taking too much of a drug development
approach.” I shook my head in disbelief. What had I done wrong? Who better than 
the RTI group to provide me with chemistry support?

Dr. Wall was livid, to say the least. Without consulting me first – totally fine
with me, though – he directly phoned the then-NCCAM director, the late Dr.
Stephen Straus. Wall relates that Straus was taken aback by someone other than
the application’s principal investigator calling to protest a grant score. Not a
wise response. He was Monroe [expletive]ing Wall. Exasperated, he warned me and
my colleagues not to waste any more time submitting grant applications to
“those crazies.”

Of course, I wouldn’t take no for any answer and continued to craft and
fine-tune my proposals. I ultimately joined RTI as an investigator and my
colleagues and I submitted 13 proposal versions with not a single one being
funded. Dr. Wall passed away in the summer of 2002, exasperated that we were
still trying. (I ultimately got the project funded by NCI’s OCCAM but the St.
John’s wort extracts did not appear to pose the same problems as the isolated
pure compounds.)

These experiences led many of us to question to quality of natural products
expertise at NCCAM and in their selection of review panels. For that reason, I
offered my services as a grant reviewer almost any time NCCAM called to ask (I
had to turn down a recent request because of other review conflicts). My feeling
was that I’d rather be part of the solution than shrug off NCCAM as a problem. 
And, in fact, I’ve learned that NCCAM has recently hired a superb natural
products chemist as an internal advisor. Perhaps, as noted in one of Trine’s
articles, the NCCAM of today is different from the NCCAM of yesteryear.

But pharmacognosy – the study of natural products – is *not* alternative
medicine. It is, in fact, the basis for at least 25% of our prescription drugs
and up to 60% of some classes of over-the-counter drugs. (And thank you, Dr.
Gorski, for repeatedly being a defender and supporter of pharmacognosy as a
non-alternative science!).

Premature clinical trials

What worries me more is how pharmacognosy is approached by NCCAM and how
damaging their supported studies can be in leading us to dismiss potentially
useful botanical medicines. In attempting to show political supporters the
benefits of alternative medicines, NCCAM seems to spend a disproportionate share
of their appropriation on expensive clinical trials. My concern has been that
clinical trials are warranted when sufficient basic science has been conducted. 
However, the rush to clinical trials has instead led to multiple clinical trials
failures.

The latest example, cited in the Tsouderos articles, was a trial of saw palmetto
berry extract for relief of urinary difficulties associated with benign
prostatic hypertrophy in men. Published this year in JAMA, the trial revealed
that urinary symptoms improved in both the placebo and saw palmetto groups.
However, the study was missing one important component: even though increasing
doses of saw palmetto extract was used, no one measured blood concentrations of 
the purported active constituents. Perhaps saw palmetto didn’t “work” better
than placebo because the doses used did not contain a high enough concentration 
of the active compound(s). The supplementary materials for the paper very nicely
showed the chemical composition of the extract used but we have no idea if
enough of those compounds made it into the blood circulation of the study
participants.

Contrast this to pharmaceutical clinical trials. The entire purpose of Phase I
drug trials is to examine dosing relative to blood levels of parent drug and
metabolites as well as getting a feel for potential adverse reactions. No one in
their right mind would attempt – or waste money doing – an expensive,
randomized, placebo-controlled drug efficacy trial without first making sure
that the drug was being dosed at levels consistent with effects observed in
preclinical models (enzyme assays, tissue or organ pharmacology, animal studies,
etc.).

Why should we care if saw palmetto wasn’t more effective than placebo in this
study? Well, for one, men with BPH might still have an option to prescription
drugs if saw palmetto was dosed at a pharmacologically-relevant level. As I
approach BPH age, this concern is not irrelevant.

In addition, saw palmetto berries are a cash crop in central Florida, as
detailed in this article from investigators at the University of Florida’s
Institute of Food and Agricultural Sciences. I’m not sure how negative clinical 
trials in JAMA might influence crop prices and consumer demand but I’d predict
that a trial with a strong positive outcome would be beneficial to Florida
farmers.

NCCAM could have great value

I still remain optimistic that NCCAM could be of value to researchers interested
in science-based investigations of treatment modalities that are not currently 
accepted as standard medical practice. While specific ICs could probably do a
better job with specific offices – using the OCCAM model at NCI – I believe that
NCCAM has accumulated enough political momentum to remain a distinct entity.
So, just as I am still willing to review grants for NCCAM, I want it to support 
the highest quality of science as long as it exists. This means supporting
investigators who have strong preliminary data for their approach, that the
approach is based in scientific fact that does not violate the basic tenets of
chemistry and physics, moderating the rush to support clinical trials until the 
necessary basic science and human pharmacokinetics are completed (for botanical 
therapies), and being more open to the kinds of scientific criticism brought
forth by journalists like Trine Tsouderos and my co-contributors here at SBM and
elsewhere.

My Christmas wish is that we stop wasting money on nonsense.

A personal aside: I’ll be changing my academic affiliation on January 3rd to
join the North Carolina State Museum of Natural Sciences as a science
communications director in their new Nature Research Center (scheduled for a
April 2012 opening). I’ve written more details about this move and a perspective
on my research career at my main blog, Terra Sigillata. While I’ll no longer be
principal investigator of my own laboratory, I still plan to have a presence in
the NRC’s Laboratory of Microbiology and Genomics and conduct citizen science
projects on secondary metabolites from microorganisms as potential therapeutics.
But the bulk of my work there will actually be even more aligned with the
mission of SBM: we’ll be showing the public how research is done rather than
just giving facts – “how do we know.” In demonstrating the scientific method and
getting people involved in local scientific projects, we hope to improve the
level of critical thinking among the general citizenry to make better choices
for themselves. I hope you’ll see my expanded professional mission represented
in my SBM writings during 2012.

The NCCIH embraces the quackery that is “functional medicine”

David Gorski on September 30, 2024

Link

[Editor note: Regular readers might—or might not have—noticed last Monday that, 
for the first time in more years than I can remember, I failed to post anything 
and didn’t even repost something from the archives or announce my absence. The
explanation is unfortunately all too simple. The Sunday before, I spent
something like 13 hours in the hall of at the emergency room of a local hospital
with my father, who had called me early Sunday morning. (Fortunately, he’s OK
now, but was admitted for a couple of days.) The exact nature of the medical
problem that precipitated this ER visit is not something I’m going to discuss
publicly other than to note that our ER sojourn made it impossible for me to
complete a post by Monday and that, unfortunately, no one could fill in at the
last moment, not even Dr. Howard. In any case, I’m back. To get back into the
groove, I thought I’d discuss something that’s been sitting in my fodder folder 
since June about NCCIH, because, well, you’ll see. Hint: It involves functional 
medicine.]

On this blog, we have been very critical of the National Center for
Complementary and Integrative Health (NCCIH), which until several ago had gone
under the name the National Center for Complementary and Alternative Medicine
(which produced the easier-to-remember NCCAM). It was a rebranding that began a 
decade ago, when NCCAM director Dr. Josephine Briggs proposed renaming NCCAM
(mainly because, wanting to be—or at least seem to be—all about the science, she
didn’t like the word “alternative” in the name) and asked the public for
suggestions. Unsurprisingly, I likened it to “polishing a turd.” A few months
later, NCCAM was rebranded as NCCIH, the better to “integrate” quackery into
health. A few years later, Dr. Briggs retired, to be replaced by a true believer
in acupuncture, Dr. Helene Langevin. Thus ended a ten year stint in which NCCAM
tried to pivot to be more scientific, mainly by trying to rebrand lifestyle
medicine such as diet and exercise as “alternative” or “integrative” and some
fairly meaningless outreach to critics such as Dr. Steve Novella, Dr. Kimball
Atwood IV, and myself. (Unfortunately, she also met with homeopaths.) From what 
I can see, with Dr. Langevin’s ascension, NCCIH started to revert back to its
old ways, “integrating” more pseudoscience into medicine.

Before I tell you what I mean, let’s go back to when I discussed how longtime
antivax activist Robert F. Kennedy, Jr. had suspended his presidential campaign 
in order to endorse Donald Trump for President. The two of them cooked up a
health-related slogan that, if you know anything about RFK Jr. or Trump, will
make you laugh: “Make America healthy again,” or MAHA. When I discussed it in
detail three weeks ago, I noted that RFK Jr. had assiduously left out any
mention of his signature health-related issue for the last two decades, namely
fear mongering about vaccines as a supposed cause of autism and chronic disease 
in children and adults, to focus on a plan whose points ranged from the
defensible (curtailing undue regulatory capture of regulatory agencies by big
pharmaceutical companies) to the usual bonkers claims that today’s children
represent the “sickest generation” to proposals like:

Devote half of research budgets from the NIH toward preventive, alternative and 
holistic approaches to health. In the current system, researchers don’t have
enough incentive to study generic drugs and root-cause therapies that look at
things like diet.

In other words, give NCCIH half of the NIH budget, as opposed to its 2024
appropriation of $174 million (compared to the overall 2024 NIH budget of $48.8 
billion). Unless Congress were to double the NIH budget, that would mean massive
cuts in all the science-based programs run by the NIH to accommodate the shift 
towards studying quackery.

Another of RFK Jr.’s proposals involved functional medicine:

Require nutrition classes and functional medicine in federally funded medical
schools. Today, 7 out of 10 of the leading killers of Americans are chronic
diseases that are preventable, sometimes through improved eating habits. Yet
about 80% of medical schools don’t require a course in nutrition.

As I noted at the time, RFK Jr. yoked a relatively unobjectionable idea
(depending on the specifics, of course) that increasing the teaching of
nutrition in medical schools might be desirable to the pure quackery that is
functional medicine, or, as I like to call it, reams of useless tests in one
hand and a huge invoice in the other. I also noted that his complaint that there
isn’t a specific class on nutrition in many medical schools was a bit
deceptive. There are a lot of topics that we cover in medical school for which
there is no specific class but instead the topic is covered in multiple classes,
with a lot of time dedicated to it in different classes in different contexts. 
I also note that the late Dr. Harriet Hall once wrote about how in 2014 the
American Academy of Family Physicians (AAFP) placed a moratorium on continuing
medical education (CME) credit for all programs related to Functional Medicine
(FM) through 2018 because of “a lack of accompanying evidence existed to support
the practice of Functional Medicine . . . [and the AAFP] identified some
treatments as harmful and dangerous.” Unfortunately (and, sadly, predictably)
the AAFP reversed itself in 2018, although it did decide to determine what
functional medicine courses could be eligible depending on the specific topics, 
part of its general drift towards more tolerance of “integrative medicine”
quackery. Amusingly, but unfortunately ineffectively, pathologists at The
Cleveland Clinic, one of the most egregious quackademic supporters of functional
medicine, called out the “specialty” for worthless genetic testing and
prescribing of supplements.

All of this brings me to note that the NIH is already cozying up with functional
medicine quacks, as I discovered three months ago in a post by NCCIH Director
Dr. Langevin entitled New Coalition Is Another Stepping Stone Toward Whole
Person Health. Let’s take a look.

NCCIH Coalition for Whole Person Health: Run by a functional medicine quack

In June, Dr. Langevin announced a new NCCIH initiative that she sounded quite
proud of:

I am proud of the progress that the National Center for Complementary and
Integrative Health (NCCIH) has made, taking distinct steps toward supporting the
health of the whole person. Not only did we prioritize whole person health
within NCCIH by incorporating it into our strategic plan, but we have also taken
the lead in engaging colleagues within the National Institutes of Health (NIH) 
and stakeholders outside of NIH to encourage a wider conversation on integrating
a whole person approach into research. Additionally, we defined a framework for
discussion and fostered the necessary work to develop research methods that
support increasingly complex studies on whole person health.

Now, I am excited to announce a new endeavor that will help to engage patients, 
health care professionals, and researchers, called the NCCIH Coalition for Whole
Person Health (the Coalition). This independent coalition of nonprofit
organizations will allow interested stakeholders to coalesce under a common
umbrella to discuss challenges and opportunities in the research field related
to delivering whole person care to individuals. The Coalition will represent
perspectives of patients, communities, and professionals about the importance of
whole person research, interprofessional collaboration, and keeping people and 
patients at the center of the conversation.

NCCIH will interact with the Coalition through events such as scientific
meetings, retreats, roundtable discussions, webinars, and listening sessions,
including an inaugural meeting this fall. Interactions with the Coalition’s
volunteer representatives will foster information sharing, bring valuable
external perspectives to NCCIH’s work, and, conversely, ensure that stakeholders
are aware of and can amplify NCCIH’s research. This two-way flow of information
and forum for collaboration will help to tackle important challenges related to
the work of advancing research on whole person health, such as building greater
research capacity, fostering interprofessional collaboration, and identifying
the most promising areas of research.

Note the common trope used by proponents of “integrative health” or “integrative
medicine,” namely that conventional science-based medicine is not “holistic”
and does not treat the “whole person.” As I like to say, a good science-based
physician in primary care, internal medicine, family practice, pediatrics, or
any specialty involved in primary care already delivers “whole person care” to
their patients. It’s a false dichotomy that I’ve long complained about, namely
the claim that as a physician you have to embrace quackery in order to provide
“holistic” or “whole person” care, which is utter nonsense. True, far be it from
me to deny that physicians can fall short of this ideal, largely because the
current reimbursement model for medicine tends to make it very difficult for
primary care doctors to earn an income if they don’t see lots and lots of
patients, limiting the time spent with each one. My response to this complaint
is that the solution is to fix the system and reimburse primary care docs enough
to be able to afford to spend more time with each patient, something that the
vast majority of doctors would appreciate, not to outsource “holistic” or “whole
person” care to quacks like naturopaths and functional medicine doctors, most
of whom can charge whatever the market will bear because they are not reimbursed
by health insurance.

For example, in 2021 NCCIH published on its website, Whole Person Health: What
It Is and Why It’s Important:

Whole person health involves looking at the whole person—not just separate
organs or body systems—and considering multiple factors that promote either
health or disease. It means helping and empowering individuals, families,
communities, and populations to improve their health in multiple interconnected 
biological, behavioral, social, and environmental areas. Instead of just
treating a specific disease, whole person health focuses on restoring health,
promoting resilience, and preventing diseases across a lifespan.

See what I mean? Again, a good science-based primary care doctor already does
most of this, and as for the rest (communities, etc.), a good science-based
public health program will help as well.

But let’s get back to one thing: Why do I keep harping on functional medicine?
This is why. Look who will be leading the Coalition:

The Coalition will be led by two experienced professionals who are passionate
about addressing the health challenges that patients face and the role that a
whole person approach can play in meeting the health needs of people. Amy Mack, 
M.S.E.S./M.P.A., is chief executive officer of The Institute for Functional
Medicine, and Samantha Simmons, M.P.H., is chief executive officer of the
Academic Consortium for Integrative Medicine & Health. Together, they will serve
as cochairs of the Coalition and lead a steering committee of eight founding
member organizations.

The Institute for Functional Medicine (IFM)? You might remember that we at SBM
have been writing about the quackery promoted by IFM going back nearly to the
beginning of this blog, when the late great Dr. Wally Sampson first asked just
what the heck “functional medicine” even was, finding copious examples of
quackery and scientific nonsense on the IFM website. I myself once called
“functional medicine” the ultimate misnomer in the world of integrative
medicine, because of how it combines one of the worst features of conventional
science-based medicine (namely overtesting and overtreatment based on that
overcasting) with some of the worst quackery you can imagine, including
naturopathy and even homeopathy. There’s a reason that in another post I
referred to functional medicine as “reams of useless tests in one hand, a huge
invoice in the other,” a play on the famous description of homeopathy by the
comic duo Mitchel & Webb:

When someone comes in with a vague sense of unease or a touch of the nerves or
even just more money than sense, you’ll be there for them, a bottle of basically
just water in one hand, and a huge invoice in the other.

Heck, even though the main topic of this post is functional medicine and not
homeopathy, I can’t resist dropping a video of Mitchell & Webb’s famous
“Homeopathic A&E” sketch into this post before moving on:

Always a classic, and I’ll use any excuse to include this in a post, no matter
how tangential.

As I noted in my post, in my functional medicine version of this sketch, all I’d
change would be the part about a “bottle of basically just water in one hand, a
huge invoice in the other,” for which I’d substitute something like “reams of
useless and impossible-to-interpret lab results with a plan to correct each and 
every one of them in one hand, a huge invoice in the other.” That basically sums
up functional medicine.

But has functional medicine changed, or, more specifically, has IFM changed? Who
knows? Maybe it’s more scientific now, worthy of teaming up with a major NIH
center.

IFM: NCCIH’s new partner in promoting functional medicine and “whole person
medicine”

It’s been several years since I’ve perused the website of The Institute for
Functional Medicine. Perusing the leadership page of IFM, I did indeed find it
odd that the leadership of IFM contains only one MD. The rest of the membership 
consists of a naturopath and an MPH, with the rest being mostly laypeople, led
by Amy R. Mack:

Amy holds a BS degree in Biology and master’s degrees in Public Affairs and
Environmental Science. Amy spent the last 30 years in mission and
service-oriented organizations focused on empowering individuals and community
to drive systems change. As the daughter of a gastroenterologist, Amy
understands the importance of patient engagement in their own health and
witnessed the sacrifices of a physician in the search for good medicine. Today
she pulls from these experiences to lead IFM in its mission of ensuring the
widespread adoption of functional medicine.

But she is a daughter of a gastroenterologist!

Let’s just take a look at the “functional medicine model.” Hopefully longtime
readers will forgive me if this is a bit repetitive of what I’ve written before,
but I do feel the need every so often to reiterate our objections to functional
medicine. Looking over the IFM website, I can’t help but note that a lot of
what used to be public information is now either restricted content on
members-only pages or otherwise unfindable. A lot of it seems to have been
incorporated into a series of courses, some free, most paid. So I will use
Archive.org when needed, for example, to refer to this page What Is Functional
Medicine? Here’ are a couple of excerpts. First, here are its main principles:

   Functional medicine is personalized medicine that deals with primary
   prevention and underlying causes instead of symptoms for serious chronic
   disease. It is a science-based field of health care that is grounded in the
   following principles:

  1. Biochemical individuality describes the importance of individual variations in
    metabolic function that derive from genetic and environmental differences
    among individuals.

  2. Patient-centered medicine emphasizes “patient care” rather than “disease
    care,” following Sir William Osler’s admonition that “It is more important
    to know what patient has the disease than to know what disease the patient
    has.”

  3. Dynamic balance of internal and external factors.

  4. Web-like interconnections of physiological factors – an abundance of research 
    now supports the view that the human body functions as an orchestrated
    network of interconnected systems, rather than individual systems
    functioning autonomously and without effect on each other. For example, we
    now know that immunological dysfunctions can promote cardiovascular disease,
    that dietary imbalances can cause hormonal disturbances, and that
    environmental exposures can precipitate neurologic syndromes such as
    Parkinson’s disease.

  5. Health as a positive vitality – not merely the absence of disease.

  6. Promotion of organ reserve as the means to enhance health span.

In any post about functional medicine, I feel compelled to remind our readers
that the very first principle is, in essence, functional medicine’s “get out of 
jail free” card for basically anything its practitioners want to do. They can
always find ways to justify any form of treatment, be it science-based or
quackery, simply by invoking the “biochemical individuality” of the human being 
they are treating. I also like to remind my readers of my retort to this: Yes,
human beings are individuals, and each human being is unique. However, we’re not
so unique that our bodies don’t all work pretty much the same way. In other
words, in terms of biology, physiology, and yes, systems biology, human beings
are far more alike than they are different. If that weren’t the case, modern
medicine, developed before we had the tools to probe our genetic individuality, 
wouldn’t work as well as it does. FM fetishizes “biochemical individuality,” not
so much because humans are so incredibly different that each one absolutely has
to have a markedly different treatment. We’re not. Functional medicine
fetishizes “individuality” because it distinguishes functional medicine as a
brand from science-based medicine and, I suspect, because it makes its
practitioners feel good, like “total” doctors never at a loss for an explanation
for a patient’s symptoms or clinical condition, and makes patients feel like
special snowflakes whose every bit of “individuality” is being catered to. As
for the last bit about FM being a “science-using” profession, FM “uses” science 
more as a means of justifying whatever its practitioners do rather than guiding 
them to scientifically-proven treatments.

Also, functional medicine is all about the “imbalances”:

   Functional medicine is anchored by an examination of the core clinical
   imbalances that underlie various disease conditions. Those imbalances arise
   as environmental inputs such as diet, nutrients (including air and water),
   exercise, and trauma are processed by one’s body, mind, and spirit through a 
   unique set of genetic predispositions, attitudes, and beliefs. The
   fundamental physiological processes include communication, both outside and
   inside the cell; bioenergetics, or the transformation of food into energy;
   replication, repair, and maintenance of structural integrity, from the
   cellular to the whole body level; elimination of waste; protection and
   defense; and transport and circulation. The core clinical imbalances that
   arise from malfunctions within this complex system include:

  1. Hormonal and neurotransmitter imbalances

  2. Oxidation-reduction imbalances and mitochondropathy

  3. Detoxification and biotransformational imbalances

  4. Immune imbalances

  5. Inflammatory imbalances

  6. Digestive, absorptive, and microbiological imbalances

  7. Structural imbalances from cellular membrane function to the musculoskeletal
    system

   Imbalances such as these are the precursors to the signs and symptoms by
   which we detect and label (diagnose) organ system disease. Improving balance 
   – in the patient’s environmental inputs and in the body’s fundamental
   physiological processes – is the precursor to restoring health and it
   involves much more than treating the symptoms. Functional medicine is
   dedicated to improving the management of complex, chronic disease by
   intervening at multiple levels to address these core clinical imbalances and 
   to restore each patient’s functionality and health. Functional medicine is
   not a unique and separate body of knowledge. It is grounded in scientific
   principles and information widely available in medicine today, combining
   research from various disciplines into highly detailed yet clinically
   relevant models of disease pathogenesis and effective clinical management.

   Functional medicine emphasizes a definable and teachable process of
   integrating multiple knowledge bases within a pragmatic intellectual matrix
   that focuses on functionality at many levels, rather than a single treatment 
   for a single diagnosis. Functional medicine uses the patient’s story as a key
   tool for integrating diagnosis, signs and symptoms, and evidence of clinical
   imbalances into a comprehensive approach to improve both the patient’s
   environmental inputs and his or her physiological function. It is a
   clinician’s discipline, and it directly addresses the need to transform the
   practice of primary care.

No. It is not a clinician’s discipline, and it does not address the “need to
transform the practice of primary care.” Also, does the focus on “imbalances”
remind you of anything? How about “imbalances” in the four humors? Or
“imbalances” in the Five Elements in traditional Chinese medicine. Basically,
functional medicine also fetishizes “balance” in a way that sounds very much
like both ancient Asian and European medicine.

In fairness, here I generally mention that there are some things that functional
medicine (sort of) gets right, although these things tend to be no different
than the sorts of things every primary care doctor should be getting right
anyway, such as emphasizing healthy lifestyles, good nutrition, enough exercise,
adequate sleep, cessation of habits known to be deleterious to health (e.g.,
smoking). Functional medicine also claims to emphasize prevention, which is a
good thing as far as it goes, but again something that good primary care doctors
do anyway. Moreover, the functional version of “prevention” isn’t always in
line with the SBM version of prevention. Where functional medicine doctors go so
very wrong is in what Grant Ritchey once described as a major unstated premise.
That premise is that functional really does address the root causes of disease 
better than conventional medicine. It also also encompasses a lot of quackery,
such as acupuncture, chiropractic adjustments, and especially “detoxification”
programs.

No wonder it’s a perfect partner for NCCIH.

The other perfect partner for NCCIH is the Academic Consortium for Integrative
Medicine and Health, led by the other co-chair of the NCCIH Coalition for Whole 
Person Health, Samantha Simmons, MPH. You’ll recall that the ACIMH is one of the
foremost organizations promoting quackademic medicine; i.e., the “integration” 
of quackery under the guise of “integrative health” and “integrative medicine”
into academic medical centers.

When last I wrote about NCCIH’s most recent strategic plan (from 2021-2025), I
noted how the groundwork had been laid for “whole person health” that appealed
to a traditional Chinese medicine framework for multimodality diagnoses and
treatments but also pointed out that in “conventional” medicine, diagnoses are
based on science, as is the “framework” that ties the interventions together in 
multimodality treatments, which is very much in contrast with traditional
Chinese medicine. One notes that the report referred to TCM as being more
“holistic.”

The bottom line here is that “whole person health” and “whole person medicine”
serve the same purpose that the “holistic” has always served among advocates of 
medicine that is not science-based, namely an excuse to bring in all manner of
quackery in the name of being “holistic” (or treating the “whole person),
particularly adding a dash of “biochemical individuality to justify doing
whatever quackery a practitioner wants.

And if Donald Trump wins and actually keeps his word to RFK Jr., look for the
role of NCCIH and the quackery in the federal government to expand
exponentially.

“Non-pharmacological treatments for pain” ≠ CAM, no matter how much NCCIH wishes
it so

When it comes to pain, in the mythos of “complementary and alternative medicine”
(CAM), which in recent years has morphed into “integrative medicine,” anything 
that isn’t a drug is automatically rebranded as CAM, whether it’s in any way
“alternative” or not.

David Gorski on September 5, 2016

Link



I’ve had the Monday spot on this blog for quite a long time now. While there are
many advantages to posting on Monday, not the least of which is having more
time to put a post together (although that is also a disadvantage because it
incentivizes my taking more time than I sometimes should), one distinct
disadvantage is that all the Monday holidays are mine. That leaves me a choice
on, for example, Memorial Day and Labor Day every year. It’s a choice with three
options: The first is: Don’t post. (Do stop laughing, please. I know it’s me.) 
The second is: Use a guest post. I thought about this, and there are guest posts
in the pipeline, but I don’t like to use a guest post just because I’m feeling 
lazy. It strikes me as an abuse of being the managing editor. Finally, I could
post, which is what I decided to do.

I mainly decided to do a post because late last week there was something to blog
about that was pretty important and interesting, courtesy of the National
Center for Complementary and Integrative Health (NCCIH), which was formerly
known as the National Center for Complementary and Alternative Medicine (NCCAM).
Basically, on September 1, the NCCIH published a press release, “Review
Examines Clinical Trial Evidence on Complementary Approaches for Five Painful
Conditions.” Elsewhere, NCCIH Lead Epidemiologist and first author of the
review, Richard Nahin, PhD, MPH, bragged on the NCCIH blog, “New Review Offers
Providers and Researchers Evidence-Based Information on Complementary Health
Approaches for Pain.” It didn’t take long for headlines to start appearing that 
said things like:

  1. “NIH Study Gives Primary Care Docs Needed Evidence to Complement Chronic Pain 
    Treatments“

  2. “Review Suggests Safe, Effective Ways to Relieve Pain Without Meds“

  3. “Yoga, Acupuncture Can Help Some Pain, Studies Find“

You get the idea.

The NCCIH even held a Twitter chat on Thursday under the #talkpain hashtag to
promote its new review, which had been carried by Nahin in conjunction with
other investigators at the NCCIH. Co-authors included Robin Boineau, MD, MA, a
medical officer at the NIH; Partap S. Khalsa, DC, PhD, a chiropractor and Deputy
Director, Division of Extramural Research—yes, Deputy Director; Barbara J.
Stussman, BA; and Wendy J. Weber, ND, PhD, MPH, a naturopath and Branch Chief,
Clinical Research in Complementary and Integrative Health Branch, Division of
Extramural Research. If you want to know why NCCIH supports so much
pseudosciene, look no further than it having chiropractors and naturopaths in
high ranking positions. Basically, this is a review by NCCIH for NCCIH
believers.

I must admit that the Twitter chat was amusing. It was scheduled for 1 PM
Thursday. Normally at that time I’m still in clinic, as I’m seldom able to
finish my Thursday morning clinic before 1 PM, but I’ve noticed that my clinic
is often slow on weeks before major holiday weekends, and this week was no
exception. Not only was I finished before 1 PM, but I had had time to stop at
the food court and get myself some grub to chow as I watched the festivities,
which consisted of a whole lot of credulity, with a few skeptics interjecting
some reality every now and then.

Did the review article—not an original study!—rate the promotion? Let’s find
out.

Framing CAM as “non-pharmacological interventions”

The first thing I feel the need to point out here is the framing of this
article, which borrows heavily from the framing used by advocates of
“complementary and alternative medicine” (CAM), or, as it is now more frequently
called “integrative medicine” (or, as I like to call it, integrating
pseudoscience and quackery into medicine). That framing derives from a common
device used by CAM advocates since the 1990s at least, in which potentially
science-based interventions based on lifestyle changes, such as dietary
interventions and exercise, were co-opted as being somehow “CAM,” even though
there was nothing “alternative” about them. Even after CAM morphed into
“complementary and integrative” approaches, there’s nothing “complementary”
about these science-based methods, either, or at least there shouldn’t be. After
all, what is the first science- and evidence-based intervention for type II
diabetes? It’s to alter the diet, lose weight, and exercise, with the hope of
reversing it, or at least preventing the need to begin pharmacological
management. Ditto hypertension. I remember when I was first diagnosed with
hypertension several years ago, partially likely thanks to the curse of genetics
but also partially due to my sedentary lifestyle. My doctor insisted on at
least three visits to see if I could bring it down without drugs, even though I 
thought it was too high for that. I couldn’t; so I ended up on an
antihypertensive. Anecdotal evidence? Sure. However, it demonstrates that a lot 
of primary care doctors don’t go straight to the prescription pad, contrary to
the stereotype promoted by CAM advocates.

So here’s where the framing gets more sophisticated, as it does in this review
article. After co-opting sensible and potentially science-based lifestyle
interventions as being “complementary” or “integrative,” CAM advocates, such as 
Nahin et al, divide interventions into two categories, “pharmacological” and
“non-pharmacological.” Naturally, CAM claims all the non-pharmacological
interventions for its own, furthering the stereotype that science- and
evidence-based medicine is about nothing more than drug therapy:

   Back pain, joint pain, neck pain, and headaches are among the most common
   types of pain experienced by US adults (Table 1).3, 4, 5, 6 The prevalence
   rates for these conditions have remained relatively stable over time. Among
   the many pharmacological and nonpharmacological approaches that have been
   incorporated into pain management strategies are complementary health
   approaches. This broad category of care includes procedures by licensed
   practitioners such as acupuncturists, chiropractors, and massage therapists, 
   as well as self-care approaches such as relaxation techniques (eg,
   meditation) and meditative movement-based approaches (eg, yoga and tai chi)
   and natural products such a glucosamine and herbal medicines. National
   surveys going back more than 25 years have consistently found that these
   complementary approaches are used by about 30% to 40% of the US public in a
   given year,7, 8, 9, 10, 11 although use of a given approach may wax and wane 
   over time (Table 2).

There is no doubt that chronic pain has become a major public health problem.
Flowing from this public health problem has been an epidemic of abuse of
prescription opioids, an issue that has recently been prominently covered in the
press and recognized by the CDC as a massive public health problem, causing a
record number of deaths in 2014. So there’s no doubt that finding science-based 
non-opioid strategies for patients with chronic pain to obtain relief is very
important, arguably one of the top three or five priorities for public health in
the US. Naturally, whenever there’s a public health problem, CAM advocates see 
an opportunity to promote pseudoscience, such as acupuncture. Of course, the CAM
modalities examined range from quackery (acupuncture) to potentially helpful
and science-based but co-opted by CAM (various exercise approaches like tai chi 
and yoga) to supplements, which, when they work, are basically pharmacological
interventions disguised as nonpharmacological interventions.

The evidence base for CAM interventions for pain: Methods

In their review, Nahin et al examined existing evidence addressing the efficacy,
effectiveness, and safety of seven common CAM approaches: acupuncture; spinal
manipulation or osteopathic manipulation; massage therapy; tai chi; yoga;
relaxation techniques including meditation; and selected natural product
supplements, including chondroitin, glucosamine, methylsulfonylmethane (MSM),
S-adenosyl-L-methionine (SAMe), and omega-3 fatty acids. They examined these
interventions in five common painful conditions: back pain, osteoarthritis, neck
pain, severe headaches and migraine, and fibromyalgia. Their methodology is
described thusly:

   The randomized, controlled clinical trial (RCT) is considered the strongest
   study design for investigating the efficacy and safety of pharmacological,
   behavioral, and physical interventions. To identify examples of RCTs for each
   complementary approach, we performed searches of the MEDLINE database for
   articles published from January 1, 1966, through March 31, 2016, using the
   search strategy outlined in Supplemental Appendix 2 (available online at
   http://www.mayoclinicproceedings.org). In order to make this review as
   relevant as possible to primary care physicians in the United States, we
   limited this review to RCTs either proformed [sic] in the United States or
   that included participants from the United States. This decision was based on
   2 factors. First, the unique health care system in the United States vs
   other countries means that the standard care or usual care control groups
   used in the United States and other countries may vary substantially. Thus,
   whether a given complementary approach performs better than usual care in
   another country may not reflect how the approach would perform in US trials. 
   Another factor is that the training and licensure of acupuncturists,
   chiropractors, and naturopathic doctors vary substantially among countries,
   as does the marketing, regulation, and use of dietary supplements. For
   instance, in Germany, the location of some of the largest acupuncture trials,
   acupuncture is only practiced by medical doctors, whereas the vast majority 
   of acupuncture treatment in the United States is provided by licensed
   acupuncturists. Thus, the findings from German trials may not be directly
   comparable to acupuncture as practiced in the United States.

Notice something here? One sentence stood out: “Thus, whether a given
complementary approach performs better than usual care in another country may
not reflect how the approach would perform in US trials.” I can’t recall how
many times I and other members of the SBM team have pointed out that a given
intervention will nearly always perform better than usual care. In acupuncture
trials, for instance, acupuncture virtually always produces better results than 
“usual care.” What matters is whether an intervention performs better than a
sham control. In the case of acupuncture, the evidence is very clear.
Acupuncture does not perform better than sham acupuncture using the “wrong”
acupuncture points or retractable needles that disguise to both practitioner and
patient whether the needles actually enter the skin. As I like to say, it
doesn’t matter where you stick the acupuncture needles. It doesn’t even matter
if you stick the needles in, my favorite example being a German study that used 
toothpicks twirled against the skin as its sham control and found no difference 
between “true” or “verum” acupuncture over sham. That’s because acupuncture is
nothing more than theatrical placebo.

Be that as it may, basically a trial result on efficacy or effectiveness was
termed “positive” if the CAM approach led to statistically significant
improvements in pain severity, pain-related disability, and/or function,
compared to the control group. A negative result meant that there was no
difference between the intervention and control groups.

The evidence base for CAM interventions for pain: Results

The first thing I noticed reading this review is that, contrary to the headlines
about the review, the actual results of the review were far more measured
and—dare I say it?—wishy-washy. Of course, it is always thus for CAM, where the 
requirements of publishing in the peer-reviewed literature demand discussing all
the caveats and weaknesses of a finding. Keeping that in mind, here are the
conditions and CAM treatments for which Nahin et al reported “positive” results:

  1. Acupuncture and yoga for back pain

  2. Acupuncture and tai chi for osteoarthritis of the knee

  3. Massage therapy for neck pain—with adequate doses and for short-term benefit

  4. Relaxation techniques for severe headaches and migraine.

Let’s take a look at acupuncture for back pain, as reported by Nahin et al:

   We found 4 RCTs (total participants, 1092)15, 16, 17, 18 that assessed the
   clinical benefit of acupuncture for treatment of low back pain (LBP) (age
   range, 28-60 years; most participants were white) and used primary study
   outcomes of self-report of pain intensity (numeric rating scale or visual
   analog scale [VAS]) and/or functional disability (Roland-Morris Disability
   Questionnaire, Oswestry Disability Index [ODI], or Disability Rating Index). 
   Cherkin et al15, 16 reported modest improvement in pain intensity and
   function compared with usual care. In pregnant women using auricular
   acupuncture, Wang et al17 found a significant reduction in pain intensity and
   improved functional status compared with no treatment. Comparison of verum
   to sham acupuncture had mixed results, with 2 RCTS16, 18 finding no
   significant difference and 1 RCT17 finding a slight but significant
   difference. No significant adverse events were reported.

This is the very definition of a negative review. The only clearly positive
results were found in studies that compared acupuncture versus usual care or no 
treatment and only one study comparing “verum” acupuncture to sham showed a
positive result, that result being “slight but significant.” To me, “slight but 
significant” means small and statistically significant but almost certainly not 
clinically significant. This sort of result is very common in studies of
treatments that are no better than placebo controls, and the proper way to
report this would have been that there is no good evidence that acupuncture does
better than sham/placebo for low back pain.

We see the same dance with phrasing with yoga and back pain:

   We identified 6 RCTs of yoga for cLBP57, 58, 59, 60, 61, 62 (total
   participants, 596; all adults, predominantly female). Three named forms of
   yoga were studied: hatha,57, 58 viniyoga,59, 60 and iyengar61, 62; all were
   performed in group settings, with class durations from 60 to 90 minutes and
   the number of sessions ranging from 12 to 24, either once or twice per week, 
   with recommendations for home practice. Compared with usual care, 2
   studies59, 60 found that yoga provided improvements in pain and function, but
   the results were mixed when compared with exercise/stretching. A
   dose-response study57 compared once-weekly to twice-weekly classes and found 
   that they produced equivalent improvements in pain intensity and function.
   Three smaller studies compared yoga with wait list58, 61 or education
   control62 and reported significant modest reductions in pain intensity and
   function/disability. No RCTs reported significant adverse events.

Note again that the only unequivocal differences were between yoga and usual
care and that even then there was no detectable “dose-response” effect. Even
then, the effects were modest, completely consistent with placebo effects. Like 
acupuncture, when a sham intervention (non-yoga stretching) was compared with
acupuncture, the results were “mixed.” They’re always “mixed” with placebo
medicine. Again, the correct way to report this result would have been that
stretching exercises appear to help compared to doing nothing (although placebo 
effects can’t be ruled out) and that there’s no good evidence that yoga is any
better than any other form of stretching exercises for low back pain.

Tai chi also falls into this category as a form of low impact exercise designed 
to emphasize body awareness and control; there is no good evidence that it is
significantly better than other forms of low impact exercise for pretty much
anything, including pain. That doesn’t stop actual high profile CAM advocates
from somehow differentiating it from exercise. No less a figure than Dr. Brent
Bauer at the Mayo Clinic even tries to separate tai chi from other forms of
exercise:

I have many chronic pain patients who aren’t able to exercise – I often have
them try tai chi, as gentle way to get moving again #talkpain

— Brent Bauer (@babmd) September 1, 2016

I would have none of it:

Tai chi is a form of exercise! #talkpain https://t.co/4E6fh9a623

— David Gorski (@gorskon) September 1, 2016

Seriously, one more time: What is tai chi but a form of slow, gentle exercise?

Then there’s acupuncture and osteoarthritis:

   Four RCTs examined whether acupuncture could relieve symptoms associated with
   OA of the knee.87, 88, 89, 90 These studies used similar definitions of knee
   OA. Participants were predominantly female, had mean ages between 60 and 65 
   years, and had knee pain for an average of 9 to 11 years. All studies
   incorporated either the Western Ontario and McMaster Universities
   Osteoarthritis Index (WOMAC) total score or the WOMAC pain subscore as the
   primary outcomes. In 2 of the trials,89, 90 no difference was seen between
   verum acupuncture and sham acupuncture for either the primary or secondary
   outcome measure. The third trial,87 which used a sham control, found
   significantly better improvement in both the WOMAC pain subscale and function
   subscale after 14 weeks of treatment. For the 3 trials that also
   incorporated either an attention control87 or standard care controls,88, 90
   verum acupuncture produced significantly better improvement in primary and
   secondary outcomes than that observed in the control group.

I could just cut and paste the paragraph I wrote after the section on
acupuncture for low back pain, substitute the word “osteoarthritis” for “low
back pain,” and adjust the numbers to match the paragraph above, and it would
fit just as well. This is the very definition of a negative review, just like
the one for acupuncture and low back pain. Acupuncture, being the theatrical
placebo it is, does better compared to no treatment, education, or wait list
controls. Compared to sham acupuncture, the results are “mixed” with only one
study being “positive,” as in statistically significantly positive, even though 
it’s almost certainly not clinically significant.

And so it goes with the other comparisons. It’s OK, though, for CAM aficionados,
because they know that the popular press will strip their findings of all those
pesky ambiguities and make it sound as though the results were far more
positive than they were. Meanwhile, the quack press takes the reports and gives 
them headlines like Alternative Treatments Reduce Pain Safely, something this
NCCIH review definitely does not demonstrate.

The selling of “integrative medicine” by NCCIH

I’ve sometimes noted that NCCIH is not as bad when it comes to ran pseudoscience
as it was a decade ago, when it was still NCCAM. Since Dr. Josephine Briggs
took over several years ago, consistent with the previous NCCAM strategic plan
(which I like to characterize as “let’s do some real science for a change“) and 
the current plan (which I like to characterize as “meet the new plan, same as
the old plan“) there have been fewer blatantly pseudoscientific “studies”
funded, such as homeopathy, distance healing, and the like, and a shift towards 
varieties of CAM that seem less quacky on the surface. Indeed, I have not been
able to find a study of homeopathy for which NCCIH provided grant support since 
2008.

However, this shift towards co-opting sensible and potentially science-based
modalities such as diet and exercise is no less harmful, particularly given the 
presence of outright quacks like chiropractors and naturopaths in high-ranking
positions within NCCIH. Basically, reeling from all the negative studies it
funded of truly “alternative” treatments, NCCIH has seen an opportunity to seem 
relevant by more tightly co-opting “nonpharmacologic treatments for pain,”
rebranding them as somehow “integrative” or “complementary,” and then lumping
them together with the remaining pseudoscience that has enough
seemingly-positive studies combined with enough popularity among naturopaths and
other quacks that help oversee NCCIH, to imply that the whole “integrative
package” is the answer to our opioid abuse crisis.

For instance, here, co-author and naturopath Wendy Weber claims that this review
does address whether these therapies work, neglecting to point out that it
shows that they almost certainly don’t:

She also basically admits, with a whole lot of hand waving, that we don’t know
the mechanisms by which “complementary” therapies “work” for pain. Of course,
that’s because the ones reviewed almost certainly do not, hoping that “future
research” will answer those questions. Oh, and, Congress, keep funding us to do 
studies like the ones chiropractor and co-author Partap Khalsa wants to see:

In other words, let’s do more tooth fairy science and study differences in
effects in different populations, mechanism, dosage, and the like without
actually having conclusively demonstrated beforehand that the treatments under
study actually do work.

As I noted before, NCCIH is now emphasizing as its key scientific priority pain 
and difficult-to-control symptoms, in particular nonpharmacologic methods of
relieving pain. This review clearly is a result of that priority. Unfortunately,
this review also demonstrates just how little promise there is in the specific 
“nonpharmacological approaches” rebranded as CAM examined. Basically, this
review is most consistent with none of them working for chronic pain. However,
NCCIH can’t admit that, which is why the NCCIH has discussed how to do
“innovative clinical trials” by using “pragmatic clinical trials to address
questions about the integration of complementary health approaches into health
care systems, or to study the effectiveness of complementary or integrative
approaches in comparison to standard care.” Unfortunately, pragmatic trials are 
trials that are done only after more rigorous trials actually show that an
intervention works, with the intent to see how it works in the “real world.”
Doing pragmatic trials of treatments not yet shown to work is putting the cart
before the horse.

That’s pretty much CAM in a nutshell, at least CAM that doesn’t have
infinitesimally small prior probability, like homeopathy. Basically, NCCIH is
proposing to study how these CAM modalities work without having established that
they work, as it rebrands plausible potential “nonpharmacologic” treatments as 
CAM. Why does it do this? Because it has to. To steal a phrase from Harriet Hall
about naturopathy: What CAM offers that is helpful is not unique, and what it
offers that is unique is not good. As Steve Novella put it, this review and
#talkpain were basically a scam.

NCCIH and the true evolution of integrative medicine

David Gorski on June 29, 2015

Link



There can be no doubt that, when it comes to medicine, The Atlantic has an
enormous blind spot. Under the guise of being seemingly “skeptical,” the
magazine has, over the last few years, published some truly atrocious articles
about medicine. I first noticed this during the H1N1 pandemic, when The Atlantic
published an article lionizing flu vaccine “skeptic” Tom Jefferson, who,
unfortunately, happens to be head of the Vaccines Field at the Cochrane
Collaboration, entitled “Does the Vaccine Matter?” It was so bad that Mark
Crislip did a paragraph-by-paragraph fisking of the article, while Revere also
explained just where the article went so very, very wrong. Over at a blog known 
to many here, the question was asked whether The Atlantic (among other things)
matters. It didn’t take The Atlantic long to cement its lack of judgment over
medical stories by publishing, for example, a misguided defense of chelation
therapy, a rather poor article by Megan McArdle on the relationship between
health insurance status and mortality, and an article in which John Ioannidis’
work was represented as meaning we can’t believe anything in science-based
medicine. Topping it all off was the most notorious article of all, the most
blatant apologetics for alternative medicine in general and quackademic medicine
in particular that Steve Novella or I have seen in a long time. The article was
even entitled “The Triumph of New Age Medicine.”

Now The Atlantic has published an article that is, in essence, The Triumph of
New Age Medicine, Part Deux. In this case, the article is by Jennie Rothenberg
Gritz, a senior editor at The Atlantic, and entitled “The Evolution of
Alternative Medicine.” It is, in essence, pure propaganda for the paired
phenomena of “integrative” medicine and quackademic medicine, without which
integrative medicine would likely not exist. The central message? It’s the same 
central (and false) message that advocates of quackademic medicine have been
promoting for at least 25 years: “Hey, this stuff isn’t quackery any more! We’re
scientific, ma-an!” You can even tell that’s going to be the central message
from the tag line under the title:

   When it comes to treating pain and chronic disease, many doctors are turning 
   to treatments like acupuncture and meditation—but using them as part of a
   larger, integrative approach to health.

No, that’s what they say they are doing (and—who knows?—maybe they even believe 
it), but what that “integrative” approach to health actually involves is
“integrating” quackery like acupuncture with scientific medicine. Elsewhere, in 
her introduction to the article in which she explains why she did the story,
Rothenberg Gritz describes a visit to the National Center Complementary and
Integrative Health (NCCIH), which is how the National Center for Complementary
and Alternative Medicine (NCCAM) was renamed last December:

   After visiting the NIH center and talking to leading integrative physicians, 
   I can say pretty definitively that integrative health is not just another
   name for alternative medicine. There are 50 institutions around the country
   that have integrative in their name, at places like Harvard, Stanford, Duke, 
   and the Mayo Clinic. Most of them offer treatments like acupuncture, massage,
   and nutrition counseling, along with conventional drugs and surgery.

One notes that the renaming of NCCAM to eliminate the word “alternative” was a
longstanding goal of NCCAM, its supporters, and “integrative medicine”
advocates. The reason is obvious: “Alternative” implies outside the mainstream
in medicine, and that’s not the message that proponents of integrating quackery 
into medicine want to promote. One can’t help but wonder if it was a retirement 
present for Senator Tom Harkin (D-IA), the legislator most responsible for the
creation and growth of NCCAM who retired at the end of the last Congressional
term. Whatever the case, the name change was, as I put it, nothing more than
polishing a turd.

Be that as it may, no one, least of all here at SBM, argues that “integrative”
medicine is “just another name for alternative medicine.” It isn’t, as most
integrative MDs use conventional, science-based medicine as well. The problem
with “integrative” medicine is that, to paraphrase Mark Crislip, mixing cow pie 
with apple pie does not make the apple pie taste better; i.e., mixing
unscientific, pseudoscientific, and mystical quackery like acupuncture and much 
of traditional Chinese medicine does not make science-based medicine better.
Rather, it contaminates it with quackery, just as the cow pie contaminates the
apple pie.

Basically, integrative medicine is a strategy for mainstreaming alternative
medicine, even though the vast majority of alternative medicine has either not
been proven scientifically to be efficacious and safe, has been proven not to be
efficacious, or is based on physical principles that violate laws of physics
(such as homeopathy or “energy healing). Indeed, if the term “integrative
medicine” were not thus, it would be a completely unnecessary moniker. The
reason is, to paraphrase Tim Minchin, Richard Dawkins, John Diamond, Dara Ó
Briain, and any number of skeptics, there is no such thing as “alternative”
medicine because “alternative” medicine that is shown through science to work
becomes simply medicine. Thus, newly validated medical treatments have no need
to be called “integrative” because medicine will integrate them just fine on its
own. That’s what medicine does, although admittedly the process is often
messier and takes longer than we would like. Integrative medicine, like
alternative medicine before it, is a marketing term that is based on a false
dichotomy. Only unproven or disproven medicine needs the crutch of being
“integrative,” a double standard that asks us to “integrate” unproven treatments
as co-equal with science-based medicine even though they have not earned that
status.

Unfortunately, this is a false dichotomy that Rothenberg Gritz promotes
wholeheartedly. The only hint of skepticism is a brief passage near the
beginning in which she refers to Paul Offit’s 2013 book, Do You Believe in
Magic? The Sense and Nonsense of Alternative Medicine and briefly quotes him
saying what I’ve been saying all along, that “integrative medicine” is a brand, 
a marketing term, rather than a specialty. She also noted his criticism in his
book of what is now NCCIH, and includes a quote by Dr. Offit about Josephine
Briggs (the current director of NCCIH) that she “certainly was very nice” and
assured him that they “weren’t doing things like that any more” (referring to
“things” NCCCIH studied in the past, like distance healing, and magnets for
arthritis). This is, of course, hardly even a criticism at all, but rather
getting Dr. Offit to state for her Dr. Briggs’ frequent claim that NCCIH doesn’t
study pseudoscience any more. It’s a claim she made when Steve Novella, Kimball
Atwood, and I met with her five years ago, and, yes, back then Dr. Briggs was
also very nice to us, although she did rapidly turn around and, in a painful fit
of false balance, use that meeting as evidence of her even-handedness in
meeting with both critics and homeopaths. It’s a claim embedded in the 2011-2015
NCCAM strategic plan, which I now like to characterize in talks as “Hey, let’s 
do some real science for a change!” In any case, Rothenberg Gritz’s account
isn’t false balance. It’s no balance at all, with the token skeptic role taken
by Dr. Offit.



The Integrative Medicine Wheel — A good example of the branding of integrative
medicine.

Revisionist history about NCCIH

Advocates for “integrative medicine” have used a variety of talking points over 
the years, and Rothenberg Gritz hits most of them in her article quite
credulously. Indeed, it is very clear from her introduction that she was
predisposed to believe. Early in the article, she tells the tale by looking back
to the early 1990s, when she was in high school and her father was a family
physician who was clearly into some woo, including Transcendental Meditation,
Ayurveda, and the like, even going so far as to incorporate them into his
practice. The inescapable implication is that she considers her father a
trailblazer for what is now integrative medicine.

Unfortunately, it is very clear that her knowledge of history in this area,
particularly how NCCAM/NCCIH came to be, is sorely lacking, which leads her to
parrot the version of history that integrative practitioners want you to
believe:

   Back in the 1990s, the word “alternative” was a synonym for hip and
   forward-thinking. There was alternative music and alternative energy; there
   were even high-profile alternative presidential candidates like Ross Perot
   and Ralph Nader. That was the decade when doctors started to realize just how
   many Americans were using alternative medicine, starting with a 1993 paper
   published in The New England Journal of Medicine. The paper reported that one
   in three Americans were using some kind of “unconventional therapy.” Only 28
   percent of them were telling their primary-care doctors about it.

And:

   Enough Americans had similar interests that, in the early 1990s, Congress
   established an Office of Alternative Medicine within the National Institutes 
   of Health. Seven years later, that office expanded into the National Center
   for Complementary and Alternative Medicine (NCCAM), with a $50 million budget
   dedicated to studying just about every treatment that didn’t involve
   pharmaceuticals or surgery—traditional systems like Ayurveda and acupuncture 
   along with more esoteric things like homeopathy and energy healing.

Now there’s some revisionist history! The word “alternative” was just popular
because there was so much other “alternative” stuff (alternastuff?) going on in 
the early 1990s! But it’s not the 1990s any more; so “alternative” isn’t as cool
as it used to be. Of course, the word “alternative” as applied to quackery
dates back at least to the 1960s.

Longtime readers know how NCCAM really came about. One wonders if Rothenberg
Gritz ever came across Wally Sampson’s classic 2002 article, “Why the National
Center for Complementary and Alternative Medicine (NCCAM) Should Be Defunded” or
Kimball Atwood’s “The Ongoing Problem with the National Center for
Complementary and Alternative Medicine“. Even if you buy into the false notion
that NCCIH (née NCCAM) has completely reformed itself and doesn’t study or
promote quackery any more, a history lesson is important. What really happened
matters.

Basically, Sen. Tom Harkin was a believer in a lot of alternative medicine.
Thus, in 1991 he used his power as the chair of the Senate Appropriations
Committee to create the precursor to the NCCIH. His committee declared itself
“not satisfied that the conventional medical community as symbolized at the NIH 
has fully explored the potential that exists in unconventional medical
practices” and, to “more adequately explore these unconventional medical
practices,” ordered the NIH to create “an advisory panel to screen and select
the procedures for investigation and to recommend a research program to fully
test the most promising unconventional medical practices.” This advisory panel
became the first incarnation of NCCIH, the Office of Unconventional Medicine,
which was quickly renamed the Office of Alternative Medicine (OAM).

This next part is very important. NIH didn’t request this new office. There were
no scientists and physicians in the NIH leadership clamoring for such an
office. Congress didn’t respond to a “groundswell” of support to establish this 
office. The NEJM article cited by Rothenberg Gritz wasn’t even published until
nearly two years after Harkin had already started the wheels rolling and a year 
after the founding of OAM. No, a single powerful senator with a proclivity for
quackery used his power to get this enterprise off the ground, and he continued 
to nurture it over his remaining two decades in the Senate. The OAM was, in
essence, imposed on a correctly-unwilling NIH, and has been ever since. Indeed, 
after she left as NIH director, Bernardine Healy revealed that she had
considered the project to link research scientists with true believers in
therapies like homeopathy to conduct experiments as foreshadowing nothing but
disaster, but conceded that the NIH had “had no choice” because it couldn’t
refuse to carry out a mandate from Congress.

And, make no mistake, Harkin was big into quackery, not to mention being in the 
pockets of quacks:

   Harkin had been urged to take this legislative step by two constituents,
   Berkley Bedell and Frank Wiewel. Bedell, a former member of the House,
   believed that two crises in his own health had benefited from the use of
   unconventional medicine: colostrum derived from the milk of a Minnesota cow, 
   he held, had cured his Lyme disease; and 714-X, derived from camphor in
   Quebec by Gaston Naessens, had prevented recurrence of his prostate cancer
   after surgery. Bedell, giving evidence of his Lyme disease recovery at a
   Senate committee hearing, observed: “Unfortunately, Little Miss Muffet is not
   available to testify that the curds and whey which she was eating are safe.”
   Wiewel had long been a vigorous champion of immunoaugmentative therapy for
   cancer, scorned by orthodox specialists; made in the Bahamas, this mixture of
   blood sera was finally barred from import by the Food and Drug
   Administration. Wiewel then began operating from his home in Otho, Iowa, an
   agency called People Against Cancer, a referral service for cancer treatments
   that orthodox medicine considered questionable.

   Harkin, having lost two sisters to cancer, was susceptible to an interest in 
   alternative therapies. Soon after sponsoring the law that launched the Office
   of Alternative Medicine, Harkin himself became a true believer in an
   unorthodox “cure.” On Capitol Hill, Bedell introduced the senator to Royden
   Brown of Arizona, promoter of High Desert bee pollen capsules. Harkin
   suffered from allergies; persuaded by Brown to take 250 bee pollen capsules
   within five days, he rejoiced that his allergies had disappeared. The senator
   did not know at the time that Brown had recently paid a $200,000 settlement 
   under a consent agreement with the Federal Trade Commission, promising to
   cease disguising television infomercials as objective information programs
   and to stop including in his scripts dozens of false therapeutic claims for
   his capsules. These promotions also averred that “the risen Jesus Christ,
   when he came back to Earth,” had consumed bee pollen; a more recent customer,
   Brown’s infomercial declared, was Ronald Reagan. Brown later wrote Hillary
   Clinton, warning that her husband should begin dosing with bee pollen lest he
   develop fatal throat cancer.

So NCCIH started out at the urging of two quack constituents of Harkin; then
Harkin became a believer himself. Not surprisingly, it soon became clear that
the OAM was not intended to rigorously study alternative medicine, but rather to
provide a seemingly scientific rationale to promote it. The office was
initially set up with an acting director and an ad hoc panel of twenty members, 
many of whom Harkin hand-picked, including advocates of acupuncture, energy
medicine, homeopathy, Ayurvedic medicine, and several varieties of alternative
cancer treatments. Deepak Chopra and Bernard Siegel were also included. Critics 
of quackery were consulted and considered for panel membership but—surprise,
surprise!—were not selected. These pro-alt med panel members became known in the
OAM as “Harkinites.”

Against this background, the first director of the OAM, Joseph M. Jacobs, almost
immediately ran afoul of Harkin by insisting on rigorous scientific methodology
to study alternative medicine. To get an idea of what Jacobs was up against,
consider that in 1995 the inaugural issue of Alternative Therapies in Health and
Medicine featured not just one, but two, commentaries by Senator Harkin, “The
Third Approach” and “A Journal and a Journey“. In these two articles, Harkin
basically introduced the new journal as a “journey—an exploration into what has 
been called ‘left-out medicine,’ therapies that show promise but that have not
yet been accepted into the mainstream of modern medicine.” and explicitly stated
that “mainstreaming alternative practices that work is our next step.”
Unfortunately, he had a bit of a problem with the way medical science goes about
determining whether a health practice—any health practice—works and railed
against what he characterized as the “unbendable rules of randomized clinical
trials.” Citing his use of bee pollen to treat his allergies, went on to assert,
“It is not necessary for the scientific community to understand the process
before the American public can benefit from these therapies.” It is an attitude 
that did not change. In 2009, Harkin famously criticized NCCAM thusly:

   One of the purposes of this center was to investigate and validate
   alternative approaches. Quite frankly, I must say publicly that it has fallen
   short. It think quite frankly that in this center and in the office
   previously before it, most of its focus has been on disproving things rather 
   than seeking out and approving.

Truly, this was a profound misunderstanding of how science works. Also, the
reason NCCAM had failed to “validate alternative approaches” is because they
were, largely, pseudoscientific quackery that, as expected, failed scientific
testing.

Ultimately Jacobs resigned under pressure from Harkin, who repeatedly sided with
the quacks. It also didn’t help that Jacobs complained about various
“Harkinites” on the advisory panel who represented cancer scams such as Laetrile
and Tijuana cancer clinics. That Jacobs became tired of fighting and finally
resigned is especially noteworthy given that Jacobs himself had been picked to
run OAM precisely because of his openness to the idea that there were gems to be
found in the muck of alternative therapies. Meddling by Harkin was a theme that
kept repeating itself. Later, in 1998 after the then-NIH director had tried to 
impose more scientific rigor on the OAM, Harkin sponsored legislation to elevate
the OAM to a full center, and thus was the NCCAM born. Not coincidentally, the 
NIH director has much less control over full centers than over offices.

Bad science and revisionist history about how alternative medicine evolved into 
“integrative” medicine

The key message promoters of unscientific medicine hammer home again and again
is that they’re not quacks. Oh, no. They’re real scientists and don’t use
medicine that’s not scientifically proven. Rothenberg Gritz drives that point
home thusly:

   But I was intrigued by the NIH center’s name change and what it says about a 
   larger shift that’s been going on for years. The idea of alternative
   medicine—an outsider movement challenging the medical status quo—has fallen
   out of favor since my youth. Plenty of people still identify strongly with
   the label, but these days, they’re often the most extreme advocates, the ones
   who believe in using homeopathy instead of vaccines, “liver flushes” instead
   of HIV drugs, and garlic instead of chemotherapy.

   In contrast, integrative doctors see themselves as part of the medical
   establishment. “I don’t like the term ‘alternative medicine,'” says Mimi
   Guarneri, a longtime cardiologist and researcher who founded the Academy of
   Integrative Health and Medicine as well as the integrative center at Scripps.
   “Because it implies, ‘I’m diagnosed with cancer and I’m going to not do any 
   chemo, radiation, or any conventional medicine, I’m going to do juicing.'”

As I characterized it, “We’re not quacks! We’re not quacks!” Later Rothenberg
asserts:

   The actual treatments they use vary, but what ties integrative doctors
   together is their focus on chronic disease and their effort to create an
   abstract condition called wellness. In the process, they’re scrutinizing many
   therapies that were once considered alternative, subjecting them to the
   scientific method and then using them the same way they’d incorporate any
   other evidence-based medicine.

Except that that’s not the case. Here are a couple of examples that I like to
use to show why this characterization of integrative medicine is a delusion.

First, I like to cite a certain medical society that I’ve butted heads with on
more than one occasion and whose leadership really, really doesn’t like me,
namely the Society for Integrative Oncology, declaring that it has “consistently
encouraged rigorous scientific evaluation of both pre-clinical and clinical
science, while advocating for the transformation of oncology care to integrate
evidence-based complementary approaches. The vision of SIO is to have research
inform the true integration of complementary modalities into oncology care, so
that evidence-based complementary care is accessible and part of standard cancer
care for all patients across the cancer continuum.” Would that this were true! 
If that truly is the case, then how does SIO reconcile itself with the fact that
its current president, Suzanna Zick, and immediate past president, Heather
Greenlee, are both naturopaths, one of whom authored official SIO guidelines for
the integrative care of breast cancer patients? (Even more depressingly, Zick
is a naturopath working in the Department of Family Medicine at my old alma
mater the University of Michigan Medical School.) That alone puts the lie to any
claims SIO has of being scientific, given that naturopathy is a cornucopia of
quackery and pseudoscience. In particular, homeopathy—or, as I like to call it, 
The One Quackery To Rule Them All—is an integral part of naturopathy as a major 
component of the curricula of schools of naturopathy and is a required component
of the naturopathic licensing examination (NPLEX). If you don’t believe just
how quacky naturopathy is, read what they say to each other when they think no
one is watching; learn about how full of pseudoscience their education and
practice are, as related by a self-described “apostate“; and how unethical their
research can be.

Despite all this, it’s not just integrative oncology that’s embracing
naturopathy. (There’s even a specialty now known as naturopathic oncology that’s
advertised by places like the Cancer Treatment Centers of America.) Meanwhile a
whole host of integrative medicine programs offer the services of naturopaths, 
including Kansas University, UC Irvine, Beaumont Hospital (in my neck of the
woods!), the University of Maryland, and, of course, the Cleveland Clinic, where
a naturopath runs a traditional Chinese medicine clinic, just to name a few.

Now, here’s where the second point comes in. It goes way beyond naturopathy,
whose tendrils have become firmly entwined with those of “integrative oncology,”
perhaps more so than with other specialties. If, as its advocates claimed ad
nauseam to Rothenberg Gritz, integrative medicine is all about the science, then
its approach is all wrong. Let’s put it this way. They themselves admit that
many of the modalities they are using are unproven. If they truly accept that,
then for them to offer such services outside of the context of a clinical trial 
would be as unethical as offering a non-approved drug or unproven surgical
treatment to patients. Yet, as I’ve described more times than I can remember,
there are quite a few academic institutions out there offering reiki, which is
just as quacky, if not more so, than homeopathy, given that it postulates the
existence of a “healing energy” that has never been detected and in its
particulars is no different than faith healing, except that it substitutes
Eastern mystical beliefs for Christian beliefs. Under the banner of “integrative
medicine,” academic medical centers are offering high dose vitamin C for
cancer, anthroposophic medicine, and functional medicine. Indeed, there are
academic medical centers out there that offer everything from acupuncture to
chiropractic to craniosacral therapy to naturopathy. Heck, the University of
Maryland offers reflexology, reiki, and rolfing, none of which have any good
evidence to support them, while more integrative medicine programs than I can
keep track of offer acupuncture and various other bits taken from traditional
Chinese medicine, even though acupuncture is nothing more than a theatrical
placebo.

In other words, integrative medicine puts the cart before the horse.
Hilariously, Rothenberg Gritz inadvertently undermines her own praise of the
science of integrative medicine by relating that Dr. Guarneri, whom she just
represented as a paragon of science who only wants to use scientifically
validated treatments, offers onsite massage therapy, herbal baths, craniosacral 
therapy, and acupuncture, the latter two of which are pure quackery. (Oh, and
she teams with naturopaths, as well.) Indeed, craniosacral therapy is such
ridiculous quackery that Guarneri’s offering it pretty much eliminates any
chance I’ll buy her claim of adhering to science in her practice of “integrative
medicine.”

My amusement at this aside, especially irritating is Rothenberg Gritz’s
description of acupuncture. After noting that chronic pain is one reason why
people seek out alternative medicine, she writes:

   One reason pain is so hard to treat is that it isn’t just physical. It can
   carry on long after the initial illness or injury is over, and it can shift
   throughout the body in baffling ways, even lodging in phantom limbs. Two
   different people can have the same physical condition and experience the pain
   in dramatically different ways. As the Institute of Medicine report put it, 
   pain flouts “the long-standing belief regarding the strict separation between
   mind and body, often attributed to the early 17th-century French philosopher
   René Descartes.”

   This may be why so many chronic pain sufferers are drawn to traditional
   medicine: The Cartesian idea of mind-body duality never found its way into
   these ancient systems. Acupuncture, for instance, has been shown to help with
   problems like back, neck, and knee pain. But it’s very hard for science to
   figure out how it works, since it involves so many components that are mental
   as well as physical. The technique of inserting the needles, the attitude of
   the practitioner, the patient’s own attention—all of these are built into
   the treatment itself. In Acupuncture Research: Strategies for Developing an
   Evidence Base, researchers note that ancient Chinese physicians saw the mind 
   and body as “necessarily connected and inseparable.”

Note that the study to which Rothenberg Gritz links is the acupuncture
meta-analysis by Vickers et al., which so failed to show what it claimed to show
that one SBM post wasn’t enough to explain why. It required discussion by Steve
Novella, Mark Crislip, and myself, much to Vickers’ dismay.

The funny thing is, mind-body dualism is not a part of modern medicine, making
it odd that the IOM would get it so very, very wrong 11 years ago. Remember, the
concept of dualism posits that consciousness (the mind) is, in part or whole,
something separate from the brain; i.e., not (entirely) caused by the brain.
Now, if there’s anything modern neuroscience has taught us, it’s that dualism is
untenable as a scientific hypothesis, that the “mind” is wholly a manifestation
of the function and activity of the brain—or, as it’s sometimes stated, the
brain causes the mind. In other words, science-based medicine rejected mind-body
dualism a long time ago. Of course, as we’ve discussed here more times than I
can remember, when rigorously studied acupuncture has never been convincingly
shown to do anything more than placebo. Indeed, the reason why acupuncture
“outcomes” (such as they are) are so dependent on practitioner and patient is
because acupuncture is placebo.

In fact, my retort to Rothenberg Gritz’s outright silly argument about mind-body
dualism is that it’s the integrative practitioners who emphasize mind-body
dualism, whether they realize it or not. After all, they have a whole category
of therapies known as “mind-body” medicine, an implicit acceptance, at least on 
some level, of dualism. Nor does their overblown appropriation of epigenetic
studies as evidence that the “mind heals the body” (or, as I like to refer to
it, wishing makes it so), which infuses so many alternative medicine practices, 
help. In actuality, given that the vast majority of alternative medicine
practices, when rigorously studied, do no better than placebo, this new emphasis
is basically integrative medicine rebranding the pseudoscientific practices it 
“integrates” as “harnessing the power of placebo.” Since placebo effects require
that physicians in essence lie to their patients (albeit with good intent),
it’s not for nothing that Kimball Atwood and I have dubbed the placebo medicine 
as practiced by integrative medicine practitioners as a rebirth of paternalism
in medicine due to the lure of being the shaman-healer.

The rest of the article is full of the same old pro-integrative medicine tropes 
that I’ve seen over and over and over again. For example, Mark Hyman, the
“functional medicine guru” now trusted by Bill and Hillary Clinton who regularly
mangles science about autism and cancer while advocating anecdote-based
medicine, opines that we have “an acute-disease system for a chronic-disease
population,” that the “whole approach is to suppress and inhibit the
manifestations of disease,” and that “the goal should be to enhance and optimize
the body’s natural function,” whatever that means—and whatever “functional
medicine” is. (For a reminder, look at Wally Sampson’s multi-part analysis of
what functional medicine is claimed to be here, here, here, here, and here.)

Rothenberg Gritz also relies on the ever-annoying “science has been wrong
before” canard, listing all sorts of areas where medicine got it wrong before
getting it right, as though that justifies integrating alternative medicine into
science-based medicine because, I suppose, science could be wrong about that
too. It does not; it’s a fallacy. She also parrots the charge that doctors
haven’t thought enough about prevention, a claim that has always irritated me.
After all, what are vaccines, but prevention? What are diet and drugs to treat
elevated blood sugar but prevention of diabetic complications? What are
antihypertensive drugs but a means to prevent the complications of hypertension,
such as heart attacks and strokes? What are smoking cessation programs but a
means of preventing cancer, heart disease, and chronic obstructive pulmonary
disease, the three most deadly consequences of smoking? (Note how integrative
medicine only defines “prevention” as non-pharmacologic, or “natural,”
approaches.) Yes, it’s difficult to practice some forms of prevention because
making lifestyle changes, such as losing weight, drinking less, smoking less,
and exercising are hard. Patients don’t want to do them and have a hard time
achieving them. I’ve yet to see much evidence that “integrative” medicine will
do any better after having appropriated lifestyle interventions and rebranding
them as somehow being “integrative.”

What is integrative medicine, anyway?

Perhaps the most inadvertently telling passage in Rothenberg Gritz’s article
comes near the end:

   After months of speaking to leading integrative doctors and researchers, I
   found that I was still having trouble summing up exactly what integrative
   health was all about. It’s not a specialty like obstetrics or endocrinology. 
   There are integrative training programs and certifications out there, but
   none of them has been universally recognized throughout the medical
   profession. “At this point it’s really a self-declaration,” Nancy Sudak, the 
   chair of the Academy of Integrative Health and Medicine, told me. “And nobody
   has a tool kit that includes absolutely everything. It largely depends on
   who you are as a practitioner.”

In other words, integrative medicine is, as I said, a brand, not a specialty.
Pretty much every other specialty has a definition of what it encompasses that
is clear. Integrative medicine is this fuzzy entity about which I can’t help but
recall the words of Humpty Dumpty in Lewis Carroll’s Through the Looking Glass,
who said scornfully, “When I use a word, it means just what I choose it to
mean—neither more nor less.” So it is with integrative medicine, which is why
last week integrative medicine could be defended on using a fallacious argument 
that science-based medicine is “nonsense” or that “Western medicine” has lost
its soul, while this week I can sit back and grit my teeth reading an article
regurgitating the advocate line that integrative medicine is just as scientific 
as science-based medicine.

Rothenberg Gritz is correct that integrative medicine has evolved, but it hasn’t
evolved in the way she thinks it has. In her final paragraph, she wonders
whether the rise of integrative medicine is a result of cultural shifts (which
is possible) but comes to an untenable conclusion that it may be the only way to
treat chronic disease. In actuality, it is only the language that has evolved. 
I was half-tempted to recycle the introduction to my post on how integrative
medicine is a brand not a specialty, where I describe the evolution of
integrative medicine, but instead I’ll just give you the CliffsNotes version
instead and you can read the original in all its snarky glory if you like. In
fact, you should. You won’t regret it.

Basically, starting around the late 1960s and early 1970s, in a bid to gain
respectability for what was then called quackery or health fraud, the term
“alternative medicine” was coined, which didn’t have all the harsh connotations 
of the usual language. Around that same time, James Reston, a New York Times
editor, wrote about his experience undergoing an emergency appendectomy while
visiting China in 1971. His story was represented as successful “acupuncture
anesthesia,” when it was anything but, stimulating popular interest in
“alternative” medical approaches. However, the word “alternative” implied that
this was not “real” medicine, that it still was somehow unrespectable (which it 
was and still is, for good reason). Consequently, in the 1990s, around about the
time Rothenberg Gritz was in high school admiring her dad’s woo-filled medical 
practice, a new term was born: complementary and alternative medicine (CAM). The
idea was that you need not fear these quack medical practices because they
would be used in addition to medicine, not instead of it. This term contributed 
greatly to the increasing embrace of CAM by medical academia, but it was still
not good enough for its advocates. After all, the word “complementary” implies a
subsidiary status, that CAM is not the main medicine but just icing on the
cake, so to speak.

That did not sit well with advocates, who wanted their woo to be fully part of
medicine, even though they didn’t have the evidence for that to happen
naturally. Thus was born the current term “integrative medicine.” No longer did 
CAM practitioners have to settle for having their quackery be merely
“complementary” to real medicine. They could use this term to claim co-equal
status with practitioners of real medicine. The implication—the very, very, very
intentional implication—was that alternative medicine was co-equal to science- 
and evidence-based medicine, an equal partner in the “integration.” Thus was
further advanced the false dichotomy that has been used to justify alternative
medicine from the very beginning, that a physician can’t be truly “holistic”
unless he embraces pseudoscience.

The true evolution of integrative medicine is not that it has become more
scientific. Rather, it is that its advocates have gotten much, much better at
branding quackery as being medicine under the guise of being “holistic” and
“patient-centered.” It’s a false dichotomy that I reject and that Rothenberg
Gritz clearly doesn’t understand.

NCCIH Strategic Plan 2016-2021, or: Let’s try to do some real science for a
change

David Gorski on April 4, 2016

Link

It’s no secret that we at Science-Based Medicine (SBM) are not particularly fond
of the National Center for Complementary and Integrative Health (NCCIH).
Formerly known as the National Center for Complementary and Alternative Medicine
(NCCAM) and before that the Office of Alternative Medicine, NCCIH has been the 
foremost government agency funding research into quackery for the last 24 years,
and, of course, that’s the reason we at SBM have been harshly critical of NCCIH
since SBM’s inception. Basically, NCCIH not only funds studies of dubious
“alternative” therapies, but it also promotes quackery by funding “fellowships” 
at various institutions to teach “integrative medicine,” or, as we like to call 
it, “integrating” quackery with real medicine.

Indeed, back in 2009, when President Barack Obama first took office, Steve
Novella and I both suggested that the time was ripe for NCCIH to be defunded and
its functions allowed to revert back to the already existing Institutes and
Centers of the National Institutes of Health. We were under no illusions that
this would happen, given that NCCIH always had a powerful protector in the man
who was arguably more responsible for creating NCCIH and guarding it against all
attempts at defunding or, even worse, forcing it to do more rigorous science,
woo-loving Senator Tom Harkin (D-IA). Harkin is no longer in the Senate, having 
retired at the end of 2014, but NCCIH is still with us, and the nature of
government makes it very much that, unless someone with power is willing to
expend serious political capital to eliminate it, NCCIH will be with us always, 
no matter how much it tries to change its name to eliminate anything implying
pseudoscience.

So those of us who recognize that NCCIH was created to promote the “integration”
of “outside of the mainstream” or “unconventional” treatments (the vast
majority of which are quackery) into real medicine have to learn to live with
NCCIH and, as much as it might gall us, to try make lemonade out of the lemon by
prodding it to doing some actual rigorous science on “complementary and
alternative medicine” that have at least a modicum of biological plausibility
and avoid wasting taxpayer money on fairy dust treatments whose precepts either 
violate the laws of physics (e.g., reiki, homeopathy, and other “energy”
medicine) or depend on nonexistent anatomy or physiology (e.g., reflexology,
craniosacral, traditional Chinese medicine tongue diagnosis).

This brings me to something I saw on the NCCIH Director’s Blog late last week, a
post by the director Josephine Briggs, Requesting Comments on NCCIH’s Draft
Strategic Plan. Patriotic US citizen and advocate of SBM that I am, how could I 
turn down such a request? Kimball Atwood didn’t shirk from such a request back
when Dr. Briggs was asking for comments on the NCCAM 2011-2015 strategic plan,
nor did I.

In fact, you, too, can comment as well. The deadline is April 15.

The NCCIH 2016-2021 draft strategic plan: Overview

I plan on discussing each objective in the plan, but before I do it’s useful to 
get the “bird’s eye” view and compare it to previous NCCIH plans. As I read
through the draft of the NCCIH 2016-2021 strategic plan, I couldn’t help but
feel a profound sense of déjà vu. In fact, much of the new strategic plan draft 
sounds suspiciously similar to the old plan. Let’s take a look at the goals and 
objectives of the old strategic plan first:

  1. GOAL 1: Advance the science and practice of symptom management.

  2. GOAL 2: Develop effective, practical, personalized strategies for promoting
    health and well-being.

  3. GOAL 3: Enable better evidence-based decision making regarding CAM use and its
    integration into health care and health promotion.

And the strategic objectives to be used to accomplish these goals:

  1. Strategic Objective 1: Advance Research on Mind and Body Interventions,
    Practices, and Disciplines

  2. Strategic Objective 2: Advance Research on CAM Natural Products

  3. Strategic Objective 3: Increase Understanding of “Real-World” Patterns and
    Outcomes of CAM Use and Its Integration Into Health Care and Health
    Promotion

  4. Strategic Objective 4: Improve the Capacity of the Field To Carry Out Rigorous
    Research

  5. Strategic Objective 5: Develop and Disseminate Objective, Evidence-Based
    Information on CAM Interventions

Now, let’s compare to the new plan, which has eliminated overarching goals and
simply lists five strategic objectives:

  1. Objective 1: Advance Fundamental Science and Methods Development

  2. Objective 2: Improve Care for Hard-to-Manage Symptoms

  3. Objective 3: Foster Health Promotion and Disease Prevention

  4. Objective 4: Enhance the Complementary and Integrative Health Research
    Workforce (cross-cutting)

  5. Objective 5: Disseminate Objective Evidence-based Information on Complementary
    and Integrative Health Interventions (cross-cutting)

In the place of overarching goals, the draft 2016-2021 plan now lists several
scientific priorities, stating that this part of the plan will be a “living”
document, to be “updated based on public health needs, new scientific
opportunities, research results, changes in the Center’s grant portfolio, and
budgetary considerations”:

  1. Nonpharmacologic Management of Pain

  2. Neurobiological Effects and Mechanisms

  3. Innovative Approaches for Establishing Biological Signatures of Natural
    Products

  4. Disease Prevention and Health Promotion Across the Lifespan

  5. Clinical Trials Utilizing Innovative Study Designs to Assess Complementary
    Health Approaches and Their Integration into Health Care

  6. Communications Strategies and Tools to Enhance Scientific Literacy and
    Understanding of Clinical Research

One can’t help but notice the similarity between the two plans, at least in
outline. For instance, Objectives 1 and 4 in the new plan are little more than a
repackaging of Objective 4 in the old plan, all of which carry with them an
implicit admission of how poor the science carried out by NCCIH-funded
investigators has been over the years. Indeed, one of the sub-objectives of
Objective 1 is to “Develop new and improved research methods and tools for
conducting rigorous studies of complementary health approaches and their
integration into health care.” Objective 5 is even more similar in both plans;
the two even have almost identical wording. Meanwhile, Objective 3 in the old
plan is basically the same as one of the scientific priorities, namely “Clinical
Trials Utilizing Innovative Study Designs to Assess Complementary Health
Approaches and Their Integration into Health Care.” Of course, whenever you see 
any sort of discussion of “innovative study design” with respect to CAM
modalities, it almost always means “coming up with study designs that make it
look as though this quackery actually works.”

Of course, there is nothing fundamentally wrong with a new five year plan
strongly resembling the previous five-year plan. It does, however, make one
wonder what progress has been made on the objectives shared by both plans and
whether something new needs to be done to meet those objectives. For instance,
as I said about the last plan, arguing for applying more rigorous science to
just about anything is rather like arguing for mom, apple pie, and the flag; no 
one is going to contest that as a worthy goal. The problem, of course, is what
one means by “rigorous science” and how one proposes to achieve that goal.

So let’s look at the objectives, but we should do so in the context of the
stated mission of NCCIH, which is reiterated in the plan’s introduction:

   The mission of NCCIH is to define, through rigorous scientific investigation,
   the usefulness and safety of complementary and integrative health
   interventions and their roles in improving health and health care.

And:

   To address the need for objective evidence as to the safety and efficacy of
   many of these approaches, NCCIH supports rigorous scientific investigation to
   better understand how these interventions work, for whom, and the optimal
   methods of practice and delivery.

One can’t help but note the language. It’s not “if” these interventions work,
but “how,” “for whom,” and the “optimal methods of practice and delivery,” all
of which are putting the cart before the horse. The introduction also repeats
the standard tropes about one-third or more of adult Americans using some form
of CAM, in which exercise like yoga, dietary interventions, and vitamin
supplements are counted as being “CAM.” I refer to this as a “trope,” because
there is nothing alternative about any of this; it is simply a “rebranding” of
what should be part of SBM as somehow being “alternative” when it is not, a
“rebranding” that is reemphasized later in the introduction:

   NCCIH also seeks to identify strategies for promoting health and preventing
   disease. Behavioral risk factors, including an unhealthy diet, being
   overweight or obese, living a sedentary life, smoking or using tobacco
   products, and the excessive consumption of alcohol, are linked to increased
   rates of cardiovascular disease, cancer, and diabetes. Preliminary evidence
   indicates that some complementary health approaches may be useful in
   encouraging improved self-care, an improved personal sense of well-being, and
   a greater commitment to a healthy lifestyle. For example, analysis of the
   2012 NHIS data indicates that many people who practiced yoga reported that it
   motivated them to practice healthier behaviors, including eating better and 
   exercising more regularly. While causal relationships between the practice of
   complementary approaches and healthy behaviors have not been established,
   further research is needed to explore, clarify, and examine their
   relationship.

Once again, there is nothing “alternative” or “integrative” about any of this.
Any primary care doctor worth his or her salt will counsel patients to eat
healthier, lose weight, stop smoking, decrease alcohol intake, and get off their
butts and exercise. I hear the part about losing weight, eating better, and
exercising every time I see my doctor. (Fortunately, I don’t smoke and don’t
overindulge in alcohol.) As for yoga, is there anything better about it that
motivates people to practice healthier behaviors, beyond what any sort of
exercise would accomplish? Again, none of this is in any way “alternative” or
“integrative,” and none of it needs a special center at the NIH to study it.

It is also important to note that NCCIH is now emphasizing, as its key
scientific priority, pain and difficult-to-control symptoms, in particular
nonpharmacologic methods of relieving pain. While there is certainly a need for 
better research into how better to control pain without non-steroidal
anti-inflammatory drugs or opioids, both of which have significant side effects 
and the latter of which is recognized as a significant cause of addiction and
premature death, one can’t help but note that these are also problems where
assessing the benefit of any therapy is very much compounded by placebo effects,
regression to the mean, and the like. Yet, elsewhere in the plan, NCCIH
addresses how to do “innovative clinical trials” by using “pragmatic clinical
trials to address questions about the integration of complementary health
approaches into health care systems, or to study the effectiveness of
complementary or integrative approaches in comparison to standard care.”
Remember, pragmatic trials are trials that are done only after more rigorous
trials actually show that an intervention works, with the intent to see how it
works in the “real world.” Doing pragmatic trials of treatments not yet shown to
work is putting the cart before the horse.

On the other hand, it’s good to know that NCCIH has finally accepted that
plausibility is important:

   As a responsible steward of its publicly provided resources, NCCIH is highly 
   selective in the choice of topics for major clinical trials. Decisions about 
   which large-scale trials to support must be based on the strength,
   reliability, and reproducibility of signals from clinical experience and
   preliminary, smaller pilot studies, as well as on evidence of scientific
   plausibility obtained from mechanistic studies.

Of course, there appears to be a bit of a problem in defining what “plausibility
means.” Now, it is true that NCCIH hasn’t funded a study of homeopathy since
2008, as I have pointed out before, and the lack of further funding of
homeopathy argues that NCCIH leadership might really mean it about scientific
plausibility. On the other hand, given how enamored NCCIH remains with
modalities like acupuncture and various modalities from traditional Chinese
medicine (TCM) that are rooted in a prescientific understanding of physiology
and disease, I can’t help but say to NCCIH: Plausibility. You keep using that
word. I do not think it means what you think it means.

Now let’s look at the objectives.

Objective 1: Advance Fundamental Science and Methods Development

As I said before, this objective is pretty much the “mom and apple pie”
objective in that no one is going to argue against improving fundamental science
and methods. The major problem with this objective is that it is so generic. It
is an objective that pretty much any institute or center at the NIH would have.
One of the key complaints we have about NCCIH is that it doesn’t serve a
purpose that couldn’t be just as well served elsewhere in the NIH and that there
is really no scientific justification for separating CAM from the rest of
medicine, later to “integrate” it, or for needing a separate specialty. There’s 
an oft-stated aphorism in skepticism that there is no such thing as alternative 
medicine. There is medicine that has been scientifically demonstrated to be safe
and effective; there is medicine that has not been scientifically demonstrated 
to be safe and effective; and there is medicine that has been scientifically
demonstrated to be ineffective or even harmful. Most alternative medicine falls 
into the latter two categories. Moreover, when any “alternative” or “outside the
mainstream” treatment is demonstrated to be safe and effective through science,
it ceases to be “alternative” and becomes just “medicine.”

On the other hand, I would rather see NCCIH devote resources to this objective
for the simple reason that the advances that result would be applicable not just
to the study of “alternative” health practices but to medicine in general.
After all, when NCCIH lists as a strategy in this objective, “Advance
understanding of basic biological mechanisms of action of natural products,
including probiotics,” I point out that this is nothing more than natural
products pharmacology of the type that has been done for decades in academia and
industry, where active compounds are purified and isolated from natural
sources. Similarly, the studies in this objective designed to “confirm the link 
between the impact of the natural product on a biological signature (i.e.,
mechanism of action) and demonstrate an association between the change in the
biological signature and clinical outcomes in humans” are nothing but more of
the same. Again, none of this is anything different than what is done for drug
and device development elsewhere; so, if NCCIH must exist, it would do the least
harm and the most good using its resources for these ends, my distaste for the 
“rebranding” of natural products pharmacology and drug development as somehow
“integrative” notwithstanding. The more resources NCCIH devotes to Objective 1, 
the less it has for pseudoscience.

Objective 2: Improve Care for Hard-to-Manage Symptoms

There is no doubt that there are a number of conditions and symptoms that
conventional medicine has a hard time dealing with. Chronic pain is, of course, 
one of the most common and worst. It is also a major source of morbidity and
mortality due to opioid addiction, often with an iatrogenic origin beginning
with a prescription for opioid pain relievers. Consequently, it is certainly
important to improve care for chronic pain and other difficult-to-manage
symptoms. The problem with this objective is that it is not at all clear how the
proposed methodology will lead to improved care for patients suffering from
such hard-to manage symptoms. For instance, NCCIH proposes studying the use of
natural products and probiotics for symptom management to “confirm the link
between the impact of the natural product on a biological signature (i.e.,
mechanism of action) and demonstrate an association between the change in the
biological signature and clinical outcomes in humans.” Yet there is little
evidence to support this approach over any other pharmacologic approach. The
same is true of so-called mind-body practices, an area that NCCIH places a great
deal of its stock in.

Let’s recap what NCCIH means by “mind and body” approaches. I’ll take its
definition from its last strategic plan, given that no new definition is
proposed in the current draft plan. The definition is so vague as to be
essentially meaningless, as NCCIH describes “mind and body” or “mind-body”
interventions as:

   These interventions, practices, and disciplines are grouped together in this 
   plan as mind and body* approaches because, from a research perspective, they 
   all share a set of characteristics that create similar challenges in
   designing rigorous and definitive clinical investigations of their benefit
   and safety. For example, (1) it is generally difficult or impossible to mask 
   practitioners and/or participants involved in clinical research, (2) claims
   about benefit often relate to subjective clinical outcomes, (3) in practice, 
   the interventions are often individualized, or they are complicated
   procedures that are difficult to systematize or characterize fully, and (4)
   means to objectively measure the impact of the interventions on important
   biological processes are frequently lacking, particularly those that purport 
   to act through processes not understood or well characterized by modern
   science.


   *Terminology: As used in this plan, mind and body encompasses interventions
   from the three domains of mind/body medicine, manipulative and body-based
   practices, and energy medicine.

Examples listed included:

  1. Acupuncture

  2. Breath practices

  3. Meditation

  4. Guided imagery

  5. Progressive relaxation

  6. Tai chi

  7. Yoga

  8. Spinal manipulation

  9. Massage therapy

  10. Feldenkrais method

  11. Alexander technique

  12. Pilates

  13. Hypnosis

  14. Trager psychophysical integration

  15. Reiki

  16. Healing touch

  17. Qi gong

  18. Craniosacral therapy

  19. Reflexology

Notice that there’s a whole lot of quackery in there (e.g., reiki, healing
touch, craniosacral therapy, acupuncture, reflexology) mixed in with the
potentially useful, such as guided imagery, progressive relaxation, and
meditation. That’s why, right off the bat, I’m not sure if what is meant by
“mind and body” interventions in the 2016-2021 strategic plan draft is the same 
as what NCCIH meant in its 2011-2015 plan, because in the most recent draft
plan, it describes “mind and body” interventions as “massage, acupuncture, yoga,
and meditation, and natural products, such as herbs, fish oil, melatonin, and
probiotics.” The definition is as amorphous as the definition of CAM, and it
appears to change to mean whatever NCCIH needs it to mean, such that one can’t
help but think of Humpty Dumpty’s famous statement, “When I use a word, it means
just what I choose it to mean—neither more nor less.”

“Fluidity” of language or not, it’s a good thing that the quackery appears to be
gone. Indeed, on the NCCIH web page on Mind and Body Practices, the only
blatant quackery left is acupuncture, with the rest including massage therapy,
meditation, relaxation techniques, spinal manipulation, and yoga. However, it is
odd that NCCIH did not explain why it changed its definition. Whatever the
reason for the change, many of these “mind and body” interventions, other than
acupuncture, are nothing that needs a separate “alternative” label or that
requires a separate center to study them. If they were going to be studied with 
rigorous science, then, again, my distaste for the “rebranding” going on here
notwithstanding, it would be a good thing that NCCIH is using its resources this
way rather than to study homeopathy or “energy medicine.”

On the other hand, NCCIH giveth, and NCCIH taketh away. While saying it’s going 
to use rigorous science to study mind and body interventions, it then concludes 
this objective thusly:

   Given the widespread use of complementary health approaches, opportunities
   exist to employ clinical outcomes and effectiveness research methodologies to
   collect “real world” evidence about the use of specific complementary
   approaches for health care and health promotion. Pursuing this type of
   research requires creative collaboration with those who provide care in
   settings where integration of complementary health approaches could be
   studied. The “real-world” settings for such research may be quite varied, and
   could include schools, nursing homes, hospices, cancer treatment facilities,
   and settings that provide care for military personnel and Veterans.

This is simply another mention of “pragmatic” studies, or putting the cart
before the horse. Again, pragmatic studies are useful for seeing how treatments 
that have already passed muster in randomized controlled trials (RCTs) perform
in “real life,” but they cannot themselves demonstrate efficacy unless the
effect size is so enormous as to be undeniable, something that is seldom seen in
clinical research and virtually never seen in CAM research. Basically, one
purpose of pragmatic studies in CAM research is to serve as an excuse to
substitute lower quality, less rigorous clinical investigation evidence showing 
that a CAM intervention “works” for the more rigorous RCT evidence that failed
to find an effect. NCCIH really needs to remove or greatly deemphasize this
reliance on pragmatic studies to investigate CAM interventions if it wants to be
taken seriously by scientists. Of course, if NCCIH did that, it would have
almost nothing left in terms of clinical investigation.

There is another purpose of “pragmatic” research as well. As Steve Novella has
described, pragmatic studies of CAM are in essence a bait-and-switch, which he
likens to the “part of this nutritious breakfast” con, in which something like
Chocolate Frosted Sugar Bombs is described as “part” of such a breakfast because
the rest of the breakfast is nutritious all by itself; so it’s still nutritious
even with the Sugar Bombs. It’s the same way CAM researchers add something like
acupuncture to another intervention, even though they can’t separate out the
variables, and conclude that acupuncture (or insert your favorite CAM treatment 
here) is part of a “healthy regimen,” even though it is irrelevant.

Which, appropriately enough, brings us to Objective 3. Remember Chocolate
Frosted Sugar Bombs when reading this next section.

Objective 3: Foster Health Promotion and Disease Prevention

Objective 3 is perfect example of what Steve was talking about. It’s basically
studying the addition of Chocolate Frosted Sugar Bombs as part of a healthy
breakfast. In other words, it’s the “integration” of interventions that are
“alternative” by virtue of being science-based modalities rebranded as
alternative or integrative (like exercise and nutrition) or are quackery (like
acupuncture), the implication being that they are necessary or very helpful to a
“health-promoting” lifestyle. Some interventions (the rebranded ones) might
actually be part of that healthy breakfast. Other interventions (like
acupuncture) are Chocolate Frosted Sugar Bombs.

Moreover, the vast majority of Objective 3 consists of yet more examples of
putting the cart before the horse; i.e., studying how to add the Chocolate
Frosted Sugar Bombs to the breakfast without first determining whether they
should be added in the first place. This objective proposes three strategies to 
achieve its end:

  1. Investigate mechanisms of action of complementary and integrative health
    approaches in health resilience and practices that improve health and
    prevent disease.

  2. Study complementary health approaches to promote health and wellness across
    the lifespan in diverse populations.

  3. Explore research opportunities to study and assess the safety and efficacy of 
    complementary health approaches in non-clinical settings such as community- 
    and employer-based wellness programs.

One notes a heavy emphasis on using pragmatic studies of how CAM “works” in the 
“real world” and a distinct lack of emphasis on studying whether CAM “works” in 
the first place. I would counter that Objective 3 is premature and that NCCIH,
if it must exist, should study whether CAM has beneficial health effects, not
how to integrate CAM with medicine. Of course, NCCIH is not likely to do this
because its stakeholders, particularly the ones with representation on the
National Advisory Council for Complementary and Integrative Health (NACCIH), the
advisory council to which Dr. Briggs answers, do not want it, given how many
naturopaths, acupuncturists, and chiropractors sit on the council. Remember,
NCCIH was originally created as a mechanism to legitimize alternative medicine, 
which is why Sen. Harkin so famously expressed disappointment several years ago 
that NCCIH wasn’t validating enough quackery.

Objective 4: Enhance the Complementary and Integrative Health Research Workforce

Here’s another objective that is like arguing for mom and apple pie. Who can
argue against improving the research workforce? I can, at least if that
workforce is being trained to study treatments that likely have no value,
particularly considering these aims in the objective:

   In particular, the Center will focus on:

  1. Clinician-scientists, including conventionally trained physicians,
    complementary health practitioners, and other health care professionals
    (e.g., clinical psychologists, nurses) who conduct research across a wide
    range of complementary and integrative heath approaches.

  2. Scientists trained in key biomedical and behavioral research disciplines
    necessary for rigorous, state-of-the-art scientific investigation of
    complementary and integrative health interventions, practices, and
    disciplines.

  3. Individuals from groups who are underrepresented in scientific research (e.g.,
    racial and ethnic minority populations) and are interested in careers in
    complementary and integrative health research.

For one thing, if these researchers are trained, who will fund them, given the
prolonged budget crunch at NIH that began over a decade ago and has led to
periods of record low grant funding rates? Even the NCCIH budget has been flat. 
More importantly, I would argue that these clinician-scientists and scientists
would be far better utilized studying more promising interventions than anything
NCCIH currently funds. Remember, what NCCIH is talking about here is training
grants, and NCCIH training grants have not had a good record of promoting
evidence- and science-based knowledge and skills about medicine. Still, if NCCIH
must exist, training scientists in research methodology would be less harmful
than wasting money studying and promoting homeopathy or “energy medicine.”

Next up…

Objective 5: Disseminate Objective Evidence-based Information on Complementary
and Integrative Health Interventions

This is yet another “mom and apple pie” objective. The main problem with it is
what NCCIH might promote, as its definition of “evidence-based information” does
not necessarily jibe with what really is evidence-based information. In fact, I
actually hope that NCCIH really does promote objective, evidence-based
information on CAM, that it really is serious about it. If so, it would tell
people that homeopathy is nothing but water, that there is no evidence that
reiki practitioners can manipulate a “universal energy field” to heal, and that 
there’s no scientifically convincing evidence that practitioners of therapeutic 
touch can detect or manipulate human energy fields. Let’s look at what NCCIH
says about reiki, because reiki is as pure a quackery as homeopathy:

   Reiki is based on an Eastern belief in an energy that supports the body’s
   innate or natural healing abilities. However, there isn’t any scientific
   evidence that such an energy exists.

OK, close, but not quite. Reiki does depend on a belief in “energy” that
practitioners can supposedly channel into patients for healing effect. NCCIH
doesn’t mention that that “energy” comes from something called the “universal
source.” When you look at it that way, what reiki very much resembles faith
healing, substituting Eastern mystical beliefs for Judeo-Christian beliefs. If
you don’t believe me, just substitute “God” for “universal source.”

Then it goes wrong:

   Several groups of experts have evaluated the evidence on Reiki, and all of
   them have concluded that it’s uncertain whether Reiki is helpful.

   Only a small number of studies of Reiki have been completed, and most of them
   included only a few people. Different studies looked at different health
   conditions making it hard to compare their results. Many of the studies
   didn’t compare Reiki with both sham (simulated) Reiki and with no treatment. 
   Studies that include both of these comparisons are usually the most
   informative.

No, when there is no evidence that reiki “energy” exists and the intervention
has as low a scientific plausibility as reiki, it’s safe to say that it doesn’t 
work.

Here’s what NCCIH says about homeopathy:

   There is little evidence to support homeopathy as an effective treatment for 
   any specific condition.

More like no convincing evidence, but I won’t quibble about that. Also:

   Homeopathy is a controversial topic in complementary health research. A
   number of the key concepts of homeopathy are not consistent with fundamental 
   concepts of chemistry and physics. For example, it is not possible to explain
   in scientific terms how a remedy containing little or no active ingredient
   can have any effect. This, in turn, creates major challenges to rigorous
   clinical investigation of homeopathic remedies. For example, one cannot
   confirm that an extremely dilute remedy contains what is listed on the label,
   or develop objective measures that show effects of extremely dilute remedies
   in the human body.

What a weaselly, wishy-washy way of describing homeopathy. No, homeopathy is not
controversial scientifically. Its precepts violate fundamental concepts in
chemistry and physics. Barring a major change in the understanding of those
precepts, by what we know about physics and biochemistry now, homeopathy cannot 
work. That is the main “challenge” to doing clinical trials of homeopathy and
the main reason why such trials are not scientifically fruitful or even ethical.
Even considering only clinical evidence, taken as a whole, clinical trials are 
consistent with homeopathy having no effect over that of placebo. Clearly NCCIH 
has a way to go to improve its objective, evidence-based assessments.

Finally…

Top Scientific Priorities

NCCIH proposes these as its current top scientific priorities:

  1. Nonpharmacologic Management of Pain

  2. Neurobiological Effects and Mechanisms

  3. Innovative Approaches for Establishing Biological Signatures of Natural
    Products

  4. Disease Prevention and Health Promotion Across the Lifespan

  5. Clinical Trials Utilizing Innovative Study Designs To Assess Complementary
    Health Approaches and Their Integration Into Health Care

  6. Communications Strategies and Tools To Enhance Scientific Literacy and
    Understanding of Clinical Research

I’ve already touched on some of these areas above; so I won’t go into too much
detail. I can’t help but note that many of the research priorities here again
assume that much of CAM works and that there are, for instance, biomarkers that 
will correlate with various CAM interventions having a biological effect, not
asking if these CAM interventions actually have a therapeutic effect. Once
again, we see a proposal to conduct “large, pragmatic studies of pain management
addressing important clinical or health systems questions.” Such studies would 
be virtually guaranteed to be positive and “validate” almost any CAM
intervention you can think of; pragmatic studies of CAM should not be done
absent compelling RCT results showing efficacy.

One interesting thing I couldn’t help but notice were areas the NCCIH calls
“Areas of Low Programmatic Priority.” First, I noticed these:

  1. Research comparing clinical outcomes of verum and sham acupuncture.

  2. Research comparing individualized to standardized acupuncture treatment
    protocols.

The naïve one in me would like to think that these areas were given low priority
because the questions have been answered resoundingly. We know that there is no
difference between “real” and “sham” acupuncture in results, and we know that
individualizing acupuncture treatments makes no difference. As I like to say, it
doesn’t matter where you stick the needles or even if you stick the needles in.

There was also another set of interesting areas of low priority, this time in
natural products:

  1. Research focused on a single compound or well-characterized mechanistic
    target.

  2. Screening of natural product libraries in subcellular assays.

  3. Bioactivity-guided fractionation projects.

These are basically standard pharmacological studies. You look at one drug and
one cellular target for that drug. Or you can screen libraries of natural
products for activity using various biochemical assays. Or you fractionate a
crude plant extract looking for the fractions that have activity. In other
words, NCCIH has relegated to “low programmatic priority” anything resembling
standard pharmacology in favor of looking for biological “signatures” due to
crude extracts for which the active compounds might be many, looking for that
mystical “synergy.” In other words, NCCIH is assuming without evidence that
“natural” crude extracts are better than single compounds.

Finally, I couldn’t help but laugh at these last three low priority areas:

  1. Large-scale clinical trials of mind and body interventions when there are no
    preliminary data to determine appropriate dose, duration, and frequency or
    whether the patient population can adhere to the proposed intervention.

  2. Large-scale clinical trials of natural products when there are no preliminary 
    data demonstrating the availability, bioavailability, and pharmacokinetics
    of the product; a replicable effect on a biologic signature; and dosing
    studies to determine the appropriate dose to impact the biologic signature.

  3. Pragmatic trials of interventions that do not have preliminary data
    demonstrating clinical efficacy or effectiveness in large controlled trials.

Did you see that last one? NCCIH says throughout this strategic plan that it
wants to do more “pragmatic” trials, and here it says that such trials are of
low priority if there are not preliminary data from large RCTs demonstrating
efficacy. That’s quite a conundrum NCCIH has created for itself there,
particularly when it says in the previous two low-priority items that it won’t
do large-scale clinical trials of CAM or natural products without good
preliminary data or a replicable effect on a biological signature. I can’t help 
but note that if NCCIH really did adhere to these guidelines, it would never
fund any clinical trials at all. Of course we all know that NCCIH will fund
clinical trials, because its stakeholders won’t long stand for this much rigor. 
It’ll find ways to justify them and appear as though it’s not ignoring its
strategic plan.

Don’t get me wrong. As I’ve said before, NCCIH has improved under Dr. Briggs’
stewardship. She has, for the most part, eliminated funding for the worst
quackery, such as homeopathy, although when Steve Novella, Kimball Atwood, and I
met with her six years ago she wouldn’t—or couldn’t—say that NCCIH would not
fund homeopathy studies any more, and in retrospect seemed to be meeting with us
and homeopaths in order to be able to say she had “listened to both sides” more
than anything else. Unfortunately, NCCIH still remains enamored of acupuncture 
and some “energy medicine,” such as healing touch.

Like integrative medicine, NCCIH has evolved. Its original purpose was to
validate a lot of alternative medicine because a woo-friendly senator wasn’t
happy with the way that the NIH concerned itself with little things like
scientific plausibility and rigorous scientific evidence in evaluating health
interventions. In the beginning, it wasn’t that sophisticated about it and
tested all sorts of wild alternative medicine, such as homeopathy, distant
healing, and the like. As criticism mounted and the evidence became clearer and 
clearer that that woo didn’t work, eventually NCCIH started concentrating on
areas less obviously pseudoscientific and, of course, on rebranding conventional
science-based interventions like diet and exercise as somehow being part of CAM
or “integrative medicine”. It had to.

The NCCIH 2016-2021 draft strategic plan is evidence of just how narrow NCCIH’s 
purview has become. Over the last 20 years, it’s failed to validate a single
alternative medicine intervention, and, one by one, the more quacky ones have
become unsupportable, even by NCCIH. All that’s left now are rebranded SBM
interventions. As I like to say, integrative treatments that might have a basis 
in science tend, from a scientific perspective, to be pretty mundane. In the
world of “integrative medicine,” all the “sexy” interventions are the ones based
in myth, prescientific ideas, and pseudoscience, like homeopathy, acupuncture, 
and TCM, and it’s all of those that NCCIH has largely—but not completely—been
forced to abandon.

The problem at the heart of this strategic plan is that, minus the study and
promotion of quackery, NCCIH has even less of a reason to exist now than it did 
before, but it’s not going away. As long as Dr. Briggs remains in charge, it is 
likely to continue in the mode that this draft strategic plan describes. I can
live with that. Unfortunately, Dr. Briggs will not always be in charge; someday 
she will move on or retire. Her successor might not be as dedicated to trying to
avoid wasting resources studying pure quackery as she has been. That’s why the 
ideal solution would still be to defund and disband NCCIH. Until that happens,
this strategic plan is probably about as good as NCCIH will get.

NCCIH funds sauna “detoxification” study at naturopathic school

Jann Bellamy on September 15, 2016

Link





Where’s the sauna detox?

It is no secret that we at SBM are not particularly fond of the National Center 
for Complementary and Integrative Medicine (NCCIH; formerly, the National Center
for Complementary and Alternative Medicine). We’ve lamented NCCIH’s use of
limited public funds for researching implausible treatments, the unwarranted
luster NIH/NCCIH funding bestows on quack institutions, the lack of useful
research it has produced, and its failure to shoot straight with the public when
discussing alternative/ complementary/ integrative medicine. Nor does NCCIH’s
research appear to affect CAM practice. Lack of evidence of safety or
effectiveness is no impediment to use among CAM practitioners or “integrative”
physicians.

So I shouldn’t have been surprised (NCCIH’s promise to “do some real science for
a change” notwithstanding) when, a few days ago, I ran across a study of which 
I was previously unaware (for good reason, as you’ll see) on clinicaltrials.gov:

Sauna Detoxification Study: Pilot Feasibility

   The goal of this study is to assess the feasibility of the approach, conduct 
   a dose-finding investigation, and obtain pilot data on hyperthermia via sauna
   to apply in follow-up trials in the assessment of human chemical body burden
   reduction, for general wellness, detoxification, and pain reduction.

   The investigators wish to determine if a hyperthermia-based detoxification
   protocol is feasible to conduct: including assessment of recruitment,
   enrollment, retention, protocol adherence, adverse events, and changes in
   serum polychlorinated biphenyls (PCBs).

And:

Complementary and Alternative Medicine Sauna Detoxification Study: Phase I

   The purpose of this study is to determine the impact of sauna use on
   polychlorinated biphenyls (PCB) in the blood of healthy human adults, as well
   as to assess safety, feasibility, and tolerability, and effects on quality
   of life and wellness. We hope to determine if there is a link between lower
   PCB levels in blood and sauna use.

The studies were conducted at Bastyr University, which awards degrees in
pseudoscientific fields of study like naturopathy, TCM, and ayurvedic medicine, 
and funded by NCCIH to the tune of $736,938 between 2011 and 2013, under an
award titled “Complementary and Alternative Medicine Detoxification: Safety and 
Efficacy.”

And the rationale for this?

   According to our nationwide survey of Naturopathic Physicians regarding use
   of detoxification, approximately 80 percent of NDs (Naturopathic Doctors) use
   some type of detoxification interventions in clinical practice on a regular 
   basis. Of the interventions used, 66% of respondents reported using sauna
   therapy. Of the conditions treated, over 80 percent of practitioners use
   sauna-based detoxification for “general cleansing/preventive medicine.” This 
   protocol will utilize a sauna as the primary method of detoxification. . . . 
   Previous studies on hyperthermia-based protocols for detoxification have been
   methodologically challenged and are not readily reproducible. Furthermore,
   there are no studies in the literature that identify how long of a protocol
   is tolerated, is feasible in the general population, or how long is needed to
   observe PCB (or other pollutant reduction).

So, the survey confirms what we’ve long known: Naturopaths are nuts for
detoxification, despite the lack of evidence that it is of any benefit
whatsoever to patients. They love to scare the willies out of patients by
claiming our enviornments are full of disease-causing “toxins,” which must be
eliminated posthaste via saunas, supplements, and other concoctions, colonics
and restrictive diets. Otherwise, as one naturopath advised,

   If you don’t detoxify, you’ll blow up!

This survey of naturopathic detoxification practices was published in the
Journal of Alternative and Complementary Medicine and also funded by NCCIH. The 
lead author is the principle investigator, Bastyr naturopath Jason Allen. He and
the other authors, one of whom is naturopath Wendy Weber, an NCCIH employee and
recently the subject of a post by David Gorski, try to put a positive spin on
the fact that the survey showed widespread use of detoxification despite the
lack of evidence of benefit:

   The wide variety in responses regarding age, patient populations/conditions, 
   and therapies may reflect the philosophy of “comprehensive,
   multidisciplinary, and individualized interventions,” typical of the
   naturopathic profession.

The only problem being, of course, that these “comprehensive, multidisciplinary,
and individualized interventions” are a hodgepodge of quackery, detoxification 
being one of the interventions the authors admit has no basis in evidence.

The authors note that environmental chemicals can have deleterious health
effects, which is true. Yet, having just established that there is no evidence
supporting the various “detoxification” treatments as an effective therapy and
that naturopaths nevertheless use them willy-nilly for all sorts of things, the 
authors make a gigantic leap to the conclusion that:

   Detoxification therapies used by NDs may serve as an adequate means to reduce
   the body burden of synthetic chemicals found today in humans; however,
   scientifically rigorous research is needed to determine the safety and
   efficacy of these therapies.

They don’t come close to suggesting any plausible means by which “detoxification
therapies used by NDs” could possibly “reduce the body burden of synthetic
chemicals” sufficient support a trial of sauna “detoxification.” But that is the
beauty of NCCIH-sponsored research: if CAM practitioners are doing it, we must 
spend money studying it, to heck with all those pesky interim requirements other
scientists have to jump through, like animal studies, scientific plausibility
and such.

Sweating it out, or not

I did find one article on Bastyr’s website explaining the basis for Allen’s
belief that a few turns in the sauna would get rid of “toxins:”

   While subjects may literally sweat out small amounts of chemicals, the heat
   treatment’s chief benefit will most likely come from lipolysis — breaking
   down fat, where toxic substances are stored. That would allow them to move
   through the bloodstream to the kidneys and liver, which are the primary
   organs of excretion . . .

That sweating won’t really accomplish anything useful, though, and it can be
detrimental.

Dr. Dee Anna Glaser, a professor of dermatology at St. Louis University and
founding member of the International Hyperhidrosis Society, a medical group
dedicated to the study and treatment of heavy sweating, says sweat does contain 
trace amounts of toxins. But, she says, sweating has only one function – cooling
you down when you are overheated.

   Sweating for the sake of sweating has no benefit . . . Sweating heavily is
   not going to release a lot of toxins.

Dr. Glaser points out that heavy sweating can actually impair your body’s
natural detoxification system. We count on the liver and kidneys — not the sweat
glands — to filter toxins from our blood. If you don’t drink enough water to
compensate for a good sweat, dehydration could stress the kidneys and keep them 
from doing their job. So, “if you’re not careful, heavy sweating can be a bad
thing.”

Sweating definitely won’t help clear the body of mercury or other metals,
according to Donald Smith, a professor of environmental toxicology at UC Santa
Cruz, who studies treatments for metal poisoning. Almost all toxic metals in the
body are excreted through urine or feces, he says. And less than 1% are lost
through sweat. In other words, according to Smith, you’ll do far more
detoxifying in the bathroom than you ever could in a sauna.

Here’s what Smith said about one sauna company’s claim that “sweat carries
toxins out of the body and pushes [them] out of the pores, . . washes away
pesticides and industrial chemicals but is especially effective in removing
heavy metals such as lead, mercury and arsenic.”

   Baloney.

But will a sit in the sauna break down fat and cause toxins to exit the body? If
that’s a viable theory, it is apparently not well known in the field:

   Roger Clemens [is the] director of an analytical laboratory at the University
   of Southern California that evaluates environmental toxins in the food
   supply. Clemens remarked that the most efficient system for detoxification is
   not an infrared sauna but rather the kidneys, liver, gastrointestinal tract 
   and immune system. ‘Except when one of the major organs breaks down, there
   isn’t a medical device or any diet that can accelerate the body’s natural
   process of detoxification,’ he says.

I couldn’t find anything supporting what Allen says on PubMed, but just to be
sure, I ran it by my own panel of experts. Dr. Hall assures me that this doesn’t
make any sense and Dr. Crislip finds that it is indeed “nonsense.” Dr. Jones
notes that if the sauna’s heat is high enough to break down fat, it’s going to
cook your skin also. That’s good enough for me.

But, despite these substantial flaws, what if the study showed an association
between using saunas and a reduction in PCBs in the blood? Would that be
worthwhile information? Not really. While PCBs are known to be harmful and their
manufacture has been banned, blood testing for PCBs isn’t likely to yield
useful health information. And because most of us have a measurable level of
PCBs in our bodies, trial participants will be alarmed for no good reason when
their tests prove positive.

   Tests are available to measure the levels of PCBs in the blood and breast
   milk. Because PCBs are common in the environment, most people will show some 
   level. The problem, though, is that there are no reference values that define
   a “normal” level of exposure to PCBs. Thus, your physician will not be able 
   to tell you the meaning of a PCB level in your blood or breast milk beyond
   the fact that it is present. A test that shows PCBs in your blood will not
   explain how long the exposure lasted or if there will be health effects from 
   the exposure.

In other words, based on our current state of knowledge, we don’t know that
reducing PCBs in the body will produce beneficial health effects, so there is no
known value in reducing their level. Nor does testing predict treatment. If
that is the case, what’s the point of studying whether saunas are associated
with reduced level of PCBs?

If saunas don’t work, it’s not for lack of trying. Allen described his protocol 
thusly in one newspaper article on the study:

   What I’m proposing is a little more aggressive protocol, it’s like spring
   cleaning . . .

Boy, he wasn’t kidding either. In the pilot feasibility study, “low dose”
participants got 1 hour of sauna a day, 3 days a week, for 3 weeks, or 9
sessions. The “high dose” participants got a whopping 30 hours of sauna over the
3-week period, coming in for 2 hours of sauna 5 days a week. (From the
description provided, it is not clear to me how many hours of sauna participants
in the Phase I trial endured, only that their visits to the Bastyr clinic
lasted 3.5 hours.)

And the results are?

We don’t know. No results are posted for the pilot study. The Phase I trial,
which was to have been completed in April, 2014, was terminated for reasons that
are not explained. I can find no published results on PubMed and no study
results on the Bastyr or the NCCIH website. Bastyr, contrary to
clinicaltrials.gov, says the study is “completed;” NCCIH doesn’t mention the
study at all. In fact, the NCCIH’s page on “‘Detoxes’ and ‘Cleanses'” doesn’t
even mention sauna detoxification.

So, history repeats itself and the NCCIH has apparently blown almost
three-quarters of a million dollars on a questionable study of “detoxification” 
conducted at an institution that teaches its students rank quackery like
homeopathy, promotes anti-vaccination ideology, and misrepresents naturopathy
education and training to the public. To add insult to injury, Bastyr uses this 
NCCIH funding in PR to promote itself, giving it undeserved legitimacy and the
false appearance of scientific rigor. Yet, it will continue to teach
“detoxification” to its naturopathic students despite its admitted lack of
evidence of safety and effectiveness and practicing naturopaths will continue to
“detox” their patients, all to the benefit of their bottom lines.

And one more thing

While we are on the subject of naturopaths and NCCIH, it is interesting to note 
that the NCCIH website has completely sanitized its description of naturopathy, 
a development I wrote about last year on SfSBM and worth repeating here. NCCAM’s
description of naturopathy used to be refreshingly frank, with statements like:

   Although some of the individual therapies used in naturopathy have been
   studied for efficacy and safety, naturopathy as a general approach to health 
   care has not been widely researched.

   ‘Natural’ does not necessarily mean ‘safe.’ Some therapies used in
   naturopathy, such as herbal supplements and restrictive or unconventional
   diets, have the potential to be harmful if not used under the direction of a 
   well-trained practitioner.

   Some beliefs and approaches of naturopathic practitioners are not consistent 
   with conventional medicine, and their safety may not be supported by
   scientific evidence. For example, some practitioners may not recommend
   childhood vaccinations. The benefits of vaccination in preventing illness and
   death have been repeatedly proven and greatly outweigh the risks.

   Naturopathy is not a complete substitute for conventional care. Relying
   exclusively on naturopathic treatments and avoiding conventional medical care
   may be harmful or, in some circumstances (for example, a severe injury or an
   infection), have serious health consequences.

Even though none of these warnings has proven false, all of them are gone.

The public now learns only about the education and training of naturopathic
“physicians” at 4-year “medical schools” and the fact that they have “continuing
education requirements.” As well, “some U.S. states and territories have
licensing requirements for naturopathic physicians; others don’t.” The public
doesn’t learn the fact that they are licensed or registered in only a handful of
states. And, if they’re not (and NCCIH doesn’t tell you this either)
naturopathic “physicians” better not be calling themselves “physicians” or
trying to pretend they can practice as “physicians,” as that would be illegal.
To be fair, some of this information was in the former information page on
naturopathy, but it was tempered by appropriate warnings.

The public is now told that “people visit naturopathic practitioners for various
health-related purposes, including primary care, overall well-being, and
treatment of illnesses.” Of course, to the average member of the public, unaware
of the total nonsense that comprises a good portion of naturopathic practice,
this probably implies that seeing a naturopath for “primary care” or “treatment 
of illnesses” is perfectly sensible. And the NCCIH isn’t going to discourage
anyone from thinking otherwise.

The naturopathy page does link to the study showing an association between lower
vaccination rates and children seeing a CAM practitioner, and the association
between use of naturopathy and significantly more vaccine-preventable disease
diagnoses. It also says, however, that we don’t know if these associations are
simply because parents who are anti-vaccination seek out CAM practitioners, or
whether they are actually getting anti-vaccine advice. That is true, but studies
confirm the anti-vaccination ideology of naturopaths, and that should be
clearly stated. It is a fact. This is particularly disappointing in light of the
NCCIH director, Dr. Josephine Briggs, agreeing with David Gorski, Steve Novella
and Kimball Atwood that anti-vaccination ideology in CAM providers should not
be tolerated.

At the time I wrote the SfSBM post, in October of last year, if you dug around
you could still find the original information on naturopathy in the form of a
pdf. Now, that link doesn’t work and I can’t find the pdf anywhere on the
website. Consequently, the benign impression of naturopathy presented by NCCIH
goes unchallenged.

Back when he was posting on SBM, Kimball Atwood opined that

   For a number of reasons, well-argued many times here on SBM, it would be
   beneficial to American citizens if the National Center for Complementary and 
   Alternative Medicine (NCCAM) were abolished.

Six years later, NCCIH is carrying on the tradition of annoying SBM posters to
the point of their calling for its closure. Count me among them.



NCCAM manipulates spinal manipulation

Jann Bellamy on July 26, 2012

Link

“Complementary and alternative medicine,” as pediatrician and fellow blogger
John Snyder aptly stated in a recent journal article on CAM and children,

   is a term used to describe a disparate, poorly defined set of practices and
   treatment modalities presumed to be distinct from so-called ‘conventional
   medicine’.

As we have discussed here at Science-Based Medicine, this amorphous concept
facilitates a convenient fluidity in delineating the parameters of CAM. Without 
a clear definition, CAM (and integrative medicine) proponents are able to
rebrand plausible and evidence-based practices such as diet, exercise and
relaxation as CAM, a tactic we at SBM call “bait and switch.” This results in
inflation in the figures of CAM use (important because CAM is all about
popularity) and claims that CAM “works.”

Manipulating a term

Yet another example of CAM’s claiming “conventional” medicine as its own
appeared in the form of NCCAM’s most recent Clinical Digest, which discusses CAM
treatments for pain and mischaracterizes spinal manipulation as CAM.

(FYI, this edition of Clinical Digest also promotes acupuncture for pain, even
though it doesn’t work, and co-opts exercise (Tai Chi) and relaxation as CAM,
even when they aren’t.)

NCCAM’s categorization of spinal manipulation as CAM would surely come as a
surprise to the orthopedic surgeons who prescribe it, the physical therapists
who carry out those orders, and the M.D.s and D.O.s who themselves perform it.
Spinal manipulation is a physical therapy employing a high velocity, low thrust 
technique whereby a joint (such as a spinal vertebra) is moved beyond its normal
physiological range of motion. The primary purpose of the therapy is to create 
mobility in an otherwise tightened joint. While its mechanism of action is not
fully understood, it is biologically plausible and has some evidence of
effectiveness for certain types of back and neck pain. It is “conventional”
medicine.

A likely source of NCCAM’s confusion is chiropractors’ use of the term “spinal
manipulation.” Some chiropractors employ manipulation in the same way physical
therapists, MDs and DOs do – as a physical therapy for patients with back or
neck pain who have been conventionally diagnosed and found to be appropriate
candidates for this therapy. However, chiropractors also use the term “spinal
manipulation” as a synonym for “spinal adjustment” which, in their unique
vocabulary, is a treatment for the ubiquitous and nonexistent subluxation. Only 
chiropractors use the term in this manner because only chiropractors believe the
chiropractic version of the subluxation exists. There is an excellent
discussion of this distinction by Sam Homola, himself a chiropractor, on SBM and
NCCAM’s staff would do well to review it.

(By way of background, to a physician, nurse, physical therapist and other
science-based health care providers, a subluxation is a partial dislocation, as 
of a joint. Chiropractors have their own vocabulary which includes terms defined
differently than, or not used in, the common lexicon of other health care
providers.)

The chiropractic subluxation has been addressed a number of times here at SBM,
but briefly the subluxation is an ill-defined, unproven spinal pathology of no
known clinical significance. It was invented out of whole cloth in 1895 by a
self-styled “magnetic healer” who had no medical education or training. Despite 
efforts by chiropractors to backfill a scientific explanation into this
preconceived notion, there is no plausible scientific evidence that the
chiropractic subluxation exists.

Not surprisingly, chiropractors cannot agree on a definition for their
subluxation, how to diagnose one, or its clinical significance. They can’t even 
agree on a name for it – it’s variously called the vertebral subluxation
complex, manipulable lesion, spinal lesion, joint dysfunction, and so on. Nor
can they agree on its role in chiropractic – large and unremitting intramural
battles have been fought over the subject. Nevertheless, chiropractors daily
tell patients that they are suffering from subluxations which must be corrected 
at the risk of ill health. Again, one means of correction is the chiropractic
“adjustment,” which chiropractors also refer to as “manipulation.”

If chiropractors are this confused, then one can well understand how the writers
and editors of NCCAM’s website could be confused, but it’s time to set the
record straight. The correction of subluxations via a spinal
adjustment/manipulation is not the same as the use of spinal manipulation by
physical therapists and other health care providers as a means of alleviating
back or neck pain. While it is true that a chiropractor might “find” a
subluxation and claim it is the cause of a patient’s pain, this is not a
legitimate diagnostic method nor is its correction via an
adjustment/manipulation a legitimate therapy for the patient’s pain.

NCCAM does its readers a real disservice in failing to explain this critical
difference. As it stands, readers may be left with the incorrect assumption that
a chiropractor’s use of adjustments/manipulations to correct subluxations is a 
useful therapy for neck or back pain. This is especially important because some 
chiropractors have intentionally tried to exploit the efficacy of manipulation
for back pain as proof that chiropractic “works.” They have also falsely claimed
that they are more proficient at, and safer in performing, spinal manipulation 
than other practitioners, to the point of trying to use the political process to
prohibit physical therapists from employing manipulation.

But wait, it gets worse

To confound the problem, NCCAM’s discussion of manipulation as a pain therapy
refers readers to its information on chiropractic, the very practitioners who
may subject them to the ineffectual adjustment/manipulation for pain. And while 
NCCAM’s confusion over conventional manipulation versus chiropractic
manipulation for subluxations might be understandable, any sympathy should end
at this reference. As David Gorski pointed out, NCCAM discusses CAM practices in
a “weaselly, wishy-washy way,” and chiropractic is no exception:

   Chiropractic is a health care profession that focuses on the relationship
   between the body’s structure—mainly the spine—and its functioning. Although
   practitioners may use a variety of treatment approaches, they primarily
   perform adjustments (manipulations) to the spine or other parts of the body
   with the goal of correcting alignment problems, alleviating pain, improving
   function, and supporting the body’s natural ability to heal itself.

For the uninitiated, let’s decode these weaselly words. “Focuses on the
relationship between the body’s structure – mainly the spine – and it’s
functioning” is a reference to chiropractic belief that there is a spinal
pathology (the subluxation) they can detect and that it has some effect on
bodily function. The putative effect of this putative pathology is sometimes
described simply as a “misalignment” blocking “nerve flow” and at other times
more elaborately (and equally nonsensically) as “a complex of functional and/or 
structural and/or pathological articular changes that compromise neural
integrity and may influence organ system function and general health . . . .”
The reference to “adjustments (manipulations)” is an unintentional
acknowledgement of my point that chiropractors use the terms interchangeably and
describes their unproven therapy for their unproven condition, which
“correct[s] alignment problems, i.e., subluxations. “Supporting the body’s
natural ability to heal itself” is a reference to the chiropractic belief in
vitalism, their version of which is “Innate Intelligence.”

The quoted description – indeed the whole of NCCAM’s page on chiropractic –
doesn’t mention by name what even chiropractors themselves describe as its core 
concept: the subluxation. A consumer reading this page would have absolutely no 
clue that going to a chiropractor might subject him to a phony diagnosis of
“subluxations” and phony treatments to “correct” them. There is also a mention
that chiropractors use x-rays as a diagnostic tool, without telling the reader
that a chiropractor may well use x-rays to detect the nonexistent subluxation.

Criticism of this sort of thing was raised by Steve Novella, David Gorski and
Kimball Atwood at their visit with NCCAM’s director over two years ago. As Dr.
Novella said then, “the pattern of information is consistent – NCCAM staff talk 
about a strict adherence to evidence-based medicine and science being neutral,
but interspersed with this is an uncritical presentation of ancient superstition
as if it were science . . .” There he was discussing acupuncture. The only
difference here is that NCCAM is uncritically presenting a superstition of more 
recent origin, in the form of belief in “Innate Intelligence” and resulting
pseudoscientific diagnostic methods and treatments.

NCCAM also advises readers to

   Tell the chiropractor about any medications (prescription or
   over-the-counter) you take. If the chiropractor suggests a dietary
   supplement, ask about potential interactions with your medications or other
   supplements.

“If the chiropractor suggests a dietary supplement” the patient would be well
advised to ask exactly why it is being prescribed, given the paucity of evidence
for the safety or benefit of dietary supplements, and to be especially
suspicious if the chiropractor sells the supplement, an inherent conflict of
interest. And the patient should not rely on a chiropractor to know about
“potential interactions with . . . medications or other supplements.” The
patient should ask someone with sufficient training in pharmacology for that
advice, such as a pharmacist or M.D.

As well, NCCAM advises,

   Mention any medical conditions you have, and ask whether the chiropractor has
   specialized training or experience in the condition for which you are
   seeking care.

NCCAM is apparently unaware of the dubious system of chiropractic
“specialization” which results in “specialties” like chiropractic neurology,
chiropractic pediatrics,  and chiropractic family practice.  At least I hope the
writer was unaware and would not knowingly recommend these “specialists.”

Perhaps the most egregious failure, however, is the failure to warn consumers
about the risk of stroke following cervical manipulation. Here is what NCCAM
says:

   A 2009 study that drew on 9 years of hospitalization records for the
   population of Ontario, Canada analyzed 818 cases of vertebrobasilar artery
   (VBA) stroke (involving the arteries that supply blood to the back of the
   brain). The study found an association between visits to a health care
   practitioner and subsequent VBA stroke, but there was no evidence that
   visiting a chiropractor put people at greater risk than visiting a primary
   care physician. The researchers attributed the association between health
   care visits and VBA stroke to the likelihood that people with VBA dissection 
   (torn arteries) seek care for related headache and neck pain before their
   stroke.

Yes, it’s the infamous Cassidy study, a subject we’ve addressed before at SBM.
Now, I suppose it is correct that the study showed that “visiting a
chiropractor” did not put people at greater risk than “visiting a primary care
physician” if by “visiting” you mean walking in the door and having a seat in
the waiting room. The study did not look at what treatment (if any) the patients
received so it cannot legitimately claim to answer the question whether
actually being treated by a chiropractor puts one at greater risk than being
treated by a primary care physician. And it certainly does not answer the
question whether cervical manipulation puts one at risk of stroke. As Mark
Crislip pointed out in his analysis of the study, that last sentence is a
hypothesis created by the authors of the study, it is not a statement supported 
by the study’s data.

Of course, the layperson might well be left with the impression, completely
false, that cervical manipulation does not put one at risk of stroke. In fact,
vertebral artery dissection and stroke following chiropractic cervical
manipulation continues to be reported in the medical literature and no one
besides chiropractors seems to think the Cassidy study settled the question.  As
a recent article in the Journal of Neurosurgery plainly states

   Chiropractic manipulation of the cervical spine can injure the vessels of the
   head and neck and produce stroke and other debilitating symptoms.

Why is this not part of the “evidence-based information” NCCAM says it is
committed to?

In sum, where’s the science?

NCCAM’s supposed dedication to “rigorous science” is not in evidence in its
advice to consumers about chiropractic and spinal manipulation. NCCAM’s
presentation fails to live up to its promise to “maintain a strong commitment to
providing objective and authoritative evidence-based information to the public 
and health care professionals.”

Acupuncture: NCCAM Calls California’s Bluff

Ben Kavoussi on September 14, 2012

Link

   The [California Department of Consumer Affairs’] use of the term
   “endorsement” is inaccurate, may confuse the public, and may lead the public 
   to falsely conclude that NIH has made certain efficacy and/or safety
   conclusions regarding acupuncture. Further, consensus conference reports are 
   not a policy statement of NIH or the Federal Government… NIH asks that you
   correct these two points of information in your booklet and on your website.

   — Jack Killen, MD, Deputy Director, NCCAM, NIH

I have to praise the Deputy Director of the National Center for Complementary
and Alternative Medicine (NCCAM), Jack Killen, for asking the State of
California to remove a couple of false claims in a “Consumer’s Guide” on
acupuncture.

Indeed, on June 12, 2012, Dr. Killen wrote a letter to the California Department
of Consumer Affairs (DCA) expressing concerns about an informational booklet
which makes the unfounded claim that the NIH “formally” endorses acupuncture.
The booklet also incorrectly states that NIH has “found clear evidence that
needle acupuncture is effective” for a list of conditions. Here’s a snapshot of 
this publication:

Albeit the long letter, the message is clear and simple: “As a U.S. Federal
research agency, NIH does not endorse any product, service, or treatment.”

Soon after receiving the letter, the DCA removed the booklet from circulation,
deleted the online version from its website, and stopped sending out copies to
new licensees.

This official booklet has been published for over a decade. There have been 3
editions since 2002, and all claim that NIH “formally” supports acupuncture and 
that there is “clear evidence” of its efficacy.

As a result, thousands of unsuspecting patients have since 2002 chosen
acupuncture as a treatment.

I first came across the booklet in 2009. Shocked by its preposterous claims, I
wrote a letter to NCCAM the same year and asked for clarifications. Their
response contained the same essential message found in Killen’s recent letter:

   The booklet misstates the purpose of the 1997 consensus panel on acupuncture.
   As a Federal research agency, the NIH does not endorse any product, service 
   or treatment, nor are NIH consensus documents statements of policy.

   — Terry Evans, NCCAM, March 3, 2009

Since 2008, I have sent Terry Evans’ letter to the California DCA and its
Acupuncture Board on several occasions. In response, I was told each time that
although the NIH does not explicitly state that they “formally endorse”
acupuncture, “supporting statements in the 1997 report could be interpreted as
an endorsement”!

In other words, according to State of California, the NIH formally endorses
acupuncture, even if it the NCCAM – one of the institutes and centers that make 
up the NIH – explicitly says that it does not!

The latest version of this asinine statement was sent to me in May 2012 by
Reichel Everhart, the DCA Deputy Director for Board and Bureau Relations:

Just 3 months prior to Everhart’s letter, DCA’s Acupuncture Board was put in the
hot-seat by the State Senate, mainly for failing to protect the public. The
Senate explicitly told the Board that its mission was to regulate the
profession, not to promote or to protect it. But so far, the Senate criticism
have fallen on deaf ears: a senior member and former Chair of the California
Acupuncture Board made this baffling statement in a public meeting just around
the same time Everhart wrote to me:

   I think given what is in front of this Board, and the work that we are
   continuing to do to try to create legitimacy around the entire subject and to
   maintain legitimacy and to promote the profession, we should oppose anything
   that is so nebulous that should possibly detract from the standardized work 
   that is being done nationally…

   — Robert Brewer, former Chair and current member of the California
   Acupuncture Board, May 17, 2012

Brewer’s statement provides an insight on why it has taken so long to remove the
booklet in California: there is an obvious resistance to any evidence that is
not in favor of acupuncture or disputes its very purpose. California is not the 
only state with a protectionist acupuncture board: many regulatory agencies
across the US have long operated as lobbies, with the sole intent of
legitimizing and promoting the profession. As co-blogger Jann Bellamy recently
wrote in a an article about acupuncture practice acts in the US, some even allow
the practitioners to act as primary healthcare providers:

   Licensing acupuncturists and oriental medicine practitioners and giving them 
   the right to “diagnose,” “prevent” and “cure” disease and to employ other
   nonsensical “CAM” practices and products is most certainly not in the best
   interest of the public’s health, safety and welfare.

Fortunately, the Californian Senate seems to be fully aware of the absurdity of 
regulating acupuncturists as primary care providers. They also know that the
Board has a long history of acting as a shield for acupuncture training programs
and professional organizations. In March 2012, the Senate Business, Professions
and Economic Development Committee made the following comment that supports my 
argument:

   Both the [Little Hoover Commission] and Legislative Counsel did not believe
   that the law creating the Acupuncture Act intended for an acupuncturist to be
   the primary care professional responsible for coordinating (or being the
   “gatekeeper”) for the ultimate care of a patient.

The Senate Committee was referring to the 2004 findings of the Little Hoover
Commission, an independent state oversight agency that investigates the
government and makes recommendations to promote efficiency and to improve
service. The commission’s report (Report #175, September 2004) to the Governor
and the Legislature had observed:

   The policy choice to give patients direct access to acupuncturists was clear,
   but the statutory intent to regulate acupuncturists as a “primary care
   health care profession” is not. The term has many potential meanings. While
   some people may turn to acupuncturists first for everything that ails them
   (one potential meaning), it is difficult to see how practitioners of an
   alternative healing paradigm can be responsible for coordinating care with
   biomedical specialists (another potential meaning).”

   — (Regulation of Acupuncture: A Complementary Therapy Framework, page 25.)

After the 2012 sunset review, the Senate gave the Acupuncture Board two years to
address a long list of problems and concerns. My hopes are that at the end of
this deadline (or even before) the Senate realizes the futility of having a
separate board for acupuncture.

Meanwhile, what should be done with the 10,000 or more active licensees in
California? Even if they use “a smorgasbord of implausible and unproven
diagnostic methods and treatments” — as Jann Bellamy puts it — I do not foresee 
an immediate end to their licensing, especially during an economic downturn.
However, the state also has the obligation to place the protection the public at
the highest priority.

In my opinion, the best way out of this quagmire is to disallow acupuncturists
to work as primary care providers, and to require prior consulting and screening
by a physician, a nurse practitioner or a physician assistant. This is in the
best interest of the public, for it leaves the responsibility of coordinating
the ultimate care of a patient in the hands of a competent primary care
provider.

But at least for now, witchdoctors in California can no longer bluff out that
the NIH formally endorses their craft, and that there is clear evidence that it 
is works for anything!

With many thanks to Daniel Bederian-Gardner, Jann Bellamy and Paul Ingraham for 
their valuable comments. The opinions expressed here are the author’s.

                        NCCAM: the not-even-wrong agency

                                  Peter Lipson

                                      Link

The National Center for Complementary and Alternative Medicine (NCCAM) is a
government agency tasked with (among other things), “[exploring] complementary
and alternative healing practices in the context of rigorous science.” In this
space we have talked about NCCAM quite a bit, but I have to admit that I don’t
think about them very much. The other day, though, I was reading though JAMA and
I came across a study funded by the agency. The study, which showed that Ginkgo
does not prevent Alzheimer’s-type dementia, was pretty good, so I cruised on
over to NCCAM’s website to see what else they’ve been up to.

A quick glance at NCCAM’s front page:

“Ginkgo Evaluation of Memory (GEM) Study Fails To Show Benefit in Preventing
Dementia in the Elderly”

“CAM and Hepatitis C: A Focus on Herbal Supplements ‘No CAM treatment has yet
been proven effective for treating hepatitis C or its complications.’”

“Selenium and Vitamin E in Prostate Cancer Prevention Study, ‘selenium and
vitamin E supplements, taken either alone or together, did not prevent prostate 
cancer.’”

It seems that NCCAM is finding out something we already strongly suspected: 
improbable medical claims are usually wrong.  Since that’s not how they see
things,  and since I don’t believe that there is such a thing as alternative
medicine, I was curious how they defined CAM.

   CAM is a group of diverse medical and health care systems, practices, and
   products that are not presently considered to be part of conventional
   medicine. Conventional medicine is medicine as practiced by holders of M.D.
   (medical doctor) or D.O. (doctor of osteopathy) degrees and by their allied
   health professionals, such as physical therapists, psychologists, and
   registered nurses. Some health care providers practice both CAM and
   conventional medicine. While some scientific evidence exists regarding some
   CAM therapies, for most there are key questions that are yet to be answered
   through well-designed scientific studies–questions such as whether these
   therapies are safe and whether they work for the diseases or medical
   conditions for which they are used.

   The list of what is considered to be CAM changes continually, as those
   therapies that are proven to be safe and effective become adopted into
   conventional health care and as new approaches to health care emerge.
   emphasis mine, ed.

The list of NCCAM studies appears to fall into three broad categories.

The first is the “positive study”, or the type mentioned in the last paragraph
above.  How often does NCCAM shepherd newly validated CAM into the “regular”
medical world?  I couldn’t find much, but feel free to fill me in.

Next is the “negative study”.  What about the negative studies, such as the
current one about Ginkgo, or the negative evaluation of Echinacea for the common
cold;  how often is CAM rejected when there is overwhelming evidence against
it? Orac and I had a lively discussion about this a while back, but the gist is 
that alternative med beliefs are just that—beliefs.  They are taken on faith,
and no amount of evidence will cause their adherents to walk away from them. 
This is in stark contrast to reality-based scientists who, when presented with
overwhelming evidence that their hypothesis is incorrect, move on to the next
idea, or risk a life of professional exile and intellectual stagnation.

Negative studies are terrific, but not quite as useful when they ask a question 
no rational person was asking, which brings us to our final category of 
studies, which often overlaps with the first two: that of completely improbable 
ideas.  As we’ve written many, many times, claims that have no scientific basis 
and that violate the basic tenets of science are unlikely yield to scientific
investigation, and when positive results are found, they are likely to be false 
positives.  Take this list from the NCCAM website:

   Therapeutic Touch for Wrist Fractures in Postmenopausal Women

   The Use of Reiki for Patients With Advanced AIDS

   Distance Healing in Wound Healing

   All of these hypotheses are ridiculous. Why are we funding them at all?

You see, sloppy hypotheses are a mark of sloppy (and often ideological)
thinking.  Take one of the recent announcements from NCCAM: “New Research Gives 
Insight Into How Acupuncture May Relieve Pain.”

The title pretty much exemplifies the problems with the agency.  It begs the
question, assuming that acupuncture actually relieves pain, when the research is
actually rather against it.  The study looked at a small number of patients
given “sham” and “real” acupuncture (which studies have shown behave, in the
aggregate, interchangeably, with one sometimes being better than the other, or
both acting equally).  After making this questionable assumption, it then
measured changes in the brain which may or may not have anything to do with the 
intervention. “The researchers conclude that acupuncture changes resting-state
brain activity in ways that may account for its analgesic and other therapeutic 
effects.”  At least one informed reader didn’t conclude any such thing.  The
number of possibly-unrelated dots that they’ve shoved together are a pipe-dream.
A real hypothesis rests on real science with reasonable assumptions, tests the
hypothesis with the best available science, controls for confounding, and
accepts or rejects the hypothesis as warranted.

The National Center for Alternative and Complementary has failed. It funds some 
good studies that other agencies could just as easily fund.  It doesn’t help
“good” CAM become mainstream. Its negative studies are ignored by CAM-adherents.
And most important, the great preponderance of its studies “aren’t even
wrong“.  NCCAM has failed its mission and needs to go away.

NCCAM Director Dr. Josephine Briggs and the American Association of Naturopathic
                                   Physicians

                                  David Gorski

                                      Link

On Friday, one of my partners in crime here at Science-Based Medicine, Dr.
Kimball Atwood, wrote an excellent Open Letter to Dr. Josephine Briggs. Dr.
Briggs, as most regular readers of SBM know, is the Director of the National
Center for Complementary and Alternative Medicine (NCCAM). As most regular
readers of SBM also know, we at SBM have been quite critical of NCCAM for its
funding of studies of dubious scientific value, including one that I mentioned
quite early on in the history of this blog, in which an R21 grant was awarded to
investigators at the University of Arizona for a project entitled Dilution and 
succussion in homeopathic remedy dose-response patterns. The purpose of this
project was to compare the effectiveness of a homeopathic remedy at different
dilutions. It even compared remedies that are succussed (vigorously shaken) at
each dilution step against remedies that were merely stirred. Although this is
merely the most egregious example I could find at the time, two years ago I did 
catalog many more examples, as well as the “educational” grants disbursed
through NCCAM in order to teach (and, by doing so, promote) CAM.

Given NCCAM’s long history of promoting pseudoscience, we were all quite
surprised when early this year we received an e-mail from Dr. Briggs herself
inviting us to NCCAM to meet with her. Unfortunately, due to our work
obligations, Steve Novella, Kimball Atwood, and I were not able to coordinate
our schedules to travel to Bethesda and enter the heart of darkness itself until
early April. Our conversation with Dr. Briggs and her staff was cordial and
mutually respectful, as Steve Novella described, and we assured her that we
understood that studies such as the one I mentioned above were funded before her
tenure. At the same time we were a bit disappointed that Dr. Briggs appeared
far too eager to dismiss such problems as being before her time. Still, we
understood and approved of Dr. Briggs’ stated goal of making NCCAM more
scientifically rigorous, even though we did point out that there is nothing done
at NCCAM that couldn’t be done as well in the NIH’s structure before NCCAM
existed.

Unfortunately, not too long before or after Dr. Briggs met with us, she also met
with a group of homeopaths, leading us to worry that perhaps in her quest to
appear “open-minded,” Dr. Briggs was being so open-minded that her brain was in 
acute danger of falling out, particularly after we saw her infamous “science
must be neutral” director’s newsletter a month later, which Dr. Kimball skewered
as part of his open letter and I recently used as an example of misinterpreting
what scientific “neutrality” means during my talk at the SBM Workshop at TAM8 a
couple of weeks ago. In fact, I now wonder if I missed a little gray matter
oozing out of Dr. Briggs’ ears during the meeting even though I sat right next
to her.

Unfortunately, Dr. Atwood’s open letter gives me even more reason to despair,
because in it he pointed out that Dr. Briggs will be speaking at the 25th
Anniversary Convention of the American Association of Naturopathic Physicians
(AANP) from August 11-15 in Portland, OR. (One wonders if Mark Crislip would be 
willing to make an appearance there for a Very Special Episode of his Quackcast 
and thereby continue to expand his Internet empire. I realize that doing so
would really be “taking one for the team,” but think of the blogging and podcast
material!) Kimball’s explanation why this is disturbing is excellent and
detailed, as usual, but one thing he didn’t do as much of as I would have is to 
go into a bit more detail of what sorts of dubious medical modalities and even
outright quackery Dr. Briggs will be associating herself with by speaking at
this particular convention. He probably didn’t feel the need, given that he
referenced his two comprehensive deconstructions of the quackery that is
naturopathy, but I’m not as well-versed in naturopathy as he is, and, I suspect,
neither are you. Dr. Atwood didn’t need to delve into the woo that will be
presented at the AANP. I do. That’s why I thought a bit of a survey of what will
be presented at the conference was in order.

A selection of AANP speakers

Before I discuss the speakers with whom Dr. Briggs will be sharing the podium in
Portland, let’s take a look at the title of Dr. Briggs’ talk, which will be
“Complementary and Alternative Medicine: Promising Ideas from Outside the
Mainstream.” As Dr. Atwood speculates, this is probably a variation or expansion
of a slide Dr. Briggs used in her talk at the 2nd Yale Research Symposium on
Complementary and Integrative Medicine entitled “Quirky ideas from outside the
mainstream” that listed ideas that once weren’t considered mainstream medicine
but ultimately became accepted, the implication being, of course, that there are
such ideas in CAM that are now considered “quirky” but will become accepted. Of
course, ideas such as those embodied in reiki, therapeutic touch, homeopathy,
and many other CAM modalities go far beyond merely “quirky,” and the “quirky”
ideas that Dr. Briggs mentioned in her Yale talk weren’t really ever considered 
that “quirky,” but the probable implication of her talk at the AANP convention
will be that some of the ideas about health to which naturopaths cling may well 
be accepted one day.

So, based on the panel of speakers, which, according to the AANP blog, will make
this year’s woo-fest “one of the best gatherings to date,” what ideas might Dr.
Briggs consider to be quirky but likely to be accepted as mainstream in the
future? Given that the speakers are listed in alphabetical order, I couldn’t
help but notice immediately as I perused the list this “quirky idea” from
Mikhael Adams, BSc, ND, who will be giving a talk entitled Viruses & Pandemics
in the 21 st Century: Truth or Dare and the Case for Nature Cure. His talk is
described thusly:

   This presentation will explore the researched and documented facts relating
   to viruses and pandemics in the modern age and the vaccinations offered to
   prevent them, as well the immense toxic burden the average human presents
   with and its effects on the immune system. Historically, Nature Cure has
   provided us with a template for repairing and maintaining the “self-healing” 
   and “auto-regulating” mechanisms of our body. This presentation will focus on
   updated, detailed, effective, and successful “Nature Cure” for today’s
   chronic conditions.

Connoisseurs of CAM language will recognize immediately a number of code words
and phrases in this paragraph, chief among them being the “immense toxic burden”
and how it allegedly destroys our immune systems. It’s highly unlikely, of
course, that Adams will present anything resembling actual scientific evidence
to support his claims of an “immense toxic burden,” but previous experience
tells me that it’s extremely likely that he will be laying down a swath of
anti-vaccine propaganda, given his reference to “facts” relating to viruses,
pandemics, and vaccinations, particularly given how deeply imbedded anti-vaccine
beliefs are in naturopathy (only 20% of whom even recommend vaccination),
coupled with the belief that uncharacterized (and often unnamed) “toxins” are
responsible for most disease. Anyone want to lay down money that Adams’ talk
will blame vaccines for some of this “immense toxic burden” from which we all
supposedly suffer? I don’t blame you for saying no. It’d be a sucker’s bet. It’s
disappointing that Dr. Briggs would associate herself with a speaker who is
very likely to be spewing anti-vaccine pseudoscience, given that one area of
agreement we found with her in our discussion was that NCCAM must not support
the anti-vaccine beliefs that are associated with so many “alternative medical” 
modalities.

The description of Adams’ “qualifications” reads:

   Dr. Mikhael Adams, B.Sc., N.D., received his Doctor of Naturopathy from the
   National College of Naturopathic Medicine in 1981. He practiced for ten years
   in Seattle, and is now in private practice in Milton, Ontario. He uses
   drainage, nutrition, homeopathy, acupuncture and auricular medicine as his
   primary therapeutic tools. He has studied homeopathy since 1977. Dr. Adams is
   the president of the International Association of Auricular and Bioenergetic
   Medicine, past president of the North American Association of Auricular
   Medicine, and has studied intensively with Dr. Paul Nogier in France. Dr.
   Adams taught Clinical Pathology at the Northwest Institute of Acupuncture &
   Oriental Medicine from 1987 to 1993 and has been giving workshops in
   auricular medicine since 1984. Dr. Adams has been lecturing in North America 
   on homeopathy and drainage since 1988.

So he’s a homeopath, and, as SBM readers know, homeopathy is The One Quackery To
Rule Them All. It’s disappointing that Dr. Briggs would associate herself
uncritically with homeopathy, as well, although I suppose we shouldn’t be
surprised, given her earlier meeting with homeopaths.

Next, “drainage” refers to lymphatic drainage a treatment modality favored by
many naturopaths that claims to aid in “detoxification” by improving lymphatic
drainage using various nostrums, the claim being that all sorts of symptoms are 
in reality due to a failure of lymphatic drainage to “detoxify” the body
properly. Methods as varied as massage (which is used in science-based medicine,
by the way, to improve lymphatic drainage in patients with documented
lymphedema) and castor oil, although the “alternative” medical practitioners
advocating this latter approach often appear not to understand the significance 
of pitting edema. (Hint: Lymphedema is usually not pitting, and pitting edema is
usually due to cardiac, liver, or kidney abnormalities, although venous
insufficiency can also cause it.) While there is a science-based rationale for
using various physical techniques to improve lymphatic drainage in people who
suffer from lymphedema, be it post surgical or due to other causes,
science-based uses of lymphatic drainage are not what we’re talking about here.

If you really want to get a feel for what kind of practitioner Mr. Adams is, you
should check out the webpage of his group naturopathy practice, The Renascent
Integral Health Center in Milton, Ontario, which describes its approach to
patient care thusly:

   The emphasis of treatment is placed on removing the blockages that keep the
   individual from being a self-healing, auto-regulating organism. Therapies are
   implemented that support the individual’s body, as it specifically responds 
   to external stress, toxic challenges and energetic impressions held by the
   body, that have manifested into the current state of disease. Whether
   entering treatment at the centre, or having a Medical Intuitive Scan done by 
   distance, the goal becomes to target disease by identifying and addressing
   the body’s underlying imbalances that have created its symptoms. To resolve
   the symptoms, Mikhael and Alison’s approaches go beyond the given diagnosis, 
   to reinitiate the body’s ability to recognize the challenges it faces, and
   support its ability to resolve its state of disease.

It gets better. I didn’t really know for sure what Auricular Medicine or a
“Medical Intuitive” scan is. Fortunately, Adams is happy to tell us, given that 
he has a “medical intuitive” on his staff, namely his wife Alison Feather Adams.
A medical intuitive scan is:

   A Medical Intuitive Scan can be done by distance, a written report is sent,
   and a follow-up phone consultation is arranged to discuss the scan. The Scan 
   records the information held in the body, at a subconscious level, therefore 
   during the phone consult the information presented will be discussed in
   relation to what the individual is currently experiencing on a conscious
   level. Medical Intuition can give insight into the emotional and energetic
   components of the disease state that are not detected using standard
   diagnostic equipment.

Meanwhile, as best as I can figure it out, Auricular Medicine is reflexology,
only with the “mappings” of various body parts and organs to the ears, rather
than to the feet and hands. Here’s Adams’ description:

   Auricular Medicine is an energetic reflex technique in which the pulse and
   filters are used to detect points on the ear. The points that show up on the 
   ear can indicate the location of specific imbalances within the body. Through
   the use of filters we are able to identify specific dysfunctions within the 
   body.

   Auricular Medicine is a specialized field of Energetic Medicine…The Doctors
   in this clinic use Auricular Medicine as their key diagnostic tool and work
   with their clients to stimulate self-healing (vis medicatrix naturae) through
   assessment of the disease state, prevention of disease, evaluation of a
   client’s state of health, and treatment and care of client’s using means and 
   substances that are in harmony with the client’s own self healing processes.

   Auricular Medicine in conjunction with conventional medical tests can find
   and treat the cause of disease. Many conditions, acute and chronic, can be
   treated by Auricular Medicine.

I’m sure many diseases and conditions “can” be treated by Auricular Medicine.
Whether they can be treated successfully with Auricular Medicine is another
question entirely. I wonder if Adams uses Col. Niemtzow’s auricular acupuncture 
as well. He does, however, use something that he calls Inner Alchemy, which
promises to help you:

   …reconnect with your inner potential by taking you past your discomfort into 
   the wisdom of subtle energy where your intuition can guide you to see things 
   the way they really are, in truth. Truth is the foundation for healing and
   reinitiating your physical body as well as the mental, emotional and
   spiritual bodies to work together to bring you back to the state of ease and 
   health again. You come to experience the essence of who you are, and release 
   the outdated programming that the body is compensating for, and outgrown
   impressions about yourself that has been influencing you unknowingly.

I think we’ve found a new candidate for Dr. Atwood’s Weekly Waluation of the
Weasel Words of Woo.

I spent more verbiage than I had expected on just one speaker, but I suppose I
was just fortunate that the very first speaker on the list happened to provide
me with such a rich source of evidence to demonstrate how unscientific
naturopathic modalities are. In fact, the title of one of the talks listed
piqued my interest for just this reason, specifically a panel discussion by
Thomas Kruzel, M.T., ND; Dickson Thom, ND; Stephen Myers, ND, Bmed, PhD; Kate
Broderick, ND entitled Emunctorology: An Old Clinical Science Brought to a New
Generation of Naturopathic Physicians. Kimball mentioned this briefly in his
post, but I had never heard of emunctorology, either. It’s not a simple matter
to figure out what it is, other than that it has something to do with the
“organs of elimination,” namely the kidneys, colon, skin, etc., and that the
group of naturopaths writing the naturopathy text Foundations of Naturopathic
Medicine are trying to codify it as some sort of formal naturopathic study.
Also, a naturopath named Sabine Thomas, who Tweets under the ‘nym
@emunctorology, rejoiced that apparently there are FINALLY emunctorology courses
at that bastion of naturopathy, Bastyr University. Given how obsessed
naturopaths are with “detoxification,” one can only imagine what sort of “detox”
woo is encompassed by this new/old naturopathic “discipline.” No doubt it will 
include colon cleanses and sweat lodges to “flush the toxins out.”

Speaking of “toxins,” Charles Masur, ND will be giving a talk on that favorite
“toxin” in many branches of “alt-med,” namely the dreaded heavy metals, with a
talk entitled Toxic Metals in the Environment and their Role in Oxidative
Stress. One wonders if he’ll advocate provoked urine testing for heavy metals of
the kind championed by Doctor’s Data, which is currently suing Stephen Barrett 
for having had the temerity to point out that there is no scientific basis for
such a test. The optimist in me hopes not. The pessimist in me realizes that
pretty much any naturopath I’ve ever seen blaming all sorts of chronic disease
on some sort of fantastical, never adequately documented, heavy metal toxicity
also advocates chelation therapy, which is rank quackery, except in unusual case
real cases of heavy metal toxicity. Maybe Masur will be the exception. Even if 
he is, he can count on Jessica Tran, ND, to take up the slack with a talk
entitled Overview of heavy metal detoxification strategies using natural and
pharmaceutical medicines, which explicitly promises to discuss chelation
therapy.

Finally, here are a couple more “quirky” ideas being presented at the AANP
meeting. One comes from an actual medical doctor named Dr. E. Denis Wilson,
whose talk is entitled The use of T3 and herbal medicine to reset the body
temperature and recalibrate many bodily functions. Dr. Wilson promises:

   Body temperature is one of the most fundamental physiologic parameters but is
   often overlooked. Dr. Wilson will discuss the synergy between the use of T3 
   and herbal medicine to recalibrate body temperature patterns to aid in the
   restoration of good health. Thyroid endocrinology and physiology will also be
   discussed.

Quackwatch retorts:

   “Wilson’s Syndrome” entered the health marketplace in 1990, when E. Denis
   Wilson, M.D., of Longwood, Florida, coined its name. Its supposed
   manifestations include fatigue, headaches, PMS, hair loss, irritability,
   fluid retention, depression, decreased memory, low sex drive, unhealthy
   nails, easy weight gain, and about sixty other symptoms. However, Wilson
   claims that his “syndrome” can cause “virtually every symptom known to man.” 
   He also claims that it is “the most common of all chronic” ailments and
   probably takes a greater toll on society than any other medical condition.”
   Wilson claims to have discovered a type of abnormally low thyroid function in
   which routine blood tests of thyroid are often normal. He states that the
   condition is “especially brought on by stress” and can persist after the
   stress has passed. He claims that the main diagnostic sign is a body
   temperature that averages below 98.6° F (oral), and that the diagnosis is
   confirmed if the patient responds to treatment with a “special thyroid
   hormone treatment.”

Dr. Wilson’s also apparently killed at least one patient by prescribing too much
thyroid hormone. As a result, according to Quackwatch, he lost a malpractice
suit and hasn’t practiced medicine since 1992, which is when the Florida Board
of Medicine suspended his license and ordered him to undergo psychological
testing. At least he isn’t speaking the same day that Dr. Briggs is, although a 
talk by Jim Paoletti, RPh, FAARFM entitled A Holistic Natural Approach to
Treating Hypothyroidism will occur in the session right after Dr. Briggs speaks.

Perhaps my favorite talk, at least judging by its title, will be the talk by
Sharum Sharif, ND entitled Visual Homeopathy – Identifying a Person’s
Constitutional Homeopathic Remedy in Minutes, which promises:

   Patient and Hollywood videos will be used to demonstrate how to quickly
   identify a patient’s constitutional remedy by looking for simple behavioral
   cues and asking 2-5 questions. The presentation will be focused on the most
   common remedies accounting for the majority of the population of a general
   naturopathic clinic.

Who knew it was that easy? As a couple of questions, and pick out some water to 
treat your patient.

Overall, there appear to be at least seven homeopaths speaking. There’s also
Matthew Baral, ND, who is a certified Defeat Autism Now! practitioner, and if
there’s a richer source of autism and anti-vaccine quackery besides the roster
of DAN! practitioners, I am unaware of it. There’s so much more than even this
lengthy post can encompass.

What Dr. Briggs should say

I realize that Dr. Briggs is in a delicate situation. Her heart appears to be in
the right place as far as wanting to make NCCAM more science-based, but her
head doesn’t seem able to acknowledge just how deep into pseudoscience she’s
buried herself. Given that NCCAM is not going away unless somehow the public can
be rallied against it to the point where even its patron, Senator Tom Harkin
(D-IA), can no longer protect it against demands for its dissolution, something 
exceedingly unlikely to happen any time soon, I realize that NCCAM could do a
lot worse for a director than Dr. Briggs and probably will some day if its
“stakeholders” get their way. However, as some readers chastised me in the
comments of Dr. Atwood’s post, Dr. Briggs chose to accept the directorship of
NCCAM when offered, and, as was pointed out, a scientist doesn’t get to be the
director of a major center in the NIH if she isn’t a capable politician as well 
as scientist. In fact, although I don’t believe this to be the case for Dr.
Briggs, sometimes being a politician counts for more than being a scientist, as 
the appointment of Dr. Bernadine Healy to head the NIH in 1991 demonstrates. I
also understand that, when one holds a position like director of NCCAM, it is
necessary to do things like speak to the AANP, given that, in the U.S., at
least, naturopaths probably represent the most politically connected group of
CAM practitioners, perhaps as much as homeopaths in the U.K. So turning down an 
invitation to speak would probably have caused Dr. Briggs trouble.

But wouldn’t it be really cool if Dr. Briggs were to walk into the lions’ den
and speak science to woo? I realize it’s as unlikely to happen as it is for me
to find a single molecule of original remedy in a 30C homeopathic remedy, but
I’d love to see Dr. Briggs use the opportunity to speak to a large gathering of 
naturopaths to set a few things straight. For example, not too long ago, as I
pointed out in my post about “naturopathic oncology” being practiced at the
Cancer Treatment Centers of America, Timothy Birdsall, ND, FABNO, wrote a rather
telling post for the AANP blog entitled The problem with research after having 
attended the National Advisory Council for Complementary and Alternative
Medicine, the advisory body to NCCAM. Presumably Dr. Briggs knows, or at least
has met, Dr. Birdsall, given that she must deal with NCCAM’s advisory council as
part of her job. In his post, Dr. Birdsall challenged the next generation of
naturopaths to be more science-based and to produce “great scientists,” while at
the same time attacking “reductionism,” “allopathy,” and the “biochemical
model,” characterizing research as an “impediment” to homeopaths and writing:

   In the end, we must create and validate the tools to dethrone the randomized 
   controlled trial as the gold standard, and construct new ways to validate
   clinical approaches to health issues. Much as the homeopaths of 2+ centuries 
   ago created the proving as a way to better understand and utilize their
   remedies, we must refuse to be limited by the way conventional medicine views
   health and disease.

In particular, Birdsall writes:

   But ultimately, I find myself becoming offended because I believe that these 
   therapies work… Whoa! Believe? OK, but where is the role for evidence?

Where, indeed? Remember, this is the 2009 AANP Physician of the Year.

Wouldn’t it be cool if Dr. Briggs were to quote Dr. Birdsall’s article, point
out to the naturopaths that medicine is not a matter of “belief,” and educate
them that, while randomized trials have shortcomings, they are currently the
best tool we have for answering many medical questions, including many of those 
of naturopathy? Wouldn’t it be even cooler if Dr. Briggs correctly pointed out
that what Dr. Birdsall really appears to be advocating is not improving how
science is applied to medicine, but changing our medical paradigm so that
naturopathy can gain scientific acceptance using a different, much weaker
standard of evidence? If she would state boldly that, if naturopathy can’t be
scientifically validated, then it should be abandoned, I’d give her extra
points.

Then there are other things I fantasize seeing Dr. Briggs do with her talk to
the AANP:

  1. Say outright that homeopathy is water, that water doesn’t have memory (at
    least not the way homeopaths claim), and that, for homeopathy to be true,
    many of the laws of physics would have to be not just wrong, but
    spectacularly and completely wrong. Then point out that there’s no evidence 
    that our understanding of physics and chemistry is that spectacularly wrong 
    and challenge the AANP to give up homeopathy.

  2. Outline the real history of H. pylori, reminding the assembled naturopaths
    that the idea that H. pylori causes duodenal and gastric ulcers was accepted
    less than a decade after it was first proposed by Warren and Marshall in
    1984, with treatment for H. pylori being the standard of care for duodenal
    ulcers by the mid-1990s. Challenge the naturopaths to gain acceptance for
    their “quirky” ideas the same way Warren and Marshall did for their quirky
    idea, through real science and real clinical trials.

  3. Point out that using provoked urine levels of heavy metals for any diagnosis
    or monitoring of treatment is not scientifically supported and is thus best 
    viewed as quackery.

  4. Reiterate that vaccines are the single greatest medical advance there has ever
    been, arguably saving more lives than any other and tell the naturopaths
    that it is disgraceful that only 20% of naturopaths support vaccination.
    Tell them that there is no convincing scientific evidence that vaccines
    cause autism or any of the other conditions and diseases attributed to them 
    by many naturopaths. Then point out that naturopaths who “don’t believe in
    vaccination” or won’t vaccinate should not be practicing medicine.

  5. Argue that there is no good scientific evidence that there is a human “life
    energy” field or that people, needles, or touch can manipulate such a field,
    meaning that “energy medicine” produces nothing but placebo effects.

  6. Challenge the naturopaths to change their practices based on what science
    shows, just as “conventional” physicians practicing science-based medicine
    do, rather than clinging to prescientific notions of “life energy,”
    sympathetic magic (homeopathy), and ritual purification (“detoxification”)
    as the basis of their treatments.

I know. It’ll never happen. But a guy can dream, can’t he?

Unfortunately, whether Dr. Briggs realizes it or not, by speaking to the AANP
convention without criticism, she is giving it her imprimatur of approval. I
once mentioned George Annas, who is a bit of a contrarian and agreed to speak at
the National Vaccine Information Center quackfest last fall. Even after he was 
informed of the nature of the conference, he did not withdraw. According to
reports I’ve gotten, he did, however, tell it like it is and refuse to kowtow to
the anti-vaccine audience. I didn’t agree with his decision to go through with 
the talk, but I could respect it. Apparently Annas is the sort of person who
actually does like to speak to hostile audiences and rile them up by telling
them what they don’t want to hear. Similarly, I could understand and even
respect Dr. Briggs if she were to do the same and refuse to kowtow to the
pseudoscience that will be surrounding her as she gives her talk to the AANP, if
she were to point out that the ideas of the AANP go beyond “quirky” and
straight into the woo.

She won’t, though, at least not if she wants to keep her job.

                    Update on Josephine Briggs and the NCCAM

                                Kimball Atwood 

                                      Link

Dr. Gorski is in the throes of grant-writing, so I’m filling in for him today by
following up on a topic introduced a few months ago. It involves a key medical 
player in the U.S. government: Dr. Josephine Briggs, Director of the National
Center for Complementary and Alternative Medicine (NCCAM).

Background

Steve Novella and I first encountered Dr. Briggs at the 2nd Yale Research
Symposium on Complementary and Integrative Medicine in March, 2010. I reported
here that she seemed well-meaning and pro-science but that she also seemed naive
to the political realities of her office and to much of the content of “CAM”
(as illustrated by her recommending the NCCAM website, which is full of
misinformation; previously I’d noticed her unfortunate innocence of “acupuncture
anesthesia,” which is to be expected of most academics but not of the CAM
Explicator-in-Chief).

Shortly thereafter, Drs. Novella, Gorski, and I visited Dr. Briggs at the NCCAM,
after (to our surprise) she had requested our presence. Dr. Novella reported on
that visit here, noting that Dr. Briggs’s call for science to be neutral “could
easily fall into the trap of false balance (balancing legitimate scientific
evidence and analysis with pseudoscientific promotion).” She also refused to
discuss the rotten-to-the-core Trial To Assess Chelation Therapy (TACT), instead
passing the buck to the NHLBI, which also apparently will not discuss it. I
wonder why?

Nevertheless, there were suggestions at that meeting that Dr. Briggs might use
her position to do some good. We explained several examples of misinformation in
the NCCAM newsletter that we’d found in the waiting room; she seemed to agree
with at least some of our points. She portrayed an appropriate skepticism about 
homeopathy. She agreed that “CAM” advocates are especially likely to be opposed 
to vaccinations, and that the NCCAM ought to address this on its website. She
insisted, when asked (again), that the NCCAM now looks favorably upon proposals 
for legitimate natural products research—which, if true, marks a distinct shift 
from its previous bias toward zealous herbalism.

Report Card

So how’s Dr. Briggs been doing since then? Mostly not so well. Almost
immediately after Steve’s report hit the screen, we discovered that a few weeks 
before our meeting she’d met with an “international team of homeopaths” who left
the building feeling quite satisfied that they had made a favorable impression 
on Briggs and her colleagues. Her own account of both meetings revealed exactly 
the “false balance” that Dr. Novella had warned about.

A few months later Dr. Briggs made the regrettable decision to lend her
imprimatur, along with those of the NIH and the federal government, to the
formal celebration of quackery titled the “25th Anniversary Convention of the
American Association of Naturopathic Physicians” (AANP). In an open letter
posted on SBM I attempted to explain why this was a bad idea. Dr. Gorski also
expressed his dismay. So did Dr. Benway. Dr. Briggs seems to have noticed our
displeasure: according to a trusted source who viewed the eventual conference
videos, she began her talk to the naturopaths by remarking that some people had 
made the curious claim that her very presence (as a “keynote speaker”) at the
conference would imply her endorsement of the proceedings. Jeez: some people can
really jump to conclusions, eh?

Well, a few months later Dr. Briggs nominated Jane Guiltinan, ND, Past-President
of the AANP and Dean of Naturopathic Medicine for Bastyr University, to be the 
newest member of the National Advisory Council for Complementary and Alternative
Medicine (NACCAM). Here is the nominee’s Philosophy:

   Dr. Guiltinan emphasizes the concepts of treating the cause of a problem,
   supporting the body’s own healing process and encouraging patients to create
   their own wellness even in the face of serious illness. Dr. Guiltinan uses
   nutrition, plant medicine and homeopathy in her practice and believes that
   air, water, food, touch, love and laughter are some of the most powerful
   healing agents.

Not to put too fine a point on it, but with that repertoire of ‘healing agents’ 
patients will have no choice but to create their own wellness in the face of
serious illness. Dr. Briggs, of course, has no choice but to nominate such
people to the NACCAM, because such is required by (Sen. Tom Harkin’s) law. Jane 
Guiltinan, all things considered, is probably about as benign a nominee as one
could hope to find among the universe of magical thinkers from which Dr. Briggs 
must make her selections. Then again, Dr. Briggs needn’t choose to remain
Director of a bogus NIH Center.

In November, for Vaccine Awareness Week, I decided to find out whether Dr.
Briggs had yet posted any useful discussions of immunizations and antivax
fanaticism. I could find none, but I found plenty of the usual misinformation.

Since then, however, Dr. Briggs has finally posted such an article. She begins
by dangling some questionable and irrelevant bait:

   People turn to complementary and alternative medicine (CAM) seeking
   better health. Several studies have found an association between use of CAM
   and positive health behaviors such as getting regular exercise, not using
   tobacco products, and following a healthy diet. CAM use also has been
   associated with higher rates of vaccination for influenza, pneumococcus, and 
   hepatitis B among adults.

Then she squints and tiptoes onto the battlefield:

   Unfortunately, however, this may not be the case for vaccinations in
   children.

No! Really?

   A recently reported NCCAM-funded study in the Maternal and Child Health
   Journal showed that children in Washington State who received care from CAM
   providers were substantially less likely to get recommended immunizations and
   were more likely to be diagnosed with a vaccine-preventable disease.

What?? Why didn’t anyone tell us this before? Don’t worry, though, it ain’t
necessarily the poor “CAM providers”—our stakeholders, doncha know—who are at
fault here:

   The investigators note that their findings do not provide an explanation 
   for the association.

All right, it’s time to stop being so flippant, even though anyone with a
passing knowledge of sCAMmery knows that it’s both the sCAM artists and their
willing marks who collaborate in science-based medicine denial, that there have 
been countless articles for a couple of decades demonstrating the culpability of
the “providers” themselves, and that most of those articles were written
without the benefit of NCCAM funding. Here, for example. Hmmm…Washington state: 
home of the largest population of NDs in the country, and of Bastyr U. (ahem)

But enough. Other than the objections just made, Dr. Briggs’s statement on
childhood vaccinations is a pretty good one, and it links to an even better
entry, also new in April, 2011, titled NCCAM Clinical Digest: Childhood
Vaccinations/Immunizations.

Goodonya, Josie, but I still think you oughtta tell Tom Harkin to take that job 
and shove it. It doesn’t become you.

                       Dismantling NCCAM: A How-To Primer

                                  David Gorski

                                      Link

Two of the earliest posts I wrote for Science-Based Medicine were entitled The
infiltration of complementary and alternative medicine (CAM) and “integrative
medicine” into academia and The National Center for Complementary and
Alternative Medicine (NCCAM): Your tax dollars hard at work. Both were intended 
as a lament over how not only is pseudoscientific quackery, much of it based on 
a prescientific understanding of how the human body works and disease occurs,
finding its way into some of the most prestigious academic medical centers in
the U.S. (for example, Georgetown and Beth Israel) but it’s even finding its way
into the heart of the U.S. military.

Worse, aiding and abetting this infiltration is the federal government itself in
the form of NCCAM. As I discussed in my usual excruciating detail in my
original post and as Steve Novella, Kimball Atwood, and I have subsequently
discussed many times on this very blog, particularly recently (so much so that
I’m thinking of giving NCCAM its very own category here on SBM), NCCAM not only 
funds studies of dubious “alternative” therapies, such as reiki and homeopathy, 
that estimates of prior probability alone would argue to be so close to
impossible as to be not worth spending millions, much less thousands, of dollars
upon, but it also promotes quackery by funding “fellowships” at various
institutions to teach “complementary and alterantive medicine” (CAM) sometimes
also called “integrative medicine” (IM). Given that it spends over $120 million 
a year on mostly dubious studies and CAM promotion, we all have called for NCCAM
to be defunded and disbanded.

Nearly a year has passed since I wrote those two posts. Ironically enough, at
the time I wrote my first post about NCCAM for this blog, I pointed out that at 
first I had disagreed with my co-blogger Wally Sampson and his call to “defund” 
the NCCAM in an article published on Quackwatch nearly five years ago. My
original reason was that I thought that there was value in studying these
therapies to find out once and for all whether these therapies do anything
greater than placebo or not. I now admit that I was very naive, and this was how
I admitted it:

   Two developments over the last several years have led me to sour on NCCAM and
   move towards an opinion more like Dr. Sampson’s. First, after its doubling
   from FY 1998-2003, the NIH budget stopped growing. In fact, adjusting for
   inflation, the NIH budget is now contracting. NCCAM’s yearly budget remains
   in the range of $121 million a year, for well over $1 billion spent since its
   inception as the Office of Alternative Medicine in 1993. Its yearly budget
   contains enough money to fund around 75 to 100 new five year R01 grants, give
   or take. In tight budgetary times my view is that it is a grossly
   irresponsible use of taxpayer money not to prioritize funding for projects
   that have hypotheses behind them that have a reasonable chance of being true.
   Scarce NIH funds should not be for projects that have as their basis
   hypotheses that are outlandishly implausible from a scientific standpoint.
   Second, I’ve seen over the last few years how NCCAM is not only funding
   research (most of which is of the sort that wouldn’t stand a chance in a
   study section from other Institutes or Centers)) but it’s funding training
   programs. Indeed, that was the core complaint against NCCAM: that it
   facilitates and promotes the infiltration of nonscience- and
   nonevidence-based treatments falling under the rubric of so-called
   “complementary and alternative” or “integrative” medicine into academic
   medicine.

Nothing has changed since I wrote those words–except for one thing. We now have 
a new President who stated in his inaugural address:

   We will restore science to its rightful place, and wield technology’s wonders
   to raise health care’s quality and lower its cost. We will harness the sun
   and the winds and the soil to fuel our cars and run our factories. And we
   will transform our schools and colleges and universities to meet the demands 
   of a new age. All this we can do. And all this we will do.

As Kimball Atwood put it, Yes We Can! We Can Abolish the NCCAM! The big and as
yet unasked (and unanswered) question is: How? Neither defunding nor dismantling
NCCAM will be easy, and we have to think about how to preserve the functions of
NCCAM that might be worth saving.

Political obstacles

The first thing anyone has to realize about defunding NCCAM is that it will not 
be easy to develop the necessary consensus among legislators to pass the
legislation that would be necessary to disband it. Actually, that’s a huge
understatement. In fact, it may well be politically and bureaucratically
impossible, and my discussion later in this piece of what we could do with
NCCAM’s parts once it is disbanded could very well be sheer fantasy on my part
and the parts of my co-bloggers. However, I still think it’s worth discussing
how we might go about such a demolition.

The next thing to remember is that NCCAM was not created because of a
groundswell of support among physicians and scientists who saw all this quackery
out there and said, “Hey, we really ought to study homeopathy (or reiki, or
therapeutic touch [or: INSERT FAVORITE WOO HERE]) to see if there’s anything to 
it.” Rather, NCCAM was created primarily through the effort of a single
ideologue, Senator Tom Harkin (D-Iowa), a woo-friendly legislator who believed
that bee pollen had somehow cured his allergies. It was Harkin who first
assigned $2 million of his discretionary funds to establish the Office of
Unconventional Medicine in 1992. The OUM was soon renamed the Office of
Alternative Medicine (OAM). Then, as detailed in Wally’s article, the first
director of OAM resigned under Senator Harkin’s pressure because he quite
properly objected to nominees to the OAM Council who had been involved in
Laetrile and Mexican cancer clinic scams. In 1998, then NIH Director Harold
Varmus tried to bring the OAM under tighter NIH scientific control to make its
studies more rigorous and was stymied when Harkin introduced legislation to
elevate OAM to an independent Center. As has been discussed before, NCCAM is
constituted so that even its director is hamstrung in what he (or in the case of
the current Director, Josephine Briggs, she) can do because the NCCAM charter
demands that a majority of its Council members be chosen from practitioners and 
“leaders” in the CAM field. In other words, true believers control the agenda,
and it is difficult for even scientifically inclined NCCAM directors like Dr.
Briggs and her predecessor Dr. Stephen Strauss to keep NCCAM from wasting
precious grant money investigating the more ludicrous and implausible CAM
“therapies” out there–like reiki or homeopathy. The bottom line is that by
design there just isn’t that much an NCCAM director can do to change the way
NCCAM operates, at least in terms of how it awards its grants and how it
disburses its training grant money.

Given this history, does anyone doubt that Tom Harkin, aided by other
woo-friendly legislators such as Rep. Dan Burton (R-IN) and Rep. Ron Paul
(R-TX), would fight tooth and nail to protect NCCAM if they got even a whiff of 
news about a serious attempt to defund it? Does anyone doubt that the forces
that managed to pass the DSHEA of 1994 would also join in the fight?

It’s a political battle that President Obama may not consider worth the price it
would take to win, particularly given all the other problems he’s inherited and
the initiatives he wishes to pursue. For defunding NCCAM to be worth his
spending political capital to accomplish, there would have to be a groundswell
of public support. It would require letter writing campaigns, agitation, and a
lot of lobbying. It would require that advocates of science- and evidence-based 
medicine get down and dirty in the quagmire of politics. I’m not sure it’s even 
possible, given the low level of science literacy in this country that renders
most voters unlikely to understand why NCCAM is such bad science and bad policy.
We advocates of science- and evidence-based medicine could try to frame it as a
huge waste of taxpayer money, but there are many other government programs that
waste as much or even much more money. That would be a hard sell. We could try 
arguing that NCCAM funds colossal amounts of bad science and that it promotes
quackery in medical schools, but, even if we could convince President Obama of
this, it’s doubtful that we could convince enough voters to make enough of a
stink to overcome the entrenched interests defending NCCAM. I like the recent
suggestion to the Obama transition team to defund NCCAM as much as the next guy.
But just take a look at the comments near the end, after CAM advocates had been
finally warned of the initiative and started to try to vote its score down,
egged on by various pro-CAM blogs. The scientific ignorance, the “what’s the
problem? attitude, and the “health freedom” posturing (with a huge dollop of big
pharma conspiracy mongering, naturally) are depressing to behold.

But let’s imagine for one glorious moment that somehow the political support and
will were found to defund NCCAM for real. How might that look? What might be
the results?

Defunding NCCAM

It is important to note that NCCAM is not the only source of funding for CAM/IM 
research in the federal government. The federal government spends close to a
quarter of a billion dollars per year funding woo. In actuality, NCCAM’s budget 
is around $121 million a year. The other money comes from an office in the
National Cancer Institute known as the Office of Complementary and Alternative
Medicine (OCCAM, an acronym that, given what the Office studies, brings no end
of chuckling at the irony), whose budget is also around $121 million a year.
Together, that’s nearly a quarter of a billion scarce taxpayer dollars spent on 
CAM/IM. Both NCCAM and OCCAM would have to be defunded to realize that savings. 
Also, the entire NIH budget is just under $30 billion. Removing OCCAM and NCCAM 
would only be less than 1% of the NIH budget. The advantage, however, would be
that this would represent more money that could go to studies that might
actually tell us something useful or identify new treatments.

The key thing to realize is that not everything NCCAM does is worthless. One of 
the chief complaints we at SBM have had about CAM in general and NCCAM in
particular is how they have appropriated clearly science-based modalities, such 
as diet, exercise, and relaxation as being somehow “alternative.” As Wally and I
have argued before, this appropriation of these modalities represents the “foot
in the door” or the “Trojan Horse” to allow all the other woo in, or, as Steve 
Novella has called it, the “bait and switch.” Diet and exercise are the bait,
and the switch is made up of the reiki, homeopathy, acupuncture, and all the
other prescientific placebo therapies. The problem is how to separate the woo
from the potentially science-based medicine and reclaim the “bait” under the
banner of science-based medicine, which is where it belongs, and discarding the 
pseudoscience that CAM/IM tries to “switch” for the bait. To do this, I think
it’s useful to think of four divisions.

For example, let’s consider OCCAM. One huge advantage that OCCAM has is that it 
doesn’t require the presence of CAM “experts” in the study sections evaluating
grants. By and large, study sections looking at projects funded through OCCAM
are the same as study sections evaluating any other grants. This is an enormous 
difference and a huge plus not to be discounted. In fact, it’s the very reason
why, despite the fact that the director of OCCAM is led by a legitimate
scientist and physician, there is very little being done at OCCAM that couldn’t 
be done just as well distributed among appropriate study sections elsewhere.
This is a good thing. After all, CAM is not a natural, disease- or
discipline-specific area; it’s a cobbled-together, made-up wastebasket
“discipline” that includes basically anything that isn’t “conventional,” hasn’t 
been proven, or is wildly implausible from a scientific standpoint. In other
words, there is no reason for this hodge-podge of therapies and “studies” to be 
grouped together under a separate Office in the NCI or under a separate Center
in the NIH. Its components are too disparate, too unrelated to each other, and
many of its claims are actually mutually contradictory. While that may not
bother CAM/IM boosters, it should well bother scientists.

On the other hand, consider this instead. If we want to study nutritional
supplements and their potential interactions with chemotherapy, why not just
form an Office of Nutrition and Cancer and leave out the “alternative”? If we
want to do research looking for natural products that can be used to treat
cancer, why not just have an Office of Pharmacognosy, instead of having the long
and proud scientific discipline of natural products pharmacology “ghettoized”
by its increasing association with all the pseudoscience and woo that has over
the last 15 years been increasingly lumped together with the study of herbs and 
plant products under the CAM/IM label? Remember, pharmacognosy is not herbalism,
at least not as herbalists use natural products. Think of pharmacognosy of
herbalism brought into the scientific era, because herbalism is simply
pharmacognosy as practiced hundreds of years ago.

In fact, CAM could be eliminated entirely if research at each Institute of the
NIH were divided into four main areas:

  1. Drugs/pharmacology (pharmacognosy being a subdivision of this large category)

  2. Physical treatments (radiation therapy, medical devices, surgery, etc.)

  3. Nutrition (there’s where your supplements go)

  4. Lifestyle (exercise, relaxation, whatever)

There’s nothing “alternative” there, and close to everything could be
encompassed under one or two of those four labels. In fact, to some extent, the 
NIH already does this, although the exact scheme of division is more complex.
Indeed, one could replace “Drugs/pharmacology” with “systemic therapies” and
“physical treatments” with “local therapies,” and it would match part of what
NIH does fairly closely.

NCCAM, unfortunately, would be far more difficult because its very raison d’être
is not just to study pseudoscience but to promote it as well. To this end,
every level of the leadership is full of true believers except for the Director,
making NCCAM able to resist pretty much any effort to inject any consideration 
of scientific prior probability or estimates of plausibility into the
consideration of any CAM/IM method. Even the utter pseudoscience that is
homeopathy is considered as though it were any more scientifically valid that
the concepts of sympathetic magic upon which it is based. Don’t believe me? Then
remember the example I discussed before, specifically the R21 grant to study
homeopathic dilution and succussion and how they affect the dose-response curve 
of homepathic remedies. This grant was actually awarded to study whether
succussion (the vigorous shaking done with each homeopathic dilution) that,
claim homeopaths, is necessary to “potentize” homeopathic remedies affects the
dose-response characteristics of homeopathic remedies up to a 30C dilution (30
times 100-fold, or a dilution factor of 1 x 10-60). This is a dilution factor
many orders of magnitude larger than Avagaddro’s number, which is makes a 30C
homeopathic remedy nothing but water. Believe it or not, the investigators are
actually going to compare stirring with succussion to see whether succussion, as
homepaths claim, improves the dose-response curve. This is no different than
studying whether eye of newt or serpent’s tongue is more potent in casting a
magic spell.

This is also yet another reason why NCCAM would have to be utterly dismantled
and all of its component parts spread among the Institutes of the NIH in such a 
manner as to make it virtually impossible to reconstitute, at least not easily, 
if we are to eliminate as much as possible pseudoscience in the NIH.

Conclusion

NCCAM is not a scientific creation, but rather a purely a political one.
Scientists did not clamor for NCCAM or even request it; rather, the OAM and then
NCCAM were rammed down the throats of the NIH leadership primarily through the 
efforts of one powerful quackery-loving Senator. As such, NCCAM can only be
dismantled through the political process, and, unfortunately, I am not at all
optimistic that the necessary political consensus can be developed to the point 
where it is strong enough to overcome the resistance from NCCAM’s powerful
patrons in Congress that any serious initiative to defund it would provoke. That
is not to say that I don’t think that it’s totally worth trying to do. Indeed, 
there has not been a better time in years to undertake this mission, especially 
since President Obama has expressed a desire to “restore science to its rightful
place” and to heed science when developing policy upon which science impacts. I
also believe that he is serious about his pledge, and I can’t think of a better
way for our new President to demonstrate a newfound respect for what science
says than eliminating the worst festering sore of government-funded
pseudoscience currently in existence. If President Obama were to eliminate
NCCAM, that would be a far more powerful signal than appointing advisors with
actual scientific backgrounds doling out a few extra billion dollars to the NIH 
and NSF, although those, too are powerful signals. Dismantling NCCAM would be a 
signal that science, not pseudoscience, guides federal government health
research policy.

      The NCCAM Strategic Plan 2011-2015: The Good, The Bad, and The Ugly

                                  David Gorski

                                      Link

As hard as it is to believe, it’s been nearly a year since Steve Novella,
Kimball Atwood, and I were invited to meet with the director of the National
Center for Complementary and Alternative Medicine (NCCAM), Dr. Josephine Briggs.
Depending upon the day, sometimes it seems like just yesterday; sometimes it
seems like ancient history. For more details, read Steve’s account of our visit,
but the CliffsNotes version is that we had a pleasant conversation in which we 
discussed our objections to how NCCAM funds dubious science and advocacy of
complementary and alternative medicine (CAM). When we left the NIH campus, our
impression was that Dr. Briggs is well-meaning and dedicated to increasing the
scientific rigor of NCCAM studies but doesn’t understand the depths of
pseudoscience that constitute much of what passes for CAM. We were also somewhat
optimistic that we had at least managed to communicate some of our most
pressing practical concerns, chief among which is the anti-vaccine bent of so
much of CAM and how we hoped that NCCAM would at least combat some of that on
its website.

Looking at the NCCAM website, I see no evidence that there has been any move to 
combat the anti-vaccine tendencies of CAM by posting pro-vaccination pieces or
articles refuting common anti-vaccine misinformation. Of all the topics we
discussed, it was clearest that everyone, including Dr. Briggs, agreed that the 
NCCAM can’t be perceived as supporting anti-vaccine viewpoints, and although it 
doesn’t explicitly do so, neither does it do much to combat the anti-vaccine
viewpoints so ingrained in CAM. As far as I’m concerned, I’m with Kimball in
asserting that NCCAM’s silence on the matter is in effect tacit approval of
anti-vaccine viewpoints. Be that as it may, not long afterward, Dr. Briggs
revealed that she had met with homeopaths around the same time she had met with 
us, suggesting that we were simply brought in so that she could say she had met 
with “both sides.” Later, she gave a talk to the 25th Anniversary Convention of 
the American Association of Naturopathic Physicians (AANP), which is truly a
bastion of pseudoscience.

In other words, I couldn’t help but get the sinking feeling that we had been
played. Not that we weren’t mildly suspicious when we traveled to Bethesda, but 
from our perspective we really didn’t have a choice: if we were serious about
our mission to promote science-based medicine, Dr. Briggs’ was truly an offer we
could not refuse. We had to go. Period. I can’t speak for Steve or Kimball, but
I was excited to go as well. Never in my wildest dreams had it occurred to me
that the director of NCCAM would even notice what we were writing, much less
take it seriously enough to invite us out for a visit. I bring all this up
because last week NCCAM did something that might provide an indication of
whether it’s changed, whether Dr. Briggs has truly embraced the idea that
rigorous science should infuse NCCAM and all that it does, let the chips fall
where they may. Last week, NCCAM released its five year strategic plan for 2011 
to 2015.

Truly, it’s a case of The Good, The Bad, and The Ugly.

The Good (more accurately: The Least Bad)

Let’s start by listing the goals of the NCCAM Strategic Plan 2011-2015:

  1. GOAL 1: Advance the science and practice of symptom management.

  2. GOAL 2: Develop effective, practical, personalized strategies for
    promoting health and well-being.

  3. GOAL 3: Enable better evidence-based decision making regarding CAM use and
    its integration into health care and health promotion.

To accomplish these goals, NCCAM proposes five Strategic Objectives:

  1. Strategic Objective 1: Advance Research on Mind and Body Interventions,
    Practices, and Disciplines

  2. Strategic Objective 2: Advance Research on CAM Natural Products

  3. Strategic Objective 3: Increase Understanding of “Real-World” Patterns and
    Outcomes of CAM Use and Its Integration Into Health Care and Health
    Promotion

  4. Strategic Objective 4: Improve the Capacity of the Field To Carry Out
    Rigorous Research

  5. Strategic Objective 5: Develop and Disseminate Objective, Evidence-Based
    Information on CAM Interventions

As much as I detest NCCAM as a political tool foisted upon the NIH by
quackery-friendly legislators, in particular Senator Tom Harkin (D-IA), even I
have to admit that there is some good in NCCAM’s strategic plan, specifically
Objective 4: Improve the Capacity of the Field To Carry Out Rigorous Research.
If you’re a scientist, arguing against improving the capacity to do rigorous
science is akin to arguing against mom and apple pie; no serious scientist would
do it. Of course, implicit in this NCCAM objective is an admission that the CAM
research NCCAM has tended to fund in the past has not been very good, and,
worse, it is very telling that NCCAM should even find it necessary to make
improving the quality of its funded research a strategic objective. After all,
improving the the capacity of a field to carry out rigorous research should be
part of the mission of every NIH institute and center, so much so that it should
almost go without saying. Unfortunately, how NCCAM proposes to go about
improving the scientific rigor of its work isn’t exactly the way it should go
about improving the scientific rigor of its work. For example, one key method
proposed by NCCAM is to “support a variety of high-quality research training and
career development opportunities to increase the number, quality, and diversity
of CAM researchers”:

   A successful and robust CAM research enterprise must draw from two
   sources of well-trained, skilled, and experienced talent: CAM practitioners
   expert in their respective disciplines and biomedical/behavioral scientists
   expert in cutting-edge scientific methods. CAM practitioners are the key
   holders of knowledge related to the potential application of CAM
   interventions and disciplines. NCCAM has always recognized the need for
   research training and career development efforts targeted specifically toward
   this diverse community. Over the years the Center has developed a number of 
   programs aimed at enhancing CAM practitioners’ abilities to critically
   evaluate biomedical literature, participate in clinical research, and, in
   some cases, seek advanced training and career development opportunities for
   careers in the field of CAM and integrative medicine research.

All of this sounds very nice, but where the rubber meets the road, what this
means is listening to reiki practitioners, acupuncturists, therapeutic touch
practitioners, and homeopaths (in other words, believers in unsupported
modalities based on magical thinking) when setting priorities, in addition to
listening to less unreality-based CAM practitioners, such as herbalists or even 
chiropractors who stick with musculoskeletal disorders and don’t claim that
chiropractic can cure asthma or other unrelated diseases. Using such
practitioners to set research priorities and to collaborate with real scientists
is what Harriet Hall would call Tooth Fairy science. It’s putting the cart
before the horse. Implicit in this strategy is the assumption that there is an
actual phenomenon to be studied in modalities like reiki, which, let’s face it, 
is nothing more than faith healing stripped of its Christian religious
background and replaced with Eastern mysticism. If I knew that NCCAM was in
actuality trying to determine whether these phenomena exist, rather than “how”
they work, perhaps I’d be less critical. Another part of me can’t help but note 
that trying to suck real scientists into the study of pseudoscience, NCCAM is
blatantly trying to cloak various modalities in the mantle of scientific
respectability before they deserve to wear it.

Whether I’m being cynical or realistic I leave to the reader to judge.
Certainly, given that Objective 3 (Increase Understanding of “Real-World”
Patterns and Outcomes of CAM Use and Its Integration Into Health Care and Health
Promotion) seems custom-designed to develop a case for “integrating” CAM into
science-based medicine, rather that determining which modalities actually have
some utility supported by science and therefore should cease being “alternative”
and become just “medicine.”

Less irritating is Strategic Objective 2: Advance Research on CAM Natural
Products. Actually, it’s not so much “good” as least objectionable and even
somewhat scientifically defensible. Here are the strategies proposed by NCCAM:

Strategy 2.1: Harness state-of-the-art “omics” and other high-throughput
technologies and systems biology approaches of the sciences of pharmacology and 
pharmacognosy to:

  1. Elucidate biological effects, mechanisms of action, and safety
    profiles of CAM natural products

  2. Study interactions of components with each other and with host biology

  3. Build a solid biological foundation for translational research needed 
    to carry out clinical studies.

Strategy 2.2: Support translational research to build a solid biological
foundation for research on CAM natural products to:

  1. Develop and validate sensitive and reliable translational tools to
    detect and measure mechanistically relevant signatures of biological effect 
    and to measure efficacy and other outcomes

  2. Conduct preliminary/early phase studies of safety, toxicity, dosing,
    adherence, control validation, effect/sample sizes, ADME (absorption,
    distribution, metabolism, and excretion), and pharmacokinetics

  3. Build upon established and proven product integrity policies and
    processes.

Strategy 2.3: Support targeted large-scale clinical evaluation and
intervention studies of carefully selected CAM natural products.

Of course, the reason that I label this as being part of “the good” is because, 
of all the aspects of CAM, natural products represent the area with the most
scientific plausibility. On the other hand, it’s hard not to point out that
there is nothing here that natural products pharmacologists haven’t been doing
for decades. Nothing. What NCCAM is in essence describing is nothing more than
pharmacogonosy, the study of natural products pharmacology. It’s the sort of
thing that our very own David Kroll does. It’s the sort of thing that thousands 
of pharmacologists do every day. Heck, it’s even the sort of thing that a lot of
pharmaceutical companies do when they try to isolate drugs from natural
products. There are many examples of drugs that have come from natural products,
including taxol (Pacific Yew tree); vinca alkaloids (periwinkle plant); related
drugs like campothecin, irinotecan, and topotecan (Camptotheca acuminata,
a.k.a. Happy tree); and, of course, aspirin. The list is extensive, arguably
longer than the list of synthetic drugs.

In fact, what NCCAM is doing here, whether Dr. Briggs realizes it or not, is the
classic “bait and switch” that I discussed when kvetching about Dr. Oz’s
promotion of various Ayruvedic medicines and “detox” diets. In essence, NCCAM
has claimed for itself all of natural products pharmacology as being “CAM.” The 
difference is that there is a layer of belief slathered on it, specifically the 
CAM belief that somehow the natural plant is superior to purified components or 
molecules found to have medicinal value. The assumption is that the mixture of
unpurified compounds somehow allows the components in the plant or natural
product to be “synergistic.” While this sort of synergy is possible, it is
actually pretty implausible, with precious few examples known. Worse, it’s very 
hard to demonstrate true synergy between only two or three components, much less
the hundreds — or even thousands — of components in many plants used in CAM. In
reality, for all practical purposes and even when a plant does have an active
compound (or active compounds) in it that function as a drug, using whole plant 
extracts, as most CAM practitioners do, substitutes adulterated active
ingredients whose purity and potency can vary wildly for well-characterized,
predictable, purified active drug.

Actually, I don’t mind this sort of research so much, as long as it’s testing
hypotheses that are supported by sound basic science and preclinical data.
Certainly, that’s what NCCAM appears to be trying to do, and if NCCAM can’t be
dismantled (as I would prefer), its components absorbed into the appropriate
institutes and centers of the NIH, then I suppose this is the sort of research
that is least likely to cause harm and might actually produce useful results,
far more so than much of the rest of the research that NCCAM funds. However, I
continue to question why such research should now be considered “CAM” when
natural products research has long been a major area of “conventional research.”
After all, the study of natural products and herbs with useful pharmacological 
activity has been an active area of research in pharmacology since time
immemorial. There’s no scientific rationale why such studies should be
segregated away as “alternative”; they could and should be evaluated just like
any other scientific study. Worse, trying to segregate natural product
pharmacology at NCCAM devalues pharmacognosy, and by association with the other 
woo (see below) also being funded under the rubric of “CAM” makes it look like
woo too.

In fact, the entire set of goals set forth by Dr. Briggs in the introduction are
a “bait and switch.” Notice how two out of the three of these have nothing to
do with CAM. Seriously. Why is it that symptom management is CAM? Take the
example of oncology. Considerable research and effort go into trying to develop 
strategies to minimize the effects of therapy. A whole branch of anesthesiology 
is devoted to the management of chronic pain. If that’s not “symptom
management,” I don’t know what is. So what does CAM bring to the science and
practice of symptom management? Very little, I would argue, that can’t be
studied outside the context of CAM. Unfortunately, what CAM really does bring to
symptom management is pseudoscience and prescientific ideas of how the body
works. It brings qi. It brings human energy fields. It brings vitalism. Do we
really need to “integrate” nonsense with science in symptom management? Perhaps 
NCCAM can help us understand placebo effects better, for example, but that is
research that can and should be the bailiwick of other NIH institutes and
centers.

And don’t get me started on Goal 2, which, similarly, is a province of
science-based medicine. One might argue that medicine hasn’t done as good a job 
of developing personalized strategies to promote health and well-being, but the 
solution to that problem is to emphasize such strategies more in science-based
medicine, not to bring in pseudoscience.

The Bad and The Ugly

Let’s take a look at all the strategic objectives. I only discussed Strategic
Objective 2 above, but that’s just because I wanted to discuss the least
objectionable objective. Actually, in and of itself, Strategic Objective 2 is
not objectionable. After all, natural products pharmacology is something I
consider fascinating. So here are the five Strategic Objectives in the NCCAM
Strategic Plan 2011-2015. Neither would Objective 4 be objectionable if the
science were truly rigorous and subject to analyses of Bayesian prior
probability before highly improbable modalities like homeopathy or reiki are
tested in human beings.

So let’s look at Strategic Objective 5 (Develop and Disseminate Objective,
Evidence-Based Information on CAM Interventions). These sound rather benign,
don’t they? I mean, who could argue with disseminating “objective,
evidence-based information on CAM interventions,” for example? Certainly not me.
And I actually do hope that NCCAM does do that, that it really is serious about
it. If so, it would tell people that homeopathy is nothing but water, that
there is no evidence that reiki practitioners can manipulate a “universal energy
field” to heal, and that there’s no scientifically convincing evidence that
practitioners of therapeutic touch practitioners can detect or manipulate human 
energy fields. Let’s look at the key points NCCAM emphasizes about reiki:

  1. People use Reiki to promote overall health and well-being. Reiki is
    also used by people who are seeking relief from disease-related symptoms and
    the side effects of conventional medical treatments.

  2. Reiki has historically been practiced as a form of self-care.
    Increasingly, it is also provided by health care professionals in a variety 
    of clinical settings.

  3. People do not need a special background to learn how to perform Reiki.
    Currently, training and certification for Reiki practitioners are not
    formally regulated.

  4. Scientific research is under way to learn more about how Reiki may
    work, its possible effects on health, and diseases and conditions for which 
    it may be helpful.

  5. Tell your health care providers about any complementary and
    alternative practices you use. Give them a full picture of what you do to
    manage your health. This will help ensure coordinated and safe care.

Pointing out:

   Reiki is based on the idea that there is a universal (or source) energy
   that supports the body’s innate healing abilities. Practitioners seek to
   access this energy, allowing it to flow to the body and facilitate healing.

   Although generally practiced as a form of self-care, Reiki can be
   received from someone else and may be offered in a variety of health care
   settings, including medical offices, hospitals, and clinics. It can be
   practiced on its own or along with other CAM therapies or conventional
   medical treatments.

I could provide other examples, such as the entry on NCCAM for Ayruvedic
medicine. However, perhaps the most instructive example is the entry for
homeopathy. A truly science-based assessment of homeopathy would point out that 
the principles of homeopathy violate multiple well-established laws of physics
and chemistry and that, for homeopathy to work, these well-established laws
would have to be found not to be just wrong, but spectacularly wrong. It would
also point out that, for that to happen, the amount of evidence in support of
homeopathy would have to start to approach the level of evidence that tells us
that homeopathy can’t work. While NCCAM does concede that homeopathy is
“controversial” and that its tenets violate known laws of physics, it does so in
a weaselly, wishy-washy way:

   Homeopathy is a controversial area of CAM because a number of its key
   concepts are not consistent with established laws of science (particularly
   chemistry and physics). Critics think it is implausible that a remedy
   containing a miniscule amount of an active ingredient (sometimes not a single
   molecule of the original compound) can have any biological effect—beneficial
   or otherwise. For these reasons, critics argue that continuing the
   scientific study of homeopathy is not worthwhile. Others point to
   observational and anecdotal evidence that homeopathy does work and argue that
   it should not be rejected just because science has not been able to explain 
   it.

Three of its “key points” about homeopathy are:

  1. The principle of similars (or “like cures like”) is a central
    homeopathic principle. The principle states that a disease can be cured by a
    substance that produces similar symptoms in healthy people.

  2. Most analyses have concluded that there is little evidence to support 
    homeopathy as an effective treatment for any specific condition; although,
    some studies have reported positive findings.

  3. There are challenges in studying homeopathy and controversies
    regarding the field. This is largely because a number of its key concepts
    are not consistent with the current understanding of science, particularly
    chemistry and physics.

Yes, NCCAM presents a classic “tell both sides” false equivalence argument. On
the one hand, established laws of science tell us homeopathy can’t work. On the 
other hand, anecdotal evidence tells us it does work and therefore we should
study it. Never mind that the two principles upon which homeopathy is based
(“like cures like” and the law of infinitesimals) have no real basis in science,
particularly the law of infinitesimals, which states that diluting and
succussing a remedy to the point where not a single molecule is likely to remain
somehow makes it stronger.

This brings us to the meanest, ugliest, nastiest one, the meanest Strategic
Objective of them all, Strategic Objective 1 (Advance Research on Mind and Body 
Interventions, Practices, and Disciplines). Personally, I find it telling that
this is Objective 1 on the list, and NCCAM even lists examples of CAM mind-body 
interventions:

  1. Acupuncture

  2. Breath practices

  3. Meditation

  4. Guided imagery

  5. Progressive relaxation

  6. Tai chi

  7. Yoga

  8. Spinal manipulation

  9. Massage therapy

  10. Feldenkreis method

  11. Alexander technique

  12. Pilates

  13. Hypnosis

  14. Trager psychophysical integration

  15. Reiki

  16. Healing touch

  17. Qi gong

  18. Craniosacral therapy

  19. Reflexology

Here’s the “bait and switch” again. If NCCAM had restricted itself to modalities
that, right or wrong, fall under “mind-body” interventions, such as meditation,
guided imagery, breathing practices, hypnosis, and the like, I would have had
little problem with proposing to study them as a major strategic initiative of
NCCAM. Unfortunately, that’s not what NCCAM did. Notice how NCCAM also throws in
there all manner of pure quackery, such as reiki, healing touch, craniosacral
therapy, and even reflexology. Seriously, reflexology! You know, the idea that
every organ and part of the body “maps” to parts of the foot or hand, an idea
that is not supported — and, in fact, is contradicted — by what we know about
human anatomy and physiology. Placing these forms of quackery next to forms of
interventions such as guided imagery that could well turn out to be
science-based and useful implies, either wittingly or unwittingly, that
“mind-body” interventions already known to be quackery are somehow worthy of
study. Also note how NCCAM includes modalities like Tai Chi, yoga, and Pilates
in the mix as well. These are, in essence, forms of relatively gentle exercise, 
at least for most people. (Yes, I realize that some yoga workouts can become
quite intense.) What makes them more “mind-body” than other forms of low impact 
exercise? Finally, I’m really puzzled about the inclusion of massage therapy on 
this list. No doubt about it, massages feel good, and they are probably even
useful for some musculoskeletal disorders, but what makes massage therapy a
“mind-body” interaction? It’s a body-body interaction!

In fact, this very list looks to me like a blurring of the line between things
that might be true mind-body interventions (meditation, progressive relaxation, 
guided imagery, etc.) and so-called “energy medicine” (reiki, healing touch or
therapeutic touch, acupuncture, and qi gong). In fact, this is intentional, as
there is a notice after the list that states, “As used in this plan, mind and
body encompasses interventions from the three domains of mind/body medicine,
manipulative and body-based practices, and energy medicine.” The problem here is
that certain forms of what is called “mind-body” medicine might actually have
value, whereas “energy healing” is pure religion or pseudoscience. Yet they are 
lumped together.

Truly, Strategic Objective 1 is The Bad and The Ugly.

It’s also evidence that neither Dr. Briggs nor the NCCAM leadership understand
the problem that is at the heart of CAM. For example, look at this statement
from Dr. Briggs in her introduction:

   My experience as a physician who has cared for patients struggling with
   chronic, painful, and debilitating symptoms greatly informs my perspective on
   our work. When I began medical school, one of my teachers taught that “the
   secret of care of the patient is in caring for the patient.”* I took these
   words to heart. Symptoms matter, and few would dispute the fact that modern
   medicine does not always succeed in alleviating them. Few would also dispute 
   the need for better approaches for encouraging healthy lifestyle choices.
   These are places in which I believe CAM-inclusive approaches offer promise,
   and I look forward to exploring the possibilities in the years ahead.

No one, of course, is arguing that symptoms don’t matter, although I note with
some amusement that some CAMsters might not be too happy with Dr. Briggs’
emphasis on symptoms given how they like to claim that “Western medicine” treats
only the symptoms and CAM treats the “root cause” of disease. Be that as it
may, upon reading this, I can’t help but ask: How can “CAM-inclusive” practices 
offer promise above and beyond science-based medicine in encouraging healthy
lifestyle choices, particularly when so much of CAM bases its recommendations on
a prescientific understanding of how the body works? You have to know what the 
body needs before you can encourage healthy choices, and to a large degree we
already do know what most American bodies need: More exercise, more fruits and
vegetables in their diets, and less fat and calories. To add to that knowledge, 
we don’t need CAM. We need science-based medicine. More importantly, I would
wonder on what evidence, specifically, Dr. Briggs bases her assessment.

Inquiring minds want to know!

Getting NCCAM’s money’s worth: Some results of NCCAM-funded studies of
homeopathy

David Gorski on November 19, 2012

Link



Pictured: A terrible combination.

As hard as it is to believe, the Science-Based Medicine blog that you’re so
eagerly reading is fast approaching its fifth anniversary of existence. The very
first post here was a statement of purpose by Steve Novella on January 1, 2008,
and my very first post was a somewhat rambling introduction that in retrospect 
is mildly embarrassing to me. It is what it is, however. The reason I mention
this is because I want to take a trip down memory lane in order to follow up on 
one of my earliest posts for SBM, which was entitled The National Center for
Complementary and Alternative Medicine (NCCAM): Your tax dollars hard at work.
Specifically, I want to follow up on one specific study I mentioned that was
funded by NCCAM.

Even though I not-so-humbly think that, even nearly five years later, my
original post is worth reading in its entirety (weighing in at only 3,394 words,
it’s even rather short—for me, at least), I’ll spare you that and cut straight 
to the chase, the better to discuss the study. It is a study of homeopathy. Yes,
in contrast to the protestations of Dr. Josephine Briggs, the current director 
of NCCAM, that NCCAM doesn’t fund studies of such pure pseudoscience as
homeopathy anymore (although she does apparently meet with homeopaths for
“balance”), prior to Dr. Briggs’ tenure NCCAM actually did fund studies of the
magic water with mystical memory known as homeopathy. Two grants in particular I
singled out for scorn. The principal investigator for both grants was Iris
Bell, who is faculty at Andrew Weil’s center of woo at the University of
Arizona. The first was an R21 grant for a project entitled Polysomnography in
homeopathic remedy effects (NIH grant 1 R21 AT000388).

Here’s the abstract:

   DESCRIPTION (provided by applicant): Classical homeopathy is a 200-year old
   system of complementary and alternative medicine (CAM), which claims that a
   substance that can cause symptoms in a healthy person (provings) can cure
   similar symptoms in a sick person (Law of Similars). In a design synthesizing
   homeopathic provings, health psychology, and psychophysiological
   methodologies, this revised 3-year R21 exploratory study (NCCAM PAR 03-153)
   will assess the effects of two different homeopathic, plant-derived remedies 
   ([A]: Nux Vomica 30c or [B]: Coffea Cruda 30c) on polysomnographic sleep
   recordings of adult human subjects of both sexes (N=60). Primary Specific
   Aims are: I. To evaluate the effects of two different active homeopathic
   remedies versus placebo on standard sleep stages and spectral EEG in human
   subjects; and II.To determine the effects of two different active homeopathic
   remedies versus placebo on nonlinear characteristics of sleep EEG in human
   subjects; The Secondary Aim is: III. To assess the contribution of baseline
   individual difference traits and subjective expectation in modifying the
   physiological outcomes above. The study will examine the interaction of the
   remedy effects with two different human personality traits associated with
   insomnia and overlapping those of persons reported in classical homeopathy to
   respond most strongly to each remedy. Subjects will fall into two
   subclinical groups of otherwise healthy persons: (i) those who score high on 
   the personality trait of hostility (Type A/coronary-prone; contained within
   remedy picture of Nux Vomica)(n=30) and (ii) those who score high on the
   personality trait of anxiety sensitivity (panic-prone; contained within
   remedy picture of Coffea Cruda)(n=30). All subjects also will report insomnia
   from drinking coffee (a symptom common in homeopathy to both remedy types)
   and will replace it with a non-coffee caffeinated beverage for at least 7
   days before and for the duration of the study (beverage coffee is reportedly 
   a clinical antidote for many homeopathic remedies). During the 4-week
   protocol, on the first two nights of each study week, they will undergo at
   home, all-night polysomnographic sleep recordings, i.e., on days 1 and 2
   (baseline 1), 8 and 9 (placebo), 15 and 16 (baseline 2), and 22 and 23
   (remedy [A] OR remedy [B]). All will receive placebo at bedtime on day 8,
   single-blind (placebo given before any remedy to eliminate risk of carry-over
   effects and/or experimenter intentionality on placebo responses, problems
   reported in previous homeopathic provings). At bedtime on day 22, half of the
   subjects from each personality type will receive one dose of Nux Vomica and 
   half will receive one dose of Coffea Cruda on a randomized, double-blind
   basis. All participants will also record subjective sleep and symptom
   patterns over the 4 weeks. Statistical analyses will include hierarchical
   linear models and general linear models. The chosen remedies in 30c doses
   each showed specific and different effects on sleep electroencephalograms of 
   healthy animals in previous studies. This study will contribute to our
   long-range goal of understanding the neurophysiological and biopsychosocial
   mechanisms of classical homeopathic remedy treatment in patients with
   specific clinical conditions.

Leaving aside the utterly scientifically bankrupt nature of the hypotheses and
the methods of testing the, which involve homeopathic provings, health
psychology, and psychophysiological methodologies, NIH R21 grants are
exploratory grants designed to test preliminary hypotheses. As such, they are
much smaller than the usual flagship R01 grants and don’t require much
preliminary data. Actually, technically they don’t require any preliminary data,
the idea being that an idea that is based in sound science designed to explore 
a promising novel hypothesis could potentially be fundable, but in all my years 
in the lab I’ve never seen an R21 funded with no preliminary data. Be that as it
may, there’s no way that anything having to do with homeopathy could be based
in sound science, but apparently that didn’t stop NCCAM from funding the
polysomnography grant (1 R21 AT000388) for three years and scoring total funding
of $583,974. If we estimate an indirect cost rate of approximately 50%, that
means Dr. Bell scored roughly $389,000 in direct costs to do this study, the
rest going to the University of Arizona. (These days, R21s are usually only
funded for two years to a maximum of $275,000 in direct costs.) Even so, just
the very nature of homeopathy, how it involves diluting compounds to
nonexistence (note that Bell is using 30C preparations, which means they’ve been
diluted 1060-fold, or approximately 1037-fold more than Avogadro’s number),
should have been enough to kill this grant in any respectable study section. The
same is true of the second grant, which was entitled Dilution and succussion in
homeopathic remedy dose-response effects (NIH grant 1 R21 AT003212).

Here’s its abstract:

   DESCRIPTION (provided by applicant): The purpose of this revised R21
   exploratory grant to NCCAM in response to PAR-03-153 is to extend the PI’s
   previous human olfactory psychophysiology research and develop a quantitative
   electroencephalographic (qEEG) bioassay for registration of individually
   active (salient) versus inactive homeopathic remedies or placebo.
   Homeopathy’s founder, Samuel Hahnemann MD, originally proposed olfactory
   sniffing as a valid route for clinical remedy administration. Convergent
   basic science evidence suggests that succussion (vigorous shaking) in the
   preparation of homeopathic remedies from animal, mineral, and plant sources, 
   may persistently modify the physical structure of solvent to generate order, 
   i.e., a unique informational signal, even in ultra-diluted solutions beyond
   Avogadro’s number. Torres and Ruiz (1996) proposed that stochastic resonance 
   in sensory systems is a model for optimizing detection of a weak signal
   (homeopathic remedy information) by addition of noise (succussions). No
   previous research has directly examined the effects in human populations of a
   given remedy dilution prepared with different numbers of succussions.
   Specific aims for the study are: I. To evaluate the feasibility of using
   acute evoked responses in quantitative electroencephalography (qEEG) alpha
   power during olfactory administration to detect the presence of a single
   homeopathic remedy (Sulphur) at different numbers of succussions per dilution
   step, prepared at a given dilution; II. To determine the feasibility of
   using the magnitude of acute evoked responses in quantitative
   electroencephalography (qEEG) alpha power during olfactory administration to 
   detect the presence of a single homeopathic remedy at two different
   homeopathic serial dilution factors (prepared with a given number of
   succussions per dilution step); III. To evaluate the generalizability of
   findings for a separate polycrest remedy (Pulsatilla). Subjects will be N=108
   (n=54/remedy) young adult volunteers with moderate (not excellent global
   health) prescreened for potential remedy salience of either Sulphur or
   Pulsatilla and tested in a two-phase study (one remedy per phase). Each
   participant will undergo pre-screening with the Homeopathic Constitutional
   Type Questionnaire for high criterion scores for symptoms of one of the two
   test remedies, followed by three laboratory sessions spaced one week apart
   (dilution sequence subject allocation balanced within each remedy type for
   6c, 12c, and 30c potencies). Each session will involve eight presentations
   within a complete block design of randomized double-blind, placebo-
   controlled (both succussed remedy-free solvent and succussed plain distilled 
   water) olfactory sniff tests (using time-locked sniff-EEG recordings via an
   airflow pressure transducer), using a given remedy dilution prepared with
   stirring only, 10, 20, or 30 succussions. The present study fills a major
   need in homeopathic clinical research to explore and understand
   remedy-related and remedy-person interactive factors that could contribute to
   well-known problems in replicability. Findings from this and follow- up
   studies via subsequent R01s could improve standardization of homeopathic
   remedy manufacturing and prescribing used in patient care and thereby advance
   the quality of clinical treatments and research for this leading form of
   complementary and alternative medicine worldwide.

Yes, as hard as it is to believe, this is an actual, NIH-funded grant. Yes, it’s
an R21, and, yes, one could argue that it’s fairly impressive (for a believer
in homeopathy) that Dr. Bell would like to actually test the effects of
succussion on the production of homeopathic remedies. Or it would be, were it
not for the science that shows that diluting remedies far beyond Avogadro’s
number leaves not a single molecule left of the original remedy and that there
is no even remotely plausible mechanism by which homeopathic remedies so diluted
can work. The way that homeopaths hand wave as above, using terms such as
“homeopathy remedy information” should tell you all you need to know.

Putting aside just how nonsensical homeopathy is, I can’t help but note that
this is now all money that’s already been spent. As scientists, how do we judge 
the value of what came out of a grant like this? Given that, as a general rule, 
it’s often very hard to judge the value of the actual science funded by a grant 
as it’s being done or shortly thereafter, we have to rely on imperfect metrics. 
These include (1) publications that derive from the work done using the grant
funding; (2) new grants that derive from the data generated from work done on
the grant; and (3) patents that derive from work. In all fairness, we also have 
to take into account the fact that these two grants are R21s, which means
they’re designed to fund preliminary research, which by its very nature is
riskier and less likely to pan out than research funded by a nice, “safe” R01
backed by ten papers’ worth of preliminary data. Some R21s based in the soundest
and most interesting of science will result in not a whole lot of results; it’s
the nature of the beast. (Preliminary “risky” research is, well, preliminary
and risky.) Fortunately, when it comes to finding this out, it’s not as
difficult as it once was, as the NIH now requires that all papers that result
from NIH-funding be reported and made available to the public through PubMed
Central, albeit sometimes after a year embargo to satisfy the for-profit
publishers. So let’s take a look at the publications credited to these grants so
far:

Here are the publications deriving from the polysomnography/homeopathy grant (1 
R21 AT000388):

  1. Menk Otto L, Howerter A, Bell IR, Jackson N (2010). Exploring measures of
    whole person wellness: integrative well-being and psychological flourishing.
    Explore (NY) 6(6):364-70.

  2. Brooks AJ, Bell IR, Howerter A, Jackson N, Aickin M (2010). Effects of
    homeopathic medicines on mood of adults with histories of coffee-related
    insomnia. Forsch Komplementmed 17(5):250-7. PMID: 20980764.

  3. Bell IR, Howerter A, Jackson N, Aickin M, Baldwin CM, Bootzin RR (2011).
    Effects of homeopathic medicines on polysomnographic sleep of young adults
    with histories of coffee-related insomnia. Sleep Med 12(5):505-11. PMID:
    20673648.

  4. Bell IR, Koithan M (2006). Models for the study of whole systems. Integr
    Cancer Ther 5(4):293-307. PMID: 17101758.

Here are the publications deriving from the succussion grant (1 R21 AT003212):

  1. Bell IR, Howerter A, Jackson N, Brooks AJ, Schwartz GE (2012). Multiweek
    resting EEG cordance change patterns from repeated olfactory activation with
    two constitutionally salient homeopathic remedies in healthy young adults. 
    J Altern Complement Med 18(5):445-53. PMID: 22594648.

  2. Bell IR, Brooks AJ, Howerter A, Jackson N, Schwartz GE (2011).Short-term
    effects of repeated olfactory administration of homeopathic sulphur or
    pulsatilla on electroencephalographic alpha power in healthy young adults.
    Homeopathy 100(4):203-11. PMID: 21962194.

  3. Menk Otto L, Howerter A, Bell IR, Jackson N (2010). Exploring measures of
    whole person wellness: integrative well-being and psychological flourishing.
    Explore (NY) 6(6):364-70. PMID: 21040885.

So far, this is not promising. For all six papers (there’s one claimed for both 
grants), only one appears to be in a “real” journal (i.e., a journal that is not
devoted to “alternative” or “integrative” medicine). That journal is Sleep
Medicine. All of the other these journals, although ostensibly “peer-reviewed”
and, for whatever unknown but almost certainly ridiculous reason, indexed in
Medline, are the lowest of the low. Any journal whose title is Homeopathy is
clearly devoted to pure pseudoscience. Explore: The Journal of Science and
Healing is a journal known for its publication of truly ridiculous studies.
Perhaps my favorite of the bunch is from a few years ago and involved looking at
whether positive “intent” could be embedded in chocolate, much the way that
Masuro Emoto tries to embed “intent” into water. And, of course, the Journal of 
Alternative and Complementary Medicine, Forschende Komplementärmedizin (Research
in Complementary Medicine), and Integrative Cancer Therapies are well-known as 
go-to journals for all varieties of dubious “integrative” medicine. For
instance, the former advertises that it will publish papers in, among other
things, homeopathy, naturopathy, subtle energies, energy medicine, or whatever. 
(My personal favorite, something I haven’t quite yet figured out yet, is the
topic of “integrative biophysics,” which is one of the topics listed as being
relevant to this particular journal.)

Of course, it’s not enough simply to point out that these three journals are
shams masquerading as real scientific journals. You never know. Maybe these
three papers are simply awesome. Yes, I know it’s highly unlikely when the topic
is homeopathy, but, as always, it’s necessary to dive into the papers
themselves. So let’s look at a few of these papers, chosen because they piqued
my interest in some way and they represented the number of papers I could get
through in the time I had to write this. I’ll start with #3 from the
succussion/dilution grant, which is also #1 for the polysomnography grant. It’s 
also published in the second woo-iest of the journals, Explore. Or maybe it’s
the first woo-iest of the journals. After all, it doesn’t limit itself to just
one quackery, the way Homeopathy does. Looking at the paper, I have a hard time 
figuring out what the relevance is to either grant, as it is not so much about
homeopathy at all. Rather, it’s about what the authors abbreviate as WSCAM
(which echoes in my mind as “W-SCAM”). WSCAM stands for “whole systems
complementary and alternative medicine” and consists mainly of homeopathy,
traditional Chinese medicine (TCM), Ayurveda, and naturopathy, defined as
systems that “focus on the whole person indicators of health, including
patients’ experienced global well-being.” To this, Bell wants to apply
“nonlinear dynamical systems theory thusly”:

   Investigators have proposed using scientific concepts drawn from complex
   nonlinear dynamical systems theory towards improving the external validity of
   the clinical evidence base on WSCAM studies [8, 11, 12]. Several medical
   specialties are using methods of complex systems science to evaluate the
   functioning of body systems in an effort to increase diagnostic capability
   and assess patterns of disease [13–19]. Study designs such as these are well 
   suited to non-reductive WSCAM studies that evaluate whole-person outcomes,
   because they attempt to quantify complex variables. In complexity theory the 
   person is an indivisible complex adaptive system of interacting and
   interdependent parts, nested within and responsive/reactive to a complex
   environment. Synthesis of WSCAM with complexity theory suggests the need for 
   characterizing WSCAM outcomes in terms of both (a) global and local outcomes 
   and (b) positively and negatively valenced systemic behaviors (i.e.,
   symptoms, signs) [8].

Basically, Bell et al looked at the results of different measures of
psychological health, calculating what is known as the “P:N” (positive to
negative affect) ratio on a bunch of college students enrolled in an
introductory psychology course, tried to figure out if the “ratio of positive to
negatively valenced mood has a unique relationship to overall well-being
different from its individual components,” and dividing the students up into
what they called “flourisher” and “languishers.” Ultimately, they claim that
their goal is to “apply complex systems theory” to additional studies and ask if
that can “improve well being.” As I said, this study is purely observational
and not even particularly interesting. It’s also only tangentially related to
the grant, perhaps specific aim 3, which is “to assess the contribution of
baseline individual difference traits and subjective expectation in modifying
the physiological outcomes.”

Next up is a paper published in 2011. This trial was, in essence, a homeopathic 
proving, in which Bell et al had healthy college students sniff various
homeopathic remedies while hooked up to an EEG machine. I kid you not. Even more
bizarre, the students were screened and tested thusly:

   College student volunteers (ages 18–30, both sexes) from an introductory
   psychology course were screened for good health and relatively elevated
   Sulphur OR Pulsatilla symptom scores on the Homeopathic Constitutional Type
   Questionnaire. Subjects underwent a series of 3 once-weekly double-blind
   sessions during which they repeatedly sniffed the remedy matched to their CTQ
   type and solvent controls. Each remedy was given in a 6c, 12c, and 30c
   potency, one potency per week, in randomly assigned order. Solvent controls
   included both plain distilled water and a water-ethanol (95%) solution. All
   sniff test solutions were further diluted just prior to laboratory sessions
   (0.5 ml test solution in 150 ml distilled water). Within a session, remedies 
   and control solvents were administered via 2-second sniffs (8 sniffs of each 
   of 4 different succussion levels for the potency in randomized order).
   Primary outcome variable was relative EEG power (alpha 1 8–10 hertz; alpha 2 
   10–12 hertz) averaged over 19 electrode sites, including all succussions for 
   a given potency.

That’s right. Your tax dollars funded a study in which students sniffed
homeopathic remedies, two of which, the 12C and 30C, were diluted to
near-non-existence and non-existence, respectively. In the introduction the
investigators went on and on about the “nonlinear” nature of the alleged
dose-response of homeopathic remedies in previous studies. One wonders if it
ever occurred to them that this would be the result one would expect if what
they were seeing were spurious results; i.e., no consistent dose-response curve.
It doesn’t matter, though. This study was massively unimpressive. If you look
at the tables, you’ll see that there is no consistent “dose-response” curve.
“Effects” fluctuate up and down as dilution increases. In Table 2, only one
measure was statistically significantly different, and that appears to be only
because the 12C dilution produced a lower power than either the 6C dilution or
the 30C dilution. I’ll grant the investigators that that’s “nonlinear,” but it
also goes against homeopathic “theory,” which claims that diluting the solution 
makes the remedy more potent.

Table 3 looks at the number of succussion steps. Basically, the investigators
looked at whether succussion in addition to dilution matters. Again, I kid you
not. Basically, the investigators looked at four different “succussion” levels: 
no succussion (stirred), 20 succussions, 40 succussions, and 100 succussions).
Remember, whenever they are criticized for claiming that their remedies become
more potent the more that they are diluted, homeopaths will piously and
condescendingly tell us that homeopathy is so much more than just dilution. The 
succussion steps are supposedly absolutely critical, as they “potentize” the
solution of the homeopathic remedy. You might remember that the founder of
homeopathy, Samuel Hahnemann himself, recommended slapping the remedy against a 
Bible to succuss it. Three out of the four measures were not statistically
significantly different, and the one that was shows no consistent change in one 
direction based on the number of succussion steps. In other words, this is about
as close to a negative study as can be. Given the number of repeated measures
that the investigators looked at, I would have been shocked if they hadn’t found
one or two seemingly “positive” results; however, there is no consistency to
them that would suggest a real effect. In any real world scientific application,
this would be a negative study. It looks like nothing more than noise
interpreted as signal. It is rather amusing, though, how inconsistent effects
that follow no dose-response are touted as a feature, not a bug, of homeopathy.

Speaking of this very feature, I’ve saved the paper published in the “real”
journal for last, specifically the paper in Sleep Medicine. This paper actually 
took some reading, unfortunately, but I didn’t think I could avoid discussing it
because, well, it’s the only paper from these grants that appeared in a real
journal. In brief, this study examines the effect of two homeopathic remedies,
Nux Vomica or Coffea Cruda, on insomnia associated with caffeine use. Following 
the homeopathic principle (for which there is no evidence that it works as a
general rule) of like cures like, Bell et al made homeopathic remedies out of
unroasted coffee beans (Coffea Cruda). I can’t figure out the rationale for
using Nux Vomica, which is basically strychnine, but apparently homeopaths use
it for insomnia, colds, flu, bladder infections, and “premature, profuse or
erratic menstruation periods wherein the patients tend to faint before the start
of their menstruation cycle.” Why? Who knows? The one thing I do know is that
it’s a really good thing that most homeopathic remedies are diluted to
nonexistence. One wouldn’t want to be taking strychnine at pharmacological
doses. In any case, Bell et al describe the use of these two remedies thusly:

   Clinically, homeopaths report that Coffea Cruda patients are mild and timid, 
   but also irritable and oversensitive to all types of sensory stimuli,
   especially noise, as well as to positive emotions [25,26]. Nux Vomica as a
   homeopathic remedy is used clinically to treat people with competitive,
   irritable and impatient Type A-like behavioral patterns and tendencies to
   abuse alcohol, caffeine, and other substances. Both Coffea Cruda and Nux
   Vomica patients report insomnia in the middle of the night as a symptom [27].
   Taken together with the clinical reports, the animal EEG sleep data provide 
   a basis for selecting Coffea Cruda and Nux Vomica as candidate homeopathic
   remedies to test in the first homeopathic PSG research on human subjects.

I’m sold. How about you? Note that reference 27 is a book quoting Hahnemann. I
also can’t help but note that every single reference used as a basic science
justification for this study, some of which were animal studies claiming that
Coffea Cruda or Nux Vomica could decrease caffeine-induced changes in sleep in
rats, all came from not just woo journals but homeopathy journals. I took a look
at the papers, and, as one might expect, they were…underwhelming. But what
about this study?

The experimental design was rather complicated:

   Young adults of both sexes (ages 18–31) with above-average scores on
   standardized personality scales for either cynical hostility or anxiety
   sensitivity (but not both), and a history of coffee-induced insomnia,
   participated in the month-long study. At-home polysomnographic recordings
   were obtained on successive pairs of nights once per week for a total of
   eight recordings (nights 1, 2, 8, 9, 15, 16, 22, 23). Subjects (N=54)
   received placebo pellets on night 8 (single-blind) and verum pellets on night
   22 (double-blind) in 30c doses of one of two homeopathic remedies, Nux
   Vomica or Coffea Cruda. Subjects completed daily morning sleep diaries and
   weekly Pittsburgh Sleep Quality Index scales, as well as Profile of Mood
   States Scales at bedtime on polysomnography nights.

As the authors readily acknowledge, obtaining polysomnographic (PSG)
measurements at home is not a trivial matter. In any case, the factor they were 
interested in was the PSG sleep time. Well, not exactly. According to the
methods section:

   Based on the clinical literature and animal studies, primary outcome
   variables of interest were total sleep time, slow wave sleep, stage changes, 
   and awakenings after sleep onset, as a function of verum remedy versus
   placebo across all subjects. Given the exploratory and early research phase
   nature of the current study on human subjects, however, PSG sleep onset and
   rapid eye movement (REM) latencies, REM and other NREM stages, as well as
   actigraphic measures of TST, sleep onset latency, sleep efficiency, and
   fragmentation index, were examined secondarily for possible effects.

One thing I found highly irritating about this paper is the way that they
reported their findings. Rather than showing the data in a straightforward bar
graph or a table with clear descriptions of what each number means, we’re
treated to a single table, (Table 2) showing regression findings, which are
described as being within-subject Analyses on means for combined remedy nights
(22/23) versus means for combined placebo nights 8/9, controlling for gender,
personality scores, total time in bed, and means for combined baseline nights
(1/2/15/16). Unfortunately, even after reading the paper, I’m not sure exactly
how authors controlled for baseline nights. Another thing I noticed right away
is that the 95% confidence intervals were large. Really large, as in at least
half the value of the actual number, often considerably more.

Also rather curious were the findings themselves, which were that overall PSG
for the remedy week showed significantly longer TST, increased NREM sleep
including more minutes in stage 2 and increased slow wave sleep (SWS), with a
trend toward increased minutes of stage 4 sleep (β=5.8, p<0.10) compared with
placebo. The homeopathic remedies also led to more sleep disruptions after sleep
onset, with significantly increased awakenings, number of stage changes, and
more type 2 arousals compared to placebo. Sound familiar? Once again, it’s the
same thing we’ve seen before: Mixed, inconsistent results.

There’s also another issue that is mentioned in the discussion, but the authors’
explanation is not convincing. The authors note that one possible
interpretation of the data could be that the changes in sleep during the remedy 
week could be due to the passage of time and the adaptation of the subjects to
the study protocol and equipment, rather than remedy effects. They are correct
but not so convincing in their dismissal of that concern, in which they argue
that everything is hunky dory because analyses were controlled for baselines
taken on nights 1 and 2 and on nights 15 and 16. Here’s the problem. The very
experimental design calls for a single-blind placebo during the earlier
intervention week. Why single blind? Try not to laugh:

   The study design was deliberately structured with single-blind placebo
   preceding allocation to one or the other of the two remedies double-blind, in
   order to address a different potential methodological and theoretical
   concern, i.e., the reported risk of non-local or entanglement confounds of
   placebo and remedy effects, when treatment arms are administered double-blind
   in a closed system of a homeopathic study. Keeping the experimental system
   open with single blind placebo may have provided a strategy to reduce the
   risk of entanglement between placebo and remedy effects [62–65].

Yes, Bell et al just invoked quantum entanglement. If you don’t believe me,
check out references 62 through 65. Go ahead. I’ll wait. At least I was grateful
when I read the paper that Bell actually refrained from citing Lionel Milgrom. 
Little victories matter. In any case, see how pseudoscience twists a normal
protocol. There could very well be bias introduced by always having the placebo 
first and by having it be only single-blinded. However, because of some
fantastical worry about “entanglement,” instead of doing the study the way it
should be done, totally double-blinding it and not restricting whether subjects 
got the placebo or the “real” homeopathic remedy to one week, they do it in a
way that makes it less rigorous and more prone to effects not due to the
intervention. Of course, given that homeopathic remedies are basically water
packed into sugar pills and then allowed to evaporate, the very concept of a
“placebo” in a homeopathy trial is rather risible. After all, the homeopathic
remedies are every bit as much placeboes as the placeboes. Be that as it may,
this trial is not particularly convincing, either. Even the authors concede that
their “present findings do not address the question of whether or not either of
the homeopathic remedies tested here would be therapeutic for certain people
with insomnia.” Now that’s an understatement.

Two years ago, NCCAM director Josephine Briggs assured Steve Novella, Kimball
Atwood, and myself that NCCAM is a lot more rigorous now and that trials like
these two would never be funded under the new regime. That’s reassuring, but it 
doesn’t convince me. For one thing, Briggs wouldn’t say that no trial of
homeopathy would ever be funded by NCCAM, even though she conceded that
homeopathy is based on principles that are so unscientific as to be incredibly
implausible. While I understand that it’s hard for the director of an NIH center
to say “never” about anything, what this told me is that Dr. Briggs would be
willing to fund homeopathy research if it met some level of scientific rigor.
What about homeopathy could have sufficient scientific rigor to be worth
throwing hundreds of thousands of dollars at is never said, and another director
might be more lax in judgment. Besides, there is a training grant whose
principal investigator is—you guessed it!—Iris Bell and whose purpose involves
preparing its fellows to be able to study all sorts of dubious alt-med
modalities, including homeopathy. Yes, it’s the University of Arizona CAM
research training program.

So even though NCCAM claims not to fund pure quackery anymore (although that’s
debatable), it does fund education in quackery in the form of training grants.
As for grants like those of Iris Bell, it’s depressing to think that NCCAM threw
a half million dollars at studies this execrable, in addition to studies just
as bad. It’s your tax dollars still at work, funding woo.

      A homeopathy supporter notices our visit with the director of NCCAM

                                  David Gorski

                                      Link

On April 2, Steve Novella, Kimball Atwood, and I visited the National Center for
Complementary and Alternative Medicine (NCCAM) to meet with its director, Dr.
Josephine Briggs. I’m not going to rehash what was said because we agreed that
Steve would handle that task, and he did so admirably last week. I agree with
Steve that it was encouraging that Dr. Briggs apparently reads this blog and
shares many of our concerns about NCCAM, the poor science that it has funded,
and its use by promoters of unscientific medicine to promote their quackery.
Most heartening of all was that she appeared to recognize how much CAM is
infused with anti-vaccine beliefs and, worse, the promotion of these beliefs to 
the detriment of public health.

Those positive reactions to what was a friendly but frank exchange of views
notwithstanding, as we were sitting in a conference room next to Dr. Briggs’
office, I couldn’t help but wonder what the reaction of CAM promoters would be
when they found out about this meeting. Now I know. John Weeks over at The
Integrator Blog is not happy:

   Novella’s posting reads like a Fox News interview: 95% his team’s point, then
   a brief NCCAM response. That Briggs asked for the meeting likely grew out of
   an early March conference at Yale at which Novella and she both
   participated. For this, she deserves the Barack Obama Big Tent award for her 
   proven interest in sitting down with everyone, no matter which party
   affiliation or belief. (Some have said this was proven in early 2008 when
   Briggs met with me.) Arguably, Briggs takes her openness to dialogue further 
   than the President. While Obama has kept arms length from leaders who call
   for the demise of the United States, Briggs has now met with those who have
   been lobbing bombs at her professional home for years, calling steadily for
   NCCAM’s destruction.

Because our previous calls for the closing of a relatively small government
institute because we view it as a poor use of taxpayer money is just like
calling for the downfall of the United States government. Weeks clearly likes
ridiculously overblown hyperbole. Interestingly enough, what appeared to upset
Mr. Weeks the most was our discussion of homeopathy with Dr. Briggs. As Steve
put it:

   Dr. Briggs pointed out that it is not the job of the NCCAM to make final
   pronouncements about any treatment or medical claim. This is fair enough —
   but depends on context. The NCCAM is responsible for informing the public
   about so-called CAM modalities, and that should include a fair assessment of 
   the science. If the science says a treatment is worthless, the NCCAM should
   not be afraid to say so.

   Further, the NCCAM does determine what studies the NCCAM funds. The NCCAM
   accepts applications for research into homeopathy, but have not funded any in
   several years. What does this mean? Will they consider funding homeopathy
   research, and if so they are basically saying that they do not close the door
   on any medical modality, no matter how implausible or damned by negative
   evidence.

   If they will not consider funding homeopathy, then why are they accepting
   grant applications for homeopathy research? This could be construed as
   disingenuous — perhaps a way to not fund homeopathy research without having
   to say they will not fund homeopathy research.

Steve is correct. The NIH can never totally close the door on any line of
research. It can, however, set priorities. It could decide that, given the
homeopathically diluted prior plausibility of homeopathy based solely on
physics, chemistry, and biology, homeopathy is not a priority. It can make sure 
that only reviewers with the relevant background in basic and clinical science —
not “homeopathic” science — make up the study sections that review NCCAM
grants. Indeed, I was much heartened to learn from Dr. Briggs that she had
already moved peer review of CAM grants out of NCCAM-sponsored study sections
and into regular standing NIH study sections run by the Center for Scientific
Review, which is where the vast majority of NIH grants are normally reviewed.

As a sort of counterpoint to our message, Mr. Weeks described in the same post a
meeting that Dr. Briggs had with an “international homeopathic team.” Besides
the amusement I felt at the word choice (is a homeopathic team a team so diluted
that there is no one there?), the content itself was at the same time both
disturbing and full of hilarious howlers. For instance, this passage concludes
the section discussing our visit:

   That said, what would have been especially interesting is if Briggs’
   scheduler crossed wires and the anti-NCCAM bloggers and homeopathic
   researchers had showed up for the same meeting time.

I can’t speak for Steve or Kimball, but I assure Mr. Weeks, that I probably
would have enjoyed such an encounter thoroughly, although we would have been
disappointed that we wouldn’t have been able to have the discussion that we had 
planned on.

But how did the meeting between Dr. Briggs and the homeopaths go? This is how
Mr. Weeks describes it:

   Gahles, in a report to the Integrator, assessed that the meeting went “very
   well.” In her view, a presentation by Chaplin and Roy on chemistry and slides
   that “showed activity of homeopathic remedies on basophils and IgG” seemed
   to be particularly compelling to the NCCAM team in suggesting mechanism of
   action. Gahles underscored that conventional bio-markers seemed to be key in 
   stimulating interest from the NCCAM team.

   On the other hand, a presentation on quantum physics and energy medicine
   seemed to be less useful in making in the case. At one point, an NCCAM team
   member who said he found the presentation “powerful” asked what the community
   of top scientists would think. Those in the meeting responded: “We are the
   leading scientists in the field.”

More like the leading pseudoscientists in the field. The thought of a homeopath 
claiming to be a leading scientist, particularly when it comes to physics and
energy brings to mind Dr. Charlene Werner’s tortured attempt to explain
homeopathy through physics or John Benneth’s attempt to explain it as
“nanocrystalloids.” Maybe they’re the “leading scientists” of the field of
homeopathy. Or perhaps Mr. Weeks means Dana Ullman. Or maybe Jacques Benveniste.
In any case, it’s disturbing that an NCCAM team member apparently found the
presentation “powerful.” Anyone who finds the clinical research on homeopathy
“powerful” does not understand the true tenets of homeopathy and what
pseudoscience they are. Such attitudes will tend to stand in the way of attempts
to bring more rigorous science to the study of CAM.

Still, Mr. Weeks has done us an unintentional favor — two, actually. First, he
has demonstrated clearly that the CAM community wants its pseudoscience, not
rigorous science, to guide NCCAM’s research efforts. This has only reinforced my
appreciation of Dr. Briggs’ delicate situation. Every move she makes towards
bringing rigorous science to the study of CAM is certain to enrage supporters of
the purely pseudoscientific CAM modalities such as homeopathy, reiki, and
various “energy healing” modalities that are no better than faith healing under 
different belief systems than Christianity.

Second, Weeks actually points out the heart of the conflict at the heart of
NCCAM. Dr. Briggs is clearly trying to move NCCAM in a direction that we at SBM 
would approve of, namely towards a more drug discovery-oriented approach towards
herbal and botanical remedies and various supplements, as well as the study of 
exercise and various relaxation techniques. After all, these are the most
plausible remedies that fall under the general rubric of CAM, and a
pharmacognosy approach is the most likely to yield useful information and
scientific advances. But that is not what CAM proponents want. Indeed, they
resent this approach, as Weeks demonstrates:

   One of the perverse pleasures that comes from the disposition of the NIH to
   hire NCCAM leaders who have no prior experience in alternative or integrative
   medicine is to think of the culture shock when they move from a zone of
   relative comfort — drug research on fractions of botanical — into the far
   reaches such as homeopathic theory and practice. In truth, forms of energetic
   thinking and practice are infused throughout the “CAM” universe;
   homeopathy’s dance with Avogadro’s number merely makes it, with distant
   prayer, the most challenging.

“Challenging” is putting it mildly. But this is the kicker:

   It is probably good that Briggs’ extensive and admirable self-education
   process over the last 2 years preceded this meeting. The culture shock may
   had this meeting been in her first months.

I rather suspect that Mr. Weeks is correct here, only not in the way he thinks. 
I’m willing to bet that it was a major culture shock for Dr. Briggs to find out 
just how much magical thinking, religion, and pseudoscience underlie so much of 
CAM. What Weeks calls a “comfort zone” is in reality nothing more than staying
within what can be studied and demonstrated scientifically, which is what
scientists do. If homeopaths could produce anything more than centuries-old
magical thinking to support their quackery, if they could produce actual science
in the form of physics, chemistry, and biology to support their mystical
beliefs in the “memory” of water and that “like cures like,” then their
discipline would enter the realm of science, rather than being relegated to the 
realm of pseudoscience. The problem, of course, is that homeopathy and the
“energy healing” modalities are so removed from science that this is about as
unlikely to happen as there is likely to be a single molecule of active remedy
left in a 30C dilution.

Therein lies the conflict at the heart of NCCAM, and, although I approve of Dr. 
Briggs’ attempts to increase the scientific rigor of NCCAM and, given that NCCAM
isn’t going anywhere, see that as the best path towards trying to make NCCAM a 
useful center in the NIH, I’m afraid that her actions will only exacerbate the
conflict. It’s the institution and the laws that created it that are the
problem, and Dr. Briggs won’t be there forever. Her successor might not be as
dedicated to science as she is. (In fact, if people like John Weeks get their
way, you can count on it.) No matter how much Dr. Briggs may change the culture 
of NCCAM under her stewardship, all it takes is a new director to change it
right back. Directors come and go, but institutions last for generations.

Wendy Weber, a naturopath, now leads NCCIH. Let the quackery flow (even more)!

Not-A-Doctor Wendy Weber, a naturopath, has been appointed Director of the
NCCIH. Will this mean more MAHA quackery on top of the usual quackademic
medicine?

David Gorski on August 31, 2026

Link


I must confess that this week was a trying week, at least from an SBM point of
view. Between the ongoing measles outbreaks, the takeover of the Interagency
Autism Coordinating Committee (IACC) by cranks and antivaxxers, and more, as the
weekend approached I was hard-pressed (again) to decide what to write about and
feeling drained after the last few weeks, which included “autism biomed”
quackery taking over the main NIH Institute dedicated to developmental
disorders, the impending subversion of NIH peer review to allow political
appointees to decide which grant applications are funded, and more cancer
quackery from “make America healthy again” (MAHA) advocates. Then I saw what
appears to have been a little-noticed announcement from NIH Director “Podcast
Jay” Bhattacharya: Dr. Wendy Weber to serve as director of the National Center
for Complementary and Integrative Health.

Wendy Weber, ND, PhD, MPH, the new Director of theNational Center for
Complementary and AlternativeHealth.
Longtime readers will know that the National Center for Complementary and
Integrative Health (NCCIH), formerly known since the late 1990s as the National 
Center for Complementary and Alternative Medicine (NCCAM), has long been a topic
of this blog. The reason is pretty clear. NCCIH has long funded research into
what we like to call “quackademic medicine”; i.e., unproven, disproven, and
often pseudoscientific “medicine” that falls under the rubric of “alternative”
or “integrative” medicine, such as acupuncture, reiki, chiropractic, and the
like. In fairness, the spectrum of interventions studied with NCCIH-issued
grants does range from the evidence-based (e.g., diet, exercise, and all the
things that MAHA claims to be promoting) to the totally quacky, such as
homeopathy, reiki, and acupuncture (especially acupuncture). The overall result,
of course, is that lumping together all these modalities tends to cloak the
quackier elements of “complementary and alternative medicine” (CAM), or, as its 
advocates prefer to call it, “integrative medicine” under the seeming legitimacy
of lifestyle interventions, such as nutrition, exercise, and other lifestyle
elements, such as getting adequate sleep, as if it’s all equally worthy of
study.

So, why would the announcement of a new NCCIH Director “inspire” me to write
about it, given that NCCIH has existed in its current form, other than a
renaming a decade ago, for nearly three decades? Let’s go to the press release:

Today, National Institutes of Health (NIH) Director Jay Bhattacharya, M.D.,
Ph.D., announced that Wendy Weber, N.D., Ph.D., has been selected to serve as
director of NIH’s National Center for Complementary and Integrative Health
(NCCIH). Since October 2025, Dr. Weber has provided scientific leadership and
strategic counsel and contributed to budget oversight to NCCIH as acting deputy 
director. She began her new role on August 23, 2026.

“As the home of complex, multi-system health research, NCCIH is central in our
mission to understand multifaceted chronic diseases and the role of nutritional 
interventions on health,” Bhattacharya said. “Dr. Weber’s history of leadership 
in whole-person health, pain management research, and deep connection to NIH
make her a natural fit to lead the center into a new chapter of rigorous
scientific discovery.”

As the head of NCCIH, Dr. Weber will manage the administration of the center’s
approximately $170 million budget. NCCIH supports research that aims to
determine the fundamental science, usefulness, and safety of complementary and
integrative health approaches and their roles in improving health and health
care.

And:

Prior to joining NIH as a program director in 2009, Dr. Weber led clinical
investigations of complementary health interventions at Bastyr University,
Kenmore, and Massachusetts General Hospital, Boston. As a faculty member at
Bastyr University, Dr. Weber conducted clinical trials of botanical
interventions, including Echinacea for the common cold. She was the first
naturopathic physician to receive an NIH career development (K) award, which
supported her clinical trial of St. John’s Wort for
attention-deficit/hyperactivity disorder.

Dr. Weber is a licensed naturopathic physician. She received her N.D. from
Bastyr University, Kenmore, and later earned a Master of Public Health and Ph.D.
at the University of Washington, Seattle. This combination of clinical training
in naturopathic medicine and doctoral-level research training in epidemiology
gives Dr. Weber a rare dual perspective, bridging complementary health practice 
with rigorous scientific methodology.

Why is it significant that the new NCCIH Director is a naturopath? Longtime
readers will know. I will also say that, in fairness, NCCIH has been on this
trajectory for a long time, and it’s entirely possible that Not-A-Doctor Wendy
Weber might have been appointed to head NCCIH under almost any administration.
Indeed, I remember that the only good idea that I saw in the first NIH budget
proposed by the Trump administration for FY2026 last year was to eliminate
NCCIH, although the significance of eliminating NCCIH might have meant nothing, 
given that Podcast Jay has stated that he wanted to turn NIH into the “research 
arm of MAHA,” which to me sounds like turning all of NIH into NCCIH studying the
“integration” of, as Mark Crislip put it, the cow pie of alternative medicine
with the apple pie of science- and evidence-based medicine. (He also noted in
2012, “If you mix cow pie with apple pie, it does not make the cow pie taste
better; it makes the apple pie worse.”)

I also must note that the previous NCCIH Director was Helene Langevin, who was
very much into “proving” acupuncture using bad science and pseudoscience.
Indeed, from an SBM perspective, she was most famous for claiming to have
identified anatomic correlates to acupuncture “meridians” using ultrasound and
impedance measurements. (She didn’t.) Does that mean that NCCIH might as well go
full woo and hire a naturopathic quack as its director?

Naturopathy: A brief refresher

We haven’t written much about naturopathy at SBM in a long time, so it’s worth
briefly recounting what naturopathy is…and is not.

If you want to listen to what naturopaths themselves say about their specialty, 
I like to refer to what the Society of Naturopaths says about it, in particular 
about its history:

The term ‘Naturopath’ is an Anglicized version of the term ‘physician’ which was
used by Hippocrates from the Greek root word ‘physikos’ meaning ‘nature’. This 
suggests that every practitioner of naturopathic medicine should to be skilled
in Nature and must strive to know what man is in relation to food, drink,
occupation and the effects that each of these has upon the other. In this sense,
‘nature’ also means a person’s ‘nature’ or constitution.

This part sounds fairly unobjectionable, as “food, drink, occupation” and their 
effects on health are subjects that science- and evidence-based medicine has
long concerned itself with. The devil, as they say, is in the details,
specifically how naturopathy addresses these issues. Naturopathy dates back to
the late 19th century:

The main practitioner who is known to have formulated naturopathy at the
beginning of the 20th century was Benedict Lust who trained in chiropractic and 
adopted the term “Naturopath” which he purchased from a colleague of his, a Dr
John Scheel.  Lust opened the first ‘Health food store’ in America in 1895
(originally called ‘Kneipp store’) and set up the American School of
Naturopathy. In 1902 Lust replaced the Kneipp societies with the ‘Naturopathic
Society of America’, later changed to the ‘American Naturopathic Association’.
Lust claimed at one point to have 40,000 practitioners practicing naturopathy.
In the early 20th century naturopaths were on a par with doctors and were sought
after for their vast and diverse knowledge of health and disease.

Benedict Lust was quite the character. He was a chiropractor, and he
believed…well, let’s just quote his 1945 obituary in The New York Times:

The members of the American Naturopathic Association do not believe in
vaccination, drug treatments, medicinal remedies or vivisection. The president
said at the association’s convention in 1925 that “most people die from the
effects of wrong living and drugs. Cancer can be cured by natural processes
without medicine or surgery. Most diseases and chronic sicknesses are only
aggravated by the use of medicine.” Among the writings of Dr. Lust are “The
Crime of Vaccination,” “Vitalisme Series” and “Biological Blood Washing Method.”

So…naturopaths today, no matter how much they try to represent themselves as
“scientific,” follow in the footsteps of Not-A-Doctor Lust. He was antivax and
practiced a *lot* of quackery. This April, he was even a side topic of an
episode of one of my favorite podcasts, Behind the Bastards, which described a
grifter disciple of Lust named Robert Spears, who was president of the Texas
Naturopath Association from 1954-1957 and was alleged to have placed a bomb
aboard National Airlines Flight 967, an aircraft that went missing over the Gulf
of Mexico on November 16, 1959, killing 42 people. But I digress…a little. I
just wanted the chance to recommend Behind the Bastards.

Back to the Society of Naturopaths, who even mentions Sir Arbuthnot Lane, a
medical doctor and surgeon, who believed that nearly all disease results from
“autointoxication” due to the backup of fecal matter in the colon, noting:

All of the research of these naturopathic pioneers into causes of cancer via
diet, maintaining good colon health, the importance of probiotics, the problems 
of too much red meat, the need for exercise and fresh air is now being
resurrected and fed back to the general public after extensive research
confirming that what they originally said nearly 100 years ago is in fact
correct.

I’ve written about Sir Lane before as one of the “inspirations” for the
recurring fad of “detoxification” that has been consistently advocated by
naturopaths. One thing that the Society of Naturopaths doesn’t mention is that, 
as a surgeon, early in his career Lane advocated total colectomy (removal of the
entire colon) for the autointoxication that was thought to be the cause of
diseases ranging from lassitude to epilepsy. That goes far beyond just
advocating eating less meat and engaging in exercise. Moreover, even the
maligned medicine of the time advocated fresh air, better diet, and exercise.
But back to Sir Lane briefly. Given that there were no antibiotics effective
against colonic flora back then, intestinal surgery was fraught with peril due
to the high rate of sepsis and death; this approach was reckless indeed, even by
the standards of the time. Eventually, even Sir Lane came to the same
conclusion and by the 1920s had changed his mind, deciding that diet and enemas 
were the answer.

Naturally (if you’ll excuse my use of the word), naturopaths blame their fall
from favor from their glory days in the early 20th century on the Flexner
Report, whose publication in 1911 resulted in medical schools basing their
curriculum on science and eliminating various unscientific and pseudoscientific 
teachings that naturopaths espoused:

The US Flexner report of 1910 criticised the number of medical schools in the US
and called on them to have higher admission fees and higher graduation
standards. Many medical schools fell short of the standards stipulated in the
report and either closed ‘overnight’ or amalgamated with larger schools. In
addition, a medical school could not teach naturopathy or homeopathy and if it
did then graduates would not be recognised as doctors and therefore would not be
able to find work. This, together with the public’s infatuation with technology
and ‘a pill for an ill’; World War 2’s need for the development of surgery, and
growing sophistication of the American Medical Association under the leadership
of Fishbein, together with the death of Benedict Lust in 1945, all led to the
decline of naturopathy.

The naturopaths then describe today’s version of naturopathy as being—of
course!—nothing but science-based. Citing the discovery of vitamins, Linus
Pauling, and Rachel Carson as proving their contention that environment and diet
impact health (as if anyone was arguing that they do not), the Society of
Naturopaths proclaims:

Naturopathy is finally re-emerging in the 21st century as people become
disillusioned by modern medicine which only treats symptoms and rarely
addressing the cause of disease. Media coverage of a healthy diet and lifestyle 
being conducive to good health has spurred people into taking more
responsibility for their well-being and seeking out naturopathic practitioners.

Naturopathy now incorporates scientific advances in modern medicine, whilst
remaining true to its vitalistic approach. The art of modern naturopathy is to
be able to blend advances in modern medicine with the ancient traditions.
Science is beginning to prove what the ancient Eastern medical traditions have
been teaching and practicing for centuries.

At least they admit that naturopathy is based in vitalism, an ancient belief
that the difference between living and non-living things is some sort of
non-material vital force. As Dr. Peter Lipson put it:

Vitalism, an ancient and discredited philosophy, has become irrelevant in modern
thinking with two important exceptions: alternative medicine, and religion.
That, right there, should tell you something important.

One brief way that I like to describe naturopathy is thusly: Naturopathy is a
hodge-podge of mostly unscientific treatment modalities based on vitalism and
other prescientific notions of disease. As a result, typical naturopaths are
more than happy in essence to “pick one from column A and one from column B”
when it comes to pseudoscience, mixing and matching treatments including
traditional Chinese medicine, homeopathy, herbalism, Ayurvedic medicine, applied
kinesiology, anthroposophical medicine, reflexology, craniosacral therapy,
Bowen Technique, and pretty much any other form of unscientific or prescientific
medicine that you can imagine. Despite their affinity for non-science-based
medical systems, naturopaths crave the imprimatur of science. As a result, they 
desperately try to represent what they do as being science-based, and they’ve
even set up research institutes, much like the departments, divisions, and
institutes devoted to “complementary and alternative medicine” (CAM) that have
cropped up on the campuses of legitimate medical schools and academic medical
centers like so many weeds poking through the cracks in the edifice of
science-based medicine. Naturopaths also really, really don’t like it when they 
encounter criticism that their “discipline” is not science-based.

Not-A-Doctor Wendy Weber epitomizes this aspect of naturopathy.

What Not-A-Doctor Wendy Weber at NCCIH means

As far as naturopaths go, Not-A-Doctor Wendy Weber is less objectionable than
average, if only because she belongs to the group of naturopaths that claim to
be rooted in science. That being said, she has been discussed on this blog
before. She’s also been at the NIH for 15 years, which is a long time, and has
served as acting deputy director, a position from which she has now been
promoted to Director. To get an idea of her approach to the evidence regarding
“integrative” or “alternative” treatment modalities, let’s revisit her mentions 
on the blog thus far.

First, Jann Bellamy noted that Wendy Weber had co-authored a survey of
naturopaths and their use of “detox” methods, pointing out that the authors had 
stated that “environmental chemicals can have deleterious health effects,” which
is, of course, undeniably true. However, even after basically all but admitting
that there was no evidence supporting the various “detoxification” treatments, 
even as the survey showed that their use was widespread among naturopaths, the
authors contended:

As increasing evidence of the relationship between body burden and adverse
health effects of synthetic chemicals emerges, safe and effective methods of
reducing body burden levels will be a vital component of naturopathic medicine, 
and complementary, alternative, and integrative medicine in general.
Detoxification therapies used by NDs may serve as an adequate means to reduce
the body burden of synthetic chemicals found today in humans; however,
scientifically rigorous research is needed to determine the safety and efficacy 
of these therapies. The authors’ observation that only approximately 50% of
surveyed NDs reported use of laboratory measures to assess toxicant exposure, or
to determine the efficacy of treatment is surprising and could be a result of
the survey design (the validity of certain types of toxicant testing is highly
controversial, and beyond the scope of this survey). Nevertheless, it is clear
that further research and practice standards are needed.

Yes, Not-A-Doctor Weber claims to be science-based, but she is still clearly
rooted in the world of naturopathy. For one thing, again, we already have enough
evidence to know that the vast majority of the “detox” regimens used by
naturopaths are rank pseudoscience and quackery. More research is not needed.
Moreover, whether or not you should do lab testing to see if you are actually
reducing the level of a “toxin” that you are claiming that your “detox” treats
is not controversial in science-based medicine. If, for instance, I am using
chelation therapy for one of its few evidence-based indications, acute heavy
metal intoxication, then it is reasonable to check levels of the heavy metal
being removed, both to assess efficacy and tell me when I can stop therapy. That
most naturopaths don’t bother is one indication—among many—that the “toxins”
they are supposedly removing are no more real than their “detox” methods are
science-based.

The second mention of her in SBM relates to how she co-authored and then
promoted a systematic review of “complementary approaches for pain management,” 
or what NCCIH likes to call “nonpharmacologic approaches” to pain management, no
matter how much we remind them that nonpharmacologic approaches to pain
management do not necessarily equal CAM. (CAM advocates in general and
naturopaths in particular do like to claim all such interventions as being “CAM”
or “integrative.”) My personal reading of the review led me to conclude that
the evidence for, basically, all these interventions (acupuncture, massage, tai 
chi, chiropractic spinal manipulation, osteopathic spinal manipulation, yoga,
etc.) was basically either consistent with placebo effects, highly equivocal, or
negative.

None of that stopped Not-A-Doctor Weber from touting the review as telling us
what does and does not work:

Notice how Weber basically admits, with a whole lot of hand waving, that we
don’t know the mechanisms by which “complementary” therapies “work” for pain. Of
course, that’s because the ones reviewed almost certainly do not, hoping that
“future research” will answer those questions. Oh, and, Congress, keep funding
us to do more pointless studies!

In fairness, I have to note that a lot of Weber’s research is fairly pedestrian.
For example, she basically made her name 20 years ago by carrying out a
randomized controlled clinical trial of St. John’s Wort for ADHD, which
concluded that it didn’t work. She also carried out an RCT on echinacea to treat
colds in children and reported that it didn’t work. Naturopaths did not like
this. She later published a secondary analysis, concluding that “echinacea
purpurea may be effective in reducing the occurrence of subsequent URIs in
children.” Never let a good negative clinical trial go to waste, I say. Do
subgroup analyses until you find something. (In fairness, it’s not just
naturopaths who do this.)

I also found one article co-authored by her that concluded that “CAM diets were 
associated with increased quality of life in youth with diabetes, whereas
supplement use and stress-reduction activities were associated with decreased
quality of life.” I bet, at least for the supplements, although “CAM diet” was
poorly defined in this article and seemed to include some combination of
avoiding wheat and dairy, “organic/antibiotic-free/hormone-free,” and a blood
type diet. Blood type diets are, of course, utter quackery, while avoiding wheat
and dairy are appropriate only for a narrow set of conditions, not the
near-universal use that naturopaths make of such recommendations. As for
“organic/antibiotic-free/hormone-free,” such a diet is likely a wash.

Finally, I can’t help but mention, as I do in every post about naturopathy that 
I write, that you can’t have naturopathy without homeopathy, or, as I like to
call it, The One Quackery to Rule Them All. Homeopathy is an integral part of
naturopathic training, and it is included in the naturopathic licensing
examination, or NPLEX. You can’t be a licensed naturopath, as Weber is, without 
knowing what naturopaths teach about homeopathy.

So, what does this all mean for NCCIH?

One thing about the history of NCCIH dating back to its foundation as NCCAM in
1998 and even before, when it was the Office of Alternative Medicine, has been a
tension between the true believers in “alternative” medicine and CAM who
thought he had cured his allergies with bee pollen and those who seriously want 
to do science. Remember, a true believer, Sen. Tom Harkin (D-Iowa), was the
driving force behind the formation of OAM and then behind elevating OAM to a
full Center.

Basically, the OAM ran into trouble almost immediately when its first director, 
Joseph M. Jacobs, ran afoul of Sen. Harkin by insisting on rigorous scientific
methodology to study alternative medicine. To get an idea of what Jacobs was up 
against, consider that in 1995 Harkin wrote not just one, but two, commentaries,
“The Third Approach” and “A Journal and a Journey.” In these two articles,
Harkin basically advocated studying what has been “called ‘left-out medicine,’
therapies that show promise but that have not yet been accepted into the
mainstream of modern medicine,” and explicitly stated that “mainstreaming
alternative practices that work is our next step.” Unfortunately, Sen. Harkin
had a bit of a problem with the way medical science actually goes about
determining whether a health practice—any health practice—works, and railed
against what he characterized as the “unbendable rules of randomized clinical
trials.” Citing his use of bee pollen to treat his allergies, he went on to
assert, “It is not necessary for the scientific community to understand the
process before the American public can benefit from these therapies.”

Ultimately Jacobs resigned under pressure from Harkin, who repeatedly sided with
the quacks. It also didn’t help that Jacobs complained about various
“Harkinites” on the OAM advisory panel, some of whom represented cancer scams
such as Laetrile and Tijuana cancer clinics. That Jacobs became tired of
fighting and finally resigned is especially noteworthy given that Jacobs himself
had originally been chosen to run OAM precisely because of his openness to the 
idea that there might actually be gems to be discovered buried among the turds
of alternative therapies. Meddling by Harkin was a theme that kept repeating
itself. Later, in 1998 after the then-NIH director had tried to impose more
scientific rigor on the OAM, Harkin sponsored legislation to elevate the OAM to 
a full center, and thus was the NCCAM born. Not coincidentally, the NIH director
has much less control over full centers than over offices. Interference by Sen.
Harkin whenever the NIH director or NCCIH director tries to enforce more
rigorous science has been a recurring theme, right up until Sen. Harkin retired 
in 2013. Indeed, what epitomized Harkin’s attitude towards NCCAM was a complaint
he made in 2009 during his remarks to a Senate panel:

One of the purposes of this center was to investigate and validate alternative
approaches. Quite frankly, I must say publicly that it has fallen short. It
think quite frankly that in this center and in the office previously before it, 
most of its focus has been on disproving things rather than seeking out and
approving.

Tell me you don’t understand how science works without telling me you don’t
understand how science works.

Along with fellow founders of this blog, including Drs. Steve Novella, Kimball
Atwood, and the late Wally Sampson, I have repeatedly stated that I don’t object
in principle to investigating alternative medicine if it is done in a truly
scientific manner that takes into account what is already known about such
therapies. For example, given that the precepts of homeopathy violate multiple
well-established laws of physics and chemistry, for homeopathy to be valid, we
would have to discover that much of what we know about physics, chemistry, and
biochemistry is not just wrong, but spectacularly wrong. That makes studying
homeopathy in clinical trials unscientific, except perhaps as a means of
quantifying placebo effects.

As I’ve also written, the conflict at the heart of NCCIH has been: Do we serve
the alternative practitioners, or are we truly trying to look at these
treatments scientifically? One way that NCCIH has pretended to be on the side of
science is by never having an alternative medicine practitioner as its
Director. Instead, NCCIH Directors have always been physicians or scientists,
while the alternative medicine practitioners remained relegated to advisory
committee roles. Unfortunately, even that pretense has been crumbling. The last 
NCCIH Director who tried—but often failed—to remain scientific was Dr. Josephine
Briggs, who actually reached out to us in 2010 to meet and discuss about
science-based medicine. (Truly, it was a different time, and that meeting now
seems like a dream, even though Steve, Kimball, and I largely viewed the meeting
as performative, so that Dr. Briggs could claim to have reached out to “both
sides.”)

Then came Dr. Langevin, who, although a doctor, was a true believer in
acupuncture and did some horrendously bad studies trying to “validate”
acupuncture meridians.

It’s thus a natural—again, if you’ll excuse my use of the word—progression to
appoint a naturopath to helm NCCIH. Besides being a seamless slide towards more 
pseudoscience, it fits in very well with the current administration and MAHA,
which, as Podcast Jay tells us, is now setting the agenda for priorities in
biomedical research. The only question that I have is not so much how much more 
quacky NCCIH will get under the leadership of a naturopathic quack, but how much
the rest of NIH will come to resemble NCCIH under the leadership of a spineless
pandemic minimizer who has said that NIH should be the “research arm of MAHA.” 
Unfortunately, in five years, NCCIH could become totally superfluous, as the
rest of the NIH becomes indistinguishable from it. Indeed, it’s already
happening.


                     Vaccine Wars: the NCCAM Drops the Ball

                                 Kimball Atwood

                                      Link

If you go to the website of the National Center for Complementary and
Alternative Medicine (NCCAM), you’ll find that one of its self-identified roles 
is to “provide information about CAM.” NCCAM Director Josephine Briggs is proud 
to assert that the website fulfills this expectation. As many readers will
recall, three of your bloggers visited the NCCAM last April, after having
received an invitation from Dr. Briggs. We differed from her in our opinion of
the website: one of our suggestions was that the NCCAM could do a better job
providing American citizens with useful and accurate information about “CAM.”

We cited, among several examples, the website offering little response to the
dangerous problem of widespread misinformation about childhood immunizations. As
Dr. Novella subsequently reported, it seemed that we’d scored a point on that
one:

   …Dr. Briggs did agree that anti-vaccine sentiments are common in the world of
   CAM and that the NCCAM can do more to combat this. Information countering
   anti-vaccine propaganda would be a welcome addition to the NCCAM site.

In anticipation of SBM’s Vaccine Awareness Week, I decided to find out whether
such a welcome addition has come to fruition. The short answer: nope.

Go where the Money Is(n’t)

I looked on the NCCAM website in places where common sense would dictate that
such content might be found:

  1. Health Topics A-Z

  2. Be an Informed Consumer

  3. Complementary and Alternative Medicine Use in Children

  4. Resources for Health Care Providers

  5. Alerts and Advisories

  6. For your patients

In each case I searched for the terms “vaccine,” “vaccination,” “immunization,” 
“autism,” “MMR,” “thimerosal,” “mercury,” and variations of those words. No
dice. I found a couple of mentions of vaccinations by using the general NCCAM
website search function; Drs. Novella, Gorski, and I had been aware of these
when we visited Dr. Briggs in April, but for completeness’ sake I’ll cite them
here. One is in an essay titled Colds and Flu and CAM: At a Glance, dated
January, 2010. It states, correctly, that “Vaccination is the best protection
against contracting the flu,” but it offers no further comment. There is no
rebuttal of vaccine myths, nor even an acknowledgment that such myths exist.
Another is in a Message from the Director from October, 2009, which appears to
be the precursor of the “Colds and Flu” essay. Here, Dr. Briggs briefly
acknowledges vaccine myths:

   Vaccination is the best protection against contracting the flu. I know that
   many people are very concerned about the safety of the flu vaccines, but let 
   me echo the Centers for Disease Control and Prevention, as well as other
   prominent public health leaders, in assuring you that the vaccines for both
   the seasonal flu as well as H1N1 have a very good safety track record. Over
   the years, hundreds of millions of Americans have received the flu vaccine,
   and the development of the H1N1 vaccine followed the same path of safety and 
   effectiveness testing and approval.

One wonders why that language is absent from the subsequent, larger essay. Not
that including it would have addressed the problem of vaccine myths in general, 
as suggested by the search terms that I chose.

“Whole Medical Systems” lack Whole Discussions

On the NCCAM website there are other notable failures to respond to public
misinformation about immunizations. In the Homeopathy treatise there is no
mention that homeopaths have famously railed against vaccinations ever since
Constantine Hering, the “father of American homeopathy,” called them “always a
poisoning.” Nor is there any mention of Hering’s invention, “homeopathic
nosodes,” also called “homeopathic vaccinations,” which homeopaths such as Dana 
Ullman claim to be effective in preventing infectious diseases.

A similar failure exists in the Naturopathy treatise. Many influential
naturopaths are anti-vaccine; they advocate “homeopathic nosodes” or other
implausible measures. I wonder if Dr. Briggs had any inkling of this when she
flattered the American Association of Naturopathic Physicians—whose Position
Paper on Childhood Vaccinations is certain to mislead and frighten parents—with 
her presence at their annual convention in August.

Credentialing Nonsense

Linked from the “Be an Informed Consumer” page on the NCCAM website is an essay 
titled Credentialing CAM Providers: Understanding CAM Education, Training,
Regulation, and Licensing. In it we are told that

   A physician’s credentials—the licenses, certificates, and diplomas on the
   office walls—tell us about that person’s professional qualifications to
   advise and treat us. We seek similar assurances when we choose a
   complementary and alternative medicine (CAM) practitioner…

The essay hedges a bit, but is careful to suggest that “CAM” credentials are
every bit as trustworthy as those held by real doctors:

   Regulations, licenses, or certificates do not guarantee safe, effective
   treatment from any provider—conventional or CAM.

We are told that “naturopathic physicians” are licensed in 15 states and the
District of Columbia, that they have undergone apparently rigorous training in
“natural sciences and clinical sciences,” and that they have passed an
apparently rigorous, standardized exam offered to “graduates of accredited
programs” by their national organization, the American Association of
Naturopathic Physicians. The essay makes similar statements about homeopaths and
chiropractors—another group with a well-documented distaste for vaccinations.

Such claims of training and credentialing are deceptive, because the fields are 
bastions of pseudoscience. In the words of Edzard Ernst, “the most meticulous
regulation of nonsense must still result in nonsense.” Yet an unsuspecting
person looking for responsible information about “CAM” on the NCCAM website
would be led to believe, along with all the other nonsense, that the
anti-vaccination views of naturopaths, homeopaths, and chiropractors are valid
and based on science.

It is no surprise that the NCCAM “Credentialing” essay relies heavily upon the
writings of attorney Michael H. Cohen, a champion of quackery about whom we’ve
heard before on SBM.

Why?

I used to suppose that the NCCAM website ignoring vaccination hysteria was a
matter of naïveté: most NCCAM functionaries know little of the practices and
practitioners with which they are expected to be familiar. This probably remains
true to a large extent, but we know that Dr. Briggs, at least, is aware of the 
intimate relation between “CAM” advocacy and the anti-vax movement. Perhaps she 
hasn’t got around to making the promised changes on the website, but if so, why 
not? Widespread fear-mongering about vaccines being poisons and causing autism
is a far more important public health issue than whether or not glucosamine is
useful for osteoarthritis, or whether acupuncture might be useful for
fibromyalgia, or any of the rest of the standard, breezy, NCCAM fare. The
refutation of dangerous myths about vaccines ought to be a priority.

During our visit, Dr. Briggs, who has been at the NCCAM only since 2008, made a 
point of denying that she feels pressure from Congressional “CAM” demagogues
such as Dan Burton and Tom Harkin. That may seem true in the day-to-day grind of
her job, but such pressure has permeated the culture of the NCCAM since before 
its formal inception, as documented many times here on SBM and elsewhere. Rep.
Burton conducted numerous pro-quack hearings during his tenure as chairman of
the House Committee on Government Reform. His bullying of NIH directors is
largely responsible for two of the most unethical trials ever funded by the
NCCAM, the Gonzalez trial for cancer of the pancreas and the Trial to Assess
Chelation Therapy. Burton is also a champion of quacks who claim that vaccines
cause autism.

Sen. Harkin was the creator of both the NCCAM and its predecessor, the Office of
Alternative Medicine (OAM). He famously stacked the OAM advisory panel with
four pseudoscientific zealots who would be become known as “Harkinites.” He
worries that the NCCAM hasn’t spent its time “seeking out and approving
[alternative methods].” He hypes “integrative medicine” as the Next Big Thing,
the answer to

   the dogmas and biases that have made our current health care system – based
   overwhelmingly on conventional medicine – in so many ways wasteful and
   dysfunctional.

In particular, assert Sen. Harkin and other advocates, “integrative medicine”
will mean preventative medicine. I’ve discussed this deception previously: it’s 
worse than a Damned Lie. I can’t help but restate, for the occasion of Vaccine
Awareness Week, an unending source of ironic amusement for your SBM bloggers and
for rational thinkers everywhere: immunizations, also called vaccinations (for 
the first of their kind, made from cowpox exudate), are the most effective
preventative health measures ever devised; yet “alternative medicine” pushers of
every stripe, who claim special, proprietary knowledge about achieving
‘wellness,’ can dependably be counted on to oppose them.

A Web of Misinformation

The NCCAM, whether Dr. Briggs would like to admit it or not, is heavily
influenced by such sentiments. We’ve already seen how the Center’s website
whitewashes naturopaths, homeopaths, and chiropractors. We’ve seen how Dan
Burton has single-handedly forced the NCCAM to fund horrible trials and to
employ investigators who are charlatans and even criminals. We know that
National Advisory Council for Complementary and Alternative Medicine (NACCAM)
has been and continues to be, as a matter of law, a bastion of naturopaths,
chiropractors, and other quacks.

“Wait a minute,” someone might be thinking, “you can’t conclude from your cited 
evidence that Harkin himself is anti-vax.” That’s true, but it doesn’t matter.
What’s important, for the purposes of this discussion, is the company that he
and the NCCAM keep. Let’s illustrate this by citing an example from the current 
membership of the Advisory Council.

Janet Kahn is the Executive Director of the Integrated Healthcare Policy
Consortium (IHPC). The organization was founded in 2001 at the completion of the
“National Policy Dialogue to Advance Integrated Health Care: Finding Common
Ground,” whose report was co-authored by two naturopaths. As was true of that
report, the IHPC agenda and beliefs are exactly in line with those of Harkin and
other “integrative medicine” enthusiasts. The IHPC has a Federal Policy
Committee whose goal is to fearlessly and tirelessly “transform the very
architecture of the US healthcare system.” This, the IHPC intends, will be
accomplished by legislative fiat: practitioners of implausible methods will
simply be shoehorned into mainstream health care, bypassing science and rational
practice standards.

Now let’s close the anti-vax/NCCAM circle. If you’ve looked at the many
documents linked from this post, you might have noticed the name Michael Traub. 
He is a naturopath and homeopath who is on the IHPC’s Board of Directors,
Federal Policy Committee, and Steering Committee. He was co-author of the
“National Policy Dialogue” report cited just above. He is a past-President of
the American Association of Naturopathic Physicians, and last summer shared the 
podium with NCCAM Director Briggs.

In 1994, Traub published an article, titled “Homeopathic prophylaxis,” for the
Journal of Naturopathic Medicine. As previously explained,

   [The] article suggests that homeopathic products are safer and more effective
   than vaccination for preventing disease. The article’s author (Michael
   Traub, N.D.) taught public health at the National College of Naturopathic
   Medicine and helped formulate the AANP’s position papers on immunization and 
   homeopathy. He recommends tetanus vaccine but advises against measles, mumps,
   rubella, and diphtheria. After paying homage to a homeopathic treatise on
   “vaccinosis” published more than 100 years ago, Traub’s article details the
   use of homeopathic nosodes for preventing diphtheria, whooping cough, polio, 
   influenza, tuberculosis, and pneumoccal pneumonia. Nosodes are products made 
   by repeatedly diluting samples of pathological tissues, bacteria, fungi, ova,
   parasites, virus particles, yeast, disease products (such as pus), or
   excretions. The protocol Traub describes uses “200C potencies” which means
   that the nosodes are made by serially diluting the original substance
   1-to-100 a total of 200 times. (After the 12th dilution, no molecule of
   original substance remains.) Traub states that he no longer recommends
   nosodes but uses other “preventive” homeopathic strategies.

That Traub hasn’t substantially changed his tune since 1994 is suggested by the 
title of a 2004 article, “Alternatives to Flu Shots”—I won’t pay to read it, but
you can find it linked from here—and by Traub’s recent report of his own bout
with apparent H1N1 flu, which can most generously be described as ditzy. Circle 
closed; there are many more.

Conclusion

Is it possible that the ubiquitous influence of “CAM” and its fellow traveler,
anti-vaccination hysteria, is the real reason that the NCCAM website lacks
responsible, definitive information about immunizations and
pseudo-immunizations? If this is not the case, and if Dr. Briggs reads this, I
hope she’ll be reminded of our discussion in April and consider this a challenge
to show us that she is a player. I also hope that she’ll remember that her
constituents are approximately 300 million American citizens, not merely tiny
fringe groups of homeopaths, naturopaths, and Jenny McCarthy.

Trump’s new CDC Director is very pro-vaccine, but was she also at one time a
quack?

On Friday, Health and Human Services Secretary Dr. Tom Price announced the
appointment of Dr. Brenda Fitzgerald to head the CDC. Reassuringly, her record
as Georgia Public Health Commissioner was pro-vaccine and relatively
non-ideological. Not so reassuringly, a news report yesterday found that before 
entering public service she was peddling anti-aging quackery at her private
practice. Where will her balance fall now with respect to public health science 
now that she is CDC director?

David Gorski on July 10, 2017

Link

It’s hard to believe that it’s been a full ten days since my talk at NECSS
entitled Whither the antivaccine movement in the Age of Trump? At the time, I
only knew the identity of one of the most important public health figures
appointed by President Donald Trump, FDA Commissioner Dr. Scott Gottlieb. As I
noted when it was clear that he was going to be Trump’s pick, antivaxers weren’t
going to like it. Why? One reason is because Gottlieb is the ultimate pharma
shill, if such a thing exists. Another reason is that he is very pro-vaccine.
This amuses me when I consider the high hopes antivaxers had for the Trump
administration after his long, sordid history of antivaccine sentiments, his
having met with antivaccine “hero” Andrew Wakefield during the presidential
campaign, and his having met with another antivaccine “hero,” Robert F. Kennedy,
Jr., during the transition period.


Dr. Brenda Fitzgerald

At the time I gave my talk, I didn’t yet know whom Trump had chosen for CDC
Director. If I had, my talk would have been different. Dr. Brenda Fitzgerald,
the woman chosen to run the CDC does not at first glance appear to be the sort
of person who would be willing to help Trump dismantle the public health system 
by supporting the idea that vaccines cause autism, attacking the Vaccine Court, 
or calling for more bogus antivaccine “research” designed to find nonexistent
detrimental health effects due to vaccines. Indeed, as you will see, as
Georgia’s Commissioner of Public Health, she had little in her record that
appeared disturbing. When it was formally announced last Friday that Dr.
Fitzgerald is the new CDC Director, on the surface she seemed to me like any
other CDC Director, complete with a record as a leader at the state level that
is pro-vaccine and pro-public health. I was momentarily reassured. Then, just
yesterday I learned something that lessens the reassurance I initially felt.
Let’s just say that before she entered public service in 2011 she peddled
dubious anti-aging treatments. Now I’m not as sure about Dr. Fitzgerald as I was
on Friday, because whether what she’s done since then is enough to make up for 
peddling pseudoscience is something I’m having a hard time deciding.

Before I get to the details of what raised my concern, let’s start with the
reasons to be reassured first before I get into the worrisome history I learned 
yesterday morning that forced me to make major modifications to this post.

Dr. Fitzgerald: Pro-vaccine and pro-public health

To give you an idea of the relief I initially felt when I learned of Dr.
Fitzgerald’s appointment, some of you might recall that, when I heard that RFK
Jr. was meeting with Donald Trump, I mentioned that the first thought that
popped into my mind was that Trump was considering him for CDC Director or some 
other high profile public health position in the administration. Yet here we
are, six months later, and nothing’s become of the “vaccine commission” that RFK
Jr. claimed that Trump had offered him, while the new FDA Commissioner is an
ultimate pro-vaccine pharma shill. Now it appears that we have a pro-vaccine,
fairly boring, standard-issue CDC Director, the sort of CDC director that any
Republican President might have been expected to appoint:

   Fitzgerald is no newcomer to politics. She served as a health care policy
   advisor to House Speaker Newt Gingrich and U.S. Sen. Paul Coverdell, both
   Republicans. She twice ran unsuccessfully for Congress, in 1992 and 1994,
   both time [sic] as a Republican.

   Gov. Zell Miller appointed her to the state Board of Education in 1996 when
   he remade the board in hopes it would get along with the state’s first
   Republican state school superintendent, Linda Schrenko. The chairman of that 
   new board was Johnny Isakson, who is now Georgia’s senior U.S. senator.

Perhaps her association with Newt Gingrich should have been a red flag. Still,
Dr. Fitzgerald has a record that is quite pro-vaccine. Indeed, as recently as
April, she was touting not only her state’s improved vaccination rate, but
urging parents to vaccinate their children:

   During National Infant Immunization Week, April 22-29, the Georgia Department
   of Public Health and the Georgia Chapter of the American Academy of
   Pediatrics urge parents to check with their pediatrician to ensure their
   child is up-to-date on vaccinations.

   “Immunizations are the best way to protect infants and children from
   childhood diseases, like whooping cough and measles that can be
   life-threatening at young ages,” said Brenda Fitzgerald, M.D., commissioner
   of the Georgia Department of Public Health. “It is critical for parents to
   talk to their child’s doctor to ensure they are up-to-date on immunizations, 
   because no child should have to suffer a vaccine-preventable illness.”

She’s even written opinion pieces with titles like “Babies Need Their Vaccines” 
in 2014 (before the Disneyland measles outbreak), in which she rejects
antivaccine pseudoscience explicitly:

   I’ve heard all the arguments against vaccination. All have been debunked,
   including the infamous 1980s study in Europe about a similar vaccine for
   measles, mumps and rubella, and a supposed link – that we now know to be
   false – to autism, which shattered vaccine use in Europe. Outbreaks now
   plague the Continent, and here in the U.S., signs of trouble are building.

   Pertussis outbreaks in Oregon and Texas and an ongoing outbreak in California
   should alarm us. In Georgia right now there are 83 confirmed cases of this
   disease.

And then makes an emotional appeal:

   At the Georgia Department of Public Health, our team in immunizations has
   been preparing for National Infant Immunization Week, which begins today. The
   team will work to improve Georgia’s resilience to vaccine-preventable
   disease through increased immunization rates among siblings, caregivers,
   grandparents and infants. I want to reach our state’s mothers-to-be.

   I am a mother. I am vaccinated. And I ask you to join me. Choose to vaccinate
   first yourself, and then your new baby. Follow the vaccine schedule, and
   guard against diseases like whooping cough that only you can prevent before
   baby is born.

   As a board-certified obstetrician-gynecologist, I have seen the devastating
   and painful effects of whooping cough and other vaccine-preventable diseases.
   I’ve seen mothers who fear every gasp of air might be their babies’ last.

   Get vaccinated. Help spread the truth on vaccines, not the diseases they
   prevent.

These are not the sort of things that someone who is antivaccine or
antivaccine-sympathetic writes. Nor do people who are antivaccine or
antivaccine-sympathetic institute a rule requiring that a notarized state-issued
form is the only valid way parents can claim a religious exemption to school
vaccine mandates, which is the only nonmedical exemption allowed in Georgia. Nor
would an antivaccine or antivaccine-sympathetic person allow a blog that
promotes vaccination, including entries promoting the birth dose of the
hepatitis B vaccine, tells parents how to catch their children up on their shots
if they fall behind, and urges pregnant women to get their Tdap vaccine.

That sure sounded suitably pro-vaccine to me.

Of course, basically anyone who is involved in public health, especially at a
leadership level (particularly at a state leadership level) is pro-vaccine. The 
reason is simple, and it has nothing to do with “dogma,” as antivaxers will
claim. It has to do with science and the fact that vaccines work. They are the
single most effective public health intervention conceived by the human mind and
made by human hands. They do not cause autism. They do not cause all the
horrible autoimmune and other diseases that antivaxers claim. They save lives,
lots of lives. Sooner or later, anyone in public health who is intellectually
honest, regardless of ideological bent, be it liberal or conservative, comes to 
that conclusion. The “ideological conformity” in public health officials’ belief
in vaccines comes not from brainwashing, but from decades—no, hundreds— of
years of evidence.

Not unduly ideological

Interestingly, Dr. Fitzgerald has also demonstrated characteristics unusual for 
a Republican politician:

   Fitzgerald also drew headlines for a decision to rescind a job offer to a
   California physician initially offered a job as a north Georgia health
   director after reports surfaced about controversial sermons he made
   condemning gay rights and the theory of evolution.

I note that this action resulted in a lawsuit by Dr. Erick Walsh, the pastor
fired after what he said in his sermons became known. This CNSNews.com article
mentions the lawsuit, calling it a violation of religious liberty while
conveniently failing to note just what the sermons said, such as:

  1. Oprah Winfrey is harboring the spirit of the anti-Christ;

  2. The prophet Muhammad, founder of Islam, was influenced by Satan;

  3. The devil set up Catholicism;

  4. Acceptance of homosexuals is a satanic ploy to destroy America;

  5. Rapper Jay Z is a disciple of Satan;

  6. Single mothers are ruining their children;

  7. Disney movies, which are loaded with violence, sex and magic, are a satanic
    ploy to split up families;

  8. Darwin’s Theory of Evolution is a “satanic belief”;

  9. The distribution of condoms to a public in need leads to higher AIDS rates;

  10. The pope is the anti-Christ.

OK, I’ll give Dr. Walsh the one about Oprah. Maybe I’ll even give him the one
about Jay Z, too. But the rest of the list consists of nonsensical beliefs
common among the religious right, several of which could easily interfere with
the ability to carry out public health policies.

To be honest, I was rather surprised at Dr. Fitzgerald’s appointment because,
unlike her boss, Department of Health and Human Services Secretary Dr. Tom Price
(who is a member of a crank medical society that is, in essence, the John Birch
Society for physicians, namely the Association of American Physicians and
Surgeons), she appears to be reasonably competent in public health matters and
has a history of very pro-vaccine statements and championing pro-vaccine polices
in Georgia. Even better, she appears willing to buck the Republican
establishment, as her willingness to rescind Dr. Walsh’s job offer demonstrated.
Also, although she opposed federal funding of abortions and supported some
restrictions on the practice, she is on record as having said that the decision 
for an abortion should be between a woman and her physician. Indeed, when she
ran for Congress in the 1990s, anti-abortion activists distributed flyers in
church parking lots claiming that she had performed abortions herself.

Initially at least, I couldn’t find anything egregiously disqualifying in her
background online, although it is of concern that she has no research background
to speak of. (See the next section for what I missed that might or might not be
a major concern.) She is definitely pro-vaccine. She doesn’t seem to have the
typical conservative Republican hang-ups about sex, the LGBTQ community, and
evolution. On the other hand, during her tenure as Commissioner, she and
Governor Nathan Deal launched SHAPE, a statewide effort to address childhood
obesity through “physical activity before class, physical activity during class,
and more structured recess,” funded to the tune of $1 million by Coca-Cola. I
must admit that one raised my eyebrow, although it is Georgia, where pretty much
all soft drinks are referred to as “Coke” and Coca-Cola wields considerable
influence. Few are the Georgia politicians who would have had the temerity to
turn down that offer, unfortunately. It’s also another reason why antivaxers
might dislike her.

Antivaxers react to Dr. Fitzgerald’s appointment

Right on cue and not unexpectedly, antivaxers who have bothered to say anything 
let it be known that they hate this appointment. For instance, Ginger Taylor,
who is the Dunning-Kruger Effect personified, posted this to Facebook:

What’s upset her? It was Dr. Fitzgerald’s’s “Babies Need Their Vaccines” article
that I quoted earlier in this post! The tears of betrayal following Taylor’s
post are delicious. Another Trump supporter and antivaxer known to this blog is 
also very, very unhappy.

Perhaps the most hilarious reactions of all came from Patrick “Tim” Bolen, and
the antivaccine blogger and activist who goes under the ‘nym Levi Quackenboss,
both of whom are Trump supporters and both of whom think that there must be
something going on behind the scenes. We’ve met Quackenboss before; she’s the
blogger who led the harassment of a twelve year old boy who posted a pro-vaccine
video. In any case, Quackenboss, as is her wont, speculates wildly:

   Despite the fact that the CDC owns vaccine patents and the CDC publishes the 
   Advisory Committee on Immunization Practices recommended schedule that’s
   adopted by the states, here’s why I’m not going to lose any sleep over a
   vaccine zealot being appointed to the CDC:

   Dr. Brenda ultimately answers to Dr. Tom Price, and Tom Price, at minimum,
   doesn’t think the Feds have any business regulating vaccines. I’ve heard that
   autism-and-vaccines is not Tom Price’s specialty, but I’ve also heard– and
   one important person made reference to this possibility in a Vaxxed video–
   that there’s a chance that we’ve got someone coming into the CDC who does
   specialize in it, and they want to prove it.

   So, President Trump can appoint a vax lover to the CDC to appease whomever he
   needs to appease right now, as long as he tells her “You’re fired” sooner
   than later.

   Then guess what? Other people get to be the head honcho of vaccine safety–
   maybe one of our people.

Yes, there is reason to be concerned about Dr. Price, but I haven’t been able to
find any evidence that he himself is antivaccine. True, he belongs to the AAPS,
and that does not speak well of him because, at the very least, he must be more
attracted to the Ayn Rand-inspired vision of physicians unshackled by
government or anything other than their superman (and woman) abilities as
“mavericks” more than he’s repelled by the pseudoscience that the AAPS peddles. 
However, I’ve been unable to find a record of him saying anything antivaccine.
That’s why I’m more concerned about his zeal for cutting medical programs that
benefit the poor, such as Medicaid, than I am about any antivaccine
proclivities. In any case, Quackenboss is fooling herself here. Yes, it’s true
that you never know whom else Trump might try to sneak into the CDC; so we must 
be vigilant. However, it also makes no sense that Trump would hire a “vaccine
zealot,” only to fire her after putting “one of us” (an antivaxer) in another
position at CDC, especially given that the CDC director position doesn’t require
Senate approval. More than likely Secretary Price knew Dr. Fitzgerald from his 
days in Congress representing a district in Georgia.

Next up is Tim Bolen. You might remember him as cancer quack Hulda Clark’s most 
vocal defender back in the day. His grip on reality hasn’t gotten any better
since then, as you will see in his post “Trump’s Pick For CDC Head – More Than
Meets The Eye…” Based on videos of Dr. Fitzgerald discussing early childhood
development and advocating for programs to promote early language development
and reading, Bolen comes to some rather…amazing…speculations:

   In the first 2:30 of this second video you will understand Brenda’s approach 
   to child development – but watch the whole thing. Vaccines were NOT even
   mentioned, but it is NOT hard to see what a negative role they would play in 
   Brenda Fitzgerald’s, and her friends’, brain-development scenarios.

   This candidate for the CDC head, Brenda Fitzgerald MD, is a TOTAL, COMPLETE
   departure from the usual Big-Pharma-friendly appointments we are accustomed
   to seeing. This person is WITHOUT DOUBT “Patient-Centered.”

   Just look at her attitude…

   Listen to her words. Watch her body language. Can you envision this woman
   pushing a vaccine cart through a hospital looking for innocent children to
   jab full of brain-stopping crud?

   No, neither can I.

No, but I can imagine Dr. Fitzgerald promoting vaccines as a powerful way to
keep children healthy. Why? Because that’s what she did in Georgia! I don’t have
to picture it.

Bolen concludes with a fantasy imagining that on her first day as CDC Director, 
Dr. Fitzgerald calls all the CDC division heads, announces that the inspector
general of the Department of Health and Human Services will be investigating,
and orders them all to cooperate. And then she orders them all to cooperate with
RFK Jr.’s vaccine commission, which, Bolen seems to have forgotten, doesn’t
exist. Let’s just put it this way. He’s so off-base that even his antivaccine
commenters strongly imply that he must be smoking something that’s not tobacco.

So I was feeling pretty good about our having dodged a public health bullet this
weekend. Then I saw a news story in Forbes on Sunday morning, as I was
proofreading and tweaking this post. D’oh!

Dr. Fitzgerald’s quack past comes back to haunt her

When I originally alluded to my having missed a red flag, here’s what I meant.
See if you can spot it in this passage from Dr. Fitzgerald’s official bio on the
Georgia Department of Public Health website:

   Brenda Fitzgerald, M.D., serves as the Commissioner of the Georgia Department
   of Public Health (DPH) and State Health Officer. Dr. Fitzgerald, a
   board-certified Obstetrician-Gynecologist and a Fellow in Anti-Aging
   Medicine, has practiced medicine for three decades.

Can you identify the red flag? Sure, I knew you could. I’m referring, of course,
to Dr. Fitzgerald having been a Fellow in Anti-Aging Medicine. This is an
enormous red flag that I should have noticed last week while writing a post
about her for my not-so-secret other blog. Fortunately for me, Rita Rubin at
Forbes noticed, and I noticed her article, allowing me to revise this post
before it embarrassed me after going live:

   Dr. Brenda Fitzgerald, appointed Friday as director of the U.S. Centers for
   Disease Control and Prevention, is a board-certified
   obstetrician/gynecologist who saw patients for 30 years in private practice.

   Unlike any OB/GYN I know, Fitzgerald treated men as well as women. That’s
   because besides being board-certified in obstetrics and gynecology, she is a 
   fellow in “anti-aging medicine.”

I was as disappointed to learn this as Dr. David Goldstein:

   “I’m shocked,” Dr. David Goldstein, a professor of obstetrics and gynecology 
   at the New York University School of Medicine and treasurer of the
   International Menopause Society, said after I told him that Fitzgerald’s
   biography identifies her as an anti-aging medicine fellow.

   Goldstein described so-called anti-aging treatments as “snake oil” that
   “plays on people’s worst fears about their mortality.”

   “If she (Fitzgerald) was one of these people who was marketing anti-aging
   medicine, that’s scary,” he said.

Here’s the archive.org copy of the webpage for her OB/GYN practice in 2010, a
year before she was appointed Georgia’s Commissioner of Public Health. Poking
around the website, I learned that she was first “certified” in “anti-aging”
medicine in 2007, which is rather late in her practice career (she would have
been 60 years old then) and also only four years before she was appointed Public
Health Commissioner.

Particularly damning is this FAQ on Dr. Fitzgerald’s website. A couple of choice
excerpts follow:

   Q. What is the most common aging problem you see?A. “Middle age spread”. As
   we age, the hormones that regulate body metabolism decline. The problem may
   be insulin resistance, nutrient deficiency, thyroid abnormality, or other
   hormone deficiency. Most people, by the time they are forty, are simply not
   eating 5000 calories a day in beer and junk food. They are frustrated because
   they are trying to eat good things or are eating what they have always
   eaten, or less, and are still gaining weight. We are now able to accurately
   evaluate the exact cause of weight gain, and recommend a plan to correct it.

   Q. How do I know that I am taking the right supplements?A. We can now measure
   the vitamins, antioxidants, necessary fats, and proteins in your cells with 
   a simple blood test. If you like the supplements you are taking (Juice Plus, 
   for example), we can tell you what you need to add. If you do not know what
   to take, we can give you the newest research for the best replacements.

So basically, Dr. Fitzgerald was into weight loss woo as well as anti-aging woo.
(The two often go together.) She did a bunch of what were almost certainly
unnecessary lab tests in order to figure out what supplements her patients
“needed” and then ordered follow-up lab tests to see if she was giving her
patients enough supplements. As is the case with nearly all such practices, most
of it was cash on the barrelhead:

   Q. Will insurance cover anti-aging care?A. Traditional insurance plans often 
   do not cover preventive medical care. We will try to help you determine if
   you are covered, but be aware that most coverage changes often and always
   with less coverage. We will continue to seek those labs that offer the
   highest quality, best cost tests. We will be happy to arrange monthly
   payments without additional charges for you. We will always give you our
   charges before services and we are always willing to look for other ways to
   get what you need, like labs at the health department.

I also note that Dr. Fitzgerald was into prescribing Suzanne Somers’ favorite
form of woo, “bioidentical hormones.” Not good. Definitely not good.

The American Academy of Anti-Aging Medicine: A pseudomedical pseudoprofessional 
society

We’ve mentioned or discussed the American Academy of Anti-Aging Medicine (AAAAM 
or A4M) multiple times before here on SBM. Put simply, it is what Kimball Atwood
used to refer to as a pseudomedical pseudoprofessional organization (PPO).
These organizations basically exist in order to provide a veneer of
respectability to what is often gross quackery. In this case, A4M offers
“fellowships” in a number of “specialties,” including Metabolic, Nutritional and
Functional Medicine, Integrative Cancer Therapy, Stem Cell Therapy, Integrative
Medicine, and, of course, Anti-Aging Medicine. It also offers a number of
“certifications” in various specialties, such as Advanced Metabolic
Endocrinology, Weight Management, Brain Fitness, Lifestyle Coaching, Advanced
Injectables, Addiction, and Sexual Health and Treatment. Then there are a bunch 
of online courses offered for quite the sum. The Stem Cell Fellowship, for
instance, offers four modules at $2,500 per module. That’s a cool $10,000 to
complete the training. The Anti-Aging Fellowship has three modules at $2,500
apiece. The Integrative Cancer Care Fellowship has eight modules at—you guessed 
it—$2,500 apiece, for a cool $20,000 to complete the course.

It’s not clear to me exactly which fellowship Dr. Fitzgerald finished, as the
anti-aging fellowship is now referred to as the “Aesthetic Anti-Aging
Fellowship” and now includes a lot of surgical procedures, chemical peels,
Botox, hair transfer, and “body sculpting,” but maybe the fellowship was
different ten years ago. On the other hand, the module on “noninvasive body
contouring” offers:

  1. Perform body mass index measurements, anthropomorphic measurements, and
    medical photography to document clinical presentation and results

  2. Prescribe organic whole foods, low glycemic diet along with appropriate
    detoxification, hormone balancing, and treatment of food allergy for optimal
    BMI

And:

  1. Develop a working knowledge of aesthetic devices and energies used in body
    contouring including Radiofrequency, Acoustic wave, Infrared energy, a novel
    chilling device, and lymphatic massage. Gain practical knowledge from
    aesthetic experts regarding the utility and effectiveness of these devices
    as well as their specific indications

“Detoxification”? “Hormone balancing”? Treatment of what are almost certainly
nonexistent “food allergies”? Use of all sorts of devices that are almost
certainly not evidence-based? Yes, there be quackery here, just as there be
quackery over at the Stem Cell Fellowship:

   Gain expert knowledge regarding the disease background, statistics, etiology,
   current standard of care, and issues/controversies surrounding current
   treatments for many neurological and neurodegenerative conditions, including:

  1. Parkinson’s disease

  2. Dementia

  3. Alzheimer’s disease

  4. Cerebral palsy

  5. Stroke

  6. Traumatic Brain Injury

  7. Autism

  8. Amyotrophic lateral sclerosis (ALS)

  9. Huntington’s disease

  10. Spinal cord injury

  11. Neuropathy

There is no convincing clinical evidence yet that stem cell therapy improves
outcomes in stroke, ALS, Huntington’s disease, or dementia—or any of these
conditions, really. Treating someone with autism with stem cells is, in my
not-so-humble opinion, not only quackery but utter malpractice. Yet these are
the sorts of things A4M teaches its “fellows.”

And don’t get me started on “functional medicine,” training in which is also
offered by A4M. It’s quackery, too. The list goes on and on. Dr. Fitzgerald did 
one of these pseudoscience-loaded A4M “fellowships,” after which she offered
what she was taught to women and men, supposedly to help them deal with aging
better.

Pro-science versus anti-aging quackery: Where does Dr. Fitzgerald’s balance
fall?

By yesterday afternoon, I felt as though I had gotten whiplash from my turnabout
on Dr. Fitzgerald. When I first learned of her impending appointment, I started
out very relieved and happy at how pro-vaccine she is and how she seemed to hit
all the right notes on public health, particularly the importance of early
childhood reading. I was also relieved that she didn’t appear to be too dogmatic
on culture war issues embraced by conservative Republicans that could interfere
with her ability to serve as a science-based CDC director. Then I learned about
her anti-aging fellowship and her previous medical practice offering typical
dubious anti-aging treatments such as “bioidentical hormones,” detoxification,
and supplements galore. Now I’m not so sure.

One thing that interested me was the question of why. Remember, Dr. Fitzgerald
had practiced OB/GYN for over 30 years before she did her fellowship in
anti-aging medicine. She was clinical faculty at Emory University, and a
president of the Georgia OB/GYN Society. Presumably, her practice was evidence- 
and science-based. By the time she finished her A4M fellowship, she was 60 years
old. So why did she do it? On her website, it says:

   Q. Why did you become interested in anti-aging medicine?A. I got older! The
   life expectancy for women in 1900 was 48. The majority of women never reached
   the hormone depleted state of menopause just 100 years ago. Now most of us
   can expect to live half of our lives without natural optimal hormone
   production. My goal is to have all my patients, and me, be vigorous and vital
   for essentially their entire lives. I want to be struck by lightning on the 
   golf course at 120…. and I want that for you.

Clearly, Dr. Fitzgerald didn’t understand life expectancies. The reason life
expectancy was so low in 1900 was because of infectious diseases that killed
children. If a child born in 1900 made it to age 20, average life expectancy
meant that they could expect to live an additional 40-45 years, meaning the
majority of girls who made it past the high mortality period of childhood to
become women did reach menopause. It’s not a reassuring statement, and it almost
makes me wonder if Bolen might have been on to something after all.

What partially reassures me is that, since Dr. Fitzgerald became Georgia Public 
Health Commissioner, she appears not to have engaged in anything resembling
quackery. She appears to have supported science and was pro-vaccine. Her one big
misstep was that on at least one occasion she failed to stand up to a big
corporation (Coca-Cola) whose products are not good for health. That leaves a
very important question: Where does the balance fall? The answer is: I don’t
know, but I’m echoing some of the complaints I saw on the Forbes article:

   I asked a couple of women’s health advocates what they thought about having
   an anti-aging medicine doctor lead the CDC.

   “I’m so disappointed that the first female OB/GYN picked to head the CDC is
   someone who embraces the unproven and anti-scientific claims of the so-called
   anti-aging movement,” Cindy Pearson, executive director of the National
   Women’s Health Network, a nonprofit in Washington, D.C., told me.

   “The public needs someone who supports public health recommendations that are
   based on science,” Pearson said, “not someone who tries to scare her
   patients by talking about ‘the hormone-depleted state of menopause’ and
   recommending unproven and potentially dangerous bio-identical hormones.”

It’s also been noted that Dr. Fitzgerald isn’t a great pick to head the CDC
because she’s not a researcher. For instance, Diana Zuckerman, president of the 
National Center for Health Research, a nonprofit in Washington, D.C. noted:

   “Her pitch as a physician suggests that, in addition to not being a
   researcher, she was providing treatments to patients that were not based on
   credible science,” Zuckerman told me after looking at the archived website
   for Fitzgerald’s former medical practice. “If a patient wants to try such
   treatments, and a doctor wants to prescribe them—preferably giving informed
   consent that the benefits are unproven—that’s up to them.

   “But putting that doctor in charge of the CDC, a crucial public health
   agency, doesn’t make sense.”

Indeed.

Dr. Fitzgerald’s case suggests that you can be pro-vaccine and still be a quack.
Worse, not being a researcher grounded in science, Dr. Fitzgerald is in danger 
of not being able to distinguish pseudoscience from science when antivaxers come
calling (and they will come calling) to demand an “investigation” into the “CDC
whistleblower” manufactroversy and other issues relevant to vaccines. I suppose
under the Trump Administration, she’s the best we can hope for, and, more than 
that, all we can do is to hope that she consistently listens to the scientists
at the CDC.

So, am I happy with the appointment of Dr. Fitzgerald? Not nearly as much as I
used to be now that I know more about her past, information that I should have
discovered when I first read her bio on the Georgia DPH website. (Mea maxima
culpa!) She appears now to me to be like the appointment of Dr. Scott Gottlieb
as appointed FDA Commissioner. He was basically the least bad of all the known
candidates, but he is still a pharma shill who favors deregulation. Of course,
we don’t know who else was considered for CDC Director, but Dr. Fitzgerald is
similarly compromised. Yes, she is pro-vaccine, but, yes, she also sold quackery
during the last four years of her private practice before entering public
service with the State of Georgia.

Even if Dr. Fitzgerald turns out to be fine from a scientific standpoint,
though, I have no illusions about Trump and vaccine policy. As Dr. Paul Offit
wrote a couple of weeks ago, Trump’s budget takes aim at critical public health 
funding. If it passes, there will be less money for the CDC to do its job, less 
money to distribute vaccines, less money to intervene in the case of public
health threats, and in general, less resources to do its critical job. Whether
Dr. Fitzgerald can or would oppose such budget cuts, we have no way of knowing. 
Why anyone who is serious about public health would want to run the CDC under
such circumstances, I don’t know. Maybe she’s susceptible to the snake oil that 
Donald Trump and HHS Secretary Dr. Price sell.

The CDC Has Been Hollowed Out

Steven Novella on September 30, 2026

Links


A new report from the NYT tells a chilling story of how the Centers for Disease 
Control has been hollowed out over the last 18 months under Trump and RFK Jr. We
have been covering this story as it has been developing, but it is useful to
take a look at where we are and the totality of the destruction that has
occurred.

The CDC has been arguably the premiere organization in the world to track
illness, gather data, develop recommendations, and promote public health. They
are critical to detecting and responding to public health emergencies. They have
been relied upon by state and local governments, as well as people around the
world, for their guidance and help. Over the last few decades the CDC has been
one of my go-to places for definitive health information.

In under two years, this organization has been utterly devastated.

This starts with the fact that the CDC has lost 30% of it’s staff over this
short period of time. RFK defenders claim that the agency was bloated and
wasteful, but this is just a baseless rationalization. The CDC’s workforce has
been relatively flat in recent decades, with a small bump during COVID. After
the recent cuts the CDC now has almost 10% fewer employees than it did in 2012. 
Historically, the CDC has always been stretched thin. It’s budget has also been 
relatively flat, which means functionally decreased due to inflation.

By all accounts, the CDC was a lean and underfunded organization, doing heroic
work that was relied upon by health professionals around the world. Now, former 
and current CDC employees tell a story of utter collapse. There are simply too
few people to do the necessary work of the agency. Anyone who has worked for a
large organization likely has a good sense of how difficult it is to deal with
even a small reduction in staff. Those remaining have to cover more tasks,
everything becomes less efficient as you spend more and more time just doing
damage control. There is a critical point below which the entire enterprise is
overwhelmed with dysfunction. The CDC appears to be well below that threshold.

Further, these cuts have not been random but appear to have disproportionately
affected scientists and those in leadership positions. They didn’t just prune
the janitorial staff – they gutted the people making the organization function. 
Of the 20 director positions at the CDC, all but one are now staffed by
temporary appointees. Some entire programs have been shuttered, like smoking
prevention and elder safety.

Worse still – the number of political appointees has dramatically increased.
Instead of 2-3 political appointees overseeing the organization while scientists
and experts get the work done, the agency is now run by political appointees.
According to reports, those workers remaining spend a lot of their time chasing 
down every crackpot theory RFK Jr wants to follow, rather than doing good
science. They spend their time trying to prove already debunked theories, like
that maternal vaccines cause autism.

The CDC has been unable to fulfill basic functions, like putting out vaccine
recommendations for the coming flu season. They are delayed in responding to
requests for help from state and local health departments, and some requests go 
unfulfilled.

Meanwhile, the US is seeing a dramatic increase in measles. We have more cases
this year so far than any in the last 35 years. The US is at risk of losing its 
elimination status (and we may already have done so – but the CDC is failing to 
track the data that would tell us).

The current Ebola outbreak has seen 8,067 confirmed cases and 3,901 deaths, the 
second largest outbreak in history, and it is not done yet. In the 2016 outbreak
the CDC send 2,000 workers to help contain the deadly disease. Now the CDC has 
sent only 100 workers. The CDC is focused on preventing cases from reaching the 
US, not on containing the outbreak itself.

The response to these two outbreaks, measles and Ebola, by the CDC under RFK has
been anemic and ineffective. We should hope that these are the worst disease
outbreaks we face under his regime. Imagine if we face another epidemic or
pandemic during this epic dysfunction.

This is what happens when you put an incompetent, unqualified, conspiracy
mongering pseudoscientist in charge of America’s public health. This is what
happens when you prioritize ideology and a political agenda ahead of good
science and the public health. I can only hope that the public learns a lesson
from all this, without having to pay too high a price.

NIH funds training in behavioral intervention to slow progression of cancer by
improving the immune system

James Coyne on October 29, 2012

Link

Editor’s note: Because of Dr. Gorski’s appearance at CSICon over the weekend, he
will be taking this Monday off. Fortunately, Dr. Coyne will more than ably
substitute. Enjoy!

NIH is funding free training in the delivery of the Cancer to Health (C2H)
intervention package, billed as “the first evidence-based behavioral
intervention designed to patients newly diagnosed with cancer that is available 
for specialty training.” The announcement for the training claims that C2H
“yielded robust and enduring gains, including reductions in patients’ emotional 
distress, improvements in social support, treatment adherence (chemotherapy),
health behaviors (diet, smoking), and symptoms and functional status, and
reduced risk for cancer recurrence.” Is this really an “empirically supported
treatment” and does it reduce risk of cancer recurrence?

Apparently the NIH peer review committee thought there was sufficient evidence
fund this R25 training grant. Let’s look at the level of evidence for this
intervention, an exercise that will highlight some of the pseudoscience and
heavy-handed professional politics in promoting psychoneuroimmunological (PNI)
interventions.

The report of the single study (full article available here) evaluating the
efficacy of this intervention for physical health outcomes appeared in the
American Cancer Society journal Cancer in in 2008.  An earlier report (full
article available here) claimed to demonstrate the effects of the intervention
on the “secondary outcomes” of mood, immune function, health behaviors, and
adherence to cancer treatment and care.

The abstract of the 2008 Cancer article described the group intervention as a
set of strategies to “reduce stress, improve mood, alter health behaviors, and
maintain adherence to cancer treatment and care.” The abstract reported not only
a reduced risk of cancer recurrence but proclaimed “psychological interventions
as delivered and studied here can improve survival.” If this intervention
indeed improved survival, it is curious that the claim was not echoed in the
advertisements for this training program.

When the article first came out, I did a simple chi-square calculation on the
raw recurrence and death events in a pair of 2×2 cross tabulations of outcomes
for intervention versus control group. No matter how I played with the data in
figure 2, group differences nowhere near approached significance. Here is the
online calculator and below are the data in Table 2 so that you can experiment
for yourself (click to enlarge):

My colleagues and I decided to take a close look at the reports on this trial
and write a commentary to be submitted to Cancer. We took the position that
claims about reducing risk of recurrence and extending the survival of breast
cancer patients are medical claims that should be held to the same standards as 
claims about medications and medical devices improving health outcomes.  These
standards include consistency between the abstract and findings reported in the 
results section of an article, pre-specification of one or two primary outcomes 
and follow up period, pre-specification of analytic plan, presentation of
results in a way that allowed readers to evaluate the appropriateness of choice 
and interpretation of statistical tests. The latter would include transparent
presentation of unadjusted primary outcomes in analyses for time by treatment
interactions and avoidance of substitution of secondary and subgroup analyses.

To help ensure the standards are met, most biomedical journals have embraced
CONSORT as the standard for reporting results of both clinical trials and, more 
recently, for abstracts. Many journals also require publicly accessible
preregistration of trials for the publishing of later results, i.e., that
investigators declare ahead of time their intentions for sample sizes, outcomes,
and analyses, before they run the first patient. These standards are enforced
less consistency with psychosocial trials, and reregistration was not in place
at the time this clinical trial was implemented in the mid-90s. However, by the 
time these papers were published in 2004 and 2008, it had already been
established that not meeting the CONSORT reporting standards involved a high
risk of bias and unreliability of results. And investigators do not need the
coaxing of CONSORT standards for abstracts to presume that abstracts should
accurately reflect the results reported in the rest of the article.

When we submitted the commentary to Cancer, it was initially rejected, with the 
editor citing a standing policy of not accepting critical commentaries if
authors refused to respond. We asked the editor to re-evaluate the policy and
reconsider the rejection of our commentary. We argued that the policy was
inconsistent with the growing acceptance of the necessity of post publication
peer review. Essentially the policy allowed authors to suppress criticism of
their work, regardless of the validity of criticism. Furthermore, our commentary
presented not only a critique of the article, it called attention to a failure 
in editorial review that was worthy of note in itself. We therefore requested
that we be allowed to expand our commentary substantially beyond the strict word
limitations of correspondence about a particular study. After a meeting of the 
editorial board, the editor graciously accepted our requests.

In the commentary, we pointed out that the trial did not report significant
tests for unadjusted outcomes and gave no rationale for the particular follow up
period of 11 years (7 to 13) in which progression or deaths were recorded.
Investigators committing themselves to a particular observation period ahead of 
time prevents post hoc shrinking or extension of the observation period to get
more favorable results based on a peeking at the data. Nonetheless, we could
find no significant differences in the proportion of women experiencing
recurrence or dying, despite claims of the investigators to the contrary.
Furthermore, the difference in median time to recurrence, six months, or to
death, was small, given the length of observation period.

How were the investigators able to claim significant effects? By relying on
dubious multivariate analyses with too high a ratio of covariates to events
(recurrence or death). I’ll leave much of the technical statistical arguments to
the commentary, but basically, the investigators’ approach had a high risk
generating spurious effects. It’s always reassuring when results for simple
unadjusted primary outcomes in a randomized trial hold up after adjustments for 
possible confounds, although the rationale for undertaking control of any
initial differences between groups is unclear because randomization is itself
supposed to take care of any. When results are not obtained in simple unadjusted
analyses, but then show up in multivariate analyses, the suspicion is that they
are spurious, because results of multivariate analyses are often dependent on
arbitrary decisions about which covariates to include and how to score them,
decisions that can be made and revised based on peeking at the data. We should
be particularly suspicious when, as is the case in this trial, too many
covariates are entered as controls.

We went on to critically examine the earlier study of psychosocial measures,
adherence, and immune function.

   Andersen BL, Farrar WB, Golden-Kreutz DM, et al: Psychological, behavioral,
   and immune changes after a psychological intervention: A clinical trial.
   Journal of Clinical Oncology 22:3570-3580, 2004

The abstract of this article reported testing the hypothesis “psychological
intervention can reduce emotional distress, improve health behaviors and
dose-intensity, and enhance immune responses.” The results presented in the
abstract were uniformly positive in terms of effects on anxiety and improved
dietary habits, smoking, and adherence, with no negative results mentioned.

When we examined the actual methods section, we found at least nine measures of 
mood, eight measures of health behavior, four measures of adherence, and at
least 15 measures of immune function were assessed. There was no independent way
of determining which of these measures represented the primary outcome for each
domain. With so many outcomes examined, there was high risk of obtaining
apparent effects by chance.

Turning to the actual results, only one of the 9 measures of mood was
significant in time by treatment interactions. The intervention seemed to have a
significant effect on dietary behavior (although it is unclear why the
seemingly very different dietary behaviors were not analyzed) and smoking, but
no effect on exercise. As is often the case with early breast cancer patients,
rates of adherence to chemotherapy were too high to allow any differences
between intervention and control group to emerge. In terms of immune function,
results were not significant for CD3, CD4, CD8 counts cell counts, or six assays
of natural killer cell lysis. If we compare this overall pattern of results to 
what was stated in the abstract, we see a gross confirmatory bias in the
suppression of negative results and highlighting of positive ones.

Subsequent papers from this project amplified the confirmatory bias of these two
papers by declaring a reduced risk of recurrence and death from breast cancer
for intervention participants and gains for all secondary outcomes.  These
papers also cast doubt on whether the 2004 paper disclosed all of the outcome
measures that were assessed. One article stated that for the subgroup of
patients with elevated Center for Epidemiologic Studies-Depression (CES-D)
scores, the intervention reduced depressive symptoms. This outcome is not even
mentioned in earlier reports, but these subgroup analyses seem to imply that a
reduction in depressive symptoms did not occur for the full sample. It is a
reasonable inference that this null finding was suppressed in earlier reports.
CES-D scores would seem to be the preferred primary measure of mood outcome for 
such studies. The CES-D has validated clinical cut points, and it is commonly
believed that depression is the mood variable most strongly related to immune
function. Another article referred to the Beck Depression Inventory (BDI), also 
an excellent candidate for a primary outcome in a study attempting to affect
recurrence and survival via links between psychological variables and the immune
system.

Our close reading of the results reported in these two articles suggests that
the intervention is inert with respect to mood and immune function, and has no
effect on progression and survival. The intervention is hardly ready for
dissemination into the community. The designation of this intervention in
advertisements for the free training as “the first evidence-based behavioral
intervention designed to patients newly diagnosed with cancer” is premature and 
exaggerated. What could be meant by “evidence based”? Claims of “robust and
enduring gains” in all categories of outcomes are simply wrong.

My colleagues and I gave our now familiar argument that there was lack of
evidence that any psychosocial intervention could reduce risk of recurrence and 
improve survival. There was also a lack of evidence for possible mechanisms by
which such effects could conceivably be achieved.

Cancer published our commentary without a response from the authors because they
continued to refuse to provide one. Our commentary was instead accompanied by a
response from Peter Kaufmann, MD. We wondered why the choice came down to Dr.
Kaufmann and why he would accept the offer to reply to us. He had not written
much about cancer, but he is Deputy Chief of the Clinical Applications and
Prevention Branch of National Heart Lung and Blood Institute (NHLBI) and at the 
time his commentary was written, he was President of the Society of Behavioral
Medicine.

The Cancer to Health (C2H) intervention package is based on the assumption that 
psychological variables have clinically significant effects on physical health
via the immune system. Despite the lack of support for this idea with respect to
cancer, the idea remains highly attractive and resistant to rejection because
it lends prestige to psychosomatic and behavioral medicine. At the annual
meeting of SBM at which Dr. Kaufmann became president, the keynote address was
delivered by David Spiegel and basically involved debating in absentia skeptics 
and critics of the notion that psychosocial intervention could extend survival
of cancer patients, including me. I complained to Dr. Kaufmann that if Spiegel
wanted to debate me, I should have been invited to respond. Kaufmann indicated
that I would get an invitation for keynote in the future to remedy this
imbalance, but the occasion never materialized.

Subtitling his commentary “To Light a Candle,” Kaufmann conceded that my
colleagues and I had raised valid criticisms about the design and interpretation
of the C2H intervention trial. However, he took issue with our recommendation
that clinical trials of this kind be suspended until putative mechanisms could
be established by which psychological variables could influence survival.
Quoting our statement that an adequately powered trial would require “huge
investments of time, money, and professional and patient resources,” he
nonetheless called for dropping a “preoccupation with mechanisms and secondary
aims,” and instead putting the resources to increasing the sample size and
quality of an intervention trial.

I remain puzzled by Kaufmann’s argument. In the absence of specification of a
mechanism by which psychological variables could have such an effect, was
Kaufmann nonetheless suggesting that we needed a large trial to overcome the
lack of power of the moderate sized C2H trial?  I cannot imagine a NIH
administrator making a similar argument for a large scale study of an herbal
product or coffee enemas or other intervention with a similar undocumented
mechanism of influence.

Barbara Andersen, the principal investigator on both the C2H trial and the grant
for trained professionals in delivering the intervention, has never responded
in print to our criticisms and charges that the trial does not affect
progression or survival. However, she has complained to administrators of the
institutions of a number of her critics and asked that they put a stop to
behavior having negative ramifications for the field of behavioral research in
cancer. She also campaigned unsuccessfully to get another critique of a work
that we published retracted.

It is unlikely that NIH showed favoritism in funding the training grant, relying
instead on scores obtained in peer review. Reviewers must have been swayed by
the consistent confirmatory bias in presentation of the results of C2H. However,
there is a bias in NIH supported forums given to claims about psychosocial
interventions affecting physical health outcomes. Andersen and those making
similar claims regularly get invited to annual NIH sponsored symposia at
professional meetings and reiterate the claims again and again. Apparently,
there’s no room for critics on such panels.

The two papers presenting the outcomes of C2H have inaccurate abstracts and data
analytic strategies that hide that they are basically null trials. In this
respect they are not alone. Elsewhere I have documented that other psychosocial 
trials  [1,2,] conducted by PNI investigators would be revealed to be null
trials if time x treatment interactions were transparently reported for primary 
outcomes. Here is what to look for:

  1. Ignoring of negative results in main analyses of primary endpoints.

  2. Favor secondary analyses, subgroup analyses, and endpoints developed post hoc 
    over negative findings for primary analyses.

  3. Positive spin to abstract, highlighting best of results obtained using these
    strategies.

  4. Negative findings presented as if positive in subsequent publications.

PNI cancer researchers take a Texas sharpshooter approach to identifying
positive effects for immunological variables. The apocryphal Texas sharpshooter 
drove drunk around Texas with his rifle and a can of red paint and shot up the
sides of buildings. Afterwards, he would draw a bull’s-eye with some of his hits
in the center, creating the impression of an expert marksman who always hit his
mark. PNI researchers similarly collect numerous PNI measures, not on the basis
of their known association with cancer, but based on their ease of assessment. 
Measures derived from saliva samples are particularly popular. Investigators
then declare whatever measures prove significant as evidence that they have
tapped into the PNI of cancer. Further, they claim to replicate existing
studies, when existing studies obtained significant effects with different
measures. Any positive result obtained with a battery of measures is declared a 
replication, even when it is not a precise replication.

Compared to cancer, behavioral interventions in HIV+/AIDS have the advantage of 
well validated mechanisms by which behavioral interventions might conceivably
influence the immune system, and in turn, readily measurable assessments of any 
clinically significant impact. This area has attracted considerable interest
from PNI researchers, who, similar to cancer PNI researchers, praise their own
and each other’s success in modifying clinically relevant immunological
parameters. But a meta-analysis of 35 randomized controlled trials examining the
efficacy of 46 separate stress management interventions for HIV+ adults (N =
3,077) tells a different story”

   To our surprise, we did not find evidence that stress reduction interventions
   improve immune functioning or hormonal mechanisms that could influence
   immunity. These findings contrast with the PNI perspective that guided our
   work and most of the interventions included in our review  (Antoni, 2003;
   Robinson et al, 2000). Thus, even though chronic stressors are known to
   suppress both cellular and humoral markers (see Segerstrom & Miller, 2004)
   the short-term use of stress-management strategies does not seem to reverse
   these processes in patients with HIV.

PNI cancer researchers remain a self-congratulatory group with a strong
confirmatory bias in their mutual citations of the field’s claimed successes.
Judging by citation patterns in the incestuous journal Brain, Behavior, and
Immunity, one can readily get the impression that there are never any negative
studies in the PNI cancer literature.

The articles reporting results for the C2H trial continue to be highly cited,
with little apparent effect of our criticism.   With a lack of other positive
trials that can be cited, particular importance in the PNI literature has been
attached to the claims that C2H extend survival of cancer patients. There is
apparently little concern about conveying unrealistic expectations to patients
concerning effects of psychosocial intervention on their immune system, and
these claims fit with patents’ impressions and motivations for going to peer
support groups and group therapy.

Cancer patients sometimes faced difficult choices about medical interventions to
manage their disease. It is unfortunate if they are provided with
misinformation that all they need to do is get stress management interventions
to slow progression and extend their survival. Belief that these interventions
are effective can discourage them from committing themselves to more effective, 
but painful, fatiguing, and disfiguring medical interventions.

Jay Bhattacharya

Dr. Jay Bhattacharya Was Nice to Someone During a Debate. That Doesn’t Erase the
Consequences of His Misinformation.

This is what it looks like when doctors treat the pandemic as an intellectual
parlor game.

Jonathan Howard on January 17, 2025

Link

Jay Bhattacharya Will Bring Transparency to NIH

Dr. Andrew Noymer is an epidemiologist and population health scientist who
recognized COVID’s threat much earlier than most people and favored strong
measures to contain it. However, Dr. Noymer believes that SARS-CoV-2 leaked from
a lab and is a member of Biosafety Now. I previously discussed how members of
this organization care deeply about infection #1, but are utterly indifferent to
how the virus was handled after that.

Indeed, Biosafety Now has partnered with celebrity doctors such as Marty Makary 
and Jay Bhattacharya who have zero expertise in biosaftey, but instead spread
copious COVID misinformation and advocated for herd immunity via mass infection.
In the viewpoint of Biosafety Now, releasing the virus was a punishable crime, 
but misleading people about it and purposefully trying to infect people with it,
even after vaccines were available, was a forgivable oopsie.

To justify this absurdity, Biosafety Now members demand amnesia and apathy about
everything except that first infection, and they are full of insults and
vitriol towards anyone who remembers and still cares. Dr. Noymer recently penned
an article that reveals how this deliberate forgetfulness ensures we are less
prepared to handle a future pandemic as well as existing viruses.

Dr. Noymer’s article was titled Jay Bhattacharya Will Bring Much-Needed
Transparency to NIH, and this alone was problematic. Dr. Bhattacharya wasn’t
transparent that the Great Barrington Declaration (GDB) was sponsored by a proud
child labor advocate, for example. Furthermore, rather than admit his early
pandemic pronouncements were erroneous, he’s tried to obscure them by claiming
words have no meaning and that all he ever cared about was poor children. Dr.
Bhattacharya was opaque and untrustworthy throughout the pandemic, and there’s
no reason to think that will change once he gets to the NIH.

To his credit, Dr. Noymer recognized COVID’s toll. He correctly said:

The stakes could not be higher: COVID killed 15 million people worldwide in 2020
and hasn’t stopped killing, although thankfully at a lower rate more recently.

It’s true that hundreds of Americans are still dying of COVID every week. It’s
also true that, except for those over 70, Dr. Bhattacharya relentlessly sought
to numb people to this outcome, as well as to COVID’s non-fatal harms. Dr.
Bhattacharya underestimated and minimized COVID starting in March 2020 and he
never stopped. Dr. Noymer did not tell this to his readers.

Dr. Noymer also noted that he opposed Dr. Bhattacharya’s approach to COVID. He
wrote:

Jay supported the Great Barrington Declaration, while I favored a more active
and engaged public health response, broadly although not completely along the
lines of what was actually done in the United States. At times our differences
were fundamental, other times pragmatic. Nonetheless, the differences of opinion
between Jay and me on this subject were deep.

That sugarcoats things. Dr. Bhattacharya didn’t just “support” the GBD. He wrote
it. In it, he claimed that the mass infection of unvaccinated people under 60
would end in the pandemic in 3-6 months, and he pushed policies that furthered
this goal leading to needless suffering. That’s not a hard sentiment to
communicate, but beyond linking to the GBD, Dr. Noymer chose not to inform his
readers of this either.

It’s notable that while I deluge with readers with videos and quotes of Dr.
Bhattacharya, his defenders universally suppress what he said. Unlike them, I
believe his words and policies, as well as their real-world consequences, should
be amplified and remembered, not silenced and forgotten. This is especially the
case considering he will likely soon yield great power. The images below are
6-weeks apart, and though there are countless more examples, this alone should
make reasonable people wonder if Dr. Bhattacharya is really the person we want
in charge should a new pandemic occur.

Read this article

Jay invited me to this conference

Dr. Noymer didn’t care about any of this. He was willing to overlook Dr.
Bhattacharya’s misinformation and pro-infection agenda for two reasons. First,
Dr. Bhattacharya endorsed the lab leak hypothesis. Dr. Noymer wrote:

The most important outstanding item on the COVID agenda is: Where did SARS-CoV-2
– the virus that causes COVID – come from?

In reality, the most important outstanding item on the COVID agenda is how we
could have better protected people from it. Nothing about its origin impacts
this. Whether it came from a lab or an animal wouldn’t affect a single word I’ve
written about it or a single patient I saw with it, and normal people don’t
want a new virus to emerge from either source.

However, nothing else mattered to Dr. Noymer. Because he agrees with Dr.
Bhattacharya about the origin of SARS-CoV-2 and wants to block
vaccine-researchers like Dr. Peter Hotez from receiving NIH funding, he was
willing to discard Dr. Bhattachayra’s entire pandemic record. Dr. Noymer thinks 
everyone else should join him in this intentional amnesia, and he was full of
vulgar contempt for those of us who refused or can’t forget our COVID
experience.

Dr. Bhattacharya’s second qualification to run the NIH was that he was nice to
Dr. Noymer during a couple of debates. Dr. Noymer wrote:

I debated Jay over Zoom on the topic of pandemic response, so I am well aware of
his views on COVID response, as he is of mine. Our debate was not archived but 
was roughly similar to the Munk Debate I did with Jay’s Stanford colleague, John
Ioannidis, and the SoHo Forum debate I did with Jay’s Great Barrington
collaborator, Martin Kulldorff. These discussions are dated now, but they still 
reflect deep intellectual rifts that were brought into sharp relief by COVID and
the collective response to it.

What makes my endorsement of Jay all the more peculiar is that he and I still
disagree on COVID response. I know because I had the chance to talk with Jay and
others in October at a conference that he organized at Stanford, at which I
served as a panelist. What’s more, Jay invited me to this conference knowing
that his and my opinions on this subject continue to diverge. Here and in other 
examples, I have seen Jay’s commitment to hearing diverse and disagreeing
viewpoints. Jay is not one to try to muzzle a dissenting opinion.

It’s dandy that these doctors, none of whom treated COVID patients, had friendly
debates as the virus overwhelmed our morgues and hospitals. But why does that
mean everyone else is obligated to memory hole the many times Dr. Bhattacharya
declared the pandemic over? Why should we ignore his minimization of variants,
fake statistics, or anti-vaccine misinformation? Is Dr. Bhattacharya’s pairing
with Del Bigtree and ringing endorsement of RFK Jr. suddenly no big deal? Should
the victims of misinformation be casually brushed aside because Dr.
Bhattacharya was friendly to Dr. Andrew Noymer? Were these debates the highest
value, more important than the causalities of the virus being debated?

I don’t think so. I previously discussed how these “debates” were mostly empty
theater that deliberately obscured and legitimized misinformation by portraying 
it as a proper topic of disagreement. I also discussed that doctors who
prioritized these performances above all else treated the pandemic as if it was 
just a parlor game, oblivious to the fact that their “deep intellectual rifts”
were reflected in our sick, suffering patients.

While resisting pandemic amnesia is important it its own right, this isn’t just 
about the past. A new pandemic is possible. Incredibly, Dr. Noymer, who
recognized that Dr. Bhattacharya’s approach to an actual pandemic was flawed and
dangerous, nonetheless wants him in charge if there’s a future pandemic simply 
because he is “not one to try to muzzle a dissenting opinion.” What does Dr.
Noymer imagine Dr. Bhattacharya would do during another pandemic? Does he think 
Dr. Bhattacharya would try to contain it or accurately inform the public about
it? The answers are both obvious and deeply concerning to those of us who work
in hospitals.

In contrast, Dr. Noymer didn’t even consider these questions. Apparently, the
prospect of more self-congratulatory conferences, full of civil debate and
polite discussion, is so enticing that he is eager to hand enormous power to
someone he already knows will grossly mismanage a pandemic. As the bodies pile
up, we can all look forward to more verbal jousting matches.

Covidian doctors

Meanwhile, outside of staged debates, I’ve yet to see Dr. Bhattacharya engage
with “dissenting opinion” in a mature, thoughtful way. Instead of responding to 
substantive critiques, he tries to distract from them by claiming to be a victim
and asking people to feel sorry for him. He reflexively calls all criticism
“slander“, a “smear campaign” and “hit piece“. He hurls schoolyard taunts at his
critics, deliberately misrepresents their points, and rather than stand up for 
his own words, he actively denies them. Articles such as For Bhattacharya, Free 
Speech Means Freedom To Defund Dissenters and  President Levin’s First Order of 
Business: Abandoning Academic Freedom make interesting points about Dr.
Bhattacharya’s commitment to free and open debate.

This juvenile, spiteful tweet is just one example amongst many- read this from
PAI– of how Dr. Bhattacharya behaves towards doctors who treat patients. Image
the outrage it would generate if I tweeted something like that about Dr.
Bhattacharya. By using such immature slurs and childish images, he is trying to 
drive a wedge between us and our patients, telling them that we are
untrustworthy and that we, not the virus, are to blame for everything they
didn’t like about the pandemic. Dr. Noymer doesn’t care about this either and
instead depicted Dr. Bhattacharya as a scholarly gentleman who can “restore
public trust.”

“I have seen Jay’s commitment to hearing diverse and disagreeing viewpoints.”

Dr. Bhattacharya believes SARS-CoV-2 came from a lab, and he was pleasant to Dr.
Noymer during a debate. This does not obviate his atrocious pandemic record or 
mean he is qualified to lead the NIH. Pretending otherwise is just another form 
of pandemic revisionism, erasing doctors’ misinformation and erasing the
consequences that misinformation- real people.

As serious threats loom and anti-vaccine cranks prepare to take over, amnesia
and apathy about these tragedies are not virtues, and I am fully prepared to
politely debate that with anyone.


Drs. Jay Bhattacharya, Marty Makary, and a Cruel April Fool’s Day

One NIH staffer described Bhattacharya’s note as a “thank you and can’t wait to 
work with you email … in the middle of the massacre.”

Jonathan Howard on April 8, 2025

Link

April Fools Day was the perfect encapsulation of the very brief tenures of Drs. 
Jay Bhattacharya and Marty Makary, the heads of the FDA and NIH respectfully.

On that day, the article NIH Director Removes Four Main Scientists amid Massive 
Staff Purge reported:

The Trump Administration has fired four leaders and thousands of employees at
the National Institutes of Health in “one of the darkest days”.  The directors
of the National Institute of Allergy and Infectious Diseases (NIAID), the
National Institute of Child Health and Human Development (NICHD), the National
Institute on Minority Health and Health Disparities (NIMHD) and the National
Institute of Nursing Research (NINR) were informed late on 31 March that they
were being placed on administrative leave.

Another article that day, NIH Director Pledges To Implement Changes ‘Humanely’, 
reported that Dr. Bhattacharya  pledged to “implement new policies humanely”. 
Those new policies meant firing people, and to his credit Dr. Bhattacharya
acknowledged that they were entirely political in nature. “Many of our valued
colleagues are losing their jobs, which is in no way a reflection of the quality
of their work,” he said.

He’s right. Scientists weren’t fired because they were incompetent. They were
fired because of their beliefs, and they weren’t fired “humanely”.  According to
the article ‘A Cruel April Fool’s Joke’: HHS Layoffs Characterized by
Confusion, Errors:

As NIH workers were digesting the loss of their jobs, they received an
introductory email from Jay Bhattacharya, the newly confirmed director of the
medical research agency.

One NIH staffer described Bhattacharya’s note as a “thank you and can’t wait to 
work with you email … in the middle of the massacre.”

That same day contrarian podcaster Bari Weiss posted an interview with Dr.
Bhattacharya where he lamented that Dr. Francis Collins, the former NIH
director, had called him “fringe” in a private email 4.5 years previously. Dr.
Bhattacharya said that this insult was intended to “destroy” him and it “really 
hurt.”  Dr. Bhattacharya spoke about how meaningful it was that Dr. Collins had 
apologized to him privately, and he urged Dr. Collins to make a public apology
as well. At that moment, when many of his valued colleagues were “losing their
jobs”, Dr. Bhattacharya, who is the current NIH director, was feeling sorry for 
himself because he had been called a name in 2020. 

Watch that video here.

As scientists were closing their labs and cleaning out their desks, he gave
another interview on Fox News that day where he said:

We’ll never use this agency to censor scientists who disagree. If scientists are
censored, we actually can’t have excellent science.

That sounds nice, however journalists have told me they have trouble getting
on-the-record quotes from scientists. Understandably, many of them don’t want to
be caught up in the next round of purges if they criticize the wrong people.

Watch that video here.

Dr. Bhattacharya also said in that interview:

The healthcare system ought to be focused on preventing disease in the first
place.  The chronic disease problems that we have, many of them could be
prevented.  We have all these incentives to take care of people after they are
sick.  Let’s make incentives to make people healthier so that they don’t get
sick in the first place.

Again that sounds nice. However, Dr. Bhattacharya rose to fame via his proposal 
to mass infect unvaccinated people under age 60-70 to reach herd immunity in 3-6
months, and his boss, Kennedy, has devoted his career to promoting disease in
the first place.

Watch that video here.

Moreover, although Dr. Bhattacharya extolled the virtues of preventing chronic
disease, many experts in chronic disease were victims of his purge. According to
an article from that day titled Doctor Behind Award-Winning Parkinson’s
Research Among Scientists Purged From NIH:

Several top scientists charged with overseeing research into disease prevention 
and cures at the National Institutes of Health (NIH) were notified that they
were subject to a reduction in force on Tuesday as part of a devastating purge
of federal employees carried out by US Health and Human Services secretary
Robert Kennedy Jr., WIRED has learned.

Multiple sources at the NIH, granted anonymity because they were not authorized 
to talk to the media, confirmed Tuesday afternoon that at least 10 principal
investigators who were leading and directing medical research at the agency had 
been fired. Among them is Dr. Richard Youle, a leading researcher in the field
of neurodegenerative disorders previously awarded the Breakthrough Prize in Life
Sciences for his groundbreaking research identifying mechanisms behind
Parkinson’s disease.

Dr. Bhattacharya had previously given a speech called The End of Free Speech is 
the End of Science.

FDA Commissioner Marty Makary Gets Off To A Bruising Start As Agency Is Wracked 
By Layoffs

Dr. Makary had a similarly experience at the FDA. Though he had recorded a
podcast in 2022 titled Cancel Culture Isn’t Good For Science, headlines from his
start read: FDA’s New Commissioner Marty Makary Signed Off on Peter Marks
Ouster, FDA Commissioner Marty Makary Gets Off To A Bruising Start As Agency Is 
Wracked By Layoffs and The FDA Is ‘Finished’ as Firings Sweep Health Agencies.
Drug Stocks Are Falling.  According to that article:

U.S. public-health agencies on Tuesday morning, and the impact on the Food and
Drug Administration so far has been dire, according to current and former
employees.

“The FDA as we’ve known it is finished, with most of the leaders with
institutional knowledge and a deep understanding of product development and
safety no longer employed,” former FDA Commissioner Dr. Robert Califf wrote in a
LinkedIn post.

Appropriately, all three of these articles were published on April Fools Day.


Dr. Jay Bhattacharya: You Work for an Administration That Runs a Vast Censorship
Regime to Suppress Scientific Discussion. Most Authoritarian Policy I’ve Seen
From an American Government. You Should be Ashamed of Yourself.

Imagine if the fate of Tweets and YouTube vidoes was the sole concern of
scientists today.

Jonathan Howard on April 22, 2025

Link

Let’s hear the argument, let’s see the evidence that YouTube used to decide it
was misinformation. Let’s have a debate. Science works best when we have an open
debate.

Forgive me for the clickbait title of this article. It’s not my style to make
such histrionic, overwrought allegations. However, it is my style to accurately 
quote people, and I am merely repeating the words our NIH director, Dr. Jay
Bhattacharya, who said things like this about censorship, not long ago:

Those are strong words, and they seem to apply well to our current moment. What 
calamity befell Dr. Bhattacharya to make him say this? Was he fired? Was his
research defunded? Did no one know his name or what he believed? Was
“media/social media suppression” really the only thing standing between Dr.
Bhattacharya and a perfect pandemic response?

Dr. Jay Bhattacharya would have done amazing, incredible things

Dr. Bhattacharya felt grievously victimized because he was called “fringe” in an
email, and he lost a YouTube video and some Tweets. To him, this was a calamity
of epic proportions with grave implications for the future of free speech in
the U.S. After losing a YouTube video in 2021, Florida Governor Ron Desantis put
out a press release titled GOVERNOR RON DESANTIS HOLDS ROUNDTABLE WITH PUBLIC
HEALTH EXPERTS TO DISCUSS BIG TECH CENSORSHIP. It contained the following
quotes:

“There’s nothing more dangerous than being able to censor what is said in a
country, because then you are simply not ever going to even hear the truth. And 
you are entering into a phase of countries that we used to criticize severely
like the USSR, like communist China…I mean, this is almost the end of our
civilization if we have this sort of censorship, I’m afraid,” said Dr. Scott
Atlas.

“For science to work, you have to have an open exchange of ideas…If you’re going
to make an argument that something is misinformation, you should provide an
actual argument. You can’t just take it down and say, ‘Oh, it’s misinformation’ 
without actually giving a reason…Let’s hear the argument, let’s see the evidence
that YouTube used to decide it was misinformation. Let’s have a debate. Science
works best when we have an open debate,” said Dr. Jay Bhattacharya.

“We need to have debates, rather than censoring…When we do censoring and
slandering, even if we are willing to continue to speak out, there are many
other scientists that I know, including junior scientists, who do not want to
speak out because they see what’s happening to us. They don’t want to have to go
through the same thing. So, we really need a debate,” said Dr. Martin
Kulldorff.

Again, these Big Feelings from famous doctors were about a single YouTube video.
When Dr. Bhattacharya claims to have been silence and censored, this is what he
is talking about, though he may have had motives beyond pure scientific
discourse to keep people enraged and engaged with his social media feed.

Read this article here.

Reasonable people can disagree about whether Big Tech and Biden administration
overstepped their bounds in trying to limit online disinformation. Maybe
government officials should have yawned and said nothing as anti-vaccine lies
killed droves of Americans. Dr. Bhattacharya sure thinks so, and he wasn’t
afraid to challenge the government. He excoriated them obsessively and even took
a case about this to the Supreme Court. According to the Wikipedia article
Murthy v. Missouri:

The lawsuit alleges that President Joe Biden and his administration were
“working with social media giants such as Meta, Twitter, and YouTube to censor
and suppress free speech, including truthful information, related to COVID-19,
election integrity, and other topics, under the guise of combating
‘misinformation’.”

Imagine if the fate of social media posts was the sole concern of scientists
today. It all seems pretty trivial now, doesn’t it? Yet, this hysterical,
provocative language is how Dr. Bhattacharya routinely depicted a government
that requested Facebook limit deadly anti-vaccine disinformation.

This article was about social media content.

The End of Free Speech is the End of Science.

In reality, Dr. Bhattacharya was not silenced. As the video below shows, he was 
loud, prominent, and influential. He didn’t come out of nowhere when Trump
plunked him from obscurity to head the NIH. He was a celebrity on Fox News and
Twitter. Billionaires sung his praises. He made an enormous number of YouTube
videos, many of them about how he had been censored. He was on countless
podcasts and wrote many columns in international newspapers. He advised
presidents and governors. He testified in courts and before Congress. He was
everywhere, except a hospital.

Dr. Bhattacharya is doing just fine today, and he was always doing just fine.
While his feelings may have been hurt, he was famous, healthy, and gainfully
employed. Indeed, he lost his Supreme Court case, as he couldn’t show he had
been harmed in any way. Justice Amy Coney Barrett wrote the opinion, stating:

To establish standing, the plaintiffs must demonstrate a substantial risk that, 
in the near future, they will suffer an injury that is traceable to a government
defendant and redressable by the injunction they seek. Because no plaintiff has
carried that burden, none has standing to seek a preliminary injunction.

She’s right. Dr. Bhattacharya was so “censored” that he became the director of
the NIH.

Moreover, Dr. Bhattacharya’s experience was hardly unique. He was called
“fringe” because he claimed the mass infection of unvaccinated people under
60-70 would end the pandemic in 3-6 months. Big deal. Dr. Bhattacharya wrote a
fake “review” of my book and called me silly names for pointing out the flaws in
his “plan.” It’s not fun being on the receiving end of such juvenile,
content-free tantrums, but it’s not that bad either. Dr. Bhattacharya still
feels he’s owed a public apology because he was called “fringe” in an email 4.5 
years ago.

Additionally, Dr. Bhattacharya was not the only doctor who had their voice
curtailed in one way or another. I wrote about being silenced for political
reasons in an article titled I’ve Been Silenced, Censored, and Cancelled. The
Reason Why Matters. I didn’t center my identity around this or expect anyone to 
pity me. The doctors I knew who died of COVID were truly silenced. Rather, I
wrote about my canceled speech, once, fearing that it might foreshadow worse
things to come.

In contrast, Dr. Bhattacharya treated his feelings and social media content as
the central story of the pandemic. Nothing mattered more to him. While I never
heard him express remorse over a young life lost to COVID, he produced an
overwhelming amount of material depicting himself as both a “censored” scientist
and true champion of free speech. He testified before Congress about having
been a victim of a fictional “Ministry of Truth” gave and self-important talks
with grandiose titles such as The End of Free Speech is the End of Science, A
Personal COVID Perspective.

Dr. Bhattacharya’s identity was entirely based around grievance and victimhood, 
and the right-wing hive mind was eager to perpetuate the myth that he was a
suppressed Galileo (Reason, Wall Street Journal, Epoch Times, Sensible Medicine,
The Free Press, UnHerd, Tablet, The Heartland Institute, The Spectator, Fox
News, Rubin Report, ZDoggMD). They agreed he was the pandemic’s Main Character
and that his Tweets and YouTube videos mattered more than the victims of his
misinformation.

Dr. Bhattacharya promised the horrors would end once he took office. He
testified during his confirmation hearing that he would welcome dissent and
promote a culture of free speech. He promised a new era of open discussion,
where scientists would finally be free to Tweet without repercussions. No one
would have to suffer or fear as he did. “We will never use this agency to censor
scientists who disagree,” he said recently on Fox News.

NIH Director Removes Four Main Scientists Amid Massive Staff Purge

As with COVID, the depressing reality on the ground bears no relation to Dr.
Bhattacharya’s cheerful Fox News fantasy. Though Dr. Bhattacharya promised to
tolerate dissent, many articles about the NIH contain remarks from officials who
ask to “remain anonymous for fear of retaliation.” Why is this? What are they
afraid of?

Today, scientists have much more to worry about than their social media feeds.
Scientists are being purged, research is being defunded, words are being banned,
thought is being policed, universities and medical journals are being attacked.
Foreign scientists are staying away, and many domestic ones want to flee. Here 
are some recent headlines:

  1. NIH Director Removes Four Main Scientists Amid Massive Staff Purge

  2. Women, Minorities Fired in Purge of NIH Science Review Boards

  3. Trump Officials Will Screen NIH Funding Opportunities

  4. NIH Reels with Fear, Uncertainty About Future of Scientific Research

  5. NIH Freezes Funds to Harvard and Four Other Universities, But Can’t Tell Them

  6. Leading Nutrition Scientist Departs N.I.H., Citing Censorship

  7. Nobel-Winning Scientist Says His Researchers Are Fleeing the Country Because
    Of Trump’s Cruelty

  8. I Work at NIH. The Fear Among Staff Is Palpable

  9. Here Are the Words Putting Science in the Crosshairs of Trump’s Orders

  10. NIH Sued Over ‘Ideological Purge’ of DEI, Covid and Vaccine Research

  11. Medical Journals Get Letters From DOJ

  12. Growing Signs of Discontent — and Resistance — Within NIH

  13. Scientists Say NIH Officials Told Them to Scrub mRNA References on Grants

  14. At NIH, ‘Everyone is on Edge’ as They Brace for Deep Cuts and More Centralized
    Control

  15. Survey: Trump Policies Push 75% of Scientists to Consider Leaving U.S.

  16. Fauci Allies, Covid Vaccine Officials Get Ax at NIH

  17. Nearly 300 Scientists Apply for French Academic Program Amid Trump Cuts in
    U.S.

  18. NIH Bans All Future Grants to Universities with DEI Programs or Israel
    Boycotts

  19. A Sense of Foreboding Hangs Over the National Institutes of Health

  20. ‘Chaos and Confusion’ at the N.I.H., the Crown Jewel of American Science

  21. NIH Removing Outside Scientific Advisers Who Evaluate Research

This is the state of science and research under Dr. Bhattacharya’s leadership
and in the administration in which he proudly serves. “Massive” cuts to the NIH 
budget are on the horizon. Along with his COVID misinformation, this will be Dr.
Bhattacharya’s permanent legacy. No one is going to care about the YouTube
video he lost in 2021 or that he was called “fringe.”

Dr. Jay Bhattacharya’s legacy

You should be ashamed of yourself

Perhaps one day Dr. Bhattacharya will stop talking about free scientific debate 
and demonstrate a commitment to it. Until then, as with his flawed COVID
pronouncements, we are allowed to remember and amplify what he said about
censorship. He had strong feelings on the topic and expressed them often. The
stakes today are higher than Tweets and YouTube videos. Like Dr. Bhattacharya, I
call it like I see it, though I don’t feel nearly as safe and I once did.
However, if I could speak freely, I might say something like this:

Those were the words of a man who knew he had nothing to fear from the
government, but every incentive to pretend they were out to get him.


Dr. Jay Bhattacharya Tried to Summon a Social Media Mob to Bully and Silence a
Dissident Scientist, but the Mob Had Other Ideas

The mob doesn’t trust the medical establishment, and today Dr. Bhattacharya is
the medical establishment.

Jonathan Howard on June 28, 2025

Link

The bigger problem is that lockdowners like Howard (an NYU doctor, I think),
think that living your life is an irresponsible act. Sending your kids to school
is an irresponsible act.

As SBM readers know, my articles extensively quoted Dr. Jay Bhattacharya and
explained in great detail why I disagreed with him. I provide references so
anyone could check my work. I don’t just lob schoolyard taunts at him or make
dishonest straw man arguments. I always try to include videos of him speaking in
my articles, and I have a YouTube channel devoted to preserving doctors’ words.
We Want Them Infected presented the Great Barrington Declaration its entirety. 
I wanted my readers to know exactly what he said about natural immunity leading 
to herd immunity. My criticisms of Dr. Bhattacharya may have been blunt and
snarky, but they were also serious and in good faith.

That courtesy was not repaid to me. Dr. Bhattacharya never engaged with any
argument I made or data I presented. He engaged with me entirely on an emotional
level and refused to have any discussions of science and data. It was
impossible to converse with him in good faith. He called me “unhinged” and
“inane”. He was livid I refused to silence and censor him. In response to one
article- A Letter to My Critics: To Refute Me, Stand Up For Your Own Words– that
quoted him extensively, he said:

Wait, you’re sending me to a Jonathan Howard essay? I didn’t realize that you
were a troll.

I wasn’t trolling Dr. Bhattacharya. Its not my fault he was angered by his own
words.

In contrast, Dr. Bhattacharya left a long review of We Want Them Infected that
did not quote me at all. Instead, he used straw man arguments to try to
discredit my collection of quotations. Dr. Bhattacharya signaled that he was too
important to look up where I work and said:

The bigger problem is that lockdowners like Howard (an NYU doctor, I think),
think that living your life is an irresponsible act. Sending your kids to school
is an irresponsible act. The implication is that unless you comply with his
prescription — lockdown with no logical endpoint — you are irresponsible.

I never said anything like this, and Dr. Bhattacharya later admitted he hadn’t
read my book. His “review” was entirely fake.

However, beyond running from substantive discussion, Dr. Bhattacharya’s
dishonesty served another valuable purpose. He blamed me for the problems I
discussed. For example, I recognize that in August 2021, when Dr. Bhattacharya
helped run the show, the headlines read School Closures Reported In Five Florida
Counties; Districts ‘Drowning’ In COVID. Because I acknowledged such unwanted
realties Dr. Bhattacharya claimed I actively campaigned for them- sending your
kids to school is an irresponsible act.  In reality, I didn’t write about
schools and COVID until the end of 2022, after schools had been open for over a 
year.

However, by falsely claiming that my “prescription” was lockdowns forever, Dr.
Bhattacharya sought to erase SARs-COV-2 and displace its impact onto those of us
who refused to deny its impact. Anyone who recognized reality became the
villain in his narrative, not the virus, and Dr. Bhattacharya tagged me to
summon a social media mob. This obviously served as a deterrent to anyone else
who might be similarly motivated to recognize reality. No one wants to be blamed
and attacked by online marouders for problems they merely identified. I didn’t 
call for 5 counties to close their schools in Florida 4 years ago.

I will establish a culture of respect for free speech in science and scientific 
dissent at the NIH.

Dr. Bhattacharya’s behavior may seem like just another example of bad faith
engagement, and it certainly is. However, it is worth discussing because it is
still happening now and because Dr. Bhattacharya promised that things would
change once he came NIH director. During his confirmation testimony he said:

I will establish a culture of respect for free speech in science and scientific 
dissent at the NIH. Over the last few years, top NIH officials oversaw a culture
of coverup, obfuscation, and a lack of tolerance for ideas that differed from
theirs. Dissent is the very essence of science. I will foster a culture where
NIH leadership will actively encourage different perspectives and create an
environment where scientists – including early career scientists – can express
disagreement respectfully.

Dr. Bhattacharya said this because he felt he had been unfairly treated himself.
On his first day in office, when over 1,000 NIH employees were purged, Dr.
Bhattacharya lamented in a podcast with Bari Weiss that he had been called
“fringe” in a private email by the previous NIH director. He felt he was owed a 
public apology. Of course, as those of was who worked on COVID units know, being
called “fringe” isn’t that bad, and we only know about this email because of a 
FOIA request. Dr. Bhattacharya made this email famous and built his identify
around having been called “fringe”. Without his tireless efforts, no one would
have ever known he had been insulted. Predictably, Dr. Bhattacharya never
engaged with the merits of Dr. Collin’s arguments regarding his plan for herd
immunity via natural infection. He just wanted everyone to know he had been
called “fringe.”

He made a video about this not long ago titled Stanford Prof. Jay Bhattacharya
Responds to Being Called ‘Fringe’ in Collins, Fauci Emails.

“There are some patients who might have to wait until September,” Rosenberg
said. “These are all patients with metastatic cancer that is progressive. You
can imagine the difficulty as we have to tell them these things.

Though Dr. Bhattacharya claimed to value a “culture of respect for free speech
in science and scientific dissent” the news headlines under his leadership read:
More Than 70 Nutrition Scientists Call for Freedom From Censorship at NIH, NIH 
Staff Lambaste Agency Head for Censorship of Science, Leading Nutrition
Scientist Departs N.I.H., Citing Censorship, and NIH Employees Call for Academic
Freedom and Scientific Excellence in the Bethesda Declaration  Dr. Bhattacharya
was also mentioned in an article titled His Custom Cancer Therapy is in an NIH 
Freezer. He May Not Get it in Time that said:

Richard Schlueter, 56, was planting cucumbers and squash in his community garden
plot in Greensboro, Georgia, in May when he tore open a bag of soil and heard a
pop. His collarbone had snapped.

In early June, a scan revealed that the cancer that started in his tonsils was
racing through his bones. That day, he called a medical team at the National
Institutes of Health that had created an experimental cell therapy, custom-made 
to attack his cancer as part of a clinical trial. He needed it. Now.

Instead, he received more bad news: His therapy would be delayed at least a
month because of staff cuts at NIH.

A week later, Schlueter and his wife, Michelle, saw NIH Director Jay
Bhattacharya push back on concerns raised by his own staff that the ouster of
essential employees and other disruptions to the biomedical research agency were
harming science and patients. Bhattacharya said on X that objections raised in 
a document called the Bethesda Declaration contained “fundamental
misconceptions” about NIH’s new direction. Each termination was being reviewed, 
and some workers were reinstated, he added.

The article also quoted Dr. Steven Rosenberg, a giant in cancer research. It
said:

The Washington Post first reported in early April that the production of
specialized immune-cell therapies for metastatic cancer patients was delayed.
Two highly skilled technicians who prepared cells for treatments were fired in
the probationary purge in February, according to Steven Rosenberg, an NIH
immunotherapy pioneer who leads multiple trials. He declined to say how many
patients were affected, but his team now treats one patient per week, down from 
two or three before the cuts.

“There are some patients who might have to wait until September,” Rosenberg
said. “These are all patients with metastatic cancer that is progressive. You
can imagine the difficulty as we have to tell them these things.”

An official with the Department of Health and Human Services, which oversees
NIH, said the agency had ways of addressing the delays. Rosenberg has been
granted permission to hire contractors or to request help from other scientists 
from across NIH, said the official, who spoke on the condition of anonymity to
criticize an employee.

Rosenberg said he has been working urgently to try to rehire a scientist who was
fired since he was given permission to do so last week, but the federal
contracting process is slow and the scientist has been interviewing for other
jobs. He noted that to prepare the cells for patients requires special training 
that takes four to six months.

I find it deeply disappointing of Dr. Rosenberg to claim staffing issues are
delaying his research, especially in light of the funding alternatives that were
presented to him, which he has been slow in pursuing.

So how did Dr. Bhattacharya respond? Did he thank Dr. Rosenberg for bringing the
problem to his attention? Did he offer to help fix it? Did he meet with Dr.
Rosenberg privately?

No. Dr. Bhattacharya responded in a very familiar way. He said:

@NIH remains absolutely committed to the health and welfare of our clinical
trial participants, so many of whom over the years have been successfully
treated and helped advance medical knowledge by orders of magnitude. I find it
deeply disappointing of Dr. Rosenberg to claim staffing issues are delaying his 
research, especially in light of the funding alternatives that were presented to
him, which he has been slow in pursuing.

As to the current re-organization, no clinical trial has been delayed, nor has
any participant been dropped from any clinical trial. These are the facts. NIH
clinical trial participants and the American people need to know them.

Of course this is false. Journalist Max Kozlov linked to his article NIH Grant
Cuts Will Axe Clinical Trials Abroad — And Could Leave Thousands Without Care
and said:

Here is some of the other feedback Dr. Bhattacharya received.

Even Dr. Monica Gandhi said:

Indeed beyond the predicable dishonesty, Dr. Bhattacharya is repeating the same 
manipulative techniques he used with me. In Dr. Bhattacharya’s telling, I was to
blame for school closures and Dr. Rosenberg for problems in his labs. It was
Dr. Rosenberg’s fault that he was having trouble rehiring a scientist he never
wanted to fire in the first place. Apparently, the head of the NIH has no role
in helping NIH scientists, beyond vague allusions to “funding alternatives” that
Dr. Rosenberg was too slow to grasp. No wonder Dr. Bhattacharya had to be
reminded that he was the NIH director and the buck stopped with him during his
recent Senate testimony.

However, Dr. Bhattacharya didn’t criticize Dr. Rosenberg in an email intended
for a couple other people. Dr. Bhattacharya took his grievances public. By
trying to summon the mob on X, he was trying to bully and intimate Dr.
Rosenberg. He was also sending a message that any other NIH employee who
complained could expect to be similarly called out on social media. This all
seems a lot worse than being called “fringe” in an email, especially since it
comes from from a man who testified that he would “establish a culture of
respect for free speech in science and scientific dissent at the NIH.” Had Dr.
Bhattacharya been treated this way by the previous medical establishment, it
would have spawned 1,000 Tweets, dozens of YouTube videos, 10 podcasts with Bari
Weiss and Reason, and 2 documentaries.

Other dissident scientists should take note, however. The mob arrived, but
unlike in the past, they were not upset with Dr. Bhattacharya’s chosen villain. 
While Dr. Bhattacharya previously had the power to unleash a hateful horde, no
one had anything unkind to say about Dr. Rosenberg. The mob had other targets in
mind. The techniques that catapulted Dr. Bhattacharya to power are backfiring
now that he is in power. After years of being told not to trust the medical
establishment, the mob no longer trusts the medical establishment. Today, Dr.
Bhattacharya is the epitome of the medical establishment, and so the mob
directed their rage at him. Dr. Bhattacharya chose this for himself, and he only
has 3.5 more years to go. Perhaps being called “fringe” wasn’t so bad after
all.


2,500 Commentators Agree: Dr. Jay Bhattacharya Has Failed to Earn the Public’s
Trust

Rebuilding trust and honest conversations will all have to wait until Dr. Jay
Bhattacharya and the rest of our medical establishment are out of office.

Jonathan Howard on August 16, 2025

Link 

The classic example of chutzpah is the parable of a boy who murdered his
parents, only to then beg for mercy because he is now an orphan. I was reminded 
of this after reading an article in the Washington Post Dr. Jay Bhattacharya
titled Why the NIH is Pivoting Away From mRNA Vaccines. It said, “As a vaccine
for broad public use, mRNA technology has failed to earn the public’s trust.”

Who could possibly be blamed for that?

While other doctors worked in hospitals, Dr. Bhattacharya made videos that
treated rare, mild vaccine side effects as a fate worse than death. Today, he
using his own efforts to demolish trust as justification for destroying an
entire field of lifesaving, Nobel Prize winning research.

While Dr. Bhattacharya’s article is not worth reading, his rare venture outside 
his safe space unintentionally revealed something very interesting. What’s been 
obvious us to us for years at SBM is now obvious to everyone- Dr. Bhattacharya
has failed to earn the public’s trust. His article had 2,500 comments, and
though I didn’t read them all, I literally saw only a couple people support him.
Everyone knows he’s a naked emperor.

  1. Trust??? What is the objective data for Trust? How about efficacy and saving
    lives? Is that not what vaccines are supposed to do? Save lives. This is
    what happens when we have an NIH director that has never cared for a patient
    in his life. He has appeared on Fox News…the primary criteria to have a
    seat in Trump’s leadership circle.

  2. NIH scientists — the very people tasked with carrying forward the agency’s
    mission — already regard Bhattacharya as incompetent. That internal view is 
    not mere gossip; it aligns with the available data on his public statements,
    policy priorities, and evident lack of focus on actual research excellence.
    His tenure so far has been marked by political maneuvering rather than the 
    cultivation of robust, independent scientific inquiry.

  3. This is like a pyromaniac blaming the fire brigade for failing to have public 
    trust in it’s capacity to prevent conflagration.

  4. Dr. Bhattacharya (who did not pursue residency training and does not
    clinically see patients) is off base. He is not referencing any of the data 
    from when these vaccines rolled out late 2020/early 2021 in which there was 
    drastic reduction in hospitalization and mortality associated with COVID. In
    reviewing his history, he has been on the wrong side of this issue from the
    beginning and his article reflects his own opinions, which are not founded 
    on an evidence based approach. As a practicing internist/hospitalist, I am
    thankful for these vaccines, continue to recommend them to my high risk
    patients, continue to receive them for myself and family annually and am
    hopeful for mRNA technology during future pandemics. This article needs to
    be better fact checked and he should attempt to publish in a peer-reviewed
    journal.

  5. The core problem with Bhattacharya’s argument is that it mistakes public
    opinion for a legitimate scientific compass. The NIH Director’s
    responsibility is — and must remain — to prioritize the advancement of
    science for the benefit of society, not to bend to the shifting winds of
    popular sentiment. If public opinion diverges from the scientific evidence, 
    the Director’s role is to educate, to correct misinformation, and to build
    understanding — not to abandon promising technologies simply because they
    have become politically unpopular.

  6. Pure politics, zero science. What a poor excuse for a scientific opinion.

  7. This author is naive to think that the public’s distrust of mRNA vaccines is
    with these specifically- those who are anti-vax do not care to know the
    difference, this is just a stepping stone for them to attack vaccine
    research and progress in general. The pulling of mRNA vaccines are a great
    first step to start eroding scientific progress indefinitely.

  8. An anti-vaccination apologist says what? It’s not as if anyone thinks he has
    an original, intelligent thought process or valid information to
    disseminate. It’s an apologist piece attempting to explain the
    incomprehensible.

  9. As an infectious disease physician, I cannot believe what I am reading. Dr.
    Bhattacharya asserts that the vaccine “lost credibility,” which is a
    completely non-scientific assertion. The reason it lost credibility is not
    due to the actual performance of the vaccine itself, which in my observation
    was exemplary, but primarily due to a virulent attack campaign by rabid
    anti-vaxxers and political extremists with an agenda. This is a
    revolutionary technology, and in my opinion the rapid rollout of the COVID
    vaccine was about the only worthy thing to come out of the Trump
    administration. The best way I can illustrate my point is the fact that I
    could predict with a great degree of accuracy whether my COVID patients
    would live or die based on their voting history, and consequently whether
    they took the vaccine.

  10. So now the public, not doctors or scientists are the arbiters of which
    vaccines and what therapeutic drugs are available? I was, and remain, so
    very grateful for the mRNA covid vaccine, and I blame the lack of trust on
    the far right, of which this so-called scientist is a representative

  11. “the platform has failed a crucial test: earning public trust” Gee, I WONDER
    WHY!!!!!?????

  12. Science isn’t humility, it’s science. It’s facts, it’s objective and no,
    science isn’t a popularity contest. The public ambivalence that appeared was
    brought on by those who favored personal interests over the public good.
    I’m a physician and know full well that this op-ed does not in any way
    represent the thinking of the scientific community.

  13. The core problem with Bhattacharya’s argument is that it mistakes public
    opinion for a legitimate scientific compass. The NIH Director’s
    responsibility is — and must remain — to prioritize the advancement of
    science for the benefit of society, not to bend to the shifting winds of
    popular sentiment. If public opinion diverges from the scientific evidence, 
    the Director’s role is to educate, to correct misinformation, and to build
    understanding — not to abandon promising technologies simply because they
    have become politically unpopular.

  14. Science has never progressed by surrendering to what is fashionable or
    publicly palatable. If it had, we might still be bloodletting for fevers and
    rejecting germ theory because it was once met with skepticism. mRNA
    technology, like any scientific innovation, should be evaluated on rigorous 
    data about safety, efficacy, and potential, not polling numbers or media
    narratives.

  15. That is exactly why Bhattacharya is the wrong person to lead the NIH. By his
    own framing, he is allowing distrust to dictate scientific priorities rather
    than confronting the distrust with facts, transparency, and educational
    outreach. His emphasis on “public acceptance” as a deciding factor in
    whether to advance a technology reveals a willingness to subordinate
    evidence-based decision-making to political optics. That is not leadership; 
    it is acquiescence.

  16. Science should be driven by what is true, not what is trending.

  17. People don’t trust mRNA vaccines because the people in your adminstration
    spent every waking minute of the last 5 years telling the public they
    weren’t safe! The nonsense in this op-ed is no different than Trump
    undermining federal agencies and then saying govenrment doesn’t work. You
    have no shame.

  18. So Jay B believes scientific progress should be a popularity contest. Rather
    than technology being judged by the scientific merits, we should simply rely
    on opinion polling. That’s bold policy. Let’s see how it works out for
    America.

  19. This is what happens when we have an NIH director that has never cared for a
    patient in his life. He has appeared on Fox News…the primary criteria to
    have a seat in Trump’s leadership circle.

  20. This is like a pyromaniac blaming the fire brigade for failing to have public 
    trust in it’s capacity to prevent conflagrations

  21. Pure politics, zero science. What a poor excuse for a scientific opinion.

  22. This is the standard for scientific research?

  23. Anyone else smell that? I don’t think its mRNA.

  24. I cannot help but think that this is utter nonsense, and I question why the
    Post would even bother publishing it.

  25. My God, WaPo might as well platform flat earthers next.

  26. This is completely false. No reputable newspaper would print this. Why? Why?
    Why?

  27. Robert F. Kennedy Jr., is investing in new vaccine technologies — based on
    whole-virus inactivated vaccines.

  28. New vaccine technologies? This sentence alone tells you the writer does not
    have the most basic understanding of vaccines. I guess Jay doesn’t know how 
    the polio vaccine is made?

  29. Who cares? The public trust was eroded by the maga base

  30. I can think of someone who definitely has not earned the public trust.

  31. Giving MAGA medicine frontpage – the vaccine deniers easily killed 500K of
    their own kind now they want to kill the rest of us. WAPO what are you
    thinking.

  32. For a man who says he “is not here to litigate the past”, he spends a lot of
    time bashing the Biden Administration. I guess that’s what you have to do to
    stay in the good graces of the Trump Administration.

  33. Wait MAGA anti vaccine fundraiser demonize vaccines with tons of
    disinformation and your solution is to do away with vaccines.

  34. How about you make sure the correct vaccine information is out there and do
    what we did before. Run public health campaigns to promote vaccination

  35. This is entirely druid thinking about vaccines and the public. Especially the 
    bottom feeders who mistrust everything they don’t understand.

  36. This author is naive to think that the public’s distrust of mRNA vaccines is
    with these specifically- those who are anti-vax do not care to know the
    difference, this is just a stepping stone for them to attack vaccine
    research and progress in general. The pulling of mRNA vaccines are a great
    first step to start eroding scientific progress indefinitely.

  37. I hope the author has no desire to join debate club, because they would have
    almost no chance at winning any arguments if using such poor and flawed
    logic as in this article.

  38. Science has never progressed by surrendering to what is fashionable or
    publicly palatable. If it had, we might still be bloodletting for fevers and
    rejecting germ theory because it was once met with skepticism. mRNA
    technology, like any scientific innovation, should be evaluated on rigorous 
    data about safety, efficacy, and potential, not polling numbers or media
    narratives.

  39. That is exactly why Bhattacharya is the wrong person to lead the NIH. By his
    own framing, he is allowing distrust to dictate scientific priorities rather
    than confronting the distrust with facts, transparency, and educational
    outreach. His emphasis on “public acceptance” as a deciding factor in
    whether to advance a technology reveals a willingness to subordinate
    evidence-based decision-making to political optics. That is not leadership; 
    it is acquiescence.

  40. People don’t trust mRNA vaccines because the people in your adminstration
    spent every waking minute of the last 5 years telling the public they
    weren’t safe! The nonsense in this op-ed is no different than Trump
    undermining federal agencies and then saying govenrment doesn’t work. You
    have no shame.

  41. So Jay B believes scientific progress should be a popularity contest. Rather
    than technology being judged by the scientific merits, we should simply rely
    on opinion polling. That’s bold policy. Let’s see how it works out for
    America.

  42. What about the millions of people who DO trust the vaccines over horse
    dewormer and raw milk?

Of course, my personal favorite comment was by Eddy Edd.

Dr. Bhattacharya ended his article by saying:

We are entering a new era of public health, grounded not in wishful thinking or 
performative consensus, but in open inquiry and respect for the American
people’s intelligence. The only way to rebuild trust is to earn it — one honest 
conversation at a time.

That last sentence may be right, but rebuilding trust and honest conversations
will all have to wait until Dr. Bhattacharya and the rest of our medical
establishment are out of office.


Jay Bhattacharya’s “plan to drive Gold Standard Science”: A Trojan horse for
“Lysenko-izing” the NIH

Last week, the NIH published a plan to “drive Gold Standard Science.” The plan
cunningly wraps what are obvious Lysenkoist ideological purity tests disguised
as “academic freedom” and “unbiased peer review” in seemingly reasonable
proposals.

David Gorski on August 25, 2025

Link

No matter how hard I try to find other topics to write about, I always keep
coming back to the the extinction-level threat that the current administration
poses to federal programs and infrastructure public health, medicine, and
biomedical research. Some weeks, it’s vaccines, and the antivaccine policies of 
our Secretary of Health and Human Services Robert F. Kennedy Jr. designed to
eliminate access to all vaccines over the course of the second Trump
administration, the decimation of the CDC (not to mention the demonization of
its scientists and workers that led to a deranged antivax gunman spraying the
CDC campus with hundreds of rounds and killing a police officer in the process).
Other weeks, it’s turmoil at the Food and Drug Administration as a result of
the evidence-based medicine methodolatry weaponized against vaccines colliding
with right-to-try, the overarching deregulatory agenda of this administration,
and anything having to do with the “make America healthy again” (MAHA) movement.
This week, it happens to be the continued dismantling of the crown jewel of US 
biomedical research, the National Institutes of Health, fronted by the utterly
unqualified COVID-19 contrarian turned antivax-friendly useful idiot for RFK Jr.
and Office of Management and Budget Director Russell Vought, NIH Director Dr.
Jay Bhattacharya, or, as both Angela Rassmussen and I like to call him, the new 
Trofim Lysenko.

You might ask: What fresh hell is this, hot on the heels of President Donald
Trump’s executive order putting political appointees firmly in charge of
deciding who gets NIH grants? Simple. This week it’s a hidden blueprint for how 
such power will be exercised. On Friday, Dr. Bhattacharya announced the new NIH 
“plan to drive Gold Standard Research“:

🥇 Today, NIH has released its implementation plan for incorporating gold
standard science into everything we do.The plan incorporates the 9 tenets of
gold standard science adopted by the U.S. Government and aligns with @HHSgov’s
framework for achieving these principles.… pic.twitter.com/BHUAmOMKYU

— Jay Bhattacharya, MD, PhD (@NIHDirector_Jay) August 22, 2025

The first thing you’ll note is that, on the surface at least, all of these
bullet points sound totally unobjectionable and obvious. Those of us who have
applied for and participated in writing NIH grants for submission for many
years, as well as served on study sections, will immediately note that pretty
much all of these bullet points describe pre-existing NIH initiatives going back
decades designed to encourage more scientific rigor, generalizability, and
reproducibility in research projects funded by the NIH. You might therefore ask:
What’s the big deal? The answer is, of course, in the details, where, as we all
know, the Devil resides, as anyone who undertakes a critical reading of the
16-page PDF of the document will note. Much of this new plan is, as I said,
relatively unobjectionable. It’s what is buried in this plan that leads me to
view it primarily as a Trojan horse designed to turn NIH-funded research into
Lysenkoism 2.0, at least in any area in which right-wing politics leads to
science denial, particularly vaccine research, anything related to the MAHA
agenda, pandemic preparedness, and public health. That’s why I won’t spend a lot
of time discussing the OK bits. Instead, because I love mixing metaphors
ironically, I will use my usual manner of breaking such documents down, taking
advantage of one of my favorite movies of all time, The Good, the Bad, and the
Ugly, except that it’ll probably be just two divisions: The Good, followed by
The Bad and The Ugly.

But first, an overview.

“Gold Standard Science”: A meaningless platitude

After the title page, anyone reading this plan will be immediately faced
with…platitudes:

I can’t help but laugh when I see a co-author of the Great Barrington
Declaration pontificate on “gold standard science.”

While Dr. Bhattacharya is correct to point out that the NIH has long championed 
rigorous science, the immediate question anyone reading this document should ask
is: What is Dr. Bhattacharya proposing under the administration buzzword of
“Gold Standard Science” that is different from what the NIH had long been doing 
to improve the scientific rigor and reproducibility of the research it funds
dating back to decades before Dr. Bhattacharya had emerged from the primordial
soup of COVID-19 contrarian narratives to proclaim himself a free speech martyr,
just because the “let ‘er rip” natural herd immunity approach to the pandemic
codified in his “Great Barrington Declaration” was correctly and roundly
criticized by real public health physicians and scientists? Reading this
document, my feeling was a lot like what the late great Harriet Hall used to say
about naturopathy, and I’ll paraphrase a bit to make the analogy fit: What is
good about this plan is not unique (or new) to the administration’s “Gold
Standard Science,” and what is new or unique in this plan is not good.

The first tell that this document is explicitly based on President Trump’s
executive orders on “Gold Standard Science.” In the first paragraph, we read:

In 2025, the Executive Order (EO) on Restoring Gold Standard Science and Agency 
Guidance for Implementing Gold Standard Science in the Conduct and Management of
Scientific Activities directed NIH and other federal agencies to implement
principles of gold standard science in the conduct and management of all aspects
of their scientific activities. NIH strives for scientific excellence and
welcomes the opportunity to reaffirm its continued commitment to this goal. In
response to the EO and guidance, and in accordance with its continued commitment
to promoting the highest standards of scientific integrity, NIH has developed
this inaugural plan to highlight success and provide a roadmap for the future.
What follows is a description of exemplary policies, activities, and initiatives
across NIH that demonstrate the agency’s commitment to the tenets of gold
standard science.a

Again, let’s peruse the nine supposed characteristics of “Gold Standard
Science”:

  1. Reproducible

  2. Transparent

  3. Communicative of Error and Uncertainty

  4. Collaborative and Interdisciplinary

  5. Skeptical of Its Findings and Assumptions

  6. Structured for Falsifiability of Hypotheses

  7. Subject to Unbiased Peer Review

  8. Accepting of Negative Results as Positive Outcomes

  9. Without Conflicts of Interest

Let’s see if you can spot the problematic characteristics. The thing to
remember, of course, is that all of these characteristics can only be
unobjectionable if you ignore everything that the administration has been doing 
since President Trump took office again in January. If you keep in mind the
cancelation of grants that the administration finds ideologically objectionable 
due to “DEI,” Dr. Bhattacharya’s appeals to “academic freedom” to attack his
science-based critics (even labeling yours truly as a “threat to science” in the
process), the ideology-based cancellation of $500 million for mRNA vaccine
research, and everything else that led me (and others) to label this
administration’s science policies as “Lysenkoism 2.0,” then certain of these
characteristics (e.g., #3, #4, #5, #7, and #9) start sounding, to varying
degrees, more ominous.

However, before we get to the ominous parts of this plan, which can be viewed as
the Greeks within the Trojan Horse, let’s look at the actual Trojan Horse
itself hiding the invading force.

Of course, those who’ve seen the movie know that “The Good” represented by Clint
Eastwood’s character isn’t actually that good.

“Gold Standard Science”: The “good” (sort of)

Perhaps the best example of the unobjectionable bits of the plan appear in the
first point, that science be reproducible. The plan correctly points out that
reproducibility and replicability are not the same thing. In brief,
reproducibility means that multiple investigators using different methodology
can test a hypothesis and reliably come to the same conclusions, either refuting
or supporting the hypothesis, while replicability means that different
researchers using the same methods produce the same results. Over a page of this
14-page document—which is the actual page count if you remove the title page
and the splash page reproduced above—is devoted to describing past efforts of
the NIH to improve reproducibility in the research that it funds, and describes 
what the NIH already does today:

Importantly, NIH believes that making the results of NIH-funded research
available is key to advancing transparent, rigorous, and reproducible research, 
as illustrated by its Data Management and Sharing Policy, Genomic Data Sharing
Policy, Public Access Policy, Dissemination of NIH-Funded Clinical Trial
Information Policy, and other sharing policies. To ensure NIH supported data are
generated in accordance with the highest standards, NIH trains and supports
researchers in their gold-standard data sharing efforts, such as advancing FAIR 
(findability, accessibility, interoperability, and reusability) data principles.
NIH also maintains a robust modern data resource ecosystem made up of
biomedical data repositories and knowledge bases, including a repository of
common data elements (CDEs) to standardize the way data is collected and make
data from different studies more interoperable. NIH also funds databases of
standard data elements for specific areas of biomedical research, such as
genomics. Moreover, TRUST (Transparency, Responsibility, User Focus,
Sustainability, and Technology) principles are emphasized in the data resource
ecosystem to build trustworthiness and ensure long-term accessibility.
Maintaining scientific data in publicly accessible repositories facilitates
replication and supports reproducibility.

Sounds pretty good, right? So what will Dr. Bhattacharya add to these efforts?
This:

NIH continuously seeks new strategies for advancing reproducible and replicable 
biomedical approaches, and is planning to develop new, targeted funding
mechanisms and programs that foster culture change across the research
enterprise. NIH is planning new efforts to support reproducing and replicating
data and research results, including those focused on sharing negative or null
results. NIH is also identifying areas in which more tools are needed to deliver
replicable, translatable, and efficient results such as human-based research
technologies and expansion of efforts of the Interagency Coordinating Committee 
on the Validation of Alternative Methods (ICCVAM).

Programs throughout NIH are also working to incorporate research specific
priorities focused on rigor to strengthen translatability of research outcomes. 
For example, NIH is developing Reproducibility and Integrity Guidance to
Optimize Research (RIGOR) for Dietary Supplements to strengthen the experimental
design and methodological rigor applied in NIH-funded dietary supplement and
related nutrition research. A current challenge in this area of research is
limitations in research comparability and translatability when the information
characterizing a natural product is incomplete. The RIGOR for Dietary
Supplements activities may include creating best practice guidance and training 
resources, prioritizing research funding opportunities, or enhancing the review 
of NIH grant applications.

Again, the Devil resides in the details. The first paragraph lists fairly
unobjectionable ideas—and, make no mistake—these are just ideas and outlines,
rather than anything resembling an actual specific plan—to improve
reproducibility and replicability. Of course, one problem with this is that the 
current NIH budget is very much a zero-sum game, given the proposed massive cut 
(40%) in the administration’s budget request; so any resources shifted to just
reproducing past work will harm efforts to forge ahead with new research.

The second paragraph gives away the game. We at SBM have long discussed how
lacking the evidence is for most supplements and how the DSHEA of 1994 basically
allowed supplement manufacturers close to free rein to make bogus health claims
for supplements. If the people in charge of applying the RIGOR activities to
NIH funding decisions were science-based investigators, rather than what is more
likely, MAHA aficionados appointed by RFK Jr. to promote the non-evidence-based
and non-science-based use of supplements, I’d have no problem with this.
However, having watched RFK Jr. for over two decades, I am under no illusions
that those in charge will actually make sure that actual rigorous science is
applied to supplements research. It’s also pretty telling that the one specific 
example that Dr. Bhattacharya chose is supplement research. I’d love to be
proven wrong but, sadly, don’t think that I will be.

As for the metrics to determine success? The plan includes a sample evaluation
planning table for this “tenet.” Amusingly, it includes as outcomes tracked:

NIH funded studies have clear, standardized, and justifiable protocols;
comprehensive documentation; robust statistical methods; adequate sample sizes; 
validated methodologies; and appropriate controls.

Presumably Dr. Bhattacharya already has these metrics for NIH grants funded over
the last, say, two or three years, right? No? Then how does he know it’s a
problem? Moreover, the outcomes listed above are criteria for peer review; if
there’s a problem with NIH grants not meeting the standards above, then it’s the
peer review system that’s the problem. Personally, though, having served on NIH
study sections, I’ve never seen a grant garnering a fundable score that lacks
in any of the “outcomes” that Dr. Bhattacharya wants to track. I realize this is
just anecdotal experience, but if this were really a problem I do think that
I’d have seen at least one grant garner a fundable score while lacking in one or
more of the criteria listed above.

Similarly, the section on transparency is mostly unobjectionable. Once again,
the plan spends a lot of verbiage discussing what the NIH already does to
promote transparency in research funding decisions, including funding the
National Library of Medicine and PubMed, RePORTer (a searchable database of all 
NIH-funded research dating back to 1985), as well as ClinicalTrials.gov, all
programs that have been around for many years. So what can Dr. Bhattacharya add?
Not much. Dr. Bhattacharya touts “”the development of a Common Form “”working
with its federal partners to provide consistency in reporting research and
financial disclosures through the adoption of a Common Form” and requiring the
adoption of Animal Research: Reporting of In Vivo Experiments (ARRIVE)
guidelines, which basically just require more rigorous statistics to be used in 
animal experiments. In other words, this is all pretty incremental and
unremarkable.

I’m going to skip ahead to #6, “structured for falsifiability of hypotheses,
because, as you will see, #3 and #4 are problematic. The plan first notes prior 
efforts, of which anyone who’s ever written an NIH grant application in the last
decade or two will already be aware:

As stated in the Reproducible section, NIH updated its grant application and
review processes to enhance the reproducibility of research findings through
increased scientific rigor and transparency. This policy requires grant
applications to clearly outline, and be evaluated on, 1) the rigor of the prior 
research, 2) rigorous experimental design for robust and unbiased results, 3)
consideration of relevant biological variables, and 4) authentication of key
biological and/or chemical resources. Increasing emphasis on these areas
clarified NIH’s long-standing commitment to funding the best and most rigorous
science and ensured that all grant applications were held to the same gold
science standard. NIH resources and training on rigor and reproducibility help
researchers design research questions, hypotheses, and experiments to 1) allow
for rejection after thorough testing and evidence generation, and 2) support
reviewers in their fair and consistent evaluation of grant applications.

In addition to NIH’s FY23 updates to its Guidelines and Policies for the Conduct
of Research in the IRP—which emphasizes the importance of research records
documenting the entire research process from formulating research questions and 
hypotheses to interpreting data—NIH also provides training on the Responsible
Conduct of Research (RCR). To bolster the significance of RCR principles in the 
next generation of scientists, all NIH intramural researchers are required to
participate in ongoing RCR training, and all NIH research training programs are 
required to consider including instruction on RCR.

Again, all of this is old hat. So what does Dr. Bhattacharya add? Not much:

In FY25, FDA and NIH launched the Modernizing Research and Evidence (MoRE)
Glossary for more than 40 clinical research terms and definitions used to
describe design, methods, analysis, and interpretation of innovative clinical
study designs, including studies using real-world data for FDA-regulated medical
products (i.e., drug, device, or biologic). The goal of this collaboration is
to facilitate efficient, rigorously-designed clinical studies of drugs, devices,
and biological products. By providing consensus for terms and definitions, this
glossary promotes communication and the use of specific terms allowing for more
effective falsifiability of hypotheses. FDA and NIH will continue to
collaborate and explore opportunities to build out this effort and develop
additional consensus definitions for clinical research terms to aid in the
innovation of clinical study designs that support scientific, patient, clinical,
and regulatory decision-making.

That’s all very…nice. Basically, MoRE is a glossary of terms. Admittedly, it’s a
highly useful glossary of terms, but it’s basically a glossary of terms. How,
exactly, this will contribute to more rigorous science is not entirely clear to 
me. Sure, having a common dictionary can facilitate communication between FDA
and NIH, but will that necessarily lead to more rigorously designed and
conducted clinical trials? I don’t know. I do know, however, that it depends on 
how the glossary is used and operationalized, and I have little faith in Dr.
Bhattacharya and the other RFK Jr. sycophants, toadies, and lackeys who are
increasingly running the NIH.

Another issue is that the NIH doesn’t usually fund clinical trials used by
companies and sponsors in their applications for FDA approval; rather, the NIH
tends to fund preclinical research and earlier stage clinical trials that
provide the evidence base for the larger phase 3 clinical trials used for FDA
approval. More importantly, this program was developed before Bhattacharya took 
over. It’s something that the NIH was already doing. It’s all well and good that
Dr. Bhattacharya has adopted it, but I can’t help but get the feeling that he’s
trying to claim ownership of something that he had nothing to do with
developing.

Now let’s move on to #8, “Accepting of Negative Results as Positive Outcomes.”

This is by far the shortest section of the plan and is, from my reading, quite
the nothingburger. All Dr. Bhattacharya does is to mention existing efforts
started before his tenure to put raw data into data repositories to be shared
and analyzed by other scientists, to encourage the reporting of negative
results, and the NIH PrePrint Pilot program, which is designed to encourage the 
sharing of NIH-supported research as preprints by indexing preprints in PubMed
and including them in PubMed Central (PMC). What does Dr. Bhattacharya add to
this?

Not much:

In FY24, NIH released a Request for Information on Potential Solutions for
Reducing Publication Bias Against Null Studies to solicit public input on the
barriers and solutions to reducing publication bias (i.e., the preferential
dissemination of statistically significant or otherwise exciting studies) in
biomedical research. After reviewing the responses received, NIH plans to launch
new, ground-breaking initiatives to solve this multi-faceted issue

That’s right. Dr. Bhattacharya is just going to analyze the answers solicited as
part of an initiative started under the previous administration. Outstanding,
particularly the way that he appears to be claiming the initiative as his own.

That’s it for the “Good.” As you can see, these initiatives were all started
under prior regimes running the NIH, represent nothing new or groundbreaking,
and are incremental. There’s nothing wrong with incremental improvements and
tinkering with existing regulations and procedures in order to develop systems
that encourage more rigorous science. That is actually a good thing! The problem
is that, like President Trump, Dr. Bhattacharya is representing this stuff as
though it were “new” and “groundbreaking.” It’s not. Unfortunately, what might
be “new” and “groundbreaking” is not good.

Here we go again…

“Gold Standard Science” The Bad and The Ugly

It didn’t take me long to note that five out of the nine characteristics of
“Gold Standard Science” (#3, #4, #5, #7, and #9) have…problems. Unsurprisingly, 
those problems involve clear hints of ideological capture of the science that
the NIH will fund, and it isn’t even subtle. In other words, the shell of the
Trojan Horse consisting of incremental building upon efforts to improve
scientific rigor started during previous administrations hides a whole bunch of 
invaders patterned after Lysenkoism.

Let’s start with #3, “Communicative of Error and Uncertainty,” which contains
the first big “tell” of the document. After an introduction that, once again,
discusses prior efforts by the NIH to ensure scientific rigor and communicate
uncertainty in results, Dr. Bhattacharya’s plan goes where I always knew it
would go:

NIH policies have always supported the public dissemination of research.
However, academic freedom matters most in cases where scientists are pursuing
evidence that may be perceived as inconvenient or objectionable. By prioritizing
academic freedom across the agency, NIH is working to strengthen public trust.

NIH is drafting a new chapter on gold standard science for the 2025 revision of 
the comprehensive collection of Guidelines and Policies for the Conduct of
Research in the IRP. NIH is also embarking on a review of policies and practices
within its IRP to further promote academic freedom to ensure NIH scientists are
guaranteed the freedom to engage in open, academic discourse without fear of
official interference, professional disadvantage, or workplace retaliation.
Critical evaluation of evidence and a willingness to challenge the conventional 
thinking are essential for ensuring scientific rigor, meaningful results, and
communication of those results. NIH continues to encourage scientists to freely 
communicate their scientific findings to the public and through scientific
journal publications, reports, and conferences. NIH is exploring plans to shift 
its process for scholarly works from approving scientific content or findings to
reviewing exclusively for policy and regulatory compliance. Processes around
media engagement are also being modified to ensure preservation of academic
freedom.

The very same sort of language appears in #5, “Skeptical of Its Findings and
Assumptions”:

Critical to this tenet and referenced previously, NIH has announced a new,
comprehensive review of policies and practices within its IRP to ensure that
academic freedom is the rule, and not the exception. Academic freedom allows
scientists to freely express skepticism of findings and propose alternate views 
and methods. NIH will also ask scientists to evaluate and critique the efficacy 
of agency policies through a new Pilot NIH Science of Science Scholars Program. 
This program provides the opportunity for experienced “science of science”
researchers to analyze internal NIH administrative data to evaluate NIH’s
contributions and impact to biomedical research, optimize NIH’s investments, and
ensure scientific quality, rigor, and reproducibility.

Longtime readers of this blog and anyone who’s paid attention to ideological
science probably saw a whole bunch of red flags in the passage above. After all,
“academic freedom” in the parlance of people like Dr. Bhattacharya became a
tactic to deflect legitimate scientific criticism of bad science favored by the 
right. If you correctly criticized, for instance, the Great Barrington
Declaration, the manifesto backed by the right wing “free market” think tank
American Institute for Economic Research (AIER) that advocated a “let ‘er rip”
approach to the pandemic in 2020 in order to reach “natural herd immunity”—with 
a poorly thought out suggestion for the “focused protection” of high risk
groups—a plan not based in science that would lead to more death and disability 
than necessary and never would have worked, you were framed as attacking the
“academic freedom” of COVID contrarians like Dr. Bhattacharya, one of its
co-authors. If you criticized Dr. Bhattacharya too harshly, you were to him a
“threat to science” and were trying to “cancel” or “silence” him, rather than a 
scientist criticizing what he viewed as bad science. Of course, my being in any 
way a “threat” to Dr. Bhattacharya or ever having had the power to “silence” him
is rather belied by the simple fact that he is now the NIH Director and I am
just a lowly professor of surgery at a solid mid-tier medical school and the
managing editor of a popular, but not COVID-19 contrarian Substack-level
popular, blog.

This framing had the advantage of allowing Dr. Bhattacharya to falsely portray
himself as a persecuted hero of intellectual and academic freedom, while, now
that he’s in charge, behaving more like Trofim Lysenko and purging the NIH of
any science related to COVID-19 vaccines, “DEI,” transgender medicine, or
anything else that the administration doesn’t like and encouraging research into
any old pseudoscience that RFK Jr. wants in the name of MAHA. Let’s just put it
this way. What sort of reaction do I expect if and when scientists who actually
know what they are talking about criticize research being done at NIH regarding
antivax priorities, such as investigating the nonexistent “link” between
vaccines and autism. Color me…skeptical…that Dr. Bhattacharya will react well to
that or protect those who voice their concerns about the NIH agenda being
hijacked by MAHA pseudoscience. After all, his history of anger and whining in
response to criticism of his failed predictions that we’ll have “natural herd
immunity” in 3-6 months tell us how he will react to criticism now that he is no
longer an insurgent contrarian but is now solidly a leader of the medical
establishment.

But, hey, Jay might prove me wrong, and I’d be happy to be proven wrong. I just 
don’t expect it, because it’s incredibly unlikely.

Think I’m being too harsh? Let’s look at #4, “Collaborative and
Interdisciplinary.” Who could object to that? Also, the NIH has long favored
grant applications that propose research that involves multiple disciplines and 
collaborations. this is nothing new. The actual agenda can be gleaned very
easily from the actual proposal of what Dr. Bhattacharya is doing now:

To further maximize the opportunity for cross-agency collaboration, NIH plans to
launch new collaborative initiatives that directly address urgent research and 
health issues of today. In May 2025, NIH announced a landmark partnership
between NIH and the Centers for Medicaid and Medicare Services (CMS) to enable
research around the root causes of autism spectrum disorder. In collaboration
with the HHS Office of the Chief Data Officer and partner agencies including
CMS, ARPA-H, CDC, and FDA, NIH is building a Real World Data Network that will
support initiatives to study autism, chronic disease, and other key public
health concerns. NIH will also join the U.S. Food and Drug Administration (FDA) 
to form the Nutrition Regulatory Science Program, a joint innovative research
initiative to implement and accelerate a comprehensive nutrition research agenda
to inform effective food and nutrition policies to help make Americans’ food
and diets healthier. NIH also intends to prioritize and fund human-based
research technologies and expand the efforts of the multi-agency ICCVAM.

Yes, the document is referring to the initiative announced by RFK Jr. in April
in which he promised to investigate the “environmental” causes of autism and
have a report out by September, which is—yikes!—next month. True, he has fudged 
the promised date a bit, and I don’t know if there will actually be a report in 
September, but I do know this: Given that the initiative is headed by David
Geier, a longtime antivax “researcher” best known for working with his late
father Mark as part of a father-son antivax team promoting the use of puberty
blocking drugs and chelation therapy to treat “vaccine-induced autism” and
playing a major role in developing the antivax playbook for “proving” falsely
that vaccines “cause autism,” there is no doubt in my mind that whatever report 
comes out whenever, it will conclude that the main autism is vaccines, all the
evidence showing that vaccines are not associated with increased autism risk be 
damned. Moreover, I’m not even discussing the parts that are clear MAHA
involving diet, exercise, and chronic disease. Basically, “collaborative and
interdisciplinary” in this context appears to involve collaborating with cranks 
in other disciplines who have no relevant expertise in the topic of the research
grant, as long as this “collaboration” occurs in research efforts designed to
prove whatever RFK Jr. wants proven.

Let’s move on to #7, “Unbiased Peer Review.” One is tempted here to ask what Dr.
Bhattacharya means by “unbiased.” I like to point out that in any human
endeavor involving evaluation of a proposal, there is no such thing as
“unbiased.” As human beings, we all have biases; all we can do is to construct
systems that minimize the effects of the preexisting biases of reviewers.
Unfortunately, for all the appeals to “unbiased peer review” and “gold standard 
research,” I remain unconvinced that this is really what Dr. Bhattacharya is
about because it is clear that coming as close as possible to truly “unbiased
peer review” is not what the administration or RFK Jr. is about. For example,
the plan states:

Peer review at NIH proceeds via a two-tiered system involving initial peer
review for scientific and technical merit and subsequent review by National
Advisory Councils or Boards that recommend applications for funding, with
consideration of the funding ICO mission and research priorities. Both levels of
the NIH peer review process involve the consistent application of standards and
procedures that produce fair, equitable, informed, and unbiased examinations of
grant and cooperative agreement applications to NIH (see section 492 of 42
U.S.C 289a (Public Health Service Act) and Federal regulations).

This is basically true. There are two levels of evaluation of grant applications
before funding decisions are made. There is the study section level, in which
committees known as study sections review grants and assign them a priority
score based on scientific merit. Then there is the council review, where the
actual funding decisions are made. Before Trump, RFK Jr., and Bhattacharya,
these decisions by the Advisory Councils were mostly a rubber stamp of what the 
peer reviewers in the study sections did. Basically, funds from each Institute
or Center would be allocated starting with grants with the very best scores and 
then the next best, all the way down until the money ran out. Given the current 
funding levels at NIH, in recent years that tended to mean that the top 10% or
so of grant applications would be funded.

So what is Dr. Bhattacharya going to add to this? Not much, but it is
nonetheless disturbing if you know some background. I’ll simply quote first, to 
see if you can detect the problem, and then I’ll give you that background that
leads me to be very worried:

In March 2025, NIH announced a new plan to centralize the initial peer review
process for all applications for grants, cooperative agreements, and research
and development contracts solely within CSR. Centralizing peer review will make 
NIH review more efficient and minimizes appearance of preferential treatment
depending on which IC manages review.NIH is also developing a Conflict of
Interest (COI) tool for NIH staff charged with screening potential reviewers
that gathers publicly available information such as authors on publications and 
patent holders in combination with data already in NIH systems. This tool will
allow staff to more thoroughly vet reviewers for potential COIs before making
assignments to specific applications. In addition, NIH has an active Review
Integrity Committee which will host interactive workshops on specific review
integrity topics tailored to address current issues.

CSR is the Center for Scientific Review and is the part of the NIH that runs the
study sections that review incoming grant applications. You might reasonably
ask: What the heck does that even mean. For that you have to look at the actual 
March proposal:

The new centralization effort will apply to the first stage of the review
process. NIH’s CSR, which was established in 1946 to manage the scientific
review of NIH grant applications and to ensure independent, expert review free
from inappropriate influence, currently manages the peer review process for more
than 78% of NIH grants. The remaining 22% are reviewed in study sections within
23 ICs, each operating separately with its own administrative and support
overhead. The proposed consolidation would eliminate the IC-based study sections
so that CSR conducts all first-level review.

According to an analysis of FY24 data, CSR uses 0.3% of the NIH budget to review
more than 66,000 applications annually. In comparison, review costs in the ICs 
average about 300% of CSR’s costs.

On the surface, that sounds reasonable. On the surface. Again, you have to
remember what’s been happening at NIH. Last month, the NIH “disinvited” a large 
number of scientists who had been invited to serve as Advisory Council members
by the last administration and had been selected using a process in place for
decades.

Worse:

NIH staff members have been instructed to nominate replacements who are aligned 
with the priorities of the administration of US President Donald Trump — and
have been warned that political appointees might still override their
suggestions and hand-pick alternative reviewers.

You see where I’m going, right? If not, let me just bring it home a bit more,
quoting the same story:

Nature has learnt that, as a result, some staff members are screening
candidates’ social-media presences to check whether they have expressed negative
views about the Trump administration or been involved in diversity, equity and 
inclusion (DEI) efforts — a topic targeted by the president — at their
institutions.

Now, do you get it?

If not, let me quote from a recent executive order that I discussed two weeks
ago in which President Trump, in essence, put the final control of NIH grant
funding decisions in the hands of political appointees, something that’s never
been done before. Political appointees have been in charge of NIH before, but
there is a longstanding practice that grant review and grant funding decisions
be as apolitical as possible. Not anymore:

Nothing in this order shall be construed to discourage or prevent the use of
peer review methods to evaluate proposals for discretionary awards or otherwise 
inform agency decision making, provided that peer review recommendations remain 
advisory and are not ministerially ratified, routinely deferred to, or otherwise
treated as de facto binding by senior appointees or their designees.  Further, 
nothing in this order shall be construed to create any rights to any particular 
level of review or consideration for any funding applicant except as consistent 
with applicable law.

As I wrote when I first saw this EO, while it is possible to read this EO in a
way that doesn’t sound too horrible (with difficulty), to me such a view is
whistling past the graveyard of US science. This EO is basically the
formalization of what I’ve been calling the science and medical policies of this
administration: Lysenkoism 2.0. Taken in the context of this recent EO and the 
“disinvitation” of scientists “not aligned with administration priorities” to
serve on Advisory Councils, I find it very difficult not to view this “plan”
from Dr. Bhattacharya to centralize peer review to eliminate the 22% of grants
not reviewed in CSR as cut from the same cloth, designed to bring all peer
review and grant disbursement completely under the control of political
appointees. (Old NIH hands, please, tell me I’m wrong here. Tell me I’m
misunderstanding and why. I don’t think I am, though.)

Finally, let’s look at #9, “Without Conflicts of Interest.” Again, this proposal
sounds pretty innocuous on the surface. However, if you consider RFK Jr.’s
ranting about “conflicts of interest” in which anyone who disagrees with him
must be in the thrall of Big Pharma (a.k.a. the “pharma shill” gambit), it’s not
difficult to see this particular requirement being used selectively deny NIH
funding to scientists it doesn’t like. For example, one can easily see any COI
involving a pharmaceutical company as being a negative, while, again in the
spirit of MAHA, a COI involving supplements, “functional medicine,” or any other
pseudoscience that RFK Jr. likes would be overlooked.

Lysenkoism 2.0 is here

As I come to the end of my discussion, I keep wondering whether Dr. Bhattacharya
really believes that what he is proposing will genuinely improve the scientific
rigor of the research projects funded by the NIH (e.g., he’s a useful idiot for
the Trump administration, RFK Jr., and OMB Director Russell Vought whose sense 
of grievance and desire for retribution against the critics whom he views as
enemies who unjustifiably “canceled” him has led him to destroy what’s left of
his reputation by signing on to be the face of the Lysenkoization of the NIH.
The other possibility is that his sense of grievance at what he views as unfair 
criticism and his self-image as a free speech martyr led him to sign on
enthusiastically; i.e., that he is down with the entire Trumpian project with
respect to US science. I don’t know

Whatever the case, there is no longer any doubt that Lysenkoism 2.0 is here in
the US with a vengeance (literally). The characteristics are undeniable, and Dr.
Bhattacharya appears to have little or no problem with any of them, although he
does appear to have just enough shame left to try to disguise what is really
going on. In any case, in the new NIH, just as occurred in the USSR under
Lysenko for three decades, ideology trumps science, scientists not buying into
the new scientific dogma lose favor and funding and even risk being fired, while
scientists who toe the line and do research that produces results “aligned with
administration priorities) will be rewarded. As before, I can’t help but think 
that I predict that RFK Jr., acting as the willing tool of President Trump and
aided by useful idiots like Dr. Bhattacharya, will change the process by which
research grants are issued by the NIH to resemble less scientific peer review
and more political patronage, in which political appointees pull the strings and
peer review is just “advisory.”

There is a longstanding view among science-denying conspiracy theorists that the
NIH decides on the scientists to whom it wards grants based not on rigorous
peer review, but more through a process of patronage, a corrupt process that
resembles something out of The Godfather, in which the leader doles out favors
as a reward for services and loyalty, rather than an unbiased process that
rewards merit in science. Of course, as I said two weeks ago, every accusation
is a confession, and it is therefore not surprising that the new administration 
appears intent on turning the NIH grant process into a form of Lysenkoism that, 
like the old Lysenkoism, rewards political correctness over science and punishes
dissent, Dr. Bhattacharya’s performative claims to want to promote “academic
freedom” notwithstanding. I’m also sure that, RFK Jr. being RFK Jr., and Donald 
Trump being Donald Trump, there will be a lot of grift added, making the
comparison to The Godfather even more appropriate.

I fear that the damage already done in a mere six months is so great that I will
not live long enough to see it repaired, and what’s left of my science career
certainly won’t last long enough to have any hope of its correction.

What the Trump Administration apparently thinks the process of awarding grants
islike. Ironically, this appears to be exactly what they want to turn the NIH
grant awardprocess into, just substituting President Trump for the Godfather.


Goodbye to Focused Protection. Jay Bhattacharya’s Latest 1-Page Pandemic “Plan” 
is for Vulnerable People to Stop Being Vulnerable.

Jay Bhattacharya’s new “plan” is really an admission that if there’s a new
pandemic, he’s not competent enough to do any of the incredible things he “would
have” done regarding COVID. He’s not even going to try.

Jonathan Howard on November 21, 2025

Link


What they’re doing is incredibly damaging to our level of preparedness in the
U.S.

If you want to lose some sleep, here are three articles about the current state 
of pandemic preparedness that will keep you up at night.

What Would Happen to Americans in a Bird Flu Pandemic?

The Trump administration has pushed out seasoned public health officials across 
the government, including firing (and then partially rehiring) even more CDC
staff just last month. Secretary Kennedy has severely undermined the credibility
of the Advisory Committee on Immunization Practices and announced changes to
vaccine recommendations via social media. The national security office charged
with preventing and responding to biological threats has, once again, been
eliminated, along with the pandemic office established by Congress to prepare
the United States to respond to biological threats. The US Department of Health 
and Human Services (HHS) has also canceled investments in mRNA vaccines, a
platform that would allow rapid development and scale up of vaccine
manufacturing in a pandemic.

Meet The Anti-Vaccine Activist Who Could Lead the Response to the Next Pandemic

Historically led by doctors, military officers or career public health
officials, the Administration for Strategic Preparedness and Response (or ASPR, 
pronounced “Asper”) is now being directed instead by John Knox, a firefighter
turned anti-vaccine conspiracy theorist with no background in management or
public health.

Six current and former senior Health and Human Services Department officials
told MSNBC that in elevating Knox, HHS Secretary Robert F. Kennedy Jr. has
placed an unqualified activist atop one of the federal government’s most
critical health agencies…

Those HHS veterans described ASPR under Knox as adrift: Experienced scientists
and senior staff members have left or been pushed out; key roles in the agency
have been filled with conspiracy theorists and advocates of false Covid
treatments; and hundreds of millions of dollars in mRNA research contracts have 
been canceled, without good reason.

The Pandemic Next Time

In the past 10 months, President Donald Trump’s secretary of the Department of
Health and Human Services (HHS), Robert F. Kennedy Jr., has abruptly dismantled 
those efforts—along with parallel initiatives to spot emerging viral threats.
Cuts to specific programs are difficult to track. But it’s clear that more than 
$1 billion in drug and vaccine development investments have been scuttled and
more than $1 billion in anticipated funding is in limbo. “What they’re doing is 
incredibly damaging to our level of preparedness in the U.S.,” says virologist
Cristina Cassetti, who helped oversee what for years has been the world’s
largest portfolio of pandemic preparedness R&D at the National Institute of
Allergy and Infectious Diseases (NIAID) until she quit in April. “The U.S. is
leaving a huge gap”…

To develop vaccines against the flu threat, the U.S. turned to the technology
that changed the course of the COVID-19 pandemic: mRNA. Operation Warp Speed,
the multibillion-dollar crash program that Trump championed during his first
term, delivered mRNA vaccines to market 11 months after SARS-CoV-2 was
identified, faster than many experts deemed possible. That speed made mRNA an
exciting tool for combating pandemics. “If you’re trying to beat the raging fire
of a new epidemic, there’s nothing even close,” says Cassetti, who is now a
consultant to CEPI. In June 2024, BARDA awarded Moderna up to $176 million to
speed development of mRNA vaccines against H5N1. This January it announced it
would give Moderna up to $590 million more to develop products against five
other menacing subtypes of avian influenza viruses.

In May, however, HHS notified Moderna that BARDA was canceling the contracts.
“After a rigorous review, we concluded that continued investment in Moderna’s
H5N1 mRNA vaccine was not scientifically or ethically justifiable,” an HHS
spokesperson said in a statement. The technology “remains undertested,” it said,
and Biden’s administration had “concealed legitimate safety concerns from the
public”—language that echoes Kennedy’s frequent criticisms of mRNA vaccines.

Three months later, HHS announced BARDA was beginning a “coordinated wind-down” 
of mRNA vaccine development, terminating 22 projects that totaled nearly $500
million in investments. “the mRNA platform is no longer viable,” said NIH
Director Jayanta “Jay” Bhattacharya.

Of course, we can do more than speculate about how our current medical
establishment might handle a future pandemic, we can examine their actual track 
record regarding measles, pertussis, flu, and COVID.  It’s not pretty. Instead
of protecting the vulnerable, they’ve deliberately left them exposed.

Today, the COVID vaccine for healthy children and healthy pregnant women has
been removed from @CDCgov recommended immunization schedule. Bottom line:
it’s common sense and it’s good science. We are now one step closer to realizing
@POTUS’s promise to Make America Healthy Again. pic.twitter.com/Ytch2afCLP

— Secretary Kennedy (@SecKennedy) May 27, 2025

During high transmission times, older people should be offered home delivery of 
groceries and other essentials.

With this harsh dose of reality firmly in mind, we can rewind to October 2020,
the signing of the Great Barrington Declaration (GBD). Although it was just a
1-page document written under the watchful eye of a pro-tobacco, child labor
advocate, its authors claimed it miraculously cracked the code to perfectly
solve COVID. All public health officials had to do was “protect the vulnerable” 
(defined as those younger than 60-70), let “natural immunity” work its magic,
and the virus would fade away in 3-6 months. Not bad, right? Listen to Dr.
Bhattacharya discuss his first 1-page pandemic plan.

Obviously, there is nothing inherently wrong with “protecting the vulnerable”,
which the GBD termed “focused protection.” However, telling public health
officials to do this was like a coach telling their players to “score more
points than the other team.” It’s the perfect plan, but it’s not a good one, and
it will fail, a point I made in my article The Great Barrington Declaration
Wasn’t a Plan for Public Health Officials. It Was a List of Absurd Demands of
Them.

In their FAQ section, the GBD’s authors claimed they provided a clear roadmap
for how public health officials might protect vulnerable people. Yet, their
answer to the question “How do we protect older people living at home?” was just
4-sentences long and contained inactionable absurdities such as “During high
transmission times, older people should be offered home delivery of groceries
and other essentials.”

Obviously, writing that sentence was a lot easier than actually delivering
groceries and other essentials to millions of homebound seniors. Dr. Jay
Bhattacharya, one of the three authors of the GBD, had obviously given no
thought to how public health officials might actually do this. In an interview
from October 2021, a year after the publication of the GBD, he said:

We could have offered free DoorDash to older people. I mean, yeah, it would
depend on the community and the living circumstances. It would be a local thing,
right?

However, the impossibility of the GBD was its entire point. It allowed its
authors to portray public health officials as incompetent fools. In that same
interview, Dr. Bhattacharya blamed them for not figuring out how to implement
his plan. He said:

The public health community that I know has all kinds of creative ideas of how
to help people in a population be protected against disease. They’re very
creative generally in thinking of ways to do focus protection for many, many
diseases and condition

“It was a failure of imagination on the part of public health,” Dr. Bhattacharya
concluded. After all, he told them exactly how to conquer COVID. They just
refused.

The best pandemic preparedness playbook for the United States is making America 
healthy again.

Along with his Principal Deputy Director Dr. Matthew Memoli, Dr. Bhattacharya
recently released a new 1-page pandemic plan in an article titled NIH Directors:
The World Needs a New Pandemic Playbook. The Pandemic Accountability Index
penned a devastating takedown, while Drs. Jeremy Faust and Angela Rasmussen did 
a thorough refutation of every line.

As such, I will limit my discussion to their actual plan to handle a new virus. 
It was very different from the GBD and it’s foundational principle of focused
protection. Dr. Bhattacharya’s new plan is much simpler:  vulnerable people
should stop being vulnerable. He wrote:

We should learn from recent example: a metabolically healthy population,
physically active and eating nutritious food, will cope far better in the face
of a novel pathogen than a population facing a severe chronic-disease crisis…

Ultimately, public health agencies encouraging people to take whatever steps
they can to improve their health will have a dramatic effect during the next
pandemic. Whether simply by stopping smoking, controlling hypertension or
diabetes, or getting up and walking more, anything that makes the population
healthier will prepare us better for the next pandemic. The best pandemic
preparedness playbook for the United States is making America healthy again.

That’s it! That’s the entire plan. It’s terrain theory all the way down.

Like the GBD, Dr. Bhattacharya’s suggestion that Americans should be “healthy
again” isn’t inherently wrong. It would be great if people smoked less and
walked more. However, that’s hardly a brilliant insight, and it’s been tried
before. Dr. Fauci made it a point to encourage exercise as early as March 2020, 
and unlike Dr. Bhattacharya, he led by example- Dr. Anthony Fauci Is an Avid
Runner, Even When He Works 19-Hour Days.

Clearly, there is a big difference between telling people to stop smoking and
walk more and actually getting them to achieve these laudable goals, especially 
in this administration where the headlines read: Why CDC Cuts Are Being Called
‘The Greatest Gift To Tobacco Industry In The Last Half-Century’ and Dismantling
CDC’s Chronic Disease Center ‘Looks Pretty Devastating’ To Public Health
Experts. Their plan to lower the cost of GLP-1 medications, however, is a clear 
positive step.

Moreover, healthy people are not totally spared from dangerous viruses, and
while many diseases can be altered with lifestyle adjustments, many others
cannot. My patients with advanced MS can’t regrow myelin by hitting the gym, and
no one can reverse aging, the top risk factor for severe COVID. Babies were
also highly vulnerable, and we have no idea whom a novel pathogen may target. 
The average age of death in the 1918 pandemic was just 28.

We would have

So, what changed? Why does Dr. Bhattacharya’s new 1-page plan reject “focused
protection”, the central premise of his previous 1-page plan?  Obviously, the
core difference between today and 2020, when Dr. Bhattacharya wrote the GBD, is 
that he is the medical establishment, and so he’s drastically lowered his
expectations for what they might be expected to do in a pandemic.

When Dr. Bhattacharya was out of power, he demanded his predecessors become
activists and use vast government powers to instantly insulate “vulnerable”
people as COVID raged around them. He gained fame and glory by claiming he
“would have” accomplished these amazing feats himself had YouTube not stood in
his way. He marketed himself as a superhero with magic powers to bend SARS-CoV-2
to his will.  Everything would have been just fine.

Amazingly, a lot of people believed his “would have” statements and these
imagined accomplishments catapulted him to the head of the NIH. Now that he has 
real-world responsibility for the first time however, Dr. Bhattacharya has left 
that fantasy behind in his new 1-page pandemic plan. He’s not boasting about the
wonderful things he “will do” should a new virus emerge. He doesn’t claim that 
his administration is full of people who will be “very creative in thinking of
ways to do focus protection“. He no longer expects them to deliver groceries and
other essentials. In fact, he doesn’t expect them to do anything at all.

As such, his new “plan” isn’t really a plan. It’s an admission that should there
be a new pandemic, he’s not competent enough to do any of the incredible things
he supposedly “would have” done regarding COVID.  It’s also an announcement
that he won’t even try. In his vision, it’s not his job to “protect the
vulnerable”. Rather its citizens’ job to render themselves “not vulnerable” and 
make his life easier.

And if they can’t do that, tough luck. As countless people recognized, MAHA is
all about blaming patients for their illnesses and causally blowing off those
who might succumb to viruses. They had underlying conditions. The same way Dr.
Bhattacharya blamed public health officials previously, he is setting the stage 
to blame the American people for their fate moving forward. After all, Dr.
Bhattacharya told them to put down their cigarettes, put on their walking shoes,
and instantly make themselves healthy. What more could be expected of him?

A lot actually. Dr. Bhattacharya is not just a spectator anymore. It’s his job
to deliver concrete results for the American public. Specifically, it’s his job 
to enact his pandemic plan and get Americans to stop smoking and start
exercising. I’m ready for him to dazzle us all with his prowess.

Unfortunately, I don’t think that’s going to happen. While a lot has changed,
the only constant thing is that whether he is in or out of power, Dr.
Bhattacharya doesn’t expect anything of himself. It’s never his job to get
things done. His role is merely to write 1-page “plans” telling others what to
do and blaming them if they fail. His core message is this:

If COVID-26 arrives, you’ll be totally on your own. Caring, capable government
scientists won’t be there to help you in any way.

And for the first time ever, I completely believe him.


Now That It’s His Job to Control Measles, Dr. Jay Bhattacharya Suddenly Expects 
People to Trust Everyone & Everything He Spent 6 Years Attacking

With Dr. Jay Bhattacharya in power, the headlines now read “Americans Trust
Fauci Over RFK Jr. and Career Scientists Over Trump Officials.”

Jonathan Howard on March 13, 2026

Link


“Trust in Physicians and Hospitals Plummeted Since the COVID Pandemic”

Dr. Jay Bhattacharya was a pandemic influencer who rose to power spreading both 
disinformation about COVID and rage about anyone who tried to contain it. In his
telling, public health officials and doctors weren’t trying their best to stop 
a new virus from overwhelming hospitals and morgues. Rather, they were liars,
part of a “COVID cartel” and “biomedical security state”. He and other MAHA
doctors made these sorts of allegations and accusations all the time, for years.
I’ve documented it all in thick books.

However, Dr. Bhattacharya was very good at spreading doubt, a true grandmaster. 
His podcasts were very effective, and his mission to lower trust in science and 
medicine succeeded. According to as article titled Trust in Physicians and
Hospitals Plummeted Since the COVID Pandemic, Northeastern Research Says:

A grateful public called doctors health care heroes and collected personal
protective equipment and pizzas for them during the early, deadliest days of the
COVID-19 pandemic.

But nearly four years later, public trust in physicians and hospitals plummeted,
going from 71.5% in April 2020 to 40.1% in January 2024, according to a
50-state survey of U.S. adults led by Northeastern University’s distinguished
professor of political science and computer sciences.

This didn’t happen on its own. A lot of people worked very hard and deliberately
to accomplish this.

“I just want to make sure people understand that I don’t want the public health 
authorities to be discredited permanently.”

Since gaining power, however, Dr. Bhattacharya has often stated his goal is to
fix the problem he created. In one typical interview, he said:

I just want to make sure people understand that I don’t want the public health
authorities to be discredited permanently. I want reform of the public health
authorities so that they become worthy of trust.

Now that he’s in charge, Dr. Bhattacharya feels we can start trusting public
health authorities once again. In his view that problem was temporary. However, 
he is discovering that trust is not like a light switch that he can turn on and 
off based on his command alone.

“Americans Trust Fauci Over RFK Jr. and Career Scientists Over Trump Officials.”

Dr. Bhattacharya has been in office for nearly a year, first at the NIH and then
also at the CDC, we can evaluate his performance thus far. Have public health
authorities, especially the leaders of MAHA, again become widely trusted with
Dr. Bhattacharya leading the way?

It doesn’t seem that way.

MAHA doctors have learned the hard way that it’s much easier to break trust than
to rebuild it. From censorship to cancelled research, Americans recognize the
obvious incompetence and malevolence of the entire MAHA project. With Dr.
Bhattacharya in power, the headlines now read Americans Trust Fauci Over RFK Jr.
and Career Scientists Over Trump Officials.

Doctors and scientists don’t trust Dr. Bhattacharya either. Shiv Prasad, a
scientific review officer at NIH summed up the general sentiment by saying:

The NIH director position has always been a full-time job for everyone who’s
held that position, and no one has treated it as a part-time job before. It’s
unfortunate that he spends a significant amount of time either on rightwing
podcasts or addressing rightwing conventions and maybe finds time for NIH in
between those appearances.

Major medical organizations are wisely ignoring his decimation of the vaccine
schedule, and according to a data compiled by KFF, “30 states, including DC,
have announced that they are no longer going to follow CDC’s recommendations for
some or all childhood vaccines.” As the Lancet said in their article: Robert F 
Kennedy Jr: 1 Year of Failure:

Kennedy has continued to spread misinformation and push politicised agendas at
the expense of the country’s most vulnerable. When called to account for his
decisions by Congress, he has been evasive and combative. The destruction that
Kennedy has wrought in 1 year might take generations to repair, and there is
little hope for US health and science while he remains at the helm. Calls for
his resignation now number in the thousands.

So much for restoring trust.

Even Dr. Bhattacharya’s defenders, if they exist, can’t make the affirmative
case that the NIH and CDC are more trusted now than before he and MAHA took
over.

“We are now joyous that a public health official actually recommended the
measles vaccine during a measles outbreak greater than anything we’ve seen in
more than 30 years—ecstatic that a public health official finally stated the
obvious.”

However, Dr. Bhattacharya has an actual job to do today. He responsible for many
things right now. In a cruel twist of fate, the man who rose to power trying to
spread COVID is responsible for limiting measles today. Every outbreak and sick
child is happening under his watch.

And presto! Dr. Bhattacharya suddenly expects the public to trust doctors,
public health officials, and vaccines, literally everyone and everything he
spent the past 6 years attacking. “Trust is the foundation of public health
earned by openness, honesty and guidance to the best available evidence,” he
said in a recent video, where he actually recommended the MMR, the only way to
stop measles.

Trust is the foundation of public health. CDC is working closely with state and 
local leaders, surging resources, and supporting communities with the tools they
need to prevent and respond to measles. pic.twitter.com/cqpqBabeoe

— CDC (@CDCgov) March 2, 2026

Writing about this video and the soft bigotry of low expectations, Dr. Paul
Offit said:

We are now joyous that a public health official actually recommended the measles
vaccine during a measles outbreak greater than anything we’ve seen in more than
30 years—ecstatic that a public health official finally stated the obvious.
It’s hard to know whether we should praise Bhattacharya’s public service
announcement or lament how low our expectations have fallen for public health
officials

Indeed, the CDC director suggesting the MMR is as impressive as my teenage son
putting on his pants all by himself. While it’s better than nothing, I guess,
this single milquetoast video on X isn’t going to make a meaningful difference. 
I’d actually be surprised if it led to a single child being vaccinated. If Dr.
Bhattacharya actually wanted to influence vaccine-hesitant parents, he would
have been promoting the MMR loudly and constantly for the past year.

These parents have been pickled by Dr. Bhattacharya’s depiction of public health
officials as violent tyrants and Kennedy’s decade-long anti-vaccine crusade,
which is stronger than ever thanks to the MAHA Institute. One video on X isn’t
going to counter all that. And although Dr. Bhattacharya can succeed at his job 
only if parents vaccinate their children, even he can’t resist the comfort of
his safe space, an anti-vaccine podcast. As he touts the MMR with one hand, he
is still spreading anti-vaccine disinformation with the other.

(PODCAST) After Hours with NIH Director Dr. Jay BhattacharyaDr. Jay
Bhattacharya, Head of NIH and Acting CDC Director, tells about reform of a
broken system, and how he’s launching a vaccine injury effort.
pic.twitter.com/wPbk1pUTHS

— Sharyl Attkisson 🕵️‍♂️💼🥋 (@SharylAttkisson) February 28, 2026

After years of telling people not to trust the medical establishment, Dr.
Bhattacharya is now the medical establishment. It’s his job to earn the trust of
the American people, not the other way around, and he has no clue how to do
that. While it’s good that everyone finally recognizes the emperor has no
clothes, unvaccinated children will pay the price of his duplicitousness.

Dr. Bhattacharya will be just fine though, bravely podcasting his way through it
all.


Dr. Jay Bhattacharya, Who Claims He “Would Have” Perfectly Controlled COVID In
2020, Can’t Even Fix A Few Broken Windows Today

Trust in MAHA leaders has justifiably collapsed, and the sycophants who
previously glorified Dr. Jay Bhattacharya have mysteriously vanished, unwilling 
to even acknowledge what they helped unleash on us all.

Jonathan Howard on April 3, 2026

Link

“The day after the shooting, Bhattacharya went on Steve Bannon’s podcast to
criticize mRNA vaccines.”

Dr. Jay Bhattacharya portrayed himself as a neutral scientist in order to
deflect legitimate criticism. However, in reality he was core member of an
overtly political ecosystem that spread paranoia and rage about anyone who tried
to stop people from dying of COVID. He histrionically warned of a “COVID
cartel” and a “biomedical security state” on podcasts and propaganda movies. He 
proudly partnered with threatening anti-vaxxers, like Del Bigtree, who openly
dreamt of Nuremberg trials. Anyone seeking examples of Dr. Bhattacharya stoking 
fear about the CDC and COVID vaccines will find an overwhelming amount of
material. 

He did so constantly for years, including as NIH director after a gunman, his
brain rotted by anti-vaccine disinformation, shot nearly 500 rounds at the CDC, 
breaking 150 windows and killing a heroic young police officer. According to an 
article titled The CDC Shooting Was Public Health’s Jan. 6:

Kennedy’s appointees have gone even further. In 2022, the National Institutes of
Health’s now-Director Jay Bhattacharya appeared on a panel that inaccurately
claimed Covid-19 vaccines had killed 20 times as many people as they had saved. 
The day after the shooting, Bhattacharya went on Steve Bannon’s podcast to
criticize mRNA vaccines. A few days later, he doubled down in a Washington Post 
op-ed.

“Things can move slowly in government.”

Fast forward to today and Dr. Bhattacharya is the acting CDC director where,
under his “leadership”, the windows remain broken to this day. According to a
recent article about his speech to staff there:

CDC staff harbor deep resentment of Kennedy’s response to the attack. The health
secretary did not post about the shooting until the day after it occurred, and 
only after he posted pictures of himself fishing in Alaska.

Another staff member asked when windows with bullet holes from the attack would 
be replaced, saying months later they are still merely papered over.
Bhattacharya said staff had his commitment that they would be replaced, but
acknowledged things can move slowly in government.

So, let’s be clear about what happened here. Dr. Bhattacharya rose to power by
portraying himself as a superman who “would have” perfectly controlled COVID had
imaginary villains not stood in his way. Many “serious” thinkers believed his
empty boasts and were genuinely impressed by his 1-page online petition which
merely “argued for” his predecessors to do impossible things as COVID raged.
They deliberately ignored Dr. Bhattacharya’s performance as a professional
provocateur and claimed he would restore trust in public health if given power.

However, when given the opportunity to silence his critics and prove his
real-world mettle, the only thing Dr. Bhattacharya can deliver is pathetic
excuses- things can move slowly in government– about why he can’t be bothered
fix a few broken windows.

Trust in MAHA leaders has justifiably collapsed, and the sycophants who
previously glorified Dr. Bhattacharya have vanished, unwilling to even
acknowledge what they helped unleash on us all.  And while no one currently
believes that Dr. Bhattacharya “would have” handled COVID with an iota of
competence had he been in charge 6 years ago, his dismal performance in office
has shown he was he was right about one thing at least:

An Eponym for Scientific Censorship in America: Bhattacharyaism

It turns out Jay Bhattacharya’s talk, “The End of Free Speech is the End of
Science” was really a preview of coming attractions, a mission statement for his
leadership.

Jonathan Howard on April 17, 2026

Link


“The End of Free Speech is the End of Science”

Prior to obtaining power, Dr. Jay Bhattacharya made a grand display about the
importance of “free speech”- at least his own. He gave grandiose talks such as
The End of Free Speech is the End of Science and treated his Tweets and YouTube 
videos as the most consequential victims of the pandemic. Though he never showed
sympathy for COVID’s victims, he produced an overwhelming amount of
self-pitying material bemoaning the fate of his social media content. He even
took a case about his supposed “censorship” to the Supreme Court. He lost
because he “failed to show that the platforms acted in response to government
request.”

A few samples of Dr. Bhattacharya speaking loudly about he’d been “silenced” are
below.

“We’ll never us this agency to censor scientists who disagree.”

Had Dr. Bhattacharya truly been silenced, no one would know about him. However, 
his lamentations made him famous and powerful, and Dr. Bhattacharya repeatedly
promised things would be different once he was in office. Finally, under his
benevolent leadership, scientists would be able to Tweet freely, and a golden
era of scientific discourse would emerge. Though I’ve never seen him engage with
his critics in good faith, not even once, Dr. Bhattacharya made it clear that
people could openly disagree with him without fear of reprisal. “We’ll never us 
this agency to censor scientists who disagree,” he said upon becoming NIH
director.

“NIH Staff Lambaste Agency Head for Censorship of Science”

Things haven’t exactly turned out that way. It turns out his talk The End of
Free Speech is the End of Science was really a preview of coming attractions, a 
mission statement for his leadership. Dr. Bhattacharya’s tenure at the NIH began
with a headline that read ‘One of the Darkest Days’: NIH Purges Agency
Leadership Amid Mass Lay-Offs. Shortly after that, renowned NIH nutritionist
scientist Dr. Kevin Hall left because he was censored, and other scientists
wrote the Bethesda Declaration. According to an article about the Bethesda
Declaration titled NIH Staff Lambaste Agency Head for Censorship of Science:

Hundreds of staff at the National Institutes of Health are publicly condemning
the agency’s actions in recent months, including firing thousands of workers and
canceling research grants for projects that don’t align with the Trump
administration’s ideologies.

In a letter sent Monday morning to Jay Bhattacharya, the Trump-appointed NIH
director who gained notoriety for his criticism of the NIH’s handling of the
COVID-19 pandemic, more than 300 employees from across the agency called on him 
to deliver on his promise to embrace dissent, which he has called “the very
essence of science.”

Since then, Dr. Bhattacharya has doubled down on his intimidation and censorship
of dissident scientists. He’s repeatedly tried to summon social media mobs
against scientists who disagree with him, refused to meet with disgruntled NIH
staff, and has purged the most outspoken voices, such as Drs. Jenna Norton and
Jeane Marrazzo. Other prominent scientists have been purged for no reason at
all.  According to a press release titled Statement on Sudden Departure of NINDS
Director:

The American Academy of Neurology (AAN) expresses significant concern over the
abrupt decision by the National Institutes of Health (NIH) to terminate its
contract with the Director of the National Institute for Neurological Disorders 
and Stroke (NINDS). Walter Koroshetz, MD, FAAN, who has served in NINDS
leadership for nearly two decades, is a highly respected leader whose tenure has
been marked by numerous advancements in the treatment of neurological
conditions. Dr. Koroshetz’s departure will be deeply felt by neurologists,
researchers, and the many patients whose lives have been positively impacted by 
his leadership. This decision was made without consulting key neurology
stakeholders, and there was no formal announcement nor a clear succession plan
for NINDS leadership.

Over half of the 27 institutes of the NIH have no permanent director, though one
director was hired after he officiated at the wedding of JD Vance.

More recently, Dr. Bhattacharya censored a CDC study because it showed what
countless other studies have shown, the COVID vaccine reduces severe COVID
outcomes. Dr. Bhattacharya has dunked on COVID vaccines for years and the mere
existence of this study in 2026 demolishes his entire pandemic philosophy, that 
natural immunity would lead to herd immunity in 3-6 months. It’s no surprise
that he censored this study.

Elsewhere, Dr. Bhattacharya has censored entire fields of research by calling
them “DEI”, three letters he wields as a magic talisman to blithely dismiss his 
critics and cancel their research. Although Dr. Bhattacharya advanced his career
by publishing papers titled Racial Disparities in Knowledge, Attitudes and
Practices Related to Covid-19 In The USA, Racial Disparities in Survival After
Lung Transplantation, Persistent Racial Disparities in Survival After Heart
Transplantation, today he is denying such opportunities to others. “We won’t
renew them” in 2026, he said to a podcaster about his intentions to censor
research that he now deems ideologically impure.

There has been no transparency in how DEI is defined and who decides which
research to cancel. A federal judge overturned Dr. Bhattacharya’s attempts to
censor such research, at least for now, for that reason. According to the
article Hundreds of NIH Grant Terminations are ‘Void and Illegal,’ Federal Judge
Rules:

At several points during the hearing, Judge William G. Young expressed
frustration that the NIH had no formal definition of DEI despite terminating a
wide swath of grants in that area… The plaintiffs did not accuse the NIH of
racial discrimination, but Young raised the issue. “I have never seen racial
discrimination by the government like this,” in his 40 years on the bench, he
said, to which there was an audible gasp in the courtroom.

The article also quoted Heather Pierce, senior director of policy at the
Association of American Medical Colleges, who said:

The research community isn’t dealing with just the terminations of grants — that
alone would be unprecedented and incredibly disruptive. But when you add it to 
the cumulative effect of undercutting the funding infrastructure, slowing down
funding opportunities, freezing funds, slowing the drawdowns of already awarded 
grants, the cumulative effect is staggering on the research enterprise.

Indeed, another way to censor science is to starve it of funding. STAT News ran 
a long series titled American Science, Shattered about how these cuts have
silenced scientists, and Dr. Bhattacharya personally cut funding for mRNA
research. Donald Trump, whom Dr. Bhattacharya literally “loves“, isn’t done yet.
According to an article from earlier this month Trump Administration Seeks More
Funding Cuts for NIH:

A budget proposal released last week by the Trump administration seeks to cut $5
billion from the National Institutes of Health (NIH).

The cuts listed in President Donald Trump’s Fiscal Year 2027 Budget are part of 
a $15.8 billion overall reduction the administration is seeking for the
Department of Health and Human Services, which oversees NIH. The document from
the Office of Management and Budget (OMB) says the budget reductions will be
achieved through reforms and elimination of several NIH centers, including the
National Center on Minority Health and Health Disparities, which OMB said is
“replete with DEI [diversity, equity, and inclusion] expenditures.”

“NIH broke the trust of the American people with wasteful spending, misleading
information, risky research, and the promotion of dangerous ideologies that
undermine public health,” OMB said.

Other agencies slated for budget cuts the Agency for Healthcare Research and
Quality (-$129 million), and the Administration for Strategic Preparedness and
Response (ASPR, -$356 million). OMB said ASPR had been overextended by the
COVID-19 pandemic and had moved away from its mission of coordinating the
federal emergency response.

Dr. Bhattacharya previously refused to stand up for the NIH against these slurs 
and budget cuts and had to be reminded that he led the agency.

“Let’s have a debate. Science works best when we have an open debate.”

Even on Twitter, the core location of Dr. Bhattacharya’s supposed “censorship,
he still post continually from his private account, where he has blocked
countless private citizens from speaking their mind to him, a government
official. However, back In 2021 when Dr. Bhattacharya was merely a social media 
celebrity who claimed the only problem with COVID was that anyone still feared
it, YouTube, a private company, removed one of his countless videos. This became
the seminal moment of the pandemic for him, the way I’ll never forget seeing a 
COVID kill a healthy 23-year-old 6 years ago. Florida Governor Ron DeSantis
devoted an entire “roundtable” to mourn the loss of this single video and whine 
about “big tech censorship”, in which Dr. Bhattacharya indignantly said: 

For science to work, you have to have an open exchange of ideas…If you’re going 
to make an argument that something is misinformation, you should provide an
actual argument. You can’t just take it down and say, ‘Oh, it’s misinformation’ 
without actually giving a reason…Let’s hear the argument, let’s see the evidence
that YouTube used to decide it was misinformation. Let’s have a debate. Science
works best when we have an open debate.

All this from a powerful government agent whose name will be forever synonymous 
with scientific censorship.

Scientific Censor Dr. Jay Bhattacharya Doesn’t Realize He’s the Medical
Establishment Now & It’s His Job to Generate Evidence for the American People

I don’t understand why public health figures like Jay Bhattacharya who
controlled 58 billion dollars of funding uh didn’t use that money to study it
definitively and with running high quality trials.

Jonathan Howard on May 1, 2026

Link

“I don’t understand why public health figures like Tony Fauci who controlled 10 
billion dollars of funding uh didn’t use that money to study it definitively and
with running high quality trials.”

In order to obtain power, Dr. Jay Bhattacharya spent years spreading doubt about
scientists in an unending stream of podcasts, Tweets, and editorials. Though
there are countless examples, in 2023 he made a YouTube video with conspiracy
theorist Jimmy Dore in which he excoriated his predecessors for their supposed
failure to properly study ivermectin as a cure for COVID. Noting they had power 
and money, Dr. Bhattacharya said:

I think the key thing to me is that we needed to have an answer, a definitive
answer in 2020. Why did we not have one? It’s because the NIH, the NIAID, and
Tony Fauci did not actually honestly study the issue in 2020… That’s the thing I
don’t understand. I don’t understand why public health figures like Tony Fauci 
who controlled 10 billion dollars of funding uh didn’t use that money to study
it definitively and with running high quality trials.

“I’m strongly opposed to this kind of censorship. It should be out in the world 
at large for the scientific community to judge it for what it is.”

Today, Dr. Bhattacharya has vastly more power and resources than Fauci ever had,
and he recently abused his authority to censor a CDC study because it showed
the COVID vaccine is far from perfect, but it helps keep people out of ERs and
hospitals. This is not surprisingly. Multiple previous studies have shown the
same thing.

However, Dr. Bhattacharya was obviously ignorant of the Streisand effect, and
his censorship brought infinitely more attention to the study than if he had
quietly let it be published, only to be noticed by a small fraction of the
population that still care about COVID vaccines.

However, major newspapers covered his censorship, and though there was already
plenty of evidence, everyone now knows that Dr. Bhattacharya is our scientific
censor-in-chief. In one article about this, Here’s the COVID Vaccine Paper the
CDC Censored, Dr. Jeremy Faust shared the study and wrote:

The censored paper presents data on the effectiveness of Covid-19 vaccines
during the 2025–2026 season. The results suggest that, in the first few months
after vaccination (September–December 2025), this year’s vaccines were 53–55%
effective against hospitalizations among the study’s population of adults
without immune compromise.

But Jay Bhattacharya believes that the public should not see this work—or at
least that the CDC should not publish solid science carried out, in part, by its
own experts...

“I’m strongly opposed to this kind of censorship,” Dr. Michelle Barron, one of
the manuscript’s authors, told Inside Medicine. Dr. Barron, an infectious
diseases physician at the University of Colorado, believes the move is an attack
against transparency and the usual open scientific process. “It should be out
in the world at large for the scientific community to judge it for what it is,” 
she said.

Dr. Barron is right, of course, however rather than let scientists openly debate
the strengths and weaknesses of the study as a professional leader would do,
Dr. Bhattacharya instead used his greatest and only skill, spreading doubt in
podcasts, Tweets, and editorials. He claimed there were fatal flaws with the
study design, a widely used approach called “test-negative” design. According to
one article on this method:

In recent years the “test-negative” design has become the most prevalent
approach for studying and monitoring vaccine effectiveness of COVID-19 and
influenza vaccines in “real world” situations… As with all epidemiological
studies, poor study design, inconsistent implementation, and failure to take
into consideration important biases and confounders can lead to misleading
results. However, when well-designed and implemented with consistency and
attention to detail, test-negative study designs can produce accurate estimates 
of vaccine effectiveness. In fact, studies have shown that effective
test-negative designs can produce results highly consistent with randomized
trials (the “gold-standard” of epidemiological study designs) when compared
directly.

The CDC study never claimed to be a perfect study. It had a section that began, 
“The findings in this report are subject to at least four limitations.” Dr.
Bhattacharya censored that too, deliberately preventing open debate and
discussion.

Though Dr. Bhattacharya claims he objects to this design, he’s never been able
to specifically say why, and no one is gullible enough to believe methodological
concerns are why he censored the CDC study. Obviously, everyone knows that
because unvaccinated people hospitalized with COVID don’t matter to Dr.
Bhattacharya, he was bothered by the study’s results. Had it had come to a
different conclusion, there is no doubt that he would have celebrated it as
incontrovertible proof his anti-vaxx agenda was right the whole time.

“Scientific integrity demands rigor, openness to challenge and a willingness to 
follow the evidence wherever it leads, especially when it is inconvenient.”

In a futile attempt to salvage his unsalvageable reputation, Dr. Bhattacharya
penned an editorial titled Under My Leadership, the CDC Will Follow the
Evidence. In it, he blamed “misleading media coverage” for exposing his
censorship and botched basic facts about the CDC study. He sought to justify his
censorship in the most Orwellian way imaginable by writing:

For those of us who have dedicated our lives to public health, humility is not a
weakness. It means recognizing uncertainty, questions and assumptions and
insisting that evidence drives conclusions. The responsibility of the Centers
for Disease Control and Prevention is to protect the public’s health and to earn
its trust by providing accurate, transparent information. I am proud to lead
the CDC as we follow the evidence, no matter where it takes us…

At a moment when public trust in institutions like the CDC is fragile, we cannot
afford to lower our standards. Scientific integrity demands rigor, openness to 
challenge and a willingness to follow the evidence wherever it leads, especially
when it is inconvenient. That is the standard we are committed to upholding at 
the CDC.

This is this content-free doublespeak. In Dr. Bhattacharya’s telling, his
critics had everything backwards. He was forced to censor the CDC study to
defend transparent information. He was the one willing  to follow the evidence
wherever it leads. His critics lacked “rigor” and weren’t “open to challenges”
the way he was.

Notice that Dr. Bhattacharya isn’t actually making an argument with this
high-minded drivel. He’s not responding to his critics in any serious way. He’s 
ignoring their points and appealing to emotions, yet again.

However, it is clear that like his boss Kennedy, who claims that measles
outbreaks aren’t his problem because they started before he entered office, Dr. 
Bhattacharya similarly fails to grasp fundamental facts about his current
position in the world, the one he chose for himself.

Dr. Bhattacharya may be surprised to learn this, but he is the medical
establishment now. Though he rose to power by throwing stones in an unending
stream of podcasts, Tweets, and editorials, today he leads both the NIH and CDC.
As such, it’s no longer his job to cosplay as a wise, but powerless outsider
who understands research methods better than experts in the field. It’s not even
his job to “follow the evidence”.

Rather, it’s his job to generate the evidence we are supposed to follow. Since
Dr. Bhattacharya supposedly objects to the methods of study he censored, it’s
his responsibility to stop being a content creator and do better studies, ones
that meet his exacting standards. It’s his turn to dazzle us all with his
research prowess and ability to deliver concrete results for the American
people.

Put another way, I think the key thing to me is that we needed to have an
answer, a definitive answer in 2026. Why did we not have one? It’s because the
NIH, the CDC, and Jay Bhattacharya did not actually honestly study the issue in 
2026. That’s the thing I don’t understand. I don’t understand why public health 
figures like Jay Bhattacharya who controlled 58 billion dollars of funding uh
didn’t use that money to study it definitively and with running high quality
trials.


Will NIH Director Jay Bhattacharya stand up for scientists censored by the
American Diabetes Association?

Last Friday, the American Diabetes Association censored diabetes researchers at 
its annual meeting who opposed the Trump administration’s NIH policies. Will
“Flame of Freedom” winner Jay Bhattcharya speak up?

David Gorski on June 8, 2026

Link


Regular readers of this blog might have noticed that, over the last few weeks,
I’ve been trying to return to topics a lot more commonly discussed on this blog 
before the pandemic. In particular, I was trying to get back to some topics that
I used to like to cover before Donald Trump was elected to the Presidency again
in 2024, appointed a rabid antivax activist named Robert F. Kennedy Jr., to run
the Department of Health and Human Services, and, in general, set the very
worst people—e.g. “Podcast Jay” Bhattarcharya (who got the nickname due to his
propensity to spend more time podcasting than actually doing his job), Marty
Makary, Tracy Beth Høeg, Vinay Prasad, and their ilk—loose systematically
dismantling federal public health, medical, and biomedical research programs,
all while trying to eliminate as many vaccines as possible before President
Trump’s term ends in January 2029. It worked for a while, and I managed to do
posts on acupuncture, its dubious scientific justifications, functional
medicine, revisionist history about the FDA, the resurrection of a very old
antivax trope, and more “integrative medicine” exaggeration of how “powerful”
placebo effects are. True, a lot of it was framed around the “make America
healthy again” (MAHA) movement, but what is MAHA but the repackaging and fusion 
of the antivax movement with “health freedom” and “integrative medicine”
quackery? All the same old stuff that we used to warn about pre-2020 is bubbling
to the surface again. So it was this week that I wanted to do the same, based
on an interesting study of publishing patterns in “integrative medicine,” but
then I saw these headlines about a kerfuffle late last week at the annual
meeting of the American Diabetes Association (ADA):

  1. Police Remove Diabetes Experts From Conference for Distributing Critique of
    Trump Administration (New York Times)
  2. Diabetes researchers ejected from conference after criticizing White House
    (Washington Post)
  3. Police remove UW diabetes researcher and other experts from conference
    (Seattle Times)
  4. Video: Police Tussle With Diabetes Experts at ADA Meeting (MedPage Today)
  5. Scientists ejected from diabetes conference for distributing journal reprints 
    (Ars Technica)
Let’s just say that this incident, including the Streisand effect that it
provoked, tells us something about the current regime running the biomedical
science apparatus of the federal government. First, however, let’s look at what 
happened. Particularly remarkable are the identities of some of the scientists
ejected and the nature of the editorial that they were distributing. First, one 
of the researchers was University of Washington professor Steven Khan, who is
the editor-in-chief of Diabetes Care, the flagship journal of the ADA and winner
of the ADA’s Banting Medal for Scientific Achievement Award just last year.
Another, Desmond Schatz of the University of Florida, Gainesville, has been
involved with the ADA for decades and even served as President of Medicine &
Science for the ADA in 2016. In other words, these aren’t just random diabetes
experts attending the yearly ADA conference. They are the crême de la crême of
American diabetes researchers and heavily involved with the organization. As for
the article? Entitled Misguided Brushes of a Pen Continue to Dismantle and
Destroy Biomedical Research in the United States: We Can No Longer Afford
Complacency and Fear. We Must All Act Now!, it was first-authored by Dr. Kahn
and published in—you guessed it!—Diabetes Care in April 2026. Here’s how the NYT
described the incident, which occurred on Friday:

Several diabetes experts were escorted out of an influential medical conference 
by the police on Friday after they handed out copies of an editorial criticizing
the Trump administration’s attacks on scientific research.

The incident took place Friday morning at a meeting of the American Diabetes
Association in New Orleans, shortly before Dr. Jay Bhattacharya, director of the
National Institutes of Health, was scheduled to speak. An organizer announced
just before Dr. Bhattacharya’s session that he would no longer be speaking; a
senior adviser at the N.I.H. took his place.

The researchers were handing out copies of the editorial, recently published in 
the association’s flagship journal, which detailed the effects of N.I.H. cuts
and other Trump administration actions on diabetes research and outcomes, when
security staff asked them to step outside and tried to take away the papers,
said Aaron Kelly, a professor of pediatrics at the University of Minnesota who
was among the researchers escorted out. A video taken by MedPage Today, which
first reported the news, shows a tense confrontation, including a man in uniform
putting his hands on an expert.

The researchers re-entered the convention center from another entrance, but were
confronted again by security staff and police officers.

“They were clearly trying to intimidate us,” Dr. Kelly said. The police told the
researchers they would be trespassing and would be arrested if they set foot on
the premises again, said Justin Ryder, a pediatric obesity researcher at
Northwestern Medicine who had been handing out copies of the editorial.

It was also noted that some of the researchers were scheduled to present later
in the meeting over the weekend, but had their badges taken away and were told
that they could no longer attend the conference, telling them, as related by Dr.
Kahn, “Then the police officer told me if we put our feet inside the convention
center again, we’d be arrested.” Indeed, according to MedPage Today:

Kahn said he has written to ADA to be allowed to re-enter the meeting as he is
due to give a talk, present a poster, and chair a session.

Interesting. “Podcast Jay” Bhattacharya was supposed to speak, but apparently
changed plans at the last minute, sufficiently late that the announcement was
made right before the talk. One wonders why, given how boldly he has constantly 
portrayed himself a free speech “martyr” and “warrior.” One wonders if he
suspected that there might be a protest at his talk, one does. Be that as it
may, the contrast between what Podcast Jay and his cronies currently engaged in 
the destruction of federal biomedicine preach with respect to free speech and
what they practice, led me to ask: Will Podcast Jay stand up for these
scientists who were clearly brutally censored? Think about it. From the news
reports, it appears that ADA organizers didn’t just ask these scientists to stop
distributing the Diabetes Care editorial critical of the Trump administration. 
They had convention center security do it, but they also had the Louisiana State
Police assist in ejecting the scientists:

Louisiana State Police trooper Kyle Wagner said that troopers working a security
detail “were requested by event organizers to assist with removing several
individuals from the event. Troopers assisted by escorting the individuals from 
the private event, no arrests were made, and all individuals left peacefully.

Seriously, Dr. Bhattacharya, if this isn’t suppression of free speech by a
medical association (like the ones you complained about during the pandemic) I
don’t know what is.

So far, as of yesterday evening, all I hear is silence from Podcast Jay and his 
fellow free speech “martyrs.” I wonder why. After all, Podcast Jay won Reason’s 
Flame of Freedom Award in 2024 for, as Dr. Howard puts it, “his perseverance and
willingness to bravely make more YouTube videos bemoaning the fate of his lost 
YouTube video” that YouTube had taken down, all while dedicating his award to
the “millions of people censored in the name of public health.” (“Millions”
sounds like quite the exaggeration to me.) You’d think he’d be outraged at this 
obvious censorship of dissent about the Trump administration science policy,
even if it wasn’t the government directly doing it.

So far, crickets.

The ADA versus its own scientists over Trump science policy

Since the pandemic landed in the US six years ago, the constant refrain from
those now in charge of US federal medical and scientific programs has been that 
the brave maverick doctors who spread COVID-19 misinformation and disinformation
were unfairly and brutally “censored,” their “free speech” trampled upon
ruthlessly by the federal government, social media platforms, and the medical
profession. While you and I know that what was really happening is that these
contrarians, cranks, and quacks were trying to reframe any criticism of the
misinformation that they were spreading (and criticism of them for spreading
it), no matter how valid, as “suppression of speech” and “censorship.”

In fairness, there were efforts by social media platforms to rein in blatant
misinformation and by state medical boards and professional societies to impose 
consequences on physicians who used their professional standing to spread health
misinformation and disinformation. Intellectually honest people can—and
should—even have good faith debates about the circumstances in an (ostensibly)
free society under which such initiatives are appropriate and how far they
should go. Of course, good faith debate about such measures was never what COVID
contrarians have been about. If there’s one consistent trait shared by all of
these free speech “martyrs,” it’s that they disingenuously confuse and conflate 
freedom of speech with freedom from criticism of their speech and from any
consequences due to their having exercised their free speech. Unfortunately for 
them, that’s not how free speech works. They want to be brave martyrs and heroes
in their own mind, warriors for what is generally recognized as a common good: 
Freedom of speech. Yet, they seem to think that they—and, as you will see—only
they should suffer no consequences for their speech. Remember, the First
Amendment says nothing about societal consequences one might experience due to
what you say. It only says that the government can’t censor or punish you for
that speech, with certain very limited exceptions.

Since Donald Trump assumed the Presidency again a year and a half ago and “free 
speech martyrs” like Podcast Jay Bhattacharya have ascended to the highest
echelons of power in the federal biomedical apparatus. Some of them, such as
Vinay Prasad, Marty Makary, and Tracy Beth Høeg soon found that it was far
easier to take to podcasts and Substack to criticize public health interventions
during a crisis than it is to actually do the job, all while spreading
revisionist history of the pandemic. Our very own Dr. Jonathan Howard has
repeatedly—and justifiably—mocked these self-important clowns for their
arrogance and seeming assumption that just proposing things like “protecting the
vulnerable,” reopening schools, and reopening businesses during a pandemic was 
the same thing as actually doing them.

First, let’s look at the editorial that these diabetes scientists were handing
out to meeting attendees. Basically, it levels a lot of the same criticisms at
Trump administration policy that we here at SBM have been making, for instance, 
here the editorial complains about exactly what I discussed last week, the
administration’s move to shift on-the-ground decision-making about which grant
applications are funded from scientists selected for their expertise to
political appointees, while downgrading the peer review process in, for example,
study sections run by the National Institutes of Health (NIH) from being the
most important determining factor in which grant applications receive funding to
being merely “advisory,” easily overruled by political appointees

Quoth Kahn et al:

At an administrative level, each NIH institute has a medical advisory council
responsible for providing oversight and guidance to its staff. Each institute’s 
advisory council represents a second level of peer review and acts as the
ultimate arbiter for the agency’s scientific and legal integrity. Each
institute’s advisory council also provides approval for “concept clearance,”
which is required to launch new research initiatives. Further, these medical
advisory councils have a fiduciary responsibility to ensure the American
public’s tax dollars are properly expended by reviewing and approving each
institute’s grant funding pay plan, thereby ensuring funding of the most
innovative and impactful basic, clinical, and translational research. Membership
on these committees, which comprise subject matter experts from academia and
nonprofit organizations, has finite terms, after which members are either
reappointed or replaced. In the past year, neither has occurred, allowing the
Trump administration to impose its political agenda with few questions asked.
Since mid-2025, observations suggest the appointment process, which has included
traditional nonpartisan vetting, is taking a worrisome turn and is now
transitioning to more direct oversight by HHS leadership. This transition is
leading to significant and likely intentional delays in appointments, resulting 
in some institutes’ councils operating at only one-third capacity and many
councils with massive backlogs in completing their responsibilities. In
addition, the administration appears to be shifting membership expertise away
from an academic and scientific focus to reflect broader administration
priorities and including political appointees who frequently have no subject
matter expertise. A consequence of these changes is that the grant cycle is
significantly slower and oversight of grant funding is no longer a required
administrative step; it is now a deliberate policy alignment tool to ensure new 
research closely mirrors specific administrative political interests. As a
result, meritorious scientific projects that aim to improve the lives of all
Americans are not being funded. All of this is in line with what Dr. Francis
Collins recently said: “Mix politics and science, you get politics. You kind of 
lose everything else.” (7).

This editorial was published a couple of months ago. It was just last week that 
OMB Director Russell Vought published proposed rules covering how government
grants are funded that codify requirements that grants “align with
administration priorities”; that peer review be considered “advisory” and not
the primary determining factor in grant-issuing decisions; and that political
appointees have the final say over which grants are funded. While it is true
that every administration determines what its broad science priorities are and
what sort of research that it wants to fund, historically since World War II the
actual determination of what constitutes good science worthy of being funded
has been (mostly) left to the scientists on the study sections that peer review 
the grant applications and issue them priority scores based on scientific merit 
and then the councils of scientists that rank the grants based on priority
scores and, generally, fund the top-scoring grants, with some wiggle room for
grants of special interest to receive priority treatment based on factors other 
than peer review. Let’s just put it this way. Even Ronald Reagan and George W.
Bush never went anywhere near this far, directly inserting political appointees 
into granular scientific decision-making.

The editorial, as SBM did, also noted that the mass cancellation of grants early
in the Trump administration because the “Department of Government Efficiency”
(DOGE) thought they had a wife of the dreaded “diversity, equity, and inclusion”
(DEI) was catastrophic, but also pointed out something that, I now realize, I
haven’t emphasized enough:

Another new tactic is starting to severely hamper the ability of the NIH’s
institutes to foster high-impact science. The plan, which is currently being
instituted, reduces the number of Notices of Funding Opportunities (NOFOs) being
issued. Over the first 13 months since Donald Trump’s return to the White
House, NIH has issued only 84 NOFOs, compared with 787 the year before (8); this
represents an 89% reduction. Examination of funding activity using NIH RePORTER
data from the start of the current fiscal year on 1 October 2025 to the end of 
February 2026 reveals a truly troubling trend. This report, issued by the
Association of American Universities, compared this fiscal year 2026 period to
that of each of the first 5 months of 2021–2024 (9). It identified that the
current number of grant awards has been reduced by about 66%, from nearly 3,000 
to less than 1,000. In turn, this has reduced the research money provided to
investigators by 54%, from just over $1.3 billion to about $600 million.

Why is this consequential for science overall and for diabetes research? NOFOs, 
an umbrella term that includes Program Announcements and Requests for
Applications, encourage investigators to submit applications for a particular
subject matter determined to be high priority by an institute’s scientific
staff. Aside from the impact of the concerns of reduced grant funding laid out
above, there are other significant core issues and implications for fewer NOFOs 
that include efficient oversight and scientific progress as prime examples.
Further, and enormously important, while these calls for NOFOs used to be
approved by each institute’s medical advisory council, approval now rests in the
hands of the NIH Director’s office and HHS, the NIH’s parent agency, resulting 
in severe delays or even disapprovals. Furthermore, with fewer specific NOFOs
being approved, more researchers are funneled into general pools, providing
fewer opportunities to focus on specific gaps and needs identified by NIH.

This issue might be a bit too “inside baseball,” as we sometimes put it; in
other words, too much into the weeds of the details of how the NIH works when it
determines funding priorities. Let’s just say that, instead of scientific staff
of each Institute within the NIH determining funding priorities and being
allowed to issue NOFOs, the current system regresses everything to the mean, in 
terms of the importance of various areas of research, while allowing the
political appointees much freer rein to determine what areas of research are
priorities. Under MAHA, one can easily perceive how pseudoscience- and
antivax-oriented research could be prioritized over the sorts of research
projects important to understanding and treating diabetes that used to be
encouraged through NOFOs.

Then, of course, the editorial correctly points out how, even though Congress
has rejected this policy, the administration keeps trying to make massive cuts
in funding to the NIH, revealing its true aim: the evisceration of
government-funded research as an area that had been (mostly) protected from raw 
partisan politics in a norm going back 80 years. Similarly, the editorial notes 
that the administration is cutting back on multicenter clinical trials and
overall center grants, even though historically these have been very successful.
This one hit home for me, because I am faculty at an NCI-designated
comprehensive cancer center, which is the result of—you guessed it!—a center
grant. There are currently 57 NCI-designated comprehensive cancer centers, whose
Cancer Center Support Grants (sometimes called “core grants”) fund them;
unsurprisingly, they are considered the “best of the best” when it comes to
clinical care and cancer research. Do I worry about what this administration
might do to cancer center grants? You bet I do, just as much as Dr. Kahn and
colleagues are concerned about center grants that have funded Diabetes Research 
Centers, Centers for Diabetes Translation Research, Cystic Fibrosis Research and
Translation Centers, Nutrition Obesity Research Centers, and Mouse Metabolic
Phenotyping Centers.

The editorial concludes with a call to action:

Given the proposed budget cuts and the reduction in opportunities for scientists
with appropriate expertise to continue their work and drive new science, we as 
clinicians, scientists, and U.S. citizens call on members of all communities in 
our country to make their thoughts known. While we have focused this editorial
on diabetes, the threat is not limited to this disease. The proposed changes
could affect progress for every disease and every American. There is an urgent
need for all of us to bring attention to these destructive processes and halt
them before the ongoing and proposed dissolution and destruction of critical
components of our biomedical research infrastructure are completed. Enough is
enough! We call on all concerned citizens of our beloved country to contact
their congressional representatives to declare their alarm about what is
happening at HHS. We also request that all organizations established to ensure
the health and welfare of U.S. citizens clearly and loudly make their voices
heard and declare their alarm about what is happening at HHS. It is no longer
enough to stand idly by or work behind the scenes with lawmakers. Moreover, it
is no longer appropriate to fret about political backlash. Now is the time to
recognize and fight to reverse the spiraling fall of the United States of
America’s status as the foremost nation in health care innovation. As a nation, 
we must continue to believe in ensuring better health for all.

A few brushes of a pen, some clearly visible through budget requests, others
less so through internal machinations, are rapidly destroying what generations
have built. We can no longer afford complacency and fear. We must all act now!

I can’t argue with this sentiment, although I fear that it might already be too 
late. The damage done in just the last year and a half will arguably take
decades to repair, if it is ever repaired at all. Whether you believe it’s too
late or not, however, the basic message of the editorial that Dr. Kahn and
colleagues were passing out to attendees of the ADA annual conference was
basically a recounting of the damage that this administration is doing to the
federal biomedical research infrastructure and a call to action to oppose it.

Why did the ADA censor scientists so bluntly?

As I read the stories about this incident, a question kept bubbling up in my
mind: Why on earth would the ADA, a medical and scientific professional society 
dedicated to the study and treatment of diabetes, do something like this? The
reasons that they gave when reporters started contacting them were not
encouraging:

The ADA confirmed to MedPage Today that five registered scientists had been
removed from the meeting, claiming the scientists had violated the
organization’s code of conduct for conferences. “These attendees were escorted
out by our onsite event security because they demonstrated behavior not
consistent with this code of conduct,” the ADA media team said in a statement.
“They were respectfully given the opportunity to cease this behavior and chose
not to which is why they were escorted out.”

“All attendees will conduct themselves in a professional and respectful manner, 
free from any form of discrimination, harassment, or intimidation,” the code of 
conduct states. “Inappropriate conduct, including but not limited to harassment;
threatening or unwelcome physical or verbal actions; or disorderly or
disruptive conduct such as protesting, will not be tolerated.”

After all, as PZ Myers put it:

The order refusing to allow the distribution of papers is pure bullshit. It is
common practice for researchers to bring along copies of their relevant papers
and hand them out. I’ve been at poster sessions where the author brings in a
small stand and has a stack of papers that people can take away. Why would you
limit the dissemination of information at a meeting whose purpose is to
disseminate information?

In fairness to the ADA (even though they haven’t really earned it), standing
near the entrance to a convention hall and standing in front of one’s poster are
not quite the same thing, logistically speaking at a meeting. When you’re doing
a poster session, having reprints of the paper that the poster is based on is a
way to spread your work to other scientists who approach your poster and show
interest, whereas passing out papers in a public area of the convention is a
little more intrusive. Even so, PZ’s basic overall point is sound.

The email from the ADA to Dr. Kahn also stated:

The email went on to note that there are “a lot of logistics and security
measures taken when a federal official is in attendance.” A spokesperson for the
N.I.H. did not immediately respond to a request for comment.

Several of the researchers said they believed they were removed partly because
the association feared repercussions from the Trump administration.

Indeed.

The question, of course, was how broadly the ADA’s policy stated in the email
should reasonably have been interpreted. I saw no sign from the videos that the 
scientists passing out the articles had been “protesting,” harassing other
attendees, being in any way “threatening,” “disorderly,” or “disruptive.” True, 
one might say that they were “protesting,” but in about the most low-key manner 
you can imagine. All they had in their hands were piles of reprints of the
Diabetes Care editorial, and, as far as anyone has reported, all they were doing
was offering them to people entering the auditorium for what attendees thought 
was to be a talk by Dr. Bhattacharya. Yet, the organizers, instead of first
having someone politely inform Dr. Kahn and his colleagues that they weren’t
allowed to do this, apparently called security and the state police to do it.
That by itself is an intentionally intimidating action that seemed quite out of 
proportion to the task of dealing with several diabetes scientists passing out
copies of an article, at least two of whom were well-known to the ADA given past
awards, presentations, and even leadership positions. Calling the police
suggests panic.

Indeed, according to one of the scientists:

Irl Hirsch, a University of Washington endocrinologist who was among the group
handing out the editorials but did not have his badge confiscated, said that the
group was peaceful and that there were no signs or chants. Hirsch described the
situation as “censorship” by the scientific society — of leaders in the
diabetes field who were sharing an editorial that pointed out that the NIH’s
stewardship of biomedical research was having a destructive effect on diabetes
research.

It’s an imperfect analogy, but you know what this reminds me of? Back in the
day, antivax “scientific conferences,” such as Autism One, were known to sic
security and police on anyone attending their conference whom they perceived as 
an enemy, such as when pro-vaccine and pro-science advocates attended in order
to see what was being said and presented there, expelling them under threat of
arrest. Seriously, ADA, this is not a good look. Have you ever heard of the
Streisand effect? Well, you’re learning about it now. If you had just allowed
the scientists to pass out their articles, even if you thought it might be a
violation of conference policy, chances are that no one would have heard about
it. Now it’s national news—maybe even international news—with reports appearing 
in nearly every major news outlet in the US that you sicced security and state
police on a bunch of mild mannered scientists, one of whom is the editor of your
flagship journal and one of whom is a past president of your organization, who 
were doing nothing more than politely passing out a copy of an article published
in your flagship journal. It’s not a good look. In fact, it’s a public
relations disaster by any definition of the term.

The ADA annual conference is, of course, a private event, and its organizers can
determine and enforce any rules that they want to. The ADA is free to run its
annual meeting any way it wishes, but the overall reaction to this handful of
scientists passing out copies of an editorial seems more than a little overblown
given the magnitude of the perceived “offense,” which is why I add that I’m
free to accuse the ADA of rank cowardice and “obeying in advance” if I desire.
After all, NIH Director Jay Bhattacharya was originally scheduled to be the
speaker. Even though he is, as I’ve said many times, a useful idiot for the
Trump administration’s destructive policies devastating HHS science agencies,
such as the NIH, CDC, and FDA, he is the face of Trump administration
initiatives targeting the NIH and CDC, for the latter of which he currently
serves as temporary director. One might imagine that organizers of the ADA
meeting were terrified of what the Trump administration might do if they didn’t 
do anything.

The ADA still has a chance to redeem itself. Unfortunately, the conference ended
yesterday, making it too late to rescind its ban on the scientists and let Dr. 
Kahn and others scheduled to present or moderate panels do what they were
scheduled to do. However, the ADA can—and should—issue a genuine apology to
those harassed and ejected by security and police and then do something to make 
it right. Somehow, I doubt that the ADA realizes yet just how bad the hit to its
reputation due to their decision to seemingly obey in advance is. The Streisand
effect is powerful, and obeying in advance will not help them.

Unfortunately, the ADA didn’t do any of that—quite the opposite, in fact.
Yesterday, the ADA issued a statement demonstrating that its leadership has
learned nothing from the backlash:

As many of you are now aware, an incident took place at the American Diabetes
Association’s (ADA) Scientific Sessions. 

As a 501(c)(3) organization, the ADA has safeguards in place to ensure that it
complies with all IRS regulations. This includes maintaining a strictly
nonpartisan environment at all organizational events and functions while
engaging across party affiliations to advance our mission. We have always, and
will continue to welcome scientific inquiry, respectful dialogue, and diverse
perspectives in the pursuit of better outcomes for people living with diabetes
and obesity.

I’m not a lawyer, but my understanding is that remaining nonpartisan does not
require that a 501(c)(3) organization actively decide to silence criticism of
the party in power not endorsed by the organization at an organization event.
Such organizations are prohibited from supporting political candidates and
lobbying, but, unless I’m misunderstanding the restrictions, 501(c)(3) does not 
demand suppressing criticism of one party at an organization conference.
Moreover, the article being passed out is prefaced with a very definite
disclaimer that it represents only the opinions of the authors and not the
official opinion of the ADA. The above statement by the ADA is nothing but pure 
cowardice, fear that the Trump administration might try to strip the
organization of its nonprofit status if it hadn’t acted as it did. Any lawyers
or tax experts out there, feel free to educate me (and our readers) if I’m in
error.

As for Podcast Jay, here’s a great chance for him to put his money where his
mouth is, for instance, by living up to his sentiment, “If you don’t have free
speech, you cannot have science.” I agree, but freedom of speech should apply to
all. Will it? Will Dr. Bhattacharya apply this standard to scientists who are
critical of the administration in which he serves and the policies that he’s in 
charge of implementing? Or will he remain silent because these scientists who,
unlike him, were censored by a medical professional organization, are opposed to
what he is doing. There’s only one way for him to do this, and that’s to speak 
out against the censorship of Dr. Kahn and his colleagues who were censored,
ejected, and banned from the ADA conference, their lanyards and papers
confiscated. Seriously, Podcast Jay, do you really believe that free speech is
essential to science?

I think we know the answer. As is the case with nearly all these free speech
martyrs and warriors, it’s free speech for me, but not for thee, and when I face
pushback and consequences due to my speech it’s “persecution” and “censorship,”
but when you face the same it’s just consequences.


Dr. Jay Bhattacharya, Who Claimed He “Would Have” Perfectly Controlled COVID, Is
Letting Thousands of Americans Get Explosive Diarrhea Now That He Has Power

“Explosive diarrhea” is a fitting legacy for Dr. Jay Bhattacharya and everyone
else involved with the failed MAHA/MAGA project he enabled.

Jonathan Howard on July 17, 2026

Link


“We Would Have…”

SBM readers will be very familiar with my thoughts about this Tweet from Dr. Jay
Bhattacharya. While he probably sent it without much thought, it ended up being
a highly revealing comment. Like all MAHA/MAGA doctors, Dr. Bhattacharya didn’t
actually do anything when COVID raged. Rather, he spent his time on Fox News,
podcasts, and social media portraying himself as a superhero more powerful than 
SARS-CoV-2.

Incredibly, many “intelligent” people fell for this boastful fantasy, and Dr.
Bhattacharya leveraged his imagined feats of glory to gain positions of great
power and responsibility. We’ve all gotten an opportunity to evaluate his
real-world competency, which matters infinitely more than make-believe Tweets
like this.

“RFK Jr Will Disrupt the US Medical Establishment”

Dr. Bhattacharya claimed the best was yet to come, however. In November 2024, as
MAHA loomed, he wrote an article titled RFK Jr Will Disrupt the US Medical
Establishment. In it, he predictably pushed the fantasy of the optional
pandemic, treated vaccines as the worst part of the pandemic, and blamed the
“left-leaning medical establishment” for the consequences of SARS-CoV-2.
However, his main goal was to promote Kennedy as the savior of American medicine
and science. He wrote:

Medical officials failed badly in the Covid era by supporting lockdowns, school 
closures, toddler masking, and mandates. Their championing of anti-science
policies has caused massive health and social harm, which reverberates today.
The 2024 US election was a vote against the establishment and in favour of
fundamental reforms; it is unsurprising that the same establishment which
endorsed lockdowns and mandates now fights kicking and screaming against
oncoming change.

The rot, having accumulated over decades, was plain for all to see. The National
Institutes of Health (NIH), whose annual budget is $45 billion, orchestrated
under the leadership of Francis Collins and Anthony Fauci a massive suppression 
of scientific debate and research. The Centers for Disease Control and
Prevention (CDC) exaggerated risk and issued policy guidance with little
evidence in support of unprecedented vaccine mandates. The Food and Drug
Administration (FDA)’s conflicts of interest with the pharmaceutical industry
meant vaccines and therapeutics were approved with little to no evidence,
sometimes based on faulty modelling. And the Biden administration pushed all of 
this with orchestrated PR campaigns, spreading falsehoods and misinformation.

Clearly, the status quo is no longer tenable. Trust in American physicians and
hospitals dropped from 71% to 40% between 2020 and 2024, according to a July
study in JAMA. A Covid-era political realignment facilitated Trump’s electoral
win last week, with a coalition that included disenchanted Left-liberals who
rejected the centralised power of scientific bureaucrats and found an ally in
Kennedy…

His agenda will focus on decentralising power in America’s recalcitrant
scientific and medical institutions, offering an opportunity to allow true
scientific research and evidence-based policy to flourish. With his focus on
chronic disease and children, research priorities will realign with public
health ones. Kennedy also plans to confront the veil of secrecy and dishonesty
that inhibits transparency and integrity in public health and medicine. He
intends to strengthen checks and balances in Government health bureaucracies to 
confront groupthink and undue corporate influence. More than that, he is seeking
to ensure open public debate in medicine, recognising that science is
incompatible with censorship.

‘Explosive Diarrhea’ Parasite Cases Up Over 400% In A Week In Hardest-Hit State 
— As Experts Search For Source

A lot has happened since then. Have Kennedy and MAHA/MAGA doctors allowed true
scientific research and evidence-based policy to flourish as Dr. Bhattacharya
promised? It doesn’t seem that way to me,

ProPublica journalist Annie Waldman wrote a social media thread that provided a 
glimpse into what Kennedy’s disruption and MAHA/MAGA doctors’ competence looks
like in action. She noted that “Thousands of Americans are getting sick from a
foodborne parasite, and federal regulators have still not publicly identified
the source.” She then posed a vital question:

So what’s been happening in the federal government over the past year that might
be a factor in this outbreak?

Her answer revealed the incompetence and malevolence of our bumbling medical
establishment and it’s worth sharing in its entirety, along with the links she
provided.

Before we go there…what is driving the outbreak? It’s called Cyclospora, a
parasite that causes watery (sometimes explosive) diarrhea, nausea and fatigue. 
While it can be treated with antibiotics and is not typically deadly, it can
persist for weeks. Outbreak Of Diarrhea-Causing Parasite Grows to More Than
1,000 Cases

The parasite spreads through feces; and past outbreaks have been linked to fresh
produce, which may be washed or grown with contaminated water. During an
outbreak, the FDA and CDC typically work together with states to investigate and
identify the source. CDC Surveillance of Cyclosporiasis

These investigations are challenging, and federal regulators are surely working 
around the clock to figure out the source of this current outbreak. However, the
administration made some changes over the past year that may be impacting
critical regulatory work.

Last year, the FDA lost +400 workers that support inspections of everything from
dairy farms to seafood processors. More than 240 consumer safety specialists
left across the agency, including nearly 40 workers responsible for safeguarding
food. Gutted: How Deeply Trump Has Cut Federal Health Agencies

~40% of fresh vegetables are imported from foreign countries. Last year, due to 
staffing cuts, American inspections of foreign food facilities plummeted to
historic lows. Food safety experts said there would be a higher risk of
outbreaks. Foreign Food Safety Inspections Hit Historic Low After Trump Cuts

The workforce cuts coincided with other actions the administration took that
poked holes in our food safety net. Last year, the FDA announced it was delaying
compliance w/ a rule to speed up the identification and removal of harmful food
products. FDA Constituent Update.

It also suspended a quality control program that ensured consistency and
accuracy across its 170 pathogen and contaminant labs as a result of staffing
cuts. US FDA Suspends Food Safety Quality Checks After Staff Cuts.

And it quietly scaled back the Foodborne Diseases Active Surveillance Network,
also known as FoodNet, shrinking the required surveillance to just two
pathogens: salmonella and a common type of E. coli. One of the pathogens they
made optional for states to report: Cyclospora.

Today, HHS maintained on X that it never stopped tracking Cyclospora, and that
the FDA and the CDC were working with state and local partners to investigate
the current outbreak.

Ohers pointed out that the CDC team responsible for processing parasite samples 
was cut from 11 to 3 scientists, and though Ms. Waldman wrote her thread only a 
few days ago, it is already hopelessly out of date. There are now nearly 7,000
confirmed or suspected cases in over 30 states. Over 100 people have been
hospitalized, and affected individuals describe weeks of misery. One woman from 
Ohio said:

There were moments where I was literally just camped out in the bathroom… It’s
not for the weak, and it’s kind of scary to think of the effects it would have
on elderly people or young kids or people who aren’t healthy or who are already 
immunocompromised… I was extremely weak. I couldn’t even do the flight of stairs
to get into my house without getting short of breath.

As with measles, shot-out windows at the CDC, and pretty much everything else,
Dr. Bhattacharya hasn’t demonstrated an iota of competence now that he has the
opportunity to prove his real-world mettle. Though he claimed he “would have”
perfectly contained COVID, he’s totally AWOL today, with nothing to say about
the current cyclospora outbreak.

Instead of doing his job, keeping Americans safe from dangerous pathogens, Dr.
Bhattacharya is still, even today, relitigating 2020 on revisionist history
propaganda podcasts. However, in 2025, thanks to his “leadership” at the CDC and
the wreckage left by exiled MAHA/MAGA doctors at the FDA, lettuce is dangerous 
to Americans. Meanwhile Kennedy, whom Dr. Bhattacharya claimed would usher in a 
scientific golden age, is spending his time making bizarre work-out videos and
podcasts with wellness influencers.

In his article claiming that Kennedy would be a “disruptor”, Dr. Bhattacharya,
bitter and accusatory as always, said the following about his predecessors:

Yet the officials continue to deny their own culpability, avoiding a long look
in the mirror.

This wasn’t true then, but it is true now, and “explosive diarrhea” is a fitting
legacy for Dr. Bhattacharya and everyone else involved with the failed
MAHA/MAGA project he enabled.

I Wasn’t Worried About Hantavirus Until Lockdown Jay Told Me Not to Worry About 
Hantavirus

Locked down Americans sound off on Jay Bhattacharya: “It’s a violation of trust”
and “They are acting in bad faith.

Jonathan Howard on May 22, 2026

Link


“The central problem right now, I think, is the fear that people still feel
about COVID.”

Dr. Jay Bhattacharya began his career as a pandemic pundit in March 2020 by
writing a powerful defense of lockdowns. He said:

If it’s true that the novel coronavirus would kill millions without
shelter-in-place orders and quarantines, then the extraordinary measures being
carried out in cities and states around the country are surely justified.

Though Dr. Bhattacharya felt extraordinary measures were justified for dangerous
viruses, he spent the rest of the pandemic trying to convince people that
SARS-CoV-2 did not rise to the occasion. Indeed his next sentence was:

But there’s little evidence to confirm that premise—and projections of the death
toll could plausibly be orders of magnitude too high.

SARS-CoV-2 turned out to kill and injure a lot of people after all, though Dr.
Bhattacharya never looked back. As SBM readers know, he gained fame and power by
falsely numbing people to its risks. He was the boy who cried lamb. Though
there are countless examples, in April 2021 Dr. Bhattacharya said, “the central 
problem right now, I think, is the fear that people still feel about COVID.” The
Delta and then the Omicron variants arrived soon after that, killing countless 
people who followed his instructions and lived without fear.

“This is not COVID”

Fast forward to today, and Dr. Bhattacharya is making the media rounds, yet
again trying to pacify people about a virus, though he is now doing so in his
role as acting CDC director. “This is not COVID,” he said about hantavirus,
implying that maybe, just maybe, COVID was a big deal after all. “We don’t want 
to cause a public panic over this,” he added. The risk is “very, very, very
low‘” he said in another interview. After bashing and purposefully undermining
dedicated CDC employees for years, Dr. Bhattacharya lavished praise on them,
saying “I’ve been so impressed by the professionalism of the people that are
there. The disease outbreak people are true professionals.” It’s the exact same 
thing as with COVID- calm down, there’s nothing to worry about, everything is
going to be just fine.

“It’s a violation of trust” “They are acting in bad faith.”

Despite his soothing words about hantavirus, now that he has real-world
responsibility for the first time ever, Dr. Bhattacharya is using extraordinary 
measures to contain it. Lockdown Jay is back. According to an article titled
American Passenger Blocked From Leaving Federal Hantavirus Quarantine:

“They are requiring us to remain in a locked facility and threatening us,” said 
Ms. Perryman, 47, “and denying us the right to home quarantine.”

Federal health officials did not respond to requests for comment. But the order 
Ms. Perryman shared with The New York Times says officials believe she would
“constitute a probable source of infection to other people” if she left the
facility to travel to another state.

The mandatory quarantine, citing public health law, was authorized by Jay
Bhattacharya, acting director of the Centers for Disease Control and Prevention.

It turns out that Tweeting about how one “would” handle a virus is a lot easier 
than actually having to handle a virus. As someone said on social media, “It’s a
lot easier to shoot one’s mouth when one has no responsibility or
accountability for decisions that affect millions of people.”

Dr. Jeremy Faust also reported that locked down Americans are not happy with Dr.
Bhattacharya right now. He revealed that “Violations of this order may subject 
you to a criminal fine and/or up to one year in jail” and quoted one passenger
as saying:

The regulations require these orders to be issued within 72 hours of a person’s 
being ‘apprehended.’ But the CDC/HHS folks evaded that requirement by
continuously obfuscating whether we were here voluntarily since our arrival last
Monday, even in response to repeated, pointed questions. So, I think we have
plenty of reasons to believe they are acting in bad faith.

Dr. Faust also spoke to Ms. Perryman who said:

At this point, I don’t actually trust them to use information responsibly. I’m
no longer willing to offer them additional information because of a violation of
trust. I’ve in fact asked that the information that I previously provided them 
in good faith be removed if I can legally do that. Now it’s a violation of
trust.

Talk about a biomedical security state, and it’s not just with hantavirus. Dr.
Bhattacharya is also issuing travel bans to contain Ebola. In an alternate
universe where Kamala Harris’s CDC director did any of this, there is no doubt
that Dr. Bhattacharya would invite Ms. Perryman on to his podcast to let her
vent about this “violation of trust” and the horrors of the authoritarian CDC.
That’s all he did previously.

“New leadership… are the first needed steps to restore trust”

To be clear, quarantining people to limit hantavirus seems reasonable to me.
It’s better to be safe than sorry with dangerous viruses, even though hantavirus
is obviously not COVID, and I’m not particularly worried about it. However,
this is because trusted experts reassured me, not because of anything Dr.
Bhattacharya said. He’s never acknowledged his countless previous errors and
hurled juvenile, unprofessional insults at anyone who pointed them out. As such,
the problem isn’t that Dr. Bhattacharya is necessarily wrong about hantavirus, 
it’s that he’s totally untrustworthy.

Given that Dr. Bhattacharya didn’t treat COVID as COVID, can we trust him to
level with us if a dangerous virus emerged? Would Dr. Bhattacharya, Kennedy, and
the doctor who hosted the Erection Connection podcast would be able to
competently handle it, especially given they’ve already botched measles and
deliberately sabotaged our pandemic response? Would the “true professionals”
remaining at the CDC be allowed to do their job, free of political interference?

Of course not. It’s obvious to everyone that Dr. Bhattacharya has no idea what
he is doing and is making things up as he goes. He had his chance to prove his
mettle at the CDC, and the verdict is in- “it’s a violation of trust; they are
acting in bad faith.” All of this come on top of his well-established ineptitude
and malevolence at the NIH.

So, what should incompetent public health leaders do once they’ve lost the trust
of the American people? Well, back when he was a content creator who
specialized in spreading disinformation and doubt, Dr. Bhattacharya answered
that question himself.

My Sincere Message to Dr. Jay Bhattacharya: Welcome Aboard and Good Luck. We Are
Rooting for Your Success.

It seems having real-world responsibility has taught Dr. Jay Bhattacharya a
valuable lesson- it’s better to try to stop dangerous viruses rather than play
catch-up after a lot of people have already died.

Jonathan Howard on May 24, 2026

Link


“We would have…”

In my opinion, this is one of the most revealing statements of the pandemic.
Safe from his Stanford office, typing away at his keyboard, Dr. Jay Bhattacharya
claimed he “would have” handled COVID perfectly had it not been for dastardly
villains at Twitter and the NIH. If only his plan for herd immunity via natural 
immunity had been adopted, then schools would have been open, the vulnerable
would have been protected, and everything would have been just fine.

Incredibly, from Princeton professors to libertarian podcasters, an
extraordinary number of seemingly intelligent people believed him. They honestly
thought that just because Dr. Bhattacharya claimed he “would have” done amazing
things when COVID raged, that meant he actually had the skills and competence
to do them. They were genuinely impressed that Dr. Bhattacharya and his ilk
“argued for” a wonderful alternative to the horrible pandemic. They praised him 
thusly:

The authors of the Declaration argued that for the low-risk majority, normal
life should otherwise resume. Schools and restaurants should reopen, and
teaching should be in person (with special provision made for older or
immunocompromised teachers and students).

Wouldn’t it have been nice if we just ignored the virus and everything turned
out OK.

Dr. Bhattacharya was selling them an irresistible fantasy where he was a
superhero, COVID Man, More Powerful Than a Deadly Virus, and all the things we
loathed about the pandemic, the deaths and mitigations alike, were actually
caused by stupid people making stupid decisions, not a novel, deadly virus
repeatedly washing over us and changing in unpredictable ways. In his telling,
both the origins and consequences of COVID were entirely the fault of the people
whose job it was to limit it.

In this way, Dr. Bhattacharya portrayed the pandemic as essentially optional,
the product of obviously bad choices, and the credulous opinion class was
desperate to believe it the whole thing could have been avoided. None of these
people saw what COVID could do and that mattered. They were entirely
uninterested in hearing from anyone who worked in a hospital during a COVID
surge. A dose of reality would ruin their fantasy.

Health Experts ‘Stunned’ by Trump Officials’ Strict Quarantine Measures.

Well, fate has given us a cruel, but fascinating natural experiment. The COVID
fantasy world has collided with the MAHA real-world. The heroic doctors who
“would have” done amazing things have been given an opportunity to prove their
mettle. Their fictional accomplishments bought them real-world responsibility,
and unsurprisingly things are a mess. Many of them have flamed out, leaving
chaos in their wake. Tweeting and doing are two different skill sets, it turns
out.

Tweeting about RCTs isn’t that impressive

Dr. Bhattacharya remains in power, for now, and he is a changed man. In previous
articles, I have documented how he has contradicted his core pandemic stances
now that he has actual responsibilities.

Some of these changes have been for the worse. Though Dr. Bhattacharya at least 
feigned concern for the “open exchange of ideas” when it came to his YouTube
videos, today he is an eager, key member of MAGA’s vast censorship regime.

However, in Friday’s article I discussed how Dr. Bhattacharya has also
completely changed his approach to dangerous viruses. Under his leadership, the 
headlines read Health Experts ‘Stunned’ by Trump Officials’ Strict Quarantine
Measures. All of a sudden, he is taking viruses very seriously and is desperate 
to stop them. He is deploying the same “draconian lockdowns” and “extraordinary 
measures” he decried daily for years, and he is holding steadfast despite
significant criticism and pushback.

As a reminder, here’s what locked down Americans are saying right now about
their experience:

The regulations require these orders to be issued within 72 hours of a person’s 
being ‘apprehended.’ But the CDC/HHS folks evaded that requirement by
continuously obfuscating whether we were here voluntarily since our arrival last
Monday, even in response to repeated, pointed questions. So, I think we have
plenty of reasons to believe they are acting in bad faith.

And:

At this point, I don’t actually trust them to use information responsibly. I’m
no longer willing to offer them additional information because of a violation of
trust. I’ve in fact asked that the information that I previously provided them 
in good faith be removed if I can legally do that. Now it’s a violation of
trust.

I have no insight into what that led to Dr. Bhattacharya’s dramatic change of
heart. The most plausible explanation is that the White House recognized that
after their failure to contain measles, other viruses killing Americans would
not generate good headlines as the midterms approached. As one person put it on 
social media:

This is not actually the tiniest bit surprising, because while it’s fun and
games to shit all over public health when there’s no imminent threat, there is
nothing that would be worse for Trump, his people, or his legacy than a second
pandemic.

Dr. Bhattacharya’s superiors likely demanded that he put up a strong defenses
against deadly viruses, thus forcing him to choose between losing his job or
undermining his entire justification for having it in the first place.

Dr. Bhattacharya chose to keep his job. He saw what happened to his friends at
the FDA when they failed Trump, and he was willing to sacrifice his COVID
identity rather than suffer their ignominious fate. As Jeff Kunzler, the author 
of the Pandemic Accountability Index, pointed out, his Twitter avatar even says 
“no more lockdowns.” Everyone knows that by harshly locking down Americans
today, Dr. Bhattacharya is betraying everything he stood for regarding COVID and
has become the “biomedical security state” he warned about. No matter how much 
be blathers on about “medical freedom,” his actions speak for themselves. As Dr.
Julia Raifman recognized:

Maybe it was never about anti-lockdown and always about scapegoats for dividing 
& diminishing core institutions that support social goods, from public health,
to equity, to education.

Another possibility is that Dr. Bhattacharya ordered these lockdowns himself.
Perhaps it’s finally dawned on him that he is the medical establishment, and
it’s his job to protect Americans from dangerous viruses. Dr. Bhattacharya is
many things, but he is not stupid. He knows that podcasts and Tweets won’t stop 
a virus, and he is aware of something important- if another pandemic emerged, we
are much less prepared to handle it than we were in 2020, precisely because of 
his disinformation and that of his MAHA brethren. Their efforts to spread doubt 
and sabotage our pandemic response succeeded, and Dr. Bhattacharya is now forced
to deal with the consequences of his own actions.

Competent pandemic response teams cannot be conjured out of thin air, and his
current attempts to valorize the CDC workers he previously trashed are futile.
His mistrust genie has escaped and can’t be put it back in the bottle. If COVID 
2.0 arrived, we’d be doomed, and I suspect Dr. Bhattacharya has enough insight
into his own leadership abilities to know this. He doesn’t want Ebola and
hantavirus spreading under his watch. He wants to get ahead of the game.

Based on his stringent responses to these viruses, there’s every reason to
believe that if Dr. Bhattacharya actually had responsibility in 2020, he “would 
have” used the exact same “extraordinary measures” he is actually using today.
Had he been in charge 6 years ago, he would not have been able to keep schools
open or protect the vulnerable.  But such silly speculations and guessing games 
about a hypothetical 2020 where Dr. Bhattacharya ran the show misses the point
entirely. The real version of Dr. Bhattacharya is using travel bans, mandatory
airport testing, and forced quarantines. That’s all that matters. The COVID
superhero version of Dr. Bhattacharya existed entirely on social media and
YouTube.

As such, literally everything he “proposed” and “argued for” regarding COVID can
be thrown in the trash. His entire COVID output was just empty words and
baseless boasts. All of it. The same is true for the sheltered pundits who
promoted his fantasy of an optional pandemic. All of their well-reviewed books
and “heterodox” podcasts portraying Dr. Bhattacharya as COVID Man can be
similarly tossed away based on his real-world performance the past year.

But while Dr. Bhattacharya’s past cannot be erased and the enormous damage he
did cannot be reversed, I am surprised but pleased that he is taking deadly
viruses seriously, especially considering he’s torched his COVID reputation in
the process. Unlike some other doctors, his ending in the absurdist MAHA soap
opera has yet to be written. My goal here is not to say “you’ve to hand it to”
Dr. Bhattacharya or to defend his specific actions, but to recognize that
reality forced him to concede an important principle- under extraordinary
circumstances, the government can use extraordinary measures to protect
Americans from grave threats.

It seems having real-world responsibility for the first time has taught him a
valuable lesson- it’s better to try to stop dangerous viruses rather than play
catch-up after a lot of people have already died. That’s all his critics have
ever said, and it’s nice to see he’s catching up to us, finally. This all may be
a momentary blip, but as long as Dr. Bhattacharya is truly committed to keeping
Americans safe from dangerous viruses, no one should undermine him the way he
undermined his predecessors. Our message should be, welcome aboard and good
luck. We are rooting for your success.


Stephen Macedo And Frances Lee: Defend Your Essay That Dr. Jay Bhattacharya
Would Restore Trust in Public Health

From shuttered labs to kids with measles, others are paying the price for your
need to feel “special” and “heterodox,” and no one should let you forget that.

Jonathan Howard on July 26, 2026

Link


Dear Professors Macedo and Lee,

When MAHA loomed in the fall of 2024, we at SBM desperately tried to warn people
about it. We were very familiar with Kennedy and his ilk. We’d written
extensively on their fake statistics, anti-vaxx propaganda, and preposterous
predictions- that herd immunity to COVID was imminent, that immunity to it was
long lasting, that variants were nothing to worry about, and that the mass
infection of unvaccinated youth would end the pandemic in 3-6 months. We were
rightfully fearful of what they would do in power.

In a review of We Want Them Infected, my book on these disinformation doctors,
titled These ‘Experts’ Sold The U.S. On A Disastrous COVID Plan, and Never Paid 
A Professional Price, Michael Hiltzik wrote:

They’ve held credentials from some of the world’s most elite universities —
Harvard, Stanford, Johns Hopkins, Oxford. They’ve been welcomed into the highest
government policy councils. They became fixtures on television news shows and
were quoted incessantly by some of the nation’s leading newspapers.

They’re a cadre of academics and scientists who pushed a discredited solution to
the COVID pandemic, shunning masks, school closings, even vaccines, all in the 
name of reaching the elusive goal of “herd immunity,” resulting in what may have
been hundreds of thousands of unnecessary American deaths…

In a world guided by science, the promoters of an unsuccessful herd immunity
theory would long ago have lost their credibility and their public soapboxes.
The opposite has happened…

At this moment, anti-science ideology on the right appears to be in the
ascendance. Agitation against the COVID vaccine is metastasizing into an
opposition movement against all childhood vaccinations, a trend that threatens
to produce a surge in other vaccine-preventable diseases such as measles and
polio.

“The anti-vaccine movement has spotted an opportunity to sow doubt,” Howard told
me. “Getting rid of all school vaccine mandates has always been the Holy Grail 
for them.”

Howard’s book is a warning. We may be on the verge of a public health disaster, 
because the promoters of a failed theory that COVID could be fought through
“natural immunity” without vaccines have been able to wrap themselves in the
mantle of truth-tellers. But they’re not.

That was written in May 2023, as MAHA was starting to coalesce, and it seems
pretty prescient to me. Some of us saw this public health disaster coming from a
mile way, though that was no great achievement to be honest. The threat was out
in the open for everyone to see. All anyone had to do was care about it, which 
you didn’t.

While much of my pandemic writing discussed obviously poor predictions made by
MAHA/MAGA doctors, much of my subsequent writing has been devoted to obviously
poor predictions about these MAHA/MAGA doctors. That’s where you come in.

In November 2024, you wrote an essay about Dr. Jay Bhattacharya titled Restoring
Trust in Public Health. You absurdly blamed “educated elites” for the return of
Trump, and had glowing words to say about Dr. Bhattacharya. He was a
pro-Kennedy, pro-Trump doctor and advocate of herd immunity via mass infection, 
who spread copious disinformation at the behest of a proud child labor advocate.
None of this bothered you. You overlooked it all.

“Bhattacharya exemplifies qualities that were lacking in our nation’s scientific
leadership during the pandemic,” you wrote. You concluded by saying:

If the country had had more scientific leaders like Dr. Jay Bhattacharya—and
more who were willing to listen to him—our policymaking could have been based
more on evidence and less on hubris. During the pandemic democracy’s
“truth-seeking” institutions were infected by politics, partisanship, and
dogmatism. What we need now is a strong dose of fresh thinking and institutional
reform from experts prepared to challenge the reigning consensus and renew our 
commitment to the basic values of science and liberalism.

Enough time has passed that we can evaluate his performance and that of the
broader MAHA/MAGA movement he represents. How do you feel things are going so
far? How is he doing with measles, cyclosporiasis, hantavirus, and Ebola? Has he
promoted a culture of free speech? Is the scientific community enamored with
his performance thus far? Has he restored trust in public health, as you
promised he would?

We discuss these topics every week at SBM, and we have no plans to stop. Reality
doesn’t scare us.

In contrast, you’ve gone quiet as church mice. Though you couldn’t stop talking 
about public health when it came to COVID, you have nothing to say about what’s 
happening today, and you are hardly alone in this regards. Like all sheltered
MAHA fluffers, who pontificated profusely about the pandemic, you’ve retreated
to a safe space where current events can be simply ignored. As always, unwanted 
news is unmentionable news.

This silence, this refusal to even acknowledge what is happening in STEM today, 
is both shameful and unacceptable. You portrayed Dr. Bhattacharya as a COVID
superhero who had figured everything out. You publicly endorsed him as the
savior of American science and medicine in prominent forums.

No one forced you to do that, and you have responsibility for your words. You
should either make the affirmative case that you were right, that Dr.
Bhattacharya has renewed our commitment to the basic values of science and
liberalism, or admit that you were wrong, that everything you said about him in 
your essay and revisionist history book was based on a fairy tale.

We all know that you’ll never do that, however. I am very familiar with people
like you, laptop class academics who make ignorant, foolish predictions, only to
pretend like they never happened when reality proves them wrong. You’ve gotten 
your podcast invitations, and you’ve sold your books. You now have the privilege
and luxury to simply move on. You’re just more “experts” who sold the U.S. on a
disastrous plan and never paid a professional price.

As with COVID, that doesn’t mean that there’s wasn’t a price to be paid,
however. As Dr. Gregg Gonsalves put it:

I wish I could say, may they never live this down, but sadly, they were tourists
passing through public health and biomedical research, and so are long gone
now, with all of us having to clean up the mess. Frances Lee and Steven Macedo
held the door open for the far-right takeover of science.

From shuttered labs to kids sick with measles, others are paying the price for
your need to feel “special” and “heterodox,” and no one should ever let you
forget that.


Thanks to Efforts of the “Biosafety Now” Bros, Richard Ebright and Bryce
Nickels, We Are All More Vulnerable to Dangerous Viruses, Both Old & New, From
Labs & From Nature, Exactly as I Predicted.

Professors Richard Ebright and Byrce Nickels used their voice to enable the
“charlatans and quacks”, the people responsible for the devastation of our
biosafety response.

Jonathan Howard on August 20, 2026

Link

“Bhattacharya, Gupta, and Kulldorff are not merely wrong. They are charlatans
and quacks who are dispensing deadly advice, and who need to be held accountable
for their role in hundreds of thousands of preventable deaths.”

In a previous article, I discussed an organization founded by two Rutgers
professors Bryce Nickels and Richard Ebright called Biosafety Now. It described 
itself by saying:

Biosafety Now is a US-based NGO working for a future where scientific research
on pathogens supports human life without also threatening it & public trust in
science is restored. Biosafety Now believes that research that creates new,
non-natural potential pandemic pathogens poses existential risks to humanity and
provides few, if any, benefits for science, medicine, public health, or
national security. We are convinced that public health and safety require that
all such research be subject to independent external controls, rather than be
trusted to the oversight of the scientists performing or the organizations
funding the research.

They said elsewhere:

The rapidly increasing power and rapidly decreasing cost of advanced
biotechnology has made lab-generated pandemics a threat to the survival of the
human species.

So far so good. Having witnessed what the last pandemic could do, I don’t want
another deadly virus emerging from a lab or anywhere else.

My article also discussed a revealing social media exchange I had with Professor
Ebright in 2024. In 2020 Professor Ebright had strong feelings when Dr. Jay
Bhattacharya and friends announced their plan to get rid of the virus by
spreading the virus. Professor Ebright said at the time:

Bhattacharya, Gupta, and Kulldorff are not merely wrong. They are charlatans and
quacks who are dispensing deadly advice, and who need to be held accountable
for their role in hundreds of thousands of preventable deaths.

I never produced such pugnacious prose. Professor Ebright also laid out his
preferred approach, and it could not have been more opposed to Dr.
Bhattacharya’s vision of herd immunity via natural immunity. Professor Ebright
said:

Testing, tracing, quarantine of contacts, isolation of cases, partial lockdown
and distancing at all times, full lockdown when tranmission is high, masks, and,
decisively, when available, vaccines.

When vaccines arrived, Professor Ebright supported mandates too, quoting from an
article that said:

There is a straightforward ethical argument to be made for vaccine mandates:
Herd immunity is a collective good and its absence a collective harm, so
vaccination cannot be a matter solely of personal choice.

I never advocated for mandates or lockdowns.

However, despite wanting to hold Dr. Bhattacharya “accountable” in 2020,
Professor Ebright later reversed course and invited him to join Biosafety Now,
whose sole purpose was, supposedly, to protect people from dangerous viruses. 
Professor Ebright justified his willingness to promote a “charlatan and quack”
who dispensed “deadly advice” by telling me:

My views on the @gbdeclaration have not changed, but my views on Bhattacharya
have changed.

Professor Ebright never revealed what skill set a pro-virus, health economist
brought the cause of virology biosafety. He also never explained how how Dr.
Bhattacharya had redeemed himself for having caused “hundreds of thousands of
preventable deaths“, especially considering Dr. Bhattacharya spread COVID
disinformation not just in 2020, but every year since. It continues to this day.
Professor Ebright says none of that matters today, however.

To defend his toxic apathy, Professor Ebright treated 2020 as distant historical
memory and demanded that everyone else do the same. He lectured me:

His advice was wrong. Dead wrong. But it now is 2024 (not 2020), and the
discussion at hand is how to prevent a next lab-generated pandemic (not how to
respond to the last one). I will work with any person from any party and any
background to prevent a next lab-generated pandemic. The importance and urgency 
of the objective over-ride partisan differences and ideological differences (as 
should be clear to any rational person).

Only laptop class professors talk about 2020 this way. Those of us who
experienced it in hospitals don’t have Professor Ebright’s luxury of amnesia.
And though he treats frontline doctors with contempt and scorn for questioning
him, if there’s a new pandemic, we’ll be the ones risking our health, mental and
physical, while he’s safe at home spewing bile against us.

“Biosafety Now is ensuring we are much less prepared to fight a future pandemic,
as well as existing viruses such as COVID and measles.”

In a follow-up article titled A “Biosafety” Organization Partnering With Dr. Jay
Bhattacharya To Guard Against Viruses Is Like A Zebra Teaming Up With A Lion To
Promote Vegetarianism, I made a bold prediction of my own. I wrote:

Unfortunately, WWTI doctors also have unearned legitimacy because seemingly
credible organizations with with catchy names, like Biosafety Now, vouched for
them and deluged their critics with juvenile japes. When Dr. Bhattacharya
histrionically claims that mitigation measures were an epic catastrophe and that
vaccines for young people were a tragic mistake, more people will trust him
thanks to Biosafety Now’s stamp of approval. If COVID-25 arrives, there’s no way
the public would adhere to mitigation measures as they did in 2020.

People have been instructed to forget COVID’s carnage and to trust anti-vaxx
liars like Mr. Kennedy. They have been told outright to stop trusting public
health, and as a result many people now believe that measures to contain a
deadly virus are useless at best and a sign of impending Nazism at worst. By
legitimizing Dr. Bhattacharya and his ilk, Biosafety Now is ensuring we are much
less prepared to fight a future pandemic, as well as existing viruses such as
COVID and measles.

Enough time has passed to judge the wisdom of my prediction. Are we less
prepared to fight existing viruses?  That’s not a hard question to answer, and
we are just getting started. Vaccine rates and falling and anti-vaccine
disinformation is erupting from the Oval Office, with Biosafety Now leader Dr.
Bhattacharya helping to turn Wakefield’s fraud into policy. We’ll be dealing
with the consequences for decades to come.

Neither Professor Ebright or Nickels care about this however. As MAHA loomed in 
the fall of 2024, Professor Ebright minimized the threat, confidently predicting
that “measles will be not be running rampant in schools.” For his part,
Professor Nickels thought the possiblity of viruses killing and injuring
children was funny, joking with Dr. Vinay Prasad at the time:

C’mon Vinay lets do a “debate” where I take the position that RFK Jr will be a
disaster for public health and you take the other side?

I probably will just shout at you that you are an anti-vaxx fascist that loves
polio, wants to infect everyone with measles and approves of bear killing etc…

Fast forward to today and Professor Nickels’ social media amusement has become
some children’s permanent tragedy. Measles has killed and devastated children
while keeping them out of school. Of course, measles isn’t the only existing
pathogen to spread under MAHA. That list also includes the flu. pertussis, and
cyclosporiasis– viruses, bacteria, and parasites. MAHA is failing with the whole
lot of them, not that this matters to the Biosafety Now bros, however. Other
people’s children are suffering, not theirs.

What about a new pandemic? Would Trump, Kennedy, Stephen Miller, and Dr.
Bhattacharya institute the mitigations Professor Ebright supported when COVID
raged? Would they pull off another Operation Warp Speed? Would they competently 
manage a new virus, regardless of its origin?

I don’t think so, and I am sure neither Professor Ebright nor Nickels could make
the affirmative case we are better prepared to handle a pandemic with MAHA/MAGA
in charge. This crew can’t even run a meeting or fix a few shot-out windows at 
the CDC. A terrifying article titled Trump Aims To Rebuild Defenses Against
Bioweapons As AI Fears Rise revealed just how much trouble we’d be in if
COVID-26 arrived.

The White House is working to strengthen safeguards against biological attacks
after staffing cuts early in the second Trump administration depleted expertise 
in a field where officials increasingly fear artificial intelligence could make 
it easier to create deadly pathogens.

By the end of President Joe Biden’s term, the White House had built a team of as
many as 30 people focused on biological security, according to three former
government officials who worked on the issue — two for Biden and Trump, and one 
just for Biden — and spoke on the condition of anonymity to avoid professional
retaliation.

This specialized staff was charged with coordinating the web of federal agencies
that deal with biohazards and provided scientific guidance to top officials.
That team rapidly dwindled after Trump returned to office amid cuts and
reorganizations, said the three former officials, as well as a fourth former
official, who also worked for both administrations. At times, nobody at the
White House was dedicated solely to biosecurity, according to three of the
former officials.

This is the world the Biosafety Now bros deliberately unleashed on us all.

And thus it becomes clear, Biosafety Now had nothing to do with biosafety, and
Professors Ebright and Nickels are total phonies who never genuinely cared about
protecting people from dangerous viruses. Their whole schtick was a ruse,
performance art, an opportunity for them to fundraise and boost their social
media profiles.

Their legitimate sounding organization- Biosafety Now!– also provided cover for 
their obsessive revenge fantasies against public health officials tasked with
containing COVID. An article tilted ‘Lab-Leak’ Proponents At Rutgers Accused Of 
Defaming And Intimidating Covid-19 Origin Researchers began by saying:

Fraudsters. Liars. Perjurers. Felons. Grifters. Stooges. Imbeciles. Murderers.
When it comes to describing scientists whose peer-reviewed studies suggest the
COVID-19 virus made a natural jump from animals to humans, molecular biologist
Richard Ebright and microbiologist Bryce Nickels have used some very harsh
language. On X (formerly Twitter), where the two scientists from Rutgers
University are a constant presence, they have even compared fellow researchers
to Nazi war criminals and the genocidal Cambodian dictator Pol Pot.

Apparently this sort of rhetoric is needed to prevent the next lab leak
pathogen. In reality, this vileness generated headlines such as Dr. Fauci Says
His Daughters Need Security As Family Continues To Get Death Threats and
Anti-Vaxxers Stalked Peter Hotez at His Home. Who in their right mind would step
up to contain a future pandemic knowing juvenile, narcissistic trolls will
harass them, advocate for their prosecution, and blame them for the whole thing?

No matter how much they blather on about the dangers of a new pandemic moving
forward, Professors Ebright and Nickels enabled the “charlatans and quacks”
responsible for the devastation of our biosafety response. Thanks to their
personality disorders, we are all much more vulnerable to dangerous pathogens,
both old and new, from labs and from nature. This isn’t theoretical. The viruses
have already started spreading.

That’s all that matters about them, and it’s exactly what I predicted.


Trouble in (MAHA) paradise?

Even as President Donald Trump is inaugurated today and his pick for HHS
Secretary, Robert F. Kennedy, Jr. prepares to face confirmation hearings, there 
is trouble in “make America healthy” paradise.

David Gorski on January 20, 2025

Link

So it begins…

At noon today, Donald Trump will be inaugurated for a second term as President
of the United States. It’s a longtime saying on my part as editor of
Science-Based Medicine that SBM strives to be nonpartisan, but we are far from
apolitical—nor should we be apolitical. After all, we regularly take what are
inherently political positions to promote science-based medicine in public
policy. Moreover, promoting science-based medicine is not just a scientific and 
medical endeavor; it is also inherently a political endeavor, given that the
federal government regulates and funds healthcare, drug approval, and national
public health programs, while state governments regulate the practice of
medicine, as well determining vaccine requirements for school and a number of
other medicine- and public health-related requirements and local governments
have their own laws and regulations. Indeed, that is why our now-retired
contributor Jann Bellamy frequently wrote about “legislative alchemy” designed
to provide the imprimatur of the state on pseudoscientific and quack medical
practices and specialties (e.g., licensing naturopaths and expanding the scope
of practice of chiropractors) and, before the pandemic, we used to write
regularly about efforts to weaken or eliminate school vaccine mandates and and
promote “right-to-try” laws, which were custom-designed to weaken the power of
the Food and Drug Administration. Back in the day, we used to routinely talk,
for example, Senator Tom Harkin to task because he was the driving force behind 
the creation of the National Center for Complementary and Alternative Medicine
(NCCAM), which is now known as the National Center for Complementary and
Integrative Health (NCCIH) and a Democrat who once famously expressed his
disappointment that NCCAM hadn’t “validated” more CAM. Back then, the stereotype
was that the antivaccine movement and believers in alternative medicine
consisted mainly of crunchy hippie-dippy lefties, although over the last 15
years the center of gravity of the antivax movement has shifted decisively to
the far right.

We’ve also been through this once before, and there’s no reason to suspect that 
a second Trump administration will be anything but much worse in terms of its
approach to federal health and science programs than the first time around,
particularly when it comes to public health and regulating drug approval and
safety. If you doubt that, look no further than the unholy alliance between
Donald Trump and Robert F. Kennedy, Jr., one of the most prominent leaders in
the antivax movement—and arguably the most prominent leader in the US antivax
movement—for the last two decades, ever since he first outed himself as an
antivaxxer by publishing his conspiracy-fest of an antivax propaganda article,
Deadly Immunity in 2005. RFK Jr. initially ran for President as an independent
candidate, and then reality intervened last summer, leading him to suspend his
campaign and bend the knee to Donald Trump, after having sent out feelers to
Kamala Harris, who quite appropriately ignored them. His reward, when Trump won 
the election, was, first, to be granted a major advisory role in shaping health 
policy for the Trump administration, which led him to riff on Trump’s “make
America great again” (MAGA) slogan by coming up with “make America healthy
again” (MAHA), which downplayed RFK Jr.’s longstanding rabid antivax
proclivities and tried to rebrand him as a champion of healthy foods and living 
over pharmaceuticals. (It didn’t work.)

Ultimately, President-Elect Trump nominated RFK Jr. to be Secretary of the
Department of Health and Human Services, a sprawling department that encompasses
pretty much all nonmilitary federal health policy, including overseeing the
Centers for Medicare & Medicaid Services (CMS, which also oversees the
implementation of the Affordable Care Act, the National Institutes of Health
(NIH), the Food and Drug Administration (FDA), the Centers for Disease Control
and Prevention (CDC), and the Public Health Service, among other functions. It
is a nomination that, if RFK Jr. is confirmed—and, unfortunately, I predict that
he will be, probably with a handful of Democratic votes—will represent a
catastrophe for public health and medical research, although there are hopeful
signs that I might be wrong in my prediction. (I fervently hope that I am.)

Indeed, RFK Jr. has “declared war” on the FDA and clearly had a hand in
persuading Trump to nominate a series of antivaxxers, grifters, and quacks to
head various federal agencies, including “America’s Quack” Dr. Mehmet Oz to head
CMS, blast-from-the past antivaxxer Dr. Dave Weldon to head CDC, and COVID-19
contrarians and pandemic minimizers Dr. Jay Bhattacharya and Dr. Marty Makary,
for NIH Director and FDA Commissioner, respectively. If you support biomedical
research distributed by a competitive method that is about as close to insulated
from politics as you can imagine, a robust federal public health apparatus, and
strong regulation of drug approval and oppose the privatization of Medicare,
these developments are a nightmare, and RFK Jr. represents an extinction-level
threat to federal public health programs and science-based health policy.

So why do I sense trouble in MAHA-land, a disturbance in the MAHA force, if you 
will? After all, the collection of antivaxxers, quacks, and grifters who make up
the “health freedom” movement—which I like to refer to, more appropriately, as 
freedom for quacks from any pesky government interference with their grift—are
closer than they’ve ever been to total power and dismantling science-based
federal policy with respect to drug regulation, public health, food, and
vaccines. Why, then am I seeing articles with titles like Will Robert Kennedy
Jr. Betray Us And Why That Might Be A Good Thing?, while lamenting their
perception that the “new Trump administration seems to rebrand MAHA movement as 
a ‘healthy food, anti-toxins movement’; tries to distract from or even ditch
anything to do with vaccines in general, mRNA in particular.” It’s not a new
reaction, given that antivaxxers immediately noticed (and were not happy to
notice) that RFK Jr.’s initial rollout of MAHA didn’t mention vaccines once, but
it seems to be ramping up now that Trump is poised to assume power and RFK Jr. 
is about to be confirmed as HHS Secretary.

A disturbance in the (MAHA) force?

The article I cited above wondering if RFK Jr. would “betray us” was written by 
an antivaxxer of whom I’d never heard of before, Markus Mutscheller on his paid 
Substack. (Of course!) What seems to have provoked all this doubt and dismay
among the MAHA antivax faithful was a report in the Wall Street Journal that the
Trump transition team had sidelined Aaron Siri, a longtime go-to antivax
attorney who had represented RFK Jr. and his organization in past lawsuits
seeking to weaken vaccine mandates or revoke approvals for vaccines, such as a
version of the polio vaccine:

Two vaccine skeptics who had been advising Robert F. Kennedy, Jr. as he prepares
to become health secretary have been sidelined by Trump transition officials,
people familiar with the matter said, underscoring a split over immunizations in
the “Make America Healthy Again” movement.

Adviser Stefanie Spear and lawyer Aaron Siri had asked prospective
administration hires about their beliefs around vaccines even if they were
interviewing for posts that had little to do with immunizations, people familiar
with the interviews said. Kennedy, whose hearings to lead the Department of
Health and Human Services could start on Capitol Hill as early as next week,
also lobbed questions related to inoculation, the people said.

The questions were different from those asked in separate meetings with
President-elect Donald Trump’s staff, according to some of the people. Trump’s
team asked about topics traditionally important to conservatives, such as the
size of government and deregulation.

Siri is no longer advising the presidential transition, a transition spokeswoman
confirmed, and people familiar with the matter said his vaccine stances played 
a role. Spear, who had told others she would be Kennedy’s chief of staff, was
passed over for that post in favor of a veteran of the first Trump
administration—in part because of her vaccine priorities and in part because of 
her lack of experience, according to people familiar with the matter.

Can I just take this opportunity to remind the WSJ editors and reporters that
neither RFK Jr. nor his cadre of loyalists (like Aaron Siri) are “vaccine
skeptics.” They are antivaccine. No, they’re more than that, they’re antivax
activists. Stop it, mainstream press. Just stop it.

You might also recall that Aaron Siri and RFK Jr. came up with the deceptive
claim that most vaccines in the CDC-recommended childhood vaccination schedule
had never been properly tested in double-blind randomized controlled clinical
trials using a saline placebo control. I’ve discussed why this is a profoundly
dishonest and misleading claim in great detail, but I’ll give you the
CliffsNotes version. Basically, a saline placebo isn’t always the most
appropriate comparator for a control group. Moreover, if you are testing a new
vaccine against a disease for which there already exists an effective vaccine,
it is profoundly unethical to randomize children to a saline control group and
leave them unprotected. In such a case, the only ethical way to study the
vaccine is to compare it to the existing vaccine, to make sure that it is at
least noninferior and, hopefully, demonstrate that it is superior and/or more
safe. Finally, if you trace back the history of a vaccine against a given
disease, you will nearly always find that the very first version of the vaccine 
was indeed tested in an RCT using either saline placebo or other appropriate
inert comparator. Basically, Siri and RFK Jr. have misled about this repeatedly,
either through ignorance or intentionally, take your pick.

In any event, though, I am somewhat amused, although in a gallows humor sort of 
way given the direction federal health and science policy will go regardless of 
whether RFK Jr. is confirmed or not. It’s a somewhat hopeful sign that even the 
Trump transition team recognizes that catering to rabid antivaxxers is still a
loser politically, even though RFK Jr. is a rabid antivaxxer:

The moves represent a disconnect emerging between the Trump transition and a
core faction of Kennedy’s Make America Healthy Again coalition, which helped
fuel his political rise and land him a top job in the Trump administration.
Others who have embraced elements of the “MAHA” mantra, such as encouraging
healthy eating, expect that Trump’s official agenda in office will have little
to do with vaccines.

Some key players in both Trump’s world and Kennedy’s orbit think drastic action 
on vaccines would be a distraction and a political loser, people familiar with
the matter said. Ahead of the 2026 midterm elections, Kennedy should instead
focus on racking up wins in areas such as promoting healthy food and exercise,
which some people advising the transition see as more politically palatable.

Medical freedom activists formed the core of Kennedy’s early volunteer base for 
his presidential campaign, but their fight for more scrutiny on vaccines could
wind up on the cutting room floor when he takes office.

This led Sasha Latyopova, whom we’ve met before, to proclaim:

Ok, I am just the messenger here… You can see the shitshow for yourself. The
cabal is pushing the “healthy food and exercise” and “vaccines are a political
loser” message. Which is what Trump himself voiced on several occasions.

At this point, just let me recall that Donald Trump has shown susceptibility to 
antivax messaging dating back at least to 2007 and has since at least 2012
referred to a “monster shot” that causes autism. Moreover, this dalliance
between RFK Jr. is not the first one. During the transition period before the
first Trump administration, Trump dangled the opportunity to chair a “vaccine
safety commission” in front of RFK Jr., who eagerly pursued the possibility,
only to have Trump, like Lucy pulling the football out of Charlie Brown’s path, 
yank it away. Of course, nominating RFK Jr. to be HHS Secretary and, as a
cabinet member, play a central role in the health policies of his administration
are far worse than suggesting that he chair a “vaccine safety commission.” That
being said, I’ve long thought that Trump is not a true antivax believer, with
his approach to vaccines having been mostly transactional. He desperately
promoted “Operation Warp Speed” for COVID-19 vaccines and meddled with the FDA
approval process to try to get an emergency use approval for the vaccine before 
the 2020 election because he thought it would save his reelection effort, but
since has thrown tidbits to the antivax movement because they are part of his
core supporters. So of course, Trump is more than willing to throw antivaxxers
under the bus to avoid political embarrassment.

It’s not that I have any doubts over whether, as HHS Secretary, RFK Jr. will do 
his damnedest to destroy US vaccine policy, undermine confidence in vaccines,
and even try to get some vaccines pulled from the market. He almost certainly
will. It’s just that these developments suggest that all hope is not lost, that 
there will be a political price to pay, and that public health advocates have a 
chance to minimize the worst of the likely consequences of RFK Jr. being in
charge of HHS.

Donald Trump and Robert F. Kennedy, Jr. teaming up to MAHA (I guess).

The “Medical Freedom Movement” vs…pragmatism?

Let’s get back to Markus Mutscheller and his claim that RFK Jr.’s “betrayal” (if
it comes to pass) might be a good thing for the “Medical Freedom Movement.” He 
starts out with standard antivax tropes mixed with some astonishing ignorance of
basic history:

   In my view, the very core of the Medical Freedom Movement (MFM) worldwide and
   in the USA centres around and was born because of the unprecedented events
   that happened during the so-called Covid Pandemic:

  1. Dropping all established and written pandemic response plans in lockstep
    worldwide and replacing them with scientifically unfounded and unproven
    responses, like unreliable and manipulated PCR-tests, masks, social
    distancing of 1.5 m, lockdowns and banning successful repurposed drugs –
    pretty much the opposite of what the pandemic response plans recommended.

  2. Dropping almost all decade-old safety testing and rushing through one product 
    only: the novel and unknown mRNA vaccine, which actually wasn’t a
    traditional vaccine at all, because it didn’t stop transmission, the whole
    purpose of vaccines.

  3. Therefore, the WHO quickly changed the old definition of vaccines and herd
    immunity to fit reality to the new product, not the other way around

  4. But the biggest trigger for the MFM was the coercion and mandating of these
    dangerous untested substances to millions of people, breaking 75-year old
    international medical laws (Nuremberg Code) and long-established conducts of
    informed consent and many human rights. And much more, of course.

See what I mean? All the standard COVID-19 antivax conspiracy theories are
there, the claim that “repurposed drugs” like ivermectin and hydroxychloroquine 
were effective but “They” kept them from you (wrong and wrong); that mRNA
vaccines were not adequately tested (wrong); that the definition of vaccines had
been changed to accommodate mRNA vaccines (wrong); and that vaccine mandates
violate the Nuremberg Code (wrong). What struck me more, though, was the
profoundly ahistorical take. The “Medical Freedom Movement” is nothing new. We
here at SBM have been writing about the “health freedom movement” going back to 
the very beginning of this blog, which is why I have a go-to sarcastic
description of it as freedom for quacks from pesky laws and regulations that
might interfere with their quackery and grift. “Health freedom” has long been
the rallying cry that united antivaxxers with quacks, proclaimed by parents who 
refused to use science- and evidence-based medicine to treat their children for 
potentially deadly but treatable diseases, like cancer. The so-called MFM is
just the health freedom movement rebranded and energized by COVID-19, social
media, misinformation, and disinformation.

So what, according to Mutscheller, is behind this “betrayal” of the MFM by
Trump? This:

Thanks to stupid and captured seemingly MFM aligned big influencers like Dr
Robert Malone and Jeff Childers, to name just two, millions of American MFM
voters somehow, incredibly naïve and driven by wishful thinking, thought that
Trump was anti-mRNA or at least anti-pandemic response and voted for him.

I wrote about the immense MFM betrayal of Dr. Malone in my article Fuck You, Dr.
Robert Malone !!! which hit a raw nerve with over 14.000 Substack views so far,
generating over 460 likes and over 270 comments.

Meanwhile, Jeff Childers, an initial fierce anti-vaccine dissident, convinced
his huge readership, that Trump is secretly anti-mRNA but can’t officially say
so until elected, because it would lose him too many votes.

Doing so, he tapped into some collective wishful thinking and totally ignored
the facts.

The obvious facts were, that Trump wasn’t secretly against the mRNA vaccines at 
all. He boasted and lied endlessly about how “his” Operation Warp Speed saved
hundreds of millions of lives and openly declared on Rogan, that “big pharma are
his friends.”

Once again, it amuses me how antivaxxers turn on their own, like Dr. Robert
“inventor of mRNA vaccines” Malone, who as a graduate student did play a role in
early experiments that ultimately demonstrated that mRNA could be injected into
muscle and result in the production of the protein coded for by the mRNA but
who didn’t really have any practical role in actually development the vaccines
and ultimately went full antivax conspiracy theorist.

Mutscheller is not optimistic about the outcome, though. After first mentioning 
that he thinks that RFK Jr. might be downplaying his antivax stance for purposes
of achieving confirmation—really, do ya think?—he then speculates:

Even the best case scenario looks dire.

The best case scenario is that Kennedy gets nominated as HHS secretary and
actively tries to get the mRNA vaccines paused or banned. And to dial done the
childhood vaccine program.

I believe he is personally convinced about the harm of vaccines but that won’t
matter.

What matters: Is he is allowed to stop them. And I don’t think his boss will
allow it. I am not aware of any anti-vaccine statement by Trump whatsoever.
Hence the shift to food and toxins which Trump might sanction.

And if Kennedy goes against the vaccines anyway, we all know how that will end: 
“You’re fired.”

So Kennedy has two choices.

He can either go along with the boss and the pro-medical and pro-pharma vibe of 
the majority of the Trump admin and betray and lose most of his base voters, or 
he stays true to his conviction and pre-election talks and uses his short tenure
as HHS secretary (before he gets fired) to raise awareness about the harms of
mRNA and other vaccines on another level and goes down with his integrity and
reputation intact and positions himself stronger for 2028.

Anything else, like jumping on the food and toxin bandwagon and ignoring the
vaccines will be seen as betrayal by the MFM.

So he needs to be watched closely and called out early.

Again, Mutscheller is pretty ignorant of history if he’s unaware of “any
antivaccine statements by “anti-vaccine statement by Trump whatsoever,” but
whatever. He’s not entirely wrong here that the “rebranding” of RFK Jr.’s
antivax stance into a “MAHA” movement that focuses on his also conspiracy-laden 
views on food and “natural medicine” likely has a lot to do with just how
toxic—if you’ll excuse the term—his antivax stance has been.

Who, however, are the villains in this conspiracy theory keeping RFK Jr. from
realizing the fullness of his MAHA vision, a fullness that includes getting rid 
of vaccines? I was amused to learn by referring back to Latyopova’s article that
it’s the brother-sister team of health care entrepreneurs grifters, Calley and 
Casey Means. According to Latyopova, the Means siblings are the ones undermining
the purity of RFK Jr.’s MAHA vision by deemphasizing the antivax conspiracy
theories and pseudoscience. She bases her conspiracy theory on the writing of
Debbie Lerman, a “retired science writer and visual artist in Philadelphia,” who
is also an “investigative researcher/writer” and—of course!— a Brownstone
Institute Fellow. Her only qualifications to pontificate on the pandemic and
medicine? She has a “degree in English from Harvard” and apparently worked as a 
science writer.

SAMPLE ARTICLE #1To show how the pandemic response was centrally coordinated, I
will provide an overview of how it took place in different countries and how
nearly identical each country’s response was.Coordination of the Global
Pandemic Responsehttps://t.co/nUAaA6MSpL

— Brownstone Institute (@brownstoneinst) October 10, 2024

SAMPLE ARTICLE #3Events like the Olympics no longer symbolize the aspiration of
a world of nations to live and compete peacefully with one another. They are
now a testament to the dissolution of nations.Our Hunger Games Unfold in
Parishttps://t.co/pPcCDeOfm9

— Brownstone Institute (@brownstoneinst) October 10, 2024

You get the idea. She’s a full-on conspiracy theorist who fits right in at
Brownstone. Amusingly, though (to me), Lerman spends a lot of digital ink
pointing out how the Means siblings are not true believers, that they’re
entrepreneurs, and that they aren’t to be trusted. I actually agree that they
are not to be trusted, but not for the reasons Lerman states. Rather, they are
not to be trusted because they sell highly dubious health services and products,
but let’s see the quintessence of Lerman’s complaints about them:

So far we’ve seen that Casey and Calley Means spent their entire lives before
2024 getting degrees from, or dropping out of, prestigious academic
institutions; working for globally influential businesses and organizations;
founding, selling, and investing in companies worth tens of millions of dollars;
and, during Covid, complaining that we should be focused on obesity rather than
the death and destruction wrought by lockdowns and mRNA vaccines.

This, to me, seems sufficient evidence of a lack of connectedness with the
medical freedom movement, rebranded as MAHA when RFK Jr. joined the Trump
campaign – which is when the Means siblings suddenly emerged as powerful
political players.

But there’s so much more to the story. In order to reconcile what we just
learned about the incompatibility of the Meanses’ resumes with their abrupt rise
to MAHA prominence, Casey and Calley and their media promoters have had to
undertake impressive campaigns of contorted messaging, obfuscation and
misinformation.

The wag in me can’t help but retort that, far from being insufficient evidence
of “connectedness with the medical freedom movement,” the Means siblings’
history of “getting degrees from, or dropping out of, prestigious academic
institutions; working for globally influential businesses and organizations;
founding, selling, and investing in companies worth tens of millions of dollars;
and, during Covid, complaining that we should be focused on obesity” represent 
very compelling evidence that they are everything the MFM promotes, given that
they promote policies that would make it easier for for quacks to grift and
fleece consumers by selling nostrums and services that are not supported by
science or evidence. Lerner is just upset that the Means siblings don’t
prioritize antivax grift the way she thinks that they should.

Indeed, Lerner even concedes that the Means’ messaging with respect to obesity, 
“chemicals” in the environment, big pharma, and the like are “largely true,”
before complaining:

The problem with this messaging is not whether it’s true. The problem is that it
distracts from and dissipates the urgency of the post-Covid medical freedom
agenda: exposing the atrocities of the lockdown-until-vaccine response,
repealing all the laws and regulations that made it possible, and preventing
further injury and death from mRNA vaccine products.

Another huge problem with the Meanses’ message – an intentional one, I would
contend – is that it obscures the acute recent rises in death and illness since 
the introduction of the mRNA shots, by claiming that “metabolic dysfunction”
caused by poisons in our food and environment is the underlying cause of
everything.

To antivaxxers and anti-public health activists like Lerner, vaccines are by far
their most important bogeyman that must be eliminated. To her, the Means
siblings, quacks though they are, are insufficiently pure in their antivax
stances. Indeed, it’s not even clear that they are antivax at all, having
apparently embraced some of the antivax religion for expediency, rather than
because they actually believe in it. There also seems to be a bit of annoyance
at them for being Johnny-come-latelys to the whole MFM movement, an annoyance
previously expressed by antivax quack Dr. Peter McCullough over their outsized
influence on Trump and RFK Jr., a resentment that leads Lerman to urge her
readers to “resist” attempts to redirect and defuse their antivax demands.

Meanwhile, Latyopova warns:

I thought he [RFK Jr.] was sincere about trying to undo the vax mandates and
trying to stop the horror of covid military campaign. I am not so sure anymore. 
While reading Debbie’s article, I had to look up the numerous investors in Casey
Means company Levels, a rather stupid “metabolic profile” venture that employs 
a handful of people, but somehow raised $100M in investments in 3 years. One of 
the investors is Arielle Zuckerberg! Yes, she is Zuck’s younger sister. Another 
one is Rachel Swanson (likely a relative of Tucker Carlson). The lead investor
is Marc Andreesen. There are numerous who-is-who in VC and private equity listed
as investors. What is so special about this amazing business??? Nothing! This
looks to me like a PAC/special interest lobby outfit/ political money funneling 
group that is putting all the pressure their money and connections can buy to
subvert the genuine health freedom activists (who have no such money and
connections) and divert all public attention away from the damage caused by
vaccines into inane messaging like “healthy food choices”.

It remains to be seen what will happen, of course. Too many members, financial
backers and the deep state affiliates of the Trump admin will defend the mRNA
tech and vaccines from which they profit mightily. Don’t drink too much hopium, 
stay vigilant and voice your concerns. The government officials must fear the
public, not the other way around. There is a long road ahead, regardless, and I 
urge everyone to push back at every opportunity on the bullshit promoted by the 
likes of the Means duo.

Of course, running a bogus “metabolic profile” company is the very epitome of
MFM. Meanwhile, Mutscheller argues that one good thing about this “betrayal” by 
RFK Jr., which does not surprise him at all, is that it might spark a spiritual 
awakening:

But all hope is not lost. There could be a real silver lining to the downfall of
the rationalistic-materialistic paradigm. It could ignite a jump in
consciousness and spiritual awareness. It could drive billions of people into
spiritual practice.

To me, the only solution to this crisis of democracy and decency is spiritual
and within each of us. Only when enough people wake up to that and do their own 
inner work, there might be a change in society and politics.

And:

Therefore, as painful it sometimes is, getting disillusioned and losing all hope
about the outside world, can be a blessing in disguise that opens up our truly 
magnificent inner world and the deep, peaceful knowledge of our hearts of who
and what we really are.

I encourage Mutscheller and his fellow travelers to pursue a “spiritual” revival
and leave public health alone, but I fear that won’t happen.

Will factional disputes among antivaxxers prevent the worst?

I have little hope that the Senate will actually reject RFK Jr.’s nomination. I 
hope I’m wrong, but fear that I am not. This leads me to wonder whether the
factional disputes revealed in the MFM movement between the die-hard antivaxxers
and the “pragmatists” (who actually are fairly antivax but don’t see vaccines
as a “die-on-that-hill” issue…yet) that should derail their pursuit of
deregulating medicine so that quackery can flourish and promoting a very
specific idea of what “heathy eating” looks like will mitigate the upcoming
public health disaster. The last time I mentioned these factional disputes in
this context, I invoke the classic movie, Monty Python’s Life of Brian, which
satirized religious and revolutionary movements through the comical (often
darkly comical) misadventures of the main character Brian. As you might
remember, in the movie Brian is born on the same day as (and next door to)
Jesus, and, as a result, after he grows up to become a man ends up being
mistaken for the Messiah. Basically, the latest round of cries of “betrayal”
from antivax MAHA loyalists comes across as the continuation of the struggle
between The People’s Front of Judea (say, Sasha Latyopova, Debbie Lerman, and
Drs. Paul Alexander and Peter McCullough) and and all the more “radical”
antivaxxers who have expressed alarm at RFK Jr.’s failure to mention vaccines in
his MAHA agenda) battling The Judean People’s Front (represented Calley and
Casey Means and their allied ilk), with RFK Jr. being viewed as either a
turncoat or opportunist and Trump the useful idiot.

Indeed, the J.R.R. Tolkien can’t help but see these MAHA hardliners portraying
the Means siblings as Gríma Wormtongue, whispering words of surrender on behalf 
of the turncoat evil wizard Saruman to weaken the will of King Théoden, turning 
him into an enfeebled, confused, elderly man, and they’re trying to persuade
Théoden to throw off the yoke of Wormtongue’s whispered, will-weakening
enchantments, throw off defeatism with respect to banning vaccines, and embrace 
his MAHA purity. OK, I realize that I might have let my love of The Lord of the 
Rings novels and films go too far, as I have yet to figure out where RFK Jr.
falls in this analogy. Maybe he’s King Théoden. Maybe he’s Éomer, Théoden’s
nephew and one of the only leaders of the Rohirrim who keep the faith and will
to fight, as Theoden succumbs further and further into defeatism, before, of
course, being freed from the spell by Gandalf.

Gríma Wormtongue sapping King Théoden’s will with whispers of hopelessness
and—dare I say?—a pragmatic approach to the Dark Lord Sauron and his turncoat
lackey, the wizard Saruman.

The bottom line is that there is a very real and very nasty factional dispute
among the MFM/MAHA movement over vaccines between the “pragmatists,” who are
still mostly antivaccine but don’t see the issue as worth fighting over right
now given the political cost, and the true believers, who feel betrayed that RFK
Jr. and Donald Trump are not putting “investigating” and eliminating first
COVID-19 vaccines and then the rest of the vaccine schedule at the very top of
their healthcare agenda. Who will win? I honestly don’t know. What I do know is 
that, whoever does win this dispute, public health loses. Biomedical science
loses. Drug innovation, regulation, and safety lose. We all lose. The only
question is: How badly will we lose? How bad will it get before there is a
reaction that starts to reverse the decline?

Never before have we faced a threat to science-based medical policy, public
health, and vaccines as dire as the current one. However, the very existence of 
this factional dispute and the apparent recognition on the part of Trump and the
“pragmatists” that antivax conspiracy mongering is still a political loser for 
all but the most hardcore MAGA/MAHA antivaxxers gives me hope that coordinated
resistance and political pressure could forestall the worst, possibly even
blocking RFK Jr.’s confirmation. I’m not saying I’m optimistic that it will,
just that I believe that is is possible, and we have to hold on to that as we
resist the encroachment of ideologically motivated pseudoscience into the very
heart of federal health policy.


Lysenkoism 2.0 continues: Podcast Jay wants to turn NIH into the “research arm” 
of MAHA

NIH Director Jay Bhattacharya has recently said that he wants to transform the
NIH into the “research arm of MAHA” and a “central driver of the MAHA agenda.”
Lysenkoism 2.0 continues apace at NIH.

David Gorski on February 2, 2026

Link


One aspect of the Trump administration’s war on science and expertise that has
not given nearly the attention that it deserves by the mainstream press is the
current carnage at the National Institutes of Health (NIH) under the
“leadership” of its current director, Dr. Jayanta Bhattacharya. While the
mainstream press is filled with stories—and rightly so!—about what the longtime 
antivax activist who is now Secretary of Health and Human Services, Robert F.
Kennedy Jr., has done thus far to dismantle the Centers for Disease Control and 
Prevention (CDC) as a reliable federal resource for public health, eliminating
as many vaccines as he can from the US schedule as fast as he can (as if he
senses that he has less than three years to eliminate all vaccines in the US),
and working on turning the Food and Drug Administration (FDA) into yet another
arm of his antivax quackery-fueled “make America healthy again” (MAHA) movement,
the dismantling of the NIH and, with it, likely the dominance in biomedical
research that the US has enjoyed for decades gets a lot less attention. Worse,
when it does get attention, there’s an unfortunately good chance that it will be
in the form of a fawning interview in the New York Times by a hack pundit like 
Ross Douthat about “restoring trust” in science, which is—among other
things—what prodded me last week to get off my duff and write a post that I’ve
been meaning to write for weeks now about how Dr. Bhattacharya is serving as the
useful idiot and figurehead under which the NIH is being transformed into the
“research arm” of MAHA. If that’s not Lysenkoism 2.0 (as I’ve been calling it), 
I don’t know what is.

Taken in context, the MAHA takeover of the NIH under the figurehead “direction” 
of Dr. Bhattacharya is, as I’ve written before, an extinction-level threat to
public health and biomedical research in this country. Quite frankly, it could
well mean the end of the relatively apolitical—or at least nonpartisan—research 
agenda of the NIH for a generation, with the NIH being turned into yet another
patronage system under a profoundly transactional President.

Before I get to discussing in depth how Dr. Bhattacharya’s puppetmasters are
bringing back the ghost of Trofim Lysenko, let’s look at a little backdrop. What
has the administration been doing to the NIH over the last year?

Hollowing out federal scientific expertise

Before a discussion of what Dr. Bhattacharya claims and says, it’s useful to
compare whatever he says to an actual analysis published in Science a week ago, 
US government has lost more than 10,000 STEM Ph.D.s since Trump took office:

Some 10,109 doctoral-trained experts in science and related fields left their
jobs last year as President Donald Trump dramatically shrank the overall federal
workforce. That exodus was only 3% of the 335,192 federal workers who exited
last year but represents 14% of the total number of Ph.D.s in science,
technology, engineering, and math (STEM) or health fields employed at the end of
2024 as then-President Joe Biden prepared to leave office.

The numbers come from employment data posted earlier this month by the White
House Office of Personnel Management (OPM). At 14 research agencies Science
examined in detail, departures outnumbered new hires last year by a ratio of 11 
to one, resulting in a net loss of 4224 STEM Ph.D.s. The graphs that follow show
the impact is particularly striking at such scientist-rich agencies as the
National Science Foundation (NSF). But across the government, these departing
Ph.D.s took with them a wealth of subject matter expertise and knowledge about
how the agencies operate.

This is a dramatic brain drain, as well as loss of institutional memory and
expertise. As PZ Myers put it, “They aren’t coming back, you know.” He’s right, 
too:

Perhaps you would like me to reassure you that once we throw the rascals out and
elect responsible politicians who respect the role science has played in
American prosperity, we’ll just hire them back. No, sorry, this isn’t like
rehiring workers at the Amazon warehouse. A science hire is accompanied by a
large investment in equipment and personnel.

Correct. Let’s assume a best-case scenario for US federal support of science,
one in which a science-loving Democratic candidate elected on a promise to
rebuild HHS agencies is elected in 2028. By January 20, 2029, when that
candidate will take office, the vast majority of the scientists who have been
forced out will have either found other jobs in industry (or, less likely,
academia), left the US to find work elsewhere, or been forced to change their
careers. The “just hire them back” attitude shows a profound lack of
understanding of how scientific programs are built. Here’s a graphical
representation of the carnage in terms of overall staffing at key federal
scientific agencies, many at HHS:

Worse, as RFK Jr. implants his MAHA agenda into every HHS agency, the scientists
hired over the next three years to replace some of the ones forced out will
likely all have to bend the knee to the MAHA agenda. Many will be believers or
at least sympathetic to MAHA, and they will have reshaped the federal science
workforce, and a new President dedicated to restoring past norms won’t be able
to just purge them the way that President Trump has purged so many scientists
from the federal government.

I want to talk about one more thing before I look in depth at what Bhattacharya 
claims that he wants to do and balance it against what the Trump administration 
is actually doing to the NIH, with him as the willing figurehead. As you will
see, it’s very much of a piece with what Soviet scientist Trofim Lysenko did to 
Soviet agriculture for decades: Replace rigorous science with ideology-based
“science.” I’ve written about that before a number of times; so if you want more
information, I refer you to my posts on the subject, specifically “Make America
Healthy Again”: The new Lysenkoism, Lysenkoism 2.0 and the dismantling of the
NIH, and Jay Bhattacharya’s “plan to drive Gold Standard Science”: A Trojan
horse for Lysenko-izing the NIH.

But first, a bit about what the NIH was and why its coming transformation into a
research arm for MAHA matters.

The NIH: Crown jewel of US federal science

I’ve said it before many times, but I’ll start by saying it again here. The NIH,
along with the National Science Foundation, represents one of the crown jewels 
of US federal science. One reason is that it is the largest public funder of
biomedical research in the world, with a budget before Donald Trump took over of
over $47 billion. However, its sheer size with respect to how much it funds
biomedical research is not the whole story. One reason why the NIH has been such
a driver of innovation and scientific discovery since a major reorganization in
1948 that created several of the Institutes that make up the NIH is the manner 
in which it funds biomedical research. While there has long been a large and
healthy intramural research effort at the actual NIH campus in Bethesda, MD,
complete with clinical trials carried out at the NIH Clinical Center, the
largest hospital in the US devoted entirely to clinical research, most of the
funding of biomedical research by the NIH consists of research grants to
universities, hospitals, research institutes, and private companies through a
highly competitive process in which researchers submit grant applications to the
NIH.

It turns out that over 80% of NIH funding goes to funding extramural research
grants (extramural=not funding labs at the NIH itself). Moreover, there is a
long-defined, rigorous, and codified process used by the NIH to evaluate grant
applications. It begins with the submission of a grant to the NIH, and the NIH
has a number of granting mechanisms designed for different purposes. For
example, the R21 grant is designed for preliminary work, often the “higher risk”
studies that the brave mavericks demand, and doesn’t require a lot of
preliminary data. (The claim that it can require no preliminary data, however,
is generally nonsense. You need at least some data.) R21s can fund up to two
years and cannot be renewed.

In contrast, the granddaddy of them all, the “gold standard” grant for an
individual investigator, small groups of co-investigators, or collaborators, is 
the R01, which can be funded for up to five years (it’s also one of the only
grant mechanisms where the investigator can propose basically anything, rather
than having to address a particular topic or question). At the end of that time,
the investigator can apply for a competitive renewal, which can extend the
grant for up to another five years, and so on ad infinitum. There are a number
of other grant mechanisms, which include training grants for graduate students, 
center grants (e.g., for cancer centers), larger multi-investigator grants, and 
more targeted grants—Wikipedia has a nice list here—but in general all of them
are scored by groups of scientists with the relevant expertise in a review group
called a study section, of which there are dozens in the NIH arranged by topic 
into Review Branches at the Center for Scientific Review. Many of these study
sections are permanent, but the NIH can and does set up temporary study sections
for topics of special interest at the time. Again, the system is about
scientific rigor and funding the best science, at least as much as any
human-created and run institution can be.

Is the NIH perfect? Obviously not. I’ve had a number of complaints about the
NIH, including how low the paylines have fallen. (Before Trump, paylines had
fallen below the 10th percentile, meaning that less than 10% of grant
applications were funded, and now they’ve fallen below the 5th percentile.)
Similarly, I’ve on occasion discussed how the NIH funding system doesn’t
encourage new researchers enough, all too often leading to a “rich get richer”
situation. Indeed, my complaints sometimes even echo those of people like Dr.
Prasad; it’s just that I view their proposed “solutions” to be, in general, very
bad ideas. However, it is and remains (for now) an amazing example of what
government can accomplish when motivated by the public good. Moreover, it still 
maintains broad bipartisan support. When the Trump administration submitted a
budget in May that would have cut the NIH budget by 40%, Congress pushed back.
Its FY2026 budget appears not just to restore the cuts but to increase the NIH
budget by 1%. Of course, that is, in essence, a budget cut accounting for
inflation, and the NIH budget has been flat or slowly declining for years, but
it’s a hopeful sign. From my perspective, many of the problems—not all,
obviously, but many—with the NIH could be solved with more robust and stable
funding.

What really makes the NIH stand out, however, is just how assiduously
administrations since the Truman administration have insulated it from political
considerations and generally not meddled—at least not overmuch—in scientific
decisions. Of course, I realize that it is impossible to completely insulate the
NIH from politics. After all, each administration chooses an NIH Director, and 
Congress examines the budget request from each Director and administration and
decides on its appropriations, sometimes including legislation tasking NIH
Directors to emphasize certain priorities or set up specific programs. Usually, 
such Congressional mandates have broad bipartisan support, rather than
representing an ideological program like MAHA. The Cancer Moonshot initiative
championed by Sen. Joe Biden in 2016 is one example of an NIH research program
mandated by Congress. Although I thought the Cancer Moonshot overhyped what
could be accomplished, it nonetheless had broad support. Sometimes, such
meddling is less than benign, for instance when Sen. Tom Harkin championed the
National Center for Complementary and Alternative Medicine (NCCAM, now renamed
the National Center for Complementary and Integrative Health, or NCCIH),
creating and protecting a Center devoted to studying the sort of pseudoscience
that MAHA champions. One might even look to NCCIH as a precursor and cautionary 
tale as to what can happen when political and ideological meddling infects the
NIH.

Even if one views NCCIH as a predecessor to the MAHA Research Institute NIH, our
complaints published on SBM about NCCIH going back to the very beginnings of
this blog about how NCCIH represents ideological pseudoscience that the NIH was 
forced to accept and fund due to political meddling seem almost quaint compared 
to what is happening at the NIH now, which is the full-on Lysenkoization of the 
NIH, even as its funding decisions increasingly become ideology-based rather
than science-based.

Podcast Jay lets his COVID freak flag fly

Regular readers will know that SBM (in particular Dr. Jonathan Howard and I)
view Dr. Bhattacharya as not only grossly unqualified to lead such a large and
prestigious institution as the NIH, and that’s even leaving aside how he got the
job. Recall that Dr. Bhattacharya first rose to prominence in October 2020 as
one of the three co-authors of the Great Barrington Declaration, a bit of
dangerous pseudoepidemiology that proposed a “let ‘er rip” approach to the
pandemic to develop “natural herd immunity” within three to six months, with a
vaguely defined “focused protection” of the vulnerable. I (and many others)
viewed the GBD as unrealistic and downright eugenicist (or social Darwinist,
take your pick). It was obvious at the time that it never would have worked,
and—surprise!—real-world evidence in the five years since showed that it didn’t.
Even the Brownstone Institute, founded by neo-Confederate Jeffrey Tucker, has
implicitly admitted that the GBD couldn’t have worked. The GBD did,
unfortunately, succeed in devastating public health programs and trust in public
health, however.

Even if you leave aside Dr. Bhattacharya’s longtime role as a crank peddling
COVID-19 pandemic minimization and then later “skepticism” over vaccines, when
nominated he quite simply didn’t have the resume of a typical NIH Director. He
had never practiced medicine. He had never made major contributions to
biomedical research. (He’s a health economist.) He had never run a large
organization. So it’s no surprise that he’s been, since the beginning, more of a
figurehead, a useful idiot, under whose apparent “leadership” the
administration is dismantling what’s good about the NIH in favor of ideology.
Indeed, it is apparent that the person who is really running the NIH is NIH
Deputy Director Dr. Matthew Memoli, with Dr. Bhattacharya being derisively
referred to by much of the NIH staff as “Podcast Jay” because of his propensity 
to do lots of podcasts while leaving the actual hard work of actually running
the NIH to Dr. Memoli, who basically does President Trump’s bidding. Indeed, his
figurehead status, in which Dr. Memoli is described as running the NIH day to
day “with a heavy hand,” while Podcast Jay is is busy “devoting more time to
external events such as speeches and podcasts,” is what makes Dr. Bhattacharya’s
faltering efforts to convince the scientific community that he really is in
charge and really does have the best interests of the NIH at heart increasingly 
risible. (He missed many in-person meetings of the NIH’s 27 institute and center
directors held every other Thursday morning, a long-standing tradition.)

Which brings us back to Podcast Jay’s interview with Ross Douthat of the NYT
(complete interview on YouTube above), who introduces the interview in a
nauseating manner that basically portrays RFK Jr. and his dauphins like Dr.
Bhattacharya as “brave maverick doctors” who will “restore trust” in science and
public health. Here’s a taste, if you can stand it:

The problem is that those confident authorities, inevitably, got some big things
wrong. And the outsiders and skeptics sometimes got things right. And as
pandemic-era life got more and more miserable, big parts of the public simply
stopped trusting the experts entirely.

So now here we are in 2026, and the outsiders are in charge. One of them is Dr. 
Jay Bhattacharya. He’s in charge of the N.I.H., tasked with reforming the
world’s largest biomedical research agency. But the more important task, to my
mind, is proving that an outsider perspective can succeed in restoring public
trust in science and medicine — as opposed to undermining that trust even
further.

I swear, whenever I hear the administration or its apologists like Douthat say
that it is “restoring trust” by dismantling public health and scientific
institutions, I get very Vietnam War-era vibes of “It became necessary to
destroy the town to save it.” (Of course, it’s worse than that, as the Trump
administration doesn’t appear to want to “save” the NIH.) While it’s tempting
just to satirize Podcast Jay’s interview in the manner that Dr. Howard did last 
week, I felt obligated to look at the whole damned thing. (Henceforth, I will
refer to Dr. Bhattacharya as Podcast Jay.) Also note the normalization of
Podcast Jay. To Douthat, he’s not a crank, contrarian, or pseudoscience pusher
(which he actually is). Oh, no. To Douthat, Podcast Jay is a brave maverick, an 
“outsider and skeptic.” (Podcast Jay has proven himself to be anything but a
skeptic, in the same way that RFK Jr. is not a “vaccine skeptic.”)

Podcast Jay does revel in his “outsider” status, though, as he brags about
Anthony Fauci having referred to him (accurately, IMHO) as a “fringe
epidemiologist”:

Douthat: What form did those attacks take?

Bhattacharya: At the university, there was an investigation into the study’s
funding, all of which had been cleared up before the study was even done. It was
entirely spurious. At the N.I.H., the former head of the N.I.H. wrote an email 
to Tony Fauci in October 2020 calling me a “fringe epidemiologist” — I love that
term, by the way.

Douthat: Yes.

Bhattacharya: It’s fantastic. It’s hopefully going to go on my grave.

The whole thing was absolutely extraordinary. What was needed was an honest
scientific debate.

I might’ve been wrong. Like, look, let’s have a scientific debate and
discussion. Let’s have alternate voices. But instead, the ethos of public health
was that just having the debate at all was a dangerous thing.

That’s, if you want to ask me — you started with what went wrong — that is the
fundamental thing that went wrong.

The only way someone revels in being called “fringe” is if he thinks he is
correct. If real experts, real scientists called me “fringe,” I’d take a close
look at what I’ve been saying and wonder if I might be wrong. In his arrogance
of ignorance, Podcast Jay has no doubt that he is correct, his call for “debate 
and discussion” and “alternate voices” notwithstanding. Indeed, at one point, he
sounds as though he might be admitting that he could be wrong:

Douthat: So part of what happened with public health authorities is that they
were concerned about the wilder, crazier outsider narratives. And there’s a
question here that I wrestle with a lot, which is: Once you yourself are an
outsider critic, how do you maintain your own equilibrium and not get pulled
into the wilder world of conspiracy theories? Because that happens to a lot of
people. They start out with a reasonable critique of an establishment, they
discover something the authorities have gotten wrong, and then they move from
that to a worldview where the authorities are always wrong about everything.

Bhattacharya: OK, so let me answer the immediate question, and then the broader 
question. So the immediate question is: How do I personally — I mean, I do my
very best to be grounded by the data, and I read pretty broadly, including
people that I disagree with. I have always had as a scientist this idea that the
best way for me to always be right is to change my mind when I’m wrong. You
have to have this epistemic humility in the face of very complicated questions
or you’re going to be wrong.

I’ve never met an excellent scientist who didn’t believe they were wrong all the
time. Because there are just complicated questions where you don’t know the
answer. You have a hypothesis. The data you develop don’t match the hypothesis. 
You have to be open to the possibility of changing the hypothesis.

So that kind of scientific training, and especially the epistemic humility
around that scientific training, has helped me a ton on that. And it’s hard
because you get enamored with your own ideas very, very easily, especially if
you’ve invested a lot in them.

Interestingly, this is one case where Douthat asked a reasonable question, and
Podcast Jay comes across as almost…reasonable, as almost…humble. He’s not wrong,
either. At least, the words that come out of his mouth aren’t wrong. The
problem is that his behavior and words before this interview belie everything he
just said in response to Douthat’s question. Podcast Jay hasn’t shown any
humility. He hasn’t shown any sign of introspection. Other than superficial
words, he hasn’t shown any evidence that he has ever wondered whether his
proclamations since the GBD might have been not just wrong, but spectacularly
wrong. Whether Podcast Jay, who has labeled me as a “threat to science,”
believes it or not, I question myself all the time. Indeed, I sometimes think
that the reason I get so few invitations to be on podcasts is because I don’t
come across as confident and utterly certain that I’m correct as people like
Podcast Jay.

Podcast Jay also demonstrates that, as I like to say, with MAHA every accusation
is a confession:

Douthat: And what is your diagnosis of why there was such a closing of ranks?

Bhattacharya: So I think there’s two levels to this, all right? First of all,
this is an analogy to this. When you’re a third-year medical student — I was in 
medical school once — that’s the first time you see patients. You put on a white
coat and, my God, the effect that putting on a white coat has on the desire for
the patients to tell you stuff. People tell you everything about their lives.
And they have problems that they want you to solve. And the instinct that you
have with the white coat on — you’re 24 years old, 25 years old — is to answer
their questions, even when you don’t know the answer.

All of public health found itself in that position. They’re facing an uncertain 
threat. There’s no real science yet about it. It’s a brand-new disease. The
entirety of society is looking at them, saying: “What should we do about this?
What’s the wise, right thing to do about this?” And you don’t know the answer.

As a med student, you have to learn to say, “I don’t know.” You have to learn to
say that. It’s not an easy instinct. And public health failed at that, at
large. So they looked to leaders, like Tony Fauci and others, to guide them on
what to say in that setting. And those leaders also failed at that.

As a board-certified practicing cancer surgeon with a PhD, I can’t help but
reiterate that Podcast Jay never actually practiced medicine after medical
school. He’s never taken care of patients except under the close supervision
under which medical students take care of patients. This is also a specious
argument. As is the case with a lot of COVID “contrarians,” Podcast Jay likes to
pretend that, just because COVID-19 was a new disease caused by a new virus
(SARS-CoV-2), we didn’t know anything about it or anything about how to slow its
spread. This ignores the simple fact that SARS-CoV-2 is a coronavirus, and we
knew a lot about coronaviruses before COVID-19 appeared, so much so that it was 
obvious that a “natural herd immunity” solution as proposed in the GBD was
highly unlikely to work because coronaviruses are known to mutate so quickly
that they can evade “natural immunity” (more properly called postinfection
immunity) and reinfect the same people. Cranks like Podcast Jay like to pretend 
that SARS-CoV-2 was a blank slate, something entirely new, and that we knew
nothing about it or how to combat it, when decades of public health research and
practice were there to draw upon and make inferences from. Tellingly, when
public health officials inevitably got some things wrong, Podcast Jay routinely 
implied that we shouldn’t trust anything they said.

Before I move on to Podcast Jay’s vision of the NIH as the MAHA Research
Institute, I note that right after this he expresses his belief in lab leak
conspiracy theories, claiming that the “best available evidence” is for a lab
origin for SARS-CoV-2 and that it is a “near certainty” that the virus came from
a lab. He and Douthat then go on and on rehashing all the usual “lab leak”
conspiracy claims that I won’t rehash here other than to refer to the SBM lab
leak tag, which will lead the interested reader to several posts by yours truly 
and others explaining why “lab leak” is a conspiracy theory and SARS-CoV-2
almost certainly had a natural origin. Of course, none of the actual evidence
stops Podcast Jay from repeatedly reaffirming that he thinks SARS-CoV-2 almost
certainly came from a lab and that “They” (apparently Anthony Fauci and his
minions, as well as the scientific community) somehow covered up the evidence.

Worse, he thinks that it was a sense of guilt on the part of scientists for
having “created” the pandemic that led scientists to insist on “lockdowns”
(seriously, Dr. Howard’s satirical take on Podcast Jay’s interviews is totally
spot-on):

Douthat: But are you saying they tried to shut down knowledge and debate about
the origins? Or are you saying that the attempts to crush Covid itself through
lockdowns and so on were a kind of expression of guilt? Like, “I have to be able
to crush this disease because I, myself, released it.”

Bhattacharya: I’m saying both. So imagine that you’ve done this. You’ve
recommended the lockdowns, you’ve recommended the school closures, you’ve
recommended a set of measures that are going to harm the poor, you know are
going to harm the children, but you’re doing it because you want to suppress the
spread of this deadly disease that, in the back of your mind, maybe you think
you might have been responsible for. Maybe you can’t admit that to yourself.

You do it, and it doesn’t work. It doesn’t work. It’s summer of 2020 and it’s
very, very clear the disease is still there. The Chinese claim that they got rid
of the disease, but that result is not replicated anywhere on earth other than 
there.

And so you’re like: “Well, what went wrong? We just didn’t do it hard enough.”

The problem is a lot of people have been hurt. There are people in the
scientific community, pesky “fringe epidemiologists,” who are saying: “Look,
this is a really bad idea. And you can’t get the political will to do this
unless for something so extraordinary.” In the scientific community, you need
absolute unanimity. And if there’s debate, it’s not going to happen. You’re not 
going to have another lockdown.

And so what you do is you suppress speech, you suppress dissent, and you make
sure that anyone who dissents, that their reputation is destroyed so that other 
people won’t speak up.

And, later in the interview:

Bhattacharya: I don’t think it would’ve cost more lives. I think ultimately
lockdowns ended up killing more people than would’ve been killed had those
lockdowns not happened.

Douthat: Just to clarify what you mean: Through missed cancer screenings?
Through secondary — what is the mechanism?

Bhattacharya: Yeah, exactly. People died at home with heart attacks in 2020
because they didn’t go to the hospital. But also, more broadly, the economic
dislocations caused by the lockdowns certainly killed vast numbers of people.

First of all, where on earth did Podcast Jay get the idea that you need
“absolute unanimity” to propose a policy? That is an impossible standard,
particularly for anything as important as the question of what to do to combat a
pandemic from a new virus! Moreover, the so-called “suppression” of speech
didn’t work, did it? After all, Podcast Jay is now NIH Director, and before that
he frequently appeared in the national media, in which he portrayed himself as 
a persecuted scientist like Galileo. He gave speeches in front of huge crowds,
complaining about how “silenced” he had been. Now he’s still complaining about
“lockdowns,” even though it’s been years since anything resembling a “lockdown” 
in response to COVID-19 has been in force anywhere. Next, notice how Podcast Jay
can’t cite a single study or statistic to justify his claims. The question of
whether people might have died through missed cancer screenings is a very
complex one, given the very complexity of the question of whether screening for 
specific cancers and affects overall mortality in those screened. Podcast Jay is
allegedly an epidemiologist. He ought to know better, but doesn’t. He’s simply 
parroting anti-lockdown talking points without pointing to actual evidence.

Same as it ever was. But what about turning the NIH into the MAHA Research
Institute?

I find it *extremely* disturbing that Jay Bhattacharya—who campaigned for RFK Jr
during RFK’s Presidential run—is repositioning the NIH to be the research arm
of RFK Jr’s anti-vaccine, anti-science MAHA movement😨

— Prof Gavin Yamey (@gavinyamey.bsky.social) 2026-01-28T22:43:00.756Z

Podcast Jay wants to refashion the NIH in the image of MAHA

As I said above, the interview with Ross Douthat was one reason I felt compelled
to write about the NIH today. Moreover, it’s not enough just to demonstrate yet
again that Podcast Jay is a conspiracy theorist who is utterly unqualified to
lead the NIH. Rather, what caught my attention was what Podcast Jay said at an
appearance at Duke University:

Bhattacharya discussed the NIH’s key role in the Make America Healthy Again
movement spearheaded by Robert F. Kennedy Jr., the Secretary of the Department
of Health and Human Services.

“I want the NIH to be a central driver of the MAHA agenda,” Bhattacharya said.
“Essentially, it’s kind of the research arm of MAHA.”

Throughout the talk, Bhattacharya emphasized rebuilding public trust as a
priority of his new vision for the NIH. He attributes low trust to science and
public health to controversies surrounding pandemic policies and the
post-pandemic landscape, which he said fueled “acrimony among scientists.”

Lysenkoism 2.0 indeed. I will admit right here that previous administrations
have worked to make the NIH more responsive to what they saw at the time as the 
health priorities of the American people. Of course they have! Presidents are
expected to enact their promised agendas after they are elected. However, such
past efforts were never driven by an ideological agenda as at odds with science 
as MAHA is. MAHA, after all, is based on a social Darwinist/eugenicist emphasis 
on health as solely personal responsibility and virtue devoid of acknowledgement
of the social determinants of health that implies that if you only live the
right way, eat the right foods, and do the right activities and exercises you
will not fall prey to chronic disease, along with the moralistic shaming of
people who fail to meet their exacting standards as deserving whatever illness
they develop, not to mention its core antivax tenets, and its promotion of all
manner of supplements and unproven treatments.

On Friday, Podcast Jay led a panel discussion at the MAHA Institute—yes at the
MAHA Institute—under the super-cringy title, Reclaiming Science: The People’s
NIH Round Table with Director Jay Bhattacharya:

Big Event TodayMAHA INSTITUTE PRESENTSReclaiming Science: The People's NIHwith
Dr. Jay BhattacharyaJanuary 30, 202612:00–5:00pmRegistration Starting at
11:00amThe Willard HotelThe Crystal Room1401 Pennsylvania Ave NWWashington, DC
200041/5

— Jeremy Berg (@jeremymberg.bsky.social) 2026-01-30T11:58:28.526Z

The People’s NIH? How Lysenkoist of Podcast Jay!

Featured Speakers3/5

— Jeremy Berg (@jeremymberg.bsky.social) 2026-01-30T11:58:28.528Z

Again, I couldn’t help but think:

The title "Reclaiming Science: The People's NIH"reminds me of this"The purpose
of the Great Proletarian Cultural Revolution is to destroy the old culture. You 
cannot stop us!”An unnamed Red Guard, 19665/5

— Jeremy Berg (@jeremymberg.bsky.social) 2026-01-30T11:58:28.530Z

And:

Exactly. I recall "people's science" working out real well for science under
Mao.

— Ferric Fang, MD (@fangferric.bsky.social) 2026-01-30T22:22:50.300Z

Indeed.

I will confess right now that I didn’t listen to every minute of it. It is,
after all, nearly five hours long. Here’s the video if you’re interested in
punishing yourself more than I have punished myself listening to parts of it:

I will say that a lot of typical MAHA talking points were belabored in this
conference, including more lab leak conspiracy theories, Podcast Jay
pontificating on how we need to find the true “cause” of autism, bemoaning that 
public health supposedly treated our neighbors as “biohazards” during the
pandemic, and the like. I will admit to being pleasantly surprised when, around 
the 2:20 mark, the panel was asked about the claimed link between COVID-19
vaccines and cancer, and NCI Director Dr. Anthony Letai stated that “we can rule
out a big signal with regard to say co vaccination inducing tumors.” He also
explained the same sorts of things that I’ve been explaining, how if you give
billions of people a vaccine there will be cancers diagnosed soon after
vaccination. He also pointed out how little evidence there is that COVID-19 even
has a plausible mechanism. He did, however, waffle and said we couldn’t (yet)
rule out a lesser effect. I’m guessing that RFK Jr. won’t be pleased with this, 
especially since Podcast Jay basically agreed with Dr. Letai, although I think
he’ll be happy that Podcast Jay did say that he’ll nonetheless investigate.

The deep incoherence at the heart of MAHA and the NIH

One of the recurring themes that has popped up in all of Podcast Jay’s
appearances, such as at the NYT, at Duke, and in the MAHA Institute “People’s
NIH” panel is something repeatedly called the “replication” crisis. One example 
occurred near the beginning of the MAHA Institute panel, when Podcast Jay
pontificated:

The second scientific revolution then is the replication revolution. Rather than
using the metrics of how many papers are we publishing as a metric for success,
instead what we’ll what we’ll what we’ll look at as a metric for success
successful scientific idea is are you are you do you have an idea where other
people looking at the same idea tend to find the same thing as you. Um this is
not just narrow replication of of of one one one paper or one idea. It’s a it’s 
a really broad science. includes for instance um reproduction. So uh if two
scientists disagree that often leads to constructive ways forward in science
deciding well there’s some new ideas that may come out of that disagreement. Uh 
it’s not just are you right or wrong. Uh it’s a reestablishment of science as a 
fundamentally collaborative enterprise. A lot of times what happens in in
science is is that uh is that you know some when someone comes to me and says
Jay I want to replicate your paper. I view that as a threat, but it shouldn’t be
a threat. It should be seen as a as a as a as an honor because my ideas are
worthy of replication, worthy of of uh being subject to replication. Um it it’s 
a fundamental change in how science works so that much of the frustration that I
think many of the people in the room have felt with science can get addressed.

Here’s Podcast Jay talking about the same thing with Ross Douthat:

You can’t replicate every single paper. It’s hundreds of thousands — like,
millions — of ideas. And I also don’t want the government to decide which ideas 
ought to be replicated. [Chuckles.] Frankly, as a conservative, that makes me
really queasy.

What you have to do is you have to crowdsource — have the scientific community
identify what are the key ideas that need replication. If they turn out to be
true, then they would send science one way. If it turns out to be false, it
would send science in another way.

You do that by essentially using the normal process of the N.I.H. to seek grant 
applications from the scientific community to do replication. And that has a big
effect on essentially creating a cadre of researchers who are honored by the
scientific community, because if I give them N.I.H. grants, then that’s a marker
of scientific success.

Sounds reasonable, right? Steve Novella has written about the “replication
crisis” before. So have I. We both agree that the sensationalist narrative of a 
“replication crisis” is overblown, while admitting that we do have a replication
problem. One thing that I like to point out is that replication is built into
the scientific endeavor, albeit imperfectly, when other investigators try to
build upon observations of other investigators’ work. To do that, they have to
replicate part or all of what they did, sometimes in a different way.

Longtime readers might recall that I’ve also discussed how, when I first started
working with angiogenesis inhibitors in the 1990s, a lot of investigators,
myself included, had difficulties replicating the spectacular results reported
by Dr. Judah Folkman. It’s not that we didn’t observe anti-tumor effects from
the inhibitors; rather, we didn’t see effects as dramatic as what Dr. Folkman’s 
lab had published. Fortunately, Dr. Folkman was a diligent, dedicated, and
helpful researcher and was more than happy to assist laboratories that wanted to
build on his work. Indeed, in my experience in science, scientists are usually 
flattered, not threatened, when another group wants to replicate their work.
Often, such contacts lead to collaborations, in which different scientists bring
different strengths. Has Podcast Jay never collaborated? Or maybe no one ever
expressed enough interest in his findings to contact him. Or maybe, as is often 
the case, this particular accusation is a confession. I won’t say that
scientists are never threatened and defensive, but I will say that I think
Podcast Jay exaggerated the problem…big time. As for funding replication
studies, what Podcast Jay is suggesting is an old idea, that the NIH should fund
studies that attempt to replicate key scientific findings. The devil, of
course, is in the details, and I don’t trust Podcast Jay and his gang that can’t
science straight to solve this problem when the NIH has been struggling with
this very question for literally decades. I do love, however, the way that
Podcast Jay makes it seem as though MAHA was the first ever to bring up this
problem.

No one—and I mean no one—defends irreproducible science. Actually, that’s not
quite right. MAHA defends it all the time, with RFK Jr. promoting bad studies by
cranks and antivaxxers to justify his policies. True, the vast majority of
those studies were not NIH-funded. Even so, if Podcast Jay were really about
making science more rigorous, he’d look into those studies and develop policies 
to make sure that the NIH doesn’t fund studies like those. Instead, he harps on 
the “replication crisis” without actually mentioning all the layoffs (excuse me,
reductions in force, or RIFs), budget cuts, and other chaos happening under his
watch that will make it impossible for the NIH to implement new initiatives
without dramatic effects on other NIH functions. It’s a zero-sum game.

Moreover, remember that the real reason that MAHA wants to harp on the
“replication crisis” has less to do with the actual replication problem and more
to do with attacking inconvenient science that RFK Jr. doesn’t like. In other
words, contrary to what Podcast Jay claims, the purpose of the effort is not to 
“restore trust,” but to decrease it by casting doubt on the “replication” of
scientific findings. After all, he and his fellow COVID-19 contrarians, antivax 
RFK Jr. and his boss Donald Trump most of all, played a major role in the
decline in trust in science and public health, and the situation certainly
hasn’t gotten better. As Jonathan Howard likes to ask: They’ve been in office a 
year. What have they done to restore trust in science, given that trust in
science and US federal science agencies like the CDC has plummeted since this
time last year?

Patronage, thy name is Trump…and MAHA

There was a huge clue last week about what the administration really wants to do
with the NIH. Remember, the NIH is pretty close to a meritocracy. At least,
it’s less prone to political pressure than the average federal agency, and
that’s by design. It’s managed to stay that way for nearly 80 years…until now.

On Bluesky:

New NIH funding strategy has been formalized.I really do hope scientists
understand what this means for the future of science (funding) – it's not
subtle.www.niaid.nih.gov/about/unifie…

— Kristian G. Andersen (@kgandersen.bsky.social) 2026-01-30T20:31:09.717Z

Not subtle at all: your research, it says, needs to align with HHS (i.e., RFK
Jr's) priorities

— Prof Gavin Yamey (@gavinyamey.bsky.social) 2026-01-30T20:51:17.362Z

Of course, this is what I’ve long been predicting. Let’s take a look:

The key part of this is how the last two steps repeatedly emphasize aligning
with HHS priorities. Now, it’s always been true to some extent that NIH-funded
research has to align with NIH priorities. However, that’s not quite what we’re 
talking about here. What we’re actually talking about is putting the final
funding decisions into the hands of political appointees, rather than the usual 
career scientists who have traditionally sat on the advisory councils that look 
at scored grants to come to a decision regarding which grants will be funded
within the budget available:

Just to give the TL;DR on this one:*The* main purpose of the EO is to move
funding priorities and decisions away from experts and career professionals over
to political appointees. With the ultimate power held by Vought / OMB.

— Kristian G. Andersen (@kgandersen.bsky.social) 2025-08-07T22:55:00.775Z

A little less TL;DR, a few things to note in particular.1️⃣ "senior appointees" 
will be appointed by the President and will have full authority over funding
priorities. In coordination with OMB (giving Vought outsized power).

— Kristian G. Andersen (@kgandersen.bsky.social) 2025-08-08T00:21:54.392Z

2️⃣ Senior appointees (again, appointed by the President) also have full
authority over the awarding of grants (not just funding priorities).

— Kristian G. Andersen (@kgandersen.bsky.social) 2025-08-08T00:21:54.393Z

3️⃣ Senior appointees will have full discretion to do whatever the heck they
want to do, no matter what pesky subject matter experts might say.And,
specifically, they need to advance the President's priorities.

— Kristian G. Andersen (@kgandersen.bsky.social) 2025-08-08T00:21:54.394Z

And if you don’t believe me, check out this story in Nature from last month:

Crucial grant-review panels for more than half of the institutes that make up
the US National Institutes of Health (NIH) are on track to lose all their voting
members within the year. Federal law requires these panels to review
applications for all but the smallest grants before funding can be awarded,
meaning that the ability of those institutes to issue new grants could soon be
frozen.

All of the NIH’s 21 institutes and three of its six centres have their own
panel, called an advisory council. Membership on the councils has been dwindling
as members serve out their terms without replacements being appointed. At 12 of
the institutes and one of the centres, the last voting member’s term is set to 
expire by the end of this year, according to rosters on federal websites (see
‘Shrinking pool of advisers’). It typically takes several years for a new member
to be onboarded.

Dozens of scientists who were poised to fill these vacancies were dismissed last
year by the administration of US President Donald Trump, Nature reported in
July.

That’s right. The Trump administration appears to be clearing the deck in order 
to replace advisory council members with political appointees who will have
final say over which grants are funded. Still don’t believe me? After all, some 
of these panels, if they have no members, will simply be unable to fund any
grants, thus freezing grant issuing in scientific subjects the administration
doesn’t like. Maybe, but take a look at this:

The statute allows the HHS secretary, Robert F. Kennedy Jr, to circumvent the
vetting process and handpick panellists. This practice is very rare but not
unprecedented, Lauer says. The HHS spokesperson did not respond to Nature’s
queries about whether Kennedy plans to do this.

RFK Jr. will do it. Mark my words. I predict that by the end of 2026 this
process for appointing advisory council members will no longer be rare. It will 
be the norm. RFK Jr. will pick whomever he wants as panelists, and they will
dole out grants as patronage, rewarding MAHA supporters and MAHA-aligned
projects, all while eliminating funding for science projects that conflict with 
the administration’s ideology.

The NIH has been an engine of scientific and economic development for 76 years. 
It is the crown jewel of US science and a shining example of what government can
do when it actually does act for the public good. Longtime readers might
remember a post from three years ago, when I discussed a conspiracy theory in
which antivaxxers and COVID-19 cranks portrayed NIH grant funding decisions as
if Anthony Fauci personally doles out NIH dollars like a mob boss to scientists 
who support him and withholds grant dollars from those who do not or those who
do research that he doesn’t approve of. That makes it especially ironic how,
under the “leadership” of the useful idiot Podcast Jay, the Trump administration
is clearly moving to turn the system by which the NIH funds grants into one in 
which Trump’s minions dole out research funds based on loyalty, rather than the 
strength of their science.

Lysenko couldn’t have done it better himself, and the damage to US science will 
take a generation to recover from; that is, if we can ever recover from it.


Dr. Jay Bhattacharya on Measles: “I Think I’ve Done My Best.”

As football coach Bill Parcells famously said, “you are what your record says
you are”.

Jonathan Howard on August 27, 2026

Link


“Florida Leads Nation in Number of COVID-19 Deaths of Nursing Home Residents and
Staff.”

Football coach Bill Parcells famously said, “you are what your record says you
are”. Though SBM readers know about it already, Dr. Jay Bhattacharya had a
horrific record advising Gov. Ron DeSantis during Florida’s brutal Delta wave in
the summer of 2021. Although he claimed the state had “protected the
vulnerable,” here’s what he actually accomplished when he had the chance to put 
his ideas into practice:

1. He failed to protect “vulnerable” people: “Florida Leads Nation in Number of
COVID-19 Deaths of Nursing Home Residents and Staff,” August 2021.
2. He failed to protect “not vulnerable” people: “Child Covid Deaths More Than
Doubled in Florida as Kids Returned to the Classroom,” September 2021.
3. He failed to keep schools open: “School Closures Reported In Five Florida
Counties; Districts ‘Drowning’ In COVID,” August 2021.
4. He failed to protect educators: “15 Miami-Dade Public School Staff Members Die
of COVID In Just 10 Days,” September 2021.
5. He failed to achieve herd immunity: “Florida’s COVID Deaths Reach Nearly 6,000
in 2024,” January 2025.
6. He failed to protect education: “Florida Ranks Last In Reading, Warns Nationwide
Education Report“, May 2026
“We called for focused protection of vulnerable elderly and called for many
policies.”

Florida turned out to be a preview of coming attractions, and more people should
have paid attention it at the time. Unfortunately, instead of caring about
reality, many influential pundits ignored Florida’s warning and glorified Dr.
Bhattacharya simply because he called for things. Members of sheltered Opinion
Class felt this was a big deal.

Indeed, in August 2021, during the worst of it all in Florida, Dr. Bhattacharya 
wasn’t in the hospital to witness what his precious “natural immunity” was doing
to citizens, both young and old. Rather, he was busy giving promoting both
himself and “natural immunity” in the media.

He gave an interview to the misinformation publication Unherd that month,
boasting of his 1-page online petition. The interview was titled Prof. Jay
Bhattacharya: I stand by the Great Barrington Declaration, and it opened by
saying:

Professor Jay Bhattacharya is one of the famous voices to have emerged out of
the pandemic. A vocal critic of lockdowns, his name became synonymous with the
controversial Great Barrington Declaration, which called for an “alternative
approach to the pandemic” that would entail no lockdowns. Along with
co-signatories Sunetra Gupta and Martin Kulldforff (who featured on UnHerd last 
year), the trio argued that public health strategies should instead centre on
the ‘focused protection’ of at-risk groups while keeping society as open as
possible so the healthy parts of the population could build herd immunity.

This was 100% true, and everyone should be in complete agreement about it. Dr.
Bhattacharya wanted society to open as open as possible so the healthy parts of 
the population could build herd immunity. Even during the middle of Florida’s
Delta wave, he wanted them infected.

He also became a famous voice because he called for things and argued that other
people should do them. Here’s a smattering things Dr. Bhattacharya called for
on social media alone:

1. Focused protection of vulnerable elderly and many policies
2. We had twenty suggestions for how to accomplish focused protection in the gbd,
and we called for public health to join in thinking creatively to think of more
3. A study to get a better estimate so we could make better decisions
4. Keeping schools open in Oct. 2020
We should also be clear that not only did Dr. Bhattacharya call for many things,
this is all he did. He wasn’t in schools, hospitals, or nursing homes putting
his plan into practice. As COVID raged, he was busy calling for things in
podcasts, YouTube videos, editorials, and Tweets.

He further claimed that that he was were in charge, he would be able to do them.
He would simply flip the “on” switch and everything would turn out just fine.
How nice! Conversely, he blasted public health leaders for not doing all the
things he called for.  Why didn’t those fools just flip the “on” switch?

Fundamentally, Dr. Bhattacharya was a content creator who portrayed him as a
pandemic superhero- COVID MAN, More Powerful Than a Deadly Virus. In the Fantasy
of the Optional Pandemic, the virus was magically erased from the equation, and
there was no difference between calling for something and actually doing it.

“Infant in Pennsylvania is one of the two measles deaths reported this week”

Things are very different today. Based on all the wonderful, amazing things he
called for and would have done, Dr. Bhattacharya was elevated to a position of
great authority and responsibility.

Dr. Bhattacharya’s days of calling for things are over. Now, it is our turn to
call for things and to say we would do them. It’s his job to do everything we
call for and to deliver concrete results. We have the right to excoriate him
when he fails to do everything we call for, just like he did with his
predecessors.

Feel free to share in the comments what you would call for Dr. Bhattacharya to
do. One of you may call for him to stop censoring scientists. That’s a good
idea. Someone else might call for him to stop appointing unqualified people with
dangerous beliefs to lead the NIH. That’s important too. Anyone can call for
Dr. Bhattacharya to do whatever they want, and there’s no shortage of complaints
regarding his dismal performance in office.

For my part, I am calling for Dr. Bhattacharya to control measles. Things are
going very poorly right now. Measles seems to be everywhere. Children are
suffering. A few of them have died, most recently an infant in Pennsylvania.
Measles is straining local budgets and impacting education, as reported by the
article A Study Shows Just How Much School Absences Soar in a Measles Outbreak.

It’s not the only virus spreading now. Though he previously claimed he would
have perfectly contained COVID, today the headlines read CDC: COVID Infections
Likely Rising in 50 States and South Texas School District Cancels Classes Amid 
COVID-19 Spread. It’s Florida’s Delta wave all over again, but now for the
entire country and with multiple viruses, as well as bacteria and parasites.

Once again you are what your record says you are. Here’s Dr. Bhattacharya’s
record.

“I think I’ve done my best.”

Dr. Bhattacharya was recently confronted about his failure with measles by
Margaret Brennan. In addition to blaming Biden, he boasted about a video he
posted to X six months ago where he encouraged the MMR.

There is no reason to think this lone social media post changed the mind of a
single parent, however, Dr. Bhattacharya was extraordinarily proud of it. “I
think I’ve done my best,” he said, and I believe him. He is not capable of doing
better than this. Posting a single social media video is the best he can do to 
control dangerous viruses, and while he absolutely deserves a participation
trophy for it, his “best” obviously isn’t good enough

Unfortunately, we are probably just getting started. Only the MMR can contain
measles, and with anti-vaxx disinformation flying from the Oval Office, it’s no 
surprise that the headlines read Kindergarten Routine Vaccination Rates Continue
to Decline.

So while Dr. Bhattacharya may be doing his best, he obviously needs a lot of him
help. Since I am calling for him to contain measles, I will also tell him what 
I would do.

I would blanket the media with the facts. I would tell parents measles is
dangerous while the MMR is safe and effective at every opportunity. This is
exactly what Ms. Brennan suggested. She and I hit on the same idea, not because 
it is brilliant, but because it is obvious.

I would further travel and encourage vaccination during public meetings. I would
send a diverse group of HHS employees to spread this message to different
communities. I would call out anti-vaccine disinformation spread by Stephen
Miller, Kennedy, and Trump, even this honesty cost me my job.I would not debase 
myself and the entire medical profession by nodding along as they lied about
vaccines.

But that’s what Dr. Bhattacharya chose to do.

And until he gets measles under control, we should all point out his gross
incompetence and call for him to get his act together in podcasts, YouTube
videos, editorials, and Tweets. He’s the medical establishment now, and this is 
what he signed up for.



Jay Bhattacharya, October 2020: “Let People Face the Risk of the Disease.”

Dr. Jay Bhattacharya sought to spread a deadly pathogen. Does he belong in the
HHS Hall of Heroes with legends who tried to contain them?

Jonathan Howard on September 29, 2026

Link


The HHS Hall of Heroes appropriately features three legends when it comes to
limiting infectious diseases: John Snow, Ignaz Semmelweis, and Joseph Lister.
The most recent addition to this list of giants is Dr. Jay Bhattacharya, our
current NIH director and former CDC leader. However, not only have measles and
cyclosporiasis spread during his brief tenure, but we also must remember what he
said when COVID raged to judge whether or not he deserves membership in this
esteemed group.

To do that, let’s flash back to October 2020, a pivotal point in the pandemic.
Vaccines arrived just two months later, but so did the pandemic’s worst wave,
when 3,000 Americans would die of COVID daily. We knew by then that infections
in younger people invariably spilled into older people, and those of us who
worked on COVID units knew the virus was not always benign for them either.
Indeed, COVID became a leading killer of young adults in 2021. Everyone had
every incentive to avoid the virus at that time, both for ourselves and our
neighbors.

However, Dr. Bhattacharya felt differently at that time. While other doctors
were working on COVID wards, he was dressed in a suit, ensconced in a bucolic
retreat in Great Barrington, Massachusetts, with a film crew recording his
pronouncements. When it came to people under age 70, Dr. Bhattacharya was on the
side of the virus, and he didn’t hide it all. Staring into the camera, he
announced that he wanted to:

Let people face the risk of the disease who actually don’t face a very large
risk of mortality if they were to be infected.

Full video here

John Snow discovered a water pump was the source of a cholera outbreak. Ignaz
Semmelweis demonstrated that hand washing could reduce infections and save lives
in obstetrical clinics, while Joseph Lister proved that sterilizing surgical
instruments did the same. For his part, Dr. Bhattacharya spread fake statistics 
to purposefully infect countless millions of people with a novel, mutating,
dangerous virus at the worst possible moment of the pandemic.

As one social media commentator said, one of these is not like the others. It’s 
pretty obvious who stands out, and since our current HHS leaders won’t remind
you of why, it’s up to us to remember.

With Brains Pickled by Social Media, Our Dishonest, Sheltered, Juvenile Medical 
Establishment Keeps Trying to Sic Vengeful Online Mobs Against Doctors Who
Actually Care for Patients

There are a lot of unstable, angry people out there, and it’s easy to get
powerful guns in the US.

Jonathan Howard on August 21, 2025

Link

What brings them to recommend to babies that have zero risk vaccines that could 
harm their heart?!

Retsef Levi is a Professor of Operations Management at MIT and ACIP member who
experienced the pandemic from his laptop. He was a spectator. However, this lack
of real-world responsibility didn’t stop him from claiming he knew more about
how to keep children healthy than pediatricians, the doctors who will be there
if your child gets sick. Unlike them, he believes unvaccinated babies should
suffer from COVID in perpetuity.

Recently, after government disinformation forced the American Academy of
Pediatrics (AAP) to issue independent vaccine guidelines, Levi responded with
the following Tweet.

August 19, 2025

This is the kind of obvious nonsense that I’ve debunked here for years.

  1. Levi feels parents should be denied the right to protect their children
    because the COVID vaccine isn’t popular, an outcome he worked tirelessly to 
    create.

  2. Babies do not have “zero risk” of COVID. In reality, they have the highest
    risk of all children, and they don’t arrive with natural immunity. At least 
    in their formal publications, even disinformation doctors Vinay Prasad and
    Marty Makary were forced to concede that their risk was “on par with those
    for adults 50 to 64 years old.”

  3. The vaccine isn’t perfect, but it helps protect our youngest children.

  4. Despite Levi’s emotionally manipulative use of a broken heart emoji, the
    vaccine poses no risk to babies. Vaccine-myocarditis almost exclusively
    occurs in males ages 12-24, and even then, it is rare, mild, and transient. 
    Levi treats this as a fate worse than death from COVID. He yawns at that.

Incredibly, people like this are in charge of vaccine policy for the entire
country thanks to RFK Jr. and all the doctors who enabled him.

Astonishing that pro-mercury in kids is their battle cry!! @AmerAcadPeds

However Levi is doing more than spreading disinformation. Although he is a
member of the the ACIP, he is behaving like a teenage Twitter troll, lobbing
unprofessional attacks against the AAP. While medical societies are not
sacrosanct or beyond reproach, they are composed of doctors who care for
patients in the real world, unlike Levi. Unintentionally revealing what
motivates him, Levi speculated the AAP was motivated by financial interests,
personal vendetta and fanaticism. He simply can’t imagine that pediatricians
just want to keep children healthy.

Unfortunately, these vile, juvenile accusations are par for the course for our
medical establishment. They’ve behaved like this way for years, and such
accusations are what catapulted them to power in the first place. Other recent
examples are below:

July 1, 2025

This is disinformation. In reality, vaccines do not contain elemental mercury.

August 19, 2025

This is disinformation. In reality, vaccines save money by keeping children out 
of the hospital.

August 15, 2025

This is disinformation. In reality, the AMA’s support for vaccine mandates in
2021 is not the reason Nobel Prize winning research is being defunded in 2025.

Dr. Vinay Prasad, meanwhile wrote entire essays like this.

If you stand for evidence based public health interventions, you basically get a
target placed on your by DHHS leadership

Safe in their offices, their brains pickled by social media, our juvenile
medical establishment is united not just in their disregard for basic facts, but
in their contempt and loathing for anyone who operates in the real world.
Children’s health is just a game to them, an opportunity to score another
Twitter dunk against their anointed villains, doctors who work in clinics and
hospitals. Our medical establishment is not trying to make logical, scientific
arguments. They are appealing to raw emotions. They are trying to make people
furious, rageful, and distrustful- a story I tell in the sequel to We Want Them 
Infected.

Article is here

However, this is about more than just another attempt to summon a vengeful
social media mob. This is dangerous. There are a lot of unstable, angry people
out there, and it’s easy to get powerful guns in the US. Three of the four
tweets attacking the AMA and AAP were sent after the horrific terrorist attack
at the CDC. If that happens again, we’ll know why and who bears responsibility.

Read that here


                        Politics and Science at the HHS

                                 Steven Novella

                                      Link

When politics and science collide, shenanigans are likely to ensue. Politics is 
often antithetical to science because the former is about persuasion and value
judgments while the latter is about objectivity and transparency. Science cannot
function properly under the yoke of political ideology.

The infiltration of unscientific and anti-scientific practices and ideas into
mainstream medicine is primarily an act of politics and ideology trumping
science. The latest example of this comes from the Department of Health and
Human Services (HHS) who put out a press release on June 16th declaring that:
“HHS Secretary and Chinese Minister of Health Sign Memorandum of Understanding
on Traditional Chinese Medicine Research.” The press release states:

   “Many Americans incorporate alternative medical practices into their personal
   health care and are interested in the potential of a variety of traditional 
   Chinese medicine approaches,” Secretary Leavitt said. “This project will
   advance our understanding of when and how to appropriately integrate
   traditional Chinese medicine with Western medical approaches to improve the
   health of the American and Chinese people.”

This statement is so common among the political apologists for unscientific
medicine that is has become almost a cliche. The first claim in Secretary
Leavitt’s statement is that “Many Americans incorporate alternative medical
practices into their personal health care…” This is misleading and irrelevant.
The primary problem is with the use of the term “alternative medicine” without
providing any kind of definition. This is a false category because the
modalities that are generally included in so-called CAM do not necessarily have 
anything in common except for the fact that they lack adequate scientific
justification to be considered part of mainstream medicine. That is, except for 
those treatments that CAM proponents sneak into this category to misleadingly
inflate its apparent size and impact – like exercise, nutrition, physical
therapy, etc. These modalities can be scientific (depending upon how they are
applied) and have no place under the CAM umbrella.

The false category of CAM allows proponents of dubious treatments to claim that 
their treatments are popular because many people exercise or take vitamins. It
would have been more appropriate and intellectually honest for Secretary Leavitt
to inform us as to the popularity of Traditional Chinese Medicine (TCM)
modalities. He emphasizes his point by informing us that:

   Thirty-six percent of Americans use some form of complementary and
   alternative medicine (CAM), according to the 2002 National Health Interview
   Survey.

As I discussed in a previous entry, this number is highly inflated and therefore
deliberately misleading. How about the core TCM modality – acupuncture? The
same data shows that use of acupuncture remains low, about 1%. TCM does not even
rank among the top 10 so-called CAM modalities, according to the NCCAM.

In addition to being factually misleading, the implied argument is a logical
fallacy – the argument ad populi: CAM is popular therefore it should be
supported. Well, the majority of Americans (2/3) believe that creationism should
be taught in public schools. That does not mean that the Department of
Education should support the teaching of ideology and religious belief as
science in public schools. Neither does the (exaggerated) popularity of CAM mean
that the HHS and medical research institutions should spend public money and
publicly support unscientific modalities as if they were legitimate.

Secretary Leavitt also stated that: “This project will advance our understanding
of when and how to appropriately integrate traditional Chinese medicine with
Western medical approaches to improve the health of the American and Chinese
people.” This is a good example of ideological spin – manipulating perceptions
through language. He states that we need to understand “when” and “how” to
integrate TCM – but he neglects the most important question (arguably the only
important question) – if we should integrate TCM. We should only integrate
methods that are safe and effective. How about an SBM analysis to find out if
any TCM modality is safe and effective and for what.

Of course, if any TCM method was backed by sufficient evidence to conclude that 
it was safe and effective – it would already be part of mainstream scientific
medicine. The only modalities that require political pressure to force them into
our health care system are those that are not backed by good science. This gets
back to the notion that politics tends to contaminate science – to rig the game
of science and change the rules so that a politically popular modality gets a
free pass. The public health is not served by this type of political meddling
into the science of medicine.

Secretary Leavitt also promotes the false dichotomy of “Western” medicine vs
TCM. This creates the false impression that this HHS memorandum is simply a
cultural exchange, as if medicine were only about culture. That is what the
promoters of CAM would have the public believe – that different modalities are
only about culture and not about science.

It is also worth noting that this initiative was coordinated in part by the
National Center for Complementary and Alternative Medicine (NCCAM) – a political
animal created by pro-CAM politicians and forced down the throats of scientists
at the NIH, and another excellent example of politics intruding on science.
This memorandum is evidence for the ongoing mischief that is caused by using
politics to trump science.

The health of Americans is best served by allowing the best scientific evidence 
available to inform health policy. What the HHS has done is bow before the
faddish political correctness of the day and thereby subvert the course of
science to ideology. The public deserves better.

A department adrift from its own “Gold” standards

Phantom citations, misinformation, and imbalance in HHS communications

David Weinberg on July 29, 2025

Link

The motto of the Department of Health and Human Services (HHS) is “Improving the
health, safety, and well-being of America.”  Many of the most recognizable
government health organizations (e.g. Food and Drug Administration, National
Institutes of Health, Centers for Disease Control and Prevention, and many
others) reside within this Cabinet-level department. Priorities and policy
decisions among the organizations within HHS are critically important to the
health, safety, and well-being of Americans. These priorities and policy
decisions should be based on careful analysis of available data, with
consideration of the risks, benefits, and costs of competing alternatives. The
ability to clearly communicate this information is critical to the public
understanding and acceptance of these activities, as well as the credibility of 
the Department. 

HHS has issued a series policy explanations justified with problematic sources, 
including citation of non-existent references. Even when references are
correctly cited, the contents have repeatedly been misrepresented. There has
been a consistent lack of balance. For instance high-quality studies most
accurately representing vaccine safety and efficacy have been disregarded, while
low quality studies exaggerating risks have been highlighted.

HHS FAQ to Congress

A few weeks ago I wrote a SBM article discussing the sloppy scholarship in a
communication from HHS to Congress. The FAQ from HHS was meant to explain
changes in vaccine recommendations, namely, the withdrawl of recommendations for
COVID vaccination in healthy children and pregnant women. The FAQ was a mess,
with prioritization of low-quality studies that grossly exaggerated risks, while
ignoring much higher-quality safety-affirming studies. There was outright
misrepresentation of the content of multiple citations. One study was cited as
documenting an increased risk of placental blood clotting in pregnant women, but
the cited study contained nothing relevant to placental blood clotting. One
cited study was in pre-publication and had not been peer reviewed. The journal
explicitly stated that the article “…should not be used to guide clinical
practice,” yet this article was one of a handful used by HHS to justify a policy
decision.

This sloppy document would be laughable if it were not from the most
consequential US health organization to the Congress of the United States. If I 
were supervising a trainee on a project, and if that trainee produced a document
of this sort, I would seriously consider removing them from the project. We
should expect better from the leadership of our most critical governmental
organizations.

This was not the first or last time HHS exhibited sloppy scholarship.

The MAHA Report

On Feb 13, 2025 President Trump issued Executive Order 14212. The report
instructed the  Make America Health Again (MAHA) Commission to deliver a Make
Our Children Healthy Again Assessment. The report was to focus on childhood
illness in the US, specifying certain subjects for inquiry, and to deliver the
report within 100 days.

The MAHA Commission, chaired by RFK Jr. delivered the report (often referred to 
as the “MAHA Report”) on May 22, 2025,   It was a 78-page report with over 500
references. News outlets quickly discovered troubling errors and irregularities 
in the report. There were 7 references to non-existent papers. Thirty-seven of
the references were entered multiple times. There were numerous
misrepresentations of the results of citations. Authors of cited papers note
that their papers were inaccurately represented. Some of the references had the 
strange text string “oaicite” in the URL’s.

In general, the MAHA reaches conclusions consonant with RFK Jr.’s long espoused 
beliefs and was a dream-come-true for health influencers. The libertarian
think-tank CATO institute posted a critique entitled: Premade Conclusions,
Post-Hoc Data: The Problem with the MAHA Report. which concludes thusly:

Good public health policy demands humility, precision, and honesty—especially
when the stakes are high. The MAHA Report offers none of these. If we want to
build a healthier future for our children, we must resist the temptation of
prepackaged conclusions and demand evidence-driven thinking, not ideology in
disguise. When the government controls both the research agenda and the health
advice, it risks turning scientific inquiry into propaganda and personal health 
into political theater.

How could this happen?

In a document the size of the MAHA Report, it would not be surprising to find a 
few errors. But there are major errors: non-existent references, incorrect
authors and journals, inaccurate reporting of the findings of research studies. 
What could account for all of these irregularities and inaccuracies? The
presence of the “oaicite” string in some of the reference provides a smoking
gun. This a fingerprint of use of Artificial Intelligence (AI) in creation of
the report”: “oaicite” is a placeholder for a link to a reference to be added
later.  If for some reason the reference is not added “oaicite” will persist in 
the output. This text string is meaningless and confusing to the reader but is
an artifact of AI output.

Use of AI as a tool is not surprising, or particularly concerning. The presence 
of errors such as phantom references, duplicate references, and the placeholder 
“oaicite” are exactly the types of artifacts known to be produced by large
language models. The frequency, severity, and obviousness of many of the errors,
however, suggest insufficient human supervision and review prior to
dissemination of the MAHA Report. 

If you prompt an AI large language model to reach a particular conclusion, it
will generally comply.  I would be very curious to learn what prompts the AI was
given in generation of the MAHA report.

An oopsie from the first meeting of RFK Jr.’s Advisory Committee on Immunization
Practices.

The Advisory Committee on Immunization Practices (ACIP) is a committee of up to 
19 experts convened periodically to advise the CDC with vaccine recommendations 
and schedules. Members of the committee are customarily filled and vacated on a 
rotating basis. RFK Jr, in his wisdom as HHS Secretary dismissed the entire
membership of the ACIP, and reconstituted it with a streamlined panel of eight
handpicked members, including several members with strong anti-vaccine
pedigrees. Dr. Gorski discussed the new ACIP here and here.

Lyn Redwood, former leader of Children’s Health Defense, an anti-vaccine group
founded by RFK Jr. was scheduled to deliver a presentation at the first meeting 
of the newly reconstituted  ACIP.  Ms Redwood is not a member of the ACIP, but
holds an ambiguous position in HHS. Her presentation was purported to be a
review of the preservative thimerosal in vaccines. Redwood has been a long-time 
supporter of a discredited link between thimerosal in vaccines and autism.  Her 
report was posted on the CDC website in advance of her presentation. Eagle-eyed 
observers quickly discovered a fictitious reference.  According to Reuters:

It makes reference to a study called “Low-level neonatal thimerosal exposure:
Long-term consequences in the brain,” published in the journal Neurotoxicology
in 2008, and co-authored by UC Davis Professor Emeritus Robert Berman.

But according to Berman, “it’s not making reference to a study I published or
carried out.”

Berman said he co-authored a similarly named study in a different journal –
Toxicological Sciences – that came to different conclusions than those suggested
by Redwood.

Just to clarify: Ms Redwood supported her conclusions with a fictitious study.
If you charitably believe that it was a simple mistake in formatting the
reference, one would reach an even more incriminating conclusion: she
misrepresented the study she intended to cite.

Coincident with the ACIP meeting, the CDC posted a summary entitled
“Thimerosal-containing vaccines and neurodevelopmental outcomes. Review of the
evidence.” This was a thorough review of the literature. This report included
studies supporting the safety of thimerosal in vaccines, as well as studies
suggesting elevated risk. Each study was accurately summarized. The authors of
the report pointed out consistent “methodological limitations” in the studies
suggesting excess risk. The overwhelming evidence supported the safety of
thimerosal, and lack of credible evidence for a causal relationship between
thimerosal and autism spectrum disorders. This report was quickly removed from
the CDC website but is preserved here.

The creation of this CDC summary demonstrates two things:

  1. There are professionals within HHS capable of critically and fairly reviewing 
    the literature on a subject.

  2. The current leadership of HHS is not interested in a critical and fair
    evaluation of the literature. The report promptly disappeared from the CDC
    website.

HHS standards vs 2025 HHS practice

Scholarly communication is an art and a science. One of the obligations of
scholarly communication is the need to “show your work.” If you make an
assertion based on existing science it should be supported. The references
should be representative of the best data on the subject and should be
accurately portrayed in the document. One of the cardinal rules I learned as a
fledgling academic communicator was this: Never cite an article you have not
read.

How should we judge the scholarship and scientific communication practices of
the 2025 HHS? There are no communication police but HHS does have some internal 
documents explaining principals and practice standards for scientific
communications.

From The Office of the Assistant Secretary for Planning and Evaluation (APSE)
comes this document  entitled: HHS Guidelines for Ensuring and Maximizing the
Quality, Objectivity, Utility, and Integrity of Information Disseminated to the 
Public.

Within the document is this directive about quality standards:

Quality is to be ensured and established at levels appropriate to the nature and
timeliness of the information to be disseminated, and specific standards may be
adopted that are appropriate to the various categories of information that is
disseminated. Agencies are to develop a process for reviewing the quality of
information before it is disseminated. Further, information quality is to be
treated as an integral step in every aspect of the information development
process.

How rigorously are quality standards being followed when documents contain
fictitious references and inaccurate representation of cited studies?

Another document was issued from the Office of Research Integrity entitled: 
“Avoiding Plagiarism, Self-plagiarism, and Other Questionable Writing Practices:
A Guide to Ethical Writing.” The Office of Research Integrity (ORI) resides
within HHS. This is a 70 page treatise on responsible, ethical communication in 
the scientific arena. It deals with plagiarism, accurate citation of the
literature, conflicts of interest, etc. This document is written primarily for
researchers engaged in writing grants and scientific reports. One would hope
that similarly high standards would apply to written documents used to inform
decisions about HHS priorities and policies relevant to the health of US
citizens.

Here are a few quotes.

Obviously, literature cited in support of our hypotheses must be grounded in
sound arguments, tight research methodologies, and flawless data. Citing
references known to be methodologically or logically deficient in support of our
work is ethically problematic, particularly if we fail to mention these
shortcomings. Likewise, if in our search for relevant literature we become aware
of important relevant evidence that runs contrary to our data or point of view,
we have an ethical obligation to cite such evidence, either in the introduction
or the discussion section of our paper. We must not do this dismissively, but
in an unbiased manner.

References play a crucial role in scholarly and scientific writing for they
allow the reader to explore in more detail a given line of thinking or evidence.
For these reasons, it is important that authors strive for accuracy when
listing references in manuscripts

…some authors to provide what others view as a biased review of the relevant
literature. That is, in placing their data or theory in the context of existing 
relevant work, authors sometimes cite only references that are favorable to
their position. However, consistent with the basic tenets of ethical writing and
scientific objectivity, we have a responsibility to cite all relevant material,
even work that may contradict our own position. Failure to do so compromises
our professional obligation to remain unbiased and is antithetical to the
primary mission of a scientist’s search for truth.

Conclusion

The White House released an Executive Order called Restoring Gold Standard
Science. In it, the terms “transparent” and “transparency” are used repeatedly
as features of Gold Standard Science.

In this article I have presented recent communication practices of HHS and found
them lacking. Unfortunately, the communication practices are reflective of a
more serious problem: a lack of rigor and lack of seriousness in parsing the
best evidence for the purpose of setting HHS priorities and policies. HHS has
fallen short in transparency and Gold Standard Science.

Review and compliance with the guidance from  Office of the Assistant Secretary 
for Planning and Evaluation and Office of Research Integrity would be good steps
in the right direction.


Antivaccine pseudoscience disguised as autism advocacy in the Minnesota
legislature

Recently, Sen. Jim Abeler of Minnesota created the MN Autism Council, an
advisory panel tasked with advising the legislature on autism policy. A closer
look at the story reveals that Sen. Abeler is a chiropractor, two of the members
are antivaxers, and one of them was a founding member tasked with forming the
council. This is how antivaccine activism is disguised as autism advocacy.

David Gorski on January 28, 2019

Link



Earlier this week, the World Health Organization included vaccine hesitancy on
its list of top ten global health threats for 2019. In his discussion of the
issue, Steve Novella recounted a depressing litany of outbreaks of
vaccine-preventable diseases all over the world, particularly in Europe, to
which vaccine hesitancy and the antivaccine movement have been major
contributors. Thus far in the US, we’ve avoided the massive outbreaks of measles
that are continuing in Europe and Israel, for instance. That’s not to say that 
we don’t have our own outbreaks. Currently, there are measles outbreaks in New
York City in ultra-Orthodox Jewish populations and Clark County, Washington
(just across the Columbia River from Portland). A couple of years ago,
antivaxers contributed directly to a large measles outbreak among the Somali
immigrant population in Minnesota. Basically, local antivaccine groups laying
the groundwork by taking advantage of an observation that there appeared to be a
higher prevalence of autism among the children of Somali immigrants by
promoting Andrew Wakefield’s discredited and fraudulent research linking the MMR
vaccine to autism. As a result, uptake of the measles-mumps-rubella (MMR)
vaccine plummeted. Basically, antivaxers targeted a vulnerable
community—repeatedly—with antivaccine propaganda. Indeed, Andrew Wakefield
himself even paid Minnesota a visit in 2010. Even as the outbreak was raging,
antivaxers doubled down, sending Mark Blaxill there to tell the Somalis, in
essence, not to listen to the public health authorities desperately trying to
contain the outbreak.

In light of that recent history, it was particularly disturbing to see what was 
reported in Minnesota last week:

   Autism activists are concerned that the appointment of vaccine skeptics to a 
   newly formed state council gives credibility to views the state has struggled
   to dispel.

   The MN Autism Council was formed last fall by Sen. Jim Abeler, R-Anoka, to
   discuss autism and advise the Legislature on public policy.

   Abeler said he wants the group to represent diverse viewpoints and said it
   will be focused on issues like housing, employment and education, not
   vaccines.

First of all, it is very common for antivaxers who believe against all evidence 
that vaccines cause autism to cloak their true nature in autism advocacy, at
least for purposes of appearing “respectable” and insinuating themselves into
advisory committees for government and nonprofits. In fairness, some of them
actually do autism advocacy work because many of them became antivaxers after
having a child diagnosed with autism. The problem is that these same antivaxers 
use their autism advocacy to promote their antivaccine views as well. Indeed, an
unfortunate problem with autism advocacy in the age of Wakefield is that autism
advocacy is all too often tainted with antivaccine views. Some autism advocacy 
groups, like Autism Speaks, have tried to have it both ways, doing a “nudge,
nudge, wink, wink” in their stances on vaccines and autism.

So who is Sen. Abeler, and who are the antivaxers now serving on the Minnesota
Autism Council? Well, surprise, surprise, Jim Abeler is a chiropractor, or, as I
like to say, a substandard physical therapist with delusions of grandeur. His
clinic website features the usual chiropractic quackery about subluxations and
spinal manipulation, but also includes quackery for ADHD, colic, ear infections,
pregnancy, and chiropractic care for children. It describes Abeler thusly:

   His technique includes a gentle approach to spinal care utilizing the use of 
   an Activator for adjusting, kinesiology, spinal and muscular balancing,
   nutritional advice and a strong emphasis on personal responsibility on the
   part of the patient. In addition, Dr. Abeler looks for underlying causes of
   any disturbance or disruption (which may or may not be causing symptoms at
   the time) and make whatever interventions and lifestyle adjustments that
   would optimize the conditions for normal function.

In other words, the usual “we treat the underlying causes” nonsense favored by
alternative medicine practitioners everywhere.

Elsewhere on Abeler’s website, we find a blog post on how chiropractic can
“boost your immunity”:

   Chiropractic adjustments can remove misalignments, allowing the nerves in
   your spine to operate with less interference. When the brain and nervous
   system are able to communicate effectively your immune system is back running
   at full capacity. Anoka chiropractic doctors may also reduce your back pain,
   neck pain, jaw pain, headaches, and shoulder pain so you can function in
   your day-to-day life more efficiently. While chiropractic treatment can
   influence your immune system directly, it can also heal your body so you are 
   in a position to be more active.

And for children:

   Kids seem to be at the mercy of just about every type of virus and illness
   out there and childhood immunity is always a hot topic of conversation.
   Things like ear infections, colds, allergies, and tonsillitis can cause a lot
   of discomfort and become serious in some cases. Just as with adults,
   children can receive chiropractic treatment that will ease tension on nerves 
   and improve their immune response.

Interestingly, even doing Google Advanced Searches, I was unable to find any
posts on vaccines on Jim Abeler’s website. Ditto when I searched for the word
“autism”. However, there are strong reasons to suspect nonetheless that Sen.
Abeler is antivaccine. The first of these is that he’s a chiropractor, and
chiropractic as a “profession” is rife with antivaccine views, with many, if not
most, chiropractors discouraging vaccination in favor of their quackery.
Chiropractic is like naturopathy in that respect, full of antivaccine
pseudoscience. Second, he chose two prominent antivaxers to be on the panel,
Wayne Rohde, co-founder of the Vaccine Safety Council of Minnesota, one of the
groups involved in promoting antivaccine views among the Somali immigrants in
its state, and Patti Carroll, who was involved with organizing antivaccine
outreach in the Minnesota Somali community. Rohde is also an executive for
Health Choice, a group that believes that most chronic health issues in children
are due to “unhealthy choices,” including “industrial processed foods, side
effects of vaccine choices, and other environmental and lifestyle factors.” If
you check out the Vaccine Safety Council’s website, you’ll find it packed with
the usual antivaccine talking points:

   GUIDING PRINCIPLES

  1. We demand full disclosure by government and health officials of both the risks
    and benefits of vaccines.

  2. We support unbiased safety studies for every vaccine and every combination of 
    vaccines the government recommends.

  3. We provide education on dishonest representation, legal issues, parental
    choice, and true informed consent.

  4. We advocate for complete transparency by state and federal officials in
    vaccine law and policy decisions.

  5. We promote consumer safety by calling for vaccines free from mercury, aluminum
    and other dangerous ingredients.

  6. We work to preserve individual freedoms by opposing mandatory vaccination.

Note the antivaccine dog whistles, such as “unbiased safety studies”
(translation: any study not run by big pharma or the government or academic
institutions), “full disclosure” of “risks and benefits” (in reality, vastly
inflating the risks and downplaying the benefits of vaccination), the promotion 
of vaccines free from “mercury, aluminum, and other dangerous ingredients”
(mercury isn’t in childhood vaccines anymore and haven’t been for over 16 years,
and none of the other ingredients in vaccines are dangerous at the doses used),
and, of course, the “vaccine freedom” gambit. Elsewhere on the website, you can
find videos by antivaxers such as the producer of the antivaccine propaganda
film disguised as a documentary VAXXED, Del Bigtree, along with links to VAXXED 
itself and a host of other antivaccine propaganda videos. The reading list on
the website includes the usual list of antivaccine books, and the “research”
section of the website includes Pubmed links to studies frequently
misinterpreted as supporting antivaccine views or horrible studies by antivaxers
themselves.

Amusingly, Kim Stagliano over at the antivaccine blog Age of Autism is crying
“Help, help, I’m being repressed!” as antivaxers are wont to do whenever they
are called out by the press:

   Wayne Rohde has written a carefully researched book on The Vaccine Court that
   every American should read. He moved to Minnesota from Oklahoma to help his 
   son. His son Nick was the namesake of “Nicki’s Law” which in 2008, fought for
   medical coverage for autism in Oklahoma. Monday (May 19), two newspapers –
   both in predominantly Republican communities – published editorials in
   support of “Nick’s Law,” a measure by Senator Jay Paul Gumm that would
   require health insurance policies cover diagnosis and treatment for autistic 
   children. Patti Carroll has worked tooth and nail for ALL people with autism 
   in Minnesota and also to protect those not “yet” touched. She was especially 
   involved in helping the immigrant Somali population as they faced autism for 
   the very first time, once here in America. To offend them by writing them off
   as mere “antivaxxers” is an insult in the extreme.

It is all very well and good that Rohde fought to pass Nick’s Law (which
ultimately did not pass, from what I gather), but it is not well and good that
he now fights in Minnesota to demonize vaccines. As for Patti Carroll, I can’t
help but note that the link chosen by Stagliano to represent the “good” she did 
for the Somali immigrant community in Minnesota was to a post entitled “MN
Department of Public Health Coerces Somali Families into MMR Vaccine“, with an
image proclaiming “the bully vaccine.” Basically, it’s a blog post by Patti
Carroll about how she was trying to counter the MN Department of Public Health’s
efforts to persuade Somalis to vaccinate their children. If you want an example
of how antivaxers equate autism advocacy with their antivaccine activism, I
can’t think of a better example! Stagliano and Carroll actually thought Carroll 
was doing good by fueling a measles outbreak by persuading a vulnerable
population that vaccines cause autism and that they should therefore not
vaccinate their children against a highly contagious disease.

Which leads us to Stagliano’s usual drama:

   We are the new N word. We are the new R word. I was supposed to speak at an
   autism school somewhere in the United States in 2 weeks. I was hired as
   keynote speaker for their annual fund raiser. Some parents at this fine
   private school caught wind that “KIM ROSSI OH YOU MEAN STAGLIANO THE
   ANTIVAXXER” is being hired and guess what? They got me FIRED from the job.
   They cancelled my signed contract. I was really looking forward to meeting a 
   new group and sharing my experiences by using my humor to make them laugh.

To which I say: Good for those parents! Well done! As for Stagliano, her
comparison of the criticism and deserved ostracism that antivaxers experience to
the racism and persecution that black people have suffered over centuries in
this country is so overwrought and off-base as to be deeply offensive. I suppose
I should be grateful that she didn’t compare herself to Jews during the
Holocaust as well, because other antivaxers have done just that.

Getting back to Wayne Rhode, we see in an article in The Daily Beast that he
invokes exactly the same persecution complex, just without the offensive
analogies:

   Abeler, who believes doctors should tell parents the “pluses and minuses of
   vaccines,” appointed anti-vaxxer Wayne Rohde, co-founder of the Vaccine
   Safety Council of Minnesota, a group that is skeptical of vaccines, and Patti
   Carroll, who was involved with organizing anti-vaccine outreach in the
   Minnesota Somali community.

   Rohde refutes the label of “anti-vaxxer.” “Those who question vaccine safety 
   are quickly marginalized as saying ‘We’re anti-vax,’” Rohde told the Star
   Tribune.

No, Rohde is called an antivaxer because that’s what he has demonstrated himself
to be, through a long history of words and actions. He’s even written an
antivaccine book, The Vaccine Court: The Dark Truth of America’s Vaccine Injury 
Compensation Program, full of misinformation about and mischaracterizations of
the National Vaccine Injury Compensation Program. I can tell just from the
blurbs that it includes the same sorts of misinformation and half-truths that
the Canary Party, an antivaccine group associated with Jennifer Larson of the
Vaccine Safety Council of Minnesota, has been pushing for at least six or seven 
years now.

Now, let’s look a bit at Abeler’s history with Rhodes and Carroll:

You can read the whole post on Facebook if you like, but I’ll quote relevant
passages:

   In spring 2018, Senator Jim Abeler SD 35 proposed legislastion [sic] for a
   statewide autism registry in Minnesota.

   Following public outcry, particularly from the #actuallyautistic and greater 
   disability justice community, the proposed legislation was pulled. After a
   community meeting, Sen. Abeler appointed two parent advocates, Jean Bender
   and Wayne Rhode, to design a new task force-type group for the state of MN.
   Dr. Sheryl Grassie, executive director of the MN Consortium of Citizens with 
   Disabilities, volunteered to contribute as well. The Autism Spectrum Planning
   Group was formed.

It is very telling that Abeler picked an antivaxer as one of three key people
who set up this task force! As for the others, Dr. Grassie seems legit, and Jean
Bender is a board member for the Autism Society of Minnesota. That they would
work with an antivaccine activist like Wayne Rhode does not speak well of them, 
however. It’s a deal with the devil that demands too much.

Of course, Abeler denies that vaccines will be an issue:

   Abeler told the Daily Beast that the goal of the council is “to address the
   present and future needs for education, employment, housing, transportation
   and independent living in the autism community.” He added, “There is no plan 
   or intention of taking any positions about vaccines.”

   Rohde told the Star Tribune that while he does support parents’ rights not to
   vaccinate, “we’re not about causation within the council. The council is all
   about how to deal and help those who are afflicted, and their families and
   those who provide services.” Rohde has a son on the autism spectrum.

Of course, I don’t believe this for one second. Here’s why. Note the part about 
how the council is allegedly “all about how to deal and help those who are
afflicted.” That’s basically code for adding autism quackery to the mix of “how 
to help” autistic people, and most autism quackery is based on pseudoscience
claiming that vaccines cause autism. Don’t believe me? Think I’m reading too
much into this phrase because I’ve been too close to the issue for too long,
rather than that I know antivaccine code phrases? Well consider this.

As mentioned above, the original idea for the panel was the Autism Spectrum
Planning Group and was born in the wake of the outcry over legislation that Sen.
Abeler had introduced, SD 35, which would have created a statewide autism
registry in Minnesota. Thus, the autism task force ultimately formed was, in
essence, Plan B. However, that didn’t stop Abeler from going to Plan C when he
didn’t like how the task force was turning out. After months of planning by a
group that included autistic people, Abeler did this:

   Over approximately four months, The ASPG met and developed a mission
   statement, a purpose statement, a group structure [sic], representation
   priorities, and a proposed list of members for The Minnesota Autism Council. 
   The first meeting of the council was scheduled for November 8th, 2018.

   Recently, two members of the group—Wayne Rhode and Dr. Sheryl Grassie, both
   original members—met privately with Sen. Abeler. As a result of that meeting,
   Sen Abeler scrapped both The ASPG and our progress. He then created a new
   work group, appointed leadership that includes no autistic members, and
   instructed them to form a council that does not reflect the priorities the
   ASPG spent four months identifying. The ASPG was not consulted or informed
   prior to Sen. Abeler’s announcement of these changes during the commitee
   [sic] hearing on 10/17/2018.

   It is vital to note two things:

  1. These changes remove all autistic voices from the leadership team that will
    design and implement The Minnesota Autism Council.

  2. These changes implicitly invite multiple specific organizations to the table
    that prioritize treating and/or curing autism. These organizations were not 
    included in the proposed membership developed by The ASPG.

Sen. Abeler is a chiropractor. Although he doesn’t mention autism on his
website, it would not surprise me in the least if he treats autistic children,
trying to “cure” them with adjustments. He has an autistic child. He knows
antivaxers and thinks enough of them to appoint two of them to an important
state council to advise the government on priorities and policies to help
autistic people. If Sen. Abeler is not antivaccine (which, the more I read about
him, the more I doubt), he’s at the very least what I like to call
antivaccine-adjacent.

The pro-vaccine members of the panel are also laboring under this delusion:

   “If their total focus was to come up with a recommendation related to
   vaccination, yes, it might give me pause,” she said. “But on the other hand, 
   it seems this group is focusing more on how they can support families.”

   Sonya Emerick, who is involved with the MN Autism Council, said she is
   worried about having vaccine skeptics in the group. But she wants to focus on
   the work, rather than lingering on that. If a group with such a wide range
   of opinions can move forward with shared policy priorities, she said it could
   have major effects on Minnesotans.

Sure, it will likely be this way in the beginning. However, if there’s one thing
I’ve learned about antivaxers, it’s that they can’t keep their antivaccine
pseudoscience from infecting everything they do, particularly when it comes to
autism advocacy. Minnesota autism advocates know this:

   Idil Abdull, a longtime autism advocate at the Capitol, was part of the
   previous task force and clashed with some members of the group. She is not
   part of Abeler’s committee, but has aired concerns with it.

   “The fact that he appointed so many people from the anti-vaccine community
   who will try to divide us is heartbreaking,” Abdull said.

And that is exactly what will happen. It might not happen right away. Antivaxers
can “play nice” for a while. However, eventually, their pseudoscientific
beliefs will infect the deliberations. For example, it would not in the least
bit surprise me if the antivaxers on the panel start advocating that the state
support “autism biomed” quackery for autistic children or promote funding for
alternative medicine practitioners like naturopaths. Belief in such quackery
often goes hand-in-hand with the belief that vaccines cause autism, and it’s
quite possible to promote antivaccine beliefs without explicitly mentioning
vaccines. Promoting autism biomed quackery is one way to do that. Antivaxers
know this, which is why they lobby so hard to attach themselves to government
autism advocacy and advisory panels, even when the mission of the panel does not
include childhood vaccination.

This is why antivaxers should never be on government panels. Such panels should 
indeed include people with a diversity of backgrounds, beliefs, and opinions,
but it is essential not to think that “diversity” must mean including people
with dangerous pseudoscientific beliefs. That, unfortunately, is exactly what
Sen. Abeler and Minnesota have done.

Texas: Ground zero for the politicization of school vaccine mandates

Vaccine policies and school vaccine mandates have traditionally been as close to
a nonpartisan issue as there can be in the US. Unfortunately, in Texas
antivaccine activists and conservative activists threaten to change that. The
antivaccine group Texans for Vaccine Choice has formed an unholy alliance with
antiregulation conservative activists to attack school vaccine mandates.
Antivaxers all over the country are doing the same thing.

David Gorski on March 5, 2018

Link



One of the stereotypes that I hear from time to time from fellow skeptics that
really irritates me is the stereotype of antivaxers and being primarily
hippie-dippy, granola-crunching left wingers. Sure, there is an element of that 
in the antivaccine movement, but in reality, as I’ve said many times before,
antivaccine pseudoscience and conspiracy beliefs transcend political boundaries,
and, yes, it’s true that areas with a lot of affluent people on the coasts
where the politics tends to lean heavily liberal, have suffered outbreaks of
vaccine-preventable illnesses. However, there is also a very strong strain of
antivaccine views on the right as well, including General Bert Stubblebine III’s
Natural Solutions Foundation, far right libertarians, and others who distrust
the government, including government-recommended vaccine schedules.

An excellent example of how antivaxers have successfully co-opted the political 
zeitgeist of the moment by latching on to conservative or libertarian political 
rhetoric is in progress in the state of Texas. I’ve written about this several
times on my not-so–secret other blog and once here about how antivaxers have
attached their pseudoscience to small government, anti-regulation conservative
rhetoric in my home state of Michigan and briefly alluded to it in a post about 
whether antivaxers are winning, but I haven’t much discussed it here. Recent
events, however, have provided me the opportunity to remedy that oversight.
Specifically, an antivaccine group known as Texans for Vaccine Choice is
inserting itself into politics by backing candidates opposed to vaccine mandates
and influencing the legislature. Before I discuss exactly what Texans for
Vaccine Choice is doing, let’s take a look at this group and other antivaxers in
Texas.

Antivaxers in Texas

Texas is home to many things, but, unfortunately for it and the nation as a
whole, it is home to the most prominent antivaccine “scientist” of all, Andrew
Wakefield, who lives in Austin. (Internet entrepreneur, quack, supplement
hawker, and all around conspiracy crank Mike Adams also lives near Austin.)
Looking back, I find it hard to believe that, as of last month, it’s been 20
years since Wakefield first published his now-retracted case series implying
that the MMR vaccine is associated with autism in The Lancet, thus launching the
modern iteration of the antivaccine movement. Whether these cranks inspired
Texans for Vaccine Choice or not, I do not know, but I first took more than a
passing notice of this group a little more than a year ago, when Science first
reported how much the number of nonmedical exemptions in Texas had soared from
2003 to 2015. I discussed this problem before, but since the visual is striking,
I’ll post the same graph again that I posted then:

There was a 19-fold increase in the number of nonmedical exemptions to school
vaccine mandates, from 2,300 in 2003 to 45,000 in 2015. The graph included in
the Texas Observer article I mentioned above shows that trend continuing
alarmingly, with the total number of exemptions in 2016 surpassing 50,000. Yes, 
vaccination rates in Texas remain high overall, but this is a worrisome trend,
and, as is usually the case, there are pockets of high rates of vaccine refusal 
throughout the state that can serve as niduses for outbreaks of
vaccine-preventable diseases, with some schools having exemption rates in double
digit percentages. If Texans for Vaccine Choice has its way, the rates of
nonmedical exemptions will continue to climb, and more areas of the state will
have vaccine uptake rates falling below the level needed for effective herd
immunity.

Many states have groups like Texans for Vaccine Choice (my own state has at
least one that I’m aware of), but, like Texas, Texans for Vaccine Choice is big,
at least bigger and more active than most groups like it. They’re also trying
to mobilize antivaxers to act to persuade the legislature to do what they want:

   In San Antonio, 80 miles southwest of the state capital, Texans for Vaccine
   Choice convened a happy hour to encourage attendees to get more involved
   politically. The event was among dozens of outreach events the group has
   hosted across the state. The relatively new group has boosted its profile,
   aided by a savvy social-media strategy, and now leads a contentious fight
   over vaccines that is gearing up in the current legislative session.

If you wander over to the Texans for Vaccine Choice website, you’ll see that
it’s pretty slick and that it also is full of the standard antivaccine talking
points and misinformation. For instance, it proudly proclaims that this is about
“freedom,” saying that “we promote the preservation of personal liberties and
informed consent by opposing measures to limit vaccine choice rights or
discriminate against those who exercise such rights.” Here’s an example on
Twitter of the sort of rhetoric this group uses to disguise its antivaccine
bent:

Vaccine Injury Awareness Day 3/25#TX4VaxChoice #txlege @84thLegislature @TXlege 
http://t.co/znYbycKG50 pic.twitter.com/gmxIu7picS

— Texans 4 Vax Choice (@TXforVaxChoice) March 25, 2015

Of course, whenever an antivaxer says “freedom,” what he really means is the
“freedom” to expose his child and community to potentially deadly infectious
diseases and the “freedom” to use whatever quackery on his child that he so
desires. Similarly, when an antivaxer says, “informed consent,” I like to go all
Princess Bride on him, saying something like: “Informed. You keep using that
word. I do not think it means what you think it means.” The reason, of course,
is that the “informing” that antivaxers do and want is to vastly exaggerate the 
risks of vaccines, even attributing risks to them that are not supported by
science, and to downplay the benefits of vaccines.

Of course, Jackie Schlegel, founder of Texans for Vaccine Choice, and its
executive director, strenuously denies that she or the group is antivaccine:

   Schlegel is irritated when people refer to her or her group as
   “anti-vaccine.” She’s not against vaccines, she says. She believes in
   “parental choice,” “medical privacy” and “liberty” — powerful conjuring words
   in Texas politics. Mandatory vaccinations are lawmakers “reaching their
   hands into our homes and taking our rights,” Schlegel said.

That’s how antivaxers make allies of and appeal to conservatives and
libertarians, by invoking the magic words of “parental choice” and “liberty.”
They argue that it’s not about vaccines but rather about “FREEDOM!” from evil
government mandates. Make no mistake, however. Schlegel and Texans for Vaccine
Choice are antivaccine. For example, on their website, you can find blog posts
misrepresenting herd immunity by citing antivaxers like Dr. Kelly Brogan (yes,
the same Kelly Brogan who recently was a keynote speaker at Gwyneth Paltrow’s In
Goop Health wellness expo) and standard antivaccine talking points about
vaccine “failure,” posts exaggerating the risks of vaccines and downplaying the 
benefits, conspiracy mongering rants about big pharma, and basically every
antivaccine trope you can think of. Texans for Vaccine Choice deny that the
group is antivaccine. That is false, either a lie or a delusion. I know
antivaccine when I see it, and Texans for Vaccine Choice is about as antivaccine
as they come. That is not surprising. Jackie Schlegel, founder of the group,
has a 16-year-old daughter with autism and believes vaccines caused it and likes
to refer to pro-vaccine advocates the “Pro-Grab-Them-and-Stab-Them-at-any-Cost 
Camp.”

Unfortunately, she and her group have been very effective, as you will see.

Texans for Vaccine Choice is targeting pro-vaccine state representatives

Last week, I came across a story in the Texas Observer by Sophie Novack entitled
“How Anti-Vaxxers are Injecting Themselves into the Texas Republican
Primaries.” (I know, I know. “Injecting.” the headline is a bit of an old
vaccine trope.) The article itself, however, should be reason for concern.

By way of background, you should know a couple of things. First, in 2015 State
Representative Jason Villalba (R-Dallas) introduced a bill into the Texas House 
that, if passed, would have eliminated nonmedical exemptions to school vaccine
mandates in the same manner that SB 277 did in California that same year.
Second, State Representative Sarah Davis (R-West University Place) is a vocal
supporter of vaccines. Acting on her beliefs, she introduced multiple
pro-vaccine bills last year: a bill that’s a lot like what Michigan requires in 
that it would have required parents to review educational material about
vaccines before claiming personal belief exemption to school vaccine mandates; a
bill that would have required reporting human papilloma virus (HPV)
immunization rates; a bill allowing minors to consent to HPV vaccination; and a 
bill that would have changed the state law to redefine opt-out decisions as
“non-medical,” deleting reasons “of conscience, including a religious belief.”. 
None of those bills passed; they didn’t even make it out of committee.

Because they are in districts that lean heavily Republican, for these two
Representatives the most important race is the Republican primary tomorrow (with
a run-off on May 22 if needed), and they are being targeted by antivaxers in
that primary:

   A measles outbreak in Ellis County last month. A surge in mumps cases in 2017
   that led to the highest annual total in Texas in 23 years. Skyrocketing
   vaccine exemptions among kids. Public health experts warn Texas is on the
   precipice of a major disease outbreak, and point to the growing anti-vaccine 
   movement in the state as the main culprit. But Texans for Vaccine Choice,
   which began as a group of “mad moms in minivans” and quickly grew into an
   influential political group, is more determined than ever to fight for what
   they say is their right to “medical freedom,” and unseat their enemies in the
   Republican primary.

   “This is a human rights issue,” said Jackie Schlegel, the group’s executive
   director, in a Facebook Live video last month. Schlegel, who insists her
   group is not anti-vaccine, but rather “pro-vaccine choice,” lamented what she
   says is uncivil treatment from doctors and lawmakers opposed to their
   mission. “There is a war on women, and it starts with a war on mothers,” she 
   said.

   A single mom who says one of her kids was injured by vaccines, Schlegel
   started Texans for Vaccine Choice in response to a 2015 bill by state
   Representative Jason Villalba, R-Dallas, that would have eliminated
   non-medical “conscience” exemptions for vaccines at public schools.
   Exemptions are a matter of “liberty,” “parental choice” and “privacy,” says
   Schlegel, who did not respond to requests for an interview.

Here is the video referred to above:

Notice how Schlegel is using a time-dishonored antivaccine technique of labeling
criticism of their pseudoscientific views as “bullying” or hatred and contempt 
for mothers and women in general, even co-opting the “war on women” as applying 
to mothers refusing to vaccinate their children. I wanted to gag when these two 
started likening the antivaccine movement to the civil rights movement in the
1950s and 1960s.

There was also an excellent report on HBO’s Vice News showing the scope of the
problem of antivaccine sentiment in Texas and how it is fusing with
anti-government conservative movements:

If antivaxers are successful in targeting pro-vaccine legislators, the problem
of lower vaccine coverage will only continue:

   This primary cycle is a continuation of a grudge match between Villalba and
   the anti-vaxxers, who also campaigned against the Dallas Republican in 2016. 
   Texans for Vaccine Choice designated his [Villaba’s] primary challenger,
   interior design firm owner Lisa Luby Ryan, as a “priority campaign,” and
   Schlegel has blockwalked with Ryan, who also picked up a batch of
   endorsements from other far-right groups including Empower Texans, on
   multiple occasions.

Not surprisingly, I had never heard of Lisa Luby Ryan before; so I did a bit of 
Googling. It turns out that she’s a far right wing fundamentalist Christian,
which is not at all unusual in Texas, and has appeared in a film in which she
confessed all her past sins and how she came to God. Interestingly enough, there
is not a single word about vaccines on her website that I could find, and I
searched using Google Advanced Search. Similarly, there’s nothing on her Twitter
feed about vaccines (advanced search again). It’s almost as though she’s a
stealth antivaxer.

Susanna Dokupil, a lawyer and a board member of the Seasteading Institute, seems
to be keeping her antivaccine beliefs on the down-low as well:

   Texans for Vaccine Choice picked the wrong race to target, said Davis, whose 
   district includes the Texas Medical Center, the world’s largest medical
   complex. Peter Hotez, a leading expert on vaccines and director of the Texas 
   Children’s Center for Vaccine Development at the center, has taken to social 
   media to warn about Texans for Vaccine Choice, which he calls an
   “anti-science hate group.” It “has somehow convinced [lawmakers] this is a
   political issue, not a health issue,” Hotez told the Observer. “It’s very
   nefarious what they’re doing.”

   Davis says she’s glad to talk about vaccines in her race, but is taking the
   involvement of Texans for Vaccine Choice seriously. “If I were to somehow
   lose this primary and they take credit for defeating a vaccine advocate, then
   their strength would grow because they would feel empowered,” she told the
   Observer. “And other members would probably think twice about wanting to get 
   involved in advancing good, sound public policy dealing with vaccines. I
   think the ramifications are big.”

As for her denials that she is antivaccine and her statement that all of her
children and she are “fully vaccinated,” let’s just put it this way. If Texans
for Vaccine Choice is donating heavily to your campaign, blockwalking with you, 
and calling you their “MVP” and top priority to get elected, those are some
really good indications that you are probably antivaccine or at least
functionally no different from an antivaxer in that your agenda with respect to 
vaccines aligns closely with that of antivaxers. The latter possibility is quite
possible, because Dokupil is a libertarian seasteading advocate who is
basically opposed to most government regulations with respect to “choice.” When 
it comes to vaccine mandates, it doesn’t really matter if Dokupil is antivaccine
or not. Her vote will be the same as any antivaxer’s, against vaccine mandates.

So it looks very unlikely that Dokupil will unseat Davis. Personally, I’d love
to have seen the reactions to Dokupil’s supporters who belong to Texans for
Vaccine Choice by health care professionals in Davis’ district. On the other
hand, maybe, just like Dokupil herself, Texans for Vaccine Choice don’t even
mention her stance of vaccines when campaigning for her. Similarly Villaba is
not particularly worried about Ryan’s challenge. Unfortunately, that’s not the
only way Texans for Vaccine Choice is flexing its muscle:

   “It’s really scary how impactful they are,” Davis said of Texans for Vaccine 
   Choice. “Last session, I couldn’t even get any hearings on my pro-vaccine
   bills. They really have been able to bully and intimidate a lot of members.
   And they’ve made vaccines controversial, which makes members nervous. … It
   really shouldn’t be controversial.”

   From July to January, Texans for Vaccine Choice’s political action committee,
   or PAC, has raised about $56,000 in political contributions, largely from
   small donors. Of the more than $60,000 the group has spent during that time
   period, about two-thirds has gone to its own nonprofit arm, with the
   remainder directed to a handful of Republican candidates, according to
   campaign finance data. Though the anti-vaxxers’ fundraising is modest, they
   are able to mobilize grassroots support for candidates through blockwalking, 
   phone banking and online messaging. Schlegel posts daily videos on Facebook
   from campaign events and is shown shaking Abbott’s hand in his new ad from a 
   rally for Dokupil in the Houston area last week.

The Texas Observer reported on how effective antivaxers, led by Texans for
Vaccine Choice, have been in causing a legislative stalemate on any bills having
to do with vaccines. They’ve also persuaded legislators to introduce lots of
“vaccine choice” bills. Fortunately, none of them have gone anywhere—yet. For
instance, only one of the six antivax bills introduced in the last session got a
full committee hearing. Specifically, HB 1124, a bill authored by Matt Krause, 
a far-right member of the House Freedom Caucus from Fort Worth, would have made 
it easier for children to claim exemptions to immunization. Currently, a parent 
who wants a personal belief exemption for her child in public school must apply 
in writing for an exemption affidavit from the Department of State Health
Services, which takes up to a week to process. HB 1124 would have eliminated the
requirement for the written request by letting parents print out a blank
exemption form from the health agency’s website.

Fighting Texas antivaccine pseudoscience

Sadly, at least thus far, it’s been an uphill fight for advocates of child
health in Texas:

   Peter Hotez, director of the Texas Children’s Hospital Center for Vaccine
   Development, predicts that 2017 could be the year the anti-vaccination
   movement gains ascendancy in the United States. Texas could lead the way, he 
   said, because some public schools are dangerously close to the threshold at
   which measles outbreaks can be expected. A third of students at some private 
   schools are unvaccinated.

   “We’re losing the battle,” Hotez said.

   Although the anti-vaccine movement has been strong in other states, including
   California, Oregon, Washington and Colorado, experts say the effort in Texas
   is among the most organized and politically active.

   “It’s a great example of an issue that has a targeted, small minority but an 
   intense minority who are willing to mobilize and engage in direct action,”
   said Mark Jones, a political science professor at Rice University in Houston.

Dr. Hotez is Texas’ answer to Paul Offit. He’s rapidly becoming one of the
foremost vaccine advocates in the world. If you want to know more about him, he 
was recently profiled in Texas Monthly. Think of it this way. I pointed out the 
last time I wrote about Texas that, if antivaxers view Paul Offit as Darth
Vader, Lord Voldemort, and the Dark Lord Sauron all rolled up into one, they’re 
starting to view Dr. Hotez as Darth Vader or Sauron, at least, thanks to his
staunch advocacy for vaccines as the best means to protect children from deadly 
diseases. That’s a good thing, as is how much antivaccine activist J.B. Handley 
hates Dr. Hotez. I probably only qualify to them as one of Sauron’s orcs.

In any case, pro-vaccine advocates are just plain outgunned by the antivaxers.
Consider the story of Jinny Suh, who runs Immunize Texas, a group working to
counter the antivaccine message of groups like Texans for Vaccine Choice. She’s 
fighting a brave battle, but is hopelessly outgunned by Texans for Vaccine
Choice:

   But immunization advocates like Suh say it’s hard to counter the passion of
   her opponents. Most people consider vaccinations to be such a basic part of
   life, like clean drinking water, that it’s hard to motivate them to take time
   to show up at lawmakers’ offices.

   “We’re completely outgunned,” said Suh, adding there are only about a dozen
   members whom she can call on to show up for events. Immunize Texas is part of
   the Immunization Project.

   Suh often writes emails and posts to the group’s Facebook account from her
   cellphone while caring for her two sons. She juggles her immunization
   advocacy, a mostly volunteer gig, with other businesses she runs from home.

Also, the message equating “vaccine choice” with “freedom” resonates very
strongly in conservative Texas:

   One particularly strong strain of anti-vaccine rhetoric in Texas is
   libertarian and anti-government. Texans for Vaccine Choice receives help and 
   expertise from “friendly” lawmakers and groups such as Empower Texans, said
   Jonathan Stickland, a tea party Republican representative from Tarrant County
   and a key supporter. Political experts consider Empower Texans the state’s
   most sophisticated and influential conservative organization.

   “Our message resonates with people,” said Schlegel, 37, in a brief interview 
   after a day of meetings at the Capitol. “Texans value parental rights,” she
   said. “We have a message of liberty. We have a message of choice.”

As I’ve said more times than I can remember, antivaccine pseudoscience is an
irrationality that appeals to both the right and the left, but for different
reasons. On the left, it’s often due to a belief that “natural” is somehow
better coupled with distrust of big business, especially big pharma, while on
the right it’s “freedom” and anti-government rhetoric. Think of it this way.
Political operatives know that people tend to be more passionate when they are
against something rather than for something. It’s easier to get them to donate
and do stuff to oppose a policy rather than to promote a policy. That was how
the Tea Party got started, and we’re seeing a similar passion on the left in
response to Donald Trump. So the antivaccine movement in Texas has slick, glossy
literature, complete with red, white, and blue emblems to go along with the
lies that vaccines aren’t tested adequately for safety and are full of
“questionable ingredients” (a.k.a. “toxins”), while Suh doesn’t even have
business cards.

They also have a message that resonates in a state like Texas, and knowledge
doesn’t matter:

   When the group recently sought volunteers on Facebook for “engagement days”
   at the state Capitol this month and in March, one woman said she wanted to
   help but was concerned she didn’t know enough about vaccines. Don’t worry,
   she was told. “Very little talk about vaccines and a LOT of talk about
   parental rights and CHOICE.”

I also remind you of a speech given by Del Bigtree in Michigan last year:

Del Bigtree, as you might remember, produced the antivaccine propaganda film
VAXXED, which was directed by Andrew Wakefield. You might also remember that he 
spent most of his time framing vaccine mandates as an issue of “freedom” and
concluded thusly:

   If we do not fight now, then there will be nothing left to fight for. And I
   think that is where everyone in this room, I pray you realize how important
   you are in this historic moment. We will never be stronger than we are right 
   now. We will never be healthier than we are right now. Our children are
   looking like this, a generation of children, as we’ve said on The Doctors
   television show this is the first generation of children that will not live
   to be as old as their parents. Are we going to stand…are we going to sit down
   and take it? Or are we going to stand up and say: This is a historic moment,
   that my forefathers, those from Jefferson all the way to Martin Luther King,
   the moments where people stood up and something inside of them said I’m
   going to stand for freedom and I’m going to stand for it now. That is in our 
   DNA. It is pumping through me, and I pray that you feel it pumping through
   you, because we must look back. Our grandchildren will look back and thank us
   for having stood up one more time and been the generation that said, “We the
   People of the United States of America stood for freedom, stand for freedom.
   We will die for freedom today.”

Histrionic? Yes. Overwrought? Definitely. Grandiose? Well, it is Del Bigtree.
Even so, it’s not hard to see how this can be a very effective message among
libertarian and government-distrusting conservatives. Also think of Rand Paul’s 
now-infamous quote: “The state doesn’t own the children. Parents own the
children, and it is an issue of freedom.” The antivaccine movement is full of
this attitude, namely that parental “rights” trump any rights children might
have as autonomous beings. The right of the child and any public health
considerations are subsumed to parental “freedom to choose” and “parental
rights,” with children viewed, in essence, as their parents’ property or an
extension of the parents, to do with as they will, never mind what’s actually
best for the child.

The politicization of school vaccine mandates

Here’s what worries me. Traditionally state vaccination policy and school
vaccine mandates have been as close to a nonpartisan issue as we have in this
country. There has usually been broad bipartisan support for such mandates and
the idea that children should be vaccinated in order to attend school. It’s a
consensus that has served the country well for many decades now. What I fear is 
that this consensus is breaking down, and—even worse—school vaccine policies are
becoming a partisan issue, every bit as bitter and divided as many others.

I’m not the only one who’s had such fears, too. For instance, Saad Omer and
Sarah Despres over at Politico expressed a fear that vaccine policy will become 
as politicized as climate science, noting:

   Increased politicization of the vaccination issue would be deadly, because it
   could spawn new anti-vaccination converts and further insulate the debate
   from scientific research, potentially lowering immunization rates and
   increasing the risk of disease. The likelihood of infectious disease
   outbreaks increases substantially when there is a “critical mass” of
   unprotected individuals in a community. For most diseases against which we
   vaccinate, this critical mass is achieved when at least 10 percent-20 percent
   of the population is un-vaccinated. Therefore, even a 70 percent-30 percent 
   split in public opinion in favor of vaccines could result in an unacceptably 
   low immunization rate. This type of divide will inevitably lead to reduced
   immunization rates and disease outbreaks. Thousands of people could die. So
   as the country becomes increasingly divided, we must ensure that vaccine
   remains on the fringes of both parties.

There’s a bit of false equivalence in the article, such as neglecting to note
that powerful mainstream conservative forces in Texas and elsewhere are behind
groups like Texans for Vaccine Choice, while there is no equivalent support on
the “other side” to match. In essence, Empower Texans is using antivaccine
conspiracy theorists like those running Texans for Vaccine Choice as cannon
fodder in a larger battle to decrease government regulation and promote far
right wing causes. Indeed, that’s why I’m so concerned. What I’ve sensed
watching the antivaccine movement over the last three or four years is a
distinct rightward shift in its preferred politics. That’s not to say that left 
wingers don’t have antivaccine dog whistles of their own (I’m talking to you,
Jill Stein), but by far the loudest and most active antivaccine voices appear to
come from the right these days, and the most effective antivaccine dog whistles
are linked to “freedom” and “parental rights.” This phenomenon predates Donald 
Trump as well. For example, Texans for Vaccine Choice sprang into being in 2015,
when in the wake of the Disneyland measles outbreak, the state legislature
considered bill like California SB 277, and that’s when I first started to
notice the convergence of right wing politics and antivaccine beliefs to an
extent far greater than I had ever seen before.

As I’ve said before on at least one occasion, unfortunately now that we’ve gone 
down this road, I don’t see a clear path to preventing the further
politicization of school vaccine mandates and state vaccine policy. I fear that 
it might require much bigger outbreaks than we’ve seen thus far before we as a
nation come to our senses again about vaccines. Texans for Vaccine Choice is but
a symptom, and I fear that we’ll see more examples of antivaxers effectively
entering politics before the fever breaks.

Make measles great again: A case study of the politicization of school vaccine
requirements in Michigan

Protecting our children through school vaccine requirements has long had strong 
bipartisan support. Unfortunately, the antivaccine movement has had success
linking “vaccine choice” with “freedom” and “parental rights”, leading to a
surge of right wing antivaccine activism that has undermined that bipartisan
consensus. Two bills under consideration by the Michigan legislature represent a
microcosm of what is going on in much of the US.

David Gorski on May 1, 2017

Link



Last week, I wrote about how antivaccine activists have been targeting the
Somali immigrant community in Minnesota, with disastrous results in terms of
public health, with Andrew Wakefield himself having made at least a couple of
visits to proselytize his religion in which vaccines are Satan. Basically, MMR
uptake among the Minnesota Somali community’s children has plunged over the last
decade, from 92% to 42%. Completely predictably, that very same community is in
the midst of a measles outbreak, whose toll has risen to 32 since last week
(and is continuing to rise), making it bigger than the last outbreak among the
Somalis in 2011. Meanwhile, yesterday a coalition of antivaccine groups targeted
the same community with the message that the “epidemic is autism, not measles,”
featuring antivaccine activist Mark Blaxill. I can’t help but wonder how many
children will be sickened before this particular outbreak is contained and
whether it will spread far beyond the Twin Cities area where it is concentrated 
now. That doesn’t even consider my concern about the politicization of what used
to be a bipartisan consensus on school vaccine mandates.

Such thoughts were on my mind as I received a letter from my State
Representative Jeff Noble on Saturday. My wife received an identical letter the 
same day. The reason was that we had both reached out to his office to express
alarm and opposition to two bills related to school vaccine requirements and
policy being considered in the Michigan House right now, HB 4425 and HB 4426.
Rep. Noble told us, in essence, thanks for contacting his office, but bugger
off. Here’s the letter:

Neither my wife nor I reacted very well to this letter, as you might imagine.
After all, unlike me my wife is a pediatric nurse practitioner in primary care. 
She administers vaccines every day.



Michigan State Senator Patrick J. Colbeck in action.

So, what, you may ask, are HB 4425 and HB 4426? What did Rep. Noble mean by his 
comment about how the “intent of the legislation is to reign [sic] in the
department who [sic] has overstepped the boundaries that were implemented by
past legislatures”? I also can’t help but note that there’s another, darker
provision in these bills that Rep. Noble conveniently left out of his letter, as
you will see. Unfortunately, both my State Senator Patrick Colbeck (who has
antivaccine-sympathetic proclivities) and now my State Representative Jeff
Noble, have shown a—shall we say?—openness to antivaccine advocacy. Indeed, Sen.
Colbeck is the main sponsor of the Senate versions of these bills, SB 299 and
SB 300. I also should have checked more closely, as I subsequently learned that 
Rep. Noble strongly supports HB 4425 and HB 4426 to the point of co-sponsoring
them. To understand what is happening in Michigan, it’s necessary to go back a
couple of years, when the Michigan Department of Health and Human Services
(MDHHS) instituted a new rule making the process to obtain personal belief
exemptions (PBEs) to school vaccine requirements more difficult. HB 4425 and HB 
4426 are explicitly designed to reverse that rule and forbid MDHHS from making
new rules like it in the future.

A solution to low vaccine uptake that is working

In response to increasing nonmedical exemptions to school vaccine mandates and
falling vaccination rates, as well as pertussis outbreaks, particularly a big
pertussis outbreak in 2012, the MDHHS decided to do something about it. In
brief, the state emulated California’s first attempt to combat the rising tide
of PBEs. Basically, starting January 1, 2015, the MDHHS altered the rules
regarding requirements for parents to claim personal belief exemptions to
vaccine mandates, patterning its policy change on California Bill AB 2109, a
bill from a few years ago that sought to tighten up requirements for PBEs in
California. AB 2109 required parents seeking PBEs to meet with a physician or
other enumerated health care practitioner to receive counseling on the risks of 
opting their children out of school vaccine requirements. The physician would
then have to sign the PBE form to verify that he had counseled the parents. Of
course, in the wake of the Disneyland measles outbreak a year ago, California
passed a far stronger measure, SB 277, which, beginning with the 2016-2017
school year, eliminated PBEs in California. SB 277 has already shown results in 
decreasing the rates of PBEs and increasing vaccine uptake.



Michigan Representative Jeffrey Noble mingling with his future constituents
after the election in November.

The rule change took effect on January 1, 2015. Since then, parents seeking PBEs
to school vaccine requirements must visit their local county health department 
office to:

  1. Be educated by a local health worker about the benefits of vaccination and the
    risks of disease.

  2. Sign the universal state form that includes a statement of acknowledgement
    that parents understand they may be putting their own children and others at
    risk by refusing the shots. Only the state form is allowed. No substitute
    forms are allowed any more, as they were in the past.

Why did the MDHHS make this rule change? Simple:

   Michigan has one of the highest immunization waiver rates in the country,
   with some counties reporting waiver rates up to 12.5% (that is, more than 12%
   of school-age students in these places have not received all vaccinations). 
   In addition, individual school buildings have reported even higher waiver
   rates. High nonmedical waiver rates can leave communities susceptible to the 
   entry of diseases such as measles, chickenpox, and pertussis (whooping cough)
   by undermining community or “herd” immunity that protects vulnerable
   children (for example, children who cannot be vaccinated for medical reasons 
   and children with compromised immune systems). Herd immunity can also slow
   the spread of disease if a high proportion of individuals are immune to the
   disease in a community. Immunization is one of the most effective ways to
   protect children from harmful diseases and even death.

The result of Michigan’s abysmal vaccine uptake rates have been outbreaks,
particularly a large pertussis outbreak in 2012, out of which was born a
campaign by a mother whose baby died of pertussis to increase vaccine uptake.
There have also been measles outbreaks.

Short of an SB 277-like law banning nonmedical exemptions, this is the best that
the MDHHS could do, and it’s working too. Early data indicate that PBE rates
are declining and vaccine uptake is starting to increase in Michigan.

Not surprisingly, the antivaccine movement really, really, really doesn’t like
this rule. As soon as the rule was publicly announced, it was attacked, with the
most common claim being that the MDHHS broke the law because it didn’t have the
power to institute such a rule. This is a fallacious argument, as the rule was 
approved, as such rules must be, by the Joint Committee on Administrative Rules,
a bipartisan legislative committee charged with the legislative oversight of
administrative rules proposed by state agencies. Basically, JCAR reviews state
agency regulations and, if it takes no action, allows them to go into effect
after 15 legislative days. The committee is composed of lawmakers, giving it a
legislative imprimatur, but it is not the Legislature itself, thus avoiding the 
political rancor that can accompany debate on controversial issues.
Antivaccinationists have described this as a “stealth move,” but it was entirely
legal, and the rule change is having its intended effect.

Antivaccine parents were outraged and immediately started targeting the offices 
of a few sympathetic legislators, such as Rep. Thomas Hooker:

   Concerned parents came in droves to the state capital Wednesday morning to
   protest a new vaccine waiver policy which opponents say bullies parents.

   But supporters say the new policy, which requires parents to make an
   appointment with the county health department to officially obtain a waiver, 
   is working. Although some counties had already been doing this, it’s a big
   change for parents who had previously been able to waive their child’s
   vaccinations with a quick signature in a school’s office.

   Reps. Mike Callton, R-Nashville, and Thomas Hooker, R-Byron Center, held a
   joint hearing of their respective Health Policy and Families, Children and
   Seniors committees Wednesday morning to discuss the change.

   “A lot of parents got upset right there because they felt it’s their right,
   why should they have to drive all the way to the health department? And for
   some of them it’s not that easy and some of the health departments aren’t
   real nice,” Callton said.

   Parents testified Wednesday about the extra trouble of making health
   department appointments, which serve primarily to educate them about vaccines
   before opting out with a waiver.

My reaction at the time was basically: Oh, poor parents! They’re being “bullied”
because they can’t just sign a piece of paper and let their children degrade
herd immunity and endanger other children with infectious diseases any more.
They actually have to go to the health department and listen to science-based
information before signing a state-mandated waiver form that acknowledges that
the risks to their child and their community of not vaccinating have been
explained to them and that they understand. This complaint is of a piece with
other things that antivaccine parents characterize as “bullying,” such as simply
questioning their beliefs in the slightest.

Unfortunately, these parents have enough clout to have resulted in HB 4425 and
HB 4426 plus their Senate counterparts SB 299 and SB 300, which, if passed,
would strike down this rule and bar MDHHS from writing new rules like it in the 
future. That’s not all it will do if passed, though, nor are the current bills
the first attempt to reverse the MDHHS administrative rule.

Pro-disease legislation being considered in Michigan

Fresh off the first case of measles in Michigan this year, having another go at 
reversing the MDHHS rule:

   Michigan Republicans have decided to throw established science and concerns
   for public health out the window by introducing bills that are clearly
   catered to the anti-vaccine crowd — and will ultimately put the public’s
   health at risk.

   According to MLive, “parents seeking an exemption to vaccinations must be
   educated by a local health worker about vaccines and sign a universal state
   form, which includes a statement of acknowledgement that parents understand
   they could be putting children at risk by refusing the shots.”

   Under the proposed bills, the rule would be eliminated.

   According to health officials, this rule helped drive down vaccine waivers,
   which led to more kids getting immunized. Data from 2015 showed that Michigan
   ranked 43rd lowest in the nation for immunizations covering kids from 19 to 
   35 months. So clearly, we still have some work to do.

Not surprisingly, there was a statement from my very own state senator, Sen.
Patrick Colbeck:

   “The rules enacted by DHHS pertaining to parents who wish to opt out of
   vaccinations for their children go beyond the intent of the current law,
   which was to inform parents of potential consequences of their choices, but
   now seems to have a punitive intent,” Sen. Colbeck said. “Whenever a
   department promulgates rules that go beyond the intent of the legislation, it
   is then the role of the Legislature to make sure those rules are reined back
   in. It was never the intention of the Legislature to see a vaccination
   opt-out procedure put into place that essentially mandates that parents have 
   to take time off of work to meet with specific people, view videos, or sign
   inflammatory forms to exert a right they should be able to exercise more
   simply.

   “State legislators are increasingly concerned about departments implementing 
   rules that go beyond legislative intent. There is a strong desire to reform
   the administrative rule-making process across the board, thereby limiting the
   need for retroactive correction.”

Notice how much he sounds like Rep. Noble? Not surprisingly, Sen. Colbeck is the
sponsor of SB 299 and SB 300. In any event, given that the rule passed the
Joint Committee on Administrative Rules, it’s hard to argue that it went beyond 
the intent of existing legislation; otherwise, JCAR would likely have nixed the 
proposed rule when it considered it. This is the “wedge” that antivaxers in
Michigan are using, though. They’re appealing to conservative legislators using 
the antivaccine dog whistles of “freedom” and “parental rights,” bolstered with 
an appeal to conservatives’ distrust of regulation. Indeed, on the website of
the antivaccine group Michigan for Vaccine Choice you can find exactly those
arguments, plus the claim that the MDHHS “overreached.”

The bills I’ve been discussing are not the first time that some Michigan
legislators have tried to reverse the rule change on PBEs requiring a trip to
the county health office and the use of only the state form to claim an
exemption. Before HB 4425/6 and SB 299/300, there were HB 5126 and HB 5127,
whose primary sponsor was Rep. Hooker and which were introduced during the
2015-2016 legislative session. Fortunately, they failed to pass; in fact, they
didn’t even make it out of the Committee on Health Policy. HB 4425/6 and SB
299/300, introduced this year, are basically identical to the previous bills and
are now under consideration by a different committee, the Committee on
Education Reform. Vaccine advocates tell me that there will likely be at least a
hearing on these bills sometime during the next several weeks, which, if it
happens, will be further than they got last time.

First, let’s take a look at the relevant part of HB 4425:

   (2) A child is exempt from this part if a parent, guardian, or person in loco
   parentis of the child presents a written statement to the administrator of
   the child’s school or operator of the group program to the effect that the
   requirements of this part cannot be met because of religious convictions or
   other objection to immunization.

   (3) THE DEPARTMENT’S AUTHORITY TO PROMULGATE RULES UNDER SECTION 9227 DOES
   NOT INCLUDE THE AUTHORITY TO PROMULGATE OR ENFORCE A RULE THAT IMPOSES A
   DIFFERENT OR ADDITIONAL REQUIREMENT FOR A CHILD TO BE EXEMPT FROM THIS PART
   THAN THOSE DESCRIBED IN THIS SECTION OR THAT REQUIRES THE EXEMPTIONS
   DESCRIBED IN THIS SECTION TO BE ON A FORM PRESCRIBED BY THE DEPARTMENT.

   (4) IF THE DEPARTMENT PROVIDES INFORMATION TO THE PUBLIC ON THE EXEMPTIONS
   DESCRIBED IN THIS SECTION, THEN WITH THAT INFORMATION THE DEPARTMENT SHALL
   INCLUDE INFORMATION ABOUT THE EFFECTIVENESS AND POTENTIAL RISKS OF
   IMMUNIZATION FOR DISEASES FOR WHICH THE DEPARTMENT REQUIRES IMMUNIZATION
   UNDER SECTION 9227.

Basically, this law, if passed, would handcuff MDHHS by explicitly forbidding it
from making it any harder for parents to claim a PBE than to present a signed
written statement to the school administrator saying, in essence, “I don’t
wanna.” You can also spot the influence antivaxers had in drafting this bill by 
the rather obviously antivaccine-inspired language about the “potential risks of
immunization.” Finally, you can see that Rep. Noble is a co-sponsor of HB 4425,
something I should have noticed before I contacted his office. He’s also the
primary sponsor of HB 4426.

If handcuffing the MDHHS regarding the education and forms requirement to obtain
a PBE were all that these bills do, it would be bad enough. However, HB 4425
goes beyond that and seeks to make it difficult for local health officers to
contain small outbreaks and prevent them from becoming large outbreaks.

Make measles great again! Or: How to make small outbreaks bigly

By far the worst part of these bills is found in this language in HB 4425, which
is basically custom-made to make it easier for single cases of
vaccine-preventable disease to become outbreaks, for small outbreaks to become
large outbreaks, and large outbreaks to become epidemics:

   (2) THE DEPARTMENT’S AUTHORITY TO PROMULGATE RULES UNDER SECTION 5111 DOES
   NOT INCLUDE THE AUTHORITY TO PROMULGATE OR ENFORCE A RULE ALLOWING A LOCAL
   HEALTH OFFICER WHO CONFIRMS OR REASONABLY SUSPECTS THAT AN INDIVIDUAL
   ATTENDING A SCHOOL OR GROUP PROGRAM HAS A COMMUNICABLE DISEASE TO, AS A
   DISEASE CONTROL MEASURE THAT IS NOT IN THE CASE OF AN EPIDEMIC, EXCLUDE FROM 
   ATTENDANCE AN INDIVIDUAL WHO LACKS DOCUMENTATION OF IMMUNITY OR IS OTHERWISE 
   CONSIDERED SUSCEPTIBLE TO THE COMMUNICABLE DISEASE. AS USED IN THIS
   SUBSECTION, “GROUP PROGRAM” MEANS THAT TERM AS DESCRIBED IN SECTION 9211.

What this provision would do is to prevent the MDHHS from empowering local
health officers to bar unvaccinated children from school if they suspect or
confirm a case (or cases) of a vaccine-preventable disease in that school.
Presumably, that would mean that only MDHHS could take such an action. So much
for local autonomy that conservatives claim to champion!

I looked at this provision, looked at it, and then looked at it again. For the
life of me I can’t figure out any reasonable rationale for such a law, other
than to strip the MDHHS of a power that would make its ability to contain
outbreaks easier. Basically, the only purpose this provision will serve, if
passed, is to endanger children who are not vaccinated thanks to PBEs, while at 
the same time inserting additional susceptible children into an environment
where a contagious disease resides, thus making outbreaks more likely. This
provision is, at its core, a near-perfect strategy to make it much more likely
that a single case of disease becomes a small outbreak and that a small outbreak
grows into a large one—or even becomes an epidemic. Here’s a hint for Rep.
Hooker, Sen. Colbeck, and the rest of the sponsors of these ill-advised bills:
By the time you have a large outbreak or an epidemic, it’s too late. Keeping
unvaccinated children out of school is a strategy that works best if it’s done
early in the course of an evolving outbreak, and empowering local health
officers to do just that would provide the flexibility needed to act early. This
law, if passed, could easily result in a public health disaster.

The politicization of vaccine policy

There has been a long history of bipartisan consensus on vaccine policy and
school vaccine mandates in this country. Unfortunately, this consensus is being 
undermined, and bills like HB 4425/6 and SB 299/300 are the result. My personal 
suspicion is that, energized by the fight against California SB 277, antivaccine
activists stumbled upon a successful strategy based linking “vaccine choice”
with “freedom” in general, “parental rights,” and the distrust of the government
baked into conservative politics. Thus, over the last five years or so, the
loudest voices in the antivaccine movement have increasingly tended to come from
the right, not the left, such that vaccine policy even featured prominently in 
the second Republican debate, largely thanks to Donald Trump’s long history of
antivaccine rhetoric and the increasing alignment with antivaccine groups with
Tea Party and right wing political groups. To me, this alignment in rhetoric and
viewpoint was epitomized by an interview with Sen. Rand Paul (who really is
antivaccine) two years ago in which he said, “The state doesn’t own the
children. Parents own the children, and it is an issue of freedom.”
Antivaccine-sympathetic physicians like “Dr. Bob” Sears, in particular, traffic 
in these “parental rights” and “freedom” antivaccine dog whistles. Antivaxers
were further energized when it was revealed that Donald Trump had met with
disgraced British antivaccine gastroenterologist Andrew Wakefield in August and 
then again when he met with antivaccine activist Robert F. Kennedy, Jr. in
January, allegedly about a vaccine safety commission.

There have always been politicians who are antivaccine. (Think, for example,
Rep. Dan Burton, who held endless hearings on the “risks” of vaccines and the
“autism epidemic” in the late 1990s and early 2000s.) However, they have
generally been the fringe, to whom few paid much attention and whose antivaccine
views fewer still supported. Unfortunately, antivaccine activists have become
very good at conflating the “freedom” to refuse vaccines with “freedom.” Worse, 
they are fringe no longer, and vaccine policy is being politicized in a way that
it has never been before. Indeed, a couple of months ago, The Washington Post
published an article, “Trump energizes the anti-vaccine movement in Texas“, and 
it’s not just in Texas where they’re being energized. (It doesn’t seem to matter
that Trump appointed an honest-to-goodness pharma shill who is very pro-vaccine
as FDA Commissioner.) Indeed, the article explicitly makes my point:

   One particularly strong strain of anti-vaccine rhetoric in Texas is
   libertarian and anti-government. Texans for Vaccine Choice receives help and 
   expertise from “friendly” lawmakers and groups such as Empower Texans, said
   Jonathan Stickland, a tea party Republican representative from Tarrant County
   and a key supporter. Political experts consider Empower Texans the state’s
   most sophisticated and influential conservative organization.

   “Our message resonates with people,” said Schlegel, 37, in a brief interview 
   after a day of meetings at the Capitol. “Texans value parental rights,” she
   said. “We have a message of liberty. We have a message of choice.”

It is a powerful message that is difficult to counter. As I’ve said more times
than I can remember, antivaccine pseudoscience is an irrationality that appeals 
to both the right and the left, but for different reasons. On the left, it’s
often due to a belief that “natural” is somehow better, coupled with distrust of
big business, especially big pharma. On the right it’s “freedom” and
anti-government rhetoric. Think of it this way. Political operatives know that
people tend to be more passionate when they are against something rather than
for something. It’s easier to get them to donate and volunteer to oppose a
policy rather than to promote a policy. That was how the Tea Party got started, 
and we’re seeing what might be the start of a similar passion on the left in
response to Donald Trump.

Sadly, here in Michigan we really do have a large number of legislators who
conflate “freedom” with the freedom to endanger public health and fetishize
“parental rights” without even considering the rights of the child. It’s almost 
as though they’re trying to turn Michigan into Romania, with its massive ongoing
measles outbreak. Evidence of the susceptibility of our legislators to
antivaccine dog whistles comes from a recent trip to Michigan by Del Bigtree,
producer of the antivaccine propaganda film VAXXED, to meet with legislators.
For instance, here is Bigtree interviewing Rep. Hooker:

Note how Rep. Hooker is spouting off about “parental rights” and “parental
choice” in the usual way that antivaccine activists do, such that the child is
basically viewed as the parents’ property instead of an autonomous being with
rights of his or her own, such as the right to good medical care. Good medical
care, I note, includes standard of care preventative medicines such as the
CDC-recommended vaccine schedule. Hooker also blathers on about “big pharma” in 
a typical conspiratorial manner. He even invokes one of the most brain dead
antivaccine arguments there are, an argument that fundamentalist Christians make
about the HPV vaccine:

   Obviously, as a parent and a grandparent myself, it’s important to me that
   parents have their rights protected and, you know, their choice of what’s
   best for their kids. I think of the immunization Gardasil. If my children are
   raised in a godly Christian home, they don’t need Gardasil, because they’re 
   going to make the wise choices, and again, the advertisements they’re putting
   out on television to the parent (“You could have protected me and let me
   have an immunization as a child”) takes the responsibility away from the kid,
   who should be making the responsibility for having sex outside of marriage.

No, vaccination with Gardasil does not lead to promiscuity.

When, near the end of the interview, Hooker brought up the “aborted fetal tissue
in vaccines” distortion, I had to stop and thank my lucky stars that Rep.
Hooker was term-limited. I’m thankful now that he’s no longer in the House.
Unfortunately, there are many to take his place.

Bigtree also managed to meet with a number of other legislators, including Sen. 
Phil Pavlov, Rep. Hank Vaupel, and Rep. Mike Callton. Pavlov represents the 25th
District, which encompasses much of the Thumb area of the state, while
Representative Vaupel represents a district that includes several exurbs
northwest of Detroit and Rep. Caldon represents a rural district west of
Lansing. Sadly, there was at least one Democrat on the list, specifically Sen.
Vincent Gregory, whose district covers several of the northern suburbs,
including Farmington Hills, Southfield, Farmington, Ferndale, and more. This
swath of northern suburbs encompasses an area where I’d guess that much of
Detroit’s antivaccine contingent resides; no wonder Sen. Gregory is a co-sponsor
of SB 299 and SB 300. Bigtree exults that his meeting with Gregory was one of
the best meetings he’s ever had with a Democrat and how Gregory promised he’d
get Bigtree’s antivaccine concerns heard by the Congressional Black Caucus in
Detroit. Meanwhile, through it all, Bigtree was driven around by a
representative from Michigan for Vaccine Choice, one of our state antivaccine
groups, the same one that’s promoting HB 4425/6 and SB 299/300.

Bigtree wrapped up his visit to my state with a fundraiser for the Michigan
Vaccine Freedom PAC, which is exactly what you think it is and lists Rep. Noble 
as supporting “vaccine choice” and “legislative oversight,” and opposing
“vaccine discrimination”:

In his talk, Bigtree spends a lot of time arguing for “health freedom,”
portraying “vaccine choice” as an integral part of health freedom, where the
parents have the right to refuse vaccination for their children. Of course, as
I’ve mentioned in this very post and more posts than I can remember, the problem
with this argument is that it completely ignores the autonomy of children.
Children are not the property of their parents. They are not extensions of their
parents. They are autonomous beings who have an existence outside of their
parents and who have the right to medical care, including the right be protected
against vaccine-preventable diseases, regardless of the misguided beliefs of
their parents who refuse to vaccinate. Not surprisingly, Del Bigtree traces his 
antivaccine activism (I know, I know, he doesn’t think that he’s antivaccine) to
the introduction of SB 277, the California bill that is now law that has
eliminated nonmedical exemptions to school vaccine mandates.

He concludes:

   If we do not fight now, then there will be nothing left to fight for. And I
   think that is where everyone in this room, I pray you realize how important
   you are in this historic moment. We will never be stronger than we are right 
   now. We will never be healthier than we are right now. Our children are
   looking like this, a generation of children, as we’ve said on The Doctors
   television show this is the first generation of children that will not live
   to be as old as their parents. Are we going to stand…are we going to sit down
   and take it? Or are we going to stand up and say: This is a historic moment,
   that my forefathers, those from Jefferson all the way to Martin Luther King,
   the moments where people stood up and something inside of them said I’m
   going to stand for freedom and I’m going to stand for it now. That is in our 
   DNA. It is pumping through me, and I pray that you feel it pumping through
   you, because we must look back. Our grandchildren will look back and thank us
   for having stood up one more time and been the generation that said, “We the
   People of the United States of America stood for freedom, stand for freedom.
   We will die for freedom today.”

Histrionic? Yes. Overwrought? Definitely. Grandiose? Well, it is Del Bigtree.
Even so, it’s not hard to see how this can be a very effective message among
libertarian and government-distrusting conservatives.

What can science and public health advocates do?

Sadly, now that we’ve gone down this road, I don’t see a clear path to
preventing the further politicization of school vaccine mandates and state
vaccine policy. I fear that it might require much bigger outbreaks than we’ve
seen thus far before we as a nation come to our senses about vaccines, at least.
Vaccine advocates have science on our side, but the antivaccine movement has
emotional stories and passion. If we can’t match that passion and couple it with
science we will lose.

Medical societies should be leading the way in this fight, particularly those
representing specialties that care for children. Fortunately, one such group is 
leading the way:

State physicians groups are also opposed. For example, the Michigan Academy of
Family Physicians, which issued an action alert to urge state legislators to
vote no on HB 4425 and HB 4426, as did the Michigan State Medical Society. Then,
of course, there is the Alliance for Immunization in Michigan, an organization 
of health care professionals who advocate for vaccines.

Although Michigan medical groups have started to stir themselves to oppose the
bill, so far I’ve seen little other than the action alerts above. What will be
more important, however, is for parents in affected states to become active. For
example, Michigan’s first pro-vaccine parent advocacy group is now up and
running, The Cooperative for Safe Kids (Facebook). Not surprisingly, the group
opposes HB 4425 and HB 4426, as well it should. Then there’s the Franny Strong
Foundation and its I Vaccinate campaign, which was born out of the tragic death 
of its founder’s baby to pertussis during the 2012 outbreak.

The same is true in every state where antivaccine groups are influencing the
legislature to weaken school vaccine requirements. Pro-vaccine advocates need to
be active at the local level, working to elect pro-vaccine legislators, to
defeat antivaccine-sympathetic legislators, and to defeat bad legislation like
HB 4425 and HB 4426. Unfortunately, the situation around the country is like
that in Texas, where the antivaccine groups outgun pro-vaccine groups in terms
of funding and activism. Unless we can reverse this situation, the antivaccine
movement will succeed in making measles great again, not to mention several
other vaccine-preventable diseases.

                 Lies, Damned Lies, and ‘Integrative Medicine’

                                Kimball Atwood 

                                      Link

Last week, two events took place in Washington that ought to inspire trepidation
in the minds of all who value ethical, rational, science-based medicine and
ethical, rational, biomedical research. One was the Senate Panel titled
Integrative Care: A Pathway to a Healthier Nation, previously discussed by my
fellow bloggers David Gorski, Peter Lipson, and Steve Novella, and also by the
indefatigable Orac (here and here); the other was the ”Summit on Integrative
Medicine and the Health of the Public“ convened by the Institute of Medicine
(IOM) and paid for by the Bravewell Collaborative, previewed six weeks ago by
fellow blogger Wally Sampson. This post will make a few additional comments
about those meetings.

Senator Harkin and the Scientific Method

Thanks to Dr. Lipson, I didn’t have to listen to the Senate Panel video to find 
out that Senator Tom Harkin (D-Iowa) made this statement of disappointment
regarding his own creation, the National Center for Complementary and
Alternative Medicine (NCCAM):

One of the purposes of this center was to investigate and validate alternative
approaches. Quite frankly, I must say publicly that it has fallen short. It
think quite frankly that in this center and in the office previously before it, 
most of its focus has been on disproving things rather than seeking out and
approving. (from last week’s hearings, time marker approx. 17:20)

Are scientists at the NIH really too afraid of Harkin to explain to him how
science works? Apparently so. Otherwise Harkin might learn that his statement is
more wrong-headed than it would be for one of us to complain that the Supreme
Court ought to assume that a defendant is guilty until proven innocent, rather
than the other way around. In scientific inquiry, for those who don’t know, good
experimental design is always directed at disproving a hypothesis, even one
that pleases its investigator. The rest of Harkin’s sentiment—”seeking out and
approving”—is incoherent.

The Selling of ‘Integrative Medicine’: Snyderman Trumps Weil

Spin doctors shilling for ‘integrative medicine,’ which the NCCAM defines as
“combining treatments from conventional medicine and CAM,” appear to have now
decided that subtler language is more likely to sell the product. We’ve
previously seen an example offered by ‘integrative’ Mad Man Andrew Weil:

The addition of proven CAM to conventional medicine would be an improvement, yet
this combination alone is not what could be defined as integrative
medicine….Integrative medicine is defined as healing-oriented medicine that
reemphasizes the relationship between patient and physician, and integrates the 
best of complementary and alternative medicine with the best of conventional
medicine. We believe that this synthesis of humanistic medicine, patient- and
relationship-centered care, preventive health, allopathy, and CAM is the model
for creating an improved system of health care.

It takes someone who knows his way around a faculty meeting much better than
does ex-hippie Weil, however, to understand that the surest way to usher
‘integrative medicine’ into the curricula of medical schools is to press the
delete button whenever the pesky ‘CAM’ term comes up, and to replace it with a
few trendy slogans that everyone can agree on. Ralph Snyderman, MD, the former
Chancellor for Health Affairs at Duke University, is just such a person. As far 
back as 2002, Snyderman wrote:

   Integrative medicine is an approach to the practice of health care based on a
   sound scientific approach with an emphasis on the responsibility of the
   physician to engage the patient in his or her own unique plan for health.
   Essential aspects include the recognition of the importance of the mind-body 
   relationship and a willingness to consider unconventional modalities with
   informed skepticism and scientific evaluation. Above all, integrative
   medicine encompasses the caring bond between the patient and the caregiver,
   and the responsibility of the latter to enable the patient to benefit from a 
   full array of modalities that can be shown to benefit health.

No surprise, then, that Snyderman was a key figure in last week’s ”Summit.” Here
is how he introduced the topic prior to the meeting:

   “What we currently have is not a health care system, but a disease care
   system,” said Ralph Snyderman, M.D., chair of the Summit Planning Committee
   and chancellor emeritus of Duke University. “The summit will explore how
   science and a patient-centered, prospective, integrated approach to care can 
   make a positive difference.”

It seems that ‘integrative medicine’ now might have something to do with
preventive medicine, ‘patient-centered care,’ and fixing the health care system.
The Summit’s Issue Background, authored by professional writer Vicki Weisfeld, 
makes it official:

   Integrative medicine orients the health care process to create a seamless
   engagement by patients and caregivers in the full range factors known to be
   effective and necessary for the achievement of optimal health over the course
   of one’s life. In integrative medicine, patients are active partners in
   their health and providers care for them as individuals in different life
   circumstances, rather than just treating their illnesses. Thus, integrative
   medicine takes into account biological, psychological, social, and spiritual 
   aspects of individuals’ lives, draws the best evidence for their needs and
   circumstances, and engages both treatment and prevention, including diet,
   exercise, stress management, emotional wellbeing, and socio-environmental
   factors. Integrative medicine makes use of the best conventional care and the
   latest advances in predictive, preventive, and personalized medicine and
   uses all appropriate evidence-based prevention, treatment and supportive
   approaches. Finally, it asks physicians to serve as guides, role models, and 
   mentors and to recall that “healing is always possible, even when curing is
   not.”

   Widespread implementation of an integrative medicine approach would
   fundamentally transform our nation’s current fragmented, inefficient,
   expensive, and reactive “sick care” system to one that is more proactive,
   personal, efficient, and appropriately focused on enhancing the health of
   each person and the population as a whole. Five chronic conditions—mood
   disorders, diabetes, heart disease, asthma, and high blood pressure—now
   account for more than half of all U.S. health expenditures. The onset and
   serious consequences of these conditions may have been partly or wholly
   preventable. Current patterns of care do little to enhance health, prevent
   illness, or treat it efficiently and effectively when it occurs. The
   reimbursement system encourages this pattern, by financially rewarding units 
   of service, rather than outcomes, prevention, and the integration of care
   processes that each patient should expect. Little encouragement, through
   incentives or care patterns, is offered to individuals to take active part in
   their own care to enhance wellness and minimize disease.

Hmmm. No ‘CAM’ mentioned there. Nor will you find it until the bottom of page 3,
where it is dressed up as “proven complementary approaches,” without further
comment:

   In 1910, the Flexner Report changed American medicine by insisting that
   doctors should be trained to diagnose and treat illnesses using the
   scientific tools of the day. Since then, the medical sciences have splintered
   into more and more specialties concerned with narrower and narrower aspects 
   of the human body. Medicine’s focus on pathophysiology alone, and the
   reductionist perspective, do not well serve the many patients whose complex
   problems are incompletely understood

   and treated by “find it and fix it” approaches.

   As the Flexner centenary approaches, it is again time to reevaluate the
   training in U.S. medical schools…This requires taking a broader view of
   individual patients that takes into account the social, family, and physical 
   environments in which they function as well as the patient’s own empowerment 
   and motivation. It requires use of the best conventional medicine and
   cutting-edge diagnostic and treatment methods in combination with appropriate
   mentoring, compassion, and proven complementary approaches.

You don’t see it again until p. 9:

   Some elements of an integrated approach to health care also have their roots 
   in practices that began under the rubric of complementary and alternative
   medicine (CAM). The effectiveness of such approaches has been strengthened as
   experience and evidence has [sic] been gained.

Aha, you’re thinking: we’re about to find out what those mysterious, “proven
complementary approaches” are! Think again, because here is the rest of the
paragraph:

   In 2003-2004, the National Center for Complementary and Alternative Medicine 
   sponsored a series of grants to strengthen awareness and knowledge about
   complementary and alternative medicine practices among medical students. The 
   goal was to broaden the array of evidence-based techniques that physicians
   have at their disposal. A common finding from these projects was that culture
   change, including faculty development, was a necessary accompaniment to
   curriculum changes, and the result is a growing presence of relevant courses 
   in the nursing and medical curricula. Expansion of these trends will require 
   additional research, resources, incentives, continuing education courses,
   licensure requirements, and, perhaps, ultimately, reimbursement incentives.

It seems that ‘experience and evidence’ have shown that the only way to foist
implausible medical claims into medical and nursing school curricula is to dupe 
medical and nursing students, bribe faculty members, and twist some arms. Or,
perhaps, to pretend that ‘integrative medicine’ does not involve prescribing
non-existent drugs, manipulating non-existent ‘energy fields’ and non-existent
‘rhythms,’ balancing non-existent ‘qi’ in various non-existent organs through
non-existent ‘meridians’ and non-existent ‘acupuncture points,’ correcting
non-existent ‘subluxations,’ diagnosing and treating diseases by examining
non-existent homunculi on ears, eyes, and feet, hosing non-existent toxins out
of colons, and all the rest.

How much easier it must be, when faced with a profession that has become
maddeningly wedded to science—that vexing ”reductionist perspective”—to pretend 
that one’s pet project doesn’t include such anti-scientific drivel (well, maybe 
it includes a little of the socially acceptable sort: “mindfulness meditation,
acupuncture, massage and biofeedback…nutritional practices and dietary
supplements” is what you get in this essay). Instead, why not claim that the
program is about ‘patient-centered care,’ prevention, improving access to care, 
improving reimbursement for primary care physicians, making health care less
expensive, considering psycho-social aspects of patient care, improving
communication skills among health care professionals, and other uncontroversial 
topics?

So what if these have long been recognized as worthy goals, both individually
and in the aggregate, since well before ‘integrative medicine’ or ‘CAM’ began to
contaminate rational discourse in medical schools and government? So what if
‘integrative medicine’ has nothing new to add to them? This is all of little
concern to the savvy chairman, who knows that the most important determinant of 
smooth sailing at a meeting is to avoid saying anything that might awaken the
participants.

Is ‘Integrative Medicine’ Preventive Medicine?

Does ‘integrative medicine’ have anything to add to preventive medicine? You’d
sure think so if you’d emerged from a 40-year coma last week to read the Issue
Background:

   Since integrative medicine begins from the perspective of maintaining and
   promoting individual health, it is necessarily closely attuned to the array
   of behavioral and environmental factors that put health at risk. Inevitably, 
   the health system must look beyond the individual patient to broader social
   and environmental influences. As mentioned, many environmental factors
   require public health advocacy and intervention. However, even individual
   behavior, such as smoking and exercise, is susceptible to social and
   environmental approaches. Widespread anti-smoking advocacy and supportive
   public policies, like anti-smoking rules in workplaces and public spaces,
   increased tobacco taxes, and consumer education programs have changed the
   environment in the United States from a pro-smoking to largely anti-smoking
   culture. Similarly, public policies that promote exercise by building bike,
   jogging, and walking trails, corporations and city planners that encourage
   office and residential buildings to include gyms and showers, and an array of
   other public policies support a health-promotion culture. Health
   professionals have credibility in public discussions of such policies and can
   do a great deal for their own patients and the community by endorsing such
   pro-health initiatives. Medical researchers and health policy analysts can
   develop the clinical research and public policy assessments on which sound
   public policies can be based.

Really, now. That such spin was apparently composed with a straight face can
only be a measure of how few people will read it. Which, alas, is exactly what
the Bravewell crowd has in mind, and why Snyderman is such a brilliant choice as
Propaganda Chief. The prevention hype is everywhere; here’s Harkin again, this 
time from his written statement:

   We need a paradigm shift that places a much greater emphasis on preventing
   disease and keeping people healthy rather than merely treating people once
   they become sick. Integrative care can help us achieve this goal.

But has ‘integrative medicine’ or any of its ‘CAM’ progenitors contributed
anything to real preventive medicine, as introduced yesterday by Peter Lipson?
Have any of the preventive measures that most physicians can think of right off 
the bat—oh, in no particular order, by no means comprehensive, and not without
uncertainties about usefulness or best uses: immunizations, blood pressure
measurement and treatment, cholesterol screening and treatment, mammography,
occult blood in stool, colonoscopy, smoking cessation, folate and iron in
pregnancy, other prenatal care, bone density, weight, diet, exercise, pap
smears, skin exams for melanoma, prostate-specific antigen, and many more—been
introduced by ‘integrative medicine’? Let’s look. First, a list of

Preventive Measures Supported by Science that have been Advanced by Modern
Medicine and Public Health



       Guide to Clinical Preventive Services, 2008

       Recommendations of the U.S. Preventive Services Task Force

       The Guide to Clinical Preventive Services includes U.S. Preventive
       Services Task Force (USPSTF) recommendations on screening, counseling,
       and preventive medication topics and includes clinical considerations for
       each topic. This new pocket guide provides general practitioners,
       internists, family practitioners, pediatricians, nurses, and nurse
       practitioners with an authoritative source for making decisions about
       preventive services.

       Contents

       Foreword

       Preface

       Section 1. Preventive Services Recommended by the USPSTF

       Section 2. Recommendations for Adults

       Cancer

       * Aspirin/NSAIDS for Prevention of Colorectal Cancer

       Bladder Cancer in Adults, Screening

       Breast and Ovarian Cancer Susceptibility, Genetic Risk Assessment and
       BRCA Mutation Testing

       Breast Cancer, Chemoprevention

       Breast Cancer, Screening

       Cervical Cancer, Screening

       Colorectal Cancer, Screening

       Lung Cancer Screening

       Oral Cancer, Screening

       Ovarian Cancer, Screening

       Pancreatic Cancer, Screening

       Prostate Cancer, Screening

       Skin Cancer, Counseling to Prevent

       Skin Cancer, Screening

       Testicular Cancer, Screening

       Vitamin Supplementation to Prevent Cancer and Cardiovascular Disease,
       Routine

       Heart, Vascular, and Respiratory Diseases

       Abdominal Aortic Aneurysm, Screening

       Aspirin for the Primary Prevention of Cardiovascular Events

       * Carotid Artery Stenosis, Screening

       * Chronic Obstructive Pulmonary Disease, Screening

       Coronary Heart Disease, Screening

       * High Blood Pressure, Screening

       Lipid Disorders in Adults, Screening

       Peripheral Arterial Disease, Screening

       Infectious Diseases

       Asymptomatic Bacteriuria, Screening

       * Chlamydial Infection, Screening

       Genital Herpes, Screening

       Gonorrhea, Screening

       Hepatitis B Virus Infection, Screening

       Hepatitis C in Adults, Screening

       HIV, Screening

       Syphilis Infection, Screening

       Injury and Violence

       Family and Intimate Partner Violence, Screening

       * Motor Vehicle Occupant Restraints and Avoidance of Alcohol Use While
       Driving, Counseling

       Mental Health Conditions and Substance Abuse

       Alcohol Misuse, Screening and Behavioral Counseling Interventions in
       Primary Care to Reduce

       Dementia, Screening

       Depression, Screening

       * Illicit Drug Use, Screening

       Suicide Risk, Screening

       Tobacco Use and Tobacco-Caused Disease, Counseling to Prevent

       Metabolic, Nutritional, and Endocrine Conditions

       Diet, Behavioral Counseling in Primary Care to Promote a Healthy

       Hemochromatosis, Screening

       Hormone Therapy for the Prevention of Chronic Conditions in
       Postmenopausal Women

       Iron Deficiency Anemia, Screening

       Obesity in Adults, Screening

       Physical Activity, Behavioral Counseling in Primary Care to Promote

       Thyroid Disease, Screening

       Type 2 Diabetes Mellitus in Adults, Screening

       Musculoskeletal Conditions

       Low Back Pain in Adults, Primary Care Interventions to Prevent

       Osteoporosis in Postmenopausal Women, Screening

       Obstetric and Gynecologic Conditions

       * Bacterial Vaginosis in Pregnancy, Screening

       Breastfeeding, Behavioral Interventions to Promote

       Gestational Diabetes Mellitus, Screening

       Rh (D) Incompatibility, Screening

       Vision Disorders

       Glaucoma, Screening

       Section 3. Recommendations for Children

       Blood Lead Levels in Children and Pregnant Women, Screening

       Dental Caries in Preschool Children, Prevention

       Hip Dysplasia, Screening

       Idiopathic Scoliosis in Adolescents, Screening

       * Lipid Disorders in Children, Screening

       Newborn Hearing Screening

       Overweight in Children and Adolescents, Screening and Interventions

       * Sickle Cell Disease, Screening

       Speech and Language Delay in Preschool Children, Screening

       Visual Impairment in Children Younger Than Age 5 Years, Screening

       Appendixes

       Appendix A. How the U.S. Preventive Services Task Force Grades Its
       Recommendations

       Appendix B. Members of the U.S. Preventive Services Task Force 2001-2004

       Appendix C. Acknowledgments

       Appendix D. ACIP Recommended Immunization Schedules

       * New recommendations 2007 to March 2008.

And now:

Preventive Measures Supported by Science that have been Advanced by ‘Integrative
Medicine’

Got it?

                       The Golden State of Pseudo-Science

                                  Ben Kavoussi

                                      Link

The state of California (CA) which is home to the most advanced education and
research in biomedical sciences, computational biology, genomics and proteomics,
etc, is also home to 19 institutions that have state-approved training programs
in Traditional Chinese Medicine (TCM), a pseudo-medicine that is based on ideas
and practices sourced by ancient cosmology, mythology, astrology, and a range
of other pre-scientific beliefs that have been partially “sanitized” during the 
Maoist era.

Emerging out of the recent hype about complementary and alternative medicine
(CAM), the educational curricula of these institutions include the study of
acupuncture’s point-and-meridian system, the health and safety beliefs of
ancient and medieval China, humoral pathology, herbalism, Asian massage, and a
limited amount of modern biomedical sciences at a level below what is required
from vocational nurses. These curricula are supposed to provide the necessary
knowledge and skills for the graduates to pass a comprehensive state licensing
exam and provide “primary” healthcare in CA. However, pursuant to CA Code of
Regulations, Title 16, Section 1399.451(b) it is improper for these “primary”
healthcare providers, “to disseminate any advertising which represents in any
manner that they can cure any type of disease, condition or symptom!”
Nonetheless, both the internet and the local press abound with ads by CA
licensed practitioners who claim that acupuncture can cure or mitigate many
diseases, ranging from allergies and infertility to stroke and paralysis.

Under the banner of CAM, a handful of these practitioners also advertise that
they can communicate with spirits and heal with crystals, colors or sounds; they
practice healing touch (reiki) and distance healing (via PayPal!); provide
spiritual counseling and ministerial services, and make implausible medical
claims such as healing a chronic condition with just one needle!

All 19 programs are approved by the CA Department Affairs’ (DCA) Board of
Acupuncture, since CA law requires that the content of an acupuncture training
program be assessed and approved by the State.

Baffled by the absurdity of some of the content of these programs and the
outrageous claims of some of the graduates, I addressed the DCA’s Board of
Acupuncture on June 20, 2008, to request the repeal of state-approved healthcare
programs that endorse the teaching of vitalism, metaphysics and
snake-oil-science. To clarify the matter, I reminded the Board that vitalism is 
a doctrine that stipulates that the functions of a living organism are due to a 
transcendental vital faculty distinct from physicochemical forces, which
distinguishes living organisms from non-living matter. Vitalism was the
fundamental dogma of natural sciences and medicine in the West until the 19th
Century where disease was believed to derive from interruptions to the flow of a
vital principle, called pneuma, and imbalances in four humors. Eastern
traditions have similar notions such as qi in China, ki in Japan and doshas in
India. I also reminded the Board that vitalism was disproved in the 19th Century
by Friedrich Wohler who showed that it is possible to synthesize an organic
substance in the laboratory. Louis Pasteur disproved a related concept called
“spontaneous generation.” More recently, Stanley Miller, during a landmark
experiment in 1953, demonstrated that organic substances could be created by
very simple physical processes from inorganic substances.

The counterargument presented by the former Chair of DCA’s Acupuncture Board,
Dr. Adam Burke, is instrumental in understanding the thought process behind the 
official legitimization of voodoo science and New Age nonsense in the Golden
State. Dr. Burke, who is also a Senior Research Advisor to the American
Association of Oriental Medicine and the Co-Director of the Institute for
Holistic Healing Studies at San Francisco State University (SFSU), stated that:

   If you biomedicalize it all… if we strip the history and the philosophy and
   the understanding of that, we have shut out millennia of understanding of
   human illness that could enrich our understanding of healing people. That
   would be such a historic loss… I don’t think we’ll completely understand
   these things. The Journal of Alternative and Complementary Medicine, also
   Mary Ann Liebert, hardcore, very big science journal editor – Distant
   Healing. They don’t know how but some of the people at the Institute of
   Noetic Sciences, which was founded by an astronaut, up in Marin, they are
   doing research on distant healing. They principle investigator is a
   physicist. They are getting their research published in the best physics
   journals in the United States. They’re trying to show the physical nature of 
   these phenomena. We don’t understand them but it’s not metaphysics. I mean I 
   wish there had been more metaphysics when I was in school and I don’t imagine
   schools have gone backwards. I imagine they are going more towards
   integrative medicine.

Now, does not this sound like the ultimate in anti-rationalism and anti-science 
coming from the Chair (former) of a State Board with the mandate of protecting
the public health, safety and welfare? The entire text is available at the
following link:

www.acupuncture.ca.gov/about_us/minutes/20080620.pdf

A few weeks later, I got an official letter from the DCA, stating that after
careful review, the Board had not found anything objectionable in the curricula 
of state-approved TCM schools.

I gather that the dreadful mixture of anti-intellectualism, anti-rationalism and
low expectations at the New Age of Unreason is doomed to remain the basis for
many public health policies in the Golden State. And as long as Chinese
metaphysics and vitalism are perceived as anything but pre-scientific and
disproved worldviews, pseudo-doctors and purveyors of TCM woo-woo will continue 
to provide the community of believers with medical astrology, alchemy, humoral
pathology and even dialogue with the dead, heal with incantations, crystals,
colors or sounds, remotely or via touch, and make implausible medical claims–all
with the full blessing and endorsement of the CA Department of Consumer
Affairs.

Weston Price’s Appalling Legacy

Harriet HallonOctober 13, 2015

Tweet





Not recommended

One of our readers requested a post about the Weston A. Price Foundation (WAPF).
I knew it was not a trustworthy source of medical information, but I had not
imagined just how atrocious it really was. After spending some time on the
website, I realized that it is not just a cornucopia of false information about 
dentistry and nutrition, but is full of anti-vaccine propaganda and bizarre and 
dangerous health advice that could result in serious harm to patients.

The purpose of the Weston A. Price Foundation

It is a non-profit, tax-exempt charity founded in 1999 to disseminate the
research of Weston A. Price, who “established the parameters of human health and
determined the optimum characteristics of human diets.” (He did no such thing!)
It publishes a journal “dedicated to exploring the scientific validation of
dietary, agricultural and medical traditions through the world.” That statement 
reveals how poorly they understand science. The purpose of science is not to
“validate” traditions and beliefs; it is to ask “if” those traditions offer any 
demonstrable benefits, and if the beliefs correspond to reality.

Who was Weston A. Price?

He was an American dentist who lived from 1870 to 1948. He did research in
support of the focal infection theory. He claimed that root canal therapy
created hidden infections that spread toxins or bacteria into the rest of the
body to cause systemic diseases like arthritis, and that those teeth should have
been extracted, not repaired. Mainstream dentistry was wary of endodontic
therapy for a time, but the trend was reversed after better-designed, more
rigorous research showed that root canals didn’t have systemic consequences.
Nevertheless, “holistic” and “biological” dentists who still believe the focal
infection myth are still extracting teeth unnecessarily. Rational Wiki calls
Price “the patron saint of crank dentistry.”

Looking for the cause of tooth decay, Price traveled to non-Western countries
and observed indigenous peoples. Based on his unsystematic observations, he
claimed that the Western diet was responsible for everything from tooth decay to
tuberculosis. He claimed that a diet of nutrient-dense whole foods and animal
fats would allow humans to achieve perfect physical form and perfect health
generation after generation. His nutrition claims went far beyond the evidence. 
Dr. William Jarvis called his work a classic example of the “myth of the healthy
savage.” A review in The Journal of the American Medical Association
characterized his approach as evangelical rather than scientific.

Dietary guidelines

The WAPF dietary guidelines can be found here. They are a mixed bag:

  1. Good advice supported by evidence, like eating more vegetables.

  2. Advice not supported by good evidence, like using unrefined Celtic sea salt,
    cooking only in stainless steel, cast iron, glass, or good quality enamel,
    thinking positive thoughts, and practicing forgiveness.

  3. Dangerous advice: drinking raw milk and avoiding pasteurization. They even
    hold an annual raw milk symposium. They also recommend frequent consumption 
    of raw meat, raw fish, and raw shellfish.

They claim that cod liver oil is our number one superfood. They recommend that
everyone’s diet should include fermented cod liver oil mixed with organic butter
oil. Even the infamous Dr. Mercola questioned these recommendations, and WAPF
offered a point-by-point rebuttal that I found less than convincing.

Heart disease

The WAPF website’s section on heart disease and statins is full of
misinformation and distortion of cherry-picked studies. Much of it regurgitates 
misleading propaganda from THINCS, The International Network of Cholesterol
Skeptics. In fact, they recommend Uffe Ravnskov’s book The Cholesterol
Myths.Among other claims, they say for women at any age, and for men over 60,
higher cholesterol levels are associated with longevity and there is no reason
to reduce them even if they are very high. This is simply not true. Elsewhere
they acknowledge that high cholesterol is a risk factor and claim that it can be
lowered with artichoke extract. A 2013 Cochrane review of artichoke extract
found the published evidence unconvincing.

Homeopathy

There is a whole section of articles on homeopathy. It is recommended for things
like home dental care, treating the effects of electromagnetic radiation, using
dilute coffee for insomnia, homeopathic metallic gold for male infertility, and
homeopathic iodine for hypothyroidism. They even recommend a homeopathy first
aid kit.

Detoxification

After appropriately debunking many of the common myths about detoxification,
they offer their own detox myths. They offer two programs of detoxification. In 
one, the need for detox is diagnosed by a consistent overly loud voice, a red
face, hard and rigid pressure points used in acupressure or oriental medicine,
strong body odors, a strong pulse, and a thick yellow coating on the tongue. The
remedy is dietary manipulation and stimulation of the organs of elimination
with fermented drinks, higher doses of vitamin C, and bitter herbs like
dandelion and Oregon grape root. They also recommend exercise, castor oil packs,
dry skin brushing, probiotics, liver tonics, dry saunas. They recommend
eliminating coffee from the diet, but then they recommend the use of coffee
enemas for detoxification!!

Dental myths

They are firmly anti-fluoridation and they recommend removal of mercury amalgam 
fillings. They reject the policies of the American Dental Association.

Vaccines

The WAPF is firmly ensconced in the unscientific anti-vaxxer camp. They don’t
just suggest that we are giving “too many, too soon;” they suggest that all
vaccines are evil, doing more harm than good. Instead of vaccines, they advocate
nutrition and homeopathic prophylaxis.

They say:

   Childhood diseases are either mild or nonexistent when parents practice the
   kind of good nutrition that we advocate. Diets rich in vitamins A and C can
   protect children against disease much better than vaccinations, and with side
   effects that are good, never harmful. Public health policy should be aimed
   at accurate information about nutrition, not the promotion of vaccinations
   that actually suppress the immune system and often have tragic side effects.

The most recent issue of their journal was devoted to vaccines. The very
language they use makes their bias clear:

  1. “We are struggling against one of the most dangerous, diabolical and powerful 
    cults in the U.S.; that is, ‘science-based’ and ‘evidence-based medicine’
    within the Church of Scientism.”

  2. Vaccination is “injecting cow belly pus and horse hoof pus into babies.”

  3. Bill Gates is “a delusional global dictator.”

  4. Paul Offit is one of the “principal harbingers of vaccine barbarism.”

They repeat all the usual anti-vaccine myths and misinformation. Those have all 
been adequately covered on this blog before, and I won’t bother to address them 
here.

Ask the Doctor

The website features a Q and A section called “Ask the Doctor.” It gives
holistic advice that is almost consistently wrong and often dangerous:

  1. They recommend the GAPS protocol

  2. Salt intake should be at least 1 ½ tsp a day.

  3. For high blood pressure, the outcomes are not affected by lowering BP with
    medication. (Demonstrably false)

  4. Gallstones are not a sign of gallbladder disease. The stones will dissolve if 
    you just eat more cholesterol. (!?)

  5. Anthroposophical remedies like Erysidoron 1 for fever in children. It is made 
    from the honeybee, (because beehives maintain a temperature of 98.6°) and
    belladonna.

  6. Echinacea is an immune enhancer that helps our white blood cells recognize and
    move to the site of the infection; it should be used in virtually all
    infections at any site.

  7. Measles is the only cure for nephrotic syndrome.

  8. Infections, particularly strep infections, cause cancer to resolve.

  9. We have 4 bodies: the physical or earth body, the fluid or etheric body, the
    emotional body or astral body, and the warmth body or mental body.

  10. Herpes can be treated with St. John’s wort and the lauric acid found in
    coconut oil.

  11. For skin cancer: Iscador and caustic escharotic salves.

  12. For rheumatoid arthritis: a diet rich in good fats, including raw cream and
    butter, “warming” herbal extracts like Boswellia complex and willow bark
    extract. No mention of the DMARDS (disease modifying anti-rheumatic drugs)
    that have been proven effective in preventing joint damage and permanent
    disability.

  13. For sunburn: a homeopathic remedy made from Spanish fly.

  14. Tetanus: instead of vaccination, you can rely on scrupulous wound care and
    nutrition. Vaccination makes patients susceptible to HIV and hepatitis C (He
    says “I can’t find the original reference, but I remember a patient showing
    me the research in the early 1990s”).

I won’t pretend to have read everything on the website. It was so distressing
that I had to stop to protect my blood pressure and my sanity.

Conclusion: One of the worst sites on the internet

Since I started writing for Science-Based Medicine almost 8 years ago, I have
visited many, many websites offering questionable information about health. In
my opinion, the Weston A. Price Foundation is one of the worst. It is full of
misinformation and dangerous advice. It might be useful in reverse: if you read 
it on WAPF, it is probably wrong.

      Connecticut Legislature Intrudes on Debate Over Chronic Lyme Disease

                                 Steven Novella

                                      Link

The tick borne spirochete infection known as Lyme disease was named after Lyme, 
CT – a part of the country where the disease remains endemic. It is therefore
especially poignant that the Connecticut state senate unanimously passed Public 
Act No. 09-128: AN ACT CONCERNING THE USE OF LONG-TERM ANTIBIOTICS FOR THE
TREATMENT OF LYME DISEASE.The bill had previously passed the state House, also
unanimously.

This is a terrible bill that is both anti-science and anti-consumer protection. 
How it passed both houses without dissent reflects exactly why such
micro-management decisions should not be made by politicians.  It is the result 
of lobbying by a narrow interest group and does not reflect either the state of 
the science on Lyme disease nor the proper role of regulation to ensure
standards of care within medicine.

This is also not an isolated case. There is already a similar law in Rhode
Island, and there have been similar bills proposed in Pennsylvania,
Massachusetts, and New York, and a bill in Maryland that would compel insurance 
companies to pay for antibiotic treatment for chronic Lyme disease CLD.   This
is part of a coordinated effort by individuals and organizations who hold an
ideological opinion regarding the cause and treatment of CLD. They wish to use
the political process to win a victory for their view that they have been unable
to win in the arena of science (sound familiar).

The bill now awaits Governor Rell’s signature, which given the heavy political
support for this bill seems almost certain.

This bill represents much which is wrong with the state of science and medicine 
in the US.

Standard of Care vs Health Freedom

In the US each state is responsible for the regulation of medical practice,
through each state’s board of health. They license physicians, nurses, and other
health care practitioners, and they are also responsible for protecting the
public by maintaining an appropriate standard of care.  They primarily do this
by disciplining practitioners – suspending or even revoking their license or
restricting the scope of their practice.

Generally there are two legal standards at work. The lower or easier standard is
for the state to investigate the practice of a licensed professional to
determine if their actions are substantially below the standard of care, and if 
they determine that it is, discipline is appropriate.

The higher standard is for the state to act against a health care provider based
upon harm that has already been done to one or more specific patients/clients
based upon the complaints brought by those clients. This higher standard is not 
at issue – there is general support for the rights of patients to bring
complaints against health care providers. And of course, this is parallel to and
separate from the civil system of malpractice.

Incidentally, there are also ethical standards that can be enforced by the
state. Some of these have nothing to do with the standard of care (like not
sleeping with your patients), but rather with professionalism. But some do have 
implications for actual practice, for example not practicing outside of your
area of training.

What is at issue here is the capacity of state licensing boards to monitor and
maintain a minimal standard of care and to discipline providers who violate this
standard of care. This standard has been under continuous assault to weaken and
even eliminate it, in the name of health care freedom.

It is important to note that the state boards of health do not determine what
the standard of care is – they just enforce it. The standard of care, by
definition, is the consensus of practice among recognized experts. The standard 
is based largely upon the published evidence as incorporated into practice based
also on experience and a basic scientific understanding of physiology. Often
there are published guidelines by professional organizations – essentially
saying, “this is the standard of care.”

State regulators turn to the experts to tell them if what a licensed
professional is doing is acceptable within the standard of care or if it falls
unacceptably below. The standard of care is a rapidly moving target, as new
evidence is published, technology evolves, and practices change.

What the CT state legislature has done with their recent decision is to intrude 
on the process of determining what the standard of care is. It is the role of
politicians and government to determine what to regulate, what the goals of
regulation are, and to set up a mechanism for determining the details and
enforcement of regulation. But it is not their role to determine those details
themselves. As I described above, that is best left to experts.

CT state representatives and senators have unanimously decided to carve out an
exception in the standard of care for the use of antibiotics for the treatment
of chronic Lyme disease. The bill essentially says that the state cannot
discipline a health care practitioner solely for using long term antibiotics to 
treat chronic Lyme disease – a controversial topic. In so doing they have
decided to impose the political process and their imperfect understanding of a
complex scientific issue above the consensus of scientific opinion. While I
believe they probably thought they were doing good, they have done harm, even
malfeasance, by displaying astounding arrogance and naivete.

The political process is simply not capable of tracking the standard of medical 
care. It is too slow a process and too subject to political bias. Will the state
change this law as new scientific evidence is published? I highly doubt it.
This is one of those laws that will linger on the books for decades, regardless 
of scientific opinion and new evidence.

Do these legislators really believe that the information they received was
complete and representative? Rather – they were lobbied by narrow interest
groups (Lyme Disease Association, Inc., Newtown Lyme Disease Task Force,
Ridgefield Lyme Disease Task Force,Time For Lyme, Inc., Eastern Connecticut
Chapter, Lyme Disease Association) who are dedicated to a specific minority
scientific conclusion regardless of the evidence. It is always the case that
those with a vested interest in a political outcome are the ones with the
attention and endurance to push for their cause.

This is why the legislative process is simply not designed to micromanage the
standard of care. The legislators should have had the wisdom to simply
acknowledge that determining a specific, complex, and evolving scientific
question is simply not within their purview or the capability of the
legislature.

This bill is a specific application of a more global effort to weaken
enforcement of the standard of care. Many states have so-called health care
freedom laws which carve out exceptions for “alternative” practices. Essentially
they say that the state cannot act against the license of a practitioner for
any practice (no matter how outrageous) if that practice is “alternative.” Some 
states require that patients be informed that a specific practice is
“alternative”, but that’s about it. I doubt that the average patient would
understand by “alternative” they mean not subject to any standard of care and
beyond the reach of regulation, unless the burden of proving harm is met after
the fact.

Chronic Lyme Disease

The current scientific and medical issues surrounding the concept of CLD
highlights the folly of trying to capture this complex and rapidly evolving
scientific question with a snapshot of political opinion.

The problem begins with the fact that Chronic Lyme Disease is not a discrete
entity. The term has been used to refer to at least four different clinical
situations, as outlined by Adriana Marques in her recent review:

   Category 1 – symptoms of unknown cause, with no evidence of Borrelia
   burgdorferi infection

   Category 2 – a well-defined illness unrelated to B. burgdorferi infection

   Category 3 – symptoms of unknown cause, with antibodies against B.
   burgdorferi but no history of objective clinical findings that are consistent
   with Lyme disease

   Category 4 – post-Lyme disease syndrome

In all of these types of cases there are patients who believe they are
chronically infected with the Lyme spirochete, but they do not meet proven and
accepted criteria for such a diagnosis. But it increases confusion to lump all
four categories together, as the CT bill does.

What is not controversial is that Lyme disease is a tick-born infection with the
spirochete bacteria Borrelia burgdorferi (in the US, while two other Borrelia
species are common in Europe). The infection has an early  phase, characterized 
by a rash, often referred to as a targeted rash called erythema migrans, as well
as fever, headache, and fatigue.There is also a late phase with arthritis,
carditis (inflammation of the heart), and meningoencephalitis (inflammation of
the brain and meninges). A common manifestation of the latter is Bell’s Palsy or
facial weakness.

s also not controversial that the spirochete usually responds to antibiotics.
Rapid treatment in the early phase with doxycycline or other antibiotics know to
be active against B. burgdorferi usually prevents development of late stage
symptoms, and the late stage can also be treated, although usually IV
antibiotics, such as ceftriaxone need to be used for 4-6 weeks.

The controversy lies with those who believe they have chronic infection with
Lyme spirochetes despite adequate antibiotic therapy, or who never had clear
evidence of Lyme infection in the first place.

The current consensus of scientific opinion on this matter is reflected by two
recent reviews, that of Marques cited above and another by Phillip Baker:

Marques concludes:

   At this point, the overwhelming evidence shows that prolonged antibiotic 
   therapy, as tested in the clinical trials, does not offer lasting or
   substantive benefit in treating patients who have post-Lyme disease syndrome.
   Therefore, it is time to move forward to test other approaches that may help
   these patients. Unfortunately, no prospective studies of other treatment
   modalitiesfor patients who have post-Lyme disease syndrome have been
   performed.

And Baker:

   The results of NIH-supported studies acknowledge that some patients with 
   “chronic Lyme  disease/ posttreatment Lyme disease syndrome” indeed have
   deficits with respect to their physical health status. No doubt such patients
   experience significant pain and therefore require appropriate medical
   attention and care. However, because there is no evidence to indicate that
   their symptoms are caused by a persistent Borrelia burgdorferi infection,
   other options must be considered to determine their cause and how such
   patients might be treated to relieve their symptoms. Without direct evidence 
   for a persistent infection, it is clear that extended antibiotic therapy is
   not the answer; it remains an unproven and unsafe therapeutic approach that
   is neither justified nor in the best interest of the public health. This is
   in accord with the views expressed by many outstanding experts in infectious 
   disease.

To summarize these points, and emphasize my own experience and interpretation – 
at present there is insufficient evidence to support the conclusion that
patients in any of the four categories above have chronic Lyme infection. The
clinical evidence that we have for category 4 – CLD, is, on the balance,
negative. There are significant risks to using long term antibiotics, and these 
risks far outweigh the unproven benefits – even if we accept the mild and
equivocal improvements in some trials.

Further, the political and popular controversy surrounding the question of
antibiotics has distracted Lyme care and research away from other avenues that
may be more fruitful.

It is interesting that in response to the opinions expressed above, the typical 
response (I give as evidence various comments to my blog entry from yesterday)
is to accuse doctors and scientists of not believing or not caring for patient
who believe they have CLD. But read the opinions above – these researchers
accept that this population of patient is suffering with symptoms. Their only
goal is to understand their true medical situation so as to effectively treat
it. They are against the use of antibiotics not because of some defect of
empathy, but because the science simply does not support it.

But as we have seen with many grassroots popular campaigns against the
scientific medical consensus – having a meaningful conversation between the
public and the medical community is all but impossible as the voices that
dominate in the public are accusatory bordering on paranoid, distort the
scientific opinion, and demonize the medical profession and all who oppose their
views.

This replicates the situation seen with the anti-vaccination movement, as well
as chelation doctors who claim, despite decades of evidence to the contrary,
that chelation therapy can treat heart disease and a long list of other
conditions.

In addition to the science being strongly against the belief that there are
large numbers of patients suffering from chronic Lyme infection despite
antibiotic use, we can begin to see the true complexity of this medical
question. The four categories of patients above do not even capture the full
range of individual patients that fit into this broad syndrome.

For example, there are patients who come to believe they have CLD because of
misinformation they have received on the internet or by others. This then
becomes the focus of their attention and their efforts to find help for their
symptoms. Meanwhile, the true underlying diagnosis is being missed. Some of
these patients may have multiple sclerosis, some other autoimmune disease, a
primary sleep disorder, chronic fatigue syndrome, infection with some other
agent such as a virus – the list of alternatives is long. Focusing on Lyme
disease, in an atmosphere of distrust for the medical profession, is
counterproductive in these cases to say the least.

At the other end of the spectrum are the category 4 patients who actually had
Lyme disease, maybe even late stage Lyme disease, and now have chronic symptoms 
(such as fatigue and difficulty concentrating) after being treated. This is a
genuine medical mystery at the moment – we do not know why such symptoms persist
in a small percentage (maybe 5%) of Lyme patients. It is possible that these
are symptoms of cellular damage done by the infection. It is also possible that 
the infection has triggered a post-infectious immune disorder. It is also
possible that a secondary infection that is not sensitive to the antibiotics may
be at work.

And there is the possibility that a minority of cases are infected with
resistant Lyme. This possibility has not been dismissed or ignored, as is often 
charged. Rather it has been studied – the results were just negative. Therefore 
it is prudent to move onto the other hypothesis and study them.

What about patients who believe they have been helped by antibiotics? Most
readers will guess my first answer – the well known placebo effect. Also, many
of the symptoms of CLD tend to have a natural variation over time in some
patients, who will then seek treatment when their symptoms are at their greatest
and then credit the inevitable decrease in symptoms on the treatment.

But there are other intriguing possibilities. Baker points out that many
antibiotics used to treat Lyme disease also have pharmacological effects, such
as anti-inflammatory effects or effects similar to drugs used to treat chronic
neurological conditions. This may produce an actual symptomatic benefit in some 
patients. If this is true, then we can more effectively target CLD symptoms with
better and safer anti-inflammatory and neuropathic medications. So far, trials 
have not been done with these approaches.

There are many other points to be made, but this is sufficient to capture the
meat of the issue, and to set up my next point. Individual physicians treating
patients with CLD with chronic antibiotics could fall along a very long
spectrum. They could have different criteria for who qualifies for treatment.
Some may only treat category 3, and only continue treatment if there is an
objective response. While others may treatment anybody who thinks they may have 
CLD with no criteria for monitoring treatment.

With the current system of regulation, each individual practitioner could be
judged according to their practice, and individual decisions could be rendered. 
Having a minority opinion is not sufficient to be disciplined for substandard
care, and so some physicians may have looser criteria for prescribing
antibiotics and not be targeted for discipline. While there may also be those
physicians who are recklessly and dangerously prescribing antibiotics for
patients who likely have another specific diagnosis, and truly deserve to have
their practice restricted.

Under the proposed law, all such distinctions are wiped away, and there will be 
blanket protection for anyone prescribing antibiotics for CLD, not matter how
they define it and what criteria they use. This is the core absurdity of
imposing a simple law upon a complex scientific medical issue.

And as I stated yesterday – this is a rapidly moving target. There are questions
that are still being asked, and further research is likely to clarify the
situation even further. If the science moves farther and farther away from the
use of antibiotics, there is unlikely to be a grassroots lobby to reverse this
unwise law. We will be stuck with it, and the state will have lost an important 
mechanism to protect the public against possibly dangerous quacks who can then
exploit this special exemption.

Conclusion

The new CT bill, when passed into law as it almost certainly will be, is a grave
mistake. It is legislative arrogance and naivete at the same time. Yet there is
likely to be similar efforts in other states. Advocates of ideology tend to be 
more relentless and motivated than the defenders of reason.

This also reflects a broader syndrome – minority or discredited medical ideas
that persist in a cult-like fashion after they have failed the test of
scientific evidence. The emotions and thought processes that sustain these
movements are remarkably similar across a wide range of issues. What is also
distressingly similar is the use (I would argue abuse) of the political process 
to rig the game of science – to secure political victories to rectify scientific
failures. This represents a harmful intrusion of politics into science, and the
public suffers.

“Chronic Lyme” VIP Daniel Cameron disciplined by New York medical authorities

“Chronic Lyme” guru Daniel Cameron, MD, has been put on 3-year probation by New 
York medical authorities. Will fellow “Lyme literate” doctors take note?

Jann Bellamy on June 22, 2017

Link



The medical practice of “Lyme literate” guru Daniel Cameron, MD, will be closely
supervised by the authorities during a three-year probation imposed last week
by the New York State Board for Professional Medical Conduct (BPMC). The order
was based on professional misconduct charges filed against Cameron earlier this 
year.

Cameron agreed to the imposition of sanctions during administrative proceedings 
on the charges and a consent order was entered by the BPMC based on his
concession. He stipulated that

   he could not successfully defend against at least one of the acts of
   misconduct alleged. Those allegations included practicing the profession of
   medicine with negligence on more than one occasion, incompetence on more than
   one occasion, gross negligence, gross incompetence, and/or failing to
   maintain accurate patient medical records.

Who is Daniel Cameron, MD?

Cameron is a solo practitioner in Mt. Kisco, NY, and board certified in internal
medicine, but not fellowship-trained in infectious diseases and not
board-certified in that sub-specialty. He also holds an MPH and describes
himself as epidemiologist. According to his website, he:

   is a nationally recognized leader for his expertise in the diagnosis and
   treatment of Lyme disease and other tick-borne illnesses.

That is partially true. He is a “recognized leader” among those who consider
“chronic Lyme” a real disease and who treat it with long-term antibiotics,
sometimes for months to years. He is not a “recognized leader” among
board-certified infectious diseases doctors and other experts who agree that
“chronic Lyme” is not a real disease and who rely on well-conducted trials
showing that long-term antibiotics do not substantially improve the outcome for 
patients diagnosed with so-called “chronic Lyme.” Long-term antibiotics can, in 
fact, result in serious harm, including death, a subject our good friend Orac
covered just yesterday over on Respectful Insolence. The CDC, the Infectious
Diseases Society of America (IDSA), the American Academy of Pediatrics, the
American College of Physicians, the Medical Letter and the American Academy of
Neurology all reject the notion that “chronic Lyme” exists and that long-term
antibiotics are an appropriate treatment.

(Orac’s post nicely summarizes the differences between real Lyme disease and
“chronic Lyme,” “a prototypical fake medical diagnosis,” and the dangers of
long-term antibiotics, as have posts on SBM, here, here, here, and here.)

That has not stopped “Lyme literate” doctors from banding together to form the
International Lyme and Associated Diseases Society (ILADS) and issuing their own
guidelines for the diagnosis and treatment of “chronic Lyme,” guidelines based 
on very low levels of evidence that are accepted only by themselves and, in
contrast to the IDSA guidelines, no other professional medical organization.
ILADS teaches physicians and other practitioners how to become “Lyme literate,” 
although there is precious little information about the courses on the ILADS
website. ILADS, again in contrast to IDSA, is not an ACCME-accredited provider
of continuing medical education and, to my knowledge, none of its courses
qualify for continuing medical education credit. Nor are ILADS guidelines taught
as appropriate in any medical school, residency or fellowship program.

Unfortunately, according to Cameron,

   ILADS healthcare providers currently serve more than 100,000 patients with
   Lyme and associated tick-borne diseases in the USA and around the world.

Cameron is a leading light among the “Lyme literate.” He is the past president
of ILADS and is the lead author of both the original ILADS guidelines and its
2014 update. He has testified before several state legislatures promoting the
protection of “Lyme literate” doctors from prosecution by state medical boards, 
including the legislature in New York, where such a bill became law. He also
makes presentations to Lyme support groups, spreading the gospel of “chronic
Lyme.”

He has written a number of articles in the medical literature promoting the
notion that “chronic Lyme” exists and that long-term antibiotics are an
appropriate treatment, including two in the bottom-feeder journal, Medical
Hypotheses, known for its publication of pseudoscientific papers.

His bibliography includes a letter to the editor of the New England Journal of
Medicine, complaining about an article by infectious diseases experts rejecting 
“chronic Lyme” as a valid diagnosis and its “treatment” with long-term
antibiotics. The evidence, Cameron claimed, is actually in “clinical equipoise.”
This drew a sharp rebuke from the article’s authors:

   The term ‘clinical equipoise,’ used by Cameron, is difficult to justify in
   view of the published reports of five double-blind, randomized,
   placebo-controlled clinical trials that have convincingly demonstrated that
   antibiotic treatment of post–Lyme disease symptoms is not in the best
   interests of patients. Our article summarizes the consensus among clinicians 
   who practice evidence-based medicine . . .

The direct implication being, of course, that Cameron is not one “among
clinicians who practice evidence-based medicine.”

Cameron, for his part, brushes off the expert opinion of infectious diseases
doctors versus “chronic Lyme” pseudoscience manufactroversy as simply “different
points of view:”

   Only by airing these different points of view will the medical and scientific
   community reach a better understanding of controversial topics such as
   treatment of chronic Lyme disease. Meanwhile, physicians must be able to
   exercise their clinical judgment and patients should be provided with
   treatment options.

With that, let’s turn to how, in the view of the New York state medical
authorities, Cameron exercised his “clinical judgment” and provided patients
with “treatment options.”

“Clinical judgment” and “treatment options”

Apparently, New York’s medical misconduct procedures do not require the
physician charged to stipulate to any particular acts of misconduct as a
condition of settling his case. Rather, as noted, Cameron simply stated he was
unable to “successfully defend against at least one of the acts of misconduct
alleged” and agreed to the imposition of sanctions. This means the allegations
in the state’s Statement of Charges were never proven, as it was unnecessary to 
reach a decision on the factual issues once Cameron decided to settle. However, 
per the Office of Professional Medical Conduct’s (OPMC) standard procedures, the
allegations in the Statement of Charges were based on expert review of
Cameron’s patients’ records and they remain uncontested by Cameron.

The state’s allegations were based on Cameron’s care of seven patients.
According to the Statement of Charges, some of his more egregious actions
include:

  1. Continuing to prescribe narcotics to a patient diagnosed with bipolar disorder
    and narcotic abuse for two years after the patient had moved to another
    state.

  2. Failing to follow up on previous diagnostic tests and symptoms indicative of
    multiple sclerosis, “thereby depriving the patient of an accurate diagnosis 
    and years of effective therapy for her progressive disease.”

  3. Failing to appropriately and timely evaluate a patient, who suffered from
    Parkinson’s disease, when she complained of pain associated with a PICC line
    inserted at Cameron’s direction for parenteral antibiotics, which itself
    was done without an appropriate physical examination or “clinical
    re-assessments for consideration of any alternative diagnoses and/or
    treatment.”

  4. Failing to consider “other infections or inflammatory processes” in a patient 
    with a recent termination of pregnancy and diverticulitis, who had abnormal 
    lab results, including abnormal liver function tests and an elevated
    sedimentation rate, and failure to order a CT scan of the abdomen and pelvis
    as well as additional blood testing.

The state wisely avoided specifically challenging Cameron’s diagnosis of his
patients with “chronic Lyme” or his treating “chronic Lyme” with long-term
antibiotics. In fact, the term is never mentioned. In doing so, it circumvented 
the quagmire of arguing over “different points of view” and concentrated on the 
fact that Cameron quite simply failed his patients by giving them substandard
care, “chronic Lyme” or no “chronic Lyme.” This strategy also avoided any shield
which might have been provided by New York’s foolish law aimed at protecting
“Lyme literate” doctors.

Yet the fingerprints of “chronic Lyme” diagnosis and treatment show through loud
and clear in the state’s case. For each and every patient, Cameron was charged 
with:

  1. Repeatedly failing to take and/or note an adequate history of present illness.

  2. Repeatedly failing to perform and/or note an appropriate physical examination.

  3. Failing to appropriately construct a differential diagnosis and pursue a
    through diagnostic evaluation.

  4. Failing to maintain records accurately reflecting care and treatment rendered 
    to the patient.

For six of the seven, he was charged with:

   Treating patients inappropriately with an ongoing and escalating antibiotic
   regimen without appropriate sequential physical examinations and clinical
   reassessments for consideration of any alternative diagnoses and/or
   treatment.

And for four of them, according to the state, Cameron failed to follow up in a
timely fashion when the patient developed possible adverse reactions to therapy.

Two of the patients who presented with complaints of fatigue and paiwn had
previous diagnoses and treatment for Lyme disease, 9 and 16 years earlier,
fitting the “Lyme literate” notion that their current complaints are most
certainly sequelae to inadequately-treated Lyme and cannot be attributed to
other causes.

Reading between the lines, Cameron had only one tool, a hammer, so he saw every 
problem as a nail. The possibility that the patient might be suffering from
something other than “chronic Lyme” was tossed aside via inadequate physical
exams and medical records, failing to consider other diagnoses, and bulldozing
ahead with inappropriate long-term antibiotics, adverse consequences be damned.

Of course, if you think about it, substandard care and “Lyme literacy” would
appear to go hand-in-hand. It is hard to imagine the “Lyme literate” doctor, who
routinely ignores medical science in favor of unvalidated testing, makes
repeated diagnoses of a fake disease, and orders unwarranted long-term
antibiotics, otherwise delivering standard-of-care medical practice. As with the
Cameron case, this offers a way forward to state medical boards hamstrung by
laws designed to protect the misconduct that is “chronic Lyme” from disciplinary
action.

Terms of three-year probation

In entering into his probationary period, Cameron is in the company of other
“Lyme literate” doctors who have had their medical practices questioned by their
peers, up to and including discipline imposed by medical regulators (also, here
and here).

Hopefully, Cameron will be hard-pressed to continue his usual M.O. under the
terms of the Board’s Consent Order. He has agreed to practice medicine only when
monitored by a licensed physician (a “practice monitor”) who must be “board
certified in an appropriate specialty considering [Cameron’s] specialty of
practice, who is familiar with the diagnostic and treatment modalities practiced
and offered by [him].”

The practice monitor can see all of Cameron’s records and must visit his office 
“on a random unannounced basis at least monthly” and examine no fewer than 20
records. The monitor’s review is to determine whether Cameron’s medical practice
“is prudent and competent.” Any perceived deviation from prudent care or
refusal to cooperate must be reported to the OPMC within 24 hours. The monitor
must also report to the OPMC quarterly and Cameron must pay the expenses of
monitoring.

Cameron gets to propose his own monitor to the OPMC. This, coupled with the
language about familiarity with Cameron’s “diagnostic and treatment modalities,”
leaves some concern that a fellow traveler would be put in charge. The fact
that the OPMC must approve the monitor, plus the broad authority given to the
OPMC in the Consent Order to look at his records and otherwise investigate what 
he is up to, somewhat allays those concerns.

He must also, among other things:

  1. Obtain written informed consent from each patient “specifically addressing all
    aspects of treatment” and provide the OPMC with copies of his consent
    forms.

  2. Fully document all discussions with patients concerning his evaluation and
    treatment “and of the patient’s need to pursue conventional medical care
    elsewhere, if indicated.” This is of some concern as well, as it implies
    Cameron is free to provide unconventional medical care as long as he tells
    the patient she needs the conventional kind.

  3. Obtain and review medical records from physicians who previously or are
    currently treating his patients and refer patients to other physicians for
    further evaluation and treatment “where medically warranted and beyond the
    scope of [Cameron’s] role with regard to the patient.”

  4. Maintain at least $2 million per occurrence/$6 million per policy year limit
    medical malpractice insurance.

  5. Complete CME courses as directed by OPMC.

But, Legislative Alchemy

Whether Cameron’s case will prove to be a cautionary tale for other “Lyme
literate” doctors remains to be seen. Even as one branch of state government
successfully prosecutes a “Lyme literate” doctor, another branch, the
legislature, is considering forcing insurers to cover treatment of “chronic
Lyme,” the subject of no less than three bills now pending. (Assembly Bill 114, 
Senate Bill 4713, Senate Bill 670). Three other bills are sympathetic to the
cause in that they will give “chronic Lyme” advocates yet another venue to argue
for insurance coverage. (Assembly Bill 4863, Senate Bill 2168, Assembly Bill
6927). Pseudoscience, it seems, is endemic in the state of New York.

Quack Protection Acts advance in state legislatures

Proposed laws in Wisconsin and Massachusetts would protect quacks who defraud
patients with useless, and sometimes dangerous, nostrums, by essentially
allowing them to practice medicine without a license. These Quack Protection
Acts should not pass.

Jann Bellamy on December 2, 2021

Link



Today, for reasons that will become apparent in a moment, we begin with a look
at the website of Rosanne Lindsay, a Wisconsin naturopath who uses the initials 
“N.D.” (Naturopathic Doctor) after her name even though she graduated from the
Trinity College of Natural Health. Trinity is an unaccredited (by any agency
recognized by the U.S. Department of Education) online school where one can
become a “Certified Traditional Naturopath” after a 16-week course. The clinical
component of the course, also conducted online, involves the evaluation of two 
(yes, two) patients of one’s choice. The only requirements for entry into the
naturopathic program are a high school diploma and completion of two
prerequisite Trinity programs totaling 76 hours. (To give you a flavor of the
quality of Trinity’s programs, Trinity also offers certifications in quack
practices like homeopathy and iridology.)

So, for far less than the number of hours the average medical student would
spend in class or a clinical setting in a few weeks of education and training,
one can complete the entire Trinity naturopathic program, including
prerequisites, without the pesky college degree, MCAT, 4 years of medical
school, multi-year residency, U.S. Medical Licensing Exam, and other such
requirements designed to ensure that those who diagnose and treat people are
competent to do so.

Despite this modest, and highly questionable, education, Lindsay, who also
advertises herself as a herbalist, apparently feels qualified to diagnose and
treat thyroid disease. She has even authored a book that claims one can “reverse
thyroid disease naturally”. She advises that

   You don’t have to take a hormone for the rest of your life. Synthetic
   hormones block communication between all the glands of the endocrine system. 
   Simply come back into balance and your thyroid come [sic] back online to make
   its own.

How? Lindsay

   uses Applied Kinesiology to access information to identify nutrient
   deficiencies and toxicities, and to create custom herbal tinctures as part of
   a custom 8-week protocol. In addition to replenishing lost minerals, healing
   foods and medicinal teas are recommended to help cleanse and support the
   liver, kidneys, colon, and lymph. Yoga and meditation or other energy healing
   modalities may be suggested to enhance your plan to bring you back into
   balance.

Applied kinesiology is rank quackery and this is dangerous advice for anyone
actually suffering from thyroid disease, who should be under the care of, at the
least, a primary care physician and in some cases a specialist, such as an
endocrinologist. Naturopaths should not try to treat endocrine disorders.

Lindsay’s nonsense about thyroid disease is bad enough, but where she really
excels in scientific gobbledygook is in her rants about COVID which, she claims 
“is not a true virus, nor is it infectious”. Masks are therefore unnecessary and
are really “a test to see who follows orders for the new Global Reset“, a truly
bizarre conspiracy theory involving the UN and “world governments” whose agenda
is “to remove inherent rights if the people consent to immoral dictates”, which
include, in her mind, public health measures designed to control the spread of 
COVID.

She appears to believe (it’s hard to follow) that the introduction of radios in 
the early 1900s was the real cause of the 1918 influenza pandemic (which was
actually healed with homeopathy, according to her) and the rollout of 5G is just
déjà vu, with the powers-that-be pretending that a new virus is the cause of
illness, when it is actually “radiation poisoning”. Also, there are nanobots in 
COVID vaccines which can be deployed for nefarious purposes. And so on.

You would think that the good folks elected to the Wisconsin Legislature would
be appalled by such threats to the public’s health and doing all they could to
protect Wisconsonites from practitioners such as Lindsay.

But, no, they are not. Unfortunately, since I last wrote about the topic in
April, bills in Wisconsin (and Massachusetts, as you’ll read below) have
advanced and the Wisconsin Legislature appears dangerously close to passing a
new law that protects “complementary and alternative health care practitioners” 
like Lindsay and leaves them free to treat thyroid disease and other serious
conditions.

Lindsay is, in fact, the president of the National Health Freedom Coalition
which, along with its sister organization, National Health Freedom Action,
advocates for the passage of so-called “health freedom” laws or, as I prefer to 
call them, Quack Protection Acts, because what they really do is protect quacks 
from prosecution for the unlicensed practice of medicine and other regulated
health care professions, like psychotherapy and midwifery. Her COVID diatribes
are no surprise, given that these organizations are rabidly anti-vaccination and
heavily promote bills designed to handicap public health officials in fighting 
infectious diseases like COVID.

The quack bills

Wisconsin defines the practice of medicine as

   examin[ing] into the fact, condition or cause of human health or disease, or 
   to treat, operate, prescribe or advise for the same, by any means or
   instrumentality.

Practicing medicine without a license can result in a fine of up to $10,000 and 
imprisonment of up to 9 months. The state can also issue a cease-and-desist
order to halt unlicensed practice. This gives you some idea of the seriousness
with which the state of Wisconsin regards unlicensed practice, at least until
now.

Lindsay’s unconventional (to put it nicely) advice regarding the cause of, and
her treatments for, thyroid disease fall within the definition of the practice
of medicine, potentially subjecting her to a cease-and-desist order, a
substantial fine, and jail time. But if Wisconsin Assembly Bill (AB) 86 passes, 
that will no longer be the case (as long as she follows a few easily-met
requirements) and the state will be powerless to stop her and others like her.

The great irony here is that, should a medical doctor diagnose and treat thyroid
disease like Lindsay does, he or she would be subject to discipline for falling
below the standard of care, especially if the patient was harmed.

AB 86 is the Assembly’s version of Senate Bill (SB 98), which already passed the
Senate, leaving the Assembly’s vote the last stop before the Governor’s desk. A
public hearing before the Assembly Committee on Health was held in July but the
Committee has yet to vote on the bill, which has many co-sponsors. There’s
plenty of time left, however, as the AB 86 will carry over to the 2022
legislative session.

Sadly, only the Wisconsin Association of Marriage and Family Therapists actually
showed up to testify in person against the bill, although the National
Association of Social Workers filed written testimony opposing it and the
Wisconsin Council on Mental Health suggested amendments to protect mental health
patients. The Wisconsin Nurses Association registered its opposition but did
not provide testimony. Otherwise, the medical community was AWOL, at least as
far as the Legislature’s website shows.

Lindsay herself testified in favor of AB 86, where she told the Committee that

   As a group, we naturopaths and other holistic practitioners, remain
   unlicensed simply because we do not cause harm in what we offer.

That is patently untrue. Naturopaths and “holistic practitioners” can, and do,
cause plenty of harm, a subject we’ve covered many times here on SBM.
Unfortunately, this false premise ran through much of the supporting testimony: 
that complementary and alternative practitioners use only “safe” and “gentle”
treatments, which are somehow also tremendously effective.

Typical of other “health freedom” bills, AB 86 offers unlicensed “complementary 
and alternative” health care practitioners a “safe harbor” from prosecution for 
violating any licensing law (such as engaging in unlicensed practice) as long as
the practitioner follows certain procedures and does not engage in prohibited
activities, most of which, like taking x-rays, they aren’t interested in anyway.
In this, the bill essentially allows an unlicensed practitioner to practice as 
if he or she were actually a licensed health care professional if they stay
within these parameters, the details of which we’ll get to in a moment.

Considering that “alternative medicine” is, by definition, used as an
alternative to “conventional” medicine, the bill specifically contemplates that 
the public will see these unlicensed practitioners to treat their medical
problems, no matter how serious, without the benefit of competent medical
advice. In fact, the bill nowhere requires that the unlicensed practitioner
recommend that his “client” (which is what the practitioner’s patients are
called) seek medical advice, no matter how dire her condition, and a suggestion 
that the bill be amended to add a referral requirement was shot down by the
“health freedom” crowd and failed to make it into the final version.

In addition to medicine, the bill covers, among others, nursing, dentistry,
midwifery, respiratory therapy, pharmacy, speech pathology, all mental health
professions (including psychotherapy and marriage and family therapy), and
optometry. Thus, as I read the bill, not only could complementary and
alternative practitioners treat disease, they could also deliver babies,
dispense drugs (in the form of herbs), fix your teeth, examine your eyes, and
treat even the most difficult mental disorders, as long as they are otherwise in
compliance with the proposed legislation.

A “complementary and alternative health care practitioner” is defined in the
bill as an unlicensed practitioner who offers “complementary and alternative
health care services”, that is, any “health care practice or method of healing
therapy or modality” not prohibited by the bill. Prohibited acts include
surgery, setting fractures, skin punctures “except by pricking a finger for
purposed of blood screening”(for which no education or training is specified),
x-rays, prescribing drugs, chiropractic adjustments, recommending that a client 
discontinue medical treatment and making “a diagnosis of a medical disease other
than a general assessment regarding normal structure or function in humans”.

[A proposed amendment changes this to “make a diagnosis of a medical disease or 
mental disorder” but “does not prohibit a complementary and alternative health
care practitioner from responding generally to a client’s expressed concerns”. I
cannot tell whether the Committee voted to include this change in the bill.]

It is not clear that the prohibition against making a diagnosis of a “medical
disease” would include quack diagnoses like adrenal fatigue and leaky gut.
Curiously, if not for diagnosis of a disease, why does the bill permit “blood
screening”? In any event, how hard could it be for the unlicensed practitioner
to shoehorn his “diagnosis” into the catchall “general assessment regarding
normal structure or function”. (Just look at what dietary supplement companies
have done with their limitation to “structure and function” claims.)

Luckily for the unlicensed practitioner, if a diagnosis has already been made by
an actual medical professional, he is free to treat the disease or condition
without limitation, including cancer, severe mental illness, neurological
diseases like MS and ALS, allergies, asthma – you name it – with no prohibitions
on the age or medical condition of the patient.

The bill specifically permits obviously fraudulent practices like craniosacral
therapy, “detoxification“, healing touch, homeopathy, polarity therapy, and
reflexology. Also allowed are potentially dangerous practices like Ayurveda,
traditional naturopathy, and “healing practices” using food, supplements, and
nutrients, as well as herbalism. These are listed by way of example only, the
sole limitation being the imagination of a charlatan and whatever nostrums he or
she might cook up.

There are a few other low-bar prohibitions, like taking kickbacks and sexual
contact with a client. And, just to show how committed to public safety the
Legislature is, anyone who is convicted of a felony, but has not completed his
sentence, is prohibited from being a complementary and alternative health care
provider. Anyone who is convicted of a felony “relat(ing) to providing health
care” is barred altogether. So, if you’ve committed, I presume, felony Medicare 
fraud, you’re barred, but not if you are a convicted of, for example, sexual
assault, wire fraud, child endangerment, or, for that matter, homicide, as long 
as you’ve completed your sentence.

There is one prohibition that could potentially prove problematic for unlicensed
practitioners. They cannot

   falsely advertise or provide false information about the complementary and
   alternative health care practitioner’s degree, training, experience, or other
   qualification or about a complementary and alternative health care service.

It appears impossible to practice complementary and alternative health care
without providing false information. And the provision seems totally incongruous
when the bill specifically allows practices, like craniosacral therapy and
homeopathy, that are based on falsehoods, leaving me wondering how it would be
enforced.

Finally, the bill requires disclosures to clients of information like the fact
that the unlicensed provider is, well, unlicensed, as well as fees and any
degrees, training, experience, or qualifications he holds, no matter how
pathetically inadequate they are. (No education or training is actually
required, it’s just that you have to disclose it if you have them.)

The practitioner is not required to record the client’s complaint, diagnosis,
prognosis, treatment plan, or results. Although the client is entitled to

   complete and current information concerning the . . . practitioner’s
   assessment of the client and the recommended complementary and alternative
   health care service that is to be provided, included the expected duration of
   the service and access to the client’s records and written information in
   the client’s records

This information doesn’t have to be in writing or recorded in the client’s
records; only “the nature of the . . . service to be provided” must be written.

There are penalties for violations. The state can “request” that the unlicensed 
provider “correct” the violation. For other than failure to follow the
disclosure requirements, the state can issue a cease and desist order and assess
a fine of up to $10,000.

While better than nothing, this falls far short. Why? Well, remember, per this
bill:

  1. Any charlatan (convicted felons included), with no medical education or
    training whatsoever (or, education and training that does more harm than
    good) is allowed to treat any disease or condition, no matter how serious,
    in any patient of any age, with supplements, herbs, “energy” therapies,
    homeopathy, and whatever other quack remedies he or she can dream up.

  2. Mentally, physically, or financially harming clients, even repeatedly, is not 
    itself a violation and not subject to enforcement.

  3. There is no requirement that practitioners suggest the client seek medical
    attention or refer cases to a competent practitioner.

Within these liberal parameters, far too much harm can be done and the state
will be powerless to stop it.

A similar Quack Protection Act is pending in the Massachusetts General Court
(the state’s legislature) only these bills provide even fewer guardrails than
Wisconsin bill. (Because of these similarities, I won’t discuss the bills in
detail.) House Bill 2343 and the companion Senate Bill 1380 allow the practice
of “complementary and alternative health care”, defined as anything that is not 
prohibited in the bill, which is not much: surgery, using radiation and
fluoroscopy, prescribing drugs, providing a medical diagnosis or chiropractic
adjustment or massage therapy, or pretending to be a licensed health care
provider. That’s it. Other than these, apparently anything goes, again limited
only by a charlatan’s imagination.

The Massachusetts bills also have similar disclosure requirements, only fewer of
them. For example, no disclosure about fees is necessary. There are no
prohibitions against sexual misconduct or the like, and (like Wisconsin, but
worse) any felon (apparently even while serving his or her sentence) can set
him/herself up as a practitioner. There is no enforcement mechanism and
apparently the state can do nothing to curb quackery if these bills pass, no
matter what physical, mental, or financial harm occurs.

A hearing before a joint Senate-House Committee was held on October 15th, along 
with several dozen other bills. It does not appear that the Committee has voted 
but, again, there is plenty of time left.

In my view, no one who is not properly educated and trained should be allowed to
“assess” or treat anyone in need of medical care at all, ever, and certainly
the state should not have any part in facilitating obviously fraudulent health
care practices.

    2. In what other profession or industry is this tolerated? None, to my
      knowledge. We do not permit unregulated banks run by people who have no
      education or training in finance to hold deposits, make loans, operate
      without audits, and so on, based on the fiction that they are providing
      “complementary and alternative” banking services. We do not permit
      unlicensed lawyers who didn’t go to law school or pass the bar to give
      legal advice, represent clients in court, and draft contracts and estate
      plans, based on the fiction that they are providing “complementary and
      alternative” legal services. We do not permit unregulated utility
      companies run by people untrained in the safe provision of these public
      services to offer electricity, gas, sewage treatment, and water to the
      public based on the fiction that they are providing “complementary and
      alternative” utilities. Ironically, we only allow this harmful nonsense in
      the one area that people value most: their health.

The war on the science-based regulation of medicine accelerates

Last week, it was reported how increasingly there is a war on the science-based 
regulation of medicine and physicians. It’s an old story, but unfortunately the 
forces arrayed against science-based policy have been emboldened by the pandemic
and an stronger alliance with political groups that are against government
regulation in general.

David Gorski on October 31, 2022

Link



   You really think it’s all new.You really think about it too,The old man
   scoffed as he spoke to me,I’ll tell you a thing or two.

                                              The Clash, Something About England

Add this as another chapter to a series that I really should have called
“Everything Old Is New Again”, even if the title grates a bit, coming across as,
“We told you so”. I’ve long written about how there’s a war against
science-based regulation of doctors’ practice by the states, just as there’s a
war against science-based policies regarding drug approval, vaccine mandates,
and public health. This war predates the pandemic, and not by a little. For
example, previously I wrote about how autism and cancer quack Dr. Rashid Buttar 
had mobilized public support to neuter the North Carolina Medical Board and
prevent it from disciplining doctors who practice quackery associated with
“integrative medicine”. This happened 13 years ago. Since then, this war on the 
regulation of medicine has only accelerated, as I’ve described before a number
of times. Unfortunately, last week it became increasingly clear that this war is
only accelerating, and it involves old school antivax physicians who have taken
advantage of the rise of what I like to refer to as the “new school”
antivaxxers who only started promoting antivaccine propaganda after the
introduction of COVID-19 vaccines nearly two years ago. It’s gotten to the point
where “new school” antivaxxers are becoming increasingly indistinguishable from
“old school” antivaxxers.

What reminded me of this is a story published last week in Vice by Anna Merlan, 
“Crank Doctors and Their Allies Are Ready for War With the Medical
Establishment“. Think of it as Dr. Rashid Buttar calling the North Carolina
Board a “rabid dog” 15 years ago when it tried to discipline his “unprofessional
conduct” related to his cancer and antivaccine autism quackery, but
nationalized and backed by political organizations dedicated to the weakening of
government regulation. Before I discuss Anna Merlan’s story and put it into
context in my inimitable fashion, let me just go back and quote what Dr. Buttar 
said in 2007, quoted by The Charlotte Observer and other newspapers:

   Armed with complaints from Kenny and three others, the state board accuses
   Buttar of unprofessional conduct for departing from prevailing medical
   practice by treating patients with experimental, ineffective therapies and
   charging “exorbitant” fees.

   A public hearing is set for Feb. 20, after which the board could reprimand
   the doctor or revoke, suspend or put limits on his license.

   Buttar, 41, who has tangled with the board before, denies wrongdoing and vows
   to retaliate.

   “I’ve been itching for a fight,” he said. “I’m going to make this into a huge
   thing. … I told the (state) legislature that the medical board was a rabid
   dog, and they needed to put it down.”

Also, I’ll remind you of the sort of quackery that Dr. Buttar practiced—and
still practices:

   But Buttar believes most patients with cancer also have high levels of heavy 
   metals, such as mercury, and other toxins, such as pesticides, because of
   environmental exposure.

   “Chelation works for the right things,” he said. “It’s not a panacea. But it 
   works phenomenally well for chronic disease.”

   Buttar’s practice also has two hyperbaric oxygen chambers — and more on the
   way. The treatment, which floods the body with oxygen, is commonly used to
   accelerate wound healing. But Buttar uses it to fight cancer because, he
   says, cancer cells can’t thrive in an oxygen-rich environment.

   He acknowledges most of his treatments have not been proven by standard
   means, such as controlled clinical trials. But he said they have been
   effective in his practice over 10 years.

The story notes that Dr. Buttar’s therapy for cancer patients ranged from
$40,000-60,000 for two months, and, of course, he didn’t take insurance. (Sound 
familiar? The grift continues, and Buttar is now one of the “Disinformation
Dozen“.) Unfortunately, Dr. Buttar’s practice and his war against the North
Carolina Medical Board (which he mostly won) was a precursor of what we are
seeing today. Basically, he got a slap on the wrist, being temporarily
restricted from treating cancer patients and children. The medical board did not
do what was really warranted, strip him of his medical license, or, as I
described what I thought that he deserved at the time in 2008, “having his
medical license stripped from him, cut up in front of his face, and then the
fragments ritually burned”.

“You really think it’s all new”

In her article, Merlan reports about two state medical boards, the ones in Ohio 
and Maine, that are attempting to rein in two different “old school” antivax
quacks, Drs. Sherri Tenpenny (who referred to vaccines as “transhumanism” two
years before the pandemic and now characterized COVID-19 vaccines as a “method
of mass destruction” while claiming that they could magnetize recipients to the 
point where silverware would stick to them) and Meryl Nass, who used to spread
antivax nonsense about Ebola but has pivoted to fear-mongering about COVID-19
vaccines.

As Merlan notes:

   “Once I realized I was being used as a poster child in a national fear
   campaign designed to purge doctors who think independently, I decided to
   fight back,” Nass wrote in a recent blog on Substack. “Fortunately,
   Children’s Health Defense is helping with my legal expenses, which is what
   allows me to mount a strong defense against the bulldozing of free speech,
   patient autonomy and choice, and the doctor-patient relationship. There is a 
   lot riding on the outcome.”

   In one sense, Nass is correct: What’s happening to her and Tenpenny is part
   of a much larger trend, and a brewing, culture-wide showdown. State medical
   boards and certification bodies face growing pressure to take action against 
   crank doctors, and more and more often, they’re heeding that call. This
   summer, Kory and Peter McCullough, who have both loudly advocated for
   discredited COVID treatments, said they were at risk of losing their board
   certification from the American Board of Internal Medicine. California
   governor Gavin Newsom recently signed a new law that will make doctors
   subject to professional discipline if they repeat “false or misleading”
   medical information to their patients. And the Federation of State Medical
   Boards recently issued a strongly worded statement and a position paper on
   the problem of physicians spreading medical misinformation, and the
   consequences they should face.

It is, of course, nothing new that “brave maverick doctors” (a.k.a. quacks)
always portray attempts to discipline them, stop them from committing fraud by
misrepresenting ineffective treatments as miracle cures, or otherwise prevent
them from endangering patients and others as “tyranny”, “persecution”, and
“attacks on free speech”, all while portraying themselves as victims in order to
rally support from their supporters (and, of course, raise money). Examples are
legion and include the aforementioned Rashid Buttar, as well as cancer quack
Stanislaw Burzynski and antivax pediatricians “Dr. Bob” Sears and Dr. Paul
Thomas. Indeed, among antivaxxers it’s a strategy pioneered by the godfather of 
the modern antivaccine movement, Andrew Wakefield when he was struck off
(delicensed) in the UK.

So what’s different now? Before the pandemic, quacks and antivaxxers did indeed 
use investigations and disciplinary actions by state medical boards and the FDA 
as a tool for fundraising and firing up their supporters. Dr. Buttar even
managed to use the disciplinary actions against him in order to rally support to
get the law in North Carolina changed to make it far more friendly to quacks.
In retrospect, Buttar’s success against the “rabid dog” of the North Carolina
Medical Board was a harbinger of things to come. All that was needed was a
global pandemic that anti-regulation and anti-government political forces were
able to successfully weaponize against laws that empower state medical boards
and other regulatory bodies to regulate the practice of medicine, resulting in
this:

   Anti-vaccine organizations and public figures have proclaimed that they’re
   outraged by these actions, saying they infringe on free speech and the
   privacy of the doctor-patient relationship. But they also quite clearly see
   an opportunity, taking this moment as a chance to grandstand, promote more
   COVID misinformation, turn the reprimanded doctors into martyrs for free
   speech, and, above all, fundraise.

   And they have powerful allies, like Wisconsin senator Ron Johnson, who
   recently told an anti-vaccine audience he’s in a “guerilla war” against the
   medical establishment and what he called “woke doctors.” (Johnson complained 
   those doctors “will not question authority, don’t have the courage and
   compassion to practice medicine. They just follow orders.”)

   There are also clear signs that medical boards trying to sanction crank
   doctors is becoming the next major culture war fight. In several states,
   legislation has been introduced that is aimed at limiting medical board power
   or explicitly allowing “off-label” treatments—that is, things like
   ivermectin and hydroxychloroquine— for COVID. (The prescription of drugs
   outside their intended use, it should be noted, is incredibly common. It’s
   difficult to imagine what a regulatory regime that would still permit it
   while barring discredited COVID treatments would look like.)

   Meanwhile, some medical experts say what medical bodies are doing to respond 
   to the problem of crank doctors isn’t enough.

   “At this point, I’m disappointed and I’m just pissed,” Nick Sawyer told
   Motherboard. He’s a co-founder of No License for Disinformation, which was
   founded to respond to the problem of doctors promoting COVID and vaccine
   misinformation.

Dr. Sawyer is a mensch, and I commend him for taking this fight on, given the
threats and abuse that have been aimed at him since he started trying to shame
state medical boards into actually protecting the public from quacks promoting
COVID-19 misinformation, quackery, and antivaccine views under their MDs and
DOs.

It’s also interesting that Sen. Ron Johnson figures so prominently. Actually, it
isn’t.

From “right-to-try” to COVID-19 quackery

Sen. Ron Johnson is actually a key figure here, but not because over the last
three years he has become fully antivaccine. Before the pandemic, I used to
write about him in the context of promoting a federal “right-to-try” law. I used
to write fairly frequently about “right-to-try” laws, which were passed in many
states (including, unfortunately, my own), before Sen. Johnson spearheaded a
federal right-to-try law, which ultimately passed. In brief, “right-to-try”
promises to help patients by allowing patients with terminal illnesses access to
experimental therapeutics that have only passed phase 1 clinical trials. I long
described these bills and laws as a sham, because (1) phase 1 trials are the
barest minimum of safety trials that usually only include less than 50 patients;
(2) the federal government (through the FDA) regulates drug approval, not
states; (3) there was nothing in these laws that helps patients actually pay for
what are often very expensive treatments; and (4) there was nothing to help
drug companies actually comply with such requests, given that often experimental
drugs are made in small batches just large enough for the clinical trials
needed to gain FDA approval. Between Sen. Ron Johnson and then-Vice President
Mike Pence, unfortunately, a federal version of “right-to-try” did become law.
It has been a miserable failure so far, even at achieving its stated goals.

Along with other things, right-to-try did, however, lay the groundwork for laws 
being proposed to protect COVID-19 quacks for promoting antivaccine
disinformation and prescribing ineffective treatments like ivermectin and
hydroxychloroquine, which I’ve likened to acupuncture. Moreover, right-to-try
comes from the same DNA as efforts by quacks before right-to-try was ever a
glimmer in the eye of the political flacks at the Goldwater Institute. Its
purpose was to defang the FDA and greatly weaken its ability to regulate drug
approval and to create legal uncertainty.

State medical boards, old school antivaxxers, and new school antivaxxers

Sherri Tenpenny and Meryl Nass are, without a doubt, what I would refer to as
“old school” antivaxxers in that they had been antivax quacks for a long time
before the pandemic. Indeed, Merlan notes as much about Tenpenny in this
hilarious passage:

   Nor are vaccines, by any measure, a new preoccupation for [Tenpenny]: During 
   remarks made aboard a 2016 cruise for conspiracy theorists, which I attended,
   Tenpenny downplayed the risks of measles—a disease that can be deadly—to
   young children while advocating against MMR vaccines. She also told her
   audience that, in general, they shouldn’t need to be vaccinated as long as
   they avoided “filth countries,” a phrase that has lodged immovably in my
   memory.

At the time, I referred to it as the “Woo Boat,” and it featured a veritable
rogues’ gallery of cranks, quacks, and antivaxxers, including not just Tenpenny 
but Andrew Wakefield, who held forth in various lectures and panels on topics
like:

   GMOs, Monsanto, bee colony collapse, ecology, global warming, climate change,
   fracking, HIV, autism, big pharma, medical suppression, vaccinations,
   flouridation, political corruption, government corruption, forbidden
   archeology, forbidden religion, Federal Reserve, truth about money, World
   Bank, IRS, strawman, property title, admiralty law, martial law, Bohemian
   Grove, Skull and Bones, JFK, cover-ups, September 11, Star Wars agenda,
   nuclear plants, chemtrails, HAARP, crop circles, IRS, MK-Ultra, Fukashima,
   NASA, NSA, Bilderbergs, sustainability, military industrial complex,
   pentagon, Waco, Malaysia 370, Pan Am 103, TWA 800, Gulf Oil Spill,
   Halliburton, Obama, Ruby Ridge, OK City, Vatican, New World Order, false
   flags, Montauk, privacy, surveillance, Area 51, Dulce, Project Rainbow, Nazi 
   Bell, Vrill, U.S.S. Eldridge, Iron Mountain, psyops, population mangement,
   subliminal ads, Nibiru / Planet X, Cointel Pro, technology suppression,
   entity possession, electoral fraud, identity chips, 2nd amendment, and so
   much more.

It was therefore no surprise that, when COVID-19 vaccines received emergency use
approval (EUA) by the FDA in December 2020, antivaxxers like Tenpenny and Nass 
repurposed their old antivaccine narratives to the task of demonizing the new
vaccines and spreading as much fear and distrust about them as they could. It’s 
also not surprising that they immediately embraced unproven treatments for
COVID-19 over vaccines, such as ivermectin:

   The medical board began investigating [Nass] after she prescribed
   hydroxychloroquine and ivermectin to a COVID-positive family of three – two
   parents and their adult son– charging that she failed to follow proper
   standards of care. All three people ultimately ended up in the hospital; a
   concerned doctor who treated one of them made a report to the medical board. 
   Separately, a midwife reported Nass’ conduct to the board in December, saying
   that earlier in the year, one of her pregnant clients tested positive for
   COVID and said she was prescribed hydroxychloroquine by Nass. A progress note
   that Nass wrote on September 21 for the patient contained, according to the 
   board, “no patient history, no physical examination, no medical
   decision-making, no patient informed consent, no coordination of care, and no
   recommended follow-up.”

We in the medical profession have it drilled into our heads from the first day
we set foot on the hospital wards as bright-eyed and bushy-tailed young medical 
students that if it isn’t documented in the chart it is assumed not to have been
done. Even if you don’t think that Nass did anything wrong in the latter case
described above (obviously, my assessment is that she practiced grossly under
the standard of care to the point of medical malpractice), I can’t help but note
how she shares something I see in a lot of quacks: A sheer sloppiness in her
approach to medical documentation that would be, in and of itself, a danger to
patients even she were practicing perfectly defensible science-based medicine. I
noted that sort of sloppiness from Dr. Bob Sears in his clinic notes when the
California Board of Medicine disciplined him. As a physician myself, I see
passages like the one above and wonder: Doesn’t Nass ever worry about getting
sued? After all, the best protection against a malpractice suit is rigorous
documentation of everything you do treating patients. Apparently malpractice
suits aren’t a concern.

But I digress.

Let’s look at a “new school” antivax physician who is mentioned in this article 
as well, Dr. Peter McCullough, along with Peter Kory and Robert Malone. The
reason I mention this is because, soon after Merlan’s article was published I
started noticing a lot of Substack posts and social media outrage from
antivaxxers about the Texas Medical Board trying to discipline Dr. McCullough.
For instance, Steve Kirsch wrote a Substack yesterday titled “Dr. Peter
McCullough is being progressively stripped of his medical credentials“, ranting:

   Peter McCullough is an author of 677 articles published in the scientific
   peer-reviewed journals. He’s one of the most respected cardiologists in the
   world. He’s been right about everything throughout the pandemic. He has an
   encyclopedic memory of every paper he’s ever read. And he’s just a wonderful,
   nice person to boot. You really never met a nicer guy.

   He’s sacrificed everything so he can speak the truth about the COVID
   policies. If there was one COVID advisor that the government should be
   listening to, Dr. Peter McCullough would be at the top of every list.

Personally, I like to mention McCullough as an example of a doctor who might
have seemed legitimate taking a sudden crank turn, and indeed he’s featured in
SBM for his conspiracy theories and misinformation, including parroting of old
antivax tropes like “depopulation” by vaccines and weaponizing the medical
literature to attack COVID-19 vaccines.

What brought him into the narrative (again) of antivaxxers this week is that he 
was apparently fired as a journal editor, as Dr. Paul Alexander rants in a
Substack titled “Dr. Peter McCullough, leader of freedom movement, top global
cardiologist, stripped of medical licenses & credentials by Texas medical
boards; why? he spoke of early treatment & danger of the vaccine“:

   I know Peter personally and know what he has gone through. He is being
   attacked and smeared and slandered because he stood against the fraud COVID
   vaccines and he pioneered early treatment with Zelenko. He was the senior
   author on many of the early treatment papers and algorithms we wrote and he
   was very gracious asking me to write a follow-up paper as senior author, but 
   always he led with Dr. Risch and Dr. Oskoui, Dr. Fareed, and Dr. Zev Zelenko 
   was senior scientist…

And:

   Dr. McCullough is a cardiologist and was vice chief of internal medicine at
   Baylor University Medical Center and a professor at Texas A&M University.
   McCullough is editor-in-chief of the journals Reviews in Cardiovascular
   Medicine and Cardiorenal Medicine. He was and is an advocate for early
   COVID-19 treatment that included hydroxychloroquine.

   “I was terminated as the Editor-In-Chief of Cardiorenal Medicine and Reviews 
   in Cardiovascular Medicine after years of service and rising impact factors. 
   There was no phone call, no board meeting, no due process. Just e-mails or
   certified letters. Powerful dark forces are working in academic medicine to
   expunge any resistance to the vax.

I can only say: Good! Why any journal that wished to remain even the least bit
reputable would keep someone like McCullough on as its editor after his
promotion of ivermectin and the idea that COVID-19 vaccines are causing a
“holocaust”, I don’t know. The odd thing is that he was apparently terminated in
March; it’s interesting how these narratives keep resurfacing at “convenient”
times, such as now, when the Texas Medical Board is investigating him.

The Wheel of Time

   The Wheel of Time turns, and Ages come and pass, leaving memories that become
   legend. Legend fades to myth, and even myth is long forgotten when the Age
   that gave it birth comes again.

                               Robert Jordan, The Wheel of Time series of novels

I’ve long written about the battle between those who want to weaken the
scientific standards behind medical practice and hamstring federal and state
regulatory bodies that try to protect the public from quackery and dangerous
medical misinformation. It used to be that we would argue against moves to make 
“integrative medicine” quackery respectable and off-limits to such bodies or to 
weaken the FDA with ideologically-inspired laws like “right-to-try”. Before
“right-to-try”, I would argue that, although these efforts were dangerous to
patients, it was still a relatively small group of doctors and ideologues
pushing them. Then came right-to-try, which rallied libertarian-leaning
anti-regulation advocates in many states to bring pressure on the federal
government. Ultimately, as ideology “right-to-try” succeeded because of its
message, even if as policy it has failed utterly. State after state passed
right-to-try laws, and ultimately, when Republicans controlled the Presidency
and both houses of Congress, a federal “right-to-try” law passed. However,
policy was never the interest of those promoting right-to-try. Weakening the
FDA’s drug approval regulatory apparatus was, which is where right-to-try
succeeded in its intended purpose.

Now, as Anna Merlan notes:

   This is, of course, of a piece with the politics of the moment: The states
   trying to legalize or formalize the use of drugs like ivermectin are largely 
   conservative-leaning ones, where denying the reality that Donald Trump lost
   the last election brings political advantage. If Republican politicians get
   the sense that standing up for quackery and against the basic processes of
   the administrative state is a useful wedge issue, there’s no reason to think 
   more of them won’t join in. And in the meantime, the ivermectin and
   hydroxychloroquine discourse is leading to increasingly weird, bizarre and
   [sic] worrying real-world encounters. Last December, the president of the
   California medical board said she was followed and harassed by people
   belonging to America’s Frontline Doctors, four of whom confronted her in a
   dark parking garage and followed her to her home. (The incident ended without
   physical violence.)

Back when I first started writing about the antivaccine movement, roughly 20
years ago, the stereotype of the typical antivaxxer was that of a hippy-dippy
granola-crunching lefty. That stereotype was never really accurate, as there has
always been a right-wing presence in the antivaccine movement and evidence from
a decade ago strongly suggested that antivaccine beliefs were roughly equally
prevalent among conservatives and liberals. However, over the last decade, there
has been a strong political shift in the antivaccine movement to the right, and
it is no longer even possible to argue rationally that the antivaccine movement
hasn’t aligned itself with conservative/libertarian, even far-right, political 
movements. It’s a process that picked up steam in 2015 when, during the fight to
pass California SB 277, a law that banned nonmedical exemptions to school
vaccine mandates, antivaxxers hit on a message that attracted conservatives who 
distrusted government and, especially, government regulation, namely resistance 
to vaccine “mandates”, which were characterized as an unacceptable assault on
“freedom” and “parental rights”.

As I like to say, “Come for the ‘freedom’; stay for the antivaccine conspiracy
theories and pseudoscience”. The end result is that conservatives who had allied
with antivaxxers to oppose the “government overreach” of vaccine mandates were 
steeped in antivaccine conspiracy theories and pseudoscience, and many of these 
new recruits started to believe them. Then came the pandemic.

Now, as Merlan observes:

   There’s a strong reason to think that all of this is just beginning, and that
   the endgame here is not just to question reality, but to bend it into a
   shape more favorable to the COVID deniers and the broader pseudomedical
   universe they’re part of. Part of the strategy for getting there is to force 
   loud, public showdowns between these two versions of the world. Medical
   boards records show that after Nass prescribed hydroxychloroquine to her
   COVID patient and lied to a pharmacist to get it, she reported what she’d
   done herself.

I would add this twist. I now tend to characterize the antivaccine movement as
the dog who actually caught the car. It won over a large segment of the right
that now includes much of the GOP and pundits like Tucker Carlson, who was lying
about the CDC Advisory Committee on Immunization Practices (ACIP) just a couple
of weeks ago. As a result, however, it’s no longer running the antivax show.
Rather, the antivaccine movement appears to have been absorbed by a much larger 
enterprise, one that opposes public health interventions, including vaccines,
but also wants to weaken or eliminate all the systems in place to regulate
physicians and the practice of medicine.

Unfortunately, this is not a new movement. We as a nation have been here before.
The first medical licensure law in the US, the Medical Practices Act, was
passed by the state legislature of New York in 1806. The act empowered the state
to license practitioners, meaning that only licensed physicians could recover
their fees in courts. The act also fined unlicensed practitioners $25.00 for
practicing without a license. Other states soon passed similar laws, which
immediately ran into serious resistance from practitioners of Thomsonian
medicine, a kind of herbalism founded by Samuel Thomson.

The history of Samuel Thomson and Thomsonian medicine is quite interesting. In
brief, it was the death of one of Thomson’s patients that led many states to
pass laws to restrict the practice of unconventional medicine, much of it having
been long practiced by enslaved Black people. As a result of the efforts of
Thomson and his Thomsonians, by the 1850s most states had seriously weakened or 
even repealed their medical licensure laws or had never had such laws to begin
with.

Although the situation in the first half of the 19th century was different in
that at the time “conventional” medicine was still largely based on the four
humors and unscientific practices, which makes it harder from today’s
perspective to defend them, the situation is much different in that now medicine
has a strong scientific basis. Sure, there are areas where the science is less 
certain and the evidentiary base for standard-of-care not as strong as for
others, but we are nowhere near the situation in medicine 200 years ago. Even
so, I fear that science is not enough and that history is repeating itself. Just
as Thomsonians invoked “freedom” and reflected the Jacksonian zeitgeist of the 
time, so, too, are the ideologues using the pandemic as an excuse to gut state
and federal regulations of medicine reflecting the zeitgeist of our current
time. One notes that once the Thomsonians had succeeded, it wasn’t until the
Flexner Report in 1911 that conventional science-based medicine truly reasserted
itself.

I also note that Thomson, despite claiming that every person could be their own 
physician and heal themselves, still claimed that only he alone had unlocked the
secrets of healing and health. Even as he chastised conventional physicians for
their hubris, he himself was full of hubris and jealously guarded his own
patent rights. Not coincidentally, he became very wealthy. Sound familiar? (I
really should do a more detailed post just about Samuel Thomson.)

History repeats itself, indeed, I fear. The pandemic was just a very effective
accelerant, along with social media.

Do You Believe in Magic? Oregon Does. Chiropractic and Acupuncture for Pain.

Mark Crislip on August 7, 2015

Link





Pictured: OHP and HERB picking “evidence-based treatment options”

Do You Believe in Magic?

   Do you believe in magic for a back pains fix

   How the needles can free her, where ever it pricks

   And it’s magic, if the chi is groovy

   It makes you feel happy like an old-time movie

   I’ll tell you about the magic, and it’ll free your soul

   But it’s like trying to tell a CAM ’bout randomized control

   If you believe in magic don’t bother to choose

   Although subluxation is simply a ruse

   Just go and get adjusted on the table

   It won’t wipe off the pain no matter how hard you try

   Your wallet is empty and you can’t seem to find

   How you got there, so just blow your mind

   If you believe in magic, come along with me

   We’ll CAM until morning paid for by the OHP

   And maybe, if the CAM is right

   I’ll meet you tomorrow, sort of late at night

   And we’ll go dancing, baby, then you’ll see

   How the magic’s in the CAM and the CAM’s in me

   Yeah, do you believe in magic

   Yeah, believe in the magic of a back pains fix

   Believe in the magic of CAM

   Believe in the magic that can set you free

   Oh, talking ’bout magic

   Do you believe like I believe… Do you believe in magic

   Do you believe like I believe… Do you believe, believer

   Do you believe like I believe… Do you believe in magic

   The Lovin’ Spoonful. Sort-of.

Maybe not my best lyrics.

More Oregon magic

It continues.

Oregon has a problem with prescription pain pills. Oregon leads the nation in
the abuse of such drugs, federal statistics show, with Oregon’s rate of
prescription drug abuse 39 percent higher than the national average. Go us.

Why that is, I do not know. As an Infectious Disease doctor I prescribe a
narcotic about once a year. There are real problems with the treatment of
chronic pain and while I am aware of the issues and the changes over the last 25
years, it does not impact my practice, so my knowledge of the issues is basic.

I am also well aware of the Oregon Health Plan (OHP). The OHP was intended to
make health care more available to the working poor, while rationing benefits.
They were fairly transparent that resources were fixed and not everything would 
be covered.

Given limited resources, part of the plan has always included a prioritization
of treatments and diagnostics, paying for care that give the most bang for the
buck. Not a perfect way to ration care and as is always the case, no good deed
goes unpunished.

Another effect of limiting care, according to the Bend Bulletin, may be that:

   OHP members who suffer back pain have been left with no choice but to take
   drugs, and the policy could be contributing to Oregon’s high rate of narcotic
   abuse

since other interventions to treat back pain are not paid for. Interventions
like acupuncture and chiropractic.

New guidelines were recently updated by the Health Evidence Review Board (HERB) 
and as a result:

   The new guidelines open the door to acupuncture, chiropractic, cognitive
   behavioral therapy, osteopathic manipulation and physical and occupational
   therapy.

To be picky, the guidelines do not say chiropractic, but “spinal manipulation,” 
although the codes to be used are those for chiropractic manipulation. And as is
so often the case, the title of an organization often does not describe what
they actually do. As in the ‘Health Evidence Review’ part. As the local ID
expert in my hospital, or for this blog, when I review the evidence, I try to
read as much as is possible, not only relying on reviews, but as much of the
primary literature as I can. I found that the primary literature is
misrepresented by not only reviews, but the authors of the primary literature.
This is perhaps particularly true in the SCAM world, as the careful evaluation
of a paper will determine.

HERB reviews reviews

As best I can tell, the HERB relied on two reviews, “Diagnosis and Treatment of 
Low Back Pain: A Joint Clinical Practice Guideline” from the American College of
Physicians and the American Pain Society from 2007 and “Nonpharmacologic
Therapies for Acute and Chronic Low Back Pain: A Review of the Evidence for an
American Pain Society/American College of Physicians Clinical Practice
Guideline” from 2007.

That is it. Two reviews, from 2007, from the same journal (from the same
issue!). That hardly seems a sufficient basis upon which to make decisions.

The first review notes:

   For chronic low back pain, moderately effective nonpharmacologic therapies
   include acupuncture (114–115)…spinal manipulation (108)

Reference 114 concludes:

   For chronic low back pain, acupuncture is more effective for pain relief and 
   functional improvement than no treatment or sham treatment immediately after 
   treatment and in the short-term only. Acupuncture is not more effective than 
   other conventional and “alternative” treatments. The data suggest that
   acupuncture and dry-needling may be useful adjuncts to other therapies for
   chronic low back pain. Because most of the studies were of lower methodologic
   quality, there is a clear need for higher quality trials in this area.

And 115:

   The quantity and quality of the included trials varied.

   CONCLUSIONS: Acupuncture effectively relieves chronic low back pain. No
   evidence suggests that acupuncture is more effective than other active
   therapies.

To add to the mix, the Cochrane review notes:

   For chronic low-back pain, acupuncture is more effective for pain relief and 
   functional improvement than no treatment or sham treatment immediately after 
   treatment and in the short-term only. Acupuncture is not more effective than 
   other conventional and “alternative” treatments. The data suggest that
   acupuncture and dry-needling may be useful adjuncts to other therapies for
   chronic low-back pain. Because most of the studies were of lower
   methodological quality, there certainly is a further need for higher quality 
   trials in this area.

Virtually every acupuncture meta-analysis, from the first one in 1980, has some 
variation of

   Various potential sources of bias, including problems with blindness,
   precluded a conclusive finding although most results apparently favoured
   acupuncture.

The second reference used by HERB? For acupuncture they state:

   For chronic low back pain, both systematic reviews found acupuncture
   moderately more effective than no treatment or sham treatments for short-term
   (<6 weeks’ [16] or <3 months’ [17–18] duration) pain relief. Acupuncture was
   also associated with moderate short-term improvements in functional status
   compared with no treatment (standardized mean differences, 0.62 [CI, 0.30 to 
   0.95][16], and 0.63 [CI, 0.19 to 1.08][17–18]), but not compared with sham
   therapies

As we have noted, if a therapy is no better than sham/placebo

IT DOES NOT WORK.

Sorry.

I yelled.

But sometimes I just get too aggravated by the double standards of SCAM
evidence. To continue:

   A recent, higher-quality trial not included in the systematic reviews found
   no differences between acupuncture and sham acupuncture for pain or function 
   (Appendix Table 8) (130).

   Evidence of longer-term benefits from acupuncture is mixed. Acupuncture was
   moderately superior for long-term (>6 weeks’ duration) pain relief compared
   with sham TENS in 2 trials and compared with no additional treatment in 5
   trials, although there were no significant differences compared with sham
   acupuncture. One higher-quality trial found no differences in pain 1 year
   after acupuncture therapy compared with provision of a self-care education
   book (161). A higher-quality trial not included in the systematic reviews
   found clinically insignificant differences (<5 points on 100-point scales)
   between acupuncture and no acupuncture for pain and function after 6 months .
   Another recent, higher-quality trial found acupuncture slightly superior to 
   usual care on Short Form–36 pain scores after 24 months (weighted mean
   difference, 8 points [CI, 0.7 to 15.3 points]) and for recent use of
   medications for low back pain (60% vs. 41%), although ODI scores and other
   outcomes did not differ.

So for acupuncture approval, OHP relied on reviews of meta-analysis, and the
primary sources suggest the therapies result in at best short term efficacy, the
positive effects likely due to poor methodologies and long term effects that
were ‘slightly superior’ or ‘clinically insignificant’.

They evidently did not review the literature to show that acupuncture is a
theatrical placebo, has no basis in reality-based medicine and that most
positive effects are due to bias in poorly done studies.

   …results should be interpreted in the context of the limitations identified, 
   particularly in relation to the heterogeneity in the study characteristics
   and the low methodological quality in many of the included studies.

Thin gruel indeed to justify the State paying for acupuncture. My tax dollars in
action. Or my tax dollars inaction, since they did not do what I would consider
due diligence in reviewing the literature.

Same as it ever was.

Chiropractic steps up to the wand

The analysis of chiropractic is equally unimpressive.

Reference 108, a meta-analysis, states:

   Spinal manipulative therapy had no statistically or clinically significant
   advantage over general practitioner care, analgesics, physical therapy,
   exercises, or back school. Results for patients with chronic low back pain
   were similar. Radiation of pain, study quality, profession of manipulator,
   and use of manipulation alone or in combination with other therapies did not 
   affect these results.

   CONCLUSIONS:

   There is no evidence that spinal manipulative therapy is superior to other
   standard treatments for patients with acute or chronic low back pain.

And that chiropractic is no better other therapies:

   High quality evidence suggests that there is no clinically relevant
   difference between SMT and other interventions for reducing pain and
   improving function in patients with chronic low-back pain.

The conclusions of the second reference used by HERB are equally tepid about the
benefits of chiropractic.

   For low back pain of unspecified duration, 1 higher-quality trial (681
   patients) found no differences in pain, functional status, or other outcomes 
   between patients randomly assigned to chiropractic versus medical management.
   The other trial (1334 patients) found spinal manipulation to be slightly
   superior to usual care for pain and disability (about 5 points on 100-point
   scales) after 3 months in patients with subacute or chronic low back pain,
   although effects were not as pronounced after 12 months, and differences on
   the RDQ did not reach clinical significance (about 1 point). Manipulation and
   exercise did not significantly differ, and the addition of manipulation to
   exercise therapy was no better than exercise alone.

Not, as was mentioned in the newspaper, that:

   Large, randomized trials have shown that for chronic back pain, acupuncture
   and chiropractic therapy are equally helpful, said Dr. Richard Deyo,
   professor of evidence-based medicine at Oregon Health & Science University.
   He served on a task force that advised the Health Evidence Review Commission.
   “Different people respond to different things,” he said. “The outcomes tend 
   to be very similar, in the short term at least.”

It is more accurate to say they are equal placebos, doing nothing, since short
term improvement is just what one would expect from a placebo that does nothing 
to the underlying process. I do not think I read the same papers as Dr. Deyo.
And if you tend towards the Bayesian approach, it your intervention has no prior
plausibility, like acupuncture or chiropractic, then any positive result is
likely a false positive.

And should I mention that the deliberate use of placebos are unethical? Naw.

Scraped knees and entomophagy

I will mention in passing that I have long been of the opinion that most SCAMs
are the equivalent of kissing a child’s boo-boo or apes grooming each other.
Chiropractic and acupuncture are touch-based elaborate treatment rituals and
much of their perceived beneficial effects could be from:

   mounting evidence that more elaborate treatment rituals trigger larger
   nonspecific effects. The reasons for this remain unclear. In a pilot field
   study, we investigated the role of psychophysiological changes during a
   touch-based healing ritual for improvements in subjective
   well-being….Subjective well-being increased significantly from before to
   after the ritual. The analysis of psychophysiological changes revealed a
   significant increase in respiratory rate from baseline to ritual, while skin 
   conductance, heart rate, and heart rate variability did not change. Increases
   in [skin conductance levels] as well as decreases in respiratory rate from
   baseline to ritual were significantly associated with improvements in
   subjective well-being…. Conclusion. Higher sympathetic arousal during a
   touch-based healing ritual predicted improvements in subjective well-being.

So the state is going to pay for the metaphorical picking and eating of lice.

And this also ignores the question of the state paying for practitioners of
magical pseudo-medicines and all the associated useless interventions and
beliefs espoused by chiropractors, naturopaths and traditional Chinese medicine 
practitioners noted at length on this blog.

It hardly seems like a good use of Oregon’s resources, nor a good approach to
chronic back pain. It seems that Ben Goldacre’s aphorism is being ignored: Just 
because there are flaws in aircraft design that doesn’t mean flying carpets
exist.

Oregon chooses flying carpets.

They do suggest a possible benefit:

   The expense of a broader range of treatments could be offset by a decline in 
   narcotics use

And I hope they do some epidemiologic studies to show benefit of adding
pseudo-medicines to OHP, although I am not so sure the cost is worth the lack of
benefit.

Credentialing magic

Being credentialed is a necessary pain. I have to document for my hospitals and 
some insurance companies that I am trained in my specialty and should be
competent to practice medicine. It is a lot of paperwork and it has to be kept
up to date. I am, however, credentialed in reality-based medicine.

How do you credential someone in a field that is based in pseudo-medicine,
divorced from reality, with a panoply of imaginary diseases treated with equally
imaginary therapies? Like naturopathy?

As noted by one author who desperately wants to give his difficult patients to
naturopaths:

   Unfortunately, a number of serious difficulties can be encountered by
   internal medicine, family medicine, and pediatric physicians who refer
   patients to, or attempt to comanage patients with, naturopathic physicians.

And:

   Yet because of differentials in paradigm and/or clinical experience,
   naturopaths commonly order laboratory tests that are either unrecognizable or
   seem inappropriate to internists.

They don’t seem inappropriate, they are inappropriate, but to be expected from
an education and training dominated by nonsense. I have discussed at length why 
naturopathic training is useless for diagnosis and treatment. It is an old joke,
but ND really does mean Not a Doctor.

It does not worry my alma mater, Oregon Health Sciences University, who ignores 
the whole science part of their title so they can credential naturopaths. How
they do it is detailed in “A Framework for Credentialing Naturopathic Physicians
in Academic Health Centers: Oregon Health and Science University.”

They state:

   To maintain consistency with the rigorous standards applied to all
   credentialed healthcare professionals at the institution, the requirements
   include postdoctoral training (clinical or research) in an AHC to establish
   cultural competence and the completion of one year in a residency approved by
   the Council on Naturopathic Medical Education or two years of direct
   clinical practice in a hospital accredited by the Joint Commission or the
   Centers for Medicare and MedicaidServices to establish clinical competence.

But pay no attention to the content of the education. Being extensively trained 
in pseudo-medicine does not mean the practitioner should be allowed to take care
of patients, especially at a University.

So what good is:

  1. Successful graduation from a 4-year accredited, post-baccalaureate, training
    program with designation as a Doctor of Naturopathic Medicine

  2. Successful completion of one year CNME (Council on Naturopathic Medicine
    Education) accredited residency or evidence of 2 years direct clinical
    practice in a Joint Commission or CMS accredited hospital or academic
    medical center

  3. Post-Doctoral Training for at least 2 years in an Academic Medical Center

  4. Successful completion of NPLEX (Naturopathic Physicians Licensing
    Examinations) with a current license as an Oregon Licensed Naturopathic
    Physician

  5. Additional Active Clinical Practice for at least 2 years, immediately
    preceding the request for clinical privileges at OHSU, documentable via
    reports of specific activities from the locations of practice

When it is all based in nonsense? Playing doctor does not make you a doctor.

OHSU does have far more requirements than most practicing naturopaths have who
pretend they can function as primary care physicians.

Pseudo-medicine. Paid for by the state, approved by the University.

And lest you be smug, I bet the same things are happening in your state.

Mortality and lack of health insurance

David Gorski on October 15, 2012

Link

The 2012 election campaign is in full swing, and, for better or worse, health
care is one of the major defining issues of the election. How can it not be,
given the passage of the Patient Protection and Affordable Care Act (PPACA),
also colloquially known as “Obamacare,” was one of the Obama administration’s
major accomplishments and arguably the largest remaking of the American health
care system since Medicare in 1965? It’s also been singularly unpopular thus
far, contributing to the Republican takeover of the House of Representatives in 
the 2010 elections, as well as the erosion of Democratic control of the Senate. 
Given that this is a medical blog dedicated to discussing the scientific basis
of medicine and not a political or health policy blog, I am not going to go into
the reasons for a lot of this. What I am going discuss is a recent eruption of 
the central problem that led President Obama to make the PPACA one of the
central policy initiatives, if not the central policy initiative, of his first
term. That problem is the issue of people without health insurance, who number
roughly 50 million, with a further estimate that 86.7 million people were
uninsured at some point during the two year period from 2007 to 2008,
representing about 29% of the total U.S. population under 65.

The question that bubbled to the surface last week in the form of a statement by
Republican challenger Mitt Romney, and a tear-inducing op-ed piece published
yesterday in the New York Times by Nicholas Kristof entitled A Possibly Fatal
Mistake, is what the health impact of not having insurance is for those millions
of people. This is a question that can be addressed scientifically and is,
despite its politically charged nature, correctly within the purview of
science-based medicine. What to do about it, in contrast, is a matter for
politics and public policy. So first let’s examine the question.

A clueless statement and an op-ed that puts a face on the problem

Before we discuss the evidence regarding the health effects of being uninsured, 
let’s look Romney’s statement and why it resulted in so much blowback. Romney
made his assertion during an interview with the editors of The Columbus
Dispatch:

   “We don’t have a setting across this country where if you don’t have
   insurance, we just say to you, ‘Tough luck, you’re going to die when you have
   your heart attack,'” he said as he offered more hints as to what he would
   put in place of “Obamacare,” which he has pledged to repeal.

   “No, you go to the hospital, you get treated, you get care, and it’s paid
   for, either by charity, the government or by the hospital. We don’t have
   people that become ill, who die in their apartment because they don’t have
   insurance.”

   He pointed out that federal law requires hospitals to treat those without
   health insurance — although hospital officials frequently say that drives up 
   health-care costs.

Romney was referring to the Emergency Medical Treatment and Active Labor Act
(EMTALA), a federal law passed in 1986 under the Reagan administration that
requires hospitals to provide care to anyone needing emergency treatment
regardless of citizenship, legal status, or ability to pay. Hospitals may only
transfer or discharge patients requiring emergency care after stabilization,
when their condition requires transfer to a tertiary care hospital, or against
medical advice. It is highly unlikely that any person who has ever worked in an 
emergency room or cared for the uninsured would make such a statement. Emergency
rooms are not equipped to treat complex conditions; all they can do is to treat
the acute problem. In addition, tertiary care hospitals receive a lot of
patients admitted under EMTALA, who are transferred at the drop of a hat. Well
do I remember my days as a surgery resident rotating in the county hospital,
when we used to joke about the Friday afternoon phone calls to transfer patients
who had failed a wallet biopsy. We even knew what time was the “witching hour,”
when we were most likely to get such calls. Of course, the problem with EMTALA 
was (and is) that there were no provisions for reimbursement for uncompensated
care. Basically, hospitals were forced by law to eat the costs of caring for the
uninsured.

Since completing fellowship, I have held faculty positions in two of the 41
NCI-designated comprehensive cancer centers in the U.S., both of which take care
of a lot of uninsured patients. In New Jersey, I used to take care of quite a
few illegal immigrants. Here in Detroit, it’s the uninsured and the poor, so
much so that a large fraction of my practice is made up of the uninsured and
Medicaid patients. I’ve seen more women than I can remember who waited far
longer than they should have to see a doctor for their breast cancer because
they couldn’t afford it. Over the years, all too often my patients have been
symptomatic for quite some time, and when they finally do present their tumors
are larger, more difficult to treat, and more likely to kill them. They
represent the female equivalent of Kristof’s uninsured friend Scott, who is the 
human face of the issue discussed in his NYT op-ed and tells his story:

   In 2011 I began having greater difficulty peeing. I didn’t go see the doctor 
   because that would have been several hundred dollars out of pocket — just
   enough disincentive to get me to make a bad decision.

   Early this year, I began seeing blood in my urine, and then I got scared. I
   Googled “blood in urine” and turned up several possible explanations. I
   remember sitting at my computer and thinking, “Well, I can afford the cost of
   an infection, but cancer would probably bust my bank and take everything in 
   my I.R.A. So I’m just going to bet on this being an infection.”

   I was extremely busy at work since it was peak tax season, so I figured I’d
   go after April 15. Then I developed a 102-degree fever and went to one of
   those urgent care clinics in a strip mall. (I didn’t have a regular physician
   and hadn’t been getting annual physicals.)

   The doctor there gave me a diagnosis of prostate infection and prescribed
   antibiotics. That seemed to help, but by April 15 it seemed to be getting
   worse again. On May 3 I saw a urologist, and he drew blood for tests, but the
   results weren’t back yet that weekend when my health degenerated rapidly.

   A friend took me to the Swedish Medical Center Emergency Room near my home.
   Doctors ran blood labs immediately. A normal P.S.A. test for prostate cancer 
   is below 4, and mine was 1,100. They also did a CT scan, which turned up
   possible signs of cancerous bone lesions. Prostate cancer likes to spread to 
   bones.

   I also had a blood disorder called disseminated intravascular coagulation,
   which is sometimes brought on by prostate cancer. It basically causes you to 
   destroy your own blood cells, and it’s abbreviated as D.I.C. Medical students
   joke that it stands for “death is close.”

I realize that right now I’m referring to my anecdotal experience. However, one 
anecdote is that of a man who gambled and lost because health insurance was too 
expensive. The rest is my experience in a highly specialized field in a city
with high unemployment and poverty. It is quite possible that such experience
can be misleading, and certainly one of the key messages we promote on this blog
is that anecdotal experience is inherently potentially misleading. (That’s why 
it’s the primary evidence used by promoters of unscientific or pseudoscientific 
medicine.) In a way, Kristof’s friend’s story would seem to confirm Romney’s
statement, at least on the surface. Scott did, after all, end up getting
excellent medical care for his stage IV prostate cancer, and, although he
probably could have afforded health insurance if he had stretched a bit, did
make a choice not to purchase insurance. But, then, as I said, anecdotes can be 
misleading.

The evidence

Before we get into the data itself, it is not much of a stretch to imagine that 
not having health insurance would result in worse health outcomes. What I am
trying to say using SBM-speak is that the hypothesis that people without health 
insurance will be more likely to have health problems and die unnecessarily than
people who have decent health insurance is a hypothesis with a fairly high
degree of prior plausibility. After all, if you’re uninsured, you’re less likely
to see a physician except when you get sick, less likely to be able to pay for 
your medications (particularly if they are expensive), and less likely to
undergo routine preventative care. It’s thus plausible that being uninsured
would be associated with an increased risk of death or poor health outcomes.
None of this means we don’t have to do the research and look at the evidence;
all it does is to suggest hypotheses to test and emphasize that these hypotheses
have a reasonable chance of being consistent with the data.

Even twenty years ago, this question was of intense interest. One of the seminal
studies examining the relationship between health insurance and health outcomes
was published in JAMA by Franks et al., who prospectively followed 4,694 adults
older than 25 years who reported they were uninsured or privately insured in
the first National Health and Nutrition Examination Survey (NHANES I), a
representative cohort of the US population from initial interview in 1971
through 1975 until 1987. They found a 25% higher risk of mortality in the
uninsured after adjusting for age, smoking, alcohol consumption, obesity,
education and income. This effect was evident in all sociodemographic health
insurance and mortality groups examined.

In 2002, the Institute of Medicine estimated that over 18,000 Americans between 
the ages of 25-64 die annually because of lack of health insurance, a number
comparable to the number who died of diabetes, stroke, or homicide in 2001.
Among the conclusions of this report:

  1. Uninsured adults are less likely than adults with any kind of health coverage 
    to receive preventive and screening services and to receive them on a timely
    basis. Health insurance that provides coverage of preventive and screening 
    services is likely to result in greater and more appropriate use of these
    services.

  2. Uninsured cancer patients generally are in poorer health and are more likely
    to die prematurely than persons with insurance, largely because of delayed
    diagnosis. This finding is supported by population-based studies of persons 
    with breast, cervical, colorectal, and prostate cancer and melanoma.

  3. Uninsured adults with diabetes are less likely to receive recommended
    services. Lacking health insurance for longer periods increases the risk of 
    inadequate care for this condition and can lead to uncontrolled blood sugar 
    levels, which, over time, put diabetics at risk for additional chronic
    disease and disability.

  4. Uninsured adults with hypertension or high blood cholesterol have diminished
    access to care, are less likely to be screened, are less likely to take
    prescription medication if diagnosed, and experience worse health outcomes.

  5. Uninsured patients with end-stage renal disease begin dialysis with more
    severe disease than do those who had insurance before beginning dialysis.

  6. Uninsured adults with HIV infection are less likely to receive highly
    effective medications that have been shown to improve survival and die
    sooner than those with coverage.

  7. Uninsured patients who are hospitalized for a range of conditions are more
    likely to die in the hospital, to receive fewer services when admitted, and 
    to experience substandard care and resultant injury than are insured
    patients.

  8. Uninsured persons with trauma are less likely to be admitted to the hospital, 
    more likely to receive fewer services when admitted, and are more likely to 
    die than are insured trauma victims.

  9. Uninsured patients with acute cardiovascular disease are less likely to be
    admitted to a hospital that performs angiography or revascularization
    procedures, are less likely to receive these diagnostic and treatment
    procedures, and are more likely to die in the short term.

In 2008, the Urban Institute updated the IOM numbers by applying the methodology
used by the IOM to more recent Census Bureau estimates of the uninsured, and
estimated that in 2006 there were 22,000 excess deaths that could be attributed 
to lack of health insurance. The Urban Institute also suggested that the IOM
analysis might have underestimated the number of deaths resulting from being
uninsured. Its rationale was as follows:

   The underlying longitudinal studies on which IOM relied did not specify the
   impact of insurance coverage on mortality by 10-year age groups. Rather, they
   documented the relationship between insurance and mortality across the sum
   total of all surveyed age groups. The IOM’s methodology implicitly assumed
   that insurance reduces mortality by the identical percentage for each 10-year
   age band, which the underlying research did not show. More grounded in the
   research would be an application of differential mortality estimates to all
   adults age 25–64, as was done for those longitudinal studies, rather than
   separately to each age group within this range. For 2000–06, this alternative
   approach raises the estimated number of excess deaths by an average of 20.5 
   percent a year.

In 2009, in a study from Harvard Medical School and the Cambridge Health
Alliance, Wilper et al. published updated estimate of excess mortality
associated with lack of insurance in the American Journal of Public Health. This
analysis used methodology similar to that of Franks et al. applied to the third
National Health and Nutrition Examination Survey (NHANES III), specifically
9,004 patients between ages 17 and 64 with complete baseline data for interview 
and physical examination. They found that the hazard ratio for death for the
uninsured was 1.40 (confidence interval 1.06 to 1.84) compared to those with
private health insurance. This particular study is the source of a rather famous
number: 45,000 patients die due to lack of insurance each year. This particular
study is at the high end of the estimates of excess deaths associated with lack
of health insurance, which is why it not surprisingly often comes in for the
most criticism, particularly given that it was supported by a partisan group,
Physicians for a National Health Program. That’s why I tend to view this study
as an outlier, but even outliers can sometimes tell us something. Whether the
Harvard study was an outlier or not, that same year, the IOM updated its 2002
report. One of its conclusions was:

   In contrast, the body of evidence on the effects of uninsurance on adults’
   health has strengthened considerably since 2002. Numerous studies have
   addressed some of the methodological shortcomings of past research. As
   discussed further below, 17 observational and 13 quasi-experimental rigorous 
   analyses have reported significant findings related to health insurance and
   adults’ health (Table 3-3) (McWilliams, 2008). The quality and consistency of
   the recent research findings is striking. As would be expected, health
   insurance is clearly most beneficial for adults who need medical attention,
   particularly for adults with common chronic conditions or acute conditions
   for which effective treatments are available. Furthermore, national studies
   assessing the effects of near-universal Medicare coverage after age 65
   suggest that uninsured near-elderly adults who are acutely or chronically ill
   substantially benefit from gaining health insurance coverage.

   There are 13 recent studies on the health effects of health insurance
   coverage for children, including 5 studies that used quasi-experimental
   methods (Aizer, 2007; Bermudez and Baker, 2005; Cousineau et al., 2008;
   Currie et al., 2008; Howell et al., 2008a). These studies suggest that health
   insurance is beneficial for children in several ways, resulting in more
   timely diagnosis of serious health conditions, fewer avoidable
   hospitalizations, better asthma outcomes, and fewer missed school days
   (Aizer, 2007; Bermudez and Baker, 2005; Cousineau et al., 2008; Currie et
   al., 2008; Damiano et al., 2003; Fox et al., 2003; Froehlich et al., 2007;
   Howell and Trenholm, 2007; Howell et al., 2008a,b; Maniatis et al., 2005;
   Szilagyi et al., 2004, 2006).

But that’s not all. Since it’s my specialty, I’ll start by looking at some of
the evidence regarding the outcomes of breast cancer patients who are uninsured 
compared to those who have health insurance. For example, a study published this
year examining the outcomes of 2,157 hospital admissions for women with spinal 
metastases from breast cancer. Analyses were adjusted for differences in patient
age, gender, primary tumor histology, socioeconomic status, hospital bed size, 
and hospital teaching status. The investigators found that women operated on for
spinal metastases from breast cancer tended to do worse and have a higher risk 
of death if they were uninsured than if they had private insurance. The authors 
concluded that the poorer outcomes observed among the uninsured were primarily
due to the uninsured patients being significantly more likely to have a
nonelective hospital admission and present with myelopathy. Although this study 
had some limitations, namely that it couldn’t account for lesser quality private
insurance (for instance, plans with high copays and/or poorer coverage) and
variations in Medicaid eligibility by state. Also, the database used only
includes in-hospital data and therefore couldn’t examine long-term outcomes.

Since surgery is also my specialty, I thought I’d also point out that there is
considerable evidence that being uninsured or underinsured is associated with
worse outcomes after surgery. For example, a recent study published in the
Annals of Surgery from LePar et al. at the University of Virginia examined
outcomes from 893,658 major surgical operations and found that mortality was
considerably worse in Medicare, Medicaid, and the uninsured than they were in
patients with private insurance. Adjusting for age, gender, income, geographic
region, operation, and 30 comorbid conditions eliminated the outcome disparity
for Medicare patients, but Medicaid and uninsured payer status still
independently conferred the highest adjusted risks of mortality.

In fact, the list of conditions and procedures for which being uninsured is
associated with poorer outcomes and higher mortality goes on and on: cardiac
valve surgery, surgery for colorectal cancer, breast cancer treatment and
outcomes, trauma mortality (including among children), and abdominal aortic
aneurysms, to name a few. Moreover, analysis of survey data from patients who
were uninsured but then became old enough to be enrolled in Medicare suggests
that “acquisition of Medicare coverage was associated with improved trends in
self-reported health for previously uninsured adults, particularly those with
cardiovascular disease or diabetes.” In summary, there is a large and robust
body of evidence suggesting that people do, in fact, die because of lack of
health insurance.

Not so fast…

Of course, for a question as complex and prone to confounders as whether lack of
health insurance is associated with poorer outcomes, including mortality, there
are always those who are not convinced by existing observational data.
Certainly, lack of health insurance can be a marker, not a cause, for poor
health and subsequent poor outcomes, and teasing out the various confounding
factors is not a trivial task. Perhaps the most widely cited study questioning
this relationship was featured prominently in an oft-cited article in the lay
press by Megan McArdle in The Atlantic entitled Myth diagnosis. It’s a study by 
Richard Kronick published in Health Services Research in 2009 that questions the
IOM report from 2002:

   These results demonstrate that if two people are otherwise similar at
   baseline on characteristics controlled for in the model presented in Table 3,
   but one is insured and the other uninsured, their likelihood of survival
   over a 2–16-year follow-up period is nearly identical. Further, I show that
   survival probabilities for the insured and uninsured are similar even among
   disadvantaged subsets of the population; that there are no differences for
   long-term uninsured compared with short-term uninsured; that the results are 
   no different when the length of the follow-up period is shortened; and that
   there are no differences when causes of death are restricted to those causes 
   thought to be amenable to the quality of health care.

Basically, Kronick found no relationships between insurance status and
mortality. While this study was large (600,000 subjects) and controlled, it is
also an outlier, just as much as the Harvard study is an outlier. Again, that
doesn’t mean it was a bad study; outliers can often tell us something, and what 
Kronick seems to be telling us is that the magnitude of the effect on mortality 
associated with lack of insurance might not be as large as previously thought.
Might. It is, remember, just one study, as large as it might be. McArdle might
refer to Kronick’s study as “what may be the largest and most comprehensive
analysis yet done of the effect of insurance on mortality,” which sounds
incredibly impressive, but the simple fact is that no single study can provide
the answer, particularly to question as complex as whether having no health
insurance status is associated with increased mortality and poor outcomes.
Kronick’s study also has a significant problem that was pointed out in this post
by Ezra Klein, namely that people in poor health are more likely to seek health
insurance, which would tend to obscure any positive relationship between health
insurance and health status.

McArdle also makes another argument against such a relationship:

   This result is not, perhaps, as shocking as it seems. Health care heals, but 
   it also kills. Someone who lacked insurance over the past few decades might
   have missed taking their Lipitor, but also their Vioxx or Fen-Phen. According
   to one estimate, 80,000 people a year are killed just by “nosocomial
   infections”—infections that arise as a result of medical treatment. The only 
   truly experimental study on health insurance, a randomized study of almost
   4,000 subjects done by Rand and concluded in 1982, found that increasing the 
   generosity of people’s health insurance caused them to use more health care, 
   but made almost no difference in their health status.

I hate to say it, but McArdle is drifting rather close to Gary Null territory
here, in which she seems to be arguing that whatever benefit having decent
health insurance might convey, it’s about the same as the harm that
“conventional” medicine does. In other words, her argument seems to be that
providing people more access to health care will cause as much harm as benefit, 
making it a wash whether one is insured or not. Of course, that argument cuts
both ways, if you accept estimates of over 100,000 “deaths by medicine” per year
in that it would imply that having health insurance confers a benefit in terms 
of mortality reduction that is much larger than the numbers we have would
suggest, making the imperative to improve health care coverage and decrease
medical errors a much more reasonable conclusion from such an argument than
concluding that striving for universal coverage would not reduce mortality. Be
that as it may, more problematic is that like many proponents of dubious
medicine and science, McArdle cherry picked the literature, choosing one study
that is an outlier and a thirty year old study from the RAND Corporation that
showed what she wanted and in essence dismissed the rest. In refuting McArdle,
by J. Michael McWilliams, MD, PhD, Assistant Professor of Health Care Policy and
Medicine at Harvard Medical School and an associate physician in the Division
of General Medicine at Brigham and Women’s Hospital points this out and
speculates:

   How many lives would universal coverage save each year? A rigorous body of
   research tells us the answer is many, probably thousands if not tens of
   thousands. Short of the perfect study, however, we will never know the exact 
   number.

Indeed.

Policy implications

The very term “science-based medicine” was chosen intentionally. Medicine itself
is not a science. It can’t be. There are too many other factors that influence 
treatments, including patient preference, resource allocation, and level of
skill of individual practitioners, to name just a few. Our central thesis is
that medicine should be based on science and that the best health care is based 
on science. My purpose in writing this post was not to advocate for any specific
solution to the problem of the uninsured, although people who know me know my
politics and my position on the matter. Rather, it is to lay out the science
studying the question of the relationship between health insurance status and
health outcomes. While we do frequently say that correlation does not
necessarily equal causation, in some cases the correlation is so tight that it
strongly suggests causation. This is one such case. Given that there is no
ethical way ever to do a randomized clinical trial in which people are randomly 
assigned to be insured or uninsured, much as is the case for examining health
outcomes between vaccinated and unvaccinated children, we are forced to rely on 
observational and quasi-experimental data. Those data support the hypothesis
that providing health insurance to as many people as possible is associated with
better health outcomes and that lack of insurance is associated with poorer
health outcomes. That is the science. When someone like Mitt Romney claims that 
no one ever dies from lack of insurance in the U.S., he is demonstrably wrong.

What we as a society decide do with the results of the science examining this
question is less a matter of science than it is of politics and policy.

Strains, sprains and pains

Jann Bellamy on December 29, 2011

Link

What do you think would happen if you gave a bunch of “complementary and
alternative medicine” practitioners access to a big pot of money — say, up to
$10,000 per patient — and let them treat patients virtually without restriction,
hampered only by a fee schedule. No utilization review, no refusal based on a
treatment being “experimental” — none of the usual foils which trip up CAM
practitioners in the health insurance field.

Think they’d run up the bill? Yes, they would.

In fact, that’s exactly the scenario playing out in Florida right now with the
state’s no-fault auto insurance.

Good intentions, and the road from there

Some background: The Florida legislature mandated no-fault motor vehicle
insurance coverage personal injury protection (or “PIP” coverage, as it is
commonly called) for all vehicles in 1971. The laudable goal was to give those
injured in auto accidents ready access to money for economic losses, such as
medical bills and lost wages, without having to determine who was at fault, a
process litigation could delay for several years. Up to $10,000 in coverage is
currently required for all vehicles.

For medical bills, this coverage is meant mainly for temporary, and therefore
generally minor, injuries. Bodily injury coverage — and the necessity for
proving fault — takes over for more permanent injuries. Indeed, for 2007,
according to a recent report by the Insurance Research Council (IRC), 70% of
injuries reported by no-fault auto insurance claimants were sprains and strains.

By statute, only medical doctors, osteopaths, dentists, and chiropractors can
supervise, order, or prescribe medical services for PIP claims. However,
physical therapy, massage, and acupuncture can be prescribed by the provider.

Medical costs represent 90% of all claimed economic losses, according to an
analysis of 2007 Florida PIP claims, even though coverage is meant for other
expenses due to injury as well, such as lost wages. In fact, medical expenses
eat up so much of the $10,000 limit that there is often little — or no — money
left for lost wages.

Since 1971, vehicle and highway safety have improved dramatically, reducing the 
severity of crashes and resulting injuries. According to the Florida Highway
Patrol, between 2006 and 2010 alone there were 21,000 fewer traffic accidents
and only a 1.5 percent increase in the number of drivers.

So, over time, there’s a trend toward fewer, less serious, accidents. As well,
the injuries covered by PIP are mainly minor and self-limiting. But in Florida
PIP coverage rates are out of control. According to a report issued by Florida’s
Chief Financial Officer (CFO) Jeff Atwater the state’s paid PIP losses per auto
have increased over 66 % in the last 2.5 years, and PIP premiums will double
every 3 years if the trend continues.

Faced with these stats, the CFO (whose office regulates insurance) decided to
look into things and gave the Office of Insurance Consumer Advocate the task of 
doing so. The Consumer Advocate’s report [PDF], issued this month, produced some
very interesting data on the question I posed in the first paragraph.

And the results are …

The Consumer Advocate found that, for 2010, the most expensive average provider 
charge per PIP claim was paid to these top three providers:

  1. Massage Therapist: $4,350

  2. Acupuncture: $3,674

  3. Chiropractor: $3,482

In contrast, the three provider types with the lowest charge per claimant were:

  1. Emergency Medicine: $1,613

  2. General Practice: $1,826

  3. Orthopedic Surgery: $2,810

Yes, you read that right. Over 4,000 bucks for massage therapy but only about
$1,600 for the ER doc.

Remember that a full 70% of these claims were — if the 2007 stats held true for 
2010 — for strains and sprains. And let me go out on a limb here and guess that 
the emergency medicine doctors and orthopedic surgeons were treating the more
serious types of injuries. Yet, they still came out far below the average per
claim charges for massage therapists, acupuncturists, and chiropractors.

And there are other interesting stats in the report.

Forty-three percent of Florida PIP claimants saw a chiropractor in 2007,
compared to 25% seeing a General Practitioner and 9% seeing a Physical
Therapist. According to an IRC report referenced by the Consumer Advocate:

   Chiropractors are the largest percentage of medical providers submitting
   charges for treating PIP claimants and had the highest average total charge
   per claimant as compared with other medical providers.

Although, as we can see from the data for 2010, even they have been surpassed in
average charge per claimant by massage therapists and acupuncturists.

As well, the IRC report noted:

   Treatment by a GP tends to involve many fewer visits than treatment by other 
   types of providers. For PIP claims countrywide closed in 2007, claimants
   treated by GPs had 4.8 GP visits, on average. In contrast, PIP claimants
   treated by a chiropractor had 21.7 chiropractor visits, on average.

That’s right, rounded off, 5 visits versus 22 visits, over four times as many.
Think of the poor patient: maybe 22 times getting off work or getting a baby
sitter. The carbon footprint alone for 22 visits is alarming. And all this for a
strain or sprain?

But is it worth it?

All of this raises an obvious question: Even if treatments by massage
therapists, acupuncturists and chiropractors are more expensive, are they worth 
it?

First, let’s examine that $4,000+ worth of massage therapy. Under state law,
“massage” means

   the manipulation of the soft tissues of the human body with the hand, foot,
   arm, or elbow, whether or not such manipulation is aided by hydrotherapy,
   including colonic irrigation, or thermal therapy; any electrical or
   mechanical device; or the application to the human body of a chemical or
   herbal preparation.

(I know, I know, colonic irrigation! Massage is routinely associated with
quackery, unfortunately.)

While the use of “any electrical or mechanical device” might seem scarily broad 
and open to abuse in pumping up the bill, it appears that the massage therapists
billing for treatment of PIP claimants were actually performing, well, massage.
In 2010, massage and deep tissue massage were among the top ten billed
procedures in PIP claims. Measured in 15 minute increments, called “units,”
there were a whopping 1,836,308 units of deep tissue massage billed, and an even
more whopping 4,051,016 units of what is generically referred to as “massage”
billed. That’s almost 6 million units total, which equals one 15 minute massage 
for about every third person in the whole state of Florida. (1)

I’m no biostatistician, but I did look on PubMed to see what the evidence might 
be for massage. One Cochrane Review found that “massage might be beneficial for 
patients with subacute and chronic non-specific low-back pain, especially when
combined with exercises and education.” In the cited studies, massage (of
several different types), lasted between 10 minutes and one hour, for between
one and 10 sessions.g

SBM assistant editor Paul Ingraham, a former massage therapist, has written in
detail about another paper, with the revealing and title, “Massage Therapy
Kinda, Sorta Works for Back Pain: It works, but not very well.” Damned with
faint praise? That’s what Paul said.

A 2007 Cochrane Review found that “No recommendations for practice can be made
at this time because the effectiveness of massage for neck pain remains
uncertain.” I couldn’t find any good evidence on cost-effectiveness compared
with other treatments.

In his very evidence-centric low back pain book, Paul Ingraham concedes the
cost-effectiveness problem with a personal anecdote:

   Thus, hunting for trigger points [a common form of “advanced” massage]
   invariably involves expensive fumbling around. When I was a Registered
   Massage Therapist, I was painfully aware that $1.67 was flying out of my
   patient’s pocket every single minute as I hunted around for their trigger
   points — I ought to be damned good to justify that kind of expense, and the
   sad truth is that I wasn’t always, and I was supposedly unusually expert at
   it (the author of an entire books about back pain and trigger points).

Thus, my lightly evidence-based conclusion is that, while massage might be
beneficial for some types of low back pain (if this is the problem presented by 
the sprain or strain at hand), at $4,350 a pop it doesn’t appear that you’re
getting your money’s worth.

Massage is often included as CAM by CAM proponents. I am not so sure that is a
correct characterization. But for the purposes of this post, I’ll cede the point
because it illustrates something proponents don’t particularly like to
acknowledge: that what they call “CAM” can have some very real adverse effects
on the public, even if they are not of the physical sort, a point I’ll return to
later.

Let’s move on to the far more studied acupuncture and chiropractic, which won
second and third place, respectively, in the category we’ll call “Most Expensive
Provider of Treatment for Mostly Inconsequential Injuries.”

Sorting out the details on acupuncture is complicated by the broad scope of
practice given acupuncturists under Florida law:

   Acupuncture shall include, but not be limited to, the insertion of
   acupuncture needles and the application of moxibustion to specific areas of
   the human body and the use of electroacupuncture, Qi Gong, oriental massage, 
   herbal therapy, dietary guidelines, and other adjunctive therapies, as
   defined by board rule.

“As defined by board rule” is a boon to acupuncturists, because the acupuncture 
board has helped itself to a whole bunch of nonsense, including cupping,
“thermal methods,” magnets, reflexology, laser biostimulation (whatever that
is), recommendation of supplements and homeopathic preparations (which
acupuncturists can also sell to the patient) and herbology.

Thus, we cannot know from the Consumer Advocate’s report how much of a billed
procedure was acupuncture or “thermal methods” or cupping. But from the fact
that, as the law now stands, acupuncture would have to be prescribed by a
covered provider (M.D., osteopath, chiropractor or dentist) or performed by the 
covered provider himself, I think we can safely assume that most of what was
done was acupuncture, although we don’t know what kind.

Acupuncture of all stripes has been the subject of numerous posts here at SBM,
and we know that it doesn’t work for anything. Period. This was recently
confirmed by yet another study. Thus the $3,674 per claim paid to acupuncturists
is a huge waste of money.

The problem will get worse if a bill proposed for the 2012 legislative session
becomes law. It would amend the no-fault auto insurance statute to include
licensed acupuncturists as covered providers. This would mean that the
acupuncturist is in total control of the diagnosis and treatment, no referral
required. Magnets, anyone?

And finally, bringing up the rear of the top three, is chiropractic. In Florida,
we adhere to the traditional, D. D. Palmer definition of chiropractic:

   the science, philosophy, and art of the adjustment, manipulation, and
   treatment of the human body in which vertebral subluxations and other
   malpositioned articulations and structures that are interfering with the
   normal generation, transmission, and expression of nerve impulse between the 
   brain, organs, and tissue cells of the body, thereby causing disease, are
   adjusted, manipulated, or treated, thus restoring the normal flow of nerve
   impulse which produces normal function and consequent health by chiropractic 
   physicians using specific chiropractic adjustment or manipulation techniques 
   taught in chiropractic colleges accredited by the Council on Chiropractic
   Education.

As we know, the vertebral subluxation doesn’t exist. But tell that to the
Florida Legislature.

Given the ubiquity of chiropractic belief in the subluxation, and the fact that,
according to chiropractors, these putative subluxations can be caused by
accidents, it seems reasonable to conclude that at least some of the $3,482 per 
PIP claim charged by chiropractors is going to the detection and correction of
the non-existent subluxation (or one of its many iterations, such as manipulable
lesion or joint dysfunction) which is, after all, the very definition of
chiropractic practice in Florida.

But even when chiropractors branch out and include other treatments, the results
are unimpressive. A recent Cochrane Review looked at, for low back pain, “a
combination of therapies such as SMT or adjustment, massage, thermotherapies,
electrotherapies, the use of mechanical devices, exercise programs, nutritional 
advice, orthotics, lifestyle modification, and patient education” rendered by
chiropractors. (2) The conclusion:

   Combined chiropractic interventions slightly improved pain and disability in 
   the short-term and pain in the medium-term for acute and subacute LBP.
   However, there is currently no evidence that supports or refutes that these
   interventions provide a clinically meaningful difference for pain or
   disability in people with LBP when compared to other interventions.

It is interesting to note that several of the therapies employed by
chiropractors and included in the Cochrane Review are among the top ten PIP
procedures billed for 2010. In addition to “Chiropractic Manipulation, 3-4
regions,” which came in number 10, at 1,023,671 procedures, we have the
following, along with the number of these procedures performed last year on PIP 
claimants by all providers:

  1. Electrical Stimulation (15 min.): 1,172,400

  2. Electrical Stimulation (time not specified): 2,219,955

  3. Hot Pack/Cold Pack: 2,315,997

  4. Ultrasound Modality (15 min.): 2,324,928

What’s the harm?

The harm caused by CAM providers and their therapies is generally reported in
terms of side effects of those therapies. Here, we have evidence of a larger
economic harm to the general public. Three CAM providers — as defined by CAM
proponents — are the most expensive providers of PIP-insured claims. Of these,
the main therapy of two — acupuncture and chiropractic — are scientifically
implausible and have (as one might guess) no evidence of effectiveness. The
third, massage, is the most expensive, with limited evidence of effectiveness
and no evidence that it is more cost effective than other treatments.

And all this for mostly sprains and strains.

Obviously, there are other drivers of these huge premium increases in the PIP
system. One is out and out fraud. Another is increased litigation, and here it
is fair to note that claimants under chiropractic care were more likely to have 
an attorney. For 2007, the association between the type of provider and having
an attorney were:

  1. Chiropractor: 62%

  2. Orthopedist: 24%

  3. Physical Therapist: 15%

And here’s the harm.

According to the Consumer Advocate’s report, some Florida families are paying
$3,500 annually in PIP premiums for $10,000 in PIP coverage. That’s right: more 
than a third of the total coverage amount in premiums.

Another example from the report: A retired couple in Tampa with one car insured 
by State Farm paid $471 in PIP premiums this year. The average family with teen 
drivers and two cars in Tampa paid almost $2,000 to State Farm for the same
coverage. If this family earned the $40,000 median income for Hillsborough
County (Tampa), they would be paying an astounding five percent of that income
for $10,000 in PIP coverage.

We don’t know from the Consumer Advocate’s report how much of this can be
attributed to diagnosis and treatment of conditions that don’t exist by covered 
providers. Nor can we know how much can be attributed to expensive treatment by 
massage therapists where less expensive but equally effective treatment might
take its place.But we do know this. When given the opportunity to treat mostly
minor, self-limiting injuries with methods of dubious, or no, effectiveness, and
given expansive insurance coverage, CAM providers come out on top in terms of
expense. And I’ll bet that’s a statistic you’ll never see CAM proponents quote.

Notes

1. According to the 2000 census, the population of Florida is 15,982,378.

2. To the uninitiated, the referenced “adjustment” means, in chiropractic lingo,
adjustment of the aforementioned vertebral subluxation which, as noted, can’t
do the patient any good because spinal subluxations don’t exist.

Obamacare, the Oregon Experiment, and Medicaid

David Gorski on September 30, 2013

Link

Tomorrow, as mandated by the Patient Protection and the Affordable Care Act
(PPACA, often called just the Affordable Care Act, or ACA, or “Obamacare”), the 
government-maintained health insurance exchanges will open for business (that
is, assuming the likely government shutdown doesn’t stop them temporarily). We
here at SBM have written about the ACA quite a few times, but I would like to
write about it in perhaps an entirely different context than you’re used to now 
that the biggest change mandated by the law is here. Just to see the contrast,
I’ll mention that Jann Bellamy has written about the ACA in the context of how
provisions have been inserted by promoters of “complementary and alternative
medicine” (CAM) could potentially provide an “in” for requiring reimbursement of
CAM practitioners for their services by insurance plans sold through the
exchanges or even how CAM practitioners might promote themselves as primary care
providers (PCPs) under Obamacare, as did Matt Roman. I myself warned about
legislative meddling that might permit funding of religion-based health care in 
the exchanges, and Kimball Atwood sounded early warnings about insertion of the 
provisions that Jann warned about. Instead, view this discussion as a follow-up 
to a post I did almost a year ago that used a statement by Mitt Romney during
the height of the Presidential campaign as a jumping off point to look at the
relationship between health insurance status and mortality. While we at SBM try 
to remain more or less apolitical, in some cases (licensing of naturopaths, for 
example) it is not possible to disentangle science from politics, and we have to
dive in. Also, politics is the art of the possible; so, policy-wise, what is
best as determined by science might well not be what is possible politically.

The reason I wanted to revisit this topic is because of a political battle that 
went on for quite some time over the last several months to expand Medicaid in
Michigan according to the dictates of the ACA. The reason that this battle is
occurring in many states is because when the Supreme Court ruled last year that 
the individual mandate requiring that citizens have health insurance was
Constitutional, one provision that it ruled unconstitutional was the mandatory
expansion of Medicaid in states participating in the Medicaid program to cover
all people under 65 up to 133% of the federal poverty level. States thus had to 
decide whether or not they would accept the Medicaid expansion. In our state,
Governor Rick Snyder supported the expansion. Even though he is Republican, he
is also a businessman and realized that it was a good deal, with the federal
government covering 100% of the cost for the first three years and then phase
down to 90% of the cost in 2020. The bill to expand Medicaid managed to pass the
House of Representatives, but then it stalled in the Senate. Unfortunately—and 
this is what got me involved—my state Senator Patrick Colbeck led the opposition
to the Medicaid expansion in the Senate, much to my chagrin and disappointment.
His argument, which is being repeated elsewhere in the blogosphere, is that
Medicaid is worthless and doesn’t improve health outcomes. Instead, he endorsed 
an alternative that (or so he claimed) places Medicaid-eligible patients into in
essence low cost, high deductible concierge practices, with health savings
accounts. This was a plan promoted by practices like BlueSky Health. Ultimately 
Mr. Colbeck lost, and Medicaid was expanded in Michigan in a plan that was
characterized by John Z. Ayanian in this week’s New England Journal of Medicine 
as “a pragmatic pathway to link Republican and Democratic priorities for health 
care.”

However, the whole kerfuffle got me to thinking. In my post a year ago, I
basically asked what the evidence was that access to health insurance improves
health outcomes, but I didn’t really stratify the question into kinds of health 
insurance. Rather, I just looked at being uninsured versus having health
insurance. After my little Facebook encounter with one of my elected
representatives, I wondered what, exactly, was the state of evidence. So I
decided to do this post. In the U.S., currently we have in essence three kinds
of health insurance, broadly speaking: private insurance, Medicare, and
Medicaid. Medicare, for those of our readers from other countries, is a plan
that covers the medical care of people 65 and over and those receiving Social
Security disability benefits. It is funded through payroll taxes and directly
paid for by the federal government. Medicaid, in contrast, is a plan designed
for low income people who fall below certain income levels. Also in contrast, it
is jointly funded by the states and the federal government with each
participating state administering the plan and having wide leeway to decide
eligibility requirements within the limits of federal regulations that determine
the minimal standards necessary for states to receive matching funds. Indeed,
the loss of this leeway to determine the income level at which a person is
eligible for Medicaid is one of the reasons the provision for Medicaid expansion
was part of the Supreme Court challenge to the ACA. These days, most Medicaid
plans hire private health maintenance organizations (HMOs) to provide insurance.
Finally, what needs to be understood is that, compared to private insurance,
Medicare reimbursement rates tend to be lower and Medicaid reimbursement rates
are lower still, which is part of the reason why a lot of doctors don’t accept
Medicaid. Increases in reimbursement under the ACA might well help this
situation.

Observational evidence

With that admittedly lengthy introduction behind us, let’s look at the science
of the question of whether Medicaid is as useless as Mr. Colbeck and others
claim that it is. It’s a huge set of studies, many conflicting and many also
unable to control completely for confounders that interact with insurance
status, such as socioeconomic status, risk factors like tobacco and alcohol
abuse, and the like. Not surprisingly, unlike claims of Medicaid detractors,
it’s complicated, and, like most complicated issues in medicine, there are
studies that can be cherry picked by anyone to make whatever point he wants
(which is exactly what my state Senator tended to do). A good place to start
(for me, at least) is my original post from a year ago, because there was one
study to which I alluded that showed differences in outcomes in cancer patients 
that correlate with their insurance status. Specifically, this is the University
of Virginia study from 2010 which found that Medicaid and uninsured status were
independently associated with increased risk-adjusted mortality. I mentioned
that, but didn’t dwell on it, because the question I was examining was not
Medicaid versus private insurance but rather having health insurance versus no
health insurance. In this study, however, the authors noted the multifactorial
causes of poorer outcomes in Medicaid patients. There are other studies that
find similar outcome disparities. For instance, using the National Inpatient
Sample (NIS) database, which is a stratified random sample of all hospital
discharges in the United States maintained by the Agency for Healthcare Research
and Quality as part of the Healthcare Cost and Utilization Project, a 2003
study from the University of Michigan found that for abdominal aortic aneurysms 
(AAA) uninsured and Medicaid status were associated with higher mortality and
rupture rates:

   Operative mortality rates after elective AAA repair were greater (P =.04) for
   patients with no insurance (2.6%) or Medicaid (2.7%), compared with patients
   with private insurance (1.2%). Similarly, operative mortality rates for AAA 
   repair after rupture were greater (P =.001) in patients without insurance
   (45.3%) or Medicaid (31.3%), compared with patients with private insurance
   (26.2%).

Of course, in this study, Medicaid patients did better than the uninsured for
some outcomes. For instance, if you look at the adjusted odds ratio for AAA
rupture, Medicaid status had no effect, with an odds ratio of 0.84 (0.55-1.3,
p=0.41), while no insurance produced an odds ratio of 2.3 (1.5-3.5, p=0.001).
From the point of view of this study, it is better to have Medicaid than to be
uninsured but not as good as having private insurance. This is not entirely
surprising because of the low reimbursement rates of Medicaid, which limit the
choices of physicians and institutions for Medicaid patients and make it
prohibitive for many private primary care doctors to care for Medicaid patients.
Similar results were found in a 2011 study of cardiac valve replacement from
the University of Virginia, which showed the best outcomes in terms of mortality
and in-hospital complications in patients with private insurance, followed by
Medicare patients, Medicaid patients, and the uninsured, who had the worst
outcomes of all. They also reported that Medicaid patients accrued the longest
hospital stays and highest costs. Consistent with this, a 2013 study from the
University of Virginia of pediatric surgery patients undergoing mostly urgent
surgery for appendectomy, intussusception, decortication, pyloromyotomy,
congenital diaphragmatic hernia repair, and colonic resection for Hirschsprung’s
disease showed that uninsured patients were at increased risk for mortality,
while Medicaid patients were at increased risk of morbidity.

Of course, the question really boils down to whether it is equivalent to be
uninsured versus having Medicaid, which some studies seem to indicate, or not.
Again, this is a very complicated question, because studies looking at specific 
outcomes can be confounded by uninsured patients getting Medicaid. For instance,
uninsured patients who are diagnosed with cancer in our state frequently
qualify immediately for Medicaid and are no longer uninsured. This leads to a
rather frustrating situation for some of my patients who are uninsured and
suspected of having cancer but can’t afford the biopsy necessary to prove it and
make them eligible for Medicaid. We have other resources, including limited
state funds and charitable funds administered through our cancer center that can
pay for such biopsies, but it’s very frustrating to cancer doctors that such
resources are even necessary given how great the need is.

All of this leads to a potential explanation, and quite a reasonable explanation
at that, as to why Medicaid patients do more poorly than patients with private 
insurance in some studies (the ones touted by Mr. Colbeck as indicating that
Medicaid is worthless and doesn’t improve health outcomes), and that’s the delay
in treatment. This was alluded to as a possible cause in the AAA study from
2003, but it’s suggested more explicitly as a cause in a 2012 study from the
Brigham and Women’s Hospital examining outcomes after surgery for spinal
metastases. This study found higher mortality rates for the uninsured and
Medicaid patients, as well as higher complication rates. However, these were
crude estimates. When the investigators adjusted for acuity of presentation,
there was no significant differences in the risk of death or complications
between privately insured patients and Medicaid patients or the uninsured,
leading the authors to conclude that, “This nationwide study suggests that
disparities based on insurance status for patients undergoing surgery for spinal
metastases may be attributable to a higher acuity of presentation.” A recent
systematic review of outcomes in lung cancer patient mortality came to similar
conclusions:

   The mechanisms underlying care disparities for patients without insurance and
   for those who receive Medicaid are unclear but probably multifactorial (6,
   41). There are likely patient-related factors, such as individual differences
   in health behaviors such as smoking, income, education, and comorbidities.
   Others may stem from a differential ability to interact with the healthcare
   system, differences in the care provided by institutions that serve Medicaid 
   and uninsured patients, and less access to better-quality care. Our review
   indicates that some of these latter mechanisms may be important based on
   studies that show differential rates of receiving guideline-concordant care
   (31, 32), receiving care at a university cancer center (29), receipt of
   surgery or radiation therapy (20), and receipt of care at high-volume centers
   (27, 28). Although uninsured patients and those with Medicaid may be more
   likely to be treated at certain centers, no studies directly adjusted for
   center-level effects, so we cannot determine their role on the assessed
   outcomes (42).

Taken together, from my perspective, the evidence is consistent with a
conclusion that having Medicaid results in better health outcomes than not
having Medicaid but that those outcomes are not as good as those associated with
having private insurance (although one study did find a paradoxical result).
Most likely this is due to a combination of socioeconomic status and lack of
primary care resources, all leading to their presenting at a later stage in
their disease, as these studies, which are just a more recent sampling of
existing studies, clearly indicate. For some conditions, Medicaid patients do as
poorly as the uninsured, and those are the studies cited by legislators like
Mr. Colbeck to argue against Medicaid expansion. Sometimes they are intermediate
in their outcomes, not as good as patients with private insurance but not as
bad as the uninsured. These tend to be the studies ignored by legislators like
Mr. Colbeck and the pundits that he cites. However you analyze the evidence,
however, it is clear that Medicaid patients do have worse outcomes, sometimes a 
lot worse, than patients with private insurance, and that the cause is almost
certainly multifactorial in such a way that simply getting access to bare-bones 
health insurance like Medicaid can’t remedy. Many of these studies have
unmeasured confounders that result in worse outcomes in Medicaid patients. As
Frakt et al have argued, selection bias in these studies explains a lot of the
results:

   It’s far more likely that such results are driven by selection bias. Medicaid
   enrollees (including dual-eligible recipients of both Medicaid and Medicare)
   tend to be sicker than uninsured patients and to have lower socioeconomic
   status, poorer nutrition, and fewer community and family resources. Medical
   and social service providers may also help the sickest or neediest patients
   to enroll in Medicaid — a more direct cause of selection bias. Few of these
   potential confounders can be completely addressed using commonly available
   clinical or population data.

   Health economists use an alternative approach in analyzing Medicaid’s
   outcomes that seeks to eliminate selection bias related to unobservable
   factors affecting enrollment and health outcomes. By exploiting the variation
   in Medicaid eligibility rules or other program characteristics influencing
   states’ enrollment rates, scholars have consistently found that Medicaid
   coverage leads to health improvements.4,5 The assumption behind these
   “instrumental variables” approaches is that Medicaid enrollment depends on
   state-level eligibility rules but patients’ health status does not.

Personally, I suspect that there is a lot of selection bias in these studies.
Young healthy adults without insurance who are eligible might not enroll in
Medicaid because they don’t think they need it and also tend not to need the
procedures examined in the studies I discussed. In contrast, if you’re sick and 
eligible for Medicaid, you’ll be more likely to enroll because you need the
treatment. Also, as I’ve pointed out before, in studies of cancer, there is a
lot of crossover between the uninsured and Medicaid recipients, because in some 
states like mine a cancer diagnosis makes an adult who might not have been
eligible for Medicaid (remember, some states restrict Medicaid eligibility using
more than just income) will suddenly become eligible. I’ve lost count of the
number of patients I’ve taken care of for whom this was true. The same thing
happens in emergency rooms all over the place, where hospitals, confronted with 
an uninsured patient, help him apply for Medicaid during the course of an acute 
illness.

Would expanding Medicaid result in better health outcomes?

Of course, the name of this blog is Science-Based Medicine, and the question
that results from the confusing and conflicting mass of studies sampled above is
whether expanding Medicaid would result in better health outcomes for the
people who receive the expanded coverage. This is a much more difficult question
to answer, but there have been studies designed to address it. The two most
prominent are frequent “targets” of discussion. The previous studies that I’ve
cited are all retrospective studies, with all the attendant shortcomings of
retrospective studies, and none of them address this question. They simply found
correlations, and some of them tried to explain these correlations.

One study that is often touted as strong evidence that expanding Medicaid
eligibility will likely result in better health outcomes was a study published
in the NEJM a year ago. What the investigators did was to identify states that
had expanded Medicaid to cover childless adults (in many states childless adults
have not been eligible for Medicaid coverage) between 2000 and 2005 to allow
comparisons for a five year period before the expansion and after the expansion:

   Three states met our criteria: Arizona, which expanded eligibility to
   childless adults with incomes below 100% of the federal poverty level in
   November 2001 and to parents with incomes up to 200% of the federal poverty
   level in October 2002; Maine, which expanded eligibility to childless adults 
   with incomes up to 100% of the federal poverty level in October 2002; and New
   York, which expanded eligibility to childless adults with incomes up to 100%
   of the federal poverty level and parents with incomes up to 150% of the
   federal poverty level in September 2001.

The controls selected were neighboring states without Medicaid expansions that
were closest in population and demographic characteristics to the three states
with Medicaid expansions. The primary outcome examined was annual county-level
all-cause mortality per 100,000 adults between the ages of 20 and 64 years
(stratified according to age, race, and sex), obtained from the Compressed
Mortality File of the Centers for Disease Control and Prevention (CDC) from 1997
through 2007, totaling 68,012 observations specific to an age group, race, sex,
year, and county. Secondary outcomes included percentages of persons with
Medicaid, without any health insurance, and in “excellent” or “very good” health
(from the Current Population Survey, a total of 169,124 persons) and the
percentage unable to obtain needed care in the past year because of cost (from
the Behavioral Risk Factor Surveillance System, a total of 192,148 persons).
Multivariate analyses were carried out, and prespecified subgroup analyses, and 
as an additional test the same analyses were carried out for people over 65, who
were eligible for Medicare and whose Medicaid eligibility was therefore not
affected by the Medicaid expansion. Overall, the investigators found a 6.1%
relative reduction in the risk of death among adults between the ages of 20 and 
65, leading them to estimate this:

   A relative reduction of 6% in population mortality would be achieved if
   insurance reduced the individual risk of death by 30% and if the 1-year risk 
   of death for new Medicaid enrollees was 1.9% (Table S4 in the Supplementary
   Appendix). This degree of risk reduction is consistent with the Institute of 
   Medicine’s estimate that health insurance may reduce adult mortality by 25%, 
   though other researchers have estimated greater35 or much smaller36 effects
   of coverage. A baseline risk of death of 1.9% approximates the risk for a
   50-year-old black man with diabetes or for all men between the ages of 35 and
   49 years who are in self-reported poor health. The lower end of our
   confidence interval implies a relative reduction in the individual risk of
   death of 18%.

This study did, of course, have a fair number of confounders and shortcomings.
For one thing, it was not a randomized design, and it was an ecological study,
which tends to overestimate effects. Also, as the authors point out, states tend
to decide to expand Medicaid when the economy is doing well and they can afford
to do it. Also, there is a correlation between states willing to expand
Medicaid and investment in other measures designed to improve public health. On 
the other hand, the authors reported found that new Medicaid enrollees tended to
be older, disproportionately minorities, and twice as likely to be in fair or
poor health as the general population, all of which to them suggested a higher
risk of mortality. In other words, this study was promising, but by no means
slam-dunk evidence that Medicaid expansion will result in better health
outcomes.

The Oregon study

No discussion of this issue is complete without a consideration of a study in
Oregon designed to look at the effect of Medicaid expansion. Its most recent
results were reported in the NEJM five months ago and were seized upon by
advocates on all sides, but in particular the “Medicaid expansion doesn’t work” 
and “Medicaid is harmful” side. It’s a curious study in that, had it been
proposed to me before I already knew that it had been begun, I would have
seriously questioned whether the study was ethical and would pass an
institutional review board. Obviously it did, and the reason is that it wasn’t
the investigators who did the randomization. Rather, Katherine Baicker and her
colleagues took advantage of an existing randomization. What happened is this.
In 2008, because its legislature found the money to fund additional Medicaid
coverage, Oregon used a lottery system to determine who of a waiting list of
90,000 would have a chance at getting Medicaid. Selected adults won the right to
apply for Medicaid and got it if they met the eligibility requirements. A
sample of adults who won the Medicaid lottery were compared to adults who
participated in the lottery but didn’t win. Outcome measures examined included
blood-pressure, cholesterol, and glycated hemoglobin levels; screening for
depression; medication inventories; and self-reported diagnoses, health status, 
health care utilization, and out-of-pocket spending for such services. This
sample was limited to the Portland metropolitan area because of logistical
constraints and consisted of 20,745 people: 10,405 selected in the lottery (the 
lottery winners) and 10,340 not selected (the control group), of which a total
of 12,229 persons in the study sample responded to the survey. Interviews were
conducted between September 2009 and December 2010 and took place an average of 
25 months after the lottery began.

This was a rare opportunity to take advantage of an existing natural experiment 
in whether providing Medicaid coverage to the uninsured actually does what it is
intended to do. Unfortunately, given its timing, the results of the study have 
become a political punching bag with the Oregon study in essence being used as a
weapon against the whole of Obamacare and misrepresented as being slam dunk
evidence that Medicare is at least useless. In essence, as Ashish Jha put it,
the Oregon Study became a Rorschach test of sorts, confirming people’s biases
about whether Medicaid is “good” or “bad.”

So what did it show?

The results were mixed and rather disappointing in some respects but not
entirely unexpected given the short follow-up time of only two years:

   We found no significant effect of Medicaid coverage on the prevalence or
   diagnosis of hypertension or high cholesterol levels or on the use of
   medication for these conditions. Medicaid coverage significantly increased
   the probability of a diagnosis of diabetes and the use of diabetes
   medication, but we observed no significant effect on average glycated
   hemoglobin levels or on the percentage of participants with levels of 6.5% or
   higher. Medicaid coverage decreased the probability of a positive screening 
   for depression (−9.15 percentage points; 95% confidence interval, −16.70 to
   −1.60; P = 0.02), increased the use of many preventive services, and nearly
   eliminated catastrophic out-of-pocket medical expenditures.

As has been pointed out at The Incidental Economist, this led those opposing
Obamacare to declare the experiment a failure. Some go so far as to declare that
the ACA has completely failed, that Medicaid is a horrible thing, and that
anyone who tries to argue against this is a “Medicaid denier.” (I kid you not;
unfortunately, Avik Roy, a “health policy columnist” for Forbe.com, used this
very term. One notes that Mr. Roy is a person known for making seriously bad
arguments.) Unfortunately, my state Senator buys into these arguments. I also
agree with Jha when he challenges physicians to go through all 62 pages of the
supplementary appendix describing the methodology in detail because this study
is as good as any study on the matter likely to be done in a generation.

So is it really as bad as that? Of course not. The study is, as are most studies
of this type, messy and early results are disappointing, but by no means is it 
time to declare failure yet. For one thing, improved mental health outcomes are 
improved outcomes. The way critics of Medicaid ignore this result or pooh-pooh
it to me is consistent with how we give short shrift to mental health in this
country, viewing mental illness as somehow not being “real” illness. Also, the
marked decrease in financial distress reported in this study is no small thing. 
For another thing, lack of statistical significance doesn’t necessarily mean
that there is no treatment effect. It can mean that, but it can also mean that
the numbers are too small and the study is underpowered, which it could well be.
Indeed, the authors themselves concede as much:

   Hypertension, high cholesterol levels, diabetes, and depression are only a
   subgroup of the set of health outcomes potentially affected by Medicaid
   coverage. We chose these conditions because they are important contributors
   to morbidity and mortality, feasible to measure, prevalent in the low-income 
   population in our study, and plausibly modifiable by effective treatment
   within a 2-year time frame. Nonetheless, our power to detect changes in
   health was limited by the relatively small numbers of patients with these
   conditions; indeed, the only condition in which we detected improvements was 
   depression, which was by far the most prevalent of the four conditions
   examined. The 95% confidence intervals for many of the estimates of effects
   on individual physical health measures were wide enough to include changes
   that would be considered clinically significant — such as a
   7.16-percentage-point reduction in the prevalence of hypertension. Moreover, 
   although we did not find a significant change in glycated hemoglobin levels, 
   the point estimate of the decrease we observed is consistent with that which 
   would be expected on the basis of our estimated increase in the use of
   medication for diabetes. The clinical-trial literature indicates that the use
   of oral medication for diabetes reduces the glycated hemoglobin level by an 
   average of 1 percentage point within as short a time as 6 months.15 This
   estimate from the clinical literature suggests that the 5.4-percentage-point 
   increase in the use of medication for diabetes in our cohort would decrease
   the average glycated hemoglobin level in the study population by 0.05
   percentage points, which is well within our 95% confidence interval. Beyond
   issues of power, the effects of Medicaid coverage may be limited by the
   multiple sources of slippage in the connection between insurance coverage and
   observable improvements in our health metrics; these potential sources of
   slippage include access to care, diagnosis of underlying conditions,
   prescription of appropriate medications, compliance with recommendations, and
   effectiveness of treatment in improving health.

The Incidental Economist thinks that most likely the reason that the results,
although trending in the right direction, didn’t achieve statistical
significance was because the study was underpowered. Jha thinks it’s because
Medicaid only addresses access to care and not quality of care. Both are likely 
contributors, but I tend to think that The Incidental Economist is likely to be 
closer to being correct. Contrary to analyses claiming that this study was not
underpowered, for a controlled study of this type, the fraction of subjects with
each condition very much matters. If only 5% of the population have a
condition, that’s only around 300 subjects in each group. When looking at all
these subgroups, absent dramatic improvements in certain parameters or high
prevalence of the conditions being examined, it is hard to detect statistically 
significant differences, particularly in a short time frame. Finally, these
measures are all surrogate measures. What will really be interesting to
determine will take considerably more time than two years to determine, namely
whether Medicaid coverage decreases morbidity and overall mortality. Indeed, The
Incidental Economist asks a very pertinent question: “What is reasonable to
expect? How much does private insurance affect these values? Do we know? No.
There is no RCT of private insurance vs. no insurance. No one claims we have to 
have one. We just “know” private insurance works.”

The bottom line

As I stated earlier, as much as we would like political policy to be
science-based, particularly in health care, it can’t be said enough that
politics is the art of the possible, and the ACA is what was possible at the
time it was being negotiated. As a product of a messy political process, it is
far from perfect. The question is whether the claims made for the ACA and its
provisions are supported by evidence. Because a large part of mechanism by which
the ACA will decrease the number of uninsured is through the Medicaid
expansion, studies like the Oregon study are very important for determining
whether it has a reasonable chance of succeeding in improving the health
outcomes of these people. As is all too frequently the case, the error bars are 
large surrounding the data relating Medicaid and health outcomes, and
unfortunately the most recently reported results of the Oregon study come after 
too brief a time to make any definitive pronouncements, attacks on it by
anti-Obamacare pundits notwithstanding. Moreover, when it comes to public
policy, science is certainly a major consideration, but so are economics and
justice. Reasonable people might disagree on where the balance should be struck,
but nothing is served by distorting the science for political ends.
Unfortunately, there is a lot of that going on right now and, I suspect, it will
only get worse before it gets better.

Obamacare and CAM

Jann Bellamy on July 12, 2012

Link

Practitioners of so-called “complementary and alternative medicine” currently
enjoy a certain measure of government largesse in the form of state laws
mandating coverage of their services by private health insurance plans. The
federal Patient Protection and Affordable Care Act (often referred to as the
Affordable Care Act, or “ACA,” and sometimes as “Obamacare”) has the potential
of putting a significant dent in this forced coverage of pseudoscientific health
care.

All states require private health insurers to cover certain health care services
by law. These mandates can be in the form of requirements that specific health 
care services or treatments be covered, that certain providers be covered, or
that certain populations be covered.

Mandates are ubiquitous, inconsistent among states and costly. One insurance
industry trade group calculates that there are currently 2,262 separate state
mandates. Some are supported by clear evidence of benefit, such as immunizations
and mammograms. Others, unfortunately, require coverage of “CAM” services, such
as acupuncture and chiropractic. (In fact, acupuncture is typically not covered
by small group plans unless required by state mandate.) Whether beneficial or
not, all agree that these mandates increase premium costs to the consumer, most 
estimated to be from less than one percent to five percent of premiums,
depending on the mandate. Chiropractic coverage, for example, can vary from
state to state, from limiting the insured to a specific number of visits per
year all the way to requiring chiropractors to be covered on par with medical
doctors.

The ACA’s effect on state mandates

The ACA is nothing if not complicated, but bear with me. Under the ACA, all
health insurance plans sold to individuals and small businesses must cover
“essential health benefits” (EHBs). This includes plans sold on the state-run
exchanges, where certain individuals (including those who wouldn’t otherwise
have access to health insurance) can purchase insurance. The ACA requires these 
plans to cover:

  1. Ambulatory patient services

  2. Emergency services

  3. Hospitalization

  4. Maternity and newborn care

  5. Mental health and substance use disorder services

  6. Prescription drugs

  7. Rehabilitative and habilitative services and devices

  8. Laboratory services

  9. Preventive and wellness services and chronic disease management

  10. Pediatric services, including oral and vision care

Congress left it up to the U.S. Department of Health and Human Services (HHS) to
further define “essential health benefits” within these broad categories. The
individual states will continue in their role as health insurance regulators,
although they must now operate within the parameters of the ACA. As mentioned,
state functions include management of the ACA-mandated health insurance
exchanges, where federal subsidies are available to assist those who cannot
afford the premiums. Importantly, the ACA prevents federal subsidies from paying
for state mandates which exceed EHBs, as defined by HHS. States will be
required to pick up the tab for the extra cost of non-EHB mandates themselves.
This is a huge disincentive for states to keep mandates that do not fall within 
the EHB definition.

Institute of Medicine recommendations

How HHS defines EHBs will be critical step in ridding the private health
insurance system of CAM. To help decide what EHBs should include, HHS turned to 
the Institute of Medicine

   to recommend a process that would help HHS do two things: 1) define the
   benefits that should be in the EHB, and 2) update the benefits to take into
   account advances in science, gaps in access, and the impact of any benefit
   changes on cost. . . . The charge of the [IOM] committee specifically was not
   to decide what is covered in the EHB but rather to propose a set of criteria
   and methods that should be used in deciding what benefits are most important
   for coverage.

Two summaries of the IOM’s recommendations indicate that, if followed by HHS,
those recommendations could go a long way in eliminating pseudoscience from
insurance coverage. In one summary, the IOM stated that “only medically
necessary services should be covered” and that the benefit package “needs to be 
based on credible evidence of effectiveness.” In a second report summary setting
forth specific EHB criteria, the IOM included these salient features under the 
topic heading “Criteria to Guide EHB Content on Specific Components:”

   The individual service, device or drug for the EHB must:

   Be safe – expected benefits should be greater than expected harms.

   Be medically effective and supported by a sufficient evidence base, or in the
   absence of evidence on effectiveness, a credible standard of care is used.

   Demonstrate meaningful improvement in outcomes over current effective
   services/treatments.

   Be a medical service, not serving primarily a social or educational service.

   Be cost effective, so that the health gain for individual and population
   health is sufficient to justify the additional cost to taxpayers and
   consumers.

In addition, the IOM included as criteria under the topic, “Criteria to Guide
Methods for Defining and Updating the EHB:”

   Methods for defining, updating, and prioritizing must be:

   Transparent. The rational for all decisions about benefit design, and changes
   is made publicly available. . . .

   Sensitive to value. To be accountable to taxpayers and plan members, the
   covered service must provide a meaningful health benefit. . . .

   Responsive to new information. EHB will change over time as new scientific
   information becomes available. . . .

   Data driven. An evaluation of the care included in the EHB is based on
   objective clinical evidence and actuarial reviews.

If you find this less than a perfect recipe for the delivery of science-based
medicine, it is nevertheless a vast improvement over the current system of state
mandates, where coverage is too often based on the lobbying efforts of special 
interest groups. If these strictures are implemented, we should see the eventual
elimination of coverage for acupuncture and a good bit of chiropractic and
naturopathy. At the very least, if coverage decisions are transparent, those
decisions which fudge on the evidence will be sitting there in plain view, open 
for criticism.

HHS on EHBs

HHS has yet to issue regulations (which would be legally binding) defining
exactly what “essential health benefits” are, but some guidance has been issued 
so that the states can begin setting up their health insurance exchanges.
Unfortunately, HHS has opted for a system which retains state mandates, at least
for now, and fails to fully implement the IOM’s recommendations. HHS decided
that states can formulate the minimum requirements for a health insurance plan
by choosing, within certain limits, an existing health plan offered in their
state as a benchmark. All insurance plans offered on the exchanges and in the
individual and small group markets must be “substantially equal” to the
benchmark plan.

For 2014 and 2015, states can choose benchmark plans subject to state mandates. 
Because benchmark plans define what EHBs are for a particular state, the state
mandates would automatically be within the definition of EHBs if a private
insurance plan is chosen. This is essentially a run-around of the requirement
that the federal government not pay for state mandates.

However, there is room for optimism. Starting in 2016, HHS will revisit the
benchmark issue and has the option of excluding any particular state mandate
from EHBs. This means that if a state chose a benchmark plan which included
state mandates, the state would have to pick up the tab for the cost of those
benefits axed by HHS. Given the fiscal situation of states, it is highly
unlikely they will continue to mandate coverage for benefits they must pay for
through premium subsidies for those who cannot afford to purchase insurance via 
the exchanges.

As the ACA matures, there is even greater potential for elimination of CAM. One 
of the primary missions of the Affordable Care Act is to make health insurance, 
well, more affordable. To the extent plans are larded with ineffective CAM
treatments that do not improve outcomes they defeat the purpose of the ACA.
Fortunately, the ACA requires HHS to periodically review and update EHBs, using,
among other criteria, changes in medical evidence and scientific advancement.
So, finally, the government will be legally required to look at the evidence in 
determining what benefits must be covered by private health insurance.

According to HHS, private insurers will be required to look at the evidence as
well.

   Under the benchmark framework, we note that the provision of a ‘substantially
   equal’ standard would allow health insurance issuers to update their
   benefits on an annual basis and they would be expected on an ongoing basis to
   reflect improvements in the quality and practice of medicine.

Finally, HHS said that the “benchmark approach” isn’t the last word in
determining EHBs. It intends to propose a process of evaluation of this initial 
system. Again, changes in medical evidence and scientific advancement are a
legally mandated part of this evaluation.

California implements the ACA

Let’s see how the ACA is playing out in California. California Senate Bill 951
and the similar Assembly Bill 1453, both of which define the EHBs for California
under the ACA, are moving through the state legislature. Both peg EHBs to a
Kaiser Foundation small group HMO. The original bills included specific services
which must be covered by plans, including acupuncture and chiropractic
services. However, the bills in their current form exclude specific coverage
mandates.

While most consumer health groups lauded the plan, or were at least optimistic, 
guess who was complaining about lack of coverage? According to California
Healthline, “representatives for the chiropractic industry . . . worried that
those services weren’t adequately included among the essential benefits.” And,
according to a legislative committee report, the California Chiropractic
Association opposed Senate Bill 951 unless it was amended, asking that the
Legislature reexamine the possible choices for an EHB plan to select one that
includes chiropractic benefits. (It is not clear to me whether the benchmark
Kaiser plan totally excludes chiropractic coverage or substantially limits it.)

As well, “The Council of Acupuncture and Oriental Medicine Association write
they are pleased to see SB 951 recognize acupuncture as an EHB, but they are
concerned SB 951 will only apply to acupuncture for treatment of pain and
nausea.” This is so even though acupuncture doesn’t work, but it’s a step in the
right direction.

Thus, even though states, at this point, need not base coverage decisions on
actual evidence, at least one state (and a large one at that) has voluntarily
chosen to limit coverage of two CAM providers. Let’s hope this is a trend.

Summary

In sum, the ACA requires that individual and small group health insurance
policies cover “essential health benefits,” which the Department of Health and
Human Services is working to define. HHS has turned to the Institute of Medicine
for advice, which, if taken, will require that EHBs be both cost effective and 
evidence based as determined through a transparent process. This should
eventually severely curtail or eliminate legally required coverage of “CAM”
practices. If state legislatures mandate non-ESB coverage, such as “CAM”
practices, those states will be required to absorb the additional cost in
subsidies for people who can’t afford premiums.

In the interim, states can choose benchmark plans on which all individual and
small group policies must be based. Mindful that keeping costs down is essential
to the success of the health insurance purchasing exchanges required by the
ACA, states are more likely to choose benchmarks which offer no-frills benefits.
If California’s experience is any indication, efforts will be made to curtail, 
if not eliminate, CAM from essential benefits packages during this interim
period.

As cost considerations and evidence-based decisions take hold in the coming
years (if all goes as planned and the ACA remains law), we should see CAM
providers eliminated or, at the least, more severely curtailed in health
insurance coverage. Perhaps I am being overly optimistic, but the mechanisms are
certainly in place for this to happen. And since you and I pay for CAM coverage
through increased premiums, it will be an economic benefit to us all.

Obamacare and CAM II: Discrimination (or not) against CAM

Jann Bellamy on October 4, 2012

Link

Supporters of science-based medicine have expressed concern over this provision 
in the Patient Protection and Affordable Care Act (“Obamacare,” or the “ACA.”):

   SEC. 2706. NON-DISCRIMINATION IN HEALTH CARE.

   (a) PROVIDERS.—A group health plan and a health insurance issuer offering
   group or individual health insurance coverage shall not discriminate with
   respect to participation under the plan or coverage against any health care
   provider who is acting within the scope of that provider’s license or
   certification under applicable State law. This section shall not require that
   a group health plan or health insurance issuer contract with any health care
   provider willing to abide by the terms and conditions for participation
   established by the plan or issuer. Nothing in this section shall be construed
   as preventing a group health plan, a health insurance issuer, or the
   Secretary from establishing varying reimbursement rates based on quality or
   performance measures.

Section 2706 (now codified as 42 U.S.C. Sec. 300gg-5) goes into effect in 2014
and covers virtually all individual and group insurance market policies,
although it is not clear whether it will apply to existing policies
“grandfathered” in 2010 by the ACA.

Section 2706 was not part of the U.S House of Representatives version of the ACA
but was included in the Senate version (which ultimately passed) under the
guidance of (surprise!) Sen. Tom Harkin (D-Iowa). It was heavily lobbied by the 
American Chiropractic Association and other “CAM” providers, as well as some
“conventional” providers like nurse anesthetists and optometrists. The
legislative history (reports, committee minutes, floor debates and the like
which precede a vote on a bill) indicates it was specifically included to
prevent discrimination against CAM providers.  This is of obvious concern to
anyone who supports science-based, or for that matter evidence-based, medicine, 
as there is nothing to indicate that scientific plausibility or evidence (or the
lack thereof) actually affects CAM practices. It should also concern insurers
and those who pay for insurance (employers and individuals) to the extent it
might require payment for CAM treatments, as ineffective treatments will
negatively affect their bottom line. The U.S. Departments of Health and Human
Services (HHS) and Labor and the Treasury Department, which are charged with
issuing regulations implementing the ACA, have not yet promulgated regulations
for Section 2706. The American Medical Association House of Delegates has
already passed a resolution seeking its repeal.

There is no discussion of exactly what this provision might mean or how it will 
be implemented in the legal literature, or, for that matter, any health care
literature that I can find. On the web, CAM practitioners and proponents claim
it will “end discrimination” against CAM by insurance companies, although I can 
find few examples of exactly how they think they’ve been discriminated against. 
According to one chiropractic commentator, chiropractors have been excluded from
coverage for spinal manipulation in some cases, or in others reimbursed at a
lower rate than M.D.s, but that is all I could find in the way of specific
examples. There is even less about exactly how CAM practitioners expect to
benefit. While the American Association of Acupuncture and Chinese Medicine and 
the American Association of Naturopaths welcomed the passage of Section 2706,
they don’t offer specifics as to how it might increase insurance coverage for
their practices although I imagine they’re busy figuring out the details,
perhaps not in a way that’s open for public viewing.

To the extent CAM practitioners expect Section 2706 to increase insurance
coverage for their services or increase reimbursement, yes that will likely
happen to a certain extent. And of course the ACA greatly increases the number
of insured people. But I don’t expect it to be quite the boon they seem to be
expecting. And here’s why.

Discrimination

But first, a little legal tutorial. A central question in interpretation of
Section 2607 is how the term “discriminate” will be defined. It is undefined in 
the ACA or in any regulations (so far). Very broadly, to “discriminate” means to
treat a person differently than others based on a group to which he belongs
rather than on merit.

In enacting regulations, I anticipate the federal agencies charged with
promulgating them will look to the well-developed body of law of employment
discrimination. First, there are some similarities between choosing workers to
do a particular job and choosing health care providers to perform particular
services. Second, it avoids having to completely reinvent the wheel. Third, it
is an area with which one of the agencies involved, the Department of Labor,
already has considerable expertise. Fourth, insurers, who are themselves large
employers, are already familiar with compliance with the anti-discrimination
laws.

So let’s have a very brief look at some basic principles of employment law to
understand what “discrimination” might mean. Discrimination can be overt (“I’m
not hiring you because I don’t think women can be delivery drivers.”) Or
discrimination can be in the form of an employment practice that has a disparate
impact on a particular group. (The ability to lift 75 pounds for a delivery
driver position will have an adverse impact on the hiring of women.) However,
criteria reasonably related to the requirements for a job are not discriminatory
even if they have an adverse impact on a particular group. (The ability to lift
75 pounds is a legitimate criterion due to the fact that delivery drivers will 
regularly have to lift this amount of weight.) This includes education, training
or a having a particular type of license or certificate as long as they are
reasonably related to requirements of a particular job. (Having a commercial
drivers license for the delivery driver position would be a permissible job
requirement, because it’s required by law, even though it would have a disparate
impact on women because fewer women have this type of license.)

Given the assumption that employment law principles will be incorporated into
interpretation of Section 2706, what will be the effect of the
“Non-Discrimination in Health Care” section of the ACA on CAM practices? At this
point, we can’t know, but here are some thoughts.

Being a covered provider doesn’t mean everything you provide is covered

First, the ACA prescribes 10 broad areas of coverage that must be provided by
(virtually) all insurance plans. These categories are:

  1. Ambulatory patient services

  2. Emergency services

  3. Hospitalization

  4. Maternity and newborn care

  5. Prescription drugs

  6. Rehabilitative and habilitative services and devices

  7. Laboratory services

  8. Preventive and wellness services and chronic disease management

  9. Pediatric services, including oral and vision care

One notable feature of this list is that most of these categories aren’t within 
an acupuncturist’s or chiropractor’s scope of practice. A greater number are
within that of a naturopath, although scope of practice varies among the 16
states in which they are licensed. You can look forward to naturopaths making a 
huge effort to further expand their licensing because insurers can no longer
exclude licensed naturopaths as a group from coverage. However, this cuts both
ways. In order to get insurance companies out of the game, naturopaths have
previously been able to exclude themselves from mandated coverage to get a
naturopath licensing law passed. That is no longer an option. This will give
insurance companies a reason to fight their licensing bills if insurers think
naturopaths will drive up their costs.

As explained in a previous post, instead of promulgating a defined set of
benefits deemed “essential” for insurance coverage, the Department of Health and
Human Services (HHS) has punted to the states to choose a “benchmark” plan from
certain types of health plans sold in each state. On October 1st, states not
making that choice automatically defaulted to a federal employee insurance plan 
as the benchmark.

Nevertheless, federal regulations are being put into place which specifically
define “essential health benefits.” This has already been completed for
preventive services, which must be covered without any co-pay or having to meet 
a deductible. And what do they include? For all adults, services recommended by 
the  U.S. Preventive Services Task Force (USPSTF) for prevention which have an
evidence grade of “A” or “B.” For children, it includes routine vaccinations
recommended by the Advisory Committee on Immunization Practices of the Centers
for Disease Control as well as preventive care guidelines for children from the 
American Academy of Pediatrics. For women HHS apparently developed its own list.
(All of the guidelines can be found here.)

And is there a CAM diagnostic method or treatment among them? Nope.

But, you may well ask, could some of these preventive services be provided by a 
CAM practitioner, even though they are science and evidence based? That is
highly unlikely to happen for chiropractors and acupuncturists, despite
chiropractors’ claims otherwise or the alarming scope of practice granted to
acupuncturists.  Many of the services (e.g., adult and childhood vaccinations)
are simply not within their scope of practice. And while chiropractors may claim
to offer some of the preventive services (e.g., obesity screening and
counseling) most people are going to have these services provided by their
primary care physicians. This is because the ACA requires everyone to select a
primary care physician, which can be a pediatrician for children. (In addition, 
women are not required to get a referral for OB/GYN-provided preventative
healthcare.) Why would anyone get obesity counseling from his chiropractor if he
is already getting it from his PCP? And, if he does get it, I seriously doubt
the insurer will pay for it twice.

This does leave open the possibility that naturopaths could be designated as
PCPs by patients in states where they are licensed to provide the full range of 
PCP services. However, if the naturopaths wish to be reimbursed for preventive
services, they will have to stick to those mandated by the HHS. And any
treatment will have to be covered by the insurer or the patient will have to pay
for it out of pocket. For example, one covered preventive service is diabetes
screening for adults. But that will not force insurers to cover non-EBM/SBM
naturopathic practices like this, as described on the American Association of
Naturopathic Physicians website:

   Patients [with diabetes] will be given various supplements, which are
   invaluable. They work synergistically with the other aspects of the
   comprehensive protocol to replace deficient nutrients; help lower their
   glucose levels and decrease their insulin resistance; reduce inflammation,
   lipids and blood pressure; and protect them from diabetic induced damage.
   Patients may at times need to continue on standard prescriptive medication,
   may need to start medications or commonly, due to naturopathic care, may be
   able to reduce or stop medications. The naturopathic physician will
   effectively monitor the need for medication and make appropriate suggestions 
   about the need for their use. . . . Naturopathic treatment of diabetes can be
   incredibly effective and naturopathic physicians should be the first type of
   doctor a diabetic patient seeks out for long term care.

Which brings me to this thought: now that everyone will have insurance coverage,
I wonder how long it will take patients to figure out that, if they go to an
M.D., D.O., or A.R.N.P as their PCP, their diagnosis and treatment is covered,
but when they go to an N.D. as their PCP, not all of their diagnoses and
treatments are covered.

But I digress.

Different treatment is not always discriminatory treatment

Let’s examine a few scenarios where the same therapy is provided by both a CAM
practitioner and conventional practitioners. (All scenarios assume these
practitioners are within the insurer’s provider network.)

Scenario 1:

Three providers, a D.O., and physical therapist and a chiropractor, provide
spinal manipulation for low back pain. Assuming an insurer covers spinal
manipulation as a treatment for low back pain, will the insurer have to
reimburse for it at the same rate, no matter who provides it?

Yes, I think so.

Scenario 2:

Same facts, but a chiropractor manipulates the cervical spine, based on his
“detection” of a “subluxation” in the neck, which he thinks is causing the low
back pain.

No payment, because the insurer’s not covering treatment based on diagnosis of a
chiropractic subluxation is not “discrimination” against the D.C. Even though
the chiropractor is being treated differently than the D.O. or the P.T. (charges
for his spinal manipulation for back pain are not reimbursed) there is a
reasonable, non-discriminatory reason for it (subluxation is not a valid
diagnosis).

Scenario 3:

Same facts as 1. The insurer limits spinal manipulation for low back pain to a
course of four treatments. The D.C. wants to perform a course of eight
manipulations.

Not reimbursing for the full course of eight treatments is not discrimination
unless the D.C. can show the limitation to four treatments is a pretext for
discrimination against chiropractors, who routinely prescribe more manipulations
for low back pain than D.O. or P.T.s. However, if the scientific evidence
supports four treatments as the standard recommended therapy for acute back
pain, the insurer has a reasonable, non-discriminatory reason for refusing
coverage, thus there is no discrimination against the chiropractor.

Scenario 4:

Same facts as 1. Chiropractors seek higher reimbursement rates from insurers,
claiming they have better education and training in performing spinal
manipulation than P.T.s and therefore should be reimbursed at a higher rate.

It would be a violation of the Act for insurers to raise rates for chiropractors
but not P.T.s because current evidence does not support the conclusion that
chiropractic manipulation is any more effective than that done by P.T.s. Under
the Act, insurers can differentiate between providers giving the same treatments
for the same condition only if quality or performance measures support that
differentiation.

I’ll leave it at that with the hypotheticals with the warning that many more
such factual situations will have to be resolved as the law is fleshed out.
(Such as: What if a naturopath can provide some, but not all, preventive
services? Will the insurance company have to reimburse her for those within her 
scope of practice, allowing the patient to split his preventive care between a
naturopath and his M.D. PCP? What about a chiropractor who claims he practices
“pediatric chiropractic?”)

Stay tuned

I’ll be following development of the ACA as it relates to CAM providers  and
report back to you. Coming soon: The “Patient-Centered Medical Home” and CAM.

Obamacare and CAM III: Great Expectations

Jann Bellamy on October 18, 2012

Link

In a previous post, we looked at how so-called “complementary and alternative
medicine” (or “CAM”) might fit into the definition of “essential health
benefits,” which must be covered by insurers pursuant to the Patient Protection 
and Affordable Care Act (“Obamacare,” or the “ACA”). In another, we contemplated
what it might mean for insurers to “discriminate” against CAM providers, which 
is prohibited by the ACA. In both posts, the conclusion reached was that these
provisions of Obamacare might not incorporate CAM practices into health care at 
the level CAM providers were hoping for. Here again we examine how the great
expectations of CAM promoters may not be met in health care reform.

This time, we take a look at some additional provisions of the ACA that CAM
lobbyists and their friends in Congress managed to insert into the healthcare
overhaul. Of course, whether the ACA is around for much longer will depend on
the outcome of the November elections, although Gov. Romney’s promise to “repeal
Obamacare” if elected president will happen only if his party wins a majority
in both the House of Representatives and Senate. 

Patient-Centered Medical Home

As part of its effort to bring down costs and improve healthcare, the ACA is all
about primary care. Every person is to have a primary care physician
coordinating his care, ideally in what is known as the “Patient-Centered Medical
Home,” or “PCMH.” This is how the Kaiser Family Foundation defines the idea:

   A health care setting where patients receive comprehensive primary care
   services; have an ongoing relationship with a primary care provider who
   directs and coordinates their care; have enhanced access to nonemergent
   primary, secondary, and tertiary care; and have access to linguistically and 
   culturally appropriate care.

Actually, the PCMH existed as a model of health care delivery before the ACA,
which simply adopted its tenets. It was largely developed by the by the National
Committee for Quality Assurance [NCQA] with input from the American College of 
Physicians, the American Academy of Family Physicians, the American Academy of
Pediatrics and the American Osteopathic Association. Notably absent from this
list are any CAM provider organizations. From this collaboration NCQA developed 
a “Physician Practice Connections Recognition Program” as a gold standard for
medical practices. This model forms the basis of the NCQA’s PCMH Recognition
Program, which allows PCMH-recognized practices to take advantage of financial
incentives offered by health plans and employers as well as government-sponsored
programs, including grants and contracts offered by Medicare and Medicaid under
the ACA.

And guess who wants to be primary care providers under the ACA? Chiropractors.

NCQA has six “must pass” standards for PCMHs the application of which to any
chiropractic practice will guarantee that no chiropractor will head a PCMH. One 
of these is that the PCP must “Plan and Manage Care” and chiropractors simply do
not have the education and training to manage the wide range of conditions seen
by a PCP. Three features of the care management requirement are deal-killers.
Patient management has to include the ability to implement evidence-based
guidelines. As Harriet Hall has amply demonstrated even those who advocate most 
strongly for DCs as PCPs are unable to do this. As well, their “education
programs” (actually, hotel conference room seminars) for primary care are
grossly inadequate for actual practice as a PCP. Another is the requirement that
the PCMH be able to manage medications and have the capacity for electronic
prescribing. Since chiropractors can’t prescribe the vast array of medications
necessary for primary care practice their becoming PCPs is simply a non-starter.

Apparently unaware of the rigorous standards for PCMHs, The Foundation for
Chiropractic Progress issued a white paper on “The Role of Chiropractic in the
Patient-Centered Medical Home.” Most of the document advocates for the
chiropractor as a provider of services for back and neck pain and headaches.
But, ever the optimists, the chiropractors assert that they also have a role as 
primary care providers, a subject we’ve addressed here (and here and here) at
SBM a number of times. The paper provides these reasons in support:

  1. Patients may use a DC as a first point of contact within the healthcare
    system. (True, but they don’t do it for primary care.)

  2. The American Chiropractic Association thinks it’s a good idea.

  3. The Joint Commission recognizes DCs as “physicians.” (True, but also
    podiatrists, dentists and optometrists, and no one is claiming they are
    PCPs.)

  4. Two states define DCs as PCPs.

Wow. I’m convinced, aren’t you?

In fact, it doesn’t appear Congress had DCs as PCPs in mind at all when it
drafted the ACA. The law provides money for more training in family medicine,
general internal medicine, general pediatrics and physician assistants, but not 
DCs. The ACA also supports the creation of Community Health Teams through grants
and contracts with HHS. These teams are “to provide support services for
primary care practices” which, to be eligible for federal money, shall:

   Ensure that the health team . . . includes an interdisciplinary,
   interprofessional team of health care providers, as determined by the
   Secretary [of HHS]; such team may include medical specialists, nurses,
   pharmacists, nutritionists, dieticians, social workers, behavioral and mental
   health providers (including substance use disorder prevention and treatment 
   providers), doctors of chiropractic, licensed complementary and alternative
   medicine practitioners and physicians assistants.

If Congress thought DCs could be PCPs, why would it include DCs among the
optional members of the health team run by the PCP?

Finally, Medicare, the source of funding for many of HHS’s demonstration
projects, covers chiropractic only for “subluxation” correction. Despite what
Daniel David Palmer thought that simply won’t do as primary care.

Even as part of the “health teams” supporting PCPs it looks like there may not
be much of a role for chiropractors and other CAM providers whose selection as
part of the team is optional. Proponents of CAM and “integrative” medicine are
all excited about this provision because it specifically mentions them!!! Their 
enthusiasm might well be tempered with a look at a few other provisions. The ACA
also provides that:

   In addition, the health team must:

   Provide coordination of the appropriate use of complementary and alternative 
   (CAM) services to those who request such services.

So, in sum:

  1. CAM must be provided only to those patients who request such services and its 
    use must be “appropriate.”

  2. Medical team care must be “safe and high quality care through
    evidence-informed medicine . . . and continuous quality improvements.”

  3. Care must be cost-effective.

  4. Providers must “collect and report data that permits evaluation of the success
    of the collaborative effort on patient outcomes” and identify areas for
    improvement.

  5. Providers must provide a care plan to the team for each patient and access to 
    the patient’s medical records.

In other words, CAM providers will have to practice in a setting unlike any they
have ever seen and will have other health care providers looking closely at
what they do. I seriously doubt your usual CAM providers will be prepared for
this kind of scrutiny, cost control limitations and performance evaluations. Nor
will they be allowed to perform such nonsense as cupping, applied kinesiology
and cranial sacral therapy and the like. (But wouldn’t you just love to see the 
PCP’s face when that report came up in the patient’s medical record?)

Accountable Care Organizations

One of the other key patient care/cost saving devices of the ACA is the
Accountable Care Organization, which the Kaiser Family Foundation describes
thusly:

   A network of health care providers that band together to provide the full
   continuum of health care services for patients. The network would receive a
   payment for all care provided to a patient, and would be held accountable for
   the quality and cost of care. Proposed pilot programs in Medicare and
   Medicaid would provide financial incentives for these organizations to
   improve quality and reduce costs by allowing them to share in any savings
   achieved as a result of these efforts.

Whether this model will work is the subject of some debate. And whether ACOs
will incorporate CAM providers is not clear. Even an article in the CAM-friendly
Journal of Alternative and Complementary Medicine, funded by (surprise!) the
National Center for Complementary and Alternative Medicine (NCCAM), could make
only a weak case for inclusion. The authors’ pro-CAM argument centered mostly
around the fact that CAM is popular and there are a lot of CAM practitioners,
both of which are irrelevant to their inclusion in ACOs. And they optimistically
note that the “developing empirical evidence on both cost and efficacy of CAM
from ongoing research activities funded primarily by [NCCAM] will likely help
inform which CAM services might be included in ACOs.” I find their enthusiasm
misplaced, as I know of no research which would support CAM inclusion in ACOs.

But even these authors were forced to admit that “due to extreme diversity among
CAM providers and newly emerging modalities . . . it [is] difficult to
consistently define what constitutes CAM,” a point we here at SBM have made
numerous times. I do have to admire the careful wordsmithing which resulted in
the phrase “newly emerging modalities,” or what we might less charitably
describe as “things people make up.” As well, “unless long-term benefits of CAM 
use for general health are proven empirically, CAM use for general health in
ACOs will be controversial.” I would say “non-existent,” as no ACO is going to
tolerate unproven treatments bringing down the all-important bottom line, which 
means less money for the other providers. Finally, “should CAM practitioner
services become involved in ACOs, monitoring appropriate use will likely be a
considerable challenge.” In other words, they aren’t used to being watched.

Naturopaths made their own pitch for inclusion in ACOs. While the American
Association of Naturopathic Physicians (AANP) correctly noted that naturopaths
aren’t covered providers under Medicare (which operates the ACA’s ACO
demonstration projects), they nevertheless implored HHS to consider them in a
2011 letter. In addition to the ubiquitous “CAM is popular” argument, they
claimed that naturopaths are “highly trained primary care providers” whose
standards are “on par with that of conventional medicine” who “play a
significant role in reducing the rate and impact of chronic disease in
underserved populations,” assertions all nicely refuted in a series of posts by 
Kimball Atwood, collected here.

In their plea to HHS, the AANP could come up with only two studies to support
their broad assertions of quality care. One was a small study of patients with
back pain comparing the cost-effectiveness of “naturopathic care” (acupuncture, 
relaxation exercises, exercise and dietary advice, and a back care booklet)
compared to standardized physiotherapy education and a back care booklet. The
other was unpublished results from a “randomized controlled pragmatic trial of
the whole practice of naturopathic medicine.”

CAM on Board

The ACA also creates a number of Boards, Commissions and the like to provide
advice on the healthcare system. CAM proponents managed to require that CAM
providers be included as members.

One of these new bodies is the National Health Car Workforce Commission, which
the American Association of Family Physicians describes as:

   dedicated to making recommendations regarding health care workforce issues.
   According to some analysts, this commission could emerge as the dominant
   force in driving and shaping the nation’s health care workforce policies. . .
   . The commission will make recommendations to Congress, the U.S. Department 
   of Labor and HHS on a broad range of workforce-related topics, including
   national workforce priorities and goals, current and projected workforce
   supply, and needs and assessments of current education and training
   activities.

The fifteen initial members were appointed in 2010, but nothing happened after
that because Congress never provided funding. The members hold MD, RN, PhD, MPH,
DDS, and JD degrees. There are also a couple of health care executives but no
CAM practitioners.

Where the ACA requires inclusion on other advisory bodies, CAM practitioners
appointed hold advanced degrees as well as their CAM degrees and are but a few
among many other practitioners, including MDs, RNs, dentists, MPHs, PhDs and the
like, all with their own agendas. For example, CAM proponents seemed very
excited about the  Advisory Group on Prevention, Health Promotion, and
Integrative and Public Health Council, which has one acupuncturist who is also
an RN and Catholic nun on board (go figure). It also includes Dr. Dean Ornish.
However, if the minutes of the first meetings are any indication, CAM is pretty 
much being ignored.

Be careful what you wish for

I wonder if CAM practioners really want to be a part of health care reform and
question their enthusiasm at being included. It seems the last thing CAM
providers would welcome into their practices is greater accountability, more
supervision by MDs, DOs, PAs and nurses, access to their patient records,
application of evidence-based standards, and required demonstrations of
cost-effectiveness, all of which they’ve pretty much avoided to this point.

                                Gulf War Illness

                                  Harriet Hall

                                      Link

One-fourth of the veterans of the 1990-91 Gulf War complain of persistent memory
and concentration problems, chronic headaches, widespread pain,
gastrointestinal problems, and other chronic abnormalities not explained by
well-established diagnoses. Treatments are ineffective and symptoms do not
improve over time. Gulf War Syndrome or Gulf War Illness is a controversial
diagnosis, and some have questioned whether it really exists. Now a new report
from the Research Advisory Committee on Gulf War Veterans’ Illnesses has
concluded that Gulf War Illness is real and that it is probably attributable to 
pyridostigmine bromide (PB) and pesticide exposures.

Its major conclusions:

   Gulf War illness is a serious condition that affects at least one fourth of
   the 697,000 U.S. veterans who served in the 1990-1991 Gulf War.

   Gulf War illness fundamentally differs from trauma and stress-related
   syndromes described after other wars.

   Evidence strongly and consistently indicates that two Gulf War neurotoxic
   exposures are causally associated with Gulf War illness: 1) use of
   pyridostigmine bromide (PB) pills, given to protect troops from effects of
   nerve agents, and 2) pesticide use during deployment.

The Research Advisory Committee on Gulf War Veterans’ Illnesses was mandated by 
Congress and appointed in 2002. The report, published November 17, 2008, is an
exhaustive review of all available data, including some that is unpublished. It 
runs to 454 pages, has multiple authors and consultants, lists 1840 references
and has multiple appendices. I can’t pretend to have mastered all the
information, but I have read enough to understand the basis of their
conclusions. They are based on good evidence and logic, but they leave me with
some doubts.

Evidence Suggesting GWI Isn’t Real

Skeptics have pointed out that ill-defined syndromes have been reported after
every conflict, attributed to everything from shell shock to Agent Orange. Two
1996 articles in the New England Journal of Medicine found no difference in
hospitalizations or in death rates from illness in Gulf War veterans. A 1998
study found that Gulf War veterans were less likely to be hospitalized for
unexplained illnesses and were healthier overall than veterans who were not
deployed. In a 2000 study, factor analysis did not identify a unique Gulf War
syndrome. A 2006 report by the The US Institute of Medicine found that although 
veterans of the first Gulf War report significantly more symptoms of illness
than soldiers of the same period who were not deployed, studies have found no
cluster of symptoms that constitute a syndrome unique to Gulf War veterans. The 
Committee’s report addresses these and other arguments and rejects them.

GWI Is Real, But What Is It?

The Committee says “there is no question that Gulf War illness is a real
condition with real causes and serious consequences for affected veterans.” I
don’t think anyone questions that these people are really impaired and are
suffering, but that doesn’t say anything about diagnosis or cause.

GWI is a “complex of multiple symptoms not explained by familiar medical or
psychiatric diagnoses.” It “does not fit neatly into our current concepts of
disease.” We don’t really even have an acceptable case definition. Diagnosis
depends on subjective self-reports of symptoms. There are no objective findings 
on routine clinical tests. Objective findings on non-routine and experimental
tests have generally been of small magnitude, uncertain significance, and have
not resulted in anything useful for diagnosis.

   …neuropsychological studies in Gulf War veterans consistently indicate that
   symptomatic veterans are affected by persistent, but subtle, “subclinical”
   central nervous system damage. Symptomatic veterans exhibit decrements in
   attention and executive system functioning, memory, visuospatial skills,
   psychomotor functioning, and mood. In some instances, study results reflected
   slowed response latencies across several cognitive domains. Measured
   deficits are generally modest and are not identified in all Gulf War veterans
   with cognitive symptoms. Characterizing Gulf war illness-related cognitive
   effects requires careful testing and analytic methods…

And I would add, it requires considering that many of these tests are
effort-dependent: individuals who report symptoms may not try as hard to
succeed.

There is some overlap with other multisystem illnesses like chronic fatigue
syndrome (CFS), fibromyalgia, and multiple chemical sensitivity (MCS); but the
Committee believes they are distinct entities. “The illness appears not to be
the result of a single cause producing a well-known effect” and a synergistic
effect of multiple causes may be implicated.

“Studies consistently indicate that Gulf War illness is not the result of combat
or other stressors and that Gulf War veterans have lower rates of posttraumatic
stress disorder than veterans of other wars.” “No similar widespread,
unexplained symptomatic illness has been identified in veterans who have served 
in war zones since the Gulf War, including current Middle East deployments.”

In various studies of different populations with different diagnostic criteria, 
the prevalence of unexplained multisystem illness ranged from 8-36% in those who
were not deployed and 29-65% in those who served in the Gulf.

Other Factors Not Ruled Out

The Committee looked at a large number of suspects including psychological
stress, Kuwaiti oil fires, depleted uranium (DU), vaccines, nerve agents,
infectious disease, fine sand and airborne particulates, exhaust from tent
heaters, other fuel exposures, solvents, and freshly-applied CARC (chemical
agent resistant coating) paint. The evidence was not sufficient to either
implicate or rule out most of these.

They found a consistent association of Gulf War illness with exposure to PB and 
pesticides across studies of Gulf War veterans, with a convincing dose/response 
relationship. Those exposed to one suspected cause were usually exposed to
several. Rates of GWI and exposures were higher among Army and Marines than Navy
and Air Force, higher among enlisted than officers, and higher among forward
troops than rear troops.

The other suspects that couldn’t be entirely ruled out could be involved via
multiple exposures and synergism.

Other Gulf War Illnesses

Brain cancer? Veterans who were downwind from the Khamisiyah munitions
demolitions in March 1991 have died from brain cancer at twice the rate of other
Gulf War veterans. It is suspected, but not proven, that low levels of the
chemical warfare nerve agents sarin and cyclosarin were released into the air
during that operation.

Birth defects? There was a significant, but modest, excess of birth defects in
children of Gulf War veterans compared to non-deployed veterans. But information
on specific types of birth defects was inconsistent, and overall rates were
within the normal range found in the general population.

Effects on spouses? There didn’t seem to be any consistent effects on spouses. A
mysterious “burning semen” phenomenon was reported by wives but was never
explained. On the other hand, Gulf veterans’ spouses had significantly fewer
skin anomalies, such as moles, skin tags, and scars. (This is a good example of 
the “noise” that plagues studies like this.)

ALS? A cluster of cases of amyotrophic lateral sclerosis (Lou Gehrig’s disease) 
was found, mainly in the Air Force. In September, 2008, VA Secretary James Peake
announced that all U.S. veterans, of all eras, would be given presumptive
service connection for ALS.

Disability Claims

There was a similar controversy about illness due to Agent Orange after the Viet
Nam war. Eventually, the VA agreed to presumptively recognize a series of
health conditions related to Agent Orange. Vietnam veterans with one or more of 
these conditions do not have to show that their illness(es) is (are) related to 
their military service to get disability compensation.

  1. Chloracne occurring within 1 year of exposure to Agent Orange.

  2. Non-Hodgkin’s lymphoma.

  3. Soft tissue sarcoma (other than osteosarcoma, chondrosarcoma, Kaposi’s
    sarcoma, or mesothelioma).

  4. Hodgkin’s disease

  5. Porphyria cutanea tarda (must occur within 1 year of exposure).

  6. Multiple myeloma

  7. Respiratory cancers, including cancers of the lung, larynx, trachea, and
    bronchus.

  8. Prostate cancer.

  9. Acute and subacute transient peripheral neuropathy (must appear within 1 year 
    of exposure and resolve within 2 years of date of onset).

  10. Type 2 diabetes.

  11. Chronic lymphocytic leukemia

In addition, veterans’ children with spina bifida are covered.

Think about this for a minute. How many of those veterans would have developed
diseases like diabetes and prostate cancer if they had never gone to Viet Nam?
Compensating victims of Agent Orange means we have to compensate a lot of other 
people who are not victims.

The same thing is true for GWI. If 8-36% of the nondeployed have the same
symptoms, diagnosing the 29-65% of the deployed who have those symptoms means we
will be labeling far too many. Incidentally, I find the 65% figure hard to
swallow, and so did the Committee – they estimated ¼ to 1/3.

There are special provisions that allow Gulf War veterans disabled by chronic
symptoms that are not explained by a specific diagnosis to receive disability
compensation for “undiagnosed illnesses.” You’d think everyone who served in the
Gulf would be reporting difficult-to-diagnose symptoms for purposes of
financial gain, but as of February, 2008, just two percent of Gulf War veterans 
had applied. Despite all the reports of bothersome symptoms, most patients with 
GWI are employed and functioning reasonably well.

Effects of PB and Pesticides

Only about 62% of ground troops reported using pesticides and only about half of
them took PB for varying periods (sometimes very brief). Some of them used
higher-than-recommended amounts of pesticides: these exposures were reduced by
stricter guidelines in Iraq, but that resulted in more cases of leishmaniasis.

According to the FDA website,

   Pyridostigmine bromide was first approved in 1955, and has been prescribed by
   doctors to treat patients with myasthenia gravis for over 40 years. To date,
   no long-term health problems thought to be associated with pyridostigmine
   bromide have been reported by these patients.

The reported side effects and the signs of overdose of PB overlap but do not
match the GWI syndrome. Symptoms reported for acute pesticide toxicity and for
long-term low-dose exposure to pesticides in peacetime are not a good match for 
GWI either.

Both PB and pesticides are acetylcholinesterase inhibitors. It’s been speculated
that the combination and the concomitant exposure to other risk factors may
have caused unexpected synergisms. There is also some evidence that people with 
certain genetic polymorphisms might be uniquely susceptible.

Paradoxically, PB has been tried as a TREATMENT for multisystem illnesses like
CFS and fibromyalgia.

Suspicions Roused

Anthrax shots were suspicious because they caused a high incidence of mild
reactions and because they were given in a hush-hush setting and often weren’t
even identified. They had not been extensively tested but military authorities
decided the military risk outweighed the risk of the vaccine and justified
omitting informed consent. They imposed secrecy for security reasons – we didn’t
want the enemy to know we thought they had biological weapons and were
protecting our troops.

The military does a lot of things for military reasons that would not be
acceptable in a civilian setting. They couldn’t afford to have a flu epidemic
depleting their troops, so everyone was required to get annual flu shots back
when the package inserts said “Not intended for children or healthy adults.”

The troops didn’t like the idea of taking PB tablets. Some people got side
effects from them; these individuals were more likely to report symptoms of GWI 
later on. I remember when I was a flight surgeon we required our flyers to take 
a test dose to make sure they wouldn’t have any bad reactions that would
interfere with flying skills. Some of them objected strenuously to taking a
medicine when they weren’t sick, but they would have faced a court-martial for
disobeying orders if they didn’t comply. Anecdotally, I don’t remember any of
them complaining of side effects from the test dose.

There were frequent false alarms of chemical warfare. Initial alarms could be
triggered by factors such as fuel vapors and engine exhaust, oily smoke, blowing
sand, and low batteries on the units. Initial alarms had to be verified by
further, more accurate tests. Verification was often not possible in battlefield
situations. Logs went missing. The most likely exposure to chemical agents, at 
Khamisiyah, was never actually verified. It was rated “likely” but not certain.

Things like these led to a lot of suspicion and resentment. It contributed to a 
mindset that the government was lying and was knowingly endangering personnel.
Some people were on the lookout for any symptom that might corroborate their
suspicions.

Recommendations

Hundreds of studies have been done; millions have been spent. The report
recommends spending much more to study GWI further, to do long-term followup,
and to find effective treatment. I have mixed feelings about this. Research
money is short. It’s hard to quantify exposures this long after the fact; it’s
hard to decide what treatments to test when you don’t know the cause. There have
already been some poorly conceived attempts to treat GWI with long courses of
antibiotics and with various alternative therapies. On the other hand, we might 
learn something that we could apply to other illnesses and to future wars.

Conclusion

When a subject is as highly charged as this one, I despair of ever knowing the
truth. We all want to support our troops. We want to give their symptoms a name.
We want to find a cause. With all the emotions and the political concerns, it
is practically impossible to maintain true scientific objectivity. The very
choice of what to study and how to study it embodies some degree of bias. The
Committee’s report was a noble effort, but I’m not entirely convinced. It
bothers me that the symptoms are subjective and poorly defined. It bothers me
that the known effects of PB/pesticides are not a good match for the symptoms of
GWI. If you look at enough factors, you are guaranteed to find significant
correlations that are not causal. Before I read this study I didn’t know what to
think about GWI. Now, after reading it, I still don’t know.

               WHO Partnering with Traditional Healers in Africa

                                 Steven Novella

                                      Link

There is an AIDS epidemic in Africa, and efforts to fight it are hampered by the
endemic social problems of that continent. Chief among them are the lack of
sufficient modern health resources, the spread of destructive rumors and myths
about HIV/AIDS, and even the persistence of HIV denial in Africa (although this 
last factor is better than in the past).

The World Health Organization (WHO) and the International HIV/AIDS Alliance are 
teaming up with the Traditional Health Practitioners Association of Zambia
(THPAZ) to address the first problem – the lack of health services. Most
Zambians use traditional healers for primary health care. The WHO has therefore 
decided to utilize traditional healers in the fight against AIDS. There are
interesting pros and cons to this policy, but it must first be recognized that
there is no ideal solution to the problem. The resources to provide optimal
modern health care to treat and prevent HIV/AIDS (which would need to include a 
massive education program) in Zambia and the rest of Africa simply do not exist.
One might argue that the world should provide those resources, but let’s put
that issue aside and focus on what to do in the meantime.

The arguments given in favor of this WHO strategy are:

   Traditional healers far outnumber biomedical workers in the rural areas.

   They are consulted, not only because they are closer and more affordable 
   than their Western-trained counterparts, but also because they are embedded, 
   extensively and firmly, within Ugandan culture.

   Traditional healers are highly respected and widely consulted by
   communities.

In the various articles I read discussing this issue, even those entirely
favorable to the idea, conspicuously absent is any mention of whether or not the
interventions provided by traditional healers are safe and effective. It’s not 
even an afterthought – it’s as if it is a non-issue.

However, if we are to focus on the potential benefits of such a policy we could 
envision a program to train traditional healers essentially to implement a
science-based program of counseling and basic health care while also using them 
to funnel patients to modern health treatments. In addition traditional healers 
could be trained how not to interfere with modern treatments – for example by
not giving herbs that might reduce the effectiveness of anti-HIV drugs. Also
they will need to be educated so that they do not spread myths and
misconceptions, and in fact so that they can help to counter them. Until such an
education program is in full swing, however, the policy of using traditional
healers is likely to be counter-productive. As one report notes:

   According to the 2006 survey by THPAZ, only 13 percent of the traditional
   healers in the country had been in contact with modern medical doctors or
   facilities.

In essence the goal is to use an existing infrastructure of trusted primary care
providers (traditional healers) to get them to help the HIV/AIDS program,
rather than hinder it. The only alternative strategy would be to replace this
infrastructure with a modern science-based medical system – ideal but not
realistic. These two strategies are also not mutually exclusive – efforts can be
made to maximize the availability of modern health care in the region, while
using traditional healers to fill the gap, or at least make sure they are not
working against the system.

But there are significant pitfalls to using traditional healers. I have already 
stated some – most have had no contact with modern medical doctors. By all
accounts traditional healers in the region rely upon treatments that are
worthless at best, and may even be harmful. There is every likelihood that
despite some modern medical education, many traditional methods will be
retained.

The biggest pitfall of a partnership is that it will be used as a sign of
validation of traditional healing methods, whether or not they are safe and
effective. Already there are attempts to validate herbal treatments for HIV/AIDS
in Africa. Dr Sekagya Yahaya Hills is a dentist and traditional healer who is
promoting herbal remedies as effective in treating HIV/AIDS. Not surprisingly we
are seeing the same pattern as elsewhere with the promotion of herbs as drugs –
preliminary small studies of poor design being used to justify unlikely
treatments. Many herbs are, in fact, drugs but they contain a mixture of
chemicals that are not purified, are not quantified, and have unknown
bioavailability (as well has half-life and other pharmacological properties).
This makes them very poor drugs. The experience in the US is likely to be
typical – herbs that seemed promising in preliminary studies have almost all
been useless when studied in large well-controlled trials.  In addition they
have drug-drug interactions and potential side effects and toxicities that were 
not apparent before being carefully studied.

Treating HIV is very challenging, and it is also a recent plague on humanity. It
seems very unlikely that any traditionally used herb would be safe and
effective against HIV. Despite the low probability, it is reasonable to test
candidate herbs (as long as it is done ethically) but only well-controlled
studies should be performed.

A more plausible research program would be to screen hundred of candidate herbs 
for in vitro activity – demonstrating that there is some biological activity
that could plausibly fight HIV. Then follow up with animal testing of those
herbs that seem promising on the screening test. And finally conduct preliminary
then definitive testing in humans – and once you have a product that is proven 
safe and effective, recommend it for usage. This, of course, all s0unds
suspiciously like pharmacognacy and drug development. But this is not what is
happening. Rather, the preliminary research is bypassed and we have only
preliminary and unreliable clinical studies.

What is very likely to happen is that traditional healers, propped up by an
alliance with the WHO, will stick to their traditional methods, supported by
those like Dr. Sekagya Yahaya Hills, who will use bad science as a rubber stamp 
to endorse traditional treatments.

It is a real dilemma – a devil’s bargain. It seems necessary and potentially
useful to enlist the help of traditional healers, given the realities on the
ground in Africa. But the potential to do more harm than good is extreme. The
WHO should therefore go into any such collaboration with their eyes wide open,
and not naive to the power of cultural belief, the highly sophisticated
anti-scientific propaganda of the CAM movement, and the potential for reliance
upon bad science. The WHO should therefore focus on regulation, which is an
admitted problem:

   The other concern is a weak regulation of traditional medicine, leaving
   people living with HIV open to abuse by unscrupulous healers who promote
   cures for AIDS or persuade their patients to cease life-prolonging drugs such
   as the antiretroviral treatment.

Therefore any such partnership should be contingent on careful scientific
scrutiny and improved regulations.

Conclusion

Given the cultural and health care realities in Africa, it does seem necessary
for the WHO to partner with local traditional healers in order to implement any 
widespread public health program. The endorsement of traditional healers may be 
necessary to achieve public acceptance of “Western” medicine. It is also
necessary to counter myths and misconceptions about HIV/AIDS, and this must
begin with the locally recognized health authorities – the traditional healers.

But the WHO should resist pressures to “respect” local traditions themselves as 
if they are acceptable alternatives to science-based medicine. In the promotion 
of health, which is the WHO’s mandate, utilizing treatments that are safe and
effective is the only ethical option. Promoters of unscientific treatments,
however, often resort to an appeal to cultural sensitivity and a false dichotomy
between “Western” science and the beliefs of other cultures. Whether or not Dr.
Hill’s herbs are an effective alternative to proven anti-HIV drugs will be
determined by objective science, not culture, and bad science should not be
excused with appeals to cultural sensitivity.

Without maintaining a strong dedication to science-based medicine this WHO
program will likely become an epic example of the axiom that the road to ruin is
paved with good intentions.

The World Health Organization promotes quackery yet again

The World Health Organization held the First WHO Traditional Medicine Global
Summit this weekend. Unfortunately, its claims of being “evidence-based” aside, 
the conference followed the WHO’s usual pattern of serving as propaganda, not
science. The summit was one-sided, organized by believers with the only speakers
being believers, to promote a predetermined policy goal of promoting
traditional medicine and justify “integrating” it with science-based medicine.

David Gorski on August 21, 2023

Link



The World Health Organization concluded its First WHO Traditional Medicine
Global Summit on Friday. The conference was co-hosted by the Indian government
and held in Gandhinagar, India, where the WHO had set up a Global Centre for
Traditional Medicine, with help from $250 million from the Indian government.
Unfortunately, as we have long lamented, the WHO has long had a penchant for
promoting “traditional medicine,” particularly Traditional Chinese Medicine but 
also Ayurveda and others, as “evidence-based” and worthy of being “integrated”
with science-based medicine, and this conference is just one more example of how
far down that road the WHO has gone. To get an idea of how this meeting is
being described and promoted by its stakeholders, I refer you to a statement by 
the Indian government released on August 17, the first day of the summit:

   WHO’s first ever Global Summit on Traditional Medicine inaugurated as part of
   the G20 Health Minister’s Meeting in Gandhinagar, Gujarat.

   By embracing ancient wisdom and modern science, we can collectively work
   towards achieving the health-related Sustainable Development Goals while
   fostering a ‘One Earth, One Family, One Future’ ethos: Dr. Mansukh Mandaviya.

   “In modern times, the demand for natural and herbal-based pharmaceuticals and
   cosmetics underscores the enduring significance of traditional healing
   practices.”

   “WHO’s Global Centre for Traditional Medicine headquartered in Jamnagar,
   Gujarat, accelerates advancements in Traditional Medicine globally.”

   Traditional Medicine can play a huge role in honouring cultural diversity,
   empowering communities, and celebrating our shared heritage: Shri Sarbanand
   Sonowal.

   I hope that the Gujarat Declaration, will integrate use of traditional
   medicines in national health systems, and help unlock the power of
   traditional medicine through science: Dr. Tedros Adhanom Ghebreyesus, WHO
   Director-General.

But what does the WHO itself say? Its statement announcing the summit listed the
usual examples of medicines that derive from natural products used in some
traditional medicine systems and touted how “evidence-based” the summit would
be, before stating:

   In response to this increased global interest and demand, WHO, with the
   support of the Government of India, established in March 2022 the WHO Global 
   Centre for Traditional Medicine as a knowledge hub with a mission to catalyse
   ancient wisdom and modern science for the health and well-being of people
   and the planet. The WHO Traditional Medicine Centre scales up WHO’s existing 
   capacity in traditional medicine and supplements the core WHO functions of
   governance, norms and country support carried out across the six regional
   Offices and Headquarters.

   The Centre focuses on partnership, evidence, data, biodiversity and
   innovation to optimize the contribution of traditional medicine to global
   health, universal health coverage, and sustainable development, and is also
   guided by respect for local heritages, resources and rights.

Elsewhere, the WHO writes about its summit:

   “Traditional medicine can play an important and catalytic role in achieving
   the goal of universal health coverage and meeting global health-related
   targets that were off-track even before the disruption caused by the COVID-19
   pandemic,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
   “Bringing traditional medicine into the mainstream of health care —
   appropriately, effectively, and above all, safely based on the latest
   scientific evidence — can help bridge access gaps for millions of people
   around the world. It would be an important step toward people-centered and
   holistic approaches to health and well-being.”

Does this language sound familiar, particularly the parts about “ancient
wisdom”? It is the language used by “integrative medicine” advocates to justify 
the “integration” of quackery with science-based medicine. Indeed, I immediately
harkened back to an article I wrote for this blog nearly a decade ago about how
Chairman Mao and his Communist government undertook a very systematic and
intentional effort to retcon the history of Traditional Chinese Medicine. I’ll
just drop a couple of quotes that I cited in that post for your edification:

   “This One Medicine,” exulted the president of the Chinese Medical Association
   in 1952, “will possess a basis in modern natural sciences, will have
   absorbed the ancient and the new, the Chinese and the foreign, all medical
   achievements—and will be China’s New Medicine!”

Sound familiar? “This One Medicine” is about as simple a statement of what
“integrative medicine” intends as I’ve ever encountered, and this one is 71
years old. Indeed, the WHO’s rationale that using “traditional medicine” to
“bridge access gaps” is exactly the same as one major rationale that Chairman
Mao used to promote traditional Chinese medicine. When he took power in the late
1940s, China did not have enough “Western”-trained doctors, leading to the idea
of recruiting “traditional healers” (“barefoot doctors”), giving them some
basic training in hygiene and more modern medical practices, and sending them to
fill in the massive gaps in China’s healthcare system then.

I’ll cite another quote from Alan Levinovitz, whose writings in part inspired my
2014 article, in which he described how Chairman Mao understood that he needed 
to address the objections of proponents of scientific medicine:

   His [Mao’s] solution was a two-pronged approach. First, inconsistent texts
   and idiosyncratic practices had to be standardized. Textbooks were written
   that portrayed Chinese medicine as a theoretical and practical whole, and
   they were taught in newly founded academies of so-called “traditional Chinese
   medicine,” a term that first appeared in English, not Chinese. Needless to
   say, the academies were anything but traditional, striving valiantly to
   “scientify” the teachings of classics that often contradicted one another and
   themselves. Terms such as “holism” (zhengtiguan) and “preventative care”
   (yufangxing) were used to provide the new system with appealing foundational 
   principles, principles that are now standard fare in arguments about the
   benefits of alternative medicine.

I like to say that there is nothing new under the sun when it comes to
antivaccine narratives, but it turns out that this principle also applies to
narratives used to promote “ancient wisdom” as co-equal with science-based
medicine. In essence, the WHO has been engaged in an effort to “scientify”
(which I define as the effort to make practices based in prescientific mysticism
and pseudoscience appear scientific) all of “traditional medicine,” as Mao
tried (and, unfortunately, largely succeeded) to scientify TCM in the 1950s and 
as the Chinese government continues to do to this day. It’s an effort that has
manifest itself in the WHO’s addition of “traditional medicine” diagnoses to the
all-important ICD-11, the successor to the currently used ICD-10, a
standardized system of alphanumeric codes for diagnoses maintained by the World 
Health Organization used throughout the world for billing, epidemiology,
research, and cataloging causes of death. (Steve Novella described it as the WHO
“endorsing quackery,” and he was correct.)

So let’s take a look at this conference. The entire proceedings can be found on 
video here.

The WHO’s promotion of traditional medicine vs. reality

Several days before the event, I noticed that the WHO had started promoting its 
summit on X, the social media platform formerly known as Twitter. I’m going to
quote some of these Tweets because they reveal some very important things.
Here’s the first part of the WHO’s promotion:

In 1969, Tu Youyou was tasked to search for antimalarial drugs.  She turned to
ancient Chinese #TraditionalMedicine books & discovered artemisinin. In 2015, Tu
Youyou was awarded the Nobel Prize for her work on #malaria, which has saved
millions of lives.https://t.co/TrcGF8rdeL pic.twitter.com/hqqn1D2idW

— World Health Organization (WHO) (@WHO) August 10, 2023

These are common rationales used by proponents of “traditional medicine,” namely
that the existence of medicines derived from plants and other natural products,
some of which were used in traditional medicine practices, validates the whole 
of traditional medicine. Of course, we’ve already discussed the example of Tu
Youyou and why her winning the Nobel Prize for the discovery of artemisinin as
an effective treatment for malaria does not somehow validate traditional Chinese
medicine. Rather, it represented the triumph of natural products pharmacology, 
not herbalism or Traditional Chinese medicine. As Scott Gavura put it, alone
“artemisinin isn’t effective as a treatment – it is eliminated too quickly from 
the body,” and added that what “finally turned artemisinin into a useful drug
and brought this treatment to patients was in fact Big Pharma.”

The WHO continued:

For millions of people around the world #TraditionalMedicine is their first stop
for health and well-being.

Which of these have you used?🖐️ Acupuncture🥣Ayurveda🌿Herbal medicine💊
Homeopathy🍃 Naturopathy💆‍♀️ Osteopathy🍵 Traditional Chinese medicine☀️ Unani
medicine pic.twitter.com/VY9PUq7TMW

— World Health Organization (WHO) (@WHO) August 12, 2023

Aside from the repetition of Chairman Mao’s rationale for using TCM, I must say 
that it was definitely news to me that homeopathy, naturopathy, and osteopathy
are in any way “traditional medicine.” After all, as longstanding readers of
this blog know, homeopathy was “discovered” by a German physician named Samuel
Hahnemann in the late 18th century, just 227 years ago, making me wonder if it
could even qualify as “traditional” European medicine. Naturopathy, too, is
European in origin, which alone doesn’t disqualify it as “traditional.” What
does disqualify it as “traditional” is that it is an even more recent
development than homeopathy, having arisen from the “natural cure” movement in
Europe in the 1800s, and only having been named “naturopathy” in 1895, with the 
first school of naturopathy founded in 1901. As for osteopathy, it was invented 
in the US in 1874, founded by Andrew Taylor Still, a 19th-century American
physician, Civil War surgeon, and Kansas state and territorial legislator.

As for norethindrone, this is an example that I had never seen advocates point
to as validation of traditional medicine before, which is why I did a bit of
Googling and PubMed searching. It turns out that this is just another example of
the WHO citing a natural product that came to be used as a medicine as if that 
in itself validated “traditional medicine.” Norethindrone was indeed derived
from two species of inedible wile Mexican yams, cabeza de negro (Dioscorea
mexicana) and barbasco (D. composita), in the local language, and the use of the
drug as birth control came about through nothing more remarkable (or
“traditional”) than the application of pharmacognosy, the branch of pharmacology
devoted to finding compounds in natural products that have medicinal
properties.

The promotion continued:

WHO’s #TraditionalMedicine programme aims to build solid evidence base for
policies and standards on traditional medicine practices and products, helping
countries integrate it into their health systems & regulate its quality.

Here's how: https://t.co/Mld5hoIabv pic.twitter.com/wzaAXVNAHG

— World Health Organization (WHO) (@WHO) August 14, 2023

This represents yet another example of putting the cart before the horse. Note
how the WHO doesn’t say that it will study traditional medicine to see if it
works or to identify specific practices that might work. Rather, it assumes that
traditional medicine works and promises to work to “build solid evidence base
for policies and standards on traditional medicine practices and products,
helping countries integrate it into their health systems & regulate its
quality.”

Only after days of promotion, which began a week before the summit, does the WHO
get around to caveats:

Listen to Dr Susan Wieland explain how to safely use #TraditionalMedicine.

Find out more in our FAQs:📌 https://t.co/BcDKRntETt

🔉 @lswieland pic.twitter.com/IccWYU792J

— World Health Organization (WHO) (@WHO) August 15, 2023

Out of curiosity, I looked at the FAQ referred to above and found more of the
WHO putting the cart before the horse, for example:

   A remarkable and rapid modernization of the ways traditional medicine is
   being studied can help realize the potential and promise of traditional
   medicine and traditional knowledge, for health and well-being. Taking clues
   from traditional uses, new clinically effective drugs can be identified
   through research methods such as ethnopharmacology and reverse pharmacology.

   The application of new technologies in health and medicine can open new
   frontiers of knowledge on traditional medicine. Artificial intelligence (AI) 
   has emerged as a game-changer, revolutionizing the study and practice of
   traditional healing systems. AI’s advanced algorithms and machine learning
   capabilities can allow researchers to explore extensive traditional medical
   knowledge, map evidence and identify once elusive trends.

AI…it had to be…AI. Seriously, just as adding AI to homeopathy doesn’t make it
any less pseudoscientific (or ridiculous), adding AI to all of traditional
medicine will not make it scientific. Notice the assumption, though. The WHO
assumes that there is enormous promise in studying traditional medicine and
combining it with science-based medicine. This proposition, as lawyers would
say, assumes facts not in evidence, and even the WHO’s caveats about traditional
medicine are the weakest of weak sauce. For example, I laughed out loud when
the WHO asserted, seemingly reasonably, that natural products and traditional
medicine practices “must pass the same level of scrutiny as modern
pharmaceuticals.” Notice what precedes this statement:

#TraditionalMedicine practices and products must pass the same level of scrutiny
as modern pharmaceuticals. 

Over 120 Member States have passed laws or regulations for herbal medicines,
enhancing their safety and efficacy.https://t.co/nlTGS1BRYB
pic.twitter.com/yIE6ofjah8

— World Health Organization (WHO) (@WHO) August 16, 2023

That’s right. Only right after pure boosterism for traditional medicine by an
athlete does the WHO suggest that traditional medicine should be subject to the 
same scientific standards as science-based medicine. Here’s the problem. It
already has been, for the most part, and been found wanting. I like to quote
Dara ÓBriain on herbal medicine:

   I’m sorry, ‘herbal medicine’, “Oh, herbal medicine’s been around for
   thousands of years!” Indeed it has, and then we tested it all, and the stuff 
   that worked became ‘medicine’. And the rest of it is just a nice bowl of soup
   and some potpourri, so knock yourselves out.

Indeed. Or, to paraphrase an adage, “alternative medicine” that has been show
through science to be effective and safe ceases to be “alternative” and becomes 
just “medicine.” In fairness, we “haven’t tested it all,” but it’s pretty
unlikely that there’s much left untested that’s hiding any sort of amazing new
treatments and cures, no matter how much the WHO wants this to be so or how much
into a pretzel it has to twist the definition of “traditional medicine” in
order to include other popular forms of alternative medicine, like naturopathy, 
homeopathy, and osteopathy. Moreover, any sort of medicine that includes
homeopathy as potentially “science-based” is anything but science-based. I
strongly suspect that the WHO included these European and American forms of
quackery as being somehow “traditional medicine” in order to get European and
American advocates of quackery on board with its summit.

A one-sided summit

But what about the summit itself? Let’s just say that my perusal and sampling of
some of the talks showed it to be entirely consistent with the WHO’s promotion 
of traditional medicine and gauzy propaganda videos like this one:

Again, this video is propaganda, not reality.

It is not entirely unreasonable to hold a conference to examine traditional
medicine practices and treatments in light of modern science. However, that is
not what this is about. As Edzard Ernst was quoted saying in an article
published in Nature, although he included his full statement (of which the
Nature article only used a brief excerpt) on his blog:

   The WHO has a long history of uncritically promoting alternative therapies.
   The Indian government has recently advocated irresponsibly dangerous
   nonsense, such as the use of homeopathy for the prevention and treatment of
   covid infections. The two together make an ominous initiative when it comes
   to alternative medicine.

   Of course, there is nothing wrong in hosting a constructive dialogue about
   this subject. What seem ill-conceived, however, is the fact that the
   conference exclusively includes speakers who are staunch proponents of
   alternative medicine, a subject that, after all, remains highly
   controversial. Progress is not created by voicing one-sided, biased opinions.
   I fear that this meeting will result in the often before voiced platitudes
   and wishful thinking which no true scientist is then able to take seriously.

The Nature article only quoted the last sentence of this statement. Ernst,
however, has nailed exactly the problem with this summit and pretty much every
other conference held on “integrative medicine”: They are organized by believers
in alternative medicine and include as speakers only believers, suffused with
this “cart before the horse” mentality, for example, inadvertently described in 
the Nature article:

   Lisa Susan Wieland, director of Cochrane Complementary Medicine at the
   University of Maryland School of Medicine in Baltimore, and an external
   adviser for the summit, says that the participants will discuss ways to
   gather evidence for traditional healing systems.

   Wieland says that the quality and quantity of research for traditional
   medicine needs to improve before conclusive statements can be made about its 
   safety and efficacy. “A lot has changed over the past 15 years,” she says.
   “Where there was previously insufficient good-quality research to determine
   what does and doesn’t work, we are now seeing more and better research on
   some traditional medicine.”

Cochrane Complementary Medicine? I hadn’t known before reading this that there
was a Cochrane Complementary Medicine or that it was coordinated at the
University of Maryland, an institution that has featured in this blog many times
before since very early on for the uncritical promotion of “integrating”
quackery into science-based medicine by its Integrative Medicine program. After 
having read this, I looked at the list of members of the advisory group for this
summit. Every single member, from co-chairs Lisa Susan Weiland and Bhushan
Patwardhan on down, holds a high-ranking faculty, advocacy, or government
position in “integrative” or “traditional” medicine. You might think that if the
WHO were truly interested in a science-based approach to studying “traditional 
medicine” it might include at least a token skeptic or two on the advisory group
and among the speakers. It didn’t. That’s because the conclusions of the summit
were foreordained before it was even convened.

Again, this is not about using science to study what does and doesn’t work in
“traditional medicine.” It is about assuming that traditional medicine is of
immense value on par with that of science-based medicine and then looking for
evidence to support that conclusion. Again, it’s about putting the cart before
the horse, as evidenced by just the titles and descriptions of some of the
sessions, such as “Planetary health and well-being for all: Learning from
Indigenous knowledges, and traditional, complementary and integrative health
systems,” “Integrative health for well—being at all ages,” and “Contribution of 
Traditional Medicine to Healthcare Systems.” (Also, note the titles of many WHO 
press releases on the conference, like WHO summit aims to unlock power of
traditional medicine through science. and describing its Global Centre for
Traditional Medicine as Catalysing ancient wisdom and modern science for the
health of people and the planet.) Again, note the assumptions, namely that
traditional medicine is an important part of “planetary health and well-being
for all” that we have to learn from and that traditional medicine has already
made great contributions to the healthcare systems of many nations, if only we
would just recognize that. (And, make no mistake, the purpose of this summit is 
to promote that idea as justification not just for the $250 million spent to
found the WHO’s Global Centre for Traditional Medicine but for the continued
promotion of traditional medicine and its “integration”—whether science-based
practitioners like it or want it or not—into the global health system through
the ICD-11 and other means.

Unsurprisingly, the day after the summit ended, the WHO released a statement,
Global partners commit to advance evidence-based traditional, complementary and 
integrative medicine, which concluded pretty much what I expected the WHO to
conclude from the day that I learned about this summit, which now seems to have 
renamed “traditional medicine” to “traditional, complementary, and integrative
medicine” (TCIM):

   Preliminary findings from the WHO Global Survey on Traditional Medicine 2023 
   shared at the Summit indicate that around 100 countries have TCIM related
   national policies and strategies.  In many WHO Member States, TCIM treatments
   are part of the essential medicine lists, essential health service packages,
   and are covered by national health insurance schemes.  A large majority of
   people seek traditional, complementary and integrative medicine interventions
   for treatment, prevention and management of noncommunicable diseases,
   palliative care and rehabilitation.

   Dr Bruce Aylward, Assistant Director-General, Universal Health Coverage, Life
   Course at WHO, highlighted the need for a “stronger evidence base—a WHO
   priority—to enable countries to develop appropriate regulations and policies 
   around traditional, complementary, and integrative medicine.”

Tell me something I didn’t know 15 years ago, when this blog was founded.
Advocates of unproven and disproven treatments always claim that there is
“insufficient evidence” and that we need a “stronger evidence base.” The latter 
statement is one of those vague generalities that is always true to one degree
or another. It is something that believers in prescientific and pseudoscientific
traditional medicine approachers were saying 20 years ago, when I first became 
heavily involved in assessing “nontraditional” health claims, that they continue
to argue now, and that they will likely continue to argue long after I have
shuffled off this mortal coil.

It is thus utterly unsurprising that the WHO press release after the conference 
concludes:

   In closing the Summit, Dr Hans Kluge, WHO Regional Director for Europe said, 
   “Together, we have gently shaken up the status quo that has, for far too
   long, separated different approaches to medicine and health. By taking aim at
   silos, we are saying we will collaborate all the more to find optimal ways
   to bring traditional, complementary and integrative medicine well under the
   umbrella of primary health care and universal health coverage.”  He further
   added, “We have reiterated how crucial it is to get better evidence on the
   effectiveness, safety and quality of traditional and complementary medicine. 
   That means innovative methodologies for assessing and evaluating outcomes.”

   Dr Shyama Kuruvilla, Senior Strategic Adviser and lead for the WHO
   Traditional Medicine Global Centre, who also led the organization of the
   Summit said, “We learnt much about the existing policies, tools and
   practices. But it is clear we have a long journey ahead in using science to
   further understand, develop and deliver the full potential of TCIM approaches
   to improve people’s health and well-being in harmony with the planet that
   sustains us.”

   The Summit’s summary document included conclusions and commitments from
   participants on wide-ranging issues, from global policy, leadership,
   innovation, health workforce, data, evidence, monitoring, regulation, legal
   frameworks and protecting biodiversity and sustainable development.

The WHO and other believers in traditional medicine are now touting the Gujarat 
Declaration as the key to “integrating” traditional medicine into medicine going
forward. Of note, the Gujarat Declaration was referenced in the opening remarks
by WHO Director-General Tedros Adhanom Ghebreyesus:

   This summit is an important opportunity to advance the understanding and use 
   of traditional medicine.

   The Gujarat Declaration—the main outcome of this Global Summit—if effectively
   implemented, will enhance the appropriate integration of traditional
   medicine into national health systems.

   Let me leave you with three specific requests.

   First, we urge all countries to commit to examining how best to integrate
   traditional and complementary medicine into their national health systems.

   Second, I urge you all to identify specific, evidence-based and actionable
   recommendations that can inform the next WHO traditional medicine global
   strategy.

   Third, I urge you to use this meeting as the starting point for a global
   movement to unlock the power of traditional medicine through science and
   innovation.

   Once again, my thanks to India for its hospitality and leadership in this
   area.

Again, note how the purpose of this summit was not to determine whether
traditional medicine has value and to demonstrate what does and doesn’t work.
Rather, the purpose was to promote the “integration” of “traditional medicine”
into science-based medicine and to go looking for evidence to justify that
predetermined goal.

Let me suggest something that might seem a bit heretical to the WHO as it exists
now. The $250 million spent on its quackery-promoting Traditional Medicine
Global Centre would be much better spent on—dare I say?—more traditional public 
health programs in areas of the world that desperately need them, programs
promoting clean water, vaccination, and  better nutrition, as well as providing 
“on-the-ground” public health workers and medical personnel to bring
science-based medicine, rather than unproven woo, to the people who need it
most. The WHO has done such good work in these areas over the decades, and it
saddens me to see it slipping more and more into a mindset that promotes
medicine based on mysticism and prescientific religious belief systems, such as 
TCM and Ayurveda, as somehow being co-equal with science-based medicine to the
point that they should be “integrated” with it. That is not promoting “planetary
health and well-being for all.” Rather, it is shunting precious global health
care funds away from science-based public health and medicine to promote
unproven and disproven “ancient knowledge.”

WHO On Traditional Medicine

Steven Novella on January 21, 2026

Link


Recently the World Health Organization published their guidelines on traditional
medicine, actually referring to the category of “traditional, complementary and
integrative medicine (TCIM) practices.” As has long been the case, there are
some good parts to their approach, but also some concerning aspects, and at
times it feels self-contradictory.

The problems begin with their definition. I dislike lumping traditional,
complementary, and integrative into one category. I understand the concept of
“traditional” medicine – beliefs, philosophies, and practices of medicine in
traditional uses in a culture prior to the advent of scientific medicine.
Traditional practices are still in wide use in many parts of the world, and
understanding them can be very beneficial. They should be studied and hopefully 
regulated.

“Complementary” medicine, however, is a marketing slogan. It assumes the
practices in question complement (implying in a helpful way) scientific
medicine. The same it true for “integrative” medicine, as if there is utility to
integrating the practices in question. Also, both terms imply that the methods 
are not being used instead of scientific medicine, but in practice this is often
not the case.

What this framing does is allow the peddlers of fantastical, unscientific, and
even disproven therapies to ride the coattails of traditional methods, which
they do for marketing purposes. Here is how the WHO defines traditional methods 
– “Traditional medicine emphasizes nature-based remedies and holistic,
personalized approaches to restore balance of mind, body and environment.”

This definition is, in my opinion, mostly propaganda. First, what does
“nature-based” mean? There is no meaningful operational definition of “natural”,
and such appeals are often little more than the appeal to nature fallacy. I
also challenge the notion that they are “holistic”, which means that they
address all aspects of health and illness. The opposite is often the case – they
are based on narrow philosophies that ignore vast swaths of biology, mechanisms
of illness, and possible interventions. Modern medicine is far more holistic
than any TCIM approach.

Often, prescientific philosophies of medicine and TCIM methods take an overly
simplistic view of health. They often are based one “the one cause of all
disease” approach, or boil down the complexities of biology into a simple (and
incorrect) system. Acupuncture is all based on manipulating chi, for example.
Pulse diagnosis thinks that all health conditions are reflected in patterns in
the pulse. Many are variations of the life force or the four humors. This is not
holistic.

The part about personalized approaches may be true sometimes (not universally), 
but as implemented by TCIM methods can be a double-edged sword. First,
individual treatment is only helpful if the factors on which you are
individualizing the treatment are real. Homeopathic treatments can be
“individualized” but based entirely on fantasy. Often the individualization is a
bug not a feature – the traditional approach does not recognize the basic
concept of disease, that there are specific mechanisms of illness that can be
shared across individuals. Rather, everyone has their own particular “illness”. 
This may be individualized, but it is contrary to science and not helpful.

Similarly, restoring balance may be a good thing, but what, exactly, are you
balances. If you are balancing things that don’t actually exist, like ying and
yang (like the humors), it’s not helpful. “Balance” is an ancient concept, and
is overly relied upon in pre-scientific philosophies. If you think the only
thing that can possibly be wrong with someone’s health is that they are out of
balance, that is likely not to be effective or holistic.

But all these terms are great marketing terms, which is why modern alternative
medicine promoters like them, and tying them to ancient traditional methods is
just more good marketing. So the WHO, whether intentionally or not (I guess it
depends on who was involved in creating these statements) is promoting modern
snake oil in the guise of studying traditional medicine.

Elsewhere, the WHO statement gets it right. They state:

“Integration of TCIM within national health systems must be done appropriately, 
effectively, and safely, based on the latest scientific evidence. WHO supports
countries that want to embrace traditional medicine practices to do so in a
science-based manner to avoid patient harm and ensure safe, effective, and
quality health care. An evidence-based approach to traditional medicine,
establishing efficacy and safety through rigorous scientific validation, is
crucial, even if they have been used for a long period. This not only guarantees
that treatment is effective and safe, but provides the rigorous evidence needed
for the recommendation of traditional medicine in WHO guidelines.”

It’s hard to disagree with any of this. If this were truly their focus, that
would be great. And I agree – we should rigorously study widely used traditional
methods. But then what do we do with the results? Are there any cases of the
WHO condemning and working for stopping traditional methods that are shown to
lack efficacy? If evidence can only be used to support methods, that is not
sufficient. It’s even counterproductive, acting like a ratchet to promote
questionable methods.

Later in the same statement they write: “Therapies like acupuncture, herbal
medicine, and yoga are increasingly used alongside biomedical interventions to
ease pain, reduce side effects, and improve quality of life for chronic
conditions.”

I understand that the WHO is trying to leverage existing traditional medicine
infrastructure to get effective treatments to people who lack access to modern
biomedicine. I also get that they are trying to be respectful to local cultures 
and traditions. They do need to take a global perspective. And I applaud their
stated dedication to a scientific approach. In the past they have even taken
hard stances against things like homeopathy (although under pressure from
scientists).

Unfortunately at times they fall victim to pro-CAM propaganda and the clever
marketing of shoddy research.


Why Is American Healthcare So Expensive?

It’s not as complicated as you may think.

Steven Novella on September 20, 2023

Link



Americans spend more on healthcare than other similar countries. This fact is
not in dispute – but the causes of this disparity are often debated. It is
common to use this fact to support whatever narrative you want to tell about
American healthcare. It is often used to imply that Americans are sicker, or
that the healthcare we deliver is less effective. But there is likely a simpler 
explanation.

First let’s look at the numbers. In 2021 the US spent 17.8% of GDP on
healthcare, $10,687 per person. The next closest country was Germany who spent
12.8% and $6,524 per person. At the low end, South Korea spent 8.8% and $2,874
per person. The US is clearly an outlier for industrialized nations.

Of note, US citizens do not have the highest out-of-pocket healthcare expenses
($1,225 per household). That would be Switzerland at $1,577. South Korea, who
has the lowest total cost, has one of the highest out-of-pocket costs at $1,040.
The countries with the lowest household cost were those with socialized
medicine, in the $500-$800 range.

There are a number of hypotheses to explain the US outlier effect. Americans may
be more unhealthy, requiring more healthcare. American healthcare may rely more
on expensive advanced technology. We may deliver unnecessarily more healthcare 
with diminishing returns. The delivery and payment for healthcare may be less
efficient. Or, Americans may be simply paying more for essentially the same
healthcare. All of these things may be true to some extent at the same time.

While there are important demographic differences between US citizens and other 
industrialized nations, the gap in conditions like obesity and diabetes is
closing and does not explain the cost difference. What the research primarily
shows is that Americans pay more for the same healthcare services.

A 2018 study published in JAMA found that social spending and healthcare
utilization were not substantially different between the US and other similar
countries. Rather, the main difference that explains the higher costs is that
the same healthcare goods and services simply cost more in the US.

Part of the issue is administrative costs, which are estimated to be between 15%
and 30% of all healthcare costs in the US. This is partly due to the fact that 
the US system is more complex than most other similar nations. The primarily
problem, however, is not the complexity itself but the lack of standardization. 
Our patchwork system has no standardized forms or rules. There are entire
occupations, such as coding and billing specialists, that don’t even exist in
other countries. This is an area where thoughtful regulation could impose
standardization on the industry to reduce costs and administrative waste.

Drug prices are another outlier. About 9% of total healthcare costs, and 12% of 
personal costs, were due to prescription drugs. Total drug costs were estimated 
to be 2.5 times higher than similar industrialized nations. That alone can
account for a significant portion of higher US healthcare costs. For some
individual drugs, they can cost 10 times as much in the US than other nations.
This is entirely due to the fact that the US does not regulate drug prices while
other countries do, therefore the pharmaceutical industry will simply make the 
bulk of its profit in the US where it can charge as much as the market will
allow.

Hospital care is perhaps the single biggest contributor to US healthcare costs, 
amounting to 31% of total healthcare expenses. Again, in the US the same
hospital services can cost 2-3 times as much as identical services in other
countries. US hospitals charge more for everything from MRI scans to knee
surgery.

Meanwhile, utilization of hospital services is not dramatically different in the
US vs similar countries. The US is average-to-slightly-above-average in terms
if ordering MRI scans and performing knee surgery.

What all this means is that if we are going to address the extremely high and
rising healthcare costs in the US we will need to follow the evidence. Reducing 
hospital stays and healthcare utilization will have only a negligible impact.
There are some marginal gains to be made when it comes to practicing
cost-effective medicine. You don’t really need to prescribe that new expensive
drug when and older cheaper drug is essentially equivalent. We definitely need
to keep an eye on the overall efficiency of healthcare delivery and practice.
But when it comes to overall costs, such measures are just nibbling around the
edges.

The dominant factor in increased US healthcare costs is that we pay more for the
same goods and services. This is due to the regulatory and market environment
in the US. A large piece of this is also our increased administrative costs,
which is likely the lowest hanging fruit when it comes to reducing healthcare
costs. Standardizing and streamlining healthcare administration is a no-brainer.
Allowing Medicare and Medicaid to negotiate for drug prices is another measure 
with broad expert support. Drug prices should be more equitably distributed
among industrialized nations (while subsidizing poorer nations). Hospital costs 
need to be brought in line with more international standards as well.

The good news is – these are all straightforward regulatory issues which can be 
informed by many examples in other nations. We can dramatically reduce US
healthcare costs, and bring them in line with international averages, without
having to wrestle with complex demographic or biomedical issues that don’t have 
clear solutions.

Health Savings Accounts and Quackery Revisited

Health savings accounts don’t require medical treatments to be safe or effective
for consumers. This leads to taxpayer-supported quackery.

Jann Bellamy on March 16, 2017

Link



Health savings accounts (HSAs) were a small share of the health care insurance
market when I first wrote about HSAs and quackery a little over a year ago. They
still are, but Republicans hope all that will change when they “repeal and
replace” Obamacare with Trumpcare. HSA expansion is part of almost every GOP
replacement plan under consideration, including the current frontrunner, the
American Health Care Act.

Under current law, HSAs are paired with high-deductible health insurance
policies. Consumers make tax-free contributions to their HSAs and the money
grows tax-free. Consumers pay the full cost of medical care out of their HSAs
until the deductible is met, although some preventive services, such as vaccines
and screenings, are exempt from this requirement. No tax is paid on the
distributions from the HSA either, giving the taxpayer a triple benefit.

Trumpcare keeps these basics in place, but increases the annual contribution
limit from $3,400 for individuals and $6,700 for families to $6,550 and $13,000 
respectively. It will allow use of HSA funds to purchase OTC drugs without a
health care provider’s prescription, which is currently required.

According to a recent Kaiser Health News story, the conservative principle
behind HSAs is that consumers should have more “skin in the game” when they
purchase health care services and products. If consumers can both save money
tax-free for health care costs and then decide when to spend that money, they
will make smarter choices, which will eventually slow rising health care costs.

   ‘It makes people more conscious that the health care they are getting is
   being paid for with real dollars and not coming out of the ether,’ said Joe
   Antos with the American Enterprise Institute.

Actual experience with HSAs, which were introduced in 2003, shows that overall
spending on medical care does go down, but not necessarily for good reasons. In 
the first year or two, HSA holders cut back on everything, including screening
exams and other preventive care that could reduce expenses in the long term,
even when these were exempt from the deductible. ER visits went up.

It is disturbing that HSA holders are making bad choices by eschewing good
health care. My concern is that, without the limitations imposed on their
choices by traditional health insurance, they will make worse choices by opting 
for bad health care.

Their data is a decade old, but, according to the NCCIH, Americans spend about
$34 billion a year out-of-pocket on “CAM,” but how the NCCIH defines “CAM” is
unreliable (due to rebranding “conventional” modalities as CAM) and highly
variable. CAM practitioner visits comprised almost $12 billion of this. In 2014,
there were $37 billion in dietary supplement sales. According to the FDA,
Americans spend about $3 billion dollars a year on homeopathic remedies.

All of this indicates to me that, left to their own devices, Americans do not
make smarter choices when they have “skin in the game.” Given a pot of money
that is a “tax-break trifecta,” why would they do any better?

And about that “ether” the American Enterprise Institute spokesperson mentioned.
When consumers make their own choices, they are free to ignore the evidence.
When the “ether” is calling the shots, not so much.

To give credit where it’s due, the “ether” (otherwise known as public and
private health insurers) performs an important service in keeping costs down by 
refusing to cover tests and treatments that aren’t backed by sufficient evidence
of effectiveness, including outright quackery, at least most of the time.
Consider, for example, this partial list of exclusions from Aetna’s health
insurance coverage for CAM, which, incidentally, reads like standard orders for 
a naturopathic “physician”:

  1. Acupressure

  2. Anti-oxidant function testing

  3. Applied kinesiology

  4. Aromatherapy

  5. Bioenergetic therapy

  6. Bioidentical hormones

  7. Chelation

  8. Colonic irrigation/colon hydrotherapy

  9. Craniosacral therapy

  10. Functional intracellular analysis (micronutrient testing)

  11. Gerson therapy

  12. Hydrogen peroxide therapy

  13. Intravenous micronutrient therapy (Myers’ cocktail)

  14. Intravenous vitamin C infusion

  15. Live blood cell analysis

  16. Macrobiotic diet

  17. Magnet therapy

  18. Megavitamin therapy (also known as orthomolecular medicine)

  19. Mesotherapy

  20. Mistletoe (Iscador)

  21. Ozone therapy

  22. Reflexology

  23. Reiki

  24. Therapeutic touch

Aetna also excludes from coverage much of what chiropractors and acupuncturists 
offer (although, in my view, they are being overly generous), as well as
Burzynski’s “antineoplastons” treatments.

I fear HSAs, which are poised for “millions more customers” now that Republicans
are in control, will make it much easier to pay for, at best, tests and
treatments that have insufficient evidence of safety and effectiveness, and, at 
worst, outright quackery, for two reasons: first, the loose standards for
qualified medical expenses and, second, nobody’s checking anyway.

“Qualified medical expenses”

HSAs can be used to pay for “qualified medical expenses,” which are defined by
the IRS using the same rules as if you were taking a deduction for unreimbursed 
medical and dental expenses. “Medical expenses” include:

   the costs of diagnosis, cure, mitigation, treatment, or prevention of
   disease, and the costs for treatments affecting any part or function of the
   body. These expenses include payments for legal medical services rendered by 
   physicians, surgeons, dentists, and other medical practitioners. They include
   the costs of equipment, supplies, and diagnostic devices needed for these
   purposes. Medical care expenses must be primarily to alleviate or prevent a
   physical or mental defect or illness. They don’t include expenses that are
   merely beneficial to general health, such as vitamins or a vacation.

According to the IRS, in addition to physicians and dentists, chiropractors and 
Christian Science practitioners are specifically included, so there is no
question that “medical expenses” incurred by their patients are eligible for
payment via an HSA. Acupuncture is included among permissible treatments, but it
is unclear who makes the call on whether it’s an eligible medical expense.

The phrase “payments for legal medical services rendered by . . . other medical 
practitioners” in the IRS’s rules at least implies that naturopaths, homeopaths,
acupuncturists and TCM practitioners are covered in states where they are
regulated if they have the legal authority to diagnose and treat. Unfortunately,
via the magic of Legislative Alchemy, diagnosis and treatment is, to my
knowledge, legal in all states where these practitioners are licensed or
registered. (Exception: Mississippi acupuncturists.)

Companies offering HSAs take differing views on the scope of CAM eligible for
payment via an HSA. (For a fee, these companies manage the money in your HSA and
provide a debit card or on-line account for disbursements.) HSA for America
advises potential customers that:

   Only health insurance policies that allow to [sic] you open a health savings 
   account give you tax deductions to offset the cost of therapies not covered
   by traditional health insurance. You can use HSA funds for acupuncture,
   aromatherapy, Ayurvedic Medicine, homeopathy, nutritional consulting, and
   Traditional Chinese Medicine (TCM), among other therapies. It is good to be
   in control of your own healthcare, as much as possible. Having money in an
   HSA provides some of this healthcare freedom.

Conexis, one of the largest HSA providers, is more cautious, saying that
alternative healers, foods, herbs, dietary supplements and visits to naturopaths
are “potentially” covered if you “retain additional supporting documentation
proving medical need for the service or product.” The FSA Store, another
provider, takes the position that homeopathic remedies can be paid for out of an
HSA if a physician signs a Letter of Medical Necessity. Principle Financial
Group says that homeopathic remedies and “supplements prescribed by alternative 
providers (i.e., Naturopath, Acupuncturist)” are usually not covered under an
HSA.

Aetna, on the other hand, says that acupuncture is eligible only “when
recommended by a health care professional for a medical condition.” As for
“alternative providers,” Aetna takes the position that:

   When recommended by a health care professional for a medical condition, the
   cost of a homeopathic or holistic treatment/procedure may be a qualified
   medical expense. . . . Naturopathic procedures and treatments using natural
   agents such as air, water or sunshine are generally not qualified medical
   expenses

Questions about use of HSA funds for dietary supplements and homeopathic
remedies would be cleared up by a bill sponsored by (surprise!) Sens. Orrin
Hatch and Marco Rubio. They’ve reprised their legislative effort from last year 
with a bill allowing up to $1,000 worth of dietary supplements and homeopathic
remedies to be paid for out of your HSA, no questions asked. (S. 403; companion 
bill: H.R. 277) The bill also allows purchase of exercise equipment, whether you
use it or not.

Naturopaths naturally take a more expansive view of HSA coverage. According to
the California Naturopathic Doctors Association

   Money in your HSA can be used to pay for qualifying medical expenses,
   including medical appointments with your naturopathic doctor, lab tests,
   prescribed supplements, over-the-counter products, and other medically
   necessary prescribed services (for instance, massages for back pain). Some
   HSAs provide a debit-like card, others require you to submit receipts for
   reimbursement. You may ask your [naturopathic] doctor for a Letter of Medical
   Necessity detailing your dietary supplement prescriptions for reimbursement.

The IRS itself and the courts appear to take an expansive view of what
constitutes legitimate medical expenses as well, even where there is lack of
proven effectiveness. There is no reason to believe they would apply a different
standard for HSAs. According to a CHILD (Children’s Healthcare is a Legal Duty)
newsletter:

   Since the 1950s the IRS has allowed bills sent by Christian Science
   practitioners for their prayers to be deducted from federal income tax as
   medical care expenses. . . . In 2000, the IRS wrote that the “experience,
   qualification, or title” of the person rendering the services is irrelevant
   to whether they are allowed as a deductible medical care expense. Whether
   anyone besides the person paying for the service thinks it is medical is also
   irrelevant. . . . Thus, the only real criterion was that the person paying
   for the service believes its primary purpose is to heal, prevent, relieve, or
   diagnose disease. If the customer believed that, then the service was
   deductible medical care.

Courts have ruled that treatments by a naturopathic doctor (consultation and
dietary supplements), were deductible as medical expenses, as well as Navajo
“sings,” and “holistic” cancer treatments. The fact that these were not
prescribed by a medical doctor was deemed irrelevant.

That is bad enough where medical expense deductions are concerned, but cases are
rare because taking the deduction requires an outlay of greater than 10% of
your adjusted gross income for most people. HSA distributions for medical
expenses, on the other hand, can be for any amount.

Given this liberal interpretation of “medical expenses” and the utter lack of
any requirement in the law creating HSAs that diagnoses and treatments be
evidence-based (or even safe, for that matter), HSAs appear ripe for
exploitation by quacks and charlatans, especially if the number of HSA holders
increases according to the current Congress’s desires.

But who’s looking anyway?

Of course, there is always the possibility that the IRS will disagree with your 
claim, but who’s keeping track?

The only reporting required for HSAs is filing a form with your income tax
return showing the total amount you spent on “qualified medical expenses”. No
documentation or other explanation is required. Only if your return is audited
by the IRS will the veracity of your medical expenses possibly be questioned,
necessitating your providing supporting documentation.

But fewer than 1% of individual tax returns are audited. Chances of being
audited are 1-in-119, and falling due to existing budget cuts, which are only
going to get worse if the current administration has its way. If your return
doesn’t include income from a business, rental property, or a farm, or business 
expense deductions or earned income credit, the chance of being audited drops to
about 1-in-330.

In other words, your conventional insurance policy isn’t going to pay for that
Myer’s cocktail or Gerson therapy, but if you pay for it with funds from your
HSA, there’s little chance you’ll be challenged by the IRS, either because you
won’t get audited or the IRS (and the courts) agree these are legitimate medical
expenses. Either way, it’s a loss for consumers and taxpayers.

Docs v. Glocks: government regulation of physician speech

Jann Bellamy on January 21, 2016

Link



A few years ago, an Ocala, Florida, pediatrician, as part of a routine visit,
asked a patient’s mother whether she kept firearms in the home. She refused to
answer, feeling the question constituted an invasion of her right to privacy.
The pediatrician then terminated the relationship and told the mother she had 30
days to find a new doctor for her child. In another incident, a mother reported
she was separated from her children while medical staff asked them whether
their mother owned firearms. And, according to a Florida legislator, he was told
to remove firearms from the home during an appointment with his daughter’s
pediatrician.

Complaints to Florida legislators about these and similar incidents prompted the
introduction of a bill that would have, among other things, criminalized any

   verbal or written inquiry by a . . . physician, nurse, or other medical staff
   person regarding the ownership of a firearm by a patient or the family of a 
   patient or the presence of a firearm in a private home . . .

As finally passed by the legislature and signed by Governor Rick Scott, the 2011
Firearm Owners Privacy Act subjects physicians to disciplinary action for
making “verbal or written inquiry” into a patient’s firearm ownership when the
physician does not “in good faith believe” such inquiries are “relevant to the
patient’s medical care or safety of others.” The Act included amendments to the 
Florida Patient’s Bill of Rights and Responsibilities, adding similar
provisions. (The Act also applies to health care facilities, but here we will
discuss only its effect on physicians and their patients.) Physicians may not
enter any information regarding firearm ownership into the patient’s medical
record if they know this information is not “relevant to the patient’s medical
care or safety, or the safety of others.” They may not “discriminate” against a 
patient “based solely on the patient’s Second Amendment right to own firearms or
ammunition.” Finally, physicians must refrain from “unnecessarily harassing” a 
patient regarding firearm ownership during an examination.

Shortly after Gov. Scott signed the Act into law, several physicians filed suit 
in federal district court challenging its constitutionality (Wollschlaeger v.
Governor of Florida). The controversy was dubbed “Docs v. Glocks,” a term widely
adopted by the media. Similar legislation has been introduced in at least 12
other states.

The Act, the physicians said, was an unconstitutional infringement on their
First Amendment right to freedom of speech and was unconstitutionally vague
because they were not fairly put on notice as to what they were expected to do
to comply with the Act. (We’ll mostly focus here on the First Amendment issues.)

According to their complaint, the new law had caused them to change their
practices in several ways. Previously, and in accordance with the American
Medical Association’s policy guide’s suggestion that such questions were
important to child safety and public health, these physicians had variously
inquired about gun ownership as part of routine patient questionnaires, asked
patients whether they owned firearms if there were other risk factors present
(e.g., depression), and discussed firearms as part of routine preventive
counseling. (The American Academy of Pediatrics, the American Academy of Family 
Physicians, and the American College of Physicians all recommend providing
counseling and guidance on firearm safety as well.) All of these activities were
viewed by the physicians as consistent with good medical practice.

After the Act, these physicians stopped asking firearm-related questions, in
questionnaires or orally, either routinely or when the patient seemed upset by
the inquiry, or stopped discussing firearm safety altogether, although some
continued to do this by framing the inquiry in hypothetical terms not specific
to the patient’s circumstances.

The U.S. District Court for the Southern District of Florida agreed with the
physicians and prohibited enforcement of the law. The state appealed. In three
separate opinions, all citing different grounds for its decision, a three-judge 
panel of the U.S. Court of Appeals for the 11th Circuit upheld the Act over the 
vigorous dissent by one of the panel’s judges. We’ll return to those decisions
shortly.

Government limitations on physicians’ speech

Over the past several years, federal appellate courts have addressed similar
First Amendment challenges to laws that restrict physicians’ speaking to
patients, either by forbidding them from discussing certain subjects or by
compelling physicians to give patients legislatively-scripted information. In
both situations, physicians may find the legislature’s requirements medically
questionable. A key issue in these cases is the degree of deference the courts
give to the states in deciding if the state’s restrictions violate the
physician’s First Amendment right to free speech.

When the government tries to regulate the content of a person’s speech, as
opposed to regulating the time or place where it occurs, the law is subject to
strict scrutiny by the courts in determining its constitutionality. Under strict
scrutiny, the court will find the government’s regulation invalid unless the
state can demonstrate that it is justified by a compelling government interest
and is narrowly drawn to serve that interest. This is the most demanding
standard of review and courts rarely find content-based restrictions
constitutional. Restrictions aimed at particular speakers or particular
viewpoints are also highly disfavored by the courts.

Some types of speech are entitled to less protection, such as commerical speech,
which is protected as long as it is truthful. Courts apply an intermediate
level of scrutiny in these situations and content-related speech restrictions
will be upheld only if the state can show the law directly advances a
substantial government interest and that the law is drafted in a way that will
achieve that interest.

Note that none of these categories of speech are actually mentioned in the First
Amendment nor are the standards for court review. All of this is case law
developed by the courts because, the U.S. Supreme Court decided long ago, the
courts are the final authority in determining the constitutionality of
government actions. Note also that the parameters of each level of scrutiny are 
stated in very broad terms, leaving plenty of room for interpretation. Of
course, all of these cases present particular facts, and it would be impossible 
to fashion some bright-line test of constitutionality.

The appellate courts have been all over the board in deciding challenges to
physician-patient communications, sometimes referred to more broadly as
“professional speech.” The Ninth Circuit Court of Appeals upheld a California
law banning so-called “sexual orientation conversion therapy” (SOCT) by finding 
that the therapy, although spoken, was simply a form of treatment, not unlike
surgery. Thus, the therapy was really conduct, not speech at all, and therefore 
unprotected by the First Amendment. The Third Circuit also upheld a New Jersey
law banning SOCT. The court decided the physician’s speech, in the form of
therapy, was entitled to some level of First Amendment protection, but found
that the ban was a permissible restriction on professional communication between
a physician and patient, applying an intermediate scrutiny standard.

The Fourth Circuit also found intermediate scrutiny of professional speech
appropriate and struck down a state law forcing physicians to display
ultrasounds to patients seeking abortions, as well as to convey certain scripted
information those patients. Conversely, the Fifth and Eighth Circuits upheld
similar laws passed in Texas and South Dakota, respectively, reasoning that
limitations on physician speech are part and parcel of the state’s power to
regulate medicine and that restrictions are valid as long as they are “truthful,
relevant and non-misleading,” applying the same standard used to review
commercial advertising. The Texas law requires a physician to perform an
ultrasound on a patient seeking an abortion so she can hear the fetal heartbeat 
and to explain the ultrasound’s results. Even though none of this is medically
necessary, the court found it meets the “truthful, relevant and non-misleading” 
test. On the same grounds, the Eighth Circuit let stand a South Dakota law
requiring physicians to tell a patient seeking abortion that she

   has an existing relationship with that unborn human being and that the
   relationship enjoys protection under the United States Constitution . . .
   [and] that by having an abortion, her existing relationship and her existing 
   constitutional rights with regards to that relationship will be terminated.

Again, medically unnecessary, but truthful, relevant and not misleading, and
therefore constitutional.

I imagine your agreement, or lack thereof, with these decisions may be
influenced by how you feel about gun control, abortion rights and SOPT. That is 
a natural response. However, any decision by an appellate court is binding
precedent for all district courts within its circuit, and for that appellate
court’s later decisions (unless overturned). Thus, it is important to keep in
mind that the same rationale is going to apply to a later case where you may
have an entirely different view of the issue under consideration.

The “Docs v. Glocks” case

Remarkably, the 11th Circuit, presented with the physicians’ challenge to
Florida’s law, issued three separate opinions based on three different standards
of review. (Again, this was a two-judge majority of a three-judge panel, over a
vigorous dissent by the third judge.)

There was notable firepower on both sides of the argument in the form of amicus 
briefs. (These are briefs filed by non-parties who are interested in the outcome
of the case.) On the physicians’ side is the AMA, the American Academy of
Pediatrics, numerous other physician groups, the American Public Health
Association, the ACLU, suicide-prevention groups and Children’s Healthcare is a 
Legal Duty. The American Bar Association is among these as well, because of the 
implications for state attempts to restrict another form of professional speech:
attorney-client communications. The National Rifle Association is the heavy
hitter on the other side, filing a brief in support of the state.

In the first opinion, Wollschlaeger v. Governor of Florida I, decided in 2014,
the court found that, because the law restricts only speech by a physician in
the context of the physician-patient relationship, but irrelevant (at least in
the court’s view) to medical care, it was totally exempt from First Amendment
protection. As the dissent pointed out, Florida’s ban silenced doctors on a
single topic to prevent them from communicating a message unpopular with the
legislature to their patients, thereby scoring a home run of sorts by putting
aside not only the courts’ traditional hostility toward content-based
restrictions on speech, but also toward restrictions aimed at particular
speakers and particular viewpoints.

The physician-appellees petition for rehearing, and, in the second opinion,
Wollschlaeger II, issued in July, 2015, the court held that the First Amendment 
was implicated after all. But, finding that the law survived the intermediate
scrutiny standard required for restrictions on professional speech, the court
upheld the law again.

The court then asked the parties to file new briefs discussing the implications 
of a recently-decided Supreme Court case. Although the case wasn’t directly on
point, the court thought it might possibly require a less forgiving standard
than intermediate scrutiny. Upon further consideration, but without deciding
that strict scrutiny was indeed required, the court found that, if it were, the 
law’s restrictions on physician speech were nevertheless constitutional. This
decision, Wollschlaeger III, was issued in December.

The physicians have filed a petition for rehearing by the full 11th Circuit.
Whether the full court hears the case or not, the U.S. Supreme Court may
eventually agree to consider the matter because of the conflicting decisions
among the appellate courts.

Criticism of Wollschlaeger

One commentator, constitutional law professor Eugene Volokh, posting on the
Volokh Conspiracy blog (carried by the Washington Post), disagrees with the
court’s analysis, calling it “quite wrong.” This is of some significance because
Volokh is an avid supporter of the Second Amendment. I imagine his is an early 
exemplar of what will become widespread criticism of the case from across the
spectrum. (He also criticized the first two opinions, as did others in legal
academia: Duke, Case Western, Harvard, Cardozo, and the University of Pittsburgh
all have critical articles in their legal literature.)

Prof. Volokh provides a helpful summary of just how much the Docs v. Glocks law,
as interpreted by the 11th Circuit, impinges on physician-patient
communications.

  1. A doctor can’t ask all patients whether they own guns, “even if the doctor
    believes that this information would indeed be useful in giving general
    advice about safe gun storage, the supposed dangers of any gun ownership,
    and the like.”

  2. “[A]sking patients about gun ownership and entering that information into the 
    medical record requires that the information be ‘relevant to the patient’s
    medical care or safety, or the safety of others.’ And, according to the
    panel majority, ‘relevant’ here [and in situations described below] means
    relevant based on ‘some particularized information about the individual
    patient, for example, that the patient is suicidal or has violent
    tendencies.'”

  3. Doctors can “turn away patients for refusing to answer questions about guns”
    so long as the questions are “relevant” but can’t “turn away patients for
    answering the questions with ‘yes, I own a gun.'”

  4. Doctors are banned “from unnecessarily harassing a patient about firearm
    ownership during an examination.” This means “that a doctor ‘should not
    disparage firearm-owning patients, and should not persist in attempting to
    speak to the patient about firearm ownership when the subject is not
    relevant . . . to medical care or safety.'”

So how are these restrictions justified by a compelling state interest narrowly 
tailored to its purpose? Volokh finds they aren’t. I agree.

The first “compelling” reason is protection of the Second Amendment right to
keep and bear arms. But wait, as Prof. Volokh points out, stating the obvious,
the Second Amendment, like the First, Third, Fourth, and so on, is a restriction
on the government, not private individuals. And even if it did apply to private
action, the physician can’t do anything to interfere with the patient’s
constitutional right to keep and bear arms, no matter how annoying her questions
might be.

The court’s rationale for this restriction on a private citizen’s speech is the 
“imbalance of power” between physician and patient. That, the court says, means 
the patient could be dissuaded from exercising his constitutional rights. But,
as Prof. Volokh says, persuasion and dissuasion are exactly the sort of activity
that is protected by the First Amendment. He finds equally unconvincing the
court’s view that the restrictions are permissible because the patient is a
“captive audience.”

And what’s next? He asks: Can the Florida legislature now prohibit questions
that implicate other constitutionally protected rights?

   “Are you sexually active?” “Are you using contraceptives?” “What kinds of
   contraceptives are you using?” “Do you want to have children at some point?” 
   “Have you ever been pregnant?” “How many sexual partners have you had in the 
   past year?” “Are you engaging in anal sex?” “How much television do your
   children watch?” “Do your children play violent videogames?”

Prof. Volokh concludes by echoing a point I made earlier. The 11th Circuit’s
opinion, he says,

   can apply to a wide range of situations where the government can claim some
   supposed tension (however indirect) between constitutional rights, some
   “power imbalance” between speaker and listener, or some “vulnerability” or
   “captivity” of the listener. If not reversed, it will set a dangerous
   precedent for speech far outside the gun debate.

Closer to the SBM home, my concern about legislative bodies making medical
judgments is reinforced by state laws promoting politically-favored messages not
necessarily consistent with evidence-based medical practice. (I do not include 
the SOCT bans in this category. There the legislature’s judgment was medically
sound.) As we’ve discussed a number of times on SBM, legislators sometimes
wander far outside the boundaries of science in making decisions affecting
healthcare: Legislative Alchemy, the 21st Century Cures Act, non-medical
vaccination exemptions, and “Right to Try” statutes. Physician questioning about
gun ownership is, in my view, based on a reasonable judgment that discussing it
is, at least arguably, a medically sound preventive medicine practice. Yet, the
court, in requiring “relevancy” to a specific patient’s medical care based on a
“‘some particularized information about the individual patient” effectively
overrules the physician’s judgment. The same is true of state laws requiring
physicians to make scripted speeches containing medically irrelevant
information. Perhaps we need a constitutional “right to science” to protect the 
public against scientifically unsound legislative decisions.

An SBM Advocate Goes To Washington

An update on the strategies and deceptions used by the CAM movement to promote
their treatments.

Steven Novella on April 5, 2023

Link



Last week I was invited to be involved in a roundtable discussion for a US
senate committee on healthcare. This was a closed session without reporters, so 
I don’t feel at liberty to discuss details, but it did help crystalize for me
the current thoughts and strategies of those promoting complementary and
alternative medicine (CAM). I can give my overall impressions of where I think
we are, partly informed by my recent experience.

Alternative, No – Complementary, No – Integrative

CAM proponents use a lot of bait-and-switch or what David Gorski has dubbed
“Trojan Horse” strategies to push their treatments. Interestingly, it’s mostly
the same exact treatments that have been around for 50 years or more. When we
talk of CAM we are still mostly referring to homeopathy, acupuncture,
chiropractic manipulation, energy medicine, and herbal medicine. There are
branding tweaks, or new versions of these things, but the core concepts are the 
same. It doesn’t matter if you call them alternative, complementary, or
integrative. It’s the same stuff.

The evolution of the branding, however, is to reassure those who care about
things such as the standard of care in medicine that they will not be replacing 
proven therapies, and are offered in addition to them. First, this is never
entirely true. If a CAM method is being placed somewhere in the hierarchy of
treatments, then it is displacing or delaying non-CAM therapies. Also, health
care is often resource limited. If a patient is availing themselves of
acupuncture, that is using up their limited resources of time and health-care
dollars. Proper treatment trials should also be done one at a time, or else you 
can’t know what is working. So while you are trying acupuncture (or whatever)
you may not be doing the next thing.

Further, the very concept of “integrative” medicine is flawed to its core. What,
exactly, are they integrating into what? Try to answer this question without
just referring to euphemisms – no alternative or complementary methods,
traditional, non-mainstream, etc. None of these really work, nor can they be
operationally defined. If, for example, you define it as integrating
non-mainstream methods into mainstream medicine, that provokes the question of
why they are non-mainstream in the first place. And also – there already is a
mechanism for that. It’s called science and evidence. The implication is that we
should be integrating methods based on something other than the best available 
science. And once they are integrated, wouldn’t that then make them mainstream? 
So then what are they?

All of this rhetorical dancing is to avoid the obvious answer – integrative
medicine is all about creating a double standard (legally, academically,
professionally) so that treatments and methods that are below the line of
scientific medicine can be integrated with those that are above the line. That’s
it, and the laws that are pushed to promote CAM explicitly carve out this
double standard.

Integrative medicine is preventive medicine/health promotion

This is the most annoying aspect of the CAM propaganda – the retconning of CAM
into preventive medicine. This is nothing short of gaslighting. The first piece 
of this strategy is to slander mainstream medicine by saying it is not about
disease prevention, only disease intervention. This is not to say we do a
perfect job sufficiently emphasizing prevention. Healthcare is complex, it is
very difficult to get people to change their habits, and we do nothing
perfectly. But this does not mean we don’t do prevention or that CAM providers
are better at it.

Most primary care is about disease prevention and health promotion. This is all 
science based – good nutrition, sleep hygiene, exercise, taking aspirin for
vascular prevention, treating high blood pressure, lowering cholesterol, smoking
cessation, etc. The amount of research being done on preventive strategies and 
slowly being integrated into the standard of practice is staggering. And it’s
all mainstream science-based medicine. None of the CAM modalities I listed above
have any preventive value (or arguably, any value).

But this line is rhetorically very powerful. If they can slip in this
equivalency, then they have already won. To further support this approach CAM
proponents are very liberal in defining what is CAM. They would love to include 
all nutrition and exercise – but again, this is anti-historical gaslighting.

Part of this complete breakfast

I believe I was the first one here to use this reference, because it is perfect 
for what is happening. Remember the old commercials where something like a
breakfast pastry was shown next to orange juice, eggs, fruit, and toast and said
to be “part of this complete breakfast”. Even as a child I saw through this
scam – sure, it may be part of that breakfast, but it’s an irrelevant part.

Good science-based medicine should endeavor to isolate variables as much as
possible. That is what the entire placebo-controlled trial is about. We cannot
make causal conclusion unless the variable of interest is isolated. The problem 
for CAM proponents is that when you properly isolate the variable that is at the
core of their treatment, it doesn’t work. After thousands of clinical trials,
for example, acupuncture researchers still have not been able to demonstrate
scientifically that acupuncture points mean anything. They do not appear to
exist – their own research concludes this. Similarly, there is no “life energy” 
behind energy medicine, subluxation theory has been essentially disproven, and
the principles of homeopathy are demonstrable nonsense.

The ideas and claims at the heart of these CAM methods have never been
scientifically demonstrated, and go against pretty much all of modern biology,
physiology, biochemistry, and even sometimes the laws of physics. So what’s a
CAM proponent to do? One approach is to simply never isolate these core
variables in a clinical study. Mix in a bunch of interventions that are almost
guaranteed to be helpful (tracking nutrition, health coaching, sleep hygiene,
compliance monitoring) and then claim that the CAM treatment “worked”. Or
simply, don’t properly blind the study. That way you can claim that non-specific
placebo effects are evidence that the treatment works. One way to do this is
pragmatic studies, looking at real-world use. But these studies cannot be used
to make efficacy claims – for the reasons stated, they are not blinded and don’t
isolate variables. Pragmatic studies should only be done on treatments that
have already demonstrated efficacy.

Appeal to anecdote

I almost always hear the phrase, “I have seen it work in my practice” from CAM
proponents justifying their non-science based interventions. Of course, this is 
anecdotal, it means close to nothing. Anecdotal evidence leads us to the
conclusions we want to be true (quoting Barry Beyerstein), not the truth.
Legions of patients swore by all kinds of nonsensical treatments throughout
history, that we now know to be nothing but snake oil.

The appeal to anecdote can also sometime be camouflaged with euphemisms. We see 
this treatment working individually, even if it cannot be demonstrated with
group level data. Translation – this treatment does not work when studied
scientifically, so I am going to refer to anecdotes instead.

This approach can be further obscured by referring to individualized or
personalized medicine. These sound good, because they are, but the problem is – 
you should not be individualizing treatments that have no proven efficacy. When 
I give a patient a treatment trial, I give them something that has been proven
statistically to work, and then I see if it works in them (you still never
really know, you can only know the statistics). What you cannot do is use
individual level data as if it were evidence for efficacy.

Oh, yeah!

One final strategy is to say that, well, mainstream medicine is not all
evidence-based either. This is actually a complex question, and not statement
like this can fairly capture that complexity. In scientific medicine we use a
hierarchy of evidence, starting with the most evidence based treatments
(individualized by history, comorbidities, and priorities), and then proceed
from there as necessary. At the same time we are trying to improve the evidence 
base for everything we do. The vast majority of day-to-day medical practice is
solidly evidence-based, but we don’t have proven treatments for everything, so
we often have to make do with less-than definitive evidence.

However, there is a line we should not go below. We should not use treatments
that have been adequately demonstrated to be harmful or worthless. We should
also not use treatments that have no evidence to support their use and have a
prior probability of close to zero. We also should not use treatments that have 
been studied for decades without being able to prove specific efficacy, and just
pretend these are still experimental.

This also gets us back to my first point – the goal of scientific medicine it to
improve the base of scientific evidence for medicine, to improve the standard
of care, and to increase the effectiveness of translating evidence into best
practice. Yes, medicine is not perfect. But like all sciences, it is
self-correcting. While there is a major movement within medicine to constantly
tweak and improve the scientific base, there is a simultaneous movement that
seeks to carve out a double standard that explicitly lowers the standard of
evidence, of science, and even of ethics within medicine.

At the end of the day, the CAM movement is all about integrating old,
unscientific, failed treatments into modern medicine. Everything else is
distraction.

Medicare and Alternative Medicine

Medicare is paying for nonsense.

Harriet Hall on November 15, 2022

Link





Taxpayer dollars are paying for this

I recently wrote about the free preventive medicine appointments offered by
Medicare. Those are worthwhile and are based on good science, but I was
surprised to see that Medicare sometimes departs from rigorously science-based
standards. They also cover alternative medicine treatments based on fantasy.

Chiropractic

According to Medicare.gov:

   Medicare Part B (Medical Insurance) covers manipulation of the spine by a
   chiropractor or other qualified provider to correct a subluxation (when the
   spinal joints fail to move properly, but the contact between the joints
   remains intact).

The chiropractic subluxation is the essential basis of chiropractic theory.
Chiropractors originally believed bones were actually out of place, that these
subluxations interfered with the nervous system, that they caused 100% of all
disease, and that spinal manipulation put the displaced bones back into place.
When x-rays showed no such thing, they re-defined the subluxation as:

   …a complex of functional and/or structural and/or pathological articular
   changes that compromise neural integrity and may influence organ system
   function and general health.

This meaningless gibberish allowed them to practice spinal manipulation on
anyone they wanted to.

In 2009, an article came out in the Journal of Chiropractic and Osteopathy. 3 of
its 4 co-authors were chiropractors. They pointed out that no evidence for the 
existence of chiropractic subluxations has ever been demonstrated, and that
there is no supportive evidence for the association of the chiropractic
subluxation with any disease process or of creating suboptimal health conditions
requiring intervention. They said the subluxation construct was nothing but
unsupported speculation.

They concluded:

   The subluxation construct has no valid clinical applicability.

Chiropractors were now confirming what the critics of chiropractic had been
saying for decades. The whole theory underlying chiropractic was a myth. That
admission by chiropractors themselves should have put an end to chiropractic
claims but it didn’t. Most chiropractors continued to promote the unproven
claims. And Medicare fell for the claims.

Acupuncture

Medicare covers up to 12 acupuncture visits in 90 days for chronic low back
pain, with 8 additional visits if the patient shows improvement. (It doesn’t
cover acupuncture for any other condition.)

Acupuncture is a myth that posits acupuncture points and meridians that have
never been shown to exist. I punctured the acupuncture myth here. Medicare’s
coverage is not based on rigorous science. Yes, there are studies showing that
acupuncture “works” but there are all sorts of reasons that studies can reach
false conclusions. In the case of acupuncture, the studies are great examples of
what I call “Tooth Fairy science”, studying something that has never been shown
to exist. They only demonstrate placebo responses.

An explanation

At first I was puzzled as to why Medicare approved these treatments, but I came 
across a Cochrane review that may explain their thinking. It allegedly showed
that acupuncture is effective for healing a hordeolum (a stye), a painful
inflamed oil gland on the eyelid where the eyelash meets the lid. Styes usually 
resolve in a week with no treatment needed but warm compresses, although many
other treatments may be used. The review found 6 studies, all from China where
negative studies are seldom if ever published. A total of 531 patients were
treated either with acupuncture alone or in combination with conventional
treatments and the results were compared to the results of conventional
treatment alone.

The findings of the review

  1. Acupuncture may increase the chance of the hordeolum getting better compared
    with using antibiotics and/or warm compresses (low-certainty evidence).

  2. Acupuncture combined with antibiotics and/or warm compresses compared with
    antibiotics and/or warm compresses may slightly increase the chance of the
    hordeolum getting better (low-certainty evidence).

  3. It is uncertain whether there are any harmful effects of acupuncture for
    hordeolum.

Note the caveats “may” and “may slightly decrease” and that they found the
evidence was of “low-certainty”. And that they have not ruled out possible
harmful effects.

The authors’ conclusions:

   Low-certainty evidence suggests that acupuncture with or without conventional
   treatments may provide short-term benefits for treating acute hordeolum when
   compared with conventional treatments alone. The certainty of the evidence
   was low to very low mainly due to small sample sizes, inadequate allocation
   concealment, lack of masking of the outcome assessors, inadequate or unclear 
   randomization method, and a high or unreported number of dropouts. All RCTs
   were conducted in China, which may limit their generalizability to
   non-Chinese populations.

My conclusion

Apparently Medicare doesn’t support good science-based medicine. They only
require a published controlled study and don’t care if the evidence is flimsy or
is based on mythical concepts. Disappointing! Especially since they are forcing
us taxpayers to foot the bill.

Geriatric Preventive Medicine Appointments Covered by Medicare

Medicare offers free preventive medicine visits for those over 65: the Welcome
to Medicare visit and the Annual Wellness Visit. Increased awareness of these
benefits would improve health care, save taxpayer money, and reduce inequities
of preventive medicine care for underserved populations.

Harriet Hall on November 8, 2022

Link



The population is aging. More than 56 million Americans are older than 65 years 
     and eligible for Medicare. Many of the elderly develop chronic health
conditions: heart disease, cancer, cerebrovascular disease, diabetes, arthritis,
  hearing loss, poor vision, dementia, and many others. Some of these increase
the risk of death; others make the “golden years” a time of decline and misery, 
     with limited activity and decreased quality of life. Many of them are
    potentially preventable. One of Medicare’s goals is prevention. A recent
    monograph on geriatric care published in the American Academy of Family
   Physicians’ FP Essentials CME series provided an excellent overview of the
facts. The text of the monograph is not available to non-subscribers, so I have 
             summarized the information here for your convenience.

Welcome to Medicare

The Welcome to Medicare visit was established in 2005. It is a one-time
preventive service for all new Medicare beneficiaries enrolled in Medicare Part 
B. It must occur within the first 12 months after enrollment in Medicare part B.
It covers patients enrolled in Medicare Advantage plans if they were enrolled
when they were first eligible for Part B.

The Welcome to Medicare visit includes a review of the patient’s medical
history, current medications, lifestyle factors (such as diet, smoking, and
exercise), functional status, a brief physical exam, and education and
counselling about preventive services. It includes end-of-life planning and
gives the patient a written plan for when preventive services such as screenings
and vaccines will be needed.

Annual Wellness Visits

Medicare also covers an Annual Wellness Visit (AWV) once a year. It doesn’t
require waiting exactly 365 days between visits but can be scheduled any time in
the same calendar month. It updates any changes in information and risk
assessment since the last exam. It includes a focused physical exam, assessment 
of cognitive function and mobility, and screening for depression. It updates the
plan for preventive services, providing the patient with a new written 5- to
10-year plan. It usually takes 30-40 minutes. To increase efficiency, multiple
team members can be involved. If the physician chooses to provide additional
services not covered in the AWV, these are billed separately.

Only focused physical exams are covered. Complete routine physical examinations 
are not covered by Medicare, since they have not been shown to improve health
outcomes. The goal of a complete physical is to assist in diagnosis, while the
goal of the AWV is to promote healthful habits and behavior. AWVs have been
shown to increase patient use of screenings, preventive services, and
vaccinations. They have been associated with reduced spending on hospital
admissions and outpatient services. AWVs reduce the cost burden to taxpayers by 
5.7%. There is limited evidence about other outcomes.

Since these appointments are free, they could do a lot to address inequities in 
preventive services for underserved groups. Unfortunately, not many Medicare
beneficiaries know about them. Only 19% of Medicare patients have taken
advantage of the opportunity. Providers need to spread the word. You can help by
telling your elderly friends.

David Tredinnick – Quack Candidate for Health Select Committee Chair

Steven Novella on June 17, 2015

Link

Today the UK Parliament will have a vote for the chair of the Health Select
Committee. The two choices could not be more starkly different, so much so that 
this vote might be seen as a referendum on two world views, one that respects
science and another that confuses pseudoscience and spirituality for medicine.

On one side we have Sarah Wollaston, the previous chair, who is a former general
practitioner and has taken a solid stand against pseudoscience in medicine. She
has previously tweeted, for example, “Homeopathy can also have serious harms
when masquerading as a ‘vaccine’.”

Tredinnick, on the other hand, has previously argued that the NHS should
incorporate astrology into the healthcare system. I have previously argued that 
homeopathy is the most absurd and easily debunked major form of alternative
medicine. Astrology, however, is arguably more absurd, I had just never heard it
offered as a basis for healthcare. Tredinnick has at least accomplished setting
a new low bar for alternative medicine nonsense.

Tredinnick appears to be a true-believer, fully steeped in the propaganda that
is CAM (so-called complementary and alternative medicine). He has said:

   Ninety per cent of pregnant French women use homeopathy. Astrology is a
   useful diagnostic tool enabling us to see strengths and weaknesses via the
   birth chart.

   And, yes, I have helped fellow MPs. I do foresee that one day astrology will 
   have a role to play in healthcare.

That is frightening enough, but he goes on to say of his critics:

   Opposition to astrology is driven by “superstition, ignorance and prejudice”,
   he said. “It tends to be based on superstition, with scientists reacting
   emotionally, which is always a great irony.

   “They are also ignorant, because they never study the subject and just say
   that it is all to do with what appears in the newspapers, which it is not,
   and they are deeply prejudiced, and racially prejudiced, which is troubling.”

You need to have a profound level of scientific illiteracy to hold such
opinions. These statements also represent irony of epic proportions. Astrology, 
of course, is nothing but superstition, and is steeped in scientific ignorance. 
Scientists are dismissive of astrology because it is patent nonsense, not
because they do not understand it. There is no possible way for the apparent
alignment of stars and planets as subjectively viewed from earth to affect the
personality or fates of people on earth. Astrologers have also had a couple
thousand years to make their case, and have failed to do so. There is simply
nothing there but pre-scientific superstition.

It is also interesting that Tredinnick thinks dismissing astrology is “racially 
prejudiced.” I wonder what race he is talking about. Actually, he did clarify
this in a 2009 statement in which he wrote:

   I am talking about a long-standing discipline-an art and a science-that has
   been with us since ancient Egyptian, Roman, Babylonian and Assyrian times. It
   is part of the Chinese, Muslim and Hindu cultures. Criticism is deeply
   offensive to those cultures, and I have a Muslim college in my constituency.

The Babylonians might find it offensive also. Is Tredinnick aware that these
ancient astrological systems are mutually incompatible with each other? So which
astrological system should the UK health service use? I would argue that it is 
offensive to these modern people to claim that their culture is based upon
superstition and pseudoscience.

Now, as the vote for chair draws near, he is doubling down on this
philosophy-based approach to medicine (charitably described). He has written an 
editorial in the Huff Post UK, in which he writes:

   Across the world in some of the largest populated countries like India and
   China patients are routinely treated with therapies like homeopathy, herbal
   medicine and acupuncture alongside orthodox Western medicine. This provides a
   more rounded treatment plan and brings about better patient outcomes in
   combining the best of what both philosophies have to offer.

He offers this as evidence that CAM is being integrated into “orthodox”
medicine. However, these are examples of modern medicine being incorporated into
areas that previously relied upon pre-scientific healthcare methods.

You will also note that he refers to both as “philosophies.” This is a clue that
he is well-read in pro-CAM propaganda, which largely advocates philosophy-based
(rather than science-based) medicine. He is trying to subtly argue that
science-based medicine is just another philosophy, and thereby put CAM on an
equal footing. This is a similar strategy to what creationists use, arguing that
the evolutionary “model” is just another “faith,” and therefore on equal
footing with the creationist “model.” They both make clever use of language in
an attempt to create a false equivalency, and gloss over the fact that one
(modern medicine and evolutionary theory) is legitimate science and the other
(CAM and creationism) is pseudoscience.

He then makes two statements that directly contradict each other:

   Some people think that all complementary therapies should be available on the
   NHS, some people think none should, and some believe, as I do, that we need 
   to determine what works for what conditions and provide those treatments for 
   patients. We cannot get bogged down with demands for randomised controlled
   trial (RCT) evidence, as some do.

Tredinnick wants to separate what works from what doesn’t work, but doesn’t want
to get “bogged down” in actual evidence. I do have to say, he captures the
essence of CAM quite well. Of course, if you do research to identify what works 
and for what conditions then you are not doing CAM, you are doing regular
medicine. CAM proponents are in a difficult ideological position. They desire
the mantle of legitimacy, which means claiming to be evidence-based. However,
scientific evidence has already shown that their main treatments (homeopathy,
acupuncture, energy medicine) do not work. They need to have it both ways, so
what do they do?

First, they misrepresent the evidence. Tredinnick wrote previously:

   Attacks have also been made on the efficacy of homeopathy. A letter was sent 
   to the World Health Organisation warning against the use of homeopathy, but
   it ignored the very clear randomised, double-blind trials that proved that it
   is effective in the particular area of childhood diarrhoea on which it was
   criticised.

You see that CAM proponents are happy to cite double-blind placebo controlled
trials when they think it supports their side, then criticize them as
closed-minded when the results are negative. Further, the evidence for the
efficacy of homeopathy for diarrhea is negative. Tredinnick, like other
homeopathy advocates, is cherry picking one review of a few studies, ignoring
other reviews which found the evidence negative, and a later larger trial that
was clearly negative. This is a great example of not understanding (or caring)
how to properly evaluate clinical evidence. As with homeopathy for any
indication, there is no evidence showing a clear effect that can be replicated. 
There is only inconsistent marginal evidence. Cherry picking, however, can put
lipstick on any pig, no matter how ugly (with appropriate apologies to our
porcine friends).

If Tredinnick wants evidence, but not pesky double-blind studies that have a
frustrating tendency to be negative with regard to his preferred treatments,
what kind of evidence does Tredinnick want? He tells us:

   It is hypocrisy by many who demand it, as much of conventional medicine that 
   is routinely used in the NHS does not have the RCT evidence that is demanded 
   of complementary therapies, which are less invasive with far less
   side-effects. We live in a real-world where real world patient experience and
   outcomes must play a part.

He plays the “real-world” evidence card. This is a clever way to refer to
pragmatic and other study designs that are not meant to be efficacy trials. In
other words – they are not adequately controlled and therefore cannot (and
should not) be used to determine if a treatment works. He therefore wants to use
the wrong kind of evidence, less rigorous evidence, which can more easily be
manipulated to manufacture the appearance of evidence to support his preferred
treatments. This is naked pseudoscience.

He also again tries to make the false-equivalency argument, that mainstream
medicine also does not uniformly have high quality RTC evidence behind it. This 
is an overstatement of the facts, and ignores the real point. Medicine should be
based on the best currently-available evidence, and appropriately and ethically
follows a hierarchy of evidence. Simply because we do not have high quality
evidence for every possible decision, that does not mean we can abandon the
rules of evidence and use highly implausible treatments that are not backed by
quality evidence.

Again, this is a similar intellectual strategy to the creationists, who will
pick at details that are not currently understood within evolutionary theory as 
if this means we can abandon the entire theory, or treat competing ideas as if
they were legitimate.

Tredinnick completes the usual set of political arguments for nonsense with
this:

   Patients are usually more open-minded than many of the doctors who treat
   them, and we must work to ensure that patients really do have information and
   choice in our Health Service rather than being given choice, as long as it’s
   one of the options their doctor or CCG allows them to choose.

The “open minded” gambit is also a common ploy. Being “open minded” is treated
as a virtue, identical to the way having faith is treated for spiritual belief
systems. I have argued that science is the most open-minded system humans have
developed, for all ideas are treated within (ideally) a pure meritocracy of
logic and evidence, and all conclusions are tentative and open to new evidence.

Ironically, it is Tredinnick and his ilk who are being supremely closed minded. 
He is closed to the evidence which states that homeopathy does not work, and
astrology is nothing but superstition. If the current evidence has not already
convinced Tredinnick that these modalities do not work, than no amount of
evidence ever will – because he is closed-minded to that possibility.

Finally he makes an appeal to choice, which politically is very effective.
However, choice does not mean that the government has to endorse and pay for
nonsense. Further, the treatments he favors violate patient information and
informed consent. I doubt anyone would buy a homeopathic remedy if the package
truthfully stated what was inside. Patients can only make free choices if they
are given scientifically accurate and thorough information – that is what we
advocate, and what Tredinnick and CAM advocates oppose, by spreading
misinformation and propaganda regarding their preferred magical and
pseudoscientific treatments.

Conclusion

It is difficult to imagine a worse choice for chair of the Health Select
Committee than Tredinnick. From what he says and writes he clearly does not
understand medical science (and probably science in general) and is profoundly
confused by anti-scientific propaganda, which he is now spreading further.

We’ll post an update to the outcome of the vote when it’s available.


Edit: There is a change.org petition to oppose Tredinnick.

Update 06/18/2015: Wollaston defeated Tredinnick 532 to 64.

Importing drugs from Canada won’t lower drug prices for Americans

The Trump administration has approved the bulk importation of prescription drugs
from Canada. But Canada isn’t on board with this plan, and it’s not going to
reduce drug prices for Americans.

Scott Gavura on October 15, 2020

Link



At the end of September, President Donald Trump announced that his
administration will allow the importation of prescription drugs from Canada as a
strategy to reduce prescription drug prices for Americans. This isn’t allowing 
Americans to cross into Canada to have their prescriptions filled. (The border
is closed, by the way). Rather, this is a bulk importation scheme that would
potentially move large quantities of drugs from Canada to various states. While 
seen by some as an election gift to Florida, this announcement is also
responsive to requests from other states, like Vermont, Colorado and others.
Federal endorsement of these state-based proposals is a significant pivot away
from previous positions which have strongly rejected this approach, citing
(among other reasons) an unacceptable risk to consumers. So what’s changed? Is
this actually feasible, and will it lower drug prices for Americans? And what
will this do to Canadians?

Importation? Or Reimportation?

It’s called “importation” from Canada, but that may not be the most accurate
term. Reimportation of drugs, manufactured in the US, is more likely. The
prescription drug business is enormous, with a handful of massive companies
operating as global entities. While head offices may be in the US, Europe, or
elsewhere, companies have a presence in each country they sell in, to market
products according to that country’s standards and requirements. However, it
isn’t economical for every company to make each drug in every country. Most
prescription drugs are manufactured in a small number of facilities for
worldwide distribution – in some cases, the entire world’s supply of a drug may 
come from one single facility. Finished Dosage Forms (i.e., final prescription
products) or Active Pharmaceutical Ingredients (API) (i.e., the raw material)
constantly move around the world to supply local needs. This table, from a 2019 
FDA Report on Drug Shortages, identifies that Canada has few facilities that
manufacture for the US market:

Finished dosage forms for American prescription drugs are most likely to
originate from facilities that are within the US (37%) followed by India (24%)
and the European Union (18%) compared to Canada (4%). It is far more likely that
a prescription drug that might be “imported” from Canada actually originated in
the United States, and is being reimported than a drug was manufactured in
Canada and would then be “imported” into the United States. This should not be a
surprise, as Canada, while massive in geography, is tiny by population, with
just 37.8 million residents – roughly a tenth of the USA. Canada’s entire
population is just slightly smaller than that of California. Its pharmaceutical 
market, as expected, is also relatively small, making up only 2% of the world’s 
market (compared to America’s disproportionate 44%).

What is this strange northern land of lower cost prescription drugs?

Much is made of Canada’s universal healthcare system. The Canada Health Act
defines the overarching principles of medicare, and stipulates that some health 
services must be provided at no charge (e.g., physician services, hospital care)
to all residents. Canadian provinces are responsible for the delivery of health
care to their residents, not the federal government. In general prescription
drugs are not covered under the Act, so there is no guarantee of universal,
no-cost access. Canada’s prescription drug system, consequently, is broadly
similar to that of the US. Each province has its own programs to help residents 
pay for drug costs, and may determine eligibility based income levels (e.g.,
social assistance), age (e.g., seniors), or overall drug costs (e.g.,
catastrophic cost coverage). There may be copays and deductibles in these
programs. Many Canadians receive insurance for prescription drugs through their 
employer, with programs that also have copays and deductibles. The result is
that Canadians rely on a mix of paying cash, public insurance, and private
insurance programs in order to obtain prescribed drugs.

Where Canada differs significantly from the United States is in how
manufacturers establish pricing for their pharmaceuticals. The Patented
Medicines Prices Review Board (PMPRB), an independent quasi-judicial tribunal,
regulates the maximum price of all patented (i.e., non-generic) prescription
drugs. From their website:

   Patentees are required by law to file information about the prices and sales 
   of their patented drug products in Canada at introduction and then twice a
   year until the patent expires. The Patent Act along with the Patented
   Medicines Regulations set out the filing requirements.

   The PMPRB reviews the average price of each strength of an individual dosage 
   form of each patented medicine. In most cases, this unit is consistent with
   the Drug Identification Number (DIN) assigned by Health Canada at the time
   the drug is approved for sale in Canada.

   There are five factors used for determining whether a drug product is
   excessively priced, as outlined in section 85 of the Act:

  1. the prices at which the medicine has been sold in the relevant market

  2. the prices at which other medicines in the same therapeutic class have been
    sold in the relevant market

  3. the prices at which the medicine and other medicines in the same therapeutic
    class have been sold in countries other than Canada

  4. changes in the Consumer Price Index

  5. any other factors that may be set out in regulations

One of the key features of this approach (that is also being studied in the US) 
is the benchmarking of list prices against other countries. The PMPRB determines
what the Canadian “non-excessive” price should be, based in part on an
examination of pricing in a ‘basket” of countries (currently: France, Germany,
Italy, Sweden, Switzerland, the United Kingdom, and the United States). From
this basket of prices, the median international price is identified. Because the
US price is typically an outlier (as it is usually much higher), the Canadian
price that is ultimately determined to be “non-excessive” is more closely
aligned to the rest of the international comparators, and often significantly
less than the US price. Manufacturers do not have to sell any drug in Canada,
but if they choose to, they must comply with the PMPRB requirements.

Not all drugs are publicly funded by public or private drug insurance plans.
There is an established process in Canada of health technology assessment to
evaluate the value of new drugs which is similar to programs that exist in other
countries. Pharmaceutical manufacturers may negotiate additional confidential
discounts with public and private insurers when drugs are not felt to offer
value-for-money based on their list price, even when that price is felt to be
“non-excessive”. Canadians that pay cash for their prescriptions, however, can
be assured that the PMPRB’s rules ensures that their prescription prices are
benchmarked and monitored, and the list prices cannot be arbitrarily increased
by the manufacturer over time.

What drugs are we talking about?

High prescription drug costs are a challenge facing all health systems around
the world. But the USA is an outlier, with very high prescription drug prices
that often continue to rise over time, and a real patchwork of programs that
leave many Americans without comprehensive prescription drug insurance. Canadian
list prices (compared to most other countries) are high, but on balance, are
significantly lower than the US. It is worth reiterating that that this process 
of benchmarking and monitoring list prices applies to patented (brand name)
drugs only (i.e., no generic equivalent exists). Generic prices are a different 
matter. Once a drug loses its patent, any manufacturer can potentially make it, 
and the generic drug market in the US is large and very competitive. Generic
drugs have traditionally been cheaper in the US compared to Canada, and while
Canadian generic prices have been dropping over past several years, I don’t
think there is anything in Canada anywhere close to something like Walmart’s
$4/month generic drug pricing.

How would importation actually work?

Let’s take the Florida model as an example. Based on the Florida proposal, (see 
“Canadian Prescription Drug Importation Concept Paper“) the state would select a
vendor, who would contract with a wholesaler in Canada. The Canadian wholesaler
would then presumably buy drugs from Canadian-based pharmaceutical companies,
and then supply that Canadian-labelled drug (in bulk quantities) to a wholesaler
in Florida. As per the state’s analysis:

   Once the vendor identifies drugs that provide the highest potential for cost 
   savings to the state, it must identify Canadian suppliers who are in full
   compliance with relevant Canadian federal and provincial laws and regulations
   and who have agreed to export the identified prescription drugs. The vendor 
   must verify that these Canadian suppliers meet all of the requirements of the
   program, will meet or exceed federal prescription drug tracking and tracing 
   requirements, and will export prescription drugs at prices that will provide 
   cost savings to the state.

There is a long list of exceptions which include any biologic drug (e.g.,
insulin, some drugs to treat cancer, or autoimmune diseases), any injectable
drug, and any controlled drug (e.g., narcotic). The bill requires the importer
to validate the quality and safety of imported drugs, including laboratory
testing of products. (It should be noted that Health Canada’s regulatory and
manufacturing standards are largely equivalent to those of the FDA’s, but
importation could increase the risk of counterfeit drugs entering the market.)
There would be no difference for shoppers at the pharmacy level, but the drugs
coming from Canada would have different labeling and identifiers, which might
include tablet markings, etc. The proposal assumes that these drugs would be
relabelled to meet US requirements. (Who would do this is unclear.) Patients
would access their prescriptions at their pharmacy as per usual – there would be
no need for residents to do anything different. Presumably, any savings from
the importation and relabelling would be passed on to the consumer, and wouldn’t
be sucked up by other middlemen in the process. Florida’s concept paper
estimates savings of over $150 million per year. In contrast, an analysis of
Vermont’s proposal suggested the cost of implementing an importation program
would outweigh the savings.

So what’s stopping this process? Until just recently, it was the US Department
of Health and Human Services (HHS). Since 2003, it has had the power to approve 
importation programs. But no administration (Republican or Democrat) has ever
approved one.

About-face? Or calling the state’s bluff?

In July 2019 the HHS and the FDA announced what it called a “Safe Importation
Action Plan” which advanced the framework for drug importation, and removes
federal barriers to states that want to try this approach. Two pathways were
described:

  1. Pathway 1 allows states, wholesalers and pharmacists to propose “demonstration
    projects” for importation of drugs from Canada. Participants need to prove 
    that importation poses no additional risk to consumers.

  2. Pathway 2 allows manufacturers to reimport versions of their own drugs that
    they are already selling to foreign markets, and to sell them in the
    American market at lower cost.

If you’re scratching your head over the logic in pathway 2, you’re not alone.
One commentary noted:

   Certain manufacturers have recently begun to market lower cost versions of
   their drugs under different NDCs, as an alternative to the existing
   higher-priced version but unaccompanied by rebates. It is uncertain whether
   manufacturers who wish to offer lower cost versions of their existing drugs
   in the U.S. would find Pathway 2 more advantageous than simply introducing a 
   new, lower cost version to the U.S. market (under a new NDC) without
   importing it.

Canadian opposition

An essential part of any importation plan is the willingness of pharmaceutical
manufacturers and wholesalers in Canada to support exports, and for the Canadian
government to approve it. Like every other country, drug shortages are not
uncommon in Canada and there are concerns that any large-scale importation
scheme would quickly lead to drug shortages for Canadians. One paper examined
the potential for this and concluded that substantial importation would
completely deplete the Canadian pharmaceutical drug supply within several
months:

   The risks are high for the Canadian health care system if the U.S. were to
   legalize drug importation, unless Canada has a dramatic increase in domestic 
   drug manufacturing shipments and/or a dramatic increase in the supply of
   imported prescription drugs. Without these, the threat to the Canadian drug
   supply is real. Drug shortages will undoubtedly occur.

Canadians are understandably concerned about the potential for its own drug
supply market to be severely disrupted. While its own prescription drug pricing 
and funding system is not perfect, it is not equipped to deal with a surge in
demand driven by millions of Americans. Health Canada is now expected to take
legislative steps to oppose any importation plan. A statement says it will “take
action to ensure Canadians have uninterrupted access to the prescription drugs 
they need”. These steps could include prohibiting bulk exports of products
manufactured and labelled for the Canadian market, or requiring export permits
on all exported drugs, to both increase the export price and/or limit the size
of the export market.

The other group that is expected to strongly opposed this plan are
pharmaceutical manufacturers on both sides of the border. It is unlikely any
pharmaceutical company in Canada would be willing to increase its supply just
for that supply to be shipped to the US, when an American affiliate is already
selling the exact same product at what may be a much higher price. No Canadian
pharmaceutical company would likely compromise their ability to meet Canadian
demand, simply to see that supply shipped to the US. Innovative Medicines
Canada, which represents these companies, has stated,

   Canada cannot supply medicines and vaccines to a market ten times larger than
   its own population without jeopardizing Canadian supplies and causing
   shortages.

Canada isn’t America’s pharmacy

Importing Canadian-sourced pharmaceuticals is an idea that is unlikely to be
workable at scale, and could very well be blocked by Canada before it ever gets 
off the ground. If implemented, it could lead to severe drug shortages for
Canadians. Even then, it would still not solve the prescription drug price
problems that face millions of Americans. Because the fact is that Americans
don’t need Canadian drugs. They need Canadian drug prices. And that’s possible
without any importation at all. America is the world’s largest pharmaceutical
market and there is no reason why it cannot have the most competitive pricing in
the world. There is nothing stopping it from implementing pharmaceutical
policies (already in place in Canada and elsewhere) that make pharmaceutical
drugs more affordable for consumers. But it will take an acknowledgement of
ownership of the problem, and a willingness to make the hard decisions to bring 
affordable drugs to more Americans.

Disclosure: The author is a Canadian. And a pharmacist.

Photos from flickr users Wellness GM and David Goehring used under a CC license.

Another blow to the anti-vaccine movement as legislation change forces a name
change

Rachael Dunlop on December 23, 2012

Link

Earlier this year, Australia’s anti-vaccine lobby, the Australian Vaccination
Network (AVN), took the NSW Government to the Supreme Court. In dispute was
their license to fundraise which had been revoked and a public warning, issued
because they refused to put a Quack Miranda on their website.

The public warning was posted after the NSW government investigated their
website following two complaints, one from a concerned citizen and one from the 
parents of a 4 week old girl who had died of pertussis.

The complaints accused the AVN of peddling dangerous health misinformation
including that vaccines were linked to autism and that pertussis was “nothing
more than a bad cough”.

The AVN had always insisted that the HCCC did not have jurisdiction over them
because they were not health care providers or educators in the “traditional
sense”. It is true that health legislation in NSW is very much out of date in
the Internet age. The rules say you can complain only if you can demonstrate
direct harm as a result of taking someone’s dodgy advice. For example you had a 
stroke because of a chiropractor’s adjustments or a punctured lung from
acupuncture. Just having a website full of woo-woo wasn’t really covered.

So the AVN challenged the HCCC on these grounds and, to the surprise of many of 
us, they won. Those who were present in the court that day recall the Judge
urging the HCCC Barrister to present evidence for direct harm. And the worst
thing was the HCCC apparently had this information, but for reasons unknown to
us, did not present it. Those who were there said the HCCC Barrister dropped the
ball big time that day. And they were right.

Within hours the public warning was expunged and shortly after that the
authority to fundraise was returned. As if nothing ever happened.

But something did happen that day. Two things in fact, one that would impact on 
the AVN months later.

Firstly, an unintended consequence of suing the government was that they became 
classified as health care providers. Judge Adamson accepted that “the complaints
concerned a health service provided by a health service provider” thus exposing
them to future prosecution.

Secondly, the Judge made an observation about the AVN’s name. During the case
she was not convinced by Dorey’s claims “to educate her subscribers and the
general public into making decisions about vaccinations”. As Justice Adamson put
it, “It seems slightly coy that your client is so shy about admitting what it
is on about”.

By July of 2012, Dorey had an inkling that something was afoot after she was
tipped off by a journalist that there was a campaign brewing for her to change
the name of her organisation. She issued a press release saying “The Australian 
Vaccination Network has no intention of changing its name and any group or
government department that believes it has the right to try and force us to do
so will find themselves strenuously opposed.”  Dorey continued, “It is not up to
a third party to say what we can and cannot call ourselves. The last time I
checked, Australia was still a democracy. Will they be coming for our books
next?”. (More on that later, and the answer is yes).

But on Friday December 14th, her worst fears were realised when the NSW
Department of Fair Trading came knocking to deliver an order that she change her
name or face deregistration. In a news article describing the move, the Fair
Trading Minister emphasised: “this is not a request, this is an order”.

The order makes reference to numerous complaints from health care professionals,
the public and notably the Australian Medical Association that the name
“Australian Vaccine Network” was misleading and was confusing people searching
for information on vaccination.

For a week Dorey went very quiet, neglecting her Twitter feed and Facebook page.
Many of us suspected she was seeking legal advice on how to challenge the
government’s order. It turns out this is a very serious matter since if she
can’t settle on a mutually agreed name by February 21st, 2013, her business can 
be wound-up, an audit conducted and any debts become the responsibility of the
committee members, including her. Estimates calculated from financial statements
obtained via freedom of information indicate she owes at least $400,000 in
undelivered magazine subscriptions, and there are likely other accounting
discrepancies.

But any hope of avoiding the order via legal channels were well and truly
quashed on Friday December 21st, when the NSW Government changed the law to
prevent “a name that is likely to mislead the public in relation to the nature, 
objects or association…”

That’s right. They changed the law. It was an early Christmas present for those 
of us who have been campaigning to see the end of the AVN’s dissemination of
misinformation and callous disregard for the health of children. And it was a
huge blow for the anti-vaccine movement in Australia.

What’s in a name?

Whilst the name the AVN gives the impression they are a neutral resource for
vaccination information, scratching the surface of their website and other
literature quickly reveals an anti-vaccine agenda (incidentally, I don’t
recommend going to their site at the moment as it has been hacked and you will
likely be redirected to a cheap pills seller, or get yourself a nasty virus).

Publicly they use phrases like “pro-choice and “vaccine safety watchdog” but in 
truth they are anything but. The investigation by the HCCC (which was not
overturned, just the public warning was) found that the AVN website “provides
information that is solely anti-vaccination, contains information that is
incorrect and misleading, and quotes selectively from research to suggest that
vaccination may be dangerous.”

Giving the lie to their claimed “pro-choice” stance, the AVN sells T-Shirts
emblazoned with “Love Them, Protect Them, Never Inject Them”, and a children’s
book designed to teach kids to embrace infectious disease called “Melanie’s
Marvellous Measles”.

And who could forget Meryl Dorey comparing vaccination to “rape with full
penetration”? She has also been accused of harassing the parents of a child who 
died from pertussis by telephoning the health department to enquire about the
true cause of death. It seems she didn’t believe it was pertussis that killed
the child, frequently stating she “supposedly” died of pertussis, thus deepening
the parents’ grief even further. In another ghoulish act, she has suggested
commenters on her Facebook page contact a different set of grieving parents to
enquire of the child’s vaccination status at death, thus inferring a vaccine was
implicated.  Callous in the extreme.

In recent years Australian journalists, urged on by grass roots campaigners like
“Stop the AVN” (SAVN), have been increasingly challenging Dorey on her public
face of “pro-choice” by routinely referring to the AVN as “The Anti-Vaccination 
Network” and asking her which vaccines she would recommend. Her response is
usually along the lines of “… it is not the place of the AVN to tell people
which vaccines are good…” but such evasion will only fool so many people for so 
long.

In addition, the media has recently copped a bollocking for lending credibility 
to her dangerous nonsense by using her as a source. It is strongly rumoured that
some media outlets now have a complete ban on speaking to her under any
circumstances.

The issue of the misleading name has led to confusion for the public and
professionals alike, with The Australian College of Midwives’ being recent
victims. They mistakenly sent out invitations (later withdrawn) to an AVN
seminar to all their members because they were unaware that the AVN was an
“anti-immunisation lobby”.

Parents commenting on the SAVN page share similar stories;

“Dear Meryl, I was attracted to the AVN several years ago because the name
suggested that you might be a reputable source of information about vaccination 
(I was preparing for an overseas trip). I found nothing of the sort on your
site…..I was indeed misled and deceived by your name. And I’m not the only one.”

In 2009, the Australian Skeptics, with sponsorship from philanthropist and
aviator Dick Smith, took out an ad in the Australian newspaper to warn parents
not to look to the AVN for health information. During the flurry of publicity
that ensued, Dick Smith said;

“They are actually anti-vaccination, and they should put on every bit of their
material that they are anti-vaccination in great big words. They have every
right for that belief but they should communicate it clearly so people are not
misled.”

Yet, the practice of anti-vaccine groups using misleading names is not new. In
the US there is the National Vaccine Information Centre, or NVIC, who refer to
themselves a vaccine watch dog, and in New Zealand there is VINE, or Vaccination
Information Network. Though the latter are at least honest about their agenda. 
Erwin Alber who runs the organisation doesn’t try to disguise his nutbaggery.

But it’s pretty obvious why the AVN are so keen to disguise their true agenda.  
I can’t imagine parents looking to the “Anti-Vaccine Network” for unbiased
advice. But when parents hit Google and type in vaccination, one of the first
hits they get is the AVN. And with more than half of us turning to Dr Google to 
research health, this constitutes a lot of people who are potentially being
misled.

What does it all mean?

An order to change your name might not seem like such a big deal until you look 
into the specifics. The AVN are allowed to use “Inc” after their name but this
also means they have to abide by certain rules.

The AVN have 2 months to comply and a right to appeal, but if they decide not to
comply or the groups can’t agree on a name, they risk being closed down.
According to the legislation, the Commissioner has the right to seize their
assets, conduct a full audit and distribute funds however he sees fit (but
specifically not to the committee members, meaning Dorey will see none of it).

Even to those of us who are not forensic accountants, her accounts appear a
mess. She has yet to submit her financial statements for 2011, which were due
nearly 12 months ago and there are other examples of apparently missing funds.
She continues to sell subscriptions to a magazine that she consistently fails to
deliver, and when people enquire of its whereabouts on Facebook, she deletes
their comments.

The AVN will also lose their domain name if they cannot come up with a name that
has “AVN” as its acronym.

Before the legislation was changed on Friday, effectively closing all loopholes 
for the AVN, Ms Dorey responded to the order in the only way she knows, with
accusations of “suppression of free speech” and “government bully boys”. And in 
a bizarre analogy she questioned why she was being targeted when “Greenpeace is 
not green, nor do they go around looking for peace…”

Of course this is not an issue of free speech, as the NSW Fair Trading Minster
Anthony Roberts explained, “People do not have the freedom of choice when it
comes to endangering others….it’s the equivalent of saying a bloke can speed
down the road and endanger others… this is not a victimless issue, it’s about
the ability to stop pain and suffering.”

The AVN are free to say and write what they like, but as long as they choose to 
live under the roof of the Department of Fair Trading they must choose a name
that accurately describes the activities of the organisation.

As the Minister put in no uncertain terms on Australian radio:

“What we are asking this organisation to do is be upfront and honest with people
and stop misleading people … for far too long this organisation has been
misleading individuals and getting away with it

“These people aren’t about pro-choice, these people are about pushing an
anti-vaccine line.”

So here’s my suggestion for a new name for the AVN: change it to The
Anti-Vaccination Network. That way there can be absolutely no confusion about
your agenda and you get to keep your domain name. There’s no point hiding behind
a veil of “pro-choice” anymore, that veil has been lifted and you’re not
fooling anyone anymore.

Regulating CAM Aussie Style

Jann Bellamy on March 31, 2016

Linl



CAM proponents view National Health Interview Surveys recording the supposed
popularity of CAM, an amorphous conflation of anything from conventional medical
advice to mythical methods, as an invitation to unleash even more unproven
remedies on the public. My interpretation is quite different. I see the same
figures as proof that we are doing too little to protect the public from
pseudoscience.

In fact, state and federal governments are acting as handmaidens to the CAM
industry by legalizing practices and products that have insufficient proof of
safety and efficacy and, in some cases, are so scientifically implausible that
they can never meet that standard. The federal government keeps “integrative”
medicine centers at major academic institutions and private foundations afloat
with taxpayer money by funding research that has failed to improve public health
or the treatment of disease, despite seemingly endless trials, because “more
research is needed”.

As we shall see, Australia has a more effective regulatory system for dealing
with CAM. And the advocacy group Friends of Science in Medicine (FSM), an
organization with goals similar to our own Society for Science-Based Medicine,
is keeping the government on its toes, investigating violations of the law on
its own and reporting them. We in the US could learn something from their two
recent successful campaigns attacking misleading health claims.

Diagnostic testing: gateway to quackery

Diagnostic testing is the CAM practitioner’s gateway to bogus diagnoses and
treatments. There are tests for “chronic” Lyme disease, dubious food
sensitivities, various “toxicities”, supposed nutritional deficiencies, genetic 
tests for alleged susceptibility to disease, and so forth. In the US, regulation
of diagnostic testing is multi-jurisdictional. First, the state where the
practitioner works must have granted him or her the authority to diagnose and to
use various means of diagnostic testing. (This rule seems to be honored mostly 
in the breach by naturopaths.) For example, some states specifically permit
chiropractors to perform “hair analysis”. More typically, a practice act will
contain the authority to order (and perhaps perform) lab analyses and do
physical exams, without being specific. (See., e.g., Massachusetts Senate Bill
2148, which would register naturopaths.) If the practitioner uses a diagnostic
method improperly, he is subject to discipline by his state regulatory board if 
he has fallen below the standard of care for his profession.

The actual diagnostic testing process and testing devices are regulated by both 
the states and the federal government. Clinical laboratories must be certified
by their states as well as the Center for Medicare and Medicaid Services (CMS)
before they can accept human samples for diagnostic testing. In addition to CMS,
two other federal agencies, the FDA and the CDC, are involved in regulating
testing devices, whether used in laboratories or clinical settings.

To date, the FDA has taken a hand-off approach to regulating one type of
testing: laboratory-developed tests (LDTs), that is, tests developed and
performed at a single laboratory. This lack of regulation has been a boon to
dubious lab tests, but the FDA’s final regulatory framework for LDTs, scheduled 
for 2016, may spell doom for at least some of these.

You can how this system fails the consumer when a health care profession
embraces pseudoscience, their state practice act permits it, they are
self-governed, and the FDA has decided to ignore bogus lab tests. Obviously, we 
need a more effective system.

Australia does it better

Australia’s Therapeutic Goods Administration (TGA) regulates prescription and
over-the-counter medicines, dietary supplements, blood products, biologics,
medical devices and in vitro diagnostic devices – their supply, import, export, 
manufacturing, and advertising. No product can be sold unless it is registered
with the TGA.

According to the Australian Health Practitioner Regulation Agency (AHPRA), all
registered health professions are regulated by nationally consistent legislation
under the National Registration and Accreditation Scheme, although each
profession is governed by its own national board. (Registration appears to be
the equivalent of state licensing here.) Australia has rejected the registration
of naturopaths, although they do have a voluntary professional organization.

AHPRA works with the Boards as an umbrella organization supporting the Boards
and their regulatory functions, including registration and investigating
complaints. Together with the AHPRA, the Boards jointly developed advertising
guidelines to assist health care practitioners, whether registered or not, in
complying with the advertising laws, which prohibit (as is true in the US) false
and misleading advertising, among other things. Interestingly, testimonials (an
ubiquitous feature of practitioner and product advertising here) are
prohibited, as is direct-to-consumer drug advertising.

In 2013, Friends of Science in Medicine, supported by The Royal College of
Pathologists of Australasia, issued a paper on pathology tests offered in
Australia. The paper has a simple explanation of the three characteristics that 
determine the validity of a lab test that I, as a layman, found useful:

  1. Does the test result reflect the reality in the patient’s body? In other
    words, does the measurement in the test tube accurately reflect the
    measurement in the patient’s blood (or whatever tissue is being analysed)?
    This characteristic of the test is called its “analytical validity”.

  2. Does the test result have a significant relationship with the disease in
    question? In other words, is the measurement typically abnormal in patients 
    with a particular disease? Can the test result be used to predict that a
    person is likely to develop a particular disease? This characteristic of the
    test is called its “clinical validity”.

  3. Does the test result provide additional information that is not already
    available? In other words, does the test result enable the patient to make a
    health care decision that would not have been otherwise possible? If the
    test result simply confirms something that the patient already knows, then
    the test has not provided useful information. This characteristic of the
    test is called its “clinical utility”.

The paper identified many tests with no proven validity being offered in
Australia. Among them:  live blood analysis, salivary hormone tests, iridology
and kinesiology testing, vega tests, “functional” pathology tests (e.g., liver
detoxification profile), and pseudo-diagnostic machines (e.g., “Electro-dermal
screening“). (If you click on the links in this list, you’ll see that all of
these are available in the US as well.)

More recently,

   FSM documented over 700 websites links, mostly offered by naturopaths as part
   of their initial patient consultations, to a range of pseudo-diagnostic
   interventions . . . A series of reports documenting images from
   practitioners, sponsors and training institutions were sent to the TGA with a
   request for an investigation of the following . . .

Documented tests included hemaview/live blood analysis, electrodermal screening,
body scanning devices, taste testing for zinc deficiency, hair analysis,
urinary indican test, and Thyroflex websites. You can see screen shots of the
websites by clicking on each of the tests in the list in FSM’s newsletter, which
is most illuminating. One marvels at the credulity of naturopaths and other
“alternative” practitioners, as revealed on their websites. A sampling of what
FSM uncovered:

   The ESTek [body scanning] systems is a combination of non-invasive
   biosensors, with fast measurement (5 minutes) and results immediately
   available, to provide an overview of the homeostasis (internal environment
   and the main regulatory mechanisms of the human body processes and response).

And is a handy tool for selling patients nutritional supplements based on the
“results”.

   The Thyroflex test is performed by measuring the reaction time, or reflex, of
   the brachioradialis muscle of the forearm. A small reflex hammer is used to 
   strike the reflex region of the brachioradialis muscle. Then using a
   specially developed software program the Thyroflex measures the response rate
   of the muscle within milliseconds. There is a strong correlation between
   your reflexes and your metabolic rate.

I imagine there is also a “strong correlation” between the results and the
patient’s being prescribed glandulars, made from desiccated animal organs and
touted as a “natural” alternative to prescription drugs like Synthroid. Websites
claim the Thyroflex is 98.5% accurate. The Thyroflex is actually approved by
the FDA, as pointed out by one website. However, it is listed as a neurological 
diagnostic device. Perhaps the FDA should have been tipped off by the name that 
it wasn’t going to be used that way.

The complaints were investigated by the TGA, which resulted in nearly 100
website links for Hemaview being deleted or amended, including links on the
websites of the naturopaths’ national organization and other CAM organization
websites. The TGA continues to investigate the other complaints.

Compare this to the way state regulatory boards protect naturopathic doctors, as
opposed to the public. Britt Hermes has detailed the failings of Arizona’s
naturopathic board. The California Naturopathic Doctors Association recently
warned its members to be careful about advertising biotherapeutic drainage and
electrodermal screening, not because they are quackery, but because it might not
look good to legislators considering naturopathic practice expansion.

In 2014, the Washington State Office of Laboratory Quality Assurance (LQA) cited
a Spokane naturopathic clinic for conducting “live blood cell analysis,” for
which it was not licensed. The clinic director then asked the Washington State
Board of Naturopathy to resolve a jurisdictional issue regarding who had say-so 
over whether the tests in question could be performed because, in the clinic’s
view, this type of “live blood cell analysis” was one within the “statutorily
designated naturopathic scope of practice.”

First under consideration was the “Bolen Blood Procedure,” described by the
Board as follows:

   The Bolen Blood Procedure uses a finger lancet and five to six drops of
   bloods are placed on a clean slide to dry (no reagents are used in the slide 
   preparation). When dry, the slide is then observed under a microscope to
   detect blood vitality.

Next under consideration was the “Carroll Food Intolerance Evaluation,” which,
as described by the Board,

   uses a finger lance to collect a dime-size circle of blood on a piece of
   absorbent paper, which is put into a small envelope and placed upon the
   patient’s forehead. A glass rod is used to locate acupuncture point “Stomach 
   25” on the abdomen, which then interacts with skin current to produce a “tug”
   (an electro-magnetic response, a normal “positive”). Food samples in glass
   containers are then placed on top of the envelope and if the food is
   incompatible to the patient, a negative skin response occurs (no “tug”
   effect).

It hardly bears mentioning that both of these tests are pseudoscience. Yet, the 
State Board of Naturopathy decided that the Board

   governs what naturopathic physicians can do (to include performing laboratory
   tests) and, as an [federally] approved program, LQA governs how those
   laboratory tests are done based on federal . . . laws.

What is significant here is not who controls what aspect of testing. It is that 
the that the Board was perfectly comfortable with these tests being used at all,
even in the face of the fact that, as the Board itself states in its policy
statement, rather grandly,

   The Washington State Legislature has granted the Board of Naturopathy . . .
   the authority to protect public health and safety by regulating the
   competency and quality of licensed naturopathic physicians.

Australian Chiropractic Board clamps down on advertising

The Chiropractic Board of Australia recently issued a reminder that chiropractic
advertisements need to conform to required standards, developed in cooperation 
with the AHPRA, prohibiting any statement or claim that is “false, misleading or
deceptive or create[s] and unreasonable expectation of beneficial treatment.”
Advertising claims in Australia, according to the Board, must meet a high level 
of evidence, usually “meta-analysis, systematic reviews or one or more high
quality and well respected and acknowledged studies.” The Board warned that
chiropractors who make deceptive claims risk prosecution and disciplinary
action. It even went so far as putting out a media release, publicly reinforcing
its warning to chiropractors.

The warning was issued in response to urging from FSM. The organization had
documented images from hundreds of chiropractic websites which didn’t meet the
required standards, despite repeated guidance from the Board.

The Board’s Statement on Advertising specifically mentions

   claims in advertising that there is a relationship between manual therapy
   (e.g. manipulation) for spinal problems and achieving general wellness or
   treating various organic diseases and infections; or that spinal problems may
   have a direct role in various organic diseases and infections. There is
   insufficient scientific evidence to support these claims.

Of particular concern, the Board says, are

   claims in advertising relating to infants and children. Claims suggesting
   that manual therapy for spinal problems can assist with general wellness
   and/or benefit a variety of paediatric syndromes and organic conditions are
   not supported by satisfactory evidence. This includes claims relating to
   developmental and behavioural disorders, ADHD, autistic spectrum disorders,
   asthma, infantile colic, bedwetting, ear infections and digestive problems.

The Board also warned chiropractors not to make statements that are
anti-vaccination or discourage vaccination in any way. In fact, they shouldn’t
be giving vaccination advice at all. Patients are to be referred to an
“appropriately qualified health care professional for advice.”

Finally, the Board reminded chiropractors that they are not trained to apply any
direct treatment to an unborn child. They should not provide “an obstetric
breech correction technique” to the fetus. (The latter is known to chiropractors
as the “Webster technique.”)

Compare this to the rampant pseudoscience that characterizes American
chiropractic practice. In fact, in the US, chiropractic professional
organizations like the American Chiropractic Association and the International
Chiropractors’ Association openly encourage chiropractic practices that would
subject chiropractors to discipline if they practiced in Australia.

For example, the International Chiropractic Pediatrics Association is openly
anti-vaccination, while the ACA takes a more “dog whistle” approach. The ICPA
promotes the Webster Technique, based on the absurd notion that chiropractors
can somehow effect the equivalent of an external cephalic version of a breech
baby.

Many chiropractors claim they can treat the very pediatric conditions the
Australian Chiropractic Board warns about: developmental and behavioral
disorders, ADHD, autistic spectrum disorders, asthma, infantile colic,
bedwetting, ear infections, and digestive problems. Both the ACA and the Council
on Chiropractic Education encourage the notion that chiropractors are capable
of acting as primary care physicians. (They are not.) An ACA “specialty council”
offers a “board certification” for “chiropractic internists.”

American chiropractic schools and organizations could greatly improve the
reputation of chiropractic in this country by adhering to the same requirements 
as those imposed in Australia. But they won’t. They are far too entrenched in
promoting pseudoscience and hustling for an expanded scope of practice.

Can the US emulate Australia?

There are many impediments to implementing a more sensible system of controlling
the rampant advertising and practice of pseudoscience in the US. The imprimatur
of legitimacy bestowed on practitioners, by licensing, and on products, by the 
illusion of regulation, means many (perhaps most) Americans are wholly unaware
that there is nothing more than the effective equivalent of magic behind many of
these practices and lack of evidence of efficacy and safety supporting those
that at least have scientific plausibility. (An effort aided by “integrative”
medical practitioners who supply the surgical tape holding the wool firmly in
place over consumers’ eyes.) Without public recognition of the extent to which
they are being fleeced, there won’t be any public will to change the system. And
you can bet that state and federal legislators aren’t going to mess with a
system that makes billions for the CAM industry, especially when it fills their 
campaign coffers.

Australia’s New Antiscience Party

Steven Novella on June 29, 2016

Link



In a perfect world, high quality science would inform politics and policy.
Science cannot determine policy by itself because there are also value judgments
and trade-offs that need to be negotiated. At the least, however, policy should
be consistent with the best available science.

We, of course, don’t live in a perfect world. Too often politics and ideology
seem to inform, or corrupt, science. It is so much easier to just cherry pick
the science that seems to confirm what you already believe, than to go through
the process of changing your beliefs to accommodate the evidence. The stronger
the ideology, the greater the motivated reasoning used to defend it, without
apparent practical limit. For core ideologies that are part of someone’s
identity, there does not appear to be any amount of evidence that will change
their beliefs.

Anti-scientific motivated reasoning is often codified in specific organizations,
institutions, or professions. Political parties are essentially organized
ideologies, and when that ideology is predominantly pseudoscientific, you have
organized pseudoscience.

Health Australia Party

Such appears to be the case with a recent political party that has been formed
in Australia, the Health Australia Party (HAP). From reading their policies and 
propaganda it seems pretty clear that they were founded by proponents of
alternative medicine (CAM), using all of the unscientific talking points of CAM.

Their brief summary of their health policy is littered with red flags of CAM
propaganda:

   Quality medicine for all people, with access to the best of proven natural
   and pharmaceutical medicine. Remove the influence of multinational
   pharmaceutical companies. Affordable medicine – using evidence from unbiased 
   real-world clinical studies and targeted spending. Reform the health
   bureaucracy. Apply research funds wisely.Build a health-creation system, not 
   a disease-management system.

First they promote a false dichotomy between “natural” medicine and
“pharmaceutical” medicine. There is really no such thing as “natural” medicine, 
just the appeal to nature logical fallacy. There is no operational way to define
“natural” and it is often just used as a marketing buzzword to refer to
unscientific medicine. For example, some herbal remedies are toxic, and many
pharmaceuticals are derived from natural substances.

Further, it is very telling that they characterize all of mainstream medicine as
“pharmaceutical.” This is typical CAM propaganda, making it seem like
mainstream medicine just uses drugs and surgery, ignoring all of the other
interventions developed and used by mainstream medical science.

To emphasize this point they follow up with an appeal to Big Pharma
fearmongering, referring to the “influence of multinational pharmaceutical
companies.” I suppose they would replace this with the influence of
international snake oil peddlers.

They next refer to “unbiased real-world clinical studies.” For anyone familiar
with CAM propaganda, this is obvious code for –we reject any scientific studies 
where we disagree with the results as “biased.” Further, we want to rely on
“real world” studies, which are not efficacy trials and not properly blinded and
controlled, because we can guarantee positive results for our nonsense.

They finish with a flourish of another false dichotomy – health creation vs
disease management, which is how they characterize “natural” medicine vs
mainstream medicine. This is patently false. What distinguishes these two
approaches is being properly science-based, and that is it. Mainstream medicine 
is preventive, it is properly holistic, and it does promote health. CAM sells
itself as all of these things, but it is none of them. Its only defining
characteristic is preferring methods that do not work or are untested and
largely implausible.

Policies and crank magnetism

To demonstrate all of this, let’s look at some of their specific policies. This 
also gives us a view into another phenomenon called “crank magnetism” (a term
coined by Mark Hoofnagle on the Denialism Blog in 2007). Those who believe in
one form of pseudoscience tend to believe in others.

The situation is actually a bit more complicated than that. When looking
specifically at conspiracy theories, for example, people tend to be more
believing of conspiracies that are in line with their political ideology.
However, there is a subset of people (about 10%) that believe in all
conspiracies. The same is true of anti-science, it tends to follow ideology, but
there are those for whom anti-science is their ideology.

In the case of HAP, and CAM in general, I think there is a little of both going 
on, meaning that people who are generally anti-science will be attracted to CAM,
but CAM also attracts those with a particular naturalistic ideology. It also
attracts straight con artists, who thrive in an environment dominated by low
standards of evidence and magical belief.

The primary HAP policy with respect to health care is to make Australia’s
healthcare system entirely “integrative” – they would fully integrate
pseudoscience and nonsense into the health care system, abandoning any notion of
a science-based standard of care.

HAP’s policies include standard anti-fluoridation nonsense:

   The HAP believes that sodium fluoride, hydrofluorosilic acid and other
   chemical products called “fluoride” are toxic chemical waste products that
   are classified as class 6 poisons and should not be placed into public water 
   supplies. Medicating a population through the water supply is in breach of
   accepted medical ethical codes as there is neither informed consent, nor the 
   ability to opt out .It is noted that 97% of the Western European population
   and the population of Japan drinks nonfluoridated water.

This goes beyond getting the science wrong to mischaracterizing fluoridation as 
“medicating the populace.”

Their general policy toward health care is:

   The HAP believes that natural medicine should be placed on an equal footing
   with pharmaceutical medicine.

Again, “natural” medicine is just code for alternative medicine, which means no 
science-based standard of care. They want snake oil peddlers and quacks to be
treated as equal to science-based health care professionals. Essentially they
want to accomplish politically what they have been unable to accomplish
scientifically, another common anti-science strategy.

Along those lines they also endorse “academic freedom,” which again is code for 
wanting to give crank researchers the same funding, respect, and power as
science-based researchers:

   The HAP recognises with great concern the attempts by well-resourced and
   influential lobby groups to stifle academic freedom within Australian
   universities and research institutes. The HAP will expose and oppose such
   attempts to prevent researchers from undertaking and publishing potentially
   controversial research, and will support the heads of institutions who stand 
   up against individuals and groups who oppose academic freedom.

“Academic freedom,” as used by creationists and CAM proponents, effectively
means no academic standards.

They also endorse electromagnetic hypersensitivity pseudoscience:

   The HAP supports the following initiatives which are needed due to the
   changing electromagnetic environment in which we live. (a) The establishment 
   of a national Agency dedicated to researching the situation about
   electro-smog, particularly EMR emissions from electrical and wireless devices
   that are potentially damaging or harmful to humans. That national agency,
   whilst based in Canberra, should have State branches in each of the major
   cities in Australia. The Canberra office would act as a clearing house or
   headquarters, but the real work to be done at the city or state level in the 
   State branches.

Regarding scientific research, they say:

   Australia should develop protocols to ensure that the nation receives
   appropriate commercial rewards from publically funded research.

Translation – goodbye basic science research.

They do not specifically mention vaccines, which I have to believe is a
calculated choice given how unpopular anti-vaccine views are in Australia
recently. They do state, however that they:

   Defend the right of every person/parent/legal guardian to choose to decline
   invasive medical procedures/interventions with no resultant punitive action
   of any kind.

That, of course, is code for the right to refuse vaccines without any
consequences.

Candidates

Given the above it is no surprise that the candidates for the HAP are themselves
dubious health practitioners. For example, Dr. Isaac Golden is a homeopath.
Homeopathy is 100% pure pseudoscience, which unsurprisingly has been
demonstrated in numerous clinical trials to be completely worthless. Anyone who 
endorses or uses homeopathy, in my opinion, is a pseudoscientist and quack.
Golden’s bio states:

   He is a world authority on homoeoprophylaxis – the use of homoeopathic
   medicines for specific infectious disease prevention – and was the first
   person to be awarded a PhD from a mainstream Australian University for
   research on a homoeopathic topic.

Homeoprophylaxis involves using useless homeopathic potions instead of vaccines 
for infectious disease prevention. This is particularly dangerous homeopathy
pseudoscience.

Homeopathy, however, is not mentioned in the policy, just “natural medicine,”
showing that the HAP is using “natural medicine” as a substitute for dubious
unscientific alternative medicine.

Of the 8 candidates profiled on their website, 6 are practicing homeopaths,
naturopaths, reflexologists, or massage therapists. Two have an interest in
natural medicine, but do not seem to have a practice (yet, they are both very
young).

Health Pseudoscience Party

The HAP appears to be just a group of CAM practitioners trying to use the
political process to advance their quack profession. They are certainly not the 
only political party organized around extreme or narrow ideology, but it is
interesting to see CAM ideology so clearly and openly demonstrated.

Ideology in general does have a tendency to breed antiscience, but in this case 
antiscience is the ideology.

Australia ends insurance subsidies for naturopathy, homeopathy, and more

The Australian government has eliminated the insurance subsidy for 17
alternative health practices due to a lack of evidence for efficacy. This is a
win for medicine and Australian taxpayers.

Scott Gavura on October 19, 2017

Link





A more accurate reflexology chart

Public health care systems face criticism when they spend money on treatments
that don’t work. With ageing populations and the rising cost of treatments,
there’s more and more scrutiny of what these programs pay for. One of the most
effective ways that insurance programs can reduce the use of a health service or
treatment is to simply stop paying for it. But this is relatively uncommon,
because once a benefit’s in place, there tends to be a lot of resistance to
change – even if the move was wrongheaded to begin with. That’s one of the
(many) reasons this blog has been critical of permitting the licensing of
alternative-to-health providers like homeopaths and naturopaths. Legislation
gives the alternative medicine a veneer of legitimacy (scientific or otherwise),
and this legislative alchemy is the first step towards insurance coverage.

When public insurance doesn’t pay, private insurance may step in. And private
insurance programs, from my observation, tend to be less evidence-based than
public programs. They’re often offered as a benefit to employees, and so the
occasional massage may be seen as a nice perk, even though it may not be
medically necessary. Australia has a comprehensive public healthcare system
which is supplemented by private insurance to cover the cost of treatments and
service that are not publicly funded. In 2012 the Australian government
announced a review of “natural” treatments covered by these private insurance
plans to determine if these therapies were effective, safe, and provided good
value for money. While you might wonder why a government would care about what
private insurance covers, it’s because the Australian government offers a rebate
on insurance premiums, effectively subsidizing their cost. The review sought to
determine if a variety of treatment were backed by good scientific evidence and
deserved tax subsidies. The answer may not surprise you.

The Review of the Australian Government Rebate on Natural Therapies for Private 
Health Insurance

In 2015, the Australian government completed a review of natural products
covered by private health insurance plans. The authors looked for direct
evidence of efficacy, focusing on systematic reviews and randomized controlled
trials (for which there was little evidence.) The review evaluated the following
treatments:

  1. Alexander technique, a form of physical therapy with elements of mindfulness, 
    was not supported by much evidence beyond short-term back pain.

  2. Aromatherapy, the use of essential oils with therapeutic intent, had no
    convincing evidence of effectiveness for any purpose.

  3. Bowen therapy, a form of massage, had insufficient evidence to make any
    conclusions about safety or efficacy.

  4. Buteyko is a Russian breathing technique claimed to be effective for asthma
    and other respiratory disorders, but with a lack of objective efficacy.

  5. Feldenkrais is a gentle form of physical therapy lacking good evidence of
    efficacy.

  6. Herbalism/western herbalism (Chinese and Ayurvedic medicine were excluded from
    the review) encompasses hundreds (thousands) of what are effectively
    impure, non-standardized drugs. There was no data on the overall efficacy
    identified.

  7. Homeopathy is an elaborate placebo system where sugar pills are felt to offer 
    medicinal effects. There was no evidence found to suggest homeopathy was
    effective for any condition.

  8. Iridology is the study of irises based on the belief that patterns can help
    diagnose disease. There is a lack of evidence for the practice, for any
    condition.

  9. Kinesiology, or more properly “applied” kinesiology, is a pseudoscientific
    combination of chiropractic, acupuncture, and biomechanics. Unlike the
    science of kinesiology, “applied” kinesiology has no evidence to support its
    use.

  10. Massage or manual therapies can encompass a variety of physical treatments.
    This is another difficult-to-evaluate field, and there’s a lack of good
    evidence for many of the conditions treated with massage.

  11. Naturopathy is an alternative medicine practice still based on the idea of
    vitalism that encompasses many of the therapies on this list, but also
    conventional therapies. The overall evidence for naturopathic approaches is 
    weak.

  12. Pilates is an exercise practice based on strengthening the “core” muscles.
    While it’s very popular there is little evidence in place to support claims 
    of benefit, with the possible exception of low back pain.

  13. Reflexology is the practice of applying pressure to different parts of the
    soles of the feet – effectively a form of massage, with the intent of
    treating other organs in the body. There’s no evidence to show any objective
    health benefits.

  14. Rolfing is form of physical therapy with elements of energy medicine and
    massage. There’s a lack of evidence evaluating Rolfing and demonstrating its
    effectiveness.

  15. Shiatsu is a combination of acupressure and massage intended to open your
    “energy flows”. There’s a lack of evidence showing it’s effective for any
    condition.

  16. Tai chi is a slow martial art intended to balance your chi or “life force”.
    Despite the extensive evidence, the quality of evidence to support efficacy 
    is low. It was felt to be safe, however.

  17. Yoga can encompass strengthening, mobilization, flexibility and meditation.
    There was weak evidence found for yoga helping forms of depression, but
    insufficient evidence for most conditions.

As I discussed earlier, the review didn’t consider plausibility in its review,
which was a huge oversight. Practices like homeopathy and iridology are pure
pseudoscience, while therapies like Pilates, yoga and tai chi are forms of
exercise which have far more potential to offer some therapeutic benefits. The
authors concluded, however, that the lack of evidence signaled that these
treatments could not fairly be considered “evidence based”.

The end of insurance subsidies

Not surprisingly, based on the report, the Australian government has now removed
coverage for all 17 therapies studied in the initial review. This move is part 
of an overall strategy to reduce the cost of private insurance for consumers,
and boosting coverage for services like mental health. Not surprisingly,
organizations like the Australian Homeopathic Association are not impressed.
What this means is that while people can still choose to access these therapies,
they cannot be offered benefits under these private insurance programs.
Notably, not on the list are chiropractic, acupuncture and reiki, none of which 
were included in the initial review – it’s not clear to me what their current
status is under these programs.

While Australian government should be commended for acting on the expert advice 
it received, it’s worth noting that the committee, had they considered
plausibility, might have arrived at slightly different conclusions about some of
these interventions. Ultimately, however, it’s fair to ask if any of these
modalities deserve tax subsidies, which was the overall point of this work. As I
noted earlier, cutting entitlements is difficult, and Australia’s decision to
end these subsidies, on the basis of a lack of evidence, will hopefully trigger 
similar reviews in other countries.

Italy’s Antivaccine Government – The Attack on Experts Continues

Anti-vaccine Italian government fires its entire Health Council. This is
unfortunately part of a bigger trend against expertise and reality-based policy.

Steven Novella on December 5, 2018

Link



In a surprising move, the Italian government fired all 30 members of its Higher 
Health Council on Monday. This is a council of scientific experts, typically
with 3-year terms, whose job it is to advise the government on science and
health issues. As an isolated incident this is concerning enough, but
unfortunately this is part of a deeper trend we need to confront.

The firing has some context. The Health minister, Giulia Grillo, is part of the 
Five Star Movement (M5S), which is now the senior member of Italy’s ruling
coalition. M5S is a populist movement who has outspoken anti-vaccine views, and 
supports dubious alternative medical practices. When an anti-vaccine government 
suddenly fires all their health experts, there is reason for concern.

Defenders of this move argue that the council members were appointed by the
previous “left wing” government, but that is not a defense, it actually just
adds to the concern. Some components of government are supposed to be
expert-based and apolitical. These are usually components that act in an
advisory role, provide intelligence or information, or manage technical areas.

Nonpartisan expertise is critical to running a complex society, and medicine
certainly qualified as an area where we should collectively be making decision
based upon logic, science, and the best evidence available. Medical decisions
should not devolve into a partisan or ideological fight.

That is the bigger issue here. Obviously it is concerning that Italy’s
government is effectively anti-vaccine. They have already moved to remove the
need for parents to have a doctor certify that their children are vaccinated, in
favor of “self certification.” This essentially makes vaccines voluntary.

Not by coincidence, Europe, and especially Italy, are in the grips of a massive 
measles outbreak. This does provide some natural push back against the
antivaccine movement, as fear of infectious disease does tend to affect public
opinion. We saw this happen in the US after the Disneyland outbreak. But we
shouldn’t require disease outbreaks before we get serious about a preventive
measure. It’s like getting serious about fire safety after your house burns
down.

But again – this affair is just a symptom of a deeper problem. There is mostly
argument and little consensus about the complex causes, with many people
pointing to the disruption caused by social media. But regardless of the
cause(s) we seem to be in an era of backlash against “elites”, which includes
scientific and health experts. Political and social movements have been
successful in selling the idea that everyone’s opinion is equal, that facts
don’t even really exist. They are whatever you want them to be.

Experts and institutions are seen, not as a mechanism for quality control and
professional standards, but of oppression. This of course is one step away from 
metaphorical torches and pitch forks, which is essentially what we are now
seeing in Italy and elsewhere.

There are always going to be abuses and failures to point to in order to justify
opposition to the experts. No one and no institution is perfect. The optimal
answer is to make the institutions better, not to burn them down in favor of
anything goes.

All of this dovetails with the alternative medicine movement. At its core,
alternative medicine is about an attack on medical expertise. Proponents use
conspiracy theories to attack the institutions of medicine. They attack
mainstream medicine as not being evidence-based, as being in the pocket of
industry, and of being protectionist. Meanwhile they argue that the rules of
science should be weakened, watered down, or even ignored in favor of medical
populism (usually marketed as health care freedom). Alternative medicine is an
attack on the very concept of expertise and professionalism, on reality-based
medicine.

As an example of the connection between political populism and alternative
medicine, both of which attack facts and experts, the M5S party early on
championed a fake cure known as Stamina:

   “The great risk of the current situation is highlighted by the case of
   Vannoni in Italy, in which the Stamina Foundation initially succeeded in
   obtaining direct authorisation from the Italian government to administer an
   unproven therapy to patients, thus bypassing the country’s regulatory
   authorities,” says the report.

   In March 2015, David Vannoni was convicted of conspiracy and fraud for
   administering unproven stem cell therapies to patients at his Stamina
   Foundation. Vannoni, who was not trained as a scientist or doctor, claimed
   that bone marrow cells could be converted to neural cells to cure diseases
   such as Parkinson’s disease, muscular dystrophy and spinal muscular atrophy.

Stamina was nothing but a fraud, typical of the fake stem cell clinics that have
popped up over the last 20 years to capitalize on the stem cell hype. This
highlights the reasons why we have standard procedures for testing new potential
therapies – primarily to protect patients. There are objective, transparent,
and tested methods for determining the safety and effectiveness of a treatment. 
There is no legitimate reason to bypass those methods.

Charlatans claim that those methods (which one might refer to as science-based
medicine) are there only as a barrier, but that is false. When you bypass the
system, you don’t end up with miracle cures, which is what the con-artists want 
you to believe. You end up with fake cures exploiting sick people and their
families.

M5S championed this fake cure, because it was in line with their populist
anti-expertise agenda. Now we can only wait to see who they will appoint in
place of the experts that formerly made up the Health Council.

We are also long past time for the medical profession to wake up and notice how 
their core values are being hollowed out by the infiltration of alternative
pseudoscience. The problem is that incidents like this one are often viewed as
isolated and on the fringe. Wrong. This is now mainstream. The charlatans have
already won, and now we have to undo the damage that has been done.

Physician aid-in-dying laws spread amid legal challenges

Legalization of physician aid-in-dying is increasing in the U.S. but opponents
are taking their opposition to the courts and Congress.

Jann Bellamy on August 31, 2017

Link



Laws in California, Colorado, Oregon, Vermont, Washington State, and Washington,
D.C., allow physician aid-in-dying, also known as physician-assisted suicide
and death with dignity. (Some oppose the use of the word “suicide,” a point
we’ll return to shortly, but here I’ll use these terms interchangeably.) In
Montana, a court decision provides protection from prosecution to physicians who
assist patients in dying. All told, almost 20% of Americans live in a
jurisdiction where they can access life-ending drugs, prescribed by a physician,
if they are terminally ill and meet other eligibility requirements. Several of 
these laws are currently facing legal challenges.

According to the National Conference of State Legislatures, death with dignity
legislation has been considered, but not passed, in at least 20 states. Oregon
was the first state to allow physician-assisted suicide, in 1997, but the pace
has quickened in the last few years. Colorado legalized the process last year
via ballot initiative. The California and Vermont laws passed in 2015 and 2013, 
respectively. D.C.’s law is on the books but won’t be fully implemented until
October 1st.

All state death with dignity statutes have guidelines for participating patients
and physicians, such as eligibility and reporting requirements. According to
one organization supporting physician aid-in-dying laws:

   to qualify under Death with Dignity statutes, you must be an adult resident
   of a state where such a law is in effect, . . . mentally competent, i.e.
   capable of making and communicating your healthcare decisions; and diagnosed 
   with a terminal illness that will lead to death within six months, as
   confirmed by two physicians. The process entails two oral requests, one
   written request, waiting periods, and other requirements.

None of the laws requires a physician or health care facility to participate.

Because of reporting requirements, we have statistics on how many patients have 
taken advantage of death with dignity laws and some of their characteristics.
For example, in Washington State, in 2016:

  1. Of 248 participants (as they are called in the state’s report), 240 are known 
    to have died, 192 after ingesting the medication

  2. Prescriptions were written by 140 different physicians and dispensed by 47
    different pharmacists

  3. The youngest was 33 years old; the oldest, 98

  4. 77% had cancer; 8% ALS or similar neuro-degenerative disease; 16% had heart,
    respiratory and other diseases

  5. Loss of autonomy (87%), loss of ability to participate in activities that make
    life enjoyable (84%), and loss of dignity (68%) were their chief concerns

  6. 88% died at home and 77% were enrolled in hospice care

In California, for the first 6 months of the program (which started in June,
2016):

  1. 258 patients started the “end-of-life option process;” 111 died after
    ingestion of the prescribed medication (for some, status is still pending).

  2. 191 prescriptions were written by 173 physicians

  3. 84% were receiving hospice and/or palliative care

  4. 59% had cancer; 18% had ALS or other neuromuscular disorder; 15% had heart or 
    lung disease

  5. 87% were at least 60 years old

According the Los Angeles Times, patients and health care professionals are
seeing an unexpected benefit from the new law:

   [P]hysicians across the state say the conversations that health workers are
   having with patients are leading to patients’ fears and needs around dying
   being addressed better than ever before. They say the law has improved
   medical care for sick patients, even those who don’t take advantage of it.

Dr. Bob Uslander, a specialist in palliative and hospice care interviewed for
the article, said he thinks the “unprecedented interest” surrounding the new law
will lead to more thoughtful end-of-life planning, such as more people drafting
advanced care directives.

Statistics from Oregon quoted in the article seem to bear out the conclusion
that a state’s having an assisted suicide law promotes conversation about
end-of-life options: while only 1 out of 640 terminally ill patients took lethal
medications, 1 of 50 talked to their physician about it and 1 in 6 talked to
their families about it.

The American Medical Association opposes physician aid-in-dying, but some state 
medical societies have taken a neutral stance when assisted suicide laws were
debated. The Catholic Church, some Congressional Republicans and anti-abortion
groups oppose these laws as well. According to the LA Times, in California,
Catholic and church-affiliated hospitals (13% of all acute care hospitals in the
state), forbid physicians affiliated with their hospitals from prescribing
aid-in-dying medications. But most Americans support aid-in-dying laws. For 15
years, between 66 and 69% of Americans have responded affirmatively to the
following question:

   When a person has a disease that cannot be cured, do you think doctors should
   be allowed by law to end the patient’s life by some painless means if the
   patient and his family request it.

As for other countries, voluntary euthanasia is legal in the Netherlands,
Belgium, Columbia, and Luxembourg. Assisted suicide is legal in Switzerland,
Germany, Japan, and Canada. What’s the difference?

   Physician-assisted suicide entails making lethal means available to the
   patient to be used at a time of the patient’s own choosing. By contrast,
   voluntary active euthanasia entails the physician taking an active role in
   carrying out the patient’s request, and usually involves intravenous delivery
   of a lethal substance.

Some, including the American Public Health Association, take issue with the word
“suicide,” preferring “aid-in-dying” or “physician-assisted death.” The
advocacy organization Death with Dignity explains why:

   Because the person is in the process of dying and seeking the option to
   hasten an already inevitable and imminent death, the request to hasten a
   death isn’t equated with suicide. The patient’s primary objective is not to
   end an otherwise open-ended span of life, but to find dignity in an already
   impending exit from this world. They’re participating in an act to shorten
   the agony of their final hours, not killing themselves; cancer (or another
   common underlying condition) is killing them.

Opposition supports legal and legislative challenges

Opponents are turning to the courts and to Congress to fight aid-in-dying laws. 
In California, several physicians and a Tennessee-based conservative
organization called the American Academy of Medical Ethics (AAME), which also
opposes abortion and same-sex relationships, filed suit, challenging the
constitutionality of the state’s End of Life Option Act. (The AAME appears to
have a close relationship with another conservative medical group, the Christian
Medical & Dental Associations, which opposes state legislation banning
so-called “conversion therapy.” They share a chief executive.) Plaintiffs are
represented by the Life Legal Defense Foundation, which gained some notoriety
for its involvement in the legal defense of criminal charges and a civil action 
against anti-abortion activist David Daleiden, of the Planned Parenthood
(heavily edited) videos fame.

The suit claims the law violates the equal protection and due process clauses of
the U.S. Constitution by treating terminally ill patients differently from
others. According to the plaintiffs, while protective interventions are legally 
required when others are a potential harm to themselves, the same is not
required when a terminally ill person requests life-ending drugs. The California
Attorney General’s office, which is defending the law, argued that the
plaintiffs are alleging hypotheticals, not facts, and that, rather than
depriving patients of anything, the law actually gives them a right, protected
by the many safeguards in the statute. Earlier this summer, the judge denied the
state’s motion for judgment on the pleadings, which sought to resolve the
issues without further proceedings, allowing the case to proceed to trial.

In Vermont, the Christian Medical & Dental Associations and another organization
representing physicians and other health care providers who oppose, on
religious and ethical grounds, physician-assisted death for the terminally ill, 
sought an injunction against state authorities from taking any action against
them under the provisions of Vermont’s law permitting physician-assisted dying.

The plaintiffs alleged that their refusal to inform patients of the choices
available under the law could subject them to disciplinary action by the state
medical board or criminal or civil action. The state denied any such action
would take place and sought to dismiss the suit. The judge found that the law
imposed no affirmative obligation on the plaintiffs to recommend or prescribe a 
lethal dose of medication to a patient. The plaintiffs also alleged that they
might nevertheless be required by the state’s informed consent law, which
obligates physicians to inform patients about all choices and options relevant
to medical treatment, to tell terminally ill patients about the availability of 
lethal medications and that failure to do so could subject them to sanctions.
However, because both the plaintiffs and the state agreed that a referral to a
website in response to a patient’s positive inquiry is sufficient to satisfy the
state’s informed consent requirements, the judge found, again, that the
plaintiffs were under no threat of adverse action and dismissed the suit on
jurisdictional grounds, there being no “case or controversy” for the court to
adjudicate.

(For readers wanting more information, the court’s order dismissing the suit
contains a detailed description of how Vermont’s assisted suicide statute, which
is typical of such laws, works.)

Unfortunately, this did not end the matter. The plaintiffs and Attorney General 
then entered into a Consent Agreement in which they stipulated that state law
did not require physicians to counsel or refer patients to the
physician-assisted dying process unless the patient specifically inquired about 
it. Terminally ill patients and two organizations supporting death with dignity 
laws, who had been allowed to join the suit, were not informed of the Consent
Agreement and objected by filing a Motion to Strike the Agreement. They argued
that, while the court may have ruled that the plaintiffs were under no threat of
adverse consequences because the parties agreed referral to a website was
sufficient to discharge a physician’s obligation, it never ruled that the law
itself imposes no duty on a physician to affirmatively inform patients of all
options, including physician-assisted death. Thus, the plaintiffs and Attorney
General had no right to try use backdoor methods to force that interpretation
into the court records via their Agreement. The Attorney General’s office then
reversed course and said it had no objection to striking the Agreement. The
court has yet to rule on the pending motion.

In Washington, D.C., the district’s assisted suicide law is under attack from
House Republicans, using Congress’s authority to oversee the District in an
attempt to block, or at least cripple, its implementation. After an out-an-out
attempt to block the law failed, Republicans are now trying to use the
appropriations process to cripple the law’s implementation by barring funding
for it. These efforts brought rebukes from both Democrats and D.C. officials,
among them Rep. Mike Quigley (D-Ill.):

   When it comes to issues like who can carry a gun and where, or who can marry 
   whom, Republicans are ardent supporters of states’ rights; but when it comes 
   to a woman’s right to choose or assisted suicide, suddenly the decisions of
   local elected officials are superseded by members of Congress.

New York attempts judicial route to establish right

Not all of the recent lawsuits seek to inhibit physician aid-in-dying. Patients,
physicians and advocacy organizations in New York filed suit seeking a
declaration that a state statute prohibiting “assisting” a “suicide” did not
apply to a physician providing aid-in-dying, relying on the same claimed
distinction between the two quoted earlier in this post. They also argue that
the statute violated the rights of privacy and equal protection guaranteed by
the New York State Constitution. They lost at the trial level and on their first
appeal.

The appellate court rejected the plaintiffs’ argument that there was a
distinction between “aid-in-dying” and “suicide,” deciding that, whatever
terminology was used,

   The word ‘suicide’ has a straightforward meaning and a dictionary is hardly
   necessary to construe the thrust of Penal Law §§ 120.30 and 125.15 [the
   statutes prohibiting suicide assistance]. It is traditionally defined as ‘the
   act or an instance of taking one’s own life voluntarily and intentionally,’ 
   especially ‘by a person of years of discretion and of sound mind’
   (Merriam-Webster’s Collegiate Dictionary [11th ed 2003], suicide). Whatever
   label one puts on the act that plaintiffs are asking us to permit, it
   unquestionably fits that literal description, since there is a direct
   causative link between the medication proposed to be administered by
   plaintiff physicians and their patients’ demise.

The court also rejected the argument that state constitutional protections
prohibit the application of the state’s criminal law to physician-assisted
suicide. Like the U.S. Supreme Court, the New York court held that, while there 
is a right to refuse medical treatment, even if it hastens death, there is no
right to assistance in taking one’s life.

Interestingly, New York’s highest court agreed to consider the case and heard
oral arguments on May 30th. Several organizations filed amicus briefs, including
the National Association of Criminal Defense Lawyers, the American Medical
Students Association, the American Medical Women’s Association and the American 
College of Legal Medicine, supporting the plaintiffs in their appeal. A decision
is pending.

With public approval of physician aid-in-dying at near 70% and some physician
organizations ending long-standing medical establishment opposition, it would
appear the number of states legalizing it should increase. Much of the active
opposition is from religious groups. Interestingly, these groups are also the
ones most adamantly opposed to same-sex marriage and abortion rights, both of
which are also supported by a majority of Americans. While the former has gained
legal recognition despite objections, the latter is under increasing attack,
with state legislatures and Congress whittling away at reproductive freedoms. It
remains to be seen whether aid-in-dying legislative efforts and favorable
judicial treatment strengthens or weakens as these cultural forces play
themselves out. Science-based medicine can end suffering by hastening death but 
cannot answer the question whether it should do so.

Animal rights activism: Petitions aren’t science

Those who hold positions contrary to what science tells us frequently challenge 
defenders of science to a “debate,” seemingly believing that all truth can be
arrived at by staged debates. Such debates are almost alway biased toward the
person defending pseudoscience and rarely fruitful. In a public forum, rhetoric 
frequently trumps science. If a scientist accepting such a challenge is not a
skilled public debater, he will probably be perceived to have lost the debate.

David Gorski on February 3, 2014

Link

I had originally planned on writing about a different topic today, but, as is so
often the case in blogging, something came up that caught my attention, much as
the errant thought of a squirrel distracts Dug the Dog. It’s no big deal. My
original topic is not time-sensitive, and I’ll get to it next week (that is,
unless something like this happens again). In any case, my tendency towards
blogging ADHD notwithstanding, the “inspiration” for this post began on Friday
morning, making it timely. Let me tell you what happened, and then I’ll delve
into the topic.

We all have our daily rituals, and I’m no different. When I wake up in the
morning, I usually check my iPhone to see how many e-mails I’ve gotten
overnight. If there’s time before I have to leave for work, I’ll frequently go
through them all right then, answering ones I can answer quickly and filing for 
later responses those that I can’t. If I don’t have time (as in I overslept),
I’ll check them whenever I get an opportunity. Last Friday, I was rather
surprised to see that the little badge on the Mail app showed well over three
times the usual number of messages I get overnight, even accounting for e-mail
notifications of comments on the blogs and the usual smattering of mailing list 
messages and the odd junk spam that got through the filters. So having that many
messages in my unread mail queue caught my attention. Even when a new troll
shows up in the comments of one of the blogs, I usually don’t get that many
notifications. I figured I’d better go and check to see what was going on right 
then, rather than waiting until later. What I found was something that I never
would have guessed.

As odd as it seems to me now, I had apparently been targeted by a Change.org
petition Animal Experimenters – JUSTIFY YOUR SCIENCE CLAIMS.

I was rather puzzled. I’ve developed a bit of microcelebrity (or, as I sometimes
refer to it when I’m feeling less arrogant, nanocelebrity) as the proverbial
proponent of science-based medicine and scourge of quackery. When it comes to
topics that are likely to result in a backlash against me by cranks, to the few 
thousand people who read my stuff, both here and on my not-so-secret other blog,
I’m known not so much for my defense of animal research (although I do from
time to time write to defend it and to castigate animal rights extremists who
threaten scientists) as for writing about the antivaccine movement, cancer
quackery, and other forms of pseudoscience. For instance, antivaccinationists
have tried to get me fired from my job. Over the years, cancer quacks have
harassed me at work, tried to get me fired, and threatened me with lawsuits.
More recently, a supporter of Stanislaw Burzynski complained to my cancer center
director and the president of my practice plan about my activism with respect
to the Burzynski Clinic. I’ve even been the victim of a frivolous complaint
against me to the Michigan Board of Medicine by (I’m 95% sure) a Burzynski
patient who didn’t like my analysis of her case. The complaint was promptly
found to be groundless, but there is a complaint on my record nonetheless. These
are the usual sources of criticism against me, not animal rights activists.
None of this is to say that animal rights activists don’t occasionally attack
me. Ray Greek, for instance, most definitely did not like it the last time I
criticized him on this blog, but that was almost six years ago, ancient history 
in blog time, and the last time I launched a broadside at animal rights
activists on this blog was in 2008.

That is not saying I haven’t been vocal speaking out against animal rights
activists and how they negatively impact biomedical research, but it’s only been
sporadically at my not-so-secret other blog. In particular, I’ve made it a
point to speak out against a group known as Negotiation Is Over, a group led by 
a truly scary woman named Camille Marino, who recently got involved in a legal
kerfuffle over her activities against a researcher at my home institution that
led to her serving a term in prison, from which she was recently released.
(She’s also a woman who has made it clear that she is intentionally targeting
students as the “soft underbelly of the vivisectionist movement” and has no
compunction about justifying violence against researchers, similar to the way
that Steve Best does, which is why it’s so ironic that Best is not so happy now 
that Marino has turned her tactics against him.) It’s just that it’s by far
nowhere near the top of the list of my usual topics, which made me honored but
at the same time puzzled that I am mentioned in the petition with so many much
more accomplished scientists than I. Moreover, I was even more puzzled at being 
included on this list given that the petition was clearly aimed at the
government of the UK, asking MPs to support something called EDM 263, which
appears to be a call for public debates on the use of animals in research.
Unfortunately, the game is revealed by the way this appeal is described:

   Please use our template letter and follow the STEPS 1 – 4 to ask your MP to
   sign EDM 263, calling for scientists from the vivisection community to agree 
   to participate in properly moderated public scientific debates with leading
   medical experts who oppose animal experiments on human medical and scientific
   grounds.

Whenever you see the word “vivisectionist” to describe researchers who do animal
research, you can be quite sure that you’re not dealing with people with
reasonable questions about how animals are used in research. Real scientists
almost never use the term “vivisection” because, although it has taken on a
broader meaning with respect to animal research, based on the history of the use
of the word, “vivisection” still implies surgery conducted for experimental
purposes on living animals to view living internal structures; i.e., dissection 
of living animals. These days, virtually no animal experimentation can be
accurately referred to as “vivisection,” as strict rules and regulations mandate
minimization of pain and suffering. Animal rights activists tend to like to
refer to all animal research, whether it involves surgery or not, as
“vivisection” and to scientists who use animals in their experiments as
“vivisectionists” because of the negative connotation of the word. That’s why
the word “vivisectionist” is rarely used by scientists but is frequently used by
animal rights activists and why use of the word “vivisectionist” is as reliable
a tipoff as there is to identify an animal rights activist, every bit as useful
as “dis-ease” or “out-fection” instead of “disease” or “infection,” as very
reliable signs of a quack or supporter of quackery.

I’ll get back to the group behind this petition in a moment, which is known as
For Life On Earth (FLOE). First I’d like to address the petition itself and its 
demand for a “debate,” after which I’ll discuss the actual claimed science
arguing against animal research a bit and then finish by coming back to this
group. As a prelude, however, let me point out that I won’t be dealing (much)
with the morality of animal research, mainly because I believe that whether or
not animal research is morally acceptable is not primarily a scientific
question. Science can inform the consideration of the question of animal
research, but in the end it’s a moral question. That is not to say that science 
is irrelevant, because part of the consideration of the moral question of
whether and when it is acceptable to use animals in research is the issue of how
much value to science animal research brings. How utilitarian you want to be
considering this question is something that can be discussed, but animal rights 
activists often invoke an extreme negative version of a utilitarian argument in 
that they try to portray as animal research as not just useless (i.e., providing
no useful scientific information), but even as harmful or providing misleading 
or mistaken scientific conclusions. If that is the case, then it’s a no-brainer 
that animal research cannot be justified ever because in that case it would
cause suffering to animals but provide no benefit in terms of scientific
advancements that could lead to improved medical care. Unfortunately, as I
documented six years ago, animal rights activists have a distressing tendency to
use truly bad arguments to do everything they can to paint animal research as
useless or even harmful to the science of medicine. These arguments tend to fall
into one or more of three categories:

  1. Animal research doesn’t teach us anything of value or even misleads us (i.e., 
    it is bad science).

  2. Animal research does not predict human physiology or response to disease, or
    animals are “just too different from humans to give reliable results” (i.e.,
    it is bad science).

  3. There are better ways of getting the information that do not use animals
    (i.e., there is better science available than using animals.)

As I’ve said on several occasions, I tend to look at these arguments as three
facets of what is in essence the same argument, specifically what I like to call
an “argument from imperfection” also known as the Nirvana fallacy. In other
words, because animal models have imperfections and all-too-often don’t predict 
human physiology or drug response as well as the critics think that they should,
then by implication all animal research is bad science. It is an example of
demanding 100% perfection or certainty before accepting something, a bar that no
science can ever meet, and of concrete thinking typical of extremists.
Antivaccinationists are particularly fond of this sort of concrete thinking, in 
which vaccines must be 100% effective in preventing disease and 100% safe, or
they are worthless.

Like the case with many holding dubious scientific beliefs whom many would
consider cranks, one favorite tool to promote their agenda is “public debate.”
I’ve seen it many times myself. For example, I’ve had HIV denialists and
antivaccine activists challenge me to “live” public debates over their favorite 
topics. This challenge through a Change.org petition is no different. In fact,
it’s a perfect example of a principle that I’ve called “all truth comes from
live public debate.” Besides the challenges I’ve personally had directed at me, 
I can point to several more examples just off the top of my head. For example,
antivaccine guru Andrew Wakefield challenged Dr. David Salisbury to a “live
public debate” about whether the MMR vaccine causes autism or not. (Hint to
Wakefield: It doesn’t.) Regular readers might also remember another example,
Suzanne Somers’ doctor, antivaccinationist, and all around supporter of all
things quacking, Julian Whitaker, debating Steve Novella at FreedomFest, which
happened to be going on in Las Vegas at the same time as TAM in 2012; Michael
Shermer’s “debate” with Deepak Chopra; and antivaccine propagandist David Kirby 
debating author Arthur Allen. More recently, a fan of Stanislaw Burzynski named 
Randy Hinton was “calling out” what he referred to as the “medical mafia” to
debate. Still more recently, Bill Nye the Science Guy has foolishly (in my
opinion) agreed to a “debate” about creationism and evolution with
arch-creationist Ken Ham. The debate will be held tomorrow. Worse, he agreed to 
do it on Ham’s home turf, the Creation Museum in Kentucky.

Basically, this petition demonstrates once again the “all truth comes from live 
public debate” belief so prevalent among cranks. I’ll call it the omne verum est
a forensem principle. (Latin sounds so much more cool for this, but I have no
idea whether this is the best translation—or even grammatically correct; maybe
Latin scholars out there can suggest better.) They seem to think that science is
decided in public debates and view the quite understandable reluctance among
scientists like myself and skeptics to engage cranks in such spectacles as
“cowardice.” It is not, but cranks continue to labor under the delusion that
science is somehow decided in such forums, which are a variant of a sort of
argumentum ad populum, in which something is argued to be true because it is
popular or, in a debate, an argument is thought to be closer to the truth
because it is more popular. Science doesn’t work that way. It is decided on
evidence presented at scientific conferences and in peer-reviewed journals,
where the real scientific debate plays out until it is temporarily settled and
scientists come to a provisional consensus. That provisional consensus, of
course, is always subject to change as new observations, data, and experimental 
results come to light, but it takes observations, data, and experimental results
to change the consensus, not “live public debates.” Such “live public debates” 
have only one purpose: To sway public opinion to a viewpoint not supported by
science, in the process elevating pseudoscience or the unproven to the same
plain as the scientific consensus as a scientifically viable “alternative,” no
more, no less.

The fact is, pseudoscientists, pseudohistorians, and cranks desperately want to 
debate accepted experts in the field in which they apply their crankery. The
reason is simple. While, knowingly (or, more commonly, unknowingly) they poo-poo
science and the scientific method, at the same time they desperately crave its 
validation. They desperately want to be seen as “one of the boys,” whose ideas
are worthy of being taken seriously by scientists, and such “debates” usually
give them exactly what they want. Indeed, debates on college campuses (or, in
the case of homeopaths, in academic medical centers) are not viewed as a means
of getting at the truth, but rather as a means of P.R. Putting the
pseudoscientist on the same stage as a legitimate scientist elevates the
pseudoscientist unduly and mistakenly gives the impression to lay people that
there is a genuine scientific controversy to be debated when the only
controversy being debated is, in fact, ideological. This is because getting a
scientist to agree to a debate allows them to portray their pseudoscience as
being on equal footing with accepted science, or at least in the same ballpark. 
Thus, simply being seen on the same stage on an equal footing with a respected
scientist, is a victory for the pseudoscientist. Regardless of what actually
happens in the debate, it is a virtual certainty that the crank and the
supporters of crankery will trumpet it as a “victory” or, at the very minimum,
as a “validation” that science is beginning to take them seriously.

If animal rights activists—or antivaccinationists, purveyors of “alternative
medicine,” HIV/AIDS denialists, creationists, 9/11 Truthers, or the like—want to
convince scientists, there is one way to do so: Publish their data and do
battle where scientists normally do battle, in the scientific literature and in 
scientific conferences. “Live public debates” might sway a few souls when the
odd hapless scientist or skeptic unprepared for the Gish gallop makes the
mistake of going up against a smooth talking crank, but the scientific consensus
remains unchanged. I realize that not all skeptics agree with me, and I find it
hard to be critical of Steven Novella, Michael Shermer, or even Bill Nye for
feeling duty-bound to answer the call.

In the case of animal rights activists, the call for public debates is similarly
dubious, as becomes obvious from some of the verbiage in the petition:

   By signing this petition, your letter will automatically be sent to high
   profile animal experimenters and their supportive colleagues, inviting them
   to go head to head in properly moderated, public scientific debates with the 
   world’s leading medical experts who oppose animal experiments, purely on
   human medical and scientific grounds – namely that misapplying results from
   animal experiments, to try and ‘predict’ human responses, causes immense harm
   to human patients. Current understanding of evolutionary biology is now able
   to explain why this is the case.

If you note the two links, you’ll see that both of them are pretty much rehashes
of Ray Greek’s arguments, which were not particularly convincing to me the
first time around and haven’t gotten any better with age. One of them is a video
produced by FLOE:

Particularly irrelevant is the way the argument begins with a reference to
Claude Bernard in 1847 as the man who allegedly “institutionalized” animal
research as being “predictive” of human responses. Yes, I’m always convinced by 
an appeal to a 167-year-old understanding of science by one man, who rejected
the theory of evolution and apparently believed that experiments on animals were
“entirely conclusive for the toxicology and hygiene of man.” One wonders
whether science has advanced since 1847. Apparently, FLOE simultaneously doesn’t
think so and does. At one point, it is argued that animal testing hasn’t
advanced since then, but then at another point, the discoveries of Ignaz
Semmelweis, Joseph Lister, John Snow, Edward Jenner, Charles Darwin, and Albert 
Einstein (whose relevance to the science of animal research is never explained) 
are briefly mentioned, after which FLOE fast forwards 100 years to 2009 to Ray
Greek’s book Animal Models in the Light of Evolution, whose image appears as the
narrator intones that science brings us complexity theory. Particularly
insulting to one’s intelligence is how it’s intoned that animal models predict
human responses only 31% of the time. What responses? What animal models? Animal
models vary widely in how well they predict human responses, depending on the
physiological response, the specific animal model, the drug, and the process
being studied. To lump them all together into a figure like this is well-nigh
meaningless.

A good way to think of it comes from this recent review of animal models for
predicting immune responses:

   Besides the animal model itself, the experimental setup will also affect
   predictive value. Differences in dose, immunization route, frequency of
   administration and impurities in the formulation have the potential to affect
   immunogenicity and its assessment (32). Moreover, with respect to product
   quality, preclinical protein products which are used in animal studies do not
   always reflect the final products used to treat patients. Another difficulty
   in translating animal results to human patients is a difference between labs
   in antibody assays that are used. These differences hamper comparison of
   results gained in different labs and therefore compromise predictive value of
   animal models. In patient research, several initiatives have begun to
   standardize antibody assays and thus improve comparability (34). Adjusting
   the antibody assays used in animal research to these standardized assays
   would likely improve predictive value of the models.

The video cited in the FLOE petition then compares the predictive value
generally required of clinical laboratory tests, which is stated to be 90%, a
coin flip (50%), and the purported predictive value for animal tests for human
response (31%). Even if 31% is an accurate estimate, do you see the problem with
this argument? There is a huge difference between a test that is going to be
used on humans to make a diagnosis (like a CT scan or blood test) and a test
that is often being used to screen for a response (animal studies). Anyone who
says something like this has no clue how clinical medicine works. There are lots
of tests in routine use whose predictive value is less than 90%, sometimes
considerably less than 90%. Examples include mammography for breast cancer. Only
around 25% of those found to have suspicious lesions on mammography actually
turn out to have breast cancer.

One point that I find rather odd is how FLOE emphasizes that the medical experts
it wants to be part of these debates accept the last seven out of nine uses of 
animals in research:

  1. Animals as models for disease

  2. Animals as test subjects; e.g. drug testing

  3. Animals as spare parts

  4. Animals as factories

  5. Animal tissue to study basic physiological principles

  6. Animals for dissection in education

  7. Animals as a modality for ideas (heuristic)

  8. To benefit other animals

  9. Knowledge for knowledge sake

It is only the first two that FLOE claims to be contesting, although it can’t
resist mentioning that “for these viable methods there already exist some more
efficient, less expensive, human biology based alternatives.” Don’t believe it. 
Focusing on the first two is the thin edge of the wedge for animal rights
activists to go after the last seven.

So what is EDM 263? This is its text:

   That this House notes the new campaign For Life On Earth which is critical of
   avoidable experiments on animals; is alarmed that all studies measuring the 
   claimed ability of animals to predict human responses expose a low success
   rate in the region of 31 per cent; further notes that a success rate in the
   region of 90 per cent is required by medical practice; further notes that the
   National Cancer Institute has said that cures for cancer have been lost
   because studies in rodents have been believed; and calls for properly
   moderated scientific public debates on the misleading results and bad science
   of animal experiments.

Again, the use of this 31% figure in comparison to an alleged 90% figure for
medical tests is an utter insult to the intelligence of any physician who knows 
about medical testing for the reasons I mentioned above, but it sure sounds
plausible to people who don’t know about the science of medical testing. It
didn’t take me long to find out that the source of the claim that the NCI has
said that cures have been lost due to too much trust in rodent models is
misleading as well. it comes from a 1997 article in Science:

   Pharmaceutical companies often test drug candidates in animals carrying
   transplanted human tumors, a model called a xenograft. But not only have very
   few of the drugs that showed anticancer activity in xenografts made it into 
   the clinic, a recent study conducted at the National Cancer Institute (NCI)
   also suggests that the xenograft models miss effective drugs. The animals
   apparently do not handle the drugs exactly the way the human body does. And
   attempts to use human cells in culture don’t seem to be faring any better,
   partly because cell culture provides no information about whether a drug will
   make it to the tumor sites.

The whole point of the article was that back in 1997 none of the common methods 
used to screen potential new anticancer drugs for activity—animal, cell culture,
or other—had been sufficiently effective in identifying anticancer activity.
The entire article was a cry for better methods. Over the last 17 years, a lot
of effort has gone into doing this, both using animals and not. For example,
mouse avatars are an innovative idea that might have real promise for predictive
modeling for individual patients. I’ve written about them before. (If that
worked out, wouldn’t that burn FLOE?) Moreover, the NCI, far from saying that
animal research is useless, maintains a website that provides information on
animal models, when they are useful, and for what purposes. Make no mistake,
mouse models have been very useful indeed.

Let’s come back to that 31% figure. As you can tell, it bugs me, but not for the
reasons that Ray Greek, for example, might think (namely, that it is such a
damning indictment of animal research). It just smells so…fishy. Greek
frequently uses it in his talking points and articles, and FLOE flogs it
endlessly in its video and on its website. Where did it come from? Speaking of
Research tells me! It’s worth going there for the details, but I’ll feed you the
summary:

   Our ‘region of 31%’, then, is based on a “very approximate estimate” of one
   small aspect of animal research, by a Department of Health doctor in 1978
   based on 45 drugs that happened to have been licenced in the last year. Not
   only does the paper conclude that animal experiments correlate to human
   reactions, in terms of prediction it was a generation ago, it was a different
   regulatory environment, it was based on a 35-year old understanding of
   toxicology, it had a sample size of 45 and it was a rough analysis. The claim
   that this paper shows that animal studies have a “low success rate of 31%’” 
   is simply pseudoscience.

As is so common with these sorts of arguments, animal rights activists
misconstrue animal testing as animal research. This particular animal rights
activist has used a cherry-picked number, a guessed percentage, that was based
on an incorrect interpretation of a paper from more than 35 years ago. Based on 
this, and dubious claims of “harm” from animal research, FLOE demands not just
that animal models be phased out, but rather eliminated immediately. I kid you
not.

And what, you ask, will replace them? Good question. I’m still asking that
myself. All we get are vague references to “complexity” theory and all sorts of 
fancy gobbledygook about evolution and genetics that do not make the point that 
FLOE is trying to make. For instance, it is stated that we should study the
genetic variation between humans, which can convey medical data. Wow. So
brilliant! It’s not as though medical researchers would ever have thought of
that on their own. Oh, wait…they have! It goes under various names: personalized
medicine, highly stratified medicine, genomic medicine. It’s not as though
medical researchers haven’t been doing this for more than a decade, ever since
the development of cDNA microarrays allowed the simultaneous analysis of the
expression of every gene on a cDNA microarray chip. The movement has accelerated
now that next generation sequencing techniques are becoming widely available.
It’s not an either-or proposition. We can continue to exploit advances in
genomic medicine while retaining and improving upon animal models that have
proven useful. What FLOE is promoting is a false dichotomy: Animal research or
genomic medicine, as if we can’t do both. Moreover, animal research informs
personalized medicine; the mouse avatars I mentioned were just one example of
how. Just consider the example of Herceptin if you don’t believe that.

The video concludes with a list of the “many valid research methods” that don’t 
use animals. These include in vitro studies of human tissue, which we already
do; epidemiology, which we already do; the study of bacteria, viruses, and
fungi, which we already do; autopsy and cadaver studies, which we already do;
genetic research, which we already do; clinical research, which we already do;
and post-marketing drug surveillance, which we already do. Indeed, as the video 
concluded, I really wondered what the point was. We already do all those forms
of research. Seriously. The words of the great Robert Weinberg come to mind:

   Dr. Greek says the silliest things, […] implying that people are not studying
   human tumors, and implying that the kinds of experiments that one can do in 
   mice can be done as well in humans — truly mindless!

The sheer oversimplification of complex issues made me wonder what FLOE is. It
appears to be a propaganda group to promote Ray Greek’s ideas. The petition
demanding a “debate” is nothing more than the typical crank ploy whose basis is 
a mistaken belief that all truth comes from public debate. Although I’m quite
honored to be included on the list of scientists who are being challenged to
debate the issue, I must politely decline.

The utility of animal research for medical advancement is a legitimate topic to 
discuss, but the discussion would not be furthered by a public debate of the
sort proposed by FLOE. It is a question that is already being debated by
scientists and ethicists in the medical literature based on actual data and
science rather than dubious arguments. Moreover, the use of animals in research 
is already being de-emphasized. Regulations mandating the “three Rs” (reduction,
refinement, replacement) are already in force and having an effect. The
morality of animal research is a question that can’t be answered just by
science, but science sure can refute the claims of animal rights activists that 
animal research provides no knowledge and benefit to medical science.

The Prince of CAM

Steven Novella on November 23, 2011

Link

Prince Charles is a big supporter of “natural” medicine, which in practice means
unscientific and ineffective medicine. He has no particular expertise in this
area, and there is absolutely no legitimate reason why he should have any
influence over the practice of medicine in the UK. But he is the Prince of
Wales, and he has chosen to use that celebrity to promote CAM.

Prince Charles has also recently been criticized for his credulous support for
medical nonsense. The Telegraph recently reported that Simon Singh, co-author
with Edzard Ernst of Trick or Treatment, and exposer of CAM pseudoscience, spoke
about Prince Charles at the recent Hay Festival in India. Singh had some sharp 
criticism, including:

   He only wants scientific evidence if it backs up his view of the natural
   treatment of health conditions…

   We presented evidence that disputes the value of alternative medicine and
   despite this he hasn’t changed his mind…

Singh’s point is that Prince Charles is ideologically “fixated” on CAM and
natural remedies, and this fixation trumps science and evidence. This seems to
be true, and is not surprising since the psychological evidence suggests that
this is how most people operate most of the time. We are all subject to
confirmation bias and a host of other biases that cause us to hold and defend
our ideological beliefs against disconfirming evidence. It takes a  certain
dedication to the process of science and evidence to overcome these innate
emotional responses.

I would argue that being in an influential position, like the Prince of Wales,
and actually using that influence to advocate for a certain position, comes with
it the responsibility for due diligence – to make sure that the position you
are supporting is valid.

In 1993 Prince Charles founded a Foundation for Integrative Health, whose
mission is to explore:

   “how safe, proven complementary therapies can work in conjunction with
   mainstream medicine”

The statement is very revealing – the Prince wants to show how CAM works and can
be integrated. He does not want to explore if it works. This is not a subtle
difference or quibbling about word choice. This represents a fundamental flaw in
Prince Charles’ approach to the issue. Scientific evidence is a means of
backfilling justification for beliefs he already has, not a tool for
understanding the world and figuring out which medical interventions are safe
and effective.

The Prince is not just an advocate for CAM in the UK, he appears to actively and
effectively lobby for its promotion, or at least removal of science-based
standards that would stand in the way of abject quackery. David Colquhoun
reports on Prince Charles’ lobbying of the MHRA:

   The Medicines and Healthcare products Regulatory Agency (MHRA) is an
   executive agency of the Department of Health). It is roughly the UK
   equivalent of the Food and Drugs Administration (FDA) in the USA.

   The MHRA has just betrayed the trust placed in it by the public by allowing
   untrue claims to be put on the labels of homeopathis and herbal treatments,
   apparently under pressure from the government and the Prince of Wales, as
   described below, and here. The cause such outrage that the MHRA was censured 
   by an annulment debate.in the House of Lords, It also caused condemnations to
   be issued by the many learned societies, most of which you can read at the
   links here. For example, Royal Society, the Medical Research Council, the
   Academy of Medical Sciences, the Royal College of Pathologists, the
   Biosciences Federation (which represents 40 affiliated societies), the
   Physiological Society and the British Pharmacological Society.

Prince Charles has also meddles in the career of Edzard Ernst, the only
professor of complementary and alternative medicine, who has published over 1000
articles examining the evidence (or lack thereof) for specific CAM claims and
modalities. Again David Colquhoun reports:

   A letter was sent from Clarence House to the vice-chancellor of Exeter
   University, Steve Smith. The letter alleged a breach of confidence by Ernst. 
   Having been sent a draft of the Smallwood report, Ernst was so horrified by
   the scientific standards in that document, he felt obliged, in the public
   interest, to speak out about it. Ernst was contacted by a newspaper, which
   had a copy of the draft, and described the initial findings as “outrageous
   and deeply flawed”. He added: “It is based on such poor science, it’s just
   hair-raising. The Prince … also seems to have overstepped his constitutional 
   role”

Ernst was essentially let go from his position, but is now back working part
time.

The Prince of Wales is not only a supporter of dubious health products, like
homeopathy, but sells them as well. His Duchy Original Detox Tincture is a
classic bit of snake oil.

It should be noted that we in the US have our equivalent of Prince Charles, or
at least as close as we can get. Senator Tom Harkin has been as meddling and
effective an advocate for unscientific medicine in the US as Prince Charles has 
been in the UK. Harkin is largely responsible for DSHEA, a terrible law and a
gift to the supplement industry. He is also the power behind the NCCAM, which
has funneled billions of dollars into researching implausible health claims and 
products, with little to show for it except a few studies of herbal remedies
that are useful only in providing evidence for lack of effectiveness. Harkin is 
the source of as many embarrassing quotes as Prince Charles. Regarding the NCCAM
he complained:

   One of the purposes of this center was to investigate and validate
   alternative approaches. Quite frankly, I must say publicly that it has fallen
   short. It think quite frankly that in this center and in the office
   previously before it, most of its focus has been on disproving things rather 
   than seeking out and approving.

We see here the exact same mentality as the Prince – the purpose of spending
billions of dollars of tax payers money is not to find out if highly implausible
methods work, but to demonstrate that they do work. Harkin does not seem to
know how science works, and gives no evidence of caring. We find out which
treatments work by designing studies capable of showing that they do not work.
Only when a treatment passes through several well-designed studies do we begin
to accept them as evidence-based. Harkin apparently wants his pet, the NCCAM, to
spend our money to prove his highly dubious and unscientific ideology to be
correct.

There is a lesson here in the appropriate relationship between politics and
science, and the harm that results when that relationship is abused.

Prince Charles Alternative Medicine Charity Closes

Steven Novella on May 16, 2012

Link

The Princes Foundation for Integrated Health closed shop in 2010. Now the
company that ran the foundation has officially closed. The foundation was a
vanity project by Prince Charles, who had a soft spot for so-called alternative 
medicine and natural therapies. The foundation was established in 1993 and in
the last 19 years has misinformed the public about CAM therapies, promoted
nonsense like homeopathy, and has been an official royal seal of approval on the
anti-science in medicine movement in the UK.

In short the foundation was an excellent example of why political ideology
should not interfere with the normal process of science. The website for the
charity no longer exists, but this is what it said about it’s mission:

   “The Prince’s Foundation for Integrated Health is a UK charity championing an
   integrated approach to health.

   “The Foundation works towards a culture of health and wellbeing with people
   and communities taking more responsibility for their own health, and where
   health professionals collaborate and share learning in the best interests of 
   their patients.

   “Integrated health means an approach to health which:

  1. “emphasises prevention and self-care

  2. “looks at the person in the round, taking into account the effects on health
    of lifestyle, environment and emotional wellbeing

  3. “brings together the safest and most effective aspects of mainstream medical
    science and complementary healthcare.”

This is typical CAM bait and switch. Preventive medicine, healthy lifestyles,
and taking a complete approach to health is not alternative or complementary –
it is part of mainstream science-based medicine. All of that is actually a
misdirection from the real goal of the CAM or “integrative” movement – to
promote health products and services that fail to meet minimal standards of
evidence and plausibility, or which have already been shown to be ineffective.
The Prince’s Foundation was not exception, promoting over the years every form
of quackery from homeopathy to Reiki.

Perhaps the best criticism of the foundation came from Edzard Ernst who wrote:

   He seems to think that the nation should be force-fed on alternative medicine
   today, while research into these treatments might be conducted some time in 
   the future. I, on the other hand, have often pointed out that research has to
   come first; it should sort out the wheat from the chaff and, subsequently,
   we might consider integrating those treatments that demonstrably generate
   more good than harm. I therefore think that the FIH has become a lobby group 
   for unproven and disproven treatments populated by sycophants.

Of course – integrating therapies proven by science is called science-based
medicine. Edzard correctly points out that the purpose of the CAM category is to
put practice before evidence, and even to go against the evidence, or redefine 
what should pass for evidence in medicine.

There was some speculation about what the company might do in the wake of the
Foundation’s closing, but that has now ended with the demise of the company that
funded the charity. When the Foundation closed in 2010 it was amid an
embezzlement scandal. Although the Foundation claimed it was planning on closing
because it had achieved it objective, and just sped up the timetable because of
the allegations. But now those allegations have killed the sponsoring company. 
The Mail online reports:

   The revelation led to the foundation’s finance director George Gray, 50,
   being jailed for three years for embezzling the sum over two years.

   Southwark Crown Court heard how Gray regularly transferred up to £5,000 a
   time from the charity into his bank account to cover payments on his £700,000
   mortgage.

It is heartening to see an organization dedicated to anti-science in medicine go
under, but it is a shame that it took an unrelated scandal to do it. It would
have been better if the Foundation closed because people finally came to their
senses.

In the US we have our own versions of the Prince’s Foundation, namely the
National Center for Complementary and Alternative Medicine (NCCAM) and the
Dietary Supplement Health and Education Act of 1994 (DSHEA). The NCCAM is a
vanity project of its major sponsor, Senator Tom Harkin, as much as the Prince’s
Foundation was a project of Prince Charles. Likewise DSHEA was the result of
the personal ideology of two senators, Harkin and Orin Hatch. The misnamed DSHEA
essentially deregulated the supplement industry, leading to an explosion of
dubious products, an expansion of the multi-billion dollar supplement industry, 
and all without a bit of evidence that there has been any benefit to the health 
of Americans. In fact, it is possible (and I think it’s likely) that there has
been net harm.

It is unfortunate that a few politically powerful individuals can have such a
disproportionate influence on an issue as important as health care. It is also
generally not a good thing when politics or ideology are used to trump science –
and that, at its core, is what CAM is.

